<SEC-DOCUMENT>0001397702-20-000007.txt : 20200302
<SEC-HEADER>0001397702-20-000007.hdr.sgml : 20200302
<ACCEPTANCE-DATETIME>20200302171738
ACCESSION NUMBER:		0001397702-20-000007
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		114
CONFORMED PERIOD OF REPORT:	20191231
FILED AS OF DATE:		20200302
DATE AS OF CHANGE:		20200302

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Silk Road Medical Inc
		CENTRAL INDEX KEY:			0001397702
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				208777622
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38847
		FILM NUMBER:		20678292

	BUSINESS ADDRESS:	
		STREET 1:		1213 INNSBRUCK DR.
		CITY:			SUNNYVALE
		STATE:			CA
		ZIP:			94089-2918
		BUSINESS PHONE:		6505669060

	MAIL ADDRESS:	
		STREET 1:		1213 INNSBRUCK DR.
		CITY:			SUNNYVALE
		STATE:			CA
		ZIP:			94089-2918
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>silk-20191231.htm
<DESCRIPTION>10-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2020 Workiva--><!--r:dad5b714-6959-4e39-8c51-cdabce9e0669,g:fba3822a-5587-4181-9cc4-63667bdb118e,d:58f397e86dfd4fc4ac3b8695cd31238e--><html xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:us-gaap="http://fasb.org/us-gaap/2018-01-31" xmlns:silk="http://silkroadmed.com/20191231" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:srt="http://fasb.org/srt/2018-01-31" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns="http://www.w3.org/1999/xhtml" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:link="http://www.xbrl.org/2003/linkbase"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>silk-20191231</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV80L2ZyYWc6ZTRhZmI2YzM3MzZhNDRkODljY2JhMTMzYmFhOTQyOTIvdGFibGU6Mjc2Mzc0YzUyZGY3NDAxZDg0M2RkNWNjNWZiNDI1MDMvdGFibGVyYW5nZToyNzYzNzRjNTJkZjc0MDFkODQzZGQ1Y2M1ZmI0MjUwM18zLTEtMS0xLTA_be9a71d2-90c2-4465-9140-16e0df67110e">0001397702</ix:nonNumeric><ix:nonNumeric contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" name="dei:CurrentFiscalYearEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV80L2ZyYWc6ZTRhZmI2YzM3MzZhNDRkODljY2JhMTMzYmFhOTQyOTIvdGFibGU6Mjc2Mzc0YzUyZGY3NDAxZDg0M2RkNWNjNWZiNDI1MDMvdGFibGVyYW5nZToyNzYzNzRjNTJkZjc0MDFkODQzZGQ1Y2M1ZmI0MjUwM180LTEtMS0xLTE1OA_90c54837-2187-4928-9c3f-4c7b3b2e61d7">--12-31</ix:nonNumeric><ix:nonNumeric contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV80L2ZyYWc6ZTRhZmI2YzM3MzZhNDRkODljY2JhMTMzYmFhOTQyOTIvdGFibGU6Mjc2Mzc0YzUyZGY3NDAxZDg0M2RkNWNjNWZiNDI1MDMvdGFibGVyYW5nZToyNzYzNzRjNTJkZjc0MDFkODQzZGQ1Y2M1ZmI0MjUwM18xMS0xLTEtMS0xNjA_55e66505-c609-47ff-8b28-f7567dfb7011">2019</ix:nonNumeric><ix:nonNumeric contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV80L2ZyYWc6ZTRhZmI2YzM3MzZhNDRkODljY2JhMTMzYmFhOTQyOTIvdGFibGU6Mjc2Mzc0YzUyZGY3NDAxZDg0M2RkNWNjNWZiNDI1MDMvdGFibGVyYW5nZToyNzYzNzRjNTJkZjc0MDFkODQzZGQ1Y2M1ZmI0MjUwM18xMi0xLTEtMS0xNjA_ac724f30-9e7e-483a-a1d8-b3316db3c011">FY</ix:nonNumeric><ix:nonNumeric contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV80L2ZyYWc6ZTRhZmI2YzM3MzZhNDRkODljY2JhMTMzYmFhOTQyOTIvdGFibGU6Mjc2Mzc0YzUyZGY3NDAxZDg0M2RkNWNjNWZiNDI1MDMvdGFibGVyYW5nZToyNzYzNzRjNTJkZjc0MDFkODQzZGQ1Y2M1ZmI0MjUwM18xMy0xLTEtMS0w_72aa21f6-d268-41f0-be53-adf55b3bc62f">false</ix:nonNumeric><ix:nonFraction unitRef="number" contextRef="i3f5cb6d7533a41b3ab5c731853816aeb_D20190313-20190313" decimals="4" name="us-gaap:StockholdersEquityNoteStockSplitConversionRatio1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8zNTc3L2ZyYWc6YWNhNWQwOTYwNjFiNDAzYTlkM2U3MzRhMGVlMWY2NDkvdGV4dHJlZ2lvbjphY2E1ZDA5NjA2MWI0MDNhOWQzZTczNGEwZWUxZjY0OV8yMTk5MDIzMjU1NTk0_566543a4-ec2d-4104-a87d-ee131c0a5b8e">.3704</ix:nonFraction><ix:nonNumeric contextRef="i047616b3b96f40259dae391a81638613_D20190101-20191231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90ZXh0cmVnaW9uOjZmZWQwNzhkNzVjYTQ1NWU4OTcyY2RkYjU1Nzc0NWRkXzMyOTg1MzQ5NDkxMTE_2fc458bb-3e66-4101-b8da-1c4fb228a229">P3Y</ix:nonNumeric><ix:nonNumeric contextRef="i5fe1f6eae7624d96b5070b1632bdf4d3_D20190101-20191231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90ZXh0cmVnaW9uOjZmZWQwNzhkNzVjYTQ1NWU4OTcyY2RkYjU1Nzc0NWRkXzMyOTg1MzQ5NDkxMTU_fb1b7f55-5035-426c-9941-0c64a4cba092">P5Y</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="silk-20191231.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i8cac1e6fdc7c4cc1b0a6c0885ea13522_I20200228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i67c494a371a04303ae82b13756a123f9_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib1a82135571248368e03bddf4304bc01_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6e1fca0c7e7e4562a33eec6ef093c73f_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i81d78a9636e34b158306cb1e7cf203a5_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0980ae5f9b0d4a1d8d2ded0faf7fb77e_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i875f802c129642f1ba841126240b68a4_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie3817a2997b54e13adbd3f8f1650b444_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i517a0560ef9f4f6a822a0a124dd39744_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i24fdf32d0a37459b9db5fc564063b7f5_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i70437b3fd9084ab18848599576d75854_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i532518b8a5e649659408304a8b441189_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i078a473226e5469f8b43b5c341ea2777_I20180101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201409Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if3906640531a47a789a69ee035108cfd_I20180101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201409Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if7fa5ba84e534af1b2d35b63277a0541_I20180101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201609Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3d970a6f053141c8adef36f595567ea2_I20180101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201609Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibfd8d47f8c2e498f97e7e0e1de986a52_I20180101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201609Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i486e6203c31e4389a7bfae59308a9fdf_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9c2de9078e6d4638b12de94ce89dcf8f_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie5422de912814b909007e41dfe62434c_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i372f9742dd2f42ca8e67497abb64e072_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ide97ade70a5e4b9fb300e7cf6f1de815_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i67b8527276b74fc8b42f80e4649752f6_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i32f0795bc684401e95ede404c8ba027a_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i034315faec014251b182a3d66bbaabaa_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0e663b10e19444c782441b76f73225f8_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i30323612426c417f9cb96084012048a3_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i128760dd6ffe4a6bbcffc708f475df73_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0872d194a51d4edcad754b82ad9b0396_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icc70fdca20a04c6ab43a9d230a3bb9b3_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1ef328d4a82d454f837101558bfddfe2_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2a50ab8679f64d4e9e5c5ef5f5850abf_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1fa63ac295464df58c38a6649e35436f_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4e66b2f70f744286ad2b2575bbd8de82_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i92a29de035d648249198240ca0cb4b8b_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iec5a27c85b024faeaa754c4a163a1274_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i52088a0c6adf42bd8f967682ae5eabef_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7462368c462e4bd490bca37af6860f56_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i183f22ec2ae24c28af10423035463332_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">silk:RedeemableConvertiblePreferredStockWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3b88e1cc16544cd09f30471712be03e7_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">silk:RedeemableConvertiblePreferredStockWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6392e7d9184e4e68a1862ac1a23c3c37_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">silk:CommonStockWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ief833aecb87341158807940d3631f438_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">silk:CommonStockWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i61f1ed462e8447ffab9c8334784ff07d_D20190401-20190430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6ed3f43f8f3b4ec3b256ad182faa9d25_I20190430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iba3487b4fc2c4dce923c5b7f62c0537c_D20190401-20190430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">silk:IPOUnderwritingDiscountsAndCommissionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iee7e39f90c474f35b760d777c5110c8f_D20190401-20190430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">silk:IPOOtherExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3ff09a6410f6470c9bc375b415065a88_D20190801-20190831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">silk:SecondPublicOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-08-01</xbrli:startDate><xbrli:endDate>2019-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2cf16617a08a49c5ba94c598a0c73b8e_D20190801-20190831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-08-01</xbrli:startDate><xbrli:endDate>2019-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8c8377ba457f49a9969abe8f8a528e68_I20190831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">silk:SecondPublicOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i3f5cb6d7533a41b3ab5c731853816aeb_D20190313-20190313"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-03-13</xbrli:startDate><xbrli:endDate>2019-03-13</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i733162f186ac41fb8f9b99aa842ef13f_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">silk:CorrectionOfProvisionsForReturnsFromCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iec135774dba44b3cb207fe343988137e_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia68f07ad6fdb42d6837b98ba4cba8d55_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i047616b3b96f40259dae391a81638613_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5fe1f6eae7624d96b5070b1632bdf4d3_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0f51c2607db4468eba9bb514ae0e4471_I20190101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201602Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic94e339422444d219c38d07bb9e37715_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2e1fe8d050bb4a7b9f6556eaab0f6abd_I20190101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201602Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2fe97d6c47914971bb09d925222705a9_I20190101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i098a8c90a714485c88e5e439c93fd1fe_D20190501-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-05-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2658f65419d24aacb4ed4233d75211b7_D20190501-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-05-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2a4cd45d3ea346e09975b91b19f7932f_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9b9b073cbf81459fbce0e491293244fd_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibd915c83c8b6404bb5a637937ffca6c6_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">silk:RedeemableConvertiblePreferredStockWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia72cde864bbc4dc18c35b893b41f4dec_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">silk:RedeemableConvertiblePreferredStockWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i869e207d48f649aba79d5a398971f471_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie37285cde19b46798cf9ecb3d7e8e7ce_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i41b8867a9c614370bb9151a0da07f34d_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">silk:CommonStockWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8ca29bbf162449f8b42d0edd6cafd993_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">silk:CommonStockWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="segment"><xbrli:measure>silk:segment</xbrli:measure></xbrli:unit><xbrli:context id="i11a85190a9064adf9756e907b72ab81e_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iea42b3ddd43e48b7ad739160a6355912_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8eda7181425346cbb7f781c8cd52aefd_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3154f26e217748508ca43b15910d4ab7_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i82c527872b3d4fd290ad3917440837f9_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i515b5eafffb247339a3b64d3ae67d43b_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7a1d59cac7d948139b04deae23e13fb8_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib459ddf8987d4fc0a4427c93f88a000a_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i692d279131c24a49ba70cd82d78e0497_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib7b24582c8bf49e99df758604eab3abb_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i506cf4e4add641df967ba7f06a1bfa17_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i34e6e9e2e2974a8f804997693d613758_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iadf6d107d54849849c8bd9ee571aaf22_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iff1b3fd1a5a741808c1bfd931652d7a4_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia337a287632c4d2aa7cecbd25f4f1784_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie66ece3747d34884887e66fe24d152f1_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8de1bb3daed54738a88a86d2689b10ce_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i19e0a6db758545d68ed21b0a945cc60f_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id10e93e4a6cc4706bff1d8eb9e0dad18_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idcfab15292df4659a682cf4c3e009b01_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5ffa4f8eee864a558fefbc3fc931f9eb_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id62c0d16fbf34863a1344fb61a82dc68_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3ff608b2639149898494a31eaf193271_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5fae0f510baf4fbcb8ab06bb60002490_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idd88a7fb35bc4bbfb9f94fdef50dfdef_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib9c2e225f695462c85b06ffc0db23f77_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i49a7a83783f84c3982d721d07ccbada7_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9beac03666384655936e1b43302c9e0d_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2cf6f35566bc4706a43eaf580cce3381_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i751eabc279934cf590084b42a75319d8_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i682c50ee10764018a2a9d81b7a596283_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if488b5abfdda4d3a8085d2171b9717d8_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if244f20dd62e4eb5ac07166f1d16fcc1_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i48e873776ce54fb78ea86ee6468dd7ce_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1c2894de35e642cab6de34c3ff5418b2_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputOptionVolatilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7493e1ba4b784b10bbdb551639b996d8_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6f1f166882e84b0d80d658c2f7290c71_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i73355ec5b9114196885f43773e313806_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountForLackOfMarketabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i75704913843f46ea87de6f08f1952574_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id719d5cbdbe541ab86698a19fee6fb0d_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i02820e2a66c44977989d03b1fffaede1_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2f9bf5b113a1441481893ba9f910f9cf_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i507134e9c9aa43a28501de3b98f309ca_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0d613bf9b2a14909a35df00d8a23da58_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i24c078f64bcf4a558a6eb9707a027214_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic83cfde8eac24427a5b7c49a8127d817_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">silk:LongTermInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i865a5a03baaf4a64b9eb712f44655277_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5b1c140e3f174d628388c3f67f069432_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ief7e81456214489ba291e117b1b06060_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibf79c9f5d41a43c0bbf17c7e0f0f94d7_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2cdfbb16655f454e85b113e66702358b_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i54b13dd93afe499f9eda02e58485e8ba_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3eb7140b29f74c85bd43c66d2cab8f1d_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibe305b8c4cc94fa5a038d2f95ad17a9b_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9c7143f51286457db347c4a2163a630d_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1ccf70059f7d4165acf299107d6c8761_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id62906738f144d84bc9d557ddc169284_I20151031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">silk:TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2015-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id77e08ef6b1e4d26923913e53db9186d_I20151031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">silk:TermLoanTrancheAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2015-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i16c13b04e0bd4554b32d832a2eee0af3_I20151031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">silk:TermLoanTrancheBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2015-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1ad5b6c72b9d43eb9409533a1389160e_I20170430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">silk:TermLoanTrancheBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i77aa0ed0241849f98e4736227590410c_I20180930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">silk:TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i96c7f06d98d442a59802339444e89dae_D20180901-20180930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">silk:TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-01</xbrli:startDate><xbrli:endDate>2018-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i54b82514b8694d3b98494d64e98b4745_I20180930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2018-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7ac0d334898e4fb1897fd7e5822858ab_D20160101-20161231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2016-01-01</xbrli:startDate><xbrli:endDate>2016-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i28c5cd5abfce4c7aa5c44b0f651c9ad8_D20170101-20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2017-01-01</xbrli:startDate><xbrli:endDate>2017-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i24d31e2c272041379e7662e50a4130b0_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">us-gaap:ScenarioForecastMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4225226f93604e02af259bb86559e5b8_D20151001-20151031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2015-10-01</xbrli:startDate><xbrli:endDate>2015-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5675339c673448139076ebcb2b762771_I20151031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2015-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i69a4c0c247dc496998d701bc90ebe115_I20151031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">silk:PreferredStockWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2015-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6665fb41539543faa5c665e0459d1cf6_D20170701-20170731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-07-01</xbrli:startDate><xbrli:endDate>2017-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4c8c2ee5923d47dfb022beb8e861a8c5_I20170731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7f1961a81c2146ba86c1873951eb5d0f_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idef65aa8bbea40b3adcc724c6f06297a_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">silk:SeriesA1PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4afaed3dd6794f36b67d203a6ae5b570_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i12798862adb04861a6ae8feb9c091437_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0002f1df204e4ba9aec2b7e505502fde_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4be1e55866334204b2d9b1643c2315e7_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i85f16463983d4272b900d0242c5a7b00_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">silk:PreferredStockWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3fd781122bcd466f8d1f4fc674767318_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">silk:PreferredStockWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iea7780a1616443f08f0fda6ff705a8ec_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">silk:PreferredStockWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="vote"><xbrli:measure>silk:vote</xbrli:measure></xbrli:unit><xbrli:context id="i7e4541352c2a44929295cae86c4b2a1c_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i22fe2abf909a4987bfe246f58fedaf54_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">silk:SeriesA1PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib7e1120b4a744e978a8b7a345369d7a5_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib86a3e190d06442abdb93108d5a238e6_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic4860da07e274940b7dda28b5b824fd4_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">silk:IncentiveandNonqualifiedStockOptionExercisedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i447ce34fe05a46278994221dbd0e0819_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">silk:IncentiveandNonqualifiedStockOptionExercisedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3dcad0503bdf4e5eba8e00589d3e2a59_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">silk:IncentiveandNonqualifiedStockOptionIssuedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i88bdc53e6793436cb3ebaa916528f65b_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">silk:IncentiveandNonqualifiedStockOptionIssuedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib065e570d4804ab887f6bb6e1fec5a75_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">silk:EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idaa6eb381396400786f1ca3efdf5b014_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">silk:EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7c6d2473a2234f6fae9d4b0c9b650a4f_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">silk:CommonStockWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1add56f0eae7469e989ed855f525f96b_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">silk:CommonStockWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if8633988d4034e2c837d8cfec30261f2_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">silk:CommonStockWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9b5314b8f65d48ffb39568a32e1ae70e_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">silk:TwoThousandNineteenStockOptionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5c3d2d26b9a1456fa6a38583e15b0dee_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">silk:TwoThousandNineteenStockOptionPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id374ce4879bf48d69346a02ab7b52f9e_D20190301-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">silk:TwoThousandNineteenStockOptionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-03-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i188f88bd74544c788b5f388916b2ffd9_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">silk:TwoThousandNineteenStockOptionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4579105f1eae463bbc80b9182ebdface_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">silk:IncentiveStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i09b415be50aa4620acbb4b68a3d03255_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">silk:NonqualifiedStockOptionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie740d91c6b54459faa35c174c4cc3dbe_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">silk:IncentiveandNonqualifiedStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:PrincipalOwnerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0ca865b5bbab452998af805b9a59eb9a_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">silk:IncentiveandNonqualifiedStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaa805919be064beda12a6545c3d07fcd_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">silk:ExercisePriceOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8d08513aaa4d42039e2e5145986ff348_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">silk:ExercisePriceOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9168c8a79f074245b359c1eabebd2867_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">silk:ExercisePriceOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6cf6ea883ee84acc9631ce618bef5f1c_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">silk:ExercisePriceOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6e1de668b6f54e6f9e86b8d5f1188b44_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">silk:ExercisePriceTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaec558563b4843c5b260f5fe73e22f01_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">silk:ExercisePriceTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0e5c6cb252b942de9df54fcafdb03c57_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">silk:ExercisePriceTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8e43b208e0754e78903aecd89161bdcb_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">silk:ExercisePriceTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iee86434ad814473fa2012397d08d7c63_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">silk:ExercisePriceThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idb8741dc808745c1ac9cfaa8b95bf8c6_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">silk:ExercisePriceThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i580ea82051b046c086a55b23cbe96b48_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">silk:ExercisePriceThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia1a2680b0c4640b4a319ee060427817d_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">silk:ExercisePriceThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4a6ce09ec8ba42acab7925c328fd9e56_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">silk:ExercisePriceFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i36d7682595324850a7a7a098e56bcdd5_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">silk:ExercisePriceFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i80e1df55cd6f4ff3a796ff102aa5ac3c_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">silk:ExercisePriceFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ide54ca5d5c78499cb82e54623e321d1d_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">silk:ExercisePriceFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7d7592590c814df5ad461b54e146b3b9_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9e2e6766734d4127a261bbe5ec027002_D20190301-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-03-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib91f8a2aac654fce98f1b02f8c99f196_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8b3d2f66951844b589a808406d5fb193_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i10afc7fc69ce46cd8b9478e8ac0d56b0_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0804bae1f65e4f6196a788f2e067af2c_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i859497a16f11489db5d922955dbeed5d_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8918167e82b447cfb3b692315e36731e_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0ac3add721de4c95964529b527a87faf_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if3367b49450540498cf774db610f6b6b_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i053d16b53cd8429ca7577e64137c4073_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic9a24cc8c2884fee93b26726701eda19_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id2b8c23dfe7b4a01a7eab1d91fe07c43_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i679bcaee6cf74e85907dc8a0359cf4fd_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7a5998ad299245269f1d4f24167005aa_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i67c3f66fec9c4c4387a07595b56bd76b_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if8375b4a63c74b3f9a8c71549841fb7e_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7a626cb9bbb248679c22a7a00441bdd3_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i43fdc98e9d1c4ea183dc2c37ade70da5_I20141231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">silk:NeuroCoIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2014-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic91bbe5141184edf9c4a395e69721932_D20140101-20141231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">silk:NeuroCoIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2014-01-01</xbrli:startDate><xbrli:endDate>2014-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0e7714d1fef74572b8628cbea233e040_D20150101-20151231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">silk:NeuroCoIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2015-01-01</xbrli:startDate><xbrli:endDate>2015-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaf615eabb3f14a45afa67326aa12db72_I20181217"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">silk:NeuroCoIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-17</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if64e9115ac9b48a7b91422658f25ee6d_D20181217-20181217"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">silk:NeuroCoIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-17</xbrli:startDate><xbrli:endDate>2018-12-17</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i129f46ce6e8d4fa98d362bb8455a8c28_I20181217"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2018-12-17</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie7d5bfb4355c4753b62069b31a28328b_D20200101-20200101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-01-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if8352f2dec42436aa6815358749e14c2_I20200131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">silk:TwoThousandNineteenStockOptionPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8e407444496e48f09abc6f0747a028bc_D20200201-20200229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">silk:TwoThousandNineteenStockOptionPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-02-01</xbrli:startDate><xbrli:endDate>2020-02-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i36441150a0d742e990ee101edcbe8518_I20200131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4e27136927b743769274f523ec2a41e7_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icd407c3335324384be91497048cf5f08_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i88f7bdc9a6e24592abadfd8d6f1e1bc0_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie6ccdb76509c4f75a0d36602c75f6151_D20190101-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3efe8595a2ad4f2991c93a7d62cff16f_D20181001-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2018-10-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i93f9aed079644f15b2c34904c4aaa35c_D20180701-20180930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2018-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if2a4604d433c48d698f29d76aa7a770b_D20180401-20180630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2018-04-01</xbrli:startDate><xbrli:endDate>2018-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4209466b8e53444e9359f5893b730654_D20180101-20180331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001397702</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-03-31</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i58f397e86dfd4fc4ac3b8695cd31238e_1"></div><div style="height:9pt;width:100%;"><div style="text-indent:18pt;margin-bottom:9pt;"><span><br/></span></div></div><div style="text-align:right;"><span><br/></span></div><div style="text-align:right;margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:98.000%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="height:3pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td></tr></table></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;">UNITED STATES</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;">SECURITIES AND EXCHANGE COMMISSION </span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Washington, D.C. 20549 </span></div><div style="text-align:center;margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:36.834%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:20.330%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:36.836%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="height:3pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-bottom:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr></table></div><div style="text-align:center;margin-bottom:2pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:15pt;font-weight:700;line-height:120%;">FORM <ix:nonNumeric contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xL2ZyYWc6ZDc4MGVjNWIyZWRlNDg0ZmFlMzU5ODlmOGEzYWY0MjYvdGV4dHJlZ2lvbjpkNzgwZWM1YjJlZGU0ODRmYWUzNTk4OWY4YTNhZjQyNl8yMTk5MDIzMjU5Mzcy_e865568b-a7eb-409c-844d-8ef36e9b35ae">10-K</ix:nonNumeric></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">(Mark One)</span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:0.1%;"></td><td style="width:2.438%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:95.362%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial Unicode MS',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" format="ixt-sec:boolballotbox" name="dei:DocumentAnnualReport" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xL2ZyYWc6ZDc4MGVjNWIyZWRlNDg0ZmFlMzU5ODlmOGEzYWY0MjYvdGFibGU6NWYwMWE1ZmE1NDk2NGQ0OTk2YWY1NDcxY2I0MzExODAvdGFibGVyYW5nZTo1ZjAxYTVmYTU0OTY0ZDQ5OTZhZjU0NzFjYjQzMTE4MF8wLTAtMS0xLTI5_1fdd0a1a-88b4-4458-bd57-87754fe0f458">&#9746;</ix:nonNumeric></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;">For the fiscal year ended </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"><ix:nonNumeric contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xL2ZyYWc6ZDc4MGVjNWIyZWRlNDg0ZmFlMzU5ODlmOGEzYWY0MjYvdGV4dHJlZ2lvbjpkNzgwZWM1YjJlZGU0ODRmYWUzNTk4OWY4YTNhZjQyNl8yMTk5MDIzMjU5Mzc4_09297cd7-b6b9-4a8d-8729-bfe3fd1d5653">December 31, 2019</ix:nonNumeric></span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;"> .</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;">OR</span></div><div style="text-align:center;margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:0.1%;"></td><td style="width:2.438%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:95.362%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial Unicode MS',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" format="ixt-sec:boolballotbox" name="dei:DocumentTransitionReport" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xL2ZyYWc6ZDc4MGVjNWIyZWRlNDg0ZmFlMzU5ODlmOGEzYWY0MjYvdGFibGU6ODFlOTg2ODc3YjIxNDY3ZGFmYTQ0MDYxZmNiOWU4MmUvdGFibGVyYW5nZTo4MWU5ODY4NzdiMjE0NjdkYWZhNDQwNjFmY2I5ZTgyZV8wLTAtMS0xLTMx_1d8d38ae-6f2e-4caf-9bec-c8ce199d3468">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="text-align:center;margin-bottom:3pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;">For the transition period from      to      </span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;">Commission File Number: <ix:nonNumeric contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xL2ZyYWc6ZDc4MGVjNWIyZWRlNDg0ZmFlMzU5ODlmOGEzYWY0MjYvdGV4dHJlZ2lvbjpkNzgwZWM1YjJlZGU0ODRmYWUzNTk4OWY4YTNhZjQyNl8yMTk5MDIzMjU5Mzk2_9e18b081-9f3b-4e13-8733-0720b1565d33">001-38847</ix:nonNumeric></span></div><div style="text-align:center;margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:36.834%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:20.330%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:36.836%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="height:3pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-bottom:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr></table></div><div style="text-align:center;margin-bottom:2pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:15pt;font-weight:700;line-height:120%;"><ix:nonNumeric contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xL2ZyYWc6ZDc4MGVjNWIyZWRlNDg0ZmFlMzU5ODlmOGEzYWY0MjYvdGV4dHJlZ2lvbjpkNzgwZWM1YjJlZGU0ODRmYWUzNTk4OWY4YTNhZjQyNl8yMTk5MDIzMjU5Mzk4_90daeb3d-2f74-47ff-a3b9-0389bb80861d">SILK ROAD MEDICAL, INC.</ix:nonNumeric></span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:120%;">(Exact name of registrant as specified in its charter) </span></div><div style="text-align:center;margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:36.834%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:20.330%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:36.836%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="height:3pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-bottom:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr></table></div><div style="margin-bottom:3pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:1pt;font-weight:400;line-height:120%;"> </span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:31.333%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:31.333%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:31.334%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xL2ZyYWc6ZDc4MGVjNWIyZWRlNDg0ZmFlMzU5ODlmOGEzYWY0MjYvdGFibGU6YWM3MDE2Mjk5ZWY3NDc0ZGJjY2MwZmM2ZmM4ZWNkYTkvdGFibGVyYW5nZTphYzcwMTYyOTllZjc0NzRkYmNjYzBmYzZmYzhlY2RhOV8wLTAtMS0xLTUw_37377075-47e1-46b5-aafa-7f80d558b493">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3841</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xL2ZyYWc6ZDc4MGVjNWIyZWRlNDg0ZmFlMzU5ODlmOGEzYWY0MjYvdGFibGU6YWM3MDE2Mjk5ZWY3NDc0ZGJjY2MwZmM2ZmM4ZWNkYTkvdGFibGVyYW5nZTphYzcwMTYyOTllZjc0NzRkYmNjYzBmYzZmYzhlY2RhOV8wLTItMS0xLTUz_d8c63871-000a-48ea-86ab-e43ce3c70f7f">20-8777622</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%;">(State or other jurisdiction of</span></div><div style="text-align:center;margin-bottom:1pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%;">incorporation or organization)</span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Primary Standard Industrial<br/>Classification Code Number)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(I.R.S. Employer<br/>Identification Number)</span></td></tr></table></div><div style="text-align:center;margin-bottom:2pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:7.58pt;font-weight:700;line-height:120%;"><ix:nonNumeric contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xL2ZyYWc6ZDc4MGVjNWIyZWRlNDg0ZmFlMzU5ODlmOGEzYWY0MjYvdGV4dHJlZ2lvbjpkNzgwZWM1YjJlZGU0ODRmYWUzNTk4OWY4YTNhZjQyNl8yMTk5MDIzMjU5NDIz_fbf61baf-ba58-45a4-bb8c-c415b80efef5">1213 Innsbruck Dr.</ix:nonNumeric> <ix:nonNumeric contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xL2ZyYWc6ZDc4MGVjNWIyZWRlNDg0ZmFlMzU5ODlmOGEzYWY0MjYvdGV4dHJlZ2lvbjpkNzgwZWM1YjJlZGU0ODRmYWUzNTk4OWY4YTNhZjQyNl8yMTk5MDIzMjU5NDQz_99cc0b41-a791-46c4-996a-d9bcd21a5bdd">Sunnyvale</ix:nonNumeric>, <ix:nonNumeric contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xL2ZyYWc6ZDc4MGVjNWIyZWRlNDg0ZmFlMzU5ODlmOGEzYWY0MjYvdGV4dHJlZ2lvbjpkNzgwZWM1YjJlZGU0ODRmYWUzNTk4OWY4YTNhZjQyNl8yMTk5MDIzMjU5NDU0_c6d28b3e-9a7a-4c7d-86b8-8473fd94f66c">CA</ix:nonNumeric> <ix:nonNumeric contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xL2ZyYWc6ZDc4MGVjNWIyZWRlNDg0ZmFlMzU5ODlmOGEzYWY0MjYvdGV4dHJlZ2lvbjpkNzgwZWM1YjJlZGU0ODRmYWUzNTk4OWY4YTNhZjQyNl8yMTk5MDIzMjU5NDU4_259482e4-bc64-4e5d-a610-959ec0dcc533">94089</ix:nonNumeric>, (<ix:nonNumeric contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xL2ZyYWc6ZDc4MGVjNWIyZWRlNDg0ZmFlMzU5ODlmOGEzYWY0MjYvdGV4dHJlZ2lvbjpkNzgwZWM1YjJlZGU0ODRmYWUzNTk4OWY4YTNhZjQyNl8yMTk5MDIzMjU5NDY1_b3d8e34f-121b-4111-ae36-2889a1372f2a">408</ix:nonNumeric>) <ix:nonNumeric contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xL2ZyYWc6ZDc4MGVjNWIyZWRlNDg0ZmFlMzU5ODlmOGEzYWY0MjYvdGV4dHJlZ2lvbjpkNzgwZWM1YjJlZGU0ODRmYWUzNTk4OWY4YTNhZjQyNl8yMTk5MDIzMjU5NDcw_ccbd7f36-0e21-4d2e-9957-14f0c8208a5f">720-9002</ix:nonNumeric> </span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:7.58pt;font-weight:700;line-height:120%;">(Address, including zip code, and telephone number, including area code, of registrant&#8217;s principal executive offices)</span></div><div style="text-align:center;margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:36.834%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:20.330%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:36.836%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="height:3pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-bottom:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr></table></div><div style="text-align:center;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="text-align:center;margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:36.333%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:21.333%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:36.334%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Title of each class</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Trading Symbol(s)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xL2ZyYWc6ZDc4MGVjNWIyZWRlNDg0ZmFlMzU5ODlmOGEzYWY0MjYvdGFibGU6ZmIyMGU1MTQzOGNlNDExZGI3NTgyYWVjNWYzNjRhYjcvdGFibGVyYW5nZTpmYjIwZTUxNDM4Y2U0MTFkYjc1ODJhZWM1ZjM2NGFiN18xLTAtMS0xLTg5_bf900797-f1f8-42a3-95da-eedbc0921764">Common Stock</ix:nonNumeric></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xL2ZyYWc6ZDc4MGVjNWIyZWRlNDg0ZmFlMzU5ODlmOGEzYWY0MjYvdGFibGU6ZmIyMGU1MTQzOGNlNDExZGI3NTgyYWVjNWYzNjRhYjcvdGFibGVyYW5nZTpmYjIwZTUxNDM4Y2U0MTFkYjc1ODJhZWM1ZjM2NGFiN18xLTEtMS0xLTg5_ab16aa04-c7f4-4636-a0ee-9c454147a304">SILK</ix:nonNumeric></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xL2ZyYWc6ZDc4MGVjNWIyZWRlNDg0ZmFlMzU5ODlmOGEzYWY0MjYvdGFibGU6ZmIyMGU1MTQzOGNlNDExZGI3NTgyYWVjNWYzNjRhYjcvdGFibGVyYW5nZTpmYjIwZTUxNDM4Y2U0MTFkYjc1ODJhZWM1ZjM2NGFiN18xLTItMS0xLTg5_ec205080-a0e7-450e-ac66-c958afc0669c">Nasdaq Global Market</ix:nonNumeric></span></td></tr></table></div><div style="padding-left:18pt;"><span><br/></span></div><div style="text-indent:18pt;text-align:center;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Securities registered pursuant to Section 12(g) of the Act:</span></div><div style="text-indent:18pt;text-align:center;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">None</span></div><div style="text-indent:18pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.</span></div><div style="text-indent:18pt;text-align:right;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Yes&#160;&#160;&#9744;&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" name="dei:EntityWellKnownSeasonedIssuer" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xL2ZyYWc6ZDc4MGVjNWIyZWRlNDg0ZmFlMzU5ODlmOGEzYWY0MjYvdGV4dHJlZ2lvbjpkNzgwZWM1YjJlZGU0ODRmYWUzNTk4OWY4YTNhZjQyNl8yMTk5MDIzMjU5NDgw_8fda091a-320c-4131-8110-d2e364e2b86c">No</ix:nonNumeric>&#160;&#160;&#9746;</span></div><div style="text-indent:18pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</span></div><div style="text-indent:18pt;text-align:right;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Yes&#160;&#160;&#9744;&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" name="dei:EntityVoluntaryFilers" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xL2ZyYWc6ZDc4MGVjNWIyZWRlNDg0ZmFlMzU5ODlmOGEzYWY0MjYvdGV4dHJlZ2lvbjpkNzgwZWM1YjJlZGU0ODRmYWUzNTk4OWY4YTNhZjQyNl8yMTk5MDIzMjU5NDg0_d9a9ec7e-0977-45bd-b420-1d364d9d9831">No</ix:nonNumeric>&#160;&#160;&#9746;</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xL2ZyYWc6ZDc4MGVjNWIyZWRlNDg0ZmFlMzU5ODlmOGEzYWY0MjYvdGV4dHJlZ2lvbjpkNzgwZWM1YjJlZGU0ODRmYWUzNTk4OWY4YTNhZjQyNl8yMTk5MDIzMjU5NDg4_c050a95e-b55f-477e-9d7c-62da049824af">Yes</ix:nonNumeric>&#160;&#160;&#9746;   No&#160;&#160;&#9744;</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xL2ZyYWc6ZDc4MGVjNWIyZWRlNDg0ZmFlMzU5ODlmOGEzYWY0MjYvdGV4dHJlZ2lvbjpkNzgwZWM1YjJlZGU0ODRmYWUzNTk4OWY4YTNhZjQyNl8yMTk5MDIzMjU5NDkz_bc3eae4e-cb48-4024-86a9-fc3e6ccdc916">Yes</ix:nonNumeric>&#160;&#160;&#9746;&#160;&#160;&#160;&#160;No&#160;&#160;&#9744;</span></div><div style="text-indent:18pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer&#8221;, &#8220;smaller reporting company&#8221;, and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act. (Check one):</span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:21.333%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:2.577%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:45.777%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:21.333%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:2.580%;"></td><td style="width:0.1%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Large&#160;accelerated&#160;filer</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial Unicode MS',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#9744;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accelerated filer</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial Unicode MS',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#9744;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xL2ZyYWc6ZDc4MGVjNWIyZWRlNDg0ZmFlMzU5ODlmOGEzYWY0MjYvdGFibGU6Y2E2N2IxOGMxNWFkNGExN2EzYjYwNWMzYjg2ZmY1NjUvdGFibGVyYW5nZTpjYTY3YjE4YzE1YWQ0YTE3YTNiNjA1YzNiODZmZjU2NV8xLTAtMS0xLTEyNQ_fa8c3c15-174a-4318-9f77-f402fb1e87d4">Non-accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial Unicode MS',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#9746;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Smaller&#160;reporting&#160;company</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial Unicode MS',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" format="ixt-sec:boolballotbox" name="dei:EntitySmallBusiness" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xL2ZyYWc6ZDc4MGVjNWIyZWRlNDg0ZmFlMzU5ODlmOGEzYWY0MjYvdGFibGU6Y2E2N2IxOGMxNWFkNGExN2EzYjYwNWMzYjg2ZmY1NjUvdGFibGVyYW5nZTpjYTY3YjE4YzE1YWQ0YTE3YTNiNjA1YzNiODZmZjU2NV8xLTQtMS0xLTEyOQ_1a4e2b99-d8e6-4597-995c-a3d0a9459ba2">&#9746;</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Emerging growth company</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial Unicode MS',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xL2ZyYWc6ZDc4MGVjNWIyZWRlNDg0ZmFlMzU5ODlmOGEzYWY0MjYvdGFibGU6Y2E2N2IxOGMxNWFkNGExN2EzYjYwNWMzYjg2ZmY1NjUvdGFibGVyYW5nZTpjYTY3YjE4YzE1YWQ0YTE3YTNiNjA1YzNiODZmZjU2NV8yLTEtMS0xLTEyNw_63a35599-3d7a-4e0d-aefd-3ebeea3e1a9c">&#9746;</ix:nonNumeric></span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr></table></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act.&#160;&#160;<ix:nonNumeric contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" format="ixt-sec:boolballotbox" name="dei:EntityExTransitionPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xL2ZyYWc6ZDc4MGVjNWIyZWRlNDg0ZmFlMzU5ODlmOGEzYWY0MjYvdGV4dHJlZ2lvbjpkNzgwZWM1YjJlZGU0ODRmYWUzNTk4OWY4YTNhZjQyNl8yMTk5MDIzMjU5NDk4_256e50f3-ef31-4f96-82db-db84c6af46b1">&#9746;</ix:nonNumeric></span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes  <ix:nonNumeric contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" format="ixt-sec:boolballotbox" name="dei:EntityShellCompany" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xL2ZyYWc6ZDc4MGVjNWIyZWRlNDg0ZmFlMzU5ODlmOGEzYWY0MjYvdGV4dHJlZ2lvbjpkNzgwZWM1YjJlZGU0ODRmYWUzNTk4OWY4YTNhZjQyNl8yMTk5MDIzMjU5NTAx_284cee9b-ff2d-4997-9660-43a5935af3fb">&#9744;</ix:nonNumeric> No  &#9746;</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The aggregate market value of the registrant&#8217;s common stock held by non-affiliates of the registrant was approximately $<ix:nonFraction unitRef="usd" contextRef="i8cac1e6fdc7c4cc1b0a6c0885ea13522_I20200228" decimals="-5" format="ixt:numdotdecimal" name="dei:EntityPublicFloat" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xL2ZyYWc6ZDc4MGVjNWIyZWRlNDg0ZmFlMzU5ODlmOGEzYWY0MjYvdGV4dHJlZ2lvbjpkNzgwZWM1YjJlZGU0ODRmYWUzNTk4OWY4YTNhZjQyNl8yMTk5MDIzMjYwMzky_8968b99f-da47-4f0b-af81-f2ba38864d0e">818.0</ix:nonFraction>&#160;million as of February 28, 2020 based on the closing sale price of the registrant&#8217;s common stock on </span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">the NASDAQ Global Market on such date.  Shares held by persons who may be deemed affiliates have been excluded.  This determination of affiliate status is not necessarily a conclusive determination for other purposes.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">As of February 28, 2020</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">, t</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">he number of outstanding shares of the registrant's common stock, par value $0.001 per share, was <ix:nonFraction unitRef="shares" contextRef="i8cac1e6fdc7c4cc1b0a6c0885ea13522_I20200228" decimals="INF" format="ixt:numdotdecimal" name="dei:EntityCommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xL2ZyYWc6ZDc4MGVjNWIyZWRlNDg0ZmFlMzU5ODlmOGEzYWY0MjYvdGV4dHJlZ2lvbjpkNzgwZWM1YjJlZGU0ODRmYWUzNTk4OWY4YTNhZjQyNl8yMTk5MDIzMjU5NTA0_a129f2c6-a2b3-4d72-9f34-0dfd7b07edf7">31,353,906</ix:nonFraction>.</span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:98.000%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="height:3pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td></tr></table></div><div><span><br/></span></div><div id="i58f397e86dfd4fc4ac3b8695cd31238e_7"></div><div style="position:relative;width:100%;height:9pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-indent:18pt;margin-bottom:9pt;"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><div style="text-align:center;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;">TABLE OF CONTENTS</span></div><div style="text-align:center;margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:10.000%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:77.840%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:6.160%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Page</span></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_10">Part I</a></span></div></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_13">Item 1.</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_13">Business</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:right;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_13">4</a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_16">Item 1A.</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_16">Risk Factors</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:right;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_16">52</a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_19">Item 1B.</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_19">Unresolved Staff Comments</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:right;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_19">96</a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_22">Item 2. </a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_22">Properties</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:right;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_22">96</a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_25">Item 3.</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_25">Legal Proceedings</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:right;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_25">96</a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_28">Item 4.</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_28">Mine Safety Disclosures</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:right;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_28">96</a></span></div></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_31">Part II</a></span></div></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_34">Item 5.</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_34">Market for Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:right;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_34">97</a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_37">Item 6.</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_37">Selected Financial Data</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:right;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_37">99</a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_40">Item 7.</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_40">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:right;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_40">101</a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_43">Item 7A.</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_43">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:right;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_43">111</a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_46">Item 8.</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_46">Financial Statements and Supplementary Data</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:right;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_46">112</a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_49">Item 9.</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_49">Changes in and Disagreements With Accountants on Accounting and Financial Disclosure</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:right;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_49">147</a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_52">Item 9A.</a></span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"> </span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_52">Controls and Procedures</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:right;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_52">148</a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_55">Item 9B.</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_55">Other Information</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:right;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_55">149</a></span></div></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_58">Part III</a></span></div></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_61">Item 10.</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_61">Directors, Executive Officers and Corporate Governance</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:right;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_61">150</a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_64">Item 11.</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_64">Executive Compensation</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:right;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_64">158</a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_67">Item 12.</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_67">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:right;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_67">174</a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_70">Item 13.</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_70">Certain Relationships and Related Transactions, and Director Independence</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:right;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_70">176</a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_73">Item 14.</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_73">Principal Accounting Fees and Services</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:right;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_73">178</a></span></div></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_76">Part IV</a></span></div></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_79">Item 15.</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_79">Exhibits and Financial Statement Schedules</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:right;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_79">179</a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_262">Item 16.</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_262">Form 10-K Summary</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:right;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_262">182</a></span></div></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_265">Signatures</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:right;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_265">182</a></span></div></td></tr></table></div><div style="text-indent:18pt;margin-bottom:9pt;"><span><br/></span></div><div style="margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:35.120%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:23.760%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:35.120%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="height:3pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-bottom:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr></table></div><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div style="text-align:center;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;">CAUTIONARY NOTES REGARDING FORWARD-LOOKING STATEMENTS</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">This Annual Report on Form 10-K contains forward-looking statements concerning our business, operations and financial performance and condition, as well as our plans, objectives and expectations for our business, operations and financial performance and condition. Any statements contained herein that are not statements of historical facts may be deemed to be forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as &#8220;anticipate,&#8221; &#8220;assume,&#8221; &#8220;believe,&#8221; &#8220;contemplate,&#8221; &#8220;continue,&#8221; &#8220;could,&#8221; &#8220;due,&#8221; &#8220;estimate,&#8221; &#8220;expect,&#8221; &#8220;goal,&#8221; &#8220;intend,&#8221; &#8220;may,&#8221; &#8220;objective,&#8221; &#8220;plan,&#8221; &#8220;predict,&#8221; &#8220;potential,&#8221; &#8220;positioned,&#8221; &#8220;seek,&#8221; &#8220;should,&#8221; &#8220;target,&#8221; &#8220;will,&#8221; &#8220;would&#8221; and other similar expressions that are predictions of or indicate future events and future trends, or the negative of these terms or other comparable terminology.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">These forward-looking statements include, but are not limited to, statements about:</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">our plans to conduct further clinical trials;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">our plans and expected timeline related to our products, or developing new products, to address additional indications or to obtain regulatory approvals or clearances or otherwise;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">the expected use of our products by physicians;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">our expectations regarding the number of procedures that will be performed with our products, the number of physicians we expect to train, and the number of our sales territories;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">our ability to obtain, maintain and expand regulatory clearances for our current products and any new products we create;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">the expected growth of our business and our organization;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">our expected uses of the net proceeds from our initial public offering;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">our expectations regarding government and third-party payer coverage and reimbursement;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">our ability to retain and recruit key personnel, including the continued development of a sales and marketing infrastructure;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">our ability to obtain an adequate supply of materials and components for our products from our third-party suppliers, most of whom are single-source suppliers;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">our ability to manufacture sufficient quantities of our products with sufficient quality;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">our ability to obtain and maintain intellectual property protection for our products;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">our ability to expand our business into new geographic markets;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">our compliance with extensive Nasdaq requirements and government laws, rules and regulations both in the United States and internationally;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">our estimates of our expenses, ongoing losses, future revenue, capital requirements and our need for, or ability to obtain, additional financing;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">our expectations regarding the time during which we will be an emerging growth company under the JOBS Act;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">our ability to identify and develop new and planned products and/or acquire new products; and</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">developments and projections relating to our competitors or our industry.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We believe that it is important to communicate our future expectations to our investors. However, there may be events in the future that we are not able to accurately predict or control and that may cause our actual results to differ materially from the expectations we describe in our forward-looking statements. These forward-looking statements are based on management&#8217;s current expectations, estimates, forecasts and projections about our business and the industry in which we operate and management&#8217;s beliefs and assumptions and are not guarantees of future performance or development and involve known and unknown risks, uncertainties and other factors that are in some cases beyond our control. As a result, any or all of our forward-looking statements in this Annual Report on Form 10-K may turn out to be inaccurate. Factors that may cause actual results to differ materially from current expectations include, among other things, those listed under &#8220;Risk Factors&#8221; and elsewhere in this Annual Report on Form 10-K. </span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">These forward-looking statements speak only as of the date of this Annual Report on Form 10-K. We assume no obligation to update or revise these forward-looking statements for any reason, even if new information becomes available in the future. You should not rely upon forward-looking statements as predictions of future events. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee that the future results, levels of activity, performance or events and circumstances reflected in the forward-looking statements will be achieved or occur. We undertake no obligation to update publicly any forward-looking statements for any reason after the date of this Annual Report on Form 10-K to conform these statements to actual results or to changes in our expectations.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">You should read this Annual Report on Form 10-K and the documents that we reference in this Annual Report on Form 10-K and have filed with the SEC as exhibits to this Annual Report on Form 10-K with the understanding that our actual future results, levels of activity, performance and events and circumstances may be materially different from what we expect.</span></div><div id="i58f397e86dfd4fc4ac3b8695cd31238e_10"></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">1</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><div style="text-align:center;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;">PART I</span></div><div id="i58f397e86dfd4fc4ac3b8695cd31238e_13"></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Item 1. Business</span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Overview</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We are a medical device company focused on reducing the risk of stroke and its devastating impact.  We believe a key to stroke prevention is minimally-invasive and technologically advanced intervention to safely and effectively treat carotid artery disease, one of the leading causes of stroke.  We have pioneered a new approach for the treatment of carotid artery disease called transcarotid artery revascularization, or TCAR, which we seek to establish as the standard of care.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">TCAR relies on two novel concepts - minimally-invasive direct carotid access in the neck and high-rate blood flow reversal during the procedure to protect the brain - and combines the benefits of innovative endovascular techniques with fundamental surgical principles.  TCAR using our portfolio of products has been clinically demonstrated to reduce the upfront morbidity and mortality risks commonly associated with surgical procedures for carotid endarterectomy while maintaining a reduction in long-term stroke risk.  We are the first and only company to obtain FDA approvals, secure specific Medicare reimbursement coverage, and commercialize products engineered and indicated for use in patients who require carotid revascularization, but are at high risk for adverse events from carotid endarterectomy and who meet certain treatment criteria.  As of December 31, 2019, more t</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">han 16,000 TC</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">AR procedures have been performed globally, including more than 8,400 in the United States in 2019.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Carotid artery disease is the progressive buildup of plaque causing narrowing of the arteries in the front of the neck, which supply blood flow to the brain.  Plaque can embolize, or break away from the arterial wall, and travel toward the brain and interrupt critical blood supply, leading to an ischemic stroke.  Carotid artery disease is one of the leading causes of stroke, and stroke is one of the most catastrophic, debilitating, and costly conditions worldwide.  We believe the best way to mitigate the mortality, morbidity and cost burden of stroke is to prevent strokes in the first place.  Clinical evidence has demonstrated that with proper diagnosis and treatment, stroke due to carotid artery disease is mostly preventable. </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We believe there were approximately 4.3 million people with carotid artery disease in the United States in 2018, with an estimated 427,000 new diagnoses in 2018, </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">and existing treatment options have substantial safety and effectiveness limitations.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The main goal of treating carotid artery disease is to prevent a future stroke.  Unfortunately, one of the main complications of existing treatments for carotid artery disease is causing a stroke, along with other procedure-related adverse events.  When intervention beyond medical management is warranted, the current standard of care for reduction in stroke risk is an invasive carotid revascularization procedure called carotid endarterectomy, or CEA.  To perform a CEA, a physician makes a large incision in the neck, cuts the carotid artery open, and then removes the plaque from inside the vessel.  CEA was first performed in 1953, and while generally effective at reducing stroke risk in the long term, large randomized clinical trials have demonstrated that CEA is associated with a significant risk of adverse events, including cranial nerve injury, heart attack, wound complications, and, in some cases, even stroke and death.  These risks are elevated in certain patient populations. </span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">To address the invasiveness of CEA, transfemoral carotid artery stenting, or CAS, was developed in the 1990s.  The CAS procedure uses minimally-invasive catheters traveling from a puncture site in the groin to place a stent in the carotid artery in the neck to restrain the plaque and prevent embolization that could cause a stroke.  While both CEA and CAS have been clinically demonstrated to reduce long-term stroke risk, randomized clinical trials and other studies have shown that CAS, relative to CEA, often results in an almost two-fold increase in stroke within 30 days following treatment, which we believe is due to inadequate protection of the brain.  We believe this represents an unacceptable trade-off relative to the current standard of care of CEA.  As such, after almost 30 years of development, CAS has achieved limited adoption and narrow reimbursement coverage in the United States.  CEA remains the standard of care and represented approximately </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">83% of the approximately 168,000 carotid revascularization </span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">4</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">procedures performed in the United States in 2018. </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Therefore, we believe reducing the rate of morbidity and mortality of CEA is an unmet clinical need that continues to persist.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">TCAR is a minimally-invasive procedure that addresses the morbidity of CEA and the 30-day stroke risk of CAS while maintaining a reduction in long-term stroke risk beyond the first 30 days.  TCAR starts with a small incision in the neck slightly above the collarbone, otherwise known as transcarotid access, through which our ENROUTE Transcarotid Stent System, or ENROUTE stent, is placed during a period of temporary high-rate blood flow reversal that is enabled by our ENROUTE Transcarotid Neuroprotection System, or ENROUTE NPS. Blood flow reversal directs embolic debris that could cause a stroke away from the brain, while the stent braces the plaque and prevents embolization to afford a reduction in long-term stoke risk.  We believe that by meeting the standard of brain protection and reduction in 30-day and long-term stroke risk afforded by CEA, while providing benefits commensurate with an endovascular, minimally-invasive approach, TCAR could become the preferred alternative for carotid revascularization.  Additionally, we believe that as our technology becomes more widely adopted, TCAR may become a compelling alternative for patients who are treated with medical management alone each year.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Based on the estimated 427,000 new carotid artery disease diagnoses that occurred in the United States in 2018, we believe a total annual U.S. market opportunity of approximately $2.6 billion exists for our portfolio of TCAR products.  There were approximately 168,000 carotid revascularization procedures performed in 2018, which we estimate to represent a market conversion opportunity greater than $1.0 billion.  More than&#160;8,4</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">00 </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">TCAR procedures were performed in 2019 in the United States using our products, representing less than 2% of annual diagnoses of carotid artery disease in the United States.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The safety, effectiveness and clinical advantages of TCAR have been demonstrated in multiple clinical trials, post-market studies and registries that have evaluated outcomes in more than 11,900 patients or patient pairs in propensity matched scoring analysis in the United States and Europe to date.  The results of our U.S. pivotal trial, ROADSTER, reflect the lowest reported 30-day stroke rate for any prospective, multicenter clinical trial of carotid stenting of which we are aware.  Our ROADSTER 2 post-approval study was completed in 2019 and showed a thirty-day stroke rate of 0.6%.  Additionally, data on real-world outcomes of TCAR relative to CEA and CAS have continued to accrue through the ongoing TCAR Surveillance Project, which is an ongoing open-ended registry sponsored by the Society for Vascular Surgery through the Vascular Quality Initiative, or VQI.  In June 2019, updated outcomes from the TCAR Surveillance Project were presented at the 2019 Vascular Annual Meeting, or VAM.  In a propensity matched analysis of TCAR and CEA with 5,160 patients in each cohort, TCAR provided similar in-hospital stroke rates as compared to CEA but had significantly lower odds of in-hospital myocardial infarction and 30-day death and composite stroke and death, and TCAR patients were less likely to suffer a cranial nerve injury and remain in the hospital longer than one day.  In a study published in the </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Journal of the American Medical Association</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> in December 2019, a propensity matched analysis of 3,286</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> patients in each cohort showed i</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">n-hospital stroke or death was 1.6% for TCAR versus 3.1% for CAS. The differences favoring TCAR persisted through 30 days and 1 year.  </span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We manufacture the ENROUTE NPS and distribute our portfolio of TCAR products from our facility in Sunnyvale, California.  We market and sell our products in the United States through a direct sales organization consisting of 35 sales representatives and 61 clinical support specialists as of December 31, 2019, that are focused on driving adoption of TCAR among the approximately 2,750 physicians and 750 hospitals in the United States that we believe are responsible for over 80% of carotid revascularization procedures each year.  While our current commercial focus is on the U.S. market, our ENROUTE NPS and ENROUTE stent have obtained CE Mark approval, allowing us to commercialize in Europe in the future.  We are also pursuing regulatory clearances in China and Japan.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">TCAR is reimbursed based on established current procedural technology, or CPT, codes and International Classification of Diseases, or ICD-10, codes related to carotid stenting that track to Medicare Severity Diagnosis Related Group, or MS&#8208;DRG classifications.  In September 2016, the Centers for Medicare and Medicaid Services, or CMS, made coverage available for TCAR in symptomatic and asymptomatic patients at high risk for adverse events from CEA, or high surgical risk, treated at facilities </span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">5</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">participating in the Society for Vascular Surgery&#8217;s TCAR Surveillance Project using FDA-cleared and approved transcarotid devices.  Our ENROUTE NPS and stent are currently the only FDA-cleared and approved transcarotid devices.  Carotid artery disease is most often a disease of the elderly and, as such, CMS is the primary payer for carotid revascularization procedures, and we estimate that the high surgical risk patient population represents approximately two-thirds of the treated patient population.  We plan to pursue expansion of FDA labeling for the ENROUTE stent, currently indicated for use in certain patients at high risk for adverse events from CEA, and, upon FDA approval of broader indication(s), pursue CMS coverage for our products in the remaining one-third of treated patients who qualify under such broader indication(s), including patients who are deemed standard surgical risk.  </span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We have experienced considerable growth since we began commercializing our products in the United States in late 2015.  Our revenue increased to $63.4 million for the year ended December 31, 2019 compared to $34.6&#160;million for the year ended December 31, 2018, representing growth of&#160;83%, and our net losses were $52.4 million and </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">$37.6 m</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">illion for the years ended December 31, 2019 and 2018, respectively.  As of December 31, 2019 and 2018, our accumulated deficit was $191.5&#160;million and $139.1 million, respectively.</span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Our Competitive Strengths</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We believe the continued growth of our company will be driven by the following competitive strengths:</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt;">Paradigm-shifting transcarotid access and flow reversal technologies.</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">  TCAR, as pioneered by our FDA-approved products, presents an entirely new, minimally-invasive procedure in a disease state where conventional surgical treatment options have not advanced significantly for over 60 years.  TCAR combines two key concepts: minimally-invasive direct carotid access in the neck, and high-rate blood flow reversal to protect the brain.  Our technology combines the benefits of innovative endovascular techniques with fundamental surgical principles.  Our goal is to leverage our disruptive technology and growing body of clinical evidence to establish our products as the part of an improved standard of care for treating qualifying patients who require carotid revascularization. </span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt;">Compelling body of clinical and economic evidence.  </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The benefits of TCAR are supported by data from over 11,900 patients enrolled across several multi-center clinical trials, post market studies and real-world registries that support favorable patient outcomes and value-based care.  In November 2015, the Journal of Vascular Surgery reported that TCAR demonstrated the lowest 30-day stroke rate of any prospective, multicenter carotid stent trial.  Data from the Society for Vascular Surgery&#8217;s TCAR Surveillance Project show that TCAR compares favorably to CEA and CAS with a low in-hospital and 30-day stroke and death risk and low procedure-related adverse events.  TCAR has demonstrated shorter procedure times, a shorter length of hospital stay and reduced adverse event rates compared to the standard of care, CEA.  For hospitals seeking to improve quality metrics, drive throughput and increase profitability, we believe TCAR results in higher efficiency and increased cost savings.  In addition, by reducing the overall burden of stroke, we believe TCAR is beneficial to payers.  We believe our growing body of clinical evidence and favorable value proposition will continue to support increased adoption of TCAR.</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt;">Established reimbursement linked to our unique regulatory label.  </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">TCAR is reimbursed under established codes and payment levels. CMS coverage for TCAR in certain high surgical risk patients treated at facilities participating in the Society for Vascular Surgery&#8217;s TCAR Surveillance Project mandates the use of FDA-cleared transcarotid flow reversal neuroprotection devices and FDA-approved transcarotid stents.  We are currently the only company to have obtained transcarotid FDA labeling, thereby offering the only transcarotid devices currently eligible for CMS reimbursement coverage through the Society for Vascular Surgery&#8217;s TCAR Surveillance Project.  </span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">6</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt;">Procedure-focused approach to product innovation and service.</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">  Our product portfolio was developed to support the technical aspects of TCAR and is currently the only suite of devices specifically designed for carotid access through the neck, or the transcarotid approach.  Our research and development strategy strives to optimize safety, effectiveness and ease-of-use through a family of integrated products designed to minimize the learning curve and drive adoption by physicians.  In addition, our commercial organization is clinically consultative and trained in many aspects of carotid artery disease treatment, from patient selection and pre-operative planning to procedural support and post-operative care.  As a result, our commercial organization provides a level of service and support that we believe is valued by our physician customers and drives customer loyalty.  </span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt;">Strong relationships and engagement with key medical societies and governmental agencies.</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">  We have developed strong working relationships with key groups including the FDA, CMS, and the Society for Vascular Surgery.  By listening and responding to the needs of key stakeholders, we believe we have been able to achieve efficient regulatory approval timelines, coverage and alignment with key medical societies in the vascular field regarding the benefits of TCAR.  We believe our approach to engaging these key stakeholders will continue to help drive our business success.</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt;">Broad intellectual property portfolio.</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">  As of December 31, 2019 , we held 76 patents globally that include device, apparatus and method claims surrounding TCAR and our suite of current and potential future products, as well as for treating other vascular diseases and enabling other transcarotid procedures, primarily directed at acute ischemic stroke, other neurovascular procedures, repair of the aorta and transcatheter aortic valve repair, or TAVR.  In addition, we believe that our trade secrets, including manufacturing know-how, provide additional barriers to entry.</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt;">Industry-experienced senior management team</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">.  Our senior management team consists of seasoned medical device professionals with deep industry experience.  Our team has successfully lead and managed dynamic growth phases in organizations and commercialized products in markets driven by converting open surgical procedures to endovascular alternatives and expanding access to new procedures for patients.  Members of our team have worked with well-regarded medical technology companies such as Boston Scientific, Medtronic, Abbott, Johnson &amp; Johnson, Stryker, Cardinal Health and Roche.</span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Our Market Opportunity</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">The Burden of Stroke</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Stroke is a disease that affects the arteries leading to and within the brain.  There are two key types of stroke: an ischemic stroke, which occurs when a blood vessel that carries oxygen and nutrients to the brain is blocked by a clot, and a hemorrhagic stroke, which occurs when one of these same blood vessels ruptures.  If blood flow is stopped for more than a few seconds, the brain is deprived of oxygenated blood and brain cells can die.  Depending on where in the brain the stroke occurs, the consequences of stroke can include difficulty talking, memory loss, cognitive issues, paralysis or loss of muscle movement, inability to attend to bodily needs or care, pain, emotional problems, and death.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Although stroke is often considered preventable, it remains one of the most catastrophic and common conditions worldwide.  The American Heart Association, or AHA, estimated that the global prevalence of stroke was 42.4 million in 2015, with ischemic strokes representing approximately 87% of the total number of strokes in the U.S. and approximately two thirds of all strokes worldwide.  According to a 2013 study published in the Neuroepidemiology Journal, there are an estimated 6.9 million new or recurrent ischemic strokes globally each year.  The AHA expects the incidence of stroke to more than double between 2010 and 2050 as demographic trends contribute to an increase in the prevalence of disease states that are commonly associated with strokes.</span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">7</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In the United States, stroke is a major contributor to long-term disability and mortality and disproportionately affects women, the elderly and certain ethnic populations.  According to the AHA, stroke was the fifth leading cause of death in the United States in 2014, and results in the death of approximately 140,000 people each year.  Stroke ranked in the top 10 most expensive conditions for Medicare, Medicaid, and private insurers in 2013, and according to the AHA, direct medical stroke-related costs will more than double in the United States, from $36.7 billion in 2015 to $94.3 billion in 2035.  </span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We believe the best way to mitigate the mortality, morbidity and cost burden of stroke is to prevent strokes in the first place.  While strokes can be caused by a wide variety of conditions, the Society for Vascular Surgery estimates that carotid artery disease is the primary cause of up to one-third of strokes.  Based on AHA&#8217;s estimated 690,000 ischemic strokes in the United States every year, carotid artery disease is the cause of up to 230,000 ischemic strokes annually.  Clinical evidence has demonstrated that with proper diagnosis and treatment, stroke due to carotid artery disease is mostly preventable.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Overview of Carotid Artery Disease</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Carotid artery disease, also known as carotid artery stenosis, is the narrowing of the carotid arteries that reside in the neck, one on each side, which are two of the four main blood vessels that supply oxygen to the brain.  The narrowing of the carotid arteries is usually caused by atherosclerosis, which is the buildup of cholesterol, fat, calcium and other substances on the walls of arteries.  Over time and as people age, an area of atherosclerotic plaque, also called a lesion, is formed.  Plaque buildup can lead to narrowing or blockage in the carotid artery, often at the bifurcation of the common carotid and internal carotid arteries.  </span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Carotid plaques in particular are often unstable or crumbly, and a piece of plaque or a blood clot, known as emboli, can break away from the wall of the carotid artery, travel through the bloodstream and get stuck in one of the brain&#8217;s smaller arteries.  When these arteries experience an interrupted or seriously reduced blood supply, the surrounding cells and tissue are deprived of oxygen leading to an ischemic stroke.  </span></div><div style="text-align:center;margin-bottom:12pt;"><img src="silk-20191231_g1.jpg" alt="silk-20191231_g1.jpg" style="height:293px;width:400px;"/></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Diagnosis and Referral Pathways for Carotid Artery Disease</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Based on data from Modus Health Group, carotid artery disease was prevalent in approximately 4.3&#160;million people in the United States in 2018, which represented approximately 1.7% of the adult population in 2018, and reflects an increase in prevalence from approximately 4.1 million people in the </span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">8</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">United States in 2017. Prevalence generally increases with age. Unfortunately for many patients, carotid artery disease is frequently asymptomatic, or silent, and the first symptom is often a stroke.  In 2018, an estimated 427,000 patients in the United States were diagnosed with carotid artery disease severe enough to warrant treatment, reflecting an increase from an estimated 403,000 patients in 2017</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">. Patients are diagnosed with carotid artery disease either because they have been non-invasively screened for the disease or they have experienced symptoms ranging from a major or minor stroke to a transient ischemic attack, or TIA, in which neurologic symptoms resolve within 24 hours.  </span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">For asymptomatic patients, a primary care physician or a specialist such as a vascular surgeon or cardiologist may screen for carotid artery disease based on the presence of risk factors, including age, family history, history of smoking, high cholesterol, high blood pressure, obesity, diabetes or atherosclerosis in other areas like the heart and legs.  When a potential carotid stenosis is detected, the physician will typically refer the patient to a vascular laboratory for a non-invasive ultrasound to definitively diagnose the presence and degree of stenosis, or narrowing of the artery.  The degree of stenosis is reported as a percentage of the vessel diameter.  There is a correlation between higher degrees of stenosis and increased risk of stroke. </span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Symptomatic patients who have survived a stroke or experienced a TIA are typically referred to a neurologist for care and physiological assessment.  If the patient is found to have underlying carotid artery stenosis, the neurologist will typically refer the patient to a vascular surgeon for urgent treatment to prevent a recurrent stroke.  The majority of patients in the United States who are referred for a carotid revascularization procedure receive care from a vascular surgeon.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Once a patient is diagnosed with carotid artery disease, the treatment paradigm is influenced by the patient&#8217;s symptom status, disease progression and degree of stenosis, as well as factors that may place them at higher risk of adverse events, including their age, anatomic characteristics, and co-morbidities such as cardiovascular and respiratory disease.  Patients diagnosed with carotid artery disease are recommended for treatment with medical management, which includes pharmaceutical treatments and lifestyle modifications such as smoking cessation and control of diabetes, hypertension and lipid, or fatty acid, abnormalities.  As the degree of stenosis increases, carotid revascularization procedures may also be prescribed.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">For example, published guidelines by the Society for Vascular Surgery recommend that symptomatic patients be treated with CEA if they present with carotid artery stenosis greater than or equal to 50%.  For asymptomatic patients, the guidelines recommend CEA for stenosis greater than or equal to 60%, provided that the risk of stroke and death within 30 days of the procedure is below 3% and life expectancy is greater than three years.  The risk of stroke and death within 30 days is subjective and typically depends on the patient&#8217;s surgical risk factors as well as the skill and experience of the treating physician.  The guidelines for CAS procedures are more limiting than those for CEA procedures due primarily to the increased stroke risk associated with CAS.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In 2018, of the estimated 4.3 million individuals in the United States with carotid artery disease, and of the approximately 427,000 patients that were newly diagnosed, approximately 168,000 patients were treated with a revascularization procedure, representing an increase of approximately 6% in newly diagnosed patients relative to 403,000 patients in 2017, and an increase of approximately 10% in revascularization procedures relative to approximately 152,000 procedures in 2017. T</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">he remaining patients are managed medically and monitored to assess the progression of stenosis and any new or recurrent neurologic symptoms.  </span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Existing Alternatives for Carotid Revascularization and Their Limitations</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Existing treatment options for carotid revascularization procedures include CEA and CAS.  Both surgical removal of plaque with CEA and stenting of plaque with CAS have demonstrated clinical effectiveness in reducing long-term stroke risk, which is stroke occurring more than 30 days after the procedure. This has been shown in multiple randomized trials across different surgical techniques and </span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">9</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">stent designs, including trials with multi-year follow up that, in some cases, extend out to 10 years.  However, CEA and CAS have been associated with adverse events within 30 days.  </span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Carotid Endarterectomy, or CEA</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">CEA, which was first performed in 1953, is an invasive surgical procedure, typically performed under general anesthesia.  The procedure involves a ten- to fifteen-centimeter incision extending from the base of the neck towards the earlobe, followed by the meticulous dissection of multiple tissue and muscle layers to open and expose the internal, external and common carotid arteries, collectively known as the carotid bifurcation.  During the surgical exposure of the carotid bifurcation, great care is required to avoid damaging the cranial nerves that travel in and around the carotid arteries and related veins.  Damage to these nerves, which control functions like speaking, swallowing, facial sensation, taste and saliva production, is a potential side-effect of CEA and can result in transient and permanent quality of life issues and stroke-like symptoms.  </span></div><div style="text-align:center;margin-bottom:12pt;"><img src="silk-20191231_g2.jpg" alt="silk-20191231_g2.jpg" style="height:491px;width:624px;"/></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Once the bifurcation is exposed, the carotid arteries are then clamped above and below the disease, temporarily halting blood flow to the brain from that artery, so that the artery can be cut open to remove the plaque.  Due to the length of the surgery, a shunt is sometimes placed to allow blood flow to bypass the clamped arteries and reach the brain.  After the plaque is removed, the artery is closed, and the vessels are unclamped to restore blood flow.  The long incisional wound is then sutured closed, though the resulting scar presents a cosmetic disadvantage.</span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">10</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Data from large randomized clinical trials have demonstrated that CEA in addition to medical management is more effective at reducing long-term stroke risk than medical management alone, which has established CEA as the standard of care.  Importantly, many of these trials primarily included standard surgical risk patients who were relatively young, free of co-morbidities and deemed reasonably able to withstand the stress of an invasive surgery.  </span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Data from these trials and other studies, including real world registries, have indicated that the surgical impact from a large incision combined with factors such as procedure time, general anesthesia and patient-specific risk factors can result in known adverse events, including nerve injury, heart attack and even stroke and death.  CEA also presents a risk of wound complications, including bleeding and infection, and leaves behind a significant scar.  These adverse events can also lead to longer hospital stays that are costly to providers and payers.  Further, patient recovery times can be significant after a major vascular surgery like CEA.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Transfemoral Carotid Artery Stenting, or CAS</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">To address the invasiveness of CEA, in the 1990s physicians and medical device companies developed CAS, which uses minimally-invasive techniques to place a stent in the carotid artery.  The first carotid stents were approved by the FDA in 2004 for high surgical risk patients, marking the beginning of the CAS market in the United States.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In a CAS procedure, a small puncture is made in the groin and a sheath is inserted through which a physician can navigate catheters.  The physician navigates the catheters inside the body through approximately three feet of vessels and arteries of the leg, abdomen, chest and neck, up to and often beyond the lesion itself, in order to place a stent to brace the plaque and prevent it from embolizing.  Significant technical skill is required to maneuver catheters through these vessels and their twists and turns.  Patients may also have significant atherosclerotic disease along the navigation pathway, and the catheters can scrape the inner lining of the arteries and dislodge plaque and embolic debris, which can travel to the brain and cause neurologic injury or stroke during or after the procedure.  While embolic protection devices, which are designed to capture debris dislodged during the procedure, may be used to reduce these risks, the brain is not protected while they are maneuvered into place, and they do not always safely capture all debris once in position.</span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">11</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><div style="text-align:center;margin-bottom:12pt;"><img src="silk-20191231_g3.jpg" alt="silk-20191231_g3.jpg" style="height:398px;width:200px;"/></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">While CAS is less invasive than CEA, multiple randomized clinical studies and real-world registries have consistently shown an almost two-fold increase in the risk of stroke within 30 days relative to CEA.  CAS has also been clinically demonstrated to result in showers of microemboli to the brain, which can cause neurologic injuries including memory loss as well as cognitive decline and dementia while increasing the risk of future stroke. The procedure-related stroke risks are further elevated in elderly, female, symptomatic and other at-risk patients who tend to have smaller or more distended and diseased vessels.  </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">As a result, CAS is performed in a minority of carotid revascularization procedures, representing only 14% of the estimated 168,000 carotid procedures performed in the United States in 2018. </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> By contrast, after multiple decades of technology innovation and clinical development, minimally-invasive endovascular procedures targeted at arterial diseases in the legs, abdomen, heart and brain have become the standard of care and represented approximately 70% to 85% of procedures in other areas of the vasculature in 2012 as compared to open surgical alternatives.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Major Trials Comparing CEA and CAS</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The principal clinical trial evaluating CEA and CAS is the Stenting versus Endarterectomy for Treatment of Carotid-Artery Stenosis trial, known as CREST.  CREST was a multi-center randomized controlled trial in the United States that compared CEA to CAS in symptomatic and asymptomatic patients deemed to be at standard risk for adverse events from CEA, or standard surgical risk.  This trial, which by protocol excluded high surgical risk patients, was sponsored by the National Institutes of Health and is considered by many physicians to be the landmark trial comparing CEA and CAS.  A number of other randomized controlled trials have further established the basis of comparison between CEA and CAS.  In addition, post-market registries sponsored by the Society for Vascular Surgery have assessed CEA and CAS in real world practice.  Results comparing CEA and CAS from the CREST trial and the Society for Vascular Surgery registry are shown in tables below.  In our presentation of the results of the CREST trial, we have indicated incidence rates in percentage terms, regardless of sample size.  Statistically significant differences are demonstrated by p-values of less than 0.05, which is the commonly accepted threshold for statistical significance.  This follows the convention of standard clinical practice.  </span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">12</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">CREST Trial Results </span></div><div style="text-align:center;margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:99.519%;"><tr><td style="width:1.0%;"></td><td style="width:16.196%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:6.534%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.605%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:7.661%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.605%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:8.789%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.605%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:6.534%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.605%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:8.789%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.605%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:6.534%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.605%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:8.789%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.605%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:6.539%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">30-day Stroke</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">30-day Stroke/Death</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4 Year Ipsilateral Stroke</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="12" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Patient Cohort</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Incidence</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">p-value</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Incidence</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">p-value</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Incidence</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">p-value</span></td></tr><tr><td colspan="3" rowspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">All Patients</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">CEA</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">n=1,240</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.3%&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" rowspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.01&#160;</span></td><td rowspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.3%&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" rowspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.005&#160;</span></td><td rowspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.7%&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" rowspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">NR</span></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">CAS</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">n=1,262</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.1%&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.4%&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.6%&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" rowspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Asymptomatic</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">CEA</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">n=587</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.4%&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" rowspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.15&#160;</span></td><td rowspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.4%&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" rowspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.15&#160;</span></td><td rowspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.9%&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" rowspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">NR</span></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">CAS</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">n=594</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.5%&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.5%&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.5%&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" rowspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Symptomatic</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">CEA</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">n=653</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.2%&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" rowspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.043&#160;</span></td><td rowspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.2%&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" rowspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.019&#160;</span></td><td rowspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.5%&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" rowspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">NR</span></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">CAS</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">n=668</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5.5%&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6.0%&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.7%&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" rowspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Male</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">CEA</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">n=823</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.4%&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" rowspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.26&#160;</span></td><td rowspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.4%&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" rowspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.13&#160;</span></td><td rowspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.3%&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" rowspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">NR</span></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">CAS</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">n=807</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.3%&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.7%&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.6%&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" rowspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Female</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">CEA</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">n=417</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.2%&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" rowspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.013&#160;</span></td><td rowspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.2%&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" rowspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.013&#160;</span></td><td rowspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.4%&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" rowspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">NR</span></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">CAS</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">n=455</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5.5%&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5.5%&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.5%&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" rowspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Age </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;">&gt;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">75 years</span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">CEA</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">n=353</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.1%&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" rowspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.035&#160;</span></td><td rowspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.7%&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" rowspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">NR</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.4%&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" rowspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">NR</span></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">CAS</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">n=333</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6.9%&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8.1%&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.0%&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" rowspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Age &lt;75 years</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">CEA</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">n=887</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.0%&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" rowspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">NR</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.1%&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" rowspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">NR</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.8%&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" rowspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">NR</span></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">CAS</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">n=929</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.1%&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.6%&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.1%&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td></tr></table></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">NR - p-values not reported; rates are manually calculated from data presented in the respective publications.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">While there was a statistically significant difference in 30-day stroke and 30-day stroke/death favoring CEA, CAS had a significantly lower rate of myocardial infarction of 1.1% compared to CEA at 2.3%, with a p-value equal to 0.03. We believe that this can be largely attributed to the more invasive nature of CEA.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In the FDA analysis of CREST which led to FDA approval of a carotid stent for use in standard surgical risk patients, the rate of acute cranial nerve injury was a secondary endpoint.  Patients with an acute cranial nerve injury were evaluated again at the 6-month follow-up visit to determine if the injury persisted. As shown in the table below, patients randomized to the CEA arm had a statistically significant higher rate of acute cranial nerve injury, many of which persisted at the 6-month evaluation. Eighty percent of the cranial nerve injuries involved a motor deficit, such as difficulty swallowing.</span></div><div style="text-align:center;margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:53.769%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:11.942%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:11.942%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:11.944%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cranial Nerve Injury</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">CEA</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">CAS</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">p-value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">n=1,176</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">n=1,131</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="margin-top:2pt;margin-bottom:2pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Cranial Nerve Injury </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;">(Acute)</span></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5.3%&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.0%&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&lt;0.0001&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="margin-top:2pt;margin-bottom:2pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Cranial Nerve Injury </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;">(Persisting at 6 months)</span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.1%&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.0%&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&lt;0.0001&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In an analysis of patients who received their randomized treatment assignment without crossover, CEA procedure time was more than twice that of CAS. Additionally, CEA patients had a hospital length of stay of 3.0 days compared to 2.6 days for CAS patients. The difference in hospital length of stay was statistically significant.</span></div><div style="text-align:center;margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:53.769%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:11.942%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:11.942%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:11.944%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Procedural Information</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">CEA</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">CAS</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">p-value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">n=1,193</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">n=1,213</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="margin-top:2pt;margin-bottom:2pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Mean procedure time (mins)</span></div></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">171</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">69</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">NR</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="margin-top:2pt;margin-bottom:2pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Length of stay (days)</span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.6</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.011</span></td></tr></table></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">13</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In a publication of the primary long-term endpoint of post-procedural ipsilateral stroke, or a stroke on the same side as the original carotid revascularization procedure, over the 10-year follow-up period, ipsilateral stroke occurred in 6.9% of CAS patients and 5.6% of CEA patients. The difference was not statistically significant. Furthermore, there was no statistical difference when outcomes were analyzed separately for symptomatic and asymptomatic patients. There was also no statistical difference between CAS and CEA at any other year of follow-up from year one through year nine. These data demonstrate that both CAS and CEA provide the same durable reduction of long-term stroke risk.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Society for Vascular Surgery Vascular Registry</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In 2013, members of the Society for Vascular Surgery Vascular Registry, the precursor to the VQI, published outcomes for CEA and CAS in high surgical risk patients using CMS high risk criteria per the National Coverage Determination.  The objective of the analysis was to determine objectively if the CMS high risk criteria demonstrated differential and biased outcomes in CEA and CAS due to the over-representation of high risk patients for CAS.  The authors also sought to determine if the rate of adverse events in high risk patients is lower in CAS than CEA as the surgical high risk criteria would suggest.  The primary endpoint was a composite of stroke, death and myocardial infarction at 30 days.  In a risk adjusted analysis, CAS had a significantly higher rate of stroke, death and myocardial infarction compared to CEA.  For the high risk cohort, the rates of stroke for CEA and CAS were 3.6% and 4.9%, respectively; the rates of stroke and death for CEA and CAS were 4.8% and 6.2%, respectively.</span></div><div style="margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:99.839%;"><tr><td style="width:1.0%;"></td><td style="width:17.261%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:11.322%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.602%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:11.322%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.602%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:9.717%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.602%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:11.322%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.602%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:11.322%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.602%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:9.724%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">CEA High Risk</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">CAS High Risk</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Symptomatic</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Asymptomatic</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">All</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Symptomatic</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Asymptomatic</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">All</span></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">n=936</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">n=1,418</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">n=2,354</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">n=1,538</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">n=1,844</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">n=3,382</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Stroke/death/myocardial infarction</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7.3%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5.0%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5.9%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9.1%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5.4%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7.1%</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Stroke/death</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6.4%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.7%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.8%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7.9%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.8%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6.2%</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Stroke</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.9%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.7%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.6%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6.7%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.4%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.9%</span></td></tr></table></div><div style="margin-bottom:9pt;"><span><br/></span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Our Solution</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">With our portfolio of TCAR products, we have pioneered a new approach for the treatment of patients who are at high risk for adverse events from CEA and qualify for a TCAR procedure, and we are seeking to expand the indication for our TCAR products in an effort to improve the standard of care for treating carotid artery diseases or conditions that require carotid revascularization.  TCAR is a minimally-invasive solution that addresses the risk of morbidity of CEA and the 30-day stroke risk of CAS, while providing the equivalent clinical benefit of these conventional surgical procedures and a reduction in long-term stroke risk.  We believe that by meeting the standard of brain protection and reduction in 30-day and long-term stroke risks associated with CEA in a minimally-invasive manner, TCAR offers an attractive alternative for patients, providers and payers and has the potential to successfully penetrate the entire carotid revascularization market.  We plan to seek FDA approval for expanded indication(s) to make our TCAR products and related procedures available to more patients who may benefit from such surgical procedures.   </span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Transcarotid Artery Revascularization, or TCAR</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">TCAR relies on two novel concepts: minimally-invasive direct carotid access in the neck, and high-rate blood flow reversal during the procedure to protect the brain.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The TCAR procedure begins with a two- to three-centimeter incision slightly above the collarbone, thereby obviating the need to maneuver catheters from the groin.  The incision is made just above the collarbone to expose a small section of the carotid artery well below the carotid stenosis and most of the cranial nerves.  A puncture is made into the carotid artery using our transcarotid access kit, and our </span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">14</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">proprietary sheath is placed inside the carotid artery.  This sheath is connected to the rest of our flow reversal system, which lies outside the body, and ends in a connection to our venous sheath in the patient&#8217;s groin.  After the carotid artery is clamped just below the sheath, the pressure gradient between the high-pressure arterial system in the neck and the low-pressure venous system in the groin creates the blood flow reversal, which redirects dislodged plaque and debris away from the brain where it is captured in an external filter in our system.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">While the brain is protected by flow reversal, our guidewire is navigated across the lesion and our transcarotid stent is delivered and placed in the carotid artery to stabilize the plaque against the wall of the artery, trapping the lesion and reducing the risk of a future stroke.  The short distance enabled by our transcarotid access allows for accurate stent placement.  Balloon catheters can also be used to pre-dilate the lesion or further expand the stent when appropriate.  Any debris released during these steps of the procedure is directed safely away from the brain by the flow reversal.  Clinical studies have shown that patients can tolerate this temporary redirection of blood flow, which usually lasts for approximately ten minutes, due to the redundant network of arteries in the brain that enable it to receive blood flow and oxygen through multiple pathways.  After our transcarotid stent is implanted, the blood flow is returned to normal, the system is removed, and the artery and small wound are sutured closed.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following diagram depicts our portfolio of TCAR products:</span></div><div style="text-align:center;margin-bottom:12pt;"><img src="silk-20191231_g4.jpg" alt="silk-20191231_g4.jpg" style="height:472px;width:518px;"/></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">15</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Key Clinical Advantages of TCAR</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We believe the key advantages of TCAR relative to CEA and CAS include:</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt;">Reduction in stroke risk.</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">  In our pivotal ROADSTER clinical trial, TCAR demonstrated a 30-day stroke rate of 1.4% in 141 high surgical risk patients.  In the study publication from the Journal of Vascular Surgery in November 2015, the authors reported that the 30-day stroke rate of 1.4% was the lowest reported for any prospective, multicenter trial of carotid artery stenting.  Our ROADSTER 2 post approval study was completed in 2019 and showed a 30-day stroke rate of 0.6% in 632 patients.  In separate propensity matched analyses from the TCAR Surveillance Project, TCAR showed similarly low in-hospital strokes rates compared to CEA (odds ratio 0.80; 95%CI 0.58-1.11; p=0.19) and statistically significant lower in-hospital stroke rates compared to CAS (1.3% for TCAR versus 2.4% for CAS; Relative Risk 0.54 95%CI 0.38 to 0.79; p=0.001).  </span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt;">Low surgical morbidity</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">.  The minimally-invasive nature of TCAR offers inherent advantages that can mitigate adverse events typically associated with CEA, including cranial nerve injury and myocardial infarction.  Propensity matched data from the Society for Vascular Surgery&#8217;s TCAR Surveillance Project in 5,160 patients in each cohort showed TCAR provided a statistically significant reduction in the rate of in-hospital cranial nerve injury, myocardial infarction and composite stroke, death and myocardial infarction as compared to CEA patients.  Similarly, data from our ROADSTER study indicated that TCAR had a heart attack rate of 0.7% in high surgical risk patients within 30 days of the procedure.  CREST data regarding standard surgical risk patients showed a 30-day heart attack rate of 2.3% and 1.1% for CEA and CAS, respectively.</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt;">Minimal patient discomfort and rapid recovery.</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">  While the typical incision required for CEA is ten to fifteen centimeters long, the TCAR incision is generally two to three centimeters long, leaving behind a much smaller wound and scar that often only requires non-opioid pain medications and little more than a steri-strip to cover the operative wound.  In our ROADSTER clinical study, 53% of TCAR procedures were performed under local anesthesia.  In addition, multiple analyses of real-world data from the Society for Vascular Surgery&#8217;s TCAR Surveillance Project showed a statistically significant reduction in the likelihood that a TCAR patient would require a hospital stay in excess of one day as compared to a CEA patient.</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt;">Reduction in the risk of microembolic debris.</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">  While large emboli have dominated clinical focus and discussion due to the ability to cause clinically diagnosed stroke or TIAs, there is a growing body of evidence that indicates that showers of micro emboli to the brain, which, for example, may be caused by the CAS procedure, can cause neurologic injuries including memory loss, cognitive decline and dementia, while increasing the risk of future stroke.  Data from our PROOF clinical trial indicated that only 18% of studied TCAR patients presented with new white lesions occurring on the same side of the brain, or ipsilateral, as the treated carotid artery, as shown on diffusion-weighted magnetic resonance imaging studies.  This rate of new white lesions, which indicate brain injury, was comparable to published data for CEA procedures and significantly lower than published data for CAS procedures, which show a range of 45% to 87% of patients with new white ipsilateral lesions.</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt;">Short adoption curve for physicians new to TCAR.</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> In a publication from the TCAR Surveillance Project in January 2020, the authors reviewed 3,456 TCAR procedures performed by 417 unique practitioners at 178 centers.  Patients were grouped into four levels based upon the physicians&#8217; experience with TCAR at the time of procedure: novice (1-5 cases), intermediate (6-20 cases), advanced (20-30 cases) and expert (&gt;30 cases). Of the patients analyzed, 41% of patients were treated by novice physicians, 40% of patients were treated by intermediate physicians, 9% of patients were treated by advanced physicians and 10% of patients were treated by expert physicians. The authors noted that TCAR novices can achieve the same clinical outcomes as expert practitioners, while in comparison CAS requires more than 50 cases to </span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">16</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><div style="padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">achieve proficiency. The incidence of stroke and death was not statistically significantly different for novice practitioners (1.5%) compared to expert practitioners (1.4%; p=0.90).</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We believe the results of our clinical studies provide evidence that TCAR may offer significantly better reduction in stroke risk than CAS and similar reduction in stroke risk compared to CEA, the current standard of care for carotid revascularization, allowing physicians to present the minimally-invasive alternative of TCAR to patients without compromising the reduction in stroke risk they would expect in a CEA procedure.  We believe the growing clinical evidence base from our ongoing and future studies and the Society for Vascular Surgery&#8217;s TCAR Surveillance Project will continue to drive confidence in the procedure and support continued adoption.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Benefits to Other Key Stakeholders</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In addition to offering clinical benefits to patients, we believe that TCAR also offers valuable non-clinical benefits for providers and payers relative to CEA and CAS.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Providers</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We believe TCAR allows for improved hospital workflow given the simplicity, predictability, and efficiency of the procedure as compared to CEA and CAS.  By allowing direct access to the carotid artery rather than requiring the physician to navigate the vasculature as in CAS, and allowing the physician to place a stent to trap plaque rather than requiring the time-consuming and physically burdensome surgical removal of carotid plaque as in CEA, we believe TCAR is a more efficient and predictable procedure.  Data from the Society of Vascular Surgery&#8217;s TCAR Surveillance Project has shown that the average TCAR procedure time has been statistically significantly shorter and that there has been a statistically significant reduction in the percent of hospital stays longer than one day, relative to CEA.  These benefits can help hospitals to better utilize their operating room capacity and fixed overhead and reduce the number of procedures associated with hospital stays longer than one day, which could result in financial losses for hospitals.  We believe the economic benefits are further aided by the reduction in expensive adverse events that are borne by capitated providers or absorbed within 90-day global periods related to hospital reimbursement.  Through third-party consultants, we have performed economic analyses of TCAR using our own clinical data from the ROADSTER study and published data for CEA surrounding cost inputs for both procedures and national weighted average reimbursement rates. We believe the results of these analyses show that TCAR compares favorably to CEA in terms of hospital margins and economic value proposition for the procedure itself as well as the full length of hospital stay.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Payers</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Stroke is one of the costliest conditions for the healthcare system and ranked in the top ten most expensive conditions for Medicare, Medicaid, and private insurers in 2013.  By reducing the 30-day stroke risk from the procedure and the long-term stroke risk from the disease after 30 days, we believe that TCAR mitigates the significant cost burden associated with the morbidity of stroke victims.  In addition to reducing costs associated with stroke, we believe TCAR also helps to reduce downstream costs associated with cranial nerve injuries, myocardial infarction, microembolization and other adverse events.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Our Product Portfolio</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">TCAR is enabled by our proprietary portfolio of TCAR products designed to provide direct access to the carotid artery, effective reduction in stroke risk throughout the procedure, and long-term restraint of carotid plaque.  In addition to enabling the safety and effectiveness of TCAR, our proprietary products are specifically designed to enable a short learning curve, consistent ease of use and physician comfort.  Our products are also currently the only devices cleared and approved by the FDA specifically for transcarotid use.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Today, our product portfolio consists of the following four single use components.  Based on our experience, the full product portfolio is used in the majority of TCAR procedures.  In the future we plan to  </span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">17</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">continue to expand our product portfolio to include additional tools and devices to support the TCAR procedure.</span></div><div style="text-align:center;margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:19.955%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:24.121%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:49.924%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;border-top:1pt solid #000000;border-left:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;">ENROUTE Transcarotid Neuroprotection System</span></div></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><img src="silk-20191231_g5.jpg" alt="silk-20191231_g5.jpg" style="height:38px;width:148px;"/></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;border-right:1pt solid #000000;padding-right:1pt;"><div style="text-indent:-18pt;padding-left:18pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt;">Used to directly access the common carotid artery and initiate temporary blood flow reversal</span></div><div style="text-indent:-18pt;padding-left:18pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt;">Allows for flow modulation enabling lesion imaging and patient tolerability</span></div><div style="text-indent:-18pt;padding-left:18pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt;">Only FDA-cleared transcarotid neuroprotection system </span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;border-top:1pt solid #000000;border-left:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-style:italic;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">ENROUTE Transcarotid Stent System</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><img src="silk-20191231_g6.jpg" alt="silk-20191231_g6.jpg" style="height:92px;width:138px;"/></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;border-right:1pt solid #000000;padding-right:1pt;"><div style="text-indent:-18pt;padding-left:18pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt;">Self-expanding, self-tapering stent with clinical data regarding lasting safety outcomes </span></div><div style="text-indent:-18pt;padding-left:18pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt;">Transcarotid delivery system improves the accuracy and the overall ergonomics of the TCAR procedure </span></div><div style="text-indent:-18pt;padding-left:18pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt;">Only FDA approved transcarotid stent system </span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;border-top:1pt solid #000000;border-left:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-style:italic;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">ENHANCE Transcarotid Peripheral Access Kit</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><img src="silk-20191231_g7.jpg" alt="silk-20191231_g7.jpg" style="height:14px;width:158px;"/></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;border-right:1pt solid #000000;padding-right:1pt;"><div style="text-indent:-18pt;padding-left:18pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt;">Used to gain initial access to the common carotid artery </span></div><div style="text-indent:-18pt;padding-left:18pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt;">Only access kit specifically designed for use in the common carotid artery</span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;border-top:1pt solid #000000;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-style:italic;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">ENROUTE 0.014&#8221; Guidewire</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;border-top:1pt solid #000000;border-bottom:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><img src="silk-20191231_g8.jpg" alt="silk-20191231_g8.jpg" style="height:60px;width:87px;"/></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;border-top:1pt solid #000000;border-bottom:1pt solid #000000;padding-left:1pt;border-right:1pt solid #000000;padding-right:1pt;"><div style="text-indent:-18pt;padding-left:18pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt;">Main conduit for navigating and crossing the target lesion for delivery of interventional devices</span></div><div style="text-indent:-18pt;padding-left:18pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt;">Short working length and proprietary tip designed for TCAR</span></div></td></tr></table></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our ENROUTE NPS and ENROUTE stent are FDA cleared and approved, respectively.  The ENROUTE NPS is cleared for transcarotid vascular access, introduction of diagnostic agents and therapeutic devices, and embolic protection during carotid artery angioplasty and stenting procedures for patients diagnosed with carotid artery stenosis and who have appropriate anatomy, and the ENROUTE stent (PMA P140026) is approved for use in conjunction with the ENROUTE NPS for the treatment of patients at high risk for adverse events from CEA who require carotid revascularization and meet certain criteria.</span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Our Target Market</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We are working to establish TCAR as the preferred alternative to both CEA and CAS for the treatment of patients with carotid artery disease.  Because TCAR offers clinically proven, minimally-invasive reduction in stroke risk, we believe that </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">TCAR can offer a better solution for the approximately 168,000&#160;patients treated in the United States in 2018, most of whom were treated with either CEA or CAS, which we estimate to be a near-term market conversion opportunity greater than $1.0 billion.  Additionally, we believe that as our technology becomes more widely adopted, TCAR may become a compelling alternative for patients that are treated with medical management alone each year.  As a result, we believe the potential addressable opportunity for TCAR includes the approximately 427,000&#160;individuals in the United States who were diagnosed with carotid artery disease in 2018, representing a total U.S. target market opportunity of approximately $2.6 billion in 2018. </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Currently, our ENROUTE stent is indicated for use in patients who are considered high surgical risk, and either are symptomatic with greater than or equal to 50% stenosis or are asymptomatic with greater than or equal to 80% stenosis.  The labeled indications for use for our other products, including the ENROUTE NPS, are agnostic to surgical risk status.  Based on the FDA label of high surgical risk for our stent, CMS provides reimbursement coverage for TCAR in patients who are considered a high surgical risk but not standard surgical risk.  </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">According to published studies and primary research, we believe the high surgical risk population represents approximately two-thirds, or over 111,000, of the approximately 168,000 patients treated for carotid artery disease in the United States in 2018, mo</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">st of whom were treated with either CEA or CAS.  We are currently focused on clinical development activities to support </span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">18</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">label expansion for our ENROUTE stent to standard surgical risk patients.  We would then seek an associated expansion in CMS reimbursement coverage.  </span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">While our current commercial focus is on the U.S. market, our ENROUTE NPS and ENROUTE stent have obtained CE Mark approval, allowing us to commercialize in Europe in the future.  We intend to pursue regulatory clearances or approvals in China, Japan, and other select international markets.  Carotid artery disease and stroke are prevalent, devastating and costly conditions worldwide, and we estimate that a significant opportunity exists for TCAR outside the United States, since the United States represents only 10% of the estimated global incidence of ischemic stroke.</span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Our Growth Strategy</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our mission is to be the global leader in the treatment of carotid artery disease.  We seek to improve the standard of care for carotid revascularization by targeting the market for CEA and CAS procedures and expanding the application and regulatory authorization for our TCAR products to include patients treated with medical management alone.  Our growth strategies include:</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt;">Strategically expanding our U.S. sales force and marketing activities</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">.  As of December 31, 2019, we have approximately 640 hospital accounts across 33 active sales territories.  To date, we have taken a measured approach to account targeting and physician training.  Over time, we plan to selectively add highly qualified personnel to our commercial organization with a strategic mix of selling professionals and clinical specialists to cover the concentrated group of approximately 2,750 physicians and 750 hospitals that we believe perform 80% of carotid revascularization procedures.  As we grow the size of our U.S. sales organization, we plan to remain focused on educating hospitals and physicians regarding the benefits of TCAR and the expanding clinical evidence base, which we believe will increase the adoption of TCAR in existing hospital accounts while expanding our new account and trained physician base.</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt;">Scaling professional education to drive physician use.</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">  As of December 31, 2019, we have trained approximately 1,440 physicians in the United States.  Our education and training courses are led by a highly regarded faculty of key opinion leaders in vascular surgery, allowing for significant peer-to-peer interaction and influence from experienced TCAR practitioners.  These courses have been fully subscribed since inception.  We believe these professional education initiatives are a key differentiator in driving successful outcomes during the learning curve of TCAR and establishing the confidence physicians need to adopt TCAR.  We plan to continue conducting these courses while regionalizing the course locations, continuously improving the program, and expanding our physician faculty.</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt;">Increasing TCAR adoption. </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> In our existing account and trained physician base, we have shown an ability to drive adoption in high surgical risk patients where CEA might otherwise be riskier or technically challenging, as well as in patients with anatomy or risk factors unfavorable for CAS.  Our strategy is to continue educating physicians in the approved indications for our TCAR products, and to expand the approved uses of our products across broader patient subgroups, as physicians&#8217; experience and confidence with the procedure accrues and our clinical evidence base expands through the Society for Vascular Surgery&#8217;s TCAR Surveillance Project and our ongoing and future studies.  We also plan to continue converting CEA or CAS procedures to TCAR in current hospital accounts by training additional physicians in these accounts.  </span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt;">Building</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">our</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">clinical</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">evidence</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">base</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">.  Vascular surgeons typically rely on clinical evidence to drive changes in their practice.  Primary care physicians and specialist referrers like neurologists and cardiologists also scrutinize clinical evidence. We completed the ROADSTER 2 study in 2019 and the results were subsequently presented in June 2019 at the VAM in National Harbor, Maryland, and we expect the data to be published in a peer-reviewed medical journal in the future.  We plan to continue to build our clinical evidence base by commencing new clinical studies intended to support marketing efforts and regulatory initiatives.  We also expect the </span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">19</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><div style="padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Society for Vascular Surgery&#8217;s ongoing TCAR Surveillance Project registry to continue to grow and produce valuable presentations and published papers with comparative data and sub-group analyses that will further define the role of TCAR across patient populations.  </span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt;">Broadening the indication for the ENROUTE stent and expanding reimbursement.</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">  We plan to continue to work to expand FDA labeling for the ENROUTE stent to address the approximately one-third of treated patients who present standard surgical risk.  If we obtain approval of a label expansion, we intend to pursue Medicare coverage for TCAR in standard surgical risk patients.</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt;">Pursuing international markets.</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">  Carotid artery disease and stroke are prevalent, devastating and costly conditions worldwide, and we estimate that a significant opportunity exists for TCAR outside the United States.  We currently have CE Mark for the ENROUTE NPS and ENROUTE stent, which would allow us to commercialize in Europe in the future.  We are also actively working towards regulatory clearances for our products in China and Japan.  </span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt;">Continuing our history of innovation in and beyond TCAR.</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">  We are currently developing additional and next generation products to support and improve TCAR to meet the evolving needs of physicians and their patients.  We also have a broad intellectual property platform and, in the future, we intend to leverage our expertise and the physiologic and engineering advantages made possible by our transcarotid approach to develop new products targeting procedures and vascular disease states in the heart, aortic arch and brain. </span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Clinical Data</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The safety, effectiveness and clinical advantages of TCAR have been observed in multiple clinical trials and post-market studies that have collectively evaluated more than 11,900 patients in the United States and Europe to date.  Our first-in-human trial, the PROOF Study, was initiated as a feasibility study to assess the safety and performance of the ENROUTE NPS and later was expanded to support CE marking of the ENROUTE NPS.  Data from the PROOF Study were also used to support FDA approval of the investigational device exemption, or IDE, for the ROADSTER Study.  Data from the pivotal cohort of the ROADSTER Study supported FDA 510(k) clearance of the ENROUTE NPS, and a subset of the data supported pre-market, or PMA, approval of the ENROUTE stent.  The results of the pivotal phase of the ROADSTER study were published in November 2015 in the Journal of Vascular Surgery.  We have completed a post market approval study, ROADSTER 2, which was designed to evaluate the outcomes in TCAR procedures using the ENROUTE stent used in conjunction with the ENROUTE NPS in broader, &#8220;real&#8209;world&#8221; use in 692 patients.  Data on TCAR outcomes also continues to accrue through the Society for Vascular Surgery-sponsored TCAR Surveillance Project, an ongoing real&#8209;world, open-ended regis</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">try which includes over 8,100 patients treated with TCAR as of December 31, 2019</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">.</span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">20</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Summary of Key Clinical Trials</span></div><div style="text-align:center;margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:99.519%;"><tr><td style="width:1.0%;"></td><td style="width:21.993%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.605%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:16.196%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.605%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:16.196%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.605%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:16.196%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.605%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:16.199%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">PROOF</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">ROADSTER</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">ROADSTER 2</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">TCAR Surveillance Project</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Study Type</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">First in Human<br/>CE Marking<br/>DW-MRI Sub-Study</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">U.S. Pivotal IDE Study</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">U.S. Post-Approval Study</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Real world observation </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Patients</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">75 pivotal<br/>56 DW-MRI Sub-<br/>Study</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">141 Pivotal<br/>78 Continued<br/>Access<br/>52 Stent Sub-<br/>Study</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">692</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Open Ended</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Profile</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">High Surgical Risk and Standard Surgical Risk</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">High Surgical Risk</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">High Surgical Risk</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">High Surgical Risk</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Status/Publication</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Complete<br/>J Endovasc Ther.  2017 Apr;24(2):265-270</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Complete<br/>J Vasc Surg.  2015 Nov;62(5):1227-34<br/>(pivotal cohort only)</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Complete</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Enrolling &gt;8,100 patients as of December 31, 2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Carotid Stent Systems Used</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">CE Marked Carotid Stents, including the Cordis Precise Stent</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">FDA Approved Carotid Stents, including the Cordis Precise Stent</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">ENROUTE Transcarotid Stent System</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">ENROUTE Transcarotid Stent System</span></td></tr></table></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Summary of TCAR Clinical Trial Outcomes </span></div><div style="text-align:center;margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:99.519%;"><tr><td style="width:1.0%;"></td><td style="width:25.536%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.605%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:8.305%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.605%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:8.305%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.605%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:6.534%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.605%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:8.305%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.605%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:6.534%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.605%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:8.305%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.605%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:6.541%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">PROOF</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">ROADSTER - pivotal phase</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">ROADSTER - continued access</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Pooled ROADSTER</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">ITT population</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">ITT population</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Per-protocol</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">ITT population</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Per-protocol</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">ITT population</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Per-protocol</span></td></tr><tr><td colspan="45" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Stroke at 30 days</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-indent:-9pt;padding-left:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">All stroke</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">(1)</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">All stroke and death</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr><tr><td colspan="45" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other adverse events at 30 days</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Myocardial infarction</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-indent:-9pt;padding-left:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">Cranial Nerve Injury</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%;">(Acute)</span></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">NR&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">NR&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">NR&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">Cranial Nerve Injury</span></div><div style="text-indent:-9pt;padding-left:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%;">(persisting at 6 months)</span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">NR&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">NR&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">NR&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="44" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Procedural information&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Mean procedure time (mins)</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">NR&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">73.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">NR&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">72.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">NR&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">73.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">NR&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">Mean length of stay </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%;">(days)</span></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">NR&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">NR&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">NR&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">NR&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%;">_________________</span></div><div style="text-indent:-18pt;padding-left:18pt;margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%;">(1)</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:9.45pt;">All strokes observed have been minor strokes; No major strokes have been observed.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">PROOF First-in-human Clinical Trial</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our first-in-human trial, the PROOF Study, was a single-arm trial conducted at one trial site in Europe from 2009 to 2012.  The PROOF Study was initiated as a feasibility study to assess the safety and performance of the ENROUTE NPS in a limited number of patients, initially enrolling 10 patients.  The PROOF Study was later expanded to 75 patients to collect the clinical data necessary to support CE marking of the ENROUTE NPS.  Data from the PROOF Study were also used to support FDA approval of the IDE for the ROADSTER Study.</span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">21</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The PROOF Study enrolled patients that were classified as high surgical risk, as well as patients classified as standard surgical risk.  The results from the PROOF Study demonstrated that TCAR was technically feasible and resulted in a stroke incidence of 1.3% within 30 days, which was significantly lower than that reported for CAS in prior clinical trials.  </span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Additionally, a sub-study of 56 patients underwent pre- and post-procedure diffusion-weighted magnetic resonance image scanning, or DW-MRI, to detect new white lesions on the ipsilateral side of the brain as a sensitive surrogate marker of microemboli and brain injury.  The analysis resulted in only 18% of the treatment population presenting with ipsilateral new white lesions, which was also comparable to that reported for CEA in prior clinical trials and significantly less than that reported in prior CAS trials.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Pivotal ROADSTER Clinical Trial </span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our pivotal trial, the ROADSTER Study, was a single-arm trial conducted at 17 sites across the United States and one site in Europe from 2012 to 2014.  The design of the ROADSTER Study, which was used to support FDA 510(k) clearance of the ENROUTE NPS, was largely based upon predicate embolic prevention studies and followed the relevant FDA guidance published in 2008.  In the pivotal phase, the ROADSTER study enrolled 141 patients that were classified as being at high surgical risk.  </span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The primary endpoint of the ROADSTER Study was a hierarchical composite of stroke, death or myocardial infarction within 30 days.  Key secondary endpoints included acute device, technical and procedural success at 30 days, as well as cranial nerve injury at six months.  The results of the ROADSTER Study were analyzed on an &#8220;intention to treat,&#8221; or ITT basis, as well as a &#8220;per protocol,&#8221; or PP basis.  The ITT results accounted for all patients enrolled in the clinical trial, including patients treated despite major protocol deviations.  The PP results included only patients that met all of the inclusion and none of the exclusion criteria and who were compliant with the protocol-mandated study medication regimen.  There were no patients lost to follow-up in either the ITT or PP cohorts.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">On an ITT basis, the primary endpoint event rate in the pivotal phase of the ROADSTER Study was a 3.5% hierarchical composite rate of stroke, death or myocardial infarction at 30 days, comprised of two strokes, or a 1.4% incidence, two deaths, or a 1.4% incidence, and one myocardial infarction, or a 0.7% incidence.  Both deaths were respiratory in nature and were independently adjudicated as not related to the device.  There were no site-reported cardiovascular or neurologic deaths, although our independent clinical events committee adjudicated one death as cardiovascular.  There were no major strokes.  There was one report of an acute cranial nerve injury, representing a 0.7% incidence, which resolved within six months.  These data supported FDA 510(k) clearance of the ENROUTE NPS.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In the PP analysis, the primary endpoint event rate was 2.9%, comprised of one stroke, or a 0.7% incidence, two deaths, or a 1.5% incidence, and one myocardial infarction, or a 0.7% incidence.  </span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">A continued access phase of the ROADSTER Study was conducted during the time that the 510(k) premarket notification for the ENROUTE NPS was under review by FDA.  This phase enrolled an additional 78 patients with the same primary and secondary endpoints as the pivotal phase of the ROADSTER Study.  The results of the continued access phase were similar to those reported in the pivotal phase of the ROADSTER study.  The ENROUTE NPS was 510(k) cleared by the FDA in February&#160;2015.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Following a pre-submission interaction with the FDA, the FDA permitted data from a sub-analysis of 52 patients in the ROADSTER Study who were treated with the Cordis Precise Pro RX Carotid Stent System to be used, in conjunction with existing data from Cordis on CAS clinical trials performed with the Cordis Precise Pro RX, to support our pre-market approval application for the ENROUTE stent.  The ENROUTE and Precise stent systems share the same design for the stent implant itself, and differ only in the design of the delivery system.  Based on this data, the PMA for the ENROUTE stent was approved in May 2015.</span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">22</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We also initiated a separate sub-study of patients treated PP in the ROADSTER pivotal and continued access cohorts to assess the longer-term rate of ipsilateral stroke beyond 30 days.  This sub-analysis, which consisted of 164 patients including 112 from the pivotal phase and 52 from the continued access phase, provided insight into the ability of TCAR to limit stroke incidence in longer-term follow-up.  At one-year follow-up, the ipsilateral stroke rate was 0.6% and the mortality rate was 3.7% past 30 days in patients with a life expectancy of 1 year. </span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">ROADSTER 2 U.S. Post Market Approval Study</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The ROADSTER 2 Post Approval Study was a condition of PMA approval for the ENROUTE stent.  The study evaluated the outcomes in TCAR using the ENROUTE stent in conjunction with the ENROUTE NPS in broader, &#8220;real world&#8221; use.  Like the sub-analysis from the ROADSTER Study that led to PMA approval of the ENROUTE stent, the primary endpoint, which was assessed on a PP basis, is the rate of procedural success at 30 days in high surgical risk patients with a three year minimum life expectancy.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The ROADSTER 2 post approval study enrolled 692 patients at 42 sites.  61.8% of the participating patients were treated by physicians that did not participate in the ROADSTER Study.  The FDA mandated that at least 70% of the sites be new sites.  Enrollment commenced in 2015.  Enrollment and final 30-day follow-up assessments were completed in 2019.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In the ROADSTER 2 final report submitted to the FDA in October 2019, data on 632 patients treated PP were presented. The procedural success rate in ROADSTER 2 was 97.9%.  The lower bound of the 2-sided 95% exact binomial confidence intervals of the observed procedural success rate significantly exceeds the </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">a priori </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">threshold of 85% (p&lt;0.0001). The primary endpoint of ROADSTER 2 was met and, as a result the rate of procedural success in ROADSTER 2 compares favorably to the rate of procedural success in the combined pivotal and continued access cohorts of the initial ROADSTER study. Other key clinical endpoints include the rates of hierarchical ipsilateral stroke, death and myocardial infarction, cardiac death, neurologic death and cranial nerve injury. These key clinical endpoints in ROADSTER 2 are summarized in the following table:</span></div><div style="text-align:center;margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:84.057%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:11.943%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="6" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">ROADSTER 2: key clinical endpoints at 30 days</span></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">N=632</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Stroke and death at 30 days</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">All stroke</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">All stroke and death</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other adverse events at 30 days</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Ipsilateral Stroke</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Rate of Death - Cardiac</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Rate of Death - neurologic</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Rate of Death - Other</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Rate of Acute Cranial Nerve Injuries (ITT)</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Myocardial infarction</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Procedural information</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Mean procedure time (mins)</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">74.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Mean length of stay (days)</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">23</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Data from a subset of ROADSTER 2 subjects (n=155) is being analyzed to assess the incidence of ipsilateral stroke from day 31 through day 365 post-procedure.  These data are expected to be published in the future.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">The Society for Vascular Surgery&#8217;s TCAR Surveillance Project</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The TCAR Surveillance Project was implemented in September 2016 as an initiative of the Society for Vascular Surgery Patient Safety Organization.  The TCAR Surveillance Project is an ongoing, open-ended registry that was designed to monitor the safety and effectiveness of transcarotid stents placed directly into the carotid artery while reversing blood flow within the carotid artery.  It is intended to compare TCAR with CEA in centers that participate in the Society for Vascular Surgery Vascular Quality Initiative, or VQI.  The TCAR Surveillance Project was reviewed by the FDA and deemed to be a scientifically valid extension study of TCAR, thereby allowing CMS to provide coverage within the parameters of the existing National Coverage Determination.  The Society for Vascular Surgery VQI is designed to improve the quality, safety, effectiveness and cost of vascular health care by collecting and exchanging information, and it is available to all providers of vascular health care and their respective institutions.  Because data from CAS procedures are also collected in the Society for Vascular Surgery VQI, comparisons of TCAR to CAS can also be made.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Eligible patients must meet the inclusion criteria specified for the TCAR Surveillance Project.  Generally, patients must be at high surgical risk and must have had their TCAR procedure performed using any FDA-cleared transcarotid proximal embolic protection device utilizing flow reversal, such as our ENROUTE NPS, and any FDA-approved transcarotid stent, such as our ENROUTE stent</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">.  </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">To date, the ENROUTE stent and the ENROUTE NPS are the only such devices cleared and approved by the FDA. </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;"> </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">TCAR procedures entered into the Society for Vascular Surgery VQI carotid artery stenting registry for the TCAR Surveillance Project are eligible for reimbursement by Medicare if the patients meet the requirements set forth above.  We believe the TCAR Surveillance Project represents a unique collaboration between a physician specialty society, the FDA and CMS.  We believe it also marks the first time that CMS has granted broader reimbursement for a stent-based treatment paradigm for carotid artery disease in a registry not managed by industry.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The TCAR Surveillance Project is intended to be a repository for TCAR procedures and outcomes data to broaden the clinical evidence base for TCAR.  TCAR is one of many surgical and endovascular procedures that is tracked by the Society for Vascular Surgery VQI.  Over time, it is expected that physicians and academic researchers will query the database and produce publications in peer review journals, and present data at medical conferences, regarding the safety and effectiveness of TCAR in real world use.  </span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The primary outcome measure of the TCAR Surveillance Project is one-year ipsilateral stroke or death.  The TCAR Surveillance Project also tracks in-hospital stroke, death and myocardial infarction.  Other secondary outcomes, such as cranial nerve injury and re-intervention, are also being reported.  For the secondary outcome measures, any stroke will be counted and in-hospital stroke events are not limited to the ipsilateral side.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In the Society for Vascular Surgery Vascular Quality Initiative 2019 Annual Report, it was reported that 292 centers have contributed more than 8,100 TCAR cases to the CAS VQI registry.  In an article for </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Endovascular Today</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">, in August 2019, Marc Schermerhorn, M.D. reported that TCAR accounted for more than 50% of the procedures entered into the CAS registry of the SVS VQI in the first four months of 2019. In a</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">n email from the TCAR steering committee, they further p</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">rojected that TCAR would account for more than 4,000 procedures during 2019 while CAS would account for just over 3,000 procedures.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">TCAR Surveillance Project: TCAR vs. CEA</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Contemporaneous comparative outcomes fro</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">m January 2016 to September 2018 were presented in November 2018</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> in both unadjusted analyses as well as analyses adjusted for the baseline characteristics of the patient populations.  In general, patients treated with TCAR were older than patients treated with </span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">24</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">CEA, and were more likely to have coronary co-morbidities, renal dysfunction and a prior carotid intervention.  Below is a summary of the outcomes presented and the patient demographics in which there was a statistically significant difference between the populations.</span></div><div style="text-align:center;margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:53.769%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:11.942%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:11.942%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:11.944%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="21" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">TCAR vs. CEA Unadjusted Outcomes (in hospital)</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Stroke and other adverse events</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">TCAR<br/>(%)<br/>N=2,545</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">CEA<br/>(%)<br/>N=43,114</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">P-value</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Major adverse events at 30 days</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Stroke/Death</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.09&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Stroke/Death/Myocardial infarction</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.17&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Stroke</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.27&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Death</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.04&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">30-day Death</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.08&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other adverse events at 30 days</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Myocardial infarction</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.71&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cranial nerve injury</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&lt;.001&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Bleeding</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.05&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other procedural information</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Mean procedure time (mins)</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">75.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">116.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&lt;0.001&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Length of stay &gt;1 day</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">29&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">32&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&lt;0.01&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div style="text-indent:18pt;text-align:center;margin-bottom:9pt;"><span><br/></span></div><div style="text-align:center;margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:53.769%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:11.942%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:11.942%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:11.944%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="21" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">TCAR vs. CEA Baseline Demographics (% of patients)</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">TCAR<br/>N=2,545</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">CEA<br/>N=43,114</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">P-value</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Age</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">73.1 + 9.4</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">70.6 + 9.6</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&lt;.001</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Female</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">36.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">39.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&lt;.01</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Coronary artery disease</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">51.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">26.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&lt;.001</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Prior congestive heart failure</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">18.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&lt;.001</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Prior coronary artery bypass grafting</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">23.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">19.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&lt;.001</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Prior percutaneous coronary intervention</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">28.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">22.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&lt;.001</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Chronic obstructive pulmonary disease</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">29.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">23.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&lt;.001</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Glomerular filtration rate&lt;60</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">40.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">34.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&lt;.001</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Current smoker</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">23.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">25.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.05</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Prior carotid revascularization</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">30.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">15.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&lt;.001</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Aspirin</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">89.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">83.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&lt;.001</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Antiplatelet</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">84.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">34.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&lt;.001</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Statin</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">88.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">83.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&lt;.001</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Beta-blockers</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">55.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">51.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&lt;.001</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Anticoagulants</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&lt;.001</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Anesthesia</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">82.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">92.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&lt;.001</span></td></tr></table></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The unadjusted results to date from the TCAR Surveillance Project show that TCAR has provided similar in-hospital reduction in stroke risk as compared to CEA, despite treating sicker, older patients with TCAR, and TCAR showed significantly lower risk of cranial nerve injury.  The incidence of in-hospital </span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">25</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">death in the unadjusted outcomes was slightly higher for TCAR due to the co-morbidities in the TCAR patients.  Patients treated with TCAR were generally older and had more co-morbidities than the cohort of patients treated with CEA.  As such, the odds ratio of in-hospital death between TCAR and CEA is the same when adjusting for patient risk factors.  </span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In the unadjusted analysis, cranial nerve injury and bleeding were significantly different between TCAR and CEA.&#160; TCAR patients had a ten-fold reduction in risk of cranial nerve injury when compared to CEA, and TCAR had a significantly higher rate of bleeding.  When adjusting for risk and in a propensity matched analysis, the rate of bleeding was not significantly different between TCAR and CEA; however, the significantly lower risk of cranial nerve injury with TCAR remained.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Average TCAR procedure time was significantly shorter and there was a significant reduction in the percentage of hospital stays longer than one day, relative to CEA.  These benefits can help hospitals to better utilize their operating room capacity and fixed overhead and reduce the number of procedures associated with hospital stays longer than one day, which have been shown to result in financial losses for the hospital facilities.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">TCAR Surveillance Project: TCAR vs. CAS</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In a similar analysis comparing TCAR to CAS, TCAR showed significantly lower rates of stroke and death; stroke, death and myocardial infarction; in hospital death; and death within 30 days in both the adjusted and unadjusted analysis.  When adjusted for baseline risk characteristics associated with the patient population, the difference in bleeding events was no longer significant.  Below is a summary of the outcomes presented and patient demographics for patient characteristics with a statistically significant difference between the populations.</span></div><div style="text-align:center;margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:53.769%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:11.942%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:11.942%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:11.944%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="21" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">TCAR vs. CAS Unadjusted Outcomes (in hospital)</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Stroke and other adverse events</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">TCAR<br/>(%)<br/>N=2,545</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">CAS<br/>(%)<br/>N=9,460</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">P-Value</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Stroke/Death</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&lt;.001</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Stroke/Death/Myocardial infarction</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&lt;.001</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Stroke</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.02</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">In-hospital Death</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&lt;.001</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">30-day Death</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&lt;.001</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Myocardial infarction</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.62</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Bleeding</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&lt;.001</span></td></tr></table></div><div style="text-indent:18pt;text-align:center;margin-bottom:9pt;"><span><br/></span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">26</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><div style="text-align:center;margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:53.769%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:11.942%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:11.942%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:11.944%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="21" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">TCAR vs CAS Baseline Demographics (% of patients)</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">TCAR<br/>N=2,545</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">CAS<br/>N=9,460</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">P-Value</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Age</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">73.1 + 9.4</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">69.6 + 3.7</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&lt;.001</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Black</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&lt;.01</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Asymptomatic</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">52.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">38.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&lt;.001</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Coronary artery disease</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">51.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">38.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&lt;.001</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Prior congestive heart failure</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">18.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">16.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&lt;.01</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Prior coronary artery bypass grafting</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">23.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">20.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&lt;.01</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Prior percutaneous coronary intervention</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">28.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">25.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.01</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Chronic obstructive pulmonary disease</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">29.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">27.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.03</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Glomerular filtration rate&lt;60</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">40.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">34.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&lt;.001</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Current Smoker</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">23.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">28.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&lt;.001</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Prior CEA</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">25.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">28.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&lt;.01</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Prior CAS</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">19.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&lt;.001</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Aspirin</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">89.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">85.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&lt;.001</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Antiplatelet (other than aspirin)</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">84.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">74.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&lt;.001</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Statin</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">88.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">81.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&lt;.001</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Beta-blockers</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">55.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">52.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.03</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Anticoagulants</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.02</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Medical high risk</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">59.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">36.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&lt;.001</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Anatomic high risk</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">50.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">43.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&lt;.001</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">General Anesthesia</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">82.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">20.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&lt;.001</span></td></tr></table></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Since November 2018, the TCAR Surveillance Project Steering Committee has presented and published updated comparisons of TCAR to both CEA and CAS.  In June 2019, updated outcomes from the TCAR Surveillance Project were presented at VAM.  The outcomes featured data from 5,716 patients treated with TCAR and 44,442 patients treated with CEA.  In a propensity matched analysis of TCAR and CEA with 5,160 patients in each cohort, TCAR provided similar in-hospital stroke rates as compared to CEA, but had significantly lower odds of in-hospital myocardial infarction and composite stroke, death and myocardial infarction.  TCAR patients were also significantly less likely to suffer a cranial nerve injury and to remain in the hospital longer than one day.  TCAR had lower odds of 30-day death (34% lower), 30-day myocardial infarction (64% lower), 30-day stroke and death (46% lower), and composite stroke, death and myocardial infarction (53% lower).</span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">27</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><div style="text-align:center;margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:45.756%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.441%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:23.480%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.441%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:23.482%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Propensity Score Matching (N=5,160 in each cohort)</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-style:italic;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">OR (95% CI)</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-style:italic;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">P-value</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">In-Hospital Outcomes</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Death</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.86 (0.46-1.61)</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.63</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Ipsilateral Stroke</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.92 (0.64-1.32)</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.64</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Stroke</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.80 (0.58-1.11)</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.19</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">MI</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.41 (0.26-0.66)</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;">&lt;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%;">0.001</span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Stroke/Death</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.77 (0.57-1.04)</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.09</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Stroke/Death/MI</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.65 (0.50-0.84)</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&lt;0.01</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cranial Nerve Injury</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.13 (0.07-0.22)</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&lt;0.001</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Post-procedural Hypotension</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.66 (1.47-1.87)</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&lt;0.001</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Post-procedural Hypertension</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.64 (0.57-0.71)</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&lt;0.001</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Bleeding with intervention</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.17 (0.83-1.65)</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.38</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Non-Home discharge</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.75 (0.64-0.87)</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&lt;0.001</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Hospital Stay for more than 1 day</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.74 (0.68-0.80)</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&lt;0.001</span></td></tr></table></div><div style="text-indent:18pt;margin-bottom:9pt;"><span><br/></span></div><div style="text-align:center;margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:29.730%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.441%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:10.019%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.441%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:9.378%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.441%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:8.737%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.441%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:8.096%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.441%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:8.096%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.441%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:8.098%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">30-Day Outcomes</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Unadjusted</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Adjusted</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:top;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">CEA</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:top;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">TCAR</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:top;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">P-value</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:top;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">CEA</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:top;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">TCAR</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:top;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">P-value</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Mortality</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:top;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">308 (0.70)</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:top;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">40 (0.70)</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:top;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.95</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:top;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Ref.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:top;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.66 (0.46-0.95)</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:top;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.03</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Stroke</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">241 (1.4)</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">16 (1.1)</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.46</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Ref.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.68 (0.39-1.20)</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.18</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">MI</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">140 (0.80)</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9 (0.6)</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.52</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Ref.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.36 (0.16-0.83)</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.02</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Stroke/Death</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">323 (1.8)</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">19 (1.4)</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.19</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Ref.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.54 (0.33-0.89)</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.02</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Stroke/Death/MI</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">453 (2.6)</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">27 (1.9)</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.13</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Ref.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.47 (0.30-0.74)</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&lt;0.01</span></td></tr></table></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In December 2019, the steering committee of the TCAR Surveillance Project published a comparison of outcomes for TCAR and CAS in the </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Journal of the American Medical Association</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">.  During the study period (September 2016 through May 2019), 5,251 patients underwent TCAR and 6,640 patients underwent CAS. After propensity score matching, there were 3,286</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> pairs of </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">patients available for analysis.  As was the case in the VAM presentation comparing TCAR and CEA, TCAR patients were older and had more medical co-morbidities.  In-hospital stroke or death was 1.6% for TCAR versus 3.1% for CAS. TCAR was associated with significantly lower risks of in-hospital stroke alone (1.3% for TCAR versus 2.4% for CAS) and in-hospital death alone (0.4% for TCAR versus 1.0% for CAS). The differences favoring TCAR persisted through 30 days and 1 year. Key clinical and procedural outcomes are summarized in the following table:</span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">28</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><div style="text-align:center;margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:95.673%;"><tr><td style="width:1.0%;"></td><td style="width:31.668%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.470%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:13.577%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.470%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:13.577%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.470%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:14.917%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.470%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:13.581%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Outcome</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">TCAR<br/>(n=3,286)</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">CAS<br/>(n=3,286)</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Relative Risk<br/>(95% CI)</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:150%;">P </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:150%;">Value</span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Stroke or death (in hospital)</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:top;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.6%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:top;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.1%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:top;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.51 (0.37 to 0.72)</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:top;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&lt;.001</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Stroke or death (30 days)</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.9%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.7%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.54 (0.38 to 0.79)</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&lt;.001</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Stroke or death (1 year)</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5.1%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9.6%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.52 (0.41 to 0.66)</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&lt;.001</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Stroke (in hospital)</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.3%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.4%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.54 (0.38 to 0.79)</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.001</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Stroke (30 days)</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.3%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.5%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.53 (0.37 to 0.76)</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&lt;.001</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Death (in hospital)</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.4%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.0%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.44 (0.23 to 0.82)</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.008</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Death (30 days)</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.8%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.5%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.52 (0.32 to 0.84)</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.007</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Myocardial Infarction</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.2%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.3%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.70 (0.27 to 1.84)</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.47</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Access site bleeding complication</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.5%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.8%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.93 (0.72 to 1.19)</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.55</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div style="text-indent:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:150%;">Interventional treatment</span></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.3%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.8%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.63 (1.02 to 2.61)</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.04</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div style="text-indent:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:150%;">Blood transfusion</span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.8%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.2%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.85 (0.60 to 1.19)</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.33</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Technical Failure</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.5%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.2%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.37 (0.20 to 0.66)</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&lt;.001</span></td></tr></table></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In another publication from the SVS VQI published in the Journal of the American College of Surgeons in January 2020, Kashyap, et al, examined the learning curve of TCAR performed by surgeons participating in the TCAR Surveillance Project.  The authors reviewed 3,456 TCAR procedures performed by 417 unique practitioners at 178 centers.  Patients were grouped into four levels based upon the physicians&#8217; experience with TCAR at the time of procedure: novice (1-5 cases), intermediate (6-20 cases), advanced (20-30 cases) and expert (&gt;30 cases). Of the patients analyzed, 41% of patients were treated by novice physicians, 40% of patients were treated by intermediate physicians, 9% of patients were treated by advanced physicians and 10% of patients were treated by expert physicians. There was no significant difference in the baseline characteristics by surgeon case experience with three exceptions; expert physicians were more likely to treat patients with moderate or severe congestive heart failure, novice and intermediate physicians were more likely to treat patients with prior CEA or CAS, and advanced and expert physicians were more likely to treat patients with CMS medical high-risk criteria. There was a statistically significant reduction in operative time (novice 81.7 mins, expert 59.6 mins; p&lt;.001) and flow reversal time (novice 12.2 mins, expert 9.7 mins; p&lt;.001) over the four levels. There was a decrease in fluoroscopy time and contrast usage up to the advanced level. Bleeding complications were significantly less frequent in the advanced and expert groups of physicians. There was no difference in the incidence of cranial nerve injury across the groups of physicians. Expert physicians were more likely to use local anesthesia compared to the other three categories of physicians.  There was no difference in the technical failure rate across the four categories of physicians.  The rate of composite stroke, stroke alone and death did not differ between the categories.  The authors noted that TCAR novices can achieve the same clinical outcomes as expert practitioners, while in comparison CAS requires more than 50 cases to achieve proficiency.  The following table summarizes unadjusted outcomes by surgeon case experience:</span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">29</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><div style="text-align:center;margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:20.275%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.441%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:12.903%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.441%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:12.903%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.441%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:12.903%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.441%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:12.903%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.441%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:12.908%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Outcome</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Novice<br/>Cases 1-5<br/>(n=1,426)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Intermediate<br/>Cases 6-20<br/>(n=1,375)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Advanced<br/>Cases 20-30<br/>(n=307)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Expert<br/>Cases &gt;30<br/>(n=348)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:150%;">P</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:150%;"> Value</span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Stroke/death</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:top;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.5%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:top;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.4%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:top;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.0%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:top;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.4%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:top;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.9</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Stroke/death/MI</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.8%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.6%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.0%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.3%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.84</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Stroke</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.2%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.2%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.0%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.2%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.99</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">TIA</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.8%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.0%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.7%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.3%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.65</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Death</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.3%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.4%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.0%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.6%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.39</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">MI</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.4%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.2%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.0%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.9%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.2</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cranial nerve injury</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.2%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.4%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.0%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.0%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.51</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Bleeding complications</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.9%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.4%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.6%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.2%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.03</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Technical Failure</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.5%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.7%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.3%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.0%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.45</span></td></tr></table></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In January 2020, the SVS VQI published data on the impact of age on in-hospital outcomes after TCAR, CAS and CEA in the </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Journal of Vascular Surgery</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">.  Patients entered in the SVS VQI CAS and CEA registries between 2015 and November 2018 were included in the analysis.  The study cohort included 3,152 TCAR patients, 10,381 CAS patients and 61,650 CEA patients. Patients were divided into three age groups (&#8804;70 years, 71-79 years and &#8805;80 years). As was the case in previous analyses from the SVS VQI, TCAR patients were older and more likely to have major co-morbidities such as coronary artery disease, congestive heart disease, chronic kidney disease and a higher ASA classification. Over 25% of the TCAR patients were 80 years of age or older compared to 15.8% of CAS patients and 17.6% of CEA patients. </span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The rates of in-hospital stroke/death after TCAR were 1.4% in patients &#8804;70 years, 1.9% in patients 71-79 years and 1.5% in patients &#8805;80 years. The differences between age groups were not significant (p=0.55). The comparison of TCAR to CEA across different age groups showed no differences in outcomes and no interaction between treatment and age in predicting in-hospital stroke/death (p=0.80). As with prior analyses, TCAR had significantly lower odds of cranial nerve injury compared to CEA across the three age groups (84%, 79% and 95% respectively). </span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Conversely, in patients age &gt;/+80, TCAR was associated with a 72% reduction in stroke risk (1.0% vs 4.7%; OR 0.28; 95%CI, 0.12-0.65; p&lt;0.01), a 65% reduction in the risk of stroke/death (1.5% vs 4.6%; OR 0.35; 95%CI 0.20-0.62; p&lt;0.001) and a 76% reduction in stroke/death/myocardial infarction (2.5% vs 5.3%; OR 0.24; 95%CI 0.12-0.47; p&lt;0.001) when compared to CAS. The stroke risk for CAS doubled at age 85 compared to TCAR; the stroke/death risk for CAS doubled at age 77 compared to TCAR. No significant differences were noted between TCAR and CEA with age.</span></div><div style="text-align:center;margin-bottom:9pt;"><img src="silk-20191231_g9.gif" alt="silk-20191231_g9.gif" style="height:220px;width:362px;"/></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">30</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><div style="text-indent:18pt;text-align:justify;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Adjusted odds ratios (ORs) of in-hospital stroke (left) and stroke/death (right) after TCAR vs CAS for age-by-treatment interaction. In each graph, the first dotted vertical line represents the age at which the odds of the outcomes in CAS compared with TCAR become significant. The second dotted vertical line represents the age at which the odds in CAS become double that of TCAR.</span></div><div style="text-align:center;margin-bottom:9pt;"><img src="silk-20191231_g10.gif" alt="silk-20191231_g10.gif" style="height:226px;width:368px;"/></div><div style="text-indent:18pt;text-align:justify;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Adjusted odds ratios of in-hospital stroke (left) and stroke/death (right) for age-by-treatment (CEA vs TCAR) interaction.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The authors attributed the significant increase in odds of adverse outcomes after CAS compared with TCAR in patients &#8805;80 years of age to the increased prevalence of severe aortic arch disease and target lesion calcification and ulceration in the elderly. The authors concluded that TCAR is relatively safe regardless of patient age independent of symptomatic status and other medical comorbidities. </span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Ongoing and Planned TCAR Studies</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In addition to the Society for Vascular Surgery&#8217;s TCAR Surveillance Project, we have one ongoing study in the European Union enrolling up to 50 patients and evaluating the rate of sub-clinical embolization, or new white lesions, as detected on DW-MRI in recently symptomatic patients.  The primary endpoint is the rate of ipsilateral new white lesions as seen on DW-MRI at 30 days compared to pre-procedure baseline white lesions.  The evaluation of the presence of new white lesions is conducted in a blinded fashion by an independent neuroradiologist.  </span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We are conducting a similar study at four hospitals in the United States and one in the European Union.  We have obtained Institutional review board and ethics committee approvals and enrollment began in the third quarter of 2019.  The primary endpoint is the rate of ipsilateral new white lesions at 30 days.  Enrollment of up to 75 patients is planned in this study.</span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Our Commercial Strategy</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We designed our commercial strategy and built our direct sales force to target primarily vascular surgeons across the United States, who we believe represent the specialty most frequently responsible for managing the care of and receiving referrals for patients with carotid artery disease.  We believe there are approximately 2,750&#160;physicians that perform an estimated 80% of annual carotid revascularization procedures in the United States.  Vascular surgeons are skilled in endovascular procedures and our sales, marketing, professional education and medical affairs efforts are focused on driving adoption and supporting their practice development by offering them an innovative, safe, effective and minimally-invasive alternative for treating carotid artery disease.  </span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In the United States, we market and sell our portfolio of TCAR products for TCAR through a direct sales organization consisting of 35 sales representatives, known as area managers, or AMs, and </span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">31</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">61&#160;clinical support specialists, known as therapy development specialists, or TDSs, as of December 31, 2019.  Our sales professionals have substantial experience launching and establishing new disruptive therapies and converting open surgical procedures to minimally-invasive alternatives.  We primarily market our products directly to vascular surgeons, their staffs, operating room managers and hospital administrators.  We also market to other specialists with experience in CEA and/or CAS with the appropriate skill set for TCAR, including neurosurgeons, cardiothoracic surgeons and non-surgical interventionalists in radiology, neuroradiology and cardiology.  We do not currently sell our products in markets outside the United States.  </span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our AMs are responsible for developing territory business plans, targeting and opening new accounts, promoting the benefits of TCAR and our products, and driving adoption and penetration of TCAR. In addition, they help physicians and their staff to build TCAR programs, drive certain referral initiatives, and provide resources to help with practice development, reimbursement and patient education. Together with the TDSs, they also support the training and proper use of our TCAR portfolio of products and provide clinically consultative support for patient selection, pre-procedure planning, procedure support, and post-procedure care. As we continue to grow the size of our U.S. sales organization, with a focus on increasing adoption of TCAR by existing customers and expanding our current customer base, we expect to focus on adding a strategic mix of area managers and therapy development specialists. </span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Additionally, we support our sales organization with marketing and market and practice development initiatives.  We plan to continue to expand and enhance our marketing and analytics capabilities to support our growing commercial organization and customer base.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Professional Education and Sales Training </span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We are focused on developing strong relationships with our customers and devote significant resources to training and educating physicians in the use of TCAR and our associated products.  Our Office of Medical Affairs leads our physician education and training programs in addition to disseminating the scientific information and clinical data supporting TCAR.  The Office of Medical Affairs also leads compliance activities.  </span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our practice is to require physicians to complete a training program before performing TCAR, which is also a regulatory requirement derived from the PMA approval of the ENROUTE stent.  To facilitate training, we have developed a robust training course including clinical and procedural details as well as hands-on workshops designed to provide the highest potential for successful outcomes.  We also selectively provide training through physician proctors on an as needed basis.  </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">As of December 31, 2019, we have trained and certified over 1,440 physicians in the United States.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Through the Office of Medical Affairs, our highly specialized area managers and therapy development specialists, along with other key employees, receive in-depth training and develop a thorough understanding of carotid artery disease, patient selection, imaging interpretation, procedure planning, reimbursement and regulatory policies to meaningfully support our customers and maintain compliance.  Our extensive training and continuous education program consists of in-person foundational training, procedure observation, and sales skills development.  Our personnel are selected based on their focus on patient outcomes and the entire customer experience in addition to their technical aptitude.</span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Coverage and Reimbursement</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Since achieving regulatory clearances and approvals for our portfolio of TCAR products, we have successfully launched our products, driven adoption of TCAR and made significant progress securing reimbursement codes and payer coverage.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">During the ROADSTER trial, the Society for Vascular Surgery helped to guide modifications of existing reimbursement coding descriptions to ensure their applicability to TCAR.  In 2015, we also confirmed with CMS that TCAR, like CAS, was considered under the purview of the National Coverage Determination 20.7, or NCD, for Percutaneous Transluminal Angioplasty.&#160;</span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">32</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">According to the Healthcare Utilization Project, Medicare is the primary payer for carotid revascularization procedures, representing approximately 78% of the payer mix for CEA and CAS procedures in 2014.  TCAR is currently covered by CMS in high surgical risk patients who are symptomatic with greater than or equal to 70% stenosis.  As of September 2016, TCAR is also covered by CMS in the TCAR Surveillance Project for high surgical risk patients who are either symptomatic with greater than or equal to 50% stenosis or asymptomatic with greater than or equal to 80% stenosis.  We intend to seek FDA label expansion for our ENROUTE stent and CMS coverage for TCAR in standard surgical risk patients, as well as seek new and expanded coverage for TCAR in commercial payer coverage policies.  </span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">TCAR, like CAS, is only reimbursed by Medicare as an inpatient procedure and therefore reimbursed to hospitals under the DRG system.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">There are three key aspects of reimbursement in the United States: coding, coverage and payment.</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt;">Coding</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> refers to distinct numeric and alphanumeric billing codes that are used by healthcare providers to report the provision of medical procedures and the use of supplies for specific patients to payers.  CPT codes are published by the American Medical Association and are used to report medical services and procedures performed by or under the direction of physicians.  Medicare pays physicians for services based on submission of a claim using one or more specific CPT codes.  Physician payment for procedures may vary according to site of service.  Hospitals are reimbursed for inpatient procedures based on Medicare Severity Diagnosis Related Group, or MS-DRG classifications derived from ICD-10-CM diagnosis and ICD-10-PCS codes that describe the patient&#8217;s diagnoses and procedure(s) performed during the hospital stay.  MS-DRGs closely calibrate payment for groups of services based on the severity of a patient&#8217;s illness.  One single MS-DRG payment is intended to cover all hospital costs associated with treating an individual during his or her hospital stay, with the exception of physician charges associated with performing medical procedures, which are reimbursed through CPT codes and payments.  </span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt;">Payment</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> refers to the amount paid to providers for specific procedures and supplies.  Payment is generally determined by the specific CPT and billing code.  In addition, there may be separate numeric codes, under which the billing code is classified, to establish a payment amount.  </span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt;">Coverage</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> refers to decisions made by individual payers as to whether or not to pay for a specific procedure and related supplies and if so, under what conditions, including specific diagnoses and clinical indications.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Coding for Physicians</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In 2014, the Society for Vascular Surgery helped to guide an editorial change by the American Medical Association to CPT 37215 to be inclusive of TCAR.&#160; The Category I CPT code for TCAR, effective January 1, 2015, is CPT 37215: Transcatheter placement of intravascular stent(s), cervical carotid artery, open or percutaneous, including angioplasty, when performed, and radiological supervision and interpretation; with distal embolic protection.  Published CMS guidance confirms that reverse flow embolic protection systems, such as our ENROUTE NPS, qualify as distal embolic protection under this code.  This code has a 90-day global period.  Coverage and payment for CPT code 37215 is only available from CMS in the inpatient setting, subject to the terms of the National Coverage Determination Manual Section 20.7, and only available in facilities certified to have met CMS&#8217;s minimum facility standards for performing carotid artery stenting, which include local credentialing requirements.  Hospitals participating in the VQI are considered to meet CMS&#8217;s minimum facility standards.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Coding for Hospitals</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">There are a&#160;number of appropriate ICD-10-CM diagnosis codes that describe occlusions and stenosis of carotid arteries for asymptomatic patients as well as cerebral infarction due to embolus and thrombus of carotid arteries for symptomatic patients, which establish medical necessity. &#160;The proper ICD-10-PCS </span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">33</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">procedure codes for TCAR are 037H3DZ, 037J3DZ, 037K3DZ and 037L3DZ, and the appropriate MS-DRGs for TCAR are 034 when the patient presents with major complications or co-morbidities, 035 when the patient presents with a complication or co-morbidity, and 036 for patients without complications or co-morbidities.&#160;  </span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Payment for Physicians</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The 2020 national average physician professional fee payment for CPT code 37215 is approximately $1,050.  We believe physicians feel this level of payment represents a reasonable amount for TCAR.  CEA procedures are reimbursed under CPT code 35301, for which the 2020 national average physician professional fee payment is $1,187.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Payment for Hospitals</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The national unadjusted 2020 payment amounts for MS-DRGs 034, 035 and 036 are $23,512, $14,427 and $10,968 respectively.&#160; Based on prior procedure volumes, we estimate that the average payment amount across these three codes is $13,850 in 2020.&#160; These single MS DRG payments are intended to cover all hospital costs associated with treating an individual during his or her hospital stay, with the exception of physician charges associated with performing medical procedures. We believe that facilities feel this level of payment represents a reasonable amount for the treatment of patients with carotid artery disease. CEA procedures are reimbursed under MS-DRGs 037, 038 and 039. &#160;We expect the national unadjusted 2020 payment amounts for MS-DRGs 037, 038 and 039 to be $20,315, $10,493 and $7,086 respectively.&#160; Based on prior procedure volumes, we estimate that the average payment amount across these three codes to be $9,360. &#160;The base payment amounts for MS-DRGs may vary greatly by individual acute-care hospital for a number of reasons including but not limited to geographic, teaching status, case-mix index, and use of electronic health record systems.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Coverage</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">According to the Healthcare Utilization Project, the Center for Medicare and Medicaid Services, or CMS, was the primary payer for carotid procedures, covering 78% of CEA procedures and 77% of CAS procedures in 2014.  In 2015, we also confirmed with CMS that TCAR, like CAS, was considered under the purview of the National Coverage Determination, or NCD, for Percutaneous Transluminal Angioplasty.  Coverage of TCAR by CMS, other government, and commercial payers is important for our commercial development.  Currently, pursuant to the NCD for Percutaneous Transluminal Angioplasty, TCAR is covered by CMS under certain circumstances for high surgical risk patients; as well as certain other instances, including participation in certain trials and studies.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Patients at high risk for adverse events from CEA are defined as having significant comorbidities or anatomic risk factors and would be poor candidates for CEA.  Symptoms of carotid artery stenosis include carotid transient ischemic attack, focal cerebral ischemia producing a nondisabling stroke, and transient monocular blindness.  The determination that a patient is at high risk for adverse events from CEA and the patient&#8217;s symptoms arising from carotid artery stenosis must be documented in the patient&#8217;s medical records.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">CMS has created a list of minimum standards modeled in part on professional society statements on competency.  All facilities must at least meet CMS standards in order to receive coverage for CAS, inclusive of TCAR, for high surgical risk patients.  Participation in the Society for Vascular Surgery&#8217;s Vascular Quality Initiative can provide evidence of compliance to these standards to CMS.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The TCAR Surveillance Project is an FDA-approved extension study.  We understand that Medicare has reimbursed hospitals and physicians for symptomatic patients with greater than or equal to 50% carotid artery stenosis and asymptomatic high surgical risk patients with greater than or equal to 80% carotid artery stenosis who participate in the TCAR Surveillance Project.  For billing purposes, facilities and providers can submit claims for the TCAR Surveillance Project using National Clinical Trial identifier NCT02850588.</span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">34</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">ROADSTER 2 is another FDA-approved Post Approval Study that was completed in 2019.  Patients who met the inclusion/exclusion criteria for ROADSTER 2 were eligible for CMS coverage under the NCD under certain circumstances.  Providers billed the Pre-Market Approval number assigned to the stent system by the FDA, P140026, to obtain reimbursement.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The ENROUTE NPS and the ENROUTE stent are also included&#160;in the CREST-2 Companion Registry, or C2R, but not in the CREST 2 randomized clinical trial itself.  The objective of C2R is to promote the rapid initiation and completion of enrollment in the CREST-2 randomized clinical trial (clinicaltrials.gov ID NCT02089217).  Patient eligibility will include standard surgical risk and high surgical risk patients with symptomatic or asymptomatic carotid artery disease.  Patients will be followed for the occurrence of post-procedural complications.  The primary safety and quality endpoint for C2R is the occurrence of any stroke or death within the 30-day period following the stenting procedure.  The safety and quality results from C2R will guide selection of interventionists for participation in the CREST-2 randomized clinical trial.  Enrollment into C2R began in 2015 and will continue until publication of the primary results of the randomized trial.  Providers can bill CMS for TCAR patients enrolled in this registry using&#160;NCT02240862.</span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Research, Development and Clinical Programs</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our research and development activities encompass basic research, clinical research and product development.  Our engineering team has mechanical engineering, project management, materials science, and prototyping expertise.  In addition, our clinical research organization has trial design and management, data collection and biostatistics expertise.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our research and development efforts are currently focused on improving and expanding our portfolio of TCAR products and their labeled indications for use to further improve and simplify the treatment experience for a broad base of patients and physicians.  We have worked together with vascular surgeons such as Enrique Criado M.D., and David Chang M.D., the pioneers of TCAR, to develop our products.  We believe our research and development capabilities, clinical and regulatory organizations and unique insights will enable us to continue to lead this emerging category. </span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Following the completion of our ROADSTER 2 Post Approval Study, our current clinical program consists of ongoing studies in the European Union and United States to evaluate the rate of sub-clinical embolization as detected through DW-MRI in recently symptomatic patients.  We expect to utilize the results of these clinical studies to support our marketing efforts and encourage continued adoption of TCAR.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We also have a broad intellectual property platform addressing the transcarotid approach and, in the future, we intend to leverage our expertise to develop new products targeting market opportunities and disease states that could benefit from the physiologic and engineering advantages made possible by our transcarotid approach, including in the heart, aortic arch and brain. </span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">For the fiscal years ended December 31, 2019 and 2018, our research, development and clinical expenses were $12.3 million and $10.3 million, respectively.</span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Competition</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">TCAR is a relatively new procedure category and as such the basis of competition for our products is with respect to alternative carotid revascularization procedures.  We are positioning TCAR as an alternative to the existing procedures CEA and CAS, and therefore compete primarily with manufacturers of medical devices used in those procedures.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The major manufacturers of products, such as patches and shunts, used in connection with CEA include LeMaitre Vascular, Getinge / Maquet, Baxter, Terumo, Gore and Edwards.  Many of these companies are large public companies or divisions of publicly-traded companies and have several competitive advantages, including established relationships with vascular surgeons who commonly </span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">35</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">perform the CEA procedure, significantly greater name recognition and significantly greater sales and marketing resources.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Companies with actively marketed FDA-approved stents and embolic protection devices for use with CAS procedures include Abbott, Medtronic, Boston Scientific, and Cardinal.  Other companies have approved devices not currently marketed in the United States, including Gore and InspireMD.  Additionally, some companies have stents and other products under development for use in CAS procedures, including Terumo.  Most of these companies have several competitive advantages including the following: more established sales and marketing programs and networks, larger portfolio of products, longer operating histories, established relationships with healthcare professionals and greater name recognition.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In addition to competing for market share for TCAR, we also compete against these companies for personnel, including qualified personnel that are necessary to grow our business.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We believe the principal competitive factors in our market include the following:</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Patient outcomes and adverse event rates;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Patient experience;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Acceptance by treating physicians and referral sources;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Physician learning curve;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Ease-of-use and reliability;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Patient recovery time and level of discomfort;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Economic benefits and cost savings;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Availability of reimbursement; and</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Strength of clinical evidence.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We also compete against manufacturers of medications used for medical management of carotid artery disease, including aspirin and statins.  Many such companies are large public companies or divisions of publicly-traded companies and have several competitive advantages including the following: established treatment patterns where drugs are generally first-line therapy and invasive procedures or surgery are considered later; established relationships with general practitioners who commonly prescribe such medications; significantly greater name recognition; and significantly greater sales and marketing resources, including direct-to-consumer advertising.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Finally, we may compete with medical device and pharmaceutical manufacturers outside the United States when we pursue plans to market our products internationally.  Among other competitive advantages, such companies may have more established sales and marketing programs and networks, established relationships with healthcare professionals and greater name recognition in such markets.</span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Intellectual Property</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We actively seek to protect the intellectual property and proprietary technology that we believe is important to our business, which includes seeking and maintaining patents covering our technology and products, proprietary processes and any other inventions that are commercially or strategically important to the development of our business.  We also rely upon trademarks to build and maintain the integrity of our brand, and we seek to protect the confidentiality of trade secrets that may be important to the development of our business.</span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">36</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">To protect our proprietary rights, we rely on a combination of trademark, copyright, patent, trade secret and other intellectual property laws, employment, confidentiality and invention assignment agreements, and protective contractual provisions with our employees, contractors, consultants, suppliers, partners and other third parties.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">As of December 31, 2019, we owned</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> 76 patents globally, of which 53 were issued U.S. patents and 23 were patents outside of the United States. &#160;Our patents expire between November 2024 and December 2034.</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Our material patents, their jurisdiction, expiration date and the product to which they relate, are listed in the table below:</span></div><div style="margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:18.512%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:18.512%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:18.512%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:36.464%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;border-left:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Jurisdiction</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;border-left:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Patent No.</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;border-left:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Expiration Date</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;border-left:1pt solid #000000;padding-left:1pt;border-right:1pt solid #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Related Product</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:middle;border-top:1pt solid #000000;border-left:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">US</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:middle;border-top:1pt solid #000000;border-left:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8,002,728&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:middle;border-top:1pt solid #000000;border-left:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12/2/2025</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:middle;border-top:1pt solid #000000;border-left:1pt solid #000000;padding-left:1pt;border-right:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Transcarotid Neuroprotection System</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:middle;border-top:1pt solid #000000;border-left:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">US</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:middle;border-top:1pt solid #000000;border-left:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8,343,089&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:middle;border-top:1pt solid #000000;border-left:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6/22/2025</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:middle;border-top:1pt solid #000000;border-left:1pt solid #000000;padding-left:1pt;border-right:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Transcarotid Neuroprotection System<br/>Transcarotid Stent System</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:middle;border-top:1pt solid #000000;border-left:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">US</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:middle;border-top:1pt solid #000000;border-left:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8,157,760&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:middle;border-top:1pt solid #000000;border-left:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9/3/2030</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:middle;border-top:1pt solid #000000;border-left:1pt solid #000000;padding-left:1pt;border-right:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Transcarotid Neuroprotection System</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:middle;border-top:1pt solid #000000;border-left:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">US</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:middle;border-top:1pt solid #000000;border-left:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8,784,355&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:middle;border-top:1pt solid #000000;border-left:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8/7/2029</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:middle;border-top:1pt solid #000000;border-left:1pt solid #000000;padding-left:1pt;border-right:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Transcarotid Neuroprotection System</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:middle;border-top:1pt solid #000000;border-left:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">US</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:middle;border-top:1pt solid #000000;border-left:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8,740,834&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:middle;border-top:1pt solid #000000;border-left:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3/6/2029</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:middle;border-top:1pt solid #000000;border-left:1pt solid #000000;padding-left:1pt;border-right:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Transcarotid Neuroprotection System</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:middle;border-top:1pt solid #000000;border-left:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">US</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:middle;border-top:1pt solid #000000;border-left:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9,011,364&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:middle;border-top:1pt solid #000000;border-left:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4/10/2031</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:middle;border-top:1pt solid #000000;border-left:1pt solid #000000;padding-left:1pt;border-right:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Transcarotid Neuroprotection System</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:middle;border-top:1pt solid #000000;border-left:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">US</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:middle;border-top:1pt solid #000000;border-left:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9,833,555&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:middle;border-top:1pt solid #000000;border-left:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10/26/2029</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:middle;border-top:1pt solid #000000;border-left:1pt solid #000000;padding-left:1pt;border-right:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Transcarotid Neuroprotection System</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:middle;border-top:1pt solid #000000;border-left:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Europe</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:middle;border-top:1pt solid #000000;border-left:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,173,425&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:middle;border-top:1pt solid #000000;border-left:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7/18/2028</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:middle;border-top:1pt solid #000000;border-left:1pt solid #000000;padding-left:1pt;border-right:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Transcarotid Neuroprotection System</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:middle;border-top:1pt solid #000000;border-left:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">France</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:middle;border-top:1pt solid #000000;border-left:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,173,425&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:middle;border-top:1pt solid #000000;border-left:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7/18/2028</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:middle;border-top:1pt solid #000000;border-left:1pt solid #000000;padding-left:1pt;border-right:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Transcarotid Neuroprotection System</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:middle;border-top:1pt solid #000000;border-left:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Germany</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:middle;border-top:1pt solid #000000;border-left:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,173,425&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:middle;border-top:1pt solid #000000;border-left:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7/18/2028</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:middle;border-top:1pt solid #000000;border-left:1pt solid #000000;padding-left:1pt;border-right:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Transcarotid Neuroprotection System</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:middle;border-top:1pt solid #000000;border-left:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Italy</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:middle;border-top:1pt solid #000000;border-left:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,173,425&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:middle;border-top:1pt solid #000000;border-left:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7/18/2028</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:middle;border-top:1pt solid #000000;border-left:1pt solid #000000;padding-left:1pt;border-right:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Transcarotid Neuroprotection System</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:middle;border-top:1pt solid #000000;border-left:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Great Britain</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:middle;border-top:1pt solid #000000;border-left:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,173,425&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:middle;border-top:1pt solid #000000;border-left:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7/18/2028</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:middle;border-top:1pt solid #000000;border-left:1pt solid #000000;padding-left:1pt;border-right:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Transcarotid Neuroprotection System</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:middle;border-top:1pt solid #000000;border-left:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Japan</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:middle;border-top:1pt solid #000000;border-left:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,290,290&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:middle;border-top:1pt solid #000000;border-left:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7/18/2028</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:middle;border-top:1pt solid #000000;border-left:1pt solid #000000;padding-left:1pt;border-right:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Transcarotid Neuroprotection System</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:middle;border-top:1pt solid #000000;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Japan</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:middle;border-top:1pt solid #000000;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,693,661&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;border-bottom:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:middle;border-top:1pt solid #000000;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7/18/2028</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:middle;border-top:1pt solid #000000;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding-left:1pt;border-right:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Transcarotid Neuroprotection System</span></td></tr></table></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">As of December 31, 2019, we had 57 pending patent applications globally, including 29 in the United States and 28 outside the United States.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">As of December 31, 2019, we had trademark registrations for &#8220;Silk Road Medical,&#8221; the &#8220;Silk Road Medical&#8221; logo, &#8220;Enroute&#8221; and the &#8220;Enroute&#8221; logo and &#8220;Enhance&#8221; in the United States, and various other countries.  Including these trademark registrations,</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> our trademark portfolio contained 24 trademark registrations/ applications.</span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">37</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The term of individual patents depends on the legal term for patents in the countries in which they are granted.  In most countries, including the United States, the patent term is generally 20 years from the earliest claimed filing date of a nonprovisional patent application in the applicable country.  We cannot assure that patents will be issued from any of our pending applications or that, if patents are issued, they will be of sufficient scope or strength to provide meaningful protection for our technology.  Notwithstanding the scope of the patent protection available to us, a competitor could develop treatment methods or devices that are not covered by our patents.  Furthermore, numerous U.S. and foreign-issued patents and patent applications owned by third parties exist in the fields in which we are developing products.  Because patent applications can take many years to issue, there may be applications unknown to us, which applications may later result in issued patents that our existing or future products or technologies may be alleged to infringe.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">There has been substantial litigation regarding patent and other intellectual property rights in the medical device industry.  In the future, we may need to engage in litigation to enforce patents issued or licensed to us, to protect our trade secrets or know-how, to defend against claims of infringement of the rights of others or to determine the scope and validity of the proprietary rights of others.  Litigation could be costly and could divert our attention from other functions and responsibilities.  Furthermore, even if our patents are found to be valid and infringed, a court may refuse to grant injunctive relief against the infringer and instead grant us monetary damages and/or ongoing royalties. Such monetary compensation may be insufficient to adequately offset the damage to our business caused by the infringer&#8217;s competition in the market.&#8221;</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Adverse determinations in litigation could subject us to significant liabilities to third parties, could require us to seek licenses from third parties and could prevent us from manufacturing, selling or using the product, any of which could severely harm our business.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We also seek to maintain certain intellectual property and proprietary know-how as trade secrets, and generally require our partners to execute non-disclosure agreements prior to any substantive discussions or disclosures of our technology or business plans.  Our trade secrets include proprietary account analytics, user training methods, and operational processes.  For more information, please see &#8220;Risk Factors&#8212;Risks Related to Intellectual Property.&#8221;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"> </span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Manufacturing and Supply </span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We currently manufacture the ENROUTE NPS at and distribute all of our products from our approximately 31,000 square foot facility in Sunnyvale, California.  This facility provides approximately 8,000 square feet of space for our production and distribution operations, including manufacturing, quality control and storage. </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> While we believe our existing facility will be sufficient to meet our manufacturing needs for at least the next four years we intend to supplement our distribution operations with a third-party logistics and warehousing service and/or additional leased facilities.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our manufacturing and distribution operations are subject to regulatory requirements of the FDA&#8217;s Quality System Regulation, or QSR, for medical devices sold in the United States, set forth in 21 CFR part 820, and the European Medical Device Directive 93/42/EEC and amendments, or MDD, for medical devices marketed in the European Union.  When the new EU Medical Regulations take effect in May 2020, our design examination certificates under the MDD remain valid until their expiration.  Compliance with the EU MDR will be executed prior to the expiration of the current MDD certificates. We are also subject to applicable local regulations relating to the environment, waste management and health and safety matters, including measures relating to the release, use, storage, treatment, transportation, discharge, disposal, sale, labeling, collection, recycling, treatment and remediation of hazardous substances.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The FDA monitors compliance with the QSR through periodic inspections of our facilities.  Our suppliers&#8217; facilities are also subject to FDA regulations, including the QSR, and unannounced inspections by the FDA and other similar regulatory authorities.  Our European Union Notified Body, British Standards </span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">38</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Institute, or BSI, monitors compliance with the MDD requirements through both annual scheduled audits and periodic unannounced audits of our manufacturing facilities as well as our contract manufacturers&#8217; facilities.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our failure, or the failure of our suppliers, to maintain acceptable quality requirements and compliance with all applicable healthcare laws and regulatory requirements could result in the shutdown or significant disruption of our manufacturing operations or the recall of our products, which would harm our business.  In the event that one of our suppliers fails to maintain acceptable quality requirements or regulatory compliance, we may have to qualify a new supplier and could experience a material adverse effect to manufacturing and manufacturing delays as a result.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our quality management system is ISO 13485 and MDD Certified. We have been an FDA registered medical device establishment and California licensed medical device manufacturer since 2011.  We moved to our current Sunnyvale, California facility in June 2018, which was registered with the FDA in June 2018 and was issued a California device manufacturing license&#160;in August 2018.  An ISO 13485 audit was conducted in September 2018 and our facility was recommended for certification.&#160; </span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The FDA conducted a total of five establishment inspections of our manufacturing facility in Sunnyvale, California in 2014, 2015, 2016 and 2020.  A one-observation Form 483 Notice of Observation was issued in April 2015 relating to a transcription error in patient line listings and no additional follow up with the FDA was required.  In February 2020, a one-observation Form 483 Notice of Observation was issued relating to the calibration method used for a specific type of measurement tool. In response, we have initiated a Corrective and Preventive Action, or CAPA, that we believe addresses the single FDA Observation.  We believe that we are in compliance, in all material respects, with all applicable FDA requirements, including the QSR.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Since obtaining ISO 13485 certification in 2011, BSI has conducted scheduled surveillance audits annually, recertification audits every third year, and periodic unannounced audits since the initial certification period starting in 2011 for compliance with ISO 13485 and MDD.  The most recent recertification audit was conducted in September 2017, and no major non-conformities were identified.  The most recent surveillance audit was conducted in October 2019, and no major non-conformities were identified.  The most recent unannounced audit was conducted in July 2014, and no major non-conformities were identified.  We believe that we are in compliance, in all material respects, with all ISO 13485 and MDD requirements.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Manufacturing of the materials and components of the ENROUTE NPS are provided by approved suppliers, all of which are single source suppliers of key components, sub-assemblies and materials.  We purchase finished transcarotid access kit, guidewires and stents through contract manufacturers.  Cardinal is our contract manufacturer and currently the sole source supplier for the ENROUTE stent.  We typically maintain several months&#8217; worth of ENROUTE stents in inventory, and we estimate that it would take between one and two years to qualify a second source supplier for our ENROUTE stent.  The suppliers for the ENROUTE NPS and our other product lines are evaluated, qualified and approved through a stringent supplier management program, which includes various evaluations, assessments, qualifications, validations, testing and inspection to ensure the supplier can meet acceptable quality requirements.  We implement a strict change control policy with our key suppliers to ensure that no component or process changes are made without our prior approval.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Order quantities and lead times for components purchased from suppliers are based on our forecasts derived from historical demand and anticipated future demand.  Lead times for components may vary depending on the size of the order, time required to fabricate and test the components, specific supplier requirements and current market demand for the components, sub-assemblies and materials.  We perform assembly, testing, inspection and final product release activities for the ENROUTE NPS.  Finished ENROUTE NPS devices are ethylene oxide sterilized at a qualified supplier.  </span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">39</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Government Regulation</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">United States Food &amp; Drug Administration</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our products and operations are subject to extensive and ongoing regulation by the FDA under the Federal Food, Drug, and Cosmetic Act, or FDCA, and its implementing regulations, as well as other federal and state regulatory bodies in the United States.  The laws and regulations govern, among other things, product design and development, pre-clinical and clinical testing, manufacturing, packaging, labeling, storage, record keeping and reporting, clearance or approval, marketing, distribution, promotion, import and export, and post-marketing surveillance.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Unless an exemption applies, each new or significantly modified medical device we seek to commercially distribute in the United States will require either a premarket notification to the FDA requesting permission for commercial distribution under Section&#160;510(k) of the Federal Food, Drug and Cosmetic Act, or FDCA, also referred to as a 510(k) clearance, or approval from the FDA of a PMA application.  Both the 510(k) clearance and PMA processes can be resource intensive, expensive, and lengthy, and require payment of significant user fees, unless an exemption is available.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Device classification</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Under the FDCA, medical devices are classified into one of three classes-Class&#160;I, Class&#160;II or Class&#160;III-depending on the degree of risk associated with each medical device and the extent of control needed to provide reasonable assurances with respect to safety and effectiveness.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Class&#160;I includes devices with the lowest risk to the patient and are those for which safety and effectiveness can be reasonably assured by adherence to a set of FDA regulations, referred to as the General Controls for Medical Devices, which require compliance with the applicable portions of the QSR, facility registration and product listing, reporting of adverse events and malfunctions, and appropriate, truthful and non-misleading labeling and promotional materials.  Some Class&#160;I devices, also called Class&#160;I reserved devices, also require premarket clearance by the FDA through the 510(k) premarket notification process described below.  Most Class&#160;I products are exempt from the premarket notification requirements.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Class&#160;II devices are those that are subject to the General Controls, and special controls as deemed necessary by the FDA to ensure the safety and effectiveness of the device.  These special controls can include performance standards, patient registries, FDA guidance documents and post-market surveillance.  Most Class&#160;II devices are subject to premarket review and clearance by the FDA.  Premarket review and clearance by the FDA for Class&#160;II devices is accomplished through the 510(k) premarket notification process.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Class&#160;III devices include devices deemed by the FDA to pose the greatest risk such as life-supporting or life-sustaining devices, or implantable devices, in addition to those deemed novel and not substantially equivalent following the 510(k) process.  The safety and effectiveness of Class&#160;III devices cannot be reasonably assured solely by the General Controls and Special Controls described above.  Therefore, these devices are subject to the PMA application process, which is generally more costly and time consuming than the 510(k) process.  Through the PMA application process, the applicant must submit data and information demonstrating reasonable assurance of the safety and effectiveness of the device for its intended use to the FDA&#8217;s satisfaction.  Accordingly, a PMA application typically includes, but is not limited to, extensive technical information regarding device design and development, pre-clinical and clinical trial data, manufacturing information, labeling and financial disclosure information for the clinical investigators in device studies.  The PMA application must provide valid scientific evidence that demonstrates to the FDA&#8217;s satisfaction a reasonable assurance of the safety and effectiveness of the device for its intended use.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">If a new medical device does not qualify for the 510(k) premarket notification process because no predicate device to which it is substantially equivalent can be identified, the device is automatically </span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">40</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">classified into Class III. The Food and Drug Administration Modernization Act of 1997 established a new route to market for low to moderate risk medical devices that are automatically placed into Class III due to the absence of a predicate device, called the &#8220;Request for Evaluation of Automatic Class III Designation,&#8221; or the de novo classification process. This process allows a manufacturer whose novel device is automatically classified into Class III to request down-classification of its medical device into Class I or Class II on the basis that the device presents low or moderate risk, rather than requiring the submission and approval of a PMA. If the manufacturer seeks reclassification into Class II, the manufacturer must include a draft proposal for special controls that are necessary to provide a reasonable assurance of the safety and effectiveness of the medical device. The FDA may reject the reclassification petition if it identifies a legally marketed predicate device that would be appropriate for a 510(k) or determines that the device is not low to moderate risk and requires PMA or that general controls would be inadequate to control the risks and special controls cannot be developed.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">The investigational device process</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In the United States, absent certain limited exceptions, human clinical trials intended to support medical device clearance or approval require an IDE application.  Some types of studies deemed to present &#8220;non-significant risk&#8221; are deemed to have an approved IDE once certain requirements are addressed and IRB approval is obtained.  If the device presents a &#8220;significant risk&#8221; to human health, as defined by the FDA, the sponsor must submit an IDE application to the FDA and obtain IDE approval prior to commencing the human clinical trials.  The IDE application must be supported by appropriate data, such as animal and laboratory testing results, showing that it is safe to test the device in humans and that the testing protocol is scientifically sound.  The IDE application must be approved in advance by the FDA for a specified number of subjects.  Generally, clinical trials for a significant risk device may begin once the IDE application is approved by the FDA and the study protocol and informed consent are approved by appropriate institutional review boards at the clinical trial sites.  There can be no assurance that submission of an IDE will result in the ability to commence clinical trials, and although the FDA&#8217;s approval of an IDE allows clinical testing to go forward for a specified number of subjects, it does not bind the FDA to accept the results of the trial as sufficient to prove the product&#8217;s safety and effectiveness, even if the trial meets its intended success criteria.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">All clinical trials must be conducted in accordance with the FDA&#8217;s IDE regulations that govern investigational device labeling, prohibit promotion and specify an array of recordkeeping, reporting and monitoring responsibilities of study sponsors and study investigators.  Clinical trials must further comply with the FDA&#8217;s good clinical practice regulations for institutional review board approval and for informed consent and other human subject protections.  Required records and reports are subject to inspection by the FDA.  The results of clinical testing may be unfavorable, or, even if the intended safety and effectiveness success criteria are achieved, may not be considered sufficient for the FDA to grant marketing approval or clearance of a product.  The commencement or completion of any clinical trial may be delayed or halted, or be inadequate to support approval of a PMA application, for numerous reasons, including, but not limited to, the following:</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">The FDA or other regulatory authorities do not approve a clinical trial protocol or a clinical trial, or place a clinical trial on hold;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Patients do not enroll in clinical trials at the rate expected;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Patients do not comply with trial protocols;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Patient follow-up is not at the rate expected;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Patients experience adverse events;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Patients die during a clinical trial, even though their death may not be related to the products that are part of the trial;</span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">41</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Device malfunctions occur with unexpected frequency or potential adverse consequences;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Side effects or device malfunctions of similar products already in the market that change the FDA&#8217;s view toward approval of new or similar PMAs or result in the imposition of new requirements or testing;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Institutional review boards and third-party clinical investigators may delay or reject the trial protocol;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Third-party clinical investigators decline to participate in a trial or do not perform a trial on the anticipated schedule or consistent with the clinical trial protocol, investigator agreement, investigational plan, good clinical practices, the IDE regulations, or other FDA or IRB requirements;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Third-party investigators are disqualified by the FDA;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">We or third-party organizations do not perform data collection, monitoring and analysis in a timely or accurate manner or consistent with the clinical trial protocol or investigational or statistical plans, or otherwise fail to comply with the IDE regulations governing responsibilities, records, and reports of sponsors of clinical investigations;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Third-party clinical investigators have significant financial interests related to us or our study such that the FDA deems the study results unreliable, or the company or investigators fail to disclose such interests;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Regulatory inspections of our clinical trials or manufacturing facilities, which may, among other things, require us to undertake corrective action or suspend or terminate our clinical trials;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Changes in government regulations or administrative actions;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">The interim or final results of the clinical trial are inconclusive or unfavorable as to safety or effectiveness; or</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">The FDA concludes that our trial design is unreliable or inadequate to demonstrate safety and effectiveness.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">The 510(k) approval process</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Under the 510(k) process, the manufacturer must submit to the FDA a premarket notification, demonstrating that the device is &#8220;substantially equivalent,&#8221; as defined in the statute, to a legally marketed predicate device.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">A predicate device is a legally marketed device that is not subject to premarket approval, i.e., a device that was legally marketed prior to May 28, 1976 (pre-amendments device) and for which a PMA is not required, a device that has been reclassified from Class III to Class II or I, or a device that was previously found substantially equivalent through the 510(k) process.  To be &#8220;substantially equivalent,&#8221; the proposed device must have the same intended use as the predicate device, and either have the same technological characteristics as the predicate device or have different technological characteristics and not raise different questions of safety or effectiveness than the predicate device.  Clinical data is sometimes required to support substantial equivalence.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">After a 510(k) premarket notification is submitted, the FDA determines whether to accept it for substantive review.  If it lacks necessary information for substantive review, the FDA will refuse to accept the 510(k) notification.  If it is accepted for filing, the FDA begins a substantive review.  The Medical Device User Fee Amendments sets a performance goal of 90 days for FDA review of a 510(k) submission, but the review time can be delayed if FDA raises questions or requests addition information during the review process.  As a practical matter, clearance often takes longer, and clearance is never </span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">42</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">assured.  Although many 510(k) premarket notifications are cleared without clinical data, the FDA may require further information, including clinical data, to make a determination regarding substantial equivalence, which may significantly prolong the review process.  If the FDA agrees that the device is substantially equivalent, it will grant clearance to commercially market the device.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">If the FDA determines that the device is not &#8220;substantially equivalent&#8221; to a predicate device, or if the device is automatically classified into Class III, the device sponsor must then fulfill the much more rigorous premarketing requirements of the PMA approval process, or seek reclassification of the device through the de novo process.  A manufacturer can also submit a petition for direct de novo review if the manufacturer is unable to identify an appropriate predicate device and the new device or new use of the device presents a moderate or low risk.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">After a device receives 510(k) clearance, any modification that could significantly affect its safety or effectiveness, or that would constitute a new or major change in its intended use, will require a new 510(k) clearance or, depending on the modification, could require a PMA application or de novo classification.  The FDA requires each manufacturer to determine whether the proposed change requires submission of a 510(k) or a PMA in the first instance, but the FDA can review any such decision and disagree with a manufacturer&#8217;s determination.  Many minor modifications are accomplished by a letter-to-file in which the manufacture documents the change in an internal letter-to-file.  The letter-to-file is in lieu of submitting a new 510(k) to obtain clearance for such change.  The FDA can always review these letters to file in an inspection.  If the FDA disagrees with a manufacturer&#8217;s determination regarding whether a new premarket submission is required for the modification of an existing device, the FDA can require the manufacturer to cease marketing and/or recall the modified device until 510(k) clearance or approval of a PMA application is obtained.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Over the last several years, the FDA has proposed reforms to its 510(k) clearance process, and such proposals could include increased requirements for clinical data and a longer review period, or could make it more difficult for manufacturers to utilize the 510(k) clearance process for their products.  For example, in November 2018, FDA officials announced forthcoming steps that the FDA intends to take to modernize the premarket notification pathway under Section 510(k) of the FDCA. Among other things, the FDA announced that it planned to develop proposals to drive manufacturers utilizing the 510(k) pathway toward the use of newer predicates. These proposals included plans to potentially sunset certain older devices that were used as predicates under the 510(k) clearance pathway, and to potentially publish a list of devices that have been cleared on the basis of demonstrated substantial equivalence to predicate devices that are more than 10 years old. In May 2019, the FDA solicited public feedback on these proposals.  The FDA requested public feedback on whether it should consider certain actions that might require new authority, such as whether to sunset certain older devices that were used as predicates under the 510(k) clearance pathway. These proposals have not yet been finalized or adopted, and the FDA may work with Congress to implement such proposals through legislation. </span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">More recently, in September 2019, the FDA finalized guidance describing an optional &#8220;safety and performance based&#8221; premarket review pathway for manufacturers of &#8220;certain, well-understood device types&#8221; to demonstrate substantial equivalence under the 510(k) clearance pathway by showing that such device meets objective safety and performance criteria established by the FDA, thereby obviating the need for manufacturers to compare the safety and performance of their medical devices to specific predicate devices in the clearance process. The FDA intends to develop and maintain a list device types appropriate for the &#8220;safety and performance based&#8221; pathway and will continue to develop product-specific guidance documents that identify the performance criteria for each such device type, as well as the testing methods recommended in the guidance documents, where feasible.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">The PMA approval process</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Following receipt of a PMA application, the FDA conducts an administrative review to determine whether the application is sufficiently complete to permit a substantive review.  If it is not, the agency will refuse to file the PMA.  If it is, the FDA will accept the application for filing and begin the review.  The FDA, </span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">43</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">by statute and by regulation, has 180 days to review a filed PMA application, although the review of an application more often occurs over a significantly longer period of time.  During this review period, the FDA may request additional information or clarification of information already provided, and the FDA may issue a major deficiency letter to the applicant, requesting the applicant&#8217;s response to deficiencies communicated by the FDA.  The FDA considers a PMA or PMA supplement to have been voluntarily withdrawn if an applicant fails to respond to an FDA request for information (e.g., major deficiency letter) within a total of 360 days.  Before approving or denying a PMA, an FDA advisory committee may review the PMA at a public meeting and provide the FDA with the committee&#8217;s recommendation on whether the FDA should approve the submission, approve it with specific conditions, or not approve it.  The FDA is not bound by the recommendations of an advisory committee, but it considers such recommendations carefully when making decisions.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Prior to approval of a PMA, the FDA may conduct inspections of the clinical trial data and clinical trial sites, as well as inspections of the manufacturing facility and processes.  Overall, the FDA review of a PMA application generally takes between one and three years, but may take significantly longer.  The FDA can delay, limit or deny approval of a PMA application for many reasons, including:</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">The device may not be shown safe or effective to the FDA&#8217;s satisfaction;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">The data from pre-clinical studies and/or clinical trials may be found unreliable or insufficient to support approval;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">The manufacturing process or facilities may not meet applicable requirements; and</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Changes in FDA approval policies or adoption of new regulations may require additional data.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">If the FDA evaluation of a PMA is favorable, the FDA will issue either an approval letter, or an approvable letter, the latter of which usually contains a number of conditions that must be met in order to secure final approval of the PMA.  When and if those conditions have been fulfilled to the satisfaction of the FDA, the agency will issue a PMA approval letter authorizing commercial marketing of the device, subject to the conditions of approval and the limitations established in the approval letter.  If the FDA&#8217;s evaluation of a PMA application or manufacturing facilities is not favorable, the FDA will deny approval of the PMA or issue a not approvable letter.  The FDA also may determine that additional tests or clinical trials are necessary, in which case the PMA approval may be delayed for several months or years while the trials are conducted and data is submitted in an amendment to the PMA, or the PMA is withdrawn and resubmitted when the data are available.  The PMA process can be expensive, uncertain and lengthy and a number of devices for which the FDA approval has been sought by other companies have never been approved by the FDA for marketing.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">New PMA applications or PMA supplements are required for modification to the manufacturing process, equipment or facility, quality control procedures, sterilization, packaging, expiration date, labeling, device specifications, ingredients, materials or design of a device that has been approved through the PMA process.  PMA supplements often require submission of the same type of information as an initial PMA application, except that the supplement is limited to information needed to support any changes from the device covered by the approved PMA application and may or may not require as extensive technical or clinical data or the convening of an advisory panel, depending on the nature of the proposed change.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In approving a PMA application, as a condition of approval, the FDA may also require some form of post-approval study or post-market surveillance, whereby the applicant conducts a follow-up study or follows certain patient groups for a number of years and makes periodic reports to the FDA on the clinical status of those patients when necessary to protect the public health or to provide additional or longer term safety and effectiveness data for the device.  The FDA may also require post-market surveillance for certain devices cleared under a 510(k) notification, such as implants or life-supporting or life-sustaining devices used outside a device user facility.  The FDA may also approve a PMA application with other </span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">44</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">post-approval conditions intended to ensure the safety and effectiveness of the device, such as, among other things, restrictions on labeling, promotion, sale, distribution and use.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Pervasive and Continuing Regulation </span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">After a device is placed on the market, numerous regulatory requirements continue to apply.  These include:</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">The FDA&#8217;s QSR, which requires manufacturers, including their suppliers, to follow stringent design, testing, control, documentation and other quality assurance procedures during all aspects of the manufacturing process;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Labeling regulations and FDA prohibitions against the promotion of products for uncleared, unapproved or off-label uses;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Medical device reporting, or MDR, regulations, which require that manufacturers report to the FDA if their device may have caused or contributed to a death or serious injury or malfunctioned in a way that would likely cause or contribute to a death or serious injury if the malfunction were to recur;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Medical device recalls, which require that manufacturers report to the FDA any recall of a medical device, provided the recall was initiated to either reduce a risk to health posed by the device, or to remedy a violation of the FDCA caused by the device that may present a risk to health; and</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Post-market surveillance regulations, which apply when necessary to protect the public health or to provide additional safety and effectiveness data for the device.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We have registered with the FDA as a medical device manufacturer and a specification developer and have obtained a manufacturing license from the California Department of Public Health, or CDPH.  The FDA and CDPH have broad post-market and regulatory enforcement powers.  We are subject to unannounced inspections by the FDA and the Food and Drug Branch of CDPH to determine our compliance with the QSR and other regulations, and these inspections may include the manufacturing facilities of our suppliers.  Additionally, our Notified Body, the British Standards Institution, or BSI, regularly inspects our manufacturing, design and operational facilities to ensure ongoing ISO&#160;13485 compliance in order to maintain our CE mark.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Failure to comply with applicable regulatory requirements can result in enforcement action by the FDA, which may include any of the following sanctions:</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Warning letters, fines, injunctions, consent decrees and civil penalties;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Repair, replacement, refunds, recall or seizure of our products;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Operating restrictions, partial suspension or total shutdown of production;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Refusing our requests for 510&#160;(k) clearance or premarket approval of new products, new intended uses or modifications to existing products;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Withdrawing 510 (k) clearance or premarket approvals that have already been granted; and</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Criminal prosecution.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">European Union</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our portfolio of TCAR products is regulated in the European Union as a medical device per the European Union Directive 93/42/EEC, also known as the Medical Device Directive, or MDD.  The MDD sets out the basic regulatory framework for medical devices in the European Union.  The system of </span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">45</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">regulating medical devices operates by way of a certification for each medical device.  Each certified device is marked with the CE mark which shows that the device has a Certificat de Conformit&#233;.  There are national bodies known as Competent Authorities in each member state which oversee the implementation of the MDD within their jurisdiction.  The means for achieving the requirements for the CE mark vary according to the nature of the device.  Devices are classified in accordance with their perceived risks, similarly to the U.S. system.  The class of a product determines the conformity assessment required before the CE mark can be placed on a product.  Conformity assessments for our products are carried out as required by the MDD.  Each member state can appoint Notified Bodies within its jurisdiction.  If a Notified Body of one member state has issued a Certificat de Conformit&#233;, the device can be sold throughout the European Union without further conformance tests being required in other member states.  The CE mark is contingent upon continued compliance with the applicable regulations and the quality system requirements of the ISO&#160;13485 standard.  Our current CE mark is issued by BSI.  When the new EU Medical Regulations take effect in May 2020, our design examination certificates under the MDD remain valid until their expiration.  Compliance with the EU MDR will be executed prior to the expiration of the current MDD certificates. </span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Health Insurance Portability and Accountability Act</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Health Insurance Portability and Accountability Act of 1996, or HIPAA, as amended by the Health Information Technology for Economic and Clinical Health Act, or HITECH, established federal protection for the privacy and security of health information.  Under HIPAA, the Department of Health and Human Services, or HHS, has issued regulations to protect the privacy and security of protected health information used or disclosed by &#8220;Covered Entities,&#8221; including healthcare providers and their Business Associates.  HIPAA also regulates standardization of data content, codes and formats used in healthcare transactions and standardization of identifiers for health plans and providers.  The privacy regulations protect medical records and other protected health information by limiting their use and release, giving patients the right to access their medical records and limiting most disclosures of health information to the minimum amount necessary to accomplish an intended purpose.  The HIPAA security standards require the adoption of administrative, physical, and technical safeguards and the adoption of written security policies and procedures.  HIPAA requires Covered Entities to execute Business Associate Agreements with their Business Associates and subcontractors, who provide services to Covered Entities and who need access to protected health information.  In addition, companies that would not otherwise be subject to HIPAA may become contractually obligated to follow HIPAA requirements through agreements with Covered Entities and Business Associates, and some of our customers may require us to agree to these provisions.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In addition, HIPAA and other federal privacy regulations, such as Section 5 of the Federal Trade Commission Act, there are a number of state laws regarding the privacy and security of health information and personal data that apply to us.  The compliance requirements of these laws, including additional breach reporting requirements, and the penalties for violation vary widely, and new privacy and security laws in this area are evolving.  Requirements of these laws and penalties for violations vary widely.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">If we or our operations are found to be in violation of HIPAA, HITECH, or their implementing regulations, we may be subject to penalties, including civil and criminal penalties, fines, and exclusion from participation in federal or state healthcare programs, and the curtailment or restructuring of our operations.  HITECH increased the civil and criminal penalties that may be imposed against Covered Entities, their Business Associates and possibly other persons, and gave state attorneys general new authority to file civil actions for damages or injunctions in federal courts to enforce the federal HIPAA laws and seek attorney&#8217;s fees and costs associated with pursuing federal civil actions.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">U.S. Federal, State and Foreign Fraud and Abuse Laws</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The federal and state governments have enacted, and actively enforce, a number of laws to address fraud and abuse in federal healthcare programs.  Our business is subject to compliance with these laws.</span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">46</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Anti-Kickback Statutes</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The federal Anti-Kickback Statute prohibits persons from knowingly and willfully soliciting, offering, receiving or providing remuneration, directly or indirectly, in exchange for or to induce either the referral of an individual, or the furnishing or arranging for a good or service, for which payment may be made under a federal healthcare program, such as Medicare or Medicaid.  A person or entity does not need to have actual knowledge of the statute or specific intent to violate it to have committed a violation.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The definition of &#8220;remuneration&#8221; has been broadly interpreted to include anything of value, including, for example, gifts, certain discounts, the furnishing of free supplies, equipment or services, credit arrangements, payment of cash and waivers of payments.  Several courts have interpreted the statute&#8217;s intent requirement to mean that if any one purpose of an arrangement involving remuneration is to induce referrals of federal healthcare covered businesses, the statute has been violated.  Violations of the federal Anti-Kickback Statute may result in civil monetary penalties up to $104,330 for each violation, plus up to three times the remuneration involved.  Civil penalties for such conduct can further be assessed under the federal False Claims Act.  Violations can also result in criminal penalties, including criminal fines of up to $100,000 and imprisonment of up to 10 years.  Similarly, violations can result in exclusion from participation in government healthcare programs, including Medicare and Medicaid.  In addition, some kickback allegations have been claimed to violate the Federal False Claims Act.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Office of Inspector General, or OIG, of the HHS has issued a series of regulations known as &#8220;safe harbors.&#8221; These safe harbors set forth provisions that, if all their applicable requirements are met, will assure healthcare providers and other parties that they will not be prosecuted under the Anti-Kickback Statute.  The failure of a transaction or arrangement to fit precisely within one or more safe harbors does not necessarily mean that it is per se illegal or that prosecution will be pursued.  However, conduct and business arrangements that do not fully satisfy an applicable safe harbor may result in increased scrutiny by government enforcement authorities such as OIG.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Many states have adopted laws similar to the Anti-Kickback Statute.  Some of these state prohibitions apply to referral of recipients for healthcare products or services reimbursed by any source, not only government healthcare programs, and may apply to payments made directly by the patient.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Government officials have focused their enforcement efforts on the marketing of healthcare services and products, among other activities, and recently have brought cases against companies, and certain individual sales, marketing and executive personnel, for allegedly offering unlawful inducements to potential or existing customers in an attempt to procure their business.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Federal False Claims Act</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The federal False Claims Act, or FCA, imposes liability on any person or entity that, among other things, knowingly presents, or causes to be presented, a false or fraudulent claim for payment by a federal healthcare program.  The </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">qui tam</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> provisions of the FCA allow a private individual to bring actions on behalf of the federal government alleging that the defendant has violated the FCA and to share in any monetary recovery.  In addition, various states have enacted false claims laws analogous to the FCA, and many of these state laws apply where a claim is submitted to any third-party payer and not only a federal healthcare program.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">When an entity is determined to have violated the FCA, it may be required to pay up to three times the actual damages sustained by the government, plus civil fines and penalties ranging from $11,665 and $23,331 for each false claim, subject to adjustment for inflation.  As part of any settlement, the government may require the entity to enter into a corporate integrity agreement, which imposes certain compliance, certification and reporting obligations.  There are many potential bases for liability under the FCA.  Liability arises, primarily, when an entity knowingly submits, or causes another to submit, a false claim for reimbursement to the federal government.  The federal government has used the FCA to assert liability on the basis of kickbacks, or in instances in which manufacturers have provided billing or coding advice to providers that the government considered to be inaccurate.  In these cases, the manufacturer </span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">47</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">faces liability for &#8220;causing&#8221; a false claim.  In addition, the federal government has prosecuted companies under the FCA in connection with off-label promotion of products.  Our activities relating to the reporting of discount and rebate information and other information affecting federal, state and third-party reimbursement of our products and the sale and marketing of our products may be subject to scrutiny under these laws.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We are exposed to the risk of fraud or other misconduct by our employees, collaborators, vendors, principal investigators, consultants, independent contractors, and commercial partners. It is not always possible to identify and deter employee misconduct, and the precautions we take to detect and prevent this activity may not be effective in controlling unknown or unmanaged risks or losses or in protecting us from governmental investigations or other actions or lawsuits stemming from a failure to comply with these laws or regulations. If any such actions are instituted against us, and we are not successful in defending ourselves or asserting our rights, those actions could have a significant impact on our business, including the imposition of significant fines or other sanctions.  While we are unaware of any current matters, we are unable to predict whether we will be subject to actions under the FCA or a similar state law, or the impact of such actions.  Whether or not we are successful in defending against any such actions or investigations, we could incur substantial costs, including legal fees, and divert the attention of management in defending ourselves against any of these claims or investigations, which could have a material adverse effect on our business and financial condition. </span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Civil Monetary Penalties</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Civil Monetary Penalty Act of 1981 imposes penalties against any person or entity that, among other things, is determined to have presented or caused to be presented a claim to a federal healthcare program that the person knows or should know is for an item or service that was not provided as claimed or is false or fraudulent, or offering or transferring remuneration to a federal healthcare beneficiary that a person knows or should know is likely to influence the beneficiary&#8217;s decision to order or receive items or services reimbursable by the government from a particular provider or supplier.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Open Payments</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Physician Payments Sunshine Act, known as &#8220;Open Payments&#8221; and enacted as part of the Affordable Care Act, requires all pharmaceutical and medical device manufacturers of products covered by Medicare, Medicaid or the Children&#8217;s Health Insurance Program to report annually to HHS:&#160;payments and transfers of value to physicians, certain other healthcare providers, and teaching hospitals, and ownership and investment interests held by physicians and their immediate family members.  Additionally, on October 24, 2018, President Trump signed into law the &#8220;Substance Use-Disorder Prevention that Promoted Opioid Recovery and Treatment for Patients and Communities Act&#8221; which in part (under a provision entitled &#8220;Fighting the Opioid Epidemic with Sunshine&#8221;) extends the reporting and transparency requirements for physicians in the Physician Payments Sunshine Act to physician assistants, nurse practitioners, and other mid-level practitioners (with reporting requirements going into effect in 2022 for payments made in 2021).  Applicable manufacturers are required to submit annual reports to CMS.  Failure to submit required information may result in civil monetary penalties of up to $176,495 per annual report for failing to report payments in a timely manner.  Knowingly failing to submit payment information may result in a civil money penalty of up to $1,176,638.  We are subject to Open Payments and the information we disclose may lead to greater scrutiny, which may result in modifications to established practices and additional costs.  Additionally, similar reporting requirements have also been enacted on the state level domestically, and an increasing number of countries worldwide either have adopted or are considering similar laws requiring transparency of interactions with healthcare professionals.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Foreign Corrupt Practices Act</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Foreign Corrupt Practices Act, or FCPA, prohibits any U.S. individual or business from paying, offering, or authorizing payment or offering of anything of value, directly or indirectly, to any foreign official, political party or candidate for the purpose of influencing any act or decision of the foreign entity in order </span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">48</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">to assist the individual or business in obtaining or retaining business.  The FCPA also obligates companies whose securities are listed in the United States to comply with accounting provisions requiring us to maintain books and records that accurately and fairly reflect all transactions of the corporation, including international subsidiaries, if any, and to devise and maintain an adequate system of internal accounting controls for international operations.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">International Laws</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In Europe, various countries have adopted anti-bribery laws providing for severe consequences in the form of criminal penalties and significant fines for individuals or companies committing a bribery offense.  Violations of these anti-bribery laws, or allegations of such violations, could have a negative impact on our business, results of operations and reputation.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">For instance, in the United Kingdom, under the U.K.  Bribery Act 2010, a bribery occurs when a person offers, gives or promises to give a financial or other advantage to induce or reward another individual to improperly perform certain functions or activities, including any function of a public nature.  Bribery of foreign public officials also falls within the scope of the U.K.  Bribery Act 2010.  An individual found in violation of the U.K.  Bribery Act 2010, faces imprisonment of up to ten years.  In addition, the individual can be subject to an unlimited fine, as can commercial organizations for failure to prevent bribery.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">There are also international privacy laws that impose restrictions on the access, use, and disclosure of health information.  All of these laws may impact our business.  Our failure to comply with these privacy laws or significant changes in the laws restricting our ability to obtain required patient information could significantly impact our business and our future business plans.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">U.S. Centers for Medicare and Medicaid Services</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Medicare is a federal program administered by CMS through fiscal intermediaries and carriers.  Available to individuals age 65 or over, and certain other individuals, the Medicare program provides, among other things, healthcare benefits that cover, within prescribed limits, the major costs of most medically necessary care for such individuals, subject to certain deductibles and copayments.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">CMS has established guidelines for the coverage and reimbursement of certain products and procedures by Medicare.  In general, in order to be reimbursed by Medicare, a healthcare procedure furnished to a Medicare beneficiary must be reasonable and necessary for the diagnosis or treatment of an illness or injury, or to improve the functioning of a malformed body part.  The methodology for determining coverage status and the amount of Medicare reimbursement varies based upon, among other factors, the setting in which a Medicare beneficiary received healthcare products and services.  Any changes in federal legislation, regulations and policy affecting CMS coverage and reimbursement relative to the procedure using our products could have a material effect on our performance.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">CMS also administers the Medicaid program, a cooperative federal/state program that provides medical assistance benefits to qualifying low income and medically needy persons.  State participation in Medicaid is optional, and each state is given discretion in developing and administering its own Medicaid program, subject to certain federal requirements pertaining to payment levels, eligibility criteria and minimum categories of services.  The coverage, method and level of reimbursement vary from state to state and is subject to each state&#8217;s budget restraints.  Changes to the availability of coverage, method or level of reimbursement for TCAR may affect future revenue negatively if reimbursement amounts are decreased or discontinued.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">All CMS programs are subject to statutory and regulatory changes, retroactive and prospective rate adjustments, administrative rulings, interpretations of policy, intermediary determinations, and government funding restrictions, all of which may materially increase or decrease the rate of program payments to healthcare facilities and other healthcare providers, including those paid for TCAR.</span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">49</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">United States Health Reform</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Changes in healthcare policy could increase our costs and subject us to additional regulatory requirements that may interrupt commercialization of our current and future solutions.  Changes in healthcare policy could increase our costs, decrease our revenue and impact sales of and reimbursement for our current and future products.  The ACA substantially changes the way healthcare is financed by both governmental and private insurers, and significantly impacts our industry.  The United States and some foreign jurisdictions are considering or have enacted a number of legislative and regulatory proposals to change the healthcare system in ways that could affect our ability to sell our products profitably.  Among policy makers and payers in the United States and elsewhere, there is significant interest in promoting changes in healthcare systems with the stated goals of containing healthcare costs, improving quality or expanding access.  Current and future legislative proposals to further reform healthcare or reduce healthcare costs may limit coverage of or lower reimbursement for the procedures associated with the use of our products.  The cost containment measures that payers and providers are instituting and the effect of any healthcare reform initiative implemented in the future could impact our revenue from the sale of our products.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The implementation of the Affordable Care Act in the United States, for example, has changed healthcare financing and delivery by both governmental and private insurers substantially, and affected medical device manufacturers significantly.  The Affordable Care Act imposed, among other things, a 2.3% federal excise tax, with limited exceptions, on any entity that manufactures or imports Class&#160;I, II and III medical devices offered for sale in the United States that began on January&#160;1, 2013.  Through a series of legislative amendments, the tax was suspended for 2016 through 2019.  In December 2019, this excise tax was permanently repealed for medical device sales, effective after December 31, 2019.  The Affordable Care Act also provided incentives to programs that increase the federal government&#8217;s comparative effectiveness research, and implemented payment system reforms including a national pilot program on payment bundling to encourage hospitals, physicians and other providers to improve the coordination, quality and efficiency of certain healthcare services through bundled payment models.  Additionally, the Affordable Care Act has expanded eligibility criteria for Medicaid programs and created a new Patient-Centered Outcomes Research Institute to oversee, identify priorities in, and conduct comparative clinical effectiveness research, along with funding for such research.  We do not yet know the full impact that the Affordable Care Act will have on our business.  There have been judicial and Congressional challenges to certain aspects of the Affordable Care Act, and we expect additional challenges and amendments in the future.  Moreover, the Trump Administration and the U.S. Congress may take further action regarding the Affordable Care Act, including, but not limited to, repeal or replacement.  On December 18, 2019, the U.S. Court of Appeals for the 5th Circuit upheld the District Court ruling that the individual mandate was unconstitutional and remanded the case to the District Court to determine whether the remaining provisions of the ACA are invalid.  It is unclear how this decision, subsequent appeals, and other efforts to repeal and replace the ACA will impact the healthcare industry or our business operations.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In addition, other legislative changes have been proposed and adopted since the Affordable Care Act was enacted.  For example, the Budget Control Act of 2011, among other things, included reductions to CMS payments to providers of 2% per fiscal year, which went into effect on April&#160;1, 2013 and, due to subsequent legislative amendments to the statute, will remain in effect through 2029 unless additional Congressional action is taken.  Additionally, the American Taxpayer Relief Act of 2012, among other things, reduced CMS payments to several providers, including hospitals, and increased the statute of limitations period for the government to recover overpayments to providers from three to five years.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We believe that there will continue to be proposals by legislators at both the federal and state levels, regulators and third-party payers to reduce costs while expanding individual healthcare benefits.  Certain of these changes could impose additional limitations on the rates we will be able to charge for our current and future products or the amounts of reimbursement available for our current and future products from governmental agencies or third-party payers.  Current and future healthcare reform legislation and policies could have a material adverse effect on our business and financial condition.</span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">50</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Employees</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">As of December 31, 2019, we had 224 full-time employees.  We believe that the success of our business will depend, in part, on our ability to attract and retain qualified personnel.  None of our employees are represented by a labor union or are a party to a collective bargaining agreement and we believe that our employee relations are good.  </span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Corporate and other Information</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We were incorporated in Delaware on March 21, 2007 as Silk Road Medical, Inc. Our principal executive offices are located at 1213 Innsbruck Drive, Sunnyvale, CA 94089, and our telephone number is (408) 720-9002. Our website address is www.silkroadmed.com. Investors and others should note that we announce material financial information to our investors using SEC filings, press releases, our investor relations website, public conference calls and webcasts. We use these channels as well as social media to communicate with investors, customers and the public about our company, our products and other issues. It is possible that information we post on social media channels could be deemed to be material information. We encourage investors, our customers and others interested in our company to review the information we post on our Facebook page (https://www.facebook.com/SilkRoadMed/) and Twitter feed (https://twitter.com/silkroadmed). The information on, or that may be accessed through, our website and social media channels is not incorporated by reference into this Annual Report on Form 10-K and should not be considered a part of this Annual Report on Form 10-K.</span></div><div id="i58f397e86dfd4fc4ac3b8695cd31238e_16"></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">51</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Item 1A. Risk Factors</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We have identified the following risks and uncertainties that may have a material adverse effect on our business, financial condition, results of operations and future growth prospects. Our business could be harmed by any of these risks. The risks and uncertainties described below are not the only ones we face. The occurrence of any of the following risks or additional risks and uncertainties not presently known to us or that we currently believe to be immaterial could materially and adversely affect our business, financial condition, results of operations and future prospects. The trading price of our common stock could decline due to any of these risks, and you may lose all or part of your investment. In assessing these risks, you should also refer to the other information contained in this Annual Report on Form 10-K, including our condensed financial statements and related notes. Please also see &#8220;Cautionary Notes Regarding Forward-Looking Statements.&#8221;</span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Risks Related to Our Business</span></div><div style="text-indent:18pt;margin-top:6pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">We are an early-stage company with a history of net losses, we expect to incur operating losses in the future and we may not be able to achieve or sustain profitability.  We have a limited history operating as a commercial company.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We have incurred net losses since our inception in March 2007.  For the years ended December 31, 2019 and 2018, we had a net loss of $52.4 million, and $37.6 million, respectively, and we expect to continue to incur additional losses in the future.  As of December 31, 2019, we had an accumulated deficit of $191.5 million.  To date, we have financed our operations primarily through equity and debt financings and from sales of our portfolio of TCAR products that enable transcarotid artery revascularization, or TCAR.  The losses and accumulated deficit have primarily been due to the substantial investments we have made to develop our products, as well as for costs related to general research and development, including clinical and regulatory initiatives to obtain marketing approval, sales and marketing efforts and infrastructure improvements.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We fully commercialized our products in the United States in 2016 and therefore do not have a long history operating as a commercial company.  Over the next several years, we expect to continue to devote a substantial amount of our resources to expand commercialization efforts and increase adoption of TCAR using our products, improve and expand reimbursement for TCAR, and develop additional products.  In addition, as a newly public company, we incur significant legal, accounting and other expenses that we did not incur as a private company.  Accordingly, we expect to continue to incur operating losses for the foreseeable future and we cannot assure you that we will achieve profitability in the future or that, if we do become profitable, we will sustain profitability.  Our failure to achieve and sustain profitability in the future will make it more difficult to finance our business and accomplish our strategic objectives, which would have a material adverse effect on our business, financial condition and results of operations and cause the market price of our common stock to decline.  In addition, failure of our products to significantly penetrate the target markets would negatively affect our business, financial condition and results of operations.</span></div><div style="text-indent:18pt;margin-top:6pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">We rely on, and currently sell products to enable, TCAR, a single and new procedure.  We have limited commercial sales experience regarding TCAR, which makes it difficult to evaluate our current business, predict our future prospects and forecast our financial performance and growth.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">To date, all of our revenue has been derived, and we expect it to continue to be derived in the near term, from sales of our products that enable TCAR.  TCAR is a new treatment option for certain patients diagnosed with carotid artery disease and, as a result, physician awareness of TCAR and our products, and experience with TCAR and our products, is limited.  As a result, our Company and products have limited brand recognition and TCAR has limited recognition within the medical industry.  The novelty of TCAR and our products that enable the procedure, together with our limited commercialization experience, make it difficult to evaluate our current business and predict our future prospects.  A number of factors that are outside of our control may contribute to fluctuations in our financial results, including:</span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">52</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Physician and hospital demand for our products and the extent of adoption of TCAR, including the rate at which physicians recommend our products and TCAR to their patients;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Positive or negative media coverage, or public, patient and/or physician perception, of our products and TCAR or competing products and procedures;  </span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Any safety or effectiveness concerns that arise regarding our products or TCAR;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Unanticipated delays in product development or product launches;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Our ability to maintain our current or obtain further regulatory clearances or approvals; </span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Delays in, or failure of, product and component deliveries by our third-party suppliers; and</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Introduction of new products or procedures for treating carotid artery disease that compete with our products and the TCAR procedure.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">It is therefore difficult to predict our future financial performance and growth, and such forecasts are inherently limited and subject to a number of uncertainties.  If our assumptions regarding the risks and uncertainties we face, which we use to plan our business, are incorrect or change due to circumstances in our business or our markets, or if we do not address these risks successfully, our operating and financial results could differ materially from our expectations and our business could suffer.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In addition, because we devote substantially all of our resources to our products that enable TCAR and rely on our products and the adoption of TCAR as our sole source of revenue, any factors that negatively impact our products or TCAR, or result in a decrease in sales of products, could have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Our business is dependent upon the broad adoption of TCAR by hospitals and physicians.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">To date, a substantial majority of our product sales and revenue have been derived from a limited number of hospitals and physicians who have adopted TCAR.  Our future growth and profitability largely depends on our ability to increase physician awareness of TCAR and on the willingness of physicians to adopt our products and TCAR, and to recommend the procedure to their patients.  Physicians may not adopt our products unless they are able to determine, based on experience, clinical data, medical society recommendations and other analyses, that our products provide a safe and effective treatment alternative for carotid artery disease.  Even if we are able to raise awareness among physicians, physicians tend to be slow in changing their medical treatment practices and may be hesitant to select our products or TCAR for recommendation to patients for a variety of reasons, including:</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Long-standing relationships with competing companies and distributors that sell other products, such as stents and embolic protection devices for transfemoral carotid artery stenting, or CAS; </span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Competitive response and negative selling efforts from providers of alternative carotid revascularization products;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Lack of experience with our products and concerns that we are relatively new to market;  </span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Perceived liability risk generally associated with the use of new products and procedures;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Lack or perceived lack of sufficient clinical evidence, including long-term data, supporting clinical benefits;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Reluctance to change to or use new products and procedures; </span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Perceptions that our products are unproven; and</span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">53</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Time commitment and skill development that may be required to gain familiarity and proficiency with TCAR and our products.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Physicians play a significant role in determining the course of a patient&#8217;s treatment for carotid artery disease and, as a result, the type of treatment that will be recommended or provided to a patient.  We focus our sales, marketing and education efforts primarily on vascular surgeons, and aim to educate referring physicians such as vascular surgeons, cardiologists, radiologists, neurologists, neurosurgeons and general practitioners regarding the patient population that would benefit from TCAR.  However, we cannot assure you that we will achieve broad education or market acceptance among these practitioners.  For example, if diagnosing physicians that serve as the primary point of contact for patients are not made aware of TCAR, they may not refer patients to physicians for treatment using our products, and those patients may instead not seek treatment at all or may be treated with alternative procedures.  In addition, some physicians may choose to utilize TCAR on only a subset of their total patient population or may not adopt TCAR at all.  If a physician experiences an adverse event in one or more of their TCAR patients or elects to convert TCAR to CEA mid-procedure, they may not continue offering and performing TCAR at the same rate or at all.  Further, as TCAR is a new procedure, it may not fit into the workstreams of certain physicians.  If we are not able to effectively demonstrate that TCAR is beneficial in a broad range of patients, adoption of TCAR will be limited and may not occur as rapidly as we anticipate or at all, which would have a material adverse effect on our business, financial condition and results of operations.  We cannot assure you that TCAR or our products will achieve broad market acceptance among hospitals and physicians.  Any failure of TCAR or our products to satisfy demand or to achieve meaningful market acceptance and penetration will harm our future prospects and have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In addition, the medical device industry&#8217;s relationship with physicians is under increasing scrutiny by the Health and Human Services Office of the Inspector General, or OIG, the Department of Justice, or DOJ, state attorneys general, and other foreign and domestic government agencies.  Our failure to comply with laws, rules and regulations governing our relationships with physicians, or an investigation into our compliance by the OIG, DOJ, state attorneys general or other government agencies, could significantly harm our business.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In most cases, before physicians can use our products for the first time, our products must be approved for use by a hospital's new product or value analysis committee, or the staff of a hospital or health system.  Following such approval, we may be required to enter into a purchase contract.  Such approvals or requirements to enter into a purchase contract could deter or delay the use of our products by physicians.  We cannot provide assurance that our efforts to obtain such approvals, enter into purchase contracts, or generate adoption will be successful or increase the use of our products, and if we are not successful, it could have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Adoption of TCAR depends upon positive clinical data and medical society recommendations, and negative clinical data or medical society recommendations would adversely affect our business.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The rate of adoption of TCAR and sales of our products that facilitate the procedure is heavily influenced by clinical data.  Although the Society for Vascular Surgery&#8217;s TCAR Surveillance Project contains real world data comparing procedures, we have not conducted head-to-head clinical trials to compare TCAR to the procedures historically available to patients, such as CEA or CAS, which may limit the adoption of TCAR.  Additionally, the Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">2</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> clinical trial is currently being conducted by the National Institutes of Health, which compares the effectiveness of each of CEA and CAS with best medical management solutions.  Although we estimate that enrollment will not be completed until 2022, interim results have been released from time to time.  At the completion of the four-year follow-up, the trial could conclude that medical management alone achieves the same therapeutic results as CEA and/or CAS, which could have an adverse impact on the adoption of TCAR.  Finally, our competitors and third parties may also conduct </span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">54</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">clinical trials of our products without our participation.  Unfavorable or inconsistent clinical data from existing or future clinical trials conducted by us, our competitors or third parties, the interpretation of our or other clinical data or findings of new or more frequent adverse events, could have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">As physicians are influenced by guidelines issued by physician organizations, such as the Society for Vascular Surgery, the rate of adoption of TCAR and sales of our products that facilitate the procedure are also heavily influenced by medical society recommendations.  We believe the Society for Vascular Surgery&#8217;s Clinical Practice Guidelines, or SVS Guidelines, are of particular importance to the broader market acceptance of TCAR.  The most current SVS Guidelines on the management of carotid artery disease, published in 2011, do not specifically mention TCAR as a treatment for carotid artery disease, but generally discuss CAS and embolic protection methods, including flow reversal.  If the next version of the SVS Guidelines do not recommend TCAR, or if the Society for Vascular Surgery issues a negative or limited statement regarding TCAR, physicians may not adopt or continue to use TCAR or our products at the same rate or at all, which would have a material adverse effect on our business, financial condition and results of operations.  Additionally, if key opinion leaders who currently support TCAR cease to recommend TCAR or our products, our business, financial condition and results of operations will be adversely affected.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Adoption of TCAR depends upon appropriate physician training, and inadequate training may lead to negative patient outcomes, affect adoption of TCAR and adversely affect our business.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The success of TCAR depends in part on the skill of the physician performing the procedure and on our customers&#8217; adherence to appropriate patient selection and proper techniques provided in training sessions conducted by our training faculty.  For example, we train our customers to ensure correct use of our ENROUTE NPS and proper deployment of our ENROUTE stent.  However, physicians rely on their previous medical training and experience when performing TCAR, and we cannot guarantee that all such physicians will have the necessary surgical and endovascular skills to perform the procedure.  While we mandate physician attendance at our TCAR training program or training with proctors, we do not control which physicians perform TCAR or how much training they receive.  Physicians who have not completed our training sessions may nonetheless attempt to perform TCAR.  If physicians perform TCAR in a manner that is inconsistent with its labeled indications, with components that are not our products or without adhering to or completing our training sessions, their patient outcomes may not be consistent with the outcomes achieved in our and other clinical trials, studies or registries of TCAR.  This result may negatively impact the perception of patient benefit and safety and limit adoption of TCAR and our products that facilitate the procedure, which would have a material adverse effect on our business, financial condition and results of operations.  Additionally, physician organizations may adopt physician credentialing guidelines requiring TCAR training more extensive than our training program.  If physicians conclude that we do not provide adequate TCAR training, they may be less likely to adopt TCAR and our products, which could have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">A pandemic, epidemic or outbreak of an infectious disease, such as COVID-19, or coronavirus, may adversely affect our business. </span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">If a pandemic, epidemic or outbreak of an infectious disease occurs, our business may be adversely affected. In December 2019, a novel strain of coronavirus, COVID-19, was identified in Wuhan, China. This virus continues to spread globally and, as of February 2020, has spread to over 50 countries, including the United States.  Such events may result in a period of business and manufacturing disruption, and in reduced sales and operations, any of which could materially affect our business, financial condition and results of operations.  For example, the spread of COVID-19 in the United States may result in travel restrictions impacting our sales professionals and therapy development specialists who support them.  Travel restrictions may also reduce the number of physicians travelling to attend our training programs, which would result in fewer physicians trained on the TCAR procedure.  In addition, hospitals may reduce staffing and postpone certain procedures in response to COVID-19 or divert </span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">55</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">resources to treat those patients with an infectious disease.  Hospitals may also limit access for non-patients, including our sales professionals and therapy development specialists, which would negatively impact our access to physicians and their patients.  Any of the foregoing actions could adversely affect our sales and the revenue we derive as a result.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The outbreak and persistence of COVID-19 in international markets that we have targeted for our international expansion may also delay preparation for and launch of such expansion efforts. The spread of an infectious disease, including COVID-19, could result in the inability of our suppliers to deliver components or raw materials to us on a timely basis. If there were a shortage of supply, the cost of these materials or components may increase and harm our ability to provide our products on a cost-effective basis. In connection with any supply shortages in the future, reliable and cost-effective replacement sources may not be available on short notice or at all, and this may force us to increase prices and face a corresponding decrease in demand for our products.  In the event that any of our suppliers were to discontinue production of our key product components, developing alternate sources of supply for these components would be time consuming, difficult and costly. The extent to which the coronavirus impacts our business will depend on future developments, which are highly uncertain and cannot be predicted, including new information which may emerge concerning the severity of the coronavirus and the actions to contain the coronavirus or treat its impact, among others.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">We have limited long-term data regarding the safety and effectiveness of our products, including our ENROUTE stent and TCAR generally.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our products enable TCAR, which is a novel procedure, and our success depends on acceptance of our products and TCAR by the medical industry, including physicians and hospitals.  The FDA reviews our products for safety and effectiveness, prior to commercial launch of these products. Thereafter, physicians, through their own use of the products and evaluation of clinical data, make their own decisions as to whether our products are safe and effective for their patients and improve their clinical outcomes.  Important factors upon which the effectiveness of our products, including our ENROUTE stent, will be measured include but are not limited to long-term data regarding the risk of stroke and death and the rates of restenosis and reintervention following TCAR.  The long-term clinical benefits of procedures that use our products are not known.  We have limited data on the ENROUTE stent and TCAR up to one year.  Any failure of our stent or in-stent restenosis of the carotid artery following deployment of the stent could deter physicians from adopting our products and could have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The results of short-term clinical experience of our products do not necessarily predict long-term clinical benefit.  We believe that physicians will compare the rates of long-term risk of stroke and death, as well as restenosis and reintervention for procedures using our products, against alternative procedures, such as CEA and CAS.  If the long-term data do not meet physicians&#8217; expectations, or if long-term data indicate that our products are not as safe or effective as other treatment options or as current short-term data would suggest, our products may not become widely adopted, physicians may recommend alternative treatments for their patients and our business could be harmed.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">If we are not able to maintain adequate levels of third-party coverage and reimbursement for the procedures using our products, if third parties rescind or modify their coverage or delay payments, or if patients are left with significant out-of-pocket costs, it would have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">TCAR is currently covered under certain circumstances for certain patients by the Centers for Medicare and Medicaid Services, and has been covered by some commercial payers, independent networks and other entities not governed by the National Coverage Determination.  In the United States, we derive our revenue from sales to hospitals and medical centers, which typically bill all or a portion of the costs and fees associated with our products to various third-party payers, including Medicare, Medicaid, Veterans&#8217; Administration, private commercial insurance companies, health maintenance organizations and other healthcare-related organizations, and then bill patients for any applicable </span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">56</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">deductibles or co-payments.  For example, our contracts are with the hospitals and medical centers that purchase our products for use with TCAR and not with the commercial payers.  As a result, access to adequate coverage and reimbursement for our products by third-party payers is essential to the acceptance of our products by our customers.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">However, in the United States, there is no uniform policy of coverage and reimbursement for medical device products and services among third-party payers, so coverage and reimbursement can differ significantly from payer to payer, and each coverage decision and level of reimbursement is independent.  As a result, third-party reimbursement may not be available or adequate for our products, and there is no guarantee that we will be able to maintain our current levels of coverage or reimbursement or be able to expand coverage to other insurance carriers.  Further, payers continually review new technologies for possible coverage and can, without notice, deny or limit coverage for products and procedures or delay coverage approval until further clinical data are available.  As a result, the coverage determination process is often a time-consuming and costly process that may require us to provide scientific and clinical support for the use of our products to each payer separately, with no assurance that coverage and adequate reimbursement will be obtained, or maintained if obtained.  If third-party reimbursement is not available or adequate for TCAR procedures using our products, or if there is any decline in the amount that payers are willing to reimburse our customers for TCAR or our products, new customers may not adopt, or may reduce their rate of adoption of, our products and we could experience additional pricing pressure, any of which could have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our products are reimbursed primarily on a per-patient prior authorization basis for patients covered by commercial insurers and on a medical necessity basis for certain patients covered by the Centers for Medicare and Medicaid Services.  Based on reimbursement information regarding CEA and CAS, we estimate that approximately 75% of carotid procedures are reimbursed by Medicare/Medicaid and approximately 25% are reimbursed by commercial payers.  Current Procedure Terminology, or CPT, codes are developed and issued by the American Medical Association, or AMA.  The U.S. Centers for Medicare &amp; Medicaid Services, or CMS, determines Medicare physician payments based on formulas within the Medicare Resource-Based Relative Value Scale, which uses Relative Value Units, or RVUs.  </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The AMA/Specialty Society RVS Update Committee, or RUC, provides periodic recommendations to CMS on the RVU values, but CMS makes the final decisions about Medicare payments. </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> In the future, Medicare physician payments for TCAR using our products may change based on a new RUC review recommendation.  </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">CMS makes the final determination regarding Medicare hospital and physician payments.  I</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">f the Society for Vascular Surgery recommended changes to the RVUs or declined to support the use of TCAR or the Medicare National Coverage Determination no longer covers TCAR, there would be a material adverse effect on our business, financial condition and results of operations.  If this were to occur, commercial insurance companies could also adjust payment rates at which they reimburse TCAR using our products.  Other carotid artery disease treatments, such as CEA, may be more widely covered or subject to different co-pay policies and requirements.  If patients are required to cover all or a part of the cost of TCAR or our products out-of-pocket, they may be less likely to elect to use our products and/or undergo the procedure.  Additionally, patients may elect to reduce or defer out-of-pocket costs during times of economic uncertainty or periods of legislative change.  If hospital, physician and/or patient demand for TCAR, and thus our products that facilitate the procedure, is adversely affected by third-party reimbursement policies and decisions, it will have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Internationally, reimbursement systems in foreign markets vary significantly by country and by region within some countries, and reimbursement approvals must be obtained on a country-by-country basis.  In certain international markets, a product must be approved for reimbursement before it can be approved for sale in that country.  Additionally, many international markets have government-managed healthcare systems that control reimbursement for products and procedures.  In most markets there are both private insurance systems and government-managed systems.  If sufficient levels of coverage and </span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">57</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">reimbursement are not available for TCAR or our current or future products, in either the United States or internationally, the demand for our products and our revenues will be adversely affected.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Additionally, when payers combine their operations, the combined company may elect to reimburse for TCAR at the lowest rate paid by any of the participants in the consolidation or use its increased size to negotiate reduced rates.  If one of the payers participating in the consolidation does not reimburse for TCAR at all, the combined company may elect not to reimburse for TCAR, which would adversely impact our business, financial condition and results of operations.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">If we fail to comply with our obligations in our intellectual property license from Cardinal Health, we could lose license rights that are important to our business. </span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We are a party to a license agreement with Cordis Corporation, or Cordis, which was acquired by Cardinal Health, under which Cordis has granted us a worldwide, non-exclusive, royalty-bearing license to certain of its intellectual property related to the PRECISE&#174; carotid stent for transcervical treatment of carotid artery disease with an intravascular stent for certain applications for accessing blood vessels through the neck and cervical area. This license agreement imposes, and we expect that any future license agreements will impose, certain diligence, royalty, and other obligations on us. If we fail to comply with these obligations, our licensors, including Cardinal Health, may have the right to reduce the scope of our rights or terminate these agreements, in which event we may not be able to develop and market any product that is covered by these agreements. Termination of this license for failure to comply with such obligations or for other reasons, or reduction or elimination of our licensed rights under it or any other license, may result in our having to negotiate new or reinstated licenses on less favorable terms or our not having sufficient intellectual property rights to operate our business or cause us to enter into a new license for a different stent. The occurrence of such events could materially harm our business and financial condition. </span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The risks described elsewhere pertaining to our intellectual property rights also apply to the intellectual property rights that we in-license, and any failure by us or our licensors, including Cordis, to obtain, maintain, defend and enforce these rights could have a material adverse effect on our business. In some cases we do not have control over the prosecution, maintenance or enforcement of the patents that we license, and may not have sufficient ability to provide input into the patent prosecution, maintenance and defense process with respect to such patents, and our licensors may fail to take the steps that we believe are necessary or desirable in order to obtain, maintain, defend and enforce the licensed patents.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">We rely on Cardinal Health to supply the ENROUTE stent, and if Cardinal Health fails to supply the ENROUTE stent in sufficient quantities or at all, it will have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We rely on Cardinal Health to manufacture the ENROUTE stent pursuant to a supply agreement between us and Cordis Corporation, which was acquired by Cardinal Health.  We strive to maintain an inventory of several months&#8217; worth of ENROUTE stents to guard against potential shortfalls in supply, and we estimate that it would take one to two years to find an alternative supplier for our ENROUTE stent and multiple years to identify and seek approval for another stent, and in each case qualify it for use with our other products.  In addition, Cardinal Health currently manufactures the ENROUTE stent at a facility in Juarez, Mexico.  The current political and trade relationship between the United States and Mexico is strained and may deteriorate.  If Cardinal Health&#8217;s ability to manufacture the ENROUTE stent is interrupted as a result, or if Cardinal Health breaches its supply agreement with us, we may not have a sufficient number of stents for delivery to support TCAR procedures.  Any shortfall in the supply of ENROUTE stents may result in lower adoption rates for TCAR, fewer TCAR procedures being performed generally, and a material adverse effect on our business, financial condition and results of operations.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">TCAR involves surgical risks and is contraindicated in certain patients, which may limit adoption.</span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">58</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Risks of TCAR using our products include the risks that are common to surgical and endovascular procedures, including perforation, dissection, embolization, bleeding, infection, nerve injury and restenosis.  Endovascular procedures occurring in the carotid arteries also include the additional risks of stroke, heart attack and death.  We are aware of certain characteristics and features of TCAR that may prevent widespread market adoption, including the fact that physicians would need to adopt a new procedure, and that training for physicians will be required to enable them to effectively operate our products.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our current products are contraindicated, and therefore should not be used, in certain patients.  Our ENROUTE NPS is contraindicated in patients in whom antiplatelet and/or anticoagulation therapy is contraindicated; patients with uncorrected bleeding disorders; patients with severe disease of the ipsilateral common carotid artery; and patients with uncontrollable intolerance to flow reversal.  Our ENROUTE stent is contraindicated in patients in whom antiplatelet and/or anticoagulation therapy is contraindicated; patients in whom the ENROUTE NPS is unable to be placed; patients with uncorrected bleeding disorders; patients with known allergies to nitinol; and patients with lesions in the ostium of the common carotid artery.  Our ENHANCE peripheral access kit is contraindicated in patients with a known or suspected obstruction in the vessel.  Our ENROUTE guidewire is contraindicated in patients judged not acceptable for percutaneous intervention.  Additionally, patients that lack at least five centimeters of common carotid artery free of significant disease are not indicated for our ENROUTE NPS.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">We have limited experience manufacturing our products in commercial quantities and we face manufacturing risks that may adversely affect our ability to manufacture products and could reduce our gross margins and negatively affect our business and operating results.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our business strategy depends on our ability to manufacture our current and future products in sufficient quantities and on a timely basis to meet customer demand, while adhering to product quality standards, complying with regulatory quality system requirements and managing manufacturing costs.  We have a facility located in Sunnyvale, California, where we assemble and package certain of our products, and inspect, release and ship all of our products.  We currently produce our ENROUTE NPS at this facility, and we and the contract manufacturers of our other products do not have redundant facilities.  If our or our manufacturing partners&#8217; facilities suffers damage, or a force majeure event, this could materially impact our ability to operate.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We are also subject to numerous other risks relating to our manufacturing capabilities, including:</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Quality and reliability of components, sub-assemblies and materials that we source from third-party suppliers, who are required to meet our quality specifications, the majority of which are our single source suppliers for the products they supply;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Our or our manufacturing partners&#8217; inability to secure components, sub-assemblies and materials in a timely manner, in sufficient quantities or on commercially reasonable terms;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Our or our manufacturing partners&#8217; inability to maintain compliance with quality system requirements or pass regulatory quality inspections;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Our or our manufacturing partners&#8217; failure to increase production capacity or volumes to meet demand;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Our or our manufacturing partners&#8217; inability to design or modify production processes to enable us to produce future products efficiently or implement changes in current products in response to design or regulatory requirements; and</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Difficulty identifying and qualifying, and obtaining new regulatory approvals, for alternative suppliers for components in a timely manner.</span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">59</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">These risks are likely to be exacerbated by our limited experience with our current products and manufacturing processes.  As demand for our products increases, we will have to invest additional resources to purchase components, sub-assemblies and materials, hire and train employees and enhance our manufacturing processes.  If we fail to increase our production capacity efficiently, we may not be able to fill customer orders on a timely basis, our sales may not increase in line with our expectations and our operating margins could fluctuate or decline.  In addition, although we expect some of our products in development to share product features, components, sub-assemblies and materials with our existing products, the manufacture of these products may require modification of our or our manufacturing partners&#8217; current production processes or unique production processes, the hiring of specialized employees, the identification of new suppliers for specific components, sub-assemblies and materials or the development of new manufacturing technologies.  It may not be possible for us or our manufacturing partners&#8217; to manufacture these products at a cost or in quantities sufficient to make these products commercially viable or to maintain current operating margins, all of which could have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">We depend on a limited number of single source suppliers to manufacture our components, sub-assemblies and materials, which makes us vulnerable to supply shortages and price fluctuations that could have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We rely on single source suppliers for the components, sub-assemblies and materials for our ENROUTE NPS.  These components, sub-assemblies and materials are critical and there are relatively few alternative sources of supply.  We have not qualified or obtained necessary regulatory approvals for additional suppliers for most of these components, sub-assemblies and materials, and we do not carry a significant inventory of these items.  While we believe that alternative sources of supply may be available, we cannot be certain whether they will be available if and when we need them, or that any alternative suppliers would be able to provide the quantity and quality of components and materials that we would need to manufacture our products if our existing suppliers were unable to satisfy our supply requirements.  To utilize other supply sources, we would need to identify and qualify new suppliers to our quality standards and obtain any additional regulatory approvals required to change suppliers, which could result in manufacturing delays and increase our expenses.  Our manufacturing partners rely on single source suppliers as well, and are subject to the foregoing risks.  </span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our and our manufacturing partners&#8217; dependence on third-party suppliers subjects us to a number of risks that could impact our ability to manufacture our products and harm our business, including:</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Interruption of supply resulting from modifications to, or discontinuation of, a supplier&#8217;s operations;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Delays in product shipments resulting from uncorrected defects, reliability issues or a supplier&#8217;s failure to produce components that consistently meet our quality specifications;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Price fluctuations due to a lack of long-term supply arrangements with our suppliers for key components;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Inability to obtain adequate supply in a timely manner or on commercially reasonable terms;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Difficulty identifying and qualifying alternative suppliers for components in a timely manner;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Inability of suppliers to comply with applicable provisions of the QSR or other applicable laws or regulations enforced by the FDA and state regulatory authorities;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Inability to adequately ensure the quality of products and components manufactured by third parties;</span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">60</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Production delays related to the evaluation and testing of products and components from alternative suppliers and corresponding regulatory qualifications; </span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Delays in delivery by our suppliers due to changes in demand from us or their other customers; and</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">An outbreak of disease or similar public health threat, such as the existing threat of coronavirus, particularly as it may impact our supply chain should the slowdown in China persist.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Although we require our third-party suppliers to supply us with components that meet our specifications and comply with applicable provisions of the QSR and other applicable legal and regulatory requirements in our agreements and contracts, and we perform incoming inspection, testing or other acceptance activities to ensure the components meet our requirements, there is a risk that our suppliers will not always act consistent with our best interests, and may not always supply components that meet our requirements or supply components in a timely manner.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Our results of operations could be materially harmed if we are unable to accurately forecast customer demand for our products and manage our inventory.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We seek to maintain sufficient levels of inventory in order to protect ourselves from supply interruptions, but keep limited components, sub-assemblies, materials and finished products on hand.  To ensure adequate inventory supply and manage our operations with our manufacturing partners and suppliers, we forecast anticipated materials requirements and demand for our products in order to predict inventory needs and then place orders with our suppliers based on these predictions.  Our ability to accurately forecast demand for our products could be negatively affected by many factors, including our limited historical commercial experience regarding TCAR, rapid growth, failure to accurately manage our expansion strategy, product introductions by competitors, an increase or decrease in customer demand for our products, our failure to accurately forecast customer acceptance of new products, unanticipated changes in general market conditions or regulatory matters and weakening of economic conditions or consumer confidence in future economic conditions.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Inventory levels in excess of customer demand may result in a portion of our inventory becoming obsolete or expiring, as well as inventory write-downs or write-offs, which would impair the strength of our brand.  From time to time, we ship products with short shelf life to customers for procedures, and to the extent those products are not used and expire, we may exchange them, and this may materially and adversely affect our gross margin.  Conversely, if we underestimate customer demand for our products or our own requirements for components, subassemblies and materials, our manufacturing partners and suppliers may not be able to deliver components, sub-assemblies and materials to meet our requirements, which could result in inadequate inventory levels or interruptions, delays or cancellations of deliveries to our customers, any of which would damage our reputation, customer relationships and business.  In addition, several components, sub-assemblies and materials incorporated into our products require lengthy order lead times, and additional supplies or materials may not be available when required on terms that are acceptable to us or our manufacturing partners, or at all, and our manufacturing partners and suppliers may not be able to allocate sufficient capacity in order to meet our increased requirements, any of which could have an adverse effect on our ability to meet customer demand for our products and our results of operations.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Our quarterly and annual results may fluctuate significantly and may not fully reflect the underlying performance of our business.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our quarterly and annual results of operations, including our revenue, net income or net loss and cash flow, may vary significantly in the future, and period-to-period comparisons of our operating results may not be meaningful.  Accordingly, the results of any one quarter or period should not be relied upon as an indication of future performance.  Our quarterly and annual financial results may fluctuate as a result of a variety of factors, many of which are outside our control and, as a result, may not fully reflect the underlying performance of our business.  Fluctuations in quarterly and annual results may decrease the </span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">61</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">value of our common stock.  Because our quarterly results may fluctuate, period-to-period comparisons may not be the best indication of the underlying results of our business and should only be relied upon as one factor in determining how our business is performing.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">We have a limited total addressable market based on our current labeling restrictions.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The total addressable market for TCAR is limited by a number of factors.  Approximately 168,000 patients with carotid artery disease in the United States received treatment in the form of surgical or endovascular intervention in 2018.  Of this group, we estimate that approximately one-third would be outside the scope of the FDA-approved labeling for the ENROUTE stent, as those patients are not deemed to be at high risk for adverse events from CEA, or high surgical risk.  The current FDA-approved labeling for the ENROUTE stent is limited to patients at high risk for adverse events from CEA. Patients at high risk for adverse events from CEA are defined as having significant comorbidities and/or anatomic risk factors, and/or advanced age, that would make them riskier candidates for CEA.  Furthermore, the safety and effectiveness of TCAR has not been established for certain patients. For example, the FDA-cleared labeling for the ENROUTE NPS states that patients should have at least five centimeters of common carotid artery free of significant disease for initial access to the artery and positioning of the ENROUTE sheath.  In addition, per the FDA-approved labeling for the ENROUTE stent, TCAR is limited to asymptomatic patients with carotid artery stenosis of at least 80% and symptomatic patients with carotid artery stenosis of at least 50%, both of which must also be high surgical risk. In addition, physicians may choose to perform CEA in patients with certain anatomical characteristics, including heavily calcified carotid arteries, calcified lesions and severe vessel tortuosity.  Finally, current labeling for our products includes contraindications for certain patients, thus further reducing our total addressable market. </span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Expanding the addressable market for TCAR is dependent upon labeling and reimbursement expansion initiatives.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The ENROUTE stent is not currently indicated for use in standard surgical risk patients.  To access a larger portion of the market for carotid artery disease, we will need to obtain approval by the FDA for a label expansion of the ENROUTE stent in standard surgical risk patients and obtain corresponding reimbursement coverage expansion for TCAR.  FDA approval of an ENROUTE stent label expansion will require additional data from clinical studies or registries, which we intend to pursue.  However, there are no guarantees that we will be able to obtain such clinical data or FDA approval of a label expansion for the ENROUTE stent, or that any label expansion or additional reimbursement coverage will be sufficient to adequately access the standard risk portion of the market for carotid artery disease patients.  If we are unable to obtain labeling and reimbursement coverage expansion, it may have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Changes in public health insurance coverage and government reimbursement rates for the TCAR procedures using our products could affect the adoption of our products and our future revenue.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The federal government is considering ways to change, and has changed, the manner in which healthcare services are paid for in the United States.  Individual states may also enact legislation that impacts Medicaid payments to hospitals and physicians.  In addition, CMS establishes Medicare payment levels for hospitals and physicians on an annual basis, which can increase or decrease payment to such entities.  Internationally, medical reimbursement systems vary significantly from country to country, with some countries limiting medical centers&#8217; spending through fixed budgets, regardless of levels of patient treatment, and other countries requiring application for, and approval of, government or third-party reimbursement.  Even if we succeed in bringing our products to market in additional foreign countries, uncertainties regarding future healthcare policy, legislation and regulation, as well as private market practices, could affect our ability to sell our products in commercially acceptable quantities at acceptable prices.</span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">62</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Cost-containment efforts of our customers, purchasing groups and governmental organizations could have a material adverse effect on our sales and profitability.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In an effort to reduce costs, many hospitals in the United States have become members of Group Purchasing Organizations, or GPOs, and Integrated Delivery Networks, or IDNs.  GPOs and IDNs negotiate pricing arrangements with medical device companies and distributors and then offer these negotiated prices to affiliated hospitals and other members.  GPOs and IDNs typically award contracts on a category-by-category basis through a competitive bidding process.  Bids are generally solicited from multiple providers with the intention of driving down pricing or reducing the number of vendors.  Due to the highly competitive nature of the GPO and IDN contracting processes, we may not be able to obtain new, or maintain existing, contract positions with major GPOs and IDNs.  Furthermore, the increasing leverage of organized buying groups may reduce market prices for our products and/or require administrative fees, thereby reducing our revenue and/or margins.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">While having a contract with a GPO or IDN for a given product category can facilitate sales to members of that GPO or IDN, such contract positions can offer no assurance that any level of sales will be achieved, as sales are typically made pursuant to individual purchase orders.  Even when a provider is the sole contracted supplier of a GPO or IDN for a certain product category, members of the GPO or IDN are generally free to purchase from other suppliers.  Furthermore, GPO and IDN contracts typically are terminable without cause by the GPO or IDN upon 60 to 90 days&#8217; notice.  Accordingly, the members of such groups may choose to purchase alternative products due to the price or quality offered by other companies, which could result in a decline in our revenue.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">We may not be able to achieve or maintain satisfactory pricing and margins for our products.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Manufacturers of medical devices have a history of price competition, and we can give no assurance that we will be able to achieve satisfactory prices for our products or maintain prices at the levels we have historically achieved.  Any decline in the amount that payers reimburse our customers for TCAR could make it difficult for customers to continue using, or to adopt, our products and could create additional pricing pressure for us.  If we are forced to lower the price we charge for our products, our gross margins will decrease, which will adversely affect our ability to invest in and grow our business.  If we are unable to maintain our prices, or if our costs increase and we are unable to offset such increase with an increase in our prices, our margins could erode.  We will continue to be subject to significant pricing pressure, which could harm our business and results of operations.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">If we are unable to manage the anticipated growth of our business, our future revenue and operating results may be harmed.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Any growth that we experience in the future will require us to expand our sales, general and administrative personnel, manufacturing and distribution operations, and facilities and information technology infrastructure.  In addition to the need to scale our organization, future growth will impose significant added responsibilities on management, including the need to identify, recruit, train and integrate additional employees.  Rapid expansion in personnel could mean that less experienced people manufacture, market and sell our products, which could result in inefficiencies and unanticipated costs, reduced quality and disruptions to our operations.  In addition, rapid and significant growth may strain our administrative and operational infrastructure.  Our ability to manage our business and growth will require us to continue to improve our operational, financial and management controls, reporting systems and procedures.  If we are unable to manage our growth effectively, it may be difficult for us to execute our business strategy and our business could be harmed.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">As demand for our products or any of our future products increases, we will need to continue to scale our capacity, expand customer service, billing and systems processes and enhance our internal quality assurance program.  We cannot assure you that any increases in scale, related improvements and quality assurance will be successfully implemented or that appropriate personnel will be available to facilitate the growth of our business.  Failure to implement necessary procedures, transition to new processes or hire </span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">63</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">the necessary personnel could result in higher costs or inability to meet increased demand.  If we encounter difficulty meeting market demand, quality standards or physician expectations, our reputation could be harmed and our business could suffer.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Due to our recent growth in our business, we are actively looking for additional facilities to store finished goods and to supplement the shipping and receiving capacity of our main offices in Sunnyvale, California.  We are also searching for additional space to provide offices for the employees we expect to hire in California.  Finally, we are in the process of determining whether to supplement our distribution operations with third-party logistics and warehousing services and/or additional leased facilities in other parts of the country.  There is competition for office, shipping and warehousing space in the San Francisco Bay area and we can provide no assurance that we will find additional space or that such space will be on reasonable terms or that we will be successful in our efforts to contract with third parties elsewhere to augment our logistics and warehousing capabilities.  If we are unable to obtain additional space or support on commercially reasonable terms our costs may go up or our business operations may be adversely affected.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">If our manufacturing facility becomes damaged or inoperable, or if we are required to vacate a facility, we may be unable to produce the products we manufacture or we may experience delays in production or an increase in costs, which could adversely affect our results of operations.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We currently maintain our research and development, manufacturing and non-field-based sales, general and administrative operations in a building located in Sunnyvale, California, which is situated on or near earthquake fault lines, and we do not have redundant facilities.  Should our building be significantly damaged or destroyed by natural or man-made disasters, such as earthquakes, fires or other events, it could take months to relocate or rebuild, during which time our employees may seek other positions, our research, development and manufacturing would cease or be delayed and our products may be unavailable.  Moreover, the use of a new facility or new manufacturing, quality control, or environmental control equipment or systems generally requires FDA review and, with respect to certain products, approval of a PMA supplement.  Because of the time required to authorize manufacturing in a new facility under FDA, the State of California and non-U.S. regulatory requirements, we may not be able to resume production on a timely basis even if we are able to replace production capacity in the event we lose manufacturing capacity.  While we maintain property and business interruption insurance, such insurance has limits and would only cover the cost of rebuilding and relocating and lost revenue, but not general damage, losses caused by earthquakes, losses we may suffer due to our products being replaced by competitors&#8217; products or loss in value due to associated decreases in our stock price.  The inability to perform our research, development and manufacturing activities, combined with our limited inventory of materials and components and manufactured products, may cause physicians to discontinue using our products or harm our reputation, and we may be unable to reestablish relationships with such physicians in the future.  Consequently, a catastrophic event at our facility could have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Furthermore, the current lease for our manufacturing facility expires in 2024, and our operations are growing at a pace that may require us to find a replacement or expansion facility sooner.  We may be unable to renew our lease or find a new facility on commercially reasonable terms.  If we were unable or unwilling to renew at the proposed rates, relocating our manufacturing facility would involve significant expense in connection with the movement and installation of key manufacturing equipment and any necessary recertification with regulatory bodies, and we cannot assure investors that such a move would not delay or otherwise adversely affect our manufacturing activities or operating results.  If our manufacturing capabilities were impaired by our move, we may not be able to manufacture and ship our products in a timely manner, which would adversely impact our business.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In addition, we rely on our manufacturing partners to supply certain of our products, and our partners are subject to similar risks with respect to their facilities.  If our manufacturing partners&#8217; facilities are damaged or destroyed and their ability to supply products to us is limited, it could negatively affect our reputation, physician relationships and TCAR adoption, all of which could have a material adverse effect </span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">64</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">on our business, financial condition and results of operations.  Several of our products are sterilized at a particular third party facility, with limited alternate facilities. If an event occurs that results in damage to or closure of one or more of such facilities, we may be unable to sterilize such products at the previous levels or at all. Because of the time required to approve and license a sterilization facility, a third party may not be available on a timely basis to replace capacity in the event sterilization capacity is lost.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">We have limited experience in training and marketing and selling our products, and if we fail in our training, to increase our sales and marketing capabilities or to develop broad brand awareness, our growth will be impeded and our business will suffer.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We have limited experience marketing and selling our products.  We currently rely on our direct sales force to sell our products in targeted geographic regions in the U.S., and any failure to maintain and grow our direct sales force could harm our business.  The members of our direct sales force are highly trained and possess substantial technical and clinical expertise, which we believe is critical in driving adoption of TCAR.  The members of our U.S. sales force are at-will employees.  The loss of these personnel to competitors, or otherwise, could materially harm our business.  If we are unable to retain our direct sales force personnel or replace them with individuals of equivalent technical and clinical expertise and qualifications, or if we are unable to successfully instill such technical and clinical expertise in replacement personnel, our revenues and results of operations could be materially harmed.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In order to generate future growth, we plan to continue to expand and leverage our sales, marketing, and medical affairs infrastructure to increase our trained physician and hospital customer base and our business.  Identifying and recruiting qualified sales, marketing and medical affairs personnel and training them on TCAR, on applicable federal and state laws and regulations, and on our internal policies and procedures requires significant time, expense and attention.  It often takes several months or more before a sales representative is fully trained and productive.  Our sales force may subject us to higher fixed costs than those of companies with competing products, such as stents, that utilize independent third parties, which could place us at a competitive disadvantage.  Our business may be harmed if our efforts to expand and train our sales force do not generate a corresponding increase in revenue, and our higher fixed costs may slow our ability to reduce costs in the face of a sudden decline in demand for our products.  Any failure to hire, develop and retain talented sales personnel, to achieve desired productivity levels in a reasonable period of time or timely reduce fixed costs, could have a material adverse effect on our business, financial condition and results of operations.  Our ability to increase our customer base and achieve broader market acceptance of our products will depend to a significant extent on our ability to expand our marketing efforts.  We plan to dedicate significant resources to our marketing programs.  Our business may be harmed if our marketing efforts and expenditures do not generate a corresponding increase in revenue.  In addition, we believe that developing and maintaining broad awareness of our brand in a cost effective manner is critical to achieving broad acceptance of our products and penetrating new accounts.  Brand promotion activities may not generate patient or physician awareness or increase revenue, and even if they do, any increase in revenue may not offset the costs and expenses we incur in building our brand.  Our medical affairs department may not train physicians at a rate sufficient to expand our physician base in a manner consistent with our business plan.  If we fail to successfully promote, maintain and protect our brand, we may fail to attract or retain the physician acceptance necessary to realize a sufficient return on our brand building efforts, or to achieve the level of brand awareness that is critical for broad adoption of our products.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">The market for our products is highly competitive.  If our competitors are able to develop or market carotid artery disease treatments that are safer, more effective or gain greater acceptance in the marketplace, than any products we develop, our commercial opportunities will be reduced or eliminated.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our industry is highly competitive, subject to change and significantly affected by new product introductions and other activities of industry participants.  We are initially positioning TCAR as an alternative to CEA and CAS in high surgical risk patients.  CEA has historically been performed by vascular surgeons as the primary surgical solution for carotid artery disease.  The major manufacturers of </span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">65</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">products, such as patches and shunts, used in connection with CEA include LeMaitre Vascular, Getinge / Maquet, Baxter, Terumo, Gore and Edwards.  Some competitors market products for use in CAS, such as peripheral access kits, stents, distal and proximal embolic protection devices, guidewires, balloons and sheaths.  Such companies include Abbott, Boston Scientific, Cardinal Health, Medtronic, Terumo, Gore and InspireMD.  These technologies, other products that are in current clinical trials, new drugs or additional indications for existing drugs could demonstrate better safety, effectiveness, clinical results, lower costs or greater physician and patient acceptance.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We compete, or may compete in the future, against other companies which have longer operating histories, more established products and greater resources, which may prevent us from achieving significant market penetration or improved operating results.  These companies enjoy several competitive advantages, including:</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Greater financial and human capital resources;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Significantly greater name recognition;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Established relationships with vascular surgeons and other treating specialties, referring physicians, customers and third-party payers;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Additional lines of products, and the ability to offer rebates or bundle products to offer greater discounts or incentives to gain a competitive advantage; and</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Established sales, marketing and worldwide distribution networks.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Because of the size of the market opportunity for the treatment of carotid artery disease, we believe potential competitors have historically dedicated and will continue to dedicate significant resources to aggressively promote their products or develop new products.  New treatment options may be developed that could compete more effectively with our products due to the prevalence of carotid artery disease and the extensive research efforts and technological progress that exist within the market.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Defects or failures associated with our products could lead to recalls, safety alerts or litigation, as well as significant costs and negative publicity.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our business is subject to significant risks associated with manufacture, distribution and use of medical devices that are placed inside the human body, including the risk that patients may be severely injured by or even die from the misuse or malfunction of our products caused by design flaws or manufacturing defects.  In addition, component failures, design defects, off-label uses or inadequate disclosure of product-related information could also result in an unsafe condition or the injury or death of a patient.  These problems could lead to a recall or market withdrawal of, or issuance of a safety alert relating to, our products and could result in significant costs, negative publicity and adverse competitive pressure.  The circumstances giving rise to recalls are unpredictable, and any recalls of existing or future products could have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We provide a limited warranty that our products are free of material defects and conform to specifications, and offer to repair, replace or refund the purchase price of defective products.  As a result, we bear the risk of potential warranty claims on our products.  In the event that we attempt to recover some or all of the expenses associated with a warranty claim against us from our suppliers or vendors, we may not be successful in claiming recovery under any warranty or indemnity provided to us by such suppliers or vendors and any recovery from such vendor or supplier may not be adequate.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The medical device industry has historically been subject to extensive litigation over product liability claims.  Operating in the area of the neck with the brain as the end organ is dangerous and presents risks of adverse events such as bleeding, arterial dissection, cranial nerve injury, myocardial infarction, stroke and death, which subject us to a greater risk of being involved in litigation than companies with products </span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">66</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">used in less critical areas of the body.  We may be subject to product liability claims if our products cause, or merely appear to have caused, an injury or death, even if due to physician error.  In addition, an injury or death that is caused by the activities of our suppliers, such as those that provide us with components and raw materials, or by an aspect of a treatment used in combination with our products, such as a complementary drug or anesthesia, may be the basis for a claim against us by patients, hospitals, physicians or others purchasing or using our products, even if our products were not the actual cause of such injury or death.  We may choose to settle any claims to avoid fault and complication not due to failure of our products.  An adverse outcome involving one of our products could result in reduced market acceptance and demand for all of our products, and could harm our reputation and our ability to market our products in the future.  In some circumstances, adverse events arising from or associated with the design, manufacture or marketing of our products could result in the suspension or delay of regulatory reviews of our premarket notifications or applications for marketing.  Any of the foregoing problems could disrupt our business and have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Although we carry product liability insurance in the United States and in other countries in which we conduct business, including for clinical trials and product marketing, we can give no assurance that such coverage will be available or adequate to satisfy any claims.  Product liability insurance is expensive, subject to significant deductibles and exclusions, and may not be available on acceptable terms, if at all.  If we are unable to obtain or maintain insurance at an acceptable cost or on acceptable terms with adequate coverage or otherwise protect against potential product liability claims, we could be exposed to significant liabilities.  A product liability claim, recall or other claim with respect to uninsured liabilities or for amounts in excess of insured liabilities could have a material adverse effect on our business, financial condition and results of operations.  Defending a suit, regardless of its merit or eventual outcome, could be costly, could divert management&#8217;s attention from our business and might result in adverse publicity, which could result in reduced acceptance of our products in the market, product recalls or market withdrawals.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We are required to file adverse event reports under Medical Device Reporting, or MDR, regulations with the FDA, which reports are publicly available on the FDA&#8217;s website.  We are required to file MDRs if our products may have caused or contributed to a serious injury or death or malfunctioned in a way that could likely cause or contribute to a serious injury or death if it were to recur.  Any such MDR that reports a significant adverse event could result in negative publicity, which could harm our reputation and future sales.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Our ability to compete depends on our ability to innovate successfully and deliver any new products in a timely manner.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The market for our products is competitive, dynamic, and marked by rapid and substantial technological development and product innovation.  New entrants or existing competitors could attempt to develop products that compete directly with ours.  Demand for our products and future related products could be diminished by equivalent or superior products and technologies offered by competitors.  If we are unable to innovate successfully, our products could become obsolete and our revenue would decline as our customers purchase our competitors&#8217; products.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We are currently focused on development of existing products for TCAR and other indications, new products for TCAR and new products for other indications.  If we are unable to develop new products, applications or features due to constraints, such as insufficient cash resources, high employee turnover, inability to hire personnel with sufficient technical skills or a lack of other research and development resources, we may not be able to maintain our competitive position compared to other companies.  Furthermore, many of our competitors devote a considerably greater amount of funds to their research and development programs than we do, and those that do not may be acquired by larger companies that would allocate greater resources to research and development programs.  Our failure or inability to devote adequate research and development resources or compete effectively with the research and development programs of our competitors could harm our business.</span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">67</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Any significant delays in our product launches may significantly impede our ability to enter or compete in a given market and may reduce the sales that we are able to generate from these products.  We may experience delays in any phase of a product development, including during research and development, clinical trials, regulatory review, manufacturing and marketing.  Delays in product introductions could have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">The failure of TCAR to meet patient expectations or the occurrence of adverse events from TCAR could impair our financial performance.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our future success depends upon patients having an experience with TCAR that meets their expectations in order to increase physician demand for our products as a result of positive feedback, social media and word-of-mouth.  Patients may be dissatisfied if their expectations of the procedure and results, among other things, are not met.  Despite what we believe to be the safety profile of our products, patients may experience adverse events such as arterial restenosis or dissection, cranial nerve injury, wound complications, transient ischemic attacks, stroke, heart attack, and death.  If the results of TCAR do not meet the expectations of the patients, or patients experience adverse events, it could discourage patients from referring TCAR to others.  Dissatisfied patients may express negative opinions through social media.  Any failure to meet patient expectations and any resulting negative publicity could harm our reputation and future sales.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">We depend on our senior management team and the loss of one or more key employees or an inability to attract and retain highly skilled employees could harm our business.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our success depends largely on the continued services of key members of our executive management team and others in key management positions.  For example, the services of Erica Rogers, our Chief Executive Officer, and Lucas Buchanan, our Chief Financial Officer, are essential to driving adoption of our products, executing on our corporate strategy and ensuring the continued operations and integrity of financial reporting within our company.  In addition, the services of Andrew Davis, our Executive Vice President of Global Sales and Marketing, are critical to driving the growth in sales of our products.  Any of our employees may terminate their employment with us at any time.  We do not currently maintain key person life insurance policies on any of our employees.  If we lose one or more key employees, we may experience difficulties in competing effectively, developing our technologies and implementing our business strategy.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In addition, our research and development programs, and sales efforts depend on our ability to attract and retain highly skilled engineers and sales professionals.  We may not be able to attract or retain qualified engineers and sales professionals in the future due to the competition for qualified personnel.  We have from time to time experienced, and we expect to continue to experience, difficulty in hiring and retaining employees with appropriate qualifications.  Many of the companies with which we compete for experienced personnel have greater resources than we do.  When we hire employees from competitors or other companies, their former employers have previously and may in the future attempt to assert that these employees or we have breached legal obligations, which may result in a diversion of our time and resources and, potentially, damages.  In addition, job candidates and existing employees, particularly in the San Francisco Bay Area, often consider the value of the stock awards they receive in connection with their employment along with salary, benefits and other factors.  If the perceived benefits of our stock awards decline, either because we are a public company or for other reasons, it may harm our ability to recruit and retain highly skilled employees.  If we fail to attract new personnel or fail to retain and motivate our current personnel, our business and future growth prospects would be harmed.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">The use, misuse or off-label use of our products may result in injuries that lead to product liability suits, which could be costly to our business.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The ENROUTE stent has been approved by the FDA for the treatment of high surgical risk patients who require carotid revascularization and meet certain treatment parameters.  If physicians expand the patient population in which they elect to use our products that is outside of the intended use approved by </span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">68</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">the FDA, then the use, misuse, or off-label use of our products may result in outcomes and adverse events including stroke, myocardial infarction and death, potentially leading to product liability claims.  Our products are not indicated for use in all patients with carotid artery disease, and therefore cannot be marketed or advertised in the United States for certain uses without additional approvals or clearances from the FDA.  However, we cannot prevent a physician from using our products for off-label applications or using components or products that are not our products when performing TCAR.  In addition, we cannot guarantee that physicians are trained by us or their peers prior to utilizing our products.  Complications resulting from the use of our products off-label or use by physicians who have not been trained appropriately, or at all, may expose us to product liability claims and harm our reputation.  Moreover, if the FDA determines that our promotional materials or physician training, including our paid consultants&#8217; educational materials, constitutes promotion of an off-label use, it could request that we modify our training or promotional materials or subject us to enforcement action, including warning letters, untitled letters, fines, penalties, or seizures.  If we are found to have promoted such off-label uses, we may become subject to significant liability.  The federal government has levied large civil and criminal fines and/or other penalties against companies for alleged improper promotion and has investigated, prosecuted, and/or enjoined several companies from engaging in off-label promotion.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In addition, if our products are defectively designed, manufactured or labeled, contain defective components or are misused, we may become subject to costly litigation initiated by physicians, hospitals or patients.  Product liability claims are especially prevalent in the medical device industry and could harm our reputation, divert management&#8217;s attention from our core business, be expensive to defend and may result in sizable damage awards against us.  Although we maintain product liability insurance, we may not have sufficient insurance coverage for future product liability claims.  We may not be able to obtain insurance in amounts or scope sufficient to provide us with adequate coverage against all potential liabilities.  Any product liability claims brought against us, with or without merit, could increase our product liability insurance rates or prevent us from securing continuing coverage, harm our reputation, significantly increase our expenses, and reduce product sales.  Product liability claims could cause us to incur significant legal fees and deductibles and claims in excess of our insurance coverage would be paid out of cash reserves, harming our financial condition and operating results.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">We may need substantial additional funding and may not be able to raise capital when needed, which could force us to delay, reduce or eliminate our product development programs and commercialization efforts.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We believe that our cash and cash equivalents and investments as of December&#160;31, 2019, and expected revenue, will be sufficient to meet our capital requirements and fund our operations for at least the next 12 months.  However, we have based these estimates on assumptions that may prove to be incorrect, and we could spend our available financial resources much faster than we currently expect.  Our future funding requirements will depend on many factors, including:</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">The degree and rate of market acceptance of TCAR and our products;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Whether we acquire third-party companies, products or technologies;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Restructuring, refinancing or repayment of debt;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">The scope and timing of investment in our sales force; </span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">The scope and timing of investment in physician training;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">The scope, rate of progress and cost of our current or future clinical studies;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">The scope, rate of progress and cost of our research and development activities; </span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">The scope, rate of progress and cost of additional regulatory clearances or approvals; </span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">The costs associated with any product recall that may occur;</span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">69</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">The costs of attaining, defending and enforcing our intellectual property rights;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">The emergence of competing technologies or other adverse market developments; and</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">The rate at which we expand internationally.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We may seek to raise additional capital through equity offerings or debt financings and such additional financing may not be available to us on acceptable terms, or at all.  In addition, any additional equity or debt financing that we raise may contain terms that are not favorable to us or our stockholders.  For example, if we raise funds by issuing equity or equity-linked securities, the issuance of such securities could result in dilution to our stockholders.  Any equity securities issued also may provide for rights, preferences or privileges senior to those of holders of our common stock.  In addition, the issuance of additional equity securities by us, or the possibility of such issuance, may cause the market price of our common stock to decline.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In addition, the terms of debt securities issued or borrowings could impose significant restrictions on our operations including restrictive covenants, such as limitations on our ability to incur additional debt or issue additional equity, limitations on our ability to pay dividends, limitations on our ability to acquire or license intellectual property rights, and other operating restrictions that could adversely affect our ability to conduct our business.  </span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In the event that we enter into collaborations or licensing arrangements to raise capital, we may be required to accept unfavorable terms, such as relinquishment or licensing of certain technologies or products that we otherwise would seek to develop or commercialize ourselves, or reserve for future potential arrangements when we might otherwise be able to achieve more favorable terms.  In addition, we may be forced to work with a partner on one or more of our products or market development programs, which could lower the economic value of those programs to us.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">If we are unable to obtain adequate financing on terms satisfactory to us when we require it, we may terminate or delay the development of one or more of our products, delay clinical trials necessary to market our products, or delay establishment of sales and marketing capabilities or other activities necessary to commercialize our products.  If this were to occur, our ability to grow and support our business and to respond to market challenges could be significantly limited, which could have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">We have a significant amount of debt, which may affect our ability to operate our business and secure additional financing in the future.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">As of December 31, 2019, we had an aggregate of approximately $44.9&#160;million in principal and interest outstanding under our term loan agreement.  We must make significant interest only quarterly payments under the loan agreement, which has diverted and will continue to divert resources from other activities.  Our obligations under the term loan agreement are collateralized by substantially all of our assets, including our material intellectual property, and we are subject to customary financial and operating covenants limiting our ability to, among other things, relocate or dispose of assets, undergo a change in control, merge or consolidate, enter into certain transactions with affiliates, make acquisitions, incur debt, pay dividends, grant liens, repurchase stock and make investments, in each case subject to certain exceptions.  The covenants related to the term loan agreement, as well as any future financing agreements into which we may enter, may restrict our ability to finance our operations and engage in, expand or otherwise pursue our business activities and strategies.  While we have not previously breached and are not currently in breach of these or any other covenants contained in our term loan agreement, there can be no guarantee that we will not breach these covenants in the future.  Our ability to comply with these covenants may be affected by events beyond our control, and future breaches of any of these covenants could result in a default under the loan agreement.  If not waived, future defaults could cause all of the outstanding indebtedness under the term loan agreement to become immediately due and payable and terminate commitments to extend further credit.  If we do not have or are unable to generate sufficient cash available to repay our debt obligations when they become due and payable, </span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">70</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">either upon maturity or in the event of a default, our assets could be foreclosed upon and we may not be able to obtain additional debt or equity financing on favorable terms, if at all, which may negatively impact our ability to operate and continue our business as a going concern.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">We may acquire other companies or technologies, or enter into license agreements, distribution arrangements or strategic partnerships, which could fail to result in a commercial product or generate sales, divert our management&#8217;s attention, result in additional dilution to our stockholders and otherwise disrupt our operations and harm our operating results.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Although we currently have no agreements or commitments to complete any such transactions and are not involved in negotiations to do so, we may in the future seek to acquire, license or invest in businesses, products or technologies that we believe could complement or expand our portfolio, enhance our technical capabilities or otherwise offer growth opportunities.  We could also seek to enter into distribution arrangements or strategic partnerships with third parties that we believe could increase our revenue or offer other commercial benefits.  However, we cannot assure you that we would be able to successfully complete any acquisition, license agreement or distribution agreement we choose to pursue, or that we would be able to successfully integrate any business or product or technology in a cost-effective and non-disruptive manner.  Similarly, we cannot guarantee that we would derive benefits from any distribution arrangement or other strategic partnership.  The pursuit of potential acquisition, license or partnering opportunities may divert the attention of management and cause us to incur various costs and expenses in identifying, investigating and pursuing suitable transactions, whether or not they are consummated.  We may not be able to identify desirable acquisition targets or strategic partners, or be successful in entering into an agreement with any particular target or partner, or obtain the expected benefits of any acquisition, license, investment or other strategic partnership arrangement.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">To date, the growth of our operations has been largely organic, and we have limited experience in acquiring other businesses or technologies.  We may not be able to successfully integrate any acquired personnel, operations and technologies, or effectively manage the combined business following an acquisition.  Acquisitions could also result in dilutive issuances of equity securities, the use of our available cash, or the incurrence of debt, which could harm our operating results.  In addition, if an acquired business, product or technology fails to meet our expectations, our operating results, business and financial condition may suffer.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Our ability to utilize our net operating loss carryforwards may be limited</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">As of December 31, 2019, we had U.S. federal and state net operating loss carryforwards, or NOLs, </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">of $167.9&#160;million and $148.4 million, respectively.  Our U.S. federal NOLs arising in tax years ending on or before December 31, 2017 are subject to expiration and will begin to expire in 2027 (U.S. federal NOLs arising in tax years ending after December 31, 2017 are not subject to expiration) and our state NOLs will begin to expire in 2028.  We may use these NOLs to offset taxable income for U.S. federal and state income tax purposes.  However, Section 382 of the Internal Re</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">venue Code of 1986, as amended, or the Code, may limit the NOLs we may use in any year for U.S. federal income tax purposes in the event of certain changes in ownership of our company.  An &#8220;ownership change&#8221; pursuant to Section 382 of the Code generally occurs if one or more stockholders or groups of stockholders who own at least 5% of a company&#8217;s stock increase their ownership by more than 50 percentage points over their lowest ownership percentage within a rolling three-year period.  Similar rules may apply under state tax laws.  Although we have not performed a formal study under Section 382 of the Code, we believe we may have experienced at least one &#8220;ownership change&#8221; in the past and may have experienced others.  In addition, future issuances or sales of our stock, including certain transactions involving our stock that are outside of our control, could result in future &#8220;ownership changes.&#8221; &#8220;Ownership changes&#8221; that have occurred in the past or that may occur in the future could result in the imposition of an annual limit on the amount of pre-ownership change NOLs and other tax attributes we can use to reduce our taxable income or income tax liability, potentially increasing and accelerating our liability for income taxes, and also potentially causing those tax attributes to expire unused.  Any limitation on using NOLs could, depending on the extent of such limitation and the NOLs previously used, result in our retaining less cash after payment of U.S. </span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">71</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">federal and state income taxes during any year in which we have taxable income, rather than losses, than we would be entitled to retain if such NOLs were available as an offset against such income for U.S. federal and state income tax reporting purposes, which could adversely impact our operating results.  Furthermore, under the Tax Cuts and Jobs Act of 2017, although the treatment of U.S. federal NOLs arising in tax years beginning on or before December 31, 2017 has generally not changed, U.S. federal NOLs arising in tax years beginning after December 31, 2017 may only be used to offset 80% of our taxable income.  This change may require us to pay U.S. federal income taxes in future years despite generating a loss for federal income tax purposes in prior years.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">As international expansion of our business occurs, it will expose us to market, regulatory, political, operational, financial, legal and economic risks associated with doing business outside of the United States.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our long-term strategy is to increase our international presence, including but not limited to securing regulatory approvals in Japan and China.  We have the right to affix the CE Mark to our products, allowing us to commercialize in Europe in the future.  This strategy may include establishing and maintaining physician outreach and education capabilities outside of the United States and expanding our relationships with international distributors, providers and payers.  Doing business internationally involves a number of risks, including:</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Difficulties in staffing and managing our international operations; </span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Multiple, conflicting and changing laws and regulations such as tax laws, privacy laws, export and import restrictions, employment laws, regulatory requirements and other governmental approvals, permits and licenses;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Reduced or varied protection for intellectual property rights in some countries; </span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Obtaining regulatory clearance where required for our products in various countries;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Requirements to maintain data and the processing of that data on servers located within such countries;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Complexities associated with managing multiple payer reimbursement regimes, government payers or patient self-pay systems;  </span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Difficulties in adequately training and managing international distributors;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Limits on our ability to penetrate international markets if we are required to manufacture our products locally;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Financial risks, such as longer payment cycles, difficulty collecting accounts receivable, foreign tax laws and complexities of foreign value-added tax systems, the effect of local and regional financial pressures on demand and payment for our products and exposure to foreign currency exchange rate fluctuations;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Restrictions on the site-of-service for use of our products and the economics related thereto for physicians, providers and payers;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Natural disasters, political and economic instability, including wars, terrorism, political unrest, outbreak of disease, boycotts, curtailment of trade and other market restrictions; and</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Regulatory and compliance risks that relate to maintaining accurate information and control over activities subject to regulation under the United States Foreign Corrupt Practices Act of 1977, or FCPA, U.K. Bribery Act of 2010 and comparable laws and regulations in other countries.</span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">72</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Any of these factors could significantly harm our future international expansion and operations and, consequently, have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Additionally, pursuant to the terms of our intellectual property license with Cardinal Health, we do not have the right to sell the ENROUTE stent through distributors, which may be desirable as we expand internationally.  If we fail to renegotiate our agreement with Cardinal Health to enable sale of the ENROUTE stent through international distributors, our ability to expand our business internationally may be harmed, which could have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Security breaches, loss of data and other disruptions could compromise sensitive information related to our business or our customers or patients, or prevent us from accessing critical information and expose us to liability, which could adversely affect our business and our reputation.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In the ordinary course of our business, we may become exposed to, or collect and store sensitive data, including procedure-based information and legally-protected health information, credit card, and other financial information, insurance information, and other potentially personally identifiable information.  We also store sensitive intellectual property and other proprietary business information.  Although we take measures to protect sensitive information from unauthorized access or disclosure, our information technology, or IT, and infrastructure, and that of our other technology partners, may be vulnerable to cyber attacks by hackers or viruses or breached due to employee error, malfeasance or other disruptions.  We rely extensively on IT systems, networks and services, including internet sites, data hosting and processing facilities and tools, physical security systems and other hardware, software and technical applications and platforms, some of which are managed, hosted, provided and/or used by third-parties or their vendors, to assist in conducting our business.  A significant breakdown, invasion, corruption, destruction or interruption of critical information technology systems or infrastructure, by our workforce, others with authorized access to our systems or unauthorized persons could negatively impact operations.  The ever-increasing use and evolution of technology, including cloud-based computing, creates opportunities for the unintentional dissemination or intentional destruction of confidential information stored in our or our third-party providers' systems, portable media or storage devices.  We could also experience a business interruption, theft of confidential information or reputational damage from industrial espionage attacks, malware or other cyber-attacks, which may compromise our system infrastructure or lead to data leakage, either internally or at our third-party providers.  Although the aggregate impact on our operations and financial condition has not been material to date, we have been the target of events of this nature and expect them to continue as cybersecurity threats have been rapidly evolving in sophistication and becoming more prevalent in the industry.  We are investing in protections and monitoring practices of our data and IT to reduce these risks and continue to monitor our systems on an ongoing basis for any current or potential threats.  There can be no assurance, however, that our efforts will prevent breakdowns or breaches to our or our third-party providers&#8217; databases or systems that could adversely affect our business.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">We could be adversely affected by violations of the FCPA and similar worldwide anti-bribery laws and any investigation, and the outcome of any investigation, by government agencies of possible violations by us of the FCPA could have a material adverse effect on our business.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The FCPA and similar worldwide anti-bribery laws prohibit companies and their intermediaries from corruptly providing any benefits to government officials for the purpose of obtaining or retaining business.  We are in the process of further enhancing policies and procedures intended to help ensure compliance with these laws.  In the future, we may operate in parts of the world that have experienced governmental corruption to some degree.  Moreover, because of the significant role government entities play in the regulation of many foreign healthcare markets, we may be exposed to heightened FCPA and similar risks arising from our efforts to seek regulatory approval of and reimbursement for our products in such countries.  We cannot assure you that our internal control policies and procedures will protect us from </span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">73</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">improper acts committed by our employees or agents.  Violations of these laws, or allegations of such violations, would significantly disrupt our business and have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Risks Related to Our Intellectual Property</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">We may become a party to intellectual property litigation or administrative proceedings that could be costly and could interfere with our ability to sell and market our products.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The medical device industry has been characterized by extensive litigation regarding patents, trademarks, trade secrets, and other intellectual property rights, and companies in the industry have used intellectual property litigation to gain a competitive advantage.  It is possible that U.S. and foreign patents and pending patent applications or trademarks controlled by third parties may be alleged to cover our products, or that we may be accused of misappropriating third parties&#8217; trade secrets.  Additionally, our products include components that we purchase from vendors, and may include design components that are outside of our direct control.  Our competitors, many of which have substantially greater resources and have made substantial investments in patent portfolios, trade secrets, trademarks, and competing technologies, may have applied for or obtained, or may in the future apply for or obtain, patents or trademarks that will prevent, limit or otherwise interfere with our ability to make, use, sell and/or export our products or to use product names.  Moreover, in recent years, individuals and groups that are non-practicing entities, commonly referred to as &#8220;patent trolls,&#8221; have purchased patents and other intellectual property assets for the purpose of making claims of infringement in order to extract settlements.  From time to time, we may receive threatening letters, notices or &#8220;invitations to license,&#8221; or may be the subject of claims that our products and business operations infringe or violate the intellectual property rights of others.  The defense of these matters can be time consuming, costly to defend in litigation, divert management&#8217;s attention and resources, damage our reputation and brand and cause us to incur significant expenses or make substantial payments.  Vendors from whom we purchase hardware or software may not indemnify us in the event that such hardware or software is accused of infringing a third-party&#8217;s patent or trademark or of misappropriating a third-party&#8217;s trade secret.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Since patent applications are confidential for a period of time after filing, we cannot be certain that we were the first to file any patent application related to our products. Competitors may also contest our patents, if issued, by showing the patent examiner that the invention was not original, was not novel or was obvious. In litigation, a competitor could claim that our patents, if issued, are not valid for a number of reasons. If a court agrees, we would lose our rights to those challenged patents.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In addition, we may in the future be subject to claims by our former employees or consultants asserting an ownership right in our patents or patent applications, as a result of the work they performed on our behalf. Although we generally require all of our employees and consultants and any other partners or collaborators who have access to our proprietary know-how, information or technology to assign or grant similar rights to their inventions to us, we cannot be certain that we have executed such agreements with all parties who may have contributed to our intellectual property, nor can we be certain that our agreements with such parties will be upheld in the face of a potential challenge, or that they will not be breached, for which we may not have an adequate remedy.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Further, if such patents, trademarks, or trade secrets are successfully asserted against us, this may harm our business and result in injunctions preventing us from selling our products, license fees, damages and the payment of attorney fees and court costs.  In addition, if we are found to willfully infringe third-party patents or trademarks or to have misappropriated trade secrets, we could be required to pay treble damages in addition to other penalties.  Although patent, trademark, trade secret, and other intellectual property disputes in the medical device area have often been settled through licensing or similar arrangements, costs associated with such arrangements may be substantial and could include ongoing royalties.  We may be unable to obtain necessary licenses on satisfactory terms, if at all.  If we do not obtain necessary licenses, we may not be able to redesign our products to avoid infringement.</span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">74</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Similarly, interference or derivation proceedings provoked by third parties or brought by the U.S. Patent and Trademark Office, or USPTO, may be necessary to determine priority with respect to our patents, patent applications, trademarks or trademark applications.  We may also become involved in other proceedings, such as reexamination, inter parties review, derivation or opposition proceedings before the USPTO or other jurisdictional body relating to our intellectual property rights or the intellectual property rights of others.  Adverse determinations in a judicial or administrative proceeding or failure to obtain necessary licenses could prevent us from manufacturing our products or using product names, which would have a significant adverse impact on our business, financial condition and results of operations.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Additionally, we may file lawsuits or initiate other proceedings to protect or enforce our patents or other intellectual property rights, which could be expensive, time consuming and unsuccessful.  Competitors may infringe our issued patents or other intellectual property.  To counter infringement or unauthorized use, we may be required to file infringement claims, which can be expensive and time-consuming.  Any claims we assert against perceived infringers could provoke these parties to assert counterclaims against us alleging that we infringe their intellectual property.  In addition, in a patent infringement proceeding, a court may decide that a patent of ours is invalid or unenforceable, in whole or in part, construe the patent&#8217;s claims narrowly or refuse to stop the other party from using the technology at issue on the grounds that our patents do not cover the technology in question.  Furthermore, even if our patents are found to be valid and infringed, a court may refuse to grant injunctive relief against the infringer and instead grant us monetary damages and/or ongoing royalties. Such monetary compensation may be insufficient to adequately offset the damage to our business&#160;caused by the infringer&#8217;s competition in the market.  An adverse result in any litigation proceeding could put one or more of our patents at risk of being invalidated or interpreted narrowly, which could adversely affect our competitive business position, financial condition and results of operations.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Our success will depend on our ability to obtain, maintain and protect our intellectual property rights.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In order to remain competitive, we must develop, maintain and protect the proprietary aspects of our brands, technologies and data.  We rely on a combination of contractual provisions, confidentiality procedures and patent, copyright, trademark, trade secret and other intellectual property laws to protect the proprietary aspects of our brands, technologies and data.  These legal measures afford only limited protection, and competitors or others may gain access to or use our intellectual property and proprietary information.  Our success will depend, in part, on preserving our trade secrets, maintaining the security of our data and know-how and obtaining and maintaining other intellectual property rights.  We may not be able to obtain or maintain intellectual property or other proprietary rights necessary to our business or in a form that provides us with a competitive advantage.  In addition, our trade secrets, data and know-how could be subject to unauthorized use, misappropriation, or disclosure to unauthorized parties, despite our efforts to enter into confidentiality agreements with our employees, consultants, clients and other vendors who have access to such information, and could otherwise become known or be independently discovered by third parties.  Our intellectual property, including trademarks, could be challenged, invalidated, infringed, and circumvented by third parties, and our trademarks could also be diluted, declared generic or found to be infringing on other marks.  If any of the foregoing occurs, we could be forced to re-brand our products, resulting in loss of brand recognition and requiring us to devote resources to advertising and marketing new brands, and suffer other competitive harm.  Third parties may also adopt trademarks similar to ours, which could harm our brand identity and lead to market confusion.  Failure to obtain and maintain intellectual property rights necessary to our business and failure to protect, monitor and control the use of our intellectual property rights could negatively impact our ability to compete and cause us to incur significant expenses.  The intellectual property laws and other statutory and contractual arrangements in the United States and other jurisdictions we depend upon may not provide sufficient protection in the future to prevent the infringement, use, violation or misappropriation of our trademarks, data, technology and other intellectual property and services, and may not provide an adequate remedy if our intellectual property rights are infringed, misappropriated or otherwise violated.</span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">75</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We rely, in part, on our ability to obtain, maintain, expand, enforce, and defend the scope of our intellectual property portfolio or other proprietary rights, including the amount and timing of any payments we may be required to make in connection with the licensing, filing, defense and enforcement of any patents or other intellectual property rights.  The process of applying for and obtaining a patent is expensive, time consuming and complex, and we may not be able to file, prosecute, maintain, enforce or license all necessary or desirable patent applications at a reasonable cost, in a timely manner, or in all jurisdictions where protection may be commercially advantageous, or we may not be able to protect our proprietary rights at all.  Despite our efforts to protect our proprietary rights, unauthorized parties may be able to obtain and use information that we regard as proprietary.  In addition, the issuance of a patent does not ensure that it is valid or enforceable, so even if we obtain patents, they may not be valid or enforceable against third parties.  Our patent applications may not result in issued patents and our patents may not be sufficiently broad to protect our technology.  Moreover, even if we are able to obtain patent protection, such patent protection may be of insufficient scope to achieve our business objectives.  Issued patents may be challenged, narrowed, invalidated or circumvented.  Decisions by courts and governmental patent agencies may introduce uncertainty in the enforceability or scope of patents owned by or licensed to us.  Furthermore, the issuance of a patent does not give us the right to practice the patented invention.  Third parties may have blocking patents that could prevent us from marketing our own products and practicing our own technology.  Alternatively, third parties may seek approval to market their own products similar to or otherwise competitive with our products.  In these circumstances, we may need to defend and/or assert our patents, including by filing lawsuits alleging patent infringement.  In any of these types of proceedings, a court or agency with jurisdiction may find our patents invalid, unenforceable or not infringed; competitors may then be able to market products and use manufacturing and analytical processes that are substantially similar to ours.  Even if we have valid and enforceable patents, these patents still may not provide protection against competing products or processes sufficient to achieve our business objectives.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">If we are unable to protect the confidentiality of our other proprietary information, our business and competitive position may be harmed.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In addition to patent protection, we also rely on other proprietary rights, including protection of trade secrets, and other proprietary information that is not patentable or that we elect not to patent.  However, trade secrets can be difficult to protect and some courts are less willing or unwilling to protect trade secrets.  To maintain the confidentiality of our trade secrets and proprietary information, we rely heavily on confidentiality provisions that we have in contracts with our employees, consultants, collaborators and others upon the commencement of their relationship with us.  We cannot guarantee that we have entered into such agreements with each party that may have or have had access to our trade secrets or proprietary technology and processes.  We may not be able to prevent the unauthorized disclosure or use of our technical knowledge or other trade secrets by such third parties, despite the existence generally of these confidentiality restrictions.  These contracts may not provide meaningful protection for our trade secrets, know-how, or other proprietary information in the event of any unauthorized use, misappropriation, or disclosure of such trade secrets, know-how, or other proprietary information.  There can be no assurance that such third parties will not breach their agreements with us, that we will have adequate remedies for any breach, or that our trade secrets will not otherwise become known or independently developed by competitors.  Despite the protections we do place on our intellectual property or other proprietary rights, monitoring unauthorized use and disclosure of our intellectual property is difficult, and we do not know whether the steps we have taken to protect our intellectual property or other proprietary rights will be adequate.  In addition, the laws of many foreign countries will not protect our intellectual property or other proprietary rights to the same extent as the laws of the United States.  Consequently, we may be unable to prevent our proprietary technology from being exploited abroad, which could affect our ability to expand to international markets or require costly efforts to protect our technology.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">To the extent our intellectual property or other proprietary information protection is incomplete, we are exposed to a greater risk of direct competition.  A third party could, without authorization, copy or </span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">76</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">otherwise obtain and use our products or technology, or develop similar technology.  Our competitors could purchase our products and attempt to replicate some or all of the competitive advantages we derive from our development efforts or design around our protected technology.  Our failure to secure, protect and enforce our intellectual property rights could substantially harm the value of our products, brand and business.  The theft or unauthorized use or publication of our trade secrets and other confidential business information could reduce the differentiation of our products and harm our business, the value of our investment in research and development or acquisitions could be reduced and third parties might make claims against us related to losses of their confidential or proprietary information.  Any of the foregoing could materially and adversely affect our business, financial condition and results of operations.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Further, it is possible that others will independently develop the same or similar technology or otherwise obtain access to our unpatented technology, and in such cases we could not assert any trade secret rights against such parties.  Costly and time consuming litigation could be necessary to enforce and determine the scope of our trade secret rights and related confidentiality and nondisclosure provisions.  If we fail to obtain or maintain trade secret protection, or if our competitors obtain our trade secrets or independently develop technology similar to ours or competing technologies, our competitive market position could be materially and adversely affected.  In addition, some courts are less willing or unwilling to protect trade secrets and agreement terms that address non-competition are difficult to enforce in many jurisdictions and might not be enforceable in certain cases.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We also seek to preserve the integrity and confidentiality of our data and other confidential information by maintaining physical security of our premises and physical and electronic security of our information technology systems. While we have confidence in these individuals, organizations and systems, agreements or security measures may be breached and detecting the disclosure or misappropriation of confidential information and enforcing a claim that a party illegally disclosed or misappropriated confidential information is difficult, expensive and time-consuming, and the outcome is unpredictable. Further, we may not be able to obtain adequate remedies for any breach.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Obtaining and maintaining patent protection depends on compliance with various procedural, document submission, fee payment and other requirements imposed by governmental patent agencies, and our patent protection could be reduced or eliminated for non-compliance with these requirements.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The USPTO and various foreign governmental patent agencies require compliance with a number of procedural, documentary, fee payment and other similar provisions during the patent application process. In addition, periodic maintenance fees on issued patents often must be paid to the USPTO and foreign patent agencies over the lifetime of the patent. While an unintentional lapse can in many cases be cured by payment of a late fee or by other means in accordance with the applicable rules, there are situations in which noncompliance can result in abandonment or lapse of the patent or patent application, resulting in partial or complete loss of patent rights in the relevant jurisdiction. Non-compliance events that could result in abandonment or lapse of a patent or patent application include, but are not limited to, failure to respond to official actions within prescribed time limits, non-payment of fees and failure to properly legalize and submit formal documents. If we fail to maintain the patents and patent applications covering our products, we may not be able to stop a competitor from marketing products that are the same as or similar to our products, which would have a material adverse effect on our business.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">We may not be able to protect our intellectual property rights throughout the world.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">A company may attempt to commercialize competing products utilizing our proprietary design, trademarks or tradenames in foreign countries where we do not have any patents or patent applications and where legal recourse may be limited.  This may have a significant commercial impact on our foreign business operations.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Filing, prosecuting and defending patents or trademarks on our current and future products in all countries throughout the world would be prohibitively expensive.  The requirements for patentability and </span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">77</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">trademarking may differ in certain countries, particularly developing countries.  The laws of some foreign countries do not protect intellectual property rights to the same extent as laws in the United States.  Consequently, we may not be able to prevent third parties from utilizing our inventions and trademarks in all countries outside the United States.  Competitors may use our technologies or trademarks in jurisdictions where we have not obtained patent or trademark protection to develop or market their own products and further, may export otherwise infringing products to territories where we have patent and trademark protection, but enforcement on infringing activities is inadequate.  These products or trademarks may compete with our products or trademarks, and our patents, trademarks or other intellectual property rights may not be effective or sufficient to prevent them from competing.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Many companies have encountered significant problems in protecting and defending intellectual property rights in foreign jurisdictions.  The legal systems of certain countries, particularly certain developing countries, do not favor the enforcement of patents, trademarks and other intellectual property protection, which could make it difficult for us to stop the infringement of our patents and trademarks or marketing of competing products in violation of our proprietary rights generally.  Proceedings to enforce our patent and trademarks rights in foreign jurisdictions could result in substantial costs and divert our efforts and attention from other aspects of our business, could put our patents and trademarks at risk of being invalidated or interpreted narrowly and our patent or trademark applications at risk, and could provoke third parties to assert claims against us.  We may not prevail in any lawsuits that we initiate and the damages or other remedies awarded, if any, may not be commercially meaningful.  In addition, certain countries in Europe and certain developing countries, including India and China, have compulsory licensing laws under which a patent owner may be compelled to grant licenses to third parties.  In those countries, we may have limited remedies if our patents are infringed or if we are compelled to grant a license to our patents to a third party, which could materially diminish the value of those patents.  This could limit our potential revenue opportunities.  Accordingly, our efforts to enforce our intellectual property rights around the world may be inadequate to obtain a significant commercial advantage from the intellectual property that we own or license.  Finally, our ability to protect and enforce our intellectual property rights may be adversely affected by unforeseen changes in foreign intellectual property laws.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">We may be subject to claims that we or our employees have misappropriated the intellectual property of a third party, including trade secrets or know-how, or are in breach of non-competition or non-solicitation agreements with our competitors and third parties may claim an ownership interest in intellectual property we regard as our own.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Many of our employees and consultants were previously employed at or engaged by other medical device, biotechnology or pharmaceutical companies, including our competitors or potential competitors.  Some of these employees, consultants and contractors, may have executed proprietary rights, non-disclosure and non-competition agreements in connection with such previous employment.  Although we try to ensure that our employees and consultants do not use the intellectual property, proprietary information, know-how or trade secrets of others in their work for us, we may be subject to claims that we or these individuals have, inadvertently or otherwise, misappropriated the intellectual property or disclosed the alleged trade secrets or other proprietary information, of these former employers or competitors.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Additionally, we may be subject to claims from third parties challenging our ownership interest in intellectual property we regard as our own, based on claims that our employees or consultants have breached an obligation to assign inventions to another employer, to a former employer, or to another person or entity.  Litigation may be necessary to defend against any other claims, and it may be necessary or we may desire to enter into a license to settle any such claim; however, there can be no assurance that we would be able to obtain a license on commercially reasonable terms, if at all.  If our defense to those claims fails, in addition to paying monetary damages, a court could prohibit us from using technologies or features that are essential to our products, if such technologies or features are found to incorporate or be derived from the trade secrets or other proprietary information of the former employers.</span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">78</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">An inability to incorporate technologies or features that are important or essential to our products could have a material adverse effect on our business, financial condition and results of operations, and may prevent us from selling our products.  In addition, we may lose valuable intellectual property rights or personnel.  Even if we are successful in defending against these claims, litigation could result in substantial costs and could be a distraction to management.  Any litigation or the threat thereof may adversely affect our ability to hire employees or contract with independent sales representatives.  A loss of key personnel or their work product could hamper or prevent our ability to commercialize our products, which could have an adverse effect on our business, financial condition and results of operations.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Changes in patent law could diminish the value of patents in general, thereby impairing our ability to protect our existing and future products.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Recent patent reform legislation could increase the uncertainties and costs surrounding the prosecution of patent applications and the enforcement or defense of issued patents.  In 2011, the Leahy-Smith America Invents Act, or the Leahy-Smith Act, was signed into law.  The Leahy-Smith Act includes a number of significant changes to U.S. patent law.  These include provisions that affect the way patent applications are prosecuted and also may affect patent litigation.  These also include provisions that switched the United States from a &#8220;first-to-invent&#8221; system to a &#8220;first-to-file&#8221; system, allow third-party submission of prior art to the USPTO during patent prosecution and set forth additional procedures to attack the validity of a patent by the USPTO administered post grant proceedings.  Under a first-to-file system, assuming the other requirements for patentability are met, the first inventor to file a patent application generally will be entitled to the patent on an invention regardless of whether another inventor had made the invention earlier.  The USPTO recently developed new regulations and procedures to govern administration of the Leahy-Smith Act, and many of the substantive changes to patent law associated with the Leahy-Smith Act, and in particular, the first to file provisions, only became effective in 2013.  Accordingly, it is not clear what, if any, impact the Leahy-Smith Act will have on the operation of our business.  The Leahy-Smith Act and its implementation could increase the uncertainties and costs surrounding the prosecution of our patent applications and the enforcement or defense of our issued patents, all of which could have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In addition, patent reform legislation may pass in the future that could lead to additional uncertainties and increased costs surrounding the prosecution, enforcement and defense of our patents and applications.  Furthermore, the U.S. Supreme Court and the U.S. Court of Appeals for the Federal Circuit have made, and will likely continue to make, changes in how the patent laws of the United States are interpreted.  Similarly, foreign courts have made, and will likely continue to make, changes in how the patent laws in their respective jurisdictions are interpreted.  We cannot predict future changes in the interpretation of patent laws or changes to patent laws that might be enacted into law by U.S. and foreign legislative bodies.  Those changes may materially affect our patents or patent applications and our ability to obtain additional patent protection in the future.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">The failure of third parties to meet their contractual, regulatory, and other obligations could adversely affect our business.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We rely on suppliers, vendors, outsourcing partners, consultants, alliance partners and other third parties to research, develop, manufacture and commercialize our products and manage certain parts of our business.  Using these third parties poses a number of risks, such as: (i) they may not perform to our standards or legal requirements; (ii) they may not produce reliable results; (iii) they may not perform in a timely manner; (iv) they may not maintain confidentiality of our proprietary information; (v) disputes may arise with respect to ownership of rights to technology developed with our partners; and (vi) disagreements could cause delays in, or termination of, the research, development or commercialization of our products or result in litigation or arbitration.  Moreover, some third parties are located in markets subject to political and social risk, corruption, infrastructure problems and natural disasters, in addition to country-specific privacy and data security risk given current legal and regulatory environments.  Failure of third parties to meet their contractual, regulatory, and other obligations may materially affect our business.</span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">79</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">If our trademarks and tradenames are not adequately protected, then we may not be able to build name recognition in our markets and our business may be adversely affected.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We rely on trademarks, service marks, tradenames and brand names to distinguish our products from the products of our competitors, and have registered or applied to register these trademarks.  We cannot assure you that our trademark applications will be approved.  During trademark registration proceedings, we may receive rejections.  Although we are given an opportunity to respond to those rejections, we may be unable to overcome such rejections.  In addition, in proceedings before the USPTO and comparable agencies in many foreign jurisdictions, third parties are given an opportunity to oppose pending trademark applications and to seek to cancel registered trademarks.  Opposition or cancellation proceedings may be filed against our trademarks, and our trademarks may not survive such proceedings.  In the event that our trademarks are successfully challenged, we could be forced to rebrand our products, which could result in loss of brand recognition and could require us to devote resources towards advertising and marketing new brands and managing through regulatory implications such as relabeling.  At times, competitors may adopt trade names or trademarks similar to ours, thereby impeding our ability to build brand identity and possibly leading to market confusion.  Certain of our current or future trademarks may become so well known by the public that their use becomes generic and they lose trademark protection.  Over the long term, if we are unable to establish name recognition based on our trademarks and trade names, then we may not be able to compete effectively and our business, financial condition and results of operations may be adversely affected.</span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Risks Related to Government Regulation</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Healthcare policy changes, including recently enacted legislation reforming the U.S. healthcare system, could harm our business, financial condition and results of operations.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In the United States, there have been and continue to be a number of legislative initiatives to contain healthcare costs.  In March 2010, the Affordable Care Act was enacted in the United States, which made a number of substantial changes in the way healthcare is financed by both governmental and private insurers.  Among other ways in which it may affect our business, the Affordable Care Act:</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Established a new Patient-Centered Outcomes Research Institute to oversee and identify priorities in comparative clinical effectiveness research in an effort to coordinate and develop such research;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Implemented payment system reforms including a national pilot program on payment bundling to encourage hospitals, physicians and other providers to improve the coordination, quality and efficiency of certain healthcare services through bundled payment models; and</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Expanded the eligibility criteria for Medicaid programs.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We do not yet know the full impact that the Affordable Care Act will have on our business.  The taxes imposed by the Affordable Care Act and the expansion in the government&#8217;s role in the U.S. healthcare industry may result in decreased sale of our products and, lower reimbursement by payers for our products, all of which may have a material adverse effect on our business, financial condition and results of operations.  The Trump Administration and the U.S. Congress may take further action regarding the Affordable Care Act, including, but not limited to, repeal or replacement.  Most recently, the Tax Cuts and Jobs Act of 2017 was enacted, which, among other things, removes penalties for not complying with the individual mandate to carry health insurance.  Additionally, all or a portion of the Affordable Care Act and related subsequent legislation may be modified, repealed or otherwise invalidated through judicial challenge, which could result in lower numbers of insured individuals, reduced coverage for insured individuals and adversely affect our business, financial condition and results of operations.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In addition, other legislative changes have been proposed and adopted since the Affordable Care Act was enacted.  On August&#160;2, 2011, the Budget Control Act of 2011 was signed into law, which, among other things, reduced Medicare payments to providers by 2% per fiscal year, effective on April&#160;1, 2013 </span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">80</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">and, due to subsequent legislative amendments to the statute, will remain in effect through 2029 unless additional Congressional action is taken.  On January&#160;2, 2013, the American Taxpayer Relief Act of 2012 was signed into law, which, among other things, reduced Medicare payments to several providers, including hospitals, and increased the statute of limitations period for the government to recover overpayments to providers from three to five years.  The Medicare Access and CHIP Reauthorization Act of 2015, or MACRA, enacted on April&#160;16, 2015, repealed the formula by which Medicare made annual payment adjustments to physicians and replaced the former formula with fixed annual updates and a new system of incentive payments scheduled to begin in 2019 that are based on various performance measures and physicians&#8217; participation in alternative payment models such as accountable care organizations.  It is unclear what effect new quality and payment programs, such as MACRA, may have on our business, financial condition, results of operations or cash flows.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We expect additional state and federal healthcare policies and reform measures to be adopted in the future.&#160; Any of these could make it more difficult and costly for us to obtain regulatory clearances or approvals for our products or to manufacture, market or distribute our products after clearance or approval is obtained.&#160; They could result in reduced demand for our products or result in additional pricing pressure.&#160; Any such reforms could have a material adverse effect on our industry generally and on our customers.&#160; Any changes of, or uncertainty with respect to, future coverage or reimbursement rates could affect demand for our products, which in turn could impact our ability to successfully commercialize our products and could have an adverse material effect on our business, financial condition and results of operations. &#160;Changes and reforms in the European Union and other countries where we may decide to commercialize could have similar effects.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Changes in the CMS fee schedules may harm our revenue and operating results.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Government payers, such as Centers for Medicare and Medicaid Services, or CMS, as well as insurers, have increased their efforts to control the cost, utilization and delivery of healthcare services.  From time to time, the U.S. Congress has considered and implemented changes in the CMS fee schedules in conjunction with budgetary legislation.  Reductions of reimbursement by Medicare or Medicaid for procedures that use our products or changes in policy regarding coverage of these procedures, such as adding requirements for payment, or prior authorizations, may be implemented from time to time.  Reductions in the reimbursement rates and changes in payment policies of other third-party payers may occur as well.  Similar changes in the past have resulted in reduced payments for procedures that use medical device products as well as added costs and have added more complex regulatory and administrative requirements.  Further changes in federal, state, local and third-party payer regulations or policies may have a material adverse impact on the demand for our products and on our business.  Actions by agencies regulating insurance or changes in other laws, regulations, or policies may also have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">If we fail to comply with broad based healthcare and other governmental regulations, we could face substantial fines and penalties and our business, results of operations and financial condition could be adversely affected.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The products we offer are highly regulated, and there can be no assurance that the regulatory environment in which we operate will not change significantly and adversely in the future.  Our arrangements with physicians, hospitals and medical centers will expose us to broadly applicable fraud and abuse and other laws and regulations that may restrict the financial arrangements and relationships through which we market, sell and distribute our products.  Our employees, consultants, and commercial partners may engage in misconduct or other improper activities, including non-compliance with regulatory standards and requirements.  Federal and state healthcare laws and regulations that may affect our ability to conduct business, include, without limitation:</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Federal and state laws and regulations regarding billing and claims payment applicable to TCAR and regulatory agencies enforcing those laws and regulations;</span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">81</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">FDA prohibitions against the advertisement, promotion and labeling of our products for off-label uses, or uses outside the specific indications approved by the FDA;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">The federal Anti-Kickback Statute, which broadly prohibits, among other things, any person from knowingly and willfully offering, soliciting, receiving or providing remuneration, directly or indirectly, in exchange for or to induce either the referral of an individual for, or the purchase, order or recommendation of, any good or service for which payment may be made under federal healthcare programs, such as the CMS programs.  A person or entity does not need to have actual knowledge of the statute or specific intent to violate it to have committed a violation.  Moreover, the government may assert that a claim including items or services resulting from a violation of the federal Anti-Kickback Statute constitutes a false or fraudulent claim for purposes of the federal civil False Claims Act.  Violations of the federal Anti-Kickback Statute may result in civil monetary penalties up to $176,495 for each violation, plus up to three times the remuneration involved.  Civil penalties for such conduct can further be assessed under the federal False Claims Act.  Violations can also result in criminal penalties, including criminal fines of up to $100,000 and imprisonment of up to 10&#160;years.  Similarly, violations can result in mandatory exclusion from participation in government healthcare programs, including Medicare and Medicaid;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">The federal False Claims Act, which prohibits, among other things, individuals or entities from knowingly presenting, or causing to be presented, false claims, or knowingly using false statements, to obtain payment from the federal government.  These laws can apply to manufacturers who provide inaccurate information on coverage, coding, and reimbursement of their products to persons who bill third-party payers.  Private individuals can bring False Claims Act &#8220;qui tam&#8221; actions, on behalf of the government and such individuals, commonly known as &#8220;whistleblowers,&#8221; may share in amounts paid by the entity to the government in fines or settlement.  When an entity is determined to have violated the federal civil False Claims Act, the government may impose civil fines and penalties ranging from $11,655 to $23,331 for each false claim, plus treble damages, and exclude the entity from participation in Medicare, Medicaid and other federal healthcare programs;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Federal criminal laws that prohibit executing a scheme to defraud any healthcare benefit program or making, or causing to be made, false statements relating to healthcare matters;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">The federal Civil Monetary Penalties Law, which prohibits, among other things, offering or transferring remuneration to a federal healthcare beneficiary that a person knows or should know is likely to influence the beneficiary&#8217;s decision to order or receive items or services reimbursable by the government from a particular provider or supplier;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">The FCPA, the U.K. Bribery Act of 2010, and other local anti-corruption laws that apply to our international activities;</span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">The federal Physician Payment Sunshine Act, or Open Payments, created under the Patient Protection and Affordable Care Act, as amended by the Health Care and Education Affordability Reconciliation Act, or Affordable Care Act, and its implementing regulations, which requires manufacturers of drugs, medical devices, biologicals and medical supplies for which payment is available under Medicare, Medicaid, or the Children&#8217;s Health Insurance Program to report annually to the U.S. Department of Health and Human Services, or HHS, information related to payments or other transfers of value made to licensed physicians, certain other healthcare professionals, and teaching hospitals, and requires applicable manufacturers and group purchasing organizations, to report annually ownership and investment interests held by physicians and their immediate family members.  Additionally, on October 24, 2018, President Trump signed into law the &#8220;Substance Use-Disorder Prevention that Promoted Opioid Recovery and Treatment for Patients and Communities Act&#8221; which in part (under a provision entitled &#8220;Fighting the Opioid Epidemic with Sunshine&#8221;) extends the reporting and transparency requirements for physicians in the Physician Payments Sunshine Act to physician assistants, </span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">82</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><div style="padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">nurse practitioners, and other mid-level practitioners (with reporting requirements going into effect in 2022 for payments made in 2021).  Applicable manufacturers are required to submit annual reports to CMS.  Our failure to submit required information on time may result in civil monetary penalties of $11,766 per failure up to an aggregate of $176,495 per year (or up to an aggregate of $1.177 million per year for &#8220;knowing failures&#8221;), for all payments, transfers of value or ownership or investment interests that are not timely, accurately, and completely reported in an annual submission, and may result in liability under other federal laws or regulations;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">HIPAA, as amended by the Health Information Technology for Economic and Clinical Health Act, and its implementing regulations, which impose certain requirements relating to the privacy, security and transmission of individually identifiable health information; HIPAA also created criminal liability for knowingly and willfully falsifying or concealing a material fact or making a materially false statement in connection with the delivery of or payment for healthcare benefits, items or services.  Failure to comply with the HIPAA privacy and security standards when applicable can result in civil monetary penalties up to $59,522 per violation, not to exceed $1.79&#160;million per calendar year for non-compliance of an identical provision, and, in certain circumstances, criminal penalties with fines up to $250,000 per violation and/or imprisonment.  State attorneys general can also bring a civil action to enjoin a HIPAA violation or to obtain statutory damages on behalf of residents of his or her state; and</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Analogous state and foreign law equivalents of each of the above federal laws, such as anti-kickback and false claims laws which may apply to items or services reimbursed by any third-party payer, including commercial insurers or patients; state laws that require device companies to comply with the industry&#8217;s voluntary compliance guidelines and the applicable compliance guidance promulgated by the federal government or otherwise restrict payments that may be made to healthcare providers and other potential referral sources; state laws that require device manufacturers to report information related to payments and other transfers of value to physicians and other healthcare providers or marketing expenditures; consumer protection and unfair competition laws, which broadly regulate marketplace activities and activities that potentially harm customers, foreign and state laws, including the E.U. General Data Protection Regulation, or GDPR, governing the privacy and security of health information in certain circumstances, many of which differ from each other in significant ways and may not have the same effect, thus complicating compliance efforts; and state laws related to insurance fraud in the case of claims involving private insurers.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Because of the breadth of these laws and the narrowness of available statutory and regulatory exemptions or safe harbors, it is possible that some of our activities, such as stock-option compensation paid to physicians, could be subject to challenge under one or more of such laws.  Any action brought against us for violations of these laws or regulations, even successfully defended, could cause us to incur significant legal expenses and divert our management&#8217;s attention from the operation of our business.  We may be subject to private &#8220;qui tam&#8221; actions brought by individual whistleblowers on behalf of the federal or state governments.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The growth of our business and sales organization and our expansion outside of the United States may increase the potential of violating these laws or our internal policies and procedures.  The risk of our being found in violation of these or other laws and regulations is further increased by the fact that many have not been fully interpreted by the regulatory authorities or the courts, and their provisions are open to a variety of interpretations.  Any action brought against us for violation of these or other laws or regulations, even if we successfully defend against it, could cause us to incur significant legal expenses and divert our management&#8217;s attention from the operation of our business.  If our operations are found to be in violation of any of the federal, state and foreign laws described above or any other current or future fraud and abuse or other healthcare laws and regulations that apply to us, we may be subject to penalties, including significant criminal, civil, and administrative penalties, damages, fines, imprisonment, for individuals, exclusion from participation in government programs, such as Medicare and Medicaid, and </span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">83</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">we could be required to curtail or cease our operations.  Any of the foregoing consequences could seriously harm our business and our financial results.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">If we fail to obtain and maintain necessary regulatory clearances or approvals for our products, or if clearances or approvals for future products and indications are delayed or not issued, our commercial operations would be harmed.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our products are subject to extensive regulation by the FDA in the United States and by regulatory agencies in other countries where we do business.  Government regulations specific to medical devices are wide ranging and govern, among other things:</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Product design, development and manufacture;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Laboratory, preclinical and clinical testing, labeling, packaging, storage and distribution;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Premarketing clearance or approval;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Record keeping;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Product marketing, promotion and advertising, sales and distribution; and</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Post marketing surveillance, including reporting of deaths or serious injuries and recalls and correction and removals.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Before a new medical device, or a new intended use for an existing product, can be marketed in the United States, a company must first submit and receive either 510(k) clearance pursuant to Section 510(k) of the Food, Drug and Cosmetic Act, or the FDCA, or approval of a premarket approval, or PMA, application from the FDA, unless an exemption applies.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In many cases, the process of obtaining PMA approval, which was required for the ENROUTE stent, is much more rigorous, costly, lengthy and uncertain than the 510(k) clearance process.  In the 510(k) clearance process, the FDA must determine that a proposed device is &#8220;substantially equivalent&#8221; to a device legally on the market, known as a &#8220;predicate&#8221; device, in order to clear the proposed device for marketing.  To be &#8220;substantially equivalent,&#8221; the proposed device must have the same intended use as the predicate device, and either have the same technological characteristics as the predicate device or have different technological characteristics and not raise different questions of safety or effectiveness than the predicate device.  Clinical data is sometimes required to support substantial equivalence.  In the PMA approval process, the FDA must determine that a proposed device is safe and effective for its intended use based on extensive data, including technical, pre-clinical, clinical trial, manufacturing and labeling data.  The PMA process is typically required for devices for which the 510(k) process cannot be used and that are deemed to pose the greatest risk.  Modifications to products that are approved through a PMA application generally need prior FDA approval of a PMA supplement.  Similarly, some modifications made to products cleared through a 510(k) may require a new 510(k), or such modification may put the device into class III and require PMA approval.  The FDA&#8217;s 510(k) clearance process usually takes from three to 12 months, but may last longer.  The process of obtaining a PMA generally takes from one to three years, or even longer, from the time the PMA is submitted to the FDA until an approval is obtained.  Any delay or failure to obtain necessary regulatory approvals or clearances would have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The FDA can delay, limit or deny clearance or approval of a device for many reasons, including:</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Our inability to demonstrate to the satisfaction of the FDA or the applicable regulatory entity or notified body that our products are safe or effective for their intended uses;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">The disagreement of the FDA or the applicable foreign regulatory body with the design, conduct or implementation of our clinical trials or the analyses or interpretation of data from pre-clinical studies or clinical trials;</span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">84</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Serious and unexpected adverse device effects experienced by participants in our clinical trials;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">The data from our pre-clinical studies and clinical trials may be insufficient to support clearance or approval, where required;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Our inability to demonstrate that the clinical and other benefits of the device outweigh the risks;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">An advisory committee, if convened by the applicable regulatory authority, may recommend against approval of our application or may recommend that the applicable regulatory authority require, as a condition of approval, additional preclinical studies or clinical trials, limitations on approved labeling or distribution and use restrictions, or even if an advisory committee, if convened, makes a favorable recommendation, the respective regulatory authority may still not approve the product;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">The applicable regulatory authority may identify significant deficiencies in our manufacturing processes, facilities or analytical methods or those of our third party contract manufacturers;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">The potential for approval policies or regulations of the FDA or applicable foreign regulatory bodies to change significantly in a manner rendering our clinical data or regulatory filings insufficient for clearance or approval; and</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">The FDA or foreign regulatory authorities may audit our clinical trial data and conclude that the data is not sufficiently reliable to support approval or clearance.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Similarly, regulators may determine that our financial relationships with our principal investigators resulted in a perceived or actual conflict of interest that may have affected the interpretation of a study, the integrity of the data generated at the applicable clinical trial site or the utility of the clinical trial itself.  Even if we are granted regulatory clearances or approvals, they may include significant limitations on the indicated uses for the product, which may limit the market for the product.  Moreover, the FDA and European Union regulatory authorities strictly regulate the labeling, promotion and advertising of our products, including comparative and superiority claims vis a vis competitors&#8217; products, that may be made about products.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">As a condition of approving a PMA application, the FDA may also require some form of post-approval study or post-market surveillance, whereby the applicant conducts a follow-up study or follows certain patient groups for a number of years and makes periodic reports to the FDA on the clinical status of those patients when necessary to protect the public health or to provide additional safety and effectiveness data for the device.  As a part of our PMA approval, we agreed with the FDA to conduct a post-approval study at a minimum of 30 sites in the United States to evaluate the safety and effectiveness of our products in at least 600 subjects. </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> We have completed enrollment in this study and submitted our final report to the FDA. On February 11, 2020 we received notice from the FDA of their review and that we have fulfilled the post-approval study requirement.  Therea</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">fter, the product labeling must be updated and submitted in a PMA supplement, including any adverse event data, from the post-approval study.  Failure to have conducted the post-approval study in compliance with applicable regulations or to have timely completed required post-approval studies or comply with other post-approval requirements could result in withdrawal of approval of the PMA, which would harm our business.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In addition, we are required to investigate all product complaints we receive, and timely file reports with the FDA, including MDRs that require that we report to regulatory authorities if our products may have caused or contributed to a death or serious injury or malfunctioned in a way that would likely cause or contribute to a death or serious injury if the malfunction were to recur.&#160; If these reports are not submitted in a timely manner, regulators may impose sanctions and we may be subject to product liability or regulatory enforcement actions, including warning letters, untitled letters, fines, civil penalties, recalls, seizures, operating restrictions, denial of requests for 510(k) clearance or premarket approval of new products, new intended uses or modifications to existing products, withdrawal of current 510(k) clearances or premarket approvals and narrowing of approved or cleared product labeling, all of which </span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">85</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">could harm our business.&#160; In addition, the FDA may provide notice of and conduct additional inspections, such as &#8220;for cause&#8221; inspections, of our business, sites and facilities as part of its review process.  We recently identified the need to implement corrective actions to our complaint handling procedures, which may have caused a delay in timely submission of 20 MDR reports to the FDA since we began commercialization in 2015.&#160; As of January 31, 2020, we had filed 160 MDR reports with the FDA for adverse events including stroke, arterial dissection, stent thrombosis and wound complications.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">If we initiate a correction or removal action for our products to reduce a significant risk to health posed by our products, we would be required to submit a publicly available correction and removal report to the FDA and, in many cases, similar reports to other regulatory agencies.  This report could be classified by the FDA as a device recall which could lead to increased scrutiny by the FDA, other international regulatory agencies and our customers regarding the quality and safety of our products.  Furthermore, the submission of these reports could be used by competitors against us and cause physicians to delay or cancel prescriptions, which could harm our reputation.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The FDA and the Federal Trade Commission, or FTC, also regulate the advertising, promotion and labeling of our products to ensure that the claims we make are consistent with our regulatory clearances and approvals, that there is adequate and reasonable scientific data to substantiate the claims and that our promotional labeling and advertising is neither false nor misleading in any respect.  If the FDA or FTC determines that any of our advertising or promotional claims are misleading, not substantiated or not permissible, we may be subject to enforcement actions, including adverse publicity, warning letters, and we may be required to revise our promotional claims and make other corrections or restitutions.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The FDA and state authorities have broad investigation and enforcement powers.  Our failure to comply with applicable regulatory requirements could result in enforcement action by the FDA or state agencies, which may include any of the following sanctions:</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Adverse publicity, warning letters, fines, injunctions, consent decrees and civil penalties;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Repair, replacement, refunds, recalls, termination of distribution, administrative detention or seizure of our products;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Operating restrictions, partial suspension or total shutdown of production;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Denial of our requests for 510(k) clearance or premarket approval of new products, new intended uses or modifications to existing products;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Withdrawal of 510(k) clearance or premarket approvals that have already been granted; and</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Criminal prosecution.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">If any of these events were to occur, our business and financial condition could be harmed.  In addition, the FDA&#8217;s and other regulatory authorities&#8217; policies may change and additional government regulations may be enacted that could prevent, limit or delay regulatory approval of our products.  For example, in December 2016, the 21st Century Cures Act, or Cures Act, was signed into law.  The Cures Act, among other things, is intended to modernize the regulation of medical devices and spur innovation, but its ultimate implementation is unclear.  If we are slow or unable to adapt to changes in existing requirements or the adoption of new requirements or policies, or if we are not able to maintain regulatory compliance, we may lose any marketing approval that we may have obtained and we may not achieve or sustain profitability, which would adversely affect our business, financial condition and results of operations.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Our clinical trials may fail to demonstrate competent and reliable evidence of the safety and effectiveness of our products, which would prevent or delay commercialization of our products in development.</span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">86</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We may be required to conduct clinical studies that demonstrate competent and reliable evidence that our products are safe and effective before we can commercialize our products.&#160; Clinical testing is expensive and can take many years to complete, and its outcome is inherently uncertain.  We cannot be certain that our planned clinical trials or any other future clinical trials will be successful. In addition, even if such clinical trials are successfully completed, we cannot guarantee that the FDA or foreign regulatory authorities will interpret the results as we do, and more trials could be required before we submit our products for approval. To the extent that the results of the trials are not satisfactory to the FDA or foreign regulatory authorities for support of a marketing application, we may be required to expend significant resources, which may not be available to us, to conduct additional trials in support of potential approval of our products. Even if regulatory approval is secured for any of our products, the terms of such approval may limit the scope and use of our products, which may also limit their commercial potential.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Material modifications to our products may require new 510(k) clearances, premarket approval, or CE Marks, or may require us to recall or cease marketing our products until new clearances or approvals are obtained.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Material modifications to the intended use or technological characteristics of our products will require new 510(k) clearances, premarket approvals or CE Marks prior to implementing the modifications, or require us to recall or cease marketing the modified devices until these clearances or approvals are obtained.  Furthermore, changes to our manufacturing facility or supplier of components used in our products require prior FDA approval of a PMA supplement.  The FDA requires device manufacturers to initially make and document a determination of whether or not a modification requires a new approval, supplement or clearance; however, the FDA can review a manufacturer&#8217;s decision.  Any modification to an FDA cleared device that would significantly affect its safety or effectiveness or that would constitute a major change in its intended use would require a new 510(k) clearance or approval of a PMA supplement.  We may not be able to obtain additional 510(k) clearances or premarket approvals for new products or for modifications to, or additional indications for, our products in a timely fashion, or at all.  Delays in obtaining required future clearances would harm our ability to introduce new or enhanced products in a timely manner, which in turn would harm our future growth.  We have made modifications to our products in the past that we believe do not require additional clearances or approvals, and we may make additional modifications in the future.  If the FDA or an EU Notified Body disagrees and requires new clearances or approvals for any of these modifications, we may be required to recall and to stop selling or marketing our products as modified, which could harm our operating results and require us to redesign our products.  In these circumstances, we may be subject to significant enforcement actions.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">If we, or our suppliers, fail to comply with the FDA&#8217;s QSR or the European Union&#8217;s Medical Device Directive, our manufacturing or distribution operations could be delayed or shut down and our revenue could suffer.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our manufacturing and design processes and those of our third-party component suppliers are required to comply with the FDA&#8217;s Quality System Regulation, or QSR, and the European Union&#8217;s Medical Device Directive, or MDD, both of which cover procedures and documentation of the design, testing, production, control, quality assurance, labeling, packaging, storage and shipping of our products.  We are also subject to similar state requirements and licenses, and to ongoing ISO 13485 compliance in our operations, including design, manufacturing, and service, to maintain our CE Mark.  In addition, we must engage in extensive recordkeeping and reporting and must make available our facilities and records for periodic unannounced inspections by governmental agencies, including the FDA, state authorities, EU Notified Bodies and comparable agencies in other countries.  If we fail a regulatory inspection, our operations could be disrupted and our manufacturing interrupted.  Failure to take timely and adequate corrective action in response to an adverse regulatory inspection could result in, among other things, a shutdown of our manufacturing or product distribution operations, significant fines, suspension of marketing clearances and approvals, seizures or recalls of our device, operating restrictions and criminal prosecutions, any of which would cause our business to suffer.  Furthermore, our key component suppliers may not currently be or may not continue to be in compliance with applicable regulatory </span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">87</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">requirements, which may result in manufacturing delays for our products and cause our revenue to decline.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We are registered with the FDA as a medical device specifications developer and manufacturer.  The FDA has broad post-market and regulatory enforcement powers.  We are subject to unannounced inspections by the FDA and the Food and Drug Branch of the California Department of Public Health, or CDPH, and our Notified Body to determine our compliance with the QSR and other regulations at both our design and manufacturing facilities, and these inspections may include the manufacturing facilities of our suppliers.  These inspections may be initiated as a result of concerns regarding the safety of our products or the components thereof.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We can provide no assurance that we will continue to remain in material compliance with the QSR or MDD.  If the FDA, CDPH or our notified body in the European Union, the British Standards Institution, or BSI, inspect any of our facilities and discover compliance problems, we may have to cease manufacturing and product distribution until we can take the appropriate remedial steps to correct the audit findings.  Taking corrective action may be expensive, time consuming and a distraction for management and if we experience a delay at our manufacturing facility we may be unable to produce our products, which would harm our business.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">With the transition from the MDD to the new European Union Medical Device Regulation, or MDR, notified bodies are required to seek designation to operate as conformity assessment authorities under the new law, which is effective in May 2020. Should our notified body fail to obtain such designation or the scope of their designation does not include our product category, then our ability to apply the CE mark and commercialize in the European Union may be interrupted.&#160; Identification and engagement of a new and properly designated notified body is a time consuming process that may require comprehensive quality system audits and new conformity assessment certifications for our products.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">The impact of the new EU Medical Device Regulation may be costly and disruptive to our business.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In 2017, the European Union released new regulations to ensure patient safety with the use of pharmaceuticals, medical devices and in-vitro diagnostics that will go into effect over a three-year period from 2020 to 2022. The new regulations replace predecessor directives and emphasize a global convergence of regulations.  Major changes include:</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Reclassification of some products;</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Greater emphasis on clinical data;</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Data transparency, including publication of clinical trial data and safety summaries;</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Defined content and structure for technical files to support registration;</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Unique device identification system;</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Greater burden on post-market surveillance and clinical follow-up;</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Reduction of adverse event reporting time from 30 to 15 days after the event; and </span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">More power to notified bodies.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Complying with these new regulations may result in Europe being less attractive as a &#8220;first market&#8221; destination.  Marketing authorization timelines will become more protracted and the costs of operating in Europe will increase. A significantly more costly path to regulatory compliance is anticipated.  Adjusting to the new Medical Device Regulation may prove to be costly and disruptive to our business.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Our products may in the future be subject to product recalls that could harm our reputation.</span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">88</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The FDA and similar governmental authorities in other countries have the authority to require the recall of commercialized products in the event of material regulatory deficiencies or defects in design or manufacture.  A government mandated or voluntary recall by us could occur as a result of component failures, manufacturing errors or design or labeling defects.  Recalls of our products would divert managerial attention, be expensive, harm our reputation with customers and harm our financial condition and results of operations.  A recall announcement would also negatively affect our stock price.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Compliance with environmental laws and regulations could be expensive, and failure to comply with these laws and regulations could subject us to significant liability.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our research and development and manufacturing operations involve the use of hazardous substances and are subject to a variety of federal, state, local and foreign environmental laws and regulations relating to the storage, use, discharge, disposal, remediation of, and human exposure to, hazardous substances and the sale, labeling, collection, recycling, treatment and disposal of products containing hazardous substances.  Liability under environmental laws and regulations can be joint and several and without regard to fault or negligence.  Compliance with environmental laws and regulations may be expensive and noncompliance could result in substantial liabilities, fines and penalties, personal injury and third-party property damage claims and substantial investigation and remediation costs.  Environmental laws and regulations could become more stringent over time, imposing greater compliance costs and increasing risks and penalties associated with violations.  We cannot assure you that violations of these laws and regulations will not occur in the future or have not occurred in the past as a result of human error, accidents, equipment failure or other causes.  The expense associated with environmental regulation and remediation could harm our financial condition and operating results.</span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Risks Related to Ownership of Our Common Stock</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">The market price of our common stock may be volatile and fluctuate substantially, which could result in substantial losses for purchasers of our common stock.</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">The market price of our common stock is likely to be highly volatile and may fluctuate substantially due to many factors, including:</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Changes in analysts&#8217; estimates, investors&#8217; perceptions, recommendations by securities analysts or our failure to achieve analysts&#8217; estimates;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Quarterly variations in our or our competitors&#8217; results of operations;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Periodic fluctuations in our revenue, which could be due in part to the way in which we recognize revenue;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">The financial projections we may provide to the public, any changes in these projections or our failure to meet these projections;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">General market conditions and other factors unrelated to our operating performance or the operating performance of our competitors;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Changes in reimbursement by current or potential payers;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Changes in operating performance and stock market valuations of other technology companies generally, or those in the medical device industry in particular;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Actual or anticipated changes in regulatory oversight of our products;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">The results of our clinical trials;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">The loss of key personnel, including changes in our board of directors and management;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Product recalls or other problems associated with our products;</span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">89</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Legislation or regulation of our market;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Lawsuits threatened or filed against us, including litigation by current or former employees alleging wrongful termination, sexual harassment, whistleblower or other claims;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">The announcement of new products or product enhancements by us or our competitors;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Announced or completed acquisitions of businesses or technologies by us or our competitors;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Announcements related to patents issued to us or our competitors and related litigation; and</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Developments in our industry.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In recent years, the stock markets generally have experienced extreme price and volume fluctuations that have often been unrelated or disproportionate to the operating performance of listed companies. Broad market and industry factors may significantly affect the market price of our common stock, regardless of our actual operating performance.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In addition, in the past, stockholders have instituted securities class action litigation following periods of market volatility. If we were to become involved in securities litigation, it could subject us to substantial costs, divert resources and the attention of management from our business and harm our business, results of operations, financial condition and reputation. These factors may materially and adversely affect the market price of our  common stock.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">If securities or industry analysts do not publish research or reports about our business, or publish negative reports about our business, our share price and trading volume could decline.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The trading market for our common stock depends in part on the research and reports that securities or industry analysts publish about us or our business, our market and our competitors.  We do not have any control over these analysts.  If one or more of the analysts who cover us downgrade our shares or change their opinion of our business, our share price would likely decline.  If one or more of these analysts cease coverage of our company or fail to regularly publish reports on us, we could lose visibility in the financial markets, which could cause our share price or trading volume to decline.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">A sale of a substantial number of shares of our common stock may cause the price of our common stock to decline.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">If our existing stockholders sell, or indicate an intention to sell, substantial amounts of our common stock in the public market after the lapse of lock-up and other legal restrictions on resale, the trading price of our common stock could decline.  If these additional shares are sold, or if it is perceived that they will be sold, in the public market, the trading price of our common stock could decline.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The holders of an aggregate of 7,835,229 shares of our outstanding common stock, h</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">ave rights, subject to some conditions, to require us to file registration statements covering their shares or to include their shares in registration statements that we may file for ourselves or our stockholders.  Registration of these shares under the Securities Act would result in the shares becoming freely tradable without restriction under the Securities Act, except for shares held by our affiliates as defined in Rule 144 under the Securities Act.  Any sales of securities by these stockholders could have a material adverse effect on the market price of our common stock.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Our directors, officers and principal stockholders have significant voting power and may take actions that may not be in the best interests of our other stockholders.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">As of February 28, 2020, our directors, officers and each stockholder holding 5% or more of our outstanding common stock and their affiliates beneficially owned approximately 40</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">.3% of o</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">ur outstanding common stock in the aggregate. In addition, we are required to nominate and use commercially reasonable efforts to have a number of individuals proportionate to the number of shares of common </span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">90</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">stock held by entities affiliated with Warburg Pincus &amp; Co. compared to the number of shares of common stock outstanding, designated by Warburg Pincus &amp; Co., elected to the board of directors.  As a result, the above stockholders, and Warburg Pincus &amp; Co., acting alone, will be able to exert significant influence over the management and affairs of our company and most matters requiring stockholder approval, including the election of directors and approval of significant corporate transactions.  We have not elected under the rules of the Nasdaq Stock Market to take advantage of the "controlled company" exemption to opt out of any corporate governance requirements, but this concentration of ownership may have the effect of delaying or preventing a change in control, might adversely affect the market price of our common stock and may not be in the best interests of our other stockholders.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">We have previously identified two material weaknesses in our internal control over financial reporting and may identify additional material weaknesses in the future or otherwise fail to maintain an effective system of internal controls, which may result in material misstatements of our financial statements or cause us to fail to meet our periodic reporting obligations.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Prior to the completion of our initial public offering, we were a private company and had limited accounting and financial reporting personnel and other resources with which to address our internal controls and procedures.  In connection with the audit of our financial statements for the year ended December 31, 2017, we and our independent registered public accounting firm identified two material weaknesses in our internal control over financial reporting.  A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting such that there is a reasonable possibility that a material misstatement of our annual or interim financial statements will not be prevented or detected on a timely basis.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We determined that we had a material weakness because we did not maintain a sufficient complement of personnel with an appropriate degree of knowledge, experience, and training, commensurate with our accounting and reporting requirements.  As a result, there were a number of post initial close&#160;adjustments that were material to the financial statements.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The second material weakness relates to the fact that we did not appropriately design and implement controls over the review and approval of manual journal entries and the related supporting journal entry calculations, resulting in inappropriate segregation of duties over manual journal entries.  This material weakness could result in a misstatement of account balances or disclosures that would result in a material misstatement to the annual or interim financial statements that would not be prevented or detected.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">With the oversight of senior management and our audit committee, we began the implementation of remediation steps in 2018. These efforts focused on (i)&#160;the hiring of personnel with technical accounting and financial reporting experience and (ii)&#160;the implementation of improved accounting and financial reporting procedures and systems to improve the completeness, timeliness and accuracy of our financial reporting and disclosures including the assessment of more judgmental areas of accounting.  We believe the measures described above will remediate the material weaknesses identified and strengthen our internal control over financial reporting.  While we believe the steps taken in our remediation initiatives outlined above are sufficient to remediate the material weaknesses in internal control over financial reporting, our improvements, including the enhanced controls, have not operated for a sufficient period of time to demonstrate that the material weaknesses are fully remediated.  As such, the remediation initiatives outlined above were not sufficient to fully remediate the material weaknesses in internal control over financial reporting for the year ended December 31, 2019. We are committed to continuing to improve our internal control processes and will continue to diligently and vigorously review our financial reporting controls and procedures.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">While we continue with our plan to remediate the material weaknesses, we cannot predict the success of such plan or the outcome of our assessment of these plans at this time.  We can give no assurance that this implementation will remediate these deficiencies in internal control or that additional material weaknesses or significant deficiencies in our internal control over financial reporting will not be </span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">91</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">identified in the future.  Our failure to implement and maintain effective internal control over financial reporting could result in errors in our financial statements that could result in a restatement of our financial statements, causing us to fail to meet our reporting obligations.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">We are obligated to develop and maintain proper and effective internal controls over financial reporting and any failure to maintain the adequacy of these internal controls may adversely affect investor confidence in our company and, as a result, the value of our common stock.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We are required, pursuant to Section 404 of the Sarbanes-Oxley Act, or Section 404, to furnish a report by management on the effectiveness of our internal control over financial reporting for the year ended December 31, 2020.  This assessment will need to include disclosure of any material weaknesses identified by our management in our internal control over financial reporting.  Our independent registered public accounting firm will not be required to attest to the effectiveness of our internal control over financial reporting until our first annual report required to be filed with the SEC following the date we are no longer an &#8220;emerging growth company,&#8221; as defined in the Jumpstart Our Business Startups Act of 2012, or the JOBS Act.  At such time as we are required to obtain auditor attestation, if we then have a material weakness, we would receive an adverse opinion regarding our internal control over financial reporting from our independent registered accounting firm.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We are continuing the costly and challenging process of compiling the system and processing documentation necessary to perform the evaluation needed to comply with Section 404, and we may not be able to complete our evaluation, testing and any required remediation in a timely fashion.  Our compliance with Section 404 will require that we incur substantial accounting expense and expend significant management efforts.  We currently do not have an internal audit group, and we will need to hire additional accounting and financial staff with appropriate public company experience and technical accounting knowledge and compile the system and process documentation necessary to perform the evaluation needed to comply with Section 404.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">During our evaluation of our internal control, </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">if we are unable to remediate our material weaknesses or if we identify additional material weaknesses in our internal control over financial reporting, we will be unable to assert that our internal control over financial reporting is effective.  We cannot assure you that there will not be material weaknesses or significant deficiencies in our internal control over financial reporting in the future.  Any failure to maintain internal control over financial reporting could severely inhibit our ability to accurately report our financial condition or results of operations.  If we are unable to conclude that our internal control over financial reporting is effective, or if our independent registered public accounting firm determines we have an additional material weakness  or significant deficiency in our internal control over financial reporting, we could los</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">e investor confidence in the accuracy and completeness of our financial reports, the market price of our ordinary shares could decline, and we could be subject to sanctions or investigations by Nasdaq, the SEC or other regulatory authorities.  Failure to remedy our current and any future material weakness in our internal control over financial reporting, or to implement or maintain other effective control systems required of public companies, could also restrict our future access to the capital markets.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">We are an &#8220;emerging growth company&#8221; and a &#8220;smaller reporting company&#8221; and we cannot be certain if the reduced disclosure requirements applicable to us will make our common stock less attractive to investors.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We currently qualify as an &#8220;emerging growth company&#8221; under the JOBS Act.  For as long as we continue to be an emerging growth company, we may take advantage of certain exemptions from reporting requirements that are applicable to other public companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404, reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.  To the extent that we continue to qualify as a "smaller reporting company," as such term is defined in Rule 12b-2 under the </span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">92</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Securities Exchange Act of 1934, after we cease to qualify as an emerging growth company, we will continue to be permitted to make certain reduced disclosures in our periodic reports and other documents that we file with the SEC.  We cannot predict if investors will find our common stock less attractive to the extent we rely on available exemptions.  If some investors do find our common stock less attractive, there may be a less active trading market for our common stock and our stock price may be more volatile or may decline.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We will remain an emerging growth company until the earlier of (1) the last day of the fiscal year following the fifth anniversary of our initial public offering, (2) the last day of the fiscal year in which we have total annual revenue of more than $1.07 billion, (3) the date on which we are deemed to be a large accelerated filer, which means the market value of our common stock that is held by non-affiliates exceeds $700 million as of the prior June 30th, and (4) the date on which we have issued more than $1.0 billion in non-convertible debt securities during the prior three-year period.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Anti-takeover provisions in our amended and restated certificate of incorporation and bylaws, and Delaware law, could discourage a change in control of our company or a change in our management.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our amended and restated certificate of incorporation and bylaws contain provisions that might enable our management to resist a takeover.  These provisions include:</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">A classified board of directors;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Advance notice requirements applicable to stockholders for matters to be brought before a meeting of stockholders and requirements as to the form and content of a stockholders&#8217; notice;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">A supermajority stockholder vote requirement for amending certain provisions of our amended and restated certificate of incorporation and bylaws;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">The right to issue preferred stock without stockholder approval, which could be used to dilute the stock ownership of a potential hostile acquirer;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Allowing stockholders to remove directors only for cause;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">A requirement that the authorized number of directors may be changed only by resolution of the board of directors;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Allowing all vacancies, including newly created directorships, to be filled by the affirmative vote of a majority of directors then in office, even if less than a quorum, except as otherwise required by law;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">A requirement that our stockholders may only take action at annual or special meetings of our stockholders and not by written consent;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Limiting the forum to Delaware for certain litigation against us; and</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Limiting the persons that can call special meetings of our stockholders to our board of directors, the chairperson of our board of directors, the chief executive officer or the president, in the absence of a chief executive officer.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">These provisions might discourage, delay or prevent a change in control of our company or a change in our management.  The existence of these provisions could adversely affect the voting power of holders of common stock and limit the price that investors might be willing to pay in the future for shares of our common stock.  In addition, because we are incorporated in Delaware, we are governed by the provisions of Section 203 of the Delaware General Corporation Law, which generally prohibits a Delaware corporation from engaging in any of a broad range of business combinations with any &#8220;interested&#8221; </span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">93</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">stockholder for a period of three years following the date on which the stockholder became an &#8220;interested&#8221; stockholder.  See &#8220;Description of Capital Stock.&#8221;</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Our amended and restated certificate of incorporation and bylaws provide that the Court of Chancery of the State of Delaware will be the sole and exclusive forum for substantially all disputes between us and our stockholders, which could limit our stockholders&#8217; abilities to obtain a favorable judicial forum for disputes with us or our directors, officers or employees.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our amended and restated certificate of incorporation and bylaws provide that, unless we consent in writing to the selection of an alternative forum, the sole and exclusive forum, to the fullest extent permitted by law, for (1)&#160;any derivative action or proceeding brought on our behalf, (2)&#160;any action asserting a claim of breach of a fiduciary duty owed by any of our directors, officers or other employees to us or our stockholders, (3)&#160;any action asserting a claim against the company or any director or officer of the company arising pursuant to any provision of the Delaware General Corporation Law, (4)&#160;any action to interpret, apply, enforce or determine the validity of our amended and restated certificate of incorporation or bylaws, or (5)&#160;any other action asserting a claim that is governed by the internal affairs doctrine shall be the Court of Chancery of the State of Delaware or federal court located within the State of Delaware if the Court of Chancery does not have jurisdiction, in all cases subject to the court&#8217;s having jurisdiction over indispensable parties named as defendants. A complaint asserting a cause of action under the Securities Act may be brought in state or federal court.  With respect to the Securities Exchange Act of 1934, or Exchange Act, only claims brought derivatively under the Exchange Act would be subject to the forum selection clause described above.  The enforceability of similar choice of forum provisions in other companies' certificates of incorporation and bylaws has been challenged in legal proceedings, and it is possible that, in connection with any action, a court could find the choice of forum provisions contained in our amended and restated certificate of incorporation and bylaws to be inapplicable or unenforceable in such action.  Although we believe these provisions benefit us by providing increased consistency in the application of Delaware law for the specified types of actions and proceedings, the provisions may have the effect of discouraging lawsuits against us or our directors and officers.  Alternatively, if a court were to find the choice of forum provision contained in our amended and restated certificate of incorporation and bylaws to be inapplicable or unenforceable in an action, we may incur additional costs associated with resolving such action in other jurisdictions, which could harm our business, financial condition and operating results.  Any person or entity purchasing or otherwise acquiring any interest in our shares of capital stock shall be deemed to have notice of and consented to this exclusive forum provision, but will not be deemed to have waived our compliance with the federal securities laws and the rules and regulations thereunder. </span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">We have not paid dividends in the past and do not expect to pay dividends in the future, and, as a result, any return on investment may be limited to the value of our stock.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We have never paid cash dividends and do not anticipate paying cash dividends in the foreseeable future.  The payment of dividends will depend on our earnings, capital requirements, financial condition, prospects for future earnings and other factors our board of directors may deem relevant.  In addition, our loan agreement limits our ability to, among other things, pay dividends or make other distributions or payments on account of our common stock, in each case subject to certain exceptions.  If we do not pay dividends, our stock may be less valuable because a return on your investment will only occur if our stock price appreciates and you then sell our common stock.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">If we are unable to implement and maintain effective internal control over financial reporting, investors may lose confidence in the accuracy and completeness of our reported financial information and the market price of our common stock may be negatively affected.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our chief financial officer had not previously been the chief financial officer of a publicly traded company and our chief executive officer had not previously been the chief executive officer of a publicly traded company.  As a public company, we are required to maintain internal control over financial reporting and to report any material weaknesses in such internal control.  We are required, pursuant to </span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">94</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Section 404, to evaluate and determine the effectiveness of our internal control over financial reporting and, beginning with our second annual report after the completion of our initial public offering in April 2019, provide a management report on the internal control over financial reporting.  This assessment will need to include disclosure of any material weaknesses identified by our management in our internal control over financial reporting.  Our independent registered public accounting firm will not be required to attest to the effectiveness of our internal control over financial reporting until our first annual report required to be filed with the SEC following the date we are no longer an &#8220;emerging growth company,&#8221; as defined in the JOBS Act.  At such time as we are required to obtain auditor attestation, if we then have a material weakness, we would receive an adverse opinion regarding our internal control over financial reporting from our independent registered accounting firm.  If we </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">are unable to remediate our material weaknesses or if we </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">have an additional material weakness in our internal control over financial reporting, we may not detect errors on a timely basis and our financial statements may be materially misstated.  We are implementing the process and documentation necessary to perform the evaluation needed to comply with Section 404.  We may not be able to complete our evaluation, testing and any required remediation in a timely fashion.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">If we </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">are unable to remediate our material weaknesses or if we </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">have additional material weaknesses in our internal control over financial reporting in the future, we may not detect errors on a timely basis and our financial statements may be materially misstated.  We are beginning the costly and challenging process of compiling the system and processing documentation necessary to perform the evaluation needed to comply with Section 404, and we may not be able to complete our evaluation, testing and any required remediation in a timely fashion.  Our compliance with Section 404 will require that we incur substantial accounting expense and expend significant management efforts. We currently do not have an internal audit group, and we will need to hire additional accounting and financial staff with appropriate public company experience and technical accounting knowledge and compile the system and process documentation necessary to perform the evaluation needed to comply with Section 404.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">During our evaluation of our internal control, if we </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">are unable to remediate our material weaknesses or if we </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">identify additional material weaknesses in our internal control over financial reporting in the future, we will be unable to assert that our internal control over financial reporting is effective.  We cannot assure you that there will not be material weaknesses or significant deficiencies in our internal control over financial reporting in the future.  Any failure to maintain internal control over financial reporting could severely inhibit our ability to accurately report our financial condition or results of operations.  If we are unable to conclude that our internal control over financial reporting is effective, or if our independent registered public accounting firm determines we were </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">unable to remediate our material weaknesses or we </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">have a material weakness or significant deficiency in our internal control over financial reporting in the future, we could lose investor confidence in the accuracy and completeness of our financial reports, the market price of our ordinary shares could decline, and we could be subject to sanctions or investigations by Nasdaq, the SEC or other regulatory authorities, which could require additional financial and management resources and could result in fines, trading suspensions or other remedies.  Failure to remedy any material weakness in our internal control over financial reporting, or to implement or maintain other effective control systems required of public companies, could also restrict our future access to the capital markets.</span></div><div id="i58f397e86dfd4fc4ac3b8695cd31238e_19"></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">95</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Item 1B. Unresolved Staff Comments</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">None.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span><br/></span></div><div id="i58f397e86dfd4fc4ac3b8695cd31238e_22"></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Item 2. Properties</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We currently lease approximately 31,000 square feet for our corporate headquarters and manufacturing facility located in Sunnyvale, California under a lease agreement which terminates in 2024. We have an additional option to extend the lease term for a period of five&#160;years.  The option must be exercised no more than 12&#160;months and no less than nine months prior to the expiration of the applicable term.  Our operations are growing at a pace that may require us to find a replacement or expansion facility sooner.</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">  We believe that additional space can be obtained on commercially reasonable terms as needed.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span><br/></span></div><div id="i58f397e86dfd4fc4ac3b8695cd31238e_25"></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Item 3. Legal Proceedings</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We are not currently a party to any material legal proceedings. From time to time we may become involved in legal proceedings or investigations, which could have an adverse impact on our reputation, business and financial condition and divert the attention of our management from the operation of our business.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span><br/></span></div><div id="i58f397e86dfd4fc4ac3b8695cd31238e_28"></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Item 4. Mine Safety Disclosures</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Not applicable.</span></div><div id="i58f397e86dfd4fc4ac3b8695cd31238e_31"></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">96</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><div style="text-align:center;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;">PART II</span></div><div id="i58f397e86dfd4fc4ac3b8695cd31238e_34"></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Item 5. Market for Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Price Range of Common Stock</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our common stock began trading on the NASDAQ Global Market under the symbol &#8220;SILK&#8221; on April 4, 2019. Prior to that time, there was no public market for our common stock.  In our initial public offering, our common stock priced at $20.00 per share on April 3, 2019.  The following table sets forth on a per share basis, for the periods indicated, the low and high sale prices of our common stock as reported by the NASDAQ Global Market.</span></div><div style="margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:68.192%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:12.262%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:1.082%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:12.264%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Year Ended December 31, 2019</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">High&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Low&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Second Quarter (beginning April 4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">51.50&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">30.87&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Third Quarter</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">49.89&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">31.22&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fourth Quarter</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">40.79&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">27.83&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Holders of Record</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">At February 28, 2020, there were approximately 91 stockholders of record of our common stock, and the closing price per share of our common stock was $39.85.  Since many of our shares of common stock are held by brokers and other institutions on behalf of stockholders, we are unable to estimate the total number of stockholders represented by these record holders.</span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Dividends</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We have never declared or paid, and do not anticipate declaring or paying, any cash dividends on any of our capital stock. We do not anticipate paying any dividends in the foreseeable future, and we currently intend to retain all available funds and any future earnings for use in the operation of our business, to finance the growth and development of our business and for future repayment of debt. Future determinations as to the declaration and payment of dividends, if any, will be at the discretion of our board of directors and will depend on then-existing conditions, including our operating results, financial condition, contractual restrictions, capital requirements, business prospects and other factors our board of directors may deem relevant. In addition, our term loan agreement limits our ability to pay dividends or make other distributions or payments on account of our common stock, in each case subject to certain exceptions.</span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Stock Performance Graph</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following graph illustrates a comparison of the total cumulative stockholder return on our stock with the total return for</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> (i) the NASDAQ Composite Index (U.S.) and (ii) the NASDAQ Medical Equipment Index for the period from April 4, 2019 (the first day of trading of our common stock), through </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">December 31, 2019.  The graph assumes an investment of $100 in our common stock at market close on April 4, 2019 and the reinvestment of dividends, if any. The comparisons in the table are not intended to forecast or be indicative of possible future performance of our common stock. This graph shall not be deemed &#8220;soliciting material&#8221; or be deemed &#8220;filed&#8221; for purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities under that Section, and shall not be deemed to be incorporated by reference into any of our filings under the Securities Act of 1933, as amended (the "Securities Act"), whether made before or after the date hereof and irrespective of any general incorporation language in any such filing.</span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">97</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;"> </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><div style="text-indent:18pt;text-align:center;margin-bottom:9pt;"><img src="silk-20191231_g11.gif" alt="silk-20191231_g11.gif" style="height:352px;width:624px;"/></div><div style="margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:39.826%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.441%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:11.621%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.441%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:10.019%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.441%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:13.224%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.441%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:12.746%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$100 investment in stock or index</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">April 4, <br/>2019</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2019&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 30, 2019&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 31, 2019&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Silk Road Medical, Inc. (SILK)</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">100&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">134&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">90&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">112&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">NASDAQ Composite</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">100&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">102&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">102&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">115&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">NASDAQ Medical Equipment</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">100&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">100&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">94&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">108&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Recent Sales of Unregistered Securities</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">None.</span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Use of Proceeds</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Our initial public offering of 6,000,000 shares of common stock was effected through a registration statement on Form S-1 (File No. 333-230045), which was declared effective on April 3, 2019 and pursuant to which we sold an aggregate 6,000,000 shares of our common stock at a public offering price of $20.00 per share for an aggregate offering price of $120.0 million. On April 4, 2019, the underwriters fully exercised their option to purchase 900,000 additional shares of common stock from the selling stockholders pursuant to the underwriting agreement. When our initial public offering closed on April 8, 2019, we received net proceeds of $109.1 million, after deducting underwriting discounts and commissions of $8.4 million and other expenses of $2.5 million. No payments for such expenses were made directly or indirectly to any of our officers or directors or persons holding 10 percent or more of our securities.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">J.P. Morgan Securities LLC and Merrill Lynch, Pierce, Fenner &amp; Smith Incorporated acted as representatives of the underwriters for the offering. There has been no material change in the planned use of proceeds from our initial public offering as described in our final prospectus filed with the SEC on April 4, 2019 pursuant to Rule 424(b) of the Securities Act.</span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">98</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;"> </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Purchases of Equity Securities by the Issuer and Affiliated Purchasers</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">None.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span><br/></span></div><div id="i58f397e86dfd4fc4ac3b8695cd31238e_37"></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Item 6. Selected Financial Data</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We derived the selected statements of operations data for the years ended December&#160;31, 2019 and 2018 and the balance sheets data as of December 31, 2019 and 2018 from our audited financial statements appearing elsewhere in this Annual Report on Form 10-K.  You should read this data together with our audited financial statements and related notes thereto included elsewhere in this and the information under the caption &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations.&#8221; The selected financial data included in this section are not intended to replace the audited financial statements and related notes thereto included elsewhere in this Annual Report on Form 10-K.  Our historical results are not necessarily indicative of our future results.</span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Statements of Operations Data:</span></div><div style="text-align:justify;margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:67.711%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:13.224%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:11.463%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Years Ended December 31,</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-style:italic;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(in thousands, except share and per share data)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Revenue</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">63,354&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">34,557&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cost of goods sold</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">15,927&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10,874&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:24.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gross profit</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">47,427&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">23,683&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operating expenses:</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Research and development</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12,272&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10,258&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Selling, general and administrative</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">63,220&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">34,820&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:24.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total operating expenses</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">75,492&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">45,078&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Loss from operations</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(28,065)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(21,395)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interest income (expense), net</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(3,296)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(4,172)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other income (expense), net</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(21,054)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(12,063)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:24.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net loss</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(52,415)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(37,630)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net loss attributable to non-controlling interest</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:24.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net loss attributable to Silk Road Medical, Inc. common stockholders</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(52,415)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(37,629)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net loss per share attributable to Silk Road Medical, Inc. common stockholders, basic and diluted</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.28)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(39.16)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted average common shares used to compute net loss per share attributable to Silk Road Medical, Inc. common stockholders, basic and diluted</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">22,956,679&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">960,882&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div style="text-align:justify;"><span><br/></span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">99</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Balance Sheets Data:</span></div><div style="margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:67.711%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td style="width:1.0%;"></td><td style="width:12.583%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:12.104%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">As of December 31,</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-style:italic;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(in thousands)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">39,181&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">24,990&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Short-term investments</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">51,508&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Working capital</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">95,558&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">27,824&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total assets</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">137,402&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">42,743&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Long-term debt</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">44,879&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">44,201&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Convertible preferred stock warrant liability</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">16,091&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Convertible preferred stock</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">105,235&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accumulated deficit</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(191,526)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(139,111)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total stockholders&#8217; equity (deficit)</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">71,891&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(134,553)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div style="text-indent:18pt;margin-bottom:9pt;"><span><br/></span></div><div id="i58f397e86dfd4fc4ac3b8695cd31238e_40"></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">100</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Item 7. Management&#8217;s Discussion And Analysis Of Financial Condition And Results Of Operations</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">You should read the following discussion and analysis of our financial condition and results of operations together with the section entitled &#8220;Selected financial data&#8221; and our audited financial statements and related notes thereto included elsewhere in this Annual Report on Form 10-K.  This discussion and other parts of this Annual Report on Form 10-K contain forward-looking statements that involve risks and uncertainties, such as statements of our plans, objectives, expectations and intentions, that are based on the beliefs of our management, as well as assumptions made by, and information currently available to, our management.  Our actual results could differ materially from those discussed in these forward-looking statements.  Factors that could cause or contribute to such differences include, but are not limited to, those discussed in the section of this Annual Report on Form 10-K entitled &#8220;Risk Factors.&#8221;</span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Overview</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We are a medical device company focused on reducing the risk of stroke and its devastating impact.  We believe a key to stroke prevention is minimally-invasive and technologically advanced intervention to safely and effectively treat carotid artery disease, one of the leading causes of stroke.  We have pioneered a new approach for the treatment of carotid artery disease called transcarotid artery revascularization, or TCAR, which we seek to establish as the standard of care.  We manufacture and sell in the United States our portfolio of TCAR products, which are designed to provide direct access to the carotid artery, effective reduction in stroke risk throughout the procedure, and long-term restraint of carotid plaque.  </span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We began commercializing our products in the United States in late 2015.  Our products are currently the only devices cleared and approved by the FDA specifically for transcarotid use.  While our current commercial focus is on the U.S. market, our products have obtained CE Mark approval, allowing us to commercialize in Europe in the future.  We also intend to pursue regulatory clearances in China, Japan, and other select international markets.  TCAR is reimbursed based on established current procedural technology, or CPT, codes and International Classification of Diseases, or ICD-10, codes related to carotid stenting that track to Medicare Severity Diagnosis Related Group, or MS-DRG, classifications.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We designed our commercial strategy and built our direct sales force with a particular focus on vascular surgery practices.  Vascular surgeons are skilled in endovascular procedures, and our sales and marketing efforts are focused on driving adoption and supporting their practice development by offering them an innovative, safe, effective and minimally-invasive alternative for treating carotid artery disease.  We also market to other specialists with experience in CEA or CAS with the appropriate skill set for TCAR, including neurosurgeons, cardiothoracic surgeons and non-surgical interventionalists in radiology, neuroradiology and cardiology.  We also work on developing strong relationships with physicians and hospitals that we have identified as key opinion leaders.  We consider the hospitals and medical centers where the procedure is performed to be our customers, as they typically are responsible for purchasing our products. </span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We manufacture and distribute the ENROUTE NPS at our facility in Sunnyvale, California, using components and sub-assemblies manufactured both in-house and by third party manufacturers and suppliers.  We purchase our other products from third-party contract manufacturers, including our ENROUTE stent.  Many of these third-party manufacturers and outside vendors are currently single-source suppliers.  While we expect that our existing manufacturing facility will be sufficient to meet our anticipated growth through at least the next four years </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">we intend to supplement our distribution operations with a third-party logistics and warehousing service and/or additional leased facilities</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In April 2019, we completed our initial public offering by issuing 6,000,000 shares of common stock, at a public offering price of $20.00 per share, for net proceeds of approximately $109.1 million after deducting underwriting discounts and commissions and expenses. In August 2019, we completed a secondary public offering of 4,200,000 shares of common stock by selling stockholders, and the exercise in full of the underwriters' option to purchase 630,000 additional shares of common stock from selling </span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">101</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">stockholders, at a public offering price of $39.50 per share. We received no proceeds from the sale of our common stock by the selling stockholders. </span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Prior to our initial public offering in April 2019, our primary sources of capital were private placements of convertible preferred stock, debt financing arrangements and revenue from sales of our products.  As of&#160;December 31, 2019, we had cash and cash equivalents of $39</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">.2&#160;million, investments of $69.7 million, long-term debt of $44.9</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;million and an accumulated deficit of $191</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">.5&#160;mill</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">ion.  Since inception, we have raised a total of $214.3&#160;million in net proceeds from the sale of equity securities, including net proceeds of approximately $109.1&#160;million from our initial public offering in April 2019.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Key Business Metric - Number of U.S. TCAR procedures</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We regularly review a number of operating and financial metrics, including the number of procedures performed in the United States, to evaluate our business, measure our performance, identify trends affecting our business, formulate our business plan and make strategic decisions. The following table lists the number of procedures performed in each of the three month periods as indicated:</span></div><div style="text-align:center;margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:23.320%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:7.134%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:6.333%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:6.493%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:6.333%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:7.134%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:6.333%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:6.493%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:6.820%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="45" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Three Months Ended</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">March 31, 2018</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2018</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Sept. 30, 2018</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Dec. 31, 2018</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">March 31, 2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Sept. 30, 2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Dec. 31, 2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Number of U.S. procedures</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">774&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,008&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,243&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,548&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,724&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,997&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,255&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,458&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div style="text-indent:18pt;margin-top:15pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We define a procedure as any instance in which our ENROUTE NPS is used and for which we have a record that the procedure was performed.  A procedure that is started and then aborted, or converted to a different procedure, after the ENROUTE NPS is used would count as a procedure. The number of procedures is an indicator of our ability to drive adoption and generate revenue, and is helpful in tracking the progress of our business. We believe that it is representative of our current business; however, we anticipate this may be substituted for additional or different metrics as our business grows. </span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span><br/></span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Components of our Results of Operations</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Revenue</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We currently derive all of our revenue from the sale of our portfolio of TCAR products to hospitals and medical centers in the United States.  Each of our products is purchased individually, and the majority of our revenue is derived from sales of the ENROUTE NPS and ENROUTE stent.  No single customer accounted for 10% or more of our revenue during the during the years ended December 31, 2019 and 2018.&#160; We expect revenue to increase in absolute dollars as we expand our sales territories</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">, new accounts and trained physician base a</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">nd as existing physicians perform more TCAR procedures.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We expect our revenue to fluctuate from quarter-to-quarter due to a variety of factors, including seasonality.  For example, in the first quarter, our results can be harmed by adverse weather and by resetting of annual patient healthcare insurance plan deductibles, both of which may cause patients to delay elective procedures.  Holiday and summer vacations by physicians and/or their patients can also affect procedure volumes that in turn affect hospital ordering patterns. We have also seen procedure volumes moderate during major medical conferences when significant portions of our customer base are attending the conferences.  </span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Cost of Goods Sold and Gross Margin</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We manufacture the ENROUTE NPS in California at our facility in Sunnyvale.  We purchase our other products from third party manufacturers.  Cost of goods sold consists primarily of costs related to materials, components and sub-assemblies, direct labor, manufacturing overhead, reserves for excess, obsolete and non-sellable inventories as well as distribution-related expenses.  Overhead costs include the cost of quality assurance, material procurement, inventory control, facilities, equipment and operations </span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">102</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">supervision and management.  Cost of goods sold also includes depreciation expense for production equipment and certain direct costs such as those incurred for shipping our products and royalties related to the sale of our ENROUTE stent.  We expense all inventory provisions as cost of goods sold.  We record adjustments to our inventory valuation for estimated excess, obsolete and non-sellable inventories based on assumptions about future demand, past usage, changes to manufacturing processes and overall market conditions.  We expect cost of goods sold to increase in absolute dollars to the extent more of our products are sold.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We calculate gross margin as gross profit divided by revenue.  Our gross margin has been and will continue to be affected by a variety of factors, primarily average selling prices, product sales mix, production and ordering volumes, manufacturing costs, product yields, headcount and cost-reduction strategies.  We expect our gross margin to increase over the long-term as our production and ordering volumes increase and as we spread the fixed portion of our overhead costs over a larger number of units produced.  We intend to use our design, engineering and manufacturing know-how and capabilities to further advance and improve the efficiency of our manufacturing processes, which we believe will reduce costs and have a positive long-term impact on our gross margin.  However, our gross margin could fluctuate from quarter to quarter as we introduce new products, due to the timing of certain manufacturing engineering projects, as we adopt new manufacturing processes and technologies and as we expand our distribution operations and </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">infrastructure to support long term growth and risk mitigation.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Research and Development Expenses</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Research and development, or R&amp;D, expenses consist primarily of engineering, product development, clinical studies to develop and support our products, regulatory expenses, medical affairs, and other costs associated with products and technologies that are in development.  These expenses include employee compensation, including stock-based compensation, supplies, consulting, prototyping, testing, materials, travel expenses, depreciation and an allocation of facility overhead expenses.  Additionally, R&amp;D expenses include costs associated with our clinical studies, including clinical trial design, clinical trial site initiation and study costs, data management, related travel expenses and the cost of products used for clinical trials, internal and external costs associated with our regulatory compliance and quality assurance functions and overhead costs.  We expect R&amp;D expenses as a percentage of revenue to vary over time depending on the level and timing of our new product development efforts, as well as our clinical development, clinical trial and other related activities.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Selling, General and Administrative Expenses</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Selling, general and administrative, or SG&amp;A, expenses consist primarily of compensation for personnel, including stock-based compensation, related to selling and marketing functions, physician education programs, commercial operations and analytics, reimbursement, finance, information technology and human resource functions.  Other SG&amp;A expenses include sales commissions, training, travel expenses, promotional activities, marketing initiatives, market research and analysis, conferences and trade shows, professional services fees (including legal, audit and tax fees), insurance costs, general corporate expenses and allocated facilities-related expenses.  We expect SG&amp;A expenses to continue to increase in absolute dollars as we expand our infrastructure to both drive and support the anticipated growth in revenue and due to additional legal, accounting, insurance and other expenses associated with being a public company.  In addition, we will continue exploring sales and marketing expansion opportunities in international geographies.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Interest Income (Expense), net</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Interest income (expense), net consists primarily of cash interest incurred on our outstanding indebtedness and non-cash interest related to the amortization of debt discount and issuance costs associated with our term loan agreement.  We may, at our election, pay a portion of the interest on our term loan through the incurrence of additional indebtedness as payment-in-kind, or PIK.  Our interest expense was partially offset by interest income earned on our investments.</span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">103</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Other Income (Expense), net</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Other income (expense), net primarily consists of gains and losses resulting from the remeasurement of the fair value of our convertible preferred stock warrant liability at each balance sheet date. We recorded adjustments to the estimated fair value of the convertible preferred stock warrants until they were exercised in connection with our initial public offering in April 2019.  At such time, the final fair value of the warrant liability was reclassified to stockholders&#8217; equity (deficit) and we no longer record any related periodic fair value adjustments.</span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Results of Operations:</span></div><div style="text-align:center;margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:65.628%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:13.384%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:13.386%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Years Ended December 31,</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-style:italic;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(in thousands)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Revenue</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">63,354&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">34,557&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Costs of goods sold</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">15,927&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10,874&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:29.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gross profit</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">47,427&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">23,683&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operating expenses:</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Research and development</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12,272&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10,258&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Selling, general and administrative</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">63,220&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">34,820&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:29.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total operating expenses</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">75,492&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">45,078&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Loss from operations</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(28,065)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(21,395)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interest income (expense), net</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(3,296)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(4,172)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other income (expense), net</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(21,054)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(12,063)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:29.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net loss</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(52,415)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(37,630)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div style="text-indent:18pt;margin-bottom:9pt;"><span><br/></span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Comparison of Years Ended December 31, 2019 and 2018</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Revenue. </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Revenue increased $28.8&#160;million, or&#160;83%, to $63.4&#160;million during the year ended December&#160;31, 2019, compared to $34.6 million during the year ended December&#160;31, 2018.  The increase in revenue was attributable to an increase in the number of products sold as we expanded our sales territories, increased the number of new accounts, trained more physicians in TCAR and as physicians performed more TCAR procedures.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Cost of Goods Sold and Gross Margin. </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Cost of goods sold increased $5.0 million, or&#160;46%, to $15.9&#160;million during the year ended December&#160;31, 2019, compared to $10.9&#160;million during the year ended December&#160;31, 2018.  This increase was attributable to the increase in the number of products sold and additional manufacturing overhead costs as we invested significantly in our operational infrastructure to support anticipated future growth.  Gross margin for the year ended December&#160;31, 2019 increased to&#160;75%, compared to 69% in the year ended December&#160;31, 2018.  Gross margin increased as our production and ordering volumes increased and we were able to spread the fixed portion of our overhead costs over a larger number of units produced.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Research and Development Expenses. </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> R&amp;D expenses increased $2.0 million, or&#160;20%, to $12.3&#160;million during the year ended December&#160;31, 2019, compared to $10.3&#160;million during the year ended December&#160;31, 2018.  The increase in R&amp;D expenses was primarily attributable to an increase of $1.4 million in personnel-related expenses including stock-based compensation, an increase of $0.3 million in clinical and regulatory expense, an increase of $0.3 million relating to educational grants, an increase of $0.2 million in product development materials and costs, an increase of $0.2 million in software related expense, and an increase of $0.1 million in outside services, partially offset by a decrease in travel and the allocation of facilities expense. </span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">104</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Selling, General and Administrative Expenses. </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> SG&amp;A expenses increased $28.4&#160;million, or&#160;82%, to $63.2&#160;million during the year ended December&#160;31, 2019, compared to $34.8&#160;million during the year ended December&#160;31, 2018.  The increase in SG&amp;A expenses is primarily attributable to an increase of $17.9 million in personnel-related expenses, an increase of $2.5 million in consulting, legal and professional fees, an increase of $2.2 million in marketing, tradeshow and promotional costs, an increase of $1.9 million in travel expenses, an increase of $1.3 million in insurance costs, an increase of $1.1 million in physician training and travel related costs, an increase of $0.8 million in software related expense, and an increase of $0.7 million relating to depreciation and the allocation of facilities and related expenses.  Personnel-related expenses included stock-based compensation expense of $2.4&#160;million and $0.6&#160;million for the years ended December&#160;31, 2019 and 2018, respectively.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Interest Income (Expense), Net. </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Interest income (expense), net decreased</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> $0.9&#160;million, or&#160;21%, to an expense of $3.3&#160;million during the year ended December&#160;31, 2019, compared to an expense of $4.2&#160;million during the year ended December&#160;31, 2018.  </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">This decreased expense was attributable to interest income earned on our investments, partially offset by the additional interest expense associated with the $15.0&#160;million of additional borrowings in September 2018 under our term loan agreement. As of December 31, 2019 and 2018, the aggregate outstanding principal balance (including interest paid-in-kind) under the term loan agreement was $44.9 million and $44.2&#160;million, respectively. </span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Other Income (Expense), Net. </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Other income (expense), net increased to an expense of $21.1&#160;million during the year ended December&#160;31, 2019, compared to an expense of $12.1 million during the year ended December 31, 2018.  The decrease was primarily attributed to the remeasurement of our convertible preferred stock warrants and recognition of the change in fair value.</span></div><div style="margin-bottom:9pt;"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Liquidity and Capital Resources</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">As of&#160;December 31, 2019, we had cash and cash equivalents of $39.</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">2&#160;million and investments of $69.7 million, an accumulated deficit of $191.5&#160;million and $44.9&#160;million </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">outstanding under our term loan agreement. No borrowings remain available under this credit facility.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In April 2019, we completed our initial public offering by issuing 6,000,000 shares of common stock, at a public offering price of $20.00 per share, for net proceeds of approximately $109.1 million after deducting underwriting discounts and commissions and expenses. In August 2019, we completed a secondary public offering of 4,200,000 shares of common stock by selling stockholders, and the exercise in full of the underwriters' option to purchase 630,000 additional shares of common stock from selling stockholders, at a public offering price of $39.50 per share. We received no proceeds from the sale of the common stock by the selling stockholders.  </span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Prior to our initial public offering, our primary sources of capital were private placements of convertible preferred stock, debt financing agreements and revenue from the sale of our products.  </span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We believe that our cash and cash equivalents and available-for-sale investments as of December 31, 2019, together with our expected revenue, will be sufficient to meet our capital requirements and fund our operations for at least the next 12 months.</span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">105</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Cash Flows</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table summarizes our cash flows for each of the periods presented below:</span></div><div style="text-align:center;margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:68.512%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:11.942%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:11.944%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Years Ended December 31,</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-style:italic;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(in thousands)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net cash (used in) provided by:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:18pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operating activities</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(29,610)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(21,695)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:18pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Investing activities</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(69,956)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2,270)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:18pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Financing activities</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">113,757&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">15,424&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net increase (decrease) in cash, cash equivalents and restricted cash</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">14,191&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(8,541)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div style="text-indent:18pt;margin-bottom:9pt;"><span><br/></span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Net Cash Used in Operating Activities</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Net cash used in operating activities for the y</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">ear ended December</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;31, 2019 was $29.6&#160;million, consisting primarily of a net loss of $52.4&#160;million and a decrease in net operating assets of $3.0&#160;million, partially offset by non-cash charges of $25.8&#160;million.  The decrease in net operating assets was primarily due to an increase in accounts receivable, inventories and prepaid expenses and other current assets </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">to support the growth of our operations</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">, partially offset by increases in accounts payable and accrued liabilities, due to timing of payments and growth of our operations.  The non-cash charges primarily consisted of depreciation, stock-based compensation, non-cash interest expense and other charges related to our term loan agreement, and an increase in the fair value of the convertible preferred stock warrants.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Net cash used in operating activities for the year ended December&#160;31, 2018 was $21.7&#160;million, consisting primarily of a net loss of $37.6&#160;million partially offset by an increase in net operating assets of $0.9&#160;million and non-cash charges of $15.0&#160;million.  The increase in net operating assets was primarily due to an increase in accounts receivable, inventories and prepaid expenses and other current assets to support the growth of our operations, partially offset by increases in accrued and other liabilities, due to timing of payments and growth of our operations.  The non-cash charges primarily consisted of depreciation, stock-based compensation, non-cash interest expense and other charges related to our term loan agreement, and an increase in the fair value of the convertible preferred stock warrants.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Net Cash Used in Investing Activities</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Net cash used in investing activities in the year ended December&#160;31, 2019 w</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">as $70.0&#160;milli</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">on consisting of purchases of available-for-sale investments of $69.4 million and purchases of property and equipment of $535,000.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Net cash used in investing activities in the year ended December&#160;31, 2018 was $2.3&#160;million primarily consisting of purchases of property and equipment.  </span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Net Cash Provided by Financing Activities</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Net cash provided by financing activities in the year ended December&#160;31, 2019 was $113.8&#160;million, primarily attributable to proceeds of $109.4 million from our initial public offering, net of issuance costs paid, proceeds of $2.6 million from stock option exercises and purchases under our employee stock purchase plan and warrant exercises of $1.8 million.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Net cash provided by financing activities in the year ended December&#160;31, 2018 was $15.4&#160;million primarily attributable to proceeds of $15.0 million from additional borrowings under the term loan agreement, and $0.7 million of proceeds from the exercise of stock options, partially offset by cash paid for deferred initial public offering costs of $0.2 million.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span><br/></span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">106</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Term Loan Agreement</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In October 2015, we entered into the term loan agreement and related security agreement with Capital Resource Group ("CRG"), providing for a term loan facility of up to $30.0 million, available in tranches on the terms and conditions set forth in the term loan agreement.  In September 2018, we entered into a fifth amendment to the term loan agreement, or Fifth Amendment, to increase the aggregate term loan commitments from up to $30.0&#160;million to up to $55.0 million, to extend the commitment period from March 29, 2017 to June&#160;30,&#160;2019, to extend the maturity date from September 30, 2021 to December 31, 2022, and to amend certain other terms.  </span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">As of December 31, 2019, the aggregate outstanding principal balance (including interest PIK) under the term loan agreement was</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> $44.9 mil</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">lion.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Prior to the Fifth Amendment, the term loans bore interest at a rate of 13.0% per annum, which interest rate was reduced to 10.75% on and after the effective date of the Fifth Amendment, and which interest rate was further reduced to 10.00% on and after the consummation of our initial public offering.  We may, at our election, pay the interest through a combination of cash and PIK.  The interest is payable in cash and PIK as follows: prior to the Fifth Amendment, 8.50% per annum in cash and 4.50% PIK; on or after the Fifth Amendment, 8.0% per annum in cash and 2.75% PIK; and on and after the consummation of our initial public offering, 8.0% per annum in cash and 2.0% PIK.  Interest is due and payable quarterly in arrears.  The outstanding principal amount under the term loan agreement, together with all accrued and unpaid interest, is due and payable on December 31, 2022.  We may prepay the term loan agreement, in whole or in part, at any time. </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> During 2019 and 2018, we incurred $5.0 million and $4.3 million, respectively, in interest expense in connection with the term loan agreement.  During 2019 and 2018, we made cash interest payments of $4.2 million and $2.7 million, respectively, and issued $0.3&#160;million and $1.2 million in PIK interest for the year ended December 31, 2019 and 2018, respectively.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our obligations under the term loan agreement are guaranteed by our existing and future subsidiaries, subject to exceptions for certain foreign subsidiaries.  Our obligations under the term loan agreement are secured by substantially all of our assets, including our material intellectual property, and the assets of our guarantor subsidiaries, subject to certain exceptions.  There are currently no guarantor subsidiaries.  Additionally, we and our subsidiaries are subject to customary affirmative and negative covenants, including covenants that limit or restrict the ability of us and our subsidiaries to, among other things, incur indebtedness, grant liens, merge or consolidate, make investments, dispose of assets, make acquisitions, pay dividends or make distributions, repurchase stock and enter into certain transactions with affiliates, in each case subject to certain exceptions.  We are also required to maintain minimum liquidity that exceeds the greater of $3.0 million or the minimum cash balance required under any permitted accounts receivable credit facility.  In addition, we must achieve minimum annual revenue of $40.0 million in 2020.  If we fail to satisfy the minimum annual revenue covenant in any measurement period, we can cure the resulting default by raising the revenue shortfall in additional equity or in subordinated debt within 90 days of such calendar year in which the shortfall occurred.  As of the date of this Annual Report on Form 10-K, we were in compliance with all covenants under the term loan agreement.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The term loan agreement is subject to customary events of default that include, among other things, non-payment defaults, inaccuracy of representations and warranties, covenant defaults, cross-defaults to material indebtedness and material agreements, bankruptcy and insolvency defaults, material judgment defaults, ERISA defaults, a change of control default and a material adverse change default.  The occurrence of an event of default could result in the acceleration of the obligations under the term loan agreement.  Under certain circumstances, a default interest rate will apply on all obligations during the existence of an event of default at a per annum rate equal to 4.0% above the applicable interest rate.  On November 14, 2018, we entered into a sixth amendment to the term loan agreement to amend a covenant regarding the timeline for provision of audited financial statements.  In June 2019, we entered into a </span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">107</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">seventh amendment to the term loan agreement to amend the definition of permitted cash equivalents to reflect updated flexibility.</span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Cordis License Agreement</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In December 2010, we entered into a license agreement, or the Cordis License Agreement, with Cordis Corporation, or Cordis, which is now a subsidiary of Cardinal Health. Pursuant to the Cordis License Agreement, Cordis has granted us a worldwide, non-exclusive, royalty-bearing license to certain of its intellectual property related to the PRECISE&#174; carotid stent, or the Licensed IP, for transcervical treatment of carotid artery disease with an intravascular stent for certain applications for accessing blood vessels through the neck and cervical area. Cordis may not license the Licensed IP in our licensed field of use to any other third party during the term of the Cordis License Agreement.  </span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We have paid Cordis a one-time license execution fee and are obligated to pay royalties to Cordis on a calendar quarter basis during the term of the Cordis License Agreement, calculated based on net sales of the licensed products we sell during the preceding quarterly period. The license granted under Cordis License Agreement shall remain in full force and effect on a country by country basis until the last to expire of the Licensed IP in such country.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Cordis License Agreement requires us to work exclusively with either Cordis or Confluent Medical Technologies, Inc. (f/k/a Nitinol Devices and Components, Inc.), or Confluent, for the development, manufacture and supply of the licensed products. If either Cordis or Confluent cannot continue to manufacture or supply the licensed products, we can seek a third party manufacturer with the prior written consent of Cordis.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We have the right to assign or transfer the Cordis License Agreement to an entity that succeeds all or substantially all of our equity or assets.  The Cordis License Agreement may be terminated by either party in the event of uncured material breach by the other party that remains uncured for 60 days (or 30 days for payment related breaches), or bankruptcy of the other party.</span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Cordis Supply Agreement</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In October 2011, we entered into a supply agreement, or Cordis Supply Agreement, with Cordis and have since entered into four amendments in March and July 2012, April 2013 and April 2018. Pursuant to the Cordis Supply Agreement, Cordis has assisted in the development of a transcarotid stent delivery system according to our specifications with a PRECISE&#174; carotid stent implant, or ENROUTE stent, has supplied the ENROUTE stent through preclinical and clinical trials, and continues to supply the ENROUTE stent for our commercial sale. The Cordis Supply Agreement will continue in full force and effect until the earlier to occur of (i) termination of the Cordis License Agreement; (ii) our election if and when Cordis approves another manufacturer; (iii) mutual written termination; or (iv) termination pursuant to the terms therein. The Cordis Supply Agreement may be terminated by either party in the event of uncured material breach by the other party that remains uncured for 30 days, or bankruptcy of the other party.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We are obligated under the Cordis Supply Agreement to purchase a minimum volume of the ENROUTE stent annually.  This obligation is binding until the natural expiration of the Cordis License Agreement, due to expiration of the last-to-expire of the Licensed IP, if the Cordis License Agreement remains in effect through such natural expiration.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Cordis has the exclusive right to manufacture and supply the ENROUTE stent during the term of the Cordis Supply Agreement. However, if Cordis is not able to supply the ENROUTE stent, upon our election, Cordis shall permit Confluent or a third party manufacturer to provide supply of the ENROUTE stent, provided that Cordis retains the right to manufacture and supply the ENROUTE stent to us to the extent it is able to do so. Notwithstanding the foregoing, we, without Cordis&#8217; consent, may work directly with Confluent for the development and supply of next-generation products that materially expand or change the specification of the ENROUTE stent. </span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">108</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Lease Agreements</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We currently lease our headquarters in Sunnyvale, California pursuant to a lease agreement which terminates in October&#160;2024.  We have an additional option to extend the lease term for a period of five&#160;years.  The option must be exercised no more than 12&#160;months and no less than nine months prior to the expiration of the applicable term.  The facility lease is for approximately 31,000 square feet.&#160;</span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Off-Balance Sheet Arrangements</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We currently have no off-balance sheet arrangements, such as structured finance, special purpose entities, or variable interest entities.</span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Contractual Obligations and Commitments</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our principal obligations consist of the operating lease for our facility, our term loan agreement and non-cancellable inventory purchase commitments.  The following table sets out, as of December&#160;31, 2019, our contractual obligations due by period:</span></div><div style="text-align:center;margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:35.500%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:9.698%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:9.698%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:9.698%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:9.698%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:9.703%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="27" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Payments Due by Period</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-style:italic;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(in thousands)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Less Than 1 Year</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1-3 Years</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3-5 Years</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">More Than 5 Years</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operating lease obligations</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,006&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,082&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,919&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,007&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Term loan agreement with CRG</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,454&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">52,698&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">57,152&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Non-cancellable purchase commitments</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,807&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,260&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,030&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7,097&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9,267&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">57,040&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,949&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">69,256&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div style="text-indent:18pt;margin-bottom:9pt;"><span><br/></span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The non-cancellable purchase commitments primarily consist of ENROUTE stents and other inventory components.</span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Critical Accounting Policies and Estimates</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Management&#8217;s discussion and analysis of our financial condition and results of operations is based on our financial statements, which have been prepared in accordance with U.S. generally accepted accounting principles.  The preparation of these financial statements requires us to make estimates and assumptions for the reported amounts of assets, liabilities, revenue, expenses and related disclosures.  Our estimates are based on our historical experience and on various other factors that we believe are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources.  Actual results may differ from these estimates under different assumptions or conditions and any such differences may be material.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">While our significant accounting policies are more fully described in Note&#160;2 of our audited financial statements included in this Annual Report on Form 10-K, we believe the following discussion addresses our most critical accounting policies, which are those that are most important to our financial condition and results of operations and require our most difficult, subjective and complex judgments.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Revenue Recognition</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We adopted Accounting Standards Codification, or ASC, Topic 606,&#160;&#8220;Revenue from Contracts with Customers,&#8221; using the modified retrospective method applied to contracts which were not completed as of that date effective January 1, 2018. Under ASC 606, revenue is recognized when a customer obtains control of promised goods or services, in an amount that reflects the consideration which the entity expects to receive in exchange for those goods or services. To determine revenue recognition for </span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">109</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">arrangements that an entity determines are within the scope of ASC 606, we perform the following five steps: </span></div><div style="text-indent:-26.88pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">(i)</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18pt;">identify the contract(s) with a customer; </span></div><div style="text-indent:-29.1pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">(ii)</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18pt;">identify the performance obligations in the contract; </span></div><div style="text-indent:-31.32pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">(iii)</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18pt;">determine the transaction price;</span></div><div style="text-indent:-31.88pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">(iv)</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18pt;">allocate the transaction price to the performance obligations in the contract; and </span></div><div style="text-indent:-29.66pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">(v)</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18pt;">recognize revenue when (or as) the entity satisfies a performance obligation.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our revenue is generated from the sale of our products to hospitals and medical centers in the United States through direct sales representatives.  Revenue is recognized when obligations under the terms of a contract with customers are satisfied, which occurs with the transfer of control of our products to customers, either upon shipment of the product or delivery of the product to the customer under our standard terms and conditions.&#160;&#160;Revenue is measured as the amount of consideration we expect to receive in exchange for transferring the goods.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">For sales where the sales representative hand delivers product directly to the hospital or medical center from the sales representative&#8217;s trunk stock inventory, we recognize revenue upon delivery, which represents the point in time when control transfers to the customer.  For sales which are sent directly to hospitals and medical centers, the transfer of control occurs at the time of shipment or delivery of the product.&#160; There are no further performance obligations by us or the sales representative to the customer after delivery under either method of sale. </span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We accept product returns at our discretion or if the product is defective as manufactured.  We establish estimated provisions for returns based on historical experience and consideration of other factors that we believe could significantly impact our expected returns, which provisions are classified within accrued liabilities on our balance sheet.&#160; We have elected to expense shipping and handling costs as incurred and include them within cost of goods sold.  In those cases where we invoice shipping and handling costs to customers, we will classify the amounts billed as a component of revenue.</span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">JOBS Act Accounting Election</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">As an emerging growth company under the Jumpstart Our Business Startups Act of 2012, we are eligible to take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies.  We have irrevocably elected not to avail ourselves of the exemption from new or revised accounting standards and, therefore, are subject to the same new or revised accounting standards as other public companies that are not emerging growth companies.</span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Recently Issued Accounting Pronouncements </span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We adopted ASC 842, &#8220;Leases,&#8221; on January 1, 2019 using the modified retrospective method for all leases not substantially completed as of the date of adoption.&#160; We elected to apply the package of practical expedients, which allowed us to not reassess: (i)&#160;whether expired or existing contracts contain leases; (ii)&#160;lease classification for any expired or existing leases; and (iii)&#160;initial direct costs for any existing lease.  See Note 3 to our financial statements included elsewhere in this Annual Report on Form 10-K for recently adopted accounting pronouncements.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">See Note 3 to our financial statements included elsewhere in this Annual Report on Form 10-K for new accounting pronouncements not yet adopted as of the date of this Annual Report on Form 10-K.</span></div><div id="i58f397e86dfd4fc4ac3b8695cd31238e_43"></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">110</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Item 7A. Quantitative and Qualitative Disclosures About Market Risk</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We are exposed to market risks in the ordinary course of our business. These risks primarily include risk related to interest rate sensitivities and foreign currency exchange rate sensitivity.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Interest Rate Risk</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We had cash, cash equivalents and investments of $108.9 million as of December 31, 2019; which consisted of </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">bank deposits, money market funds, U.S. government securities, corporate bonds/notes, asset-backed securities and commercial paper.  The primary objectives of our investment activities are the preservation of capital and support of our liquidity requirements.  Our investments are exposed to market risk due to fluctuations in interest rates, which may affect our income and the fair market value of our investments.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We do not enter into investments for trading or speculative purposes and have not used any derivative financial instruments to manage our interest rate risk exposure.  A hypothetical 10% change in interest rates would not have a material impact on the value of our cash and cash equivalents or our investments as of December 31, 2019.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Credit Risk</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">As of December&#160;31, 2019 and 2018, our cash and cash equivalents were maintained with two financial institutions in the United States, and our current deposits are likely in excess of insured limits.  We have reviewed the financial statements of these institutions and believe each to have sufficient assets and liquidity to conduct its operations in the ordinary course of business with little or no credit risk to us.  Our cash equivalents and investments are invested in highly rated money market funds, </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">U.S. government securities, corporate bonds/notes, asset-backed securities and commercial paper</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our accounts receivable primarily relate to revenue from the sale of our products to hospitals and medical centers in the United States.  No customer represented 10% or more of our accounts receivable as of December&#160;31, 2019 or 2018.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Foreign Currency Risk</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our business is primarily conducted in U.S. dollars.  Any transactions that may be conducted in foreign currencies are not expected to have a material effect on our results of operations, financial position or cash flows.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span><br/></span></div><div id="i58f397e86dfd4fc4ac3b8695cd31238e_46"></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">111</span></div></div></div><hr style="page-break-after:always"/><div style="height:90pt;width:100%;"><div style="text-align:center;"><span><br/></span></div><div style="text-indent:18pt;text-align:center;margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:91.228%;"><tr><td style="width:1.0%;"></td><td style="width:98.000%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-bottom:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%;">Silk Road Medical, Inc.</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;">Index to Financial Statements</span></div></td></tr></table></div></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Item 8. Financial Statements and Supplementary Data</span></div><div id="i58f397e86dfd4fc4ac3b8695cd31238e_82"></div><div style="text-indent:18pt;text-align:center;margin-bottom:9pt;"><span><br/></span></div><div style="text-align:center;margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:89.506%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:6.494%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Page(s)</span></td></tr><tr><td colspan="3" style="height:14pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_85">Report of Independent Registered Public Accounting Firm</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_85">113</a></span></div></td></tr><tr><td colspan="3" style="height:3pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Financial Statements:</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="height:3pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="padding-left:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_88">Balance Sheets as of December 31, 2019 and December 31, 2018</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_88">114</a></span></div></td></tr><tr><td colspan="3" style="height:3pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="padding-left:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_94">Statements of Operations and Comprehensive Loss for the years ended December 31, 2019 and December 31, 2018</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_94">115</a></span></div></td></tr><tr><td colspan="3" style="height:3pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="padding-left:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_100">Statements of Redeemable Convertible Preferred Stock and Stockholders' Equity (Deficit) for the years ended December 31, 2019 and December 31, 2018</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_100">116</a></span></div></td></tr><tr><td colspan="3" style="height:3pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="padding-left:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_106">Statements of Cash Flows for the years ended December 31, 2019 and December 31, 2018 of Cash Flows for the years ended December 31, 2019 and December 31, 2018</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_106">117</a></span></div></td></tr><tr><td colspan="3" style="height:3pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_109">Notes to Financial Statements</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_109">118</a></span></div></td></tr><tr><td colspan="3" style="height:3pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="height:3pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="height:3pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="height:3pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="height:3pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="height:3pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr></table></div><div style="text-indent:18pt;text-align:center;margin-bottom:9pt;"><span><br/></span></div><div id="i58f397e86dfd4fc4ac3b8695cd31238e_85"></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">112</span></div></div></div><hr style="page-break-after:always"/><div style="height:81pt;width:100%;"><div style="text-indent:18pt;margin-bottom:9pt;"><span><br/></span></div></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;">Report of Independent Registered Public Accounting Firm</span></div><div style="text-indent:18pt;text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;">To the Board of Directors and Stockholders of Silk Road Medical, Inc.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%;">Opinion on the Financial Statements</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;">We have audited the accompanying balance sheets of Silk Road Medical, Inc. (the &#8220;Company&#8221;) as of December 31, 2019 and 2018, and the related statements of operations and comprehensive loss, of statements of redeemable convertible preferred stock and stockholders&#8217; equity (deficit) and of cash flows for the years then ended, including the related notes and financial statement schedule listed in the index appearing under Item 15 (collectively referred to as the &#8220;financial statements&#8221;). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2019 and 2018, and the results of its operations and its cash flows for the years then ended in conformity with accounting principles generally accepted in the United States of America.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;">Change in Accounting Principle</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;">As discussed in Note 2 to the financial statements, the Company changed the manner in which it accounts for leases in 2019.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%;">Basis for Opinion</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;">These financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on the Company&#8217;s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;">We conducted our audits of these financial statements in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company's internal control over financial reporting. Accordingly, we express no such opinion.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;">Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;">/s/ PricewaterhouseCoopers LLP </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;">San Jose, California</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;">March 2, 2020</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;">We have served as the Company&#8217;s auditor since 2013.</span></div><div id="i58f397e86dfd4fc4ac3b8695cd31238e_88"></div><div style="text-indent:18pt;text-align:center;margin-bottom:9pt;"><span><br/></span></div><div style="position:relative;width:100%;height:63pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">113</span></div></div></div><hr style="page-break-after:always"/><div style="height:81pt;width:100%;"><div style="text-align:center;margin-bottom:3pt;"><span><br/></span></div><div style="text-align:center;margin-bottom:3pt;"><span><br/></span></div><div style="text-indent:18pt;text-align:center;margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:98.000%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-bottom:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:12pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Silk Road Medical, Inc.<br/>Balance Sheets</span></td></tr></table></div></div><div style="margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:69.314%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:11.942%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:11.943%;"></td><td style="width:1.0%;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(in thousands, except share and per share data)</span></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 31,</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Assets</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cash and cash equivalents</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfNS0xLTEtMS0w_9c876782-73e6-45e3-b2ef-70ae67a508d0">39,181</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfNS0zLTEtMS0w_562024b5-9657-4db7-a56e-a46e73697340">24,990</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Short-term investments</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShortTermInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfNi0xLTEtMS02MDk_be4ac000-4a6c-47c9-ae94-5a722ef4d8f8">51,508</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:ShortTermInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfNi0zLTEtMS02MDk_4bb54916-88b4-4cbc-a4ec-a72e6f2ebbfc">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="padding-left:11.25pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">Accounts receivable, net of allowances of $<ix:nonFraction unitRef="usd" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfNi0wLTEtMS0wL3RleHRyZWdpb246OWYwY2VmNWZmZmRlNDA3YzgwZDMzYjQzN2NlZjY4YmZfMzI5ODUzNDg4MzQ0MQ_acd0916a-148b-42f1-ab43-d462d2293fe6">45</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfNi0wLTEtMS0wL3RleHRyZWdpb246OWYwY2VmNWZmZmRlNDA3YzgwZDMzYjQzN2NlZjY4YmZfMzI5ODUzNDg4MzQ0OQ_05b41582-8867-4567-be18-130711ae7dd4">22</ix:nonFraction> at December&#160;31, 2019 and 2018, respectively</span></div></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfNi0xLTEtMS0w_4856396b-0067-433e-9506-712154864668">8,601</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfNi0zLTEtMS0w_477bcedd-04d3-4553-805b-f165252a99c0">6,382</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Inventories</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfNy0xLTEtMS0w_6a25fb60-4c33-41e6-8729-7a8637464921">10,322</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfNy0zLTEtMS0w_f8022f46-7e15-4f50-b4be-b7ee07ad409d">5,744</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Prepaid expenses and other current assets</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfOC0xLTEtMS0w_1e4d1333-ed50-43d8-8e8d-bddc13925611">2,878</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfOC0zLTEtMS0w_3e00aacb-5cd6-4890-9f42-5a383b15e1e0">1,408</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:36pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total current assets</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfOS0xLTEtMS0w_0e0f83bf-26bc-45c4-a38b-0bda8a80d7fe">112,490</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfOS0zLTEtMS0w_dd9e78e0-5783-4df0-b729-9f7f4e0501f4">38,524</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Long-term investments</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMTEtMS0xLTEtMTE1NA_a276d77e-7277-4cba-90a0-7fbfa602918f">18,224</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:LongTermInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMTEtMy0xLTEtMTE1NA_6555c30b-0d7a-43ac-904e-8a530e38766f">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Property and equipment, net</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMTAtMS0xLTEtMA_1a9d05cc-588c-49a3-8793-5b6dc94dd43d">2,734</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMTAtMy0xLTEtMA_528535af-cfb9-433a-ac5a-da8aecb0f0bc">2,880</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Restricted cash</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="-3" name="us-gaap:RestrictedCashNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMTEtMS0xLTEtMA_31b6edc5-60c3-42f3-aa9c-fa7381aa93ff">310</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231" decimals="-3" name="us-gaap:RestrictedCashNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMTEtMy0xLTEtMA_06d97578-eb39-42eb-8563-390d9c042f34">310</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other non-current assets</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMTItMS0xLTEtMA_7cf8b81e-20cf-46c1-9286-a82c93bd5b78">3,644</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMTItMy0xLTEtMA_e417b86c-4589-455c-98c9-8a82047c64d7">1,029</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:36pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total assets</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMTMtMS0xLTEtMA_e2e1c96b-a28f-4a7e-814c-bb39faea3e81">137,402</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMTMtMy0xLTEtMA_8397a049-c38f-45e2-8afa-bb6f7557c344">42,743</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="6" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Liabilities, redeemable convertible preferred stock and stockholders&#8217; equity (deficit)</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Current liabilities:</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accounts payable</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMTctMS0xLTEtMA_afd98cd1-2ae4-4fc6-bef7-3931d8e005d8">1,898</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMTctMy0xLTEtMA_e04c677c-4255-4d38-a216-fc381e47e85c">1,252</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accrued liabilities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMTgtMS0xLTEtMA_7a2afc73-95d9-42fb-8cfa-5fae835e6f6d">15,034</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMTgtMy0xLTEtMA_14b74377-216e-4c05-bc5a-913784c09518">9,448</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:36pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total current liabilities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMTktMS0xLTEtMA_fb365d77-bb1a-491e-a80b-c11c513a853d">16,932</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMTktMy0xLTEtMA_7763a787-270f-4fcb-bd68-f5535bdd6e97">10,700</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Long-term debt</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMjAtMS0xLTEtMA_c202f47d-5518-4923-8be0-157a501ad1ae">44,879</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMjAtMy0xLTEtMA_4c1a8fca-8ffa-4c6c-8514-eb08de244866">44,201</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Redeemable convertible preferred stock warrant liability</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="-3" format="ixt:zerodash" name="silk:PreferredStockWarrantLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMjEtMS0xLTEtMA_9f2585e3-4d02-4393-bd68-0754c4fcd1ff">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231" decimals="-3" format="ixt:numdotdecimal" name="silk:PreferredStockWarrantLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMjEtMy0xLTEtMA_f3220c4d-51be-44df-a463-4561f4b1bf03">16,091</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other liabilities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMjItMS0xLTEtMA_2dcd1bb2-200b-4f03-9fb1-ac4152f91bee">3,700</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMjItMy0xLTEtMA_18e27628-6f84-46b1-a775-ce1d67748285">1,069</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:36pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total liabilities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Liabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMjMtMS0xLTEtMA_ea92731d-c8f3-4974-9e89-d98445621654">65,511</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Liabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMjMtMy0xLTEtMA_32d1ee30-2b38-4ef3-8191-71051ffef3d2">72,061</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Commitments and contingencies (Note 7)</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><ix:nonFraction unitRef="usd" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMjUtMS0xLTEtMA_fa87819c-8d30-492a-98b1-8aa02da5425e"></ix:nonFraction></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><ix:nonFraction unitRef="usd" contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMjUtMy0xLTEtMA_702de309-f8b5-4943-a906-541399c2d4fe"></ix:nonFraction></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">Redeemable convertible preferred stock issuable in series, $<ix:nonFraction unitRef="usdPerShare" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="INF" name="us-gaap:TemporaryEquityParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMjctMC0xLTEtMC90ZXh0cmVnaW9uOjhkMGE1MjU3OWQzNTRkNjBhMTMyYTIwYTAyYmQ5ZjY5XzMyOTg1MzQ4ODM0MTQ_ec3d9f5a-d8c2-457f-b3ab-b0aa898e7d17"><ix:nonFraction unitRef="usdPerShare" contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231" decimals="INF" name="us-gaap:TemporaryEquityParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMjctMC0xLTEtMC90ZXh0cmVnaW9uOjhkMGE1MjU3OWQzNTRkNjBhMTMyYTIwYTAyYmQ5ZjY5XzMyOTg1MzQ4ODM0MTQ_f0b1775d-2bdd-4232-a60e-895d53dd2f44">0.001</ix:nonFraction></ix:nonFraction> par value </span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="padding-left:11.25pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">Shares authorized: <ix:nonFraction unitRef="shares" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:TemporaryEquitySharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMjgtMC0xLTEtMC90ZXh0cmVnaW9uOjY5M2UzNGI4MzI5NTQxZjhiNTExZmM2NGVkYmJhNWJmXzI3NDg3NzkwNjk1NDI_283e5154-4331-43cc-bb7c-9a64d9d3135b">None</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquitySharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMjgtMC0xLTEtMC90ZXh0cmVnaW9uOjY5M2UzNGI4MzI5NTQxZjhiNTExZmM2NGVkYmJhNWJmXzY1OTcwNjk3NjY3NTI_9af0d346-febe-4012-b221-627d41448aea">24,069,615</ix:nonFraction> at December 31, 2019 and 2018, respectively</span></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="padding-left:11.25pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">Shares issued and outstanding: <ix:nonFraction unitRef="shares" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:TemporaryEquitySharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMjktMC0xLTEtMC90ZXh0cmVnaW9uOjk3MmI1YmVhYTA2MzQ0ZjQ4MWQ2YTFhZmM2ZjNlZTQ4XzI3NDg3NzkwNjk1NTQ_49765644-1198-4e6e-aae8-d5dfe7f714c9"><ix:nonFraction unitRef="shares" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:TemporaryEquitySharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMjktMC0xLTEtMC90ZXh0cmVnaW9uOjk3MmI1YmVhYTA2MzQ0ZjQ4MWQ2YTFhZmM2ZjNlZTQ4XzI3NDg3NzkwNjk1NTQ_d496093a-a22d-42e9-acbd-5d582f390844">None</ix:nonFraction></ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquitySharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMjktMC0xLTEtMC90ZXh0cmVnaW9uOjk3MmI1YmVhYTA2MzQ0ZjQ4MWQ2YTFhZmM2ZjNlZTQ4XzMyOTg1MzQ4ODM0MzY_697c984d-21c2-4869-830d-1900e8ffb674"><ix:nonFraction unitRef="shares" contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquitySharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMjktMC0xLTEtMC90ZXh0cmVnaW9uOjk3MmI1YmVhYTA2MzQ0ZjQ4MWQ2YTFhZmM2ZjNlZTQ4XzMyOTg1MzQ4ODM0MzY_881c0137-70c4-46c4-aa2b-11850ac851dd">21,233,190</ix:nonFraction></ix:nonFraction> at December 31, 2019 and 2018, respectively</span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="padding-left:11.25pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">Liquidation preference: <ix:nonFraction unitRef="usd" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:TemporaryEquityLiquidationPreference" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMzAtMC0xLTEtMC90ZXh0cmVnaW9uOjExYzM0ZTdkMzVjODQ4MjdiMDNmMWQ0NTdmODA2Y2MwXzI3NDg3NzkwNjk1NDM_43339976-67fd-4d57-b3c9-b6be6f635bf6">None</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquityLiquidationPreference" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMzAtMC0xLTEtMC90ZXh0cmVnaW9uOjExYzM0ZTdkMzVjODQ4MjdiMDNmMWQ0NTdmODA2Y2MwXzMyOTg1MzQ4ODM0MjU_30dc7539-a692-48ea-965e-0e72d01c037b">121,144</ix:nonFraction> at December 31, 2019 and 2018, respectively</span></div></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMzAtMS0xLTEtMA_ac48c241-bf65-4a4b-b904-79696899d778">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMzAtMy0xLTEtMA_3484ab93-5e99-4512-b71c-97a3d5c2e446">105,235</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="height:3pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Stockholders&#8217; equity (deficit):</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">Preferred stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMzQtMC0xLTEtNjY5L3RleHRyZWdpb246YWQzYmQwMmRhNTk0NGEzYTg4ZGYzYzc2MWZhMjg5ZWZfMzI5ODUzNDg4MzM3Mg_472f89fe-be9e-4d5a-8a7b-daf8e2fc32c2"><ix:nonFraction unitRef="usdPerShare" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMzQtMC0xLTEtNjY5L3RleHRyZWdpb246YWQzYmQwMmRhNTk0NGEzYTg4ZGYzYzc2MWZhMjg5ZWZfMzI5ODUzNDg4MzM3Mg_5d50563f-bfbf-42c0-96b8-226f165dd5cc">0.001</ix:nonFraction></ix:nonFraction> par value </span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="padding-left:11.25pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">Shares authorized: <ix:nonFraction unitRef="shares" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:PreferredStockSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMzUtMC0xLTEtNzA0L3RleHRyZWdpb246NDFjMzdhNmU4YjU2NGE0MjlmZTg5NGUxMDRhNWQ1MzRfMzI5ODUzNDg4MzQyMw_25e2c3a3-1c71-4293-a72f-6eb603cddca9">5,000,000</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMzUtMC0xLTEtNzA0L3RleHRyZWdpb246NDFjMzdhNmU4YjU2NGE0MjlmZTg5NGUxMDRhNWQ1MzRfMjc0ODc3OTA2OTY5MQ_7445b496-5c93-4330-b03e-9c191f037b74">none</ix:nonFraction> at December 31, 2019 and 2018, respectively </span></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="padding-left:11.25pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">Shares issued and outstanding: <ix:nonFraction unitRef="shares" contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMzYtMC0xLTEtNzA4L3RleHRyZWdpb246MmQ4ODk0ODk5Y2FjNDBjOGI3N2JiYjM0ZWExOTk2MDVfMjc0ODc3OTA2OTUxMw_1918c77c-8c9e-4a49-8ec4-720b5147d16f"><ix:nonFraction unitRef="shares" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMzYtMC0xLTEtNzA4L3RleHRyZWdpb246MmQ4ODk0ODk5Y2FjNDBjOGI3N2JiYjM0ZWExOTk2MDVfMjc0ODc3OTA2OTUxMw_248d08f4-d922-4ad5-b37e-b920e0b3b1ed"><ix:nonFraction unitRef="shares" contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMzYtMC0xLTEtNzA4L3RleHRyZWdpb246MmQ4ODk0ODk5Y2FjNDBjOGI3N2JiYjM0ZWExOTk2MDVfMjc0ODc3OTA2OTUxMw_531f3faa-c504-4405-b860-74a824ab81cc"><ix:nonFraction unitRef="shares" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMzYtMC0xLTEtNzA4L3RleHRyZWdpb246MmQ4ODk0ODk5Y2FjNDBjOGI3N2JiYjM0ZWExOTk2MDVfMjc0ODc3OTA2OTUxMw_6c878701-ddb9-4aea-bf7e-a768834e0ca4">None</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> at December 31, 2019 and 2018</span></div></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:PreferredStockValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMzYtMS0xLTEtNzUy_f757541e-cfb8-4cb7-8d72-d3f0ec27c4fa">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:PreferredStockValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMzYtMy0xLTEtNzUy_4f12ec19-fef3-4dc1-8d75-255af41a45fd">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">Common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOjVlNDE5MzI3ZjExOTRhNDRiOTIwMGQ1Mjg2M2MzMTJiXzMyOTg1MzQ4ODMzNjk_d8127b1c-92c8-453c-a3bd-66207ff909e5"><ix:nonFraction unitRef="usdPerShare" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOjVlNDE5MzI3ZjExOTRhNDRiOTIwMGQ1Mjg2M2MzMTJiXzMyOTg1MzQ4ODMzNjk_e5e38ca6-18d6-423c-a8cc-002cd4e86159">0.001</ix:nonFraction></ix:nonFraction> par value </span></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="padding-left:11.25pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">Shares authorized: <ix:nonFraction unitRef="shares" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOjUyOGJkMGE4YTc0YzRiNzNiZjY4YzZiMjM4M2RlNDg0XzMyOTg1MzQ4ODM0MzI_9434ab46-6fbe-43d6-a298-aa9d225e592c">100,000,000</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOjUyOGJkMGE4YTc0YzRiNzNiZjY4YzZiMjM4M2RlNDg0XzMyOTg1MzQ4ODM0NDM_4863ad7c-ed7c-43f1-95c3-48413d662da8">29,879,220</ix:nonFraction> at December 31, 2019 and 2018, respectively</span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="padding-left:11.25pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">Shares issued and outstanding: <ix:nonFraction unitRef="shares" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOjQ0NzU4MmY1ZTNhOTRlNzI4OTMxYTg1NDNjYzNmZGE1XzY1OTcwNjk3NjY3NjM_72054368-71a4-4d1b-b605-5534c31fbc39"><ix:nonFraction unitRef="shares" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOjQ0NzU4MmY1ZTNhOTRlNzI4OTMxYTg1NDNjYzNmZGE1XzY1OTcwNjk3NjY3NjM_b5185c27-c069-4052-915e-44c0d1fd3c97">31,255,267</ix:nonFraction></ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOjQ0NzU4MmY1ZTNhOTRlNzI4OTMxYTg1NDNjYzNmZGE1XzY1OTcwNjk3NjY3Njk_319984f9-21f1-4ab1-9028-14458326afe1"><ix:nonFraction unitRef="shares" contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOjQ0NzU4MmY1ZTNhOTRlNzI4OTMxYTg1NDNjYzNmZGE1XzY1OTcwNjk3NjY3Njk_c5f1f8c0-f7ea-4a0e-bd45-b5d9b9960708">1,135,310</ix:nonFraction></ix:nonFraction> at December 31, 2019 and 2018, respectively </span></div></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMzUtMS0xLTEtMA_07bbb82c-bd65-4e5e-b0b3-60c5c1017824">31</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMzUtMy0xLTEtMA_793e1d7b-ceaf-44d9-b716-2a8677dd1aad">1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Additional paid-in capital</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdditionalPaidInCapital" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMzYtMS0xLTEtMA_a702a4f8-99c3-4077-bc68-ed457f6c0536">263,384</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdditionalPaidInCapital" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMzYtMy0xLTEtMA_0a7d2601-e299-4a35-9b6d-ac25ce14957e">4,557</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accumulated other comprehensive income</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfNDEtMS0xLTEtNzcw_feb44c31-565f-4f14-9828-b38c438406e6">2</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfNDEtMy0xLTEtNzcw_854fa8c4-22dd-4384-bf9a-ad78cee86dd7">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accumulated deficit</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMzctMS0xLTEtMA_c77f0281-5bcd-4fc8-9658-31df194dcd58">191,526</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMzctMy0xLTEtMA_5a7d9f60-35dc-4e46-bf78-2d1790558611">139,111</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:36pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total stockholders&#8217; equity (deficit)</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMzgtMS0xLTEtMA_227f8b2f-7151-4000-ba35-ac5f0c650ca0">71,891</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMzgtMy0xLTEtMA_c6b8922a-a6ce-477b-9afb-f03293f4bced">134,553</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:36pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total liabilities and stockholders&#8217; equity (deficit)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMzktMS0xLTEtMA_716b4cc9-8fa6-47e7-920d-f824d84a7058">137,402</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMzktMy0xLTEtMA_bb297a98-2db8-4baa-a44e-b77c4a67f512">42,743</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr></table></div><div style="text-indent:18pt;text-align:center;margin-bottom:9pt;"><span><br/></span></div><div id="i58f397e86dfd4fc4ac3b8695cd31238e_94"></div><div style="text-indent:18pt;text-align:center;margin-bottom:9pt;"><span><br/></span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The accompanying notes are an integral part of these financial statements.</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">114</span></div></div></div><hr style="page-break-after:always"/><div style="height:90pt;width:100%;"><div style="text-align:center;margin-bottom:3pt;"><span><br/></span></div><div style="text-align:center;margin-bottom:3pt;"><span><br/></span></div><div style="text-indent:18pt;text-align:center;margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:98.000%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-bottom:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;">Silk Road Medical, Inc.</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%;">Statements of Operations and Comprehensive Loss</span></div></td></tr></table></div></div><div style="text-align:center;margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:69.314%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:11.942%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:11.943%;"></td><td style="width:1.0%;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-style:italic;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(in thousands, except share and per share data)</span></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Year Ended December 31,</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Revenue</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV85NC9mcmFnOmRlYjQyNzI0MmVkYjQ5M2NhMWE2Mzg5NWI5YmIwOWM5L3RhYmxlOjg4OTQyYzhjOTI5ZTQ5YmFiNjdiYjkxNWUyNzhmMDk1L3RhYmxlcmFuZ2U6ODg5NDJjOGM5MjllNDliYWI2N2JiOTE1ZTI3OGYwOTVfMi0xLTEtMS0w_b2d5bb02-985a-493f-9cec-104069a7ecce">63,354</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV85NC9mcmFnOmRlYjQyNzI0MmVkYjQ5M2NhMWE2Mzg5NWI5YmIwOWM5L3RhYmxlOjg4OTQyYzhjOTI5ZTQ5YmFiNjdiYjkxNWUyNzhmMDk1L3RhYmxlcmFuZ2U6ODg5NDJjOGM5MjllNDliYWI2N2JiOTE1ZTI3OGYwOTVfMi0zLTEtMS0w_e1d99d6d-c932-490d-b3de-0818266cd412">34,557</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cost of goods sold</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV85NC9mcmFnOmRlYjQyNzI0MmVkYjQ5M2NhMWE2Mzg5NWI5YmIwOWM5L3RhYmxlOjg4OTQyYzhjOTI5ZTQ5YmFiNjdiYjkxNWUyNzhmMDk1L3RhYmxlcmFuZ2U6ODg5NDJjOGM5MjllNDliYWI2N2JiOTE1ZTI3OGYwOTVfMy0xLTEtMS0w_58f6785d-03e8-4d02-af18-98ae6df0a003">15,927</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV85NC9mcmFnOmRlYjQyNzI0MmVkYjQ5M2NhMWE2Mzg5NWI5YmIwOWM5L3RhYmxlOjg4OTQyYzhjOTI5ZTQ5YmFiNjdiYjkxNWUyNzhmMDk1L3RhYmxlcmFuZ2U6ODg5NDJjOGM5MjllNDliYWI2N2JiOTE1ZTI3OGYwOTVfMy0zLTEtMS0w_94f21b11-27a2-4f6e-9f7f-5a417fb776d7">10,874</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:24.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gross profit</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV85NC9mcmFnOmRlYjQyNzI0MmVkYjQ5M2NhMWE2Mzg5NWI5YmIwOWM5L3RhYmxlOjg4OTQyYzhjOTI5ZTQ5YmFiNjdiYjkxNWUyNzhmMDk1L3RhYmxlcmFuZ2U6ODg5NDJjOGM5MjllNDliYWI2N2JiOTE1ZTI3OGYwOTVfNC0xLTEtMS0w_d8b1562f-8950-4bf1-8928-2302dd3b692b">47,427</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV85NC9mcmFnOmRlYjQyNzI0MmVkYjQ5M2NhMWE2Mzg5NWI5YmIwOWM5L3RhYmxlOjg4OTQyYzhjOTI5ZTQ5YmFiNjdiYjkxNWUyNzhmMDk1L3RhYmxlcmFuZ2U6ODg5NDJjOGM5MjllNDliYWI2N2JiOTE1ZTI3OGYwOTVfNC0zLTEtMS0w_d82846b7-e976-4105-a43a-0627d715267d">23,683</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operating expenses:</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Research and development</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV85NC9mcmFnOmRlYjQyNzI0MmVkYjQ5M2NhMWE2Mzg5NWI5YmIwOWM5L3RhYmxlOjg4OTQyYzhjOTI5ZTQ5YmFiNjdiYjkxNWUyNzhmMDk1L3RhYmxlcmFuZ2U6ODg5NDJjOGM5MjllNDliYWI2N2JiOTE1ZTI3OGYwOTVfNi0xLTEtMS0w_6bcd35d5-c21b-4509-be08-a45167a0b0fe">12,272</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV85NC9mcmFnOmRlYjQyNzI0MmVkYjQ5M2NhMWE2Mzg5NWI5YmIwOWM5L3RhYmxlOjg4OTQyYzhjOTI5ZTQ5YmFiNjdiYjkxNWUyNzhmMDk1L3RhYmxlcmFuZ2U6ODg5NDJjOGM5MjllNDliYWI2N2JiOTE1ZTI3OGYwOTVfNi0zLTEtMS0w_ca6e7ad7-5d06-4e7f-a8c5-9e4df6d31b54">10,258</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Selling, general and administrative</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV85NC9mcmFnOmRlYjQyNzI0MmVkYjQ5M2NhMWE2Mzg5NWI5YmIwOWM5L3RhYmxlOjg4OTQyYzhjOTI5ZTQ5YmFiNjdiYjkxNWUyNzhmMDk1L3RhYmxlcmFuZ2U6ODg5NDJjOGM5MjllNDliYWI2N2JiOTE1ZTI3OGYwOTVfNy0xLTEtMS0w_af6a9d5b-c292-49cf-bf22-be08a68f8e40">63,220</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV85NC9mcmFnOmRlYjQyNzI0MmVkYjQ5M2NhMWE2Mzg5NWI5YmIwOWM5L3RhYmxlOjg4OTQyYzhjOTI5ZTQ5YmFiNjdiYjkxNWUyNzhmMDk1L3RhYmxlcmFuZ2U6ODg5NDJjOGM5MjllNDliYWI2N2JiOTE1ZTI3OGYwOTVfNy0zLTEtMS0w_c31f4570-47ed-41eb-885f-d8e66d9c5d51">34,820</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:24.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total operating expenses</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV85NC9mcmFnOmRlYjQyNzI0MmVkYjQ5M2NhMWE2Mzg5NWI5YmIwOWM5L3RhYmxlOjg4OTQyYzhjOTI5ZTQ5YmFiNjdiYjkxNWUyNzhmMDk1L3RhYmxlcmFuZ2U6ODg5NDJjOGM5MjllNDliYWI2N2JiOTE1ZTI3OGYwOTVfOC0xLTEtMS0w_663d9098-b9e0-4d8c-8899-696b8234af6c">75,492</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV85NC9mcmFnOmRlYjQyNzI0MmVkYjQ5M2NhMWE2Mzg5NWI5YmIwOWM5L3RhYmxlOjg4OTQyYzhjOTI5ZTQ5YmFiNjdiYjkxNWUyNzhmMDk1L3RhYmxlcmFuZ2U6ODg5NDJjOGM5MjllNDliYWI2N2JiOTE1ZTI3OGYwOTVfOC0zLTEtMS0w_4f83cac2-ea6a-498d-a3b9-1f58be02c658">45,078</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Loss from operations</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV85NC9mcmFnOmRlYjQyNzI0MmVkYjQ5M2NhMWE2Mzg5NWI5YmIwOWM5L3RhYmxlOjg4OTQyYzhjOTI5ZTQ5YmFiNjdiYjkxNWUyNzhmMDk1L3RhYmxlcmFuZ2U6ODg5NDJjOGM5MjllNDliYWI2N2JiOTE1ZTI3OGYwOTVfOS0xLTEtMS0w_bdc534fa-3097-42d4-9d57-228c1c5398d8">28,065</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV85NC9mcmFnOmRlYjQyNzI0MmVkYjQ5M2NhMWE2Mzg5NWI5YmIwOWM5L3RhYmxlOjg4OTQyYzhjOTI5ZTQ5YmFiNjdiYjkxNWUyNzhmMDk1L3RhYmxlcmFuZ2U6ODg5NDJjOGM5MjllNDliYWI2N2JiOTE1ZTI3OGYwOTVfOS0zLTEtMS0w_7452215e-d3b9-4a12-8aca-1711356bc407">21,395</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interest income</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InvestmentIncomeInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV85NC9mcmFnOmRlYjQyNzI0MmVkYjQ5M2NhMWE2Mzg5NWI5YmIwOWM5L3RhYmxlOjg4OTQyYzhjOTI5ZTQ5YmFiNjdiYjkxNWUyNzhmMDk1L3RhYmxlcmFuZ2U6ODg5NDJjOGM5MjllNDliYWI2N2JiOTE1ZTI3OGYwOTVfMTAtMS0xLTEtMA_6892d8c1-754a-4882-9110-f76c1e3c61ea">1,656</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231" decimals="-3" name="us-gaap:InvestmentIncomeInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV85NC9mcmFnOmRlYjQyNzI0MmVkYjQ5M2NhMWE2Mzg5NWI5YmIwOWM5L3RhYmxlOjg4OTQyYzhjOTI5ZTQ5YmFiNjdiYjkxNWUyNzhmMDk1L3RhYmxlcmFuZ2U6ODg5NDJjOGM5MjllNDliYWI2N2JiOTE1ZTI3OGYwOTVfMTAtMy0xLTEtMA_dd69fdff-bedc-4c84-9280-6e1aa1e6bb73">189</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interest expense</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV85NC9mcmFnOmRlYjQyNzI0MmVkYjQ5M2NhMWE2Mzg5NWI5YmIwOWM5L3RhYmxlOjg4OTQyYzhjOTI5ZTQ5YmFiNjdiYjkxNWUyNzhmMDk1L3RhYmxlcmFuZ2U6ODg5NDJjOGM5MjllNDliYWI2N2JiOTE1ZTI3OGYwOTVfMTEtMS0xLTEtMA_66684829-f690-44c1-b4bf-ae9bdfd79a3b">4,952</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV85NC9mcmFnOmRlYjQyNzI0MmVkYjQ5M2NhMWE2Mzg5NWI5YmIwOWM5L3RhYmxlOjg4OTQyYzhjOTI5ZTQ5YmFiNjdiYjkxNWUyNzhmMDk1L3RhYmxlcmFuZ2U6ODg5NDJjOGM5MjllNDliYWI2N2JiOTE1ZTI3OGYwOTVfMTEtMy0xLTEtMA_51959093-c81c-448c-82e0-1520a1484ff5">4,361</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other income (expense), net</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV85NC9mcmFnOmRlYjQyNzI0MmVkYjQ5M2NhMWE2Mzg5NWI5YmIwOWM5L3RhYmxlOjg4OTQyYzhjOTI5ZTQ5YmFiNjdiYjkxNWUyNzhmMDk1L3RhYmxlcmFuZ2U6ODg5NDJjOGM5MjllNDliYWI2N2JiOTE1ZTI3OGYwOTVfMTItMS0xLTEtMA_2cb0431b-4d36-4e5f-a816-02651f3c4d25">21,054</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV85NC9mcmFnOmRlYjQyNzI0MmVkYjQ5M2NhMWE2Mzg5NWI5YmIwOWM5L3RhYmxlOjg4OTQyYzhjOTI5ZTQ5YmFiNjdiYjkxNWUyNzhmMDk1L3RhYmxlcmFuZ2U6ODg5NDJjOGM5MjllNDliYWI2N2JiOTE1ZTI3OGYwOTVfMTItMy0xLTEtMA_d95c990d-f90a-479d-806c-58063c22b187">12,063</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:24.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net loss</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV85NC9mcmFnOmRlYjQyNzI0MmVkYjQ5M2NhMWE2Mzg5NWI5YmIwOWM5L3RhYmxlOjg4OTQyYzhjOTI5ZTQ5YmFiNjdiYjkxNWUyNzhmMDk1L3RhYmxlcmFuZ2U6ODg5NDJjOGM5MjllNDliYWI2N2JiOTE1ZTI3OGYwOTVfMTMtMS0xLTEtMA_56aa056d-10b2-46b7-8d08-da131799bd73">52,415</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV85NC9mcmFnOmRlYjQyNzI0MmVkYjQ5M2NhMWE2Mzg5NWI5YmIwOWM5L3RhYmxlOjg4OTQyYzhjOTI5ZTQ5YmFiNjdiYjkxNWUyNzhmMDk1L3RhYmxlcmFuZ2U6ODg5NDJjOGM5MjllNDliYWI2N2JiOTE1ZTI3OGYwOTVfMTMtMy0xLTEtMA_a7d243a2-9ae5-499d-a2e3-76632aa7acba">37,630</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net loss attributable to non-controlling interest</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV85NC9mcmFnOmRlYjQyNzI0MmVkYjQ5M2NhMWE2Mzg5NWI5YmIwOWM5L3RhYmxlOjg4OTQyYzhjOTI5ZTQ5YmFiNjdiYjkxNWUyNzhmMDk1L3RhYmxlcmFuZ2U6ODg5NDJjOGM5MjllNDliYWI2N2JiOTE1ZTI3OGYwOTVfMTQtMS0xLTEtMA_1be7ccd5-9181-4ce6-b6c6-30a757d5d587">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV85NC9mcmFnOmRlYjQyNzI0MmVkYjQ5M2NhMWE2Mzg5NWI5YmIwOWM5L3RhYmxlOjg4OTQyYzhjOTI5ZTQ5YmFiNjdiYjkxNWUyNzhmMDk1L3RhYmxlcmFuZ2U6ODg5NDJjOGM5MjllNDliYWI2N2JiOTE1ZTI3OGYwOTVfMTQtMy0xLTEtMA_91f964b8-e444-4b4c-92b9-9105d8f78789">1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:24.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net loss attributable to Silk Road Medical, Inc. common stockholders</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV85NC9mcmFnOmRlYjQyNzI0MmVkYjQ5M2NhMWE2Mzg5NWI5YmIwOWM5L3RhYmxlOjg4OTQyYzhjOTI5ZTQ5YmFiNjdiYjkxNWUyNzhmMDk1L3RhYmxlcmFuZ2U6ODg5NDJjOGM5MjllNDliYWI2N2JiOTE1ZTI3OGYwOTVfMTUtMS0xLTEtMA_b01213af-4c55-47cf-a91d-92f598e83323">52,415</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV85NC9mcmFnOmRlYjQyNzI0MmVkYjQ5M2NhMWE2Mzg5NWI5YmIwOWM5L3RhYmxlOjg4OTQyYzhjOTI5ZTQ5YmFiNjdiYjkxNWUyNzhmMDk1L3RhYmxlcmFuZ2U6ODg5NDJjOGM5MjllNDliYWI2N2JiOTE1ZTI3OGYwOTVfMTUtMy0xLTEtMA_f71df9d7-7710-441c-bb2d-4747caa4f880">37,629</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other comprehensive loss:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Unrealized gain on investments, net</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV85NC9mcmFnOmRlYjQyNzI0MmVkYjQ5M2NhMWE2Mzg5NWI5YmIwOWM5L3RhYmxlOjg4OTQyYzhjOTI5ZTQ5YmFiNjdiYjkxNWUyNzhmMDk1L3RhYmxlcmFuZ2U6ODg5NDJjOGM5MjllNDliYWI2N2JiOTE1ZTI3OGYwOTVfMTctMS0xLTEtODQ1_63297d63-eb2e-496b-8099-5fcf19ebc4c4">2</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV85NC9mcmFnOmRlYjQyNzI0MmVkYjQ5M2NhMWE2Mzg5NWI5YmIwOWM5L3RhYmxlOjg4OTQyYzhjOTI5ZTQ5YmFiNjdiYjkxNWUyNzhmMDk1L3RhYmxlcmFuZ2U6ODg5NDJjOGM5MjllNDliYWI2N2JiOTE1ZTI3OGYwOTVfMTctMy0xLTEtODQ1_3a639919-8146-4431-ae4d-53940668a61c">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net change in other comprehensive loss</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV85NC9mcmFnOmRlYjQyNzI0MmVkYjQ5M2NhMWE2Mzg5NWI5YmIwOWM5L3RhYmxlOjg4OTQyYzhjOTI5ZTQ5YmFiNjdiYjkxNWUyNzhmMDk1L3RhYmxlcmFuZ2U6ODg5NDJjOGM5MjllNDliYWI2N2JiOTE1ZTI3OGYwOTVfMTgtMS0xLTEtOTQ4OA_732f6213-0fa6-411b-8159-91ba88ebc94d">2</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV85NC9mcmFnOmRlYjQyNzI0MmVkYjQ5M2NhMWE2Mzg5NWI5YmIwOWM5L3RhYmxlOjg4OTQyYzhjOTI5ZTQ5YmFiNjdiYjkxNWUyNzhmMDk1L3RhYmxlcmFuZ2U6ODg5NDJjOGM5MjllNDliYWI2N2JiOTE1ZTI3OGYwOTVfMTgtMy0xLTEtOTQ4OA_7a1fe4c1-ae90-409d-97a8-002e274f389e">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:24.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net loss and comprehensive loss attributable to Silk Road Medical, Inc. common stockholders</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="silk:NetIncomeLossAndComprehensiveIncomeLossNetOfTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV85NC9mcmFnOmRlYjQyNzI0MmVkYjQ5M2NhMWE2Mzg5NWI5YmIwOWM5L3RhYmxlOjg4OTQyYzhjOTI5ZTQ5YmFiNjdiYjkxNWUyNzhmMDk1L3RhYmxlcmFuZ2U6ODg5NDJjOGM5MjllNDliYWI2N2JiOTE1ZTI3OGYwOTVfMTktMS0xLTEtODYw_481aca5c-a836-4e76-a6ca-cf5ac5d00ef2">52,413</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="silk:NetIncomeLossAndComprehensiveIncomeLossNetOfTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV85NC9mcmFnOmRlYjQyNzI0MmVkYjQ5M2NhMWE2Mzg5NWI5YmIwOWM5L3RhYmxlOjg4OTQyYzhjOTI5ZTQ5YmFiNjdiYjkxNWUyNzhmMDk1L3RhYmxlcmFuZ2U6ODg5NDJjOGM5MjllNDliYWI2N2JiOTE1ZTI3OGYwOTVfMTktMy0xLTEtODYw_2be9e1a8-93b2-44b7-9360-f042424d4600">37,629</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net loss per share attributable to Silk Road Medical, Inc. common stockholders, basic and diluted </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usdPerShare" contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasicAndDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV85NC9mcmFnOmRlYjQyNzI0MmVkYjQ5M2NhMWE2Mzg5NWI5YmIwOWM5L3RhYmxlOjg4OTQyYzhjOTI5ZTQ5YmFiNjdiYjkxNWUyNzhmMDk1L3RhYmxlcmFuZ2U6ODg5NDJjOGM5MjllNDliYWI2N2JiOTE1ZTI3OGYwOTVfMTYtMS0xLTEtMA_f61e9123-d18c-4685-8217-7ceaef21a2cb">2.28</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usdPerShare" contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasicAndDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV85NC9mcmFnOmRlYjQyNzI0MmVkYjQ5M2NhMWE2Mzg5NWI5YmIwOWM5L3RhYmxlOjg4OTQyYzhjOTI5ZTQ5YmFiNjdiYjkxNWUyNzhmMDk1L3RhYmxlcmFuZ2U6ODg5NDJjOGM5MjllNDliYWI2N2JiOTE1ZTI3OGYwOTVfMTYtMy0xLTEtMA_c2070a05-fdc8-467b-89a9-e1e9f0499e9f">39.16</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted average common shares used to compute net loss per share attributable to Silk Road Medical, Inc. common stockholders, basic and diluted</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV85NC9mcmFnOmRlYjQyNzI0MmVkYjQ5M2NhMWE2Mzg5NWI5YmIwOWM5L3RhYmxlOjg4OTQyYzhjOTI5ZTQ5YmFiNjdiYjkxNWUyNzhmMDk1L3RhYmxlcmFuZ2U6ODg5NDJjOGM5MjllNDliYWI2N2JiOTE1ZTI3OGYwOTVfMTctMS0xLTEtMA_0ac01e45-dbd8-487d-95cb-278500cf812a">22,956,679</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV85NC9mcmFnOmRlYjQyNzI0MmVkYjQ5M2NhMWE2Mzg5NWI5YmIwOWM5L3RhYmxlOjg4OTQyYzhjOTI5ZTQ5YmFiNjdiYjkxNWUyNzhmMDk1L3RhYmxlcmFuZ2U6ODg5NDJjOGM5MjllNDliYWI2N2JiOTE1ZTI3OGYwOTVfMTctMy0xLTEtMA_39aa3ef8-52ea-4528-9a94-a4fc9ca122a2">960,882</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr></table></div><div style="text-indent:18pt;text-align:center;margin-bottom:9pt;"><span><br/></span></div><div id="i58f397e86dfd4fc4ac3b8695cd31238e_100"></div><div style="text-indent:18pt;text-align:center;margin-bottom:9pt;"><span><br/></span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The accompanying notes are an integral part of these financial statements.</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">115</span></div></div></div><hr style="page-break-after:always"/><div style="height:90pt;width:100%;"><div style="text-align:center;margin-bottom:3pt;"><span><br/></span></div><div style="text-align:center;margin-bottom:3pt;"><span><br/></span></div><div style="text-indent:18pt;text-align:center;margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:99.884%;"><tr><td style="width:1.0%;"></td><td style="width:98.000%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-bottom:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:12pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Silk Road Medical, Inc. <br/>Statements of Redeemable Convertible Preferred Stock and Stockholders&#8217; Equity (Deficit)</span></td></tr></table></div></div><div style="text-align:center;margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:24.157%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:5.986%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.378%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:4.828%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.378%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.378%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:5.407%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.378%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:4.018%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.378%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:5.523%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.378%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:6.680%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.378%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:8.069%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.262%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:5.291%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.378%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:4.955%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-style:italic;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(in thousands, except share data)</span></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Redeemable Convertible<br/>Preferred Stock</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-left:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Common Stock</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" rowspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Additional<br/>Paid-in Capital</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" rowspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accumulated Deficit</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" rowspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accumulated Other <br/>Comprehensive<br/>Income</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" rowspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Non-controlling Interest</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" rowspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Shares</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Amount</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-left:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Shares</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Amount</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balances at December 31, 2017</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="ib1a82135571248368e03bddf4304bc01_I20171231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquitySharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzE1LTEtMS0xLTA_0874e3a2-2f99-4a08-ba32-76143a529d26">21,233,190</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib1a82135571248368e03bddf4304bc01_I20171231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzE1LTMtMS0xLTA_dc0098d7-1e56-42e8-8108-027783819ff6">105,235</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-left:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i6e1fca0c7e7e4562a33eec6ef093c73f_I20171231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzE1LTYtMS0xLTA_0af2612f-a5e8-44b9-b5ef-fde26830b400">663,270</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6e1fca0c7e7e4562a33eec6ef093c73f_I20171231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzE1LTgtMS0xLTA_0336e68d-4a41-4bd4-a40f-a462d9b51bf0">1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i81d78a9636e34b158306cb1e7cf203a5_I20171231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzE1LTEwLTEtMS0w_1c587bdc-01ce-47bd-b9c1-9ad20407d950">2,977</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i0980ae5f9b0d4a1d8d2ded0faf7fb77e_I20171231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzE1LTEyLTEtMS0w_3a3a0cb6-f85e-44dd-97c0-1a7905668c0a">101,556</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i875f802c129642f1ba841126240b68a4_I20171231" decimals="-3" format="ixt:zerodash" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzE1LTE0LTEtMS05MTk_352bfbc3-1259-4b48-9690-a05387dc8ad2">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie3817a2997b54e13adbd3f8f1650b444_I20171231" decimals="-3" format="ixt:zerodash" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzE1LTE0LTEtMS0w_9a000718-f988-4a5d-9afb-a1bcb0b2eae9">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i517a0560ef9f4f6a822a0a124dd39744_I20171231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzE1LTE2LTEtMS0w_58f41035-fd7b-4dd9-a044-b54634a60537">98,578</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-indent:-9pt;padding-left:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;">Exercise of stock options</span></div></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-left:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i24fdf32d0a37459b9db5fc564063b7f5_D20180101-20181231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzE2LTYtMS0xLTA_90446859-18c9-428e-81fe-b1dcae1db807">438,578</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i70437b3fd9084ab18848599576d75854_D20180101-20181231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzE2LTEwLTEtMS0w_6d1fa0e6-3b60-49a3-a12c-82f6f7053e06">656</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzE2LTE2LTEtMS0w_da4b7199-b3a2-43aa-b1be-24efd1b35f14">656</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-indent:-9pt;padding-left:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;">Employee stock-based compensation</span></div></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-left:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i70437b3fd9084ab18848599576d75854_D20180101-20181231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzE3LTEwLTEtMS0w_1a69ab75-2cf8-400a-96ef-19188d28d6e9">728</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzE3LTE2LTEtMS0w_baf3b417-3bc6-4298-b581-c3e7398bb94a">728</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-indent:-9pt;padding-left:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;">Nonemployee stock-based compensation</span></div></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-left:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i70437b3fd9084ab18848599576d75854_D20180101-20181231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzE4LTEwLTEtMS0w_2cbb2344-5e6b-4e5f-9d2f-57621fa722ab">183</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzE4LTE2LTEtMS0w_ea324f7d-6d0d-4f95-bdd2-3a8a17b2f450">183</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-indent:-9pt;padding-left:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;">NeuroCo common stock issuance</span></div></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-left:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i532518b8a5e649659408304a8b441189_D20180101-20181231" decimals="-3" name="us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzE5LTE0LTEtMS0w_6138f33e-dacc-4634-aadf-72e874ce7f3a">1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231" decimals="-3" name="us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzE5LTE2LTEtMS0w_acae1742-8a7c-41d0-b32e-0f0f8fd93efd">1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Issuance of common stock in connection with NeuroCo merger</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-left:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i24fdf32d0a37459b9db5fc564063b7f5_D20180101-20181231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzIwLTYtMS0xLTA_d561a9de-e6f9-4059-b0b2-103823dc1a52">33,462</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzIwLTE2LTEtMS0w_f6ed81b4-90e0-48a6-96b1-3d8d76ed5639">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cumulative effect of change in accounting principle - ASC 606 adoption</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-left:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i078a473226e5469f8b43b5c341ea2777_I20180101" decimals="-3" name="us-gaap:CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzIxLTEyLTEtMS0w_b3505260-9d54-4994-b4cb-13b3ca1345be">87</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="if3906640531a47a789a69ee035108cfd_I20180101" decimals="-3" name="us-gaap:CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzIxLTE2LTEtMS0w_719a662c-ef01-4b18-98b0-e960e8219a40">87</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cumulative effect of change in accounting treatment - ASU 2016-09</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-left:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="if7fa5ba84e534af1b2d35b63277a0541_I20180101" decimals="-3" name="us-gaap:CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzIyLTEwLTEtMS0w_dd40051f-d5d7-4682-8910-d341fb092894">13</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i3d970a6f053141c8adef36f595567ea2_I20180101" decimals="-3" sign="-" name="us-gaap:CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzIyLTEyLTEtMS0w_120b4d87-6b98-4863-8b48-b73ab5c0a136">13</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ibfd8d47f8c2e498f97e7e0e1de986a52_I20180101" decimals="-3" format="ixt:zerodash" name="us-gaap:CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzIyLTE2LTEtMS0w_df9abf38-6ebe-48aa-9c2c-4c9955ff8132">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-indent:-9pt;padding-left:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;">Net loss and comprehensive loss</span></div></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-left:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i486e6203c31e4389a7bfae59308a9fdf_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzIzLTEyLTEtMS0w_e5c5869f-83f9-41df-b803-eea1bcad1bb9"><ix:nonFraction unitRef="usd" contextRef="i486e6203c31e4389a7bfae59308a9fdf_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzIzLTEyLTEtMS0w_f1efa857-6afc-425f-9953-3e76d9a7511f">37,629</ix:nonFraction></ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i532518b8a5e649659408304a8b441189_D20180101-20181231" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzIzLTE0LTEtMS0w_23e47d5b-51db-460d-8e10-2d41da10ee2b"><ix:nonFraction unitRef="usd" contextRef="i532518b8a5e649659408304a8b441189_D20180101-20181231" decimals="-3" sign="-" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzIzLTE0LTEtMS0w_611d4619-8fdf-457e-976e-5aff72095e5b">1</ix:nonFraction></ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzIzLTE2LTEtMS0w_78e77cb2-5589-4e86-86f5-d4dd234c862b"><ix:nonFraction unitRef="usd" contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzIzLTE2LTEtMS0w_cdb5b19a-19f1-4c75-a99e-e81eb1a1784e">37,630</ix:nonFraction></ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balances at December 31, 2018</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i9c2de9078e6d4638b12de94ce89dcf8f_I20181231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquitySharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzI0LTEtMS0xLTA_709bc8da-50f4-4e48-a36c-19cedcf97128">21,233,190</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9c2de9078e6d4638b12de94ce89dcf8f_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzI0LTMtMS0xLTA_b82b2be9-8190-4ad8-b5b7-874fb791d470">105,235</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="ie5422de912814b909007e41dfe62434c_I20181231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzI0LTYtMS0xLTA_e05d3910-cf21-4617-99d0-c6614240ed1c">1,135,310</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie5422de912814b909007e41dfe62434c_I20181231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzI0LTgtMS0xLTA_5b56830c-7cf6-4644-9326-f5a77ea86ae5">1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i372f9742dd2f42ca8e67497abb64e072_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzI0LTEwLTEtMS0w_9c2d7163-c2e6-47a4-a6b1-595a8bda4326">4,557</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ide97ade70a5e4b9fb300e7cf6f1de815_I20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzI0LTEyLTEtMS0w_a5bc5e91-c153-4c25-b76a-4c5f4164a170">139,111</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i67b8527276b74fc8b42f80e4649752f6_I20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzI0LTE0LTEtMS05MTk_c6ccc6aa-5918-4a3d-945e-2a0069b58de2">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i32f0795bc684401e95ede404c8ba027a_I20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzI0LTE0LTEtMS0w_606912d7-d9e5-4270-b1b3-f83c3112d7f5">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzI0LTE2LTEtMS0w_ca1227d8-f0bb-477a-9531-a8741546cdba">134,553</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Exercise of Series C preferred stock warrants</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i034315faec014251b182a3d66bbaabaa_D20190101-20191231" decimals="INF" format="ixt:numdotdecimal" name="silk:StockIssuedDuringPeriodSharesExerciseOfWarrants" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzI1LTEtMS0xLTk2NA_1ceea147-0abe-4ef7-baef-28b1a4655cd8">292,361</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i034315faec014251b182a3d66bbaabaa_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="silk:StockIssuedDuringPeriodValueExerciseOfWarrants" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzI1LTMtMS0xLTk2NA_10bc88fc-f9a2-4e83-bf60-365edb19a75a">1,784</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Exercise of common stock warrants</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i0e663b10e19444c782441b76f73225f8_D20190101-20191231" decimals="INF" format="ixt:numdotdecimal" name="silk:StockIssuedDuringPeriodSharesExerciseOfWarrants" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzI2LTYtMS0xLTk3Mg_57ed43a7-c0fa-4435-a781-fe8600ea7c66">3,764</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i30323612426c417f9cb96084012048a3_D20190101-20191231" decimals="-3" name="silk:StockIssuedDuringPeriodValueExerciseOfWarrants" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzI2LTEwLTEtMS05NzI_970268bf-597b-4512-b4d6-d4a5329db4e7">31</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" decimals="-3" name="silk:StockIssuedDuringPeriodValueExerciseOfWarrants" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzI2LTE4LTEtMS05NzI_d2627966-bb87-461c-abb7-7f9cf517201b">31</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;">Issuance of common stock in connection with IPO, net of underwriting discount, commissions and offering costs of $<ix:nonFraction unitRef="usd" contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsOfStockIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzI3LTAtMS0xLTEwMzYvdGV4dHJlZ2lvbjozY2RhNTAwMjkxNWQ0ZGNkYmM5NTM5ZjIyMWQ0ZTRmOV8zMjk4NTM0ODgzNDU3_de7fca63-61cf-43fd-9dda-6b7785d79895">2,481</ix:nonFraction></span></div></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i0e663b10e19444c782441b76f73225f8_D20190101-20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzI3LTYtMS0xLTk3Mg_6068f55b-fe1b-4fa8-b80a-8462d9a8d226">6,000,000</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0e663b10e19444c782441b76f73225f8_D20190101-20191231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzI3LTgtMS0xLTk3Mg_86fed58a-2531-4638-842e-1b8441f56693">6</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i30323612426c417f9cb96084012048a3_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzI3LTEwLTEtMS05NzI_5fba8759-0404-4a41-993d-41356e586967">109,113</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzI3LTE4LTEtMS05NzI_9f10eff9-f076-4d6d-b577-2dfd0cf8bee5">109,119</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Conversion of preferred stock to common stock upon IPO</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="shares" contextRef="i034315faec014251b182a3d66bbaabaa_D20190101-20191231" decimals="INF" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzI4LTEtMS0xLTk2NA_d940979a-331d-4cbd-ae22-0cf73ec4b204">23,178,555</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i034315faec014251b182a3d66bbaabaa_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueConversionOfUnits" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzI4LTMtMS0xLTk2NA_d45e5d72-a94a-4df6-be97-ce6cb50a6bd6">144,140</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i0e663b10e19444c782441b76f73225f8_D20190101-20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzI4LTYtMS0xLTk3Mg_2795e1e8-8ed3-4362-a1da-fda82614754b">23,178,555</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0e663b10e19444c782441b76f73225f8_D20190101-20191231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueConversionOfUnits" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzI4LTgtMS0xLTk3Mg_9460d81a-4b88-4fb6-8ebb-3964c98abaa2">23</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i30323612426c417f9cb96084012048a3_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueConversionOfUnits" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzI4LTEwLTEtMS05NzI_62d16787-9d50-43f7-bd0f-2878a47f2381">144,117</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueConversionOfUnits" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzI4LTE4LTEtMS05NzI_fe1825f4-e3dd-4137-814c-7635169e7eb2">144,140</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net exercise of Series C preferred stock warrants upon IPO</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i128760dd6ffe4a6bbcffc708f475df73_D20190101-20191231" decimals="INF" format="ixt:numdotdecimal" name="silk:StockIssuedDuringPeriodSharesExerciseOfWarrants" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzI5LTEtMS0xLTk2NA_42a193de-48e9-429f-9814-1d293192406e">1,653,004</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i128760dd6ffe4a6bbcffc708f475df73_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="silk:StockIssuedDuringPeriodValueExerciseOfWarrants" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzI5LTMtMS0xLTk2NA_56c9dee6-cdaf-4a9a-a9f0-55caa1326c52">37,121</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net exercise of common stock warrants upon IPO</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i0872d194a51d4edcad754b82ad9b0396_D20190101-20191231" decimals="INF" format="ixt:numdotdecimal" name="silk:StockIssuedDuringPeriodSharesExerciseOfWarrants" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzMwLTYtMS0xLTk3Mg_a6c29883-3e11-4317-8f9e-69d9de26ab14">2,204</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="icc70fdca20a04c6ab43a9d230a3bb9b3_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="silk:StockIssuedDuringPeriodValueExerciseOfWarrants" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzMwLTE4LTEtMS05NzI_c7d4b196-f830-4f67-83f1-4df5b79337c8">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Exercise of stock options</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i0e663b10e19444c782441b76f73225f8_D20190101-20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzMxLTYtMS0xLTk3Mg_9582a799-82b7-4733-9903-024c324c11e3">873,786</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0e663b10e19444c782441b76f73225f8_D20190101-20191231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzMxLTgtMS0xLTk3Mg_afc5edfa-47be-4ea2-a274-6dadf806b85a">1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i30323612426c417f9cb96084012048a3_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzMxLTEwLTEtMS05NzI_ee4d4627-ce6d-40a2-8f86-70512025a008">1,541</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzMxLTE4LTEtMS05NzI_bcc5cbe4-0572-41ca-a93f-af27e0d314d3">1,542</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Issuance of common stock under employee stock purchase plan</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i0e663b10e19444c782441b76f73225f8_D20190101-20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzMyLTYtMS0xLTk3Mg_d0066eb3-2041-498a-b2e2-8f9999e32737">61,648</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i30323612426c417f9cb96084012048a3_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzMyLTEwLTEtMS05NzI_73b01ed7-2fc8-4273-af69-b899a4a6bde0">1,048</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzMyLTE4LTEtMS05NzI_e7e2e13e-a1b9-459c-8eb1-6456ad474062">1,048</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Employee stock-based compensation</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i30323612426c417f9cb96084012048a3_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzMzLTEwLTEtMS05NzI_693412c4-a0b9-4bbd-aedb-9f5ae9c3bf40">2,887</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzMzLTE4LTEtMS05NzI_1f565a84-bee8-4795-861d-9a90b8c7e8aa">2,887</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Nonemployee stock-based compensation</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i30323612426c417f9cb96084012048a3_D20190101-20191231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzM0LTEwLTEtMS05NzI_1d35ada4-5459-4ec6-a5ee-9eedec6b3961">90</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzM0LTE4LTEtMS05NzI_56fffee2-f522-487c-b70b-124d324c1673">90</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net loss</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i1ef328d4a82d454f837101558bfddfe2_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzM1LTEyLTEtMS05NzI_7723f493-c3d6-48c0-8df5-6f20f9322dba">52,415</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzM1LTE4LTEtMS05NzI_16fdd335-2f1a-49f6-8437-ac114b1e888e">52,415</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Unrealized gains on investments, net</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i2a50ab8679f64d4e9e5c5ef5f5850abf_D20190101-20191231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzM2LTE0LTEtMS05NzI_a6305b99-5440-43e8-a3e6-c2256177a489">2</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzM2LTE4LTEtMS05NzI_a677a549-d1c0-4aa1-98cf-e365ff4551b1">2</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balances at December 31, 2019</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i1fa63ac295464df58c38a6649e35436f_I20191231" decimals="INF" format="ixt:zerodash" name="us-gaap:TemporaryEquitySharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzM3LTEtMS0xLTk2NA_7aba0aa9-7bae-46f0-83a6-ce32d2730866">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1fa63ac295464df58c38a6649e35436f_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzM3LTMtMS0xLTk2NA_0db7cbe1-32d7-4815-b8c9-b6412a54e6db">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-left:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i4e66b2f70f744286ad2b2575bbd8de82_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzM3LTYtMS0xLTk3Mg_06f56f5b-5135-4b84-99b3-89bcddca581f">31,255,267</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4e66b2f70f744286ad2b2575bbd8de82_I20191231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzM3LTgtMS0xLTk3Mg_a114d983-2120-4e15-8c8e-1540da07631b">31</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i92a29de035d648249198240ca0cb4b8b_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzM3LTEwLTEtMS05NzI_154802fc-b05d-434d-93cf-840821545280">263,384</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="iec5a27c85b024faeaa754c4a163a1274_I20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzM3LTEyLTEtMS05NzI_d79865a4-4a9e-4b32-ae44-1037e231bdf2">191,526</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i52088a0c6adf42bd8f967682ae5eabef_I20191231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzM3LTE0LTEtMS05NzI_c66867ec-ea08-46e4-af0d-5c0ecba10963">2</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7462368c462e4bd490bca37af6860f56_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzM3LTE2LTEtMS05NzI_5e35661c-a742-48f5-bf0b-f7d438af381b">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzM3LTE4LTEtMS05NzI_b25b6b0c-ee97-43df-a4f9-0de43a17fe69">71,891</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div style="text-indent:18pt;text-align:center;margin-bottom:9pt;"><span><br/></span></div><div id="i58f397e86dfd4fc4ac3b8695cd31238e_106"></div><div style="text-indent:18pt;text-align:center;margin-bottom:9pt;"><span><br/></span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The accompanying notes are an integral part of these financial statements.</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">116</span></div></div></div><hr style="page-break-after:always"/><div style="height:90pt;width:100%;"><div style="text-align:center;margin-bottom:3pt;"><span><br/></span></div><div style="text-align:center;margin-bottom:3pt;"><span><br/></span></div><div style="text-indent:18pt;text-align:center;margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:98.000%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-bottom:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;">Silk Road Medical, Inc.</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%;">Statements of Cash Flows</span></div></td></tr></table></div></div><div style="text-align:center;margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:73.320%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:10.019%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.441%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:10.020%;"></td><td style="width:1.0%;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-style:italic;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(in thousands)</span></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Year Ended December 31,</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cash flows from operating activities</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net loss</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzMtMS0xLTEtMA_3fec88e6-35c9-4a8e-99d1-5d8328fc4e38">52,415</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzMtMy0xLTEtMA_1693eb42-3a5c-49c8-8891-73109619853e">37,630</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Adjustments to reconcile net loss to net cash used in operating activities:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Depreciation and amortization expense</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzUtMS0xLTEtMA_3f8885de-bcfd-4b6c-9006-8a0ac1c81fcf">712</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzUtMy0xLTEtMA_869e29bc-0638-4d4b-9986-0b706e6bdaf1">517</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Stock-based compensation expense</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzYtMS0xLTEtMA_754dd843-94a8-4c6e-816a-7b626ad4d01c">2,977</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231" decimals="-3" name="us-gaap:ShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzYtMy0xLTEtMA_8591b428-9634-4543-89e9-1f866c9da4a9">911</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Change in fair value of redeemable convertible preferred stock warrant liability</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FairValueAdjustmentOfWarrants" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzctMS0xLTEtMA_3663d307-5bb4-4703-86dc-fc162405df08">21,030</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FairValueAdjustmentOfWarrants" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzctMy0xLTEtMA_3a4784dc-17c4-4c1a-a609-24b6d32b6ded">11,906</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accretion of discount on investments</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" decimals="-3" name="us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzgtMS0xLTEtMTA2OQ_35e3ea85-88cb-4a1f-af1a-fcf55a1393a6">309</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzgtMy0xLTEtMTA2OQ_c9fd59a9-19e9-4070-b7ed-2d3985910f8b">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Amortization of debt discount and debt issuance costs</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" decimals="-3" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzgtMS0xLTEtMA_e5dcfd38-ea8d-467b-9643-3514c029ac6d">46</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231" decimals="-3" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzgtMy0xLTEtMA_1ade05c1-499d-4541-ac04-d74cbf3d169b">68</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Amortization of right-of-use asset</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" decimals="-3" name="silk:OperatingLeaseRightOfUseAssetAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzEwLTEtMS0xLTEwNzQ_2de95f29-8201-46ec-b6c8-67613c933971">582</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Non-cash interest expense</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" decimals="-3" name="us-gaap:PaidInKindInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzktMS0xLTEtMA_7665241d-2dab-498e-a507-5cb2764dd275">672</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaidInKindInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzktMy0xLTEtMA_822d7984-0441-4874-bd1c-ae0b3a51cf1b">1,555</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Loss on disposal of property and equipment</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzEwLTEtMS0xLTA_1e96bee0-3ac1-4eee-9da6-33fd135e4a5d">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231" decimals="-3" sign="-" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzEwLTMtMS0xLTA_fb25e629-635a-428a-b886-09aa8df32008">159</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Provision for doubtful accounts receivable</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" decimals="-3" name="us-gaap:ProvisionForDoubtfulAccounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzExLTEtMS0xLTA_b85b7399-f018-4635-8d5a-72603337186c">23</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231" decimals="-3" sign="-" name="us-gaap:ProvisionForDoubtfulAccounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzExLTMtMS0xLTA_df5858c2-f74e-4008-af76-5dc503f530bd">123</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Provision for excess and obsolete inventories</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" decimals="-3" name="us-gaap:InventoryWriteDown" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzEyLTEtMS0xLTA_caa6eb0f-78f5-4585-879c-cdc1ee2a92d5">118</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231" decimals="-3" name="us-gaap:InventoryWriteDown" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzEyLTMtMS0xLTA_7c20bbe7-ee5f-4529-8b55-11379a946858">23</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Changes in assets and liabilities</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:24.75pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accounts receivable</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzE0LTEtMS0xLTA_124fe92e-6a9e-4b53-9ffc-3a463519b5cd">2,241</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzE0LTMtMS0xLTA_c8a9fdcf-af01-48b6-9d93-bcaac6896a81">446</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:24.75pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Inventories</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInInventories" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzE1LTEtMS0xLTA_d975f91f-0ec4-49f7-9124-d99b8907a361">4,696</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInInventories" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzE1LTMtMS0xLTA_61495ac4-3093-47d7-8e66-59dcfff66c57">2,565</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:24.75pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Prepaid expenses and other current assets</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzE2LTEtMS0xLTA_2357f7c5-e8f4-49e9-bade-207a9ba985ad">1,471</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzE2LTMtMS0xLTA_c4015c58-0531-41ae-8cd3-aefaf6ad75c8">1,128</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:24.75pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other assets</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzE3LTEtMS0xLTA_15430cbb-64d6-43e5-9db0-37608c9b37b1">552</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzE3LTMtMS0xLTA_6f1f1fb2-8bbc-4f6f-a992-3949996230b5">62</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:24.75pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accounts payable</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzE4LTEtMS0xLTA_0487f096-ab30-4d68-a9d0-464f81594193">615</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzE4LTMtMS0xLTA_e5281cb4-c95f-4229-b9bb-19df20060415">309</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:24.75pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accrued liabilities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzE5LTEtMS0xLTA_e9543c75-6864-4ef4-99b0-248fc3b7ce7d">4,964</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzE5LTMtMS0xLTA_a543785f-67dd-476a-98bb-41781cacba6c">5,023</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:24.75pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other liabilities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzIwLTEtMS0xLTA_14a71c83-eaae-49cc-8744-6f04db7bb6e7">769</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherOperatingLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzIwLTMtMS0xLTA_be88fded-ea63-4243-a068-1fb93d793b10">406</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:47.25pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net cash used in operating activities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzIxLTEtMS0xLTA_4cbe7550-9981-498a-9c6d-21ff343c013d">29,610</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzIxLTMtMS0xLTA_f1fc7534-9892-4915-9048-e6b11c47b88a">21,695</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cash flows from investing activities</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Purchase of property and equipment</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzI0LTEtMS0xLTA_5668dc0d-84d9-4165-b380-56d4e2d0efac">535</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzI0LTMtMS0xLTA_8452fbef-16cc-4d38-8b6d-9dca36f43341">2,276</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Proceeds from sale of property and equipment</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzI1LTEtMS0xLTA_e9f8fcbe-a275-4195-a456-37618cd19176">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231" decimals="-3" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzI1LTMtMS0xLTA_81d4a5be-9c83-46c6-8369-2baf5971f38f">6</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Purchases of investments</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzI4LTEtMS0xLTEwODk_81bdb566-8acd-4908-88e0-4ce5625d10a1">69,421</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:PaymentsToAcquireInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzI4LTMtMS0xLTEwODk_3358223f-d01c-46f3-8632-8e1e92ba1c30">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:47.25pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net cash used in investing activities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzI2LTEtMS0xLTA_fb820983-820d-4d97-ab84-6e475d5cba0a">69,956</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzI2LTMtMS0xLTA_4ec24c8f-e5f2-45e4-856a-9e74f86880c1">2,270</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cash flows from financing activities</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Proceeds from initial public offering, net of underwriting discount, commissions and offering costs paid</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzMyLTEtMS0xLTExMDE_9d4fd417-e932-4dd8-990c-9f0af72eca39">109,352</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231" decimals="-3" sign="-" name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzMyLTMtMS0xLTExMDE_891c1ea5-ea8e-4cd1-9aa1-1435ea5cc36f">233</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Proceeds from long-term debt</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzI5LTEtMS0xLTA_ca51036c-3a2e-48d7-b8a0-1d63384ff8d8">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzI5LTMtMS0xLTA_256b70c5-4984-4010-af84-04ff6458e3e3">15,000</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Proceeds from issuance of common stock</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzMwLTEtMS0xLTA_cd76f8c8-5eaa-40cc-a12e-9af98cdb5b27">2,590</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzMwLTMtMS0xLTA_ceac81a1-cdb0-4c50-92ed-a21e8a87b01a">656</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Proceeds from exercise of redeemable convertible preferred stock warrants</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i183f22ec2ae24c28af10423035463332_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromWarrantExercises" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzMxLTEtMS0xLTA_9fbfafd4-ed87-4b80-9132-26c65490a1e8">1,784</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3b88e1cc16544cd09f30471712be03e7_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:ProceedsFromWarrantExercises" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzMxLTMtMS0xLTA_7708089f-2f47-4675-8c99-1f4d31ec2726">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Proceeds from exercise of common stock warrants</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6392e7d9184e4e68a1862ac1a23c3c37_D20190101-20191231" decimals="-3" name="us-gaap:ProceedsFromWarrantExercises" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzM2LTEtMS0xLTExMDg_8702f8f6-2f91-4008-9dde-03ae85f7fe39">31</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ief833aecb87341158807940d3631f438_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:ProceedsFromWarrantExercises" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzM2LTMtMS0xLTExMDg_27de0df8-b210-4fbd-a1ba-a36e36fd5c91">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Non-controlling interest</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:ProceedsFromMinorityShareholders" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzMyLTEtMS0xLTA_b6253a85-b965-4d64-8449-d6a7d0cfb157">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231" decimals="-3" name="us-gaap:ProceedsFromMinorityShareholders" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzMyLTMtMS0xLTA_99e4aea5-c9b9-4923-8001-23f7eb0a85cd">1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:47.25pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net cash provided by financing activities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzM0LTEtMS0xLTA_0f531537-4d99-467a-8f06-13460e37c867">113,757</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzM0LTMtMS0xLTA_8d20efd5-44f7-404a-8070-4ba7a86f9294">15,424</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net change in cash, cash equivalents and restricted cash</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzM1LTEtMS0xLTA_2c320a43-ed39-4aca-8165-a03791732931">14,191</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzM1LTMtMS0xLTA_2e72f499-4ade-4fff-9ee6-9c49a5f643a4">8,541</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cash, cash equivalents and restricted cash, beginning of year</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzM2LTEtMS0xLTA_273df366-8f3f-47a8-ac24-d6af92c5a123">25,300</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i517a0560ef9f4f6a822a0a124dd39744_I20171231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzM2LTMtMS0xLTA_ddef9c8c-6b06-4e35-8048-9a9ea5fe77e7">33,841</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cash, cash equivalents and restricted cash, end of year</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzM3LTEtMS0xLTA_90cea716-9828-4198-b7b8-acd802342d1f">39,491</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzM3LTMtMS0xLTA_308d2323-d67c-4535-b6dc-011c08729d48">25,300</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Supplemental disclosure of cash flow information</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cash paid for interest</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzQwLTEtMS0xLTA_933b83e5-c57b-47ee-b4d0-9c283348dad6">4,234</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzQwLTMtMS0xLTA_d871036a-40b6-4cbd-8328-ef5b279360fe">2,738</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Non-cash investing and financing activities:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accounts payable and accrued liabilities for purchases of property and equipment</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" decimals="-3" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzQzLTEtMS0xLTA_ec55e5e1-a767-48e3-8d23-702939d0d460">32</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231" decimals="-3" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzQzLTMtMS0xLTA_5b0623a8-35e7-49a9-89a6-228d1120a176">6</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Landlord paid tenant improvements</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:PaymentsForTenantImprovements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzQ0LTEtMS0xLTA_e6114f63-d752-4917-ad9d-1fbaaba99442">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231" decimals="-3" name="us-gaap:PaymentsForTenantImprovements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzQ0LTMtMS0xLTA_a72e6f3e-14d1-407c-b737-770cdda341da">794</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Unpaid deferred offering costs</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="silk:StockIssuanceCostsIncurredButNotYetPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzQ1LTEtMS0xLTA_8e8112c1-2cc7-4837-97df-7dee4e72caa6">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231" decimals="-3" name="silk:StockIssuanceCostsIncurredButNotYetPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzQ1LTMtMS0xLTA_00f2b420-a90a-4a96-8e5e-038579489419">717</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Right-of-use asset obtained in exchange for lease obligation</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzUwLTEtMS0xLTExMzE_eb66ca21-a665-4fbb-a278-8ee620c5c46a">3,982</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net exercise of redeemable convertible preferred stock warrants to preferred stock</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ConversionOfStockAmountIssued1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzUxLTEtMS0xLTExMzE_dec5c07a-8277-4e70-be2c-e33c515ec93d">37,121</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:ConversionOfStockAmountIssued1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzUxLTMtMS0xLTExMzE_a8029bbe-606b-4027-909d-3ba353985156">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Conversion of redeemable convertible preferred stock to common stock upon initial public offering</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ConversionOfStockAmountConverted1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzUyLTEtMS0xLTExMzE_33e2f459-8786-4f72-ae4f-e4dd44997e82">144,140</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:ConversionOfStockAmountConverted1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzUyLTMtMS0xLTExMzE_7d6ec168-4dcc-45dd-8332-d49521df6de8">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr></table></div><div style="text-indent:18pt;text-align:center;margin-bottom:9pt;"><span><br/></span></div><div id="i58f397e86dfd4fc4ac3b8695cd31238e_109"></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The accompanying notes are an integral part of these financial statements.</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">117</span></div></div></div><hr style="page-break-after:always"/><div style="height:90pt;width:100%;"><div style="margin-bottom:9pt;"><span><br/></span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">1.&#160;<ix:nonNumeric contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDkvZnJhZzo4OTFiYTkwOGFmZGM0NzBhOWQ3ZTdmOTU4ZGFhY2IwZi90ZXh0cmVnaW9uOjg5MWJhOTA4YWZkYzQ3MGE5ZDdlN2Y5NThkYWFjYjBmXzIxOTkwMjMyNjg1OTI_e33e08d2-abc4-4bc8-8af6-160de5a2e4db" continuedAt="ie9f384608bbe4c9786e7ec62eaff8d33" escape="true">Formation and Business of the Company </ix:nonNumeric></span></div><ix:continuation id="ie9f384608bbe4c9786e7ec62eaff8d33"><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">The Company</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Silk Road Medical, Inc. (the &#8220;Company&#8221;) was incorporated in the state of Delaware on March&#160;21,&#160;2007.  The Company has developed a technologically advanced, minimally-invasive solution for patients with carotid artery disease who are at risk for stroke.  The Company&#8217;s portfolio of TCAR products enable a new procedure, referred to as transcarotid artery revascularization, or TCAR, that combines the benefits of endovascular techniques and surgical principles.  The Company&#8217;s manufactures and sells in the United States its portfolio of TCAR products which are designed to provide direct access to the carotid artery, effective reduction in stroke risk throughout the procedure, and long-term restraint of carotid plaque.  The Company commercialized its products in the United States in April 2016. </span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Liquidity</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In the course of its activities, the Company has incurred losses and negative cash flows from operations since its inception.  As of December&#160;31, 2019, the Company had an accumulated deficit of $<ix:nonFraction unitRef="usd" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDkvZnJhZzo4OTFiYTkwOGFmZGM0NzBhOWQ3ZTdmOTU4ZGFhY2IwZi90ZXh0cmVnaW9uOjg5MWJhOTA4YWZkYzQ3MGE5ZDdlN2Y5NThkYWFjYjBmXzMyOTg1MzQ4ODcwNTI_6fdcae2a-88c0-485a-907c-fc1e67285411">191,526,000</ix:nonFraction>.  The Company expects to incur losses for the foreseeable future.  The Company</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> believes tha</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">t its cash and cash equivalents of $<ix:nonFraction unitRef="usd" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDkvZnJhZzo4OTFiYTkwOGFmZGM0NzBhOWQ3ZTdmOTU4ZGFhY2IwZi90ZXh0cmVnaW9uOjg5MWJhOTA4YWZkYzQ3MGE5ZDdlN2Y5NThkYWFjYjBmXzMyOTg1MzQ4ODcwNzg_6ef6bb01-f957-43c2-8f8d-15a823350c48">39,181,000</ix:nonFraction> and available-for-sale investments of $<ix:nonFraction unitRef="usd" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDkvZnJhZzo4OTFiYTkwOGFmZGM0NzBhOWQ3ZTdmOTU4ZGFhY2IwZi90ZXh0cmVnaW9uOjg5MWJhOTA4YWZkYzQ3MGE5ZDdlN2Y5NThkYWFjYjBmXzM4NDgyOTA3MDQxMTE_a773eef9-fca0-43d9-8ce4-1bb75b744a17">69,732,000</ix:nonFraction> at December&#160;31, 2019, as well as its expected revenues will provide sufficient funds to allow the Company to fund its planned current operations for the next twelve months from the issuance of these financial statements.  </span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Reverse Stock Split</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">On March 13, 2019, the Company&#8217;s Board of Directors approved an amendment to the Company&#8217;s amended and restated certificate of incorporation to effect a 1-for-2.7 reverse stock split of the Company&#8217;s common stock and redeemable convertible preferred stock to be consummated prior to the effectiveness of the Company&#8217;s planned initial public offering (&#8220;IPO&#8221;).  The reverse stock split was effected on March 27, 2019.  The par values of the common stock and redeemable convertible preferred stock were not adjusted as a result of the reverse stock split.  All the common stock, redeemable convertible preferred stock, stock options and warrants, and related per share amounts in the financial statements have been retroactively adjusted for all periods presented to give effect to the reverse stock split.</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Public Offerings</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In April 2019, the Company issued and sold <ix:nonFraction unitRef="shares" contextRef="i61f1ed462e8447ffab9c8334784ff07d_D20190401-20190430" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDkvZnJhZzo4OTFiYTkwOGFmZGM0NzBhOWQ3ZTdmOTU4ZGFhY2IwZi90ZXh0cmVnaW9uOjg5MWJhOTA4YWZkYzQ3MGE5ZDdlN2Y5NThkYWFjYjBmXzM4NDgyOTA3MDQxMjM_e33a2438-d422-4bcf-b964-048160544f19">6,000,000</ix:nonFraction> shares of its common stock in its IPO at a public offering price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i6ed3f43f8f3b4ec3b256ad182faa9d25_I20190430" decimals="INF" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDkvZnJhZzo4OTFiYTkwOGFmZGM0NzBhOWQ3ZTdmOTU4ZGFhY2IwZi90ZXh0cmVnaW9uOjg5MWJhOTA4YWZkYzQ3MGE5ZDdlN2Y5NThkYWFjYjBmXzM4NDgyOTA3MDQxMzE_a4903343-efb8-4751-adcb-19111f745184">20.00</ix:nonFraction> per share, for net proceeds of approximately $<ix:nonFraction unitRef="usd" contextRef="i61f1ed462e8447ffab9c8334784ff07d_D20190401-20190430" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDkvZnJhZzo4OTFiYTkwOGFmZGM0NzBhOWQ3ZTdmOTU4ZGFhY2IwZi90ZXh0cmVnaW9uOjg5MWJhOTA4YWZkYzQ3MGE5ZDdlN2Y5NThkYWFjYjBmXzM4NDgyOTA3MDQxNDU_ab445d3b-524c-409d-8640-255e4bac1921">109,119,000</ix:nonFraction> after deducting underwriting discounts and commissions of approximately $<ix:nonFraction unitRef="usd" contextRef="iba3487b4fc2c4dce923c5b7f62c0537c_D20190401-20190430" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsOfStockIssuanceCosts" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDkvZnJhZzo4OTFiYTkwOGFmZGM0NzBhOWQ3ZTdmOTU4ZGFhY2IwZi90ZXh0cmVnaW9uOjg5MWJhOTA4YWZkYzQ3MGE5ZDdlN2Y5NThkYWFjYjBmXzM4NDgyOTA3MDQxNTc_b94d75eb-9825-4e59-a0d9-314b2f1bef97">8,400,000</ix:nonFraction> and expenses of approximately $<ix:nonFraction unitRef="usd" contextRef="iee7e39f90c474f35b760d777c5110c8f_D20190401-20190430" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsOfStockIssuanceCosts" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDkvZnJhZzo4OTFiYTkwOGFmZGM0NzBhOWQ3ZTdmOTU4ZGFhY2IwZi90ZXh0cmVnaW9uOjg5MWJhOTA4YWZkYzQ3MGE5ZDdlN2Y5NThkYWFjYjBmXzM4NDgyOTA3MDQxNjk_185386f6-064f-4fe0-a1bd-be344f18e7f0">2,481,000</ix:nonFraction>. Upon the closing of the IPO, all shares of redeemable convertible preferred stock then outstanding converted into shares of common stock and the Company's outstanding warrants to purchase shares of common and redeemable convertible preferred stock were exercised, or automatically net exercised absent a prior election. The exercises resulted in the reclassification of the fair value of the related redeemable convertible preferred stock warrant liability to additional paid-in capital. </span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In August 2019, the Company completed a secondary public offering of <ix:nonFraction unitRef="shares" contextRef="i3ff09a6410f6470c9bc375b415065a88_D20190801-20190831" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDkvZnJhZzo4OTFiYTkwOGFmZGM0NzBhOWQ3ZTdmOTU4ZGFhY2IwZi90ZXh0cmVnaW9uOjg5MWJhOTA4YWZkYzQ3MGE5ZDdlN2Y5NThkYWFjYjBmXzM4NDgyOTA3MDQxODA_a0f0568f-7a93-4f08-bb3a-cbb681ad15d4">4,200,000</ix:nonFraction> shares of its common stock sold by certain selling stockholders, and the exercise in full of the underwriters' option to purchase <ix:nonFraction unitRef="shares" contextRef="i2cf16617a08a49c5ba94c598a0c73b8e_D20190801-20190831" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDkvZnJhZzo4OTFiYTkwOGFmZGM0NzBhOWQ3ZTdmOTU4ZGFhY2IwZi90ZXh0cmVnaW9uOjg5MWJhOTA4YWZkYzQ3MGE5ZDdlN2Y5NThkYWFjYjBmXzM4NDgyOTA3MDQxODk_4d8522c5-3b5f-49d3-a88d-5de925a4fcc0">630,000</ix:nonFraction> additional shares of its common stock from certain selling stockholders, at a public offering price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i8c8377ba457f49a9969abe8f8a528e68_I20190831" decimals="INF" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDkvZnJhZzo4OTFiYTkwOGFmZGM0NzBhOWQ3ZTdmOTU4ZGFhY2IwZi90ZXh0cmVnaW9uOjg5MWJhOTA4YWZkYzQ3MGE5ZDdlN2Y5NThkYWFjYjBmXzM4NDgyOTA3MDQxOTc_6868d927-33a0-44b6-b082-14e27a86c844">39.50</ix:nonFraction> per share. The Company did not receive any of the proceeds from the sale of the shares of its common stock from the selling stockholders.</span></div></ix:continuation><div style="text-align:justify;margin-bottom:12pt;"><span><br/></span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">  </span></div><div id="i58f397e86dfd4fc4ac3b8695cd31238e_115"></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">118</span></div></div></div><hr style="page-break-after:always"/><div style="height:90pt;width:100%;"><div style="margin-bottom:9pt;"><span><br/></span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">2.&#160;<ix:nonNumeric contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" name="us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90ZXh0cmVnaW9uOjZmZWQwNzhkNzVjYTQ1NWU4OTcyY2RkYjU1Nzc0NWRkXzMxMzM5_a3794ccb-1efc-4d1a-8939-c5eda03e7aa5" continuedAt="i2faeb92e3eb549b9821edb0399952228" escape="true">Summary of Significant Accounting Policies</ix:nonNumeric></span></div><ix:continuation id="i2faeb92e3eb549b9821edb0399952228" continuedAt="i2989308481254d71a9e926b184faeee0"><ix:nonNumeric contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90ZXh0cmVnaW9uOjZmZWQwNzhkNzVjYTQ1NWU4OTcyY2RkYjU1Nzc0NWRkXzMxMzQ3_8154f54f-ce00-4046-b7fc-69e9c7fbaf0f" escape="true"><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Basis of Preparation</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The accompanying financial statements have been prepared in accordance with the accounting principles generally accepted in the United States of America (&#8220;U.S. GAAP&#8221;).  </span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Adjustment to Prior Period Financial Statements</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company has adjusted the accompanying December 31, 2018 balance sheet to increase each of the accounts receivable and accrued liabilities balances by $<ix:nonFraction unitRef="usd" contextRef="i733162f186ac41fb8f9b99aa842ef13f_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90ZXh0cmVnaW9uOjZmZWQwNzhkNzVjYTQ1NWU4OTcyY2RkYjU1Nzc0NWRkXzIxOTkwMjMzNDMzNzQ_db39ce40-e3d0-4ed0-a1bd-c5d84d789990">1,860,000</ix:nonFraction> to correct for an immaterial prior year error in the classification of provisions for returns from customers.</span></div></ix:nonNumeric><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"><ix:nonNumeric contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" name="us-gaap:ConsolidationPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90ZXh0cmVnaW9uOjZmZWQwNzhkNzVjYTQ1NWU4OTcyY2RkYjU1Nzc0NWRkXzMxMzQ4_7eb0ccc5-ee8c-48e3-b330-e1475829706d" continuedAt="i5f3a199006bc4a86954b794a54dbfc8e" escape="true">Principles of Consolidation</ix:nonNumeric></span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"><ix:continuation id="i5f3a199006bc4a86954b794a54dbfc8e">As of December 31, 2017, the consolidated financial statements of the Company include the accounts of Silk Road Medical, Inc. and its consolidated variable interest entity (&#8220;VIE&#8221;).  Disclosure regarding the Company&#8217;s participation in the VIE is included in Note 12, &#8220;Variable Interest Entity &#8211; NeuroCo&#8221;.  On December 17, 2018, the Company acquired all assets and assumed all liabilities of its VIE.  All intercompany balances and transactions have been eliminated in consolidation.</ix:continuation>  </span></div><ix:nonNumeric contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90ZXh0cmVnaW9uOjZmZWQwNzhkNzVjYTQ1NWU4OTcyY2RkYjU1Nzc0NWRkXzMxMzQx_1c41c7f9-9e94-4287-9d4a-5e14cc30e201" escape="true"><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Use of Estimates</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The preparation of financial statements in conformity with U.S.&#160;GAAP requires management to make estimates and assumptions that affect the amounts and disclosures reported in the financial statements.  Management uses judgment when making estimates related to provisions for accounts receivable and excess and obsolete inventories, the valuation of deferred tax assets, the reserves for sales returns, stock-based compensation, and for periods prior to the Company's IPO, the valuation of common stock and redeemable convertible preferred stock warrants.  Management bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources.  Although these estimates are based on the Company&#8217;s knowledge of current events and actions it may undertake in the future, actual results may ultimately differ from these estimates and assumptions.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" name="us-gaap:FairValueOfFinancialInstrumentsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90ZXh0cmVnaW9uOjZmZWQwNzhkNzVjYTQ1NWU4OTcyY2RkYjU1Nzc0NWRkXzMxMzQ5_7d56b839-8482-4da2-a34d-a805bf3367bf" escape="true"><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Fair Value of Financial Instruments</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company has evaluated the estimated fair value of its financial instruments as of December&#160;31, 2019 and 2018.  The carrying amounts of certain of the Company&#8217;s financial instruments, which include cash equivalents, short-term investments, long-term investments, restricted cash, accounts receivable, accounts payable and accrued liabilities approximate their respective fair values because of the short-term nature of these instruments.  Management believes that its long-term debt bears interest at the prevailing market rates for instruments with similar characteristics (Level 2 within the fair value hierarchy); accordingly, the carrying value of this instrument approximates its fair value.  Prior to the Company's IPO, fair value accounting was applied to the redeemable convertible preferred stock warrant liability.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" name="us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90ZXh0cmVnaW9uOjZmZWQwNzhkNzVjYTQ1NWU4OTcyY2RkYjU1Nzc0NWRkXzMxMzMw_445c7a07-5c8b-4cb8-bdeb-133d00c9584f" continuedAt="i66a286fa42f146ea803a905581bb28ed" escape="true"><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Cash, Cash Equivalents and Restricted Cash</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company considers all highly liquid investments with an original maturity of three months or less at the time of purchase to be cash equivalents.  Cash equivalents are considered available-for-sale marketable securities and are recorded at fair value, based on quoted market prices.  As of December&#160;31, 2019 and 2018, the Company&#8217;s cash equivalents are entirely comprised of investments in money market funds.  </span></div></ix:nonNumeric></ix:continuation><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">119</span></div></div></div><hr style="page-break-after:always"/><div style="height:90pt;width:100%;"><div style="margin-bottom:9pt;"><span><br/></span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><ix:continuation id="i2989308481254d71a9e926b184faeee0" continuedAt="i68c8b9b5d95c4ecdb1e727f802a51dec"><ix:continuation id="i66a286fa42f146ea803a905581bb28ed" continuedAt="ibcc34d34827544699afe15713dd539ed"><ix:nonNumeric contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" name="us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90ZXh0cmVnaW9uOjZmZWQwNzhkNzVjYTQ1NWU4OTcyY2RkYjU1Nzc0NWRkXzMxMzM2_a884c050-a2cd-401d-a443-321f3a9a1d7e" escape="true"><ix:nonNumeric contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" name="us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90ZXh0cmVnaW9uOjZmZWQwNzhkNzVjYTQ1NWU4OTcyY2RkYjU1Nzc0NWRkXzMxMzUw_a7205185-2d26-460b-aad8-eea4b182458f" escape="true"><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the balance sheets that sum to the total of the same amounts shown in the statements of cash flows (in thousands):</span></div><div style="margin-bottom:12pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:69.314%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:11.942%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:11.943%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 31,</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cash and cash equivalents</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90YWJsZTozMjExMTlhYTJmYWY0M2MwOGVkOWMyMWRiOWM0NGQ2ZS90YWJsZXJhbmdlOjMyMTExOWFhMmZhZjQzYzA4ZWQ5YzIxZGI5YzQ0ZDZlXzItMS0xLTEtMA_af6e98a6-8b94-4161-b09b-04b7092e100d">39,181</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90YWJsZTozMjExMTlhYTJmYWY0M2MwOGVkOWMyMWRiOWM0NGQ2ZS90YWJsZXJhbmdlOjMyMTExOWFhMmZhZjQzYzA4ZWQ5YzIxZGI5YzQ0ZDZlXzItMy0xLTEtMA_74796bcb-87e9-45b8-b398-1a0c0d2fd170">24,990</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Restricted cash</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="-3" name="us-gaap:RestrictedCashNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90YWJsZTozMjExMTlhYTJmYWY0M2MwOGVkOWMyMWRiOWM0NGQ2ZS90YWJsZXJhbmdlOjMyMTExOWFhMmZhZjQzYzA4ZWQ5YzIxZGI5YzQ0ZDZlXzMtMS0xLTEtMA_f2f672d7-8b27-48d1-88ad-38b8467c8dfd">310</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231" decimals="-3" name="us-gaap:RestrictedCashNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90YWJsZTozMjExMTlhYTJmYWY0M2MwOGVkOWMyMWRiOWM0NGQ2ZS90YWJsZXJhbmdlOjMyMTExOWFhMmZhZjQzYzA4ZWQ5YzIxZGI5YzQ0ZDZlXzMtMy0xLTEtMA_b612df3b-f3db-479d-b6fb-a547170ea4b2">310</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total cash, cash equivalents and restricted cash</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90YWJsZTozMjExMTlhYTJmYWY0M2MwOGVkOWMyMWRiOWM0NGQ2ZS90YWJsZXJhbmdlOjMyMTExOWFhMmZhZjQzYzA4ZWQ5YzIxZGI5YzQ0ZDZlXzQtMS0xLTEtMA_707e3707-f024-4cdd-adc5-14c36b08b882">39,491</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90YWJsZTozMjExMTlhYTJmYWY0M2MwOGVkOWMyMWRiOWM0NGQ2ZS90YWJsZXJhbmdlOjMyMTExOWFhMmZhZjQzYzA4ZWQ5YzIxZGI5YzQ0ZDZlXzQtMy0xLTEtMA_25324cfb-ba91-4c6d-8d4e-c00cea8aa982">25,300</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div></ix:nonNumeric></ix:nonNumeric><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">    </span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Restricted cash as of December&#160;31, 2019 and 2018 consists of a letter of credit of $<ix:nonFraction unitRef="usd" contextRef="iec135774dba44b3cb207fe343988137e_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RestrictedCashNoncurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90ZXh0cmVnaW9uOjZmZWQwNzhkNzVjYTQ1NWU4OTcyY2RkYjU1Nzc0NWRkXzM4NDgyOTA3NDAzNjA_2df307b6-aa4b-488d-8b63-08df00874be2"><ix:nonFraction unitRef="usd" contextRef="ia68f07ad6fdb42d6837b98ba4cba8d55_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RestrictedCashNoncurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90ZXh0cmVnaW9uOjZmZWQwNzhkNzVjYTQ1NWU4OTcyY2RkYjU1Nzc0NWRkXzM4NDgyOTA3NDAzNjA_db4035bc-e246-4aa2-b0e9-1f8e225b787a">310,000</ix:nonFraction></ix:nonFraction> representing collateral for the Company&#8217;s facility lease. </span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Investments</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Short-term investments consist of debt securities classified as available-for-sale and have original maturities greater than 90 days, but less than one year as of the balance sheet date. Long-term investments have maturities greater than one year as of the balance sheet date. All investments are recorded at fair value based on the fair value hierarchy.  Money market funds are classified within Level 1 of the fair value hierarchy, and commercial paper, corporate bonds/notes, United States Government securities, and asset-backed securities are classified within Level 2 of the fair value hierarchy. </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Unrealized gains and losses, deemed temporary in nature, are reported as a separate component of accumulated other comprehensive income (loss).  The cost of available-for-sale investments sold is based on the specific-identification method. Realized gains and losses are included in earnings, and are der</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">ived for specific-identification method for determining the costs of investments sold. Amortization of premiums and accretion of discounts are reported as a component of interest income.</span></div></ix:continuation><div style="margin-bottom:12pt;"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"><ix:continuation id="ibcc34d34827544699afe15713dd539ed">A decline in the fair value of any security below cost that is deemed other than temporary results in a charge to earnings and the corresponding establishment of a new cost basis for the investment.</ix:continuation> </span></div><ix:nonNumeric contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" name="us-gaap:ConcentrationRiskCreditRisk" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90ZXh0cmVnaW9uOjZmZWQwNzhkNzVjYTQ1NWU4OTcyY2RkYjU1Nzc0NWRkXzMxMzMx_6222c9ba-49cf-4b0c-bdef-dfe89cef3f17" continuedAt="id8b204aa8beb4245806410f8f1a0f74b" escape="true"><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Concentration of Credit Risk, and Other Risks and Uncertainties</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Financial instruments that potentially subject the Company to credit risk consist of cash and cash equivalents, investments and accounts receivable to the extent of the amounts recorded on the balance sheet.  Cash, cash equivalents, and investments are deposited in financial institutions which, at times, may be in excess of federally insured limits. Cash equivalents are invested in highly rated money market funds. The Company invests in a variety of financial instruments, such as, but not limited to, commercial paper, corporate bonds/notes, United States Government securities, asset-backed securities and, by policy, limits the amount of credit exposure with any one financial institution or commercial issuer. The Company has not experienced any material losses on its deposits of cash and cash equivalents or investments during the years ended December 31, 2019 and 2018.</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company&#8217;s accounts receivable are due from a variety of health care organizations in the United States.  At December&#160;31, 2019 and 2018, no customer represented 10% or more of the Company&#8217;s accounts receivable.  For the years ended December&#160;31, 2019 and 2018, there were no customers that represented 10% or more of revenue.  </span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company provides for uncollectible amounts when specific credit problems are identified.  In doing so, the Company analyzes historical bad debt trends, customer credit worthiness, current economic trends and changes in customer payment patterns when evaluating the adequacy of the allowance for doubtful accounts.</span></div></ix:nonNumeric></ix:continuation><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">120</span></div></div></div><hr style="page-break-after:always"/><div style="height:90pt;width:100%;"><div style="margin-bottom:9pt;"><span><br/></span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><ix:continuation id="i68c8b9b5d95c4ecdb1e727f802a51dec" continuedAt="i405c3014a61347b398bcf317b06cd1af"><ix:continuation id="id8b204aa8beb4245806410f8f1a0f74b"><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company manufactures certain of its commercial products in-house.  Certain of the Company&#8217;s product components and sub-assemblies continue to be manufactured by sole suppliers, the most significant of which is the ENROUTE stent.  Disruption in component or sub-assembly supply from these manufacturers or from in-house production would have a negative impact on the Company&#8217;s financial position and results of operations.</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company is subject to certain risks, including that its devices may not be approved or cleared for marketing by governmental authorities or be successfully marketed.  There can be no assurance that the Company&#8217;s products will achieve widespread adoption in the marketplace, nor can there be any assurance that existing devices or any future devices can be developed or manufactured at an acceptable cost and with appropriate performance characteristics.  The Company is also subject to risks common to companies in the medical device industry, including, but not limited to, new technological innovations, dependence upon third-party payers to provide adequate coverage and reimbursement, dependence on key personnel and suppliers, protection of proprietary technology, product liability claims, and compliance with government regulations.</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Existing or future devices developed by the Company may require approvals or clearances from the FDA or international regulatory agencies.  In addition, in order to continue the Company&#8217;s operations, compliance with various federal and state laws is required.  If the Company were denied or delayed in receiving such approvals or clearances, it may be necessary to adjust operations to align with the Company&#8217;s currently approved portfolio.  If clearance for the products in the current portfolio were withdrawn by the FDA, this would have a material adverse impact on the Company.</span></div></ix:continuation><ix:nonNumeric contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" name="us-gaap:TradeAndOtherAccountsReceivablePolicy" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90ZXh0cmVnaW9uOjZmZWQwNzhkNzVjYTQ1NWU4OTcyY2RkYjU1Nzc0NWRkXzIxOTkwMjMzMjQ3MTU_1dfe41da-4440-49f0-bd34-c8c463f7842b" escape="true"><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Accounts Receivable</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Trade accounts receivable are recorded at the invoiced amount and do not bear interest.  The Company estimates allowances for doubtful accounts.  Specifically, the Company makes estimates on the collectability of customer accounts based primarily on analysis of historical trends and experience and changes in customers&#8217; financial condition.  The Company uses its judgment, based on the best available facts and circumstances, and records an allowance against amounts due to reduce the receivable to the amount that is expected to be collected.  These specific allowances are reevaluated and adjusted as additional information is received that impacts the amount reserved.  During the years ended December 31, 2019 and 2018, the Company did not experience any material credit-related losses.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" name="us-gaap:InventoryPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90ZXh0cmVnaW9uOjZmZWQwNzhkNzVjYTQ1NWU4OTcyY2RkYjU1Nzc0NWRkXzIxOTkwMjMzMjQ3MTY_27554467-eb03-4e30-b42e-dd32fdffafc9" escape="true"><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Inventories</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Inventories are valued at the lower of cost to purchase or manufacture the inventory or net realizable value.  Cost is determined using the first-in, first-out method for all inventories.  Net realizable value is determined as the estimated selling prices in the ordinary course of business, less reasonably predictable costs of completion, disposal and transportation.  The Company regularly reviews inventory quantities in consideration of actual loss experiences, projected future demand, and remaining shelf life prior to sale to record a provision for excess and obsolete inventory when appropriate.  The Company&#8217;s policy is to write down inventory that has become obsolete, inventory that has a cost basis in excess of its expected lower of cost or net realizable value, and inventory in excess of expected requirements.  The estimate of excess quantities is judgmental and primarily dependent on the Company&#8217;s estimates of future demand for a particular product.  If the estimate of future demand is too high, the Company may have to increase the reserve for excess inventory for that product and record a charge to the cost of goods sold.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90ZXh0cmVnaW9uOjZmZWQwNzhkNzVjYTQ1NWU4OTcyY2RkYjU1Nzc0NWRkXzIxOTkwMjMzMjQ3MTc_f67e6c0a-b2cb-4b32-86dc-1838991d1b6e" continuedAt="i2f5b33c3dd4a4148b43550980d29c11a" escape="true"><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Property and Equipment</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Property and equipment are recorded at cost less accumulated depreciation or amortization.  Repairs and maintenance costs are expensed as incurred.  Depreciation and amortization are calculated using the straight-line method over the estimated useful lives of the assets, typically <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90ZXh0cmVnaW9uOjZmZWQwNzhkNzVjYTQ1NWU4OTcyY2RkYjU1Nzc0NWRkXzMyOTg1MzQ5NDkxMTE_2fc458bb-3e66-4101-b8da-1c4fb228a229">three</span> to <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90ZXh0cmVnaW9uOjZmZWQwNzhkNzVjYTQ1NWU4OTcyY2RkYjU1Nzc0NWRkXzMyOTg1MzQ5NDkxMTU_fb1b7f55-5035-426c-9941-0c64a4cba092">five</span> years.  Leasehold </span></div></ix:nonNumeric></ix:continuation><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">121</span></div></div></div><hr style="page-break-after:always"/><div style="height:90pt;width:100%;"><div style="margin-bottom:9pt;"><span><br/></span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><ix:continuation id="i405c3014a61347b398bcf317b06cd1af" continuedAt="ie65352ea6ff941b49e56906bba20a76c"><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"><ix:continuation id="i2f5b33c3dd4a4148b43550980d29c11a">improvements are amortized using the straight-line method over the shorter of the lease term or estimated useful economic life of the asset.  When assets are retired or otherwise disposed of, the cost and accumulated depreciation are removed from the balance sheet and any resulting gain or loss is reflected in operations in the period realized.</ix:continuation></span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"><ix:nonNumeric contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" name="us-gaap:DeferredChargesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90ZXh0cmVnaW9uOjZmZWQwNzhkNzVjYTQ1NWU4OTcyY2RkYjU1Nzc0NWRkXzMxMzQy_6c3fb3cb-7f8c-4249-acab-1796d1d1cf72" continuedAt="if4c2e771c29e40d7ae422f26e7f34050" escape="true">Deferred Public Offering Costs</ix:nonNumeric></span></div><div style="margin-bottom:12pt;"><ix:continuation id="if4c2e771c29e40d7ae422f26e7f34050" continuedAt="i05b8d3e08e654596b1a9dd666362d51c"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Specific incremental legal, accounting and other fees and costs directly attributable to a proposed or actual offering of securities may properly be deferred and charged against the gross proceeds of the offering.  </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">As of December&#160;31, 2018, there were $<ix:nonFraction unitRef="usd" contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredOfferingCosts" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90ZXh0cmVnaW9uOjZmZWQwNzhkNzVjYTQ1NWU4OTcyY2RkYjU1Nzc0NWRkXzMyOTg1MzQ5MTQ5NDk_283dd04a-5b7e-4961-afaf-b8fc4009192c">950,000</ix:nonFraction> of offering costs primarily consisting of legal and accounting fees that were capitalized in other non-current assets on the balance sheet of which $<ix:nonFraction unitRef="usd" contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsOfStockIssuanceCosts" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90ZXh0cmVnaW9uOjZmZWQwNzhkNzVjYTQ1NWU4OTcyY2RkYjU1Nzc0NWRkXzMyOTg1MzQ5NDY5NDE_f74e2e0d-e9ba-4ee7-87a5-88326b435ba7">233,000</ix:nonFraction> had been paid.  <ix:nonFraction unitRef="usd" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:DeferredOfferingCosts" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90ZXh0cmVnaW9uOjZmZWQwNzhkNzVjYTQ1NWU4OTcyY2RkYjU1Nzc0NWRkXzIxOTkwMjMzMjQ3MjM_d5f73093-1ff1-4d05-8fd2-21711edbe635">No</ix:nonFraction> deferred offering costs were capitalized as of </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">December&#160;31, 2019</span></ix:continuation><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"><ix:continuation id="i05b8d3e08e654596b1a9dd666362d51c">.</ix:continuation> </span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"><ix:nonNumeric contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90ZXh0cmVnaW9uOjZmZWQwNzhkNzVjYTQ1NWU4OTcyY2RkYjU1Nzc0NWRkXzIxOTkwMjMzMjQ3MTg_fda5a6f5-66e1-4f0c-b961-8be160a2bded" continuedAt="ifcc8c703926946e0b1b7b703a51b6440" escape="true">Impairment of Long-Lived Assets</ix:nonNumeric></span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"><ix:continuation id="ifcc8c703926946e0b1b7b703a51b6440">The Company reviews long-lived assets, including property and equipment, for impairment whenever events or changes in business circumstances indicate that the carrying amount of the assets may not be fully recoverable.  If indicators of impairment exist, an impairment loss would be recognized when estimated undiscounted future cash flows expected to result from the use of the assets and their eventual disposition are less than their carrying amount.  Impairment, if any, is measured as the amount by which the carrying amount of the long-lived assets exceeds their fair value.</ix:continuation>  The Company did not record any impairment of long-lived assets during the years ended December&#160;31, 2019 and 2018.</span></div><ix:nonNumeric contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" name="us-gaap:LesseeLeasesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90ZXh0cmVnaW9uOjZmZWQwNzhkNzVjYTQ1NWU4OTcyY2RkYjU1Nzc0NWRkXzIxOTkwMjMzMjQ3MTk_d3adc324-acb4-40e0-808b-b472a0f24d3e" continuedAt="ic58af2caa8c440a7b3f00c7185f11e64" escape="true"><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Leases</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company adopted Accounting Standards Codification (&#8220;ASC&#8221;) 842, "Leases," on January 1, 2019 and used the modified retrospective method for all leases not substantially completed as of the date of adoption and the package of practical expedients available in the standard.  As a result of adopting ASC 842, the Company recorded an operating lease right-of-use ("ROU") asset of $<ix:nonFraction unitRef="usd" contextRef="i0f51c2607db4468eba9bb514ae0e4471_I20190101" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90ZXh0cmVnaW9uOjZmZWQwNzhkNzVjYTQ1NWU4OTcyY2RkYjU1Nzc0NWRkXzMyOTg1MzQ5NDkxMjc_e6aa646d-67b5-45ee-810a-bc3e20340f0a">3,982,000</ix:nonFraction> included within other non-current assets and operating lease liabilities of $<ix:nonFraction unitRef="usd" contextRef="i0f51c2607db4468eba9bb514ae0e4471_I20190101" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiability" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90ZXh0cmVnaW9uOjZmZWQwNzhkNzVjYTQ1NWU4OTcyY2RkYjU1Nzc0NWRkXzMyOTg1MzQ5NDkxMzk_76704d09-d685-4143-8158-94cff8c03a97">5,190,000</ix:nonFraction> included within accrued liabilities and other liabilities on the balance sheet related to its facility lease, based on the present value of the future lease payments on the date of adoption.  The operating lease right-of-use asset also includes adjustments for prepayments and excludes lease incentives.  The adoption did not have an impact on prior periods or on the Company's statements of operations and comprehensive loss.</span></div><ix:nonNumeric contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" name="silk:AssetsAndLiabilitiesLesseeTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90ZXh0cmVnaW9uOjZmZWQwNzhkNzVjYTQ1NWU4OTcyY2RkYjU1Nzc0NWRkXzIxOTkwMjMzMjQ3MjE_de41b5aa-c1f8-43e1-8f27-a06fffc5f87a" continuedAt="i02c3d9e32cea4300aeefb7b2a001aba8" escape="true"><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The disclosure impact of the adoption of ASC 842 on the balance sheet was as follows (in thousands):</span></div><div style="margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:51.685%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:13.224%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.441%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:12.903%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.441%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:12.906%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance Sheet:</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance at December 31, 2018</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Adjustments Due to ASC 842</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance at January 1, 2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other non-current assets</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic94e339422444d219c38d07bb9e37715_I20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:OtherAssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90YWJsZTpiYzg5NjFlNmZhNTk0OGQzODUzNjg1YWU2OGE2MDk5Yi90YWJsZXJhbmdlOmJjODk2MWU2ZmE1OTQ4ZDM4NTM2ODVhZTY4YTYwOTliXzEtMS0xLTEtNDEzOA_1e1ff5f6-18c4-45e8-8886-7872e7c35efc">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i2e1fe8d050bb4a7b9f6556eaab0f6abd_I20190101" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90YWJsZTpiYzg5NjFlNmZhNTk0OGQzODUzNjg1YWU2OGE2MDk5Yi90YWJsZXJhbmdlOmJjODk2MWU2ZmE1OTQ4ZDM4NTM2ODVhZTY4YTYwOTliXzEtMy0xLTEtNDEzOA_358c9bc2-1a8d-41e3-b855-056bcaf2d9c1">3,982</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i2fe97d6c47914971bb09d925222705a9_I20190101" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90YWJsZTpiYzg5NjFlNmZhNTk0OGQzODUzNjg1YWU2OGE2MDk5Yi90YWJsZXJhbmdlOmJjODk2MWU2ZmE1OTQ4ZDM4NTM2ODVhZTY4YTYwOTliXzEtNS0xLTEtNDEzOA_8d8b08fc-3383-4e4b-b052-622239521572">3,982</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accrued liabilities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic94e339422444d219c38d07bb9e37715_I20181231" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90YWJsZTpiYzg5NjFlNmZhNTk0OGQzODUzNjg1YWU2OGE2MDk5Yi90YWJsZXJhbmdlOmJjODk2MWU2ZmE1OTQ4ZDM4NTM2ODVhZTY4YTYwOTliXzItMS0xLTEtNDEzOA_ba53f061-0b50-4a55-85c7-11c946662857">139</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i2e1fe8d050bb4a7b9f6556eaab0f6abd_I20190101" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90YWJsZTpiYzg5NjFlNmZhNTk0OGQzODUzNjg1YWU2OGE2MDk5Yi90YWJsZXJhbmdlOmJjODk2MWU2ZmE1OTQ4ZDM4NTM2ODVhZTY4YTYwOTliXzItMy0xLTEtNDEzOA_7934dcfc-d208-414d-bc0b-a1ecde57ef44">582</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i2fe97d6c47914971bb09d925222705a9_I20190101" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90YWJsZTpiYzg5NjFlNmZhNTk0OGQzODUzNjg1YWU2OGE2MDk5Yi90YWJsZXJhbmdlOmJjODk2MWU2ZmE1OTQ4ZDM4NTM2ODVhZTY4YTYwOTliXzItNS0xLTEtNDEzOA_9ba5a9f1-4997-46ce-912b-3526cdb28be0">721</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other liabilities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic94e339422444d219c38d07bb9e37715_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90YWJsZTpiYzg5NjFlNmZhNTk0OGQzODUzNjg1YWU2OGE2MDk5Yi90YWJsZXJhbmdlOmJjODk2MWU2ZmE1OTQ4ZDM4NTM2ODVhZTY4YTYwOTliXzMtMS0xLTEtNDEzOA_071f2c14-a115-4f6a-bd8f-1a69c03218ed">1,069</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i2e1fe8d050bb4a7b9f6556eaab0f6abd_I20190101" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90YWJsZTpiYzg5NjFlNmZhNTk0OGQzODUzNjg1YWU2OGE2MDk5Yi90YWJsZXJhbmdlOmJjODk2MWU2ZmE1OTQ4ZDM4NTM2ODVhZTY4YTYwOTliXzMtMy0xLTEtNDEzOA_a86506d1-fb4e-4676-838d-cf50b9ff6dcc">3,400</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i2fe97d6c47914971bb09d925222705a9_I20190101" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90YWJsZTpiYzg5NjFlNmZhNTk0OGQzODUzNjg1YWU2OGE2MDk5Yi90YWJsZXJhbmdlOmJjODk2MWU2ZmE1OTQ4ZDM4NTM2ODVhZTY4YTYwOTliXzMtNS0xLTEtNDEzOA_85c5f910-6ea7-4583-9e8e-5731e9076fd0">4,469</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:12pt;"><span><br/></span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company considers if an arrangement is a lease at inception if it obtains the right to control the use of an identified asset under a leasing arrangement with an initial term greater than twelve months.  The Company determines whether a contract conveys the right to control the use of an identified asset for a period of time if the contract contains both the right to obtain substantially all of the economic benefits from the use of the identified asset and the right to direct the use of the identified asset.  The Company also evaluates the nature of each lease to determine whether it is an operating or financing lease and recognizes the right-of-use asset and lease liabilities based on the present value of future minimum lease </span></div></ix:nonNumeric></ix:continuation><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">122</span></div></div></div><hr style="page-break-after:always"/><div style="height:90pt;width:100%;"><div style="margin-bottom:9pt;"><span><br/></span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><ix:continuation id="ie65352ea6ff941b49e56906bba20a76c" continuedAt="i1014dc324dc84081b6ef5ade81ab23c2"><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"><ix:continuation id="ic58af2caa8c440a7b3f00c7185f11e64">payments over the expected lease term.  The Company&#8217;s leases do not generally contain an implicit interest rate and therefore the Company uses the incremental borrowing rate it would expect to pay to borrow on a similar collateralized basis over a similar term in order to determine the present value of its lease payments.  The Company&#8217;s considers renewal options in the determination of the lease term if the option to renew is reasonably certain.  Variable lease costs represent payments that are dependent on usage, a rate or index.  Variable lease costs, which consists primarily of taxes, insurance and common area maintenance costs, are expensed as incurred, as the Company has elected to account separately for contracts that contain lease and non-lease components, consistent with its historical practice.  The Company does not have any finance leases.</ix:continuation></span></div><ix:nonNumeric contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" name="silk:WarrantsClassifiedAsLiabilitiesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90ZXh0cmVnaW9uOjZmZWQwNzhkNzVjYTQ1NWU4OTcyY2RkYjU1Nzc0NWRkXzIxOTkwMjMzMjQ3MjA_d4ec6ad4-cd07-4f09-bc24-a1744f375fb9" escape="true"><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Redeemable Convertible Preferred Stock Warrant Liability</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Prior to its IPO, the Company accounted for its warrants for shares of redeemable convertible preferred stock as a liability based upon the characteristics and provisions of each instrument.  Redeemable convertible preferred stock warrants classified as a liability were initially recorded at their fair value on the date of issuance and are subject to remeasurement at each subsequent balance sheet date.  Any change in fair value as a result of a remeasurement was recognized as a component of other income (expense), net in the statements of operations and comprehensive loss.  </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company recorded adjustments to the estimated fair value of the redeemable convertible preferred stock warrants until they were exercised. Upon their exercise, the final fair value of the warrant liability was reclassified to stockholders&#8217; equity (deficit). Subsequent to its IPO, the Company no longer recorded any related periodic fair value adjustments.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" name="us-gaap:StockholdersEquityNoteRedeemablePreferredStockIssuePolicy" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90ZXh0cmVnaW9uOjZmZWQwNzhkNzVjYTQ1NWU4OTcyY2RkYjU1Nzc0NWRkXzMxMzMz_c4628660-06ec-444f-8aba-d236958da036" escape="true"><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Redeemable Convertible Preferred Stock</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Prior to its IPO, the Company recorded its redeemable convertible preferred stock at fair value on the dates of issuance, net of issuance costs, and classified the redeemable convertible preferred stock outside of stockholders&#8217; equity (deficit) on the balance sheet as events triggering the liquidation preferences were not solely within the Company&#8217;s control. Upon the closing of the Company's IPO, all shares of convertible preferred stock then outstanding converted into an aggregate of <ix:nonFraction unitRef="shares" contextRef="i098a8c90a714485c88e5e439c93fd1fe_D20190501-20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90ZXh0cmVnaW9uOjZmZWQwNzhkNzVjYTQ1NWU4OTcyY2RkYjU1Nzc0NWRkXzM4NDgyOTA3ODM4NDU_3a891ad1-d24d-4d9f-9df3-74b30aed33f3">23,178,555</ix:nonFraction> shares of common stock resulting in the reclassification of $<ix:nonFraction unitRef="usd" contextRef="i2658f65419d24aacb4ed4233d75211b7_D20190501-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueConversionOfUnits" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90ZXh0cmVnaW9uOjZmZWQwNzhkNzVjYTQ1NWU4OTcyY2RkYjU1Nzc0NWRkXzM4NDgyOTA3ODM4NzM_e7b3993d-bd27-4c0a-9971-1a3cc2e48063">144,140,000</ix:nonFraction> from outside of stockholders&#8217; equity (deficit) to additional paid-in capital.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90ZXh0cmVnaW9uOjZmZWQwNzhkNzVjYTQ1NWU4OTcyY2RkYjU1Nzc0NWRkXzMxMzM0_31a541c0-e500-490d-b6a3-39966fa5bcf7" continuedAt="if7237b47925341a5937008b51e6b543d" escape="true"><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Revenue Recognition</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">On&#160;January&#160;1, 2018, the Company adopted ASC Topic 606,&#160;&#8220;Revenue from Contracts with Customers,&#8221; using the modified retrospective method applied to contracts which were not completed as of that date.&#160;&#160;Under ASC 606, revenue is recognized when a customer obtains control of promised goods or services, in an amount that reflects the consideration which the entity expects to receive in exchange for those goods or services.  To determine revenue recognition for arrangements that an entity determines are within the scope of ASC 606, the Company performs the following five steps: </span></div><div style="text-indent:-26.88pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">(i)</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18pt;">identify the contract(s) with a customer; </span></div><div style="text-indent:-29.1pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">(ii)</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18pt;">identify the performance obligations in the contract; </span></div><div style="text-indent:-31.32pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">(iii)</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18pt;">determine the transaction price;</span></div><div style="text-indent:-31.88pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">(iv)</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18pt;">allocate the transaction price to the performance obligations in the contract; and </span></div><div style="text-indent:-29.66pt;padding-left:36pt;margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">(v)</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18pt;">recognize revenue when (or as) the entity satisfies a performance obligation.</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Under ASC 606, assuming all other revenue recognition criteria have been met, the Company will recognize revenue earlier for arrangements where the Company has satisfied its performance obligations </span></div></ix:nonNumeric></ix:continuation><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">123</span></div></div></div><hr style="page-break-after:always"/><div style="height:90pt;width:100%;"><div style="margin-bottom:9pt;"><span><br/></span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><ix:continuation id="i1014dc324dc84081b6ef5ade81ab23c2" continuedAt="ifcadb79d9ae74eb3a2fd714a86a028f8"><ix:continuation id="if7237b47925341a5937008b51e6b543d" continuedAt="i494f7e7aec3c40c48a22f1d1c2c2a048"><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">but have not issued invoices.&#160;&#160;As of December&#160;31, 2019 and 2018, the Company recorded $<ix:nonFraction unitRef="usd" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:UnbilledReceivablesCurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90ZXh0cmVnaW9uOjZmZWQwNzhkNzVjYTQ1NWU4OTcyY2RkYjU1Nzc0NWRkXzMyOTg1MzQ5NDY5MTU_b8aeac04-b8ee-4c8f-ae30-1285f78b1dde">102,000</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:UnbilledReceivablesCurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90ZXh0cmVnaW9uOjZmZWQwNzhkNzVjYTQ1NWU4OTcyY2RkYjU1Nzc0NWRkXzM4NDgyOTA3ODM4OTM_e95df534-3cee-4b03-a3b7-bbd3a16a59f1">128,000</ix:nonFraction>, respectively, of unbilled receivables, which are included in accounts receivable, net on the balance sheet, as the Company has an unconditional right to payment as of the end of the applicable period.&#160;&#160;</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company&#8217;s revenue is generated from the sale of its products to hospitals and medical centers in the United States through direct sales representatives.  Revenue is recognized when obligations under the terms of a contract with customers are satisfied, which occurs with the transfer of control of the Company&#8217;s products to its customers, either upon shipment of the product or delivery of the product to the customer under the Company&#8217;s standard terms and conditions.&#160;&#160;The Company&#8217;s products are readily available for usage as soon as the customer possesses it.  Upon receipt, the customer controls the economic benefits of the product, has significant risks and rewards, and the legal title.  The Company has present right to payment; therefore, the transfer of control is deemed to happen at a point in time.  Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring the goods.</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">For sales where the Company&#8217;s sales representative hand delivers product directly to the hospital or medical center from the sales representative&#8217;s trunk stock inventory, the Company recognizes revenue upon delivery, which represents the point in time when control transfers to the customer.  Upon delivery there are legally-enforceable rights and obligations between the parties which can be identified, commercial substance exists and collectibility is probable.  For sales which are sent directly from the Company to hospitals and medical centers, the transfer of control occurs at the time of shipment or delivery of the product.&#160; There are no further performance obligations by the Company or the sales representative to the customer after delivery under either method of sale.  As allowed under the practical expedient, the Company does not disclose the value of unsatisfied performance obligations for (i) contracts with an original expected length of one year or less and (ii) contracts for which it recognizes revenue at the amount to which it has the right to invoice for services performed.</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company&#160;is entitled to the total consideration for the products ordered by customers&#160;as&#160;product pricing&#160;is&#160;fixed according to the terms of customer contracts and payment terms&#160;are&#160;short.  Payment terms fall within the one-year guidance for the practical expedient which allows the Company to forgo adjustment of the promised amount of consideration for the effects of a significant financing component.  The Company&#160;excludes&#160;taxes assessed by governmental authorities on revenue-producing transactions from the measurement of the transaction price.</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Costs associated with product sales include commissions and royalties.  The Company applies the practical expedient and recognizes commissions and royalties as expense when incurred because the expense is incurred at a point in time and the amortization period is less than one year.&#160; Commissions are recorded as selling expense&#160;and royalties are recorded as&#160;cost of revenue&#160;in the&#160;statements of operations and comprehensive loss.</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company accepts product returns at its discretion or if the product is defective as manufactured.  The Company establishes estimated provisions for returns based on historical experience and considers other factors that it believes could significantly impact its expected returns, which provisions are classified within accrued liabilities on our balance sheet.&#160; The Company elected to expense shipping and handling costs as incurred and includes them in the cost of goods sold.  In those cases where the Company bills shipping and handling costs to customers, it will classify the amounts billed as a component of revenue.</span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Cost of Goods Sold</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company manufactures certain of its portfolio of TCAR products at its facility and purchases other products from third party manufacturers.  Cost of goods sold consists primarily of costs related to </span></div></ix:continuation></ix:continuation><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">124</span></div></div></div><hr style="page-break-after:always"/><div style="height:90pt;width:100%;"><div style="margin-bottom:9pt;"><span><br/></span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><ix:continuation id="ifcadb79d9ae74eb3a2fd714a86a028f8" continuedAt="i1bf405b801d0444a83ce51d319984e52"><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"><ix:continuation id="i494f7e7aec3c40c48a22f1d1c2c2a048">materials, components and subassemblies, manufacturing overhead costs, direct labor, reserves for excess, obsolete and non-sellable inventories as well as distribution-related expenses.  A significant portion of the Company&#8217;s cost of goods sold currently consists of manufacturing overhead costs.  These overhead costs include the cost of quality assurance, material procurement, inventory control, facilities, equipment and operations supervision and management.  Cost of goods sold also includes depreciation expense for production equipment and certain direct costs such as shipping costs and royalties.</ix:continuation></span></div><ix:nonNumeric contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" name="us-gaap:ResearchAndDevelopmentExpensePolicy" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90ZXh0cmVnaW9uOjZmZWQwNzhkNzVjYTQ1NWU4OTcyY2RkYjU1Nzc0NWRkXzMxMzQz_90db7b4d-5d90-4714-8419-0c8b54e4b6c0" escape="true"><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Research and Development</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company expenses research and development costs as incurred.  Research and development expenses consist primarily of engineering, product development, clinical studies to develop and support the Company&#8217;s products, regulatory expenses, medical affairs and other costs associated with products and technologies that are in development.  Research and development expenses include employee compensation, including stock-based compensation, supplies, consulting, prototyping, testing, materials, travel expenses, depreciation and an allocation of facility overhead expenses.  Additionally, research and development expenses include costs associated with our clinical studies including clinical trial design, clinical site reimbursement, data management, travel expenses and the cost of products used for clinical trials and internal and external costs associated with the Company&#8217;s regulatory compliance and quality assurance functions, including the costs of outside consultants and contractors that assist in the process of submitting and maintaining regulatory filings, and overhead costs. </span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Clinical Trials</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company accrues and expenses costs for its clinical trial activities performed by third parties, including clinical research organizations and other service providers, based upon estimates of the work completed over the life of the individual study in accordance with associated agreements.  The Company determines these accruals through discussion with internal personnel and outside service providers as to progress or stage of completion of trials or services pursuant to contracts with clinical research organizations and other service providers and the agreed-upon fee to be paid for such services.</span></div></ix:nonNumeric><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"><ix:nonNumeric contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" name="us-gaap:AdvertisingCostsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90ZXh0cmVnaW9uOjZmZWQwNzhkNzVjYTQ1NWU4OTcyY2RkYjU1Nzc0NWRkXzMxMzQ0_ebcff87b-6b76-4bc0-b73f-c6a79250c771" continuedAt="i2fe82d62bf85489ea721d658ce37a08d" escape="true">Advertising Costs</ix:nonNumeric></span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"><ix:continuation id="i2fe82d62bf85489ea721d658ce37a08d">The Company expenses advertising costs as incurred.  Advertising costs include design and production costs, including website development, physician and patient testimonial videos, written media campaigns, and other items.</ix:continuation>  Advertising costs of $<ix:nonFraction unitRef="usd" contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdvertisingExpense" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90ZXh0cmVnaW9uOjZmZWQwNzhkNzVjYTQ1NWU4OTcyY2RkYjU1Nzc0NWRkXzMyOTg1MzQ5MTY2ODE_33c40a03-eb0b-4a10-9a94-21c3534a9e1f">362,000</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdvertisingExpense" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90ZXh0cmVnaW9uOjZmZWQwNzhkNzVjYTQ1NWU4OTcyY2RkYjU1Nzc0NWRkXzMyOTg1MzQ5MTY2OTE_8a3afcd2-57a1-4f01-85d0-a792eb375fe5">186,000</ix:nonFraction> were expensed during the years ended December&#160;31, 2019 and 2018, respectively.</span></div><ix:nonNumeric contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90ZXh0cmVnaW9uOjZmZWQwNzhkNzVjYTQ1NWU4OTcyY2RkYjU1Nzc0NWRkXzMxMzUy_1090a717-b98a-4e22-8a13-d54fd5ecd1da" escape="true"><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Foreign Currency</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company records net gains and losses resulting from foreign exchange transactions as a component of foreign currency exchange gains or losses in other income (expense), net.  The Company had no material foreign currency exchange gains or losses during the years ended December&#160;31, 2019 and 2018.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90ZXh0cmVnaW9uOjZmZWQwNzhkNzVjYTQ1NWU4OTcyY2RkYjU1Nzc0NWRkXzMxMzM3_98d6d2e7-ad4c-4bda-b3f1-b30f90b33dfa" continuedAt="ia80067af24e249d7af7a6a8766f5154b" escape="true"><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Stock&#8211;Based Compensation</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company accounts for stock-based compensation in accordance with Financial Accounting Standards Board (&#8220;FASB&#8221;) ASC 718,&#160;&#8220;Compensation-Stock Compensation.&#8221;  ASC 718 requires the recognition of compensation expense, using a fair-value based method, for costs related to all share-based payments including stock options.  ASC 718 requires companies to estimate the fair value of all share-based payment option awards on the date of grant using an option pricing model.  The fair value of stock options is recognized over the period during which an optionee is required to provide services in exchange for the option award, known as the requisite service period (usually the vesting period), on a </span></div></ix:nonNumeric></ix:continuation><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">125</span></div></div></div><hr style="page-break-after:always"/><div style="height:90pt;width:100%;"><div style="margin-bottom:9pt;"><span><br/></span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><ix:continuation id="i1bf405b801d0444a83ce51d319984e52" continuedAt="iefcc25b4f2884868b5e507e916bcf986"><ix:continuation id="ia80067af24e249d7af7a6a8766f5154b"><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">straight-line basis.  For performance-based stock options, the Company will assess the probability of performance conditions being achieved in each reporting period.  The amount of stock-based compensation expense recognized in any one period related to performance-based stock options can vary based on the achievement or anticipated achievement of the performance conditions.</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In March 2016, the FASB issued Accounting Standards Update ("ASU") No. 2016-09,&#160;&#8220;Stock Compensation (Topic 718): Improvements to Employee Shared-Based Payment Accounting.&#8221;&#160; Under ASU 2016-09, entities are permitted to make an accounting policy election to either estimate forfeitures on share-based payment awards, as previously required, or to recognize forfeitures as they occur.  The Company made an accounting policy election to account for forfeitures as they occur.  This change has been applied on a modified retrospective basis, resulting in a cumulative-effect adjustment to increase the beginning accumulated deficit by $<ix:nonFraction unitRef="usd" contextRef="i3d970a6f053141c8adef36f595567ea2_I20180101" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90ZXh0cmVnaW9uOjZmZWQwNzhkNzVjYTQ1NWU4OTcyY2RkYjU1Nzc0NWRkXzMyOTg1MzQ5MTY3MDk_368b2f71-ebff-4e2f-99a1-fb51bc0d59bf">13,000</ix:nonFraction>&#160;as of January&#160;1, 2018, the date of adoption.</span></div></ix:continuation><ix:nonNumeric contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" name="us-gaap:IncomeTaxPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90ZXh0cmVnaW9uOjZmZWQwNzhkNzVjYTQ1NWU4OTcyY2RkYjU1Nzc0NWRkXzIxOTkwMjMzNDI2MDk_14d708f2-1528-45d9-9b09-713f355ddb40" escape="true"><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Income Taxes</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company accounts for income taxes under the liability method, whereby deferred tax assets and liabilities are determined based on the difference between the financial statements and tax bases of assets and liabilities using the enacted tax rates in effect for the year in which the differences are expected to affect taxable income.  A valuation allowance is established when necessary to reduce deferred tax assets to the amounts expected to be realized.</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company also follows the provisions of ASC 740-10, &#8220;Accounting for Uncertainty in Income Taxes.&#8221;  ASC 740-10 prescribes a comprehensive model for the recognition, measurement, presentation and disclosure in financial statements of any uncertain tax positions that have been taken or expected to be taken on a tax return.  No liability related to uncertain tax positions is recorded on the financial statements.  It is the Company&#8217;s policy to include penalties and interest expense related to income taxes as part of the provision for income taxes.</span></div></ix:nonNumeric><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"><ix:nonNumeric contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" name="us-gaap:ComprehensiveIncomePolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90ZXh0cmVnaW9uOjZmZWQwNzhkNzVjYTQ1NWU4OTcyY2RkYjU1Nzc0NWRkXzIxOTkwMjMzNDI2MDg_79537c5e-5b9f-483d-bda6-2da8764dcb36" continuedAt="i24b5129130dc42cfa64239b3261b646a" escape="true">Comprehensive Loss</ix:nonNumeric></span></div><div style="margin-bottom:9pt;"><ix:continuation id="i24b5129130dc42cfa64239b3261b646a" continuedAt="i9b316d7551ad49b9b84cb13b85882bd5"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Comprehensive loss consists of net loss and changes in unrealized gains and losses on investments classified as available-for-sale.  For the year ended </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">December&#160;31, 2019</span></ix:continuation><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"><ix:continuation id="i9b316d7551ad49b9b84cb13b85882bd5">, the Company&#8217;s unrealized gains and losses on available-for-sale investments represent the only component of other comprehensive loss that are excluded from the reported net loss and that are presented in the statements of operations and comprehensive income.  Accumulated other comprehensive loss is presented in the accompanying balance sheets as a component of stockholders' equity (deficit).  For the year ended December&#160;31, 2018, there was no difference between the Company's comprehensive loss and its net loss.</ix:continuation>  </span></div><ix:nonNumeric contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" name="us-gaap:EarningsPerSharePolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90ZXh0cmVnaW9uOjZmZWQwNzhkNzVjYTQ1NWU4OTcyY2RkYjU1Nzc0NWRkXzMxMzI4_8cca239f-8960-49c6-b65c-84f3704faf7c" continuedAt="i50d29ef4ec654f7982d2bcafabb61785" escape="true"><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Net Loss per Share Attributable to Common Stockholders</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Basic net loss per share is computed by dividing the net loss attributable to common stockholders by the weighted average number of shares of common stock outstanding during the period, without consideration for potential dilutive common shares.  Diluted net loss per share is computed by dividing the net loss attributable to common stockholders by the weighted average number of shares of common stock and potentially dilutive securities outstanding for the period.  For purposes of the diluted net loss per share calculation, redeemable convertible preferred stock and warrants, and common stock options are considered to be potentially dilutive securities.  Since the Company was in a loss position for all periods presented, basic net loss per share is the same as diluted net loss per share as the inclusion of all potential dilutive common shares would have been anti-dilutive.</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company allocates no loss to participating securities because they have no contractual obligation to share in the losses of the Company.  The shares of the Company&#8217;s redeemable convertible preferred </span></div></ix:nonNumeric></ix:continuation><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">126</span></div></div></div><hr style="page-break-after:always"/><div style="height:90pt;width:100%;"><div style="margin-bottom:9pt;"><span><br/></span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><ix:continuation id="iefcc25b4f2884868b5e507e916bcf986"><ix:continuation id="i50d29ef4ec654f7982d2bcafabb61785"><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">stock participate in any dividends declared by the Company and are therefore considered to be participating securities.</span></div><ix:nonNumeric contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90ZXh0cmVnaW9uOjZmZWQwNzhkNzVjYTQ1NWU4OTcyY2RkYjU1Nzc0NWRkXzMxMzQ1_13ec7bd0-e436-483b-8cf0-70b19ecd12ab" escape="true"><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Net loss per share was determined as follows (in thousands, except share and per share data):</span></div><div style="margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:69.314%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:11.942%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:11.943%;"></td><td style="width:1.0%;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Year Ended December 31,</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net loss attributable to Silk Road Medical, Inc. common stockholders</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90YWJsZTo5MWI2OGNiMDkwYzc0NmRiYWViOTA2YjE1MTkwNTIxNS90YWJsZXJhbmdlOjkxYjY4Y2IwOTBjNzQ2ZGJhZWI5MDZiMTUxOTA1MjE1XzItMS0xLTEtMA_434aa863-32ec-449f-bb68-56cd234788e0">52,415</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90YWJsZTo5MWI2OGNiMDkwYzc0NmRiYWViOTA2YjE1MTkwNTIxNS90YWJsZXJhbmdlOjkxYjY4Y2IwOTBjNzQ2ZGJhZWI5MDZiMTUxOTA1MjE1XzItMy0xLTEtMA_f5e63e5e-510a-463f-a58c-be36fdf268f3">37,629</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted average common stock outstanding used to compute net loss per share, basic and diluted</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90YWJsZTo5MWI2OGNiMDkwYzc0NmRiYWViOTA2YjE1MTkwNTIxNS90YWJsZXJhbmdlOjkxYjY4Y2IwOTBjNzQ2ZGJhZWI5MDZiMTUxOTA1MjE1XzMtMS0xLTEtMA_d9b49e64-d0c0-45fa-aad1-3a82d7c4c1fd">22,956,679</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90YWJsZTo5MWI2OGNiMDkwYzc0NmRiYWViOTA2YjE1MTkwNTIxNS90YWJsZXJhbmdlOjkxYjY4Y2IwOTBjNzQ2ZGJhZWI5MDZiMTUxOTA1MjE1XzMtMy0xLTEtMA_72c083d0-bde7-4ea2-97a8-af32914d3023">960,882</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net loss per share attributable to Silk Road Medical, Inc. common stockholders, basic and diluted</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usdPerShare" contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasicAndDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90YWJsZTo5MWI2OGNiMDkwYzc0NmRiYWViOTA2YjE1MTkwNTIxNS90YWJsZXJhbmdlOjkxYjY4Y2IwOTBjNzQ2ZGJhZWI5MDZiMTUxOTA1MjE1XzQtMS0xLTEtMA_34d74d63-d359-44ef-b841-630cfb3e4f8e">2.28</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usdPerShare" contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasicAndDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90YWJsZTo5MWI2OGNiMDkwYzc0NmRiYWViOTA2YjE1MTkwNTIxNS90YWJsZXJhbmdlOjkxYjY4Y2IwOTBjNzQ2ZGJhZWI5MDZiMTUxOTA1MjE1XzQtMy0xLTEtMA_cff85dae-cfb5-46e1-9af8-9fdd8f6997df">39.16</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90ZXh0cmVnaW9uOjZmZWQwNzhkNzVjYTQ1NWU4OTcyY2RkYjU1Nzc0NWRkXzMxMzM4_2490877a-59ca-41c0-89e0-5bb33bbfad2d" escape="true"><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following potentially dilutive securities outstanding have been excluded from the computation of diluted weighted average shares outstanding because such securities have an antidilutive impact due to the Company&#8217;s net loss:</span></div><div style="text-align:center;margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:69.314%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:11.942%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:11.943%;"></td><td style="width:1.0%;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 31,</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Redeemable convertible preferred stock outstanding</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i2a4cd45d3ea346e09975b91b19f7932f_D20190101-20191231" decimals="0" format="ixt:zerodash" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90YWJsZToxZTI4MzRiOTZmNTY0MjUyOTRjNjY5YTMzNzJhNTgyNi90YWJsZXJhbmdlOjFlMjgzNGI5NmY1NjQyNTI5NGM2NjlhMzM3MmE1ODI2XzItMS0xLTEtMA_b0418f60-87d5-40b8-9ef2-2cba2fdca4d8">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i9b9b073cbf81459fbce0e491293244fd_D20180101-20181231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90YWJsZToxZTI4MzRiOTZmNTY0MjUyOTRjNjY5YTMzNzJhNTgyNi90YWJsZXJhbmdlOjFlMjgzNGI5NmY1NjQyNTI5NGM2NjlhMzM3MmE1ODI2XzItMy0xLTEtMA_848a81be-3a21-4e5c-a2b1-e1952023252c">21,233,190</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Redeemable convertible preferred stock warrants outstanding</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="ibd915c83c8b6404bb5a637937ffca6c6_D20190101-20191231" decimals="0" format="ixt:zerodash" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90YWJsZToxZTI4MzRiOTZmNTY0MjUyOTRjNjY5YTMzNzJhNTgyNi90YWJsZXJhbmdlOjFlMjgzNGI5NmY1NjQyNTI5NGM2NjlhMzM3MmE1ODI2XzMtMS0xLTEtMA_28956940-2644-4e71-952b-5c92383b179e">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="ia72cde864bbc4dc18c35b893b41f4dec_D20180101-20181231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90YWJsZToxZTI4MzRiOTZmNTY0MjUyOTRjNjY5YTMzNzJhNTgyNi90YWJsZXJhbmdlOjFlMjgzNGI5NmY1NjQyNTI5NGM2NjlhMzM3MmE1ODI2XzMtMy0xLTEtMA_185e7cf2-0d04-4aba-935f-b95024753282">2,672,502</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Common stock options</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i869e207d48f649aba79d5a398971f471_D20190101-20191231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90YWJsZToxZTI4MzRiOTZmNTY0MjUyOTRjNjY5YTMzNzJhNTgyNi90YWJsZXJhbmdlOjFlMjgzNGI5NmY1NjQyNTI5NGM2NjlhMzM3MmE1ODI2XzQtMS0xLTEtMA_913f678e-4b47-45a6-bcae-9af77b83f60c">4,310,790</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="ie37285cde19b46798cf9ecb3d7e8e7ce_D20180101-20181231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90YWJsZToxZTI4MzRiOTZmNTY0MjUyOTRjNjY5YTMzNzJhNTgyNi90YWJsZXJhbmdlOjFlMjgzNGI5NmY1NjQyNTI5NGM2NjlhMzM3MmE1ODI2XzQtMy0xLTEtMA_f23c97cf-03b1-47ea-be08-92b2a6d2f021">4,364,377</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Common stock warrants outstanding</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i41b8867a9c614370bb9151a0da07f34d_D20190101-20191231" decimals="0" format="ixt:zerodash" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90YWJsZToxZTI4MzRiOTZmNTY0MjUyOTRjNjY5YTMzNzJhNTgyNi90YWJsZXJhbmdlOjFlMjgzNGI5NmY1NjQyNTI5NGM2NjlhMzM3MmE1ODI2XzUtMS0xLTEtMA_60ea80bc-5ad4-44ee-9b93-f538a06af69a">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i8ca29bbf162449f8b42d0edd6cafd993_D20180101-20181231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90YWJsZToxZTI4MzRiOTZmNTY0MjUyOTRjNjY5YTMzNzJhNTgyNi90YWJsZXJhbmdlOjFlMjgzNGI5NmY1NjQyNTI5NGM2NjlhMzM3MmE1ODI2XzUtMy0xLTEtMA_03504753-4cd5-4c18-9402-a23db81c2246">7,527</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90YWJsZToxZTI4MzRiOTZmNTY0MjUyOTRjNjY5YTMzNzJhNTgyNi90YWJsZXJhbmdlOjFlMjgzNGI5NmY1NjQyNTI5NGM2NjlhMzM3MmE1ODI2XzYtMS0xLTEtMA_637f011e-e288-4a74-b3d0-3add14ae0c06">4,310,790</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90YWJsZToxZTI4MzRiOTZmNTY0MjUyOTRjNjY5YTMzNzJhNTgyNi90YWJsZXJhbmdlOjFlMjgzNGI5NmY1NjQyNTI5NGM2NjlhMzM3MmE1ODI2XzYtMy0xLTEtMA_9137e328-d155-40cd-ae8f-6655b726090e">28,277,596</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span></div><ix:nonNumeric contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" name="us-gaap:SegmentReportingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90ZXh0cmVnaW9uOjZmZWQwNzhkNzVjYTQ1NWU4OTcyY2RkYjU1Nzc0NWRkXzMxMzUz_edc58ccc-4883-422c-9acb-9964248bcd95" escape="true"><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Segment and Geographical Information</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company operates and manages its business as <ix:nonFraction unitRef="segment" contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfOperatingSegments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90ZXh0cmVnaW9uOjZmZWQwNzhkNzVjYTQ1NWU4OTcyY2RkYjU1Nzc0NWRkXzMyOTg1MzQ5NDkyMTk_958e6082-3b0b-45b1-97ac-c7b1f40460b1"><ix:nonFraction unitRef="segment" contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfReportableSegments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90ZXh0cmVnaW9uOjZmZWQwNzhkNzVjYTQ1NWU4OTcyY2RkYjU1Nzc0NWRkXzMyOTg1MzQ5NDkyMTk_e8f82ab3-632a-4371-ab8d-23a8585f1be5">one</ix:nonFraction></ix:nonFraction> reportable and operating segment.  The Company&#8217;s chief executive officer, who is the chief operating decision maker, reviews financial information on an aggregate basis for purposes of allocating resources and evaluating financial performance.  All of the Company&#8217;s long-lived assets are based in the United States.  Long-lived assets are comprised of property and equipment.  All of the Company&#8217;s revenue was in the United States for the years ended December&#160;31, 2019 and 2018, based on the shipping location of the external customer.</span></div></ix:nonNumeric></ix:continuation><div style="text-indent:18pt;margin-bottom:9pt;"><span><br/></span></div><div id="i58f397e86dfd4fc4ac3b8695cd31238e_121"></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">3.&#160;<ix:nonNumeric contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" name="us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMjEvZnJhZzo3NjU0MWU0YjQ0ZTI0YWEwOTE4MDg5MzdlZWIzMmY4Yy90ZXh0cmVnaW9uOjc2NTQxZTRiNDRlMjRhYTA5MTgwODkzN2VlYjMyZjhjXzcxODM_50a08e93-38bd-4076-aaa3-53accb31e086" continuedAt="i50c8c14b85244aae9306e4d3e7ca8976" escape="true"><ix:nonNumeric contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMjEvZnJhZzo3NjU0MWU0YjQ0ZTI0YWEwOTE4MDg5MzdlZWIzMmY4Yy90ZXh0cmVnaW9uOjc2NTQxZTRiNDRlMjRhYTA5MTgwODkzN2VlYjMyZjhjXzcxODQ_b53aed5b-f135-444e-930d-3653db1e1916" continuedAt="i52fe9cd2f5534a95a2f0e833ec77a606" escape="true">Recent Accounting Pronouncements</ix:nonNumeric></ix:nonNumeric></span></div><ix:continuation id="i50c8c14b85244aae9306e4d3e7ca8976" continuedAt="i90119a11bce54deb949c2f2d1886cb83"><ix:continuation id="i52fe9cd2f5534a95a2f0e833ec77a606" continuedAt="id15e0cbab6a94db7b47ca1d3b0bcc14b"><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Recently Adopted Accounting Standards</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In February 2016, the FASB issued ASU No. 2016-02, "Leases," that supersedes ASC 840, "Leases." Subsequently, the FASB issued several updates to ASU No. 2016-02, codified in ASC Topic 842 (&#8220;ASC 842&#8221;). The Company adopted ASC 842 on January 1, 2019 using the modified retrospective method for all leases not substantially completed as of the date of adoption.  The Company elected to apply the package of practical expedients, which allowed the Company to not reassess: (i) whether expired or existing contracts contain leases; (ii) lease classification for any expired or existing leases; and (iii) initial direct costs for any existing lease.</span></div></ix:continuation></ix:continuation><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">127</span></div></div></div><hr style="page-break-after:always"/><div style="height:90pt;width:100%;"><div style="margin-bottom:9pt;"><span><br/></span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><ix:continuation id="i90119a11bce54deb949c2f2d1886cb83"><ix:continuation id="id15e0cbab6a94db7b47ca1d3b0bcc14b"><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Recently Issued Accounting Standards</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In June 2016, the FASB issued ASU 2016-13, Measurement of Credit Losses on Financial Statements.  This update provides financial statement users with more decision-useful information about the expected credit losses on financial instruments and other commitments to extend credit held by a reporting entity at each reporting date.  The update replaces the incurred loss impairment methodology in current GAAP with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates.  ASU 2016-13 became effective for the Company on January 1, 2020.  The Company does not believe that the adoption of this new guidance will have a material impact on its financial statements.</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In August 2018, the FASB issued ASU 2018-13, Fair Value Measurement, which changed the disclosure requirements for fair value measurements by removing, adding and modifying certain disclosures.  ASU 2018-13 became effective for the Company on January 1, 2020.  </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company does not believe that the adoption of this new guidance will have a material impact on its financial statements and related disclosures.</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In August 2018, the FASB issued ASU 2018-15, Cloud Computing Arrangements, which aligns the requirements for capitalizing implementation costs in a Cloud Computing Arrangement service contract with the requirements for capitalizing implementation costs incurred for an internal-use software license.  ASU 2018-15 became effective for the Company on January 1, 2020.</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">  The Company does not believe that the adoption of this new guidance will have a material impact on its financial statements and related disclosures.</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes, which enhances and simplifies various aspects of the income tax accounting guidance related to intraperiod tax allocation, interim period accounting for enacted changes in tax law, and the year-to-date loss limitation in interim period tax accounting.  ASU 2019-12 also amends other aspects of the guidance to reduce complexity in certain areas.  ASU 2019-12 will become effective for the Company on January 1, 2021.  Early adoption is permitted.  The Company is evaluating the impact of adopting this guidance to its financial statements and related disclosures.</span></div></ix:continuation></ix:continuation><div style="text-indent:18pt;margin-bottom:9pt;"><span><br/></span></div><div id="i58f397e86dfd4fc4ac3b8695cd31238e_127"></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">4.&#160;<ix:nonNumeric contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMjcvZnJhZzphNzhkMmY3MGI4ZDY0ODdkYmIwZDE0NmE1MTE5OTBlMC90ZXh0cmVnaW9uOmE3OGQyZjcwYjhkNjQ4N2RiYjBkMTQ2YTUxMTk5MGUwXzM3OTM_93636668-8b40-491f-891e-0a4149a32c88" continuedAt="i413bb67e37e04afebc6afd4981bb2156" escape="true">Fair Value Measurements</ix:nonNumeric></span></div><ix:continuation id="i413bb67e37e04afebc6afd4981bb2156" continuedAt="i78c229eb02364528a47a7294c01ffc51"><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company measures certain financial assets and liabilities at fair value on a recurring basis, including cash equivalents, investments, and the Company's previously outstanding preferred stock warrants.  Fair value is an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants.  As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or a liability.  A three-tier fair value hierarchy is established as a basis for considering such assumptions and for inputs used in the valuation methodologies in measuring fair value:</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Level 1 &#8211; quoted prices in active markets are identical assets and liabilities;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Level 2 &#8211; observable inputs other than quotes prizes in active markets for identical assets and liabilities;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Level 3 &#8211; unobservable inputs.</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Assets and liabilities measured at fair value are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. The Company&#8217;s assessment of the significance of a particular input to the fair value measurement in its entirety requires management to make judgments and consider factors specific to the asset or liability.  The Company&#8217;s cash equivalents are classified within </span></div></ix:continuation><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">128</span></div></div></div><hr style="page-break-after:always"/><div style="height:90pt;width:100%;"><div style="margin-bottom:9pt;"><span><br/></span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><ix:continuation id="i78c229eb02364528a47a7294c01ffc51" continuedAt="i130960aee5f24b10846d165f9080062d"><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Level 1 of the fair value hierarchy because they are valued using quoted market prices, broker or dealer quotations, or alternative pricing sources with reasonable levels of price transparency.  The corporate bonds/notes, commercial paper, asset-backed securities and U.S. government securities are classified as Level 2 as they are valued based upon quoted market prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active and model-based valuation techniques for which all significant inputs are observable in the market or can be corroborated by observable market data for substantially the full term of the assets. </span></div><ix:nonNumeric contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMjcvZnJhZzphNzhkMmY3MGI4ZDY0ODdkYmIwZDE0NmE1MTE5OTBlMC90ZXh0cmVnaW9uOmE3OGQyZjcwYjhkNjQ4N2RiYjBkMTQ2YTUxMTk5MGUwXzE5NzkxMjA5MzEyNDA0_c0be6920-fc06-47ce-90db-d5012e0c7738" escape="true"><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following tables sets forth by level within the fair value hierarchy the Company&#8217;s assets and liabilities that are reported at fair value as of December&#160;31, 2019 and 2018, using the inputs defined above (in thousands):</span></div><div style="margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:37.743%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:12.583%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.441%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:12.583%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.441%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:12.583%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.441%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:12.585%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-style:italic;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:9pt;font-weight:400;font-style:italic;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="21" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 31, 2019</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Level 1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Level 2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Level 3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Assets:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Money market funds</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i11a85190a9064adf9756e907b72ab81e_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMjcvZnJhZzphNzhkMmY3MGI4ZDY0ODdkYmIwZDE0NmE1MTE5OTBlMC90YWJsZToxMDJkMGM4YTk0N2E0NTk4YTI0NjZkZDBkYjRhZGY4Mi90YWJsZXJhbmdlOjEwMmQwYzhhOTQ3YTQ1OThhMjQ2NmRkMGRiNGFkZjgyXzMtMS0xLTEtNDY5NA_de90c0ff-0f23-4c3c-8e17-deeed27bdbe6">34,363</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iea42b3ddd43e48b7ad739160a6355912_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMjcvZnJhZzphNzhkMmY3MGI4ZDY0ODdkYmIwZDE0NmE1MTE5OTBlMC90YWJsZToxMDJkMGM4YTk0N2E0NTk4YTI0NjZkZDBkYjRhZGY4Mi90YWJsZXJhbmdlOjEwMmQwYzhhOTQ3YTQ1OThhMjQ2NmRkMGRiNGFkZjgyXzMtMy0xLTEtNDY5NA_21ed35d9-8cca-490c-98c4-2df68c428ea8">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i8eda7181425346cbb7f781c8cd52aefd_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMjcvZnJhZzphNzhkMmY3MGI4ZDY0ODdkYmIwZDE0NmE1MTE5OTBlMC90YWJsZToxMDJkMGM4YTk0N2E0NTk4YTI0NjZkZDBkYjRhZGY4Mi90YWJsZXJhbmdlOjEwMmQwYzhhOTQ3YTQ1OThhMjQ2NmRkMGRiNGFkZjgyXzMtNS0xLTEtNDY5NA_67d287ba-c262-4f04-bda6-613c3748f602">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3154f26e217748508ca43b15910d4ab7_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMjcvZnJhZzphNzhkMmY3MGI4ZDY0ODdkYmIwZDE0NmE1MTE5OTBlMC90YWJsZToxMDJkMGM4YTk0N2E0NTk4YTI0NjZkZDBkYjRhZGY4Mi90YWJsZXJhbmdlOjEwMmQwYzhhOTQ3YTQ1OThhMjQ2NmRkMGRiNGFkZjgyXzMtNy0xLTEtNDY5NA_8a7f04dd-ec9e-4dfc-ba7d-cb6623349787">34,363</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Commercial paper</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i82c527872b3d4fd290ad3917440837f9_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMjcvZnJhZzphNzhkMmY3MGI4ZDY0ODdkYmIwZDE0NmE1MTE5OTBlMC90YWJsZToxMDJkMGM4YTk0N2E0NTk4YTI0NjZkZDBkYjRhZGY4Mi90YWJsZXJhbmdlOjEwMmQwYzhhOTQ3YTQ1OThhMjQ2NmRkMGRiNGFkZjgyXzQtMS0xLTEtNDY5NA_427ee6dc-05e9-4338-9052-f5d7bd605d04">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i515b5eafffb247339a3b64d3ae67d43b_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMjcvZnJhZzphNzhkMmY3MGI4ZDY0ODdkYmIwZDE0NmE1MTE5OTBlMC90YWJsZToxMDJkMGM4YTk0N2E0NTk4YTI0NjZkZDBkYjRhZGY4Mi90YWJsZXJhbmdlOjEwMmQwYzhhOTQ3YTQ1OThhMjQ2NmRkMGRiNGFkZjgyXzQtMy0xLTEtNDY5NA_7a5bc4aa-3a93-47b6-930f-9fdb7c6ef1b2">9,919</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7a1d59cac7d948139b04deae23e13fb8_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMjcvZnJhZzphNzhkMmY3MGI4ZDY0ODdkYmIwZDE0NmE1MTE5OTBlMC90YWJsZToxMDJkMGM4YTk0N2E0NTk4YTI0NjZkZDBkYjRhZGY4Mi90YWJsZXJhbmdlOjEwMmQwYzhhOTQ3YTQ1OThhMjQ2NmRkMGRiNGFkZjgyXzQtNS0xLTEtNDY5NA_c840d5b2-e3c8-4c5e-ba47-038ac2119b56">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib459ddf8987d4fc0a4427c93f88a000a_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMjcvZnJhZzphNzhkMmY3MGI4ZDY0ODdkYmIwZDE0NmE1MTE5OTBlMC90YWJsZToxMDJkMGM4YTk0N2E0NTk4YTI0NjZkZDBkYjRhZGY4Mi90YWJsZXJhbmdlOjEwMmQwYzhhOTQ3YTQ1OThhMjQ2NmRkMGRiNGFkZjgyXzQtNy0xLTEtNDY5NA_412831fe-e66d-40ed-b396-a34ad5b887d7">9,919</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Corporate bonds/notes</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i692d279131c24a49ba70cd82d78e0497_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMjcvZnJhZzphNzhkMmY3MGI4ZDY0ODdkYmIwZDE0NmE1MTE5OTBlMC90YWJsZToxMDJkMGM4YTk0N2E0NTk4YTI0NjZkZDBkYjRhZGY4Mi90YWJsZXJhbmdlOjEwMmQwYzhhOTQ3YTQ1OThhMjQ2NmRkMGRiNGFkZjgyXzUtMS0xLTEtNDY5NA_240f625e-2450-4c1f-a8bd-957e3ac2b007">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib7b24582c8bf49e99df758604eab3abb_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMjcvZnJhZzphNzhkMmY3MGI4ZDY0ODdkYmIwZDE0NmE1MTE5OTBlMC90YWJsZToxMDJkMGM4YTk0N2E0NTk4YTI0NjZkZDBkYjRhZGY4Mi90YWJsZXJhbmdlOjEwMmQwYzhhOTQ3YTQ1OThhMjQ2NmRkMGRiNGFkZjgyXzUtMy0xLTEtNDY5NA_ffeab215-7e18-4756-a1a7-c46ab192c381">10,176</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i506cf4e4add641df967ba7f06a1bfa17_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMjcvZnJhZzphNzhkMmY3MGI4ZDY0ODdkYmIwZDE0NmE1MTE5OTBlMC90YWJsZToxMDJkMGM4YTk0N2E0NTk4YTI0NjZkZDBkYjRhZGY4Mi90YWJsZXJhbmdlOjEwMmQwYzhhOTQ3YTQ1OThhMjQ2NmRkMGRiNGFkZjgyXzUtNS0xLTEtNDY5NA_e48d6c2b-6f3e-4259-8f73-8a3d5fe594b2">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i34e6e9e2e2974a8f804997693d613758_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMjcvZnJhZzphNzhkMmY3MGI4ZDY0ODdkYmIwZDE0NmE1MTE5OTBlMC90YWJsZToxMDJkMGM4YTk0N2E0NTk4YTI0NjZkZDBkYjRhZGY4Mi90YWJsZXJhbmdlOjEwMmQwYzhhOTQ3YTQ1OThhMjQ2NmRkMGRiNGFkZjgyXzUtNy0xLTEtNDY5NA_7788db42-63ae-43a5-8cfa-e071e096c293">10,176</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">U.S. government securities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iadf6d107d54849849c8bd9ee571aaf22_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMjcvZnJhZzphNzhkMmY3MGI4ZDY0ODdkYmIwZDE0NmE1MTE5OTBlMC90YWJsZToxMDJkMGM4YTk0N2E0NTk4YTI0NjZkZDBkYjRhZGY4Mi90YWJsZXJhbmdlOjEwMmQwYzhhOTQ3YTQ1OThhMjQ2NmRkMGRiNGFkZjgyXzYtMS0xLTEtNDY5NA_f539b151-a69f-4efa-9b1d-7c1137ffe05f">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iff1b3fd1a5a741808c1bfd931652d7a4_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMjcvZnJhZzphNzhkMmY3MGI4ZDY0ODdkYmIwZDE0NmE1MTE5OTBlMC90YWJsZToxMDJkMGM4YTk0N2E0NTk4YTI0NjZkZDBkYjRhZGY4Mi90YWJsZXJhbmdlOjEwMmQwYzhhOTQ3YTQ1OThhMjQ2NmRkMGRiNGFkZjgyXzYtMy0xLTEtNDY5NA_de8b8875-3cf2-482d-83dc-5b519344ca5e">44,456</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia337a287632c4d2aa7cecbd25f4f1784_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMjcvZnJhZzphNzhkMmY3MGI4ZDY0ODdkYmIwZDE0NmE1MTE5OTBlMC90YWJsZToxMDJkMGM4YTk0N2E0NTk4YTI0NjZkZDBkYjRhZGY4Mi90YWJsZXJhbmdlOjEwMmQwYzhhOTQ3YTQ1OThhMjQ2NmRkMGRiNGFkZjgyXzYtNS0xLTEtNDY5NA_b52c4bff-9d2e-4a39-937a-bdf3b61bd49b">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie66ece3747d34884887e66fe24d152f1_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMjcvZnJhZzphNzhkMmY3MGI4ZDY0ODdkYmIwZDE0NmE1MTE5OTBlMC90YWJsZToxMDJkMGM4YTk0N2E0NTk4YTI0NjZkZDBkYjRhZGY4Mi90YWJsZXJhbmdlOjEwMmQwYzhhOTQ3YTQ1OThhMjQ2NmRkMGRiNGFkZjgyXzYtNy0xLTEtNDY5NA_54e14962-34b8-4d4d-b27f-1390fe2a40be">44,456</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Asset-backed securities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i8de1bb3daed54738a88a86d2689b10ce_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMjcvZnJhZzphNzhkMmY3MGI4ZDY0ODdkYmIwZDE0NmE1MTE5OTBlMC90YWJsZToxMDJkMGM4YTk0N2E0NTk4YTI0NjZkZDBkYjRhZGY4Mi90YWJsZXJhbmdlOjEwMmQwYzhhOTQ3YTQ1OThhMjQ2NmRkMGRiNGFkZjgyXzctMS0xLTEtNDY5NA_973229fe-622b-4d84-b731-b928a433f8fe">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i19e0a6db758545d68ed21b0a945cc60f_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMjcvZnJhZzphNzhkMmY3MGI4ZDY0ODdkYmIwZDE0NmE1MTE5OTBlMC90YWJsZToxMDJkMGM4YTk0N2E0NTk4YTI0NjZkZDBkYjRhZGY4Mi90YWJsZXJhbmdlOjEwMmQwYzhhOTQ3YTQ1OThhMjQ2NmRkMGRiNGFkZjgyXzctMy0xLTEtNDY5NA_e9178e73-b45d-4bd2-81a7-ce106a0f7c46">5,181</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id10e93e4a6cc4706bff1d8eb9e0dad18_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMjcvZnJhZzphNzhkMmY3MGI4ZDY0ODdkYmIwZDE0NmE1MTE5OTBlMC90YWJsZToxMDJkMGM4YTk0N2E0NTk4YTI0NjZkZDBkYjRhZGY4Mi90YWJsZXJhbmdlOjEwMmQwYzhhOTQ3YTQ1OThhMjQ2NmRkMGRiNGFkZjgyXzctNS0xLTEtNDY5NA_fe33c2e3-0397-4e09-a787-094276418b1b">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idcfab15292df4659a682cf4c3e009b01_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMjcvZnJhZzphNzhkMmY3MGI4ZDY0ODdkYmIwZDE0NmE1MTE5OTBlMC90YWJsZToxMDJkMGM4YTk0N2E0NTk4YTI0NjZkZDBkYjRhZGY4Mi90YWJsZXJhbmdlOjEwMmQwYzhhOTQ3YTQ1OThhMjQ2NmRkMGRiNGFkZjgyXzctNy0xLTEtNDY5NA_5b3c1203-705b-4f16-a55a-f094c57f4269">5,181</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5ffa4f8eee864a558fefbc3fc931f9eb_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMjcvZnJhZzphNzhkMmY3MGI4ZDY0ODdkYmIwZDE0NmE1MTE5OTBlMC90YWJsZToxMDJkMGM4YTk0N2E0NTk4YTI0NjZkZDBkYjRhZGY4Mi90YWJsZXJhbmdlOjEwMmQwYzhhOTQ3YTQ1OThhMjQ2NmRkMGRiNGFkZjgyXzgtMS0xLTEtNDY5NA_057001ed-3bf5-4d14-b04f-f9b5f49ab4e8">34,363</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id62c0d16fbf34863a1344fb61a82dc68_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMjcvZnJhZzphNzhkMmY3MGI4ZDY0ODdkYmIwZDE0NmE1MTE5OTBlMC90YWJsZToxMDJkMGM4YTk0N2E0NTk4YTI0NjZkZDBkYjRhZGY4Mi90YWJsZXJhbmdlOjEwMmQwYzhhOTQ3YTQ1OThhMjQ2NmRkMGRiNGFkZjgyXzgtMy0xLTEtNDY5NA_e088b1d5-cc09-4a2c-b5bd-bfbcc660abc8">69,732</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3ff608b2639149898494a31eaf193271_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMjcvZnJhZzphNzhkMmY3MGI4ZDY0ODdkYmIwZDE0NmE1MTE5OTBlMC90YWJsZToxMDJkMGM4YTk0N2E0NTk4YTI0NjZkZDBkYjRhZGY4Mi90YWJsZXJhbmdlOjEwMmQwYzhhOTQ3YTQ1OThhMjQ2NmRkMGRiNGFkZjgyXzgtNS0xLTEtNDY5NA_88cd30cf-298d-4d7c-bdfd-8b82dcbaf0d0">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5fae0f510baf4fbcb8ab06bb60002490_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMjcvZnJhZzphNzhkMmY3MGI4ZDY0ODdkYmIwZDE0NmE1MTE5OTBlMC90YWJsZToxMDJkMGM4YTk0N2E0NTk4YTI0NjZkZDBkYjRhZGY4Mi90YWJsZXJhbmdlOjEwMmQwYzhhOTQ3YTQ1OThhMjQ2NmRkMGRiNGFkZjgyXzgtNy0xLTEtNDY5NA_25cbeaea-ead7-4322-ad25-21a92a62cb8f">104,095</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span></div><div style="margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:37.743%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:12.583%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.441%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:12.583%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.441%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:12.583%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.441%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:12.585%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-style:italic;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:9pt;font-weight:400;font-style:italic;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="21" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 31, 2018</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Level 1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Level 2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Level 3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Assets:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Money market funds</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idd88a7fb35bc4bbfb9f94fdef50dfdef_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMjcvZnJhZzphNzhkMmY3MGI4ZDY0ODdkYmIwZDE0NmE1MTE5OTBlMC90YWJsZTo3NGI0OWJiNmJmNDY0ZDRlOGZkZmJiNTRlZTYyYzgyMi90YWJsZXJhbmdlOjc0YjQ5YmI2YmY0NjRkNGU4ZmRmYmI1NGVlNjJjODIyXzMtMS0xLTEtNTY3NA_dbb52700-022e-4bb0-b84b-73b8e0c91ae8">10,495</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib9c2e225f695462c85b06ffc0db23f77_I20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMjcvZnJhZzphNzhkMmY3MGI4ZDY0ODdkYmIwZDE0NmE1MTE5OTBlMC90YWJsZTo3NGI0OWJiNmJmNDY0ZDRlOGZkZmJiNTRlZTYyYzgyMi90YWJsZXJhbmdlOjc0YjQ5YmI2YmY0NjRkNGU4ZmRmYmI1NGVlNjJjODIyXzMtMy0xLTEtNTY3NA_284665ed-fec4-4184-a0da-a57a8360dac6">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i49a7a83783f84c3982d721d07ccbada7_I20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMjcvZnJhZzphNzhkMmY3MGI4ZDY0ODdkYmIwZDE0NmE1MTE5OTBlMC90YWJsZTo3NGI0OWJiNmJmNDY0ZDRlOGZkZmJiNTRlZTYyYzgyMi90YWJsZXJhbmdlOjc0YjQ5YmI2YmY0NjRkNGU4ZmRmYmI1NGVlNjJjODIyXzMtNS0xLTEtNTY3NA_11034f36-e633-4849-8afb-2e6aba46c730">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9beac03666384655936e1b43302c9e0d_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMjcvZnJhZzphNzhkMmY3MGI4ZDY0ODdkYmIwZDE0NmE1MTE5OTBlMC90YWJsZTo3NGI0OWJiNmJmNDY0ZDRlOGZkZmJiNTRlZTYyYzgyMi90YWJsZXJhbmdlOjc0YjQ5YmI2YmY0NjRkNGU4ZmRmYmI1NGVlNjJjODIyXzMtNy0xLTEtNTY3NA_d64da2b9-0156-499e-b183-8d9270b8c041">10,495</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Redeemable convertible warrant liability</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i2cf6f35566bc4706a43eaf580cce3381_I20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:DerivativeLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMjcvZnJhZzphNzhkMmY3MGI4ZDY0ODdkYmIwZDE0NmE1MTE5OTBlMC90YWJsZTo3NGI0OWJiNmJmNDY0ZDRlOGZkZmJiNTRlZTYyYzgyMi90YWJsZXJhbmdlOjc0YjQ5YmI2YmY0NjRkNGU4ZmRmYmI1NGVlNjJjODIyXzMtMS0xLTEtNDc0Ng_d3bed2f0-9600-4394-9bfa-b8c6ce743f62">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i751eabc279934cf590084b42a75319d8_I20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:DerivativeLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMjcvZnJhZzphNzhkMmY3MGI4ZDY0ODdkYmIwZDE0NmE1MTE5OTBlMC90YWJsZTo3NGI0OWJiNmJmNDY0ZDRlOGZkZmJiNTRlZTYyYzgyMi90YWJsZXJhbmdlOjc0YjQ5YmI2YmY0NjRkNGU4ZmRmYmI1NGVlNjJjODIyXzMtMy0xLTEtNDc0Ng_fc81c8ea-d1d7-4477-bf7e-878b916e207b">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i682c50ee10764018a2a9d81b7a596283_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMjcvZnJhZzphNzhkMmY3MGI4ZDY0ODdkYmIwZDE0NmE1MTE5OTBlMC90YWJsZTo3NGI0OWJiNmJmNDY0ZDRlOGZkZmJiNTRlZTYyYzgyMi90YWJsZXJhbmdlOjc0YjQ5YmI2YmY0NjRkNGU4ZmRmYmI1NGVlNjJjODIyXzMtNS0xLTEtNDc0Ng_554d4acd-1dea-4bcd-94e3-c3174f48ac11">16,091</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="if488b5abfdda4d3a8085d2171b9717d8_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMjcvZnJhZzphNzhkMmY3MGI4ZDY0ODdkYmIwZDE0NmE1MTE5OTBlMC90YWJsZTo3NGI0OWJiNmJmNDY0ZDRlOGZkZmJiNTRlZTYyYzgyMi90YWJsZXJhbmdlOjc0YjQ5YmI2YmY0NjRkNGU4ZmRmYmI1NGVlNjJjODIyXzMtNy0xLTEtNDc0Ng_7d6bfab2-42b6-4fce-a714-98bac1e6d163">16,091</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div></ix:nonNumeric><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">As a derivative liability, the redeemable convertible warrants were initially recorded at fair value and were subject to remeasurement at each balance sheet date.  Any change in fair value as a result of a remeasurement was recognized as a component of other income (expense), net in the statements of operations and comprehensive loss.  The Company&#8217;s redeemable convertible warrant liability was classified within Level 3 of the fair value hierarchy.  </span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">At December&#160;31, 2018, the fair value of the redeemable convertible warrant liability was determined by using an option pricing model to allocate the total enterprise value to the various securities within the Company&#8217;s capital structure.  The fair value of the redeemable convertible warrant liability was based on both the estimated fair value of the Company&#8217;s common stock of $<ix:nonFraction unitRef="usdPerShare" contextRef="if244f20dd62e4eb5ac07166f1d16fcc1_I20181231" decimals="INF" name="us-gaap:SharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMjcvZnJhZzphNzhkMmY3MGI4ZDY0ODdkYmIwZDE0NmE1MTE5OTBlMC90ZXh0cmVnaW9uOmE3OGQyZjcwYjhkNjQ4N2RiYjBkMTQ2YTUxMTk5MGUwXzMxMDQ_c5bdecec-ba78-48f7-a2a3-393547f6b4e0">11.29</ix:nonFraction> as of December&#160;31, 2018 and on valuation models discounted at current implied market rates which are based on Level 3 inputs.  </span></div></ix:continuation><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">129</span></div></div></div><hr style="page-break-after:always"/><div style="height:90pt;width:100%;"><div style="margin-bottom:9pt;"><span><br/></span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><ix:continuation id="i130960aee5f24b10846d165f9080062d"><ix:nonNumeric contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" name="us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMjcvZnJhZzphNzhkMmY3MGI4ZDY0ODdkYmIwZDE0NmE1MTE5OTBlMC90ZXh0cmVnaW9uOmE3OGQyZjcwYjhkNjQ4N2RiYjBkMTQ2YTUxMTk5MGUwXzM3OTQ_4f184abb-1c99-4a0e-a2f3-b361f1c41874" escape="true"><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Additionally, the model&#8217;s inputs reflected assumptions that market participants would use in pricing the instrument in a current period transaction and included:</span></div><div style="text-align:center;margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:99.839%;"><tr><td style="width:1.0%;"></td><td style="width:80.182%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:15.818%;"></td><td style="width:1.0%;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 31,</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Time to liquidity (years)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="i48e873776ce54fb78ea86ee6468dd7ce_I20181231" format="ixt-sec:duryear" name="us-gaap:WarrantsAndRightsOutstandingTerm" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMjcvZnJhZzphNzhkMmY3MGI4ZDY0ODdkYmIwZDE0NmE1MTE5OTBlMC90YWJsZToxYzYzMjE4NWY4MDQ0YTQ3OTQ1NTE2YjQwZDI3YWRlNy90YWJsZXJhbmdlOjFjNjMyMTg1ZjgwNDRhNDc5NDU1MTZiNDBkMjdhZGU3XzItMy0xLTEtMA_40ea2c61-915c-4191-ab06-fe88723caea6">0.57</ix:nonNumeric></span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Expected volatility</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i1c2894de35e642cab6de34c3ff5418b2_I20181231" decimals="3" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMjcvZnJhZzphNzhkMmY3MGI4ZDY0ODdkYmIwZDE0NmE1MTE5OTBlMC90YWJsZToxYzYzMjE4NWY4MDQ0YTQ3OTQ1NTE2YjQwZDI3YWRlNy90YWJsZXJhbmdlOjFjNjMyMTg1ZjgwNDRhNDc5NDU1MTZiNDBkMjdhZGU3XzMtMy0xLTEtMA_535598b1-5dc8-4a1c-a24c-90f9e7bffb4a">62.5</ix:nonFraction>%&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Discounted cash flow rate</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i7493e1ba4b784b10bbdb551639b996d8_I20181231" decimals="3" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMjcvZnJhZzphNzhkMmY3MGI4ZDY0ODdkYmIwZDE0NmE1MTE5OTBlMC90YWJsZToxYzYzMjE4NWY4MDQ0YTQ3OTQ1NTE2YjQwZDI3YWRlNy90YWJsZXJhbmdlOjFjNjMyMTg1ZjgwNDRhNDc5NDU1MTZiNDBkMjdhZGU3XzQtMy0xLTEtMA_250edca7-63dd-4b1c-8055-db8d1f19da2a">12.0</ix:nonFraction>%&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Risk-free interest rate</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i6f1f166882e84b0d80d658c2f7290c71_I20181231" decimals="3" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMjcvZnJhZzphNzhkMmY3MGI4ZDY0ODdkYmIwZDE0NmE1MTE5OTBlMC90YWJsZToxYzYzMjE4NWY4MDQ0YTQ3OTQ1NTE2YjQwZDI3YWRlNy90YWJsZXJhbmdlOjFjNjMyMTg1ZjgwNDRhNDc5NDU1MTZiNDBkMjdhZGU3XzUtMy0xLTEtMA_78e033da-0650-458c-9ec1-4332744851aa">2.6</ix:nonFraction>%&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Marketability discount rate</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i73355ec5b9114196885f43773e313806_I20181231" decimals="2" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMjcvZnJhZzphNzhkMmY3MGI4ZDY0ODdkYmIwZDE0NmE1MTE5OTBlMC90YWJsZToxYzYzMjE4NWY4MDQ0YTQ3OTQ1NTE2YjQwZDI3YWRlNy90YWJsZXJhbmdlOjFjNjMyMTg1ZjgwNDRhNDc5NDU1MTZiNDBkMjdhZGU3XzYtMy0xLTEtMA_37eeaf97-6f71-4b8b-93da-2ee564f9848a">14</ix:nonFraction>%&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr></table></div></ix:nonNumeric><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The final fair value of the redeemable convertible warrants was remeasured on the date of the Company's initial public offering in April 2019. The final fair value of the redeemable convertible warrant liability was based on the fair value of the Company's common stock at the time of its initial public offering. The following table provides a reconciliation of the beginning and ending balances of the Company's redeemable convertible warrant liability are summarized below (in thousands):</span></div><div style="margin-bottom:9pt;"><ix:nonNumeric contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMjcvZnJhZzphNzhkMmY3MGI4ZDY0ODdkYmIwZDE0NmE1MTE5OTBlMC90ZXh0cmVnaW9uOmE3OGQyZjcwYjhkNjQ4N2RiYjBkMTQ2YTUxMTk5MGUwXzM3OTI_d62ab2b1-b14a-45de-9b95-53a6e1e2b208" escape="true"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:84.057%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:11.943%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fair value at December 31, 2017</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i517a0560ef9f4f6a822a0a124dd39744_I20171231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMjcvZnJhZzphNzhkMmY3MGI4ZDY0ODdkYmIwZDE0NmE1MTE5OTBlMC90YWJsZTozMzYyZGJmNGZhM2Q0YjhkYTQ5OGVmZTc3NDc4NjJhZC90YWJsZXJhbmdlOjMzNjJkYmY0ZmEzZDRiOGRhNDk4ZWZlNzc0Nzg2MmFkXzItMS0xLTEtMA_89201195-fb8c-4e71-9888-0d991d3d18e8">4,185</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Change in fair value recorded in other income (expense), net</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMjcvZnJhZzphNzhkMmY3MGI4ZDY0ODdkYmIwZDE0NmE1MTE5OTBlMC90YWJsZTozMzYyZGJmNGZhM2Q0YjhkYTQ5OGVmZTc3NDc4NjJhZC90YWJsZXJhbmdlOjMzNjJkYmY0ZmEzZDRiOGRhNDk4ZWZlNzc0Nzg2MmFkXzMtMS0xLTEtMA_a4c6cbce-8003-4bd5-a00c-9ee4292099dc">11,906</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fair value at December 31, 2018</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMjcvZnJhZzphNzhkMmY3MGI4ZDY0ODdkYmIwZDE0NmE1MTE5OTBlMC90YWJsZTozMzYyZGJmNGZhM2Q0YjhkYTQ5OGVmZTc3NDc4NjJhZC90YWJsZXJhbmdlOjMzNjJkYmY0ZmEzZDRiOGRhNDk4ZWZlNzc0Nzg2MmFkXzQtMS0xLTEtMA_b1522e77-f516-4100-98ce-11d36f8cc954">16,091</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Change in fair value recorded in other income (expense), net</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMjcvZnJhZzphNzhkMmY3MGI4ZDY0ODdkYmIwZDE0NmE1MTE5OTBlMC90YWJsZTozMzYyZGJmNGZhM2Q0YjhkYTQ5OGVmZTc3NDc4NjJhZC90YWJsZXJhbmdlOjMzNjJkYmY0ZmEzZDRiOGRhNDk4ZWZlNzc0Nzg2MmFkXzUtMS0xLTEtMTU0OA_483e05fb-5aeb-4f6d-bf1d-a2330ba81902">21,030</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Reclassification upon IPO</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="silk:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityReclassifications" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMjcvZnJhZzphNzhkMmY3MGI4ZDY0ODdkYmIwZDE0NmE1MTE5OTBlMC90YWJsZTozMzYyZGJmNGZhM2Q0YjhkYTQ5OGVmZTc3NDc4NjJhZC90YWJsZXJhbmdlOjMzNjJkYmY0ZmEzZDRiOGRhNDk4ZWZlNzc0Nzg2MmFkXzYtMS0xLTEtMTU0OA_a5872cf2-96d0-47ed-927b-7186fcdaa6c0">37,121</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fair Value at December 31, 2019</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMjcvZnJhZzphNzhkMmY3MGI4ZDY0ODdkYmIwZDE0NmE1MTE5OTBlMC90YWJsZTozMzYyZGJmNGZhM2Q0YjhkYTQ5OGVmZTc3NDc4NjJhZC90YWJsZXJhbmdlOjMzNjJkYmY0ZmEzZDRiOGRhNDk4ZWZlNzc0Nzg2MmFkXzctMS0xLTEtMTU0OA_dfdff853-b2a1-48d3-a89a-813c38e98bdc">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></ix:nonNumeric></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">There were no transfers between fair value hierarchy levels during the years ended December&#160;31, 2019 and 2018.</span></div></ix:continuation><div id="i58f397e86dfd4fc4ac3b8695cd31238e_130"></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">130</span></div></div></div><hr style="page-break-after:always"/><div style="height:90pt;width:100%;"><div style="margin-bottom:9pt;"><span><br/></span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">5.&#160;<ix:nonNumeric contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" name="us-gaap:SupplementalBalanceSheetDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90ZXh0cmVnaW9uOjMxMWRhYjU4MTA4YjRiMjFhMmQ0Mzc5M2YwYzliNGY1XzI4NQ_b28b0ae8-ee8d-4276-8428-046485897bb3" continuedAt="i5b2bb68397f243e4b0b03f6adb389335" escape="true">Balance Sheet Components</ix:nonNumeric></span></div><ix:continuation id="i5b2bb68397f243e4b0b03f6adb389335" continuedAt="i600f5358ef4c47f3975ebf172837b45e"><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Investments</span></div><ix:nonNumeric contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" name="us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90ZXh0cmVnaW9uOjMxMWRhYjU4MTA4YjRiMjFhMmQ0Mzc5M2YwYzliNGY1XzIxOTkwMjMyNTg3ODA_d396574c-df78-423b-a6b1-c6cc2cf68f2f" escape="true"><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The fair value of the Company's available-for-sale investments as of December&#160;31, 2019 are as follows (in thousands):</span></div><div style="margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:31.974%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:16.750%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.441%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:11.942%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.441%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:13.224%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.441%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:14.187%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-style:italic;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:9pt;font-weight:400;font-style:italic;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="21" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 31, 2019</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gross Unrealized</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Estimated</span></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Amortized Cost&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gains&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Losses&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fair Value&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Money market funds</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i75704913843f46ea87de6f08f1952574_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTo3YmMzZjhiMDhhMGI0OWMwYTg1NjMyMDFiNjlmZDJmNy90YWJsZXJhbmdlOjdiYzNmOGIwOGEwYjQ5YzBhODU2MzIwMWI2OWZkMmY3XzMtMS0xLTEtNDU0MQ_a12709f9-3ca2-482a-aa0a-3c09b605ee83">34,363</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i75704913843f46ea87de6f08f1952574_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTo3YmMzZjhiMDhhMGI0OWMwYTg1NjMyMDFiNjlmZDJmNy90YWJsZXJhbmdlOjdiYzNmOGIwOGEwYjQ5YzBhODU2MzIwMWI2OWZkMmY3XzMtMy0xLTEtNDU0MQ_dea9622a-b237-42c5-a99e-ec738b96fa05">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i75704913843f46ea87de6f08f1952574_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTo3YmMzZjhiMDhhMGI0OWMwYTg1NjMyMDFiNjlmZDJmNy90YWJsZXJhbmdlOjdiYzNmOGIwOGEwYjQ5YzBhODU2MzIwMWI2OWZkMmY3XzMtNS0xLTEtNDU0MQ_0e98a683-6174-43e4-a29b-5b4f27baea94">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i75704913843f46ea87de6f08f1952574_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTo3YmMzZjhiMDhhMGI0OWMwYTg1NjMyMDFiNjlmZDJmNy90YWJsZXJhbmdlOjdiYzNmOGIwOGEwYjQ5YzBhODU2MzIwMWI2OWZkMmY3XzMtNy0xLTEtNDU0MQ_ba95bbe4-b13f-44d9-8fe9-3892cfe5c455">34,363</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Commercial paper</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id719d5cbdbe541ab86698a19fee6fb0d_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTo3YmMzZjhiMDhhMGI0OWMwYTg1NjMyMDFiNjlmZDJmNy90YWJsZXJhbmdlOjdiYzNmOGIwOGEwYjQ5YzBhODU2MzIwMWI2OWZkMmY3XzQtMS0xLTEtNDU0MQ_99f5891d-be70-4fb0-beab-3abc618400f4">9,919</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id719d5cbdbe541ab86698a19fee6fb0d_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTo3YmMzZjhiMDhhMGI0OWMwYTg1NjMyMDFiNjlmZDJmNy90YWJsZXJhbmdlOjdiYzNmOGIwOGEwYjQ5YzBhODU2MzIwMWI2OWZkMmY3XzQtMy0xLTEtNDU0MQ_478eaa6c-9aa7-4849-8974-3dfc5694e997">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id719d5cbdbe541ab86698a19fee6fb0d_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTo3YmMzZjhiMDhhMGI0OWMwYTg1NjMyMDFiNjlmZDJmNy90YWJsZXJhbmdlOjdiYzNmOGIwOGEwYjQ5YzBhODU2MzIwMWI2OWZkMmY3XzQtNS0xLTEtNDU0MQ_71c88e18-b0d2-467b-8dc8-77dc1eefe7ec">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id719d5cbdbe541ab86698a19fee6fb0d_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTo3YmMzZjhiMDhhMGI0OWMwYTg1NjMyMDFiNjlmZDJmNy90YWJsZXJhbmdlOjdiYzNmOGIwOGEwYjQ5YzBhODU2MzIwMWI2OWZkMmY3XzQtNy0xLTEtNDU0MQ_2844c67b-caf8-4d8d-8ec5-da01fcdb8796">9,919</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Corporate bonds/notes</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i02820e2a66c44977989d03b1fffaede1_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTo3YmMzZjhiMDhhMGI0OWMwYTg1NjMyMDFiNjlmZDJmNy90YWJsZXJhbmdlOjdiYzNmOGIwOGEwYjQ5YzBhODU2MzIwMWI2OWZkMmY3XzUtMS0xLTEtNDU0MQ_30c8b575-4909-444c-91e6-801df9915a23">10,180</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i02820e2a66c44977989d03b1fffaede1_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTo3YmMzZjhiMDhhMGI0OWMwYTg1NjMyMDFiNjlmZDJmNy90YWJsZXJhbmdlOjdiYzNmOGIwOGEwYjQ5YzBhODU2MzIwMWI2OWZkMmY3XzUtMy0xLTEtNDU0MQ_856a1443-56ad-4b77-9d24-0e4101d8b783">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i02820e2a66c44977989d03b1fffaede1_I20191231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTo3YmMzZjhiMDhhMGI0OWMwYTg1NjMyMDFiNjlmZDJmNy90YWJsZXJhbmdlOjdiYzNmOGIwOGEwYjQ5YzBhODU2MzIwMWI2OWZkMmY3XzUtNS0xLTEtNDU0MQ_c0cc647f-2abe-4ea9-b067-38d576da2ae3">4</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i02820e2a66c44977989d03b1fffaede1_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTo3YmMzZjhiMDhhMGI0OWMwYTg1NjMyMDFiNjlmZDJmNy90YWJsZXJhbmdlOjdiYzNmOGIwOGEwYjQ5YzBhODU2MzIwMWI2OWZkMmY3XzUtNy0xLTEtNDU0MQ_e98fe96e-f7e0-4289-8ae2-f2d600f7592e">10,176</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">U.S. government securities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i2f9bf5b113a1441481893ba9f910f9cf_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTo3YmMzZjhiMDhhMGI0OWMwYTg1NjMyMDFiNjlmZDJmNy90YWJsZXJhbmdlOjdiYzNmOGIwOGEwYjQ5YzBhODU2MzIwMWI2OWZkMmY3XzYtMS0xLTEtNDU0MQ_cf928f5f-fc21-4b30-8654-23adea52cf6c">44,450</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i2f9bf5b113a1441481893ba9f910f9cf_I20191231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTo3YmMzZjhiMDhhMGI0OWMwYTg1NjMyMDFiNjlmZDJmNy90YWJsZXJhbmdlOjdiYzNmOGIwOGEwYjQ5YzBhODU2MzIwMWI2OWZkMmY3XzYtMy0xLTEtNDU0MQ_d35f1183-c713-46f1-bc4f-dc84a0612a43">9</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i2f9bf5b113a1441481893ba9f910f9cf_I20191231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTo3YmMzZjhiMDhhMGI0OWMwYTg1NjMyMDFiNjlmZDJmNy90YWJsZXJhbmdlOjdiYzNmOGIwOGEwYjQ5YzBhODU2MzIwMWI2OWZkMmY3XzYtNS0xLTEtNDU0MQ_ed7c2f5b-b7a6-4ed7-8c76-3068deee1fbc">3</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i2f9bf5b113a1441481893ba9f910f9cf_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTo3YmMzZjhiMDhhMGI0OWMwYTg1NjMyMDFiNjlmZDJmNy90YWJsZXJhbmdlOjdiYzNmOGIwOGEwYjQ5YzBhODU2MzIwMWI2OWZkMmY3XzYtNy0xLTEtNDU0MQ_d81212e3-bd9d-4df5-af2c-291ca06a2f87">44,456</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Asset-backed securities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i507134e9c9aa43a28501de3b98f309ca_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTo3YmMzZjhiMDhhMGI0OWMwYTg1NjMyMDFiNjlmZDJmNy90YWJsZXJhbmdlOjdiYzNmOGIwOGEwYjQ5YzBhODU2MzIwMWI2OWZkMmY3XzctMS0xLTEtNDU0MQ_2fc9a76f-6cca-4361-9d1e-8d0f51789a37">5,181</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i507134e9c9aa43a28501de3b98f309ca_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTo3YmMzZjhiMDhhMGI0OWMwYTg1NjMyMDFiNjlmZDJmNy90YWJsZXJhbmdlOjdiYzNmOGIwOGEwYjQ5YzBhODU2MzIwMWI2OWZkMmY3XzctMy0xLTEtNDU0MQ_a13c1094-b147-408b-b887-85c9f9c9f35a">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i507134e9c9aa43a28501de3b98f309ca_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTo3YmMzZjhiMDhhMGI0OWMwYTg1NjMyMDFiNjlmZDJmNy90YWJsZXJhbmdlOjdiYzNmOGIwOGEwYjQ5YzBhODU2MzIwMWI2OWZkMmY3XzctNS0xLTEtNDU0MQ_dcdb739a-4b1d-423c-ad5a-2249b3381b87">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i507134e9c9aa43a28501de3b98f309ca_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTo3YmMzZjhiMDhhMGI0OWMwYTg1NjMyMDFiNjlmZDJmNy90YWJsZXJhbmdlOjdiYzNmOGIwOGEwYjQ5YzBhODU2MzIwMWI2OWZkMmY3XzctNy0xLTEtNDU0MQ_17a4efdf-d691-43d9-bf68-65de6cfc8d89">5,181</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTo3YmMzZjhiMDhhMGI0OWMwYTg1NjMyMDFiNjlmZDJmNy90YWJsZXJhbmdlOjdiYzNmOGIwOGEwYjQ5YzBhODU2MzIwMWI2OWZkMmY3XzgtMS0xLTEtNDU0MQ_ef46cb9e-68ac-4cce-93a8-62bb3476e460">104,093</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTo3YmMzZjhiMDhhMGI0OWMwYTg1NjMyMDFiNjlmZDJmNy90YWJsZXJhbmdlOjdiYzNmOGIwOGEwYjQ5YzBhODU2MzIwMWI2OWZkMmY3XzgtMy0xLTEtNDU0MQ_1a474ef3-80f5-4a0a-8d9d-582dfa2535e3">9</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTo3YmMzZjhiMDhhMGI0OWMwYTg1NjMyMDFiNjlmZDJmNy90YWJsZXJhbmdlOjdiYzNmOGIwOGEwYjQ5YzBhODU2MzIwMWI2OWZkMmY3XzgtNS0xLTEtNDU0MQ_d22fd191-2985-4409-a066-74b7a5643303">7</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTo3YmMzZjhiMDhhMGI0OWMwYTg1NjMyMDFiNjlmZDJmNy90YWJsZXJhbmdlOjdiYzNmOGIwOGEwYjQ5YzBhODU2MzIwMWI2OWZkMmY3XzgtNy0xLTEtNDU0MQ_576d0e2a-b62f-47bd-80b7-83ecfe2d9e10">104,095</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Classified as:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0d613bf9b2a14909a35df00d8a23da58_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTo3YmMzZjhiMDhhMGI0OWMwYTg1NjMyMDFiNjlmZDJmNy90YWJsZXJhbmdlOjdiYzNmOGIwOGEwYjQ5YzBhODU2MzIwMWI2OWZkMmY3XzExLTctMS0xLTQ1NjA_567285c5-39fc-496c-8edd-05aaa9a694d4">34,363</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Short-term investments</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i24c078f64bcf4a558a6eb9707a027214_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTo3YmMzZjhiMDhhMGI0OWMwYTg1NjMyMDFiNjlmZDJmNy90YWJsZXJhbmdlOjdiYzNmOGIwOGEwYjQ5YzBhODU2MzIwMWI2OWZkMmY3XzEyLTctMS0xLTQ1NjA_124ece4e-0d0e-434a-9373-b4f9dde271cc">51,508</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Long-term investments</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic83cfde8eac24427a5b7c49a8127d817_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTo3YmMzZjhiMDhhMGI0OWMwYTg1NjMyMDFiNjlmZDJmNy90YWJsZXJhbmdlOjdiYzNmOGIwOGEwYjQ5YzBhODU2MzIwMWI2OWZkMmY3XzEzLTctMS0xLTQ1NjA_7d090854-4d35-4ee6-99e7-d2a97bdfd738">18,224</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTo3YmMzZjhiMDhhMGI0OWMwYTg1NjMyMDFiNjlmZDJmNy90YWJsZXJhbmdlOjdiYzNmOGIwOGEwYjQ5YzBhODU2MzIwMWI2OWZkMmY3XzE0LTctMS0xLTQ1NjA_6ac2a790-2e4a-4794-a33e-f043dcdccb29">104,095</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div></ix:nonNumeric><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span></div><ix:nonNumeric contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" name="us-gaap:FairValueByBalanceSheetGroupingTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90ZXh0cmVnaW9uOjMxMWRhYjU4MTA4YjRiMjFhMmQ0Mzc5M2YwYzliNGY1XzIxOTkwMjMyNTg3ODE_b7ad419f-89ce-4a29-b782-2960bb2bbcc8" escape="true"><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table summarizes the fair value of the Company&#8217;s cash equivalents, short-term and long-term investments classified by maturity as of December&#160;31, 2019 (in thousands):</span></div><div style="margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:80.211%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:15.789%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-style:italic;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:9pt;font-weight:400;font-style:italic;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 31,</span></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Amounts maturing within one year</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="-3" format="ixt:numdotdecimal" name="silk:CashAndCashEquivalentsFairValueDisclosureMaturingWithinOneYear" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTo0MzMyYjYzMWYwOGE0OGY1OWRjYmI2MWUxZThkYWZmZC90YWJsZXJhbmdlOjQzMzJiNjMxZjA4YTQ4ZjU5ZGNiYjYxZTFlOGRhZmZkXzItMS0xLTEtNDU4MA_36ac39cf-1d5e-49ce-a0be-b18679cfb1dd">85,871</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Amounts maturing after one year through two years</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="-3" format="ixt:numdotdecimal" name="silk:CashAndCashEquivalentsFairValueDisclosureMaturingAfterOneYearThroughTwoYears" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTo0MzMyYjYzMWYwOGE0OGY1OWRjYmI2MWUxZThkYWZmZC90YWJsZXJhbmdlOjQzMzJiNjMxZjA4YTQ4ZjU5ZGNiYjYxZTFlOGRhZmZkXzMtMS0xLTEtNDU4MA_c1cadff9-75b9-4a7a-95bd-43b7ff43e801">18,224</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTo0MzMyYjYzMWYwOGE0OGY1OWRjYmI2MWUxZThkYWZmZC90YWJsZXJhbmdlOjQzMzJiNjMxZjA4YTQ4ZjU5ZGNiYjYxZTFlOGRhZmZkXzQtMS0xLTEtNDU4MA_fc3aa3a6-c748-4209-9949-b411808e74cb">104,095</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Available-for-sale investments held as of December&#160;31, 2019 had a weighted average days to maturity of <ix:nonNumeric contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" format="ixt-sec:durday" name="us-gaap:DebtSecuritiesAvailableForSaleTerm" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90ZXh0cmVnaW9uOjMxMWRhYjU4MTA4YjRiMjFhMmQ0Mzc5M2YwYzliNGY1XzMyOTg1MzQ4ODYwMTI_4a31ef8c-9c88-410f-8b70-c7f5fb7977f7">291</ix:nonNumeric> days. </span></div><ix:nonNumeric contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" name="us-gaap:ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90ZXh0cmVnaW9uOjMxMWRhYjU4MTA4YjRiMjFhMmQ0Mzc5M2YwYzliNGY1XzIxOTkwMjMyNTg3ODI_19bc8304-f6a0-4896-ae4a-576893e26347" escape="true"><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table presents the Company's available-for-sale investments that were in an unrealized loss position as of December&#160;31, 2019 (in thousands):</span></div><div style="margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:62.102%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:15.467%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.441%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:15.790%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-style:italic;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:9pt;font-weight:400;font-style:italic;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-bottom:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 31, 2019</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Less than 12 months</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Assets:</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fair Value</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Unrealized Loss</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Corporate bonds/notes</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i02820e2a66c44977989d03b1fffaede1_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTo3ZDcxMjg5YzdjODk0NzRlYTViM2M3YmVmNTRjYTI4NS90YWJsZXJhbmdlOjdkNzEyODljN2M4OTQ3NGVhNWIzYzdiZWY1NGNhMjg1XzMtMS0xLTEtNDYyMQ_6d227332-b81c-492b-872a-82d2eaa7d449">10,128</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i02820e2a66c44977989d03b1fffaede1_I20191231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTo3ZDcxMjg5YzdjODk0NzRlYTViM2M3YmVmNTRjYTI4NS90YWJsZXJhbmdlOjdkNzEyODljN2M4OTQ3NGVhNWIzYzdiZWY1NGNhMjg1XzMtMy0xLTEtNDYyMQ_c077caa3-9a6b-4206-9fa1-50cebf5cccfe">4</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">U.S. government securities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i2f9bf5b113a1441481893ba9f910f9cf_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTo3ZDcxMjg5YzdjODk0NzRlYTViM2M3YmVmNTRjYTI4NS90YWJsZXJhbmdlOjdkNzEyODljN2M4OTQ3NGVhNWIzYzdiZWY1NGNhMjg1XzQtMS0xLTEtNDYyMQ_d95170ba-7647-4338-8975-88ce90edbf22">19,067</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i2f9bf5b113a1441481893ba9f910f9cf_I20191231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTo3ZDcxMjg5YzdjODk0NzRlYTViM2M3YmVmNTRjYTI4NS90YWJsZXJhbmdlOjdkNzEyODljN2M4OTQ3NGVhNWIzYzdiZWY1NGNhMjg1XzQtMy0xLTEtNDYyMQ_aaec8811-b933-4f8b-9928-e9903fa30e7d">3</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTo3ZDcxMjg5YzdjODk0NzRlYTViM2M3YmVmNTRjYTI4NS90YWJsZXJhbmdlOjdkNzEyODljN2M4OTQ3NGVhNWIzYzdiZWY1NGNhMjg1XzUtMS0xLTEtNDYyMQ_0547ae6b-6b57-4f29-a4c6-fbb5de8b1efe">29,195</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTo3ZDcxMjg5YzdjODk0NzRlYTViM2M3YmVmNTRjYTI4NS90YWJsZXJhbmdlOjdkNzEyODljN2M4OTQ3NGVhNWIzYzdiZWY1NGNhMjg1XzUtMy0xLTEtNDYyMQ_58328439-e0ce-43bf-b2b9-c90e20ec5565">7</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div></ix:nonNumeric><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span></div></ix:continuation><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">131</span></div></div></div><hr style="page-break-after:always"/><div style="height:90pt;width:100%;"><div style="margin-bottom:9pt;"><span><br/></span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><ix:continuation id="i600f5358ef4c47f3975ebf172837b45e" continuedAt="if8b3f5b42bc943cca043e9f63a4f4014"><ix:nonNumeric contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90ZXh0cmVnaW9uOjMxMWRhYjU4MTA4YjRiMjFhMmQ0Mzc5M2YwYzliNGY1XzI4Ng_fd51b496-3c86-4ab3-bd64-2d9d728a3094" escape="true"><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Inventories</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Components of inventories were as follows (in thousands): </span></div><div style="text-align:center;margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:69.314%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:11.942%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:11.943%;"></td><td style="width:1.0%;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-style:italic;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:9pt;font-weight:400;font-style:italic;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 31,</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Raw materials</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryRawMaterialsNetOfReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTpjM2U4YzNiNmJmOTA0MmE5OThjZGVjNDMzOTM1N2MwOS90YWJsZXJhbmdlOmMzZThjM2I2YmY5MDQyYTk5OGNkZWM0MzM5MzU3YzA5XzItMS0xLTEtMA_39b1a59f-7163-4e10-9f23-f50c55f6ffd9">1,203</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryRawMaterialsNetOfReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTpjM2U4YzNiNmJmOTA0MmE5OThjZGVjNDMzOTM1N2MwOS90YWJsZXJhbmdlOmMzZThjM2I2YmY5MDQyYTk5OGNkZWM0MzM5MzU3YzA5XzItMy0xLTEtMA_2bdca060-56cc-4910-88fa-82e4328ffec9">1,054</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Finished products</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTpjM2U4YzNiNmJmOTA0MmE5OThjZGVjNDMzOTM1N2MwOS90YWJsZXJhbmdlOmMzZThjM2I2YmY5MDQyYTk5OGNkZWM0MzM5MzU3YzA5XzMtMS0xLTEtMA_7c46ade9-427d-4bd4-8c26-72c3fcd88728">9,119</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTpjM2U4YzNiNmJmOTA0MmE5OThjZGVjNDMzOTM1N2MwOS90YWJsZXJhbmdlOmMzZThjM2I2YmY5MDQyYTk5OGNkZWM0MzM5MzU3YzA5XzMtMy0xLTEtMA_01a04b6a-ad40-4e6c-ac6f-0444b98835d2">4,690</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTpjM2U4YzNiNmJmOTA0MmE5OThjZGVjNDMzOTM1N2MwOS90YWJsZXJhbmdlOmMzZThjM2I2YmY5MDQyYTk5OGNkZWM0MzM5MzU3YzA5XzQtMS0xLTEtMA_4a446b19-0cfb-47d2-8a6e-8d255b4bce1f">10,322</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTpjM2U4YzNiNmJmOTA0MmE5OThjZGVjNDMzOTM1N2MwOS90YWJsZXJhbmdlOmMzZThjM2I2YmY5MDQyYTk5OGNkZWM0MzM5MzU3YzA5XzQtMy0xLTEtMA_dd329170-0eb7-45aa-87c3-5c461bc9df93">5,744</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr></table></div></ix:nonNumeric><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">As of December&#160;31, 2019 and 2018, there were <ix:nonFraction unitRef="usd" contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90ZXh0cmVnaW9uOjMxMWRhYjU4MTA4YjRiMjFhMmQ0Mzc5M2YwYzliNGY1XzIxOTkwMjMyNTg3ODQ_1d5219cb-a365-44c5-84d9-2f84b54e5795"><ix:nonFraction unitRef="usd" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90ZXh0cmVnaW9uOjMxMWRhYjU4MTA4YjRiMjFhMmQ0Mzc5M2YwYzliNGY1XzIxOTkwMjMyNTg3ODQ_a3a8f531-84c8-48a7-946b-8ddf80a336e8">no</ix:nonFraction></ix:nonFraction> work-in-process inventories.</span></div><ix:nonNumeric contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90ZXh0cmVnaW9uOjMxMWRhYjU4MTA4YjRiMjFhMmQ0Mzc5M2YwYzliNGY1XzI4Nw_58f651df-0725-4361-8d6d-c3828af9d3ea" escape="true"><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Property and Equipment, Net</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Property and equipment, net consisted of the following (in thousands):</span></div><div style="text-align:center;margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:69.314%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:11.942%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:11.943%;"></td><td style="width:1.0%;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-style:italic;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:9pt;font-weight:400;font-style:italic;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 31,</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Furniture and fixtures</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i865a5a03baaf4a64b9eb712f44655277_I20191231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTo4N2Y2MGY3ZGU5OGQ0MzYzYmExMGU5MGJjNTVmNDZlYS90YWJsZXJhbmdlOjg3ZjYwZjdkZTk4ZDQzNjNiYTEwZTkwYmM1NWY0NmVhXzItMS0xLTEtMA_cdee7c10-d45c-42b3-ba4e-c031a3415285">657</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5b1c140e3f174d628388c3f67f069432_I20181231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTo4N2Y2MGY3ZGU5OGQ0MzYzYmExMGU5MGJjNTVmNDZlYS90YWJsZXJhbmdlOjg3ZjYwZjdkZTk4ZDQzNjNiYTEwZTkwYmM1NWY0NmVhXzItMy0xLTEtMA_95b83fdd-fc08-44d5-84a5-db4e837790a2">517</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Equipment</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ief7e81456214489ba291e117b1b06060_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTo4N2Y2MGY3ZGU5OGQ0MzYzYmExMGU5MGJjNTVmNDZlYS90YWJsZXJhbmdlOjg3ZjYwZjdkZTk4ZDQzNjNiYTEwZTkwYmM1NWY0NmVhXzMtMS0xLTEtMA_7fdc80dd-a326-4b17-ac9f-c0d2da0e4fcc">1,295</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ibf79c9f5d41a43c0bbf17c7e0f0f94d7_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTo4N2Y2MGY3ZGU5OGQ0MzYzYmExMGU5MGJjNTVmNDZlYS90YWJsZXJhbmdlOjg3ZjYwZjdkZTk4ZDQzNjNiYTEwZTkwYmM1NWY0NmVhXzMtMy0xLTEtMA_cf948db5-ed06-468b-9da2-03964bcc0e87">1,217</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Software</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i2cdfbb16655f454e85b113e66702358b_I20191231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTo4N2Y2MGY3ZGU5OGQ0MzYzYmExMGU5MGJjNTVmNDZlYS90YWJsZXJhbmdlOjg3ZjYwZjdkZTk4ZDQzNjNiYTEwZTkwYmM1NWY0NmVhXzQtMS0xLTEtMA_59d59ff6-4efe-4293-a893-ffed3613d365">18</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i54b13dd93afe499f9eda02e58485e8ba_I20181231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTo4N2Y2MGY3ZGU5OGQ0MzYzYmExMGU5MGJjNTVmNDZlYS90YWJsZXJhbmdlOjg3ZjYwZjdkZTk4ZDQzNjNiYTEwZTkwYmM1NWY0NmVhXzQtMy0xLTEtMA_9016984b-d37f-4c19-b925-c4f2f81daf4a">76</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Leasehold improvements</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3eb7140b29f74c85bd43c66d2cab8f1d_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTo4N2Y2MGY3ZGU5OGQ0MzYzYmExMGU5MGJjNTVmNDZlYS90YWJsZXJhbmdlOjg3ZjYwZjdkZTk4ZDQzNjNiYTEwZTkwYmM1NWY0NmVhXzUtMS0xLTEtMA_5e5195f4-7bdf-46f0-b3a4-8f1924215601">1,991</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ibe305b8c4cc94fa5a038d2f95ad17a9b_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTo4N2Y2MGY3ZGU5OGQ0MzYzYmExMGU5MGJjNTVmNDZlYS90YWJsZXJhbmdlOjg3ZjYwZjdkZTk4ZDQzNjNiYTEwZTkwYmM1NWY0NmVhXzUtMy0xLTEtMA_a5f266ad-6085-41b8-8682-6223c067a674">1,978</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTo4N2Y2MGY3ZGU5OGQ0MzYzYmExMGU5MGJjNTVmNDZlYS90YWJsZXJhbmdlOjg3ZjYwZjdkZTk4ZDQzNjNiYTEwZTkwYmM1NWY0NmVhXzYtMS0xLTEtMA_d1b64a52-187a-4a01-beb8-316329aa5746">3,961</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTo4N2Y2MGY3ZGU5OGQ0MzYzYmExMGU5MGJjNTVmNDZlYS90YWJsZXJhbmdlOjg3ZjYwZjdkZTk4ZDQzNjNiYTEwZTkwYmM1NWY0NmVhXzYtMy0xLTEtMA_4579de23-aff7-4741-88fd-b229cbfef5c5">3,788</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Less:  Accumulated depreciation and amortization</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTo4N2Y2MGY3ZGU5OGQ0MzYzYmExMGU5MGJjNTVmNDZlYS90YWJsZXJhbmdlOjg3ZjYwZjdkZTk4ZDQzNjNiYTEwZTkwYmM1NWY0NmVhXzctMS0xLTEtMA_58089f2d-54cc-434e-ba76-fe828da7b480">1,550</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTo4N2Y2MGY3ZGU5OGQ0MzYzYmExMGU5MGJjNTVmNDZlYS90YWJsZXJhbmdlOjg3ZjYwZjdkZTk4ZDQzNjNiYTEwZTkwYmM1NWY0NmVhXzctMy0xLTEtMA_0171a6b9-65b8-4dd0-8679-7c49ee942332">946</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Add:  Construction-in-progress</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9c7143f51286457db347c4a2163a630d_I20191231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTo4N2Y2MGY3ZGU5OGQ0MzYzYmExMGU5MGJjNTVmNDZlYS90YWJsZXJhbmdlOjg3ZjYwZjdkZTk4ZDQzNjNiYTEwZTkwYmM1NWY0NmVhXzgtMS0xLTEtMA_b13be333-94f5-4a70-b494-ac8cca0a3b2e">323</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1ccf70059f7d4165acf299107d6c8761_I20181231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTo4N2Y2MGY3ZGU5OGQ0MzYzYmExMGU5MGJjNTVmNDZlYS90YWJsZXJhbmdlOjg3ZjYwZjdkZTk4ZDQzNjNiYTEwZTkwYmM1NWY0NmVhXzgtMy0xLTEtMA_2f67093c-96cd-49f6-83bb-2022a7aee9e1">38</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTo4N2Y2MGY3ZGU5OGQ0MzYzYmExMGU5MGJjNTVmNDZlYS90YWJsZXJhbmdlOjg3ZjYwZjdkZTk4ZDQzNjNiYTEwZTkwYmM1NWY0NmVhXzktMS0xLTEtMA_cf31399c-9254-480d-9546-056cec79c131">2,734</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTo4N2Y2MGY3ZGU5OGQ0MzYzYmExMGU5MGJjNTVmNDZlYS90YWJsZXJhbmdlOjg3ZjYwZjdkZTk4ZDQzNjNiYTEwZTkwYmM1NWY0NmVhXzktMy0xLTEtMA_5cca43ba-2a0e-4ef0-886a-a40ada880bf5">2,880</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr></table></div></ix:nonNumeric><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Depreciation and amortization expense was $<ix:nonFraction unitRef="usd" contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Depreciation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90ZXh0cmVnaW9uOjMxMWRhYjU4MTA4YjRiMjFhMmQ0Mzc5M2YwYzliNGY1XzMyOTg1MzQ4ODM2Njk_4eabf89c-ba5c-4625-8439-38106698f0ff">712,000</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Depreciation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90ZXh0cmVnaW9uOjMxMWRhYjU4MTA4YjRiMjFhMmQ0Mzc5M2YwYzliNGY1XzMyOTg1MzQ4ODM2Nzk_1f1f08c9-cff5-46d2-b283-a819237b4b51">517,000</ix:nonFraction> for the years ended December&#160;31, 2019 and 2018, respectively.</span></div></ix:continuation><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">132</span></div></div></div><hr style="page-break-after:always"/><div style="height:90pt;width:100%;"><div style="margin-bottom:9pt;"><span><br/></span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><ix:continuation id="if8b3f5b42bc943cca043e9f63a4f4014"><ix:nonNumeric contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" name="us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90ZXh0cmVnaW9uOjMxMWRhYjU4MTA4YjRiMjFhMmQ0Mzc5M2YwYzliNGY1XzI4OA_8172a42f-7df7-4ba0-9e64-ac427a15f969" escape="true"><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Accrued Liabilities</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Accrued liabilities consisted of the following (in thousands):</span></div><div style="text-align:center;margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:69.314%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:11.942%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:11.943%;"></td><td style="width:1.0%;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-style:italic;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:9pt;font-weight:400;font-style:italic;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 31,</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accrued payroll and related expenses</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedSalariesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTplMDQwNjQwOTk0ZWE0ZjVhOGI1NDIxMDRlZDdiZmQyZC90YWJsZXJhbmdlOmUwNDA2NDA5OTRlYTRmNWE4YjU0MjEwNGVkN2JmZDJkXzItMS0xLTEtMA_a31bd9b9-ecc0-4335-8cfa-6e77d5ebca79">9,151</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedSalariesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTplMDQwNjQwOTk0ZWE0ZjVhOGI1NDIxMDRlZDdiZmQyZC90YWJsZXJhbmdlOmUwNDA2NDA5OTRlYTRmNWE4YjU0MjEwNGVkN2JmZDJkXzItMy0xLTEtMA_14385fa6-f416-4305-823e-7c4550dd5e19">5,157</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Provision for sales returns</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="-3" format="ixt:numdotdecimal" name="silk:ProvisionsForSalesReturns" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTplMDQwNjQwOTk0ZWE0ZjVhOGI1NDIxMDRlZDdiZmQyZC90YWJsZXJhbmdlOmUwNDA2NDA5OTRlYTRmNWE4YjU0MjEwNGVkN2JmZDJkXzMtMS0xLTEtNDg1Mw_df95ced0-6813-4fbd-89a4-6b0ffbcabb20">2,419</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231" decimals="-3" format="ixt:numdotdecimal" name="silk:ProvisionsForSalesReturns" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTplMDQwNjQwOTk0ZWE0ZjVhOGI1NDIxMDRlZDdiZmQyZC90YWJsZXJhbmdlOmUwNDA2NDA5OTRlYTRmNWE4YjU0MjEwNGVkN2JmZDJkXzMtMy0xLTEtNDg1Mw_5ed67c62-adae-45d4-80ca-0428978c2a48">1,862</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accrued professional services</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="-3" name="us-gaap:AccruedProfessionalFeesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTplMDQwNjQwOTk0ZWE0ZjVhOGI1NDIxMDRlZDdiZmQyZC90YWJsZXJhbmdlOmUwNDA2NDA5OTRlYTRmNWE4YjU0MjEwNGVkN2JmZDJkXzMtMS0xLTEtMA_1e69cbea-5838-4d04-a9ae-32adcdb9a3de">682</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedProfessionalFeesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTplMDQwNjQwOTk0ZWE0ZjVhOGI1NDIxMDRlZDdiZmQyZC90YWJsZXJhbmdlOmUwNDA2NDA5OTRlYTRmNWE4YjU0MjEwNGVkN2JmZDJkXzMtMy0xLTEtMA_d7c805c4-e218-45a3-b401-958587604645">1,014</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operating lease liability</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTplMDQwNjQwOTk0ZWE0ZjVhOGI1NDIxMDRlZDdiZmQyZC90YWJsZXJhbmdlOmUwNDA2NDA5OTRlYTRmNWE4YjU0MjEwNGVkN2JmZDJkXzQtMS0xLTEtMTYxOA_19f2e9e4-fb57-4f41-adfd-8e2f1cd05675">769</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accrued royalty expense</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="-3" name="us-gaap:AccruedRoyaltiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTplMDQwNjQwOTk0ZWE0ZjVhOGI1NDIxMDRlZDdiZmQyZC90YWJsZXJhbmdlOmUwNDA2NDA5OTRlYTRmNWE4YjU0MjEwNGVkN2JmZDJkXzQtMS0xLTEtMA_a013d04f-a4cc-45c9-8685-14da9005eb08">470</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231" decimals="-3" name="us-gaap:AccruedRoyaltiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTplMDQwNjQwOTk0ZWE0ZjVhOGI1NDIxMDRlZDdiZmQyZC90YWJsZXJhbmdlOmUwNDA2NDA5OTRlYTRmNWE4YjU0MjEwNGVkN2JmZDJkXzQtMy0xLTEtMA_128113d6-da94-4794-bf8a-b0207ed34cc9">313</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Deferred revenue</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTplMDQwNjQwOTk0ZWE0ZjVhOGI1NDIxMDRlZDdiZmQyZC90YWJsZXJhbmdlOmUwNDA2NDA5OTRlYTRmNWE4YjU0MjEwNGVkN2JmZDJkXzYtMS0xLTEtMTYyMw_0428258b-4721-4a3e-b991-dacb49464c73">304</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTplMDQwNjQwOTk0ZWE0ZjVhOGI1NDIxMDRlZDdiZmQyZC90YWJsZXJhbmdlOmUwNDA2NDA5OTRlYTRmNWE4YjU0MjEwNGVkN2JmZDJkXzYtMy0xLTEtMTYyMw_21b79ee5-2025-4018-81d8-e6175b1604b0">137</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accrued travel expenses</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="-3" name="silk:AccruedTravelExpensesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTplMDQwNjQwOTk0ZWE0ZjVhOGI1NDIxMDRlZDdiZmQyZC90YWJsZXJhbmdlOmUwNDA2NDA5OTRlYTRmNWE4YjU0MjEwNGVkN2JmZDJkXzUtMS0xLTEtMA_774d7a9d-dc92-43c8-a0f5-eaeaedcc1a9d">431</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231" decimals="-3" name="silk:AccruedTravelExpensesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTplMDQwNjQwOTk0ZWE0ZjVhOGI1NDIxMDRlZDdiZmQyZC90YWJsZXJhbmdlOmUwNDA2NDA5OTRlYTRmNWE4YjU0MjEwNGVkN2JmZDJkXzUtMy0xLTEtMA_c65703bf-1432-404d-8962-1ec1da3c0418">270</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accrued clinical expenses</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="-3" name="silk:AccruedClinicalExpensesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTplMDQwNjQwOTk0ZWE0ZjVhOGI1NDIxMDRlZDdiZmQyZC90YWJsZXJhbmdlOmUwNDA2NDA5OTRlYTRmNWE4YjU0MjEwNGVkN2JmZDJkXzYtMS0xLTEtMA_ea674f0d-4cc5-4c26-844d-501f5ecc8a18">241</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231" decimals="-3" name="silk:AccruedClinicalExpensesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTplMDQwNjQwOTk0ZWE0ZjVhOGI1NDIxMDRlZDdiZmQyZC90YWJsZXJhbmdlOmUwNDA2NDA5OTRlYTRmNWE4YjU0MjEwNGVkN2JmZDJkXzYtMy0xLTEtMA_27b819f2-c33d-43ce-854a-1d1868fa2fed">244</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accrued other expenses</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTplMDQwNjQwOTk0ZWE0ZjVhOGI1NDIxMDRlZDdiZmQyZC90YWJsZXJhbmdlOmUwNDA2NDA5OTRlYTRmNWE4YjU0MjEwNGVkN2JmZDJkXzctMS0xLTEtMA_d19c1a98-0d06-4d65-a84f-5db7ea5063ab">567</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTplMDQwNjQwOTk0ZWE0ZjVhOGI1NDIxMDRlZDdiZmQyZC90YWJsZXJhbmdlOmUwNDA2NDA5OTRlYTRmNWE4YjU0MjEwNGVkN2JmZDJkXzctMy0xLTEtMA_c591d78f-cc3c-419c-9e84-bc17b41faa25">451</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTplMDQwNjQwOTk0ZWE0ZjVhOGI1NDIxMDRlZDdiZmQyZC90YWJsZXJhbmdlOmUwNDA2NDA5OTRlYTRmNWE4YjU0MjEwNGVkN2JmZDJkXzgtMS0xLTEtMA_2d27fc87-0979-4eba-8192-b8d2794a2cd2">15,034</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTplMDQwNjQwOTk0ZWE0ZjVhOGI1NDIxMDRlZDdiZmQyZC90YWJsZXJhbmdlOmUwNDA2NDA5OTRlYTRmNWE4YjU0MjEwNGVkN2JmZDJkXzgtMy0xLTEtMA_f910009a-562f-422c-b4c1-94d214938699">9,448</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="text-indent:18pt;text-align:center;margin-bottom:9pt;"><span><br/></span></div><div id="i58f397e86dfd4fc4ac3b8695cd31238e_136"></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">6.&#160;<ix:nonNumeric contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzYvZnJhZzoxOTU5MjdlNmJiMzM0YTFlOTUzMzQyYTNiNmRiYzA3YS90ZXh0cmVnaW9uOjE5NTkyN2U2YmIzMzRhMWU5NTMzNDJhM2I2ZGJjMDdhXzUzODU_57da87ba-b580-4085-b98d-4f41ac2496e4" continuedAt="i371a67fd033c413f9c191da98693ebe1" escape="true">Long-term Debt</ix:nonNumeric></span></div><ix:continuation id="i371a67fd033c413f9c191da98693ebe1" continuedAt="i03f97d7d945c4021a3b6a1a08b43164f"><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In October&#160;2015, the Company entered into a term loan agreement with Capital Resource Group ("CRG").  The term loan agreement provides for up to $<ix:nonFraction unitRef="usd" contextRef="id62906738f144d84bc9d557ddc169284_I20151031" decimals="INF" format="ixt:numdotdecimal" name="silk:DebtMaximumBorrowingCapacity" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzYvZnJhZzoxOTU5MjdlNmJiMzM0YTFlOTUzMzQyYTNiNmRiYzA3YS90ZXh0cmVnaW9uOjE5NTkyN2U2YmIzMzRhMWU5NTMzNDJhM2I2ZGJjMDdhXzMyOTg1MzQ4ODk3MDY_9baba33c-d28b-4479-90de-2cafec5869d0">30,000,000</ix:nonFraction> in term loans split into two tranches as follows: (i) the Tranche A Loans provided for $<ix:nonFraction unitRef="usd" contextRef="id77e08ef6b1e4d26923913e53db9186d_I20151031" decimals="INF" format="ixt:numdotdecimal" name="silk:DebtMaximumBorrowingCapacity" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzYvZnJhZzoxOTU5MjdlNmJiMzM0YTFlOTUzMzQyYTNiNmRiYzA3YS90ZXh0cmVnaW9uOjE5NTkyN2U2YmIzMzRhMWU5NTMzNDJhM2I2ZGJjMDdhXzMyOTg1MzQ4ODk3MTQ_0955bf4a-716d-4d75-835f-d9cd445a5249">20,000,000</ix:nonFraction> in term loans, and (ii) the Tranche B Loans provided for up to $<ix:nonFraction unitRef="usd" contextRef="i16c13b04e0bd4554b32d832a2eee0af3_I20151031" decimals="INF" format="ixt:numdotdecimal" name="silk:DebtMaximumBorrowingCapacity" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzYvZnJhZzoxOTU5MjdlNmJiMzM0YTFlOTUzMzQyYTNiNmRiYzA3YS90ZXh0cmVnaW9uOjE5NTkyN2U2YmIzMzRhMWU5NTMzNDJhM2I2ZGJjMDdhXzMyOTg1MzQ4ODk3MTg_da213811-2dd9-418e-9956-8d3ab59ef5de">10,000,000</ix:nonFraction> in term loans.  The Company drew down the Tranche A Loans on October 13, 2015.  The Tranche B Loans were available to be drawn prior to March 29, 2017.  In January 2017, the term loan agreement was amended to extend the commitment period of the Tranche B Loans to April 28, 2017.  In April 2017, the Company drew down $<ix:nonFraction unitRef="usd" contextRef="i1ad5b6c72b9d43eb9409533a1389160e_I20170430" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzYvZnJhZzoxOTU5MjdlNmJiMzM0YTFlOTUzMzQyYTNiNmRiYzA3YS90ZXh0cmVnaW9uOjE5NTkyN2U2YmIzMzRhMWU5NTMzNDJhM2I2ZGJjMDdhXzMyOTg1MzQ4ODk3MjI_34da79ca-bdb1-498c-9e06-31c12059fc02">5,000,000</ix:nonFraction> of the available Tranche B Loans.  </span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In September 2018, the Company entered into Amendment No. 5 to the term loan agreement with CRG.  Under the amended terms of the amended loan agreement the maturity date was extended to December 31, 2022 and the repayment schedule of the existing term loans were changed to interest only so that the outstanding principal amount of the term loans will be payable in a single installment at maturity.  The related fixed interest rate was changed to equal <ix:nonFraction unitRef="number" contextRef="i77aa0ed0241849f98e4736227590410c_I20180930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzYvZnJhZzoxOTU5MjdlNmJiMzM0YTFlOTUzMzQyYTNiNmRiYzA3YS90ZXh0cmVnaW9uOjE5NTkyN2U2YmIzMzRhMWU5NTMzNDJhM2I2ZGJjMDdhXzMyOTg1MzQ4ODk3MjY_6ed94941-3bea-4a4e-975b-7fb07b63ff1f">10.75</ix:nonFraction>% per annum, due and payable quarterly in arrears.  At the election of the Company, <ix:nonFraction unitRef="number" contextRef="i77aa0ed0241849f98e4736227590410c_I20180930" decimals="4" name="silk:DebtInstrumentInterestRatePaidInKind" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzYvZnJhZzoxOTU5MjdlNmJiMzM0YTFlOTUzMzQyYTNiNmRiYzA3YS90ZXh0cmVnaW9uOjE5NTkyN2U2YmIzMzRhMWU5NTMzNDJhM2I2ZGJjMDdhXzMyOTg1MzQ4ODk3MzA_f1f79637-6b78-4b87-b327-cb6039de1064">2.75</ix:nonFraction>% of the interest due and payable may be &#8220;paid in kind&#8221; and added to the then outstanding principal and <ix:nonFraction unitRef="number" contextRef="i77aa0ed0241849f98e4736227590410c_I20180930" decimals="3" name="silk:DebtInstrumentInterestRatePaidInCash" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzYvZnJhZzoxOTU5MjdlNmJiMzM0YTFlOTUzMzQyYTNiNmRiYzA3YS90ZXh0cmVnaW9uOjE5NTkyN2U2YmIzMzRhMWU5NTMzNDJhM2I2ZGJjMDdhXzMyOTg1MzQ4ODk3MzQ_24c1e796-f89b-41f7-87ee-537ed98933b3">8.0</ix:nonFraction>% of the interest due and payable paid in cash.  All unpaid principal, and accrued and unpaid interest, is due and payable in full on December 31,&#160;2022.  The amended term loan agreement also provided for additional term loans in an aggregate principal amount of up to $<ix:nonFraction unitRef="usd" contextRef="i77aa0ed0241849f98e4736227590410c_I20180930" decimals="INF" format="ixt:numdotdecimal" name="silk:DebtMaximumBorrowingCapacity" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzYvZnJhZzoxOTU5MjdlNmJiMzM0YTFlOTUzMzQyYTNiNmRiYzA3YS90ZXh0cmVnaW9uOjE5NTkyN2U2YmIzMzRhMWU5NTMzNDJhM2I2ZGJjMDdhXzMyOTg1MzQ4ODk3Mzg_bad2442f-2d5a-4bfc-a352-2cdaf2436fa3">25,000,000</ix:nonFraction> and allowed for the conversion into shares of common stock, at the Company&#8217;s option, of up to <ix:nonFraction unitRef="number" contextRef="i96c7f06d98d442a59802339444e89dae_D20180901-20180930" decimals="INF" name="silk:DebtInstrumentConvertibleMaximumPercentageOfOutstandingLoans" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzYvZnJhZzoxOTU5MjdlNmJiMzM0YTFlOTUzMzQyYTNiNmRiYzA3YS90ZXh0cmVnaW9uOjE5NTkyN2U2YmIzMzRhMWU5NTMzNDJhM2I2ZGJjMDdhXzMyOTg1MzQ4ODk3NDI_bf215310-2797-4ed3-b65e-e4a43f5e518d">25</ix:nonFraction>% of the outstanding loans under the term loan agreement in connection with an initial public offering of the Company&#8217;s common stock which results in market capitalization of at least $<ix:nonFraction unitRef="usd" contextRef="i77aa0ed0241849f98e4736227590410c_I20180930" decimals="INF" format="ixt:numdotdecimal" name="silk:DebtInstrumentConvertibleMarketCapitalization" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzYvZnJhZzoxOTU5MjdlNmJiMzM0YTFlOTUzMzQyYTNiNmRiYzA3YS90ZXh0cmVnaW9uOjE5NTkyN2U2YmIzMzRhMWU5NTMzNDJhM2I2ZGJjMDdhXzMyOTg1MzQ4ODk3NDY_b4f02372-d7c0-49af-a3a4-978252783087">250,000,000</ix:nonFraction>.  In September 2018, the Company drew down an additional $<ix:nonFraction unitRef="usd" contextRef="i54b82514b8694d3b98494d64e98b4745_I20180930" decimals="INF" format="ixt:numdotdecimal" name="silk:DebtMaximumBorrowingCapacity" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzYvZnJhZzoxOTU5MjdlNmJiMzM0YTFlOTUzMzQyYTNiNmRiYzA3YS90ZXh0cmVnaW9uOjE5NTkyN2U2YmIzMzRhMWU5NTMzNDJhM2I2ZGJjMDdhXzMyOTg1MzQ4ODk3NTA_753b3e42-f2fa-4cf5-8b82-8b54f12844bf">15,000,000</ix:nonFraction> under the term loan agreement with CRG.  </span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In June 2019, the Company entered into Amendment No. 7 to the term loan agreement with CRG to reflect flexibility with respect to permitted cash investments.</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company may voluntarily prepay the borrowings in full.  The Tranche A borrowing required a payment, on the borrowing date, of a financing fee equal to <ix:nonFraction unitRef="number" contextRef="id77e08ef6b1e4d26923913e53db9186d_I20151031" decimals="INF" name="silk:DebtInstrumentInterestRateFinancingFee" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzYvZnJhZzoxOTU5MjdlNmJiMzM0YTFlOTUzMzQyYTNiNmRiYzA3YS90ZXh0cmVnaW9uOjE5NTkyN2U2YmIzMzRhMWU5NTMzNDJhM2I2ZGJjMDdhXzMyOTg1MzQ4ODk3NTQ_8e333174-7a88-411c-95b7-a19af91a86c6">1.75</ix:nonFraction>% of the borrowed loan principal, which is recorded as a discount to the debt.  In addition, a facility fee equal to <ix:nonFraction unitRef="number" contextRef="id77e08ef6b1e4d26923913e53db9186d_I20151031" decimals="INF" name="silk:DebtInstrumentInterestRateFacilityFee" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzYvZnJhZzoxOTU5MjdlNmJiMzM0YTFlOTUzMzQyYTNiNmRiYzA3YS90ZXh0cmVnaW9uOjE5NTkyN2U2YmIzMzRhMWU5NTMzNDJhM2I2ZGJjMDdhXzMyOTg1MzQ4ODk3NTg_88a2e4d1-8330-4b6c-9aa9-244feaa0dfe0">5.0</ix:nonFraction>% of the amounts borrowed plus any &#8220;paid in kind&#8221; is payable at the end of the term or when the borrowings are repaid in full.  A long-term </span></div></ix:continuation><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">133</span></div></div></div><hr style="page-break-after:always"/><div style="height:90pt;width:100%;"><div style="margin-bottom:9pt;"><span><br/></span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><ix:continuation id="i03f97d7d945c4021a3b6a1a08b43164f"><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">liability is being accreted using the effective interest method for the facility fee over the term of the loan agreement.  The borrowings are collateralized by a security interest in substantially all of the Company&#8217;s assets.</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company is subject to financial covenants related to liquidity and minimum trailing revenue targets that begin in December&#160;31, 2016 and are tested on an annual basis.  The liquidity covenant requires the Company to maintain an amount which shall exceed the greater of (i) $<ix:nonFraction unitRef="usd" contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" decimals="INF" format="ixt:numdotdecimal" name="silk:DebtInstrumentCovenantMaximumLiquidityAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzYvZnJhZzoxOTU5MjdlNmJiMzM0YTFlOTUzMzQyYTNiNmRiYzA3YS90ZXh0cmVnaW9uOjE5NTkyN2U2YmIzMzRhMWU5NTMzNDJhM2I2ZGJjMDdhXzMyOTg1MzQ4ODk3NjI_1c517d73-78c6-4de2-840d-0e9d2716a4de">3,000,000</ix:nonFraction> and (ii) the minimum cash balance, if any, required of the Company by a creditor to the extent the&#160;Company has incurred permitted priority debt.  The Company had to achieve minimum net revenue of $<ix:nonFraction unitRef="usd" contextRef="i7ac0d334898e4fb1897fd7e5822858ab_D20160101-20161231" decimals="INF" format="ixt:numdotdecimal" name="silk:DebtInstrumentCovenantMinimumNetRevenueAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzYvZnJhZzoxOTU5MjdlNmJiMzM0YTFlOTUzMzQyYTNiNmRiYzA3YS90ZXh0cmVnaW9uOjE5NTkyN2U2YmIzMzRhMWU5NTMzNDJhM2I2ZGJjMDdhXzMyOTg1MzQ4ODk3NjY_2e8eea7a-4507-4287-b7d7-efde2ad363cb">1,000,000</ix:nonFraction> in 2016, $<ix:nonFraction unitRef="usd" contextRef="i28c5cd5abfce4c7aa5c44b0f651c9ad8_D20170101-20171231" decimals="INF" format="ixt:numdotdecimal" name="silk:DebtInstrumentCovenantMinimumNetRevenueAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzYvZnJhZzoxOTU5MjdlNmJiMzM0YTFlOTUzMzQyYTNiNmRiYzA3YS90ZXh0cmVnaW9uOjE5NTkyN2U2YmIzMzRhMWU5NTMzNDJhM2I2ZGJjMDdhXzMyOTg1MzQ4ODk3NzA_76358b0f-b1cc-4651-90e7-4e06373ec5d7">5,000,000</ix:nonFraction> in 2017, $<ix:nonFraction unitRef="usd" contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231" decimals="INF" format="ixt:numdotdecimal" name="silk:DebtInstrumentCovenantMinimumNetRevenueAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzYvZnJhZzoxOTU5MjdlNmJiMzM0YTFlOTUzMzQyYTNiNmRiYzA3YS90ZXh0cmVnaW9uOjE5NTkyN2U2YmIzMzRhMWU5NTMzNDJhM2I2ZGJjMDdhXzMyOTg1MzQ4ODk3NzQ_395fb00a-3414-42ca-8bf0-fdccde588011">15,000,000</ix:nonFraction> in 2018, and must achieve minimum net revenue of $<ix:nonFraction unitRef="usd" contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" decimals="INF" format="ixt:numdotdecimal" name="silk:DebtInstrumentCovenantMinimumNetRevenueAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzYvZnJhZzoxOTU5MjdlNmJiMzM0YTFlOTUzMzQyYTNiNmRiYzA3YS90ZXh0cmVnaW9uOjE5NTkyN2U2YmIzMzRhMWU5NTMzNDJhM2I2ZGJjMDdhXzMyOTg1MzQ4ODk3Nzg_e37d771c-f71b-46d3-93e4-ec299f1d6c61">30,000,000</ix:nonFraction> in 2019 and $<ix:nonFraction unitRef="usd" contextRef="i24d31e2c272041379e7662e50a4130b0_D20200101-20201231" decimals="INF" format="ixt:numdotdecimal" name="silk:DebtInstrumentCovenantMinimumNetRevenueAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzYvZnJhZzoxOTU5MjdlNmJiMzM0YTFlOTUzMzQyYTNiNmRiYzA3YS90ZXh0cmVnaW9uOjE5NTkyN2U2YmIzMzRhMWU5NTMzNDJhM2I2ZGJjMDdhXzMyOTg1MzQ4ODk3ODI_5752aa82-a2ae-4eda-9552-dcf8cb3063c9">40,000,000</ix:nonFraction> in 2020.  The liquidity financial covenant has a <ix:nonNumeric contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" format="ixt-sec:durday" name="silk:DebtInstrumentLiquidityCovenantTerm" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzYvZnJhZzoxOTU5MjdlNmJiMzM0YTFlOTUzMzQyYTNiNmRiYzA3YS90ZXh0cmVnaW9uOjE5NTkyN2U2YmIzMzRhMWU5NTMzNDJhM2I2ZGJjMDdhXzMyOTg1MzQ4ODk3ODY_8b66d687-5ffb-4a44-ae50-e7870d016df8">90</ix:nonNumeric>-day equity cure period following end of the calendar year to issue additional shares of equity interests in exchange for cash, or to borrow permitted cure debt.  In addition, the term loan agreement prohibits the payment of cash dividends on the Company&#8217;s capital stock and also places restrictions on mergers, sales of assets, investments, incurrence of liens, incurrence of indebtedness and transactions with affiliates.  CRG may accelerate the payment terms of the term loan agreement upon the occurrence of certain events of default set forth therein, which include the failure of the Company to make timely payments of amounts due under the term loan agreement, the failure of the Company to adhere to the covenants set forth in the term loan agreement, the insolvency of the Company or upon the occurrence of a material adverse change.  As of December&#160;31, 2019, the Company was in compliance with all applicable financial covenants.  As of December&#160;31, 2019, management does not believe that it is probable that the above clauses will be triggered within the next twelve months, therefore, the debt is classified as long-term on the balance sheet.</span></div><ix:nonNumeric contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" name="us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzYvZnJhZzoxOTU5MjdlNmJiMzM0YTFlOTUzMzQyYTNiNmRiYzA3YS90ZXh0cmVnaW9uOjE5NTkyN2U2YmIzMzRhMWU5NTMzNDJhM2I2ZGJjMDdhXzUzODY_4ba8a593-79a0-4190-b0ec-b55fe128d568" escape="true"><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Future maturities under the term loan agreement as of December&#160;31, 2019 are as follows (in thousands):</span></div><div style="margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:83.256%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:11.943%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Year Ending December 31:</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Amount</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzYvZnJhZzoxOTU5MjdlNmJiMzM0YTFlOTUzMzQyYTNiNmRiYzA3YS90YWJsZTo3NDgyNjQ4NzllMTQ0M2E4YmUxNmRjNjI0NDVkNWNlNS90YWJsZXJhbmdlOjc0ODI2NDg3OWUxNDQzYThiZTE2ZGM2MjQ0NWQ1Y2U1XzItMi0xLTEtMA_a1ab850d-9da8-4b82-a3eb-0b8c0b5528d3">4,454</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2021</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzYvZnJhZzoxOTU5MjdlNmJiMzM0YTFlOTUzMzQyYTNiNmRiYzA3YS90YWJsZTo3NDgyNjQ4NzllMTQ0M2E4YmUxNmRjNjI0NDVkNWNlNS90YWJsZXJhbmdlOjc0ODI2NDg3OWUxNDQzYThiZTE2ZGM2MjQ0NWQ1Y2U1XzMtMi0xLTEtMA_328d9084-5760-4f47-b54b-63c4c38941ef">4,442</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2022</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzYvZnJhZzoxOTU5MjdlNmJiMzM0YTFlOTUzMzQyYTNiNmRiYzA3YS90YWJsZTo3NDgyNjQ4NzllMTQ0M2E4YmUxNmRjNjI0NDVkNWNlNS90YWJsZXJhbmdlOjc0ODI2NDg3OWUxNDQzYThiZTE2ZGM2MjQ0NWQ1Y2U1XzQtMi0xLTEtMA_f42d5c55-6c87-4ac3-8aa8-461c89f51615">48,256</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="-3" format="ixt:numdotdecimal" name="silk:LongTermDebtGrossBeforeAccretionOfClosingFees" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzYvZnJhZzoxOTU5MjdlNmJiMzM0YTFlOTUzMzQyYTNiNmRiYzA3YS90YWJsZTo3NDgyNjQ4NzllMTQ0M2E4YmUxNmRjNjI0NDVkNWNlNS90YWJsZXJhbmdlOjc0ODI2NDg3OWUxNDQzYThiZTE2ZGM2MjQ0NWQ1Y2U1XzUtMi0xLTEtMA_dc5aadf2-a20a-4875-b05c-0c20e4c76b48">57,152</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Add: Accretion of closing fees</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="-3" format="ixt:numdotdecimal" name="silk:LongTermDebtAccretionOfClosingFees" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzYvZnJhZzoxOTU5MjdlNmJiMzM0YTFlOTUzMzQyYTNiNmRiYzA3YS90YWJsZTo3NDgyNjQ4NzllMTQ0M2E4YmUxNmRjNjI0NDVkNWNlNS90YWJsZXJhbmdlOjc0ODI2NDg3OWUxNDQzYThiZTE2ZGM2MjQ0NWQ1Y2U1XzYtMi0xLTEtMA_7e03ba0e-3d42-495c-bc17-2e25fc93cf56">1,205</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzYvZnJhZzoxOTU5MjdlNmJiMzM0YTFlOTUzMzQyYTNiNmRiYzA3YS90YWJsZTo3NDgyNjQ4NzllMTQ0M2E4YmUxNmRjNjI0NDVkNWNlNS90YWJsZXJhbmdlOjc0ODI2NDg3OWUxNDQzYThiZTE2ZGM2MjQ0NWQ1Y2U1XzctMi0xLTEtMA_38876a84-46a5-4384-81c3-6fd150861c4b">58,357</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Less: Amount representing interest</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="-3" format="ixt:numdotdecimal" name="silk:LongTermDebtUnpaidInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzYvZnJhZzoxOTU5MjdlNmJiMzM0YTFlOTUzMzQyYTNiNmRiYzA3YS90YWJsZTo3NDgyNjQ4NzllMTQ0M2E4YmUxNmRjNjI0NDVkNWNlNS90YWJsZXJhbmdlOjc0ODI2NDg3OWUxNDQzYThiZTE2ZGM2MjQ0NWQ1Y2U1XzgtMi0xLTEtMA_06ea7926-c17b-4f6b-945d-8d73dd8f92d6">13,339</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Less: Amount representing debt discount and debt issuance costs</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzYvZnJhZzoxOTU5MjdlNmJiMzM0YTFlOTUzMzQyYTNiNmRiYzA3YS90YWJsZTo3NDgyNjQ4NzllMTQ0M2E4YmUxNmRjNjI0NDVkNWNlNS90YWJsZXJhbmdlOjc0ODI2NDg3OWUxNDQzYThiZTE2ZGM2MjQ0NWQ1Y2U1XzktMi0xLTEtMA_6ee95b55-3683-4fac-b5e6-63128c971d2f">139</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:36pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Present value of minimum payments</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzYvZnJhZzoxOTU5MjdlNmJiMzM0YTFlOTUzMzQyYTNiNmRiYzA3YS90YWJsZTo3NDgyNjQ4NzllMTQ0M2E4YmUxNmRjNjI0NDVkNWNlNS90YWJsZXJhbmdlOjc0ODI2NDg3OWUxNDQzYThiZTE2ZGM2MjQ0NWQ1Y2U1XzEwLTItMS0xLTA_7023e9fa-0ffe-432b-a1c7-a92ee05dc221">44,879</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div></ix:nonNumeric><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In October 2015, CRG purchased <ix:nonFraction unitRef="shares" contextRef="i4225226f93604e02af259bb86559e5b8_D20151001-20151031" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzYvZnJhZzoxOTU5MjdlNmJiMzM0YTFlOTUzMzQyYTNiNmRiYzA3YS90ZXh0cmVnaW9uOjE5NTkyN2U2YmIzMzRhMWU5NTMzNDJhM2I2ZGJjMDdhXzMyOTg1MzQ4ODk3OTA_bdc40c8f-5964-451d-bfbd-0ee964a4c662">327,759</ix:nonFraction> shares of the Company&#8217;s Series C redeemable convertible preferred stock at $<ix:nonFraction unitRef="usdPerShare" contextRef="i5675339c673448139076ebcb2b762771_I20151031" decimals="INF" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzYvZnJhZzoxOTU5MjdlNmJiMzM0YTFlOTUzMzQyYTNiNmRiYzA3YS90ZXh0cmVnaW9uOjE5NTkyN2U2YmIzMzRhMWU5NTMzNDJhM2I2ZGJjMDdhXzMyOTg1MzQ4ODk3OTQ_96b1b111-044a-467a-8629-9538e1b78c73">6.11</ix:nonFraction> per share.  In addition, CRG received warrants to purchase <ix:nonFraction unitRef="shares" contextRef="i69a4c0c247dc496998d701bc90ebe115_I20151031" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ClassOfWarrantOrRightOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzYvZnJhZzoxOTU5MjdlNmJiMzM0YTFlOTUzMzQyYTNiNmRiYzA3YS90ZXh0cmVnaW9uOjE5NTkyN2U2YmIzMzRhMWU5NTMzNDJhM2I2ZGJjMDdhXzMyOTg1MzQ4ODk3OTg_7b79eaaf-a97a-4313-80b5-0507034d8020">163,877</ix:nonFraction> shares of the Company&#8217;s Series C redeemable convertible preferred stock at an exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i5675339c673448139076ebcb2b762771_I20151031" decimals="INF" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzYvZnJhZzoxOTU5MjdlNmJiMzM0YTFlOTUzMzQyYTNiNmRiYzA3YS90ZXh0cmVnaW9uOjE5NTkyN2U2YmIzMzRhMWU5NTMzNDJhM2I2ZGJjMDdhXzMyOTg1MzQ4ODk4MDI_b5b1a6ee-1aae-43cf-8b53-9084473af430">6.11</ix:nonFraction> per share.  Upon the closing of the IPO, the warrants were net exercised, based on the IPO price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i6ed3f43f8f3b4ec3b256ad182faa9d25_I20190430" decimals="INF" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzYvZnJhZzoxOTU5MjdlNmJiMzM0YTFlOTUzMzQyYTNiNmRiYzA3YS90ZXh0cmVnaW9uOjE5NTkyN2U2YmIzMzRhMWU5NTMzNDJhM2I2ZGJjMDdhXzMyOTg1MzQ4ODk4MTg_a4903343-efb8-4751-adcb-19111f745184">20.00</ix:nonFraction> per share, into shares of common stock. </span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In July 2017, CRG purchased <ix:nonFraction unitRef="shares" contextRef="i6665fb41539543faa5c665e0459d1cf6_D20170701-20170731" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzYvZnJhZzoxOTU5MjdlNmJiMzM0YTFlOTUzMzQyYTNiNmRiYzA3YS90ZXh0cmVnaW9uOjE5NTkyN2U2YmIzMzRhMWU5NTMzNDJhM2I2ZGJjMDdhXzMyOTg1MzQ4ODk4MDY_f6c3ca47-6ad9-4cdd-a260-7924c9c3d18c">163,877</ix:nonFraction> shares of the Company&#8217;s Series C convertible preferred stock at $<ix:nonFraction unitRef="usdPerShare" contextRef="i4c8c2ee5923d47dfb022beb8e861a8c5_I20170731" decimals="INF" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzYvZnJhZzoxOTU5MjdlNmJiMzM0YTFlOTUzMzQyYTNiNmRiYzA3YS90ZXh0cmVnaW9uOjE5NTkyN2U2YmIzMzRhMWU5NTMzNDJhM2I2ZGJjMDdhXzMyOTg1MzQ4ODk4MTA_05eee9e0-91d2-4b01-94e3-f7dcb7a986b1">6.11</ix:nonFraction> per share.</span></div></ix:continuation><div id="i58f397e86dfd4fc4ac3b8695cd31238e_139"></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">134</span></div></div></div><hr style="page-break-after:always"/><div style="height:90pt;width:100%;"><div style="margin-bottom:9pt;"><span><br/></span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">7.&#160;<ix:nonNumeric contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzkvZnJhZzoxMzVmYTRlNzEwNzg0YTI5OTAxNmEzOWU5YmIyZGIzZi90ZXh0cmVnaW9uOjEzNWZhNGU3MTA3ODRhMjk5MDE2YTM5ZTliYjJkYjNmXzM4MDg_65045684-3416-444b-994b-75d025b73943" continuedAt="ie6f37f8af88543e8b3bc6c0018a7c1fb" escape="true">Commitments and Contingencies</ix:nonNumeric></span></div><ix:continuation id="ie6f37f8af88543e8b3bc6c0018a7c1fb" continuedAt="i1ee8df8a4aee4331819a7210bd7e9ce8"><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Operating Lease and Rights of Use</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company&#8217;s operating lease obligation consists of leased office, laboratory, and manufacturing space under a non-cancellable operating lease that expires in October&#160;2024. The lease agreement includes a renewal provision allowing the Company to extend this lease for an additional period of <ix:nonNumeric contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" format="ixt-sec:durwordsen" name="us-gaap:LesseeOperatingLeaseRenewalTerm" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzkvZnJhZzoxMzVmYTRlNzEwNzg0YTI5OTAxNmEzOWU5YmIyZGIzZi90ZXh0cmVnaW9uOjEzNWZhNGU3MTA3ODRhMjk5MDE2YTM5ZTliYjJkYjNmXzIxOTkwMjMyNjczNTg_e1c396a3-2b0d-44d9-a8b2-1a154817d486">five years</ix:nonNumeric>.   Operating lease costs were $<ix:nonFraction unitRef="usd" contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseCost" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzkvZnJhZzoxMzVmYTRlNzEwNzg0YTI5OTAxNmEzOWU5YmIyZGIzZi90ZXh0cmVnaW9uOjEzNWZhNGU3MTA3ODRhMjk5MDE2YTM5ZTliYjJkYjNmXzMyOTg1MzQ4ODgwOTQ_03767b85-c487-45af-a0bf-c5a9729d6dd1">870,000</ix:nonFraction> for the year ended December&#160;31, 2019.  Cash paid for amounts included in the measurement of operating lease liabilities was $<ix:nonFraction unitRef="usd" contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeasePayments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzkvZnJhZzoxMzVmYTRlNzEwNzg0YTI5OTAxNmEzOWU5YmIyZGIzZi90ZXh0cmVnaW9uOjEzNWZhNGU3MTA3ODRhMjk5MDE2YTM5ZTliYjJkYjNmXzMyOTg1MzQ4ODgyMjM_e49ddef3-24a3-4a27-b5da-496fcc24b087">721,000</ix:nonFraction> for the year ended December&#160;31, 2019.  As of December&#160;31, 2019, the weighted average discount rate was approximately <ix:nonFraction unitRef="number" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="4" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzkvZnJhZzoxMzVmYTRlNzEwNzg0YTI5OTAxNmEzOWU5YmIyZGIzZi90ZXh0cmVnaW9uOjEzNWZhNGU3MTA3ODRhMjk5MDE2YTM5ZTliYjJkYjNmXzMyOTg1MzQ4ODgyMTM_a89a99f0-00e4-410f-ac51-e15d0b5d5496">6.50</ix:nonFraction>% and the weighted average remaining lease term was <ix:nonNumeric contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" format="ixt-sec:duryear" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzkvZnJhZzoxMzVmYTRlNzEwNzg0YTI5OTAxNmEzOWU5YmIyZGIzZi90ZXh0cmVnaW9uOjEzNWZhNGU3MTA3ODRhMjk5MDE2YTM5ZTliYjJkYjNmXzMyOTg1MzQ4ODgyNDk_f8a060c1-5db5-4a78-9e2f-04157e5661b5">4.83</ix:nonNumeric> years.  <ix:continuation id="i02c3d9e32cea4300aeefb7b2a001aba8" continuedAt="i50eca64b828e4525a5eb729005e5d116">Balance sheet information as of December&#160;31, 2019 consists of the following (in thousands):</ix:continuation></span></div><div style="margin-bottom:9pt;"><ix:continuation id="i50eca64b828e4525a5eb729005e5d116"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:77.647%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.441%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:17.712%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operating Lease:</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operating lease right-of-use asset in other non-current assets</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzkvZnJhZzoxMzVmYTRlNzEwNzg0YTI5OTAxNmEzOWU5YmIyZGIzZi90YWJsZTo1NTM0NjY2MDgxZTg0YWYxODM0N2Q4YTliMzE0MzA5NS90YWJsZXJhbmdlOjU1MzQ2NjYwODFlODRhZjE4MzQ3ZDhhOWIzMTQzMDk1XzEtMi0xLTEtMTc5Ng_c09bb0fc-73c6-4015-abb2-f86cd0ce1c93">3,400</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operating lease liability in accrued liabilities</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzkvZnJhZzoxMzVmYTRlNzEwNzg0YTI5OTAxNmEzOWU5YmIyZGIzZi90YWJsZTo1NTM0NjY2MDgxZTg0YWYxODM0N2Q4YTliMzE0MzA5NS90YWJsZXJhbmdlOjU1MzQ2NjYwODFlODRhZjE4MzQ3ZDhhOWIzMTQzMDk1XzItMi0xLTEtMTc5OQ_86d17ef7-9077-4432-9b7a-476ae57205b3">769</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operating lease liability in other liabilities</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzkvZnJhZzoxMzVmYTRlNzEwNzg0YTI5OTAxNmEzOWU5YmIyZGIzZi90YWJsZTo1NTM0NjY2MDgxZTg0YWYxODM0N2Q4YTliMzE0MzA5NS90YWJsZXJhbmdlOjU1MzQ2NjYwODFlODRhZjE4MzQ3ZDhhOWIzMTQzMDk1XzMtMi0xLTEtMTc5OQ_e3043960-e486-40be-b8c7-3ae9eda12aea">3,700</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total operating lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzkvZnJhZzoxMzVmYTRlNzEwNzg0YTI5OTAxNmEzOWU5YmIyZGIzZi90YWJsZTo1NTM0NjY2MDgxZTg0YWYxODM0N2Q4YTliMzE0MzA5NS90YWJsZXJhbmdlOjU1MzQ2NjYwODFlODRhZjE4MzQ3ZDhhOWIzMTQzMDk1XzQtMi0xLTEtMTc5OQ_7671a70c-ba9b-4105-9de2-224a40f4a2fa">4,469</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></ix:continuation></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span></div><ix:nonNumeric contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzkvZnJhZzoxMzVmYTRlNzEwNzg0YTI5OTAxNmEzOWU5YmIyZGIzZi90ZXh0cmVnaW9uOjEzNWZhNGU3MTA3ODRhMjk5MDE2YTM5ZTliYjJkYjNmXzIxOTkwMjMyNjczNTY_89fa738b-a998-4555-978e-faeb177d7ca6" escape="true"><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table summarizes the Company's operating lease maturities as of December&#160;31, 2019 (in thousands):</span></div><div style="margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:76.980%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.436%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:18.384%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Year Ending December 31:</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Amount</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzkvZnJhZzoxMzVmYTRlNzEwNzg0YTI5OTAxNmEzOWU5YmIyZGIzZi90YWJsZTo3NzY3NTg3MDE0OTk0ZTYwYWQxMDIxZTk2ZjY3OTkxZi90YWJsZXJhbmdlOjc3Njc1ODcwMTQ5OTRlNjBhZDEwMjFlOTZmNjc5OTFmXzEtMS0xLTEtMTg4NQ_203afe91-1577-4fc1-aca5-f372945244f8">1,037</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2021</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzkvZnJhZzoxMzVmYTRlNzEwNzg0YTI5OTAxNmEzOWU5YmIyZGIzZi90YWJsZTo3NzY3NTg3MDE0OTk0ZTYwYWQxMDIxZTk2ZjY3OTkxZi90YWJsZXJhbmdlOjc3Njc1ODcwMTQ5OTRlNjBhZDEwMjFlOTZmNjc5OTFmXzItMS0xLTEtMTg4NQ_20343808-d473-4db0-a1a7-34c2b340d727">1,066</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2022</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzkvZnJhZzoxMzVmYTRlNzEwNzg0YTI5OTAxNmEzOWU5YmIyZGIzZi90YWJsZTo3NzY3NTg3MDE0OTk0ZTYwYWQxMDIxZTk2ZjY3OTkxZi90YWJsZXJhbmdlOjc3Njc1ODcwMTQ5OTRlNjBhZDEwMjFlOTZmNjc5OTFmXzMtMS0xLTEtMTg4NQ_b9bd1dc7-f2b9-4a1e-87b7-ae436db79c5c">1,096</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2023</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzkvZnJhZzoxMzVmYTRlNzEwNzg0YTI5OTAxNmEzOWU5YmIyZGIzZi90YWJsZTo3NzY3NTg3MDE0OTk0ZTYwYWQxMDIxZTk2ZjY3OTkxZi90YWJsZXJhbmdlOjc3Njc1ODcwMTQ5OTRlNjBhZDEwMjFlOTZmNjc5OTFmXzQtMS0xLTEtMTg4NQ_2f8a605f-c9f2-4489-a7c7-9b01559066ac">1,127</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2024</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzkvZnJhZzoxMzVmYTRlNzEwNzg0YTI5OTAxNmEzOWU5YmIyZGIzZi90YWJsZTo3NzY3NTg3MDE0OTk0ZTYwYWQxMDIxZTk2ZjY3OTkxZi90YWJsZXJhbmdlOjc3Njc1ODcwMTQ5OTRlNjBhZDEwMjFlOTZmNjc5OTFmXzUtMS0xLTEtMTg4NQ_5a97ae2f-83fb-44d1-8c86-a0f623d94579">904</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total lease payments</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzkvZnJhZzoxMzVmYTRlNzEwNzg0YTI5OTAxNmEzOWU5YmIyZGIzZi90YWJsZTo3NzY3NTg3MDE0OTk0ZTYwYWQxMDIxZTk2ZjY3OTkxZi90YWJsZXJhbmdlOjc3Njc1ODcwMTQ5OTRlNjBhZDEwMjFlOTZmNjc5OTFmXzYtMS0xLTEtMTg4NQ_1934f6b0-b804-41fb-92b5-7b81b5cc4e37">5,230</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Less: imputed interest</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzkvZnJhZzoxMzVmYTRlNzEwNzg0YTI5OTAxNmEzOWU5YmIyZGIzZi90YWJsZTo3NzY3NTg3MDE0OTk0ZTYwYWQxMDIxZTk2ZjY3OTkxZi90YWJsZXJhbmdlOjc3Njc1ODcwMTQ5OTRlNjBhZDEwMjFlOTZmNjc5OTFmXzctMS0xLTEtMTg4NQ_e3d5844f-8536-49ca-8d7a-75a3da228eee">761</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:18pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Present value of lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzkvZnJhZzoxMzVmYTRlNzEwNzg0YTI5OTAxNmEzOWU5YmIyZGIzZi90YWJsZTo3NzY3NTg3MDE0OTk0ZTYwYWQxMDIxZTk2ZjY3OTkxZi90YWJsZXJhbmdlOjc3Njc1ODcwMTQ5OTRlNjBhZDEwMjFlOTZmNjc5OTFmXzgtMS0xLTEtMTg4NQ_d7dc6cde-51cc-4e95-8212-b18fb7eaf0dc">4,469</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:12pt;"><span><br/></span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">135</span></div></div></div><hr style="page-break-after:always"/><div style="height:90pt;width:100%;"><div style="margin-bottom:9pt;"><span><br/></span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><ix:continuation id="i1ee8df8a4aee4331819a7210bd7e9ce8" continuedAt="ia3eacdfade08460082f6bcbe6bdbac85"><ix:nonNumeric contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" name="us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzkvZnJhZzoxMzVmYTRlNzEwNzg0YTI5OTAxNmEzOWU5YmIyZGIzZi90ZXh0cmVnaW9uOjEzNWZhNGU3MTA3ODRhMjk5MDE2YTM5ZTliYjJkYjNmXzM4MDk_44e87016-4702-4463-b9ad-9279e46cad0c" escape="true"><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The aggregate future minimum lease payments under ASC 840 as of December&#160;31, 2018 were as follows (in thousands):</span></div><div style="margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:83.416%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.441%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:11.943%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Year Ending December 31:</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total Minimum<br/>Lease Payments</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzkvZnJhZzoxMzVmYTRlNzEwNzg0YTI5OTAxNmEzOWU5YmIyZGIzZi90YWJsZTo3NTUzM2Y0NDJhMTU0OTliOTAwNGMyMzAzOGU0OGJhMy90YWJsZXJhbmdlOjc1NTMzZjQ0MmExNTQ5OWI5MDA0YzIzMDM4ZTQ4YmEzXzEtMS0xLTEtMA_8546d274-386f-4a92-a7eb-4bf6b23c28bd">1,002</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzkvZnJhZzoxMzVmYTRlNzEwNzg0YTI5OTAxNmEzOWU5YmIyZGIzZi90YWJsZTo3NTUzM2Y0NDJhMTU0OTliOTAwNGMyMzAzOGU0OGJhMy90YWJsZXJhbmdlOjc1NTMzZjQ0MmExNTQ5OWI5MDA0YzIzMDM4ZTQ4YmEzXzItMS0xLTEtMA_72b6e859-d4d4-4708-82c4-3e0b3e5dc170">1,002</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2021</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzkvZnJhZzoxMzVmYTRlNzEwNzg0YTI5OTAxNmEzOWU5YmIyZGIzZi90YWJsZTo3NTUzM2Y0NDJhMTU0OTliOTAwNGMyMzAzOGU0OGJhMy90YWJsZXJhbmdlOjc1NTMzZjQ0MmExNTQ5OWI5MDA0YzIzMDM4ZTQ4YmEzXzMtMS0xLTEtMA_9e9a6d3b-e3a2-42df-80d0-484bc0fd596e">1,031</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2022</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFourYears" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzkvZnJhZzoxMzVmYTRlNzEwNzg0YTI5OTAxNmEzOWU5YmIyZGIzZi90YWJsZTo3NTUzM2Y0NDJhMTU0OTliOTAwNGMyMzAzOGU0OGJhMy90YWJsZXJhbmdlOjc1NTMzZjQ0MmExNTQ5OWI5MDA0YzIzMDM4ZTQ4YmEzXzQtMS0xLTEtMA_c86317e5-a400-4e6c-bde3-d5b52a6b871d">1,044</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2023 and thereafter</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFiveYears" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzkvZnJhZzoxMzVmYTRlNzEwNzg0YTI5OTAxNmEzOWU5YmIyZGIzZi90YWJsZTo3NTUzM2Y0NDJhMTU0OTliOTAwNGMyMzAzOGU0OGJhMy90YWJsZXJhbmdlOjc1NTMzZjQ0MmExNTQ5OWI5MDA0YzIzMDM4ZTQ4YmEzXzUtMS0xLTEtMA_803b56a7-e658-4046-9098-501e1a788557">1,920</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeasesFutureMinimumPaymentsDue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzkvZnJhZzoxMzVmYTRlNzEwNzg0YTI5OTAxNmEzOWU5YmIyZGIzZi90YWJsZTo3NTUzM2Y0NDJhMTU0OTliOTAwNGMyMzAzOGU0OGJhMy90YWJsZXJhbmdlOjc1NTMzZjQ0MmExNTQ5OWI5MDA0YzIzMDM4ZTQ4YmEzXzYtMS0xLTEtMA_3a97f9d2-1a3c-4801-a05c-edc4fb8a2db4">5,999</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div></ix:nonNumeric><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Purchase Obligations</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Purchase obligations consist of agreements to purchase goods and services entered into in the ordinary course of business.  As of December&#160;31, 2019, the Company had non-cancellable purchase obligations to suppliers of $<ix:nonFraction unitRef="usd" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PurchaseObligation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzkvZnJhZzoxMzVmYTRlNzEwNzg0YTI5OTAxNmEzOWU5YmIyZGIzZi90ZXh0cmVnaW9uOjEzNWZhNGU3MTA3ODRhMjk5MDE2YTM5ZTliYjJkYjNmXzMyOTg1MzQ4ODcxODA_cc90fae2-6f56-43bd-947b-e4090c846be1">7,097,000</ix:nonFraction>.</span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Indemnification</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In the normal course of business, the Company enters into contracts and agreements with suppliers and other parties that contain a variety of representations and warranties and may provide for indemnification of the counterparty.  The Company&#8217;s exposure under these agreements is unknown because it involves claims that may be made against it in the future but have not yet been made.  To date, the Company has not been subject to any claims or been required to defend any action related to its indemnification obligations.</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company indemnifies each of its directors and officers for certain events or occurrences, subject to certain limits, while the director is or was serving at the Company&#8217;s request in such capacity, as permitted under Delaware law and in accordance with its certificate of incorporation and bylaws.  The term of the indemnification period lasts as long as a director may be subject to any proceeding arising out of acts or omissions of such director in such capacity.  The maximum amount of potential future indemnification is unlimited; however, the Company currently holds director liability insurance.  The Company believes that the fair value of these indemnification obligations is minimal.  Accordingly, the Company has not recognized any liabilities relating to these obligations as of December&#160;31, 2019.</span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Contingencies </span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company is not involved in any pending legal proceedings that it believes could have a material adverse effect on its financial condition, results of operations or cash flows. From time to time, the Company may pursue litigation to assert its legal right and such litigation may be costly and divert the efforts and attention of its management and technical personnel which could adversely affect its business. The Company accrues a liability for such matters when it is probable that future expenditures will be made and such expenditures can be reasonably estimated. There were no contingent liabilities requiring accrual at December&#160;31, 2019 and 2018.</span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Legal Matters</span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In February 2019, a former employee, through counsel, advised the Company that he had filed a charge of discrimination against the Company with the California Department of Fair Employment &amp; Housing, or </span></div></ix:continuation><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">136</span></div></div></div><hr style="page-break-after:always"/><div style="height:90pt;width:100%;"><div style="margin-bottom:9pt;"><span><br/></span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"><ix:continuation id="ia3eacdfade08460082f6bcbe6bdbac85">DFEH.  The former employee&#8217;s complaint alleged sexual harassment and retaliation in violation of the California Department of Fair Employment &amp; Housing Act.  The complaint did not allege specific damages. The Company and the former employee participated in mediation on July 30, 2019 and reached a settlement that required the Company to pay an amount that was not material to its financial statements, which amount was fully paid as of December&#160;31, 2019.</ix:continuation></span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span><br/></span></div><div id="i58f397e86dfd4fc4ac3b8695cd31238e_145"></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">8.&#160;<ix:nonNumeric contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNDUvZnJhZzoxY2M4ZDYxMThmYTQ0ZmViOTNhMjY5M2JmMjUxNzc2OS90ZXh0cmVnaW9uOjFjYzhkNjExOGZhNDRmZWI5M2EyNjkzYmYyNTE3NzY5XzYwNjk_59478646-ee80-4361-9788-eed193de74d7" continuedAt="i0018732a45fe451f89799861bc389b7c" escape="true">Redeemable Convertible Preferred Stock</ix:nonNumeric></span></div><ix:continuation id="i0018732a45fe451f89799861bc389b7c" continuedAt="ie182b400cc304659b12a53490078d4c8"><ix:nonNumeric contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" name="us-gaap:TemporaryEquityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNDUvZnJhZzoxY2M4ZDYxMThmYTQ0ZmViOTNhMjY5M2JmMjUxNzc2OS90ZXh0cmVnaW9uOjFjYzhkNjExOGZhNDRmZWI5M2EyNjkzYmYyNTE3NzY5XzYwNzA_1f68b5eb-5cf6-4a77-b266-ab343e547d9d" escape="true"><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company had the following redeemable convertible preferred stock issued and outstanding at December&#160;31, 2018 (in thousands except share amounts): </span></div><div style="text-align:center;margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:99.839%;"><tr><td style="width:1.0%;"></td><td style="width:23.040%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:11.964%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.602%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:11.964%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.602%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:11.964%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.602%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:12.927%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.602%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:12.933%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Shares<br/>Authorized</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Shares Issued and<br/>Outstanding</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Per share <br/>Preference</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Preferential<br/>Liquidation Value (in thousands)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Carrying Value (in thousands)</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Series</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Series A</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i7f1961a81c2146ba86c1873951eb5d0f_I20181231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquitySharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNDUvZnJhZzoxY2M4ZDYxMThmYTQ0ZmViOTNhMjY5M2JmMjUxNzc2OS90YWJsZTowN2UxNWY1NTUyYjM0ODlmOWEyODAyOGI1Y2ZmODUxOC90YWJsZXJhbmdlOjA3ZTE1ZjU1NTJiMzQ4OWY5YTI4MDI4YjVjZmY4NTE4XzMtMS0xLTEtMA_7eff8a58-4beb-4fa1-ad42-4e3f4281cccd">1,629,629</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i7f1961a81c2146ba86c1873951eb5d0f_I20181231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquitySharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNDUvZnJhZzoxY2M4ZDYxMThmYTQ0ZmViOTNhMjY5M2JmMjUxNzc2OS90YWJsZTowN2UxNWY1NTUyYjM0ODlmOWEyODAyOGI1Y2ZmODUxOC90YWJsZXJhbmdlOjA3ZTE1ZjU1NTJiMzQ4OWY5YTI4MDI4YjVjZmY4NTE4XzMtMy0xLTEtMA_1e6b6163-4b6d-4384-99d1-5cae7d830eb4"><ix:nonFraction unitRef="shares" contextRef="i7f1961a81c2146ba86c1873951eb5d0f_I20181231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquitySharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNDUvZnJhZzoxY2M4ZDYxMThmYTQ0ZmViOTNhMjY5M2JmMjUxNzc2OS90YWJsZTowN2UxNWY1NTUyYjM0ODlmOWEyODAyOGI1Y2ZmODUxOC90YWJsZXJhbmdlOjA3ZTE1ZjU1NTJiMzQ4OWY5YTI4MDI4YjVjZmY4NTE4XzMtMy0xLTEtMA_33b8a757-a488-4eb9-9958-706f485826b0">1,629,626</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="i7f1961a81c2146ba86c1873951eb5d0f_I20181231" decimals="2" name="us-gaap:TemporaryEquityLiquidationPreferencePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNDUvZnJhZzoxY2M4ZDYxMThmYTQ0ZmViOTNhMjY5M2JmMjUxNzc2OS90YWJsZTowN2UxNWY1NTUyYjM0ODlmOWEyODAyOGI1Y2ZmODUxOC90YWJsZXJhbmdlOjA3ZTE1ZjU1NTJiMzQ4OWY5YTI4MDI4YjVjZmY4NTE4XzMtNS0xLTEtMA_edd82fdc-693d-454f-a04f-120eab13f8d2">2.70</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7f1961a81c2146ba86c1873951eb5d0f_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquityLiquidationPreference" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNDUvZnJhZzoxY2M4ZDYxMThmYTQ0ZmViOTNhMjY5M2JmMjUxNzc2OS90YWJsZTowN2UxNWY1NTUyYjM0ODlmOWEyODAyOGI1Y2ZmODUxOC90YWJsZXJhbmdlOjA3ZTE1ZjU1NTJiMzQ4OWY5YTI4MDI4YjVjZmY4NTE4XzMtNy0xLTEtMA_7c474796-11b3-4d63-b6ea-e4fbfc361ff6">4,400</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7f1961a81c2146ba86c1873951eb5d0f_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNDUvZnJhZzoxY2M4ZDYxMThmYTQ0ZmViOTNhMjY5M2JmMjUxNzc2OS90YWJsZTowN2UxNWY1NTUyYjM0ODlmOWEyODAyOGI1Y2ZmODUxOC90YWJsZXJhbmdlOjA3ZTE1ZjU1NTJiMzQ4OWY5YTI4MDI4YjVjZmY4NTE4XzMtOS0xLTEtMA_3b67ee1a-1d3a-46a0-b78a-476bf327fa4c">4,369</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Series A-1</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="idef65aa8bbea40b3adcc724c6f06297a_I20181231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquitySharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNDUvZnJhZzoxY2M4ZDYxMThmYTQ0ZmViOTNhMjY5M2JmMjUxNzc2OS90YWJsZTowN2UxNWY1NTUyYjM0ODlmOWEyODAyOGI1Y2ZmODUxOC90YWJsZXJhbmdlOjA3ZTE1ZjU1NTJiMzQ4OWY5YTI4MDI4YjVjZmY4NTE4XzQtMS0xLTEtMA_f9e8293a-6406-4701-b781-b72f002f46d6">1,111,111</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="idef65aa8bbea40b3adcc724c6f06297a_I20181231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquitySharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNDUvZnJhZzoxY2M4ZDYxMThmYTQ0ZmViOTNhMjY5M2JmMjUxNzc2OS90YWJsZTowN2UxNWY1NTUyYjM0ODlmOWEyODAyOGI1Y2ZmODUxOC90YWJsZXJhbmdlOjA3ZTE1ZjU1NTJiMzQ4OWY5YTI4MDI4YjVjZmY4NTE4XzQtMy0xLTEtMA_74417e5f-d728-4767-bf04-369ba33e30cd"><ix:nonFraction unitRef="shares" contextRef="idef65aa8bbea40b3adcc724c6f06297a_I20181231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquitySharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNDUvZnJhZzoxY2M4ZDYxMThmYTQ0ZmViOTNhMjY5M2JmMjUxNzc2OS90YWJsZTowN2UxNWY1NTUyYjM0ODlmOWEyODAyOGI1Y2ZmODUxOC90YWJsZXJhbmdlOjA3ZTE1ZjU1NTJiMzQ4OWY5YTI4MDI4YjVjZmY4NTE4XzQtMy0xLTEtMA_cf3e4991-c5d9-420e-a6d3-d422025977b5">1,111,109</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="idef65aa8bbea40b3adcc724c6f06297a_I20181231" decimals="2" name="us-gaap:TemporaryEquityLiquidationPreferencePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNDUvZnJhZzoxY2M4ZDYxMThmYTQ0ZmViOTNhMjY5M2JmMjUxNzc2OS90YWJsZTowN2UxNWY1NTUyYjM0ODlmOWEyODAyOGI1Y2ZmODUxOC90YWJsZXJhbmdlOjA3ZTE1ZjU1NTJiMzQ4OWY5YTI4MDI4YjVjZmY4NTE4XzQtNS0xLTEtMA_f73dbaaa-0e38-434c-b8c8-b643cd685d4c">3.38</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idef65aa8bbea40b3adcc724c6f06297a_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquityLiquidationPreference" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNDUvZnJhZzoxY2M4ZDYxMThmYTQ0ZmViOTNhMjY5M2JmMjUxNzc2OS90YWJsZTowN2UxNWY1NTUyYjM0ODlmOWEyODAyOGI1Y2ZmODUxOC90YWJsZXJhbmdlOjA3ZTE1ZjU1NTJiMzQ4OWY5YTI4MDI4YjVjZmY4NTE4XzQtNy0xLTEtMA_5bfdb187-45b9-4d84-8a56-aa103286311b">3,755</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idef65aa8bbea40b3adcc724c6f06297a_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNDUvZnJhZzoxY2M4ZDYxMThmYTQ0ZmViOTNhMjY5M2JmMjUxNzc2OS90YWJsZTowN2UxNWY1NTUyYjM0ODlmOWEyODAyOGI1Y2ZmODUxOC90YWJsZXJhbmdlOjA3ZTE1ZjU1NTJiMzQ4OWY5YTI4MDI4YjVjZmY4NTE4XzQtOS0xLTEtMA_a7f46a9d-6f47-4bd6-8fe3-76537c49786f">3,723</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Series B</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i4afaed3dd6794f36b67d203a6ae5b570_I20181231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquitySharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNDUvZnJhZzoxY2M4ZDYxMThmYTQ0ZmViOTNhMjY5M2JmMjUxNzc2OS90YWJsZTowN2UxNWY1NTUyYjM0ODlmOWEyODAyOGI1Y2ZmODUxOC90YWJsZXJhbmdlOjA3ZTE1ZjU1NTJiMzQ4OWY5YTI4MDI4YjVjZmY4NTE4XzUtMS0xLTEtMA_59fcc3b7-100e-4c69-b0e3-43b8dda1d5c5">6,264,470</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i4afaed3dd6794f36b67d203a6ae5b570_I20181231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquitySharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNDUvZnJhZzoxY2M4ZDYxMThmYTQ0ZmViOTNhMjY5M2JmMjUxNzc2OS90YWJsZTowN2UxNWY1NTUyYjM0ODlmOWEyODAyOGI1Y2ZmODUxOC90YWJsZXJhbmdlOjA3ZTE1ZjU1NTJiMzQ4OWY5YTI4MDI4YjVjZmY4NTE4XzUtMy0xLTEtMA_a03796bd-331c-4174-9351-fc812910bdc5"><ix:nonFraction unitRef="shares" contextRef="i4afaed3dd6794f36b67d203a6ae5b570_I20181231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquitySharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNDUvZnJhZzoxY2M4ZDYxMThmYTQ0ZmViOTNhMjY5M2JmMjUxNzc2OS90YWJsZTowN2UxNWY1NTUyYjM0ODlmOWEyODAyOGI1Y2ZmODUxOC90YWJsZXJhbmdlOjA3ZTE1ZjU1NTJiMzQ4OWY5YTI4MDI4YjVjZmY4NTE4XzUtMy0xLTEtMA_fe6a84ae-970b-493c-ba80-bf07c85418ac">6,264,463</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="i4afaed3dd6794f36b67d203a6ae5b570_I20181231" decimals="2" name="us-gaap:TemporaryEquityLiquidationPreferencePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNDUvZnJhZzoxY2M4ZDYxMThmYTQ0ZmViOTNhMjY5M2JmMjUxNzc2OS90YWJsZTowN2UxNWY1NTUyYjM0ODlmOWEyODAyOGI1Y2ZmODUxOC90YWJsZXJhbmdlOjA3ZTE1ZjU1NTJiMzQ4OWY5YTI4MDI4YjVjZmY4NTE4XzUtNS0xLTEtMA_542e0d09-45e0-4e6d-be11-dd4b94485859">6.11</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4afaed3dd6794f36b67d203a6ae5b570_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquityLiquidationPreference" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNDUvZnJhZzoxY2M4ZDYxMThmYTQ0ZmViOTNhMjY5M2JmMjUxNzc2OS90YWJsZTowN2UxNWY1NTUyYjM0ODlmOWEyODAyOGI1Y2ZmODUxOC90YWJsZXJhbmdlOjA3ZTE1ZjU1NTJiMzQ4OWY5YTI4MDI4YjVjZmY4NTE4XzUtNy0xLTEtMA_f0e19e54-2567-4382-b6ea-7d4c9b646161">38,276</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4afaed3dd6794f36b67d203a6ae5b570_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNDUvZnJhZzoxY2M4ZDYxMThmYTQ0ZmViOTNhMjY5M2JmMjUxNzc2OS90YWJsZTowN2UxNWY1NTUyYjM0ODlmOWEyODAyOGI1Y2ZmODUxOC90YWJsZXJhbmdlOjA3ZTE1ZjU1NTJiMzQ4OWY5YTI4MDI4YjVjZmY4NTE4XzUtOS0xLTEtMA_2baebe6c-a176-4edb-ac22-cd4df8a40801">38,014</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Series C</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i12798862adb04861a6ae8feb9c091437_I20181231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquitySharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNDUvZnJhZzoxY2M4ZDYxMThmYTQ0ZmViOTNhMjY5M2JmMjUxNzc2OS90YWJsZTowN2UxNWY1NTUyYjM0ODlmOWEyODAyOGI1Y2ZmODUxOC90YWJsZXJhbmdlOjA3ZTE1ZjU1NTJiMzQ4OWY5YTI4MDI4YjVjZmY4NTE4XzYtMS0xLTEtMA_a26f9948-41b1-4a22-92cf-7c49711b3959">15,064,405</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i12798862adb04861a6ae8feb9c091437_I20181231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquitySharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNDUvZnJhZzoxY2M4ZDYxMThmYTQ0ZmViOTNhMjY5M2JmMjUxNzc2OS90YWJsZTowN2UxNWY1NTUyYjM0ODlmOWEyODAyOGI1Y2ZmODUxOC90YWJsZXJhbmdlOjA3ZTE1ZjU1NTJiMzQ4OWY5YTI4MDI4YjVjZmY4NTE4XzYtMy0xLTEtMA_9030f5ed-722f-4df6-a503-32f7237d00a3"><ix:nonFraction unitRef="shares" contextRef="i12798862adb04861a6ae8feb9c091437_I20181231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquitySharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNDUvZnJhZzoxY2M4ZDYxMThmYTQ0ZmViOTNhMjY5M2JmMjUxNzc2OS90YWJsZTowN2UxNWY1NTUyYjM0ODlmOWEyODAyOGI1Y2ZmODUxOC90YWJsZXJhbmdlOjA3ZTE1ZjU1NTJiMzQ4OWY5YTI4MDI4YjVjZmY4NTE4XzYtMy0xLTEtMA_fd506d5f-35fb-491b-9fc6-b3ff5b2ca7cb">12,227,992</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="i12798862adb04861a6ae8feb9c091437_I20181231" decimals="2" name="us-gaap:TemporaryEquityLiquidationPreferencePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNDUvZnJhZzoxY2M4ZDYxMThmYTQ0ZmViOTNhMjY5M2JmMjUxNzc2OS90YWJsZTowN2UxNWY1NTUyYjM0ODlmOWEyODAyOGI1Y2ZmODUxOC90YWJsZXJhbmdlOjA3ZTE1ZjU1NTJiMzQ4OWY5YTI4MDI4YjVjZmY4NTE4XzYtNS0xLTEtMA_2045bac7-eaa7-462b-b1e1-6fe169995908">6.11</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i12798862adb04861a6ae8feb9c091437_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquityLiquidationPreference" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNDUvZnJhZzoxY2M4ZDYxMThmYTQ0ZmViOTNhMjY5M2JmMjUxNzc2OS90YWJsZTowN2UxNWY1NTUyYjM0ODlmOWEyODAyOGI1Y2ZmODUxOC90YWJsZXJhbmdlOjA3ZTE1ZjU1NTJiMzQ4OWY5YTI4MDI4YjVjZmY4NTE4XzYtNy0xLTEtMA_b8d07496-2ff5-4039-9b0f-04c1c9a363ef">74,713</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i12798862adb04861a6ae8feb9c091437_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNDUvZnJhZzoxY2M4ZDYxMThmYTQ0ZmViOTNhMjY5M2JmMjUxNzc2OS90YWJsZTowN2UxNWY1NTUyYjM0ODlmOWEyODAyOGI1Y2ZmODUxOC90YWJsZXJhbmdlOjA3ZTE1ZjU1NTJiMzQ4OWY5YTI4MDI4YjVjZmY4NTE4XzYtOS0xLTEtMA_2d5a5be9-3cde-4ef4-97f6-11ae41fe54b1">59,129</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquitySharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNDUvZnJhZzoxY2M4ZDYxMThmYTQ0ZmViOTNhMjY5M2JmMjUxNzc2OS90YWJsZTowN2UxNWY1NTUyYjM0ODlmOWEyODAyOGI1Y2ZmODUxOC90YWJsZXJhbmdlOjA3ZTE1ZjU1NTJiMzQ4OWY5YTI4MDI4YjVjZmY4NTE4XzctMS0xLTEtMA_15130904-43b5-48e6-aae4-2b6ff7f9b152">24,069,615</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquitySharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNDUvZnJhZzoxY2M4ZDYxMThmYTQ0ZmViOTNhMjY5M2JmMjUxNzc2OS90YWJsZTowN2UxNWY1NTUyYjM0ODlmOWEyODAyOGI1Y2ZmODUxOC90YWJsZXJhbmdlOjA3ZTE1ZjU1NTJiMzQ4OWY5YTI4MDI4YjVjZmY4NTE4XzctMy0xLTEtMA_17224ae7-9a51-45ec-bf34-3bd332f7d61d"><ix:nonFraction unitRef="shares" contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquitySharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNDUvZnJhZzoxY2M4ZDYxMThmYTQ0ZmViOTNhMjY5M2JmMjUxNzc2OS90YWJsZTowN2UxNWY1NTUyYjM0ODlmOWEyODAyOGI1Y2ZmODUxOC90YWJsZXJhbmdlOjA3ZTE1ZjU1NTJiMzQ4OWY5YTI4MDI4YjVjZmY4NTE4XzctMy0xLTEtMA_a1d4d1ec-fedf-4cbf-8e63-898326c54aa1">21,233,190</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquityLiquidationPreference" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNDUvZnJhZzoxY2M4ZDYxMThmYTQ0ZmViOTNhMjY5M2JmMjUxNzc2OS90YWJsZTowN2UxNWY1NTUyYjM0ODlmOWEyODAyOGI1Y2ZmODUxOC90YWJsZXJhbmdlOjA3ZTE1ZjU1NTJiMzQ4OWY5YTI4MDI4YjVjZmY4NTE4XzctNy0xLTEtMA_42478671-1978-4f56-8b54-3afff7369fe7">121,144</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNDUvZnJhZzoxY2M4ZDYxMThmYTQ0ZmViOTNhMjY5M2JmMjUxNzc2OS90YWJsZTowN2UxNWY1NTUyYjM0ODlmOWEyODAyOGI1Y2ZmODUxOC90YWJsZXJhbmdlOjA3ZTE1ZjU1NTJiMzQ4OWY5YTI4MDI4YjVjZmY4NTE4XzctOS0xLTEtMA_1d1f4b70-1cb9-4ab7-9838-90295942fe83">105,235</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr></table></div></ix:nonNumeric><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Upon the closing of the IPO, all shares of redeemable convertible preferred stock then outstanding converted into shares of common stock.  As of December&#160;31, 2019, the Company does <ix:nonFraction unitRef="shares" contextRef="i0002f1df204e4ba9aec2b7e505502fde_I20191231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:TemporaryEquitySharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNDUvZnJhZzoxY2M4ZDYxMThmYTQ0ZmViOTNhMjY5M2JmMjUxNzc2OS90ZXh0cmVnaW9uOjFjYzhkNjExOGZhNDRmZWI5M2EyNjkzYmYyNTE3NzY5XzIxOTkwMjMyNzQyNzE_8fd77f27-f276-4adb-9b5f-1ce3f2c8a3ee"><ix:nonFraction unitRef="shares" contextRef="i0002f1df204e4ba9aec2b7e505502fde_I20191231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:TemporaryEquitySharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNDUvZnJhZzoxY2M4ZDYxMThmYTQ0ZmViOTNhMjY5M2JmMjUxNzc2OS90ZXh0cmVnaW9uOjFjYzhkNjExOGZhNDRmZWI5M2EyNjkzYmYyNTE3NzY5XzIxOTkwMjMyNzQyNzE_fb2ceba1-e5ac-4661-9ac9-d7d0ad82636d">no</ix:nonFraction></ix:nonFraction>t have any redeemable convertible preferred stock issued or outstanding.</span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Redeemable Convertible Preferred Stock Warrant</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">s</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Upon the closing of the IPO, all of the outstanding redeemable convertible preferred stock warrants were exercised, or net exercised based on the IPO price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i4be1e55866334204b2d9b1643c2315e7_I20191231" decimals="INF" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNDUvZnJhZzoxY2M4ZDYxMThmYTQ0ZmViOTNhMjY5M2JmMjUxNzc2OS90ZXh0cmVnaW9uOjFjYzhkNjExOGZhNDRmZWI5M2EyNjkzYmYyNTE3NzY5XzMyOTg1MzQ4OTYwMTU_6c07cb01-4df0-49e3-93aa-b5896c6c2f0e">20.00</ix:nonFraction> per share, into <ix:nonFraction unitRef="shares" contextRef="i85f16463983d4272b900d0242c5a7b00_D20190101-20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ConversionOfStockSharesConverted1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNDUvZnJhZzoxY2M4ZDYxMThmYTQ0ZmViOTNhMjY5M2JmMjUxNzc2OS90ZXh0cmVnaW9uOjFjYzhkNjExOGZhNDRmZWI5M2EyNjkzYmYyNTE3NzY5XzMyOTg1MzQ4OTYwMjY_eff83768-62fe-40c3-a3c4-32a7320891ee">1,945,365</ix:nonFraction> shares of common stock.  As of December&#160;31, 2019 and 2018, warrants to purchase an aggregate of <ix:nonFraction unitRef="shares" contextRef="i3fd781122bcd466f8d1f4fc674767318_I20191231" decimals="INF" name="us-gaap:ClassOfWarrantOrRightOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNDUvZnJhZzoxY2M4ZDYxMThmYTQ0ZmViOTNhMjY5M2JmMjUxNzc2OS90ZXh0cmVnaW9uOjFjYzhkNjExOGZhNDRmZWI5M2EyNjkzYmYyNTE3NzY5XzMyOTg1MzQ4OTYwNjI_cf048bc5-5241-4471-bf9e-5cb2823acf99">0</ix:nonFraction> and  <ix:nonFraction unitRef="shares" contextRef="iea7780a1616443f08f0fda6ff705a8ec_I20181231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ClassOfWarrantOrRightOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNDUvZnJhZzoxY2M4ZDYxMThmYTQ0ZmViOTNhMjY5M2JmMjUxNzc2OS90ZXh0cmVnaW9uOjFjYzhkNjExOGZhNDRmZWI5M2EyNjkzYmYyNTE3NzY5XzMyOTg1MzQ4OTYwNTk_58306bd9-edb0-4a42-ab27-319454330af9">2,672,502</ix:nonFraction>, respectively, shares of Series C redeemable convertible preferred stock were outstanding.</span></div></ix:continuation><div style="text-indent:18pt;margin-bottom:9pt;"><span><br/></span></div><div id="i58f397e86dfd4fc4ac3b8695cd31238e_151"></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">9.&#160;<ix:continuation id="ie182b400cc304659b12a53490078d4c8" continuedAt="i6c05fcdaf881426e848aff5223c09bcb">Stockholders' Equity (Deficit)</ix:continuation></span></div><ix:continuation id="i6c05fcdaf881426e848aff5223c09bcb" continuedAt="i543c1ebc6ddb46b499654b5237fb1a44"><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Preferred Stock</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">At December&#160;31, 2019, the Company&#8217;s certificate of incorporation, as amended and restated, authorizes the Company to issue up to <ix:nonFraction unitRef="shares" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:PreferredStockSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTEvZnJhZzpiYzNmZDczMGFlM2U0ODFlOTUwMWIzYmUwMDZkMWIxZi90ZXh0cmVnaW9uOmJjM2ZkNzMwYWUzZTQ4MWU5NTAxYjNiZTAwNmQxYjFmXzMyOTg1MzQ4ODQ5MjU_6964241e-108d-41ef-81e7-c54dff6ea3ab">5,000,000</ix:nonFraction> shares of preferred stock with $<ix:nonFraction unitRef="usdPerShare" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTEvZnJhZzpiYzNmZDczMGFlM2U0ODFlOTUwMWIzYmUwMDZkMWIxZi90ZXh0cmVnaW9uOmJjM2ZkNzMwYWUzZTQ4MWU5NTAxYjNiZTAwNmQxYjFmXzMyOTg1MzQ4ODQ5MzM_faeea9d0-ec80-4b90-bc67-07140f80484d">0.001</ix:nonFraction> par value per share, of which no shares were issued and outstanding.</span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Common Stock</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">At December&#160;31, 2019, the Company&#8217;s certificate of incorporation, as amended and restated, authorizes the Company to issue up to <ix:nonFraction unitRef="shares" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTEvZnJhZzpiYzNmZDczMGFlM2U0ODFlOTUwMWIzYmUwMDZkMWIxZi90ZXh0cmVnaW9uOmJjM2ZkNzMwYWUzZTQ4MWU5NTAxYjNiZTAwNmQxYjFmXzMyOTg1MzQ4ODYxNDQ_59b2367d-379c-445b-a5c3-97dd0f99da06">100,000,000</ix:nonFraction> shares of common stock with $<ix:nonFraction unitRef="usdPerShare" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTEvZnJhZzpiYzNmZDczMGFlM2U0ODFlOTUwMWIzYmUwMDZkMWIxZi90ZXh0cmVnaW9uOmJjM2ZkNzMwYWUzZTQ4MWU5NTAxYjNiZTAwNmQxYjFmXzMyOTg1MzQ4ODYxNTI_626ff06c-1d31-434d-a546-fed022784202">0.001</ix:nonFraction> par value per share, of which <ix:nonFraction unitRef="shares" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTEvZnJhZzpiYzNmZDczMGFlM2U0ODFlOTUwMWIzYmUwMDZkMWIxZi90ZXh0cmVnaW9uOmJjM2ZkNzMwYWUzZTQ4MWU5NTAxYjNiZTAwNmQxYjFmXzMyOTg1MzQ4ODYxNjQ_3b8fa04b-a79e-4f3b-95c6-506fc9982ce8"><ix:nonFraction unitRef="shares" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTEvZnJhZzpiYzNmZDczMGFlM2U0ODFlOTUwMWIzYmUwMDZkMWIxZi90ZXh0cmVnaW9uOmJjM2ZkNzMwYWUzZTQ4MWU5NTAxYjNiZTAwNmQxYjFmXzMyOTg1MzQ4ODYxNjQ_3d1118fd-1985-4dbf-9a5a-f8342494aaef">31,255,267</ix:nonFraction></ix:nonFraction> shares were issued and outstanding.  The holders of common stock are also entitled to receive dividends whenever funds are legally available, when and if declared by the Board of Directors.  As of December&#160;31, 2019, <ix:nonFraction unitRef="usd" contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:DividendsCommonStock" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTEvZnJhZzpiYzNmZDczMGFlM2U0ODFlOTUwMWIzYmUwMDZkMWIxZi90ZXh0cmVnaW9uOmJjM2ZkNzMwYWUzZTQ4MWU5NTAxYjNiZTAwNmQxYjFmXzIxOTkwMjMyNTk0NTI_2a8cc5aa-566b-4ff2-8dbf-e07caf4c3ae9">no</ix:nonFraction> dividends have been declared to date.  Each share of common stock is entitled to <ix:nonFraction unitRef="vote" contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" decimals="INF" format="ixt-sec:numwordsen" name="silk:CommonStockVotePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTEvZnJhZzpiYzNmZDczMGFlM2U0ODFlOTUwMWIzYmUwMDZkMWIxZi90ZXh0cmVnaW9uOmJjM2ZkNzMwYWUzZTQ4MWU5NTAxYjNiZTAwNmQxYjFmXzIxOTkwMjMyNTk0NjA_6d86283e-8352-4091-971e-c9c3c3ac4718">one</ix:nonFraction> vote.</span></div></ix:continuation><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">137</span></div></div></div><hr style="page-break-after:always"/><div style="height:90pt;width:100%;"><div style="margin-bottom:9pt;"><span><br/></span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><ix:continuation id="i543c1ebc6ddb46b499654b5237fb1a44"><ix:nonNumeric contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" name="us-gaap:ScheduleOfStockByClassTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTEvZnJhZzpiYzNmZDczMGFlM2U0ODFlOTUwMWIzYmUwMDZkMWIxZi90ZXh0cmVnaW9uOmJjM2ZkNzMwYWUzZTQ4MWU5NTAxYjNiZTAwNmQxYjFmXzEyMDM_3d0e52c9-6d95-4ae5-ace0-467452e0d837" escape="true"><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">At December&#160;31, 2019 and 2018, the Company had reserved common stock for future issuances as follows:</span></div><div style="text-align:center;margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:70.596%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:11.301%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:11.302%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 31,</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Conversion of Series A redeemable convertible preferred stock</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i7e4541352c2a44929295cae86c4b2a1c_I20191231" decimals="INF" format="ixt:zerodash" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTEvZnJhZzpiYzNmZDczMGFlM2U0ODFlOTUwMWIzYmUwMDZkMWIxZi90YWJsZTpkYjZlZGY0ZWExNjE0YmRlYjQ1NThiMmNlMjU5NjRmOS90YWJsZXJhbmdlOmRiNmVkZjRlYTE2MTRiZGViNDU1OGIyY2UyNTk2NGY5XzItMS0xLTEtMA_a7e31752-7f7c-4244-92aa-c4f2a65aebbd">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i7f1961a81c2146ba86c1873951eb5d0f_I20181231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTEvZnJhZzpiYzNmZDczMGFlM2U0ODFlOTUwMWIzYmUwMDZkMWIxZi90YWJsZTpkYjZlZGY0ZWExNjE0YmRlYjQ1NThiMmNlMjU5NjRmOS90YWJsZXJhbmdlOmRiNmVkZjRlYTE2MTRiZGViNDU1OGIyY2UyNTk2NGY5XzItMy0xLTEtMA_deca01c1-e56b-4b1b-9d64-5054559ccb3d">1,629,629</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Conversion of Series A-1 redeemable convertible preferred stock</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i22fe2abf909a4987bfe246f58fedaf54_I20191231" decimals="INF" format="ixt:zerodash" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTEvZnJhZzpiYzNmZDczMGFlM2U0ODFlOTUwMWIzYmUwMDZkMWIxZi90YWJsZTpkYjZlZGY0ZWExNjE0YmRlYjQ1NThiMmNlMjU5NjRmOS90YWJsZXJhbmdlOmRiNmVkZjRlYTE2MTRiZGViNDU1OGIyY2UyNTk2NGY5XzMtMS0xLTEtMA_eb1e8dd0-6875-4fd9-a610-73df6a667c60">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="idef65aa8bbea40b3adcc724c6f06297a_I20181231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTEvZnJhZzpiYzNmZDczMGFlM2U0ODFlOTUwMWIzYmUwMDZkMWIxZi90YWJsZTpkYjZlZGY0ZWExNjE0YmRlYjQ1NThiMmNlMjU5NjRmOS90YWJsZXJhbmdlOmRiNmVkZjRlYTE2MTRiZGViNDU1OGIyY2UyNTk2NGY5XzMtMy0xLTEtMA_c2912053-64e8-4040-af8f-9bed66226030">1,111,111</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Conversion of Series B redeemable convertible preferred stock</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="ib7e1120b4a744e978a8b7a345369d7a5_I20191231" decimals="INF" format="ixt:zerodash" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTEvZnJhZzpiYzNmZDczMGFlM2U0ODFlOTUwMWIzYmUwMDZkMWIxZi90YWJsZTpkYjZlZGY0ZWExNjE0YmRlYjQ1NThiMmNlMjU5NjRmOS90YWJsZXJhbmdlOmRiNmVkZjRlYTE2MTRiZGViNDU1OGIyY2UyNTk2NGY5XzQtMS0xLTEtMA_90891bc2-b93b-4d1d-a02c-884a6d41f0eb">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i4afaed3dd6794f36b67d203a6ae5b570_I20181231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTEvZnJhZzpiYzNmZDczMGFlM2U0ODFlOTUwMWIzYmUwMDZkMWIxZi90YWJsZTpkYjZlZGY0ZWExNjE0YmRlYjQ1NThiMmNlMjU5NjRmOS90YWJsZXJhbmdlOmRiNmVkZjRlYTE2MTRiZGViNDU1OGIyY2UyNTk2NGY5XzQtMy0xLTEtMA_ab45c2d4-6d79-40c9-be72-5dbe173e7a09">6,264,470</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Conversion of Series C redeemable convertible preferred stock and warrants</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="ib86a3e190d06442abdb93108d5a238e6_I20191231" decimals="INF" format="ixt:zerodash" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTEvZnJhZzpiYzNmZDczMGFlM2U0ODFlOTUwMWIzYmUwMDZkMWIxZi90YWJsZTpkYjZlZGY0ZWExNjE0YmRlYjQ1NThiMmNlMjU5NjRmOS90YWJsZXJhbmdlOmRiNmVkZjRlYTE2MTRiZGViNDU1OGIyY2UyNTk2NGY5XzUtMS0xLTEtMA_74109b30-3e0b-4cdb-8d9b-9b3d790cfc5a">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i12798862adb04861a6ae8feb9c091437_I20181231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTEvZnJhZzpiYzNmZDczMGFlM2U0ODFlOTUwMWIzYmUwMDZkMWIxZi90YWJsZTpkYjZlZGY0ZWExNjE0YmRlYjQ1NThiMmNlMjU5NjRmOS90YWJsZXJhbmdlOmRiNmVkZjRlYTE2MTRiZGViNDU1OGIyY2UyNTk2NGY5XzUtMy0xLTEtMA_fdac2070-b449-4821-9fce-b72b8eac3448">15,064,405</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Exercise of options under stock plan</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="ic4860da07e274940b7dda28b5b824fd4_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTEvZnJhZzpiYzNmZDczMGFlM2U0ODFlOTUwMWIzYmUwMDZkMWIxZi90YWJsZTpkYjZlZGY0ZWExNjE0YmRlYjQ1NThiMmNlMjU5NjRmOS90YWJsZXJhbmdlOmRiNmVkZjRlYTE2MTRiZGViNDU1OGIyY2UyNTk2NGY5XzYtMS0xLTEtMA_372453e1-8573-43a5-b293-6b7f23fbd682">4,310,790</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i447ce34fe05a46278994221dbd0e0819_I20181231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTEvZnJhZzpiYzNmZDczMGFlM2U0ODFlOTUwMWIzYmUwMDZkMWIxZi90YWJsZTpkYjZlZGY0ZWExNjE0YmRlYjQ1NThiMmNlMjU5NjRmOS90YWJsZXJhbmdlOmRiNmVkZjRlYTE2MTRiZGViNDU1OGIyY2UyNTk2NGY5XzYtMy0xLTEtMA_e5506397-fc4a-42ea-85c6-5967f208df25">4,364,377</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Issuance of options under stock plan</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i3dcad0503bdf4e5eba8e00589d3e2a59_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTEvZnJhZzpiYzNmZDczMGFlM2U0ODFlOTUwMWIzYmUwMDZkMWIxZi90YWJsZTpkYjZlZGY0ZWExNjE0YmRlYjQ1NThiMmNlMjU5NjRmOS90YWJsZXJhbmdlOmRiNmVkZjRlYTE2MTRiZGViNDU1OGIyY2UyNTk2NGY5XzctMS0xLTEtMA_42b7f501-6463-40ff-9e53-57ea35245674">1,554,690</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i88bdc53e6793436cb3ebaa916528f65b_I20181231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTEvZnJhZzpiYzNmZDczMGFlM2U0ODFlOTUwMWIzYmUwMDZkMWIxZi90YWJsZTpkYjZlZGY0ZWExNjE0YmRlYjQ1NThiMmNlMjU5NjRmOS90YWJsZXJhbmdlOmRiNmVkZjRlYTE2MTRiZGViNDU1OGIyY2UyNTk2NGY5XzctMy0xLTEtMA_2cebc1a9-ab21-4ef9-aa2d-14d9dc172785">57,889</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Issuance of common stock under employee stock purchase plan</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="ib065e570d4804ab887f6bb6e1fec5a75_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTEvZnJhZzpiYzNmZDczMGFlM2U0ODFlOTUwMWIzYmUwMDZkMWIxZi90YWJsZTpkYjZlZGY0ZWExNjE0YmRlYjQ1NThiMmNlMjU5NjRmOS90YWJsZXJhbmdlOmRiNmVkZjRlYTE2MTRiZGViNDU1OGIyY2UyNTk2NGY5XzgtMS0xLTEtMzAxNw_fe7740e9-7c25-4ed7-9417-05f9da299eca">372,352</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="idaa6eb381396400786f1ca3efdf5b014_I20181231" decimals="INF" format="ixt:zerodash" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTEvZnJhZzpiYzNmZDczMGFlM2U0ODFlOTUwMWIzYmUwMDZkMWIxZi90YWJsZTpkYjZlZGY0ZWExNjE0YmRlYjQ1NThiMmNlMjU5NjRmOS90YWJsZXJhbmdlOmRiNmVkZjRlYTE2MTRiZGViNDU1OGIyY2UyNTk2NGY5XzgtMy0xLTEtMzAxNw_cbba9010-95ac-40ba-8e12-d75a08975734">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Warrants to purchase common stock</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i7c6d2473a2234f6fae9d4b0c9b650a4f_I20191231" decimals="INF" format="ixt:zerodash" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTEvZnJhZzpiYzNmZDczMGFlM2U0ODFlOTUwMWIzYmUwMDZkMWIxZi90YWJsZTpkYjZlZGY0ZWExNjE0YmRlYjQ1NThiMmNlMjU5NjRmOS90YWJsZXJhbmdlOmRiNmVkZjRlYTE2MTRiZGViNDU1OGIyY2UyNTk2NGY5XzgtMS0xLTEtMA_f6d9a6da-3fd0-4af3-87f9-bdcc4e770114">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i1add56f0eae7469e989ed855f525f96b_I20181231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTEvZnJhZzpiYzNmZDczMGFlM2U0ODFlOTUwMWIzYmUwMDZkMWIxZi90YWJsZTpkYjZlZGY0ZWExNjE0YmRlYjQ1NThiMmNlMjU5NjRmOS90YWJsZXJhbmdlOmRiNmVkZjRlYTE2MTRiZGViNDU1OGIyY2UyNTk2NGY5XzgtMy0xLTEtMA_9e8d80ec-a212-4755-b112-87a66435810b">7,527</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTEvZnJhZzpiYzNmZDczMGFlM2U0ODFlOTUwMWIzYmUwMDZkMWIxZi90YWJsZTpkYjZlZGY0ZWExNjE0YmRlYjQ1NThiMmNlMjU5NjRmOS90YWJsZXJhbmdlOmRiNmVkZjRlYTE2MTRiZGViNDU1OGIyY2UyNTk2NGY5XzktMS0xLTEtMA_ca985bd5-629c-4fe3-a76e-30195ec606f8">6,237,832</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTEvZnJhZzpiYzNmZDczMGFlM2U0ODFlOTUwMWIzYmUwMDZkMWIxZi90YWJsZTpkYjZlZGY0ZWExNjE0YmRlYjQ1NThiMmNlMjU5NjRmOS90YWJsZXJhbmdlOmRiNmVkZjRlYTE2MTRiZGViNDU1OGIyY2UyNTk2NGY5XzktMy0xLTEtMA_74ec168c-8a24-4f80-b066-a5605eb63671">28,499,408</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div></ix:nonNumeric><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Common Stock Warrant</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">s</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In connection with the IPO, the common stock warrants were cash, or net exercised based on the IPO price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i4be1e55866334204b2d9b1643c2315e7_I20191231" decimals="INF" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTEvZnJhZzpiYzNmZDczMGFlM2U0ODFlOTUwMWIzYmUwMDZkMWIxZi90ZXh0cmVnaW9uOmJjM2ZkNzMwYWUzZTQ4MWU5NTAxYjNiZTAwNmQxYjFmXzMyOTg1MzQ4ODcxNzY_faa44ab6-93ae-49da-95a5-66a8c4a27632">20.00</ix:nonFraction> per share into <ix:nonFraction unitRef="shares" contextRef="if8633988d4034e2c837d8cfec30261f2_D20190101-20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ConversionOfStockSharesConverted1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTEvZnJhZzpiYzNmZDczMGFlM2U0ODFlOTUwMWIzYmUwMDZkMWIxZi90ZXh0cmVnaW9uOmJjM2ZkNzMwYWUzZTQ4MWU5NTAxYjNiZTAwNmQxYjFmXzMyOTg1MzQ4ODcxODM_77db5e17-657a-4993-b139-d36a58bf573a">5,968</ix:nonFraction> shares of common stock.  As of December&#160;31, 2019 and 2018, warrants to purchase an aggregate of <ix:nonFraction unitRef="shares" contextRef="i7c6d2473a2234f6fae9d4b0c9b650a4f_I20191231" decimals="INF" name="us-gaap:ClassOfWarrantOrRightOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTEvZnJhZzpiYzNmZDczMGFlM2U0ODFlOTUwMWIzYmUwMDZkMWIxZi90ZXh0cmVnaW9uOmJjM2ZkNzMwYWUzZTQ4MWU5NTAxYjNiZTAwNmQxYjFmXzMyOTg1MzQ4ODcxOTI_5936bb04-2574-417a-a9da-78fc24270618">0</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i1add56f0eae7469e989ed855f525f96b_I20181231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ClassOfWarrantOrRightOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTEvZnJhZzpiYzNmZDczMGFlM2U0ODFlOTUwMWIzYmUwMDZkMWIxZi90ZXh0cmVnaW9uOmJjM2ZkNzMwYWUzZTQ4MWU5NTAxYjNiZTAwNmQxYjFmXzMyOTg1MzQ4ODcxOTk_70340c9c-ebb5-4cdb-acda-d92c9ac6d0ee">7,527</ix:nonFraction> shares of common stock were outstanding.</span></div></ix:continuation><div style="text-indent:18pt;margin-bottom:9pt;"><span><br/></span></div><div id="i58f397e86dfd4fc4ac3b8695cd31238e_157"></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">10.&#160;<ix:nonNumeric contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90ZXh0cmVnaW9uOmY0Yzg3Yjg5ZmY2NzRjYTQ4ODFiZWU1MWY3YTk1NWExXzYyMDM_65184d3c-a88c-4f87-a562-0792ada2dd33" continuedAt="i97508d2c5982490ea78951103cfd3296" escape="true">Stock Option Plans</ix:nonNumeric></span></div><ix:continuation id="i97508d2c5982490ea78951103cfd3296" continuedAt="i28f0b074c71e4d488f98286b5e1447c0"><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In 2007, the Company established its 2007 Stock Option Plan which provided for the granting of stock options to employees, directors and consultants of the Company.  In connection with its acquisition of NeuroCo in December 2018, the Company also assumed NeuroCo&#8217;s 2015 Equity Incentive Plan.  In March 2019, the Company's Board of Directors approved the termination of the 2007 Stock Option Plan and the NeuroCo 2015 Equity Incentive Plan and the adoption of the 2019 Equity Incentive Plan, or the 2019 Plan, which became effective immediately prior to the Company's IPO.  The 2019 Plan provides for the grant of ISOs to employees and for the grant of NSOs, restricted stock, restricted stock units, stock appreciation rights, performance units and performance shares to employees, directors and consultants.  A total of <ix:nonFraction unitRef="shares" contextRef="i9b5314b8f65d48ffb39568a32e1ae70e_I20190331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90ZXh0cmVnaW9uOmY0Yzg3Yjg5ZmY2NzRjYTQ4ODFiZWU1MWY3YTk1NWExXzMyOTg1MzQ4OTI3NTE_1bd84c01-0125-410b-ac10-a570926b6e08">2,317,000</ix:nonFraction> shares of common stock were initially reserved for issuance pursuant to the 2019 Plan.  In addition, the shares reserved for issuance under the 2019 Plan will also include shares reserved but not issued under the 2007 Stock Option Plan, plus any share awards granted under the 2007 Stock Option Plan that expire or terminate without having been exercised in full or that are forfeited or repurchased.  In addition, the number of shares available for issuance under the 2019 Plan will also include an annual increase on the first day of each fiscal year beginning in fiscal 2020, equal to the lesser of (i) <ix:nonFraction unitRef="shares" contextRef="i5c3d2d26b9a1456fa6a38583e15b0dee_I20190331" decimals="INF" format="ixt:numdotdecimal" name="silk:ShareBasedCompensationArrangementBySharebasedPaymentAwardNumberOfAdditionalSharesAllowableUnderThePlan" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90ZXh0cmVnaW9uOmY0Yzg3Yjg5ZmY2NzRjYTQ4ODFiZWU1MWY3YTk1NWExXzMyOTg1MzQ4OTI3NjI_55291cbb-4177-414f-a5c0-737ed61046f5">3,000,000</ix:nonFraction> shares; (ii) <ix:nonFraction unitRef="number" contextRef="id374ce4879bf48d69346a02ab7b52f9e_D20190301-20190331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90ZXh0cmVnaW9uOmY0Yzg3Yjg5ZmY2NzRjYTQ4ODFiZWU1MWY3YTk1NWExXzMyOTg1MzQ4OTI3Njg_0e4f4e95-2af6-4a21-b20a-7292282ddd2e">4.0</ix:nonFraction>% of the outstanding shares of common stock as of the last day of the immediately preceding fiscal year; or (iii) an amount as determined by the Board of Directors.  As of December&#160;31, 2019, the Company has reserved <ix:nonFraction unitRef="shares" contextRef="i188f88bd74544c788b5f388916b2ffd9_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90ZXh0cmVnaW9uOmY0Yzg3Yjg5ZmY2NzRjYTQ4ODFiZWU1MWY3YTk1NWExXzMyOTg1MzQ4OTI3OTk_8208b388-24ac-4890-8c44-f594a5dd9834">2,366,251</ix:nonFraction> shares of common stock for issuance under the 2019 Plan.</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The exercise price of ISOs and NSOs shall not be less than <ix:nonFraction unitRef="number" contextRef="i4579105f1eae463bbc80b9182ebdface_I20191231" decimals="INF" name="silk:SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExerciseThresholdasaPercentageofSharePrice" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90ZXh0cmVnaW9uOmY0Yzg3Yjg5ZmY2NzRjYTQ4ODFiZWU1MWY3YTk1NWExXzMyOTg1MzQ5ODE0NDA_8eb60c63-de2b-4ff1-adc8-862a4c96ca21">100</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i09b415be50aa4620acbb4b68a3d03255_I20191231" decimals="INF" name="silk:SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExerciseThresholdasaPercentageofSharePrice" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90ZXh0cmVnaW9uOmY0Yzg3Yjg5ZmY2NzRjYTQ4ODFiZWU1MWY3YTk1NWExXzMyOTg1MzQ5ODE0NDQ_2e51231e-cdca-465d-b26e-ab1fb439bd4b">85</ix:nonFraction>% of the estimated fair value of the shares on the date of grant, respectively, as determined by the Board of Directors.  The exercise price of ISOs and NSOs granted to a 10% stockholder shall not be less than <ix:nonFraction unitRef="number" contextRef="ie740d91c6b54459faa35c174c4cc3dbe_I20191231" decimals="INF" name="silk:SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExerciseThresholdasaPercentageofSharePrice" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90ZXh0cmVnaW9uOmY0Yzg3Yjg5ZmY2NzRjYTQ4ODFiZWU1MWY3YTk1NWExXzMyOTg1MzQ5ODE0NTI_46f89ab6-69cf-4589-b075-d895f68e35c9">110</ix:nonFraction>% of the estimated fair value of the shares on the date of grant as determined by the Board of Directors.  To date, options have a term of <ix:nonNumeric contextRef="i0ca865b5bbab452998af805b9a59eb9a_D20190101-20191231" format="ixt-sec:durwordsen" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90ZXh0cmVnaW9uOmY0Yzg3Yjg5ZmY2NzRjYTQ4ODFiZWU1MWY3YTk1NWExXzMyOTg1MzQ5ODE0NTY_9d25a097-816a-4e5c-8b81-c3b85b1ad67a">ten years</ix:nonNumeric> and generally vest over <ix:nonNumeric contextRef="i0ca865b5bbab452998af805b9a59eb9a_D20190101-20191231" format="ixt-sec:duryear" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90ZXh0cmVnaW9uOmY0Yzg3Yjg5ZmY2NzRjYTQ4ODFiZWU1MWY3YTk1NWExXzMyOTg1MzQ5ODE0NjA_a8156d97-8a3e-41f7-96b9-7564c5abc458">4</ix:nonNumeric> years from date of grant.</span></div></ix:continuation><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">138</span></div></div></div><hr style="page-break-after:always"/><div style="height:90pt;width:100%;"><div style="margin-bottom:9pt;"><span><br/></span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><ix:continuation id="i28f0b074c71e4d488f98286b5e1447c0" continuedAt="i83c19765117f4a329de7b186b034200d"><ix:nonNumeric contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90ZXh0cmVnaW9uOmY0Yzg3Yjg5ZmY2NzRjYTQ4ODFiZWU1MWY3YTk1NWExXzYyMDQ_4bee9973-e168-4dc8-9326-c0b5f3e8e8b0" escape="true"><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Activity under the Company&#8217;s 2007 Stock Option Plan, NeuroCo 2015 Equity Incentive Plan and 2019 Plan is set forth below:</span></div><div style="text-align:center;margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:99.839%;"><tr><td style="width:1.0%;"></td><td style="width:32.670%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:10.841%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.602%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:10.841%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.602%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:8.754%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.602%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:10.199%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.602%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:11.487%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="21" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Options Outstanding</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Shares Available for Grant</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Number of Shares</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted Average Exercise Price</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted Average Remaining Contractual Term (in Years)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Aggregate Intrinsic Value (in thousands)</span></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balances, December 31, 2017</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i517a0560ef9f4f6a822a0a124dd39744_I20171231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZTplNzIyY2M0NGM5ZmM0NWY3YTM1ODE1YjY3NTlmNzYyYS90YWJsZXJhbmdlOmU3MjJjYzQ0YzlmYzQ1ZjdhMzU4MTViNjc1OWY3NjJhXzctMS0xLTEtMA_74a59ad0-671f-4154-ae0e-3161814bc171">328,290</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i517a0560ef9f4f6a822a0a124dd39744_I20171231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZTplNzIyY2M0NGM5ZmM0NWY3YTM1ODE1YjY3NTlmNzYyYS90YWJsZXJhbmdlOmU3MjJjYzQ0YzlmYzQ1ZjdhMzU4MTViNjc1OWY3NjJhXzctMy0xLTEtMA_9c4982a5-76b2-4255-ad34-486e3ec887de">4,308,890</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="i517a0560ef9f4f6a822a0a124dd39744_I20171231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZTplNzIyY2M0NGM5ZmM0NWY3YTM1ODE1YjY3NTlmNzYyYS90YWJsZXJhbmdlOmU3MjJjYzQ0YzlmYzQ1ZjdhMzU4MTViNjc1OWY3NjJhXzctNS0xLTEtMA_4bbdbc3c-d137-4357-8261-38e3c0e097ec">3.09</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="i28c5cd5abfce4c7aa5c44b0f651c9ad8_D20170101-20171231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZTplNzIyY2M0NGM5ZmM0NWY3YTM1ODE1YjY3NTlmNzYyYS90YWJsZXJhbmdlOmU3MjJjYzQ0YzlmYzQ1ZjdhMzU4MTViNjc1OWY3NjJhXzctNy0xLTEtMA_082947b2-452e-4e15-82dc-49cd84d3ccc5">7.81</ix:nonNumeric></span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i517a0560ef9f4f6a822a0a124dd39744_I20171231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZTplNzIyY2M0NGM5ZmM0NWY3YTM1ODE1YjY3NTlmNzYyYS90YWJsZXJhbmdlOmU3MjJjYzQ0YzlmYzQ1ZjdhMzU4MTViNjc1OWY3NjJhXzctOS0xLTEtMA_2f275264-ac44-4cec-b7d0-44d1488af609">5,073</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Authorized</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZTplNzIyY2M0NGM5ZmM0NWY3YTM1ODE1YjY3NTlmNzYyYS90YWJsZXJhbmdlOmU3MjJjYzQ0YzlmYzQ1ZjdhMzU4MTViNjc1OWY3NjJhXzgtMS0xLTEtMA_75fa4d22-ed41-4c40-8c5d-a5f4860185e9">223,664</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Options granted</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="shares" contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZTplNzIyY2M0NGM5ZmM0NWY3YTM1ODE1YjY3NTlmNzYyYS90YWJsZXJhbmdlOmU3MjJjYzQ0YzlmYzQ1ZjdhMzU4MTViNjc1OWY3NjJhXzktMS0xLTEtMA_ae169960-6244-4069-8f88-41492e4ca9a5">629,716</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZTplNzIyY2M0NGM5ZmM0NWY3YTM1ODE1YjY3NTlmNzYyYS90YWJsZXJhbmdlOmU3MjJjYzQ0YzlmYzQ1ZjdhMzU4MTViNjc1OWY3NjJhXzktMy0xLTEtMA_20f83985-f008-4e61-9d8f-d67cfca5a3af">629,716</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZTplNzIyY2M0NGM5ZmM0NWY3YTM1ODE1YjY3NTlmNzYyYS90YWJsZXJhbmdlOmU3MjJjYzQ0YzlmYzQ1ZjdhMzU4MTViNjc1OWY3NjJhXzktNS0xLTEtMA_d2332efe-2179-4502-9cef-23c4fbc61055">6.51</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Options exercised</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="shares" contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZTplNzIyY2M0NGM5ZmM0NWY3YTM1ODE1YjY3NTlmNzYyYS90YWJsZXJhbmdlOmU3MjJjYzQ0YzlmYzQ1ZjdhMzU4MTViNjc1OWY3NjJhXzEwLTMtMS0xLTA_91cea72f-58a8-473b-96f6-1ddd72428507">438,578</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZTplNzIyY2M0NGM5ZmM0NWY3YTM1ODE1YjY3NTlmNzYyYS90YWJsZXJhbmdlOmU3MjJjYzQ0YzlmYzQ1ZjdhMzU4MTViNjc1OWY3NjJhXzEwLTUtMS0xLTA_4c0652b0-1e5c-4391-ac5c-e381d14e0b6b">1.50</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Options cancelled</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZTplNzIyY2M0NGM5ZmM0NWY3YTM1ODE1YjY3NTlmNzYyYS90YWJsZXJhbmdlOmU3MjJjYzQ0YzlmYzQ1ZjdhMzU4MTViNjc1OWY3NjJhXzExLTEtMS0xLTA_0630b444-2ebd-4bf6-bed3-feb7088b6c57">135,651</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="shares" contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZTplNzIyY2M0NGM5ZmM0NWY3YTM1ODE1YjY3NTlmNzYyYS90YWJsZXJhbmdlOmU3MjJjYzQ0YzlmYzQ1ZjdhMzU4MTViNjc1OWY3NjJhXzExLTMtMS0xLTA_3d7e2590-20dd-41eb-8031-6a5b284ed4bc">135,651</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZTplNzIyY2M0NGM5ZmM0NWY3YTM1ODE1YjY3NTlmNzYyYS90YWJsZXJhbmdlOmU3MjJjYzQ0YzlmYzQ1ZjdhMzU4MTViNjc1OWY3NjJhXzExLTUtMS0xLTA_3fdfc04e-deca-42cc-a82e-bda4b651d522">1.56</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balances, December 31, 2018</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZTplNzIyY2M0NGM5ZmM0NWY3YTM1ODE1YjY3NTlmNzYyYS90YWJsZXJhbmdlOmU3MjJjYzQ0YzlmYzQ1ZjdhMzU4MTViNjc1OWY3NjJhXzEyLTEtMS0xLTA_7949cc6f-217b-4520-95ff-1c0cfb7a5830">57,889</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZTplNzIyY2M0NGM5ZmM0NWY3YTM1ODE1YjY3NTlmNzYyYS90YWJsZXJhbmdlOmU3MjJjYzQ0YzlmYzQ1ZjdhMzU4MTViNjc1OWY3NjJhXzEyLTMtMS0xLTA_c67bff9a-2205-4098-a68b-1794216915c8">4,364,377</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZTplNzIyY2M0NGM5ZmM0NWY3YTM1ODE1YjY3NTlmNzYyYS90YWJsZXJhbmdlOmU3MjJjYzQ0YzlmYzQ1ZjdhMzU4MTViNjc1OWY3NjJhXzEyLTUtMS0xLTA_09cd306d-61bd-4b7b-8476-079c0d85c95a">3.79</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZTplNzIyY2M0NGM5ZmM0NWY3YTM1ODE1YjY3NTlmNzYyYS90YWJsZXJhbmdlOmU3MjJjYzQ0YzlmYzQ1ZjdhMzU4MTViNjc1OWY3NjJhXzEyLTctMS0xLTA_995eb542-801f-4e4a-8c79-a244c0fd7237">7.36</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZTplNzIyY2M0NGM5ZmM0NWY3YTM1ODE1YjY3NTlmNzYyYS90YWJsZXJhbmdlOmU3MjJjYzQ0YzlmYzQ1ZjdhMzU4MTViNjc1OWY3NjJhXzEyLTktMS0xLTA_bb21ff08-6c3f-4cfe-9a4f-ca18c72f96ee">33,132</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Authorized</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZTplNzIyY2M0NGM5ZmM0NWY3YTM1ODE1YjY3NTlmNzYyYS90YWJsZXJhbmdlOmU3MjJjYzQ0YzlmYzQ1ZjdhMzU4MTViNjc1OWY3NjJhXzEzLTEtMS0xLTA_666ae073-8da3-4a5e-a432-0799d49d0b19">2,317,000</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Options granted</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="shares" contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZTplNzIyY2M0NGM5ZmM0NWY3YTM1ODE1YjY3NTlmNzYyYS90YWJsZXJhbmdlOmU3MjJjYzQ0YzlmYzQ1ZjdhMzU4MTViNjc1OWY3NjJhXzE0LTEtMS0xLTA_fb92ee51-c7bb-4f41-9cc5-a413d16a5839">848,023</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZTplNzIyY2M0NGM5ZmM0NWY3YTM1ODE1YjY3NTlmNzYyYS90YWJsZXJhbmdlOmU3MjJjYzQ0YzlmYzQ1ZjdhMzU4MTViNjc1OWY3NjJhXzE0LTMtMS0xLTA_13494431-8381-4c88-8b8f-be238a0a9be5">848,023</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZTplNzIyY2M0NGM5ZmM0NWY3YTM1ODE1YjY3NTlmNzYyYS90YWJsZXJhbmdlOmU3MjJjYzQ0YzlmYzQ1ZjdhMzU4MTViNjc1OWY3NjJhXzE0LTUtMS0xLTA_7b1bb28e-e9bd-4507-816f-f04158de4f94">22.77</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Options exercised</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="shares" contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZTplNzIyY2M0NGM5ZmM0NWY3YTM1ODE1YjY3NTlmNzYyYS90YWJsZXJhbmdlOmU3MjJjYzQ0YzlmYzQ1ZjdhMzU4MTViNjc1OWY3NjJhXzE1LTMtMS0xLTA_09018d50-4064-422b-9542-c4b6210a75c6">873,786</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZTplNzIyY2M0NGM5ZmM0NWY3YTM1ODE1YjY3NTlmNzYyYS90YWJsZXJhbmdlOmU3MjJjYzQ0YzlmYzQ1ZjdhMzU4MTViNjc1OWY3NjJhXzE1LTUtMS0xLTA_4e7a0eac-166c-4c71-96db-2c3ff1371222">1.77</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Options cancelled</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZTplNzIyY2M0NGM5ZmM0NWY3YTM1ODE1YjY3NTlmNzYyYS90YWJsZXJhbmdlOmU3MjJjYzQ0YzlmYzQ1ZjdhMzU4MTViNjc1OWY3NjJhXzE2LTEtMS0xLTA_b95f034c-8bb5-4160-ad19-aed52af7612a">27,824</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="shares" contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZTplNzIyY2M0NGM5ZmM0NWY3YTM1ODE1YjY3NTlmNzYyYS90YWJsZXJhbmdlOmU3MjJjYzQ0YzlmYzQ1ZjdhMzU4MTViNjc1OWY3NjJhXzE2LTMtMS0xLTA_109ec7cb-f1a7-4f6c-99ca-46c0098cdcc8">27,824</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZTplNzIyY2M0NGM5ZmM0NWY3YTM1ODE1YjY3NTlmNzYyYS90YWJsZXJhbmdlOmU3MjJjYzQ0YzlmYzQ1ZjdhMzU4MTViNjc1OWY3NjJhXzE2LTUtMS0xLTA_8bda3d39-b06f-47dc-9ed6-c08282a7b30c">8.71</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balances December 31, 2019</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZTplNzIyY2M0NGM5ZmM0NWY3YTM1ODE1YjY3NTlmNzYyYS90YWJsZXJhbmdlOmU3MjJjYzQ0YzlmYzQ1ZjdhMzU4MTViNjc1OWY3NjJhXzE3LTEtMS0xLTA_1b6f4382-4477-4555-b732-7b779ec16f65">1,554,690</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZTplNzIyY2M0NGM5ZmM0NWY3YTM1ODE1YjY3NTlmNzYyYS90YWJsZXJhbmdlOmU3MjJjYzQ0YzlmYzQ1ZjdhMzU4MTViNjc1OWY3NjJhXzE3LTMtMS0xLTA_3bcd0d0e-a7fb-430e-9361-9bdbcbf12832">4,310,790</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZTplNzIyY2M0NGM5ZmM0NWY3YTM1ODE1YjY3NTlmNzYyYS90YWJsZXJhbmdlOmU3MjJjYzQ0YzlmYzQ1ZjdhMzU4MTViNjc1OWY3NjJhXzE3LTUtMS0xLTA_8ccc55e1-f8bd-4f44-b4b5-2b1044c44656">7.91</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZTplNzIyY2M0NGM5ZmM0NWY3YTM1ODE1YjY3NTlmNzYyYS90YWJsZXJhbmdlOmU3MjJjYzQ0YzlmYzQ1ZjdhMzU4MTViNjc1OWY3NjJhXzE3LTctMS0xLTA_d817c7f4-9736-4b67-9776-1fca8e5a466d">7.27</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZTplNzIyY2M0NGM5ZmM0NWY3YTM1ODE1YjY3NTlmNzYyYS90YWJsZXJhbmdlOmU3MjJjYzQ0YzlmYzQ1ZjdhMzU4MTViNjc1OWY3NjJhXzE3LTktMS0xLTA_58a1fcf4-4765-4479-82d8-3fe6a8ca89bf">140,234</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Vested and exercisable at December 31, 2019</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZTplNzIyY2M0NGM5ZmM0NWY3YTM1ODE1YjY3NTlmNzYyYS90YWJsZXJhbmdlOmU3MjJjYzQ0YzlmYzQ1ZjdhMzU4MTViNjc1OWY3NjJhXzE4LTMtMS0xLTA_39e91df8-ff2a-4f94-8831-e0ff24b145b4">2,514,891</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZTplNzIyY2M0NGM5ZmM0NWY3YTM1ODE1YjY3NTlmNzYyYS90YWJsZXJhbmdlOmU3MjJjYzQ0YzlmYzQ1ZjdhMzU4MTViNjc1OWY3NjJhXzE4LTUtMS0xLTA_b8532f13-97fc-46b4-8e78-4ce29daa8a82">4.27</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZTplNzIyY2M0NGM5ZmM0NWY3YTM1ODE1YjY3NTlmNzYyYS90YWJsZXJhbmdlOmU3MjJjYzQ0YzlmYzQ1ZjdhMzU4MTViNjc1OWY3NjJhXzE4LTctMS0xLTA_37fe6af4-5de6-418a-843b-a4bfdfa37425">6.38</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZTplNzIyY2M0NGM5ZmM0NWY3YTM1ODE1YjY3NTlmNzYyYS90YWJsZXJhbmdlOmU3MjJjYzQ0YzlmYzQ1ZjdhMzU4MTViNjc1OWY3NjJhXzE4LTktMS0xLTA_5959a37a-3314-407b-9a88-2a53b77f2236">90,854</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Vested and expected to vest at December 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZTplNzIyY2M0NGM5ZmM0NWY3YTM1ODE1YjY3NTlmNzYyYS90YWJsZXJhbmdlOmU3MjJjYzQ0YzlmYzQ1ZjdhMzU4MTViNjc1OWY3NjJhXzE5LTMtMS0xLTA_5673668c-702b-499b-b6c3-d1314fe70e37">4,310,790</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZTplNzIyY2M0NGM5ZmM0NWY3YTM1ODE1YjY3NTlmNzYyYS90YWJsZXJhbmdlOmU3MjJjYzQ0YzlmYzQ1ZjdhMzU4MTViNjc1OWY3NjJhXzE5LTUtMS0xLTA_2285a630-27b6-4379-812a-c2074208e394">7.91</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZTplNzIyY2M0NGM5ZmM0NWY3YTM1ODE1YjY3NTlmNzYyYS90YWJsZXJhbmdlOmU3MjJjYzQ0YzlmYzQ1ZjdhMzU4MTViNjc1OWY3NjJhXzE5LTctMS0xLTA_75b1f8fb-d72f-43cd-aee2-ea32589d34d6">7.27</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZTplNzIyY2M0NGM5ZmM0NWY3YTM1ODE1YjY3NTlmNzYyYS90YWJsZXJhbmdlOmU3MjJjYzQ0YzlmYzQ1ZjdhMzU4MTViNjc1OWY3NjJhXzE5LTktMS0xLTA_ee3f5bd6-093f-4931-8caa-82c77313398e">140,234</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div></ix:nonNumeric><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The aggregate intrinsic value of options exercised during the years ended December&#160;31, 2019 and 2018 was $<ix:nonFraction unitRef="usd" contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90ZXh0cmVnaW9uOmY0Yzg3Yjg5ZmY2NzRjYTQ4ODFiZWU1MWY3YTk1NWExXzMyOTg1MzQ4OTQ0Mjk_80de1a52-ddb0-407e-9788-f59ef4c76f93">24,867,000</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90ZXh0cmVnaW9uOmY0Yzg3Yjg5ZmY2NzRjYTQ4ODFiZWU1MWY3YTk1NWExXzMyOTg1MzQ4OTQ0NDc_50b11972-9b62-4a9f-b440-4434b75e9438">787,000</ix:nonFraction>, respectively.  The aggregate intrinsic value was calculated as the difference between the exercise prices of the underlying options and the estimated fair value of the common stock on the date of exercise.  The weighted-average grant date fair value of options granted during the years ended  December&#160;31, 2019 and 2018 was $<ix:nonFraction unitRef="usdPerShare" contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90ZXh0cmVnaW9uOmY0Yzg3Yjg5ZmY2NzRjYTQ4ODFiZWU1MWY3YTk1NWExXzMyOTg1MzQ4OTY4NDA_ad3287e8-8e36-4300-95c7-be62d0a83c47">10.17</ix:nonFraction> and $<ix:nonFraction unitRef="usdPerShare" contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90ZXh0cmVnaW9uOmY0Yzg3Yjg5ZmY2NzRjYTQ4ODFiZWU1MWY3YTk1NWExXzMyOTg1MzQ4OTY4NDc_6aeb2402-6c4e-4285-83d1-50a6e7472153">2.93</ix:nonFraction> per share, respectively.  The total fair value of options vested during the years ended December&#160;31, 2019 and 2018 was $<ix:nonFraction unitRef="usdPerShare" contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90ZXh0cmVnaW9uOmY0Yzg3Yjg5ZmY2NzRjYTQ4ODFiZWU1MWY3YTk1NWExXzMyOTg1MzQ4OTY4ODI_0e94af28-32c9-451f-87ef-17874ba2cc26">2,221,000</ix:nonFraction> and $<ix:nonFraction unitRef="usdPerShare" contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90ZXh0cmVnaW9uOmY0Yzg3Yjg5ZmY2NzRjYTQ4ODFiZWU1MWY3YTk1NWExXzMyOTg1MzQ4OTY4OTI_fcc2e769-01de-4c49-bc8e-a9933c3b8df4">569,000</ix:nonFraction>, respectively, based on the grant date fair value.</span></div><ix:nonNumeric contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" name="us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90ZXh0cmVnaW9uOmY0Yzg3Yjg5ZmY2NzRjYTQ4ODFiZWU1MWY3YTk1NWExXzYyMDU_d7dfb659-83be-45b0-8b95-4fdb8f93404f" escape="true"><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table summarizes information about stock options outstanding and vested as of December&#160;31, 2019:</span></div><div style="text-align:center;margin-bottom:12pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:21.444%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.437%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:12.832%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.597%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:13.311%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.597%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:11.875%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.597%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:12.832%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.597%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:11.881%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Options Outstanding</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Options Vested</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Exercise Price</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Options Outstanding</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted Average Remaining Contractual Term (in Years)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted Average Exercise Price</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Number Exercisable</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted Average Exercise Price</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">$<ix:nonFraction unitRef="usdPerShare" contextRef="iaa805919be064beda12a6545c3d07fcd_I20191231" decimals="2" name="silk:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZToxOWY1MzQyOGYyNTc0ZDU5OTQ1MTA1MjdkYzk0MTY5MC90YWJsZXJhbmdlOjE5ZjUzNDI4ZjI1NzRkNTk5NDUxMDUyN2RjOTQxNjkwXzMtMC0xLTEtMC90ZXh0cmVnaW9uOjgyN2Y3NjQwMzBkOTQxMmE5MjM5ODA1ZDRhNGQ1YzU2XzMyOTg1MzQ4ODMzNTU_f7060e02-bbfd-41f4-9301-f02a1e162444">1.35</ix:nonFraction> - $<ix:nonFraction unitRef="usdPerShare" contextRef="i8d08513aaa4d42039e2e5145986ff348_I20191231" decimals="2" name="silk:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZToxOWY1MzQyOGYyNTc0ZDU5OTQ1MTA1MjdkYzk0MTY5MC90YWJsZXJhbmdlOjE5ZjUzNDI4ZjI1NzRkNTk5NDUxMDUyN2RjOTQxNjkwXzMtMC0xLTEtMC90ZXh0cmVnaW9uOjgyN2Y3NjQwMzBkOTQxMmE5MjM5ODA1ZDRhNGQ1YzU2XzMyOTg1MzQ4ODMzNDk_c121df4c-42dc-4104-95e7-ce394a51df12">3.16</ix:nonFraction></span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i9168c8a79f074245b359c1eabebd2867_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZToxOWY1MzQyOGYyNTc0ZDU5OTQ1MTA1MjdkYzk0MTY5MC90YWJsZXJhbmdlOjE5ZjUzNDI4ZjI1NzRkNTk5NDUxMDUyN2RjOTQxNjkwXzMtMS0xLTEtMA_8cecfbab-6d18-444a-8298-ce20e0aaee38">2,072,765</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="i6cf6ea883ee84acc9631ce618bef5f1c_D20190101-20191231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZToxOWY1MzQyOGYyNTc0ZDU5OTQ1MTA1MjdkYzk0MTY5MC90YWJsZXJhbmdlOjE5ZjUzNDI4ZjI1NzRkNTk5NDUxMDUyN2RjOTQxNjkwXzMtMy0xLTEtMA_4e308219-a7de-43fa-b3a8-58ae508468ff">5.86</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="i9168c8a79f074245b359c1eabebd2867_I20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZToxOWY1MzQyOGYyNTc0ZDU5OTQ1MTA1MjdkYzk0MTY5MC90YWJsZXJhbmdlOjE5ZjUzNDI4ZjI1NzRkNTk5NDUxMDUyN2RjOTQxNjkwXzMtNS0xLTEtMA_78ee53a9-8793-409d-87a9-655435ae2136">1.84</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i9168c8a79f074245b359c1eabebd2867_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZToxOWY1MzQyOGYyNTc0ZDU5OTQ1MTA1MjdkYzk0MTY5MC90YWJsZXJhbmdlOjE5ZjUzNDI4ZjI1NzRkNTk5NDUxMDUyN2RjOTQxNjkwXzMtNy0xLTEtMA_d5991bf5-ba30-46b0-9ab6-48cf0a36022c">1,770,060</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="i9168c8a79f074245b359c1eabebd2867_I20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZToxOWY1MzQyOGYyNTc0ZDU5OTQ1MTA1MjdkYzk0MTY5MC90YWJsZXJhbmdlOjE5ZjUzNDI4ZjI1NzRkNTk5NDUxMDUyN2RjOTQxNjkwXzMtOS0xLTEtMA_c4eeec4f-3531-4728-b48e-8f08eba5e2f9">1.71</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">$<ix:nonFraction unitRef="usdPerShare" contextRef="i6e1de668b6f54e6f9e86b8d5f1188b44_I20191231" decimals="2" name="silk:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZToxOWY1MzQyOGYyNTc0ZDU5OTQ1MTA1MjdkYzk0MTY5MC90YWJsZXJhbmdlOjE5ZjUzNDI4ZjI1NzRkNTk5NDUxMDUyN2RjOTQxNjkwXzQtMC0xLTEtMC90ZXh0cmVnaW9uOjA0ZmM4OTc0MWRhZDQ5MGI5MDA0OGMzYTVjOTRjZmVhXzMyOTg1MzQ4ODMzNTA_08414f24-d1ac-49fc-b5e3-12f928532a66">4.73</ix:nonFraction> - $<ix:nonFraction unitRef="usdPerShare" contextRef="iaec558563b4843c5b260f5fe73e22f01_I20191231" decimals="2" name="silk:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZToxOWY1MzQyOGYyNTc0ZDU5OTQ1MTA1MjdkYzk0MTY5MC90YWJsZXJhbmdlOjE5ZjUzNDI4ZjI1NzRkNTk5NDUxMDUyN2RjOTQxNjkwXzQtMC0xLTEtMC90ZXh0cmVnaW9uOjA0ZmM4OTc0MWRhZDQ5MGI5MDA0OGMzYTVjOTRjZmVhXzMyOTg1MzQ4ODMzNTc_7c164254-a58e-4546-8953-8e963f47f200">8.27</ix:nonFraction></span></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i0e5c6cb252b942de9df54fcafdb03c57_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZToxOWY1MzQyOGYyNTc0ZDU5OTQ1MTA1MjdkYzk0MTY5MC90YWJsZXJhbmdlOjE5ZjUzNDI4ZjI1NzRkNTk5NDUxMDUyN2RjOTQxNjkwXzQtMS0xLTEtMA_0d086fe7-5d6f-43e6-8473-38e777403731">919,355</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="i8e43b208e0754e78903aecd89161bdcb_D20190101-20191231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZToxOWY1MzQyOGYyNTc0ZDU5OTQ1MTA1MjdkYzk0MTY5MC90YWJsZXJhbmdlOjE5ZjUzNDI4ZjI1NzRkNTk5NDUxMDUyN2RjOTQxNjkwXzQtMy0xLTEtMA_6d52165f-0fb6-4a9c-8c20-5d2981905bf2">8.23</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="i0e5c6cb252b942de9df54fcafdb03c57_I20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZToxOWY1MzQyOGYyNTc0ZDU5OTQ1MTA1MjdkYzk0MTY5MC90YWJsZXJhbmdlOjE5ZjUzNDI4ZjI1NzRkNTk5NDUxMDUyN2RjOTQxNjkwXzQtNS0xLTEtMA_f7dac302-5c26-418b-a46a-f2a08501e05c">5.81</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i0e5c6cb252b942de9df54fcafdb03c57_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZToxOWY1MzQyOGYyNTc0ZDU5OTQ1MTA1MjdkYzk0MTY5MC90YWJsZXJhbmdlOjE5ZjUzNDI4ZjI1NzRkNTk5NDUxMDUyN2RjOTQxNjkwXzQtNy0xLTEtMA_a89582fc-0016-42be-96af-aac7663f4dd1">383,077</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="i0e5c6cb252b942de9df54fcafdb03c57_I20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZToxOWY1MzQyOGYyNTc0ZDU5OTQ1MTA1MjdkYzk0MTY5MC90YWJsZXJhbmdlOjE5ZjUzNDI4ZjI1NzRkNTk5NDUxMDUyN2RjOTQxNjkwXzQtOS0xLTEtMA_b465e8f9-d973-454a-a8be-c7b0d338eb3b">5.72</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">$<ix:nonFraction unitRef="usdPerShare" contextRef="iee86434ad814473fa2012397d08d7c63_I20191231" decimals="2" name="silk:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZToxOWY1MzQyOGYyNTc0ZDU5OTQ1MTA1MjdkYzk0MTY5MC90YWJsZXJhbmdlOjE5ZjUzNDI4ZjI1NzRkNTk5NDUxMDUyN2RjOTQxNjkwXzUtMC0xLTEtMC90ZXh0cmVnaW9uOjAyNDY2MTIzMjczMTQ3MjliYmU0N2JhNjQ4NzZhZDk3XzMyOTg1MzQ4ODMzNTM_969f28a7-855d-4e7d-a669-ea2ea74b76ec">11.29</ix:nonFraction> - $<ix:nonFraction unitRef="usdPerShare" contextRef="idb8741dc808745c1ac9cfaa8b95bf8c6_I20191231" decimals="2" name="silk:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZToxOWY1MzQyOGYyNTc0ZDU5OTQ1MTA1MjdkYzk0MTY5MC90YWJsZXJhbmdlOjE5ZjUzNDI4ZjI1NzRkNTk5NDUxMDUyN2RjOTQxNjkwXzUtMC0xLTEtMC90ZXh0cmVnaW9uOjAyNDY2MTIzMjczMTQ3MjliYmU0N2JhNjQ4NzZhZDk3XzMyOTg1MzQ4ODMzNjE_98f9b38c-c5da-4be0-bebf-76a88b35b7ca">20.00</ix:nonFraction></span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i580ea82051b046c086a55b23cbe96b48_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZToxOWY1MzQyOGYyNTc0ZDU5OTQ1MTA1MjdkYzk0MTY5MC90YWJsZXJhbmdlOjE5ZjUzNDI4ZjI1NzRkNTk5NDUxMDUyN2RjOTQxNjkwXzUtMS0xLTEtMA_02265539-2818-444a-9158-a8bc30e92722">1,192,804</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="ia1a2680b0c4640b4a319ee060427817d_D20190101-20191231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZToxOWY1MzQyOGYyNTc0ZDU5OTQ1MTA1MjdkYzk0MTY5MC90YWJsZXJhbmdlOjE5ZjUzNDI4ZjI1NzRkNTk5NDUxMDUyN2RjOTQxNjkwXzUtMy0xLTEtMA_b859a02e-aa5e-4076-b84b-812b3835dcc7">8.73</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="i580ea82051b046c086a55b23cbe96b48_I20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZToxOWY1MzQyOGYyNTc0ZDU5OTQ1MTA1MjdkYzk0MTY5MC90YWJsZXJhbmdlOjE5ZjUzNDI4ZjI1NzRkNTk5NDUxMDUyN2RjOTQxNjkwXzUtNS0xLTEtMA_f534d379-1e7e-4d1d-af51-ea2f24b5534f">16.63</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i580ea82051b046c086a55b23cbe96b48_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZToxOWY1MzQyOGYyNTc0ZDU5OTQ1MTA1MjdkYzk0MTY5MC90YWJsZXJhbmdlOjE5ZjUzNDI4ZjI1NzRkNTk5NDUxMDUyN2RjOTQxNjkwXzUtNy0xLTEtMA_96f00829-f004-4151-88a0-3d2d98ff2f8b">352,383</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="i580ea82051b046c086a55b23cbe96b48_I20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZToxOWY1MzQyOGYyNTc0ZDU5OTQ1MTA1MjdkYzk0MTY5MC90YWJsZXJhbmdlOjE5ZjUzNDI4ZjI1NzRkNTk5NDUxMDUyN2RjOTQxNjkwXzUtOS0xLTEtMA_915be9b6-4b6e-49f2-89bf-e2f9a79899d5">14.46</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">$<ix:nonFraction unitRef="usdPerShare" contextRef="i4a6ce09ec8ba42acab7925c328fd9e56_I20191231" decimals="2" name="silk:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZToxOWY1MzQyOGYyNTc0ZDU5OTQ1MTA1MjdkYzk0MTY5MC90YWJsZXJhbmdlOjE5ZjUzNDI4ZjI1NzRkNTk5NDUxMDUyN2RjOTQxNjkwXzYtMC0xLTEtMC90ZXh0cmVnaW9uOmFlOTZjMGQ5M2Q0OTQ3MDM4NGNkMzk2ZDNkMTI5NGZjXzMyOTg1MzQ4ODMzNTM_91867fcd-2784-4021-a02f-f171acd00c40">36.47</ix:nonFraction> - $<ix:nonFraction unitRef="usdPerShare" contextRef="i36d7682595324850a7a7a098e56bcdd5_I20191231" decimals="2" name="silk:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZToxOWY1MzQyOGYyNTc0ZDU5OTQ1MTA1MjdkYzk0MTY5MC90YWJsZXJhbmdlOjE5ZjUzNDI4ZjI1NzRkNTk5NDUxMDUyN2RjOTQxNjkwXzYtMC0xLTEtMC90ZXh0cmVnaW9uOmFlOTZjMGQ5M2Q0OTQ3MDM4NGNkMzk2ZDNkMTI5NGZjXzMyOTg1MzQ4ODMzNjE_40fe5b5d-1869-46f9-aaeb-eb104974caec">48.53</ix:nonFraction></span></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i80e1df55cd6f4ff3a796ff102aa5ac3c_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZToxOWY1MzQyOGYyNTc0ZDU5OTQ1MTA1MjdkYzk0MTY5MC90YWJsZXJhbmdlOjE5ZjUzNDI4ZjI1NzRkNTk5NDUxMDUyN2RjOTQxNjkwXzYtMS0xLTEtMA_adaf0b67-39cb-40a6-abf3-8b7a598f0543">125,866</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="ide54ca5d5c78499cb82e54623e321d1d_D20190101-20191231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZToxOWY1MzQyOGYyNTc0ZDU5OTQ1MTA1MjdkYzk0MTY5MC90YWJsZXJhbmdlOjE5ZjUzNDI4ZjI1NzRkNTk5NDUxMDUyN2RjOTQxNjkwXzYtMy0xLTEtMA_89a553fb-43ef-4087-a18e-3ad74f9e1c17">9.69</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="i80e1df55cd6f4ff3a796ff102aa5ac3c_I20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZToxOWY1MzQyOGYyNTc0ZDU5OTQ1MTA1MjdkYzk0MTY5MC90YWJsZXJhbmdlOjE5ZjUzNDI4ZjI1NzRkNTk5NDUxMDUyN2RjOTQxNjkwXzYtNS0xLTEtMA_e1501d8e-d91e-4bc1-9ff8-b8c2fd4f4d48">40.50</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i80e1df55cd6f4ff3a796ff102aa5ac3c_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZToxOWY1MzQyOGYyNTc0ZDU5OTQ1MTA1MjdkYzk0MTY5MC90YWJsZXJhbmdlOjE5ZjUzNDI4ZjI1NzRkNTk5NDUxMDUyN2RjOTQxNjkwXzYtNy0xLTEtMA_f4b2a959-1677-4657-b345-e619be783df7">9,371</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="i80e1df55cd6f4ff3a796ff102aa5ac3c_I20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZToxOWY1MzQyOGYyNTc0ZDU5OTQ1MTA1MjdkYzk0MTY5MC90YWJsZXJhbmdlOjE5ZjUzNDI4ZjI1NzRkNTk5NDUxMDUyN2RjOTQxNjkwXzYtOS0xLTEtMA_83429a3c-af7c-4169-afd6-5f448e1696c8">45.57</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZToxOWY1MzQyOGYyNTc0ZDU5OTQ1MTA1MjdkYzk0MTY5MC90YWJsZXJhbmdlOjE5ZjUzNDI4ZjI1NzRkNTk5NDUxMDUyN2RjOTQxNjkwXzE0LTEtMS0xLTA_fd3f0eb3-814d-4b47-99be-b8747557299f">4,310,790</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZToxOWY1MzQyOGYyNTc0ZDU5OTQ1MTA1MjdkYzk0MTY5MC90YWJsZXJhbmdlOjE5ZjUzNDI4ZjI1NzRkNTk5NDUxMDUyN2RjOTQxNjkwXzE0LTMtMS0xLTA_4ff55030-019b-4d07-b116-caa596cfb5e6">7.27</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZToxOWY1MzQyOGYyNTc0ZDU5OTQ1MTA1MjdkYzk0MTY5MC90YWJsZXJhbmdlOjE5ZjUzNDI4ZjI1NzRkNTk5NDUxMDUyN2RjOTQxNjkwXzE0LTUtMS0xLTA_ea9a363f-1409-4a10-8d3b-dab2e68d1384">7.91</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZToxOWY1MzQyOGYyNTc0ZDU5OTQ1MTA1MjdkYzk0MTY5MC90YWJsZXJhbmdlOjE5ZjUzNDI4ZjI1NzRkNTk5NDUxMDUyN2RjOTQxNjkwXzE0LTctMS0xLTA_f651e8f0-9667-4483-bc33-b8dffd15940d">2,514,891</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZToxOWY1MzQyOGYyNTc0ZDU5OTQ1MTA1MjdkYzk0MTY5MC90YWJsZXJhbmdlOjE5ZjUzNDI4ZjI1NzRkNTk5NDUxMDUyN2RjOTQxNjkwXzE0LTktMS0xLTA_e865a109-97f2-41c1-9342-53f33b8df722">4.27</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">139</span></div></div></div><hr style="page-break-after:always"/><div style="height:90pt;width:100%;"><div style="margin-bottom:9pt;"><span><br/></span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><ix:continuation id="i83c19765117f4a329de7b186b034200d" continuedAt="i6ea98028a5084d72bde5dd9a91213695"><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">2019 Employee Stock Purchase Plan</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In March 2019, the Company's Board of Directors adopted the 2019 Employee Stock Purchase Plan, or the 2019 ESPP, under which eligible employees are permitted to purchase common stock at a discount through payroll deductions.  A total of <ix:nonFraction unitRef="shares" contextRef="i7d7592590c814df5ad461b54e146b3b9_I20190331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90ZXh0cmVnaW9uOmY0Yzg3Yjg5ZmY2NzRjYTQ4ODFiZWU1MWY3YTk1NWExXzMyOTg1MzQ4OTQzOTk_62d3395e-a6f3-4d4a-b023-40fcc704afb1">434,000</ix:nonFraction> shares of common stock are reserved for issuance and will be increased on the first day of each fiscal year, beginning in 2020, by an amount equal to the lesser of (i)&#160;<ix:nonFraction unitRef="shares" contextRef="i7d7592590c814df5ad461b54e146b3b9_I20190331" decimals="INF" format="ixt:numdotdecimal" name="silk:ShareBasedCompensationArrangementBySharebasedPaymentAwardNumberOfAdditionalSharesAllowableUnderThePlan" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90ZXh0cmVnaW9uOmY0Yzg3Yjg5ZmY2NzRjYTQ4ODFiZWU1MWY3YTk1NWExXzMyOTg1MzQ4OTQ0MTA_2eab0b58-6e16-40c7-ac8a-02d75e0ad448">1,200,000</ix:nonFraction> shares (ii)&#160;<ix:nonFraction unitRef="number" contextRef="i9e2e6766734d4127a261bbe5ec027002_D20190301-20190331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90ZXh0cmVnaW9uOmY0Yzg3Yjg5ZmY2NzRjYTQ4ODFiZWU1MWY3YTk1NWExXzMyOTg1MzQ4OTQ0MTY_c83f2ae6-58e3-43c3-a784-c1938fe86e37">1.0</ix:nonFraction>% of the outstanding shares of common stock as of the last day of the immediately preceding fiscal year; or (iii)&#160;an amount as determined by the Board of Directors.  The price of the common stock purchased will be the lower of <ix:nonFraction unitRef="number" contextRef="i9e2e6766734d4127a261bbe5ec027002_D20190301-20190331" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90ZXh0cmVnaW9uOmY0Yzg3Yjg5ZmY2NzRjYTQ4ODFiZWU1MWY3YTk1NWExXzMyOTg1MzQ4OTQ0MjE_19c83a30-65eb-4cc4-afb7-13c8bcd0f092">85</ix:nonFraction>% of the fair market value of the common stock at the beginning of an offering period or at the end of a purchase period.  The 2019 ESPP was effective upon adoption by the Company's Board of Directors but was not in use until the completion of the Company's IPO in April 2019.  The 2019 ESPP is intended to qualify as an "employee stock purchase plan" within the meaning of Section&#160;423 of the Internal Revenue Code of 1986, as amended.</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">As of December&#160;31, 2019, <ix:nonFraction unitRef="shares" contextRef="ib91f8a2aac654fce98f1b02f8c99f196_D20190101-20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90ZXh0cmVnaW9uOmY0Yzg3Yjg5ZmY2NzRjYTQ4ODFiZWU1MWY3YTk1NWExXzM4NDgyOTA3NTg3NzQ_65a75bba-ccb6-4cb9-81ec-68e1b235a682">61,648</ix:nonFraction> shares of common stock have been issued to employees participating in the 2019 ESPP and <ix:nonFraction unitRef="shares" contextRef="i8b3d2f66951844b589a808406d5fb193_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90ZXh0cmVnaW9uOmY0Yzg3Yjg5ZmY2NzRjYTQ4ODFiZWU1MWY3YTk1NWExXzM4NDgyOTA3NTg4MDc_e262c9e5-e349-4e6b-a710-47e5317a6b9b">372,352</ix:nonFraction> shares were available for future issuance under the 2019 ESPP.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span><br/></span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Stock-Based Compensation</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company estimated the fair value of stock options using the Black&#8211;Scholes option pricing model.  The fair value of employee and nonemployee stock options is being amortized on a straight&#8211;line basis over the requisite service period of the awards.  <ix:nonNumeric contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90ZXh0cmVnaW9uOmY0Yzg3Yjg5ZmY2NzRjYTQ4ODFiZWU1MWY3YTk1NWExXzIxOTkwMjMzNjA2Nzg_5a5b22df-446d-4203-9a8d-6bd0ccbaf3a2" continuedAt="i77e1502cd48b4496b0b2dd5ba3442af8" escape="true">The fair value of employee and nonemployee stock options was estimated using the following assumptions for the years ended December&#160;31, 2019 and 2018:</ix:nonNumeric></span></div><div style="text-align:center;margin-bottom:9pt;"><ix:continuation id="i77e1502cd48b4496b0b2dd5ba3442af8" continuedAt="i6fe32792d79543848aad06d784b36901"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:62.903%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:15.147%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:15.149%;"></td><td style="width:1.0%;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Year Ended December 31,</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Expected term (in years)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"><ix:nonNumeric contextRef="i047616b3b96f40259dae391a81638613_D20190101-20191231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZTozYmVjNDY2MDk5YzY0ZmIxOTE0NTJjMzBjYTJmNWYwZC90YWJsZXJhbmdlOjNiZWM0NjYwOTljNjRmYjE5MTQ1MmMzMGNhMmY1ZjBkXzItMS0xLTEtMC90ZXh0cmVnaW9uOjQ4M2NlZTBkNzk4ZjRmNjI4ZGU1MGE4YTcwY2NlNzBmXzE5NzkxMjA5MzAwMDA1_e483108e-984c-45e5-97f4-1eb9f2165204">5.00</ix:nonNumeric> - <ix:nonNumeric contextRef="i5fe1f6eae7624d96b5070b1632bdf4d3_D20190101-20191231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZTozYmVjNDY2MDk5YzY0ZmIxOTE0NTJjMzBjYTJmNWYwZC90YWJsZXJhbmdlOjNiZWM0NjYwOTljNjRmYjE5MTQ1MmMzMGNhMmY1ZjBkXzItMS0xLTEtMC90ZXh0cmVnaW9uOjQ4M2NlZTBkNzk4ZjRmNjI4ZGU1MGE4YTcwY2NlNzBmXzE5NzkxMjA5MzAwMDEx_9d000e66-fade-43c8-842e-395ec14d0d0f">6.25</ix:nonNumeric></span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"><ix:nonNumeric contextRef="i10afc7fc69ce46cd8b9478e8ac0d56b0_D20180101-20181231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZTozYmVjNDY2MDk5YzY0ZmIxOTE0NTJjMzBjYTJmNWYwZC90YWJsZXJhbmdlOjNiZWM0NjYwOTljNjRmYjE5MTQ1MmMzMGNhMmY1ZjBkXzItMy0xLTEtMC90ZXh0cmVnaW9uOmYxM2VmZjFiMjdhZDQ0NWY4MDNhZDljZDhkNTQzZGI3XzE5NzkxMjA5Mjk5OTg3_6be1e7b4-3a16-4f36-ae4f-c766689e70da">5.00</ix:nonNumeric> - <ix:nonNumeric contextRef="i0804bae1f65e4f6196a788f2e067af2c_D20180101-20181231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZTozYmVjNDY2MDk5YzY0ZmIxOTE0NTJjMzBjYTJmNWYwZC90YWJsZXJhbmdlOjNiZWM0NjYwOTljNjRmYjE5MTQ1MmMzMGNhMmY1ZjBkXzItMy0xLTEtMC90ZXh0cmVnaW9uOmYxM2VmZjFiMjdhZDQ0NWY4MDNhZDljZDhkNTQzZGI3XzE5NzkxMjA5Mjk5OTk5_ddde7a45-402f-4539-b09b-935950241949">6.25</ix:nonNumeric></span></div></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Expected volatility</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"><ix:nonFraction unitRef="number" contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZTozYmVjNDY2MDk5YzY0ZmIxOTE0NTJjMzBjYTJmNWYwZC90YWJsZXJhbmdlOjNiZWM0NjYwOTljNjRmYjE5MTQ1MmMzMGNhMmY1ZjBkXzMtMS0xLTEtMC90ZXh0cmVnaW9uOmMyYTJlYjc5YzFmNDQ1ZmU4MjQ2NWVmNTg1NzFjM2Y0XzI3NDg3NzkwNjk0NjI_3a37ec16-5b17-4683-b274-6bd99f72f8fe">42.4</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZTozYmVjNDY2MDk5YzY0ZmIxOTE0NTJjMzBjYTJmNWYwZC90YWJsZXJhbmdlOjNiZWM0NjYwOTljNjRmYjE5MTQ1MmMzMGNhMmY1ZjBkXzMtMS0xLTEtMC90ZXh0cmVnaW9uOmMyYTJlYjc5YzFmNDQ1ZmU4MjQ2NWVmNTg1NzFjM2Y0XzI3NDg3NzkwNjk0Njk_02f5d0a9-9fe0-4a46-887c-bf81ea12b6fe">42.9</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"><ix:nonFraction unitRef="number" contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZTozYmVjNDY2MDk5YzY0ZmIxOTE0NTJjMzBjYTJmNWYwZC90YWJsZXJhbmdlOjNiZWM0NjYwOTljNjRmYjE5MTQ1MmMzMGNhMmY1ZjBkXzMtMy0xLTEtMC90ZXh0cmVnaW9uOjE5MzJkZWNiZTQyODRkNmJiODYyNTY0MTZiZjE3NjEyXzI3NDg3NzkwNjk0NjI_56990614-7bf3-4be8-9ef6-1fb75e83acc1">38.0</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZTozYmVjNDY2MDk5YzY0ZmIxOTE0NTJjMzBjYTJmNWYwZC90YWJsZXJhbmdlOjNiZWM0NjYwOTljNjRmYjE5MTQ1MmMzMGNhMmY1ZjBkXzMtMy0xLTEtMC90ZXh0cmVnaW9uOjE5MzJkZWNiZTQyODRkNmJiODYyNTY0MTZiZjE3NjEyXzI3NDg3NzkwNjk0Njk_06596320-3e94-4f02-a6dc-5938f495ed37">38.8</ix:nonFraction>%</span></div></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Risk-free interest rate</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"><ix:nonFraction unitRef="number" contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZTozYmVjNDY2MDk5YzY0ZmIxOTE0NTJjMzBjYTJmNWYwZC90YWJsZXJhbmdlOjNiZWM0NjYwOTljNjRmYjE5MTQ1MmMzMGNhMmY1ZjBkXzQtMS0xLTEtMC90ZXh0cmVnaW9uOjYyNjE2OTFjYjY0ODRiNzg5MjAwMTY1ZTk2ZmE5NzllXzI3NDg3NzkwNjk0NjI_72d5621b-63c1-4888-bd19-0339d784bac1">1.47</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZTozYmVjNDY2MDk5YzY0ZmIxOTE0NTJjMzBjYTJmNWYwZC90YWJsZXJhbmdlOjNiZWM0NjYwOTljNjRmYjE5MTQ1MmMzMGNhMmY1ZjBkXzQtMS0xLTEtMC90ZXh0cmVnaW9uOjYyNjE2OTFjYjY0ODRiNzg5MjAwMTY1ZTk2ZmE5NzllXzI3NDg3NzkwNjk0Njk_3b136740-c086-4e3f-a473-626781dc76cd">2.54</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"><ix:nonFraction unitRef="number" contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZTozYmVjNDY2MDk5YzY0ZmIxOTE0NTJjMzBjYTJmNWYwZC90YWJsZXJhbmdlOjNiZWM0NjYwOTljNjRmYjE5MTQ1MmMzMGNhMmY1ZjBkXzQtMy0xLTEtMC90ZXh0cmVnaW9uOjg0NzU5NGQwNzA1MzQyYTNhNDc0MmRiNDY1YzVkZWNhXzI3NDg3NzkwNjk0NjI_25acd42d-3754-45a0-8b2f-8d5bd0dc51f8">2.68</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZTozYmVjNDY2MDk5YzY0ZmIxOTE0NTJjMzBjYTJmNWYwZC90YWJsZXJhbmdlOjNiZWM0NjYwOTljNjRmYjE5MTQ1MmMzMGNhMmY1ZjBkXzQtMy0xLTEtMC90ZXh0cmVnaW9uOjg0NzU5NGQwNzA1MzQyYTNhNDc0MmRiNDY1YzVkZWNhXzI3NDg3NzkwNjk0Njk_c4eeb8c4-d163-488b-8e35-f93ff9a6ca50">2.98</ix:nonFraction>%</span></div></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Dividend yield</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" decimals="2" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZTozYmVjNDY2MDk5YzY0ZmIxOTE0NTJjMzBjYTJmNWYwZC90YWJsZXJhbmdlOjNiZWM0NjYwOTljNjRmYjE5MTQ1MmMzMGNhMmY1ZjBkXzUtMS0xLTEtMA_5ddde67e-44a2-4236-9915-2ccf1cf50eb7">&#8212;</ix:nonFraction>%&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231" decimals="2" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZTozYmVjNDY2MDk5YzY0ZmIxOTE0NTJjMzBjYTJmNWYwZC90YWJsZXJhbmdlOjNiZWM0NjYwOTljNjRmYjE5MTQ1MmMzMGNhMmY1ZjBkXzUtMy0xLTEtMA_2d7ef2e9-3818-44ba-8e3c-6519de493502">&#8212;</ix:nonFraction>%&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr></table></ix:continuation></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Prior to completion of the Company's IPO, the fair value of common stock was determined by the Company&#8217;s Board of Directors, who considered, among other things, contemporaneous valuations of the Company&#8217;s common stock prepared by an unrelated third-party valuation firm in accordance with the guidance provided by the American Institute of Certified Public Accountants Practice Guide, Valuation of Privately-Held-Company Equity Securities Issued as Compensation.  For stock options granted after the completion of the IPO, the fair value of the underlying common stock is based on the closing price of the Company's common stock on The NASDAQ Global Market on the date of grant.  The expected term of stock options represents the weighted-average period the stock options are expected to remain outstanding.  The Company does not have sufficient historical exercise and post-vesting termination activity to provide accurate data for estimating the expected term of options and has opted to use the &#8220;simplified method,&#8221; whereby the expected term equals the arithmetic average of the vesting term and the original contractual term of the option.  The expected stock price volatility assumption was determined by examining the historical volatilities for industry peers, as the Company does not have sufficient trading history for the Company&#8217;s common stock.  The Company will continue to analyze the historical stock price volatility and expected term assumption as more historical data for the&#160;Company&#8217;s common stock becomes available.  The risk-free interest rate assumption is based on the U.S. Treasury instruments whose term was consistent with the expected term of the&#160;Company&#8217;s stock options.  The expected dividend assumption is based on the Company&#8217;s history and expectation of dividend payouts.</span></div></ix:continuation><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">140</span></div></div></div><hr style="page-break-after:always"/><div style="height:90pt;width:100%;"><div style="margin-bottom:9pt;"><span><br/></span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><ix:continuation id="i6ea98028a5084d72bde5dd9a91213695"><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Effective January 1, 2018, the Company made an accounting policy election to account for forfeitures as they occur. </span></div><ix:continuation id="i6fe32792d79543848aad06d784b36901"><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The fair value of the shares to be issued under the Company&#8217;s 2019 ESPP was estimated using the Black-Scholes valuation model with the following assumptions for the year ended December&#160;31, 2019:</span></div><div style="text-align:center;margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:73.961%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:21.238%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Year Ended<br/>December 31,</span></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Expected term (in years)</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"><ix:nonNumeric contextRef="i859497a16f11489db5d922955dbeed5d_D20190101-20191231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZTowMjE1OGQ2MWNjODU0MWZiODUyZDYwNmY0Yzc4MDc3OC90YWJsZXJhbmdlOjAyMTU4ZDYxY2M4NTQxZmI4NTJkNjA2ZjRjNzgwNzc4XzItMy0xLTEtMjUyMS90ZXh0cmVnaW9uOjAzOGY4OTZjYzkwYzRkYzViOGE3MDVjYjBiYjMzMmQ1XzIxOTkwMjMyNTU1NzE_269d7b70-fd8c-49e5-9138-af8eb1104715">0.50</ix:nonNumeric> - <ix:nonNumeric contextRef="i8918167e82b447cfb3b692315e36731e_D20190101-20191231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZTowMjE1OGQ2MWNjODU0MWZiODUyZDYwNmY0Yzc4MDc3OC90YWJsZXJhbmdlOjAyMTU4ZDYxY2M4NTQxZmI4NTJkNjA2ZjRjNzgwNzc4XzItMy0xLTEtMjUyMS90ZXh0cmVnaW9uOjAzOGY4OTZjYzkwYzRkYzViOGE3MDVjYjBiYjMzMmQ1XzIxOTkwMjMyNTU1Nzc_936ffba1-537e-4d0e-a0fd-8cbbedfc1142">0.63</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Expected volatility</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"><ix:nonFraction unitRef="number" contextRef="ib91f8a2aac654fce98f1b02f8c99f196_D20190101-20191231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZTowMjE1OGQ2MWNjODU0MWZiODUyZDYwNmY0Yzc4MDc3OC90YWJsZXJhbmdlOjAyMTU4ZDYxY2M4NTQxZmI4NTJkNjA2ZjRjNzgwNzc4XzMtMy0xLTEtMjUyMS90ZXh0cmVnaW9uOjZkMWY3ZGRjMTc4MzRiOGM4YjI0NjcwNWNhNzBjZTk4XzE5NzkxMjA5Mjk5OTkw_2917a645-4298-4035-b9fb-41001ed6662b">44.4</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="ib91f8a2aac654fce98f1b02f8c99f196_D20190101-20191231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZTowMjE1OGQ2MWNjODU0MWZiODUyZDYwNmY0Yzc4MDc3OC90YWJsZXJhbmdlOjAyMTU4ZDYxY2M4NTQxZmI4NTJkNjA2ZjRjNzgwNzc4XzMtMy0xLTEtMjUyMS90ZXh0cmVnaW9uOjZkMWY3ZGRjMTc4MzRiOGM4YjI0NjcwNWNhNzBjZTk4XzE5NzkxMjA5Mjk5OTk3_7ceff1f6-f72c-4031-8ba2-9cd9a3ae8218">47.8</ix:nonFraction>%</span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"><ix:nonFraction unitRef="number" contextRef="ib91f8a2aac654fce98f1b02f8c99f196_D20190101-20191231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZTowMjE1OGQ2MWNjODU0MWZiODUyZDYwNmY0Yzc4MDc3OC90YWJsZXJhbmdlOjAyMTU4ZDYxY2M4NTQxZmI4NTJkNjA2ZjRjNzgwNzc4XzQtMy0xLTEtMjUyMS90ZXh0cmVnaW9uOjdjYmE1MGVmNGY4YzRmYWFhOTgzOTYxNzcyZGM5MWEwXzE5NzkxMjA5Mjk5OTkw_bdea0b14-1476-40d1-94eb-6f6f1ff97ff9">1.58</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="ib91f8a2aac654fce98f1b02f8c99f196_D20190101-20191231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZTowMjE1OGQ2MWNjODU0MWZiODUyZDYwNmY0Yzc4MDc3OC90YWJsZXJhbmdlOjAyMTU4ZDYxY2M4NTQxZmI4NTJkNjA2ZjRjNzgwNzc4XzQtMy0xLTEtMjUyMS90ZXh0cmVnaW9uOjdjYmE1MGVmNGY4YzRmYWFhOTgzOTYxNzcyZGM5MWEwXzE5NzkxMjA5Mjk5OTk3_db3194b6-b302-4a91-8ae2-bdf5508f7ff0">2.45</ix:nonFraction>%</span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Dividend yield</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="ib91f8a2aac654fce98f1b02f8c99f196_D20190101-20191231" decimals="INF" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZTowMjE1OGQ2MWNjODU0MWZiODUyZDYwNmY0Yzc4MDc3OC90YWJsZXJhbmdlOjAyMTU4ZDYxY2M4NTQxZmI4NTJkNjA2ZjRjNzgwNzc4XzUtMy0xLTEtMjUyMQ_507b0a26-4da7-4b5e-8121-91e8c48fbb10">&#8212;</ix:nonFraction>%&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div></ix:continuation><ix:nonNumeric contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90ZXh0cmVnaW9uOmY0Yzg3Yjg5ZmY2NzRjYTQ4ODFiZWU1MWY3YTk1NWExXzYyMDg_82c9b47a-b549-4c74-8f2f-b4c8d867e951" escape="true"><div style="margin-top:18pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Total stock-based compensation expense relating to the Company&#8217;s stock options and 2019 ESPP during the years ended December&#160;31, 2019 and 2018, is as follows (in thousands):</span></div><div style="text-align:center;margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:69.314%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:11.942%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:11.943%;"></td><td style="width:1.0%;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Year Ended December 31,</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cost of goods sold</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0ac3add721de4c95964529b527a87faf_D20190101-20191231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZToyY2I0YjgxYTA2ZWU0YThiYWI4NzQwNGQ5NzUyMDVlNi90YWJsZXJhbmdlOjJjYjRiODFhMDZlZTRhOGJhYjg3NDA0ZDk3NTIwNWU2XzItMS0xLTEtMA_694f5c7a-7524-4211-9ea9-3ffe88924d9d">179</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="if3367b49450540498cf774db610f6b6b_D20180101-20181231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZToyY2I0YjgxYTA2ZWU0YThiYWI4NzQwNGQ5NzUyMDVlNi90YWJsZXJhbmdlOjJjYjRiODFhMDZlZTRhOGJhYjg3NDA0ZDk3NTIwNWU2XzItMy0xLTEtMA_c4276ffe-d70c-4761-8f15-7cda35ef3476">51</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Research and development expenses</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i053d16b53cd8429ca7577e64137c4073_D20190101-20191231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZToyY2I0YjgxYTA2ZWU0YThiYWI4NzQwNGQ5NzUyMDVlNi90YWJsZXJhbmdlOjJjYjRiODFhMDZlZTRhOGJhYjg3NDA0ZDk3NTIwNWU2XzMtMS0xLTEtMA_f2d77c37-7b69-4db1-b41c-f3d261e09a07">426</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic9a24cc8c2884fee93b26726701eda19_D20180101-20181231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZToyY2I0YjgxYTA2ZWU0YThiYWI4NzQwNGQ5NzUyMDVlNi90YWJsZXJhbmdlOjJjYjRiODFhMDZlZTRhOGJhYjg3NDA0ZDk3NTIwNWU2XzMtMy0xLTEtMA_0257d33d-09e7-422d-9155-a379b0f01692">256</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Selling, general and administrative expenses</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id2b8c23dfe7b4a01a7eab1d91fe07c43_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZToyY2I0YjgxYTA2ZWU0YThiYWI4NzQwNGQ5NzUyMDVlNi90YWJsZXJhbmdlOjJjYjRiODFhMDZlZTRhOGJhYjg3NDA0ZDk3NTIwNWU2XzQtMS0xLTEtMA_8284f75d-7752-4436-83b3-7840674f1275">2,372</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i679bcaee6cf74e85907dc8a0359cf4fd_D20180101-20181231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZToyY2I0YjgxYTA2ZWU0YThiYWI4NzQwNGQ5NzUyMDVlNi90YWJsZXJhbmdlOjJjYjRiODFhMDZlZTRhOGJhYjg3NDA0ZDk3NTIwNWU2XzQtMy0xLTEtMA_7783071d-1530-4621-94d9-1dd7644988bb">604</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZToyY2I0YjgxYTA2ZWU0YThiYWI4NzQwNGQ5NzUyMDVlNi90YWJsZXJhbmdlOjJjYjRiODFhMDZlZTRhOGJhYjg3NDA0ZDk3NTIwNWU2XzUtMS0xLTEtMA_3e6821be-2f00-4277-bc7e-eeac4daef28c">2,977</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZToyY2I0YjgxYTA2ZWU0YThiYWI4NzQwNGQ5NzUyMDVlNi90YWJsZXJhbmdlOjJjYjRiODFhMDZlZTRhOGJhYjg3NDA0ZDk3NTIwNWU2XzUtMy0xLTEtMA_9d76e1c0-c22a-4827-9429-137fc4064da0">911</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr></table></div></ix:nonNumeric><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">  </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">As of December&#160;31, 2019, there was total unrecognized compensation costs of $<ix:nonFraction unitRef="usd" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90ZXh0cmVnaW9uOmY0Yzg3Yjg5ZmY2NzRjYTQ4ODFiZWU1MWY3YTk1NWExXzMyOTg1MzQ5Mzg3OTY_3442f2d9-934d-46e3-b5c4-939d6019015b">8,539,000</ix:nonFraction> related to stock options, which are expected to be recognized over a period of approximately <ix:nonNumeric contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" format="ixt-sec:duryear" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90ZXh0cmVnaW9uOmY0Yzg3Yjg5ZmY2NzRjYTQ4ODFiZWU1MWY3YTk1NWExXzMyOTg1MzQ5Mzg4MDY_2750c6e7-bd07-4268-8938-f0ab31d8bd76">3.04</ix:nonNumeric> years and $<ix:nonFraction unitRef="usd" contextRef="i8b3d2f66951844b589a808406d5fb193_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90ZXh0cmVnaW9uOmY0Yzg3Yjg5ZmY2NzRjYTQ4ODFiZWU1MWY3YTk1NWExXzM4NDgyOTA3NTk5MTU_9d875858-57fb-43eb-83c0-9f7556e819c1">219,000</ix:nonFraction> related to the 2019 ESPP, which the Company will recognize over <ix:nonNumeric contextRef="ib91f8a2aac654fce98f1b02f8c99f196_D20190101-20191231" format="ixt-sec:duryear" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90ZXh0cmVnaW9uOmY0Yzg3Yjg5ZmY2NzRjYTQ4ODFiZWU1MWY3YTk1NWExXzM4NDgyOTA3NTk5Mjc_e4737f54-5bae-4dc2-a3c9-c8d2cfd9bcd2">0.39</ix:nonNumeric> years.</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">.</span></div></ix:continuation><div id="i58f397e86dfd4fc4ac3b8695cd31238e_163"></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">11.&#160;<ix:nonNumeric contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90ZXh0cmVnaW9uOjEwNmFlN2EyY2M2YzQxNzA4MTA3NjE0MjhhZDUwMTEwXzU5MTQ_3877fec8-00c0-44e1-877f-5d63ff8601be" continuedAt="i91639b659fc945fa941a811d96d632c7" escape="true">Income Taxes</ix:nonNumeric></span></div><ix:continuation id="i91639b659fc945fa941a811d96d632c7" continuedAt="i9321471bd55b439fa04fe1a584cac7c9"><ix:nonNumeric contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90ZXh0cmVnaW9uOjEwNmFlN2EyY2M2YzQxNzA4MTA3NjE0MjhhZDUwMTEwXzU5MTU_09fd3ca0-c116-4828-be5d-e52f527dcbc7" escape="true"><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The components of income before taxes are as follows (in thousands):</span></div><div style="text-align:right;margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:69.314%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:11.942%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:11.943%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Year Ended December 31,</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">United States</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90YWJsZTpkOTk0NjBmZWM3OTc0OWZkYmY5OTgzOWYzZjJmZmU1Ny90YWJsZXJhbmdlOmQ5OTQ2MGZlYzc5NzQ5ZmRiZjk5ODM5ZjNmMmZmZTU3XzItMS0xLTEtMA_71cc7bab-9a62-4028-9b92-aa87fadfc1e4">52,415</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90YWJsZTpkOTk0NjBmZWM3OTc0OWZkYmY5OTgzOWYzZjJmZmU1Ny90YWJsZXJhbmdlOmQ5OTQ2MGZlYzc5NzQ5ZmRiZjk5ODM5ZjNmMmZmZTU3XzItMy0xLTEtMA_0e01511e-7c21-4773-bbca-b706bbc66eb4">37,630</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">International</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90YWJsZTpkOTk0NjBmZWM3OTc0OWZkYmY5OTgzOWYzZjJmZmU1Ny90YWJsZXJhbmdlOmQ5OTQ2MGZlYzc5NzQ5ZmRiZjk5ODM5ZjNmMmZmZTU3XzMtMS0xLTEtMA_41efc564-bb63-415d-885f-9e10bdc51ff8">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90YWJsZTpkOTk0NjBmZWM3OTc0OWZkYmY5OTgzOWYzZjJmZmU1Ny90YWJsZXJhbmdlOmQ5OTQ2MGZlYzc5NzQ5ZmRiZjk5ODM5ZjNmMmZmZTU3XzMtMy0xLTEtMA_27837327-9e36-4799-9f61-91d55dc13aef">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90YWJsZTpkOTk0NjBmZWM3OTc0OWZkYmY5OTgzOWYzZjJmZmU1Ny90YWJsZXJhbmdlOmQ5OTQ2MGZlYzc5NzQ5ZmRiZjk5ODM5ZjNmMmZmZTU3XzQtMS0xLTEtMA_93a47ef0-e732-445b-9edf-4da1c56ea1b9">52,415</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90YWJsZTpkOTk0NjBmZWM3OTc0OWZkYmY5OTgzOWYzZjJmZmU1Ny90YWJsZXJhbmdlOmQ5OTQ2MGZlYzc5NzQ5ZmRiZjk5ODM5ZjNmMmZmZTU3XzQtMy0xLTEtMA_e06d641e-c32c-4328-9ab9-149737fff0f9">37,630</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">141</span></div></div></div><hr style="page-break-after:always"/><div style="height:90pt;width:100%;"><div style="margin-bottom:9pt;"><span><br/></span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><ix:continuation id="i9321471bd55b439fa04fe1a584cac7c9" continuedAt="id66182e669154b2483653bee907162d3"><ix:nonNumeric contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90ZXh0cmVnaW9uOjEwNmFlN2EyY2M2YzQxNzA4MTA3NjE0MjhhZDUwMTEwXzU5MTY_3c4444d6-4263-423c-929d-3c0b2fff4f70" escape="true"><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">A reconciliation of the statutory U.S. federal rate to the Company&#8217;s effective tax rate is as follows (in thousands):</span></div><div style="text-align:center;margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:69.314%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:11.942%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:11.943%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Year Ended December 31,</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Tax at federal statutory rate</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90YWJsZTozNjg0YTZhYmE2ZDE0MDYwOTJmYzM0YzAzZDQ3YzJkZS90YWJsZXJhbmdlOjM2ODRhNmFiYTZkMTQwNjA5MmZjMzRjMDNkNDdjMmRlXzItMS0xLTEtMA_a363256d-27d8-4271-bd4a-6cdb5c521455">11,007</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90YWJsZTozNjg0YTZhYmE2ZDE0MDYwOTJmYzM0YzAzZDQ3YzJkZS90YWJsZXJhbmdlOjM2ODRhNmFiYTZkMTQwNjA5MmZjMzRjMDNkNDdjMmRlXzItMy0xLTEtMA_431e1eb1-e2b0-4d61-a1e8-19a085e6cffa">7,902</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">State taxes, net of federal benefit</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90YWJsZTozNjg0YTZhYmE2ZDE0MDYwOTJmYzM0YzAzZDQ3YzJkZS90YWJsZXJhbmdlOjM2ODRhNmFiYTZkMTQwNjA5MmZjMzRjMDNkNDdjMmRlXzMtMS0xLTEtMA_dc6a3e2d-8a28-4510-95bf-4fbc6f282c5a">2,270</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90YWJsZTozNjg0YTZhYmE2ZDE0MDYwOTJmYzM0YzAzZDQ3YzJkZS90YWJsZXJhbmdlOjM2ODRhNmFiYTZkMTQwNjA5MmZjMzRjMDNkNDdjMmRlXzMtMy0xLTEtMA_1c9e965a-392c-4f7e-8b60-5c2b84c531bd">1,582</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Permanent differences</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxReconciliationNondeductibleExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90YWJsZTozNjg0YTZhYmE2ZDE0MDYwOTJmYzM0YzAzZDQ3YzJkZS90YWJsZXJhbmdlOjM2ODRhNmFiYTZkMTQwNjA5MmZjMzRjMDNkNDdjMmRlXzQtMS0xLTEtMA_5012cb9e-8224-4f92-bc8e-35cfcbfc4c05">4,731</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231" decimals="-3" name="us-gaap:IncomeTaxReconciliationNondeductibleExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90YWJsZTozNjg0YTZhYmE2ZDE0MDYwOTJmYzM0YzAzZDQ3YzJkZS90YWJsZXJhbmdlOjM2ODRhNmFiYTZkMTQwNjA5MmZjMzRjMDNkNDdjMmRlXzQtMy0xLTEtMA_6d1c0d92-41b3-433c-b25a-f6b7d53c0976">289</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Loss on Series C warrant liability</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="silk:EffectiveIncomeTaxRateReconciliationWarrantLiabilityAdjustmentAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90YWJsZTozNjg0YTZhYmE2ZDE0MDYwOTJmYzM0YzAzZDQ3YzJkZS90YWJsZXJhbmdlOjM2ODRhNmFiYTZkMTQwNjA5MmZjMzRjMDNkNDdjMmRlXzUtMS0xLTEtMA_c0fb733d-aede-4a71-a813-7696790cbe92">5,330</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="silk:EffectiveIncomeTaxRateReconciliationWarrantLiabilityAdjustmentAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90YWJsZTozNjg0YTZhYmE2ZDE0MDYwOTJmYzM0YzAzZDQ3YzJkZS90YWJsZXJhbmdlOjM2ODRhNmFiYTZkMTQwNjA5MmZjMzRjMDNkNDdjMmRlXzUtMy0xLTEtMA_bbd03f06-a7ba-44ba-bfe2-2be4f32b8293">2,500</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Change in valuation allowance</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90YWJsZTozNjg0YTZhYmE2ZDE0MDYwOTJmYzM0YzAzZDQ3YzJkZS90YWJsZXJhbmdlOjM2ODRhNmFiYTZkMTQwNjA5MmZjMzRjMDNkNDdjMmRlXzctMS0xLTEtMA_9cb0fe0a-b3d9-4dd7-8bf8-b5b377266da2">12,797</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90YWJsZTozNjg0YTZhYmE2ZDE0MDYwOTJmYzM0YzAzZDQ3YzJkZS90YWJsZXJhbmdlOjM2ODRhNmFiYTZkMTQwNjA5MmZjMzRjMDNkNDdjMmRlXzctMy0xLTEtMA_27dbe2f4-e3f6-4c99-afff-2cb4f8417809">6,197</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">General business credits</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" decimals="-3" name="us-gaap:IncomeTaxReconciliationTaxCredits" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90YWJsZTozNjg0YTZhYmE2ZDE0MDYwOTJmYzM0YzAzZDQ3YzJkZS90YWJsZXJhbmdlOjM2ODRhNmFiYTZkMTQwNjA5MmZjMzRjMDNkNDdjMmRlXzgtMS0xLTEtMA_6ee59761-bac2-47cf-8ffd-ba3a3166aa19">319</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationTaxCredits" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90YWJsZTozNjg0YTZhYmE2ZDE0MDYwOTJmYzM0YzAzZDQ3YzJkZS90YWJsZXJhbmdlOjM2ODRhNmFiYTZkMTQwNjA5MmZjMzRjMDNkNDdjMmRlXzgtMy0xLTEtMA_e5e26ad8-1e73-4618-aeef-ca382c5f3791">136</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" decimals="-3" name="us-gaap:IncomeTaxReconciliationOtherReconcilingItems" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90YWJsZTozNjg0YTZhYmE2ZDE0MDYwOTJmYzM0YzAzZDQ3YzJkZS90YWJsZXJhbmdlOjM2ODRhNmFiYTZkMTQwNjA5MmZjMzRjMDNkNDdjMmRlXzktMS0xLTEtMA_9fb667f5-f677-4605-ab32-3f53fd0adaab">208</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231" decimals="-3" name="us-gaap:IncomeTaxReconciliationOtherReconcilingItems" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90YWJsZTozNjg0YTZhYmE2ZDE0MDYwOTJmYzM0YzAzZDQ3YzJkZS90YWJsZXJhbmdlOjM2ODRhNmFiYTZkMTQwNjA5MmZjMzRjMDNkNDdjMmRlXzktMy0xLTEtMA_04a8aedb-aa5d-48e3-b8ba-c15031452cf3">376</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Provision for income taxes</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90YWJsZTozNjg0YTZhYmE2ZDE0MDYwOTJmYzM0YzAzZDQ3YzJkZS90YWJsZXJhbmdlOjM2ODRhNmFiYTZkMTQwNjA5MmZjMzRjMDNkNDdjMmRlXzEwLTEtMS0xLTA_5364846d-4813-4085-a0ec-46204facc847">8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90YWJsZTozNjg0YTZhYmE2ZDE0MDYwOTJmYzM0YzAzZDQ3YzJkZS90YWJsZXJhbmdlOjM2ODRhNmFiYTZkMTQwNjA5MmZjMzRjMDNkNDdjMmRlXzEwLTMtMS0xLTA_80ee01cc-cfc6-4b25-901b-7b10a71704f8">14</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div></ix:nonNumeric><div style="margin-top:18pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company's provision for income taxes are included within other income (expense) on the statements of operations and comprehensive loss.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span><br/></span></div><ix:nonNumeric contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90ZXh0cmVnaW9uOjEwNmFlN2EyY2M2YzQxNzA4MTA3NjE0MjhhZDUwMTEwXzU5MTI_79be2884-52cd-439c-8e2b-1d1d05a103bb" escape="true"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Significant components of the Company&#8217;s net deferred tax assets as of December&#160;31, 2019 and 2018 consist of the following (in thousands):</span></div><div style="text-align:center;margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:69.314%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:11.942%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:11.943%;"></td><td style="width:1.0%;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 31,</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Deferred tax assets:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net operating loss carryforwards</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90YWJsZTplZjllZjc1MWRlZDQ0ZTA0OGYwMTg2MGE2MWExN2Y3Yi90YWJsZXJhbmdlOmVmOWVmNzUxZGVkNDRlMDQ4ZjAxODYwYTYxYTE3ZjdiXzMtMS0xLTEtMA_94824926-3cb1-48ef-aa13-bd47eba305b9">44,574</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90YWJsZTplZjllZjc1MWRlZDQ0ZTA0OGYwMTg2MGE2MWExN2Y3Yi90YWJsZXJhbmdlOmVmOWVmNzUxZGVkNDRlMDQ4ZjAxODYwYTYxYTE3ZjdiXzMtMy0xLTEtMA_432c8bb0-7fbf-484a-892e-da9fd0b6aac3">33,815</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Research and development credits</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90YWJsZTplZjllZjc1MWRlZDQ0ZTA0OGYwMTg2MGE2MWExN2Y3Yi90YWJsZXJhbmdlOmVmOWVmNzUxZGVkNDRlMDQ4ZjAxODYwYTYxYTE3ZjdiXzQtMS0xLTEtMA_26ea60b9-9bc1-41bb-b3a4-432c29ed1699">5,287</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90YWJsZTplZjllZjc1MWRlZDQ0ZTA0OGYwMTg2MGE2MWExN2Y3Yi90YWJsZXJhbmdlOmVmOWVmNzUxZGVkNDRlMDQ4ZjAxODYwYTYxYTE3ZjdiXzQtMy0xLTEtMA_5a1b1074-b490-414b-8548-eb96cf431e46">4,944</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Capitalized start-up costs/Intangibles</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="-3" name="us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90YWJsZTplZjllZjc1MWRlZDQ0ZTA0OGYwMTg2MGE2MWExN2Y3Yi90YWJsZXJhbmdlOmVmOWVmNzUxZGVkNDRlMDQ4ZjAxODYwYTYxYTE3ZjdiXzUtMS0xLTEtMA_94752cf7-7dc0-40b8-b83d-b00239373a5c">11</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231" decimals="-3" name="us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90YWJsZTplZjllZjc1MWRlZDQ0ZTA0OGYwMTg2MGE2MWExN2Y3Yi90YWJsZXJhbmdlOmVmOWVmNzUxZGVkNDRlMDQ4ZjAxODYwYTYxYTE3ZjdiXzUtMy0xLTEtMA_e97e2d85-43e5-4051-8693-8699ff4754d6">16</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accruals and reserves</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90YWJsZTplZjllZjc1MWRlZDQ0ZTA0OGYwMTg2MGE2MWExN2Y3Yi90YWJsZXJhbmdlOmVmOWVmNzUxZGVkNDRlMDQ4ZjAxODYwYTYxYTE3ZjdiXzYtMS0xLTEtMA_73a38d54-924d-4cb9-b050-22d1c5030b32">2,227</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90YWJsZTplZjllZjc1MWRlZDQ0ZTA0OGYwMTg2MGE2MWExN2Y3Yi90YWJsZXJhbmdlOmVmOWVmNzUxZGVkNDRlMDQ4ZjAxODYwYTYxYTE3ZjdiXzYtMy0xLTEtMA_d266ae22-faa0-466f-acdf-b646acbea988">1,169</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Property and equipment</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="-3" name="us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90YWJsZTplZjllZjc1MWRlZDQ0ZTA0OGYwMTg2MGE2MWExN2Y3Yi90YWJsZXJhbmdlOmVmOWVmNzUxZGVkNDRlMDQ4ZjAxODYwYTYxYTE3ZjdiXzctMS0xLTEtMA_3ff7f08c-dcf5-4441-bf41-35ea41a14e7d">188</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231" decimals="-3" name="us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90YWJsZTplZjllZjc1MWRlZDQ0ZTA0OGYwMTg2MGE2MWExN2Y3Yi90YWJsZXJhbmdlOmVmOWVmNzUxZGVkNDRlMDQ4ZjAxODYwYTYxYTE3ZjdiXzctMy0xLTEtMA_1f21855d-67e6-4c75-b4de-284c790347fb">82</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Stock-based compensation</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90YWJsZTplZjllZjc1MWRlZDQ0ZTA0OGYwMTg2MGE2MWExN2Y3Yi90YWJsZXJhbmdlOmVmOWVmNzUxZGVkNDRlMDQ4ZjAxODYwYTYxYTE3ZjdiXzgtMS0xLTEtMA_022cf173-d828-44c8-9d06-8384b5155d0d">568</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90YWJsZTplZjllZjc1MWRlZDQ0ZTA0OGYwMTg2MGE2MWExN2Y3Yi90YWJsZXJhbmdlOmVmOWVmNzUxZGVkNDRlMDQ4ZjAxODYwYTYxYTE3ZjdiXzgtMy0xLTEtMA_1f27f031-fb15-476f-828c-f626d92ce2df">274</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operating lease liability</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="-3" format="ixt:numdotdecimal" name="silk:DeferredTaxAssetsOperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90YWJsZTplZjllZjc1MWRlZDQ0ZTA0OGYwMTg2MGE2MWExN2Y3Yi90YWJsZXJhbmdlOmVmOWVmNzUxZGVkNDRlMDQ4ZjAxODYwYTYxYTE3ZjdiXzktMS0xLTEtODY3OQ_7673f9c0-1c15-4d0d-8c97-da8da663271a">1,133</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total deferred tax assets</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90YWJsZTplZjllZjc1MWRlZDQ0ZTA0OGYwMTg2MGE2MWExN2Y3Yi90YWJsZXJhbmdlOmVmOWVmNzUxZGVkNDRlMDQ4ZjAxODYwYTYxYTE3ZjdiXzktMS0xLTEtMA_825dd3d2-2ea0-47d0-adc1-64c36908045b">53,988</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90YWJsZTplZjllZjc1MWRlZDQ0ZTA0OGYwMTg2MGE2MWExN2Y3Yi90YWJsZXJhbmdlOmVmOWVmNzUxZGVkNDRlMDQ4ZjAxODYwYTYxYTE3ZjdiXzktMy0xLTEtMA_e5d2770c-ea61-483f-b579-c3d4d415fe83">40,300</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Less:  Valuation allowance</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90YWJsZTplZjllZjc1MWRlZDQ0ZTA0OGYwMTg2MGE2MWExN2Y3Yi90YWJsZXJhbmdlOmVmOWVmNzUxZGVkNDRlMDQ4ZjAxODYwYTYxYTE3ZjdiXzEwLTEtMS0xLTA_d51a2abe-b523-45f8-a66d-b696a504fe7a">53,126</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90YWJsZTplZjllZjc1MWRlZDQ0ZTA0OGYwMTg2MGE2MWExN2Y3Yi90YWJsZXJhbmdlOmVmOWVmNzUxZGVkNDRlMDQ4ZjAxODYwYTYxYTE3ZjdiXzEwLTMtMS0xLTA_eb48f420-6f69-4bb6-a861-aa1a4c57e666">40,300</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operating lease asset</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="-3" name="silk:DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90YWJsZTplZjllZjc1MWRlZDQ0ZTA0OGYwMTg2MGE2MWExN2Y3Yi90YWJsZXJhbmdlOmVmOWVmNzUxZGVkNDRlMDQ4ZjAxODYwYTYxYTE3ZjdiXzEzLTEtMS0xLTg2OTg_1909678a-cfc2-4782-8ad0-3625f4f6a88f">862</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total deferred tax liabilities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90YWJsZTplZjllZjc1MWRlZDQ0ZTA0OGYwMTg2MGE2MWExN2Y3Yi90YWJsZXJhbmdlOmVmOWVmNzUxZGVkNDRlMDQ4ZjAxODYwYTYxYTE3ZjdiXzE0LTEtMS0xLTg2OTg_7f04fd58-983b-4bae-a409-1ed78cfcd025">862</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:DeferredIncomeTaxLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90YWJsZTplZjllZjc1MWRlZDQ0ZTA0OGYwMTg2MGE2MWExN2Y3Yi90YWJsZXJhbmdlOmVmOWVmNzUxZGVkNDRlMDQ4ZjAxODYwYTYxYTE3ZjdiXzE0LTMtMS0xLTg2OTg_75d03909-ff92-43de-a18c-06b97c34ff7e">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net deferred tax assets</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:DeferredTaxAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90YWJsZTplZjllZjc1MWRlZDQ0ZTA0OGYwMTg2MGE2MWExN2Y3Yi90YWJsZXJhbmdlOmVmOWVmNzUxZGVkNDRlMDQ4ZjAxODYwYTYxYTE3ZjdiXzExLTEtMS0xLTA_c96d9e37-0ec2-437f-a327-a50b9e14b517">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:DeferredTaxAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90YWJsZTplZjllZjc1MWRlZDQ0ZTA0OGYwMTg2MGE2MWExN2Y3Yi90YWJsZXJhbmdlOmVmOWVmNzUxZGVkNDRlMDQ4ZjAxODYwYTYxYTE3ZjdiXzExLTMtMS0xLTA_3e681890-124f-4369-b3be-253cf6c9ddeb">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr></table></div></ix:nonNumeric><div style="margin-top:18pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In assessing the realizability of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized.  The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible.  Management believes it is more likely than not that the deferred tax assets will not be realized; accordingly, a valuation allowance has been established on U.S. net deferred tax assets.  The valuation allowance increased $<ix:nonFraction unitRef="usd" contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90ZXh0cmVnaW9uOjEwNmFlN2EyY2M2YzQxNzA4MTA3NjE0MjhhZDUwMTEwXzMyOTg1MzQ4ODk2NDg_8c4e06dc-b549-424c-95b8-cd1df366b500">12,826,000</ix:nonFraction> during the year ended December&#160;31, 2019 and increased by $<ix:nonFraction unitRef="usd" contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90ZXh0cmVnaW9uOjEwNmFlN2EyY2M2YzQxNzA4MTA3NjE0MjhhZDUwMTEwXzMyOTg1MzQ4ODk2MzY_aa9e849a-f556-44ce-a9a6-096a8c3bb6bf">6,197,000</ix:nonFraction> during the year ended December&#160;31, 2018.</span></div></ix:continuation><div style="text-indent:18pt;margin-bottom:9pt;"><span><br/></span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">142</span></div></div></div><hr style="page-break-after:always"/><div style="height:90pt;width:100%;"><div style="margin-bottom:9pt;"><span><br/></span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><ix:continuation id="id66182e669154b2483653bee907162d3"><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">As of December&#160;31, 2019, the Company had net operating loss carryforwards of approximately $<ix:nonFraction unitRef="usd" contextRef="i7a5998ad299245269f1d4f24167005aa_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLossCarryforwards" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90ZXh0cmVnaW9uOjEwNmFlN2EyY2M2YzQxNzA4MTA3NjE0MjhhZDUwMTEwXzMyOTg1MzQ4ODk2NjI_64210714-3805-4357-b0ea-224955a344e0">167,948,000</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i67c3f66fec9c4c4387a07595b56bd76b_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLossCarryforwards" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90ZXh0cmVnaW9uOjEwNmFlN2EyY2M2YzQxNzA4MTA3NjE0MjhhZDUwMTEwXzMyOTg1MzQ4ODk2NzY_4ba22953-27a9-49b3-9bf1-1dd991be57c8">148,380,000</ix:nonFraction> for federal and state income tax purposes, respectively.  The federal and state net operating loss carryforwards begin to expire in 2027 and 2028, respectively.  Federal NOL carryforwards generated in tax years beginning in 2018 are not subject to expiration.  Federal NOLs that arose on or after January 1, 2018 can be carried forward indefinitely against future income, but can only be used to offset a maximum of <ix:nonFraction unitRef="number" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="2" name="silk:OperatingLossCarryforwardOffsetMaximumPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90ZXh0cmVnaW9uOjEwNmFlN2EyY2M2YzQxNzA4MTA3NjE0MjhhZDUwMTEwXzIxOTkwMjMyNjcyOTQ_f16e8c49-c725-4dbb-806a-4dac15e8e2a9">80</ix:nonFraction>% of the Company's federal taxable income in any year.</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The federal and state net operating loss carryforwards may be subject to significant limitations under Section 382 and Section 383 of the Internal Revenue Code and similar provisions under state law.  Federal tax legislation enacted in December 2017, commonly known as the Tax Cuts and Jobs Act, contains provisions that limit the federal net operating loss carryforwards that may be used in any given year in the event of special occurrences, including significant ownership changes.  A Section 382 &#8220;ownership change&#8221; generally occurs if one or more stockholders or groups of stockholders, who own at least 5% of the Company&#8217;s stock, increase their ownership by more than 50 percentage points over their lowest ownership percentage within a rolling three-year period.  The Company may have previously experienced, and may in the future experience, one or more Section 382 &#8220;ownership changes,&#8221; including in connection with the Company&#8217;s initial public offering.  If so, the Company may lose some or all of the tax benefits of its NOLs and tax credits.  The extent of such limitations for prior years, if any, has not yet been formally determined.</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">At December&#160;31, 2019, the Company had $<ix:nonFraction unitRef="usd" contextRef="if8375b4a63c74b3f9a8c71549841fb7e_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TaxCreditCarryforwardAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90ZXh0cmVnaW9uOjEwNmFlN2EyY2M2YzQxNzA4MTA3NjE0MjhhZDUwMTEwXzMyOTg1MzQ4ODk2ODg_f2abc3dd-9943-4f6a-b994-3abb82ca4d58">4,320,000</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i7a626cb9bbb248679c22a7a00441bdd3_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TaxCreditCarryforwardAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90ZXh0cmVnaW9uOjEwNmFlN2EyY2M2YzQxNzA4MTA3NjE0MjhhZDUwMTEwXzMyOTg1MzQ4ODk3MDA_b2fab44d-8b9e-4331-ad36-d077c889a14d">2,860,000</ix:nonFraction> of federal and state research and development credit carryforwards, respectively.  If not utilized, the federal credits will expire beginning in 2027.  The California Research and Development credits can be carried forward indefinitely.</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">As of December&#160;31, 2019, the Company had $<ix:nonFraction unitRef="usd" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefits" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90ZXh0cmVnaW9uOjEwNmFlN2EyY2M2YzQxNzA4MTA3NjE0MjhhZDUwMTEwXzMyOTg1MzQ4ODk3MTI_6e59db40-c54a-4e96-828f-a97443f8ab2a">1,436,000</ix:nonFraction> of unrecognized tax benefits.  The Company does not have any tax positions for which it is reasonably possible that the total amount of gross unrecognized would increase or decrease within twelve months of the year ended December&#160;31, 2019. If recognized, $<ix:nonFraction unitRef="usd" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="INF" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90ZXh0cmVnaW9uOjEwNmFlN2EyY2M2YzQxNzA4MTA3NjE0MjhhZDUwMTEwXzIxOTkwMjMyNjcyODE_d9aba9be-b7ac-44a2-8061-22ed9e18de1c">0</ix:nonFraction> would affect the effective tax rate.</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company recognizes interest and penalties related to uncertain tax positions in income tax expense.  There was <ix:nonFraction unitRef="usd" contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90ZXh0cmVnaW9uOjEwNmFlN2EyY2M2YzQxNzA4MTA3NjE0MjhhZDUwMTEwXzIxOTkwMjMyNjcyODQ_0a50cc26-c481-4efb-b557-d24b067f99b7"><ix:nonFraction unitRef="usd" contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90ZXh0cmVnaW9uOjEwNmFlN2EyY2M2YzQxNzA4MTA3NjE0MjhhZDUwMTEwXzIxOTkwMjMyNjcyODQ_5fbac096-7d5e-4fe6-a2d6-9fb2ec44e69b">no</ix:nonFraction></ix:nonFraction> such expense recorded during the years ended December&#160;31, 2019 and 2018.</span></div><ix:nonNumeric contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" name="us-gaap:SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90ZXh0cmVnaW9uOjEwNmFlN2EyY2M2YzQxNzA4MTA3NjE0MjhhZDUwMTEwXzU5MTM_a4b85e83-89c9-456a-89a8-84c9a859a838" escape="true"><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">A reconciliation of the unrecognized tax benefits from January 1, 2018 to December&#160;31, 2019 is as follows (in thousands):</span></div><div style="text-align:center;margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:69.314%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:11.942%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:11.943%;"></td><td style="width:1.0%;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 31,</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance at the beginning of year</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefits" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90YWJsZToxYzQzNTcxZjQxNDA0NTkzYTgwNjU2MzJiYjBjN2UwOS90YWJsZXJhbmdlOjFjNDM1NzFmNDE0MDQ1OTNhODA2NTYzMmJiMGM3ZTA5XzItMS0xLTEtMA_684f3b27-15e2-4dca-9177-b847eb49b22f">1,348</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i517a0560ef9f4f6a822a0a124dd39744_I20171231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90YWJsZToxYzQzNTcxZjQxNDA0NTkzYTgwNjU2MzJiYjBjN2UwOS90YWJsZXJhbmdlOjFjNDM1NzFmNDE0MDQ1OTNhODA2NTYzMmJiMGM3ZTA5XzItMy0xLTEtMA_7fd3ff8f-8104-40c4-bdf5-613f61ba96c9">615</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Increases related to current years&#8217; tax positions</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90YWJsZToxYzQzNTcxZjQxNDA0NTkzYTgwNjU2MzJiYjBjN2UwOS90YWJsZXJhbmdlOjFjNDM1NzFmNDE0MDQ1OTNhODA2NTYzMmJiMGM3ZTA5XzMtMS0xLTEtMA_ef25ccec-3c9f-4d99-921a-dcc59387dabf">88</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90YWJsZToxYzQzNTcxZjQxNDA0NTkzYTgwNjU2MzJiYjBjN2UwOS90YWJsZXJhbmdlOjFjNDM1NzFmNDE0MDQ1OTNhODA2NTYzMmJiMGM3ZTA5XzMtMy0xLTEtMA_93cd0e38-6675-4140-8456-17bbb42c4137">118</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Increases/(decreases) related to prior years&#8217; tax positions</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90YWJsZToxYzQzNTcxZjQxNDA0NTkzYTgwNjU2MzJiYjBjN2UwOS90YWJsZXJhbmdlOjFjNDM1NzFmNDE0MDQ1OTNhODA2NTYzMmJiMGM3ZTA5XzQtMS0xLTEtMA_44f9e0b7-5332-416f-afdc-342cedbd6607">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90YWJsZToxYzQzNTcxZjQxNDA0NTkzYTgwNjU2MzJiYjBjN2UwOS90YWJsZXJhbmdlOjFjNDM1NzFmNDE0MDQ1OTNhODA2NTYzMmJiMGM3ZTA5XzQtMy0xLTEtMA_c965523e-c235-4cee-abf9-600934290540">615</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance at end of year</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i67c494a371a04303ae82b13756a123f9_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefits" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90YWJsZToxYzQzNTcxZjQxNDA0NTkzYTgwNjU2MzJiYjBjN2UwOS90YWJsZXJhbmdlOjFjNDM1NzFmNDE0MDQ1OTNhODA2NTYzMmJiMGM3ZTA5XzUtMS0xLTEtMA_eacd9df6-8740-4294-8ab0-f7724d8e1efa">1,436</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefits" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90YWJsZToxYzQzNTcxZjQxNDA0NTkzYTgwNjU2MzJiYjBjN2UwOS90YWJsZXJhbmdlOjFjNDM1NzFmNDE0MDQ1OTNhODA2NTYzMmJiMGM3ZTA5XzUtMy0xLTEtMA_4815116f-db42-427a-a0f8-e4bd8a33ad02">1,348</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr></table></div></ix:nonNumeric><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company currently has no federal or state tax examinations in progress nor has it had any federal or state tax examinations since its inception.  As a result of the Company&#8217;s net operating loss carryforwards, all of its tax years are subject to federal and state tax examination.</span></div></ix:continuation><div style="text-indent:18pt;margin-bottom:9pt;"><span><br/></span></div><div id="i58f397e86dfd4fc4ac3b8695cd31238e_169"></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">143</span></div></div></div><hr style="page-break-after:always"/><div style="height:90pt;width:100%;"><div style="margin-bottom:9pt;"><span><br/></span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">12.&#160;<ix:nonNumeric contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" name="us-gaap:BusinessCombinationDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjkvZnJhZzo3ZGZhMTkxN2ZiNDE0OTFiYjVhNjQ5NjhjNDg1MjFhMC90ZXh0cmVnaW9uOjdkZmExOTE3ZmI0MTQ5MWJiNWE2NDk2OGM0ODUyMWEwXzQyMDc_314c66a0-3e08-4d0a-98ff-75a3e1170ded" continuedAt="i9d09426779684d3caf3869d1330cef06" escape="true">Acquisition of Variable Interest Entity - NeuroCo</ix:nonNumeric></span></div><ix:continuation id="i9d09426779684d3caf3869d1330cef06"><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In December&#160;2014, the Board of Directors of the Company approved the sale of certain intellectual property of Silk Road Medical, Inc., to a newly incorporated entity, NeuroCo, Inc.  In consideration for the intellectual property, a promissory note was executed between the two parties for the principal sum of $<ix:nonFraction unitRef="usd" contextRef="i43fdc98e9d1c4ea183dc2c37ade70da5_I20141231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:NotesReceivableRelatedParties" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjkvZnJhZzo3ZGZhMTkxN2ZiNDE0OTFiYjVhNjQ5NjhjNDg1MjFhMC90ZXh0cmVnaW9uOjdkZmExOTE3ZmI0MTQ5MWJiNWE2NDk2OGM0ODUyMWEwXzMyOTg1MzQ4ODc2MTk_2ae30c01-9be3-483e-b3d0-7e4226914b77">498,000</ix:nonFraction> with an interest rate of <ix:nonFraction unitRef="number" contextRef="i43fdc98e9d1c4ea183dc2c37ade70da5_I20141231" decimals="INF" name="silk:NotesReceivableRelatedPartiesInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjkvZnJhZzo3ZGZhMTkxN2ZiNDE0OTFiYjVhNjQ5NjhjNDg1MjFhMC90ZXh0cmVnaW9uOjdkZmExOTE3ZmI0MTQ5MWJiNWE2NDk2OGM0ODUyMWEwXzMyOTg1MzQ4ODc2MjM_b71b6006-d3de-429e-a9b9-f740e9bc4ccd">2.74</ix:nonFraction>% per annum, payable on the earlier of <ix:nonNumeric contextRef="ic91bbe5141184edf9c4a395e69721932_D20140101-20141231" format="ixt-sec:duryear" name="silk:NotesReceivableRelatedPartiesTerm" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjkvZnJhZzo3ZGZhMTkxN2ZiNDE0OTFiYjVhNjQ5NjhjNDg1MjFhMC90ZXh0cmVnaW9uOjdkZmExOTE3ZmI0MTQ5MWJiNWE2NDk2OGM0ODUyMWEwXzMyOTg1MzQ4ODc2Mjc_d21e91c2-eebe-4425-aae5-520d21715ece">10</ix:nonNumeric> years from the date of promissory note, or upon the occurrence of an event of default.  The intellectual property transfer was recorded at its carrying value of zero as of December&#160;31, 2014.  During 2015 NeuroCo issued $<ix:nonFraction unitRef="usd" contextRef="i0e7714d1fef74572b8628cbea233e040_D20150101-20151231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjkvZnJhZzo3ZGZhMTkxN2ZiNDE0OTFiYjVhNjQ5NjhjNDg1MjFhMC90ZXh0cmVnaW9uOjdkZmExOTE3ZmI0MTQ5MWJiNWE2NDk2OGM0ODUyMWEwXzMyOTg1MzQ4ODc2MzE_e4beaf46-2a72-43bf-a7ad-358ecc9d9b24">154,000</ix:nonFraction> in common stock to stockholders of the Company.  During the year ended December 31, 2018, NeuroCo issued common stock upon the exercise of stock options.  These common stock issuance amounts, as they are related to non-controlling investors, were reported as non-controlling interests in subsidiary in the Company&#8217;s financial statements and are offset by NeuroCo losses consolidated by the Company.</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Additionally, NeuroCo incurred research and development related expenses paid for by the Company which were added in to the original promissory note.  </span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company had identified NeuroCo as a VIE of which the Company is the primary beneficiary.  Pursuant to the accounting guidance for consolidating VIEs the main consideration was given to the fact that the amount of total equity investment at risk is not sufficient to permit NeuroCo to finance its activities without additional subordinated financial support.  Additionally, NeuroCo and Silk Road Medical had the same Board of Directors and senior management composition, determining the Company to have the power to direct the activities that most significantly impact NeuroCo&#8217;s economic performance and the obligation to absorb losses and the right to receive benefits.  Accordingly, the financial results of NeuroCo were included in the Company&#8217;s financial statements.  </span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">On December 17, 2018, the Company and NeuroCo entered into the Agreement and Plan of Merger (the &#8220;Merger Agreement&#8221;) pursuant to which the Company acquired all assets and assumed all liabilities of NeuroCo (the &#8220;Merger&#8221;).  The Merger closed on the same day (the &#8220;Closing&#8221;) and was consummated through a stock-for-stock transaction based on the relative values of the Company&#8217;s and NeuroCo&#8217;s equity.  In consideration for <ix:nonFraction unitRef="number" contextRef="iaf615eabb3f14a45afa67326aa12db72_I20181217" decimals="INF" name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjkvZnJhZzo3ZGZhMTkxN2ZiNDE0OTFiYjVhNjQ5NjhjNDg1MjFhMC90ZXh0cmVnaW9uOjdkZmExOTE3ZmI0MTQ5MWJiNWE2NDk2OGM0ODUyMWEwXzMyOTg1MzQ4ODc2MzU_96f82791-6590-4a39-96b8-d78a06e2f330">100</ix:nonFraction>% equity interest of NeuroCo, the Company issued <ix:nonFraction unitRef="shares" contextRef="if64e9115ac9b48a7b91422658f25ee6d_D20181217-20181217" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjkvZnJhZzo3ZGZhMTkxN2ZiNDE0OTFiYjVhNjQ5NjhjNDg1MjFhMC90ZXh0cmVnaW9uOjdkZmExOTE3ZmI0MTQ5MWJiNWE2NDk2OGM0ODUyMWEwXzMyOTg1MzQ4ODc2Mzk_9634af5d-0665-4f9d-aafb-30748d6f6538">33,462</ix:nonFraction> shares of its common stock and the above promissory note in the amount of approximately $<ix:nonFraction unitRef="usd" contextRef="if64e9115ac9b48a7b91422658f25ee6d_D20181217-20181217" decimals="-3" format="ixt:numdotdecimal" name="silk:BusinessCombinationConsiderationTransferredNotesPayableForgiven" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjkvZnJhZzo3ZGZhMTkxN2ZiNDE0OTFiYjVhNjQ5NjhjNDg1MjFhMC90ZXh0cmVnaW9uOjdkZmExOTE3ZmI0MTQ5MWJiNWE2NDk2OGM0ODUyMWEwXzMyOTg1MzQ4ODc2NDM_0756d3c2-0744-4f69-9fd0-e8e2e95d8c85">1,600,000</ix:nonFraction> as of the Closing was settled and canceled.  As a result of the Merger, NeuroCo merged into the Company with the Company being the surviving corporation.</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">As the Company already controlled and consolidated NeuroCo and retained the control over NeuroCo&#8217;s business after the Merger, the Company accounted for the acquisition of equity interest in NeuroCo as an equity transaction.  Therefore, the Company did not recognize a gain or loss in its net loss or comprehensive loss for acquisition of NeuroCo.  As the carrying amount of the non-controlling interest as of the Closing was <ix:nonFraction unitRef="usd" contextRef="i129f46ce6e8d4fa98d362bb8455a8c28_I20181217" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NoncontrollingInterestInVariableInterestEntity" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjkvZnJhZzo3ZGZhMTkxN2ZiNDE0OTFiYjVhNjQ5NjhjNDg1MjFhMC90ZXh0cmVnaW9uOjdkZmExOTE3ZmI0MTQ5MWJiNWE2NDk2OGM0ODUyMWEwXzMyOTg1MzQ4ODc2NDc_512958bc-b42f-4f52-8f10-1cd924938ffd">zero</ix:nonFraction>, the Company recorded the consideration paid as a decrease to the Company&#8217;s additional paid-in capital within stockholder&#8217;s equity (deficit). </span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">As part of the Merger, the Company assumed NeuroCo&#8217;s 2015 Equity Incentive Plan (the &#8220;NeuroCo Plan&#8221;) along with all of NeuroCo&#8217;s rights and obligations under the NeuroCo Plan, except that the number of shares and exercise price of the assumed options have been adjusted based on the Merger exchange ratio of the Company&#8217;s common stock and NeuroCo&#8217;s common stock.  Similarly, the Company assumed outstanding warrants to purchase NeuroCo&#8217;s common stock such that the number of shares and exercise price of the assumed warrants have been adjusted based on the Merger exchange ratio of the Company&#8217;s common stock and NeuroCo&#8217;s common stock.  The options and warrants to purchase shares of the Company&#8217;s common stock were fully vested upon issuance, as they were replacing fully vested options and warrants to purchase NeuroCo common stock.</span></div></ix:continuation><div style="margin-bottom:12pt;"><span><br/></span></div><div id="i58f397e86dfd4fc4ac3b8695cd31238e_172"></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">144</span></div></div></div><hr style="page-break-after:always"/><div style="height:90pt;width:100%;"><div style="margin-bottom:9pt;"><span><br/></span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">13.&#160;<ix:nonNumeric contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" name="us-gaap:DefinedContributionPlanDisclosuresTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNzIvZnJhZzo4Y2ZkNzk1ODRhOGI0MWQ3YTI3Mjg0Y2IwNjI5ZDY1Zi90ZXh0cmVnaW9uOjhjZmQ3OTU4NGE4YjQxZDdhMjcyODRjYjA2MjlkNjVmXzQ5NA_8b453eec-db4a-42b2-87e1-1a650a98dc0b" continuedAt="i39722f9a9a3f48b3b7205726898a3424" escape="true">401(k) Plan</ix:nonNumeric></span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"><ix:continuation id="i39722f9a9a3f48b3b7205726898a3424">The Company has a qualified retirement plan under section&#160;401(k)&#160;of the Internal Revenue Code (&#8220;IRC&#8221;) under which participants may contribute up to <ix:nonFraction unitRef="number" contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" decimals="INF" name="us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNzIvZnJhZzo4Y2ZkNzk1ODRhOGI0MWQ3YTI3Mjg0Y2IwNjI5ZDY1Zi90ZXh0cmVnaW9uOjhjZmQ3OTU4NGE4YjQxZDdhMjcyODRjYjA2MjlkNjVmXzMyOTg1MzQ4ODQyNjY_f90d57f3-acec-461d-b410-eff13c93bd79">90</ix:nonFraction>% of their eligible compensation, subject to maximum deferral limits specified by the IRC.  The Company may make a discretionary matching contribution to the 401(k)&#160;plan and may make a discretionary employer contribution to each eligible employee each year.  Through December 31, 2019, the Company has made <ix:nonFraction unitRef="usd" contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:DefinedContributionPlanCostRecognized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNzIvZnJhZzo4Y2ZkNzk1ODRhOGI0MWQ3YTI3Mjg0Y2IwNjI5ZDY1Zi90ZXh0cmVnaW9uOjhjZmQ3OTU4NGE4YjQxZDdhMjcyODRjYjA2MjlkNjVmXzMyOTg1MzQ4ODQyNzA_710e3ee9-3af2-452c-8605-34f3f465f5da">no</ix:nonFraction> contributions to the 401(k)&#160;plan.  Beginning in January 2020, the Company started matching employees' contributions to the 401(k) plan at <ix:nonFraction unitRef="number" contextRef="ie7d5bfb4355c4753b62069b31a28328b_D20200101-20200101" decimals="INF" name="us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNzIvZnJhZzo4Y2ZkNzk1ODRhOGI0MWQ3YTI3Mjg0Y2IwNjI5ZDY1Zi90ZXh0cmVnaW9uOjhjZmQ3OTU4NGE4YjQxZDdhMjcyODRjYjA2MjlkNjVmXzMyOTg1MzQ4ODQyNzU_ae1cd68d-ea56-4c34-960b-8d85ff63e83e">50</ix:nonFraction>% of the first <ix:nonFraction unitRef="number" contextRef="ie7d5bfb4355c4753b62069b31a28328b_D20200101-20200101" decimals="INF" name="us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNzIvZnJhZzo4Y2ZkNzk1ODRhOGI0MWQ3YTI3Mjg0Y2IwNjI5ZDY1Zi90ZXh0cmVnaW9uOjhjZmQ3OTU4NGE4YjQxZDdhMjcyODRjYjA2MjlkNjVmXzMyOTg1MzQ4ODQyNzk_d472f25c-ecb0-43dd-ab76-17aa6d6c1942">5</ix:nonFraction>% of compensation deferred to the 401(k) plan.</ix:continuation></span></div><div style="margin-bottom:12pt;"><span><br/></span></div><div id="i58f397e86dfd4fc4ac3b8695cd31238e_175"></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">14.&#160;<ix:nonNumeric contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" name="us-gaap:SubsequentEventsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNzUvZnJhZzoyOTlmMWJjYmUyMGQ0YTY4YTE4OWQyYWM3YTM0MDJmYi90ZXh0cmVnaW9uOjI5OWYxYmNiZTIwZDRhNjhhMTg5ZDJhYzdhMzQwMmZiXzE0NTI_c16b95ee-8f5d-49f3-9f58-80fc8576de11" continuedAt="i6e3f4a411347416d9862c2b94b1257fd" escape="true">Subsequent Events</ix:nonNumeric></span></div><ix:continuation id="i6e3f4a411347416d9862c2b94b1257fd"><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">2019 Equity Incentive Plan</span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In January 2020, the number of shares of common stock authorized for issuance under the 2019 Plan was automatically increased by <ix:nonFraction unitRef="shares" contextRef="if8352f2dec42436aa6815358749e14c2_I20200131" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNzUvZnJhZzoyOTlmMWJjYmUyMGQ0YTY4YTE4OWQyYWM3YTM0MDJmYi90ZXh0cmVnaW9uOjI5OWYxYmNiZTIwZDRhNjhhMTg5ZDJhYzdhMzQwMmZiXzMyOTg1MzQ4ODc5NDI_5d8f80ad-6685-4398-ad7b-8c2c317ea025">1,250,210</ix:nonFraction> shares, which was ratified by the Company's Board of Directors in February 2020.</span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In February 2020, the Company&#8217;s Board of Directors approved the grant of options to purchase <ix:nonFraction unitRef="shares" contextRef="i8e407444496e48f09abc6f0747a028bc_D20200201-20200229" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNzUvZnJhZzoyOTlmMWJjYmUyMGQ0YTY4YTE4OWQyYWM3YTM0MDJmYi90ZXh0cmVnaW9uOjI5OWYxYmNiZTIwZDRhNjhhMTg5ZDJhYzdhMzQwMmZiXzMyOTg1MzQ4ODc5NTk_5ff0ad5f-0d59-46f5-be4a-c634056188e0">92,885</ix:nonFraction> shares of common stock under the 2019 Plan with an exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i8e407444496e48f09abc6f0747a028bc_D20200201-20200229" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNzUvZnJhZzoyOTlmMWJjYmUyMGQ0YTY4YTE4OWQyYWM3YTM0MDJmYi90ZXh0cmVnaW9uOjI5OWYxYmNiZTIwZDRhNjhhMTg5ZDJhYzdhMzQwMmZiXzMyOTg1MzQ4ODc5NjY_8eab6619-694b-442a-b7b8-10f71cfe20d0">47.20</ix:nonFraction> per share. </span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">2019 Employee Stock Purchase Plan</span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In January 2020, the number of shares of common stock authorized for issuance under the 2019 ESPP was automatically increased by <ix:nonFraction unitRef="shares" contextRef="i36441150a0d742e990ee101edcbe8518_I20200131" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNzUvZnJhZzoyOTlmMWJjYmUyMGQ0YTY4YTE4OWQyYWM3YTM0MDJmYi90ZXh0cmVnaW9uOjI5OWYxYmNiZTIwZDRhNjhhMTg5ZDJhYzdhMzQwMmZiXzMyOTg1MzQ4ODc5NTE_ce40f68f-9f3b-45be-92c8-cdbd84e71920">312,552</ix:nonFraction> shares, which was ratified by the Company's Board of Directors  in February 2020.</span></div></ix:continuation><div id="i58f397e86dfd4fc4ac3b8695cd31238e_3354"></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">145</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="margin-bottom:9pt;"><span><br/></span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">15. &#160;<ix:nonNumeric contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" name="us-gaap:QuarterlyFinancialInformationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8zMzU0L2ZyYWc6ODkzMGUxMjE0YjY0NDQ5YjhhOTZlYzc4OGU4OTg2NTgvdGV4dHJlZ2lvbjo4OTMwZTEyMTRiNjQ0NDliOGE5NmVjNzg4ZTg5ODY1OF8yMTk5MDIzMjU2Mjgx_3e15fde5-63be-4c65-8130-79c5c91b174f" continuedAt="i7289bd765ab74f72878b034eb575a7a6" escape="true">Quarterly Financial Information (unaudited)</ix:nonNumeric></span></div><ix:continuation id="i7289bd765ab74f72878b034eb575a7a6"><ix:nonNumeric contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231" name="us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8zMzU0L2ZyYWc6ODkzMGUxMjE0YjY0NDQ5YjhhOTZlYzc4OGU4OTg2NTgvdGV4dHJlZ2lvbjo4OTMwZTEyMTRiNjQ0NDliOGE5NmVjNzg4ZTg5ODY1OF8yMTk5MDIzMjU2Mjg0_3854cdf1-5864-4c79-a733-7b131aa27329" escape="true"><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table provides selected unaudited quarterly financial data for the years ended December&#160;31, 2019 and 2018 (in thousands, except per share data):</span></div><div style="margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:40.467%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.441%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:12.262%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.441%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:13.544%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.441%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:10.019%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:10.984%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="21" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Three Months Ended</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 31, 2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 30, 2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">March 31, 2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Revenue</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4e27136927b743769274f523ec2a41e7_D20191001-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8zMzU0L2ZyYWc6ODkzMGUxMjE0YjY0NDQ5YjhhOTZlYzc4OGU4OTg2NTgvdGFibGU6YzVjNGNhMjA4ODAwNDM2NTkzMWNmMTEwNGYyYjQyNjkvdGFibGVyYW5nZTpjNWM0Y2EyMDg4MDA0MzY1OTMxY2YxMTA0ZjJiNDI2OV8yLTItMS0xLTM3NjE_dc102c1a-8b91-4d68-a623-0cad678b4881">18,634</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="icd407c3335324384be91497048cf5f08_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8zMzU0L2ZyYWc6ODkzMGUxMjE0YjY0NDQ5YjhhOTZlYzc4OGU4OTg2NTgvdGFibGU6YzVjNGNhMjA4ODAwNDM2NTkzMWNmMTEwNGYyYjQyNjkvdGFibGVyYW5nZTpjNWM0Y2EyMDg4MDA0MzY1OTMxY2YxMTA0ZjJiNDI2OV8yLTQtMS0xLTM3NjE_808be4a7-3141-46a6-baf7-758a37e61d49">17,026</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i88f7bdc9a6e24592abadfd8d6f1e1bc0_D20190401-20190630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8zMzU0L2ZyYWc6ODkzMGUxMjE0YjY0NDQ5YjhhOTZlYzc4OGU4OTg2NTgvdGFibGU6YzVjNGNhMjA4ODAwNDM2NTkzMWNmMTEwNGYyYjQyNjkvdGFibGVyYW5nZTpjNWM0Y2EyMDg4MDA0MzY1OTMxY2YxMTA0ZjJiNDI2OV8yLTYtMS0xLTM3NjE_649d8255-627d-483c-9738-0a57be3a2157">14,928</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie6ccdb76509c4f75a0d36602c75f6151_D20190101-20190331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8zMzU0L2ZyYWc6ODkzMGUxMjE0YjY0NDQ5YjhhOTZlYzc4OGU4OTg2NTgvdGFibGU6YzVjNGNhMjA4ODAwNDM2NTkzMWNmMTEwNGYyYjQyNjkvdGFibGVyYW5nZTpjNWM0Y2EyMDg4MDA0MzY1OTMxY2YxMTA0ZjJiNDI2OV8yLTgtMS0xLTM3NjE_081e0cd5-595a-4b50-b5e4-aa39e602362b">12,766</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gross profit</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4e27136927b743769274f523ec2a41e7_D20191001-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8zMzU0L2ZyYWc6ODkzMGUxMjE0YjY0NDQ5YjhhOTZlYzc4OGU4OTg2NTgvdGFibGU6YzVjNGNhMjA4ODAwNDM2NTkzMWNmMTEwNGYyYjQyNjkvdGFibGVyYW5nZTpjNWM0Y2EyMDg4MDA0MzY1OTMxY2YxMTA0ZjJiNDI2OV8zLTItMS0xLTM3NjE_c95c3718-8d26-48e6-a674-22a9c8c1b3ef">13,913</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="icd407c3335324384be91497048cf5f08_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8zMzU0L2ZyYWc6ODkzMGUxMjE0YjY0NDQ5YjhhOTZlYzc4OGU4OTg2NTgvdGFibGU6YzVjNGNhMjA4ODAwNDM2NTkzMWNmMTEwNGYyYjQyNjkvdGFibGVyYW5nZTpjNWM0Y2EyMDg4MDA0MzY1OTMxY2YxMTA0ZjJiNDI2OV8zLTQtMS0xLTM3NjE_b6976e4d-a282-4153-a2a0-6f7f42b11c18">12,856</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i88f7bdc9a6e24592abadfd8d6f1e1bc0_D20190401-20190630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8zMzU0L2ZyYWc6ODkzMGUxMjE0YjY0NDQ5YjhhOTZlYzc4OGU4OTg2NTgvdGFibGU6YzVjNGNhMjA4ODAwNDM2NTkzMWNmMTEwNGYyYjQyNjkvdGFibGVyYW5nZTpjNWM0Y2EyMDg4MDA0MzY1OTMxY2YxMTA0ZjJiNDI2OV8zLTYtMS0xLTM3NjE_3945dd9a-56c2-476a-942a-98d067692516">11,231</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie6ccdb76509c4f75a0d36602c75f6151_D20190101-20190331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8zMzU0L2ZyYWc6ODkzMGUxMjE0YjY0NDQ5YjhhOTZlYzc4OGU4OTg2NTgvdGFibGU6YzVjNGNhMjA4ODAwNDM2NTkzMWNmMTEwNGYyYjQyNjkvdGFibGVyYW5nZTpjNWM0Y2EyMDg4MDA0MzY1OTMxY2YxMTA0ZjJiNDI2OV8zLTgtMS0xLTM3NjE_fa56c466-da6a-4987-8fdc-d2035bdf5458">9,427</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net loss</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i4e27136927b743769274f523ec2a41e7_D20191001-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8zMzU0L2ZyYWc6ODkzMGUxMjE0YjY0NDQ5YjhhOTZlYzc4OGU4OTg2NTgvdGFibGU6YzVjNGNhMjA4ODAwNDM2NTkzMWNmMTEwNGYyYjQyNjkvdGFibGVyYW5nZTpjNWM0Y2EyMDg4MDA0MzY1OTMxY2YxMTA0ZjJiNDI2OV80LTItMS0xLTM3NjE_a58e6229-d640-4d57-8472-ebae129684fc">8,291</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="icd407c3335324384be91497048cf5f08_D20190701-20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8zMzU0L2ZyYWc6ODkzMGUxMjE0YjY0NDQ5YjhhOTZlYzc4OGU4OTg2NTgvdGFibGU6YzVjNGNhMjA4ODAwNDM2NTkzMWNmMTEwNGYyYjQyNjkvdGFibGVyYW5nZTpjNWM0Y2EyMDg4MDA0MzY1OTMxY2YxMTA0ZjJiNDI2OV80LTQtMS0xLTM3NjE_f4ed40d4-bc73-4d07-9ef2-55c5a5be95f7">8,007</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i88f7bdc9a6e24592abadfd8d6f1e1bc0_D20190401-20190630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8zMzU0L2ZyYWc6ODkzMGUxMjE0YjY0NDQ5YjhhOTZlYzc4OGU4OTg2NTgvdGFibGU6YzVjNGNhMjA4ODAwNDM2NTkzMWNmMTEwNGYyYjQyNjkvdGFibGVyYW5nZTpjNWM0Y2EyMDg4MDA0MzY1OTMxY2YxMTA0ZjJiNDI2OV80LTYtMS0xLTM3NjE_2610789f-1f58-492c-a65f-a4adcc5740df">11,959</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ie6ccdb76509c4f75a0d36602c75f6151_D20190101-20190331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8zMzU0L2ZyYWc6ODkzMGUxMjE0YjY0NDQ5YjhhOTZlYzc4OGU4OTg2NTgvdGFibGU6YzVjNGNhMjA4ODAwNDM2NTkzMWNmMTEwNGYyYjQyNjkvdGFibGVyYW5nZTpjNWM0Y2EyMDg4MDA0MzY1OTMxY2YxMTA0ZjJiNDI2OV80LTgtMS0xLTM3NjE_8d420c42-6071-4169-b419-e72d6499c164">24,158</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net loss per share, basic and diluted</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usdPerShare" contextRef="i4e27136927b743769274f523ec2a41e7_D20191001-20191231" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasicAndDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8zMzU0L2ZyYWc6ODkzMGUxMjE0YjY0NDQ5YjhhOTZlYzc4OGU4OTg2NTgvdGFibGU6YzVjNGNhMjA4ODAwNDM2NTkzMWNmMTEwNGYyYjQyNjkvdGFibGVyYW5nZTpjNWM0Y2EyMDg4MDA0MzY1OTMxY2YxMTA0ZjJiNDI2OV81LTItMS0xLTM3NjE_72debd59-e561-4e89-bcef-42ce6eecfeb6">0.27</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usdPerShare" contextRef="icd407c3335324384be91497048cf5f08_D20190701-20190930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasicAndDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8zMzU0L2ZyYWc6ODkzMGUxMjE0YjY0NDQ5YjhhOTZlYzc4OGU4OTg2NTgvdGFibGU6YzVjNGNhMjA4ODAwNDM2NTkzMWNmMTEwNGYyYjQyNjkvdGFibGVyYW5nZTpjNWM0Y2EyMDg4MDA0MzY1OTMxY2YxMTA0ZjJiNDI2OV81LTQtMS0xLTM3NjE_0769c988-ec34-4a7e-b290-4063141a52fc">0.26</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usdPerShare" contextRef="i88f7bdc9a6e24592abadfd8d6f1e1bc0_D20190401-20190630" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasicAndDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8zMzU0L2ZyYWc6ODkzMGUxMjE0YjY0NDQ5YjhhOTZlYzc4OGU4OTg2NTgvdGFibGU6YzVjNGNhMjA4ODAwNDM2NTkzMWNmMTEwNGYyYjQyNjkvdGFibGVyYW5nZTpjNWM0Y2EyMDg4MDA0MzY1OTMxY2YxMTA0ZjJiNDI2OV81LTYtMS0xLTM3NjE_3ac638b5-c079-4662-b3e2-c570000cdb17">0.42</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usdPerShare" contextRef="ie6ccdb76509c4f75a0d36602c75f6151_D20190101-20190331" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasicAndDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8zMzU0L2ZyYWc6ODkzMGUxMjE0YjY0NDQ5YjhhOTZlYzc4OGU4OTg2NTgvdGFibGU6YzVjNGNhMjA4ODAwNDM2NTkzMWNmMTEwNGYyYjQyNjkvdGFibGVyYW5nZTpjNWM0Y2EyMDg4MDA0MzY1OTMxY2YxMTA0ZjJiNDI2OV81LTgtMS0xLTM3NjE_bb711cc7-b796-4334-b24d-833d01fa2c76">20.12</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div style="text-indent:18pt;margin-bottom:9pt;"><span><br/></span></div><div style="margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:40.788%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.441%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:11.621%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.441%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:14.025%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.441%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:10.820%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.441%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:10.182%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="21" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Three Months Ended</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 31, 2018</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 30, 2018</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2018</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">March 31, 2018</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Revenue</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3efe8595a2ad4f2991c93a7d62cff16f_D20181001-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8zMzU0L2ZyYWc6ODkzMGUxMjE0YjY0NDQ5YjhhOTZlYzc4OGU4OTg2NTgvdGFibGU6ZjY4MzVjZjQzNzg4NGZiZjlhY2MxNTAwYWZmNzBiZDIvdGFibGVyYW5nZTpmNjgzNWNmNDM3ODg0ZmJmOWFjYzE1MDBhZmY3MGJkMl8yLTItMS0xLTM3OTU_a9e46602-c0e1-4d74-9973-da967f7c1982">11,470</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i93f9aed079644f15b2c34904c4aaa35c_D20180701-20180930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8zMzU0L2ZyYWc6ODkzMGUxMjE0YjY0NDQ5YjhhOTZlYzc4OGU4OTg2NTgvdGFibGU6ZjY4MzVjZjQzNzg4NGZiZjlhY2MxNTAwYWZmNzBiZDIvdGFibGVyYW5nZTpmNjgzNWNmNDM3ODg0ZmJmOWFjYzE1MDBhZmY3MGJkMl8yLTQtMS0xLTM3OTU_026167ca-85b9-4174-ae96-be81976934c0">9,614</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="if2a4604d433c48d698f29d76aa7a770b_D20180401-20180630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8zMzU0L2ZyYWc6ODkzMGUxMjE0YjY0NDQ5YjhhOTZlYzc4OGU4OTg2NTgvdGFibGU6ZjY4MzVjZjQzNzg4NGZiZjlhY2MxNTAwYWZmNzBiZDIvdGFibGVyYW5nZTpmNjgzNWNmNDM3ODg0ZmJmOWFjYzE1MDBhZmY3MGJkMl8yLTYtMS0xLTM3OTU_0a98aa95-3d44-4336-a29c-6afe8a68a7b5">7,767</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4209466b8e53444e9359f5893b730654_D20180101-20180331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8zMzU0L2ZyYWc6ODkzMGUxMjE0YjY0NDQ5YjhhOTZlYzc4OGU4OTg2NTgvdGFibGU6ZjY4MzVjZjQzNzg4NGZiZjlhY2MxNTAwYWZmNzBiZDIvdGFibGVyYW5nZTpmNjgzNWNmNDM3ODg0ZmJmOWFjYzE1MDBhZmY3MGJkMl8yLTgtMS0xLTM3OTU_086e3ed7-da29-464f-b70f-1d09a750241d">5,706</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gross profit</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3efe8595a2ad4f2991c93a7d62cff16f_D20181001-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8zMzU0L2ZyYWc6ODkzMGUxMjE0YjY0NDQ5YjhhOTZlYzc4OGU4OTg2NTgvdGFibGU6ZjY4MzVjZjQzNzg4NGZiZjlhY2MxNTAwYWZmNzBiZDIvdGFibGVyYW5nZTpmNjgzNWNmNDM3ODg0ZmJmOWFjYzE1MDBhZmY3MGJkMl8zLTItMS0xLTM3OTU_40b613ee-6e99-44b7-9242-b97a8ca59424">7,803</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i93f9aed079644f15b2c34904c4aaa35c_D20180701-20180930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8zMzU0L2ZyYWc6ODkzMGUxMjE0YjY0NDQ5YjhhOTZlYzc4OGU4OTg2NTgvdGFibGU6ZjY4MzVjZjQzNzg4NGZiZjlhY2MxNTAwYWZmNzBiZDIvdGFibGVyYW5nZTpmNjgzNWNmNDM3ODg0ZmJmOWFjYzE1MDBhZmY3MGJkMl8zLTQtMS0xLTM3OTU_c637e750-273a-4221-9a99-bb2274a26c05">6,732</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="if2a4604d433c48d698f29d76aa7a770b_D20180401-20180630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8zMzU0L2ZyYWc6ODkzMGUxMjE0YjY0NDQ5YjhhOTZlYzc4OGU4OTg2NTgvdGFibGU6ZjY4MzVjZjQzNzg4NGZiZjlhY2MxNTAwYWZmNzBiZDIvdGFibGVyYW5nZTpmNjgzNWNmNDM3ODg0ZmJmOWFjYzE1MDBhZmY3MGJkMl8zLTYtMS0xLTM3OTU_366f98e8-8f56-4937-872a-38f9414c3a53">5,376</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4209466b8e53444e9359f5893b730654_D20180101-20180331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8zMzU0L2ZyYWc6ODkzMGUxMjE0YjY0NDQ5YjhhOTZlYzc4OGU4OTg2NTgvdGFibGU6ZjY4MzVjZjQzNzg4NGZiZjlhY2MxNTAwYWZmNzBiZDIvdGFibGVyYW5nZTpmNjgzNWNmNDM3ODg0ZmJmOWFjYzE1MDBhZmY3MGJkMl8zLTgtMS0xLTM3OTU_804f0bc3-2da0-4327-9dfc-171d6c7804b3">3,772</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net loss</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i3efe8595a2ad4f2991c93a7d62cff16f_D20181001-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8zMzU0L2ZyYWc6ODkzMGUxMjE0YjY0NDQ5YjhhOTZlYzc4OGU4OTg2NTgvdGFibGU6ZjY4MzVjZjQzNzg4NGZiZjlhY2MxNTAwYWZmNzBiZDIvdGFibGVyYW5nZTpmNjgzNWNmNDM3ODg0ZmJmOWFjYzE1MDBhZmY3MGJkMl80LTItMS0xLTM3OTU_d8e7319c-5aae-4bab-b13d-57da9da4f9e1">15,618</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i93f9aed079644f15b2c34904c4aaa35c_D20180701-20180930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8zMzU0L2ZyYWc6ODkzMGUxMjE0YjY0NDQ5YjhhOTZlYzc4OGU4OTg2NTgvdGFibGU6ZjY4MzVjZjQzNzg4NGZiZjlhY2MxNTAwYWZmNzBiZDIvdGFibGVyYW5nZTpmNjgzNWNmNDM3ODg0ZmJmOWFjYzE1MDBhZmY3MGJkMl80LTQtMS0xLTM3OTU_51e47615-85bd-4c9a-880d-6c1766a219df">8,953</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="if2a4604d433c48d698f29d76aa7a770b_D20180401-20180630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8zMzU0L2ZyYWc6ODkzMGUxMjE0YjY0NDQ5YjhhOTZlYzc4OGU4OTg2NTgvdGFibGU6ZjY4MzVjZjQzNzg4NGZiZjlhY2MxNTAwYWZmNzBiZDIvdGFibGVyYW5nZTpmNjgzNWNmNDM3ODg0ZmJmOWFjYzE1MDBhZmY3MGJkMl80LTYtMS0xLTM3OTU_6393b54d-0280-46e4-bd14-d7db7e8488aa">7,651</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i4209466b8e53444e9359f5893b730654_D20180101-20180331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8zMzU0L2ZyYWc6ODkzMGUxMjE0YjY0NDQ5YjhhOTZlYzc4OGU4OTg2NTgvdGFibGU6ZjY4MzVjZjQzNzg4NGZiZjlhY2MxNTAwYWZmNzBiZDIvdGFibGVyYW5nZTpmNjgzNWNmNDM3ODg0ZmJmOWFjYzE1MDBhZmY3MGJkMl80LTgtMS0xLTM3OTU_18f1b587-17d7-4c9b-a06e-454762125db6">5,408</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net loss per share, basic and diluted</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usdPerShare" contextRef="i3efe8595a2ad4f2991c93a7d62cff16f_D20181001-20181231" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasicAndDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8zMzU0L2ZyYWc6ODkzMGUxMjE0YjY0NDQ5YjhhOTZlYzc4OGU4OTg2NTgvdGFibGU6ZjY4MzVjZjQzNzg4NGZiZjlhY2MxNTAwYWZmNzBiZDIvdGFibGVyYW5nZTpmNjgzNWNmNDM3ODg0ZmJmOWFjYzE1MDBhZmY3MGJkMl81LTItMS0xLTM3OTU_03e4a1f8-7ab5-474b-b939-1fd5fa7fbab5">14.12</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usdPerShare" contextRef="i93f9aed079644f15b2c34904c4aaa35c_D20180701-20180930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasicAndDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8zMzU0L2ZyYWc6ODkzMGUxMjE0YjY0NDQ5YjhhOTZlYzc4OGU4OTg2NTgvdGFibGU6ZjY4MzVjZjQzNzg4NGZiZjlhY2MxNTAwYWZmNzBiZDIvdGFibGVyYW5nZTpmNjgzNWNmNDM3ODg0ZmJmOWFjYzE1MDBhZmY3MGJkMl81LTQtMS0xLTM3OTU_87bf30b4-ef69-4528-a180-4a9047f62cd2">8.49</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usdPerShare" contextRef="if2a4604d433c48d698f29d76aa7a770b_D20180401-20180630" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasicAndDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8zMzU0L2ZyYWc6ODkzMGUxMjE0YjY0NDQ5YjhhOTZlYzc4OGU4OTg2NTgvdGFibGU6ZjY4MzVjZjQzNzg4NGZiZjlhY2MxNTAwYWZmNzBiZDIvdGFibGVyYW5nZTpmNjgzNWNmNDM3ODg0ZmJmOWFjYzE1MDBhZmY3MGJkMl81LTYtMS0xLTM3OTU_91ae453a-e4a3-49ee-b3b4-1bb0936e441c">8.16</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usdPerShare" contextRef="i4209466b8e53444e9359f5893b730654_D20180101-20180331" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasicAndDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8zMzU0L2ZyYWc6ODkzMGUxMjE0YjY0NDQ5YjhhOTZlYzc4OGU4OTg2NTgvdGFibGU6ZjY4MzVjZjQzNzg4NGZiZjlhY2MxNTAwYWZmNzBiZDIvdGFibGVyYW5nZTpmNjgzNWNmNDM3ODg0ZmJmOWFjYzE1MDBhZmY3MGJkMl81LTgtMS0xLTM3OTU_fc104088-02c6-401e-8b2f-c2998624c425">7.31</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="text-indent:18pt;margin-bottom:9pt;"><span><br/></span></div><div id="i58f397e86dfd4fc4ac3b8695cd31238e_49"></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">146</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="margin-bottom:9pt;"><span><br/></span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Item 9. Changes in and Disagreements With Accountants on Accounting and Financial Disclosure</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">None.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span><br/></span></div><div id="i58f397e86dfd4fc4ac3b8695cd31238e_52"></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">147</span></div></div></div><hr style="page-break-after:always"/><div style="height:81pt;width:100%;"><div style="margin-bottom:9pt;"><span><br/></span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Item 9A. Controls and Procedures</span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Evaluation of Disclosure Controls and Procedures</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The term &#8220;disclosure controls and procedures,&#8221; as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act refers to controls and procedures that are designed to provide reasonable assurance that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC&#8217;s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the company&#8217;s management, including its principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure. Our management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives and our management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures. Our disclosure controls and procedures are designed to provide reasonable assurance of achieving their control objectives.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our management, with the participation of our President and Chief Executive Officer and our Chief Financial Officer, have evaluated our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended) prior to the filing of this Annual Report on Form 10-K. Based on that evaluation, our President and Chief Executive Officer and our Chief Financial Officer have concluded that, as of December 31, 2019, the end of the period covered by this Annual Report on Form 10-K, our disclosure controls and procedures were not effective because of the material weaknesses described below.</span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Material Weaknesses in Internal Control Over Financial Reporting</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In connection with our preparation for our initial public offering, we identified two material weaknesses in our internal control over financial reporting for the year ended December&#160;31, 2017.  A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting such that there is a reasonable possibility that a material misstatement of our annual or interim financial statements will not be prevented or detected on a timely basis.  The first material weakness identified was that we did not maintain a sufficient complement of resources with an appropriate level of accounting knowledge, experience and training commensurate with our structure and financial reporting requirements.  The second material weakness was that we did not appropriately design and implement controls over the review and approval of manual journal entries and the related supporting journal entry calculations resulting in inappropriate segregation of duties over manual journal entries.  These material weaknesses resulted in audit adjustments to the Company's financial statements for the years ended December 31, 2017, 2018 and 2019, which did not result in a restatement to the Company&#8217;s annual or interim financial statements.  Additionally, these material weaknesses could result in misstatements of the account balances or disclosures that would result in a material misstatement to the annual or interim financial statements that would not be prevented or detected.</span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Remediation Plan and Other Information</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">With the oversight of senior management and our audit committee, we executed the implementation of remediation steps in 2018.  These efforts focused on (i) the hiring of personnel with technical accounting and financial reporting experience and (ii) the implementation of improved accounting and financial reporting procedures and systems to improve the completeness, timeliness and accuracy of our financial reporting and disclosures including the assessment of more judgmental areas of accounting. While we believe the measures described above will remediate the material weaknesses identified and strengthen our internal control over financial reporting, both the implemented and enhanced controls have not operated for a sufficient period of time to demonstrate that the material weaknesses are fully </span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">148</span></div></div></div><hr style="page-break-after:always"/><div style="height:81pt;width:100%;"><div style="margin-bottom:9pt;"><span><br/></span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">remediated.  As such, the remediation initiatives outlined above were not sufficient to fully remediate the material weaknesses in internal control over financial reporting for the year ended December 31, 2019. We are committed to continuing to improve our internal control processes and will continue to diligently and vigorously review our financial reporting controls and procedures.</span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Changes in Internal Control over Financial Reporting</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">As described under the Remediation Plan and Other Information section above, we enhanced controls related to our journal entry process during the quarter ended December 31, 2019. There were no other changes in our internal control over financial reporting that occurred during the most </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">recent fiscal quarter c</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">overed by this Annual Report on Form 10-K that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.</span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Management&#8217;s Annual Report on Internal Control Over Financial Reporting</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">This Annual Report on Form 10-K does not include a report of management&#8217;s assessment regarding internal control over financial reporting or an attestation report of the Company&#8217;s independent registered public accounting firm due to a transition period established by the rules of the SEC for newly public companies.</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">  </span></div><div id="i58f397e86dfd4fc4ac3b8695cd31238e_55"></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Item 9B. Other Information</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">None.</span></div><div id="i58f397e86dfd4fc4ac3b8695cd31238e_58"></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">149</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Content</a><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">s</a></span></div></div><div style="text-align:center;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;">PART III</span></div><div id="i58f397e86dfd4fc4ac3b8695cd31238e_61"></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Item 10. Directors, Executive Officers and Corporate Governance</span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Executive Officers and Directors</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table sets forth information, as of February 28, 2020, regarding our executive officers and directors.</span></div><div style="text-align:justify;margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:32.294%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:5.852%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:54.252%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Name</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Age</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Title</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Executive Officers</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Erica J. Rogers</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">56&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">President, Chief Executive Officer and Director</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Lucas W. Buchanan</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">42&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Chief Financial Officer</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Andrew S. Davis</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">51&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Executive Vice President of Global Sales and Marketing</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Richard M. Ruedy</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">53&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Executive Vice President of Regulatory Affairs, Clinical Affairs and Quality Assurance</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Non-Employee Directors</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="padding-left:11.25pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Ruoxi Chen</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(1)(2)</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">36&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Director</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Tony M. Chou, M.D.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">59&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Director</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Amr Kronfol</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">39&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Director</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="padding-left:11.25pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Jack W. Lasersohn</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(2)</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">66&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Director</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="padding-left:11.25pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Robert E. Mittendorff, M.D.</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(2)</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">43&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Director</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="padding-left:11.25pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Elizabeth H. Weatherman</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(1)</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">60&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Director</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="padding-left:11.25pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Donald J. Zurbay</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(1)</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">52&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Director</span></td></tr></table></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%;">_________________</span></div><div style="text-indent:-18pt;padding-left:18pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%;">(1)</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:9.45pt;">Member of the audit committee.</span></div><div style="text-indent:-18pt;padding-left:18pt;margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%;">(2)</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:9.45pt;">Member of the compensation committee.</span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Executive Officers</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Erica J. Rogers.  </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Ms. Rogers has served as our President and Chief Executive Officer and a member of our board of directors since October 2012.  Ms. Rogers previously served as Chief Operating Officer of Medicines360, a non-profit pharmaceutical company developing drugs and devices for women from June 2010 to October 2012.  Ms. Rogers was an Executive Vice President at Nanosys, Inc. from December 2008 to March 2010.  Prior to that, Ms. Rogers founded and was Chief Executive Officer of Allux Medical, and co-founded Visiogen, which was acquired by Abbott Medical Optics in 2009.  She worked previously in neurovascular marketing at Target Therapeutics and peripheral vascular sales and sales training at Boston Scientific.  Ms. Rogers received a B.S. in zoology from San Diego State University.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We believe Ms. Rogers&#8217; management experience in the medical device industry, her experience in founding and building medical device companies and her extensive understanding of our business, operations, and strategy qualify her to serve on our board of directors.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Lucas W. Buchanan</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">.  </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Mr. Buchanan has served as our Chief Financial Officer since July 2016 and since August 2009 has held multiple roles including Executive Vice President, Commercialization and Corporate Development and Vice President, Marketing and Business Development.  From May 2013 to May 2014, Mr. Buchanan was a Senior Director of Strategy and Corporate Development at Impax Laboratories.  From 2009 to 2011, Mr. Buchanan was part of our early team while employed at The Vertical Group, a venture capital firm and the founder of our company.  He previously worked at Medtronic and at Ernst &amp; Young Corporate Finance LLC.  Mr. Buchanan received a B.A. in economics from Duke University and an M.B.A. in health care management from The Wharton School at the University of Pennsylvania.</span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">150</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Content</a><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">s</a></span></div></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Andrew S. Davis</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">.  Mr. Davis joined us in May 2015 as our Executive Vice President of Global Sales and Marketing.  From September 2014 to May 2015, Mr. Davis was Vice President of Sales and Marketing for U.S. and Canada in the Advanced Wound Therapy Group of Acelity.  Mr. Davis previously held various leadership positions at Medtronic from 1999 until September 2014, where he most recently served as U.S. Vice President of Sales for CoreValve catheter-based therapies and prior to that U.S. Vice President of Sales for Endovascular.  Prior to Medtronic, Mr. Davis worked in sales at Boston Scientific.  Mr. Davis received a B.S. in political science from Florida State University.</span></div><div style="text-indent:18pt;text-align:justify;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Richard M. Ruedy</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">. </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Mr. Ruedy joined us in 2011 and is the Executive Vice President of Clinical and Regulatory Affairs, and Quality Assurance. Mr. Ruedy was previously Vice President of Regulatory, Clinical and Quality for Nevro Corporation from 2009 to 2010 Prior to Nevro, Mr. Ruedy served as Vice President of Regulatory Clinical and Quality affairs of Cardica Inc. from April 2007 to May 2009. Mr. Ruedy also previously served as Director of Regulatory Affairs at Abbott Vascular, co-founded Acta Vascular (acquired by Covidien) and previously held positions of increasing responsibility at Edwards Lifescienses, Medtronic, TriPath Imaging (acquired by Becton Dickinson), and Parallax Medical (acquired by Arthrocare). Mr. Ruedy received a B.A. in English and international relations from Bucknell University.</span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Non-Employee Directors</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Ruoxi Chen</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">.  Mr. Chen has served as a member of our board of directors since August 2016.  Since August 2011 Mr. Chen has been employed at Warburg Pincus, where he is currently a Principal, focusing on healthcare and consumer investments.  Mr. Chen previously worked as an Associate at The Carlyle Group from 2007 to 2009 and in investment banking at Citigroup Global Markets from 2005 to 2007.  Mr.&#160;Chen received a B.S. in economics and computer science from Duke University and an M.B.A. from Harvard Business School.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We believe Mr. Chen is qualified to serve on our board of directors due to his extensive experience as a private equity investor in healthcare and medical device companies.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Tony M. Chou, M.D</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">.  </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Dr. Chou has served as a member of our board of directors since March 2007.  Dr. Chou has been a general partner at The Vertical Group, a healthcare-focused venture capital firm, since August 2006.  After joining The Vertical Group, Dr. Chou co-founded our company in 2007 and served as Chief Executive Officer until November 2010.  Prior to that, Dr. Chou had general management and business development responsibilities in the Abbott Vascular Division of Abbott Laboratories and last served as Division Vice President and General Manager of vascular closure, managing the FDA approval and global launch of the Perclose and Starclose products.  Dr. Chou was previously the Director of the Adult Cardiac Catheterization Laboratory at the University of California, San Francisco, where he is currently Associate Professor of Medicine.  Dr. Chou received a B.S. in physics and electrical engineering from Carnegie Mellon University and an M.D. from Case Western Reserve University.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We believe Dr. Chou is qualified to serve on our board of directors due to his role as a co-founder of our company, background as a practicing physician and professor of medicine, experience in the medical device industry and extensive knowledge of our business.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Amr Kronfol</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">.  Mr. Kronfol has served on our board of directors since March 2019. Mr. Kronfol has been employed at Warburg Pincus since 2009, where he has been a Managing Director since 2018, focusing on investment activities in the healthcare, technology and consumer/retail industries. He previously worked at Merrill Lynch, where he was a Vice President in the fixed income division and at Tigris Consulting. Mr. Kronfol serves on the boards of a number of private medical and technology companies. Mr. Kronfol received an A.B. in computer science from Princeton University and an M.B.A. from The Wharton School at the University of Pennsylvania.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We believe that Mr. Kronfol is qualified to serve on our board of directors due to his extensive experience as a private equity investor and as a director of companies in the medical device industry.</span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">151</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Content</a><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">s</a></span></div></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Jack W. Lasersohn, J.D</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">.</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">  Mr. Lasersohn has served as a member of our Board since April 2007.  Since 1988, Mr. Lasersohn has been a general partner, or a principal of the general partner, of The Vertical Group, L.P., a private venture capital firm that is focused on the fields of medical technology and biotechnology.  The Vertical Group was a co-founder of our company.  Prior to joining The Vertical Group&#8217;s predecessor, F. Eberstadt, in 1981, Mr. Lasersohn was a corporate attorney with Cravath, Swaine &amp; Moore LLP.  Mr. Lasersohn served on the board of directors of Masimo Corporation, a publicly traded global medical technology company, from January 1995 to 2017 and has served on the board of directors of OncoMed Pharmaceuticals, Inc., a publicly traded clinical development-stage biopharmaceutical company, since July 2005.  He also serves on the boards of a number of private medical device and biotechnology companies.  Mr. Lasersohn is the past Chairman of the Medical Industry Group of the National Venture Capital Association, or NVCA, and previously served on the Executive Committee of the board of directors of the NVCA.  Mr. Lasersohn has also served, by appointment, on various committees advising the U.S. Food and Drug Administration and the Center for Medicare and Medicaid Services.  He holds a B.S. in physics from Tufts University, an M.A. from The Fletcher School of Law and Diplomacy, and a J.D. from Yale Law School.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We believe Mr. Lasersohn is qualified to serve on our board of directors due to his extensive experience as a venture capital investor and as a member of the boards of directors of multiple public and private medical device and biotechnology companies.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Robert E. Mittendorff, M.D</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">.  </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Dr. Mittendorff has served on our board of directors since July 2017.  Dr. Mittendorff has been a partner at Norwest Venture Partners since February 2012.  Dr. Mittendorff was previously the VP of Marketing and Business Development at Hansen Medical, Inc.  Dr. Mittendorff currently serves on the board of directors of several private companies and is also a board certified emergency physician.  Dr. Mittendorff received a B.S. in biomedical engineering from Johns Hopkins University, an M.D. from Harvard Medical School and an M.B.A. from Harvard Business School.  </span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We believe Dr. Mittendorff is qualified to serve on our board of directors due to his background as a practicing physician, extensive experience as an investor and his role as a board member of several medical device companies.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Elizabeth H. Weatherman</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">. Ms. Weatherman has served on our board of directors since April 2013. Ms. Weatherman has been a Special Limited Partner of Warburg Pincus since January 2016. Ms. Weatherman previously was a Managing Director of Warburg Pincus and a member of the firm&#8217;s Executive Management Group. Ms. Weatherman joined Warburg Pincus in 1988 and led the firm&#8217;s Healthcare Group from 2008 to 2015. Ms. Weatherman serves on the board of directors of Wright Medical Group, N.V., Vapotherm Inc., and Nevro Corp., all publicly traded medical device companies.  She serves on the Advisory Council of the Stanford Graduate School of Business, and on the board of trustees of Mount Holyoke College and Saint Ann&#8217;s School in Brooklyn, NY.  Ms. Weatherman received a B.A. from Mount Holyoke College and an M.B.A. from the Stanford Graduate School of Business.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We believe that Ms. Weatherman is qualified to serve on our board of directors due to her extensive experience as a private equity investor and a director of public companies in the medical device industry.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Donald J. Zurbay</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">.  Mr. Zurbay has served on our board of directors since March 2018.  Mr. Zurbay has been Chief Financial Officer of Patterson Companies, Inc., a publicly traded global medical device company, since June 2018.  From March 2004 to February 2017, Mr. Zurbay held various leadership positions at St. Jude Medical, Inc., where he most recently served as Vice President and Chief Financial Officer from August 2012 to January 2017.  Mr. Zurbay previously worked at PricewaterhouseCoopers as an Assurance and Business Advisory Services Senior Manager.  Prior to PricewaterhouseCoopers, he was a General Accounting Manager at The Valspar Corporation.  Prior to The Valspar Corporation, Mr. Zurbay was an auditor at Deloitte &amp; Touche.  Mr. Zurbay is a member of the American Institute of Certified Accountants and the Minnesota Society of Certified Public Accountants.  Mr. Zurbay received a B.S. in business with an emphasis in accounting from the University of Minnesota.</span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">152</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Content</a><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">s</a></span></div></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We believe that Mr. Zurbay is qualified to serve on our board of directors due to his current and prior experience at leading publicly traded healthcare companies, including as a Chief Financial Officer, and his financial experience and expertise.</span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Executive Officers</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Each of our executive officers serves at the discretion of our board of directors and holds office until his or her successor is duly elected and qualified or until his or her earlier resignation or removal. There are no family relationships among any of our directors or executive officers.</span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Board of Directors</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our business is managed under the direction of our board of directors, which currently consists of eight directors.  Our directors hold office until the earlier of their death, resignation, removal or disqualification, or until their successors have been elected and qualified.  We do not have a chair of our board of directors.  Our board of directors does not have a formal policy on whether the roles of chief executive officer and chair of our board of directors should be separate.  The members of our board of directors were elected in compliance with the provisions of our amended and restated certificate of incorporation and a stockholders agreement among certain of our stockholders, and, under the terms of such stockholders agreement, the stockholders who are party to the stockholders agreement have agreed to vote their respective shares to elect: (1) one director who is our then-current Chief Executive Officer, currently Erica J. Rogers; (2) two directors designated by the holders of the Series A preferred stock, currently Dr. Tony M. Chou and Jack W. Lasersohn; (3) three directors designated by the holders of the Series B preferred stock, currently Amr Kronfol, Ruoxi Chen, and Donald Zurbay; and (4) two directors designated by the holders of the Series C preferred stock (one of whom shall be designated by Norwest subject to their ownership of at least 50% of the shares of Series C preferred stock purchased by them pursuant to the Series C Preferred Stock Purchase Agreement), currently Dr. Robert E. Mittendorff and Elizabeth H. Weatherman.  Dr. Chou and Mr. Lasersohn were designated and appointed as directors by the Vertical Group; Messrs. Chen, Kronfol and Zurbay and Ms. Weatherman were appointed as directors by Warburg; and Dr. Mittendorff was appointed as a director by Norwest.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">For as long as Warburg owns at least ten percent (10%) of our issued and outstanding common stock, we will nominate and use commercially reasonable efforts (including, without limitation, soliciting proxies for each designee of Warburg to the same extent we do so for any of its other nominees to the board of directors) to have such number of individuals designated by Warburg elected to the board of directors so that the number of individuals designated by Warburg for election to the board of directors as compared to the size of the board of directors is proportionate to the number of shares of issued and outstanding common stock then owned by Warburg as compared to the number of shares of issued and outstanding common stock at such time; provided, however, that as long as Warburg owns at least ten percent (10%) of the issued and outstanding common stock, Warburg has the right to designate at least one (1) individual for election to our board of directors.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our board of directors was divided into three classes with staggered three-year terms.  Our first annual meeting of stockholders will be in 2020.  At each annual meeting of stockholders, the successors to directors whose terms then expire will be elected to serve from the time of election and qualification until the third annual meeting following election or until their earlier death, resignation or removal.  Our directors are divided among the three classes as follows:</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Class I directors are Ms. Rogers and Messrs. Kronfol and Lasersohn, and their terms will expire at our annual meeting of stockholders to be held in 2020;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Class II directors are Dr. Mittendorff, Dr. Chou and Mr. Chen, and their terms will expire at our annual meeting of stockholders to be held in 2021; and </span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Class III directors are Mr. Zurbay and Ms. Weatherman, and their terms will expire at our annual meeting of stockholders to be held in 2022.</span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">153</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Content</a><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">s</a></span></div></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">This classification of the board of directors, together with the ability of the stockholders to remove our directors only for cause and the inability of stockholders to call special meetings, may have the effect of delaying or preventing a change in control or management.  See &#8220;Description of Capital Stock&#8212;Anti-Takeover Effects or Provisions of our Amended and Restated Certificate of Incorporation, our Amended and Restated Bylaws and Delaware Law&#8221; for a discussion of other anti-takeover provisions that are included in our amended and restated certificate of incorporation.</span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Director Independence</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our common stock is quoted on The Nasdaq Stock Market.  Under the rules of The Nasdaq Stock Market, independent directors must comprise a majority of a listed company&#8217;s board of directors within a specified period of time after listing on The Nasdaq Stock Market.  Under Nasdaq Listing Rule 5605(a)(2), a director will qualify as an &#8220;independent director&#8221; only if, in the opinion of the company&#8217;s board of directors, that person does not have a relationship that would interfere with the exercise of independent judgment in carrying out the responsibilities of a director.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our board of directors has reviewed the independence of each director and determined that Dr. Chou, Mr. Lasersohn, Dr. Mittendorff, Ms. Weatherman and Mr. Zurbay, representing five of our eight directors, are independent directors under the rules of The Nasdaq Stock Market.  Our board of directors will review the independence of each director at least annually.  During these reviews, the board of directors will consider transactions and relationships between each director, and his or her immediate family and affiliates, and our company and its management to determine whether any such transactions or relationships are inconsistent with a determination that the director is independent.  This review will be based primarily on responses of the directors to questions in a directors&#8217; and officers&#8217; questionnaire regarding employment, business, familial, compensation and other relationships with our company including its management.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In addition, the rules of The Nasdaq Stock Market require that, subject to specified exceptions, each member of a listed company&#8217;s audit, compensation, and nominating and governance committees be independent. In order to be considered independent for purposes of Rule 10A-3 under the Exchange Act, a member of an audit committee of a listed company may not, other than in his or her capacity as a member of the audit committee, the board of directors, or any other board committee: (i) accept, directly or indirectly, any consulting, advisory, or other compensatory fee from the listed company or any of its subsidiaries; or (ii) be an affiliated person of the listed company or any of its subsidiaries.  Members of the compensation committee must also satisfy additional independence requirements set forth in Nasdaq Listing Rule 5605(d)(2).  In order to be considered independent for purposes of Nasdaq Listing Rule 5605(d)(2), a member of a compensation committee of a listed company may not, other than in his or her capacity as a member of the compensation committee, the board of directors, or any other board committee, accept, directly or indirectly, any consulting, advisory or other compensatory fee from the listed company or any of its subsidiaries.  Additionally, the board of directors of the listed company must consider whether the compensation committee member is an affiliated person of the listed company or any of its subsidiaries and, if so, must determine whether such affiliation would impair the director&#8217;s judgment as a member of the compensation committee.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We believe that a majority of our directors and the composition of our board of directors meets the requirements for independence under the current requirements of the SEC and The Nasdaq Stock Market.  As required by The Nasdaq Stock Market, we anticipate that our independent directors will meet in regularly scheduled executive sessions at which only independent directors are present.  We intend to comply with future governance requirements to the extent they become applicable to us.</span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Corporate Governance</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We believe that good corporate governance is important to ensure that, as a public company, we will be managed for the long-term benefit of our stockholders.  We and our board of directors have been reviewing the corporate governance policies and practices of other public companies, as well as those </span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">154</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Content</a><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">s</a></span></div></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">suggested by various authorities in corporate governance.  We have also considered the provisions of the Sarbanes-Oxley Act and the rules of the SEC and The Nasdaq Stock Market.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Based on this review, our board of directors has taken steps to implement many of these provisions and rules.  In particular, our board of directors has approved charters for the audit committee, compensation committee and nominating and corporate governance committee, as well as a code of business conduct and ethics applicable to all of our directors, officers and employees. </span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Board Committees</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our board of directors has established a standing audit committee, a compensation committee and a nominating and corporate governance committee.  Our board of directors has assessed the independence of the members of each of these standing committees as defined under the rules of The Nasdaq Stock Market and, in the case of the audit committee, the independence requirements of Rule 10A-3 under the Securities Exchange Act of 1934, as amended, or Exchange Act.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Audit Committee</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Ms. Weatherman and Messrs. Chen and Zurbay serve on our audit committee.  Mr. Zurbay serves as the chair of the audit committee.  Our board of directors has determined that Ms. Weatherman and Mr. Zurbay meet the independence and experience requirements applicable to audit committee members under the rules of The Nasdaq Stock Market and the SEC and that Mr. Zurbay is an &#8220;audit committee financial expert&#8221; as defined under applicable rules of the SEC.  Our board of directors has assessed whether all members of the audit committee meet the composition requirements of The Nasdaq Stock Market, including the requirements regarding financial literacy and financial sophistication.  Our board of directors found that Ms. Weatherman and Messrs. Chen and Zurbay have met the financial literacy and financial sophistication requirements under SEC and The Nasdaq Stock Market rules.  Mr. Chen is currently not considered to be an independent audit committee member within the meaning of applicable SEC and Nasdaq rules, but our board has determined to keep him on the audit committee based on his qualifications and experience.  As a result, Mr. Chen does not fall under the safe harbor provision of Rule 10A-3 of the Exchange Act and is not considered independent under such rule.  Until we locate a suitable replacement for Mr. Chen, we plan to rely on SEC and Nasdaq rules for phasing in new independent audit committee members.  The audit committee&#8217;s primary responsibilities include:</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Appointing, approving the compensation of, and assessing the qualifications and independence of our independent registered public accounting firm, which currently is PricewaterhouseCoopers LLP;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Reviewing and discussing with management and our independent registered public accounting firm our annual and quarterly financial statements and related disclosures;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Preparing the audit committee report required by SEC rules to be included in our annual proxy statements;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Monitoring our internal control over financial reporting, disclosure controls and procedures;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Reviewing our risk management status;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Establishing policies regarding hiring employees from our independent registered public accounting firm and procedures for the receipt and retention of accounting related complaints and concerns;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Meeting independently with our independent registered public accounting firm and management; and</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Monitoring compliance with the code of business conduct and ethics for financial management.</span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">155</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Content</a><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">s</a></span></div></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">All audit and non-audit services must be approved in advance by the audit committee.  Our board of directors has adopted a written charter for the audit committee, which is available on our website.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Compensation Committee</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Dr. Mittendorff and Messrs. Chen and Lasersohn serve on our compensation committee.  Mr.&#160;Lasersohn serves as the chair of the compensation committee.  Dr. Mittendorff and Mr. Lasersohn meet the independence requirements of Nasdaq Rule 5605(d)(2).  Mr. Chen is not currently considered to be independent and our board has determined to keep Mr. Chen on the compensation committee in reliance on Nasdaq Rule 5605(d)(2)(B). The compensation committee&#8217;s responsibilities include:</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Annually reviewing and approving corporate goals and objectives relevant to compensation of our chief executive officer and our other executive officers;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Annually reviewing and making recommendations to our board of directors with respect to the compensation of our chief executive officer and determining the compensation for our other executive officers;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Reviewing and making recommendations to our board of directors with respect to director compensation; and</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Overseeing and administering our equity incentive plans.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our chief executive officer and our vice president of human resources make compensation recommendations for our other executive officers and initially proposes the corporate and departmental performance objectives under our Executive Incentive Compensation Plan to the compensation committee.  From time to time, our compensation committee may use outside compensation consultants to assist it in analyzing our compensation programs and in determining appropriate levels of compensation and benefits.  For example, we have periodically engaged Compensia, Inc., to help develop our compensation philosophy, select of a group of peer companies to use for compensation benchmarking purposes and cash and equity compensation levels for our directors, executives and other employees based on current market practices. Our board of directors has adopted a written charter for the compensation committee, which is available on our website.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Nominating and Corporate Governance Committee</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Ms. Weatherman and Messrs. Lasersohn and Zurbay serve on our nominating and corporate governance committee.  Ms. Weatherman serves as the chair of the nominating and corporate governance committee.  The nominating and corporate governance committee's responsibilities include:</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">identifying individuals qualified to become members of our board of directors; </span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">recommending to our board of directors the persons to be nominated for election as directors and to each of our board&#8217;s committees; </span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">reviewing and making recommendations to our board of directors with respect to management succession planning; </span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">developing, updating and recommending to our board of directors corporate governance principles and policies; and  </span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">overseeing the evaluation of our board of directors and committees.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We expect our nominating and corporate governance committee to adopt a written charter that satisfies the applicable listing standards of The NASDAQ Stock Market. Once adopted, a copy of the charter of our nominating and corporate governance committee will be available on our website. </span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">156</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Content</a><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">s</a></span></div></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Code of Business Conduct and Ethics</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our board of directors has adopted a code of business conduct and ethics that applies to all of our employees, officers and directors, including those officers responsible for financial reporting.  Our code of business conduct and ethics is available on our website at www.silkroadmed.com.  We intend to disclose any amendments to the code, or any waivers of its requirements, on our website to the extent required by the applicable rules and exchange requirements.  The inclusion of our website address in this Annual Report on Form 10-K does not incorporate by reference into this Annual Report on Form 10-K the information on or accessible through our website.</span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Limitation on Liability and Indemnification Matters</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our amended and restated certificate of incorporation contains provisions that limit the liability of our directors for monetary damages to the fullest extent permitted by Delaware law.  Consequently, our directors will not be personally liable to us or our stockholders for monetary damages for any breach of fiduciary duties as directors, except liability for:</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Any breach of the director&#8217;s duty of loyalty to us or our stockholders;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Any act or omission not in good faith or that involves intentional misconduct or a knowing violation of law;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Unlawful payments of dividends or unlawful stock repurchases or redemptions as provided in Section 174 of the Delaware General Corporation Law; or</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Any transaction from which the director derived an improper personal benefit.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our board of directors has adopted an amended and restated certificate of incorporation and amended and restated bylaws, and it provides that we are required to indemnify our directors and officers, in each case to the fullest extent permitted by Delaware law.  Our amended and restated bylaws also provides that we are obligated to advance expenses incurred by a director or officer in advance of the final disposition of any action or proceeding, and permits us to secure insurance on behalf of any officer, director, employee or other agent for any liability arising out of his or her actions in that capacity regardless of whether we would otherwise be permitted to indemnify him or her under Delaware law.  We have entered, and expect to continue to enter, into agreements to indemnify our directors, executive officers and other employees as determined by our board of directors.  With specified exceptions, these agreements provide for indemnification for related expenses including, among other things, attorneys&#8217; fees, judgments, fines and settlement amounts incurred by any of these individuals in any action or proceeding.  Insofar as indemnification for liabilities arising under the Securities Act may be permitted to our directors, officers and controlling persons pursuant to the foregoing provisions, or otherwise, we have been advised that, in the opinion of the SEC, such indemnification is against public policy as expressed in the Securities Act, and is, therefore, unenforceable.  We believe that these bylaw provisions and indemnification agreements are necessary to attract and retain qualified persons as directors and officers.  We also maintain directors&#8217; and officers&#8217; liability insurance.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The limitation of liability and indemnification provisions in our amended and restated certificate of incorporation and amended and restated bylaws may discourage stockholders from bringing a lawsuit against our directors and officers for breach of their fiduciary duty.  They may also reduce the likelihood of derivative litigation against our directors and officers, even though an action, if successful, might benefit us and our stockholders.  Further, a stockholder&#8217;s investment may be adversely affected to the extent that we pay the costs of settlement and damages.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span><br/></span></div><div id="i58f397e86dfd4fc4ac3b8695cd31238e_64"></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">157</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Content</a><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">s</a></span></div></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Item 11. Executive Compensation</span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Summary Compensation Table</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">This discussion contains forward looking statements that are based on our current plans, considerations, expectations and determinations regarding future compensation programs. Actual compensation programs that we adopt may differ materially from currently planned programs as summari</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">zed in this discussion.  As an &#8220;emerging growth company&#8221; as defined in the JOBS Act, we are not required to include a Compensation Discussion and Analysis section and have elected to comply with the scaled disclosure requirements applicable to emerging growth companies.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table provides information regarding the total compensation for services rendered in all capacities that was earned by our principal executive officer and our two other most highly compensated executive officers who were serving as executive officers during the years ended December 31, 2019 and 2018. These individuals were our named executive officers for 2019 and 2018.</span></div><div style="text-align:justify;margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:17.711%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.441%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:3.128%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.441%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:5.532%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.441%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:5.051%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.441%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:3.929%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.441%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:6.493%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.441%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:8.737%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.441%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:8.096%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.441%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:8.416%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.441%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:7.138%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:6pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Name and Principal Position</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:6pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Year</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:6pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Salary<br/>($)</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:700;line-height:100%;">Bonus</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:700;line-height:100%;">($)</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:3.9pt;font-weight:700;line-height:100%;vertical-align:top;">(1)</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:6pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Stock Awards<br/>($)</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:700;line-height:100%;">Option Awards</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:700;line-height:100%;">($)</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:3.9pt;font-weight:700;line-height:100%;vertical-align:top;">(2)</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:700;line-height:100%;">Non-Equity Incentive Plan Compensation</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:700;line-height:100%;">($)</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:3.9pt;font-weight:700;line-height:100%;vertical-align:top;">(3)</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:6pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Non-Qualified Deferred Compensation Earnings<br/>($)</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:6pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">All Other Compensation<br/>($)</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:6pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total<br/>($)</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:6.5pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Erica J. Rogers</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">421,167&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">64,500&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,734,154&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">459,240&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,850&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,683,911&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:6.5pt;font-weight:400;font-style:italic;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">President, Chief Executive Officer and Director</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">390,000&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">234,000&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">624,000&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:6.5pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Lucas W. Buchanan</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">365,583&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">46,250&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">635,071&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">329,300&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">14,646&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,390,850&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:6.5pt;font-weight:400;font-style:italic;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Chief Financial Officer</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">350,000&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">210,000&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">560,000&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:6.5pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Andrew S. Davis</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">430,583&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">54,375&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">334,249&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">387,150&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11,817&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,218,174&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:6.5pt;font-weight:400;font-style:italic;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Executive Vice President, Global Sales and Marketing</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">415,000&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">199,000&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12,067&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">626,067&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:6.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div style="text-align:justify;"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%;">_________________</span></div><div style="text-indent:-18pt;padding-left:18pt;"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%;">(1)</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:9.45pt;">Amounts for 2018 reflect a year-end discretionary bonus paid on February 15, 2019.  Amounts for 2019 reflect a year-end discretionary bonus paid on February 28, 2020.</span></div><div style="text-indent:-18pt;padding-left:18pt;"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%;">(2)</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:9.45pt;">The amounts reported represent the aggregate grant-date fair value of the stock options awarded to the named executive officers calculated in accordance with ASC Topic 718. Such grant-date fair value does not take into account any estimated forfeitures related to service-vesting conditions. The assumptions used in calculating the grant-date fair value of the options reported in this column are set forth in &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8212;Critical Accounting Policies and Estimates&#8212;Common Stock Valuation and Stock-</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%;">Based Compensation.&#8221;</span></div><div style="text-indent:-18pt;padding-left:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%;">(3)</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:9.45pt;">Non-Equity Incentive Plan Compensation amounts for 2019 for all named executive officers were paid on February 28, 2020, pursuant to our 2019 Bonus Plan, as described in the section below titled &#8220;Executive Compensation&#8212;Non-Equity Incentive Plan Compensation.&#8221;</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Narrative Disclosure to Summary Compensation Table</span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Non-Equity Incentive Plan Compensation</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We provide each of our named executive officers an opportunity to receive formula-based incentive payments.  The payments are based on a target incentive amount for each named executive officer.  In addition, based on exceptional performance of each of our named executive officers during 2019, our board of directors determined to provide each named executive officer an additional discretionary bonus that was in excess of the amount determined under our 2019 Bonus Plan.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Non-Equity Incentive Payments for 2019</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">For 2019, the target incentive amount and year-end payments for Erica J. Rogers, Lucas W. Buchanan and Andrew S. Davis under our 2019 Bonus Plan were as follows:</span></div><div style="text-align:center;margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:55.051%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:11.942%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:25.405%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Named Executive Officer</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%;">Target</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"> </span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%;">Award</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%;">($)</span></div></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%;">Actual&#160;Award Amount Based on Corporate Performance</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%;">($)</span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Erica J. Rogers</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">258,000&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">459,240&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Lucas W. Buchanan</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">185,000&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">329,300&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Andrew S. Davis</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">217,500&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">387,150&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">158</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Content</a><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">s</a></span></div></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The 2019 Bonus Plan provided for non-equity incentive compensation based upon our achievement of performance goals for 2019 at 178% of target. The actual target incentive payments were weighted 100% toward achievement of Company goals which included achieving revenue and clinical outcome targets.  </span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Outstanding Equity Awards at 2019 Year-End</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table sets forth information regarding outstanding stock options and stock awards held by our named executive officers as of December 31, 2019:</span></div><div style="text-align:justify;margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:14.025%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:6.974%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:10.179%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:7.615%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:9.698%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:6.173%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:6.974%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:6.974%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:6.980%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="33" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:6.5pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Option Awards</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:6.5pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Stock Awards</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:6.5pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Name</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;">Grant Date</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:4.22pt;font-weight:700;line-height:100%;vertical-align:top;">(1)</sup></div></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;">Vesting Commencement Date</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:4.22pt;font-weight:700;line-height:100%;vertical-align:top;">(2)</sup></div></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:6.5pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Number of Securities Underlying Unexercised Options (#) Exercisable</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:6.5pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Number of Securities Underlying Unexercised Options (#) Unexercisable</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;">Option Exercise Price ($)</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:4.22pt;font-weight:700;line-height:100%;vertical-align:top;">(3)</sup></div></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:6.5pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Option Expiration Date</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:6.5pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Number&#160;of Shares or Units of Stock&#160;That Vested (#)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:6.5pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Market Value&#160;of Shares&#160;or Units of Stock&#160;That Have Not Vested ($)</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-style:italic;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Erica J. Rogers</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12/14/2012</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10/23/2012</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">81,510&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.38&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12/14/2022</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12/14/2012</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10/23/2012</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">82,512&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.38&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12/14/2022</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12/24/2014</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12/24/2014</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">61,728&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.46&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12/24/2024</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12/3/2015</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12/3/2015</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">143,290&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.60&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12/13/2025</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8/4/2016</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8/4/2016</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">216,049&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">43,210&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.60&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8/4/2026</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9/30/2016</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9/30/2016</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">330&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8.27&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9/30/2026</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11/30/2017</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8/1/2017</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">43,209&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">30,865&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6.11&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11/30/2027</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11/30/2017</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8/1/2017</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">213,888&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">152,778&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12.15&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11/30/2027</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11/30/2017</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8/1/2017</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">22,222&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12.15&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11/30/2027</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4/3/2019</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4/3/2019</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">50,493&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">252,469&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">20.00&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4/3/2029</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-style:italic;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Lucas W. Buchanan</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12/24/2014</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12/24/2014</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7,408&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.46&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12/24/2024</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12/3/2015</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12/3/2015</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">207,795&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.60&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12/3/2025</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8/4/2016</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8/4/2016</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">41,666&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8,334&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.60&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8/4/2026</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9/30/2016</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9/30/2016</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">398&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8.27&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9/30/2026</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11/30/2017</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8/1/2017</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">42,630&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">35,899&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.73&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11/30/2027</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11/30/2017</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8/1/2017</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">19,652&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">14,037&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12.15&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11/30/2027</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11/30/2017</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8/1/2017</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">25,847&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12.15&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11/30/2027</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4/3/2019</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4/3/2019</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11,728&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">58,642&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">20.00&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4/3/2029</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:11pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:11pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:11pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:11pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:11pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:11pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:11pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:11pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:11pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:11pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:11pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:11pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:11pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:11pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:11pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:11pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:11pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-style:italic;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Andrew S. Davis</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6/23/2015</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5/5/2015</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">125,623&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.46&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6/23/2025</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12/3/2015</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12/3/2015</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">45,780&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.60&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12/3/2025</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11/30/2017</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8/1/2017</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">36,111&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.73&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11/30/2027</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11/30/2017</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8/1/2017</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">49,150&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">35,109&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.73&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11/30/2027</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9/13/2018</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8/1/2018</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">987&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,975&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6.11&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9/13/2028</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4/3/2019</span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4/3/2019</span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6,172&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">30,865&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">20.00&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4/3/2029</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%;">_________________</span></div><div style="text-indent:-18pt;padding-left:18pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%;">(1)</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:9.45pt;">Each of the outstanding stock options was granted pursuant to our 2007 Stock Plan or 2019 Equity Incentive Plan.</span></div><div style="text-indent:-18pt;padding-left:18pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%;">(2)</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:9.45pt;">Options generally vest over four years from the vesting commencement date in 48 equal monthly amounts, subject to continued service through each such vesting date, provided that the option grants to (x) Ms. Rogers on November 30, 2017 for 74,074 and 388,888 shares, respectively, (y) Mr. Buchanan on November 30, 2017, for 86,157 and 59,536 shares, respectively, and (z) Mr. Davis on November 30, 2017, for 120,370 shares will accelerate and fully vest if the applicable optionee experiences an involuntary termination under certain circumstances within the 12 month period following a change in control of the Company.  The option grants to (i) Ms. Rogers on November 30, 2017, for 22,222 shares, (ii) Mr. Buchanan on November 30, 2017, for 25,847 shares and (iii) Mr. Davis on November 30, 2017, for 36,111 shares all vest upon the earlier of a change in control of the Company or the two year anniversary of the initial public offering of the Company&#8217;s common stock, provided that each such option will accelerate and fully vest upon the involuntary termination of the applicable optionee under certain circumstances.  The option grant to Mr. Buchanan on December 3, 2015 for 226,995 shares vested 85,122 shares on the vesting commencement date and the remaining shares vested over thirty months from the vesting commencement date in equal monthly amounts.  The option grants to Mr. Davis on June 23, 2015 and September 13, 2018 for 138,893 shares and 2,962 shares, respectively, vest over four years from the vesting commencement date, with 25% vested on the one year anniversary of the vesting commencement date, and with the remaining amount vesting monthly over the subsequent 36 months in equal amounts.</span></div><div style="text-indent:-18pt;padding-left:18pt;margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%;">(3)</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:9.45pt;">This column represents the fair market value of our common stock on the date of grant, as determined by our board of directors.</span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">159</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Content</a><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">s</a></span></div></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Pension Benefits and Nonqualified Deferred Compensation</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We do not provide a pension plan for our employees, and none of our named executive officers participated in a nonqualified deferred compensation plan in 2019.</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"> </span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Executive Officer Confirmatory Employment Letters</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In March 2019, we entered into confirmatory employment letters with each of our named executive officers.  Each letter has no specific term and provides for&#160;at-will&#160;employment.  Each letter also provides that for our 2019 fiscal year, the applicable employee will have the opportunity to earn a target annual cash bonus based on achieving performance objectives established by our board of directors or compensation committee equal to a percentage of the employee&#8217;s annual base salary, with such percentage being 60% for Ms. Rogers, 50% for Mr. Buchanan, and 50% for Mr. Davis, respectively.  Each letter also provides for an annual base salary, with such salary being $430,000 for Ms. Rogers, $370,000 for Mr. Buchanan, and $435,000 for Mr. Davis.</span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Executive Officer Change in Control and Severance Agreements</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In March 2019, we entered into change of control and severance agreements with each of our named executive officers, which superseded all previous severance and change of control arrangements we had entered into with these employees. Each of these agreements has a term of three years. Under each of these agreements, if, within the period three months prior to and 12 months following a &#8220;change of control&#8221; (such period, the change in control period), we terminate the employment of the applicable employee without &#8220;cause&#8221; (excluding by reason of the employee&#8217;s death or &#8220;disability,&#8221;) or the employee resigns for &#8220;good reason&#8221; (as such terms are defined in the employee&#8217;s change of control and severance agreement) and the employee executes a separation agreement and release of claims that becomes effective and irrevocable within 60 days following the employee&#8217;s termination, the employee is entitled to receive (i) a lump sum severance payment, less applicable withholdings, equal to the payment of employee&#8217;s base salary, as then in effect, of 18 months for Ms. Rogers, 12 months for Mr. Buchanan, and six months for Mr. Davis, respectively, plus, for Ms. Rogers and Mr. Davis, one additional month for each year the applicable employee has remained our employee through the termination date (with partial years of employment rounded up to a whole year), up to a limit of 24 months for Ms. Rogers and 12 months for Mr. Davis, respectively (such monthly period, the severance period) (ii) a lump sum payment, less applicable withholdings, equal to a percentage of the employee&#8217;s annual target bonus for the year in which the termination occurs, with such percentage being 100% for Ms. Rogers and Mr. Buchanan and 50% for Mr. Davis, respectively, plus, for Ms. Rogers and Mr. Davis, 8.33% for each full year the applicable employee has remained our employee through the termination date (with partial years of employment rounded up to a whole year), up to a limit of 200% for Ms. Rogers and 100% for Mr. Davis, respectively, (iii) reimbursement of premiums to maintain group health insurance continuation benefits pursuant to &#8220;COBRA&#8221; for the employee and the employee&#8217;s dependents through the applicable employee&#8217;s severance period (with an additional limit of 18 months for Ms. Rogers), and (iv) accelerated vesting as to 100% of the employee&#8217;s outstanding unvested equity awards.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In addition, under each of these agreements, if, outside of the change in control period, we terminate the employment of the applicable employee without cause (excluding by reason of the employee&#8217;s death or disability), or the employee resigns for good reason, and the employee executes a separation agreement and release of claims that becomes effective and irrevocable within 60 days following the employee&#8217;s termination, the employee is entitled to receive (i) a lump sum severance payment, less applicable withholdings, equal to the payment of, for Ms. Rogers and Mr. Buchanan, the employee&#8217;s base salary, as then in effect, for 12 months for Ms. Rogers, nine months for Mr. Buchanan, respectively, and for Mr. Davis, six months of Mr. Davis&#8217; average total annualized cash compensation, as measured over the prior 12 month period preceding Mr. Davis&#8217; termination of employment, including salary, commissions and bonuses, and (ii) reimbursement of premiums to maintain group health insurance continuation benefits pursuant to &#8220;COBRA&#8221; for the employee and the employee&#8217;s dependents for 12 months for Ms. Rogers, nine months for Mr. Buchanan, and six months for Mr. Davis, respectively. </span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">160</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Content</a><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">s</a></span></div></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Under each of these agreements, in the event any payment to the applicable employee pursuant to his or her change of control and severance agreement would be subject to the excise tax imposed by Section 4999 of the Internal Revenue Code, as amended, or the Code (as a result of a payment being classified as a parachute payment under Section 280G of the Code), the employee will receive such payment as would entitle the employee to receive the greatest after-tax benefit, even if it means that we pay him or her a lower aggregate payment so as to minimize or eliminate the potential excise tax imposed by Section 4999 of the Code.</span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Employee Benefit and Stock Plans</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">2019 Equity Incentive Plan</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our board of directors adopted, and our stockholders approved, our 2019 Equity Incentive Plan, or the 2019 Plan.  Our 2019 Plan became effective upon the completion of our initial public offering in April 2019.  Our 2019 Plan permits the grant of incentive stock options, within the meaning of Section 422 of the Code, to our employees and any parent and subsidiary corporations&#8217; employees, and for the grant of nonstatutory stock options, restricted stock, restricted stock units, stock appreciation rights, performance units and performance shares to our employees, directors and consultants and our parent and subsidiary corporations&#8217; employees and consultants.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Authorized Shares</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">.  A total of 2,317,000&#160;shares of our common stock are reserved for issuance pursuant to the 2019 Plan.  In addition, the shares reserved for issuance under our 2019 Plan will also include shares reserved but not issued under the 2007 Stock Plan, as amended, or the 2007 Plan, and shares subject to stock options or similar awards granted under the 2007 Plan that expire or terminate without having been exercised in full and shares issued pursuant to awards granted under the 2007 Plan that are forfeited to or repurchased by us (provided that the maximum number of shares that may be added to the 2019 Plan pursuant to this sentence is 4,170,676&#160;shares).  In addition, shares may become available under the 2019 Plan as described below.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The number of shares available for issuance under the 2019 Plan includes an annual increase on the first day of each fiscal year beginning in fiscal 2019, equal to the lesser of:</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">3,000,000&#160;shares;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">4% of the outstanding shares of common stock as of the last day of our immediately preceding fiscal year; or</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">such other amount as our board of directors may determine.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">If an award expires or becomes unexercisable without having been exercised in full, is surrendered pursuant to an exchange program, or, with respect to restricted stock, restricted stock units, performance units or performance shares, is forfeited or repurchased due to failure to vest, the unpurchased shares (or for awards other than stock options or stock appreciation rights, the forfeited or repurchased shares) will become available for future grant or sale under our 2019 Plan.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">With respect to stock appreciation rights, the net shares issued will cease to be available under the 2019 Plan and all remaining shares will remain available for future grant or sale under the 2019 Plan.  Shares used to pay the exercise price of an award or satisfy the tax withholding obligations related to an award will become available for future grant or sale under our 2019 Plan.  To the extent an award is paid out in cash rather than shares, such cash payment will not result in reducing the number of shares available for issuance under our 2019 Plan.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Plan Administration</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">.  Our board of directors or one or more committees appointed by our board of directors will administer our 2019 Plan.  In addition, if we determine it is desirable to qualify transactions under the 2019 Plan as exempt under Rule 16b-3 of the Exchange Act, or Rule 16b-3, such transactions will be structured to satisfy the requirements for exemption under Rule 16b-3.  Subject to the provisions of </span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">161</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Content</a><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">s</a></span></div></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">our 2019 Plan, the administrator will have the power to administer our 2019 Plan and make all determinations deemed necessary or advisable for administering the 2019 Plan, such as the power to determine the fair market value of our common stock, select the service providers to whom awards may be granted, determine the number of shares covered by each award, approve forms of award agreements for use under the 2019 Plan, determine the terms and conditions of awards (such as the exercise price, the times or times at which the awards may be exercised, any vesting acceleration or waiver or forfeiture restrictions, and any restriction or limitation regarding any award or the shares relating thereto), construe and interpret the terms of our 2019 Plan and awards granted under it, to prescribe, amend, and rescind rules relating to our 2019 Plan, including creating sub-plans, and to modify or amend each award, such as the discretionary authority to extent the post-termination exercisability period of awards (provided that no option or stock appreciation right will be extended past its original maximum term, and to allow a participant to defer the receipt of payment of cash or the delivery of shares that would otherwise be due to such participant under an award.  The administrator also will have the authority to institute an exchange program by which (i) outstanding awards may be surrendered or cancelled in exchange for awards of the same type which may have a higher or lower exercise price and/or different terms, awards of a different type and/or cash, (ii) participants have the opportunity to transfer outstanding awards to a financial institution or other person or entity selected by the administrator, or (iii) the exercise price of an outstanding award is increased or reduced.  The administrator&#8217;s decisions, interpretations, and other actions will be final and binding on all participants.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Stock Options</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">.  Stock options may be granted under our 2019 Plan.  The exercise price of options granted under our 2019 Plan must at least be equal to the fair market value of our common stock on the date of grant.  The term of an incentive stock option may not exceed 10 years, except that with respect to any participant who owns more than 10% of the voting power of all classes of our outstanding stock, the term must not exceed five years and the exercise price must equal at least 110% of the fair market value on the grant date.  The administrator will determine the methods of payment of the exercise price of an option, which may include cash, shares or other property acceptable to the administrator, as well as other types of consideration permitted by applicable law.  After the termination of service of an employee, director or consultant, he or she may exercise his or her option for the period of time stated in his or her option agreement.  Generally, if termination is due to death or disability, the option will remain exercisable for 12 months.  In all other cases, the option will generally remain exercisable for three months following the termination of service.  However, in no event may an option be exercised later than the expiration of its term.  Subject to the provisions of our 2019 Plan, the administrator determines the other terms of options.  </span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Stock Appreciation Rights</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">.  Stock appreciation rights may be granted under our 2019 Plan.  Stock appreciation rights allow the recipient to receive the appreciation in the fair market value of our common stock between the exercise date and the date of grant.  Stock appreciation rights may not have a term exceeding 10 years.  After the termination of service of an employee, director or consultant, he or she may exercise his or her stock appreciation right for the period of time stated in his or her option agreement.  However, in no event may a stock appreciation right be exercised later than the expiration of its term.  Subject to the provisions of our 2019 Plan, the administrator determines the other terms of stock appreciation rights, including when such rights become exercisable and whether to pay any increased appreciation in cash or with shares of our common stock, or a combination thereof, except that the per share exercise price for the shares to be issued pursuant to the exercise of a stock appreciation right will be no less than 100% of the fair market value per share on the date of grant.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Restricted Stock</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">.  Restricted stock may be granted under our 2019 Plan.  Restricted stock awards are grants of shares of our common stock that vest in accordance with terms and conditions established by the administrator.  The administrator will determine the number of shares of restricted stock granted to any employee, director or consultant and, subject to the provisions of our 2019 Plan, will determine the terms and conditions of such awards.  The administrator may impose whatever conditions for lapse of the restriction on the shares it determines to be appropriate (for example, the administrator may set restrictions based on the achievement of specific performance goals or continued service to us); provided, </span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">162</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Content</a><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">s</a></span></div></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">however, that the administrator, in its sole discretion, may accelerate the time at which any restrictions will lapse or be removed.  Recipients of restricted stock awards generally will have voting and dividend rights with respect to such shares upon grant without regard to the restriction, unless the administrator provides otherwise.  Shares of restricted stock as to which the restrictions have not lapsed are subject to our right of repurchase or forfeiture.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Restricted Stock Units.  </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Restricted stock units may be granted under our 2019 Plan.  Restricted stock units are bookkeeping entries representing an amount equal to the fair market value of one share of our common stock.  Subject to the provisions of our 2019 Plan, the administrator will determine the terms and conditions of restricted stock units, including the vesting criteria (which may include accomplishing specified performance criteria or continued service to us) and the form and timing of payment.  Notwithstanding the foregoing, the administrator, in its sole discretion, may accelerate the time at which any restricted stock units will vest.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Performance Units and Performance Shares</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">.  Performance units and performance shares may be granted under our 2019 Plan.  Performance units and performance shares are awards that will result in a payment to a participant only if performance goals established by the administrator are achieved or the awards otherwise vest.  The administrator will establish organizational or individual performance goals or other vesting criteria in its discretion, which, depending on the extent to which they are met, will determine the number and/or the value of performance units and performance shares to be paid out to participants.  After the grant of a performance unit or performance share, the administrator, in its sole discretion, may reduce or waive any performance criteria or other vesting provisions for such performance units or performance shares.  </span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Performance units shall have an initial dollar value established by the administrator prior to the grant date.  Performance shares shall have an initial value equal to the fair market value of our common stock on the grant date.  The administrator, in its sole discretion, may pay earned performance units or performance shares in the form of cash, in shares or in some combination</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Outside Directors</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">.  Our 2019 Plan will provide that all outside (non-employee) directors will be eligible to receive all types of awards (except for incentive stock options) under our 2019 Plan.  In connection with our initial public offering, we implemented a formal policy pursuant to which our outside directors will be eligible to receive equity awards under our 2019 Plan.  Our 2019 Plan includes a maximum annual limit of $500,000 of cash compensation and equity awards that may be paid, issued, or granted to an outside director in any fiscal year, increased to $1,000,000 for the fiscal year an individual initially becomes a member of our board of directors.  For purposes of this limitation, the value of equity awards is based on the grant date fair value (determined in accordance with GAAP).  Any cash compensation paid or equity awards granted to a person for his or her services as an employee, or for his or her services as a consultant (other than as an outside director), will not count for purposes of the limitation.  The maximum limit does not reflect the intended size of any potential compensation or equity awards to our outside directors.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Non-Transferability of Awards</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">.  Unless the administrator provides otherwise, our 2019 Plan generally does not allow for the transfer of awards and only the recipient of an award may exercise an award during his or her lifetime.  If the administrator makes an award transferable, such award will contain such additional terms and conditions as the administrator deems appropriate.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Certain Adjustments</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">.  In the event of certain changes in our capitalization, to prevent diminution or enlargement of the benefits or potential benefits available under our 2019 Plan, the administrator will adjust the number and class of shares that may be delivered under our 2019 Plan and/or the number, class and price of shares covered by each outstanding award and the numerical share limits set forth in our 2019 Plan.  In the event of our proposed liquidation or dissolution, the administrator will notify participants as soon as practicable and all awards will terminate immediately prior to the consummation of such proposed transaction.</span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">163</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Content</a><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">s</a></span></div></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Merger or Change in Control</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">.  Our 2019 Plan provides that in the event of a merger or change in control, as defined under our 2019 Plan, each outstanding award will be treated as the administrator determines, without a participant&#8217;s consent.  The administrator is not required to treat all awards, all awards held by a participant, or all awards of the same type, similarly.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In the event that a successor corporation or its parent or subsidiary does not assume or substitute an equivalent award for any outstanding award, then such award will fully vest, all restrictions on such award will lapse, all performance goals or other vesting criteria applicable to such award will be deemed achieved at 100% of target levels and such award will become fully exercisable, if applicable, for a specified period prior to the transaction, unless specifically provided for otherwise under the applicable award agreement or other written agreement with the participant.  The award will then terminate upon the expiration of the specified period of time.  If an option or stock appreciation right is not assumed or substituted, the administrator will notify the participant in writing or electronically that such option or stock appreciation right will be exercisable for a period of time determined by the administrator in its sole discretion and the option or stock appreciation right will terminate upon the expiration of such period.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In addition, in the event of a change in control, each outside director&#8217;s options and stock appreciation rights, if any, will vest fully and become immediately exercisable, all restrictions on his or her restricted stock and restricted stock units will lapse and all performance goals or other vesting requirements for his or her performance shares and units will be deemed achieved at 100% of target levels, and all other terms and conditions met.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Forfeiture and Clawback.  </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">All awards granted under our 2019 Plan will be subject to recoupment under any clawback policy that we are required to adopt under applicable law.  In addition, the administrator will be able to provide in an award agreement that the recipient&#8217;s rights, payments, and benefits with respect to such award will be subject to reduction, cancellation, forfeiture, or recoupment upon the occurrence of specified events.  In the event of any accounting restatement, the recipient of an award will be required to repay a portion of the proceeds received in connection with the settlement of an award earned or accrued under certain circumstances.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Amendment, Termination</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">.  The administrator will have the authority to amend, suspend or terminate the 2019 Plan provided such action will not impair the existing rights of any participant.  Our 2019 Plan will automatically terminate in 2029, unless we terminate it sooner.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">2019 Employee Stock Purchase Plan</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our board of directors adopted, and our stockholders have approved, our 2019 Employee Stock Purchase Plan, or ESPP.  Our ESPP became effective in connection with our initial public offering in April 2019.  We believe that allowing our employees to participate in our ESPP provides them with a further incentive towards ensuring our success and accomplishing our corporate goals.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The ESPP includes a component that is intended to qualify as an &#8220;employee stock purchase plan&#8221; under Section 423 of the Internal Revenue Code of 1986, as amended, or the 423 Component, and a component that does not comply with Section 423, or the Non-423 Component.  For purposes of this disclosure, a reference to the &#8220;ESPP&#8221; will mean the 423 Component.  Unless determined otherwise by the administrator, each of our future non-U.S. subsidiaries, if any, will participate in a separate offering under the Non-423 Component.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Authorized shares</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">.  A total of 434,000&#160;shares of our common stock are available for sale.  In addition, our ESPP provides for annual increases in the number of shares available for issuance under the ESPP on the first day of each fiscal year beginning in fiscal year 2019, equal to the lesser of:</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">1% of the outstanding shares of our common stock on the last day of the previous fiscal year;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">1,200,000&#160;shares; or</span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">164</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Content</a><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">s</a></span></div></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">such other amount as may be determined by our board of directors.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Plan Administration</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">.  Our board of directors, or a committee appointed by our board of directors will administer our ESPP, and have full but non-exclusive authority to interpret the terms of our ESPP and determine eligibility to participate, subject to the conditions of our ESPP, as described below.  Our compensation committee will administer our ESPP.  The administrator will have full and exclusive discretionary authority to construe, interpret, and apply the terms of the ESPP, to delegate ministerial duties to any of our employees, to designate separate offerings under the ESPP, to designate our subsidiaries and affiliates as participating in the ESPP, to determine eligibility, to adjudicate all disputed claims filed under the ESPP and to establish procedures that it deems necessary or advisable for the administration of the ESPP, such as adopting such procedures, sub-plans, and appendices to the enrollment agreement as are necessary or appropriate to permit participation in the ESPP by employees who are foreign nationals or employed outside the U.S.  The administrator&#8217;s findings, decisions, and determinations will be final and binding on all participants to the full extent permitted by law.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Eligibility</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">.  Generally, all of our employees will be eligible to participate if they are customarily employed by us, or any participating subsidiary, for at least 20 hours per week and more than five months in any calendar year.  The administrator will have the discretion prior to an enrollment date for all options granted on such enrollment date in an offering, determine that an employee who (i) has not completed at least two years of service (or a lesser period of time determined by the administrator) since his or her last hire date, (ii) customarily works not more than 20 hours per week (or a lesser period of time determined by the administrator), (iii) customarily works not more than five months per calendar year (or a lesser period of time determined by the administrator), (iv) is a highly compensated employee within the meaning of Section 414(v) of the Code or is an officer or subject to disclosure requirements under Section 16(a) of the Exchange Act, is or is not eligible to participate in such offering period.</span></div><div style="text-indent:18pt;text-align:justify;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">However, an employee may not be granted rights to purchase shares of our common stock under our ESPP if such employee:</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">immediately after the grant would own capital stock possessing 5% or more of the total combined voting power or value of all classes of our capital stock; or</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">hold rights to purchase shares of our common stock under all of our employee stock purchase plans that accrue at a rate that exceeds $25,000 worth of shares of our common stock for each calendar year.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Offering Periods</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">.  Our ESPP will include a component that allows us to make offerings intended to qualify under Section&#160;423 of the Code and a component that allows us to make offerings not intended to qualify under Section&#160;423 of the Code to designated companies, as described in our ESPP.  Our ESPP will provide for six-month offering periods.  The offering periods will be scheduled to start on the first trading day on or after May 20th and November 20th of each year, except for the first offering period, which will commenced on the first trading day on or after completion of our initial public offering and will end on the first trading day on or after November 20, 2019.  Each offering period will consist of one 6-month purchase period, which will commence with one exercise date and end with the next exercise date.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Contributions</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">.  Our ESPP will permit participants to purchase shares of our common stock through payroll deductions of up to 10% of their eligible compensation.  A participant will be able to purchase a maximum of 2,000 shares of our common stock during a purchase period.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Exercise of Purchase Right</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">.  Amounts deducted and accumulated by the participant will be used to purchase shares of our common stock at the end of each six-month purchase period.  The purchase price of the shares will be 85% of the lower of the fair market value of our common stock on the first trading day of each offering period or on the exercise date.  Participants will be able to end their participation at any time during an offering period and will be paid their accrued contributions that have not yet been used to </span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">165</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Content</a><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">s</a></span></div></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">purchase shares of our common stock.  Participation will end automatically upon termination of employment with us.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Non-Transferability</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">.  A participant will not be able to transfer rights granted under our ESPP.  If our compensation committee permits the transfer of rights, it may only be done by will, the laws of descent and distribution or as otherwise provided under our ESPP.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Merger or Change in Control</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">.  Our ESPP will provide that in the event of a merger or change in control, as defined under our ESPP, a successor corporation may assume or substitute each outstanding purchase right.  If the successor corporation refuses to assume or substitute for the outstanding purchase right, the offering period then in progress will be shortened, and a new exercise date will be set that will be before the date of the proposed merger or change in control.  The administrator will notify each participant that the exercise date has been changed and that the participant&#8217;s option will be exercised automatically on the new exercise date unless prior to such date the participant has withdrawn from the offering period.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Amendment; Termination</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">.  The administrator will have the authority to amend, suspend or terminate our ESPP, except that, subject to certain exceptions described in our ESPP, no such action may adversely affect any outstanding rights to purchase shares of our common stock under our ESPP.  Our ESPP automatically will terminate in fiscal year 2039 unless we terminate it sooner.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">2007 Stock Plan, as Amended</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our board of directors adopted, and our stockholders approved, our 2007 Stock Plan, or the 2007 Plan, in March 2007.  Our 2007 Plan was most recently amended in June 2018.  Our 2007 Plan allows for the grant of incentive stock options, within the meaning of Section 422 of the Internal Revenue Code of 1986, as amended, to our employees and our parent and subsidiary corporations&#8217; employees, and for the grant of nonstatutory stock options and shares of common stock to our employees, directors and consultants and our parent and subsidiary corporations&#8217; employees, directors and consultants.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Authorized Shares</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">.  Our 2007 Plan was terminated in connection with our initial public offering in April 2019, and accordingly, no shares are available for issuance under the 2007 Plan.  Our 2007 Plan continues to govern outstanding awards granted thereunder.  As of December 31, 2019, options to purchase 3,499,992 shares of our common stock remained outstanding under our 2007 Plan.  In the event that an outstanding option or other right for any reason expires or is canceled, the shares allocable to the unexercised portion of such option or other right shall be added to the number of shares then available for issuance under the 2019 Plan once adopted by our board of directors and our stockholders.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Plan Administration</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">.  Our board of directors or a committee of our board (the administrator) administers our 2007 Plan.  Subject to the provisions of the 2007 Plan, the administrator has the full authority and discretion to take any actions it deems necessary or advisable for the administration of the 2007 Plan.  All decisions, interpretations and other actions of the administrator are final and binding on all participants in the 2007 Plan.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Options</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">.  The 2007 Plan was terminated, and accordingly, no additional options may be granted under our 2007 Plan.  Prior to the termination of the 2007 Plan the exercise price per share of all options must equal at least 100% of the fair market value per share of our common stock on the date of grant, as determined by the administrator.  The term of a stock option may not exceed 10 years.  With respect to any participant who owns 10% of the voting power of all classes of our outstanding stock as of the grant date, the term of an incentive stock option granted to such participant must not exceed five years and the exercise price per share of such incentive stock option must equal at least 110% of the fair market value per share of our common stock on the date of grant, as determined by the administrator.  The 2007 Plan administrator determines the terms and conditions of options.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">After termination of an employee, director or consultant, he or she may exercise his or her option for the period of time as specified in the applicable option agreement.  If termination is due to death or </span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">166</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Content</a><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">s</a></span></div></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">disability, the option generally will remain exercisable for at least six months.  In all other cases, the option will generally remain exercisable for at least 30 days.  However, an option generally may not be exercised later than the expiration of its term.  </span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Shares of Common Stock</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">.  Prior to the termination of the 2007 Plan shares of our common stock may be granted under our 2007 Plan as a purchasable award.  The administrator will determine the purchase price and the number of shares granted to the award recipient.  Stock purchase rights generally must be exercised within 90 days of grant.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Transferability of Awards</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">.  Unless our administrator provides otherwise, our 2007 Plan generally does not allow for the transfer or assignment of options or stock purchase rights, except by will or by the laws of descent and distribution.&#160; Shares issued upon exercise of an option will be subject to such terms and conditions as the administrator may determine, including rights of first refusal and other transfer restrictions.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Certain Adjustments</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">.  In the event of a subdivision of our outstanding stock, a declaration of a dividend payable in shares, a combination or consolidation of our outstanding stock into a lesser number of shares, a reclassification, or any other increase or decrease in the number of issued shares of stock effected without receipt of consideration by us, the 2007 Plan will be appropriately adjusted by the administrator as to the class and maximum number of securities subject to the 2007 Plan and the class, number of securities and price per share of common stock subject to outstanding awards under the 2007 Plan, provided that our administrator will make any adjustments as may be required by Section 25102(o) of the California Corporations Code.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Merger or Change in Control</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">.  Our 2007 Plan provides that, in the event that we are a party to a merger or change in control, outstanding options and stock purchase rights may be assumed or substituted by the successor corporation or a parent or subsidiary thereof.  In the event the successor corporation refuses to assume or substitute for the option or stock purchase right, then the vesting of such awards will be fully accelerated and the administrator will notify the holder in writing or electronically that such awards will be fully exercisable and vested for a period as determined by the administrator, and such awards will terminate upon expiration of such period.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Amendment; Termination</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">.  Our board of directors terminated the 2007 Plan in April 2019 and no further awards will be granted thereunder.  All outstanding awards will continue to be governed by their existing terms.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">NeuroCo, Inc. 2015 Equity Incentive Plan</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In connection with our acquisition of NeuroCo, Inc. on December 17, 2018, our board of directors approved the assumption of the NeuroCo, Inc. 2015 Equity Incentive Plan, or the NeuroCo Plan. </span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Authorized Shares</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">. The NeuroCo Plan was terminated on April 3, 2019, and, accordingly, no shares will be available for issuance under this plan. Our NeuroCo Plan will continue to govern outstanding awards granted thereunder.  As of December 31, 2019, options to purchase 857 shares of our common stock remained outstanding under the NeuroCo Plan.  </span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Plan Administration</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">. Our board of directors or a committee thereof appointed by our board of directors has the authority to administer the NeuroCo Plan. Subject to the provisions of the NeuroCo Plan, the administrator has the power to determine the terms of awards, including the recipients, the number of shares subject to each award, the exercise price, if any, the fair market value of a share of our common stock, the vesting schedule applicable to the awards, together with any vesting acceleration, and the terms of the award agreement for use under the NeuroCo Plan. The administrator also has the authority, subject to the terms of the NeuroCo Plan, to institute an exchange program under which (1)&#160;outstanding awards may be surrendered or cancelled in exchange for awards of the same type (which may have lower or higher exercise prices and different terms), awards of a different type and/or cash, (2)&#160;participants would have the opportunity to transfer any outstanding awards to a financial institution or </span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">167</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Content</a><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">s</a></span></div></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">other person or entity selected by the administrator and/or (3)&#160;the exercise price of an outstanding award is increased or reduced, to prescribe rules and regulations pertaining to the NeuroCo Plan, including establishing sub-plans for the purposes of satisfying applicable foreign laws, and to construe and interpret the NeuroCo Plan and awards granted thereunder.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Stock Options</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">. The NeuroCo Plan was terminated, and accordingly, no additional options may be granted under the NeuroCo Plan.  Prior to the termination of the NeuroCo Plan the exercise price per share of all options must equal at least 100% of the fair market value per share of our common stock on the date of grant. The term of an option may not exceed 10 years. An incentive stock option held by an employee who owns more than 10% of the total combined voting power of all classes of our stock, or any parent or subsidiary corporations, may not have a term in excess of five years and must have an exercise price of at least 110% of the fair market value per share of our common stock on the date of grant. The administrator will determine the methods of payment of the exercise price of an option, which may include cash, shares, promissory notes or certain other property or other consideration acceptable to the administrator. After the termination of service of an employee, director or consultant, the participant may exercise his or her option, to the extent vested as of such date of termination, within 30 days of termination or such longer period of time as stated in his or her option agreement. If termination is due to death or disability, the option will remain exercisable, to the extent vested as of such date of termination, for six months or such longer period of time as stated in his or her option agreement. However, in no event may an option be exercised later than the expiration of its term.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Restricted Stock</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">. The NeuroCo Plan was terminated, and accordingly, no restricted stock may be granted under the NeuroCo Plan. Restricted stock awards are grants of shares of our common stock that are subject to various restrictions, including restrictions on transferability and forfeiture provisions. Shares of restricted stock will vest, and the restrictions on such shares will lapse, in accordance with terms and conditions established by the administrator. Recipients of restricted stock awards will generally have rights equivalent to those of a stockholder with respect to such shares upon grant without regard to vesting.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Restricted Stock Units</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">. The NeuroCo Plan was terminated, and accordingly, no restricted stock units may be granted under the NeuroCo Plan. Restricted stock units are bookkeeping entries representing an amount equal to the fair market value of one share of our common stock. The administrator determines the terms and conditions of restricted stock units including the vesting criteria, which may include accomplishing specified performance criteria or continued service to us, and the form and timing of payment. Notwithstanding the foregoing, the administrator, in its sole discretion may accelerate the time at which any restrictions will lapse or be removed.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Stock Appreciation Rights</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">. The NeuroCo Plan was terminated, and accordingly, no stock appreciation rights may be granted under the NeuroCo Plan. Stock appreciation rights allow the recipient to receive the appreciation in the fair market value of shares of our common stock between the exercise date and the date of grant. Subject to the provisions of the NeuroCo Plan, the administrator determines the terms of stock appreciation rights, including when such rights become exercisable and whether to pay any increased appreciation in cash or with shares of our common stock, or a combination thereof, except that the per share exercise price for the shares to be issued pursuant to the exercise of a stock appreciation right will be no less than 100% of the fair market value per share on the date of grant.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Transferability of Awards</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">. Unless the administrator provides otherwise, the NeuroCo Plan generally does not allow for the transfer of awards other than by will or the laws of descent and distribution and only the recipient of an option may exercise such an award during his or her lifetime.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Certain Adjustments</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">. In the event of certain changes in our capitalization, to prevent diminution or enlargement of the benefits or potential benefits available under the NeuroCo Plan, the administrator will adjust the number and class of shares that may be delivered under the NeuroCo Plan and/or the number, class and price of shares covered by each outstanding award. In the event of our proposed liquidation or </span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">168</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Content</a><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">s</a></span></div></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">dissolution, the administrator will notify participants as soon as practicable, and all unexercised awards will terminate immediately prior to the consummation of such proposed transaction.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Merger or Change in Control</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">. The NeuroCo Plan provides that in the event of a merger or change in control, as defined under the NeuroCo Plan, each outstanding award will be treated as the administrator determines, including, without limitation, that each award be assumed or substituted for an equivalent award. In the event that awards are not assumed or substituted for, then the administrator will notify holders that such awards will fully vest and such awards will become fully exercisable, if applicable, for a specified period prior to the transaction. The award will then terminate upon the expiration of the specified period of time for no consideration, unless otherwise determined by the administrator.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Amendment, Termination</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">. As noted above, as of April 3, 2019, the NeuroCo Plan was terminated and no further awards will be granted thereunder. All outstanding awards will continue to be governed by their existing terms.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Executive Incentive Compensation Plan</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our board of directors has adopted an Executive Incentive Compensation Plan, or the Bonus Plan, which became effective upon the completion of our initial public offering in April 2019.  The Bonus Plan is administered by our compensation committee.  The Bonus Plan allows our compensation committee to provide cash incentive awards to selected employees, including our named executive officers, based upon performance goals established by our compensation committee.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Under the Bonus Plan, our compensation committee determines the performance goals applicable to any award, which goals may include, without limitation:  (i)&#160;attainment of research and development milestones, (ii)&#160;bookings, (iii) business divestitures and acquisitions, (iv) cash flow, (v) cash position, (vi) contract awards or backlog, (vii) customer renewals, (viii) customer retention rates from an acquired company, subsidiary, business unit or division, (ix)&#160;earnings (which may include earnings before interest and taxes, earnings before taxes, and net taxes), (x) earnings per share, (xi) expenses, (xii) gross margin, (xiii) growth in stockholder value relative to the moving average of the S&amp;P 500 Index or another index, (xiv)&#160;internal rate of return, (xv) market share, (xvi) net income, (xvii) net profit, (xviii) net sales, (xix) new product development, (xx) new product invention or innovation, (xxi) number of customers, (xxii) operating cash flow, (xxiii) operating expenses, (xxiv) operating income, (xxv)&#160;operating margin, (xxvi) overhead or other expense reduction, (xxvii) product defect measures, (xxviii) product release timelines, (xxix) productivity, (xxx) profit, (xxxi) retained earnings, (xxxii) return on assets, (xxxiii) return on capital, (xxxiv) return on equity, (xxxv) return on investment, (xxxvi) return on sales, (xxxvii) revenue, (xxxviii) revenue growth, (xxxix) sales results, (xl) sales growth, (xli) stock price, (xlii) time to market, (xliii) total stockholder return, (xliv) working capital, a (xlv) individual objectives such as peer reviews or other subjective or objective criteria, (xlvi) clinical quality metrics, (xlvii) regulatory milestones related to the U.S. Food and Drug Administration, Centers for Medicare and Medicaid Services, or other government agencies, (xlviii) intellectual property milestones, (xlix) physician training, and (l) any other goals or metrics related to the optimal management of a medical device company.  Performance goals that include our financial results may be determined in accordance with GAAP or such financial results may consist of non-GAAP financial measures and any actual results may be adjusted by the compensation committee for one-time items or unbudgeted or unexpected items when performance goals that include our financial results may be determined in accordance with GAAP, or such financial results may consist of non-GAAP financial measures, and any actual results may be adjusted by the compensation committee for one-time items or unbudgeted or unexpected items when determining whether the performance goals have been met.  The goals may be on the basis of any factors the compensation committee determines relevant, and may be adjusted on an individual, divisional, business unit or company-wide basis.  The performance goals may differ from participant to participant and from award to award.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our compensation committee may, in its sole discretion and at any time, increase, reduce or eliminate a participant&#8217;s actual award, and/or increase, reduce or eliminate the amount allocated to the bonus pool for a particular performance period.  The actual award may be below, at or above a participant&#8217;s target </span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">169</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Content</a><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">s</a></span></div></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">award, in the compensation committee&#8217;s discretion.  Our compensation committee may determine the amount of any reduction on the basis of such factors as it deems relevant, and it is not required to establish any allocation or weighting with respect to the factors it considers.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Actual awards are paid in cash only after they are earned, which usually requires continued employment through the date a bonus is paid.  Our compensation committee has the authority to amend, alter, suspend or terminate the Bonus Plan provided such action does not impair the existing rights of any participant with respect to any earned bonus.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">401(k) Plan</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We maintain a tax-qualified retirement plan that provides eligible employees with an opportunity to save for retirement on a tax advantaged basis.  We may make a discretionary matching contribution to the 401(k) plan, and may make a discretionary employer contribution to each eligible employee each year.  Through December 31, 2019, we have not made any matching or profits sharing contributions into the 401(k) plan.  Beginning in January 2020, we started matching employees' contributions to the 401(k) plan at 50% of the first 5% of compensation deferred to the 401(k) plan.  All participants&#8217; interests in their deferrals are 100% vested when contributed.  Pre-tax contributions are allocated to each participant&#8217;s individual account and are then invested in selected investment alternatives according to the participants&#8217; directions.  The 401(k) plan is intended to qualify under Sections 401(a) and 501(a) of the Code.  As a tax-qualified retirement plan, contributions to the 401(k) plan and earnings on those contributions are not taxable to the employees until distributed from the 401(k) plan, and all contributions are deductible by us when made.</span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Director Compensation</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Prior to the completion of our initial public offering in April 2019, except for Donald Zurbay, non-employee members of our board of directors did not receive any cash compensation for service on our board of directors or committees, including attending board and committee meetings.  However, we did reimburse our non-employee directors for travel, lodging and other reasonable expenses incurred in attending board, committee and other company related meetings.  In addition, from time to time we have granted stock options to some of our directors.  </span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our Board of Directors approved our Outside Director Compensation Policy in April 2019 to compensate each non-employee director for his or her service. Our board of directors will have the discretion to revise non-employee director compensation as it deems necessary or appropriate.  Each non-employee director is eligible to receive compensation for his or her service consisting of annual cash retainers and equity awards, as described below:</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Cash Compensation</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">.  All non-employee directors are entitled to receive the following cash compensation for their services:</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">$40,000 per year for services as a board member;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">$46,000 per year additionally for service as chairman of the board of directors;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">$20,000 per year additionally for service as chairman of the audit committee;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">$8,000 per year additionally for service as an audit committee member;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">$15,000 per year additionally for service as chairman of the compensation committee; </span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">$6,000 per year additionally for service as a compensation committee member;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">$5,000 per year additionally for service as a nominating and corporate governance committee member; and</span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">170</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Content</a><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">s</a></span></div></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">$9,000 per year additionally for service as chairman of the nominating and corporate governance committee.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Each annual cash retainer and additional annual fee is paid quarterly in arrears on a prorated basis.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Each non-employee director may also elect to receive all or part of his or her cash retainer and additional fee payments in the form of stock options under our 2019 Plan. Elections to receive cash retainer and additional fee payments in the form of options with respect to services to be performed during the period commencing on the date of an annual meeting of our stockholders, or an Annual Meeting, and ending on the following year&#8217;s Annual Meeting must generally be made on or prior to December 31st of the year prior to the year in which such annual period commences, or such earlier deadline as established by our board of directors or compensation committee (an &#8220;annual election&#8221;). Each individual who first becomes a non-employee director is permitted to elect to convert cash retainer and additional fee payments payable in the same calendar year through the date of the following year&#8217;s Annual Meeting into options, provided that the election is made prior to the date the individual becomes a non-employee director (an &#8220;initial election&#8221;). </span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">All options granted in lieu of cash retainer and additional fee payments will vest in quarterly installments that generally track when cash retainer or additional fee payments would have been paid, with the final vesting event occurring on the date of the next Annual Meeting following the date of grant.  Options granted in connection with an annual election will generally be granted on the date of the next Annual Meeting following the calendar year in which the election is made.  Options granted in connection with an initial election will generally be granted either on the fifth of the month following the month of the individual&#8217;s election or appointment to our board of directors or on the date of the next Annual Meeting that occurs in the same calendar year as the individual&#8217;s election or appointment to our board of directors. </span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Equity Compensation</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">.  Non-employee directors are entitled to receive all types of awards (except incentive stock options) under the 2019 Plan (or the applicable equity plan in place at the time of grant), including discretionary awards not covered under the Outside Director Compensation Policy.  Nondiscretionary, automatic grants of stock options are made to our non-employee directors as follows:</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt;">Initial Option Grant</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">.  Each person who first becomes a non-employee director will be granted an award of stock options with a value of $175,000.</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt;">Annual Option Grant</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">.  Each non-employee director will be granted an award of stock options with a value of $100,000 on the date of each Annual Meeting, beginning with the 2020 Annual Meeting.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The &#8220;value&#8221; for the options described above means the grant date fair value calculated in accordance with the Black-Scholes option valuation methodology, or such other methodology our board of directors or compensation committee may determine.  The term of each option described above will be ten years from the date of grant, subject to earlier termination as provided in the 2019 Plan.  The exercise price per share of each option will equal the closing trading price of a share of our common stock on the date of grant. </span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Subject to the applicable provisions of the 2019 Plan as further described under the section titled &#8220;Employee Benefit and Stock Plans,&#8221; (i) each Initial Option Grant will be scheduled to vest as to one-third of the shares subject to such Initial Option Grant on each annual anniversary of the date the applicable non-employee&#8217;s service as a non-employee director commenced, subject to the non-employee director continuing to provide services to the Company through the applicable vesting date and (ii) each Annual Option Grant will be scheduled to vest on the earlier of (a) the annual anniversary of the date of grant of such Annual Option Grant, or (b) the day immediately prior to the Annual Meeting next following the date the Annual Option is granted, provided that for either (a) or (b), the non-employee director has remained in continuous service with the Company through the applicable vesting date. Additionally, pursuant to our Outside Director Compensation Policy, in the event of a change in control, each outstanding and </span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">171</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Content</a><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">s</a></span></div></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">unvested equity award, including each Initial Option Grant and Annual Option Grant, held by a non-employee director who remains in continuous service through the date of such change in control will accelerate and fully vest.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Pursuant to our Outside Director Compensation Policy, no non-employee director may be issued, in any fiscal year, cash compensation and equity awards with an aggregate value greater than $500,000, increased to $1,000,000 for the fiscal year an individual initially becomes a member of our board of directors.  Any cash compensation paid or equity awards granted to an individual for his or her services as an employee, for his or her services as a consultant (other than as a non-employee director), will not count for purposes of this limitation.</span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">2019 Director Compensation Table</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table sets forth a summary of the compensation received by our non-employee directors during our fiscal year ended December 31, 2019:</span></div><div style="text-align:justify;margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:52.807%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:11.942%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:12.903%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:11.945%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Name</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;margin-top:2pt;margin-bottom:2pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%;">Fees Earned or Paid in Cash ($) </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;vertical-align:top;">(1)</sup></div></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;margin-top:2pt;margin-bottom:2pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%;">Option&#160;Awards  </span></div><div style="text-align:center;margin-top:2pt;margin-bottom:2pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%;">($) </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;vertical-align:top;">(2)(3)</sup></div></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total&#160;($)</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Ruoxi Chen</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">31,500&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">102,903&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">134,403&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Tony M. Chou, M.D.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">23,333&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">97,071&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">120,404&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Amr Kronfol</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">23,333&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">97,071&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">120,404&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Jack W. Lasersohn</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">32,756&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">103,312&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">136,068&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Robert E. Mittendorf, M.D.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">26,833&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">99,560&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">126,393&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Elizabeth H. Weatherman</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">29,212&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">100,395&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">129,607&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Donald J. Zurbay</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">51,168&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">80,411&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">131,579&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%;">_________________</span></div><div style="text-indent:-18pt;padding-left:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%;">(1)</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:9.45pt;">The amounts reported represent the aggregate dollar amount of all fees earned or paid in cash to each non-employee director for their service as a director during fiscal year 2019, including any annual retainer fees, committee and/or chairmanship fees.  Certain non-employee directors elected to receive their cash retainer and additional fee payments in the form of stock options.  The fair value of stock option awards received in lieu of cash was $53,992 for Mr. Chen, $39,994 for Dr. Chou, $39,994 for Mr. Kronfol, $54,984 for Mr. Lasersohn, $45,983 for Dr. Mittendorf, and $47,985 for Ms. Weatherman.</span></div><div style="text-indent:-18pt;padding-left:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%;">(2)</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:9.45pt;">The amount reported represents the aggregate grant-date fair value of the stock options awarded, calculated in accordance with ASC Topic 718.  Such grant-date fair value does not take into account any estimated forfeitures related to service-vesting conditions.  The assumptions used in calculating the grant-date fair value of the options reported in this column are set forth in &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8212;Critical Accounting Policies and Estimates&#8212;Common Stock Valuation and Stock-Based Compensation.&#8221;</span></div><div style="text-indent:-18pt;padding-left:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%;">(3)</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:9.45pt;">These amounts include the additional value of the option awards received by Mr. Chen ($22,492), Dr. Chou ($16,660), Mr. Kronfol ($16,660), Mr. Lasersohn ($22,900), Dr. Mittendorf ($19,149), and Ms. Weatherman ($19,985) in connection with their respective elections to receive their cash retainers and additional fees in the form of stock options.</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Options outstanding as of December 31, 2019, held by our non-employee directors were as follows:</span></div><div style="margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:78.288%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.441%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:17.071%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Name</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Shares Subject to Outstanding Options</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Ruoxi Chen</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11,849</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Tony M. Chou, M.D.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11,087</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Amr Kronfol</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11,087</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Jack W. Lasersohn</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11,903</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Robert E. Mittendorf, M.D.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11,413</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Elizabeth H. Weatherman</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">46,707</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Donald J. Zurbay</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">184,147</span></td></tr></table></div><div><span><br/></span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Directors who are also our employees receive no additional compensation for their service as directors.  During 2019, Erica J. Rogers, who is one of our directors, was also an employee of our </span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">172</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Content</a><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">s</a></span></div></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">company.  See &#8220;Executive Compensation&#8212;Summary Compensation Table&#8221; for additional information about the compensation for Ms. Rogers.</span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Compensation Committee Interlocks and Insider Participation</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">None of our executive officers serves as a member of the board of directors or compensation committee, or other committee serving an equivalent function, of any other entity that has one or more of its executive officers serving as a member of our board of directors or its compensation committee.  None of the current members of the compensation committee of our board of directors has been one of our employees within the past five years.</span></div><div id="i58f397e86dfd4fc4ac3b8695cd31238e_67"></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">173</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Content</a><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">s</a></span></div></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table provides information concerning beneficial ownership of our common stock as of February 28, 2020, by:</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Each stockholder, or group of affiliated stockholders, that we know owns more than 5% of our outstanding common stock;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Each of our executive officers;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Each of our directors; and</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">All of our executive officers and directors as a group.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The percentage of shares beneficially owned is computed on the basis of</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> 31,353,906 </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">shares of our common stock outstanding as of February 28, 2020. Beneficial ownership is determined in accordance with the rules of the SEC, and generally includes voting power or investment power with respect to the securities held. We have deemed shares of our common stock subject to stock options that are currently exercisable or exercisable within 60 days of February 28, 2020, to be outstanding and to be beneficially owned by the person holding the stock option for the purpose of computing the percentage ownership of that person. We did not deem these shares outstanding, however, for the purpose of computing the percentage ownership of any other person. </span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Except as indicated in the footnotes to this table, (i) the persons or entities named have sole voting and investment power with respect to all shares of our common stock shown as beneficially owned by them, and (ii) the address for each beneficial owner is c/o Silk Road Medical, Inc., 1213 Innsbruck Dr, Sunnyvale, CA 94089.</span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:72.839%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:9.858%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.441%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:9.861%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;">Shares Beneficially</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;">Owned</span></div></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Name of Beneficial Owner</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Number of<br/>Shares</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Percentage</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5% and Greater Stockholders:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;">Entities affiliated with Warburg Pincus &amp; Co</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;vertical-align:top;">(1)</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,906,301&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">18.8%&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;">Entities affiliated with Wells Fargo &amp; Company</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;vertical-align:top;">(2)</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,309,767&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7.4%&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;">Entities affiliated with Janus</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;vertical-align:top;">(3)</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,928,928&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6.2%&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Executive Officers and Directors:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;">Erica J. Rogers</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;vertical-align:top;">(4)</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,117,890&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.5%&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;">Lucas W. Buchanan</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;vertical-align:top;">(5)</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">435,024&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.4%&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;">Andrew S. Davis</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;vertical-align:top;">(6)</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">238,338&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">*&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;">Richard M. Ruedy</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;vertical-align:top;">(7)</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">198,994&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">*&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;">Elizabeth H. Weatherman</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;vertical-align:top;">(8)</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">303,742&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.0%&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;">Tony M. Chou, M.D.</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;vertical-align:top;">(9)</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">97,799&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">*&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;">Ruoxi Chen</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;vertical-align:top;">(10)</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,204&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">*&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;">Amr Kronfol</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;vertical-align:top;">(11)</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,632&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">*&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;">Jack W. Lasersohn</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;vertical-align:top;">(12)</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7,304&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">*&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;">Robert E. Mittendorff, M.D.</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;vertical-align:top;">(13)</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,877&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">*&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;">Donald J. Zurbay</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;vertical-align:top;">(14)</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">91,268&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">*&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-indent:-9pt;padding-left:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;">All executive officers and directors as a group </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;">(11 persons)</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;vertical-align:top;">(15)</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,496,072&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7.8%&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div style="text-align:justify;margin-bottom:3pt;"><span><br/></span></div><div style="text-align:justify;margin-bottom:3pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%;">_________________</span></div><div style="text-indent:-18pt;padding-left:18pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%;">*</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:15.28pt;">Represents ownership of less than 1%.</span></div><div style="text-indent:-18pt;padding-left:18pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%;">(1)</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:9.45pt;">Consists of (i) 183,090 shares of common stock beneficially owned by Warburg Pincus X Partners, L.P. (&#8220;WPXP&#8221;), and (ii) 5,723,211 shares of common stock beneficially owned by WP X Finance, L.P. (&#8220;WP X Finance&#8221;).  WPX GP, L.P., a Delaware limited partnership (&#8220;WPX GP&#8221;), is the managing general partner of WP X Finance. Warburg Pincus Private Equity X, L.P., a Delaware limited partnership (&#8220;WP X&#8221;), is the general </span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">174</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Content</a><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">s</a></span></div></div><div style="padding-left:18pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%;">partner of WPX GP. Warburg Pincus X, L.P., a Delaware limited partnership (&#8220;WPX LP&#8221;), is the general partner of WPX and WPXP. Warburg Pincus X GP L.P., a Delaware limited partnership (&#8220;WP X GP LP&#8221;), is the general partner of WPX LP. WPP GP LLC, a Delaware limited liability company (&#8220;WPP GP&#8221;), is the general partner of WP X GP LP. Warburg Pincus Partners, L.P., a Delaware limited partnership (&#8220;WP Partners&#8221;), is the managing member of WPP GP. Warburg Pincus Partners GP LLC, a Delaware limited liability company (&#8220;WP Partners GP&#8221;), is the general partner of WP Partners. Warburg Pincus &amp; Co., a New York general partnership (&#8220;WP&#8221;), is the managing member of WP Partners GP. The business address for each of these entities and individuals is c/o Warburg Pincus &amp; Co., 450 Lexington Avenue, New York, New York 10017.</span></div><div style="padding-left:18pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%;">Ruoxi Chen, a Principal at Warburg Pincus &amp; Co., and Amr Kronfol, a Managing Director at Warburg Pincus &amp; Co., are members of our board of directors, and both have no voting or dispositive power with respect to any of the above referenced shares and each disclaims beneficial ownership of such shares except to the extent of his or her respective pecuniary interest therein. All indirect holders of the above referenced shares disclaim beneficial ownership of all applicable shares except to the extent of their pecuniary interest therein.</span></div><div style="text-indent:-18pt;padding-left:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%;">(2)    Consists of 2,309,767 shares of common stock held by entities affiliated with Wells Fargo and Company, based on information provided by Wells Fargo and Company in Schedule 13G filed with the SEC on February 4, 2020.</span></div><div style="text-indent:-18pt;padding-left:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%;">(3)    Consists of 1,928,928 shares of common stock held by entities affiliated with Janus Henderson Group PLC, based on information provided by Janus Henderson Group PLC in Schedule 13G filed with the SEC on February 14, 2020.  The shares owned by Janus Henderson Capital Fund, Janus Henderson Global Life Sciences Fund and Buoybreeze (collectively, the &#8220;Funds&#8221;) may be deemed to be beneficially owned by Janus Capital Management LLC (&#8220;Janus&#8221;), an investment advisor registered under the Investment Advisers Act of 1940, who acts as investment adviser for the Funds set forth above and has the ability to make decisions with respect to the voting and disposition of the shares subject to the oversight of the board of trustees (or similar entity) of each Fund.  Under the terms of its management contract with each Fund, Janus has overall responsibility for directing the investments of the Fund in accordance with the Fund&#8217;s investment objective, policies and limitation.  Each Fund has one or more portfolio managers appointed by and serving at the pleasure of Janus who makes decisions with respect to the disposition of the Shares. The address for Janus is 151 Detroit Street, Denver, CO 80206.</span></div><div style="text-indent:-18pt;padding-left:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%;">(4)</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:9.45pt;">Consists of (i) 97,546 shares of common stock held directly by Ms. Rogers, (ii) 83,843 shares of common stock held by Kevin J. Surace and Erica J. Rogers, as Trustees of The Surace/Rogers Family Trust, and (iii)&#160;936,501 shares of common stock issuable pursuant to options held directly by Ms. Rogers exercisable within 60 days of February 28, 2020.</span></div><div style="text-indent:-18pt;padding-left:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%;">(5)</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:9.45pt;">Consists of (i) 89,410 shares of common stock held directly by Mr. Buchanan, (ii)&#160;13,518&#160;shares of common stock held by the Buchanan Grandchildren&#8217;s Irrevocable Trust, and (iii) 332,096 shares of common stock issuable pursuant to options held directly by Mr. Buchanan exercisable within 60 days of February 28, 2020.</span></div><div style="text-indent:-18pt;padding-left:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%;">(6)</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:9.45pt;">Consists of (i) 13,540 shares of common stock held directly by Mr. Davis, and (ii) 224,798 shares of common stock issuable pursuant to options held directly by Mr. Davis exercisable within 60 days of February 28, 2020.</span></div><div style="text-indent:-18pt;padding-left:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%;">(7)</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:9.45pt;">Consists of (i) 7,794 shares of common stock held directly by Mr. Ruedy, (ii) 70&#160;shares of common stock held by Linda Ruedy, and (iii) 191,130 shares of common stock issuable pursuant to options held directly by Mr. Ruedy exercisable within 60 days of February 28, 2020.</span></div><div style="text-indent:-18pt;padding-left:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%;">(8)</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:9.45pt;">Consists of (i) 275,394 shares of common stock held directly by Ms. Weatherman, and (ii) 28,348 shares of common stock issuable pursuant to options held directly by Ms. Weatherman and exercisable within 60 days of February 28, 2020.</span></div><div style="text-indent:-18pt;padding-left:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%;">(9)</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:9.45pt;">Consists of (i) 96,197 shares of common stock held directly by Dr. Chou, and (ii) 1,632 shares of common stock issuable pursuant to options held directly by Dr. Chou exercisable within 60 days of February 28, 2020.</span></div><div style="text-indent:-18pt;padding-left:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%;">(10)</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:5.56pt;">Consists of 2,204 shares of common stock issuable pursuant to options held directly by Mr. Chen exercisable within 60 days of February 28, 2020.</span></div><div style="text-indent:-18pt;padding-left:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%;">(11)</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:5.56pt;">Consists of 1,632 shares of common stock issuable pursuant to options held directly by Mr. Kronfol exercisable within 60 days of February 28, 2020.</span></div><div style="text-indent:-18pt;padding-left:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%;">(12)</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:5.56pt;">Consists of (i) 5,060 shares of common stock held directly by Mr. Lasersohn, and (ii) 2,244 shares of common stock issuable pursuant to options held directly by Mr. Lasersohn exercisable within 60 days of February 28, 2020.</span></div><div style="text-indent:-18pt;padding-left:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%;">(13)</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:5.56pt;">Consists of 1,877 shares of common stock issuable pursuant to options held directly by Dr. Mittendorf exercisable within 60 days of February 28, 2020.</span></div><div style="text-indent:-18pt;padding-left:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%;">(14)</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:5.56pt;">Consists of 91,268 shares of common stock issuable pursuant to options held directly by Mr. Zurbay exercisable within 60 days of February 28, 2020.</span></div><div style="text-indent:-18pt;padding-left:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%;">(15)</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:5.56pt;">Consists of (i) 682,342 shares of common stock and common stock purchase warrants held by our current directors and officers and entities affiliated with certain of our current directors and officers, and (ii) 1,813,730 shares of common stock issuable pursuant to stock options held by such directors and officers and exercisable within 60 days of February 28, 2020.</span></div><div style="text-indent:18pt;text-align:justify;margin-bottom:9pt;"><span><br/></span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Equity Compensation Plan Information</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table summarizes our equity compensation plan information as of December 31, 2019. Information is included for equity compensation plans approved by our stockholders. We do not have any equity compensation plans not approved by our stockholders. </span></div><div style="margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:50.403%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.441%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:11.942%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.441%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:10.660%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.441%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:17.072%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Plan Category</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(a) Number of Securities to be Issued Upon Exercise of Outstanding Options, Warrants and Rights </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;">&#160;(b) Weighted Average Exercise Price of Outstanding Options, Warrants and Rights</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;vertical-align:top;">(2)</sup></div></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(c) Number of Securities Remaining Available for Future Issuance Under Equity Compensation Plans (Excluding Securities Reflected in Column (a))</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;">Equity Compensation Plan Approved by Stockholders</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;"> (1)</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,310,790&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7.91&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,927,042&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Equity Compensation Plan Not Approved by Stockholders</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,310,790&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,927,042&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%;">_________________</span></div><div style="text-indent:-18pt;padding-left:18pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%;">(1)</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:9.45pt;">Includes the following plans: 2007 Stock Option Plan, NeuroCo 2015 Equity Incentive Plan, 2019 Equity Incentive Plan (&#8220;2019 Plan&#8221;), and 2019 Employee Stock Purchase Plan (&#8220;2019 ESPP&#8221;). Our 2019 Plan provides that on January 1st of each fiscal year commencing in 2020 and ending on (and including) January 1, 2029, the number of shares authorized for issuance under the 2019 Plan is automatically increased by a number </span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">175</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Content</a><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">s</a></span></div></div><div style="padding-left:18pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%;">equal to the lesser of (i) 3,000,000 shares; (ii) 4.0% of the outstanding shares of our common stock as of the last day of the immediately preceding fiscal year or; (iii) such other amount as our board of directors may determine. Our 2019 ESPP provides that on January 1st of each fiscal year commencing in 2020 and ending on (and including) January 1, 2039, the number of shares authorized for issuance under the 2019 ESPP is automatically increased by a number equal to the lesser of (i) 434,000 shares; (ii) 1.0% of the outstanding shares of our common stock as of the last day of the immediately preceding fiscal year; or (iii) such other amount as our board of directors may determine. </span></div><div style="text-indent:-18pt;padding-left:18pt;margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%;">(2)</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:9.45pt;">The weighted average exercise price relates solely to outstanding stock option shares.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span><br/></span></div><div id="i58f397e86dfd4fc4ac3b8695cd31238e_70"></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Item 13. Certain Relationships and Related Transactions, and Director Independence</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Other than compensation arrangements, we describe below transactions and series of similar transactions, since January 1, 2017, to which we were a party or will be a party, in which:</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">The amounts involved exceeded or will exceed $120,000; and</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Any of our directors, executive officers, or holders of more than 5% of our common stock, or any member of the immediate family of the foregoing persons, had or will have a direct or indirect material interest.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Compensation arrangements for our directors and named executive officers are described elsewhere in this Annual Report on Form 10-K.</span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Certain Transactions with Related Persons</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">During 2017 and 2018, the wife of Richard Ruedy, Executive Vice President of Clinical and Regulatory Affairs and Quality Assurance, was employed by the Company as Senior Director of Clinical and Regulatory Affairs. In 2017, Mr. Ruedy&#8217;s wife earned total compensation of $204,883.  In 2018, Mr. Ruedy&#8217;s wife earned total compensation and severance of $315,900.  Total compensation includes salary and bonus.&#160; In 2019, Mr. Ruedy&#8217;s wife transitioned to a regulatory consultant at a rate of $30,000 per month through March 31, 2019.  The compensation of Mr. Ruedy&#8217;s wife was consistent with that of other employees with equivalent qualifications and responsibilities and holding similar positions, and Mr. Ruedy recused himself from any decision regarding the hiring of, or compensation related to his wife.  </span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Series C Preferred Stock Financing</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Between August 2014 and July 2017, we issued an aggregate 12,227,992 shares of our Series C preferred stock at a purchase price of $6.11 per share.  The aggregate purchase price in the table below reflects the price paid for the Series C preferred stock only and not for the warrants.  The shares of Series C preferred stock converted into an aggregate of 12,227,992 shares of common stock upon the completion of our initial public offering.  The table below sets forth the number of shares of Series C preferred stock and the number of warrant shares issued in connection with our Series C preferred stock financing to our directors, executive officers and holders of more than 5% of our capital stock:</span></div><div style="text-align:justify;margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:46.717%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:14.025%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.921%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:14.025%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:14.510%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Name</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%;">Number of</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"> </span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%;">Shares</span></div></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Number of Warrant Shares</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%;">Aggregate</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"> </span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%;">Purchase</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"> </span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%;">Price</span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><div style="margin-top:2pt;margin-bottom:2pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Entities affiliated with Warburg Pincus &amp; Co.</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(1)</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,904,180&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,214,626&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">36,027,324.24&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="margin-top:2pt;margin-bottom:2pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Entities affiliated with Janus</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(2)</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,458,210&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">14,999,999.68&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="margin-top:2pt;margin-bottom:2pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Entities affiliated Norwest Venture Partners</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(3)</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,458,210&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">14,999,999.68&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="margin-top:2pt;margin-bottom:2pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Entities affiliated with The Vertical Group, Inc.</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(4)</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">656,015&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">246,067&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,003,022.74&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Elizabeth H. Weatherman</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">163,880&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">40,970&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">999,995.76&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="margin-top:2pt;margin-bottom:2pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Erica J. Rogers</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(5)</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9,012&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,638&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">54,997.10&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="margin-top:2pt;margin-bottom:2pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Lucas W. Buchanan</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(6)</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">18,843&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,915&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">114,993.32&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Andrew S. Davis</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12,290&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">74,998.10&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">176</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Content</a><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">s</a></span></div></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%;">_________________</span></div><div style="text-indent:-18pt;padding-left:18pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%;">(1)</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:9.45pt;">Affiliates of Warburg Pincus holding our securities, whose shares are aggregated for purposes of reporting the above share purchase information, are WP X Finance, L.P., which purchased 5,721,152 shares, and Warburg Pincus X Partners, L.P., which purchased 183,028&#160;shares. </span></div><div style="text-indent:-18pt;padding-left:18pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%;">(2)</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:9.45pt;">Affiliates of Janus holding our securities, whose shares are aggregated for purposes of reporting the above share purchase information, are Buoybreeze + Co (a State Street Nominee), which purchased 1,610,446 shares, and Janus Capital Funds PLC on behalf of its Series Janus Global Life Sciences Fund, which purchased 847,764 shares.  </span></div><div style="text-indent:-18pt;padding-left:18pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%;">(3)</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:9.45pt;">The affiliate of Norwest Venture Partners holding our securities is Norwest Venture Partners XIII, LP, which purchased 2,458,210&#160;shares.</span></div><div style="text-indent:-18pt;padding-left:18pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%;">(4)</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:9.45pt;">Affiliates of the Vertical Group holding our securities, whose shares are aggregated for purposes of reporting the above share purchase information, are Vertical Fund I, L.P., which purchased 524,814 shares, and Vertical Fund II, L.P., which purchased 131,201 shares.  </span></div><div style="text-indent:-18pt;padding-left:18pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%;">(5)</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:9.45pt;">Includes 9,012 shares held of record by The Surace/Rogers Family Trust, of which Erica J. Rogers, one of our executive officers, serves as trustee.</span></div><div style="text-indent:-18pt;padding-left:18pt;margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%;">(6)</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:9.45pt;">Includes 10,651 shares held of record by the Buchanan Grandchildren&#8217;s Irrevocable Trust, of which Mr. Buchanan, one of our executive officers, serves as trustee.</span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Stockholders Agreement</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In July 2017, in connection with the final closing of our Series C preferred stock financing, we entered into an amended and restated stockholders agreement with certain holders of our convertible preferred stock, including entities with which certain of our directors are affiliated.  </span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Registration Rights Agreement</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In July 2017, in connection with the final closing of our Series C preferred stock financing, we entered into an amended and restated registration rights agreement with certain holders of our convertible preferred stock, including entities with which certain of our directors are affiliated.  The amended and restated registration rights agreement was amended on March 21, 2019.  For a detailed description of registration rights under this agreement (as amended), see &#8220;Description of Capital Stock&#8212;Registration Rights.&#8221; Upon the completion of our initial public offering in April 2019, the information rights and right of first refusal under the stockholders agreement terminated.</span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Indemnification Agreements</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We have entered into indemnification agreements with each of our directors and executive officers.  These agreements, among other things, require us to indemnify each director and executive officer to the fullest extent permitted by Delaware law, including indemnification of expenses such as attorneys&#8217; fees, judgments, penalties, fines and settlement amounts incurred by the director or officer in any action or proceedings, including any action or proceeding by or in right of us, arising out of the person&#8217;s service as a director or officer.  Insofar as indemnification for liabilities arising under the Securities Act may be permitted to our directors, officers and controlling persons pursuant to the foregoing provisions, or otherwise, we have been advised that, in the opinion of the SEC, such indemnification is against public policy as expressed in the Securities Act, and is, therefore, unenforceable.</span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">NeuroCo Merger</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We established a holding company, NeuroCo, Inc., to hold certain intellectual property and to undertake certain research and development activities.  On December 17, 2018, we and NeuroCo entered into an Agreement and Plan of Merger pursuant to which we acquired all assets, including the assignment of all patents, and assumed all liabilities of NeuroCo.  The merger closed on the same day and was consummated through a stock-for-stock transaction based on the relative values of our equity and NeuroCo&#8217;s equity.  In consideration for 100% equity interest of NeuroCo, we issued 33,462 shares of our common stock, and a promissory note in the principal amount of approximately $1.6 million was settled and canceled.  We assumed NeuroCo&#8217;s 2015 Equity Incentive Plan, or the NeuroCo Plan.  As of the merger closing, the outstanding options to purchase common stock of NeuroCo under the NeuroCo Plan converted to options to purchase 1,442 shares of our common stock, and all outstanding warrants to purchase common stock of NeuroCo converted to warrants to purchase 7,527 shares of our common stock.  As a result of the merger, NeuroCo merged into our company, with our company being the surviving corporation.</span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">177</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Content</a><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">s</a></span></div></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Policies and Procedures for Related Party Transactions</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our board of directors has approved a policy that our executive officers, directors, nominees for election as a director, beneficial owners of more than 5% of any class of our common stock and any members of the immediate family of any of the foregoing persons are not permitted to enter into a related person transaction with us without the prior consent of our audit committee.  Any request for us to enter into a transaction with an executive officer, director, nominee for election as a director, beneficial owner of more than 5% of any class of our common stock or any member of the immediate family of any of the foregoing persons in which the amount involved exceeds $120,000 and such person would have a direct or indirect interest must first be presented to our audit committee for review, consideration and approval.  In approving or rejecting any such proposal, our audit committee is to consider the material facts of the transaction, including, but not limited to, whether the transaction is on terms no less favorable than terms generally available to an unaffiliated third party under the same or similar circumstances and the extent of the related person&#8217;s interest in the transaction.  We did not have a formal review and approval policy for related party transactions at the time of any of the transactions described above.  However, all of the transactions described above were entered into after presentation, consideration and approval by our board of directors.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span><br/></span></div><div id="i58f397e86dfd4fc4ac3b8695cd31238e_73"></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Item 14. Principal Accounting Fees and Services</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table presents fees for professional audit services and other services billed to us by PricewaterhouseCoopers LLP, or PwC, for our fiscal years ended December 31, 2019 and 2018: </span></div><div style="margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:68.833%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.441%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:11.942%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.441%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:11.943%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Year Ending December 31, </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">Audit fees</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">(1)</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,774,000&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">641,000&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Audit related fees</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Tax fees</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">All other fees</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,000&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">22,000&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,775,000&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">663,000&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%;">_________________</span></div><div style="text-indent:-18pt;padding-left:18pt;text-align:justify;margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%;">(1)</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:9.45pt;">Audit fees consist of professional services rendered for the audits of our financial statements and reviews of quarterly financial statements. The audit fees incurred in 2019 also include fees of $857,000 related to services performed in connection with our initial public offering, which was completed in April 2019 and our follow-on offering, which was completed in August 2019, and review of documents filed with the SEC. </span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Auditor Independence </span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In our fiscal year ended December 31, 2019, there were no other professional services provided by PwC that would have required our audit committee to consider their compatibility with maintaining the independence of PwC. </span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Audit Committee Policy on Pre-Approval of Audit and Permissible Non-Audit Services of Independent Registered Public Accounting Firm </span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our audit committee expects to establish a policy governing our use of the services of our independent registered public accounting firm. Under this policy, our audit committee will be required to pre-approve all audit and non-audit services performed by our independent registered public accounting firm in order to ensure that the provision of such services does not impair the public accountants&#8217; independence. All fees paid to PwC for our fiscal years ended December 31, 2019 and 2018 were pre-approved by our audit committee. </span></div><div id="i58f397e86dfd4fc4ac3b8695cd31238e_76"></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">178</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Content</a><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">s</a></span></div></div><div style="text-align:center;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;">PART IV</span></div><div id="i58f397e86dfd4fc4ac3b8695cd31238e_79"></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Item&#160;15.&#160;&#160;Exhibits and Financial Statement Schedules</span></div><div style="text-indent:-36pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">(a)</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt;">Exhibits.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">See the Exhibit&#160;Index immediately preceding the signature page hereto for a list of exhibits filed as part of this registration statement on Form 10-K, which Exhibit&#160;Index is incorporated herein by reference.</span></div><div style="text-indent:-36pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">(b)</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.24pt;">Financial Statement Schedules.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">All other schedules have been omitted because the information required to be set forth therein is not applicable or is shown in the financial statements or notes thereto. The table below presents Schedule II, Valuation and Qualifying Accounts, detailing the activity of the allowance for doubtful accounts and the provision for sales returns for the years ended December 31, 2019 and 2018 (in thousands):</span></div><div style="text-align:center;margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:43.512%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:10.820%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:10.820%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:10.820%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:10.824%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Description</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance at Beginning of Year</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Charged to expenses</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Write offs</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance at End of Year</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Allowance for doubtful accounts receivable:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Year ended December 31, 2019</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">22&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">23&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">45&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Year ended December 31, 2018</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">149&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(123)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">22&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div style="text-indent:18pt;text-align:center;margin-bottom:9pt;"><span><br/></span></div><div style="text-align:center;margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:43.993%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.441%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:10.980%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.441%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:10.820%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.441%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:10.820%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.441%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:10.823%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Description</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance at Beginning of Year</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Charged to expenses</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Write offs</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance at End of Year</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Provision for sales returns:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Year ended December 31, 2019</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,862&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,765&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,208&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,419&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Year ended December 31, 2018</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">462&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,958&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">558&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,862&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div style="text-indent:18pt;text-align:center;margin-bottom:9pt;"><span><br/></span></div><div id="i58f397e86dfd4fc4ac3b8695cd31238e_259"></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">179</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-indent:18pt;margin-bottom:9pt;"><span><br/></span></div></div><div style="text-align:center;margin-bottom:9pt;-sec-extract:summary;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;">EXHIBIT INDEX</span></div><div style="margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:6.493%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:45.435%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:3.929%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:8.737%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:5.051%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:7.615%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:8.740%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="12" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Incorporated by Reference</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Exhibit<br/>Number</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Exhibit Description</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Form</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">File No.</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Exhibit</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Filing<br/>Date</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Filed/Furnished<br/>Herewith</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1397702/000162828019004024/srmexhibit31.htm">3.1</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1397702/000162828019004024/srmexhibit31.htm">Amended and Restated Certificate of Incorporation of the registrant</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8-K</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">001-38847</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.1</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4/8/2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;border-right:1pt solid #000;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1397702/000162828019004024/srmexhibit32.htm">3.2</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1397702/000162828019004024/srmexhibit32.htm">Amended and Restated Bylaws of the registrant</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8-K</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">001-38847</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.2</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4/8/2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;border-right:1pt solid #000;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1397702/000162828019010142/srmexhibit41followons-.htm">4.1</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1397702/000162828019010142/srmexhibit41followons-.htm">Specimen Common Stock Certificate of the registrant</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">S-1</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">333-233044</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.1</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8/6/2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;border-right:1pt solid #000;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1397702/000162828019010142/srmexhibit42followons-.htm">4.2</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1397702/000162828019010142/srmexhibit42followons-.htm">Amended and Restated Registration Rights Agreement by and among the registrant and certain stockholders, dated July 7, 2017</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">S-1</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">333-233044</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.2</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8/6/2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;border-right:1pt solid #000;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1397702/000162828019010142/srmexhibit43followons-.htm">4.3</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1397702/000162828019010142/srmexhibit43followons-.htm">Amended and Restated Stockholders Agreement by and among the registrant and certain stockholders, dated July 7, 2017</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">S-1</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">333-233044</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.3</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8/6/2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;border-right:1pt solid #000;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1397702/000162828019010142/srmexhibit44followons-.htm">4.4</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1397702/000162828019010142/srmexhibit44followons-.htm">Amendment to the Amended and Restated Registration Rights Agreement, dated March 21, 2019</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">S-1</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">333-233044</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.4</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8/6/2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;border-right:1pt solid #000;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="silk201910-kexhibit45d.htm">4.5</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="silk201910-kexhibit45d.htm">Description of the registrant&#8217;s securities registered pursuant to Section 12 of the Securities Exchange Act of 1934</a></span></div></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;border-right:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">*</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1397702/000162828019010142/srmexhibit101followons.htm">10.1</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1397702/000162828019010142/srmexhibit101followons.htm">Form of Indemnification Agreement for directors and executive officers</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">S-1</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">333-233044</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10.1</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8/6/2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;border-right:1pt solid #000;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1397702/000162828019010142/srmexhibit102followons.htm">10.2+</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1397702/000162828019010142/srmexhibit102followons.htm">2007 Stock Plan, as amended, and related form agreement</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">S-1</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">333-233044</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10.2</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8/6/2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;border-right:1pt solid #000;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1397702/000162828019010142/srmexhibit103followons.htm">10.3+</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1397702/000162828019010142/srmexhibit103followons.htm">2019 Employee Stock Purchase Plan and related form agreements</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">S-1</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">333-233044</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10.3</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8/6/2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;border-right:1pt solid #000;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1397702/000162828019010142/srmexhibit104followons.htm">10.4+</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1397702/000162828019010142/srmexhibit104followons.htm">Executive Incentive Compensation Plan</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">S-1</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">333-233044</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10.4</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8/6/2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;border-right:1pt solid #000;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1397702/000162828019010142/srmexhibit105followons.htm">10.5+</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1397702/000162828019010142/srmexhibit105followons.htm">2019 Equity Incentive Plan and related form agreements</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">S-1</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">333-233044</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10.5</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8/6/2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;border-right:1pt solid #000;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1397702/000162828019010142/srmexhibit106followons.htm">10</a><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1397702/000162828019010142/srmexhibit106followons.htm">.6#</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1397702/000162828019010142/srmexhibit106followons.htm">Supply Agreement by and between the registrant and Cordis Corporation, dated October 21, 2011, as amended by the Amendment dated March 12, 2012, the Second Amendment to Supply Agreement dated July 12, 2012, the Third Amendment to Supply Agreement dated April 19, 2013 and the Fourth Amendment to Supply Agreement dated April 9, 2018</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">S-1</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">333-233044</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10.6</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8/6/2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;border-right:1pt solid #000;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1397702/000162828019010142/srmexhibit107followons.htm">10.7#</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1397702/000162828019010142/srmexhibit107followons.htm">License Agreement by and between the registrant and Cordis Corporation, dated December 17, 2010</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">S-1</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">333-233044</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10.7</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8/6/2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;border-right:1pt solid #000;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1397702/000162828019010142/srmexhibit108followons.htm">10.8</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1397702/000162828019010142/srmexhibit108followons.htm">Quality Assurance Agreement by and among the registrant and Lake Region Medical and affiliates, dated May 4, 2015</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">S-1</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">333-233044</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10.8</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8/6/2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;border-right:1pt solid #000;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1397702/000162828019010142/srmexhibit109followons.htm">10.9#</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1397702/000162828019010142/srmexhibit109followons.htm">Amended and Restated Manufacturing and Supply Agreement by and between the registrant and Galt Medical Corporation, dated January 10, 2018</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">S-1</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">333-233044</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10.9</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8/6/2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;border-right:1pt solid #000;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1397702/000162828019010142/srmexhibit1010-followo.htm">10.1</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1397702/000162828019010142/srmexhibit1010-followo.htm">Term Loan Agreement by and among the registrant, certain affiliates of CRG Partners III L.P. as lenders and certain subsidiary guarantors, dated October 13, 2015, as amended by Amendment No. 1 to Term Loan Agreement dated January 3, 2017, Amendment No. 2 to Term Loan Agreement dated June 22, 2017, Amendment No. 3 to Term Loan Agreement dated November 30, 2017, Amendment No. 4 to Term Loan Agreement dated June 25, 2018, Amendment No. 5 to Term Loan Agreement dated September 4, 2018, Amendment No. 6 to Term Loan Agreement dated November 14, 2018 and effective as of October 31, 2018, and Amendment No. 7 to Term Loan Agreement dated June 11, 2019</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">S-1</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">333-233044</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10.1</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8/6/2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;border-right:1pt solid #000;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1397702/000162828019010142/srmexhibit1011followon.htm">10.11</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1397702/000162828019010142/srmexhibit1011followon.htm">Lease Agreement by and between the registrant and Hanover Properties Ltd., dated November 30, 2017</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">S-1</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">333-233044</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10.11</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8/6/2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;border-right:1pt solid #000;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1397702/000162828019010142/srmexhibit1012followon.htm">10.12</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1397702/000162828019010142/srmexhibit1012followon.htm">Director Offer Letter for Donald Zurbay dated as of February 6, 2018</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">S-1</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">333-233044</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10.12</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8/6/2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;border-right:1pt solid #000;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1397702/000162828019010142/srmexhibit1013followon.htm">10.13+</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1397702/000162828019010142/srmexhibit1013followon.htm">Confirmatory Employment Letter between the registrant and Erica Rogers, dated as of March 21, 2019</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">S-1</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">333-233044</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10.13</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8/6/2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;border-right:1pt solid #000;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1397702/000162828019010142/srmexhibit1014followon.htm">10.14+</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1397702/000162828019010142/srmexhibit1014followon.htm">Confirmatory Employment Letter between the registrant and Lucas Buchanan, dated as of March 21, 2019</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">S-1</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">333-233044</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10.14</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8/6/2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;border-right:1pt solid #000;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-bottom:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10.15+</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000;border-bottom:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1397702/000162828019010142/srmexhibit1015followon.htm">Confirmatory Employment Letter between the registrant and Richard Ruedy, dated as of March 21, 2019</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-bottom:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">S-1</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-bottom:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">333-233044</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-bottom:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10.15</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-bottom:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8/6/2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;border-right:1pt solid #000;padding-right:1pt;"></td></tr></table></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;-sec-extract:summary;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">180</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-indent:18pt;margin-bottom:9pt;"><span><br/></span></div></div><div style="margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:6.493%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:45.435%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:3.929%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:8.737%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:5.051%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:7.615%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:8.740%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1397702/000162828019010142/srmexhibit1016followon.htm">10.16+</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1397702/000162828019010142/srmexhibit1016followon.htm">Confirmatory Employment Letter between the registrant and Andrew Davis, dated as of March 21, 2019</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">S-1</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">333-233044</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10.16</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8/6/2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;border-right:1pt solid #000;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1397702/000162828019010142/srmexhibit1017followon.htm">10.17+</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1397702/000162828019010142/srmexhibit1017followon.htm">Change in Control and Severance Agreement between the registrant and Erica Rogers, dated as of March 21, 2019</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">S-1</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">333-233044</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10.17</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8/6/2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;border-right:1pt solid #000;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1397702/000162828019010142/srmexhibit1018followon.htm">10.18+</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1397702/000162828019010142/srmexhibit1018followon.htm">Change in Control and Severance Agreement between the registrant and Lucas Buchanan, dated as of March 21, 2019</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">S-1</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">333-233044</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10.18</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8/6/2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;border-right:1pt solid #000;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1397702/000162828019010142/srmexhibit1019followon.htm">10.19+</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1397702/000162828019010142/srmexhibit1019followon.htm">Change in Control and Severance Agreement between the registrant and Richard Ruedy, dated as of March 21, 2019</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">S-1</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">333-233044</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10.19</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8/6/2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;border-right:1pt solid #000;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1397702/000162828019010142/srmexhibit1020followon.htm">10.20+</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1397702/000162828019010142/srmexhibit1020followon.htm">Change in Control and Severance Agreement between the registrant and Andrew Davis, dated as of March 21, 2019</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">S-1</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">333-233044</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10.2</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8/6/2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;border-right:1pt solid #000;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="silk201910-kexhibit231.htm">23.1</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="silk201910-kexhibit231.htm">Consent of Independent Registered Public Accounting Firm</a></span></div></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;border-right:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">*</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_265">24.1</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_265">Power of Attorney</a></span></div></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;border-right:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">*</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="silk201910-kexhibit311.htm">31.1</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="silk201910-kexhibit311.htm">Certification of Principal Executive Officer pursuant to Securities Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</a></span></div></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;border-right:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">*</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="silk201910-kexhibit312.htm">31.2</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="silk201910-kexhibit312.htm">Certification of Principal Financial Officer pursuant to Securities Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</a></span></div></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;border-right:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">*</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="silk201910-kexhibit321.htm">32.1</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="silk201910-kexhibit321.htm">Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</a></span></div></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;border-right:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">**</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">101.INS</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">XBRL Instance Document</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;border-right:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">*</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">101.SCH</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">XBRL Taxonomy Extension Schema Document</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;border-right:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">*</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">101.CAL</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">XBRL Taxonomy Extension Calculation Linkbase Document</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;border-right:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">*</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">101.DEF</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">XBRL Taxonomy Extension Definition Linkbase Document<br/></span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;border-right:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">*</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">101.LAB</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">XBRL Taxonomy Extension Label Linkbase Document</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;border-right:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">*</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-bottom:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">101.PRE</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000;border-bottom:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">XBRL Taxonomy Extension Presentation Linkbase Document</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-bottom:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;border-right:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">*</span></td></tr></table></div><div style="text-indent:-36pt;padding-left:36pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%;">*&#160;Filed herewith.</span></div><div style="text-indent:-36pt;padding-left:36pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%;">**&#160;Furnished herewith.</span></div><div style="text-indent:-36pt;padding-left:36pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%;">+&#160;Indicates a management contract or compensatory plan or arrangement.</span></div><div style="text-indent:-36pt;padding-left:36pt;text-align:justify;margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%;">#&#160;Portions of this exhibit (indicated by asterisks) have been omitted pursuant to a grant of confidential treatment.  The omitted information has been filed separately with the SEC.</span></div><div id="i58f397e86dfd4fc4ac3b8695cd31238e_262"></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;-sec-extract:summary;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">181</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-align:center;margin-bottom:9pt;"><span><br/></span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i58f397e86dfd4fc4ac3b8695cd31238e_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Item 16. Form 10-K Summary</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Not applicable.</span></div><div id="i58f397e86dfd4fc4ac3b8695cd31238e_265"></div><div style="text-align:center;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;">Signatures</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Pursuant to the requirements of Section 13 and 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this Annual Report on Form 10-K to be signed on its behalf by the undersigned, thereunto duly authorized.</span></div><div style="text-align:right;margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:42.551%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:2.967%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:2.967%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:43.515%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="6" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">SILK ROAD MEDICAL, INC.</span></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="height:12pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:12pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:12pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:12pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">March 2, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">By:</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">/s/ Erica J. Rogers</span></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Erica J. Rogers</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;">President, Chief Executive Officer and Director</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;">(Principal Executive Officer)</span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">March 2, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">By:</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">/s/ Lucas W. Buchanan</span></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Lucas W. Buchanan</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;">Chief Financial Officer </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;">(Principal Financial Officer and Principal Accounting Officer)</span></div></td></tr></table></div><div style="text-indent:18pt;margin-bottom:9pt;"><span><br/></span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below hereby constitutes and appoints Erica J.  Rogers and Lucas W.  Buchanan, and each of them acting individually, as his or her true and lawful attorneys-in-fact and agents, with full power of each to act alone, with full powers of substitution and resubstitution, for him and in his name, place and stead, in any and all capacities, to sign any and all amendments to this Annual Report on Form 10-K, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, with full power of each to act alone, full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully for all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or his or their substitutes, may lawfully do or cause to be done by virtue hereof.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, this Annual Report on Form 10-K has been signed by the following persons in the capacities and on the dates indicated: </span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">182</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div style="text-indent:18pt;margin-bottom:9pt;"><span><br/></span></div></div><div style="text-align:center;margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:99.839%;"><tr><td style="width:1.0%;"></td><td style="width:27.695%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.602%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:46.314%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.602%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:18.387%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Signature</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Title</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Date</span></td></tr><tr><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">/s/ Erica J. Rogers</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" rowspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:middle;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">President, Chief Executive Officer and Director<br/>(Principal Executive Officer)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" rowspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">March 2, 2020</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Erica J. Rogers</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="height:3pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">/s/ Lucas W. Buchanan</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" rowspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:middle;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Chief Financial Officer<br/>(Principal Financial Officer)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" rowspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">March 2, 2020</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Lucas W. Buchanan</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="height:3pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">/s/ Ruoxi Chen</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" rowspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:middle;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Director</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" rowspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">March 2, 2020</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Ruoxi Chen</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="height:3pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">/s/ Tony M. Chou</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" rowspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:middle;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Director</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" rowspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">March 2, 2020</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Tony M. Chou, M.D.</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="height:3pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">/s/ Amr Kronfol</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" rowspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:middle;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Director</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" rowspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">March 2, 2020</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Amr Kronfol</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="height:3pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">/s/ Jack W. Lasersohn</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" rowspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:middle;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Director</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" rowspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">March 2, 2020</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Jack W. Lasersohn</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="height:3pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">/s/ Robert E. Mittendorff</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" rowspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:middle;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Director</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" rowspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">March 2, 2020</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Robert E. Mittendorff, M.D.</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="height:3pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">/s/ Elizabeth H. Weatherman</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" rowspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:middle;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Director</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" rowspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">March 2, 2020</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Elizabeth H. Weatherman</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="height:3pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">/s/ Donald J. Zurbay</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" rowspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:middle;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Director</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" rowspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">March 2, 2020</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Donald J. Zurbay</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td></tr></table></div><div style="text-indent:18pt;text-align:center;margin-bottom:9pt;"><span><br/></span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">183</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.5
<SEQUENCE>2
<FILENAME>silk201910-kexhibit45d.htm
<DESCRIPTION>EX-4.5
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="i4c7ec3906fe849aaacf24b48fbd3e4e8_1"></div><div style="height:51.75pt;width:100%;"><div style="text-align:right;"><font><br></font></div><div style="text-align:right;"><font><br></font></div><div style="text-align:right;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;">Exhibit 4.5</font></div><div style="text-align:right;"><font><br></font></div></div><div style="text-align:right;"><font><br></font></div><div style="text-align:center;"><font><br></font></div><div style="text-align:center;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;">DESCRIPTION OF THE REGISTRANT&#8217;S SECURITIES</font></div><div style="text-align:center;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;">REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES</font></div><div style="text-align:center;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;">EXCHANGE ACT OF 1934</font></div><div style="text-align:center;"><font><br></font></div><div style="text-align:center;"><font><br></font></div><div style="text-indent:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Silk Road Medical, Inc. (the &#8220;Company&#8221;) has one class of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended&#58; our common stock, par value $0.001 per share.</font></div><div style="text-indent:36pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">As used in this summary, the terms &#8220;Silk Road Medical,&#8221; &#8220;the Company,&#8221; &#8220;we,&#8221; &#8220;our&#8221; and &#8220;us&#8221; refer to Silk Road Medical, Inc.</font></div><div style="text-indent:36pt;text-align:justify;"><font><br></font></div><div style="text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration: underline;">Description of Common Stock</font></div><div style="text-align:justify;"><font><br></font></div><div style="text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;">                </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">The following is a description of the material terms and provisions relating to our common stock.</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;">  </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">The following description is a summary that is not complete and is subject to and qualified in its entirety by reference to our amended and restated certificate of incorporation and our amended and restated bylaws, and to provisions of the Delaware General Corporation Law.</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;">  </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Copies of our amended and restated certificate of incorporation and our amended and restated bylaws, each of which may be amended from time to time, are included as exhibits to the Annual Report on Form 10-K to which this description is an Exhibit.</font></div><div style="text-align:justify;"><font><br></font></div><div style="text-indent:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%;">Voting Rights</font></div><div style="text-indent:36pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Each holder of our common stock is entitled to one vote for each share on all matters submitted to a vote of the stockholders, including the election of directors.</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;">  </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Our stockholders do not have cumulative voting rights in the election of directors.</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;">  </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Accordingly, holders of a majority of the voting shares are able to elect all of the directors.</font></div><div style="text-indent:36pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%;">Dividends</font></div><div style="text-indent:36pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Subject to preferences that may be applicable to any then outstanding convertible preferred stock, holders of our common stock are entitled to receive dividends, if any, as may be declared from time to time by our board of directors out of legally available funds.</font></div><div style="text-indent:36pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%;">Liquidation</font></div><div style="text-indent:36pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">In the event of our liquidation, dissolution or winding up, holders of our common stock will be entitled to share ratably in the net assets legally available for distribution to stockholders after the payment of all of our debts and other liabilities and the satisfaction of any liquidation preference granted to the holders of any then outstanding shares of convertible preferred stock.</font></div><div style="text-indent:36pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%;">Rights and Preferences</font></div><div style="text-indent:36pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Holders of our common stock have no preemptive, conversion, subscription or other rights, and there are no redemption or sinking fund provisions applicable to our common stock.</font></div><div style="text-indent:36pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%;">Fully Paid and Nonassessable</font></div><div style="text-indent:36pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">All of our outstanding shares of common stock are fully paid and nonassessable.</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="text-indent:36pt;"><font><br></font></div><div style="text-indent:36pt;"><font><br></font></div><div style="position:relative;width:100%;height:78.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">1</font></div></div></div><hr style="page-break-after:always"><div style="height:51.75pt;width:100%;"><div style="text-align:right;"><font><br></font></div><div style="text-align:right;"><font><br></font></div><div style="text-align:right;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;">Exhibit 4.5</font></div><div style="text-align:right;"><font><br></font></div></div><div style="text-indent:36pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;">Anti-Takeover Effects or Provisions of our Amended and Restated Certificate of Incorporation, our Amended and Restated Bylaws and Delaware Law</font></div><div style="text-indent:36pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Some provisions of Delaware law and our amended and restated certificate of incorporation and our amended and restated bylaws that are in effect contain provisions that could make the following transactions more difficult&#58; acquisition of us by means of a tender offer&#59; acquisition of us by means of a proxy contest or otherwise&#59; or removal of our incumbent officers and directors.</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;">  </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">It is possible that these provisions could make it more difficult to accomplish or could deter transactions that stock holders may otherwise consider to be in their best interest or in our best interests, including transactions that might result in a premium over the market price for our shares.</font></div><div style="text-indent:36pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">These provisions, summarized below, are expected to discourage coercive takeover practices and inadequate takeover bids.</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;">  </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">These provisions are also designed to encourage persons seeking to acquire control of us to first negotiate with our board of directors.</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;">  </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">We believe that the benefits of increased protection of our potential ability to negotiate with the proponent of a non-friendly or unsolicited proposal to acquire or restructure us outweigh the disadvantages of discouraging these proposals because negotiation of these proposals could result in an improvement of their terms.</font></div><div style="text-indent:36pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%;">Delaware Anti-Takeover Statute</font></div><div style="text-indent:36pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">We are subject to Section 203 of the General Corporation Law of the State of Delaware, which prohibits a Delaware corporation from engaging in any business combination with any interested stockholder for a period of three years after the date that such stockholder became an interested stockholder, with the following exceptions&#58;</font></div><div style="text-indent:36pt;text-align:justify;"><font><br></font></div><div style="text-indent:-18pt;padding-left:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%;">&#8226;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:13.8pt;">Before such date, the board of directors of the corporation approved either the business combination or the transaction that resulted in the stockholder becoming an interested holder&#59;</font></div><div style="text-align:justify;"><font><br></font></div><div style="text-indent:-18pt;padding-left:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%;">&#8226;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:13.8pt;">Upon completion of the transaction that resulted in the stockholder becoming an interested stockholder, the interested stockholder owned at least 85% of the voting stock of the corporation outstanding at the time the transaction began, excluding for purposes of determining the voting stock outstanding (but not the outstanding voting stock owned by the interested stockholder) those shares owned (i) by persons who are directors and also officers and (ii) employee stock plans in which employee participants do not have the right to determine confidentially whether shares held subject to the plan will be tendered in a tender or exchange offer&#59; or</font></div><div style="text-align:justify;"><font><br></font></div><div style="text-indent:-18pt;padding-left:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%;">&#8226;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:13.8pt;">On or after such date, the business combination is approved by the board of directors and authorized at an annual or special meeting of the stockholders, and not by written consent, by the affirmative vote of at least 66 2&#47;3% of the outstanding voting stock that is not owned by the interested stockholder.</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;">  </font></div><div style="text-align:justify;"><font><br></font></div><div style="text-indent:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">In general, Section 203 defines business combination to include the following&#58;</font></div><div style="text-indent:36pt;text-align:justify;"><font><br></font></div><div style="text-indent:-18pt;padding-left:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%;">&#8226;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:13.8pt;">Any merger or consolidation involving the corporation and the interested stockholder&#59;</font></div><div style="text-align:justify;"><font><br></font></div><div style="text-indent:-18pt;padding-left:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%;">&#8226;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:13.8pt;">Any sale, transfer, pledge or other disposition of 10% or more of the assets of the corporation involving the interested stockholder&#59;</font></div><div style="text-align:justify;"><font><br></font></div><div style="text-indent:-18pt;padding-left:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%;">&#8226;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:13.8pt;">Subject to certain exceptions, any transaction that results in the issuance or transfer by the corporation of any stock of the corporation to the interested stockholder&#59;</font></div><div style="text-align:justify;"><font><br></font></div><div style="text-indent:-18pt;padding-left:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%;">&#8226;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:13.8pt;">Any transaction involving the corporation that has the effect of increasing the proportionate share of the stock or any class or series of the corporation beneficially owned by the interested stockholder&#59; or</font></div><div style="text-align:justify;"><font><br></font></div><div style="position:relative;width:100%;height:78.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">2</font></div></div></div><hr style="page-break-after:always"><div style="height:51.75pt;width:100%;"><div style="text-align:right;"><font><br></font></div><div style="text-align:right;"><font><br></font></div><div style="text-align:right;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;">Exhibit 4.5</font></div><div style="text-align:right;"><font><br></font></div></div><div style="text-indent:-18pt;padding-left:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%;">&#8226;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:13.8pt;">The receipt by the interested stockholder of the benefit of any loss, advances, guarantees, pledges or other financial benefits by or through the corporation.</font></div><div style="text-align:justify;"><font><br></font></div><div style="text-indent:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">In general, Section 203 defines interested stockholder as an entity or person beneficially owning 15% or more of the outstanding voting stock of the corporation or any entity or person affiliated with or controlling or controlled by such entity or person.</font></div><div style="text-indent:36pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%;">Undesignated Preferred Stock</font></div><div style="text-indent:36pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">The ability to authorize undesignated preferred stock makes it possible for our board of directors to issue preferred stock with voting or other rights or preferences that could impede the success of any attempt to acquire us.</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;">  </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">These and other provisions may have the effect of deterring hostile takeovers or delaying changes in control or management of our company.</font></div><div style="text-indent:36pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%;">Special Stockholder Meetings</font></div><div style="text-indent:36pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Our amended and restated bylaws provide that a special meeting of stockholders may be called only by our board of directors, the chairperson of our board of directors, or our Chief Executive Officer or President.</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;">  </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">This provision might delay the ability of our stockholders to force consideration of a proposal or for stockholders controlling a majority of our common stock to take any action, including the removal of directors.</font></div><div style="text-indent:36pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%;">Requirements for Advance Notification of Stockholder Nominations and Proposals</font></div><div style="text-indent:36pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Our amended and restated bylaws establish advance notice procedures with respect to stockholder proposals and the nomination of candidates for election as directors, other than nominations made by or at the direction of the board of directors or a committee of the board of directors.</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;">  </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Our amended and restated bylaws also specify certain requirements regarding the form and content of a stockholder&#8217;s notice.</font></div><div style="text-indent:36pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;">Advance Notice of Stockholder Business</font></div><div style="text-indent:36pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">If a stockholder is submitting a stockholder proposal related to the business of the company, such stockholder must&#58; (i) be a stockholder of record at the time notice is given, (ii) submit the notice in a timely manner, and (iii) such business must be of a proper matter for stockholder action in accordance with our bylaws and applicable law.</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;">  </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">To be in proper written form, a stockholder&#8217;s notice related to the business of the company must contain the following items&#58; (i) a brief description of the business intended to be brought before the annual meeting, the text of the proposed business (including the text of any resolutions proposed for consideration) and the reasons for conducting such business at the annual meeting, (ii) the name and address of the stockholder proposing such business, (iii) the class and number of shares that are held of record or are beneficially held by the stockholder, (iv) whether and the extent to which any hedging activities have been entered into by or on behalf of such stockholder with respect to our securities, (v) any material interest of the stockholder in such business, (vi) a statement whether such stockholder will deliver a proxy statement or form of proxy to holders required under applicable law to carry the proposal.</font></div><div style="text-indent:36pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;">Advance Notice of Director Nominations</font></div><div style="text-indent:36pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">If a stockholder is submitting a nomination in connection with an annual meeting, such stockholder must&#58; (i) be a stockholder of record at the time notice if given, and (ii) submit the notice in a timely manner.</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;">  </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">To be in proper written form, a stockholder&#8217;s notice related to director nominations must contain the following items with respect to each nominee&#58; (i) the name, age, business address and residence address of the nominee, (ii) the principal occupation or employment of the nominee, (iii) the class and number of shares of the company that are held of record or are beneficially owned by the nominee and any derivative positions held or beneficially held by the nominee, (iv) whether and the extent to which any hedging activities have been entered into by or on behalf of the nominee with respect to our securities, (v) a description of all arrangements or understandings between or among the stockholder, any nominee or any other person or persons pursuant to which the nominations are to be made by the stockholder and (vi) a written statement executed by the nominee acknowledging and representing that the nominee intends to serve a full term on our board of directors if elected.</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;">  </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">With respect to the stockholder, the notice must contain the following items&#58; (i) the name and address of the stockholder proposing such business, (ii) the class and number of shares that are held of </font></div><div style="position:relative;width:100%;height:78.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">3</font></div></div></div><hr style="page-break-after:always"><div style="height:51.75pt;width:100%;"><div style="text-align:right;"><font><br></font></div><div style="text-align:right;"><font><br></font></div><div style="text-align:right;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;">Exhibit 4.5</font></div><div style="text-align:right;"><font><br></font></div></div><div style="text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">record or are beneficially held by the stockholder, (iii) whether and the extent to which any hedging activities have been entered into by or on behalf of such stockholder with respect to our securities, (iv) any material interest of the stockholder in such business, and (v) a statement whether such stockholder will deliver a proxy statement or form of proxy reasonably believed by such stockholder to be necessary to elect such nominee.</font></div><div style="text-indent:36pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%;">Elimination of Stockholder Action by Written Consent</font></div><div style="text-indent:36pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Our amended and restated certificate of incorporation and our amended and restated bylaws eliminate the right of stockholders to act by written consent without a meeting.</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;">  </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">As a result, a holder controlling a majority of our common stock would not be able to amend our amended and restated bylaws or remove directors without holding a meeting of our stockholders called in accordance with our amended and restated bylaws.</font></div><div style="text-indent:36pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%;">Classified Board&#59; Election and Removal of Directors</font></div><div style="text-indent:36pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Our amended and restated certificate of incorporation and amended and restated bylaws authorizes only our board of directors to fill vacant directorships, including newly created seats.</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;">  </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">In addition, the number of directors constituting our board of directors are permitted to be set only by a resolution adopted by our board of directors.</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;">  </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">These provisions prevent a stockholder from increasing the size of our board of directors and then gaining control of our board of directors by filling the resulting vacancies with its own nominees.</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;">  </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">This makes it more difficult to change the composition of our board of directors but promotes continuity of management.</font></div><div style="text-indent:36pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Our board of directors is divided into three classes.</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;">  </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">The directors in each class will serve for a three-year term, one class being elected each year by our stockholders, with staggered three-year terms.</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;">  </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Only one class of directors will be elected at each annual meeting of our stockholders, with the other classes continuing for the remainder of their respective three-year terms.</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;">  </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Because our stockholders do not have cumulative voting rights, our stockholders holding a majority of the shares of common stock outstanding will be able to elect all of our directors up for election.</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;">  </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">In addition, our amended and restated certificate of incorporation provides that directors may only be removed for cause.</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;">  </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">For more information on the classified board, see the section entitled &#8220;Management&#8212;Board of Directors&#8221; in our Annual Report on Form 10-K to which this description is an Exhibit. This system of electing and removing directors may tend to discourage a third party from making a tender offer or otherwise attempting to obtain control of us, because it generally makes it more difficult for stockholders to replace a majority of the directors.</font></div><div style="text-indent:36pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%;">Exclusive Forum</font></div><div style="text-indent:36pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Our amended and restated certificate of incorporation and bylaws provides that, unless we consent in writing to the selection of an alternative forum, the sole and exclusive forum, to the fullest extent permitted by law, for (1) any derivative action or proceeding brought on our behalf, (2) any action asserting a claim of breach of a fiduciary duty owed by any of our directors, officers or other employees to us or our stockholders, (3) any action asserting a claim against the company or any director or officer of the company arising pursuant to any provision of the Delaware General Corporation Law, our amended and restated certificate of incorporation or bylaws, or (4) any other action asserting a claim that is governed by the internal affairs doctrine shall be the Court of Chancery of the State of Delaware or federal court located within the State of Delaware if the Court of Chancery does not have jurisdiction, in all cases subject to the court&#8217;s having jurisdiction over indispensable parties named as defendants.</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;">  </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">A complaint asserting a cause of action under the Securities Act may be brought in state or federal court.</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;">  </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">With respect to the Securities Exchange Act of 1934, or Exchange Act, only claims brought derivatively under the Exchange Act would be subject to the forum selection clause described above.</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;">  </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">The enforceability of similar choice of forum provisions in other companies&#8217; certificates of incorporation and bylaws has been challenged in legal proceedings, and it is possible that, in connection with any action, a court could find the choice of forum provisions contained in our amended and restated certificate of incorporation and bylaws to be inapplicable or unenforceable in such action.</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;">  </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Although we believe these provisions benefit us by providing increased consistency in the application of Delaware law for the specified types of actions and proceedings, the provisions may have the effect of discouraging lawsuits against us or our directors and officers.</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;">  </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Any person or entity purchasing or otherwise acquiring any interest in our shares of common stock shall be deemed to have notice of and consented to this exclusive forum provision, but will not be deemed to have waived our compliance with the federal securities laws and the rules and regulations thereunder.</font></div><div style="position:relative;width:100%;height:78.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">4</font></div></div></div><hr style="page-break-after:always"><div style="height:51.75pt;width:100%;"><div style="text-align:right;"><font><br></font></div><div style="text-align:right;"><font><br></font></div><div style="text-align:right;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;">Exhibit 4.5</font></div><div style="text-align:right;"><font><br></font></div></div><div style="text-indent:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%;">Amendment of Charter Provisions</font></div><div style="text-indent:36pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">The amendment of any of the above provisions, except for the provision making it possible for our board of directors to issue preferred stock, would require approval by holders of at least 66 2&#47;3% of the voting power of our then outstanding voting stock.</font></div><div style="text-indent:36pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">The provisions of the Delaware General Corporation Law, our amended and restated certificate of incorporation and our amended and restated bylaws may have the effect of discouraging others from attempting hostile takeovers and, as a consequence, they may also inhibit temporary fluctuations in the market price of our common stock that often result from actual or rumored hostile takeover attempts.</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;">  </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">These provisions may also have the effect of preventing changes in our management.</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;">  </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">It is possible that these provisions could make it more difficult to accomplish transactions that stockholders may otherwise deem to be in their best interests.</font></div><div style="text-indent:36pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;">Exchange Listing</font></div><div style="text-indent:36pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Our common stock is quoted on The Nasdaq Global Market under the symbol &#8220;SILK.&#8221;</font></div><div style="text-indent:36pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;">Transfer Agent</font></div><div style="text-indent:36pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">The transfer agent for our common stock is American Stock Transfer &#38; Trust Company, LLC.</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;">  </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">The transfer agent&#8217;s address is 6201 15th Avenue, Brooklyn, NY 11219.</font></div><div><font><br></font></div><div style="position:relative;width:100%;height:78.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">5</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>3
<FILENAME>silk201910-kexhibit231.htm
<DESCRIPTION>EX-23.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="i97c498f6ded64cf79d1d15ed2446ea74_1"></div><div style="height:42.75pt;width:100%;"><div style="text-align:right;"><font><br></font></div><div style="text-align:right;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;">Exhibit 23.1</font></div></div><div style="text-align:right;"><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:center;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;">CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</font></div><div style="text-align:center;"><font><br></font></div><div style="text-align:center;"><font><br></font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;">We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 (No. 333-230778) of Silk Road Medical, Inc. of our report dated March 2, 2020 relating to the financial statements and financial statement schedule, which appears in this Form 10-K.</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;">&#47;s&#47; PricewaterhouseCoopers LLP </font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;">San Jose, California </font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;">March 2, 2020</font></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>4
<FILENAME>silk201910-kexhibit311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="i5a28a5cd75224607babb2af62b0fe108_1"></div><div style="height:42.75pt;width:100%;"><div style="text-align:right;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;">Exhibit 31.1</font></div></div><div style="text-align:right;"><font><br></font></div><div style="text-align:center;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;">CERTIFICATION OF CHIEF EXECUTIVE OFFICER</font></div><div style="text-align:center;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%;">Pursuant to</font></div><div style="text-align:center;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%;">Securities Exchange Act Rules 13a-14(a) and 15d-14(a),</font></div><div style="text-align:center;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%;">As Adopted Pursuant to</font></div><div style="text-align:center;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%;">Section 302 of the Sarbanes-Oxley Act of 2002</font></div><div style="text-align:center;"><font><br></font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">I, Erica J. Rogers, certify that&#58;</font></div><div><font><br></font></div><div><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:2.093%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:2.093%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:89.814%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">I have reviewed this Annual Report on Form 10-K of Silk Road Medical, Inc.&#59;</font></td></tr></table></div><div><font><br></font></div><div><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:2.093%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:2.093%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:89.814%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></td></tr></table></div><div><font><br></font></div><div><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:2.093%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:2.093%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:89.814%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></td></tr></table></div><div><font><br></font></div><div><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:2.093%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:2.093%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:89.814%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and we have&#58;</font></td></tr></table></div><div><font><br></font></div><div><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:11.596%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:2.093%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:80.311%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">a.</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></td></tr></table></div><div><font><br></font></div><div><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:11.596%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:2.093%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:80.311%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">b.</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></td></tr></table></div><div><font><br></font></div><div><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:11.596%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:2.093%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:80.311%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">c.</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></td></tr></table></div><div><font><br></font></div><div><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:2.093%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:2.093%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:89.814%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></td></tr></table></div><div><font><br></font></div><div><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:11.596%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:2.093%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:80.311%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">a.</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></td></tr></table></div><div><font><br></font></div><div><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:11.596%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:2.093%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:80.311%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">b.</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div style="margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:29.239%;"><tr><td style="width:1.0%;"></td><td style="width:98.000%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#47;s&#47; Erica J. Rogers</font></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Erica J. Rogers</font></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Chief Executive Officer</font></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div style="margin-top:6pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">(Principal Executive Officer)</font></div></td></tr></table></div><div style="margin-top:6pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> </font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Date&#58; March 2, 2020</font></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>5
<FILENAME>silk201910-kexhibit312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="i35a5c98a23854babb9e320a93234463d_1"></div><div style="height:42.75pt;width:100%;"><div style="text-align:right;"><font><br></font></div><div style="text-align:right;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;">Exhibit 31.2</font></div></div><div style="text-align:right;"><font><br></font></div><div style="text-align:center;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;">CERTIFICATION OF CHIEF FINANCIAL OFFICER</font></div><div style="text-align:center;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%;">Pursuant to</font></div><div style="text-align:center;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%;">Securities Exchange Act Rules 13a-14(a) and 15d-14(a),</font></div><div style="text-align:center;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%;">As Adopted Pursuant to</font></div><div style="text-align:center;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%;">Section 302 of the Sarbanes-Oxley Act of 2002</font></div><div style="text-align:center;"><font><br></font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">I, Lucas W. Buchanan, certify that&#58;</font></div><div><font><br></font></div><div><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:2.093%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:2.093%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:89.814%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">I have reviewed this Annual Report on Form 10-K of Silk Road Medical, Inc.&#59;</font></td></tr></table></div><div><font><br></font></div><div><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:2.093%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:2.093%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:89.814%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></td></tr></table></div><div><font><br></font></div><div><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:2.093%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:2.093%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:89.814%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></td></tr></table></div><div><font><br></font></div><div><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:2.093%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:2.093%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:89.814%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and we have&#58;</font></td></tr></table></div><div><font><br></font></div><div><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:11.596%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:2.093%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:80.311%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">a.</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></td></tr></table></div><div><font><br></font></div><div><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:11.596%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:2.093%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:80.311%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">b.</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></td></tr></table></div><div><font><br></font></div><div><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:11.596%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:2.093%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:80.311%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">c.</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></td></tr></table></div><div><font><br></font></div><div><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:2.093%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:2.093%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:89.814%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></td></tr></table></div><div><font><br></font></div><div><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:11.596%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:2.093%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:80.311%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">a.</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></td></tr></table></div><div><font><br></font></div><div><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:11.596%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:2.093%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:80.311%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">b.</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div style="margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:29.239%;"><tr><td style="width:1.0%;"></td><td style="width:98.000%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#47;s&#47; Lucas W. Buchanan</font></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Lucas W. Buchanan</font></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Chief Financial Officer</font></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">(Principal Financial Officer)</font></div></td></tr></table></div><div style="margin-top:6pt;"><font><br></font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Date&#58; March 2, 2020</font></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>6
<FILENAME>silk201910-kexhibit321.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="iadcb90385478483084f1287fe92921cc_1"></div><div style="height:42.75pt;width:100%;"><div style="text-align:right;"><font><br></font></div><div style="text-align:right;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;">Exhibit 32.1</font></div></div><div style="text-align:right;"><font><br></font></div><div><font><br></font></div><div style="text-align:center;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;">CERTIFICATIONS OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER</font></div><div style="text-align:center;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%;">PURSUANT TO</font></div><div style="text-align:center;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%;">18 U.S.C. SECTION 1350,</font></div><div style="text-align:center;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%;">AS ADOPTED PURSUANT TO</font></div><div style="text-align:center;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%;">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center;"><font><br></font></div><div style="text-align:center;"><font><br></font></div><div style="text-align:center;"><font><br></font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:95%;">In connection with the Annual Report of Silk Road Medical, Inc. (the &#8220;Company&#8221;) on Form 10-K for the fiscal year ended December 31, 2019, as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), I certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge&#58;</font></div><div><font><br></font></div><div style="text-indent:-18pt;padding-left:36pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;">1.</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;padding-left:9pt;">The Report, fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934, as amended&#59; and</font></div><div><font><br></font></div><div style="text-indent:-18pt;padding-left:36pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;">2.</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;padding-left:9pt;">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div><font><br></font></div><div><font><br></font></div><div><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:35.233%;"><tr><td style="width:1.0%;"></td><td style="width:98.000%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><font style="font-size:12pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#47;s&#47; Erica J. Rogers</font></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><font style="font-size:12pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Erica J. Rogers</font></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><font style="font-size:12pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Chief Executive Officer</font></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><font style="font-size:12pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Principal Executive Officer)</font></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;">Date&#58; March 2, 2020</font></div><div><font><br></font></div><div><font><br></font></div><div><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:35.233%;"><tr><td style="width:1.0%;"></td><td style="width:98.000%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><font style="font-size:12pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#47;s&#47; Lucas W. Buchanan</font></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><font style="font-size:12pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Lucas W. Buchanan</font></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><font style="font-size:12pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Chief Financial Officer</font></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><font style="font-size:12pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Principal Financial Officer)</font></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;">Date&#58; March 2, 2020</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>7
<FILENAME>silk-20191231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:dad5b714-6959-4e39-8c51-cdabce9e0669,g:fba3822a-5587-4181-9cc4-63667bdb118e-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:silk="http://silkroadmed.com/20191231" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://silkroadmed.com/20191231">
  <xs:import namespace="http://fasb.org/srt/2018-01-31" schemaLocation="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2018-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2019-01-31" schemaLocation="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="silk-20191231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="silk-20191231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="silk-20191231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="silk-20191231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://silkroadmed.com/role/CoverPage">
        <link:definition>0001001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheets" roleURI="http://silkroadmed.com/role/ConsolidatedBalanceSheets">
        <link:definition>1001002 - Statement - Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheetsParenthetical" roleURI="http://silkroadmed.com/role/ConsolidatedBalanceSheetsParenthetical">
        <link:definition>1002003 - Statement - Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofOperationsandComprehensiveLoss" roleURI="http://silkroadmed.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss">
        <link:definition>1003004 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit" roleURI="http://silkroadmed.com/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit">
        <link:definition>1004005 - Statement - Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders' Equity (Deficit)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficitParenthetical" roleURI="http://silkroadmed.com/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficitParenthetical">
        <link:definition>1005006 - Statement - Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders' Equity (Deficit) (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofCashFlows" roleURI="http://silkroadmed.com/role/ConsolidatedStatementsofCashFlows">
        <link:definition>1006007 - Statement - Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FormationandBusinessoftheCompany" roleURI="http://silkroadmed.com/role/FormationandBusinessoftheCompany">
        <link:definition>2101101 - Disclosure - Formation and Business of the Company</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FormationandBusinessoftheCompanyDetails" roleURI="http://silkroadmed.com/role/FormationandBusinessoftheCompanyDetails">
        <link:definition>2402401 - Disclosure - Formation and Business of the Company (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPolicies" roleURI="http://silkroadmed.com/role/SummaryofSignificantAccountingPolicies">
        <link:definition>2103102 - Disclosure - Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesPolicies" roleURI="http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesPolicies">
        <link:definition>2204201 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesTables" roleURI="http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesTables">
        <link:definition>2305301 - Disclosure - Summary of Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesAdjustmenttoPriorPeriodFinancialStatementsDetails" roleURI="http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesAdjustmenttoPriorPeriodFinancialStatementsDetails">
        <link:definition>2406402 - Disclosure - Summary of Significant Accounting Policies - Adjustment to Prior Period Financial Statements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesCashCashEquivalentsandRestrictedCashDetails" roleURI="http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesCashCashEquivalentsandRestrictedCashDetails">
        <link:definition>2407403 - Disclosure - Summary of Significant Accounting Policies - Cash, Cash Equivalents and Restricted Cash (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails" roleURI="http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails">
        <link:definition>2408404 - Disclosure - Summary of Significant Accounting Policies - Property and Equipment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesDeferredInitialPublicOfferingCostsDetails" roleURI="http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesDeferredInitialPublicOfferingCostsDetails">
        <link:definition>2409405 - Disclosure - Summary of Significant Accounting Policies - Deferred Initial Public Offering Costs (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesLeasesDetails" roleURI="http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesLeasesDetails">
        <link:definition>2410406 - Disclosure - Summary of Significant Accounting Policies - Leases (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesASC842ImpactonCondensedConsolidatedBalanceSheetDetails" roleURI="http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesASC842ImpactonCondensedConsolidatedBalanceSheetDetails">
        <link:definition>2411407 - Disclosure - Summary of Significant Accounting Policies - ASC 842 Impact on Condensed Consolidated Balance Sheet (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesRedeemableConvertiblePreferredStockDetails" roleURI="http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesRedeemableConvertiblePreferredStockDetails">
        <link:definition>2412408 - Disclosure - Summary of Significant Accounting Policies - Redeemable Convertible Preferred Stock (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesRevenueRecognitionDetails" roleURI="http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesRevenueRecognitionDetails">
        <link:definition>2413409 - Disclosure - Summary of Significant Accounting Policies - Revenue Recognition (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesAdvertisingCostsDetails" roleURI="http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesAdvertisingCostsDetails">
        <link:definition>2414410 - Disclosure - Summary of Significant Accounting Policies - Advertising Costs (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesStockBasedCompensationDetails" roleURI="http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesStockBasedCompensationDetails">
        <link:definition>2415411 - Disclosure - Summary of Significant Accounting Policies - Stock-Based Compensation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesScheduleofEarningsPerShareDetails" roleURI="http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesScheduleofEarningsPerShareDetails">
        <link:definition>2416412 - Disclosure - Summary of Significant Accounting Policies - Schedule of Earnings Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesScheduleofPotentiallyDilutiveSecuritiesNotIncludedinCalculationofEarningsperShareDetails" roleURI="http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesScheduleofPotentiallyDilutiveSecuritiesNotIncludedinCalculationofEarningsperShareDetails">
        <link:definition>2417413 - Disclosure - Summary of Significant Accounting Policies - Schedule of Potentially Dilutive Securities Not Included in Calculation of Earnings per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesSegmentandGeographicalInformationDetails" roleURI="http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesSegmentandGeographicalInformationDetails">
        <link:definition>2418414 - Disclosure - Summary of Significant Accounting Policies - Segment and Geographical Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RecentAccountingPronouncements" roleURI="http://silkroadmed.com/role/RecentAccountingPronouncements">
        <link:definition>2119103 - Disclosure - Recent Accounting Pronouncements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurements" roleURI="http://silkroadmed.com/role/FairValueMeasurements">
        <link:definition>2120104 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsTables" roleURI="http://silkroadmed.com/role/FairValueMeasurementsTables">
        <link:definition>2321302 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsRecurringAssetsandLiabilitiesDetails" roleURI="http://silkroadmed.com/role/FairValueMeasurementsRecurringAssetsandLiabilitiesDetails">
        <link:definition>2422415 - Disclosure - Fair Value Measurements - Recurring Assets and Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsNarrativeDetails" roleURI="http://silkroadmed.com/role/FairValueMeasurementsNarrativeDetails">
        <link:definition>2423416 - Disclosure - Fair Value Measurements - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsFairValueAssumptionsDetails" roleURI="http://silkroadmed.com/role/FairValueMeasurementsFairValueAssumptionsDetails">
        <link:definition>2424417 - Disclosure - Fair Value Measurements - Fair Value Assumptions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsChangesinRedeemableConvertibleWarrantLiabilityDetails" roleURI="http://silkroadmed.com/role/FairValueMeasurementsChangesinRedeemableConvertibleWarrantLiabilityDetails">
        <link:definition>2425418 - Disclosure - Fair Value Measurements - Changes in Redeemable Convertible Warrant Liability (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetComponents" roleURI="http://silkroadmed.com/role/BalanceSheetComponents">
        <link:definition>2126105 - Disclosure - Balance Sheet Components</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetComponentsTables" roleURI="http://silkroadmed.com/role/BalanceSheetComponentsTables">
        <link:definition>2327303 - Disclosure - Balance Sheet Components (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetComponentsFairValueofAvailableForSaleInvestmentsDetails" roleURI="http://silkroadmed.com/role/BalanceSheetComponentsFairValueofAvailableForSaleInvestmentsDetails">
        <link:definition>2428419 - Disclosure - Balance Sheet Components - Fair Value of Available-For-Sale Investments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetComponentsFairValueofCashEquivalentsShortTermandLongTermInvestmentsDetails" roleURI="http://silkroadmed.com/role/BalanceSheetComponentsFairValueofCashEquivalentsShortTermandLongTermInvestmentsDetails">
        <link:definition>2429420 - Disclosure - Balance Sheet Components - Fair Value of Cash Equivalents, Short-Term and Long-Term Investments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetComponentsAvailableforSaleInvestmentsinUnrealizedLossPositionDetails" roleURI="http://silkroadmed.com/role/BalanceSheetComponentsAvailableforSaleInvestmentsinUnrealizedLossPositionDetails">
        <link:definition>2430421 - Disclosure - Balance Sheet Components - Available-for-Sale Investments in Unrealized Loss Position (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetComponentsScheduleofInventoryDetails" roleURI="http://silkroadmed.com/role/BalanceSheetComponentsScheduleofInventoryDetails">
        <link:definition>2431422 - Disclosure - Balance Sheet Components - Schedule of Inventory (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetComponentsNarrativeDetails" roleURI="http://silkroadmed.com/role/BalanceSheetComponentsNarrativeDetails">
        <link:definition>2432423 - Disclosure - Balance Sheet Components - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetComponentsPropertyPlantandEquipmentDetails" roleURI="http://silkroadmed.com/role/BalanceSheetComponentsPropertyPlantandEquipmentDetails">
        <link:definition>2433424 - Disclosure - Balance Sheet Components - Property, Plant and Equipment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetComponentsAccruedLiabilitiesDetails" roleURI="http://silkroadmed.com/role/BalanceSheetComponentsAccruedLiabilitiesDetails">
        <link:definition>2434425 - Disclosure - Balance Sheet Components - Accrued Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongtermDebt" roleURI="http://silkroadmed.com/role/LongtermDebt">
        <link:definition>2135106 - Disclosure - Long-term Debt</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongtermDebtTables" roleURI="http://silkroadmed.com/role/LongtermDebtTables">
        <link:definition>2336304 - Disclosure - Long-term Debt (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongtermDebtTermLoanNarrativeDetails" roleURI="http://silkroadmed.com/role/LongtermDebtTermLoanNarrativeDetails">
        <link:definition>2437426 - Disclosure - Long-term Debt - Term Loan Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongtermDebtFutureMaturitiesUndertheTermLoanDetails" roleURI="http://silkroadmed.com/role/LongtermDebtFutureMaturitiesUndertheTermLoanDetails">
        <link:definition>2438427 - Disclosure - Long-term Debt - Future Maturities Under the Term Loan (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongtermDebtSeriesCNarrativeDetails" roleURI="http://silkroadmed.com/role/LongtermDebtSeriesCNarrativeDetails">
        <link:definition>2439428 - Disclosure - Long-term Debt - Series C Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencies" roleURI="http://silkroadmed.com/role/CommitmentsandContingencies">
        <link:definition>2140107 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesTables" roleURI="http://silkroadmed.com/role/CommitmentsandContingenciesTables">
        <link:definition>2341305 - Disclosure - Commitments and Contingencies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesLeaseNarrativeDetails" roleURI="http://silkroadmed.com/role/CommitmentsandContingenciesLeaseNarrativeDetails">
        <link:definition>2442429 - Disclosure - Commitments and Contingencies - Lease Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesBalanceSheetInformationDetails" roleURI="http://silkroadmed.com/role/CommitmentsandContingenciesBalanceSheetInformationDetails">
        <link:definition>2443430 - Disclosure - Commitments and Contingencies - Balance Sheet Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesOperatingLeaseMaturitiesDetails" roleURI="http://silkroadmed.com/role/CommitmentsandContingenciesOperatingLeaseMaturitiesDetails">
        <link:definition>2444431 - Disclosure - Commitments and Contingencies - Operating Lease Maturities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesOperatingLeaseMaturitiesDetails_1" roleURI="http://silkroadmed.com/role/CommitmentsandContingenciesOperatingLeaseMaturitiesDetails_1">
        <link:definition>2444431 - Disclosure - Commitments and Contingencies - Operating Lease Maturities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesTopic840AggregateFutureMinimumLeasePaymentsDetails" roleURI="http://silkroadmed.com/role/CommitmentsandContingenciesTopic840AggregateFutureMinimumLeasePaymentsDetails">
        <link:definition>2445432 - Disclosure - Commitments and Contingencies - Topic 840 Aggregate Future Minimum Lease Payments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesPurchaseObligationNarrativeDetails" roleURI="http://silkroadmed.com/role/CommitmentsandContingenciesPurchaseObligationNarrativeDetails">
        <link:definition>2446433 - Disclosure - Commitments and Contingencies - Purchase Obligation Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RedeemableConvertiblePreferredStock" roleURI="http://silkroadmed.com/role/RedeemableConvertiblePreferredStock">
        <link:definition>2147108 - Disclosure - Redeemable Convertible Preferred Stock</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RedeemableConvertiblePreferredStockTables" roleURI="http://silkroadmed.com/role/RedeemableConvertiblePreferredStockTables">
        <link:definition>2348306 - Disclosure - Redeemable Convertible Preferred Stock (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RedeemableConvertiblePreferredStockScheduleofRedeemableConvertiblePreferredStockDetails" roleURI="http://silkroadmed.com/role/RedeemableConvertiblePreferredStockScheduleofRedeemableConvertiblePreferredStockDetails">
        <link:definition>2449434 - Disclosure - Redeemable Convertible Preferred Stock - Schedule of Redeemable Convertible Preferred Stock (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RedeemableConvertiblePreferredStockNarrativeDetails" roleURI="http://silkroadmed.com/role/RedeemableConvertiblePreferredStockNarrativeDetails">
        <link:definition>2450435 - Disclosure - Redeemable Convertible Preferred Stock - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityDeficit" roleURI="http://silkroadmed.com/role/StockholdersEquityDeficit">
        <link:definition>2151109 - Disclosure - Stockholders' Equity (Deficit)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityDeficitTables" roleURI="http://silkroadmed.com/role/StockholdersEquityDeficitTables">
        <link:definition>2352307 - Disclosure - Stockholders' Equity (Deficit) (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityDeficitNarrativeDetails" roleURI="http://silkroadmed.com/role/StockholdersEquityDeficitNarrativeDetails">
        <link:definition>2453436 - Disclosure - Stockholders' Equity (Deficit) - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityDeficitSharesReservedforFutureIssuanceDetails" roleURI="http://silkroadmed.com/role/StockholdersEquityDeficitSharesReservedforFutureIssuanceDetails">
        <link:definition>2454437 - Disclosure - Stockholders' Equity (Deficit) - Shares Reserved for Future Issuance (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockOptionPlans" roleURI="http://silkroadmed.com/role/StockOptionPlans">
        <link:definition>2155110 - Disclosure - Stock Option Plans</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockOptionPlansTables" roleURI="http://silkroadmed.com/role/StockOptionPlansTables">
        <link:definition>2356308 - Disclosure - Stock Option Plans (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockOptionPlansNarrativeDetails" roleURI="http://silkroadmed.com/role/StockOptionPlansNarrativeDetails">
        <link:definition>2457438 - Disclosure - Stock Option Plans - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockOptionPlansActivityUnderCompensationPlanDetails" roleURI="http://silkroadmed.com/role/StockOptionPlansActivityUnderCompensationPlanDetails">
        <link:definition>2458439 - Disclosure - Stock Option Plans - Activity Under Compensation Plan (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockOptionPlansInformationbyExercisePriceDetails" roleURI="http://silkroadmed.com/role/StockOptionPlansInformationbyExercisePriceDetails">
        <link:definition>2459440 - Disclosure - Stock Option Plans - Information by Exercise Price (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockOptionPlansStockOptionAssumptionsDetails" roleURI="http://silkroadmed.com/role/StockOptionPlansStockOptionAssumptionsDetails">
        <link:definition>2460441 - Disclosure - Stock Option Plans - Stock Option Assumptions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockOptionPlansStockbasedCompensationDetails" roleURI="http://silkroadmed.com/role/StockOptionPlansStockbasedCompensationDetails">
        <link:definition>2461442 - Disclosure - Stock Option Plans - Stock-based Compensation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://silkroadmed.com/role/IncomeTaxes">
        <link:definition>2162111 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesTables" roleURI="http://silkroadmed.com/role/IncomeTaxesTables">
        <link:definition>2363309 - Disclosure - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesComponentsofIncomeBeforeTaxesDetails" roleURI="http://silkroadmed.com/role/IncomeTaxesComponentsofIncomeBeforeTaxesDetails">
        <link:definition>2464443 - Disclosure - Income Taxes - Components of Income Before Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesReconciliationofUSStatutoryRateDetails" roleURI="http://silkroadmed.com/role/IncomeTaxesReconciliationofUSStatutoryRateDetails">
        <link:definition>2465444 - Disclosure - Income Taxes - Reconciliation of U.S Statutory Rate (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesNetDeferredTaxAssetsDetails" roleURI="http://silkroadmed.com/role/IncomeTaxesNetDeferredTaxAssetsDetails">
        <link:definition>2466445 - Disclosure - Income Taxes - Net Deferred Tax Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesNarrativeDetails" roleURI="http://silkroadmed.com/role/IncomeTaxesNarrativeDetails">
        <link:definition>2467446 - Disclosure - Income Taxes - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesReconciliationofUnrecognizedTaxBenefitsDetails" roleURI="http://silkroadmed.com/role/IncomeTaxesReconciliationofUnrecognizedTaxBenefitsDetails">
        <link:definition>2468447 - Disclosure - Income Taxes - Reconciliation of Unrecognized Tax Benefits (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionofVariableInterestEntityNeuroCo" roleURI="http://silkroadmed.com/role/AcquisitionofVariableInterestEntityNeuroCo">
        <link:definition>2169112 - Disclosure - Acquisition of Variable Interest Entity - NeuroCo</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionofVariableInterestEntityNeuroCoDetails" roleURI="http://silkroadmed.com/role/AcquisitionofVariableInterestEntityNeuroCoDetails">
        <link:definition>2470448 - Disclosure - Acquisition of Variable Interest Entity - NeuroCo (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="A401kPlan" roleURI="http://silkroadmed.com/role/A401kPlan">
        <link:definition>2171113 - Disclosure - 401(k) Plan</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="A401kPlanDetails" roleURI="http://silkroadmed.com/role/A401kPlanDetails">
        <link:definition>2472449 - Disclosure - 401(k) Plan (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEvents" roleURI="http://silkroadmed.com/role/SubsequentEvents">
        <link:definition>2173114 - Disclosure - Subsequent Events</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEventsNarrativeDetails" roleURI="http://silkroadmed.com/role/SubsequentEventsNarrativeDetails">
        <link:definition>2474450 - Disclosure - Subsequent Events - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="QuarterlyFinancialInformationunaudited" roleURI="http://silkroadmed.com/role/QuarterlyFinancialInformationunaudited">
        <link:definition>2175115 - Disclosure - Quarterly Financial Information (unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="QuarterlyFinancialInformationunauditedTables" roleURI="http://silkroadmed.com/role/QuarterlyFinancialInformationunauditedTables">
        <link:definition>2376310 - Disclosure - Quarterly Financial Information (unaudited) (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="QuarterlyFinancialInformationunauditedDetails" roleURI="http://silkroadmed.com/role/QuarterlyFinancialInformationunauditedDetails">
        <link:definition>2477451 - Disclosure - Quarterly Financial Information (unaudited) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="silk_LongTermDebtGrossBeforeAccretionOfClosingFees" abstract="false" name="LongTermDebtGrossBeforeAccretionOfClosingFees" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="silk_TwoThousandNineteenStockOptionPlanMember" abstract="true" name="TwoThousandNineteenStockOptionPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="silk_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset" abstract="false" name="DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="silk_IncentiveStockOptionMember" abstract="true" name="IncentiveStockOptionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="silk_IPOUnderwritingDiscountsAndCommissionsMember" abstract="true" name="IPOUnderwritingDiscountsAndCommissionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="silk_DebtInstrumentLiquidityCovenantTerm" abstract="false" name="DebtInstrumentLiquidityCovenantTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="silk_PreferredStockWarrantLiability" abstract="false" name="PreferredStockWarrantLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="silk_ExercisePriceOneMember" abstract="true" name="ExercisePriceOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="silk_IncentiveandNonqualifiedStockOptionIssuedMember" abstract="true" name="IncentiveandNonqualifiedStockOptionIssuedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="silk_DebtInstrumentCovenantMaximumLiquidityAmount" abstract="false" name="DebtInstrumentCovenantMaximumLiquidityAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="silk_IncentiveandNonqualifiedStockOptionMember" abstract="true" name="IncentiveandNonqualifiedStockOptionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="silk_ExercisePriceThreeMember" abstract="true" name="ExercisePriceThreeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="silk_TermLoanTrancheAMember" abstract="true" name="TermLoanTrancheAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="silk_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityReclassifications" abstract="false" name="FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityReclassifications" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="silk_CommonStockWarrantsMember" abstract="true" name="CommonStockWarrantsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="silk_SeriesA1PreferredStockMember" abstract="true" name="SeriesA1PreferredStockMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="silk_CommonStockWarrantMember" abstract="true" name="CommonStockWarrantMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="silk_CashAndCashEquivalentsFairValueDisclosureMaturingAfterOneYearThroughTwoYears" abstract="false" name="CashAndCashEquivalentsFairValueDisclosureMaturingAfterOneYearThroughTwoYears" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="silk_CashAndCashEquivalentsFairValueDisclosureMaturingWithinOneYear" abstract="false" name="CashAndCashEquivalentsFairValueDisclosureMaturingWithinOneYear" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="silk_ProvisionsForSalesReturns" abstract="false" name="ProvisionsForSalesReturns" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="silk_TermLoanMember" abstract="true" name="TermLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="silk_LongTermDebtUnpaidInterest" abstract="false" name="LongTermDebtUnpaidInterest" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="silk_AccruedTravelExpensesCurrent" abstract="false" name="AccruedTravelExpensesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="silk_DebtInstrumentInterestRateFacilityFee" abstract="false" name="DebtInstrumentInterestRateFacilityFee" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="silk_RedeemableConvertiblePreferredStockWarrantsMember" abstract="true" name="RedeemableConvertiblePreferredStockWarrantsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="silk_AssetsAndLiabilitiesLesseeTableTextBlock" abstract="false" name="AssetsAndLiabilitiesLesseeTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="silk_NeuroCoIncMember" abstract="true" name="NeuroCoIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="silk_ExercisePriceTwoMember" abstract="true" name="ExercisePriceTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="silk_DeferredTaxAssetsOperatingLeaseLiability" abstract="false" name="DeferredTaxAssetsOperatingLeaseLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="silk_IncentiveandNonqualifiedStockOptionExercisedMember" abstract="true" name="IncentiveandNonqualifiedStockOptionExercisedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="silk_TermLoanTrancheBMember" abstract="true" name="TermLoanTrancheBMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="silk_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExerciseThresholdasaPercentageofSharePrice" abstract="false" name="SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExerciseThresholdasaPercentageofSharePrice" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="silk_StockIssuedDuringPeriodValueExerciseOfWarrants" abstract="false" name="StockIssuedDuringPeriodValueExerciseOfWarrants" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="silk_DebtInstrumentConvertibleMaximumPercentageOfOutstandingLoans" abstract="false" name="DebtInstrumentConvertibleMaximumPercentageOfOutstandingLoans" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="silk_StockIssuedDuringPeriodSharesExerciseOfWarrants" abstract="false" name="StockIssuedDuringPeriodSharesExerciseOfWarrants" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="silk_ExercisePriceFourMember" abstract="true" name="ExercisePriceFourMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="silk_OperatingLossCarryforwardOffsetMaximumPercent" abstract="false" name="OperatingLossCarryforwardOffsetMaximumPercent" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="silk_BusinessCombinationConsiderationTransferredNotesPayableForgiven" abstract="false" name="BusinessCombinationConsiderationTransferredNotesPayableForgiven" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="silk_NetIncomeLossAndComprehensiveIncomeLossNetOfTaxAttributableToParent" abstract="false" name="NetIncomeLossAndComprehensiveIncomeLossNetOfTaxAttributableToParent" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="silk_EmployeeStockPurchasePlanMember" abstract="true" name="EmployeeStockPurchasePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="silk_DebtInstrumentConvertibleMarketCapitalization" abstract="false" name="DebtInstrumentConvertibleMarketCapitalization" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="silk_DebtMaximumBorrowingCapacity" abstract="false" name="DebtMaximumBorrowingCapacity" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="silk_LongTermInvestmentsMember" abstract="true" name="LongTermInvestmentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="silk_EffectiveIncomeTaxRateReconciliationWarrantLiabilityAdjustmentAmount" abstract="false" name="EffectiveIncomeTaxRateReconciliationWarrantLiabilityAdjustmentAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="silk_NotesReceivableRelatedPartiesTerm" abstract="false" name="NotesReceivableRelatedPartiesTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="silk_DebtInstrumentCovenantMinimumNetRevenueAmount" abstract="false" name="DebtInstrumentCovenantMinimumNetRevenueAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="silk_DebtInstrumentInterestRateFinancingFee" abstract="false" name="DebtInstrumentInterestRateFinancingFee" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="silk_ShareBasedCompensationArrangementBySharebasedPaymentAwardNumberOfAdditionalSharesAllowableUnderThePlan" abstract="false" name="ShareBasedCompensationArrangementBySharebasedPaymentAwardNumberOfAdditionalSharesAllowableUnderThePlan" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="silk_OperatingLeaseRightOfUseAssetAmortization" abstract="false" name="OperatingLeaseRightOfUseAssetAmortization" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="silk_StockIssuanceCostsIncurredButNotYetPaid" abstract="false" name="StockIssuanceCostsIncurredButNotYetPaid" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="silk_DebtInstrumentInterestRatePaidInCash" abstract="false" name="DebtInstrumentInterestRatePaidInCash" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="silk_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardsAvailableforGrantRollForward" abstract="true" name="SharebasedCompensationArrangementbySharebasedPaymentAwardAwardsAvailableforGrantRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="silk_LongTermDebtAccretionOfClosingFees" abstract="false" name="LongTermDebtAccretionOfClosingFees" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="silk_CommonStockVotePerShare" abstract="false" name="CommonStockVotePerShare" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="silk_NonqualifiedStockOptionsMember" abstract="true" name="NonqualifiedStockOptionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="silk_PreferredStockWarrantsMember" abstract="true" name="PreferredStockWarrantsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="silk_SecondPublicOfferingMember" abstract="true" name="SecondPublicOfferingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="silk_AccruedClinicalExpensesCurrent" abstract="false" name="AccruedClinicalExpensesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="silk_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:perShareItemType"/>
  <xs:element id="silk_NotesReceivableRelatedPartiesInterestRateStatedPercentage" abstract="false" name="NotesReceivableRelatedPartiesInterestRateStatedPercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="silk_DebtInstrumentInterestRatePaidInKind" abstract="false" name="DebtInstrumentInterestRatePaidInKind" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="silk_WarrantsClassifiedAsLiabilitiesPolicyTextBlock" abstract="false" name="WarrantsClassifiedAsLiabilitiesPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="silk_IPOOtherExpensesMember" abstract="true" name="IPOOtherExpensesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="silk_CorrectionOfProvisionsForReturnsFromCustomersMember" abstract="true" name="CorrectionOfProvisionsForReturnsFromCustomersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>8
<FILENAME>silk-20191231_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:dad5b714-6959-4e39-8c51-cdabce9e0669,g:fba3822a-5587-4181-9cc4-63667bdb118e-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://silkroadmed.com/role/CoverPage" xlink:type="simple" xlink:href="silk-20191231.xsd#CoverPage"/>
  <link:calculationLink xlink:role="http://silkroadmed.com/role/CoverPage" xlink:type="extended"/>
  <link:roleRef roleURI="http://silkroadmed.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="silk-20191231.xsd#ConsolidatedBalanceSheets"/>
  <link:calculationLink xlink:role="http://silkroadmed.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_a7fc366e-4725-49c9-a430-bd54caf726f1" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_f4ed273b-dcf8-44c2-a2a2-5868aa4e1650" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_a7fc366e-4725-49c9-a430-bd54caf726f1" xlink:to="loc_us-gaap_LiabilitiesCurrent_f4ed273b-dcf8-44c2-a2a2-5868aa4e1650" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_8ccb1bcf-8055-430b-ba07-45a50ca02e1f" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_a7fc366e-4725-49c9-a430-bd54caf726f1" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_8ccb1bcf-8055-430b-ba07-45a50ca02e1f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_PreferredStockWarrantLiability_a9961e79-67b4-4a38-a591-f43b942cc2aa" xlink:href="silk-20191231.xsd#silk_PreferredStockWarrantLiability"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_a7fc366e-4725-49c9-a430-bd54caf726f1" xlink:to="loc_silk_PreferredStockWarrantLiability_a9961e79-67b4-4a38-a591-f43b942cc2aa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_747f4f19-235b-435b-afad-41bede42e140" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_a7fc366e-4725-49c9-a430-bd54caf726f1" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_747f4f19-235b-435b-afad-41bede42e140" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_e17dabae-e0e0-46c4-a0d1-74b8339651fe" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_7482fe80-ec63-483d-a05c-0a85ef683515" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_e17dabae-e0e0-46c4-a0d1-74b8339651fe" xlink:to="loc_us-gaap_AssetsCurrent_7482fe80-ec63-483d-a05c-0a85ef683515" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_c24fd163-956c-429e-b6a0-6552c0fd4d6c" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_e17dabae-e0e0-46c4-a0d1-74b8339651fe" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_c24fd163-956c-429e-b6a0-6552c0fd4d6c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_c891da46-6398-4f41-aacf-8ba899164534" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_e17dabae-e0e0-46c4-a0d1-74b8339651fe" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_c891da46-6398-4f41-aacf-8ba899164534" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_c8ea6e83-e5e6-4f98-9f9e-00521f37b057" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_e17dabae-e0e0-46c4-a0d1-74b8339651fe" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_c8ea6e83-e5e6-4f98-9f9e-00521f37b057" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments_071e53cf-9b76-42e5-8806-bc40e567f208" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermInvestments"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_e17dabae-e0e0-46c4-a0d1-74b8339651fe" xlink:to="loc_us-gaap_LongTermInvestments_071e53cf-9b76-42e5-8806-bc40e567f208" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_5325cbf4-d9d9-4575-89e5-edc951e3a435" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_b134f341-804c-4ea3-89da-769a4904da08" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_5325cbf4-d9d9-4575-89e5-edc951e3a435" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_b134f341-804c-4ea3-89da-769a4904da08" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_17ffdf0f-8166-44f1-a6b7-f2afd99ad45b" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_5325cbf4-d9d9-4575-89e5-edc951e3a435" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_17ffdf0f-8166-44f1-a6b7-f2afd99ad45b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_3874d341-d692-42a6-aa6b-1a3ba548f10e" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_5325cbf4-d9d9-4575-89e5-edc951e3a435" xlink:to="loc_us-gaap_InventoryNet_3874d341-d692-42a6-aa6b-1a3ba548f10e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_447743a0-f1be-4ba4-b84e-b5b3ddb5d919" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_5325cbf4-d9d9-4575-89e5-edc951e3a435" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_447743a0-f1be-4ba4-b84e-b5b3ddb5d919" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_9458073e-8c27-4f74-a6a3-7cec21bb346e" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShortTermInvestments"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_5325cbf4-d9d9-4575-89e5-edc951e3a435" xlink:to="loc_us-gaap_ShortTermInvestments_9458073e-8c27-4f74-a6a3-7cec21bb346e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_7a1f8628-65c5-4dc4-9df3-21d0b17c4670" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_831d1d8d-b5ce-49cb-9218-f0f3ad1c5a18" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_7a1f8628-65c5-4dc4-9df3-21d0b17c4670" xlink:to="loc_us-gaap_AccountsPayableCurrent_831d1d8d-b5ce-49cb-9218-f0f3ad1c5a18" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_a38ffc25-d192-4afb-bc7b-4d98b346b6a6" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_7a1f8628-65c5-4dc4-9df3-21d0b17c4670" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_a38ffc25-d192-4afb-bc7b-4d98b346b6a6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_3d2a9c6e-19c0-4d6d-98da-196a6ada1f08" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_d3453f12-4a45-49b0-9ecd-163be0f1e2d6" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_3d2a9c6e-19c0-4d6d-98da-196a6ada1f08" xlink:to="loc_us-gaap_Liabilities_d3453f12-4a45-49b0-9ecd-163be0f1e2d6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_8840f274-2e1f-4ab2-8572-e191338d036b" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_3d2a9c6e-19c0-4d6d-98da-196a6ada1f08" xlink:to="loc_us-gaap_CommitmentsAndContingencies_8840f274-2e1f-4ab2-8572-e191338d036b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_11cd6f2c-467f-4587-967e-0cadcbfcc09e" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_3d2a9c6e-19c0-4d6d-98da-196a6ada1f08" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_11cd6f2c-467f-4587-967e-0cadcbfcc09e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_1a0c8bea-04fc-4a22-a44c-63d3b23b72cb" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_3d2a9c6e-19c0-4d6d-98da-196a6ada1f08" xlink:to="loc_us-gaap_StockholdersEquity_1a0c8bea-04fc-4a22-a44c-63d3b23b72cb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_70cf2f95-8026-4c19-9e0d-2312ff4c418f" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_2e905f9e-87b1-4873-bdff-1aea28440013" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_70cf2f95-8026-4c19-9e0d-2312ff4c418f" xlink:to="loc_us-gaap_CommonStockValue_2e905f9e-87b1-4873-bdff-1aea28440013" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_35d6330c-d74f-4cd7-a004-fed04cc05592" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_70cf2f95-8026-4c19-9e0d-2312ff4c418f" xlink:to="loc_us-gaap_AdditionalPaidInCapital_35d6330c-d74f-4cd7-a004-fed04cc05592" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_05b520ee-6998-4f33-b287-27bb10529613" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_70cf2f95-8026-4c19-9e0d-2312ff4c418f" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_05b520ee-6998-4f33-b287-27bb10529613" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_93e0b4bb-16de-4b49-a8cd-8ce2eeead2a8" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_70cf2f95-8026-4c19-9e0d-2312ff4c418f" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_93e0b4bb-16de-4b49-a8cd-8ce2eeead2a8" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="silk-20191231.xsd#ConsolidatedBalanceSheetsParenthetical"/>
  <link:calculationLink xlink:role="http://silkroadmed.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="extended"/>
  <link:roleRef roleURI="http://silkroadmed.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss" xlink:type="simple" xlink:href="silk-20191231.xsd#CondensedConsolidatedStatementsofOperationsandComprehensiveLoss"/>
  <link:calculationLink xlink:role="http://silkroadmed.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_9a144cee-cd27-4858-86ba-96d24c6f4bb1" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_b500dd7b-2110-4402-8811-321ca1c412ec" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_9a144cee-cd27-4858-86ba-96d24c6f4bb1" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_b500dd7b-2110-4402-8811-321ca1c412ec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_c1eed54d-4768-4f26-b0f0-630de503b4d4" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_9a144cee-cd27-4858-86ba-96d24c6f4bb1" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_c1eed54d-4768-4f26-b0f0-630de503b4d4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_e20e3168-5639-4c94-9e36-5314dc2a56bb" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_eeb2d119-09ab-41ad-ba7f-172fb569eba9" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GrossProfit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_e20e3168-5639-4c94-9e36-5314dc2a56bb" xlink:to="loc_us-gaap_GrossProfit_eeb2d119-09ab-41ad-ba7f-172fb569eba9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_dc8e5590-a2e9-47d2-9e77-623688e39d3a" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_e20e3168-5639-4c94-9e36-5314dc2a56bb" xlink:to="loc_us-gaap_OperatingExpenses_dc8e5590-a2e9-47d2-9e77-623688e39d3a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_9e47c302-fe6c-4511-b43a-14aec528e4c6" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_310e4f7e-78e5-4a2f-8e15-26b84ef178ae" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_9e47c302-fe6c-4511-b43a-14aec528e4c6" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_310e4f7e-78e5-4a2f-8e15-26b84ef178ae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_NetIncomeLossAndComprehensiveIncomeLossNetOfTaxAttributableToParent_e577d130-dc2d-4146-83cd-3fe91a8ec869" xlink:href="silk-20191231.xsd#silk_NetIncomeLossAndComprehensiveIncomeLossNetOfTaxAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_18218fb1-7c16-4789-a375-c7886c1e6d43" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_silk_NetIncomeLossAndComprehensiveIncomeLossNetOfTaxAttributableToParent_e577d130-dc2d-4146-83cd-3fe91a8ec869" xlink:to="loc_us-gaap_NetIncomeLoss_18218fb1-7c16-4789-a375-c7886c1e6d43" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_45d51e3c-ec44-4829-b815-de3179e2ef66" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_silk_NetIncomeLossAndComprehensiveIncomeLossNetOfTaxAttributableToParent_e577d130-dc2d-4146-83cd-3fe91a8ec869" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_45d51e3c-ec44-4829-b815-de3179e2ef66" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_65c7b8b7-5acc-473d-a7db-6462506d24e0" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_27630c75-584a-4219-af5a-4211a10abb98" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_65c7b8b7-5acc-473d-a7db-6462506d24e0" xlink:to="loc_us-gaap_OperatingIncomeLoss_27630c75-584a-4219-af5a-4211a10abb98" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_bc28d0b4-eb5d-4211-88dd-af3e1e9d21b1" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_65c7b8b7-5acc-473d-a7db-6462506d24e0" xlink:to="loc_us-gaap_InvestmentIncomeInterest_bc28d0b4-eb5d-4211-88dd-af3e1e9d21b1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_d87ef4b7-e8da-4f6a-bf90-6baf692c684e" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_65c7b8b7-5acc-473d-a7db-6462506d24e0" xlink:to="loc_us-gaap_InterestExpense_d87ef4b7-e8da-4f6a-bf90-6baf692c684e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_ce75f882-245e-4f3b-903b-c997bb608fe6" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_65c7b8b7-5acc-473d-a7db-6462506d24e0" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_ce75f882-245e-4f3b-903b-c997bb608fe6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_c339d174-ce27-471a-b1bf-94cb8ce1b670" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_17d3f5b8-7941-416b-9637-67c2000225c2" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_c339d174-ce27-471a-b1bf-94cb8ce1b670" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_17d3f5b8-7941-416b-9637-67c2000225c2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_f2a1b702-b639-42ce-bd72-3afc59d23327" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_c339d174-ce27-471a-b1bf-94cb8ce1b670" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_f2a1b702-b639-42ce-bd72-3afc59d23327" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_10d712d9-54f7-4f0e-a461-db47a4c516e7" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_70a2dac1-e980-43e4-89be-1cc2a7b909c2" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_10d712d9-54f7-4f0e-a461-db47a4c516e7" xlink:to="loc_us-gaap_ProfitLoss_70a2dac1-e980-43e4-89be-1cc2a7b909c2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_3f623850-a7fe-4d57-92b2-acd6b19dd1df" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_10d712d9-54f7-4f0e-a461-db47a4c516e7" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_3f623850-a7fe-4d57-92b2-acd6b19dd1df" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit" xlink:type="simple" xlink:href="silk-20191231.xsd#CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit"/>
  <link:calculationLink xlink:role="http://silkroadmed.com/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit" xlink:type="extended"/>
  <link:roleRef roleURI="http://silkroadmed.com/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficitParenthetical" xlink:type="simple" xlink:href="silk-20191231.xsd#CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficitParenthetical"/>
  <link:calculationLink xlink:role="http://silkroadmed.com/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficitParenthetical" xlink:type="extended"/>
  <link:roleRef roleURI="http://silkroadmed.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="silk-20191231.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:calculationLink xlink:role="http://silkroadmed.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_af9c8cb8-7b4e-4967-aa13-c2a34b910556" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_9234fc60-187c-45ea-b5ea-dc3094d1754a" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_af9c8cb8-7b4e-4967-aa13-c2a34b910556" xlink:to="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_9234fc60-187c-45ea-b5ea-dc3094d1754a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_a4bbc300-bee8-4e1d-bc90-b8bf0668a170" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_af9c8cb8-7b4e-4967-aa13-c2a34b910556" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_a4bbc300-bee8-4e1d-bc90-b8bf0668a170" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_a64769fa-1592-4588-80d6-b36c46737ac6" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_af9c8cb8-7b4e-4967-aa13-c2a34b910556" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_a64769fa-1592-4588-80d6-b36c46737ac6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromWarrantExercises_c1c228ba-fbfc-4c4b-86b8-7f294f40013f" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromWarrantExercises"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_af9c8cb8-7b4e-4967-aa13-c2a34b910556" xlink:to="loc_us-gaap_ProceedsFromWarrantExercises_c1c228ba-fbfc-4c4b-86b8-7f294f40013f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMinorityShareholders_47fc6c6a-4977-4e4b-83bc-4dc7b5c863e9" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromMinorityShareholders"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_af9c8cb8-7b4e-4967-aa13-c2a34b910556" xlink:to="loc_us-gaap_ProceedsFromMinorityShareholders_47fc6c6a-4977-4e4b-83bc-4dc7b5c863e9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_68a8a3ae-91f1-47fe-a203-054372eda713" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_d9c7c458-6b3b-4838-8517-3394b7df97bb" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_68a8a3ae-91f1-47fe-a203-054372eda713" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_d9c7c458-6b3b-4838-8517-3394b7df97bb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_a442b81f-5dea-4b17-a93c-f6fe27dd9b83" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_68a8a3ae-91f1-47fe-a203-054372eda713" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_a442b81f-5dea-4b17-a93c-f6fe27dd9b83" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments_e13cf671-c7ab-4d83-956f-5186f74c9ec7" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_68a8a3ae-91f1-47fe-a203-054372eda713" xlink:to="loc_us-gaap_PaymentsToAcquireInvestments_e13cf671-c7ab-4d83-956f-5186f74c9ec7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ee8d8345-f857-43a8-a5d5-80d9e4589dfd" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_764e921c-5569-49ee-80ec-fcfb4fe9e255" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ee8d8345-f857-43a8-a5d5-80d9e4589dfd" xlink:to="loc_us-gaap_ProfitLoss_764e921c-5569-49ee-80ec-fcfb4fe9e255" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_75213bdc-c30f-4c1c-aa39-439049fd0688" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ee8d8345-f857-43a8-a5d5-80d9e4589dfd" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_75213bdc-c30f-4c1c-aa39-439049fd0688" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_628e78b5-bbe1-44b2-a690-77b510402595" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ee8d8345-f857-43a8-a5d5-80d9e4589dfd" xlink:to="loc_us-gaap_ShareBasedCompensation_628e78b5-bbe1-44b2-a690-77b510402595" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants_d80ca948-3945-4d5f-a0e7-d4b5aac6bcda" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ee8d8345-f857-43a8-a5d5-80d9e4589dfd" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants_d80ca948-3945-4d5f-a0e7-d4b5aac6bcda" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_45557715-e3b2-4009-aa02-1732f13560bf" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ee8d8345-f857-43a8-a5d5-80d9e4589dfd" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_45557715-e3b2-4009-aa02-1732f13560bf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_OperatingLeaseRightOfUseAssetAmortization_3df2e11b-653d-4018-86cb-edfd9c729914" xlink:href="silk-20191231.xsd#silk_OperatingLeaseRightOfUseAssetAmortization"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ee8d8345-f857-43a8-a5d5-80d9e4589dfd" xlink:to="loc_silk_OperatingLeaseRightOfUseAssetAmortization_3df2e11b-653d-4018-86cb-edfd9c729914" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaidInKindInterest_399d3462-f7ff-42fd-9936-27054704e734" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaidInKindInterest"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ee8d8345-f857-43a8-a5d5-80d9e4589dfd" xlink:to="loc_us-gaap_PaidInKindInterest_399d3462-f7ff-42fd-9936-27054704e734" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_c821f2b3-e84d-4356-8724-1bca41e95461" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ee8d8345-f857-43a8-a5d5-80d9e4589dfd" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_c821f2b3-e84d-4356-8724-1bca41e95461" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWriteDown_9106c4f9-b721-4874-9353-a489d495aaa7" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InventoryWriteDown"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ee8d8345-f857-43a8-a5d5-80d9e4589dfd" xlink:to="loc_us-gaap_InventoryWriteDown_9106c4f9-b721-4874-9353-a489d495aaa7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_55a6e3de-fefa-4a62-9c9f-17fc0c9e85f0" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ee8d8345-f857-43a8-a5d5-80d9e4589dfd" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_55a6e3de-fefa-4a62-9c9f-17fc0c9e85f0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_aced2e64-c517-4129-9fdb-c6c203a13417" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ee8d8345-f857-43a8-a5d5-80d9e4589dfd" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_aced2e64-c517-4129-9fdb-c6c203a13417" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1ab86b34-f401-490d-82aa-78d5882d0671" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ee8d8345-f857-43a8-a5d5-80d9e4589dfd" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1ab86b34-f401-490d-82aa-78d5882d0671" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_43418ecc-7a74-4267-ba75-21216d375cc5" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:calculationArc order="13" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ee8d8345-f857-43a8-a5d5-80d9e4589dfd" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_43418ecc-7a74-4267-ba75-21216d375cc5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_d3257655-516a-433f-9d7a-c5de72324d6c" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ee8d8345-f857-43a8-a5d5-80d9e4589dfd" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_d3257655-516a-433f-9d7a-c5de72324d6c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_3a12fa22-9bfe-49d5-9285-1322dac2d3b7" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:calculationArc order="15" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ee8d8345-f857-43a8-a5d5-80d9e4589dfd" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_3a12fa22-9bfe-49d5-9285-1322dac2d3b7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_544ac4f2-c410-4c1a-ba91-0902cf0f1952" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:calculationArc order="16" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ee8d8345-f857-43a8-a5d5-80d9e4589dfd" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_544ac4f2-c410-4c1a-ba91-0902cf0f1952" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_5f4e6aea-160e-4fa1-ae73-656e5a97a1fb" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:calculationArc order="17" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ee8d8345-f857-43a8-a5d5-80d9e4589dfd" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_5f4e6aea-160e-4fa1-ae73-656e5a97a1fb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_aafd0867-1f3a-4cb5-9868-2407248ed51a" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:calculationArc order="18" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ee8d8345-f857-43a8-a5d5-80d9e4589dfd" xlink:to="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_aafd0867-1f3a-4cb5-9868-2407248ed51a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_23e7140d-7441-4c13-8cac-613be1da5390" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_41a20d97-596f-4956-ad22-47600429f549" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_23e7140d-7441-4c13-8cac-613be1da5390" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_41a20d97-596f-4956-ad22-47600429f549" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_10f4e131-e20f-45a2-872f-bc593757ee21" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_23e7140d-7441-4c13-8cac-613be1da5390" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_10f4e131-e20f-45a2-872f-bc593757ee21" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_6d6d1d8b-90bb-48fc-8cf2-35f89eff0dc7" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_23e7140d-7441-4c13-8cac-613be1da5390" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_6d6d1d8b-90bb-48fc-8cf2-35f89eff0dc7" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/FormationandBusinessoftheCompany" xlink:type="simple" xlink:href="silk-20191231.xsd#FormationandBusinessoftheCompany"/>
  <link:calculationLink xlink:role="http://silkroadmed.com/role/FormationandBusinessoftheCompany" xlink:type="extended"/>
  <link:roleRef roleURI="http://silkroadmed.com/role/FormationandBusinessoftheCompanyDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#FormationandBusinessoftheCompanyDetails"/>
  <link:calculationLink xlink:role="http://silkroadmed.com/role/FormationandBusinessoftheCompanyDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://silkroadmed.com/role/SummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="silk-20191231.xsd#SummaryofSignificantAccountingPolicies"/>
  <link:calculationLink xlink:role="http://silkroadmed.com/role/SummaryofSignificantAccountingPolicies" xlink:type="extended"/>
  <link:roleRef roleURI="http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="silk-20191231.xsd#SummaryofSignificantAccountingPoliciesPolicies"/>
  <link:calculationLink xlink:role="http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended"/>
  <link:roleRef roleURI="http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="silk-20191231.xsd#SummaryofSignificantAccountingPoliciesTables"/>
  <link:calculationLink xlink:role="http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesAdjustmenttoPriorPeriodFinancialStatementsDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#SummaryofSignificantAccountingPoliciesAdjustmenttoPriorPeriodFinancialStatementsDetails"/>
  <link:calculationLink xlink:role="http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesAdjustmenttoPriorPeriodFinancialStatementsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesCashCashEquivalentsandRestrictedCashDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#SummaryofSignificantAccountingPoliciesCashCashEquivalentsandRestrictedCashDetails"/>
  <link:calculationLink xlink:role="http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesCashCashEquivalentsandRestrictedCashDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_d4848965-6719-4101-b309-d3c40d447a9f" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_81dbb92e-7671-43a6-a425-eccc98efbf32" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_d4848965-6719-4101-b309-d3c40d447a9f" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_81dbb92e-7671-43a6-a425-eccc98efbf32" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_f89d2345-b7a6-4df2-ae46-f0e77041717f" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_d4848965-6719-4101-b309-d3c40d447a9f" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_f89d2345-b7a6-4df2-ae46-f0e77041717f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails"/>
  <link:calculationLink xlink:role="http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesDeferredInitialPublicOfferingCostsDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#SummaryofSignificantAccountingPoliciesDeferredInitialPublicOfferingCostsDetails"/>
  <link:calculationLink xlink:role="http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesDeferredInitialPublicOfferingCostsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesLeasesDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#SummaryofSignificantAccountingPoliciesLeasesDetails"/>
  <link:calculationLink xlink:role="http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesLeasesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesASC842ImpactonCondensedConsolidatedBalanceSheetDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#SummaryofSignificantAccountingPoliciesASC842ImpactonCondensedConsolidatedBalanceSheetDetails"/>
  <link:calculationLink xlink:role="http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesASC842ImpactonCondensedConsolidatedBalanceSheetDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesRedeemableConvertiblePreferredStockDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#SummaryofSignificantAccountingPoliciesRedeemableConvertiblePreferredStockDetails"/>
  <link:calculationLink xlink:role="http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesRedeemableConvertiblePreferredStockDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesRevenueRecognitionDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#SummaryofSignificantAccountingPoliciesRevenueRecognitionDetails"/>
  <link:calculationLink xlink:role="http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesRevenueRecognitionDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesAdvertisingCostsDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#SummaryofSignificantAccountingPoliciesAdvertisingCostsDetails"/>
  <link:calculationLink xlink:role="http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesAdvertisingCostsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesStockBasedCompensationDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#SummaryofSignificantAccountingPoliciesStockBasedCompensationDetails"/>
  <link:calculationLink xlink:role="http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesStockBasedCompensationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesScheduleofEarningsPerShareDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#SummaryofSignificantAccountingPoliciesScheduleofEarningsPerShareDetails"/>
  <link:calculationLink xlink:role="http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesScheduleofEarningsPerShareDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesScheduleofPotentiallyDilutiveSecuritiesNotIncludedinCalculationofEarningsperShareDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#SummaryofSignificantAccountingPoliciesScheduleofPotentiallyDilutiveSecuritiesNotIncludedinCalculationofEarningsperShareDetails"/>
  <link:calculationLink xlink:role="http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesScheduleofPotentiallyDilutiveSecuritiesNotIncludedinCalculationofEarningsperShareDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesSegmentandGeographicalInformationDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#SummaryofSignificantAccountingPoliciesSegmentandGeographicalInformationDetails"/>
  <link:calculationLink xlink:role="http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesSegmentandGeographicalInformationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://silkroadmed.com/role/RecentAccountingPronouncements" xlink:type="simple" xlink:href="silk-20191231.xsd#RecentAccountingPronouncements"/>
  <link:calculationLink xlink:role="http://silkroadmed.com/role/RecentAccountingPronouncements" xlink:type="extended"/>
  <link:roleRef roleURI="http://silkroadmed.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="silk-20191231.xsd#FairValueMeasurements"/>
  <link:calculationLink xlink:role="http://silkroadmed.com/role/FairValueMeasurements" xlink:type="extended"/>
  <link:roleRef roleURI="http://silkroadmed.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="silk-20191231.xsd#FairValueMeasurementsTables"/>
  <link:calculationLink xlink:role="http://silkroadmed.com/role/FairValueMeasurementsTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://silkroadmed.com/role/FairValueMeasurementsRecurringAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#FairValueMeasurementsRecurringAssetsandLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://silkroadmed.com/role/FairValueMeasurementsRecurringAssetsandLiabilitiesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://silkroadmed.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#FairValueMeasurementsNarrativeDetails"/>
  <link:calculationLink xlink:role="http://silkroadmed.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://silkroadmed.com/role/FairValueMeasurementsFairValueAssumptionsDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#FairValueMeasurementsFairValueAssumptionsDetails"/>
  <link:calculationLink xlink:role="http://silkroadmed.com/role/FairValueMeasurementsFairValueAssumptionsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://silkroadmed.com/role/FairValueMeasurementsChangesinRedeemableConvertibleWarrantLiabilityDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#FairValueMeasurementsChangesinRedeemableConvertibleWarrantLiabilityDetails"/>
  <link:calculationLink xlink:role="http://silkroadmed.com/role/FairValueMeasurementsChangesinRedeemableConvertibleWarrantLiabilityDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://silkroadmed.com/role/BalanceSheetComponents" xlink:type="simple" xlink:href="silk-20191231.xsd#BalanceSheetComponents"/>
  <link:calculationLink xlink:role="http://silkroadmed.com/role/BalanceSheetComponents" xlink:type="extended"/>
  <link:roleRef roleURI="http://silkroadmed.com/role/BalanceSheetComponentsTables" xlink:type="simple" xlink:href="silk-20191231.xsd#BalanceSheetComponentsTables"/>
  <link:calculationLink xlink:role="http://silkroadmed.com/role/BalanceSheetComponentsTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://silkroadmed.com/role/BalanceSheetComponentsFairValueofAvailableForSaleInvestmentsDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#BalanceSheetComponentsFairValueofAvailableForSaleInvestmentsDetails"/>
  <link:calculationLink xlink:role="http://silkroadmed.com/role/BalanceSheetComponentsFairValueofAvailableForSaleInvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_4c1f6721-eeb1-4857-98da-9653e3d44f45" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_132985f7-ea43-4fbe-9558-8fe48c545c97" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_4c1f6721-eeb1-4857-98da-9653e3d44f45" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_132985f7-ea43-4fbe-9558-8fe48c545c97" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_00510e31-ed5e-4732-87c6-307df2518ad7" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_4c1f6721-eeb1-4857-98da-9653e3d44f45" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_00510e31-ed5e-4732-87c6-307df2518ad7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_e28f761b-993f-47d3-ab65-bb1ae68d913c" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_4c1f6721-eeb1-4857-98da-9653e3d44f45" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_e28f761b-993f-47d3-ab65-bb1ae68d913c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/BalanceSheetComponentsFairValueofCashEquivalentsShortTermandLongTermInvestmentsDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#BalanceSheetComponentsFairValueofCashEquivalentsShortTermandLongTermInvestmentsDetails"/>
  <link:calculationLink xlink:role="http://silkroadmed.com/role/BalanceSheetComponentsFairValueofCashEquivalentsShortTermandLongTermInvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_454563db-2e9a-4629-b497-d6b186587dec" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_CashAndCashEquivalentsFairValueDisclosureMaturingAfterOneYearThroughTwoYears_bc2ef2d5-3f01-4e60-b638-b5b098d66ee9" xlink:href="silk-20191231.xsd#silk_CashAndCashEquivalentsFairValueDisclosureMaturingAfterOneYearThroughTwoYears"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_454563db-2e9a-4629-b497-d6b186587dec" xlink:to="loc_silk_CashAndCashEquivalentsFairValueDisclosureMaturingAfterOneYearThroughTwoYears_bc2ef2d5-3f01-4e60-b638-b5b098d66ee9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_CashAndCashEquivalentsFairValueDisclosureMaturingWithinOneYear_349f0f67-839a-48cb-a39f-77411e6f439f" xlink:href="silk-20191231.xsd#silk_CashAndCashEquivalentsFairValueDisclosureMaturingWithinOneYear"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_454563db-2e9a-4629-b497-d6b186587dec" xlink:to="loc_silk_CashAndCashEquivalentsFairValueDisclosureMaturingWithinOneYear_349f0f67-839a-48cb-a39f-77411e6f439f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/BalanceSheetComponentsAvailableforSaleInvestmentsinUnrealizedLossPositionDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#BalanceSheetComponentsAvailableforSaleInvestmentsinUnrealizedLossPositionDetails"/>
  <link:calculationLink xlink:role="http://silkroadmed.com/role/BalanceSheetComponentsAvailableforSaleInvestmentsinUnrealizedLossPositionDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://silkroadmed.com/role/BalanceSheetComponentsScheduleofInventoryDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#BalanceSheetComponentsScheduleofInventoryDetails"/>
  <link:calculationLink xlink:role="http://silkroadmed.com/role/BalanceSheetComponentsScheduleofInventoryDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_8f1e9c91-a9cb-475f-a6c5-ff6394726c84" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_6a6275a1-4862-4567-9300-451b6dc2fcfd" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_8f1e9c91-a9cb-475f-a6c5-ff6394726c84" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_6a6275a1-4862-4567-9300-451b6dc2fcfd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_67a9ff3e-7aee-4170-9f7b-c1c346227ab6" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_8f1e9c91-a9cb-475f-a6c5-ff6394726c84" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_67a9ff3e-7aee-4170-9f7b-c1c346227ab6" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/BalanceSheetComponentsNarrativeDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#BalanceSheetComponentsNarrativeDetails"/>
  <link:calculationLink xlink:role="http://silkroadmed.com/role/BalanceSheetComponentsNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://silkroadmed.com/role/BalanceSheetComponentsPropertyPlantandEquipmentDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#BalanceSheetComponentsPropertyPlantandEquipmentDetails"/>
  <link:calculationLink xlink:role="http://silkroadmed.com/role/BalanceSheetComponentsPropertyPlantandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_da9e4560-ba3f-46b6-9d26-0a1820eea8ef" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_46ad6e23-9606-467f-9b98-bd436a3a77fa" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_da9e4560-ba3f-46b6-9d26-0a1820eea8ef" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_46ad6e23-9606-467f-9b98-bd436a3a77fa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_875ad436-8123-4322-a09c-f8b57ba308d2" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_da9e4560-ba3f-46b6-9d26-0a1820eea8ef" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_875ad436-8123-4322-a09c-f8b57ba308d2" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/BalanceSheetComponentsAccruedLiabilitiesDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#BalanceSheetComponentsAccruedLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://silkroadmed.com/role/BalanceSheetComponentsAccruedLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_e1991632-29d6-4774-9e56-f7450853dfa9" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedSalariesCurrent_01d08b31-40a2-42cf-9724-46b5d8e77987" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccruedSalariesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_e1991632-29d6-4774-9e56-f7450853dfa9" xlink:to="loc_us-gaap_AccruedSalariesCurrent_01d08b31-40a2-42cf-9724-46b5d8e77987" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_ed11c9b4-f708-4a91-bc6f-e94ee09ee54b" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_e1991632-29d6-4774-9e56-f7450853dfa9" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_ed11c9b4-f708-4a91-bc6f-e94ee09ee54b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedRoyaltiesCurrent_d3aa8be9-c2cb-4160-b0bf-6e75629a5472" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccruedRoyaltiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_e1991632-29d6-4774-9e56-f7450853dfa9" xlink:to="loc_us-gaap_AccruedRoyaltiesCurrent_d3aa8be9-c2cb-4160-b0bf-6e75629a5472" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_AccruedTravelExpensesCurrent_d78045c9-1786-470e-a77b-d1212acdc687" xlink:href="silk-20191231.xsd#silk_AccruedTravelExpensesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_e1991632-29d6-4774-9e56-f7450853dfa9" xlink:to="loc_silk_AccruedTravelExpensesCurrent_d78045c9-1786-470e-a77b-d1212acdc687" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_AccruedClinicalExpensesCurrent_0a51dc78-046d-40f3-b146-62fe270d967d" xlink:href="silk-20191231.xsd#silk_AccruedClinicalExpensesCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_e1991632-29d6-4774-9e56-f7450853dfa9" xlink:to="loc_silk_AccruedClinicalExpensesCurrent_0a51dc78-046d-40f3-b146-62fe270d967d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_7c026ade-0daf-4b50-9129-741a27a25a6e" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_e1991632-29d6-4774-9e56-f7450853dfa9" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_7c026ade-0daf-4b50-9129-741a27a25a6e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_5f8e7836-78a0-445a-8514-1546383e5b86" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_e1991632-29d6-4774-9e56-f7450853dfa9" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_5f8e7836-78a0-445a-8514-1546383e5b86" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_fcddf0a2-9752-4173-96f3-00c20b260fe5" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_e1991632-29d6-4774-9e56-f7450853dfa9" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_fcddf0a2-9752-4173-96f3-00c20b260fe5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_ProvisionsForSalesReturns_ae9399bd-7f92-435e-8a92-fa276c2a25f3" xlink:href="silk-20191231.xsd#silk_ProvisionsForSalesReturns"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_e1991632-29d6-4774-9e56-f7450853dfa9" xlink:to="loc_silk_ProvisionsForSalesReturns_ae9399bd-7f92-435e-8a92-fa276c2a25f3" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/LongtermDebt" xlink:type="simple" xlink:href="silk-20191231.xsd#LongtermDebt"/>
  <link:calculationLink xlink:role="http://silkroadmed.com/role/LongtermDebt" xlink:type="extended"/>
  <link:roleRef roleURI="http://silkroadmed.com/role/LongtermDebtTables" xlink:type="simple" xlink:href="silk-20191231.xsd#LongtermDebtTables"/>
  <link:calculationLink xlink:role="http://silkroadmed.com/role/LongtermDebtTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://silkroadmed.com/role/LongtermDebtTermLoanNarrativeDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#LongtermDebtTermLoanNarrativeDetails"/>
  <link:calculationLink xlink:role="http://silkroadmed.com/role/LongtermDebtTermLoanNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://silkroadmed.com/role/LongtermDebtFutureMaturitiesUndertheTermLoanDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#LongtermDebtFutureMaturitiesUndertheTermLoanDetails"/>
  <link:calculationLink xlink:role="http://silkroadmed.com/role/LongtermDebtFutureMaturitiesUndertheTermLoanDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_cf706760-6f09-4f32-b1f8-ad9dfc523017" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_d7a3aa78-deeb-48cc-b176-07b3aa3965f5" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_cf706760-6f09-4f32-b1f8-ad9dfc523017" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_d7a3aa78-deeb-48cc-b176-07b3aa3965f5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_LongTermDebtUnpaidInterest_3ab76931-0dec-4dbe-9606-c3cf569c1202" xlink:href="silk-20191231.xsd#silk_LongTermDebtUnpaidInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_cf706760-6f09-4f32-b1f8-ad9dfc523017" xlink:to="loc_silk_LongTermDebtUnpaidInterest_3ab76931-0dec-4dbe-9606-c3cf569c1202" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_08dae5a5-010f-4f90-af36-c88befd1f7a2" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_cf706760-6f09-4f32-b1f8-ad9dfc523017" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_08dae5a5-010f-4f90-af36-c88befd1f7a2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_dc8d50af-a707-4b79-9ef8-0f0d77eac8a3" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_LongTermDebtGrossBeforeAccretionOfClosingFees_d7db2d56-efaf-47bd-8e21-e2546ebcbcd0" xlink:href="silk-20191231.xsd#silk_LongTermDebtGrossBeforeAccretionOfClosingFees"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_dc8d50af-a707-4b79-9ef8-0f0d77eac8a3" xlink:to="loc_silk_LongTermDebtGrossBeforeAccretionOfClosingFees_d7db2d56-efaf-47bd-8e21-e2546ebcbcd0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_LongTermDebtAccretionOfClosingFees_4c590e60-ff2b-4599-bf4c-e01f917e6e9e" xlink:href="silk-20191231.xsd#silk_LongTermDebtAccretionOfClosingFees"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_dc8d50af-a707-4b79-9ef8-0f0d77eac8a3" xlink:to="loc_silk_LongTermDebtAccretionOfClosingFees_4c590e60-ff2b-4599-bf4c-e01f917e6e9e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_LongTermDebtGrossBeforeAccretionOfClosingFees_972b9976-ce2f-44f7-8445-530d8ff5ab86" xlink:href="silk-20191231.xsd#silk_LongTermDebtGrossBeforeAccretionOfClosingFees"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_f63966df-467d-4e30-a678-e85de8151925" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_silk_LongTermDebtGrossBeforeAccretionOfClosingFees_972b9976-ce2f-44f7-8445-530d8ff5ab86" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_f63966df-467d-4e30-a678-e85de8151925" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_4245f74e-deba-4397-800d-ad58adcf744d" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_silk_LongTermDebtGrossBeforeAccretionOfClosingFees_972b9976-ce2f-44f7-8445-530d8ff5ab86" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_4245f74e-deba-4397-800d-ad58adcf744d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_8853ee67-6405-4e2f-b200-10b303cc803d" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_silk_LongTermDebtGrossBeforeAccretionOfClosingFees_972b9976-ce2f-44f7-8445-530d8ff5ab86" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_8853ee67-6405-4e2f-b200-10b303cc803d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/LongtermDebtSeriesCNarrativeDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#LongtermDebtSeriesCNarrativeDetails"/>
  <link:calculationLink xlink:role="http://silkroadmed.com/role/LongtermDebtSeriesCNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://silkroadmed.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="silk-20191231.xsd#CommitmentsandContingencies"/>
  <link:calculationLink xlink:role="http://silkroadmed.com/role/CommitmentsandContingencies" xlink:type="extended"/>
  <link:roleRef roleURI="http://silkroadmed.com/role/CommitmentsandContingenciesTables" xlink:type="simple" xlink:href="silk-20191231.xsd#CommitmentsandContingenciesTables"/>
  <link:calculationLink xlink:role="http://silkroadmed.com/role/CommitmentsandContingenciesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://silkroadmed.com/role/CommitmentsandContingenciesLeaseNarrativeDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#CommitmentsandContingenciesLeaseNarrativeDetails"/>
  <link:calculationLink xlink:role="http://silkroadmed.com/role/CommitmentsandContingenciesLeaseNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://silkroadmed.com/role/CommitmentsandContingenciesBalanceSheetInformationDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#CommitmentsandContingenciesBalanceSheetInformationDetails"/>
  <link:calculationLink xlink:role="http://silkroadmed.com/role/CommitmentsandContingenciesBalanceSheetInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_7c034c36-1fbf-498d-acf2-0363ed290e6c" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_c076e1ce-79d5-40b3-89f2-b27604c1f621" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_7c034c36-1fbf-498d-acf2-0363ed290e6c" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_c076e1ce-79d5-40b3-89f2-b27604c1f621" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_270c0e9e-1db8-4557-bd59-8cac3ce0d0ca" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_7c034c36-1fbf-498d-acf2-0363ed290e6c" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_270c0e9e-1db8-4557-bd59-8cac3ce0d0ca" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/CommitmentsandContingenciesOperatingLeaseMaturitiesDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#CommitmentsandContingenciesOperatingLeaseMaturitiesDetails"/>
  <link:calculationLink xlink:role="http://silkroadmed.com/role/CommitmentsandContingenciesOperatingLeaseMaturitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_8421a10b-75e5-451d-b2ef-3769719a5338" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_fb3266ac-7b33-4bfd-9319-58954ccba54b" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_8421a10b-75e5-451d-b2ef-3769719a5338" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_fb3266ac-7b33-4bfd-9319-58954ccba54b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_4a282bc1-1c05-4d41-90c6-e4e334cedcd9" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_8421a10b-75e5-451d-b2ef-3769719a5338" xlink:to="loc_us-gaap_OperatingLeaseLiability_4a282bc1-1c05-4d41-90c6-e4e334cedcd9" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/CommitmentsandContingenciesOperatingLeaseMaturitiesDetails_1" xlink:type="simple" xlink:href="silk-20191231.xsd#CommitmentsandContingenciesOperatingLeaseMaturitiesDetails_1"/>
  <link:calculationLink xlink:role="http://silkroadmed.com/role/CommitmentsandContingenciesOperatingLeaseMaturitiesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_707093e0-0e4a-4d65-8be4-7593bbb53dee" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_cae87d10-53cb-4f27-adbe-28a4ce4c0827" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_707093e0-0e4a-4d65-8be4-7593bbb53dee" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_cae87d10-53cb-4f27-adbe-28a4ce4c0827" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_ec2dd59c-52b4-43a3-afb8-6cd9c562c9e5" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_707093e0-0e4a-4d65-8be4-7593bbb53dee" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_ec2dd59c-52b4-43a3-afb8-6cd9c562c9e5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_17f36bff-c259-4072-a9ae-4129c4b8d695" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_707093e0-0e4a-4d65-8be4-7593bbb53dee" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_17f36bff-c259-4072-a9ae-4129c4b8d695" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_2e67c30c-69a5-4333-ab40-b3c79f316a29" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_707093e0-0e4a-4d65-8be4-7593bbb53dee" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_2e67c30c-69a5-4333-ab40-b3c79f316a29" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_8a6f1422-c57f-4311-8910-f5854f6e7393" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_707093e0-0e4a-4d65-8be4-7593bbb53dee" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_8a6f1422-c57f-4311-8910-f5854f6e7393" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/CommitmentsandContingenciesTopic840AggregateFutureMinimumLeasePaymentsDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#CommitmentsandContingenciesTopic840AggregateFutureMinimumLeasePaymentsDetails"/>
  <link:calculationLink xlink:role="http://silkroadmed.com/role/CommitmentsandContingenciesTopic840AggregateFutureMinimumLeasePaymentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_9b748f8b-b4ab-4ef2-8186-f7fae4d0546d" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_129ee29c-e4e6-4f13-aa17-14f3495e4ad9" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_9b748f8b-b4ab-4ef2-8186-f7fae4d0546d" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_129ee29c-e4e6-4f13-aa17-14f3495e4ad9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_b64eaff4-480d-47d1-8579-8ddb830af5d6" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_9b748f8b-b4ab-4ef2-8186-f7fae4d0546d" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_b64eaff4-480d-47d1-8579-8ddb830af5d6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_62dd596a-115c-46fd-83b8-87cb43a61b61" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_9b748f8b-b4ab-4ef2-8186-f7fae4d0546d" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_62dd596a-115c-46fd-83b8-87cb43a61b61" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_39136efe-67a8-43bf-a191-202a35dbe976" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_9b748f8b-b4ab-4ef2-8186-f7fae4d0546d" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_39136efe-67a8-43bf-a191-202a35dbe976" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_67956230-6c38-4eed-b5b1-f7ef72be315b" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_9b748f8b-b4ab-4ef2-8186-f7fae4d0546d" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_67956230-6c38-4eed-b5b1-f7ef72be315b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/CommitmentsandContingenciesPurchaseObligationNarrativeDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#CommitmentsandContingenciesPurchaseObligationNarrativeDetails"/>
  <link:calculationLink xlink:role="http://silkroadmed.com/role/CommitmentsandContingenciesPurchaseObligationNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://silkroadmed.com/role/RedeemableConvertiblePreferredStock" xlink:type="simple" xlink:href="silk-20191231.xsd#RedeemableConvertiblePreferredStock"/>
  <link:calculationLink xlink:role="http://silkroadmed.com/role/RedeemableConvertiblePreferredStock" xlink:type="extended"/>
  <link:roleRef roleURI="http://silkroadmed.com/role/RedeemableConvertiblePreferredStockTables" xlink:type="simple" xlink:href="silk-20191231.xsd#RedeemableConvertiblePreferredStockTables"/>
  <link:calculationLink xlink:role="http://silkroadmed.com/role/RedeemableConvertiblePreferredStockTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://silkroadmed.com/role/RedeemableConvertiblePreferredStockScheduleofRedeemableConvertiblePreferredStockDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#RedeemableConvertiblePreferredStockScheduleofRedeemableConvertiblePreferredStockDetails"/>
  <link:calculationLink xlink:role="http://silkroadmed.com/role/RedeemableConvertiblePreferredStockScheduleofRedeemableConvertiblePreferredStockDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://silkroadmed.com/role/RedeemableConvertiblePreferredStockNarrativeDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#RedeemableConvertiblePreferredStockNarrativeDetails"/>
  <link:calculationLink xlink:role="http://silkroadmed.com/role/RedeemableConvertiblePreferredStockNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://silkroadmed.com/role/StockholdersEquityDeficit" xlink:type="simple" xlink:href="silk-20191231.xsd#StockholdersEquityDeficit"/>
  <link:calculationLink xlink:role="http://silkroadmed.com/role/StockholdersEquityDeficit" xlink:type="extended"/>
  <link:roleRef roleURI="http://silkroadmed.com/role/StockholdersEquityDeficitTables" xlink:type="simple" xlink:href="silk-20191231.xsd#StockholdersEquityDeficitTables"/>
  <link:calculationLink xlink:role="http://silkroadmed.com/role/StockholdersEquityDeficitTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://silkroadmed.com/role/StockholdersEquityDeficitNarrativeDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#StockholdersEquityDeficitNarrativeDetails"/>
  <link:calculationLink xlink:role="http://silkroadmed.com/role/StockholdersEquityDeficitNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://silkroadmed.com/role/StockholdersEquityDeficitSharesReservedforFutureIssuanceDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#StockholdersEquityDeficitSharesReservedforFutureIssuanceDetails"/>
  <link:calculationLink xlink:role="http://silkroadmed.com/role/StockholdersEquityDeficitSharesReservedforFutureIssuanceDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://silkroadmed.com/role/StockOptionPlans" xlink:type="simple" xlink:href="silk-20191231.xsd#StockOptionPlans"/>
  <link:calculationLink xlink:role="http://silkroadmed.com/role/StockOptionPlans" xlink:type="extended"/>
  <link:roleRef roleURI="http://silkroadmed.com/role/StockOptionPlansTables" xlink:type="simple" xlink:href="silk-20191231.xsd#StockOptionPlansTables"/>
  <link:calculationLink xlink:role="http://silkroadmed.com/role/StockOptionPlansTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://silkroadmed.com/role/StockOptionPlansNarrativeDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#StockOptionPlansNarrativeDetails"/>
  <link:calculationLink xlink:role="http://silkroadmed.com/role/StockOptionPlansNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://silkroadmed.com/role/StockOptionPlansActivityUnderCompensationPlanDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#StockOptionPlansActivityUnderCompensationPlanDetails"/>
  <link:calculationLink xlink:role="http://silkroadmed.com/role/StockOptionPlansActivityUnderCompensationPlanDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://silkroadmed.com/role/StockOptionPlansInformationbyExercisePriceDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#StockOptionPlansInformationbyExercisePriceDetails"/>
  <link:calculationLink xlink:role="http://silkroadmed.com/role/StockOptionPlansInformationbyExercisePriceDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://silkroadmed.com/role/StockOptionPlansStockOptionAssumptionsDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#StockOptionPlansStockOptionAssumptionsDetails"/>
  <link:calculationLink xlink:role="http://silkroadmed.com/role/StockOptionPlansStockOptionAssumptionsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://silkroadmed.com/role/StockOptionPlansStockbasedCompensationDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#StockOptionPlansStockbasedCompensationDetails"/>
  <link:calculationLink xlink:role="http://silkroadmed.com/role/StockOptionPlansStockbasedCompensationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://silkroadmed.com/role/IncomeTaxes" xlink:type="simple" xlink:href="silk-20191231.xsd#IncomeTaxes"/>
  <link:calculationLink xlink:role="http://silkroadmed.com/role/IncomeTaxes" xlink:type="extended"/>
  <link:roleRef roleURI="http://silkroadmed.com/role/IncomeTaxesTables" xlink:type="simple" xlink:href="silk-20191231.xsd#IncomeTaxesTables"/>
  <link:calculationLink xlink:role="http://silkroadmed.com/role/IncomeTaxesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://silkroadmed.com/role/IncomeTaxesComponentsofIncomeBeforeTaxesDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#IncomeTaxesComponentsofIncomeBeforeTaxesDetails"/>
  <link:calculationLink xlink:role="http://silkroadmed.com/role/IncomeTaxesComponentsofIncomeBeforeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_f95407f3-90ef-4a24-8ff8-60ca6f59e8b2" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_ad983ca3-35e9-446a-9afb-db9bd8583540" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_f95407f3-90ef-4a24-8ff8-60ca6f59e8b2" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_ad983ca3-35e9-446a-9afb-db9bd8583540" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_ff88a2be-eeb5-45f3-bf5f-0afbcaff5f09" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_f95407f3-90ef-4a24-8ff8-60ca6f59e8b2" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_ff88a2be-eeb5-45f3-bf5f-0afbcaff5f09" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/IncomeTaxesReconciliationofUSStatutoryRateDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#IncomeTaxesReconciliationofUSStatutoryRateDetails"/>
  <link:calculationLink xlink:role="http://silkroadmed.com/role/IncomeTaxesReconciliationofUSStatutoryRateDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_24c5f485-b6b0-4d58-8d85-96c27a0861bb" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_b40364df-8659-411b-8e97-c1dc3fdc7be8" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_24c5f485-b6b0-4d58-8d85-96c27a0861bb" xlink:to="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_b40364df-8659-411b-8e97-c1dc3fdc7be8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_ec72cdec-5aa5-4f9f-a46c-de1a530049d2" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_24c5f485-b6b0-4d58-8d85-96c27a0861bb" xlink:to="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_ec72cdec-5aa5-4f9f-a46c-de1a530049d2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpense_41ac3883-6974-4c3b-84e7-bca03fb80081" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_24c5f485-b6b0-4d58-8d85-96c27a0861bb" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpense_41ac3883-6974-4c3b-84e7-bca03fb80081" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_EffectiveIncomeTaxRateReconciliationWarrantLiabilityAdjustmentAmount_6fd90af1-a23f-429c-ac36-23c82a9a41ed" xlink:href="silk-20191231.xsd#silk_EffectiveIncomeTaxRateReconciliationWarrantLiabilityAdjustmentAmount"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_24c5f485-b6b0-4d58-8d85-96c27a0861bb" xlink:to="loc_silk_EffectiveIncomeTaxRateReconciliationWarrantLiabilityAdjustmentAmount_6fd90af1-a23f-429c-ac36-23c82a9a41ed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_d3c5e530-3ef1-44d8-80e7-d4eafa01a05b" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_24c5f485-b6b0-4d58-8d85-96c27a0861bb" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_d3c5e530-3ef1-44d8-80e7-d4eafa01a05b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxCredits_10e38c85-bcc3-44f2-a866-4ba41a690de2" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxReconciliationTaxCredits"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_24c5f485-b6b0-4d58-8d85-96c27a0861bb" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxCredits_10e38c85-bcc3-44f2-a866-4ba41a690de2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherReconcilingItems_71114844-0425-4fa1-b50d-c51af6a27923" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxReconciliationOtherReconcilingItems"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_24c5f485-b6b0-4d58-8d85-96c27a0861bb" xlink:to="loc_us-gaap_IncomeTaxReconciliationOtherReconcilingItems_71114844-0425-4fa1-b50d-c51af6a27923" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/IncomeTaxesNetDeferredTaxAssetsDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#IncomeTaxesNetDeferredTaxAssetsDetails"/>
  <link:calculationLink xlink:role="http://silkroadmed.com/role/IncomeTaxesNetDeferredTaxAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_578ad8ee-ce49-4eef-882a-3dd42e81f979" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_9e296229-bd61-4c3e-bb67-f25df634b721" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_578ad8ee-ce49-4eef-882a-3dd42e81f979" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_9e296229-bd61-4c3e-bb67-f25df634b721" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_78a4df13-fc57-4d2c-847d-b023ee916c59" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_578ad8ee-ce49-4eef-882a-3dd42e81f979" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_78a4df13-fc57-4d2c-847d-b023ee916c59" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_04c7934e-6e52-48be-84ad-a205c03d70b0" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_578ad8ee-ce49-4eef-882a-3dd42e81f979" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_04c7934e-6e52-48be-84ad-a205c03d70b0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_eb08bbc7-c1fd-4091-8438-074af0e64ccb" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_ee261841-7679-4929-9457-9738f42b9a72" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_eb08bbc7-c1fd-4091-8438-074af0e64ccb" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_ee261841-7679-4929-9457-9738f42b9a72" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_cb84b14d-e331-4811-9a53-1ee19903cece" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_eb08bbc7-c1fd-4091-8438-074af0e64ccb" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_cb84b14d-e331-4811-9a53-1ee19903cece" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_8d9593f7-7e56-4e9d-8f05-3b26a5cb0085" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_eb08bbc7-c1fd-4091-8438-074af0e64ccb" xlink:to="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_8d9593f7-7e56-4e9d-8f05-3b26a5cb0085" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_6d3e747a-43f1-428f-8230-7e54b5c90df5" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_eb08bbc7-c1fd-4091-8438-074af0e64ccb" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_6d3e747a-43f1-428f-8230-7e54b5c90df5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_c1b99f90-25da-41e6-bdc6-6624d5a593fe" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_eb08bbc7-c1fd-4091-8438-074af0e64ccb" xlink:to="loc_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_c1b99f90-25da-41e6-bdc6-6624d5a593fe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_cb281d49-53c7-4e59-a06e-61a9a2179111" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_eb08bbc7-c1fd-4091-8438-074af0e64ccb" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_cb281d49-53c7-4e59-a06e-61a9a2179111" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_DeferredTaxAssetsOperatingLeaseLiability_48400639-5c1d-4664-9f43-c225c58fea3e" xlink:href="silk-20191231.xsd#silk_DeferredTaxAssetsOperatingLeaseLiability"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_eb08bbc7-c1fd-4091-8438-074af0e64ccb" xlink:to="loc_silk_DeferredTaxAssetsOperatingLeaseLiability_48400639-5c1d-4664-9f43-c225c58fea3e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_48087517-592a-4fb9-9b6b-fe876d8ae58d" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset_46becc4e-9b8f-45e5-9708-a82e43503307" xlink:href="silk-20191231.xsd#silk_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_48087517-592a-4fb9-9b6b-fe876d8ae58d" xlink:to="loc_silk_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset_46becc4e-9b8f-45e5-9708-a82e43503307" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/IncomeTaxesNarrativeDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#IncomeTaxesNarrativeDetails"/>
  <link:calculationLink xlink:role="http://silkroadmed.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://silkroadmed.com/role/IncomeTaxesReconciliationofUnrecognizedTaxBenefitsDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#IncomeTaxesReconciliationofUnrecognizedTaxBenefitsDetails"/>
  <link:calculationLink xlink:role="http://silkroadmed.com/role/IncomeTaxesReconciliationofUnrecognizedTaxBenefitsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://silkroadmed.com/role/AcquisitionofVariableInterestEntityNeuroCo" xlink:type="simple" xlink:href="silk-20191231.xsd#AcquisitionofVariableInterestEntityNeuroCo"/>
  <link:calculationLink xlink:role="http://silkroadmed.com/role/AcquisitionofVariableInterestEntityNeuroCo" xlink:type="extended"/>
  <link:roleRef roleURI="http://silkroadmed.com/role/AcquisitionofVariableInterestEntityNeuroCoDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#AcquisitionofVariableInterestEntityNeuroCoDetails"/>
  <link:calculationLink xlink:role="http://silkroadmed.com/role/AcquisitionofVariableInterestEntityNeuroCoDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://silkroadmed.com/role/A401kPlan" xlink:type="simple" xlink:href="silk-20191231.xsd#A401kPlan"/>
  <link:calculationLink xlink:role="http://silkroadmed.com/role/A401kPlan" xlink:type="extended"/>
  <link:roleRef roleURI="http://silkroadmed.com/role/A401kPlanDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#A401kPlanDetails"/>
  <link:calculationLink xlink:role="http://silkroadmed.com/role/A401kPlanDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://silkroadmed.com/role/SubsequentEvents" xlink:type="simple" xlink:href="silk-20191231.xsd#SubsequentEvents"/>
  <link:calculationLink xlink:role="http://silkroadmed.com/role/SubsequentEvents" xlink:type="extended"/>
  <link:roleRef roleURI="http://silkroadmed.com/role/SubsequentEventsNarrativeDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#SubsequentEventsNarrativeDetails"/>
  <link:calculationLink xlink:role="http://silkroadmed.com/role/SubsequentEventsNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://silkroadmed.com/role/QuarterlyFinancialInformationunaudited" xlink:type="simple" xlink:href="silk-20191231.xsd#QuarterlyFinancialInformationunaudited"/>
  <link:calculationLink xlink:role="http://silkroadmed.com/role/QuarterlyFinancialInformationunaudited" xlink:type="extended"/>
  <link:roleRef roleURI="http://silkroadmed.com/role/QuarterlyFinancialInformationunauditedTables" xlink:type="simple" xlink:href="silk-20191231.xsd#QuarterlyFinancialInformationunauditedTables"/>
  <link:calculationLink xlink:role="http://silkroadmed.com/role/QuarterlyFinancialInformationunauditedTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://silkroadmed.com/role/QuarterlyFinancialInformationunauditedDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#QuarterlyFinancialInformationunauditedDetails"/>
  <link:calculationLink xlink:role="http://silkroadmed.com/role/QuarterlyFinancialInformationunauditedDetails" xlink:type="extended"/>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>9
<FILENAME>silk-20191231_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:dad5b714-6959-4e39-8c51-cdabce9e0669,g:fba3822a-5587-4181-9cc4-63667bdb118e-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://silkroadmed.com/role/CoverPage" xlink:type="simple" xlink:href="silk-20191231.xsd#CoverPage"/>
  <link:definitionLink xlink:role="http://silkroadmed.com/role/CoverPage" xlink:type="extended" id="ifc8ccc1b7ead4848be8d6180d8beb8ea_e3320b02-307e-4f5b-9f99-637f8219bc44"/>
  <link:roleRef roleURI="http://silkroadmed.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="silk-20191231.xsd#ConsolidatedBalanceSheets"/>
  <link:definitionLink xlink:role="http://silkroadmed.com/role/ConsolidatedBalanceSheets" xlink:type="extended" id="i7b6c15ce4e2743ada58f69b5a47fca35_669bce5f-c09c-4e85-acda-99c597482088"/>
  <link:roleRef roleURI="http://silkroadmed.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="silk-20191231.xsd#ConsolidatedBalanceSheetsParenthetical"/>
  <link:definitionLink xlink:role="http://silkroadmed.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="extended" id="i017ca07ab3da464c8558d1df41ebb3c6_363e0fb3-72db-4dee-9e96-10c7a26a3557"/>
  <link:roleRef roleURI="http://silkroadmed.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss" xlink:type="simple" xlink:href="silk-20191231.xsd#CondensedConsolidatedStatementsofOperationsandComprehensiveLoss"/>
  <link:definitionLink xlink:role="http://silkroadmed.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss" xlink:type="extended" id="ib53781bd14bf46acbc345ba001199cd6_52471659-d639-467c-9f99-55582375639b"/>
  <link:roleRef roleURI="http://silkroadmed.com/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit" xlink:type="simple" xlink:href="silk-20191231.xsd#CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit"/>
  <link:definitionLink xlink:role="http://silkroadmed.com/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit" xlink:type="extended" id="ic74cb8ed803049ebaaeefcd573a304e7_56c2ab8a-14cf-41be-86bb-1f218269d86c">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_87f4c9af-a1c9-4d29-9c3f-9a78f663e6b0" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityAbstract_ee30c17b-1a7e-4e14-863e-43e51da66b70" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TemporaryEquityAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_87f4c9af-a1c9-4d29-9c3f-9a78f663e6b0" xlink:to="loc_us-gaap_TemporaryEquityAbstract_ee30c17b-1a7e-4e14-863e-43e51da66b70" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_da69f02b-bc00-438c-841a-f557acd9915b" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityAbstract_ee30c17b-1a7e-4e14-863e-43e51da66b70" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_da69f02b-bc00-438c-841a-f557acd9915b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_3c9339b7-b824-4802-adbf-504fa1aca260" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityAbstract_ee30c17b-1a7e-4e14-863e-43e51da66b70" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_3c9339b7-b824-4802-adbf-504fa1aca260" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_StockIssuedDuringPeriodValueExerciseOfWarrants_6c0995ff-7619-4001-a33b-c3bcfa526ebc" xlink:href="silk-20191231.xsd#silk_StockIssuedDuringPeriodValueExerciseOfWarrants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityAbstract_ee30c17b-1a7e-4e14-863e-43e51da66b70" xlink:to="loc_silk_StockIssuedDuringPeriodValueExerciseOfWarrants_6c0995ff-7619-4001-a33b-c3bcfa526ebc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_StockIssuedDuringPeriodSharesExerciseOfWarrants_84f49195-ecc0-4dba-b3dd-68845da44907" xlink:href="silk-20191231.xsd#silk_StockIssuedDuringPeriodSharesExerciseOfWarrants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityAbstract_ee30c17b-1a7e-4e14-863e-43e51da66b70" xlink:to="loc_silk_StockIssuedDuringPeriodSharesExerciseOfWarrants_84f49195-ecc0-4dba-b3dd-68845da44907" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_55dbf86d-7a0e-4e59-a1e1-485c1e011ee9" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_79b9e79d-bf29-4cf5-9542-4158baee0bce" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_349f1b53-9313-4968-94a0-4a28ee6d0d1a" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_87f4c9af-a1c9-4d29-9c3f-9a78f663e6b0" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_349f1b53-9313-4968-94a0-4a28ee6d0d1a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_17f4d6fc-e26e-4dc0-b69f-8b9edc6ec934" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_349f1b53-9313-4968-94a0-4a28ee6d0d1a" xlink:to="loc_us-gaap_SharesOutstanding_17f4d6fc-e26e-4dc0-b69f-8b9edc6ec934" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f2fe1ab7-b9de-4d90-a173-6d31d78cce89" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_349f1b53-9313-4968-94a0-4a28ee6d0d1a" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f2fe1ab7-b9de-4d90-a173-6d31d78cce89" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_84b80e00-753a-4fb3-ac49-0f481d528a48" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_349f1b53-9313-4968-94a0-4a28ee6d0d1a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_84b80e00-753a-4fb3-ac49-0f481d528a48" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_ba7f28d0-1b10-4224-a510-9e5d81df1243" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_349f1b53-9313-4968-94a0-4a28ee6d0d1a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_ba7f28d0-1b10-4224-a510-9e5d81df1243" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_d66fcc11-aa10-4454-b0f5-07f15702154b" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_349f1b53-9313-4968-94a0-4a28ee6d0d1a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_d66fcc11-aa10-4454-b0f5-07f15702154b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_245709ef-87c2-4bb2-9b3b-273e95c884cd" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_349f1b53-9313-4968-94a0-4a28ee6d0d1a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_245709ef-87c2-4bb2-9b3b-273e95c884cd" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits_40e7b34f-5db3-471b-b8db-908fab3d8178" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_349f1b53-9313-4968-94a0-4a28ee6d0d1a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits_40e7b34f-5db3-471b-b8db-908fab3d8178" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfUnits_c3f463ac-b62b-45a9-bd29-ad56e68b1371" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfUnits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_349f1b53-9313-4968-94a0-4a28ee6d0d1a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfUnits_c3f463ac-b62b-45a9-bd29-ad56e68b1371" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_17f2e6d3-00ef-4a26-86b4-f21361934350" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_349f1b53-9313-4968-94a0-4a28ee6d0d1a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_17f2e6d3-00ef-4a26-86b4-f21361934350" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_bbb29cb7-5de3-42e4-9054-efbbe0df7a12" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_349f1b53-9313-4968-94a0-4a28ee6d0d1a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_bbb29cb7-5de3-42e4-9054-efbbe0df7a12" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition_2c264dc0-ea2b-4f4f-9b0e-d70eeec82dbb" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_349f1b53-9313-4968-94a0-4a28ee6d0d1a" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition_2c264dc0-ea2b-4f4f-9b0e-d70eeec82dbb" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_47a1417c-0d87-4644-a07a-72a9c2f9c0c4" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_349f1b53-9313-4968-94a0-4a28ee6d0d1a" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_47a1417c-0d87-4644-a07a-72a9c2f9c0c4" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance_dd6bf89d-4a94-4170-aa52-f00ea097f529" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_349f1b53-9313-4968-94a0-4a28ee6d0d1a" xlink:to="loc_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance_dd6bf89d-4a94-4170-aa52-f00ea097f529" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_3cfd6c76-19c7-4652-806b-b0521da55aa2" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_349f1b53-9313-4968-94a0-4a28ee6d0d1a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_3cfd6c76-19c7-4652-806b-b0521da55aa2" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_f3d4324d-9a1a-4e92-afbc-f051d75103c4" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_349f1b53-9313-4968-94a0-4a28ee6d0d1a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_f3d4324d-9a1a-4e92-afbc-f051d75103c4" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption_23db25cc-7b79-4d21-ac86-5b8d73340e6c" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_349f1b53-9313-4968-94a0-4a28ee6d0d1a" xlink:to="loc_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption_23db25cc-7b79-4d21-ac86-5b8d73340e6c" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_4a307f04-f54c-4c34-b1ef-ad2c55a0c838" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_349f1b53-9313-4968-94a0-4a28ee6d0d1a" xlink:to="loc_us-gaap_ProfitLoss_4a307f04-f54c-4c34-b1ef-ad2c55a0c838" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_3da1c0f0-ff13-47ea-842c-b9fb269337bb" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_349f1b53-9313-4968-94a0-4a28ee6d0d1a" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_3da1c0f0-ff13-47ea-842c-b9fb269337bb" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_49ccc3e6-e3bb-443d-a01a-50dc8356f7e7" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_349f1b53-9313-4968-94a0-4a28ee6d0d1a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_49ccc3e6-e3bb-443d-a01a-50dc8356f7e7" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_ab98cdee-7c3e-4a1e-b9ec-27fcd4377f8c" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_724b7a67-8f3d-4eb9-a288-6679918b454a" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_a370ce27-27b4-481d-ac67-4367c9497937" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_87f4c9af-a1c9-4d29-9c3f-9a78f663e6b0" xlink:to="loc_us-gaap_StatementTable_a370ce27-27b4-481d-ac67-4367c9497937" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_7e5cc87c-03c8-4e5f-ae27-c7b25072b11e" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_a370ce27-27b4-481d-ac67-4367c9497937" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_7e5cc87c-03c8-4e5f-ae27-c7b25072b11e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_7e5cc87c-03c8-4e5f-ae27-c7b25072b11e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_7e5cc87c-03c8-4e5f-ae27-c7b25072b11e" xlink:to="loc_us-gaap_EquityComponentDomain_7e5cc87c-03c8-4e5f-ae27-c7b25072b11e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_4012ea52-956e-466a-8dc7-fc080e83d452" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_7e5cc87c-03c8-4e5f-ae27-c7b25072b11e" xlink:to="loc_us-gaap_EquityComponentDomain_4012ea52-956e-466a-8dc7-fc080e83d452" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockMember_3ccb32a5-ea06-4353-b11d-e0f8acf880c8" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_4012ea52-956e-466a-8dc7-fc080e83d452" xlink:to="loc_us-gaap_PreferredStockMember_3ccb32a5-ea06-4353-b11d-e0f8acf880c8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_d7ce38a5-024f-4350-ab10-69b77aa6cf2e" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_4012ea52-956e-466a-8dc7-fc080e83d452" xlink:to="loc_us-gaap_CommonStockMember_d7ce38a5-024f-4350-ab10-69b77aa6cf2e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_35f02eb8-797b-4353-9a0f-fe6f8b71f41d" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_4012ea52-956e-466a-8dc7-fc080e83d452" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_35f02eb8-797b-4353-9a0f-fe6f8b71f41d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_9cbe5693-760a-40d0-9772-911d5ac245d6" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_4012ea52-956e-466a-8dc7-fc080e83d452" xlink:to="loc_us-gaap_RetainedEarningsMember_9cbe5693-760a-40d0-9772-911d5ac245d6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_1260e7d8-a465-4431-914d-cec891e197e9" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_4012ea52-956e-466a-8dc7-fc080e83d452" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_1260e7d8-a465-4431-914d-cec891e197e9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_d7c75289-ad67-42a1-af3d-c781136015ff" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_4012ea52-956e-466a-8dc7-fc080e83d452" xlink:to="loc_us-gaap_NoncontrollingInterestMember_d7c75289-ad67-42a1-af3d-c781136015ff" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_84c50a92-c58a-461e-863e-8bfd609eb9e0" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_a370ce27-27b4-481d-ac67-4367c9497937" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_84c50a92-c58a-461e-863e-8bfd609eb9e0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_84c50a92-c58a-461e-863e-8bfd609eb9e0_default" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_84c50a92-c58a-461e-863e-8bfd609eb9e0" xlink:to="loc_us-gaap_TypeOfAdoptionMember_84c50a92-c58a-461e-863e-8bfd609eb9e0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_abe9c01f-5f4a-411b-b1d6-26ed90024395" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_84c50a92-c58a-461e-863e-8bfd609eb9e0" xlink:to="loc_us-gaap_TypeOfAdoptionMember_abe9c01f-5f4a-411b-b1d6-26ed90024395" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201409Member_a874fcf3-8aa5-4418-8a38-2fbb443f4016" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountingStandardsUpdate201409Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfAdoptionMember_abe9c01f-5f4a-411b-b1d6-26ed90024395" xlink:to="loc_us-gaap_AccountingStandardsUpdate201409Member_a874fcf3-8aa5-4418-8a38-2fbb443f4016" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201609Member_45330c3e-e46f-4050-bfb8-780b96068ac9" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountingStandardsUpdate201609Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfAdoptionMember_abe9c01f-5f4a-411b-b1d6-26ed90024395" xlink:to="loc_us-gaap_AccountingStandardsUpdate201609Member_45330c3e-e46f-4050-bfb8-780b96068ac9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_5abadd61-e83c-4984-a6d4-cde115b3cf80" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_a370ce27-27b4-481d-ac67-4367c9497937" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_5abadd61-e83c-4984-a6d4-cde115b3cf80" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_5abadd61-e83c-4984-a6d4-cde115b3cf80_default" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_5abadd61-e83c-4984-a6d4-cde115b3cf80" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_5abadd61-e83c-4984-a6d4-cde115b3cf80_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_910e56c5-ddb5-4dfc-b55a-3eae2ae411a2" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_5abadd61-e83c-4984-a6d4-cde115b3cf80" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_910e56c5-ddb5-4dfc-b55a-3eae2ae411a2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IPOMember_531cd989-45c5-483a-a07f-76e0850bc552" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IPOMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_910e56c5-ddb5-4dfc-b55a-3eae2ae411a2" xlink:to="loc_us-gaap_IPOMember_531cd989-45c5-483a-a07f-76e0850bc552" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficitParenthetical" xlink:type="simple" xlink:href="silk-20191231.xsd#CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficitParenthetical"/>
  <link:definitionLink xlink:role="http://silkroadmed.com/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficitParenthetical" xlink:type="extended" id="ibcda22143b164c89985d1c518c632737_d487aa84-bc32-4aec-828a-c1e5fd43f6e6"/>
  <link:roleRef roleURI="http://silkroadmed.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="silk-20191231.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:definitionLink xlink:role="http://silkroadmed.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended" id="id98adaa4a9124201b6c243ba15eb0147_f79d8cc5-4be4-49da-ad97-fcc39d934300">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_f02a30e4-2d83-4f2c-a397-a62a04b55d01" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_82779318-0425-4f78-b53c-4f1a138b7bdb" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f02a30e4-2d83-4f2c-a397-a62a04b55d01" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_82779318-0425-4f78-b53c-4f1a138b7bdb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_585f764d-f7ab-4014-9538-2be8a0daa4e6" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_82779318-0425-4f78-b53c-4f1a138b7bdb" xlink:to="loc_us-gaap_ProfitLoss_585f764d-f7ab-4014-9538-2be8a0daa4e6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_80af5ce6-5fc0-4634-ba0e-61dd2ec1f767" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_82779318-0425-4f78-b53c-4f1a138b7bdb" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_80af5ce6-5fc0-4634-ba0e-61dd2ec1f767" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_162957d3-df22-4250-bd4b-0cc06c7a4fe6" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_80af5ce6-5fc0-4634-ba0e-61dd2ec1f767" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_162957d3-df22-4250-bd4b-0cc06c7a4fe6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_6f546595-ea43-4f84-b3d2-f4fb82baece7" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_80af5ce6-5fc0-4634-ba0e-61dd2ec1f767" xlink:to="loc_us-gaap_ShareBasedCompensation_6f546595-ea43-4f84-b3d2-f4fb82baece7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants_e4d5febc-4b88-4bb9-a88c-730f2bd3c8b2" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_80af5ce6-5fc0-4634-ba0e-61dd2ec1f767" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants_e4d5febc-4b88-4bb9-a88c-730f2bd3c8b2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_20af7200-9750-4c18-8c43-7ccc86b452da" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_80af5ce6-5fc0-4634-ba0e-61dd2ec1f767" xlink:to="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_20af7200-9750-4c18-8c43-7ccc86b452da" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_d0d31334-8b8d-4adf-b72a-bf4efd349aee" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_80af5ce6-5fc0-4634-ba0e-61dd2ec1f767" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_d0d31334-8b8d-4adf-b72a-bf4efd349aee" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_OperatingLeaseRightOfUseAssetAmortization_ca936cd1-6694-4f51-9228-4e72b2764f41" xlink:href="silk-20191231.xsd#silk_OperatingLeaseRightOfUseAssetAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_80af5ce6-5fc0-4634-ba0e-61dd2ec1f767" xlink:to="loc_silk_OperatingLeaseRightOfUseAssetAmortization_ca936cd1-6694-4f51-9228-4e72b2764f41" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaidInKindInterest_2079e421-25d3-475d-9b04-353845692640" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaidInKindInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_80af5ce6-5fc0-4634-ba0e-61dd2ec1f767" xlink:to="loc_us-gaap_PaidInKindInterest_2079e421-25d3-475d-9b04-353845692640" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_77c3e951-a3cb-44a1-8841-e8faf11b9d2c" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_80af5ce6-5fc0-4634-ba0e-61dd2ec1f767" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_77c3e951-a3cb-44a1-8841-e8faf11b9d2c" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_84f37978-1f08-45ca-b372-d17173d2cb1b" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_80af5ce6-5fc0-4634-ba0e-61dd2ec1f767" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_84f37978-1f08-45ca-b372-d17173d2cb1b" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWriteDown_3e7cc213-3241-4839-ae8c-f25fbbfc105f" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InventoryWriteDown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_80af5ce6-5fc0-4634-ba0e-61dd2ec1f767" xlink:to="loc_us-gaap_InventoryWriteDown_3e7cc213-3241-4839-ae8c-f25fbbfc105f" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_076e1826-c13e-4869-af77-345bb817dfd9" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_82779318-0425-4f78-b53c-4f1a138b7bdb" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_076e1826-c13e-4869-af77-345bb817dfd9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_e7b370cf-fc91-4721-a647-9f0ac6a09677" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_076e1826-c13e-4869-af77-345bb817dfd9" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_e7b370cf-fc91-4721-a647-9f0ac6a09677" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_90cf7823-a308-4859-aa7e-801a6409ab22" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_076e1826-c13e-4869-af77-345bb817dfd9" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_90cf7823-a308-4859-aa7e-801a6409ab22" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_f6d32f1a-4dab-4fa4-95c8-1348cd4867c9" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_076e1826-c13e-4869-af77-345bb817dfd9" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_f6d32f1a-4dab-4fa4-95c8-1348cd4867c9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_b9bdfc22-91f0-4f15-939b-0fcef2ec8493" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_076e1826-c13e-4869-af77-345bb817dfd9" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_b9bdfc22-91f0-4f15-939b-0fcef2ec8493" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_77bd4399-cb14-4046-9074-334c1efb57bf" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_076e1826-c13e-4869-af77-345bb817dfd9" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_77bd4399-cb14-4046-9074-334c1efb57bf" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_788fa5f5-150a-415d-beec-6687d6109693" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_076e1826-c13e-4869-af77-345bb817dfd9" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_788fa5f5-150a-415d-beec-6687d6109693" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_83dac2ec-5a79-4494-809b-5a1456ffa8a2" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_076e1826-c13e-4869-af77-345bb817dfd9" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_83dac2ec-5a79-4494-809b-5a1456ffa8a2" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_edc29516-5f35-4a81-a7bf-a64ef5e2689e" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_82779318-0425-4f78-b53c-4f1a138b7bdb" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_edc29516-5f35-4a81-a7bf-a64ef5e2689e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_0e5fcd49-129d-45a3-9f63-139b6d871dda" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f02a30e4-2d83-4f2c-a397-a62a04b55d01" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_0e5fcd49-129d-45a3-9f63-139b6d871dda" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_0b3331bb-d216-41d7-b3de-3f8a0cc7bf8b" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_0e5fcd49-129d-45a3-9f63-139b6d871dda" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_0b3331bb-d216-41d7-b3de-3f8a0cc7bf8b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_a17fed5c-b7a1-42d6-a531-165f0da4c8a5" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_0e5fcd49-129d-45a3-9f63-139b6d871dda" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_a17fed5c-b7a1-42d6-a531-165f0da4c8a5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments_3fc52584-b024-4468-84e3-0ff09c1b9c35" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_0e5fcd49-129d-45a3-9f63-139b6d871dda" xlink:to="loc_us-gaap_PaymentsToAcquireInvestments_3fc52584-b024-4468-84e3-0ff09c1b9c35" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_e1ee10ed-28f3-4c9f-904b-8a6a6b192867" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_0e5fcd49-129d-45a3-9f63-139b6d871dda" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_e1ee10ed-28f3-4c9f-904b-8a6a6b192867" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_08488814-3ff6-4968-a923-cca49be56732" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f02a30e4-2d83-4f2c-a397-a62a04b55d01" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_08488814-3ff6-4968-a923-cca49be56732" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_fbea9e19-4a9e-49ed-8c8d-31b8fd4bb060" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_08488814-3ff6-4968-a923-cca49be56732" xlink:to="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_fbea9e19-4a9e-49ed-8c8d-31b8fd4bb060" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_87cd3295-45b6-4262-930c-4166aca18ef0" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_08488814-3ff6-4968-a923-cca49be56732" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_87cd3295-45b6-4262-930c-4166aca18ef0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_ba7a8094-ee92-42b9-910a-00e2a1215560" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_08488814-3ff6-4968-a923-cca49be56732" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_ba7a8094-ee92-42b9-910a-00e2a1215560" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromWarrantExercises_c50c4c4e-baab-4689-91e5-4c7cc7633ff4" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromWarrantExercises"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_08488814-3ff6-4968-a923-cca49be56732" xlink:to="loc_us-gaap_ProceedsFromWarrantExercises_c50c4c4e-baab-4689-91e5-4c7cc7633ff4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMinorityShareholders_3ff881b6-52e1-43a3-bf03-4e95f712833c" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromMinorityShareholders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_08488814-3ff6-4968-a923-cca49be56732" xlink:to="loc_us-gaap_ProceedsFromMinorityShareholders_3ff881b6-52e1-43a3-bf03-4e95f712833c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_71cae9bf-6630-4350-9581-22eb7016d561" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_08488814-3ff6-4968-a923-cca49be56732" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_71cae9bf-6630-4350-9581-22eb7016d561" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_6a897d19-a7e6-40a0-8ed5-5f831fe7ff6c" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f02a30e4-2d83-4f2c-a397-a62a04b55d01" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_6a897d19-a7e6-40a0-8ed5-5f831fe7ff6c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4e1f5809-d4f9-4bb9-9101-2c014e6ac7c7" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f02a30e4-2d83-4f2c-a397-a62a04b55d01" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4e1f5809-d4f9-4bb9-9101-2c014e6ac7c7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4dbaadd8-2483-46a9-9df8-5cf356ad1bd2" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_e505619a-6fdc-4479-8c06-a42f7ffb8fa2" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f02a30e4-2d83-4f2c-a397-a62a04b55d01" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_e505619a-6fdc-4479-8c06-a42f7ffb8fa2" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_cb63e966-309c-44e6-915c-c1537c04c62d" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_e505619a-6fdc-4479-8c06-a42f7ffb8fa2" xlink:to="loc_us-gaap_InterestPaidNet_cb63e966-309c-44e6-915c-c1537c04c62d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_16c49039-baab-4f9c-bc0e-fb59365af1f3" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f02a30e4-2d83-4f2c-a397-a62a04b55d01" xlink:to="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_16c49039-baab-4f9c-bc0e-fb59365af1f3" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_0696f8b5-5aaa-499f-97b8-e2541a2a9377" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_16c49039-baab-4f9c-bc0e-fb59365af1f3" xlink:to="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_0696f8b5-5aaa-499f-97b8-e2541a2a9377" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForTenantImprovements_85ae9961-9c82-4d34-a49a-cb121a0bc620" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsForTenantImprovements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_16c49039-baab-4f9c-bc0e-fb59365af1f3" xlink:to="loc_us-gaap_PaymentsForTenantImprovements_85ae9961-9c82-4d34-a49a-cb121a0bc620" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_StockIssuanceCostsIncurredButNotYetPaid_e3c0b14f-679c-43e1-bc84-f02cb1e2cc72" xlink:href="silk-20191231.xsd#silk_StockIssuanceCostsIncurredButNotYetPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_16c49039-baab-4f9c-bc0e-fb59365af1f3" xlink:to="loc_silk_StockIssuanceCostsIncurredButNotYetPaid_e3c0b14f-679c-43e1-bc84-f02cb1e2cc72" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_ce9c1066-86ad-45f7-8cd4-3ab7157497f3" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_16c49039-baab-4f9c-bc0e-fb59365af1f3" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_ce9c1066-86ad-45f7-8cd4-3ab7157497f3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockAmountIssued1_f5796c00-7dbf-4c75-b8e8-627394bd1198" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConversionOfStockAmountIssued1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_16c49039-baab-4f9c-bc0e-fb59365af1f3" xlink:to="loc_us-gaap_ConversionOfStockAmountIssued1_f5796c00-7dbf-4c75-b8e8-627394bd1198" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockAmountConverted1_2629988e-d46a-4c40-99f6-6dcfcabf7fad" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConversionOfStockAmountConverted1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_16c49039-baab-4f9c-bc0e-fb59365af1f3" xlink:to="loc_us-gaap_ConversionOfStockAmountConverted1_2629988e-d46a-4c40-99f6-6dcfcabf7fad" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_82c0912d-e873-44a8-95d1-baba45e5781d" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_f02a30e4-2d83-4f2c-a397-a62a04b55d01" xlink:to="loc_us-gaap_StatementTable_82c0912d-e873-44a8-95d1-baba45e5781d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_762a6edb-17d4-4821-8b39-cb020ce6f05d" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_82c0912d-e873-44a8-95d1-baba45e5781d" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_762a6edb-17d4-4821-8b39-cb020ce6f05d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_762a6edb-17d4-4821-8b39-cb020ce6f05d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_762a6edb-17d4-4821-8b39-cb020ce6f05d" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_762a6edb-17d4-4821-8b39-cb020ce6f05d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_fb900833-e197-4433-b324-743b2b39bc4a" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_762a6edb-17d4-4821-8b39-cb020ce6f05d" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_fb900833-e197-4433-b324-743b2b39bc4a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_RedeemableConvertiblePreferredStockWarrantsMember_084e8b5d-7619-4ccf-b696-0f32b8156c7f" xlink:href="silk-20191231.xsd#silk_RedeemableConvertiblePreferredStockWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_fb900833-e197-4433-b324-743b2b39bc4a" xlink:to="loc_silk_RedeemableConvertiblePreferredStockWarrantsMember_084e8b5d-7619-4ccf-b696-0f32b8156c7f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_CommonStockWarrantMember_1d8b0ce7-5a3d-4e7e-8858-5d522837a121" xlink:href="silk-20191231.xsd#silk_CommonStockWarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_fb900833-e197-4433-b324-743b2b39bc4a" xlink:to="loc_silk_CommonStockWarrantMember_1d8b0ce7-5a3d-4e7e-8858-5d522837a121" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/FormationandBusinessoftheCompany" xlink:type="simple" xlink:href="silk-20191231.xsd#FormationandBusinessoftheCompany"/>
  <link:definitionLink xlink:role="http://silkroadmed.com/role/FormationandBusinessoftheCompany" xlink:type="extended" id="icaa0300d48bb40db9d408a1b98c0ddef_598fb129-5cea-47b2-a481-800e62f2ba9b"/>
  <link:roleRef roleURI="http://silkroadmed.com/role/FormationandBusinessoftheCompanyDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#FormationandBusinessoftheCompanyDetails"/>
  <link:definitionLink xlink:role="http://silkroadmed.com/role/FormationandBusinessoftheCompanyDetails" xlink:type="extended" id="i7d0921296b3f41cab9e13591f6854f3b_57f53dd7-f6e7-46e7-8251-0893588c9b9f">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_195d92bb-8da4-4f09-b392-192c3140ab9d" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_c048dc4b-9684-48f8-93ec-4960d588ecb9" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_195d92bb-8da4-4f09-b392-192c3140ab9d" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_c048dc4b-9684-48f8-93ec-4960d588ecb9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_28bad84d-204b-4d00-8d9a-f42939288dd2" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_195d92bb-8da4-4f09-b392-192c3140ab9d" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_28bad84d-204b-4d00-8d9a-f42939288dd2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_db145a56-88ba-4a84-aaa4-06cc71b82017" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_195d92bb-8da4-4f09-b392-192c3140ab9d" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_db145a56-88ba-4a84-aaa4-06cc71b82017" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_25c4087a-dc08-49f0-b6b4-d1254cb0e65a" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_195d92bb-8da4-4f09-b392-192c3140ab9d" xlink:to="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_25c4087a-dc08-49f0-b6b4-d1254cb0e65a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_601c91ea-c535-4a36-8236-9c47116cf7e8" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_195d92bb-8da4-4f09-b392-192c3140ab9d" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_601c91ea-c535-4a36-8236-9c47116cf7e8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_534471a6-762b-43fc-ae5f-229e8166f34c" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_195d92bb-8da4-4f09-b392-192c3140ab9d" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_534471a6-762b-43fc-ae5f-229e8166f34c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_edf82f2c-f043-4fc7-8419-9289f07c1959" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_195d92bb-8da4-4f09-b392-192c3140ab9d" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_edf82f2c-f043-4fc7-8419-9289f07c1959" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_78b8bf52-be6f-43d2-b230-f9879d24572b" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_195d92bb-8da4-4f09-b392-192c3140ab9d" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_78b8bf52-be6f-43d2-b230-f9879d24572b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_efdd1b62-3ae0-4b34-9591-ee7c4a52c3ae" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_195d92bb-8da4-4f09-b392-192c3140ab9d" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_efdd1b62-3ae0-4b34-9591-ee7c4a52c3ae" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_30ea0bdd-01a2-4f32-8526-df74ef765214" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsequentEventTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsequentEventLineItems_195d92bb-8da4-4f09-b392-192c3140ab9d" xlink:to="loc_us-gaap_SubsequentEventTable_30ea0bdd-01a2-4f32-8526-df74ef765214" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_524de0e7-4155-414d-b78e-b013272501db" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_30ea0bdd-01a2-4f32-8526-df74ef765214" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_524de0e7-4155-414d-b78e-b013272501db" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_524de0e7-4155-414d-b78e-b013272501db_default" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_524de0e7-4155-414d-b78e-b013272501db" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_524de0e7-4155-414d-b78e-b013272501db_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_7f569505-856f-47fe-937e-9f40d8684c36" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_524de0e7-4155-414d-b78e-b013272501db" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_7f569505-856f-47fe-937e-9f40d8684c36" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IPOMember_eee174db-06e8-484b-b8f1-9bdfed79183c" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IPOMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_7f569505-856f-47fe-937e-9f40d8684c36" xlink:to="loc_us-gaap_IPOMember_eee174db-06e8-484b-b8f1-9bdfed79183c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_IPOUnderwritingDiscountsAndCommissionsMember_68f6658c-dca6-45b3-9bca-dc2108755e6a" xlink:href="silk-20191231.xsd#silk_IPOUnderwritingDiscountsAndCommissionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_7f569505-856f-47fe-937e-9f40d8684c36" xlink:to="loc_silk_IPOUnderwritingDiscountsAndCommissionsMember_68f6658c-dca6-45b3-9bca-dc2108755e6a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_IPOOtherExpensesMember_700e1a45-651c-448f-864d-a8a8c43796f7" xlink:href="silk-20191231.xsd#silk_IPOOtherExpensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_7f569505-856f-47fe-937e-9f40d8684c36" xlink:to="loc_silk_IPOOtherExpensesMember_700e1a45-651c-448f-864d-a8a8c43796f7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_SecondPublicOfferingMember_5dac737d-8872-40e3-93f4-cdf3ec1acbf3" xlink:href="silk-20191231.xsd#silk_SecondPublicOfferingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_7f569505-856f-47fe-937e-9f40d8684c36" xlink:to="loc_silk_SecondPublicOfferingMember_5dac737d-8872-40e3-93f4-cdf3ec1acbf3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OverAllotmentOptionMember_fcbc2c9a-6007-4640-ae6e-5391ce3244c5" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OverAllotmentOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_7f569505-856f-47fe-937e-9f40d8684c36" xlink:to="loc_us-gaap_OverAllotmentOptionMember_fcbc2c9a-6007-4640-ae6e-5391ce3244c5" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/SummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="silk-20191231.xsd#SummaryofSignificantAccountingPolicies"/>
  <link:definitionLink xlink:role="http://silkroadmed.com/role/SummaryofSignificantAccountingPolicies" xlink:type="extended" id="i21c0e380ea554020a1ed95a78875763d_4ab0d49a-5595-43cb-85b3-973d7dd1f31b"/>
  <link:roleRef roleURI="http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="silk-20191231.xsd#SummaryofSignificantAccountingPoliciesPolicies"/>
  <link:definitionLink xlink:role="http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended" id="i9754a749bf1a4213b20c82203de2065c_90b1e04e-60af-419f-9733-66b74f89a8a5"/>
  <link:roleRef roleURI="http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="silk-20191231.xsd#SummaryofSignificantAccountingPoliciesTables"/>
  <link:definitionLink xlink:role="http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="extended" id="ied03fc3705e349e49721864c12eeb7cb_621565fa-cf93-4a92-802e-cfc8bab08077"/>
  <link:roleRef roleURI="http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesAdjustmenttoPriorPeriodFinancialStatementsDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#SummaryofSignificantAccountingPoliciesAdjustmenttoPriorPeriodFinancialStatementsDetails"/>
  <link:definitionLink xlink:role="http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesAdjustmenttoPriorPeriodFinancialStatementsDetails" xlink:type="extended" id="i99f16557767d4ad1ac8cdd2312c0c6d3_6d0e7f59-98b1-4982-8a6c-274f13814d76">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_e71e80ed-47aa-4964-a011-7e5be524b423" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_cd613b36-637e-4831-875c-06d09131bcfc" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_e71e80ed-47aa-4964-a011-7e5be524b423" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_cd613b36-637e-4831-875c-06d09131bcfc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_ac76c971-9a7c-457a-aaf9-e3693c6b784f" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_e71e80ed-47aa-4964-a011-7e5be524b423" xlink:to="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_ac76c971-9a7c-457a-aaf9-e3693c6b784f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis_04bdf8e7-38a0-4d47-964b-f651ae8a92fe" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RestatementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_ac76c971-9a7c-457a-aaf9-e3693c6b784f" xlink:to="loc_srt_RestatementAxis_04bdf8e7-38a0-4d47-964b-f651ae8a92fe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_04bdf8e7-38a0-4d47-964b-f651ae8a92fe_default" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RestatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RestatementAxis_04bdf8e7-38a0-4d47-964b-f651ae8a92fe" xlink:to="loc_srt_RestatementDomain_04bdf8e7-38a0-4d47-964b-f651ae8a92fe_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_e825d56f-d44f-414b-9616-9665188a8dd9" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RestatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RestatementAxis_04bdf8e7-38a0-4d47-964b-f651ae8a92fe" xlink:to="loc_srt_RestatementDomain_e825d56f-d44f-414b-9616-9665188a8dd9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAdjustmentMember_6e8b3f67-db74-424b-85cd-98c4cfa06196" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RestatementAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RestatementDomain_e825d56f-d44f-414b-9616-9665188a8dd9" xlink:to="loc_srt_RestatementAdjustmentMember_6e8b3f67-db74-424b-85cd-98c4cfa06196" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis_5d9598c5-fc1d-46cd-9da2-7a8cb0e463ac" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_ac76c971-9a7c-457a-aaf9-e3693c6b784f" xlink:to="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis_5d9598c5-fc1d-46cd-9da2-7a8cb0e463ac" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForErrorCorrectionDomain_5d9598c5-fc1d-46cd-9da2-7a8cb0e463ac_default" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdjustmentsForErrorCorrectionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis_5d9598c5-fc1d-46cd-9da2-7a8cb0e463ac" xlink:to="loc_us-gaap_AdjustmentsForErrorCorrectionDomain_5d9598c5-fc1d-46cd-9da2-7a8cb0e463ac_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForErrorCorrectionDomain_8e731fd5-4175-45d7-9ae8-a997ab744ebd" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdjustmentsForErrorCorrectionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis_5d9598c5-fc1d-46cd-9da2-7a8cb0e463ac" xlink:to="loc_us-gaap_AdjustmentsForErrorCorrectionDomain_8e731fd5-4175-45d7-9ae8-a997ab744ebd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_CorrectionOfProvisionsForReturnsFromCustomersMember_57dfd3e5-4dd0-4a46-a211-f892265ff7d3" xlink:href="silk-20191231.xsd#silk_CorrectionOfProvisionsForReturnsFromCustomersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsForErrorCorrectionDomain_8e731fd5-4175-45d7-9ae8-a997ab744ebd" xlink:to="loc_silk_CorrectionOfProvisionsForReturnsFromCustomersMember_57dfd3e5-4dd0-4a46-a211-f892265ff7d3" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesCashCashEquivalentsandRestrictedCashDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#SummaryofSignificantAccountingPoliciesCashCashEquivalentsandRestrictedCashDetails"/>
  <link:definitionLink xlink:role="http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesCashCashEquivalentsandRestrictedCashDetails" xlink:type="extended" id="i6eba54ed9fb24e59ac137351a8e55261_6d05831b-0c0c-4bf3-a911-99dbccfa1ff3">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems_ae7a31ff-800f-4f7c-a12a-aaf753dc199b" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_31ee8c69-8302-411a-b614-e6c9b3e0e992" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems_ae7a31ff-800f-4f7c-a12a-aaf753dc199b" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_31ee8c69-8302-411a-b614-e6c9b3e0e992" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_bac6af62-cdd1-44ab-b815-aa1718631a3c" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems_ae7a31ff-800f-4f7c-a12a-aaf753dc199b" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_bac6af62-cdd1-44ab-b815-aa1718631a3c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_8408b515-7b4b-47db-a80a-27ae39684a50" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems_ae7a31ff-800f-4f7c-a12a-aaf753dc199b" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_8408b515-7b4b-47db-a80a-27ae39684a50" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable_ef893162-1bdd-46c9-9b86-0a46da1513ab" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems_ae7a31ff-800f-4f7c-a12a-aaf753dc199b" xlink:to="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable_ef893162-1bdd-46c9-9b86-0a46da1513ab" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis_cca5adb7-5485-4100-81a1-5502f2b1396a" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable_ef893162-1bdd-46c9-9b86-0a46da1513ab" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis_cca5adb7-5485-4100-81a1-5502f2b1396a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_cca5adb7-5485-4100-81a1-5502f2b1396a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis_cca5adb7-5485-4100-81a1-5502f2b1396a" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_cca5adb7-5485-4100-81a1-5502f2b1396a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_bf64ceef-1e7b-4532-b32f-7083e17ed33c" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis_cca5adb7-5485-4100-81a1-5502f2b1396a" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_bf64ceef-1e7b-4532-b32f-7083e17ed33c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_86ab006c-0719-40de-98f6-c4e71b73bf27" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LetterOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_bf64ceef-1e7b-4532-b32f-7083e17ed33c" xlink:to="loc_us-gaap_LetterOfCreditMember_86ab006c-0719-40de-98f6-c4e71b73bf27" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails"/>
  <link:definitionLink xlink:role="http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails" xlink:type="extended" id="i8c7db73024364bd2af3563ae1ed1471a_d25b9e09-dd5b-43b4-b387-244fea0313a5">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c7ca1230-1351-4188-b926-ccc9148ee86c" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_e8d465ac-78d7-4746-8cc1-c3bfc3da2e51" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c7ca1230-1351-4188-b926-ccc9148ee86c" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_e8d465ac-78d7-4746-8cc1-c3bfc3da2e51" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_ca7472cf-e3cd-4ef2-be68-4ea0fb37cf7e" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c7ca1230-1351-4188-b926-ccc9148ee86c" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_ca7472cf-e3cd-4ef2-be68-4ea0fb37cf7e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_51db8746-e2b6-4772-8249-2b76d5b09fef" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_ca7472cf-e3cd-4ef2-be68-4ea0fb37cf7e" xlink:to="loc_srt_RangeAxis_51db8746-e2b6-4772-8249-2b76d5b09fef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_51db8746-e2b6-4772-8249-2b76d5b09fef_default" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_51db8746-e2b6-4772-8249-2b76d5b09fef" xlink:to="loc_srt_RangeMember_51db8746-e2b6-4772-8249-2b76d5b09fef_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_26f43eb3-ff18-41ab-9d94-b190c3bed8d0" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_51db8746-e2b6-4772-8249-2b76d5b09fef" xlink:to="loc_srt_RangeMember_26f43eb3-ff18-41ab-9d94-b190c3bed8d0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_010d4af4-588d-4856-99f5-9a0f2f32f327" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_26f43eb3-ff18-41ab-9d94-b190c3bed8d0" xlink:to="loc_srt_MinimumMember_010d4af4-588d-4856-99f5-9a0f2f32f327" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_365d793b-2881-4db2-bdb5-6457b39df045" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_26f43eb3-ff18-41ab-9d94-b190c3bed8d0" xlink:to="loc_srt_MaximumMember_365d793b-2881-4db2-bdb5-6457b39df045" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesDeferredInitialPublicOfferingCostsDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#SummaryofSignificantAccountingPoliciesDeferredInitialPublicOfferingCostsDetails"/>
  <link:definitionLink xlink:role="http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesDeferredInitialPublicOfferingCostsDetails" xlink:type="extended" id="ief6dd4a86dd04fc285230587e2f80e18_b77b7b42-56ab-4c28-b80e-dabacb57ad84"/>
  <link:roleRef roleURI="http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesLeasesDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#SummaryofSignificantAccountingPoliciesLeasesDetails"/>
  <link:definitionLink xlink:role="http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesLeasesDetails" xlink:type="extended" id="idede8c1ed14e4605bb9bb2bc637f1e15_0cf643f8-9593-482c-bc94-ade2ff5ccc4b">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_529a6b34-c9e4-4d51-bde9-6f87abb8818d" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_287c5e32-5a18-44a3-881c-4da4a101d82d" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_529a6b34-c9e4-4d51-bde9-6f87abb8818d" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_287c5e32-5a18-44a3-881c-4da4a101d82d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_f3750807-e3fe-47f1-9690-8b60938b39d9" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_529a6b34-c9e4-4d51-bde9-6f87abb8818d" xlink:to="loc_us-gaap_OperatingLeaseLiability_f3750807-e3fe-47f1-9690-8b60938b39d9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_cadcc409-3565-4d89-8345-fc4742fa0769" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_529a6b34-c9e4-4d51-bde9-6f87abb8818d" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_cadcc409-3565-4d89-8345-fc4742fa0769" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_ae480e48-abac-4807-a053-925d0f63583e" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_cadcc409-3565-4d89-8345-fc4742fa0769" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_ae480e48-abac-4807-a053-925d0f63583e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_ae480e48-abac-4807-a053-925d0f63583e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_ae480e48-abac-4807-a053-925d0f63583e" xlink:to="loc_us-gaap_TypeOfAdoptionMember_ae480e48-abac-4807-a053-925d0f63583e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_31dbb4ba-ab88-4658-b610-85d8b52856fe" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_ae480e48-abac-4807-a053-925d0f63583e" xlink:to="loc_us-gaap_TypeOfAdoptionMember_31dbb4ba-ab88-4658-b610-85d8b52856fe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201602Member_7255d29b-4e01-4dfe-9851-5e755e37f1ed" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountingStandardsUpdate201602Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfAdoptionMember_31dbb4ba-ab88-4658-b610-85d8b52856fe" xlink:to="loc_us-gaap_AccountingStandardsUpdate201602Member_7255d29b-4e01-4dfe-9851-5e755e37f1ed" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesASC842ImpactonCondensedConsolidatedBalanceSheetDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#SummaryofSignificantAccountingPoliciesASC842ImpactonCondensedConsolidatedBalanceSheetDetails"/>
  <link:definitionLink xlink:role="http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesASC842ImpactonCondensedConsolidatedBalanceSheetDetails" xlink:type="extended" id="i0897776ab7eb4a66abca72350da5bce7_bba7ceb3-1af6-4608-9a06-6844db2d71c7">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_53c35cbc-3934-412c-9afd-9d4480fa7b42" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_03a2b387-65dc-46c2-bcb0-9db82ab5c781" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_53c35cbc-3934-412c-9afd-9d4480fa7b42" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_03a2b387-65dc-46c2-bcb0-9db82ab5c781" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_0762e853-ec72-48f4-a564-da07d9807f35" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_53c35cbc-3934-412c-9afd-9d4480fa7b42" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_0762e853-ec72-48f4-a564-da07d9807f35" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_b32bc76b-4516-4773-8c28-a1f62e2287af" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_53c35cbc-3934-412c-9afd-9d4480fa7b42" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_b32bc76b-4516-4773-8c28-a1f62e2287af" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_6ff977d2-ab40-41ac-b97e-3bf0f3ba5558" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_53c35cbc-3934-412c-9afd-9d4480fa7b42" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_6ff977d2-ab40-41ac-b97e-3bf0f3ba5558" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis_cd36e127-000d-42db-a0cb-e441dd206a74" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RestatementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_6ff977d2-ab40-41ac-b97e-3bf0f3ba5558" xlink:to="loc_srt_RestatementAxis_cd36e127-000d-42db-a0cb-e441dd206a74" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_cd36e127-000d-42db-a0cb-e441dd206a74_default" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RestatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RestatementAxis_cd36e127-000d-42db-a0cb-e441dd206a74" xlink:to="loc_srt_RestatementDomain_cd36e127-000d-42db-a0cb-e441dd206a74_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_87a4e22e-805f-461b-a3a5-1416fed61a13" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RestatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RestatementAxis_cd36e127-000d-42db-a0cb-e441dd206a74" xlink:to="loc_srt_RestatementDomain_87a4e22e-805f-461b-a3a5-1416fed61a13" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioPreviouslyReportedMember_5959bd86-3083-427f-9a57-663e08a09051" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RestatementDomain_87a4e22e-805f-461b-a3a5-1416fed61a13" xlink:to="loc_srt_ScenarioPreviouslyReportedMember_5959bd86-3083-427f-9a57-663e08a09051" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAdjustmentMember_6c76ee13-e794-4d87-9321-751883f83a34" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RestatementAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RestatementDomain_87a4e22e-805f-461b-a3a5-1416fed61a13" xlink:to="loc_srt_RestatementAdjustmentMember_6c76ee13-e794-4d87-9321-751883f83a34" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_88696028-9721-47a5-a03b-f9b59be1c5b0" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_6ff977d2-ab40-41ac-b97e-3bf0f3ba5558" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_88696028-9721-47a5-a03b-f9b59be1c5b0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_88696028-9721-47a5-a03b-f9b59be1c5b0_default" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_88696028-9721-47a5-a03b-f9b59be1c5b0" xlink:to="loc_us-gaap_TypeOfAdoptionMember_88696028-9721-47a5-a03b-f9b59be1c5b0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_064290f5-9a90-4ac9-a59f-025dfb92a50b" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_88696028-9721-47a5-a03b-f9b59be1c5b0" xlink:to="loc_us-gaap_TypeOfAdoptionMember_064290f5-9a90-4ac9-a59f-025dfb92a50b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201602Member_50ea127f-1683-4a64-b26d-91b4acababe1" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountingStandardsUpdate201602Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfAdoptionMember_064290f5-9a90-4ac9-a59f-025dfb92a50b" xlink:to="loc_us-gaap_AccountingStandardsUpdate201602Member_50ea127f-1683-4a64-b26d-91b4acababe1" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesRedeemableConvertiblePreferredStockDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#SummaryofSignificantAccountingPoliciesRedeemableConvertiblePreferredStockDetails"/>
  <link:definitionLink xlink:role="http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesRedeemableConvertiblePreferredStockDetails" xlink:type="extended" id="ib53220a8a0b64d3d9b1cc9e73aa450d0_91715717-8184-4ebb-87d9-c0944c5fd63b">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_167978eb-bcf0-4a6a-97d9-2c01013f008f" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits_4fca4044-72b7-4f3e-8bfb-bb5637e0b639" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_167978eb-bcf0-4a6a-97d9-2c01013f008f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits_4fca4044-72b7-4f3e-8bfb-bb5637e0b639" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfUnits_dcafa0b3-720f-42c0-9159-fd01fdf4bf5d" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfUnits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_167978eb-bcf0-4a6a-97d9-2c01013f008f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfUnits_dcafa0b3-720f-42c0-9159-fd01fdf4bf5d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_f74ba437-3106-4360-8472-f553f4387678" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_167978eb-bcf0-4a6a-97d9-2c01013f008f" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_f74ba437-3106-4360-8472-f553f4387678" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_11157405-74c9-4cab-9dac-44f24a53725d" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_f74ba437-3106-4360-8472-f553f4387678" xlink:to="loc_us-gaap_StatementClassOfStockAxis_11157405-74c9-4cab-9dac-44f24a53725d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_11157405-74c9-4cab-9dac-44f24a53725d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_11157405-74c9-4cab-9dac-44f24a53725d" xlink:to="loc_us-gaap_ClassOfStockDomain_11157405-74c9-4cab-9dac-44f24a53725d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_0e7374ac-22d1-4c59-9675-63c1047c21a9" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_11157405-74c9-4cab-9dac-44f24a53725d" xlink:to="loc_us-gaap_ClassOfStockDomain_0e7374ac-22d1-4c59-9675-63c1047c21a9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_c66c3307-4ce1-4815-9245-5a43f16d9ee5" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_0e7374ac-22d1-4c59-9675-63c1047c21a9" xlink:to="loc_us-gaap_CommonStockMember_c66c3307-4ce1-4815-9245-5a43f16d9ee5" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesRevenueRecognitionDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#SummaryofSignificantAccountingPoliciesRevenueRecognitionDetails"/>
  <link:definitionLink xlink:role="http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesRevenueRecognitionDetails" xlink:type="extended" id="ic0192e6edd614cc781c63e3a38e59b6e_5eb8785b-b896-4227-9ccd-a45df0cc19e0"/>
  <link:roleRef roleURI="http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesAdvertisingCostsDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#SummaryofSignificantAccountingPoliciesAdvertisingCostsDetails"/>
  <link:definitionLink xlink:role="http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesAdvertisingCostsDetails" xlink:type="extended" id="iae2e9ec729064d35867a28f0cf49dc34_1481ca3f-f2b4-4145-8cd9-e885ce96fd9e"/>
  <link:roleRef roleURI="http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesStockBasedCompensationDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#SummaryofSignificantAccountingPoliciesStockBasedCompensationDetails"/>
  <link:definitionLink xlink:role="http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesStockBasedCompensationDetails" xlink:type="extended" id="i247e6dd6475b48c7b3d3a1ef096551e6_6f9bc0cb-de87-4de7-9fcf-c507f39f816d">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_42c3367a-7506-4dbe-a545-e6446b38251b" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption_474a5b65-245d-474e-82cb-ce5c35a43ef4" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_42c3367a-7506-4dbe-a545-e6446b38251b" xlink:to="loc_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption_474a5b65-245d-474e-82cb-ce5c35a43ef4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_5dcb7a3a-9a29-4eca-b60e-8e475ba5b031" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_42c3367a-7506-4dbe-a545-e6446b38251b" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_5dcb7a3a-9a29-4eca-b60e-8e475ba5b031" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_179363b2-7efb-44df-86ee-9f2724750c6e" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_5dcb7a3a-9a29-4eca-b60e-8e475ba5b031" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_179363b2-7efb-44df-86ee-9f2724750c6e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_179363b2-7efb-44df-86ee-9f2724750c6e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_179363b2-7efb-44df-86ee-9f2724750c6e" xlink:to="loc_us-gaap_EquityComponentDomain_179363b2-7efb-44df-86ee-9f2724750c6e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_cc177794-ea22-40f9-95ed-a667bfd987bb" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_179363b2-7efb-44df-86ee-9f2724750c6e" xlink:to="loc_us-gaap_EquityComponentDomain_cc177794-ea22-40f9-95ed-a667bfd987bb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_565be127-34b9-4ed2-b9b5-d26c1c404038" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_cc177794-ea22-40f9-95ed-a667bfd987bb" xlink:to="loc_us-gaap_RetainedEarningsMember_565be127-34b9-4ed2-b9b5-d26c1c404038" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_f5eda7bb-1be4-4df2-98ca-65fbb65076a5" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_5dcb7a3a-9a29-4eca-b60e-8e475ba5b031" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_f5eda7bb-1be4-4df2-98ca-65fbb65076a5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_f5eda7bb-1be4-4df2-98ca-65fbb65076a5_default" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_f5eda7bb-1be4-4df2-98ca-65fbb65076a5" xlink:to="loc_us-gaap_TypeOfAdoptionMember_f5eda7bb-1be4-4df2-98ca-65fbb65076a5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_0f9d419b-bf5a-4514-89ef-e1e9c49ebeb6" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_f5eda7bb-1be4-4df2-98ca-65fbb65076a5" xlink:to="loc_us-gaap_TypeOfAdoptionMember_0f9d419b-bf5a-4514-89ef-e1e9c49ebeb6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201609Member_cb109221-87d3-410e-9018-07112b558fff" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountingStandardsUpdate201609Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfAdoptionMember_0f9d419b-bf5a-4514-89ef-e1e9c49ebeb6" xlink:to="loc_us-gaap_AccountingStandardsUpdate201609Member_cb109221-87d3-410e-9018-07112b558fff" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesScheduleofEarningsPerShareDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#SummaryofSignificantAccountingPoliciesScheduleofEarningsPerShareDetails"/>
  <link:definitionLink xlink:role="http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesScheduleofEarningsPerShareDetails" xlink:type="extended" id="if1114f81c11e4e3ca5b0ee4eb9d78716_d7fc9da6-34d4-497d-896f-11571fb2fd33"/>
  <link:roleRef roleURI="http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesScheduleofPotentiallyDilutiveSecuritiesNotIncludedinCalculationofEarningsperShareDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#SummaryofSignificantAccountingPoliciesScheduleofPotentiallyDilutiveSecuritiesNotIncludedinCalculationofEarningsperShareDetails"/>
  <link:definitionLink xlink:role="http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesScheduleofPotentiallyDilutiveSecuritiesNotIncludedinCalculationofEarningsperShareDetails" xlink:type="extended" id="i10a20a33c35241088d7980d73d904062_bd81803b-0a53-4e65-b34c-3fb4c0521f59">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_bae0aba1-7c07-4cdc-a7b3-7b140a6686a8" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_408ca237-b301-47e0-8289-a5209caca931" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_bae0aba1-7c07-4cdc-a7b3-7b140a6686a8" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_408ca237-b301-47e0-8289-a5209caca931" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_2337e942-e3ef-4c6c-825a-f5294ac9a227" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_bae0aba1-7c07-4cdc-a7b3-7b140a6686a8" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_2337e942-e3ef-4c6c-825a-f5294ac9a227" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_9a819ba6-4d92-49a4-9f5c-e8903a7b67a3" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_2337e942-e3ef-4c6c-825a-f5294ac9a227" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_9a819ba6-4d92-49a4-9f5c-e8903a7b67a3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_9a819ba6-4d92-49a4-9f5c-e8903a7b67a3_default" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_9a819ba6-4d92-49a4-9f5c-e8903a7b67a3" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_9a819ba6-4d92-49a4-9f5c-e8903a7b67a3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_0c63c098-e6f9-4279-94f7-88af3ad878fc" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_9a819ba6-4d92-49a4-9f5c-e8903a7b67a3" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_0c63c098-e6f9-4279-94f7-88af3ad878fc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableConvertiblePreferredStockMember_5b1fff9b-015c-45ca-aac7-e72c8534b50c" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RedeemableConvertiblePreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_0c63c098-e6f9-4279-94f7-88af3ad878fc" xlink:to="loc_us-gaap_RedeemableConvertiblePreferredStockMember_5b1fff9b-015c-45ca-aac7-e72c8534b50c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_RedeemableConvertiblePreferredStockWarrantsMember_50ba76e1-b95c-49af-8f23-dcef022c9228" xlink:href="silk-20191231.xsd#silk_RedeemableConvertiblePreferredStockWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_0c63c098-e6f9-4279-94f7-88af3ad878fc" xlink:to="loc_silk_RedeemableConvertiblePreferredStockWarrantsMember_50ba76e1-b95c-49af-8f23-dcef022c9228" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_b106c3ec-93ca-477c-8b10-6ee70edac851" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_0c63c098-e6f9-4279-94f7-88af3ad878fc" xlink:to="loc_us-gaap_EmployeeStockOptionMember_b106c3ec-93ca-477c-8b10-6ee70edac851" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_CommonStockWarrantMember_b69011df-6d44-4d24-94e3-e66d64935f56" xlink:href="silk-20191231.xsd#silk_CommonStockWarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_0c63c098-e6f9-4279-94f7-88af3ad878fc" xlink:to="loc_silk_CommonStockWarrantMember_b69011df-6d44-4d24-94e3-e66d64935f56" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesSegmentandGeographicalInformationDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#SummaryofSignificantAccountingPoliciesSegmentandGeographicalInformationDetails"/>
  <link:definitionLink xlink:role="http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesSegmentandGeographicalInformationDetails" xlink:type="extended" id="i48ffdeab13874e0585a0be7d711d5706_a5edb7bf-6671-4a0e-9ec8-960cf5c6ad3e"/>
  <link:roleRef roleURI="http://silkroadmed.com/role/RecentAccountingPronouncements" xlink:type="simple" xlink:href="silk-20191231.xsd#RecentAccountingPronouncements"/>
  <link:definitionLink xlink:role="http://silkroadmed.com/role/RecentAccountingPronouncements" xlink:type="extended" id="i9b623c5a9d2b459080a8880f8dd73c03_36ac172f-34b4-4635-bfde-c067370db690"/>
  <link:roleRef roleURI="http://silkroadmed.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="silk-20191231.xsd#FairValueMeasurements"/>
  <link:definitionLink xlink:role="http://silkroadmed.com/role/FairValueMeasurements" xlink:type="extended" id="i5fbb101aa98c4538a6a67da68c8851d2_d7b6ff0a-117a-4ca4-9841-ba6b59d99468"/>
  <link:roleRef roleURI="http://silkroadmed.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="silk-20191231.xsd#FairValueMeasurementsTables"/>
  <link:definitionLink xlink:role="http://silkroadmed.com/role/FairValueMeasurementsTables" xlink:type="extended" id="i2506277ae8fd4e18a69267ed34daca3e_a2c26f70-bf08-4093-9d0f-4510a9f8a507"/>
  <link:roleRef roleURI="http://silkroadmed.com/role/FairValueMeasurementsRecurringAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#FairValueMeasurementsRecurringAssetsandLiabilitiesDetails"/>
  <link:definitionLink xlink:role="http://silkroadmed.com/role/FairValueMeasurementsRecurringAssetsandLiabilitiesDetails" xlink:type="extended" id="i7b55924037db4c44a72b2352602891da_5ae2a9cb-ee98-4961-8133-90dee724262a">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_3fe53c63-aa7f-4c39-bf94-8a0fdf388c73" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_77186464-6173-4732-a120-0ea15f9973aa" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_3fe53c63-aa7f-4c39-bf94-8a0fdf388c73" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_77186464-6173-4732-a120-0ea15f9973aa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_cbd7a803-2048-4e13-abf5-090279d79047" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_3fe53c63-aa7f-4c39-bf94-8a0fdf388c73" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_cbd7a803-2048-4e13-abf5-090279d79047" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_dbe843be-2d6d-471d-8187-1229381674d8" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativeLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_3fe53c63-aa7f-4c39-bf94-8a0fdf388c73" xlink:to="loc_us-gaap_DerivativeLiabilities_dbe843be-2d6d-471d-8187-1229381674d8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_cdd48259-0c18-4f6f-b74c-9cb4a38ca109" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_3fe53c63-aa7f-4c39-bf94-8a0fdf388c73" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_cdd48259-0c18-4f6f-b74c-9cb4a38ca109" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_c174cbcb-dacf-4caa-9f1a-2eb722913f11" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_cdd48259-0c18-4f6f-b74c-9cb4a38ca109" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_c174cbcb-dacf-4caa-9f1a-2eb722913f11" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_c174cbcb-dacf-4caa-9f1a-2eb722913f11_default" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_c174cbcb-dacf-4caa-9f1a-2eb722913f11" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_c174cbcb-dacf-4caa-9f1a-2eb722913f11_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_147d2b27-b83b-4f9b-9b50-05bbf2e78672" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_c174cbcb-dacf-4caa-9f1a-2eb722913f11" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_147d2b27-b83b-4f9b-9b50-05bbf2e78672" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_f9692eb9-b96f-4d64-bbd2-f108c037032b" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_147d2b27-b83b-4f9b-9b50-05bbf2e78672" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_f9692eb9-b96f-4d64-bbd2-f108c037032b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_72cb301b-d755-47eb-b765-802fca415eb2" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_cdd48259-0c18-4f6f-b74c-9cb4a38ca109" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_72cb301b-d755-47eb-b765-802fca415eb2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_72cb301b-d755-47eb-b765-802fca415eb2_default" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_72cb301b-d755-47eb-b765-802fca415eb2" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_72cb301b-d755-47eb-b765-802fca415eb2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_34dd0a89-ebdb-43af-967f-63c6e82588a0" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_72cb301b-d755-47eb-b765-802fca415eb2" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_34dd0a89-ebdb-43af-967f-63c6e82588a0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_8ce53c10-8192-424b-b77f-b4c63cbf89ac" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_34dd0a89-ebdb-43af-967f-63c6e82588a0" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_8ce53c10-8192-424b-b77f-b4c63cbf89ac" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_25bc623a-3c00-49bc-b002-8d8e741ddb45" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_34dd0a89-ebdb-43af-967f-63c6e82588a0" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_25bc623a-3c00-49bc-b002-8d8e741ddb45" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_ced02fce-918e-4df5-97fd-d8fb99629959" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_34dd0a89-ebdb-43af-967f-63c6e82588a0" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_ced02fce-918e-4df5-97fd-d8fb99629959" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_2243953b-aff2-4486-815e-acba5f9b76ad" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_cdd48259-0c18-4f6f-b74c-9cb4a38ca109" xlink:to="loc_us-gaap_FinancialInstrumentAxis_2243953b-aff2-4486-815e-acba5f9b76ad" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2243953b-aff2-4486-815e-acba5f9b76ad_default" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_2243953b-aff2-4486-815e-acba5f9b76ad" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2243953b-aff2-4486-815e-acba5f9b76ad_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_fcefe597-0e07-439c-b7af-d2f62dc94b6e" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_2243953b-aff2-4486-815e-acba5f9b76ad" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_fcefe597-0e07-439c-b7af-d2f62dc94b6e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_37030bc0-75e9-4d0c-9532-2c02a6f2dc02" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_fcefe597-0e07-439c-b7af-d2f62dc94b6e" xlink:to="loc_us-gaap_MoneyMarketFundsMember_37030bc0-75e9-4d0c-9532-2c02a6f2dc02" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperNotIncludedWithCashAndCashEquivalentsMember_44ee1935-857f-4682-9d68-7dabbf0cd8be" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommercialPaperNotIncludedWithCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_fcefe597-0e07-439c-b7af-d2f62dc94b6e" xlink:to="loc_us-gaap_CommercialPaperNotIncludedWithCashAndCashEquivalentsMember_44ee1935-857f-4682-9d68-7dabbf0cd8be" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_31b8fffa-33f4-423f-b085-ae88658a3bab" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_fcefe597-0e07-439c-b7af-d2f62dc94b6e" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_31b8fffa-33f4-423f-b085-ae88658a3bab" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_e4019b2b-c3fe-431d-8d97-dcf597dd1aad" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_fcefe597-0e07-439c-b7af-d2f62dc94b6e" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_e4019b2b-c3fe-431d-8d97-dcf597dd1aad" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_74485255-94c1-4475-881e-18b4338cdd44" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_fcefe597-0e07-439c-b7af-d2f62dc94b6e" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_74485255-94c1-4475-881e-18b4338cdd44" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemablePreferredStockMember_b6a6a500-9a59-45ab-9a5e-fd92f8942f57" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RedeemablePreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_fcefe597-0e07-439c-b7af-d2f62dc94b6e" xlink:to="loc_us-gaap_RedeemablePreferredStockMember_b6a6a500-9a59-45ab-9a5e-fd92f8942f57" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#FairValueMeasurementsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://silkroadmed.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="extended" id="ida9cad21079c42f2b7aa9afa137866bf_e101dfef-093b-4398-ac7c-89621f9befcd">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_a495b573-67a6-4ac5-acf9-6163d2cc6acc" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_0ee46785-52d6-40c9-8b03-581aa59e41e1" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_a495b573-67a6-4ac5-acf9-6163d2cc6acc" xlink:to="loc_us-gaap_SharePrice_0ee46785-52d6-40c9-8b03-581aa59e41e1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_f61838cd-9acf-485b-9bb3-a4bfef302986" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_a495b573-67a6-4ac5-acf9-6163d2cc6acc" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_f61838cd-9acf-485b-9bb3-a4bfef302986" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_07b6ed4d-26be-413d-ab37-3673c7ec0aa2" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_f61838cd-9acf-485b-9bb3-a4bfef302986" xlink:to="loc_us-gaap_StatementClassOfStockAxis_07b6ed4d-26be-413d-ab37-3673c7ec0aa2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_07b6ed4d-26be-413d-ab37-3673c7ec0aa2_default" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_07b6ed4d-26be-413d-ab37-3673c7ec0aa2" xlink:to="loc_us-gaap_ClassOfStockDomain_07b6ed4d-26be-413d-ab37-3673c7ec0aa2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_cf9823a5-f8ba-45ec-917d-96352d34449e" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_07b6ed4d-26be-413d-ab37-3673c7ec0aa2" xlink:to="loc_us-gaap_ClassOfStockDomain_cf9823a5-f8ba-45ec-917d-96352d34449e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_4cc862dc-15e8-4c21-aee2-09f587e5bcfc" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_cf9823a5-f8ba-45ec-917d-96352d34449e" xlink:to="loc_us-gaap_CommonStockMember_4cc862dc-15e8-4c21-aee2-09f587e5bcfc" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/FairValueMeasurementsFairValueAssumptionsDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#FairValueMeasurementsFairValueAssumptionsDetails"/>
  <link:definitionLink xlink:role="http://silkroadmed.com/role/FairValueMeasurementsFairValueAssumptionsDetails" xlink:type="extended" id="ia789b6b9990e4f69b25e199ead5a9bfa_c40f4c43-8941-4c14-a348-5907e68cb36d">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_81b2deb2-83d1-47fb-aa7f-e3db813e98e4" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingTerm_a4e6d21e-56d1-4350-99db-d672489c67c6" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WarrantsAndRightsOutstandingTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_81b2deb2-83d1-47fb-aa7f-e3db813e98e4" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingTerm_a4e6d21e-56d1-4350-99db-d672489c67c6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingMeasurementInput_d37f84c0-4831-42f4-8ab9-79d796948f0b" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WarrantsAndRightsOutstandingMeasurementInput"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_81b2deb2-83d1-47fb-aa7f-e3db813e98e4" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingMeasurementInput_d37f84c0-4831-42f4-8ab9-79d796948f0b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_b7f8b6e5-ee7f-4875-88c8-c0792e726b42" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_81b2deb2-83d1-47fb-aa7f-e3db813e98e4" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_b7f8b6e5-ee7f-4875-88c8-c0792e726b42" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_3f019db1-f8fd-45b4-bb99-0c3ee94a048f" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_b7f8b6e5-ee7f-4875-88c8-c0792e726b42" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_3f019db1-f8fd-45b4-bb99-0c3ee94a048f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_3f019db1-f8fd-45b4-bb99-0c3ee94a048f_default" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_3f019db1-f8fd-45b4-bb99-0c3ee94a048f" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_3f019db1-f8fd-45b4-bb99-0c3ee94a048f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_07e6d770-6c9d-40d9-b2cc-cb26976471c0" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_3f019db1-f8fd-45b4-bb99-0c3ee94a048f" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_07e6d770-6c9d-40d9-b2cc-cb26976471c0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_d640fe40-07e4-45b6-a695-ec8012806778" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_07e6d770-6c9d-40d9-b2cc-cb26976471c0" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_d640fe40-07e4-45b6-a695-ec8012806778" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_7c311539-7d9d-4f9e-b333-f6aa693783c6" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_b7f8b6e5-ee7f-4875-88c8-c0792e726b42" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_7c311539-7d9d-4f9e-b333-f6aa693783c6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7c311539-7d9d-4f9e-b333-f6aa693783c6_default" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_7c311539-7d9d-4f9e-b333-f6aa693783c6" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7c311539-7d9d-4f9e-b333-f6aa693783c6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_75f227c9-9e75-4454-ac43-709884970ea3" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_7c311539-7d9d-4f9e-b333-f6aa693783c6" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_75f227c9-9e75-4454-ac43-709884970ea3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_81834ae7-c79f-4674-848a-5650d7dea0ac" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_75f227c9-9e75-4454-ac43-709884970ea3" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_81834ae7-c79f-4674-848a-5650d7dea0ac" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_a7112928-94ea-4753-bfac-e6f67969c9ea" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_b7f8b6e5-ee7f-4875-88c8-c0792e726b42" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_a7112928-94ea-4753-bfac-e6f67969c9ea" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_a7112928-94ea-4753-bfac-e6f67969c9ea_default" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_a7112928-94ea-4753-bfac-e6f67969c9ea" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_a7112928-94ea-4753-bfac-e6f67969c9ea_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_3e8e4efb-780b-46c3-96eb-fc3a7cecab48" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_a7112928-94ea-4753-bfac-e6f67969c9ea" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_3e8e4efb-780b-46c3-96eb-fc3a7cecab48" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputOptionVolatilityMember_256d1945-0fcc-4662-9b74-a6dc06c05d55" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MeasurementInputOptionVolatilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_3e8e4efb-780b-46c3-96eb-fc3a7cecab48" xlink:to="loc_us-gaap_MeasurementInputOptionVolatilityMember_256d1945-0fcc-4662-9b74-a6dc06c05d55" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember_ae17e2e0-80a2-4edb-87de-aafa184dee00" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_3e8e4efb-780b-46c3-96eb-fc3a7cecab48" xlink:to="loc_us-gaap_MeasurementInputDiscountRateMember_ae17e2e0-80a2-4edb-87de-aafa184dee00" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_3c6dda5e-de00-49bf-a4b3-88ca3977952a" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_3e8e4efb-780b-46c3-96eb-fc3a7cecab48" xlink:to="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_3c6dda5e-de00-49bf-a4b3-88ca3977952a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountForLackOfMarketabilityMember_693aabc7-449d-4283-9ee0-58992f3a82a4" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MeasurementInputDiscountForLackOfMarketabilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_3e8e4efb-780b-46c3-96eb-fc3a7cecab48" xlink:to="loc_us-gaap_MeasurementInputDiscountForLackOfMarketabilityMember_693aabc7-449d-4283-9ee0-58992f3a82a4" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/FairValueMeasurementsChangesinRedeemableConvertibleWarrantLiabilityDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#FairValueMeasurementsChangesinRedeemableConvertibleWarrantLiabilityDetails"/>
  <link:definitionLink xlink:role="http://silkroadmed.com/role/FairValueMeasurementsChangesinRedeemableConvertibleWarrantLiabilityDetails" xlink:type="extended" id="i6b809bad846d44e5b38779153487d4b2_0a4c3ea9-bd47-4a17-9403-dbfef60e09f6"/>
  <link:roleRef roleURI="http://silkroadmed.com/role/BalanceSheetComponents" xlink:type="simple" xlink:href="silk-20191231.xsd#BalanceSheetComponents"/>
  <link:definitionLink xlink:role="http://silkroadmed.com/role/BalanceSheetComponents" xlink:type="extended" id="i96355a6dcc2442a58b7d8525f5db3d6a_b956f178-782e-4558-8935-7b444ed3f55a"/>
  <link:roleRef roleURI="http://silkroadmed.com/role/BalanceSheetComponentsTables" xlink:type="simple" xlink:href="silk-20191231.xsd#BalanceSheetComponentsTables"/>
  <link:definitionLink xlink:role="http://silkroadmed.com/role/BalanceSheetComponentsTables" xlink:type="extended" id="i406d1ac3c79f4bada7a0077dbbd1ec9e_ba5eeb6c-ac4d-4e1b-b330-aa654924864e"/>
  <link:roleRef roleURI="http://silkroadmed.com/role/BalanceSheetComponentsFairValueofAvailableForSaleInvestmentsDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#BalanceSheetComponentsFairValueofAvailableForSaleInvestmentsDetails"/>
  <link:definitionLink xlink:role="http://silkroadmed.com/role/BalanceSheetComponentsFairValueofAvailableForSaleInvestmentsDetails" xlink:type="extended" id="iaaa66f029abc4be3b84d80290174973b_802974b1-71ec-479e-9cf6-2af362d9af79">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_ada3e279-37b1-4ed8-8534-f35455fff482" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_847c021f-5756-4615-b6fe-9bfdd2dd7071" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_ada3e279-37b1-4ed8-8534-f35455fff482" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_847c021f-5756-4615-b6fe-9bfdd2dd7071" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_f7649f41-e0b3-458d-9e3b-50f453e1ecc5" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_ada3e279-37b1-4ed8-8534-f35455fff482" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_f7649f41-e0b3-458d-9e3b-50f453e1ecc5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_5f47e773-9b08-4084-ad41-5f0b85eb78a9" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_ada3e279-37b1-4ed8-8534-f35455fff482" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_5f47e773-9b08-4084-ad41-5f0b85eb78a9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_1481bf21-d05f-40e3-a636-bfad271ba94e" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_ada3e279-37b1-4ed8-8534-f35455fff482" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_1481bf21-d05f-40e3-a636-bfad271ba94e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_3f7765fa-7c68-492d-92bd-d5c57561e09b" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_ada3e279-37b1-4ed8-8534-f35455fff482" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_3f7765fa-7c68-492d-92bd-d5c57561e09b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_422dbed5-2644-4c33-9612-eb173d0848b2" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_3f7765fa-7c68-492d-92bd-d5c57561e09b" xlink:to="loc_us-gaap_FinancialInstrumentAxis_422dbed5-2644-4c33-9612-eb173d0848b2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_422dbed5-2644-4c33-9612-eb173d0848b2_default" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_422dbed5-2644-4c33-9612-eb173d0848b2" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_422dbed5-2644-4c33-9612-eb173d0848b2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_89602efc-fe61-4598-96f5-de91a99ae971" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_422dbed5-2644-4c33-9612-eb173d0848b2" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_89602efc-fe61-4598-96f5-de91a99ae971" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_158fa876-8f87-43b0-a097-755db6ab5eb7" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_89602efc-fe61-4598-96f5-de91a99ae971" xlink:to="loc_us-gaap_MoneyMarketFundsMember_158fa876-8f87-43b0-a097-755db6ab5eb7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_eac2d93a-b009-4d8a-be57-2d11c49df18f" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_89602efc-fe61-4598-96f5-de91a99ae971" xlink:to="loc_us-gaap_CommercialPaperMember_eac2d93a-b009-4d8a-be57-2d11c49df18f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_e172aa63-48bc-4644-92ea-c3d4b2a41733" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_89602efc-fe61-4598-96f5-de91a99ae971" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_e172aa63-48bc-4644-92ea-c3d4b2a41733" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember_336c9c2e-e598-497d-a461-d81020e56795" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_89602efc-fe61-4598-96f5-de91a99ae971" xlink:to="loc_us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember_336c9c2e-e598-497d-a461-d81020e56795" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_35401df7-af10-477a-97fe-206e22e4705e" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_89602efc-fe61-4598-96f5-de91a99ae971" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_35401df7-af10-477a-97fe-206e22e4705e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashEquivalentsMember_240327c3-fd5e-4ea5-af6d-a2ea363b08f0" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_89602efc-fe61-4598-96f5-de91a99ae971" xlink:to="loc_us-gaap_CashEquivalentsMember_240327c3-fd5e-4ea5-af6d-a2ea363b08f0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestmentsMember_927781cf-7c99-4efb-8e79-61f42e4c0ea6" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_89602efc-fe61-4598-96f5-de91a99ae971" xlink:to="loc_us-gaap_ShortTermInvestmentsMember_927781cf-7c99-4efb-8e79-61f42e4c0ea6" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_LongTermInvestmentsMember_faca6978-df5e-4aaa-9da1-23803932355b" xlink:href="silk-20191231.xsd#silk_LongTermInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_89602efc-fe61-4598-96f5-de91a99ae971" xlink:to="loc_silk_LongTermInvestmentsMember_faca6978-df5e-4aaa-9da1-23803932355b" xlink:type="arc" order="7"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/BalanceSheetComponentsFairValueofCashEquivalentsShortTermandLongTermInvestmentsDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#BalanceSheetComponentsFairValueofCashEquivalentsShortTermandLongTermInvestmentsDetails"/>
  <link:definitionLink xlink:role="http://silkroadmed.com/role/BalanceSheetComponentsFairValueofCashEquivalentsShortTermandLongTermInvestmentsDetails" xlink:type="extended" id="i233eb388eed841a8b1cf321ca3fba729_0d0d217f-577c-42fe-badd-3f04e81fd624"/>
  <link:roleRef roleURI="http://silkroadmed.com/role/BalanceSheetComponentsAvailableforSaleInvestmentsinUnrealizedLossPositionDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#BalanceSheetComponentsAvailableforSaleInvestmentsinUnrealizedLossPositionDetails"/>
  <link:definitionLink xlink:role="http://silkroadmed.com/role/BalanceSheetComponentsAvailableforSaleInvestmentsinUnrealizedLossPositionDetails" xlink:type="extended" id="i87e29170c206469b9a281975db5a934d_031cb449-829e-4815-8bed-29d789c0a6c2">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_1b086bcc-0661-469b-94f1-8f80f50eddc2" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_ece82096-a30a-4e47-bca7-e1023d7653bb" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_1b086bcc-0661-469b-94f1-8f80f50eddc2" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_ece82096-a30a-4e47-bca7-e1023d7653bb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_58b66f37-0298-4be8-a54a-b74389efa864" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_1b086bcc-0661-469b-94f1-8f80f50eddc2" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_58b66f37-0298-4be8-a54a-b74389efa864" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_3c1a8c01-4d2a-43bb-a745-fbee1e3479c5" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_1b086bcc-0661-469b-94f1-8f80f50eddc2" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_3c1a8c01-4d2a-43bb-a745-fbee1e3479c5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_944ef27d-22c7-4d45-9b7b-fec76b181942" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_3c1a8c01-4d2a-43bb-a745-fbee1e3479c5" xlink:to="loc_us-gaap_FinancialInstrumentAxis_944ef27d-22c7-4d45-9b7b-fec76b181942" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_944ef27d-22c7-4d45-9b7b-fec76b181942_default" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_944ef27d-22c7-4d45-9b7b-fec76b181942" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_944ef27d-22c7-4d45-9b7b-fec76b181942_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2a887947-5af2-464b-ada0-f76d61e77186" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_944ef27d-22c7-4d45-9b7b-fec76b181942" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2a887947-5af2-464b-ada0-f76d61e77186" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_c4431b04-db4b-4d5b-9186-ce024d1cc341" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2a887947-5af2-464b-ada0-f76d61e77186" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_c4431b04-db4b-4d5b-9186-ce024d1cc341" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember_5616b2c2-b4ba-495f-b723-a6fdcba08f4e" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2a887947-5af2-464b-ada0-f76d61e77186" xlink:to="loc_us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember_5616b2c2-b4ba-495f-b723-a6fdcba08f4e" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/BalanceSheetComponentsScheduleofInventoryDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#BalanceSheetComponentsScheduleofInventoryDetails"/>
  <link:definitionLink xlink:role="http://silkroadmed.com/role/BalanceSheetComponentsScheduleofInventoryDetails" xlink:type="extended" id="i9a62b9e28de9422199cdd0d269638081_4cdd2c0c-617d-41ad-8f49-36257976f1d3"/>
  <link:roleRef roleURI="http://silkroadmed.com/role/BalanceSheetComponentsNarrativeDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#BalanceSheetComponentsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://silkroadmed.com/role/BalanceSheetComponentsNarrativeDetails" xlink:type="extended" id="ib6e3ba8beb514bd1b50a594fd4ee6f56_70085660-2813-4d26-8128-e3de409bda83"/>
  <link:roleRef roleURI="http://silkroadmed.com/role/BalanceSheetComponentsPropertyPlantandEquipmentDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#BalanceSheetComponentsPropertyPlantandEquipmentDetails"/>
  <link:definitionLink xlink:role="http://silkroadmed.com/role/BalanceSheetComponentsPropertyPlantandEquipmentDetails" xlink:type="extended" id="i6875e07b623a4f1d95b39c9800dcd40c_f1797729-fb04-4c3f-bb16-dfa34cea43de">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5ca33061-d6c0-48a8-ab4f-baa54cadfa79" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_fb290701-142f-4276-9bf4-18fb2113cc27" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5ca33061-d6c0-48a8-ab4f-baa54cadfa79" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_fb290701-142f-4276-9bf4-18fb2113cc27" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_4ac250f3-3f2d-4f2e-b522-1fcfdb9ddf62" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5ca33061-d6c0-48a8-ab4f-baa54cadfa79" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_4ac250f3-3f2d-4f2e-b522-1fcfdb9ddf62" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_4137c2cd-df4f-418f-b563-70ea43c0a3d8" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5ca33061-d6c0-48a8-ab4f-baa54cadfa79" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_4137c2cd-df4f-418f-b563-70ea43c0a3d8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_be2bcbe5-c4ed-430a-b4b3-35f72e072680" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5ca33061-d6c0-48a8-ab4f-baa54cadfa79" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_be2bcbe5-c4ed-430a-b4b3-35f72e072680" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_4002e70b-a54b-4d0d-bce2-00e976309fe8" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_be2bcbe5-c4ed-430a-b4b3-35f72e072680" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_4002e70b-a54b-4d0d-bce2-00e976309fe8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4002e70b-a54b-4d0d-bce2-00e976309fe8_default" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_4002e70b-a54b-4d0d-bce2-00e976309fe8" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4002e70b-a54b-4d0d-bce2-00e976309fe8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a0044df5-1434-4cd9-97f2-17614664e157" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_4002e70b-a54b-4d0d-bce2-00e976309fe8" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a0044df5-1434-4cd9-97f2-17614664e157" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_e1e2b5e8-f1b7-4237-b5c6-3b0027bf3780" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a0044df5-1434-4cd9-97f2-17614664e157" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_e1e2b5e8-f1b7-4237-b5c6-3b0027bf3780" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember_d5a130f2-cfce-4143-a0d6-a98cfc792f93" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a0044df5-1434-4cd9-97f2-17614664e157" xlink:to="loc_us-gaap_EquipmentMember_d5a130f2-cfce-4143-a0d6-a98cfc792f93" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_f0f3162f-9b6e-48ed-be33-40fda56f5a63" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a0044df5-1434-4cd9-97f2-17614664e157" xlink:to="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_f0f3162f-9b6e-48ed-be33-40fda56f5a63" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_59fbe796-9a24-4a6f-a792-35d1d9d435cf" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a0044df5-1434-4cd9-97f2-17614664e157" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_59fbe796-9a24-4a6f-a792-35d1d9d435cf" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_c9ab9c1d-c9e1-4ee7-9616-4c13e6a64435" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a0044df5-1434-4cd9-97f2-17614664e157" xlink:to="loc_us-gaap_ConstructionInProgressMember_c9ab9c1d-c9e1-4ee7-9616-4c13e6a64435" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/BalanceSheetComponentsAccruedLiabilitiesDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#BalanceSheetComponentsAccruedLiabilitiesDetails"/>
  <link:definitionLink xlink:role="http://silkroadmed.com/role/BalanceSheetComponentsAccruedLiabilitiesDetails" xlink:type="extended" id="i7db55b5264b74ff088e6fdaf82e026c6_7eeb560a-3bb5-4a15-84d1-2aa831594d3c"/>
  <link:roleRef roleURI="http://silkroadmed.com/role/LongtermDebt" xlink:type="simple" xlink:href="silk-20191231.xsd#LongtermDebt"/>
  <link:definitionLink xlink:role="http://silkroadmed.com/role/LongtermDebt" xlink:type="extended" id="i354075474f9f4e89ba481347c3a3673c_380eabaf-8f7c-47cd-8178-9bd75a15c44e"/>
  <link:roleRef roleURI="http://silkroadmed.com/role/LongtermDebtTables" xlink:type="simple" xlink:href="silk-20191231.xsd#LongtermDebtTables"/>
  <link:definitionLink xlink:role="http://silkroadmed.com/role/LongtermDebtTables" xlink:type="extended" id="idb9a8a1260fc48efbf029601d8a9261a_113bee5d-0bea-4535-b1bb-fd2dd937bcb5"/>
  <link:roleRef roleURI="http://silkroadmed.com/role/LongtermDebtTermLoanNarrativeDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#LongtermDebtTermLoanNarrativeDetails"/>
  <link:definitionLink xlink:role="http://silkroadmed.com/role/LongtermDebtTermLoanNarrativeDetails" xlink:type="extended" id="ide99dba77dd44ee7bb56114c9db79100_e2dd0b61-b4aa-4197-b4fd-6d9ba128249a">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_5b0bc06e-ac77-4207-9307-25b917ff382e" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_DebtMaximumBorrowingCapacity_b74b9c34-59ee-46ca-a1e6-f91d1b990fc4" xlink:href="silk-20191231.xsd#silk_DebtMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5b0bc06e-ac77-4207-9307-25b917ff382e" xlink:to="loc_silk_DebtMaximumBorrowingCapacity_b74b9c34-59ee-46ca-a1e6-f91d1b990fc4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_5749a561-13b6-4aca-abe1-c965996839f6" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5b0bc06e-ac77-4207-9307-25b917ff382e" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_5749a561-13b6-4aca-abe1-c965996839f6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_23b52855-e204-4f41-8c95-505be5c5b4d0" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5b0bc06e-ac77-4207-9307-25b917ff382e" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_23b52855-e204-4f41-8c95-505be5c5b4d0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_DebtInstrumentInterestRatePaidInKind_014026f6-0073-4839-bc59-a9694eb3ef56" xlink:href="silk-20191231.xsd#silk_DebtInstrumentInterestRatePaidInKind"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5b0bc06e-ac77-4207-9307-25b917ff382e" xlink:to="loc_silk_DebtInstrumentInterestRatePaidInKind_014026f6-0073-4839-bc59-a9694eb3ef56" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_DebtInstrumentInterestRatePaidInCash_ca3ba4a9-b762-4455-af13-f714277e3411" xlink:href="silk-20191231.xsd#silk_DebtInstrumentInterestRatePaidInCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5b0bc06e-ac77-4207-9307-25b917ff382e" xlink:to="loc_silk_DebtInstrumentInterestRatePaidInCash_ca3ba4a9-b762-4455-af13-f714277e3411" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_DebtInstrumentConvertibleMaximumPercentageOfOutstandingLoans_34aefb2e-2b59-4731-92ef-47cc8a0f1c06" xlink:href="silk-20191231.xsd#silk_DebtInstrumentConvertibleMaximumPercentageOfOutstandingLoans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5b0bc06e-ac77-4207-9307-25b917ff382e" xlink:to="loc_silk_DebtInstrumentConvertibleMaximumPercentageOfOutstandingLoans_34aefb2e-2b59-4731-92ef-47cc8a0f1c06" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_DebtInstrumentConvertibleMarketCapitalization_906fef73-2016-48f8-a369-39f7dd1a5141" xlink:href="silk-20191231.xsd#silk_DebtInstrumentConvertibleMarketCapitalization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5b0bc06e-ac77-4207-9307-25b917ff382e" xlink:to="loc_silk_DebtInstrumentConvertibleMarketCapitalization_906fef73-2016-48f8-a369-39f7dd1a5141" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_DebtInstrumentInterestRateFinancingFee_83387a90-651c-4216-879e-30394ab90692" xlink:href="silk-20191231.xsd#silk_DebtInstrumentInterestRateFinancingFee"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5b0bc06e-ac77-4207-9307-25b917ff382e" xlink:to="loc_silk_DebtInstrumentInterestRateFinancingFee_83387a90-651c-4216-879e-30394ab90692" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_DebtInstrumentInterestRateFacilityFee_9351c485-85d6-4094-8cf2-f8e9cf12484a" xlink:href="silk-20191231.xsd#silk_DebtInstrumentInterestRateFacilityFee"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5b0bc06e-ac77-4207-9307-25b917ff382e" xlink:to="loc_silk_DebtInstrumentInterestRateFacilityFee_9351c485-85d6-4094-8cf2-f8e9cf12484a" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_DebtInstrumentCovenantMaximumLiquidityAmount_8d890e14-50d2-485a-8d94-d219f66a6fd8" xlink:href="silk-20191231.xsd#silk_DebtInstrumentCovenantMaximumLiquidityAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5b0bc06e-ac77-4207-9307-25b917ff382e" xlink:to="loc_silk_DebtInstrumentCovenantMaximumLiquidityAmount_8d890e14-50d2-485a-8d94-d219f66a6fd8" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_DebtInstrumentCovenantMinimumNetRevenueAmount_50431558-6e78-4c7a-82a2-4a66b946fc83" xlink:href="silk-20191231.xsd#silk_DebtInstrumentCovenantMinimumNetRevenueAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5b0bc06e-ac77-4207-9307-25b917ff382e" xlink:to="loc_silk_DebtInstrumentCovenantMinimumNetRevenueAmount_50431558-6e78-4c7a-82a2-4a66b946fc83" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_DebtInstrumentLiquidityCovenantTerm_57adab46-3314-4bf9-96c7-dbf80d50ff7a" xlink:href="silk-20191231.xsd#silk_DebtInstrumentLiquidityCovenantTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5b0bc06e-ac77-4207-9307-25b917ff382e" xlink:to="loc_silk_DebtInstrumentLiquidityCovenantTerm_57adab46-3314-4bf9-96c7-dbf80d50ff7a" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_5d7a6a50-3195-4474-93e6-76381c859e76" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5b0bc06e-ac77-4207-9307-25b917ff382e" xlink:to="loc_us-gaap_LongTermDebt_5d7a6a50-3195-4474-93e6-76381c859e76" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_dfdc44e4-3b09-4258-9d6e-ce3060907ee7" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5b0bc06e-ac77-4207-9307-25b917ff382e" xlink:to="loc_us-gaap_DebtInstrumentTable_dfdc44e4-3b09-4258-9d6e-ce3060907ee7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_f9e9c818-bb92-423d-b5cf-2f1a566bfdb7" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_dfdc44e4-3b09-4258-9d6e-ce3060907ee7" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_f9e9c818-bb92-423d-b5cf-2f1a566bfdb7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_f9e9c818-bb92-423d-b5cf-2f1a566bfdb7_default" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_f9e9c818-bb92-423d-b5cf-2f1a566bfdb7" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_f9e9c818-bb92-423d-b5cf-2f1a566bfdb7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_56dfee8e-621e-40e6-979e-d620564d19c0" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_f9e9c818-bb92-423d-b5cf-2f1a566bfdb7" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_56dfee8e-621e-40e6-979e-d620564d19c0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_TermLoanMember_f9e065d2-b9f1-4337-818e-f144e7c4d3c0" xlink:href="silk-20191231.xsd#silk_TermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_56dfee8e-621e-40e6-979e-d620564d19c0" xlink:to="loc_silk_TermLoanMember_f9e065d2-b9f1-4337-818e-f144e7c4d3c0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_TermLoanTrancheAMember_1f39e956-d4a4-4ac3-b826-12ee9f09cdfd" xlink:href="silk-20191231.xsd#silk_TermLoanTrancheAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_56dfee8e-621e-40e6-979e-d620564d19c0" xlink:to="loc_silk_TermLoanTrancheAMember_1f39e956-d4a4-4ac3-b826-12ee9f09cdfd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_TermLoanTrancheBMember_4db6e0b7-6ac4-4923-a52a-d16218b850b7" xlink:href="silk-20191231.xsd#silk_TermLoanTrancheBMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_56dfee8e-621e-40e6-979e-d620564d19c0" xlink:to="loc_silk_TermLoanTrancheBMember_4db6e0b7-6ac4-4923-a52a-d16218b850b7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementScenarioAxis_8c83d97a-f298-4d07-ac91-58d87c801eaa" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_dfdc44e4-3b09-4258-9d6e-ce3060907ee7" xlink:to="loc_us-gaap_StatementScenarioAxis_8c83d97a-f298-4d07-ac91-58d87c801eaa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScenarioUnspecifiedDomain_8c83d97a-f298-4d07-ac91-58d87c801eaa_default" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementScenarioAxis_8c83d97a-f298-4d07-ac91-58d87c801eaa" xlink:to="loc_us-gaap_ScenarioUnspecifiedDomain_8c83d97a-f298-4d07-ac91-58d87c801eaa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScenarioUnspecifiedDomain_f022d098-b208-4dd9-a0a3-6b7fa4fa54c2" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementScenarioAxis_8c83d97a-f298-4d07-ac91-58d87c801eaa" xlink:to="loc_us-gaap_ScenarioUnspecifiedDomain_f022d098-b208-4dd9-a0a3-6b7fa4fa54c2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScenarioForecastMember_296db6aa-ee61-43b9-97fd-ee6a8304c0b2" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScenarioForecastMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScenarioUnspecifiedDomain_f022d098-b208-4dd9-a0a3-6b7fa4fa54c2" xlink:to="loc_us-gaap_ScenarioForecastMember_296db6aa-ee61-43b9-97fd-ee6a8304c0b2" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/LongtermDebtFutureMaturitiesUndertheTermLoanDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#LongtermDebtFutureMaturitiesUndertheTermLoanDetails"/>
  <link:definitionLink xlink:role="http://silkroadmed.com/role/LongtermDebtFutureMaturitiesUndertheTermLoanDetails" xlink:type="extended" id="ia047416b673e4c2db5eb24b3daa8f779_594edaaa-7be2-459d-8610-35ce766edc58"/>
  <link:roleRef roleURI="http://silkroadmed.com/role/LongtermDebtSeriesCNarrativeDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#LongtermDebtSeriesCNarrativeDetails"/>
  <link:definitionLink xlink:role="http://silkroadmed.com/role/LongtermDebtSeriesCNarrativeDetails" xlink:type="extended" id="ib8676259080c429990ae226ff955ade0_5ede8e0d-06eb-4f58-a08d-81fa5817d9ec">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_62ebed39-a29e-46f4-959c-1b8a52001882" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_90082289-9b64-4f90-9f4b-85dab5dedd12" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_62ebed39-a29e-46f4-959c-1b8a52001882" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_90082289-9b64-4f90-9f4b-85dab5dedd12" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_3ccfef09-e63e-485f-b5de-2abd1d834415" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_62ebed39-a29e-46f4-959c-1b8a52001882" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_3ccfef09-e63e-485f-b5de-2abd1d834415" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_e31ba745-c752-49d7-a6ee-dda0017b4b26" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_62ebed39-a29e-46f4-959c-1b8a52001882" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_e31ba745-c752-49d7-a6ee-dda0017b4b26" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_ff2bd1af-e99e-47d4-9493-44e36132a2fe" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_62ebed39-a29e-46f4-959c-1b8a52001882" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_ff2bd1af-e99e-47d4-9493-44e36132a2fe" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_ac59eab9-cfaa-4f3d-b9d9-ac03bbbe3307" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_ff2bd1af-e99e-47d4-9493-44e36132a2fe" xlink:to="loc_us-gaap_StatementClassOfStockAxis_ac59eab9-cfaa-4f3d-b9d9-ac03bbbe3307" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_ac59eab9-cfaa-4f3d-b9d9-ac03bbbe3307_default" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_ac59eab9-cfaa-4f3d-b9d9-ac03bbbe3307" xlink:to="loc_us-gaap_ClassOfStockDomain_ac59eab9-cfaa-4f3d-b9d9-ac03bbbe3307_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_8e609f79-8679-4203-9dd8-835718f4cf60" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_ac59eab9-cfaa-4f3d-b9d9-ac03bbbe3307" xlink:to="loc_us-gaap_ClassOfStockDomain_8e609f79-8679-4203-9dd8-835718f4cf60" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesCPreferredStockMember_2a4d15f6-415c-4e52-b2ae-8615eae5f742" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SeriesCPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_8e609f79-8679-4203-9dd8-835718f4cf60" xlink:to="loc_us-gaap_SeriesCPreferredStockMember_2a4d15f6-415c-4e52-b2ae-8615eae5f742" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_525fe101-e8ad-4448-8d45-a99ce02a7eda" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_ff2bd1af-e99e-47d4-9493-44e36132a2fe" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_525fe101-e8ad-4448-8d45-a99ce02a7eda" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_525fe101-e8ad-4448-8d45-a99ce02a7eda_default" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_525fe101-e8ad-4448-8d45-a99ce02a7eda" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_525fe101-e8ad-4448-8d45-a99ce02a7eda_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_036a2072-6f57-411b-8d77-468c49835c8a" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_525fe101-e8ad-4448-8d45-a99ce02a7eda" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_036a2072-6f57-411b-8d77-468c49835c8a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_PreferredStockWarrantsMember_f381bdb0-c808-45e5-a166-b954365b5e46" xlink:href="silk-20191231.xsd#silk_PreferredStockWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_036a2072-6f57-411b-8d77-468c49835c8a" xlink:to="loc_silk_PreferredStockWarrantsMember_f381bdb0-c808-45e5-a166-b954365b5e46" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="silk-20191231.xsd#CommitmentsandContingencies"/>
  <link:definitionLink xlink:role="http://silkroadmed.com/role/CommitmentsandContingencies" xlink:type="extended" id="i6395b0d1a64d4e73a6f5f092cbbd7060_a88572bb-4bce-4d16-809b-e99d75e40785"/>
  <link:roleRef roleURI="http://silkroadmed.com/role/CommitmentsandContingenciesTables" xlink:type="simple" xlink:href="silk-20191231.xsd#CommitmentsandContingenciesTables"/>
  <link:definitionLink xlink:role="http://silkroadmed.com/role/CommitmentsandContingenciesTables" xlink:type="extended" id="ibc1144ad7f0c4114a5ed7c111a916a36_ca7799ff-4827-4346-ac30-db66498d0f54"/>
  <link:roleRef roleURI="http://silkroadmed.com/role/CommitmentsandContingenciesLeaseNarrativeDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#CommitmentsandContingenciesLeaseNarrativeDetails"/>
  <link:definitionLink xlink:role="http://silkroadmed.com/role/CommitmentsandContingenciesLeaseNarrativeDetails" xlink:type="extended" id="ic0e6186ba7134e7c9328bba6902ae7dc_32afc5a4-2a84-4cd2-b263-9d7768639f5e"/>
  <link:roleRef roleURI="http://silkroadmed.com/role/CommitmentsandContingenciesBalanceSheetInformationDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#CommitmentsandContingenciesBalanceSheetInformationDetails"/>
  <link:definitionLink xlink:role="http://silkroadmed.com/role/CommitmentsandContingenciesBalanceSheetInformationDetails" xlink:type="extended" id="id8e65a3c178141498747036414931645_54cc38fb-2162-474e-bb0b-04c46bcf60b2"/>
  <link:roleRef roleURI="http://silkroadmed.com/role/CommitmentsandContingenciesOperatingLeaseMaturitiesDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#CommitmentsandContingenciesOperatingLeaseMaturitiesDetails"/>
  <link:definitionLink xlink:role="http://silkroadmed.com/role/CommitmentsandContingenciesOperatingLeaseMaturitiesDetails" xlink:type="extended" id="ic7f6eb762b034c118019d9702efc240c_7d7e4a44-d03b-4f9a-8b67-fbb73ac249e5"/>
  <link:roleRef roleURI="http://silkroadmed.com/role/CommitmentsandContingenciesTopic840AggregateFutureMinimumLeasePaymentsDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#CommitmentsandContingenciesTopic840AggregateFutureMinimumLeasePaymentsDetails"/>
  <link:definitionLink xlink:role="http://silkroadmed.com/role/CommitmentsandContingenciesTopic840AggregateFutureMinimumLeasePaymentsDetails" xlink:type="extended" id="if9325417b4c24e4ca4c26ef03c80295b_ea29ef79-95f6-45f1-a6e5-ec19e5eb6768"/>
  <link:roleRef roleURI="http://silkroadmed.com/role/CommitmentsandContingenciesPurchaseObligationNarrativeDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#CommitmentsandContingenciesPurchaseObligationNarrativeDetails"/>
  <link:definitionLink xlink:role="http://silkroadmed.com/role/CommitmentsandContingenciesPurchaseObligationNarrativeDetails" xlink:type="extended" id="i3560a9b84e8a4edb85ea08a621251f51_8495a210-4ef0-4285-a5ff-06047329a52a"/>
  <link:roleRef roleURI="http://silkroadmed.com/role/RedeemableConvertiblePreferredStock" xlink:type="simple" xlink:href="silk-20191231.xsd#RedeemableConvertiblePreferredStock"/>
  <link:definitionLink xlink:role="http://silkroadmed.com/role/RedeemableConvertiblePreferredStock" xlink:type="extended" id="i667a0c82d16e4a989bce01a843480de8_569dee04-ed37-4aa2-9898-a0ad8c4d1d37"/>
  <link:roleRef roleURI="http://silkroadmed.com/role/RedeemableConvertiblePreferredStockTables" xlink:type="simple" xlink:href="silk-20191231.xsd#RedeemableConvertiblePreferredStockTables"/>
  <link:definitionLink xlink:role="http://silkroadmed.com/role/RedeemableConvertiblePreferredStockTables" xlink:type="extended" id="i66fe8d7a19f54fff9b63a5c6a48d872e_da278283-5355-4123-afe2-b3d70129f42e"/>
  <link:roleRef roleURI="http://silkroadmed.com/role/RedeemableConvertiblePreferredStockScheduleofRedeemableConvertiblePreferredStockDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#RedeemableConvertiblePreferredStockScheduleofRedeemableConvertiblePreferredStockDetails"/>
  <link:definitionLink xlink:role="http://silkroadmed.com/role/RedeemableConvertiblePreferredStockScheduleofRedeemableConvertiblePreferredStockDetails" xlink:type="extended" id="id3bbfcad02f548c3912ec236c3d69b1e_f5064691-b3f8-4497-83d0-c1c7d4f88d5b">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityLineItems_faf14733-3996-4d59-a673-884aa2729b63" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TemporaryEquityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesAuthorized_e590aff0-ab2f-44f7-870f-72f717fd5e88" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TemporaryEquitySharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_faf14733-3996-4d59-a673-884aa2729b63" xlink:to="loc_us-gaap_TemporaryEquitySharesAuthorized_e590aff0-ab2f-44f7-870f-72f717fd5e88" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesIssued_ad1b3611-0b3d-4499-952a-539ba6cd154f" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TemporaryEquitySharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_faf14733-3996-4d59-a673-884aa2729b63" xlink:to="loc_us-gaap_TemporaryEquitySharesIssued_ad1b3611-0b3d-4499-952a-539ba6cd154f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_fd9c7001-0390-44d7-b657-977961f8aae4" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_faf14733-3996-4d59-a673-884aa2729b63" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_fd9c7001-0390-44d7-b657-977961f8aae4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityLiquidationPreferencePerShare_cd994d09-7bab-4aeb-b1ab-8b9c9b400e6e" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TemporaryEquityLiquidationPreferencePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_faf14733-3996-4d59-a673-884aa2729b63" xlink:to="loc_us-gaap_TemporaryEquityLiquidationPreferencePerShare_cd994d09-7bab-4aeb-b1ab-8b9c9b400e6e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityLiquidationPreference_934d0481-8c79-47fe-a801-d8eef41ae5d9" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TemporaryEquityLiquidationPreference"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_faf14733-3996-4d59-a673-884aa2729b63" xlink:to="loc_us-gaap_TemporaryEquityLiquidationPreference_934d0481-8c79-47fe-a801-d8eef41ae5d9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_541f97b9-6a67-44a3-b7f1-20b36b41473a" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_faf14733-3996-4d59-a673-884aa2729b63" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_541f97b9-6a67-44a3-b7f1-20b36b41473a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityByClassOfStockTable_bc6dc07a-cffb-45e2-a5de-4651335875cb" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TemporaryEquityByClassOfStockTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_TemporaryEquityLineItems_faf14733-3996-4d59-a673-884aa2729b63" xlink:to="loc_us-gaap_TemporaryEquityByClassOfStockTable_bc6dc07a-cffb-45e2-a5de-4651335875cb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_3ea05169-df2b-491f-9e37-bf162c06b22a" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_TemporaryEquityByClassOfStockTable_bc6dc07a-cffb-45e2-a5de-4651335875cb" xlink:to="loc_us-gaap_StatementClassOfStockAxis_3ea05169-df2b-491f-9e37-bf162c06b22a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_3ea05169-df2b-491f-9e37-bf162c06b22a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_3ea05169-df2b-491f-9e37-bf162c06b22a" xlink:to="loc_us-gaap_ClassOfStockDomain_3ea05169-df2b-491f-9e37-bf162c06b22a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_d8750f43-d092-4772-ac06-b38a139ce547" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_3ea05169-df2b-491f-9e37-bf162c06b22a" xlink:to="loc_us-gaap_ClassOfStockDomain_d8750f43-d092-4772-ac06-b38a139ce547" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesAPreferredStockMember_4193e14f-ea68-46bd-8ac4-683b310a24e6" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_d8750f43-d092-4772-ac06-b38a139ce547" xlink:to="loc_us-gaap_SeriesAPreferredStockMember_4193e14f-ea68-46bd-8ac4-683b310a24e6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_SeriesA1PreferredStockMember_d044815b-c7a0-49ac-97ea-767f546109fc" xlink:href="silk-20191231.xsd#silk_SeriesA1PreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_d8750f43-d092-4772-ac06-b38a139ce547" xlink:to="loc_silk_SeriesA1PreferredStockMember_d044815b-c7a0-49ac-97ea-767f546109fc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesBPreferredStockMember_25cb2daa-c1ec-4c7c-8231-5b719767bdc4" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_d8750f43-d092-4772-ac06-b38a139ce547" xlink:to="loc_us-gaap_SeriesBPreferredStockMember_25cb2daa-c1ec-4c7c-8231-5b719767bdc4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesCPreferredStockMember_487da819-7c18-49a2-8d42-e4a8dc4b81b8" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SeriesCPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_d8750f43-d092-4772-ac06-b38a139ce547" xlink:to="loc_us-gaap_SeriesCPreferredStockMember_487da819-7c18-49a2-8d42-e4a8dc4b81b8" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/RedeemableConvertiblePreferredStockNarrativeDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#RedeemableConvertiblePreferredStockNarrativeDetails"/>
  <link:definitionLink xlink:role="http://silkroadmed.com/role/RedeemableConvertiblePreferredStockNarrativeDetails" xlink:type="extended" id="i8e8754c83f084e65ad2996de73f7069d_d517f573-c79f-44ec-8b10-f059fe057c4d">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityLineItems_a4ab0e8a-0508-40f1-9677-2268fdeeb026" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TemporaryEquityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesIssued_7958787a-4887-4c55-bb8a-8e1ffca4c7e5" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TemporaryEquitySharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_a4ab0e8a-0508-40f1-9677-2268fdeeb026" xlink:to="loc_us-gaap_TemporaryEquitySharesIssued_7958787a-4887-4c55-bb8a-8e1ffca4c7e5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_2daf0d75-392c-4bc6-a003-cb359095b8da" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_a4ab0e8a-0508-40f1-9677-2268fdeeb026" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_2daf0d75-392c-4bc6-a003-cb359095b8da" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_5d823580-6c78-48c6-a04a-605ba3a0ce90" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_a4ab0e8a-0508-40f1-9677-2268fdeeb026" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_5d823580-6c78-48c6-a04a-605ba3a0ce90" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockSharesConverted1_01fca7e6-4c24-45d7-9ba1-d36dd426bb64" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConversionOfStockSharesConverted1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_a4ab0e8a-0508-40f1-9677-2268fdeeb026" xlink:to="loc_us-gaap_ConversionOfStockSharesConverted1_01fca7e6-4c24-45d7-9ba1-d36dd426bb64" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_8db12fd1-6f5d-4c06-a32c-1252d2ebe266" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_a4ab0e8a-0508-40f1-9677-2268fdeeb026" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_8db12fd1-6f5d-4c06-a32c-1252d2ebe266" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityByClassOfStockTable_4f62d6ee-df45-4ef6-9a5d-c62200c4fd13" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TemporaryEquityByClassOfStockTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_TemporaryEquityLineItems_a4ab0e8a-0508-40f1-9677-2268fdeeb026" xlink:to="loc_us-gaap_TemporaryEquityByClassOfStockTable_4f62d6ee-df45-4ef6-9a5d-c62200c4fd13" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_f1f284b0-42c1-4530-b05f-5cc81ce924a6" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_TemporaryEquityByClassOfStockTable_4f62d6ee-df45-4ef6-9a5d-c62200c4fd13" xlink:to="loc_us-gaap_StatementClassOfStockAxis_f1f284b0-42c1-4530-b05f-5cc81ce924a6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_f1f284b0-42c1-4530-b05f-5cc81ce924a6_default" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_f1f284b0-42c1-4530-b05f-5cc81ce924a6" xlink:to="loc_us-gaap_ClassOfStockDomain_f1f284b0-42c1-4530-b05f-5cc81ce924a6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_bb08db65-100b-4bd3-86aa-15bc12a2606a" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_f1f284b0-42c1-4530-b05f-5cc81ce924a6" xlink:to="loc_us-gaap_ClassOfStockDomain_bb08db65-100b-4bd3-86aa-15bc12a2606a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertiblePreferredStockMember_ca1fbfcb-51c0-4e81-99a4-9d73cf6d7f7e" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConvertiblePreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_bb08db65-100b-4bd3-86aa-15bc12a2606a" xlink:to="loc_us-gaap_ConvertiblePreferredStockMember_ca1fbfcb-51c0-4e81-99a4-9d73cf6d7f7e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_0b792b8e-9506-481a-91a0-4f6bae5cfc69" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_TemporaryEquityByClassOfStockTable_4f62d6ee-df45-4ef6-9a5d-c62200c4fd13" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_0b792b8e-9506-481a-91a0-4f6bae5cfc69" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_0b792b8e-9506-481a-91a0-4f6bae5cfc69_default" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_0b792b8e-9506-481a-91a0-4f6bae5cfc69" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_0b792b8e-9506-481a-91a0-4f6bae5cfc69_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_ef6d85ec-6a9c-4efd-9306-03f6a0da6b5c" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_0b792b8e-9506-481a-91a0-4f6bae5cfc69" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_ef6d85ec-6a9c-4efd-9306-03f6a0da6b5c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_PreferredStockWarrantsMember_e83b73bf-0b7b-4a88-8a09-229a446847c3" xlink:href="silk-20191231.xsd#silk_PreferredStockWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_ef6d85ec-6a9c-4efd-9306-03f6a0da6b5c" xlink:to="loc_silk_PreferredStockWarrantsMember_e83b73bf-0b7b-4a88-8a09-229a446847c3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_9c41cb20-6732-489c-915f-36e50e7cd5c9" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_TemporaryEquityByClassOfStockTable_4f62d6ee-df45-4ef6-9a5d-c62200c4fd13" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_9c41cb20-6732-489c-915f-36e50e7cd5c9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_9c41cb20-6732-489c-915f-36e50e7cd5c9_default" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_9c41cb20-6732-489c-915f-36e50e7cd5c9" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_9c41cb20-6732-489c-915f-36e50e7cd5c9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_e902e915-55df-49a8-ba1d-96891d344b5b" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_9c41cb20-6732-489c-915f-36e50e7cd5c9" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_e902e915-55df-49a8-ba1d-96891d344b5b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IPOMember_d7d04e44-da4b-4813-ab48-cc545598f775" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IPOMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_e902e915-55df-49a8-ba1d-96891d344b5b" xlink:to="loc_us-gaap_IPOMember_d7d04e44-da4b-4813-ab48-cc545598f775" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/StockholdersEquityDeficit" xlink:type="simple" xlink:href="silk-20191231.xsd#StockholdersEquityDeficit"/>
  <link:definitionLink xlink:role="http://silkroadmed.com/role/StockholdersEquityDeficit" xlink:type="extended" id="ia67deed800ed4200a23824624f3cf27f_5c48b458-8d5b-4eed-9451-624721592de0"/>
  <link:roleRef roleURI="http://silkroadmed.com/role/StockholdersEquityDeficitTables" xlink:type="simple" xlink:href="silk-20191231.xsd#StockholdersEquityDeficitTables"/>
  <link:definitionLink xlink:role="http://silkroadmed.com/role/StockholdersEquityDeficitTables" xlink:type="extended" id="i91a48fef73e54f0a9932af37bf02b36a_21c0ede8-7d9f-4ea3-a462-3a895d30a469"/>
  <link:roleRef roleURI="http://silkroadmed.com/role/StockholdersEquityDeficitNarrativeDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#StockholdersEquityDeficitNarrativeDetails"/>
  <link:definitionLink xlink:role="http://silkroadmed.com/role/StockholdersEquityDeficitNarrativeDetails" xlink:type="extended" id="ia6f964da8c454dfc99fc3c9c977f52b6_3c3cf352-d7a1-4901-983c-691c562ea06e">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems_f415f6dd-54c5-4a51-97e0-796f9a43bcfc" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_b1ff9645-f422-4c06-8268-058ad38dd0f8" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_f415f6dd-54c5-4a51-97e0-796f9a43bcfc" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_b1ff9645-f422-4c06-8268-058ad38dd0f8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_0b3b630b-bc23-4cd2-9db6-d98ed743335c" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_f415f6dd-54c5-4a51-97e0-796f9a43bcfc" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_0b3b630b-bc23-4cd2-9db6-d98ed743335c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_baa6d74d-9b00-4e06-838e-a4bed58bbfad" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_f415f6dd-54c5-4a51-97e0-796f9a43bcfc" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_baa6d74d-9b00-4e06-838e-a4bed58bbfad" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_bc688820-4725-41b8-b54b-a3822febf502" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_f415f6dd-54c5-4a51-97e0-796f9a43bcfc" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_bc688820-4725-41b8-b54b-a3822febf502" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_861ae87f-829f-42f8-8bcd-77705ccdc34f" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_f415f6dd-54c5-4a51-97e0-796f9a43bcfc" xlink:to="loc_us-gaap_CommonStockSharesIssued_861ae87f-829f-42f8-8bcd-77705ccdc34f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_da276cce-f183-4dd5-94e3-e1e45b0ca354" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_f415f6dd-54c5-4a51-97e0-796f9a43bcfc" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_da276cce-f183-4dd5-94e3-e1e45b0ca354" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStock_1d8dc7a7-f23c-49db-8ce6-3a581035a59d" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DividendsCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_f415f6dd-54c5-4a51-97e0-796f9a43bcfc" xlink:to="loc_us-gaap_DividendsCommonStock_1d8dc7a7-f23c-49db-8ce6-3a581035a59d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_CommonStockVotePerShare_55362649-01b8-4f45-83ea-0474ba7b5bd2" xlink:href="silk-20191231.xsd#silk_CommonStockVotePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_f415f6dd-54c5-4a51-97e0-796f9a43bcfc" xlink:to="loc_silk_CommonStockVotePerShare_55362649-01b8-4f45-83ea-0474ba7b5bd2" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_c4460019-facc-481d-adb4-2d2622dbbc8a" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_f415f6dd-54c5-4a51-97e0-796f9a43bcfc" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_c4460019-facc-481d-adb4-2d2622dbbc8a" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockSharesConverted1_d6d8b164-69e0-4430-928a-3b68963f96b9" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConversionOfStockSharesConverted1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_f415f6dd-54c5-4a51-97e0-796f9a43bcfc" xlink:to="loc_us-gaap_ConversionOfStockSharesConverted1_d6d8b164-69e0-4430-928a-3b68963f96b9" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_dd2aeef1-e0b6-40c8-8e82-ab7815b96c6d" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_f415f6dd-54c5-4a51-97e0-796f9a43bcfc" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_dd2aeef1-e0b6-40c8-8e82-ab7815b96c6d" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable_2463a20b-8e2a-4e6a-934c-b37b19bea98b" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_f415f6dd-54c5-4a51-97e0-796f9a43bcfc" xlink:to="loc_us-gaap_ClassOfWarrantOrRightTable_2463a20b-8e2a-4e6a-934c-b37b19bea98b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_eeec04d3-b2f3-4b68-89e5-7e1c6504b67e" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_2463a20b-8e2a-4e6a-934c-b37b19bea98b" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_eeec04d3-b2f3-4b68-89e5-7e1c6504b67e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_eeec04d3-b2f3-4b68-89e5-7e1c6504b67e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_eeec04d3-b2f3-4b68-89e5-7e1c6504b67e" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_eeec04d3-b2f3-4b68-89e5-7e1c6504b67e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_c0eff54d-9c61-411f-b31b-cb004f923656" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_eeec04d3-b2f3-4b68-89e5-7e1c6504b67e" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_c0eff54d-9c61-411f-b31b-cb004f923656" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_CommonStockWarrantsMember_52beb7ee-9fa3-4e24-aa4d-26f01e0d8f50" xlink:href="silk-20191231.xsd#silk_CommonStockWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_c0eff54d-9c61-411f-b31b-cb004f923656" xlink:to="loc_silk_CommonStockWarrantsMember_52beb7ee-9fa3-4e24-aa4d-26f01e0d8f50" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_CommonStockWarrantMember_83f545c4-e61d-4219-adf2-632fb29ca82d" xlink:href="silk-20191231.xsd#silk_CommonStockWarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_c0eff54d-9c61-411f-b31b-cb004f923656" xlink:to="loc_silk_CommonStockWarrantMember_83f545c4-e61d-4219-adf2-632fb29ca82d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_fcf27a35-220f-443b-9d8d-a6453af9ded0" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_2463a20b-8e2a-4e6a-934c-b37b19bea98b" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_fcf27a35-220f-443b-9d8d-a6453af9ded0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_fcf27a35-220f-443b-9d8d-a6453af9ded0_default" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_fcf27a35-220f-443b-9d8d-a6453af9ded0" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_fcf27a35-220f-443b-9d8d-a6453af9ded0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_4d07fdb7-e155-49b1-9e56-5a7da0766e08" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_fcf27a35-220f-443b-9d8d-a6453af9ded0" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_4d07fdb7-e155-49b1-9e56-5a7da0766e08" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IPOMember_0e9e9a50-ecbe-4e7d-809e-9f3285081cdc" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IPOMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_4d07fdb7-e155-49b1-9e56-5a7da0766e08" xlink:to="loc_us-gaap_IPOMember_0e9e9a50-ecbe-4e7d-809e-9f3285081cdc" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/StockholdersEquityDeficitSharesReservedforFutureIssuanceDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#StockholdersEquityDeficitSharesReservedforFutureIssuanceDetails"/>
  <link:definitionLink xlink:role="http://silkroadmed.com/role/StockholdersEquityDeficitSharesReservedforFutureIssuanceDetails" xlink:type="extended" id="i0a71bea702914b6ebf5f41742f27ead7_f29d0f3c-9d3e-4443-9e7d-616a661e7c2d">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_703d4dc2-c8f2-4515-998a-b2b83df1e849" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_1e28490d-e22a-48c1-9cc5-1f2316ec5284" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_703d4dc2-c8f2-4515-998a-b2b83df1e849" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_1e28490d-e22a-48c1-9cc5-1f2316ec5284" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_af4d2c05-60c5-4fd9-a9f8-e8782d72b1e8" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_703d4dc2-c8f2-4515-998a-b2b83df1e849" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_af4d2c05-60c5-4fd9-a9f8-e8782d72b1e8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_41910512-644f-46ad-8893-829f13a45f47" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_af4d2c05-60c5-4fd9-a9f8-e8782d72b1e8" xlink:to="loc_us-gaap_StatementClassOfStockAxis_41910512-644f-46ad-8893-829f13a45f47" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_41910512-644f-46ad-8893-829f13a45f47_default" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_41910512-644f-46ad-8893-829f13a45f47" xlink:to="loc_us-gaap_ClassOfStockDomain_41910512-644f-46ad-8893-829f13a45f47_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_3f6de653-8639-492f-a38d-7ac50e35fe83" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_41910512-644f-46ad-8893-829f13a45f47" xlink:to="loc_us-gaap_ClassOfStockDomain_3f6de653-8639-492f-a38d-7ac50e35fe83" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesAPreferredStockMember_fe173c03-ed84-4c71-95cb-73daa375738e" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_3f6de653-8639-492f-a38d-7ac50e35fe83" xlink:to="loc_us-gaap_SeriesAPreferredStockMember_fe173c03-ed84-4c71-95cb-73daa375738e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_SeriesA1PreferredStockMember_a05d560f-90a1-4bb3-8898-3bce04a98e0a" xlink:href="silk-20191231.xsd#silk_SeriesA1PreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_3f6de653-8639-492f-a38d-7ac50e35fe83" xlink:to="loc_silk_SeriesA1PreferredStockMember_a05d560f-90a1-4bb3-8898-3bce04a98e0a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesBPreferredStockMember_9df4ad6f-0a57-4d12-879f-fa8feae761dd" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_3f6de653-8639-492f-a38d-7ac50e35fe83" xlink:to="loc_us-gaap_SeriesBPreferredStockMember_9df4ad6f-0a57-4d12-879f-fa8feae761dd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesCPreferredStockMember_d971e29c-bea2-4e08-9b1c-01e2fe7afa89" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SeriesCPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_3f6de653-8639-492f-a38d-7ac50e35fe83" xlink:to="loc_us-gaap_SeriesCPreferredStockMember_d971e29c-bea2-4e08-9b1c-01e2fe7afa89" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_eb0d5a52-3346-4043-b3d2-ea791477ea9b" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_af4d2c05-60c5-4fd9-a9f8-e8782d72b1e8" xlink:to="loc_us-gaap_AwardTypeAxis_eb0d5a52-3346-4043-b3d2-ea791477ea9b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_eb0d5a52-3346-4043-b3d2-ea791477ea9b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_eb0d5a52-3346-4043-b3d2-ea791477ea9b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_eb0d5a52-3346-4043-b3d2-ea791477ea9b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ee2aa987-62f2-4a6a-8b09-12a6c0d98a21" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_eb0d5a52-3346-4043-b3d2-ea791477ea9b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ee2aa987-62f2-4a6a-8b09-12a6c0d98a21" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_IncentiveandNonqualifiedStockOptionExercisedMember_b91c7099-9e69-4d2a-acb7-caf249a8aa37" xlink:href="silk-20191231.xsd#silk_IncentiveandNonqualifiedStockOptionExercisedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ee2aa987-62f2-4a6a-8b09-12a6c0d98a21" xlink:to="loc_silk_IncentiveandNonqualifiedStockOptionExercisedMember_b91c7099-9e69-4d2a-acb7-caf249a8aa37" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_IncentiveandNonqualifiedStockOptionIssuedMember_cae57a88-307e-47c4-addc-93c99e1a679c" xlink:href="silk-20191231.xsd#silk_IncentiveandNonqualifiedStockOptionIssuedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ee2aa987-62f2-4a6a-8b09-12a6c0d98a21" xlink:to="loc_silk_IncentiveandNonqualifiedStockOptionIssuedMember_cae57a88-307e-47c4-addc-93c99e1a679c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_EmployeeStockPurchasePlanMember_7163287f-52c8-4c4e-912d-cae30c68ffc6" xlink:href="silk-20191231.xsd#silk_EmployeeStockPurchasePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ee2aa987-62f2-4a6a-8b09-12a6c0d98a21" xlink:to="loc_silk_EmployeeStockPurchasePlanMember_7163287f-52c8-4c4e-912d-cae30c68ffc6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_eb3567a4-e227-4177-848a-a3954b26b233" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_af4d2c05-60c5-4fd9-a9f8-e8782d72b1e8" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_eb3567a4-e227-4177-848a-a3954b26b233" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_eb3567a4-e227-4177-848a-a3954b26b233_default" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_eb3567a4-e227-4177-848a-a3954b26b233" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_eb3567a4-e227-4177-848a-a3954b26b233_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_570178c1-12a1-47fb-bdfa-3dc9deaab1e8" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_eb3567a4-e227-4177-848a-a3954b26b233" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_570178c1-12a1-47fb-bdfa-3dc9deaab1e8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_CommonStockWarrantsMember_7983cf3c-bbeb-4088-a82e-8e5f82c9fbf9" xlink:href="silk-20191231.xsd#silk_CommonStockWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_570178c1-12a1-47fb-bdfa-3dc9deaab1e8" xlink:to="loc_silk_CommonStockWarrantsMember_7983cf3c-bbeb-4088-a82e-8e5f82c9fbf9" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/StockOptionPlans" xlink:type="simple" xlink:href="silk-20191231.xsd#StockOptionPlans"/>
  <link:definitionLink xlink:role="http://silkroadmed.com/role/StockOptionPlans" xlink:type="extended" id="i2ba36ff032ae488b939af43216259a36_0c15c6c6-902d-48b9-8a6b-a8ba0837bed8"/>
  <link:roleRef roleURI="http://silkroadmed.com/role/StockOptionPlansTables" xlink:type="simple" xlink:href="silk-20191231.xsd#StockOptionPlansTables"/>
  <link:definitionLink xlink:role="http://silkroadmed.com/role/StockOptionPlansTables" xlink:type="extended" id="i439e23fe14ec4fbe98a30c026b5d14ac_1e6009e6-7880-48fc-b10c-58a928d328dc"/>
  <link:roleRef roleURI="http://silkroadmed.com/role/StockOptionPlansNarrativeDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#StockOptionPlansNarrativeDetails"/>
  <link:definitionLink xlink:role="http://silkroadmed.com/role/StockOptionPlansNarrativeDetails" xlink:type="extended" id="i2cefaf9d57334b45af29c15b267cd6b1_7ea6251e-b1fc-4a4a-8938-4031c1b76b2d">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a6bd2b50-2484-4df1-b1c6-3db619b4cc5f" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_e23bb93a-d913-4f2d-adae-44b8b2e6a4eb" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a6bd2b50-2484-4df1-b1c6-3db619b4cc5f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_e23bb93a-d913-4f2d-adae-44b8b2e6a4eb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_6b70cbcd-907e-4657-8af1-3c93c7f2ee44" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a6bd2b50-2484-4df1-b1c6-3db619b4cc5f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_6b70cbcd-907e-4657-8af1-3c93c7f2ee44" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExerciseThresholdasaPercentageofSharePrice_30680e47-ea11-486c-b736-7fb3d044535d" xlink:href="silk-20191231.xsd#silk_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExerciseThresholdasaPercentageofSharePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a6bd2b50-2484-4df1-b1c6-3db619b4cc5f" xlink:to="loc_silk_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExerciseThresholdasaPercentageofSharePrice_30680e47-ea11-486c-b736-7fb3d044535d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_907fc83c-cbf4-4b00-8134-23c08fcb8bf8" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a6bd2b50-2484-4df1-b1c6-3db619b4cc5f" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_907fc83c-cbf4-4b00-8134-23c08fcb8bf8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_b57fb013-f908-44c6-b869-2633a466f03e" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a6bd2b50-2484-4df1-b1c6-3db619b4cc5f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_b57fb013-f908-44c6-b869-2633a466f03e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_d109d1b0-ccf5-4968-9c70-906ba27bca08" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a6bd2b50-2484-4df1-b1c6-3db619b4cc5f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_d109d1b0-ccf5-4968-9c70-906ba27bca08" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_479c5104-674b-4354-9bfe-de1f13043472" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a6bd2b50-2484-4df1-b1c6-3db619b4cc5f" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_479c5104-674b-4354-9bfe-de1f13043472" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_0577b004-f0b6-4dce-bf77-38b6c6e6a30e" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a6bd2b50-2484-4df1-b1c6-3db619b4cc5f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_0577b004-f0b6-4dce-bf77-38b6c6e6a30e" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_45697e21-01ff-42de-8f41-feab8e2e1373" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a6bd2b50-2484-4df1-b1c6-3db619b4cc5f" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_45697e21-01ff-42de-8f41-feab8e2e1373" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum_2352a1a7-4f2f-401d-8955-ac3c47891668" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a6bd2b50-2484-4df1-b1c6-3db619b4cc5f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum_2352a1a7-4f2f-401d-8955-ac3c47891668" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_2f27c1d9-a1d4-41b4-878a-c43ff2cbc595" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a6bd2b50-2484-4df1-b1c6-3db619b4cc5f" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_2f27c1d9-a1d4-41b4-878a-c43ff2cbc595" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_9ee4c360-2682-4ed4-8d73-00ac84a17a16" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a6bd2b50-2484-4df1-b1c6-3db619b4cc5f" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_9ee4c360-2682-4ed4-8d73-00ac84a17a16" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_ShareBasedCompensationArrangementBySharebasedPaymentAwardNumberOfAdditionalSharesAllowableUnderThePlan_7eff3595-fe1c-447d-bb38-794816e289f5" xlink:href="silk-20191231.xsd#silk_ShareBasedCompensationArrangementBySharebasedPaymentAwardNumberOfAdditionalSharesAllowableUnderThePlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a6bd2b50-2484-4df1-b1c6-3db619b4cc5f" xlink:to="loc_silk_ShareBasedCompensationArrangementBySharebasedPaymentAwardNumberOfAdditionalSharesAllowableUnderThePlan_7eff3595-fe1c-447d-bb38-794816e289f5" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_eae2c4e1-0999-4fd5-8a84-1177636b5b70" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a6bd2b50-2484-4df1-b1c6-3db619b4cc5f" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_eae2c4e1-0999-4fd5-8a84-1177636b5b70" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_2c645b26-2526-4e07-a6f0-e4b98dd10730" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a6bd2b50-2484-4df1-b1c6-3db619b4cc5f" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_2c645b26-2526-4e07-a6f0-e4b98dd10730" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_e22e24b8-9e46-4847-8d6d-16bd7ebfa9a9" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a6bd2b50-2484-4df1-b1c6-3db619b4cc5f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_e22e24b8-9e46-4847-8d6d-16bd7ebfa9a9" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bbd5d95c-6b8c-4ffb-a15e-25855023e744" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a6bd2b50-2484-4df1-b1c6-3db619b4cc5f" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bbd5d95c-6b8c-4ffb-a15e-25855023e744" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_01799a6e-b1e2-44dc-9deb-7aefda42ef9a" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bbd5d95c-6b8c-4ffb-a15e-25855023e744" xlink:to="loc_us-gaap_PlanNameAxis_01799a6e-b1e2-44dc-9deb-7aefda42ef9a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_01799a6e-b1e2-44dc-9deb-7aefda42ef9a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_01799a6e-b1e2-44dc-9deb-7aefda42ef9a" xlink:to="loc_us-gaap_PlanNameDomain_01799a6e-b1e2-44dc-9deb-7aefda42ef9a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_ed7441b2-8b52-4671-86ca-fe6db240e1e6" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_01799a6e-b1e2-44dc-9deb-7aefda42ef9a" xlink:to="loc_us-gaap_PlanNameDomain_ed7441b2-8b52-4671-86ca-fe6db240e1e6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_TwoThousandNineteenStockOptionPlanMember_a5adb130-360b-4293-a97b-1ac04ca0d5d1" xlink:href="silk-20191231.xsd#silk_TwoThousandNineteenStockOptionPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_ed7441b2-8b52-4671-86ca-fe6db240e1e6" xlink:to="loc_silk_TwoThousandNineteenStockOptionPlanMember_a5adb130-360b-4293-a97b-1ac04ca0d5d1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_9bdfeb4b-c605-4d3d-9236-e743c8b16fcc" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bbd5d95c-6b8c-4ffb-a15e-25855023e744" xlink:to="loc_srt_RangeAxis_9bdfeb4b-c605-4d3d-9236-e743c8b16fcc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_9bdfeb4b-c605-4d3d-9236-e743c8b16fcc_default" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_9bdfeb4b-c605-4d3d-9236-e743c8b16fcc" xlink:to="loc_srt_RangeMember_9bdfeb4b-c605-4d3d-9236-e743c8b16fcc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_491d5372-ef03-4b91-9f16-c8aa267f41f4" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_9bdfeb4b-c605-4d3d-9236-e743c8b16fcc" xlink:to="loc_srt_RangeMember_491d5372-ef03-4b91-9f16-c8aa267f41f4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_9dfed674-6e9c-4f5f-84d7-4f66355c2512" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_491d5372-ef03-4b91-9f16-c8aa267f41f4" xlink:to="loc_srt_MaximumMember_9dfed674-6e9c-4f5f-84d7-4f66355c2512" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_46c508cf-45b5-41b6-8277-802f315772cf" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bbd5d95c-6b8c-4ffb-a15e-25855023e744" xlink:to="loc_us-gaap_AwardTypeAxis_46c508cf-45b5-41b6-8277-802f315772cf" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_46c508cf-45b5-41b6-8277-802f315772cf_default" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_46c508cf-45b5-41b6-8277-802f315772cf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_46c508cf-45b5-41b6-8277-802f315772cf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_55127b27-bbc1-4010-a619-88d2566c8d56" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_46c508cf-45b5-41b6-8277-802f315772cf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_55127b27-bbc1-4010-a619-88d2566c8d56" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_IncentiveStockOptionMember_ad54921c-4a79-41f8-a708-4d314b30aaf1" xlink:href="silk-20191231.xsd#silk_IncentiveStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_55127b27-bbc1-4010-a619-88d2566c8d56" xlink:to="loc_silk_IncentiveStockOptionMember_ad54921c-4a79-41f8-a708-4d314b30aaf1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_NonqualifiedStockOptionsMember_40d50c64-f95a-49f9-bcac-a8983fc190dc" xlink:href="silk-20191231.xsd#silk_NonqualifiedStockOptionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_55127b27-bbc1-4010-a619-88d2566c8d56" xlink:to="loc_silk_NonqualifiedStockOptionsMember_40d50c64-f95a-49f9-bcac-a8983fc190dc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_IncentiveandNonqualifiedStockOptionMember_692c9f88-10d3-44a9-a1e0-3d35b63df82e" xlink:href="silk-20191231.xsd#silk_IncentiveandNonqualifiedStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_55127b27-bbc1-4010-a619-88d2566c8d56" xlink:to="loc_silk_IncentiveandNonqualifiedStockOptionMember_692c9f88-10d3-44a9-a1e0-3d35b63df82e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_0f5679f5-4d4c-426c-81ec-042f0d9ad079" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_55127b27-bbc1-4010-a619-88d2566c8d56" xlink:to="loc_us-gaap_EmployeeStockOptionMember_0f5679f5-4d4c-426c-81ec-042f0d9ad079" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_c78b9ad2-14e2-4f66-b849-6026b2fe38bb" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bbd5d95c-6b8c-4ffb-a15e-25855023e744" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_c78b9ad2-14e2-4f66-b849-6026b2fe38bb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_c78b9ad2-14e2-4f66-b849-6026b2fe38bb_default" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_c78b9ad2-14e2-4f66-b849-6026b2fe38bb" xlink:to="loc_us-gaap_RelatedPartyDomain_c78b9ad2-14e2-4f66-b849-6026b2fe38bb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_ff1bc4d6-a6f9-4f3f-82c6-8625f78008af" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_c78b9ad2-14e2-4f66-b849-6026b2fe38bb" xlink:to="loc_us-gaap_RelatedPartyDomain_ff1bc4d6-a6f9-4f3f-82c6-8625f78008af" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrincipalOwnerMember_57fc00ef-fb24-4897-be6c-68eba2a27625" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PrincipalOwnerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_ff1bc4d6-a6f9-4f3f-82c6-8625f78008af" xlink:to="loc_us-gaap_PrincipalOwnerMember_57fc00ef-fb24-4897-be6c-68eba2a27625" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/StockOptionPlansActivityUnderCompensationPlanDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#StockOptionPlansActivityUnderCompensationPlanDetails"/>
  <link:definitionLink xlink:role="http://silkroadmed.com/role/StockOptionPlansActivityUnderCompensationPlanDetails" xlink:type="extended" id="if0e35768005b4ccc9c82a09418ef54f4_d7930173-bf1b-45f1-89d3-dd7e866241e3"/>
  <link:roleRef roleURI="http://silkroadmed.com/role/StockOptionPlansInformationbyExercisePriceDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#StockOptionPlansInformationbyExercisePriceDetails"/>
  <link:definitionLink xlink:role="http://silkroadmed.com/role/StockOptionPlansInformationbyExercisePriceDetails" xlink:type="extended" id="ia581ebb1dba3427fb3c9af303176b881_c452ad69-0c37-42d1-a5fa-8e30e29f5da4">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_fa6ef3d0-0f4c-4e19-b414-e0df683402c8" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice_cbdfc92b-e4b6-47ea-8b14-1018a739ee3b" xlink:href="silk-20191231.xsd#silk_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_fa6ef3d0-0f4c-4e19-b414-e0df683402c8" xlink:to="loc_silk_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice_cbdfc92b-e4b6-47ea-8b14-1018a739ee3b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_e63b3f70-f98d-4b3e-a049-ed13de429733" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_fa6ef3d0-0f4c-4e19-b414-e0df683402c8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_e63b3f70-f98d-4b3e-a049-ed13de429733" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_89f332b5-31a0-4e5b-bb06-57b3b20fcda0" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_fa6ef3d0-0f4c-4e19-b414-e0df683402c8" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_89f332b5-31a0-4e5b-bb06-57b3b20fcda0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_9e3ff7eb-8f15-4335-93eb-792c143992ee" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_fa6ef3d0-0f4c-4e19-b414-e0df683402c8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_9e3ff7eb-8f15-4335-93eb-792c143992ee" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c0eba447-6942-40c7-8362-dcd41529762c" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_fa6ef3d0-0f4c-4e19-b414-e0df683402c8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c0eba447-6942-40c7-8362-dcd41529762c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_cbf14faa-983a-4cb4-993e-cd1c4d235377" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_fa6ef3d0-0f4c-4e19-b414-e0df683402c8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_cbf14faa-983a-4cb4-993e-cd1c4d235377" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_4efc3e62-fb94-40f4-a78b-eab25c960149" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_fa6ef3d0-0f4c-4e19-b414-e0df683402c8" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_4efc3e62-fb94-40f4-a78b-eab25c960149" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_a7c35ee6-b9a7-433b-ba44-90a6b2b2a941" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_4efc3e62-fb94-40f4-a78b-eab25c960149" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_a7c35ee6-b9a7-433b-ba44-90a6b2b2a941" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_a7c35ee6-b9a7-433b-ba44-90a6b2b2a941_default" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_a7c35ee6-b9a7-433b-ba44-90a6b2b2a941" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_a7c35ee6-b9a7-433b-ba44-90a6b2b2a941_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_6297eb4a-9368-40bf-9fb7-6cf6190a560d" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_a7c35ee6-b9a7-433b-ba44-90a6b2b2a941" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_6297eb4a-9368-40bf-9fb7-6cf6190a560d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_ExercisePriceOneMember_ecc44e93-15e6-4297-bf88-3de60dd820ca" xlink:href="silk-20191231.xsd#silk_ExercisePriceOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_6297eb4a-9368-40bf-9fb7-6cf6190a560d" xlink:to="loc_silk_ExercisePriceOneMember_ecc44e93-15e6-4297-bf88-3de60dd820ca" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_ExercisePriceTwoMember_86cb29ad-1d99-45f4-bb82-2b24f93959db" xlink:href="silk-20191231.xsd#silk_ExercisePriceTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_6297eb4a-9368-40bf-9fb7-6cf6190a560d" xlink:to="loc_silk_ExercisePriceTwoMember_86cb29ad-1d99-45f4-bb82-2b24f93959db" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_ExercisePriceThreeMember_56d079fb-599d-474d-82e6-9e59870c2dda" xlink:href="silk-20191231.xsd#silk_ExercisePriceThreeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_6297eb4a-9368-40bf-9fb7-6cf6190a560d" xlink:to="loc_silk_ExercisePriceThreeMember_56d079fb-599d-474d-82e6-9e59870c2dda" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_ExercisePriceFourMember_6182c2e8-0fcf-4d79-8da9-f03cb1abf23b" xlink:href="silk-20191231.xsd#silk_ExercisePriceFourMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_6297eb4a-9368-40bf-9fb7-6cf6190a560d" xlink:to="loc_silk_ExercisePriceFourMember_6182c2e8-0fcf-4d79-8da9-f03cb1abf23b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_2eab8ad8-68cd-4d07-8e8a-bf2810c9b11c" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_4efc3e62-fb94-40f4-a78b-eab25c960149" xlink:to="loc_srt_RangeAxis_2eab8ad8-68cd-4d07-8e8a-bf2810c9b11c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_2eab8ad8-68cd-4d07-8e8a-bf2810c9b11c_default" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_2eab8ad8-68cd-4d07-8e8a-bf2810c9b11c" xlink:to="loc_srt_RangeMember_2eab8ad8-68cd-4d07-8e8a-bf2810c9b11c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_405bfe98-43fc-4e7f-96c2-41546b0fa567" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_2eab8ad8-68cd-4d07-8e8a-bf2810c9b11c" xlink:to="loc_srt_RangeMember_405bfe98-43fc-4e7f-96c2-41546b0fa567" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_6ec5f017-c39c-42cf-b312-0fabf6f3fa75" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_405bfe98-43fc-4e7f-96c2-41546b0fa567" xlink:to="loc_srt_MinimumMember_6ec5f017-c39c-42cf-b312-0fabf6f3fa75" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_a141cb1a-cbff-4f7d-8bb6-51085916a788" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_405bfe98-43fc-4e7f-96c2-41546b0fa567" xlink:to="loc_srt_MaximumMember_a141cb1a-cbff-4f7d-8bb6-51085916a788" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/StockOptionPlansStockOptionAssumptionsDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#StockOptionPlansStockOptionAssumptionsDetails"/>
  <link:definitionLink xlink:role="http://silkroadmed.com/role/StockOptionPlansStockOptionAssumptionsDetails" xlink:type="extended" id="i34dcfa49c5494af886050e3eb80ad435_96be231b-40b8-45f0-9702-c4f98ea6b14e">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e1bdc8cb-f2eb-45de-9c16-882f0825ede3" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_bcdf524c-b44d-40cd-9fa2-906ca5bb685c" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e1bdc8cb-f2eb-45de-9c16-882f0825ede3" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_bcdf524c-b44d-40cd-9fa2-906ca5bb685c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_d018766b-580b-4cc7-9be9-958d839ce84a" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e1bdc8cb-f2eb-45de-9c16-882f0825ede3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_d018766b-580b-4cc7-9be9-958d839ce84a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_b08281a7-7b81-4337-a3d8-8246b317eb0a" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e1bdc8cb-f2eb-45de-9c16-882f0825ede3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_b08281a7-7b81-4337-a3d8-8246b317eb0a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_f74c406b-60cb-454a-8697-2b7b29999cd3" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e1bdc8cb-f2eb-45de-9c16-882f0825ede3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_f74c406b-60cb-454a-8697-2b7b29999cd3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_e799cd83-29b0-4498-abff-a3029de9f191" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e1bdc8cb-f2eb-45de-9c16-882f0825ede3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_e799cd83-29b0-4498-abff-a3029de9f191" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_cf08281d-cd04-45ff-be3f-0ab6e6578239" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e1bdc8cb-f2eb-45de-9c16-882f0825ede3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_cf08281d-cd04-45ff-be3f-0ab6e6578239" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9d1012f8-9268-4456-8102-3f12b4693b20" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e1bdc8cb-f2eb-45de-9c16-882f0825ede3" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9d1012f8-9268-4456-8102-3f12b4693b20" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_3bc1132e-d73c-4a43-9ba2-d8aa3206e8a0" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9d1012f8-9268-4456-8102-3f12b4693b20" xlink:to="loc_srt_RangeAxis_3bc1132e-d73c-4a43-9ba2-d8aa3206e8a0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_3bc1132e-d73c-4a43-9ba2-d8aa3206e8a0_default" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_3bc1132e-d73c-4a43-9ba2-d8aa3206e8a0" xlink:to="loc_srt_RangeMember_3bc1132e-d73c-4a43-9ba2-d8aa3206e8a0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_afac2682-1490-4206-bc3b-5b56b2c6e0f4" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_3bc1132e-d73c-4a43-9ba2-d8aa3206e8a0" xlink:to="loc_srt_RangeMember_afac2682-1490-4206-bc3b-5b56b2c6e0f4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_80ce4a6f-8532-42ea-bf6a-f13d2e8ed8f1" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_afac2682-1490-4206-bc3b-5b56b2c6e0f4" xlink:to="loc_srt_MinimumMember_80ce4a6f-8532-42ea-bf6a-f13d2e8ed8f1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_fe2a3261-621c-4209-bc45-d4461f9406e8" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_afac2682-1490-4206-bc3b-5b56b2c6e0f4" xlink:to="loc_srt_MaximumMember_fe2a3261-621c-4209-bc45-d4461f9406e8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_27ccb98f-9f89-48cd-a0f8-e19366a45804" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9d1012f8-9268-4456-8102-3f12b4693b20" xlink:to="loc_us-gaap_AwardTypeAxis_27ccb98f-9f89-48cd-a0f8-e19366a45804" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_27ccb98f-9f89-48cd-a0f8-e19366a45804_default" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_27ccb98f-9f89-48cd-a0f8-e19366a45804" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_27ccb98f-9f89-48cd-a0f8-e19366a45804_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a45cce2c-df11-40ac-801b-64943a2effc8" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_27ccb98f-9f89-48cd-a0f8-e19366a45804" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a45cce2c-df11-40ac-801b-64943a2effc8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_599262c9-6f05-4514-b6d5-66c214c2078f" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a45cce2c-df11-40ac-801b-64943a2effc8" xlink:to="loc_us-gaap_EmployeeStockOptionMember_599262c9-6f05-4514-b6d5-66c214c2078f" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/StockOptionPlansStockbasedCompensationDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#StockOptionPlansStockbasedCompensationDetails"/>
  <link:definitionLink xlink:role="http://silkroadmed.com/role/StockOptionPlansStockbasedCompensationDetails" xlink:type="extended" id="ib623eca04257465db9c61a7ccac1021e_4f6c0191-4da3-4b5e-9fcc-a38b4c0c62ea">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_d25574de-d58b-4891-ad16-1b6ea3da5b8c" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_7cf67dea-5216-4f5d-9da7-ac7e82034368" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_d25574de-d58b-4891-ad16-1b6ea3da5b8c" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_7cf67dea-5216-4f5d-9da7-ac7e82034368" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_51d112d9-82b2-4d67-b95a-4301269b44b3" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_d25574de-d58b-4891-ad16-1b6ea3da5b8c" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_51d112d9-82b2-4d67-b95a-4301269b44b3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_9cb4c209-cd64-4133-bee7-532124ff7545" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_51d112d9-82b2-4d67-b95a-4301269b44b3" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_9cb4c209-cd64-4133-bee7-532124ff7545" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_9cb4c209-cd64-4133-bee7-532124ff7545_default" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_9cb4c209-cd64-4133-bee7-532124ff7545" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_9cb4c209-cd64-4133-bee7-532124ff7545_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_8623c958-fdb5-44ed-8e18-6747ba8c7789" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_9cb4c209-cd64-4133-bee7-532124ff7545" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_8623c958-fdb5-44ed-8e18-6747ba8c7789" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_b79c93ff-a68b-40d2-a585-6b9e56d25f36" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_8623c958-fdb5-44ed-8e18-6747ba8c7789" xlink:to="loc_us-gaap_CostOfSalesMember_b79c93ff-a68b-40d2-a585-6b9e56d25f36" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_ac191d96-19f2-453c-b111-830b7b7b75ad" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_8623c958-fdb5-44ed-8e18-6747ba8c7789" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_ac191d96-19f2-453c-b111-830b7b7b75ad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_7c1d3923-8506-43b3-9046-fe1203afa833" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_8623c958-fdb5-44ed-8e18-6747ba8c7789" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_7c1d3923-8506-43b3-9046-fe1203afa833" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/IncomeTaxes" xlink:type="simple" xlink:href="silk-20191231.xsd#IncomeTaxes"/>
  <link:definitionLink xlink:role="http://silkroadmed.com/role/IncomeTaxes" xlink:type="extended" id="i74583b281aea4ab882ec5691d513fddb_1f8faa61-0759-4f64-adce-4f3f27402e31"/>
  <link:roleRef roleURI="http://silkroadmed.com/role/IncomeTaxesTables" xlink:type="simple" xlink:href="silk-20191231.xsd#IncomeTaxesTables"/>
  <link:definitionLink xlink:role="http://silkroadmed.com/role/IncomeTaxesTables" xlink:type="extended" id="i554ee29b82b845a4a6821115260ef759_c855e102-56b1-4904-87ff-757fd998ddb9"/>
  <link:roleRef roleURI="http://silkroadmed.com/role/IncomeTaxesComponentsofIncomeBeforeTaxesDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#IncomeTaxesComponentsofIncomeBeforeTaxesDetails"/>
  <link:definitionLink xlink:role="http://silkroadmed.com/role/IncomeTaxesComponentsofIncomeBeforeTaxesDetails" xlink:type="extended" id="i69018f34e24a432e80733bc3bef4062e_8d49c51e-2935-4e7a-be42-5851aa961fc0"/>
  <link:roleRef roleURI="http://silkroadmed.com/role/IncomeTaxesReconciliationofUSStatutoryRateDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#IncomeTaxesReconciliationofUSStatutoryRateDetails"/>
  <link:definitionLink xlink:role="http://silkroadmed.com/role/IncomeTaxesReconciliationofUSStatutoryRateDetails" xlink:type="extended" id="i34dfc10b85d649cdba4a99d1662be86d_8d60e7ee-e4a8-40e6-8cec-de4ddc21ccbe"/>
  <link:roleRef roleURI="http://silkroadmed.com/role/IncomeTaxesNetDeferredTaxAssetsDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#IncomeTaxesNetDeferredTaxAssetsDetails"/>
  <link:definitionLink xlink:role="http://silkroadmed.com/role/IncomeTaxesNetDeferredTaxAssetsDetails" xlink:type="extended" id="i44da8bbbc01140efb13fac86bbb86ea9_83efdbc4-eee8-4eff-89ed-e82943326f89"/>
  <link:roleRef roleURI="http://silkroadmed.com/role/IncomeTaxesNarrativeDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#IncomeTaxesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://silkroadmed.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended" id="i49ebe3c499fe49b7bafe6474ac62bcb0_56c009f7-ed3c-4e4d-a556-adca5fd4f37f">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems_0434ae59-f0f3-4506-8f22-eec8ac54f8a5" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_114f4979-ab19-45bc-bfa2-4fee92483c34" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0434ae59-f0f3-4506-8f22-eec8ac54f8a5" xlink:to="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_114f4979-ab19-45bc-bfa2-4fee92483c34" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_ee16ab30-530a-4790-a1d9-6093db5ee281" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0434ae59-f0f3-4506-8f22-eec8ac54f8a5" xlink:to="loc_us-gaap_OperatingLossCarryforwards_ee16ab30-530a-4790-a1d9-6093db5ee281" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_OperatingLossCarryforwardOffsetMaximumPercent_4ab87325-77ee-4fd1-a670-2f787d8972c3" xlink:href="silk-20191231.xsd#silk_OperatingLossCarryforwardOffsetMaximumPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0434ae59-f0f3-4506-8f22-eec8ac54f8a5" xlink:to="loc_silk_OperatingLossCarryforwardOffsetMaximumPercent_4ab87325-77ee-4fd1-a670-2f787d8972c3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount_185509f5-20e1-4e8b-9bc0-7832d2e84209" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0434ae59-f0f3-4506-8f22-eec8ac54f8a5" xlink:to="loc_us-gaap_TaxCreditCarryforwardAmount_185509f5-20e1-4e8b-9bc0-7832d2e84209" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_ffa4b737-87ee-48e1-8e97-c4d44c76bf15" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0434ae59-f0f3-4506-8f22-eec8ac54f8a5" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_ffa4b737-87ee-48e1-8e97-c4d44c76bf15" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_c2726856-6d3e-44ad-9b28-321559bcc08d" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0434ae59-f0f3-4506-8f22-eec8ac54f8a5" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_c2726856-6d3e-44ad-9b28-321559bcc08d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_8d2767bd-248a-4004-8c76-174173887f64" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0434ae59-f0f3-4506-8f22-eec8ac54f8a5" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_8d2767bd-248a-4004-8c76-174173887f64" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable_6b915f47-70de-4243-a266-2bfd2ece13ad" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0434ae59-f0f3-4506-8f22-eec8ac54f8a5" xlink:to="loc_us-gaap_OperatingLossCarryforwardsTable_6b915f47-70de-4243-a266-2bfd2ece13ad" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAxis_102f7655-553b-46c2-8b8f-cddada96e53a" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TaxCreditCarryforwardAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_6b915f47-70de-4243-a266-2bfd2ece13ad" xlink:to="loc_us-gaap_TaxCreditCarryforwardAxis_102f7655-553b-46c2-8b8f-cddada96e53a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain_102f7655-553b-46c2-8b8f-cddada96e53a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis_102f7655-553b-46c2-8b8f-cddada96e53a" xlink:to="loc_us-gaap_TaxCreditCarryforwardNameDomain_102f7655-553b-46c2-8b8f-cddada96e53a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain_b3956113-900a-4929-a6e9-cdd712e6a88e" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis_102f7655-553b-46c2-8b8f-cddada96e53a" xlink:to="loc_us-gaap_TaxCreditCarryforwardNameDomain_b3956113-900a-4929-a6e9-cdd712e6a88e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchMember_2808fc3b-1d51-41f1-bbdc-4af5286cd7fa" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain_b3956113-900a-4929-a6e9-cdd712e6a88e" xlink:to="loc_us-gaap_ResearchMember_2808fc3b-1d51-41f1-bbdc-4af5286cd7fa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_e28112a2-666f-42ad-9ea7-c4da0e4fd690" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_6b915f47-70de-4243-a266-2bfd2ece13ad" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_e28112a2-666f-42ad-9ea7-c4da0e4fd690" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_e28112a2-666f-42ad-9ea7-c4da0e4fd690_default" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_e28112a2-666f-42ad-9ea7-c4da0e4fd690" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_e28112a2-666f-42ad-9ea7-c4da0e4fd690_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_53299e50-90ea-46ba-a065-1848c0452fd1" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_e28112a2-666f-42ad-9ea7-c4da0e4fd690" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_53299e50-90ea-46ba-a065-1848c0452fd1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_9d81a9d0-321b-4b28-bf2e-3e9c4e4cc7b4" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DomesticCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_53299e50-90ea-46ba-a065-1848c0452fd1" xlink:to="loc_us-gaap_DomesticCountryMember_9d81a9d0-321b-4b28-bf2e-3e9c4e4cc7b4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_2273e3c2-8257-4ac6-9a97-e4eb24a4914d" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_53299e50-90ea-46ba-a065-1848c0452fd1" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_2273e3c2-8257-4ac6-9a97-e4eb24a4914d" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/IncomeTaxesReconciliationofUnrecognizedTaxBenefitsDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#IncomeTaxesReconciliationofUnrecognizedTaxBenefitsDetails"/>
  <link:definitionLink xlink:role="http://silkroadmed.com/role/IncomeTaxesReconciliationofUnrecognizedTaxBenefitsDetails" xlink:type="extended" id="ie3b0b3d49a274768a7e883cfbc6bb48d_087ab0dc-c5aa-49dc-a423-1f2fe3456585"/>
  <link:roleRef roleURI="http://silkroadmed.com/role/AcquisitionofVariableInterestEntityNeuroCo" xlink:type="simple" xlink:href="silk-20191231.xsd#AcquisitionofVariableInterestEntityNeuroCo"/>
  <link:definitionLink xlink:role="http://silkroadmed.com/role/AcquisitionofVariableInterestEntityNeuroCo" xlink:type="extended" id="if55b56c022664d5abff06e26d25d1b51_588da84a-2fcc-4e35-b27a-650f081029d9"/>
  <link:roleRef roleURI="http://silkroadmed.com/role/AcquisitionofVariableInterestEntityNeuroCoDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#AcquisitionofVariableInterestEntityNeuroCoDetails"/>
  <link:definitionLink xlink:role="http://silkroadmed.com/role/AcquisitionofVariableInterestEntityNeuroCoDetails" xlink:type="extended" id="i5e38df1ee62c4769a602caeb9e135a40_fac5b9a1-121e-4255-9f7c-0086ee15fefc">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_a981867e-23dd-4d53-973c-bbc8fcf0ce36" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableRelatedParties_f7a37aff-8697-4708-8574-03ad0104ebc2" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NotesReceivableRelatedParties"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a981867e-23dd-4d53-973c-bbc8fcf0ce36" xlink:to="loc_us-gaap_NotesReceivableRelatedParties_f7a37aff-8697-4708-8574-03ad0104ebc2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_NotesReceivableRelatedPartiesInterestRateStatedPercentage_5a57dab0-af55-436c-b6ca-32400d8bdfc7" xlink:href="silk-20191231.xsd#silk_NotesReceivableRelatedPartiesInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a981867e-23dd-4d53-973c-bbc8fcf0ce36" xlink:to="loc_silk_NotesReceivableRelatedPartiesInterestRateStatedPercentage_5a57dab0-af55-436c-b6ca-32400d8bdfc7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_NotesReceivableRelatedPartiesTerm_ef371d59-1735-4893-ad44-db52ea459c3a" xlink:href="silk-20191231.xsd#silk_NotesReceivableRelatedPartiesTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a981867e-23dd-4d53-973c-bbc8fcf0ce36" xlink:to="loc_silk_NotesReceivableRelatedPartiesTerm_ef371d59-1735-4893-ad44-db52ea459c3a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_2ec36e86-a319-42f2-a7f2-c1604c9786a7" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a981867e-23dd-4d53-973c-bbc8fcf0ce36" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_2ec36e86-a319-42f2-a7f2-c1604c9786a7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_60314751-2578-4818-993e-47491dd1dbce" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a981867e-23dd-4d53-973c-bbc8fcf0ce36" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_60314751-2578-4818-993e-47491dd1dbce" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_4b863ebb-4948-49f7-a5ee-f7673f0d8571" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a981867e-23dd-4d53-973c-bbc8fcf0ce36" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_4b863ebb-4948-49f7-a5ee-f7673f0d8571" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_BusinessCombinationConsiderationTransferredNotesPayableForgiven_1fe107a6-116e-4e3d-82cf-6882947a4f98" xlink:href="silk-20191231.xsd#silk_BusinessCombinationConsiderationTransferredNotesPayableForgiven"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a981867e-23dd-4d53-973c-bbc8fcf0ce36" xlink:to="loc_silk_BusinessCombinationConsiderationTransferredNotesPayableForgiven_1fe107a6-116e-4e3d-82cf-6882947a4f98" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestInVariableInterestEntity_4ef49d97-8190-46fa-a469-e605456d75a1" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NoncontrollingInterestInVariableInterestEntity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a981867e-23dd-4d53-973c-bbc8fcf0ce36" xlink:to="loc_us-gaap_NoncontrollingInterestInVariableInterestEntity_4ef49d97-8190-46fa-a469-e605456d75a1" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a41e7a74-9ff4-4878-b9c5-8c16efc763ce" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a981867e-23dd-4d53-973c-bbc8fcf0ce36" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a41e7a74-9ff4-4878-b9c5-8c16efc763ce" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_be0171fc-8b99-4f8d-aafa-56eaad7f2ab9" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a41e7a74-9ff4-4878-b9c5-8c16efc763ce" xlink:to="loc_dei_LegalEntityAxis_be0171fc-8b99-4f8d-aafa-56eaad7f2ab9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_be0171fc-8b99-4f8d-aafa-56eaad7f2ab9_default" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_be0171fc-8b99-4f8d-aafa-56eaad7f2ab9" xlink:to="loc_dei_EntityDomain_be0171fc-8b99-4f8d-aafa-56eaad7f2ab9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_f135d615-ecb9-454d-9f60-984f74952228" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_be0171fc-8b99-4f8d-aafa-56eaad7f2ab9" xlink:to="loc_dei_EntityDomain_f135d615-ecb9-454d-9f60-984f74952228" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_NeuroCoIncMember_d8538eac-8170-429c-a626-354d171a4080" xlink:href="silk-20191231.xsd#silk_NeuroCoIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_f135d615-ecb9-454d-9f60-984f74952228" xlink:to="loc_silk_NeuroCoIncMember_d8538eac-8170-429c-a626-354d171a4080" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_0f2f9692-4104-4c7a-af6d-122189e3c004" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a41e7a74-9ff4-4878-b9c5-8c16efc763ce" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_0f2f9692-4104-4c7a-af6d-122189e3c004" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0f2f9692-4104-4c7a-af6d-122189e3c004_default" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_0f2f9692-4104-4c7a-af6d-122189e3c004" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0f2f9692-4104-4c7a-af6d-122189e3c004_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d584757c-960d-463b-9b3f-5950b909f2da" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_0f2f9692-4104-4c7a-af6d-122189e3c004" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d584757c-960d-463b-9b3f-5950b909f2da" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_NeuroCoIncMember_5e11cf08-b07c-4652-a84b-981ecb642b0f" xlink:href="silk-20191231.xsd#silk_NeuroCoIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d584757c-960d-463b-9b3f-5950b909f2da" xlink:to="loc_silk_NeuroCoIncMember_5e11cf08-b07c-4652-a84b-981ecb642b0f" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/A401kPlan" xlink:type="simple" xlink:href="silk-20191231.xsd#A401kPlan"/>
  <link:definitionLink xlink:role="http://silkroadmed.com/role/A401kPlan" xlink:type="extended" id="iea6a64a114b445a6be537429f9a3871d_93f13d8e-746c-4b62-a82c-d095da437391"/>
  <link:roleRef roleURI="http://silkroadmed.com/role/A401kPlanDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#A401kPlanDetails"/>
  <link:definitionLink xlink:role="http://silkroadmed.com/role/A401kPlanDetails" xlink:type="extended" id="iecb044d763ee42fbb3e4bbb87894e79d_de41564d-17e4-497b-86d7-b28668a03812">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_c9172da6-33b7-4289-8528-4878a48a13c4" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_fd58814f-2004-468a-99e2-1dc22f25e0d1" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_c9172da6-33b7-4289-8528-4878a48a13c4" xlink:to="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_fd58814f-2004-468a-99e2-1dc22f25e0d1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized_06430897-5d1a-4515-b6f7-880ae9a04840" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_c9172da6-33b7-4289-8528-4878a48a13c4" xlink:to="loc_us-gaap_DefinedContributionPlanCostRecognized_06430897-5d1a-4515-b6f7-880ae9a04840" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_55bfb665-1782-4a99-848d-240a5a0772c7" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_c9172da6-33b7-4289-8528-4878a48a13c4" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_55bfb665-1782-4a99-848d-240a5a0772c7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_02a147f7-6f2b-4f68-9ab0-445cbe4a3a54" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_c9172da6-33b7-4289-8528-4878a48a13c4" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_02a147f7-6f2b-4f68-9ab0-445cbe4a3a54" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_749c120e-7472-4b16-93d2-fb78212e24b5" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsequentEventTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsequentEventLineItems_c9172da6-33b7-4289-8528-4878a48a13c4" xlink:to="loc_us-gaap_SubsequentEventTable_749c120e-7472-4b16-93d2-fb78212e24b5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_e4e9d9f6-7864-4037-9c4d-0d952cdb199d" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_749c120e-7472-4b16-93d2-fb78212e24b5" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_e4e9d9f6-7864-4037-9c4d-0d952cdb199d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_e4e9d9f6-7864-4037-9c4d-0d952cdb199d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_e4e9d9f6-7864-4037-9c4d-0d952cdb199d" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_e4e9d9f6-7864-4037-9c4d-0d952cdb199d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_f2b09640-f1bd-40d7-98c6-1ec89cd1e7fa" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_e4e9d9f6-7864-4037-9c4d-0d952cdb199d" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_f2b09640-f1bd-40d7-98c6-1ec89cd1e7fa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_33a36fa1-8c74-47e2-b459-d1027303922c" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_f2b09640-f1bd-40d7-98c6-1ec89cd1e7fa" xlink:to="loc_us-gaap_SubsequentEventMember_33a36fa1-8c74-47e2-b459-d1027303922c" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/SubsequentEvents" xlink:type="simple" xlink:href="silk-20191231.xsd#SubsequentEvents"/>
  <link:definitionLink xlink:role="http://silkroadmed.com/role/SubsequentEvents" xlink:type="extended" id="ia22d437453c94c0397c8f5d34c4115aa_dba15dd1-99a0-49e5-967f-62fcd2bc2c84"/>
  <link:roleRef roleURI="http://silkroadmed.com/role/SubsequentEventsNarrativeDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#SubsequentEventsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://silkroadmed.com/role/SubsequentEventsNarrativeDetails" xlink:type="extended" id="ie0581e2aa9b6485c9dc6101b670aebf7_e61884be-3685-46dc-8341-82a21ce2a854">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_711d0148-e3ab-4861-8fcf-d499347a08f9" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_babf3326-0993-48b8-b2c9-589409aa7caa" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_711d0148-e3ab-4861-8fcf-d499347a08f9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_babf3326-0993-48b8-b2c9-589409aa7caa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_72191584-510a-41d6-95a0-421ceb206dab" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_711d0148-e3ab-4861-8fcf-d499347a08f9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_72191584-510a-41d6-95a0-421ceb206dab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_b85dbb19-7ed9-4fda-9027-077cc697db71" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_711d0148-e3ab-4861-8fcf-d499347a08f9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_b85dbb19-7ed9-4fda-9027-077cc697db71" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_e89fc732-db56-4f91-bcea-0aa7418f7ea6" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_711d0148-e3ab-4861-8fcf-d499347a08f9" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_e89fc732-db56-4f91-bcea-0aa7418f7ea6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_52045452-2e6a-4ba8-8207-8b669d1f0010" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsequentEventTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsequentEventLineItems_711d0148-e3ab-4861-8fcf-d499347a08f9" xlink:to="loc_us-gaap_SubsequentEventTable_52045452-2e6a-4ba8-8207-8b669d1f0010" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_a1e3c8bd-14d8-4722-ae79-07bb97282000" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_52045452-2e6a-4ba8-8207-8b669d1f0010" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_a1e3c8bd-14d8-4722-ae79-07bb97282000" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_a1e3c8bd-14d8-4722-ae79-07bb97282000_default" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_a1e3c8bd-14d8-4722-ae79-07bb97282000" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_a1e3c8bd-14d8-4722-ae79-07bb97282000_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_9affed03-7460-4997-bc30-9f9f9672ba89" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_a1e3c8bd-14d8-4722-ae79-07bb97282000" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_9affed03-7460-4997-bc30-9f9f9672ba89" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_930d982c-003e-4721-a4bb-5bc4fec7e2be" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_9affed03-7460-4997-bc30-9f9f9672ba89" xlink:to="loc_us-gaap_SubsequentEventMember_930d982c-003e-4721-a4bb-5bc4fec7e2be" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_ecb629f4-1e6b-4075-90da-4de86d92618e" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_52045452-2e6a-4ba8-8207-8b669d1f0010" xlink:to="loc_us-gaap_PlanNameAxis_ecb629f4-1e6b-4075-90da-4de86d92618e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_ecb629f4-1e6b-4075-90da-4de86d92618e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_ecb629f4-1e6b-4075-90da-4de86d92618e" xlink:to="loc_us-gaap_PlanNameDomain_ecb629f4-1e6b-4075-90da-4de86d92618e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_3798d82e-c8ec-4e89-b336-da669cd2fb04" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_ecb629f4-1e6b-4075-90da-4de86d92618e" xlink:to="loc_us-gaap_PlanNameDomain_3798d82e-c8ec-4e89-b336-da669cd2fb04" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_TwoThousandNineteenStockOptionPlanMember_32e5630f-87f0-4d49-b522-50cfb60052c7" xlink:href="silk-20191231.xsd#silk_TwoThousandNineteenStockOptionPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_3798d82e-c8ec-4e89-b336-da669cd2fb04" xlink:to="loc_silk_TwoThousandNineteenStockOptionPlanMember_32e5630f-87f0-4d49-b522-50cfb60052c7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_19a1ffea-cecc-46ea-a059-426ecdfd6a24" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_52045452-2e6a-4ba8-8207-8b669d1f0010" xlink:to="loc_us-gaap_AwardTypeAxis_19a1ffea-cecc-46ea-a059-426ecdfd6a24" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_19a1ffea-cecc-46ea-a059-426ecdfd6a24_default" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_19a1ffea-cecc-46ea-a059-426ecdfd6a24" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_19a1ffea-cecc-46ea-a059-426ecdfd6a24_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8e277f85-af42-4a35-845b-8525a106f8a0" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_19a1ffea-cecc-46ea-a059-426ecdfd6a24" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8e277f85-af42-4a35-845b-8525a106f8a0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_08f6d69b-cc6e-4fbc-bc9a-7d2de8852dac" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8e277f85-af42-4a35-845b-8525a106f8a0" xlink:to="loc_us-gaap_EmployeeStockOptionMember_08f6d69b-cc6e-4fbc-bc9a-7d2de8852dac" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/QuarterlyFinancialInformationunaudited" xlink:type="simple" xlink:href="silk-20191231.xsd#QuarterlyFinancialInformationunaudited"/>
  <link:definitionLink xlink:role="http://silkroadmed.com/role/QuarterlyFinancialInformationunaudited" xlink:type="extended" id="i1e98ad1e35424628ac3634e8763f9a08_5eb0ae05-34ce-4de8-b6ec-92d0cf3380ff"/>
  <link:roleRef roleURI="http://silkroadmed.com/role/QuarterlyFinancialInformationunauditedTables" xlink:type="simple" xlink:href="silk-20191231.xsd#QuarterlyFinancialInformationunauditedTables"/>
  <link:definitionLink xlink:role="http://silkroadmed.com/role/QuarterlyFinancialInformationunauditedTables" xlink:type="extended" id="i637cd754bdd64e63a784a9fc8fa5210f_140eefe1-011f-46df-acae-e6cd344287f0"/>
  <link:roleRef roleURI="http://silkroadmed.com/role/QuarterlyFinancialInformationunauditedDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#QuarterlyFinancialInformationunauditedDetails"/>
  <link:definitionLink xlink:role="http://silkroadmed.com/role/QuarterlyFinancialInformationunauditedDetails" xlink:type="extended" id="i4fff43ff2ae04df1a3f5449793b31743_7247b35c-7ff2-4994-93e5-feaac029912d"/>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>10
<FILENAME>silk-20191231_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:dad5b714-6959-4e39-8c51-cdabce9e0669,g:fba3822a-5587-4181-9cc4-63667bdb118e-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_silk_NotesReceivableRelatedPartiesTerm_450402b1-62d8-4392-a223-eee39684bc39_terseLabel_en-US" xlink:label="lab_silk_NotesReceivableRelatedPartiesTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes receivable, term</link:label>
    <link:label id="lab_silk_NotesReceivableRelatedPartiesTerm_label_en-US" xlink:label="lab_silk_NotesReceivableRelatedPartiesTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Receivable, Related Parties, Term</link:label>
    <link:label id="lab_silk_NotesReceivableRelatedPartiesTerm_documentation_en-US" xlink:label="lab_silk_NotesReceivableRelatedPartiesTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Receivable, Related Parties, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_silk_NotesReceivableRelatedPartiesTerm" xlink:href="silk-20191231.xsd#silk_NotesReceivableRelatedPartiesTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_silk_NotesReceivableRelatedPartiesTerm" xlink:to="lab_silk_NotesReceivableRelatedPartiesTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201409Member_a38b9091-88c0-4fa1-af36-8bddc0ad4f8c_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201409Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative effect of change in accounting principle - ASC 606 adoption</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201409Member_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201409Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2014-09 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201409Member" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountingStandardsUpdate201409Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdate201409Member" xlink:to="lab_us-gaap_AccountingStandardsUpdate201409Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeriesBPreferredStockMember_7fad6cfb-28ae-438e-9ea1-ab7b405c2573_terseLabel_en-US" xlink:label="lab_us-gaap_SeriesBPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series B</link:label>
    <link:label id="lab_us-gaap_SeriesBPreferredStockMember_23cda130-bacd-47a7-af30-6234bff1c5ec_verboseLabel_en-US" xlink:label="lab_us-gaap_SeriesBPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion of Series B redeemable convertible preferred stock</link:label>
    <link:label id="lab_us-gaap_SeriesBPreferredStockMember_label_en-US" xlink:label="lab_us-gaap_SeriesBPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series B Preferred Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesBPreferredStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeriesBPreferredStockMember" xlink:to="lab_us-gaap_SeriesBPreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_56e77136-c369-4f0a-91c9-4350eded5644_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_9f1a6e29-5429-40a4-a7ed-2f224c243188_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Maturities, Repayments of Principal in Next Twelve Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTerm_a94e1376-3ff1-4e13-9aea-6f2ce13a080a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average days to maturity</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTerm_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTerm" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTerm" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_984f2eaa-1e59-47d3-861c-7129e8a620bd_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average discount rate</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_silk_DebtInstrumentInterestRatePaidInKind_43e75fe2-dbe7-44b4-bec9-bfc6c321968d_terseLabel_en-US" xlink:label="lab_silk_DebtInstrumentInterestRatePaidInKind" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate paid-in-kind</link:label>
    <link:label id="lab_silk_DebtInstrumentInterestRatePaidInKind_label_en-US" xlink:label="lab_silk_DebtInstrumentInterestRatePaidInKind" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Paid-In-Kind</link:label>
    <link:label id="lab_silk_DebtInstrumentInterestRatePaidInKind_documentation_en-US" xlink:label="lab_silk_DebtInstrumentInterestRatePaidInKind" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Paid-In-Kind</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_silk_DebtInstrumentInterestRatePaidInKind" xlink:href="silk-20191231.xsd#silk_DebtInstrumentInterestRatePaidInKind"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_silk_DebtInstrumentInterestRatePaidInKind" xlink:to="lab_silk_DebtInstrumentInterestRatePaidInKind" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember_32b3a2ea-2c68-45aa-a317-a327185a4388_terseLabel_en-US" xlink:label="lab_us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. government securities</link:label>
    <link:label id="lab_us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Government-sponsored Enterprises Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember" xlink:to="lab_us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_f1006f2e-2f05-4606-b6d9-4b4c772a26cc_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_dce3294f-27c7-4f72-a8d5-ae7c509986cb_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonemployee stock-based compensation</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Share-based Compensation, Stock Options, Requisite Service Period Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_6523236c-e39a-4237-8279-1e66d9af95be_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_label_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:to="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_28751468-f132-4ea0-ac9c-4f0824baee1d_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_9838c096-bbc4-4f96-b721-acd3e52d6f6c_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of Compensation Related Costs, Share-based Payments [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of Compensation Related Costs, Share-based Payments [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_6d3bde94-1b33-4b77-b366-9a85c129cd60_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation expensed not yet recognized, period for recognition</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_115bb68f-9709-4db6-ac47-efb16898b34f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued other expenses</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_58551032-a95f-439e-b4d2-86d4f73699fd_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDiluted_c4389e26-8c2f-4b6d-a1e8-a014782618e0_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss per share attributable to Silk Road Medical, Inc. common stockholders, basic and diluted (in USD per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDiluted_18d24c3b-2d6a-4fe4-9a1e-131868f75381_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDiluted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss per share, basic and diluted (in USD per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic and Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDiluted" xlink:to="lab_us-gaap_EarningsPerShareBasicAndDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_217e65d5-fd0f-418e-bcb7-0b8102f0715d_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected term (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_silk_IncentiveStockOptionMember_23bba462-31c7-4cdb-87f6-984bdf7f77c4_terseLabel_en-US" xlink:label="lab_silk_IncentiveStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ISO</link:label>
    <link:label id="lab_silk_IncentiveStockOptionMember_label_en-US" xlink:label="lab_silk_IncentiveStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incentive Stock Option [Member]</link:label>
    <link:label id="lab_silk_IncentiveStockOptionMember_documentation_en-US" xlink:label="lab_silk_IncentiveStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incentive Stock Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_silk_IncentiveStockOptionMember" xlink:href="silk-20191231.xsd#silk_IncentiveStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_silk_IncentiveStockOptionMember" xlink:to="lab_silk_IncentiveStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanDisclosuresTableTextBlock_644ecb60-adbb-4ae7-abca-ed3766702fe4_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanDisclosuresTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">401(k) Plan</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanDisclosuresTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanDisclosuresTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan Disclosures [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanDisclosuresTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DefinedContributionPlanDisclosuresTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanDisclosuresTableTextBlock" xlink:to="lab_us-gaap_DefinedContributionPlanDisclosuresTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_silk_CorrectionOfProvisionsForReturnsFromCustomersMember_80e713c5-7fdf-45e8-9b2d-f30ff325175c_terseLabel_en-US" xlink:label="lab_silk_CorrectionOfProvisionsForReturnsFromCustomersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Correction Of Provisions For Returns From Customers</link:label>
    <link:label id="lab_silk_CorrectionOfProvisionsForReturnsFromCustomersMember_label_en-US" xlink:label="lab_silk_CorrectionOfProvisionsForReturnsFromCustomersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Correction Of Provisions For Returns From Customers [Member]</link:label>
    <link:label id="lab_silk_CorrectionOfProvisionsForReturnsFromCustomersMember_documentation_en-US" xlink:label="lab_silk_CorrectionOfProvisionsForReturnsFromCustomersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Correction Of Provisions For Returns From Customers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_silk_CorrectionOfProvisionsForReturnsFromCustomersMember" xlink:href="silk-20191231.xsd#silk_CorrectionOfProvisionsForReturnsFromCustomersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_silk_CorrectionOfProvisionsForReturnsFromCustomersMember" xlink:to="lab_silk_CorrectionOfProvisionsForReturnsFromCustomersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_1eabeb09-460e-432d-ac7f-e41d19521348_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock in connection with IPO, net of underwriting discount, commissions and offering costs of $2,481</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_afb81843-7e53-43c9-82ea-75aa9a4577ca_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Value of common stock issued</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityByClassOfStockTable_10dbce3d-46dc-45c4-83d2-8306a6e322c7_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityByClassOfStockTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, by Class of Stock [Table]</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityByClassOfStockTable_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityByClassOfStockTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, by Class of Stock [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityByClassOfStockTable" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TemporaryEquityByClassOfStockTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="lab_us-gaap_TemporaryEquityByClassOfStockTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTable_f71f5c18-8f83-459e-b2b1-26ef42ffd9d8_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTable_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsequentEventTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTable" xlink:to="lab_us-gaap_SubsequentEventTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_619a8b52-472c-4907-be58-df85cbf081bd_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_silk_StockIssuedDuringPeriodSharesExerciseOfWarrants_85895566-7121-40f6-b775-e6a41b826129_terseLabel_en-US" xlink:label="lab_silk_StockIssuedDuringPeriodSharesExerciseOfWarrants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of warrants (in shares)</link:label>
    <link:label id="lab_silk_StockIssuedDuringPeriodSharesExerciseOfWarrants_label_en-US" xlink:label="lab_silk_StockIssuedDuringPeriodSharesExerciseOfWarrants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Exercise Of Warrants</link:label>
    <link:label id="lab_silk_StockIssuedDuringPeriodSharesExerciseOfWarrants_documentation_en-US" xlink:label="lab_silk_StockIssuedDuringPeriodSharesExerciseOfWarrants" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Exercise Of Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_silk_StockIssuedDuringPeriodSharesExerciseOfWarrants" xlink:href="silk-20191231.xsd#silk_StockIssuedDuringPeriodSharesExerciseOfWarrants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_silk_StockIssuedDuringPeriodSharesExerciseOfWarrants" xlink:to="lab_silk_StockIssuedDuringPeriodSharesExerciseOfWarrants" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_336cfd6e-aed5-409c-a789-d4de4e4f33c3_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, useful life</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_e044dc19-9979-48e0-868f-2b1f65c6d2c4_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Intrinsic Value, vested and exercisable</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RestatementAdjustmentMember_7eac85fe-4009-4152-8a3e-2d3392253c14_terseLabel_en-US" xlink:label="lab_srt_RestatementAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restatement Adjustment</link:label>
    <link:label id="lab_srt_RestatementAdjustmentMember_label_en-US" xlink:label="lab_srt_RestatementAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restatement Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAdjustmentMember" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RestatementAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RestatementAdjustmentMember" xlink:to="lab_srt_RestatementAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_726b2795-593a-4436-9bb6-39a02b219c6f_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_2de40309-6e9a-4879-a094-73a267f16943_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_55061436-cb5f-43cf-ba70-807791fa57e3_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_9b116c81-b295-4731-8556-594a3d9d04f7_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsLineItems_cf527e77-6eb8-4733-b8a1-21e3a2c06f49_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Line Items]</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsLineItems_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="lab_us-gaap_OperatingLossCarryforwardsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputRiskFreeInterestRateMember_8199ab7d-f16a-43a1-a484-41470df26d4d_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk-free interest rate</link:label>
    <link:label id="lab_us-gaap_MeasurementInputRiskFreeInterestRateMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Risk Free Interest Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:to="lab_us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_ef183493-ba97-4590-8dd8-6e9b38d9b350_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected volatility, minimum</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_b7491890-9df9-41e3-a7dc-c304ec04555e_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_7d162b0a-3448-4861-bb91-c530a5768dd1_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating loss carryforwards</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwards" xlink:to="lab_us-gaap_OperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_3b14add1-cc79-4713-bf2d-4c1337716522_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNetAbstract_a47e48dd-d5e4-4de6-a2ce-cb644515377d_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNetAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets:</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNetAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNetAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract" xlink:to="lab_us-gaap_DeferredTaxAssetsNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityTableTextBlock_17ce2100-7e80-4a05-90df-cd0951e59974_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Convertible Preferred Stock Issued and Outstanding</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TemporaryEquityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityTableTextBlock" xlink:to="lab_us-gaap_TemporaryEquityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_e6368718-4e71-4577-aea4-423fb4e0d882_terseLabel_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction-in-progress</link:label>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_label_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in Progress [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConstructionInProgressMember" xlink:to="lab_us-gaap_ConstructionInProgressMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits_0ec0f596-2072-4eb7-b737-14803620cca3_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion of preferred stock to common stock upon IPO (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Conversion of Units</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:type="arc" order="1"/>
    <link:label id="lab_silk_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardsAvailableforGrantRollForward_7c02ae59-0fcb-4408-8d1f-4b73a18b3572_terseLabel_en-US" xlink:label="lab_silk_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardsAvailableforGrantRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Available for Grant</link:label>
    <link:label id="lab_silk_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardsAvailableforGrantRollForward_label_en-US" xlink:label="lab_silk_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardsAvailableforGrantRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Awards Available for Grant [Roll Forward]</link:label>
    <link:label id="lab_silk_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardsAvailableforGrantRollForward_documentation_en-US" xlink:label="lab_silk_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardsAvailableforGrantRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Awards Available for Grant [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_silk_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardsAvailableforGrantRollForward" xlink:href="silk-20191231.xsd#silk_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardsAvailableforGrantRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_silk_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardsAvailableforGrantRollForward" xlink:to="lab_silk_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardsAvailableforGrantRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_b0935951-0a14-4503-8034-5fd3491c2f97_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseCost_ab21340d-b150-46bb-8e4d-5d45164c38e3_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease costs</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseCost_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseCost" xlink:to="lab_us-gaap_OperatingLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_d271dc21-b013-4828-8a0c-7e1f6dc1161a_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits that would impact effective tax rate</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits that Would Impact Effective Tax Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_333236d2-ad7e-42b2-92e4-3392d5555d6a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Liabilities Measure on a Recurring Basis</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_f88d1ed3-9776-4707-965f-618c21cb8838_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation, Stock Options, Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation, Stock Options, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_bc817195-aa31-4737-a298-1bf0ee69b9f6_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_faab04db-f396-468a-849c-aa09d4f80525_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_e3f73f3e-44ad-4f43-900c-3cc5fddad3bf_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: imputed interest</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_465ac89a-f09c-4b53-a80c-a8eab80e3072_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_e8a91588-c59a-4fd6-bd57-a5c92d0c582d_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock_e890ef5c-5eaa-4be6-bace-28baf7a2926e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-For-Sale Investments in Unrealized Loss Position</link:label>
    <link:label id="lab_us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Unrealized Loss on Investments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover page.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0b9e31ae-225c-4659-81eb-2d8fd51d7724_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_b37737cc-5c60-4236-824c-f31a3777ec41_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_b6f64f19-3655-4293-b4df-cd2f73827d5b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options Outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_815fb2ee-b31c-45cc-805b-e1ba2acd84c0_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_07c8248e-968c-405e-9072-fb4d80aa2ff0_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_label_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockLineItems" xlink:to="lab_us-gaap_ClassOfStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_10307a97-53eb-473f-8334-4b444fc4ad8d_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity interest acquired</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Percentage of Voting Interests Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:to="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityLiquidationPreference_32069ed3-c919-41f9-b917-7c2d94adb723_verboseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityLiquidationPreference" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liquidation preference</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityLiquidationPreference_688786ce-1f66-4b20-891a-dda30fe93efa_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityLiquidationPreference" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferential Liquidation Value (in thousands)</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityLiquidationPreference_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityLiquidationPreference" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Liquidation Preference</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityLiquidationPreference" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TemporaryEquityLiquidationPreference"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityLiquidationPreference" xlink:to="lab_us-gaap_TemporaryEquityLiquidationPreference" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_4b779c00-2037-40cd-a1eb-34a70ed257f7_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Fair Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_6e19bc04-2de5-438a-b75b-15ec2b21628f_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Adoption [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_label_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Adoption [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfAdoptionMember" xlink:to="lab_us-gaap_TypeOfAdoptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_522e5d0f-6a9f-4c09-9cab-8ddbd6aa46ec_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Future Maturities Under the Term Loan Agreement</link:label>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Maturities of Long-term Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_bfad86bd-85f3-4d74-8b34-0acc20578185_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_5a9efee5-76f4-42e0-9592-540255debf25_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of operating segments</link:label>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Operating Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfOperatingSegments" xlink:to="lab_us-gaap_NumberOfOperatingSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanCostRecognized_b6dd4d8b-9264-4ad1-8142-56a230bc06a3_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employer discretionary contribution</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanCostRecognized_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanCostRecognized" xlink:to="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialPaperMember_3356e28d-d035-4aa8-9c74-b3b5ef864234_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial paper</link:label>
    <link:label id="lab_us-gaap_CommercialPaperMember_label_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialPaperMember" xlink:to="lab_us-gaap_CommercialPaperMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_2a4c3b2b-861a-41ca-90f6-6394b02d759f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Exercise Price, vested and expected to vest (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_a538763a-b019-4d94-898e-b7a4c30e7327_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Maturities, Repayments of Principal in Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_bc886f0e-c24e-4cf1-9007-545e66c0e04f_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development expenses</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_7c08b28a-2028-48b7-81b3-ecac537f1d64_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (expense), net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_9992ce92-41c3-4662-82d3-ab5829731b2a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividend yield</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1214cc99-8b63-44da-8326-74745eae02bf_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_5452a9c0-5afb-4445-bd62-a6642ba9e3e1_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_17919137-d2f6-4e4d-9de9-3df0584e9b4c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares of common stock reserved for issuance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_silk_TermLoanMember_0bed1745-630c-4aee-bd4a-3c13fb34e0cb_terseLabel_en-US" xlink:label="lab_silk_TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan</link:label>
    <link:label id="lab_silk_TermLoanMember_label_en-US" xlink:label="lab_silk_TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan [Member]</link:label>
    <link:label id="lab_silk_TermLoanMember_documentation_en-US" xlink:label="lab_silk_TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_silk_TermLoanMember" xlink:href="silk-20191231.xsd#silk_TermLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_silk_TermLoanMember" xlink:to="lab_silk_TermLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IPOMember_fd682341-a18f-4440-be15-fa68f3419ddf_terseLabel_en-US" xlink:label="lab_us-gaap_IPOMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IPO</link:label>
    <link:label id="lab_us-gaap_IPOMember_label_en-US" xlink:label="lab_us-gaap_IPOMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IPO [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IPOMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IPOMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IPOMember" xlink:to="lab_us-gaap_IPOMember" xlink:type="arc" order="1"/>
    <link:label id="lab_silk_LongTermDebtGrossBeforeAccretionOfClosingFees_8314f7e5-027d-4430-a442-ea19d1a4bd52_totalLabel_en-US" xlink:label="lab_silk_LongTermDebtGrossBeforeAccretionOfClosingFees" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt, gross before accretion of closing fees</link:label>
    <link:label id="lab_silk_LongTermDebtGrossBeforeAccretionOfClosingFees_label_en-US" xlink:label="lab_silk_LongTermDebtGrossBeforeAccretionOfClosingFees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Gross, Before Accretion Of Closing Fees</link:label>
    <link:label id="lab_silk_LongTermDebtGrossBeforeAccretionOfClosingFees_documentation_en-US" xlink:label="lab_silk_LongTermDebtGrossBeforeAccretionOfClosingFees" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Gross, Before Accretion Of Closing Fees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_silk_LongTermDebtGrossBeforeAccretionOfClosingFees" xlink:href="silk-20191231.xsd#silk_LongTermDebtGrossBeforeAccretionOfClosingFees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_silk_LongTermDebtGrossBeforeAccretionOfClosingFees" xlink:to="lab_silk_LongTermDebtGrossBeforeAccretionOfClosingFees" xlink:type="arc" order="1"/>
    <link:label id="lab_silk_EmployeeStockPurchasePlanMember_c4668a36-7b43-4af6-beef-702c52fc6e46_terseLabel_en-US" xlink:label="lab_silk_EmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock under employee stock purchase plan</link:label>
    <link:label id="lab_silk_EmployeeStockPurchasePlanMember_label_en-US" xlink:label="lab_silk_EmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan [Member]</link:label>
    <link:label id="lab_silk_EmployeeStockPurchasePlanMember_documentation_en-US" xlink:label="lab_silk_EmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_silk_EmployeeStockPurchasePlanMember" xlink:href="silk-20191231.xsd#silk_EmployeeStockPurchasePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_silk_EmployeeStockPurchasePlanMember" xlink:to="lab_silk_EmployeeStockPurchasePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_831edef7-5408-45fc-9dcf-2aaa12283370_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021</link:label>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_label_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases, Future Minimum Payments, Due in Three Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:to="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnbilledReceivablesCurrent_956f6d1b-65a6-4f3e-8605-3b4e3135d83d_terseLabel_en-US" xlink:label="lab_us-gaap_UnbilledReceivablesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unbilled receivables</link:label>
    <link:label id="lab_us-gaap_UnbilledReceivablesCurrent_label_en-US" xlink:label="lab_us-gaap_UnbilledReceivablesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unbilled Receivables, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnbilledReceivablesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_UnbilledReceivablesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnbilledReceivablesCurrent" xlink:to="lab_us-gaap_UnbilledReceivablesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_9ed025d9-1f76-4238-92b8-a07c0bf84d0f_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_f867a5ce-5ba8-4bdf-847b-a06b85e0173f_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percent of purchase of price of common stock</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsCommonStock_20cca5d4-2cdd-4f27-91a6-98d42ea61de7_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends declared</link:label>
    <link:label id="lab_us-gaap_DividendsCommonStock_label_en-US" xlink:label="lab_us-gaap_DividendsCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DividendsCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsCommonStock" xlink:to="lab_us-gaap_DividendsCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestInVariableInterestEntity_b2c86d90-929b-4909-aea6-11b977f55de0_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestInVariableInterestEntity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying amount of the non-controlling interest</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestInVariableInterestEntity_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestInVariableInterestEntity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest in Variable Interest Entity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestInVariableInterestEntity" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NoncontrollingInterestInVariableInterestEntity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestInVariableInterestEntity" xlink:to="lab_us-gaap_NoncontrollingInterestInVariableInterestEntity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_fb42c425-8b18-4c38-90fc-996d6f3a67ab_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_9a6a9ccf-d5e4-4960-9563-4684943768fe_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_8de11f0f-17bc-4881-819b-45e4f3d4d87c_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Domestic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_53aca07c-6965-4c88-a21a-a00124efe1bc_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_020dc8cc-2f8b-46fe-83fc-935e8afc0500_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total inventory</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_2bc0b5f4-ac8d-44d9-a314-9db61f6c5f4a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_823bbe64-9b34-4554-aa02-801be1c569bc_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_bae4cf0e-4b2f-4dc1-b85b-d12f6d6fb8bf_periodStartLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_09edd21d-39e1-43df-93e1-7c6b781fdd26_periodEndLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RedeemablePreferredStockMember_b3d367a3-b67b-4c31-9ad9-dfe99b2329f1_terseLabel_en-US" xlink:label="lab_us-gaap_RedeemablePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Preferred Stock</link:label>
    <link:label id="lab_us-gaap_RedeemablePreferredStockMember_label_en-US" xlink:label="lab_us-gaap_RedeemablePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Preferred Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemablePreferredStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RedeemablePreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RedeemablePreferredStockMember" xlink:to="lab_us-gaap_RedeemablePreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_bcfb630d-85f6-4fe6-a565-646fff905213_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_f602fd08-755e-4266-852b-427592cfccdc_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized start-up costs/Intangibles</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Goodwill and Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:to="lab_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForTenantImprovements_2f158da0-ab46-4e0c-b8d2-b84413c79ec0_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForTenantImprovements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Landlord paid tenant improvements</link:label>
    <link:label id="lab_us-gaap_PaymentsForTenantImprovements_label_en-US" xlink:label="lab_us-gaap_PaymentsForTenantImprovements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Tenant Improvements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForTenantImprovements" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsForTenantImprovements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForTenantImprovements" xlink:to="lab_us-gaap_PaymentsForTenantImprovements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_5c02643f-fa32-4eea-a0e0-25848ae9191c_negatedLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Loss, Less than 12 months</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3958e9f8-204e-4dd3-aa9e-4f7b6df5fecf_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net change in cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_silk_OperatingLeaseRightOfUseAssetAmortization_c08c8fd7-23e1-4521-9585-8adb1555d84b_terseLabel_en-US" xlink:label="lab_silk_OperatingLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of right-of-use asset</link:label>
    <link:label id="lab_silk_OperatingLeaseRightOfUseAssetAmortization_label_en-US" xlink:label="lab_silk_OperatingLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-Of-Use Asset, Amortization</link:label>
    <link:label id="lab_silk_OperatingLeaseRightOfUseAssetAmortization_documentation_en-US" xlink:label="lab_silk_OperatingLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-Of-Use Asset, Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_silk_OperatingLeaseRightOfUseAssetAmortization" xlink:href="silk-20191231.xsd#silk_OperatingLeaseRightOfUseAssetAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_silk_OperatingLeaseRightOfUseAssetAmortization" xlink:to="lab_silk_OperatingLeaseRightOfUseAssetAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingChangesAndErrorCorrectionsAbstract_d3fed6a0-1483-4372-b4b8-fc85f1aa88e6_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Changes and Error Corrections [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingChangesAndErrorCorrectionsAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Changes and Error Corrections [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountingChangesAndErrorCorrectionsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:to="lab_us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_635816ec-8263-431b-bc6b-7f434e4aa7ee_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate intrinsic value of options exercised</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_5008341c-a2ad-4468-8d0d-02aa9164c1cd_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_ba997647-3392-4500-bc23-20a8a8a32192_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares issued and outstanding: 31,255,267 and 1,135,310 at December 31, 2019 and 2018, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_199ab345-a549-453f-a2fd-18c60f3301f5_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_322cd397-467e-4ef1-a604-78030526ad28_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_dff3a9f6-9fe4-42f1-904e-ed878a68e522_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Unrealized Gains</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_6f3e6894-f0c1-4131-a8b4-93db6b61acd9_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in assets and liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_713e7b3b-7085-4375-b771-41c3f777a632_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_41ba3c4b-eae5-4c4e-8c55-e2612618184d_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Table]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:to="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_c07aa913-6e13-4833-a870-728c4c2f61f1_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_92858c8c-0ddf-4554-aa6a-c051a33036f7_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation expensed not yet recognized</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Stock Options</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesReceivableRelatedParties_18d8d5b2-71a5-4759-b94d-e8f476df2bca_terseLabel_en-US" xlink:label="lab_us-gaap_NotesReceivableRelatedParties" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Promissory note amount</link:label>
    <link:label id="lab_us-gaap_NotesReceivableRelatedParties_label_en-US" xlink:label="lab_us-gaap_NotesReceivableRelatedParties" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Receivable, Related Parties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableRelatedParties" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NotesReceivableRelatedParties"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesReceivableRelatedParties" xlink:to="lab_us-gaap_NotesReceivableRelatedParties" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_45aba8f5-3165-4b35-9677-0dbb05c4fdcc_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_silk_DebtInstrumentInterestRatePaidInCash_ac9ba81a-0d73-4a58-adaa-328f408d56f2_terseLabel_en-US" xlink:label="lab_silk_DebtInstrumentInterestRatePaidInCash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate paid in cash</link:label>
    <link:label id="lab_silk_DebtInstrumentInterestRatePaidInCash_label_en-US" xlink:label="lab_silk_DebtInstrumentInterestRatePaidInCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Paid In Cash</link:label>
    <link:label id="lab_silk_DebtInstrumentInterestRatePaidInCash_documentation_en-US" xlink:label="lab_silk_DebtInstrumentInterestRatePaidInCash" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Paid In Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_silk_DebtInstrumentInterestRatePaidInCash" xlink:href="silk-20191231.xsd#silk_DebtInstrumentInterestRatePaidInCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_silk_DebtInstrumentInterestRatePaidInCash" xlink:to="lab_silk_DebtInstrumentInterestRatePaidInCash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_94b3e92d-36a1-4861-aae1-da0742ddc672_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_d2bdc414-ae2e-486d-b48e-5dc0ceae9488_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_4001ee9c-0adf-4d69-8de1-696512f22ef6_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_66d65376-cbf4-4f62-8eae-1b77bb8c0adc_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option Pricing Model Assumptions</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_fd93fae9-140a-4b0a-84a6-b14b744e3921_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use asset</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_015acb73-5230-4e53-9eaf-6199483ddf15_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use asset in other non-current assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaidInKindInterest_22852e3d-d929-4ea4-924e-1076b177c0db_terseLabel_en-US" xlink:label="lab_us-gaap_PaidInKindInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash interest expense</link:label>
    <link:label id="lab_us-gaap_PaidInKindInterest_label_en-US" xlink:label="lab_us-gaap_PaidInKindInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Paid-in-Kind Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaidInKindInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaidInKindInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaidInKindInterest" xlink:to="lab_us-gaap_PaidInKindInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_422c1fd0-2c59-4534-be2a-a2f551641521_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average remaining lease term</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_e3c48ba2-b009-467c-8e5e-2f91571c170c_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_4e9138e1-7100-42e1-8906-14cae83f92bd_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Shares, vested and exercisable (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_6e96228d-6ff4-40f1-8b98-06c0d6b6c85d_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Exercisable (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_5bb3d3cb-3b83-438a-97fb-08460765b6e4_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAmount_b6dbbf6f-6ba0-463f-b686-ca1315a8b8f9_verboseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development tax credits</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAmount_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardAmount" xlink:to="lab_us-gaap_TaxCreditCarryforwardAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_7866a7a0-7c1a-4244-b030-f62f387f0aa1_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_289b99ea-2f6f-45e2-92f3-bc1ea3e9acb8_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OverAllotmentOptionMember_08b534b8-8950-4d95-befd-6730247268e0_terseLabel_en-US" xlink:label="lab_us-gaap_OverAllotmentOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Over-Allotment Option</link:label>
    <link:label id="lab_us-gaap_OverAllotmentOptionMember_label_en-US" xlink:label="lab_us-gaap_OverAllotmentOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Over-Allotment Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OverAllotmentOptionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OverAllotmentOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OverAllotmentOptionMember" xlink:to="lab_us-gaap_OverAllotmentOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquitySharesIssued_2fc34c1c-1136-48c2-8454-0e35e7edb421_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary equity, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_TemporaryEquitySharesIssued_c010e6d3-aa01-4a8b-a0f8-f1ba2529c912_verboseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesIssued" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued (in shares)</link:label>
    <link:label id="lab_us-gaap_TemporaryEquitySharesIssued_label_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TemporaryEquitySharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquitySharesIssued" xlink:to="lab_us-gaap_TemporaryEquitySharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_868b0f1b-91ac-4240-8077-bb2540fd3329_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_2aa5e932-fde9-461e-931d-0441afe06efb_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration of Credit Risk, and Other Risks and Uncertainties</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Credit Risk, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:to="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationTaxCredits_6769222b-5cec-438c-a03d-9f396e4c3bd0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationTaxCredits" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General business credits</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationTaxCredits_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationTaxCredits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Credit, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxCredits" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxReconciliationTaxCredits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationTaxCredits" xlink:to="lab_us-gaap_IncomeTaxReconciliationTaxCredits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_9483115b-ad02-4199-86aa-c6b701961a9f_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020</link:label>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_label_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases, Future Minimum Payments, Due in Two Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:to="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_b426a776-bc11-4b2d-8265-0f29edb70b8c_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_f914e766-ab7e-4a4e-b694-157907d1091b_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_508063c0-0b99-4f5a-a7e2-a716a8cdfb99_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_silk_NonqualifiedStockOptionsMember_fdcd167f-336c-455c-b091-dfd931affd9e_terseLabel_en-US" xlink:label="lab_silk_NonqualifiedStockOptionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NSO</link:label>
    <link:label id="lab_silk_NonqualifiedStockOptionsMember_label_en-US" xlink:label="lab_silk_NonqualifiedStockOptionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonqualified Stock Options [Member]</link:label>
    <link:label id="lab_silk_NonqualifiedStockOptionsMember_documentation_en-US" xlink:label="lab_silk_NonqualifiedStockOptionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonqualified Stock Options [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_silk_NonqualifiedStockOptionsMember" xlink:href="silk-20191231.xsd#silk_NonqualifiedStockOptionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_silk_NonqualifiedStockOptionsMember" xlink:to="lab_silk_NonqualifiedStockOptionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRenewalTerm_ce6ae09e-1e97-4f36-8fb1-3b6c61c9730e_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Renewal term</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRenewalTerm_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Renewal Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:to="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterestsAbstract_bfd34e6a-7ed9-4ca6-a88b-d7ade507f8a7_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterestsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable convertible preferred stock issuable in series, $0.001 par value</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterestsAbstract_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterestsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterestsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterestsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterestsAbstract" xlink:to="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterestsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_silk_TermLoanTrancheAMember_2b8c0d12-d09f-4aa5-8d93-2c04f35a183c_terseLabel_en-US" xlink:label="lab_silk_TermLoanTrancheAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan, Tranche A</link:label>
    <link:label id="lab_silk_TermLoanTrancheAMember_label_en-US" xlink:label="lab_silk_TermLoanTrancheAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan, Tranche A [Member]</link:label>
    <link:label id="lab_silk_TermLoanTrancheAMember_documentation_en-US" xlink:label="lab_silk_TermLoanTrancheAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan, Tranche A [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_silk_TermLoanTrancheAMember" xlink:href="silk-20191231.xsd#silk_TermLoanTrancheAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_silk_TermLoanTrancheAMember" xlink:to="lab_silk_TermLoanTrancheAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_92262e83-48ed-4198-a12c-8bf259fee775_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_75938ef3-eef3-4002-bf70-cdda69e9acdd_terseLabel_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and Local Jurisdiction</link:label>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_label_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and Local Jurisdiction [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:to="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_ad2fab79-a1a8-4286-b292-1e551314a399_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_silk_DeferredTaxAssetsOperatingLeaseLiability_6c819e41-b512-46fc-b90b-0f8b20ddc3d4_terseLabel_en-US" xlink:label="lab_silk_DeferredTaxAssetsOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liability</link:label>
    <link:label id="lab_silk_DeferredTaxAssetsOperatingLeaseLiability_label_en-US" xlink:label="lab_silk_DeferredTaxAssetsOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Lease, Liability</link:label>
    <link:label id="lab_silk_DeferredTaxAssetsOperatingLeaseLiability_documentation_en-US" xlink:label="lab_silk_DeferredTaxAssetsOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_silk_DeferredTaxAssetsOperatingLeaseLiability" xlink:href="silk-20191231.xsd#silk_DeferredTaxAssetsOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_silk_DeferredTaxAssetsOperatingLeaseLiability" xlink:to="lab_silk_DeferredTaxAssetsOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_92b2e3ef-e9b3-48ea-aea4-053d51e5dfbd_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of the Available-For-Sale Investments</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_e4b41707-9a55-4820-a12e-1785c815ef73_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use asset obtained in exchange for lease obligation</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_b8f731cf-3fa6-4592-9a1a-50c49aefbe13_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsAbstract" xlink:to="lab_us-gaap_BusinessCombinationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_5cdac55f-3601-4661-84d1-92d4ec15e45f_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options cancelled (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_ab0440ee-2455-471e-a2c9-faf0df53cf94_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options cancelled (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharePrice_af207fe3-318f-45cf-abe7-b94a93ae6533_terseLabel_en-US" xlink:label="lab_us-gaap_SharePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of stock (in USD per share)</link:label>
    <link:label id="lab_us-gaap_SharePrice_label_en-US" xlink:label="lab_us-gaap_SharePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharePrice" xlink:to="lab_us-gaap_SharePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c6f34374-33ca-4788-bde6-f0ec1fb0e31e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3ea72e5e-d6af-41af-ab1f-bc478b8347cd_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_silk_OperatingLossCarryforwardOffsetMaximumPercent_43b8e702-79ef-4038-a790-bb1adfb1e6df_terseLabel_en-US" xlink:label="lab_silk_OperatingLossCarryforwardOffsetMaximumPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percent maximum of federal taxable income to offset with net operating losses</link:label>
    <link:label id="lab_silk_OperatingLossCarryforwardOffsetMaximumPercent_label_en-US" xlink:label="lab_silk_OperatingLossCarryforwardOffsetMaximumPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforward, Offset Maximum, Percent</link:label>
    <link:label id="lab_silk_OperatingLossCarryforwardOffsetMaximumPercent_documentation_en-US" xlink:label="lab_silk_OperatingLossCarryforwardOffsetMaximumPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforward, Offset Maximum, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_silk_OperatingLossCarryforwardOffsetMaximumPercent" xlink:href="silk-20191231.xsd#silk_OperatingLossCarryforwardOffsetMaximumPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_silk_OperatingLossCarryforwardOffsetMaximumPercent" xlink:to="lab_silk_OperatingLossCarryforwardOffsetMaximumPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_19c96162-eb3d-4bce-8679-38fc55e5daea_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_silk_IncentiveandNonqualifiedStockOptionIssuedMember_cabd5289-c899-49a1-af28-9adb9ae05638_terseLabel_en-US" xlink:label="lab_silk_IncentiveandNonqualifiedStockOptionIssuedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of options under stock plan</link:label>
    <link:label id="lab_silk_IncentiveandNonqualifiedStockOptionIssuedMember_label_en-US" xlink:label="lab_silk_IncentiveandNonqualifiedStockOptionIssuedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incentive and Nonqualified Stock Option, Issued [Member]</link:label>
    <link:label id="lab_silk_IncentiveandNonqualifiedStockOptionIssuedMember_documentation_en-US" xlink:label="lab_silk_IncentiveandNonqualifiedStockOptionIssuedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incentive and Nonqualified Stock Option, Issued [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_silk_IncentiveandNonqualifiedStockOptionIssuedMember" xlink:href="silk-20191231.xsd#silk_IncentiveandNonqualifiedStockOptionIssuedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_silk_IncentiveandNonqualifiedStockOptionIssuedMember" xlink:to="lab_silk_IncentiveandNonqualifiedStockOptionIssuedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_61f94e41-5d8d-4730-9684-509e60494db5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Income Tax Expense (Benefit)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts_0e923c7e-e5e6-4b81-a9c7-3b31fb13dcc1_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of debt discount and debt issuance costs</link:label>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts_label_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Debt Issuance Costs and Discounts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:to="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeriesAPreferredStockMember_958dd1dd-cbc2-4a48-a29f-b8559c848cb1_terseLabel_en-US" xlink:label="lab_us-gaap_SeriesAPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series A</link:label>
    <link:label id="lab_us-gaap_SeriesAPreferredStockMember_acbb8dee-515a-4aba-95d7-dc830de922b3_verboseLabel_en-US" xlink:label="lab_us-gaap_SeriesAPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion of Series A redeemable convertible preferred stock</link:label>
    <link:label id="lab_us-gaap_SeriesAPreferredStockMember_label_en-US" xlink:label="lab_us-gaap_SeriesAPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series A Preferred Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesAPreferredStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeriesAPreferredStockMember" xlink:to="lab_us-gaap_SeriesAPreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_silk_CommonStockWarrantMember_5bc841d0-a402-4c6f-88f9-a52bdf43f078_terseLabel_en-US" xlink:label="lab_silk_CommonStockWarrantMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock warrants outstanding</link:label>
    <link:label id="lab_silk_CommonStockWarrantMember_label_en-US" xlink:label="lab_silk_CommonStockWarrantMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock Warrant [Member]</link:label>
    <link:label id="lab_silk_CommonStockWarrantMember_documentation_en-US" xlink:label="lab_silk_CommonStockWarrantMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock Warrant [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_silk_CommonStockWarrantMember" xlink:href="silk-20191231.xsd#silk_CommonStockWarrantMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_silk_CommonStockWarrantMember" xlink:to="lab_silk_CommonStockWarrantMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationOtherReconcilingItems_3c23f1bf-d03f-44ac-a2d9-9f7aa1dcc2a1_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationOtherReconcilingItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationOtherReconcilingItems_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationOtherReconcilingItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherReconcilingItems" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxReconciliationOtherReconcilingItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationOtherReconcilingItems" xlink:to="lab_us-gaap_IncomeTaxReconciliationOtherReconcilingItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_33bef3f9-04b0-43d8-bc66-8f9137fc03e9_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principles of Consolidation</link:label>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_eabfb6a5-bc0b-4b77-8080-6ed06104f4d5_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected volatility, maximum</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_e6ae0b4d-05ad-47a5-baa4-b3133e7ed870_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_60a565f9-cdac-4d85-ae36-3bdbe1838835_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Present value of minimum payments</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_79e6f14f-a693-45b9-bdf4-4d8b24ae1d7e_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_c9c0cff2-dbac-41ef-850a-90ce7fa2f82a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertiblePreferredStockMember_f49be9a2-b416-4643-a163-8a003b29f1f2_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Preferred Stock</link:label>
    <link:label id="lab_us-gaap_ConvertiblePreferredStockMember_label_en-US" xlink:label="lab_us-gaap_ConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Preferred Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertiblePreferredStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConvertiblePreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertiblePreferredStockMember" xlink:to="lab_us-gaap_ConvertiblePreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetBackedSecuritiesMember_0698f051-c6be-4a85-abb6-db2cc2a5c856_terseLabel_en-US" xlink:label="lab_us-gaap_AssetBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset-backed securities</link:label>
    <link:label id="lab_us-gaap_AssetBackedSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_AssetBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset-backed Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetBackedSecuritiesMember" xlink:to="lab_us-gaap_AssetBackedSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition_fa1cb694-332a-4a10-b55d-583dacab6722_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee stock-based compensation</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Share-based Compensation, Employee Stock Purchase Program, Requisite Service Period Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition" xlink:type="arc" order="1"/>
    <link:label id="lab_silk_CashAndCashEquivalentsFairValueDisclosureMaturingAfterOneYearThroughTwoYears_38e66d3c-41a5-4198-ac23-ce59ecd3c101_terseLabel_en-US" xlink:label="lab_silk_CashAndCashEquivalentsFairValueDisclosureMaturingAfterOneYearThroughTwoYears" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts maturing after one year through two years</link:label>
    <link:label id="lab_silk_CashAndCashEquivalentsFairValueDisclosureMaturingAfterOneYearThroughTwoYears_label_en-US" xlink:label="lab_silk_CashAndCashEquivalentsFairValueDisclosureMaturingAfterOneYearThroughTwoYears" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash And Cash Equivalents, Fair Value Disclosure, Maturing After One Year Through Two Years</link:label>
    <link:label id="lab_silk_CashAndCashEquivalentsFairValueDisclosureMaturingAfterOneYearThroughTwoYears_documentation_en-US" xlink:label="lab_silk_CashAndCashEquivalentsFairValueDisclosureMaturingAfterOneYearThroughTwoYears" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash And Cash Equivalents, Fair Value Disclosure, Maturing After One Year Through Two Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_silk_CashAndCashEquivalentsFairValueDisclosureMaturingAfterOneYearThroughTwoYears" xlink:href="silk-20191231.xsd#silk_CashAndCashEquivalentsFairValueDisclosureMaturingAfterOneYearThroughTwoYears"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_silk_CashAndCashEquivalentsFairValueDisclosureMaturingAfterOneYearThroughTwoYears" xlink:to="lab_silk_CashAndCashEquivalentsFairValueDisclosureMaturingAfterOneYearThroughTwoYears" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_7c846203-3cda-4b8b-bea2-f28302d1816b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_a55cf332-1d5d-4596-9659-5db0a87b5f9c_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_59dae32a-7e21-458f-94e7-4807bc510771_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_c86ea2a3-85b8-4cca-b935-817091df7578_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Present value of lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6a863e2c-a9ab-42d3-8e8b-ccfd753256be_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Award [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Award [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_silk_NotesReceivableRelatedPartiesInterestRateStatedPercentage_a6310f1a-c468-4152-a414-e5b221904afb_terseLabel_en-US" xlink:label="lab_silk_NotesReceivableRelatedPartiesInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes receivable, interest rate</link:label>
    <link:label id="lab_silk_NotesReceivableRelatedPartiesInterestRateStatedPercentage_label_en-US" xlink:label="lab_silk_NotesReceivableRelatedPartiesInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Receivable, Related Parties, Interest Rate, Stated Percentage</link:label>
    <link:label id="lab_silk_NotesReceivableRelatedPartiesInterestRateStatedPercentage_documentation_en-US" xlink:label="lab_silk_NotesReceivableRelatedPartiesInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Receivable, Related Parties, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_silk_NotesReceivableRelatedPartiesInterestRateStatedPercentage" xlink:href="silk-20191231.xsd#silk_NotesReceivableRelatedPartiesInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_silk_NotesReceivableRelatedPartiesInterestRateStatedPercentage" xlink:to="lab_silk_NotesReceivableRelatedPartiesInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_59f35c93-268b-4435-9fcd-0d52c7dd1d14_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityLineItems_a37fc505-1249-46e7-a348-ea3da2a637eb_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity [Line Items]</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityLineItems_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TemporaryEquityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityLineItems" xlink:to="lab_us-gaap_TemporaryEquityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_586ed414-0fa6-4fef-8b6c-053f83ef4178_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage employee contribution</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:to="lab_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_c77475e1-0841-4100-a5fa-514ce5770737_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development credits</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Credit Carryforwards, Research</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_c137c9cb-3f16-4f94-bff4-6080523745f3_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recent Accounting Pronouncements</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements and Changes in Accounting Principles [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_0f89e808-adc4-4385-8a35-5df6222f7ad8_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employer contribution match percentage</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Employer Matching Contribution, Percent of Match</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:to="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_c473da6c-e8c2-4eeb-b971-f76fe7dbfba6_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_4beabc8c-dfda-4d6e-9dcd-f203502733ef_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowances for accounts receivables</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for Doubtful Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_7d3ac010-b358-4c7b-af32-439de3dcef11_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accruals and reserves</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d1f03a0a-387d-4561-9194-bc88fb18f611_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_e6e64b6e-df8d-47a6-a38e-37f38af08ffa_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_label_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases, Future Minimum Payments Due</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:to="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_7d588ac4-ff3c-4fb2-bdd0-0b3801a939ce_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_label_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventLineItems" xlink:to="lab_us-gaap_SubsequentEventLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_silk_BusinessCombinationConsiderationTransferredNotesPayableForgiven_19533a83-4eab-43e4-9f73-4406fbe060f3_terseLabel_en-US" xlink:label="lab_silk_BusinessCombinationConsiderationTransferredNotesPayableForgiven" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consideration given, amount of notes payable forgiven</link:label>
    <link:label id="lab_silk_BusinessCombinationConsiderationTransferredNotesPayableForgiven_label_en-US" xlink:label="lab_silk_BusinessCombinationConsiderationTransferredNotesPayableForgiven" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Notes Payable Forgiven</link:label>
    <link:label id="lab_silk_BusinessCombinationConsiderationTransferredNotesPayableForgiven_documentation_en-US" xlink:label="lab_silk_BusinessCombinationConsiderationTransferredNotesPayableForgiven" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Notes Payable Forgiven</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_silk_BusinessCombinationConsiderationTransferredNotesPayableForgiven" xlink:href="silk-20191231.xsd#silk_BusinessCombinationConsiderationTransferredNotesPayableForgiven"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_silk_BusinessCombinationConsiderationTransferredNotesPayableForgiven" xlink:to="lab_silk_BusinessCombinationConsiderationTransferredNotesPayableForgiven" xlink:type="arc" order="1"/>
    <link:label id="lab_silk_PreferredStockWarrantsMember_9c4a6973-849b-47fb-b789-4555d315b449_terseLabel_en-US" xlink:label="lab_silk_PreferredStockWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock Warrants</link:label>
    <link:label id="lab_silk_PreferredStockWarrantsMember_label_en-US" xlink:label="lab_silk_PreferredStockWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock Warrants [Member]</link:label>
    <link:label id="lab_silk_PreferredStockWarrantsMember_documentation_en-US" xlink:label="lab_silk_PreferredStockWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_silk_PreferredStockWarrantsMember" xlink:href="silk-20191231.xsd#silk_PreferredStockWarrantsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_silk_PreferredStockWarrantsMember" xlink:to="lab_silk_PreferredStockWarrantsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeriesCPreferredStockMember_76174941-7060-4977-a86d-2c1c403ce493_terseLabel_en-US" xlink:label="lab_us-gaap_SeriesCPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series C</link:label>
    <link:label id="lab_us-gaap_SeriesCPreferredStockMember_648a7f65-cd2a-4b33-93d6-e31c20dc7f6e_verboseLabel_en-US" xlink:label="lab_us-gaap_SeriesCPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion of Series C redeemable convertible preferred stock and warrants</link:label>
    <link:label id="lab_us-gaap_SeriesCPreferredStockMember_label_en-US" xlink:label="lab_us-gaap_SeriesCPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series C Preferred Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesCPreferredStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SeriesCPreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeriesCPreferredStockMember" xlink:to="lab_us-gaap_SeriesCPreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAdjustmentOfWarrants_223c73ca-4eda-4655-97b1-f9ef7f5807d6_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAdjustmentOfWarrants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in fair value of redeemable convertible preferred stock warrant liability</link:label>
    <link:label id="lab_us-gaap_FairValueAdjustmentOfWarrants_label_en-US" xlink:label="lab_us-gaap_FairValueAdjustmentOfWarrants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Adjustment of Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAdjustmentOfWarrants" xlink:to="lab_us-gaap_FairValueAdjustmentOfWarrants" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_6e8d1290-c1d2-4823-ab6a-135c02500c1a_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholders&#8217; equity (deficit)</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_11fd7411-ff95-4c74-a7d3-e25d5eb402dd_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options cancelled (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_2ac08eb6-de50-47f7-9615-29766dd52adf_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option vesting term</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_b7ae502f-a7a3-4cc5-8263-8a1e9b03346e_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating loss carryforwards</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_577b42e2-fc0a-4c3d-a77e-c4b3f2ed80c2_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liability in other liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightOutstanding_3f9d7154-8589-47a3-b781-9029bc43bba9_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightOutstanding_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="lab_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_98fdff34-66e0-45b1-a661-b7f56110f768_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition and Cost of Goods Sold</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_silk_ProvisionsForSalesReturns_0cef919c-9124-4668-85fe-09c5440d9a52_terseLabel_en-US" xlink:label="lab_silk_ProvisionsForSalesReturns" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for sales returns</link:label>
    <link:label id="lab_silk_ProvisionsForSalesReturns_label_en-US" xlink:label="lab_silk_ProvisionsForSalesReturns" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provisions For Sales Returns</link:label>
    <link:label id="lab_silk_ProvisionsForSalesReturns_documentation_en-US" xlink:label="lab_silk_ProvisionsForSalesReturns" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provisions For Sales Returns</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_silk_ProvisionsForSalesReturns" xlink:href="silk-20191231.xsd#silk_ProvisionsForSalesReturns"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_silk_ProvisionsForSalesReturns" xlink:to="lab_silk_ProvisionsForSalesReturns" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_9cd163ce-4728-465d-9b52-22ad688acc8f_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock_447dc87e-3ac8-42be-a039-a8cd05580550_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Cash Equivalents, Short-Term and Long-Term Equivalents</link:label>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:to="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_ab9975bd-2b23-4913-95d5-83c928bc2114_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation expense for share-based awards</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_b96a4546-7641-4f77-b156-fb321bdf4be2_verboseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allocated Share-based Compensation Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_4ec39605-e0f0-47aa-9a43-75f80c2d575d_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_b0cd4716-dc41-461e-a7f1-8f52d7db12e4_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Intrinsic Value, vested and expected to vest</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_silk_WarrantsClassifiedAsLiabilitiesPolicyTextBlock_93411c5b-3eaf-4851-a800-bce0ab30ea28_terseLabel_en-US" xlink:label="lab_silk_WarrantsClassifiedAsLiabilitiesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Convertible Preferred Stock Warrant Liability</link:label>
    <link:label id="lab_silk_WarrantsClassifiedAsLiabilitiesPolicyTextBlock_label_en-US" xlink:label="lab_silk_WarrantsClassifiedAsLiabilitiesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants Classified As Liabilities [Policy Text Block]</link:label>
    <link:label id="lab_silk_WarrantsClassifiedAsLiabilitiesPolicyTextBlock_documentation_en-US" xlink:label="lab_silk_WarrantsClassifiedAsLiabilitiesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants Classified As Liabilities [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_silk_WarrantsClassifiedAsLiabilitiesPolicyTextBlock" xlink:href="silk-20191231.xsd#silk_WarrantsClassifiedAsLiabilitiesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_silk_WarrantsClassifiedAsLiabilitiesPolicyTextBlock" xlink:to="lab_silk_WarrantsClassifiedAsLiabilitiesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_e8c390f4-b65a-4130-b7de-67d39edc20d6_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares issued as consideration (in shares)</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Number of Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:to="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_fad7406d-d248-4527-837b-25f98d243062_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentAnnualReport_cb47de4f-0472-4c39-bf19-1c4e5edf7803_terseLabel_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:label id="lab_dei_DocumentAnnualReport_label_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentAnnualReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentAnnualReport" xlink:to="lab_dei_DocumentAnnualReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_33d3af2c-7dcf-4cba-a394-3069a095e21f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Loss Per Share Determination</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_9571b50c-8baa-4bd9-bbf8-598f8d39f700_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_0ad9d827-e380-4b2f-a616-af1914b2b0de_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_b2f20760-f0bc-4a4a-af1c-430a766c8b27_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of stock options (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_a53219e3-49ad-4d71-b268-e22763638025_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_afbf5d9b-cac2-4003-bac0-caa63344d352_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:to="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_4bf60973-7222-4115-896e-4b8c53ff2660_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_silk_NeuroCoIncMember_44caa693-7e78-4804-a697-c856e046771e_terseLabel_en-US" xlink:label="lab_silk_NeuroCoIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NeuroCo, Inc</link:label>
    <link:label id="lab_silk_NeuroCoIncMember_label_en-US" xlink:label="lab_silk_NeuroCoIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NeuroCo, Inc [Member]</link:label>
    <link:label id="lab_silk_NeuroCoIncMember_documentation_en-US" xlink:label="lab_silk_NeuroCoIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NeuroCo, Inc [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_silk_NeuroCoIncMember" xlink:href="silk-20191231.xsd#silk_NeuroCoIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_silk_NeuroCoIncMember" xlink:to="lab_silk_NeuroCoIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_silk_AccruedClinicalExpensesCurrent_1bfee294-d31d-4210-aa6f-0504064cb795_terseLabel_en-US" xlink:label="lab_silk_AccruedClinicalExpensesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued clinical expenses</link:label>
    <link:label id="lab_silk_AccruedClinicalExpensesCurrent_label_en-US" xlink:label="lab_silk_AccruedClinicalExpensesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Clinical Expenses, Current</link:label>
    <link:label id="lab_silk_AccruedClinicalExpensesCurrent_documentation_en-US" xlink:label="lab_silk_AccruedClinicalExpensesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Clinical Expenses, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_silk_AccruedClinicalExpensesCurrent" xlink:href="silk-20191231.xsd#silk_AccruedClinicalExpensesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_silk_AccruedClinicalExpensesCurrent" xlink:to="lab_silk_AccruedClinicalExpensesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_silk_AssetsAndLiabilitiesLesseeTableTextBlock_02dbf923-0bc4-44e2-a738-7f2e3e9276a1_verboseLabel_en-US" xlink:label="lab_silk_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of ASC 842 Impact of Adoption on Condensed Consolidated Balance Sheet</link:label>
    <link:label id="lab_silk_AssetsAndLiabilitiesLesseeTableTextBlock_598a84d1-efd3-422e-a796-8f31da6b79ad_terseLabel_en-US" xlink:label="lab_silk_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Information</link:label>
    <link:label id="lab_silk_AssetsAndLiabilitiesLesseeTableTextBlock_label_en-US" xlink:label="lab_silk_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets And Liabilities, Lessee [Table Text Block]</link:label>
    <link:label id="lab_silk_AssetsAndLiabilitiesLesseeTableTextBlock_documentation_en-US" xlink:label="lab_silk_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets And Liabilities, Lessee [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_silk_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:href="silk-20191231.xsd#silk_AssetsAndLiabilitiesLesseeTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_silk_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:to="lab_silk_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions_01660861-0e1b-4634-a8ee-6a552276433f_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock in connection with NeuroCo merger</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireInvestments_fc943389-7b16-4f73-96eb-5f46c13d5973_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of investments</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireInvestments_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireInvestments" xlink:to="lab_us-gaap_PaymentsToAcquireInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockPricePerShare_7959c160-c5b8-4586-a135-3e103c5f0d04_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockPricePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock issued, price per share (in USD per share)</link:label>
    <link:label id="lab_us-gaap_SaleOfStockPricePerShare_label_en-US" xlink:label="lab_us-gaap_SaleOfStockPricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Price Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockPricePerShare" xlink:to="lab_us-gaap_SaleOfStockPricePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteRedeemablePreferredStockIssuePolicy_820d374e-ad25-4084-97ff-70167dbfb0ca_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteRedeemablePreferredStockIssuePolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Convertible Preferred Stock</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteRedeemablePreferredStockIssuePolicy_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteRedeemablePreferredStockIssuePolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note, Redeemable Preferred Stock, Issue, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteRedeemablePreferredStockIssuePolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquityNoteRedeemablePreferredStockIssuePolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteRedeemablePreferredStockIssuePolicy" xlink:to="lab_us-gaap_StockholdersEquityNoteRedeemablePreferredStockIssuePolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_e83d8a6f-f4e5-413d-80da-2c7bbf407024_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_ba74d7fd-948f-4f0f-80ed-bd8b5d219fb3_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_f3f924a5-33d0-4de2-b058-485169d63534_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk-free interest rate, maximum</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:type="arc" order="1"/>
    <link:label id="lab_silk_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset_4e05669e-8586-4cbe-b6ae-79a298d00997_negatedLabel_en-US" xlink:label="lab_silk_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease asset</link:label>
    <link:label id="lab_silk_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_silk_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Operating Lease, Right-Of-Use Asset</link:label>
    <link:label id="lab_silk_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset_documentation_en-US" xlink:label="lab_silk_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Operating Lease, Right-Of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_silk_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset" xlink:href="silk-20191231.xsd#silk_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_silk_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset" xlink:to="lab_silk_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_silk_ExercisePriceFourMember_7984b330-dfae-4766-ac55-3a4ae4dd9cb5_verboseLabel_en-US" xlink:label="lab_silk_ExercisePriceFourMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Four</link:label>
    <link:label id="lab_silk_ExercisePriceFourMember_label_en-US" xlink:label="lab_silk_ExercisePriceFourMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Four [Member]</link:label>
    <link:label id="lab_silk_ExercisePriceFourMember_documentation_en-US" xlink:label="lab_silk_ExercisePriceFourMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Four [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_silk_ExercisePriceFourMember" xlink:href="silk-20191231.xsd#silk_ExercisePriceFourMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_silk_ExercisePriceFourMember" xlink:to="lab_silk_ExercisePriceFourMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_4786d246-ca33-48d6-8834-def62646a196_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Exercise Price, vested and exercisable (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_611da8e3-34b8-4f59-8f03-84f21b66a689_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-Based Compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_e0076715-2541-41c6-b4bc-c6c48efa737f_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_af5fd73b-2fca-4fdd-b7da-a66f9d6171ed_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryPolicyTextBlock" xlink:to="lab_us-gaap_InventoryPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_1931731b-9b2c-4d45-b375-b7f6c0d02251_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Noncurrent Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_c67f1537-49e5-41e5-9130-802b8a611b49_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of property and equipment</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:to="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_b0f96cfb-17a5-447f-b6d2-557a24adb6da_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Raw materials</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:to="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201602Member_e3ff1a0f-8eb5-439d-835f-6a25843f82cb_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201602Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments Due to ASC 842</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201602Member_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201602Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2016-02 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201602Member" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountingStandardsUpdate201602Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdate201602Member" xlink:to="lab_us-gaap_AccountingStandardsUpdate201602Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_bf5dd230-b184-4c8b-aaa7-1aa4bb93fd3d_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments for New Accounting Pronouncements [Axis]</link:label>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_label_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments for New Accounting Pronouncements [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_33eee2d6-5893-49e7-b63c-1d20b6d6a3bd_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_fc8da667-1dc1-4fb2-9dca-fd1c3af2ba13_negatedLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_silk_ExercisePriceThreeMember_78f2f1b4-ed2b-43f3-84da-4930e9cdde98_verboseLabel_en-US" xlink:label="lab_silk_ExercisePriceThreeMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Three</link:label>
    <link:label id="lab_silk_ExercisePriceThreeMember_label_en-US" xlink:label="lab_silk_ExercisePriceThreeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Three [Member]</link:label>
    <link:label id="lab_silk_ExercisePriceThreeMember_documentation_en-US" xlink:label="lab_silk_ExercisePriceThreeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Three [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_silk_ExercisePriceThreeMember" xlink:href="silk-20191231.xsd#silk_ExercisePriceThreeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_silk_ExercisePriceThreeMember" xlink:to="lab_silk_ExercisePriceThreeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_865fcf60-7fec-4074-adae-3b350a9c1fdb_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from long-term debt</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_silk_DebtInstrumentCovenantMaximumLiquidityAmount_8d59206a-39d9-4adb-a487-ba67e169f20e_terseLabel_en-US" xlink:label="lab_silk_DebtInstrumentCovenantMaximumLiquidityAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum liquidity amount</link:label>
    <link:label id="lab_silk_DebtInstrumentCovenantMaximumLiquidityAmount_label_en-US" xlink:label="lab_silk_DebtInstrumentCovenantMaximumLiquidityAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Maximum Liquidity, Amount</link:label>
    <link:label id="lab_silk_DebtInstrumentCovenantMaximumLiquidityAmount_documentation_en-US" xlink:label="lab_silk_DebtInstrumentCovenantMaximumLiquidityAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Maximum Liquidity, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_silk_DebtInstrumentCovenantMaximumLiquidityAmount" xlink:href="silk-20191231.xsd#silk_DebtInstrumentCovenantMaximumLiquidityAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_silk_DebtInstrumentCovenantMaximumLiquidityAmount" xlink:to="lab_silk_DebtInstrumentCovenantMaximumLiquidityAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_silk_CashAndCashEquivalentsFairValueDisclosureMaturingWithinOneYear_7179ebae-23f8-4366-b38f-585aa7185d09_terseLabel_en-US" xlink:label="lab_silk_CashAndCashEquivalentsFairValueDisclosureMaturingWithinOneYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts maturing within one year</link:label>
    <link:label id="lab_silk_CashAndCashEquivalentsFairValueDisclosureMaturingWithinOneYear_label_en-US" xlink:label="lab_silk_CashAndCashEquivalentsFairValueDisclosureMaturingWithinOneYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash And Cash Equivalents, Fair Value Disclosure, Maturing Within One Year</link:label>
    <link:label id="lab_silk_CashAndCashEquivalentsFairValueDisclosureMaturingWithinOneYear_documentation_en-US" xlink:label="lab_silk_CashAndCashEquivalentsFairValueDisclosureMaturingWithinOneYear" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash And Cash Equivalents, Fair Value Disclosure, Maturing Within One Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_silk_CashAndCashEquivalentsFairValueDisclosureMaturingWithinOneYear" xlink:href="silk-20191231.xsd#silk_CashAndCashEquivalentsFairValueDisclosureMaturingWithinOneYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_silk_CashAndCashEquivalentsFairValueDisclosureMaturingWithinOneYear" xlink:to="lab_silk_CashAndCashEquivalentsFairValueDisclosureMaturingWithinOneYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermInvestments_e778b166-0dd6-4b7a-aef9-dde491212f9e_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term investments</link:label>
    <link:label id="lab_us-gaap_LongTermInvestments_label_en-US" xlink:label="lab_us-gaap_LongTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermInvestments" xlink:to="lab_us-gaap_LongTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_silk_CommonStockWarrantsMember_629e0c71-89e1-44ff-abf6-a5b932fb820d_terseLabel_en-US" xlink:label="lab_silk_CommonStockWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants to Purchase Common Stock</link:label>
    <link:label id="lab_silk_CommonStockWarrantsMember_8b89b3a7-862d-4f72-afb3-9cb1b9056489_verboseLabel_en-US" xlink:label="lab_silk_CommonStockWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants to purchase common stock</link:label>
    <link:label id="lab_silk_CommonStockWarrantsMember_label_en-US" xlink:label="lab_silk_CommonStockWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock Warrants [Member]</link:label>
    <link:label id="lab_silk_CommonStockWarrantsMember_documentation_en-US" xlink:label="lab_silk_CommonStockWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_silk_CommonStockWarrantsMember" xlink:href="silk-20191231.xsd#silk_CommonStockWarrantsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_silk_CommonStockWarrantsMember" xlink:to="lab_silk_CommonStockWarrantsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_60a80d8b-5688-4bbf-ae99-604ee151cd3f_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScenarioUnspecifiedDomain_fecd1932-5d0b-45cf-88e5-bbdeb7ca1cf4_terseLabel_en-US" xlink:label="lab_us-gaap_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario, Unspecified [Domain]</link:label>
    <link:label id="lab_us-gaap_ScenarioUnspecifiedDomain_label_en-US" xlink:label="lab_us-gaap_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario, Unspecified [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScenarioUnspecifiedDomain" xlink:to="lab_us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_801a2643-4f63-4f33-a983-b55ab2f7721e_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_f38c4720-ea9d-49a3-835b-ab2b0d9201c5_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finished products</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:to="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis_1a1c0df2-1cf5-4d6f-8880-a6f75befdb31_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash and Cash Equivalents [Axis]</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash and Cash Equivalents [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_23bc80fc-1886-4521-9671-2d6fe1fc19fd_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recent Accounting Pronouncements</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_88e86e9e-d885-4bf5-8194-c138354e1c80_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in the Redeemable Convertible Warrant Liability</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_01df2e3c-30cb-441e-bb5d-4b7072f68159_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_3506ba71-8800-45fe-8185-6ad2b3c1f2e0_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax at federal statutory rate</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:to="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_c8662542-8ae6-4ee8-a92d-1345941fea2c_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_eaca1656-5e0c-4f97-998e-afb43af2990b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_eaa379a6-bcbe-4331-b962-1b104959256d_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_d5218fe4-859e-48e4-a1c4-3a4349c6502b_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_b160e670-47dd-42b5-b45f-afe59cc5a3d2_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_3ad6b06d-e6bd-45e2-9a41-0eb3d8e442f2_negatedLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Unrealized Losses</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_23454445-cf93-4470-a0ee-873dd11e6b7c_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option term</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_48019df9-f842-4aea-aaa2-f6bb71b0ea71_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:to="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum_2e44a1f8-f0d9-4b19-b76c-fed4d246a8e4_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percent of outstanding shares of common stock</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Percentage of Outstanding Stock Maximum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_c5fc638b-393e-4181-ac90-544a1128d6f3_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Line Items]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance_16796e1a-3131-4ba7-9942-053e6ad357a4_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NeuroCo common stock issuance</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Increase from Subsidiary Equity Issuance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" xlink:to="lab_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_silk_SeriesA1PreferredStockMember_91543494-996f-4426-8e98-d008044693df_terseLabel_en-US" xlink:label="lab_silk_SeriesA1PreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series A-1</link:label>
    <link:label id="lab_silk_SeriesA1PreferredStockMember_3ccb1741-3d52-4c32-bb24-53b5165be9e3_verboseLabel_en-US" xlink:label="lab_silk_SeriesA1PreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion of Series A-1 redeemable convertible preferred stock</link:label>
    <link:label id="lab_silk_SeriesA1PreferredStockMember_label_en-US" xlink:label="lab_silk_SeriesA1PreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series A-1 Preferred Stock [Member]</link:label>
    <link:label id="lab_silk_SeriesA1PreferredStockMember_documentation_en-US" xlink:label="lab_silk_SeriesA1PreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series A-1 Preferred Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_silk_SeriesA1PreferredStockMember" xlink:href="silk-20191231.xsd#silk_SeriesA1PreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_silk_SeriesA1PreferredStockMember" xlink:to="lab_silk_SeriesA1PreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_893c3aca-aea8-4b12-bec4-1c7d548b6b48_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_silk_EffectiveIncomeTaxRateReconciliationWarrantLiabilityAdjustmentAmount_1d087da0-eb66-4e26-a2eb-895dc307cd88_terseLabel_en-US" xlink:label="lab_silk_EffectiveIncomeTaxRateReconciliationWarrantLiabilityAdjustmentAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on Series C warrant liability</link:label>
    <link:label id="lab_silk_EffectiveIncomeTaxRateReconciliationWarrantLiabilityAdjustmentAmount_label_en-US" xlink:label="lab_silk_EffectiveIncomeTaxRateReconciliationWarrantLiabilityAdjustmentAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Warrant Liability Adjustment, Amount</link:label>
    <link:label id="lab_silk_EffectiveIncomeTaxRateReconciliationWarrantLiabilityAdjustmentAmount_documentation_en-US" xlink:label="lab_silk_EffectiveIncomeTaxRateReconciliationWarrantLiabilityAdjustmentAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Warrant Liability Adjustment, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_silk_EffectiveIncomeTaxRateReconciliationWarrantLiabilityAdjustmentAmount" xlink:href="silk-20191231.xsd#silk_EffectiveIncomeTaxRateReconciliationWarrantLiabilityAdjustmentAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_silk_EffectiveIncomeTaxRateReconciliationWarrantLiabilityAdjustmentAmount" xlink:to="lab_silk_EffectiveIncomeTaxRateReconciliationWarrantLiabilityAdjustmentAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LetterOfCreditMember_b1fcb253-6691-41cd-b574-007550c0e54b_terseLabel_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letter of Credit</link:label>
    <link:label id="lab_us-gaap_LetterOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letter of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LetterOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LetterOfCreditMember" xlink:to="lab_us-gaap_LetterOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_d33fcf35-1957-4652-95d2-9410d45d32c0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_db93b779-51c0-47dc-9739-2fe23b76a2cd_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_silk_DebtInstrumentInterestRateFinancingFee_204555f1-2086-41fa-95fa-2963bd151d65_terseLabel_en-US" xlink:label="lab_silk_DebtInstrumentInterestRateFinancingFee" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing fee</link:label>
    <link:label id="lab_silk_DebtInstrumentInterestRateFinancingFee_label_en-US" xlink:label="lab_silk_DebtInstrumentInterestRateFinancingFee" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Financing Fee</link:label>
    <link:label id="lab_silk_DebtInstrumentInterestRateFinancingFee_documentation_en-US" xlink:label="lab_silk_DebtInstrumentInterestRateFinancingFee" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Financing Fee</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_silk_DebtInstrumentInterestRateFinancingFee" xlink:href="silk-20191231.xsd#silk_DebtInstrumentInterestRateFinancingFee"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_silk_DebtInstrumentInterestRateFinancingFee" xlink:to="lab_silk_DebtInstrumentInterestRateFinancingFee" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_4826bc81-4f74-4296-baf9-4fe8d9e38b18_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issued and sold common stock (in shares)</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_0dae5d36-5237-490d-81ec-7dd863639a7e_verboseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary equity, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Number of Shares Issued in Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_720f63c6-5300-4c6c-a5ef-ad40d5827bea_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_1c339e1f-b7f6-4d29-a1f7-07596c6bc5b2_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityPublicFloat_31235c81-062c-4f43-8b18-04a9375bff8f_terseLabel_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:label id="lab_dei_EntityPublicFloat_label_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityPublicFloat"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityPublicFloat" xlink:to="lab_dei_EntityPublicFloat" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_bb460178-5753-4eb5-ae0b-1872767f1db7_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Components</link:label>
    <link:label id="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Balance Sheet Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SupplementalBalanceSheetDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:to="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_d53e16fb-ebce-497f-bc5b-a9129ec63399_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_377635e6-9846-4722-9dc7-27a387e19526_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis_ab5aa6bd-5902-460b-a81e-a757f34f04ee_terseLabel_en-US" xlink:label="lab_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments for Error Corrections [Axis]</link:label>
    <link:label id="lab_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis_label_en-US" xlink:label="lab_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments for Error Corrections [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis" xlink:to="lab_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_2f105ef9-ed8e-4baf-afd6-437be75bb693_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt drawn down</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_70db86e4-2f23-44b2-9ca2-516768273904_totalLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt, gross</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:to="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_7640be6b-ac7b-48e9-ada4-90faeaa80a7a_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_db86f5d0-06a9-4322-9d54-debdaab8afc5_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_a81bffbc-13f0-4bd7-81f4-5e3a4436e280_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares authorized: 5,000,000 and none at December 31, 2019 and 2018, respectively</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_6b90add0-e63a-43e8-afa5-36d73ef49c0d_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsAbstract" xlink:to="lab_us-gaap_SubsequentEventsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_b6ff8a42-6b16-49fb-8ebd-51b212fad40a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-Based Compensation Expense Relating to Stock Options to Employees and Nonemployees</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_31cb98a6-7206-43b7-8ce6-0786c7f10e26_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWriteDown_91cf44b9-689f-486a-be70-6c2f6d7076cb_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWriteDown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for excess and obsolete inventories</link:label>
    <link:label id="lab_us-gaap_InventoryWriteDown_label_en-US" xlink:label="lab_us-gaap_InventoryWriteDown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Write-down</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWriteDown" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InventoryWriteDown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWriteDown" xlink:to="lab_us-gaap_InventoryWriteDown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_04492507-fdfa-4bef-a5cf-f61ce556bd2f_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_ac3ec481-b9f2-44f1-996a-78889832f148_totalLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesOutstanding_4fcbd8ca-dbf5-42c7-80b2-e3b1a9a77c62_periodStartLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_6ac0585e-9c04-4f91-b384-a294e14b6db0_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_label_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesOutstanding" xlink:to="lab_us-gaap_SharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_f8d694b3-a61e-4d5b-99a2-0f895d7b710f_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_66b0cb7e-d0f4-45f5-b285-1ffc5271790f_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental disclosure of cash flow information</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_28f5b65b-8eaa-4dda-bbce-3dbb012f4d2a_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total deferred tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_7ffb6cd6-9c7f-497a-be87-2a0241efb0eb_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_c53d223f-db2c-4003-b039-3f65dce1ff11_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_label_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases, Future Minimum Payments, Due in Four Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:to="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_e39aee13-f32e-4c1b-b915-161346804517_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_6026bf3d-87d7-429f-af12-90f4f78a6dd1_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_37e88b19-1cad-48d4-8ad2-5cbd15af8601_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_89dc6b35-49a4-4814-9fdf-115e00973481_periodStartLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at the beginning of year</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_272ca21a-8d6d-4fc1-aa4a-98f842005d4d_periodEndLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of year</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_7bd446c7-0ac7-4313-91ed-15242361a7bf_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of goods sold</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_67c08dfa-80b0-44e4-a54c-ae7bdd6d2cda_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LegalEntityAxis_a73b4061-a3a4-4f6d-8345-641f84466746_terseLabel_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:label id="lab_dei_LegalEntityAxis_label_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LegalEntityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LegalEntityAxis" xlink:to="lab_dei_LegalEntityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_96cdb3cd-4cc7-4737-8419-372d7cb90c2a_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019</link:label>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases, Future Minimum Payments Due, Next Twelve Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:to="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_54a0ad31-d1dd-426f-a3fc-5e002164be69_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Amount representing debt discount and debt issuance costs</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioPreviouslyReportedMember_5d4b2e86-55bb-4b94-a432-a542e688016a_terseLabel_en-US" xlink:label="lab_srt_ScenarioPreviouslyReportedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Previously Reported</link:label>
    <link:label id="lab_srt_ScenarioPreviouslyReportedMember_label_en-US" xlink:label="lab_srt_ScenarioPreviouslyReportedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Previously Reported [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioPreviouslyReportedMember" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioPreviouslyReportedMember" xlink:to="lab_srt_ScenarioPreviouslyReportedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_2fbae4f5-a28e-4ad2-a814-e44479f34745_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-controlling Interest</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestMember" xlink:to="lab_us-gaap_NoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrincipalOwnerMember_bafb8a29-5756-4a03-88a0-f5fd0f9d96c8_terseLabel_en-US" xlink:label="lab_us-gaap_PrincipalOwnerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">10% Stockholders</link:label>
    <link:label id="lab_us-gaap_PrincipalOwnerMember_label_en-US" xlink:label="lab_us-gaap_PrincipalOwnerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal Owner [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrincipalOwnerMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PrincipalOwnerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrincipalOwnerMember" xlink:to="lab_us-gaap_PrincipalOwnerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_e258a8d5-80de-4958-b804-e5c3fdcc7066_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_a2ce1cda-4d47-492d-9c0c-7ac375c8ca38_verboseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 ESPP</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock_1801d988-9ea1-4f75-ae62-47db3078ef89_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment and Geographical Information</link:label>
    <link:label id="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_3134cfab-067c-4caa-b148-9ccbe68720f0_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityDomain_18c7b397-aa19-41bd-bb58-3f441eb31161_terseLabel_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:label id="lab_dei_EntityDomain_label_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityDomain" xlink:to="lab_dei_EntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_1cf79a9a-41f4-4e15-a7d2-7c86f657289d_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_silk_IPOUnderwritingDiscountsAndCommissionsMember_ac765d58-0cbd-4981-9f24-59d07e66e844_terseLabel_en-US" xlink:label="lab_silk_IPOUnderwritingDiscountsAndCommissionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IPO - Underwriting Discounts And Commissions</link:label>
    <link:label id="lab_silk_IPOUnderwritingDiscountsAndCommissionsMember_label_en-US" xlink:label="lab_silk_IPOUnderwritingDiscountsAndCommissionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IPO - Underwriting Discounts And Commissions [Member]</link:label>
    <link:label id="lab_silk_IPOUnderwritingDiscountsAndCommissionsMember_documentation_en-US" xlink:label="lab_silk_IPOUnderwritingDiscountsAndCommissionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IPO - Underwriting Discounts And Commissions [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_silk_IPOUnderwritingDiscountsAndCommissionsMember" xlink:href="silk-20191231.xsd#silk_IPOUnderwritingDiscountsAndCommissionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_silk_IPOUnderwritingDiscountsAndCommissionsMember" xlink:to="lab_silk_IPOUnderwritingDiscountsAndCommissionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_silk_DebtInstrumentLiquidityCovenantTerm_2d9e40c3-731d-44b8-bcd2-05e907ce59c9_terseLabel_en-US" xlink:label="lab_silk_DebtInstrumentLiquidityCovenantTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity cure period</link:label>
    <link:label id="lab_silk_DebtInstrumentLiquidityCovenantTerm_label_en-US" xlink:label="lab_silk_DebtInstrumentLiquidityCovenantTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Liquidity Covenant, Term</link:label>
    <link:label id="lab_silk_DebtInstrumentLiquidityCovenantTerm_documentation_en-US" xlink:label="lab_silk_DebtInstrumentLiquidityCovenantTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Liquidity Covenant, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_silk_DebtInstrumentLiquidityCovenantTerm" xlink:href="silk-20191231.xsd#silk_DebtInstrumentLiquidityCovenantTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_silk_DebtInstrumentLiquidityCovenantTerm" xlink:to="lab_silk_DebtInstrumentLiquidityCovenantTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems_67580a79-3a41-4ee1-a6ad-3aeb5dcd83d5_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash and Cash Equivalents Items [Line Items]</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash and Cash Equivalents Items [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromMinorityShareholders_d5f07bdc-a177-47e0-a6be-4224fad88f08_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromMinorityShareholders" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-controlling interest</link:label>
    <link:label id="lab_us-gaap_ProceedsFromMinorityShareholders_label_en-US" xlink:label="lab_us-gaap_ProceedsFromMinorityShareholders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Noncontrolling Interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMinorityShareholders" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromMinorityShareholders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromMinorityShareholders" xlink:to="lab_us-gaap_ProceedsFromMinorityShareholders" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable_b988c391-ad23-4832-9045-af733c88a506_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restrictions on Cash and Cash Equivalents [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restrictions on Cash and Cash Equivalents [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable" xlink:to="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquitySharesOutstanding_bc9215e2-36b8-42af-9051-095eba6e56cb_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary equity, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_TemporaryEquitySharesOutstanding_e2394a20-de1d-43ab-9185-bb7bc61e3f0a_periodStartLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary equity, beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_TemporaryEquitySharesOutstanding_d28044a7-f80b-4a2e-b102-f80ea613c580_periodEndLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary equity, ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_TemporaryEquitySharesOutstanding_dde5b831-4342-49dc-bc73-16177ba0f241_verboseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_TemporaryEquitySharesOutstanding_label_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquitySharesOutstanding" xlink:to="lab_us-gaap_TemporaryEquitySharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_d0786736-9222-4f56-b0f1-ce7aa7da9467_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_e50b8c5f-51fb-4bcc-b6cb-84f6e6dde430_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Loss per Share Attributable to Common Stockholders and Unaudited Pro Forma Net Loss per Share Attributable to Common Stockholders</link:label>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_43abcf02-e682-4647-ae18-517f68a18782_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred shares (in USD per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_silk_DebtMaximumBorrowingCapacity_1e8802f8-3622-4dc7-8760-5cabcb1ad1a1_terseLabel_en-US" xlink:label="lab_silk_DebtMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term loan agreement amount</link:label>
    <link:label id="lab_silk_DebtMaximumBorrowingCapacity_label_en-US" xlink:label="lab_silk_DebtMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Maximum Borrowing Capacity</link:label>
    <link:label id="lab_silk_DebtMaximumBorrowingCapacity_documentation_en-US" xlink:label="lab_silk_DebtMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_silk_DebtMaximumBorrowingCapacity" xlink:href="silk-20191231.xsd#silk_DebtMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_silk_DebtMaximumBorrowingCapacity" xlink:to="lab_silk_DebtMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyDomain_fef2b4f3-1882-447c-985a-10af2508448c_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyDomain" xlink:to="lab_us-gaap_RelatedPartyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_32b5c038-903c-49ea-9242-e1090e9f9807_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_98fdee23-f35c-4d55-a5f5-748e6dba3155_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_7848721d-c943-4f03-b9d9-f4d0d7718ddf_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_9d03f17f-33a5-4385-ac1c-3d2910b9c857_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_a1f1f5cd-1bea-4c66-b369-bf05c465c3b2_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive loss:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_ed566e2f-7ce8-4e58-81ff-c66337eb83bf_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_cbd24240-0da1-4183-afdf-f69955f4262b_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease Maturities</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_b4794894-30a4-412a-939f-16cbb9d5f360_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityLiquidationPreferencePerShare_a320ac74-2d09-4f61-82f4-c3f55b7fd96f_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityLiquidationPreferencePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Per share Preference (in USD per share)</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityLiquidationPreferencePerShare_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityLiquidationPreferencePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Liquidation Preference Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityLiquidationPreferencePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TemporaryEquityLiquidationPreferencePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityLiquidationPreferencePerShare" xlink:to="lab_us-gaap_TemporaryEquityLiquidationPreferencePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputDiscountRateMember_5ac37cbd-7106-4d4b-b350-63afbf158745_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discounted cash flow rate</link:label>
    <link:label id="lab_us-gaap_MeasurementInputDiscountRateMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Discount Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputDiscountRateMember" xlink:to="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredChargesPolicyTextBlock_b2f327a7-440d-4910-b212-10e6af938f6b_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredChargesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Public Offering Costs</link:label>
    <link:label id="lab_us-gaap_DeferredChargesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_DeferredChargesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Charges, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredChargesPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredChargesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredChargesPolicyTextBlock" xlink:to="lab_us-gaap_DeferredChargesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_a9430bf9-30c1-4e61-842c-d3e8286ce457_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unaudited Quarterly Financial Information</link:label>
    <link:label id="lab_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quarterly Financial Information [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_5ba3049f-6f59-4897-b345-68fee71c513d_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_7fbaec38-cd8d-4800-b462-bfb31f936775_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash, beginning of year</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_5d2a15ad-b907-4fe2-8d8b-e4492b9907e9_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash, end of year</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_601325f3-0e59-4af5-b6f1-bcb9952a3a38_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_30fb297f-4094-4953-9462-f9759560da2c_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityExTransitionPeriod_9ddf6da6-d50d-44a4-94fa-396e712a8fbf_terseLabel_en-US" xlink:label="lab_dei_EntityExTransitionPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Ex Transition Period</link:label>
    <link:label id="lab_dei_EntityExTransitionPeriod_label_en-US" xlink:label="lab_dei_EntityExTransitionPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Ex Transition Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityExTransitionPeriod" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityExTransitionPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityExTransitionPeriod" xlink:to="lab_dei_EntityExTransitionPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_f0f89ec3-6cdb-4662-a330-38cca47502e6_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of options vested (in USD per share)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_0a2512a4-6a20-489f-9978-49a4ca44478f_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_2ce0ef99-06fe-4ab6-9e6b-0b6f717f4d27_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventories</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_silk_DebtInstrumentConvertibleMaximumPercentageOfOutstandingLoans_55869d3f-9f82-47b4-8f73-fa433bffa863_terseLabel_en-US" xlink:label="lab_silk_DebtInstrumentConvertibleMaximumPercentageOfOutstandingLoans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of outstanding loans</link:label>
    <link:label id="lab_silk_DebtInstrumentConvertibleMaximumPercentageOfOutstandingLoans_label_en-US" xlink:label="lab_silk_DebtInstrumentConvertibleMaximumPercentageOfOutstandingLoans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Maximum Percentage Of Outstanding Loans</link:label>
    <link:label id="lab_silk_DebtInstrumentConvertibleMaximumPercentageOfOutstandingLoans_documentation_en-US" xlink:label="lab_silk_DebtInstrumentConvertibleMaximumPercentageOfOutstandingLoans" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Maximum Percentage Of Outstanding Loans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_silk_DebtInstrumentConvertibleMaximumPercentageOfOutstandingLoans" xlink:href="silk-20191231.xsd#silk_DebtInstrumentConvertibleMaximumPercentageOfOutstandingLoans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_silk_DebtInstrumentConvertibleMaximumPercentageOfOutstandingLoans" xlink:to="lab_silk_DebtInstrumentConvertibleMaximumPercentageOfOutstandingLoans" xlink:type="arc" order="1"/>
    <link:label id="lab_silk_TermLoanTrancheBMember_2f9c6aec-56c2-4a45-bcaf-eb572d3fe2b3_terseLabel_en-US" xlink:label="lab_silk_TermLoanTrancheBMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan, Tranche B</link:label>
    <link:label id="lab_silk_TermLoanTrancheBMember_label_en-US" xlink:label="lab_silk_TermLoanTrancheBMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan, Tranche B [Member]</link:label>
    <link:label id="lab_silk_TermLoanTrancheBMember_documentation_en-US" xlink:label="lab_silk_TermLoanTrancheBMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan, Tranche B [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_silk_TermLoanTrancheBMember" xlink:href="silk-20191231.xsd#silk_TermLoanTrancheBMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_silk_TermLoanTrancheBMember" xlink:to="lab_silk_TermLoanTrancheBMember" xlink:type="arc" order="1"/>
    <link:label id="lab_silk_NetIncomeLossAndComprehensiveIncomeLossNetOfTaxAttributableToParent_228de283-21f1-4601-8ae3-e98c84dc5fd9_totalLabel_en-US" xlink:label="lab_silk_NetIncomeLossAndComprehensiveIncomeLossNetOfTaxAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss and comprehensive loss attributable to Silk Road Medical, Inc. common stockholders</link:label>
    <link:label id="lab_silk_NetIncomeLossAndComprehensiveIncomeLossNetOfTaxAttributableToParent_label_en-US" xlink:label="lab_silk_NetIncomeLossAndComprehensiveIncomeLossNetOfTaxAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) And Comprehensive Income (Loss), Net Of Tax, Attributable To Parent</link:label>
    <link:label id="lab_silk_NetIncomeLossAndComprehensiveIncomeLossNetOfTaxAttributableToParent_documentation_en-US" xlink:label="lab_silk_NetIncomeLossAndComprehensiveIncomeLossNetOfTaxAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) And Comprehensive Income (Loss), Net Of Tax, Attributable To Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_silk_NetIncomeLossAndComprehensiveIncomeLossNetOfTaxAttributableToParent" xlink:href="silk-20191231.xsd#silk_NetIncomeLossAndComprehensiveIncomeLossNetOfTaxAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_silk_NetIncomeLossAndComprehensiveIncomeLossNetOfTaxAttributableToParent" xlink:to="lab_silk_NetIncomeLossAndComprehensiveIncomeLossNetOfTaxAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_48fd8e89-89da-469f-9e9c-be376c9ed138_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Long-Lived Assets</link:label>
    <link:label id="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3a152502-6795-429b-98fa-ee6989a5b2dd_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightLineItems_86032be2-7f4d-477d-841e-98c6522d3adb_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right [Line Items]</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightLineItems_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="lab_us-gaap_ClassOfWarrantOrRightLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_a990881e-53ab-48a5-a76b-29b8130730d2_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement Frequency [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_17640ece-c391-41f4-8713-6410a1b47856_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range [Axis]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_a8090077-cdab-4edb-92a1-a42c2e1627e2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Potentially Dilutive Securities Outstanding Excluded from Diluted Weighted Average Shares Outstanding</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_17142618-66c8-4fc5-81e9-cb8b09677d61_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transactions and Translations Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_20de9813-ce77-439b-8db2-719889456bdb_terseLabel_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for doubtful accounts receivable</link:label>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_label_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for Doubtful Accounts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:to="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_d9f85c6a-e865-449a-8d29-9a84d839e69c_terseLabel_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_label_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityWellKnownSeasonedIssuer" xlink:to="lab_dei_EntityWellKnownSeasonedIssuer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_8512a3f1-e9a2-41e4-a0f5-ab3ef643f08d_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_a9a84b36-78a1-4cae-bae2-a1a601ea34d6_totalLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_82fa23bf-f368-404a-8623-4a2039625c61_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due Next Twelve Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesMember_55c4460d-dec8-44dc-9dfd-23ed0aba2937_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of goods sold</link:label>
    <link:label id="lab_us-gaap_CostOfSalesMember_label_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesMember" xlink:to="lab_us-gaap_CostOfSalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_ad4a39bb-902e-4a33-a933-06475648d4c5_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityParOrStatedValuePerShare_f8448036-7e3d-4fe9-8a40-a94a0fd11fc7_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary equity, par value (in USD per share)</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:to="lab_us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_35a64465-4df3-4ec3-8cdc-2b0a68b0b3c3_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGross" xlink:to="lab_us-gaap_DeferredTaxAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_36c7b71d-0a31-4d88-97e0-c00eb4e178e4_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsForErrorCorrectionDomain_25ee018e-6994-43c3-8b86-5e2246c7e2aa_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsForErrorCorrectionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments for Error Correction [Domain]</link:label>
    <link:label id="lab_us-gaap_AdjustmentsForErrorCorrectionDomain_label_en-US" xlink:label="lab_us-gaap_AdjustmentsForErrorCorrectionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments for Error Correction [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForErrorCorrectionDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdjustmentsForErrorCorrectionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsForErrorCorrectionDomain" xlink:to="lab_us-gaap_AdjustmentsForErrorCorrectionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConversionOfStockAmountIssued1_86bece94-1147-4865-a2f3-622c80a6f03f_terseLabel_en-US" xlink:label="lab_us-gaap_ConversionOfStockAmountIssued1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net exercise of redeemable convertible preferred stock warrants to preferred stock</link:label>
    <link:label id="lab_us-gaap_ConversionOfStockAmountIssued1_label_en-US" xlink:label="lab_us-gaap_ConversionOfStockAmountIssued1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion of Stock, Amount Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockAmountIssued1" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConversionOfStockAmountIssued1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConversionOfStockAmountIssued1" xlink:to="lab_us-gaap_ConversionOfStockAmountIssued1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quarterly Financial Information Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_QuarterlyFinancialInformationDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:to="lab_us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_silk_ShareBasedCompensationArrangementBySharebasedPaymentAwardNumberOfAdditionalSharesAllowableUnderThePlan_4052e27e-82ba-44d0-a503-bb63e90c93c8_terseLabel_en-US" xlink:label="lab_silk_ShareBasedCompensationArrangementBySharebasedPaymentAwardNumberOfAdditionalSharesAllowableUnderThePlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of additional shares allowable under the plan (in shares)</link:label>
    <link:label id="lab_silk_ShareBasedCompensationArrangementBySharebasedPaymentAwardNumberOfAdditionalSharesAllowableUnderThePlan_label_en-US" xlink:label="lab_silk_ShareBasedCompensationArrangementBySharebasedPaymentAwardNumberOfAdditionalSharesAllowableUnderThePlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-based Payment Award, Number Of Additional Shares Allowable Under The Plan</link:label>
    <link:label id="lab_silk_ShareBasedCompensationArrangementBySharebasedPaymentAwardNumberOfAdditionalSharesAllowableUnderThePlan_documentation_en-US" xlink:label="lab_silk_ShareBasedCompensationArrangementBySharebasedPaymentAwardNumberOfAdditionalSharesAllowableUnderThePlan" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-based Payment Award, Number Of Additional Shares Allowable Under The Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_silk_ShareBasedCompensationArrangementBySharebasedPaymentAwardNumberOfAdditionalSharesAllowableUnderThePlan" xlink:href="silk-20191231.xsd#silk_ShareBasedCompensationArrangementBySharebasedPaymentAwardNumberOfAdditionalSharesAllowableUnderThePlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_silk_ShareBasedCompensationArrangementBySharebasedPaymentAwardNumberOfAdditionalSharesAllowableUnderThePlan" xlink:to="lab_silk_ShareBasedCompensationArrangementBySharebasedPaymentAwardNumberOfAdditionalSharesAllowableUnderThePlan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputDiscountForLackOfMarketabilityMember_f841d1fc-91af-4f66-b623-03e519c54bc1_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputDiscountForLackOfMarketabilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketability discount rate</link:label>
    <link:label id="lab_us-gaap_MeasurementInputDiscountForLackOfMarketabilityMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputDiscountForLackOfMarketabilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Discount for Lack of Marketability [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountForLackOfMarketabilityMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MeasurementInputDiscountForLackOfMarketabilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputDiscountForLackOfMarketabilityMember" xlink:to="lab_us-gaap_MeasurementInputDiscountForLackOfMarketabilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermInvestmentsMember_c8fc0dc6-c89a-4483-84c3-0447a365dc69_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term investments</link:label>
    <link:label id="lab_us-gaap_ShortTermInvestmentsMember_label_en-US" xlink:label="lab_us-gaap_ShortTermInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Investments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestmentsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermInvestmentsMember" xlink:to="lab_us-gaap_ShortTermInvestmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e1e98aaa-a3d3-4b6f-ac31-d5be99fbf9e1_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net loss to net cash used in operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_bb26b751-f8b4-44ad-8302-0c6c686706bb_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_f7d54d97-e115-453d-8403-0462626c03b8_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_6e41fa5e-233d-4b7f-bcd5-30d7a88fc65a_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liquidation preference: $121,144 at December 31, 2017 and 2018</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_40085768-f10e-4048-a45b-4d38787d64a6_periodStartLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary equity, beginning balance</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_54279023-0d7e-474e-b590-838a10666a41_periodEndLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary equity, ending balance</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_3ab2a153-489a-4c89-beed-5e2be46a676f_verboseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying Value (in thousands)</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Carrying Amount, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:to="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_01bf5384-cf00-43c8-b195-5c1cebb09030_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-sale investments</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_silk_DebtInstrumentConvertibleMarketCapitalization_b9af5882-4862-414c-ae7a-da0923f5f711_terseLabel_en-US" xlink:label="lab_silk_DebtInstrumentConvertibleMarketCapitalization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Market capitalization (greater than)</link:label>
    <link:label id="lab_silk_DebtInstrumentConvertibleMarketCapitalization_label_en-US" xlink:label="lab_silk_DebtInstrumentConvertibleMarketCapitalization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Market Capitalization</link:label>
    <link:label id="lab_silk_DebtInstrumentConvertibleMarketCapitalization_documentation_en-US" xlink:label="lab_silk_DebtInstrumentConvertibleMarketCapitalization" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Market Capitalization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_silk_DebtInstrumentConvertibleMarketCapitalization" xlink:href="silk-20191231.xsd#silk_DebtInstrumentConvertibleMarketCapitalization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_silk_DebtInstrumentConvertibleMarketCapitalization" xlink:to="lab_silk_DebtInstrumentConvertibleMarketCapitalization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_51c03769-27a2-44df-8c05-fb523458fb24_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increases/(decreases) related to prior years&#8217; tax positions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_3dce0cf6-ebfc-4aee-8810-6874312428ca_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_a19295a4-bbb9-4432-820c-a30debb61b7c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk-free interest rate, minimum</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_d598403b-31ab-4aef-9faa-4ab8e7927fda_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Remaining Contractual Term (in Years), vested and expected to vest</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_db85ac06-bf46-4385-8829-4094199cfffd_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_4b0e113e-b2a5-49d6-8e4e-2a0354d474b2_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdvertisingCostsPolicyTextBlock_7185cee7-c39d-44bd-8838-304db73b7c90_terseLabel_en-US" xlink:label="lab_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advertising Costs</link:label>
    <link:label id="lab_us-gaap_AdvertisingCostsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advertising Costs, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdvertisingCostsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:to="lab_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_36803682-c45f-45da-9f0d-a500a8c937e5_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Work-in-process inventories</link:label>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Work in Process, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:to="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_6f57e86e-5c57-409d-89ad-2327f285ff5c_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Valuation allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_0f5feb5a-7f2b-4b10-95cb-058bb902d29d_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock reserved for future issuance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_label_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Capital Shares Reserved for Future Issuance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_421ca690-6faf-47db-942f-2c41025b16cf_terseLabel_en-US" xlink:label="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Government Agencies Debt Securities</link:label>
    <link:label id="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Government Agencies Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:to="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_d632708f-4ce7-4421-8b91-0b1b8866ff8a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Shares, vested and expect to vest (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_3f0d5226-4a92-4d08-b6ae-f1b717467073_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and stockholders&#8217; equity (deficit)</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_96207c00-0b5b-49de-bd6f-6a2ab71803e4_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_silk_DebtInstrumentCovenantMinimumNetRevenueAmount_14280e31-8de4-49ee-b348-ef69df7ccbf2_terseLabel_en-US" xlink:label="lab_silk_DebtInstrumentCovenantMinimumNetRevenueAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum net revenue target</link:label>
    <link:label id="lab_silk_DebtInstrumentCovenantMinimumNetRevenueAmount_label_en-US" xlink:label="lab_silk_DebtInstrumentCovenantMinimumNetRevenueAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Minimum Net Revenue, Amount</link:label>
    <link:label id="lab_silk_DebtInstrumentCovenantMinimumNetRevenueAmount_documentation_en-US" xlink:label="lab_silk_DebtInstrumentCovenantMinimumNetRevenueAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Minimum Net Revenue, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_silk_DebtInstrumentCovenantMinimumNetRevenueAmount" xlink:href="silk-20191231.xsd#silk_DebtInstrumentCovenantMinimumNetRevenueAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_silk_DebtInstrumentCovenantMinimumNetRevenueAmount" xlink:to="lab_silk_DebtInstrumentCovenantMinimumNetRevenueAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WarrantsAndRightsOutstandingMeasurementInput_82190875-aaed-420e-a3dc-3b66fd880807_terseLabel_en-US" xlink:label="lab_us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement input</link:label>
    <link:label id="lab_us-gaap_WarrantsAndRightsOutstandingMeasurementInput_label_en-US" xlink:label="lab_us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants and Rights Outstanding, Measurement Input</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WarrantsAndRightsOutstandingMeasurementInput"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:to="lab_us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_1928e9e4-3070-4dec-abd9-149433fd5298_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and accrued liabilities for purchases of property and equipment</link:label>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_label_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Expenditures Incurred but Not yet Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:to="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_76a6bfc9-0666-4215-ba2b-994ce5dab235_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Property, Plant and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:to="lab_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_1d369cd6-4d9b-48cc-bf6e-6f615bc87771_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on disposal of property and equipment</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Property Plant Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:to="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption_9711a444-6599-433d-89ee-c49bd312246f_terseLabel_en-US" xlink:label="lab_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative effect of change in accounting principle/treatment</link:label>
    <link:label id="lab_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption_4c09f238-77bf-4140-8358-e8ba36ed0ced_negatedLabel_en-US" xlink:label="lab_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative effect of change in accounting principle/treatment</link:label>
    <link:label id="lab_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption_label_en-US" xlink:label="lab_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect of New Accounting Principle in Period of Adoption</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption" xlink:to="lab_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_aa391bd7-a452-4c39-a624-d85298db2887_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_37f3d395-784e-45ba-8f67-e1565a75f6b2_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_bdf5d2a5-9d25-45d0-8975-730b524dd02c_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_91fa1eff-6fe0-41b7-b381-6679eac7a4e0_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents and Restricted Cash</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:to="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_26be72f1-a21e-4a44-93d4-8ceeeaac1648_terseLabel_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money market funds</link:label>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_label_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money Market Funds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MoneyMarketFundsMember" xlink:to="lab_us-gaap_MoneyMarketFundsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardNameDomain_89ec28c9-149f-45d0-b652-7938b8a5760d_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardNameDomain_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain" xlink:to="lab_us-gaap_TaxCreditCarryforwardNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_a433336a-8400-4777-b92a-50cf52a3623b_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_05af64bd-7fcd-4b3d-b3b8-6024d9a738ff_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State taxes, net of federal benefit</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:to="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_f9e64fc3-7d9a-4ce4-b9d2-de4160da5c86_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_416f22d0-5cf8-416f-8442-463cc9117898_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_9d3b081f-45de-4b82-8b3c-d0494448b604_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_c7e3a84a-6a71-4ad4-8695-752766f3850d_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_45dee8fc-107f-4714-873a-36fe4f5f6761_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_244f1c4c-d6a6-4b06-87d7-ce4df8240e08_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_be4835c8-5d1b-43ab-93c0-18dc87cda033_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Convertible Preferred Stock</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_e64c7ee5-aafb-4d92-a842-cdc10225e0f4_verboseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity (Deficit)</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_f5bcace3-957e-4030-a4ba-687bc2fa8f6e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_ce6c5aa2-3cda-442b-a595-e239978df42d_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_395ce169-6ee4-46de-80d1-88ff031ae260_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits, income tax penalties and interest expense</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_1914b890-d16d-433f-bdea-a183fa0f5f04_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurements, Recurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_silk_SecondPublicOfferingMember_01a0a64e-be51-4193-90c6-d6c51ea6b242_terseLabel_en-US" xlink:label="lab_silk_SecondPublicOfferingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Second Public Offering</link:label>
    <link:label id="lab_silk_SecondPublicOfferingMember_label_en-US" xlink:label="lab_silk_SecondPublicOfferingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Second Public Offering [Member]</link:label>
    <link:label id="lab_silk_SecondPublicOfferingMember_documentation_en-US" xlink:label="lab_silk_SecondPublicOfferingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Second Public Offering</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_silk_SecondPublicOfferingMember" xlink:href="silk-20191231.xsd#silk_SecondPublicOfferingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_silk_SecondPublicOfferingMember" xlink:to="lab_silk_SecondPublicOfferingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfStockIssuanceCosts_75e94a5c-3e40-4875-ba6d-46d7f73ee952_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Offering costs</link:label>
    <link:label id="lab_us-gaap_PaymentsOfStockIssuanceCosts_53d34686-8b36-4d53-9fc3-d7354c09e6ca_verboseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of deferred offering costs</link:label>
    <link:label id="lab_us-gaap_PaymentsOfStockIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Stock Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_e17be4d1-9dca-4f35-9f20-9b5f3c5ba3c7_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in USD per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_f611db40-38a7-42eb-8926-11998cc306f3_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Par value (in USD per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_7aa6cbbe-a4d7-43e7-8907-613d5e8ee87d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_8ab751bd-0012-45a0-b3a2-d23224437658_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold improvements</link:label>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_label_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseholdImprovementsMember" xlink:to="lab_us-gaap_LeaseholdImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_44704d47-cbf9-4316-a5b6-4de2bd8cf56a_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of stock options</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_f4a45d91-2d7c-417e-acb9-90a09575a4c8_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liability</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_9757f507-0fbb-4207-af18-9d337d923680_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock under employee stock purchase plan (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Employee Stock Purchase Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityVoluntaryFilers_52c47629-1027-49cd-abdc-2eaaf47d7381_terseLabel_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:label id="lab_dei_EntityVoluntaryFilers_label_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityVoluntaryFilers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityVoluntaryFilers" xlink:to="lab_dei_EntityVoluntaryFilers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_a350bfb1-f2dd-47c1-8742-56d5d99bf431_totalLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortized Cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_df8fe49a-002e-4f66-9ff3-0c6bb0c65067_terseLabel_en-US" xlink:label="lab_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Software</link:label>
    <link:label id="lab_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_label_en-US" xlink:label="lab_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Software and Software Development Costs [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:to="lab_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_b6afcb60-904f-40a7-b588-e447a2923b62_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, gross</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_911f7fae-e1b2-4593-95e7-9dedc61cfe3f_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_ca125c95-61ec-48fa-b51f-9da1cc22c533_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, redeemable convertible preferred stock and stockholders&#8217; equity (deficit)</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_1d8334cb-ca5a-48a9-97b1-da5b454d2799_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Intrinsic Value, awards outstanding</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementScenarioAxis_6775886a-de01-475e-8fda-37976cbcbd3f_terseLabel_en-US" xlink:label="lab_us-gaap_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementScenarioAxis_label_en-US" xlink:label="lab_us-gaap_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementScenarioAxis" xlink:to="lab_us-gaap_StatementScenarioAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_1b8488f5-e69c-4127-9d30-61f9723e619c_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Remaining Contractual Term (in Years), vested and exercisable</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_37a22cbb-32b9-4783-9120-2af9c7da1729_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net change in other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_57f94217-4add-4a29-ad71-1c01bb427e81_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_silk_StockIssuanceCostsIncurredButNotYetPaid_381ad6fd-d8c7-48ed-9254-36efc72ff7ab_terseLabel_en-US" xlink:label="lab_silk_StockIssuanceCostsIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unpaid deferred offering costs</link:label>
    <link:label id="lab_silk_StockIssuanceCostsIncurredButNotYetPaid_label_en-US" xlink:label="lab_silk_StockIssuanceCostsIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issuance Costs Incurred But Not Yet Paid</link:label>
    <link:label id="lab_silk_StockIssuanceCostsIncurredButNotYetPaid_documentation_en-US" xlink:label="lab_silk_StockIssuanceCostsIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issuance Costs Incurred But Not Yet Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_silk_StockIssuanceCostsIncurredButNotYetPaid" xlink:href="silk-20191231.xsd#silk_StockIssuanceCostsIncurredButNotYetPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_silk_StockIssuanceCostsIncurredButNotYetPaid" xlink:to="lab_silk_StockIssuanceCostsIncurredButNotYetPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashNoncurrent_6290ec85-14cd-49a9-880a-d978c21e0290_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash</link:label>
    <link:label id="lab_us-gaap_RestrictedCashNoncurrent_label_en-US" xlink:label="lab_us-gaap_RestrictedCashNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashNoncurrent" xlink:to="lab_us-gaap_RestrictedCashNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_QuarterlyFinancialInformationTextBlock_22b55f62-eecd-4853-99f1-7d18ea9deaf4_terseLabel_en-US" xlink:label="lab_us-gaap_QuarterlyFinancialInformationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quarterly Financial Information (unaudited)</link:label>
    <link:label id="lab_us-gaap_QuarterlyFinancialInformationTextBlock_label_en-US" xlink:label="lab_us-gaap_QuarterlyFinancialInformationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quarterly Financial Information [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_QuarterlyFinancialInformationTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_QuarterlyFinancialInformationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_QuarterlyFinancialInformationTextBlock" xlink:to="lab_us-gaap_QuarterlyFinancialInformationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_720600ff-955e-4298-bce0-013306b0abd9_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:to="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_silk_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice_4a19eedb-19ee-4e97-93ec-e9e75d10115b_terseLabel_en-US" xlink:label="lab_silk_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price (in USD per share)</link:label>
    <link:label id="lab_silk_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_silk_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Outstanding And Exercisable, Weighted Average Exercise Price</link:label>
    <link:label id="lab_silk_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice_documentation_en-US" xlink:label="lab_silk_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Outstanding And Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_silk_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice" xlink:href="silk-20191231.xsd#silk_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_silk_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice" xlink:to="lab_silk_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_401e9125-f8a6-4e69-b3f8-29798f705134_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percent of matching contribution of the employee's pay</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:to="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_silk_IPOOtherExpensesMember_428c5978-fbac-438a-bb05-9a641cecda93_terseLabel_en-US" xlink:label="lab_silk_IPOOtherExpensesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IPO - Other Expenses</link:label>
    <link:label id="lab_silk_IPOOtherExpensesMember_label_en-US" xlink:label="lab_silk_IPOOtherExpensesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IPO - Other Expenses [Member]</link:label>
    <link:label id="lab_silk_IPOOtherExpensesMember_documentation_en-US" xlink:label="lab_silk_IPOOtherExpensesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IPO - Other Expenses [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_silk_IPOOtherExpensesMember" xlink:href="silk-20191231.xsd#silk_IPOOtherExpensesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_silk_IPOOtherExpensesMember" xlink:to="lab_silk_IPOOtherExpensesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_40266485-33ad-400a-87e3-ed1986873c08_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_1b390350-fb70-42a9-a780-e2cf08a29cfe_terseLabel_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and fixtures</link:label>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_label_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and Fixtures [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FurnitureAndFixturesMember" xlink:to="lab_us-gaap_FurnitureAndFixturesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_6e4511fa-11fc-4693-b0f3-d8fddae8d6c3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_290e01ed-b187-483a-9551-7371ca65fa33_terseLabel_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityDisclosureAbstract_9841d0e5-ffa8-4abd-b839-ab3771008e90_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TemporaryEquityDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityDisclosureAbstract" xlink:to="lab_us-gaap_TemporaryEquityDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_22768efe-0a3d-44ce-8aa5-d72642a79f9d_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies (Note 7)</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_92377150-8807-4a71-a878-05ba790205fc_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Foreign</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_a6419746-0f30-4ed0-84ee-346901e8f36b_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in valuation allowance</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_silk_LongTermDebtUnpaidInterest_3071f144-064e-46aa-9a1e-ef67b727b65f_negatedTerseLabel_en-US" xlink:label="lab_silk_LongTermDebtUnpaidInterest" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Amount representing interest</link:label>
    <link:label id="lab_silk_LongTermDebtUnpaidInterest_label_en-US" xlink:label="lab_silk_LongTermDebtUnpaidInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Unpaid Interest</link:label>
    <link:label id="lab_silk_LongTermDebtUnpaidInterest_documentation_en-US" xlink:label="lab_silk_LongTermDebtUnpaidInterest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Unpaid Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_silk_LongTermDebtUnpaidInterest" xlink:href="silk-20191231.xsd#silk_LongTermDebtUnpaidInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_silk_LongTermDebtUnpaidInterest" xlink:to="lab_silk_LongTermDebtUnpaidInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_silk_LongTermDebtAccretionOfClosingFees_7f8cbd3a-4be0-4dbd-bccc-ab7426a26f85_terseLabel_en-US" xlink:label="lab_silk_LongTermDebtAccretionOfClosingFees" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Add: Accretion of closing fees</link:label>
    <link:label id="lab_silk_LongTermDebtAccretionOfClosingFees_label_en-US" xlink:label="lab_silk_LongTermDebtAccretionOfClosingFees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Accretion Of Closing Fees</link:label>
    <link:label id="lab_silk_LongTermDebtAccretionOfClosingFees_documentation_en-US" xlink:label="lab_silk_LongTermDebtAccretionOfClosingFees" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Accretion Of Closing Fees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_silk_LongTermDebtAccretionOfClosingFees" xlink:href="silk-20191231.xsd#silk_LongTermDebtAccretionOfClosingFees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_silk_LongTermDebtAccretionOfClosingFees" xlink:to="lab_silk_LongTermDebtAccretionOfClosingFees" xlink:type="arc" order="1"/>
    <link:label id="lab_silk_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityReclassifications_47d7c156-939a-44d9-bfbf-0293b041fd89_negatedLabel_en-US" xlink:label="lab_silk_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityReclassifications" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification upon IPO</link:label>
    <link:label id="lab_silk_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityReclassifications_label_en-US" xlink:label="lab_silk_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityReclassifications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement With Unobservable Inputs Reconciliation, Recurring Basis, Liability, Reclassifications</link:label>
    <link:label id="lab_silk_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityReclassifications_documentation_en-US" xlink:label="lab_silk_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityReclassifications" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement With Unobservable Inputs Reconciliation, Recurring Basis, Liability, Reclassifications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_silk_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityReclassifications" xlink:href="silk-20191231.xsd#silk_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityReclassifications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_silk_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityReclassifications" xlink:to="lab_silk_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityReclassifications" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract_ed6b8755-bbb4-47b9-9d55-d1f7e5e2f16d_terseLabel_en-US" xlink:label="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash investing and financing activities:</link:label>
    <link:label id="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract_label_en-US" xlink:label="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash Investing and Financing Items [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_df4e84e4-1eea-4ae8-abc3-fcb83198d75b_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive securities excluded from computation of earnings per share (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_b4f29995-1c2f-4619-8117-e8fdc168b676_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightTable_1b48d626-0870-4142-873a-ba04393841b3_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right [Table]</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightTable_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable" xlink:to="lab_us-gaap_ClassOfWarrantOrRightTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_b93db7a5-2dea-4107-a550-6d148952969e_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeInterest" xlink:to="lab_us-gaap_InvestmentIncomeInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_8c60c213-4d4d-49d4-81a8-a39d404ef87f_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_615cb520-06f4-4a7a-a862-1d064d2120df_negatedLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in fair value recorded in other income (expense), net</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_4e49c1b0-cb4b-4d67-9bbe-61a3d262fc6d_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTextBlock_f3fcc55d-f33d-408d-b64d-623cd809022b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reserved Common Stock for Future Issuances</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfStockByClassTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockByClassTextBlock" xlink:to="lab_us-gaap_ScheduleOfStockByClassTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_53ae78c5-e472-44c1-9a9e-43bf35a2028d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gain on investments, net</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_db35c0dc-4500-470c-bd7c-32cd4ec4ee24_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsTextBlock" xlink:to="lab_us-gaap_SubsequentEventsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_708754df-270c-4576-af3a-606034e9eabf_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeAxis" xlink:to="lab_us-gaap_MeasurementInputTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScenarioForecastMember_5073b2d2-0f30-436c-9b10-cf4a09f151d9_terseLabel_en-US" xlink:label="lab_us-gaap_ScenarioForecastMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario, Forecast</link:label>
    <link:label id="lab_us-gaap_ScenarioForecastMember_label_en-US" xlink:label="lab_us-gaap_ScenarioForecastMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario, Forecast [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScenarioForecastMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScenarioForecastMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScenarioForecastMember" xlink:to="lab_us-gaap_ScenarioForecastMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromWarrantExercises_53e8a343-da06-4194-bd69-844e8da49336_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromWarrantExercises" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from exercise of warrants</link:label>
    <link:label id="lab_us-gaap_ProceedsFromWarrantExercises_label_en-US" xlink:label="lab_us-gaap_ProceedsFromWarrantExercises" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Warrant Exercises</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromWarrantExercises" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromWarrantExercises"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromWarrantExercises" xlink:to="lab_us-gaap_ProceedsFromWarrantExercises" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_1cd2052a-5364-43f0-b29d-8a906a21d59b_terseLabel_en-US" xlink:label="lab_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Error Corrections and Prior Period Adjustments Restatement [Line Items]</link:label>
    <link:label id="lab_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_label_en-US" xlink:label="lab_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Error Corrections and Prior Period Adjustments Restatement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:to="lab_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_de0f8e75-3e56-467f-a97a-5155b6b3318b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_07c389b9-2088-408b-939d-35fdd8bd5ed9_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_5deab431-7794-4eba-9738-fdd68dc99d74_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net of allowances of $45 and $22 at December&#160;31, 2019 and 2018, respectively</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_216cee91-b903-4970-8f49-bbfe3a4c98bd_verboseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Net, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_04fc43a4-ca36-4264-9b6a-27b39f7d93c0_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_efe93efe-b71d-47d6-9e36-3c32b3cfa8c5_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Leases [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RedeemableConvertiblePreferredStockMember_66c4484a-60bb-4b22-8944-7a259b91036d_terseLabel_en-US" xlink:label="lab_us-gaap_RedeemableConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable convertible preferred stock outstanding</link:label>
    <link:label id="lab_us-gaap_RedeemableConvertiblePreferredStockMember_label_en-US" xlink:label="lab_us-gaap_RedeemableConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Convertible Preferred Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableConvertiblePreferredStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RedeemableConvertiblePreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RedeemableConvertiblePreferredStockMember" xlink:to="lab_us-gaap_RedeemableConvertiblePreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_430edbd2-ba8d-4d07-8407-7ee7170dfcb5_verboseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive loss</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAxis_f304c516-ba23-44bd-b78a-d8ae7d189f9d_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward [Axis]</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAxis_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TaxCreditCarryforwardAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis" xlink:to="lab_us-gaap_TaxCreditCarryforwardAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock_8d60ee8e-382b-401b-a9c8-b43a2bca7553_terseLabel_en-US" xlink:label="lab_us-gaap_SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Unrecognized Tax Benefits</link:label>
    <link:label id="lab_us-gaap_SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock_label_en-US" xlink:label="lab_us-gaap_SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Positions for which Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock" xlink:to="lab_us-gaap_SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_5298261c-834f-4b40-b702-74e2df541c93_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restrictions on Cash and Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restrictions on Cash and Cash Equivalents [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_251b1d91-63b2-428c-a339-bd3ef0bf61e1_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_508fdbb3-2718-4c09-923d-119bd487829c_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023 and thereafter</link:label>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_label_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases, Future Minimum Payments, Due in Five Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:to="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpense_1fd25986-1044-4138-9f0a-488201907741_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Permanent differences</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpense_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:to="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_04c0c637-7f90-4270-a5c6-715865b001bb_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_0512e22a-6927-43af-9061-723cb27ba0b2_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConversionOfStockSharesConverted1_8e9ceda2-1943-4f0f-a6a4-795a85e6747e_terseLabel_en-US" xlink:label="lab_us-gaap_ConversionOfStockSharesConverted1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares of common stock converted (in shares)</link:label>
    <link:label id="lab_us-gaap_ConversionOfStockSharesConverted1_label_en-US" xlink:label="lab_us-gaap_ConversionOfStockSharesConverted1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion of Stock, Shares Converted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockSharesConverted1" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConversionOfStockSharesConverted1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConversionOfStockSharesConverted1" xlink:to="lab_us-gaap_ConversionOfStockSharesConverted1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_3b8b86ae-9d7e-4c1c-867f-e8cf499a1b81_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_silk_PreferredStockWarrantLiability_48608335-5443-46e1-aa41-1e68736f62dc_terseLabel_en-US" xlink:label="lab_silk_PreferredStockWarrantLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable convertible preferred stock warrant liability</link:label>
    <link:label id="lab_silk_PreferredStockWarrantLiability_label_en-US" xlink:label="lab_silk_PreferredStockWarrantLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock Warrant Liability</link:label>
    <link:label id="lab_silk_PreferredStockWarrantLiability_documentation_en-US" xlink:label="lab_silk_PreferredStockWarrantLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock Warrant Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_silk_PreferredStockWarrantLiability" xlink:href="silk-20191231.xsd#silk_PreferredStockWarrantLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_silk_PreferredStockWarrantLiability" xlink:to="lab_silk_PreferredStockWarrantLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_0d85f323-0863-4416-842f-6f92368ccf95_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate bonds/notes</link:label>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:to="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_e368f570-38fa-4b2a-92b7-170abc437df9_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_3fc17f19-b7da-4722-9601-219c298dae1b_terseLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_43823e17-f958-43ed-a15d-f6f0aa91a346_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_ef359c80-99d3-486f-872a-a8bab63b0613_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_f3bc80d1-426a-43a7-bff7-d92aca7e4179_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses:</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy_598dbd2d-3e4a-4b6a-a182-c4c80cb1fa45_terseLabel_en-US" xlink:label="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable</link:label>
    <link:label id="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy_label_en-US" xlink:label="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade and Other Accounts Receivable, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:to="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_b21c358e-a976-4bf6-b86b-d321610dff6c_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_dd092777-1628-45a0-a9f9-7844187ff9d2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss attributable to non-controlling interest</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_silk_AccruedTravelExpensesCurrent_e99b0da3-0da0-4eaf-93f7-d78db2fee32e_terseLabel_en-US" xlink:label="lab_silk_AccruedTravelExpensesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued travel expenses</link:label>
    <link:label id="lab_silk_AccruedTravelExpensesCurrent_label_en-US" xlink:label="lab_silk_AccruedTravelExpensesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Travel Expenses, Current</link:label>
    <link:label id="lab_silk_AccruedTravelExpensesCurrent_documentation_en-US" xlink:label="lab_silk_AccruedTravelExpensesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Travel Expenses, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_silk_AccruedTravelExpensesCurrent" xlink:href="silk-20191231.xsd#silk_AccruedTravelExpensesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_silk_AccruedTravelExpensesCurrent" xlink:to="lab_silk_AccruedTravelExpensesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_c3602fd8-a99b-42f8-b66d-9c5720efa5b8_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_03fae69c-feb3-409a-b0b7-f028ef2195f7_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_217302c4-52e3-4163-b6fd-bb130b6691c1_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdvertisingExpense_4d52d1b1-58d3-4a0c-8eef-afd0482f633c_terseLabel_en-US" xlink:label="lab_us-gaap_AdvertisingExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advertising expense</link:label>
    <link:label id="lab_us-gaap_AdvertisingExpense_label_en-US" xlink:label="lab_us-gaap_AdvertisingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advertising Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdvertisingExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdvertisingExpense" xlink:to="lab_us-gaap_AdvertisingExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_dcdb3952-8946-4491-998e-ef59328eb59b_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_88b3db3a-0f92-47ab-980d-bc99c639354e_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development and Clinical Trials</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_silk_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExerciseThresholdasaPercentageofSharePrice_1ecd9ee9-5061-4fc4-8377-dda22297271f_terseLabel_en-US" xlink:label="lab_silk_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExerciseThresholdasaPercentageofSharePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise threshold as a percentage of fair value of shares</link:label>
    <link:label id="lab_silk_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExerciseThresholdasaPercentageofSharePrice_label_en-US" xlink:label="lab_silk_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExerciseThresholdasaPercentageofSharePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercise Threshold as a Percentage of Share Price</link:label>
    <link:label id="lab_silk_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExerciseThresholdasaPercentageofSharePrice_documentation_en-US" xlink:label="lab_silk_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExerciseThresholdasaPercentageofSharePrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercise Threshold as a Percentage of Share Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_silk_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExerciseThresholdasaPercentageofSharePrice" xlink:href="silk-20191231.xsd#silk_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExerciseThresholdasaPercentageofSharePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_silk_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExerciseThresholdasaPercentageofSharePrice" xlink:to="lab_silk_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExerciseThresholdasaPercentageofSharePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedRoyaltiesCurrent_8b6f5090-5fa5-43f5-8059-d38862030a17_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedRoyaltiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued royalty expense</link:label>
    <link:label id="lab_us-gaap_AccruedRoyaltiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedRoyaltiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Royalties, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedRoyaltiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccruedRoyaltiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedRoyaltiesCurrent" xlink:to="lab_us-gaap_AccruedRoyaltiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_a38f8eee-8399-438e-9d5b-ad590dfc31f7_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock in connection with NeuroCo merger (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquitySharesAuthorized_cb863050-adee-4608-a1fc-7b0b4ca4c9f8_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary equity, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_TemporaryEquitySharesAuthorized_751569c7-3ad5-485f-bec8-92283f7838f0_verboseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_TemporaryEquitySharesAuthorized_label_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TemporaryEquitySharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquitySharesAuthorized" xlink:to="lab_us-gaap_TemporaryEquitySharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_7fd16d30-20ae-4c5d-9d42-514b15cff0ae_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of reportable segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments" xlink:to="lab_us-gaap_NumberOfReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_dca0aac7-5ca3-41c7-a63b-f0c7547b5a59_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityAbstract_63ff6600-1814-4e9f-bb52-52cde0a77610_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityAbstract_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TemporaryEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityAbstract" xlink:to="lab_us-gaap_TemporaryEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTable_38e23ea6-8602-4434-8bde-537da8645abb_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Table]</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTable_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_c67aa470-7703-45b8-b857-5e058517e142_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock under employee stock purchase plan</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Employee Stock Purchase Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquipmentMember_87d3afc7-11c8-4731-ac98-abf8c9dac252_terseLabel_en-US" xlink:label="lab_us-gaap_EquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment</link:label>
    <link:label id="lab_us-gaap_EquipmentMember_label_en-US" xlink:label="lab_us-gaap_EquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquipmentMember" xlink:to="lab_us-gaap_EquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_a3e8fd61-d42e-4784-8540-c608d52170e8_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredOfferingCosts_1a4db959-8b29-46e3-8eb3-ecc06a07f31e_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredOfferingCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred initial public offering costs</link:label>
    <link:label id="lab_us-gaap_DeferredOfferingCosts_label_en-US" xlink:label="lab_us-gaap_DeferredOfferingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Offering Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredOfferingCosts" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredOfferingCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredOfferingCosts" xlink:to="lab_us-gaap_DeferredOfferingCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_0fafddfc-3606-494b-990d-9026764f5a9a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average grant date fair value (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_ddd1cc25-fea6-42fc-8fe2-82ddc9602e5c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Accumulated depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockMember_97ba03d0-961d-4fb6-8ccd-11079cf638eb_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Convertible Preferred Stock</link:label>
    <link:label id="lab_us-gaap_PreferredStockMember_label_en-US" xlink:label="lab_us-gaap_PreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockMember" xlink:to="lab_us-gaap_PreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy_d00d198c-90a0-4630-a46d-58dbcb75985b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Financial Instruments</link:label>
    <link:label id="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy_label_en-US" xlink:label="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Financial Instruments, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_6794f3e7-cbae-40a7-8077-a4824355eda3_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightDomain_fdb4692f-6241-45c6-ae83-7c52a3ceaa36_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain" xlink:to="lab_us-gaap_ClassOfWarrantOrRightDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConversionOfStockAmountConverted1_4c4d3860-4049-4567-b7d5-86b1010c3816_terseLabel_en-US" xlink:label="lab_us-gaap_ConversionOfStockAmountConverted1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion of redeemable convertible preferred stock to common stock upon initial public offering</link:label>
    <link:label id="lab_us-gaap_ConversionOfStockAmountConverted1_label_en-US" xlink:label="lab_us-gaap_ConversionOfStockAmountConverted1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion of Stock, Amount Converted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockAmountConverted1" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConversionOfStockAmountConverted1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConversionOfStockAmountConverted1" xlink:to="lab_us-gaap_ConversionOfStockAmountConverted1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_1787aa1f-f0ce-41b8-b0bf-b8d181243d79_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_e1351087-f721-4bdd-a60a-ae5b26a157fb_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_e851e6ff-f59b-4b84-b7ba-6ea63600b022_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_silk_ExercisePriceOneMember_6f383a06-3991-4fa7-baa9-f84ffc074baf_terseLabel_en-US" xlink:label="lab_silk_ExercisePriceOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price One</link:label>
    <link:label id="lab_silk_ExercisePriceOneMember_label_en-US" xlink:label="lab_silk_ExercisePriceOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price One [Member]</link:label>
    <link:label id="lab_silk_ExercisePriceOneMember_documentation_en-US" xlink:label="lab_silk_ExercisePriceOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price One [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_silk_ExercisePriceOneMember" xlink:href="silk-20191231.xsd#silk_ExercisePriceOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_silk_ExercisePriceOneMember" xlink:to="lab_silk_ExercisePriceOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_708c3a94-f755-4173-bf49-75adf18cdd91_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_4fba0da5-fb2c-4843-a722-2da9201dd0b2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_0252a615-34dd-4dfb-a060-d0124e9f0327_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Option Plans</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of Compensation Related Costs, Share-based Payments [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_silk_IncentiveandNonqualifiedStockOptionMember_fd108444-1ac7-452a-8831-9df08058088c_terseLabel_en-US" xlink:label="lab_silk_IncentiveandNonqualifiedStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ISO and NSO</link:label>
    <link:label id="lab_silk_IncentiveandNonqualifiedStockOptionMember_label_en-US" xlink:label="lab_silk_IncentiveandNonqualifiedStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incentive and Nonqualified Stock Option [Member]</link:label>
    <link:label id="lab_silk_IncentiveandNonqualifiedStockOptionMember_documentation_en-US" xlink:label="lab_silk_IncentiveandNonqualifiedStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incentive and Nonqualified Stock Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_silk_IncentiveandNonqualifiedStockOptionMember" xlink:href="silk-20191231.xsd#silk_IncentiveandNonqualifiedStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_silk_IncentiveandNonqualifiedStockOptionMember" xlink:to="lab_silk_IncentiveandNonqualifiedStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_5d9979b3-81ad-4026-8f73-06c7747cfb3c_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock in connection with IPO, net of underwriting discount, commissions and offering costs (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_2d7069c9-9ef8-40ea-87d1-671ee4dcb6f1_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition of Variable Interest Entity - NeuroCo</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_silk_IncentiveandNonqualifiedStockOptionExercisedMember_09fa2981-3747-4b48-8d43-836b87005ef6_terseLabel_en-US" xlink:label="lab_silk_IncentiveandNonqualifiedStockOptionExercisedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of options under stock plan</link:label>
    <link:label id="lab_silk_IncentiveandNonqualifiedStockOptionExercisedMember_label_en-US" xlink:label="lab_silk_IncentiveandNonqualifiedStockOptionExercisedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incentive and Nonqualified Stock Option, Exercised [Member]</link:label>
    <link:label id="lab_silk_IncentiveandNonqualifiedStockOptionExercisedMember_documentation_en-US" xlink:label="lab_silk_IncentiveandNonqualifiedStockOptionExercisedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incentive and Nonqualified Stock Option, Exercised [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_silk_IncentiveandNonqualifiedStockOptionExercisedMember" xlink:href="silk-20191231.xsd#silk_IncentiveandNonqualifiedStockOptionExercisedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_silk_IncentiveandNonqualifiedStockOptionExercisedMember" xlink:to="lab_silk_IncentiveandNonqualifiedStockOptionExercisedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_4e3a5702-2774-4c29-87c8-c1e19869b92f_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for interest</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PurchaseObligation_17e91774-f384-4028-ad9f-00f5d0be92cb_terseLabel_en-US" xlink:label="lab_us-gaap_PurchaseObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase obligation</link:label>
    <link:label id="lab_us-gaap_PurchaseObligation_label_en-US" xlink:label="lab_us-gaap_PurchaseObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligation" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PurchaseObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PurchaseObligation" xlink:to="lab_us-gaap_PurchaseObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_silk_LongTermInvestmentsMember_7d58a4d6-dc9a-4210-864b-324534744d57_terseLabel_en-US" xlink:label="lab_silk_LongTermInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term investments</link:label>
    <link:label id="lab_silk_LongTermInvestmentsMember_label_en-US" xlink:label="lab_silk_LongTermInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Investments [Member]</link:label>
    <link:label id="lab_silk_LongTermInvestmentsMember_documentation_en-US" xlink:label="lab_silk_LongTermInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_silk_LongTermInvestmentsMember" xlink:href="silk-20191231.xsd#silk_LongTermInvestmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_silk_LongTermInvestmentsMember" xlink:to="lab_silk_LongTermInvestmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_18ee69d9-9612-4426-ae29-2c9d69a6d3ca_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation and Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_e7f05752-5893-4a1e-95cd-5aefddb7414a_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_dfa458e8-eea0-4b90-aeb5-6cd3a9c24d9a_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeDomain" xlink:to="lab_us-gaap_MeasurementInputTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_0e8776e8-87b3-4e0f-9821-0256f96aed89_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_4c75dedf-a0b9-4074-9d93-4aef8025162d_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_c82e5960-3cd9-45ea-94e4-dff909edaa2f_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Preparation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_d1bbf845-967e-4e16-971b-3b45a8995682_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_1d03a678-89bb-48b5-94df-9ae4f20199df_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum Future Lease Payment Previously Disclosed Under ASC 840</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201609Member_080210ef-f6c4-41d1-8354-2eddc1ea5e13_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201609Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative effect of change in accounting treatment - ASU 2016-09</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201609Member_f43cb45e-e781-4ea7-8497-dd267e91cf32_verboseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201609Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2016-09</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201609Member_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201609Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2016-09 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201609Member" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountingStandardsUpdate201609Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdate201609Member" xlink:to="lab_us-gaap_AccountingStandardsUpdate201609Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_fce3f124-826d-48a6-a686-04ade98a77dc_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of common stock</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_d378745b-20db-407c-a834-59c9e03b2abc_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (decrease) in deferred tax asset valuation allowance</link:label>
    <link:label id="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_label_en-US" xlink:label="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:to="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_38d86a85-0091-4c61-87b6-33aedba0d521_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stated interest rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_71268bfa-94de-4083-a210-36af9bc83d25_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Domain]</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_e9745a28-dc5e-43e4-a96e-19a84868bfc1_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Maturities, Repayments of Principal in Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_a952766a-1497-4a42-8e11-4214e15cefac_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net proceeds</link:label>
    <link:label id="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_label_en-US" xlink:label="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Consideration Received on Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:to="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_def66ca9-2ef6-4ab5-b4c1-4db6ae8a200a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options granted (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_aaa4de76-810c-40c7-a1fd-20c44fabd48c_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise price (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WarrantsAndRightsOutstandingTerm_0142e3a1-8cdb-4c19-b3b1-e0419cde4753_terseLabel_en-US" xlink:label="lab_us-gaap_WarrantsAndRightsOutstandingTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Time to liquidity (years)</link:label>
    <link:label id="lab_us-gaap_WarrantsAndRightsOutstandingTerm_label_en-US" xlink:label="lab_us-gaap_WarrantsAndRightsOutstandingTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants and Rights Outstanding, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingTerm" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WarrantsAndRightsOutstandingTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantsAndRightsOutstandingTerm" xlink:to="lab_us-gaap_WarrantsAndRightsOutstandingTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_c1607344-f951-4369-b388-4d2c5a3c4072_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_49c4326e-56f8-42dd-816d-5a8dcc6f96a1_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_8eb1ec9c-bcc5-43f4-b1c3-00b2e11438ff_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable" xlink:to="lab_us-gaap_ScheduleOfStockByClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_84e74c43-ae7f-41f9-b24c-322d6686b0c5_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reverse stock split</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note, Stock Split, Conversion Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:to="lab_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_4217d520-5e21-4984-86bf-b7daa270deab_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average common shares used to compute net loss per share attributable to Silk Road Medical, Inc. common stockholders, basic and diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_23b6e6bd-3de1-4e2d-a27f-644b8ebaa213_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average common stock outstanding used to compute net loss per share, basic and diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic and Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:to="lab_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_b5a53c22-65a7-482d-8521-3c06bf471b9e_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive income</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_adcca3b8-dcc1-4206-8fe5-2db0d069edb1_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_silk_RedeemableConvertiblePreferredStockWarrantsMember_1010c51d-4c3c-4f53-8a9b-d7f9af641d40_terseLabel_en-US" xlink:label="lab_silk_RedeemableConvertiblePreferredStockWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable convertible preferred stock warrants outstanding</link:label>
    <link:label id="lab_silk_RedeemableConvertiblePreferredStockWarrantsMember_label_en-US" xlink:label="lab_silk_RedeemableConvertiblePreferredStockWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Convertible Preferred Stock Warrants [Member]</link:label>
    <link:label id="lab_silk_RedeemableConvertiblePreferredStockWarrantsMember_documentation_en-US" xlink:label="lab_silk_RedeemableConvertiblePreferredStockWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Convertible Preferred Stock Warrants [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_silk_RedeemableConvertiblePreferredStockWarrantsMember" xlink:href="silk-20191231.xsd#silk_RedeemableConvertiblePreferredStockWarrantsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_silk_RedeemableConvertiblePreferredStockWarrantsMember" xlink:to="lab_silk_RedeemableConvertiblePreferredStockWarrantsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_f861ee52-bda1-4b8c-877d-26e2c173c74f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares of common stock reserved for issuance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_69234c25-eb29-4690-81b4-9ddc1eb017fb_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_d274f398-7e6a-47ae-9c6b-363dc0c95fbf_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_c2ad71b3-633f-4d9c-9ea6-dd6b8f535a79_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Remaining Contractual Term (in Years), awards outstanding</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_0fb53b3d-8e66-48f7-b30d-2c7bde89abee_verboseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Remaining Contractual Term (in Years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_ca141c0c-947e-43db-9114-e855d7a278a0_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Less than 12 months</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_00e1ee3e-307a-48c4-981a-0087bc420c35_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_3a5703ab-dff1-453c-a34f-527c91c7f8be_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent" xlink:to="lab_us-gaap_LongTermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_db629ad1-d68f-4218-a697-08042d22ba20_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_7fb65338-f2dc-4aa1-a2a9-436345e69447_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Error Corrections and Prior Period Adjustment Restatement [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Error Corrections and Prior Period Adjustment Restatement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable" xlink:to="lab_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_770902d0-d0f2-4720-aaf1-4dc3a750f05b_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Formation and Business of the Company</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_silk_StockIssuedDuringPeriodValueExerciseOfWarrants_0360b4f1-76fd-4907-957e-254efdc174b9_terseLabel_en-US" xlink:label="lab_silk_StockIssuedDuringPeriodValueExerciseOfWarrants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of warrants</link:label>
    <link:label id="lab_silk_StockIssuedDuringPeriodValueExerciseOfWarrants_label_en-US" xlink:label="lab_silk_StockIssuedDuringPeriodValueExerciseOfWarrants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Exercise Of Warrants</link:label>
    <link:label id="lab_silk_StockIssuedDuringPeriodValueExerciseOfWarrants_documentation_en-US" xlink:label="lab_silk_StockIssuedDuringPeriodValueExerciseOfWarrants" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Exercise Of Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_silk_StockIssuedDuringPeriodValueExerciseOfWarrants" xlink:href="silk-20191231.xsd#silk_StockIssuedDuringPeriodValueExerciseOfWarrants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_silk_StockIssuedDuringPeriodValueExerciseOfWarrants" xlink:to="lab_silk_StockIssuedDuringPeriodValueExerciseOfWarrants" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermInvestments_ac21851a-2e89-49ea-8c3c-d3072d3398b0_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term investments</link:label>
    <link:label id="lab_us-gaap_ShortTermInvestments_label_en-US" xlink:label="lab_us-gaap_ShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermInvestments" xlink:to="lab_us-gaap_ShortTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_f4801160-bd9b-43a0-8cc8-691de7521c2d_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_51213337-6e04-4bea-948e-49bf4be58966_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_d456ddd2-eb74-4b67-ba8d-3bdb9ea62be3_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Exercise Price (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_bf2d73b2-ce69-4acb-baac-0b2914f72328_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_5cf0069d-364f-4f83-8ee4-84f1093fac4f_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_378365b9-1f7f-42d2-9c3c-7991c764001a_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilities_82e8ff91-8937-49b7-aa9a-5c8197b50451_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilities_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativeLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilities" xlink:to="lab_us-gaap_DerivativeLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_ba3ff28f-55c6-4559-ab9c-1342e20cbbe5_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract_b40d2022-2ada-4c03-a131-2027dcf77b96_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, $0.001 par value</link:label>
    <link:label id="lab_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Number of Shares, Par Value and Other Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:to="lab_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_ff90a416-6534-4316-9aec-fbc8e144f993_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightAxis_42eff122-4710-417e-b134-02d5bd339778_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right [Axis]</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightAxis_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis" xlink:to="lab_us-gaap_ClassOfWarrantOrRightAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_3e080613-3dcb-49e8-a9bb-298b2b542436_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_silk_CommonStockVotePerShare_cbddfb95-b5ae-4cf0-8066-c79f3684f972_terseLabel_en-US" xlink:label="lab_silk_CommonStockVotePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of votes entitled per share of common stock</link:label>
    <link:label id="lab_silk_CommonStockVotePerShare_label_en-US" xlink:label="lab_silk_CommonStockVotePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Vote Per Share</link:label>
    <link:label id="lab_silk_CommonStockVotePerShare_documentation_en-US" xlink:label="lab_silk_CommonStockVotePerShare" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Vote Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_silk_CommonStockVotePerShare" xlink:href="silk-20191231.xsd#silk_CommonStockVotePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_silk_CommonStockVotePerShare" xlink:to="lab_silk_CommonStockVotePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_d71fa2ae-1541-4b6d-b5bb-ef59976daab2_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_6364c0b1-2879-43fd-b45c-93a228408e3f_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialPaperNotIncludedWithCashAndCashEquivalentsMember_3ce8b851-45cd-4c1b-9247-b923bfd231bc_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaperNotIncludedWithCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper, Not Included with Cash and Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_CommercialPaperNotIncludedWithCashAndCashEquivalentsMember_label_en-US" xlink:label="lab_us-gaap_CommercialPaperNotIncludedWithCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper, Not Included with Cash and Cash Equivalents [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperNotIncludedWithCashAndCashEquivalentsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommercialPaperNotIncludedWithCashAndCashEquivalentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialPaperNotIncludedWithCashAndCashEquivalentsMember" xlink:to="lab_us-gaap_CommercialPaperNotIncludedWithCashAndCashEquivalentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_867b83f9-0be5-483a-afec-91cc7d5d417f_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_silk_ExercisePriceTwoMember_8ebce290-5f83-45a9-9356-425bc76eb510_verboseLabel_en-US" xlink:label="lab_silk_ExercisePriceTwoMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Two</link:label>
    <link:label id="lab_silk_ExercisePriceTwoMember_label_en-US" xlink:label="lab_silk_ExercisePriceTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Two [Member]</link:label>
    <link:label id="lab_silk_ExercisePriceTwoMember_documentation_en-US" xlink:label="lab_silk_ExercisePriceTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Two [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_silk_ExercisePriceTwoMember" xlink:href="silk-20191231.xsd#silk_ExercisePriceTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_silk_ExercisePriceTwoMember" xlink:to="lab_silk_ExercisePriceTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_92b675de-7f9d-4fc0-aa8d-3dae39d9a662_negatedLabel_en-US" xlink:label="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accretion of discount on investments</link:label>
    <link:label id="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_label_en-US" xlink:label="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accretion (Amortization) of Discounts and Premiums, Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:to="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedSalariesCurrent_503bc7fc-8086-49ec-a26a-de8ec81ba60b_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedSalariesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued payroll and related expenses</link:label>
    <link:label id="lab_us-gaap_AccruedSalariesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedSalariesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Salaries, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedSalariesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccruedSalariesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedSalariesCurrent" xlink:to="lab_us-gaap_AccruedSalariesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputOptionVolatilityMember_d3458be8-9c79-49c5-b4ce-96f3027ea129_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputOptionVolatilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected volatility</link:label>
    <link:label id="lab_us-gaap_MeasurementInputOptionVolatilityMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputOptionVolatilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Option Volatility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputOptionVolatilityMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MeasurementInputOptionVolatilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputOptionVolatilityMember" xlink:to="lab_us-gaap_MeasurementInputOptionVolatilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceInitialPublicOffering_6146e5c9-55ea-4f75-aa42-8fc8768022cc_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from initial public offering, net of underwriting discount, commissions and offering costs paid</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceInitialPublicOffering_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance Initial Public Offering</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:to="lab_us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:type="arc" order="1"/>
    <link:label id="lab_silk_DebtInstrumentInterestRateFacilityFee_8930727f-2ec8-4441-a439-b9522f172e83_terseLabel_en-US" xlink:label="lab_silk_DebtInstrumentInterestRateFacilityFee" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Facility fee</link:label>
    <link:label id="lab_silk_DebtInstrumentInterestRateFacilityFee_label_en-US" xlink:label="lab_silk_DebtInstrumentInterestRateFacilityFee" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Facility Fee</link:label>
    <link:label id="lab_silk_DebtInstrumentInterestRateFacilityFee_documentation_en-US" xlink:label="lab_silk_DebtInstrumentInterestRateFacilityFee" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Facility Fee</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_silk_DebtInstrumentInterestRateFacilityFee" xlink:href="silk-20191231.xsd#silk_DebtInstrumentInterestRateFacilityFee"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_silk_DebtInstrumentInterestRateFacilityFee" xlink:to="lab_silk_DebtInstrumentInterestRateFacilityFee" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_9b5539d2-128b-40e1-bfb3-fe017f178e04_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_e9a9dbf7-85d7-4a76-b015-39252774efc4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_d4c9027e-ef4c-4349-9468-44efe88eafb2_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net of Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsNet" xlink:to="lab_us-gaap_DeferredTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_b92f3a94-3dad-4375-b075-50e4a3a5b803_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders&#8217; equity (deficit):</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_80a9dcf8-fdb5-4f5e-a887-36c9c14b7a7e_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_0305f621-32a2-4ac7-b18e-521f0a56da39_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash and Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash and Cash Equivalents [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RestatementAxis_089e897e-96bc-4028-9382-1e8972c74e53_terseLabel_en-US" xlink:label="lab_srt_RestatementAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restatement [Axis]</link:label>
    <link:label id="lab_srt_RestatementAxis_label_en-US" xlink:label="lab_srt_RestatementAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restatement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RestatementAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RestatementAxis" xlink:to="lab_srt_RestatementAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsTable_9ce3c786-3690-4f74-ad90-9e06d57a74dd_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Table]</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsTable_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable" xlink:to="lab_us-gaap_OperatingLossCarryforwardsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_41312551-49b4-4390-bde2-cccecc4959e4_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_945467ed-4031-4aed-a221-1f006439e351_totalLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nett loss</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_1c20b617-2ff5-43e8-b392-ba4ddb717002_terseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_3a690f2e-81bf-4a6b-bf55-39bb5657f377_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchMember_8f4ea67d-79a2-4ac4-a558-54cc3d27a558_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research Tax Credit Carryforward</link:label>
    <link:label id="lab_us-gaap_ResearchMember_label_en-US" xlink:label="lab_us-gaap_ResearchMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research Tax Credit Carryforward [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchMember" xlink:to="lab_us-gaap_ResearchMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfUnits_39d8e3be-3e2d-48fb-876b-8feef534fb8a_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfUnits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion of preferred stock to common stock upon IPO</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfUnits_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfUnits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Conversion of Units</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfUnits" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfUnits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfUnits" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfUnits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DomesticCountryMember_07018677-7800-4ccb-b17c-fc15b2b9476d_terseLabel_en-US" xlink:label="lab_us-gaap_DomesticCountryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Tax Authority</link:label>
    <link:label id="lab_us-gaap_DomesticCountryMember_label_en-US" xlink:label="lab_us-gaap_DomesticCountryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Tax Authority [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DomesticCountryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DomesticCountryMember" xlink:to="lab_us-gaap_DomesticCountryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_ad0f4243-2b52-41d3-9a2b-7b55a9cce9c2_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_d67de9ac-9794-4ea7-9b37-f0b82d4b72a1_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization expense</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_4b452d07-70a4-4182-8aea-dfe0c7f813dd_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increases related to current years&#8217; tax positions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_silk_TwoThousandNineteenStockOptionPlanMember_90636ab5-dea4-4954-ae72-4606de933783_terseLabel_en-US" xlink:label="lab_silk_TwoThousandNineteenStockOptionPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 Stock Option Plan</link:label>
    <link:label id="lab_silk_TwoThousandNineteenStockOptionPlanMember_label_en-US" xlink:label="lab_silk_TwoThousandNineteenStockOptionPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand Nineteen Stock Option Plan [Member]</link:label>
    <link:label id="lab_silk_TwoThousandNineteenStockOptionPlanMember_documentation_en-US" xlink:label="lab_silk_TwoThousandNineteenStockOptionPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand Nineteen Stock Option Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_silk_TwoThousandNineteenStockOptionPlanMember" xlink:href="silk-20191231.xsd#silk_TwoThousandNineteenStockOptionPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_silk_TwoThousandNineteenStockOptionPlanMember" xlink:to="lab_silk_TwoThousandNineteenStockOptionPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedProfessionalFeesCurrent_399d6d70-6d13-467e-8686-339eeb53c3ee_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued professional services</link:label>
    <link:label id="lab_us-gaap_AccruedProfessionalFeesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Professional Fees, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedProfessionalFeesCurrent" xlink:to="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashEquivalentsMember_f4e5e9b8-6ed8-4981-9444-dce9a0f38074_terseLabel_en-US" xlink:label="lab_us-gaap_CashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashEquivalentsMember_label_en-US" xlink:label="lab_us-gaap_CashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Equivalents [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashEquivalentsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashEquivalentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashEquivalentsMember" xlink:to="lab_us-gaap_CashEquivalentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_140f64c1-85f2-4e50-b2a6-540932dcd76e_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative expenses</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expenses [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_8eb283b1-c981-4daa-8148-fa48631aa6fd_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss attributable to Silk Road Medical, Inc. common stockholders</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_b00d753a-37a7-4598-94d8-80d88cf793a2_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss attributable to Silk Road Medical, Inc. common stockholders</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_1452579d-ed72-4186-ae84-14ed6049581e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercised (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_3162b3a8-fb3c-4fcd-9c2e-a55097391e43_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RestatementDomain_9df1bcab-965c-448e-96f6-c933c9818893_terseLabel_en-US" xlink:label="lab_srt_RestatementDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restatement [Domain]</link:label>
    <link:label id="lab_srt_RestatementDomain_label_en-US" xlink:label="lab_srt_RestatementDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restatement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RestatementDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RestatementDomain" xlink:to="lab_srt_RestatementDomain" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>11
<FILENAME>silk-20191231_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:dad5b714-6959-4e39-8c51-cdabce9e0669,g:fba3822a-5587-4181-9cc4-63667bdb118e-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://silkroadmed.com/role/CoverPage" xlink:type="simple" xlink:href="silk-20191231.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://silkroadmed.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_d2ce96e3-851f-40f3-bb3a-66ea0cf177b2" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_73d6435e-ba31-4b50-bc22-721992766db2" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d2ce96e3-851f-40f3-bb3a-66ea0cf177b2" xlink:to="loc_dei_EntityRegistrantName_73d6435e-ba31-4b50-bc22-721992766db2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_7c33887b-fea2-410d-8856-18632ffb9047" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d2ce96e3-851f-40f3-bb3a-66ea0cf177b2" xlink:to="loc_dei_EntityCentralIndexKey_7c33887b-fea2-410d-8856-18632ffb9047" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_10f10caf-6d4d-4dfd-b758-14ceabac0aeb" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d2ce96e3-851f-40f3-bb3a-66ea0cf177b2" xlink:to="loc_dei_EntityFilerCategory_10f10caf-6d4d-4dfd-b758-14ceabac0aeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_f803d2d4-de47-465a-b8c6-02a2a1d020a5" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d2ce96e3-851f-40f3-bb3a-66ea0cf177b2" xlink:to="loc_dei_EntitySmallBusiness_f803d2d4-de47-465a-b8c6-02a2a1d020a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_36e72ccb-8344-4ded-a4a7-c1e2331bee8b" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d2ce96e3-851f-40f3-bb3a-66ea0cf177b2" xlink:to="loc_dei_EntityEmergingGrowthCompany_36e72ccb-8344-4ded-a4a7-c1e2331bee8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityExTransitionPeriod_bcf75256-c1a4-483f-8bea-e3a9753c106f" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityExTransitionPeriod"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d2ce96e3-851f-40f3-bb3a-66ea0cf177b2" xlink:to="loc_dei_EntityExTransitionPeriod_bcf75256-c1a4-483f-8bea-e3a9753c106f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_d12a3614-b41d-4ae7-9004-3687ae1d6313" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d2ce96e3-851f-40f3-bb3a-66ea0cf177b2" xlink:to="loc_dei_DocumentType_d12a3614-b41d-4ae7-9004-3687ae1d6313" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_d8bbe80d-fdab-4f83-bcb2-caa29443a462" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d2ce96e3-851f-40f3-bb3a-66ea0cf177b2" xlink:to="loc_dei_AmendmentFlag_d8bbe80d-fdab-4f83-bcb2-caa29443a462" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport_a9fab1ff-72d0-4d2a-b75e-7be4d902752c" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentAnnualReport"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d2ce96e3-851f-40f3-bb3a-66ea0cf177b2" xlink:to="loc_dei_DocumentAnnualReport_a9fab1ff-72d0-4d2a-b75e-7be4d902752c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_e87e34a5-fab0-496a-a690-fc8c8c5534f9" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d2ce96e3-851f-40f3-bb3a-66ea0cf177b2" xlink:to="loc_dei_DocumentTransitionReport_e87e34a5-fab0-496a-a690-fc8c8c5534f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_bf98fcd9-455c-4cb2-89f4-a854d80e94c0" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d2ce96e3-851f-40f3-bb3a-66ea0cf177b2" xlink:to="loc_dei_DocumentPeriodEndDate_bf98fcd9-455c-4cb2-89f4-a854d80e94c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_efca5162-6543-4438-a6db-94008f501b33" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d2ce96e3-851f-40f3-bb3a-66ea0cf177b2" xlink:to="loc_dei_EntityFileNumber_efca5162-6543-4438-a6db-94008f501b33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_5e90aae3-ad96-4fb6-83f1-25942a5f1bb1" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d2ce96e3-851f-40f3-bb3a-66ea0cf177b2" xlink:to="loc_dei_EntityIncorporationStateCountryCode_5e90aae3-ad96-4fb6-83f1-25942a5f1bb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_655c6ea8-609d-4b83-a891-45c7969e7899" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d2ce96e3-851f-40f3-bb3a-66ea0cf177b2" xlink:to="loc_dei_EntityTaxIdentificationNumber_655c6ea8-609d-4b83-a891-45c7969e7899" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_c6399224-5996-4dc2-b8d7-0ad0026e5d2a" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d2ce96e3-851f-40f3-bb3a-66ea0cf177b2" xlink:to="loc_dei_EntityAddressAddressLine1_c6399224-5996-4dc2-b8d7-0ad0026e5d2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_c2ec25d7-b067-48b3-bfa4-85df18be20da" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d2ce96e3-851f-40f3-bb3a-66ea0cf177b2" xlink:to="loc_dei_EntityAddressCityOrTown_c2ec25d7-b067-48b3-bfa4-85df18be20da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_d32ccb41-a23f-4550-82d4-afbdbeba7309" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d2ce96e3-851f-40f3-bb3a-66ea0cf177b2" xlink:to="loc_dei_EntityAddressStateOrProvince_d32ccb41-a23f-4550-82d4-afbdbeba7309" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_9aa0efef-295f-4670-bea2-c20e926e64e6" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d2ce96e3-851f-40f3-bb3a-66ea0cf177b2" xlink:to="loc_dei_EntityAddressPostalZipCode_9aa0efef-295f-4670-bea2-c20e926e64e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_24d5c5e4-7832-446f-852f-883ad9fd180f" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d2ce96e3-851f-40f3-bb3a-66ea0cf177b2" xlink:to="loc_dei_CityAreaCode_24d5c5e4-7832-446f-852f-883ad9fd180f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_7d37a57f-4b14-4142-a6a4-cd0b42a9d8a3" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d2ce96e3-851f-40f3-bb3a-66ea0cf177b2" xlink:to="loc_dei_LocalPhoneNumber_7d37a57f-4b14-4142-a6a4-cd0b42a9d8a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_0259a4b7-84f5-40d5-a624-83bdc9b3e7bb" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d2ce96e3-851f-40f3-bb3a-66ea0cf177b2" xlink:to="loc_dei_Security12bTitle_0259a4b7-84f5-40d5-a624-83bdc9b3e7bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_7d7feb87-75ca-403c-b30a-1535223d83c6" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d2ce96e3-851f-40f3-bb3a-66ea0cf177b2" xlink:to="loc_dei_TradingSymbol_7d7feb87-75ca-403c-b30a-1535223d83c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_a4e13bcf-1551-4196-a01e-907e5a0c55a6" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d2ce96e3-851f-40f3-bb3a-66ea0cf177b2" xlink:to="loc_dei_SecurityExchangeName_a4e13bcf-1551-4196-a01e-907e5a0c55a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_974d0aa8-f358-488d-afeb-6a1a34277968" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d2ce96e3-851f-40f3-bb3a-66ea0cf177b2" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_974d0aa8-f358-488d-afeb-6a1a34277968" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers_22b0d89d-0ec0-4820-ae3c-8639243fad3f" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityVoluntaryFilers"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d2ce96e3-851f-40f3-bb3a-66ea0cf177b2" xlink:to="loc_dei_EntityVoluntaryFilers_22b0d89d-0ec0-4820-ae3c-8639243fad3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_e0d792a0-10a7-475e-8ab9-f7b0854d2848" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d2ce96e3-851f-40f3-bb3a-66ea0cf177b2" xlink:to="loc_dei_EntityCurrentReportingStatus_e0d792a0-10a7-475e-8ab9-f7b0854d2848" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_e378e273-47f6-4164-89de-9ccf6c090da9" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d2ce96e3-851f-40f3-bb3a-66ea0cf177b2" xlink:to="loc_dei_EntityInteractiveDataCurrent_e378e273-47f6-4164-89de-9ccf6c090da9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_5426e20b-8c6b-42f1-a67a-371c2c8e5f42" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d2ce96e3-851f-40f3-bb3a-66ea0cf177b2" xlink:to="loc_dei_EntityShellCompany_5426e20b-8c6b-42f1-a67a-371c2c8e5f42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat_6cdd779d-59e2-40ca-b2d2-2c4cb4546f09" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityPublicFloat"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d2ce96e3-851f-40f3-bb3a-66ea0cf177b2" xlink:to="loc_dei_EntityPublicFloat_6cdd779d-59e2-40ca-b2d2-2c4cb4546f09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_f1c3c1b2-cde1-4b5d-85d2-05c2d2613faa" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d2ce96e3-851f-40f3-bb3a-66ea0cf177b2" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_f1c3c1b2-cde1-4b5d-85d2-05c2d2613faa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_bd738a6b-a5e1-4211-b4e5-c515ba4953a9" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d2ce96e3-851f-40f3-bb3a-66ea0cf177b2" xlink:to="loc_dei_CurrentFiscalYearEndDate_bd738a6b-a5e1-4211-b4e5-c515ba4953a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_f0cf5993-1197-4373-8ea0-b10fa1a42724" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d2ce96e3-851f-40f3-bb3a-66ea0cf177b2" xlink:to="loc_dei_DocumentFiscalYearFocus_f0cf5993-1197-4373-8ea0-b10fa1a42724" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_4eea495e-c83f-4176-9db2-da30ad6e1325" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d2ce96e3-851f-40f3-bb3a-66ea0cf177b2" xlink:to="loc_dei_DocumentFiscalPeriodFocus_4eea495e-c83f-4176-9db2-da30ad6e1325" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="silk-20191231.xsd#ConsolidatedBalanceSheets"/>
  <link:presentationLink xlink:role="http://silkroadmed.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_4dcd8fcf-acbf-4810-8e1b-fa0e1e4ebe38" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_c311b90a-cd5a-491e-841c-eb14c0c67647" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_4dcd8fcf-acbf-4810-8e1b-fa0e1e4ebe38" xlink:to="loc_us-gaap_AssetsAbstract_c311b90a-cd5a-491e-841c-eb14c0c67647" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_7252293a-8780-4bea-a358-9cbab3619058" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_c311b90a-cd5a-491e-841c-eb14c0c67647" xlink:to="loc_us-gaap_AssetsCurrentAbstract_7252293a-8780-4bea-a358-9cbab3619058" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_2cdd77cf-600b-4b3a-a533-4e5f7a639bb9" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_7252293a-8780-4bea-a358-9cbab3619058" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_2cdd77cf-600b-4b3a-a533-4e5f7a639bb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_01c0e3d0-148e-495f-8d1f-90c22b23c6e0" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShortTermInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_7252293a-8780-4bea-a358-9cbab3619058" xlink:to="loc_us-gaap_ShortTermInvestments_01c0e3d0-148e-495f-8d1f-90c22b23c6e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_43e71bb7-636a-4f34-bca1-eb5be1950ea5" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_7252293a-8780-4bea-a358-9cbab3619058" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_43e71bb7-636a-4f34-bca1-eb5be1950ea5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_55856861-0dbb-4e0b-b7bb-72b0b9dc5d49" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_7252293a-8780-4bea-a358-9cbab3619058" xlink:to="loc_us-gaap_InventoryNet_55856861-0dbb-4e0b-b7bb-72b0b9dc5d49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_decd9686-5d70-4174-8343-b4d0f2b557c4" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_7252293a-8780-4bea-a358-9cbab3619058" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_decd9686-5d70-4174-8343-b4d0f2b557c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_a1ab621b-bd91-408d-905c-6ec93bec952b" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_7252293a-8780-4bea-a358-9cbab3619058" xlink:to="loc_us-gaap_AssetsCurrent_a1ab621b-bd91-408d-905c-6ec93bec952b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments_c5f3dd46-6a9a-4f71-abb7-8d1cd5ee70fb" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_c311b90a-cd5a-491e-841c-eb14c0c67647" xlink:to="loc_us-gaap_LongTermInvestments_c5f3dd46-6a9a-4f71-abb7-8d1cd5ee70fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_6c5080c8-cdf7-481a-bc6f-f887f8530d7a" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_c311b90a-cd5a-491e-841c-eb14c0c67647" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_6c5080c8-cdf7-481a-bc6f-f887f8530d7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_5772712f-629c-4426-ade8-99b6dd703419" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_c311b90a-cd5a-491e-841c-eb14c0c67647" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_5772712f-629c-4426-ade8-99b6dd703419" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_b27acab1-0152-419e-bf6d-076e7647eb6e" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_c311b90a-cd5a-491e-841c-eb14c0c67647" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_b27acab1-0152-419e-bf6d-076e7647eb6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_909d5e75-02db-4dc2-974e-36a7f6642f30" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_c311b90a-cd5a-491e-841c-eb14c0c67647" xlink:to="loc_us-gaap_Assets_909d5e75-02db-4dc2-974e-36a7f6642f30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_17edf7f2-7077-4748-aa63-e7ee2ff2e2f7" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_4dcd8fcf-acbf-4810-8e1b-fa0e1e4ebe38" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_17edf7f2-7077-4748-aa63-e7ee2ff2e2f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_279a8fb0-3fb8-43f6-92bf-6c42a080921c" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_17edf7f2-7077-4748-aa63-e7ee2ff2e2f7" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_279a8fb0-3fb8-43f6-92bf-6c42a080921c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_edea0107-e05f-4048-a189-20906ee58c42" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_279a8fb0-3fb8-43f6-92bf-6c42a080921c" xlink:to="loc_us-gaap_AccountsPayableCurrent_edea0107-e05f-4048-a189-20906ee58c42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_e57cfdf1-7b81-4f8b-9ecc-e83f36d573d4" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_279a8fb0-3fb8-43f6-92bf-6c42a080921c" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_e57cfdf1-7b81-4f8b-9ecc-e83f36d573d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_7cd86e2b-13e8-45c5-bb4b-7d290b0ca658" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_279a8fb0-3fb8-43f6-92bf-6c42a080921c" xlink:to="loc_us-gaap_LiabilitiesCurrent_7cd86e2b-13e8-45c5-bb4b-7d290b0ca658" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_fe2dbc30-7d56-4e74-955f-a35ec7e064d7" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_17edf7f2-7077-4748-aa63-e7ee2ff2e2f7" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_fe2dbc30-7d56-4e74-955f-a35ec7e064d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_PreferredStockWarrantLiability_0c974ab0-bb42-4133-82a8-b560fa0521a2" xlink:href="silk-20191231.xsd#silk_PreferredStockWarrantLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_17edf7f2-7077-4748-aa63-e7ee2ff2e2f7" xlink:to="loc_silk_PreferredStockWarrantLiability_0c974ab0-bb42-4133-82a8-b560fa0521a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_fdee877e-5e83-4da8-b6b2-e1083faefd6d" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_17edf7f2-7077-4748-aa63-e7ee2ff2e2f7" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_fdee877e-5e83-4da8-b6b2-e1083faefd6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_00890197-faf5-49a6-997b-3455ee169abf" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_17edf7f2-7077-4748-aa63-e7ee2ff2e2f7" xlink:to="loc_us-gaap_Liabilities_00890197-faf5-49a6-997b-3455ee169abf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_d0a7061a-8204-472f-b894-b50c95674982" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_17edf7f2-7077-4748-aa63-e7ee2ff2e2f7" xlink:to="loc_us-gaap_CommitmentsAndContingencies_d0a7061a-8204-472f-b894-b50c95674982" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterestsAbstract_9c9db6c8-fe6f-433b-bd10-40f6b507fb12" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterestsAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_17edf7f2-7077-4748-aa63-e7ee2ff2e2f7" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterestsAbstract_9c9db6c8-fe6f-433b-bd10-40f6b507fb12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_81b91104-0fa8-4508-83cd-f0153fb5eddc" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterestsAbstract_9c9db6c8-fe6f-433b-bd10-40f6b507fb12" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_81b91104-0fa8-4508-83cd-f0153fb5eddc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_a98064dd-5fe6-4a13-b980-9978498646ee" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_17edf7f2-7077-4748-aa63-e7ee2ff2e2f7" xlink:to="loc_us-gaap_StockholdersEquityAbstract_a98064dd-5fe6-4a13-b980-9978498646ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract_8f8a8714-bd5e-406c-9aea-624300af313f" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_a98064dd-5fe6-4a13-b980-9978498646ee" xlink:to="loc_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract_8f8a8714-bd5e-406c-9aea-624300af313f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_bcafbc84-1adf-4490-be32-e30f855acb19" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract_8f8a8714-bd5e-406c-9aea-624300af313f" xlink:to="loc_us-gaap_PreferredStockValue_bcafbc84-1adf-4490-be32-e30f855acb19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_939a2389-7902-4923-968a-f909fc26111a" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_a98064dd-5fe6-4a13-b980-9978498646ee" xlink:to="loc_us-gaap_CommonStockValue_939a2389-7902-4923-968a-f909fc26111a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_e4c9c80c-6fa3-4df7-ae2b-4586d04cd24b" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_a98064dd-5fe6-4a13-b980-9978498646ee" xlink:to="loc_us-gaap_AdditionalPaidInCapital_e4c9c80c-6fa3-4df7-ae2b-4586d04cd24b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_ba9eddd8-3f96-40c0-bfbd-e699f083e7bd" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_a98064dd-5fe6-4a13-b980-9978498646ee" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_ba9eddd8-3f96-40c0-bfbd-e699f083e7bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_02812495-714e-4a7b-8d33-1c4f0deaba92" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_a98064dd-5fe6-4a13-b980-9978498646ee" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_02812495-714e-4a7b-8d33-1c4f0deaba92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_d8196c83-fc85-48c6-9ddf-f0fa32e559f5" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_a98064dd-5fe6-4a13-b980-9978498646ee" xlink:to="loc_us-gaap_StockholdersEquity_d8196c83-fc85-48c6-9ddf-f0fa32e559f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_76074dc3-c8ea-4fe2-8678-a54676d55754" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_17edf7f2-7077-4748-aa63-e7ee2ff2e2f7" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_76074dc3-c8ea-4fe2-8678-a54676d55754" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="silk-20191231.xsd#ConsolidatedBalanceSheetsParenthetical"/>
  <link:presentationLink xlink:role="http://silkroadmed.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_5cab6e9b-0994-4a88-8854-3632e8b3b862" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_ed5e23b4-9219-4a59-b88b-3af14ee5cd69" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_5cab6e9b-0994-4a88-8854-3632e8b3b862" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_ed5e23b4-9219-4a59-b88b-3af14ee5cd69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_0429e02f-1855-41e9-a0d1-82544a889a86" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_5cab6e9b-0994-4a88-8854-3632e8b3b862" xlink:to="loc_us-gaap_CommonStockSharesIssued_0429e02f-1855-41e9-a0d1-82544a889a86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_8cb4afd4-3647-4525-9bcf-61aaa5eac2a5" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_5cab6e9b-0994-4a88-8854-3632e8b3b862" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_8cb4afd4-3647-4525-9bcf-61aaa5eac2a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_20196b6f-7b78-47da-99d8-bbb05305038a" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_5cab6e9b-0994-4a88-8854-3632e8b3b862" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_20196b6f-7b78-47da-99d8-bbb05305038a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_b5273f07-a9a7-47e8-be86-bd59e6abddca" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_5cab6e9b-0994-4a88-8854-3632e8b3b862" xlink:to="loc_us-gaap_PreferredStockSharesIssued_b5273f07-a9a7-47e8-be86-bd59e6abddca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_776b4d62-9d8a-4088-8767-28aced1b0f6e" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_5cab6e9b-0994-4a88-8854-3632e8b3b862" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_776b4d62-9d8a-4088-8767-28aced1b0f6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_868956ca-fdd6-4246-b473-9db4985f5f9c" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_5cab6e9b-0994-4a88-8854-3632e8b3b862" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_868956ca-fdd6-4246-b473-9db4985f5f9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_56523f00-1954-459a-b590-97b828180116" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_5cab6e9b-0994-4a88-8854-3632e8b3b862" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_56523f00-1954-459a-b590-97b828180116" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityLiquidationPreference_d672db77-36b6-46ec-8175-55136eac53a6" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TemporaryEquityLiquidationPreference"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_5cab6e9b-0994-4a88-8854-3632e8b3b862" xlink:to="loc_us-gaap_TemporaryEquityLiquidationPreference_d672db77-36b6-46ec-8175-55136eac53a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_1ebaa7af-eb21-4f20-95cf-005930fe381f" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_5cab6e9b-0994-4a88-8854-3632e8b3b862" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_1ebaa7af-eb21-4f20-95cf-005930fe381f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesIssued_47e27732-5a2c-47c6-bd67-c4ef790209cc" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TemporaryEquitySharesIssued"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_5cab6e9b-0994-4a88-8854-3632e8b3b862" xlink:to="loc_us-gaap_TemporaryEquitySharesIssued_47e27732-5a2c-47c6-bd67-c4ef790209cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesAuthorized_a68b6740-62cc-484f-b87a-d2c7244e2bf4" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TemporaryEquitySharesAuthorized"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_5cab6e9b-0994-4a88-8854-3632e8b3b862" xlink:to="loc_us-gaap_TemporaryEquitySharesAuthorized_a68b6740-62cc-484f-b87a-d2c7244e2bf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityParOrStatedValuePerShare_6809b024-71bc-4b30-b418-fa1e5d44b5f4" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_5cab6e9b-0994-4a88-8854-3632e8b3b862" xlink:to="loc_us-gaap_TemporaryEquityParOrStatedValuePerShare_6809b024-71bc-4b30-b418-fa1e5d44b5f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_548227a7-5e4d-40c2-9f54-ff7bdab9da34" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_5cab6e9b-0994-4a88-8854-3632e8b3b862" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_548227a7-5e4d-40c2-9f54-ff7bdab9da34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss" xlink:type="simple" xlink:href="silk-20191231.xsd#CondensedConsolidatedStatementsofOperationsandComprehensiveLoss"/>
  <link:presentationLink xlink:role="http://silkroadmed.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_0b7f1e63-8be0-4ce2-ac90-14fc6329442f" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_a2df3b0f-1775-445d-9cfc-b7e406eda659" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0b7f1e63-8be0-4ce2-ac90-14fc6329442f" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_a2df3b0f-1775-445d-9cfc-b7e406eda659" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_af7bc53c-7618-4722-84ef-1fc1bf8bf17d" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0b7f1e63-8be0-4ce2-ac90-14fc6329442f" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_af7bc53c-7618-4722-84ef-1fc1bf8bf17d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_e0845911-fe47-4759-82df-fa302e389985" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0b7f1e63-8be0-4ce2-ac90-14fc6329442f" xlink:to="loc_us-gaap_GrossProfit_e0845911-fe47-4759-82df-fa302e389985" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_91919222-66ee-45d3-9d1f-2068319b2495" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0b7f1e63-8be0-4ce2-ac90-14fc6329442f" xlink:to="loc_us-gaap_OperatingExpensesAbstract_91919222-66ee-45d3-9d1f-2068319b2495" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_883b22b7-2d3b-4f88-a9e5-df9e15d89708" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_91919222-66ee-45d3-9d1f-2068319b2495" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_883b22b7-2d3b-4f88-a9e5-df9e15d89708" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_8666dbe6-c630-4aa1-a277-106f3fc30c3c" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_91919222-66ee-45d3-9d1f-2068319b2495" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_8666dbe6-c630-4aa1-a277-106f3fc30c3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_a5bc75d3-36a0-41d0-9528-c25b75549d8d" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_91919222-66ee-45d3-9d1f-2068319b2495" xlink:to="loc_us-gaap_OperatingExpenses_a5bc75d3-36a0-41d0-9528-c25b75549d8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_3789df8f-6701-41cb-9908-a33167f61545" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0b7f1e63-8be0-4ce2-ac90-14fc6329442f" xlink:to="loc_us-gaap_OperatingIncomeLoss_3789df8f-6701-41cb-9908-a33167f61545" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_955f9997-f280-4ea3-9bc6-bbb4d8d3f680" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0b7f1e63-8be0-4ce2-ac90-14fc6329442f" xlink:to="loc_us-gaap_InvestmentIncomeInterest_955f9997-f280-4ea3-9bc6-bbb4d8d3f680" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_fa4d5297-4a5a-4cde-8291-9b3fa097e84c" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0b7f1e63-8be0-4ce2-ac90-14fc6329442f" xlink:to="loc_us-gaap_InterestExpense_fa4d5297-4a5a-4cde-8291-9b3fa097e84c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_84d713b2-eafa-4ea5-ab3d-0c37b477774b" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0b7f1e63-8be0-4ce2-ac90-14fc6329442f" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_84d713b2-eafa-4ea5-ab3d-0c37b477774b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_0563c7c2-19cb-47f5-9d34-63e82f1f5f47" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0b7f1e63-8be0-4ce2-ac90-14fc6329442f" xlink:to="loc_us-gaap_ProfitLoss_0563c7c2-19cb-47f5-9d34-63e82f1f5f47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_8195b914-3748-40e4-b8d4-314515b56227" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0b7f1e63-8be0-4ce2-ac90-14fc6329442f" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_8195b914-3748-40e4-b8d4-314515b56227" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_1ef69391-1ea9-402d-ad8c-22340f25a85a" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0b7f1e63-8be0-4ce2-ac90-14fc6329442f" xlink:to="loc_us-gaap_NetIncomeLoss_1ef69391-1ea9-402d-ad8c-22340f25a85a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_830fe81f-1ce0-4841-a9e1-d2a9c800436a" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0b7f1e63-8be0-4ce2-ac90-14fc6329442f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_830fe81f-1ce0-4841-a9e1-d2a9c800436a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_a27b4651-2cf8-4b77-9147-6d56bdd4ca36" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_830fe81f-1ce0-4841-a9e1-d2a9c800436a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_a27b4651-2cf8-4b77-9147-6d56bdd4ca36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_ee4e8773-4b3b-4e0c-bf78-b250549c7b53" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_830fe81f-1ce0-4841-a9e1-d2a9c800436a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_ee4e8773-4b3b-4e0c-bf78-b250549c7b53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_NetIncomeLossAndComprehensiveIncomeLossNetOfTaxAttributableToParent_00f2e0c7-79c9-4f41-a0b6-9faf1d350685" xlink:href="silk-20191231.xsd#silk_NetIncomeLossAndComprehensiveIncomeLossNetOfTaxAttributableToParent"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0b7f1e63-8be0-4ce2-ac90-14fc6329442f" xlink:to="loc_silk_NetIncomeLossAndComprehensiveIncomeLossNetOfTaxAttributableToParent_00f2e0c7-79c9-4f41-a0b6-9faf1d350685" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDiluted_6f6d0636-3486-413e-a684-9b860b44d6e1" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0b7f1e63-8be0-4ce2-ac90-14fc6329442f" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDiluted_6f6d0636-3486-413e-a684-9b860b44d6e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_a43672a3-d947-405c-b287-e2a9a44a6e08" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0b7f1e63-8be0-4ce2-ac90-14fc6329442f" xlink:to="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_a43672a3-d947-405c-b287-e2a9a44a6e08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit" xlink:type="simple" xlink:href="silk-20191231.xsd#CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit"/>
  <link:presentationLink xlink:role="http://silkroadmed.com/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_fbb68068-a371-44f7-86f8-dc8b1acc0ca6" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_a370ce27-27b4-481d-ac67-4367c9497937" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_fbb68068-a371-44f7-86f8-dc8b1acc0ca6" xlink:to="loc_us-gaap_StatementTable_a370ce27-27b4-481d-ac67-4367c9497937" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_7e5cc87c-03c8-4e5f-ae27-c7b25072b11e" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_a370ce27-27b4-481d-ac67-4367c9497937" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_7e5cc87c-03c8-4e5f-ae27-c7b25072b11e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_4012ea52-956e-466a-8dc7-fc080e83d452" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_7e5cc87c-03c8-4e5f-ae27-c7b25072b11e" xlink:to="loc_us-gaap_EquityComponentDomain_4012ea52-956e-466a-8dc7-fc080e83d452" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockMember_3ccb32a5-ea06-4353-b11d-e0f8acf880c8" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_4012ea52-956e-466a-8dc7-fc080e83d452" xlink:to="loc_us-gaap_PreferredStockMember_3ccb32a5-ea06-4353-b11d-e0f8acf880c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_d7ce38a5-024f-4350-ab10-69b77aa6cf2e" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_4012ea52-956e-466a-8dc7-fc080e83d452" xlink:to="loc_us-gaap_CommonStockMember_d7ce38a5-024f-4350-ab10-69b77aa6cf2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_35f02eb8-797b-4353-9a0f-fe6f8b71f41d" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_4012ea52-956e-466a-8dc7-fc080e83d452" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_35f02eb8-797b-4353-9a0f-fe6f8b71f41d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_9cbe5693-760a-40d0-9772-911d5ac245d6" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_4012ea52-956e-466a-8dc7-fc080e83d452" xlink:to="loc_us-gaap_RetainedEarningsMember_9cbe5693-760a-40d0-9772-911d5ac245d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_1260e7d8-a465-4431-914d-cec891e197e9" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_4012ea52-956e-466a-8dc7-fc080e83d452" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_1260e7d8-a465-4431-914d-cec891e197e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_d7c75289-ad67-42a1-af3d-c781136015ff" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_4012ea52-956e-466a-8dc7-fc080e83d452" xlink:to="loc_us-gaap_NoncontrollingInterestMember_d7c75289-ad67-42a1-af3d-c781136015ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_84c50a92-c58a-461e-863e-8bfd609eb9e0" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_a370ce27-27b4-481d-ac67-4367c9497937" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_84c50a92-c58a-461e-863e-8bfd609eb9e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_abe9c01f-5f4a-411b-b1d6-26ed90024395" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_84c50a92-c58a-461e-863e-8bfd609eb9e0" xlink:to="loc_us-gaap_TypeOfAdoptionMember_abe9c01f-5f4a-411b-b1d6-26ed90024395" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201409Member_a874fcf3-8aa5-4418-8a38-2fbb443f4016" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountingStandardsUpdate201409Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfAdoptionMember_abe9c01f-5f4a-411b-b1d6-26ed90024395" xlink:to="loc_us-gaap_AccountingStandardsUpdate201409Member_a874fcf3-8aa5-4418-8a38-2fbb443f4016" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201609Member_45330c3e-e46f-4050-bfb8-780b96068ac9" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountingStandardsUpdate201609Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfAdoptionMember_abe9c01f-5f4a-411b-b1d6-26ed90024395" xlink:to="loc_us-gaap_AccountingStandardsUpdate201609Member_45330c3e-e46f-4050-bfb8-780b96068ac9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_5abadd61-e83c-4984-a6d4-cde115b3cf80" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_a370ce27-27b4-481d-ac67-4367c9497937" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_5abadd61-e83c-4984-a6d4-cde115b3cf80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_910e56c5-ddb5-4dfc-b55a-3eae2ae411a2" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_5abadd61-e83c-4984-a6d4-cde115b3cf80" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_910e56c5-ddb5-4dfc-b55a-3eae2ae411a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IPOMember_531cd989-45c5-483a-a07f-76e0850bc552" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IPOMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_910e56c5-ddb5-4dfc-b55a-3eae2ae411a2" xlink:to="loc_us-gaap_IPOMember_531cd989-45c5-483a-a07f-76e0850bc552" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_87f4c9af-a1c9-4d29-9c3f-9a78f663e6b0" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_a370ce27-27b4-481d-ac67-4367c9497937" xlink:to="loc_us-gaap_StatementLineItems_87f4c9af-a1c9-4d29-9c3f-9a78f663e6b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityAbstract_ee30c17b-1a7e-4e14-863e-43e51da66b70" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TemporaryEquityAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_87f4c9af-a1c9-4d29-9c3f-9a78f663e6b0" xlink:to="loc_us-gaap_TemporaryEquityAbstract_ee30c17b-1a7e-4e14-863e-43e51da66b70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_da69f02b-bc00-438c-841a-f557acd9915b" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityAbstract_ee30c17b-1a7e-4e14-863e-43e51da66b70" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_da69f02b-bc00-438c-841a-f557acd9915b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_3c9339b7-b824-4802-adbf-504fa1aca260" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityAbstract_ee30c17b-1a7e-4e14-863e-43e51da66b70" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_3c9339b7-b824-4802-adbf-504fa1aca260" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_StockIssuedDuringPeriodValueExerciseOfWarrants_6c0995ff-7619-4001-a33b-c3bcfa526ebc" xlink:href="silk-20191231.xsd#silk_StockIssuedDuringPeriodValueExerciseOfWarrants"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityAbstract_ee30c17b-1a7e-4e14-863e-43e51da66b70" xlink:to="loc_silk_StockIssuedDuringPeriodValueExerciseOfWarrants_6c0995ff-7619-4001-a33b-c3bcfa526ebc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_StockIssuedDuringPeriodSharesExerciseOfWarrants_84f49195-ecc0-4dba-b3dd-68845da44907" xlink:href="silk-20191231.xsd#silk_StockIssuedDuringPeriodSharesExerciseOfWarrants"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityAbstract_ee30c17b-1a7e-4e14-863e-43e51da66b70" xlink:to="loc_silk_StockIssuedDuringPeriodSharesExerciseOfWarrants_84f49195-ecc0-4dba-b3dd-68845da44907" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_55dbf86d-7a0e-4e59-a1e1-485c1e011ee9" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityAbstract_ee30c17b-1a7e-4e14-863e-43e51da66b70" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_55dbf86d-7a0e-4e59-a1e1-485c1e011ee9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_79b9e79d-bf29-4cf5-9542-4158baee0bce" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityAbstract_ee30c17b-1a7e-4e14-863e-43e51da66b70" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_79b9e79d-bf29-4cf5-9542-4158baee0bce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_349f1b53-9313-4968-94a0-4a28ee6d0d1a" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_87f4c9af-a1c9-4d29-9c3f-9a78f663e6b0" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_349f1b53-9313-4968-94a0-4a28ee6d0d1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_17f4d6fc-e26e-4dc0-b69f-8b9edc6ec934" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_349f1b53-9313-4968-94a0-4a28ee6d0d1a" xlink:to="loc_us-gaap_SharesOutstanding_17f4d6fc-e26e-4dc0-b69f-8b9edc6ec934" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f2fe1ab7-b9de-4d90-a173-6d31d78cce89" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_349f1b53-9313-4968-94a0-4a28ee6d0d1a" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f2fe1ab7-b9de-4d90-a173-6d31d78cce89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_84b80e00-753a-4fb3-ac49-0f481d528a48" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_349f1b53-9313-4968-94a0-4a28ee6d0d1a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_84b80e00-753a-4fb3-ac49-0f481d528a48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_ba7f28d0-1b10-4224-a510-9e5d81df1243" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_349f1b53-9313-4968-94a0-4a28ee6d0d1a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_ba7f28d0-1b10-4224-a510-9e5d81df1243" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_d66fcc11-aa10-4454-b0f5-07f15702154b" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_349f1b53-9313-4968-94a0-4a28ee6d0d1a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_d66fcc11-aa10-4454-b0f5-07f15702154b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_245709ef-87c2-4bb2-9b3b-273e95c884cd" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_349f1b53-9313-4968-94a0-4a28ee6d0d1a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_245709ef-87c2-4bb2-9b3b-273e95c884cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits_40e7b34f-5db3-471b-b8db-908fab3d8178" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_349f1b53-9313-4968-94a0-4a28ee6d0d1a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits_40e7b34f-5db3-471b-b8db-908fab3d8178" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfUnits_c3f463ac-b62b-45a9-bd29-ad56e68b1371" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfUnits"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_349f1b53-9313-4968-94a0-4a28ee6d0d1a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfUnits_c3f463ac-b62b-45a9-bd29-ad56e68b1371" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_17f2e6d3-00ef-4a26-86b4-f21361934350" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_349f1b53-9313-4968-94a0-4a28ee6d0d1a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_17f2e6d3-00ef-4a26-86b4-f21361934350" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_bbb29cb7-5de3-42e4-9054-efbbe0df7a12" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_349f1b53-9313-4968-94a0-4a28ee6d0d1a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_bbb29cb7-5de3-42e4-9054-efbbe0df7a12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition_2c264dc0-ea2b-4f4f-9b0e-d70eeec82dbb" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_349f1b53-9313-4968-94a0-4a28ee6d0d1a" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition_2c264dc0-ea2b-4f4f-9b0e-d70eeec82dbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_47a1417c-0d87-4644-a07a-72a9c2f9c0c4" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_349f1b53-9313-4968-94a0-4a28ee6d0d1a" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_47a1417c-0d87-4644-a07a-72a9c2f9c0c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance_dd6bf89d-4a94-4170-aa52-f00ea097f529" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_349f1b53-9313-4968-94a0-4a28ee6d0d1a" xlink:to="loc_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance_dd6bf89d-4a94-4170-aa52-f00ea097f529" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_3cfd6c76-19c7-4652-806b-b0521da55aa2" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_349f1b53-9313-4968-94a0-4a28ee6d0d1a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_3cfd6c76-19c7-4652-806b-b0521da55aa2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_f3d4324d-9a1a-4e92-afbc-f051d75103c4" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_349f1b53-9313-4968-94a0-4a28ee6d0d1a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_f3d4324d-9a1a-4e92-afbc-f051d75103c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption_23db25cc-7b79-4d21-ac86-5b8d73340e6c" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_349f1b53-9313-4968-94a0-4a28ee6d0d1a" xlink:to="loc_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption_23db25cc-7b79-4d21-ac86-5b8d73340e6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_4a307f04-f54c-4c34-b1ef-ad2c55a0c838" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_349f1b53-9313-4968-94a0-4a28ee6d0d1a" xlink:to="loc_us-gaap_ProfitLoss_4a307f04-f54c-4c34-b1ef-ad2c55a0c838" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_3da1c0f0-ff13-47ea-842c-b9fb269337bb" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_349f1b53-9313-4968-94a0-4a28ee6d0d1a" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_3da1c0f0-ff13-47ea-842c-b9fb269337bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_49ccc3e6-e3bb-443d-a01a-50dc8356f7e7" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_349f1b53-9313-4968-94a0-4a28ee6d0d1a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_49ccc3e6-e3bb-443d-a01a-50dc8356f7e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_ab98cdee-7c3e-4a1e-b9ec-27fcd4377f8c" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_349f1b53-9313-4968-94a0-4a28ee6d0d1a" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_ab98cdee-7c3e-4a1e-b9ec-27fcd4377f8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_724b7a67-8f3d-4eb9-a288-6679918b454a" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_349f1b53-9313-4968-94a0-4a28ee6d0d1a" xlink:to="loc_us-gaap_SharesOutstanding_724b7a67-8f3d-4eb9-a288-6679918b454a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficitParenthetical" xlink:type="simple" xlink:href="silk-20191231.xsd#CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficitParenthetical"/>
  <link:presentationLink xlink:role="http://silkroadmed.com/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficitParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_1091c31f-d82d-457e-84bf-431b12749dda" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_514113f2-4789-4949-bf94-245a984d5e7c" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_1091c31f-d82d-457e-84bf-431b12749dda" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_514113f2-4789-4949-bf94-245a984d5e7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="silk-20191231.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:presentationLink xlink:role="http://silkroadmed.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_053a33d0-6ffa-41c9-852d-2a98358eec54" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_82c0912d-e873-44a8-95d1-baba45e5781d" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_053a33d0-6ffa-41c9-852d-2a98358eec54" xlink:to="loc_us-gaap_StatementTable_82c0912d-e873-44a8-95d1-baba45e5781d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_762a6edb-17d4-4821-8b39-cb020ce6f05d" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_82c0912d-e873-44a8-95d1-baba45e5781d" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_762a6edb-17d4-4821-8b39-cb020ce6f05d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_fb900833-e197-4433-b324-743b2b39bc4a" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_762a6edb-17d4-4821-8b39-cb020ce6f05d" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_fb900833-e197-4433-b324-743b2b39bc4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_RedeemableConvertiblePreferredStockWarrantsMember_084e8b5d-7619-4ccf-b696-0f32b8156c7f" xlink:href="silk-20191231.xsd#silk_RedeemableConvertiblePreferredStockWarrantsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_fb900833-e197-4433-b324-743b2b39bc4a" xlink:to="loc_silk_RedeemableConvertiblePreferredStockWarrantsMember_084e8b5d-7619-4ccf-b696-0f32b8156c7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_CommonStockWarrantMember_1d8b0ce7-5a3d-4e7e-8858-5d522837a121" xlink:href="silk-20191231.xsd#silk_CommonStockWarrantMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_fb900833-e197-4433-b324-743b2b39bc4a" xlink:to="loc_silk_CommonStockWarrantMember_1d8b0ce7-5a3d-4e7e-8858-5d522837a121" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_f02a30e4-2d83-4f2c-a397-a62a04b55d01" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_82c0912d-e873-44a8-95d1-baba45e5781d" xlink:to="loc_us-gaap_StatementLineItems_f02a30e4-2d83-4f2c-a397-a62a04b55d01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_82779318-0425-4f78-b53c-4f1a138b7bdb" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f02a30e4-2d83-4f2c-a397-a62a04b55d01" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_82779318-0425-4f78-b53c-4f1a138b7bdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_585f764d-f7ab-4014-9538-2be8a0daa4e6" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_82779318-0425-4f78-b53c-4f1a138b7bdb" xlink:to="loc_us-gaap_ProfitLoss_585f764d-f7ab-4014-9538-2be8a0daa4e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_80af5ce6-5fc0-4634-ba0e-61dd2ec1f767" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_82779318-0425-4f78-b53c-4f1a138b7bdb" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_80af5ce6-5fc0-4634-ba0e-61dd2ec1f767" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_162957d3-df22-4250-bd4b-0cc06c7a4fe6" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_80af5ce6-5fc0-4634-ba0e-61dd2ec1f767" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_162957d3-df22-4250-bd4b-0cc06c7a4fe6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_6f546595-ea43-4f84-b3d2-f4fb82baece7" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_80af5ce6-5fc0-4634-ba0e-61dd2ec1f767" xlink:to="loc_us-gaap_ShareBasedCompensation_6f546595-ea43-4f84-b3d2-f4fb82baece7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants_e4d5febc-4b88-4bb9-a88c-730f2bd3c8b2" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_80af5ce6-5fc0-4634-ba0e-61dd2ec1f767" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants_e4d5febc-4b88-4bb9-a88c-730f2bd3c8b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_20af7200-9750-4c18-8c43-7ccc86b452da" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_80af5ce6-5fc0-4634-ba0e-61dd2ec1f767" xlink:to="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_20af7200-9750-4c18-8c43-7ccc86b452da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_d0d31334-8b8d-4adf-b72a-bf4efd349aee" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_80af5ce6-5fc0-4634-ba0e-61dd2ec1f767" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_d0d31334-8b8d-4adf-b72a-bf4efd349aee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_OperatingLeaseRightOfUseAssetAmortization_ca936cd1-6694-4f51-9228-4e72b2764f41" xlink:href="silk-20191231.xsd#silk_OperatingLeaseRightOfUseAssetAmortization"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_80af5ce6-5fc0-4634-ba0e-61dd2ec1f767" xlink:to="loc_silk_OperatingLeaseRightOfUseAssetAmortization_ca936cd1-6694-4f51-9228-4e72b2764f41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaidInKindInterest_2079e421-25d3-475d-9b04-353845692640" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaidInKindInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_80af5ce6-5fc0-4634-ba0e-61dd2ec1f767" xlink:to="loc_us-gaap_PaidInKindInterest_2079e421-25d3-475d-9b04-353845692640" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_77c3e951-a3cb-44a1-8841-e8faf11b9d2c" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_80af5ce6-5fc0-4634-ba0e-61dd2ec1f767" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_77c3e951-a3cb-44a1-8841-e8faf11b9d2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_84f37978-1f08-45ca-b372-d17173d2cb1b" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_80af5ce6-5fc0-4634-ba0e-61dd2ec1f767" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_84f37978-1f08-45ca-b372-d17173d2cb1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWriteDown_3e7cc213-3241-4839-ae8c-f25fbbfc105f" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InventoryWriteDown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_80af5ce6-5fc0-4634-ba0e-61dd2ec1f767" xlink:to="loc_us-gaap_InventoryWriteDown_3e7cc213-3241-4839-ae8c-f25fbbfc105f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_076e1826-c13e-4869-af77-345bb817dfd9" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_82779318-0425-4f78-b53c-4f1a138b7bdb" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_076e1826-c13e-4869-af77-345bb817dfd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_e7b370cf-fc91-4721-a647-9f0ac6a09677" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_076e1826-c13e-4869-af77-345bb817dfd9" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_e7b370cf-fc91-4721-a647-9f0ac6a09677" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_90cf7823-a308-4859-aa7e-801a6409ab22" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_076e1826-c13e-4869-af77-345bb817dfd9" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_90cf7823-a308-4859-aa7e-801a6409ab22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_f6d32f1a-4dab-4fa4-95c8-1348cd4867c9" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_076e1826-c13e-4869-af77-345bb817dfd9" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_f6d32f1a-4dab-4fa4-95c8-1348cd4867c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_b9bdfc22-91f0-4f15-939b-0fcef2ec8493" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_076e1826-c13e-4869-af77-345bb817dfd9" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_b9bdfc22-91f0-4f15-939b-0fcef2ec8493" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_77bd4399-cb14-4046-9074-334c1efb57bf" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_076e1826-c13e-4869-af77-345bb817dfd9" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_77bd4399-cb14-4046-9074-334c1efb57bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_788fa5f5-150a-415d-beec-6687d6109693" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_076e1826-c13e-4869-af77-345bb817dfd9" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_788fa5f5-150a-415d-beec-6687d6109693" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_83dac2ec-5a79-4494-809b-5a1456ffa8a2" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_076e1826-c13e-4869-af77-345bb817dfd9" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_83dac2ec-5a79-4494-809b-5a1456ffa8a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_edc29516-5f35-4a81-a7bf-a64ef5e2689e" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_82779318-0425-4f78-b53c-4f1a138b7bdb" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_edc29516-5f35-4a81-a7bf-a64ef5e2689e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_0e5fcd49-129d-45a3-9f63-139b6d871dda" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f02a30e4-2d83-4f2c-a397-a62a04b55d01" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_0e5fcd49-129d-45a3-9f63-139b6d871dda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_0b3331bb-d216-41d7-b3de-3f8a0cc7bf8b" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_0e5fcd49-129d-45a3-9f63-139b6d871dda" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_0b3331bb-d216-41d7-b3de-3f8a0cc7bf8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_a17fed5c-b7a1-42d6-a531-165f0da4c8a5" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_0e5fcd49-129d-45a3-9f63-139b6d871dda" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_a17fed5c-b7a1-42d6-a531-165f0da4c8a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments_3fc52584-b024-4468-84e3-0ff09c1b9c35" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_0e5fcd49-129d-45a3-9f63-139b6d871dda" xlink:to="loc_us-gaap_PaymentsToAcquireInvestments_3fc52584-b024-4468-84e3-0ff09c1b9c35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_e1ee10ed-28f3-4c9f-904b-8a6a6b192867" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_0e5fcd49-129d-45a3-9f63-139b6d871dda" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_e1ee10ed-28f3-4c9f-904b-8a6a6b192867" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_08488814-3ff6-4968-a923-cca49be56732" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f02a30e4-2d83-4f2c-a397-a62a04b55d01" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_08488814-3ff6-4968-a923-cca49be56732" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_fbea9e19-4a9e-49ed-8c8d-31b8fd4bb060" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_08488814-3ff6-4968-a923-cca49be56732" xlink:to="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_fbea9e19-4a9e-49ed-8c8d-31b8fd4bb060" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_87cd3295-45b6-4262-930c-4166aca18ef0" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_08488814-3ff6-4968-a923-cca49be56732" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_87cd3295-45b6-4262-930c-4166aca18ef0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_ba7a8094-ee92-42b9-910a-00e2a1215560" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_08488814-3ff6-4968-a923-cca49be56732" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_ba7a8094-ee92-42b9-910a-00e2a1215560" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromWarrantExercises_c50c4c4e-baab-4689-91e5-4c7cc7633ff4" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromWarrantExercises"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_08488814-3ff6-4968-a923-cca49be56732" xlink:to="loc_us-gaap_ProceedsFromWarrantExercises_c50c4c4e-baab-4689-91e5-4c7cc7633ff4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMinorityShareholders_3ff881b6-52e1-43a3-bf03-4e95f712833c" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromMinorityShareholders"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_08488814-3ff6-4968-a923-cca49be56732" xlink:to="loc_us-gaap_ProceedsFromMinorityShareholders_3ff881b6-52e1-43a3-bf03-4e95f712833c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_71cae9bf-6630-4350-9581-22eb7016d561" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_08488814-3ff6-4968-a923-cca49be56732" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_71cae9bf-6630-4350-9581-22eb7016d561" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_6a897d19-a7e6-40a0-8ed5-5f831fe7ff6c" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f02a30e4-2d83-4f2c-a397-a62a04b55d01" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_6a897d19-a7e6-40a0-8ed5-5f831fe7ff6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4e1f5809-d4f9-4bb9-9101-2c014e6ac7c7" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f02a30e4-2d83-4f2c-a397-a62a04b55d01" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4e1f5809-d4f9-4bb9-9101-2c014e6ac7c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4dbaadd8-2483-46a9-9df8-5cf356ad1bd2" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f02a30e4-2d83-4f2c-a397-a62a04b55d01" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4dbaadd8-2483-46a9-9df8-5cf356ad1bd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_e505619a-6fdc-4479-8c06-a42f7ffb8fa2" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f02a30e4-2d83-4f2c-a397-a62a04b55d01" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_e505619a-6fdc-4479-8c06-a42f7ffb8fa2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_cb63e966-309c-44e6-915c-c1537c04c62d" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_e505619a-6fdc-4479-8c06-a42f7ffb8fa2" xlink:to="loc_us-gaap_InterestPaidNet_cb63e966-309c-44e6-915c-c1537c04c62d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_16c49039-baab-4f9c-bc0e-fb59365af1f3" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f02a30e4-2d83-4f2c-a397-a62a04b55d01" xlink:to="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_16c49039-baab-4f9c-bc0e-fb59365af1f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_0696f8b5-5aaa-499f-97b8-e2541a2a9377" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_16c49039-baab-4f9c-bc0e-fb59365af1f3" xlink:to="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_0696f8b5-5aaa-499f-97b8-e2541a2a9377" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForTenantImprovements_85ae9961-9c82-4d34-a49a-cb121a0bc620" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsForTenantImprovements"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_16c49039-baab-4f9c-bc0e-fb59365af1f3" xlink:to="loc_us-gaap_PaymentsForTenantImprovements_85ae9961-9c82-4d34-a49a-cb121a0bc620" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_StockIssuanceCostsIncurredButNotYetPaid_e3c0b14f-679c-43e1-bc84-f02cb1e2cc72" xlink:href="silk-20191231.xsd#silk_StockIssuanceCostsIncurredButNotYetPaid"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_16c49039-baab-4f9c-bc0e-fb59365af1f3" xlink:to="loc_silk_StockIssuanceCostsIncurredButNotYetPaid_e3c0b14f-679c-43e1-bc84-f02cb1e2cc72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_ce9c1066-86ad-45f7-8cd4-3ab7157497f3" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_16c49039-baab-4f9c-bc0e-fb59365af1f3" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_ce9c1066-86ad-45f7-8cd4-3ab7157497f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockAmountIssued1_f5796c00-7dbf-4c75-b8e8-627394bd1198" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConversionOfStockAmountIssued1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_16c49039-baab-4f9c-bc0e-fb59365af1f3" xlink:to="loc_us-gaap_ConversionOfStockAmountIssued1_f5796c00-7dbf-4c75-b8e8-627394bd1198" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockAmountConverted1_2629988e-d46a-4c40-99f6-6dcfcabf7fad" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConversionOfStockAmountConverted1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_16c49039-baab-4f9c-bc0e-fb59365af1f3" xlink:to="loc_us-gaap_ConversionOfStockAmountConverted1_2629988e-d46a-4c40-99f6-6dcfcabf7fad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/FormationandBusinessoftheCompany" xlink:type="simple" xlink:href="silk-20191231.xsd#FormationandBusinessoftheCompany"/>
  <link:presentationLink xlink:role="http://silkroadmed.com/role/FormationandBusinessoftheCompany" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_dd71f131-3fa2-4b5e-83ca-c3847424509d" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_dccf3e08-3f9e-459a-b2d3-f211d3c008d2" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_dd71f131-3fa2-4b5e-83ca-c3847424509d" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_dccf3e08-3f9e-459a-b2d3-f211d3c008d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/FormationandBusinessoftheCompanyDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#FormationandBusinessoftheCompanyDetails"/>
  <link:presentationLink xlink:role="http://silkroadmed.com/role/FormationandBusinessoftheCompanyDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_810d0452-6725-46a5-9a5f-cdfd6e5e7ad9" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_30ea0bdd-01a2-4f32-8526-df74ef765214" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsequentEventTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_810d0452-6725-46a5-9a5f-cdfd6e5e7ad9" xlink:to="loc_us-gaap_SubsequentEventTable_30ea0bdd-01a2-4f32-8526-df74ef765214" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_524de0e7-4155-414d-b78e-b013272501db" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_30ea0bdd-01a2-4f32-8526-df74ef765214" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_524de0e7-4155-414d-b78e-b013272501db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_7f569505-856f-47fe-937e-9f40d8684c36" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_524de0e7-4155-414d-b78e-b013272501db" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_7f569505-856f-47fe-937e-9f40d8684c36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IPOMember_eee174db-06e8-484b-b8f1-9bdfed79183c" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IPOMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_7f569505-856f-47fe-937e-9f40d8684c36" xlink:to="loc_us-gaap_IPOMember_eee174db-06e8-484b-b8f1-9bdfed79183c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_IPOUnderwritingDiscountsAndCommissionsMember_68f6658c-dca6-45b3-9bca-dc2108755e6a" xlink:href="silk-20191231.xsd#silk_IPOUnderwritingDiscountsAndCommissionsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_7f569505-856f-47fe-937e-9f40d8684c36" xlink:to="loc_silk_IPOUnderwritingDiscountsAndCommissionsMember_68f6658c-dca6-45b3-9bca-dc2108755e6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_IPOOtherExpensesMember_700e1a45-651c-448f-864d-a8a8c43796f7" xlink:href="silk-20191231.xsd#silk_IPOOtherExpensesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_7f569505-856f-47fe-937e-9f40d8684c36" xlink:to="loc_silk_IPOOtherExpensesMember_700e1a45-651c-448f-864d-a8a8c43796f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_SecondPublicOfferingMember_5dac737d-8872-40e3-93f4-cdf3ec1acbf3" xlink:href="silk-20191231.xsd#silk_SecondPublicOfferingMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_7f569505-856f-47fe-937e-9f40d8684c36" xlink:to="loc_silk_SecondPublicOfferingMember_5dac737d-8872-40e3-93f4-cdf3ec1acbf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OverAllotmentOptionMember_fcbc2c9a-6007-4640-ae6e-5391ce3244c5" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OverAllotmentOptionMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_7f569505-856f-47fe-937e-9f40d8684c36" xlink:to="loc_us-gaap_OverAllotmentOptionMember_fcbc2c9a-6007-4640-ae6e-5391ce3244c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_195d92bb-8da4-4f09-b392-192c3140ab9d" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_30ea0bdd-01a2-4f32-8526-df74ef765214" xlink:to="loc_us-gaap_SubsequentEventLineItems_195d92bb-8da4-4f09-b392-192c3140ab9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_c048dc4b-9684-48f8-93ec-4960d588ecb9" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_195d92bb-8da4-4f09-b392-192c3140ab9d" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_c048dc4b-9684-48f8-93ec-4960d588ecb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_28bad84d-204b-4d00-8d9a-f42939288dd2" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_195d92bb-8da4-4f09-b392-192c3140ab9d" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_28bad84d-204b-4d00-8d9a-f42939288dd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_db145a56-88ba-4a84-aaa4-06cc71b82017" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_195d92bb-8da4-4f09-b392-192c3140ab9d" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_db145a56-88ba-4a84-aaa4-06cc71b82017" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_25c4087a-dc08-49f0-b6b4-d1254cb0e65a" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_195d92bb-8da4-4f09-b392-192c3140ab9d" xlink:to="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_25c4087a-dc08-49f0-b6b4-d1254cb0e65a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_601c91ea-c535-4a36-8236-9c47116cf7e8" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_195d92bb-8da4-4f09-b392-192c3140ab9d" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_601c91ea-c535-4a36-8236-9c47116cf7e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_534471a6-762b-43fc-ae5f-229e8166f34c" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_195d92bb-8da4-4f09-b392-192c3140ab9d" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_534471a6-762b-43fc-ae5f-229e8166f34c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_edf82f2c-f043-4fc7-8419-9289f07c1959" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_195d92bb-8da4-4f09-b392-192c3140ab9d" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_edf82f2c-f043-4fc7-8419-9289f07c1959" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_78b8bf52-be6f-43d2-b230-f9879d24572b" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_195d92bb-8da4-4f09-b392-192c3140ab9d" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_78b8bf52-be6f-43d2-b230-f9879d24572b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_efdd1b62-3ae0-4b34-9591-ee7c4a52c3ae" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_195d92bb-8da4-4f09-b392-192c3140ab9d" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_efdd1b62-3ae0-4b34-9591-ee7c4a52c3ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/SummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="silk-20191231.xsd#SummaryofSignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://silkroadmed.com/role/SummaryofSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_983a1f43-f437-4354-86e1-6923b23bdbe5" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_9511ba7f-7c43-4771-b3c8-2d35417b56db" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_983a1f43-f437-4354-86e1-6923b23bdbe5" xlink:to="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_9511ba7f-7c43-4771-b3c8-2d35417b56db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="silk-20191231.xsd#SummaryofSignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_cb4b7fbf-78ad-45ef-ae48-dd34795a25ad" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_b7a4a83a-ec2f-42b4-934b-0da23043322a" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_cb4b7fbf-78ad-45ef-ae48-dd34795a25ad" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_b7a4a83a-ec2f-42b4-934b-0da23043322a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_896575e6-6db8-4da0-bdab-c9b8976e47a6" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_cb4b7fbf-78ad-45ef-ae48-dd34795a25ad" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_896575e6-6db8-4da0-bdab-c9b8976e47a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_6a90e0c5-4319-4bf5-b857-de2a74e05cc0" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_cb4b7fbf-78ad-45ef-ae48-dd34795a25ad" xlink:to="loc_us-gaap_UseOfEstimates_6a90e0c5-4319-4bf5-b857-de2a74e05cc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_26a2b3b3-7aed-42fe-811c-efb7763b16e4" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_cb4b7fbf-78ad-45ef-ae48-dd34795a25ad" xlink:to="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_26a2b3b3-7aed-42fe-811c-efb7763b16e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_0211956d-083d-4e6d-88f7-425331d75f11" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_cb4b7fbf-78ad-45ef-ae48-dd34795a25ad" xlink:to="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_0211956d-083d-4e6d-88f7-425331d75f11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk_1659ab85-915f-4572-81dd-5d6f991b0170" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_cb4b7fbf-78ad-45ef-ae48-dd34795a25ad" xlink:to="loc_us-gaap_ConcentrationRiskCreditRisk_1659ab85-915f-4572-81dd-5d6f991b0170" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeAndOtherAccountsReceivablePolicy_14875451-f3aa-4917-8409-5f2fac3ec2fd" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_cb4b7fbf-78ad-45ef-ae48-dd34795a25ad" xlink:to="loc_us-gaap_TradeAndOtherAccountsReceivablePolicy_14875451-f3aa-4917-8409-5f2fac3ec2fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock_3fecf5f2-d2cc-4dbc-97c0-365589362d10" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_cb4b7fbf-78ad-45ef-ae48-dd34795a25ad" xlink:to="loc_us-gaap_InventoryPolicyTextBlock_3fecf5f2-d2cc-4dbc-97c0-365589362d10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_66577c88-86cf-40a4-acd3-5bfbd4bf94e1" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_cb4b7fbf-78ad-45ef-ae48-dd34795a25ad" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_66577c88-86cf-40a4-acd3-5bfbd4bf94e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredChargesPolicyTextBlock_6a49b615-da32-4a49-ad26-5661098c6a70" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredChargesPolicyTextBlock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_cb4b7fbf-78ad-45ef-ae48-dd34795a25ad" xlink:to="loc_us-gaap_DeferredChargesPolicyTextBlock_6a49b615-da32-4a49-ad26-5661098c6a70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_3fb08fc6-32a0-4f5a-be2f-931ab615448b" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_cb4b7fbf-78ad-45ef-ae48-dd34795a25ad" xlink:to="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_3fb08fc6-32a0-4f5a-be2f-931ab615448b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock_2c9bc010-ceed-455e-83ab-10ce9fc6df3e" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_cb4b7fbf-78ad-45ef-ae48-dd34795a25ad" xlink:to="loc_us-gaap_LesseeLeasesPolicyTextBlock_2c9bc010-ceed-455e-83ab-10ce9fc6df3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_WarrantsClassifiedAsLiabilitiesPolicyTextBlock_22f262d5-d581-4f50-a668-91ff9047f646" xlink:href="silk-20191231.xsd#silk_WarrantsClassifiedAsLiabilitiesPolicyTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_cb4b7fbf-78ad-45ef-ae48-dd34795a25ad" xlink:to="loc_silk_WarrantsClassifiedAsLiabilitiesPolicyTextBlock_22f262d5-d581-4f50-a668-91ff9047f646" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteRedeemablePreferredStockIssuePolicy_2b85744d-9f18-4b71-a864-4861a7d85f5c" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquityNoteRedeemablePreferredStockIssuePolicy"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_cb4b7fbf-78ad-45ef-ae48-dd34795a25ad" xlink:to="loc_us-gaap_StockholdersEquityNoteRedeemablePreferredStockIssuePolicy_2b85744d-9f18-4b71-a864-4861a7d85f5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_b67f9f41-b667-4b66-ab44-8cb28e70c3bb" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_cb4b7fbf-78ad-45ef-ae48-dd34795a25ad" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_b67f9f41-b667-4b66-ab44-8cb28e70c3bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_68ff2811-202f-40a4-bb7b-2d758e11fc83" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_cb4b7fbf-78ad-45ef-ae48-dd34795a25ad" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_68ff2811-202f-40a4-bb7b-2d758e11fc83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingCostsPolicyTextBlock_9fe7a5f5-d234-4a62-8da0-41a5e020137c" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdvertisingCostsPolicyTextBlock"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_cb4b7fbf-78ad-45ef-ae48-dd34795a25ad" xlink:to="loc_us-gaap_AdvertisingCostsPolicyTextBlock_9fe7a5f5-d234-4a62-8da0-41a5e020137c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_c74a4505-9f62-4333-86fd-2dd7937ddf08" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_cb4b7fbf-78ad-45ef-ae48-dd34795a25ad" xlink:to="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_c74a4505-9f62-4333-86fd-2dd7937ddf08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_dc1b3f69-0c48-4e2f-8966-4f8513548919" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_cb4b7fbf-78ad-45ef-ae48-dd34795a25ad" xlink:to="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_dc1b3f69-0c48-4e2f-8966-4f8513548919" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_e160111e-ead7-4bf6-b9f6-ecd6ff9a799e" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_cb4b7fbf-78ad-45ef-ae48-dd34795a25ad" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_e160111e-ead7-4bf6-b9f6-ecd6ff9a799e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_e1a78888-9501-4ab1-a50b-1e612acd1fc5" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_cb4b7fbf-78ad-45ef-ae48-dd34795a25ad" xlink:to="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_e1a78888-9501-4ab1-a50b-1e612acd1fc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_9e9adfdf-f568-4130-aa9e-46405fb09cfd" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_cb4b7fbf-78ad-45ef-ae48-dd34795a25ad" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_9e9adfdf-f568-4130-aa9e-46405fb09cfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_f50e8556-064e-45fe-8b0d-4240b6c6f09c" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_cb4b7fbf-78ad-45ef-ae48-dd34795a25ad" xlink:to="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_f50e8556-064e-45fe-8b0d-4240b6c6f09c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_6ed4f7c5-02ae-41b3-88be-3d95c00c0b0e" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_cb4b7fbf-78ad-45ef-ae48-dd34795a25ad" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_6ed4f7c5-02ae-41b3-88be-3d95c00c0b0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="silk-20191231.xsd#SummaryofSignificantAccountingPoliciesTables"/>
  <link:presentationLink xlink:role="http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_a6aafdeb-d838-4509-aeaa-abcbf378dd90" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_751ea69d-3a60-44a4-9f98-602a94940c11" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a6aafdeb-d838-4509-aeaa-abcbf378dd90" xlink:to="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_751ea69d-3a60-44a4-9f98-602a94940c11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_c4129d23-2600-432d-85ab-3785dd822ad3" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a6aafdeb-d838-4509-aeaa-abcbf378dd90" xlink:to="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_c4129d23-2600-432d-85ab-3785dd822ad3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_AssetsAndLiabilitiesLesseeTableTextBlock_097c8b81-a339-4250-8c4a-6e59898706e8" xlink:href="silk-20191231.xsd#silk_AssetsAndLiabilitiesLesseeTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a6aafdeb-d838-4509-aeaa-abcbf378dd90" xlink:to="loc_silk_AssetsAndLiabilitiesLesseeTableTextBlock_097c8b81-a339-4250-8c4a-6e59898706e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_e2332da9-09b9-45e2-aa3c-88b647d19ff4" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a6aafdeb-d838-4509-aeaa-abcbf378dd90" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_e2332da9-09b9-45e2-aa3c-88b647d19ff4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_2dc64ed1-f3f8-4149-b651-97ca690a087a" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a6aafdeb-d838-4509-aeaa-abcbf378dd90" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_2dc64ed1-f3f8-4149-b651-97ca690a087a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesAdjustmenttoPriorPeriodFinancialStatementsDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#SummaryofSignificantAccountingPoliciesAdjustmenttoPriorPeriodFinancialStatementsDetails"/>
  <link:presentationLink xlink:role="http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesAdjustmenttoPriorPeriodFinancialStatementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_7db97e81-0874-4ddf-a8eb-75651e6f3eef" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_ac76c971-9a7c-457a-aaf9-e3693c6b784f" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_7db97e81-0874-4ddf-a8eb-75651e6f3eef" xlink:to="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_ac76c971-9a7c-457a-aaf9-e3693c6b784f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis_04bdf8e7-38a0-4d47-964b-f651ae8a92fe" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RestatementAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_ac76c971-9a7c-457a-aaf9-e3693c6b784f" xlink:to="loc_srt_RestatementAxis_04bdf8e7-38a0-4d47-964b-f651ae8a92fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_e825d56f-d44f-414b-9616-9665188a8dd9" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RestatementDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementAxis_04bdf8e7-38a0-4d47-964b-f651ae8a92fe" xlink:to="loc_srt_RestatementDomain_e825d56f-d44f-414b-9616-9665188a8dd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAdjustmentMember_6e8b3f67-db74-424b-85cd-98c4cfa06196" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RestatementAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementDomain_e825d56f-d44f-414b-9616-9665188a8dd9" xlink:to="loc_srt_RestatementAdjustmentMember_6e8b3f67-db74-424b-85cd-98c4cfa06196" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis_5d9598c5-fc1d-46cd-9da2-7a8cb0e463ac" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_ac76c971-9a7c-457a-aaf9-e3693c6b784f" xlink:to="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis_5d9598c5-fc1d-46cd-9da2-7a8cb0e463ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForErrorCorrectionDomain_8e731fd5-4175-45d7-9ae8-a997ab744ebd" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdjustmentsForErrorCorrectionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis_5d9598c5-fc1d-46cd-9da2-7a8cb0e463ac" xlink:to="loc_us-gaap_AdjustmentsForErrorCorrectionDomain_8e731fd5-4175-45d7-9ae8-a997ab744ebd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_CorrectionOfProvisionsForReturnsFromCustomersMember_57dfd3e5-4dd0-4a46-a211-f892265ff7d3" xlink:href="silk-20191231.xsd#silk_CorrectionOfProvisionsForReturnsFromCustomersMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForErrorCorrectionDomain_8e731fd5-4175-45d7-9ae8-a997ab744ebd" xlink:to="loc_silk_CorrectionOfProvisionsForReturnsFromCustomersMember_57dfd3e5-4dd0-4a46-a211-f892265ff7d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_e71e80ed-47aa-4964-a011-7e5be524b423" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_ac76c971-9a7c-457a-aaf9-e3693c6b784f" xlink:to="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_e71e80ed-47aa-4964-a011-7e5be524b423" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_cd613b36-637e-4831-875c-06d09131bcfc" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_e71e80ed-47aa-4964-a011-7e5be524b423" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_cd613b36-637e-4831-875c-06d09131bcfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesCashCashEquivalentsandRestrictedCashDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#SummaryofSignificantAccountingPoliciesCashCashEquivalentsandRestrictedCashDetails"/>
  <link:presentationLink xlink:role="http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesCashCashEquivalentsandRestrictedCashDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_3c8d4163-e98f-42c1-8761-9fd949544190" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable_ef893162-1bdd-46c9-9b86-0a46da1513ab" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3c8d4163-e98f-42c1-8761-9fd949544190" xlink:to="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable_ef893162-1bdd-46c9-9b86-0a46da1513ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis_cca5adb7-5485-4100-81a1-5502f2b1396a" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable_ef893162-1bdd-46c9-9b86-0a46da1513ab" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis_cca5adb7-5485-4100-81a1-5502f2b1396a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_bf64ceef-1e7b-4532-b32f-7083e17ed33c" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis_cca5adb7-5485-4100-81a1-5502f2b1396a" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_bf64ceef-1e7b-4532-b32f-7083e17ed33c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_86ab006c-0719-40de-98f6-c4e71b73bf27" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LetterOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_bf64ceef-1e7b-4532-b32f-7083e17ed33c" xlink:to="loc_us-gaap_LetterOfCreditMember_86ab006c-0719-40de-98f6-c4e71b73bf27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems_ae7a31ff-800f-4f7c-a12a-aaf753dc199b" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable_ef893162-1bdd-46c9-9b86-0a46da1513ab" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems_ae7a31ff-800f-4f7c-a12a-aaf753dc199b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_31ee8c69-8302-411a-b614-e6c9b3e0e992" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems_ae7a31ff-800f-4f7c-a12a-aaf753dc199b" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_31ee8c69-8302-411a-b614-e6c9b3e0e992" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_bac6af62-cdd1-44ab-b815-aa1718631a3c" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems_ae7a31ff-800f-4f7c-a12a-aaf753dc199b" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_bac6af62-cdd1-44ab-b815-aa1718631a3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_8408b515-7b4b-47db-a80a-27ae39684a50" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems_ae7a31ff-800f-4f7c-a12a-aaf753dc199b" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_8408b515-7b4b-47db-a80a-27ae39684a50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails"/>
  <link:presentationLink xlink:role="http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_1903f1bc-8259-4181-8ed4-56ff9a67ee55" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_ca7472cf-e3cd-4ef2-be68-4ea0fb37cf7e" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1903f1bc-8259-4181-8ed4-56ff9a67ee55" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_ca7472cf-e3cd-4ef2-be68-4ea0fb37cf7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_51db8746-e2b6-4772-8249-2b76d5b09fef" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_ca7472cf-e3cd-4ef2-be68-4ea0fb37cf7e" xlink:to="loc_srt_RangeAxis_51db8746-e2b6-4772-8249-2b76d5b09fef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_26f43eb3-ff18-41ab-9d94-b190c3bed8d0" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_51db8746-e2b6-4772-8249-2b76d5b09fef" xlink:to="loc_srt_RangeMember_26f43eb3-ff18-41ab-9d94-b190c3bed8d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_010d4af4-588d-4856-99f5-9a0f2f32f327" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_26f43eb3-ff18-41ab-9d94-b190c3bed8d0" xlink:to="loc_srt_MinimumMember_010d4af4-588d-4856-99f5-9a0f2f32f327" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_365d793b-2881-4db2-bdb5-6457b39df045" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_26f43eb3-ff18-41ab-9d94-b190c3bed8d0" xlink:to="loc_srt_MaximumMember_365d793b-2881-4db2-bdb5-6457b39df045" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c7ca1230-1351-4188-b926-ccc9148ee86c" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_ca7472cf-e3cd-4ef2-be68-4ea0fb37cf7e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c7ca1230-1351-4188-b926-ccc9148ee86c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_e8d465ac-78d7-4746-8cc1-c3bfc3da2e51" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c7ca1230-1351-4188-b926-ccc9148ee86c" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_e8d465ac-78d7-4746-8cc1-c3bfc3da2e51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesDeferredInitialPublicOfferingCostsDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#SummaryofSignificantAccountingPoliciesDeferredInitialPublicOfferingCostsDetails"/>
  <link:presentationLink xlink:role="http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesDeferredInitialPublicOfferingCostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_38dba0eb-02bc-40ed-a807-ad7e32f2f374" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredOfferingCosts_523b17e8-83a9-4369-908b-00e6dace2844" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredOfferingCosts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_38dba0eb-02bc-40ed-a807-ad7e32f2f374" xlink:to="loc_us-gaap_DeferredOfferingCosts_523b17e8-83a9-4369-908b-00e6dace2844" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_5fa89969-2e4c-4c37-ab1e-ec5238a94237" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_38dba0eb-02bc-40ed-a807-ad7e32f2f374" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_5fa89969-2e4c-4c37-ab1e-ec5238a94237" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesLeasesDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#SummaryofSignificantAccountingPoliciesLeasesDetails"/>
  <link:presentationLink xlink:role="http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesLeasesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_cb1965bb-f5a4-4c0e-966a-e6dc1e2530be" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_cadcc409-3565-4d89-8345-fc4742fa0769" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_cb1965bb-f5a4-4c0e-966a-e6dc1e2530be" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_cadcc409-3565-4d89-8345-fc4742fa0769" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_ae480e48-abac-4807-a053-925d0f63583e" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_cadcc409-3565-4d89-8345-fc4742fa0769" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_ae480e48-abac-4807-a053-925d0f63583e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_31dbb4ba-ab88-4658-b610-85d8b52856fe" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_ae480e48-abac-4807-a053-925d0f63583e" xlink:to="loc_us-gaap_TypeOfAdoptionMember_31dbb4ba-ab88-4658-b610-85d8b52856fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201602Member_7255d29b-4e01-4dfe-9851-5e755e37f1ed" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountingStandardsUpdate201602Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfAdoptionMember_31dbb4ba-ab88-4658-b610-85d8b52856fe" xlink:to="loc_us-gaap_AccountingStandardsUpdate201602Member_7255d29b-4e01-4dfe-9851-5e755e37f1ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_529a6b34-c9e4-4d51-bde9-6f87abb8818d" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_cadcc409-3565-4d89-8345-fc4742fa0769" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_529a6b34-c9e4-4d51-bde9-6f87abb8818d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_287c5e32-5a18-44a3-881c-4da4a101d82d" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_529a6b34-c9e4-4d51-bde9-6f87abb8818d" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_287c5e32-5a18-44a3-881c-4da4a101d82d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_f3750807-e3fe-47f1-9690-8b60938b39d9" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_529a6b34-c9e4-4d51-bde9-6f87abb8818d" xlink:to="loc_us-gaap_OperatingLeaseLiability_f3750807-e3fe-47f1-9690-8b60938b39d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesASC842ImpactonCondensedConsolidatedBalanceSheetDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#SummaryofSignificantAccountingPoliciesASC842ImpactonCondensedConsolidatedBalanceSheetDetails"/>
  <link:presentationLink xlink:role="http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesASC842ImpactonCondensedConsolidatedBalanceSheetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_6fc6e0ee-4999-45e3-859c-b5e229bcfad7" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_6ff977d2-ab40-41ac-b97e-3bf0f3ba5558" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6fc6e0ee-4999-45e3-859c-b5e229bcfad7" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_6ff977d2-ab40-41ac-b97e-3bf0f3ba5558" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis_cd36e127-000d-42db-a0cb-e441dd206a74" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RestatementAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_6ff977d2-ab40-41ac-b97e-3bf0f3ba5558" xlink:to="loc_srt_RestatementAxis_cd36e127-000d-42db-a0cb-e441dd206a74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_87a4e22e-805f-461b-a3a5-1416fed61a13" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RestatementDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementAxis_cd36e127-000d-42db-a0cb-e441dd206a74" xlink:to="loc_srt_RestatementDomain_87a4e22e-805f-461b-a3a5-1416fed61a13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioPreviouslyReportedMember_5959bd86-3083-427f-9a57-663e08a09051" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementDomain_87a4e22e-805f-461b-a3a5-1416fed61a13" xlink:to="loc_srt_ScenarioPreviouslyReportedMember_5959bd86-3083-427f-9a57-663e08a09051" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAdjustmentMember_6c76ee13-e794-4d87-9321-751883f83a34" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RestatementAdjustmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementDomain_87a4e22e-805f-461b-a3a5-1416fed61a13" xlink:to="loc_srt_RestatementAdjustmentMember_6c76ee13-e794-4d87-9321-751883f83a34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_88696028-9721-47a5-a03b-f9b59be1c5b0" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_6ff977d2-ab40-41ac-b97e-3bf0f3ba5558" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_88696028-9721-47a5-a03b-f9b59be1c5b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_064290f5-9a90-4ac9-a59f-025dfb92a50b" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_88696028-9721-47a5-a03b-f9b59be1c5b0" xlink:to="loc_us-gaap_TypeOfAdoptionMember_064290f5-9a90-4ac9-a59f-025dfb92a50b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201602Member_50ea127f-1683-4a64-b26d-91b4acababe1" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountingStandardsUpdate201602Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfAdoptionMember_064290f5-9a90-4ac9-a59f-025dfb92a50b" xlink:to="loc_us-gaap_AccountingStandardsUpdate201602Member_50ea127f-1683-4a64-b26d-91b4acababe1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_53c35cbc-3934-412c-9afd-9d4480fa7b42" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_6ff977d2-ab40-41ac-b97e-3bf0f3ba5558" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_53c35cbc-3934-412c-9afd-9d4480fa7b42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_03a2b387-65dc-46c2-bcb0-9db82ab5c781" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_53c35cbc-3934-412c-9afd-9d4480fa7b42" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_03a2b387-65dc-46c2-bcb0-9db82ab5c781" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_0762e853-ec72-48f4-a564-da07d9807f35" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_53c35cbc-3934-412c-9afd-9d4480fa7b42" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_0762e853-ec72-48f4-a564-da07d9807f35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_b32bc76b-4516-4773-8c28-a1f62e2287af" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_53c35cbc-3934-412c-9afd-9d4480fa7b42" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_b32bc76b-4516-4773-8c28-a1f62e2287af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesRedeemableConvertiblePreferredStockDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#SummaryofSignificantAccountingPoliciesRedeemableConvertiblePreferredStockDetails"/>
  <link:presentationLink xlink:role="http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesRedeemableConvertiblePreferredStockDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_bbe92711-6a34-4513-81cf-032455efcba9" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_f74ba437-3106-4360-8472-f553f4387678" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_bbe92711-6a34-4513-81cf-032455efcba9" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_f74ba437-3106-4360-8472-f553f4387678" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_11157405-74c9-4cab-9dac-44f24a53725d" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_f74ba437-3106-4360-8472-f553f4387678" xlink:to="loc_us-gaap_StatementClassOfStockAxis_11157405-74c9-4cab-9dac-44f24a53725d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_0e7374ac-22d1-4c59-9675-63c1047c21a9" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_11157405-74c9-4cab-9dac-44f24a53725d" xlink:to="loc_us-gaap_ClassOfStockDomain_0e7374ac-22d1-4c59-9675-63c1047c21a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_c66c3307-4ce1-4815-9245-5a43f16d9ee5" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_0e7374ac-22d1-4c59-9675-63c1047c21a9" xlink:to="loc_us-gaap_CommonStockMember_c66c3307-4ce1-4815-9245-5a43f16d9ee5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_167978eb-bcf0-4a6a-97d9-2c01013f008f" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_f74ba437-3106-4360-8472-f553f4387678" xlink:to="loc_us-gaap_ClassOfStockLineItems_167978eb-bcf0-4a6a-97d9-2c01013f008f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits_4fca4044-72b7-4f3e-8bfb-bb5637e0b639" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_167978eb-bcf0-4a6a-97d9-2c01013f008f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits_4fca4044-72b7-4f3e-8bfb-bb5637e0b639" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfUnits_dcafa0b3-720f-42c0-9159-fd01fdf4bf5d" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfUnits"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_167978eb-bcf0-4a6a-97d9-2c01013f008f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfUnits_dcafa0b3-720f-42c0-9159-fd01fdf4bf5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesRevenueRecognitionDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#SummaryofSignificantAccountingPoliciesRevenueRecognitionDetails"/>
  <link:presentationLink xlink:role="http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesRevenueRecognitionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_d09d05da-72d9-4776-a02d-2b682799d02b" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnbilledReceivablesCurrent_ac5ac461-cf5d-4605-83d7-528f08cb27ab" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_UnbilledReceivablesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d09d05da-72d9-4776-a02d-2b682799d02b" xlink:to="loc_us-gaap_UnbilledReceivablesCurrent_ac5ac461-cf5d-4605-83d7-528f08cb27ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesAdvertisingCostsDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#SummaryofSignificantAccountingPoliciesAdvertisingCostsDetails"/>
  <link:presentationLink xlink:role="http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesAdvertisingCostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_cdc402b7-d681-4d0c-b8d5-cd90b9f2bd82" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingExpense_7cbe8d5a-4fe1-4711-8078-164c53731c20" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdvertisingExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_cdc402b7-d681-4d0c-b8d5-cd90b9f2bd82" xlink:to="loc_us-gaap_AdvertisingExpense_7cbe8d5a-4fe1-4711-8078-164c53731c20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesStockBasedCompensationDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#SummaryofSignificantAccountingPoliciesStockBasedCompensationDetails"/>
  <link:presentationLink xlink:role="http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesStockBasedCompensationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_990a2ffc-c12b-4dac-85a5-5dce20344fbe" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_5dcb7a3a-9a29-4eca-b60e-8e475ba5b031" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_990a2ffc-c12b-4dac-85a5-5dce20344fbe" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_5dcb7a3a-9a29-4eca-b60e-8e475ba5b031" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_179363b2-7efb-44df-86ee-9f2724750c6e" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_5dcb7a3a-9a29-4eca-b60e-8e475ba5b031" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_179363b2-7efb-44df-86ee-9f2724750c6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_cc177794-ea22-40f9-95ed-a667bfd987bb" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_179363b2-7efb-44df-86ee-9f2724750c6e" xlink:to="loc_us-gaap_EquityComponentDomain_cc177794-ea22-40f9-95ed-a667bfd987bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_565be127-34b9-4ed2-b9b5-d26c1c404038" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_cc177794-ea22-40f9-95ed-a667bfd987bb" xlink:to="loc_us-gaap_RetainedEarningsMember_565be127-34b9-4ed2-b9b5-d26c1c404038" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_f5eda7bb-1be4-4df2-98ca-65fbb65076a5" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_5dcb7a3a-9a29-4eca-b60e-8e475ba5b031" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_f5eda7bb-1be4-4df2-98ca-65fbb65076a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_0f9d419b-bf5a-4514-89ef-e1e9c49ebeb6" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_f5eda7bb-1be4-4df2-98ca-65fbb65076a5" xlink:to="loc_us-gaap_TypeOfAdoptionMember_0f9d419b-bf5a-4514-89ef-e1e9c49ebeb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201609Member_cb109221-87d3-410e-9018-07112b558fff" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountingStandardsUpdate201609Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfAdoptionMember_0f9d419b-bf5a-4514-89ef-e1e9c49ebeb6" xlink:to="loc_us-gaap_AccountingStandardsUpdate201609Member_cb109221-87d3-410e-9018-07112b558fff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_42c3367a-7506-4dbe-a545-e6446b38251b" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_5dcb7a3a-9a29-4eca-b60e-8e475ba5b031" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_42c3367a-7506-4dbe-a545-e6446b38251b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption_474a5b65-245d-474e-82cb-ce5c35a43ef4" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_42c3367a-7506-4dbe-a545-e6446b38251b" xlink:to="loc_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption_474a5b65-245d-474e-82cb-ce5c35a43ef4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesScheduleofEarningsPerShareDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#SummaryofSignificantAccountingPoliciesScheduleofEarningsPerShareDetails"/>
  <link:presentationLink xlink:role="http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesScheduleofEarningsPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_caf539aa-df13-48e8-a1a5-9aefa98f129a" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_0c42d6dd-cb48-4cab-979e-e8578daa5db6" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_caf539aa-df13-48e8-a1a5-9aefa98f129a" xlink:to="loc_us-gaap_NetIncomeLoss_0c42d6dd-cb48-4cab-979e-e8578daa5db6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_04fd0f5a-f69d-428f-af8e-2f068d801c04" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_caf539aa-df13-48e8-a1a5-9aefa98f129a" xlink:to="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_04fd0f5a-f69d-428f-af8e-2f068d801c04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDiluted_05f9be26-e584-456f-a854-87f9e2e2d022" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_caf539aa-df13-48e8-a1a5-9aefa98f129a" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDiluted_05f9be26-e584-456f-a854-87f9e2e2d022" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesScheduleofPotentiallyDilutiveSecuritiesNotIncludedinCalculationofEarningsperShareDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#SummaryofSignificantAccountingPoliciesScheduleofPotentiallyDilutiveSecuritiesNotIncludedinCalculationofEarningsperShareDetails"/>
  <link:presentationLink xlink:role="http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesScheduleofPotentiallyDilutiveSecuritiesNotIncludedinCalculationofEarningsperShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_be79c95e-ffbe-4b81-957a-576d9767b99d" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_2337e942-e3ef-4c6c-825a-f5294ac9a227" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_be79c95e-ffbe-4b81-957a-576d9767b99d" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_2337e942-e3ef-4c6c-825a-f5294ac9a227" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_9a819ba6-4d92-49a4-9f5c-e8903a7b67a3" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_2337e942-e3ef-4c6c-825a-f5294ac9a227" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_9a819ba6-4d92-49a4-9f5c-e8903a7b67a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_0c63c098-e6f9-4279-94f7-88af3ad878fc" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_9a819ba6-4d92-49a4-9f5c-e8903a7b67a3" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_0c63c098-e6f9-4279-94f7-88af3ad878fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableConvertiblePreferredStockMember_5b1fff9b-015c-45ca-aac7-e72c8534b50c" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RedeemableConvertiblePreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_0c63c098-e6f9-4279-94f7-88af3ad878fc" xlink:to="loc_us-gaap_RedeemableConvertiblePreferredStockMember_5b1fff9b-015c-45ca-aac7-e72c8534b50c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_RedeemableConvertiblePreferredStockWarrantsMember_50ba76e1-b95c-49af-8f23-dcef022c9228" xlink:href="silk-20191231.xsd#silk_RedeemableConvertiblePreferredStockWarrantsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_0c63c098-e6f9-4279-94f7-88af3ad878fc" xlink:to="loc_silk_RedeemableConvertiblePreferredStockWarrantsMember_50ba76e1-b95c-49af-8f23-dcef022c9228" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_b106c3ec-93ca-477c-8b10-6ee70edac851" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_0c63c098-e6f9-4279-94f7-88af3ad878fc" xlink:to="loc_us-gaap_EmployeeStockOptionMember_b106c3ec-93ca-477c-8b10-6ee70edac851" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_CommonStockWarrantMember_b69011df-6d44-4d24-94e3-e66d64935f56" xlink:href="silk-20191231.xsd#silk_CommonStockWarrantMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_0c63c098-e6f9-4279-94f7-88af3ad878fc" xlink:to="loc_silk_CommonStockWarrantMember_b69011df-6d44-4d24-94e3-e66d64935f56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_bae0aba1-7c07-4cdc-a7b3-7b140a6686a8" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_2337e942-e3ef-4c6c-825a-f5294ac9a227" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_bae0aba1-7c07-4cdc-a7b3-7b140a6686a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_408ca237-b301-47e0-8289-a5209caca931" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_bae0aba1-7c07-4cdc-a7b3-7b140a6686a8" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_408ca237-b301-47e0-8289-a5209caca931" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesSegmentandGeographicalInformationDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#SummaryofSignificantAccountingPoliciesSegmentandGeographicalInformationDetails"/>
  <link:presentationLink xlink:role="http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesSegmentandGeographicalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_12a8c519-ee75-4b77-85f0-88137962f6b2" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_8792ffa0-0d75-4574-9e83-3c672a067f1b" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_12a8c519-ee75-4b77-85f0-88137962f6b2" xlink:to="loc_us-gaap_NumberOfReportableSegments_8792ffa0-0d75-4574-9e83-3c672a067f1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_44759464-b2df-4330-bc45-5196ba19aa23" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_12a8c519-ee75-4b77-85f0-88137962f6b2" xlink:to="loc_us-gaap_NumberOfOperatingSegments_44759464-b2df-4330-bc45-5196ba19aa23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/RecentAccountingPronouncements" xlink:type="simple" xlink:href="silk-20191231.xsd#RecentAccountingPronouncements"/>
  <link:presentationLink xlink:role="http://silkroadmed.com/role/RecentAccountingPronouncements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingChangesAndErrorCorrectionsAbstract_cf53ac95-a631-4f36-81d9-022d2ad2a826" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountingChangesAndErrorCorrectionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_f9681b14-4eaa-4bec-89ee-876aaf614d9b" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingChangesAndErrorCorrectionsAbstract_cf53ac95-a631-4f36-81d9-022d2ad2a826" xlink:to="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_f9681b14-4eaa-4bec-89ee-876aaf614d9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="silk-20191231.xsd#FairValueMeasurements"/>
  <link:presentationLink xlink:role="http://silkroadmed.com/role/FairValueMeasurements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_8bb1ae25-9cce-4658-8516-c6d2be452783" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_dc8ee2dc-9026-4abb-ae83-09bfd11fda71" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_8bb1ae25-9cce-4658-8516-c6d2be452783" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_dc8ee2dc-9026-4abb-ae83-09bfd11fda71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="silk-20191231.xsd#FairValueMeasurementsTables"/>
  <link:presentationLink xlink:role="http://silkroadmed.com/role/FairValueMeasurementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_24a75ccf-1d73-435e-8356-f963ac263b02" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_b04e90c3-0be6-46d3-9907-67eff4b46030" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_24a75ccf-1d73-435e-8356-f963ac263b02" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_b04e90c3-0be6-46d3-9907-67eff4b46030" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_17c47946-41ce-4f80-b0c4-962e71b95faf" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_24a75ccf-1d73-435e-8356-f963ac263b02" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_17c47946-41ce-4f80-b0c4-962e71b95faf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_46b90745-a17b-46c3-808f-80f6f77c257e" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_24a75ccf-1d73-435e-8356-f963ac263b02" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_46b90745-a17b-46c3-808f-80f6f77c257e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/FairValueMeasurementsRecurringAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#FairValueMeasurementsRecurringAssetsandLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://silkroadmed.com/role/FairValueMeasurementsRecurringAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_ae1b65ba-2b38-4557-9bb4-d7bab852d2dd" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_cdd48259-0c18-4f6f-b74c-9cb4a38ca109" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_ae1b65ba-2b38-4557-9bb4-d7bab852d2dd" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_cdd48259-0c18-4f6f-b74c-9cb4a38ca109" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_c174cbcb-dacf-4caa-9f1a-2eb722913f11" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_cdd48259-0c18-4f6f-b74c-9cb4a38ca109" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_c174cbcb-dacf-4caa-9f1a-2eb722913f11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_147d2b27-b83b-4f9b-9b50-05bbf2e78672" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_c174cbcb-dacf-4caa-9f1a-2eb722913f11" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_147d2b27-b83b-4f9b-9b50-05bbf2e78672" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_f9692eb9-b96f-4d64-bbd2-f108c037032b" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_147d2b27-b83b-4f9b-9b50-05bbf2e78672" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_f9692eb9-b96f-4d64-bbd2-f108c037032b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_72cb301b-d755-47eb-b765-802fca415eb2" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_cdd48259-0c18-4f6f-b74c-9cb4a38ca109" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_72cb301b-d755-47eb-b765-802fca415eb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_34dd0a89-ebdb-43af-967f-63c6e82588a0" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_72cb301b-d755-47eb-b765-802fca415eb2" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_34dd0a89-ebdb-43af-967f-63c6e82588a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_8ce53c10-8192-424b-b77f-b4c63cbf89ac" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_34dd0a89-ebdb-43af-967f-63c6e82588a0" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_8ce53c10-8192-424b-b77f-b4c63cbf89ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_25bc623a-3c00-49bc-b002-8d8e741ddb45" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_34dd0a89-ebdb-43af-967f-63c6e82588a0" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_25bc623a-3c00-49bc-b002-8d8e741ddb45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_ced02fce-918e-4df5-97fd-d8fb99629959" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_34dd0a89-ebdb-43af-967f-63c6e82588a0" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_ced02fce-918e-4df5-97fd-d8fb99629959" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_2243953b-aff2-4486-815e-acba5f9b76ad" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_cdd48259-0c18-4f6f-b74c-9cb4a38ca109" xlink:to="loc_us-gaap_FinancialInstrumentAxis_2243953b-aff2-4486-815e-acba5f9b76ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_fcefe597-0e07-439c-b7af-d2f62dc94b6e" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_2243953b-aff2-4486-815e-acba5f9b76ad" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_fcefe597-0e07-439c-b7af-d2f62dc94b6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_37030bc0-75e9-4d0c-9532-2c02a6f2dc02" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_fcefe597-0e07-439c-b7af-d2f62dc94b6e" xlink:to="loc_us-gaap_MoneyMarketFundsMember_37030bc0-75e9-4d0c-9532-2c02a6f2dc02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperNotIncludedWithCashAndCashEquivalentsMember_44ee1935-857f-4682-9d68-7dabbf0cd8be" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommercialPaperNotIncludedWithCashAndCashEquivalentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_fcefe597-0e07-439c-b7af-d2f62dc94b6e" xlink:to="loc_us-gaap_CommercialPaperNotIncludedWithCashAndCashEquivalentsMember_44ee1935-857f-4682-9d68-7dabbf0cd8be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_31b8fffa-33f4-423f-b085-ae88658a3bab" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_fcefe597-0e07-439c-b7af-d2f62dc94b6e" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_31b8fffa-33f4-423f-b085-ae88658a3bab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_e4019b2b-c3fe-431d-8d97-dcf597dd1aad" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_fcefe597-0e07-439c-b7af-d2f62dc94b6e" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_e4019b2b-c3fe-431d-8d97-dcf597dd1aad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_74485255-94c1-4475-881e-18b4338cdd44" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_fcefe597-0e07-439c-b7af-d2f62dc94b6e" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_74485255-94c1-4475-881e-18b4338cdd44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemablePreferredStockMember_b6a6a500-9a59-45ab-9a5e-fd92f8942f57" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RedeemablePreferredStockMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_fcefe597-0e07-439c-b7af-d2f62dc94b6e" xlink:to="loc_us-gaap_RedeemablePreferredStockMember_b6a6a500-9a59-45ab-9a5e-fd92f8942f57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_3fe53c63-aa7f-4c39-bf94-8a0fdf388c73" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_cdd48259-0c18-4f6f-b74c-9cb4a38ca109" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_3fe53c63-aa7f-4c39-bf94-8a0fdf388c73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_77186464-6173-4732-a120-0ea15f9973aa" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_3fe53c63-aa7f-4c39-bf94-8a0fdf388c73" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_77186464-6173-4732-a120-0ea15f9973aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_cbd7a803-2048-4e13-abf5-090279d79047" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_3fe53c63-aa7f-4c39-bf94-8a0fdf388c73" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_cbd7a803-2048-4e13-abf5-090279d79047" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_dbe843be-2d6d-471d-8187-1229381674d8" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativeLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_3fe53c63-aa7f-4c39-bf94-8a0fdf388c73" xlink:to="loc_us-gaap_DerivativeLiabilities_dbe843be-2d6d-471d-8187-1229381674d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#FairValueMeasurementsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://silkroadmed.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_0fc682b2-1ab0-4cc3-9c6b-c0e5ca255754" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_f61838cd-9acf-485b-9bb3-a4bfef302986" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_0fc682b2-1ab0-4cc3-9c6b-c0e5ca255754" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_f61838cd-9acf-485b-9bb3-a4bfef302986" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_07b6ed4d-26be-413d-ab37-3673c7ec0aa2" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_f61838cd-9acf-485b-9bb3-a4bfef302986" xlink:to="loc_us-gaap_StatementClassOfStockAxis_07b6ed4d-26be-413d-ab37-3673c7ec0aa2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_cf9823a5-f8ba-45ec-917d-96352d34449e" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_07b6ed4d-26be-413d-ab37-3673c7ec0aa2" xlink:to="loc_us-gaap_ClassOfStockDomain_cf9823a5-f8ba-45ec-917d-96352d34449e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_4cc862dc-15e8-4c21-aee2-09f587e5bcfc" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_cf9823a5-f8ba-45ec-917d-96352d34449e" xlink:to="loc_us-gaap_CommonStockMember_4cc862dc-15e8-4c21-aee2-09f587e5bcfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_a495b573-67a6-4ac5-acf9-6163d2cc6acc" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_f61838cd-9acf-485b-9bb3-a4bfef302986" xlink:to="loc_us-gaap_ClassOfStockLineItems_a495b573-67a6-4ac5-acf9-6163d2cc6acc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_0ee46785-52d6-40c9-8b03-581aa59e41e1" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_a495b573-67a6-4ac5-acf9-6163d2cc6acc" xlink:to="loc_us-gaap_SharePrice_0ee46785-52d6-40c9-8b03-581aa59e41e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/FairValueMeasurementsFairValueAssumptionsDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#FairValueMeasurementsFairValueAssumptionsDetails"/>
  <link:presentationLink xlink:role="http://silkroadmed.com/role/FairValueMeasurementsFairValueAssumptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_32f30d66-3470-42d0-8845-c7bc2d7012a7" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_b7f8b6e5-ee7f-4875-88c8-c0792e726b42" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_32f30d66-3470-42d0-8845-c7bc2d7012a7" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_b7f8b6e5-ee7f-4875-88c8-c0792e726b42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_3f019db1-f8fd-45b4-bb99-0c3ee94a048f" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_b7f8b6e5-ee7f-4875-88c8-c0792e726b42" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_3f019db1-f8fd-45b4-bb99-0c3ee94a048f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_07e6d770-6c9d-40d9-b2cc-cb26976471c0" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_3f019db1-f8fd-45b4-bb99-0c3ee94a048f" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_07e6d770-6c9d-40d9-b2cc-cb26976471c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_d640fe40-07e4-45b6-a695-ec8012806778" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_07e6d770-6c9d-40d9-b2cc-cb26976471c0" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_d640fe40-07e4-45b6-a695-ec8012806778" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_7c311539-7d9d-4f9e-b333-f6aa693783c6" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_b7f8b6e5-ee7f-4875-88c8-c0792e726b42" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_7c311539-7d9d-4f9e-b333-f6aa693783c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_75f227c9-9e75-4454-ac43-709884970ea3" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_7c311539-7d9d-4f9e-b333-f6aa693783c6" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_75f227c9-9e75-4454-ac43-709884970ea3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_81834ae7-c79f-4674-848a-5650d7dea0ac" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_75f227c9-9e75-4454-ac43-709884970ea3" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_81834ae7-c79f-4674-848a-5650d7dea0ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_a7112928-94ea-4753-bfac-e6f67969c9ea" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_b7f8b6e5-ee7f-4875-88c8-c0792e726b42" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_a7112928-94ea-4753-bfac-e6f67969c9ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_3e8e4efb-780b-46c3-96eb-fc3a7cecab48" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_a7112928-94ea-4753-bfac-e6f67969c9ea" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_3e8e4efb-780b-46c3-96eb-fc3a7cecab48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputOptionVolatilityMember_256d1945-0fcc-4662-9b74-a6dc06c05d55" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MeasurementInputOptionVolatilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_3e8e4efb-780b-46c3-96eb-fc3a7cecab48" xlink:to="loc_us-gaap_MeasurementInputOptionVolatilityMember_256d1945-0fcc-4662-9b74-a6dc06c05d55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember_ae17e2e0-80a2-4edb-87de-aafa184dee00" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_3e8e4efb-780b-46c3-96eb-fc3a7cecab48" xlink:to="loc_us-gaap_MeasurementInputDiscountRateMember_ae17e2e0-80a2-4edb-87de-aafa184dee00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_3c6dda5e-de00-49bf-a4b3-88ca3977952a" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_3e8e4efb-780b-46c3-96eb-fc3a7cecab48" xlink:to="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_3c6dda5e-de00-49bf-a4b3-88ca3977952a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountForLackOfMarketabilityMember_693aabc7-449d-4283-9ee0-58992f3a82a4" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MeasurementInputDiscountForLackOfMarketabilityMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_3e8e4efb-780b-46c3-96eb-fc3a7cecab48" xlink:to="loc_us-gaap_MeasurementInputDiscountForLackOfMarketabilityMember_693aabc7-449d-4283-9ee0-58992f3a82a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_81b2deb2-83d1-47fb-aa7f-e3db813e98e4" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_b7f8b6e5-ee7f-4875-88c8-c0792e726b42" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_81b2deb2-83d1-47fb-aa7f-e3db813e98e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingTerm_a4e6d21e-56d1-4350-99db-d672489c67c6" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WarrantsAndRightsOutstandingTerm"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_81b2deb2-83d1-47fb-aa7f-e3db813e98e4" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingTerm_a4e6d21e-56d1-4350-99db-d672489c67c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingMeasurementInput_d37f84c0-4831-42f4-8ab9-79d796948f0b" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WarrantsAndRightsOutstandingMeasurementInput"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_81b2deb2-83d1-47fb-aa7f-e3db813e98e4" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingMeasurementInput_d37f84c0-4831-42f4-8ab9-79d796948f0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/FairValueMeasurementsChangesinRedeemableConvertibleWarrantLiabilityDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#FairValueMeasurementsChangesinRedeemableConvertibleWarrantLiabilityDetails"/>
  <link:presentationLink xlink:role="http://silkroadmed.com/role/FairValueMeasurementsChangesinRedeemableConvertibleWarrantLiabilityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_2dfc8a18-c9d4-427d-8fbd-8bdfa6d75a01" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_d8625a7b-0e55-4ae7-a881-4faa430ad7e7" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_2dfc8a18-c9d4-427d-8fbd-8bdfa6d75a01" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_d8625a7b-0e55-4ae7-a881-4faa430ad7e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_336c8398-d081-4e76-9f06-f46fe06cf585" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_d8625a7b-0e55-4ae7-a881-4faa430ad7e7" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_336c8398-d081-4e76-9f06-f46fe06cf585" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_93ae08af-d6c4-4e83-b2dc-555db4f404a9" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_d8625a7b-0e55-4ae7-a881-4faa430ad7e7" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_93ae08af-d6c4-4e83-b2dc-555db4f404a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityReclassifications_fca1ea3c-2b8a-4e4d-83ee-8c776cbe99d6" xlink:href="silk-20191231.xsd#silk_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityReclassifications"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_d8625a7b-0e55-4ae7-a881-4faa430ad7e7" xlink:to="loc_silk_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityReclassifications_fca1ea3c-2b8a-4e4d-83ee-8c776cbe99d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_a816266a-ccee-415f-a6d2-37d662de807d" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_d8625a7b-0e55-4ae7-a881-4faa430ad7e7" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_a816266a-ccee-415f-a6d2-37d662de807d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/BalanceSheetComponents" xlink:type="simple" xlink:href="silk-20191231.xsd#BalanceSheetComponents"/>
  <link:presentationLink xlink:role="http://silkroadmed.com/role/BalanceSheetComponents" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_342c2e19-5c1c-4098-aa9e-fb7e6816b7e6" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_2ffc1883-6b00-4ffa-9648-274774d0e0fc" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SupplementalBalanceSheetDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_342c2e19-5c1c-4098-aa9e-fb7e6816b7e6" xlink:to="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_2ffc1883-6b00-4ffa-9648-274774d0e0fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/BalanceSheetComponentsTables" xlink:type="simple" xlink:href="silk-20191231.xsd#BalanceSheetComponentsTables"/>
  <link:presentationLink xlink:role="http://silkroadmed.com/role/BalanceSheetComponentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f61f6859-b100-4bd2-993c-806023c85e7d" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_8f17b1e8-9c14-4a56-8ae2-ce5e0e4605c6" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f61f6859-b100-4bd2-993c-806023c85e7d" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_8f17b1e8-9c14-4a56-8ae2-ce5e0e4605c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock_435f0c7f-0100-4eec-83d1-fc39ae0188b4" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f61f6859-b100-4bd2-993c-806023c85e7d" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock_435f0c7f-0100-4eec-83d1-fc39ae0188b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock_f2ce0f23-5753-4844-a9c6-e583efcd270b" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f61f6859-b100-4bd2-993c-806023c85e7d" xlink:to="loc_us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock_f2ce0f23-5753-4844-a9c6-e583efcd270b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_198b0903-27d6-4eff-b992-302f2baa4f3f" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f61f6859-b100-4bd2-993c-806023c85e7d" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_198b0903-27d6-4eff-b992-302f2baa4f3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_4d426f11-9785-4e4e-b53c-65d519a275a6" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f61f6859-b100-4bd2-993c-806023c85e7d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_4d426f11-9785-4e4e-b53c-65d519a275a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_b03e2d78-392f-4944-90b9-81bcde3b6ccb" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f61f6859-b100-4bd2-993c-806023c85e7d" xlink:to="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_b03e2d78-392f-4944-90b9-81bcde3b6ccb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/BalanceSheetComponentsFairValueofAvailableForSaleInvestmentsDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#BalanceSheetComponentsFairValueofAvailableForSaleInvestmentsDetails"/>
  <link:presentationLink xlink:role="http://silkroadmed.com/role/BalanceSheetComponentsFairValueofAvailableForSaleInvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_70494b65-bd57-47b3-b164-934524de58f7" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_3f7765fa-7c68-492d-92bd-d5c57561e09b" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_70494b65-bd57-47b3-b164-934524de58f7" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_3f7765fa-7c68-492d-92bd-d5c57561e09b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_422dbed5-2644-4c33-9612-eb173d0848b2" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_3f7765fa-7c68-492d-92bd-d5c57561e09b" xlink:to="loc_us-gaap_FinancialInstrumentAxis_422dbed5-2644-4c33-9612-eb173d0848b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_89602efc-fe61-4598-96f5-de91a99ae971" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_422dbed5-2644-4c33-9612-eb173d0848b2" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_89602efc-fe61-4598-96f5-de91a99ae971" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_158fa876-8f87-43b0-a097-755db6ab5eb7" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_89602efc-fe61-4598-96f5-de91a99ae971" xlink:to="loc_us-gaap_MoneyMarketFundsMember_158fa876-8f87-43b0-a097-755db6ab5eb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_eac2d93a-b009-4d8a-be57-2d11c49df18f" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_89602efc-fe61-4598-96f5-de91a99ae971" xlink:to="loc_us-gaap_CommercialPaperMember_eac2d93a-b009-4d8a-be57-2d11c49df18f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_e172aa63-48bc-4644-92ea-c3d4b2a41733" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_89602efc-fe61-4598-96f5-de91a99ae971" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_e172aa63-48bc-4644-92ea-c3d4b2a41733" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember_336c9c2e-e598-497d-a461-d81020e56795" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_89602efc-fe61-4598-96f5-de91a99ae971" xlink:to="loc_us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember_336c9c2e-e598-497d-a461-d81020e56795" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_35401df7-af10-477a-97fe-206e22e4705e" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_89602efc-fe61-4598-96f5-de91a99ae971" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_35401df7-af10-477a-97fe-206e22e4705e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashEquivalentsMember_240327c3-fd5e-4ea5-af6d-a2ea363b08f0" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashEquivalentsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_89602efc-fe61-4598-96f5-de91a99ae971" xlink:to="loc_us-gaap_CashEquivalentsMember_240327c3-fd5e-4ea5-af6d-a2ea363b08f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestmentsMember_927781cf-7c99-4efb-8e79-61f42e4c0ea6" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_89602efc-fe61-4598-96f5-de91a99ae971" xlink:to="loc_us-gaap_ShortTermInvestmentsMember_927781cf-7c99-4efb-8e79-61f42e4c0ea6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_LongTermInvestmentsMember_faca6978-df5e-4aaa-9da1-23803932355b" xlink:href="silk-20191231.xsd#silk_LongTermInvestmentsMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_89602efc-fe61-4598-96f5-de91a99ae971" xlink:to="loc_silk_LongTermInvestmentsMember_faca6978-df5e-4aaa-9da1-23803932355b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_ada3e279-37b1-4ed8-8534-f35455fff482" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_3f7765fa-7c68-492d-92bd-d5c57561e09b" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_ada3e279-37b1-4ed8-8534-f35455fff482" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_847c021f-5756-4615-b6fe-9bfdd2dd7071" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_ada3e279-37b1-4ed8-8534-f35455fff482" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_847c021f-5756-4615-b6fe-9bfdd2dd7071" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_f7649f41-e0b3-458d-9e3b-50f453e1ecc5" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_ada3e279-37b1-4ed8-8534-f35455fff482" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_f7649f41-e0b3-458d-9e3b-50f453e1ecc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_5f47e773-9b08-4084-ad41-5f0b85eb78a9" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_ada3e279-37b1-4ed8-8534-f35455fff482" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_5f47e773-9b08-4084-ad41-5f0b85eb78a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_1481bf21-d05f-40e3-a636-bfad271ba94e" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_ada3e279-37b1-4ed8-8534-f35455fff482" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_1481bf21-d05f-40e3-a636-bfad271ba94e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/BalanceSheetComponentsFairValueofCashEquivalentsShortTermandLongTermInvestmentsDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#BalanceSheetComponentsFairValueofCashEquivalentsShortTermandLongTermInvestmentsDetails"/>
  <link:presentationLink xlink:role="http://silkroadmed.com/role/BalanceSheetComponentsFairValueofCashEquivalentsShortTermandLongTermInvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f0a8a16c-f0b7-436d-8b9b-4c4d4a4860fe" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_CashAndCashEquivalentsFairValueDisclosureMaturingWithinOneYear_ada81b3d-2e0c-42ac-8548-bbf331027390" xlink:href="silk-20191231.xsd#silk_CashAndCashEquivalentsFairValueDisclosureMaturingWithinOneYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f0a8a16c-f0b7-436d-8b9b-4c4d4a4860fe" xlink:to="loc_silk_CashAndCashEquivalentsFairValueDisclosureMaturingWithinOneYear_ada81b3d-2e0c-42ac-8548-bbf331027390" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_CashAndCashEquivalentsFairValueDisclosureMaturingAfterOneYearThroughTwoYears_e7563d5a-aeba-418a-9e3e-5071de0eb357" xlink:href="silk-20191231.xsd#silk_CashAndCashEquivalentsFairValueDisclosureMaturingAfterOneYearThroughTwoYears"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f0a8a16c-f0b7-436d-8b9b-4c4d4a4860fe" xlink:to="loc_silk_CashAndCashEquivalentsFairValueDisclosureMaturingAfterOneYearThroughTwoYears_e7563d5a-aeba-418a-9e3e-5071de0eb357" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_58ce41cb-0de8-4812-8c39-c7b95b33e1fb" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f0a8a16c-f0b7-436d-8b9b-4c4d4a4860fe" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_58ce41cb-0de8-4812-8c39-c7b95b33e1fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/BalanceSheetComponentsAvailableforSaleInvestmentsinUnrealizedLossPositionDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#BalanceSheetComponentsAvailableforSaleInvestmentsinUnrealizedLossPositionDetails"/>
  <link:presentationLink xlink:role="http://silkroadmed.com/role/BalanceSheetComponentsAvailableforSaleInvestmentsinUnrealizedLossPositionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_552bc765-88d2-429c-952d-761f4a0e620d" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_3c1a8c01-4d2a-43bb-a745-fbee1e3479c5" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_552bc765-88d2-429c-952d-761f4a0e620d" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_3c1a8c01-4d2a-43bb-a745-fbee1e3479c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_944ef27d-22c7-4d45-9b7b-fec76b181942" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_3c1a8c01-4d2a-43bb-a745-fbee1e3479c5" xlink:to="loc_us-gaap_FinancialInstrumentAxis_944ef27d-22c7-4d45-9b7b-fec76b181942" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2a887947-5af2-464b-ada0-f76d61e77186" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_944ef27d-22c7-4d45-9b7b-fec76b181942" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2a887947-5af2-464b-ada0-f76d61e77186" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_c4431b04-db4b-4d5b-9186-ce024d1cc341" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2a887947-5af2-464b-ada0-f76d61e77186" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_c4431b04-db4b-4d5b-9186-ce024d1cc341" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember_5616b2c2-b4ba-495f-b723-a6fdcba08f4e" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2a887947-5af2-464b-ada0-f76d61e77186" xlink:to="loc_us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember_5616b2c2-b4ba-495f-b723-a6fdcba08f4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_1b086bcc-0661-469b-94f1-8f80f50eddc2" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_3c1a8c01-4d2a-43bb-a745-fbee1e3479c5" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_1b086bcc-0661-469b-94f1-8f80f50eddc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_ece82096-a30a-4e47-bca7-e1023d7653bb" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_1b086bcc-0661-469b-94f1-8f80f50eddc2" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_ece82096-a30a-4e47-bca7-e1023d7653bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_58b66f37-0298-4be8-a54a-b74389efa864" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_1b086bcc-0661-469b-94f1-8f80f50eddc2" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_58b66f37-0298-4be8-a54a-b74389efa864" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/BalanceSheetComponentsScheduleofInventoryDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#BalanceSheetComponentsScheduleofInventoryDetails"/>
  <link:presentationLink xlink:role="http://silkroadmed.com/role/BalanceSheetComponentsScheduleofInventoryDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_85cd239f-2e21-4d13-a559-0e1bcf780fd8" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_d97eaff5-18aa-4188-8a0d-803e0000f7f6" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_85cd239f-2e21-4d13-a559-0e1bcf780fd8" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_d97eaff5-18aa-4188-8a0d-803e0000f7f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_55dea0a0-c2c3-4161-a488-11dfda3519f6" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_85cd239f-2e21-4d13-a559-0e1bcf780fd8" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_55dea0a0-c2c3-4161-a488-11dfda3519f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_6b45875d-2a8d-4617-afd8-a594192daac1" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_85cd239f-2e21-4d13-a559-0e1bcf780fd8" xlink:to="loc_us-gaap_InventoryNet_6b45875d-2a8d-4617-afd8-a594192daac1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/BalanceSheetComponentsNarrativeDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#BalanceSheetComponentsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://silkroadmed.com/role/BalanceSheetComponentsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_c87cd74c-da69-4ec2-a788-9eca2bc4f58e" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTerm_7c8b132d-b509-4806-b1c7-5e02ef1c426e" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTerm"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_c87cd74c-da69-4ec2-a788-9eca2bc4f58e" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTerm_7c8b132d-b509-4806-b1c7-5e02ef1c426e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_7230a4d3-1b2e-461e-83a7-f170116d701a" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_c87cd74c-da69-4ec2-a788-9eca2bc4f58e" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_7230a4d3-1b2e-461e-83a7-f170116d701a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_4af84dc8-fc06-4598-b14b-13ecf08708c7" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_c87cd74c-da69-4ec2-a788-9eca2bc4f58e" xlink:to="loc_us-gaap_Depreciation_4af84dc8-fc06-4598-b14b-13ecf08708c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/BalanceSheetComponentsPropertyPlantandEquipmentDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#BalanceSheetComponentsPropertyPlantandEquipmentDetails"/>
  <link:presentationLink xlink:role="http://silkroadmed.com/role/BalanceSheetComponentsPropertyPlantandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_209ff2a2-f520-4196-b12c-c71c6ee2da33" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_be2bcbe5-c4ed-430a-b4b3-35f72e072680" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_209ff2a2-f520-4196-b12c-c71c6ee2da33" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_be2bcbe5-c4ed-430a-b4b3-35f72e072680" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_4002e70b-a54b-4d0d-bce2-00e976309fe8" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_be2bcbe5-c4ed-430a-b4b3-35f72e072680" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_4002e70b-a54b-4d0d-bce2-00e976309fe8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a0044df5-1434-4cd9-97f2-17614664e157" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_4002e70b-a54b-4d0d-bce2-00e976309fe8" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a0044df5-1434-4cd9-97f2-17614664e157" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_e1e2b5e8-f1b7-4237-b5c6-3b0027bf3780" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a0044df5-1434-4cd9-97f2-17614664e157" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_e1e2b5e8-f1b7-4237-b5c6-3b0027bf3780" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember_d5a130f2-cfce-4143-a0d6-a98cfc792f93" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquipmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a0044df5-1434-4cd9-97f2-17614664e157" xlink:to="loc_us-gaap_EquipmentMember_d5a130f2-cfce-4143-a0d6-a98cfc792f93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_f0f3162f-9b6e-48ed-be33-40fda56f5a63" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a0044df5-1434-4cd9-97f2-17614664e157" xlink:to="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_f0f3162f-9b6e-48ed-be33-40fda56f5a63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_59fbe796-9a24-4a6f-a792-35d1d9d435cf" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a0044df5-1434-4cd9-97f2-17614664e157" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_59fbe796-9a24-4a6f-a792-35d1d9d435cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_c9ab9c1d-c9e1-4ee7-9616-4c13e6a64435" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a0044df5-1434-4cd9-97f2-17614664e157" xlink:to="loc_us-gaap_ConstructionInProgressMember_c9ab9c1d-c9e1-4ee7-9616-4c13e6a64435" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5ca33061-d6c0-48a8-ab4f-baa54cadfa79" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_be2bcbe5-c4ed-430a-b4b3-35f72e072680" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5ca33061-d6c0-48a8-ab4f-baa54cadfa79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_fb290701-142f-4276-9bf4-18fb2113cc27" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5ca33061-d6c0-48a8-ab4f-baa54cadfa79" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_fb290701-142f-4276-9bf4-18fb2113cc27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_4ac250f3-3f2d-4f2e-b522-1fcfdb9ddf62" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5ca33061-d6c0-48a8-ab4f-baa54cadfa79" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_4ac250f3-3f2d-4f2e-b522-1fcfdb9ddf62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_4137c2cd-df4f-418f-b563-70ea43c0a3d8" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5ca33061-d6c0-48a8-ab4f-baa54cadfa79" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_4137c2cd-df4f-418f-b563-70ea43c0a3d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/BalanceSheetComponentsAccruedLiabilitiesDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#BalanceSheetComponentsAccruedLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://silkroadmed.com/role/BalanceSheetComponentsAccruedLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_1e8b8dbc-3854-4dd5-bba4-b95bede4074f" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedSalariesCurrent_58d7b57d-f7dc-4b4b-bcce-32670c08946d" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccruedSalariesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_1e8b8dbc-3854-4dd5-bba4-b95bede4074f" xlink:to="loc_us-gaap_AccruedSalariesCurrent_58d7b57d-f7dc-4b4b-bcce-32670c08946d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_ProvisionsForSalesReturns_af9ab9da-6ffa-4cce-aaae-45356bd6eaad" xlink:href="silk-20191231.xsd#silk_ProvisionsForSalesReturns"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_1e8b8dbc-3854-4dd5-bba4-b95bede4074f" xlink:to="loc_silk_ProvisionsForSalesReturns_af9ab9da-6ffa-4cce-aaae-45356bd6eaad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_6c99bcf3-fa57-40b8-a2e8-625f172de83c" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_1e8b8dbc-3854-4dd5-bba4-b95bede4074f" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_6c99bcf3-fa57-40b8-a2e8-625f172de83c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_1270ea63-9fe7-43fd-a32d-d35db593052f" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_1e8b8dbc-3854-4dd5-bba4-b95bede4074f" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_1270ea63-9fe7-43fd-a32d-d35db593052f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedRoyaltiesCurrent_f94aa082-b156-40be-a7bf-23bb65102c72" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccruedRoyaltiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_1e8b8dbc-3854-4dd5-bba4-b95bede4074f" xlink:to="loc_us-gaap_AccruedRoyaltiesCurrent_f94aa082-b156-40be-a7bf-23bb65102c72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_6d2020b8-e1b3-4742-8112-f6c9aad8e3ed" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_1e8b8dbc-3854-4dd5-bba4-b95bede4074f" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_6d2020b8-e1b3-4742-8112-f6c9aad8e3ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_AccruedTravelExpensesCurrent_14f2a84a-cc50-4a39-adc6-2fd2b1e21134" xlink:href="silk-20191231.xsd#silk_AccruedTravelExpensesCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_1e8b8dbc-3854-4dd5-bba4-b95bede4074f" xlink:to="loc_silk_AccruedTravelExpensesCurrent_14f2a84a-cc50-4a39-adc6-2fd2b1e21134" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_AccruedClinicalExpensesCurrent_db5df0a4-eba0-48c9-beaf-4fc87a9c39e3" xlink:href="silk-20191231.xsd#silk_AccruedClinicalExpensesCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_1e8b8dbc-3854-4dd5-bba4-b95bede4074f" xlink:to="loc_silk_AccruedClinicalExpensesCurrent_db5df0a4-eba0-48c9-beaf-4fc87a9c39e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_112bb52e-11db-454f-afeb-c198abd30e10" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_1e8b8dbc-3854-4dd5-bba4-b95bede4074f" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_112bb52e-11db-454f-afeb-c198abd30e10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_22128587-a84c-4765-8922-71b8166756c7" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_1e8b8dbc-3854-4dd5-bba4-b95bede4074f" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_22128587-a84c-4765-8922-71b8166756c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/LongtermDebt" xlink:type="simple" xlink:href="silk-20191231.xsd#LongtermDebt"/>
  <link:presentationLink xlink:role="http://silkroadmed.com/role/LongtermDebt" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_abf6cd89-6831-4315-a163-ff71125d6790" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_fa687c8a-879c-4406-88cc-cc72b42b9992" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_abf6cd89-6831-4315-a163-ff71125d6790" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_fa687c8a-879c-4406-88cc-cc72b42b9992" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/LongtermDebtTables" xlink:type="simple" xlink:href="silk-20191231.xsd#LongtermDebtTables"/>
  <link:presentationLink xlink:role="http://silkroadmed.com/role/LongtermDebtTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_6c0175fd-f137-45a4-8f1e-298f4c905492" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_4d09ec05-33cb-45df-999f-394f4050f73c" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_6c0175fd-f137-45a4-8f1e-298f4c905492" xlink:to="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_4d09ec05-33cb-45df-999f-394f4050f73c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/LongtermDebtTermLoanNarrativeDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#LongtermDebtTermLoanNarrativeDetails"/>
  <link:presentationLink xlink:role="http://silkroadmed.com/role/LongtermDebtTermLoanNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_a2aa4728-2f43-4059-ac2d-19c409e359a3" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_dfdc44e4-3b09-4258-9d6e-ce3060907ee7" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_a2aa4728-2f43-4059-ac2d-19c409e359a3" xlink:to="loc_us-gaap_DebtInstrumentTable_dfdc44e4-3b09-4258-9d6e-ce3060907ee7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_f9e9c818-bb92-423d-b5cf-2f1a566bfdb7" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_dfdc44e4-3b09-4258-9d6e-ce3060907ee7" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_f9e9c818-bb92-423d-b5cf-2f1a566bfdb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_56dfee8e-621e-40e6-979e-d620564d19c0" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_f9e9c818-bb92-423d-b5cf-2f1a566bfdb7" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_56dfee8e-621e-40e6-979e-d620564d19c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_TermLoanMember_f9e065d2-b9f1-4337-818e-f144e7c4d3c0" xlink:href="silk-20191231.xsd#silk_TermLoanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_56dfee8e-621e-40e6-979e-d620564d19c0" xlink:to="loc_silk_TermLoanMember_f9e065d2-b9f1-4337-818e-f144e7c4d3c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_TermLoanTrancheAMember_1f39e956-d4a4-4ac3-b826-12ee9f09cdfd" xlink:href="silk-20191231.xsd#silk_TermLoanTrancheAMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_56dfee8e-621e-40e6-979e-d620564d19c0" xlink:to="loc_silk_TermLoanTrancheAMember_1f39e956-d4a4-4ac3-b826-12ee9f09cdfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_TermLoanTrancheBMember_4db6e0b7-6ac4-4923-a52a-d16218b850b7" xlink:href="silk-20191231.xsd#silk_TermLoanTrancheBMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_56dfee8e-621e-40e6-979e-d620564d19c0" xlink:to="loc_silk_TermLoanTrancheBMember_4db6e0b7-6ac4-4923-a52a-d16218b850b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementScenarioAxis_8c83d97a-f298-4d07-ac91-58d87c801eaa" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_dfdc44e4-3b09-4258-9d6e-ce3060907ee7" xlink:to="loc_us-gaap_StatementScenarioAxis_8c83d97a-f298-4d07-ac91-58d87c801eaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScenarioUnspecifiedDomain_f022d098-b208-4dd9-a0a3-6b7fa4fa54c2" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementScenarioAxis_8c83d97a-f298-4d07-ac91-58d87c801eaa" xlink:to="loc_us-gaap_ScenarioUnspecifiedDomain_f022d098-b208-4dd9-a0a3-6b7fa4fa54c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScenarioForecastMember_296db6aa-ee61-43b9-97fd-ee6a8304c0b2" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScenarioForecastMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScenarioUnspecifiedDomain_f022d098-b208-4dd9-a0a3-6b7fa4fa54c2" xlink:to="loc_us-gaap_ScenarioForecastMember_296db6aa-ee61-43b9-97fd-ee6a8304c0b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_5b0bc06e-ac77-4207-9307-25b917ff382e" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_dfdc44e4-3b09-4258-9d6e-ce3060907ee7" xlink:to="loc_us-gaap_DebtInstrumentLineItems_5b0bc06e-ac77-4207-9307-25b917ff382e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_DebtMaximumBorrowingCapacity_b74b9c34-59ee-46ca-a1e6-f91d1b990fc4" xlink:href="silk-20191231.xsd#silk_DebtMaximumBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5b0bc06e-ac77-4207-9307-25b917ff382e" xlink:to="loc_silk_DebtMaximumBorrowingCapacity_b74b9c34-59ee-46ca-a1e6-f91d1b990fc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_5749a561-13b6-4aca-abe1-c965996839f6" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5b0bc06e-ac77-4207-9307-25b917ff382e" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_5749a561-13b6-4aca-abe1-c965996839f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_23b52855-e204-4f41-8c95-505be5c5b4d0" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5b0bc06e-ac77-4207-9307-25b917ff382e" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_23b52855-e204-4f41-8c95-505be5c5b4d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_DebtInstrumentInterestRatePaidInKind_014026f6-0073-4839-bc59-a9694eb3ef56" xlink:href="silk-20191231.xsd#silk_DebtInstrumentInterestRatePaidInKind"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5b0bc06e-ac77-4207-9307-25b917ff382e" xlink:to="loc_silk_DebtInstrumentInterestRatePaidInKind_014026f6-0073-4839-bc59-a9694eb3ef56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_DebtInstrumentInterestRatePaidInCash_ca3ba4a9-b762-4455-af13-f714277e3411" xlink:href="silk-20191231.xsd#silk_DebtInstrumentInterestRatePaidInCash"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5b0bc06e-ac77-4207-9307-25b917ff382e" xlink:to="loc_silk_DebtInstrumentInterestRatePaidInCash_ca3ba4a9-b762-4455-af13-f714277e3411" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_DebtInstrumentConvertibleMaximumPercentageOfOutstandingLoans_34aefb2e-2b59-4731-92ef-47cc8a0f1c06" xlink:href="silk-20191231.xsd#silk_DebtInstrumentConvertibleMaximumPercentageOfOutstandingLoans"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5b0bc06e-ac77-4207-9307-25b917ff382e" xlink:to="loc_silk_DebtInstrumentConvertibleMaximumPercentageOfOutstandingLoans_34aefb2e-2b59-4731-92ef-47cc8a0f1c06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_DebtInstrumentConvertibleMarketCapitalization_906fef73-2016-48f8-a369-39f7dd1a5141" xlink:href="silk-20191231.xsd#silk_DebtInstrumentConvertibleMarketCapitalization"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5b0bc06e-ac77-4207-9307-25b917ff382e" xlink:to="loc_silk_DebtInstrumentConvertibleMarketCapitalization_906fef73-2016-48f8-a369-39f7dd1a5141" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_DebtInstrumentInterestRateFinancingFee_83387a90-651c-4216-879e-30394ab90692" xlink:href="silk-20191231.xsd#silk_DebtInstrumentInterestRateFinancingFee"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5b0bc06e-ac77-4207-9307-25b917ff382e" xlink:to="loc_silk_DebtInstrumentInterestRateFinancingFee_83387a90-651c-4216-879e-30394ab90692" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_DebtInstrumentInterestRateFacilityFee_9351c485-85d6-4094-8cf2-f8e9cf12484a" xlink:href="silk-20191231.xsd#silk_DebtInstrumentInterestRateFacilityFee"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5b0bc06e-ac77-4207-9307-25b917ff382e" xlink:to="loc_silk_DebtInstrumentInterestRateFacilityFee_9351c485-85d6-4094-8cf2-f8e9cf12484a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_DebtInstrumentCovenantMaximumLiquidityAmount_8d890e14-50d2-485a-8d94-d219f66a6fd8" xlink:href="silk-20191231.xsd#silk_DebtInstrumentCovenantMaximumLiquidityAmount"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5b0bc06e-ac77-4207-9307-25b917ff382e" xlink:to="loc_silk_DebtInstrumentCovenantMaximumLiquidityAmount_8d890e14-50d2-485a-8d94-d219f66a6fd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_DebtInstrumentCovenantMinimumNetRevenueAmount_50431558-6e78-4c7a-82a2-4a66b946fc83" xlink:href="silk-20191231.xsd#silk_DebtInstrumentCovenantMinimumNetRevenueAmount"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5b0bc06e-ac77-4207-9307-25b917ff382e" xlink:to="loc_silk_DebtInstrumentCovenantMinimumNetRevenueAmount_50431558-6e78-4c7a-82a2-4a66b946fc83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_DebtInstrumentLiquidityCovenantTerm_57adab46-3314-4bf9-96c7-dbf80d50ff7a" xlink:href="silk-20191231.xsd#silk_DebtInstrumentLiquidityCovenantTerm"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5b0bc06e-ac77-4207-9307-25b917ff382e" xlink:to="loc_silk_DebtInstrumentLiquidityCovenantTerm_57adab46-3314-4bf9-96c7-dbf80d50ff7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_5d7a6a50-3195-4474-93e6-76381c859e76" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5b0bc06e-ac77-4207-9307-25b917ff382e" xlink:to="loc_us-gaap_LongTermDebt_5d7a6a50-3195-4474-93e6-76381c859e76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/LongtermDebtFutureMaturitiesUndertheTermLoanDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#LongtermDebtFutureMaturitiesUndertheTermLoanDetails"/>
  <link:presentationLink xlink:role="http://silkroadmed.com/role/LongtermDebtFutureMaturitiesUndertheTermLoanDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_e3d4eb2e-db3c-449c-9a90-0781a4f3ad71" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_312b4276-8c41-4f9f-831a-443f63f19cc7" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_e3d4eb2e-db3c-449c-9a90-0781a4f3ad71" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_312b4276-8c41-4f9f-831a-443f63f19cc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_dd4f90ee-7e04-4696-8abd-0a17e969c6e7" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_e3d4eb2e-db3c-449c-9a90-0781a4f3ad71" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_dd4f90ee-7e04-4696-8abd-0a17e969c6e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_2c475a93-224e-49d3-876f-84d3e390e853" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_e3d4eb2e-db3c-449c-9a90-0781a4f3ad71" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_2c475a93-224e-49d3-876f-84d3e390e853" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_LongTermDebtGrossBeforeAccretionOfClosingFees_b5c7b5ed-181e-490e-85d8-0552e94bc631" xlink:href="silk-20191231.xsd#silk_LongTermDebtGrossBeforeAccretionOfClosingFees"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_e3d4eb2e-db3c-449c-9a90-0781a4f3ad71" xlink:to="loc_silk_LongTermDebtGrossBeforeAccretionOfClosingFees_b5c7b5ed-181e-490e-85d8-0552e94bc631" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_LongTermDebtAccretionOfClosingFees_605b9907-fe7d-4684-b7a2-af7803801b8b" xlink:href="silk-20191231.xsd#silk_LongTermDebtAccretionOfClosingFees"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_e3d4eb2e-db3c-449c-9a90-0781a4f3ad71" xlink:to="loc_silk_LongTermDebtAccretionOfClosingFees_605b9907-fe7d-4684-b7a2-af7803801b8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_52923591-7650-477d-ab0e-6041054dd858" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_e3d4eb2e-db3c-449c-9a90-0781a4f3ad71" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_52923591-7650-477d-ab0e-6041054dd858" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_LongTermDebtUnpaidInterest_6df6e267-4df5-4c84-a739-25f9951d9974" xlink:href="silk-20191231.xsd#silk_LongTermDebtUnpaidInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_e3d4eb2e-db3c-449c-9a90-0781a4f3ad71" xlink:to="loc_silk_LongTermDebtUnpaidInterest_6df6e267-4df5-4c84-a739-25f9951d9974" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_de1b47eb-c9c9-4d69-b4cd-95b7635cb60b" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_e3d4eb2e-db3c-449c-9a90-0781a4f3ad71" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_de1b47eb-c9c9-4d69-b4cd-95b7635cb60b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_6396be97-09d7-4fc2-8619-1ff64ef3faed" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_e3d4eb2e-db3c-449c-9a90-0781a4f3ad71" xlink:to="loc_us-gaap_LongTermDebt_6396be97-09d7-4fc2-8619-1ff64ef3faed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/LongtermDebtSeriesCNarrativeDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#LongtermDebtSeriesCNarrativeDetails"/>
  <link:presentationLink xlink:role="http://silkroadmed.com/role/LongtermDebtSeriesCNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_5baad799-adb5-4c89-ad69-0c7186197e89" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_ff2bd1af-e99e-47d4-9493-44e36132a2fe" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_5baad799-adb5-4c89-ad69-0c7186197e89" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_ff2bd1af-e99e-47d4-9493-44e36132a2fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_ac59eab9-cfaa-4f3d-b9d9-ac03bbbe3307" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_ff2bd1af-e99e-47d4-9493-44e36132a2fe" xlink:to="loc_us-gaap_StatementClassOfStockAxis_ac59eab9-cfaa-4f3d-b9d9-ac03bbbe3307" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_8e609f79-8679-4203-9dd8-835718f4cf60" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_ac59eab9-cfaa-4f3d-b9d9-ac03bbbe3307" xlink:to="loc_us-gaap_ClassOfStockDomain_8e609f79-8679-4203-9dd8-835718f4cf60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesCPreferredStockMember_2a4d15f6-415c-4e52-b2ae-8615eae5f742" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SeriesCPreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_8e609f79-8679-4203-9dd8-835718f4cf60" xlink:to="loc_us-gaap_SeriesCPreferredStockMember_2a4d15f6-415c-4e52-b2ae-8615eae5f742" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_525fe101-e8ad-4448-8d45-a99ce02a7eda" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_ff2bd1af-e99e-47d4-9493-44e36132a2fe" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_525fe101-e8ad-4448-8d45-a99ce02a7eda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_036a2072-6f57-411b-8d77-468c49835c8a" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_525fe101-e8ad-4448-8d45-a99ce02a7eda" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_036a2072-6f57-411b-8d77-468c49835c8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_PreferredStockWarrantsMember_f381bdb0-c808-45e5-a166-b954365b5e46" xlink:href="silk-20191231.xsd#silk_PreferredStockWarrantsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_036a2072-6f57-411b-8d77-468c49835c8a" xlink:to="loc_silk_PreferredStockWarrantsMember_f381bdb0-c808-45e5-a166-b954365b5e46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_62ebed39-a29e-46f4-959c-1b8a52001882" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_ff2bd1af-e99e-47d4-9493-44e36132a2fe" xlink:to="loc_us-gaap_ClassOfStockLineItems_62ebed39-a29e-46f4-959c-1b8a52001882" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_90082289-9b64-4f90-9f4b-85dab5dedd12" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_62ebed39-a29e-46f4-959c-1b8a52001882" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_90082289-9b64-4f90-9f4b-85dab5dedd12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_3ccfef09-e63e-485f-b5de-2abd1d834415" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_62ebed39-a29e-46f4-959c-1b8a52001882" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_3ccfef09-e63e-485f-b5de-2abd1d834415" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_e31ba745-c752-49d7-a6ee-dda0017b4b26" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_62ebed39-a29e-46f4-959c-1b8a52001882" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_e31ba745-c752-49d7-a6ee-dda0017b4b26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="silk-20191231.xsd#CommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://silkroadmed.com/role/CommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_93a0410d-0f5b-48d1-b6bf-68a31599a5eb" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_106803e0-0c76-4625-8eed-fe7b6bb708af" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_93a0410d-0f5b-48d1-b6bf-68a31599a5eb" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_106803e0-0c76-4625-8eed-fe7b6bb708af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/CommitmentsandContingenciesTables" xlink:type="simple" xlink:href="silk-20191231.xsd#CommitmentsandContingenciesTables"/>
  <link:presentationLink xlink:role="http://silkroadmed.com/role/CommitmentsandContingenciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_a38f6bdc-5fd4-4799-b121-d9b083df7a96" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_AssetsAndLiabilitiesLesseeTableTextBlock_9bb6af9e-bfc7-4b59-9a80-82231e5b0aec" xlink:href="silk-20191231.xsd#silk_AssetsAndLiabilitiesLesseeTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_a38f6bdc-5fd4-4799-b121-d9b083df7a96" xlink:to="loc_silk_AssetsAndLiabilitiesLesseeTableTextBlock_9bb6af9e-bfc7-4b59-9a80-82231e5b0aec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_5fd90c48-22a8-4777-bd4c-2118bc7d0239" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_a38f6bdc-5fd4-4799-b121-d9b083df7a96" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_5fd90c48-22a8-4777-bd4c-2118bc7d0239" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_56d9d099-901d-4a4e-a707-b51d19ffb619" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_a38f6bdc-5fd4-4799-b121-d9b083df7a96" xlink:to="loc_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_56d9d099-901d-4a4e-a707-b51d19ffb619" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/CommitmentsandContingenciesLeaseNarrativeDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#CommitmentsandContingenciesLeaseNarrativeDetails"/>
  <link:presentationLink xlink:role="http://silkroadmed.com/role/CommitmentsandContingenciesLeaseNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_1d5dd994-d710-4bd5-affd-ac99295c7a6d" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_a41facef-76b3-4ebf-a9a6-266f5681bdd8" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_1d5dd994-d710-4bd5-affd-ac99295c7a6d" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_a41facef-76b3-4ebf-a9a6-266f5681bdd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_eca3b779-bf81-4797-af6b-1604dd705523" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_1d5dd994-d710-4bd5-affd-ac99295c7a6d" xlink:to="loc_us-gaap_OperatingLeaseCost_eca3b779-bf81-4797-af6b-1604dd705523" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_e526ffaa-a87b-462e-8ead-aed40a0f968c" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_1d5dd994-d710-4bd5-affd-ac99295c7a6d" xlink:to="loc_us-gaap_OperatingLeasePayments_e526ffaa-a87b-462e-8ead-aed40a0f968c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_bf1bf9d0-4783-40ae-a28e-41deb756e1e9" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_1d5dd994-d710-4bd5-affd-ac99295c7a6d" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_bf1bf9d0-4783-40ae-a28e-41deb756e1e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_42b70711-326a-414c-87e4-4d9e0ee8e3f1" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_1d5dd994-d710-4bd5-affd-ac99295c7a6d" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_42b70711-326a-414c-87e4-4d9e0ee8e3f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/CommitmentsandContingenciesBalanceSheetInformationDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#CommitmentsandContingenciesBalanceSheetInformationDetails"/>
  <link:presentationLink xlink:role="http://silkroadmed.com/role/CommitmentsandContingenciesBalanceSheetInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_6198d5b7-e877-402a-8111-caf7c8154f96" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_4620a16f-eb80-4e43-bbe8-cc91838e127a" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_6198d5b7-e877-402a-8111-caf7c8154f96" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_4620a16f-eb80-4e43-bbe8-cc91838e127a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_ba897c1c-5fef-4c6f-b4f1-38d9e117b434" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_6198d5b7-e877-402a-8111-caf7c8154f96" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_ba897c1c-5fef-4c6f-b4f1-38d9e117b434" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_52a7077a-112f-4501-8021-5428ee47363f" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_6198d5b7-e877-402a-8111-caf7c8154f96" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_52a7077a-112f-4501-8021-5428ee47363f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_67946621-8c79-4810-a639-c35a0908f52f" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_6198d5b7-e877-402a-8111-caf7c8154f96" xlink:to="loc_us-gaap_OperatingLeaseLiability_67946621-8c79-4810-a639-c35a0908f52f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/CommitmentsandContingenciesOperatingLeaseMaturitiesDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#CommitmentsandContingenciesOperatingLeaseMaturitiesDetails"/>
  <link:presentationLink xlink:role="http://silkroadmed.com/role/CommitmentsandContingenciesOperatingLeaseMaturitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_703d0e72-1f4a-4d64-a936-0b4908feffb4" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_c3e9c236-8320-44cd-b3c8-1ae12b374842" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_703d0e72-1f4a-4d64-a936-0b4908feffb4" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_c3e9c236-8320-44cd-b3c8-1ae12b374842" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_acda1915-f8f6-4c3a-9e80-3ec58c1bdf2e" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_703d0e72-1f4a-4d64-a936-0b4908feffb4" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_acda1915-f8f6-4c3a-9e80-3ec58c1bdf2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_6f59d9a2-5a67-44f3-8a76-cc45b813a044" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_703d0e72-1f4a-4d64-a936-0b4908feffb4" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_6f59d9a2-5a67-44f3-8a76-cc45b813a044" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_4e8ee92c-c5cb-4240-9f8f-16ebb6b72a5b" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_703d0e72-1f4a-4d64-a936-0b4908feffb4" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_4e8ee92c-c5cb-4240-9f8f-16ebb6b72a5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_14f5c26c-2a84-4161-8b29-8ca3d1ce8386" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_703d0e72-1f4a-4d64-a936-0b4908feffb4" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_14f5c26c-2a84-4161-8b29-8ca3d1ce8386" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_53bf66aa-e0a7-40d4-8217-a0bd79646620" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_703d0e72-1f4a-4d64-a936-0b4908feffb4" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_53bf66aa-e0a7-40d4-8217-a0bd79646620" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_87b949ca-776d-45d1-aaa6-63c0a4ca381a" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_703d0e72-1f4a-4d64-a936-0b4908feffb4" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_87b949ca-776d-45d1-aaa6-63c0a4ca381a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_f41846bf-48be-492c-a5a7-efa06e13ec71" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_703d0e72-1f4a-4d64-a936-0b4908feffb4" xlink:to="loc_us-gaap_OperatingLeaseLiability_f41846bf-48be-492c-a5a7-efa06e13ec71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/CommitmentsandContingenciesTopic840AggregateFutureMinimumLeasePaymentsDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#CommitmentsandContingenciesTopic840AggregateFutureMinimumLeasePaymentsDetails"/>
  <link:presentationLink xlink:role="http://silkroadmed.com/role/CommitmentsandContingenciesTopic840AggregateFutureMinimumLeasePaymentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_4e062442-c22d-4a98-b13c-90f25747efac" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_306723d6-0ed3-48a3-bebd-fb225a9f7372" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_4e062442-c22d-4a98-b13c-90f25747efac" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_306723d6-0ed3-48a3-bebd-fb225a9f7372" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_8c0dc523-e17a-4ec3-afc9-8d066360eceb" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_4e062442-c22d-4a98-b13c-90f25747efac" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_8c0dc523-e17a-4ec3-afc9-8d066360eceb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_4b88a837-f4fc-4747-bb69-b1733a8135e8" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_4e062442-c22d-4a98-b13c-90f25747efac" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_4b88a837-f4fc-4747-bb69-b1733a8135e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_5276df92-f6d9-4068-a9ef-d1509f52a460" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_4e062442-c22d-4a98-b13c-90f25747efac" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_5276df92-f6d9-4068-a9ef-d1509f52a460" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_e4db6499-8941-4350-9872-03efe5e55a93" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_4e062442-c22d-4a98-b13c-90f25747efac" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_e4db6499-8941-4350-9872-03efe5e55a93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_aee12376-92d2-4327-bf7a-9d0d14ee2342" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_4e062442-c22d-4a98-b13c-90f25747efac" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_aee12376-92d2-4327-bf7a-9d0d14ee2342" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/CommitmentsandContingenciesPurchaseObligationNarrativeDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#CommitmentsandContingenciesPurchaseObligationNarrativeDetails"/>
  <link:presentationLink xlink:role="http://silkroadmed.com/role/CommitmentsandContingenciesPurchaseObligationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_79d151a3-9c12-4664-8fe9-e0b709b7b980" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligation_af2d5b6e-46cd-464c-97b9-01562de24336" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PurchaseObligation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_79d151a3-9c12-4664-8fe9-e0b709b7b980" xlink:to="loc_us-gaap_PurchaseObligation_af2d5b6e-46cd-464c-97b9-01562de24336" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/RedeemableConvertiblePreferredStock" xlink:type="simple" xlink:href="silk-20191231.xsd#RedeemableConvertiblePreferredStock"/>
  <link:presentationLink xlink:role="http://silkroadmed.com/role/RedeemableConvertiblePreferredStock" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityDisclosureAbstract_bfd2a2ad-a388-4396-ba01-d85d5d995a8e" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TemporaryEquityDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_59dd7fdd-d081-4450-99e7-d020613763d0" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityDisclosureAbstract_bfd2a2ad-a388-4396-ba01-d85d5d995a8e" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_59dd7fdd-d081-4450-99e7-d020613763d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/RedeemableConvertiblePreferredStockTables" xlink:type="simple" xlink:href="silk-20191231.xsd#RedeemableConvertiblePreferredStockTables"/>
  <link:presentationLink xlink:role="http://silkroadmed.com/role/RedeemableConvertiblePreferredStockTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityDisclosureAbstract_6205b6eb-5f0f-4da7-a371-1bdebde9f41c" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TemporaryEquityDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityTableTextBlock_d19e826e-a200-419c-b54e-c746d1c6bdbd" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TemporaryEquityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityDisclosureAbstract_6205b6eb-5f0f-4da7-a371-1bdebde9f41c" xlink:to="loc_us-gaap_TemporaryEquityTableTextBlock_d19e826e-a200-419c-b54e-c746d1c6bdbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/RedeemableConvertiblePreferredStockScheduleofRedeemableConvertiblePreferredStockDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#RedeemableConvertiblePreferredStockScheduleofRedeemableConvertiblePreferredStockDetails"/>
  <link:presentationLink xlink:role="http://silkroadmed.com/role/RedeemableConvertiblePreferredStockScheduleofRedeemableConvertiblePreferredStockDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityDisclosureAbstract_a669b7ce-a5cd-4f9d-96e0-81ff3f8fb52b" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TemporaryEquityDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityByClassOfStockTable_bc6dc07a-cffb-45e2-a5de-4651335875cb" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TemporaryEquityByClassOfStockTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityDisclosureAbstract_a669b7ce-a5cd-4f9d-96e0-81ff3f8fb52b" xlink:to="loc_us-gaap_TemporaryEquityByClassOfStockTable_bc6dc07a-cffb-45e2-a5de-4651335875cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_3ea05169-df2b-491f-9e37-bf162c06b22a" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityByClassOfStockTable_bc6dc07a-cffb-45e2-a5de-4651335875cb" xlink:to="loc_us-gaap_StatementClassOfStockAxis_3ea05169-df2b-491f-9e37-bf162c06b22a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_d8750f43-d092-4772-ac06-b38a139ce547" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_3ea05169-df2b-491f-9e37-bf162c06b22a" xlink:to="loc_us-gaap_ClassOfStockDomain_d8750f43-d092-4772-ac06-b38a139ce547" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesAPreferredStockMember_4193e14f-ea68-46bd-8ac4-683b310a24e6" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_d8750f43-d092-4772-ac06-b38a139ce547" xlink:to="loc_us-gaap_SeriesAPreferredStockMember_4193e14f-ea68-46bd-8ac4-683b310a24e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_SeriesA1PreferredStockMember_d044815b-c7a0-49ac-97ea-767f546109fc" xlink:href="silk-20191231.xsd#silk_SeriesA1PreferredStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_d8750f43-d092-4772-ac06-b38a139ce547" xlink:to="loc_silk_SeriesA1PreferredStockMember_d044815b-c7a0-49ac-97ea-767f546109fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesBPreferredStockMember_25cb2daa-c1ec-4c7c-8231-5b719767bdc4" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_d8750f43-d092-4772-ac06-b38a139ce547" xlink:to="loc_us-gaap_SeriesBPreferredStockMember_25cb2daa-c1ec-4c7c-8231-5b719767bdc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesCPreferredStockMember_487da819-7c18-49a2-8d42-e4a8dc4b81b8" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SeriesCPreferredStockMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_d8750f43-d092-4772-ac06-b38a139ce547" xlink:to="loc_us-gaap_SeriesCPreferredStockMember_487da819-7c18-49a2-8d42-e4a8dc4b81b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityLineItems_faf14733-3996-4d59-a673-884aa2729b63" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TemporaryEquityLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityByClassOfStockTable_bc6dc07a-cffb-45e2-a5de-4651335875cb" xlink:to="loc_us-gaap_TemporaryEquityLineItems_faf14733-3996-4d59-a673-884aa2729b63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesAuthorized_e590aff0-ab2f-44f7-870f-72f717fd5e88" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TemporaryEquitySharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_faf14733-3996-4d59-a673-884aa2729b63" xlink:to="loc_us-gaap_TemporaryEquitySharesAuthorized_e590aff0-ab2f-44f7-870f-72f717fd5e88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesIssued_ad1b3611-0b3d-4499-952a-539ba6cd154f" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TemporaryEquitySharesIssued"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_faf14733-3996-4d59-a673-884aa2729b63" xlink:to="loc_us-gaap_TemporaryEquitySharesIssued_ad1b3611-0b3d-4499-952a-539ba6cd154f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_fd9c7001-0390-44d7-b657-977961f8aae4" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_faf14733-3996-4d59-a673-884aa2729b63" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_fd9c7001-0390-44d7-b657-977961f8aae4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityLiquidationPreferencePerShare_cd994d09-7bab-4aeb-b1ab-8b9c9b400e6e" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TemporaryEquityLiquidationPreferencePerShare"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_faf14733-3996-4d59-a673-884aa2729b63" xlink:to="loc_us-gaap_TemporaryEquityLiquidationPreferencePerShare_cd994d09-7bab-4aeb-b1ab-8b9c9b400e6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityLiquidationPreference_934d0481-8c79-47fe-a801-d8eef41ae5d9" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TemporaryEquityLiquidationPreference"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_faf14733-3996-4d59-a673-884aa2729b63" xlink:to="loc_us-gaap_TemporaryEquityLiquidationPreference_934d0481-8c79-47fe-a801-d8eef41ae5d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_541f97b9-6a67-44a3-b7f1-20b36b41473a" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_faf14733-3996-4d59-a673-884aa2729b63" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_541f97b9-6a67-44a3-b7f1-20b36b41473a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/RedeemableConvertiblePreferredStockNarrativeDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#RedeemableConvertiblePreferredStockNarrativeDetails"/>
  <link:presentationLink xlink:role="http://silkroadmed.com/role/RedeemableConvertiblePreferredStockNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityDisclosureAbstract_9cabaf76-585c-4530-ae24-37568ece44dc" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TemporaryEquityDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityByClassOfStockTable_4f62d6ee-df45-4ef6-9a5d-c62200c4fd13" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TemporaryEquityByClassOfStockTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityDisclosureAbstract_9cabaf76-585c-4530-ae24-37568ece44dc" xlink:to="loc_us-gaap_TemporaryEquityByClassOfStockTable_4f62d6ee-df45-4ef6-9a5d-c62200c4fd13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_f1f284b0-42c1-4530-b05f-5cc81ce924a6" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityByClassOfStockTable_4f62d6ee-df45-4ef6-9a5d-c62200c4fd13" xlink:to="loc_us-gaap_StatementClassOfStockAxis_f1f284b0-42c1-4530-b05f-5cc81ce924a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_bb08db65-100b-4bd3-86aa-15bc12a2606a" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_f1f284b0-42c1-4530-b05f-5cc81ce924a6" xlink:to="loc_us-gaap_ClassOfStockDomain_bb08db65-100b-4bd3-86aa-15bc12a2606a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertiblePreferredStockMember_ca1fbfcb-51c0-4e81-99a4-9d73cf6d7f7e" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConvertiblePreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_bb08db65-100b-4bd3-86aa-15bc12a2606a" xlink:to="loc_us-gaap_ConvertiblePreferredStockMember_ca1fbfcb-51c0-4e81-99a4-9d73cf6d7f7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_0b792b8e-9506-481a-91a0-4f6bae5cfc69" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityByClassOfStockTable_4f62d6ee-df45-4ef6-9a5d-c62200c4fd13" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_0b792b8e-9506-481a-91a0-4f6bae5cfc69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_ef6d85ec-6a9c-4efd-9306-03f6a0da6b5c" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_0b792b8e-9506-481a-91a0-4f6bae5cfc69" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_ef6d85ec-6a9c-4efd-9306-03f6a0da6b5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_PreferredStockWarrantsMember_e83b73bf-0b7b-4a88-8a09-229a446847c3" xlink:href="silk-20191231.xsd#silk_PreferredStockWarrantsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_ef6d85ec-6a9c-4efd-9306-03f6a0da6b5c" xlink:to="loc_silk_PreferredStockWarrantsMember_e83b73bf-0b7b-4a88-8a09-229a446847c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_9c41cb20-6732-489c-915f-36e50e7cd5c9" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityByClassOfStockTable_4f62d6ee-df45-4ef6-9a5d-c62200c4fd13" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_9c41cb20-6732-489c-915f-36e50e7cd5c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_e902e915-55df-49a8-ba1d-96891d344b5b" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_9c41cb20-6732-489c-915f-36e50e7cd5c9" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_e902e915-55df-49a8-ba1d-96891d344b5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IPOMember_d7d04e44-da4b-4813-ab48-cc545598f775" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IPOMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_e902e915-55df-49a8-ba1d-96891d344b5b" xlink:to="loc_us-gaap_IPOMember_d7d04e44-da4b-4813-ab48-cc545598f775" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityLineItems_a4ab0e8a-0508-40f1-9677-2268fdeeb026" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TemporaryEquityLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityByClassOfStockTable_4f62d6ee-df45-4ef6-9a5d-c62200c4fd13" xlink:to="loc_us-gaap_TemporaryEquityLineItems_a4ab0e8a-0508-40f1-9677-2268fdeeb026" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesIssued_7958787a-4887-4c55-bb8a-8e1ffca4c7e5" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TemporaryEquitySharesIssued"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_a4ab0e8a-0508-40f1-9677-2268fdeeb026" xlink:to="loc_us-gaap_TemporaryEquitySharesIssued_7958787a-4887-4c55-bb8a-8e1ffca4c7e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_2daf0d75-392c-4bc6-a003-cb359095b8da" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_a4ab0e8a-0508-40f1-9677-2268fdeeb026" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_2daf0d75-392c-4bc6-a003-cb359095b8da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_5d823580-6c78-48c6-a04a-605ba3a0ce90" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_a4ab0e8a-0508-40f1-9677-2268fdeeb026" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_5d823580-6c78-48c6-a04a-605ba3a0ce90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockSharesConverted1_01fca7e6-4c24-45d7-9ba1-d36dd426bb64" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConversionOfStockSharesConverted1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_a4ab0e8a-0508-40f1-9677-2268fdeeb026" xlink:to="loc_us-gaap_ConversionOfStockSharesConverted1_01fca7e6-4c24-45d7-9ba1-d36dd426bb64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_8db12fd1-6f5d-4c06-a32c-1252d2ebe266" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_a4ab0e8a-0508-40f1-9677-2268fdeeb026" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_8db12fd1-6f5d-4c06-a32c-1252d2ebe266" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/StockholdersEquityDeficit" xlink:type="simple" xlink:href="silk-20191231.xsd#StockholdersEquityDeficit"/>
  <link:presentationLink xlink:role="http://silkroadmed.com/role/StockholdersEquityDeficit" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_1f5a559a-06ca-4d37-b0dc-52352ce4868d" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_1cc933e8-5e3e-429b-a67f-3e288dfcea64" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_1f5a559a-06ca-4d37-b0dc-52352ce4868d" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_1cc933e8-5e3e-429b-a67f-3e288dfcea64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/StockholdersEquityDeficitTables" xlink:type="simple" xlink:href="silk-20191231.xsd#StockholdersEquityDeficitTables"/>
  <link:presentationLink xlink:role="http://silkroadmed.com/role/StockholdersEquityDeficitTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_e1e8ec6c-ac4b-46d9-962c-1121f18cc9df" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTextBlock_b2587fcd-a6ab-4593-a590-943727d7b56b" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfStockByClassTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_e1e8ec6c-ac4b-46d9-962c-1121f18cc9df" xlink:to="loc_us-gaap_ScheduleOfStockByClassTextBlock_b2587fcd-a6ab-4593-a590-943727d7b56b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/StockholdersEquityDeficitNarrativeDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#StockholdersEquityDeficitNarrativeDetails"/>
  <link:presentationLink xlink:role="http://silkroadmed.com/role/StockholdersEquityDeficitNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_bed98fb0-d3ee-4ffd-a925-f8ab21ef3ca0" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable_2463a20b-8e2a-4e6a-934c-b37b19bea98b" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_bed98fb0-d3ee-4ffd-a925-f8ab21ef3ca0" xlink:to="loc_us-gaap_ClassOfWarrantOrRightTable_2463a20b-8e2a-4e6a-934c-b37b19bea98b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_eeec04d3-b2f3-4b68-89e5-7e1c6504b67e" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_2463a20b-8e2a-4e6a-934c-b37b19bea98b" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_eeec04d3-b2f3-4b68-89e5-7e1c6504b67e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_c0eff54d-9c61-411f-b31b-cb004f923656" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_eeec04d3-b2f3-4b68-89e5-7e1c6504b67e" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_c0eff54d-9c61-411f-b31b-cb004f923656" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_CommonStockWarrantsMember_52beb7ee-9fa3-4e24-aa4d-26f01e0d8f50" xlink:href="silk-20191231.xsd#silk_CommonStockWarrantsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_c0eff54d-9c61-411f-b31b-cb004f923656" xlink:to="loc_silk_CommonStockWarrantsMember_52beb7ee-9fa3-4e24-aa4d-26f01e0d8f50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_CommonStockWarrantMember_83f545c4-e61d-4219-adf2-632fb29ca82d" xlink:href="silk-20191231.xsd#silk_CommonStockWarrantMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_c0eff54d-9c61-411f-b31b-cb004f923656" xlink:to="loc_silk_CommonStockWarrantMember_83f545c4-e61d-4219-adf2-632fb29ca82d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_fcf27a35-220f-443b-9d8d-a6453af9ded0" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_2463a20b-8e2a-4e6a-934c-b37b19bea98b" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_fcf27a35-220f-443b-9d8d-a6453af9ded0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_4d07fdb7-e155-49b1-9e56-5a7da0766e08" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_fcf27a35-220f-443b-9d8d-a6453af9ded0" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_4d07fdb7-e155-49b1-9e56-5a7da0766e08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IPOMember_0e9e9a50-ecbe-4e7d-809e-9f3285081cdc" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IPOMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_4d07fdb7-e155-49b1-9e56-5a7da0766e08" xlink:to="loc_us-gaap_IPOMember_0e9e9a50-ecbe-4e7d-809e-9f3285081cdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems_f415f6dd-54c5-4a51-97e0-796f9a43bcfc" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_2463a20b-8e2a-4e6a-934c-b37b19bea98b" xlink:to="loc_us-gaap_ClassOfWarrantOrRightLineItems_f415f6dd-54c5-4a51-97e0-796f9a43bcfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_b1ff9645-f422-4c06-8268-058ad38dd0f8" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_f415f6dd-54c5-4a51-97e0-796f9a43bcfc" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_b1ff9645-f422-4c06-8268-058ad38dd0f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_0b3b630b-bc23-4cd2-9db6-d98ed743335c" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_f415f6dd-54c5-4a51-97e0-796f9a43bcfc" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_0b3b630b-bc23-4cd2-9db6-d98ed743335c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_baa6d74d-9b00-4e06-838e-a4bed58bbfad" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_f415f6dd-54c5-4a51-97e0-796f9a43bcfc" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_baa6d74d-9b00-4e06-838e-a4bed58bbfad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_bc688820-4725-41b8-b54b-a3822febf502" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_f415f6dd-54c5-4a51-97e0-796f9a43bcfc" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_bc688820-4725-41b8-b54b-a3822febf502" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_861ae87f-829f-42f8-8bcd-77705ccdc34f" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_f415f6dd-54c5-4a51-97e0-796f9a43bcfc" xlink:to="loc_us-gaap_CommonStockSharesIssued_861ae87f-829f-42f8-8bcd-77705ccdc34f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_da276cce-f183-4dd5-94e3-e1e45b0ca354" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_f415f6dd-54c5-4a51-97e0-796f9a43bcfc" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_da276cce-f183-4dd5-94e3-e1e45b0ca354" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStock_1d8dc7a7-f23c-49db-8ce6-3a581035a59d" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DividendsCommonStock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_f415f6dd-54c5-4a51-97e0-796f9a43bcfc" xlink:to="loc_us-gaap_DividendsCommonStock_1d8dc7a7-f23c-49db-8ce6-3a581035a59d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_CommonStockVotePerShare_55362649-01b8-4f45-83ea-0474ba7b5bd2" xlink:href="silk-20191231.xsd#silk_CommonStockVotePerShare"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_f415f6dd-54c5-4a51-97e0-796f9a43bcfc" xlink:to="loc_silk_CommonStockVotePerShare_55362649-01b8-4f45-83ea-0474ba7b5bd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_c4460019-facc-481d-adb4-2d2622dbbc8a" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_f415f6dd-54c5-4a51-97e0-796f9a43bcfc" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_c4460019-facc-481d-adb4-2d2622dbbc8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockSharesConverted1_d6d8b164-69e0-4430-928a-3b68963f96b9" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConversionOfStockSharesConverted1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_f415f6dd-54c5-4a51-97e0-796f9a43bcfc" xlink:to="loc_us-gaap_ConversionOfStockSharesConverted1_d6d8b164-69e0-4430-928a-3b68963f96b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_dd2aeef1-e0b6-40c8-8e82-ab7815b96c6d" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_f415f6dd-54c5-4a51-97e0-796f9a43bcfc" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_dd2aeef1-e0b6-40c8-8e82-ab7815b96c6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/StockholdersEquityDeficitSharesReservedforFutureIssuanceDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#StockholdersEquityDeficitSharesReservedforFutureIssuanceDetails"/>
  <link:presentationLink xlink:role="http://silkroadmed.com/role/StockholdersEquityDeficitSharesReservedforFutureIssuanceDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_7ed1222f-7104-44d5-b51f-beef1bd474db" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_af4d2c05-60c5-4fd9-a9f8-e8782d72b1e8" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_7ed1222f-7104-44d5-b51f-beef1bd474db" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_af4d2c05-60c5-4fd9-a9f8-e8782d72b1e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_41910512-644f-46ad-8893-829f13a45f47" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_af4d2c05-60c5-4fd9-a9f8-e8782d72b1e8" xlink:to="loc_us-gaap_StatementClassOfStockAxis_41910512-644f-46ad-8893-829f13a45f47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_3f6de653-8639-492f-a38d-7ac50e35fe83" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_41910512-644f-46ad-8893-829f13a45f47" xlink:to="loc_us-gaap_ClassOfStockDomain_3f6de653-8639-492f-a38d-7ac50e35fe83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesAPreferredStockMember_fe173c03-ed84-4c71-95cb-73daa375738e" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_3f6de653-8639-492f-a38d-7ac50e35fe83" xlink:to="loc_us-gaap_SeriesAPreferredStockMember_fe173c03-ed84-4c71-95cb-73daa375738e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_SeriesA1PreferredStockMember_a05d560f-90a1-4bb3-8898-3bce04a98e0a" xlink:href="silk-20191231.xsd#silk_SeriesA1PreferredStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_3f6de653-8639-492f-a38d-7ac50e35fe83" xlink:to="loc_silk_SeriesA1PreferredStockMember_a05d560f-90a1-4bb3-8898-3bce04a98e0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesBPreferredStockMember_9df4ad6f-0a57-4d12-879f-fa8feae761dd" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_3f6de653-8639-492f-a38d-7ac50e35fe83" xlink:to="loc_us-gaap_SeriesBPreferredStockMember_9df4ad6f-0a57-4d12-879f-fa8feae761dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesCPreferredStockMember_d971e29c-bea2-4e08-9b1c-01e2fe7afa89" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SeriesCPreferredStockMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_3f6de653-8639-492f-a38d-7ac50e35fe83" xlink:to="loc_us-gaap_SeriesCPreferredStockMember_d971e29c-bea2-4e08-9b1c-01e2fe7afa89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_eb0d5a52-3346-4043-b3d2-ea791477ea9b" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_af4d2c05-60c5-4fd9-a9f8-e8782d72b1e8" xlink:to="loc_us-gaap_AwardTypeAxis_eb0d5a52-3346-4043-b3d2-ea791477ea9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ee2aa987-62f2-4a6a-8b09-12a6c0d98a21" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_eb0d5a52-3346-4043-b3d2-ea791477ea9b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ee2aa987-62f2-4a6a-8b09-12a6c0d98a21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_IncentiveandNonqualifiedStockOptionExercisedMember_b91c7099-9e69-4d2a-acb7-caf249a8aa37" xlink:href="silk-20191231.xsd#silk_IncentiveandNonqualifiedStockOptionExercisedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ee2aa987-62f2-4a6a-8b09-12a6c0d98a21" xlink:to="loc_silk_IncentiveandNonqualifiedStockOptionExercisedMember_b91c7099-9e69-4d2a-acb7-caf249a8aa37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_IncentiveandNonqualifiedStockOptionIssuedMember_cae57a88-307e-47c4-addc-93c99e1a679c" xlink:href="silk-20191231.xsd#silk_IncentiveandNonqualifiedStockOptionIssuedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ee2aa987-62f2-4a6a-8b09-12a6c0d98a21" xlink:to="loc_silk_IncentiveandNonqualifiedStockOptionIssuedMember_cae57a88-307e-47c4-addc-93c99e1a679c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_EmployeeStockPurchasePlanMember_7163287f-52c8-4c4e-912d-cae30c68ffc6" xlink:href="silk-20191231.xsd#silk_EmployeeStockPurchasePlanMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ee2aa987-62f2-4a6a-8b09-12a6c0d98a21" xlink:to="loc_silk_EmployeeStockPurchasePlanMember_7163287f-52c8-4c4e-912d-cae30c68ffc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_eb3567a4-e227-4177-848a-a3954b26b233" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_af4d2c05-60c5-4fd9-a9f8-e8782d72b1e8" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_eb3567a4-e227-4177-848a-a3954b26b233" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_570178c1-12a1-47fb-bdfa-3dc9deaab1e8" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_eb3567a4-e227-4177-848a-a3954b26b233" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_570178c1-12a1-47fb-bdfa-3dc9deaab1e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_CommonStockWarrantsMember_7983cf3c-bbeb-4088-a82e-8e5f82c9fbf9" xlink:href="silk-20191231.xsd#silk_CommonStockWarrantsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_570178c1-12a1-47fb-bdfa-3dc9deaab1e8" xlink:to="loc_silk_CommonStockWarrantsMember_7983cf3c-bbeb-4088-a82e-8e5f82c9fbf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_703d4dc2-c8f2-4515-998a-b2b83df1e849" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_af4d2c05-60c5-4fd9-a9f8-e8782d72b1e8" xlink:to="loc_us-gaap_ClassOfStockLineItems_703d4dc2-c8f2-4515-998a-b2b83df1e849" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_1e28490d-e22a-48c1-9cc5-1f2316ec5284" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_703d4dc2-c8f2-4515-998a-b2b83df1e849" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_1e28490d-e22a-48c1-9cc5-1f2316ec5284" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/StockOptionPlans" xlink:type="simple" xlink:href="silk-20191231.xsd#StockOptionPlans"/>
  <link:presentationLink xlink:role="http://silkroadmed.com/role/StockOptionPlans" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_bd314102-a4a5-430c-bc33-40d8fb4b98b8" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_216465f2-fe57-4195-91a8-7f7f4161ec70" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_bd314102-a4a5-430c-bc33-40d8fb4b98b8" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_216465f2-fe57-4195-91a8-7f7f4161ec70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/StockOptionPlansTables" xlink:type="simple" xlink:href="silk-20191231.xsd#StockOptionPlansTables"/>
  <link:presentationLink xlink:role="http://silkroadmed.com/role/StockOptionPlansTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a6e428df-7589-4586-8263-90f48e9f3d21" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_636d4379-eac6-46e8-a355-472758bc7664" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a6e428df-7589-4586-8263-90f48e9f3d21" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_636d4379-eac6-46e8-a355-472758bc7664" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_24608dac-2b2f-4319-960c-be8126ba5b17" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a6e428df-7589-4586-8263-90f48e9f3d21" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_24608dac-2b2f-4319-960c-be8126ba5b17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_e44f5d71-b0a1-4875-b88e-f52fcb4fc7e7" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a6e428df-7589-4586-8263-90f48e9f3d21" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_e44f5d71-b0a1-4875-b88e-f52fcb4fc7e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_49b93072-958a-4ec6-8ba2-9c61f76aaa32" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a6e428df-7589-4586-8263-90f48e9f3d21" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_49b93072-958a-4ec6-8ba2-9c61f76aaa32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/StockOptionPlansNarrativeDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#StockOptionPlansNarrativeDetails"/>
  <link:presentationLink xlink:role="http://silkroadmed.com/role/StockOptionPlansNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_9c632264-64ee-4981-beea-e0d02bf14cb8" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bbd5d95c-6b8c-4ffb-a15e-25855023e744" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_9c632264-64ee-4981-beea-e0d02bf14cb8" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bbd5d95c-6b8c-4ffb-a15e-25855023e744" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_01799a6e-b1e2-44dc-9deb-7aefda42ef9a" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bbd5d95c-6b8c-4ffb-a15e-25855023e744" xlink:to="loc_us-gaap_PlanNameAxis_01799a6e-b1e2-44dc-9deb-7aefda42ef9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_ed7441b2-8b52-4671-86ca-fe6db240e1e6" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_01799a6e-b1e2-44dc-9deb-7aefda42ef9a" xlink:to="loc_us-gaap_PlanNameDomain_ed7441b2-8b52-4671-86ca-fe6db240e1e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_TwoThousandNineteenStockOptionPlanMember_a5adb130-360b-4293-a97b-1ac04ca0d5d1" xlink:href="silk-20191231.xsd#silk_TwoThousandNineteenStockOptionPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_ed7441b2-8b52-4671-86ca-fe6db240e1e6" xlink:to="loc_silk_TwoThousandNineteenStockOptionPlanMember_a5adb130-360b-4293-a97b-1ac04ca0d5d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_9bdfeb4b-c605-4d3d-9236-e743c8b16fcc" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bbd5d95c-6b8c-4ffb-a15e-25855023e744" xlink:to="loc_srt_RangeAxis_9bdfeb4b-c605-4d3d-9236-e743c8b16fcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_491d5372-ef03-4b91-9f16-c8aa267f41f4" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_9bdfeb4b-c605-4d3d-9236-e743c8b16fcc" xlink:to="loc_srt_RangeMember_491d5372-ef03-4b91-9f16-c8aa267f41f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_9dfed674-6e9c-4f5f-84d7-4f66355c2512" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_491d5372-ef03-4b91-9f16-c8aa267f41f4" xlink:to="loc_srt_MaximumMember_9dfed674-6e9c-4f5f-84d7-4f66355c2512" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_46c508cf-45b5-41b6-8277-802f315772cf" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bbd5d95c-6b8c-4ffb-a15e-25855023e744" xlink:to="loc_us-gaap_AwardTypeAxis_46c508cf-45b5-41b6-8277-802f315772cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_55127b27-bbc1-4010-a619-88d2566c8d56" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_46c508cf-45b5-41b6-8277-802f315772cf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_55127b27-bbc1-4010-a619-88d2566c8d56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_IncentiveStockOptionMember_ad54921c-4a79-41f8-a708-4d314b30aaf1" xlink:href="silk-20191231.xsd#silk_IncentiveStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_55127b27-bbc1-4010-a619-88d2566c8d56" xlink:to="loc_silk_IncentiveStockOptionMember_ad54921c-4a79-41f8-a708-4d314b30aaf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_NonqualifiedStockOptionsMember_40d50c64-f95a-49f9-bcac-a8983fc190dc" xlink:href="silk-20191231.xsd#silk_NonqualifiedStockOptionsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_55127b27-bbc1-4010-a619-88d2566c8d56" xlink:to="loc_silk_NonqualifiedStockOptionsMember_40d50c64-f95a-49f9-bcac-a8983fc190dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_IncentiveandNonqualifiedStockOptionMember_692c9f88-10d3-44a9-a1e0-3d35b63df82e" xlink:href="silk-20191231.xsd#silk_IncentiveandNonqualifiedStockOptionMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_55127b27-bbc1-4010-a619-88d2566c8d56" xlink:to="loc_silk_IncentiveandNonqualifiedStockOptionMember_692c9f88-10d3-44a9-a1e0-3d35b63df82e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_0f5679f5-4d4c-426c-81ec-042f0d9ad079" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_55127b27-bbc1-4010-a619-88d2566c8d56" xlink:to="loc_us-gaap_EmployeeStockOptionMember_0f5679f5-4d4c-426c-81ec-042f0d9ad079" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_c78b9ad2-14e2-4f66-b849-6026b2fe38bb" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bbd5d95c-6b8c-4ffb-a15e-25855023e744" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_c78b9ad2-14e2-4f66-b849-6026b2fe38bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_ff1bc4d6-a6f9-4f3f-82c6-8625f78008af" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_c78b9ad2-14e2-4f66-b849-6026b2fe38bb" xlink:to="loc_us-gaap_RelatedPartyDomain_ff1bc4d6-a6f9-4f3f-82c6-8625f78008af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrincipalOwnerMember_57fc00ef-fb24-4897-be6c-68eba2a27625" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PrincipalOwnerMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_ff1bc4d6-a6f9-4f3f-82c6-8625f78008af" xlink:to="loc_us-gaap_PrincipalOwnerMember_57fc00ef-fb24-4897-be6c-68eba2a27625" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a6bd2b50-2484-4df1-b1c6-3db619b4cc5f" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bbd5d95c-6b8c-4ffb-a15e-25855023e744" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a6bd2b50-2484-4df1-b1c6-3db619b4cc5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_e23bb93a-d913-4f2d-adae-44b8b2e6a4eb" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a6bd2b50-2484-4df1-b1c6-3db619b4cc5f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_e23bb93a-d913-4f2d-adae-44b8b2e6a4eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_6b70cbcd-907e-4657-8af1-3c93c7f2ee44" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a6bd2b50-2484-4df1-b1c6-3db619b4cc5f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_6b70cbcd-907e-4657-8af1-3c93c7f2ee44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExerciseThresholdasaPercentageofSharePrice_30680e47-ea11-486c-b736-7fb3d044535d" xlink:href="silk-20191231.xsd#silk_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExerciseThresholdasaPercentageofSharePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a6bd2b50-2484-4df1-b1c6-3db619b4cc5f" xlink:to="loc_silk_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExerciseThresholdasaPercentageofSharePrice_30680e47-ea11-486c-b736-7fb3d044535d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_907fc83c-cbf4-4b00-8134-23c08fcb8bf8" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a6bd2b50-2484-4df1-b1c6-3db619b4cc5f" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_907fc83c-cbf4-4b00-8134-23c08fcb8bf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_b57fb013-f908-44c6-b869-2633a466f03e" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a6bd2b50-2484-4df1-b1c6-3db619b4cc5f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_b57fb013-f908-44c6-b869-2633a466f03e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_d109d1b0-ccf5-4968-9c70-906ba27bca08" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a6bd2b50-2484-4df1-b1c6-3db619b4cc5f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_d109d1b0-ccf5-4968-9c70-906ba27bca08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_479c5104-674b-4354-9bfe-de1f13043472" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a6bd2b50-2484-4df1-b1c6-3db619b4cc5f" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_479c5104-674b-4354-9bfe-de1f13043472" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_0577b004-f0b6-4dce-bf77-38b6c6e6a30e" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a6bd2b50-2484-4df1-b1c6-3db619b4cc5f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_0577b004-f0b6-4dce-bf77-38b6c6e6a30e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_45697e21-01ff-42de-8f41-feab8e2e1373" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a6bd2b50-2484-4df1-b1c6-3db619b4cc5f" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_45697e21-01ff-42de-8f41-feab8e2e1373" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum_2352a1a7-4f2f-401d-8955-ac3c47891668" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a6bd2b50-2484-4df1-b1c6-3db619b4cc5f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum_2352a1a7-4f2f-401d-8955-ac3c47891668" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_2f27c1d9-a1d4-41b4-878a-c43ff2cbc595" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a6bd2b50-2484-4df1-b1c6-3db619b4cc5f" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_2f27c1d9-a1d4-41b4-878a-c43ff2cbc595" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_9ee4c360-2682-4ed4-8d73-00ac84a17a16" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a6bd2b50-2484-4df1-b1c6-3db619b4cc5f" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_9ee4c360-2682-4ed4-8d73-00ac84a17a16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_ShareBasedCompensationArrangementBySharebasedPaymentAwardNumberOfAdditionalSharesAllowableUnderThePlan_7eff3595-fe1c-447d-bb38-794816e289f5" xlink:href="silk-20191231.xsd#silk_ShareBasedCompensationArrangementBySharebasedPaymentAwardNumberOfAdditionalSharesAllowableUnderThePlan"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a6bd2b50-2484-4df1-b1c6-3db619b4cc5f" xlink:to="loc_silk_ShareBasedCompensationArrangementBySharebasedPaymentAwardNumberOfAdditionalSharesAllowableUnderThePlan_7eff3595-fe1c-447d-bb38-794816e289f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_eae2c4e1-0999-4fd5-8a84-1177636b5b70" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a6bd2b50-2484-4df1-b1c6-3db619b4cc5f" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_eae2c4e1-0999-4fd5-8a84-1177636b5b70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_2c645b26-2526-4e07-a6f0-e4b98dd10730" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a6bd2b50-2484-4df1-b1c6-3db619b4cc5f" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_2c645b26-2526-4e07-a6f0-e4b98dd10730" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_e22e24b8-9e46-4847-8d6d-16bd7ebfa9a9" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a6bd2b50-2484-4df1-b1c6-3db619b4cc5f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_e22e24b8-9e46-4847-8d6d-16bd7ebfa9a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/StockOptionPlansActivityUnderCompensationPlanDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#StockOptionPlansActivityUnderCompensationPlanDetails"/>
  <link:presentationLink xlink:role="http://silkroadmed.com/role/StockOptionPlansActivityUnderCompensationPlanDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_cfd063ce-f466-4be2-ac2e-4320ea838285" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardsAvailableforGrantRollForward_fad643ac-02ed-4c7f-bd43-b84c4733d9f5" xlink:href="silk-20191231.xsd#silk_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardsAvailableforGrantRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_cfd063ce-f466-4be2-ac2e-4320ea838285" xlink:to="loc_silk_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardsAvailableforGrantRollForward_fad643ac-02ed-4c7f-bd43-b84c4733d9f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_1fe1f881-ced2-4453-9de8-cb2f02ff89fa" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_silk_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardsAvailableforGrantRollForward_fad643ac-02ed-4c7f-bd43-b84c4733d9f5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_1fe1f881-ced2-4453-9de8-cb2f02ff89fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_323b68c7-1fd2-46ea-8442-2bdb973af52c" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_silk_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardsAvailableforGrantRollForward_fad643ac-02ed-4c7f-bd43-b84c4733d9f5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_323b68c7-1fd2-46ea-8442-2bdb973af52c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_08913692-4ae8-471a-90e1-2cb916a7700a" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_silk_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardsAvailableforGrantRollForward_fad643ac-02ed-4c7f-bd43-b84c4733d9f5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_08913692-4ae8-471a-90e1-2cb916a7700a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_ce8b2ad0-5809-4ca6-999c-a374d7dd9108" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_silk_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardsAvailableforGrantRollForward_fad643ac-02ed-4c7f-bd43-b84c4733d9f5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_ce8b2ad0-5809-4ca6-999c-a374d7dd9108" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_49777eee-9bea-47f9-8a3f-94f9f75e58ef" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_silk_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardsAvailableforGrantRollForward_fad643ac-02ed-4c7f-bd43-b84c4733d9f5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_49777eee-9bea-47f9-8a3f-94f9f75e58ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_b208b6f4-0cb8-4d46-aa4b-5921898f97f2" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_cfd063ce-f466-4be2-ac2e-4320ea838285" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_b208b6f4-0cb8-4d46-aa4b-5921898f97f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c783f39a-e97d-427a-a15f-1852e4745516" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_b208b6f4-0cb8-4d46-aa4b-5921898f97f2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c783f39a-e97d-427a-a15f-1852e4745516" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_66db0177-032f-4014-b387-f2bf6184f889" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_b208b6f4-0cb8-4d46-aa4b-5921898f97f2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_66db0177-032f-4014-b387-f2bf6184f889" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_09700714-8053-42ea-81cd-e531c7191803" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_b208b6f4-0cb8-4d46-aa4b-5921898f97f2" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_09700714-8053-42ea-81cd-e531c7191803" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_d003e36a-8222-42b7-aeeb-d2062f00b28b" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_b208b6f4-0cb8-4d46-aa4b-5921898f97f2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_d003e36a-8222-42b7-aeeb-d2062f00b28b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_9ece071c-b668-47df-ac83-8f76468f2383" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_b208b6f4-0cb8-4d46-aa4b-5921898f97f2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_9ece071c-b668-47df-ac83-8f76468f2383" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_50b8902c-f152-4f5e-8784-3d21898ae1c7" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_cfd063ce-f466-4be2-ac2e-4320ea838285" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_50b8902c-f152-4f5e-8784-3d21898ae1c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_cb1b5d7f-3660-48bd-a95f-c57cff9fb2d0" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_50b8902c-f152-4f5e-8784-3d21898ae1c7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_cb1b5d7f-3660-48bd-a95f-c57cff9fb2d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_d92e8ea8-efa8-40d9-914f-bf255432dbbd" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_50b8902c-f152-4f5e-8784-3d21898ae1c7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_d92e8ea8-efa8-40d9-914f-bf255432dbbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_3444dd4c-c313-4060-9f21-d7d701bb718f" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_50b8902c-f152-4f5e-8784-3d21898ae1c7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_3444dd4c-c313-4060-9f21-d7d701bb718f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_ad2e2fd9-8a29-43f8-8558-61aafdaa0c02" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_50b8902c-f152-4f5e-8784-3d21898ae1c7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_ad2e2fd9-8a29-43f8-8558-61aafdaa0c02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_bbf8bd06-40d7-4b3a-95d2-1f12b3adc563" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_50b8902c-f152-4f5e-8784-3d21898ae1c7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_bbf8bd06-40d7-4b3a-95d2-1f12b3adc563" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_19eb9e92-f1a3-4231-a641-59116da741b6" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_cfd063ce-f466-4be2-ac2e-4320ea838285" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_19eb9e92-f1a3-4231-a641-59116da741b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_b8a8dcc4-ae4e-4491-8050-b6128291fd20" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_cfd063ce-f466-4be2-ac2e-4320ea838285" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_b8a8dcc4-ae4e-4491-8050-b6128291fd20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_4e2adce4-089d-4265-96d8-3b0a9aa4147c" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_cfd063ce-f466-4be2-ac2e-4320ea838285" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_4e2adce4-089d-4265-96d8-3b0a9aa4147c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_170eb0ed-7ed5-4a12-ab1d-51aa208ffe0a" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_cfd063ce-f466-4be2-ac2e-4320ea838285" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_170eb0ed-7ed5-4a12-ab1d-51aa208ffe0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_97af2f4e-f5d0-4df2-ab26-4fc272ef198e" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_cfd063ce-f466-4be2-ac2e-4320ea838285" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_97af2f4e-f5d0-4df2-ab26-4fc272ef198e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_c17984c8-6801-4465-8f44-651067bd25bd" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_cfd063ce-f466-4be2-ac2e-4320ea838285" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_c17984c8-6801-4465-8f44-651067bd25bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_0ac12652-e70e-4887-a811-1258281c3596" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_cfd063ce-f466-4be2-ac2e-4320ea838285" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_0ac12652-e70e-4887-a811-1258281c3596" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_7c621ad0-c18f-47a1-9475-9c03b0cb3959" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_cfd063ce-f466-4be2-ac2e-4320ea838285" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_7c621ad0-c18f-47a1-9475-9c03b0cb3959" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_4665c607-114a-4b79-954f-09c7842bc8a7" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_cfd063ce-f466-4be2-ac2e-4320ea838285" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_4665c607-114a-4b79-954f-09c7842bc8a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_5e6a72c0-6f92-47de-9648-33bab6f12297" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_cfd063ce-f466-4be2-ac2e-4320ea838285" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_5e6a72c0-6f92-47de-9648-33bab6f12297" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/StockOptionPlansInformationbyExercisePriceDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#StockOptionPlansInformationbyExercisePriceDetails"/>
  <link:presentationLink xlink:role="http://silkroadmed.com/role/StockOptionPlansInformationbyExercisePriceDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_8133d11a-0e7a-4c5e-9f92-e349ac4cc17f" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_4efc3e62-fb94-40f4-a78b-eab25c960149" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_8133d11a-0e7a-4c5e-9f92-e349ac4cc17f" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_4efc3e62-fb94-40f4-a78b-eab25c960149" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_a7c35ee6-b9a7-433b-ba44-90a6b2b2a941" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_4efc3e62-fb94-40f4-a78b-eab25c960149" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_a7c35ee6-b9a7-433b-ba44-90a6b2b2a941" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_6297eb4a-9368-40bf-9fb7-6cf6190a560d" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_a7c35ee6-b9a7-433b-ba44-90a6b2b2a941" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_6297eb4a-9368-40bf-9fb7-6cf6190a560d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_ExercisePriceOneMember_ecc44e93-15e6-4297-bf88-3de60dd820ca" xlink:href="silk-20191231.xsd#silk_ExercisePriceOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_6297eb4a-9368-40bf-9fb7-6cf6190a560d" xlink:to="loc_silk_ExercisePriceOneMember_ecc44e93-15e6-4297-bf88-3de60dd820ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_ExercisePriceTwoMember_86cb29ad-1d99-45f4-bb82-2b24f93959db" xlink:href="silk-20191231.xsd#silk_ExercisePriceTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_6297eb4a-9368-40bf-9fb7-6cf6190a560d" xlink:to="loc_silk_ExercisePriceTwoMember_86cb29ad-1d99-45f4-bb82-2b24f93959db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_ExercisePriceThreeMember_56d079fb-599d-474d-82e6-9e59870c2dda" xlink:href="silk-20191231.xsd#silk_ExercisePriceThreeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_6297eb4a-9368-40bf-9fb7-6cf6190a560d" xlink:to="loc_silk_ExercisePriceThreeMember_56d079fb-599d-474d-82e6-9e59870c2dda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_ExercisePriceFourMember_6182c2e8-0fcf-4d79-8da9-f03cb1abf23b" xlink:href="silk-20191231.xsd#silk_ExercisePriceFourMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_6297eb4a-9368-40bf-9fb7-6cf6190a560d" xlink:to="loc_silk_ExercisePriceFourMember_6182c2e8-0fcf-4d79-8da9-f03cb1abf23b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_2eab8ad8-68cd-4d07-8e8a-bf2810c9b11c" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_4efc3e62-fb94-40f4-a78b-eab25c960149" xlink:to="loc_srt_RangeAxis_2eab8ad8-68cd-4d07-8e8a-bf2810c9b11c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_405bfe98-43fc-4e7f-96c2-41546b0fa567" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_2eab8ad8-68cd-4d07-8e8a-bf2810c9b11c" xlink:to="loc_srt_RangeMember_405bfe98-43fc-4e7f-96c2-41546b0fa567" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_6ec5f017-c39c-42cf-b312-0fabf6f3fa75" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_405bfe98-43fc-4e7f-96c2-41546b0fa567" xlink:to="loc_srt_MinimumMember_6ec5f017-c39c-42cf-b312-0fabf6f3fa75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_a141cb1a-cbff-4f7d-8bb6-51085916a788" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_405bfe98-43fc-4e7f-96c2-41546b0fa567" xlink:to="loc_srt_MaximumMember_a141cb1a-cbff-4f7d-8bb6-51085916a788" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_fa6ef3d0-0f4c-4e19-b414-e0df683402c8" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_4efc3e62-fb94-40f4-a78b-eab25c960149" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_fa6ef3d0-0f4c-4e19-b414-e0df683402c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice_cbdfc92b-e4b6-47ea-8b14-1018a739ee3b" xlink:href="silk-20191231.xsd#silk_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_fa6ef3d0-0f4c-4e19-b414-e0df683402c8" xlink:to="loc_silk_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice_cbdfc92b-e4b6-47ea-8b14-1018a739ee3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_e63b3f70-f98d-4b3e-a049-ed13de429733" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_fa6ef3d0-0f4c-4e19-b414-e0df683402c8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_e63b3f70-f98d-4b3e-a049-ed13de429733" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_89f332b5-31a0-4e5b-bb06-57b3b20fcda0" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_fa6ef3d0-0f4c-4e19-b414-e0df683402c8" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_89f332b5-31a0-4e5b-bb06-57b3b20fcda0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_9e3ff7eb-8f15-4335-93eb-792c143992ee" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_fa6ef3d0-0f4c-4e19-b414-e0df683402c8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_9e3ff7eb-8f15-4335-93eb-792c143992ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c0eba447-6942-40c7-8362-dcd41529762c" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_fa6ef3d0-0f4c-4e19-b414-e0df683402c8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c0eba447-6942-40c7-8362-dcd41529762c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_cbf14faa-983a-4cb4-993e-cd1c4d235377" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_fa6ef3d0-0f4c-4e19-b414-e0df683402c8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_cbf14faa-983a-4cb4-993e-cd1c4d235377" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/StockOptionPlansStockOptionAssumptionsDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#StockOptionPlansStockOptionAssumptionsDetails"/>
  <link:presentationLink xlink:role="http://silkroadmed.com/role/StockOptionPlansStockOptionAssumptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6d4268f6-e844-43d6-8f6e-943032770984" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9d1012f8-9268-4456-8102-3f12b4693b20" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6d4268f6-e844-43d6-8f6e-943032770984" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9d1012f8-9268-4456-8102-3f12b4693b20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_3bc1132e-d73c-4a43-9ba2-d8aa3206e8a0" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9d1012f8-9268-4456-8102-3f12b4693b20" xlink:to="loc_srt_RangeAxis_3bc1132e-d73c-4a43-9ba2-d8aa3206e8a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_afac2682-1490-4206-bc3b-5b56b2c6e0f4" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_3bc1132e-d73c-4a43-9ba2-d8aa3206e8a0" xlink:to="loc_srt_RangeMember_afac2682-1490-4206-bc3b-5b56b2c6e0f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_80ce4a6f-8532-42ea-bf6a-f13d2e8ed8f1" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_afac2682-1490-4206-bc3b-5b56b2c6e0f4" xlink:to="loc_srt_MinimumMember_80ce4a6f-8532-42ea-bf6a-f13d2e8ed8f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_fe2a3261-621c-4209-bc45-d4461f9406e8" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_afac2682-1490-4206-bc3b-5b56b2c6e0f4" xlink:to="loc_srt_MaximumMember_fe2a3261-621c-4209-bc45-d4461f9406e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_27ccb98f-9f89-48cd-a0f8-e19366a45804" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9d1012f8-9268-4456-8102-3f12b4693b20" xlink:to="loc_us-gaap_AwardTypeAxis_27ccb98f-9f89-48cd-a0f8-e19366a45804" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a45cce2c-df11-40ac-801b-64943a2effc8" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_27ccb98f-9f89-48cd-a0f8-e19366a45804" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a45cce2c-df11-40ac-801b-64943a2effc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_599262c9-6f05-4514-b6d5-66c214c2078f" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a45cce2c-df11-40ac-801b-64943a2effc8" xlink:to="loc_us-gaap_EmployeeStockOptionMember_599262c9-6f05-4514-b6d5-66c214c2078f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e1bdc8cb-f2eb-45de-9c16-882f0825ede3" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9d1012f8-9268-4456-8102-3f12b4693b20" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e1bdc8cb-f2eb-45de-9c16-882f0825ede3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_bcdf524c-b44d-40cd-9fa2-906ca5bb685c" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e1bdc8cb-f2eb-45de-9c16-882f0825ede3" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_bcdf524c-b44d-40cd-9fa2-906ca5bb685c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_d018766b-580b-4cc7-9be9-958d839ce84a" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e1bdc8cb-f2eb-45de-9c16-882f0825ede3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_d018766b-580b-4cc7-9be9-958d839ce84a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_b08281a7-7b81-4337-a3d8-8246b317eb0a" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e1bdc8cb-f2eb-45de-9c16-882f0825ede3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_b08281a7-7b81-4337-a3d8-8246b317eb0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_f74c406b-60cb-454a-8697-2b7b29999cd3" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e1bdc8cb-f2eb-45de-9c16-882f0825ede3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_f74c406b-60cb-454a-8697-2b7b29999cd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_e799cd83-29b0-4498-abff-a3029de9f191" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e1bdc8cb-f2eb-45de-9c16-882f0825ede3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_e799cd83-29b0-4498-abff-a3029de9f191" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_cf08281d-cd04-45ff-be3f-0ab6e6578239" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e1bdc8cb-f2eb-45de-9c16-882f0825ede3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_cf08281d-cd04-45ff-be3f-0ab6e6578239" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/StockOptionPlansStockbasedCompensationDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#StockOptionPlansStockbasedCompensationDetails"/>
  <link:presentationLink xlink:role="http://silkroadmed.com/role/StockOptionPlansStockbasedCompensationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_76730b08-6506-4fbf-b2cc-1692b65855b5" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_51d112d9-82b2-4d67-b95a-4301269b44b3" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_76730b08-6506-4fbf-b2cc-1692b65855b5" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_51d112d9-82b2-4d67-b95a-4301269b44b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_9cb4c209-cd64-4133-bee7-532124ff7545" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_51d112d9-82b2-4d67-b95a-4301269b44b3" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_9cb4c209-cd64-4133-bee7-532124ff7545" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_8623c958-fdb5-44ed-8e18-6747ba8c7789" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_9cb4c209-cd64-4133-bee7-532124ff7545" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_8623c958-fdb5-44ed-8e18-6747ba8c7789" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_b79c93ff-a68b-40d2-a585-6b9e56d25f36" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_8623c958-fdb5-44ed-8e18-6747ba8c7789" xlink:to="loc_us-gaap_CostOfSalesMember_b79c93ff-a68b-40d2-a585-6b9e56d25f36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_ac191d96-19f2-453c-b111-830b7b7b75ad" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_8623c958-fdb5-44ed-8e18-6747ba8c7789" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_ac191d96-19f2-453c-b111-830b7b7b75ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_7c1d3923-8506-43b3-9046-fe1203afa833" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_8623c958-fdb5-44ed-8e18-6747ba8c7789" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_7c1d3923-8506-43b3-9046-fe1203afa833" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_d25574de-d58b-4891-ad16-1b6ea3da5b8c" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_51d112d9-82b2-4d67-b95a-4301269b44b3" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_d25574de-d58b-4891-ad16-1b6ea3da5b8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_7cf67dea-5216-4f5d-9da7-ac7e82034368" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_d25574de-d58b-4891-ad16-1b6ea3da5b8c" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_7cf67dea-5216-4f5d-9da7-ac7e82034368" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/IncomeTaxes" xlink:type="simple" xlink:href="silk-20191231.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://silkroadmed.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_9910bab8-a119-438e-8f9b-0e80c219a03b" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_0833c18d-c308-41eb-a02a-a5e106cb0fde" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_9910bab8-a119-438e-8f9b-0e80c219a03b" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_0833c18d-c308-41eb-a02a-a5e106cb0fde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/IncomeTaxesTables" xlink:type="simple" xlink:href="silk-20191231.xsd#IncomeTaxesTables"/>
  <link:presentationLink xlink:role="http://silkroadmed.com/role/IncomeTaxesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_47d518ac-d104-4e82-a400-0b1beb785df0" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_ff669086-1bf6-4217-91f8-0f013c83500a" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_47d518ac-d104-4e82-a400-0b1beb785df0" xlink:to="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_ff669086-1bf6-4217-91f8-0f013c83500a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_1cd96c25-2a83-458a-b92a-5279833e37f0" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_47d518ac-d104-4e82-a400-0b1beb785df0" xlink:to="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_1cd96c25-2a83-458a-b92a-5279833e37f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_412ff8ad-5012-4256-abc2-9aee8e56ec9d" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_47d518ac-d104-4e82-a400-0b1beb785df0" xlink:to="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_412ff8ad-5012-4256-abc2-9aee8e56ec9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock_50a41c61-cd37-44fc-981a-a3cfeb4745c0" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_47d518ac-d104-4e82-a400-0b1beb785df0" xlink:to="loc_us-gaap_SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock_50a41c61-cd37-44fc-981a-a3cfeb4745c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/IncomeTaxesComponentsofIncomeBeforeTaxesDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#IncomeTaxesComponentsofIncomeBeforeTaxesDetails"/>
  <link:presentationLink xlink:role="http://silkroadmed.com/role/IncomeTaxesComponentsofIncomeBeforeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_d7cf2c9d-6708-4f97-b561-113450a1acd6" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_29c8850f-f15b-4266-9384-aaf751a79490" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_d7cf2c9d-6708-4f97-b561-113450a1acd6" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_29c8850f-f15b-4266-9384-aaf751a79490" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_d15f299d-b8b6-4753-a305-1226a1c12eab" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_d7cf2c9d-6708-4f97-b561-113450a1acd6" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_d15f299d-b8b6-4753-a305-1226a1c12eab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_9b3dea3f-af9b-4891-bff7-c2e14bcdfd5b" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_d7cf2c9d-6708-4f97-b561-113450a1acd6" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_9b3dea3f-af9b-4891-bff7-c2e14bcdfd5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/IncomeTaxesReconciliationofUSStatutoryRateDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#IncomeTaxesReconciliationofUSStatutoryRateDetails"/>
  <link:presentationLink xlink:role="http://silkroadmed.com/role/IncomeTaxesReconciliationofUSStatutoryRateDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_fc113fd5-1e71-46cb-82c4-3fa5aa708318" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_e3561e6d-7136-413d-9726-030618fe53dc" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_fc113fd5-1e71-46cb-82c4-3fa5aa708318" xlink:to="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_e3561e6d-7136-413d-9726-030618fe53dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_f5ca5148-aa04-46a1-bcda-689e5338d6ed" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_fc113fd5-1e71-46cb-82c4-3fa5aa708318" xlink:to="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_f5ca5148-aa04-46a1-bcda-689e5338d6ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpense_228bf745-6396-48ce-8179-72c3db17062c" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_fc113fd5-1e71-46cb-82c4-3fa5aa708318" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpense_228bf745-6396-48ce-8179-72c3db17062c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_EffectiveIncomeTaxRateReconciliationWarrantLiabilityAdjustmentAmount_5e046ea4-9998-45c8-ae1a-3875de37477d" xlink:href="silk-20191231.xsd#silk_EffectiveIncomeTaxRateReconciliationWarrantLiabilityAdjustmentAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_fc113fd5-1e71-46cb-82c4-3fa5aa708318" xlink:to="loc_silk_EffectiveIncomeTaxRateReconciliationWarrantLiabilityAdjustmentAmount_5e046ea4-9998-45c8-ae1a-3875de37477d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_3dd31e0e-fb41-4d1c-ab59-cdff0552d36a" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_fc113fd5-1e71-46cb-82c4-3fa5aa708318" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_3dd31e0e-fb41-4d1c-ab59-cdff0552d36a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxCredits_b135dca5-68d8-4673-8131-716fee8a2b86" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxReconciliationTaxCredits"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_fc113fd5-1e71-46cb-82c4-3fa5aa708318" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxCredits_b135dca5-68d8-4673-8131-716fee8a2b86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherReconcilingItems_ce5c8647-21c4-47ac-8fe8-a505205442ff" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxReconciliationOtherReconcilingItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_fc113fd5-1e71-46cb-82c4-3fa5aa708318" xlink:to="loc_us-gaap_IncomeTaxReconciliationOtherReconcilingItems_ce5c8647-21c4-47ac-8fe8-a505205442ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_2600bd60-3f55-4330-8c05-fc0d19d9368f" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_fc113fd5-1e71-46cb-82c4-3fa5aa708318" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_2600bd60-3f55-4330-8c05-fc0d19d9368f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/IncomeTaxesNetDeferredTaxAssetsDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#IncomeTaxesNetDeferredTaxAssetsDetails"/>
  <link:presentationLink xlink:role="http://silkroadmed.com/role/IncomeTaxesNetDeferredTaxAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_04d28095-aa9f-4eec-b227-5af46f2949f9" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNetAbstract_1e049f77-a451-43fa-80ad-d290f65137d9" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsNetAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_04d28095-aa9f-4eec-b227-5af46f2949f9" xlink:to="loc_us-gaap_DeferredTaxAssetsNetAbstract_1e049f77-a451-43fa-80ad-d290f65137d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_6e4aaec2-4723-4de0-b9ba-766bc9ef2dc9" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_1e049f77-a451-43fa-80ad-d290f65137d9" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_6e4aaec2-4723-4de0-b9ba-766bc9ef2dc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_5d7ccbc0-b7c7-4589-8f95-656a3a1c01b4" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_1e049f77-a451-43fa-80ad-d290f65137d9" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_5d7ccbc0-b7c7-4589-8f95-656a3a1c01b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_662c4db3-4056-445b-a6d9-bdad4224702f" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_1e049f77-a451-43fa-80ad-d290f65137d9" xlink:to="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_662c4db3-4056-445b-a6d9-bdad4224702f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_b115fcd2-c5c5-400d-9e07-8bcb5f97c6bf" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_1e049f77-a451-43fa-80ad-d290f65137d9" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_b115fcd2-c5c5-400d-9e07-8bcb5f97c6bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_31e2a135-3a78-4809-85ea-2f4952af1090" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_1e049f77-a451-43fa-80ad-d290f65137d9" xlink:to="loc_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_31e2a135-3a78-4809-85ea-2f4952af1090" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_2153e2ae-f98f-4ce7-a643-be878f473123" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_1e049f77-a451-43fa-80ad-d290f65137d9" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_2153e2ae-f98f-4ce7-a643-be878f473123" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_DeferredTaxAssetsOperatingLeaseLiability_f2530f56-d047-418c-83f8-f4dd193ea28b" xlink:href="silk-20191231.xsd#silk_DeferredTaxAssetsOperatingLeaseLiability"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_1e049f77-a451-43fa-80ad-d290f65137d9" xlink:to="loc_silk_DeferredTaxAssetsOperatingLeaseLiability_f2530f56-d047-418c-83f8-f4dd193ea28b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_88268efe-a33b-4d9f-9004-a1672ee2b2c0" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_1e049f77-a451-43fa-80ad-d290f65137d9" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_88268efe-a33b-4d9f-9004-a1672ee2b2c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_a2ef18bf-ee3a-4924-8f5c-32b0135afe00" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_1e049f77-a451-43fa-80ad-d290f65137d9" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_a2ef18bf-ee3a-4924-8f5c-32b0135afe00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset_ad32aeef-b6f2-40d7-acc4-ac16ca1869be" xlink:href="silk-20191231.xsd#silk_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_1e049f77-a451-43fa-80ad-d290f65137d9" xlink:to="loc_silk_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset_ad32aeef-b6f2-40d7-acc4-ac16ca1869be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_e953b6ab-ff0b-4cfa-b22e-5f44b20ad136" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_1e049f77-a451-43fa-80ad-d290f65137d9" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_e953b6ab-ff0b-4cfa-b22e-5f44b20ad136" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_bbfa6e28-752f-4646-b7d6-9190d48eb8ec" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_1e049f77-a451-43fa-80ad-d290f65137d9" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_bbfa6e28-752f-4646-b7d6-9190d48eb8ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/IncomeTaxesNarrativeDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#IncomeTaxesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://silkroadmed.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_315a0b18-177a-40e6-8f3c-6bb618978fe5" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable_6b915f47-70de-4243-a266-2bfd2ece13ad" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_315a0b18-177a-40e6-8f3c-6bb618978fe5" xlink:to="loc_us-gaap_OperatingLossCarryforwardsTable_6b915f47-70de-4243-a266-2bfd2ece13ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAxis_102f7655-553b-46c2-8b8f-cddada96e53a" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TaxCreditCarryforwardAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_6b915f47-70de-4243-a266-2bfd2ece13ad" xlink:to="loc_us-gaap_TaxCreditCarryforwardAxis_102f7655-553b-46c2-8b8f-cddada96e53a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain_b3956113-900a-4929-a6e9-cdd712e6a88e" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis_102f7655-553b-46c2-8b8f-cddada96e53a" xlink:to="loc_us-gaap_TaxCreditCarryforwardNameDomain_b3956113-900a-4929-a6e9-cdd712e6a88e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchMember_2808fc3b-1d51-41f1-bbdc-4af5286cd7fa" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain_b3956113-900a-4929-a6e9-cdd712e6a88e" xlink:to="loc_us-gaap_ResearchMember_2808fc3b-1d51-41f1-bbdc-4af5286cd7fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_e28112a2-666f-42ad-9ea7-c4da0e4fd690" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_6b915f47-70de-4243-a266-2bfd2ece13ad" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_e28112a2-666f-42ad-9ea7-c4da0e4fd690" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_53299e50-90ea-46ba-a065-1848c0452fd1" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_e28112a2-666f-42ad-9ea7-c4da0e4fd690" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_53299e50-90ea-46ba-a065-1848c0452fd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_9d81a9d0-321b-4b28-bf2e-3e9c4e4cc7b4" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DomesticCountryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_53299e50-90ea-46ba-a065-1848c0452fd1" xlink:to="loc_us-gaap_DomesticCountryMember_9d81a9d0-321b-4b28-bf2e-3e9c4e4cc7b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_2273e3c2-8257-4ac6-9a97-e4eb24a4914d" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_53299e50-90ea-46ba-a065-1848c0452fd1" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_2273e3c2-8257-4ac6-9a97-e4eb24a4914d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems_0434ae59-f0f3-4506-8f22-eec8ac54f8a5" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_6b915f47-70de-4243-a266-2bfd2ece13ad" xlink:to="loc_us-gaap_OperatingLossCarryforwardsLineItems_0434ae59-f0f3-4506-8f22-eec8ac54f8a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_114f4979-ab19-45bc-bfa2-4fee92483c34" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0434ae59-f0f3-4506-8f22-eec8ac54f8a5" xlink:to="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_114f4979-ab19-45bc-bfa2-4fee92483c34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_ee16ab30-530a-4790-a1d9-6093db5ee281" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0434ae59-f0f3-4506-8f22-eec8ac54f8a5" xlink:to="loc_us-gaap_OperatingLossCarryforwards_ee16ab30-530a-4790-a1d9-6093db5ee281" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_OperatingLossCarryforwardOffsetMaximumPercent_4ab87325-77ee-4fd1-a670-2f787d8972c3" xlink:href="silk-20191231.xsd#silk_OperatingLossCarryforwardOffsetMaximumPercent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0434ae59-f0f3-4506-8f22-eec8ac54f8a5" xlink:to="loc_silk_OperatingLossCarryforwardOffsetMaximumPercent_4ab87325-77ee-4fd1-a670-2f787d8972c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount_185509f5-20e1-4e8b-9bc0-7832d2e84209" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0434ae59-f0f3-4506-8f22-eec8ac54f8a5" xlink:to="loc_us-gaap_TaxCreditCarryforwardAmount_185509f5-20e1-4e8b-9bc0-7832d2e84209" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_ffa4b737-87ee-48e1-8e97-c4d44c76bf15" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0434ae59-f0f3-4506-8f22-eec8ac54f8a5" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_ffa4b737-87ee-48e1-8e97-c4d44c76bf15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_c2726856-6d3e-44ad-9b28-321559bcc08d" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0434ae59-f0f3-4506-8f22-eec8ac54f8a5" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_c2726856-6d3e-44ad-9b28-321559bcc08d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_8d2767bd-248a-4004-8c76-174173887f64" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0434ae59-f0f3-4506-8f22-eec8ac54f8a5" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_8d2767bd-248a-4004-8c76-174173887f64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/IncomeTaxesReconciliationofUnrecognizedTaxBenefitsDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#IncomeTaxesReconciliationofUnrecognizedTaxBenefitsDetails"/>
  <link:presentationLink xlink:role="http://silkroadmed.com/role/IncomeTaxesReconciliationofUnrecognizedTaxBenefitsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_ac35e15b-cdbc-44d0-b6be-452d9d89f2b4" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_186018f5-4bea-4130-ab91-1c65b4db6f9d" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ac35e15b-cdbc-44d0-b6be-452d9d89f2b4" xlink:to="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_186018f5-4bea-4130-ab91-1c65b4db6f9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_b0de15aa-959a-40f7-b558-69c880824f7a" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_186018f5-4bea-4130-ab91-1c65b4db6f9d" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_b0de15aa-959a-40f7-b558-69c880824f7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_44851d42-8ad7-4df2-845d-16445508bcb9" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_186018f5-4bea-4130-ab91-1c65b4db6f9d" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_44851d42-8ad7-4df2-845d-16445508bcb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_3616a5f5-9789-40c5-919c-ee2c83fa3fbf" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_186018f5-4bea-4130-ab91-1c65b4db6f9d" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_3616a5f5-9789-40c5-919c-ee2c83fa3fbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_e31dd25d-f728-4734-912e-134c8d4bc3fc" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_186018f5-4bea-4130-ab91-1c65b4db6f9d" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_e31dd25d-f728-4734-912e-134c8d4bc3fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/AcquisitionofVariableInterestEntityNeuroCo" xlink:type="simple" xlink:href="silk-20191231.xsd#AcquisitionofVariableInterestEntityNeuroCo"/>
  <link:presentationLink xlink:role="http://silkroadmed.com/role/AcquisitionofVariableInterestEntityNeuroCo" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_ffd57db3-544e-4dce-9a7b-adefe9c8d93b" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock_c1937904-9849-4336-aa29-5df372a647d8" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_ffd57db3-544e-4dce-9a7b-adefe9c8d93b" xlink:to="loc_us-gaap_BusinessCombinationDisclosureTextBlock_c1937904-9849-4336-aa29-5df372a647d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/AcquisitionofVariableInterestEntityNeuroCoDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#AcquisitionofVariableInterestEntityNeuroCoDetails"/>
  <link:presentationLink xlink:role="http://silkroadmed.com/role/AcquisitionofVariableInterestEntityNeuroCoDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_8c4233ca-a9c7-4719-815f-847a3c7b1722" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a41e7a74-9ff4-4878-b9c5-8c16efc763ce" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_8c4233ca-a9c7-4719-815f-847a3c7b1722" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a41e7a74-9ff4-4878-b9c5-8c16efc763ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_be0171fc-8b99-4f8d-aafa-56eaad7f2ab9" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a41e7a74-9ff4-4878-b9c5-8c16efc763ce" xlink:to="loc_dei_LegalEntityAxis_be0171fc-8b99-4f8d-aafa-56eaad7f2ab9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_f135d615-ecb9-454d-9f60-984f74952228" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_be0171fc-8b99-4f8d-aafa-56eaad7f2ab9" xlink:to="loc_dei_EntityDomain_f135d615-ecb9-454d-9f60-984f74952228" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_NeuroCoIncMember_d8538eac-8170-429c-a626-354d171a4080" xlink:href="silk-20191231.xsd#silk_NeuroCoIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_f135d615-ecb9-454d-9f60-984f74952228" xlink:to="loc_silk_NeuroCoIncMember_d8538eac-8170-429c-a626-354d171a4080" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_0f2f9692-4104-4c7a-af6d-122189e3c004" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a41e7a74-9ff4-4878-b9c5-8c16efc763ce" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_0f2f9692-4104-4c7a-af6d-122189e3c004" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d584757c-960d-463b-9b3f-5950b909f2da" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_0f2f9692-4104-4c7a-af6d-122189e3c004" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d584757c-960d-463b-9b3f-5950b909f2da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_NeuroCoIncMember_5e11cf08-b07c-4652-a84b-981ecb642b0f" xlink:href="silk-20191231.xsd#silk_NeuroCoIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d584757c-960d-463b-9b3f-5950b909f2da" xlink:to="loc_silk_NeuroCoIncMember_5e11cf08-b07c-4652-a84b-981ecb642b0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_a981867e-23dd-4d53-973c-bbc8fcf0ce36" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a41e7a74-9ff4-4878-b9c5-8c16efc763ce" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_a981867e-23dd-4d53-973c-bbc8fcf0ce36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableRelatedParties_f7a37aff-8697-4708-8574-03ad0104ebc2" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NotesReceivableRelatedParties"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a981867e-23dd-4d53-973c-bbc8fcf0ce36" xlink:to="loc_us-gaap_NotesReceivableRelatedParties_f7a37aff-8697-4708-8574-03ad0104ebc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_NotesReceivableRelatedPartiesInterestRateStatedPercentage_5a57dab0-af55-436c-b6ca-32400d8bdfc7" xlink:href="silk-20191231.xsd#silk_NotesReceivableRelatedPartiesInterestRateStatedPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a981867e-23dd-4d53-973c-bbc8fcf0ce36" xlink:to="loc_silk_NotesReceivableRelatedPartiesInterestRateStatedPercentage_5a57dab0-af55-436c-b6ca-32400d8bdfc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_NotesReceivableRelatedPartiesTerm_ef371d59-1735-4893-ad44-db52ea459c3a" xlink:href="silk-20191231.xsd#silk_NotesReceivableRelatedPartiesTerm"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a981867e-23dd-4d53-973c-bbc8fcf0ce36" xlink:to="loc_silk_NotesReceivableRelatedPartiesTerm_ef371d59-1735-4893-ad44-db52ea459c3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_2ec36e86-a319-42f2-a7f2-c1604c9786a7" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a981867e-23dd-4d53-973c-bbc8fcf0ce36" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_2ec36e86-a319-42f2-a7f2-c1604c9786a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_60314751-2578-4818-993e-47491dd1dbce" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a981867e-23dd-4d53-973c-bbc8fcf0ce36" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_60314751-2578-4818-993e-47491dd1dbce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_4b863ebb-4948-49f7-a5ee-f7673f0d8571" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a981867e-23dd-4d53-973c-bbc8fcf0ce36" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_4b863ebb-4948-49f7-a5ee-f7673f0d8571" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_BusinessCombinationConsiderationTransferredNotesPayableForgiven_1fe107a6-116e-4e3d-82cf-6882947a4f98" xlink:href="silk-20191231.xsd#silk_BusinessCombinationConsiderationTransferredNotesPayableForgiven"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a981867e-23dd-4d53-973c-bbc8fcf0ce36" xlink:to="loc_silk_BusinessCombinationConsiderationTransferredNotesPayableForgiven_1fe107a6-116e-4e3d-82cf-6882947a4f98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestInVariableInterestEntity_4ef49d97-8190-46fa-a469-e605456d75a1" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NoncontrollingInterestInVariableInterestEntity"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a981867e-23dd-4d53-973c-bbc8fcf0ce36" xlink:to="loc_us-gaap_NoncontrollingInterestInVariableInterestEntity_4ef49d97-8190-46fa-a469-e605456d75a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/A401kPlan" xlink:type="simple" xlink:href="silk-20191231.xsd#A401kPlan"/>
  <link:presentationLink xlink:role="http://silkroadmed.com/role/A401kPlan" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_ebebb018-a6f0-4bc9-a744-0e4ea2e761e6" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanDisclosuresTableTextBlock_98658dc4-8fef-4386-bd56-60a3156a5632" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DefinedContributionPlanDisclosuresTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_ebebb018-a6f0-4bc9-a744-0e4ea2e761e6" xlink:to="loc_us-gaap_DefinedContributionPlanDisclosuresTableTextBlock_98658dc4-8fef-4386-bd56-60a3156a5632" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/A401kPlanDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#A401kPlanDetails"/>
  <link:presentationLink xlink:role="http://silkroadmed.com/role/A401kPlanDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_fe84cc61-a17a-4a5c-a44b-71e7e1cc1bc6" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_749c120e-7472-4b16-93d2-fb78212e24b5" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsequentEventTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_fe84cc61-a17a-4a5c-a44b-71e7e1cc1bc6" xlink:to="loc_us-gaap_SubsequentEventTable_749c120e-7472-4b16-93d2-fb78212e24b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_e4e9d9f6-7864-4037-9c4d-0d952cdb199d" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_749c120e-7472-4b16-93d2-fb78212e24b5" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_e4e9d9f6-7864-4037-9c4d-0d952cdb199d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_f2b09640-f1bd-40d7-98c6-1ec89cd1e7fa" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_e4e9d9f6-7864-4037-9c4d-0d952cdb199d" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_f2b09640-f1bd-40d7-98c6-1ec89cd1e7fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_33a36fa1-8c74-47e2-b459-d1027303922c" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_f2b09640-f1bd-40d7-98c6-1ec89cd1e7fa" xlink:to="loc_us-gaap_SubsequentEventMember_33a36fa1-8c74-47e2-b459-d1027303922c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_c9172da6-33b7-4289-8528-4878a48a13c4" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_749c120e-7472-4b16-93d2-fb78212e24b5" xlink:to="loc_us-gaap_SubsequentEventLineItems_c9172da6-33b7-4289-8528-4878a48a13c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_fd58814f-2004-468a-99e2-1dc22f25e0d1" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_c9172da6-33b7-4289-8528-4878a48a13c4" xlink:to="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_fd58814f-2004-468a-99e2-1dc22f25e0d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized_06430897-5d1a-4515-b6f7-880ae9a04840" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_c9172da6-33b7-4289-8528-4878a48a13c4" xlink:to="loc_us-gaap_DefinedContributionPlanCostRecognized_06430897-5d1a-4515-b6f7-880ae9a04840" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_55bfb665-1782-4a99-848d-240a5a0772c7" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_c9172da6-33b7-4289-8528-4878a48a13c4" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_55bfb665-1782-4a99-848d-240a5a0772c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_02a147f7-6f2b-4f68-9ab0-445cbe4a3a54" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_c9172da6-33b7-4289-8528-4878a48a13c4" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_02a147f7-6f2b-4f68-9ab0-445cbe4a3a54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/SubsequentEvents" xlink:type="simple" xlink:href="silk-20191231.xsd#SubsequentEvents"/>
  <link:presentationLink xlink:role="http://silkroadmed.com/role/SubsequentEvents" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_a0302b40-1521-43da-ab2d-e0d06bc255fc" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock_b1a33143-bf9d-4694-a2be-efe3836dc008" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_a0302b40-1521-43da-ab2d-e0d06bc255fc" xlink:to="loc_us-gaap_SubsequentEventsTextBlock_b1a33143-bf9d-4694-a2be-efe3836dc008" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/SubsequentEventsNarrativeDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#SubsequentEventsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://silkroadmed.com/role/SubsequentEventsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_f0cc5bda-bb1c-4803-99d8-16f3f3ecd02c" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_52045452-2e6a-4ba8-8207-8b669d1f0010" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsequentEventTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_f0cc5bda-bb1c-4803-99d8-16f3f3ecd02c" xlink:to="loc_us-gaap_SubsequentEventTable_52045452-2e6a-4ba8-8207-8b669d1f0010" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_a1e3c8bd-14d8-4722-ae79-07bb97282000" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_52045452-2e6a-4ba8-8207-8b669d1f0010" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_a1e3c8bd-14d8-4722-ae79-07bb97282000" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_9affed03-7460-4997-bc30-9f9f9672ba89" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_a1e3c8bd-14d8-4722-ae79-07bb97282000" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_9affed03-7460-4997-bc30-9f9f9672ba89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_930d982c-003e-4721-a4bb-5bc4fec7e2be" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_9affed03-7460-4997-bc30-9f9f9672ba89" xlink:to="loc_us-gaap_SubsequentEventMember_930d982c-003e-4721-a4bb-5bc4fec7e2be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_ecb629f4-1e6b-4075-90da-4de86d92618e" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_52045452-2e6a-4ba8-8207-8b669d1f0010" xlink:to="loc_us-gaap_PlanNameAxis_ecb629f4-1e6b-4075-90da-4de86d92618e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_3798d82e-c8ec-4e89-b336-da669cd2fb04" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_ecb629f4-1e6b-4075-90da-4de86d92618e" xlink:to="loc_us-gaap_PlanNameDomain_3798d82e-c8ec-4e89-b336-da669cd2fb04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_silk_TwoThousandNineteenStockOptionPlanMember_32e5630f-87f0-4d49-b522-50cfb60052c7" xlink:href="silk-20191231.xsd#silk_TwoThousandNineteenStockOptionPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_3798d82e-c8ec-4e89-b336-da669cd2fb04" xlink:to="loc_silk_TwoThousandNineteenStockOptionPlanMember_32e5630f-87f0-4d49-b522-50cfb60052c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_19a1ffea-cecc-46ea-a059-426ecdfd6a24" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_52045452-2e6a-4ba8-8207-8b669d1f0010" xlink:to="loc_us-gaap_AwardTypeAxis_19a1ffea-cecc-46ea-a059-426ecdfd6a24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8e277f85-af42-4a35-845b-8525a106f8a0" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_19a1ffea-cecc-46ea-a059-426ecdfd6a24" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8e277f85-af42-4a35-845b-8525a106f8a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_08f6d69b-cc6e-4fbc-bc9a-7d2de8852dac" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8e277f85-af42-4a35-845b-8525a106f8a0" xlink:to="loc_us-gaap_EmployeeStockOptionMember_08f6d69b-cc6e-4fbc-bc9a-7d2de8852dac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_711d0148-e3ab-4861-8fcf-d499347a08f9" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_52045452-2e6a-4ba8-8207-8b669d1f0010" xlink:to="loc_us-gaap_SubsequentEventLineItems_711d0148-e3ab-4861-8fcf-d499347a08f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_babf3326-0993-48b8-b2c9-589409aa7caa" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_711d0148-e3ab-4861-8fcf-d499347a08f9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_babf3326-0993-48b8-b2c9-589409aa7caa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_72191584-510a-41d6-95a0-421ceb206dab" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_711d0148-e3ab-4861-8fcf-d499347a08f9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_72191584-510a-41d6-95a0-421ceb206dab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_b85dbb19-7ed9-4fda-9027-077cc697db71" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_711d0148-e3ab-4861-8fcf-d499347a08f9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_b85dbb19-7ed9-4fda-9027-077cc697db71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_e89fc732-db56-4f91-bcea-0aa7418f7ea6" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_711d0148-e3ab-4861-8fcf-d499347a08f9" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_e89fc732-db56-4f91-bcea-0aa7418f7ea6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/QuarterlyFinancialInformationunaudited" xlink:type="simple" xlink:href="silk-20191231.xsd#QuarterlyFinancialInformationunaudited"/>
  <link:presentationLink xlink:role="http://silkroadmed.com/role/QuarterlyFinancialInformationunaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_d90d28d2-c67c-4157-9dc2-194aecff3857" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_QuarterlyFinancialInformationDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_QuarterlyFinancialInformationTextBlock_c7026845-6038-4d46-904e-579a045bb645" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_QuarterlyFinancialInformationTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_d90d28d2-c67c-4157-9dc2-194aecff3857" xlink:to="loc_us-gaap_QuarterlyFinancialInformationTextBlock_c7026845-6038-4d46-904e-579a045bb645" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/QuarterlyFinancialInformationunauditedTables" xlink:type="simple" xlink:href="silk-20191231.xsd#QuarterlyFinancialInformationunauditedTables"/>
  <link:presentationLink xlink:role="http://silkroadmed.com/role/QuarterlyFinancialInformationunauditedTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_16cef886-c991-4c11-bcd4-1b792730ce68" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_QuarterlyFinancialInformationDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_8701a726-5d62-409e-950e-437d7684ad5c" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_16cef886-c991-4c11-bcd4-1b792730ce68" xlink:to="loc_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_8701a726-5d62-409e-950e-437d7684ad5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://silkroadmed.com/role/QuarterlyFinancialInformationunauditedDetails" xlink:type="simple" xlink:href="silk-20191231.xsd#QuarterlyFinancialInformationunauditedDetails"/>
  <link:presentationLink xlink:role="http://silkroadmed.com/role/QuarterlyFinancialInformationunauditedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_f482ee41-6686-40a0-a0bf-ca05ba7d47d2" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_QuarterlyFinancialInformationDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_59fb9469-6111-4ca1-b472-8a1fe72cd424" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_f482ee41-6686-40a0-a0bf-ca05ba7d47d2" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_59fb9469-6111-4ca1-b472-8a1fe72cd424" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_a4be557c-3476-4102-81bb-06aa364bd3ac" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_f482ee41-6686-40a0-a0bf-ca05ba7d47d2" xlink:to="loc_us-gaap_GrossProfit_a4be557c-3476-4102-81bb-06aa364bd3ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_f2b40104-3c23-45ff-9902-78ab662ec449" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_f482ee41-6686-40a0-a0bf-ca05ba7d47d2" xlink:to="loc_us-gaap_ProfitLoss_f2b40104-3c23-45ff-9902-78ab662ec449" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDiluted_ca3d4151-405c-4eac-bfa4-feca68394d6e" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_f482ee41-6686-40a0-a0bf-ca05ba7d47d2" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDiluted_ca3d4151-405c-4eac-bfa4-feca68394d6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>silk-20191231_g1.jpg
<TEXT>
begin 644 silk-20191231_g1.jpg
M_]C_X1'[17AI9@  24DJ  @    .   ! P !    N L   $! P !    F @
M  (! P #    M@    ,! P !    !0    8! P !     @   !(! P !
M 0   !4! P !     P   !H!!0 !    O    !L!!0 !    Q    !P! P !
M     0   "@! P !     @   #$! @ B    S    #(! @ 4    [@   &F'
M!  !    ! $  # !   (  @ " # QBT $"<  ,#&+0 0)P  061O8F4@4&AO
M=&]S:&]P($-#(#(P,3D@*%=I;F1O=W,I #(P,3@Z,3(Z,#4@,3 Z,S<Z-3,
M   #  &@ P !     0    *@!  !    N L   .@!  !    F @
M  8  P$#  $    &    &@$%  $   !^ 0  &P$%  $   "& 0  * $#  $
M   "     0($  $   ". 0   @($  $   !E$        $@    !    2
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M2^/_  WWW1/HO 4E(& O_]G_[2;Z4&AO=&]S:&]P(#,N,  X0DE-! 0
M &\< 5H  QLE1QP!6@ #&R5'' %:  ,;)4<< 5H  QLE1QP!6@ #&R5'' %:
M  ,;)4<< 5H  QLE1QP!6@ #&R5'' %:  ,;)4<< 5H  QLE1QP!6@ #&R5'
M' %:  ,;)4<< 5H  QLE1QP"   "    .$))300E       0H%>WGO0DT#<K
M\QL(*V-[Y3A"24T$.@     !(P   !     !       +<')I;G1/=71P=70
M   %     %!S=%-B;V]L 0    !);G1E96YU;0    !);G1E     $-L<FT
M   /<')I;G13:7AT965N0FET8F]O;      +<')I;G1E<DYA;65415A4
M( !/ &8 9@!I &, 90!J &4 =  @ $H -@ T #  ,  @ ', 90!R &D 90!S
M "  6P T #$ -0 P $0 -0!=       /<')I;G10<F]O9E-E='5P3V)J8P
M  P 4 !R &\ ;P!F "  4P!E '0 =0!P       *<')O;V93971U<     $
M    0FQT;F5N=6T    ,8G5I;'1I;E!R;V]F    "7!R;V]F0TU92P X0DE-
M!#L      BT    0     0      $G!R:6YT3W5T<'5T3W!T:6]N<P   !<
M    0W!T;F)O;VP      $-L8G)B;V]L      !29W--8F]O;       0W)N
M0V)O;VP      $-N=$-B;V]L      !,8FQS8F]O;       3F=T=F)O;VP
M     $5M;$1B;V]L      !);G1R8F]O;       0F-K9T]B:F,    !
M    4D="0P    ,     4F0@(&1O=6) ;^            !'<FX@9&]U8D!O
MX            $)L("!D;W5B0&_@            0G)D5%5N=$8C4FQT
M            0FQD(%5N=$8C4FQT                4G-L=%5N=$8C4'AL
M0'+            *=F5C=&]R1&%T86)O;VP!     %!G4'-E;G5M     %!G
M4',     4&=00P    !,969T56YT1B-2;'0               !4;W @56YT
M1B-2;'0               !38VP@56YT1B-0<F- 60           !!C<F]P
M5VAE;E!R:6YT:6YG8F]O;      .8W)O<%)E8W1";W1T;VUL;VYG
M  QC<F]P4F5C=$QE9G1L;VYG          UC<F]P4F5C=%)I9VAT;&]N9P
M       +8W)O<%)E8W14;W!L;VYG       X0DE- ^T      ! !+     $
M 0$L     0 !.$))300F       .             #^    X0DE-! T
M  0   !X.$))3009       $    'CA"24T#\P      "0           0 X
M0DE-)Q        H  0         !.$))30/U      !( "]F9@ ! &QF9@ &
M       ! "]F9@ ! *&9F@ &       ! #(    ! %H    &       ! #4
M   ! "T    &       !.$))30/X      !P  #_____________________
M________ ^@     _____________________________P/H     /______
M______________________\#Z     #_____________________________
M ^@  #A"24T$         @  .$))300"       (  $       $X0DE-!#
M      0! 0$!.$))300M       &  $   !\.$))300(       0     0
M D    )      #A"24T$'@      !      X0DE-!!H      O8    (
M$     $       !N=6QL     P    AB87-E3F%M951%6%0    % %4 <P!E
M '(       9B;W5N9'-/8FIC     0       %)C=#$    $     %1O<"!L
M;VYG          !,969T;&]N9P          0G1O;6QO;F<   B8     %)G
M:'1L;VYG   +N     9S;&EC97-6;$QS     4]B:F,    !       %<VQI
M8V4    2    !W-L:6-E241L;VYG          =G<F]U<$E$;&]N9P
M   &;W)I9VEN96YU;0    Q%4VQI8V5/<FEG:6X    -875T;T=E;F5R871E
M9     !4>7!E96YU;0    I%4VQI8V54>7!E     $EM9R     &8F]U;F1S
M3V)J8P    $       !28W0Q    !     !4;W @;&]N9P          3&5F
M=&QO;F<          $)T;VUL;VYG   (F     !29VAT;&]N9P  "[@    #
M=7)L5$585     $       !N=6QL5$585     $       !-<V=E5$585
M  $       9A;'1486=415A4     0      #F-E;&Q497AT27-(5$U,8F]O
M; $    (8V5L;%1E>'1415A4     0      "6AO<GI!;&EG;F5N=6T    /
M15-L:6-E2&]R>D%L:6=N    !V1E9F%U;'0    )=F5R=$%L:6=N96YU;0
M  ]%4VQI8V5697)T06QI9VX    '9&5F875L=     MB9T-O;&]R5'EP965N
M=6T    115-L:6-E0D=#;VQO<E1Y<&4     3F]N90    ET;W!/=71S971L
M;VYG          IL969T3W5T<V5T;&]N9P         ,8F]T=&]M3W5T<V5T
M;&]N9P         +<FEG:'1/=71S971L;VYG     #A"24T$*       #
M  (_\        #A"24T$%       !    , X0DE-! P     $($    !
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M1I2DA;25Q-3D]*6UQ=7E]59F=H:6IK;&UN;V)S='5V=WAY>GM\?_V@ , P$
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M%G[P+?O&U +K7$AT@@P6D$$$=BTH=PM9398P;GL:7P2 (;[GZGVM]@=[DQE
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M]./;MXA>"I(0_P '_!79KTOC_P -]]T3Z+P%)2!@+__9 #A"24T$(0
M70    $!    #P!! &0 ;P!B &4 ( !0 &@ ;P!T &\ <P!H &\ <    !<
M00!D &\ 8@!E "  4 !H &\ = !O ', : !O '  ( !# $, (  R #  ,0 Y
M     0 X0DE-#Z      !A9M;W!T     P    $         !P    $
M  $  /__________    9     '_____                     0    #_
M____      3_____     /____\     _____P    #_____          #_
M    _P   /\   #_    _P   /\   #_    _P   /\   #_    _P   /\
M  #_    _P   /\   #_    _P   /\   #_    _P   /\   #_    _P
M /\   #_    _P   /\   #_    _P   /\   #_    _P   /\   #_
M_P   /\   #_    _P   /\   #_    _P   /\   #_    _P   /\   #_
M    _P   /\   #_    _P   /\   #_    _P   /\   #_    _P   /\
M  #_    _P   /\   #_    _P   /\   #_    _P   /\   #_    _P
M /\   #_    _P   /\   #_    _P   /\   #_    _P   /\   #_
M_P   /\   #_    _P   /\   #_    _P   /\   #_    _P   /\   #_
M    _P   /\   #_    _P   /\   #_    _P   /\   #_    _P   /\
M  #_    _P   /\   #_    _P   /\   #_    _P   /\   #_    _P
M /\   #_    _P   /\   #_    _P   /\   #_    _P   /\   #_
M_P   /\   #_    _P   /\   #_    _P   /\   #_    _P   /\   #_
M    _P   /\   #_    _P   /\   #_    _P   /\   #_    _P   /\
M  #_    _P   /\   #_    _P   /\   #_    _P   /\   #_    _P
M /\   #_    _P   /\   #_    _P   /\   #_    _P   /\   #_
M_P   /\   #_    _P   /\   #_    _P   /\   #_    _P   /\   #_
M    _P   /\   #_    _P   /\   #_    _P   /\   #_    _P   /\
M  #_    _P   /\   #_    _P   /\   #_    _P   /\   #_    _P
M /\   #_    _P   /\   #_    _P   /\   #_    _P   /\   #_
M_P   /\   #_    _P   /\   #_    _P   /\   #_    _P   /\   #_
M    _P   /\   #_    _P   /\   #_    _P   /\   #_    _P   /\
M  #_    _P   /\   #_    _P   /\   #_    _P   /\   #_    _P
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M;VP     $&5M<&AA<VEZ959E8W1O<G-B;V]L      5F;&]O<FQO;F<
M.$))30^A       M;7-E=    !     !       $;G5L;     $    '5F5R
M<VEO;FQO;F<      #A"24T/H@      "&US-'<    #.$))300!      '4
M  8                                 "
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M ,D;I !V2>@ P% " '?PQ@ ! *\8V@!Z$@L G/F4 'DIKP"*VD\ >$%4  $
M?2%( 'H=7P!STET >4.E &J#<0!X:>H  0!5#^  =Q.^ %-+/ !V<,0 48:6
M '7-R  ! 'HA[P!>-'  >B'O %XT< !Z(>\ 7C1P  $!(.HS $ I) $@ZC,
M0"DD 2#J,P! *20  0$E4 , :_Y: 250 P!K_EH!)5 # &O^6@ ! 27BB0"G
MO& !)'-% *?C$P$C! ( J G'.$))30?0!E!A=&@@,0    $$  8
M                        "                                  #
M  <    !                          0!15.D /.1* $R>.( \PF, 1^>
M'@#R@?  ! #S[5, \1'1 .4-'P#NB5D UBSH .P X@ $ ,>NF #H;E$ OW6?
M -YC5@"UI)8 TF7R  0 Q6Q* ,.F< #!@ED N\OA +RC^ "R!M0 ! "TP L
MJ"2% *39/0"H)(4 E&K@ *@DA0 $ (.[2P"D\)0 =..J *3Z50!J99, I0$Z
M  0 6FKD *;DV@!4-VP I=P] $X#\P"DTZ(X0DE-!]$&4&%T:" R     +8
M!@                                 (
M          , !     $                         ! $V8D4 ,0D0 1OZ
MJ0 JXDX! 9,, "2[C  $ -B0NP :E48 N>/H !SW7 ";-Q8 'UEP  0 ;5N)
M !^SO0 YI H )G6=  7LC@ M-WT !/_WBU< *D#E_^OE#  IO^7_X#[  "D^
MY3A"24T'T@90871H(#,    !.  &
M  @                                  P )     0
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M_^Z>9 !C]=7_YU?F &5UL#A"24T+N U/<FEG:6Y$871A25)"   !8    !
M   !        ;G5L;     $    5:V5Y4F]O=$1E<V-R:7!T;W),:7-T5FQ,
M<P    -/8FIC     0       &YU;&P    !    $6ME>41E<V-R:7!T;W),
M:7-T5FQ,<P    %/8FIC     0       &YU;&P    !    #FME>4]R:6=I
M;DEN9&5X;&]N9P    !/8FIC     0       &YU;&P    !    $6ME>41E
M<V-R:7!T;W),:7-T5FQ,<P    %/8FIC     0       &YU;&P    !
M#FME>4]R:6=I;DEN9&5X;&]N9P    !/8FIC     0       &YU;&P    !
M    $6ME>41E<V-R:7!T;W),:7-T5FQ,<P    %/8FIC     0       &YU
M;&P    !    #FME>4]R:6=I;DEN9&5X;&]N9P     X0DE-! 8       <
M"  !  $! /_A%$IH='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O #P_>'!A
M8VME="!B96=I;CTB[[N_(B!I9#TB5S5-,$UP0V5H:4AZ<F53>DY48WIK8SED
M(C\^(#QX.GAM<&UE=&$@>&UL;G,Z>#TB861O8F4Z;G,Z;65T82\B('@Z>&UP
M=&L](D%D;V)E(%A-4"!#;W)E(#4N-BUC,30U(#<Y+C$V,S0Y.2P@,C Q."\P
M."\Q,RTQ-CHT,#HR,B @(" @(" @(CX@/')D9CI21$8@>&UL;G,Z<F1F/2)H
M='1P.B\O=W=W+G<S+F]R9R\Q.3DY+S R+S(R+7)D9BUS>6YT87@M;G,C(CX@
M/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O=70](B(@>&UL;G,Z>&UP/2)H='1P
M.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O(B!X;6QN<SID8STB:'1T<#HO+W!U
M<FPN;W)G+V1C+V5L96UE;G1S+S$N,2\B('AM;&YS.GAM<$U-/2)H='1P.B\O
M;G,N861O8F4N8V]M+WAA<"\Q+C O;6TO(B!X;6QN<SIS=$5V=#TB:'1T<#HO
M+VYS+F%D;V)E+F-O;2]X87 O,2XP+W-4>7!E+U)E<V]U<F-E179E;G0C(B!X
M;6QN<SIS=%)E9CTB:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+W-4>7!E
M+U)E<V]U<F-E4F5F(R(@>&UL;G,Z<&AO=&]S:&]P/2)H='1P.B\O;G,N861O
M8F4N8V]M+W!H;W1O<VAO<"\Q+C O(B!X;7 Z0W)E871O<E1O;VP](D%D;V)E
M(%!H;W1O<VAO<"!#4S8@*$UA8VEN=&]S:"DB('AM<#I#<F5A=&5$871E/2(R
M,#$R+3$P+3(V5#$S.C0Q.C$U+3 W.C P(B!X;7 Z365T861A=&%$871E/2(R
M,#$X+3$R+3 U5#$P.C,W.C4S+3 X.C P(B!X;7 Z36]D:69Y1&%T93TB,C Q
M."TQ,BTP-50Q,#HS-SHU,RTP.#HP,"(@9&,Z9F]R;6%T/2)I;6%G92]J<&5G
M(B!X;7!-33I);G-T86YC94E$/2)X;7 N:6ED.F$Q96,X8F-D+60Y9&8M9C0T
M82TX-V0Y+3<W,3AE8F,Y96$P-2(@>&UP34TZ1&]C=6UE;G1)1#TB861O8F4Z
M9&]C:60Z<&AO=&]S:&]P.CDT83EF-S4X+3$W9C,M,#(T8RUA-3-E+6-B-38Q
M-# X-30V92(@>&UP34TZ3W)I9VEN86Q$;V-U;65N=$E$/2)X;7 N9&ED.D4T
M.#5!13-&,#DR,#8X,3$Y-$(W0T$Q03$Q-D0W03(U(B!P:&]T;W-H;W Z0V]L
M;W)-;V1E/2(S(B!P:&]T;W-H;W Z24-#4')O9FEL93TB<U)'0B!)14,V,3DV
M-BTR+C$B/B \>&UP34TZ2&ES=&]R>3X@/')D9CI397$^(#QR9&8Z;&D@<W1%
M=G0Z86-T:6]N/2)C<F5A=&5D(B!S=$5V=#II;G-T86YC94E$/2)X;7 N:6ED
M.D4T.#5!13-&,#DR,#8X,3$Y-$(W0T$Q03$Q-D0W03(U(B!S=$5V=#IW:&5N
M/2(R,#$R+3$P+3(V5#$S.C0Q.C$U+3 W.C P(B!S=$5V=#IS;V9T=V%R94%G
M96YT/2)!9&]B92!0:&]T;W-H;W @0U,U($UA8VEN=&]S:"(O/B \<F1F.FQI
M('-T179T.F%C=&EO;CTB<V%V960B('-T179T.FEN<W1A;F-E240](GAM<"YI
M:60Z134X-4%%,T8P.3(P-C@Q,3DT0C=#03%!,3$V1#=!,C4B('-T179T.G=H
M96X](C(P,3(M,3 M,C94,3,Z-#(Z-#<M,#<Z,# B('-T179T.G-O9G1W87)E
M06=E;G0](D%D;V)E(%!H;W1O<VAO<"!#4S4@36%C:6YT;W-H(B!S=$5V=#IC
M:&%N9V5D/2(O(B\^(#QR9&8Z;&D@<W1%=G0Z86-T:6]N/2)S879E9"(@<W1%
M=G0Z:6YS=&%N8V5)1#TB>&UP+FEI9#HV,T$W134R0S@X,C V.#$Q.# X,T(S
M044Q,#)#,$4X-R(@<W1%=G0Z=VAE;CTB,C Q,RTP-"TP,U0Q.#HQ,CHR."TP
M-SHP,"(@<W1%=G0Z<V]F='=A<F5!9V5N=#TB061O8F4@4&AO=&]S:&]P($-3
M-B H36%C:6YT;W-H*2(@<W1%=G0Z8VAA;F=E9#TB+R(O/B \<F1F.FQI('-T
M179T.F%C=&EO;CTB8V]N=F5R=&5D(B!S=$5V=#IP87)A;65T97)S/2)F<F]M
M(&%P<&QI8V%T:6]N+W9N9"YA9&]B92YP:&]T;W-H;W @=&\@:6UA9V4O=&EF
M9B(O/B \<F1F.FQI('-T179T.F%C=&EO;CTB9&5R:79E9"(@<W1%=G0Z<&%R
M86UE=&5R<STB8V]N=F5R=&5D(&9R;VT@87!P;&EC871I;VXO=FYD+F%D;V)E
M+G!H;W1O<VAO<"!T;R!I;6%G92]T:69F(B\^(#QR9&8Z;&D@<W1%=G0Z86-T
M:6]N/2)S879E9"(@<W1%=G0Z:6YS=&%N8V5)1#TB>&UP+FEI9#HV-$$W134R
M0S@X,C V.#$Q.# X,T(S044Q,#)#,$4X-R(@<W1%=G0Z=VAE;CTB,C Q,RTP
M-"TP,U0Q.#HQ,CHR."TP-SHP,"(@<W1%=G0Z<V]F='=A<F5!9V5N=#TB061O
M8F4@4&AO=&]S:&]P($-3-B H36%C:6YT;W-H*2(@<W1%=G0Z8VAA;F=E9#TB
M+R(O/B \<F1F.FQI('-T179T.F%C=&EO;CTB<V%V960B('-T179T.FEN<W1A
M;F-E240](GAM<"YI:60Z-F8P.38V86,M,&%C9"UC-#1B+3AA,6$M.68X830V
M9#@R,&4U(B!S=$5V=#IW:&5N/2(R,#$X+3$R+3 U5#$P.C,W.C4S+3 X.C P
M(B!S=$5V=#IS;V9T=V%R94%G96YT/2)!9&]B92!0:&]T;W-H;W @0T,@,C Q
M.2 H5VEN9&]W<RDB('-T179T.F-H86YG960](B\B+SX@/')D9CIL:2!S=$5V
M=#IA8W1I;VX](F-O;G9E<G1E9"(@<W1%=G0Z<&%R86UE=&5R<STB9G)O;2!I
M;6%G92]T:69F('1O(&EM86=E+VIP96<B+SX@/')D9CIL:2!S=$5V=#IA8W1I
M;VX](F1E<FEV960B('-T179T.G!A<F%M971E<G,](F-O;G9E<G1E9"!F<F]M
M(&EM86=E+W1I9F8@=&\@:6UA9V4O:G!E9R(O/B \<F1F.FQI('-T179T.F%C
M=&EO;CTB<V%V960B('-T179T.FEN<W1A;F-E240](GAM<"YI:60Z83%E8SAB
M8V0M9#ED9BUF-#1A+3@W9#DM-S<Q.&5B8SEE83 U(B!S=$5V=#IW:&5N/2(R
M,#$X+3$R+3 U5#$P.C,W.C4S+3 X.C P(B!S=$5V=#IS;V9T=V%R94%G96YT
M/2)!9&]B92!0:&]T;W-H;W @0T,@,C Q.2 H5VEN9&]W<RDB('-T179T.F-H
M86YG960](B\B+SX@/"]R9&8Z4V5Q/B \+WAM<$U-.DAI<W1O<GD^(#QX;7!-
M33I$97)I=F5D1G)O;2!S=%)E9CII;G-T86YC94E$/2)X;7 N:6ED.C9F,#DV
M-F%C+3!A8V0M8S0T8BTX83%A+3EF.&$T-F0X,C!E-2(@<W12968Z9&]C=6UE
M;G1)1#TB>&UP+F1I9#I%-#@U044S1C Y,C V.#$Q.31"-T-!,4$Q,39$-T$R
M-2(@<W12968Z;W)I9VEN86Q$;V-U;65N=$E$/2)X;7 N9&ED.D4T.#5!13-&
M,#DR,#8X,3$Y-$(W0T$Q03$Q-D0W03(U(B\^(#QP:&]T;W-H;W Z1&]C=6UE
M;G1!;F-E<W1O<G,^(#QR9&8Z0F%G/B \<F1F.FQI/GAM<"YD:60Z130X-4%%
M,T8P.3(P-C@Q,3DT0C=#03%!,3$V1#=!,C4\+W)D9CIL:3X@/"]R9&8Z0F%G
M/B \+W!H;W1O<VAO<#I$;V-U;65N=$%N8V5S=&]R<SX@/"]R9&8Z1&5S8W)I
M<'1I;VX^(#PO<F1F.E)$1CX@/"]X.GAM<&UE=&$^(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @/#]X<&%C:V5T(&5N9#TB=R(_/O_B#%A)0T-?4%)/1DE,10 !
M 0  #$A,:6YO A   &UN=')21T(@6%E:( ?.  ( "0 & #$  &%C<W!-4T94
M     $E%0R!S4D="               !  #VU@ !     -,M2% @(
M                                                        $6-P
M<G0   %0    ,V1E<V,   &$    ;'=T<'0   'P    %&)K<'0   ($
M%')865H   (8    %&=865H   (L    %&)865H   )     %&1M;F0   )4
M    <&1M9&0   +$    B'9U960   -,    AG9I97<   /4    )&QU;6D
M  /X    %&UE87,   0,    )'1E8V@   0P    #')44D,   0\   (#&=4
M4D,   0\   (#&)44D,   0\   (#'1E>'0     0V]P>7)I9VAT("AC*2 Q
M.3DX($AE=VQE='0M4&%C:V%R9"!#;VUP86YY  !D97-C         !)S4D="
M($E%0S8Q.38V+3(N,0              $G-21T(@245#-C$Y-C8M,BXQ
M
M  !865H@        \U$  0    $6S%A96B                      6%E:
M(        &^B   X]0   Y!865H@        8ID  +>%   8VEA96B
M   DH   #X0  +;/9&5S8P         6245#(&AT=' Z+R]W=W<N:65C+F-H
M               6245#(&AT=' Z+R]W=W<N:65C+F-H
M                                             &1E<V,
M+DE%0R V,3DV-BTR+C$@1&5F875L="!21T(@8V]L;W5R('-P86-E("T@<U)'
M0@              +DE%0R V,3DV-BTR+C$@1&5F875L="!21T(@8V]L;W5R
M('-P86-E("T@<U)'0@                            !D97-C
M "Q2969E<F5N8V4@5FEE=VEN9R!#;VYD:71I;VX@:6X@245#-C$Y-C8M,BXQ
M               L4F5F97)E;F-E(%9I97=I;F<@0V]N9&ET:6]N(&EN($E%
M0S8Q.38V+3(N,0                                  =FEE=P
M$Z3^ !1?+@ 0SQ0  ^W,  03"P #7)X    !6%E:(       3 E6 %    !7
M'^=M96%S          $                        "CP    )S:6<@
M $-25"!C=7)V        !      %  H #P 4 !D '@ C "@ +0 R #< .P!
M $4 2@!/ %0 60!> &, : !M '( =P!\ ($ A@"+ )  E0": )\ I "I *X
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M<Z.S@Y-49";B1#7#=#87A*0G_]H # ,!  (1 Q$ /P#[^$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0?_0^_A 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$'_T?OX0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!_]+[
M^$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0?_3^_A 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$'_U/OX0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$!!_]7[^$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0?_6^_A 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$'_U_OX0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$!!_]#[^$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0?_1^_A
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$'_TOOX0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!_]/[^$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0?_4^_A 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$'_U?OX0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!
M_];[^$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0?_7^_A 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$'_T/OX0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$!!_]'[^$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0?_2^_A 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$'_T_OX0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!_]3[^$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0?_5
M^_A 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$'_UOOX0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!_]?[^$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0?_0^_A 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$'_T?OX0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$!!_]+[^$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0?_3^_A 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$'_U/OX
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$!!_]7[^$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0?_6^_A 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$'_U_OX0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!_]#[^$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0?_1^_A 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$'_TOOX0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!_]/[^$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0?_4^_A 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$'_U?OX0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$!!_];[^$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0?_7^_A 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$'_
MT/OX0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$!!_]'[^$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0?_2^_A 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$'_T_OX0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!_]3[^$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0?_5^_A 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$'_UOOX0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!_]?[
M^$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0?_0^_A 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$'_T?OX0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$!!_]+[^$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MW<*MGR?-;',X7#B);*1[3\5GMOLO^"8GT35K7X\F/3);-OIB89I64$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$'_T_OX0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0<8ZIZT=*-%/DAU-U TQE=S$
M6B6S=F<-U?QESN0!]A8^;,,=M8\-]$''4OJ]].<#7.GZFY7 UH+B9\MSZ!Q
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MQ Q^X$S26<A'$B+#@MVSZAV=WQVW6^J)^Z?P<;E^D.Y6?Y5UE_KF)^V*?:[
M9'ZV^@&I76DF3ZWR]L,CW175GFT%[E.:1N<1Y4ULVX9Y$C1B'M,S3L+"[8M[
M'W7M^7X<L1Z=/OHXO-V'N^#X\%T^=M+H_P"6KGW3?5+I]K"!L^FM69-G0=@Z
M/+KN.[GA<'<A9/#;\SF$'#$?0MVV^R^*V3$QY35Q=^+)CGIR6S;/A,3'WMG_
M *_D?G.MCF^6LN68/MI;RWBN&UV<T$K@X>\*ZC*1R1RM#XI&2,< 6OC<U[7
M["'-P*"= 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$'_]3[^$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M,S/&5XMQV\*>J(6YDR*I\NYSN=P(\;KR"S;V$X5(5:0>[YE;%P'*^WCH0/\
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M"F*VW'S$QI+)99GF3YS&),KS&TO0026PS-,K:4)\R!U'MI45#FA!E4! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!
M_]7[^$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 087.]1Y#INV%WGV;Y?E,#B6Q.O;F.%]P\"OE6L+CSROX,C:Y
MQW!!T_ZO>NOI'TJAF;<2/GO )Q;LSBYBT\+DQ,!#[;*KALN;2-)/A(RT!]#R
MN.T8<FXPX_CNC\6?%M=QF_R[)F/'A'MG1Y<=4_U,^NFN9+O+.EMM%I3+G.;&
MS-+;*FV,IC \4T=QF;KFZ-30M+1 2":M&"XK<=[VV+2W67/;/Z8WVYUO]R/'
M_;^%7G]K[5.J]:7;\XZP=4L[SRZD<YQL[S/;ZXYGN<7%D-N9'RUQ( :0*84
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M16/;%7:?*<ZR?/K./,,CS7+LXL)@'17F67MO?6SP14<L]LYS?=5;CC630$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$'_
MUOOX0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M;PEO2RL @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @__7^_A 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M[)BR8;YQY;9MNCE,4G[695V,0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0?_0^_A 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!__T?OX0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MQ=4_^+CTVO6W-QT2]5>N--O;SNL\IZIZ#R'6S9S^""YU!I.YT^8>V5N6R_\
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M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @_]+[^$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$'57KSZXO2)Z8V7+>NOJ&Z7]/LSM(S++I>^U);9IKA\8;S&2VT#I_YO.IAB
M,8;!PQ VD5#Q1Z\_\FCTLZ+-YEO0+I%U-ZWYI"7QP9WJ*:QZ3Z)N"?#%<6EU
M?QYGG,C1]YT4^2VQ(HT/%26AX]=4?U_/U*_4/G7^S^B%GICI.[-Y'VN5Z=Z+
M].IM;Z]S"!Y_D'--7MSN>2XQIYV5V-HX8<H::DAHF4?IF_K,^NO,;/475[(.
ML$V7W,S9XM2>JKJ5F6G;?*#,#R&VT7JZZGSNVC#2>5EED7(QOA#6U (>D/13
M_BYWSQ9W_J+]4EK;D<GS^ENBNCI;OFKC(+37NN7P\M-@Y]-FNW"E"'KCT8_0
MB_37Z/"TN+CHM?\ 5W.[3DIGO6;5V=:L,_+0DW>ELL=EVGY.8@$\V3G@* D$
M/4;I[TFZ6=(\I&0=*>FN@>F>1AK&_P!'Z?Z/T]H[*^6,4C!L-.V]O$:;JM0<
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(.J
MW63T.>CWU!?-2]8_39T<USF=[S_,:CS'0^26>L#YF,ABUIE$5OFT?,<7>7>M
MJ:$X@(/)GK3_ ,;CT(]0/F[SI7G75OH-FD@>;.SR'5+->:0MWOQ!N<GZ@1WF
M:2M:?NMCSV+>"3A0/(KK9_QE_5CHSYK,.AO6#I1UIR^V+GV^6YY'F_2?65T1
MXHF6EA?'-<HYL*%TV>Q"M",*T#JP[/\ ]<G].,$WUQZJM!Z0R'!SLVBDZW]%
MLOAM_O11W=X-2:6MFO:/\F2-Q:*@^&H#N;T)_P"3KZA=,?)Y=ZA>A'3CJQE\
M7)#/G^@<TS7I=JIT9H)+V\MKQN=99<RC$B*WM;)CL&U9BY![3] _^0%^G;UG
M^2R_5.M]6= M1W7EQ?TSK!I:XM<G==.H)!#K/2#\VRN* &I;/F-Q:5&)8T^%
M!Z_]/^IO3?JQD$&J^EO4#174C2]SRB#46@]4Y'J[(Y2YO.UK,UR">X@+J&O+
MSU[$&\(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(""G+-% SGFD9$PN8P.>X-!DD>
M(XXVUVN<XAK6C$D@#%!T@]3?KSZ.^G6SO<L%_!K77K(Y66^E\ENX7V]C=\I\
MMN?9E'SMA(=MMXFOFW.;&#SCC=UW/%@NG%B_J9(Y1PM_Q3R]''R<UL>R;C<V
M1N-Q/RL4\)F/>N_P6\9].EOG+Y[.OWJOZU>IK,Y+O7&HKG)-%17#GY;I#)Y)
MK#*+<$TC:RQ8]WF2TP\V5TDI%07TH%UG=]QOR36^[KN\O@M]$<Y\YK+NG;^T
M68K*8K?E63QF?\R_TSRCRBD>3A'*LN>8_+@#\HRT82F)@.9WC7;3+(_",';X
MC7L7$WWWY)ZKYK+L6'#9BLZ,<=,?:WFTABL;4_T^&+([#_.S&Y DO[O^]#7&
MIXGW!59]+>&BU-RR%LC[$&SA>?S<UOCYV875-I@:_$5W'<HJK7P6=K#>WLCC
ME\4D<;_YE_<GGNI>+A(_[@[ H1$3/!G;?++&S</->^]NSB61UE<7'$<[_P"Q
M$Q$1Z67#9"RLQ99P-'\MA#?#M\;]WN1;7FLIK^-C"+9T=O "6NNI3RAY'WFP
M-^\\]H1'H4(8IYZ/MH7FIJ+R];RNQWP0'8.VE5)2>3)QV#6GS+B5TLFTO>:4
M[B=@[ E/%:+69RS*,VS>3R<AR6\S)]>5TT,+F6<9.%9;V6C/@2KV8K[_ ((F
M6._+BQ1[]T0Y%RSHWGMYRRZ@S*SL8C0NM+8NN'-&\$-HTGM<X]RVK-E?.M\T
M:F3N.*-+(F[[(_>Y?TYTER2-T;;+)KO/[EE/S+B,SPL=7:((PV)H[ZK:LVN&
MS68K/FX_-W'+,>]=%D>7[5<WY;TQS^2(-='E^3V[6^&)SAX1P\FV%![RMB-(
MT<7?OL5:ZW3^WBR#-#Y'8R!N<ZECEDY@#9Y5%YD[B?P8<[A7=@HFZ&*=[?='
M].RGG+=<KLK>Q;33ND9 2*_U'.7,MW24V$F7GE WX-'N45KR:F3)=D_S;_5#
M._T[4%X ;[.8[%I%'6^46XJT;0&W5Q4UXD#N4:SHQ=5D?#;[4[-*Y/Y@ENHI
M\RE#JA^97,MWXN;F!$;SR_0G3"/FW\M/0ST%M!;,#+:"*W8, V")D0&ZE& *
M?0K6O&5;E/#XHC1-R'L30KY)@Q$UE5;&2.[#>A3Q7,<6SBG$\H7S(Z >[O[1
M5))GE"Z8WW#[55*Z8-_N]Z)5$! 0$! 0$$":()"_;39Q^U!1,G;7'O\ @@I%
MYXT[E.O)"@Z4#8:[$IXBD9S^P["IK$%82>:[O2L(JG$VS?\ 76J5A-85V2AQ
M  Q)H!Q]RB8.+6\TU)*+DY-IV&/,\^<*25\5AE##A\SF4S<*C:V,&I*Q773$
M]%FL_<SX\-+?FYIZ;/MGRAELAR6+);>0OE-YF5Y)\QF>92"LUY<.Q(!=BV-N
MQC-@5K+(MCQF>,JY<LY)TBEL<(\(_>V)68Q 0$! 0$! 0%*%-S@,!M^I$4A0
M=*6XAU#Q!H0B:-1SK2VG<]D$V9Y;%-, X>>PN@F?S"GYCXJ<Q&T$XJ*4FL,E
MN?+CCILNHX&UGT\=I^-^99;>,GRKS&L,-Y-'%>6\DA\$37OHV6OX:4=V%6ZH
MCBY';[OYL]%\>]Y1I_8X*U3I++M46CHKAC+?,8VGY/,FL FA>/NQS':^,['-
M.S:%7+BMRQKQY2Y/#GOPW5CASAUMN-':D;+-"[(LRE,,KXO.AM97,>8W4$D,
M@VM.T%<;.'+6G3+EHSX9BO5'M82YRG,8'^3=Y?F#)&XM,EI/'<QG94$-\5%2
M;;HXQ+)%UET5BZ)]:W G@+8[J.2,.PBFEBDB\S^X\/ H[LWJM:<4Q="UN,LM
MIW^<&NM[C=<VSO*D[.>F#NXA/03$2H^;F5H?SHA?PM(_-MAR7;1O,D!P=3BT
MU4PI285X)K2[<7VLM)FDAX8?*G:1M$L)V]M05&B$TMI!<&MQ"USQ@VZ@'DW+
M=Y<>3'#LJHIXK:+>6PO,);>X;>%K? ^60VV81C#P1W<0HX4 \,@(5K;[K=.,
M>:EV.V[6=)\8TEL&D^HVJNGV>VF>9#FV=:8SNRJ;;.,HN)K"_8.<<\3S;D-F
MC>!^8S%KP"',(P6;'DFRZ+\5TV71Y_C^]@S8K<N.<6YLC)9/E7[/QC5Z,=-?
MU$M31/L7=3-/6>JG6XCC;K;1TT.F=8!C&-8/ZE;-:_+K\8&L,UO&W$X5Q'-8
M.^[C',6[FSKCQC2?W3]GI=9W?TIL\\3DV-\XY\)]ZWT?S1]OH>D_27U>]'NI
MTEGE=OJZRL<ZNS'!:VF>1-R"]N[@L#C"^TN))(A(20UODW$C7FO*&_='.[7N
M6TW>F.ZEW\LZ3_;ZJNJ;WLW<-A[V:RMG\UNMOKGEZZ.UJWW%B @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @("#__T_OX0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0-_MN0$!!T']17ZGWH3]
M+?S]GU7]16A6:GL/,CFT'HJ\DZB:Z9=LP;8WNFM%-O9K"1YP:[,_EH][I&C%
M!X,^HK_E Y?#\_E'I2].MQ>R#S&66NNO&;-M+8.;X&R#IQH6X?)(QQ\;'OU'
M$ZE Z($D-#ROO?5?^M%^I=?7F4=/\XZ_ZNTK?7$EE<Y'T)T]=],>EN712NY7
M93J/5>EV9?9O@J=FH<XF)WN/**!VCZ"?\:3U;=0Y+;.O4+U1Z=="<NO'BXO\
MIRZ2XZN]0HY)'>;<,O+3)9[/) YY)'G1Z@G\57%C@!S![9=!/^/%^GWTC^2S
M#7^3:]]0FH;?DEDGZDZJN,ITPR\9_F66D=!MRN-T.'_E\SN+UIJ>8NPH'L1T
MNZ(=&NB&3_[?Z-]*>G72O)2QC),MZ?:-T_I&VN?+V27K,BMX//D)\3I)BY[G
M$N<XDDH.44! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 00J.(^*"
M',WC]OU((<X[?H0.<<"@AYG9]*"'.=P"!SGL^E!#S#_=0I)YG^%$TD\S_"A2
M4?,/8B#G/9]*"/F<0@>9V?2@CSCM^A YV]H]NQ!-S-XCZOK0*@["$'3#KO\
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M?*^XLI<0'07<4<C3@YH*#F) 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M$! 0$! 0$! 0?__4^_A 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M45.4J:E3E*%3E'%14J@1134K5(XM&W]^*)HH.D''"M*;TH4B%J^4XBOU4PV
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M9!I]MRK0GQ50>")56NPQ/MLQ*)3H" @(" I0E)[:**(F5N]P W>V]3!JL9)
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M_]7[^$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$&H:[Z@Z#Z7:9S#6G4K6NE.G^D,I9YF9ZHUIJ#*=,:?L&$%P-WF^=2PV\9-
M#RAT@)V"I0>"WJH_Y&WH\Z.',=/] \DU/ZF]8VWFP1YCE'FZ$Z76]U'6-XFU
MAJ"VDO[OD?1S3EV336\S0>2[:"UQ#P&ZG_JP?JL_J%:IN>F?16;6NFK#-N:.
M/I=Z4=*ZCL<V&73/\@39]K++#>:A\DL);>2R9G;V1'.Y\,;,&ASWZ:_^-_ZN
M^K]W;:L]3>O=,= ,ES2<YAF>5R73.J?5F^?<2?,SOO+')[IF46\EP">:>?/)
M9HWN)EM7.:6$/H;],_Z'/Z>_IN_I^:2=*7=<=:67E2?[NZ[W-MKB,7+/&9+/
M1#8+;3L0;)XH7NRF2>.C?SW$%Q#UOR_+[#*;&TRS*K&SRW+;"WBM+'+\OMH;
M.QLK6!@C@MK2TMFMCCC8T!K&,: !@!1!>(" @(" @(" @(" @(" @(" @("
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MZ4M6:ASR.YR^U>9>34ND,I9:YY\HV/QW3,QR9]D&EP=(]@<4'9[TP_\ )/\
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M @(" @(" @(" @(" @(/_];[^$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MN,NN((6U,U\ TN(?0;T_ZC]/^J^ELNUOTPUOI/J'H[-V%^6:IT5J#*M39!?
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MMP1M9;!V/+Q<B&8M+-O@+X]F,5LVM -TMQ7>>U0F(;MI[2^:ZAEF=8QQQ6T
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MVDMC4H$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!__7^_A 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MB,6@BA0=@T! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M @(" @("#__0^_A 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M&V0F)MV(76LK@?(GE;XB';% 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MN>?]S[/N.WW3=$3=C\:</3^_[G>E<BX<0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$'_T?OX0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$$*BM$332J*($!
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M-GNFVRORK7&E'RT;Y&J=&9H(LPL_'6-D[X#;S$$P32LHXAVC0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M#+&2US7 @@@T*Y]U-<H" @(" @(" @(" @(" @(" @(" @(/_]+[^$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M;:1Z8:,L.5T>1Z1R>VRN&ZN1&(G9CFUS&#/?7D@ \Z]O999Y#C)(XXH.5T!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M)N;$;';\*XU6Q;D:63;PWO+M5EW+1^.\DG#9OJLUN1IWX)\'8?3>?MN,NL9
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MB:ZPZ0SB @(" @(" @(" @(" @(" @(" @(/_]/[^$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MLTB.'[H\W9736ELMTO9L\^)F8YO=M$[W24,UY*W$R2%W\JWCVM!PIB<5;27
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M^_A 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M/<Q^[;]LM_%7&I)_;[U6M&EY0K-;L'N4165HA=115()'MN5E](7S(]X%-_\
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M" @(" @(" @(" @("#__U?OX0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0>*/ZA7ZWOIH]%ASKI[H::TZ_>H.R%Q92Z%TKFT+=(Z(S-@,?_RR-9VPFB@F
MA?S>9E%BV>]YF^7<-L@]LR#Y8V1?J;?KE=8^<G-M6:8R+-:>8_YS17ILZ)PW
M;<0P#SX&78@>*AHO\ZNHA4_,-95H?45Z!?T./3!Z.'9+KSJ';6GJ%Z]6(MKZ
M+6.L,HA;HK1V9,I)S=/]"7+IX(Y8) TQ9KF+KB[#V"6W-ES.B%9F:K1$/;=I
MP[E9$\5P,0#V(A% 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M [Q]'[5-(5F95A!A[=RC0JF\H;A]6&[%1771,1,\3R>P)5:*1P1$094G81@
M,2> &]0F9JJ!F.S:!M^NB5BE59E6:P4Q^A20JAG"@1-4U*>VWL0JT+4&87SL
MU?IV:[_IMKG-C_[ \PM'2PW4>91'F=#<S?PN-!1M,%BOF9N^7PKP;6*VWY?S
MHCJFV?>B>%/%5T]GMS>QS95F[1;Y_EE(;N$D W4#!RQW\0'X7[Z;U-EU?=NX
MQ^U5,^.+/ZF/6R[AY>3-R2;?:JR0UHBK'225.%:UVU4UHM.BU+L:>]1K+'-7
M$6J-5WF;WG^UM)\\]Q.YT-[?PF@ 'AEA@F'W8VC^;+[@K1IJY';[:W'9\_<:
M1'"/W_A#;]+:5L],VA8PMN,QG:/G;XMH7G;Y$%<6Q@^\[2HK5K;C<79[J\+8
MX1^,^;:@*^V"B9:\JS6UPXG?WI1,6KR.'<=WT=JFO@OP7S(^S#X5"A765XR/
M9A2G9NWHF-%;EPKA3=V'N1*E([EV''$5J1AM^E!KV8Y3E68S6UU>V%O-=6DT
M<]M<\@9<12QNYV4E90EM1]TU!WJ)MMF:S"8RY,<399-(GC">:2I..\D]I*LK
M$4A8N=7VVX(B4B*L3G>=6.06$E_?/HP>""!I'G7<Y%6P0M._B=@&)4QJR8L5
M^:_HL]O@XMRO*,VZ@9@W/,^+[;)(7D6=FPN:V=@-?(M@?PG 2S;7; E::.1O
MOQ[2SY6'6Z>,_M]SFZVMHXHXX88F0P0M;'%%&P,CC8T4#&- P 4./F9F:RR+
M(Z;,2DRIQE>1Q'>,<,/>BW!<M8!NX?VJ*U14< !3L'9WH1*T>_O^OL4R36FB
MREDI6FWOP[E/+5%JP<_'VQ42F5.I)''8*;35(\E-(<.:]U.^_N'Z3RB5I9S!
MN<WC'?E\S/')8"1I^Y&!S7!XCDXI6NL\')[/!%EOYC)'^&/Q_=[4O3;0MU99
MO=ZRSN+RIY+9V5Z6RZ1K3-EN4O(-WFMQ4 LN+X@'R]K(PUIQ6*RV;LDYK].5
ML>$>/IDWN[B['&UQ:\[I\9Y1'E;X^+FYK:^WTK+S<=$+Z.+ ?L1-T\E['%W?
M!.!PA=-9B!W?%5K5,+EK:8G;]2):QK#2MIJ[*3E\TAM;NWD^:RN_:#SV5XT4
M:XEN/([8\#'81B%,,N'-=AOZHUCG'C#C_3^O,TTYF#-)]0V.M[F+EBL<_=5T
M%S#7DADNI=CV'=.W$;'@'%3,5UALY-O;EM^=MM8YQ^WW>QS2"US6O:YKV/:'
ML>QP<Q['"K7L<W @[B%#0F!$1/BHW,KX89'Q,9)*&D0LD)$;I3A&'EM32NV@
MJHF:+1$3Q8C(\G.50W$EQ-\YFF8SNN\SON3D\Z9WW(8AM$48HV-I/:HLMZ8K
M/&>*<V3YET1$4MMTB/VYLT7 ;5=B4R[W4[?M"5*I>>F'-3WH(B2OXB/?10NC
MS]OMVE#BCS\*(B81#QV_1@I46\-E907$]W!:P17=T&"YN(V 2SM9BP2/&T#<
MHBV(FL+S??=;%LS6(X1X+YIH5*.,4540(*;AB>U0M&L*9'#:/:BE7RE%KN'M
MV%0F/"4+FVM;^VFM+VWAN[2X88Y[:X8V2*1I%*.8[Z",1N4D3=9=6V:3'-U?
MZC]*!E4%SF&46[LSTY*UWSV73-^9GRUIJ22*5D@&Y].9F_BIK6*7.7VN\^9/
M1?I=RGQ_M=(-9]/W96R7,,J#ILO<01&&N?);<P)+)2/PBGADP&XT.*T\VWI[
MUKF\.XK[F3VN%[RS#G>(/AGB/@E8 V6,C'E/,,0=[3M6JW%*.3S +:\ 9(27
M12L)#'%NR2)Q^ZX;2T_4GI0O;/,XC,RWN)0)S5L$S@8V748. JZGB'!5B5FQ
M,?7"M'"A'81B,5;FBM8T96UN X#94'$;VN&T=B<.)$UT=J?3+ZE<_P#3QJET
MTAO,WZ8:@O(GZWTM"))Y+!Y B=J_2]MS!K+V)H N811MU$WE=21D<C.9[9W&
M[;71ARS6R?L=:[[V6W>63N,$1&6/^:'T%:=U%D>K<BRG4VFLTL\ZR'/+&WS+
M*<UL)FSVE[97+/,AFAD;V8.::%I!:X!P(';XF+HBZV:Q+SNZVZRZ;;HI,<89
ME2@0$! 0$! 0$! 0$! 0$! 0$'__UOOX0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M/N]Q_>I53H" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MOM\^5]WW0^4OU!P_)[[;_>Q63]MT?@]'^/:?LHNP.BB @(" @(" @(" @("
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MC\,5KYL$3%;=/VYN<PYYM]V[5P'>VDMO++:7<3HY8W%LD3JAS3N<UPVU&+7
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MF;;HI,+E2@0$! 0$! 0$! 0$! 0$! 0?_]?[^$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M,+MAVCWJRBH@(" @(" @(" @(" @(""',.(^*"* @(" @(" @(" @(" @("
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M:&1QL:*-C8P8  ;@J\7'16=9XRR4,?M2E"I)G1D(XZT[?V**HMA?1L &SO\
M=VHF50@;U%)C@JH/-!O]MJE:C'2OJ3[8J9\()T8V5VW]^*1I&J*56;BG&3R:
M1KC6-IHW)GW\K!<YC=O-IDF6M<!)F.92 B&(;PQIH9'4- J9<D8[:\9GA'C+
M8VVWNW.3HC2V-;I\(<1].M-7N>YM<YSG\QOYVW+<PSFZ?4LN\R>>:WRZ&O\
MD0#!K1L:.+E;'9-EOO:W3K,^?[H<EO,UF''&+#I%*1'A'CZ9=DVBI[3PV*W%
MPM8YKR)FRNSZDX%9ED(V5.S >V*CTD::RR$8H,._?W*$ZKMFS9]"%-4ZA80%
M*! W$&A:X%KFD M<#M#FG CL*A+CG4/2W2N?N?-%;NR6_>2[YK+0QD3I*UYY
MK,CD/:6T*M$RV<>[RX^,]4>;C3++#J?IRT=F&GKUV>Y2RXN819S'YF1S+.8P
ME_R-R><!U,/+?7L46S;?%:4;.2=KDNZ<L=-VFOI\X;5D75W+KJ;^GZGLY=/Y
MBP\CY7,E=9>8,"V9L@\R&I_B!':IFWP8<FRNB.K%/5'V_P!KE!L\5S"VXMIH
M[B"0!S)[>1LT3VD8%LD9(*B(:4^[-)XK:1XXJW"**3=*V?(,!7>HH:\U+S1C
MC]/8I-41/V^VQ*(B-59LPX]V/U)686I"L)=@KWJ*UXHIX*@EX?7O1:O*55LW
M;V=J%(:]GKCF-_D>GR_EL\PFGO<T8!4W-AE[0\6CJ;&R/(#N(%%BO]Z8L\>/
M[F?%_3LNR\XI$>4SS]3,WNI,IRR0637ONKR)C6MRK*K=UY<PLIRQM?!!A$W\
M(+B%:Z^VW3GX0QV8<F3WN$>,S3[^+#1YMKV^+?EM,9/EL#GAYES?,9Q)Y5:U
M^5M@7<Y;AB<"J=66>%L1Z99NC9V?%DNNGRC\6[XEHY@ Z@+@#4!U/$&G>*["
MLK6G@@>''ZU*J0&AIVJ%I\87#7;MR$Q76%39CO"E5U_ZF=-&RMNM1:=M6F0M
MDESC*(F LN(R"Z:]M(0*<U*^;$!0C$8U4UY2Y/:[J=,>3ARG\/[71776AXKB
MV%S9AD;80?E+@@M^2QJ,NNW?^TSCA"\XQN/*?"<-?-BB=8_;R_<YO#GFV:3P
M_;5U^DCEMYI;:XB=#-"]T4T,K2'QO;]YKFE:<^;?XQ55:QLC3')XXC]TU/F1
M.W.:[LW':.Y5E,(,:\3"-\AAO&@FVO&@!MTP;(YP,''B-IVJ"=%]9Y@;29L-
MTT0LD<!0G\N.5[OYD;S_ );CM'X3V%9*]4>?WL<^Y-?X9^S^QN3?+NH9+:>O
M)(VA+31['#[DD;JX.:<0>*BV9MFL)OMMOCIGF]6OT_/4C=R2CH1KO,#+/"))
M-"9G=S\W/RM,\N0"64UY)6!TUFW\+VRP@GFA:.S=HWL1,;6^=)^#R\;?W>QT
MCZA[;,Q.^QQ[UNF2(Y^%_P"%WM\7K0NPNH" @(" @(" @(" @(" @("#_]#[
M^$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M&.:1QFBRGS*",>*XBV_=YZGZ"MK%%UT\):6;)BMUFZ& NL]MFMY1(7&NQF.
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M$!!__]'[^$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MSM\NTSW;?-%+K9]OA,>4\6Y+*P" @(" @(" @(" @(" @__2^_A 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M^$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M@X@C$$'804! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M(" @(" @(" @_]3[^$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0= ?7U^HWT _3ZZ=_P"Y
MNI^:#4'4+/;.Y?TXZ.Y!>VPUEK>\BK$RYD:\/&6Y1%*.6\SBZC,48#F0LN;D
MQVT@?%7G&H/7_P#KL>IZ'++.WDS++,FG,ECDUN_,<GZ%>GO1^8W'([,,RN2)
M@V>9L9\RYE$^9YD^+RX62,BC@A#[+/T\?TPN@'Z>VB6V^C;&+6W63/<NBMM?
M];,_RZWCU)G9=RS7.2Z;MN:49-DHE:'1Y?;2N=+RQONYKF6-CVAZ3(" @("
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M_]7[^$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M!?K;^,>K[J.RZY!Q0@(" @(" @(" @("#__6^_A 0$! 0$! 0$! 0$! 0$!
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MNS_-;&Z8CWL?O1ZN,>N/MB'O4NYO.1 0$! 0$! 0$! 0$'__U_OX0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MI!EGZL/I*,-!YG7[1]M7"O+<W[[%X/>)"%K_ $7[O?\ !$<MQ][Y;_6>V/\
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M @(" @(" @(" @(" @(" @(" @(" @\"OU)^IL6N^O6F^G<%]YVD>B^0G/\
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M @(/_]#[^$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MN<[:VI,GQ-/>M:_)1OX]NUB]S_[W(ZIQQ)H/;>M6_-'.6]BV\SI;#4+_ #T
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M @(" @(/_]'[^$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MRQX#ALP451Z%*XRV.]M;FSF;6*Z@EMWM<*@"5A:'4/ FH2=8HM;[MT71QB7
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M;;<7X+N-DS'LGCZ^+;%E8! 0$! 0$! 0$!!__]+[^$! 0$! 0$! 0$! 0$!
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MT 7-NLB @(" @(" @("#_]/[^$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M1BN]^8__  <W/T#5]4/SP$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M^J! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M3_\ "[[R#ZJ>Y>B\WA$L?,-O?A^]6E$-7S2U%U?9*YV(LKRYO*&F+V6CH6?
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M(" @(" @(/_4^_A 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M7 YMU,S/5-7:]MV^(BEL4:#F6IZAP\PFO;[]M5QV7<N9P;"NDPT+,-25#J2
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M]]LL6]Q?#FLMOCT71$_B_*ONW;LW:.Z[GM6X^/;9<F*[TV73;/MI5OZVG'B
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M'VQ2?35WR7-.M" @(" @(" @(/_5^_A 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0:CK[7NC.ENB]3]1>HFI
M<IT?H?1F37NH-4:FSRZ99Y5DV49?$9KJ\NIW\ .5C& O>\M8QKGN:TA\#WZB
M/K_Z[?JY^HS2?I\]/&F]57'1^+5PR;HQTHRYA@SCJ#J"DD#^IFOHN=L,<OR_
MG30LNI!;918^:^21KC>7$@?5=^EC^EOT[_3RZ9F^S+^E:T]1^N<KMF]3^I44
M#GV^76[G,N__ $/]!ONFMEM\FM96M=-,6LFS"=@N;AK&,M;:U#UA0$! 0$!
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M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MYLF6?_C9RU]7?J+MSS-ZEWDW%MWE&17+<. ?;U'N46_7'U79-?S<SZ;+)_\
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MCBN[[6[=]MOM_BQ:QZ;?WVU?1 NXO.1 0$! 0$! 0$'_UOOX0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 08K/
M<]R72^29QJ74F;9=D.GM/Y9?YUGN>9Q>V^793DV3Y7:NO<RS3,\PNW,B@M[>
M%CY9II'!K&-+G$ $H/@V_5:_4VZD?J4]9,D]+GI?L-3YET&M-9V.0Z*TSD5G
M>-U)Z@->NO18Y9J?-<K:&S#+V3&N199,UO(T_/7C6W#HXK(/I+_21_2FTAZ
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MGHXQ]E'+:SM40$! 0$! 0$'_U_OX0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M5LSWW;V\YRX__OD/#OU;Z<?TYO+[^$;;=?\ WJY^E$OIY^68@(" @(" @("
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M0ZH/$(AM>EC62]_]9Q?^I%<IVN*7W^B'&]T^&R/.?N=N.CQID&94/_QW=_\
MF[5RE_Q.I;[_ #H]#F6(X-._Z*E5GBTV1B?AV)Q(7\;C2OPP'!1-*Z"O7#X*
M84GBE)^M31-$JE(@P&H=0Y5IG+WYGG%Q\O;-<(XVL:9)[F9PJR"VB'WGFG&@
MVDT4^ADQX[\MW39&KA&ZU1U!UZ]]MI7+)M/Y*YQ:<RN"Z":1FQQDO7C# UY(
M&G_$II$<6Y&+;[?7-/5=X?V?O5;'H_EK*7.H,UOLVO'8RM@>Z"$O.)K/+S2N
M[R0G4I?O[Z].*(B&VVND-+Y90VF26(>VA$L\?S4M1A7S+CFQ2LT:M^XSWZ77
M2Z]>JK.OZ7H+(,HAI$W.]40>8V,"-GR^46<EWR%C*"A>YN%-RZ?]:;CY7;L6
M&/\ Q<L>RV)G[WI/Z4[+\UW[<;N[7Y&":>G)=%OW1+I7D>9QR9SDD$A!CGSC
M*H7M)P+);Z-CP:]A74^VY(G-9;/.Z/OAZGWG!=;M<U\<8LOGV6R]9Y11[F@4
M#3RCL#<%Z[,<GRY;K:IT2BU$P:>U-$J[68"JK6LJ36JJ&UHD1,IBWFJMAKB1
MMX_L5J+3-%RR&F[X[!W**PK5<LC[%&O,I,\5RR&OMAW(M$1"Z9%Q&&&[ZD2K
MAO#'?[Z(CFJ<JB=$53'9[8J$0I_%2NJJ(46\UW%!+#%(:.F#RVN HP>(@G T
MK4C:!CL4S-)HO;;,Q6.2[]L#4>XA2 !)  ))-  *DD[@ APUEQ]K[JQTSZ66
MCKOJ%KC3VEO"71V5_?Q/S>Y(%>2UR>W+[EY.P?E@5WKC]]W7MO;+>K?YK<?E
M,UNGT6Q6?L<WV7Z;[_\ 463Y?9=IDW'C=;;3''IR32R/:Z.:[_4MZ9Y.Z>UT
M!HS4.L9XR6LS+.YH=-93(0:!T=N#+=/:<""6L]RZ9O/U"V-DS;V[!?EG^:^>
MBWV:W?<]:[3^A'>LT1D[YO,6UCG9CB<M\>OW;(GVNHFL?U%NONI)'V^12Z:T
M':2^&/\ V_DXO+]@YCRUS3-W2N#B,#1@QV+K.Z^MOJ#<Q/R;K,$?W+:S_P 5
MU?N>B]L_1KZ'[?-L[NW-O+O'+?TV3_N61;'MEU=U7U%ZAZ^G==:TUMJC4TDA
MJ6YOG-[<6[:DFD=F'B%H%30-8*+JFZWV]WMW5O<U^6?[UTS'LX/2^V]D[/VC
M'\OM6TQ;:/\ T\=L3_Q4ZOM:0R.*W+622-,;B0TX#E=MY7$4V[BM:L3$]$4E
MR&L7Q%\UB>$\U5]W8PC:VHV&H5)MR7,T=,:L-<ZALHG^2"P.+"[=]T&A3Y%]
MTKQDCBQ4FI+9I)#F<*@C?AO*O&UN/G6M:M-0/?G;RPF9PC$-O#:AUS<3.=X6
ML9;P\SR>RG<LD[7JNI$5F4QGC'MXBZ:1%=9TCVSH[%Z%Z'>H/J:8WZ,Z1ZVO
M[.7D+<VS'*9<@R<,D-&RG,<Z\AA;Q<VM%R>T^F.[;W_Y;;WS'C,=,>VZCJW=
M?KSZ2[+%.X]PPV71_#;=UW^CILZIKZ7:33GZ</J0SAL4F?YOTYT7%*'>8R[S
MN]SZ^MSRT;SVV3PEIJ>$J[!M_P!.^[Y*3GOQXH\[INF/5;'XNA[[]=_H_;S,
M;/%N=S,<*66X[9]=\U^QSWIG].OIAEFN<NR#6FL]9ZHN9M.19E<NRZ>STWEU
MQ=Q^"ZALVPQRSB)KN8,YW\U*%QJ:+L.V_3WM6/);9NLN3+-*S2EL3/.FDS3U
MNA=P_7;ZES[:_)VO;8-O9UTMZHNRWQ'+JK,6U\:12O!VJR/T0^E_(#"YO3"V
MSN:%W,V?4^<9MG3GG_U;')*V-W<647/X/H[Z<V]*;:+YC^>Z;OQHZ/O/U8_4
M#>UB[N$XHGEBLLL]DQ$S]KE#+^@?0O*G!^7='.FUH\;'MTGE<K\-GBG8]<I9
MV;L^+_+VN*/]R/Q=;S_5_P!6;F*9^Y[FZO\ ZUT?=,-ZR_3&E\F_]XVE]-93
MN!RS3V3V) & '-;0M/TK<QX-OB_RL=MOHMMC[H<1FW^^W7_S.?+D_P 62^[[
MY9X3S!H8V5[6@4Y&.Y& 4V -H/H6?JGA5IS99.LPIESJ_>=6@KXB37?5*R1$
M>"HRXF'A$LM"*<O.XM][5$S=3BK-MD\H:KJW)]/YGDF:.SG3VG\X:VRF &:Y
M)EM^*R#D !N8G$5)VA8<V'!EQS\[';?I_%;$_?#=V6\WNUS6SM<^3%-?X,EU
MOW3#JYGWI$]/745VJC?]/[/3.86CHH(<YT/<R:=NHI6V'FEYMK>MN_Q'F(?$
M:[UUS=_27T_W"+OF;>,=W\V.>B?LT^QZ!VS]4/KCL?ROE;Z[<6<[,\1EB8KX
MS[T:>%SIOFWZ<NJY\KM\VZ6]2<KS:VE,WEY-KFUERF_:UDSF<C,XRMLL#\ *
M%\322NF[S]-\LV_,[9N(NC^7)'3/_%;6/LAZSVS]?ME%WROJ'8WX[HXW[>Z+
M[?\ @OI='HB9=<=9^F3U$=.(I+O473/.;[+( 3+G.E'1ZIRZ-@KXY'9473-%
M!S$OB%!M74.X?2/?MA;-^;;W76Q_%9[\?9K'L>F]E_4[Z([Y=&/:=PLLR3PL
MS?TKO1'72V?5.KA:#,&F1T+BZ.>)W)+#*'13Q.&!;+#)1S2-X< 5U>['29BE
M)CES]COMMT76Q?&L3PF-8GSB8TEM>GM29[I?-+?/=+YUFFGLZM7M?;YIDU[-
M8WD9::AKI(".=O%CPYIWA3MMQN=EGC<[3)=BR1PNMF8G[./HG1K;[8['N>UN
MV/<\-FXPWZ39DMBZV?5/"?.*3YN_/3#]03662"WRWJKIVVUKE\8;&=09$(<G
MU.Q@HTRW=J[_ $ETX#$D"-SN*]'[3^I>_P!M3%WG%&XM_GLI;D]<?#=]DO"_
MJ;] >S;[JW/TMN+MEDG7Y66N3#7PMN_S+(_XHAZ!].?45T;ZJQQ1Z4UIE\6;
M2AM=-ZA>S(-0,>ZGY;+&^<&S&N ,$CZT-%Z7VOZH[%WF(C9[BV+Y_P##O]R_
MV3Q]4R\"^HOT\^L?I6Z;NZ[*^<4?^-BKEQ3Y]5L5M_WHM<TN8YAY7M+7<' @
MT.PXKGYB8TETV)BZ*QJE4)<9]6NK&DNC.CKK6.K9W.8'NL\DR2V>P9KJ;.71
MF2#*LLC>?^J><^&*.KW;@>*[UWK9=AV-V^WLZ<++(^+)=RMM^^9X6QK+LGTI
M]*]U^L>\6=G[3;K3JR9+J]&''6DWWS]EMO&^[2.;PRZK=6M9=9]53ZMUG>MI
M$)8,CR.VDD;DFF,J+^9F7Y7 \TK3&>X=XY75<XTH!\[]Z[UON_;R=[O[N&EM
MD?!CM\+8^^[C=/%]P?2WTGV?Z.[7;VKLUG&DY,DQ'S,U_P#/?/A_+9'NV1I'
M.7=GTE^E:3,),JZL=4,KY,KB='?Z*TAF,'CS65I#[74F?6LPPMFGQVEN\5D-
M)'CE !] ^BOHV<DV=Z[O9[GQ8L5T?%/+)?$_PQ_#;/'C.E'BOZL?JE;@MR_2
MOTQEKEFMNYW%DZ61_%AQ71_'/#)?'PQ6V-:S'J"YQ<2YQJ3M)7KTS6:R^9(B
M(BD-2U1K3(=)0EV9W(DO"WFARNV<U]]-AX2]A-(V'^-]/>E*LV+!DS3[D:>/
M)Q);Y;J_JQ<"]S::7(=(QS5M[2,.;\PUIP^7A?3SGTVSR>$'[H5M(;DW8=G%
M+/>O\?VX>ARY;V>E>G^32S,%ME&71 ?,7<Q\R\O90*-8Y]#)/*[\,; >QH6.
MZ^+8ZKIHU*YMSDB(K=/ARC\(CS8)MOG^NASY@V^TMI!_B@RZ.5]IJ/4$+ONN
MS1["3:V[AB(F.YW ^)8O?RZS[MOVSZ?!FF<6U^"F3)X\;;?1XSY\&^6&7V.5
M6D5AEEI!8V4#0V*WMHQ'&*"G,ZF+G'>YU2=Y66VV+8Z;=(:E]]V2[KOFLSSE
M>*RJ52IY""(4+0BH6-NS%2AK5WGKY[I^4Z?CBS#,F<PNKN0DY3E'**N=?7#,
M'/&Z%IK_ !$!8YNFM+>/V0S6XHBV+\NEL\/&?1'XNNVI+N+5.I6Y-!FSIK*V
MEIFVH+CF<+N6)U+B2QMHZ\L$9)9:P1CQ.\1JK1%N..JZ=?%R6*+L>+KFW7E;
M'+T^?C,N;<JCSEN76N4Z7RIFFLEM8O*BS/.XQ)F$Y!\=S%E<9^](?$7RFO8J
MS=DOX13SG]S1N^7%TWYKNN[PMX>W]S,P:3RQLS+O,W7&?9@VA^;S:0SL8?\
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M][;FII?'VQ_9,/11<TZT(" @(" @("#_T/OX0$! 0$! 0$! 0$! 0$! 0$!
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M! 0?_]'[^$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MC^Q^A,OHY^88@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M\U$! 0$! 0$!!__2^_A 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M8^^\6"<UU+M+(G_BF/P:5?YD'DMC=1C:[,*TP^"X[+DGGQ<S9CBV(T:Z^_\
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M?_3OTU\+;Z7>EI^E,BCTWF-GG<69SQ9U;R-EM;RVF=')%(U_/1C&5,@)&+9
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M*! 0$! 0$!!__]/[^$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MLLN_V/!/]1.2[']"[OIUZHM]DY[(?H"+Z.?G8(" @(" @(" @(" @(" @("
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M^:/-+SCA_8H0IUJK1)1"J51J5"FI5&M4E(H$S-JCD2B[9[TX*QQ4U"X@()7
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M^$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MV(=W5ON*$! 0$! 0$'__U?OX0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M[:R-;[HCT17B]NND6EX[K/,IR\Q.DL,DMHIIY(Q0"2( 1.<1LJ5U7]2>Z_\
M9_I^W88KHZ\WN^<QSEW;Z\W]O9^P8^V8ICJR1T^F(XR[M81QE_+4BE":?<;@
M!BOF>WJFZ(CE+P&+=*<&[9=96]S9&^GC>T,@ 8P>$AQ;@^OV+O';K;+[(ONY
M0T[,^:S-&&R8UEQYF,A?,X _>D/PJ1N6:/BF?-W7:V]../0QLAY8WG@QQ_\
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M=NCOIFT@S1W1_25KD,$L;&Y[J2[$5]K35]T!22^U1J-[1-.YQQ$#"V"/8R,
M+WGMG:=AV?;QM]ACBR.=W&^[SNNXSZ.#X9^I_J_O_P!9=PGN/U!GG+=7W,<:
M8L4?RX\?"VGCK=/.7,CI T$UJ?I[@N2IXNMUF9T6<EQVT^FGN4^@X<5A)= ;
M#CVT2G*1CY;K$X\3W50:'K.<-MLIO:NY;'.K3S2"/_+WO-93!U=@\0JJ9-(B
M?"89]O3JNMGG;/MC5HW3R?Y/,\_RTFC01(UO;;W#H20/\)"RMO?1-V.S)#E%
M\[C6AI[<%&E'&TCFH.DXFN[:GH16(X*;I  22&AH))) PWDDH:RP\^=Y5"]S
M'WT!D;R@QQETSP3]T<L(=MX*.JV.,KQCRS&D?@#,C( ;>RO9@15KW1>0P@<7
M2D$>\!*Q/"$=$QI=,0LY,VNH\'6ENQY Y6/NFR2%QPY2R($C#%5FY;Y<3S^Q
M'YW.GL#VP6ENP"IFNG.ABINY72D=YP4UOGA">G'$TK,^C5C[O445BPRYAJC*
MK9K!5[+2'SR*#%IE<>7;OJDUMMZKYB(\=/Q;&/;7YKNG%BNNF?VX1JT+-.N.
MC,IYFLSK.,WG',!%EL%L6D]KB2T<*DKCLW=-A@TG)U3X6^]]VCL&S^D.];O7
MY,8K?&^>G^WV0T&^]2%R[G&3Z?OB:4CES7..5M.+H+-N%-WB7'W]]B:_)Q73
MX=4T^R'/8?H*(I.[W-L>,665^VZC3KOKAU-S D6M[99:QSJAEG:/N)*;!62X
M<^IIO 6K?W3N.32RED>45^V7+8OI/Z>V^N2+\L_WKJ1[(B&)?JSJOG4K.;/M
M232.=X&VD<EL/%AR@PL:*=YHL%V;?Y/\S+=[:?<V[.W_ $[M8]S;8_7'5]]6
MS0:6ZH743+FZU9F5L2PES'YK>ON(V;7,<V+Z@5$1N>/S+_\ BEANS]EMF;;=
MMCG_ '+:,Y:=.-17+&RW6MLZF#QS PSWCQCMQED^."RQ.Y_\R[VRU[]YVZ)]
MW;8X_P!VW]S+P]+91C/J344Q[+D,&WB:K)$[KEDN]LM>[?;3E@Q?\,,U!H"*
MW _U^=3$';-?N.SB&M"O\W>1&F6[VM6[-M+^.''ZK68MLGFR]P=;<KG-_P#:
MF*.[K_B%P'>](W'<(G3+=]D_@QW8>WY8I=BB/16/NEL-KFV>VCP^++LDG<!X
M>;(K8'90^.)H.*RV[WN$3QB[TV_N:>3M7:+XI,WV>C)/XMHL];:DC:!)IRUD
M _%;07=MAP:UK2%M6=QW<1[V*)]$70T,O8>US-;-Q-OE,VS^YGH=<3/!%WI[
M.(<!5T =./<US6E;%G<;OX\5T>AQ^7L-D1_1W..?3I^,LG%J;*):>:^[M":8
M7ME<0BIV#G+2/I6S;O,-W&9M],3#1O[3O+?ABV__  W1+,0W-G<CFM[JVG!V
M>7,QQ_\ "#7Z%GLR67_!=$^MIWX,^+3)9=;Z8E7+-_M\5DU8DO+[#]I45."7
ME(4G-*0?;#'L4(2T[,>W[0@A\:5.W]B"([/AV!3"LH!U#3A_:H6Y*S7[/V_4
ME*GFN&.!P(J#]JKZ5HE=1@-V4:< E/!;JGFO8Y*#;MV[B3M^A3")FJX\["OP
MIMIMV)2$(^>./NK\ E($AN/CCW[.]"JE)<AK'.)%&-+JD\!5*P<5E:O(B:2<
M9*R..-:O-0/@HC@FZ9JK^9V]@-?H4HU/-QVXU^U*RC5'S^T[_I]L$K*=4//I
M3'LVU4UDU#/V_#8,%%35#S^)&W 5]X34E#S@?AC^Q! RCB-NY*"4RBM:G#"G
M%3R-6*S//;7*/(=>1WGD3<U;BVMI+F& @@<MQY52VNXTHJ771;Q7LQ79(GIF
M-.4Z,<W6>FGFG];L6. YN69[X7@;,6R 8]BCYEGC"_R,_P#+*Z&I<@>0!G>5
M$DBG^N@KLW>)3UV^/VJ_)S4KTS[)#J/(6CG.>94&U(YOG[>E6[=CE/S+/$^5
ME_EGV2I/UAIN&GF9[ENTCP7 E)PYJ!L=23O43DQ^,+1@S3PME2&N\C(<ZU;F
MF9<AY3\CEMS(RO9+(&M'O-%7YEO*L^I;\KE_BI;Z9A3RW6&<9])>MR'2EX^S
MM9&P19KFMU#965Q/2L[(Q&7.<&&@);O41DONKTV^M:_;8L41.;)$3/*(K++_
M ".J+\M^?SNRRJ"E);7(H/,N"788W]W7E/\ A8IZ<D_%-/0I%^"V/<LFZ?&[
M]T,E8:=RG+W_ ##+8W5YA7,,PD=>WI=6M1//7E[F@!7BRVW6-9\9U4OS9+_=
MF:1X1I'L9HDDU))/$XE&-!$B @HW$GE6US*WF+H[>=[ T5<7LB)8&C>:X *8
MX(I6Z(<?]/=+S:=R>:XS #^KYU/\[>@XNMHW$NM[0NWN )<_^\:*6QO,\9LD
M6V?#;I'GY_N;F\#[/=VHU86$E,:"F/85/-*SD'&GMO421X,2^\MQ>QY?Y@%W
M):RWK8J^+Y6*5L#I.[G< ../!(IU46Z9Z>OE6E?.6*U'<_)Y#G%P#0LL)VMI
M_%,WRF_6K+;>WKSV6^;6NFEMY&GG3;[N_F?VED+6PM^HJ.39[A=U9Z>$?VN1
MVG9[?2JPTHX+6^SZSRN6*T\NYO\ ,[AGF6^5Y?&)[U\5>7SY&U#8XZ_C>0.%
M56^^+=.,^#-CQ77Q-VD6QSGA_;ZE2#-M3/(,6DBV.K:_,YO:0S4)V^6P.V#;
MBJS=?32W[63Y>&E+LGLB753JG->P:UFU#=63K*XM;Z&TS*T#V3.BR>]B9&7&
M6/!_ENY):M5JS2+ICTN8VL6_(BRV:QX^;I1G[FRZ@SR1K@Z-^;7SFO::M<TW
M!HYI&XKB\DUOF?.78<43&.V/*&,&SZ.SWK'JR4U56&A!]MJGD4AB]2RBVGTO
MG&QV7YI);O<"0?*NHJ\I.\5:<,.*SX=;+[/*)]C2W4=&7%E\)F/;#W-_3HU%
M%=:4NLE,IYLKSK4MM;Q\X#3;YW;6&?Q 1D8@2PWCFEI_$[#:5VSL63KV71SL
MF8_'\70/JG#\KNG7RR6VS^'X/4!<RZV(" @(" @(/__6^_A 0$! 0$! 0$!
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M8[3L66+;5>NZ86\G.0=M37;7#N62VC'=65A)')0XX[*]G%;%MUK#=9=,,9+
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M?J[%%^VV^ZCC$W6S]\?=+WF7:'11 0$! 0$!!__7^_A 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$'5;UG^K;IKZ)?3YK;K
M[U,N&RV6GK89?I;3$-S';9MKS7.912#36C,E+PX^==2,<^>41O%O;1SW3VF.
M!Z#X>O1CZ<>MGZU'KRU?U0ZUYEF<^@X\^L]>=?M7V/S-K8Y)I3SC;:4Z2Z*D
MD+_EI;N"V&595%SN=;64$]V[SGVY;,'Z"&EM+:=T/IG3^C-(9+EVG-*:4R7+
M-.Z;T_E%M'9Y7DN1Y-9LR_*LKR^TB ;'#!!&R*-@&#0 @SR @(" @(" @("
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M][XK?MMIZWA7^H?L5W>/T[R[S';U9-AELSQ/.+-<>3[+^J?\+[X5]1OSU$!
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M00<000@B@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MO\UMT?=/X.L?45LY>R3,?P7VW>J8F/Q?3JNXO.1 0$! 0$!!_]#[^$! 0$!
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M[3NHKCW.._%=7POMFV?O]K]3OIKKK*.J'3K074K('A^1]0-&Z8UKE#@YK_\
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MTY)<LE9? %@<1RNY)V&N(P)JL>XMZL4NT;:_HSVSR=8FXT.[:/?B%Q,RYQ.
M/[."J+<#R;QIK2"^_P!/,,:,N7-+8I> YA5KCQ 5XFMOG&OJ8ICIO\KM)]/*
M69Z!9_-I?J-EL[)#;/CO!$Z28-(:UMR^S>9&NPH6$XG8#7<N1V]_R=]BRU_B
MC_FT_%PN[P_/[5N,$\>B?;9,S^#ZT--Y@<VT[D.:.<U[LQR;++Y[V.#F.?=6
M3)WEKAM%7&A7?'E3-(" @(" @(/_T?OX0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$'RM?\ (=_4D_V3IJ;T'=',_P"35VM,
MML\R]0^=Y7<\L^GM$YA$V]R7IB)X#S,NL[C++S-65:6Y<88'"2+,) P.;OT!
M?TV&^G?I1%ZM^KV0>1ULZUZ?B_V#E&:6W+>]-^D>9!E[9S>1,*P9IJ("*\N2
M?'#9"V@_*?+>Q.#Z-T! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$$KFM>US'M:]CVEKFN <US7"CFN:<"",""APUA^5%ZS>E,O0[U8>H[I))$8
MH] ]:.H>0Y>TL,8?DL6I;B;(;AC33PRV;X)&&E"UP(P*^2>][2=CW?=;.?\
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MDE@)W5)M9<XZC6T[8@=@\UEFXC_ >"^I/T[MKWC<7TX88^V^/W/G3_5AF_\
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M#<,!@<0O0[+HNLBZ.</'\ELV9+K)Y3,>R7,"LH(" @(" @__TOOX0$! 0$!
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M4..MR3=W;IC^&VGKEU-ZA$-M[0;R9B/XJ<^#B5ZU^E\3.XW%WATZ\N'!Z_\
M0L3\W-/^'[GI;_Q_,M<[U(>L7-N=_+;=,.BN6ECONN=>ZCU#=AP!_A\@_P#B
M7U3^F]LSO=W?_<QQ]MW[GS-_JRR4CMN+QOR3[+8C_P")]4B]:?%X@(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("#J+ZX_2!T
M_P#7%Z<=<]!->,ALY<YMOZOH;5GRS;F]T'U"RJ&1VE]6V#<'$0R/?!>PL>TW
M%G-<6W.T3%P#XJ?TU?5CU)_21]<^LNAOJ%@OM.=-L_U7%TN]0&GIW3SV.ELT
MR^Z=%I/JYDP#1YT%D+@7/S,+"+S*+J22)DK_ )4M#] BTN[3,+2UO["ZM[VQ
MO;>&[L[RTFCN;2[M+F,36]U:W$)<R2.1C@]CV$AP(()!07" @(" @(" @("
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M7C7Z*]B4*SP4^9SME2-^\>]1$2=4,9>YIE]@UTE_F-C9,:*N==7<$'*.)#W
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MD]SSX_[]T^J9K'WNW"W''" @(" @(/_3^_A 0$! 0$! 0$! 0$! 0$! 0$!
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M(BXBE?Z?E,<0Y33Q-K(:XX$+H>T_R(F?!]C_ $Y9$8\UWC?]T?VN]V6#\UV
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MKR>SRV!MK86T=O%05#1XY';.>:0XN/:2G'BXF^^_+=UY)K+8X+,N<UH:7.)
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M#:;2RTRUK *[R37M62,?C,_=]S7NW5U?=MMCT^]/MEL-CDF3Y:0ZQRVT@E#
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M\B$F1V&YS@H6B_8[?X(Z[O:W'3^@\HR)[+D@YC?M/,VZNFM+(7':;>#$-/\
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M_]3[^$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0?,#_P B7]0[_P!##IW;^A_I7GGE:^ZL91!G'6W,<NN*7&F.EES(3EVBWS0'
MFCNM1R,+[N(N#AEL;HY&.BS%C@&^_P#'P_3P;T&Z./\ 5[U1R+R.KG7?(XH^
MGECF-ORWNB.C%U(R^L;UC) #%=ZF>R',)'8D6#+)K2QTUS&0^D% 0$! 0$!
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MCQ/EDJ:;%:/+168\=6.N,D=F$0CSF9K[<@4RO+_]-8Q$C?(VCWN'&HQV*U?
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MV&/Z6>/&ZWVZQ^+VU79721 0$! 0$'__U?OX0$! 0$! 0$! 0$! 0$! 0$!
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M]5L]V9LY1JR9YG+9;FGC.D^F/[&YT5^J&KTRUC6UK\YI#4EO2I.4W,C0-O-
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M@R,.96T! +S(_"C(@7NJ.Y8KL%]^L:1YI_.8<6E:SX1JV2UGS"Z;^5&VUC.
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M 0$!!__7^_A 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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ME<-?.0/ UM=M78A4F+(X2R6SDGC"L*C;]'U*OH9.$:HN((IA2B:JUK$L%F#
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MX<T4-6V<+[L\-[17L66-+7"=VN_I?[T?9J\)^I&9OS;5V:W;W%P?<S/:VK/
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MLOG9?G609]81YIE&:64N'-%/;RQRL) -"*@%!L2 @(" @(" @(" @(" @("
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M" @__]#[^$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M06&:YIEN1Y7F6=YS?V>59/D]A>9IFN:9A<16EAEN6Y?;NN[Z_OKJ<M9%##$Q
M\DLCR&M:"20 @_/1]3W4_J7^M)^IODVC>F$MZ-'9_J:+I;T;BNK>X-CHWH[I
MFYGS#/NHV<Y?X3&Z:W;?ZCS!COS?%'9-<\PP-0??3T/Z-:$]//2+IYT2Z9Y6
MW)]#=--+Y;I;3]H>1UQ+;V,5;G,\QFC:T37E[<.FO;ZX+09KB665WB>4'*B
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MJU_N\,:[%ZV^!TR @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MU$S_ '?LF'"YHKLKK8YQ?'MMF'UU+TAXX(" @(" @__1^_A 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$'SA_\ (E]=?_H(= <M])F@
M<Y^7ZF>HO+YY]<R6<_+>Z;Z(V=TZTS2&;D(<QVI;R-^5QX%LEG!F4;@TNC*#
M7O\ CG>A(=).BV<^L?J!DWD=0>O%D[)>F,5];\MWI[HU8WS9I,V@;( ^-^I,
MP@;<U((=96EE+$[DN7@A]+J @(" @(" @(" @(" @(" @(" @(" @(" @("
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MZG!>R/SO3H" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M,R^O^W>9+>"0[7PQ//>Y@<O3HUBKQ28I,PK*4" @(" @_]+[^$! 0$! 0$!
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M\Y\NPMB<2:8N=V*/?F=(IZ5NG#;'OW=7E'[TYR>^NB3F>?7\S74)M[$,R^V
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M7_%/I7:E40$! 0$'_]/[^$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M_M>8DLTDTAA@P KYLNX<6M*Z_;;;9'7?ZH=[RY;\MWRL6GC/X,A;M;&UK6X
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MSY0'36YAN .25I(=ID! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$!!X-?J7ZQL[KJI';1O,USIK(<DRO*X(_YD^<?/7&8O@:. ,KA(0< %T3Z@
MS=?<NF.%MO3/KK,O3?I;;S9V?JNTF_)U1ZJ1]T.@&G6SY#E6:9O=O;/J#.9Q
M:-N 6N$$5K!S3" #_)@J=F!=1=>FDST\H=KMK$3,\9<B:/RD97E$9<7/N,PD
M=F%S(_%[WS8L+SQY<3VE8[YK+);&GI;E&,?I]J*JR[;L43,I3J!+( YM'#F'
M @. ]Q1,:+5[0!0##WJ)2Q\PV^W8HU78',(GRQ.$5!.S\VW)V":.KF ]A^Z>
MPJ8FG%-*PQD<[;F&.9K>3G:>>,@AT4K3RR1.!Q!:X$?2I^&5HUBJTE.W9MX_
M:K<8(ACI7\KFL(/BK1P%6@U^ZXC97<D:JSI-%J\U]YWI"W-@K.XBNIK^ZC>)
M.2X-D"*CD%M_,9CC]XDJ9B8B+58I-5(3R?.R6[G59)")H1AX/*?R2MXFM0:*
M::)YT:1'&S,M2ZHE JV/*),KMB<6FX,);=/ .\@@"FY;%>G'97G=5I76QDSY
M?*WI]=*N.-//+\EM(),#'F%C:5-,66]R:LKCLJ<%M9HI=?Z_MAH;:>O'CF?+
M[);?$YXR<98QA,DMW VZD;6D3&W#G-CYC05> "<< L.2(BZ+IY:1^WDV,<UM
MFRWGK,^&LZ>MLN3Q&XEAGK6WL8IHHS0!DEW.\NF?&["O**-J%7//3$V\[ICV
M0R[6WKF+^5M8CTS-9]C897Q6\4MQ,\1PP1OFE>X@!L<;>9QJM:*S-(<A,],3
M=/"-6N:5@>^RFS29KF2YO<27;&OP+;7F(M:MVBK<:++GG^IT1PMI#6VD3.+K
MGC=,S[>#9^7^W[0L+9.7VX5VHDY1[40.5"@6-J#RBHV&F([BE!L.4ZIU#DI;
M_3\VNF1MVVT\CKJU</X3!.2/A1;&+<9L7P73Z.,>QKY=IM\_^9;'IC2?;#E?
M(>L\]HY@S*SN+63 .N\GF(83A5TEG*<?<2N1Q]RB=,UOKC]SB=QV2+Z_*NB8
M\+OWN=].=6['-@QD-Y99H^F,-399DT4\587_ 'B-YHM['EPY8_I71Z.?L<!N
M>T9,,UNMFSSXQ[7)5IJ[3,YC9+F<.73R8-@S(_*/+C0 -G=^4['91WN4W71;
M-+IHXZ=ENHBMMO5$<XU^SBX_U99FUU+?3,#?(S*UL;V*2,-,4I$9A>^.1E0Z
MM!4JV.*77>UN[2Z9P1;/&V9AL?3F;ES2^MJT\ZS;(!Q=!+C]#E>ZG-CWUM<=
MMWA+F^W]]<-JQS+CH9B%U!N4(F:2S$,F ]W]B*\V9MIWQUY'%@>TQOH<'L</
M$Q[=A!&T'!6B9C@FD7<8=;NKOHP],/79MQ-K_I%IL9Y<-<UVKM)P-T?JMCW8
M^<<TR-L;975Q_P!1%(#0 X+KG=?I3Z=[Q6[>[6SKG^.SW+_;;2OKB7?OIK]4
M/KSZ2F+.S]RR_)M_\'-/SL4^73DK,1_AF'DQUU_1;U78PW^<^F[J?::ECC;+
M-!H/J=Y>39R]M"X6F6:ORYAM)7THUGS<,7,=K@O-NZ_I5EQS.7LFX^9''Y>7
M2[T1?&D^N(?1'TO_ *H=GFZ-K]:;"<$S2)S[:M]GINPW3UQ'.>BZZG@\&NK/
M3OJ7T>UA>Z(ZO:(U+T\U3'=21G*]49=-8_.6MNXM;<Y1?.!M[RWD.+)K:5[2
M*8KH^X[=N^UY?R^]QW8K[>5T4K,^$\)]3Z"[5WWM/U-M8[AV/<V;O!DGXL=T
M32(UI=;\5D^,71$M1B/, :5/N^Z1N6&W27)9+8NT48^;SI61_P PT+L:^7&=
MA/?N"W]O?3WKN'WN*W5FO19QY^4/0ST(^N#6?I%UOEUEG.9YSGGI^SJZD@UU
MT_,S[RUR<7M&?[UTC:S&EK?VDG++/%"6LN8O,8]I>6N';?I_ZCS]HW5MN6Z;
MMM=/OV\>F)_CMCE-O.G&-'DWZD?IML/K7ME]^VQVX^YXHKAS4I-]/_!RS_%9
M?&D3=6;+J3$TJ^H?I#96^O2SJY)?6N>97J".+,](YC:R-N,OS*QO(A-;9O8O
M%0861N#(>!YJ@.!7MD9,63';?ANBZRZ(F)CA,3PF)\)?$W<;,VQR7=MS63CR
M8IFW)9,4NMNMFDVS'C7C^YV!\G%PQ--YJ!CV_L31Q5$XA I]-?L2J:)VP;Z?
M;[E.JZL(:;M_OX8*JJJV/L^/'CBB%4,&_%0(\H_L4U35#E4U35"A4U36)2TQ
M4HIX*E/IK[JJB. =I[@/B5)"F5:">%5-^ROMM1#"W^9Y;9"7YJ]M8I(6<[[<
MW$(N:4YF\L!<'$D?=%,=R3--5K;+KOAAQMF'4>S#7'+K$N:RH=>9M=VV6V@I
M_#&7&5W<UJQ==UWP6RV[=G33)=ZHUG]SC+.>HV83O?%%G +GGE;;Y!:.CC!V
M$-O[W\QX/]V.JF,>6[XIIZ&S9ML<17I]=T_A#"V^0:YU)^8VWS&&V>>87.:7
MMQ&TM(Q(,Q#B*;FL[E:,6.)UF9]*;LNWQ>'^[$-WR?I1E]N63YW>/S*7!QMK
M;F@M>-))3^8\>\*]=*1%&ODWM]VF..GSYN2+7*<NL8VP667VEK$V@#8;:)OO
M<X@N/>2E.<M*Z^^Z:W3,KSY*%[2U\$#VG:U\,3FD'[S2"*=ZK-.%$5GQ:V_0
M&1/O+F\B@?92W B?$^P>;62UN8SC/ Z/"CM[-GN6'Y=DS,Q'L9XW66+8LF>J
MGCK6%:.WUID@+8IH-5V8?X?F7BSS5D9-3S/ Y)"!@E,EO]Z/M37;9=;H^7/E
MK']B@[/].7!=::CR27+GN+G.;F^4MEMF@[>6\8T@BNS8K1FMCXHF)3&#-&N&
M[J]$Z^QKV8Z;Z7YG^7E]7WTH!9!D%TUKA4?>D9=GRF\:$U4_/CE-6:R_>V:W
M:1_>C]VK"6O3[764/=>:4S.:VC:2^*TN,TMX[B1HQ#'P1%\+G<6X=JO%_5\5
MM%[MQ@O]W+%?.D_[5S#U'U7E]ZS*=8&73Y $3LPBR=CI&.K1L\D;CRN9Q?$3
MQHEV.Z=;)/RV"Z.K%[WE5S!;Y%=7T,%U)JW.+ZVGCCGBDL7V]O;3Q/;S-<Q\
M+2>4@\:K'\N[A==+5G+9;-(QVQ/GJB_160S$&]CO,Q<&D$YA?37!<'8U>TT!
MI^'@GRK.>I&YRQ\,Q'HBBXLM(:2RR>.\L-.9/;WD1+H[MME"ZYB?2A?',\$M
M/:/BHC'9;-;8A2[<[B^)MOOF8GE5FGR[<:[:D_22LD0PK"27"JMP5K+'RW'+
MOQQ^&P*8CF>ECI;@G\7PP]Y2O(KX+-]Q3:?I!^M-912>:W==4)H5-/%.D(?-
M$ DD #$N.  VFIK0>]*0:-3SCJ#DN4AT<4AS.\%6MM[1S71M?6@$UQ]T=S:E
M.EM8]GER:S'3'C_8U;DUQK:GS$O] R5_^6/-@\V,XX1_S)21O<0U-(9O_:;7
MX8Z[_P!O5#=LBT5D&1ADD=N+^];B;R]:R5P=O,,)\#.S GM3J:N7>9LNDSTQ
MX0W#G''9@!P V )Q:^LI2[^Q2EAKS.88;@V-K#-F>8CE+[*SY3\NUWW7WLY\
M$3>_Q=BK=?$3TQK/[<62W',V]4STQXSS]$<UF<JO\Q%<ZOB(7$'^F96Y]M;M
M&T,N+H'S):;#0@'@JTNN^*?5"WS+;/\ *CUSK]G"&8M;.TLHQ%9VT%JQHH&P
M1MCP'%PQ/O*O$1'#1BFZZ^:W3,RN4131!$"(.4E0C1B[_-;++G1PRN?-=RD"
M&PM8S<7LV- 1!'BUO]Y] %$S;;I+)9BNOUCAXSI"P%KG69\WSLHR6R?]VSL9
M!)F;V[Q=7V+8Z["R('_$GO3QTC[62N.SX(ZI\9X>J/WLI99999<PLLK=D'-_
M,D%7SS.WNGG?5[SVDJT=-O!2ZZ^_6[5>\BFJ-3E"515 MK[?!*HK*'(IJC4Y
M%%353+3[?6HF8J1*@]G9[^SN25ZUT6DK-N';7[%6-%6-E80^M-M1[]P5^*(6
MQ8XUP431,T47-VUW;0>Q3"M%%S.8%KFA[>#P'#_PE3Q1PFL-6U#9RV@@U%E]
M8[S)QS7D3:AF89)7FO;65@P+F#\V$[01P*Q7Q,3UQQC[8YMG!=%U<&3A=P\K
MN4_O9\ML\ULF<[(KRQO((Y6ME;S,EAF8)&.' D$$$&HW%7TF/*6.V;[+JQ[M
MT?>XHS;(1IN\$EY/<2:5NYF1Q9M3S;O35W,_EAAS0[9K-QHUL^#HS0.J%CFZ
M[%/O:VSS\/['*X=U=EMI$5OC^'^:.=/"?+FV4S:ITVVKW-S7+*"CP77#&L(J
MU[9!XV84()J%ETE6(VFYTCW+O8W/(=39=FC61,N/*NPUH=!<ED<DA  +XB#R
MN!.YOP59BC4S;;+BUF*QXQ^/@W*%Y;+0X![:@'#%IQ%%'&&"&F]2LQ,606UB
M'#GS"^C+A7$PVK?-=6FXNY5-L:MS8V5S3=RB/O="NK]V)<ZRNR::_*9<Z5XK
M@'W4Q(J/\+5Q/<[JY;;/"/O=S[593#=?XS]T.)5QKDV#O@#>W7-L_H5Q7?@)
M*[%L63[D?XH:F:DY;HG_ ,N?O9JRQM+4C'_3PX\:1@;EBN^.?3+-B^"V8\(9
M6U!-Q;CC-"![W@);\2;Z4E];U@*6-D.%I;#X0@+UFWX8>"W_ !3Z5VI5$! 0
M$!!__]3[^$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$'&
MO63JQHSH3TIZA=9.HF8C*M$]--)9WK'4=X.0S_T_)+)]VZTL8GN;YMU<N:VV
MM( >:69\<;:N> @^!#T<]+M<?K#?JBYGKGJQ:SWFD<]U?F'6WK5$)9KC+\DZ
M7:8O(+33O36TNWAKO(F8,ITO:^(2MMB^<5,+R@_0TM[>"T@AM;6&&VMK:&.W
MM[>WC9#!;P0L$<,,,,8#6,8T!K6M     H@JH" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(/@Y_P"2]TF=I/U<Z'U]9P&*VZBZ
M#?+<W080U][E=[Y;FEP&)H]^_<O!/U-VUNW[SCW%-,EOVQ+[=_TZ]PNWWTGG
MV'52[!DI'HNA\X$,(C:&,%<:D\3O)*\QOOK-9?1>+%;9;TV+R*(5\6/8/N]B
MQS=6-&:,>OO-FR^C>7  "FQ:>;69;V&(C@S?SQJ(+1OGW!VT^Y'_ (W#ZEK?
M*TZLFD,MVYI/RL$=5_V0R%K85>+F\>9YCB ?N1[Z-:5BOS13Y>**1][+BVL=
M7S<\]=WV0W?*WT<RF&R@W84P7%YHTES&"=7(UDZK!W ?1VKB<D>\YC'.C(M-
M#7L6&=66(50:JHF55HGQ119 [$1/!@\R82Q]*;#NV8+;PSK#3S1HT2[8>9Q)
MQQPI3BN4QSHXK):P<S*8T_<MBV6I=;*R< "=M3BLBE%Q']T(QUU7]LWQ@U K
MVTV[DJK=QT?13_QU>H3=*^L'7?3]KPZRZK=%<UD YJ4SO0&?6F;VU6X>(6EW
M=@"FRI7KOZ0;WY/U%EVE=-QAGVX[HF/LF7S1_J=[7^<^A]OW.GO;/=6_\&:R
MZV?^:VU]J:^DWP:(" @(" @(" @(" @(" @(" @(" @(" @^-+_DCZP;>]?>
MFNCX(.:YR'I%'<22B0R OU!J*Y%FSD;_ "GAT9W5<"W<,?"_U3S]7<L6".-N
M.OMNE]F_Z;=E=;]/;K=S/^9N*1_NV6U]/'U.D'3S(VY'IW2^2,: W)]/Y39/
M: !25EHPSF@W\Y=7XKH>[F,.#%@G36(]C[$W=,.UQXO"(CV0YACP8#N#2<<,
M *XA=GM^&/0TJU>'/JPS@7NH?E2\R/9G.=3/JVABY+LVS&%^/-@W#L6MFGAZ
M_P!OV\7G^^K=W+)?RI$?>Z@C:*'X[%KRQ2JA4(C1.T>].,41<N&[ L,\4\]5
M=LS6T# 7O!V#9_U'L5.B9UNTA$Y(C2W65PV2I'G2''9%%M->)6.Z*1[L>N59
MN_\ ,GU0S%HRY?RB%C;9G\1'YA!V]ZT\ORXF>OWI^QGLMS7Q2R.B/M;':Y;&
M"V20F=YI4O)( ..Q<?DSW3[MND-O'M+(UO\ >GS;+;L8P - #</NB@'P6ADF
M9UEOV6VQP9>, 4X4'?C]BU)K5ECQ7#"-N.VFWVP475(\5?AO''ZEC3,Z*3@"
M=M,#QVJ\*4JEM[>6\O+:RA:7RW4\5O$T DN?*_D:  LEMLWS%L<V/IFZ[HCG
M+W4]+O3.72^1Y1926!MPS+[>]NG/91TUS=AI\1 _"T4IMQ/%:7U=O\.#86[7
M;W5NF::>4:_;+A_K?N6UV_;K-EMKXF:TFGE&OVS]CO'<-9;1-CK1SP YPH*-
M&T#L7E&YNC%BFO/B\;Q5R7U5; QW#2Y@'EAXH['E,@-&U[.%%J8/EYL,W3P4
MW5;+HMNXN1+&,.'F2 !D;.9^'AH!5QJ5PG>=W&WPQBLUNOTCQ:,V\+8YRXV<
M\9AF]Z_$ACBUHI@"7EPH3N 5-M;\K!;'C]KLEMOR-M9;/.OW-MRB*)DD'@H8
MYXHBXC N/BY:G?5<I;$SCF?+\'&Y[[KYNCE1/J:[;9%XE/+!,QP+Z<PCYJT>
M1OIO^"PXXF9IX2S[2R<EL3'&/N=;,Q\692D7'S# [E;(,<'&O*/L7+8:39H[
M7M;:8](HR^6M ;*>):".[#%=8[WDF,D8;>6OWLU]TZ5X<6W9/:OGCE>,2S@"
M=FP?M6+MV.Z['.6.37W6>W'%ML\V4S:S#\DNG- YA$9'4'\.!'<N=R17#$M*
M;X^=;Z77;69(TSF#AB?(<PUW D _N7=OTWR1_P!\BR[C,5]CN7TM'_TUCB?2
MYM_3/NQ:>K[IP2,+JQS^SI0&IDR\R%YP)\(;6H^JJ^L/I6:=]Q3X]4?8K^N]
MG7^F?</[MV.[V7Q%'U_MV#N'OPVKW!^9:* @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(/.?]4_T7V7KC]'G43I=
M86,$_4W34#^HO1F^>(VSV_472]E-)8Y,VXDH&0YU:R7.33EQY&"Y;.070LH'
MS2?\<OUFW71WK[J_T9=0[ZXRS2?7"YNLYT):9J9+5NG>MFE[ PYCD[H+GD$#
M\]RNV=;2B3QNN["QMV-YYC4/MS0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0:_JK4V4Z-TWGFJ\]N8[3*-/Y9=YI?SR/9&&P6D1E+&ND('.\@
M,C%<7$ 8E4R9+<6.<E_"V*LF+%?FRVX<<5FZ8B/6^5KK=U%N>HO4W,M=YRYT
M4NH,WN9,ELY7M=_3,E;,XFZE8ZI#WT< [9C0$X+S3=9+MSGR9I>Q;/#;L]KB
MV]O'3^U;97E\UXW*;>=LC'Y@WYE\3J?Z7(X9?F)2YIV/NI2 X?PBFS!:$Z5H
MY.(K3]M'*\3=E!0#  4  &P #<L;+Z%ZP4^OMHH(7+1P_;]2@XJE*;?;"N/8
MH36B4X]O<@MWC;W'ZE65F-F&T4]V[O1>(8F<;??CW)5:DM6</E,PFB)I!F-9
MX:@T;>1LI.SF_OM <!3:"IXQZ#A=3E)-L2)6YL>\[?JP25EF\[\-J5-*-1RT
M&VS7.K,X"67YZ,$ <P>[D>\'?P]RR3,=,2Q6VTOFWUJU_)':W66W4CFQL\RX
M@>]U *20\P%>-1@-ZGC6%KHI-LM/TV+N:SES".%L49SJ^G=-/S.GGA\WR'M\
MEM/"!LJ:K/FI$Q9X1'[VIMJW1=D\;IGU<'']_;3Y'F69V+VB"TDSH7UG<$ -
M:R8\Q$3=X)Q!W+=MKFQ=<172*^IQ<TVNX^3=[L5F8]?)NHM,MFFRR%U\^*$P
M_P!1OV,N6B*2=S3'"SE97Q'ZEKW7Y>J:6UIPTY-RRS;]$=5](G68B>,MADU!
MD67QMA9-X8FAL=O:V\DCJ; &L:,?VK#\C-=-;N?C+9C<;;';TV<(\(EK^:9C
M=9M'% [++Z*SNI&LBM)6QQ27/XGS7G,?#&QN/+O.U9L6*+;NJ;H]W5@S;F;[
M.BVR[WM/#TSZ&Q,S&XB:R&++XV1Q,9'&);^V80QC>5HI7 8+'..)F9F[CX1+
M-&XOB.F+(B(\;H/ZI>?^T5I3 5.90#&M-G!/E6?S3_PR?F<G'IC_ (H/ZK=
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M_P"!H:O6(TBCP>9K-51$" @(" @__]7[^$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$'R?_\ ):]:/]&TQT^]#^BLVY<PU:<OZK=:Q9SX
MQ:9RR]>SISI"]\LEI%YF$,V<W$#PU[/D\OD%63XAWU_0/]%G_MK_ *.<OZH:
MMRGY+JQZG3E74;//F8/+S#)NG<5J\=+M-2<X#F\UG<39U*PAKFR9@89!6!M
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MP_=XO/,^YV^3<77671-;IB/3X.J+*$5&(.((WA;<^"+O!4"JF.")>U@J=NP
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MJP'FIVKW>.#\M;HI=,>$JRE40$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!\$GZY?I9U'Z*?7;D7J8Z0_-Z4TMU
MMS^/K1HC/,GC\ANC>MVE<XM\UUM:6;V@M9*<Q=9ZAM^:C2;V2*-O);NH'V5>
MA[U2:=]9?I<Z2>H/(/E;>YUIIR&+6&2VLA<W3/4#)7G*-;Z=+'DR-CM\PAG-
MHZ6CI;5T$].65M0[8H" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MX8K8VD5W6*WQOM_ZH:N_NZ=CFN\,=_\ TR^JU>J/#1 0$! 0$'__UOOX0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!H?5'J3I'HYTWUWU7
MU[F3,GT7TXTEGVM-49B[E<ZVR73N6R9I?F")Q;YDSF1ED$+3S22%L;:N< @_
M/\])?3G67ZPOZJ-]K'J=:7%UI+5.M<SZU=8+;S)+FTR#I#H^[M[;(NGL5U@[
MR)(1D^E+9X(>V.3SL3&XH/T.H((+6"&UM88K:VMHHX+>W@C9#!!!"P1Q0PQ1
M@-:QK0&M:T  "@P054! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MTD,CXXM(Y]*,JBEYB2"VQN+4-&%&<M!1?57Z:;R=W]'[:VZ:SAZL7_!=-/\
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M 7I#QX0$! 0$!!__T/OX0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$&*SW/,HTSDF<:DU!F-KE&0Z?RK,,\SO-KZ5L%CE>493:/O\RS&\G=@
MR*"&-\LCS@&M)0?GB6$.K?UFOU92^X_JL&B^J/4A]U<BLD<VAO3?TYB\$ <V
ML=M='(K-D(< UDF:W8<1SSFH?H>Y+DV4Z<R;*=/9#E]IE&1Y#EEADV39580L
MM['+,IRNU98Y=E]E;QT;'%##&R.-C11K6@#8@R: @(" @(" @(" @(" @("
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MFOY.8MN.LG1V*[F-&WUM%#EG4S3%DZ4FOFPML,VMK:.@;Y68S$$O<4'U^("
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MQQ9)]YGPVA9:35IYMO?CR_+B*UX-AL[^TS*V9>9?<Q7=I-S"*XA=S,=RGE<
M=Q!P(*4CFPW639/3=I,+FI]MJK2%:'.HHB@75[THM$S"7F(WJ$RB'[]_%/21
M=31.)2/COV;:[D3I*L):[^['X51%)A5;*13$X?!"G.%PV6N_;]*BA%W)<,>?
M;9\%!HN&N]C]80F)A6#@1MQ^U$)D%,?S#VL!^FBD0>[<<-_%0+&5] ?;!3"9
MT82YFVXX"NWCV%6A5K]S."3CA\%)&FK"32<QJ":8TX4_M1#6,_SJ')K)UPZC
MIWDLM82<99N6O,X?P-VN/N4Q699L&&[/DZ(X1Q:KIW*IC([/LTK+?W3C+;MD
M%3$UX_GN:[82,&#\+5;R;&ZS13\OATMC26V\Q)^W]Y43Q:/)483AV5]J!02O
M8A4_MP%.T[N])1'!8Q3WV=RNARJ7Y++(I'PW.:\O-/=N:>22/*@<  </.-1P
M5*S=\.D>/[FQTVXXKDBMWARCT_N;;E.3V.6L+;. ->ZAEN)#YMU.^F+YKE]7
M.)[U:VVVUBOOOR?%/JY>QLL<.RNSMVX;E-5>8UL]VXQVCC! V@EO2T$R;C%9
M5PJ*8R$$#8 2JS,\EHMMMBMWL_?^YE+:RAMF>7"P,:YQ>_$N?)([[TDCW5)<
M=Y)41Y$S,ZKMK. K[J^Y31"J(R</JQ*FD##7F>6MO,;&RAFS?,\*V5BT/\HG
M#FN[D^")O'F->Q4NOB)Z8UEFLPW71UW>[;XS^$<UO_2<\S6ISG,?Z;:DGERO
M))71N+/PMNLR(YG&GW@P <%6E]WQ33T?O6^9CQ_Y=M9\;OPAF<OR;*\K;2PL
M;>W?M=.UG/<R.(H7R7#ZO<3O)*F(MM^&&*_)DR?'-63I[SVXE2HM;R[MK&$S
MWDT=O$-CI":N)P#8VC%Q/  I6(UDMMNNNI;%6'^?S2_!_IEC\G$:<M]F\;V-
M>TC!T%A&1(?^LA.JZ?ACURS=&.S_ #)K/A'[_P!Q_0H;@M?FUU<YL]HQCG=Y
M-B#7F!;90T;AN+B33!(L_FFI\V;=,<1;'V^U%[WQO&69##;6CF4^<O(H(Q;9
M='7^6R-E ^X=M:PX-'B=P29UZ;/7/@C^_EK/A'C_ &+ZQR^VRZ%T5LUU9'&2
MXGE=YES=3'%TUS,<7./P&P !6BV+>"MU]U\UN]7EZ%ZI5$!2A*XM8USWN:QC
M15[WN#&, VESW4 '>HDI/"& EU)9%[H,LANL[NFX>5EL?/ ';A)?/I$T<3S&
MBIUVUI&K-&&[C?2V//\ =Q4O*U3F )FN;+3T#JTBLV#,<Q:-W-<S4B:=OW6E
M/ZD\?=^V2N"WA$WSYZ1[.*>+2N4!XFO6W6<7-!6?-[F6[QVES("1&VIQ(#4C
M';QG6?,G/DI2VEL>44_M;!'''"P1PQQPQM%&QPL;$QH&P!K !17B(C@Q3,S-
M9U5 .Q)E$RFHHJK5,&\ 33LJH15;ODB@+C-+#"PCG+II8X@-QKYA"F9TK*8B
M9X15C)=0Z>A/YF=98#2H:RZBD>01N;'4GL5)OL\66,.:>%D^Q8NU=I\@F&YN
M;J@)!M,NO9Z@'=RLQVX*LY+62-MFYQ$>F82NU/9GF,>5:@F#17F9D\[0[>T-
MYZ;5/7Y3[$_E[N=UL>N%I-J/+.0NO;3.;"%I'//=9;=10L&]\DL5>5H.TGA7
M8GS(YU(P7U]R;;I],(75C!))#<V=U+ )H&RPW5K,9(WA@YF\S7\S)(W--2",
M=Q"M2)X33S4ZIB*716DZQ+2;R>675VF//CC9=V\.H["[Y&<L<K76D=S#<6Y=
M4M9(!S<M=H(W*E9^9;$\=6?IB-MDZ>$],Q[61SR46^69E,[PMAL;M]<,.6!Q
M 'OHLT-?%'5?%OC,.HN=W[K'3V;9B#RRP93=3QNKB)WVY$)[^=P4Y;NC%=?X
M1+L>&SYF:W'XS$.EN6W#[JRAFFQGHZ.YQJ?F(W<LW-VDXGO769XNVQ-89 4]
MVVO[55#6L\E,3LT<W _T(L8=HYYKD1 'AMP6S@MZNB/[_P!T5<?NKIMF^?\
MT_OEM=M&(H88FBGEPPQ@88!D8:M>^:W5\9;MMO3;;;X1'W._WZ<^5_/^HVTN
M_++ADNC-49CS\I(C=,R'*&DG=7YH@+G?IRWJ[E$_RVW3]T?BZO\ 5]_3V>;?
MYK[8^^?P>_"[^\I$! 0$! 0?_]'[^$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MT.F\HBC&$43>5AC: T4Y=@HNLY<\W^].D<H\_&7<,.VMQ>Y&LS\4^$>$>ER
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M_-->/(<.5W,9G&OP4QCLKPKZ4?F,T\)IZ-&9@RS++<-%OEN7PAN+?+L[=I'
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M^FTP8OYKYGV13\7M(NZO-Q 0$! 0$'__TOOX0$! 0$! 0$! 0$! 0$! 0$!
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M^D]A=U;+%/\ =C[GY.?56/Y/U)OL?AFR?]4N3UMN $! 0$! 0$! 0$! 0$!
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M-#,\?QRU' *(LF=;]?+DM.6+/=PZ1X_Q3^[U-AP:T-%&L8 UK0 UC&C8&M&
M'8%?@PK=]Y9QFDEW;1G$T?,QIH!4G$J.JWQ6BVZ=8B6OW^M=,9?(;8YM:WEZ
M"!\AE\T5U=5)I1[6'E9WN(5+LV.V:5K++;ML]T=73,1XSI"DW,\^S-Q%DW)L
MFMS]R;,+R&_OW-_B%E;NY&GL<Y1U7W<*1]Z>C#9\?5=/E%(]JNW2\-SRR9OF
M699Y("'ELMRZ"QPQ:T65H0WEQV.)4QCB=;YJB<\VZ8[8L^_VRS]IE]CE[0RR
MLK:S:  /(A9&ZG N J?>5:D1PAANONO^*9E>DD[23WU**4%"=$42$5!'$41*
M2,U;0[6GE/NWJ91"HJI0)^@54I8^XMH)W"2>/S2T -8]SC$VAYN;RJ\I/:0H
MF*K6W71I']K%YD?R7D $\H ;A^%P+0*X=RO.ELG.&#O83\_#>>'EBM9;=U0.
M>LLH=X3M %,5$1K5%?<IYN*>J<Q;995;C 2WDTSAQ\J'E:?B5DMXRW-A;[UU
MT\H=+NK&8-CR[+<J:>5TV9W=Y*VM/RK=M(R1VND/P7&]SO\ <MQ^,S/L=K[1
MCK??E\(B/;_L< 7?Y5S8W6X2&T><?N77W2:<' 8E<1'@YN=)B5^5"9AJF8CS
M=3Y/;TK5@N7=C+1KGX^\A;>/3:WW?MJXW-'5OL=GK_X:MTCX[\/?OVK5GBWW
MM5^EYD@@T+U0U$8B'9GJK)\F;*YM.9F2Y2Z\<QAW@&^QHNZ?2V.F#+E\;HCV
M1_:\V^M\E=U@P^%LS[9I_P#"]1UVET<0$! 0$!!__]/[^$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$'GA^JCZKO_ &SCT0]9>JV69@,OUYF^
M4CIMTJ<V01W7_HBZ\BDRG*,QL:D!TN4VPO,\+"?$RR>,:T(?-S_QH?2>[6_6
MKJ?ZO]3Y<9LCZ.Y7+T[Z=75S$7QW'4K7&7E^J<SLIR#^=E>0O-M,TD5;F['"
MI::!]JJ @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M]\^V:_BYL6^ZH(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MD^KLOS.]7V_R6VQ]G5^+O N<=8$! 0$! 0?_U/OX0$! 0$! 0$! 0$! 0$!
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ME\Z[DU?T]M8+"WS:_D)JZ?-<HDRO-YG4 \RZ>T"C4'IR@(" @(" @(" @("
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MB'&[RF9]A-SUKS.$7@<>/,W%4FR/1Z&:,U\:3[T>$ZJ(BU/EQ'E3VNH+5O\
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MW#']V)]NOXO%._Y/F]YW%W]^8_X=/P=A5R+B! 0$! 0$'__5^_A 0$! 0$!
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MG!CK[UY&ZR_P8I5!=9N^H9:1L'%Q^U1\O;1QNF3YV^NTBRA3.W"OY$?8I_\
M:QXRC_Z1XZ0MW0YR=MQ$VE=@5HOVWA,J_+WT\;HA;OM\WIRFYB[,*;>*R1?M
MN/3+'=CWW#KAR7TYR7-KS.LJB\YCFF[AEDH"08_, <T]XJ%@N_+YLL8[8G63
M#MMYFS6X[KHF*O<SI<]]OIZSLWD<ULR.%PVN(CB 8XD88M HO+_U#W%D[RW!
M;/*OHCE'V.*^K(Z-Y;CLYVQ/]GMJY^LYGMMC'#B7,Q<W%P%/NBGTE>69*5I#
MI%UOO5N8J6"5KG.=_&!S8TH?%14B*Z+]<3;H@1RL ^/85NXXZ;*L]GPU;'I3
M+Q>7;Y'-K&QAYWU^Z":-8#Q.)P7/;*9G#IXM7?YNC'$1Q<ERV<?.T1C$\@IP
M#=X&];D3JX6+YGXFVY9 &L!IMIMX=^Y;N&RD:\6CGNF9;1;QUY6[BX##;L7*
MXK8BD1ZVC?/-R1/;LL--"<@"29KVMPQ(: #0[:'8NP7V?([;\SG=6(]3BL4_
M-WDQ/!QYJ!CVPL9(3S-M8G.!QH7#F-3QHNE]_MNLSVVW\K(<_P!LF)OF;>$S
M+K#GS.6\O&4-!).,:["25YS,S;O.KPNC[W?]M6<5L^3K/81AO43*VAU&MU/E
MCB1AX?FFO)JW$4 V+[5^B\GS>R;*_P#NV_>]6Q7]7TW=/_HW?=,/L#]&+'L]
M/.A@\AP=%?/C<*'P/O7N#2Z@)([17BOI7L44[9C]?WOS5_5&8GZUW=/&WV],
M.TZY=Y\(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @Z2?J+^F&#U@>C/KIT.ALXKK5&=Z1N,_Z=/>U@DM^I
M.CGC4VBFQ7#L86W5[;1Y?<R-Q^7N)FT(<6D/EC_XUOJ;FZ:^IGJ7Z5M47<ME
MD_733<F?Z5R^]+HG6G5'I?;W%]=Y?#:S<OE27N1OS-]R?O.=E]NPM-!0/MW0
M$! 0$! 0$! 0$! 0$! 0$! J@HODICN!W8T[?M4)B&,N;AK :G90T#J$U&)Q
M'=@JS-%[;9EQ3U&ZE:9Z=:?NM1ZLS6VRK++6-[BY\C?/N"!7R+6)Y!<X[,*8
M[2M7<;C'@LZ\DTC[_0WMIM,NZR?+PQ6?LCSEXL=?_5'J?K#+/!#YVF^G$$Y&
M5Y'YTEI-GOEFK+[4+F.H^,??;#0CL)74=_W7)GF;,<],>$?MQ=[[5V3%MK8R
MY8ZKO&?P\(^]U;9;YGFLDEP)KBPCG:&.S.6-K,Q?;[1#EEL:BWCIL<X<Y&)7
M#TF78JQ;Q9_+\LM,OA$%E"(F.)?+(XE\]S*35TMQ.<7N)Q-?<IGIL^+65:79
M+O=X+UK(S*QSZ'D=6W9AS%X\+YZ'<-C2J3=U:2SV66V:,DT -))P JX\ !4F
MBQW<66G.%&Q:)6ONB,;EQ>T\(6X0MJ>S'WJLS30B)9)N'M]"K75=<-((^OO"
MI*51I ^P[J]RQW2R0K ]OMP4532JH78!1,KQ%$0?C]AVJ%J53@X;1^T;MJBJ
MT0<V[O\ ;%$=/@E)KO\ L^A5K1,:,3FSW16\=XSF+\OGCNB&;70U\JY8ZNXL
M<21MP4QK-$SPKX+UQK1S7!S7 .:=Q:X5:13L5?2FBV?C3VW;%'DM$1.BV?\
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MYVYR9OY[KKO;,RVA96 0$! 0$!!__];[^$! 0$! 0$! 0$! 0$! 0$! 0$!
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M+]=?I[%\GM&.(YUG\(]5(T\G/O0JQ$&27=]RD.GNFQ,.!\+&@;U\[?JSOO\
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M/(?$Z@I1HV-;P 5>KP6BVB>\?R6LP;4E[1"TC9S3.$8-?>GFF?!?1M+&,C:
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M?C?'LB:S]C6[KG_+]LSYO"RZGIF*1]LP^I5>HO#! 0$! 0$!!__7^_A 0$!
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M(MHIXD2D(J%7A*5$@C:KH059A+%9ME\E]!&^UE^7S*RD^9RZXPHV<"AAE_\
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MS9DA-6SVD;@*XM#[P4! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0?#M_P D[1S[3U%:6U4V'E;=9%E\3IN6G.R>
MW<TCF W/C V[UX%^J6'I[G9E\8A]P?Z;=YU_3N7:5X73]_\ :^9:1[JB./\
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M+D-/B=8S-DBM6R';1W.XMXD+USZ-FFQF?/A]D_@]'^F(IM.KQ^_A/X/.B#8
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MAO3[J'+!HS5MM"QOBH,P.0WLKA4,BM9'.% 7-#7?^-?ZBG=2?1YK;H+FU_\
M,9]Z=>H5P,HMGR<TD'3OJD;C5.1@!YYCRYU#J)N'A:SRFBF 0?1B@(" @("
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MM:,  , %ZD\*XZRF0$! 0$! 0$'_T_OX0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M6E"&7?G7NEVN#;>]:UTUUDK?NM@NVM%7P-V-DVC>L59QZ3\/W-BENXUMTO\
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M=^F=OU[J_<3PQQ2/3/\ 9$^UUCZWWD8MCCV=LZY;JS_AM_MF/8]PEW=Y@("
M@(" @("#_]3[^$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$'SG?\
M)4]0)Z=^CC0W0O+;TP9UZANI5K_5+9LG*;K0'2H0:KSL%K<<,ZFTY2N!'.-J
M#9_^.!T"_P#0Q]#.;=7LQLO(S[U%=2L\U%;7+X_*GDT-H%[]":9M96N\1:W,
M8,]NHG'!T=RUS1RD.<'T%(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M\$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M_L"*S"8#W_N2JG-,%811)4**E8*I4K"%0E45A#F2LE4.9-35(7%*%$-JE*"
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M^;U'T!U9JGI!F?G25NG9/;7#-8:,F,9Q$$65YM;Y= X"A^3>-K7(/;= 0$!
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MP+TZ(B(I'"'A\S-TS==K,JRE @(" @(" @(/_];[^$! 0$! 0$! 0$! 0$!
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M_0E2O@@!56DX0M;QI<QD#2>:YD$0(.+8Z<TA)[L*J;>-5)UT708  UHHUH
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M\/OW>F=+8]45GUP]9UVQY^(" @(" @(" @__U_OX0$! 0$! 0$! 0$! 0$!
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MR,/UQ@[WCMI;OMO;6D:=>*9LG7G[GRWT.+U)\WB @(" @(" @(" @(" @("
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M./Q7W-V#%U;G%9']V/N<M^INYC:_3NXR3ITX[J?\,OLAMHQ#;P0@4$4,48'
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M[V47?*/%:%%-$T*)0IHE(P44HC@I."<CS6T@]NRB)JLY!O\ <JSQ2L)1M]^
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MDT9%,6V%N#ALV-6>-MMK>&.V/5#+&'!;K;9;'J7KLCR$\H=DN5NY<&@V-N:
M[A5JM\G#_+'LA;HQSQMCV0LY[+3MNTQ/RK*8FOK5CK.%G. ,2,$^5AX=,>R%
M9C#$4FV/9#2M1=&M':NMI88\HLK:[DC=\O<P,,#HI7?<>9(<<":THN/W?;]E
M?9-U]D>IJ;G9;2^R;IMIZ'F[KW2M[I7/LZTIFA$MUE$[X7SM!,<XYJL=$\_>
M'*00?BNJW8ORN:+;9F8GQ^YT_<8OE7SBFM7OM_QFNK;M*^KGJST>NY7BWZI=
M(9<ULXG2EL/]7Z>9U%>0N;$30R.M+V[Q KRM/!>L_I;N_E=ZR[7^'/CK'^*R
M:_=,OFC_ %(]K_-_2&U[G$>]L]QTS//HS6S''PBZVU]Q:][?$H@(" @(" @(
M" @(" @(" @(/.W]2K4HR#H-> 2>6^2+.9FECAYGF_TM]E /+!JYI\]_,1LH
M,<5U?ZKR_+[;/K^ZGXO=/T![?.]^M+-*TG''E3KBZ=?'W8?*+D[VLNLM#P'5
MOK:1]<:M\T$CEV;\2O!>\5GMF:(TGIG[I?I3W''-VTRS$TGHNB/327J?8,:<
MCRTL(Y'0N=W<U'-%.P4P7S#?[^TMN_O7Q]KY W,W1O\ +U<:PL8SRN:[^&3#
M93 5-5PEGN4NGE,MB_6)CQAKV7O#[V_ .+)V!U:859S+7[?;U3?D_O-K<3$8
M[(GC1;Z@<0QHP^_&237CQ6QW"*VRPX-+FD9W3^E7_P#>@<._"JX;#_FPW;OA
M=>9">:0]E=VVF.*YKDT_2YZT4_ERJ0M8XMC9:P@M!YG21Q<KVMKP)7)[#6^*
M,=T>\[!V(\N&+8"((QV"H 7><?NVQ'DXF8K,SYRS3[>-]M&0UKF@FO,-AI0&
MOM1;-V.V<<>;C[K[OF2I9!9L9#=O+:AU0 :<2"W'@L/;L,6S?=/H4W.29Z;6
M%U/E\%UE\D-!SM ,!<T&DC';=V!&'P71>]8YV'<IS8M+;HU]%7)=OR4OMJXK
ME;);9A9&0 3.=&TEH-*!PH1V\5Q>_FW)CB^WG#F,=)BZ+>$.O7ZAV009UZ7-
M3WSX@^YR*]R;,8)>7F<QD&9,,@YL: @N^*YGZ#W$X^Z_)KIDLNCUQK'W.?\
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M#GZJW6TUXQY,&?;3$19?73A=SK^W)OW2?4\D.:/RJ:0,?=-+I8@:0S2 T%Y
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M_4S5B/'PK]\^KT/IV7H#R<0$! 0$! 0$! 0?_]'[^$! 0$! 0$! 0$! 0$!
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M>^:Q6EL>%L:1$>K[=7-:VV@(" @(" @(" @(/__2^_A 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 08?46?97I73^>ZGSRY;99+IS)\SS[-[Q_P!RTRO)
M[)^89A<NK3".*-[CW(/@0_1]R'-O6!^L%E/674]J^\-AJWK)ZI=8QR?G&WS&
MZGN[G(YC*:@>1J+.\J<TT_"&MI4$!^@.@(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @P>I\EM=2:<S[3]]
M$R>SSK)\QRNXB> 6/BOK1]NX$'_$L>;';EQ78KN%T3'MAGVN>_;;G'N,<TNL
MNBZ/3$U?E<^M#I[/T?\ 5+USZ=LLI+27+.HNH#:PO;RB.PO;HWUI(TT'A+)
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MNK-DG1PY:1NFNXP&U'G-&&\\P  _L7)W3$0UZ3+L%I:.2'PO&!Y7@; T##E
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M;;1WQF^5D=Y<C7%C9RRF$D9^[*&T)&QS:$57!9,<VZT_;]SM&'/%_NUU^_\
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ML2$)P/;@IA'%, KT(3*4E%>)JK,(*RLI@#NHK1.BJI397W[J#BI8YA$#9O\
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M[_5'*';MOM\>WLZ,?KGQ\V )6O+9CQ6.8&EE<"N+F<N.SQ/#0"IMXIG@N6X
M#@ /@*(NF. 596X0PN:'S9K"T&)^:ANY1M'EQ248'=[C@HC2)ECNUF+?.JZB
M_/S"YGVLMP+:/AS'Q2N'U*O"&6-;IGPT9!$K5H!O9)'&C8;=C.8X >8\R/->
MX!7C@I_%KR:/D$S[_5.:7<8_*;YS22*T8Z3RVFIX@8+-=I;$->V:Y)EV?]*V
MAG]4O4ETMT\ZWDN<O9JJTU+FK65Y69'I0G-G^:ZAHR;Y=XQ&)<!O7,]HV_S-
MS9;/*8_?=[(B(];J_P!1;SY6SRSXQ-/^FWVS,SZGU0KT)Y*(" @(" @(" @(
M"#__T_OX0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$'FQ^K[U?\ _04_
M3@]56J(+HVV9ZAZ=2]+LH\M_EW,E[U;S2WZ<3NLW"A$D%KF=S=<S2"UL3G--
M6A!X7_\ %PZ0\]_ZK>O=Y:T^7M- ](=-WO)7G^<FNM9ZUM?,.SE\C('T!QK4
MTH*A]>Z @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MUCG'C_;X2^;;7O1O6_0KJ#'TLZDW=K!F68PR.T/K&S,S,NS9MM*8(<NS.WO
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M&6*_9=%T.GG3C.'7#86W$Y( ;^5$2QNX#G=O7D?<\<8[IG''KE]"[:+\MO\
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MA;;I;'WSZGMPNS.F" @(" @(" @(" @__]3[^$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$!!\RW_ ">.K7^W/3!T$Z-6USY%YU1ZQ9CJ^\B8\A]WI_I9
MI>2VN[:1@VQ_/ZARV8U'WXF4WH.V_P#Q^.DHZ9?IK].<]FMOE<RZS:XZB]5<
MP8YG+,Z.;/?]@Y)+(:8B7+<@L[B/$CDD&\D(/;) 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0?*7_P F
M+HJ_-.EFA.J5E&6OM=8:?RR\F;C1EY;7=B&NX<Q+1\%Y'^J6VMLV=G<)BO3=
M$>V)A]1_Z<.Y7Y.YY^S3=TQ=9==/HB;9?'SEND!:&(2O880T.>QN!+B,02O
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M<GV6*]^VMOADM^]\I >'2S2"OCGG>*?POF<X?6O6LFMT^F7O%T^_/IE/S8;
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M#\ZVDY216CN6K3\5DRV=>.;)YP['DMB_'-L\X>8&JK09?J#,K5K2UD-Q(&G
M$@NPJ>W%>>[S%&+/=9:Z3N<<8\UUL>+VS_X[G5<:#]?.:: N[V"VRSK1T?U9
MIR&"X>UAO-1:4O+76>4-A)(!>VUM,Q:T4)(<0%Z9^D^^G;_4%VUNG3/CNCUV
MTNBGG2)?/?\ J-[1^?\ H&WN-ELS=LL]E]?"W)7'=7RK=;['W7=B^D'P8("
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M;##R)_C48)R*15?MC^M/0E:9@PNBB@&VXN8HJ;?"#SOP]R1XHFM%_P GMV;
MHUXT7J<B@6ELWG,\VWS)G-:=M&1>  ^^JMZ4QXKT,']O&NY$JK(^RF[]R)XK
MID?9NWJ3@NF1[,/B/?N1-%7DH/=W?!3QXHI$,?>2LMH9)G_=C8Y_^([@!VE3
M"NC@+6D<EG?P9J\<MQ<21S2D8%GFLYX8QV@M"S6\*0U<D3%W5XN==-YHV>SR
MV=K@XW&71WCB#@7W+N9U>U4FM5XBM/0SUY=ET#XXW5EG_)8T&I+I:-<X 8T
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MC/&(]M'V"    ;!@ -@IA1>Y/S&10$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0>./Z]/2X=2_
MTS>MEY#;_,YITPSCI]U1REG+S&,Y)K"UR+/K@'$M\K)\SS)Y(W"AH"2@Z!_\
M7CJ?_5^@7J9Z.2W//+H3JSI?J';6\CZOCL^IVDCD$@@#L?+$NEG.<UN#7/J:
M%^(?44@(" @(" @(" @(" @(" @(($@8DH4EY'_J<RV;<@TIH_),J;)>YO\
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MMB9ZKB1H9;.!-*1&I'&E5P,S,9NKQEDC)=.2GBX+SF0SYI=28EHE+6UIBUN
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M^2Z)^&*1_COT^R*R^HQ=T>;B @(" @(" @(" @("#__0^_A 0$! 0$! 0$!
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M]0-S?'PXOZ=OHMTT\8K7T36'HL!0 <!1=K>)(H" @(" @(" @(" @(" @("
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M_LO].7,=*LG+).KO6?ICH1\#7>*>TR>6\ZH2ES1CR,ET[#S'8'%@VD(..?\
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MZGQWK(;.!@(Y8LL8*BO*7&-K!3W[*KR/>;F,.QOOG^''/W4?'D89OSS/C?\
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MM>'Y.SLM\HCV0_*'ZRWW_<?J7=[GQR7<==>J:U\=:Q7R<T+D76! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0?GY?JS-E],OZTFI>JUC'):6F6]3?3]Z@\G?$TB1TN7Y1D.?
M9Q<Q\FTNS;+K\@C?AMJ@_0)BECGBCFAD9+#-&R6*6-P?')'(WG9(Q[<"""""
M-H05$! 0$! 0$! 0$! 0$!!;WCVQVEU(X@-9;S/<3L ;&2:J+II;,RM;%;HC
MS=$O4/ZE=.]$]+7&973V9CGMQ;N.3Y(SQ22S2#RK=URQC@ZCY*,BC&,CC08
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M%^*LUG8HJ1'@KM9L^K^Q17E":>+,6;,1[&JM#'>JYCF%ME<,]Y>/Y((;;FP
MYGN:ZI8SB2LML5BC6NNBR*SP=#.I.I\TU[JEN6P/<&QR^3:VS7$PV@<^@<^F
M!+!BYV]QHMJV+;+?O:<S=EOK['*LF4C(\IR?)&6LMS"UUI"^6-X#I'AOFW+G
ML-*ESL2>"U9OK=-SD8QS9;%L>2V;>,=:MM)K2XCDRV^8Y\;H\! ): T&ZAW8
M*(XUJ<J4X-@@M_*DD+6NFRZZ+AY%!YMNY^)DC8=V_O29A-*<.$MJRQK_ "Q!
M)7FMCR@_]R-W\J3'LV\"GFF.%&;#"&G _2#CLH%,$\%W%&6@8;!L[3O-%-59
MC14EG9;!M09;B2@@MVXR/<30.=38T<2LD1,L5TT9.PRZ2".:ZGI)?3M)<6X\
MN%&01D[ $F6&8IK/%FH+=L$4<8&QGB[7'%V)XE)(ACLPC_U>73,YN:.5WFL;
M7\R ,WC^X2"$CA*:>\QV:73KQS\KM)!5P_U]PUV%O!M=$UP_&[8 D:>])-9T
MCUJ$LC8HF0M #(V-8P#&C6"@'>H7B/!Q3J[/))7QY/EX^8N[IW+Y;-CC7\;M
MT;=KCOV*]MO.6.Z>4-7RS+FQ9Y#:L=\S=VC2^YGH#$+Z7![VC<R$8-''L4S/
MN^E7I]^G.%U:6L>>Y[>W+G?^P?(Y7,\[=<W\+?$[F/WN7;MVI7IMISE:V.N_
M3A'VM\CC\_R+!M1$UK;F[&YL5:PV[NU^URI6FK-$?PQP9QQ %<    T;*4P
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MO2RL @(" @(" @(" @(" @__TOOX0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MXUXS$<(\HYSXR]-ES+KP@(" @(" @(" @(" @(/_T_OX0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0?#+_P FS7/];]:O2;0T$WF6FA/3MD5W<1\W_E\[
MU?KO/;N]9R[N:RM<M?7::]@0?9)Z7-##ICZ9_3QTW$(MSH'H?THT=)#R\I9-
MIK0EAD\_./XB^%Q<3B34G$H.=D! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M(Q%:V5O#;6\8IX(H&"-@P[!B5V!U)=(" @(" @(" @(" @(" @__U/OX0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0?GX?JX__+Z_6FU?TXC)O+&_ZD>G
M7HO8Q \Y(S#2VG,JS6U#1_\ 3&_O6\H^LE!^@< &@-:     !0 #   ((H"
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MC^O_ '7_ +C]=Y[;9K;CF8C6L:::?:]$%VEX<(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@\&/^1QHANJOTY+S/_)\Q_37K=TOUD)0VI@;F+<QZ>.<7;FN.>M:>)([$''O
M_&=UI_7?0KU%TE/-SW.A/4;JZ"WAYJ^3DVHM#Z>SJT=0[.>\=F&&S"NTE!]%
M* @(" @(" @(" @(" @^8C]1O7=UU?\ 5['H:SG,^5:(^0TA:PM>)(H)HY/F
ML^G+6U <9?.#C_"U@.Q>=]\W7SM[ENY8_<CU<?\ FJ];^FMC^7[;AM_BS>_=
MZ^'LMB/;*WMK6*S@CMH  R)K6-P KR-Y0:#L%!V+JLW<Y=UBVD4AB,T+[N>'
M)XG4%PWS\PD:36*P::%C7-V.D=X1V+'$T]YDFWA;ZY99C&1-#(VM:QH:QC&B
M@9&QH:UH'8%AF>;-$5TA$OX4^C'O59GQ9;;5$FO ?N45YLD0LXOS'R7!V.)C
MA&X1-P+O^HX]RK,SP+;:ZL?G!_(M<2*9C8[!7_-VI$T3?;%(]*RS1_\ [%[
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M:TRO7AE'#E&6DD\*[D'BM_Q9=8&3*O69H":6@M,PZ)ZPRV"OWSF-MJ7)<[E
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M !=H=)7* @(" @(" @(" @(" @("#__6^_A 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$%.::*WBEGGD;%#!&^::5Y#61Q1M+Y)'N.P  DE!^?S^AW!-U;_
M %=]%]1;J-TS[/\ ]N ZIW@D'-RS:BT7G&3LEF!WMN,[C<#N?0[0@_0*0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M9FL^F512J(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MVZVOTW@NT_S+X\K:Q;IZ9F=?"'N2O0WQR(" @(" @(" @(" @(" @(" @("
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M8P:-DE>[!M?X0*A)I&B;9F8ZN$?:OB:4%:TX_652976LI DAD.QKG,)X>8*
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MW;=^S"NQ(BLL=9B%9D I4^W"E?K5J,=URSO8>9C7,(;- \2Q..(YP*%CNPC
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MK&,:*-:Q@Y6M:!N P"YQUI,@(" @(" @(" @(" @(" @(/_0^_A 0$! 0$!
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MPC\.+];OTXV%O;?I7;VSIU6]4^OA]CE3HWE3;;*;=Y8 99(HFCE#7\D0#!S
M5Q)JX+YO_47?3?E^5$\:_;X?<\U^O][.7=W61/")GUS_ &.[N7W<^7Y1''$
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MH/KO?;VZ:Q;?T6^BW[G:-<P\W$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!^?OZ#W_^
MA)^OAE>2'_3,R3U9^IGINZ(U:T?U:WU?H**!S217QW# T'> =H"#] A 0$!
M0$! 0$! 0$!!\Y/ZEF<2Y_ZM<ARF4\UID>C\FMX&<U6_FSW=[*X U^\0"N@?
M4=\W;V[^[;#U3Z1QQ9VVW^]=,_=^YT MLY#+G(#""W^D7ET^=XWO^>%PXU'9
M4!=<OMGIFO.';L=^MLQR<Z:VBEB;9:HL8W3'+WPRWL<8+GR9>YPD$S6C[Q96
MN&Y<9CGC9//[W,YHI3)'+[FX6M];9A;17=I*RX@N(VR->PAPH]M2UXW'&A!6
MO-8FDZ-FV8NB)C5JD\=G8W3H99;_ ">.1Y-K<VEP\Y=)5U6MD:\$1OJ35IH%
M,S-WG]['-L1=29FW[E]\MFC6AUKG8G834&YMH9V$$8!KX2,%29MYPR=-T?#=
M[4IOLSML+W+Q/%CS767O\P!H%>=]K)XA[B5%(GA-%XZK?BCV+VVO+:\89+:9
MLH'WV@TEC/"6)WB:>\*LQ325XNBZ*PK%P.'WL:$ X<""5">*PMH6B&$'$Q22
MECOQ >801\-RF9K*(C37DON;O[/WJM/!9*37X^Q(4T$JD4PVDID ^^P-?VN8
M:M/P)"(YU5@>WLVJ**SP3U^'M56A%:Z)ED@$5G@F"AB3UH1[NTGCM40)_MV
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MT?;OT1@N[=]+=NV46S,VX,=?3='5/_4UC1%E.Z2+SG"&(N;6*-U'/%:4>_\
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MX*[[$4>5S,S-9;LI! 0$! 0$! 0$! 0$! 0$! 0?_]'[^$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0>3?ZY&??[>_2U]4]RR0LFS#+>F.0P@&CI?Z]UIT
MYE5U&/\ V1+,YPX H/+?_BUY&VWZ6>KS4OET=FW4#I7D9EI]]NGM.9O?MCK_
M '?ZH3_U(/JL0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M"Z8T 8_1O*Q73+-$32JYB:1@,:]FQ8;YADB)IHOHF@]]:+7OGDV+(BC)Q-%
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MG/FG_#'*V/"/QGG+M2MIHB @(" @(" @(" @(" @(" @(/_2^_A 0$! 0$!
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MGPLCP:=NTD8;2HZ+)Y3"WS+XBMLQ*_L<RU=;2R7&;9!/=1R>%PRV\@F@A/\
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M?3O5H5F4X4JIP*^V]*DIP.&X;$B:L=VDIN/'[5/!5+12E J43P0*E6?)!/-
MK(HBBU$4KIJ41I7=Q]BHA$T@#"=Q^WX*T3")X:*H;3MX?L3R*<Y3AM-J*2JM
M83MV?2IK16E59HW#V':HXIC14 HHE69JF 4)B)5 W]R43,N-NM-^[*^C/5[,
M&/\ +DL^F.N)(WX@M>_3T\$9!XU?@L.ZGIVF6[PLN^Z7*=BQQF[YLL4Z]6?%
M_P!<2^0F>Q;%#;AS2YXAB 8T5>XAFV@^M>/[NLP^X=GDMMN\9KPYLCE-F_S6
M&44;4%L+/NC'\9VGN75-Y?;%>CVNU[3'.2*Y)T_EC\?'[G-&53"*V:T>'E;A
M2@  W;L5U_),W7:\W+Q;$1%(HP>?WQ\MWBX[/IP6;#&M%+HU>K_Z1FDA_1^N
MW4:2(<]]G6E]!V4Y'B,&76<FHLQC83^'S)X*T.UH7L'Z;[;IP;O>S'&ZS''J
MB;I^^'R]_J)[AU;OM79K9^"S+GNCSNNC';/LMN]KV). 7I4OFZ:425]P4<6-
M2<X#'=N]V]1SU98C18LP\QV][R<>&P8),IMBNJ5SJ G'9V*./%;RA1+M^_ZR
MJU6B*Z0Q]L>=UQ+7^9,6@_W6>$ )5DCA1CLO=YMSF=R?QW(@8?[D#:4^*7<(
M@LB:S/FRU>%/=NX+',LT0D)&X?V^Y0NMI#[=G:BT<5JYV(-=A&_WX?6HU7:I
MDTPM]0YC9OY>8.NGQFE'.AF>V=N/>2KW:VQ+!9[N2;7)5E. 6BN&& V\%$31
M:Z*ZMGAEJ!]BRQ+7NA"5QW'=CMX[%7GJF/%;\W;3>DS/"4K>4[<<:UV_0DK0
ML7OH3^WZU7FRQ\*W,H';B.U6\D4F5)TFTU.-2!7CN)4:U3Y)'<SN.VO;50BL
M*C("ZM0>^F^F*O$>+'=<OV0LC%2 ",#79\2IX2PS=JT[5VN,ITG:&2ZD\^\D
M:[Y3+X7-$\YI7GD)_EQ@X%Y]U2K6Q-TZ*74MBL^QU]S',9<\;_N[J)F@RC3L
M9<_+<L#GQR7M#5D&5V1\1!V.FIS.X@+)6+?<QQ6?N]*O3U1\W-/3;X?N<9ZA
MZG9YK,_[=T;9/R/3D+?)+("8)9( >4NOKF/"-E,3&PU/XB5>W';9[V2:S^W!
MCNS7Y?<PQTV_MQEC\IL;'(HQ/"YUQ><E#F;6,D>)'?>@R>%U0"<1YS@3794J
MUTT^/_A_^R_<BRV9_P K2.=]/LMC\6SV>FYLPGMY\_A%V0X7.4Z3#B+.(N=S
M-S34$E>:5XVD2$UV 4P5)S3=%:],<[N?HM\/4RQMXMF+;HZ[N,6<O\5\\_6Y
M/M;9EES22/;/=R@"641A@#6X-M[6-N#(F[&M&"T[\DW:6Z6QP_M\W(8L/RZW
M7:WSQG\(\HY0HW#I+E_R[26L.,SFDCE;7[G,-KCP5(FFK+2NBRN9W<S<NLJ,
M>!2:0?=MX=Y!'XCN2O\ %)/\L(226^6VA-'%C2&M8!S37$SS1K6#>YQ^"B*W
MRB:8[:_M+5<P%S<W L.9KKV]+1?/#@&VUN:O981/;C1K:F0C::++$V\>4?:Q
M76W3[O&;OLCP;-R1V=IR1-#(;:W(C:, &Q-H >\[2L59NFLL\1%L4CDA;1F.
MWA8?O",%W^)_C<3[RDRFV*0JD;AO_M4'-JN9R.NG2".OCE9E-H6G RS&N8SM
MI_"P%@/>LMM(B/;/X,%_O3_RQZ^*]E8V+-,OB8*1QY?=1L &'*QS6C'N5*Z2
MS4B+HCE$+XX^]53,M6O/]9?VK-K3>M:&[08;1OFRN(.[FHLT>[;,L-\=5UL1
MX_<SQ.WB3WXU6%EYM(E/SNHX)-K()'1LK]TBV;XG-X>(E9Z=-E&O'O9J\HT;
M4[V_>L<L\M6OF">\S9QV6MG91 X$\QD,SV>_ J]ND1YM>^.JZ?*B[O\ &RC;
ML,SK2W'O(<ZGOVJ]J;ITIXKN9OS<WR@_\O;%ANR*T?(!6*U!'<'/^"1I'5/'
MDB??NZ>4<?W-5U=FKHA;Y99./S,LK8WN8*EAD;RMC%/Q'::; MO;X8F/F7^I
MH;S=71/RL4\.,^?@P[H7VEO_ $^R\=],P12R-!):",(8G?23WK;BD<.#C;IK
M-9=C>F/IEZP:ATK::ITKTUU9J3*LXOIK*'.LGRMUY;W%S9N$<\,9Y@1#&XEI
ME(#"\.',2UP&YCV6ZSV?-Q8[KK9TB8AQ^?N>PVV2<.;+;;=$5F)GQX?[.+V)
M])'I<SCH9E\FI=36UJ_K-KBQDRS*,N9)%<P].]*REK[_ #"ZN6!S#>/(:9?+
M<1X6PQN=6:O:NS]KG9Q\_/']2=(C^6/WS_9XNA_4'>XW]T;;;3_2MFLSPZI_
M='*O/7P>D&1Y-:9!E=KE=F'F*W9XYI7%\]U<///<7ES(:ETDKR7O<3B2N==9
M99 0$! 0$! 0$! 0$! 0$! 0$!!__]/[^$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0?/!_P F/-SE_H#Z?6#7>+/?5)H#+WM!H3!:]-M89NYQ' /MHQWD
M(-M_XWV3#*_TZ7WP:&G4?7SJ=G+C2G.8,LR;3W,>.%@![D'OD@(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @^77_E,=*[G._2UZ?>M=C;P.?THZW3:;SB<L:+EF2=2M-31L<V0
M#F+&WN56K:$T!D!VE>>?J-MXR=JQ9Y_@OF/^*V9_^%]!?Z>.YQM?J7=]NNG_
M #\,71'C.*^/POGV/D(T9F3V295=LDY7-="7.!Q.(J OFF_^ANICPE]V;'+-
MO3?S_;1ZG].LS_J&0VSG.J1'&YM3XJ%N-0N][:Z+]O;='@]#[?DF_%29JZ@^
MN[3K;_0]IFT<59LMOH^=[1LAE::@FFRJV+9]ZL_MYNK_ %IMXR;.,L<;9^QX
M_NA:345:X;PLO7,:3J\KG%%VL:2F8Z6*O.WF:<0X DI,6W<-$1.2R??UCQ7C
M'L>*M/N.!IW+'-8XMFRZV[A*^C;@"3_9VK!=.K-3DNV5H-N!%.'Q6&ZC-;&B
M_B9W$^_9V+'=-(9[==%_$,0#2E14?40M>^=*L]OFOV[EK2V+&3CJX-..% L4
MZ59;.*]C%!AV?!:US:MTA>1X#=V'L5)9+>-%U&=HQ^Q8[F:UE,N<YEU"0:<[
MC&"!4@R#D939^*A6/^)ELXQ1Z2="<WBOLEL7<W,]M8WCFYO*,L?,8P#0"C@_
M!=C[??U61+L.ROZK(H[.0;2W<]CFCW8#:N6CC3Q<E:\R>IN529-KK4-K(*-D
MS&YGB.]S+APN&G_TQ70^[8IQ;N:\YG][I?<L<XMW=7F]1_T.NLK>DWKWT%EU
M_G$N5Y'U.RC.="W\(<&V^87]S$W,<F@N2<,)87AG]YU-Z[;^FO<(V'U1BLNN
MZ;<T39/G/&/MAX=^NO9)[O\ I]N,F.SKR;6ZW+'C$1[MTQZIBOD_0!7U,_/0
M0$! 0$! 0$! 0>=7ZCKVMZ-W1DB+@UL\S) RI)@M9:-+Z8-#GU>#@0NK_5/_
M ,C-8_:DO>OT!B9^K;>F>-(I7QF/MI&CY7]&-$FIX2&$N-_;-8:X,Y)"]U3M
MV#<OGSOTTV=]9TZ;ONH_2+O]W3VBZ9G3HNKZXB/VJ]0NF%D88+BY(-98&8XU
M/*X-: #[U\_9<L7[R9X]/5]SY#^JLT7Y8LCE/]KD34\<MA:-;,.5\S8)6@'\
M$GBY7'C3:%QW<[,N+#9;PFZD^IUK876Y,M;>588&(\T8=O+ =I-,*[5QV6:W
MM^>-&O6\;CGLP/W1!%+VCEJT;-Q)6'Y$?-^;//\ !NWW1&RTXUF/:SV?S>1E
MSW5H?EI!7':Z,@4HK3=T8KH:>UMZLL>F/O>?,\09FEW<.%6BZE+-GB#9B ?V
M+K5T^_.2?%Z]AK;M(GR_!EXKU[BTN-7&2M2:@DD<M3QXK'\Z9NBKA<F.)NF7
M(5C827EI-<@EDT=E<2,D'WHVNPY1QKM)XJ,N7KK=[&C%T698LXQ,PT5L!:]S
M#44=0DDGQ<V)J5Q]U]=7,1,5U9>C[)\=Q%Y<A8T\OF&E)"*?=[%L[6[Y&2,U
ME+M%<U]N6R<.2)MKQIX,)<.=/(;W-+CSHXW<[(03RO>W%K W<MG+ER9[_F9K
MJ^5?L]"<$=$?)VMO3,\_"/%T<]<O58Z.Z0WF0VMT(]2=3;IVF;2&.0MEM=-P
M@76HKIH::@&,1VP=O,A"[K^GW:)[I]01O,EM<6SCYDUX3?.F.WVUN]3L/;MO
M;;=%MOPV:SYSY_>\3F -  % ![@*4^A>_P!^KG8X2N&4J,#V'=3BL-Q"MA3O
M^A4U3/!*X[!393^U3$*52. ((=B"*$'?V4*M%:Z*W>;&QVI@G,EN:1OJ9(CL
M&\N:MB;^NSIOXQPEK1AFS)U8_AGC'XKPRNBY9VX/@<R9IV$.A<)&T[:@+%P9
MYF8CJCEJ^BSTBZKAO?EX>:@U)IW*,U@<#]Z1UDR1[37M)76_U V]UV3:=QB-
M+HZ9GPF8:WZI[.[==MVO=K=;8MBOKAW7SV'GM@X"O(:FG9V=J\P[K9,[2^;8
MUAXKL;XC/$3S;'DD9_IS)&@!K(GNW?P[">/8O&\LQ&XZ?&:.8R3KTRWW2C_,
M%L0.6A<"-M VHVC:N>VML1=;$>#A.XQT]?-O$X>YH:SF!Y200*D<Q)K1RY*_
MC'H<)9,1K+5,NR&5MU)=W#'\\CG.)?2K1S8"FP5WKC]Q?_#;^TN:G<VSCBRS
MA#-W;W-K&S[[ORVT_#7 T[MJV=AM8ZHR7\(U:]UT46UQ(RUA;%4 -C+W=N%!
M\3BM^VN2^;Y\6K;;-]]>;@G/KSYO,KAW-SLA#?"33F<3L%:X_8IW66ED6W?Q
M2[9ML?R\42Z?=<]0&\S.SR:.7G;;-,T[6[&R.PY<#]"]N_2GM,V;7)W;+;2<
MDTM]$/9_TY[7T8;M[=;3KFD>B'&.D<M?F.<6D,;7.+9 \AHJ?"X4^E>UX;>J
M^(AZCW'/;MMG==.FE'UV^@#I8[IMT&R6XNK?Y?,M5N&>7+' "1D<\8$+), :
M@"AQ.S"B]M^FMG^5[;;,Q2;]7Y<?KC]2Q]0?6V6S%=U8]M'RX\*Q.M/)WB78
M7C8@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @("#\_#]?&)^D/U5=<ZHA:6RWFE^AVK6%
MHHY\N4:,L,I8\'>?_8:&@]B#] UCVR,;(QP<Q[6O8X;'-<.9KAWA!,@(" @(
M" @(" @(*,C <>RA^%*E1*8EYE_J)=4LBRW14W1C,HX)(]=94Z[OI7'GO89+
M;S)LB%E$:CG^<CB?4BM 0*"JX/O&6SY/Y6[^./\ 9]KLWT]@R3GC>6_^'-/;
MQKZGS?::U!9Z<M<Q-TV:/,;>Y:^PBB_+N X QW'F3_Y8;05WD[ET+-BG)[KU
M+!EC%/5S;)/=ZUZGRP2'RLNLHVLM1=>*UB<P$8W$X_-G)K7"@&Y:L1@VON\9
M\/VX-RZ[<;SWI]V/'A_;+FG3?1+3F5B*7/)KC45Y'&R:8,I%EUNWEYN8M=][
M_JQ*P7[G+?I9[L?:RV[3%C^.>IRWEV6:?:PP9/ET$<<+1^8+1K6?X&RD8D&F
MQ:>3KG6^6YAOQ\+(HRPLW ;6@#8.7 =@'[EAZ8XMCJE7BMW 8R 4K^ 8*\4H
MK,W,)FUQ):&.*&3S;RY)9;0\C:5'WII3N8W:3OV!4I$S7DM6ZE(XSPC]N3#,
MM;BT,EQ\Q'>9A-C-<RM#"1OBA_@8-S1[U$W1.G)DMQW1KS\6*O<WN[*-\MU;
MEL3" )(AYK7.<*-C:&8U)P IM58][W89(F;8K<P\$EM<RNO<X@A-S*WDBMY8
MGEMG X5\LAS?OG\3O<K:VQ2R2EMWO7Q7R\(5K@Y,QC7VES<6ER^1D47RD]PP
M<\A^^8C5I  WC=N2VZ_^+6/.%9MQ\8F8GRF5TUERUH@MLRAS")K0PQ9G8.>7
M ?>K/$T?>[0IB;9^*VGHE$Q?&EMW5Z8_%:7&6V+C6_TZ8G8CYO*"9 T?QN;#
MRO'=0J\3/\-WM5F(C_,L]FJ:URIK@TY+J+,(>4FMO/)\PVHQY9()P'BG<DS,
M?':1$3\%WJ7H;JRVV_TS-& DX-DLYR-P ^[55_ISPK"/ZT>$Q[%7^NSP4;F&
M2YC:<986-NH1C3;'BIZ8F-)3.2G&V87UOG667!#8[R-KC3P35A?786TDILWJ
M9LNB*R1?;.M66:6D5:6D;>8$.::X[0JJS.JI2H!]QKNQQ)I^U*<E93I$0515
MT*PP]OJ5)3"K'2NSB5$Z15:)JJ^P0YU5V@4!]O>B59FS9M_93>HYI5V#:=VS
M]J<Z"J/;%7A"N![;5'&43!O5X5E5:$C55.K1P)50.Q6ACISE.!\%)*J IX*Q
M&JJT;_:BDGP5 %8A5 HD(F:IJ*Q3FF _;WJ84F4X5X43!2F%08>V&Y1(F%<"
MIC@Q7)P%:JDR@1MV\?[%(D/[5"R"E%(*(B@IJ41I\?8*4(TK79^Y(K16956L
M&_L^D8*)1-9UA4H3L[\<-VQ1Z#2-$P:/?[5*M&FB)F59K,0?M5JHXJ@;78H]
M*=(3AM E5:53 *$TB%0-]OKV((\?;M4JN&?46"[H!UI#<">F^I6^YUD0:CM"
MT^X3,;'-_@G[G._3%/\ ZR;"O#Y^/[WRQS96VC7-8.9S&<QIXB*;"O&]_DFE
M)Y/MCMED1-8CUJEGEI;(TTIO (^'[EU#=Y=9AW?:6^ZVYC70P"M15I[Z##?]
M*XBO5<Y2E(AH6>W3G/?&W'EHZ5Q)H*_=:.T[5OXK8B.J>?!JWW5OZ;>7']WI
M?01^E[IY^2>DO*\RFB#)-7]1=>ZA#]AFLXKJ#)+.1Q[/E9 %[G]"89Q?3UMW
M_F9+[O56+8^Y\6_KIO(W7Z@Y,-LUC;[?!C]$S$WW?]4/0<G#]B[E+QZ>"DXT
M]_Q^A1R1;%9JM'OQ(X;.'#>E-%YX+<N%,< .WAL(XJM%N$+=TA)J:4IO'Q"F
MB5O++RL>^M.5KG4V4H%6B\1TQ5CV2B"Q\UQIR1R3N)-:$@N'TI.LTA>V:150
MRII98P.=]Z;GN'UXS/+\?<HNXK612WTZ^MDJK&RU2.< "?<HJ+5[\*8;CM43
MXK1HLWOH36ONW*/)=I%].+#6>33N);'G%O+8N.QOGQ-YF NWDC<5ELULF/!A
MN]W+;/CHY'@E((%=],<.W:J4I.K+QBC>,K;Y[6XC9W"JRVPU,L]+.R6',*CA
MW4^A7Z6O&7DQTU@YNQI[#M'8HFV:,MN2LZL=):O!.!^OX=JK262,D+8V$KMS
MB/;:G2O\V(TA,,IF(P::[=GO)!^Q3TS.JDYK>:F[*Y&X%IV[QM["G3-=$?.A
M*+,,/C( W[*@)%M.*)R5X));FVMQ2O,< -^->SN29B$1;?<X5U[U:L\C9-8Y
M7)!=9D YDDKGM-EE[CA6:2M'R#=&#WE7LMF[6>"+KK<>D:RZF9MU)L+:\FS"
M1W^Z-0S.YV.N2Z7++67$LDG;_G%OX(A2,;Z[%LQBNF*<(^UJ3FMMU^*[[/[6
MJ.;J36MZW-]1W%_>-D/)!"WFH6C[MK:L%&,:,/!&!0;2K1TV>YCB/V\5)Z[_
M .IEF=>$>/E$?N<CY?D$L44=O*V**.(!S<GR^1K;9CAB),ZOX\'$;3$PD?Q$
ME8;LUMLTLUF?XI_^&/Q;-FWNOB+LNEL<+8X>FZ?PC3Q;OE>4<THF@9&^9K6A
MM[+$?D+1IP#+"W.#WC<XX#BL%U+=<D\>7/URV[(F_P!W!PC^*8TCRMCG/GP;
MA;VL5FQP@YG22GFN+B?\RXG=2O-(\_\ J.P;EKWY+K_BX1PCE#:QXK,7P<9X
MS/&4DLO)1K*NEDJUI.) VU<> VX+'661C9[A\-+.U_,O)O$YYQ$(=MFDI[Z!
M36NLHF?X8XC&PY?;2222 -:#+<3O/BD?2I+B?@UJ5FZ:%+;8K+&222\K<RGC
M=\P\F')\O>*.A?-@V65O_<<,7'\+<%:9CX8]<_MR4I7^I=QY1^W-)D]L.>:\
M<7/=S20LD)YA,_F!NKAG^)WA&.QJ7W4CI@QQ69N]7]K*W()BY/\ NR11 '$T
M<[' X;-RI$ZU9)X453M^H8'N"5%A?W#H+9SHJ>?)RP6H_BGE/*P^[:>Y7MBL
MJWS-MNG'EZ6(A@;_ %&&!I#H\IM"YSJXNOKO[[W;J@5/O5J^Y7Q^Y2+8ZXB/
MX(^V5>9W_L7LQ7 V5V* 5H>9IK7Z%7C;*\_''H5[J40P32G\#'$=]*#XE3;!
M.C V<1.8"O\ ZYV#:FO_ *\7S_,>'=O*!M5[I]W3G/W,5L?U/1'VRR%[.+:V
MGG-/RHGN XOIX&@=IHJ6QU71"UUW3;,M6RZ$MS%H=5SK>VH]Q&V:7\R9Q)[3
M19;IJQXHI[&R;74X_MWK'+*U9DC/E,[O'.J;J^E9&T5YG"VI"&M&^E#LP62(
MG2&&9B.J[QE<7<DAERBUC://D=YS8SB(VQ, ,LIX#Z\%>(C69X*7328MYRJ9
MI?Q9+9!L9Y[F4N\EKO$]TCC62YEWTK\30*^''\VZL\(_:C%N,\8,=+?BGA^]
MH\=G+\_9RSGFN V6\>Y[A^6Z1M(W2 [Z5=]"Y*(TJX:9K='M=M_25Z=<T]0?
M4VVR"W$UMIK*1%FFM<_:UW_L-R/SJ.M;64M<WYV](,-LT[/%(061O6_V[8W[
M[<1CC2V-;I\(_?/+V\G$]X[G9VS:3EG6^[2R/&?/RCC/LYOIIR_*+'1&F\DT
MMHW(8K?+<JM+3),DRVT:V'+\LM+:'RXIKR2H(C8!S2.'-)(XG:]Q*]!QX[,5
MD8\<4BV*1#R;+ER9\EV;+/5==-9GSE?Y+DC<L-U=W,YO\XS%[9<QS%[>4R%@
MI%;6T>/EP1#".,&FUQJXDJ[&SR @(" @(" @(" @(" @(" @(" @_]3[^$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0?,S_P H',S%Z3_3WD_,0+_U#',R
MS<XY3TVSJU#CVCYV@[T';?\ X^>7_)_IB=)KGEI_5M<]8<PKCXO+ZB7V5<V/
M_P 34PX(/:] 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MF1^V*#UX0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0:]JW3.5ZUTIJ;1N>1?,9)JW3V=:9SB
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M/%[U])TK72)CQGCZ.EZUKNSY@$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$'PJ?\
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MZ@V,_P#YQB_ZH?,X^ "*$F@'DQG$8#P#CBO#.X5IH^Y.USKZUL7E_/%;4<X
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M(" @(" @(" @(" @(" @_];[^$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0?)S_P INYY=&^B^TK_/U-URN>7GI7Y7*M+15\O?3SOO;JTWH/7W]%2W%K^E
M]Z2HVAH#M):SN*-+B*W?57/KMQJ[>2\D[J[,$'J2@(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MW/>W=67/?=?=/G,\(\HX1'*(B&QK*T! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MN+9X8PX8TCC/.9\9>4[_ 'V?N.XG<[B=9X1RB.41Y?[7,*V6F(" @(" @("
M@(" @(" @(" @(" @("#_]?[^$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0?)#_P J*1PRWT.1 ^!]]ZCY'"@Q=';Z%:PUVX![D'MA^CI$V'],STAL::AW
M3>]EV >*XUCFD[AAVN*#TN0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$'Q1_\H3IE-D7J4]+
M/6BVRH0Y?K;I=J7IWFF<1QEK+K-]#ZG.>65K<R#!T@MLY/(":\K>Q>+?JMLZ
MWX=W$?%9=;7SMFOW7/L#_31W*+^U]P[5==KBRV9(M\(R6],S'E6S5X']-,Q^
M0U/ETG-1KY8P,<"ZH(!7BW;<DX=W$V\^+ZZV%]N/<6W3IK^T/46PE%]DT3Z8
M2V]/BU=YMUIZ'H-L]6)X[^LW(YLOZBV.8AG+!>9:V&I::&6*5PV]U%BTK,>M
MYE]5XIMWMN3E,4]CI_3W=RAU:B'D125YV@X;6X%.NZWA).*R[XH2-M.4UBD>
MSL*F<M8]Z*J?(I\%U%=HNV?PR ;.)[5CGY4^2T?F;?"Z%S'=S,IYD![VU^A4
MG';=PN9;=QDM^*Q?1WS&GQ,DXFHW+#=AF8TF&:S=V5UB5]%F,.PAP'^$U'!8
M9P7PS1O,5?!?-S"W Q<ZO"BPSAOEGMW>&)XKEN96XH!S5 X&JQS@OE>-[AMC
MS7$=^^1W+#"ZF][\!0[U2<,6Q6Z5[=W?DN]RWVKX2G96O';2JP3966?YDKD/
M)'?]"B8I*T73,,KE5Q);73)(W%LC"V6+$@&:W<)X0:;:EM*=JB)I=5DLF8NT
M>K/1/.VYKIVT>'ES700RCF<"2V>,3-())- 213<!BNR;._KLAW'87]6*'.K&
M-E\ZWD ='<PR1.:14%LC"QP(/>MV-9HY*W7W9YO+/7>3G3NML^R@Q^6T7<UR
MPX\KFR2D4:2O/NYXHP[V^R/2Z/W#%&'=761P>I/Z'O623I#^HETDLYK@PY/U
M<R_4?2+-6.G,5N^74=D,ST^Z1E0'/_J=C9QQUWOH-J[A^FO<?R'U7@LF:6YX
MNQ3_ +T5M_YHAXI^NG9([S^G&\OMBM^SFS<6Z:TLGIO]71==,^A^@BOJ=^>
M@(" @(" @("#PT_6;:\:0T1/R<S'YO99?SAH_+YA/> .?VEIPW[MZ\X^OO\
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MRN:\$N8<34'>NK;G=7;B+:\G&9<O3DGKBDU37VG1=B.$L)F?S>6]PJ(N+N4
M=P6E%;[NF"S>_+F;JZ1]J>ST8ZW92:661D8Y@ &-;*_<[PBH &XK9LV=U^EL
M5JR7=QMR<(I7]O:R+;86[@P18MH,&UY:[*T^E6N[5O;O>MQW33R:]V6+N?$O
M,M+VF9L8!:U[^6F_EK7'#:M*[9YJ\-48]S$71;73@ZX:UA?'>O=(QP =S C
M%P%*+1S[;)$]$Z3+MW;MWCFV(C5Q]+<31Q/\JGF%N PVD5HJQLK9UNG]SFK<
MT1/!\XGKAMI++U1]3'/;1]^_(LS>#N?=Y/%S8=[<%]0_I[K]'[2R?X.NWV72
M[9L+Z[2R8X:NJ3[Z*U;S33-:-PYO$32NQ=QC%=DFEL5;-^YQX8ZLDK1V>RRC
ME@\+*T#SMHLGY2VW6]JSW&[+-,6D>*>.?SOYC[B1V)#6D@55;K)M^&(B",G7
MQF97+&!Q-+60FE*N=])JL<S2-;EXLB=8LE.;*9XJR#D-#0\_VJ/F6V\9JGY&
M2[A;1(RVSJ UAEC?&3C&\U('953-^UO^**2BW'O\<UQW1,>$KX-S,C%\8[*4
MHL4S@\);,1NIXS"?DO@!S21&AK0-HHKBGA"W3N>-8<N]!<[N<@ZN:,N7OB9!
M?WTN273B:#Y?-H#;X$_W^2E5GV=]ENZMF.>GM<SV+-EP=UPSDF*73-L^BZ*?
M>^C'HSF;98;5GF%S7V[8""XT,L>#@6KQKONWOV7?-QAOBDS,S'HET#ZXVEV#
M?9K+HI,75CT2[%7S"ZV)!-&8D 5P/#[%U'O..<FRNB.,3671-G=%FYB?%6R.
M41F('\8VUQ'B&*Z+AF>J9CT-WN<32'.>5WC;7)X7%P<0[Q<QP'*ZE/AL7:]M
MM+LNSZZ<W4,T3.XFV6H:WUA;0VKX+:>LQ!#N6HHW[I:2=_"BV\.TLPY)B_68
M<EVS87WWQ=?&CJWJ.[?,^:60_P N-\A.^M*G'=N7,;3'\S/;9'\4_8]![7AB
MML1SF(<$ZHSOY:TL[*-WYDSW74V.(C;4CF' \-Z]*^G>TQGW&7>7Q6+?<M]/
MD]'[-VZ<V;)N+HK$>[;Z7$DTSYYI9Y#5\KR]Q/;L^A>J;?%;M\%N&R*1;%'J
MFSPV;;;6XK8I2'O]^B[T>A?I[J'URS"U!EOL\.A-,7#F5YH<NACN,YFB>:CP
MR/,;J4Q JO4/H/8Q\G+W"Z/BNZ+9\HXS^W@^'_\ 5G]7WW[S9_1VWN]VVWY^
M6(\YF+*^FDS'A3S>^B]+?%P@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(/B=_P"4
M+#R^IKTVW'A_-Z$YK#@/'^1U OG^(\/S,,>*#ZMO0A(Z;T/>C29].>7TI^GB
M1U!0<S^D63N=0=Y0=K$! 0$! 0$! 0$!!P+ZHM+7&M?3QUBTM:-<^[S?0F>0
M6K6BKG7$-O\ -0AH&_FC%%J[['.79Y,<<[9;W;,L8=_ARSPBZ'R>= +-TV99
MHV1O+-:W-I*X/^\T1O>7,QV8_4O)M]I$/>.V4FZZFL:2[<RL\V62X?\ RK&T
ME,3=@^9E'*'"N%0,/>N/M<EEC69\&8RN^<)Y<MD:QOREE9SP%I\4D<S/&7=Q
MV;%%VGO1S8[;IF>GRA4S!_G-8VN!D:3CN;B%CF6>VV.#4,YA-S;2,VGS87@@
M8^"9KZ$+!6DMFD]*H\M827N:W_$X#LKC1498TG5*)(B:"6(G' 2,)P]ZBBT3
M":E=@KNPH56B6)SB%PMX[N,$26,[+G#"L0-)FT/8K6<:3S5OTCJ\%\QD<C&2
M,Y7MD E8X@$T?XFD%*TXK<8([9D;I9&U\R9W-(XDDG#!H[!P2LHI2M$_(=QQ
M5E=>:E+;Q3@MFBCF:12DK&OK7;3F5XF:U5FE-=6)=D%J'^992W&7R\;60^7V
MUB?A3L63KFFNK!-L?PZ*S!F]I02MAS&$4\<0\JY:-_-&<'>Y1%)\E)NOCCK]
M[*0S,F;5@<T[V/!:]IW@@I258F)5J*8@1Y3]'MBIJCTJ@;N^A$=5$[6^WVJ]
M(A695FM1%:<59K*[/B?L1%55K0-@J:=E>^J(K54:SW_#C@4I7BM6%4-QQ^%0
MD^$)A5 X8*L^96BJT)29(FO%6:*J>G1/4K!*+1*8"J@F54!3%NB/.51HXI0F
M?!4 ]OL5J(5 "4E,S315I[?4IB$:0G XXJ59E.![E:(0F 5D\%4*5)10Y(J?
M,F$P%.WMW*5)3JT*BE$H[/L1CE'?5."O), :[#\%:-43*H&@=OMN291%9E#E
M)]OM2%](A.UG 5[:*5)E<-92A/<GH5FLK@-]P^'?12K,T5 !N]O>K1%5=95
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M(Y6QX1^/BYR6TT1 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$'_T/OX0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$!!\BG_ "I7&GH2;4\I/J><6U-"6CIX&DCB
M*FG>4'N+^C\T,_31]((:\/!Z7EW,W8"_4V8/<SO:26GM"#TF0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$'SM_\ )AZ4VFL?0-ISJ:RSFFSGHIUNT9G<%W QSW6V0ZPMKK1N
M=QR!@-&27%QESR3@#&WL70/U&VL9^P1EB*SCR6^J+HFV:^7![Q_IX[G=M/KJ
M[85]W=X+[:3_ !763;?;[+8O]57Q1Z;O!'/E5VQV =$XN/X3A4E?,=G]/=QY
M2^^L$TF)CTO5OI[?-S#2N6RAW.# UA)(-:-I4D<5WS;W1=CBZ'H6RR6Y,$=+
MH#ZZLEI8Y%F@C\4-\Z!SZ?@>"[:.U6R:7.G_ %?A_IX[Z<)H\UMFWV"HZ'%(
M3 '&G!1/FLJM 'P5)3'%6:-F[CW+'*\4YKJ.E...!X*DSXLMLKI@:1B&GW#Z
M5CN9+:3R7;(XQ0\C37^Z%BF;J\66+,?.(]B^;#$X5,;"0, &BI"I-UWBR_+Q
MTKTPB&LK01MPQQ:*A8XF[6LIFVR.$0O(Q6@V#VV+'=-$QJNF1X]_%8INEFLL
MJR$46 KB:T[ L-UVK8ML9"%@C>QXI5CFOIO\)K0=ZQ3,\6:+=7?7TUYZTQ2Y
M9SD_+ROC:[FP#!^=$,<0.62@)&-%SG;,O\#G^V7Z=+NJU]#%(#O:>\+G.;FN
M&KHYZG<C_IVJLOS:*.C,Q:"][6[0_$M<[O!74?J+%%N:W-;'%USOV+IOLR1'
M%Q7TNU_FO2CJ=TXZI9&\LSGIMKO26N\LI6C[W2F>P9Y;Q/:"*M>Z ->VH!!(
M.!7%;#=W['?8=[C^+%?;?'IMF)_!U7N/;\/=NV[GM.XBMFZQ9,-WHR639,^J
MK]2/1>J\IUWH[2>N,@G;=9%K+361:JR6Y80YMQE.H<KBS?+IVD;0^&9CAWK[
M4V^?'N=O9N<4UMR6Q=$^5T1,?9+\IM]L\W;][FV&YBF3!??CNCPNLNFVZ/;$
MME69JB @(" @(" @\'OUN<V98Z7Z%9/6)DV?Z[S:?FYW^<^TR;2\[C'Y8P+/
M-F:2=QIQ7FOZB7Q;AVUG.Z^?LMG\9?7/^E&V;N^[Z_6EF&(\JW7QS\:0\!\N
M^_-LYF&-S32M.:3RS6G^)>;Y8ZL-T1X5?<F__P K3G^YZD=),UY--:?E<XN@
MFRVW%>;F: U@!IW'!?(_?;XV_?-U9,4Z<MT3'KK$^Q\H?5.WKW/<64]ZV^?O
M;OJ;,R9HV10^9$]O.Z2H#6$#"I'U+B=QW/Y5LXZ3,716OA_9XN!V.VBG5,TG
MP\?VY,&VRES AQ@+VN8&F-[<' [2*[UQ&YWWS\T77\(BD?[&[-UN&.-&Y9'E
MT]ERELT\<;100OH_E(VEI=^U4MUGW=7$[O)&72(B?-R-;6[)"V9^QK:EQ YG
M;^[%;W:=EFW_ '"W9XXKU?9Z7"9KIMMFBZD(Q#&\C*4+12FSM"]M[=]/;'9X
MK8NMB^^.,^;1G)?/-C9&4P:T8[@,3AO7+9,..VWIMLB(IX,D3-VLM4S?.+:W
M,EK'(QTX'C;7!@./B7D7?<6#9[JZFLS.D<H_:7+;7%=?$77</VX.N6N[HW$X
M>TU!< =G=@%TG-FC+FMF9X.T]MLC'&KB.]D>.<MJW&N'WB *K);TUI+LMG53
MS?/K^H;82CU-:@O'2<D=YHW15T6L!%7_ --?$['>3RBJ^C/TXRVQ]+8[(BLV
MY<L:_P"*':.VXK[MC%TW4B)NC[71^WR9L[C<70>__MQDF@'$@KO63<S;'1CT
M\9;&/86Y)^;FK/A#*LM(HQX(VM&W!N *P3?=/&:MGY%MFD0NF#E Y0!3@-_N
M6/6>*\13@K>8X4KWJM(E/7=P3F>HI0U59QI^9*83TXBHV$D*DV3#)&2$[9P=
MNSW543:M%\2J%P<"?;XJ)BB\36%>QO7Y9?Y?F<?-YF6YA99BSE-'<UC=,N:-
M.XGEHHMGINB[PF)]C)9?..^W)'\,Q/LFKZ&>@VJF7=QE3HJ&+,(;/-('APY3
M;YE"R<<O:.:A74_K[9Q&7#WK'-;<M+:4X3YLGZB=OC<;6SN]GPY;8]M'? ^.
M&4$@8'EH:F@;6H7FV[LMOQWVW<)AX79/3?%&!AO'0&$5YG"208&CBUOB:!Q7
MFMD=.6Z.%)_%SN[Q_,QUF.$0Y*GU'%:95;0LCD>^:U,SMQ$I=4'W;UWK;=TP
M;396[/HZKKHK7P=<M[7DSYKLLS%L1.CC',O,OKIUU<$G!TCFUH!7Q@46Q7YE
MWS)TKJYC#3%CC'9Z/4XIUE.VSRRYD>[D?</$+#45+3XGGX+L'8=M.;<_,I6C
MNOT_BG/N;8MBL6Q5U7SF_=?WLTY_EM(@AH</+CPP[]J]S[3LK=GM+,,<?BGT
MS^Y[3VO:QM\5N+GQN],M>S"[CL+&ZO97!L5M!+*YSJ4#6,+B<<-RYF^^++>J
M[A#L66^,>*;IY0^Q;]-W0T.@_1CZ>LM%L+6]S[0=OU%SEH#.>3->H,[]4/=.
M68.>R*ZCBJ:FC1BO=?I?;_ENR;7'PF<<9)].3WOLJ_)G]8^_7_47ZD]U[A-W
M59;E^59Y688C';'_ "S,^<S+O<NQO,A 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0?%+_P H?_\ J0],_P#_  1S[_\ ?RY0?5%Z )'3>@_T3ROH7R^D?TWR/H*#
MF?T<R9SJ#O*#MP@(" @(" @(" @(+:]MF7MG=V<K6NCN[:>VD:\5:YD\1B<'
M#A0XJ)BL43$TF)\'Q[]*;0Y1U/ZG9&X!K\LS?.;(L&!#K#/)K)P ["U>0=UL
MZ;ICPNF'O_9LG79%WC;;/V.4,QS&[M=526CKB4VMY:M M^8^5R",/:0S8#S
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M=P4TY0B=%K'$^1XN+@4?4^1$<1 P_B=7\9&TK(I/'7U?MXJ%F/,GOI\:&81
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MNH(" @(" @(" @(" @(" @(" @(" @(" @("#__3^_A 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$'RH_\ *5LC)TO](.8T-+77W5>RKC0',-/9-.!MW_+<
M/AO#U+_0VS#^I?I8>E*XYN8Q99U6R\XDD?TOKKJC+0T\V. B%.S9A1!ZQH"
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M:Y]U80$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!__4^_A 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$'S!?\ *'R\R^FWTTYMR^&RZWYYEY=P.9Z#NKEK
M??\ *'X(.\7Z >8?.?I<]";;FYOZ3J7K-E]*D\GF=7\ZS7EQV?\ F:X<4'LV
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @("#XWO^41T[O,NZJ^D3K1';-_IN;:2UWTNO+QH
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M<;\G>>U=JK[N/#ES4\\F3Y?V?)G]JOJ%7M#Y5$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MS69IPN+HGF_I[7#:&X>93L"S6^Y;U3QGAY>;#/\ 4GHY1Q\Y\/WLHX4P
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MLSYRN5*! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$'_]7[^$! 0$! 0$!
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MX)FOY?;8,=/"MLY?M^;U>NG&'N4O27A(@(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M1]V.N+\=[MM>%%?AHI.NJE*77,A@82(8R/F'@T+G#$0-/;^)6A2[72%X&@-
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M\QZ9:/OX7 ;JS.N,.SX!]%: @(" @(" @(" @(" @(" @(" @(" @(" @("
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M 0$! 0$! 0$! 0?GT_J]N_WW^M7U#TZW\Z"7J)Z9]&0,^]7YCIKI&WNXJ?\
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MN<P27$#VN9XG-;M+@,,1MHM_>UC!-_3%U(G2=(F::1,^$MS<Q2RM*TKI//\
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M3"HW:/M5HJA5'M^Y7A K1*LZ)P%.BDJ@'MO]RLCI\$:]M!P4HHF'M_:E%93
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M/KG[(AW 7+."$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!__]#[^$!
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MCS]#WT7>7F8@(" @(" @(" @(" @(" @(" @(" @(" @(" @("#_T?OX0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!U?\ 6YIDZT]&?JTTDR/S)M1>FOKC
MD]JT"KA>WW3/,X+)[!_$V8L<WM 0?)A_Q?M3BT]5?J'T:9*?U_T^Q:E$=:<Y
MTEU&RC*^:F_E_K7TH/MO0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! (J*(/EK_ .3WT?&9
M]'_3%U^L;&-]UH#JEGG3+/;X ><,DZAZ=?GF6LD)_P N.\R,@4_%-VKRG]5M
MC&7M6+>1'P739,\Z716/5$VS[7TS_IH[O.'O^^[+?=2,V&,MD?W\=\6S3TVW
MZ_X7R7Z4S&3+L]RV\C>6%MS"74W@N'WAP7S_ -OR?)SV>4T?;FUO^7FB9X?M
M^T/5C(+QN8Y)8W-2]LEK'ST(/B+-E?VKT&L761/[4>C8)C+AMOB>,.F/J6TO
M'FFG]26;HJ\UI+?P$ _ERVK3,WE^&*PS;6*0ZKW[!%V#)9=K%*^QY$1RL>T$
M.!.\$T(/<L<Q,<7FMM]ET5B54?OIN55E1I':*GX*LQ*8U5E1DC1<QOV 4QVT
M%,3O5+N*\2OH^/UK%<RQRA>QFM-Y6O=#/9K-%VPXX&OUCX*GDS6SJO(G;C[J
MK%?#+$Q71D6&FW'#%89UU9K)C@NFN:*>,#9O"Q3$SR9)FV.*[C(.^OOK\%2>
M%%HFO!>1FK?>J,L:PY%Z=9@ZPSVRGJ.6"\B<]HIS/C>0\@ [2"S#M6?;STWQ
M/@VMM?TWQY/6;)"PVD)B-8Y(8WM)H*AS-H P[5VW'-8BCM.*:VU76ILECU)I
M'.<FE'-Y]E<1QLV\\OEGRF@=ZQ;G#&;!?AG6L2V,N.,^UOQW:UB8>45Y939?
M=7V67,9CN+&XGM)8R*%KHGE@P*\[FV;+YLGC;-'G<VSBOG'.DVS1^@W^B=UR
MAZW?IX=%A-=BXS_I-#FG1C443[H7-S;RZ&N1%I[Y@$ES?,R:?+9&AVXX8+ZO
M_3WN,=Q^E=O,S6[#$XKM:_!\/_+-K\[/UR[%=V/]1]]-MM,>\Z=S9I2)^;%;
MZ>-,D7P]8EW5Y$(" @(" @_-=_53UI%KW]07U6Y];S_,VEOU=S[3=I+5Q;\O
MI,,T\T,)V#FMW8<:KY6^L,\;GZEWF6)K'S;K8_W?=_!^E?Z5;*=A^GW:=O=%
M)G;VWSZ<GO\ XN,?1_%SZVU%**?D:=<7$DUH^Y8WP#>:TJ%J=BC_ -Q==_=>
MI]MI\^KT<RJW=<-M'C:R0U!Q('/7;LV;N"WNYYHQX;K)_BT]KEM]=;CRW1/.
M*MK@RV**X?<L-.4.YFD85<?#2F\K/L\E_P"7LMOUF?N<5=GNOLC'+5.H-R+7
M2><R.Y:,L9W.YCX7-##S!U>RJY/2DS"E\Q&.Z7@#U&UAFNL=3YCF69WDUV(K
ME]G:![W%K;2S/E05#C]ZF!*X:^;K[YFYU/=;K-N+^K)=6FD>B-&A5.ZNWM!5
M*0T^JJ8U WU4<S4'-]FS&G<IT4FJB^8,/+BYW!JM%LSJPWY(MFG&4G)<S;7>
M6S T'WNY36RWE66*;<M_E"I':-&)!>[B_&GN479)]"(Q1;.NJ]8.2C>4@<6B
MBP36=6:V9B-%9O/7#$5WUK11%*:HFM:0N8W.:1@3CAP[EBOHM;,PNN9S1A\/
MM6"8B97ZKH1$SJ8T)I7;3!.F$==RHRX(%:@=@->^JK-L3-%K<E4XN"*FNTF@
MKQ[%CG'$RO&549,?+?B=K:\:8[$^765OF3Z4HG) !. W']RB<<\DQDY)FO&W
MF_8JS;*T71.LAE!!Q41&JU::O2[TIYC#)TT%F'-=<99G]ZYT9>*LBNA',QSF
M;0#XJ%7[1?=^9W."Z-+XX^<1P=U[!=/RK\5-+HK]CV,Z8W4/]*RIS?%Y\4?B
M&-/"*A?-W?/F8_J6^S)I$7S][P;ZJQW?]TS1=I2Z?O<:^H;,_F,UR_*(SS<D
MPD<P&F+8Q&W'O)P7T!] ;3Y?;9W$QK?^^KTC]+]G\OM^3>S%(NBE?3-6BYZX
M6>39?EK<'/AMVD' U< Z3'Z%W.^>O+,^#MVTCYN\OS3PB9<1=6L_&D.D.ML]
M$[H+AN7?T[+_ "S1TV89F_\ IUG'6H/XGOP_A7!]ZW,X+,=L?%==,Q_NQ/XS
M##O<_1NL..-9F;I]%+9G[YAVS_XVW2)VI?5-U5ZN7=I/+8=*>DKLER^],9^7
MBU)U"SF&SA'FD4\PY?89B* U =B,0NX?I!L/G=[S[^Z-,&*D3_>OF(]O3%WM
M?,W^I?O'Y7Z3V?9K;O>W>XZICG-F&V9GU==]C[5%]%OB(0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$!! D $D@  DDF@ &)))0?GY_HL<W57]8W0VOW#YF(9WZC
M.IEPX@N:[^NZ!U#9VT[ZUV7&:PO::_> 0?H&H" @(" @(" @(" @("#Y:/U0
M-<6>I/5CG4.53_,Q9)IK2FG@^-W,UTUG'<75VR/EKAY\W+VT71N^98R;Z8MU
MB(B'IOTSANQ=LMFZ-9NNGVTI]SA#3.60979V63VPB;=/M(;C.)XJ->9)ZS7
M<[:3LC X K@+II$WSPAV.V.J>B.,M]R]\-M:W.82#DB>72-% .2V@'E6T3.
M(&':5P]TS?,SXNQ8XMQXZQPC\%;)&G,)ILRG\0<\!K<2T.C^ZP5VA@X':J7Q
M2*0R8_>]Z6X U]M_!8)K&C-#'YCXCEL>%'YG;UK_ ' 7@CC0C8D<Y\D7<O2O
M9I1\S&X$'R;6ZN-GXJ<C:%1Q7KJUO3M6YJXO#0^ZRB.X&[FK=NYL#O%0KWQ[
MOK8\?Q:^#/-'F9]=M!J8\K@Y-M ]TM?BL<Z6Q/FOQR>IL,+R]C74-3@:G>W
MT]^Q477#=V_LPWFM#56JFJURX\\N83&I)NO*:?[D3: *9Y*1.LRRE*G@E"55
MO&E.%-G>I1IR5![8XJ5951_:I@A89E"]T+;F$?ZFR<+B(XU<QF,D=!N<%,:3
M16^.<<89"WF9<P17$9\$S&R-[*BI:1Q!P*F(I*(UU5P%DHA/RGZ!W>\[E-**
M5A5##Q]O>IBD1JJLLR!^5$8^]/+'$T;_ !/\5/<LELJ7?#KS91L0;0 4#0&@
M;L!11KP3I$<54-_;@D0I7P50PX8$[E>(1659L9/PW?4B:RJ-BV8$_;W*59N7
M#8Z[NRO [<5')6JL(]FSZU**JHB[#[U:(E6L0JB,\*=V"F=$=4\E41_NWXJ/
M0BOC*H&#@3W_ +%-$5A4#,=PWI2I7P5 WOPXX*=(/2FHFB$:#B-G;]:C5/-&
MH&Y*%9XH<V%*C[>Y6HBJ!<>X<?L-%%$5YH8D>[X#N*3,0BJ4]_P4536(2UV[
M>S<5%8J52'W=_P"]36B:H)42DJ$3JD+A7C]B*\4I=NIQ'NXJ8XU$A?7?V <5
M-L0)A)3A@*=G8%/"5::I2_B0?>:**IJD=(-^U1,S*U)4'RT&WV.Y5JF+5I)-
MVX;._%5JO%M5F^<<=W90]ZK,KQ;X,?+<;<0?M'"BK*\1/)C)9^WZ?J!43/)E
MB-&/DF)/OQQVX\%29JO%OJ6CY-I)[?L45369TM6[I*X#Z-ON43*T6TUE1+AQ
M/Q[.Q1,K1X40)]OI5:^"=9G1(7>[VQ2.*:>+QU]<FG69)UADSF.,BTUEIW+,
MYC>QA_-OK$.RC,J$#;S11D[S6JZ3]1[:ZW>3?$:7VQ/KC2?P?0/Z8=RMS=AC
M;736[;Y+K//IFE]OWS['1MTTY=RQ0<HK]Z9W*<#7!@K7XKS_ 'V*R*]4^Q[E
MV[-DNIT6^V6M9W ZZMR^6=[VD.JR/\J,4.R@QJ-A%5PO5&.^EL4\YU=DQ6_/
MQQ-]\SY1I'[W F?VT<+Y/+8UNW$"I-,?O;35<C@ONN^*:KS99C^"(AZ4?I/]
M39,GZG=1ND%Y<\N7:[TRS661P/>0P:FT=(VWS$1M<:<\V73G8*N\ENYJ[]]%
M[OY>[R[*Z=,EO5'^*WC[;9^QX'^O/9HS]EV?U!BCW]KD^3?/_IY=;?5&2W_F
M\WNP7=J]%J^7=4A=VJ8J+6YNXK:/S)#6IY6,;B^1^YC&\2K0BL0LK>&2:07E
MX!YM#\O;[66[#L<X'\?'@K5IHBDS-990'V_>D+)A]&]1)55 X*$:IQO^/L"G
M%DA \.VE:8T&!1=+Q^OMX**PF(2.'V_VJ%[?-J.9_G75Z_ LM8[:U8<#26:0
M2/(]V"F.$*74F9;0T !N_ ;1V+'5GAIV;$G45B0:>6ZTWC#F?3V^E6M^"5+H
MKDAR*S::#"NWNW!86Q1>,;OX[!PW54QP.$Z+IK?B -F-/<L5T\EJ>*);_;N4
M0M%L<DA%:\<,>Q3,1Q3$4T2#V]W8L<ZLE!QW;^/#O58B#5(17[/W!1S31"G9
ML'V*$Z)".SX=J(2'9L]NU4KJB5+^Q3P1'FM8_P"7RFG@<]F\X--!M4H6+7B(
MYC.[9&\'>:^5%4?3L"OQI#'.E96]DPQV;2ZO/+YD\AQ)+Y*O<357FE58TMA,
MS")A.Y@).&RE5$K<F#)=</>!4/NG<SW4(,5DP\L;*[B\U*S12(JPSK^W)>\H
M: UH :T4 &P # 44>E,J=/WJ]O!CF=6-S.X?%$R"WQN[IWDP@ DQ@_S)L-S1
MO6:R*Z\F+)PZ8XRL[J(6MI;Y9;&DMR\0EP^\0[&XF/?Q5ZUUE@NCIMZ(YJUP
MQMO!)'&/!# 6, W!K*;OB>]<EMO\J)X5<3NY_JS6>$,!<7L%G9R7<[A\EDUL
M)WMW7%\6\T4 XXTP6S,:T\6A.NG)/Z>.F>I>L/4>SCRNR-]G.?YL;#+/,:YU
MO#-,?,O\RN7T/);VD(<^1^/*QKJ [%M8,%^?+;M\6MUTT_M]$1K+4W6YQ;3#
M=N,TTMLBL_A$><\(?5'TCZ7Z?Z/:$R70^G8ZP9?%YN8W[VM;<YSG%PUIS'-K
MLM_%*\4:W\$89&/"P+T/:;7'L\%N#'RXSXSSEY+O][EW^ZNW.7C/"/".41Z/
MOU<EK9:8@(" @(" @(" @(" @(" @(" @(" @(" @(" @("#_]+[^$! 0$!
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MW,M%04 %-@6O.M9EM6Q$12&08,/;W+%,S5EB&?R"9L%^Q[ZB-I8^0AQ:1&)
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M50#OZ@\M:2+&)Q:]PJ/G)6'%@(_RVG:1][9L59BGI3$]4^4?:FNR/G,F:VA
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M" @(" @(" @(" @("#__U/OX0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M1X6=OA:.Q8IK$+Q%JMR6[CRO;&1VT!QV+',W\8+K<4Z3$)#9V=26RMC=N+)
M*#M"K\S)SBOIACG!@GGT^M3\N2(UAOHR /NO=CQ3JB[XK?8IT76S[F2/6JLS
M%\6$_(X?Q,-=VU4NPQ=\*UNZNL^/7T+R._LY2 V9@.VCB&GNQ6&<.6W689[=
MS@OX7+OSHW-:T/9]XG!PQW+'TS&K+U6SS2N-=F*F&2."D>/>H4F(F=5([1LV
MCZ2K<DTI-(<@0 ""*@I^6S9MP"X"^9^9,^;F;8CHB/)V@]..?<VK8,EN)2X3
M,:(0\@5EYP&,:T[2=P"Y_L>>;L_R[ITY1]SF^TY^CJQWZ4C_ &/56 "RR20-
M%'102NWBCBSD:?B2NW;K2(M]#!E_J[J*\)F(_%KN5O9;6US>/J&V]MSX85YY
M.=U!@#4 E:F6)NCIMXS^YNYK9RYK</\ --/12'CUU-SRXU/U(UCJ*ZE=/<9M
MF]U</F>>8O:)C'#4]C&M [ O/LN.W%EG%9I;;I'[_6X;)BLPY9QXM+;8I'J?
MI&?I^]/F=+O1/Z8=%,8(WY;T<T7>W #0PF[U!E;-0W;GTVN,ETZI.)WK[#^E
M=I&R^G-EMHY8K)]=T=4_>_,+]0^XSW7ZX[IOIUZMSDB/19=T1]EKN"NP.F"
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M$! 0$! 0$! 0$! 0$! 0$!!__]7[^$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M^9O$&6WLE/NV\@%,""\<H^M+8K=$+36+9G@QF5VX^9R"UH1\KEK[IX(I26;
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M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @_];[^$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$'QR_\ *4T$;77GI#ZGQ0\PS[2/5305]<-;_*.D
M\YRC4.5PRO\ _5G]:O'1C^X_WA]$7Z6NO?\ T2OT[O1WJ<S?,20="]%Z/N9R
M[G=+>=.;(]/+U\K][S-E;^<G'FK7%!WX0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M/)L:R,0@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("#_U_OX0$!
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M',;-KJ"CI&AE]&WF-22X"2@XFJY[MM\]$XY]+ENVY]?ESSU_>[A/N!!*^,N
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M=%JX[?>JROR6KC3VK\5"5 [_ (]JE%.4*)Q]ME%DC2%9KQ8;.A3+LRH<76[
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M3I[?ROMX.J'0G663PV,E8GOU-H_465:LM"^-V/-#86V;-+2*CF)PH4'W<H"
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MJ1/:U[(&.-'-<.9AE<=O<%XWO*63[FOG^Y]H;:V_)2<VD1_#^^6Q3PA[  T
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M;/=\3M43X2OR6SMA_L4<TK<[#^_[%/-$J?V5J/HWJZ.3 :C)9E-V1@9!#$W
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MCLQ8XQV12+8I#R'-EOSY;LV6:W73,S/G+8%=C$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$!!_]+[^$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M:5%:D1R6CC-*TOO)!:P;?(CD#26UV338>\-3T:IBR:5NT6PS*U;^38Q/N'#
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M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0?__3^_A 0$! 0$!
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MNMV^W,;?'ICQ\O&?&?PCEZWI:N<=7$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$'_U/OX0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M/R2[GO+NX=RW&_NXY\E^2?\ ?NF[\6[+,T1 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MC9@"UI- X&F%/J7GWT_EI=TSPGEX></JSL>6(NZ(TF>3NSJ"V;>93.W;6%Q
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M+O7I;$_\SYH_U%]PNV_Z?9<5LT_,[G%9Z8CJOF/^1]VZ^FGP$(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @T#JQU"RGI)TMZD]5<_+1D?330.L-?YR7O$3?Z7H
M[3UQJ&_!D/W:Q6[A5!\+W_'\Z?YKUU_4UFZP:F:[,[KIEHCJIUDSK,9X^:WN
M=6ZS>W0ENZ3FJ/.?+J*[O(0<08'/!JRJ#[X$! 0$! 0$! 0$! 0$! 0$&D]1
M]"Z<ZGZ$U7T\U9:LN]/:PR2^R/,HG,8\LBO82R.Z@YZ@2P2<D\+OPR,:[<J9
M+(R8[L5W"Z)B?1,4G[)9]OFR;;-9N,4TNLF)CU/D+U+TWSKHIU4ZB="];M,%
MW89G<V&5YI(QT<%Q=6CO/T_GMH9 /R;^U,3PX#>0<05YEO=ODVN:['?QLFGI
MCQ]FKV;MF\Q;W;6Y;.%\5]%WA/HG25GIN0WEW+DU_%6=D%W!+;2 'S/*!9<V
M]#C2IJ.P@K5NTUAR-DUGHNXJ&2WTNG+ZYM92^:SM1Y0(#C)\D7%UH]P/WO+)
MY'&E10J;HB_6.*++IQS,3P<E1%L3,MG>]KFS79NYI0X.81Y)>RA&T4P%-ZP3
MX-FM*-ALN>X<;V9O,7@LMX'4HV$X$X_B<J3I%(7MK.LZLQEMTV-YM>8\HYG0
M.<<>6N,3P=CF\%$Q/%DMG6DKN*3^GWN)I97S\!04@NB*G#<'*)I='G"9]V[R
MELK) T5+J#90FG=BJRF9B(7['UI4TJ-^T853AJ3$4JN6$&GQQI\%.BM$\T+9
MF 5+7L(?$X;6.&PUX;BI_%CFJX@DYV^/"1GWP*TJ-KNX[5!U2NP?B/MX(M%T
M0J-?_:<.VBB8-)GBJ\X55J)@ZFP[=HVH4J@9!LK7;\5$T*2><?XJ[/?3:%CF
MBT6R&4\:BFY5FG%:+4AE[>[WXX%5TA-)XJ;IL:@]W?L45B5XME;2W(86CQ/<
M\D!K14D#$GN"K*U*)/-YAS U!%1VCO5*RF+4AD'N]MH1-%(RD;#7WU[4)Z5(
MR]M=YV;5.J*Q"D9AMK[OM"F(T1-5)TP&&S<I@UG6=5!TW=@=FSVP4Q),44G3
MD[,.&)^"*1$*1EIB<!QK3N-46HM'WL#"0Z9G-MY6GF=WT;5322:56<N9Q,PY
M'G@7TB;P.+C7Z$I*.JV%H<PO)Z^1"&,W3.;RL[@^:G?@$I:CJGDLG<]PX^9<
MS7#MACM>;R@?[T[_  ]] IK3@:\*JT5FU@Q#(0=K8@'R;=CKA]3W\H"B;JB]
MC;%  (F!N-2X^*1U!M<\XE5UGBM$TX)C)M2@D+^W]Z&B0O[=ZC@F/)*7^_W)
M64PMI;J&+^9*QAP\/,.?_P (Q^A1$3.J*T6WS<LO_EK:1XK3S9_R8^_'Q'X*
MU(CB1=X0@8+F;^?<EC3_ )5J/+%/X72N\1]U%&D:03,SK,JT-O! /RHFM.PO
M(YI#Q)>[$I,RBV(IHKT[E5:ARX5) &\NH!@-]4TA$S"V?>6K"6\YE?N9 #(Z
MNS=^U32Z=5>J. 'WLO\ )MFPMW/N#5U#M(C;]JF(CC,E;O0G%@^6AN;B6;?R
M,_+B[11N)2L1I!-O\T_N7L-I##A'&QN&WE%?_$<4FLIX1HN@SZD1/FG#5:A7
MP34Q1%914E$:*4T1 V=^.S%3"'$6?/-K=W5N3_+FD QIX22]I [BNN;J?E9;
MK)Y2[UVVWY^"S+'.(_<XVS._IS$.V=O?1<1FS3&CL^VVU:5:E!J9^39OEV:L
M>:Y??6]TX5VQQRCSV4[6<P6MBW<X,]F:)^&8GU?[')9NUV[S9Y=I='^99-OK
MF-/9+NY%)%/%%<0.#X+B&*X@>TU:Z&=@EB<#P+2%Z'$Q=$7V\)UCT2\)NMOL
MNG'?I=;,Q/IB:3]JJ!V>[CO4Q%443AOO^->*M$)A,&U.S8/CCBIE*<,'"N['
M]BA#6];Z4M]<Z&UOHB[C9);ZRT?J;3#V2-JPOSK)IK&W+FC^"5\;_<L>;'\[
M%?AN_BMF/;#:V&\N[?W#!O[..#)9D_X;HF?LB8?&;D=M=9-F5QE.:APS+);Z
M\RB\AE!'R]YE5V[+[II8_8X/C<'5QJO&>X63;7'$4I6)\:QIJ^^=C=;FBS=5
MBZ+XBZVG"(NBL4]O%S[DUR)(F&O9B:^X573]S;2YV;#+)7,CY7&UMR/,(_-F
M_# S>*C\9W!8K(BV/F7\.4>/]BF6^Z^Z<&+CSG^6/W^"GY+(F"-@H!L'$G:Y
MU=Y.TJ9NFZ:RR6V6X[(MLX1^WM>\GZ>?4G_>_0.'25Y<>;G72C.9]+/C<[FE
M=IN_:<UTS. 34L8U\UM78#& O:OH;N'YSLD;:^??VUTV?[D^]9]\QZGQU^MG
M8/\ M/UE/<L5M,/<;(S5Y?-M]S+'KF+;O]YW:O)"9&V[3X6QF6;M)/)"SXXK
MN<15X]=/)=20M<UK7X-;$ULIK@(8QYDM2.)%%5>DSQ39;&7,DNY&^*ZD<^,'
M:V$'EC'<0%$^"]D<XYLC0ND8S:!XW=S<&A0S1X+I%EE>L=<-9:--&S$&=V]L
M+<7-_P"K8JUIJF?!:7$C8;\N;1L=AE<CV- P;)*>2,#Z%$<-><K32)KX0N;6
M$QPY5"X?F/E=<2#>7N87N)KPJE=9IR6F*=+:&[NZGOV*LQ"(B8N50J,\<!4G
MQ2C1*E4U/=QQ^U4F45U0+?;@J53713(XJLB!3S**)5DK.08G [U6YDACY6T%
M>W'M5*K\UD\*M2=)U6KOO'=V\ K<D,+:NI!>/K0FXN*U%:4'*"2LG&D*UTE@
M+MY%GF4WWO.FMXP#3&-A\MI'P*O'&*,/*9;;9$"UM6C_ +$6&S\ K51SF63^
M&%*_>QEM*^3$,<&NJ:  XNI57L^*&&^?=G[VR^B#I#-UP]0N8RSAXTUI2TGN
MKVX<TGG%Q<"V<(9#L+HA-&*;.9NY=Y^G=G&XW%;N$1]_XR\U^L.YW;3:=-O&
M^:1ZOV^Q]-67V%KE=C9Y;8PLM[.PMH;2U@C:&LB@MXQ%$QK1A@ %Z-$1;$6Q
MPAX_==-]TW7<9U7BE40$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$'__7^_A 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$'Y[O6\
MCT!_KI9MJ@_^P72^DO5EI[J9,]E(+6WZ7]9KZVU?J*RLI,&B&'),_O;$&I#3
M&6.Q:X(/T(D! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$#;@4'Q>_\IC2%]8]:_1UU';:2
M#*\VT#U$T/+F'+^2+[(M266>V]F7_P 7EYC*\#A5>-_JIM[KK]OFII-EUM?.
M)K$?;+ZY_P!-&]Q_D.Y;";HZK<N/)%O.EUDVS/H]V(EX#](LT%EJC+I \CS7
M,;6M,"X8.';N7B7:LDXMS$<J^V'V%V[)T98FM'IW&6W66,.WS+<8#M96E5WN
MZLZ^+T"R?F88FWP>0/K0R_Y76N1W'*/S;"XB&&/@F+@7?8M:_B\U^J+)LWME
MW\UNOJ=- -]<51U>=(T3_7]854PF"F.*83&NQ3IQ2G!-,>"JI6:T3--*]H43
M"T>"3GQKNX?:KQ%%I\4I=4U.S<LD1HQ73-$0ZN&\_#WI2B**K"1OVTHE-%HT
MTE7J/>D6U@B50$;TE;T*K7;=I[2JSHO7P5QW_3L6*3FJ#[%;DF)34.Q%JTC5
M<,%>"B=(+?%4+?"-YPQV[MR6\5TPW*TJ\U04K]552>"RY8=@(V# J)X$55@*
M[E6J55H]@J2MY(D*$3'(:VM?WU1CF)*$;5:)3$H$;3NK[U:$3$I1@K,4P=N&
MSVQ1BF8E+M-=@4JW:($ -) 'P4Q.JGFI$5(P2=-282\IJHK%&.G-7:..!P'9
MVE8Y7C@NFN:&XEHIQ(X+%,34K%==$XN(&T_,:#OQ HL<VW^")R61-:HB\MQ7
MQU%:5I51.._P3\_%&E07]N#0.?7;0-J**)Q7S%91^8Q<(2NOXL:-D/\ T_65
M6,-W,G=63I24IOHZ5Y)-E:<JGY4^*D[FV9X2I_/,(QCD%/[NQ1.*[QA,;B*<
M)3MOHMY?V> J/EW+?/Q^<)Q<Q$CQ@$G8?"3V)-EU.#)&;'/-=->"*@@FFXU6
M";:,L71=K"9IW[,:8;E$PMR<@]*('7G5+IM; %YFUMIYI Q\(S!CG$]P%5DV
MUM=SCC^]'WMC;17/9$_S0^@#8][>#C[\<2N[.VN&NJEX+71^NKLDCDRB2W:<
M/O3$1&G[5QG<;^C:9;_*GM<EB]W%'E;=/V:.XO\ QH,I-YZI/4+J LD+<MZ)
M,LA*&GRVR9SK_+Y&QR._B<VT>1QH>"Y/](<->_[O-RC!$?\ %?;^Y\A?ZFL_
M3]*=OP?S[N9]5N*_AZ.K[7VB+Z%?%(@(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M"#QZ_7<ZSMZ._IK]:K>WN_E,[ZNW^DNC.1'GY#.=6YRW,M4V@ Q=YFG\NSAM
M!QJ:@$$/.?\ XO71K^D='O4MU]O+2DVN.H.E^EF1W,S.61F7].\A=J;.WVA.
M)BN;C4-JR1PJ"^U#1BQR#ZG4! 0$! 0$! 0$! 0$! 0$%.6-LK',=4<P(J-K
M21@0>Q$Q-)>"7ZH/0O5TN<Y?U4BRJ6__ *?:PY>[4%E YYN;"TD?<9>V[>P5
M;<VE7-Y'GQQ$\I/+AU3OFTONGYU*\J^7[X=Y^F-_CMC\O6FM:>?[I^]Y6SYI
M'>S:?UW8,9;W,=[!E6I;5IHV#,&P^6R\\L?=BN& M-=XH2NH4Z:X[O4] ZNK
MIRV^OTLKK6V?99A99Y91\]N&-OKF-K>8&"6AFC=V5\1'O2RD^[*V6.FZ+K>'
M%E()HYGY--E\O-D]Q<LE=&YY\B.YFC/^C#L?+J?N[MQ59BE8GBR1-9MF.#DB
MUN6R>&CHWLH'PR -?'39AO' C!8FQ$^*M<6QN&B2"5UO>1D/BF;L<X;&3-_$
MT["HFL3Y+3KK'%5AS.*YA=:9I'\I(ZK'2 DP&1NR1DOX#7$!RK28FL(ZXNBE
MVC+9??/$L5C<.!GAC<YCR06W,(;2.5G'#;1)MK687MNX1+9XYAA7'#LX;E1>
M9I%5\R44&.!&^FW8*J5:\UXR0';04WBM!VHKRHK-(+@0>4T^(X%$+D&N/;QP
M4"(<1]/[4JBE4WF4H*5J3CPPV$!-.:8CDB'[JC?3N&Q57I)S\3]*:2G5*7CC
M[5IL5)BB8NF$IE''P_5[RJT6U2.E&\\>_!4HM65$S U.(Q*KPT9(B>*SDFI<
MP[<8IA7@:@BI4:4*4F#S>4D"@!J</XCB<.U4E*FZ4G?3O.P]BBB5%TU*DG9B
M?=C6B(HQIS:RQ N8W'$85/8=BM22MO)2.9QN_ELFEV_<B<1W5=13TE8E2=>S
MG[EI)C_W9&,Q[1B5-*<T<5(S7KA@+>(;RXOE/;LH-BG177R64UWRX29B><G^
M7:QM<^HVM%*E/.(1,\IE;ESI15EM,\?]V^G<QG_@;C\5*%'G:"6.N>9Q%3#E
M\-*8T(=(,<=F)3EP(K_L5&A^/DVT4!/^;<UEE/\ >Y17;WHFGAHG,+7FMQ))
M<NW"1U(A7:&QMP5?L*1SU5PYK0 UH8T8-:T - [ $3ZD.?X8_55#5*7E2E*Y
MX:*N(:-M7$ 4XFJBB*+)^86S3RM>9G?P0-,KO?RX?2IH3=$)1/>RG\FV;"-S
M[EV/?Y3,?I59HFMTRC\K-)_YB[E<#MC@ @8=QQ&-%.G@4F>:M%:V\.,4+6G^
M*G,\][SCWJ)K/%,1$<%R&D[DDJE=R1XR.:P4VN(;L[U6:HK"V^<A)Y8&2W#Z
M[(V'E_\ &<$I*.JO#5,&9A+6C8;5N&+JRR? 8*:0CWI\DW].B^_=W$L__K23
MRXQO^ZVBGAP@Z?%7B-M&.2VC!INACP][E$^:=(7;&R.Q+ P'<<7;=]% K\G9
MM_8IB)YFJ;EI^U31-$:*:%$:=BDTXH*4:)J;.U*)*?9^_8I\T3/V)P,#6@X;
M<1L169\7$/42(VM_#<B@9>6H-=@\VW/EO^CE*ZYWF)QYHOY71]L.\_2MWSMM
M=BGCCN^R[6/MJX$SB]IS8\<>)QHNK9\OC+T?:;?A+BS-\P^^TNV\P-3M&Q:%
MV6LN>P[?G#NST+U.W4_3O+"^3S+W3\TVGKVIYG@6@$EA))O\<#F4.^A7HOT_
MNOS?;;*S6['6R?5PGV4>&?6_;)[9]0Y:12S<1&6W_>TNB/1=$^US&UG$ #CO
M!'%<SZ'4E4-&_#X?2I16B<,/N^L=Z5A%4_*!NX5W''NV**B>-[H9&2L-'QN;
M(SAS,=SL)KVI6>)-M;:7<)T?)3ZTM".Z7>L#K=IZ.'Y;+,WU8[7.11@<K#E&
MMX6Y_"Z,X @323M-/Q-(W+RWZBV\8=_EMB-)GJCT7:OM;]-^Y_\ =?H[M^XF
M:WX\?RK_ /%BGHU]41ZFCZ=O))XQ%;$8'EDG/B$8WAHWN71=WCMMGKR>J/%Z
M3BR79)G'A]=WAZ/&7(4$3(H@UF\\SG.-7/?O<\[R5Q-]TW75EO8\=N.VEO\
MM\Y6MS(01#'C*['L8S89'?8KV16.J[@KDOF)Z+/BG[(\7>G].[7UQI3KU)I$
MSEMAU/TO?:?<QSB&#/<G=_6\FN&LV<_*RYC!.YU!M7=_H+>_E^^3MKI]W<63
M;3^];[UOXP\;_7'L_P"?^BX[C;%<FPS67UY_+R?T\GJUMGU/="!GF.,@^[+=
M-A8>$-L*5QXG:O:*Q#X]C664N&%\8A'WIB&O(VB,G'XK'75E\H9%C T-8!1K
M0 !2@  H**&2WC1""CS)+N<_E;_@9@/B5,Z,D:ZK@"JK5;T)N0<W-05H!7LW
M45)E>&KR-=<YC/"TU^8O(K=W 06H$CP*<3O5JT@C69;,6@YC:L&R.&5X' _=
M_<J<M5YUF/)F&_&FY3R1/&JXY?I6*K)$Z(@>W#L5)2C2B4\2I1)M$-RQ3">2
M4C[568E'!*0?<D>";5!S:$\/;!3719:2 &O>>/O5;O->)T8^78?;!5G75?\
MB6+QAL]_#X*(XIE9NKS>_M5XX$QX->8_RLNOY,:M=>/[:\W K)SACK2R?6P^
M8-=%EPB%.<FU=B ?$6EYPWXG<K6S66.^*6:-I@/+%;M!_P N(' # -&"IQE:
M[2DRU?4]P^22#*8W^6;R1LUP[;R6T3"78<7'#N6?#%)ZO!JYKI^&.?W/6_\
M2^T/;Y'H?5FIS:-BN]29M.]DSV#S186;VV-K$Q]/N.='+(0#CS#@O5?I;#\O
M93DN^*^:^J-(]GXO#OK?<SF[E\FNF.(CU\9^^(]3U37:'21 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$'_T/OX0$! 0$! 0$! 0$!
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M8,SQNA82*_X\ K4E2;H6;[Z<_==#;8['N=<2>^-E1W8J:0K7EP^U1/F38O\
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M" @(" @(" @(" @(" @(" @(" @(" @(" @("#__T?OX0$! 0$! 0$! 0$!
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M8SXGC#"1XV<:!>/;V(LB9MUGQ_=#Z_P6Y,G^9-+?".,^G^QS7;!OEM:T-:T
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MR:@Y#DO2SIWK+J!F4;W^7\S;:1T_<9X^SC=M,D_D"&-K?$Y[FM:"2 @^'/\
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M:]Q=X8KI^Q]3<;&QL9&T4;&QK&C@UHY0%[.^=$Z @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @("#_]/[^$! 0$! 0$! 0$! 0$! 0$!
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M,):*5)A.&X#;Q6.Z=44U7$<=<:4^KO*P77+=,JX9B"X##9W[E6%IB*4E6 -
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M^G]TQL]UB_OV7>VVGX/F+]>\/_TKVS=<YPY;/^')%W_Q/6=^#:#:Z@;PYCQ
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M]D3/X/J#7L;YX$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MZ$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$'__5^_A 0$!
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M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0?_UOOX0$! 0$! 0$! 0$! 0$! 0$!
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MEO"[<YYCUY;I<SKD7"" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M?D'2?S[NXEW%K7>4RF_PM4:<DTF>,JT=C:1T+8&<W\3@7NXXERB2D+P- V
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M;;9]L0^:=W;T;K+9X7W1[)EGUF:X@(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @("#_]?[^$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$!!\9W_ ">/3C_0^IO03U3Y-8<ECKW3F8]']<7,$?)"S4VC9GZBT;>7
MCZ>*XOLNO+^W::_RLM:*8"H?1!^E+ZCAZHO01Z>NH][?B_U7E.CX.FNOGOD\
MR\_WGTT=_M#,K[,=M)LRAMK;-R!^"[8:"M 'HB@(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M"#R*_78TI;ZK_2W]3@GA;*[35AH'6-OS-!=%/IWJ7E%V)HR0:%K>:I'X>8;"
M5U3ZWP1N/I?=XY_EMFO.*7VS6/#A2?*9CF]/_1S=7;;]1.WQ$S$9;K[)II-)
MLNG[9B*^,:<WP@="LW%CJC)9N8-;<-B80<0XN(-"%\N[&Z,'<YB^><_:_3+L
MNXF-Q;,_M3Q>G-XQMWE=[$*.;=9;>PT(P(N+-\>S_J7=.5'?+J7XY\)B?MA\
MZ.O<L=D^K,\L7-<WRLQN"P.(KY<KO-9L[S@L?%X;O<?R=U?9/BTT]_;MQ5K8
MF6K5*TTJ33WG$K),<(0@34[_ ';E-**SI"<=AJJJHU]_MO60X'MW=B(0.ZO&
MJF#S3"@V\*>](XG#BJ-&-=VP5[U,E%RP85J</@J+UE6!4+VS"NVM/;93>DK5
MU7<>[LQ6*>++;JO0:TX]FQ4F%E6/;CQW[A15G5,+GS*4:P5<?MWJO36:RMU3
MPCBN(QR[=I&)[>"B=8T7MBBX '?VK&M'%5::8;B46F$Y>T;_ &XI24=41Q1-
MRQH&TX?2HC',RK.6V%(W4KOY41)W$@T[%FC%;'Q2Q79KI^"%1D-U+_,?R XG
M;LHJW7X[?ABI;CSW_%-%86,9QD<]V&\X%5^;/+1>-M9QNF97$=K RG+&WWC%
M5F^Z[C*8QXXTB%SY8 \+1[@-V]8KI\96FV(X#6$=M.S%*UU6HJ-96F&/V+'=
M<K,375<"+&M,/M6.;^1TZ:KR*/ D\-XK4]BQ3*T6KN./';3# =W%8K[HHR1%
M%?D;RDFI("PS=-5J12LJ;F@8<5,375&E*+=XH,&T^G!9(GQ8KO!8RBH(.['L
M!X+)9.K#=&C'NP/?BMF.#!.BU<:DE7I2&.=5L_#$>WP5H4JMB:E65C13)I[;
ME,0BO)(XJ>!$)-JM6#CH%1**43M))]V/[ECG@O6LN^OZ?L)=U2UC<#_*T/Y)
M&W"?-HR#WU:MSML5S7>AS_88_JY:?RQ_U/7-I!:*<%S;L;S*]5>6R777'+XH
M6>9+FNF=-6T3*T$DIOYK8,KVD@+H_P!2Q-_<,=D<;K8^V9AQ.[NBS-?ENFD6
MV5]D2_2ZTG8#*M*Z:RMMJ+%N6Z?R:P;9#99BSRZ.W%J/_6?+R>Y?7."SY>"R
MRE*6Q%/"D<'Y.;O)\[=Y<LSU=5]TU\:S,U];8%E:X@(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @^+O_DZ>HX:DZP]#/2YDM_YF7],M*W_ %2UM;P25B=JW7TO])TQ
M87T9V3V&56,UU'0?RLSVFM&A](OZ77IR_P#;6?0CZ=^E=[8?T_54FB;77>OH
MI(_+O&:YZBR.UGJ"QOS0<TN7OO&94'?]NU8!@ @[_H" @(" @(" @(" @("
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M'__0^_A 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0>8_ZPGIL_\
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M6<\-U:7<$5S:W5O*R:WN;>>,2P3P31DM>Q[2'-<TD$$$&B"N@(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M @(" @(" @(" @(" @(/_]+[^$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M @(" @(" @(" @(" @(" @(/_]/[^$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MD$!F'EF'_<%WE<<5FX4-E;S,:SDC( ?H(H" @(" @(" @(" @(" @(" @("
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M80%M?.LKF, [W.A('TJ]FE\3YE\5LF/*7JE^DOGTEYT1U[IN1S"=/=2+BZC
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M3INNM\])F*/T_P"TY[;[,66S7YEEE\>$1=;%T3,^B>/-V#8X2VP=+-S%T(<
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M! 0$! 0$! 0$! 0$! 0$!!__U?OX0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M=^]SAL:"NL_5^U_-=BR^..E__#.OV3+U']'.Z_\ :OK[:5^'<Q?@G_?BMO\
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M#2-^SAAQ6.<B8QKED%2*-[#A\2L-][)T^"^CAP&P[AO- L-UZT6Z+^.$ "I
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M2PT_IC*8LERBT!: "8[>&-I=05(KO0;@@(" @(" @(" @(" @(" @(" @("
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M#97XU9W>68_RI6K\RNR*G+G@' 5KMXX++&#'7XV&[=9__+6;\PN@"'64E-Q
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MV;=OTK2NS4<U@VU8X.)\[S\MBN*/V1R';P:2L4Y7*8=IK'I>ANFCSZ:TV_\
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MLI!@<,:>_'!1S6A@KP ^7%ODDQX^6P\[J_ *.2:UNIXL9=CG?;Q 8R3M<?\
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MLF.[%DNQ7Q2ZV9B?3$TEE5900$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$'_U_OX0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$'R-?\ )K])'F0=(?6EI7+/% Z+HIU:EM82289#<9[TTU%=MB% &O\
MZGEES<R[2_+X0<&-0>KOZ'7JZ'JI]"VA<NS_ #/Y[J9T!=!T7UT)YO,O[VPT
M]81NZ?:DG$A,CVWF2FV@EN9"3->6MXZM0:![$(" @(" @(" @(" @(" @("
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M*",'E8T .X2 @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M^'D7T2RQTV137TX(AGS&4P,V>>V%K8O,=V @A=1S3[U(=[P1I,NP0%* #
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M! 0$! 0$! 0?_]'[^$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M'Z?]ZQVQ6?R]\_\ #[WX/TB%]?OS,$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$'QN?\
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M=8K663[]K_Z'.M;/-+ZZM2,?.%F^Y8R@J>8C?5=9^LL/SOIK=71QQ1;EC_\
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M$UC31Z5+LCIP@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MB=96S]@W\-ZS6\6&_1828BF\G8L\0U[M6/F!',".('$+/;32C!?SJP]P*;L
M,3V\%LV-2^*PQ,U*%M,:D@[13@MNRO%@NK2C$RM())I2M%M1+7OAC9!0'#?2
MJSVRU[HI#'3"I.-,,.]9K)8+F/E%,.._]JV;-6&Z%B\G8.X^]7YL,Q5;O;7^
MQ3$T5GBH%74E;O=N[Z<"/VJ8@TB%$C '#A_:KQ/)%*I:44HF*(B%]R66T8K)
M<R16L8&TON)!"P?%P2E=$Q68H^C;IYIN7)--Y/8,B<!9:?R++6,'+2-F797'
M"\$T&/,';5M;G+=CMMMM\;8]+OV[OMPX\=E:1;;;'W0R.NI##H/6,K14QZ6S
M@@'_ .(G#%;V[FFSRS'\EWW,]OQ0\P_3-J*727J1Z!ZGBFCMWY#UKZ99L)YC
M2*%EGK2SGEDD.YH:#S$; O.NRY9V_>-KGC3IRXY_^Z0Z?]68(WWT]W+:S%8R
M;?/;3SG'=&C]0Q?:C\K1 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$'$/7[K5HWTY]%NIW7
M/J!=?+:1Z7:.SG5N;!LC(KB_.6VQ=E^29>9/"Z[S"Z,%C9L/WYYHV;7(/A _
M3/Z*ZQ_5%_4[O^KO6.V_KVF,IUEFOJ0ZW231OFR:>*TSQMSH_I["VXJSY2[S
M%UCEL5B7 C*[>Y$8Y8* /T'4! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0?*7ZJ=12=1>ON<Q1O\V'/==YWF$?(
MXN;\C/G+K6QQX-M8F@=B\KW>7YV[S[C^:ZZGHK-/LH]PV&W_ "^QV^UI\-EM
M?32)G[:N1H(P(HN1M&Q-;;M%*49&T-9\  N.CCJY7EHSL+:M:=^P=X1CF>2]
M$>' [OWJ\:*3"0MI4<>':K(X*!%$A:?%3):VKG%K6M%7.<0&AHVDD\%;C-$<
MF)DO)KMYCRYOA!H^]E:1$P;#Y(_$5;AI**U^%5MK&*V>)GDW%R2"^YE\3SC^
M '[HX445FBW31TSZAS?*ZEU!;UIY.;7K:=CI/,K]*ZIOIZ<U\><O4^QQ\W9X
M;XYV6_N<*9G>!P?0[032JZMO+WH/;\7!PSJFZ'(_Q'8=A&[C5<-=DU=KVV'1
MU@U7F/(Z4%U34X;<3QQP6;'<Y&W%-'MGZ+IC<>F+I;*X\U;3/6@_W6:CNFMQ
M7IO9->U8I\I^^7S)]?V]/U?O8\[/^BUO7J/OSE7IYZWY@TAK[;IKJ,QD_P#<
MFA;;M'OYUG[E=%G;L]WA9<X[Z4Q?.^I^WXHYY[/OK^#P+TM>M;Y(<XR%H8WF
M?0C  >$5P7E]^:8TC1]19-K%TS==K/G^#G[(\V+6,\5  .P4X*+,NKC-QMM'
M:?TYYB;[JUI&VYB[E=FLSA6M&P91,\./OHNR=DOZM]CCTS]DO/\ ZTQ?*[#N
M+_\ #'MOAZ=!J[N\1JF 2B8341,1XHT4+4HFH?;N1-83!B(K/).&H4GF\Z_5
M8 [UH_I@QR5$!]1-R]QH"/F(]6:+-H"21M=7?[C2B[;],_\ R^[]%OW7NB_6
M7_S>P_Q7_?C?2>&E;M7'UHCR_6HJBJ-$5U*(41 5H*414I$'$OJ T9;=1O3_
M ->= 7EJZ]MM9=&.IV0&T9S^9/=76C;R3+&Q^7XBX73('M:W%Q'+O6GW+!;N
MNW;C:W16,F+);3QK9-/MHY/L>\N[?WS8[^R[IG#N,-]?"+<EO5/_  U?G6^J
MBWGN<[Z0:JF#C-JCHIH[YV<- $^9Y"U^47GF#^.K02-H!IN7B&WOF_:8LEVL
MW66^VE)^Y^C_ -41&3=X-U9PRX;)]DS'W.#\E<1R>.@V$!C&UK0XE<?NXX_O
M<?M*QS^R'?7TW9]=6.B.ITN5QLNM0Z"S#0W6/3EDX%[ILXZ?9Y%G]ERQ-\5#
M-9QQN+:'Q4J*K7VUU]FUSW8XK?BFS+;Z<<Q=^#LN/;8NY=HWG:\L^[FQ76SZ
M+K9MF?9,OOQT'U*TIU)Z=Z*ZXVV:6$>A-<Z#RCK!<YY)>6_]+R_2^89$S46;
MW=[F)(B9%8CSX[F1S@UCHGU."^C-MO,.\VF/N-DQ\O)9;DK72+9CJF9GRUB?
M0_,3?]LW?;>Y9NQW63\_!ENP=-)ZIOB[HMB+>-;M)B.,Q,/CLUCU^SJ/IYZI
MO5%DF;2V6=]4^K_5#6>A+V5HG@EM]4ZN9DNC+F2VN*B5OR\44T<;JB@K2@HO
M ^Y]O[;]28\^X[OM[-SAORY<ED7Q,TFZ[IMNMFL3'NQKKPE^B/:>S8NS?16P
M[5N<=MWY3!9;2Z*Q%](MGP_BZJ^+QAU+JO6&M\WFS[66J,\U5G5Q-)/+FN?Y
MA<9C=.FE-9# V=Q9",:!D3&AHP  %%@VNRV.PP1MMCALPXXBD6V6Q;%(X5IQ
M]==7$39..WIPQ%L>41"2U=<<K1YK7'_MNF+#PP#FXGN*PYHLKP^Q:R<M?BKY
M5I][OS^GGK2VTAULU"+^2>WN,[T'FEADK(SS,O,ZMY?F;6TD+:5JWF>/\)7!
M]U[?=W3'AV.&(NZL^&Z?&++;OZET>BR9K'./0S7]OR]UVE^PZ8GJOPW37E;;
MDB;YB?'HKISB7U7?I0Z9A9TLZU=2G-:^XUGUEN-$V$YC(F_HW23(+?*KEWGT
MI)%/F=_>R,+26AS7#[P*]Q^B;++]GN=_$?YF6<=O^##%/9-TW>Q\Y?ZAN[?G
M_K/;=NLTLV6UMBG+JRWW7SIRF(B(GRH]3UW1X.MP.>Y)W1, '8YVWZ%;DF%R
M JK+:Y%1"/\ U<PGW*8)7)_L[%"4*#W^W%$A'Q]L D$)5*P-O[$1+PH_6(\/
M73],>2/&X'J/O8V#_P!UI-3Z.%V:X;&@85]Q6>/_ -V[S_[5?_TW-"[_ /?7
M;:?_ )1C_P"NQW%8*[]GT[R5YSPA[',\E2G#L'T*DJH$?N[3VJDK)F@5XX=G
MU*%>$IG;Q4[%5>)TFJV=O._'W*ET5E>)4"JRLIN'[N]4*L/(?,O7;"VWBIM_
MS9C]%&_6K4DF?>HL;D<]Q;1;0TNN'BF%&#ECJ?\ $<%6==5KN-![:GV"'-A+
M%M;1N _F3X#8#YI4SQ1'"J6XHR.5YV-C>XTVX-*6E:,'8Q>6Z5F%7P6TIPQ)
M<T[5EN^Y%L+F1JK"9:YG@/RAB;]ZYFB@'<]_B^A9;..K%=.E%G=VS)H)+7\/
MEB-O80VC'>X@)SJF8B8HUO*9#+E[6OIYL$T\,W8YDA!-#N(4W1[U5+)TK[6M
M: U_GOILZW:7ZF:;+_Z?'F+9KJTYWLMKVPG<8LVR>X,?X'Q/D9Q#'DC$ KF-
MAO,F')9N,7QXYKZ8YQ/E,:.![KL,.ZQ9-IGC^GFBE?Y9XQ,>=LTF/8^J;IMU
M$TQU6T3D&O='W\=_D>H+&*ZA+7L=-9W'+RW>6WS&$\D]O)S12LK]X5!+2"?5
MMINL.]V]NYP36VZ/7$\XGSB=)>%;_99^W;N_9[F*763ZICE='C$QK#>5LM,0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!__]/[^$! 0$!
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MP1QNQW4]-)F/M=E^CM]';/JOMV^NFD8]QBF?\,WQ%WV3+\N'I'?&?*)+:O\
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M,[LNVX<D)K7#<5:V*S#-MK9OW%EGC=#Z4M*63+VWOGB-OERSS,8* LY"VGA
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M5>86^GM47AQKRB++VQ5W_P#<7;?IN>ON-L1RMNG['FOZB6?+^FLL\*Y,<?\
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M2)MNMF8F)XQ,:3$^<+M65$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$!!_]3[^$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M;C1 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$!!Q3USZR:*]/71[J1UNZB7W]/T9TQTCG&KL\E:
MZ-MQ<PY7:F2VRK+FRD"2\OIS%964-:R3RQQC%P0?!=Z!>C^MOU;/U0,TZH=8
M[,YQI!VL+[K[UQ9()+G)H-)9+F446D>E\#[@ .M+J5N6Z?@MR\2#+8IY&5-N
MXH/T)FM:UH:T!K6@-:UH :UH%  !L 010$! 0$! 0$! 0$! 0$! 0$! 0$!
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M" @(" @(" @("#__U?OX0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$'PE?KX>D7/?27ZQ]-^K7I(V]TSI+KMG[.H-AG61AUJ_1'J!TI>
MPYOJ26UGA!\B7,)1;:BM)'N#I+I]_P"6T,MT'UP?I[>KO(O6]Z3^EW7G+GV<
M&I,TRS_;O4W([-P#=-]3]-QLLM7Y6( 28H9I2S,;!CSS&RN;9[L7%!W50$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MO6C MM8N;;MEE_8VJ<M4PM+TDQ>6-L\C81OP>?%L[$YLD_#3Q5Z   ;  !W
M4"J2I.'UHGDQ,#?+O;^*@HYT-PWN?'RNPX5"O.L0K;QE1G;SW]NR@I'!/,=N
M!<?+::?%*:'\4>2A<-_U%H[^_(PTWAT=:?0A/&)A;W,@AMIIW;(HWN/> >4
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M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(/_6^_A 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0=)/U#_2!D7KB])_4WH1F#;.
MWU/?6 U/TNSV\ #--]4--Q276D\R=,03'!<.=+EE^]K2[Y*ZN0T<Q! ?))^@
MMZP,^](GK#U)Z2.L#KW2^CNN>I'=/LRR7/7.M7:#]06F+V7)-.MNX)B1!)F,
MS9].7L;&ATER^P,CA';(/NV0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!\:O\ RM^E%S8Y[Z+_
M %$6$$8CCN=>='L[NW1X-FD?:ZRTO#/+3>T9PZ,$[GFB\P_4G9QEVV+<3&DQ
M?9/_ %1_\3Z?_P!.7=.C+W#M4SK7%FMB?79?/_0^:>VNW0.M;^-S0Z)UO<AS
M35IY:.)!&T+YLMN^3EB^?X9_%]G6W3%+Z\*35Z!7LT&J>GV5YS;$2399;VQD
M((/.PQAMQ]!K3L7HV.[YF&W+&M8=TK;N=E;FB=;>+R7]4>3?(Z[;?L8YL>;Y
M;:76T<AEMG/LY7BG$<A6_MY]ST/+_JC#\O?Q?'\<1/LT=9@ ._?M6:9JZXJM
M%""1AAQ/O4\J)A75%E3G [>S%5B)J5\50%SB*[#L:/M4TB."8\US3E9CA7"@
MI4X;52*3*^M%S$T-:   =I[:JETUEEQVQ:OHG@#Q$X;S0#N"Q3;[VC+$Q&LJ
M\=92*U# =^%56[W>'%,5R:SP9)G@H  M>:S+9MTBD,A$X8?2J2RV^+)131L^
M\X#LWK#=;,QHSQ?;;$=3(13S2T$3:-I3G=4;J&BU[K++-;IU\%XR9,G^5&GB
MS%I:!Q#IWN></"#X:[MJULF33W-&SCP1,UR35M=JR-@ :QH&%0!0A<;DK=-9
MER6.VVV*1%&>M\:$' [EJ7:5AN6TG5G;<B@PW[?J6CD;-K+0G94[Z?0M6[71
MGMGQ9*-S1AO[%CNB631>,V>_VJL-W%,>2NWZJ#O6.66*<%QS;Q3N/[%2%*>)
MW[3BJDZIP!M(W?97!58YB4A=&VI,C&88@N:-O&JM$73RJK,VQK,Q#'S7-N ?
MSH@:_BD;CW8K8LLO\):]^7%3XH]K'2WMHT5^9B%?[X^%5L6X[YY2UKL^'G='
MM8J:^M <;B,=SL*K9QXLG\LM>_<8.5T,5<7EH3X;B(UW<U%M6X\G\K6NW&'^
M:&-?<6Q+@)V&N%.88%9[;+]-&"[)CK\4,?,]A! >UQQI1P.'%;-D35BNNLGA
M+&R4IVU6>U@NI+&SM!K[ZK/9,M>Z(XL7+V=RVK&O=,5T6+Q0GA^U9:U8=5F[
MN.W[5:.*NO);/P[MOO62U7AQ6SB"3V*RM9X0HDJT*73R4W$!KGEW*&@N<3N
MQ)<K(\GU?_IP=-7=/O1QTNCGM?E\UUZW-^HV8\S2R<G5%[S9:)0<3RV<4/*:
MD4.% 5Y?]2[OYW=[XB=,<1;[-9^UYC]2[R<_=;[+9TQQ%OXS]KN?K8?(Z+S4
M.<&EUE+@<7.YQR@4XTWK2[)6_N^*(:'8(G+WK#%*TNC['E9UBG;#TRZCRC%@
MTIG0:3]X!T'(TFN^I7MN]GH[9EKRQS]SZ@Q:8XKX/&3*S$VZL3([DC;<VKI'
M5KRL$C7.=[A5>78N5UW"OXN-R1/3=TZUB?;1^G%Z,KC+[KTK=!YLJ=SY>>G&
MGVVK]O/'';\G/4\2"5]F_3TVW=CVLV\/EVOR[^M;<EOU9W",OQ?.OK[79I<R
MZN(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @X#]4?J&T5Z4O3_ -4_4#K^5HT[TTTK>YW\@)V6
MUSJ#.Y"VPTQI7+Y9 0+G-<QFM<OMR06A\S7.HT.(#X8OTP_3OK;]4S]1K/NL
MG6^)VI=&:<U;<=?^O=[<0/?DV;WMWG3KK1O36&*4O8RUS&]C9:1V)< W*;.[
MCB(\I@0?H,@4P& &  W(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(/G@_5&U4[5GJ.T]H:"820Z5TWD%A-"P@
MM;>YS._-9.:GXO*N65KN 70/J++U]RFWECMB/7-;OQAZG](X/E]HB^8_S;[K
MO5%+8_Z9<86,38HHX6@!D<;(F-&%&Q-#&BGN75XXU=SF*11EHWQQP/=(X,;"
M"2YV%.4UVGZ%>(FM&*9UF9486OS5U9 Z++]L41\+[LC'F?\ W> 5HCI8^/H9
MV  -Y   S -   &RE$*Z4A7I11%:DJ1W^_VQ5R&/NKNWM*>:\F0X-A8.>9YW
M ,'UE3$25B-98\QYA>BLA.7VI.$<9YKJ05V/?^'#@K12->**77S7A"[@L[>U
M\,$883]YY\4CCO+I#B4G764QQ=5O6GE#KSHF<XB873:5U9DN8EP'\NSS-LF3
M7KR>%98A[UUSZJQ]?:OF_P#EWVSZITG\'HOZ7[F,7U1^6F=-QAOM],VTOM^Z
M7CS+G;(Y*.>2ZIHP8G90&@W+R?<Q-W!]0[>VVRD3Q\(XK6[S/SX#4<N!P+@<
M:8!P7"9(I=Q<[@MFFL4< :WM_/$Q;0UYR=].XK8P9*4JV>B)=;<PRUXN2"W\
M> IV\5REN>*:)^6W'3>7N8YAY:XBGNW'#8M/-FKHF,<<'-N4@1,;3W#9OQ6C
M-_5*M]FC;H[BC=NZO[UFQ3K#C\V/F]3?TS+$RNZU9R6X-.B\G8X[B?G+^9M?
M_<97IGT5;[FXR?X(^^7SY^M.2(N[=MX_]:^?^2V/Q>J@9]?U+O%?!X?I"?E'
MML[T35-3L]@I0B >_P!MJ%$_+^PCW=B)T3!H[^'<@FIM1"A=6L5[;7%I<113
MP7,,D$T$S1)#+%*PQOCE8<"QP)#@<"$B9B:VZ3'!$VQ=$VW16)TGT<W5S]&#
M4TO3K-/5GZ-,ZGE9?=&NK-SK714%[(77-YH75[1E7G6C2:B&/Y++[U]0/'F(
M.)<0/1-SDC<X,.]MX9+8KZ?#[X]3R?:8KMGN=QVZ_CBOFGG%:1/KTGUO=E:3
M?$!3$"*M *001 ]A]JA%7RS?\AW15VW6V@]6VK&-@UWZ5=?:8NFL'YM]G'2/
MJ=9:UM99@,2Z&RS3EB=_"'-'W2O._K'#T=WV6ZCADQY,<_[LQ?'WOJ7_ $][
MZ[+].]_[/&O3\O-$>J(FG_!67R/64W/0@U:[Q-[B*@U7 WVZ5>J8[NJ6\Y7%
MYA;V[#AL6AFNZ8<I@LK+D_*<M9*6@.I2E:,?(YS_ .%H:#LWU[EPNXW4V16C
ME\6*V[W:_96O[<W(N79# TU<+D4 Q=$8P>T%X!^ 7![GN%\Q2)CVM_'MK.?5
M[*+7/8HH8G-8Z8 5:.=H(&&VM%?9WW7W5NHTMW;;;;2*^O5Q+>@<[G>$XG$
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M_P"]\BLH_+U0+9G+RV^>V;H,TC+&"-DTEQ;,+C;/H'I<@(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M!>(YIG)Y>3[6VV*,7.L^/BMFYYS^'FX[#4T&W:N,R8N;E,<L!FM+F-SMM3@
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M_#=&MEWHG\)I,<X<NK><6(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MO_1%]0&H;^34&G[>\EE ;.;"X=)J+,"PGEE98QRL,5V@^[U 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!Q[U:
MU@SI]TOZA:W?*R!VEM':BSNW>\$M^=L<KEFL(Z#$E\XC8!Q*P;K+&#;9,T_P
MVS/LAM;+!.YWF+;Q_'=;'MG7['RM=-+8W%[F.;W3BY]PZ=SII27O(#O,FD>]
MW%[S4[Z+R7+.GF]VQ1$2Y@L _-' R<S;&V>0QAVW;VGPR/\ [@W+'6GK6UNU
MG@W6,<H80*<I& P :12E HA$SS7A;45 -17WC>%DY*W+*;,/%'#9L^9NFBC@
M#^5#3?-(/J4Q'BQS/@NHLNYG"YOI/FIP*L:12WBKB R,[>PE1$ZTA,Q/-?$;
M/;#8ICX4QI%4A%:\-BE-O"J0C  >W>GDM'C*'+4]V"NK&BX@(9(Q[FA[6N!<
MP['LKXV.[",%-:3KJB8K$\GS*>IW1<O3#K/U+T=Y9AL\OU1?WN2^'E;)D.=O
M_K63R1M%*-$,P8T#9RTV@KQ?NNSG9]SS[:FEMTS'^&[6WU4E]J_1W=([U]-;
M+N5:W7XK8O\ _MED=%_KZK:SZ77.WS,M=S/DY0"*GO._CW+B,F*NEL.V6WQ9
M'5=-(;3:R37K0T$Q1%VTC\Y]=G8U<;FBW'-9UG[&QCNR9*4]VWQYS^YLMGDU
MO$SG$8+CXBYPYG$D4Q*XK-FOF:3P<GAQV636(]?&6/N[,1N=@0*]V V+4B_7
MS<A-M8K"S,<; "&M[R <=N];./)=,ZRTLN.WP2NE %!AV 8\#[!;V*[A5QV6
MR/![[_IT9/\ TSTMY#=N:.;46N-=Y[S$5,D3LQBRJ+'>&_*N ]Z]H^C[.CL5
MEW\]]]WVQ'X/D;]7MQ&;ZWRXX_\ "PX;/7TS=/\ U0[S4X#VW+M#S3BC2J5*
M)N7]Q-%"=$U.ZBF@4Q&'T=J4.*>A]J[TT*(\N ]]1N^*D3\O _57']JCTCK9
MZMNA5KZB.@VN>F_);C/+FP_K&C[N<-:VPU=DI^>R63SG5\J.9[3:7#P*B":4
M#:M[MF]GM^]LW,_#PN\[9X^SCZ8AQ7>NW1W3MN3:?Q3[UG^./A]OPS/A,NQG
MZ57JCNO4EZ8,GRC6,\[.L?0NYBZ3=5,NS$N;G$E[I^ VFG-1YA!+^8'YA90A
MMS)(!S7MO>M HQ=SWF&,6;JLUMOUCU_M['G?;\TYL'1DTOL]VZ)XUC]O;$O2
MZFSZ5K0WIDI\.WN5JHDHE59E&BA%44$4HEY@?K"Z<ML^]"VN,SG>]LG3WJ1T
M5ZCV+6<OYMYDO4"WR8L<7; (,QN'@C&K:;UU7ZWQ]7TUFR<\5^+)_P .2/PF
M7JWZ);V[9?J9V^8X98RXY]%UG5]]D/S]>I.7#+.J74C+FBC;37>J(V@8#E?F
MTEQ_\'5=*FZMM7UAO\46=SW&/A3)?_U3/XHY-5KXB*5J* GEY1Q[EQ^XUB6?
M;:3#LEHD"5D;7W!H0VK&MHWN-,?I71>[^[,TC7S=S[;2ZV(ON]7)S,R"U9""
M9( :$CF$##LQQ?B2NIS?DNNI2?M_!S5]F&+*UM^R/O<6ZI9"><-\M]0YS2T-
M.'^)GT+LO;+KHXUAUCN%MG*D_MY-/Z>=+LYZS=3]$=*,@+67VO=26.0/NYW.
M%ME.5S$S9[G5W(*EL5I9,GG=@<6@;USW<.Z8.S=JS]VW/PX+)NI'&Z>%ML>=
MUTQ'DZAO<ENUQ7YYX6Q-(\9X1$>F7UX^F?+,IL_U.NAV@,I88\FZ3>C'JC_2
M((0(XK:PM+/(])9&96#8Z2-DA>VFT@KD/TDNR;G+LMWGBF3-CWF>ZG"MU]EF
ME>,1TTBO&M7C_P!>W78?T>NON^+==RMOF9XS'5=7V=/L>\M-FS[%[^^94:HE
M#"NSX=F^BE*7Z_J[$2@A5!$((A!!C<[SO*-,Y)G&H]09A:Y1D6097F&=YUFU
M]*V"RRS*<JM'WV8YA>3NP9%##&^21YP#6DI$3=-(XDS%EO5=I$?8^:WTK9AF
MWK ]5G77U]:KLKJ#2\F8W72[T_99F+'-?E>D,GC%@_,H87_RY19AC)G1DL==
MWF8C:U:OU%N8V^#'VO'.OQW_ (1[=?1%K>^CMG.[W>;ON:--<>*O_-='J]WP
MK==')ZE ]_[ETV8>BPG!]RK*\:JS,3W?3155G174%=4'&@/;@J\TK-Y^G#B=
MJHRVK<JD\5KF.E_-O!7[MK$7;</.FP&'$-"<(]*MLZZ\E&YE$<4L@VM80WM>
M?"VGO."I/%FC2$L$8BABC'X& 'M<<7'XE0M&D*J)2E1165O._P N&:0DCDCD
M=P^ZTTH2IB.2*TBK%9?4PVC#2K('2.K7[TCJUQ5^:D:Q"ZO7MAM;F9QHV*"5
MY[>5A( I]"1%29I$UX,#I^(LRBWD>/S;DON9"=I=*ZK:]P5KOBF%,<4M]*K?
MN#+6Y?6@$$IK_P!)'VIS7G@U.\@+\HL+8"CW<DA%,:Q,,H)JK1QF59CW(B5_
M#26V@DVAT;"0<<>6E:E.9QACLP8#\I%B3+=,!H*FC*NQ4Q752[6D*ES:LN89
M8)!X'M((W@[6N':#1+=-43#7K0.FN<PLKFOS-O;Q6[W&I,\1!Y)6UVC=59)C
M2)CFK9-9FV>,+2"!T^7P\F%Q:/?&QVP@PNH6$G<1@56=)IXK6Q6W1,TB9G-2
MCP>5\9&+7C:*'=P41I*8U:IJ?2>6:EM3%=Q^5=Q,<+6_B:TW$) J(W'\;#O8
M[W8K-CRW8Y]V=&/-ALS6TNC7Q<?Z4U]U+Z'YW:YKDV;9K8/RR[BN<KSW)[N:
M&>W#B/,@9< T=%(T<LUG< QO%6D$8+?P9;K,D9]M=..^.<:?M7V>+B-QAMOP
MW;7>V1EQ3RF*QZO"?MCE+WT]+'Z@.B.K]I8::Z@YAEFFM9N;!;V^;.?'8Y'G
MD[@V-C+J.9W^@NWN/\MWY#S_ "WM);$.[=K^HL>>FW[A3'DX1=PMN_=/EPGE
MX/->^_2&3:Q.\[37-AXS9QOL]7\5L>,:QSKQ>C8(< YI!:0""#4$'$$$+M#H
MZ* @(" @(" @(" @(" @(" @(" @(" @(" @(" @(/_1^_A 0$! 0$! 0$!
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M):OALX;:W)(A"#MV@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MM;FOH']3['2NB&4:(R+4 H XR2Y)K?+;^&W-=@D<WE)V@+KWU=;U?2^^M_\
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M" @__]+[^$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$&KZVT7I?J/H[573_6^2V6H]':VT]G&E=4Y!F,9EL<YR#/K"3+,VRVZ8"#R
M302O82T@BM000"@_/>U+E?5[]#O]3J"\RO\ JN<Z5TCG0S3)'RO^5AZR^F[6
MUVZ&XRVY?1L+KHVT4MI*]S#';9S8B9C7-@C+@_0/Z8=2M&=8^G>B>JO3O.K;
M46ANH6F<HU;I;.;4_EWV3YU9MO;1\D9\44S [RYX) 'Q2-?'(&O8X -Z0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @\2/URO7]_[9QZ7KGI[H'._D>O7J&M<WT=HV2RN.3,]&
MZ*$#;;7?4!IB(?#+%!.W+LKE#F/%W<"XB+ODY6@/,'_C?^@)TL^<^O?J9DE(
M8/ZUH7T[VF86_P#,G(?D_4#J9:AXV,'G:?R^5I-7',^9H+(7D/KU0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M?!65\E<-&"F3T.!O5)TUBZL^GOJMHPV[+C,7:8N]2:>;(SF\O4FDFG/\K>S
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M.M" @(" @(" @(" @(" @(" @(" @(" @(" @__3^_A 0$! 0$! 0$! 0$!
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MI-(2N(J.'&F/Q4Q53BIO#:"GUT&'8IBO-2Z/%:R4;C0X]F KVK+&K#=YL=,
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MCUW],1SF9?:+I7260=/])Z3Z?Z3B;!I70.E]/Z)TU"U@B#<BTKE,61Y6XQ@
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M" @(" @(" @(" @(" @(" @("#__U/OX0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M1?3C\P<\,T$4SK_-XZ-=\[.ZWDYQ90N >UR @(" @(" @(" @(" @(" @("
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MIX[<?ZJU?&0<>4\W<*++9L9O_P NZK6O[O9AG^O926-DUMEIJQMM>.=NI$:
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M @(" @(" @(" @(" @(" @__UOOX0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MM]TQN+)B/&-8]KL>MUQP@(" @(" @(" @(" @(" @("#_]?[^$! 0$! 0$!
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MU9WNN?3OFK'/L.M/2*Z#A]UG4+2+9 *U\<3[L/'O:%P]_P!(]VMGWMIEC_\
M!W_N=GP_J-]/7V^YW';S_P#A\<?9-S6<DS'H,>H6A)LUZO=*;++;?6VE[V^N
M[OJ%H^RL[6SLL\@NYKBYN[F[:R-C1&>9[W!H&)6WV_Z7[C&YQ5VN2(Z[:S\N
M[A$Q/AHTN\?7_8YV&>+=_@FZ<62(CYV/69MF(TZJSZ'O7JG]1[T):;DNILQ]
M5?1>Y8Q[R1IW6-AJ]Q )_E,TG\ZY_9R UW+V[\KN+ITLGV4^]\GQO]G9;%<M
MOMK]U75'77ZX?H+TH]UOIG4_4;JQ>U\N&SZ?=-\[@?<7!\+8()>H!R*-Y+L
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MZ3^Z?7'K>IG1K]2#HUU!9:Y?KIL_37/).2)]W?2_U+24UP:-+6YW;M$EJ2[
M,O8(^7>_>NT[;O.VS1$9/<F?7'M_>\_WOT[O=M,SB_J1'*E+O9S]4R] \JS;
M*L\L+?-,ES*PS?++M@DM<PRR\M[^RN(R*A\%U:N<QX[6N*Y>VZVZ.JV:QY.!
MNMNLNZ;XF)CE.DL@I5$! 0$! 0$! 0$! 0$'_]'[^$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0>$WZX7Z9P]9_1=O6?I/
MD;;CU*]$<DO9\HL[&W!O^J/3N![\SSCIZ\1CGFO[5[IK_(!XJSNN+1K:WWF1
M!Y>?\?']3-^DLZL?0+UTSYT.0Y]F-V_TYZBSJX=&,AU1>W#KK-.D-Y/<D!D&
M93.DNLD:XM++UTUF#(Z[M8X@^QQ 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MX%QBBK_VXSBX5XFJB?"&2WA-WBDE<UM7.-&M'.>QH%355HR5T:[E))L+Z?\
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MT<N+8:@@(" @(" @(" @(/_2^_A 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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ML>8WV6Y9<2NR_)XX@675TZ>[89HS9/8'TH?I+_ITY%^G[Z=[3*\]M<OO^O\
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M_9@I@NI5,,:_#W*88[D"-E*8[S3<I0ITK[Z?V4"CBO&D)J"M.SL^"B5)E*[
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MT5)(:5]A0C8*_4I3JLWQ[?ACO]RE-5JZ/ 4V=V([E'!+CG4UO)DUY%G$#/\
M23S11WD8!Y6R!]62$#?VE9+*71T\VOE]V>N.'-N;2R9C)HSS,D8UX=L%'BJH
MSUTK#'W5O)5MQ!07$5>-)F#$QN^PJ\3RE6;9G6WBQV4RMDDS"%HY>6Y\WRR:
M.C\X5<T@]JO,L5O&8AEVDAW(=HQ;VC=[T3Z5*YMK:\B,-U#'/$<>61@=0_W2
M<1[E,3X*76Q=I.K3+K1\44GG9=>363W#PM</F+?''E<#X@.PDA9K,UUDUM:>
M?98LMM)CU3K_ &PQD\>JLDN(,PLK>[AN;4M=#F^GI9I'Q/8:B3Y=CX[B$BE:
MP2MIN!*WL6]UK=I/C'[?<X#<]GNBOR_>B>4Z_MZX=F^F7ZB'J.Z71QVMYF7_
M *(^2VK6-.6:H%QG%U%%$WD;$;N0P9K  -G,Z5H[5S6W[SN\4:7?,B/'7^UU
M;>?3NQRW4NMG%=Y:?9\,_8[^])/U;^B>JI+;*NJ619UTUS5Y9%+F<#7:@TT)
M'.Y723N@:R]MF#^_;/ WN7+[?O\ MLGNYXFR?'C'[X]C@-U]*[S%6[;71DCP
MX3^Z?:]+]#=2NG_4S*HL[Z?:STWK'*Y8VR?-:?S:SS'RFOV-NH8'&2%W%DS&
MN&\+F<6;%FMZL-T71Y35US-ML^VNZ,]DV3YQ1NZRL(@(" @(" @(/__3^_A
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M;4:9L@TPPVX<W .\OG<>\E:>3\_E^*9]K>QQVG!_EVQ7T59R//<K:T!KB ,
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MI;37+#]VXB9\PP["Z*84>/\ I(*O;==;-;9F&&_'9EMI?;$^F&M:AZ=:7S\
MW.6.C<UM/FLOGC@S!CL27?GM='+N\+Z._OA;5FZKIGBOG&D_VN)S=LI[VTNZ
M?*=;?WQ[7"=MEVL^FFH/ZMTPUYGV1YM:2^9;S9??WVF<[!8>8#_3R^7.*BA#
M9'@\%M8[YLNZ]M?,3Z:3_:XS/AZK?E[W%$QZ.JW[M'>'I-^JWZD>F,EKD_5'
M*LKZHY/!Y<4L^=6[\CU4V)I'.^/.;$"*9]!@9X75K4E<OM^^[S![N>(OCSTG
MVNO;KZ8[=N:W[:9QSY:V^SB]5>C?ZH'ICZJ&UL,ZSN^Z7Z@GY6NR[6L4<.6F
M9U ([?/[0O@<"30.E$?;1<[M^][+/I=/1/G^]UG=_3?<MM6ZRV,MOC;Q]G%Z
M"Y1G63Z@L(<TR'-<MSK+;EH?;YAE5];9A93-(J#%=6CGL=@=SERUMUM\=5LU
MCR<#?9?CNZ;XF)CE.C)JRH@(" @(/__4^_A 0$! 0$! 0$! 0$! 0$! 0$!
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M8NBOBO(7/('*WWD_118[J5U9HFZ>$+^,T_F2@88!O#@L5T5X0O''W[E_!+;
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M9''&QK6,8QH:UH   ""Y0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M)N/?X1BE5;HT9-K: ^Y(G4CBF#?#]>/Q2L<R(UJE?@YKL:8 ]Q[TK6%HK13
M\4K?X>4CN4SR.,(Q4;)(-SC7LJ!V]BGJ\41Q7)'B!X@BH.P]RE>E)5F</?[N
M]$+AF_V^A2(OC;,TL=L.((VM/X7 I5$Q'-X%^KB^?>=>NJQ<[FF@U5)EG/M
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MMYLYIGLF(\>,>USLMIHB @(/_]7[^$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M@QIX46GEOF(I8W,6"OO99K/@W*S(:&AH:&D 4 H!W47$YN-9XN4Q4I2&SV9
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M*Z6RV2W<XET4\&7.=>7+34>&ZN'[!2BZ_N^];S<Z7Y*6SRMTCU\Y]<NW]O\
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MK__6^_A 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MMMMG2%_&-E<0L<Z0SVQ6%R)&Q@<Q H/CW!8Z3,Z+3=%FLRKQ^;=;*QQ#O!<
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MB(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MTF_ZL8G&G#C[E:)K"LZ357O#S"W9LYKEG=X37&JM"+N#( 5/OVU^Q16BU)5
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M;/N[FWUQ^YU+>_2MUM;]G=ZI_?\ O]K_U_OX0$! 0$! 0$! 0$! 0$! 0$!
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M;'-G]W"[DDG8RVB=)!:MGN ]PT! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$'7KJWZJN@/1".=O4+J5I_+LU@:ZFF\
MON1G>IY9 /#%_0\J\V>,G8'W#8V#>\#%:6X[CL]K7YV2*QRC6?9'XN3V?9^X
M[^D[?%/3/\4^[;[9I7U5>8/5/]7B[S">YR7H!TLNKV9QEA@U)KCS)'N)<61S
M6^F<E>>7<\.FO"-SH]ZZ_N?J6>&ULIYW?NC]_J=KV/T9$S$[W)-T_P MD?\
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MS!?BCC:__]#[^$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MKE-N]M;&V?\ ,/'SD\;;(/J50$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MV ;,=O:=^U52M,QJZ".W:?'=S,BH#CY8/-(:=RO;XHNFL=/BRH : UHP: T
M;FM%*I%4S14;\?VT5H5TJJ@4V4&!KNJK"J*#L&!.\4"D6.5>.*XN-KKF[D>#
M_=!Y6X]RR3X*6QI,LL!P/U*$J<[(W03-DH8C%)SUX!I-03LHIC34G@PFFBYE
MF;28_GQ2/F!.V6"5WY4@KMPP*F[6:L>.=*,AEHYOG93RTEO9??R>$$A)\EK9
MB*PR-/?V\:[ZJJR4MK3'$?6HE*DYGOW'LQ^M03YK=\0W@CNV5&^JK2">"U?&
M>%#M^E#1A+:/_59EALFCX<H')\4F-%8GWI6T$/+->Q4^[.' 84:)!78/>HF$
MQ/%B;Z(6]];7)9^3<CY&X_ZC^4]U>W!3'"B)FET7,-DL7EMS.T=4_+9C.& _
M>\J2CAL^M3=,3248^<>$LB^&M=W"@PK7 K',TUA>M%J^/;A[Z5[ZJM6.98N^
MM#-"]K/OM(EC.]LC=E#V[%,3$*2QTMLV]ABF83%<,;5D@P<R08.8:;B4ZJ3J
MBG5%8XK1\AGM[FVG;Y5U'#(2W#E>6L-)8>(5M*Z*S.E)2Y6>>QM^;[[6TD!%
M/$,=G;N28UT1;6;60IOH?A15K/"6.ZO IV>W!6BY24:=E>S<?<K]4*3%&+A+
MK;-[IFV.YMHYJ"N#F'E><. 5N,,=(B[U,\QP<*@@C9[^T**S"9M\%PQ^P<-F
M]6B6.87C']HVTP5E)C5<-<>WZU:+J:*3:I9A-Y5C=.!H3'Y;:;>:0\HP]ZRQ
MK,,5\4ME_]'[^$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MC-?<< %,<%58#XU/[:)*8\4CN':HBNJ8^)*/Q'>7']BLO'-:7-1)">!Y^W'
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MO%3+R?:GQHB\6PEYCW84PPKWHLZC^NZ\^4]*G4ZCN1UY)I*P'!PN-56I<RG
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M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M_7CZA_[G]48^S8I_I["RDQ73YN2EU_LMZ(]-7T=+OKPT0$! 0$! 0$! 0$!
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MI?&D2R9&.&S<IA$PH20N)$L)Y9&TP& < -A5J^*%Q;W DH'#DE;]^,[10_>
M.Y356>"_::4./$BN[MHK>2EUJU:\39NP5\-I:$X8CS9C0#X!6B9BW5AFVL^A
M_]/[^$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$!!YS_J2_IS]+_U#NC$NCM1?)Z7ZL:1AO\ ,>C_ %3;:>;>
MZ5SRXC!FR?.!"/-N<CS%T<<>8V@)(Y67$($\,9(?'/Z,_5]ZE_T6?5AJ_H]U
MGTMG_P#Z'\NH;7*^N'1^:<2P7EKRMCROJGTSNYG-MGWHM"RXL;N)[;?,[0MM
MYWM_(GM0^^;H_P!7^F_7OIMI+J[TCU9E>MNGNN,JBSC3NH<IE<^"YMWDQ3VU
MS!*&RVUU;2MDM[RSN&,FMYV20S,9(QS0')2 @(" @(" @(" @(" @(" @("
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MM)'/LSU%UW#;N$D.4VLK7MMK?F9+F%PPV\);''=7-L'RU_IK_IV=:/U7NO\
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MPP^M==OG5S]G!QUGC"/,%,"".&P8%;^VNUAARQ35WK_2NO\ Y7KWU.RPN_\
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M\+<5DF8G12(KK+__U/OX0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!Y8?JC?IA]./U$.E8$1RS1OJ$T+EM
MX[I1U.DMR&.!<Z[=H/6[K5KI;G([R4N(<&OEL)WFZMFO#KFVN@^2ST$^N_U$
M?H]>I+5W0OKMI75+>E;M5LRKK;T9S!S9,RTUF?+'##U,Z;ODD^5=>?*^3.Q\
M$WR><6/E RX6=W;A]\?2SJET^ZV=/=)]5>E>JLJUMT_UQE$&=Z9U-DLYFL<Q
ML9R6.!:\-DAGAD:^"ZM9V,F@F9)#,QDL;V-#?T! 0$! 0$! 0$! 0$! 0$!
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M>[BKDG_=C3_FH\&_6/O4=L^B-_EK[^YBW!;K_P"9-+O_ +G%S])E?03X+$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MS3(3PW=FSL":1Q2NF0;,.&Y347;(1AAVUI@HX(4;6#ES.\:!A)!!+CLJ#RX
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M8P.26-@\YE:EKW8N/':5>9U4B-'_U?OX0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MRX_&Y6B::PI='\*K/:'G%S;GRYVXD#[LK0-A:./:K1<B8J__UOOX0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MU_OX0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M8_J9]0__ %?^D=_W.V[IR763BQ_X\ON6S'^&LW?[K]/L         "@ &
M7T<_/9% 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MHQT#3,\2$_EQ.>_?1\\F(=_T-P':IE6(79 [Z]GQ&*C1?66'S::2.W;;P?\
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M#&>48_ *>$>E2=9KX,K^[VHH3Q3 5W]W?OJIJ*@_L4553T^/>:GM455KXHM
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MU6BBLP__T/OX0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MKD>F=+Z?LHLORC)LJLV<L%K9VL( &-7O>ZKWO+I'N<]SG$-N0$! 0$! 0$!
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MHZN<K3%>"GR4PX;.RFW!6K$HHE+=],:J?6K1_]'[^$! 0$! 0$! 0$! 0$!
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MTU5F-:H%HV[J [,=F!"A-%,M/#B/=N4GI4RP4V ?7VXE3$FC_]+[^$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MK?USZ+(F[\'G?ZN=SCMWT1W+/%W3,X9Q6S_>RS&.D>?O/TPU],OSN$! 0$!
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MGBD+#]-13=\%.B)M?__3^_A 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M5T'_ +?=Q2I26,@D(S2_&(#H+9V.\CPU_8ITI"(KU2K9DZZ-H]]F\LGA<V8
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MH:&BC&M#0!3[H%  .X*J4*=W;C[TI'!$E.^GMO5:*BK0***"*%$S1C3:I2G
MW;,:U[\,$0J# [*\*\>/Q1"J*[,=W>?BHCB*@W<#7?C7B%9$I_:O%%?0JCWX
M8G'@H1SJJ-H#7AN_>I%8'9OP(H-Y4BJ#]5>.&Q%9A:7\KFP>3%C-<O$$0%*^
M/[[J]@4QQJB9TI"^@C;!%'"S!L;6M&P$D"A)[U%>:(TB(7& W^^IKV(JG![/
MLQ"51Z4U2=_=P[,$\T>2>O[5"$:^V]#5 O#6ESL&M!<:X4:T5<G-#'Y?5[);
MI].:ZE<]O9$WPL:K3X*6UXRR!.'L>]56XZ%>['V^"')#F[=N'VJ*IHE%&CE&
M'P%*[RE4Q"!>-N/=V;U44W/Q._CO/8D+>A*78G97$[,%$KQ"0N[?AB?>BT*1
M=V5W8?4ICR2QK'!U]=.K@R&*/#;4^(FI^@*>1$>\A=5I#(*UCE8['8 ?":T^
M*A,JI_;2M:"O:5'DGTJ+N.(VUV J$PHN&.ZFS@!V)*8AB[9A+[V9P =+<$-/
M]R,4 I].U/ MCBK. [J\>/"JE*@1[=O!5**)'M]JE$PI.;CL_:H)2$<:;^\8
M=BA%/!__U/OX0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$%"YMK:]MKBSO+>"[M+N"6VNK6Y
MBCGMKFVGC,4]O<02@M>Q[26O8X$$$@BB#Y(?U6_T"VR_[D]17H-TV&3?ZO/-
M=^FO*XP&2'&YO\YZ+0C[KOO2/TSL/B;EA!\G+R'!/Z6GZ[FKN@UUDOIL]<EY
MJ'4O3+*[F/36FNKV96^89CU!Z4&TE^0&0Z_LI&NO,VRBU<WD$W*[,;%K71\M
MW"(H;8/L]TMJK3.N-.9)K#1FH,FU7I34N6VF<Z>U)I[,K3.,CSO*;Z(3V>8Y
M5FE@^2&>&5A#F21O+2-A09Y 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MH:]NWVWI6*IB.42R<-S?1_>;!.T4Q83&_P#\)5HFWT)I=5EX,Q8:-E:^%_\
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M;+O0D4#A0\71$KVCZ+FFQS6S_/$^VU\O_K-$3WK8Y(_\B^)]669_%Z^+N+R
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M%OMWH/_5^_A 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MG]0=WS]_[YN^];B??W6;)EGRZ[IF(]$1,1'E#EA;[B! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!X;?J?_K6](?1%:YUTGZ2').L
M'J@,$MK)IR*[=<Z(Z57$C*17O4K,,ND:^2]9421Z?M96W+@*W4MG&^%TP?-+
MZ4/0GZUOUF>M^;]>NL>L=26G3B^SCR=>^H#65HZ2TEM[&<\VA>D.G (+:YEM
M@YT4-G8-AR[+FDF9S)#';W ?<;Z5/2-T(]&/2S+NDG071EMIG(+?R;G/,XN/
M+O=6ZVSQD(AGU+K74'(R2^O9,:$AL,+"(;:&"!K(FAV60$! 0$! 0$! 0$!
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M>3S"@6//$WX;[/&VZ/;$K[:_Y6ZPY)_AR63[+XE\F%I&(W,:!]U[H^T^6\L
MK[E\UW1[E)?>=DQUQ=XMSAB;Y;9)'<Y ^\_!K !6C6[,.*XZ;IB9MMT<KCMC
MIZK]?3R]"F^\8'%K#SD5\1=RL'OVGW!1&.>>BEV;'$TMU^Y0>9IF.J\M&/\
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MV/V*#S2'&G?3#L'!$>:2G[T$"/;]B%'_UOOX0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M@S9YO,LZ;SZ@ZN7T$C&R0&;0N4ON\A>Z-P(\&:R6#FDTH:&M1CWO].MG;O\
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MB'-P_LQ1-(0+N[LPWJ$<(2DE!"OMM4\@]O>@_]?[^$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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ME@G6TMU>64M]XI.<W$=M]Z.VBC^[A_%6E25>M(T5I,S$W-JLP#F&7EV#?G(
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MB@BK(?_0^_A 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M 1$'#DA& <*UYIJ;>[8O-]UDBWAQ\?W/>-ICG)$3DX<H_>W'*VT#:&@!%-E
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M[U(UJ[U@UMB;M(CQ7DDEL:<TAF=A@.9XPQ&#<%BZ<E-(HSS=CF*3-?M2 L-
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M*)JB#A[?4A5/NV';CM-!O4I5!3X]F[<B.:8?O[/@I\T/_]'[^$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MTVLSO*;/,V$ _P#K7:OF'ZMQ39]2[Z/'+,^V(E^C/Z6[N,OZ>=GI_#M[;?\
MANNM_!YYYAD37@AT=' U#V8$$;-RZOTS$Z/1+;XOBD_VPUBXL9K8_G,,D-3R
MR@5H!LYL%@R88N^#2?!LX\]UFF3AX_O8Z:T:1S,HX'W]N*T_>LFDN1QY(I6)
MXK!UM0U H<=Q5+J3#<QW1,)"P' BAV=A6"ZV89(XH-A(.._8M>[BRQ5<!A
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M91866595E=G;9?EF69;:P6.7Y=E]E"VWL[&QLK5K8X88HVMCBBC:&M: UH
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MSBW<E-=*'5/":O_2^_A 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MOLAT;]0^^V_3_P!%=R[I%U+[,%]N/7_Q,G].S[;J^I^D(UH: UH#6M :UK0
M&@"@  V +Z_?F;Q10$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M04KBX@M()KJZFAMK:VADN+BXN)&0P6\$+#)----(0UC&-!<YSB  "2:(/G$_
M4/\ ^0?T;Z##/>EOI#CR/KQU=M_F,MONH<DLEUT8T1>MK'(^SO["1C]37<1'
MACR^9E@"0YU[,YDEL0\&/3IZ$OU!?UDNJD_7+JMJW4=MH+,[TV^?>H/JG!<_
M[?@RZ"Z=YVG.D6CK;Y6.^;;N,K8K#)X[;+;>0.9/<VTC@'A]G'H@_3F],OH(
MTA_1>C6D6WNMLSL8K7675[5;+7-.HVKW@MDE@N,V;&QECE_F-:Z/*\NCAMAR
MM?(R6<.F>'>] 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$'#77#K+D/171MQJ',
MO+O<XO/-L],Y#YS8Y\XS01\PY\>9EK!5K[J< \C2&BLCXV.X_N/<,7;MO.6_
M6Z=+;?&?W1SG\:.6[-VC/WC=QM\6EL:WW<K;?WS_  QSGRB9CPGUMK74.O\
M4N:ZLU3?R9CG.;SF:XF=5L448\-O9V<-2(H(64CAB!HUH&TU)\XW&XR[K+=G
MSS6Z[[/*/*'MNRV6W[?M[=KM;>FRWVS/.9GG,\9EISW =XW56M,RW8A:32M8
MUSWN#6-Q+B< !O5)FJ_"*RQ#.:^>+B4%MLS&WA=_F$'^=(.&\!1.G!6*W:SP
M7I/T'#[2JLT0ID]N&X?8H6]"3;W#A3AL59E,>"(%31N..]5F:<5Z<Y5V@#MW
M_3N5=9(A78*D>[NQ&)43,<EZ4A.^5D8(J-AJ=V.% J5F=59KQY*MK:&8B6;[
MAQ9&< ZFQSFG=P"CA&BL>+.L:  #M^%:8 *LUK4I,JX96E3R@&M#AC3;^Q1Z
M%HBB[B8W#:2*8@X;:5JIU3,T9.-N\ #[?<GFI/#76J[8WXGWTWX=O!3P8YUX
M+AHIM'VX)Z%:*S2![J)3F15=M=B".SL*F)U4NCDN&2M:0#M=L&_9B5DK7S4\
MI7'F*-"D)A)[>^BE%(/,[0?V@U0I'@B'U)&!H:&FX_M3CK)2$:@G]N[M37C!
M1':E?%"/+AB!PXJR ,!W>\[!V*)1.BE-8LGHZI9*S&*5H\;#P[1Q"0CBIQ-<
MYWD3M:R=HK@/!.P#^9%]HW),)B^>$\4S[4;QQQIO':HIX+Q<M7VE/IV#ZU6D
M+]2U=;;QNQ-,,=RBFJU?!;.MMN'M11TIB8YL#F-O\W<19<WPL-)[UPI_(::-
MCPV<QI[E-)B*R3/5/3"Z?:@ !H'*  T#8&MP  X*B^GH8^X@;&U\CMC YYW_
M '156XK1=3@U@9?((OZA&T_.2.=-3_N0N.%N3MV;*[U-$6S6.KFI36[;QD-U
M >25F,;C@:#!\,@[#4*LQ2L,T3U:PM.61C_SR?&ZC:@<C7'8PD#"NZN!59I/
M!EB?%J?E?T/-/(/ARG-I"^W-*,LLP=]^'@&R;1NJK4ZK:\X5B>B^G*[[)9J>
MW:]I9(QKV':US>9I]RQ\-6;26"GRMS ?E7#D-:VT]7P$TV,.UO8E4T\&/BN7
MVC_*>Q\>/B@E.+>+K>3\0[%,VUUA$32:<&4B;!([Y@.,W,?#YAYVQ8?=9&<!
M\%76E)9;8B=>*A8NEMP^XA!=-9SRQ3P[YK9SN<=Y&)"M.NGBF/+E]S?K"^BN
M(HY8G\S'X@X@@[VN&XC857AQ6XZPST4@- ?B5!2J]:X?1M[SQ1:(5??]1]ZI
M(IS0Q3QNBF8'L=@6GZ"#Q&XJ-8G0F*Q26LSOERB]MY+ISGV4H^5^:VF,.-8F
MW/=LJFE]NG%6)Z./"=%S?@L:)VD'R@.:AY@^)V!I3;Q"P77?:V[>30=1.$UU
M90--6DMD)VCQ'FJ>\#8L%UU(F6YCMF;HAH.?RFZO&V]0Z&U8Z:;MFD:6PMX8
M#%<?DNI%7.;?'6Z(</W=P+:"2SB<?-$TK9)*$2-8'5YJMV8;%QN:_6KG=IBT
MBQIK=7Y[D5Y=MRG/,URZACF:+6_N(VEU*%SH^;E/O"T;]WGQ:X[YB?*9<SC[
M7LMQ[N?#9='G;"_A]2G5#(7 '.++-XF?@SS+H+L.W?F3V_ER?^F4V=^W^+^*
M+_*8_'25;_HOLNXK_3G%7G9=,?9-8;7I[UL117DT^K-"F0<L=L^XTUF@#F,C
M%7R,M,T&UQQH) %O6?5EEDQ;N,/KMG\)_>XK+^FF7)7)L-S%?#);^-O[G.6C
MO59T.U#$RUGU?_M:\FDE;\KJVRFREC72&O*+X>9;D#9S>8*E<MM_J/M&YFGS
M>B?"_P!W[>#K6]^A?J;96S,[;YUL5UQSU_9I=]CGO3N;9?GT#K_)LRR_.;41
MQQ_-Y7>VV8P>';^99N<!7 XKFK,F/+;U8;HOCQB8F/L=3R8,NWR?+W-EV.[A
M2Z)MG[8AD)9.69CC^&X%1L_!@LO+15</>6S6[Z#$2-IB?#3FI11' F.:^:X&
MA&PBNWWJ8XZI5 :_NV%9(8YA.#[NU7A5$^(4[-O#>K1I)/!B,YD\B*.4'Q<Q
M# =[G,+1B.]7MG5KY)IJREC%\O9VT. +(6<Q I5SAS.)^-%-4Q%(HOHVN>]K
M&BKGN:QN[%QY6_2FLZ0K=,1%7S;>K34$>>^H/K%FPD\Z.37&:999D>)[K3)F
MLRJ"-H'#R2."\8[]F_,]VW-UO"+YB/1;I^#ZX^B-K&P^E>WX[_BNPVW3'G?[
MU(]KK*R"2=WYQY(Z_P B,G9_ZLDVU[ NJ;B^+9]W6?&?PAZ#M\>2^*Y9I'A'
MXRW#+8VQL:&!K&BF %-GMM7$7S,S,SJY"Z(MBD11:YX_EM9*8>%WUJ+?B1K2
M8<,32R"Z_,95A?4/C/, "<"]IQ]X7)XXCHTX^;C[KIB?>C2O&/W/6/\ 2K '
M6+JH0<'=([&H&PTUG:D%=X_3FO\ W7=5_P#)C_[Y#R#]=(C_ .K>P_\ YJ?_
M +S<]Q5Z[Q?,:QMOSKBYNOPU%K#M'Y<1J]P[W*9X45C75?*JPHJ(A)3#$YO=
MOAM)(8!6YN.6V9O$9G\!<:<!5+>*;II%(5([:*U9;6P^[ P33R$"KFV[:>*N
MP<V("5KJFG"%'+.:1MQ?O'YE[*7Q\1 SPQ 5XTJHF>4<"R*^]/-?%U02<:_'
MO*K+-&BRNYA!!/,:?EQ.?PQ \(^*B(JM-W3#'6+##9P@XOD;YTAVU?*><X^_
M!)XIMTA1O;J.VA?-*>5C.%"YY. 8T<3N5:+5B(ZI8&*.69YS"[;1X8XVUN35
MMM'RU#RW>\_0DHB)F>J4;3"V97:X.</^IQ-<%6Y:W@M[MWFOM[6O\QXDDV >
M7%CCWE1$4U)\&0::]W9L[J*O!9<1_:I0^<KUX.8[U:]77D,HVXTG&7;JQ:,L
M6.J#L-=J\3^KYK]0[B(_N_\ 1:^N?TPBGT-L9GPRS_\ =;W6#*[EQ);;POEP
MP>2(XA_U.W=P73]QCBE;YI]LO2MOEF=,=O5]D>W]S,R"\?\ >FAA'")A>ZO#
MG?\ L6M;\J.$3/I;U,]T:W1;Z(K]LK.6+$\\TSMY\?*#[FJ\7>$0I=9'\5TS
MZZ-<S4   &M:#$DFM>U;F"9FYH[FD,(R\DR^]RB_C/+)E^;9=?Q.&!$ME>QW
M3"".!8%R6">F[KCC%)]DU<'N\<9,7R[N%T76^V)B?O?9U:W;;^SL+]AJR_R[
M+[]AWEE[91W3#\'A?0]MT76Q?'.(GVQ5\.7V3CR78Y_AFZ/9,PK*RM4%:%:E
M?BK(0)IVJ4)2[?NP.^O;6B"4N_:"*[#V((<R'-:W=Q\M;3SX5C8YS:_BD.#!
M[S3<D:DTB%'+X3!9Q,?C)(/.F)P)DE\;B?H"3Q3;$PO.8?3[E5:B4G'A7WX;
MZJ*II1+S=_MMP45U6\DO-ANI39]&Q14HD+OI''ZTJ*+G#X; ./:@L,SS/+LF
ML9<TSG,;#)\KMVN?/F.:7MOE]E$QHJ2^YNG-;@-U:]BK?=99;UY)BVWQF:1]
MJV*S)FOC#@MG)?/"+8F9GU0Z;=1_75T>T:Z>QTK_ %#J/FT?.SS,FY<OT[&]
MI+:OSN\%90"/\B)U=Q7!;KZBV&#W<-<L^6EOMG\(=R[;]!]ZWM,F[IMK)_FU
MO_X8X>N8=$>HGKIZRZO;<6F49GE^@,JEYV"VTG"YN9.B<"WDGSZ]+YR2,"8Q
M&NN[GZCWV:MMDQCC^[Q]LZ_<[UV_Z![/LZ79K9W%\<[Y]WU612/;5T]S36.8
M9KF$M_FN97V:WER\OEO<SO;G,+M\QP<Y\]X][C7;6JX?)NIOGJR3-T^,S5V[
M#V_'@MZ,-EMEOA;$1'V+%V=/EQ$E'#[IK7_I6.,\,EVUT9C+\Z=+RGG+7M/*
MXUQ!&!!KN*RVYHJU[]MHWG+,U<^>W8\T#?S"0:MJ!0$\%MX\OFXW/MX<V:?S
M N+'->*X;'5#M]#BM_%D\7!;K!'K<]:;O2X1XD' ''$&N]<EBNU==W..-7.N
M07)HS$TX_0N2QW>;KVYM<MY5,2&]@&_N6[9/-PV:V(;G:RX#W##ZJ+-5Q]\4
M92.3_P!1PQV&N]6F=&"8FJ8R'B%8U2^96N]0BB0OW_V?2HE,)2_MP[U5.B7G
MQ]V"5-4/,]WUX**GH0,@[L.[M2H<^W$4!W=NY17F!DH*GOW;$JA)&15TKOOO
MP%34M8-C1]:BO)76>*J'[=E>%.)JHJF91$@VC?OI3ZU*M94Y+JWB%9)XF#@Y
M[0?A6JF(GDK-U.,K-V<V(-&2NF-<!!&^2I'"BF+9YJ=<(C,KF3^1EMT_@Z4M
MB%!OH[%3TQSDZIGA"<29Q)CRV-JW?SN=*:4J>8#>GNH][T+5MGF%]()+C,G-
MMX7DQLB@#/,<#]XUX;E-8I2BM)F=9X+X99&[&:[O)B<3SSEHQVX-VJ(N\$]'
MC*JS++!E3\L'UVF1SI*=_,4ZI.FWP7;+:V;]RVA: -HA:*>\A1,RFD)C)#$!
M5T+!N)+&"G>G%&D*#\RLF'Q7,9.\,<7D$;1X:U4TE'5;'-1_JMN[^5%=3G=Y
M<!H[MJ4IXHZX/G;MY_)RV<CC*YL>'$CZDI%.*>J9Y'/FSZ4BL[<'9S/=*>RM
M%/N\>*?>/E\Q?B_,&LQV00T!%=@YL4K;X$=7B?TUKC66\O)G?B'F<C>ZC$KX
M:'3$\51N6V+#7Y<.(KC(7/[1]XJ.J3IM7+8HHQ5D4; !4<K ",.P*-5H&-(:
M-IKCVDDU.U$PE?)%'7S)&,'%SVM ^*>A%5B[,K,'E;(Z9U:4AC=*30XT+1C1
M323JB-4OS=S)7R<OG.SQ3$1MVX. W]O8HI$<UHNGE"'EYJ_:^TM]N#0Z5P/$
MN.'8IK:M6[R0_ITDG\Z]N'BM2UI$8H-E U3U>2=?XI5&979BA,1D(QYI7/D)
M)X<Q45E-(7D=O'&/!%&P&OW6-;7Z$U3IR5PVE!LIN&S!31->2H&UXG=VT4T/
M2J-;[=ZFA55 V;?8*U!__]/[^$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MWM;+$ZL<\$G+)$\&.1C'M+0&](" @(" @(" @(" @(" @(" @(" @(" @("
M@(/CB_5:T3,_UP=8KQWF-??6.A;V-PQ:Z&?1]L(\'<"",%X?]8V3_P!_SQ=%
M8F+)_P"6'V-^E66V[Z'V=V.[IFV<L3X5C)<\J\WTW?P!Q-NV9@J:L:><BM#4
M4Q]ZZ;?M\=TZ:3YO5\.]W&/XO?CR<<YEED1JUT;XGU^[(VE#0['%:.3:W\8B
ML.8V_<\,Z7STSYM)O\G!KR@/&)H*5PK7!<??BFVM7.X=S;?2;9]DM%ER)LC9
M^>,.:Z1YQ KRU--W:M;+'3,3:V]IDMOLNB_G+79\EN;>OD.YV5_E2U.&TT=1
M:F2VV[XHI/C#?LFZS_+FL>$L<8@"&S120D'\3?"<=SJ+4OPW1K9-6[CW6O3D
MCI_;Q51:M<*MY7#$X4.W?@M:^L3[T4;^//$TI-83BS(((!&&_ '#%8YZ9ALV
MY+55MJ\'#[?I6&;;6:+HII*[BMWX5 .'?AP6*ZRV9T9+9CFO(X2"/"/O<%BO
MQ^#)%T1+/V\= -PINK2NS<M.['JV\=]M%X&4/W7'?LX+'=B9HR8XXJ[ 2["-
MY(I^&BQSBIQ9+<EG*%VXSQQN>V GE83XC39L6*,5MUU)E:Z^8LFZ+=8\UQ R
M[>QKR(V%S0=A=2O!4R666S364X_FWVQ=-(JNFVLQJ7S.''E%*8*E+8X0R?+R
M?Q7^S13=#;,^^Z69VT@>+Z IZ<D\(B%;K<5OQ3-T^%4?(<ZI@M8H@1]Z9M75
MX\JK2DTOFOH1\N^?\NV(\Y2BPYC6>1SZ[&MJQHQK2@4]4Q\$45C!==KDFOV*
MGRL4>#&AIINVGXJOO7<5NCITMA1,7%(ME2[JJE+ /JW)TRQS,PMW1[:5V]A^
MI9(ACF9HM)(]IQQJ,1]2R48KIFBR?%CW;,%DBM&"9K/ \H[:#CL*:K40=%7;
MP[4BI*QEA..W'#AV+-9')@OB>*T="!M![*?O6:(FNC6NB9XI1'V;N"S1;-&/
M@F;;N<ZI%,=E#]*RQ2V*0PWS365<6U!2AP-,!L[UFMMNNF&GEOK RQ<YU2-I
M.XXTVKD,>/31Q>7)K1EX,M8VA?RL Q)=0&E>)6WCQ3/"*RX_+N+;:UE]"7_'
MIZ166H?49U=ZO75J9HNEW3FTTYDES3P6V?\ 4#,:73P[^(9?8S,[I3VKUW]*
M.V3=W;/W#+;_ )..+;?\5\Z_\L3'K?-O^HOOT8_IO9]EPW:[G--]\?W,4:?\
M]T3ZGU]+WQ\<" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(.A7K
M8_4C]+'H.TY)>]9=;Q7NN[RQ=>:8Z/:/=:9WU+U+S BVF;DOFQLR^R>YKA_4
MLTFM[8\KVQR2R@1.#XW_ %/?J3^OW]6OJ$WH!T6TCJC(>GVI;B2'*/3[T???
MWUUGV5LF:'9CU:UDUML[,+:'F8^[DO/D\HMP&2OMXWL,Y#V6_3Q_X[73SIC_
M $/JIZX+C*>J^O8OELQR[HCD\\EQTMTQ<"D\3-:YF.234=U&>426;!'EK7"2
M.09E$YKP'TXY9E>6Y)EMADV39=8Y1E&56=MEV5Y5EEI;V&6Y;E]G"+>SL;"Q
MM6LBAABC:UD<4;0UK0&M   07R @(" @(" @(" @(" @(" @(" @(" @(-'Z
MB]0=.=,-)9IK'5%UY&79='2*WC,?SF:7\C2;3*LNBD+?,GF((:VH#0'/>6L8
MYPUMWNL.SP7;C/-(CVS/*(\Y_;1N;#8[CN6ZMVFVBMUW/E$<[I\(C^R-9AX0
M=6^JVI>KVL+[5FHI>3S";;*,JBD<^RR3*8Y'/M<NM ZE>6I=++R@R2%SR!4-
M'FV^WN7?[B<V7U1RMCPC\9YR]N[3VO;]IVENUP1YW7<[KN<S^$<HT<4N=M[C
MWX\%I3X.4CBM)96L:Z1[@QC15SG'8!O)6.?"&2*1K+"#FS&1LL@<RR8:PQ.P
M-PX'"23^[P"3-(HB(Z]9X+^M -V&%-E*;*#Z%299HB%,GOX?0HY+>A+MQW#9
MP5)E,16:0#$\!M_:HF:0O$1'!-6F &ZF_:51>(CBKM!..&(V;/;O^*K-W).D
M*KI.1G=M_9CP5%9UFJK:6OFELTP\(Q9&?Q 4(>X;^P),T5I66;:2:4XC'@H6
MB*<5VT8@[<,!3CA6BB4KEC*#LP!KOKMJ/I4=2-5S'0.&&PC$TKLIAN3JE$QH
MOXS7'[1W)U2K--%R'8"NX=P]RM6)X,=UO@K-?V[<./;BE=$4N5!)W^ZN&._L
M4U*50ENF01F1Y-*T8/Q2..QK1Q_M3R1.D*ELYX!EFIYK\: @^6S:V,5X;U:O
M*%:<YA?"7N[<=G:E2D*@D&ZOQW*8E%(4)K@L+88\9I<&MVAC=[W?8K<=2?)<
MQ@,8UM22*5.\D[25$U(M5P:4QJ.)^ /[TKJB;51KJ< >_P"I$2K-()^S]WTI
M"*1*NP#]ZFM6.5<-V;NW=V*RL3JA-;1SLY34$&L<C31\;Z8.:?K"B)F$3JH1
M/<7FWN&M9.QOA</N3QG#S&5W\1N5J12O(BZ9TGBJ.A%#AC]'P59CQ3%U.*V?
M;C<./911,,G5SX+5\( )(% TDUP( %30J*>*>N8XL%EMLZ5MS>O%'W<[BPD4
M_(C\,8'9O2Z*:>";)KK/-=/MQLH<>S:!@?<HHOU>#"9M YT#(&@5NIF085KR
M$\TFSL2V/$FZL4CBDDM0UH:T4# &@;, . V;$98F):[=6_RDKKAH/R\Q G!&
M$<FQLU!^$[')Q3$S9->7W+>:W:]I:YH<US=FX@X@@CZ"HHV+9B6O9GEK;VTF
MRZ>I+V\]K.:CEEC'-$2[;SM.WBH^&:IF.JWIGU-9M&7%YY<<US-!=Q#RN8.(
M9,(3ROY1_&.&\*9B(\X1;,SSU7KVW]K7S(Q>PC\<0Y)P/[[-_N6.8B6:+KHX
MZJ#C97[?+/*]PVQ2#RYF'B&G$=X4:PR1TW>;#36=]ECS/9\UU;C&6U=_.IM\
M'\5![U-;9UE>(FW6-5?+[Z&>[>^!PY;F)KW,=A)%-%@]CV;0?K43%(U39=$S
M6&589+"4W%JTR02.YKFU;6K2=LL0^L**Z)F)B:Q[&V6.8Q7$8DBD#F8 XXM/
M\+AMKQ59T7B(F*PSD5P"!4\*X[N(5:G%>ME!^@=ON42<%4.!]OI43P%O>0QW
M5M-;/ <V5G+1P!&RK21WJD3,:PFE8U:JWYFW@+& W$$9,,]L3^;"X&A,1/X2
M-Q6*^:RS8M(\:-#%PR6ZN[EW-Y-F+E\9D:6D0L\#&N!WUJ%K9?AI'-R.VI-U
M>4-(S$F"UEN9<9KM[IG#'G//_)B%> H%Q>:[EX.P;2V8BL\]7"N;<]O>7?F$
M<]TSSJ_P\N!8#W;5QF:[1V/:6>]Z7$&>7!9>!U3^9"]A[2TU7%9KJP[)M;?>
MBCC+.+RC9>8U :[Z 5Q>2^8FL.PX,58U<2LS!XBG)K432;]QQ&-5K;F[WO4Y
M/88_<IYM:O<SY8YN?  2N(/B!\)-""N.ONF9HYS'CB+9GR8_2FM,]T]*,PTQ
MJ'.],9C%*2ZXR/-;O+)>8.Y@Y[+9[6/!H/O-(*G\WNMEFZMM?=9_AF88O^V=
MO[KMNC?8;,O*8OMB[[X]E':S1/KAZUZ<D@M]0WV3=0,MBEB<6ZALQ:YJX1U!
M#LXRSD<21O?&Y<]M/K?N^VF(R].:(XQ?%)]5T<_3#IO<OTE^FM]6[;=>TNG6
M)QS6VOG9=6*>B8=T]&^O+I+J)UC#J_+\[T#>NF9&^YN6,SK(@Z1O*3\]94EC
M;_CAPXKMFP^N>U;GW-W;?@N\:=5OMC6(],/.>[_I']0["N3M^3'N[(X17Y>3
M_AN]V9]%SN)I?5NEM8V@O=(ZCR74MFYO.R;)LQMKUP8=@FMXW>9&1L(>P47;
M]MN]KO;/F;/+;EC^[,3[8XQZWFV_[;W#MF3Y'<L&3!='*^V;?9,Z3ZI;*'4[
M"#3&N 6W#050ZM-GQP'>%:%4X/;4CABK^E6=6!SMQEN<DM,3Y^8![QL_+A;S
MFH[U>WA,PU\FLQ;YMD#O=B-^..SWJ&14%TVSY[V1P8RRCEO'O=@UK+2(W#G.
MKN :24ZNCWIY:^S52<?S/Z<<;IB/;-/Q?*=K3.6YSJ34.>S/=+<YUJ'/,W><
M7N!S7-9KTL;3</,7@VYRW9K[\G*ZZZ?;,S5]M=OP6;/;XL$ZSCLLLT_NVQ;^
M#6K9T\CN9L'EM%?%*[Q4 P'*RI^*X+<]$<9KZ'9=O\RZ-+:1Y_N;3:0R\GBF
M+<-D;6@5INJN/FZWP9K[,D\;O9# ZA81 ]OS$]:8>("M-HP"FV_76V%8QZ?%
M+B1Q<RY: YTA<_D;STVN-*D_2N0MF)M\&K=$VW4BLS+UJ_2N CZP]46@X-Z1
MV#<>S65KO7=?TXNKW7<S_P"C'_WR'C_ZZZ?37;X__.I_^\W/;F\G,-N]S?YC
MZ0Q"A)\V7PMI3A6ON7K\/F&=(5;>-L,,<+?\IC6D\7;7.)[34J*UU(BD4542
MBH%O)(XN\J(^,CQ.VB,<3V\ FG&2O*&/?&'YC:6S0>6WC?>3N-27RN_+A#CW
MXJ*Z)K'5$0DS&1[HI&,KYE[.VQC(.R%AK,^GQQ"B/--T_;HR;6-A8V)@HV)K
M6-QP  I\%%5XTTA2=_8</<2E5_2PF;N+X[>U!\5W<L:X#_M,\<CJ<%,(NFL4
M5II8XF.<]PC9&VI<< UC1M"I-5ZQ2LM<8UV83"]G86V[1_H[=^ =C07,@XG<
M"DZ:)MF;M9X<E2Y=2*4UV,>*[\6D$JE6296T7AAA;C41LP'&E=BB>,D<%G#2
M6ZN)OPLI;QFG\/B>1[U/(C69EDV;]^_M5=4KF,'#92OO4DSH^:[UK7;+SU6=
M;II'@ML]609<>8^!IR[);6U((.T^&B\.^J+YN^H-U$?S4]EL0^P?T[QQB^A^
MVS?I$XINUX>]?=+KIEMS*]W^GA)8-DDI\ME/[K1B?@NKY[+8M]^=?"-9_<[_
M +?)?=_EVZ>,Z1^]F9&W+S^9=<HP\,# VE=W,ZI]ZU8FR/AM]K=Z<MT>]?3T
M1182VL1J7NG>=_-,_OV"BRVY+HX4CU*3@L_BK/IF6O9I;VXY:1@$4_$\D;]Y
M6Y@OOUF9<=N,6+E'VRU7-CY67W$C 0YD4[VBIQ<R(O&U;MDSTW5\''9(B+[(
M_O0^R;IO>#,.FO3/,.;F^>Z;: O"ZM>9USI"RF?COQ)JOH'9W3=L\-WCCLG_
M )8?$?<[8Q]TW6/^7-FCV9+H;@2MIH5F4*]^W9OX*8HA(7>_:*': 1LP5D)2
MXG]FY2($_3M&[O1*4GVWJ"B7F]OVHG1BKYWGW%E9;6ND-S,.,<.+6]U5,<*J
MW1K$,D7#L^P8JDS+(E+Q\< HJGTI2_9VX_ ]JK7DFGBIF3;NQW\-F%<$%,R;
M-OU>]$3+6-7:UTGH+)I=0:UU'E.F<GB:XB\S:[CM_F'M%1#96^,L\AI0,A8Y
MQ*P[C<X-KCG+N+XLMCG/X>/J;>RV6\[CGC;;#'=EOGE;$S3SF>$1YS,/.?JO
M^HE96WS.6='M-_-/ ?$-6ZPB,=O7%HGRO3L+@YVXM==2"O\ !N74][]666^Y
ML+*_WK_PM_?['I?:/TSRWTS=ZR],<?EX^/HNOX?\,>MYL]0>LNNNI&8RYAKC
M5F;ZBN"XOC@O;M[<MM6[0RQRJ'EMXFC8 R.HXKJ>Z[EN=U=U[C)-_IG2/1'!
MZ;VWL/;^V6?*V&&W%'C$:SZ;N,^UQ/<Y^'5 F!X /IOV4*TKLUSEK-K:PD^<
M.)/B.WCQ]ZQSFELQM8ABY\R<?&TFK2"17:T;^]+<M=)5OV_3[T1P9"US'S U
MP<2'8[?=3:IC)-5;L=M*QS;+8W3F2LE:3RNHV2FVNYV"V++IEI9;(AR?D,Y?
M,36H#6-^W K>QN&W%L1,N<M.M8XQU8UV(Q[:"E%R.&9==W<0[!Z;YCY;AM\/
MO'ML7+X9Y2ZQO(I68<]:?=5K/<#Q'<N3Q5=:W,QR<NY4\T:-NSCM%-JWK'"9
MN+<[:38":;!A@-F*V(X-&]EF2"FWWT^"M5@G@B9:UQ'N^."O*OI2&7M]N*K,
ME(A+YAKV#O*K6!+S';]NRNX*)F$H<Q_BIOVI,HJ<XX[3NX]JBHCS#9P]^-</
MBJU0@7@ N)  J:DT;WDE"JQFS.PC(:^X8YPQ+(ZROJ-W@JI]Y6;HB5,9G-+_
M .5R^ZDK^.6D#,14XNQ]ZCAI,J]5>$51KF\VUUI:-.]O--(!NQ.'>GN1P_<B
MM\QX'R$DF-U?74Q_A8[R8\> ;\5-?"$=->,U7$676,>(MHW.'XI.:5Y)WU=5
M*SPDZ;?!DF-# .1C& 5^XQK<-_W5%4T@?<0QT\R>-@W\\C1V[%;6>"LZ<5K)
MF=C0L\[S,*$0-<\N%<!@%-)1U6HMS%S@!;Y?=R "C2Y@B;_Z;=BHIYPB;M-(
M3MFS9^#+6V@X^?*YY]W*I]U%;DWD9F\'S+^*)IV""''_ ,3J_%36/!'O^*;^
MFA^,U[>SG"M9?+;CM\+%-?(Z:\9JJ,RJQ::F#G)V^:]T@V4#J.--W!.J3IB)
M7<=M;QT\N")E .6D;0?JVJ*ZZE(II"O3"@H.&%/=0(5/L0B4?B=OU(FJ!(:/
M$0T88N( X4Q2DHJM),PLHC1UPQQ_@CK(ZG<VOUJ>F3JM4?Z@Z3"WLKJ:NQSF
M")G#[S]R=/C)U>"!_JTPH&6EJUV]SC*\8XU P3W2MR8Y?-+_ .9OKA^RC(N6
M%@][<>*5IPA/3/BF9E=DP@F 2.'XIGND->)#L$K*:0O6QL90,8Q@X,:&[=NQ
M124\$W+\/I]R4E-3E]CPIV)1:)Y(4'#W?4IB%X1#3CA]?P5ND3!AX;TZ31/R
M=BLF/)4:P' 4X&E#MV[$IS%8,KAO[*XC94U4HKX*HCX\?H34?__4^_A 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M01\<#L]W>G2FJ<1]G9LP]NU32*%7_]7[^$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0:OK31&C>H^E\ZT1U!TKIW6^C=1V;\OS_2VJ\GR_/]/YS8R$
M.=:YEE&:1RP3,J X![#1P#A0@%!\MGKV_P"-[IS41SGJ1Z#\^M])9P_S[^[Z
M!:[S:XETM?RFLK[?I[KJ_=+<9<]U*16&<OFMR]W_ )ZSA:U@#RD].'ZF'ZB'
MZ46NV=".L^F=5Z@T+IF2&WS#H!UQ;FEI<9-D[9#''<]*]:2MGGRZUD#7?)2V
M3KS*) 72QVLI<) 'UT^B']5_TA>NFTL,HZ?:U&B.K<MN'W_17J-+99%K?SXX
MR^Z=IB3S'6>>V[>5[Q)E<\DS(@'W-O;%W( ]+4! 0$! 0$! 0$! 0$! 0$!
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MZA7T3]"[7\K]-X?')-U__%=/X1#XF_5[N/\ W#ZZW5.&"W'BC_=MB9^VZ7I
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M#JI2^/1?%+HF/3ZG=+I]ZW[-DEC#U2TV^ ON733ZETC&96_FL#1)?:=N'\P
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M-?S!U;26M<6.W\6D+>Q1[SC-S,4KSK'WOKC],$QF],_I[EQYG]']$DX[>7+
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MIHF+O%__UOOX0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MHO<0^I[J[:>?:?)Z*S:*WZ6:=OV5CKJ'J1$R>&\,;O$;7(XKOF+70RW%H_Q
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M1MP4=,K1=53,7M].*FB_Q/_7^_A 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MA"_Y^V(UFGK6,N20-VEI.P4 <>X@!(V62>$*_P#<\,13JJL7Y,#41VLSSO\
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M,@I*VUUAK>,6^99JX5 EMLM;90L>TCYF\A=B'TY: Z=Z"Z4Z2RC0?3+1FF-
M:*R"W%KDVE='Y)EVGLARV$8N%KEF5QQ1-<\^*1_+S/<2YY<XDD-R0$! 0$!
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M68-?0\10JT^**Z:KF9K+B&2"3!LC2VH_"=K7#M!QJG"43288EMT]]YEC)O\
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M'%KNU8YCG'%>VZFD\%\^'L'9O:0<:@A8V6%J^+L^JOP5*<I7CR6DUI')M%'
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M*OC/BT+,QR TKA5HW"@K@ /H6WAFLM;)I#4;=U,SB(K]X_"JW;X_HS5IQ/\
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MT/OX0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M'_2ZBE6BC)=6K#XIXP10&CN;_P!12DRM$Q'%_]'[^$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MY?J]_P"2QT7T+_4]*^CWIY?=:=1Q>;;P=2NH,&:Z.Z8VLPJ([S+--?D9_F[
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MZ)@IO_?NP4II*%,/:JF(U6H45Z)H *:$(T]OW)1*UFNK>#"21O,?\MOCD/\
MTMK]*GIKP1U6QQ6WG7<U/E[<1L_[MR2.RHC&/Q44CQ3U3,:112.6,G/->R&Y
MJ,64$<8QV>'%*^"-.:HVPMH1RP1B$4(HP@M[J.K@5.O,MB(?_]+[^$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M/0N__]/[^$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MIPT5J_U%ZG@\V"WU%>,N.FG3&.85C$[,SSZWDSJ\\M_B,4>2PQ2M'Y=V X/
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M<5PUIIQ]N!1$RC++#;1&69X8T;,*N<=K6,;O/<IB*JS-(U6L=O/F)$EV##:
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M4G.]PX[S3"@1/#67_]3[^$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M_*>GV?:H]2&K[7S866'2W*G6FD(KQE2QF8=0=4_*6;X'4_\ ,9/%F(Q'A.-
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M/W(FD<*I"\XXXT[OH0KR2%_#>?;WT0IK[S__U?OX0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M7<.K/M.7&<F+SLF?BL\;)_W:<'ACJC2.H-):@S;26K\CO]-ZFR29UKFN2YI
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MAY@X[.ZB5*3,I2\[1CVFE-F-*),D6^)S&M2?VX]B3)HC7X=F&&^J#__6^_A
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M:O<=GA8,24H3-%EYN87@I$/D;<UI+(*W+VG86Q[ IF(5]Z?)_]?[^$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M>(QL:%;6B(FWCQ7_ /49W_RLMNW##%X:P.X8'L5=.<K=4^#_T/OX0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M@]0>D'Z0/Z<'13Y:;2_I5Z=ZAS*V+'_U?JC%FG5N\EN8\6W@M^H]QF=I!("
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M 5M8K)YM?/ET:W=M/,7L_%7G;6H<*[0%RN&W2DN(S7S6JT@M?FI@1BT'@<.
M*Y+'9TVT<1FR5FO)S3HW35U>R6L%C:NNLPS&XMK#+K5C29+BZNIVVUI P 5K
M)*YK?>HOMNNOC';%9KP\YX-?YUF/'=N,L]-L1,S/A;$5F?LF?4^DGI!TTLND
M_3;2.@K1C//R7+&/SJXC8UOSVI+^EWG]\^@Q+KASHVG^!C1NHO3]CM;=CM,>
MUMXVQKYW3K=]OV/F+OG=<G>NZY^Y7SIDNGICPQVZ61_PZ^F9<GM@&TBOU>];
M?I</-W@K"*NP? *:>*DSI54$'&J13DK-W@G$5-@^..Q)GDK,U3>4HJBJ(C'M
MWXJ"J8,'8B8\DP:."(UDY>Q*E)1I3 X>U$0FY2@B&^^BM"*HAHX>W:$17P*#
MM[U**I@"?;[4B"B8-[/>5/!.D*G(!N4ZHZI342D1Q15,&[SMI[543/@K-R:G
M >U%%?%"&'[4U2D)&*GA&JT)2:8[]G955XRO$5T4Z[??OWE2R<8!^_O/8E$Q
M% [OHP^*E*%?[=J(0K_8=^]#S0JH$"?M[U*"OM]B%8*_1A^]3HA"J:(JA7ZZ
M^]*E80K[?6HKX*S<E+Z;Q]>/8E*HK,J1D_9BE813QEC[J_AM_P"8_P 9 Y8H
M_'([=0,;]J16>"U8C1C'.O;O[Q-C;D?=;XKF0'B[8T$<%>)B/-,1,S6[2/M5
MH88;8$1, +OOR'Q2//%\CL2FL\5JV6S2(5#*.-37^VI4:)K=*GYI^.%-^*%)
MYH<]=^Q$^9S>PX*U2LH<W]BG0UE*>0T!8QW>T%23YI2R$[8HL=M8V;=^Y$>F
M$OR]K6OR\)QV>6W9PH%:LB'R]F 28(:#$U8T4&WX*8F4Z>"W:+*0TALXYB#]
M_P H!G_B*MKXJZ>"LZ*SB'//':Q@# $- ]Q=B4UY)TYPQ4^=6+'_ "^7V3LR
MN]C8K>%HC;C2LDSA0!6B)YS16;K>$15*W+LSOBV7,);>U9B6VENT/;&-P<[8
M2!O5NJ.1TW7:W:,JS++5M/-#[@BG*)7GRV@?PQ-H G5,K=,2OXVLC:&QL8P<
M&-#:=U$KXK4II"J''>?VIIR0_]'[^$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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ME$'833'_ "@O53:>7_O/T[^G[/Z4\TZ9GZBZ2,E-O)_5,VSKEKV@H.?M._\
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MNX*U1,'GO4Z"8.KM.[OH1O0J_]+[^$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$&"SW2^F=46_P IJ;3N1:BM*%ORN>Y1E^;V]#M'DYA'(VAWX(.OFIO1%Z,M
M9F1^K/27Z:M132UYKK-^AW3.^O03M?'?3Y89F._O->#VH. =1?I$?IJZH,AS
M/T?=)[;S*\W^W;7/-'@5_P"V-)7MCR_]-$'".??H(?I;9USNM?3UFVG)9*ET
MN0]8^LXHX_B9;YQGUY"WL#8@.Q!Q!G'_ !Q/TY<SYODH>NNG>:M/Z/U0M9^3
M_#_N#*K[_P!-5!QCF7_&-]#%P7ORSJ_ZJLM<ZI;'-K#I-F%O'A0!C#HR*2E<
M?%*3VH-%S#_B]^F"3F_I7J/Z\V6)Y?ZAE_3W,Z"N'-\MEUI7##=Q[$&CW_\
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MV2_]&.%5QW>-[';NUY]YSMMGI_Q3[MOVS7U.?^ENSSW[ZCV?::5LRY+9O_\
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M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M?__4^_A 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0=;/5[U/;TA].?5+6,=RRVS-NG+G(\A>XD._KFH_
M_8+E[X^6AYHG3&?#8&$[EI=QW'Y;99,O.E(],Z0Y+M&U_.=QQ8.5:SZ(UG[G
MS.^G;)'/M\^U?<ASI+R<Y?9R25+R'$7%U+S.Q)IY;2:\5YK?/)[/AMCC['9*
M1QQ!IM6!L0M'NH"2:88D[@!B243'C+ P$WUT^^>#Y,)=#9-/XJ&DEQ3MV!4N
MFD439%9ZE\3CW<:?2J,T*96.92B%25XCFG W_O\ >J3Q65FC8:DJD^:T0BYS
M(&.GEP8QFRN-:X #B56=4\%A90NOK@W<[08V$T_A<YIJUG<U1,TTA$:ZMFC9
M4\Q%37P@G ;ZFBKQU7B)KU+MC,._X5296JO&,&W;C0;,#LVJLI2W-Q\LUL<<
M?G74V$$ [?Q/X-!WI$<Y5FZFG-=V%@;<.DF<)KJ>CII2/?Y;/[H43=56(YSQ
M99K*#A7X<*A$J@9L[NT8[*J$J@:!L%.Y3$:$RJAO=QV#9N4(E$- VU]_?52K
M,I^7>!3CV^Y1,HX:RC3A[^^N\)56934&W^P!*^"-5FZZ+WF*T9Y\@-'/Q;"P
M_P!Y_P"Q3_BT16O!6BLJN$MT_P"8EVAI'Y49IL8S]J=7J/2OPV@I@*;!P]RD
M,/;&IK2E4JJC393 [<<!MHIA!3X'''##V"E"7[/?C7M1"")2D@>VW#<B%(FI
MK\4%)YW=N[LPVH*1(""BXFG$;N/_ %!$J#C\-NW#O4)]"1QH.]2B%,FOT>P*
MBJ?0I%WM3<G$IS8J]NI.9MG:D&ZF&+MUM#6CIWG_ -1!VE6I$:RG7X8XIX88
M[6(11UI4N<YV+I)#BZ1YXE5F:S5:(I%(0?)3:?L]Y4)8B;,^9[H;1AN),0XM
MPA9_CDV>X(CJK\.JT<RZE_\ ,798#MBMORQW<YQ2L%)YR@QD,.,;!S4Q>[Q/
M/>XJLW+Q"/.2:[5%4Q"<&O[*?8B:>*ZC%=V&&[ZU OXV]FS$\.\J1,Z]AC=Y
M48=<3;!%""\U_ON& 4ZSJBL<.*X9'>34\US;9AH/+B/-+QHZ0_8E86B)IKHR
M,$$<(\+<=[G&KSOQ+DK*\0H7L,K'QYA;MK-;BD\8K6>UVO;VD;0IB?X2;9CW
MH96WFCN(F31.#HY&\S2#7O&&_<5662VDQ6%.>T$CA-$\P7#?NRMI0_W9 -H2
M)Y23'-:W!-PQL,P^6S"%_F6DN/E/E:/P/.YVRA4\->2G'3A+(6-U\S"'$<DS
M"8KB+?'(W!P(X':%$Q25K9ZH4Y+)[9#<6$C;>8U\R,BMO-O(>P;#VI7E*>GG
M#'V]^RRO#;7##:QW+JB-_P#+BG-,8G[.1_!6I6*QR+9BV:3I5L>SVJJ:,R8'
MV^NJ"8?'M!K10R1->*<%56HQMY_I9XLQ8*,\,%V!M,3C1LE/[I4\8Z5)]V>J
M&6!J 6FH(!!XM(P/P55X3@X4P)[:X85_<BR<4_MI@AZ4:_OQV8H%45F4*JT*
MHJP*42@%*I[?O5HE K($!! TW^W<IJA BHP_=3M4U5F4A:!]7$<:IU*3*F1A
M[5]Z53"@\8'X\/<E55D_8:?LW8J2BPE \0<UDC7!S7QRM;)'(Q[2R2*2-V#F
MN:2US3@14'!1Z2G]E/V]CQ:]6G0T=*=4.SC(+1QT1JZXN+C3[6@NCR;-GDS9
MCI>1P&#8ZF6TKMB/+M85T[N>P_*YNK'%,5_#RG^7U<O+T/;/I7ZAGNVR^5N)
M_P#<X(B+O[]O"+_7PN\+M>;H-G&2&Q#IG"5L,AYY2P5 >XU,9X4.U<9Q]V>,
M.WQ,6Q\R)GIGBTVZ9:0N=(_E#\ VHYY6BN'(-RTLF++DTCA[(<A9N-MACKF8
MKIYRQ%W=W,@(C\JQC'^?='FF<T;X;<?15<==M[+9I=6Z?".'KERMF[RWQ[E,
M=O\ -=Q]5L+6V;-SEUJ'A[\),QO*F=P(Q$#-@' !:.>+8BF3A'"VWAZW*;2;
M[KJX(F)G2<EW'U1X-ORHQ6F/BDF?X7W$AYI'D[17<#V+A=S-V32=(\.3L6TL
MLQ16-9GC,\6_6%X"&8@8;33AC7[5Q=]LQ+FL=ULQJR+,_>Z4V^7,^8E (DF)
M_P!/!R[R_8:?!9+,/3'7FFD>'.6EFW'S+IP[:.J[G/\ #'G5D+&(7[W22R&Y
M <3)</J&32 _RX0?P-.TK<G<1CLBR(I,\(\/3YN+C9?.R]=T]41QN\9\(\H7
M>86 F9R4I%3%K<#)38S#8WBJX\O3[T<63)CZO<GAS\V$EC$0 H &"C0,*$8
M K8LR>+%?CTT68NG->##(^.2&1D_S43WQOM)XG!\4L$T1#FR,< YCVD%IQ!J
M%N6>[2^=/#E/ICP:&6ET78XB+HF*75UBD\8F.$UX3#T@]//J]COY\KT+UAS*
M-F=RL@RS2/4"]?%#8WKG4@BL]82NHV*[-0(\PP9(:-EY7GF/I'T_]41GB-EW
M2:7:1;DGGX1?Y^%W">;P+ZX_3B=I-W=OINR;L>MU^WC6;><WXO&WQQ\;?X:Q
MH]*;.S%I&V'Q%P <]]03+)( XR<P^]S;01@12F"[M.LZO'(I2(A>NN(X7"(
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MTD8X@'X++9=5@OMB9X+ VHN 6/95O#E!![*.P*M-U&.;)NUX48"/3UFZ1_+
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M8C@HF9HWUX*LS5>DJ3I^'[41I'&5)TW;3N.-$U(IRA1,H[_;BIHGWU%TVX?
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M?__5^_A 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M$:D$T.%:J]LD0__6^_A 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0?,;Z[=8?^C)ZVIM/0S?,9'HF]RO
M2$(;)YL;(=-Q.S#4!H"6@&]?.TTPI2N-5Y]WK<?.WV28X6>['JX_;5ZS]-[3
M\MVS%;,:Y/?G_>X?\M&0E?4G8T;F[* ?=Y>X+@N+M$+*61L;'R/(#&-+W$G
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MS78K2C1^%N^N]:&2RW!KQO\ LC^URN*^_<Z16S']MW[H;QE]PV%C(HPUC&
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MMD7;C85W."-=(_J6Q_>MCXHCQM]<.]3B104^\QLC""'->QXYF2,<,'-((+7
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MR1H/_]?[^$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M&S:>PD+',TT656MP[-A_:JS*]L<URQI%!VX_O5)E/*C#/Y\POVPM)\F)U&T
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MM/VU0''2&>W!<8VM \-G<\T)V-\O:N7V/=MQM)BR_P#J8_">,>B?PX.G=_\
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M$10BNZF&^G8%:.*)0/=2JO:M$(]^\CO*GT"; "@QKQ.WN">D?__0^_A 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M/"]I9+!-&X$.8]I+7-.!!(45\>'[:'O<M)C73C$QPF/..3R#]3?0>7ISGO\
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M?0LD3HM'D?5CL^BJD1IAA]FWO3F/_]'[^$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MXJ8B45Y'+7MW5V=U%*:H\H_MV_%6U1Y(<HIL_;MVIK4XHAM-OQ&T*W-*1PQ
MI7A39[PKPF%G<7=M:T;(\F0_=BC!?*[< &MK]*MK),Q"@#?W8JUC;"'8'.\=
MRX;00W8U.'FCWI\G_]+[^$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MC(1M/#9\*;J_6HA>(7C !BZFZM3]JGDO1<QR-.# 7G^Z,/>4G5+(1M.\ #:
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MN/;([8FL\32.&LKH&X>02UL+*["0^0C@:8!12$ZU?__3^_A 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MJ ".\K/;AB(K+C;]Y==/NDPMX01&!0;S\-ZGW;4V]=\UE@KVX\/,S;&X/X8
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M@Y6M#178  **%O0%H' ]@PW[/WJ8(\W_U/OX0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M6B!#EX@[5-$Q,\$.48_M./>I*H<@H?B/ALJH6KJDY<?B%/(B='__U?OX0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MN]*\H(MYW<61 V#N]@HJLC[5W*4'MW]B)1 [%-451 Q]MNU1"$U IJ5J<O\
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M)3;VCLKNVJ8@JEY3LQ[:*:)J_];[^$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M::U%>7?M)&_!;%L5:U\TX<%$0%YH!CV;,=Y6>+:->^^%W%EY YG-YM@I3?N
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M:."FAP0+>SV]ZD2EM!V_4I*ZO__7^_A 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M^Z W&0DCMP43I&AQXMJB8&M:UOW0&AHIL % J)7K.5H+G'P@%Q)V #$D]E%
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MK9BB8G1+3B/J*)B8?__0^_A 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MD\4VS6-5"X<;J=MC&[\MO+)>.&Y@/AA!&]V\*>$5+M?=9)M&@-:  T-: *X
M8 *$T4+K!H?LQ#'G;1CCO[E*LKJ@<"TX@CEP)!Q%-H0G50=+;VS6Q@XC!L3!
MS//N'VJ59I">*1T@<XQ.C;7P!Q',6_WF[E$IA5]MR)2$?7MPKCQ1/I2$?;[5
M0\U)S?K&SZ4/)0<W[?AM%$3Z5%S1[_;:AP4BP</?AP4)K#B7K!FDMKI:7([-
M[FW>H6OM[@L/CBREF-WB*$><:15X<RP9[J6=,<_N<EVO%%^YC+?PLU]?+V<7
M0;/-+ EX;$!M! ;2@I@!1<7DLT=XV^XUXN*<VTF3S#RB1CARG<N+S65=AV>X
MX..\QTF&%WY=7FO*PC$\!L^M</N+:0[7L\_!KC])$CG?'RTK1G+7E.\.XE<#
MNK9B7;MCGB8B5J_3H9)'2,XA[2TM\)- <<.Q<'GQS,2[1M]S;%ULS.FJK;Y%
M*PB$1 4\4+G&@Y=[*=GU+0NPQ=/5[7(V;N8]R/3'H;-E^2.>YG-MP'*UO* Z
MM.4C:J_*I-(A7)NHNMK=.CDO*\KC@C#7-+0  #LQ!%*5WU6UCQ].K@]UG^96
M(;-#.&-Y2&AS/O\ >-[:<=H6Q,4X./B.OCQ83.<T_+HUX:YM7,<#L/\ >QV+
M#=EB)]+:P[7KUCC#C7,,Z?.'CFY7-);(*X->,,.S>%HYKYB=.$NP[3;Q2)F-
M8Y-,O<Q-31W,:'$8BOO*T[KW-8<$>#6KF\>\.:3X7-(.T[MZP77RW[,,1QAK
M_.7>99R.)%.:%QWL.P"N]I59F9]^&S%E-;8HH\SY82VE)[9^(WDLQ:>XA.F(
MFL\)7I3BK2.YV,F;]YHYP.(_$TI;%)FWQ4NNB(T8>>Y%'Q-(!)\Z UQ#MKH\
M>"V[+-8F?6ULEZZL;\2-!K4XAPX.&T*U^.DL49*Z-;U/?&"CFF@-3]==BY'9
M6=7%Q.^NZ8JT.+.*OIS[R1CV]JY?Y5'#1EF9U5[O,?-M\34A[-IVBN.Q3CLZ
M;M$9;NJSUPHY+FPCDD87#POKMX@;,5;<63,1*-M=K,*^>YSR\CFO(H1O(^/:
MJ[>RL3$K;B[FGR?.R^,5?L>YN!/&JC/CI*-OD]VGFSLV8"5U0[$1BA-,*NWK
M6B)AL71U7>I<6M_2F-./'#O*QWVS*^.[I5;J](QJ3A4'[>Y1CLKHMER?Q,,[
M-7L(%:DF@IP[5LQ@BZ-&G.YF.,LA;9L6T .W;\=RK.UK";=[T\99,9IST#:E
MV%17 5W$J+=I)?OHK6)74,KI' [22#OY?<L]NUTUAJY-]KQ;78VYF J,<%EM
MVU)X-3)OHF&W665%SF-8W%],:8 ':MO%MYXRXK<;R+=8ER'E.1?RP(\!OI]9
M7(XMOXN"W6^CC5RKDFG.;D/EX88\M/>N1Q;>FC@-SO:UU<O9)IP.Y/!X6T_#
M]XC<N3Q8*<G7MSO:1.KEW)\C9$QKW-:T"A<]U !3OV+D<>'E1P&XW7FY!RS+
M)+F@MVF& &CIRWE>^E*B)O;Q7(8\<6PX+/N)NX3HY#RW*HK=C61QANSF=M<X
M\7G>MJVUQF3)X-IM[<- PI[=VU9HAJ77592./8*4I]'O4TI&K#,U7 :/;?WJ
MT:ZRC@G[3@ ,22 *;RI&/==R2O,67L$SQ@Z=QI;Q'8?%^(]BFGBIU<K5+^G7
M#Y^:2:HY077%:RU.)9#&<& <=JFL<BDU9>&"*!O)$V@VDG%SCQ<Y1Q3I"MR]
MW$[P$*IJ;<: 5^&W>A5BWR27[W6]JXQVK3RW-T#1TG&& CZ2K4B-9XJ:W32.
M"]9!%$88(F!L432X <=@+N)[U%>,IZ8TB%W10M$)@#\?J[$2FY<?K^U$51H>
M'N/'8D";EX[CW]JF$:H\OM[T*(T/#CVU4BE<3Q6L1EF<&M&  /B>[<Q@WD[E
M,1,Z$S$<6/BM9KV1MS?-Y(FD.MK+\(&ULEP-[B-ROPTA6/>FL^QF.6FRFS
M4P55JPAR^V['M2B)E"GPPQKQ4JU*?3W\$\U9\T'OCB:72O9&T?B>YK13CBD1
MKH5HQYS.%SN2UBFO'TQ,3*1X_P 4CL%;IF-9T4F^.2VNKG,(V<SW06H>2V*"
M,?,7<KC@&C<.TJT6QZU+KKHXT4K7(&S2-O<VDFO+FG-'!+([Y>V!Q \L4'-Q
M*F;N5JD6Q.MVK/,ABB'+%&R,;FL:&X'=4*J]=%2GOWUWHBIRCM]AO0J<N/TH
M5.7Z=BFB*G*A4I^Y6C@B;BFW9[=BM16;D*>_ZJ]R(JC3W?VJ452T'MQ/!*$S
M0I^X8*:(F=0CWGVK17IHKU%/LX[MNU31%4.7:K1!5&GPW5I[]JLBH&]WL4*E
M*^WV!7H5A"FY2:4J4[P@A3ZMOU[4*<D*>WT;D*%%**2__]'[^$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M\NU93"CSAA4CE8VHW[U$>9-&P6< @@BB'X& .(%.9Y%7DGB2JRED&T:"XX
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MM0ZI*>VSM2B:H42B>H(_LW\<4HM$Q+__TOOX0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MK004^GLH>Y6*I"/;O4E0^V*E(@(5?__3^_A 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M0# LC(VGM28A:+ZS2%N<MBC8(XV -'O)--KG<528B6>R^FG!B[C+ 1]VE>(
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M+,3C,N\CG+DO+-/-C:"6AK0 7.(H&@4VFBV;<4.+S;OS;SEN3/N0!$QT-L*
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M3$E/A7Z43%R6FSXX=FU33DM$Q1"F.SX*>28H_]3[^$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M>"W/53CAN+\AUP76]J=ENW"64 _YSMP/!6TC@C6>+.PQ,8UL<;&L8T -:T4
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MG=[;E)5"GM^W]J)JA3AO]_P1:J%#MI\<*[MJ)KIH_]7[^$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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ML@4T*BM"!62BH!!"GM^Y250I]G'X(FK_UOOX0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M(J\(%9'H%:#F*8175%2E!$(A$B :(E__U_OX0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MA<T4)+N.SM)&Q"5*\;S6[Z$M<'-=&=I\QIJ-G'9@ICBB9T5&749CA<2:RM!
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M7T<5:$(;=N\_2>*LA&G]GUXJT41-2G]M.S9BI@1 [AW]_!2DI\<?>.P?8B
M]XKM.'91 ^C]E<428?LV(/_0^_A 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MJ-^-:XA!_]'[^$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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<>*_O00IMWTPQQW((\/MX<4#?4>[#"IQJ42__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>silk-20191231_g10.gif
<TEXT>
begin 644 silk-20191231_g10.gif
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M^+ @UH-;W&+-9\=9LPL+3[HF!9%69H9+<0N  @\"6VB!#UM;^#9   $P@$\
M"R3@3YU>#5 <!P$0MX59AB7 &@$,Q+/!IM$%T,$^#-@&Z: +;$#< DP0.BD"
M!72PQ66,>O_5SZP 9 % /;;6*I!CCNU::Y55QJI3%K/V(U _*_2#'5&VX@K
M"K?J:BNTM1KKJZ[.,JMKM'66%<"AAA8*[KCBEAONN>2B:VZZ[):+3[B'OOLM
MH8=^>RZ]Y1)Z[[N'FL7O4O_Z&Z[ _=I;<, & SQPPF8%\)Y$\2"PP<$+(VQQ
MQ1A3K+'"];;+ *'S?@QNR!U_K.['A<X[[\C_RANOR/:N#+/+,;\L\\TVQZL"
M41?QEC+(0 <M]-!$%VTTT"B#G'3*)@?] *&<!%  S/0N_;/205NM==9<(]TU
MR/@@L.A$@7IM-M9GZ_NUVFE?W331X!80][M3%Q"SRD#372_(4=__??7?2P>>
MMN!HLYWR;B1>I(\^V.'J.*^/1P[YY))73OGED0O$;..01XL=KP-Q_OFVMW9.
M%%'+ H"ZZJRGOOKIT<+N>NRMLPYZJQ,-L)OLK+]>.^_ _RZ\[[Z+?OE N6[[
M./*:E\Y\Y]<ZF_KGCO_::^?85Y_]]=77/@ ^7#VTPCXIOZ>%%LD+2U<'!32D
M50?^O)<  NJ7.  #X3NTPA;S0$=D%@E80/I4%QF+\&PA\@A6 K.PP/HUI ,=
M: @!3), (@T@ ?8(%ND<V"CP1:0#]G"-_!*@0: <J@.1&< ^^A(IN22P+T>1
MAU8"$(^^I+" JNL H0B0!?*A3"@'Y.!!_SH0(88,:E(DZD<"])&K?=BMAK=:
MG0I[11 -;J6 &AR(/*C"%1D6X(L! ,7#A B10>7O(9))' "VD(""#& !"YB4
M7 *@!7MH80N)6LINZ.@O!.!F?D'9S:3BH0)\N&IQ^ # !I98&2F0D(P(P5U#
MLB 7@=2C3P-A(P,J:!A\6:I08)1:ICKP+M,0$67OBD<#"D 5!.@# 21RE%GH
MP4E(EM&#%[%' I)'R40A &5X@B-N^D=!Q!S!1@%@@FD<69I;G"8!;"Q-V+90
M#P;@$3J)4J,M!\(^BFB!?@()%)_ AT=]<"!0O9E';[: #U%ITC9X9*,CH3FU
M $R*CA;\93UP8?^5;3YD4&.SB#[:2) !#+0!^^C )J-33A_U!H.(05$"K(D;
M1[+QG'WRAZ?8.+\!="!#E=F"/8KH3X$4(!\3R<(K,^F;K;B*!?JX8X 2Y9L-
M@-0J!,#-%G0#EMVP!A^_8><6(M0!!*B2 -$IJ?MP:9'2N#%26@R /0B@@H]M
M@ &_!.,6)H55!F!U4_[:X>D(L $$& 53&ZBJ%IBB5($0<8 .^>9 /M84>=@S
M7EM%@#VP.K7%+8 T]MS"(O7*&JG&@P'L"X ^ @ /CVX@H64-0%NSXBF,0--:
MURI( E6'%KG@2AZ43(MHT0*M2D)+@YXM+5I".]DL2#(BE]3"0"HY6QBE-G8K
M*Y0+5578@:U I0&X[0OR]@&5SJIE*[":;$'(1]**]"F(RIT) =HGD2S<,;H^
M^9X*,*(%@F*7)J^-R/R^RQ,S?B4!F"4O3/)!78E,2KTZ^=X9*0)-^,9$'O&(
MH$3J,5[[WL2\%^E3<OV;DFZ2#9P$ILF@)'N1[B;8)>']IUP?/!/RS9=LZ*7P
M2B!($:=J.":#:F]%ZOOAE!2@,1)1(H)+W!+Y_WY%"P-F,4@X?& 9NP3 %G&P
MC4L288<,8,([5HF+ YSA((=$'NSUYA:,+.0 ;/<BEV5R2/*;4B!+N23,?7&,
MKWP1 TN$Q%PFR??TFV/OAGDC/7;(>\\\$AP[M\ALSHB7Q2O;.(=DS)9=LITS
M<M+<[6;/('$S100,Z"Z+&"*E26^A,[)@[IIYT1(Y*5P9<LD50QHC%CZOHB_M
MD%9ET2'ZL >G-3* #327OEO8]*@7TN?]]G?5%AFR10@-:X?,&2*8K'5%!O7D
M,NNZTRB5B.XL_>M_,O7-JBXV05@)78=X6-EEA"J4]0SM2)*YC*2I-D2R'& 8
M:WN(IWZ(%O3Q;1_CH__7%=%QN9&79DKG>MT*$32&DUUM*D]DI?".][%1;2RY
MW'8?"#TKP(FKE8$+/. %1_AO";[P@Z/EN[=V2#VLG&^#R%LBNC06^?:V-[;5
MRVH=_]G'@Q9R!%SEN^UF"!LKGI!&*XZ@DRD <<\*%=PBU^8UI_G,9ZZ5G/,<
MYT&Y<$FG<FC]_3DNODVZTI?.]*8[?>E;QFZF>[9+ ,2#K2RYG]!+FO*%7!<
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MCP2@DK'G>NSSDKU%1!#$2C;)/D14C-B%?@HQ%7TR4G&H8X1R.IE36G%X*RM
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M5P/X8/B!W_F"[_F$;_B)3T/%9>+G:63MG1"?EG$L]]I57P]I,7.@\"V<'_B
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M9]_.F^7+Q2;)ER>O!1]:BK(-9NE %A\\  ,2<"!@U1\H?U?Y%R!@JOS\VP_
MJ>(!104$X]G/'P"S(L ?JPA0<"A\:))I,<5 8BR!P;@8KCB3M" 1'Z(F?"K
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MN Y@"GV0P6;QQI\S,68!.LPR2(/ Q(/P%8'C/#;3@BQ8%051$!G!"ARYBJG
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MQ]C2,@V,A$+"+@-3H9$I,@U#KV'3+P73.0T,+?4: S3 .WU3>TA3,Z53]3-
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*.I,7VZZ>@   .P$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>silk-20191231_g11.gif
<TEXT>
begin 644 silk-20191231_g11.gif
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MF@!0QE]!D1S7PXGUX)?!/0(,10 06V1RLB4LL(DG CQAX?:A0@>8D8/C* 0
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M!N!8.U%V"N / B !]H$! ,1S*K N!P!XQ'92I_>&0!<'!)@3:M< [.!Q.6$
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MF8_+%)$+=+0 DG$K%[K9KJ#+NW8ANS/KM3^GM\4[%T6ILLKK%Z=KCX'I<E!
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M''(E#L<20P:&(/\9,RFD ^;@P5ILV!0T*<A7,2D5",WCD&H0P$!?$(\F,-.
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M7<+'QO#)Z4"XKV@YDY0.BO\T)M:+N)AXBD5R%"R\B<8PM5@\@>T8PY-P2[.
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M>\778Z75-MB <L  :\U7<14-6K""0U 36DC7@%58A5VL[50( U !%U( )6F
M=P  %2 $B^66A#@ !O"'?DB2!)B'=V" =QC9DCU9DR59E66 !&A9#SC35S*'
M<K@&.+ &"6" >6 '%=C9)$F2E?79)(D'GQ79D)V'EDW9G U:I"W9GSW:HH7:
MH'79))&"'K@4,%@'I779K6W9KN7:K_7:L 7;L17;LB5;LIV'D=T$5050>F"
M!3A:DOU9:]@JPMJ F;6&O-4 .##9)#G:HPU9KYV'K1U<I"5<D159DTW<P1U9
MQE7<QE59R)5<Q&5<RD7<KI5;DO]U6<TMW*X-6I;-7*:=6LQM6J U7:5=VI]E
M@)78!P80 -5MVM0U6L.MW-J]W-LMW,M57)3=W,+=W=_UW>#MW02@6PN@ @9@
M!]D5W;B-V])UWM.%7I_5@$3YCA*P!\#UV<@%W>?EWNCUWNX%W^\]W:85@ JS
MR AJ@'B(&XN-@"-YA[=!@'59B+8QB2&XAM)R)S=3I3;@ 4!:"]>(@&K*@#RH
M2M3 @U*4#*3Z+71(IW0*J2U@8#WB@3X*I"^04\CZ@A+XA2M1, 96PJ[8C;XZ
M!&B$CT2=EJ_$B'WP!VU1@$NE 7_P$P5HH6RJN9&(@RRPH[NU '4@,!2P@S9(
MIUGJ4S__(J0+GHD((*H\,('-3+(EPP.'0 %^I:58FBB"(#"7^B,@5B4AYM]<
M4B) 2Q,2;HZ&[( >=0D=$N$7W9(OJ# ,U:;4(HC?J(;>(@!Z*(EZ,"=X@D%U
ML -62B=UVB- (J3#L(Y3.P[]I !2^$:'4(<%HP(4R.,_VC<+C@!(]F,+**D[
MPJ,^$N3_[;"5,&/$8"H%*SW,#(.^$F$Q5@]8&3_%0HF, H"5PTN/LB4\HB4^
MZH!M=;M[$Y/^;#HZ':6$:V19HH(/CF60B .\C "0 F);/JD]\J-<+B39DM>Q
MG X4Z*QC,^*06+@1"!4\*%A55H\OV"<W=@F,O MR8J4\DJ4M_XCF0?8*3>!E
M_D0,*,@#^PS2A2!4\_)E)U/G#FAF9W:G7()GAO@C3-+#<78S"[B&ZAPZ,>L-
M2:'0^*"P.VO&\*OD=.@C*L8C=\YE3ZX*>9Z-#+B 7O*+>[//*9"(?6X#<#H3
M #  +,8JCLZC6\IE=5@+ ]@C3.+!Z1@D5R(LAZZ*A9N ",.A9;PZ<Z:YC?R+
M78)D5^*J9[9I0T(J%-AF@M"$=-A/V_.*V' 1 %5I]^*LEOZ+H$CF06+F(&ZG
MA>Z JXY.,9MHORBD=7[F/_;3H8Z"HJZG,=).BRP)%'4. [!D-SNI9_8C03*\
M+<C*? +2?N:1V%P6,EOF6-H"JVZ-*__N8X#NZ#KZHU".#RB@#]2H9%<JJ3[]
MHZZ*)=-K"@/(Z]Y@T*-&++\FB1J.SD)Z:K6NHUM2-0MPZQ,#4L_V"$0VN2=V
M+V/C["7]B^G$X6MHYU4JZ$GYA3%#C+DF[(EZY"*2AXKRH_)[ GUYE@2]H0VD
MTI<HJ_LH!')R)9*J(W,HYMY."2((D]<\XOH,9HGX@H:T  QP[T^QY9)J+KK>
MJNL.EEW["RSRXW:^I9EL".2^" /@*S5Y@OU6QD5-"CN^$CR&I3JB KI[";?$
MYP+V"!/( ]?,9X:P.^J4\$^)Y$1<*!1(!Z["HUMZ[BJ!E->^BCCPJ(76<!0
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M1?,A_CGH"7]1 IU%Z50(OE H</?&I(/L,>R__/T$+8'WK!/ H9=GM42I'66
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M)6MWT)*^-)*%_YS;*>,$ _%0 488$(]J,N"-G2L4IE/]XX&YN">/4P$-$,"
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M@Q I10.LD3^<Q@%@0/! RSL &P+T(-<(&\,MVP*<QORIVU34P]: 6@?ZH 0
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M-P( 1V* )A  #0"/1HHE3@X3.^RDK1DE%@  /:1?^B6% ;!##.!A#+S136)
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M ZA ,E6#+0* /[S1Q5(=!"RQNN5HPH:JO;WO\>RFA)1[M,1!#^1!#UQ 6D=
M# "*60( (50K/K"G!#S./!# .\B##/8K@@+?U$T.#<BFV# $>!2%"3P5FR:1
M66=04A;CI\D@0"=+F>2$.O_DY22^R%SR&GL2CQ'\GF@J+,O^)RK>FE1@ !90
M2C4P(;?/&L&4N[8C[M;T;CAK\CD]U0%D]++MI@P"V\5WCPDPA!I6RLSB!'BO
M!;+W237LR]8]00/P2PGLR]9O/2T8@%%>!,#N'T!"@( BX*U!0 2,4E+&P_ !
MK3],:S\<P&?^Z#N,&FZJD3<30 *,6CX<JS+*VMB84E.N4<YVR100P>(OO@=X
M  50 !$P/N5' /"<)#&-YCM3+B\EP&UPJMF+)><L,:\1ZZYB@!HM"]>8TCO8
M@R(+M&R*Y'7^G[<F ":B2@2@@!THB$*@0QOPOH)$ !3L@V?:0S(9&+"-)S A
M:$3_0,'E>'.<C-;SJ@ ^8H _;-,\*+_!^\-!:HTI67#PA69$P .JM;T %-_E
MQ(,)U!J+R(-1O@/Q:\#ZCZ<#EE(#&(*7K4EJ7@V7A3E -  PD&!!@P<1)E2X
MD"'!."761"P2<<V$0Q0Q/@'00(  * <($,!PP)"Z@0T,)3!$   [*!$8Q$&
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M"@ ( JMG-'4,:$"G@6C?MDX,GG/=^X(T&7I%W8]O 'BZ#C#I^-R?-^'0@B#
MH)"!N-\I#DVZDL\JW2%X$L[ JE$/@6  3=\SX$#J4:=J-&\@>PPD8,_HM:WU
MA6\GOX'"^K)7B#K!J2N:X)X!HD>(C9EO174J! 'QM)'$ 6!Y""A$Q42RDVUM
MRP#A.T!R<(> [AW0-;5*B 8T@"[6\9"(12Q(\8R81"6RL$Y+=.(3PT(V@S0
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CPQWV\(=!'&(1CYC$)3;QB5&<8A6OF,4MYC"#[QB & 0$ #L!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>silk-20191231_g2.jpg
<TEXT>
begin 644 silk-20191231_g2.jpg
M_]C_X  02D9)1@ ! @$ 2 !(  #_X1<)17AI9@  34T *@    @ !P$2  ,
M   !  $   $:  4    !    8@$;  4    !    :@$H  ,    !  (   $Q
M  (    >    <@$R  (    4    D(=I  0    !    I    -  "OR    G
M$  *_(   "<0061O8F4@4&AO=&]S:&]P($-3,B!-86-I;G1O<V@ ,C P.3HQ
M,CHQ,2 Q-3HQ-3HQ-0   Z !  ,    !__\  * "  0    !   "6* #  0
M   !   !V0         & 0,  P    $ !@   1H !0    $   $> 1L !0
M  $   $F 2@  P    $  @   @$ !     $   $N @( !     $  !73
M     $@    !    2     '_V/_@ !!*1DE&  $"  !( $@  /_M  Q!9&]B
M95]#30 "_^X #D%D;V)E &2      ?_; (0 # @(" D(# D)#!$+"@L1%0\,
M# \5&!,3%1,3&!$,# P,# P1# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# $-"PL-#@T0#@X0% X.#A04#@X.#A01# P,# P1$0P,# P,#!$,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,_\  $0@ ?@"@ P$B  (1 0,1 ?_=  0
M"O_$ 3\   $% 0$! 0$!          ,  0($!08'" D*"P$  04! 0$! 0$
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MXL+7M]I;4X!V_P"E^;[%?I^N_2[0!E=-R003#6$6-)^+2L"MN3F.9E,V69H
M8[: ][MD?FN'HM^G0][OYSZ%;/3]*W?H6T9>-GU7X["<=Q(=5L81M!L9MM=Z
M>[]RS^H],G 1T XM.*.FX[?WF>B:VC(DQ(XNH_[EU^G@=;J,M=A5-S+S90[1
MXKO95E4L'[K;;<?*5I^$ZEWI;=K!]"!I"IX-]EN8]K*[*ZLNL-I=8T,'VBK]
M8J]S?\':[U,.O>[?4S(6I7;3=5N=(<. 2949U$34A8[;>:H:<4;CH;^;I+U-
M,5.8[1:W3GN)"H6L8W5IF59P&TEPWN ^9'_4J7']?L8LI'A]KU.*'%HT5P"
MN9R:?JBW*G/R&597IMWDW/K:ZO:2QCK-[&/]K]_TO]$E/U(: T9]>UUFYP&8
M\[G-:ZN;'^LYVRMIL_/]%60TB=7ITES3/^9-3Z\@9[&FO;8QSLVTM]CA;6X[
M\C98W=L?[_YW_BUO8>=AYU1OP[F9%(<6>I60YNYIVO#7M]KMKD4/_]+U54\H
M;F$>)*N*K;JU [+H[N!E"/:="2LUYU\PK_57EK]..RRGV_[U4GNW<8T2L>]I
MEKMO]70_?])6!F6,]U0 M_TUDVO_ +/JEU;/^VUG&^.2H.R8[I@D1L60Q!W#
MHG,ZI!+<VR7:%OMV_P"9Z>Q4SB=8R*K#5D55M) VNQZ+ 9/=C\?8@C+'!*U>
MFVMLQWLGW&81XY_O'[4>W#]T?8X6?E]2?A/HZRQN3C-:VMMV*WT[:VO+ZF..
M(7?8LFEMU;6/I:W$L_2_H[UAXC+<>RKHF5D,R.G=28?V3F-)---M^]F-;CES
M/4HHMR6?9NI8+ZZ_2^G_ #N/ZBZ6YAR\BS$VEUF3@Y===/A:RRO+Q_Z_Z:BN
MO_U:N<NRL7+Z!<RXAQJR[7XQ<6@!N0RC*NI_ZX^O*]'W;U+'.3#7U5H?Y?W9
ML1Y>(R4/3KH?W>+Y?^=%!TWU.GY]@>U]5X;L-(U.[8&M;8X'Z3;*KF>AZ>^N
MQ7[*KVX%5=#'^KCN;7MV.)>'5LKOV-V>VO;OIL>I7-NL<,W)!;=7:,6Z_0,N
M<:WW"]V[W?:O0W>OL_G-]%_\Y?>HLQK<C(NQA66M>&WZ#@M;&^O8?4^DZQC_
M /A&("N+7:4=&[1H$5&492XO[U_]ZMZ5V/BNKIKMWLL#P"TB7.VN8^MK6?2K
M=L]^[U/S%T/2'^CDU->UU;,K'%P:6[6UO!VV5$_RMWJ;'^]<U=EM9^L;AZE?
MZ,;##@2=MC*[/YQC]O\ Z-6STJO)^TX>:VFV^MMCJ77L8YWM.C!Z?\]Z;MW\
MYZ2@,"91/#*1L\5:\-_^A*RP&,\7N1B)Z1CMQ"N+_FNU::W-,/!@R-1.O;_.
M6ITG)Z9A!C\O*IJMN#O08][1HW^<?J?/_,_XQ9X-=K]M,V->^ 6">3MA;N=D
M/;6VK]D6YE.W5@] QL+=K?3NN;^;[JOZG^#5K!'<U5.?S4SH+N]6GE9_3[LH
MWU?6&BBES8])IQGM]H]I]:UKW_2=OV[U!N3@!U=[OK#0YF+L9D./V<-?O-C]
MESV;6U^NRM_LKV?S/J*TV\&UQ_85K":R76%N-JUFM='Z.][G6;K;-M?T/YW_
M *XQS[@PBOH-^U^KFN^SM$^YK-P;>_\ \PK_ ,Q3M5._JGU<+'W')Q;&T%MU
MCFN8\L)'I57NV;G,]C-C+?W&*YAY>)ET"[#L;93)&YG$@^X+.OZA:Q]D]%R;
M:V;XL:*';O1+P'-K]?U/TC/Z)[?4?ZG\W4M6NNNML5L%8)DM: -3S]%)3__3
M]55;(:X D<'NK*220:>2ZJPZF)"P;GEJ] R^FXN6V'@L=^^PP?\ R+O[;5SF
M?]4>H@EV'?5</W+0:W?Y[/58[_,J4$\1.HU;.+/$:'1Y:RUWBAFTGNM'+Z+U
MK'/Z;I]I'[U(%H^['=99_P"!K'M<2\L8UQ<WZ38((_KS]#^VH>$@Z@L_'$BP
M04@L]W*W>C708<8"YZIHF7.D^#=?_!/H?YGJ+4Q; (T$>'*$QHN@;-!T.I-H
M;;7F-WQ58T^I42UP+_T#O3N;]'=O9]#_ $:YG)ZCEX&<:*KO5ILK=6UM;P06
M ^FZK[+>Q]..W?[][Z;K+/S/T=BZY]AR<=S#P1#G<;1V=/[S5Q_5;[*W66^H
M^AS&_HV@-W. <Y^37D97NL<ZQC?T/H>C^E_1^G[$(@QE9D81D/E%RR'L:_0_
MYGH76)$6.*O3*1].,1_YR/+-'HU9&<+#?AM+75N<!ZSF0*KMHW?2K937;^C]
M7TZ_YRO^;LLV.<,G%=6YNC'/=D- W.&P7[&EY<UFYYN^BN>PPXY#Z'-+K+W$
MTV<SK_.3_(]%^_\ <6[957TW-MQVW, K:!8YQ:&FS8=CZVOW?HMVW_!J4@G)
M$1!KI^D==6Q'@]B4IR''M*!](_5^@?\ HK7=?>R^VW(<YU3FE[* XUB6MMO?
M+*75_H[&5_SJWOJP&U?63J^#6=N)D8;+MIDM)K<VRES_ ,YWZ*Q[5RN??1ZN
M_+R,6'M+ :S?(!!K=_,BRK^;<_\ G*%T_P!7,SIO[7OSJKA;4[$;B@.W-G1@
MW2^MGYE:LPC*AL=^H_)R.9(.21JMNE"J>G=T<"YK\;*MQK.:Z['-M;IQ]FR,
MEEK_ .K7ZU.Q:F*SJE<"^Y[X_>9_WYMBP!]9<-CWX[)M<(W4P'@SSM>[T\?<
MS_";;UJLS+<9@L??CXM4@'?D0!N^AN:YEK6;OZZ5ZD=1NQ4:!.QV=RMSR/<9
M/PA$!6;5U7$+27]0Q2&M+W%MK3# 6L=83N9[&OLK;O\ Y:+5U?I5ABO.Q[7;
M2X-KL:XD-^DYK6.<YVU%#>20L7*Q\NAF1BV-NIL$LL89:1^\THJ2G__4]56;
MD]%=?=9:WJ&91ZK_ %-E5C0UIVUU;:VOKLVU[:?YO_2776?SGT-)))3F#HKV
MBT#J6;^D#6MFQAV0[U/T6ZKZ3_S_ %/4]B:KH;J[:[3U+.L],M)8ZUNUVV#M
ML:VMOTW#])_F?S7Z-:B22G)JZ%;4YCAU3.L+-FX66-<';'-+W/:*F>ZZIOHO
MV?H_\+Z?K_I%1^MGU=IR^EOOQF%V;C?I0XDN?:UO\Y4\G^<]G\Q^Y9_-KHBY
MHY*@;OW&.>?A _SG[6I&/$".Z8RX2".CY;CM;L:6:@@$><JPQ@K.[\/-6>K8
M;>G=3NQV@-J>?4J#3(VO/NK8?S64V;ZE7.HGA52. F]9-Z)XP"-(NET\VV[J
M6 $N;P5SG7,*QEE6.Y@LQ,H>I;H0][F/+,K#<_W[?0R/S*/39^FKRK/4L6YT
M^]]-S7L$N![Z#YHO4J?M8L^SDG(L)OH &T>O6W==0*QN]N7B,LJ_XRG&3([F
MSZC_ (R_(30('I U_=_E%XQG3:*,]S#M]*JRLAF/OM:T7>_T;[K/HNIOJ]"I
M_P#/W>C;^C_PBMNCU[FWVL%[7N<P.UW;6@#:_P#>>RI[/Y;ZT.]^37C8.7BA
MS@<JQWHLEC7/8&U5VWMK;^FRGL99Z+_TEK*OTE=?\XQCOR+.H],NW3MJS&-Q
M:C[G5_:*\AV50R-VZFRS'JL]-G^$_2?GV(U1B96:COOZFUAF3AE")'&)^7H^
M71S/2;FY31]-C7 !T\M +M8_L-W+6_9M3,FK"<7?L^S*K8)EM;QO:W<^J=OO
MK_L*GTK$==BV7[3775H^T.: QE;6;[-L[_\ "5[?S[K+%T;^G9'4<9U !KMK
MK/I-DG8]OOJ9J7>YCOY[_A_64?&1D'"?2!4A_P!%&>$90N@9:\5_HE-@=,HQ
M*:Z6SOJ=93:TF8=78^GO_478=-R#;@U4Y#!>QHV%C@"3L_<GV6^SW;';+O\
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M:6-K970\+W-T<FEN9SX*/"]D:6-T/@H\+W!L:7-T/@HX0DE- ^D      '@
M P   $@ 2      "W@) _^[_[@,& E(#9P4H _P  @   $@ 2      "V (H
M  $   !D     0 # P,    !?_\  0 !                : @ &0&0
M   @                                   X0DE- ^T      !  2
M  $  0!(     0 !.$))300F       .             #^    X0DE-! T
M      0    >.$))3009       $    'CA"24T#\P      "0
M 0 X0DE-! H       $  #A"24TG$       "@ !          $X0DE- _4
M     $@ +V9F  $ ;&9F  8       $ +V9F  $ H9F:  8       $ ,@
M  $ 6@    8       $ -0    $ +0    8       $X0DE- _@      '
M /____________________________\#Z     #_____________________
M________ ^@     _____________________________P/H     /______
M______________________\#Z   .$))300(       0     0   D    )
M     #A"24T$'@      !      X0DE-!!H      UD    &
M  '9   "6    !( 90!X &@ -0 P #  ,P W #0 9 !? #0 ,  P #$ . !?
M #$    !                          $              E@   '9
M                  $                         $     $       !N
M=6QL     @    9B;W5N9'-/8FIC     0       %)C=#$    $     %1O
M<"!L;VYG          !,969T;&]N9P          0G1O;6QO;F<   '9
M %)G:'1L;VYG   "6     9S;&EC97-6;$QS     4]B:F,    !       %
M<VQI8V4    2    !W-L:6-E241L;VYG          =G<F]U<$E$;&]N9P
M       &;W)I9VEN96YU;0    Q%4VQI8V5/<FEG:6X    -875T;T=E;F5R
M871E9     !4>7!E96YU;0    I%4VQI8V54>7!E     $EM9R     &8F]U
M;F1S3V)J8P    $       !28W0Q    !     !4;W @;&]N9P
M3&5F=&QO;F<          $)T;VUL;VYG   !V0    !29VAT;&]N9P   E@
M   #=7)L5$585     $       !N=6QL5$585     $       !-<V=E5$58
M5     $       9A;'1486=415A4     0      #F-E;&Q497AT27-(5$U,
M8F]O; $    (8V5L;%1E>'1415A4     0      "6AO<GI!;&EG;F5N=6T
M   /15-L:6-E2&]R>D%L:6=N    !V1E9F%U;'0    )=F5R=$%L:6=N96YU
M;0    ]%4VQI8V5697)T06QI9VX    '9&5F875L=     MB9T-O;&]R5'EP
M965N=6T    115-L:6-E0D=#;VQO<E1Y<&4     3F]N90    ET;W!/=71S
M971L;VYG          IL969T3W5T<V5T;&]N9P         ,8F]T=&]M3W5T
M<V5T;&]N9P         +<FEG:'1/=71S971L;VYG       X0DE-!"@
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M$0P,# P,$1$,# P,# P1# P,# P,# P,# P,# P,# P,# P,# P,# P,#/_
M !$( 'X H ,!(@ "$0$#$0'_W0 $  K_Q $_   !!0$! 0$! 0         #
M  $"! 4&!P@)"@L!  $% 0$! 0$!          $  @,$!08'" D*"Q   00!
M P($ @4'!@@% PPS 0 "$0,$(1(Q!4%181,B<8$R!A21H;%"(R054L%B,S1R
M@M%#!R624_#A\6-S-1:BLH,F1)-49$7"HW0V%])5XF7RLX3#TW7C\T8GE*2%
MM)7$U.3TI;7%U>7U5F9VAI:FML;6YO8W1U=G=X>7I[?'U^?W$0 " @$"! 0#
M! 4&!P<&!34!  (1 R$Q$@1!46%Q(A,%,H&1%*&Q0B/!4M'P,R1BX7*"DD-3
M%6-S-/$E!A:BLH,')C7"TD235*,79$55-G1EXO*SA,/3=>/S1I2DA;25Q-3D
M]*6UQ=7E]59F=H:6IK;&UN;V)S='5V=WAY>GM\?_V@ , P$  A$#$0 _ /54
MR2BZ3H$E,I"4A!#BF+X0M=PIY2D>*J/NCNA'(/BFF8"X8B6_O;XIO4;XK.=D
M^?/"AZSO%-]T+O9+J[VGNGW-\5E>N\=TXN>[24O="O9/=TA;6?SA_N.U/ZC/
MW@N??DFG(L#GQ)?M']88]P_Z3[50S>HNK##:\LJ<]M-YX(;:?3;>S^51;LL2
M.4(&$D$]GK?7J_?!^:<65G\X+A!FY MESMMM;C5D,' L8?3L_P"DWV?R%>LZ
MC:P#W%#WAV7?=S5V]?(3K)PLQ[\6FQQU<%<;<2I!(%B,"&TD@AY*F'%.6TS2
M3)TE/__0]40'/<T[FN)\G<(SOHE4+[2W7P_(D4A,UVB%;;M4?5 $C@C15;KI
M[J*4J9H0M:W(UY0?7E5;+?=S/9.U[0))B>)4!))IL@ !)D9!JJ<_^18YOQK;
MZO\ U#'*RVT.:'M,M< X'R(D*E>Z*FV['.;0\6N$#6L;F93-L[_?BV7_ )OT
MT+IMIKPVXKY?;@DXMA$?X./0>3.W]-B/Q[O^N(\)J_VL?$.*G3WIVV0J9OK[
MR/B/XMW)'(8QI>X^UHDGLFR$H[@A<*EL;<WJ&96SK;#D.BD !Q[" _=_Z*7/
M]1ZGD77Y-&8_U<;(+A4YHC:R?T6R/]'[5>IM;E=0?9;)L8\[&QRVT;_=_:;N
M_L(_4^ETW5BPU[G"0WW%DS_+;^ZFVRQC6C4W77]1JRG&?M^'BY5L<>KL=C9'
M^=9B[E<O<^Z^NBOD\GP"!C"UF'@M:T;O1LIW.Y'HY.6W;_TV)"P#<VMV^=+;
M!P?^#8?^K1)]2H#T#PL?XOI>CQ\IGMKK/Z.MH:V.\<N6I3:"%RN)?$!;F%=N
MC53P+6R1=JLRBM"!09"LM"F#6+))))%#_]'U1VK2L[)J$%SA/DM%4,T.V$>&
MB!V3'=H&V6  _1]O]RJVV&/XJ5D,!(U/*IOM]W\%6R'5N8AHM;L+@2#/P/Y6
MJ=3FM.D-=W+M#]WTD-EC2\2X-$]R M>C/Z:VL>NQ]K6\/&-98S^S:*G-2A<A
M5D#Q-Q_Q59#PZU9\!ZFEZ@T/J$GR( _Z*R\AS>GY(RVB<8,%>6R 0*0=N/F?
MU^FV6?9,C_S6W8UG_:-;EW6/J[<?2QW5FTZ;/L[RZ?AZ#EC9[JF7!A=C4N=+
M0RZRBHD.!8]HJO?59^DKL?7_ #:ECB/^<%'H-&"68=<9TU;#+#<\M &GD$/,
M?7C;6!X_2&-A.DI75?9NGU4UUX[<C<75M;;74=@&QE-3_4KW-_M+@^JYG4_M
MMV-U.FRL4PY]5K2PP28?;7[?7J]OLL9^A3/;G &_UD/TH?O?R_>9HY<<Y :X
MY?HRKJZ-OU@LZ=UC)R**69%%FUKFW.+"U[?:6U. =O\ I?F^Q7Z?KOTNT 97
M3<D$$PUA%C2?BTK K;DYCF93-EF: &.V@/>[9'YKAZ+?IT/>[^<^A6ST_2MW
MZ%M&7C9]5^.PG'<2'5;&$;0;&;;7>GN_<L_J/3)P$= .+3BCIN.W]YGHFMHR
M),2.+J/^Y=?IX'6ZC+7853<R\V4.T>*[V595+!^ZVVW'RE:?A.I=Z6W:P?0@
M:0J>#?9;F/:RNRNK+K#:76-#!]HJ_6*O<W_!VN]3#KWNWU,R%J5VTW5;G2'#
M@$F5&=1$U(6.VWFJ&G%&XZ&_FZ2]33%3F.T6MTY[B0J%K&-U:9E6<!M)<-[@
M/F1_U*EQ_7[&+*1X?:]3BAQ:-%< @+F<FGZHMRIS\AE65Z;=Y-SZVNKVDL8Z
MS>QC_:_?]+_1)3]2&@-&?7M=9N<!F/.YS6NKFQ_K.=LK:;/S_15D-(G5Z=)<
MTS_F34^O(&>QIKVV,<[-M+?8X6UN._(V6-W;'^_^=_XM;V'G8>=4;\.YF12'
M%GJ5D.;N:=KPU[?:[:Y%#__2]55/*&YA'B2KBJVZM0.RZ.[@90CVG0DK->=?
M,*_U5Y:_3CLLI]O^]5)[MW&-$K'O:9:[;_5T/W_25@9EC/=4 +?]-9-K_P"S
MZI=6S_MM9QOCDJ#LF.Z8)$;%D,0=PZ)S.J02W-LEVA;[=O\ F>GL5,XG6,BJ
MPU9%5;20-KL>BP&3W8_'V((RQP2M7IMK;,=[)]QF$>.?[Q^U'MP_='V.%GY?
M4GX3Z.LL;DXS6MK;=BM].VMKR^ICCB%WV+)I;=6UCZ6MQ+/TOZ.]8>(RW'LJ
MZ)E9#,CIW4F']DYC2333;?O9C6XY<SU**+<EGV;J6"^NOTOI_P [C^HNEN8<
MO(LQ-I=9DX.7773X6LLKR\?^O^FHKK_]6KG+LK%R^@7,N(<:LNU^,7%H ;D,
MHRKJ?^N/KRO1]V]2QSDPU]5:'^7]V;$>7B,E#TZZ']WB^7_G10=-]3I^?8'M
M?5>&[#2-3NV!K6V.!^DVRJYGH>GOKL5^RJ]N!570Q_JX[FU[=CB7AU;*[]C=
MGMKV[Z;'J5S;K'#-R06W5VC%NOT#+G&M]PO=N]WVKT-WK[/YS?1?_.7WJ+,:
MW(R+L85EK7AM^@X+6QOKV'U/I.L8_P#X1B KBUVE'1NT:!%1E&4N+^]?_>K>
ME=CXKJZ:[=[+ \ M(ESMKF/K:UGTJW;/?N]3\Q=#TA_HY-37M=6S*QQ<&ENU
MM;P=ME1/\K=ZFQ_O7-79;6?K&X>I7^C&PPX$G;8RNS^<8_;_ .C5L]*KR?M.
M'FMIMOK;8ZEU[&.=[3HP>G_/>F[=_.>DH# F43PRD;/%6O#?_H2LL!C/%[D8
MB>D8[<0KB_YKM6FMS3#P8,C43KV_SEJ=)R>F808_+RJ:K;@[T&/>T:-_G'ZG
MS_S/^,6>#7:_;3-C7O@%@GD[86[G9#VUMJ_9%N93MU8/0,;"W:WT[KF_F^ZK
M^I_@U:P1W-53G\U,Z"[O5IY6?T^[*-]7UAHHI<V/2:<9[?:/:?6M:]_TG;]N
M]0;DX =7>[ZPT.9B[&9#C]G#7[S8_9<]FUM?KLK?[*]G\SZBM-O!M<?V%:PF
MLEUA;C:M9K71^CO>YUFZVS;7]#^=_P"N,<^X,(KZ#?M?JYKOL[1/N:S<&WO_
M /,*_P#,4[53OZI]7"Q]QR<6QM!;=8YKF/+"1Z55[MFYS/8S8RW]QBN8>7B9
M= NP[&V4R1N9Q(/N"SK^H6L?9/1<FVMF^+&BAV[T2\!S:_7]3](S^B>WU'^I
M_-U+5KKKK;%;!6"9+6@#4\_124__T_556R&N )'![JRDDD&GDNJL.IB0L&YY
M:O0,OIN+EMAX+'?OL,'_ ,B[^VU<YG_5'J()=AWU7#]RT&MW^>SU6._S*E!/
M$3J-6SBSQ&AT>6LM=XH9M)[K1R^B]:QS^FZ?:1^]2!:/NQW66?\ @:Q[7$O+
M&-<7-^DV""/Z\_0_MJ'A(.H+/QQ(L$%(+/=RMWHUT&'& N>J:)ESI/@W7_P3
MZ'^9ZBU,6P"-!'ARA,:+H&S0=#J3:&VUYC=\56-/J5$M<"_] [T[F_1W;V?0
M_P!&N9R>HY>!G&BJ[U:;*W5M;6\$%@/INJ^RWL?3CMW^_>^FZRS\S]'8NN?8
M<G'<P\$0YW&T=G3^\U<?U6^RMUEOJ/H<QOZ-H#=S@'.?DUY&5[K'.L8W]#Z'
MH_I?T?I^Q"(,969&$9#Y1<LA[&OT/^9Z%UB1%CBKTRD?3C$?^<CRS1Z-61G"
MPWX;2UU;G >LYD"J[:-WTJV4UV_H_5].O^<K_F[+-CG#)Q75N;HQSW9#0-SA
ML%^QI>7-9N>;OHKGL,..0^AS2ZR]Q--G,Z_SD_R/1?O_ '%NV55]-S;<=MS
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M ', : !O '     3 $$ 9 !O &( 90 @ %  : !O '0 ;P!S &@ ;P!P "
M0P!3 #(    ! #A"24T$!@      !P (  $  0$ _^$Y(6AT=' Z+R]N<RYA
M9&]B92YC;VTO>&%P+S$N,"\ /#]X<&%C:V5T(&)E9VEN/2+ON[\B(&ED/2)7
M-4TP37!#96AI2'IR95-Z3E1C>FMC.60B/SX*/'@Z>&UP;65T82!X;6QN<SIX
M/2)A9&]B93IN<SIM971A+R(@>#IX;7!T:STB,RXQ+C$M,3$R(CX*(" @/')D
M9CI21$8@>&UL;G,Z<F1F/2)H='1P.B\O=W=W+G<S+F]R9R\Q.3DY+S R+S(R
M+7)D9BUS>6YT87@M;G,C(CX*(" @(" @/')D9CI$97-C<FEP=&EO;B!R9&8Z
M86)O=70](B(*(" @(" @(" @(" @>&UL;G,Z>&%P34T](FAT=' Z+R]N<RYA
M9&]B92YC;VTO>&%P+S$N,"]M;2\B/@H@(" @(" @(" \>&%P34TZ1&]C=6UE
M;G1)1#YU=6ED.CDW1C4S14%"13=&.3$Q1$5"0C-#14$U0S)$-T1#,C0V/"]X
M87!-33I$;V-U;65N=$E$/@H@(" @(" @(" \>&%P34TZ26YS=&%N8V5)1#YU
M=6ED.CDW1C4S14%#13=&.3$Q1$5"0C-#14$U0S)$-T1#,C0V/"]X87!-33I)
M;G-T86YC94E$/@H@(" @(" \+W)D9CI$97-C<FEP=&EO;CX*(" @(" @/')D
M9CI$97-C<FEP=&EO;B!R9&8Z86)O=70](B(*(" @(" @(" @(" @>&UL;G,Z
M>&%P/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O(CX*(" @(" @(" @
M/'AA<#I#<F5A=&5$871E/C(P,#DM,3(M,3%4,34Z,30Z,SDM,#4Z,# \+WAA
M<#I#<F5A=&5$871E/@H@(" @(" @(" \>&%P.DUO9&EF>41A=&4^,C P.2TQ
M,BTQ,50Q-3HQ-3HQ-2TP-3HP,#PO>&%P.DUO9&EF>41A=&4^"B @(" @(" @
M(#QX87 Z365T861A=&%$871E/C(P,#DM,3(M,3%4,34Z,34Z,34M,#4Z,# \
M+WAA<#I-971A9&%T841A=&4^"B @(" @(" @(#QX87 Z0W)E871O<E1O;VP^
M061O8F4@4&AO=&]S:&]P($-3,B!-86-I;G1O<V@\+WAA<#I#<F5A=&]R5&]O
M;#X*(" @(" @/"]R9&8Z1&5S8W)I<'1I;VX^"B @(" @(#QR9&8Z1&5S8W)I
M<'1I;VX@<F1F.F%B;W5T/2(B"B @(" @(" @(" @('AM;&YS.F1C/2)H='1P
M.B\O<'5R;"YO<F<O9&,O96QE;65N=',O,2XQ+R(^"B @(" @(" @(#QD8SIF
M;W)M870^:6UA9V4O:G!E9SPO9&,Z9F]R;6%T/@H@(" @(" \+W)D9CI$97-C
M<FEP=&EO;CX*(" @(" @/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O=70](B(*
M(" @(" @(" @(" @>&UL;G,Z<&AO=&]S:&]P/2)H='1P.B\O;G,N861O8F4N
M8V]M+W!H;W1O<VAO<"\Q+C O(CX*(" @(" @(" @/'!H;W1O<VAO<#I#;VQO
M<DUO9&4^,SPO<&AO=&]S:&]P.D-O;&]R36]D93X*(" @(" @(" @/'!H;W1O
M<VAO<#I(:7-T;W)Y+SX*(" @(" @/"]R9&8Z1&5S8W)I<'1I;VX^"B @(" @
M(#QR9&8Z1&5S8W)I<'1I;VX@<F1F.F%B;W5T/2(B"B @(" @(" @(" @('AM
M;&YS.G1I9F8](FAT=' Z+R]N<RYA9&]B92YC;VTO=&EF9B\Q+C O(CX*(" @
M(" @(" @/'1I9F8Z3W)I96YT871I;VX^,3PO=&EF9CI/<FEE;G1A=&EO;CX*
M(" @(" @(" @/'1I9F8Z6%)E<V]L=71I;VX^-S(P,# P+S$P,# P/"]T:69F
M.EA297-O;'5T:6]N/@H@(" @(" @(" \=&EF9CI94F5S;VQU=&EO;CXW,C P
M,# O,3 P,# \+W1I9F8Z65)E<V]L=71I;VX^"B @(" @(" @(#QT:69F.E)E
M<V]L=71I;VY5;FET/C(\+W1I9F8Z4F5S;VQU=&EO;E5N:70^"B @(" @(" @
M(#QT:69F.DYA=&EV941I9V5S=#XR-38L,C4W+#(U."PR-3DL,C8R+#(W-"PR
M-S<L,C@T+#4S,"PU,S$L,C@R+#(X,RPR.38L,S Q+#,Q."PS,3DL-3(Y+#4S
M,BPS,#8L,C<P+#(W,2PR-S(L,S U+#,Q-2PS,S0S,CLP,$$Q,#@U1C@R,T5"
M1#,S,D(T-$5%.3(Q1C(T.4$X.#PO=&EF9CI.871I=F5$:6=E<W0^"B @(" @
M(#PO<F1F.D1E<V-R:7!T:6]N/@H@(" @(" \<F1F.D1E<V-R:7!T:6]N(')D
M9CIA8F]U=#TB(@H@(" @(" @(" @("!X;6QN<SIE>&EF/2)H='1P.B\O;G,N
M861O8F4N8V]M+V5X:68O,2XP+R(^"B @(" @(" @(#QE>&EF.E!I>&5L6$1I
M;65N<VEO;CXV,# \+V5X:68Z4&EX96Q81&EM96YS:6]N/@H@(" @(" @(" \
M97AI9CI0:7AE;%E$:6UE;G-I;VX^-#<S/"]E>&EF.E!I>&5L641I;65N<VEO
M;CX*(" @(" @(" @/&5X:68Z0V]L;W)3<&%C93XM,3PO97AI9CI#;VQO<E-P
M86-E/@H@(" @(" @(" \97AI9CI.871I=F5$:6=E<W0^,S8X-C0L-# Y-C L
M-# Y-C$L,S<Q,C$L,S<Q,C(L-# Y-C(L-# Y-C,L,S<U,3 L-# Y-C0L,S8X
M-C<L,S8X-C@L,S,T,S0L,S,T,S<L,S0X-3 L,S0X-3(L,S0X-34L,S0X-38L
M,S<S-S<L,S<S-S@L,S<S-SDL,S<S.# L,S<S.#$L,S<S.#(L,S<S.#,L,S<S
M.#0L,S<S.#4L,S<S.#8L,S<S.38L-#$T.#,L-#$T.#0L-#$T.#8L-#$T.#<L
M-#$T.#@L-#$T.3(L-#$T.3,L-#$T.34L-#$W,C@L-#$W,CDL-#$W,S L-#$Y
M.#4L-#$Y.#8L-#$Y.#<L-#$Y.#@L-#$Y.#DL-#$Y.3 L-#$Y.3$L-#$Y.3(L
M-#$Y.3,L-#$Y.30L-#$Y.34L-#$Y.38L-#(P,38L,"PR+#0L-2PV+#<L."PY
M+#$P+#$Q+#$R+#$S+#$T+#$U+#$V+#$W+#$X+#(P+#(R+#(S+#(T+#(U+#(V
M+#(W+#(X+#,P.T)#0C4W0D$X,4$Y0D9&-#1$,#,T.$(Y1$0P,3$U-S)"/"]E
M>&EF.DYA=&EV941I9V5S=#X*(" @(" @/"]R9&8Z1&5S8W)I<'1I;VX^"B @
M(#PO<F1F.E)$1CX*/"]X.GAM<&UE=&$^"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"CP_>'!A8VME="!E;F0](G<B/S[_[@ .061O8F4 9$
M   !_]L A  ! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! @(" @(" @(" @(# P,# P,# P,# 0$! 0$! 0$! 0$" @$" @,#
M P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P/_P  1" '9 E@# 1$  A$! Q$!_]T ! !+_\0 U     8# 0$!
M      $%!@<( P0) @H+ 0 !! ,! 0               P0%!@$"!P@)$  !
M @0% @,%!@4!!@0% 0D! @,1! 4& "$Q$@=!"%%A$W&!(A0)\)&AL3(5P=%"
M(Q;A\5)R,R078H*R)9)#4S08"L+28Z-D-28G*!$  0,"!0$& P0( P8% P +
M 0 " Q$$(3$2!09!46%Q(A,'@3(4D:%"(_"QP=%2,Q4(X6)R@I+20R06\5-S
MDQ>B8S2#);+"5'15)D1D)__:  P# 0 "$0,1 #\ ^_0Q,1$:GI"&8Z^9P(1F
M)&:H0U/C[\L"$<%>/3/VYQT\,"$#'H<X>'CUTRA@0@1E$DY?S^[3+PP(0@1U
M.FNNA_,C A 1&1)\>G\CG@0CS\3[X=8#WF.!"(&&L8=(^$(],@,"$(^&O0=.
MHCD,QE@0A$1@#'3PU)))P(0C#^.N1S)(\8DX$(1'4^.A]F4<LQ@0BW#,_?[X
M0ZG A'$>\1R'4]/? 8$(HCKU$8>72),(9X$(R? YPCU&0B<STUP(0B<\_9X9
MC+S&>!"(&/7/+7+[H>(.!"$? YZ^/E#+VX$(1CJ? PA$9:^W A $$0\($>4(
MB/F!@0A'7/SAK#4^W*&F!"&L<]"8#P/B/$@=,"$48ZD9QRA$>W(@C+QP(1@Q
M(!US'X1,?".!"$<\SX:9QRZB&4<"$(^?LRC$PATTSP(1 PR)TRB/+VZ8$(]#
MX>[H"1GX0\<"$(PAG#0?Z9^ .N!"'X:^Z,(Z^V/E@0@3#(& U^^&@ZC A",(
MYQRCURC"&1C@0@3[]"(B/3I#.).!",D9B/3W??YX$(1TZQA^ B3# A".F?D1
MI[3[L"$(PA^/@/:?+ A$#DGS!\AT_(8$(P<A ]3[.ISCI# A%NR\(& Z C0>
MZ!C@0CB?;\1'X>9'7 A $9YC6&0_ #Q.!"$=<]('W=88$( CV9 Z9"/GIG@0
MBC&,#T!\8>.!"&[7H8>WJ?YX$(XQ)SA\.FIUZ^8\,"$41[(@QT]V<?# A&"<
MH^>F>FG3K@0BCF,_&.6>0ZYD>>!"/<,L]?QR\/;@0A'/V$ F&?6&F!"$?/K]
M\8Y >6F!"+=_ZLNGMR\@<"$(ZB/74^WI[,"$%'(_A'Q$-/' A JU@>A/L.0'
MXX$($^_0B(CTZ0SB3@0C)&8CT]WW^>!"$=.L8?@(DPP(0CIGY$:>T^[ A",(
M?CX#VGRP(1 Y)\P?(=/R&!",'(0/4^SJ<XZ0P(0!CE[1#Q'E[B,"$?C]CG[X
MQC@0AD/='[O#7RP(0TAT_P!.D(ZPP(0&7D#T\/QUSP(0'3S_ -=<SK@0AI_'
MVGWX$(#\#_J?' A#\!_&/C'2 ^[ A?_0^_;QR)\<M>GO.6!"./EX0R_'7I@0
MAXG/[LS_ #P(0)AT/N&!"$?;E#I#_7I@0A&.6?Y'W&(_# A"(/E'W8$(1]NG
MA_J,"$1\.N</X:QCK@0@<L]<\LXQ$,LL"$4?#//*,>L="==<"$ 0 -<SUB<_
MNU!&!"$==>D(F.ASTC#/ A",(F!SAKH/?GUP(0TCJ?+4#7+PA@0A']6L//IT
MT(RC@0@<QH?<=-/'3+ A QAF"3F,@-(^,,"$,X1()SAE#,=(Y9C A")AXF)A
MUZ:Y# A%TT4?"'3(:$"$,"$8B![#EU_A$PZX$(9PS!R@0!#[AE$0P(0S@8QZ
M$ >,<^FH.!" C Z^/37V$>_ A$.HSA",,B<CX$:X$(\R>L#&/B(:=,C@0@(G
MH0#'6!Z =1@0BSCU$?&'XB'V&!" CED0-#I&&<"8C A&(QT(&0]PCK$?E@0B
MS!ZZPS\(G3*$,"$><<HP$<M,B<X9# A#K"!AGEX^S+SP(1D^,0('P\(_>,"$
M(^WV9=(Q @"(X$(B=-?'IG&(\(1A@0CSRRRR&H\?9X8$(HQTCK]VF777 A#_
M .(::GV0CD8:X$(XGP(_#6&9U SP(0)\E>'2&4<_+ A%F!UZC^).FA.!"/[]
M<].FIRS.!"$?:80\",X>43D<"$0C#KEUR/AIEGE@0@#EY_G[(=,^HA@0A'_B
MZGIE&,!XDC A")AU/^R$- 8QP(1@^TP)]N73IF88$(#,]?#IEI&/MP(11CK'
M7K#[LQY^W A 9^.NGA$9@Q&!".)\#$^8US_A@0A'V]?#Q,-8=,"$774^0Z]<
M\Q@0CCX1\AX]!# A")CH?P\ ,LNAP(0\!GUR,,]/OUP(0)\8@0/AX1^\8$(1
M]OLRZ1B! $1P(1$Z:^/3.,1X0C# A'GEEED-1X^SPP(11CI'7[M,NNN!"'_Q
M#34^R$<C#7 A'$^!'X:PS.H&>!"/[_#/3*.>N!"'VT/G]^N!"&O^P^[7K@0A
MK$=?NR/@<"$#[O>/X^[ A#R_AEX?PP(0RTAY^7A@0A[OPZZ:^<<"$/(YY^'M
M]W7 A?_1^_;0GKGX^(U_A@0CC]^7B1GX:>&!"(1CGX#Q/MC[<"$,X]/=&'AX
MX$(XP$21_K' A8MZLXP&9@?MI@0AO.I@ >OA ZY^6,:F]J%Z"TQ\/Y=,8K7+
M$+-"AN2<XIT.N>7GUSCC981;D#0B($(Y99:Z1URP(S1[F](I]_G[L"*(MZ!G
M$'V#^,!@6:'L7D.(U,8QCIX^Z.N!%#V(PM!U@#J8C(Q/C".!%"O04B$8I]@A
MYZ91P+%#V(MR#$DC6.6>GNC@0AN08_$,](:^V,,"S0]B!<3'+/+^G&*CM10H
MBM/^Z?R\-/<,&IO:BA7DNCJF$?/7P,(:Y8QJ;VK.GO7DO F'PC6$8G/S!]N-
M2\#&J-/?@O!>Z[CD<M/OZXQK_P JSI!PHO)?3UB8></*!TQIZA[0MA&3D%A,
MTD1B>L.OG^.-?4'5R4$#G=*+Q\XGH?MYXU,P!IFMQ;X8E8U3H_WM.@CTAKY'
M&AG/8MOIQ@O(J"08$^X1)S\NN,"<H^FK@$?SZ?\ >B(YQCEGIKC/K]I6?I2,
MP5Z^>1_O9^TC\SC;ZD"F*U^FZ(?/HB8D)\,SYB.IQI]13\2S]-DC^>1U6/'.
M,/\ 08/76/ICC@:KV)M!Z@Y=%84%P,%HZ#)9$S2?]Y7N.OV&%!-7J%H87#&F
M"S"9!&O32'YG+&WJ@D=BT],CH5Z$P#J1KGJ#[<M<;F1O0K!85[+Z8_T@>W./
MX0AC'J#L6-)7@S*1'-/AUC#[XXSZC4:5Y^92<H@](YQ@=<'J,[4:4GTNL,U"
M31,M+2H!V9EG-"4O24R[*O(5IFAUDC Y[1@1BM@RHJCE:LT^]46$K25R,VEA
MT:E)=E9>:0/$1;?&,%] TTS6 PDK=^<2/ZDGKUR&6,>J%G0>@*(3C<([AY>(
MT$!$G!ZC5GTG=B+YY&>:=?N^PQMZC.U8],]B!GV@<U)S/]1T/EF-<'J-[5@1
MNZA9!-HZ%$/;_"(A@]1G:L^FZF2\+GFD9J4D#/4Y> RW>.#6WM6/3=V+ :K+
MQR4G('4Z$YQS.6F#6U9]-W8B_=6#$[TZ#J"/NQCU6CP1Z;N@0_=&8_K$.H)B
M/Y8SZC.U8]-W8C%39/\ 6#EI$0U\_;@]1O:CTW=BRIJ#1SB-/$?=TZX-;>U8
MT.[%L)FFU=1[C#+V>.,ZV]JQ0]BR!U!ZPRR.?EX=(XS49UP001T7K>C_ 'A]
M\/'V98RL(]R3U'N(\]<^N,50CRRT/A PZ9PSQE"'E"&F<0,XC3/ A&3#.'\\
M\A[3@0A[>OV@?;@0BZ=1XY@'R)^[ A']C[(Y&/E@0A]C'(PT&<8YG A#(=#^
M?GJ<"$![/#K'7SSC@0AY@1T]OWQP(0_'2!U_'/PP(11Z_:,89&.A(P(1YQ/N
M]^L8>W A#/[?SCK# A#/V?;QC&( P(0S^WAEU\<"$,_=_IXQ\<"$0_#(?AH3
M'6.!"&>H\-#KUU,?' A']\,M8^_W8$+_TOOV,"(PC[HYB(\HPP(1Y9B&673+
M_7 A"'L U^V8A@0O)(2/9& T/L\3@0L1))\LS#WQ.!"Q+5M$/*.0AXD^S";G
M@@BA6P:21V+%O ,2<XYC[_;A$F@QR2GIN-, O ?08_%GKH/X1.,B0 ]R"PL^
M8+ ].(0$B(BLP'X1(ZY:84$G6BQ1!,SEF8CK[X>,<!E%#@C2<Z(_FDQ.9AG[
M_#\\:>IWA9],]B\&:3GK[SX>1P!]<DHV%SL40F@>A\#^?@#TP:CT*P8BTT1_
M-B'7[SGY9XUU]ZP(G5% :KU\WH,Q[?#J//&PDKD0E! XX.1F:$3'=Y0&#U ,
M"0L&W((TKQ\VB) .?M(RR_@<:&:F16/IW=5X5.I3U2">OAF>N-3*%L(":56-
M51 !@4GV:>7YXT=.Q@J4N+7_ "E:RJD(1W 0USU@>N<<)?4AV3DHVVIAI6NJ
MII CN!]D?QP>J?XDLVTJ*T-%@554DC.'CX^P9X1=<NQ&I*-M.P+ Y5M0%&.7
M4Q\\)"<UJ2-*6;9%M-3%IKJJH*._H<O9'J=2,:.N"VE7 I7Z4 @:,5JFL$Y%
M:1[5?$?'RPW?=>;YDM]!@*C%:BZN$$ N0B<CN$/+4X3^J=_&*+86>0IC\5@=
MKH20?4]IW#W"(PDZY+!J+@EFV KDL(KZ!&*QGF/BZ^ \\\).OR<B4H;# 4")
M->)W N0SB(K,0/X8!?G#$_<M?H.ND+W^_".U2XG( A643_/&/KJ85*Q_3^Y9
M45S4%9/A\6?W1T&-A?%Q J5CZ#_*MA%<S@5Q)@-8_?$9869>EO5)OV^H%&A;
MK=<(,%*$/;A87O\ F39VW#^'%;:*VDG-Q.L<E0/F,*"^/:DCM_=BLR:VW_OC
M76((]FL,;_7'-)FP(Z%!5=;"5?%[Q#V>9QGZXTS6HLL<DG.7$A*B-T3[1_*.
M#Z]9-CC@*A:ZKE3T6(C,Y^_^&#ZZN2!88BH4-<6<B-S5<YIM-;J?F+(Y6G9=
M"%$A2:;=ULVW?%.6$&$&EJKSR4D9'TSX'#FXNRT03:AI<VOV&A2=M9B03-I1
MS7?<5NVUR T[R?RW;9>27*;+<;UY""O-+%P4&J2.X)!,$J?MU8TU&"6Z<VWM
MY-0H:C]JVCL@99&4Q 'WJ0%W7M"OBTCD2=,-#>FN!3L;>#C1)CE[!LP+B1EU
M41[@,L:_7T)%4HW:R\F@2+.<C"3=!6XE+:X;%E7PGHH:_J\L:_U&E/,%M_22
M32BS"_VI^3<4P\E2PDE.U43$>\YC&?Z@<,5G^D$'%-F3YNI_R<\B;?0*G2UH
M:?E-\''D.;A+3"$Z^F[L(41DE23'IC/UYIFC^E G3I3$J_.CC:E/KF$I1T;"
MX)2!T&>OGC/]0'=3Q2W]%.'E^Y-Y'</)J5M^<1'2'J)U_P#BQJ[<0!5']%=_
M"E^G<YRTW"$TB.D2L9YGSPF=T /S!9&RNPJU/22Y2:F@(3"5'_PJ_# -S'\0
MHC^C/!II2TB_TJS2\#XC=C<;BW*HJM7;,['RK/\ ]Q0@C^X(0UW9#"[;X5Q-
M$V.T/'X<%O2W);6X1>&O^]'+[^F%VWH=U39VVD9-3[HM_2D\H-*>0%^!4('/
MI X5%T"/F327;G-Z)]-U-MP!04",NL(^SQ]F'++BK1CT3)]LYM05F%1;(_4/
M<<P? B&-FSUI5:?3D=5F3.HR.X=/#^$#'"S9VG ),Q.R"V!-))U$8]"1G_'&
M1)VK4Q.'19!,^*C[B!]\<;:V]JU+2"O8F=/BB?" _$@XSJ"P6E>OF <HC[M<
MH9P. .':BE*57KUM/T^\*SRA^. .':L4[BC];_A_'V>'CC-1VK"+ULOZ1_YN
M@QFH6:>*'K"&J1UU/3I[,"*>*,.DP@!TR!Z9:^&6!87KU!I Y]<LH^$-0,"S
M3K7!91 Z'&*CXK"'VCX^>6,H0U^_4??@0CP(0P(0P(1>7VZ98$(\"$/M^6OG
M@0O_T_OVS,1TR@8P/Y'3 A%Y=-<XB!R,"<"$4<O+/77/3H00?/ A8BHJSTRZ
M&.7XQC@0O!5 %1(&67@2.@PF7$$BBRM9Q>T9P@1UCKX981)H*E*MQ(2*_-+"
MB3!*1DDYYD?ZY81=(PB@.*=C$K4^96X8IB(D1\#[(^>$RZA'8MLLVI.3-^O-
MND*(3+I" /\ Q1^,DZ0QN":4J@M!-:+>$V8'3R )]F,5/5./IQAB5Y,U"&8C
MX1TAITRP8]BS]/WFB\F;AH03#_Q99>R!QCX)1D.BO>B^;.4#G[X0$?/&0X@8
M+#K<..HE S60,3#2.>OA@6/IZ4-:E$9WP/7/]6-2:!+!AJ:KS\]LUT)$<]/O
M UQH7CHLB$GY14K4,_M6KXH> ) A[O;AO)<EKBT-P2C8G4 $>"UG:AM$=Q,0
M2<\A_&&$_K&]F*<-MGDMJW!:+U2@ -P$?.$('W1PC+=M<VE.J=-M,<EA544P
M3!<<O'K]PZ'#-]VP4&I*"T;V!:SM1U!41E'3RPG]8RN=4X9:4:*-P2>NK1=
M"H 0C$C+3Q)Z8;F['BEVV)P.A:ZZLHNDQ$(0$,XY>&-?J_@E19N'X%JJJR2%
MH4K6(BDC*,<R(Y82DNG8'4$HVP+S4M."35U,04-RH)ZQ TR\X8:ON07?S:%.
M/HZYM6N:J@J" YDH$14KKH ,H'"?U3?_ #"E/H !J ).:1)BKK2M3.\Q!4L"
M&1'MZ^[&DMQ5ITOJ4XALZC468K375U025+)$0J( B($0A[<-Q/3YG42_TO\
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M4N"8P.1U/E'.)PA]0PYM2@MCVI%FJ@I#B0E0@8]3XCRRPD;D)T+3 + J?*U
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M-5L4JL[G]R7"5;D@*4<H%6<8:'/$F'"C<5&7,+@PA@)"ZW<!S*OV"1.W(2#
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MY72VV]H2')QCQC#XE1AGD88W^48)9EJT.U%Q39E%[M@,$G9"(]P 'MQJ<T^
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M!VA2_A089?"@A/NQ-PSE[=1:*T3&>V;'4!Q4G4BI+44!2OA)$,QX#3[\2D&
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M8A#IK'K]T<\"$/=]OSP(0Z_CKKEUP(0_,Q^T?ME@0O_0^_7KH#",3$91.!"
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M%+/Q;MN9ZQ'0>(.'*1].OR8.6<I6A<08H<2%D)S!!,<X^8P)OZI>7,)R4?\
M(%;%&9M>HJ.U"+HEY-2R4IV_,R<UMB(@J25(\],+VX!D)IC10^Y@:0 ,%O\
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MJ&X0GTV2/-2?4'V&@^Q=?X',+S;62DUTTHK7<<!:WFEE)4@NJ*LXD $0VDQ
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MRDT,"$7V^W7K@0CP(0^V708$(?;[>_ A# A?_]'[]LL\O]Z,0-<L\SYX$(>
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MR0 #XC,G(>77$).=3  :E3$,1C?33Y?\$V9NH_'+N;H.)7Z9C#,9]!Y88RN
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M *4Y ]=?9I@%1D4@^W<RF@$U7I,X81B1#*.66%&S/8-(&&:3]-W5F*Q3+_\
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MB2!WX*R%J<8S-4 ?G&2E9@7/4;2MU15J5Q,=RH]<50ZCYG$EQ%<5T* P1L9
M8P2T4KEWT^%:'O4H-\*6[-MI$U2)-UU&7JJ8;:=]@=:#;D?:3@!DJ,?*LED&
MO&$4JH4Y+X?J%J24U6*2E^JVRTVM=7I#RW)J=I4OF55"06079J293FZTH*<;
M3\224@A+AK@YU*XIA=6[;1YN+5Q="<VG,>'A^I<U+\MY-/K,T&0%RSZ0_*NH
M@II;2_B24*&2LS^.)&)WE#6M)/<M7:)XHI8R*$G_ ,%&,W*0@F"MWZ@1X^/3
M"P)(Q:0>]88TM;0]JNG].VOO6AWA]M5=;4ZVL<G_ +4XMI24.N-SM2D%;"I8
M*!O$TJ(\#EBP<:F=#NS-) TEI/>"0N"^YUF9O7+1C5_W"O[5U<^K=Q^^]W^M
M;&@4U.RWYYI:4I*T-.3U(<F%$#//UPE)]N-.=L,%YN37?^<#]N(2_LP]LPE-
M/^53_=-"F99-LM4N2:96E(6VA)&7Q!.WKDG7KCG <"O0Q:QP:(QB,U(#\PF7
MEU**MI0B/LAGITR.-ECTW]RAZY[A2IAQIMP[U1!$2"I76$#D8G#HD1M8YQZ)
M1L#R6T(JFE:U!74:@F8F$+6O<F$?BR))@J.D!A$R/D<)/P#[5FY'IL<'$55J
MJ6[3+9DOF9J89E695M3[[JX)2TVD E1Z[@,@ "23#$A;0EYJ<J*J7<@K11S-
M7C4;WK?[E-;V:<RE+%*DBM1;EI,$;%E$8)F)E0WN0ZF'3$Y ^-H$3:J"EB</
M.<E+%#FDMI1M/]0(\ # #\L/X\:$=%&7#"34'!2_1ZCM3FK,$&,>@VC+$E$]
MKZ. P4/=1.>\ $8J5Z-5=WI@DD$P )A PS,!B;M7C3WT4+);U,@=2BEJB552
M-D%"$!$'6.F7EB19(TMICFH6>'2'!O:I7I-4,$&,<\_=F8'7+#^VD&K45#2P
MN;B2,5)=,G0XE"PN @(@]<XQ@(XD(\'@J)EB<W\MQ%4_Z:^3D%#;".0&[2$3
MA_%*UKC4%,',-7-KB$^J:HY1S(AGUR TP_BE:YI..:C"PM+@>U/&16=PB20<
MCH/.!.1PYZ)(]4\99(^$ >&[P(,/XX5;\P46<BEQM(*@GH8P&D,HF)UPX2+G
M!N:4I=! 2>I&1UR$<H8$@]VHUHMQ())AEUSPNSY0D#F5OR[<7"K. &7A$$>P
MY8V6$H_:/GI@0A@0A@0A]C@0B\LO/^4,^F!"'E@0CP(1?;W?88$+_]/[]\_'
M.,=(C32.4<"%YCYB!R.774>9!P(6I4(_*/%)A\).0U\(=8&&!"C:>6$1W9$"
M)CKE'IIC(2C.J9KTVM"W)@DGT]Q1'0KAM28=2DF/LPW?\Q6Q38<G/G'@PI<4
M,@$9B+LPZ8OK43 Y@91QH1443H9!-RLU$MOAE+G]16\<A!AM0B"!&&XI@,).
M8 *U6[<Z+>;4F881,H)W/[YD @A092?2;$#GK'#2?!NKJ$]ML_BMEB8)"P2F
M*4[<R028Y9>)Q%.=J<7$9J=#015>Q,@D0*D@$1AU]NF&SCI:7)S].*#$T6.8
MFS\*D*W)4%)4$P)!B #KY8;>N'8/% I".W:8QYC5-J<F$@?J4(E22.I(U_ X
M;SS,:6Z3@I6U:''$8C),RH3(BI)@2(P,80'CX88R2@N)&5%-0P_F8-J$U9NH
M)02E2H)4F!B=1"'CYXAKRX<26Z12BE;6!P=EU3$G9X*1,)2?4,%P U@(C\,1
M3IGM%:54JR-P<*M 42.SQ;G7FR3!Q2]JO:(Z?EB-,_F=4 *=="TV[7$U-0F;
M,S)]::*E%.W<(1^(:>V$<-9):O)&2?/S&'0?J2"W,%<K.IB(J45H43E",?SP
MBQYDA>PB@%2LO\LL(;AY@MB7F/5;9)7!4 D#Q,2(#WZ8:.8)&D$T Q3ES=+C
M(%O2;H3.*2K^LY'I& RZ#/# MTDBJTD_-CT$852G+*"W)EN'Q),=# I,,QIX
MXPDYY#&V)P H</LP2^T4.2 :4 7&H$;3GJ89=3#\L+&8Z"W3A1,ZRLN6/[2!
M\"C])2OEW6MI&R"P8A48;3 =8'"8;^7K[Z+8O])SV@5U&J4Y)2FA\.:D+)4(
M9D913#S P\LLI?$)"4^II![TOQ6Z&W40*0X@PA$;D0*@>H@<+2@ZLS1($L;Y
M7$>!7/[LBJK?!O?)S9VV5XIEK/Y,J-5J5L(6MSTA3[XEG+FH(:( 042\Q,/R
M>GP+;A'+%MXY>B&^M/5(]"8:#^K[5RCF5II9</A%96/!^!-?N"HWSO)5+M;[
M^^,;SJ;3DE)V]RI+6K<#B5%"'[8O5<Q:LT^O?M26/E*VR^22$P:C&&'6[6[V
M23QD4823\.GVI3C-^9&1/8*O;Y3\5WV>6E&Y =WB)$1\0^'2!B1 XHL+BUE!
MB*E=*$8).)Z+ 7$K;4R2 =0?$Z@"/4PPKZAK6BW9&&/UUQ6DVJ*BVY'X=!#P
MB,XY9PQ@R$]$M0'%8W4E"D.I5M25#V :^<08:X1D>6-J!59T@MTE>'W"XI1B
M#"!$!UU@,]#AI)(7TJ$LTX46L5B'4J$?9]X,8X2)IT65Y]7+/;H(B,?:(1QH
M>J<-B'EQ*(O*T0 D> $,]3EYXT (.+BEM/>O")I:/.!5$#H3#*'EC:JU=&'4
MJ<5L";4F!C'+2.8)'7/IC*3,#<JE0OS?="Y*TIME*PE:VBF)(&7Q$CW#7!(-
M+6CM2EA;%]SZ@;D:+BI?')2*5-JHZW5?.5R?<DVE P(EV5*?G#KF/T(_\_EA
M"WMB\3.>/D^]6EL@:X0G+M\$S^1>-V[GXE2NF4^6?Y.1R+QY=?&==FI=<W+V
M_<EH7*Q7YIZ9E4/,I=EZO29=Z1?"U;3+3+@ W$$37%=S.USW]QH;)'-;OA<Q
MU=)8_ Y8U'11?(=L9O-O8PMG=')!<,F:YM*AT9!&?0X@]Q5UN&W*]7K=14+M
MMZ4M^YUK4S/R\DOU:=,%*OA>D%*5Z[;73:L1!RB<1=V&MD:UAJ T#]/ 8*;M
MRXATA-"7$T\3533^PI "G 1$9#+(Y&&><1AL#6@3[UCV+"_0)9QI;:VD+WC:
M$J@I,%9*!01M6"DD$$$&/AA1S T5!*T,CL!F#@? KG[=/;SQ[_F$W0KGI*F:
M-4W'9NV*K)SS]/?D"XYOG:(ZMI?H*1*N'<QO226%!(_0<:^I,S^4XU3!Y9MU
MQZ3M7T3LNX]?V*(N1>TOC6BTYZ<I5P5UMYPD2S3\W*SC(7#<@+WRZ'%HW=0H
M849?31#2]H<>TE.HY(Y#Y7>7M59..Y:9XOYXX<]"=+CU)YAMB=:FDM!LA$T:
M-,*4EM*UB V'KUTQ.[%<O&Y>L1\P;\--"N9<\V_ZAM[H)\M.S\;,:^%,%]%'
MU1VY1GOTXTJ<XV1)W#PM4'VWRJ#;K[ I,V$ALP(@EN/OQ8?<AA_J-QZ>+7MB
MD/<7 8>"J'LD_3*Z YN$@^PU_8JOS%RTB1)"'$J4$PV@P&WPCY8Y<QK@3J"]
M*1Q''34E1U<=]L+_ +$J5**MR0E$  (91(RT\=<#GEIH$Y;!4><D%,6GRTY6
M9X*7N+95$H(C %4?QTQH]SI-()2HB%*:BI\I$C+T*2,PL-@M,[\U0"$PB22?
MZ4 YQZXD;:,:<U!WCC4DFJBZMW0Y>-05*RSBQ0I5Q*P"2A4Y,I)_NKTBRVK]
M"=.N):!V;0U0[V DN*=%(=:EDH:0$Q2E.[]0&1S.'L;0'!_51=T ]AZ44HTF
M<6%(6A>L(B(A[$^8CA_&[2,LU#7#* 8J4Z3/Q*05;2,B.I2!$>.<</XO(-%*
M@J*F8#(W%2=1JD3Z:PN'50\H?EB2AN"RH#0H:=E'OHI8HU04H(\MIR)B.D(>
M6)B(U;50EQ"\M<:8U4MT.H9I"B8@PRSUAXY8>V\AJ6TR*A[B/ 5-"I<HTY\+
M:8DA0@8PRAIYQQ+1.+I&X*)N64D-#D%*M)>26XC^D0,<LHZX>-S44]@#GFN8
M4B4IPP9C #:.F8CEYX?V_P KO%1,O\QZ?DD,TYPB8C[CA^TU 4<^<M<X:< 4
M\Y,E24JZQ@1G" (SC[<+M^8)B2:)=;'CF?'"Z0ER;XI71DD)RC'[0TT&-V,#
MJU*1I5;3<2@GJ##KYG6,<*@4%$D[,I5EP0TF(@3F?O,,96%GP(0\<"$4/M_/
M A#W><?/ A#QTC]Q/\<"$>!"++WZ?8X$(_M_# A?_]3[]8>/7,Q&66@B.@P(
M0AX0/3SR&4-,Q'QP(7AQ'J(4VK122F)ANS&4/,$X$*+ZXV&'UH=A\) 4(YD&
M(!&F1QD)1F14?U,%Q&UJ 2 80CK&!Z:1PW?\Q3AK&EH)&*CJ<<>E7EN_%%*5
MC+^I<"$B'MQJG08'4 &*CJI3DV%.$I6A;P;1O5$#8B)5M*AJHG3&" 1BMS"Y
MF)(HG%0J\)BIORA4/31)R$K+B.<6FE>KEI\1&?CAG=@!F&27MP0X'I5.M,R6
MRZ,B4JW'Q@22,CY8@93I8"TXJQ0 $FN2U7*@D=,H1RZ>/74G#.1[O3?CT4H
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MO.7LP(49W8D.S:]D5*2A*5PZ*"3&,/".,A*,R*BZH!QM"X+/B4P@",X^>$7
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M'X5*,2,_SQ %U20"5,-C=Z#-0Q#L<LDLR3IF*<ATJVNM[DE/@ 3 C[L.2X&
M-#O/4)C(")XQ3-PP3CI3X>:1N)C I.66N?C".$XF.>R0 5/_ (HG(;-)4TR2
MJN=8D5-.S3[,LALPWO.H:20#%0BL@$^0SQOMVV[CN]PVTVJPFN;IQH&1L<]Q
M^#04G=7=K8V%Q<7]U'# !\SW!H^TD+35R&P[-*D;?IDY7IU>Y#7RJ5MRJ%)'
MZWGEICLS_I&TP/Q8[;MOL9O-O9MWKW"WJPXWL>D?_DO!NW85.BUC)DU$?+4
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M!J8#+W87.KR4827=!B0>@/97IVII,]C6ETCVLTYZB !XN^4?:D"I7K:]//\
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M+3;ZT @J2H".T$YP'ZCH",:5<""')0QM -0*)]*M22J\@F6GV I2=RF9AO\
MMS,LX1M#C#R0%H,-024J&1&+UP;FG*O;W<AOW%MSDM=QU5<0?(\?PO8?*6TP
M.%53^8<<XYS&QEVKD>WLGM'LTU/S,!ZM=F".A!P4'W7;52MR8$NM")J6="VY
M!W8?EYH!1<3).-IA\O,QB4L@I2M7QL*0Y\)^@_MI[C;'[C23[EL5I;67/Y;;
M_KMJ?1MINL6/J.A:[R-N"*T< "XN%<EXK]P.$[IP=MG8;[=37/"(Y@++<8QJ
MN]ND!'IF5S?.^ $BM:X-3--RNJETH=4],-I6)1,R?C>DYA1"&Y*?!@J*P"&7
MR ET)(5!P$8\W^^?L3;V%C-[A^WEI(.*ZRV]LG#_ *C;)CCHD;FZ.OX\<,L%
MZ(]H?>BZO;V+@O/YV#E!:WZ*[!_(W.+\,C'9->6YM-#58WB'I9] VN124S0^
M%092H@;X@ZH)B=,>1K6R=.Z,AU6$BA&1';CT7IZ^W!UO&0YFEVDX'.HZ'OJN
M(?U!+4F*'4IM*2'F'FRM,RF&QQ"VU%*A G*!!Q?[&QC@ )>"%SJ:_FOG3-DB
MTT\<53_M*[RI?A:M_L5X3YE*8RLH=F'%J^70E!2METK"MJ=P$#I##R?;G3/]
M:-M7$44;_48&4BNGMC?7JN\G$7U..%[I;EV&ZY)S+:4M-AYJ8:4 ?TQ6A/Q
M12<\)107,'Y<UI0=J:S6\<[M5K>,>:="KN4+NAX?N9EE[]XI\7DIBDOLQ"HZ
M1!S"@?;AUHMB"US34]R:"UW",O("F:A7QQA6&0J5J5/4I4#!,PUH8&$ O[SA
M%MI;-(-?N3-QW%C=3F.H/T[4[J9)V!,3B'?FI(YF #J5[\\_ZR1AQ%!:UQ";
MRW5YH-=>2DZ;J5F46G^NEV10E#9(4%-#(99G?" &F'__ $@CUEH\%%L;=W,M
M"">E5R?^HMRK9=Y]OU[6DU,2STU2YZW[GD0A;96)JWZU*O/>F$KB"NFN3"3_
M .$GIB'EO6MNXF0,! (/V'+XJSV^T36MM'=.:"YM2,>W_P 5('TT#(7U]-GN
MSX<G"JIRU,J]RNL2)*5EABKT9J?E7$$A8"%D*(/B,6NU>^ZXSO5OI!#9/5_T
MU<*@=RXMRFK.5[??..DD4/P&'VKBKQ]2+KY9FJ-1)AF8=_:&V*&^V>DQ2HTY
MY3FQ(&Y3LMGIKCGDK8HFL$9#@YM:GIW+T1M%[)=;?:3:,"*9X99KJ[8?;<S9
M]OL3;[*3-)80OTT-B&:(141N\/'$1>"1K"YN(5JV^YC:\,T@_%-:XJ&]).[-
MBA $HA& ST]PQ%LDD&FN:GBP.JX' I#EG"G^VZ(*B,S[1T/OP_:ZK@$RD91A
M-4X42JYE.U+9&0S*2!]X\CAPUP:?,<$QD%:)/F:"5%>])\8P.GORPNU["/F3
M61@<*5P2!-TSTP$D&"8ZC3V>6'+)RP-H :)D8]-6URP2<SZC:@VELE(.T*C\
M02G,$#4Q.)F.74SU'"@4/<,$>IH*=%.FUH(26U%.[6!RT\3'7#Z)T?E)=B5$
MS1C%^I2U0)TDHZH.T'<(:9^P$PP_C(CD ::BBA9VAK3C7JIOMZ<!4@I62E0C
M$:I(/Z3]V)2WD.MV"@IXP0,<PIZMF=CZ45$1^*/F898EK9Y=%0CJH2YZ*PEK
M/J6I&[])48&.60$?PQ.Q?RV>(5;O,G>*GNWU)^&!$,A[_P"6)2.4M+& "A5?
MNC@:]BF&CN02"(&)$1'3*'3V8D8VZ?-7-0[VA[2*]%)E/_4G773WCQ\,.6_,
M%&NR3JE3\72,3IH?QPOBFTN3?%.20$8N[1 _"F&6D=QAEEA:/(IJ[-*<?=[Q
MGXG7"BU1@@_;6'OP(1^/V^QSP(0^WVTP(0]V!"'\_P">N!"+[0P(1X$(H_G
M>>!"'N\O&.!"_]#[]X?G'\8X$($PUT]W\3@0CUB,"%']PR:A,%8 (>_N1$8C
M= *RA#+ MF@%P!R4>SLB5O;<R,XF&F4/ZA^J&$2X@D5P4E;PQE_R]$A3,D&
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M%B;J+RS!34JPYZ*<OA4N9< ;2DGPQT*W]HN16C#=<QOK'8K$"I=>3-$M.O\
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M?2*5;1%.2CF8Y??B4CD?I:*X*NWK0*T"L#;Q 0D9[OA)ZB/W^6)JW\SVZLU
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M<0'T-OMSTM,NK8;2O^TIOXA''$-QN=BVR2TV>WW$OW)DCK=MM'5IB J3(\G
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M]A0W!J44HMB&24P&/66QR_6[#M]XR0.C?'H!':W$_#!7N\GMKF4WD-:L=H>
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M=<_=E8;I%T<*7',7?Q'_ (S^^W%4_P#$K:XYN:;=G:10Z9\I0Y%]Q1;E!$C
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M-4V8]-]*2=A8WD(4=03BP6SS-)M[]6+96T[37_P59@V]KKB79WL)9.Q[M5,
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M,^'=\]\_[BMLN]W#^=MCEC:/2@;;VQ+L<2*PDUIC2JMVX_VY^WVUWVTVEQQ
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M'D^YY9JHW+529A2G'Y.:EIGTJ;3V@=J7$@K=$00(8Z3QZ[O[Z!\]W,7-J0,
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M1*X'4IRRB.IPJ5L!J-%JJF2M *EIB/TDJ(B0(@Z8 @M(S6FY/(6F$8K$0#&
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M7,%''XG+M7SM7'3&N'.Y>X[4J+26V;,OVX;=F&U (!IM9?6MEN"8;D)F99:
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M]F!"/ A%Y=(_AX:QP(6C44[I2:'_ /3K(Z9I$<8(!!!R6S?F;XJ.6E;7$Q,
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MFYFL"Y[?Y/XIX_/%%G\E<=UVSK]HE1XROQ/&A%"J53H*Z?,UJEH0Q4%32$)
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M3[X8$)W2]9I$X$KE*K3IE"M%,3LJZ#E& *'%'3 A;P>:6?@>;5I$)<0=(1$
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MW>I;F4O?,\AIU5<^M3XE.=]L=U@X5;W5W:QVDT$SVLBC:&!C": @- H.W!<
MNZCMQY$[5>497C?DF=H=0J\F6:I*SE)6MR7G)>?9?>>!4^AI\JETM+1!20HA
M$0,>K.-^XFT\[VBZW/9K6XM'V\SXG-?Y7@MZBG0J1]O>([G.^PNKRZ9/:W&D
M:OFS-< >H3@DKLN*BVY7[/X^JE5IPN>CS[M%J,K-S*962D*EZ:J[*.KAO9+E
M.2D(6SFM6Z($%'%>N=CX[NVZV>\[K:L?-;R#Y@#ZI_"7$Y:.F=5V[F>T;M:N
MDALHW"RN&&-[6$M+=#?)(*=3U&1[4[N'^&+DK?$5#N^<J=2E5U2MR$NW4*;5
MYBCU1"VVYKY42E4#:/\ W!MUHS'J2ZU3!;:"8 *4<=[L=EM8OH]T^G9Z3!6G
M0@BI/P&-/@N8[AO,M]:[5Q5\0=>?2QET@:*DM:/G/1]1B*X%.SMIYF[[I'EF
MX+/X'Y1Y0MEBV+1DZ3R+<]6NZ:I]DV[1G9<,7%.W)7ZQ,3M EI"9EF$I'J)5
M-3"T%33?J':)-OLUO7-=P?<<1LF6S9(W>O=2D-MH(7BCI)I,B"VOD;5Y.%%5
MMN]QO;38(Y[#W7LOK[:.8?26L+'/NYI@[!D,+?.Y]?Q&C1G6BO\ S]W\C7+3
M)"P>&KOK?)U6N-*I6^>;*M4I9AVD454N':J: XH2AL>QVFBHO5"H%B>J21!)
M0A0:,SP/8]GV-FY>V?\ ;I8F;?Y&/BW7?Y Z&)K#_.%M(XN,%L?,'.U:Y0 T
M-%%,[CQ?C8#O='^Z%PVKB\,@EV3B<#A//+*,;;ZR-G_Y-V\:2V%H,=N3JD?4
MT5..XJZ:)PM*7'Q7QPR]5*M?-,<IO*7*L\MR3F+CI[X?1)V59J9HMS-'L*3F
M8O3;QV/51YI)6$M)2@P%[R[B_M?MT?MO[7[F+JZNI6,W?=8VZ!.VOGL[0_,R
M#7\S]6I]348KJ?'/9[>/='9]X]V/=CCO].V>PMY9-BX\'%TEN]["&7VXNRDO
M6L_E-II@PTXJ=^P"Y*)2K8LR;DYM^GN3\S4Z$NHTYUANHR2J+7:RGYR2FGV7
MF6&)@(0'E-%3OI;0C:"3CD6_W=IQ[E^_3QLI+<QQD84H:@D#N5[]L8MRYA[0
M\?LZ^IM=C;S1R-/S "4M(-.K0 :]N*DSDF1?MGF_B>E,O3#;,[R9:LM)*ET)
MF&&J3<DY.R$FRF94I"F%%V:B\F"@49[HF&*!?1LDO+VX, #9P3X9E=4YAN@W
MW@%Q/90-+MLBA#L<@PM87#O+!I/;5<TKB;J]I]P\Q>5+;E9N?LCG.;GI&0JL
MBQ4::JK4:[53TO\ N-*FDJE9^5;GF_[S#B2VM (.1QT/B5^W;6;?;&8O=Z3-
M/3(4Q7++_8&;OPEUM=6A^G>)',<QQ#BQX#W>88@BM!3L747EB1O.VG+R<NBJ
MTV4N&HW)<U1JE2ILA2V+:K4_6)Y^KS+U!EZ6TW3V9*7G7BA++1 ET#;  8Z^
MT3^5S](:X5S[5PC9S8WL=I86T)'HQ@-U$EVD$@ DYG"I.:H'<2YJH4X3E5>-
M+$LGYEB=GY:;$G/%&[T6FYH-S"75S\VL)1O1L3M W)2(C%^V.2T,6O#37]/%
M6T2PV4K8A02$>:G;3&G[%$'*W']\<U\@75S7Q5QB*,OA"D6/S/=-JV>EXT^G
M6];,]2:9>5?ILJM ]-N?2XY./2J=NU*G V% 0Q$\-O/3WE]F6B.">,BF==#2
MX=G4+@OO]M<]CQ#:KR60R/@OXC&]XH\->:/'6GE-#CT5B:->$G87>'2:?).*
M1;M_4^G3E.+SF[:W<$FQ,I2VCX!M!=R$(C0XZ)N,+I-KN(VMHY@+@O)-Q?$;
MYZQ ]!Q'7.N"=%J7+6[![]Z937U!+$S.!F860$ERGSJ/@2H**8C<KI&!Q%7S
M6[CQ8G_F"(=^+2F,(?;;_*W3Y'O^XJWG?9;Z6Z3.U!L>FAULNQ&[86W6U$'X
MOZ<.>%W_ -;LU)3YV -([Q@D>1VPM[MVAM&.<35<+>#FTR/=UVX.,N*+_P#W
MVXXE0\E)7L8G+PD9*9_MP(*%RLVXA8@04*(Q<%75^A/]-ZNMS_TH+(E*@$M-
M67=][V@J)*MK5!Y/JLNTI22E*FQ_=@! 8$*7YSC2A7G)-O2SORE60G=+3;!]
M,F!!!*DF$8D8$+';7*'(/#=1;HEUR[U:MY)]/UG4>OM:5E%*U> U\<"%9:5I
MW"7.%.$RRW(2E4<;2M?IA$O--O+&@2%15!0P(417/VLU>ENN/VW/-SK&J&'%
M@K*?Z<P3G@0HX>L6ZJ Z&Y^E/I 5\12F*3TC ;HYC7QP(3FI#CK2TA8=:*59
MI4V4D0!$,\O?@0I9HLZ3L^(P@DY>?7/0' A2M2IZ(3!1B!D!^8!.6>!"D&0F
M0YMSB=/#PU]F!"=<N[#;IGGK#I"'4X$)>:6A0R(/7:0,P/+J,"%M@@@>PY P
MZB$($:X$+8;4,DP .><,O 1Z# A9\H:"&>?7PB-<"%Z&1$3TC F,?QZ 8$+.
M($1VC3P\\\"$<!X#KT'B/ :PP(7K3 A%]^>?L\NN!"'L_&/A@0A'[O\ ;TA'
M A'@0B^_\?R]^!"__]#[]R(^S^1_+ A ]1G]WX9Y8$(_M]LL"$/L,"$730Y]
M-(&!^XG A)L]29*HH].99"@8P<22EQ.66U0$1 ^[ 14$=%G41U495JRZDR5K
MI^R>:@5!LP0^D9$ 1(2LCW'"3XR6T;FEX[A[*-+O(H4N20FY4+;J%/FY0DY+
M=EG0D_\ A2L)+:H^ ,<1UQ;$MQZJPVE^QFFN:@"YI-*TN>A,-*!B-I2DJ!.@
MVD))A[<L0TT#Q&/THK/9W\.!+<56&\*:V\IQN;9 4"8.(!3G#('P/LQ 75K0
MU.+5;[5\;M.&)'ZU6.[: EKUEH0IP$&,,XIAU"HCIB#N0X.+8RK-9REK UT@
M:SO5;;BHR$/*?E%KEGCXB+:8'^I"80Q%RQ8CU!BK%9%D4<CH9JDG$9_^"C*J
MJG6U%,VR H A+J-Q0L0^%2_U0Q'W,#@-4>2E([LO(CFC '90?IBF'5&#-_$H
M*R&2T&*8^$!#+[\,:"E#FG<0#'LT7.%<L/L4?5*E*45$$^WKYY::82>VC:@*
M4CD>YU'9438FY=QIE0*"O:H9E/0"/Z80C^>&LGX4Y#0<T@*9;6#MBG6"%1 )
M_J!!S1F<,99'M>0')O) YSB0<$@3$LMEQ:4$A'ZMIBIN,(D)C&$?+#@.- 3G
M1'I,[,4F+5GF( QTUB#")!CUP51Z3.Q:3OJ)!V'(@[@3F8:PB##(XRDI6-;2
MBT_F5I^$" B<\E>?7,X$@0#F%X<F4D?W5@)3\6L([<R,NIAC(Z(T@=$ES4XV
MK)!VP(S!,2(=?8<.8FC5@%D4_%B$C3$Z[NVI5%*<U9QR\C#7+/#IH!3&68:J
M1G!>&W4OI*B2#$)SUUZ1.>-J#L35[ ]Q<ZM4ZJ6D)" E45HC"!.623$C2$,)
M'&H6S"06M!PJ%*]"2@E*E$P^$GP*M#G'KB+NF-#L!T*G820S##$*<[<6ELM;
M<M(1ZYQZDXK=XX@FG>K'9/< ,<59&SZF)52'G'$MM,H#KKBW-K;;:4[EN.+5
MM0AM B2HD 8B&O<>N)*G6M#VA[Q\?!3U0N8:53J++UNCRYK5$FIIR2EKIF:E
M)VWQ_-U!!"#3Z=?-;V4^[*JVK)5-MAFX:T#DF14H@8O.S\(W_<(A>21LL]MI
M4S7!]-M.T ^9WP%.]<UY)[B<8VBZ;MUO<OW#>"<+>U;ZTE>PEM6M[,34=B>\
ML>6^26DK^:=H5!=<*8N"Y>/J$\AQ&T^G3I.;I?/-Y(V$_%,SO&#:@/CDYA!(
M,UZO!>/G2QK]XW(=7?EVS2.P9O'V@_<JSZ'N3RV33,^/C^T._"VDMVYO>?EC
M/AI([$M,<+VG*4AJGU=O_)Y:6G!46Z'-T^E4BQ)6JH,4U60XVMZ4IMEKK*%"
M(JE0E:C7%:NS[JHK-9Y!S;?]UB-J;KZ;;1@(8!Z<8'80W%WQ)\%;^,^WW%..
MW7UHLC=[L34W%R?6EKVC55K?]D#Q47\NV=^Y6W7*;Z?JL56CU6EO-N-[T*EJ
MG3IBGK:VP,4!M^ &@&.=ZI1/!*TCTVN!/PR79+&[:]Y:ZNDA<R>RVV>2>,^-
M+939G[/4:]4;\NOB--MU:391(L33DU)4]MAYUY"Y42L[+RZ)E8=$ 8E22DG'
MGGW!N+MONQ9;;M\^B_GCUQGHX2&KP[M !->P)GN%S9F2_M=P:X1PAKS0D$C-
MM*=<J=JK'==NWY+U;D:^+,G56E7^)W6ZS,KI<W4$2%H-+KLI2R6F6'VI-N0G
M*H0MM+6R*D_" G<<.]A=<M^AL/IGW%NQ[VR2 @!CG/(&A^>)PS\%9^62;7#M
M.S1RACA=PUTO^8M J<_O7/'ZB=\W_5>XVQE\N3TE<MQ3%ITNHS%4;91+R%09
MG&GGY29:+#SJ'?43-;E$+*B5D$DX](>U/'W6_&]Y$1.KZDUUNU4K6E2,2>Q4
MW9-_M[#DW";2P9''9OJ=)J&U#A45& J.WX+?[;^)>2.1Y:H5VW;/JKU"=I4S
M)S-UU1U%L6/0V5I2VA#ERUUR2I#+894OU"'2J A QQT_:_9GW%YM"]W'=FEB
ML(9&N=<W&FVM6CJZ26;H!EH!)[%Z#WSWH]E.$7D]YR[E4$N]2.(9M]F'7=W*
MX"C6LMX]3G''KZ;1^)RMEQKV\VBW0GZ/67KDY[>M.HSSM-IG%[T[97#=K2LZ
M\9Y$M=G.=V-4JW)MNDNO+BY34/? -B5DX]K<#]I-G@V2PFW*YGY%>1#1*RS/
MH;>TM%/S+Z;1J#2,3&VC@"1FOF_[J^\N[OYANMWLMG%Q;;IJ^C]<P7&Y.8\G
M&/;[8O#7.:?*V1U6NH'=5&M_<P<-.\G6_9W)?.]$J%IVU6T,T+M8[2*<X]Q\
MW6$I=EV:MR[RS6T"GW;7_3;2F8=;14WDJ!#2FP<6+GT_$I..Q;%RG?BS:H*%
MNU[(XLA=B*-N+LT]1Q_$0">RA-5Q_P!K+GFEC[ES[EQ2TB&_71:6[MO;2Z2.
MN;X+5M71"E1HJ.RAR2 _W _Y [7N)*+;U!XUXNHCSD_(6A;,Y.M2=<=?9:<D
MZI?E?FUFNW96U33P2AR9=,O+D@-M(2G'CWW%]T=WNMGDXGQG:XN/\+CRL[8T
M=)3\5S,#JF)['$@$GM7UA]FO:/C6U\B@]Q.5;S/R?W.KCN%Z&N;;QNSCL+8C
M1:PFN;6A[L*G!54N&M5B\ZG3J55JI,O(IU%7(4J9J"%OII-%E'''9>5FE2LM
M,NS+4N72"Z&G'5D@JB,\<*M9'7<EK,W"-CL0,!AUH, >]>[+JTL[/;KS;[>Q
M:7WUK)*:^:K2TMZ]ZD+LLY(K=H,JLZ9FPPFV.0:E59!QYQOTI?\ <&'7ZA*D
M3"TRR&BXP8I*@"H0S) Q*\TE@W&ZV^Z+:AL;6UZX #$_O7C[V5V/D?#=E]Q-
MDA@J/K;H4(\K8I0'$-%/BTY] KS<Z<XREYW5QS5:)+,MU.E7?9\A4*'/)9E6
M9ZG2%:IJQ56UN'TC3)T*<4W-[@M),080Q7;,7>Y7)MY6Z+6,'2:9BGVJTWUG
M9[7[<;^R02MW&]88P*9N- RH\4W^?[+I/_Y*<Y(M=]F9D:CR-_D=,<#RELJE
M+BI4C5V'W'@AA*7PJ<^(C9\8)Q,6TD>WWUHS5J.7^D!)<%-Q<>TL%Q?PCZB/
M0">M2"UW< =.04O7WR+4.8;'M*VJXZN4J]+-*EJDJ9H92],S3-+;;G5T]Z32
MW+(^8FDN..N(BXX#\0ZXZO>[E_T-OZ,Y,I J/V+SJ>.6NV[QN+X:1Q5) KD#
M4X5Z53:M+CJ6KCXHMVM2C5/D%S,@B6G&W5F946'':;-%E[TU&5]0 K4V0I(!
M($<3=EJN-OB,H\]**M;TV2SD;=,<7N)J.[JJQ\L<GWMP+.<G5?BJY)BWKIJ%
MF*M!B<DE-F7J$S4JQ)RLI)SE+F6WY.=ED2,T^GTGT$?$3#$?LUG+<<RV6UMS
M00N>Z3O9H=AW>*Y_[V[Q:7?MAR.3<&CU1-;"&O\ &Y[ X@^!.&2ACDNM2\WW
M8<+TN4F4N3% I]BT^=5 ^DS.L2<DF80$H(V*0H*$ =<=?OWDV,\H/S1.IX5(
M'ZEX;O(Q]?' X>5AC'QP*>/</>3B.\5BH4V97++HRJ4A3S:E-S!4VMA2SN!$
M4D=#TRQ%;':MFV:-E/(YCZ_#O6NYW$S=XH'8@CH%U\[R63<?!])J[/Q/3UL2
MDPIPD?K,FVH$':#$A43'KBH\"<YM]OEC4X/U =F.*E^3-;)9V-R[(1@'QHOG
MPXGICS_=!VZ2P=6PJ9YQXRC,[O3+81?=$<4O?$;" C6..KJCK[]/I^#Y/Z9?
M*,@\PM'[5SMRXIT.P^('DP3*'4*!@IMUM])2088$*6[)NV:HLLU,%PS],4E&
MZ!W/R9R "LX%"?' A66DJI;]X4DL5!#-0DWV]I?/IK<9*@"-P*2H0/XX$*'+
MBX<K-O3"Z[8%0F/3)4X6&5*24P7O1DA0B/* A@6": ISVEW"WE:KK5,NZ2>?
M:2I*2\\EQ+D -@W%0( ,.N>,+5KB3BK36SRO9MXRR2MR20XL J;>+((4J'_U
M (Y8RMT]!:]IU8!89D5I7 !32FAD!N"B4;HD^S A>AQC0%?\D;" #!"@0,]!
M YY# A;;/'<M+YLS*TF$!J<HZ1C#I@0EB7M(L@;)I48G7R]V!"66J,\F ]6(
M2,B (_Q.!"56:<ZSHHGVYF$--($8$+<;E7B=1H-4C[98$+83+. @E0!B/#3P
MT\\"%G"%@ ',^V'4Y:8$+UL5X=/',>/00C@0LR00D#KGE&/7\<"%Z^WVTP(0
M^WLP(0^V?3 A# A%^&GVUZX$(\"$7M]A_F.N!"__T?OV]Q.>41'I@0CT/M\O
M/Q&6!"$<X9_<?X1P(1$ZQB?"'AE$8$(1S.N6F7\QK@0C]Q@,_L"-<"$4,_#(
M0@-/O&N!"\.-MN@H<2E:2/TK0E:<S#-*TD1.#-"CRYN++)NMI:*G16D.K24B
M;D$B3F4$_P!06R$@J!SS!QC2TBA:*>"<,N9XQ1LA 5#^9^USD&CIF*CQ]+_Y
MY1C%:J(I^7DKGDQ $^@J84S)U,")V@+;<\CB$N]K$@);C56?;.42V= YI/CB
MN;MVKF:-.S%)KTC4+=JK6YMVC7))OT>H)45$;&VYYMIM^)3DIM2TG4'%7O=I
MN(09(XS7++HN@[9R6UO&-9,]NKLJ*^*KK<[D@\M\%?RKR3!68*2!E$>(]F*K
M<Q7(?61N78%<K80O:)+:Y:#V$Y^"A&K/KE?5(4)AHG(H4DF'@I),<R,,#"'$
MEQ^"E[::4. E-7#KFF%,SU/6N#2RRL@A:%':E).H(5".>&TL+J/!814=BD8+
MM@<6N< XFB0IOY1T14M)$2"1!21K#],<0<L#HW:J&BG;2:E=+@7TRZT2%,R<
MN0H)6ER("A\0B !K &.6&DS@-(<:%2,4Y=7U,"FC.4QLK(],"()CI[(XCY?,
M\D8A.6W(:*"A35FJ;N*@D;89@QCYC4Z0PG4CJMQ-7#1GW)MS-/=:S!2J$<CJ
M?=GC =7\2PYS0*DBB1GI=:4+^%:2!'X3NB,X@C. .,U/:F<[FNT:2#FD1X[-
MQ)"01K_5H!  PCAW":L%35R:.K7#)-N;FP2K:L  &&[+=#V91CB0:P^7RK;4
M&4+C3Q2$[.?[RMI$1$&(AGIH-,.@*'+!,I[EKW:&$4[EI_-+2HA.UP&&>9U!
M/F.N-P*Y)L2T9E;S"DK<$3!61!&D.N488S1W84A(\5J'8)Z4=:@L)_4 2-V@
M@3D,M<L:.&!H$L"= ('FHI2D*A)R E#-S#;*IN88E)%E2HOU";=(2U(T^51N
MF:A/O*,&V&$./.*,$I)PU;;S7#_1@@=).[)K07'[ GC+^WM83/>SLAMQB7/(
M:T4[S16#8H5:H3S4K>3DEQA-*:1,-T&[J?4ZURQ.2SL%-/4[@BW%B^:0V^DQ
M;F+RF+(I;@^),Z4X?NX2;:)MWR?=(MOM:$Z3YYG?Z8V]?&O@H)_N0R]E-APK
M9I]UOA@7M!CMF'M=*X"H\*=Q3_I+$M,J:^5HX6$N-J3<'*#=NW]<(4"-DQ0N
M+Y:6?X&L9YN$4&HR=_U)@YM51"P%!B[E''./5;Q/8 ^Z'_\ E75'OKVLC^5O
M=EX*1BX3ROEC&R<ZY4Z.P)K]%8DQQT_ADE^9_?GW'MLE92I:7K'^23CM0KMU
M/2R)1^\+FJ<]<EU.R#8VMT]->K#TY/R5)0G)N2E5,2#"?A:80D "B;OO^\;W
M<"?=]RDF=7 .-&C'\+11H'@%T_8N+<>XU:"UV/:(;:.F):WSN[W/-7N/B5;2
MWJ\%2[<7" I*0E!.^"C_ /,4N TZ8:F=C 3K'VITZV:9@X.PQ3J^>2ZG<N(6
M4P4# ;@! $"( CB/]7U7/[$/B;&10U31K\DS.2SJ"-P6A02"?TDF('7X8C#:
M4$$NIY?VIW:S.8Z@!(7'/E2^*MVXWY>$O3YVJ24C5;IM_D&G4)B1FI^F7%/;
MFZ/79)#,M*O_ "E04A2'4K0I"G$ IS..*^XG$[O>.8\7NK"T]6_?$^$.!/J1
MD@EFEC?,\/-&FF.-%:X&;5<$WVZO @$8:YQ+6@ #JYU -(QJ<J534M*T*M=S
MG<54+@HS]FT7FFVK5I-KRU8,TJXI9F0<>J7[O1[!ICBJ[4%/S[J_2^9:98<)
M@%=1Z-]M?[0?=+>8>&1<RW.SXQMKKALKXYVR2[C=-#];6V]C#5Y;(,"9M :#
M4E>?_=;^X'ANWWQAX>'[[?6(>QTD3XX[.$>G2DUVZL8#?Q:34Y $JJ_</7>
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M22?$0S&L.@PW&Y;:14.J/'_%+';[MM"(R/$?O3^D;YI3Z4_]2@PU!.T'*/\
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M,!F4Q*LZE&1,-3NB('.(B/"'L.%X(WL\Q&"-30,U'4]-(2M14H)),!F0DGJ
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M=P=<6[3Y7@EA<.]O0]RZ@<<_2G^G%+2\M7:%P9:_(S#Z 6*[=-]W9RE*3"5
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MVVFUPT&U;*UH^GM8!_+?*S >NX:20YI+2,,RK62P;FZ:4$I$&5  0_24DG2
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MW/QR$AQ8'9 5PJGEQYQ/QI<D_+3W#W(+S$XW,M^MQQRK+R]N75*.A8"I2G7
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M6[L[4N$[+=IUF7!:E$$ZS_C]2I%EU@HEVZK/,$ET0D2_[O[W^T^Y^[6QN/\
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M+WD&U[I+IGA8YD>-&U=@ .XG.BDJKR,Y.VG>U]3U.1/5"[N69']KF/FY2=K
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M[2XEI>WU_3C_ (+ACBZ:%]/*2  %5(-J]NN7;N;3=]MO.(^X^3=,GHN<\?\
MDR ,BF:#YM+L:'-6AX*O=SBCDNUKS8DYUYJ2F1+SU+E75S;50ITZV9:;E928
M4%3TL\I+@+:7DS+94 -Z<07%9_8[G&Z6UUMEQ<<2Y1(XU@E<)MNE<1_+$ATF
M$%WRM=B%GEEE[L\>V>^L=W$'(]C:VK)XF&&]8S^-[ 7-E=0>8MS"^A#A_F?C
MSE*76S;5:]&LRGP5"UZT@4VY:<M _N!VG/+C--MP@7&"XV(0)!Q=^0\.W[B,
MD1WC;08'_)-'5T3@<J.%6XUKFN%6&][3N[W.L9:3M%"PFC_BW,8YX*?4J1')
M0).FF?W#%>J*EM?,I*A[%[^QR@=(9QSQE8475W@[A2Z.0;>Y:N?A_BZX^5K0
M9;E[3Y-KW']IU?D*V&&EO.-,V[>D_2)BY**RTY,N*2F6F6@DN*(S4<"%*7XD
M>(/Y^>!"*$?;'4CSC 1SRP(10$>L1U.D8^.1)P(1Y$^WQ'A#*)@3@0AJ8^TY
MC(:=3# A"&9.NN1$>L#G[.F!"3Z12*3;],D:)0:73J)1J7+-25,I%(DI:FTR
MG23"0AB4D)"3;8E).5:0F"&VT)0D: 8$+%1Z#0K=8FY6WZ+2:'+3]4JE;GI>
MCTZ3IK$Y6ZU.O5*LUB;:DFF&YBJ5>HS#DQ-3"P7IA]Q2W%*42<"$K9_;/^.!
M"&?A]OOZ8$(??GYQU\,X98$(??K'^8UP(0!^_P!WG$#/RP(0S^[\>ARP(7__
MUOOW^W4_D8PP(1$P/X1@?:/:,L"$"<Q[M??XYQR_' A''01A_H1XX$(=1EY1
M/AX9YQP(0,8Y#\8>Z&!"$?+[SI$]=<"$1]A,#'['K@0A'W:>^/F ?' A#/\
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M96*>WZ)*E3<S+U.N2LYMD928EF$SII]/GSZR'"RXF5VN?% QY3?;!'%O$T#
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M2O*\.?!-+L*U9NDV4VX\T[6V:S3)=R?+:BAYNH\ERDM<UK4@ME/QR-FR]X5
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M+$0[+NMO-J"NH6VI2=//$$^L1TS-+']0<**38]D@JQX([C5;(4(9%,!E$&(
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MOJ.-7$95[/ "F"K&WV+;>&&WC ;;L:&M%<FC 5_S',]Y5DK7MWT_3;#>]LD
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M8=TVQS=L;(6Q/PD$C6N<=3:'(,()/?W*Q<EX:S>X+^\VQ]H)X;D:&/?HUVY
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M@J"PE/PH)S$(=<0LLK;J:C&TC&!\>U3+ (8R", IIH='"&U*(0?A&]*D*25
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MRPW>QWHG'"JF(;ESQ1N?V+J39$XB:E65KS0 ( 9F) )(]IPST.2\CY'-#1F
MI^HDON2'$))T"C$Z #+7Q.']HTBA*KUXX$N\%+U#ESM!*04D&  (4(0U).>F
M+39BK6JJWS@T"O8I@MUUR47+3#95ZC:TN(.:<H#X%0Z*T,<L6?;S)%/&_#13
M_P 52=Q$<\3XI/DI4>*L5)S*)N59?0#!Q"5*3D=JB/B28',I5^&+I'(V1H<T
MJ@2,,;WL.8-%MQZ9F&4#E'^!_EA1:(:Y1,80S B?'K#3 A$<LB3[^ND8'33
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MUEJ'**333699M#8(0B#I0E1W$+1O22$]",<AY#MC/6E(^8=5Z"XONA,5LT3
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MW62?C K$R[ _E!XTEEPVGD(%*5P.8R3RZV9T,F\74KV31$1B"%P)?U#PVF8
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MTN,''8$0.)+>&_\ :O [+9(ZC=]P(DF>.C::F@]@.2B>)R_]Y^X5QR6YB_\
MU-M+7Q6[3B'2.)#WCM-<1V=%6*:XV8IK[LS0T+I#X(4XTPR%TZ9R!/JR"X)1
MN7D5,J:6(]<<;#'!@:6C0"79=>WQ'3L7?S=-UMD#SZ@_3%5J[D^VBB]Q%F2U
M$J$_.67R-:[\W6N+.3Z$MU%9X_NDM .&6F&79>9G;0N4-)EJQ3RL)F9514"'
M4)5A.*[C9)=6VXVPN=MN&%DT;QJ#VX4P.&L'%KLQ3!/03,6W$1I<,ZC]JX<4
MF7O+F?G6TZ#RU*WS3.0. ".*>6F+=H-"N"K\=\74F:=4S4YRK35-DY_D2BTV
MI3##] >JZZM,?L\\9=.\,)!C^2;[>\.VHV;;VW&R2M;]'(\Z!/*/E@ Q#3IJ
M'AND@M%/F5-N-BL(';B?HH?5O7EQ+B0\R',L-:-KAW*=;_X=H]]<Q]O':39%
M>E[TL6GW!4>8+HJ#=6%5D&[6MJMSS%P"<D&92FM4J?NB8H+E0?EG&EH*7Y<M
MA*(@U'B]_=W[]YYI,QS;ZYC%I;@5:27$%\A#\FL%6CM\5V'VDVD;3;[]R/<X
MW16NT19/8*27$@T11Z@*.(J' BH-*Y+LC)R;]7KDU4%L)E4OS.V4EF6TI;EI
M1G;+R,J@&#3;$O+-H2A(R"0!BSROK'H#O,W!RBA5SJO)+R223F2:DU/6IS^'
M8I@H,F&#N4 I*8H2L@*/J91(.0@ #AFV-FKQ*VN)9&Q@ X*1V9Z5EFTO@EM?
MI*5%*OCW@0 1#(@C[L62"1A8QSQ5X%%5-P$KRZCO*HFO2\0KU)=+J=GIP2$P
MW!S_ ,6\&*#T'0X7)K5WQ3*.V<(VFG15LK=86^XOXR3N(RA[(0T.6N'EOYP'
M.S6Z;TJAQ^8BK<=(9>.NGYX>-8TYA1TTTC26@X54SVE3 MUO8G,%/],1YYG#
MV/Y5$3U+J'*BM;:M-+*6E$9$9PU.0.@TS.-U%W+G,:=&&-%R:^JQQE,VM5^-
MNXJW)4R;YJ$I;%RS4JE:7DU^A(=J]HU.86F"0Y-T=B<DE+R4KT&$Q) &)C:I
M70S,>'4!-3\%SWFNV?5VKPYOYCJ'LQ;E_BNJ'/DY_P#F/].3ASN0M<LU#D+C
M6CTLU%]HI<F45RV42RO3>6$E83.AGTW8Q"F)I8T)QV#=H67UCM^\%OE T..5
M13#[^O5>=]EN9-JW:ZM@^@<^H\0<?N7.:@S<G4&:#<])213[@ITA5Y,E0);9
MGF&WRTO:-H?EUK+:Q ;5)(Z8K 9HJTC%=A>62ADK1Y7M!"Z.\#U@O(EFB[N.
MY,8',B R))RQ@L:<:(UN H'9+HU:S;3C#+GIC<DI(5F2,A'7VX=0,&DT_3%1
M\LLD@.HYJ<**E1#6B0"#E QRU/A'%BM6UT@]BK.X%S6DCM4MTUH)2DP )@0?
M 0'XXL,  <RBJET2=7@GS3TD$$Y$$0A"(]^)V+RAKAF0J[=4HVJ>\NXIQL$Y
M'33S\H8D(7%[:N-2H61FAQ R6;2(&7AJ<@<].N>%DFA&&60U,8$Z=?>#@0AF
M/]AUR.?MP(0ZPA_J<H_;RP(1Y]8>XGI]V!"$=<NL/;]\-<"$4<_]?NR.!"/_
M %P(11/^H/0G4CR P(0CI_$PRZ^1A@0C)T]OB/NT(C@0@?+[?G@0O__1^_:&
M>F64!E#VP&!"!$<\NF<8=8],"$.L?8/9IX>>!"!CKG[!'[\L\"$< ==?MF,\
ML"$/;KGI^>!"+V^[I^$8@X$(_;T.6N?\S@0BVQ!\_L(G7+ A'G]^OMTUZ#+
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M;L 7%!DNC;<?RVN/RTS48F96F8E4S6UE<Y,_,1"0E"4A 1D$QR(48QTUQ'7
M/E(&&*FHNIZ)PRWH2J4H2X/5;5Z"=RBY$+!V#= A0A 9^_#:@.) 3U@<6B@*
M5)>:]%0+S>[8# )@2AM"4K*2@ [U!,1AC<EH-6TP[$]M@X$:@0*I>FG$J8WL
M$J3DM"P$E*VU@ @I!,0I)S\,,0'/I+4@]BD7@!M:+5 ;4HA"5-)2S )2(I2H
M* ,"#$&$/9'#IU-#4U=J#F4K2J=4B D,N.#^X3 *@5!0(V1A%.T$]8X:OP=Y
M<$\Z5K@G<R@,J25(B%@)0D#(I('PQSC#=YX4\M!6B:X$FE,UL3K"B4A<4%*=
M\ G:(:>P"&6(R9M7 Z<%+VTACTDE-::EMD0I1ZD%1@?9Y1P@YM*>52$5T?-1
MF"]24\J46C,P21FD0$/,B(,,-WM.JH;BG<<AD:#]RE2VYQZO3DC1&]KRZW,R
M]'2R1$.FJ/(D0@@ZASUX'+3"MI&Z6[M(&DA[Y6M%,ZEP^_JD-PE9;6%Y<ST$
M+(7N).5&M).?A179^H+8M+K_ &M]V5OT9EIP<,6OP/8]*E$;=TG3;3I[CLVP
MP$Y(;#=40/\ R0./5?+H0_8;BS#QKMFQ4[:&@KX'J>U>#^,7KQOFWWC6Z67-
MQ*>PUJ2,?U!?(AQK+(F3/RV2BW,2[P'7^XJ8E'-V60*Y,??CD>PS$Q;E$]QU
M,N#GV:0N_P"ZQ WT<P%0Y@/^*[>]A5BBZ;SH='>*D420;<K]RS2%(2F1H%#9
M34*DZX5$_ XVT&0.JW1B5V;;#OF_1V!<#;- DD/8&8^ K]ZC]]WMNP<=W"]#
MS]5)2*(5QU/P-!^NBZB34Y_E-2J]R3"FFW;@J+U0;0M.3$ADQ3I)H0 0B6IK
M+24@9#IBH\ZW1N]<BW%UN"+1GY;!TI&:"@RZ*\<#VZ?CW'-LMY6DW1\[\/Q2
M"IK]J0:A1I=Q&U #GJK"F=Y)4I0^'850!0F.6A@.N.?WD+Y"6@$=?LQ70X;L
MZ<1YE'M5M5"B?30EH)BK:V6EA.W_ )D?U%*4*.2NN(X1@!TKC1QPIX=>[Q4Y
M:W9:&]*KF'W7]G7)M>Y8L[N8[69NWZ'SQ;<F;4NZBW!4C0K;Y3LN"DTY%7JR
M6W&9:NVVZ 9=UU!#LL0C<E;+1PVNK+9.1[+<\7Y,QQVI\@DC<SYXWCYBTCY:
MT&5*I],()J/N(ZQTZ8E9.S3M,OKB":Y7YGYVDK38Y\Y>K%354:%8STM5;7LV
MWIAYDO2LA60RTN9J5<6V'9EQ!+:6R$_J*H,+NSVJQ98VFVF1VTV\8AB#JZLJ
MZG#]OWKH!Y"+CBNS\4LX]&VP/?/+7YI)W'\L'^)K&X"M:=RN>*9)2X*5@)V)
M2LM-$%P!&94%0^(=#^!PCB2>TY]_BHQK=.)'0I1,U+R82&7 EHK()6H*2C:T
MHQ3N 45;P(^V&'=K"7.>7@X#"JB+B1I<XAX(KVIFU:Y?1:])"@($Q<*@=T5$
M_P!OXHI$/(8EX8Z,( J*J%F)TN->J@BMU5R9<6HK43O5T,=2=2<\/6AOEP20
M>WTP"\5T]J;7HK?.Z&IB8C0=3[\.A@HISSI(#\4[:)2BZ\A*1$F$<L\_+PQN
MRNL53*5XTGS8JR%FT$I](%I.4-Q40"8 &)CX8DP#1M!A11#W8DEV"LC19!#;
M2 TEN(0"K(J5'(G^K(PPX:#I&"C9'M+W5>"*]JB3NBXC5SCV]<H\;EI*ZC5[
M:F:C;&]*5*:NJWX5JW%MF"MCCU2DDLZ$[75>.'5D!K =AGFHS=&-N(I(]8)(
M5;?H0<E*OSC'GGM8N1]Q;51H[]7HM.G0J,I--,.2\ZPVVZ8(=:*D;D[<BD^&
M.M<9E.X;;=;9(ZGY9(![1E2O[%YBYA:_TK?(+H1T8'8X4"KS9=O3=LUCECBB
M<5Z<YQ9R56&J?+P4F83;-TS#U;I( ,0)>7J*IV73M$$EJ&D,0;0YIC#ZZPT@
MUS!!.!70=MD];;8I <\1X4&7<KQ\&32Y1^7;6H!S< K2($4GXB(0/PPZ86(!
M)H,*I;5_FP74RQ%J=I["@I2R0UXJU3GH3&$=<+,:X.&! 3.4@,=B*JQM$;"?
M22$DP*<X$Q\?+%BLP=+<.BK%^[ U*EJFM'^UF=$C-.6GGBR6K?,"X8*J7IP.
M."?$DF $>A\('4>.)MM*"B@;DMTMQ3A9)1 YD0A#0>(/XX>1C$ 9*'=U[4H>
M>6D<X_GGD",+I- C6,,LQ&)^PRP(1ZZCQZ$PZ>&A P(0'G^1R\XD=8X$(\QX
MG[M<"$/]<A^?MP(1_;[=<"$6L,"$/Y_;^>!"'W_[?*&4<"$/9]AGTZ9X$('^
M7^S A?_2^_?[_=H=/' A$<X:ZCKJ/'K'\\"$?M\<LX?QUP(10SB?*$/:?/SP
M(1_?_+RUUP(0^\Y]"/XGQP(0_'/QT_' A _:&4/&.>!"'GF/+[L"$/L=?9E@
M0A]LAT!,!GD,"$/YGI[<"$/&'2(TCX8$(9D^'3KY1U'W8$(>/V\/<3@0A_#[
M>&!"'\!^.>O3 A%Y_?E#V1SCE@0C_ ^_[M<\\"$/",,SX0\_'QP(0]NOW9'W
MGPP(10C&,(^0\]=?+ A#WP/B ?9GGUP(48<B5/T*5-(22%%"TD@PT3TAJ1B,
MOIP(RUIQQ4MMD!=)J=E4+F?R&T[,SGS!2/AF8)*CDK<KPA&$%9XJ%T7%M79U
M70[%@C(:.BYWW#*!=5NJ74 E354F'T+2()*G@EQ8"3T$8C%;OW-<6#I7%6S;
MG .(=U"K]<3#*6)@NMDN-*4 H@'<B/7J2DXJ]ZR,R:V*[V+Y6QMC/\M0'56T
MI>F%.MA24_\ VT6P7$N;_C(C^EL^I ^6(F1[=+V8U5DMGM+*56I(SR'BMJ94
MZ'%.JVO-C;Z"T_!\05DILPR\(8:ACFLUD#352(,C0&BB<U'<;^:^36L*4M0?
M:<4K<%J/P+9SB M1SAUQ"RO#'$N!Q*DH9&O#*'$43JHTL69-39<0N62[,-MH
M2"2PIM8#C*P8?\HD%,,S@:X.-!FG<A\OQ6=3!?0T"/14I:4J($$K&[=".6>T
M>V&,N(;34D0TNK1.J4EQ+M?$LK.Y.P?"H0*8[8ZP\L).!=1S2M@_2=#_ )4Z
MF&G?63N@4I,4$)B$B (2!_Q=<:2^8M S"7;%&0' )QJE/7E"(@.Q).[4@CIU
M"01C#XW:5D$MQ";$_(+6%J_5L.T9 $=! 0$0(9G#9\;S2E$JV=XKF$U)ILM+
M"51TB<@""<@!Y80=$^N*>6UR\.^;JIQ[8:.NZ.?N(:""HHF;[HDP^G;'^Q39
ME-3<*@(_ &Y,QRTQ,\0L_K>7;+;Z:M$X?_NC'[PJY[C;C)9\#Y)<5H1;EH_V
MW:2/O*M]9UX-\VW1]6/C P=<EC5A(MIB^I1I5KRCJ'DM*B(%UM(3 :8[U?W3
MK[?^5V#L8Q:-T^+<5X]9 ;"TXC=M%"Z:I\%\B7%+WH5NI-/?!_U%8E5)42"E
M5,JTNKJ=T2U.*]D"<<H@+H[O<XH?GD+' =I-0?U+T-"[ZD6$X(+!&6FO:W'[
M!7-?2_Q1:[?;7VW6\BL-F4Y<[B):5GIZ3=!:J%K\6MA$S)2#C>U+\M-5S<V]
M,!028.(2?T0QTFZE;PKB\UV86_U>\9I;3$@']W54;;F2\XY@V-\;?Z-MSP2
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MI8T^"K_<]$05.@^HV99:5**C KW)W;3GN4F TZ8B ?3<^K,\E-VK'S.8QF
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M( )*](=0"<AAN^"6@JG$0S(S6H]4SL4SN4I:ANC_ $PCI$'"7H@8.&*D8II
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M'DNQ*2GJ83$PS@8Y&,0##[L(F*N&83AD_F: <DBOT8$$A B2=4Q!\_=AC)
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M$H!]P'7V98W^A::4:D_ZD^M=2W6K:81F&AGF1Y>W+&[;(#(),[BX4.K%;B*
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M66(;$PSRVCQCK 9B.-39@FI:MVWSVX$K2-F2F_<&T9>2>N48],8%H.C:K?\
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MH? 8$(:Z@1(&9_(>'YX$(9:P&8'B<_  8$(=!D-/"(C$8$(>$0!#\!X'Q_#
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MRC3WG\SC!R*%CZGVG&6]%OT68Z^X?D,"T1C^!_(X.Q9Z%!7]/_","P@/Z?\
MB_\ W<"$!T_\W_I&! S0_H_\W\,"$/Z/_-_# A _U?\ %_\ O8$(NA]H_(X$
M(Q^E7N_/ A>E?U_^7 A>4_U?\)P(1C3_ ,A_,X$(NO\ Y?\ ]C A$-?<?R.!
M",?T_P#%_P#NX$(AJ/:/SP(0&H]H_/ A>T:#_B/_ *3@0O!U/M/YX$+TK57M
M3^1P(0ZJ]I_)6!"]_P!?_E_C@0@K_P#95_# A&-3[?X# A8SJCV)_/ A>U?T
<_P#$,"$?4^P?F<"$#I[Q^8P(1+_2?=^8P(7_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>silk-20191231_g3.jpg
<TEXT>
begin 644 silk-20191231_g3.jpg
M_]C_X  02D9)1@ ! 0$!+ $L  #_X1;817AI9@  24DJ  @    % !H!!0 !
M    2@   !L!!0 !    4@   "@! P !     @   #$! @ ,    6@   #(!
M @ 4    9@   'H    L 0   0   "P!   !    1TE-4" R+C$P+C@ ,C Q
M.#HQ,CHQ.2 Q,3HQ,CHS-0 (   !!  !    @     $!!  !      $   (!
M P #    X     ,! P !    !@    8! P !    !@   !4! P !     P
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M 0           0(#! 4&!P@)"@O_Q "U$  " 0,# @0#!04$!    7T! @,
M!!$%$B$Q008346$'(G$4,H&1H0@C0K'!%5+1\"0S8G*""0H6%Q@9&B4F)R@I
M*C0U-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS='5V=WAY>H.$A8:'
MB(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7
MV-G:X>+CY.7FY^CIZO'R\_3U]O?X^?K_Q  ? 0 # 0$! 0$! 0$!
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M96&"I'4$>M-JC,**** "BBB@ HHK:\)Z(_B+Q1I^F*H*2R@RY) V#EN1TX!
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M)CZ@+^9Q6=I\>=@H U;:,)&/6IZ ,#%% '(^/K6<Z;#>6Y0-$3&^\X!5L?U
M_.O/8HA"SQ#:[ B0F/D$X(_E_,U[+J>GPZKIMQ8W _=3(5/MZ'\#7E&L>'-;
MT%Q,MN;FVB3:SQ+GY?7C]<_G7+B5-VML>I@:D+<DGJ-N[4OHT?EH<@9(QR P
MY_0UL_"^]EM[B]T:20M"%$\(;^'G# ?F#^=<[I^K32(Z1*[",!EXZ#H<UL>
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M%>]^(OC&_G6:7Q)J,;*NP"VF,"XR3RL>T$\]<9_*N8HH W_^$Y\7?]#3K?\
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M 0$  @,! 0$            !!08#! <( @G_V@ , P$  A #$    ?OX
M
M
M
M
M
M
M
M
M
M                                                         1B
M1C*;$E%0
M                                   #3G6YP(X><;->6 %26;XY.<P.
M<'.S8
M                             $4ZE.GC@8,A>9"I4J4+2TL+"PM+CFIV
M>=M'(P
M                           0CHXZ.-893*93,93*7E2H*%AB,1A,1B,9
M84.?G=AVJ9
M                             "ATV>=C6&4S&<SDB,]9C(9(OJXJ(MK$
M82.1R.1C 8BPM.0G?YW"7@
M                                       TYY:.NS(9R09R02222#.F
M1<A<7%0"TQ&!(ZQ"(1"*1S$6%IS$].G-@
M                                                 <)/)AJ3.224
M2#.2262C,9#*EZW%Q4 H6F),*Q4A$)8)&(I',1:7'?IZ ,@
M
M !UR>3C$2242R2DHFDI91E,I>7E0"H *%"PPD4@&N()%2(L<P%A:<[/5IO
M
M            #KT\DEA+)9-)A*):2UFF<O*@J5!0 H4* M*&,CI!77)KEAD(
MCD<M,9O#UT<N
M                         .+'C<BDTG$XG&P)A-,Y<7%YD,J7J*%8MJA0
MH8S&8RPL*$<AFNC75KR&13"8BPG'K8Y^
M                                            0SQD<<)ILC:&R2<L
MLD&8S&<D&0R%Z9ES&0L+3$8S$83"83"83$6&$B$ UJ:V6#44P&,L))[ .=
M
M          \U'2Y/-L;1-BNP28L@RF8D$N2=;/DD6Y2XK%*H6F%,$N"HZ12-
M+@LCK',!C,1$()K$UBP2*8#&8S9GLLY,
M                                          #@IX\)IMHV];<V9++S
M,238&RB?4XO,AE,I=)6VTQF$P$>(MD58T1*AD,C$8M,,1*U\:JM:0B,8"PQG
M*#V:3P
M               6GC8XJ;<W1NC:$DRDDF1/K9$XGQ+,J76W%0"A86Q;5AB(
MI!(! 2"0EAD4M(Y"-<:HUY$(QA+"P[</5
M                                           .J3RV;0WQO3;$F,U3
M"8338QLZV))+P   "TM *%A#-::DU$0ZUZ8%QD2-?9K%UA"(I',986'K4[/
M
M       !0\:'&SD!R!-PLPSDPFD\V!LC81,JH*%    4+2@ (IIC1FJB%40Q
M& UQKDU:P"(13"6%INSVT3
M                              #@AY!-P<E-Z; SDV2=4]=C&QK81-+Z
M %I:   "@+2@*$"-%6@-<1# 6$)-:NK-=$.HI&+"TQ'H(] @
M                                                       'F@ZF
M.0')C<$@ED^-@;*MD;*)=7@  H6    %"A0H8#3''C4D$CF,CFN-::P@D2(U
M8 6$L]S$X
M                M/#@.3G)":2C8&Q392[2ME$NKP  "A8      8C31HS2
MUKHB5C,*0%UIKC7$,C& M*&$](G>(
M                                   !PD\?F_.6&[)9.-G&UK:FQ)A4
M   %"P      H:Q-$:4U2PS"6&O-<:\UI!(Q@,94PG)#VT5
M                                                     !T4=#'*
M8Y76Q-@FT-Q+MZV)G+@    6%      ".F@ET=:@@&$Q$,@FN-8:\AF$Q%2P
MCGM YF
M            #RJ<&.8QR&R>NX-Z;HV$7U<7     M*%      6&G31&F75F
M P$(AD$UYKC7D<Q%2TP'?QZ"
M                              !XT(9S,W!MI.0UR&795<"\J      "
MA0H4   *&L-*FF-,L0BD,BR:^V$0S7$0PE01SFA[)
M                                               !X?-B<T-I&^KE
M$;PRT+BX         H 4+0")&EK3&E->0D@+"()$,)"(1%A0PF,]YDL
M
M%#PJ<D.9&V.2IRI=@"\J 5*E0  4!0%     4*&,TYIHTM:@UIK37D!,*V&(
M@D,Q%3$13V =A
M                   QGA(YF<O-R<M.2&4O*@J7%0      4* H4  !0@II
M%TIH34FI-4:XL,@(A!(A>8B(>ASOD
M                                  $4\,'/XY16].:&Y+RH+BX%2XJ
M  4!0%"@  *%I0 M-8F@7CAHS2&E-:6DDR& @$$J8R&=H'JX
M                                                     &L/$IV*
M<E.1'-4GK4%Y4J7%2I4%0"@* H"J%%I0%H!0H6@M-2</./)QY=":HL)9*,9!
M->6&,B&^/;H
M                ..'CT[(.0R<JMY<2"I>"\J5+BH*@  K%*%  "A0H6EI0
M L*%#BYPPXR<=-,8B7$VJ$0@$<M()'/>A-
M                                       .#'F$[&-^<TCD%7EX+RI>
M5+BI4J "@ !C,9>7E"@!0M2U;2@+2TB' #BQQ4T!')).,I'(9#,1"(9[).<@
M
M    '4QTL<_CEU<NDEVWE2\N+RY*K<7)50  !0L,9<7@H"TH4*):46TM!0L.
M))PPX>O&2"9B:2"TPFN,)"(!Z;.Y0
M                                 #H(XP<U3G4NVK(4+C(9#*5+RH!4
M %  $HM08S$90"A:4*):MA:"TU!P,XJ<--25)A*,A4U9&(9K3N\]'@
M                                                          'F
M4V<<NKE1D,)$+#,2R62B493(7%"T%Q4%"H!0H8"A>"XM,8* L+"T$4X2<4.#
M1H*PDDE$TSFM(!#-6=A'KD
M                           \LG*8Y)6V)1>4*&8S$@D&4RF0J6E 9#(5
M+#(7 %IB,X *%#$8@4+"PH6G'#A!P@XL03*2#9$XBFK(9IS='M@R@
M                                                         \NG
M*3DIMXF5))"9%O* R%Y<"T&0N+BXH8BXD%2PM,A4 %"TJ6&O,\EMMI:#4G S
MB:<+74%#,;1-LH@&OCD%<F,L<OKM8J
M                                 #S0<A.5F_+4O7;I5;S,7&$N*F$L
M,AD*EY<6%A893,8RI<4!< 6EI ,I4L!C!K3@R<=7A4<:K"7FS-ZDY8R=EF>7
M16;&6<<IKF
M              //Q).9$@SG(R,2S,8S*904,!C,I<7EY4M+#&4,IE+2.8"I
M>5+C(EJT+ 8P6%#3G$31'%3AA !L#D)V <X)AUB=GR=?KRVLL<WJ0
M                                                        =/&A
M3EJY$YFNS +RH!4M(9<7F0N+@"TQEH+S(5* J8P"PH6%"PH6EAH).,VZ8TIP
M0T983#E$=^V;M>-2<2MV*;E>MSM&-E7+
M                                   #K\ZP.3'-3E1< 9"PL*%Y81S*
M9"XJ5!<"TL+ 5,A<5!84!:6EA0M+2TP)QZ705J#6G"3BQ@,YRA/12[(T,9JZ
MNCMVO/IV@<K.:
M                '"CI<Y.;XY$3"4;$QF(F$@Q$4J92\N !>5!0L+"@*EQ>
M4* M+2PH6%"TUQH4TJZL@QQ2N&$ R')X]!6;18<F.M:35Z],\<[3L*T
M                                                         #@9
MU$;<Y,<H-P2#(9C,# 109#*7%P*%2XN !0M+2A0H"H* L*%I:8S4&B-,:\B'
M'C@YJ2XY&=NQSRSB$O9)Q0WUG I>$UV;'95
M                                      =8'71R"-]7(CDI>7E2XC$<
MH7&8R O+05+C(   "A0M!0L!84+2TL-1''ZTIKR,:-.$KHBIR,YP=O1TQ7<L
MF\MBG&SJ [:.SBH
M                 .FCBYR4VYOSD!F*F(PF,H7EYG+BI4M +R\N   !0L!0
ML!84+2TM-><:30KKTARZ.SARZ$H<O-PG<*]1IVT<X+%XB=*G=AV$
M                                                       ="D$Y
M*;0VQN#.6E!%*N+S.9BI<5+"@!<92H  !0L!0L!:6E"PM(AQ0T1KR":&.(5I
M#&=@'/RJ3)8U=M$1.-+U&=S'/
M                            #SP4.2FS-F3C,9#*7E09209R\J6@L* M
M*F8J  "A8 8P4+"A86D$XH:0UQ -"<0-(4.SCMF-2G8MNF3>KH34)PQ>S#FH
M
M  !YS*G*C9&R)YG+S(9 4)9),H !0%"TL!G   ,8!84*%A0L+34'&C1D A''
M3B!I2X[43MR74V=A+01U^<<K>IS1>5
M                                 'G4PG,#<FY):%%YD+03B47    %
MAC,I<  #& 6EH,90L(QHS0FE->0CCAQ$U:57M([6+3F\8SA-DPZP7L0[&)
M
M !T$:HYD<@-J9 7F0R& RDLDF8 %"T%Q4H8RXO  !84!0L!C+3&:PT)IS4$
MA'&#C!K@=H'9)N4V4O7MF^ETMFQC=KS^@
M                                   !TX<+.9G()-A;E,AE,ID,!(+R
M09S*5*%A:7EY:7&(O+@  6EH!C!C+",:--&NK35D-=='&:X^02P[/CLJK#)&
M&N(&U.12<\MW
M                . '2QSLWIL222#.9C(8209#(7&<R%I82"I0M!89   "A
M8 8RA88C5G'S4FM-<134G'#5$,CG9QV^G7$O;%:4ZW.0'(CM
M                                                     UYY4.PD
MWR[,G$DDDDR N-D5,!C,Q0J9RV6Q<]_-H    +2T%A86$4T1HY-7;KB"133&
MD(9"(!VL=WG6D=E&I3K%9U=U&U
M                              !Y<-J<H-L3R83R493(1R022TQ%#*7F
M8B?GET''VMOR=39_KC     Q@QEA8:TT)I35D A$0TYKC$:PUAW.=R' XK6T
MCK^N9G:@
M            !TB<#.<FX-@;$VI)+S.6F,S&0N+2IF*D'\<W36/VW9=G$=P]
MK!@    8P8S&8S4&E-":H@D8A&J(Y@-6:H[^.RS0G!38G'SOHF@
M                                                       '$SS2
M=AF[-@;0WI*+S,5,1>9C(7@ PS]>(]8]HB]O!>[,[YD    !86EAC(YIS2G'
MS5D$PD UQB(YJC6'H\YP:TZX(YS@[)
M                                   !0\E'(SDQ/-J<@B?60RE2A82#
M.5 !0^9>D_1?%.UA_J[MGAEX    +"PL,9#-/&C-%9JB&N @D M(IITUJ^H4
MY1+JZZY)*=VKD
M                   .BS@ASHV)LC?FR)!G+BA:9"27  'RYT?Z-XMVL)];
M-M\-OH    6%AC,1K33G'OS^N/3DUJOWP8#7D,M(1I#4'9*>@%XXFI7MDF
M
M     XL>7SL,WALS<&V)1(,I>8I;5G/SDH #Y:ZE[EP_C[?UZW'P("I4%2TH
M 6%AC(9K#5''I^NI>AM.EX>_SG):??R=77D,LC7UQ\U1--Z>OC;@
M                                                           '
ME GG+S:FV-J3249S*8?S^HC]2TV'Z_  N/EKT=GT''VOK3DM.J5  !:6@L+"
M*:X@FI-*><<+Z1T]A/1^\LYYGV%F?/-<1",:Q./+')QV">L
M                                                        =.G5
M!STW9N#:$XEDDS$?\_O1?GESV<I_?!<6%"!^>3X,:%]+<R[.)^XV[?/=P  !
M0L!81S7I#6":LTQT;B]W\ >??5WH#/>6^M=W^;-:0C6_CEU?[XM,9S.=]G>X
M
M        -0>4CFYR8W1MC8$PDF8MGZX9Q]S51V=R]++90J<(ZV6_/#Y;]B>B
MLKI7W-]&^6J@   Q@Q$$A$,AFL-0<)X,G\=_'OO[L#(:E]-O5OB")^N+3?GE
MU'X[$+EZ40V!C/61V&
M                           >;2"<Q-Z;LV)+)1G+CJKJYGJM>^/UP<W[
M&,J5.@L+O7Y^M"^D/;O>UW[2^D_*X   &,$<@D(B$0UIJC5R_%3QS^@NJZN2
M^K'L?P-R+MX#@'5S.*\=W9Q6<G$$]RFT
M                                         .M#I\Y@<D.0FQ))*)!E
M/-V.VWR1U\QWER8[VWE=+ \4:MZ]\/-.]W^G>>\U^K^^?.@   %A:1B$0R*0
MS7FJ-='QU\I^Y.M,'Z%]&?6/B#NO-^<>?,+Z+N>UA>69#5-F9B2>X
M
M   0#S"<G.4G)C;&4D$HRGG'%;M\CL#ZS*Y<5]]]M\%OH?+[3/=OEIC-U^N^
M:\[^BNV>,    6F,C$,AD4AD$U9K#Y+^:?8O1VK>R^W_ $SX]]1;1XOX7TCZ
M1YWF?/.^\]YCMRPY8>O
M                             #SJ8#E1RXY(7%I),YQ'K97\V_FWV'U5
MW]=_3!N/SKWADM3'Q_U/VOP1R]?[3=K ^T<[YT   !:8R,1"(02)$2M8:H^8
M_G_U)YDT[Z ]>[9\N>@MY\>\ ^=_5OHC=?GKT9F_-]F1#LH].@
M                                                           '
M41P$Y2<S.7DHBEYG+S\\?EOV7X1X\M]D=I\1^OFV^&#X.>9_6GFS*ZA]X<UY
M[Z5SOG@   %IC(Q%(AJY^H<N/]?C6FH/+OC'M'ST_'U'[%Y?FN;NN'\.ZK]!
M_0CU+XR['[&*DFK.YST&
M                              <+.D3DAS0YJ2B.93.7GS&TGW_X#Z3]
M$>KMI\D_4!Z%\JY[^?SI>6?9&7T3YY^Z/XPW:^2U8  6EP+"PC$8BG#N/MZO
M\<W(.?':PTYT#Y#Z?\]-4^NO7'X^>X7-DO)/H&:^AOHWR=R8&E._3O
M
M     AGF,WIS$YH3"IG)!F.J<=M'Y4O'/NKCNV^6?J.V[Y[],9C1?SZ>0?6?
M.O3/E_[1=R\R[&*  $3\_NMDJ_G&6$<CD0Z,Z6Q]-8[</6>>\LU1I3S_ .9^
MG^'?,/K'V'K_ (GYEV#=]U[SX;ZLV+R;?$:-%7HH[G
M                                                    !YP(YRDY
MH;,S$DF&8J?FU\>^YO _9X?M)L'D/V1W7P/X_P#SY[KQ/U[SC[3[)JFWY.L
M .)\&1U?YYN?]G$6&,PD8B'G?';=\^-0^@?K1Z!\H:<TAT5YEZ=XR\F^I^\L
M7H'A?U;;_HWZ_P#%'9'+T9AK4T:^DCN$
M                                          '3AU^<@.:FZ)!.)QF,
MI\OM(^A/@AI7O_TUQ7F?VT]V^8_E3YQM;(Y3[+;_ .4S/UQ@ #JGI;)U3T]@
M]4YGSNAB,)'(ATITMC^-GF?V9]S_ %CX0TU:@Z)\Y]0\F^1?3?66Y939[UXG
M[XW?YLYH0C3&G/3!VZ
M                            #BQYW-V<L.2DTGFR)!F.J,?L_P"5[QG[
MM^E&O^-^TO7_ #SRSD?'N>>=?0/UM]J^<\E@  \_8K>?-.)WOZ)[7X70QF$C
MD0ZVX,I\(/(OO;[Q^Q?S[A?KAUAT'Y_ZAYW\6^B?.OHVR>N_3OCOU'E=&W!Q
MHX\:T]+G<
M                    *'F,BG(3E)MR:;@EF<S'YOO(/M_U?@M$]'YG4_-?
MM7S+V1\P_8WU6^E_ENX  'E; ^G>7,3O/U(W3YXL+#"1B$<%XNY\#O'_ +^^
MZ7L'P"Y>GJSSGY]ZMY%T;ZBX5L>,^E_J7Q-V9R].PXM'$Z@GI([G
M
M   .M3I W)R8WQLS<FP)1)/FSI?O/EC6=Z^GO2\9^>OMGCW<?SG]4_4/Z'^:
MJ@ H6GC+6O8N@NEL/U&W+Y\M,9A(::U>&?CL_ [R/[U^W_K/PA*YNAQ8\D:Q
M[1YA\T^J.OLCA_L]ZY\)\PY>GJCBYPHAGHL[P
M                                                +3S":LWQR$WA
MN#9DTF'!.GG?A'Y=];^QLGY9PSTGYIY_\X?6GU6^D/F"H!0 \!ZC[SP.\?TS
MVWPJPPD4UYJ3A/X[/PB\I^YOM;ZI\.8.3I\.KROJGN/G3R7ZKZRS^#^\7L/P
M7O\ EZ?$3BAP<A'>QZ'
M                              !Q4\S&R.0'(C?&R)Q.)Y\$?)_LOS9^
MNU]!=Y^)N=?/_P!/?4_Z<^9K[ * M/F-HGTUM<GI_P!']H\5QD,UIJS3G!>+
MN_$/RW[=^P?J7Q!K^7J:@\M:7]$]0^8?1'66QX#]!?KWPEK_ -<7 CAAP<AG
M:1ZK
M                .G3IDWIR(Y0;,V!/-B?/O3_</A_KOM/OGT/Y+[_\ ]U^
MK_T;\S7V "A0^1/G'USW[L_COO/8/*(AIS4IK%U!U[P9'XW>8?:WU4]2^(;^
M3K<R/%^@?3_5N@^S\)V75?OGZQ\1Z*.O*X3' ZCG)CVL
M                                                        4/-)
MQ$Y <K-T3S9FS./];*_F)\C^Z.^O8?D7DWSY]0_H.^AOAW/?S4H"A0^*'E_V
M?[FW?YS]=YGSS1FF-::@X^=6];,_*GS#[0^I?JOP[V-^^#MT^7_G?UEU]I'I
M^OVS0_N+Z?\ '6A3KA>&G 3&F!?<YN0
M                                          #7'D\')HY+6Q-H;<W)
M\,_*?LGHGTSP[ROY/],?J_\ 6/B?GG:PX H4/A!Y1]Q_3ST7Y-[RR6G:8UYI
M3C9QTZRZ>P_.'S3[&^R'JOPYV]^N/EA\7O,?LS4ZKN>[W/RW[,^B_*6@CK.N
M''"2TB'I5.ZE
M                        '"SRZ;PY2F[79F\.0'A75?9/E!C/4]KIWJWV
M-]'^5/7.S^.U!0$/\\GP&\D^[OK;ZC\6]C=S7]:<<./&D(YQ/H;/\Z?._K?[
MN^I?$?*+^8GYY/B#Y/\ <<S7LSV1Z!XM]<M[^:./QU><+KBY>:XY*>U"H
M
M         .G3H@Y0G)EV<;RN1' .GL'P)\J^[^S<;D/9&U^(?4'TCY/J"A$.
MO.#)_#WRG[A^O_JOP_N>QB^.&C(9MSFAPS'[5\M?/_JS[V^G_%66S@_7R_QD
M\D^X).&[??\ Z3X!]1]S^?.+IUFO#32&5-2L$]6':@
M                                                      !T8=,'
M)SDD;6MNFXGZ_/OYM]M=G8S.<QX>#[<>Q_!]I%-.<;.K^AM'R+\S^QOJ_P"K
M_#>+DZN$WQS@YFG(%Z.QVW?)?0?J7[R^G?%M]G1V-W'Y6^6?8NHQ7;]>^G_-
MOT9VOQ#AJ==KQ0UY<:@UI//:YL@
M                                       #QL<?-T<H-Y$RSXR>?_7/
M*.?\==>?>V_=GW?^<>/]\.N->FG7IG$[QX%T;Z9^K7IOQGR[]<7*TWB[(N!Y
MSQ^V_*/0OJ#[P^F?&=]GE/!>F_/CS?ZFX%C.[[_]4^7?=FR>0\%."F@B+0TQ
MJB =C'K(O
M                     !XB-X6&I*FT3YD><?7-^VZ!U7XQ]:?5WVWX#Y]E
M-.UQ(.:G",/O_@;4_<OLMZ'\H2+^0 !YNQ^V_*K1/IW[N>E?&V:SPSJWM?CO
M0/H?J?I9#ZA^L_(WKG.>;<!.&FODC6V&FC55K""=PGILJ
M                                                        #6GB
M,YVG)5E$1-(OS@\[^J>M_2/$.,>"?<GT*].^1?8NT^-\Z-R6GG+"^B_/K5O:
M_L5Z%\HR+^0 !YXZ&U?)[0OJ'[L>E?&\S]?CYN:3]$= :5[1TEPY/Z_>N_&/
MHC*:3P*7B=1C&8(U=:HUAK2$=PGI@R
M                                         '6!YH.?FZ,Q4Q1\^=&^
MD?*.[^6;'Q3[/^@^^_,OO/<?#-T7 \YX7T/YXZG[I]C/1/DR;^N,(I2*5T/T
M=F^0OGWU=]W/3/C'9?OA^4^@?4G7.H^E="?O(_;OU[X@[6[FO\(.,D(L,1$-
M6:DUIKR&=BGJ8V(
M                         /*YQ4YP3S(5,9XKU+W+Y]=WG[;U?T?UIW=*
M^C&]_.?(%N!T1B=X^8^E_1'V/]'^1]]^^N  .L.MF/B!YG]E?=GT[XOYCSXW
MXV^<?7^LUO;.A.?N??GV#X3W_P"^IQ X]6O(YC,9KC71JZUI (AN3U.<Z
M
M      !Q$\?'-DY.25DEAB//&&]"^46K^\=V;'YKZ<P>P?2#>OF_DI>#J'';
M9\M=(^D/K?Z#\J<YY\<  -)^.?\ .CY/]W_<[TGXY[NR.H_#GR[[9SX#-\!S
M&)^_WK'Q#6_GC<:*M80B.8R.0#6FMB!4$B&$[H/0IL
M                                                  #$>0#6G,C:
MDLDF(CG4G1V?X[^7_97;/KWR%Z-T#VSZ<[_\O\L,@.K.AL_RIT?Z4^JF^_+_
M &KVL( !0L/SU>9?:?TYVOP?TOF?/OBUY=]G8L#F>0[;Y[]SO2_D"PU,:*M0
M:\@&$Q$<UYKR 0"(1",; [\.YR2
M                                  >;3JTY<G()9-2R08B.<3X>_P##
MWR/[J[;]O^(.R?)/J_[ >G?&O,#*HZ:QFX?)[1_I7Z\^A?*/9G9Q%$K+;8BE
MH^,.C_3'+^;&^M<MH7S(\Y^I-)C,IZ+WOQ3[ [U\TT(QI32&K-81#&8B*D)8
M1!(1$(I&,!M#NT[C-T
M                       #H<Z,.7)OUF&8F&<L(Y%E^&7F'VMSSU7Y'UGC
M7VO]VO7_ (+YK?SD"><,'Z/\GM*^CON-Z;\;<IY.H  !X'P/J7RZP7I_JOCY
M>C=2]1T#]_1?T;YH^AFS>."PUAH31FN(9@+3 1R&12$0XBU&,!@,):=A'9)S
MDYB2
M       6GGDZ9.5G(B89#.23,6& Q'R0T?Z<ZNS_ )[M]2]I^OFX_./I3*:3
M?:/$>I^V?/7!>K?=_P!(^/L]@  '#.+N_FWT;Z=YUK?JG+NA^-)W.C]VO6OB
M_M3MX(6I 72II%U"0R,MI883"12.1"(1B.8C"83$83$7'(C?F^-V;(E$LF$H
MD$HDDDG$PRE0
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M+2A0H "TH "A0EG)CEYS$YZ<T+P
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M+*H6E2\O,A>93,9B\N+3$6D<AD Y.=^G:)4
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M<UH%Y?%]7%2XJ5+BI>7F0N+BI>7%P !88S&6)'EU5:@TI$/2AW&
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MEQ>9"],BWEY<92Z+*A$$C%A:1#7G%SCYV^>F#,
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MM[S\XR_UQYY<E7E 5!4J "XO,AF,L5JTL+$A&DEU"1+;(MK41PRM.=J'JDN
M                        !0Z[.C#@IG)!--HFY6>8C4&IB/6$PF(J5*&,
MP&,H6DLFEIUC@?3_ #+IOT'U+@-WXWB^[QC,8CT[NWAGKS:/%.P>[KPJ92<8
MN+N>--:]E\*:G[Q7KY*[\\T#FZ7<>9\_^S^Z_-7<G<P&,^/NF_1_1FB>I[+W
M_P"(/1'F/T7]7]\^<1$..1K:F1X'U/WCYP:9]"]WY#3.H>IF_P!"7JWQ+R;D
MZ8L7Y<:=]!>/M7]EY!^^#K3C[/<^=\\^K6Z?.7.NUAH"15C&(Q&,L,8!:4!5
M**!4J7EYD+SS!@_2_G5HWTS@Q>V]J=K">T=R^?\ UWM7A^S_ 'PY"Z H $M6
M@*EYDC)50(6)<%FEC0UK)<-6& XX<0()W^>@P
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M#O+(ZCW7D]&[-R&K2;^;BH2B@5+2@0MQ>5 *(6LF!=8FD-34(Q+803BR<87
M>O#L0                        Z^/)I8;@VA)22M2\$6356P#$"XR&8O*
M%2\O+C/&>HYJ^+M^0](^E/)>K^S]=\7;W63U'Z0;]\N>A\QY_*)2299%2R02
M$V*[DWLDBW'/U\W=6]S^;^J^YUX^>^?K#S=#ZE[C\^?178?(?FI\]_1'B+/^
MG\I]J^1OH9K6Z>U=A\LX\:HE&JZ^4_/_ .4?<O*[T.3\^+^@.Y>"^\]E\B1Y
MWP^_?''S#[#R\G6U/:Q7T5WGYU]H[!Y/$(]F%<)0L*E4N"W)>72W695R%YD*
M@% 7EQ6+ZR%TO572V;+^>7FO/B^2\N/V?)U[@7@ %0"I=%]"T%"Q*1@K71JJ
MU1KUB%IC352\-K4&^/:YE                       .(GCDPFS39+*,@+S
M.",D5;2XS&2*E*M+2XO+RH,!K.+M^2=&^D_$NK>X<(Y.'M_8/+_J#O?RWS?L
M8O8Q-LERYJR&0SD\V\;M-I;D!E/%V"].^/\ I7TE'XN])_'-V'C\)[[VKPWN
M_%8#Y_\ G/TKUY]5_%WKCR'WOZ2^G?/''R.;L\N83TKX]><_67://KN&_G[2
M>F_(W;7<P&M_/)\6O+_LWKCH;!QKDZGLS</#?H=MOA<<PEA0J7&0O,A<5,AD
M,AE3(MY<7E"TH6EH*%@*F0R&O_'/EEV7[XL]_&8O*EQ4N+R\O+BI4J5*%8LK
M"ED1ZUDNK37$&H)'6V-=7&SCA#/21W8                      #&>+SC!
MO#?DPH8C(9C(5+"TLDR6YY,=N,Q&(M*%"TQD<@\?8\X:;]!>#=1]YZU_=]'[
M3XQ],]U^:-O^^'8$\F&<O+S.3(V-;8VAL"892Z2Y?(.']#^+^C?3>?\ ';W7
M!R?0GS+R[@V?YN::IR>*?JOQ7W=X+N?MOZ!\6?OADIRI?FUJGN_SMTCZ$[G[
MFIPY/O)ZM\9GY\4Z[ZUX=U'W;K?J93?Y74OL;Z)\GS_WU[%J7F0S&4R&0RF0
MN+BXO+HNJX%2A:6&,P&(QF$L!4N+RXRQFK*93(9#(F9<YD+BI4J  6F-,<8J
MU:Z22(0"%;#C'4(T1Q@@$X]R&<                      Z7/.!RTY&9XK
M5L9*N*E06F**UD*ED8ZP)B6PQ%AA,$1GZ\U:9] >(M4]UZ<_/<]0;7X?]*=U
M^;IU_,LGI-647EYF)),)YL8V-; GF8JERU/'N&]#^,6C_3?*WY[)P?Z]C^8:
M#"Y.7P!]':]])O.?*^S/4OWW?GM,VYRL^.FC_37E#5/8.Z^]J'->U@OLUZ5\
MH:9^OD#YW]8ZK@R/2'4S7TWWSYJ]89OS>I>9C,9C.92]+EN+@EI5:E"A4M+0
M4+3&1B,8".8@4*E3*9C,9C,9S.9HDUE+RH   !0LDL(=<;E@V0B(0%CD8TL<
M:-/6 ]:G90                     ->>+SDAOS*52Y:E 5!:4*  %IA+#"
M8S$8C"=%ZQ[!X=TWZ%\[=?8/1FT>+_3O>/F25?S()Q-)AD+TRK(,\2ZF$TG$
MXGDHR%TEUH\+X+T_Y$:5](]D?O@Q8?8.V,!B.B/0]>^@_P"_DSL+\;YZ=]#\
MUWQOSX7^>?6G4VO>B=P]_5.Y\MHWU;W_ .:_/>,W+YS:/]'\7XNWK.QC_N)Z
M-\CS_P!<=YF3,N4R%R56I0H"A:4!86% 6%#&"TPD<CD0P%A:4!E,YE,Y),Q*
M)225O*@    %)+%L32+H+(A$()"C":>WCIHR*=VGH\
M   'FXX.<OC-60R H6@N+2A86@%@!81S&8BTQG7.)W;Q'HOTKY,QN\]CY_S3
MZV>@?)FQ_?#G)I+))DB^LT2*SQG)-2B63"4DI91GBZKTN6X^9>M>T?-_4O>>
MR*T./V36]CH>P_2?@#M3RSW;V;['XELC8Q\#_-_LC4X#<.V\KJ?HO/\ F?TY
MW/Y_^;.H>]]68K=^A\?LWL_:?&?IIMGAERW%2H  !0M* L*%I:6%"TL+ #&8
M8CU%3 N,L+ 9(S&:LQ()!(B99(6\      MBVR-'&+=:D:(2ZVS"NM3CTN@J
M&<F/:                     !H#QL<^-J3$N4"@*E2PM+2TQE"PH#&1S&6
M&,U?!D/%^A_3'C_"^G<<[N$^QWI'QUS7L8F^)-DJ7)60RQ)K,23,2$SK)B02
M:SF<SQDJI4N,Q;+\:M-^C?+."]6YQQ<W&^GG.Z_6?@'OGP/Z%]U?0?SGL[)D
MOP#\X^S,NO;7VADM9]5[-Y-]+]Q\&^)WG7UEO./L=#=#8OL%Z%\M>E\MI
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MQB,1:4*F4RF8DI+6492XO      !1+%QR:<U-0HX\L&R.<=7CIKB(>L3LT
M                  'D<RFY)*3EEEP+2TM*&$Q&,M,9:8P8XCU',10X?T=C
M\RZM[9YHZ6V]SYKSGZ#[5X3GB^KP922DE=A)FMFF>222ZRF=<A>7EQ4%A'(I
M"(B1CHCK[#\9=$^MN<]?N;?USXUXSX[]H>A,WYM]<-V^8<<Y?SP^>?9.TUG;
M>3_CJ^V-Z\.](YSSOY(^=?5^RX_WKN3I=P]G!Z_HYGO+$:M[=R_CDK'\4[,<
M,K+]'E>W:_RW*84     "TH4+2U+5H4,9&B+4=,2T* N,Q4RDHF$F,M
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M,H7% 22>DM<I>        6R8CBQQ==2D0TMO&4U:Q3L<]:
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M/Y:]PXIZ1^?;7M7B$_\ 7$         !:6&(P%D6UC*16KS*F19$9J
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MSDF6>E]LTVL2:G$P        \_=_]_/?O[QQS]_KW-T<#T'BMU\R:]Z;=O\
M\L^O-(_7<.L[CY@S>\>8\YBK]E\RB^(?9<+4/6('9_>N[%P_O\2W5YUUL)I7
M-J>Y-Y>MROC_ !S?AQ&LW/QKG&;T[O;Q7TF'U^/Z#?2_S?+_ %Q@
M   "A;)2T5DNJJ@        "AK(X;9Q8X\<8C36PSTX=R
M     Z4.GCEQ+)YLB<9C.8B"1R 03"8B$0HU]8# 4*&<RRR;^9JS$D2Y*D?E
M?66LZ3(E+D2;6UEE5L20        >>LAR?-;([[B['5]T8K"=/\ 1V7QQKWM
M$C6=GQ9+28^?\^UW5RENE^M;/2/4L7YYH'-^]'W?WK^?\>E</YAW!A=(Y9B\
M=IYW^E\WL70F\;IO,?E^9\6/V>8\]V_IOSUV-Y'] =BZ-B?77TMX/VGD-=
M          %L6U2*U?)6T          88XQ?SPJ?KC:<6K0K!.\ST8
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M,QD(U)K"&6%#*9XS&>R0LN25+E_38&0RF=,I+,RRDV1LB6NPBM        >
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MH47&8S$9DG5=%RWH*+2@     !22TT2\'.%IQ,T]L$]C'/
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MN%XCTY"P^08S)<WP>Y]]]GS?9>3>\<K_ !BXF9PWU,]*^9.[\EJ8
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M3#;&TK-+?9=%"U5     "B6+'3B<</.(KQ\U!KJ]R&^
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M$<G-W9E*+5*PMI(*%+0    ,:0SCD<8KCAQV71&H.75[)
M  !UH><#FY,,A*)YO#>DXN+4A&AEXF<=KC"<?6*"I4R&1-I+,LE2[(W%2S+)
MEMN,I/28LE-N3R22UJ       "!/W\7N3USBV1YO6'0U[E4_7EKG] @_KLTL
MB./@W)V-!^NMV#R:QYNPNP0=>S_;NA;#P2[Y[[U/Q7GF6Q7C?.[C9LF;XAEN
M3A_6Z?H[S' <5Z7:ZB]$R,GDZ>Z_/-Q[N8J!W<+U_I_J7(?WT>Z,MI_T%RWG
MGOW9/)        !9)CM@)J#3RP+()@ELLM6L2;+UW$G+C>%:0+K12!0M1:
M  ,<FO.-2\>LT%:!>/FH,)[S,P                !YR."IRE<YF)1M#>IN
MEGF0M(4:@X'7'$XLO'3 "\J93,;E,L33:KMJSF:,U9(D&PJ2DJ-PLRR4N<
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M#'902UH9HV2<[KD,JA22M% MDHM*    %B:=>*1I4U5:2706:9=:>N3L4
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M=6B<'#PW7,IXLRN\<&SG;] Y+Q/SWF/1=OP9GA''V^.<$W63U[]-?H'RIFL
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MBX"*1#"71L3D:=AG);18E%  11+**   !::%.*1I*@IJI='6F-8O8AZQ
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MQMK.91V$<FMJ4BR@ *%)*%+0   +(T-G%HT5035FD-.:Q>7'L4
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M*;PO2^*V@ #CGY= ?IUW%U9$E+LC;IO"<N<NBZR4;!=A&QLV*S282S(
M     #YI=;T3R#D\GI.3L77(X>',Z#K9O!Q]GM_@U3JC4-N[9\^Y]7V>GRS"
M.4]7I[_K<'G;TOO=@<7XA\?8F<WYG];M;'%]ON#%8*-C+Y[R67]IZGJ/DC8<
M]PKU'7Y6(V3@''L'(>OQ:;B[O"W;X]QY+0WDT/9_<C-ZS]/]L\)^JNP>1
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MF/3NN>S8.?M<HZ/4S]7)<?Y?SQ7BR/'+S\4Y.;C^6Z/I79?+?O?N/S?R#]\
M    M()K(U-:N-940P%A$(!KS6D&(M7)WY'*U6;])C]6%L6T *26E+0  !0T
MQQY-%&KMC) 71R:>W7)KU][F8               'E@X(<NC=5*-P<CCDU2T
MN*K4 %Q<4.K#S27D@G&X-X;.)=7F2)-DV6?9L5V235EDR,E           #X
MY8[UOSAF^UV?S\70.O>F1,;EH6&R/HC0\)L.K^^4]'&^<MRV"+S?OU)YYC>3
MS%=0;QP[G+?B?^.2'C^_HNKWMGU^'N[7L5W/CL-Y6V+)^K]?P_E_+YSA_J/F
M^JT;U[JK.Y[;]#@V?1R<G]]/B'X[7'^')\0Y.?A^1X.S=FT'[*[=\]^L\AJ
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MFF->:T]NG(                >&B:<M-H;!-^O*#=ET7)6T 7%Q>7QY@KK
MS$PVQN3;DXS&0DI+)Z[%-DLZ)E3(R4            /F3H7KG6GZ[?">CG/1
MVN=3LW\=*5B^YX?_ #O7)\;^>@MJSN+N=:+>/D&,Y[LE^.2=_ V_JZ[C[EG7
M['.L=UO0V(U[KGI9/LOJ8KNQAO.6_:?K<-O'G;][EK\KE-=R=^3T,EM>O^,7
M)B^(=7,\>X\IQ#EY^![#@_>&U^*_:S:O!<M@   %B:]=8:TUAKB$1S&135FK
M-?$"HQ,/57Y8ZUQO$W5%H6  I%J4M   $$T,:&M003"0C1FG(!JSVD<K
M           ,!X-.3IRM=B;1.1R\J-C5TEU% %Y<7EQX=(A(-@;A-NNT)I>9
MR43#9)L5V).B;6<J            #QEY]Z5Y4\E]/X1V>[W_ ++JVS[/!Q;0
MMBZ.R&?D<_#TQG]IWW8X\F0P6UX.OVAS8_2<?/J_WQZ_A[.7H]CLOK8OTIK^
M$\]<^=Z%_7+[AU;"ZKT[SCR;KOK'I3!<?BC<]BYWS_K1MAVG0[>3EQ7%/SR<
M7X,]QW]=C@66Z7IC<O(/M%M?S_VGSXL   "PUYK(U=:TUY"(YC(J:N74UKB"
MD<F+ZL_,Q?IK%VYORXH6  HEI10  *&N./FD-40C"0TTBZ8@&L/9!S,
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MB>J8O74QL+.1VY08T* 3&H   M-8:"32UJUA&$BFD-*035GKD[!
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M99YOSF$;FJER7* +XK5Q>>3C@A)-B;8VIM"<9#,2R<;!-HNQ-@3#(
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M'<EG<7YO&BRSDL;6T8T*!0LA0  %AJS3&I36K"(AB(!HC3&I.Y3T>
M        >,37IS5=H;<Y,<N,Q6+Z  O*EYU(>;R6; V1L3:FR,YE)).-E)L[
M=F;&)M7               'EWH[7\?M<^@,.-[]=1[78N.P_(.'I^0LWL7<^
MM\63DZ_'N_\ KM+%_OKO/;+WMG=/Y-VL+TQA<_C_ "VT_>X_/[NVW3.387O=
MAZ3EF*X^L,ASQ>3K<TX^YN>]U^(=K(<)Y\Y9Q=WA7.T'%D.*N_=E,7Z W3QO
M[>[?\\;&_D   4(!IY-);J2 D:7'48UB:HUBP2,8S(=FIWV<;EC'(TW5HL*
M!,84  "TUIJ9-36ME@V0UP$4T4:2M,=C'JP              %IX/-V<S38K
MN#E9RDO+TJH K%]"\\[G3Q,-B; V1MC9&0S$HGFSC:6;%=D22H
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M'D4Y><KC85R!.;2[.JQ=950 ,@,QXD(9-)YL3:FW)A>228;(VAM38DXN
M            !C/#>&WWP7B_3]5S]SM[4^+%@.YTEU\QT-EMGB\G%6\')NO^
M.7_O'\UYL?N.;BXSTN[QS,8389K%:34MR[*PO5]+=;6.':OE?..\\G9>%R?(
M^[Q]393,Q[^];^^Q7K9&-Q=OB'[[//MJT#TWG/._KWM?A(   %" ::326Z@U
MQ@,1KXU-:T@$,CE"1'*T]'+#LTL;FN3+<6% "DEE%   &$UYKR":\UYKI(EL
M4T"<;72'M4Y.              =,'G4YDG)9=C7)3FJ2UK)?10!6+Z&"/#]2
M":3C9FW3;+(,I*)QLS:)M9=C4DJ                 #J#AROS/Q7JG271V
MSO#!8R7C^WY*XMTZNY\YAXY.Y.AO^MP\A=?9?OJ;7CX96VZ5QS ;WAQO=YMA
M^OR3 </4^P=?C61X^^]6[O;?)T_/&QY[5_O]:CF[.7K=V'.:#D>CVSL6B?37
M8O'O7N6T4   "TUQIHT=:HUYA,!K34FN(!$,!<2HY"GHRVU-"NX3E,MU6% "
MB62J   %I$D@6PD@QKK=:0$B+J$XNN@/1QW0              >;3J@YH;XV
M1R=.:+F*R7V@ 52]1QT\<DHF$\VIN39QFK.3(G5LS:IM5V!F
M      !:>6.+9/'FI>@<)U3:NM/QD_+>R9[!TN]M^'\;_BZ-WXMW'R:GA[_-
M]X\UXGI/JTOK\/<F.PFFZV-YKT\9Q_GR'8>*YY^3XO.VQ9R3R?CAW:Y(_P">
MW6\O:N:U'O7+:=]C]H\+EW\@   8S5QIJTQJTUZX2,:PU1KH@5$,9E)9N4]#
MRR+- ;5>61=5A0 I%E    #$0HA5"()K$UL:^V!'%ZXV<_/5X
M  !Y ./',S<&V3EJ\L+BLE]H  R X,>4243"?&WK<FRC,9ZFD\V9MC:DXO
M                  .OOQW.A=<VOR1^MJ\C8_;.K^KEY_XX9W%RY?QS6<O'
MN,[K' =:]+V?#Q]^:UB/5/4U"1P?C@OY[WDS/YB#^>YS=S<,[_>X]VN3'WNI
MW#WM?[?R.L_5?8?'.Q^?&@   #":@TAJ36FOC%40U9JC7$$C%#.2DV9W]+M4
MX^NQLY>MY8E% I)9:    *$<AI$6&:Y-4NJ(!Q].*RPJ]UF8
M H>%S9',(VE;LYE'(:J5B^PH J7@ZU/,9))AL3<IN5V!D22LXV!M$VYM)957
M                      M/B1J?N?DGH;!M?S^)<_6Z[6-R\?+HN'.QN/M^
MFL+@/7O9U&#UN37\/-Y(FP=E8SM]+['V]!W^S-[F.Y'V<?ZDR.G_ $7S7F/)
MN3J@    14TZZ,U1KB$8B$FJ751KJA&$N)!))YWD<DDX\LTY>9JL2B@6Q;0
M   %A'B+9&6!&G345JEU,<4KCAZT.Q0            #3'AXY8<L-B;\YK)N
M;1=)6JJ *EY4ZJ/-I))9M#=FY)ID)9.-B;:-L;(D54
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MF B$8PE(OJ:=LQR^SA"[Y.:J+0 4DM*6@       6&@.(IQ^725PT[-/2@
M        .MCR><C3EZ[4Y1'-:V(!6*EU  7E2\J7GG8Z?-F;8W1N(EUF)D3Z
MV1LXV9/)57                    T_YY?S<Z#]4.IFI_'W9?%V^RO:?B[O
M?R'ZUX1T<Y Y^CV3EM$^P&]?-(         H0S2)H9=-4$PF,B&$L!D,Q:8B
M,0XC5A!4EG8$=LV=;KM8YW6<Q@ I):M*        H:R.*)Q:M2O#HDU[*
M       !Y^.CCDYRHVARPYD2P!%R76@ 7I5;XK60X6>138FU-N;M-@N8E).6
M>FRC:+/LV"Y                    ><>CLOPET;Z:G\7<E?CL['\=KNCVG
MXJ[0\:^PN&]3+Q.YA/66R^0_1':/%@        !A-2FE-)+JK(RXBPPEI0J7
M@L,!&(1%,10N)1SI.Y3K.679SI=@F-0!22VV@        (QQB3B%:E>*)QM?
M;9-          /(QPTY8<D-K'+JY<9@ 7276@ 9)%MQ>7F0\5&L-F;<W1MC.
M2"83S8FSC85L245                   /GE@O3OEAJ'OLG\\TG\\VQS.G^
MD-S\4W?F/TMQWB[L7O:[]$]P\"]3YGS\        "P@&H-,:@UY@,8+06E04
M,9'(I"(IA*%Q(.:2=[5UC"WFANC& "D6BJ        %#01PZM"<>.*GJ@YL
M        "T\)DTY>;LW,G,*Y.MX +Y*V@ 9(5>5,AD//T=(UL3;1N:W*35RD
MHGFP38QL;=BD]<H                  !\;]0]_\@:[ZQ6_G(_?)_0OGOTG
M@=VQZMZCK[^(O=USZR;Y\S=E=O!@       "A%36+J35IK%AI@7&4 * %IC(
MQ$(9$,)0J9SE:=YG"HUU<PEY)5A0 HEL4M         UD<.KCAICBQWF=M
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M=:FM()$6&1C"6):M#%$:HI#(I@+"TD&XD[&.Q3IFN0QSNMLN, I%M4A0
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M<PKD!< "LEU54 5B\5>7%Y1-"OC($HV!LB:; VI*3,LLF)L3<2[>S:+>
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MB*%Y/C=5S=.?QTC7(3L:7;EM"D64     !<7 J7@O*EX-8:TBFT.8
M  \QG6IRXY";).6+RPD@ )66ZJ@ J7@R%0<?-$>=#CI,-B;0VILR:7F8E$Y-
MBNR-FFP689       "A0M7%^?U$_/+K?SSZ3C[7'OQVN(<?<Z\XN_P!7\&2Z
MQX<GUMP9/@_6S'%^GG8/2V-U,W@G[Q_OK_13;O O &O^L\=Z&S[[J9S8=_!\
MR](^:.1>5?4_'?S^L_;P6_YL?OKQS>7I9.?&X>?H=YY33O96<\T[4[F!J
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MD0UAJTUBZXB$<Q&,&,CD4BQ@K 83&7$TVT;JSD\L*SC,=AUSR+;1:EJ@
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MD72V#==?,<Q]D^,=GXS]KZOK]O)W==VG/B/6&P>7?33<_GL     6E"I4J
M  836QK:UY"(9%(Y@,9C!B,!&(I'(YA+"XEQ-J>38LK7)VK+SHI0MDMM  N+
M@7%Q4O*EQ4N+BI<5+RI4N,)87$P       'DPX^<N-N;-.4'*%S@ %4K%UH
M%Z56I&.*&A-8G$%XH<3,Y/-J;8V)L"67&=)2S">3DGK/B=9,6H
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MC/4LG$@PFB.>':Z;I12+* O*E2XN+BXN*EQ<$N6XJ7%2I<5!0M!E+@
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M1QF.+UK3BIQ4U!S0U1PDG&T-H;4V,3*O,I))1,)Q/-A$XGF:@
M   !TWU<U\ ?/OJ_DW2V+>]7,\Q]O^'HWA'WEL.QB9W=US:=G">K\]YG]%MN
M\*           %"$:R-?9#6(1B.1S"8C&8P8R.12*1",8"A4SD@JD!?3)M#H
MZ3M^W;@JE%N+B\N+RXJ5+BX%Q<"I<5 !>5!:"I4      '11U\<D2>LXWAR1
M-JH  K)<66@"I>:LXDFB75'##CQK#UH=$'6I,-H;0VTFQMFEYD)!+)A-38+/
M)\3ZS@               Z;ZN:^ OGOUER3I[#O>IF>7^X?#D?PK[RVG-B)_
M>UO9]K!>K\[YK]$=M\,           %"":TUY#(A&,!&,1B,184+".12*1",
M8"T&0S UI[(-H><SFASHN*2+;BXO+B\J5+P5+BH*EX *EQ4         'G,U
M!OC.;$WR<A)R@ "LEZTJA:"J47C,<7-77&SB)ICDI[(/*YU(2S9FT-L;,F&0
MR&<E$TFQ/J?$^M@9RH              !T]U<U\!?//K3D/4S^_Z>;Y=[G\*
MQO!OO?;]C#S^]K6T[>!]79WS;Z';9X<           +2#&NK7D0B$8CD<Q&(
MPEA0L,$1:BD0BF M!4R%H/:!4ZZ.%G:YF+BLE;;RXN+BXJ5+BH+BI4 %Q<
M        8#S83#;%Y/.01OZS@  NDJM:%I:52$O$3CIK$X>O'DU2^GSM8\S'
M2A*-F;0VYLR:9"\SDJ)EDXFRS[-BNP)!4               ZDZV8^ 7G7US
MR#J9W?\ 3SG+/=O@Z+X+]^;KFP\[OZUL^YK_ *GS?G/T5VWPT
M6D @1KZAQ&J*1R.8C$82PM+# 12*1"*F)<8 +3DR>L%%AT4=@QOZJ716KBXO
M*E2XJ"I<5 !4N*@          XZ=-$\EEQLC?&Y+@  7276@"TL-)'$32UQ\
MXFFF64>VS(>=#H8DFR-H;<V9.,I>9DDK,)Q.)QL38DDJ               =
M:\&3_/GYO]@;_JYSD'2SG*_=_@N+X-]^;GEQ<[OZQL>[KWIW,^>_2';O"@
M        !:0DUZP"&12,1B.8C$8"PM+# 1B*D18IA+"A:4,)V0>E0#KXUYSD
MRE2XJ7%Q<5!4N*@ %Q<           #A!P8FEQ<;$WIL0  "Z2ZT ",<4CC*
M:JN)KQTTYWD=_@\^'GXD&Q-H;8VI.,Q>9B1$RR<L\FQL*V)+*@
M    '">+N_GA\U^Q][U<YR/IYOE7N7PG$\+^\=SR=";WM6G][7?2N8T#Z5[?
MX0           +2(:\@D,BD4C$<P&(P%A:6& C$5(BQ3$6%I9%E1SN<[[ (Q
MU:<Y-D7%2I<7 N*E0 "XN            !UV:DE%ADB=6X)I:6@ )>54 4-0
M<1-(:E.(+H34GM8Y #H0\[$@V!LS;&U-@9BXS$@F$XGDY)YL%F%P
M      !QG\=G\Z7F7V7ONMF^5=/,\C]M^((OBGW!MYPS>_JTSO:UZ/R^A_3/
M</!@          !0BD A$,B1%J*1R.8C 6%A88(C5%2(L4QEA88S$1CT =S
M X89CD)4N*@J7%0 "\J             1S@Q:9#&92:;$R H6 %9+JJH P)Q
MA>,FM-(<:.-G*3UZ =&'FXSFP-D;4VIL207&4D$PGR3ZG2SJV!-+@
M       #COX['YS_ #+[,Y#ULWS+JY79^T_$KQS[3V77YYW?U>1W]7]$Y?1O
MIWN'@@           H8" 0B'$2HI%(J1UPF L+"PP$4C)#6,6F,QF(PD0]*G
M:H ,!Q4Y$9P5+BH *EQ4              U1I"I:6IF642BA:"A8"Z2X6@#5
MG%31$(X^:$XV=^G=(!TF>9S/)-MV9M3:FR)!>9"0DQ=A).)Y.785,+P
M         #4_GE_.1YE]F\BZN<Y[P]W)Z[\?W>5?6T_H96=D-8R]_5>],GIW
MU2W3Y[            P1"J$0R*12&12.8#!&.K"PP1&J*0R.6%AC,)@()ZH.
MQ@ #2F4GEP !<5*@              &E,!4QE#*24JMI:6@H6ETE;0!C./QQ
MFS5+"-$:$X^>R3= '39Y?,Y,-D;4VILR07F0D$PV"3EV$DZW8$PO
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M1%B'4-(BPR(1".1C 8BPM,)$(I#3 MA:8C 1"">PSEX  (!E,Q<7
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MJR*<>.('KHV8 -6>#C*2R<;,VALB<2"XSDF)E; V)L(FU-))<
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M0Y(5L0AQ$LC$98Z85L*&)(JPB&8BPH8",08UU>[R2
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M>"^I6\_.';/=UT           6F AD(AD$B$8C$8P& L*&(B$,B&,M,9A(I
M(A[R*@                          L* M+2PM+"TM+2TM-&G&UU,:"S1+
MZL  !Y8.I"0338&S-L; E%QE)!)24LTFI,6:3"82"H             !\W]:
M]A^=6E_1_<_Y_/9'>P' /8_CF+X1]ZOUU=EWM:W_ &</]*=U^=^]<GJ
M       M,"0EA$(A$0C1&2/;@,!84,41*B$0L+#$82(03&>[
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ML.YKG*>QC/>6V^%^J,]YH           +"/)!MA$,A$6(E1S 8#"8P82*1#
M8BPPF B$ VI[4                            !:6@H6%"PM+2TCF@./F
MF.,GI<J  <%/&IF)9/-F;8V9,3(MYF,QG)))B74LFDXFDN+Z
M 'G'';?\4O./KSGG5S7HC+:#UYO7A^\Q.Y<0TKVF1VL#RCGQGM7:?%O9&Q^3
M@          #'$6H:0EA$-(BQB.D>7 8JQ@PD5(JX#%%E82.0R <E/8H
M                        !:6@H6%"TM+3&FF- NL.,'H$R  &J/!YF)1/
M-F;4VA.,A>9#,9B02"42R<3I)MLTRE0            #JGJYOX+^9_9W,NCL
M/HG+:%QG:/,<^5UCC7FGTQ3L87E//C/6VQ^2^Z=J\6           &(BD,AQ
M!LAK$B-4<CF QF,&$BD>(]8C&84C+$-<<T/7
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MZO,OM*N+W'N?NZ]V3D-6ZE]8^4=OXQ]K\?\ SUN3=C%=[Y?1?I?N_P Z
M       4,)#(9#(9$2(L4C&$PF(L$8JC& C&,Q$<C$(UQVP>E@
M                    4+2@!:6D4A$4U9S@R@  \MG4)()ALC:FU-C$BJF0
MJ9C(9R02Y)EL]-@LZ)MF50            !\(?.OKSKS"^A]L<V-[MR6F=+^
MN_)O(_&/M7BW'^-_SXSM/(:M]6-^^80          +3 0R(D.6'4-(LL6HYA
M,$8ZL!B(Y@(YA,1A(:0EUIW6>A0                               6E
MH!0P$4P&O.5%X  .@3ST2"6; VIMC8DHN+BXR&0S$@E$TG1L;)TLZLY4
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M'B-6$P%A8#&83 D=<)C(Q!(1K#T2=T@
M    M,9C,1@-L   <*/&!G)).-F;4VA,,P*EY>9C.2B83C8$]-@LLN
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M2(UL8CF$PEB8U%IB,)',!A(T0*@&K/51V6
M        6EI:6D@   P'@(RDHE&Q-F;4G$DO!4O,AG)235G$^2?;.)QF
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MS"83&6% 6&(C$<P$0UQKC6GKTYT
M "A:5+@   >#HU]2B63#8&S-D2C,7@N+B024FK/)R3XG5-627
M  'Q \[^MNE\7NG<7+C^PN7I]<>Q?'O/?(?L#23\S'5[8[^K?43?/F@
M    "AB(\1:B)#6&1",D=8QA,1B*%@*&(C$<C$,UIKS6GL YP
M                        4!4   'A0U)))A+)QLC8DPS&4J#(9B2DU9T3
MK-@3EFDHO             /E?IGT1X=UKV3GOY_/:'/TN$^E_,_:>J^K\>P6
M[3>7&<CY.C]7_0?EG=<O4          QD<BQ$J$0R*1HC5'3"N(Q%I:6@Q$<
MC$4@FN->:\]=G/                                        #PN:8D
MDPEDTV!L262#*7@O,Q()I.)R;!9Q.)1D             /$^O^K?*/1OI;=_
MCF[1Y.OI]I\M[0V#SJ#Y]] N?&;V]+Z+[K\^=U9/3@         +#"1"(0R&
M12*1DCK@,1C3&M"P%A&(Y$->:X@FN/6QV"
M              >&#2D@FDPED\V!+)!F,H+C*DE9A.)Q/2<LXF&4
M     ZIZ>P?!_P R^S9DY.=<78WW=Q&]]A^,>8^1_7&GY.ONOUC_ %CL'EOM
M'9_'0         +3$12(0HB615BD4CF QF,PE"TM+2,1R$:\UY!-<>L#L<
M                                      \)&K)!-)A+)Q/)9(,QE+BI
ME)),)I.)Y.2<LQ,RU            !CE^"7FGV9P+I;#R7K]_FWZX[/<_A3N
M3R+ZWU3CS<G2YKSX?Z@;Y\T3/UQ         "AC(TD.V&1(B5%(I@,!B,9A+
M"A84,!%B%6NC7U"-:>ISM
M  \%D,D$PF$PF$XED@S&8O!E))+)I.)Y/)Q,,Y4             ^6^G?0?A
M75_:-UQ=WG4Y-?Z3\T]\=7NS-9]'UWZZ^P=?VQM/C7I/-^=          6$<
MAD*(M1",1# 83"83$8RA9%M82*0C7&N(4:VO3AVV
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MS"8#"8C&)+*Q+&(1K36D$UIWV=]@
M       X^>&S,2R63"22HG5*)!F,ID+B\RDLF$PG1L*GDY)2Y
M  #YJZ?] ^!M4]SW?<P^WZN6Y3Q<FXRVH8_9_BON;QWZ_P!=^NMBGYVG)UOH
MONGSUSGM88         8R,0R*1R*12,1S 1S"8C$4+3&1B$:TUIKS6G=)Z-
M                                      !P@\9F<E$TEDDDDTDDDS&0
MREQ<9243"8338$\G$PR@            TG%W/A_Y?]L<2ZV8V7<PMO0V+:\?
MZ[![^N<-]3^5>ZL3M6^UGT?2_C\Y9^>T\IJ?T*V[P;)8        !:82(1B*
M1"+$:R.L<P$<Q&$M*1CJ,0S6FL-<:X[0/4H
M              .KSR:2"43262B02R42#,9#*7%3*2B432:3R>3HFUF*@
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MFZ?///.SB0        +3"1(BV0UBD<C$8CD8P&(P@QF AFN-8:TUILSW
M                                    #SP=#$LEDPEDDDD@E$@RF4O+
MBID)!)28LPGDXV$DZV27           'B#7_ %;Y;Z%]2;+C['(^QB-SVL3Q
MG'[3I>+M:WL8V9R]+L?L8OGG-T> >P_'/>'G?T/L<3LND_%P'8^5TOZ6[?X/
M(OY         Q$<B)#6*1R,12*1C 83"4+#"0B!&KK6FM(A[U,X
M                             !Y:.I2:3"82R22#.23.93,7E2ID)!G)
M9-)Q/)Y/)1>          #I?H[+\0O.?KO+U\MR!.2]W78[DX=TMAT=XM!W-
M?B\W0Y3?QV)7,.]@L/KOR'VYXU]D6?G\:7CYX_)U?7.S>0^TL[YF
M!:88B5$(Q&(I#(I&2.N$P%I:82&:\UIK#6D ]J'*@
M                   #QV<&)Q.)9,)!(,QG,YF,AD!4R&<D$HF$XGD\GDPO
M          ('YY/AKYY]:=68S=.2?G]\IY\?L.UAN,=?*<&X^UH^7J:?LX75
M]C$R+.6<?<['_'-L]O\ (NTLYHO,/./HO3\?)J_QRX^UA_I?N'@?='>UP
M     #&1B(12.0R&1"*1S 8"PH82)$ UM:LUI /5)VF
M                      >'33&P)Q,)225SF8S&8S%YD!<7F<SDHF$TV!/B
M;4Y,B@         ?-_5_;/G9J'ON]_7'S&_G>=G#:R_C@O#W^$<G6X_V<1J.
MSAX?+TKUV?%W>7=?*=B?CL3O5_E'O73?8=UKV]\:XNYK;^>4Y'5/JWN'@&^Y
M.L        *& BD:2+;"(1$(A&,!@,90Q$8@1K*UAK#7GH([Y
M                           !8>!B\V)/)A+,\2#+60SF0REP+B\SF8E$
MN29;L2>32=&:@        !UGU<W\)O-OL/+^.?E_)U^4_OKP^;'\4X^SU_\
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M(0R(1B.82A81R&:TUAK#6FQ/<@
M    .LSR4; VAL":2"293(7F4O+P"\N)!F))))B3EV$3:FR2+;P       #5
M?CL?$OSOZXZMZ.R<R[&.['2%^^#AO!WNL^7I]<9+4/N+MW@7J_N:\  !T)T-
MF^*GGWUAIN+MV\W2Y!ZU\C]JZMZCS#6?2,\_>LYL=V#D=0^JNV>&;+]<0
M    %A&B)4$A$*(E0R*1S 4+#"0S7&L-6FM6,>^#(
M                   =-GF0V)M#9$PD&<S)>N0O+RX O+S.9R02283B>DY9
MI(+P       8I?DGH_TSY.P/J'*.SBNR+Q;5>-?CFX+^.;J7(ZIZ_P!D\@^R
M^>\L    \R8?T#X\^?\ U3Q[DZN#LXWGOLWQ;O\ RKZNY7B-JD)A[F ]6[%Y
M3]$MC\BJ       "TP$0A$$A$,AD0CF M+3$0S7FL-4:P@GNPV@
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MB%4*(A%K 8@8R,:\U9JC5$ ]AG.P
M     #RR=5FU-J;,G&8S&0O+RH!4O!E3*LDDDN)5; G)-689RH     (/YY/
MDMI/TGY$UWUO93\=L]W \QY>G;P931_CL]?./K;O:WW!F_-ON-M'B6X_7&
M    *'S.U3W/YR:U[%C_ %Q[K??!>SYR8O,?J#E?)T)/<U[VMMGB'N/9/(P
M     +2.0B"02$0B&13 808XCU -4:J-76N/7AV$
M                  >4#K4VQM39DXSF0RE3( "\J5,AF)!))D2K-@L\FDLS
M%0    #2<?9^/NC_ $UYHP/IVSCMKM87F'8Q<CC[O'>+M]<7\=;]S ]I9GS[
M[B[3X=RG]]<       62_*+4O>_!NO>J9OSS\D].^8^QM?\ 1+]!]]Y%SXJ7
MWM;^IN^?,G<N0U<      4,!"()"()!(9$,!A!81D@FJ74FKC75ZW.QP
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M@FNL@+#(A@, +".04U*ZDU1KSU4=J
M       'E ZT-T;<VA-,YE+RH ,@*F0R&0SD@EDR)]3R>2TRJ   ..\?:^'^
M@_5'5>(WWGO'S^DLII'&OSW=)?SQ#B[76_[X."]W7OI?LWBWTGS/GEP
M      . <&2^%&A_4/%,;MVUYN+L;V?XIV_A?W9N7!Z!V+RCZ:;U\UU
M!81""0#71 J$1#"8 6$>(%:DU*:I8!Z;.XP
M            #RT=4FX-R;4G&<R&0  R O+R\RF<SDLF$\GDXF&4   P3]?&
M32/I?SAKGK7,.'(>G<QY[Q[\=KA4YN$?G]\ Y>GI._J_U_VKPSV9D=2
M        \]]#:/B%H7U'*Z>?V.:T[M;T+YTE>-?9NZ[&'^FWH?RIWMEM'
M  %A$2#+ K6D&(51# 8061&(%:@U1JB >@#O\
M               \QG3YN#<QMJG$@O,@ *EX+S(7F0SD@EI+)ZSR<2S,   ?
M.K6?9?GEIGT5S3B[O>N0U#)R<'4O#E. ./AO/C-KD]/^U&U^$>@^W@P
M        /GC@/5/F'IOT+ONGG-EZ+\Z=L]+,RM%]R[FS7G?U-]$^3\E@
M%A$(! 36+!(1&,!A!C(Q -0:DU9".R#UL
M           >=#HTVYNC;$\DEY> "I>"\R&0R&<SDJ)=3R?$ZIAFA0 '6W4S
M?P^\T^R^7<?;[/[.#Y3SXSSIC]NX)S8_C7;P/8^8T+[<[7X5V?S8\
M       89?A_H_TMT-@O3=[ULSR?V[X:YWY!]A;?I9/Z.^@?+?HS.^;
M6$(@&N-:0B)$6L,8:&(BFO-0:HUA#,Q[M)8
M            .ASSR;4W9MS8$DR%P +BX&0O,AE,QG),DRV<3B<33,5  /EA
MI/TAYKUKV+FG-T.Z>_J'FC&;UU7^^MH.[KG<.:\\^WNU^%<RY.J
M      .G>IG?A!Y]]63NCLVR[>-[/]:^0=OXI]L=OY72/JMZ5\A9K^    !C
M()KS7&O(1$(IA,10Q$0UYIS5FM(IA/5)VT
M           #IX\PFS-V;DV!*,A< "\J#(7F0RF<S$F29;.B;4TFQ(JH .#=
M?*?#OR_[6Y[?SVOW=:X'U\MY]X,KQWO:SV'F?/ONMMW@7,.3J@
M     #YGZW[!\Z=0]]W_ %,[L?1OF_N#%[+.T[U_Z+[]\P>D<_Y@    ,)!-
M>:T@$,B$8PF(M,1#C75J#6&O(Q@.RCUP
M         #K8\CFS-T;HV)+,I4 %Y4JEZWF0RF<S$DF$XF1-J;$BK@ ?/G6/
M9_#.G?0G8W+T>;=C"^8NAMO#^UA-=DM/^[VZ_.7>'9PX
M&J_/+\$- ^J.%8G>]YU\IS;W/X1YGXA]N]N]_5/JEZ7\@Y;^0   (\0*UQKS
M7D0BD8P%A88B":XU)KB"1C"#W4;4
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M?S_Z1[[\R  "AAB%4 UYKR$1"*8#&6F,CD(AD(BI&6*0R,1ST\=R
M                             X0>,22;0W1MS9DDO *I>H%Q>7F4SD@D
M$@EDLGDTF&4J#XL>>_5_5'6SG-.+N\&Z.Q<0[^J<>S.@?H/W'Y[[$Y>F
M               /EOJ_M?@'5?<>1=7+\FVCROM38_-MGYW]!?5+TCY'[%[N
MO@ 6F A&O-<0(A5$(Q@+2PL,!%B-9$6&1B&0R(1CM,]6@
M                     ZS/(YG-@;DW)M"69 "I> 5B^KS*9B09R42B832<
M3#.5,4OY_?,OM+:_OAY5P=WKSK9CB.4T;G&>\S_0!M/B50
M     ?-O7/7/FOJ7O>[ZN7YYQ<_(O<_A/F?BOVKZNVGQ;WEMOA0 %A&(*:Y=
M<02$12.82A:EBXB/& BU$B'4,A$,BDT]VEX
M          !TR>8S,2S;FY-J33,5 +RH!>7F0S$DSDDE$LG$XFF<N.'<&1^!
M/E_VOSWN83?\'>ZZXN[Q'+^?^K-B\E^R6>\Q                    ^9>M
M^P?.?4O=]EPY'EO7[W)/0?GCLOH;#N,#N'UO]'^2=OR=4 8R$0#7QKJA)$6*
M83"4*):MAAC#4:(=0R$0"&1",>T#F8
M     !Y].@3.9S9&X-O$\D5< 7%P!4O,IE)!())))A-)I-))D.A<;N/Q5\Z^
MNNP>Y@-GU\CU\<0S'GWT3V;QOZ6Y71P                   /D#J7N_B[7
M/7MGPY'D76R78/-T=MZW\D\D\J^H/>^Z?/'JC/\ F0%#"0#7IKR"L(B& PQA
MJ@*%IC,1&(A"() (1#(IZ,.]0
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M?Q#\Q//?J[JCH;)M/8?C+M+2/:MCUNW]>/0_E3)?Q$(A#(1A,9@,)88C"8#
M8C$"AB(Y%(<:^M>0""0SU"=P                                   &
M,\"$HWA/BZKHD625EDHS%P  +HNH9C,9262DF+-)I+B6?"#S'[2XWPY3M_L8
MKA?!W>+]S6O66T>,?5S8/+0                  !8?G7T_Z!XSA?0.28[<
M?0W9P_VF]2^)?)VM^O?*CS[ZLW6U^/=O;)YOQO2O8_J%N_S=W;E-,BD0BD>+
M*M,48#$8*CD8CF$PE 8S 12+$ U]:X@$([J/2H
M            !J#PD;(WILC,5,QD)!(,Y>   7E2XSF0DDHF$Y)JRS5\7;^!
M/E7W%SCLXSLKFZ/7O7[O'>[K?>NP>6?979O'0                  !TUP9
M/\\^E_1G+<?LO(\=N7U-W'YZ]P;7X=K?QV/A3Y+]WQ\OK7I?V;Y8ZK\7^D/4
M.:\\^@FW>#Q3 F!<8BM8B,1R,0TBK&,)A+ 6&(C$0@FO-<0""<T/9
M                            !Q(\4&R-^;8DEQE*F2,U9C(   5+P9C(
M9B42R<3B8=$8K=_CKYY]:=N=S!;ZSKSA[6D[>N\BR^B_>#;O!<U@
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MLD&H)$6.83"4!:82,0R :Y-<NN()ZU.S
M       =*'F@V4;ZMZ3S.7 %2\J    7Q6KS*93.2B7&IX^Y\2O-OL?N?LX3
MDGX['&/QV^&WBTG[ZL[GP_KC/^7?378?+                  !\^,7NWR,
MU?VN;P9#T'9]YO0?E#)8,9JCP!K?L'SHUCW+U_[-\W</\K]EIU>U]GO0OE"^
MP "PB&O-<:\@D,C&(Q)C46F,P$0UYK37IK5@'HP[S
M               !T$>>C91OJWIL3.7@H7%0"L75:E% %2\&4R&<DDL\>8'U
M#P'JGNWHKLX77]7.Z*7AOZX=+>&;S8WFF4TS[9[;X/FL
M  ^$6L^T^9,1O<OAR/UNV'R7W_L7D@%AKSJ7@R?PM\W^PN_/4/$^W<1W.@=(
M]4^R?H'ROVCW=>  H1C7FM-<D B+&,)B,0!C,*15UYKHUU:PUYW0>E0
M                             ><SHHV*;Y=Z;,SEX  !?%:%I: #("XR
MF8D&:7XYZ%]39G)WJXN(=+:-%/QP:_C4OSL^;%2<AJWUOVOQ#O;M88
M           <&X^U^;S3?HK%Q=SF_6R_Z(=_^5>4\O2 H1#C)\:-$^G^O,OU
M?6^X>;^?O*_<_?FR^,^VMC\E  H8" :TUR0)8=1C 8C&6@L,9%(!KS6FL-<=
MD'K(                                  'F0Z9-@;\WILR25   ,@ *
M%@!<ERC*93,><<+Z+\TM/^A/2N4TB9TMCT'5SW%/S>Z,WYIY9P^_;'FQVTR6
MI>R<[YE]%,OH8                 ^>V)WWX^Z]ZUL.#(?0#(ZA]>]M\'
MP&B/ FO>K_.+7?:/7/KWS]J/-/7.P.'I?5K=OG(  8B :PUQ (9&,!B,18"A
MB(Y"-<:U-8NM.5'LT                                  'E4ZH-@;X
MWQLR25   ,@ !1+%%9+[1<91/U\E?.OKG _7H_(:KUEB-\B_CM]A9/2OJ%OO
MRU\V-1]X\K8??^0Y+4>?Y/3_ *\Y_P IVOZ_                 'P=U7W7
MRST-FWO4SGWFW3YR]"Y#50 +#5G3?7ROPO\ .OKGOKUKY_\ 1?4Y>BO-_8?M
M?Z)\GS/UQ@ 8R#&LLUJP"(1B.8BPP@&,PD$@&L-::XEGN8
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M-=4,AD0CF,Q&(L!0Q$8AFM-6:P@'MTW0
M     !XQ.&DTW)OC;DPJ9  4*@     '0>)W[QEJ_M?<7;U^%T]@X'C]LP_C
ML?2KT;Y!YUW,!+27+UUULW\Y==]<[,[VM=E]K ^K>_K'8G+TKBH
M     !\.=2]Z\R='9^4\?9_0OO?R_P AY.J  !8:P\O8[;OC5IOT3ZBW3S+M
M[\SF>)OT9V?Q4 #&0C7D!(*PB*8#"8S&8B@,9B(1K36&L(!Z_.9
M                         'B,XX2S<&_-N3"XR        &"?OQ=K/M.D
MZ^4[%_7#T_A_0M'ULQZ*V'R3V!MO@T@DDLE'C7#^@\8_':[,[.%[-[&'[Z[.
M%OMN+P             #CWXY_@]JGO6@XN][&[NL?5O9O%P  !0B'#)^_AOH
MGU#RW].H-KT;M;%]G[P['X7< "PAFN("05A$4PF$Q&,Q%H*F AD U9K2 >H3
MLD                                  \*&L)1M3>FZ)Q>7F0H6E
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MSL[CX !C(9 ($0JAD8P&,P&(M+ "PCD1->NM(!W(=Y@
M                C'@0SDDVINC<FP,ID,Y>4,9B*     X[P]_AG6S,C\<^
MGZ^9X1T=I@<7:]9;9X+GLSF4SD@D$DA?CFZZZV8Y-R=;<_KK\LY>GGLS)D7*
M7EQ<           #R]U,]UKP9/D'YY_964T>H   !0C'FK&[A\+M&^F>4Y?4
M/1_U1\!?5KS??.W=3V>H!C(4D&V 0B(1S"83"6%ICBVKS&8R,036D [(/0@
M                                -(>%C.2C:&Y3<KL3(9DD+E!C,1A
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M_5#"0B$0R*1C 82PL,):6%A4R LB/4,BEAZ;)(
M          !UN>1"22C:&X-N;$R&8DDHDF0M(9#,):  1OS^]9^.UG*2QOSS
MY+^=WSXP7F0O,AE,IE,YF,QQ_B[>1^ME?QMOUUY7Z_.4RF4R&4S&4O+BX
M     &F_/)P?C[E/SR]B\V.F_KC     %AX)U;VWY1:K[C![FO\ /?3?!/:_
MN'RC]'O(O5.98;+T,!#(9$(J1EPF,L,):8BTH#(5!A(Q%+#O<WX
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M&*^T?!S\R_-[!Q&7[LP>:CF$C&(QEI86EI0%Y>9#(7&,PF M.VS.
M                        #H(\]DHV)MS=QLZDF4E$U)JS))ELR249;;2(
M:E-2:Q8IB*%A>   7Q6A>9"\O+S(9"XO,A<7%Y<7F0S&8S&9,BWF4O,B9"];
MRXN*E2I<"H         /G)H_TKX(T_WW0]W7.V]F\?\ G/Z_\D?=[*XKS%L>
MO\BZ_8]6:YL7KW2MPG?G]QR.8BPL+2TH4*I<MY>9"\QQAJ.8CLDVP
M                         //!T*2S8FY-V;,S&4F$Z)U3283$EK)+C&:\
MTQIDUBQ#&4*@   O*@R%YD+R\R%Q>7EY>5+B\O,AE,IE3(N4R%YD+R^+JO+B
M\N+RXJ5*@N*@       \:ZQ[5\P///JS3]G$<LSWE_=GM?Q9V1M6J_-OL];D
MFG[?]#,WA?I#YWZ!F_/ZP$<PEA84+2@*EQ<7EY>6& CF$YN<D
M                     !YP.C28;$W1O#9&0SDLV$3ZG$TEI+667@PFL-(:
M0U1&+     9 7%Y>9"\O+R\O*F0O*E2\R%YD+S(92\REY<7EQ<7%Y>7%Y<7%
MQ>7EQ<       =$8C?OCGY;]JZO]]?'E]#^F_JWQ;Y[]*\VXYDL9X2U/;/KE
MP\WOW3MMJ1C 8C&6EH+2H+BI<9"I0CD<P'*#F
M          /,1TX3#8FZ-Z;$R&<EFQ-@3R>3"422\%#":LT9HC5D8L!0MBE5
M+P"I>#(9"\N+S(7EQ>7%QD!4O+R\R%Q>9"\O+RI>5*EY<7%Y<7EYD)!E+P
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M3].81\\H^K!(,9A,1C+"A0H  "I4H8B.82AV85
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MQZZVGQ;Z4;]\M1#9GF0SGIXH8C"6%A0L*%  4!4&,Q&$M.9FR
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M^_-=P=[GG=P'VY];^#L=_.8N/FX?2H%IB,986EA0H6E  "I:6F,H;HWP
M                           !X7-<; VYN3;$PD$\GDXV!M#9D@     %
M4&$T*\831QK34$2LTLNIB9UN,AF,IF,YF)!F,I>5B^A?%M4+"AC3&N(Q&(QE
MA84*F0SD^-BFUMV<2:J      5+BH!\;?+_M7IK$;UO_ -]/[5^M?"O+.UAA
M(/FR?2<N+3&6%D650M+2TH4* N*E"TM*&Q.0@
M        '@TQ&P-N;HVI*))L#8$\V!LC9QFH     5D QFB7BZ:$T]NBDP$I
M9UDQ9)<9#.F9<YG)!G,R7K<7  H6%IB,1B,1B+#&6@J924;(VZ;0G+E
M +BX  ^:^B_3GCG5?;I[C^M7I?QUWSF?/L1)/F^?2,J4,986%I:6%I0L  +P
M4*%"2<C                               !8>!S,3S<&Z-H224FP78&Q
MC8UL4V"Y@     5D56!96FEXK7'DX_'&[;">;!)ZR2XRF<SDDD$@S&0R%0"U
M+5M,1B,1B,188C&4*F:,]3$V2[<V<2ZO     +BX  J7'DG7?7?G)HGTR_/+
M]%MX^:O7^S^,XB0?.D^C *EIC+"TM+"TL*%"A4N+BH* O.1@
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MS'@<]NF\ *%A86%I84+"@+BXO+RI0 V))
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MN8N*EI:6EA86EI0M*EQ<7EX!0H2"<
M<?/%A(-@;<W<;&KXEUL8V=;(VALTD+4      %4K**H*  H0SC5<2C@YP:HQ
MLC;QLUV5DU<I<5!4 M+3$12 D.7#6=-HNW)1()!,)\;2S:+LB4  5+BH!4N*
M@J5+@"X&*49++P>=3:'?0!0H6%A:6EI: 7EQ<7%2A0%YL0
M                #1'B\S$\VYN39&6)5; V2;)=I&R)%5       *R5*@ H
M +<4:0XJ<1LZ^7CJ9UV)L))U3995DD*!0QD<AI"6"1RA,-N;XV1GB34PV1LX
MV9L:EE05+BH!<5*@J7%0"XN * J5*G1IJST0 "A86EI:6E 5!>5,@!84!LRH
M                              -,>,C,3C;FW38&191L(V=;$V1LR05
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M7%5I8(QUJC2GJ0Y:>)B&;TW$;FMD9R6; VIMC9DHN*@J7%0"XJ5  !<5*@
M'!C@AWH 5+BPH6%"A: 7%P*EQ:4*%A*)0
M   ,)Y&+B2;(V1/+C.2C8&P-BFR62"A0      %0E9;J  (45"6RX2#9K8UI
M&6ZRJVR8BEHBFL-,:LU1WP=G'C$A&U-T;DVA)))/-H;2-E4LN*EP!<5*@ %0
M7%0    :XUQR(N*E04+"TM!:"I4 O*@Q@M,I-
M       !:>6BTS$\V!-+HS5))A/-@; E%0"@*%"@    *P2I=:   *PK%)'(
MRQ2.D=8Z1EP50J8#6&J-8:X[-.[3R"0#8FX-P;4EF<G&R-D;(EQ=0J7%0 "I
M4J5      * R@  L*%A0  %Q< 6EH*D\
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MLB49C.2B83"49 5      !<5*@       L* M* N*@  %I:2S*
M                    #@1KBID,QE +C*9B0222"@* H4!0  % "@!62MH
M  J"A@(9%2,L<PF,H7EA'(9A(Y&.[#K@XV2B<3B>2C*9B02242C(     5!4
MJ5         +2T    N*E@!0SF8                              '%3
M7%2XO,H*%2\R&<SF<J4!0H4* % 4 * % "LE2JUH   4,,1:C$8P&$Q@O+3
M1S"8C =EG&SC!()9,)A),AE,Q()!),@  !4J5!4           %A0  %2XJ"
MA:4!D)                               -$0 5+RXJ4!<7F4S&4J"A0H
M"@* H"@!0  "*HM J4*@ Q$<CD8P&,L*%X,)@,9B,1S$C'%3,2242C.92\RF
M<D$@O*E2I4             J5+04+  "XN  !84+B4
M            #5D$%2XN*E 5+B\RF0N*%"A0 H"@* %  4  *@  %06& CF
MQ&,L*%P,9A,988S>DHXD9C,2229R\N,IF,Y(,I4            %05*E06EH
M+2A0J5*E0  "A0E                               A$(%2I<  7%Q>9
M"I0H "A0% 4  *  H"H0M0  "PQ& PF,QEA0N!88C&6&,V!N3B!D,IG)!F+R
M\O,IG,YE*@         J"I4%0  "A8 "A4  %2@ !G*@
M             $8A@J5+@"A4J7%QD !0H"A0  % "@!0 "2HM J "PQF(Q&,
MQE@!4QF,L+"PRG)#AQ>93,9S,7EQ>9#,9C*5       *E05*@      H6
M J7%2A0H4!F+@                             #"12A4%Q4 %2I<5+BA
M0   H"@* H        4,9C,988BTH5!88RPM+"TY8<-+S(93,92\N+R\RF4R
ME0   5!4%2H         !:6@ %2XJ  "A4N+@
M      #&105*@J"A4J7 O*@%I0H     "@!0  J  "I86%AC+#&6E"A4L+"P
MM+2PY2<1+R\RF4REY4N+S(93(7 J5*%2H             !0H4*@N    !<7
M                              %A& !<7   N+@  "A0%"@
M *%A86%A86% "TM+"TM+#D)QXH7&0R&0R%2I>9"\REY4
M        N+@                             "A&*%Q4   N+@      4
M*% "@       *&,L+2PM* %I:6EI0L-P:LPEQ>9"\O+BI<7&0R&0
M              J5*%"I4N                              !'  !4H5
M+BH         !0 H4!6"5HH %I0L+2PM+2@!0M+2A:4-@12*7%Y>7EQ<"\N+
MR\R               J"I0H    5*EP
M    ,!0 J7%0                   8RA84+"A0H5*%"TM* E%A$*EQ>7EQ
M<"I>7%QD           !4J"I4  H"T% "I<"H
M           ,90 J    7E2A0M              +2TH6%"TH "A:4*%#.7D
M(J7%Q<7%2I<#(5+P       "I4 J5       * %0
M               "PH     5+P "A0H4            !84*%I0 %"A0H4*&
M0S$(J5+BI>5 +RI>5    *@%2H*@
M                L*     N+@    "A0H4          *%I0%"@!0H"@*%2
M20P5*EP+P5!4O!4J 5*@
M            % 4* J"@+P        "A0H"@    0H  %"P  % 4*%"I)(@*
M@N+@ 5+BH+RH
M                        !0  K)2VH*%@ !0H4*Q2J  %"01@7  N+@ "
MI>
M                    "A:4    *% 4!F,)0%2I<   7E0
M
M      6EH     !>6E    "XJ5
M                                              !0%  "T  %Y:4
M!4N !4
M                               H5 +2A<"@*@%0
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                    #__$ #T0
M  $# P(#!@4"!@,  @$%   ! @,$!1$&$@<0$Q0@(3 Q0!4B4&!P(S(()"4S
M-#46-D$F0A<G0X"@P/_:  @! 0 !!0+_ /I9NEB8.N%"T^+6P;<K>X;/ _\
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MNG9>O07A,P\(*""Y:.AT];&D%!0TYE>7%5<:+HOGIXO[7>XJMW:"M_A24_C
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M0:-Y)W6B<F"<F>RXI?\ 1*U_RT$J25%N3J4>I/V-1*EM!=+A8);'Q"MLS?\
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M%J=NMGT"N?U;C"1"$9$A"GF:NJNO=1!J#$&(-$YH(-0:@U!$&H)[O5NG[?\
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MEJU#>+84&MJ28IZVDJV^Q<.'CAPHO<444447F@T81NP0R%P3?'2N\:-WS?\
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M.MM>UR/;]!_B OG1MCD(F^/ G3O8;)WU)VG'&T>%KEV2V*IVK?Z=)F<*JO\
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MUHU!J"(8$00003ZFSZ_4M_6VFTVF#!@P8,"(()WL>1@Q[-14%0P8,&#!@5#
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M)(:V9A###2@&!:,IN]; C I-5U(;=6(V>BC9Y&) QTETR4&<9;EJ1K"M#D=
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M^$1@\3Z3^7T/P^3[ 236MY3F58][<0JQ1W]'9(]6.E2;?KZ*/D%FD_K.%_\
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M48971%9LPE'!A>\=,&X;]0PMWB,.]CNXCABIXDBA1(XHE6.-$%E5$7=55 X
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MNV=KJF^Z8J&IE#"P.\(FW!RUW[6XX=M]F8\68L?6;_L=$V0BMS>7.JE+TN4
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M=3;"Z$>D?7C)#O4.7M\:BI3[8$.(?,&"O;]/W_5CIKB_T5E,GQ*V4'].)?\
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M,+.LBJ!*H*7 T9.:2+H& -B+^:P!\,5?E?7P=9$_DE(KO"H=I8  JA1N^:I
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MH@DT1@00)%&M['&[IB:/&=TXDR[,8R-&HZH6],+_ &XZ#(C1Y]M#2$6$U(C
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M9>LCO>1!QMWCQ&(98RW:)'+>&C)Z1]N$ DC!<JY'"5>8_.\<=J+Q6^A'W^C
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MLWT&WVXKZ7REA4P'JZE='"\'&%NT:)4\.4@U>/O/B/#"4KP)O[\<M,=%GCX
M\A)SB?NWK#$,BRVCG569.!8#M#[#X\^.&@BXHNZPY=^'B5M"+KP8'GZ?1B6A
MGC++$-^,DD7/F]PUX8HHZF/K%FN@M>-SJ-[XH\/' S"6'W.;5.8;C8\[\QBM
MR^":]12,!O><@X^S$<D],W9N #J&X8@K8YK;_N;G0CX!.&C4W^L82,@ZFPY?
MXXVLJVS':.#+826 DAI0!KVF8;Y'M^C#0B*DZF+^"@5(R-/>U L/2!B"L8U
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MH$;:;V[K;G;3$$@D UUX'[^&&0GG]_#!TTN=2/3AEWAQWEY=Z_Y=^)X P[7
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M:MGY04E3+?AYD3M]=OHP=23W_OL?(%D6V3T_5TF<=9/3HHCAK8P&K*91HJR
ME15TZCL[KL)HUMU<A5!$:>HBGC2>GGCG@D]ZG@;>1^!M\9'%QOQ2!9$.C*#C
MK9$U[]/\",%[-==+GEPQ#4;C7#=H:$#@W>/3BEJ>VIN%!X;Q\Z_ $=YX'VXC
MW9$$B'CQ5O@D<1ZCB:(C7OUM;M>GT8[2Z\>6@T/AAEWCV.PUO,/FMZ">&)@X
MU,90B_:7@;?KQ)U<E]^,;WQT\X86$@[U/,";ZJVA]8PN^?/B:XX[ATQM14B#
M*)U =6GM$N]W-YWCPQL%EBPY?55I%I*N?<4D&_5PCX)[F9CZQAKJ3O<+?X7.
M)T\HADIY ;%3U;_G<O3;Z<19'U,K5$\R2$:A%.N_RO\ JQ%Y^\WFQ]MO  <!
MZ> &,N:HE:6MW-P2R&-;\!#O>ZMX@*+7YGAB50XWDTMO;H_-!T_PQ!.4GCWM
M5E[#>GE]Q@@C3B.7?@:Z'[^OOQ&H4BUQ87T^-A3I<:D6O?CZL(;7/A]]<![*
M2>%NUW =^O=C/JY:EVW-8O>TO^;Q(])UQM;4>0;,U;$[LF9/'10Z]HC>$LY
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M_P#VYZ9FD.[+20YH7T/9\DRSA;ONT2^!WO;/,7:W><)HBKW##G&V];Y)D<R
MV>K9*9>_=:[2$?HJ0?3\F>P-%UE165K#2*-84/<\IN2/T%(/SL".^(HM<(ML
M;69J,BV6SK,V.ZU/0S=6?Z61>KB'K=ACH&RPSUN>Y_* Q15I(G*Z];4,99B&
M_P!F%O;OQ$F_,/#7&Z<,F.D>MWZZDH%.E/$9I!?^$F-A<>"+_:^3/8RB\FR.
MG) WZEGJ&-M;,=Q03\U+CNWO3A([X@I],"#7'X0.:G+]E:/*T8K)FU8-X _P
M%,-\W'&QD*#'1+DIRG8C+2RE9<Q,F82 K8VF-H?'WI$]N*2&Y)\?HQU8 Q(
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M^I4G_67%/YV(. Q38Z5UW^G;+U_\SDGH]\3%K'T#%5P.)SJ<5)QTEG_0$?\
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MPW65A<,IT((.A!&A'/T8Z5^C*MV7S ;=;&"6""*85573TEUDRZ<-O>40A?\
MPS&Y8<(]0>P3;HCZ5*/;[+%HJZ2.GVDH8P*JG)"^6(@MY73KS)_AHAJC:CL\
M)([XJJ?CC:;((<[R^:CD 6762FE(]ZG .Z;\=UO-D'-3?B!BJIIJ.HFI:A#'
M-!(T<B'B&4V/JY@\Q\BF4Y36YU6Q4%!"99I3^A&GPI96X)&HU)/UXV2V1H=F
MJ0)$!-72J/*ZTKVY#QZN/FD"GS5XMYSZV"HEN&)I4@0NYTX_X8JZN2J<@:)R
M4?;@1A=3J;XAC+FY&F$4*,22;H/=Z<558%!UQM/M:F7;U-2%9JY@>.J4U^#.
M.#2<UCX<VT[)FFEJ)7FGD:661BSNYNS$]Y_>L,TM/+'/!(T4T3AXY$)5T=3<
M,I&H(.-C-KX\_@\DJRD>:P)VU\T52+_#Q#XXXRQCAYZC<N%B;&[%/$\$Z++#
M*C1RQN-Y'1Q9E8'0@@XZ2^C_ #7HTSV#;;8]YXLL\J6?W&]\MG+7ZF0#C2R^
M:N]V;7C/P;=&72/EW2'DJSJ4I\YI$1,TH+BZOP\HA'$T\IX?$/9/+$T5P<5,
M''3'23LUOQC/*6/W2$".N51YT7".;TQ^8Y^*5TT)^1/*LJK<YK8:"AB,L\I_
M1C7X4DC<%1!JS'&R>RM'LU1""$"6KF -95E>W*_Q$YK"A\Q>?G-KPCCQ/-'3
M)O,?1XG$U1)6RGXOT 8W5C&ZNIYX2$L<*H06Q)*%OZ_OXXJJS0@$\3]_5]&-
MIMLA#UE'ECB2HU26I':2'O6+D\G+>\U.6\VJN[2,SNQ=V)9F8W+$\22>)_>]
M)5U%#40U=+(T4\#B2-U-B&4W]8/ C@1C9+:F#:&CW^S'70 "KI[\^ FC'$Q/
M_8;LM\$F&7$]+29G23T%=!'54E5$T,\$JAHY(W%BI![^7<=<;6[.9]T([8TV
MT>STDK9'43EJ=C<Q]4QWI<MK.3#=T5FU9;-YRDML;M?E6W&14V<Y9(.VH6JI
MBP,M'4A?=()!QT-RC<'2Q'/$\-QBMI$ECDBE0/'*C1R(>#(X*LI\"I(.-I\D
MDR'-IZ,@]029:1S\.G<G=]:>8W<P^1&BHJG,:J&BI(FFJ*AQ'&B\R>9[E'%B
M= -<;([*4FS="L2!9:Z95-956UD?CU<=]5@C/FC3?(WV%R%2&G)Q4214D)=R
M!8>LG%1535\VZ+[F]IX#"QB!-Q?.^$>\\\+&2;_3]_JP $&)9@@XZ>.*NN"A
MF9@JHI9F8V55 ))+$Z #4D\..-IML9*LRT66.5@-TFJAH\PYK%S2,\"WG..Y
M20?WSE.:5>3UT-=1N5DB;5?@RH?/C<<U8:'VC&S^>4N>4,5=2MYUEFB)[<$P
M';B?_P"+<'6QL#<""3&?9!EFU>3U>2YM"LU+5QLM[=N&2W8FB;BLD;68$<QC
M+*W:#H$V^>AK.MGR*KD E !ZBORYG[%3#\$5$ Y<5<%"-QEO0U]%G&7TN9Y?
M,E31UD*3P3(;AD<7'H9>#+Q!!''%3"#CI"V;_&V4M40)>MRX//%;SI(;7FB[
MSH-]!?0J;:M\B"JSLJ(I9V(55&I+'0 #O)QL!L:N1T@K:R('-JM+OO:FDA87
M$"?%D/&9N/",6L^_34W,XE:.FB+N0H4&_P!_HQF%?)F$^XA/5@V4?;BF@$$=
M_A$<?UXM?%@@U^_W^_?B>H"@ZV^]L9GFT--#)45$PBAC':9CI\U?C,>2C4\A
MC:+:BHSAV@@WH*!3HE[//;@\Q'+NC\U?$ZG]][*;23[.Y@LMR]%.1'60<FCO
M[XHY2Q\4/I4]EB#05T-7!#44\BRPS(LD4BZAE;AZ#R(.JM=2 0<02XZ2M@*'
MI!V>EHI%2/-*57FRJLMVXI]WWICQ,,VBNM^XBQ%\=#&WM=L1G\_1[M8ST](]
M6U/3-4$@9?7$[H%VX4U3IKHH+*XT;$B7]?#%5 #?3Z,;>[/?B+.7>%+45?O5
M%/IHC$^[0_H.;J..X0?D/Z+]DO*I1M!717AA?=RY&_A)E\ZHL>*Q<(SI[IV@
M>P1B&((!POA9+<> ^_W^K&>9FU5)Y-"?<UT-N9Q0TFZ-\C_/[^W'5DZG#677
M[_>^*BJW.=SW8SO/:;+*=JBJEL-1'&/?)7MYD:_6>"\3;3&=Y]69W/OS'JZ=
M2>IIE)W$'QF^/(?A.?0+* /W]T=[4^15"Y)6R6I:A_VD[<(:AK>Y%N4<W+B%
MEMYH9SBFEX8@DQT_=&ASBB_[9Y'"1FV6*#F4<([=521ZBH4+JTU/SMVBE^+
M8Z#.DH;79,,@S:;_ $]D\2HKR$;]=1(-U)>]IH;!)>\ /WXF3&W&SHSW)JB!
M%O5TX-31GGUJ#6/T2KV;<SNX961F5@59258'B&!L0?$'Y#=G<EGS_-Z/+( ?
M=I 97Y10)VI9#\U ?2;6Q04$&7TL%)3H(X:>)(HE%A94%A>P%V;SF-KLQ+'4
MWP3R&,VS$Q(88SVVXVX@=WIQEE$U1(&-S?4X\GCA4 #AB>11>W+%55@7QM#M
M)391"7D/63N#U%.#VW/QCKV8P>+6UX"YX9EFE9FM0U35R%V^ G".)>21KP ^
MDG4DD_O\$J0RDAE(((X@C@1Z,;"[3#/,N5)W_P!(406*IN>U*O".H%]3O@6D
M.MI 2;;X&*>7"%)4,<BAT=2CHVJLK AE(.A!&A&.DK9G,>B+;JCVOV=#1916
MU7E,&Y[U!(6WJF@DMIU;C>* Z;AX>Y@8V5VEH-L,@H<]R]PT=7$.NC![5/4J
M+30..(9'N->*V//$T?''27L[^*,X\N@CW:/,]Z7LCLQU(]^3N&][X!XGY#>B
M+9X4>739Y41VJ,P/5TV\-5I(V\X?[:47[[1COQ(^[B>I$,32'EP[SB-7K:@R
M&YNVF*.G6EA'QB..*FHMP/#%756OKC:;::#)XM;35<H/44]_5UDMM1$#W6+D
M;JVU9:RLJ:^HDJJJ5I9I#<L>0Y*HX*BC15%@!H/XAV=SN;(<T@KHBQCOU=5$
M#834[$=8AY7TWD)!W756MIC+JZ*K@@J:>020SQK+$XYHXN/0>1'%6N#J,4\O
M#[_>^-K]EZ#;39VOR*O12M3$QIY2 7IJI1>&9+\"KVOWK<:XZ)]J*_HPVUK]
MAMI&:#+ZVK\E)E)6.FK VY35<=].IG4JK$'@RGS@;2 '7CW$<".^_=C;'9],
M_P EJZ*P\H53/1M\6HC!*=YM)JC<+[WAB2-XI'BD4I)&S(ZMH5939@1W@CY"
M\ERV7-\UH<NB%VJJA(S^:E[R,?!4!.*"FAHJ2"EA4)#3PI%&HY+&H4< !?2Y
M/,ZXF-SC,YC*PA0Z<#;UXR>D"@2,-!PQ4S;BV'UXJZBU]<;2;019/3-._;FD
MNE/#?61_'F(TN"Y'@!8D'%965%?4RU55(9)I6NQ/+N51P55&BJ+ #0#^(^C3
M:,QR'(:J3LO>3+RQT5]6EI]?C^>@OYV\ +MBFEX8IY.&/PB>C_\ &F61[:93
M%;,LI55S 1+9YJ(&XGN+$M3$W)XB,FUSCH0V]_[8;,)05LN]G.1JE-4;S>Z5
M%*!NT]1XD =5(?C =^)5QTH;/_BS.!F<";M)FF\[6'9CK%]]7N]T%I!X[WR%
M]$.3B6LKLZE7LTJBEIC_ $LPO*P^;'V?T\;X _7QQ42[B,W,BRX@@,LEVU+'
MCA5$$*@:$#%9/:YQF-:D,<LLK[D<2,[L>2J"2>_3V\N.,\S:7.*^6J<D1@E*
M>.^D<(/9'I;SF/-B?XD@GEIIHJB%S'+"ZR1NIL5=#<$8V5SZ//,LIZU2!+;J
MJJ,?P=0@&_IW-YZ?FL!<V.*>7AAXH:RGFI:A%EAGB>&6-A=7CD4JRD'O!QF=
M-7]!W2E'54^^<BKI3)&/@3Y94/[M3FUAOTI;L\;6CUWF.*:KI\QHZ:OI)!+2
MU<$=1!(I!#1RJ&4Z:<#J.1%L;8Y"F?Y)5T5AUX4S4C?%J8A=/4^L9X:-X8=&
MC=XW!5T9D=3Q5E-B#Z"/D*V&RO\ %&S&6Q,NY-41^6SW&N_4=L ^B/<'JP7P
MUYI@OP4X_?GBDI-QS(1H#V?O]_;BKDW5/T8KZCCKWXV[S@I%'ED3]NH]UJ;<
M1"I]S0_/<;Q&ALB\F_B;83:#\2YLL$S[M#7E89KGLQRWM%-^B3NL?B,>[%-+
MPU\<4\G#'35L.NVFR,[4T8;-LH#5U 0.W($!,U.#<>^)?=OH)+-:X&/P>-N#
M79?4;%YE(16Y9OS9:)#VGI+^[TXOK>!NVJ\HV/=B08Z3MG_Q5G7XPA2U)FN]
M-IYJ52VZ]/#>N)0/SCW?(3D5 V9YQEM HOY35PH?F;X+^K=!OAE6*,1KHD:*
MB#N"BRCU 6]F"VAQ1Q$OO'O]O^6-W=2_#&8U&I&,PJ5C621VLD:,[GN502Q]
M@]>,TKGS*OJ:Q_X60[@^+&O9C7]% !_$_1[M)^-\L%+.]Z[+PL4E_.E@X12^
M) ]S?D"%/%L4\O#"$,NZ=1;4'F#]F.DW**OHLZ2Z':K*$:++LPJ17Q;@(C$A
M>U=2&PL%?>)"DW/6,0++C*<UI<]RF@S>B</39A31U,9!O;?7M(>/:1MY#XKC
M;?(AGV0UE,J@U4"FJHSSZZ$$[E_Z5-Z.W>RGE@@J2I%B"00>((T(^0CHGR_R
MO:4U16Z9=22S:\I)+0QV\1O$CT8J&M@'>8*/3BDCT'+_  Q6R".,CPQF$^K8
MVUS'R;*WA4VDK'ZD?,';E.G@ OZ1_BC9G.9,BSBEK5)ZK>$54E]'IY" _K7S
MU)!LP!Q1SK)&DD;!HW59$8<&1QO*P\""",0/CI7V-BVTV/KZ%8U;,*-&KLM>
MW:6IA4DH#8D+,F]$]N1[\?@Z[72&/,-B,Q<K443R567I+HP .[5TX!U[#>Z[
MO+M#$@QTAY'^)MH)WB7=I,QO606X*SGW>,?,EN0/B,OR$=#E#U>69MF!'^L5
M,=.C<]V!"S@>&](+^CPQ6/;%(-Z07Q -U?1C,YM"+XKY;DZXVUK.OS-:<'L4
ML0'Z<G;;U@;H]7\4]'.:&OV?IU=KRT3O2/W[B=J)F_1;='S,02</# -QWWQT
MH994=&72;E^U>5*8J+,*A<P4+I'UN_NUU,;67=D#$V/G=8?BXR[,:;.,MHLT
MHW#TU?315,+#7LRJ&W;]ZFZ'Q!QTD9+^-<CDFC3>JLM)J8K#M&("U0G?Y@W^
M[L>/R$='=(*/8[+>(:IZZK>_?+*RBWZ$:\<5)+/Z\4*V([[XWMV/&:S<?UXK
M9A=F)T4%CZL9A4&KKJJI/\-/(_J+'=^BW\4]$U1:/-J?NDIYA['0^W3$+XC:
MXQTS;(+M;L;6+$F]F&6 YA0D#M%XE)DB'^UBWT\#KRQ^#KM:U=E-=LI627J,
MI<U%$'/:\DD:TL8OJ1%+J -%5\5D88,K*"K JP87#!A8@CN-]<;492<FSJMH
M['JNL,M.?C02]N/AIH#NGN(M\@RC>(7O('MTQE5,:3)\LI+;OD^7TD3"WPEA
M3?T[]Z]SZ<3BV*+EB1]U+>'WXXS>75M<;15?49;6R V8Q,J\M9#N?4?XJZ*"
M?*\T'+R>(^OK!B'EB$Z8D19(V1A=6!!!X$'D?IQG$,O13TP0UT&]'E=;5B<<
MD:AKGW:F(\B(F+-8>:%CQ(\<\,<\3!HY462-AP*2+O*1Z0<=*.3]?14^;1K>
M2C;J9[<?)Y3=2?".3B;_ ,)\@V44YJ\URZE N9ZVFBMW[\JC#*%3ZO"W+%1J
M?7BBX_?ZL5+[J'T8S=^.-LI]W+UCO[]4+?T("WUV_BKHH6TN;2\MVGCOXDLU
MO[.(C<7Q"W#"X_"%V3_&NS:9Y3QWK,CDZUF7SC1R$=:"?BHP$GJQT/[1?]H=
MB:*.63?J\J HIKF[&)1>G<^E.SZ5QFU%'7TE513"\=3#)$U^6\"%;TJUF'B,
M5M+)0U=31S#=DIIGB8'O1B/D%V IC5;7Y(@%^KJQ4'YM.K3$^H)B7AB;SN[%
M&-,5K[J'T6]&,TDU/LQMG->6DAOP$DA]9"C^[_%71=2E,HJZDC2HK-U?^ EC
M],FGKQ -,1 Z808SC+H<SR^KH:A \-73RP2H>!612I]E[XZ*ZN38W;?,]EZQ
MBD4M3-068FUPYDHI=?C"VO\ 28JDL<=)F4^39E#F<:VCKDW);#05$0 _MIND
MD\3?Y!>B2E,^U8FY4=#53-X;X%./IFQ-PP_GXI]%&*]^R=?3C,I.T?\ +&U,
MW69HR#A%$B>L]H_7_%6QE%Y%L]ED6[NN\(GD\6G)D!_J%/9BFCOA8[8B&F'2
MX]6.GK+:G9S:3*-KZ!2B5+)#5%+@>4TS;\3$CFR<>\+:^-G<ZAVDV>RS-X2#
MY721.XYK+N[LBGQ#@Z<L;9Y3^-<CJXE6\T"FI@[^LA!8C])=X>.FE_D%Z%:>
M]?G55;S*2" 'QEFZPC_E8GX'V8/G>O$8LMO#&8MH?0?9]^&,Q;M'UXS.?RBO
MJIN33/;YH-A] _BF@IVJZVEID%VGJ(HP!Q.\X&*/=BCBB3S(D2-?FH H^@#%
M"MQZ<=5IB*,@X*:8Z8=F1M)L9FU*J!JF"(UM+W]=3=NP(X;ZW4^'AIC\'S:5
MI,MK]G:A^W03== K'413&SC7NE'#D#PQ.M[\P>(Y:XVKRPY3GE;3 6B:0SP>
M,4W;'AH21X6^03H8IRF3YK4V]_KHXU/^PA)/L,N*GS<6NP'C@:+ZL9D=&'A]
M.-H:CR:CJYN:Q.%U^$W97UW8'U8)N23Q.O\ %.Q%+Y1GL$A%TI$>H/@P&[&?
MZ[#%&Y9P,9?P&$2XP]31PU$-)+4TT554AF@IGFC6><+YQBB+!W"\RH-L,NF,
MRB62%T875E96!Y@@@CT$8H4;8'IAJ**YCHJRL>-;]E6IZX[T1[K)(55?FG"O
MUL2MSMCI/ROK*:DS6->U _DTY'\G)=HSZG#"_<1\@G193>3['TC<ZJHJJ@^N
M3JAZ=(L5/W^S""\GW^_W]AT7Z,9D?.]'W^_#&W,NY0K&/X6=0?FJ"Q^FW\5=
M'M'NT]96D:RR+ A_-C&\X_K,GLQEZ=K>\0,9?RP"$C9F-E5=YCW*!=C[ <;7
M[4UN<[5U><PU$L7DM3U>6M&Q4T\%,]H3&0="Q'6,1YQ8WQL!M6NUVS\-9(5&
M84Q\FS%!I^V$728+R6H3W0 :!M\"P&*Q>RV.G_(&AS+)MI:=2KJ_DL\BCG&>
MLA9B.2:V\3C8_,US7),NK-Z_7TD9?PE50D@_K*<9YERYGEE?0L+]?"ZIWB0#
M>C(_3 Q(C12/&XL\;LC#N938CVCY ]DZ3R+9K)*8BQ7+Z=F'YTR]<WM,FN*D
MC7EA9.T3X_;C>.Y]F,RUWOOZ<;=H31POR6IL?TE;_P#3_%6S5'Y%E-#!:SF)
M97^?+[H;^@$#U8HEMN^ QE_"^.D+/1D.R695"ONU-3'Y#2:V;K:D%"PYG<CW
MV/=W\/V.AK/_ ,5[3?BV5[4V<Q&GL3H*J.[P$#A=^U'?\[%5JN.DS)%SK9O,
M(-P&2-/*8N_>B[1M?PQT45S+EM1E<A[=#-UD8/\ )2^=8=V^/IP3<W',8V\R
MS\6[05)5;0UH%7%W7?211Z'!]OR!9?3FJKJ.F4;QGJ88@!SWY%6WTXC18(HX
MDT2*-(U^;&H5?H Q528B[6&-D\;?XXKSH<;8P];E=0;>]-'+_5:Q_O?Q3D])
MY=F='3<I)DW_  13O.?ZH.*1!=0!8#N[A^K$.FZ.^V,O'97'39GWE6:4610M
M>++8O**@ W!JJA18&W..*PL>!)_8HZJ6BJJ:L@8I-2SQ3Q,.(>)PZ_2,91FD
M6>9+E^:0D%:VEBF(&N[):TJ>E) RV\,;4Q3293F"0'=D\GFL1QMN-<#U</UX
MV7J9,IVAA.\P62;J)AKVHI#;7OL2".X@8IWWU\1CI.RSRC*J?,46[T,VY(?Z
M&?37P$@7PU^0+HZH37[792MKK3RM6/W6ID,HOZ6 'CB5P%/W]6*A[FW?<V]6
M(%UQ(+*>//%9K?T7QG<'7TE5%QWX9!XWW25^D#!%B0>(-O9_%&P='OUM36D:
M4\0B0_GS<?[ /MQ0II?OQ3ZRJ/'7[_?3#5<.6Y?4U]00(:2GDJ)#>UUC0MNC
MQ8C='YQ&,WS&;-\SKLRG),E94RSF_(.Q*CT*MA^ST*9\9\NK]GY7N]$_EE("
M=>HF.[,BC\R6S<=-\Z<\5T0D21#YKJRGYK"Q^C&=T/D&9U"A;/%.ZWM8]E]Y
M3[+8R2L%524M1?WV%=[YX[+_ -H'&:4*YGEE;0N/]9II(A<<'*GJV]*O8^K$
ML;0RR1.+/$[1N.YD8J1[1\@/0UE^]6YMFC@6IZ>.DB)XB2=M]F7_ (<3*?GX
MJI0H.#,6F)\=T>C%.=T:XD86-O;BIYXK(^.,TI_)<QK(+6W)WM\TG>!]A_BC
M8^A\ERBG)%I*IC4/WV?LQC^HH(].(%W5] QEXWI+^..EO//Q?L]#E$+VGS:7
MW4!K$4<':8$<UEDW0-1YAT_(V)SUMGMH\NS"YZGK13U0!MO4\_8D]EPWJQ.R
MNH93O*R[RD<&!U!]>.D&@ZK,/*%'9JHP_AUB=E_6=#C8RL+4\U(Q[4$@E2_'
MJY/.]C#Z<1/O*#C;W+?Q=M'6;HM%6[M9'II[K[X!Z) U_3\@/1IEWXNV3IY6
MMUF8RRUAT.]N%NJC5KCD(BRVN+/XV%=-HWWU^^AQ3KO'>^^N ;+ZA@M?$PU/
MHQ4KH<;94W4YH)0-*B%6_23L'Z@?XGHJ9JRKIJ5!=IYHX_ZS"_L%\44*QK'&
M@[$*(B^"HH4?0,<%MWXRQ-1CI#SW\>;2U;QOO4M%^T:34[O5PD[[K?AULF\Y
M'C^3L)G7XZV6R^5FWJBD0T-1<]K>@ 5&[P&BW+=Y!L<;;T?E65F8+=Z9]_\
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M[S3)I#&/0NK=[DG\C9_-6RC,H:BYZI_<:A1\*&31M.931U_.48JI0XWE(96
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M<KGLAFW''"QOS[B#<8R6JZV'JB=5[2_-/'V'^>R#=6WK/[ .$.(WMJ> UO\
M3BKJ#43,Y\T=E!W*.'MX_N8-C?NQ>Z@]X&#@X/']^IYZ^G ;"MBL;>F]"@?;
M^[=#]7Y3L[7T)-VHJ\N/".IB4@ ?.B<^O%3'9CBICU]..D_9W\2[1U\,:VIZ
MH^7TO=NSDLZCQCDORTN,;/UY'5L3VD.Z_P!1PI# ,.!%QZ#_ #TC%V]&O[%\
M#"G%3+NQ[@XOQ^;_ (\/W6%KI;N."<$X?C^_8O/'A@'"G$IWI'/C^[="E65S
M/.* MV)Z*.H"][P3!;@<[)*WJ.*R/4XJH],=,^0^6Y)#F\:7GRR2TI U-).;
M/?\ -C>SXHY/)*W=X)*?5O?XCZL934];#U9.J:KXH?U'^>D8LOIU_9&!W]V)
M'WW+>ST?NL1L?3@G%\-^_8N)]&+X#?N_155^2[9Y>I-EJHZFE/B9(6*#^NJX
MK(^.*A-.&,YR^+,**LH9@#%5P2P.#PM(I /J-CZL;099-EE?5T<FD]!520GQ
MZIR%;]);'T'&1UYM%*#J-&'AS&%8.H9=0P!'K_GD!<V_8N< X&)GLNZ.+?5^
M[#0X)Q?%_P!^ISQ?!;LGT?N^RM7Y#M)DE43819E2EOFF55;V@G%4EUQ41\<5
M,?''2[E?D^T]14(MA6"(N!_*M$K7\2_:OZ,91E$].7>=MR-CO+$//UX[W)1S
M[\4,H ZGN\S[1]O\\DQ?%\# .';>8GV?Q<#B^"=/W>"0Q30RCC'+'(/2C!OL
MQ2R"KRZBJ=/VQ24\W_NQ(_VXJ8]3BH34XZ5*.^:1.5!WJ6.5=.<3,NGJ&G["
ML5(938C$=<.$B^L?JPK!A=3<'^>%\7. <##-9;=_\P=A*KR_8W(9BV\WD$<9
M\##>*WJW+8JX^.*I+$XZ5HMU\NJ;=GJJB/\ JD/]O[+R1QB\CH@/QF Q19A!
MO",3QN&-@ X)!]'\\QAC<_S!Z&ZORG8V"(G6EK*NG]"W61?[^*J*^*R/4XZ7
M:<MDM-*![S5,#Z)$U]NY^Q4323U'DL WBO&WF+^=*WQ>Y>+' IJ2F&].?*)N
M;2'>]2*=%7P_7@BAD O2@*=-X+ND>@BQ'MQ03M%)Y%*Q=2F_22-JS(/.B9N;
M1Z%2=64]ZDGY,^@>LO1YY0DZQU-/4H.Y7C:-C_6 Q*N\,5T=KXZ3*82[-U.E
M^JF@D]':*G^_BL<TD<S<3'<#T\OL.(G\CI[N1ULHZ^9N9+:J/0HM88DJZFLJ
M.KAOJ=+<_P#/EB"LJ:2<058;<;LW-^R>_#3%:2.?X5/41E&[U+!3_60D>O"G
M> />/K^3/H0K>HVCKJ2_9K,N8_I4\BOI^B6QQ7T8KH[KC;:GZ[9[-TM<^2,X
M],;*X^K&T<1\EZ]1=5DBZZW)=\=H^'(^KEC-7+QEP?/L!;XO+U8R:>&GE]U&
M[)?LEN\<+8S.E@KJ-*U -Z,C?([N#7]!L?1?#2=8:.@B.\7GC=_F(PX^G"BP
M [ODSZ,JSR/;3)VO83R24I_X\;*+^NV$-QBI7>3U??Z\9[3":AKHB+]92U"6
M\6B8?7KBJIUD2>FD%U;?B<=_%3BJIWI2:::Y5&(1CS7X-_&WMXXFZD*>%[=F
MW&_+UXV:G\HIYZ&;4/&6%_BMV6]? XR3(Y*:IEJZKBK/'3J>.Z"1UC=P(\T=
MUR>-ODTR2J-%G&658-O)ZZFDOX"5=[^S?%-*)8U=3HRAAZ" 1]&)-5.*^'>W
MAZ<9S3^2YKF-/_)5E0O_ #&Q59?25HM41!_'@P]##7'_ &4R_?WM^>WQ=\&W
MK(.GTXH\JHZ$[T,?NEK=8[%FL>-N0OX ?)J#8@CB""/5C9:N\MR3*:KCUU#3
M,3WGJU5O[0-\<01?EBJCXXV^IO)=K,W0"PDG$X_XR*]_;?Y.>BBL\JV2H%WM
M::2>E/.P23>7T:.+8346^YQ4)?'2_2&#:=)K:55#"P-N)B)C/U?)ST'UN]1Y
MM0$ZPU,-0H_-E3<;3YRCVX3D;_?GZ<5&HL.'W^YQTW4EGR2LMQ6IIK^@I*/[
MQ^3GH8K?)]IIZ4DVK:"0 =[0,LOU X4W]N)!I]GHQTSTG7;,P5(&M)F,5^\"
M9'0_4+^KY.=@J[\7[6Y).251JQ()"/B3^YG^]A.&&M;'212>5['9TMKM% E2
M@\894-_4N]\G-),::JIZA38P3Q2@CEN.&^S&7U JZ.EJEX55-!.OHFB63ZFP
M>&,\IA5Y5F5*?_$4-5$!XM$P7Z2,.NX[H>*LRG]$V_GUS_C_ *.<P%?LADTI
M;>>*F--)?DT#LBC_ -L)ZL;U]![<2B]P=;Z:XVBI?(L]S>EMNB',*I /S>M8
MK]!'R<]"V8];D5;0D_ZG7;P\%JH[@>V%OIPC XDQTGTGDNV69Z66I$%4/'K8
M5WC_ %PWKO\ )ST0YD*7-Z^D9B!54@=!WR0.#_TV?OQ#5*1QP\P(X_?ECIFI
M=W-LKK1PJ*)X#\ZGE)_NS#Y.=D*TT&T%!,#8/(8&[K3*4U]N*?- 0+M@9D+>
M=CI4W:O*J&H%BU-6;I^9/$;^K>C7Y.89#%-%*-#&ZN/T3?%-FV\B,&T8!A<\
MB+X7-M/.QM-4^69/5Q\2H64 ]\;AB1^C?Y.J"N/D\5SP7=_JZ#Z!@5Q[\3U7
M6Q21DW#HRD>D8X?)S2R[JE?'Z\"?!J,/Y[>D_3_/<_S"0V.-[QQO8?C\G5SB
MY^0;Q_\ \>]O_P"1=G__Q !=$0 ! @,$!08)!@L' 08$!@,! @, !!$%$B$Q
M$T%187$&(C*!D:$4(T)2<'*QP? '$" S8M$P0$-38'."DJ*RX14D-%!CPO&#
M%B4U1-+B=("3LQ=49*/#T#:T\O_:  @! @$!/P'_ /J6FOH[5%Z :^CI?1,*
M=H89<J:>CHY'A#SU%D5R,2;U5IWGT=S53-K;&MTI'6J)0J0ZE*L"EP C>#CZ
M.Y@C^TE5( \)%2<NF,X;=;>F](WBV[,53P4JOXD8O1>QIZ)Y65\,MB9OB\RP
MM:UUR4:T0GK.)&Z%RZY.=ET$#1KFFRRI/14@KR'JY?B1%1"G;I(V07\<X:6'
M$!7;Q]#QBL#6/I2+(EF7%T&DF7GGG%G# K5HAPN4IQ)B98;?:ERE;97+3+#J
M"E0H$Z1*7$\"DU&.)2/Q.TO%*2YJ7_,/O$&:YV<68_>*VR=5X>_W>AX_-K&_
MZ*L$J.X^R'K>8?97IY53A9<$H:3*VVG&V[IO43DJ\ %"FZM(E+07-3$E+-LM
M2TLA]DJ::%4WRA;H2I9Q44A->VN0_$[81>D75#-JC@ZL^Z%O[-58L>:"GF55
MS-P^P]Y'T!GZ&CD8K"L!79C Q .WZ$XO1RDPY6EQEQ5>"28EI<33*5-)NF9J
MXHUYB)EH<\J\UMS JXF+)4A=LR++/U3(F'%*'Y9T-J2IX[B576QJ0-_XG,HT
MDN^WY[2QVI,+40I23M,62_<>N_:"QQ&SNA!O)2K: >T?,HT23NA&KT-DT)&P
MQ>!%-N$2Z[S=-:"4'J/W?0Y0N!NQK0)-+S"FAZSOBTCK*@(LN8\&L2TJH*B\
MM+#2M:"X@WCNP&K..2Z+UJI/YJ1</6MQL#\4M%.BG)A.QYT?Q&D2JREQ"QFA
M7=$BYI9277M:3[/FFEW6]ZE 0V:CT-S*KCH^VG#BF$O1*NW9MUG4Z@/HXCF.
M?[?H<KW+MDZ/\],,H_=5I?\ 9%S1V.RG6]-*7^Z*#VQR236;M!SS&9=H=94H
M^P?BEOMW+3FOUEX?M)!AGIGC')]R_9C.U!4GL4:=WS6D]1]AD:@7#UX)[<>R
M)9=[T-VMS6$O#\DXFOJJYI]T>$45G"YG1N2DUD&7@AS&@T3W,5U))"OH<KFW
M'FY)MM)51U3BAJ'-N))ZUP](3#DO(RR6[K@;<=*5$  89G*IR SJ:4CDM+.,
M(GRZFZI<P@4U@);% 1J./>/Q3E0B[:*SYS;:NX_=#1YW&.2RZRCR/-=J.M(]
M_P TW-!R;FGJ\U*M$C/)O#^>_EJI%DJ+E-PO'XZ_0W-LZ>6>9\]M0'&F'?!>
M(I7 CFJ!U%)I0PA?A,LZWM3_ $[C=,61,^%6?+N*-7$IT3OZQKF*KQI7K^>T
MYFEM,2PI>5(K"4KIHUEU8HD[*Z(T.HPNFB0TJBFDB^M3F"R[6MU9!JEILBI5
MB'2 !%@.:>5?F"2K33CYOG J#=UH'^##8,/Q3E2B]/,@$7G&>:"<[I-:=NJ-
M$MM=%1R$M>6M,VFB7*O[JZEET*%/&)K6E:5&K*F&$3[_ (-*/.ZPFB/75S4]
MYAY5T-M:U&\=IUU/7OBPT4EBX?+-!P3_ %]#EN,^"6C,HI1"SX0V=@<Z75?O
M=T6;,<]*"04JYIQ&O##7KK6+!>+$Y.2*S@Y299X]!X#^ TXGY^4;G_?*BG!3
M2&D \*N?_P D6I>$K).A:KLPW?(PH AL*NU J4WE5 .N.3:+EC2?VPZY^^\M
M7L_#F!]#Y4+0?L>T+"M)JFC <9F+R:^*TJ"J[YJJ'%7FUAR:;F4I>204J2A8
M4*4*2D$&N\&N\'KCY.IF87;EMHF$MLH<0P9&70BXI$C+H$NPXZFF"Y@I6]B2
M5)<"S2]0<I[2EV%RDFZ\AHNJ6L7EA-Y;;:UI1CA502H)K2J[@K4B I4Q,BF-
M.8BFTG#MPB59T$NRUYB$@\=??Z'.6,K>9EYL#ZM1:7ZJL4UW5!'%42*[JP-A
MA3W@[\A:0R:<2E^GYISQ3I/JU"N., U (R.(^:U 9BW749WYEMK#_IMQRLL-
M-EV"T^%7M"AIIG.HTH&DKV$#A%D(N67()V2K/>@'W_AW%7:0VL*-/H?*W).3
MEF209;TKH<="&ZT+ANA5P':J[08Z\(L5;+TBPEU/]G,MM%MU#JE*\%0RV;S:
MBL(45("2@ A)&"<2*GY+YE#5JN3KTXZ\S:,NX[+/S9(K*LNK92A)431+>C 2
MFN%<(MR?L^V+:\(M%UY,NN9+%D-M<[PLRRJNNM)2"3=<2EL*P1<#BB;N,<G9
M333;:B*AJKJCMH>;7B<?0[:LKX99\TQ2JE-DH]='.1_$!#1+;M#@0JGQ[88I
M,RCC"L:I)'90^X]46%-&9LYJ\:N,?W=S;5O $[U(NJZX. ,2%IZ?ER;(=EU)
M5I&+1EIG&Y,(7-776AJ*F2!6FHXQ\LEI+E;,Y-V:U?TMJVTPT5(R0Q+,N3,P
M5_9*$W.*Q$HFY*RZ<KK#0[$#Z9-(!K].>5<9O;#[8DIF],)17.OL^A\IP4;)
ME;J;RU3"FTI!NDJ6TH)HK"AO7:&N&<2[KO@%I^'M3C3S)?3,2UI+TDTW=ED<
MUUR@"TKS:4!0M7#56<,2$R&Y8,6FU*MRJ'6GFK,09J5=E)LZ<L2A_)O2U2E6
M82HG8(Y/LSDU/3#G/;L&54VU9$I,L)\(0MM"FYAZ^XDOMI6NHI>07%5*D7<^
M3DKHI0O$<YXX>HC ??Z'K?E#)6F^FE$+7I6]0NKQIU'F]46=,4NG9GP_XBP9
MQIFUIFS](D&8:3,I:KBE6VGVTU_<A9HA1V)5[(LH3LU\JW)6<EWG')86F_9D
MU*G)EH2[LPI03J0I: N]'RQSRD6OR2L]* =*;0=<616XE*&$<T^22<,,<Q#>
M#;8V(3_*/IO*NW3QAI=54W?3M3_!/'S0%=ABS9G_ +PEQ7-RG:"/H?*FAQ5@
M-:$)4[X6@-A9NIO*2I/.(R%,3PBS&)QZ3F)>UII,W:$Y*H=<=;?#I$O=4U*M
MKPYBD(2*)QYA&.8AB5=;LH6?9TI.R%IR,TE;DYX2E#);<<N)2AG-YQ:L"$>2
M"<LK(E'KK+;JR[,JNAQPXEQU5+ZR=I4288:2RRVTG -H2GL'H>Y92EYIB;2.
M@=$LTQQQ1U=*))VZNE=<.6C,RORB.(;JJ7:L21FU  400\0X+^=2,T[##SJ5
M2;CR35"I=3@(\THK6/DSE%37RA.+6$E,A(.3-V[T7'PIE+I53I77+IKCB(^5
M%U4YRRLH)4I;<@G0E(&#;CP"RN]Y504B[JI6$]%/ >SZ<\JZVD_; [08E7JO
M)%<_N^G:*;TC-#_17[(E7;D_+G8^W_.D'N^A\II L!LG(3K)/#G5[HL-"V'G
M9-F64F3EP7!-/-J#ZW9M0=2PMT_6(;0"61Y"5& PU,S+#[S:"]+2^A:<NT*6
MR<CJ)&53C2.3TH53&D4GFL)J,,U*Z..T"N'#T/VI+>%R$RQ2I+94CUT<Y/>*
M0/%.$;#\=<3TJXCELJTT7W9>T.2ZF'V48EJ89= 9F4UP2C4Y=V8B+"GQ-<F9
MA!<2XN38=86M!JE02@T*3YHQ17:DC5'R-6?,-37*6T9O%2U,(;7<NT:6%+#9
M5C>4VE#=_P!881:4W(VIRPFY]HS:YI^UW62J864RZ9>7>#*!*L>4E=RJGE#$
MU"<('T[75<E0?]5'OBSW*SC:?M'^4GZ<R*R[XVM+_EB]<FVSL=0?XA"<4I/V
M1[/G^4D(_P"SJE.&ZVW,M+6:5YHK6@VQR7;FG5I?NS#4BXER:8#DTM[PL/N%
MM$RXP3=EUA+2D(3^;%10&)9'.IE4CAMBR);P>4'G.F^?8GN]$'*"3\%M-]"0
M0E9TR/5<QPX&HAQ<FS:C;DV\XVI=A3.A2AO27DA90X\V  Y5J]>6FI1=4%J%
MSG"Q&YBQI2;ET:1;+P<N-!IRZEEU=:J4I"3=<JN[0%=2E""NEZ.1LN+'Y(6I
M,DU<6N>F%J*B<4-!*4@E;AHW<"$T4:4VUBP'?"^4ZWDZ71^&W4-NH2C1@3"2
M*4)*R3>JI1)R-3F?I\H%79)&^8;'M/NBRL9]O=7^0_3>%6G!]A7L,3 NO$[#
M[##)JTUO;1_*/G^4J6?G>3:Y2705JF)AILA*@CFF\:E9Z(!I4BIIEC%CR2I.
M1EV7E(4\TRRRM2!=0 RW=2A  'BT8T)Q42I2L51*@%Y.Z&11IL#S$^ST0<KI
M*^F5G B]<7H'0,"4+/-QW&H&.O"AH1)RC<Q]<&RXTVYHYI2$NJEE'!Q*5D8:
M1M=QW1KN%!4@HI1:I]^964M+>0H,)":L)T;:RG$5%<0A)"$U%VMXA.,6HIV1
M^3,I <$U-6>TV-"WI'3,6@M.*452%**WJFJD[20(L$E?*!-]MQN9;F6Q.)=+
M96E]3@YBM" D* "2I/Y-14A%4C\!RF526E4^=-)[D*BQA6=_9)^FY]6OU%>P
MQ,IJ\1#'U#7ZM'\H^?E5_P"'H&U]/\IAR82R#>UU[:19SQ4J_MAGZEKU$^P>
MB"?EDS<H^PH7KZ#0'SD\Y/>(E'/!UJ:=N\TK*DK 2H@E( -VM$@*4Y>0E=RM
MWI)2($C)32T L*2"XBJFGO+*J7*$@J%<*W13R,,3\I4\FRN2]FLZ13%^9E4A
M:4+64)E6E3"E4;!4 A+-XG=0$*(,<FYMJ:Y4*>EVBTPZ)-PA5-)X0MT!]2@"
M0;ZTE5_"\+N>!_ <J5XV<C:\M?8FGOBPT_WE9^P?:/Z_3<^K7ZBO886*S"H9
M^J;]1/L'S\K%4DY=/G3'L28M$^,0FOE8CKJ/9%G8)' 0S]4WZB?8/1#RCES)
M6HX4<U#U'0*"A"C>6DG'FE8Q%",:W=O)>]-6S+(62O!"E)..(F6S5)Q-/&&M
M<E*-SF&B?ENG$2EF6'IT%4LJ;?#I""X+W@B_!T+0.DEQXH%#5)- 12L<FWE*
MY5WJ *4B23,)0D)::<2Y>N!( "2<U;3^ Y5N?WR10,TMK7VJ 'L,<GQ72*^P
MGO)^F]@TYZBO9&<PJ&?JF_43[!\_*Q?.D6MZU^Q/WQ:2?'M^LD>V+,3>+:?.
M4A/::0D42D;$@=WHAY7R>EDVYM(JJ771?ZMS[E4X5,<CKJ+=9)RN#_\ V)>D
M?+%+OS-C2?@MTS*'2Y+(70H6\TT7$MJ]<H":[XL":EINTK+FY<-I5.%"YUML
M@J9G&W;CLK, <Y#S"[PN*H2BA@?3Y2JOVPE'YMAL=I4K[NV+ 31EP[TCL']?
MIS!HP\?]-?L,-XS"X;P;;]1/L'S\IS?GVD^8TG^)1,6H*/-^NGWQ8B;S\LG_
M %4=R@3[/1%-L)FI9^75DZVI'61@>HQ9[[EEVLR%#GIF$,*W>/;K_+'RC.E=
MAR$TG)J:86H[G!<'>H1)V!*R'*+_ +0V<\IEN?=2NUK/K>:=F[R='.,BGBE4
MJ'0.E7.!D.'T[65I+=FOLJ0@;KJ$X18J:2I.U>'4D#Z<YA*O_JE>R)?_ !"O
M6]\(Z"/53[/GMQ5^U'?LW$=B8M0>/;'VO_5')U-Z<E?7)[$*]$?*^7,G:;<T
MV,'KCPV%;9%X=P[8ME)M7DD4UQ##3O#175^Z#)IEI=9O4-!0ZRNO- VXQ)NZ
M:4EG?SC+:NLI%>_Z;RM+:TVO;,.=RJ>Z+*%)-O>5'OI].T,)*9_5*B5']XXN
M)[U"$]%/JCV?/:"[]H3"MKR^XD>Z+1YTRGUOO_K')A'][:^RA2NZGO\ 1'RL
MDTOV>'[M52KB55UW%FZKLP5^S$G;SQLQ<J-%BRIJJB<KM*W,J]><3\Z[07:K
M7B-(N@2CU$#"]]HXQR2FO";':2354NM31VTZ:>Y7TE&B5'8">P1+F_-NJ\YU
M:NU9/OB0%)1CU >W'Z=I?X&9_5F),?W@?K4?S"!D.'S*-$D[ 3V"'5WIEQ6U
M:U=I,3?.FAO/O5\??')=']X)\UA7>4_=Z([08$Q)33'YQAQ(XE)H>V++0E87
M7-*CAQB>:%'!0T!.&61CD),4,U*D])*74C>DW3W*'9]*95<EWU>:TX?X3%GX
MND[XEA=EV1L;3[/IVG_@)G]68D_KVOUZ/YTP/FFUW):87YK2S_"8KXY4.U5/
M<#AW>\F.2Z>>^=C:!VE7W>B,XQ94G?M:U9/HJ2ZM2.!<53NI%LR:I6:>:7F0
M%8:PH??6.2CW@]K-"O-<46CP6D@8:L:?2M15RSIQ5:?W=SO21%F=.&L&T>HG
MV?3M3_ 3'J1*X/L_KV_YQ\]KKT=G3)^Q=_>('OA.*UG>81SYY6XQR83XN85O
M0GLJ??Z) KP/EDO4F:2GK*D)IWI5'+!@)F67J?6LD$[T'#N5$L[X):#3F5UU
M"AONJ!A"@M"5#)20H=8^C;9NV7.;V[O[Q ]\6>U12=](3T4^J/9].U/\#,>I
M$N/'L_KVOYQ ^;E"N[9RAY[B$]AO>Z$8!9XF)+G3#JOM1R:21*O*VO8=2$^_
MT2<IB9;E#9DT#2NA[G%(/<N.5\K?LJ4FADAQ..T.(IGQI%H"XM*\B% X9G:.
M%(L9_P (LN1=)J52[=[UDI />/HVZ:69,\$C^,1)#%KBGVP,AP'T[4_P,QZD
M,GQS/ZYL_P 8@9#YN5#E)9A&M3BE=B2/?#AN2[AUE)^*Q9P.)/E'^O=')\4L
M])\YQP]BJ>B3ETBAD7AFD.#L4@B'&_[6Y#AY "E^!)=&XLXG';S#%H)JBO'K
M,<CG"NPI>HI<6^GL=5]'E!_X5,_L?SIB0-0V?M(]L#(</IVG_@)G]63#?3;_
M %J/YA">B. ^;E6NKDNWL;6H_M*2!_+$Z;LL1M%/CC%GCFIWX]L6,BY9TN-J
M2K]XE7O]$G+A%9277YJUCM'](^31Y%H<E9B1556@4ZPJIKS%IP ZJQ:[)9=F
M9=0(T3SK12:^2LI'LCD0?^Y$CS9AY/?]'E!_X3-;@D_QB+-/BDG808&0X#Z=
MI?X":_4K/="3E4Y*![#".@CU4^SYN4AO3O!#;?95?^Z+2P;3Q'QV91(IH$C<
M(L]-R2E4[&4>ST2<L6M)9@/FNCOP]\?)/,Z&;G) JP?82ZA'VDFZH]0,<N9/
MP:W;2; P=<TZ?^JF\:==<\HY!K/]G331_)3:OXD)/T;<!-E3M/S1/[I!]T6;
M]1#9JA!VI3[/IS:;TJ^G:TOV0%8*B65?EV5;6T'N'S6TN_/N:^>>ZB?]L6AC
MAO33MB23B(:%UIM.Q"1W>B2WFM+9<R-@"OW36.14T9+E+9V5'RN757#!8P[P
M.V/E1E2BT969  $Q+E'[3:J_RK$<BDW6YX#6ZA7:FGN^C:PK9LZ/_P!.Y[(D
ML)<1+FK#)_TT^SZ:Q5"AM2H=T3(+;JT@Y*4GL-(LA>DLV45GXI*3Q3@8)H"=
M@)B;7I)MQ0\X]YK[XG%WG[NPC9\?!BRT7GV1M=;':L0,AZ)+33>D)L?Z*_9#
M#O@MH2,SBG0S;"R1L2XDGM%8^4QD/V19T\D5N.IYW^FZW3'K">N.1JJ/SJ/.
M;:5^Z5_^H?1M/_P^<_\ AW/9#'-ETTV1)&LI+':RC^4?@+5:T<Y,HV.J5^]S
M_P#=')IV_(%O6RZI/[W/]\3;FBEGU^:TL]T+54K5MJ>V.G,*.Q1^.R+";O3D
MN*5Y]?W03[O1*^F^RZGSFU#NB<24H61FDWA7:/\ B+4_[X^3]M\4*A(L3!XL
M75'^4B.3#NBM9"2?KFW&\\*X+'\A^C;!NV9.G_05WX0VKQ"1NB4%V5EQJ#2/
MY?P'*)F[-I<U.M@_M(P/M3')I=QYYDY.("DC>@X]M1'*!_12"D>4\I*!PZ2N
MX=\/JNMGA$NF\LJWF.3;59J_J0VH]9H![_1+NBTF;CLVV1T5N#J)JGNCD"XF
MTN1\Q9Z^<6#,RQ2<>:H$I[E]T,E4A::+W-5+3=U>X)<N+_AK -0",B >WZ'*
M)=RRIC[9;1^\L0W]6G@(:%UIM.Q"1W#\!;\OI99#H&+*\</)7S3WT/5%GG0S
M#+@U* / X'LK7JBWYT3$WHD*JW+INU!J"M5%+IJPYJ>(,3AYM-XB430#?')M
MFZRZ^?+4$#@C7VDCJ]$UN,79Y:@,'FDKW%0YI[@GMCY+)K13]K6:HGQJ4S"
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M ; %7DQ;T@JSK0G918(T+J[FPMGG-G+*[')R=\*L]*%&KDL="K>D8MJQQZ-
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MJ2LVTW DUK-.!/E$KK0=JL(:8=:NZ0+%:%*DU!0H_DR1KB05>DV2:U*<U8G
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M\G;LXQ<Z^%(*<(I&C4KG7B.\4V4,6?()F)Z7:UE:5&B<" :D81RU=I*2DDC
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MN&PPP^MQ(#J;CJ>D-1WI.M/>("]=(OZTX>R"NIRQ^,MD-NE!J,M8A+R%BBJ
MPI)IS%4V?T,*??;-%"HKW0I:5DU33A$NPEUUML&I<6D;Z$Q;S@E+#1*HS=#;
M &U(%5_PCM,335YL$9B$31+>@4DEQ NU\Y/DJQUIU[H79Q455KS\7'$]&NH-
M[SY4/<QPH*KU,*[-Q^^+$'A-GSL@LX)4'F:ZM)7$;KPB5=N#1.8$&E=XP/?
M0%#?F/\ F$X<8SIV$>^%HQX=_P!T4P^,]_Q6%:OCXZX%:]>J+,;O.E1\FZ!J
MK7.$8K:3Y[B$]J@,?0].V0AY1F)0IEYDDJ6D_P"'?)Q)4!]4Z3^52*$]-/E0
MAUQM9EIII33HS;<Z5/.;5DXDZE))!A3*%8CG)4*&N1W'[HM&P4(O.2P\4HU4
MUF6CNVH]D(E%2[M\"\%)4A:1@%HUI)VCR=8A;3TFJJ5+<8//0AVI-S8%9A:<
MB-=(2D+2EQ!YBTU!^.R$IV?=&CKJ,%!36M2 >D,Q U:]8,(<<1D;P'DG'"-*
MVXFCB2-NZ'$!)YB@4[\QNBP)?36BTHTHR"LTU'5WQRFF])-,RH/-8;OJV7G#
MA7> GOB9-$I%<R>P:H6YHW [AGSM?-.?"L6C:Z%M:"43=\DK.%!NW[X2T7%A
M"3BHXD]ZE$ZA%@25'IB9YQEDL)E6CD'W1SE*3M2#Y66J'1><?(I5+SF&OI1(
M3!/BUG@<\#"@#QA)J8*=><9UV>R",OBL)3S@!U#W4B08+24WNGTCUZNH1()T
MT^V!T6 75=A2@=9)/5N]#[\NS-(T;[8<2,4G):#M;6.<D\,#K!ARSYMBJI=7
MAC0S;-$S2!PZ+P'V>=]F ZE51T5X@H4+M*9@I.(AYIM;SB$8%*[X&Y0KA]\3
M4N1JJDZCEWQ(("[\N2 <7&=_G 0MA2#L.>Z HY'7! 4,0*Y5&%?6$+1<Q PV
M0%-TQ!'#'VQXNE;WW]D76U5H0>N.3;&B2\_E>-,<11,3KGA$Y,O$@A;ARV)Y
MJ>X5B9%Y*,J!1K7.D3"+J#PZS[(\'>FIA$O*MEY]U5UM WZSJ2E.M1R$(LBR
M[*HY:+XGIBM RT2& X,T!(YSZDG D\R&+4<F)JJ4):E)1A;BD)(!30<U%U/-
M2-V<)>TKCSZ<$NNK< V!6HPUS7ZC(]T U0.&?QMA"-?[T :C77U_UA39J8T6
MO?$I+U5?H"1T!37YW5#:=&V :J4<R=?]!%E2^B94\H<]\@_]-/0]YZ_1"\PQ
M,?7MA2OS@P<_>&?7COBU^3LY?$U9#Z7CY4L_S'D[FW,4.).M*J'9#UJ.R:]#
M:<L]+*&!#S:DI_8=I<(V8P)N67==86 M*@H4SKU9@C#?"SI #=&2:C(@D5A<
MN#4T(VT@M*0:IHL=_P#4"#C@4W?L_P!8+>X<#JQA2-92>J"V2>CLI3$]D _V
M?9"L*$,T!UWUB@ZZF,1U[8?',K@**K4ZML31&CO @I I]K'(4B0FO[/3.3]T
M%:6DLH1E>TIQ 5Y)IKBTPP\J6M%EQS1SJ5)<2>E+NM8$)V#;3.+*IX-:S#*P
MZZ[*^+"$F^JF= <28EC=;"5521S2"""",]6>XQ*-%Q]*C4(&"B1GN3M,"E*
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M#G\IA64*A<<A$W.2LTOSES1[$0LXN;UJ_F/WPB$UI"(L+_&*_4J'>GT9SO\
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M^C+E"N[))3^<=2.SG>Z#E\;8IEP@_?&WJ]D?)[:P<;?L:857 N,7M:5?6('
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MN]%4_.HD9=3JL5GFMH\Y9RZAF=T/NK><6XLWEJ)4H[_N&0&SY@G5"$4 I#N
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MC@1 5#:XLR>,JZ*GQ2Z!P;/M#>GO&$ A0"@:@BH.T'T,J4E"2I1"4I%22:
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M^=]I>T[LA!, $G;#3 2*G/?!$$T@F *PTU6)*04^:]%H=)6W<GXPA#:&TA"
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M((AP0XF)65\)F$I/U:><YP&0_:@"@H,A@/P"DWDD?0'X^]BK@((A**N)&_\
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MMJM5TQ(_S%O@'E /I[LBMRW/4.#@C6((SV:3U\&GRR-OBKK.ZZH@"JH"J!L
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MZDZN9=2KYV[[N/25,??J.H3SF-K>O#HW.#TC"\BR*XZ01B.0=_&C>D ]1VY
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M"1C1%>'X21:=::8[R\ "ACSR1Y)/G=71M"N0M%HU3:2V1S-,\F0W_48G#NI
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MN8[_ -GT?21]!;A)/YL::J/&DIHMGBJS[?G^WTE_@JC^&V)1RZL4B\E- /\
M27J!W'FQ!!NIZ"G%N3A&=\'R/NQH6#Q]*T?H$Z,?4,6Y-6#[6@DO8<.(ST3
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ML2R'8D;N?FJ3BMJMO#U<\W[69W_FPR\@QHR#;PVD*.*WZRHC7[\1IXJ(OT5
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M=.%BBJNM:L_\)66ADOR(Q/!R?-;S=0U&E:^FHX]W"R .W,D?;N?)4X>G]C%
M9GU@5]<I6._C14PX[?YC)T8ZXTSI"HJ==TB9LM/'^K@2T2VO:X7-RDXMCKG1
MFCV6B1'+5M7FIZ60!;Y(6*EIW8ZEX)&6^IF&'BD4K)#(T4JG<R,4=3T$8:D?
M^QUJEHN1<W;IS%&XR\QU=KBUR&0AE=;CD*.I]=[[<4U0[7K*4"DK1OX:( "3
MHE2SCGO[;;U4T5"]JK3,G!FQUBDCXTQZ'-D].%4;[8"#5Q=>,B#,78(BC:S,
M;*!?>Q(QHO1N4"?@145A  S550!)+>WBW"?-ZKQ2JKQR*4=&%U96%F4@[01J
MQ^%-&(QT'62ZE%SUA.VO@&Y(F]X)U>]^*,4NF=&OP=72D-\F1._AD'?1R+Q6
M!Z=H&!IR6L@HXHT_'8YI%5J6=1V2(KVS:_<\H/"*05OB31WL41Z6 W1M*2+^
M,R;CUM$01 O)(]Y#KLJ[<-5Z0F>621L\CS.TDLC;R[N2S'G.,D*C5R8)9_-R
M8_W_ %P/P5HZ9J<FQK9KP4B\_#OJ>V\1"0CDPDWLBTC)62:B:2BO#3CY+S'L
MLFO>HBO@1Z+T724EN_2)3*>=I6O(3R\;\J1I#1T#N??XUX&H7G$L>5O3?#S^
MQ^L%0FWK.L(CEMR1S@9'Y '5.=\&FTC23T<RGM9D*WMO1NTD7Y4;,O/U5>-V
M1U(964E64C80PL01RC"4NG U53ZE6L0?C,0_.C9,HY1:3R\)54-1'4P2=J\;
M7\S#:K#>K $> 5I-(LTM+VJ3ZVEI^9M\D0\[H.US"RA9(V5T<!D=3=64[""-
M1!\.%F(51K+,; #G)U##) 36S#=$;0@_*F.K]F'P5:;@(3[Q3W1;?*;MW^<U
MN;N@K%^,2CQ3V-?*??T+@\+/9-T2<5/0.V\]\9(PUSL"@EO0-F"U9.L9^"!$
MM1] '*GSCTX[%"&ML>H>]^?@UR@>DX($RQCQ845?7;-Z\=O*WE.?ZXV#&O+@
M8UXNNH[01CK.FTS5+ !90Y$KQCY$D@9U^EJW8-17U,]5,VV2>1I&]+$V',+#
M%[ MA3HZA:EH&(S:0K T%-E-N-'<<)/J-QP2LIV%QB.KTL/P]I%;->I6U%$^
MH]CI-:O8ZPTYD(VBV%CC18T465$ 55'( -0&/PI3QY:/3(,QL+*E8ONZ_/U2
M 6\;'!@VFA/"T[\CC=T'M6YCB^RKI05=.^*KVZ]*'6.4;-N$I9WRT&ELM-+<
M\6.>_P"+S?2XC'D;VNW'GZM:4?-2Z./6%-;M>PDB5AY<N;U8S'8FO&3DQ1<*
MF>DT9_XC4W%U/ GL$9\N6S#R/:U&CZZ)9J6JC:.6-N0C:.1E.M3M!QI70_"<
M)%1U4D,;':4[9,WR@C -SWU#!"W$3&Y'>]-MAQN:3UX.L@=.";G7@?@ND9*/
M-:32-1>&D3QK/[\P\2(-R-EQ'4Z5_P#'-(+8WJ5M11M^;I+D/8ZP9S(>2V!'
M$B1HHLJ(H55 W!5L!W":;25'!5PMWLR!K<ZMVRL-S*01B2J]C-1F&MOP;5MK
MZ*>IW\RS;3[Z,/2U]--25$>IHID*MTC<RG<ZDJ=QZHJ-'SE02.%@;C03#DDC
MV?.%F'+A86(H])6XU)(VJ2VUJ=S;A!\GMQR;_ (@J"TE [<9=K4Y/OD7R=\D
M>_MEXW;)+&RO&ZAD=3=64ZP0?#)ZYJHU8>]*<\O[-+MZ0!@KH^E_SJG[1$A_
M>?I7'XW4R.OP8.2(=$:V7SD7Y_:Z\;.XLTS\;O8UUNWFY.<X89^"A^#0[?+;
M?T;,98MAW_[VX+U,QU=XAO*WG[5!];#14^6!#\'[JUO'F[8\^L#=LQECS,[&
MP NSL>0#62<!H='3QQ-[]5_BT?HD[)T6CMA6K=*4E,>^2*.2H/F<F(>?+CLF
MF*HGY$40'U@<'K;34RMNX>!'7SY,A]>&>D--I) -D3\%,>98I.+_ *F#!7TM
M122C5EGC9+V\4GBN.="1C;BQQNZA;V4Z+%6LCQ=:USCAHJ!QWTE*;JPO8\(
M63DMB"IT=+!/1RH&@DIBK0LF[)DU>;5;JUE(%'7<"FKHF.Z>($Y>B5;H?-C*
MW%9&*LIO<%=3 CE&OSXCKH]4,Y5:@;@^Q9/G=HWS>3"5$&J.7LL1'>.-97FR
MMK'-BFFD:];1VHZT;^$C499/\U+-TW]OI72=\LL=,T5-SU,_8H0.ACF\V&=S
M=W8NQ.]F-R3TG#R<HVX<\^*C34J6GTS/V,D<;K.GXL?S9'S2#I]I<Z@-9)V
M;R3B;0OL6=9JP$Q5.E19H:8['2EW2S#9PGN<9V9F%L/4U4C2-(YEEED8L\CL
M;LS,=9)._!B@V["<$LQ)Z<1T.C*6>MJI3Q8HEN?*8]JB#>[E4&\[,1U_LJ=*
M^IU.NC(_['$;;*AMM2PWKQ8MV5K7PD%/%'!#&,J11*$1%&P*JV '<II]*4<<
M_P ',!EJ(6\:*8<=3Y['>,25FB\^E=&+=CD7\<IUUGLL2^ZJ/A(A?EC&LXUW
MU=17C=D=3F5D)5E;<58:P>0C$6C]/M?8D6DO4!5 ?Q1\X;\*\;!T<!E=2"K
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M5YMN(Y8SF25%D1AO5QF4^<'P<NCXF[-5B\UMJ4P.S_.89?(5P=O4U]T%F-E
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MLIBE4^,N\<J,+,C;U(.+$[L%#LEC7[64^HC$R>+(Z^AB,?@RJDMHW2[K$<Q
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M 64W<;&:61U:1UE"QQIP;H;EM;,W"31J8H<T1@ZYAFXJQC).LFC-,(DV32=
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MC$.C=%0Z!I*:(:]53++*_?22R9%+NQVD^;$6E#-HG1^D*;W:HHX)@:J(_#W
M#-&=:OVPUB^O$,$=;H^;@KR(TN;MK:URGM@?%QI*(RQI)"HK#:-C'(Z, 1?O
M2+\7';CS#';88?)/V8'S>KI"F)_M-().EH9/Z.?#!ZAZNCY.2IC4]$AX,^IO
M!-#%XD#O^TDM_P OPU[$-&?^6&D]-2?)X&#K6._E&I-O/A$\9[GTX7S8 YL/
MS-BUKDG_ +8BRN)"8SF8 @@^+8\G+@>?[>H,#VD=2_"R5M0'.7O8U1^)D7G
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MG(^]6.H]!Q[I&"/&.&%R+MQK.2K=2#15*QC@7--5SCO(83V23T]CB'?2'FQ
MD4(AI:=+4L'C6[::4[V<\9V.LDX6G0=<Z2FXZQ>]TT7PL_BKXB;6Q45%4]Y
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M!N"+C"TE>RI[(-%Q1QUJ7_MD/:Q5\6^TMK2K[W*&%R+,>[1W>H^$IYU]0?\
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M'S8)4F,[T.\_TP =1!W^KS8M>_/B3/JSP*!?<[=KFZ<29% E32-,"-FH[?\
MMBCD!!5Z*F5HB=3Q\$NH8#1F7*X]S*;#R9N3$,:*O":/?KP#>J/:)AZ!FQ3U
M$7&>BDFT=6KWR3TSE1F'YV++(AWXHM/PIP551S1TE94*,IFH93>EDEY7I)^*
M'.L*UL:*T@MC+4TK1U)W&6$Y3\X[1TX-]MKB^+\NW_?-C[+8\K[>H<!O]^?
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MY5_,NO[;8 \153^OK.,N+XMO.K&BJ.UG%*DLO+PL_97OS@M;S>"1A3\G!Z?
M-90D]LJU$>O>O$DMTAD^CW324P]]G:0]$2V^V3U=R-):PJH8IAT@<&WK3PSI
M#2$ALE'23U!-[>YQLPU\YL,559+?A*NHFJ'N;G--(TAU[[9K>TS;HP!_,?NQ
M?EUXMU-%4-KK)5QM)O'!Q'A7OS95MY\ #4 + <P\$C#KS:O 5',393+P4GD3
M=C-^C-F\W=,,(/N%,M^9I&9_W<G<E%5@>Y2/ YYG&=-?S6]/AFNA4]DTI+#0
M <L;MFF_TU]JTMM<A_>/_3@]'5K=),O%HJ;@HS;WVH.NW.(U]?@H8?I&&YF[
MM/M+[P;XI:CX6"-CY67C_6OW1727N.':-?)B[&/W>Y*V("[+'PZ>5"<Y]*W'
MAG06A4((@BFKYA?6LDIX*+5SIG-_:6&UK*.EC;$2\U_N&+<N#U!4L+2:1J9)
MSSQIV.+U ^"Y%^2#ACR@'NT^U,)VTL[I\R3LB^MG]'<]34'WF"63Z"$CUX+'
M:22>D]R6.L'41R@ZCBJIC[U,ZCG6_%/G6Q\,::D#%HZ22.@B\BF2VKY[/[2!
M.<N?-J'K;U8Z %]'_>^"/$'42--;.RHHY68V4>DXT=1*+=;4<$=OE!!F^L3X
M+3D;B^G"R?-;JCN^IICLGASCRX6_Z7;T=SSKOJ'B@'G;.WU$/<U/6@:JF/@W
M/YV'5ZT*^CPO65CD!:6EGG).SL4;/]V*NM?MJNJGJ#?EFE:3U9K>T>3=& OT
M1G/[P]&+\U\.WC-]G4T33D!DZZ6:0'9P<'9#ZU'@Q>8@XORV/JZH[OH9-W#K
M&WDS7B/HSW[GH:7]9.P]$:?S]S5"@7DI_P 9CY>Q]N//&6\+Z:=6RR5424,?
M+>J<(;<^7-[7A-\S?OG-ZEP>C _WMZE;7%=5)29%;=GJ&L1TA5\&VY$!P1W:
M?: C45-P><'$$PV2Q1R#YZ!OO[FF6_%ITC@'F7._UW/H]J.X;$74BQ'*#J(Q
M54NZ.4Y.>-N,A^B1X6T+HL'75ULE2X_-T\=EO\]]7M#;:UD'2YR_?B"/D7.?
MW5^_ '+U:BL*V:MJVL>5(!D%N:]_!J\ZVP1SX'@&DOMC#PG_ "W8+]3+W*2=
M@%SYL5-1\-/+)]-R1ZCW/2UZCW1>MY?+3C(3TK<?-\+)0(Q,>B:*. B_%$\_
M9I;<X!C!Z+<OM*:/Y><_-&KUMAODA8Q\T:_K7Q;JZ)@(LW6J2OY<O'/V^#!C
MHP? 53#?7'.'Z%E0#[8V[EKIKV(IY%4_+D'!I]9AW16 [8E6H7F,;:_2MQX5
MK=+5KA(*.!Y3?:[ <2->5Y'LBC>3BNTI4F\U=4RU+[[<(UPO0BV4<P'M"YV1
M(HO]=ONQF/?$MZ3?#'GMU*6F N9ZB**Q^7(H^_$40L!'&D8 V<10OW>#2,7\
M!5$6Z2'-YXW'W.>Y5B&VHJ8T/DH&E/UE3NBO7EHY_4A/A4>QO1LN;1VC9;UL
MB-Q*JO75DU:FCI=F^\U_$]K43?"%@/G-D'U1CH3%^GJ4.876G$M2;BX/!K8?
M6<'S>#1U+\W5'=\'R\\9^<AMZ[=RT%,#VD<LS#]8RHA_TW[HK!RTE3_";PHV
M@M$S#\-UT5I9$-SHZE?49#R5$HN(1WNN0[ #O9B;L3S[23C+OMKZKMR*?]^G
M%)%X[B_0B_U.#Z.K5G>*(V\\@OX.'4MX!@?Q9HS]87]7<M0-T"Q0+YD#M]>1
M^Z*@<M/./3&WA.R%)]-5:,*"DO?+NZYG'>PQG]HUE&)ZRKE>IJZN5IIYGUEG
M<ZSS =JJC4J@*+ 8S,-?VG!8[S?JQIX\J#I .9O4,4\?P<(/G<W_ *85>7JQ
M1L;+60RP=+]NG[I\'+CS8/3@> 8W\9%;T@'N2KGO?A:F9QY+2,5^K;N@\ZO^
MX<'I/V^$27*U.EJA&ZPT>&XS-\-/\'3H=;,=;=J@+$#%1I+2$KU-54OFDD:^
M1%[V*)=B11C4B#8-9NQ).9K7MK./D#8/:4Z6V!G\]PH]1.)V\7B#YO%^[ '(
M.K!51&TE/*DJ=*-?T'8>;%+70FZSQ*Q^2_?H>0JUQ;P:,>;!Z<#P#!S+E^B2
MOW=QUD^^*FF<>4$.7ZUNZ?3]AQ(.1V_>\(2Z.T-P>EM.:T*QMFI*%MF:IE74
MTB[13H<U[<(4!OB;2>F*B2IJJA\\DDAOT(HV)&O>(ME4;,95RW')MQK-EY/:
MRR;HE4=&52Y^T8D<]\U_3KPWM/P/5O:DK'_%V8ZH:D[K[EFV>7;E\&C%L7Z@
M\ %?%D8>FQ^_N.H&^9X81YY Y^JA[I'3BI')/*/KGP:S5NDZ&F"[>&JH4/T2
MV;U884U3-I><7RQ4$9X,GGJ),D8'.,W1AZ:F;\!Z+>X,%&YZZF3DFJ^*^O>L
M(C&XYAC/*1?:;ZV)Y<9*<6'+B[&Y]M7S[,W"@'GOP0^S%^G#'G/5Y\"VHC8=
MX.$T5I"0+I*!,L,CFW7L2C5_GH.V7OQQAO\ !ML9AR8M@8'=\J^2?M'<=#3^
M/-)+^S0(/XOM1W(.G%8O)42_O7\#:R!TG'&F3TW^S&V1_)3^ML=BHI)/+D"#
MU!L'K:CI(N0OPDI_>48.32 IQKU4\$2>LJS>O#"ITOI&4&]P:J4+Z%8#S8N[
M,Y.]V)/I.,S\8_9C+$@7GVG%W8GVY/-?%_AGC].N0X^;[9)8G:.6-@Z.A*LK
M+K!5AL(.(]'Z<=8*P62.L:RPU.X<*=D4QY>T<\AU8N-8.L$;_!8P1S8(Y\#P
M 1XR'U$?]^XX(?@:8>9I78GZH3NJLYY;^E0? FW';'T]4X.#JP?;I!!%)--*
MP2.*)#))(QV!44%F)Y ,?A7V7TZN7C_%M#L<P3./=:PKJX0=Y"I*J>,Q8V"Z
M7T=!?@:/2%3!%?:(UD.0'ERK8<]NK(?D'[,4<?C.6^BH7^; ',![77BXZB0E
M^O:(?\/4$DH/S,O;)Y.M>;"J)NM*AO\ AZFR&_(DG:/YB.CP7;&;E\ ITV].
MKN.N:]PL@B'^4BQGZRMW5-\I(F_TU\$G!P=6-F#C9U!'&K.[&RH@+,QY%47)
M/1B.:KB_!%"UB9JM3P[KJ]RIM37(WR9+<AP&HJ835N6TFD*D"2I;ER&UH4.W
M)&%&">3&G*G9PNE:XCH%0ZCU =6WC/&OI=<4,?)&6^FP_P"G"+T=70\+HDB-
M4\=)!F0JL3MK!V[/3A](:%A6"M09I:6.RQ50&W(O:I-R6L'V'78X:.5&CD0E
M71QE96&T,#K!ZNKJ!(J@RPCWBHO(GS;\9?,<!:Z%Z63>Z=DB_P"I1T@XS4U1
M%,/D,"?1M]7@F_)U!W>#R$=Q$\@OB>;X::67Z;EOO[J5O'@C/HS+]W@HV4GH
M&.)33-T1.?NQV+1=4U]G$M^\1C50I%?X:=%MZ,V/QJNH*1?D\)4'T+D^W ;2
M6D*NMV7CBRTT?TA>3UXOHW15+#)\.R"6<_YDF9O1;JU$GB0RO]%"<54_PU3/
M+^TD9OOZM.OC3IZKG[L4Z^+!$/WC]^%')U=%?):9CT<"X^_J-,H%)I&W%JD7
M5);8M0FK./E=N.7'!UM.0E^QU"7:"0;LL@V>2UFONZNS&S&S&:-FC;QD)4^H
MX ,W#H-TPS&WE:C]N )X&0\J',/0;''%D'0W%/K\#$<HP1SX&!W>O0.X:V7>
ME+,1Y60A?7;NN!^6(K]%O^_@7;C:<:P?3CW,'IOCW&/Z(QJC0?,7^GY'21Y*
M&J/^@^#T]6D'YPMZ%/\ 7#?)$8_TEQT=6AYHZC^'U6AGB2:)Q9DD4,I\QPTN
MC).M)-O /=H">13VT?U@,?C-,P4>^IQXC\]?OM^0U$CSXVW\"].O"G [OZ.X
M:@7L97AB],@9A]%3W73GDX0?8?">F)C[WHVM;_0?VE*/+/K48J3R.1]'B_=A
M^GJT?ZJH/U/:V(N#N.L8+<#P+GOX.)]7M?5@FEF64>+)Q'].M3ZL=FIY%^5E
MNOTA<=4>"(W\QP.; [O/<-'#X\[2>:.,K_S>Z#U#B/FD/K'A/V2/XNAZ\_Z#
M^TAYH_M?_MBJ;\[)^\<'IZL'-251]2?U_(:\7>G2_C(,C>E;8[%(R\S<8?<<
M=ZW0?ZXUJ? [<W&]'4MX0I8?@J<N?\US]T8[G/M#S.#X3]E'_HM?_ ;VB\T2
M_O-BH;E=_6Q]I?Q='U7[T/A,\XMAEQ;PA5<D?!Q#YB+?ZY;NHXD\Q]?A/V4?
M^BUW\%O:-S1Q_P ^)#RD_;[23_T^?]^+PI?EPIPI\'U,WPE1*_F9R1ZNZW'R
M3X3]E'_HU=_!;VDW,J_N'!Z?O]I)_P"GS_OQ>%.*";:S87L!OZ,#FQ;P=5S?
M!T\K#IR&WK[J/4/G\)^RC_T:N_@M[2IYE_Y6//[23_T^?]^/PI5LPNBTIB/^
M<P_E1L3TLG;0R,G2 >*WG%B.G%O!U1RR&.,?.D6_U0>[2DBLCC:K"S#I!\)>
MRC_T:N_@M[2LYD_Y7M9/\!/^_'X4JI]\LX2_-$@/VR'$%:O:U"\%)^MC[4GR
MDU?Y>%/+@'F\&TT/PDQ?S1I;[7[LC9A>"DM42\A*GL2?.?7SJK8K^=XS]*&,
M_?X2]E'_ *-7?P6]I6_J_P#E>UD_]/G_ 'HO"E+RR9Y3\^1BOU<N)H1[H!PD
M/ZV/C+]+6G0QQSKX.@C^#AOYW8_<H]J.YXRXM/56GFY1F'8T^8FT;F9L2GQX
M:=_J9/Y/"7LH_P#1J[^"WM*W]7_RL#VC_P" G_>B\*4L/P5/$GT4 ZDR;(IS
MP\?1+VP\TF<#FMBVX^#:AMRMP8_RQE^V_=<$9%X8CP\_)DC((4^6^5.@GDZD
M1\:CC/HEF'A+V4_^B5_\!O:5?D?\KV@P_P#@)_WH_"=)#MX2IA0]#2*#ZNJM
M4@[+2'-TPGW0?-U/S -RXC;HP#S>"W<]XC-]$7PS':Q+'I)OW7URXM-6D2<X
M@75$/G:Y/G#DZE$W+3,/HRG_ *O"7LG'+H2O_@/[2H'R1_#P>J,=-!4_O1>$
MZ3D0R2'YD;D?6R]4JPNK @@[P=1&)J4[$:\9/?1G6A]&WGOC*?!<@WR6C])U
M^H'NNFI!>TL@SD;HEXTA^@#;GMA4465 %4#< + >CJ:.;Y%0/0T1^_PE[(4\
M;1%</]!_:3#E2,^E&P>GJC$//2U(_</A.63='2OZ7DC ]6;VD-8HXT9X.3R#
MK4GR6U?/PIY<7\%11=+G[!]_==3I%Q_=H?4\K#ZB_2'5T:?\2/X'A+32>-HR
MM'_X=_:'Y4$1_?&&Z3]OM*3GAJ/W/">D).:GC_BL?N]H\3;'4KZ=_2#K&&B;
MMD8J>D:L6\%.>3BCYNKNH*HN2; ;R3J \^*:EWQQCA"-\K<:0_3)\W5T>?SD
MX^K'_3PEI0?_ &^L_@/U!BW1B/GIT_>;$HY)'_>/M*+R)_X?A.K?EJ@OT(D/
M\_M5J%V/97\H;#YQ]G/@>"6;FU=.[NN"XO'37J7Y.QVX,?M2GF!]I0G^\2#T
MQ_\ ;PEI(<M#5?P'QY\+TC!Q3\\ ]4G_ 'Q4#\])^\?::/\ E<,O^DW]/"9/
MCU4S>@(O\OM60[&'_P 'S8*G:IMX)"^<]U7Q/6$<:IDX-/U4-QZY&<'R![2D
M/)5_;%)_3PE6+XU+./3$V'0[5=E/F-L+TX?H&* \L;K]9#BI_6M]OM-#G^\D
M>F*0>$Z8^,]0?]>0?=[8.-^H]/\ O[/!)/=5N75;IQ2TH]YA16YWM=SYW+'V
MD'-6I_"F\)2#EC<>E3C2"#8E=5*/FSN,)TX;HQHUOUH_=.)N<J?2BGVFB/\
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M-"Z,4\:&*:KE%]AD(2.Z\I&;6=W5/FZDM.WOB\4^(XUHPYU:QP]#4:IX7,;
M[I$^YQ9EYB.IT]2.:)RDL3K)&XVJRFX.(JI;"8=CJ8QWDRCC?-;MEYCX,KX_
M&AA?Z#L/Y_BC7GEB"?3=5^_PG4Z0K95AIJ6)I978VU*-@Y6;8HWDXKM+2C*L
M\F6",^]4T?%ACZ<O&;;QF.NW5]>!SX&(=*PZDD*0U=N]8>XS?\MSSJ2=6$E7
M>.-S-_WVXY^JK2,>LJFT54NY1?BS#GC)U\J$\V%="&5@&5AL(.L$=/@N1/A*
M20?1DB;[ ?BC*/A)H%^OG_E\)23SR)%#"C22RR$*B(HNS,3L &#H[1[-'H2E
MDXNXUTJ'542?FQ[RA\L\:UL7ZHQ;HQ)!*,T<J%&',<2Z,JFUQD ,>_C/N,PZ
M1J;Y0/4N.K^!*M^S0+>B=C[I -L/.T7>\J<N4^"Z/Y?#1_2A?[[?%&EC^$J[
M^9(W^]AX2D]CFB)O_#:63+75$;:JZH3;$"-M/"VWX20>*NO ]J.HE?3"]31W
M;*-LT!]UCZ1;.GRASX1PUV51\Y=Q\V_%L$=2&JIW,<\$BR1N-S*?L.PC>I(Q
M%61V$H['51;XIP.,/);MD.]3X*H).2K@OT,X4^H_%'1\/-/(?]-1]_A%O8YH
MJ;_Q2MC_ !R:-N-0TC]Z"-:U$XU+L*)=MI7JD\GY!7C_ +%6.6C\6*8ZY8.A
M]<D?SQXHPLB&Z.+C[QYL7&WJI*Q)H:@B*LC^1?5,!X\6WG6XY,1S1.)(I45X
MW4W#*PN"#T>"58;58,.D&^(Y!L=%<=# '[_BA%'\%2)Z7>0_9;PA+7/EDK9K
MP:.IKZYJD@V9OS47;RGD%A<D#%17ULK3U=7*T\TKFY9W.OH V(NQ5 4:AU;\
MOMAKP-8P]-*=3CB,-L<@UI(O.K:\2:-K#::)LO(">]D7Y$HU\VL;1C*<7'5'
ML?KY-1N=&R-N.UJ4GUQ>=>3P5H][W/6T:$\\8X,^M?BA5_F^"C^C$I^TGP?/
M5U,BQ4]/$\TTCFRI'&,S,3T8FKV++0P9H-&4YOV*F![=E^%G/9)=5^U37DOU
M0,:M@P?:[<#7@"_KPE=3?VJF'&4;9X-K)SNO;1\_%V-A)%-W51FY2O+YM^,I
MP>HLL;%)(V5T=39E93=6!W$' X9@-(T=HZM/'\2H4>+)WW(]QX)5/@*B:/Z1
M$W_-^*%?)RU<WH5RH]0\'K[$='2ZSEFTP\;:P-30T9MXWNLRW[7(I!5_:$\@
MP<'!]OMP)X_[)4/QUW13/M_RY?4_E826,\1]G,=ZXOOQ?J0:0IB>(;317XL\
M)]TB;I':GO6 .*?2%&^>"H0.O*I[Z-QN=&NK#E'@BO@\62&7Z:LA_ACXGD\@
M)]&)'\>1V^DQ/@ZMTM-8O%'DI8M\U5)Q88QTMK8[ H).K%175;F6IJYI)YG.
MLEY&+-:][*.U5>]4!1J ]I;SXVX.O!P)Z6'K#1=]>DZU66%O\-'J>I^;E3Y>
MJV$;2DE;IBH!S,9)>MZ>]M:B&&V9+ZQG).&C_ $29A;/'+*DB\ZL&N#SXDF]
MC.E)J68"Z4>D.ST[$#M1.+3(6/?-G"^+A]&Z9HY*2I2^7-KCF2]N%@E'%EC.
MYE^< =74&#%)QD86(/)_O^N&T=5/=2+PR'OE[U_*7M7]/?8R/_\ (.PCI]I^
M#:V3_P -KW #,>+2U1U))S1R=I)R'*VXGP140[I:4M\Z*1+>IV^)]9)XE+.W
MHC;P>N@Z9[T.AK\+E/%EKW'9#R$0(>#!!VM("+CJ\W4.#@X/LATY!GT+229*
M6F?M=(U2]MG&^E@/;#WR3BGBJ;I##&D44:A8XXU"(BC8JJM@!T>T?1^EJ=6-
MB::K4 5-'+ND@DVCY2=HXN&&O$FC:]<\37>BK%!$-93WU.AW2+J$L>U&^25)
MZ@L<DT9S1/R,/Y6V-S8X-N+5P:LIVFVU.?QD._SXRMT6]H-":0DO74B?BLCM
MQJJF7O;G698-AWLEFVAO ]'R2&2)OGQ/;ZV7XGZ0;E@R?M&5/YO!T]7<&NJ
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M*V;YE_!%;091UW$AJM'R6UI50J2H&^THO&P%K@X>*12DD;M'(AVJZ'*RGG#
M@]0,GNL)$L1^4NU?GBZGIQ!5+VZJ(Y>7Y)/0>*>I$DC7J:"U+-RE5'87^='8
M$^,I[M##45((/.-8Q2U0]^A1FYGM:0>9PP^)>D#_ '.?UQL.[]$:-!U4E&]0
MX^54R66XY<L7KZAZ/:5FEW6TNE:PHA.WK>DXBVYFD+GG\$Z0X)<M/I$)I&'8
M%!G]V1>B0$GRNJ]*_P#9ZP%TY Q]T Z&(<=/-AD.U3;_ +_?B**1LM+I"U++
M?8)">P/]/B?/[NFI2>-2S<7]7-QA]<2?$O2!Y8@GTW1?O[OTN;@K3-#1I;DA
MA6_UV;J'JA1M9@HZ2;#&A=& 6-+H^G63?V9D$DQ\\C-X)T!6#WREJ8&^9(C+
M]IZO"1^[4QX>.VTY>W3YR7'3;$%4NLE0DGHXI]'V85E.5E(((U$$:P1SC%'6
M7'#<'P-2.2>+B/Z;9AR@W[MX$]K5PO'\].R)^ZP\_P 2YQ\)+!'_ *@?[$[N
M9SWJEO0+XTI67S=<Z1JY@;WXKSN5^K:W-@8&#U- T17,CZ0ADE%K]C@/#/<<
MED\%>QUM_"U8^JO5'KQ4Z-8]BF'"T_DR791_EO=>BV"#M!Q4:(E;L=<O"P7V
M=<Q#C <\D?[G=M-4CWB>.3S*PS#SK<8##6" 0>8[/B53Q_"5:GZ$<G]1W=I>
MKOEZWT=5RW\F%\>? P!U>N2-5!H^IF',\F6%?4[6\%>QR"_&RU<MN:Z+U1BG
MKT[>DD ?G@D(#?0;*WF.(YU[69 WSN^_KBEK83:2FF29;?(-ROSENIYCBFK8
M3>.IA253Y:W]1U=VT4A[98^!?RH"8M?2%#>?XE:.CYZA_P"&/Z]W:=8FW"TP
MIATU,B1 ?6ZB]0]3V0Z0*[J6D5N?CRL/W?!5'2 W-!HU,PW!JES)Z;*+^;VC
MPOK25"C#F86Q+1OKFHI&7G(7?\Z.S=2?14C=DH7X2&^TT\QO]1[CF%N[:VE/
MO4R3KT3+D/H,7UOB52IXE)?Z<K_]([N6#?6Z2I8A_EYZ@_PNJ>K)5%;&OTC/
M)TI"%B4]&H^"M/58;-&*YZ>+FCINPY?,RM[08IJH>Y5J\'+R<+'R\[1_NXU=
MHW&3H.O%'.QM#,_6L_)P<Q"W^:V4]VK&=E5#+#S9E[,I_P!-E'E?$J5?@H8$
M'T,_VOW=H"COV]34U)'ZN(1C^*>H3S8.#U-!T97*XH8I91^<G[,Q^OX)TMI*
M0A5HZ"IFN=0NL9R_6MB29^WED>1S\J1BS>LXS8/5?+[K3E:B+RH]9 \I;KY\
M03#MD4 ]&T8OLMBAJ";RQQ];S_K8>(?2+'S]V4M1LX&HBD/DJX+#SK<8O\2=
M('DGX/\ 9J$_E[NT52@_V;1S.PYZB;^D74)P>IHG1RB_7-="KBU^QJV>2_-P
M:MA(T%DC544<BJ+ >@>"9*16RRZ7JX:0:]L2]FG%M]T7 &/-;J2U4=//)30%
M1-.D3M#"6[422 9$+;@Q%^I8[#J/GQ6:.8ZE9C%Y#<=/4<OFP1BLT2[<6I3K
MF$?G8M3CSI;SCNVAFO=C3HKGY<8X-_K*?B372>-5SG_5;N[2 W4L-+2CYL7"
M'URG P.J)W%Q14-3,O-(V6-#YKGP5HK0J-Q='T9J9E_/5;<0](B7UXO@+A54
M7+$ #E)U 8IM$S4\<G75-PFD5=0PGFJ$O('U:PH.1?%"ZL34B9C13_C- [;X
M&/N9.]H6[&3O&4G6>I158V2C@9.E>,GJS# D'3YCBAKU/]GG1GYX[Y9!] G$
M<J&Z2HLB'E5P"/4>[)(3MIZEP/(E D'UL_Q(8\BD^@8=O&=CZ3W;?&G:J]Q)
MI.J"^3%(8E]"H+8484<V".I41';-HR>W^6Z,?!)8Z@H))Y -9QIS2.;,DM=+
M%!S00'@8[<UDOY\#F&+XT;3%<T$$@K*G5<<%3V>Q\M\JCJ#2,27J-$2<,2!K
M-++9)ARV7BOYCU&MVT3+*O2AOZQ?$3?(MZM6"O(<4ZLUYJ FCDY<J:XF\Z'U
M=V5E-\+ LHZ87R_9+ZOB16/XE+.WHB;NZOJV.44])42W.[)$QQ)*VMY'>1O*
M<ECZSB_)U3C1)O85!FI3_G1G5Z5'@G3FD<UI5HW@I^>>I[!';SO?S8N=9O<G
ME)QT]2LTY*O9*^3K>G)&L4\!XQ'ERWZ0.I44<ZAH:F&2"13O612I^W%?HR8'
M/1U,D6OOD![&_0R%6\^ &UKR'[\21@"ZI=+?)V>K%QL.*C1KM:/2$%T'Y^#C
M"W.4+^CNRC.Z1G@/^:C*OU\OQ(TBW]V=?I\3^;N[2QO9JM$HDY;U+A&^I<]3
M/Z_::-K ;=;5M-(3\D2KF^K?"2+VKJKKT,+CU'P1H;0$;<:KJ'KZA;^]4PX.
M*XYY7)Y.)B_+@#%)10"\U5/% @V\:1@M^@7N>88H=&PBT='31PCG*KQCYVN>
MK1:>A3B5J=:U) U=<0B\;'RXM7S,# '*+8D7Q'-O)VKZL4-<AL:6IBE.O:H8
M9UZ&6XQ%-&;I-&DB'E5U# ^@]UP3_ S12_0<-]V >47]/Q'K/E\"GIF3N[0V
MB%)O/-+6R@;"D"\&H;Y\N8>3@#"KR"_4U]70U7>[-11))S20C@F'U/!&E"C9
MJ?1Q31=/;6+4WNI'3.TF.@8OB32TJ7I]$17CN-1JYP52QY8TS-L[X>TTC0V'
M#+$:FE/)40#.GTK%?/@AA9E8@@[00=8PHOB*<;)$R-Y2[/5]F".?%&&-YJ$M
M12Z]?8M<1\\;+;H[LH)M[TL.;R@@5OK _$>WCU4(] =OY>[JM%),6CHXJ%?%
MS*O"2,MN5I,IV:TPN+<O4.//U*BA8\;1]8UAOX*H'"#S9LP\#Z7TO(;"AH9Y
MEYY,A$0^=(5&):F4YI)I9)I&.]Y&+L?.Q/5HED3+5Z0'7]5JXV:8#@T;]7%E
M7VND(57+3U3]?4VK5DJ+LPY.+)GOR:L+KPZC6R 2+\W^HQ?EQ7Z*=N+5P"HB
M'YVGU-YS&_U>[(5O<PR3Q']H7 ^BX^(](GC5=_HQ2?\ 5U!W77:1F.6.CII9
MS\Q"0.DFV)ZR7W2JGEJ)/+FD,C>:YP#BW)@^TGT>QLFDJ5@H_/4_9%]*9_ ]
M!H.)[2Z6JN%F4'C=:4?&]#3F,:]H!Z@&-&T%KP+**JKYJ:F(=[ZCJ=LL9YGP
MJ*+*H"J!N %@/,/:T6F8U[)03<!,PV\!4=KZ)0.@'"GGP 3M&)4W!KKY#:Q_
M3&C*V]DBJHUEUV[#*>#EOS!&)\V PUA@"#S'6.ZZZ'Q*A)?VD>7_ )7Q'T<G
M*]0WH$0_F[MIM"Q/:?2<P>8 V(I*<ACLW/)D6QVK?"BW)@7&Q;G!/5OU-&Z1
M4D=:U<3O;?'FM*/.A(PDB&ZR(KJ>56%QZCX&K8XWSTNB%31D.NZYXN-4L.0\
M,QC;]5@#J5OL@F2TFD).M:0G_P M3GCL.3/-F'.J*?;:1T;(-552RQKS/EO&
M1R$,!KQ+!)JD@E>&0<CQL48>D'"B^(JE=PX-^C:I]-_3U-$UA;-)ULL,Q_/4
M_8I+_.7NNMB^$IXW_9R6_P"9\1]')R1SM])HQ_+W878Y54%F)V!0+DGH&*VM
M!+4T3]:T0V@4\!*AA^M;-)?5J(Y,)JU#6?Z8YR+>WH<[9IZ&]!-R]@]R8^5$
M4]?@72VEY3Q:&BGG'*SJAX-1\IGL ,3U4[9IIY99Y6\:65R[MYV8GJ4=!3KF
MGK*B&FB%B>-*X0$VW+?,W(H)QH_1=.+14-+% .<H@#,>4LUR3O\ ;'%6ZK:#
M2*K6Q;,N9^+,J^2ZW/EX7$D![^/B^5M4^G#*=15B#YL:3T4[7-+.E5$#NBJ%
MRL%_S(RQYW[K4?"4\Z?NR?R?$>D7Q:2_TI7_ .GNQJ*!\M;I;- F4\:.G]_E
MY1JXBGE; QG(VXRWU+U+#62; #623JL!S[L=?YZ6*=X^%CH)&/#%2,RJSCB)
M(1WIWZB<24\\;130NT<L<@LR2*;,I',?]VZM1HJ1K1:1CSQ [!4P:_KQYARD
MJ/ M!H&)[2Z5J>'G4'7UI1V?UU!AZ0#U9M-SI>GT-%V&ZZFKJ@%5(/+##G)%
MC[JIU6_(4FED7LFCZC@Y&M<];U/%MRV$H0G=A3SX07QP@'8Z@<(OE;''IU_.
MQ3PLUH](PS4C#=GMPT1/08R!Y7== W+,4_:1O'_-\1T'BT<0]+RM]_=;2.0J
M(I=V.P*HN2>@8J:L&]-&>MJ);ZA3QD@-R7E-W)WW%\(+:M6.2RX)Y[]2!Y$S
M4NCK5D]Q=<RGL"'G,O&^8>I3Z;@CRPZ37@Z@J+ 5D0[8_*EBVD^)U:6MAU24
MT\<RD?((N/G#BGF.*:LB-XZB%)5^>M[>;8? FD.#?-2Z,RZ,I[&Z]@N9W%M5
MVG9U/+D'5H(9$"5E<OX0K=0S<+4 %4:VTPQ9(NA?R&D]'L/[32RHO-)E)0](
M8##Q2#*\;M&Z^*R,58'H(Q%KU&P\XQP\>N6D[,.=-D@]&OS8H:Y-1I*N"?5R
M1R*Y'G (\^(9T-TEC213RAU##[>ZJ*3Q*NG/HE6_J^(\GR8(!]6_W]U_@RG>
MU7I2Z-8ZXZ4>ZMRC/[F#MUDX&.$(Z,<$//U+#63J VDD[ ,1B5;5M;:IJSO4
ML.QP_P"4FH_*+'?U*[1]APW!F:E8CM*F+CQG=M(RG7K!PT;@JZ,4=3M#*<K
M\X((ZLNC)&XU*W"07^!DVCYCWZ P\!Z7TLY_LE'*T0\:=E*PH.=I"!B6:5LT
MDTCRR,>^>1BSMYV)/4T91LF:E@D%=6G<*>E(?*=1]TDR1V.T,>3  U "P',/
MR!QI.)5RQ5,@KH=5N)4\9O\ 6$F+<G&'FV^K'!OK5URD<H86.)Z>VI'.3G1M
M:>K&C6)O)!&:23ES4YR"_2H4]U*V]2&]!OA&\95/I%_B-6?)$"_Z$9^_NJ2:
M5LL<2-(['8%47)]&*FN>_!EN#IU\2G35&//VQYSA1;')88)Y3U.OJA;T.C65
M]?:RU6V*/YFJ5NA.7VG7\"6I-*WFU=JE4/=TYL^J0<I+G ZE/5+VH;+*/&B?
M4X_FZ0,!E-PP!!Y0=?@+1GL?B;C5LQK:E?S%-JB4\EYF5QRY#U:O3TZ6FTK+
MP5.2-?6=,2MQS239SSA1^2T5IA%V&2AG(&YNRPECN"Y74<[X&%'^[8IZU=H[
M#+T;4)]8QI'1Y/:21U2#F<<&_K1?3W712>/2P-Z8E^(VD/UJCZ,2#[NZAHR%
MNRU>N:W>TZG9_F-J\D'EQLQG(Y\9!L&+XAI:=<\T\@BC4;V8V']3S8IJ"/64
M7-._PL[:Y'].I>10![2HI0!UQ'^,4C'O9X]8%]PD%XVYFP4<%75BK*=H938J
M1N(.!@8$#GLE-91SQ]YZ.U\W@+2<JMF@HF&CJ?7<9::XD-M@/#&0&WBCJ46C
MJ<7FK:F*GCU7L9'"YNA1=FY@<4.C*9<L-#30TT8YHT"WZ2=9.\G\EI6)5S2T
M\77D5A=L],>%RKY0!7SX6W+A#OM8VPT,K 77>1J.[UXAI1(+UD4U.5OM8+PB
M^N/U]UT!Y(<G[-F3^7XC:1/][F7Z#9?N[I>5S9$4LQY@+XGJI._;BCQ8QJ1?
M,/7@&VH8L-1M@D\N#B33M2FI<T-"#XVR6<='N:_.]M^$($M35Y+/;8E5W_[0
M<?ISX&!A'[T\5_)/]-O@&OK6-A34D\M[VUK&;:^FV)IY-<D\LDLA^7(Q=C](
MG&S$NDY5O'HJF+)?9US47CC/)Q4X0^C\G+$XNLL;QL.9E(.*_1TG8^M:V: 7
MW1K(>#/GCRG'!4=ERJ3+5.+V"[<N/_"HT2!VXM3I&8Q"0>,D8!;+R7MC0-5I
MJGA6+\(TSQ5E'.9(*A3*L<J:P"KY'NP(V;+X!&PBX\_=4:_!S3I]?/\ S_$:
MO?QJRI/IF?ND4B'7)QI/(&P?./J&-F+VQS8.(*"'WU^R-\'$/='/DCUVQ!20
M+DA@C6- .1=_2=IY_;34K[6&:)O$E76C>G4>8G#1N+.C%6'(5-CU0#VR<7S;
MO %7$.VK&BIK<J.UY/JC&S&S#U)6TFD*EY+VU\%%V*/UAF\_Y26IB&1-(T\5
M4"-\J]AE_<3TX*R\>^JQV8CR\5218#4!;#/!KJZ#+6TQ';9X=;JO.R7]&-%U
MJZQ44--)?IB7NJIC\2IO].-/^GXC2/X\CM])B>Z"QV*+G#RMWQ] W#S#&S%L
M'J'2$R_C-9VM]L=/WHYB_;'S?D%JD7BS^Z?K5W_.'V' ZG,VK^G@#1])NS23
ML.@9!]IQLQ8+K.H8H:11;@::);?*RW;ZQ/Y31>DU47IJB2ED;?DG3,OFSQ^O
MJ*XW$,/OP(7.8,MK'>"+$8ZR[VCJ)X8_U#-PT%N81R!?-W571\T+_P 13]WQ
M%E;Q8W;T*3W2(AWVMNCD]H<)&P[!&>$G\@'4OSSJZ+X"J+ "P&X ;!^0>/?;
M,G,PV?TQ8[NJ#W?EVB&%%Z"W&.-F*2.VHSI?H!S'[/RNF(PN9X(>NX_*IF$O
MV ]1>;"QEM68>@X(O[LBGYR7^T'U=U2)\)3MZ5=#]E_B+7OXM'4GT0OW1?DP
MS'_8]J+CLTW'D/[J_-'K_)$CM9.-Y]_KZI')W?52<LI ^;Q?NZG"6]RC8^<\
M4?;^5J:9Q=9X)86'*)$*G[<55,XLU-430-Y44C(?W<9#OQ%(#VK 'HW?TQ"<
MW&3+A778P!'=--\K.GTHVMZ_B+I(_P!TF'TD*_?W1EY?L]J'8<2+C=+=Z/O_
M ">;>AOYM_5'=S'D4GT##-XS%O2;]2HDY<J??^6TW$%RI)4]=(.45*+*3YW9
ML \^!\H>O=A(F;?EQP=]G&7R3M]'=--)XL\9\V87]7Q%KSRI&GTYHT^_N@GV
MH7?M;I_)D'81;!4]Z;> )C\@CTZNJ/ELS?=]WY:CK0.+6Z/"GGDII&5OJR)Z
M.I;>N(W!L'(].()+[+!NC?@$;"+CS]T=&(G\>-&]*@_$2JYWIQ_^(C/W=S]/
MM<QV+]OY7-XP]?@!AXQ ZL:_)'KU_EM$UV7C05<M.6Y$GBSV^E$.I;EQ<;4.
M882)FVV&.#)UIL\D_P!.Z:?F3)] E?N^(D@\:>G'U\WW=S]'M0/RH/BGP @Y
M^J!S?EJ]K7:EEIJD="2JK?58X/552;:U8=!LP]((/GQ!,IOJ%^<':,!E-P1J
M/=#IXDI]# '[;_$2,>-6Q#_3F;[NZ[\GV_EB/ "]'47I_+Z;I@+F31U5E\I8
MRP]!&#U!C0FG%-HY144D['4%FHY&*W\J%O1'@T>@Z1:^J'%-54L5I8]6U%7C
M3$'R5^5C2?L<]DU1"VEP6TAHMTC6%)J74*BE51OIFRNER6,;G6Q4]T3)RJK?
M1-OYOB)2C^_+_ G_ *_$L?EYHCLDBDC^FI7[\5E/\!4SQ?LY&7[NK[):"C9N
MO=&U!TC J]L_ ()I81;7V:'.O3;J46F=$U#4M?03+/!*O*NU''?1NMT==ZD[
M#KQ!2>R[1\NB:DY4;2%+^,4+'4,[IJEAY6U%%Y<4^D-'5,5915<:RT]3 P>*
M6-M896'^QW,GR@R^D7^[XB4?^+_Y,G]>ZNCX@Z=@RY1U_*Z]$MI;]''ZOLN>
M?+P=-025CJYRJ56GE4@G<#L.)' "AW9@HV*&8FPYALZF2""69AM6.-G(Z;#"
M^Q7V21U47L>TE,.LJFICD$>C*Z4@*,S#*E+4'MM@24YN_.4$&X(N"-8(.\'D
M[EB;D=3Z_B)0CEJ)#Z(_^_Q;J) -552TL_SLI1OW.K[-:2G]UG]CLS9?&6GD
M6206&WL>;J1K1Q!48@U=?,O8:2GY$W-,PV#"0PTD$]5E'#U4R*\\[]\=>SFQ
MP=1H6%Z>3B%FIX[:]7)B'052YEH:B'-H:I<W8",<:AD?OC&NN(G64N#VMSW*
MC>,BGTCXAZ.7Y=2?0L7]?BWH:M U24T].QY6CD#K]5NJE+*+Q5U'64<@.])H
M;'%=[&W#7I](-#'JUR0L^:G(Y<\;)KY;XH-&QA8I12K4U;"P9YY%O9C\G9YL
M23";@H58\<G6_D\V$2HDX:BG[$7!OP3GM6./PB3>7159!/2R[^+(-_RDNIY0
M<4T^SAH8Y/.R@GN6/F!7T$CXAZ-'R:H^N#XMT%7;72:0M?Y,\977YU'5T3(#
M;\;13T.&0_;CV/\ LQ1%M2SP4VE5MV\:O>EG/+D),3WW,OBX>=#?A[*N7X/=
M;FMA'@S\%%8D+BFH:SBP5R91FV)4 9D])#+TVQHCV,4AX:?2>DZ.$HI[9.&4
MO>VX1AB>88CB46$:*@ Y%%NY67Q7^T#XAZ/')#,?2Z_]/Q;TJ+7,"QU/[&0$
M^HGJTDPU<'4PO]&13]F)(FUK50?O+=?]^C H*P\:G8H"^TA=@;D;[=HQ(DF0
MW4C=R8$]*<O!39D*]Z0<R^O%'[,=+%999Z</HF&^;@DD%C4MN#N+B,;0IOJO
MW-*O*%/H-OO^(=*GBTF;Z4LG_3\6])TI%^'H:E+<YB;+]:V"I&L$@^;5U='3
M_"4=.?1&H/V8S5$/'M;A$)1_2-_/MQQ](5XB/>9DOT9BO_?&FHJ"D:321HI)
MX*RH8S3++ .%41[%0-EL0H%[[<'1TC$SZ%K):;7MX"7L\(Z$#\'\WN8#QE8?
M?]WQ#3Y-'$/]28_?\6R#O!'IQI.F^!K:A!S#A&*ZN@]71C;3'$T/[-R/Z8^_
M%O7C(VL,"I',18C'LK]BS%A!5\/+"&U+>"43PY1LNT-5:X&L1Z]G<T1^6!Z=
M7W_$.4>)# OU,W\WQ<KS;54+#4CID0 ^M>K-#OIJV4'FX4+(,;,;,#'L1TZE
MTBTJ::":VI78N:"0MYJF)FOX@/<P/(0?B'6=%/\ ^WB^+FBZT;)J:2!O*B?,
M-?DMU=,T?^'J+<YS1_=U".IH+3E/JFT5I55S^(LRYD/[>./&BZ]#=:N@I9P1
MOSQ*;]S1GY"_9\0J_P J(>B"+XN4]4!KI*Y+GY,ZF/[;=66G)_M5!*.DQ,KC
M[[=3IZGL@7+<TD":07FZRD6<GZ*''L=<&YI:9Z!K\M#*]/\ R:N;N9>:X]?Q
M"TB?[P1]$!?N^+FF(@ 62F,Z7\:#L@^SJZ':]A),8&Z)8V7]ZW4'4TO0L,RU
M6CJN KRYX7%L:1T?(,KZ-TU4193M FBAG-QN[([CS=S,.1OM'_;XA:1/]]J/
M5*P^+E33L+B:"6*WEH5^_%33';3U$T)Z8I&C^[J:/J1[Q64\GF652?5?"ON9
M0P^<+XOU&7E!'I&/_J5H1QD$&EC41+\DUM='>WZH0GS]S..8'_?I^(5<>6LJ
M?XS_ !=TQ$%RH]3UQ'SK.@<GZ9;J#&BJF]^%H*9B?E<$H/K'M/9I0=K%I#1O
M72_+98]&R V\J:H]![FZ0?Z_$*H;EJ)CZ78_%VDK0-590@?.IW()Z;2#JZ/%
M[FG,].>;@Y6RCZ)'M-"FV4:5T#P=]=G;@=(>O\34?1YNYEZ?B">@X<\KL?6?
MB[0U:@$TU44<[^#F0_SA<;.II*C.V"K28>3/';[8C[3_ .F->=77#3TM^6S\
M$H]-;Z^Y@><?$&0\B.?JGXO5\5KE$$Z],+!]6#Q<=KBL@V+44F;YT,@(^J[>
MT_\ I;I0&PIO9&D#?YM=HJ8:_)IG%MX; [F'1\0*EN2"8^B-O NKPS+$=DD;
M(?G C#KEUJQ7T&V.UQ22; 2T1Z)%*V]-O:>Q"MV&F]EU&V;DM354O_)OB-N6
M-#Z5'<P^(%<?[I4?PG\#'PS-J[9LWTM>-F(Y -:.K>@W]I#-:_6FG*&:_BYX
MJJFO_KV\^*"3X2CIG^E"A[F\_P 0*_\ P=3_  7\#'PR&YNJO0.KI9K>YU>B
M6Z+Z2ID_GMC0,OPFB-'/]*DB/<Q^(&D/\'4?PF\$;,$CPY[(=5\LFAVU?^MZ
M/N?,+D\V/8>[&['V-Z'N>4BAA!]?<WF^(&D/\'4?PF\$;,'5BXVXV>&O96O)
MHMY?V,D<O\F/8@?_ +%0K]&$+]W<P^(%?_@ZC^$W@K9C9BX\,^S ?_8-)-]&
MF=ONQ[$SR:*B7Z+,OW?%:M_PE1_";P9K&#88V?DMO@WV9?\ \M:9]5!.<>Q?
MFI)E^C65"_=W./#]6.6FG'^FW@W9C9C5C5C6/R.H7QJ0CG.K[<<8CS8AD%*)
MN%BC?-,S/?,H;9?*-NX89.L(%S"V9!E<<ZL-8.)HU)*QRR(I.TA'*B_/J\#>
MS!/&]C6FQ_\ VZHQH!'VHVE5\PTO79?JV^*TPY8I!]0^#]F-F.,N.3&W'&!/
MGQVC^9SC5PP_S/\ MC;/]-?^G&R4],G]!C53J?*+-]IMBR(J^2H'4.*)O%BX
M/]DQC_EZE1^OF_B-X&T_3[>&T-I*+]I1S+]^-&TMK<&];J\NMGD_F[G/A]Q\
MEOL\.O'\#4./,X5_M+=2I_Q$W\1O U3$=DD$J?20C$4 U9<WUF)^_P"*QPW2
M?M\.5D/C)%(!Y)93^^OHZE4/[S/_ !6\#'H[H'Q E')(_P"\?#B#X6*2/U<(
M/X?4K?\ $S>MS\?I_P!;)^\?#E*_).@\S'(?4>I5_KB?3K\/CP_-^L;UF_AP
M,-H((Z1KPK>,H/I&*CG*'_33X_2=-_4/#M.?S2CZ(R_=@GQHT/W?=\?F\WV#
MPZH\5G'KS??A&Y8OL9OZ_'[S#[_#LJ\CAO2+?RXA/,X_=^/PZ/#L@Y5!]!_[
MXC/(Q]8_[?'X>'1S@CU7^['0X/VC[_C\/#L9^4/7JP_F/H(_1V#R$'#^0?L_
M1X.=?N_1XO1AND_H[\YPW3^CL]./,/T=G Z/T=^; _1YY_T=C!__ ,3J_\0
M+A !  (! P(% P0# 0$!     0 1(1 Q05%A('&!D?"AL<$P0%#18.'Q<*#
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MT4<P,<.U$S<Z&CF6\?A.FS\AGI$FZ[\$QS,)[*ZCISU<3>.66Y.%UX."'"3
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M@'0O03#A+_J6>ED%=55%$9P)"5IS8W0T9R\P#) ]EZ([QK-_P4'?3@5M[/\
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M!Z_23W?_ !)[G)7R$ Y(4[G!;'<^?,3;F8S+3PR^(6-*):K(S&P77-?"U'0
M>XQ#M!2EPF!VXMQ! +,*KJR+=[2QBI\=T-+\%P:$XT5L*-[-%HX1@L!8+W<>
MQ9UBRF;V9W)NS<5F;\?=*4]U>3@\_P#4>TW3M40K!?O+K%<(W?*6I?)%5/FE
M7_J!Y&?'KVE1%U4O?T(MOM  ; 'D%39Y)N3"NY,EI9%EUVN%]MWI_P")(!
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M00&KA4&_L!+ 7L?MXZUYPOM#)=O05_B+NR^^E>;(>JBIVI]9YDGWE9Z-^_\
M6T$JN]=:<.M?5%2CAN9=+4O&762JYN::+#R2/#.5OM<TV!$$1$L3(CLCT_\
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M[@MQSW3I0%'99BA;E"N\J0*"#0%:6, 6.+H=*,Q8SDYZ'V4ROF[UWN]H'%P
M\YXY#TKB8";6M4?)?M*I<ML[A*+OO>,U@6(RI"N<L>J;>%8@8,NSK$SQ%V^@
MQ2XC-*'01?8E;M [Y/M,7@<#MO=?G_6TPCZH8"N^$^.:'V@M3>F[-R50:7:/
M+X8I WCA]8L <B62E7T'3P<"&Y:\MTV9WALYV@]00_\ "@K9<$J[ !5=B9NQ
MG%^42!1[I2[.)6&(()6-+&*%PN[FX9Q'H#WHQ4#&M\&O>,'K7,%;)O<M1G51
M+?:9B;&J!7;[]96V&UQQ'56W'GXE8!%L$3SNYBE/H)#M7V4F2>]7/TJ(8$2'
M;UN>OJ1@=Y]9/?Y<WYAIO\Q]X;%PBK"N1V2WP]]!B7W_ %I9IO1.(Z+9UIT]
M"KP4%,5U=D;SC^C)R69E]JMMVZM].:$$]-%ONU>__A&=G9(VR.2XN(W)N3$H
M&)0$X:.-+,(;*ZP8KDOF]^"=DF_\@'H!Z9=>4H:#FPX>%*;;*G,>'@L9TKU'
M#NJ$*WZJMO8'WOYO"#;+;KDTLEQ9>M89T%6E7JUYI4%$W&^+!@PW&.S*^*4U
M9(;N=XL7#7ZL=K^?6/;NJ?B=9P]*"[)I>[KK>,WYOS<F_'1E^E9XQ(+'@CAE
M]FQ40;0Z1^?7$YL/!M-J$  #_P""]P#<K80;;Z>X4;54D1B !B (:IM$XC/K
M!*)?1G1*UL'JX@"<A6MGT-2)JTK*!2X44?7DW" "6R1CM215%RYF>GO!6^R<
M=(A;*K?4^;2I1T$%9#U_08>-20;[%EH. 5ZPD[C%T%[)J>1)O &_)7^@MP9!
MS.&]'OS]_F)?6!HBJEJY;/$V[*!=#B;LWH'.@Z)H7Z9/C=192B*WCU2)Y-P*
MB8$$=F3W/VE;LD]S' .Q;SGG2JUZ\]2"PY:A.H ^_P#GX)C*  6HX ,JX");
MAVA.!61; V;PI!$8@E2DV@5X",448B;=IC,#QCN#)!M KTX.^2@[Q@T"KL@*
M?7.I[;A<>ZZ^\;[>IV-2-<L-\@G2G*X"<<FS+0[BT'NPQ=@_(7[?H&^M/FR?
M&$AM%QLK'-KJILZ@(<B!36PVZ!B-TX7Z]?O  %-I [E #E9;V@'+J;W6RKC.
MNS20W"S*X(-$T+?!FW306,L,O;&52F(;"\AQPZ->5(=@J>W-]W]6FP;\!#'R
M8G_IY\43WBCZ)^-^T^L%=/HD?9 ?RGR9O9FRA\?%/GM>U,>IT(_G/W2?D+71
M?\M1"65 #JK@E8M;,NG]%0GLET8\[2]K/E!SL)A>S^PM<W+*Q-C$ #$"H0A!
MEHNB3-YT2E5K>K%ML<Y2L]XUK0;[#APRS$Y%N]_*I]^G;3"2=L%A"S7>=C6T
M!"31NPRMY)FDQH5V ,CN/(;[?TJIUC-=+FU<F*8A2)-\_&.KY8]9M^3  9/-
M>-V"O#SN#>'?P$)6B1A@8UB6=J=C18>R,,/;&'MCVZ651[--M%2I24E(.;NB
M1]Q)P^;8N/L$4O9B;*9Q[BF%9ZCCU+%-W5^G_<1SBN5KV::SNZ,]WV17XMX]
M[2/FTF>=]H8GTP>R>H#W/\@/5ON;S7H'*A[8%I\_'O%R NL"[DW[^8F]@W3'
MHB[#*XA?SE@Q"QB"!B!1X"#X%E->'5O9(:7DU'X/8IL4'#8B;_[8R39]_<(\
M8RU"N&!(O0#"GH&L6(^1H5]BP/R(L*/-:"/0="]D%JAINQ!LB-P"(K5XW8.
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M#H%1%*+7YX,I=%Z0*RBRZWZ05( SS.[\Z+&Z94DSF<E2[9N34"%8B0H' &P
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M":"31@M9@ U85,2R-,[5CQM;V%1!F6%"FC>SYO\ 3>9^ZU<>V\(&%>KJ$%0
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MOXG27TX!]O:8.\"SY9!O(8]PCO-T#%-[,Q9 #'?FC)8/D@*B'-YXJ8]NT@
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M$]OQ(?H)MG&<9MU:UC$W);%&*M2=&Z#>##.((,^ 0- YFR;HM!M^S8'VS>'
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M%G$R.>_7_D+8A[9[^BS"7_J4^D;F0Z_/*%NU_I3E LGD\1'K"H]RW(^,,C:
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M%FSF\WCF0PWDW1#V\-NE;KU-\@CD)> \)^"SI&I\)_DWHLO.JIO@?G$.PO\
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M5PR[S6Z]&Y_7[189O3=TE''1;1P8LD6290?H?/M^J=$WISAPPX@AC1T@]/K
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M+!0V5\D7VF^'N#]8%-D<=!I;$HJ#&G/AJ':4^K#7G:F^@PS,: 0(<:##XQ*
M_:8!<@/H. 4UFH>.NQH4OMFYF&C*YZCI.([;TJF A%-?*O:)U?&<>3TB4'&+
MX._G';HS)L=D4 ;>%@?9-^[ !J#.;;@\Y08J%>/'WHW#Q&*%/;'"'0 Z2H1@
M$,==Y S<4&*C$381W5]UYTW ;(MF0 &,9"]"7F.[Y#T^8@K9NS<9Z\4RF_C=
MR/3=U+TFWIBC7S&)>S=V*GT/]1<:(I&#K;GRF),MF+V7L/2.-. 9K.%W+?U
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M2Z.IM?GS<-J5*6+Q73S&^0&I.+M;VAY#;MCBGF^<%JN4U8FXQ@:KQ5M=KM
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M=@Y^X:5BB@VQ+#E!M8PE.=C4H:&!YWM3^^BDN,? :W6]3OP4F)H/&01L:5C
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MST 3<QF\])L>6CX.?TDF]XP?AO,+-V;DJ*>L'W6>.OO^]J)VIW,6>6/FS(3
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M._[%-1W)O3>E4LC=F_,$ Q4HVO<1[?O"*J+=Q'ZE]8<DV(:@3,2K]$:&\)Y
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MM!BJ+$,%ZB'M*PFKB& ,CK6.RGIM/+9X T#0)4JM*T)6M:AX0CJ?KU'<KG5
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M!I_IH(0T(3\(]/#2IPTG[C !MP#11R*EX-"''*W:\O6Y=6'^F"MV%&,=Y4=
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M7N.[O^'+O]$O^[3PAAA@00@:'@-1#GP/^DX:Y^N _P" ;P8 5$ +8D@ ;E@
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MH56<[H)>^-'&<=4AX3;0T(;0X]-!XZS;PG$!,O;H%JA4<7+NC!*F+2JZ#@&
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MFR;#L' ^Q>R(B85+[X^YU@Y\8T[76_#2Z/.K&&"&'>'>#Y\\Y=S1] AZY/\
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MHD$0,; % < %$&*#%H+291>0\W7SW=F/@4JD>$Q!M\_W,*>1*])U!0OSYA!
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MPB#(X*KUPQ.CY39;IP![2T[$!6@5Z!;[$:_044&3UA/O4-"WG@+QPV19&.>
M%@,*&Q&JR00SX=XD$K0D25]-0@RA!##H&.&;[RI?TO\ P3X=*Y_*?/OI&T,.
MAQ#####I$/9,,[$[&B:N5COHD8:///B'48,&#!A RX,-%P8/2$#H&@(((&$$
M$>:#+ERY9^YYU.UOZJI'O+X^A$?:6+LQ<B::_NM&WOP5-MAZ%L+%8W".=D-%
MNABJZ3H#V9S"%Z;WXEL>!@FTS6OIMU@8P()425*F'K*G_6@@@@/ !BJ?F\_Y
M>*_X'YJ]K?SGY:>$,,&AOI,,,,.@1V)?.W.W,D%1TY_3&#!@Z#H,&#I<&#!@
MPT!! P@@@T"#0N6:7+/VV.GHB27V26J5+!Q9R0T:.%HQ"@L[J+Z"Y9@X8$.+
M %SB!\D5*";NNMVPSM$9.+#Q=QC:)@WH9AU.Y";@9C52QT^K"P?U#!$XE<RI
M7/A T @2HP()4[S]HSZ5_@?D.EY@?9U_GW@VA@\"(=(PP0U6WB;V)N2F#3G]
M$\ P8,(.@P:@R]+@P8002022=T)))\^GSP[X2=^M9+[RV7+_ &)D*HQPK.SW
MLWIG8^.'2JP?GB;'?Q4)P=2"VK49WYQ% VMNQ!M%+DM&[:XZW$;#[E>2LZ#R
M$ 7DB.7SROK#6;>0  ]"&"-(Y1+C#%> $5 @2HF\$$26<I7T<?4?\#M_U3NC
MPT\9P\<!#I&"5*[2^6WB;F)O8E$3]4AJ08:&HWH-0="!A!!!!)H$FD:9KR?3
MI- _L**H?UR0[R57+F.1>[Z6E]J9]8&UH X,37FK:1#&^RXO +RPH#D"KQ0X
M'& 76-N4'=SI5&@G97O&>HK/N74N4<=A;L@@S!$E?65*XE2M0($"5*B0P1)7
M_L*+[?\  ^R'[/J/Z03CH-.[0((8=(/!=-S$WY5>@G@O0? /A-H> T/ :C!T
M((&6AX>G="2"32((4-_V!8$#U,?0BI4==U;ZB3+Z^6_27%F'<].\J+\K[BL1
MKD?0(<;3C8X8VZ!=%!WEK@4\W,IV:);@Y!=L%&)5BDT%H;9L67F-I-L=H(D8
M25S*\ KM*@:5HD,$2?\ .%/\#ZA_MOP4_'4X3C#;P PZ TA4/"4;DW<2K131
MWERY<'Q&A#P&H:UH:CI>@T*Z/-/-//\ 76).Z$EM'](;_L"V\QY"G[S"J5Q,
M\,.E7:F\RIVY^,L/OWFZ\EWS5/<&TVR<O0_/E2X QV6WU^^WI!I.7(7;#9%(
M;B%'0"4SG@BQ 2H951ABN)4J5J5*U",$$2>9@\L_^!O^[.9_UU!MI-O")@@T
M@\8P;>)O8C"RBXD8[Q9<&#J:$(0A#4@:5*E2M*T-_#;+9<]&B^DDDU,XX?L0
M*JYU0I/1SW]=X*7^OQ]I0#BIS2$7=1)T'+ZS.O5T^/2-9^$<V-NTI=O 1R<E
M,P#=EP729O-_:!!!!*^DJ)*E2I4J5*U= B2_^G!N#8/4'W_P*[FHO27S[:.$
MVDXPAJ'[:#M\^;0P?HH,(.)OXE%XB*)I8:$'@!H;PWAO#00@:!*UJ5I3*J&E
MR]'F\(FF2:V6D_8L2+DJL&WEE] J9JKI[OVM^7%PNY\O^O>$42L/+)->0A-X
MAXF3M,"YL+40M#J\53Z<@8'C6"O/-JL25<2)*XB1)1HJ5*E:5 E:!$E3DR[/
M, _4_P "\G>W7@1G&'&J9_70=H,?IDN48^<12\11B:RZAH%X"$-X0A T"!I6
ME,KP.MZ7'0N>C5(/!*<?LJ27"N2IWT??SQ 6ZY/F\6:^?-X50%%P)?.GW-(2
MX_)Q]X3E6T9MGU=@\)AQ%X9!+*#GBC;9HF-*B1(D2)*E?HI$B2IYA?6OV3_!
MH&S&<(<3?##!/RT[8?IL+;-_$HN.3>E+'$-9CH.A"$(0A#2I7@I\#'18L6,7
M+EZ!@QP03!^R<<;NJ*-Z<\\3>\XYL')[@K1ZTG>I1#EZ?W<&#RF%"473&N;O
M$4T$79J3<5_5P(Q((D25B5*UJ5H$")$B1T/4K['^!,H78^@'L%3Y]YPAVG'2
M:P@@^^C9^ISH1F-QZQB\2ETJYM#1WP=!N*$(H1:@@:!XV,8L6++ER^\OO+T!
M?@'%'["M#H/2YQWO &N8^J.G+O;/$P,PDV[V2]2.D,KZ+ /HPFNB.S+8V=\D
M'[RR:PO AM!.3@F*+T8D2)I4K2O%4J)&/)%74>P4_P "=Z!#Y^NJ=IQAOJ"#
M3\^TV?KB6;F.)NXCEZ%I9AX/QO0B@Z#P!H:T1T=]%WT48QBQ=%PF[2S:('Z]
M>'@DH,=DR_6R@7[1"PU5)7#,1&1<_<-#:UJ2;])0'#L,HYJ1'2M$E2I4K1-*
ME2I4K6HQ4VO1?;\/\"^)2GWAN"':':<8;^$##M/S_7WA&F;V(Y>)0LWJ^T1,
MZD[NIC<&#6@HHHH0T/#>BQ8L6+%BR]3>$$%UJ0_6KQ%7*&C?S;!O8"7+V\B+
M;YF7M1UR%)[?M3$P^4P^>>@;P_4(7*%.6%HW9;:UHDJ5$T3PUK4J5VF9\GN)
M_@+I^B>Q/^VTT_I^-?;/Z0U/Z3^L,$X_J_'Y\SI\[Z&,DSL7Z1R\1R\1$4(S
M;)5X!QN#%%!BBB@_30\%Z+%BQ8HL6++TMA@O4!M#^JKQ5*CKILV! -<WBPYO
M$,JR\OF",VY<5T-[YSQ-EW>8./E<\R.T&6!#3R';;.-VMKR\NM1(D96C$UJ5
M*T#2I4J>5D]G_ ?^!(DW;ZW.$']SC/Z:"?'TT_E##!^P?/GS,^=_E3F)!+1&
M+Q4IL276D42MUD&H,N'A$"O0'4N+488= PPRPQZ)?>#%M*S?ZSA^KJ\=:NBM
M;GB#-H)7.T4IU8J"-S?I+Y&C#SZP>RTP6B&ZQ8MP(X!*E(O&',=0?IHRHD2Y
M48Z)X:@2B5*E2H[;J'Z?X!_W#1#^]?C-DXPGQ]-?^ND_KO7P[PUP2B\1"[)<
M*/:,I2SNS;EG,+0:E'@$))/![#+###+#+#H7!T_E%X!/T*\=>"H/8@CS_:1D
M0JFN67U(_P##'J<&1R&79;XR3B!H)!+K<7V^ 0O*5EGZR/SJZ5JQUJ5I6E:5
M*E17Y->S7^ =@'D3Y]M?CK?/OJ\=4V_8<^$1&%G$ILJ90,S;D93NZ%\)@P\!
M0DT/CY>JRPRRRR^ ;Z.,RE$2)-B+Q*E>.O!4K6T!!3CSOJL3Q],QX 'R_P (
MK!Z@^\YT!ZXGN;ZCYA%7;5$Y4?OX'1)6B:)J&@2I1*E2IP=%^'_ %3R#C3LU
M]NIQ^<3^LVSA.'[#GOXP:2 VAUE.R&.,QEAJ#9369WY=SI!9<-(0:/SF?&=#
M#++*K+C"-*TM'%%MXP5.GCKP5*UJ40:B[J^C_N(Z3LS._<)\PK\3G0GK4[U6
M_J+U2U<MY=]PYWUK2M&)HG@J$"5*E:K;Y/W_ ,!WG$'ST@^\&T/]S9J\/VG&
MAXAQ?K+RB*71!$>KB*!^D-9*C%9G48#4[D-Y@WH(O+> +EI<N, 3OSSRQWT3
MP!<:G#34KQ5 \%,K6I6M=U&>2>2"J])6=%2)5(N@'%PJ. K@8NRZ>ZD>Z&Y4
MK1T8Z)I4J5H$/#4P\_\ M_@.\-OG$'O_ *T<)P@8G"?U_:^Y_0^?[[2K@+C,
MZ$;)@+C7DB(5IBG,V<SOSNP&5EFE]Y;+9<N)@$/KKN[>75"Q*FC"+)%'.,7W
MB\52O!4K6F5X*B".IAX!JEEZZ^BKTP\-8CHFB>"H&E2I6KKS*]\?X +#K'K;
M2/W@V@:)LGY07](>9_W-I/Z_LEP\/SY^)\]-/GSYWA%/,(-$L-WI T<LQI'$
M3I(AS-K,[D0YG=A]8%E)312!UG?T>YIL#7H1L1,VX/,=SA!#[0PQ_/I#6I7@
MKP5*\%>"B5I4"=A)*9JOAJK%>F%\[^--'6M0\+_@1L^L/A/E[0Y(<9@V@Q!I
MXZ>'[*MAS#P_/G^O!42X+M!S1#;H82JM^(PRA _6=[14YBG,'UGFT,.[.Y.[
M%8VA&50S&,Q*:+Z+:@@,KP5*UJ5X*97CKP4"KS_$VJY9&N!KI&.3=WWSXG1-
M$E:5J%>!CHK\K[8_G_\ M@'.'SG3R0.TVH,:']8=M<39^]K10;:E=P*B?;,O
M*9M9B.0EB6A3F$6TK=X]\-R+H"_W,Z-T:_9.773+Z[1XO8[RRYOX'6TH"5N[
MO)4]Q'SLQ,;Q>624HP%T NTOH7,RJ/;2$'?4XS/MI-*E:U*E:U*_0KQ5X6B'
M=K^LN)WIT@9Z45L;%&/&Z/B#Q.CORJ?G^?\ ^U,.C_GX!AB$&#:"8A^UO3]2
MPG&0W8F_?T2Y&P%])L4EF54^Y:(IQ^3^]SW1T$]ERKD@<GR^#Z,=Q!L^^%CV
MA:#Z?;RY9N[TV:+;?GF^]'2YO^TPW-B<>DX3%S,D^5:1M!MI"5K4K6M%>.I7
MZ L"&PW<"=^$12UV%5P'?/P5*\*> -25'P/9Y/\ /GNA>[(UXV='-MI=O1-$
M=/&&?/M*Q*E?KW^GZ2HDNG8E_$%XE3:6X:$GGI30-]#<T;OW$.W,<?::8GI]
M.>WB;4,,&(:;:A@UTRO!4KQ5*E?IEG"\ZCY]8!E&ZVW7ZVTJ5K6^B:U*AX#P
MU,:=1_GQ8=1/I*RQ@OJA#STO$L!^-4<P\%2C17ZG,^;_ *)'5RE\&-9CQI=*
MQ-DN@T]Z6T^0V>GGDT=LKOAVFU-C3V],UP8=!K4KQ5*E?K5+JCW(('3QII7C
M#P.N*=_OC_ ,2;#V#\0T';T\$(-+^/2'^] ?I5*)6BI4KP'Z7$%Z';OI?.J"
MXPB:!T<LWL2S<'G;3ZF&E*KF]W^=+L:&QXE0&@)1XJE?KU*T?T$T?$'^$5%+
M.R&>CVM0>"P-I]$-:E2OV%2I4J5*E2I7@#>#Z0&@1-XFBH.LP:FN<1JO<GL_
MJ-Z>>?9S\IVIVYVO&J\-)K3*E?KU*_8)X \::Y^5_/\ J[^Y^6@U(:!!K PP
ME2O#1*-%2F4_M@= 01.L<I6B[3W]2OA*UT0#[A#,V#\@?S,S7YO6O:FUJIJ(
MZ25^PJ4?L7?6I4K]%T7M7^?XG<>YIY-)I#4$FH! E,K6M%2G]"B42B5*E>TJ
M4^*I3*8D.(/  ZBHZ?L1CL3MRZ,MKSL?6/GC!TSM^ 7R(: 0Z<OU*94J4?M'
M]*I7@J<CR_G\QU']+\:OEA)X/-((($IUHT4RGP42M2F4RF4_K,&H,,.I- Z1
MATM]O+O:V/H99T0:XVUC7AH"#](U*E2C]T^,(%:U$U^U_/WVZ_>_IX?-/YQH
M((("!K1HJ4ZT2B5J4RGQU*E2O&!43?2$=V(PZPETKH.@JE#+*/\ 05^9V?"T
M"5 \(5HJ5^\J5J^(/&FFU_/Y#YI?[\9'JT>25 @0-*)4KPT2M%,IE/AHE$HE
M$KQTRF5$U!AAUAH.ILLK_<Y/V67U8)-((($"!#P _=5*E2I6M:LK2H'Z04G\
M^<OS_&I4\FBM2H$J!*E2O#1*-%2GQT2B42I4J5^BD$$88?$ Z##H_P 4K_NB
M @@@000)4-'Y0_;4RI4HE?M*\1_/''F?K_R5*)4J4:42I1H'BJ5HIE/BJ42B
M5J4RF5*E2I1*)4HE$HE$J)!$C%2NVBNTJ)'08\D]&7W/O*KT/<6@($""!*E0
M(3A#]A4J5*E'Z[^C4K6I6NP_GMCS_O2M0E2B42C2M:E/Z%$HE:*E/[-(D2)$
ME2I4J)$T5H'_ !@;AK]?NDE0($""!*E2H0A#]&I3HJ5^V3Q5*\=&AM_/;GI*
ME2C6I3I4K4\%2I7ZM$HE2I4J5*\=1(FB1)4J5*B1)425VC'I7]8\DJ! @0TK
M0(0A*E:*E2C]]4J5*E?IG\]O>&O&'Z-:*?W#$B1B2O DJ)*[2HD=]NGLI*RZ
M'[+*@0($"&@>$_DC^>=GR94J5^@'Z]2I4IE/[%U8DKP5$B2I42</0/S^95ZK
MW!E0($"! E&@0_D*=":4P/\ !:E2I7[:I1*)4J4RI6E2B42B41T8Z)I4HE$3
M2I431L_-[G^IDO5/Q^)4J! @:5*T(?P%2I7Z=2O\%=WP5*_B:U32I4K16E2I
M4J;CV&9+R>S_ +E2I4#0-30_<U*94J4>-E2O!7^$\NE?IFE$K]\FB:IX:E2M
M*F*[K[D.'T4]ZE2I6@:5*\!^RJ5*E2OV%:5_A3O^H'CJ5^[=*B>*I6E:,!ZP
M6>P_)K4KQ!6AM^E3*E2I1_DC^E4#]2I4IE?MJUK14J5X*E3'SH;]+[ZTRM:E
M&H:A>BI1*/\ +:T4RI1HJ4_M*)4J5^R3]"I4J5#<\YDCL^&O#7@/_%*)1*)4
MKPUXJ)4J5*_15X:\1_X^EROTJE2I4J&Q'=TJ5*_\W&T=_P!*O_):E:*E2O&;
M1\)*E$J5_P"8)<K1+T5*E?\ X'W_V@ , P$  @ #    $
M
M
M
M
M
M
M
M
M
M                                              !!((
M
M                  )( )!  (
M                                                   ))!!(!!)
M!
M                       ! (!) ( !! !)
M                                                         )
M(@)A(A!((())
M                               ! )((0)  )8   !
M
M    )!)! )"! )!02 )( (
M                                     )!(#3!!))  ( !!#  )
M
M          !!!))8)!!)))() 11)((
M                                             ((((( (0!@)((((
M-)(((
M                  !) 8  !)1) !(!))(+I)!
M                                                      89) XX
M(A(<#<1!) 0)!!
M                           @(( %!! P  C$)(!@A(()(
M                                                          !
M! )(H!DX  )H )+0!)!)))(
M                                !(()H!$!      !! ,*(K(!!
M
M      )(*! ) A(    (  ()A)(9!) (
M                                        ) ))S$,@ )   !   A)(
M*(@ )
M              !!) D(@  !    !)( )!  )A!)
M                                                ! ( <%
M     ,A@"()(!
M                      )(!$!    !(     !*3)!(( ))(
M                                                        !@#4
M(     (      #H !!)(  (
M                             ! K (A     ()     (;(!  ))(
M
M    !(SH        ()   (*9!&()!
M                                      )%%@(         ( (!A)"(
M((-((
M           )))8    ))!!     !( @( 1)!))
M                                              ! )(   ))   !(
M)  !"!( ((!!
M                    - ! (!    ( !   (  0)) )(!)
M                                                      ()0)!(
M ( (()+!((!)!!"!)((
M                           !(Q ! )!)))%!  ! ( (!! (I((((
M
M )!, )) )  ) !(   #(!!))!()!)(
M                                   !$')( 9"     ! ! +9  "8
M( !(
M         )+H !! !!(((# !!  "(! (( )(!
M                                           (I(!))!  ! ( (  !
M)() ((H! ()(
M                 )@ !     )!     !)(  ( ( ! !!
M                                                   )!A#  )((
M(((((( !) .( )8(" -)A
M                         ()"+!! ( (!! ))( (!)! +-! 13JM
M
M)( !  !)!!!(!)( *(!!! ! !((&H@
M                                 )81  !(((  ) )!((! ! !Y!) C
M&" H
M       )( !! (!( (!!!)  !   *@!((0-$)(
M                                         )(() ()!  ! )( ( !!
M! (0% (C&2(N
M               )!!) !   !   !)) (!  (!) (,4E<,
M                                                 ), !((!()(!
M    )((!  ,! 1!(HP)(
M                       !)! !(! !(     !  !!!!9=0!++:
M                                                         ()!
M !I!!(( (   ! (  !((!@! ,!8(
M                               ))  ! ))! ))(  !    !(!!! ,Y8
M"
M      )(!( )  !!)!        ((!!(< %I8
M                                       )(!0()     )!       !
M  ! 1($K1(
M             !   ! )  )))       !! !)! !$<>@
M                                               !(X)()))!!( (
M      ! 93, (H,(/
M                     !() )(()) !(    ) ) ((!)()"H!(
M                                                       !# !!
M) !!)/@    ! !()Y) )) LT
M                             !!!!!)!)(  6      ) ( ) ()!@A
M
M    ! ()!)() &8     (!  ( !()!)!
M                                     !  ((!()  *&       !!)
M))!  (
M           !   A !(  ()0    )  L2! !0= 0
M                                              !( ) )!  !SP
M  !)(/# ))(91
M                    )!! )!LP  J)!((    (I0(@(
M                                                       ()(!
MUA)*R      !  0H!2)(
M                             ! )) X !'_     !+!(1)!H)(
M
M   ( ()((.!"+     )!!)<8!;
M                                     ()( !.E(&L    ()))(AX%Z
M!(
M           !) ((/^ ($    )   )B<"9(
M                                               ()!%'P'R    !
M!(!!,0=P(
M                    !)((%L0(^    !(('! ??X
M                                                      )) ( A
M !8     ()")(J5H(
M                            ))  )Z\+$  ! (( ?(!"F)!
M
M  )()!!"TA:   R)((E(+^C)A
M                                    )!!)(8HM,   L!!(J)/"Y 1
M
M          ( ( (!^WF   $!)(SP&L!
M                                            ()(!  NH<   :((
M2 *A@!
M                  )( ))"C#*   F( )FH!AX%
M                                                     ))))(2+
M8  !/) 8'I!9Y!
M                            !!)($%P   ') )#<!3Y !
M
M (!)((/G< ((>(((BY(Y()!
M                                   !()  #_U(!(()" QP&%4%!
M
M              %MC!)(G(!(?A+R+(#(
M                                             )H))6U)! Q   $8
M(<- ("
M                    * )_I ('V (!Q8JD%A(
M                                                     )*,!$!
M)#E(!!K@&D+)"(
M                           !!-*NL)( )) 8MH>&+!!!
M
M   ($3_I+'!"( ,AY@(-( (
M                                    ( (4"A(,C  !APKP /)@((
M
M         ! 0+!(( (    2QV1=)-(!!
M                                           !  )IU1 #- I@8XZ+
M  !)(!(
M                  )))%VS *R  !FQ3KM! )I)!
M                                                   )*0(-+A #
M.   K;Z=, (()A!)
M                        !!) ("K! %"    $=!% )((! !)
M                                                          !!
M5!!.[#0"S*KP/ZF1!)()"( !!(
M                                (+! !'DS 1K   )(IP(( !(  A !
M)(
M     )!! (( ]HP .   %@_ +"*8)!!)()) !!()!( !
M                                      )((!8(()"0 #     ,- (M
M! !$!!@((!  )))((())!(
M          ) ()5) )((*BP!0   )-B  ,D3)) !(%( !))(  ! !) )( !
M                                          !)))!!X( !(@(I"%
M  -J  (!)+ MHL'5S()))(!  ! )(!( )!
M               ( ),!(((( # (;"ON   (@KA11' ()TWTV31H!%))!!%!
M(!) () !(                                       )(()*1$# !1!
M))1D+   ) F0'O!(F.;7VG@DNI?I()(/!(! 4))C-)!
M                  ( (  $ !!)(()FHH)!<?8  !(#H@6 W.A,YI MN>?Q
M+")@) !  )!!( )+H)(                               !)( ) (! )
M(!!UJ\L^X,SF/0 (I#_?[G(!UOF )!!!(>C3R(( !) (* ($()!!!(
M                         ))!)!)),!!8GK^#>4'?PL* !&1/PRQ'YS+D
M!A) ) )($:NK @I)@)! !!!_ (!(                            (((,
MH(!!)(!(!DFY93\.N&P,-8)!( 3_ /\ =1?E) $$ D D G]4:*@@  DD &@E
M&\T4$@                         $@@DL & $ @D$@).H?@@G210XD@@
MPR_:>M*2XH@ $  AD@@DF[18FT !@$"$B,/.@@$@
M     @$@&DD$@T$@@@B3ID$@DXD4B6!7AD@DD/WH$5D4@@$@D@"DD@@Q)=@!
MD@D( DEC']HDL$                         $@H@G  @D  "$:*.@N@A
M< N[+9<DD^>5;D4V(@DI!.H$D@D$4GUHH@   DP$ +.!D!PD
M             !@ @A$@V@@DD#TYX50@D7$ [HNB#$D_*,LQ\DD$$@  ($ @
M@$ D$M,D$D@$D$4KB_%B $                       $ @@DD '#@$$ $<
MNK@$@D0$DGR8IX2\,G?BH1QD$@@@ $4D$ D@$$@+ $AD D  $O$[\PD
M                    $&F   PDPL $Q&/HA@@ $4 !@6X7 \$&":Q!DDD
ML -DD$@ $@  $D@@&$@    #XU)D"P$                      @@% D@
M   D@@'$9D @H&@D@D8"1;V,D/F I.@,@H$DDDD  @@@D@$  $%D     'W5
MMOX$D                      $P@    @$ $$$K9\ D4PV@@H"A@!IG(G2
MARG9        $ $  4( DV@ Q@      5PO5%0$
M $!D$D  @$ @$B8,&N@0$%FP@T@ SD:>ELQM78 @     @ $DD $$@ $D@$@
M      %M3>&4 @                    $ D $!D$@$$$4"MM"$H(V$TDP
MD%$T2Y9?!46L2-     $ D @$ D $D LD       !C6>-DD
M        $@,@$ $D $&D@3CF@D(<#9H  D@ M# 0=,6Q/!!:B@     $@!D$
MP($D$ F        \-NPX$@                    @@ L$D @@ D$DPZBWT
MA18V,$$ @$5DC&Z3!VU>T?/G       %$$F @$ $D        S+9\F$@
M                @$ DD$$ @@$ BBLD EF2CX@   $@!3[+JF$[V9K'JL8
M        $N$ @@(         _:?%@@                    E@ U %$@$E
M@$8+@  D$/CP     &\NJ>NEZWSNLE_9(           @, J@4         9
MS=$                     $D*0$DD@ @ @*BLHD4D$%       @I:T@NC:
MXPU79VM           $F PAF         K!5@D                    $D
M$(@$ $$D@F+P2$(@%D0        <'E@][:/(43,E%           $$ F0$P
M       KSE D                    F@X $%@$$N$@$'V$ BD(F
M  +&>K<MZ<8$1=X             &3;$         #<M,
M       @\(D$$ C"@&'"4P)S$$@        A5*79O>DE4QGR(0
M  $XG(         $DM<$                    D@$D$ $@"@ ,5%@2%><4
M@        4/(HVA]XL^IM..8            &&C $@        0W,D
M              DD$ N$@$PAH"@FDP#HIA(        ^NTB2AR1W/D#;U0
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M@      /X&Y                    (@)5((((-!(*+ *! I%"
MLX%JRXEX=(O7%DM@         !H3T MN0/H      $UHY
M     ( +&I(!#!()@#4(8@:G-        !Y3O82&#N2KT2X@'          !
M[',D$$:6D      *'=I8                   ))%M!+!7) (T94))A-BY@
M       !UF3[_KJ53H6W%"2          ,"V@WLP1^^      $)V !
M             )E$  ( (*)!-;<8,(0[$        /LY2J]%OQ]9I]$,QP
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M=#1MG3^5@\],ZP        /)$3B$8V9V!LN    !\G ((
M  !9!(0 %A9   #R@-$H?B        !I+ZX]C;]EN2H7:T<0        =2;U
M0 +Z!Z "[@    SG6#                  ))!,+('X1()8 A+$ 0*I@
M     5J-%AI8=-"742QORP       (_"?D3A%Z@.0!\    !9'<9(
M          (!+#,!:?1 ! )@K)(+$:         ?KU<_W#GIK4OKM8[P
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MY%<?K.?! 'NFO'@     "-I8P2@8_P F@ $;    &KHM(
M  @" AJZ  V0 D%&D*P!T,         ':YP0:5-L.W<7ACHB9       ?N9D
M D$*$H(  $    #3)$ @                 2B%)2  TR $"F4D27@@
M     !CJ\ I=J\\!5-X .?ZD      3*_$D $05$H  Q    'NJF$@
M          $ D@EX  &F%$) 1,5@@           U[,)TS9^-%*&&M,PHC
M   $Y@!DLT@7%H@ !9     --U@$                D@E-BX  V D@4FE:
M#FH           B=[FG4[%E-X*V.E[+#P     FF@$D$POQ("  #@   $+%'
ME$                 TDPI@   @@D" 1QE$0           '%J86IN&'PU#
M48_V-=@    $ B#@DDD&B+$  Y    B-D%D                 $ EU>
M4L@0D@@I$@            &HF0RU)>+HEJS-99E$@     :L $$ DF06   ,
M    @'P@D$                $ , 3  @F DD$ -EBF             U.@
MBX.Q&]3B5W#C95^    !$$D$$B$""=$  3    F$@ @D               $
M!D.P9  @$D@,D@$("D             +7#U+2['K[(H<-X8V      BDD$N@
MMCL$$  )   $ $DL$                 D(M@)   $D D@  ,@@
M     X@R#8C9R4HD:H@7AO\ 0   !"!A(!H,*6N * !   !![)!(
M        ! )  " ! !))+(( "!(             *#@9!5\]GA5' 5DK06P
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M "PW4 @ H   "S8 020              "!"0R\ " 000!  80
M       :N(G>@'T25NM;5/G+@   &8D022"  &X  "<   " "0320
M       "285!$ "  """"2"2                 ! CPT3%C=UR17@):T
M   <"28 23-!F" #4   "2"#@&"              "2X"CD ! ( 0$ 0 J0
M                "!L K)X3ABI*^KWL    "(2 "  #>B%"  X   ".%@4&
M"               " &#@  @2" #0* @                   1>5][C.>"
M9HE")$    3 & 2*20%&A  #0    #""L*"               ""P#@ " "
M*3(2 "                    "?\[-&$-MSO?1@    "03"0   U+4 @!P
M   "40@ X0             0#":3$  "" "P62$J
M  7K=SLM\NW8X     60 2C 2 2H: @!0    ":A<Q 0              "2
M,!T " ""2002):           "0         3?(E,KY %Z      #R:"  "2
M$)R @#L      ;*7(0              2"03H #"0 "02000
M00        '>!E!#C.        " 2"P000N?!  !L     ""2  0
M     2"!@3@  @""*0 "(             2         >!.?A          #
M&;"1020B3_0 @!P       :F62             2""01@ " 02002"0P
M       "0        !(0]B1@         #&"26 0"0 O@"@#$      "21P"
M             # 201@   0":0202P            0        ")2DF$
M       34J0""2 2?30   (       0&@             ""2*P!@ " 2"20
M2B"            "2(       "Y145H          !$B"220*9150"@#D
M    "!220           "" D@0@ ""00 8&H$8           "         #
M:M8\H          2V"22 0" 9=Y  #(        #ZZ0           ""0  8
M   "0 0 00#0            0        '@LJF4         "1Z68""8"09)
M!  !>        *!<0            0 R 1    0" 00" H
M       6EWYN@          2 2  "  02,A   4        ""$"
M  "0!T 0@  "  &"2 ".                     06VQ2           2_0
M0 :2"2"2E@  <P        2P            0" 0 ?@ !# 000P 0
M               &EHYD@             6P"2 30:PB  -@       ""Z2
M          "$1  )  " 220#":#;0                    =3$*<
M   ""H "2""2802(S   -0       "9D*           0200 9@ "A2"00P4
M7Z@                   !DX"+P         "&ZB20"202  &JP@ ,0
M    3T$           "08  3@ !B  " 202(                    #?U#
M2(         0"02"2"  00"<\00 9         !"             0<P 3@
M! 0#":622^6                    ? ^E@         60P@    ""02&4X
M  'P        !020         "2240 :@ ""  20220+ 0
M    9!3U_<         9*R62" 20"01";0  9@         :           "
M2$"  %@ 0   "0"02#.@                  <$PRY         !0!0R""0
M2$00"7%<4 9         "%00         "2"   (@ 5    "28  +(
M           !UAT'<@         (6"2"0 2 "271J.H -0        21P0
M        2@Z  7@ 0  "@2"  50"                 ?H&O#K@
M   @D@0430022/PN@ 88       2 .P"         2#1(  >  0""!2:# 2
M22                "OHEXG-             "60 32 26/>J@ 0@
M" 207P         ""#"  >@ )""$002062E6               "2_AD,#6P
M           ! $  2 0" 1!CV =       0 2""@          *8R  >   "
M840"0B"1S"               I):) :P<1@          0"28 2""20#O\V
M,@     " 00" "         "24(  &    22 20 22!"0          *<&_)
M4JY)ZS-_:@         128H00 02 *%TK "      0""22 "         0 6
M  "Z    0"2""022B$0       2RXWP:7>P4@R1_KBJ.          $& ""0
M"2"*'_J =@      02   4         ""2   =   4680200"Z0 0
M0C_:SPL&EV@7/QZ3>.7        22B2" "8  3%'U@6     2 "0 0000
M     ",1  ".  00!. 22  2 B*       028A*[MF8"-\6!H!E"$I(@
M 2R2 @ #0  3 WO@6     020" "200        "250 "L  800(B 20""J"
M"       ""WI9(@   $DWR$#W)&&(U@    "1022"R"006@EI@1    0 2 0
M0 "$0       ""24P !<  (000 022!<@&0                #A_U@( #K
M@S>R2    0$002 2"2"  6&P5P  "0" 22 "00         ""1  "8    ,
MB22""""2 @               "8M$[<   %3+X@    #2 8 ""42002:9 "@
M  0""2"  2 20       "01   "H    " 022200 220
M_P (A5      D$     4 $$$$  D$0BAV <  @ $ D@DD$@@        D$I
M  /  %$ %@@$$ E@!"H                )_(+O            $TT$@@ D
M@@DDP0Q T D$$D !$$@ $        $$D$@  W  L$&T$D DTD$D$
M         R XX@             (<T $$0$DB$D E 4$ D$ @%@$ @ $
M   $D@(D@@5  $ 6$@$@ @@DTDX                6?3("
M@%D@@$$@ D@@DH! CD$  $ L!   D @      $ @D@ D6  $! $@@@$D",Q$
M4                8=:/H            D" B,@ D@L@DNDF@'@$ $@
M $$        $D$T@  "  @FD@ D$ 4D$DBR                >8VP4
M         U$$$  D D@D%@G@E@D@$@$    D $@       !$E   ;@ @! @$
M $# D@! P                ?"PTT            $$$@D   @@ DDD D&
MD@$ D @  @          $DI   Z@ HR $@@ $$ D""D@               S
MN&@0            FD$$@$@B  @ $D  D8$@@D $ $           D $P  $
M.  @DL,@D@D@$BIU$@               N^$8[            $0P@@  @DE
M$ @($"$0$ D$D  $           @ @   $8  BPED $D@D$L@D$
M       F.2X-            !DD$D @@! @$D  $@@D$ @  D
M  $D$  $X  BY@@ @DDD &H&$                1GIDC            @$
MD@$D@D%@D"D@ $DDD $  D             D@4 @ %H $ AD@   @ $ DE(@
M               C+5&3            $@&D$  B%@D @@ $ D D  @
M        $D @  @'H !@D     @D$$'.                 SJ3J5
M      @D4@LD DED$@@@ $D$@  @              $@ED@ D#8  D D@ @\
MDD@%#[P@               7U)QU            &    & B$D  $@
M$                @$A@ $#  F,  @ @ $@@D!#                 <.G
M"G            $D D$$ 4  D D   @@$D                $ $ D  %
M$4$@  $D@$$AA @                81B#2            $P($@@   (
MD   $$@                 D  @D@$T  A@E@  $D@ @@$,%@
M     %<X!%(             $$"D ,  $@$   $                   $$
M@@$D$D  %$D$  $ ED@H$"0@               $SB3"8            0H"
M&& DE@D  @                     $ @@@ D@0$ $  @  @$D$ @B$0$
M              69WG(           $D$ ,"@F $ @@@
M     $DD@  $&T  , $    @@$ $P 4@               $3$'D
M    $84@$! $@@$$D                             &$@$ DE$  D DD
M@@D@@4                1<81P           $ X&ME ! D DT@
M                   $F @ .(I    $$D4D@$I(@              $8FV=
M0           $$8$5@H FD@A$@                            @ @ $@
M @  $DDD4D$@@@@              "$2T6            $D@D  @ DD@ D
M                             @@  LQ@   $D$D A$,$@
M   'G8W^0           $,DD7 @"@@$$
M @$ D@@H!    @@ @ D$@8@              '2M.48            &TL@$
M@$ @$D                             $ @@ D@$@    $ ($$D$H4@
M           $[]'X0            <@"D $$D$D $
M               D$   $$$@E$@ PD$0             $=XA$X
M  "EDL!R $L"@$                                $@@I@    D $@
M$ $@8$             !J5\2P            @5&$D $BDE@@
M                   @ @D  D  $$D@E D @B@D             "]D#4
M          $@MH@@(B$@D                                $ $@ $@
M   @$$H( DD@D$             "2FP;0            $$(D @0@@D$
M                            @ $@$@   $@$B $D$<LQ
M   _AUH           @!TJ &  D$DL@
M   D @DD   $ D @@$D@1P@             #I7=#           $T $ @ $
M$@  $                                $$ @@     @$ @  @D$
M          6X :#           @D@$4D@ ! $D
M             $$@     D @$  D@H              UG:W0
M,HDL@$@    @                                   @D     $,>
M$$8DH             -\/J]          $HKUX $( D$F@$
M                       @   $ D@@  DHC$              MD<AL
M        LH@PDV$ D$F @                                   @
M $ @ T@ DBA@D             D-Y?'           DPXT  $ @D D$
M                              @    & $$$@ D(!9@
M'V2,K           B% E$@  @  DD
M          $$$@@$ H5($             #;&B;X          $PD&E   $D
M@$$                                        $@$$ @ @@% $
M        %P.+_@          @@ $(DLD @ @$
M                  D$D$D %DDL@             %^Y<-0          D@
MU $@$$ @@$D                                        $D$D $@@@
MDEE@            & :Z(Q          @\BD D$$@&&@D
M                         $ D$DD@D$ @$              2TWKX
M       @P @@D 4$ F@                                        D
M@@BD@  D@A @             >3"SB(         $$@%$@D 0$$T$
M                                 @DDF D@$H@@ @             E
M)/ZPX         $ @DP@$ =@ @@
M        @@F @$ @ TE@             ITVH4^          $D $@@ $@
M@                                        @$ D$ D @  @
M      & 9[Q XX         D@D5 $$&$$D$
M               @$ $$$@$@@ &D            ^AYU=5QX         D@@
M@ $D"@$B                                         @@DD$D $ DP
M6$           $KHMO1#QN          &H   $@$D@D
M                       @DDDD $$@H@CD           ! LZNTV.P(
M      @,$ $D  B $                                        $DD
M$DD $@DDD$           2D5 ZXLH>(         "$$$E@ $D
M                               D@@$$  $D$@@           #51ZL;
ML\-6Z          $@DD  $V$@
M     D %$  @ DD "A           AL=DO+W'\68         DX DD@D"@D
M                                       DD R$$  @D\@B
M  SQ/96O[T\<78          @6@&  @ $
M              @$ $@ $@ DDA          /&3)Z  N%P_=         D@
MDD $$DD                                       $@@@ $   @  DT
M         %5"2<@  +2[TT8         $D$D $@D$
M                    $@$$ D  $D EB#@        !\!Y=   '7F(:\
M      0 PDD$DD($                                      $  @!@
MD $$D$% @       '-2/>     #84E5@       $DD@DD$$@D
M                            $D@DDD   @$ FD        RME  8
M"I"0-X       $ $@$ $$
M    $$0    P4P&R@      "$LKQ(      1ARH1        #@4D $$DD@
M                                    $  $$D  @D,D$B       CZ@
MV%D      '00+$@       M PR   @$
M          $$@@ $  $L 4%D      #Q=I&+0      $M.P+P       D
M  T$0D                                      $ D @@  $@@5@D
M    P\W?\         P_SM'       DD  $ %("D
M                     !@@ @$$$A-E     !'1A/F@        #,W#O(
M    $B$4$@@ @D                                       $D$D@ @
M$$ T@P     LYI3$L          ["^'@       @D@$@@H$
M                           @D$@  @DD$4$!    #]+9.X
M !12Y$       B5@ @DL D
M$@ $    D$$B$!    K^PK4Y            R</WH     $ BD@@B$H
M                                   $ $  $ $@$D$@   "C$>MR
M          !A7,H     $J 0$ VD @
M        $D0D@   D$@- D   #L@NP8              @^I/     $D($$@
M@ $$                                       @$ @ $ D$ T" 0  9
M.B6Y               2\Y3      DDBB $D @@
M                $D$$    $ DX  @  KS%6P               "6QP
M  $DD @$@$DD                                      $$DD@  $$
M$\4&  &3PON                 &B5(    $@@  $B$ $@
M                        $@ D  $!$$$$&&@ '2Y@H
M  (+"Y    &$DD$$ $ DD                                     $&
M@ @  !$@@@ $  #@ I                   X41    4 L,@ (@$@@
M                                 $$$@ H $ @4"@( *NG$
M          %@G00   @DD D$F   @
M       $$H  H$$D$  L  5,J(                   '3N@   A@ 4 ,$$
M  @                                      @@@  H $D$$ $@ T$]0
M                   !DGP  $T  D @$DL$
M              $@$D@ H @D $DD$ 6NR0                   &5(^  $
M@D0  @B(@D@                                      @D     0  D
M D@'E]J                    &R3X  $!@$$@HFP4@ $
M                      $$DDD $  $@DD@$'=H/
M %_J6   D4(  HF"D$$@                                    $$DF
M0    @$ @DD!5(4                    %RP X DAH$"@$D$$$D$
M                              $D $0    @$ $ D@G"3
M         !]A71 D@ $@D@$$@@
M     D $$  ( $D4$!@%!?1                    G&XG[$4DD @@D$ @D
M D                                    $ @#   D $$D$= EL4U
M                 T9IOZ  $ DD $ @$H D@
M               D@$  $ $@@$H"PD                     /->U#$$$
M$$D@  @4D@@                                    D4U@    P@$%$
MF^%*X                   %<5K^A, &D2T$ @ D2$D
M                    @ D@     D$$$!$_H=8                   &\
M(!$A EDP$DL  $ D$D                                    $D@ &$
M    $ @$ PP!V                    0F K!W$F! <% @ ,D$
M                            D D@@D      $DD32P-
M      $O8$*;]A @D D@D $"T$D
M   ($$ D     $$$"!Q?<                   S!X$#_% @$D')DD $D!
M@                                   DT$@$$    &  @S'Q$/
M              ]2X$DE@P  @@ DE D@$,@
M          DPD@$  P, $$DD&<-!-0                  \" $%6/   $$
MM$ @ HF$D                                    (@@   0$ $ D 6'
MS^[                  %V!  @BK0  D$* D $@D @
M                  $@         H@ QR7;"                  $"X
M@=     $  D@$D$(@                                   $     $
M %@X $F'J Z'                 $P8  @5*>  $5D@@$ @@@@
M                          D@D       @.$E;<\Q_P#
M      "  ! )00  %)$   !"0)
M  )    !    ( %:]KA#T:                )50  ! N>0 !,I () !
M                                   ! (   (       RT-"HPX
M            %C@  ! L.@ !)"()( !!)((
M            )!        %SO!(!X2Y               J:    (-LR !!*
M))( (!!((                                   )) ()      !*U]8
M(!&["               5\     .EX !) P))!!)(
M                 !( ()((     ')?I!((/! )!            !_L
M)#S&  ), ()!!(+)(                                   ((()(!
M   .G3G!()-HU#)(           !"(     .YA  .!(!)(@( !
M                         !(+!+)((   !Q".@(  )2;)(!
M  U     !-$&@!)@))))  !((                                 !(
M(!))!)8     X[  ) !Y. )((          'HP    !(*B0())!!)! ))((
M                                  %##)!#!   )@54())( \CY)(!
M         *U0     (;7F ))(!) !!$((
M       ((!)  (!(  'LZ )))  ,@X!)!!         -8@     (D0L! !0
M))))(!)                                 !!()!(@(!   &H2P!!!)
M /3P )!!)        !DP     )82[%(H!( ())))
M               )!()(!)$+  J"[@ (( !/[I!(! )(       )8
M*KC (! )(!)(!!(                                 !()!) Y()")
M"#"( )  ! <!((! #((      &2       -*A8Q!()  ) @(!
M                      !!!  (#! !@ 0( ! !))!!( !!! )! )
M        $R4!C(  !(!((()                                 !!(
M)!I@(8U! "0 (  (() !()!(()!()             $6Y,^)!  !)!))
M                              !!!%!(8Q^)"8 "   ,) !((! )(!*(
M);!))!          -B50)Y  !!"!(-)
M     )!(!!H 8 )")    )!!  ) !() " ()H((  (        (CM]D8((!!
M((!)!(                                 ) (((@)8 !))    ! !((
M(!  ())! ))) !( (       !Y\C%!)(((()!!!
M             )))((!(( )(  !$( (! (!() !)) (! (!!)(        ,E
MG,)  !)(((() (                                  (A)8!)(  !;=
M ))(! ))(( !( (!)()()(((        ,<1A))((!) !)(!(
M                    !!(:!*))(  !8+#)!! !)! !  (!(   (  ()0@
M      !W"H !))   )( )(                                 (()!(
M (   !!'M>K- ) !!  ) ()Y(I!!%KC!X       !3, !) ! !(!!)!(
M                              ! ! #(    !(82Z2B( #)() (  $!!
M! ! ()(        8.!) ))!)(!(!))
M  !)!(  (0    ! L/J2  ) 9())0)(! ( )(  (        (FX   ))A(()
M!(!(                                !!)) )@$    ("C?V1)( !
M!,( !! $)! ) I       ) )J1   (!)(  !!!
M           ) ((!((     (31/_ % R 22  (1  $" 2 2)C0      "  =
M.""0 (   " 20                                 2 "0 "!    ""/
M]Y^)ZP24""$0   "00  2 F      2  "1:0""00"00 22 0
M                   "02"2R(6    "">MG2^0$200 "  $02""2#2@:"
M  "   "14" 0"00"0 "0                                 "02  2"
MP     ";M/47_*0P3R@  "1040""  0    0  "0![:0"2 &220"" "2
M                           "00  "0P      1.-W4_!8@2")0" : $"
M0"      00     -&00 0"2"022""
M  "#02"0"      "-MOO!9<0204 " 000@  &""   0  2   (/R0 ""00"2
M2 00                               "02$0""2       >O/_\ T&$K
M$H$DD D$BD " $ @   @ $@ &^( @ @$   D@ @
M             D*D:P       "];?:Q&D=% @D  @  ,D@$"    D  @$@ @
ML$@     D$  D                                  B&&$E@     $!
M4:[;_)YI^( D $$!P,  &(@       @$ ^H @ @D@D$ @  @
M                    $@" (6@     $$__ &MZ)T)0'=;)(!1()!-(-A (
M ((!(!  ! )  !) ! (( ()                               ) (;!H
M (     ! TV)_P#_ +6+0$(T@DALDD@D$H D @ D $   $@$   $ @D@  D
M                               D@DCD#       $$RR"W.7?UWV!F $
M@@ @ $$DD$D$$ $@  @@      $ @$ @ $
M     $D$" $D        FN0 T $6N2!*@F D$DPDD$@ $ $$  $        $
MD   $D$@                               @DD$D H@@       .  !
M%RO>L3D@$@$  DD&D$ @   $     $$   @$  @ @
M             DD$&   @  $@   $7X   &'ZCG4 D$D$$D@D$&$@  @D
M   @@          $                                 DD@6 D   $
M@@P%L    _P7Y]T@ $$DD $&$  $        @$@   $@    D$@
M                     $$@$D$$ D       IM@   $7>.A@$B@ DDD@D$
M@@       @      @  D  $ @                               $$$@
M@$$D $@@$  DY     !_TD   $ $$D@@ $      $         @  @ $
M                             $D D$$D$@@$$  $@DG$DDD  %@   @
M D $@ @      @@         @     @
M     $ $     D DD$ DC^    & @D@D$$    @DD  $D @
M  $ D @                              $ @@$D D D$$$$ @  SD@@
MD@DD@$@D@$D$ D$D@             $        @@
M           $@@@  @@$D @@@$ $ $  D@      D$D@@ $@@
M  @D   @@D   $@                               $$$ @D$D  @@@
M$@$@,    DDD@@@D@ @D@D$@         @D$   $@ @  @  $
M                    D $$DD  D$@  @$   _D@ D@@$$$@DDD @D$$@
M    D @             D@$                               $ D  $
M@    @@@D       $D@D@$@ @@  D$D@   @ @          $       $
M                           $@  $$   D@     D$DD$DD @@@$$D@ @
M  $D@@@$               D@@    $
M $ $@      $@$          $DD$ D$D@@@D @$
M                                    $    @       D @       $
MD  $ @@@DD  D                        D$
M             $           $@$B9   $@ @@ $ D@@@@
M  @D                                         $@   $@
M       D@$$  D$@D   $@           @$   @@ DD
M                  D$      $              @ D@D$DDD@$$ @@
M   D D        D                                           @
M DD             $  $ $ D@D@$     D$D$
M                          @   $@      @@         $@ @@ @
M@@$  D
M@$$D          $DDD  ED@  @  @ @D@@ DD
M                                                      #@ @
M$4  $@@ D
M                                    $@@D$$   D
M
M      $           $@
M                                        $$$$@  $   $@
M
M                  @ D@D @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M5<46:>*%,,SN4"[@%0!58 JJV S7#+%! KD2H9J&41% P<@% N&A Z2&<?\
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ME BH!<U,!P990+;,!25"LK7$'@HI14XI!B"(* 4/#UW^*?\ C,'I$#%A8@C
MKE2<&H"+@2(T#2HT5:R0A@)#&^EPQ+5 B@*R8=D9I%@B"((B")X >:6A0B%R
M">%7$^L< EZ0!!&"D27$X*'*:+G  /K@TJ:'%2>D>O9?@0)1I!SZ097CR3LA
M8_W%V,Q9D(PL%)+$,^842&",$LYUB8\N %DT&&P8NA@*!8EO9#!%$,H<"H44
M+T3,D?\ BUL;U\JC9#<>4:, S8$1!&! 1,Q6189DSH1E2#B"2B*&:E\V@2V
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MI772N"RU881DD!;H<;TP8Y *:08>.O'SC#)<J8E\))6$&3C+*!E+7!K ;!#
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MK( YP%I6]KATZQ@ZJS&K(,BY:+KG%7D!C5#BZN:"1(:^?>]V^KO>^FF-\_\
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ME$HP2,%R>$Z<B%!@S@TGA(Y<'WD^?![XXQ?6GYW.-?#==_GXPJN0"<KL9DJ
M K@)&%%$JA0! F"B*.#H3E11R(J,(-18P?+A62)JU5LTWN8@L=FK-J"!,1F\
M*F(B14-%5:2S$$0S>VF#0@%4U)I56:0^HM<6[B,E)(*P*S9XWIE!IPB 0EDL
M1$PUBP#5< 64:#%4&RQ%.%&<"%: U983 D",C27\H5$Y$!(*  S7UEG$(54U
M*$J2K1X3.01.%2J  $$"A,I:TA7!+&5(8I4"1>JA:6<9.">@DES$$A1@E$Y5
M:YP0EL%!) (QYM[WPM]7>]//O?I_S[OUB?WGQP$?/'BX_NN]QY/V;[;IY9+9
M[?H.F_[IA)!R6#Z+(H;**3"!H10!!%0P,R&(1P-M@:&H4S5"(<$N+L =(NP9
MBA",,J9&,520FFCB(;$83I52Z%*Q 1,*4/H@#+PZ!%UE0>BHQ8D04I(BHV)7
M4!U,-T4]VP\YD@O#FM4"$)%##JD405",W"*@1!&LD*A1D"(C \2BD@L0 %($
M/$<0V$C@I!J)#%-#!5<):!!! A"(!CRZSW.]YT%WT  0<(@041H<$Q09#A$"
M$)&,0F$<; ,M0$J%2(%5<+,D8!0K:MUKP#$,,0N.EV.=DF99*3E0(Q7HPRET
ML$PBLV (A9C!E5(9B4*YAZE?=4 $,$ C(!T="( K( JD0"89JQ'<:36S@$P"
MZ("3**$PS"RVG$45XHPHD23$=#$5"T8AE4N9F2"@F1PD>.$U@ME41"*W1%A3
M9 :N7DH"$I$,F=,ZS)$,PD%JR4&9+11MGDVM&(@D#.4<DE6W(YXC(G(6@9)F
M\EJQ34DM-*I0(JD5J389*S5,@PGNDZA$9$2!((G%#'U(TB4JL2U551@!LQ-(
MFT# !G%]A$S("!1$!$:(DGGWOK[XWO?/$[WN^F-[WZ>;WWOAC>_7'!BOKX;I
MSW/EKIEZZ?\ -;WOV^H52[/+P%7H8+/$:UM(YQG@80EJ2-=8#J&%4#)[(#(\
M+XM[YU-6)'&W'#EX(@Z7%3T\N_SA $6C1+(  56,&+(&T, ,I"1D5IX,P"P[
MI"4HA"H)5,;F68$8D27"%R0PCD@QA8 A0,J2A,%$A,"KI!%E*I1]#?/&]WP#
MI1)&D$K0F,L&-1%1$@%26JQ)H86TYGB#60:RYZD7JO,KJD,- &&9))#)&<00
M59 <:2*N"1I)8K2E<ZP'OABPSI *"$$D1D2E<0:()" MB$%HBQQBK5HJMJ@\
ME! V:>$F8D@4DH(C -.%]? 4%))0B;2$)P2D1008:A#$G4D28"*!QY(" ! "
M    ! %,(SU1$U)K92S1,Z5C#0LIAL4L Z907 (%T6T14B8DI6B5H833 0BI
M5D#+@)C-H8HI8F*TE@@&HYH$I"530L.,RWK6! ." &T:I,H@X832;(G@,#@&
M%R5==99;J^>N&Z7-O? *H#J%[8 !*R_><CN2SB+'YB\(8I9'"8#9:PM$%%(K
M%I)PHF-G,@5HS#(Y)MB(UP?,:NRF=ZS%A!;V,I$X!S"$M:HI,,X:DQWO"\+(
M8@:E>*7T:WF8/C -*TMEEO)P),JB D3@J-0EEL@-2X"Q F#5 1,OH;/'T\V]
M[IC?+;3PWO?OX;WOY\OMIRV1I_SX#L*%L!E#0 5: X*CB:[,D",Q:#4K7 P4
MB6"B0CD4);DA9,_Q 1,DE5&JDLU<1QX!BJE=2"L!9@(SC 0(11<&S<XUL4F:
M "F1@6*<X&3.O*:X0"L,,DZI "LDS R X&<1)D:LV(U%8HR32<RDI)8JV1@L
MT1!@EOF#)E!RE4&:L5*-^V'\L#(?)PMT,56)P(6(_BJ8I)B TRP18H]4@4C@
MA D"67Q0(JN#3WI+S9M $+8Q(C+,Z80K,&HHXJE$J)&&R$ X (,,(\"IJ38.
MB,(KDE!2L"+A%AI"!@*L H.4$(HGT:(YBB9\]&>!P%$8Q;0%$UB*%$F =; T
MIA@ BD=%:;72<^M<.G%LD(%*:%0!0MAT5QD@SC0#0 *,$XAB)KJ4W3\X:5R!
M_/YPEBVA >@((5&'"FN#WO M!$274 [L"E<9*D4HJ!M>*W*4;E.>L:L#").T
MD(*2J+&@BD,CE8*8I5(M=<!E6"HE4)$O165&9.5 $&$@)&;48*CHN8D@ &<Y
M18ID-LBT28?K<C!(B&)#*,D*2":1$H1D $F$.U!4<24&!,LJ!V @6/J&67QA
M]3"F2R332"EQ&'%.Z*A$H%351P)$S78R78@U&T&H2D585,@*-XF;58@I%VQ!
M (HJ$LD-HX,_V"<!GVNHC++)@81K@*=I]&49*4) (,X0AE.A.:CU#PIX;WRQ
M\[K]/>_UX;VEL;V^&]]O'>]Y?\COES\F]^OEW??7Y\N[;UW7P.*Y<@@ 5%@
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M'5!-@.4 A0R* *E(249SO2<9V"*:B$+>,UXY1!B@<OR:4*@&$I4&25-J58F
ME+'7G G"CH<$1RB EHC#OJFYRP;_ #36_P!3>]WK]#@W(<B6OO#TGCB*B-)9
M$UTLWW2/#;/7?+PWOMX;=Y_W_@.%>?+7GN,9SOC\>'IC>?S_ #PW;ZP* 4
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MNU/#>]V\=\\2TH\:E/7'OZ=IWKAH+$P\[O'A/20Q%';:.>5Z^V.'O7^XWO\
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M#C%$Z5E0(F'5R2;J\H%556ODY;K7>OB;-]\;SY;RS\=[GSQ^./?$;[]-\H/
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M*\.&\O7P[1G\8W%/C\^.]^G^?O?IC>]-\8\=[C&][Y_5Y5\8]:X52!#6L.#
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M$@  "$ H%H)MTP2L*JT(S7*E%T,'. X&4TTR[V@$))5=$Q(O":V2LT><E,*
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M-_Q\/SOGN=/\YG*E:[UM?QW^MZOATWITP4/?GGZ^33G7U^8\KXK%?+!&5UK
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M53U.6:S!<Y0+0BBI49F2]@A;3H@#', BAS P40:PU(C0,X&XLZ+K&R*M $4
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MI4G!AZ=3F(5R"E]!G!E^ .3E2-!LHUF5\/14<NY!9@9M#0P@AH@$#CW *&;
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M"+EDJE9P[*D2S,DP'6&,R,XC#%R""3,F$Q6[)D1G5*&!DE@5*:DQ^*8*5%$
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M"@&TE:%(JP8E4BH1E7K568I$XF'P88*B8D:NJHSE)0R^P%'U0E8(;VPH(2$
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M?+<XZ9=K4WIX.]Z;KCUY4W[XWOX_'AJS6$X%FN4VTG%:\Z<MS]I;'KOA^/\
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M%,*!*D +DQ0BI$Y:QAA$4)4JE"9JJC3I!@ZT46I(HK+H8DDF#.X'=2-6@4#
M2 40*>*[/F*9,5 DJ3B/DQ8*L(( Y25AF<49/ 20D\@)6<%I5> @4=)G)F*K
MG.!1J"W0V@Z"0%DD8 ZW A5\@2&XG59PU#Q%B4K(1-+HS6< AR)Y%5NCD)*U
M$'$@T$6$6 ED(+>XQ#B1"X* BHBHM)D6G (@497A"*UFMB>$4'>60 N0J1KZ
MIM.!FU( "<QSFO+-M@!04)CR'N#.,RN'FJ(C840"Y%;U(3#4UD0V 4B8@:H@
M0*/UM[IN7AY_;>^'MO<>,TZ]H;\NI3MB*#6!O:L17C6V*9JKZ0_G\86!=,30
M2A)'+I,5ITRF3Q.8\MOD>VKOW>S]-_?"G&WSX[_/^1O?ZQ!$91'3W\=TV^0X
M].5+]>%"\-/+M^P]./?4RONO^"<&.A0:2$ @BJ)' !K)54,22J,S W.&)929
MI=G5$;$UI$FN"1(3!1D@DUK,W:L."Q#.!5!!2PN*9N=&)$J*L#1:ME60D47"
M'3(0B:@D .K1AG$]Q)D!0QH),K*M=440!V59% :)-X:N!)'2$EJ3(@FTP*H.
M!6""EP%95!E1%*:"ZY96O#%7*I(21DHB6045Z*O?2V"?.%@'))9&P6MI),I]
M2L;B4Y(7++$2*M2A8(FL)9!M+RP$!#RP3E)-?0AEAI R"$$ Y)K##1+4P5,,
MHBM03)R*4(*X#%5# 91MD;[L:8>@,23".TDMV8FS@XE!T4 0264,(U9H84X
M2-$40JH(1 58K@MUVE2(0"*RF*5K:6R&X0(L78M $K@8DAB$@N 6:E(D&"L!
M@#$2$,3(?-*L4SF&N%DJYK0H%<Q*S.#-$FRF4$Y*SI+QOA#!(4&D)J&D&[,<
M:8@G!(#,1(5I88SM0M. 9*DDU1)8M5%K*5<K2 $2"6D@E"H43+ 3,4G"3@B
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M0C[?:9\(Z]]\>/A>^^)I[^%:TY5_5/I9[R_I]'^S&4VSTKKEP$9I$7YM_6^
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M,SI?T _F'*(6$&01N)'4G"C45C#**V9/'AAH:0R6]T%+(5"SR,&@M"KY62O
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M%G &SLL*AUF $#-%$A.-H*H9P16H,HT2":4#AQK$3)5P?I+(C-K,1435:FK
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MSB%&E10T(FUV@]3$C"3(BE><YMHH9T8Q*:P)I6:UD2JV;:F(':2A%C4,R!(
M TZ")4DB:J&'+ 'TQ17$)HJA62!((E<+.#0T4T+D(B(SB.1+4KPR9"^7? V(
M+",5.4B#-(FN!U*5!<+2?2 @,? 3@^) S)M85)D*0JPA$"-"C269G.>4$Y.'
MJ$HMFM.0M,KE2N9" 4)"41"B1$82HDS.:,!B&[((J91I619OV,5G.WCO^;/^
MAWV^WWOM]@=1PR@@"52@ *M#!R6CT(!9)8&;1P& PT*VH32KQB8I!6A>=,"+
M+86SM: U2]F2LF)NHP&8'CJ+8,0*" 4N$EB?75KARFC(:*WE-(E:_.*!%):L
M419'-1!I>I+ABB0@+$(+0>(2I0ZC!JF6>(595DEJ,1*"HQ):<MJ*J4LD0@CZ
M@RIN*7*E5S44A,"(F7 26E8(0@BSA2<FYK$T#B,S;KB/I'2!M,1LU&$"7E\=
MYSD,P-)@7]H@;O54)4B&0P"H*,4O%(X7;TSI&"*B:-JUUI?GGUPCH&%5&:Y<
M2P#(HHX%G!%+M,$*I *'V5Z)3ZVW'3]_\MZ_6I!I2/CQBW"WAO>ZX_6/GZZ5
MHF,0>4  "JX IJWJ!1.0J2:8IB=!5LZ$*3RK!1C V0"R@.+7C56]JA(Z-2PJ
M&R3E<(F]>+K<)KS',U2K^\*M0@YC6<HI+2@VF4:#$*X,U(*)>(=2_:<5&  H
MOD!+:8"; :4Q"PE8HN10O5F<VDY A(5EGR"J-J3(DPI5565JK==7ZQIJMN%P
M^J(2A$,'\24,Z(UI7+L9L*8A&$MU#*2;^Y5TUV$"PIF-\Q043(XNLTA--2R:
M8T"  0$ ()1$1 U&91P2"+09^E8;<2VA@ZP)KE-$Y17#-N&"CF-F& T$=T#G
M&2J/*@$>7V$7-?G 0!H1Y_CT\]O^@WOV\-]\5ISKRA^8\N][R\,\N.L?W&^W
MUP 5W""2@@ 8?>8H82(S6PB6F2< ! B<ZQ%)B;Z<:S@!*@A+8 OP,Q%IL%*.
MH(4J"[-2+10IFQ6C6XL@E"S+SRS-)P5 @%0I0]Y>%YTG FH)=K*DHRUIVMH8
M46!8C.TYP]:F5*$4)R27-+Y9491R"8M.=X$;41+!;01#@N:O0H(%55^N*,C"
M5$N.N*9YIDP7JH!N0+DXR%1]<UKAU)::SGJ[OV<*PN (0EG4*C.,<:6EA P-
M8BG4 788@U-+6.'2.5*6C L :,4S-9KU[YXJ!4SS=:^LX:$ *7*K "#-45J9
M9]?3<;I]F<>/O3T_Z2VS]?8N:Z2JB@6"S"4 G >9L!50I ##JU<#A FL=C-N
M)I.3 <49 )J#FMIUO+&*;5*CJG6%DE2[$M2"=95!OJBRTT>M!PD 2T@)2A$3
M%,ZR1&:8),DW<PY@,S--!G1Q62 ,2*Y2USRK-X3","#E58FI-R,A"66JZD-1
M\-X+RH%R- X6N 6E5L%BP(" !]BB9 @@&1$J(U$J. ^@J@ .@#25B8+%DYYY
M/'GKGSI@(BD1G61U&9BS.M<(.4-1N80B((&C!)L0 @H$(I9)DI3$4:7&YT>9
MZQ#; A9"O&BG-B:Z:8)M1TND5%1%!EUG#&<&27A@) Q$Q%C['>]\_I5EKR-,
M9[I:GSY-_C_D]OAZ3J9VK;Z'/S[]\-GK-,NY[X&>Z=F,9^G*]=-,I\-[_8?4
M(<QP@T^JGPRK$Y *"&1 EJ C-%)%JP@<.W\Z 0%"E8FEC%XY38+.'XB@J3*3
MR@FN4-8P0%*"3>E69-2\LX:$YTU=*2B+K'$M(0F4I.2>5Z%0U=%C!,%@@5*3
M%&EBL$WIJ8:-1#5- T'0I0%$@29F,S!!(E!4F6>8N)6&-Y6MBL6(80"#[-@?
MPE8&1 $1$23$9DAT&N8&2&K 2TJ!BM&U./M-^E<.5B(,,F(%$@8B6%SGA(;5
M9($JA<05"K"0U)(+Q22YP(,DJE;.?K1HQSLA(HDA@CYXX)S"3&W-!V(,B# '
MC;**KD2HR""4?M?3_G][G[#>]_/AO=OK#ZZ*""2@U$L6@E PIX:L5/(FC5AG
M#Q*)2+4S.=#/]RG1@4*3,6$YNI37)/-%N:\4=JMSIC72-*A2II-)U5F20Q*1
M8DR6L1TK::SK@"@"4BD $LN45RT;08%$$*W#&2(ZZAH4:P"I9I)+!%(5I-JH
M7*DE3EC U%B$RI"57A?995E*HKR+!0 ^U!A+\ I  1'!L;D$'0R0 ,UR)8+4
M5K>^<Z\H.#3 5.A4DB4 9F\T*X?4;G#N!); J0Q.(AH 0P26,RH98Q$D2)HQ
MQZ6W-YBOQ*,>E(H\>56,)7;0*:- JJ3IDD#?=J%_Z_\ 4;]\]^OD+'Q;I@]J
M>@_/T@)S*"%;=5C  :X,1#0 #(EF2BF*08-!!20DJZ=7*O%RC#4(EA"P( Z:
MS.=\$!(&QPE089O4N*+5PD(+115<SHQ#PF;&*CD)&-+5DFK2EZS6(Q'$4RI
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MH(& A(PT3T1")*J!*X!#8)*'.^J<<B#UG"9$N@UA)5)!$!B(D5H&4PNK'RC
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MHIF&$J8!2KY#(220)$V$H*%H0ZBD) #5*HXD//<):B8H,&1(LF!\WAA,<U%
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M;&AM3D(:X0\9)^6*Z$ :TP6I R%E,D RF@(H<*I15*K=5E7BM?HM)9>$@4W
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M#QWN=Q0_[W7>1;=Y\AO=<:;WS>6?F;.?FW3GN?/NWDWO=?MYU=?3[^#WIB<
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M?%^QV>&]]\:;BC]J2F $4DTD$82+#A^^<Y"_'2LP<H,%0SC*N4'OI7@8B]E
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M]\NF\\&^[OAG]K\>$%&.-<IKW\(FE:1G>]S3WZ8KR88ZZ\NO@_CWX[TKCO\
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M ,=NZ()* S6 4S,JA:F$!*H(>8/<RUPH NO)B0J06!6#,:J!I%)"7$;G?/#
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M'3"N!PY_B9]_4],;-Q1OY=>&Z>&S7COCU_\ &R9)CSDR)X3Q]9:Q&5X^>DL
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M%D2);9#)1E3FDGW"\3?)UOB%B+=B$E0&KE"MMO+KO(ONT>?7>_7R>F\]Y?\
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MS;WW\P!0 E0 "ZJ@'%:82E(C  96/&%>%<,AUP$>5!)B9AB]KF$IK#ZZ*)E
M!SK@I0 + EGE,AD2+H8@A($0.)9N%2\ E,T,0Z<P01:PR!D:WI52"!5H)@6H
MV+(VFN#$(HE!ENC.S<AF,/A&C%!2L*F8.DJ^(0G"4)'*:YFWEX*BT613$V3,
ML@&6V6$E,* IN2.?"Y)=,55D**KDL]&!9A$F&05DZVXM";RI-^&)F] TU;Z.
MJ:PK(##XU:!1(*) H20B0KA&K AQ0!%B+@$?D2$!5)8DR08)QWLD.FD002H"
M)JIYDQ*T-[YY:^%0A.PHE0IE ?[0AQ<FC+(A?)K6EJX 19!P9FA$A&>" TG!
M0-0!5;A"L#E*PU<"8(< &P0ZJRK%!IC.]\J:95GG1N<? $P& 1*(E9$F1(B9
MIB<Y%&L_)DTS:B3)Q2F60J(MAR)*PP*$155 #4,U1RR%%(DJED4B(+IN(54&
M"3"60*"<IJ4"[$1R8<(M@B%15(5E0TSB,,J2L"@+E%;0HJL<%<#:!(3$(&4W
MG*)GH0JC)MZ0:Q+67*LWG M#2R4"YSJJ)8K=@"0-(F(EBI<U7Z+.7KC>]Y>+
M:K$$3,X(>K@L'(LE"9@A%"@*;N(XHH+ %TQIBJ#OAJP7;ZO6^MN33"%!/;*N
M>LOO3$4_$ E%@&2"9.$PG@R0*"< Q8,)A. #?)@XA<[" T3PWNO]^EO>GTN5
MND;_ '.6/W^N_CZ[Y^.>][SR]=_&Y?\ B'=8^A^_"-[WW9\R@E !*L 1=6P8
M!0#(E;)*,T(TF,-&*).A%.0V4F2=3*M!8%BI0;#FH"*H5#"B!0,!H&58$L"2
M5- $@D B;FM"$5!EQ@D8"U01B@("&1K@MG@AJ)HJ"."$9&%8*R9:D*LDY2JS
M6K7!,$I95'".$I16L5G"3 *A&JM%F&69US",/58X7F2C2G*3G*4H$!$%$1(2
MT)$B0TF:8'J&$$.; .$D1!!3%5=F4P;Q*@G(!RQ N(F&M28D/W-&6V$EWBFP
M4EB*R:HD1K@DR(HD2&=(@R(6(P   !0  #0"AA#7-"D$*+4"-"4:)$P*S07$
M1(B$)&:*CB N6 .01$"X8DI.*N1!P0612-(34V*>2M-]_P S>+X2U)9GC%8B
MO33./"WJXD52992I<VG0EU(+8C7I8IPADIJ.1I&""#D%!$U*BA2F;!LUT"BP
MQK:2DNWAG\<M_MIA ^KPL?BAC,OE2F>O*.MC.:G.C1$16T41*C73#@3R)0!5
M%#H)* ,8D M0,B, 5%!84 NE$0 %EVL-:I+,0S'ZPFM!;%).9(-3\L29!41-
M-+Z44@=)*8 5S4247AB49*L0)E4PV,Q*(UKB5"AC   "@  X 4/&M9Z1^?Q;
M7ZO7V_&#Z5"<X))(C42HUP77(58G$N#$P9*$3#/@AURZKD!&R&2,7(,YXZ<:
MT!;=3$X1QM4.'3;;!IK1F"+RPF"EI0H)A_@: )$2T%>; 2YX36,[^&5(=-/3
MP_?;<3Q\D\'<_CU-?(=N7AO>V_FX_KPBD%.5.V+;[OSB_P 8^=SX[>V7IZXM
M_P %F;C%=\N/'3\^-Y[.^OEK^?[^O'>^6-[TMY=]\.]YTRQ'[(6"CNEDQ"^$
MDSR4X.JAE8F@X0%()K)2C W,UBE5C#VNT4#B*4W,10L9PN,("((J O&P).)8
M4^%D(!)58 59(,B3ID)C"T(*\YEG+4F:/I1+@H=8\F<#+W..3Z!INRT9\23B
M%=DPD-"JK,75:C2=+1PJ,EH PYPC.;JSF3&203,5KVU)RCCGBP22]ISIT[T(
M<%F"\'\?DC+$H(SBF=FF4/>^D8>4E[*)NZ%K$"JP$@RY+A0$58AIZ%<;WM\(
M6"Q$F HY&7J.>& L("A$"$-H&A11*8(KO 24%B2F("<(03#9$&Q N)DL$)#7
M"4D4,-%HP.<-1\G.VY\-[W^<*5 F63@)BJC/*\X%$75J-1H3>"U36CC!(BP6
M4KR8+98GDJDC<:T4K%J3D.4LP@C9"14)&%),QD>)P]_Z=N5L5WO3.>F./&F7
M#...OMB8NQ=F0(&<]"].N!))-R2&K LBRZHB-<9*XNFZY13AEBQ,!)0F+JG"
M]]))<-6JXHHRA8#2PP9E,Z]=K]#--#LK4"M!)CR 4O 06J&;D.LD<1@  * !
M &+3_._T#^[KYM[IN7QWNWC?5DI+2(1+7)-$13!59"!(0JT10$!4&?"]*J:1
M$5K8:9<:88:=8R41TX%8CU@OXH>L:X")$ 8D2($8HB 00I< B:"N)\#&$+(*
M(FE\>^_UBC'PY_/CU]N]OUP^K?<?N>WDY].'.\XWOUQF]O:W#Y]72TVC\Y9_
MW&][SP3G'"-/#U]_B_;&]]_]VV_C<XMC>_3R^D?C=N]SZ&][_7F4!5@*JV#5
MP>9%H%B1+P7HUF!E!DHJ6XM8%9  4(*"@'482*10EDJ"M%O*NJ $((CF0- V
M5FD(5I<@M5:&55&<IB @P--C1A2)6"PRCP-3 +,4HRVZT\P,+@<CH4>R8,6L
MC,J5%5IF 6@"N,E(&)*4$T=UD1,SB$>(D7OQY3Q+S;"!%$>-IF;WGG3F5Q1E
M^=OVG6S$.'24:XH6JKUYD0K480G10IQF4S21@2%13QD&C*!:$$H2HJDRHI.'
MK4CS%":C,!(JD@4'<A(S 3)5"A8PCU!+29)40*I-&2GC<J=.O/O6NF7@]J4>
M/+A$[<4JDD-YZQFG^3#B3:6A%2X,VEND8HBB'<Q"06HB 9R6DPI'(@-5H"0T
M%89@-P]! !4'2F,SKO=?7%[-,]]9[=6@JQ%56A!5Y!FZQA'-!:@;"%(#0U=Q
M-P2UADG.G.L-N^AC+ZPH6'E2PZ7AEPK+-6>=F1SCC(5'51&FC0F:C1.)S)(F
M)@F1NQ.>34K0F!   >7]8WO?O]+9Y-]_'>OIGA!N3SP,=\K 7,&(7()*"&JC
M A 4BT:2UC0HA9"T3E<,[5K/2<(I0B(Y&Z\98PASF]+.*MLUI5R%< Q"$2E\
MDN)29\-[[8W9-[UQ6M>7#\^&]_K&^7AO?IVQO>Z^&_>^_P!=/WX,^CWR\E-L
M>%9MQ(SI4=A; Z68>>F.7X]\.5MVY?JU9QZ?C]X_?IY;?[1O+?SEX5_?Q'SX
M;BG?;T\_ZWO\^;?/RI8(N -5]"ZT,3;Z.P@9ES<B;"@%&)M"\Q0R&M9SNU'"
MDW(*NXV7 >%%KAUY F"S  E+ ">;@Y*9!6"$)$C-0;*P0HNA/'%K-4KX[W/C
MO=,>_P"_B?YX;[8:UZST(@0AP8;(X5(&M4,M#9$2"59(U1$I W+=(=>&%%LM
M:."+UW2G;7C>5K%1*"DHI&)"%AH"'H,A3$-W6LW3-) >"E1M2!D.6NE\&8S0
MDG2>**!%!$,,EJSJ 0TP"7%C%)P5.X""-,F 3"  "F%NFZIA2CI(Z>7TYX4Y
M@<F!H4M5G.2\"JI#*H$DWA,-(G4MN,( 04FK2B$R5BR,0$86<$3+G)%F256!
M,D(K%ZYOOE\8M^=5?SP.V,UZ;KQ<C$&!"[ DSE0JJZ 2LX5Q43-ZQ*F5$J%<
M^1-BEKJ95NVG7+*88JD@ %5: *J6"+KQL*0T!=VT+6C>-',R@PS@ !8 H!:#
M&]^F-]\ !2V]?KP.^(_!Y+;_ !Y4:!D0G5HKPK4</"(TRM$P(AR@< 67#CM'
MYMT<YX8(\C+/;NDEC.HSHQGS&LEG0N1#/)N<'QKLR[^OI]"-ROOX^OD^</X]
MZ8O9_N\L5>%"*3"7_&M\'KGN"<-)X;W?'KX7W_,<.N^7I3&F]_SPWO\ 7^]K
MOMKZUIY./Y]MOAO>SY^AIO?YC3Q?L15NN071H"5G2H-5C:&3)NHF$BT%E&Y5
M30246FZYLRT28R"0BR2N!H5.>G3")Z:X"*2I $05J02I%6(F0HJ/2]5+S8"/
M$_,1\\;^.]^L?'COMN^-Z>V_3P1  @!!N(T1SDQ)71-($*NBN= Q+D4R5 B(
M@&$1*(T1LX1+X$[T9OD^W+\%5 L.&9 1% @1&$18(IF$ NRR+,-(00@@B-1(
M>(X@,+)S7 [BIH5*7AI00@(BE5"I (F O(Q$U-P!8&8<X$43@J@-1H 46T:1
MY 5RH+J*!Q6 M7,PF:EFJH2UNJO&58P!'() D#26149O(LVP0!$EJ &HJM&(
MJ50B4@8&)"0HITH@I<7EWMO\X^*7=SZX;Y)=48BX+I6%ND,.T8I5"D555R+J
M4 @)'"331SI6JD0BX(H$M  RFD 55M!*L0,D#4 #")0(A9G4I*ROO<WURQO\
M=OY'AO7>WR<O-0X<.OS]#>Z^3+CKC>^L]_$ @(0B2(Y(XX@!)+R,^"YE-(CB
M"FFL3.NDA[UQ:I,=(KK^GT9F1&0ZO?.OH_58+ZY_O3^>;3EE;I3!SG=?7M;P
MB%K->W++PZ;WM\F][<6*?CV/CPWO?Y/^!O3*/?=>F BUOI'5)*MUD%[ #VEP
MF24'2U--9"O& BK?0-)8SL9#HDWFI)84'WI6D\K=[."8*A*I*BS4(;^E@'Y*
MJ$Q 6U<54\(/#\[TRVXWO7&OS/O^+>9K3+/'++(W'X\IJ**8B(((6B 0FRU#
MMC&H3(-FMRB5*(L%ZCNO'^X):<^"?'MK3 2%\5>RU)A($T88M%(BK T)10@@
M36[O=.:!"C)("-3CTJX&A!H]'A*UG73K<L4TLJ!THA(:G,@WZ9F4DF /#I[5
M]??P@E24#%)N71)LF8;F&K9NL6HS?2U"))C7#(XE@605G)<@*Q5FU5(;H7$#
MJL#HA)FX*.B@\P+3-2XWIOEAHJW4%4= %>6&4LA%B*AI#%J95:5-01*,TI%^
M1CT2,\31I;0IT,M.-ZPU).@TM"QF5(#=F*?0#=(\FF]VS_N*'#-_.-[J^3>]
MY^7>[_14R%:R6'\>G'B$T#]9?. /Y&_CJS]'>^>/UO\ /SY-[+>$;_7O^:^-
MN'Y8MNKZX>,<)U9.M[86.\4^<?OWW.-]O'/*MM>//_7WN_T]8*^^[5Q?VQMR
MWSQO<T\-[-OGWOOAD)D.P:JP%5<(,SR:PL:3<F:$E(.!X52R*9B.-N&4W@I;
M4X_JOS^ 6706,5MF9*SF!;& W,- ( "D0![SX>N]W[^.][^9\3>_[6:^=F*7
M[[TI."QG2^N"01T(!*0:UI*N:4B 1, U&1$A"4"*%BP0388W3-,37&U@#40L
M@(40-P,F>B\J&=@ 1"8"K5'YA,E39>2 80,6FT8!&N$Q!H#'F%F"MK(2*MZ!
MA7)P!%+FE8@ #A5I5#0J._@\IWO7EC3<\\":I&ZRDSIT]<7,4@6-(M&M4Z\&
M!=+53"DB *HY3,R)KA@15)*B<RK>;D(5!J@R  ="/8PQG^/7+#J*4BJQFQ2D
M]7'A,TAB*9N<\RCZ9PV<:*SDQ%&NLN4WO@=D</:I:R0!25@2< EIH@ 0 %#I
MY][Y8WO=Z>&>]TIWQO?IS\-OBA1TM?/E]ATC=\;W[<L;WN?6+SI;>>Z<<9_.
M^FSPX_.YQO>]/K?OTQ'?>^\1..'QN>7M-<9PZ29VCCQZ8==)?3!&5LHW^LO
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MD 45#()@J$MB6QT.$+//"%U43F44?"G(W)8IE#+!?#"HF. K3 :W2SLE/#P
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M:IG-UM6E?;"@29)0ZM:[.F"*36-,Y^.&='"]T!(  ":5EHJ*P2(TL33)LU%
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M,@TS@P"<I)2",4H%B4$C@ZJL(R44&I!/"E,J-,3$2K;.M[0!%!M:S.#/%!Q
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MQ23/A?(I-L4:4M:5B@\+VY%<1+M+#!2II,TY37,P"PBJF6.L60*!K&+!,%S
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M6[=.-NEZ8)TBA_.GC.6GSYOFN&GIZL>77>_[AIZ'>GD* :!Y@B=YK\_9*F*
MHJX05 FDSRPZ*JDJA"S"16D\HBL5P@AYH0<C*([1,1@D9DG6*S$2O&I\WPS
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MJ*RU2DII18G+(P55\T4P-10 0YY9-@6%B&M>4:LQG1,*(K"S2"U(2E-(FG+
MH 7IG-U$O/%C2N!424AA9)HS>URTVPEN\1<(('44O<EXXF8@HHX*P4!;<9N%
M,4'!*(XPP:#PI"SDWQ6$%)D:)G/*\1*8*:ELFX0)JE1Y9SAC"00(002%A-5*
M1;"N:>TBYC*,0VI(7P8C(!657@I5K31M6,5FBE%1"9J3%8,M%,*09'JC4X:K
M631!X88J %\!0T5&0&5@FH*D30 $P!!0F:PDQ@B@U(T@&E*QGFRA4Q(0*068
M!691<1$V,5)*0!5A8(HK,+,P@X"BDRC6) 8XS,RWR>+H($)F0TUAR6S&9B+D
M.7)")<X+),)KH^LE'YM_,;<HB:[]O +TC.M[\&,PUUL8UX_SC\8W'CO==Z:>
M3?+?XI=QIPPU.23T1_N)4DX ]26.'YP6)OG]'>]QCUWV^DQ%;9X(.^>KI.YG
M#2KEBO+7\8W^?+?_ !,J?CWP&M=]/BGAQ[\<MQX;Y>#O>>"DWO+UYZ</? 1J
M\[^5LXNWFSE$?G/+4F$:[]HF_'N4)DD-;=/+O?+YQ\%-],;<$-32)X3A)C*&
M8UT\=[WEC]4ONN;IE7%=]9GTMC>^W/$%>/W"2(V:. *LD5:T/H+4E%QP0YE9
M,XK>8J176M*842@ $I(545R9N<FIB-$!+"9E)O?20733!( @*FHA6!Z57H9X
M"H$#4"D%:-+VYF;8I9()"TC*TK#*K3Y J(5M4-*,2$%I9&:UPOJ *U:BF:-N
MW4"Y,>!HV&7TA6: S@;@I715V@5(JT,4PIPLP@B (R_7)G$%?B9-Y,$3% TM
MAGA0$EL&'(:S[8%2L2E20S?V(Z1.!8!!,K043<@YS-*EL&.AIDA60JS&\\.$
MLZ1"5"LTS8-$XS7#))"-3*:3$P#,3;#6FI$FAETSB5O(5EPJ))-TI1T8,S#?
M69I#608=D)+:XCAU[S@V919H$9B$FKA1ZU0H0223*A VXX--4!6IC2@2Y5%C
M!3(24TR#0A:(J%<'/*Q&P@8,IB4U>5'FE)9:AB$RW8<*;4$.21GS(5Q)E36*
ML@K.F<7DRP@L62RE9A2*I:,B(O@%UD6$)$O">%BA.>&*$&DDR&MM")9F6;F)
M4K"(<1,YP3I4KE3!)JV&=P<T$-4VUF8X"-=7W@*06" @H_5(:G.U][IBTL][
M'A[TG3$912W3>G\]O:_Z^AOCN^'CG1OGQ.N7;!2;5(B\6M:(]W+&ZS/%X<@#
M'Q;/Z.M^=/3/N8I^.6X^E%9K:(R_N/?>_P"8Y\Z+\7^=/#2GZW;]8WK\;UP3
MZ6O'YQNVF[_X_P"]WWP\-]_+%M#@7U_D>:^&+V")BC(E&.D5H\*XW7+$$CF6
M\;XWO?:,;W^_[O<1B+\?">#U'?>ODK%;YQ\6?QC+?S/SX?-NWZ?N0>"$U8H0
M"@L@DT32$H2EUN4,]<H:6XUPY*PF*Q(N9/$T[7P, L3$27:MPA,K3%+U>)"!
M1D+K6F-2%&-,(U)B*M K%2DD<5O6<0*D@I696:IT4SRF(N4($E4*BA554 5:
MHIBI$9GU)*@ALH96V*97IAE"HKFTLLRZ+5H":DQ=B!K7.5(E !"K\30HAAAM
M&&B(S.:KN22(RI$X$SAR&@*0@-D)DDO+; #H 1=(:T45,M\,%2(0E]32OX"K
M@JY! UK-:LLR%=,\5+,"UK7XUM,-<VDTB@5'C-*Y@<QR7$_1"!L%)0IHS+2(
MQ5FL4.U^HU$64L!1-3!J#%THT!BD!AT,]8N6Q"D&J6T&,V9;,3$A4:E?BF"Y
M(R;(%,$%2<[&'S,EEF99TFDV7(PTQ#6(4N-%$LZ.!$V:$5I"<*,"ZC#22N&1
M&82J.8ZLG;"$-&,DF2PS'%X3:V$%,1SM<0@;S2+YRX0O8,FM;03*376=<!2)
M1(N;SJVH)62^4P[$62F(J:K];@1BH@!)6]Q6&(=>BC@EV(*Y&#G61D,W/ZO2
M]\;W/\\=\O%_'OOY\-[],;X\?AU\D_'KBDM07OH>MLL9;WOOE.]N77Z,_KBP
MJ=..=,L%C?O]+>Y\-[]<;W3GZ:^'KEKW]N?CPWE^?\7>GFWWP[YY;RORBL].
M'/GYIK&N$F.#/;>[D1QU709*6ZY7\N][KC9?UK7Y\2<[Y_K?>_B]V?[Z3>DQ
MCARO6V;:O>M<;WOEC>_6I#;PY>D?-/#>]TRSG[8AJ%R1RJ0R <VDBF$R*O55
M(EH%1RM1'!!A "L4)J-[RW,H.:&^:Q>(A"2*!&0BH1&$54820D*U9B%*1>X<
M<2B:(9F((NKEP;%"V#KUB@U]@+*A*!2F6'("4\")D;G!%M6'E$9HE@I-7%P&
ML7Q2$4S%U:%DK)=98@&$N(%%(D8%;Q?L8(T%#6!0,%8RGUQ*^N6@T*+23KQ.
M(_>5="@JKF19I@<FH%&0$59;RWX9.B!2"C&<TIWM3M7209@:(*(6>36EHPH2
M<R1*-,M3.<*Y!DT,0K:DLK6M[8:25%)IDMDBC4U3A+1B/@U P:JRD 17 *N)
MH7E!%9"$#E,"RGD99 6)*6LQ7"!!FBC+475%Y3:[BF0(S6H1 N@1-E3 +EL(
M1@R*J%RI+B0(8<,,P9!50,@O%60$*)DB;OO:3A3$0:BB#E+5;F?/$3G,R\#(
MB+\9-;5Q4P)5A!N7TAI29*S59PE2F@S+-&M?1*7P(*%0B(OK*7Y)K33!5A(5
M%FM:F429:TPY @3B(F$P23Q^79U);BR.8O-4OUPN@NBH@&G?ZF]TWJX6/3UG
M7XEX>'I=_>G'U:_1GU_&SGX[G,]^'[Q.4DY\VO/EVIC+<XWW\3,TMJT)][^4
M F)KGRIRI.1DS;!:\\==]O;&]^GTX_<UM:*P:_O'O[>//T[]-Z^&]/\ %MZ]
M_CE^/#>_UX4H]G!N*^&Z\_C+'[WOC]#??SD1P/8^/%W^<J&?AO?XK[QY;;GO
M^VO/[E&D"MEBS!8#"!<#&PK) T5<[<$NB5=$G&5 "$Q+>BR1?VRQ%$Y4(1!6
MB7(Z1@R""P H:)&3%:07Q*I<PY:DI?!PDFN&7C(3%6H611.>0,,\Q:U0B$U%
M*E,UM9<0@"<X$2501E28P<JZMHLE+Q$6FC,8 H& :B2@2@@)-FO0R$BI1-+F
M&;$S.=DS%@7216+"2T;7AAX3,H.$ID(Z$).(  5#, T00E+.D:8<+,A$7*UH
MBTN41-[X%L(A)1 ER6];\RV%"F:$(L3#;,TRC6F#HN 5>$&2*3%:1EBT*1%>
M"P'*I3"G$LR98((9"9L +=<3BA)J@2K2A(,EC#B)!1:(BA5@Y7:1?!'28@0@
M2BJUF"\7F7,!$HU&S'6FRP1ALWL!J0ABZ0L+?A@B8(5B9A(*52K4"LTR,1 (
MLVH29+"4HWA5OI0*MT1(@I$4+ZNJ5Q,:D)%<Q-+/!UR,TDADS9E8R8[V9:X1
MBXZQ&:#18I-C$A7E8ABTL9S1M[3ARF0JE)!*()B2]+S:!:"-")#(F$BER9OF
MUSD39)$4""K0(\49?7(K&OK!O/X\)K'"?)?K@_F\O'>_WX,ZZ>]]?;F7"JWH
MTOD<^+S+X9R_G'C&F'+ATO?G^CAA:AK.S]^&]]O+[9ZNZVX8M3=/I%L^M_7O
MKC3??7U_T-]^+QR'3AX/*=\<)-F&TYDQRAMYY)#6W3PR3USWT\D1O=#+QWKY
M?CU[8_M_O@<8"P8+T"-"!$3$/8J" B)*@<AJ!4PQ7#D%X%B<XF9B^"D&) ,)
M454RN5M829P%_:RI,JUFO)L(D3$UZU-$(1 +Q-<UIAB6K(,I4RD@*D6O&(GP
ME&5#$)$D3+<PHE6L*05*-+WR99UPK@:**$E?+67XIB&B7$LLUY5!3EHUQ.Y0
M(K4E48B(&BC@0 ;5%@0 JK$4*Q29P"YPE3(+4"J!H\9PG+7J>HBW1[SB1,A5
M6C%:#$H17*:&N!8&:84JL4)CG6"L7#%,D) #!59E8Z'%I,.&G(F0VE9MUXY\
M\":159=:)(I#:XSC$=E2J0H"3,I/#A0<%.I*$TT #=J1*K.*D@J4F02\V"HI
M[Q%,,! 6UDA$W* 2$P41CT< 2J(,^JN 8IR\L@IJA0&'5$ XG="31-6:@FDH
M"+%0+A"@1'"5*\9R)@Y28LQF*0"E*KDZE:-;82!4@2&E"..6N7+ 4(,-2P(D
M0:AJ=\L!DHL!#2Q:":US_F)4B"JLK,/&*RRTP06;A)JS:6C6(;VC#)-&0@L5
MX'OK1=7*T>%,I\U^64/J:W_FE)]^&$G6\T^>'DY_CZ2PK5IPRE\/K2V)02S^
M]F5,;WZX9C2IGE/R:5KA"E"E3*T>F]/.T%TQ[Y[Z_4WGP=]M</R>Y_F/?>].
M?ATG=_!G?Z1Q E2]\K>WOK]"CT?4\V_WN,^'GZ;F_P ^.FYW3VS?#Y]M[H'W
M==6C0& 4DP -%$B+C%="S7(7+8)O-<&0>@8II2\T=Z8EYY 3#NBU,CFI2T+1
M@RHK I42""+T+1B+ 5$W@M BI6F2X6X!(PYR14RQG%[8N60\3$J2UJ9D:6"J
ME8 ";S8BPS#UO23B4P#,R*Y"SI8AF,3'!0H@\0] 8:23,7!"" V$8F1LDP1H
M3+ X/2(UHD0U)GA69P$DX#D7FE)4.!3"8+0J.;G5TRDU,\6@>8%!K-(*K5YE
M,\ T($*$)6UX(BU4XN+E!B;)1ACA>Y29K5<0'J2$#Y.@:'"2FI/J290H"9IH
MH16C)6'T/<32EZ(5)FL."F<VXJ*WIRC$D%)(P+5]DS!-1;M%5+W@$5LHH V(
M2ABE:1@6, 6 <VIZ@"!.+8ZS:I=$*%,WBK."1G!*7@$K*5OW.&($(H3;(R0M
M%;\6]"<0%H S,E:Y%^%.?+$ 2%*",P-XC.:#%'A@TRI"S6,Y<BC8KF9#@ .8
M).:19@HB+^L3@<P*V=)TF"*Q%Z8"*@?)M-J18OUKA16XU8)'>A)T2S@9!,R>
M_P!G\^//>6_B/#ECUPL2Y1$/!C*D5B.*PV2D'!]$BO+E>VD6X?S'.+TZ6ZTG
MZ"]73C$]+8&>6NKP];])^D;WN;^&_;=_U_E/'GVKX?&-EWUFUJ<.%-_K72?[
MX1[SQSSROVI]?>]]OH\-TQILI^,OU3[R"\11F.8G$ <IRP@4D!&$2B0S$S\S
M&&15F B&A$Y%8<HBAB.09+A54V)J11OB8EF 9.@&+WBDN>((,P&0;)G)5'(U
MPD9$Y&)(J)D*RRP98;4GC9@-A0/SEA4JK(!1FNL$H-.$8(& G41D:I%XXZX6
MX14%D5H7DRF]>> 1I:"81$$E(8<1=,$%H"6;R8F31H5*S>(TO89"8L48O1&V
M( D3"PH4N23$E2\UDS,I<%49*6K/%^,JB&BSUB:D($UFW!I0"F"C8M-%:A=K
M2JX'.'-HA0YAJ2 4RPQI T"GJNRD^I@&KY$E&"IDPBL#7$118D(H!(2FL)K@
MTH*4NA J(@JQQQ+\0\RY&95!S(03)!4DQ'=%B5L,/&U<1",CJ2R3?1"D8IZU
M2&)J;A6X%HS&P4A J&C/3J9TQ!-)61;31D/6>E;8@AE*DA3( I,Z\.$S$DR3
M"E3.7*O?W4%  :$K9NE'5$CBY@DQ1BLW",70IE3M*5.I@ER60DB):T0[XJ0H
M(W%)$4H@TY:89>@1I !XC(\?I[WKAFD=37^7\7M^\<O)-4TY;[^3??P%*KLU
MZ4](.GDWN_T-[TWR^IOOX/XMSW/#PV[[=/\ &WO?QCK/QP\/WOKY-[G<6I]+
M>]_/EW_?#>Z$<O#?OPW[_P"%'G"!286G&L8&JI!"@1&JPDI7O@C(! 5 EQ P
MY!'4190-UM*4 IF0V5PL!+X4B9$*4J".,X?R"RL*+&@Y>!TJ?!)01A8(!Q*9
M.&!I2<!U+64X0S6<1"BP'@G4SNI$SSQP\%%J3B1RKG2VCYBH$+-(L5O2&/2]
M8; %,D-ZPUOI#*LV"-I%02UJHU.'IB!$071EF(+&J.M,\2P9M2*4BQ \TTJ5
MK$:;F%Y* WE,\S7#)$) TNC4)I,1PP))R]E* 94(9:.9AYDR9G'U@P(7MGB"
M(VDRF"(C6@A2F#BM20HH":RQIEDX%H()%"#)*9SD$K-97Y,=C%6%-L:(H,R)
MA4562,KN55*JSSK^&H/8"XBH0LQ@*H-02.B8P58,3BUVH<*")1&"]LH"+  !
M5-4A4 A)#6'22IO9T!*-]!X#I:6%F;+,>Z7.&X/)Q<DK19)HUB]#E0T:X8F&
M%FR0GCG-K,-9H8"5@229XM0C.+TMJU&:"4B09B%M<&;G,SB(C,#,B%9F6")A
MH5F<7]+RR&W8B)E$1%OI^V6\O&^M)_'[/#/>]YY>&_?CRW:*O'XWNF-^^]=?
M#EN;OSQQO?;<^$I(X>EYM2,^$8 "GYWTIBI;1SY&7SC3<4>^G7'7V_'T*Y[_
M #SIR^E73?&_I/CO>F\_\K9YN.]U^O?>^OEV<*;]O)O>^_WQT@R21&1&=\//
MF(),BDTSHZ,&4*D!(16*53@I&9+>F ((F"ZU+H58IP&(Q5]0<J2R<^)RAFET
M*LHJ:NI%"W(C/ 5*AF?6Y,VI 68((8K;"4J3*,))%I@%*!:0Z7"N0WSJXI9&
MR $$J(TF&U5*PUQ3L8"%%$I:L&4'&6S@ ",69$C%4EU2%)O-7$-)*0*K(82D
MG6.N'$!61D9R2HS<R+Y8?&"*2B$T2HSG$-M9D(UP1#F2U>]9PUJ!)RU,N),N
ML5MB%!20UE0H$@LVG3! H]Z8D0D"*4U845E:1$LA."B:$%P2C$YM0(7059J!
M<(Q<@2(.\$P1 -"I#3I(2$=>$4N)YX+SK*1%2+B:)+4X)Z!5B8.DPPDS.>'L
MZB%4*PNL,I#+"]*8#((4%QFB)2$G"*QIB32:U;7!M4K+"2"%YBIZ@9D*LX@)
M1+R>)4K2,\N$SB1.<B5D:VLS1M2EJ9T@-!*U.)56JUI[P(55\DI1SHRWDD+A
M-3#**4<4"-88IQS7/7!I)D-4*LT<RH72M]<1:#"D*J(86B8.*UC[I)<76/3!
MF:)'  IZXBZ;9:21TUXXW[[,:4]J;M3SSOO^'Z?'I;2=^U_/7>F7Q_CZ<-U\
M*[SY_K]?0K+I2.-Y^GO??U^AN^FZ^N/G/?Q]]'"!UI$"*U0ZW:%K#" :L3%2
MV:]82("L5PD0D14Z7KI-^618Z  F282VT*<.)9#6A1"A"@V8XY<:!!4E!EPX
MJ< 9$IR&KD32J)AAI$(F:D8D2!+0LPB5  6 T3& K. 0506% (E,UPJB(B!E
M!62M!FI,50TPQ7! @*XYN.>HWP:$C28@(SG)XDYWP@,@*:"^7+0L::4Q(XN-
M"P9EJ-Y,KTP+DPIL$0FI&2UF&< H 6RRB&6-)2Q+2(C"QQ18,*BP5,BC*\B8
M3:FY#5A%)1"*P32S%2IXD&@BPQ*A%L.P.LKLP-#-(O7  #E2BX* !A%(!B6<
M',YNXD&05"8B.&CV\Z44B[7*0%=7D3M)5<U4+52, A@BZ3]!(R3(XF+$ 108
MJ%FK64DK6<,.U&Z)=E%X41"X,1&[-ZH)HQ>6J[%%4B EJ!&M3:+TTARPXDEK
MDK+>88G.@077(",U22Q%'F)K/;3 E6\3 M")LK1;UGFTQ1-&4E87,ZO'XB4H
M(H4 595DR7BS&D8C$54WJT+R<-;,W^GUMN,4MZ;Y^?>_7S:<?POQBE-)JXVC
M=,$7*3%<^?\ 8Q#5E%.>YQI3]8 "#+SP2Q?6O'UKK,<,%8=O'>MOH;X=O#?;
M?7S;W[?XV^^-[W3%*<;3^&MG\^4W;XUO]3>]^WCPW2/-TMNGMEY-[WE]\\"K
M("H5BL#@%45I&C8@BLU212%"ZSFPH0;H"7$S)G%2&;4<L1PL""E@K-LC3GSQ
M$A$5\D$H;A(A*L2*3A8VKKE<%21E2M;F% B&#@%4X6!(.;$(19Q0%6H5!72;
MX1DE(;21"%)H$J4Q.0@'*U4B2LAK2CAB0TEI)" H@M6A6:!@<$9-- +;(D7M
M=8@ ,<!B3(!+!U);DQA^L*)";LD-1,MZZ&!>&,R6PHH16L0(K-< A30KR=)R
MSK:L8HC/!42H";R4EUX&%J0&5REO)(S!-$O.(AGDUPY(D 1,7O@JK0@%  ((
M;Y!K?!,(+%%$G50&(8$V,3#Q0*FA&>RL% B##">2!!2I2#80M4*S*8I+@9V(
M1E$87T@ 4A6C4$ &G***@71()"8>=><0P05 $'0*2R644<+/>!5S+)=F6$6,
M*-2Q-$-!!,W H,92XG(8 +T6&Z4JEJY11U%Z*C<0HT'+-X5.: SHHB$]$S3*
MI-J9XR&%!69M28RBB](K.&D0+%HD* F3DS"4SQ,YN^6RE7.@0TEX!],9K6^<
M?&7A;@%-^V-W^D> U$++TI"]>&WH95U_F6'-+%?U-^->DZQ[.^=*<^6/[7S]
M/WPP94BG;A]+3??PWO?Q_D:[_?DWO?QX;W%/"M:<N/T^>-Z;KC>WWU\*YZ'?
M/&][_7DKZ^F^TYQCEOE%Z3C][Z_X( )!$<Q(3")#70*O,6(4+"5(&! <LIY
MV%&6*Y<</[:*-QLJH,EB;S,1BG)5JS9D70H%:E[8-3>BDLIAI>1J1AB8"1F,
MT)BE%C:0Q/M> %*S)N0I5$DA;#))"HG FS#4EHQ-1G[ A%J0K1E"TUPL[</
M9"2 *6R,TEH F0%#9,8!)2#019I(B"88ZDTM/K.%"XET"M)))*>MF<,>,\A(
M'@M+6009G HB8!%55.*G3OF8>P4%92:N=;1%CA3"BK+8)H"$S$9UUK:#"H"I
MI43, ;Q7,BL5,30EK"!:5,69)OKA6 >J8%3HMB.ZPQB-5(7);/)@4AIAQ5"2
MZXT-46JE((P2C#HN9RV)9B$XX$N#A)]LPU 5 R3@PT")59)G#-H21SL80NC)
M5""*W,-9I#2:1@%<(E;*00R+>W#-T0D$C)+%[Y7YL-9&5#.(YWI\8%)R&,XF
MF5;@1+?MAN\6A,,-)O2^37I%\5!$BV:YD4X998*5&3#( H3%.T5RBCA[< @:
M583K,@9UUE^GO3$VX[ZXS[?/TM]O%<I9BTC%.]MURMTW3#<Y_#X<OQ\/MY_G
M!8GKP^KNGM7?+_(WI[[Y>-\;UMXY_P [?/7ZV][_ 'O7RZ[W?WQUCWJZSG:/
M#?X_;C<_&[?X)@019D*;*\VJ0H5&,\4C!"2,C(B':<,&:)@J)<7(1$7FM)8O
M+(95%.T*0UEY8,3VJPP7K)!)B+F0B$R*$,DS<0H*@7C )#0(LB%%!22L+KB9
MPN=#@+6I@L-&-,1-B J( !N)6MCC=01!2&S[D(2UO;%"64LQ8#A00.9<Q+&#
MQ$WF2$UMI6F*6B02IE6I>ULZS.#,0C%L5B')X,^F$0$3 4)94*2T)RR@PJ:"
M](TSB)=;\^",$B"XA=<K#F0H>F+U2M00<59NTDI2..%;@$,"LFU2$$($ZQ,A
M""-01*-H>?1<YQ-&Q:BDF8<BIPDP8B+,T ELQE,R0DL&EQ,AHF %H$"DP,!B
M#:=(10"I60&BC*21<1=$DUA+0J$LQ"1A#51-0U12J1!REI3"*&FC(<T"Z=8[
M@1D4(DBJMZ1KPQ%AF%,C0G.,C2)=<3&$14JYZ9UK0LG*0&:@$+RK/$G0F.,X
M=$X%E*U&*!>#2[.&&&!@ PL+^SA1)NA+"2E"2(_;Y,*4U#W/I-G?MC/VYUGT
MW;R9G?F;3Z11GC>-2+ZZ?KPC;6.^-.?PX")YKSG<=/H;WNOTM*-?3>G/PZZ[
MZ17KX;WW\'<;,6URX\/[WQO>\_\ (..]]>;YUC>ODWOGY]_D]/+8K3]_O_%<
MM9"Y:$LG@ 6$<(6QJE9"8"J%%;$5K&"$3"HQ(*# (T1SIQQ<5B-G"D%@I!E"
M\X/M:I51"R8:I;V3#.#6QA'.8L::Q@D Q0U&P[9=D7$O9 H(G1N$,Y:989@%
M A%$&1<-N%[RR8#.AJ&HQ:(4I(UQ1W56[203#.\T&N >&!3*)DFLC?L#,XC0
M2%:J9DR61J98&C20)0D)(V9BEX*CA^,J10#+,)ZID,TPA,C194U@RH,EY;4P
M"+L5E:5R5ZN52]<$81]"-,<J(K8$UC$C3'*"L1FK-%0(,C$D&P-6< )4JTLS
M%","$H-@1$4:7DNVJVKA$Q>@H:Y0RRU=;JH"L L,<U&1D0RC !25 (%&5J\U
MAY-0*35 <Y@J4F:5'APK$:NNL36][$VLQBFP#$B[-8!F9QK9R &*""U4+:CD
M1)E$F BB045"*UA;LS!F6@G#)5$"P5K>7@%HB]Y*,JI815K,N<'[XDDFZ%X"
MIT'3C+7"F,7)2(D")I'8)&2[B@6Y-V?2M/*W?37U\,XY>L_C&;T^IZ&$.=?9
MIC+K[[.?;'33U:]K^!8F^?FOB/UVB/GZ?S:F^&<M;8_._P!]=,/;_([V?CUT
MZ^>LD4+K\'//\XM]7?XQOCM.W'&O'\!\>3/IWTKPKEGC>]?'?/\ PD B")"-
M1&XF&[8($$V$PKDZ",#D.$&PRE8F#(@*F02CZ=Q:P-6&[J.-EQ-K;7E:Y,PM
MOJZX9Q!H-QJ)6Y0SBD%JF)#P\IS)0OQJ#:,*J56&5E$RO)#P@E445*VYP1;5
M9X5'5**L56<G$LFDPY8:I!WB6>$I)95Y1B6C<2@JW&_ @/0P6%9-:U;"I=M>
M]'B."0U(BY4*:>J872VA:2A+YW<VG),.$QF95+64F:7=>!A'T 6 QAB%!4;Z
M4IA>2*%Q.2JU3(5M@51(#1I,R$782]X:XDXJQ4C@2Y8 ZF9Q(,(0"=X6@L2I
M62B8I<ED1A"R=9:5D%R<!JM.0*#@HA(K3$(XW,E%2M:$E(MTH)*&"&;' #?"
M4$$+BW&E9I(&9>%9<,3$,&0E:J<Y:Q%L-1"(DIV$%!R=*3A@YC."ZY <K,U7
MP56$*@-:1KTX@R7"0"<@W=2+0XA8%B:BFNE@J4OPPIDE@"LU@ D.3&KQP$ :
M$?2OC3A^'>?+/QXY[WQ^EO>^^-[W3&>OSXZYZ?C^Z^>&I%"W$ADO^,:=_P!>
MOO;Z-:>OZQ\>3>]Z^-]_GMCUUW7_  _CK^\3NGY]_'>?3.G'7P9DTS^/,[W\
M9VP4 T^I:>[OIX[WWI_C"B(HB(C")41*B-G!^J"1:#UKE5E981R(B!)EIRJ\
M,,SBE0@!($A-F%*2:\[(**(LG-25DK$/#A:&>4T4"%FE52S2 =#E +29Z+*1
M!T80R@+8$LPRI<7L85!8Q24@)>!SBDLOIA96)F9!&;RY5-,A6B8;824)6)%E
ME*PS=IB="T1 A-!M0KQXSA!(5F24R5!*\*-+87"E*9EY U0FW&KA0P:"$5I$
MYWN->LD+%8,C XLDI',IAWC,Q*  5#B'*OA; .&( (%>64?7+ 0P P"4U&5"
M[EJX0M+)#*F9H+.8-8:UC"$&$I@)LHN*K,VSP<9#_2=5J-074.'CZ8LIJFQ(
M9.MHC#50V2S*FEFFF=XPI-:&8&)RER8K2V1+0@&Z49NEX2J%15JS2'")!0#(
MD7++&;8*WH5PC I(0B!JLC?*M3(;X11*5B+EEE&)Y2:DX=%5F LLT S6LQI3
M$-0@PQ=P*:2G,UK6(4I\,"IEO"!O;3ZC?P>_!L8^>?\ #Y\L]]'A>+3S\\WV
M;_#C*>O3$UA,AMK/0RCPI$VS<N_DWO\ ?DK7TW/X^IZ[Z>.S'QOV_.GCN-U_
MQ*Z]?+IW^'W\SJL1_*]_&?GTYQY=[WGX9?/\\V_GUQ\];_'I_CE5!*62FD2@
M6642F#%YS!"+),- F$+YL4W0$)5$-4A$A&LP,8"P924@*F:3(44',H3$R2R(
M652#4E9+QQPP8: @@R)A$NA4B3#%!"B!D!I-'6+Y6P!B:*L5DO-Y36DT83$M
M>K.66( I-+3 LIB,4!J$0AED8CA%\YOA0N;5,B85/E$R5PV82 ;D+%6BPE>$
M%1N'Q(B;V&SSIH\!54H6TEHW(64AB%P=5*4K0BS", 15BN""0 *&<2A6I<(%
MLM(""(DZLP-I(JIFL7M<A=M(K<JJ%6*#,S(Q/4)K!7%@DG),(S NIU*TAT,W
M/" VIG79E*5UAJ-<.H@@L,*7(YS8CCGAYDK!!%R]C-#$TJ1@$@2DT4TA"^3,
M3-%F<(1 ;FP'.K',SRQ,H8F1*@%XNC7I8F8Q A5@5F M02&1_? !J,JB5=);
M09Q2F"B@K$9%^5HO0MB,  ,0P(-85A92CZ>]Q_<:03Z0:_KR[W[<O#>^WAS\
MFWK^\)1Y6M/#AB[-;1PX<)I^?(1EDNGQ_?-N<:7MN>/[^EG^O9Q\>G#P><<=
MS_G9F])[[K&-[WR^MLWWZ4Q>_#E(Y=?WXUCCO6/CPW[_ *SZ'^4*,C"5$N.N
M$1'4!"+5@IG7R,&"JKJ57HA 6)7Q,+T#KJ*2UD"N80I*#MAM 5 # 42S.032
MK (0B"D36,YBV$)(U@&JU=)C(ZUQ/,-41&&H%1 Z77$I*2L2:#IFEAB\6I80
M8J@D@JB9+4*C60F^%2""+A&2)0JC-Z,LQ.(<6050K&ASB2^!C4PIC($242.>
MDX!E%JT+51JA>L+;7+$Y)!H*C7%6E#C7.L,A,A&5692+O'.ABO(G"W9:4-16
M@,3(+W*0T'JPM#'-*N&6IDBPIM%,Q+SQ#8JITJA$!DN70RPR0S2S;,U0)4E#
MG&"1 $%[%;!2>-<$55X(K @:"1MUP)U!18SE60M-Q6*IEB$1$5;&M(3,R2RT
MNN#[23, JLPHH#-\N&)B0L,#[,(I)=3>N"P)"5P$AJ$*0R2A5@$@ !8 @.A]
M+];ZYX(XWSGYR]/'>]O/R<_#V]<_UQU\GKOIXJ27E@MI\?N"#P+$WS\!OP4_
M'HGF^,M?S?OQ^H^F<3/I\5MQ\-[K3ECTW\[A\*SP/7^6Z\/#/*?6/Q./WO\
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M&Z+)#EDH##J"@<C(+29O&F"%"*L*Y R:>EC&G4C$&K2YFEI0E"(3F(UJ'8+
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M*Q(]^5\4TB^ B%B/[B$29O?]MM7",U=-+GXX:&"256 *RLQ$YMHBK320$!<
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M "!'+!S@H"ZD 55 QU1E1+ .A@X!P,*$TS]O3%@5"O\ .^%!W>V_3$ZY,@)
M)N2Q2(5%Q/LKS=71UB3WQ((MUM0UFJ5ZXH#F5]1^?3KB-26I,""5TI-H9AP!
MY 0&4 ?'VA-9Z<NV*7W6A[XK.Z;WECYWT^TSZ'S^L;YXJQDE^3?3N4DC7&<D
M<>+E7^WQ7KZ<IWR:X8'C,1:5B_I7YCS._P ==UC S7[4.>E7?*6M._W6\NV^
M_P!'3<\\5SK\:7TUO-C3R6^MO<^&N]]L:;[[_>+^IUQ[PQNG#TEQO>V_^.=2
MSVH9BB]QN,+-99,@*XD);$EIKIA)&@4DH"G7UP(P*TE183-Q:ZP*P!IHD!&+
M<LW2+Z8&4N8T,WX?-<&(C2:TS/2E^N*Y9@J3,(<JE'\(?9[[:OZUU/)IEK\>
MO]R<;WUY_2SCGZ1^?H6\&HDUC.\:\=DF-[CYQ%5BNN]VG+#RUWRI[8V^5G3O
M&4,Y_GAF>_YY4R^UF?;%RI<M\?=<K^&]^^OGR*4TTY^WG)SOO?YN_2Y>&^FX
MG]'EW[?K'#KO=:Q;$VXZGO,7RQ^]^EB<O\44-)J59PWH9($:RA(*I"4JI+5J
MI5EFLIJXBXI0J[4[8B9U)M\/'GAI,G[T7WG.T8G816ZL+*(0F<UUPZ4 6!#Q
M T(!%001$KRCNB?1OK8OBI+U9[!ZL[SC$FA')K_< 4BH8>=??X^UG6G./H;W
MOW^O%(X1X%TTM[\5S,N='$FO'2F[^N-[].V&EO:?;2_@Q%;>3?1_,?.6/Q?E
MJ]??[8ZOHU[;-?NO;QY\[=O;^4\Y$4MOWO\ ;[Y8-ZSG\6XO^.^2&DMV*Z-%
M6; JF&TGFE6E(+  "@  !1"WK*770*7TK6^%0W4_/&]N$.&,T+H5N_CWDC$\
MS3FZ?W SB$3 +'2 V&'G7TLJTH"3216T<JX0F7#S&O?>6"P4L_%/4P #C'HI
M;XP+@*IS,$.5#:C]QOTC?'Z>=\FG:O3Y^AO?ILPV:Q2^F-.//GTSV85.L!K/
MM75MHY^CW]OUTPUY9[<FIU$QO>_?RP2.9N'AX$Y\?M-[T+8]][<;WIC?ZZ9_
M<6N]_#VRUX_K'&MM-?7+U[>6Y7B.7#UR^B4]?5G&^WC^_6KZ^-:\Z<H/F?'U
M3W^/#3T[/Q/CIO)QO?IC??\ Q63@$%/5+H8^ 4&SF,-4@$Q)H*LRJ@R"U%\Y
M.$/&O*U81@LJ%I:Y:=*7PJ/ CK-7JKZ4Q$N4<:V]F<(6/UU]6>F B$2Q,A#+
M-1S1(;XA!-TT$1H H+72C@4;T.5(/[N<'FU[)E?K_<* 0M0-:->4Y83>$PI,
MIR !X+QPRX](%31D$:F?W#7]>.Z\_G+Z&>=GEEZZ=?'7>_7RVG/>6*UTYUWQ
MG S->VIKI&5_7#\GHU>GOK,8Y5F*Z[]::$$R_CK1Y4Z8UW_?+[?R/F<9\-/N
M&"7E^O?[J]S>_2^F-[_>?3RVQ-,X8M*_GK?KYE@G>]TP,U\V_CR[WT_&?AO>
M^NOQYBU=^K[_ .&4BNN%%QI)<15)@R32;)E!*Q6 Z#BLL4(7*E5R0J<UJZ81
M54XFO7+I^H3D5WU]L%>=7.7WZY3#AP5DX:@.6HSZ85#4%WS]L$%#KHL JU !
MV:8@PO;,+*M8E>D6PJB:(1RO;AHMN>#9BN:<8O76_#4P;6*=6AN=DC2DUAI7
MUX4M3#N02HT25DVR)B-5GW#>Y.C'5UF)X8WMZ^_T-[Y?3/7.O#+A/+/K>'=L
M%/CEO^S7">CWW?!:_)8K-? XW\7+>^E>BXSXQOA]O/W&6M,\^=/CIX1Z_.>^
MGT,B2OM393Z3.3''SEC^^N?B;W7%_(?GAGIOU\+YG,YUUO:_^ $I1>%Z+.'"
MIS!U)E-#/'U0*)R2$@HE"#>"BTR<,I#-595<V4:LM67.)JJ0C*JD3ETZ<XP@
MJ5<W$Z$4O."<XX1@H=G+?&<&)"MP[,GMSIBKQR,7@/"0HN(-4.\).*L18&9G
M1IST,.4W)GHR96).DUQD932<Y@>4:Y]\.2L + <L^RR]ZF%0K;TV%\.Y0T9)
M.I>$[F5< =@#"B43A"A96Q#[?C%?7EY?E?E\C^/?KO2_COG]!K3?],5F9II'
MSOEF'SRM37VCEAK\\77&[>5?W:VW=G/AOV^>'W.][Y_<[WUQ<]NN\_L^?UBF
MWY7W^Y4+H<T,7#N2^F)^L6I[L;X8](('H>J)YXJ#B<C.8J=*-LW"]"0V6434
M7UF6<Z28L6I"3&B(&".J6C 95J2)'U*UMGUK@!+TR"G,E6;UL913%2"&M6LQ
M+334F^N%V4F7++T\ E]_;WIA "E]'^WXZ899ST(]7UB8F,03>5J=(*%*,0^N
M*AI:4[UJNG;"'Y!IA!1HC7A?$ )212#1' LH(;15IZE3G-J6RK+BIG*=,GC6
MKQ<KUPXCASLTEZR;JX68AOQ/U1_N!IE&K\WZTC6V*<3(C(\)RM/:NE3#Y %R
M(5$2R,LWP:9$0U# .@V>99+8$21D:B637[;J^GX\?U\[MU<M[_>/SKOMUOY-
M[M]*_P#/SQ\89W4<M2V5,^'C-N. JZ-3Y_/-?%:FDO<RUI"S;T3[;>]]O#>_
MU]UOGR\]*1T[;O\ 5WO]_5W[[][^3?\ /LUC$=_[A2:QR-T]>.$[J+7UY>_L
MTQ+JO.U.K?1FM)BO(.)9WERBV"#G!,VU-?S2UL'#2.GLZZ:^YMS6OOU]<[&(
M5B+]3KISY,7*:02-<N\5O'' :B5C/73YGCIBO,3^YI'><HXX+4.24X_C.?7!
MAI9/;9X(UR4/)0"KR,$7=81A/;!6ZJC#KMW$R.08EYI$N#!QD+IGK>N7.<\&
M0327WMG_ &,)+R,7I(G2@>^N K@=8FDQLOQ<.608-92BA5K"13CE/K%;;[%\
M]&H$Q\DQV'VXF$$3EIJ:<NGI@K98FNL?ISUX5<5"IPS']Y="T5B01)XWG1),
MZP#F5P.B_P#/W'+ Z0()RBV:PBB,D17!()MXE.AZ@>'V^^_U?C&][]_&O6L?
M&-[]<;S^/FF(G%G*L\+%L^_"(MB-_,YY=L1VNWN1$;]\?.]\GQ?G>W.,=]^G
M./M][]\.Y^WY\;>GIX:T_>^6&@NGGO0N>BC$_J<%(,ZOJ3ZOTW?IP::N7K]1
MKPL_K>OW*%F%DAB.C7=N.$A31QQS]^>Z=\!E3V+M=TIEA(D?Z8[3.7*NEV+!
M2V*3NNMBE<IAXQC).O)/CE+IB[Q*<8R9I/'CHQC@]](J7FG<!ZY]::TM[TF'
MAE.! L#>K&=>G:.F.&%]]<];X3G-@#(R J<@)Q95"G(,-\22R0691&!@:D17
MTF$1,##)6,-!=,"811\0'N!@0MZI5,Z]Z>\VI@^UN+:>:]R9P3P'(TAX0A'&
M,3B%5,Y#5$GI5Q!FGH1'.:4 MPB,19U@OF-1R#%0#%/0>E<WMT97P$J9542A
M ":+X#4+ G)6""[1!.,B*?%#@*!*B)9L]<0@+8=.9G'&;90X0XF8368:QI-R
MLG3!&"LZZW[VZ5UQ.S$)I \YMVZ8$$@W(. M'10I!@T'5TN\ROIF8#$-M NM
MKVX?9=/;\^'/Q*_'GMAC/>GKYM]L>UZ^GS?.,1GO=<&]Y<C'*^XQ?/+*U?>-
M?3&ZN%MI)7@Y]Z9T^\WO?/[>*1^]_CPWSQ.]ZY3YY_'6)X3].M?0V9YXFL<)
MWOM2?H;Y^79Y-\.G;<_: R\+SI;OGP-6?$R<O;/=;<\)(TG>6[XN,<)0DFW<
M:]J4F>PYQP3UBV5DSQ* MHA]BA_,)7,TH%)C-(CTMGBQNU,#2TJ/I?3",0:*
M"1,Q3HO@@>YL<6'/XO&ZN*K1<P)%IFHRK2]_%P^B=A<:!YMJA.5<&)B\,<82
M^^N#'"%[7,]-F9Q%;I*I"<48ZS@A0R,5H(KY09(@K$X!T))K-#*/7K@3'!AT
MAECVPF,EF)NT0C=L,=:DY(=I]7M@$0C(3.B@#/ ;CBW=;T100D"SD(P!B<"0
MMP+-,[3-],[."8NH91#U<N$>TT5)*<HX3>*_IC'0K!8S[E;VZX!2;EH^*4PJ
ME@,(P]R%MKE&(@8#2,\DMWUS<%1855(=&O:?7$?!7)H_9;WNOAO=_-KQ_!AJ
M)J?0@)RS?"^]]3OX:ZQUCM6.O&^+FX?UNV+G,YW]_P#2WOY_7DU_-N-:$;GS
MZ5[W:9^;,T1[GYK?3R[_ #OVP5-_E]_#?Y^IF[X_/KSQRX7]?3&]\_MTJM:X
MCJ^GXQSGM^,<%ZXAR=I]\<!V/HI&+C=GBH.K.><TW!ASH97UP*FU#Z1S]\*V
M:/VKC4TX$I6X9#'MX'@.%2]ZW:2$7B(T99ASEAC)I@2%S*EYEH=S! ).2:2^
MW!UK_H.V?/Q$F4#)T9Z-S+#<DZB\"_1DR@PBD(\]49+=E)"N 8IUS]IX:6<Z
M@TG36,^">\Q7!W*,Y')B>'+7 ::Q0^#A[<,$X:\HKOIRC%FAPSY1%/?*F(XR
MK9R]\]>,9."A(\(F;Z]+UGVP!G/.LX%TA].%=QV^M2^M9Z7['FUWD;IY/3-^
MI?H\+_%^?2]'V[/Y+X---QOAY,^EN?\ -?\ 0W?PWNG\\PC4Q0"_#/*U)GU]
MO--8^'AG;S[W/GM[>/37?7#.1->QK_DR?9;TQ>R]G#EA%/S-Y?;VK1/0N)="
M$II5=&H7N?.$8EE0O2EHL,C-(SQ=3<5D]A;@G-OB\8S&+1=[X+]Y[@>A[X$[
M$35Z_%/*@D((W&H],/-6NW.9$>F)M(N9(^7.1PI!HK:1UK)[ZQ@LU&::Z=??
M2V+DS(TTYG'TM3 <-8BD-YXWZUKAI'(USY> EJ4WO+ZN_P 8V?3WO>?9G*_'
MPWOT\VSCC=]Z7\7<TQOCOKY*;YUKTME]CO?;[_=]QR\.-^7FZ6M@Z[)X<K7R
M^EUT]/SGPQO>N7Y\=_OKY==]]GA\>;KIOKC>]\_ _NZ_/^'4:)<\MG#%KE\:
M[],7)TD,Z-^7#+A5T.(=.7"GKADD)T1*+[51-JX(:S#-L%>,W[M<:N34SL$9
M5BOYOC)E1>[GPSPS#( 8X Z:KWMBNTJ[YT#SKPX48^C+R92)*,<R,.:30;>D
M. J2)6LUK/*NZXD<DV/U@)0CCTP$:="/J\W@;UZ^6TOY;?VV?GGY]-V^CO=O
M!8_.G/AUTUQOMCYIQG>4/;' KK6-#2)BL4X>3>^>^'U][]?\#GK3>]:>%O/O
MB_OO^/+KO>^;X;WW\-[WK]&_FM/?&^^,^.]G7CX&_GUO_B5G2<!]H^<5KQ?A
MG%(\$]"8PIJ2L-<FI VN\>F%A57%O!Z$A299=>HFIFK4:JQ5[PGZP*PEH/2M
M>OI.5#(UF;4K6'TJY$N)DQ05YQ'M;\?=].)SK[?/CIN,;W3%_#9VRWKEY=[W
M[_0@=Z>-]*G/^GAUWOGC>_GF1PDF,XGIXYWRM\[OT?KY<=?%X4^]YXWO?ZP?
MGT?.1!Z=K;GZV]/L/3E'#4^/C_$K2*G(KD5M.<:XO3*9GO)B]Y/MO/MF(T"G
ME9:VKE>MDC%:(EHFK)3,:%CE@RC#5/W?D/+GB\UEXPT_$>N+9C) DBH-^E\7
MTS%-;7XV8[\/NBQ\WZX9DB(SGXQ>3HXRDYZ<<;WLQGV^?U]3>^_FSX?V?C<^
M&<YVZ>'K>_Z_'DI/&/3]_' QOM]7X_PM^^\OC&OIP\\Z\>.OP3CI6:QDQ^*=
MOH[Y;]^%GM9<K?K&]R[IIX6X:_0BW!GT3Y\WKOAY-\^7^&NI3PMR3\XO=9?,
M_&%#W.X?,8I3<^,D.<"!B9T#VU75$05I%[8KAYO<.>N+-*TWE7'[/=AYT[3C
M7\'7\7WO/BUROQRF.6--S1_O3&?0^=[/H6SSSXY?CMY=]_ (F]YKNWAEQU^B
MDO;T9-^IF,V_S-[W^_I;Y:9XWO7Z/._MZ%XQ_=_+SMY-[W6W+ZAPL4WR\DUB
M(O7MSJSGS_PUUG3X<7N+\#"JDQ-N<M<*'I4=5:G*#+@WPJL5"DZHJC(:N65;
M8KY9:36O4A@R:R@G!7\#3/ F\U3TEMT-/? A%FKQ.AG/?+[K?Q\>&N_C\X;/
MQ?IC3>3?=X^EO?KY][,;[>3?;&][Y>7EQXUW^/\ ,W_<;/#?3>\\;WOEC>_U
MYN5K\YG]5Z8"-"N7+/>GT'G''^XWO?SY-[]//Z^'[WMZ:8FH:^&^^'\>]=]O
M)K$3\\<ZQ_AKOB]W"K+-E]776-=,6.<4Z)7\X3*3MDZM(B9F>& B0+*04@I,
M-9G.+WZ?(ZUOPTC.^#0.55S:!ZIVP+$D7-:#^*8)-PP^'=8T^[SW&^F"LQ%\
MN1O+&7'?'YZ^-CIO3X^GOOY/BN.7A>W\_?/R%*5>;.GB\.'O7TQDWTXZ3PX1
MSS_SLM_,>L8SWO(W;>]_KSCZM+Z<0BW[\_+$>^8--,OJTG? YZ?./WY-[[8]
MM=Z^/&G#TS)]/WC3A7W,9SP/2?S_ (2Y1.]&F]<.)Y1W_N+FMX.&1/K? H1.
MDW(IFG+*?3"0/-5UD4):P4I0]\7<Z]Y?7/TP.B:3G2#U#2<&@ZZY3TIQZWG%
M)9K=/VGW>?#Y[?/3/PY^+B?76GT-[O\ 58#E6F-[W\^/QEC]>O\ G;]>6G]S
M^ATKN[_6ML<MYTU]NT>?>GAO>_GR;W^_/:#IZ?KQ;._Q[GT*Z:Y\>7&W^&N4
MCU]D^,>T>Q.,_-]S!*I/)O[5\0  PYDS$/>&QIB\Y'L^M_;CB<$<?FCO*E<&
ME,X-:1 TY]XP0C]?0Y<YUI]ZV9\D3[XSCGZ1^?N()=4)]8?\S>GT^N^.YP2Y
M1V9I^?;CY=[WGR\)UIN,IQ;=N7XMIX1&[\?J=?UP\N_SAW;.F?AN/VQX;W^O
M\)=GZ]E9IN,/)P/8<7B;OYYYA.$,20K24N1W<XPR'*B)Q)GI-G%3.JX,IU.J
M^EYG IFFKQC^#7&HX?6](^ZWI;?)Y?6Y:< _/Q]=L_WR5;D$D5X_RGU-?YOF
M?'W^]^OCLF3WKS8]1^A(S6E2'4O?A^^!.<3P\_/PI\?K&]^_/[!SB_NQGXVY
M01OM_B"3K4Z$M2MA3VKW'YQ[G>NWIA"]9TM+ES,&&)80I;-XV:=L" U#6RE7
MTFN+SD_.+^B>53 H<';VQ$4W??"G&:/;[N*O[F:?BV-=Y%MWG%X>N^_A7V_?
MZ^GR^AO>[^;3X\8X^W?GZ</]7>_3'K2M>>5J\ST\^[SOVQEGSI/XKN/K[_'E
MWN^,^_QOKY-_C_!,CJ'<,.L<OC\8S\WSB+#OR8_'3"&QS&9FJG*:8H"(@X;T
M@O5KUQ.>4G<G%1.;\Q/QC9U<+MG*D?9]=/\ "WSQOM],I]+>]_OPW^NO^5O7
M][S^GO?IBLT.[3@17K3OY]<N/IG_ #GC>^,TC^?5WO\ 7AO>\_)2(RM\>&_?
M?3PK2W']8WO>7^$86I]\7Q>SC/S?.!2T5AO>U'N_.H\Q*;@("\6*4";4Q2<M
M#5YQRIIA(EJV]OEZ!BPWD_/OA4Z'I3?QBCC0<>KEG72J?>VQ\_4WN?":QG?R
M $\?ROS_ *])RGUP_8.XCYI]:WKPWQ^EU_>^?^'G2<EQ7=?G#/S?.)K@NFE&
M<E+0Y91E)4P-,LR$.G*K+.)GOPXBHZ>S#A)R:>C^< '$0] XVGOBQK.F3;IA
MW,R9V5]?OM_,^E/#]_KO]#.9RM/K'S/_  &]DGT,ST^?[QC.I8^]S.N_7]ZX
MI3/1OZUB>=?#9_A:KT6ECOA[X]U/[A$6A<Y9SG:9'B(RXT#DZ!&X95(XYF *
ML0RX4?/7/"KU]43\8F)H_A^/?%1V/5# 2/R2&^_W>W?KR\+WWSVG_)K#K,'*
M]8^?Q@G.)X>;>F_GPOO^='K])^3W)\=[MYM\/#/HZ<.OQKE@SY_!NOM&+6*&
MS:F,^C\?K_",AJ?=8F+\('QB<(U?V)ROPU,"RS$'!*1J154JSPB<*6Q(!:BK
M#6O2:VPSA"+"UA%W&<7]1[2XJ1U'MB=.GNQ^]<(@8I]PC>=?NE@G3&]_KPON
M/V>CXV]7PWO]^ 01S]_)/M.9\?,\/]_G]$YSKSCG2:-M=?,9<.>^GU][[?1O
MOKX<G6T7ZZ>]_P##J#@^V(!+#Z &!0<USB%G3G.O"$:663(\D::E$K7/' :+
M2U2-;Q%X)Q0X &0#;RE,^]TUOFDG*D=\,$X0G*Q/&WK;#HNB>A\M<7W$=_P_
MG[O?/PWSVXWVKC^V^AGT/GQM_P ;UBUZ].OUM[VXMY]Z_CR[WOG_ (+9Y.!!
M-S%JH9+[!7.,G]X:"+T+TE(^I/O"CF#,PYJ68K7IP<1.2LM#'"4'$Z83/*O"
M9,(I:5RSB(]#%KSW3$]9%ZC[MIPWT^KIZ]GYCS=)W?\ X&9US]&/YYHW*^_C
MOO7QWO>?T]OGW3GN?)IO)W7WC_#5/)SD!W$<9K6GI\3BXS#+J!%OI!W(X24Y
M"1.@1C-@K%)G3 K"]QJQ]0(V%KI[F' .C#M^<*G.O6#\X<HN?.^D_P ^[W:=
M\_*5##IK3$1VB,O!_'O\?\I-^'A;ZV?;Y_6.F]?'??R6F<J[Y8Y\.-<]\Y\-
M[S_P3 =SC#\XX*]VQ0JT<MS&.XM#*NI>MTRXED4,2>L2&C,E8B9T,,]E&C(9
MN@_>*I>!Z_S%#!$29<CYQ:;V*=\/\@$7<#(.H/W5[A?@PGR6\=[WW\)I.L>O
M./SX9\:YY32GS&-[W[X?Q[].GMK_ ,3O>^6.(2VO&=>%\%B;Y_<[W/E,M_/Y
MQKO(\(%'3]?CQM_@1/;!ZX9)%EC22"MN?/CB!4,@^:\)SXMJ8G&05RHGV1/&
M1IB()2-)H '43SX2X]CX<76<FD4]#WC#0)9R_>6ASKGB89]D1^,5MK[+[K?O
MO^^&]W\=]_"/GU\'\>_'^^GB\.'O7TPG3^G3+3Z6Y_W.T_R?CTQ3+C[Z<QK^
M?I7^TR.E_GCX;WMP[V1B\95S.FOKX;_'IZ_X.B/8_9_&*+C\*4="*=L.\59J
MY)1Z1EUNTQ+*AEJ J3J<_3 ^YC#;2LN1UXXO(RTX;CTQ<Y$0WL(XS3=\*C-@
M:ZGYF<7G/T/\7G@!+*]/W6DUZ4IWCP;/)MM9Z/AO]]?I\O\ A*[Y[_?U=[WR
M^M.VGAO>\_'>_P!^6O-[;W;_  11,\YUJ]';%"949;''#$GFCC8:C3B1WIBI
MTIBP5#TRBAQQ:)AQ6%)#R>@F$S6!5F^LYN?SBJO!-<S/?'#"-4.T$>N+3G2N
M=C"XHOH^ZWOMX<JG?^^/+)KO>F-E??;X;WGV_'G^,/X]_GS95XV]-,O]VLY1
M'K^(^@=S*-,C[.D<*S\_Y<#K!92_YY.F/:SZ&(M0M6L+-.=3N82)(F:!M"1U
MMPP_TJBS-1\64Z@YN$!!Q4(NW:%:2Z<,)D':D=B'>N'09R]5FW2<.@X_+/H=
MW''8GF(?;[SJVVVON/'?XQ^=.'ISZ?1F]J3KH7W;_C-_K?3A]E.^!'Y\^]?\
M1=+W0].]LNM1 SHW)BQ;A&"B64I,"MH<[6S8";XM<D>B03&D,=NQ+0J);!"<
MD!ATKEA'8@DW7@3P:8<]*>CC*:2\<O9PV:ZT:2UPY;@.R[>/;_!G/=/^+WZ9
M[T^EO>Z^&GK]AKO?2/);R[WZ?X14]:KBG'</2,\6-OZ+\/WAH%W)2"E"]R]R
M)S<"*\88<XI/K3EPEXUEJ5$)!-WO9H88R!3- HS6!+<VF>*2>(M\U/GA3"@#
M21]YK;]8B#6?4_4>V6$D-LX!$=N-YM_@?O?+WHY8SZ<(OI?X]?-IO)_Z&_+<
M^0[<O+O>^>+]/1_/AL^_+,(U,G*\XP5F/Z5_&.-9+-+4;4EN42(I8L27""*Z
M*\9I%)+S@;^*DTJRG,@_BZL09H1!$)E)"4<G3#TO#/1D[7TOQPJ//T2/SC+^
M6AIK;!1V^=8W<_NM[WUQUTWUQE>NO'6/CQWZ>G7Y/L-[Y8WOV_Y7>Y\F^WF2
M:/ES=[]/OSS _P!;T<9WA'H_G$()":$7@6L1E$.3>X8H*X*+I).K0II&) 9G
M3*4S.-5--2ULXC$4BKVSC$0RYX50BU+:K2UZV=-(<6]/EALCS3O3T<!*U!T)
MSU1V?=9^W.LS^\:YZ>2NFM/;OXZ[R-T^IO?I_P OOMNODWO=_/>/A_%_-.Z6
MUY?>P^E*O@+JE,6=3XPP3K1G.G&D7B:+6<3";$(E%64:9BT(]\4>$0ZB9I6.
M@3KBFZ3!$V(YG-)=;8!""*E$@F9M-F*97,.ARKS%/;9;"]AW/WB67:E3.9U^
MY-N<<+[Y^??KQW%O 9[IV8Q_-]^_CO<>7/V^?CU_XSK[?C[3>]Z?1WO^4A^_
MW_1CVQ8S:_0 IWOTPL41<=$L3D437T,(I5F3+4B*Y\(XG&@'#41)#+C, ')1
MRQ2%O%52D\CNX9U"3BDF9;$W*VUQ8=G.3\8SFLOZ/8PYEU/9]_W6?S[^QX7*
M='?SC>^^-[[8@]O2WMY-[W7S72MIDUD\VNX_Z33UW:9CU_P#<MVM?.)!JWO)
M!2;Z\2<7(H-LJ-+S>=17WHF92M[%WVM>V%A %,!0:]2:<DP "Q4K()9D6E4J
MN3@C-):-+RE"=-<KZF'(/%8Y_IB2 :P/&7]86 T,FM64X1\Y?=;WOCY-[W[?
M1TX/P_\ /[WOW^IO<X]-]?\  2"-D3N1B/+%,9$=,]-%K9Q4E)E^::&3,SWP
MCJ4(G1<JS0UMQF<+QZL@(8&P%XSIG*,@%\;L6ZHF>SD%$FM&8JWI%:U*H0GF
MI7DD]Y85.,L= _.$6,=8'3N%?N7A3&]Q_/J-GEP^:=Z?0WO7_EM[[^OE?G>9
MO+S5W7\>-^&^O+C<R\E";&O/CZ??0N@ .6\I]1KG@58%JRS6+19O'7.AB-E2
MSF6SB-8I70B3%M!$A.#J2+$9%4]">[D,I"JT4!#4J#/ 95JM%B[/*"8YF;-"
MBO1&.JWSTF"V(5USX<G/L841"FLP52KE>/O#+UXTXU^?'\^[^=QX[WOXP1!%
MNWX\6SO\^SX_'GWO=?\ F-[_ %]+>]YXWN_OWQ[4K-.&?Z?#GOM.]/OF@X%)
M20+9UHGUQ>K&D:N?HNW#JKD2B6G.VEJ:VP"$+$"T,J\*UB)6F(V&QG)*<4LM
M>0@3))J2(VB%$YA-<#. J*+QOE0*2&F<XJ>D]8_;9P-EJSE(7T<*I#*DLR#)
MP?N:?&]UZ>&]Z8WO?ZQ'QZ?6??3&][_?_-;U^KOO]\Y-(B<Q(>3+TP9*$K3/
MF%,[QKAP,7=T.,X04;-2UXN:TFF=Z% MX,M& 12BPTL37%IA>'2)B)AC*($<
M1@M+GF5!X,1UXX]@]*^L=L6E<^V[]<(%(Z=:1>\_<<]U@\F]SXOSO?Q/AK];
MAGO\?\L[G>O/ZV][[_X$!&=!80H\P3B8*IO$5ZQB49B62$4M0,LK>V%;D+:G
MKK$1E'+"+*&H(I#B%AMI.)RB#BQ)(UJNK(M>4"$04I%A"ER<WJ1@&"V1UH/(
MT_A:Z3OXP>N2ZD>@?<[? L?%NF/U^MY^&WZUO'?O^?\ F)C>[Y:Y8>M\NU>%
M9QO?Z^CIEO+'MZS^/#<>WS]\KR)JID4QQA3KAK2D0CQW4[81GRDFH% 0Z+PO
MIA3HA0BX%HFD4NZZ+B9")VH5EX1<ZT@Q&T#&AD%-6BX3%)P@&2,#2S1)S8&2
MT%R,$LMY)S&M6L3VT,2KR)Y[G#JJ &8@#DU3K]UEK?3>ZUQIEZ;Y?.-[V8_7
M+?M2_P!<( X1X:_\UUZ[U^AKNG'K/DY:_->WW]^$6H&D<9*<? DTLS$7%*<+
M1.768Q$$ &%*UGTLF@H5QE7*Q$?HK++4R9D7:7W*<' YUHAKA9<IJ0E$EYLR
M6HY&%0$:(B*NNO2E&LN$J.IZ9?&!ABM-U*HZ7ROGE]P;K/AZ;WKC;PIOOC/M
M\_G\7?)KS^#>7REC^?0WU\)MQMVG_F&S_/7+RY[WKV^A?$4CA'^"3]F.01]\
M04H=,RC/J!DHS)3%.8%9$LE1Y32:I-L7A=AX$@M*UD;UD[-*8!$E,3:I09BD
M4SN8 QC$31V-5!T$ET,5.IF'@ZQG2N4WX5%1DJO$CDI2[K,T+3(G)TRZ\,RD
M5G$FT0W1@'LP_G[G3G^>V^N-*SQU[1C?/?3'ZTWG^/I;WZ>.]Z>#[;W/CNV^
M^?\ R>=LFO:G7X\=/3L_$^3>^7E^?/\ JW.O"/6_#[^Y4%K4$HYDE?6:XB**
MR)+ @PCJUB>-;T(@)0M"NJCXI6*%L0BRF>:)7@S18-=< 29DX><6A."T-K84
MR*Q2-1(I0F=,Z88S2]R+\:Y9#$M<IQ6 XUB\4B*U'U3QQ)< Y<E6,F<,J?</
M76G#?Y^RWOMY.'OGOC_S?KOI]'>_WC?'MIQ\.5]Q]^A(H^BA%$ZHT<*80%,L
M$1#:L-*L<^>'&B&294<J&JY-*980%34(-2[<O2&HP9U,16Q@K*LP8FU8)HFE
M<)"BVB*+\F:3.NN%J,DPBY))%N;%WF8!<B2&YE10Y06R>6%9$@G% YU)Y8%]
M),\0GUG[C=5_>_3>^_D9RO[?3OY-[[_\V]OUNOCNOU=N^W3[QQQ+V2%2(E!1
MI:)M.$IO D<G(>#>]),"P@YC"$3J.U*X*BM63:"PSK2D.9K@5K/(0*Y(*1 8
MK,CR-'B*<G@<9M66DK;!#(-&F1+U[/!TC$*,YM6K0D6X7O2MR3%QE!9O9X?W
M+!2PH@90,STE$%J4F_W>]_OCTWO>F-\O.X.W/R[WV_Z7Y\,OQ\>.?;YWU\;\
M=/O(HB2:+"$@JPDP5TPTG*+R6CY/U2^"0]%+C>3K&65L"#*83B*L3G:M^,7Q
MEF0HIS@^C+!C34!26< SS,.#*4D<PSBLY5-9PU*(BLUI7.V@U'2!G 0@SZ#5
M7\Y8%9 84K3&LKL3:U/N<]Q7^;G$WO3=-_/V&]]_#3A^$^?^=?H;?+L^]01&
MR(\FF%CD ;15G*$V5$F%4HT*ZIE=M%(F,SOG@P23,NS#-;9@G2(<2)N9W1,R
M7223EPQ&0FHT_!2P:T$Y2I+ A6)$(A ^L4Q#9I,-YNB9!I-9N/&<(J5L1Q2+
MZP4HM(>J_HHAFTXDIIK$X7@3)9 3W^WZOI7G3VCPZ:[Z\\:=K;BWEWRWU\WQ
MX;[XSRMU_EO#<]6G3Y_YS>]/#/A7XCY^KO=_OE3V7$Q7F+5)\E\F@Q.06(7]
MK-7-,-8F@IT2;<NO*V *)0B.=8B:79)P8X.-0 H!NVXIJIA*K*!'3E5A(0;V
MP2A F9:5BN05I.49@,N 6#4T;*WX11RO>Z4+%)-(Z-8O''UJA%6:HJ&;)V%X
M?MZ[?UX:T_<U^G?![6Y>37&][]O#7G\'_-<.&E-\/I;WOX\.?^"<50-3'JAU
MPUORI2&DUX/%]<3!#43DP-*\HFB3RC$+"T00M)JB')CK2F'**(D:"&&3,QO;
M #&.1<<$"S *$-(N&S$DL",U*S<UIE&J8@#1%)K;C\$YUBF!-02.-]+4)OQY
M&*C[3&E-7R2"<X<IQ*H-<!,.B63)'[K/?3YY]/#G]#YI_>'Y\F]]O!WV?^;S
MWQWG\^&_3GK_ #/Z>][^/\"WD+U!8M,Q-2O 7+#E,\:4K <W(EXT7%Z:R$@A
M5:TRO=HLE<$B=2%=(HY3,-"L5I@9:,@_U[$Q;+ 3 '5%.)%9B+ ,1+A:Y3$2
MRB@-<B*$8N2,PP@UK>;ER;AHTG#"0$YB0%0D9K-7M7"!YST18TN=<0M$26 +
MC]%J&E#[?/M3O[_&-Z^3?/?'Z#E:_8X>W_0[FVNX==?I</'MV[]Z_O\ P+9@
M42Z'2XI,:4FN&H&=!8K-F'G>T4C!$M!9)6B:RPRWYVP=>0N4AKPF=*S6T8)4
MK8-:6[ TB\82-$Q'! PCI"MR# :U8EW,!5- (##"B*25@)$P;(ELH2], &XE
MR:1'(UMDFN))(LDD+7>C,V%R@@PW\TF22-F8<JC4:3B'P 39C$,J-R"1^[G\
MZ_\ 6-G+CI] K7QWR],;WI]Z]9PH )IJM@NJ&)":"V949I09!X6F)M:UB. M
MZ7=(UQ*R%("8*%F>E#NX@2-6.,Z%+QR):-FV*4T2KP *\&*^T28B%9@$UIDS
M28=9SK X'W4RD$4I9@"9<D%A0R.%966H"(+5"8,,L#49.%"#,O,QKGAJI2L@
MUK2: 2=([$%:LZ:#>+D$T<NCA9$0M;C$=(6PP9YE!@0""@1&1&R.8_;;WOT\
M=_C#.37*=VR^CQX;C=?-OWW^<;WZ_P#-_&.>-./X?J?K]]BOW:#R+ TH: !+
MA.B5 HMD+4)K3,ZX&J19XELV-&T9F(20R"D4F9);Q2D\-'#C#)#HT:=+D0/.
MN" %;!ZG#)MSX8<):JQFC>^9DS4AUP("2HBJ2(HS+-JFM*"$'-1"H2&*(TE%
MK3%&05 D9$$U+A6&8R(//'DBIS!HD@V$<0"4F]+S$3Q.C.17#47(A3/?QQ(
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M:%;X=P @DB=*5)DG* L"D*1J2Y UHSP9)^\^?+OE_?QX3?A^GYPV;Z?$_/\
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M?'B<N7+F\R<]'JN&@M&2NNDTF]-*-B,2,P12A>'3:VF^+R41K)L9M8S$M D
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M3L0#3-;JW5JM7[-  !$!$:(C1$N89G9P$B8C@KE!L;!F6DIIO^\X(Q$102!
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MY@JG8(FYHD+LZ#*!C$BP("7 ;HS:)JE(]2.8Y>_"XTPD?.!-P2%"5$B8.(,
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MQJQ=BVL]9R.66$S"3EG2U6F<T<[6H3AHETK4-6H=M*E4@%(I-M(_CIB/7I/
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M)9B<7MY??[%_DZ_\OO?K]9G+?J>.],;W/E(FU@N%7ZLL 1>0'T;W9TUAK@8
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M<L5BZSI!1IKGI>6=90BP NJP!Q5C #(R0#8TJ Q$H!A#2FJU2%695-265E7
M2<YKTA+Q,<6&(G#I2OH4&-Y7C*Y&':0K9 J<X0AET81!"YW &+)/0,7B,.<*
M@5$ CV?#>^_GWR^KWSW^/^2FV;P]^!3PK3\;@IQZ,>.5>L?'T2:S/I'2*]_+
MO>^6-[Y?)C>]Y>.S%N6%C^;WPG!&R@>;#A&L%+G1Q.J59ATI\ND)VG%V8:35
MGA/<K2_*B$R$!E=*P\2@"5G.]8B<R9[T],$9Y$-+G>K2L:?Y-L3VR%IDHC49
M/%:8:#5>E\^<_&6!'KSF$?8_F%K0$C4@'1@ M:Z.+6Q<89I=A*= D=>H0*5A
M,KK>+V09X%L+/I7F"&B*RR4XN;@Z,EX49$8"LUXK3ABJJSKPM.=(B+Q0EC"B
MD;.RL92\4[>4W7?ZL>-N1!\>F>/A[[GN8O)P]YQQ>/;=_)IZ[WGYL^WS^\:\
M_@:?OCC=G>\L;WIU_P">WN^"Q]'>]_O H(%=L3JY13.F*]40TE7<5XXB.:/!
MZVTO?0NYVHM)K>:UO\E[LI0)>(I*VUY4BE6N 2-FG,RKEK,VKG3$:D <^22U
M,JSUK_DE)P\\H'53"BJJN^>B]7C?%4K4"^K$Q-[4_N',%OXSV<4>YDD(B*3Q
MDEX9>!CDPLH#LXG.%0I!0S1%$;5PI$[D+(2:@"C-ZE29JTA EF(UD"@:E5'#
MR-9RSI+G2?9IE0X,CJQH(U2[3S;KS^/6E<_#EUWO3Q^<;WOV\FF^N]?^=>&?
M'^^U^OV6]^GB<\@8J,"Z2PF] D&(PM2D3$5O-XZ4U,0 Y!$UHK*D9%HS;."A
MDFR+\HXTKPPU$(RA?G7<],+-L&MN[Z8@Q 56P,%[JIRG B"603DU_P B/VL!
MK:]1VQ,@;?*?%.^'"7.C$]]U])J24#F&<H(Q54L,:X%T @X0O5EZ^)PI, 8C
MD!HU!,A*@.\EUK/0H),\.*8%"H\R (:U&ZE":#$PN2FPPI3^05&V)FB=R5(&
M4B)H#6+JJRE:@(]GR;Y\_P!>%_&/UPWZ<J$[WMR\N]W_ .4WS^CO?[^GKQ_
M?'GW.]UQO3P2HADB&)S+,?EAFM7EQ(->%BLYQA0D9JB9K6$C7AJZX,K6<M0Z
M'&E\LZX'(<;049I VFM)Y7Q(5M5%EAI5GWG6U<5QI!UX^MM<!/S5\P!.=/\
M(IR1$(3,=P?=C4JG$#\9X='A'7CIQYXK$K%())!FB((:&IY('%9$FZS.L*")
M&,\/)"!"6:$<Y$AXB+7!6)XMB51K 4(I,,G"%HBNA77>!6S-X4;81(7&G%?
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M3LY$SB5+?;;[?OPWNW_.[WV\5C7H3Y42!"-@)5X 3AG2C,(G28I<;D@XFH0
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M5(29 C1I9P2VC2S!1<574FF*?] *S3D@Y+:9M)AN (F66+*8"9T&IBSK&6I
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MN9/!&,C5?I3C%*'%BO*%I$?@I2,OYOXQ8<076=>L?-<.D:5_7"OS]_4=6F3
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M_4?9%"5-/"%>"A/$,(":'HOJ8(32!]S*OMS7#'-(*6D-%RBM<+#DQ9[)"!D
MYD& _AF'6JHKK++.1QQ,TYB%$AD(HDD6:\'"8PPE,!@,B2:6 6Q+(XFE *37
MP9F*K3.2TE;TRK_T5K'Z/'>F>^?CZ;[>_D?Q[_.-G;>GYWO<?=;WO]^?>]\O
M)^_3GYM[W3[F/B4KFAE>)_.()%JG6FZ8$$9Q!&4L6I2(O;CAS&$9LQ0NDQ%C
M2F,P4I% ,#-*P634:P(G;88JC(L*IDAU9X2G!%28 H425=2CA@Q6Z 4J62HB
MS%1PLA29))D2ZV@2+6_Z'>^^./DWRQO?+Z&_QC+\_,_/F-_HRW,^;>_;_8!
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M\\\?-6=TR_N+_5WO?Z_T-[V_]=236L?.W&]L;X?3=[A]O)O>WR''$>E-]O\
MR>,\Z5X3;KC\_.SCZXO%S/\ 3?9<^D[M\_0WOGC>_3_P_>]Y_<ZTK6G>.^-)
M*^S&OST^Q@;D_P#BE_M]_/VDWX7^QWM_QNNZ[Z>4H!I_VV^WT][[?^4/#?;C
MC?\ ,M->7T>?'MN)_P#/-[[8WOO_ .*;WV^]SX:?;?K][X?_  ?K73+7CPY8
M)B&^I^_6G+&?"GS/Q_Z%R_\ /=[U_P#G7 3QO]6OO^MZVI__ !O7_\0 +A !
M  $# @4$ P # 0$! 0$  1$ (3%!46%Q@9'PH;'!T1#A\2 P0%!@<*# _]H
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M-GIFKB.\]?;?>U'6]K$YX>;TD;7F(9PQ_*L/-.+J>WK37"[40\4!%2(C<9H
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M7'C0P3@<VTQ6Y@S8F.>V6U]",U$)F-8R//UY4,SP^ONA2(G5(@FF23MC&_\
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M>YPT\'G>C "[EVXVF<R;>E%3:"#I':.!HS).33&"Y,]O;%CI02P:T$$4"MJ
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M#E;B_8V&0OL!5%M1P6(Q2.H)0PS&B>ND6:&;O1"R@2\P";-*A! F!),2$D#
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MC1@<.3<F&K,DR;@68%B+!P#O>H^@FW="A##:[J:M&6AXR$&LX KMT:10=6:
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MY?ZW:C=K.&W?[@>,Q%1K9OY_.4,Q6N-"2&$(5=E#AI 2.]!-2JR'EBR@+_\
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MI$L1G 5XW#A**K_(4]"".!& ,49XFMGDUA161I0,-I"013806HXBU"*%($7
M1D,X9&P7LE-)U'(JB*00IDZ+)*$\*%$Y8S<911I.AY**,H*"P$2Z0LTD)!!
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M,D6Z2V]^=1+:S:8GT^,:D5L+)CZ^2_&7,<VMYZ\^3NN5H"P!VT(452\]*B4
M$+!B!@.2?_PZXX-R@8C)N4Q=*NH1&YC#/">7W4/C[(S?2-L<Z-\8.U2[\@N^
M<J"&#'G7K18MI_.UV:;F%-I'"; >#9HQT0\)<&+(NX6%N? +@U0"02$J0K=4
M3%T9XC%&@P#JDEQJ77X&UAMY,]ZMK-PL7?WBN5\/O[X5R>OZH!S+22.XHDB"
MVE XD,"$1 HSB&6)SB*4$)!(%@'6[G_,(8/P*U!6$NXQ&M!\!.&$"#I,2 +*
M1&Q'>[TTN&6!9EOK^#.6/@/;HL2@1"(H(@*,["R))(%&4"XRFT@0*RP&5L +
MJP"V0-ALP2.B%A%9"U>O^Y26+),VD#V8B>O"IK&>!U\Y<)443OC;3'"+1UJ.
M;==3GOSVVK(/G$\X5(0W$=,<\VQ4U QM'DQP[XJ44,#Q(]_O'"C21S\VX\^I
M$VDOD\C9]\I*;>;_ +^+"DVM[3\<ND:'B88Y3# !#) 4:D2XW=!^ 1;?$*__
M (;DR LBDT40 &6T)?5:,LL0IRY4ZU=0+:=H>1T0RQ4(QKMB^.=OT5-%LO5+
M6WZ58ELO"?/OE4CG/&_U<_5-YG6?6F5P42SZ7E+(N0E/;0(NH4AHG9NC#K4#
MI"%+&2BW,2)8D8*(03D! $$A<D$&#8D%I0/4F..C+!UBE.3&N?+_ );*$'&$
M6D<<VJ @+2 7A2\])G+>Q-,G)?*Z<RNXB7;_ #1:Y &X.20V;24C@,VJ&+P7
M"0)-*$%!@0 A8 #!#8 @H4KUH"X+:RM ^+D2D4S$6)4>;4*  R(*X5!L6Y>%
M0A:$2\<!BK:9A -F82* <@,-@$Z5A&9+'N;Z:;M*MMXG[9Q$E\Q-(-D;V@.'
M(,8V.-ZRX6G7TQF<:SPD.D3^S?EZZQ/<\=9Y]..]9J(\),3I\\>!K923(EMK
M[S;CIIBQ60<;XFQGV3K07DOB_OS'OSQ',FX,8_7F)!A;6OX>1ONY(.G?K+SG
MI>CSJI\#(H$("(DU)_E]W!#)T,EQ%$ $AF$;!.PAK,__  I#C:&:$5' "M(
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MN%W3[FA=8X;1;C,;==J'7GU=5P<N-<3'0[^>]:K\_M0&5YWGTF>]!P>./W3
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M\.WFASW3:7O:\^1ZTOE4X8SI3\(\[!CM6%RYN6TG-_8U*@4<-DV6V=-J,J@
MJ  NJM@ E<1>HP.$#(^9$1"07!)$-1QRQ8H5R%,"+"<O*'W 62$6L4RRR26)
MAX8((P(H1!LHQ-&>P*"P(NV3%+X*'<,I.95ADM[AS4*;Q?D1:I5$"8@0! (
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MBS5HD!A)$W  +P8 NPK%FEC*'<RM,2MD2(J)F*3SV <(' )%$"%4L[.(('8
MPO46+DRW;0ZWUYO(TJX S*YV2$W&_P ZS1UNDH(D=B!%4!IQN0N@&8%%"54
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M:ABR^YVO&^]2<>6>I_*XO?/?^QRH;AZ^U".*$I((&2D# K :%CMCDEEU&E5
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MZOWZU$SG7/V>U>%_ND:?7OUU[XJPQ/6_P=J0T@[_ #6>2\::_?OIFI+F??\
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MQ,NOG.H#M'2MTMYYI2')B@5CR*A!33.L_KWXTP2?SS?:@(MI' [;<V(C+3L
M6X>>M6C<<7/'E+I&)VH %.4OGFK0J 7.??S&;6:*"R,3SO>[@T]N)QBV<\LN
MNV'G!10SBQ[+R_=J.$ZW^ZAKIC!'O7.?.$5PO5^ZX!V_$&Q2QMZ^]3&-\:\M
M=K6X7I[Z$=N/K<]K4Y)J<;\.&2>6M 4%HLDXM:?3G-((8+QL7#>Z01<GUJ0B
MQE<!,6O,YUOM5@)><W$2R]   32!M$B%VTS@(0W2R].9EC>]QC"JY88$Q$RM
M@()@&;3=(F2!&0-GW5,A8(, #4#S<C@Y& A+$ H<9.>2&(+NO.:T\(G"$1#R
M!PT)J2=Z-MH,XM9X<:5FR*"3!$K1*07A=6[622V(7<(D&(EISA[ ZA;C$ "!
M<'V3$'QB_#)>@@MT."WMUG3=X2CF8").JP6EM $PEX$F#N"Q)C(WC&%)F286
M*(1 "H@S&D66L_$5K7B"E!(3#"2I(UZ[,:D#LG1'%'\BP0)AY!474UJU='9B
MV3B& C*$F:3N6.J9FT3)N2HJUW06#3$(#G L\6!8=(2+E=0XJJ$I09T2 ( 3
M_>I>/>H\?.E<WI^ZGPJ;DGM07F&^WR?NC9@8Z=^9.N2::.[^<%,1>\Q%<9ZV
MTGIML8(J%;3>YGC/+SE';7CG;]5!<.?WY]_@81[\J&"=K/#2HM?1^J*1M/.V
M<^G35UH(0ZCTMQ>TZ[M0@C$GQXUCU\^:<G$\\Y?\$#-LYIX,VXL<=)"9WYLP
ME$B;,<-I]1S-7"&9L\=+<.FV:A!#))NR&W Y:U<X)S-X<7SG7%"ZPZ])RVR<
M+VVO6 W@],^10AZY'D3\^]"[G/;]%:7/V*P>1[TCH.K2H-[>HSQ_\D&P&E@3
M#P+VD3JI:S"\5+UHWN)Z14@<;O+^>]&1P!>F-=-^^:FQTX8_0_&:LNG,P>\P
M[E!@6\AY:H[OI]44/S[GG[M/DGZ\+T(>2GGK387:E.Q>8.WG6E"\#]_-(VT]
M>M.6-"E@7:EE7>@.>WW00WE<QTQ&?)J;7M.;P<M<QQ*LM[ZO'8^3'K0+*V]^
MG#'S6@L<IGSM2XJ!G!&M9@R)V$H;#9!!?2<6,D1M>)H9BJ("7ELCQN!&\\FR
M'H2DXWDV+K*(5;E,6QGISOVWJ C5S]=*#JO3\JNK8CY[.FDU $9<<GTOFI6R
MZ2[D^:3QDH@!8 G?E[TBED&,Q#I+]WTH  1)C^-XZ,\,3H:67AT\.>*!;$WB
M</.82#7M:U "EW&_GK?OP(/7.-^] ,=]?]*"0T)>23SG2_[G>HYE89M;/E_F
MEB)^_&?GT2KJRAX<\S;K(Q4+61E-E51@WLG5UHG#I"8@P*60N:RNC^_M56;"
M<($.C;TN1HBNQ(WW%3;B%K@&B85HW8%Q(I?A61S-V99BP_5Z9%F"%\&D! E-
M%K?;GQ.!U[6+4Y.'%:$)/&FQ02: ;21R6E.<H&;M^,"! %EVP&]C@R1:P8,5
M\AVY+MA!HD/_ #PC8TBRC;E@")G6)/K.O2CXLA))))5(N!%YBX7N5-)0C9=0
M;DLR#H1 ;O6*>M2IPYF4Q(D12'\L'/P1%$!3#;!5J?DBH@_B$*S@Q6>)XB6:
M=S04&Y+ #+:0Q)?]-F=38@;B"4V0<;DS%JQSU0"H3ON- O'X%"[2PZ)%_9##
MI( B:2C;08*+! &2 @Q70KIJ+F)%@#"(_P#(EOCE0VQ,ZV+]^M"%#:"Y&;[]
MM=Z9(C),><)'76E&BW,0^DTSH\\;:Z]3UI5D%F=(V]?3>I''48Z6FIWSV_=(
M9*9$=O/72,TP,P3$7C@FOK$E00+QR:''4S&_.Q;+Y^/?IKQ@>#Z?\/GG>DOM
MH<W&FE\XFVD$0NQ)TXD2=+YI$11=1^YT>50.F[\YQ=\: VGZTM^]ZL6.LXMO
MG;T;ZL1L1=KS'6VO*A=>;+[FO&LO-^*&3,'LM"D@98B.;I-#@IC_ ,J!F!6%
M+K@8XQ2JIF+6NJ9TS2@-R=J$NJWR>Q9HC%AR^=8(Q:H!7R?X=ZL(V/JBH.'C
MVO2!;^3T_&L%L_9\QM42(U$ZZYI0*9TK'H^U/.EP]/F.U90[^>_X66?"E O;
MG6>&UY=][_-<H+WOC$\W3:OEBWKYII5MZA\NGZM5ZWV&_6BSN&HKX,O:C;RH
ML@565;^%RQ6%KDF%F\8ZG/;4^H2L$[X !B:$D= QVZ6#VHBT8#E.-?3E1R[8
M\\S^1+PUY5'"FD[/DQQMM1!);TMY;B=A)O,;L3B-,;=ZF2#GO+]3WCC1@I@+
MNOCC0.- %KWPKG2IF.[-E\FHR&&-Y@]LSK?>X!@ZZ_[,T 9)X[E[<XMP[5(M
MUOO'+%[=:NBRUUSE9G3G>GP" 8NDKR@$Q@*Q00NA"HR6M?6^<F-;4SI!:B3!
M)#)D>%H&LZ(KCG1%ML8I25RK?)%A!$E0MV*8P E\ $$S>TVT8UQ?G5S15TKH
M$2,KT!:$B0& !E0F.2+%+V3*"N0#7D(1]6B0I2(1DI!0VLD&2\L%WU*!BWF$
MN,EH6QFX$:[6E<)G76\9-+K8O,SFG(#'*VNL@<&3.3!&'$UA%F8%E"$1!N68
M)@A%(MO!4BKCO1,!QU-2J(QS9%QH-=S2P66RA!F2I 2^K+RS2V553=+Z2VA+
MQZDLL$",R=%@ *F/'>_/-/ M"!5G6/33"&6XFBA-3CF>8(5$F:@H$X-$=9 0
MT,+04MZ;8UA)BF5"(,@< 4626(1"D@)JE1\A'D=P7.J(N'_*9,3]:T";9Q\K
M>-+>U;,WTST<_N:&+F-B.BF8VMPXE+!ZWTG6\!C?G4MGN4EB??V^:9N&7B1]
M3Y&M9S#[N_ZIQ($)GCRWX<JF&M@>3U\MPJ!B3AM >LZZ[8H;'+?IQ\MTIR+S
M\&GG33_CD,BO,XGZVY[VP"ZN+8;2;FX;E,MDCOQG2^>6FE2IO-L1"\KP?N]!
M.NFH>H^EOBH%)FW2;X]:,=1WO67(_-*1", "LF.'FZ#_ ,HY@.YN0HU<BU<$
M( \;RZ<LT(#Q:E<Y)\>_W4T<0MO@/5Y5V#W\OVK#HO+:;G#2_P"]KC\_A.BG
MGFM"1-?FB)?(BW772)J#.#W?/>E)VB.-9O)]C\.\=_-OFEB[4&MXAMT_O'$7
MCCF,Z] OU^J-EFQ-OE?GM-<733U>7O[&#?J_OTW>%"NL<,=6T^<:<(9R7JD.
MN.$-.VUC%HD<4("2H@OF&\Z9WH 18E8NK/5#R&*S+EO'Q$9G-"#W\VH((_ +
M_'XJZ>7B\<HMG-1 ZOEJD1B8"_(VV]6&CD N!C<^N/76BF;L6'2[?KKG%1AP
MX;9AV7E%#$Z7]?W>IT4SPGJ\(^1S408B #YSYG_>+C]]'X>]3Y3._#.^OO4#
M!EH+F+9D3 @M-3@"Z<[T"3F MQG=H\XQ$!"6+I:($DU#/BHC=AA1N%"FIC2A
MR!"J+K,3*3@##"5H)8!24R0EJ>]DBI@D)+4ER4%,B0_>S^H2[I8T=*L2<=6R
M3"8B")]=-@0FAEFIFN9>6C[&.4:CH5D(SJQ=S;,WUVIT0D^L%Y)WGC9DQ-$$
M1R9@+BE2!E+@N@)"8MU'?EV-\=Q#<'H3D0E:1,\8Z0467W&T:D-KQC2UJ&*L
MG1:U\<XY+A&"\VU\FS''GH%F8;1PYQ[^D-R(H#$66VV0QITDH4KB0"?8&1FP
M.,:2@8(M,WDUC'%B\39BB>#X@W=2\GAE-(H%@8AM(429 8R$DBN[!SD>R$5:
M0AG=W->(86B,69B!DK;,)0LHMDVG_,"OX]RAVUVGO$9_M9+.G;KBTKDORHIQ
MZ7^'WZ4L,//^@?-:T><S&==:4XAXD^_G>N1V_=!H.;/3=GWK&8X:]9_=,1EC
M!GVZQRH!DDX;^<F<4D!<BXQYO_Q@D2Z=GXGXO3BQD;(8OR"<V.580Q=+\7?Y
M[!4()#WM?R>V:C##=8=99<GKWM:G@@UCDWY=JO+QGJQ\=]*!,<_4)HN8AP>:
M0B\*&X$K<(>C_P"3.3BV<%E-I'05=UV.UH-N+4'+2_"8T\TIWYH]9]_)JY#8
M'V^N^:DBSOUTZ03^JV.0'=J\&QW6WNT'59X?RLDZ>%-U=Z.]F./K$\M*6.D#
MZ5BF;:)W_I2@[QSA?C\$#$6QQX\B_#C5Z)[?''CC4S40IQSE>'W7\QMU?.E2
M:\^'OT-[LVH4@=UQRCKT>%*?!,DKLXGWZT2<#&W7^SW)%PQ!"X4SMK;[J20E
M/-F[UEZ7HW#2QVC7DTTB6TG,[QROSK!S_!&5.5!H'0K'YQ?6PU, \T^:,.1-
MM=N5.";H3[]ZC'PV9>]_"[!0;;IX?-J-EXQV_M"8UL=#AM\WWBL77W?^$RB6
M,A7N6$A+:+M3VRLIA*V&9AI,S)>U$A(7"+)@0Q&JYF+:)@@^$70Q)\\\77!8
M<+21 JE*XDLQ079IK+-.536,@8;X:#,=-57YTB</K@BS&V1*?0:S^\/$R-6[
MJPS-;TO$(Z-@2\EMP%+)9,3"V(9AIH1BSOH1.D^_LR4EH&MIC0 NJP JA+2I
M1ETOY"%A,7 QO.R7A-T,L:3)28(F#1(51GES<M^"4>1ON,/TZ8I!)>NCG):/
M9X9J*,)Q>SSN=]M3%$Y7&_S;,X;/4'TR&?/(X-18#9\(ADZ&MBRQVX2\9A+-
MIG.)OQHIH  2\=+N6QG,1>EA+JI *X+6*(E&D$,2V.RQQ$S!8CJ,"-NG $(C
M<@N=$$!:21<M -Q/^A!R5^X_G2\TF,>WQ>K+99&+7QKCAOZTXX<QQY>N&^TR
MT7:[WB.MO2KK-GUY7] [6BH;1&=^4SKRF\;4!@L;]W+UB6A!B)?/+<HKTY]8
M[6UO1@TL6V_XDD3>H0!NP,DS)[WXK9Q <+J3()=OIQSI#Q@"6;;1P71.6M65
MP7F"_"9]XOVK(S,N(OIRG?QCAZ;3;-]#/&C<WU]3X*R32'W:A .,D2]YDD;C
M9_\ )V@6-^S:NE3-MBYM8CGG'&A;P)[G[FLH9E[^<J5X<EM<BY?S:C'1CT^*
M*!M#/6_?'K0UX+MP[;5*)]-6M7&/C\3=\IG%3$C23[Y4I:?:I%N??A#259Y<
MJ@/)\ZXKBG+O;S72U/+&N.N>FN^*XIT9?.U0VM_>\]-LFJN4.T^<B:BZ>G[=
M#Q%OBZX.<!^^5(6SH>OI?]T;5@OQ L'[98:U<6GZTZ/*K>;+&F+VZMZM(C0.
M4#YBI)C7SR/P(/5YUK/3[^J,'0.Q>KTO7KCCKRH0"(M\Q_:4!(Z^U7.>.NOK
M4+3B-<6GYQ7I?WYH1!,VZ6QR^\46 V#_ (8;2( 6K,BAX-&"TQ+&1(L2,SDF
M9V$ZDB2EUX",,;P:Q*JC:-BV(EO8(+-M16C=(@[M"D"H31#$7O,V!DB8URHQ
M$NJB1YU6A0R8#$B>2)0+!0H9! 5:$&$58D(;1*NP<L!DC&HFVD02]/[GA%R'
MA#H3NT2C%RVSBZ!I*H4+(1 2*O%%&RN  HU,"6#B*DA[N6L;%0E27BF8^->&
ML4Q<$;_5[]Z)B,ZWOZ,FN]2+-[2:I\]IOQFC A2-,NOIGCT!I[<@2WX;^D2Q
M&]3@9DQFYK._UM$P<VN<]8CLZDWXI+4SF.#,CAZN8BK92Q$3K?C,1,:1:;-"
M%%\)#$X9@%)9+Q%3[W&0:PEA9%C(;)OF2=<AX",P%A5I<QRPA#19MLB?^LV;
M62./1][VORIC8.,;\^=KU9#&^\\9AA72SNEI.1?6?3V[TG(VP^:7OK>H^1QS
M:^>L$UHEK2<?-_>]!'G]_P",$6IZGR\G%322;H@;F\%WGQO-+M718#I8>7,Q
MBI2UR^J3+..=_2U"V!B>'6(CTVTJ,V,\^=_AUH1/-]Q/>A?J^H/GH;61&^K#
M3<A@;)%H_P#)*<N8(R.<H@]#6L)IJ98/HV/:A!Y)Z6\ZUES,^%WWZ16?.>Q1
MDCS+4@:&7G'D[5@X](#;XZ5*3,;5&)[=EY0]+XQ3:9THD3:=9,)ZU8G@]&I9
MBQK/EJ"6P=_7A!^(AXXG3GTO'%:D%GOUNFT6+/+2H%OIW];3ZVT&D)OW<[06
MIESI@\8VGM8K'%_2M+J^>M !-]6_4#K_ '%),87@<L?&FQI4)J<\]<38ZT0(
MX!R?7)1N;SZ1SX^U#;9LS.+8.^]&3&G7AZ:\J"4*-#'L4)!YUX5@"AG876QK
MGPN7M0$HO$&V7-];34EXB'S]UF.A]_6TXCC3D;H6[E8]?@J8F\XC>=."3]_\
M60 .H71QBMX:FDDR.]1"YDFR*XU@.1D%JCC(AO<8L294$P@E&&4LLD7>"HX*
MBDD79MNMM&1XT2]+ A+C")BAPMN3')1=AT>[\<X8_,*.I=0!**!!HQQ1(:"1
MF" *8:WS'1B(*HP$V<.J@@C-%A-7JY(P4P%LX69DBT:R*()*&Q !9 )?.@F0
M$8VW_OIF:A((0EYSAU\]*$,,&[9Y[QBV=XQ03%N=_66SC/K0]4N( (3..U+T
M3:)&VV2R7P*#41@H/W+/8](0/C!<0$ S<9G7-\=M=J'(SK.NS&+8MZ1$_(.=
MHB>9%\%L J>4HDXWMGKJ;LQ%X=D*11HL$$^*:S"@GZ]8L-A! ,A#2EE)R6J?
M7D)E=6,HX\8ZK=>1DFD#G/+?K4@A_P"M8UUC?C'/R*U29TM)-QQC(\9NZ-_/
MNC-Z)6UB8C,<\"1G5MJ40['[C^W_ .5!&;\L].-""$H<3/\ =&TQPJ"4B[%L
MSJF-H>&V;Z'65'>+8NV^*OL;V3>>N/[75/>[J1@MSH7=_L>FU^%#X?BE)+"F
M]U#(0)HQ:\A_Y&66AMT#M*A/"/C\36/E]5GS_-9:L=+%_?A0E#?^J-*SKUC5
M=?U2J3RX\7A;S<FV@?RBAZ^EE[.W-IO<VX_Q:M&J,^<=JU>,5':2-_CCTY5)
M+O:^T>=ZTM,OFF]1/G:VWQ5MO'F7X,<XJ=;?=K?O%ZB-NOG6E+/O^J4"P6Y_
M=)FO%?.-X_L10+82.V==2QD+K>I%4Y@XN_FM"1YP^:Q+]"_DT#+KGHG#:H+&
M?;]\^U&?>W-_5&Z[?-&7E0NO0\[497R[1N%[B^I\7I"' *&+99Z6H7 V?4/E
MH6": G.?.-7'-\T4R7>]C74WUTM_Q%OAADLX29.F:()B+ F!>1B+KLXM4,"8
M2LRH3%B$@LP8*=U1)H$E%F+"V G6G/#R@$OVB+&;,!@9HSW!SBW@6# 2,-$(
MFQFM4)"TG3&6V(W7$[M*FPKE5";!40;*(N;NG0&9-8 "U%$\E!7B! E%3Y85
M"CJ"E1+ZN%L_4$T B>7WO>4]*8+A=SIL7>7IQ@0B3OP];?S $H2;AB7^! 95
M@*-Y:N75QB\JA$&$X(V$&9LG*"$54WF,\+:\A @8)6A$:!X.R>IA>X0@XO=I
M'HLP#0JA)VRFCPHW9+A%02DV;NO!M'=C>8HP>$GG?6]M+1)$2HD1*VN %3N4
M;NIE:!I(TNH=2;:'%B&&"6Z'#(2X0%X%@A9I@>.A$2U/[98&5:OOUU87P*R%
MG0SG_K6)L3-HAZIF6^G/C0RIM'K0LD9_M[XM]T!Z!VY[8BS:\O\ @"L%!+&>
ML5YYY[_\(1FD\66;?HTZT,1E/#,V[6M6'P7;G&&']?-9$9_GLYN]RKY&LNOA
MOTXUF<?-Y]@MQH9G9.I6%390&WO(2Q) =/\ R8M:P<$ET0=:$;T)]GT*Q<OJ
MO0'Q7M/:LN:DPF(//+?%0MKNG#>A9"?VVO)G^U-'7MG]QSUH0SLR]3]5'#-\
M[Z]/B*S\+VOG)Z\*G*=/:IV-/6?&HIW97@4DC$O\[<K\*@'O/<@O>K[T']=-
M=N.%5OS->O.E 7TH60EB&PWS8OGAQI!V>CCUM^ZN@B]YS!KSP6,+PH VW]U:
MVT>_5TT-^%:/7OCO5IS>X?=*@9F9W\^K5$ERQT)?&@#%9MM,\M/4H!TQ]\\4
M)4VAK=$P.DTS'7ST]:O>WW*)&G+G'P4)!\L1[M$H+YB>K^Z@'F77MO$?\1J5
M<Y<7F=HNL!>F,7H067&DB>IBHY3*AE(BI%I$(UA,Q67!%,8 SHSJADK::@=3
M'%P-PAF.K@B$EQ;:.@.(":20H1<>5R(06% 0P5$B]$FM( (B9 CHG>K"%-X8
MH-BAD@4*!*%141*)9=5.6=QXN:-78)8B,7TOMGF3=$PF0L(68R$X<\)2HL 3
M.EW+UBT1:.% (,38-YCDZ9MCA5R0FN(RSF0C?GK44($(.QR6[[N46F8 DC8L
MM!6\S%.WZ-CR%G#!@*#I':MKFX6&!G8IAR@9:FD;L7025&4.7@FVL1;(@5!)
MF8@T@+;F6' JT1T"%[FXWMB8UJ*<3)Z.=YXPPYO:E"DG!E1EG14G,6+3-,@H
MW)*(73F4-7!;3.$;>MB)DX/;6:"@BI8/L%@)$A=9>>F/$,$V$46L/^J70TT6
M%ON1:-6UJ46T]<OF*6/EVX\>!K1=6;2-ISM.H9Q%Z'./>;1UN#-H:LI&C8+<
MWEORWH;KC1UN9E= ((M>:S^85P%[V-(L9O\ O)CI,YTSM-KM0$.-(%M9[&AL
M[_\  1)V]1M'GW4PP@SHV,Q,)B,73E4<69;,WWTFQ?PJ$2<Q&8/GVUX5;V>L
M1-\\XYZQ42.=^;GM0OWS?,>15_75,$;V$(FN8V?_ "+QEK:S=[FM1MX>8O7Q
MT&37[8^J%S2S;2<6_M9<Q[T,FT_7D?@N;Q[?VLWG;S$T EF<\0VJ-NM>.MU[
M4Y2(M]'QZTY>>GC2VT2>=*RZL-MC;SGS.5[;3CVVCC-[9 ML/3AG;-MWA69F
M)]./-X:[Q0S<=?7E3-IG?ZK,&?M^Z@YQJX3-!NM-L8MI;UC>L^M.U;]?,U<2
M6& .7F]+L9]7ZJP-9]<U$&KO\Z_@XYSV\\BCW,_'Q6'1]Z&O#;8_?I6;R^2A
M<MH,[6^7U*2W%FVIF,F_?!0B'#,3>2)C>-_:@MF0MUUXXQ1@^1PZ8_XHNZF@
MZ\XE):\D8S$A"1&3"=21>[S*5X, %XJ!O,O$VIFP"+9 "7T-FV%BDH&9.RN!
MU"BG30J662; KJCJ1!#$Z+\MMQKP'5+PKQ40W/"9+KFV8+]*,Y1!>. D.]G)
M$]Z2 N:)+$=+DVTVF:G$0"6W@UM%PC>(Y5:"3,S8M%R#,2LSMBLQ-DR"-[8U
M#2,LE A<IM/O=X7T"XWH,PM !"3*BZG.H;9)YT776P$,E$P";NU DA1223D4
M( W2'?-P>9R;O=I[+G$"X*L*C_&'@+('Y=_<"T%X"$7X5$(0AIF0X\DJ(U(<
M1 % PF9AK78EIIIHZT4&1&$+<3*QHMY^2%B?6Y=)D ,)BX:LT&- B"# S#&U
MX>,U* XBVT-N2VSF+T*<L(H"9%P1+0V0Q%,7DW.099;/!!#?_I]OFT><J4KV
M=2+8X23UI0):56"XM[X="^MX_5"#CKBSTJ2+#.EY#>SOM1=OU\?FAP80<2-+
M<I;ZQI0C(3SQGCSX<BAX,ZZ7ZISOI&]3U\Q60Q*7>+RX$PTZ73)+>+\[,FC>
M+:E1-\[WPMB>M^/>/]Z2)O5^%KS9MI.FEKU+8XEEYWX][;5D2-NG$]>3KB\$
MPK.(SZZQ^Q4"$SRO\9>EK%&%YCTN%$ZBJ, IEQ YY:?^3*<D_L$T1#CR5$X+
MY=3$YM&V-:^.KDG8/5/W02+GX4^[U<77H?M:$+6PWNZ?A,C3ARGO@]Z<AMY[
ME6K?8X:8>/Q3MJM'+7W]6L&9PO'QI7.L=:_:]ML%ZNKV)Z.F=/3-7X[DZ\M.
M>QTJQ-OCS*^]!2]N6&I(>,')?>*Q#T=^%8]/94R3:$G;-:^GGM5P>'N3Z15J
M/!\5!9KZ7?NA8Y=-)]:,(\F/O\"'D>ODT$ ;$4+](@X[=JQXPSSM0EX6'J_V
MB,[R"]:$1&)1SNV]/C2C ]I[1[-$S3EOM&TZWM0@#$'_ !2#QI5FYH1S01H5
M.$2I*,2PB 2Q/JE0.P!DFP2&$A#5K9I0V;C< L.%K6JX&)B172-!&QC(.K0F
M/,[PA C!<D"-ZC7YN92>EH6BJ,K&:F)I&99$<NSL4+.+0+'!#3&M[0V3- $@
M!=@(33>\Q>_<)K! S%HMA/#I<H#:9"<:IC&')M@I'3#8UQ8OB++-XOI2I3<K
MKJPSR.YII4BRBB0L2%"6EGU6'N(4IMY0($$"PT+BL(\R!7NSEC1*4:-!(K!%
M>0;B&Y7 <+J-0B6N (EM-Y5M-><A441:((1R"9!'U2=*(9"RS&5;/\, 7J$8
MPE$V01TR,AT 6B8)D=\TT$[2R,YC)L*QMB:@*$B!D8 1KFZWLLY<3H(3.#0B
MTDL7M:^72X=.<QAOAB=+4<$LPI"G$^7DQD&KF '&)=KQ,R4Z.'_3)8_OGFC2
M@2TLLO3AY/6_&AB_"W#[H8#9-CDSUU\M;&LLO V,>7UI!Q]9X2:YTC%-UHC;
M+:ZL8B/'.-8F/FR?>=*&^(G$WC-RQ,007PA>A=;8A1NO R[QAWS0PYCU]-:-
M=<&]G'0RPLVO%UMU9(M>2W"T,,Z;2M^/T</7]S_O<-2EONRQ&8]KZVFIDR,X
M(3:SK*[=Y<A-I9L76<;:;9>51JD0K8WR;\L;Q7>&+)!R]K:U"I'#ZEX0>9:^
M%0815'1"9IB!0#(W-Y'_ ) K<(R)0,X4D9W5A6DK>^\_<EJ^+VIPF\$=/U'?
MMGV<;'LZ5/%H(-.%_.%" B;V>06^**B/-/FDE?3;SVXU;W?8SUS3$>?H:_-&
M3:65^.W::S=?9I8%?ZU&W$R[Q_;Z9K>8'CF9W_B5?W-<?/SCUJ?QC:0U#/>I
M&Z1Y;B$T1..?F:D>Z_!*8I#J4@6PW+5-UTXGZ]Z@B=0&^N[YO44<CTMWOT:S
MB\K$=+=_@J 3MS\BKI<I!)L.=ITM19F+1;G0E*)9=7VQZ_@S' '30\]>@@G?
M7GGX]]:$3/,Y,7\WJ326%WNS>VDUP+1'E]KZ<G40>-YQGCPWIH'&";0D^\?\
M8EHL!D410XU1"@M005T6F<,38[6(H-E=KW$;YETLZWO173 U!NMF&$LL%LQH
MF!G;$E00R&5V;+26@ @2]$L2)LJ8EI?(0($8 2F2JAU=JM6B.)((QO*6%(<D
MZ0/%HNI8,18[Y"2^*#'2Q?0(NL'3C,A%R,9(:6;.(G,WEB\-,V+N3-X&2<9M
M<X(%Y6)$O:%OK@+RV<ZQ5XA"!(EC.  ET64<E(T$/(:M)&*P!;.$!BQ7/ RR
M*H/$FF&7+ TF,\00(, H+$2R%<1.+16XDB%H!R*8I("2 +%=FXV8"&*5 %@.
M(P("%YTF8T&H$E")+!D:8D+HFA9ETQ&2TK,P,*5>@:6+"7<DXA4<&O#BA89<
MY@TDU)2AI+3,YGC.4SFV=JO.2EQ:5#AG..6*(@D(1:78#6Y$\K;!?G45(ML\
M.1:T\J4I[DQN(@@[I&L)&X Y 3W_ .=63@S>X?N?TTNKYI6B0]3$,MVYVYU*
M2&[%Y?6+&;ND3$HH0R-[&)=WCQ2][&:D%68&^O,,$3%@M,5-8L+O?E+EPQ!F
MU*8LG'#POF#'%XE0,SB\26)2%W<N=:. Y-XNBUHTR1K&"P4(,AU)MM$])F:&
MYD8(XJ\=&<R;[5-X\T\ZE<>DWVD(XX'%,3/-C2&)<XS)KI>])J<9C2UINV;]
M-;G^]R7;"O+C_&A;&%T(ACTEQ>)N[VR6NWTU#;!(K;%]H NW9D-3,4?7<CP]
M9.-$*?[&)^O6HY>;VSW;5$QI<Z./FIV%C OTWE S>!O,O_CN/7))(!BX$5L!
M%BCZ"-;1>TV_>U%".Q\_=6#F];T\>98KT@]9/29J .+7-9;S5X7:?KX:;CR:
MSN?&..>B>HA'/V8J39>T^YW[&:47V)]Z!ZGYI4O&CUVZ.E[5!9B6+OZY[]HJ
M=\1J\3>-.K4BQ>9VCS.T- PGEYI.8XTJ 6VE.$[S]<=II#+0UXF._F+7"&8S
M&SGV[TH)V?JG:-OGQI>DG/#X5=+>([GW1=#>H2V3.^_D5BZ^]"Z]//-:-PV/
M;V_$4'F]X^&K(;6]#S2C)Q@=ZFOK 1T_?&@ ;F>L'6/JI'9KU_O8H0Y>UIOO
M/_$;]BB)6V!ZRAK3-+ "9HD'B:J5"-0DL+#*R(O=$SFZ+0-@-"#"E<P*%DR<
M5H@(>C(FP12<Q)"89AD $$I*363BLLY8XR@1=>@2 W%H)13:+68EYA :[B3N
M8MN!6EWUVE&PFEBZ-I*:(B)%GN+W3LVTHEF92ZS&N>/WK1T @#!@'&\;KD<)
MJ=,]A4A0^C89XRS10L;$D:DLH:ZG$I/ET )T*PJ-F(D6J&7D)>%A,H(0<$!%
M263:EAEDE28:91$3!%@%C$+8988O1FY3*5A(F0\8I>]*D1@0%E%4DQ"DNR8H
M\_$3UN9D-3C'-#AA745US?)NQNYH":30-:9$.1!"VL%BDEDJP2U899220A!,
MVI0%>TIMV)PK[S%KT4EDENX,PA8;SW(<"6R7$P)Y+J1=)OL6@RP")"%)TO$7
M=YQ%#-GB.F<XO$PR>ZROOK8A6=)A73/&KK*IF%]&9OG_ )E@;EL\)Q;U^&EE
MGOYP-Z#3&_2_OFV'(M*PS-\&R)Z\1S9+59=;6DT@T\^:F66-4(EC!.=+QMSI
MD;W,Q&]B1F,7USI=A*@@Q-[]6]]F7G2LNDNK?;7N029X*+'',:>1H%LU$)=1
MB+3-NIK\E0P5;$:D[N3R]3(6+3F+BWBUG:*+HYLDR79PQFUS36_X6<VVO:>>
MD-F"3,Q-);9OG7E%@3.EMA:>O71U_P!R;Q:]^,)#,6X2T92Y$;$;%Q^.C4SP
M[C128UN=.%\U.\88AX>F25=HWJ0%M8SQ;/'A\T $1F7ARFUR*S>=^67C44V\
M/F/JG+%28*8U8VPLY(_\9^X;]G#H*G!)=QN,RS*&^8J.!T.O-\^*, \\BCQ6
M(]/YWIP#,](AI'LE]O;E60C$2#;HWZZ5:O8TQ+Q;?WW$*59]SI\2D>N*@4)T
MGJ(U(<L^EPVFSSHPM\C]_,4K-HM$>FM1F1$Z^F<=*E[K_?H:>C/NIEY_KTY5
M(KISR]^_&:@K>7S'ZI;@M].5( 6<.^AQIR3==M_/-IFV_&S]4K)U\\UJ[$WC
M:+XZYX4)UB&?:U$GD_$_%:D7//+;U #8H,!R*@BV+O/^^9I0+K8/FCCYZ'M0
MF29@.-UJ,;-?FL"^1^OBC0=QOZQMK\\*@ YOUTG&?6HEI,FT8NYOZYM42V C
MV?\ B \"MS2KQ@F1HB"<@3Y9$PIA?,MY8@61+ *V!4-+.\U8 2O&"0+63ASB
MDEI1",V4!E6G6;\1F86B0K:!5-"N2,33V!@D20R,DKLV37- @V62K0PC26>1
MD<@0J3*<"1*<P$Q-AWJTR;YM#5:()-"!)<#*#%V')QSM, >VA,"!+##*NM[;
M450\GE<5&5(Q,1>)I;RT$U LD8AU,3-XIP:*5XS *5@!$P07J (%Q;@RP(E9
M+H;4$B@FZLY9$9TETDYF,0%(+0"R "<R)IG"V3/>+M"4 TBUKUFBY1D8=8NM
MJSO0AC#=E-E)D;>$VF-@C) LY&M[.,)%Y4$) F(D&#?)+QQ'2E.SHI4,Y2LK
M@$3/6B(6H%L#=;J\")(6\C0B+QJ@)EY7N<JV2%&&5#7,WS:*! $)D7%B)#?,
M&KG%0$ D 1@@F8L811QC6K)1=&YFTF'0[BQJJCKH+":;2LZ(_P"58\^Z6TZC
M,R3>/%7E:D!?6WF/BD27$6,3K'30.N2EO> CET#U: L<8F(DLS?BYMK%&++I
MI\<=>G*G3?$;$<<]B..]:0\7/S:>&+VS2-QC'%XF_7%XJ>;G*_*+=\[VNU$'
M4;%\\_UUHK3.B&8'/&!XASJ'-L'E[V^:4=(G:+YUF]HSM;\#):V]]I;1BQK$
MEIM-)9 FUMHT;*RZ8&6V9ALF,@;S:#TD]#_<+-BV.N?.].7SVJ<8P68]N-=\
M9+S;$%XWOE*NL3KG.='&LFLYK"(NH1E_NG>HL+.N>^EX*C6V;_#TOIM3#0,L
ME1)V ,N&$?\ QFGAZ(,6BZA[E"H9@FS;^G\SEH1:@]+Z^M"X8QZ>11=-9]PC
MYJXIQ\H_-9\A\U)#E"W+EK4I,QM5KB>?N:G'A+;;^VY5$O.#U==TH+\)ZYSV
MBL]ESVBHD?6+Z[QWJTI)N:6S][P\8H=43.FOA[[E'#YY;)E+\*V>03@W\^*&
M+E#(EEDZ;<JP$:1V*(!#:;<7KGE2]DD?>UZ<H;2=(8\X5ELCX1\T7O/P>]%B
M=)^(KK"W3US0N$:EN%&\['KY-&T[_$T61V2B\:3'K0P\/A^Z(QR&^N+4;Y+#
MKR[34::H==9]&KQTY;OMZU"C:V6O7N9YT('*>]_^(4JZE3%:@:-3^I,.782)
MAHW&XYI-$6$); LO*(L89@N3I1BJ9#Q**Y(+:[U ZZ;%R:2! SNT]1E3"$;,
M3),-[/ @?I#)_+)31&MC2SRTI(#1HC(PF]BS2+RV<:Q$KA1T2R.C29N8!OYC
M0>4(C<<*CD$N5&\<3,2$R=9Q;/U1)(+>3-$U<LL%RDQ)A.UM0:IXRK(JR;M!
MX,FR@TJF0,$,"+BN!IRW8%<@?@I5$7Z-@R+ENB$@7LH+=>)E,)\#@#',.&)8
M(0)(1 Y(?:+7$D((H9.,-B^)NI:<5(&"P!Q&R[F^".#-05$+0L-<RHY=;6UH
M&3/0QRB$)$IHX2@+AI@*\6<R*(E>R4)O6<, 3"I%+0S-0L6N%DBE(5(%,M"2
M5B%$J(6&]R-#6[1+C)6!F#!Q+*.+,B1A*TD+.EY+WG62I,Y21ETD;Z3N-H(F
MCGPQ*8B<))<K6_Y; D:PHY-K9VG:E,^[\VH)[A'6_K4 8G0X?W?C%0T&^KJ<
M<7EP6L&U&%E8R\N4^7RE3+C:5.-G+Z:PSKQ(TY.<9<9_=!=7666)MF^KY&*
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M5OZ")U?3])0@[^'Q_P 0N0/#$IQ@ DN E4/HJ@)J%P;+@S8L5MJXL@!8TEE
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MM$JC%H:DXN$P.281 B1:<FEP2: -0&1A9S:*?-=)I6-AD)3$&U38!(0Y"%F
M39;I--VS)L,X$ZSC&B1=R?FB@R(KSLF9<B2)A=JS!Z1P_P"-;,P[QI8B)R7[
MLF)I1,Z?%MXTY:%23S4Q;-YV@Q?I60>.=0QQUESKM,PS8G-KYMMPC$M.S?A+
MH7[L=J:>TK>W!WG%EGE=1;&JWX;]+YFIUO\ =WVC2]NE,4FVKQT)IV;M\=,;
M[:6@-:NNYU72;S-G.' [6I+9NZZSPXMJGM($$D,MGCC#B]0&)1"63H&YC6:$
M$Z%IM<]':\8S28V3732V>*/"&^W'*Q)UZVES<JTS*D^D7624T=P5F&M-'Y=?
M7-;$6.(QL<\/RZD$P\>>^@0:0Q>]1JQ,VA8C,Q?;'6*B-)7!9BYGF=#FV9F^
M9VSTX\K_ .N6TI&AC:VFCP[5$08C7!P,OP<*=3,S.&0]97GGTH7:.^;1ISLW
MOVN".^,:[YUB@EGG:UHPG32*AETR>YFK[I][]XUBW H'ZY* [CPQ-QI_XMGU
MZ!4J$R#8-AD:A(DSV#-K^]JN< ,8A??9H]A/Q\T)'F;?- O*W0CWL5PAB_%G
M]Z:4H%O8(X2'4GAG-2 FT006(ZZ^W*I@QRQIKB([L58W%C>Y[11J@Z>8[XF@
M)MP;7\UQ:)UIT)@W\'.<\<5$5X^S/O4C-I])^(]:DB36_MFV]2KAIQXZW7A:
MHRSIZ[T!X.G+S3\#./.G*MR?2G>-ZN%KQCYHQ;8?<J0:NG"^/2H0!V?7^4Y.
MQONVX>:_C!G,$^M&T[OIY-!+%3,%@S-Y\\BF 8"3;OYC!-"6, 2\O/[4SI'[
M@TWS,]Z<" LO'<YQI>KY$W"=8F+^=Z0C:6\9U^.F:P.1[?\ "P- P3M6P29I
M3AI,Q364@9C $%1)*&N"9!)%58;2A+PA^35!!.1C0LSP;8.R*: VE@LQBVMZ
MMT%=FUR1?B,1EX(61 %S,76)+27X&H:NT%@0@TA+2NT&*)D"1.(@2;EW!I4@
M1S0MT #%A=@Y-"^Q D Q YF1'>[VVXB&RG=JB'ED=7)>8F1+C+L95)S%')?K
MA[]:7/%()2SFYOXX/CWHL*&%(H"V !A% 8M%2[Q8#\*3CJ*@J\F*4CGT!@4T
MD-R!YU$K4#9"2 M H)+()AE@598 $(3N58LY7( !4LA)%D1BKJZTU+&K74N4
MXHHTS14@,FCV!="E\182IS4@@IBR7O5R4=1,\KB>$0DEX+^:-A1@V:P  RQD
M!0;%@N\1,2.INTZ#T(1@LS8WN4M[IA*RL6)%I7O;F44EJ&#('+/5@,Z,.*"\
M!K1,A!NY%$0L)QI;)H2BQ5G872B1<?2.A!^R+TF129@?\*QUQSIO:(0G[MI?
MJVT9(LF)M'F>7.T4!D$<CH\;[VB8:0A-P8N77&+J;C[TZ.8ELO!]WGUK+>)[
M3XQC>:SP9O/I,>L[L5!JVYG&_IR#<);IX7NMUOF/+4@U_73?7YI!C?3W[6]:
M"9(>',UKG@S?GCMY:K)-Y':U]<$3,;XH$ <EIWSC3I>*M#BV$F>,\>^E)!RM
M*F&2^!B;%O>@TC!:[ATU(M<N &;TS;=DSG )$0<H8O</QYYZ5%YTB(\X6J(U
MUDLVM%K_ *V"DC4B$6_ XY%IO,4D*2>N_+_7 F-M.7C^ZO%L.-.>)MQX3M?O
MU4X RG'B3.<TY>>_.)^:N&MWC%^^B8]:AEN7CM#II#C,5#*[,&(9MZ?RGEF)
MBWM\S63!O0GH$;"))))(-%.=$(-"2(FB6_\ $C%1$L",+#(Q.%!:*-+I>-C!
MY/6@%X$\_/2*S>7R5P)Q\WZ4)CS5?BB1BT1;]S..U7R#L1CF3VL]Z@+!Y6-K
M^1>\4<%M+L1\N7;(TZ5J"'7I^_ J=I>9]IY]\U@X ][!%[2YHH7))YRIV6Y_
M.FMR+\*83S.S]'K4K<XAF6\=OO\ *DXZ^<?QIY/BG.;D\M?&B %@#V+6CQK-
MY?)4NAAX\3O.]2LQ,H^S$^L;FM !:.D?@R!JY7@>=:DL6@H# <*!CKI._'A/
M\*B!M< L1TV9S5L=/>+?'F:!2UV MV-\6B(H@H7;8B-W6#EFCGDZ8\S/S5@8
MY6SX6_G_ !&C[7$<H7F&1=P7:B,/J6N8Q<&&)N[T6(NI+@* .(-R;S>G+A"0
M2,"P#N7V)E0;  /0&(;1O-\5=9!$%@$P'&@N8OD4@N(A 91AC0R81;VFFY@&
M#&"^ 6S<>49:9@L.;8")F6PF1O%+4(#!"O%]CHL&E.&B3"2<C0XLN$:T^L@U
MS+2T1)-F>-281#9=0F 0#$S?2X5C<1E$$LX(01O2P#U20.,S:/(H#[YO'1L@
MVG"TD;,A;X"#<#*&P@\SBA8! @D BF6D;NEH6(^!"030%-* NY(-8L" A'3G
M$9")A$9609!!+VO%",II*65")CJV-;TFWSH2-)&0(0X8Q6)4RAP-8YH+JU 6
M5ZVE4"(&04B5;KTC^+96I=]6GL,X#4" 5$URYU'Y8 )"F6[;KA$N%I&Q;+>_
M:34+$;321S(0F%G'(!,IO  Q0V GQ(G0 R:4TLD0U*A"%(*@R=!&+3/&EF)^
M ;2!LL?*_P"%<Z\.5DXRL;8U+K$EK6U\8O$ZLU#!*0+IZ3OT'WO,DW=T.-X>
MU3IC+$\8.KGGO4CS01PZJX[Z5)LTCEO?6'TQ4RIQO%N$\-)UITS@;>>W/\J!
MF*@C1UV\=>FTEXW^=!AV8^;UW@V#C'/GRH8/&F^/9X^U6@[<O.7XC'#EMWM+
MMK21C!*\.)[9VB,GX9AC.E$0A%HE<7VD8OP]6F(Q8;:2SOL[!IDBE)N8TD@)
MV->"ZU)"1G5TY?=N7^H0/)B,1]W5]*4+>XF8R[G[]Y26]RQ%QB7;%*NJ9X1$
MZ=*,G*AWM<Y<>;K;ZLN8TVF/#A5AM+=W[=L^M7HTE[8OCTHW3$_,QZ4U<MC*
MS VE O$_\1C)WB TO$K4LHR,D## & 8 N;<=^5&#:P//7VZUF\ODK7U^*O!G
M]0/S0BXVU[/1)J2)U#.O"VSKFQFK8P\.3PO,1M>&H  OMY_*C''?RU*.6_G.
MIL08>.LQM,:=J-(D4C9CAPG^12JD1ZR\O+ZT%MKES]_/#4I$793>7CUGUJ?8
M%7XZQQRT,@[^/;\"F*&036LWE2LG2WGZ=,5A;%H[?R@KZ><M::! X>&#[V9T
MH[<[\;Q]-^-"P<8]LT)0\WH6GM/K^G9H0>K0E=[!UJ1VCKE#TBGB M%L QEC
MS+4R!X>6J[-H()UN;>OM4%JP!Z2QC6SK36=73AY#0QP)\Y3Z?\4N*77@7PF4
M;Y".$O"Y\ , $ J::8,)4J@1+6P,F$1.5E9BQ2V  ) %B5(F*03Q6U!0.  *
M,#*U39AOO1 K)()!LRU)!9PF(J0X2Y8 "7)F"068M.E$5+DS=;D2!TM9B,TH
MYF@,B94;\7,EJ@@E!1F_ N,I#WH&M)%;=4,*7(E(9M3B:*<6)9N6$F7CBE0
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M20LIBUZD4*,"F<E(F%46ABA<H4'="!*QO+I<M%!Y4D5R0EO% B!(2B3RR<6
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M-PU@.MBI$M,OZO-M\Y]I&%YB!]N<Q'K6W--XV+PS/']U$"E@+Z=.<N(36:$
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MU<GJQL=WP:ZR4Q4]$L6<VSQ,P@,&/A0SVD.IEC#5!9F,@%$#-UQ!(RVBD.T
MQ9(<+RPR/4F1QL2!0KX)Q)&+,A1IFAO 5 #=0&+23>C  *@B-XD)FTY>E7Z
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MLB2Q9:0L!+>B@%!%$))!N21%\+5<-!1 %,-Y%]6#%0DF!9A(E?B >%.!4S-
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M8N\J*2AUIA=[A'5UWMZQ%&1[=P^J$KQE^*E^LGI/H'T_\"?Q!&3R(XX&*$]
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M?TK!T.[?J6J9+<M9BT=;G>U7S+CK.G8.,XH;;<V<Z<[>M'8UF':]X\WQ41P
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M0';#/?."J5#SCYK7GXZ<G1\>DB-_;/S4B1O;F6CM4S9)>,FV&+\(W;5$(B"
MP\9MBWF?P!F6,7M;O\- 6OC&"6,[X?\ &$W8S[<:.''RWXB.P:D @ V@;4FD
M21D;^D).L4<=NQ1ORMVA*&-\>GVT<9Y])]RW6KY&;=M/C/#%6IZ_-^OEZ" -
MB*P&]WSD=Z&-;2=8^]:YC<(X;^C+6.-O>W3?O4T3:X>E]?-ZM&;1MCGS\FL"
MSF>7WQ+YH0-K6#IX?^&DMM!<&R*.0*4IU/L"(2H)L!D=^OI=N1'(4]QH*9'*
M/84. B$"1!!CE@H$0QF(7;'(]-O&*8(39H&HY9)=X2E8%4.II220H'(@R,)H
M6(").2T)<@+B:7WJ"Y[ZCZ+AM&2R"K1.D"[.22"T0 3<B$PP&$@H7LB,JPI*
MF83<1!(3%"8O>)FX4<G242A:82U],MG5PW9)A1E@9T9D S2?! :0 C$ L19#
M0F5N4"1*VBK.%"I<%X0,Z#!*B%D:5,Q5^[(-"B!2Z;:(JAM,XB7O@: R:T3=
M2KDY,SOJH O!2,M@!IBAMAC5ZA8@A($"L)D%+ 7;20$4P)R%K,TK.B4M6C&"
M0J2C!!5+( L<J6+E! 5E(8DI.4)ODH "!1C# I@9E5AG&*E>L&<P6YDC)1A&
MLQ0CPV"! IFJ&,-/MXLB$J;$2:LA#.;VR%B/*JD0#,2 "6!A=1Y&)RU83FP
M2,_U9NGO2AYGIN>#IO4P-UZV?K/&H'#,YU^9M2F>N)U'YSIOK2OIG[?YSK/I
M]TK/(ZWFV]0[B.M\SI--*3&GI;K.U,U9D]5^N]*5O/\ ?H*>>OJQ6>F/)XT$
MH<?36ID7?K#;M$M3V<$7S<].G&CD9@'!V/?RT46K/I]\#,12@!UO&MP^XIZN
MB/.OK7HC\9]/O_!0SP?(OIRI(UOMW]3^/^F6=/6TVUZNO*H,&[KUOC)?TM-2
M"0SI!Y\SF$IV9+P6CG.D\9WTK+9FYZ7TWO$?%80,;QZ;VWLZ9J)1+,G73'OM
M:]1S;&/6WUT:FVY$P0<]6>/\7 WXSF>''>*W!MC3^Z5"H.KEU]"?&H6 CT,$
MO .FC;_N0ZEIO:3F1(&'DHFQ99Y[P[$3K1PXVCCI_1WJ +QGTX<:#!..$WSV
MA^ZTDB2V9) ]=ZA6$L:R:>N>_'\*!G!ZKI^B.-IKCV\T_P ;F-$OOO;MQHB+
M8_$R;;B$NS:V9G%9*)F943JSSHW/,I'IBCCS?XK+K]498&6(.#KPO6'N;\OO
MIK%6+[QW?CW_  9 >:5(XU]L>KBCL!>3,;_1ZN]%!:TKZ6Z01MMO4>^G7$7T
MYW)I(09A^^?[J(Q:)+;.==[.:" .'KK_ .*KHU' -E#P R4$ "O-;$I92JBD
MIA2K!70I+Q,A!!N*  DRT! C,L"-%0?/I=P% 1*4,%BD(@B%(+"0Q8:N%=!A
M9;5G<I,W@I4R.1NLQ))NPSAS.[XJ+!';)S ;R0D+>:!*4"E(AE%O<U,,5E@%
M*88!FPV"21.A8U+(0@B9/<7*CM25)H!PYOD61$;)(DP?9J.C "D$TEV;!4JU
MZR((J8>):95!H1+IH&Q0%Q>+P6BG: 47$BHN6;VE!K:IVT.JF23DD(2*4&0?
MS])#"6:+KRR^R+6\QI'4BHG2PAYN&VFP82*@1-NU()!",C'.:.^-S,9N@+L+
M!6)36PCY0;IJ(IDB8X40$CG(K3!*(2H@E-B@6 +*K6^E/3)O>MQ"I/NI(B'#
M6\C4K3Z,8"<($BVY3:U3;MST$@DBP&8,MZ@WB0#N^"0DP)0?ZE8VN]JNRS?M
MOGO[4<<!;CMR_=-/!?M 44H9M/J/O2OSN\X/NLGF+58?(,?+UHKZ7GX:O)LO
M;/5S6;E;I\6]:5V-#W@[E*[S]B*;J[UK=#ST_M8O(E@]"I3(7!V5(K3S 3E+
M>FFKL4;VX?'G:L^GRTFXED$VO:+\(EKTK\9G+Y?\&(6ECL>9ORRTQH:YS>^.
M&VK_ *<SJ>><JE[.'+&L;YZ5E;N\:SA.OK:L[#/$UU[ZZ:Z5-+"G*8CZOQMQ
M*RL.O+G,2Z3H1RJXL;SCVAZ''<:S6N7.NEML\">= PBT6[:>UN5&\EL:=S#K
M]4PPY6/@_94#8\9M;AS\:U+3W(*5$9J 1$N/_<'$ #.)3"-)ND14VIB\?W^Q
M4;NQ&\1<Z:_NBR,6#X]ZD"'$EHBT8[,<J56$F-,;=7ETJ/[A;$:_/Z/P2$VN
MVEL-[WVV*\_GZ_QE-HGC7/\ #%AA)1#.&Y0-2EYBCCDO?^T<'C*UIY'L_="4
M=].*">U2.B\]_P!YZT]HW.J9T]-^L&V-V=_Y)\5D<ZRQK[#[>15\+Y%_ERUO
M6KYT<=O;UK%T&>C$=ZX-@+8OIZS;2_$I8+7M=QTMM#ZT\"9G7@:S'/.O_C@O
MX@M Y 4 B,)%$^08B1#A3)2TT90^6S@%4.IA)HTQ\.44LU)3/I#4&&/ZQ[;R
MJ2$O1$%!P&RL=$2LYM(V=K"A%]Y;6$:%Z.AC+A)G(T4M>8M9I),H$LBQQ)AG
M$RW)4]8QR4!D R-F[<9*FC A!D&8!!B\D/6BP6LQ(J&0M(AD;P<'G)<;!;2-
MR,DL2EIEI=@#HDJLMC1K=9S1]L)ELD'B&"8DEIZ:&)@61"X$Q=,U%CEQ*A!)
M2Q@BHSSCBGX#N%.L*Q5W+5\004%RTFPL !Z^-$!71J:[)6<O7>M0"4,"1!K%
MY#R("1&%*!<<.@89F ,(1-:Q&"!72)4%!  ]U "N*.^&] Q<GC);P&)*0UPA
MOD[T1FD!M.5C&6PWNN!H?RU8L9>X/AU"%0G*QF  +!++K_J@'@>_Z)JY>.8^
MK1VJ8LL+T^\\R^:O2XFFOGEZ4V:#'>?D]:5W+7$EGV*7*\Z@&=H?5GU):(GD
MO%DUTVVH^CXM\VG6KS+@?7/S6;?WB[ZTY["W._NE%T-VI(X6/(?NIN]O8]FI
M$;.X@<H_=((2R>]AS-O:T%&PC(0[-M=)OZ43"PW]6H0T!#PQ?C$^EJL\U[_C
M-Z?X2<6X_'FU7WUWUW_?^J8;<HVGUC;[J @>:Y->-DNWK)!PSQZ!#]7(K+:W
M+WX_R(BIYM.2?L]^,5'-LVT.O$;XP6MK!.28'@[9Z[\:F.=7>^OG!<5-H9&5
MFWN>WS439OHYZ>\O>KMF^4CP\FGG(E,-%\TC7F%<?]T!+")D >:$)&XX:DAS
M;IX9EOG2B'&E[8'E;KM0D\P^?BMXO$<8_4:VWJZ8E(M'TMAPWCG1 "(#Z_$%
MFMEM@A2-,>]XT,$;?XY'/\A&6$6)<51/85Q1MR \[5E'OR?JL?&BA['X_=3,
MM&.::3WM4$;YX6L_>_>C!Z'M\5JZ?-2=<][^A5R\GQ+$>LQO5TTE+WL'AWJ2
M.<R;L1]-3Q;+U36'4EQPUHHOOJ[/..%WI1CH!B,_-K\?_*O8F=;2*0J6C#)0
M"5*2;C*A2QH5-8-H5JDB;;4THK6UN')9&Q#RR<H!&6S(DOF9PVC0("00P,#$
MI.=DE&)H0CHE.X6;D&UTADPM1B[DS=C=&%.@$QF*F0>" K*"*FH!YLPT=!,Y
M Y[Q)$$S+2T3$"4-U@(FEPZFE(@01MBIQK!$2MI 35T*8<R$L#H8Q+LMB9'Z
MLD=8@6(JRE2Y"F Y")LM,"9X@AY!)F"R'=5\O-YHSH)!9045<Y202=,/T4PA
MN^U]7=AU0=J&!HT HW9NW9(5$(C#9J0<#8C%@N(G$PFH-@-\*%!G42RB\QE6
M '+ C976)*-&36P&",F,LXUR-.U8D4R@[4%:_P!4"G?38SZ4!-]7#P?9#E>E
MXHEE<SB>]JNN/T8];-+"S;M;]'K%*\4SOZ5D\UJP]K]M.5O7>N$0?>9US%7F
M_-\X+?A4DW]H=/AZ5FGS5^NU.SQRQQ]*FOT#SVJ//CJ].7J48CS!;YWVI2=E
M.]W>KD82_33-][%L5+!:SCHSWDTTK,Y?+4'%1M&;^M*3PA[^WXS=/8_PA97#
MIYBU_P!%/&9VCSM'^H2.YB@4Q:.W/AKMI5YM(DOZDZ=8K22C'QP;WB)Q?G84
M%.7#GT]YFM8071CVSANZU'<1TQQVXE\\VH9@PSBY$Z<=M"]!U3=WMYBMONW,
M\_=\:C7&CDD\YDU<6#%R[@MI6$S92G'+(*3Q9$AX_P#8#" 4< $J\@J'KDZ;
M,CJ<$*3-NIO;S?>U*6[09XQO=VH3?K;M_:F!X,ERVCZ;:T0P#<NO7AH9BH0;
M6];M6OGAWUZ>M" VG$RZW0['5M7AR_Q$M[GX,EIOC?A4!64^,,Y2'G6*\?/>
MO#HUB4-S=DOZ/K1-T[<OW]5>+LD?4QRN7WTHQ#CG7^7MUHVY_P ^*,?3@1]Q
M0EC@]"U8\VA^O8[M3N'R'N9CI>@C> (U\TWJ$(U#;&;F_HU&+;W\V_ZO//2O
M'_B!GJH=D)!U$1H)*"$>3+I#GJPH4QR*! B)8(@1UFZ(/;WA66%7L=W4M*5O
MJ.0DFF<$\E2?R4XL4T&41%R@89AC22400EU,N+HR30%:6F0EKJY%J:RX!Y@"
MA: Z7 )Z%K!\:6:2!#0)M'B4F*VH$(B%K&J"1E[&:=0&)DEPD<E"")KQ8*-3
M-6>(R#(U0S0@J59IGASH9!2,"$%W4\<#LUP@6  1NQ1,%@P8;)@M8&<,)0RV
MZLT 184Q<F[9BCX7( 2L+*RL0%UWFZH0>OV8 * )Q7Y+SH<$#-6*V&$,?ZVP
MNU&9WG4<^17/6WQ.;>8HY@]\VX<V*G7@\N*<ICR*GDY3QX.#3?%73XUI1[O5
M^*R27ZVU.C'2K;&;I.-O>:UFD^EO9]*C'@//;[[5F\SIT,4DD5(\D#:7ZK<<
M1WF:AC;'K*_5*$V'N^/"C1;MII;CF^G#E0@(T-=48#BL5\W++4=G9P@C/&]J
MP"(@[D_>GXS=/8_P1))+B)MFT_7&].N9G>?773_7-+HY^_-;T&UM8([9MZC>
MLD2P_=^%M<8B]ZL*'&/UPT[E[)"R+:_S&)/2+*Z$C-O[GC.-+4H68WVYWM;%
M\EZB4WFR.LS)TUX<KSI'%M^F=.=H-:G6[]-<Z?&&V8[#KJ/3YJ$\M$C>4A1Z
MBR((/^M,4HC$$/$-0H"IPY5.^^_CFIW3836>G$]>=0%PQC8Q4@.!?FS6,V'C
M)GHV:2%P1M$[QQC&?R*86P6F5G/"=N!.:)B_EOOG_C.;8U\\UZ5@IHV1]G$<
M(UNO"&]8O/SWKPZ/[K(Y'LT,=$X_UGWHKDUVM-L\;5?.>NUCULZ<*$#OYTHV
M\9:-R-CUN^U3!%[EN<+1*:2FF FWI6NU>VTX=YJT<4>+K!O=Q5B8T,^^,S/D
MT("T;_\ 03-LT+"1;+YZ_P#(U7)]I.&)DHD3.*#>5FUX2"Z2(I8&AHMY[D2_
M+/IM3,<X#>=.]^U-*)O+J+UCA%MG>FA6QI"DA"PIF,Q1SF-B,#.@628V(=_A
M2%@L]&!:D!A-1M.N5I)&* !=48*D??&3 1#*EEP !B2Q1,@4LOPM%42 @$L7
MOI[IT0M"[:A%QFA336X5P]AK<-UB$ 2=[TC=ZN2/4XX6.:A)/*?=#X2#>JY@
MK[ZC32W(9V0DT'5LC-<U;A==!L! QKXR6^4D(0),@       $ !8 L!8/]F;
MS6K+ZWQLGFE:#><Z$ZVMF;.+U.O-(+S-[6UCTS6?>=]6WI URD6ZY]8.NEZ=
MXV^?"E!'"W7)V*S8]3CSS,1FW!K/UT2;7\+6UK/VG@'T]ZDD]^+'WZ4Y>:WY
M6/>@FQ6WIZKGM]7J"")U>?GF:@CA=>/ZMXU>N"WK^N&:C*U!?B%HGVOWFH0F
M$QRN^76L_F]1'+.^D--A.HNO%\:<?QFZ>Q_@S:+WS:Q-]N6_6F8B(+9C-YA_
MO0M_LSVM[?7A3L\?/6\CQIKNNEM[QRO:V\3#,6"S9C._CZ:"7@X;Q:Y+M<SR
M#6S&+%M/Y,_O0I4Z9-NF]W5B2K]K??/%FWZIB<<,<./FVU(*S?;)S*1L$$-(
M)11D#(-HO_U@YWA@823*MB3M4P.F>5O>U=%9QUL^:U$F+$>;[U>.,1TC>*-C
M-G7>]](B=:B&=#C(7X03POQ/QO?WOYQHF+-[$;$-_F2=-_\ +-Y8\\O^,'/V
MO3%G+]H;,UO!M?>M73YIWZGK;XK/L=FF>(T\Y4Q?;;[VUJT;X>EOG\9<A[4(
MCFG8K%[<K^HUB)V\>]0!P(QHFOIMZT9@Y,[8L[36XRF=/U>C!.=?^DUO%N-^
M%OY^(Q<OZ<_^*:WD*M,TA]I3G%*7C>>8\]J=0Y7;QU]],&U!9V//J^.-&MN.
M@NKVL.6Z,59H-2$A6@ -UAN($H@@(@6$$HXRML1BK0D$+(4%\3<DSB^2H2<K
M><RP2<65S[M'(P#6ID)-8)V0?ABH?;[Q (:2-81B+%9BQDW@C\'<;H+,F#!=
M+T      $ %@ L 8/^!)9GCL7Y^7K<6)<Q<T9B=[Q;TZ@8B=UTT+7WI+[\YB
M9-O2KJ9NGQ[6UN5,QNSQW^N]+*O&@#N?9]WM:K+>_2YJ=YK/C+:==)UO$9XS
M6?[]/<\BEG7/.8CY9:"ENU7;Y>L'GF\,0.Q]^O+X@0VN^=J-CB_,5:O&?4.E
M^=*);+S(Q'#^6BIP8!F8AF=\\-71:L;FWZM):X-L[)I4XW@WSC\0EA_3M_@Q
M)+TO=DWS<Z#LE,ZO(OC<G2WW7GGFG^S.F-3;?I1HZ^\;<;?JK2G>-WZR;WC6
MB;D 8C2][?K9:F)'I%XC7?/"^M3 $9T/U&EMZDF(M-R=)FI-&1MB?6.7+I42
M4W,2F>IY>DI0'0EXTX'AO&"4RA5Y0D+*PU$?^M7$;)VMHB"%NB!E#W-R->O3
M-6_8+'F3&U &3>/W]UI&HG.T]_DJ9W;7C1,#PZ[M064@N[Q'M/#K^"+S.+1O
MQX5#CQY:!#EM9_RS>7GG#\8.=082O\"1GFAVK-Y5HH<>8?+5?&>/ESS6HS46
MOLWTFA8>)ZQ[>NOX%C3'I1EZOP5<(UGV-;UBOJ:3F[B[\4+!Q.&8/B^TE#0G
M ;P9&>4]JM">L;?S_J-<XT^>''2K6S.OQ%>->?7_  AN^O76GBA%DEZ%DW?[
M?W\**K:I')M\ZZ5=,8A@N6Q8YG#Y)$U("7%M;3Y0)WI4#C0$T;$Z"L082W-I
MFW*YF)%@%>5\3:ECU)EANMS,EHX):K&V WUW.A>,6@F@*&QKFV%=LD Z?\R!
M\-?7A>2*/DG3YUYY;XJZ]=;7M<M%M:"S25;X+F.[$?,3L&TWZ]S''#FKBN:'
M./3=WS2P+49\M7''C?E10WT[;/+@3FLDQJ=-M<9S/2I7F>CG4X>M7SP#[H%Q
MYSJ[J[\>!WYT\\?8\M6D:Y:TBP:Z_P!HW.1^NEBF(93C:/:=8Y\YW*)@3@)A
MO&E"'&.[]^UJ=K6 <+STUO5^['L7Y[_C)YBW^#!F)9P=;Q//JTZ[SG3YSS<5
MYYZ_[4O!W_522.4R8?YY)66V^=L,I.=]KQBB10L@#'LG:LZ);F)[VCFVO80*
MGF^^'WY7QI0HX8,_/??)-ZON+W^XDQIC]$,$9ZNV<<:?7UF,FFZ1@RY<_P#6
MZ0+#+*#9LS)$ZE3D[D?>O#NU!8Q&8EX<K==,T<<IMYQOQI@7T<;08V[,VJY[
MS6.&LMN_"B$!TM^+W]:E&+:8SOI;UP&O^6+SS^,77V:LFK&-$T\#]4TI8XP]
M)^*RY#W*SYGW*Q.7F:P=/<K YGN^?7XP;Z>9[7[UD<_DK+9KV*R.9[5CU/>T
M^L=:\N<SMG7UFAB=,=?[PT_Z9Y=BA28U(Z4W.3H1,_4;;;UM]>3_ ,)!U@0$
MY6P(%L!04+C3$,$7+)2$LS6_/^Z9Z;TZ).+X]6]B2Q2VEB_'@:1&=8OM8'LB
M/$$5,:]I $LK1]+H5O-#XA8YK6J<$G6#*009,F\Z[W,@RJO(3HRO#%S89A:I
MI#&M(5-"5B6,4+-3VMU%5RO_ )C5OE3E-6^QCU'9-O:KCS@C#O/":D)1&,\_
MB\6I;NFFEH^8#EI>E-MV?>G'J^/2=K[UVDZY?WDXE9HUZ9U.F1_N;S>VO$[1
M4B\X\Z!63S:D<03=\UK ]F\%O6U80(-_,^8H#$J]Z+&-;;T;[A/@\Y4 %R#G
M<GET]KH9@E+3-L^K(8WM4+>\N[\=J(OY3#QEYXO5AMH/D<+<SG^,GF^_^$X!
M+J\)G-L'KRNXQ:<VNWQ&G"X;_P"]!(:$(WU./#C^])M,@,R@!?.D69ZS&6C"
MVT;:_<;&9M4-CT(M,WXWVTZQR)2>G$]^51LB,VC.8TY/.)X7+'7AOF;S2K8!
MPBS%X"L@T)_ZAFUOQNM+$L196<LJO3F+V>%O.M-R+M;T*F)+H3YRJ?I7C/-Y
M3QHAKL09O9/IBW$J!8MC\&MXUY^30DSFUM Z0*3=Z9?\BYFTXW\MC;\8NOLT
M@LMHRQALLV/@)6FE\/<K/QHK/F?BK BYC77I]'&D8:.G6?FH0<W]:?S/XP>^
MW73N<ZR.?R5HQ-HGD>1M.U9\2+ZGQK3QP?DJ*P\+;PH1^V_#76X'H?O_ *K0
MRWT/F?BM,]/FMK_KSA_PK"AO&QT)C$14"U*-^"^.]3!0NVMMK;3WQ1I2\3.^
MU\;1M&-  @F5(-99MRQK,4BF&S3,Z+HDS "5KTB$!Q+ DRMK))E2U\4\4*2R
MR8-01&-IS2D&P+=EF+;J2QR.LPC\B;O@-^JRDD_Y5@6HI)PQ;'6_?A11XF[$
MR?>+[T:N\VOE+7+9OT<5FUB;=.]NV&IF.KYY"4I5\VJ"<G#7P.DM\5"/%S]>
M9>M2SSZS];G'-2S?MQL3Z/>H2O$/2_M4%F)<=[$Z=Z\3V.._/O9U0T)]Z'P/
M.$T$9F8HLS>([_=&$W?9T\U:64C$.-$'+;6:7*I>T?;UJ L*[_+A)J9[!\YV
MUIR'@??S^,WGGK\'YL>;OVT\^E[&^ OK$;\O//-/]Z214A8LYVOQM@OXS/.!
MX#<MIR[WVI[.87EPXO'.53=!5IF-/-*1%$MXMOB\9_L%FF&SVB>L7>']1F3
MO7I".!LS#3O2<$0\2* (PC)_TMT)" R+H11\.;4L-[HOO4FO<YSORT_DU&(R
M'R^QWHD3J]=K=O6IWIBU_K'"=-Z<!FQB8C/-T^]:+!R/R@UNYO8SZXD^G_*,
M<=?.GXQ=:0&X/&\(R$%5&"\42< &R4=QI7.#'J/S2A.'RQ6-FI?9\FG'#OM!
M-(@F[8>;<_$(:^:&&>-9%M?DO\5ET>QI]<M:SYCYKU/JG"3L03P+%/#@/<_7
M_2Q-L41>=K<ZFS>ZW.!^^-.$3K,_\,L(1XX&9MTS:82KFITF8W(M?SJR[F>!
M$W-^=B^<L0 WC2T>G6]'A)!9N0 7R[MJ-\0*6 ,FT#&8%TH7$IB-$PC-TF2<
M%F(FB$J(A9;2ZL:2L=:5@C6ZC;33:[S[T:!( %S&R0,."1/_ "J/5SC3VZUO
M8ZW?FV_M,4>5[IITMMQX\*E4SENZ0GW?C4\N;W)[W>G6W"GGG';[CUI@IY5%
M/+>T0^O/4QH6%?E-X&_"[F*D6_F.Y>_+-.7H[9_5,JQ(]?3G2_HQWM%-MZ1;
MZXZ[4 (F'AC]\Z68OTJ0@VG\2XEGWDHYM2>V&2^.?#5Q22EAD:Q<A[\*<\)'
MJ_VE',/</FF(W G\9:RW9T?K_!3#Y<#UICJ93:;_ %N\KUIQO\1\_P#!(+O:
M'E^JMK4??E,QNWH#F.X_R<3WJ\"'9OB\YUQ1HVN,R2^!-0QC$QMV^\:[U.<'
MC/9J^G)<'NU60K$K8_Z0,L7,/$ #&R-*F2TW)MHW]*M<#CIUM%OU4!R:>O/2
MIDSBT<)DX_VI4223T^<][8K@ +:Q-N'!_I^3/SMQZ5!M%LSO'F-.=S_'%Y_C
M/GCA1)6%U<L$IT9#2QC6Z&;<N5XC6:P.N?0?BG<YAZKYWJT&Q'>//2ECQ\]J
M<AQ9]2/?\;2SH=XXT[.<'##YSJU#U. 8I2G)'"3'(^ZR3=CTKP<BI(XD;X\>
MY_TL38CAG_DF&X5XF4QX 920S@BWM^_X$34P1'S>+88-M]S(, ;;$;N;F]HY
MU*2"(D@L<Q*#*Q<:$182*9.*09!<MDIB6@'4,$C1KP&LWM-$6)E[W6W8YM[R
M-&-@$E.$:I #=6 FHQ_4M;'*3.Q" #_F](=#IK#C%''!,WC//?'&E9B;V+]-
M<1YI5]X\3'#@V/:IY)O/J/S?M3EC0]]ZA$V\EX?NLO-OG$N?7;2IY!R^FFSQ
M/U4D\GVM[4;NS_*)-I3;GQ\:Q[[!B_8YWWKA6['VZ7J&2#>WOI2*H-OPH1O'
MI0<;8.$7]WV+6+R(G6LB1:TFGA1$+7 G=7'*G'%8C>XQZ5+)Q1MMSC];GXS=
M/8_PUQIF.)!\]*=2+C=W;S^N5^'_  )-F@<NQ:V><:9G?M4I$P,L.-.W\Q4
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M*6T[U.2]^60P8(N!#%LDZI5,3HR"O/7APFD@YM.D);3,D$;2-&ASKQK?.A!
MUBM5_P":P7OQ@-ITX]Z'5OOA:,N6 "-]:FDWSK.K;.V'4-8O.IQ0AGKMZ8&I
M5>,1.7>8]_1I8%\G^TESG8QG7W_EU*FT>Y\E0RO"3/7V_M2,SZ_J.U I:?.D
M]LZT>WSSO_?2@$6/7VL?%2,)&FE1"XW/6?,UL<_A^V@N7M?THD3KC/DUD<+]
MKOI1)-(O'+2EPKAV?YY$*DV"+HA3>3K6;8+,:J0BTSB?B@EUB=-F#K-^&*@+
M$#*=KYB>4=2ADG>_>HR;QZ7_ ,8L&VJFI#P[WWONI%H7S,]/;QIB;$<,_P##
MAC8?7U9UOVTM"'67ATRMWUO9J QO.)W+X./$['PA3Y/K3>B"TUEXW\TI@2#(
ML6WZ-O$9NXKC8G/#E*'_ #V>@0 HJD(JWN+5E_<RISE55+=5G*T]D"YQ=/3K
MFG"S9MN?'S;A4QV(XZGU%(V[R;<)M,7VTM48XVO[3KK;J8O00!L1^.5$W;D9
MS.?&^U2>+15OG/G:W^1C^_-^_P"':-NWG#]T9(SI2<87D@7"7$8<4;DGUXLE
MA79 H-:O'2=_/E7LN4Z=CR:N)[6ZJ^&V]2!<;D''%N'DWI2'&3T/JG#&_P"Z
M@Z/IK[TLW=2?#A:L);,<M.&;^E7#S;GP,9GA6ON#IOE]>U8G,QI]]6_"I ]3
M;O;GU_ZO/.W_  E2:K!"2)RDHDF]H$C2"8R?1A.7"H;Q;!KF\^R8UVID%V>"
MT=-'>D>,7H04G124(KT"@L$ 18(PQD?5=@I@I%F7CEI8C?*SP:,TBZK+;@<]
M+[PR%2$5#<\AX:UF*MQ,*P.V))#E;L+'_*%QB?;STH+LV%-MYB]O+-'JM=NS
M.VISFVE&L&+QGIW TG%XQ6>^L:_??FTY8VN\6G'%GSO4U79_7?$U.MKK>/1U
M[=Z74DG3]7K/6^D7>OZILQ;;?.L_+4&G8^L?-;!#QF_>K-XO:33QZ4A/+CI\
M-0#&<=&]"6-S[I)$WJV34>GEJ]KR?,Q0'0GA(0^7B:%H)'+"F#.&^)&'&M7^
MX0&MS3>8UMLU:#1X_7*.%0]P+AU89MOPTYUQ$/M%%2Q-_P#%D%>@/#H\6_$B
M*9B69FUM/;3'-UJYP:N\=7[_ ."4."/QFV:M1-R-.>3$^,U"J&6-(CAK:T7=
M\TL&%EGGXYXU"<:;79]N.)F:A78;^G2TS?2 1<4T4KB!#D$*^1$+QR?\V('6
MH@%:Z(3"7 HR);4+9G73%3V=K'K+?3>U^H8N(#3KO-\OZJ>>+Y\Y-7.AF$\Y
M/Q5N[ <[3WA\F?\  B67&+9Y\-R@8EG]ICV4W/\ (0!,\>OXQT\W]:)DC-72
M^N:1K(B$I6EQ*0%(EAC#OW\N'>K-T^7OQL:YIC+UX>QJ8K>6=X)V#:?"]3A?
M^RWCL7_J+.D^S2L-&Y';MC7WJ-%7)/'> R8.E1-V8M[6Y:\(FL6=^-CZ]\VK
MC9C7W]IA72D@E6(DQ(:\.'[:GCI/-TC'H;Z%.2-O#_R09*^ 6:P2EM(FU+HU
M9-*LK!38 @"A SIZW^VB:2V>-Q[OD4!,S'.^6#O0C8'R":.25$L-L<1LCEKI
MF(O*L2G)9O4G+&29;R.##!I.+M3ZYTG-EB8;3AY'&H#1D BP3+!!0++(2QC_
M )%@7MSJ$@IFYZQK _%:HZY<>D7XVY4I"M>Z6Q<OZ%.R3JG76/+DCBIF-/(]
MEK)SK%YK=_?XH3,[OKK]4CIUX=[=;3O26<</VGGQU?7Z.\UR[03YCI6RW]]-
M?F[-'"Z:GGH9J*31//6B/"T8S/Z]HHW3B7.224(3MV?W3$L8J#:LWE\E&2WB
M_/3E\4Y( 1HB#;2"/?6#>ABD&IJXS-JR;,3:(X1PO>HO.AB8F^FDY-YO3(="
M-[?V:<.G^,9F;MBSC82":0R2O&$S]^M]FF)LVW_X4D3$T80:7+:&-HR\6BO0
M<O+K%[P^7D(DE0CCFTV2+011NC5^M+7MR]5$W)N:Q+TQ$M][V9>5$4L"5;"*
M1N<O_/<79A1 O"[(V6NVFI@B]L8>./.=2KV@'CQX8B_>*'!H1)[5 $6DZ.O6
M^)Y%0XVRGUMQ-;$;U&6BQZ6QI[S,V_/.B)2]\<])^:@F_7%M"^^?Y_CSH06G
MK#[6_&+K[T,(\>5&2=ZLI4]@%Y8*7)9+%7SC?X>S'K6$GO'\(]7K6-Z<M/M_
ME1-TW'?I&F;<J-"_KCCN1M+L4Q$>>8Z5I,D#[?NBWY]>#B$&L&XF),7RZ9H<
MFNC[7TZ93>L!I(S-^4?RT8BA@3<=Y>,>3-7B6[&7TOF'?APJ6+YL_'UW_P#)
M<[HVXE&HD%'0(:>12=?D?V[%7 9QP..\!W]*D"&8C;8+E_7'80FT"KLRLWP&
MV8FU."Q3+@YCGL0(M3A(N 2C%X!AO$CI,84I\..F%&6UB%9S':I2(;3+EY:7
M!G:=;VG<.,H1)Q,H")#"G_*$0F>N&4Y8ZSBIYO:9RCR,YC2II9L7B;<!+LEF
MVE<8-UCZ;/IO%3R\9)L.9CBYB*4KMVIR\_,T5QJ1/>U3MS/"1B?.F*> G-X<
M+^9J5W.D'3APTHB#7A[[&^,=:QP6TGCV_50FB=*FET<C\48Z,=\>U"_5]W[M
M6+%[$=Z,(<^]I]:$+G/>_P"#EZ>VM--ZT=[>E]ZD!Z%PQ_=[6J2!.1'&%(UC
MXZ/ "7^Y@3312N943"<W7M^GDP(.V)ZK;@</\F+FJ;['I;TFF(@EOF('^?>]
M,3:8]>-<O^&90&S:%;^PLTH 8GR4XE\>],T!SF9(?<CC;,E1*ZR7B=SPH!MP
M;S>^-;W0MB[I0>B,TX.0CR%Q!G$M>JTD-XC1"*9&1N?\SWV6@H &XU/8;!$[
M"^,Z??*MOLXM?$;I[Z76HRWBQI;ZS/.I$8).T[,<[_&DF&QRY:3K-7$0H7]_
MV?X#$\<V/K]<*$S:UHD+Q:]K\][;_P"AVC:L'7V?Q%,K\KW4*A+)WIS0VD83
M?-.2P-QJ\7--3UX:]3A5_HR]I]'-UJZ0F>)G?X.-6A/+&FP9YN)H@O,Q>2QS
MM/A=IPQO[Z5I:F=)\_<%1)?:^FO'4]8K%G-M_?A;2Q4&KHYMRZ:ZQVJ0"=M2
M2_%M#QX9:3C9Z;X\OO4X2\,SW]QYNM*3E9\V_P#(.-JL&T;B1) N:B#PZVSR
MEXPS;-B'EN!PWQ=X/5O3$$$W2V V?BDT14(D+X*(1MA,P,6; 8A8@4BYXU-R
MF:L$$3 G:8"W-(FIHKA$YB+EM;0Q+KI=<#-A^&_)CIPH11<D1\$(E!O>P3_D
M$/K]?>T-23+:>GS.F_#8RW=7/\7OO."I];WWP_H=\PZ4JK05S-N&#7K5\^+"
M5D\VDA3:DFS4-VH;M*V/&WS0M@\X5RJYT/D>]N5ROB^*%V-O:'[K5;KU/.M&
M\\1W_E>L?KX_$[[?/GM3YPEN4_96J9AG:,7_ *:<&#@UI,B_DYJ;B%!T5^R&
M(+3J$:&1#4C[K*+0B8V;3TMUX?@0H>=O\&"[^VR<_-II5# 3:#OYJO"T)1Y;
M_B)!V\]*SX-8STX7GA,7UJ780B][YT??L5.I$P3?A,,V_E"BB9%K@FW<N!CI
M43G1V;ZD-K#<WM.;?QYP 0]$?\I^F-0*.6P JN I\53)F4=F4")-B&E-8$23
M\N,]/2:$-T&(QO?YO4B.&/<];5,\2'&.W>MM>VGS?A;LXJ(<#V/\#6\$7S?A
M:_;2:,':TQ:WD_XXHP?C%YYTJ4D9\Y:4<?-O3-&",:5 4'DS):;AK%@K@J-.
M#_/2W%"O)Y?7@W<%;C;SCS;9K%=R)$Z]9P1H6JQT?KAG?-II2#K\U>G%^D[S
M;K_*Q7X1?2^3;VQL2EUQOK'!]]EK'>^M]+6CA?GKFHH!XS+Y>)?B*E1F;DD<
MN.^KFKA#:UK\.MIX204"7X3KO>V??>^?_','EQU4J&TM"@,:0S\+]EL;Z1-/
M? 2%XKBD68; <)B.]Y]ZL$%,I XC5A)IO,1"+E*3[T0F'8O.:F-( @7A=+8$
M8C@PA-1!C$:6@&^N\J9OG-+G:;D6=;)W')G5R(P8@P!5WN3TO$O_ !!S>9H0
M;Q==>.F)SL<6F9)U9-<]#]<Z>^;SV/G-^7&E6+YW_5[=+Q0FW?L%2]7L]^=0
M,]'[Y?K>E5;>'*N%ZE<+U/NE%W_#6.OGGV,/1\[UKYOFN31>VOZX5D[1ZVO[
M=J.8O>7AFLSE\OX<,;_$U@XI]LX\L4N1<$3$.+WQ/[IYD0@Q,ACI[T X@S.C
M+MQX<*@.+@L-[;1KO5MG,$3RX3W/P&5X^<?C3_"$7^?CSC3@%EG&Q'\]>-:Y
MZW[[UZ_\*2)N13J=Q)XXTO&9X!2W0NSBT1?TP\M<$;(C"ZSHJ,:Z=LQ4PB,I
M9Z%G2)Z)JR90$RP)'(N1NLL\R*!(3];"I83(.1U_Y82O5(;@/U94)8S?KA[/
M.LF#/PCHZ'?6BP8#IZ1,-^4U\#PQZ7*.;+V(BU_2UNN*@+8QI=BV<[6OVH0(
MV/\ "$WF=(WWSZ5"+7WX9TS&8MSC_(0!^#;G^_.W0SR7\[_FWHYBE_;LM)55
MEK$S&C?4P\_NH8F;?OL;<)WBB&[/OK,<=+=&HLMO;6\<=BC0A;:[?JVBVP42
M9TORT]?1IPQH^^]0L3W].STO4.K'/I.=->E8KZD<7EK:XXWUH8(=G/&V5.W$
MVJ\-XXV^#B:Q?5K#G2'M'*SWVJ<)Q!X:Z7Y.]3$:[[G_ (SZ+T ,ZC)"E@0*
M(PH'"N63BLBD /1H3I)OW\:>7!*AET]-7;E2W*(3&W\FC$WX+"*VV"PDP8M0
MD C59D#>"UPX0LI:AT8070LC%B+P)+D@3A"Z1/21SK<^[%(WC0%*^ 63) %@
M2HF# V&UA9JEV_\ Q*#BX^Z0&[-YW]=CI<I58G"LWOUVC^E).2WN^]37HZY6
M_*WSQJ=V"?>/:U7V2^DZ<<1CAGG4\VUXPO!\Z15EF.N2]N9]S%*FV/-TI+]B
M'>]<I\XQ29$I$S^<'DUB<_AK)C$,>M:.:M7SXY%63#J3]?-9]/O\#".S6/?Z
M?VHM\3U)ZWGK5PID,;B+WF()G6(S4-BLR8NW3&?7-!!/T:Z::YFIR7)UR3>Q
MRZ:M#()J3WK,?/+_ .#&OG73PH $<EXV>F<?\AH\%XV,%L6/7%023$MB'4]^
ME1!K+.N,&CHF9)DJ80NEL)QG-IOI$\J$DA.N&.DW)RS;72D%8ZPF'RTHF0P,
MMO\ E,22QN<AJ)N6B%&([:''/7E0C9,03>R7G;VF]0KBW3I;OUJ$Q$!?-[N#
MC6F&2^.+KRWJ,L%@2,SI*V];6U_QN6Q>^!B^@VUH(B+9DS.U]-[?XF3SZ^.?
MY]*L77V_!@TJ:S8FQ.S"6=.E/)U\]*OG?X>S">M0-T7-_CJ>K11J?$9M;<VQ
M.U7"^W-Z\L-M+5/%[:;!TSGX+S$3?CO2;W(OKYQXWXR0^3IAUP_%:4]99B;V
MPQK\RTD&=,/<G;GC 5%$X8C3ZX.-.$4CJVCC9RZ\88][M&6+.DXQCK4X.3W'
MY(Z[_P#BJ JP%U<!NU*%MA@3\>)5SF6T2Y>T9C[4*P$9BUNV]I/C!2A WWF5
M/(XS>S2/$ STMGD2G&-ZF:][+Q5B53 +#&(:@]@F1B'=+\5QPJ:9U6]I:;73
M6)X59$$3%LVF)Z$3PO32 %0$3*(W$0,/_&V63$Q_>U'0W];'.(JXH7\]')/I
M4RL6EDSYEUW+R4TL$93-K:D_K?$4UYNP1ACAI)AI4\7W$3:.[K&RDR+,SCT=
MN#QJ,L3F3W/U;K7!CH,=KD>-(";6O9?FC&4$FW#@^7HA8-3LG\)I!S20]XY?
MC!Y/M6)S^ZLF87+C'Q6CFK%YGQ]5?-HB.'7MBLSE\OYPSF3YJ.#$RG7%WC:-
MM;U#+>]BXQ:]T^J@4LY:\==/:8BIU/$(]-.=MXOM66Y9$[$/)UQO% ;<;'/P
M;_N:-AV_P4%\:\FWF*9@L1DMG'6_&[VC_CY@(-YWS;U[4;&+H[1!?AF7:"Q2
M#43*\V6W VU=YJSDQ:-B\=[R\>M1$"TRAB9OR)]LZ3FA0<!0VC&U Y/^6<""
MFTFC5#;3)+$VH6BV/-'TIIF.1YO_ 'A4:++'"'QZZ9J06+WOOL]?,U<F.G',
M'&<V[XJ GA[3?K&O^!DTX[43+81F\3G77FT1E"WB)Z['QM_B$I\^/M^<'FM8
MNM8_!0]DW1-'AMM)5@.8]J4,<?1_=ZA3CIOH\/F)IB(=O/UMI4"KQOX<Y7]5
M+EMM!WFU]\N*D"6S$SOKC;TX%#A'E4[@]#C/EDQ7'VOH_NW#A$U&.DXD^;'Q
MO36NY+J<8=(G7'*]8V^S,%K1YIZ/'V<S9S^^5\T;;3GFVMXXWYZTI.)G_P 1
M_516>""F/GU4WE4FE:U1('%55H-LVV"ND# 1B\Q"ZT)@F.9&^P>6H;IOSYD?
MR1B@C54%UY0FTRC4F9FU%'D$209+-[)+=1RH66;0D@#&L0\#M4KFS,<<O?;,
M<*8I-_6'M;WI6LUA$.3) (9M-O\ C0<@\Z0GWY9Y4#\KZ[-[N*E&">4X;>O]
MQ6Z1=,9W\*+@,8M;/'WQ17MY.W ]XS4)$&MN'28AW7%\%99->I?94?OBTTA#
MGIMC3.3GK4<P7SXZGZXUF.ISU-/U-2=2.M_.E8K1U^/Q@\GVK$Y_#0TRV5HY
MJXM;]C.F.9UT/H'M_*S.7GO2P+F*4DVZ4[CR[W#IUHR_$(J>AWS1#F"*7%T(
MY?WC3%&-Z3??-HQ;5K2Z+3-L#;G."IVI$/7EH^;5K^PB=GE_BR3KL&<,WCF[
MTSE#?1GTJ(8DTN-N].77CO\ \ 38J&[G;;[IP\FH$$P>D.G#I%HJ%(O=MKN"
M[F':U7(+QB_5];9T+5>5OFP7B<;.;8CE>K_\(*_XQ,$3<D=G_D,*&E-G+99)
MLW0R$]C7>UL].7'A4 XV^K6U,<KW*L2T!MOIZ5*",D<G?YGG4JL8N+,V'I,4
M8070GMIP_P 0-Y;P$SZ8G;9HM&6;[QPO?E/^)=/CVZ_G!YK6#G1=#>FPNU)E
MW<R\-NRT$!L^Y*LEY>DU@/!]Z0B,=]_K/.DBYMK[]+XQ:F$N_P >N^+'2I8O
M*O635_6*Z!ZX_O6E%M9D\Z5;UMGTGAF_72HLKB/:=7?W8K"2S8>4V;_JG8O.
M_/33#/S-*1"VB>JXX:.G"IX)V3@1G%X[T[<P?#K_ .&J^ER*K>K#.@*K3!LQ
M.2*$J9K7P$V%Y@U@H(08WM=G>%X1MP 1$:S 30!!]Z3RTO'RC@"4!@+0SGC'
M[UJ&*?(&'.-@RXO$W&G5;HT1)$("J6;0P4!5DGB!$6TDVQ&M$7N?56-8M'>I
M+].&X2IS&C2PQ.MLCE: 2Y_S*9/,>:5(6+WXS[._ES59&8,6TGA\3M0E@TOA
MO?3;;M0@V3+(.>ZVFEVA20%[+UAYZ[S)BHE8(O.+<L2,3QH22-_2SQB+T86#
M7[P[8YM'/!GOGW:R>9O1M.WGG7\8/)]JQY/W2F>2[S7R>U'31SPM'7G6OF^:
MQZ_=8/)]J)0;QQDWI7-@)Z)4";H_,449M=+6Q>=>'D"V)0NC,\&MGYFU,I:%
M(6(7;?G)C5HR3=L3?.GQ4!<D+<7*7Q:>3:DG<Y9_PE%L^=NM.$,[^G[IB6,:
M>/\ P"<>>>;4 C>(?QFA=MD/GT7OO0ZK.MB'A8B<Y:M@1TBSQDF)?3G4\K<X
MMG%\6&;-]-*2! "C(H1>H.+PE$/<M?%.S#_C4"F %5P 2KR*F0?]61L7 #M
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MTE;9C0++<1!,$&+2XSBA&L)9L"3-[Z1UO+>$"Y##Q(1\>M&(R,#+<+YC:0:
M B=JM"1X;"*4J>$020R8@@)+_P#.AG1=?U10V-3A.O34\*' PVAMQGSE>AN1
M(W-W-AX]8J-LUX>N^DH:QM5IMK#N;?"EL7J[BV%OHV=C^;U>>(G4M]5&V^_
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M)^OC-8KMHOPUYWGQIS$YN>;V\G_@4,M)XOGFE0R%QQ(\\:PTYROURW*NKF<
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MZ4BT\O6QVIWXY/1/9IY-,CMC'O28C%CSL344=M7APV^]ZQEM)O:'WU[36 T
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MJS&>4ND\*E&\SYB_M'"HX.^O"V73ZZ3/.V\7YOK4J9W=XVU>.N.,4:-. -@
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MLSY<23##,,+IZML<LVM^P6;W_=E]JG5FT-L3S^.)O4ZWQ/G#5C<HX?(!E\E
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M +CSG0'%\Q7GG>AZV]_/(H P==?P$H;T/EZZ9[T T\X;=/\ $4[1U_3Q)[T
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MG+E/&I;MCUH L4G 4 Y[_D;FWEOW_8 <]_\ $%Q^JANW^/.G_2B8PC'@"7A
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M*%YCAGG;]UZQ^OBB0NIY\_A2XB._7C:H)B_PRS-#!F"QC<7:I%"&.606+ +
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M,.9Y_:4"S?3>:B%Y]S(6MK[T8:,[$+8UU ,;7W?\7=8+A$T8F #B 1505"F
M3KDW8=N:T7 P)/GUH;?'GM0#'K^1ZVH!@ZZ_XB=/W02)OPTG7_L^9&6#O*=
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M,>&IO?KY%*X(5)>U\BQ/,CK)%3#0WQ:[G2WNS:]7%2;,7F'C8TC"WOEM!B]
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M\OP45P8D,:E[/3M/.LCC$XX/GKK2+2O=WZG_ $XG/[IV>;]%_8UH0]7UA_E
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M_-9G+SS]U@\]_O/CI63S?>LW3V*</GO6;S6OK'=VGZXUGXU4'LH^=*,CPO\
M?I6:* X?NM?-\_59IP>6"ODHN1!FLF\[M%@-O_70<@\Z0;8SC'YDE,[;_O\
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M)C3YBE2E[Z=9G'$XMZF;"&$2*S-PD7MOH?Y&"PB+-)V6%M(92G<?+E/W'O\
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MWXJ )<1%[D2RQ,RPJ6@F1G[+B;P-A&=32+$S- O"*DR,H,VE$X)*6@0,#.
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M9=XF8YXI8%ECH&ASO5Q1DCE/ZOSHK/!G;B!G]SFL&>+FV%]'O3F&(D9\Z?\
M8PE;=.[S&((9Y+(Q<R(GG;UIY9 %47"",XYWF8B6BA90WM8B ,X2]\792UV>
M$PI."0BF"6$+.;$IN&4B=#+=%P,LQ4IY*J2P0:#>0NPLV+I(D$@UF"79(6Q*
M+?,-JD!HG4R^::^V\$;R*& 4+'_,H7*.]JQ.=+/0^:83$,EG3VK5S/;U\=*S
MYZ6<7/=<<M*Q;<G./:O@^*P=+\M<?KZK!UW=[UFZ>U8,6QON;PTSH3PQ^2YT
MCY_=&\\/6HAG3')8_M&R:E_.E'@Q/WUM6/7SXJ5]OM/U2B>4=P*9#?-QY+WW
MI(77OZ+Y%&*0OMQ)Z?\ PR-8-U\\U_&QQ\#?/:K[I*Y(O=_T";)9<0!.(BO6
M 83]55\>+(5IY/BE$>:I\U9(Y^]GIIQI[$F_7.^]O2K?J''+]<*=K1N=&3W]
MJ(>#K[?E0\&SYYK^,3O$[;/:G$<T>O\ :5M>1G+IQM/\IV.9ZV?:WK3Q?9>Y
M2QHE_2WM-)4O:'E;^4TF^US.GOO%6C<AYNMN":47!W_ZR ,_<60Q$V1$S2*1
M%"(D(FB.$;(XVI-19J8$E34JDPR8-6P66\+%F03$@92R1:+5 [ ,9GKR;R9L
MJ%/YD')8N3 V3*%NT#=H8,WDG :FJ6E(2IA!=+EYWG6=F 1S,MU09S>SRQZ8
MHMX [*"F(*U!8B;?\V;I[UB<_NLNI[5*&UY+9TY?%?!\5ES'N:Z\V]<7"/.^
M:PMQ^)]*^+XKW'??S-O2M7C-9G+Y:]SY_"0IM^$D3<BA9-I[E";[D>]"[Q/U
M0WU$^_?:L.OW27DQWC?APK71VC8?9:=I:C[#]U<0"%CB1OP#I'_PR3Y]T 2>
M><>[6:AD:#GX_P!']F 2K81;]K/TLI^X]_NKH^G'I7L'W&H(].F?0]:CY/CC
M$;MZGB$X]+^JVZ59.F^,>T<?:G:-J4@]^?Y4E\GDTX7S%*>H/G>DRQL/[]"S
M3UX2<,/WFG<.&>F*2"=(GIIZQ30+W1C%AQ,XL5<(PA?B6(ZN?BG,=>R3[^U.
MT;?W_KF]MHPVO=&P=Z<"A>XU@25(A +)424%4;B) "(!#"MC29BIDD,;)@Q"
M]B$1+19O:H7 472 0!, :KJ<Z3B..K+#@DJ"Q=FT262T"6S(D9O,R%F9O%10
MH48!FZ6B2E:869 WT%(B"=3XNI;:Q10<]3;VC$B@C"1:;_\ +F\GS/2L#GCS
MR]#/(?6*OX%AY=^7T:#/1/;[K/G/<H1/2;].N/FH);&'2$K5R/>I8<>TW]/)
MKXO6*S'SR]'V/LOX-UW\^/;\F&=\\_W\4%[:27]Y?>HL:>S^_:AEZG7/K7Q>
ML5ZIORECE>EG2%[W]T]:=V-H?;^5B]?:@A(EZ'98\D1.#_\ #I)'GZYWY-"-
M9T=+GASK-?/+?Z=/>2O8;*T^-"GC;7H]]ZU]?BD[8O')'EKFL5^?I/S6.\!#
M.MO;?KWL&,>VU]G7M%0=+/+[M1')Q^<T\\O2A%I=Q'Q[G:G@M-NXV],TM-SV
M^<%32=HMV^2ECE\7]2D9#*WV\]:4<![6?>E<\PQ[-.Z=?/-/^RV7>C"W$""(
M()$I3*XD."H0F[+%N%C5!Q#*+B0B658400S-Z&",@60H*)A"AETFZ=T;2+EB
M!*=86+BF<2 <R$&TK%F L0$.*0EQ$[A#)8=%M-RY:6A300XL:VN-M9JPA-.2
MK6"288<#6<?\N;S6L>OW5IWO[H^:*8>%WUH%^3Z-O/$Y:JST2LW]Z+S]>K1D
M8W3O;ZW:-NCZ7*&=9&W2/6A.&ENWK?ZHVG9]/(HWYE_;XI(LT).)C\B1Y3VH
M3#O9\[T<NX^GZBM?-\_=?%\4X(O,*O+CSJ$ZKOQ_:W;W]3S3E5YU?0X^OI2&
M-FU;<-.C9X__ ! F/J<]/K>;4(GG'G.9_P!(!)T>7[+5I\:5\'W*NZ3\?=61
MS3TK(U([NO2:FB6>4/+/]UXU,$Z1O@]7+?6-:TEMAY1:G)&WMI2DXF?/-?P,
M([?A2.UGO_*9/9'BTK'<GHD[Y:6)?U9CA+:V;4R%\S'4(^:C G,3?%X>46IS
M'+XI?'=ZG;PJYZ?7_8[7&&1I1$B+),$&D; $C#<EDO&KIF.% ,I6"F;0Z23$
MS$-V&H A42ZP 2#9&$DS8+RR!$6Y*Z!<2+243@382/(#-( EP8O<FV*1KC;+
MRM$ZAIC&&*:$70#!%$6!F(, [YK6#=<'KBZ:SZ4Z<M,/+)C]W_,"4BT_RAEY
M/:SZ>]&[2\=L>VU"_"7UO159+X[7.N]&58X>EN''WJ]P,_?S1L'?W_31UVS1
MOU;^WS1B'!]N-&2=3QHF>,/G3\%NZ =?./Y, \R?%'/.>_\ :"')A.-ZU<CW
M:5G8.]Q^:F:ZN<;GQVJ<^[SBW2U8]Z(MT)R ]#_Y) )#/%L*F."5AS?->Y?8
MK7U^*^3['FGQ6#A8Z _%*(WL^@?-N-8K;>M,1;;3A#?3?3VHLZ.>#3@<;>=?
MRI"\V)_=/'1VCZIXM>T3BS![C3QT>XTXC@"^GGEE M>!X6.^O[UH@CF<"6W&
M_:BU6(WW]7.-*6)Y>Y\E/'*.W\_[%E[0)[RDL";J7W*"]TE[Y$PL1TF\6;D1
M4&""9FP7'*;I!PH1$QMP!&3)1<B L39G#@BF((  EF%E(*[(!F[@!95 Z(1>
MQ4#+-[EPE1+,WM %D%<R"$*@B6<EH8S#-X)O(C,A26)DB&1C;52,E]*(F7M'
MS-93/8'),?\ *;CO\5F-I[/A46[?3 GQ$]>%>A/8_30NN,\-H];[5%,>^WZS
M&I4#+J]QG]U IN/ICTCK0>[GK._KM0ST?BC>=_/JA#':LQHX_?7TI(8=*21/
MKYI(='E^-=_$\Z.>4]OY1/=U_;;TJ +M/8:6<X^/7&-+<JU]9<VO';]4)GS$
M3\UCWI$L^/=?VY_^2 S$7=,3J5AS?-?)CL5CT^J]P^Y61S?:GM;Q^2:>.CW&
MEW0>N:4G0?/W]TI!U^?+_EES7GG.G"EIS.D3[TL<!]$BG 7TF^L-OFE<-(N]
M,?K>DE[V>OG:FLS#$$^\N^;T[Q$[,]>N6E)(WR^GR<J4!P?W\Q_V"2U3F3Q?
MT 2TR)+"5@@L(C"*LC<9M-6&$DK:$MNSAWI9)<(MAL,:8LRR3O0PF)B!8@;-
MY28;F\L[I0O,X%"P!!9>B, TB%M<SDC&B6126IM%T)N-EAT5K0QI 7)#S(*N
MN"+-KIH9&T70=HI09 9(DPF+?\QMR?/BA)C(GUY]5FT_=GUHH'>SVCUM4G7T
MY]0]J-I\G'LT$/!?24]O6A\/N>8HW>2'K]T-]T>/D>M&R9B8^*,BZF/2:S</
MY\T;COGI'XQ-I\^?QHZ^>M8]*&RWN/MI2LR:-N+.>WW6KK1]P^Z_%9/)]BM7
M-Z6UH2#Z*V/_ ,E@MD'> 7HU[GS7N7V*U]?BM')]ZR.;[4L<]S=^Z<68TY62
ME$<'K#GSZKD,8XC]?5.\;^_GQ3DC;V_'K'[^*2-N?;^WI728^9P>E(0X"'W[
MU<[.<WG2,L;4L7GCS$CTCC2PVFP<ICZILD8@Z3O:^U*$-_O]STIS\.5IZT,@
M\/\ K]6MJLF$PYHJ3Z(23BYI9)54I %F Q8.NDVFR8*N$X L@&68M$P3.3%Y
ML+"BX9&$9Q=H$GKJH8H*)2,,2%@VP7N@E0 B V#7AA#' FM@B"Y@@'.^[<-2
M4,$7X3BUBV9RO)HOQEG-=N*!)$WI_;]B+Y+0A= &Y_RI)#K0D>%Z-FVI8G&E
MCOSH9YOK?ZJ:=YCYAY-N]"1$U&WH\>/&KSSD^?YRJ0X,1QN'#3VJ"\?IYXOU
M^:"8O#?K-0JZF?NC#.C[^7_E0*:-9C:YX</PDB<*1,T;N%_.E'/?[^:&=6_*
M]XY_O:HDLD?M]ZP>?L:NF8@5>2IYUK4[$=R?BM7/V5>.?4A]_7_Y%L+M0#X,
MY4[YOFACJ_%&R\_CZ:P.3[UHYOM%*]]'M<IL',[-CT_96/0\]*1W".7GM3L,
MW+<O"G#&_GZZ_@81XU[5*YNR\L[_ %3QSGLOW2QT/1#ORZU>]8]>6]8%YD[8
MLWX4I2-3VM3N;#-ML^](CC<]5K%U]W_LCW&R?&WH:8)246*)"VU.,\ @ #&+
M!5]DL(Q,HO9BT:&8M,Q.L+A+,DV-L,W2_#+=VF4&*EHOQ0.=5PE/4@$]LL@(
M($O+5U"$4-0@LD8O8Q:-+P  ;W%BTH#$PF6;Q+*+:JR(I) %B4N$ ZX9;S1'
ME#'<LHX1$&!$'_*(4T?9\BBAZZ;<>&.M9.$]66>E#+=D].W>AF.)[];WH0]7
MUOZ1%0+&MODZQVC6LUN7)X8?;-9 OJ>;Q4U]L\JS2\S6)S\]J-QW^/[0A>YY
MZ?@WWL3S\AZTX=+-:_&M'U^D^*-MY/H^*Q[N\GP>M"[K=MWSSQ6#ROSAK)Y^
MRM\NE_(/_D2=8''85/2* !D#=PEXR,U['Q0P/!WS6)S/=HQ'+W9I1QOVD+^:
M369>UM;Q;E'/G8K3S]"E:.3Z-+T!Z1[T[IU\\TI8>3U_+B7 ]J6(VAX1X?VE
MIP'CC%^^]J?KJ3FS/U5RS-DQ'/C]M-A<=;3.<9>O,IZ$#V+?._&KAQ/;'>U*
M>UN>O:*=DV?/G_LTO <&K< ]&04T4RTP7NWOU8BQB=M(<)<"QFS#*8C+UAM.
M^A'7"RD%I$MHVO8/:4^!F!6$MY$$V5&.<;)D@;:0M)%$PE("%0K-H)9A&"$D
M6!J>@A<2625A& V;WM,T[ :)EQQNY 7)BZTP %]0.LWYO@T4WT/+Q$.ZO=)C
M_E-AXQ00S$+NYUHW^.>?4O0N'CWUOO[<:0FRWGDZ^?5"S.]GG]>%Z6&U]==H
M[GDYUSI]?16L$1Z[]O3K19WR>>342IHWY/;SE5Q-''G.A9-3W/(HX>C^ -V;
M:3G^X_ LZPQTQ]4,]?1FCF>/S^O2C?+;UT\S-:N;VDU\CK6'3XI>C=3VSPH[
M9(=X>76)MA-/_D?YY_TN#=G/-RU8]/JA<YOH4<=/0FC:-;'8_="$8R^F)]6E
M <O@[\JB1Q1[,4L=3YIV6T>G\I]Q'S\4[1M\^-*0[=OQ@<BL'1S&<SPQ2B&;
M?$Y[>],DY1G&GTUB/-F>5HX9J0#<>CJ<?2E %\!S\7TK,.V>/G$BL&U\\8OV
M:=XW^/'_ +(S0Z$"1(+&8E-J>4$V)DP6S:;3=P9+24H)* LF+!J,$YM"+O1J
M5H1JV3+Q0)I++>D( 9!(4+$!<<A:#2KU'"0-)V(R#@_35!T$&S:I@%+K(K&:
M"#%[$1&=#2P ZMV40ME\@9L1@;J25"REG,Z2EG<$UC.08H815Y#$B2(2[+%_
MY!(GF]&<#KI-I\*5O&JS\>KUYU.KQG3,6.IQ[8J<8.9'F?UK3PD3GJ:_S]4I
M/'WT[Q]UE.I;#>V+=-*2Y&JG?!"^;4A(&9CY-.7"I!TT9.S[>E"U\C1OSH8=
M3W_7Y]KO0SQ)VO\ TFAEX?'ZHZ^:'PT(DOG;$,_+VH6>9ZPSZ5KM&;4RYOFB
MA2^R]J&R%.XW_P#D3=;B&;0YNF %5@%KXJ$O-#[^*,QV[M>MONL'H4/F/0^Z
M%^1![48MM/L9K#S=\\NK]?<BO<^?7PTK%U]FM?3SUK%Y_!^,7"?>E/:.R5BX
MQ/6/JGCU=[;=J=^&>Y^CK69,69OC8Z4Y&8F"WK]T"&,%CAH=/"GB^3' UZV_
ME.Z\G#M_V%Z7)9ZDCP) &4,9%@J!:&Z.D@39)T*G(@@9 D#!!4@46-KV*"TD
M)'HL6WLX) "T5*HR@L7$;XUM(,.TI2&K(2];,@5D,(++,#,-SY* EE5A!!?&
M!O)?.UX W9W=C@T6VNULS@6Z"7M9!9<L,WBS,ZF6][WFN"B5$8R#E)2DC>9%
M1TZ (@MP0A_R&88V]RLN=7&[?MGA60A[1QMRT]KT=YU>7)+:PS4,QNYSKPU,
M5.+U/.?HU;8/T_'A:L[''&NIUSQ>56)OTW+=OW0N\3;7R];AFSSTSY:C9W/.
MT7HX>GO0!MM^#:=OF*-AXQW_ )1R=.S\U:=B?2?LI&7%MO:+>:48G3/T](K)
MY?+]UES?- >29LNC>,L7W2>-_P#Y"TX([@^Y.5&$-CXCI1QS7Z]BC#RCY7I-
MJ..GHFL73[;<:)C-YGUCSC0".4]X^*Q><9Y]JSGB<L_'S6GQDK%U]FLWE\E8
MIQ\]OQKZ>>U(F'IS2/CO2L?'";SY=I(,8&.)%NV>57H1<CR^U+&G6UK+S?&H
M8=8,1%M,^V:N!;:-G[C.]ZQ>7(TVMGC2$1Y_<]:+@[_]1C<E T41\L,UY"B:
ME+(A)A<U'M6$1(" BT+RB!)C>).(E.1&9(EJQ#+B0!Y*V&@B)84<D)+ES;9F
M4[0*S9B5LYELP7F]7^480%"&$++)F8OBH"%Q DE N2H"BH/H>$4A& VL1B\)
M0*EZZH@6 )89%)80&9LLCZF25Y$(3-KN7>T@2T4J,979W'ZV<8IT5?.\&H/$
M15!@*KJ#T;(J!D3_ )(P;Z5/UEZ[<GS%!>+7U.&;;O/O4@M\XUOYTBAN(V8X
MQ>/.-9#'I9L^OM5Q+POE]Y.5-*)#,GGF9Q%02!Q.F3G]U@:E^/\ =*L*<WA'
MZFC>=&SYR^:(AM<[31DG4_ D32/73IO0D>%^U$EVO+SOZ7B@1+?EF_F]07O/
M3F]3VXT NTR\H^W2C9Z^T_/O0EYGK%_B+6ZTBF(RL0R1JB+8!_\ D83@@DW!
M+-[3;-N]9KYY:KW8>=J*]9]P^&C;G\N?2AKS^ONCIK ;>8HWGB'K_*U<E''%
MGM_*\,[5[7G+PUK-Y?)6KI\_C-Y5I=>U+'4[W]Z4P<'G8A^(_M,@\TCW*8C&
M(SOSW3TJ25]'SMWY5 ^CF2'G#:E*<O>+=_>DY</KV"E(Y1VM_P!*(4 O%Z\!
MI!*@N%JFF8B0=(@!&@9CE8QN*&;W(VSU879#*(E ;DY3NXF2V 9(X,1IL@+=
M0LL*G,WR:DT98B66;ZU<0[75E9PE"RQN@XJ0,!-XM>3HL!>"JV*6&9Q&E)F=
M%7,6"\4.GB8H&!4."#!JBJF2P+95V1,B08F[0*,8BTFZ2L3&1YS(2;4M2+A<
MLA9SE97$A*4908@MN'>\V..Q,-9C!0+K<TDL #7_ "!!(\FA(FOTUF\S9MSY
M<:4GC_?7)5QGB/6_>]ZS&,G<OZE&RZ69X[>8*R/)UZ\)U6M0Y_?WZ5$SMF>/
M[?6A$.$GOZ>L4 $VQ\>]ZS.7GQ1B0-+=OO\ "2)N16#R?:A\/N4).GO-!EK9
M)W9[T+O ?GZH;F<Z1@\Y\*&>OK+ZI[V%T(BR\QAP?_(PXD#3=GG3O*/JG8_M
MZP>7;'I446\#/=SO1MP/HBH@,2ATQ[S1LO;V^/6H.ENNKYO4[3O[F/2CCDO=
M_=#$ZLUF\ODK7T\]:Q7SR_XS>7R4HEL3ZE*VV$\[5$^O#D=)GG2^3M<[%!9T
MC/*3UFFMPQT_CWK!PP[<MF3K--5&IRL?)[[4Y#D_?6H0C;UU]?\ H!,!0 $J
M,  *J@!+3R9.A&7X); VU3(+%P<I>&1N[F3*Q,5)1):-PDK:T%KS+G%$4"44
MKA(%H6_O$97*>V)6TPD84M<BTH$9!1)CG]])O.*.9<,S,868D=]J88T0I!$$
M#&87SD!(FK'$!+P%I#;2=4MI#8AL0)TT.H*6YN'Q!0$Q9060@"8E4:<I)=1;
MX6ZTUU8C*"(3(M>$E!WNB/'<OHV=3(.1U@B+39 E&9(.*HXQM%MEP&BK8:11
M97%L! @O_(=>_P!UD<Z]-3S2*RQD>%^/-G^5G\OKKO#Z8FI)T;:>_4]=[4+,
MZSDP]YSI6<@VQ:?I.]9R.7R?HX5FW/9TM&_2A!#HVX_5KU%W>=FA$\'GR[V^
MJ-AVMYYK3EYOO^!A;4C3^4+7S#Z?31S;?M(G89H1/7V7YBBW-2?8/>CZ3[_J
MKC/*.4'S4L8'@+ZM@7JS(<__ ",QFP";2[=V)>(:P,=7XK!\<,>OO5XX<-H?
M7'W1QT>U_G^U!?8@MW??>AIZ/5IK&]WA_*&.?H:>E8]/8UD<#XK7T\]*,'.]
M8O/\9]/JLWE\E7>.%7C2;G;^4[DVD/:QUGIZTK G7*/.VQ2O$Y)>UN&=JB#A
MIO%YZWAIV1NST^+%.(\U1]_Y6/7SY_Z!G+[:3FH\Q5*0P2W)<J*J4JN996;M
M,L2!6,D9-"%&67+$A1(Q$""5+D!+93NMZBQ1!T,DJW+0NC*($U= 9&Q"(NEL
MPX<M&2KD$(D<1:UXBX]C9H$G7@^AOCT;.:31(D"L$P%[*R )L^@P,!7*A)9%
MF5*MH0"Q01:$)$D):VB46R,DS>:@D(V5 %C"*<P4F>A:FX%1,6%R$'AD0@QF
M$)B"<S,#-UUBE$K)=(RAZ$Z.]E):-FLX3)B+D.ADAC)$X7AJ03RN)EC C*B]
MH+-2JFB&2XPB?\:2)O37-F>=#MRM-O6(W^ZCA?7W1^^%2P3E;7[8GLU"NTW$
M]>N;_-9-F.T_'S-6%VN\(M[>M7%W]F?FU)?RY]F*&>4]L^GO0EYD>]"R8M/:
M]&.:_P"##SO0B9Q+/4G[YT,O#X_3/2CW+[AGIY%&Z]^KGL5 <CWH+KFT1Z%>
MY=FS) -KVI0I=]TOJ'_R#ZG>>!>C<NHFU'&N.RRU<+?W+ZQ[5V#O;.V;8YUP
M-EY_I2K!;8.>KW^:T?76^J3CG\4%F-?CSTH<";1%KO#%^=8O/SXHVG8/4K'F
MUBL7&??\9]/JLWE\E:>3XI96Q;I_.&M+'!2WG&F7-[KGKZ^E%*C03I]T[ASZ
M1-O6:Q.QUAB5UWC>E(<)-=/-;=:4]2?;[_YR6N_ZLB.I4AUE4,!ZMM*(DAH0
M$PD&$H@0##*O8!DQE@I:(%B0E4PE9-IN(@9<1:0R;HMKB0%G$[#4_%$D.<,!
M*.KA8;JBD 1$(;ZLHXN8VT@ F,A<S-RW2<LY;9O.&+47<M\A\9TH8+0A5$5!
M)(F]W+,$&@#%T%"$X#&-0DG%"@0,%M0<D)26\*0S#D' 1J H"+_NK %'"0,H
MR.]+'26I85+<6"UK/L$"^X 0H) C&3#%KS= 8DM=D"9F8RI(A+Z-[1G*5.1;
M<LMRVL+=,CFA.P!<FG.10 A _P#).N]FH!XWY7O[^O"LT;MN3]-9X/-/4B_>
MF92,DSYO6<CB<]3;AR:$743G&W7APFLAJ6VSOKGYM5B<;VUQ'"?BCGF/?^UD
MTA4Y5<MM(YV\*%SE';^_C,]_/+T,VV](EZ%J.9O'K='WH>B>M_::'9,=@\:O
M/&5GG\A0&=)^OVM'/5GLAYQK6LH"R["V':,B#_\ (,&5E=D *V"0<4WHW WC
MI 'O5P[_ ">P=:P^6,]W/ZI;<Y>GD6J(.,!\O5J*QRVEW?CM1@GH<CS>L%YU
MZ6^??%&P;QZT(':P=*%@VL'+\8_&;R\]J]KO7L?'F_R?-\T[\)'SM2B!U,^Q
MYQIL]!R$.QFG?HEG?/M\4\&\W^*[STE_=,MT=H^O^9BOO;M%"B4F NE-I]B'
MXD?19'4EKM((B:D@0ES!M ((J! I* 048AC0FY*T5$1"5"+@L@$K 7;R3O49
MLH!D$QF0(9O:RZBT0)$"R"8NAL6)R.8*1"P+9!DRF()FW1VHK\"@/O:WT,3!
M1MEW[F95\AO:0:436=;9C!AX;B+-XA 0Y%B")<#-A$$6J4,@#>C:P(!I,$=!
ML%/$SRE)=<$08%73$32+&^T"(I@"$E$53U30L!!HF:1H*2A2X7"Y91W1&< V
M;DS"]QO,D8!*]T4:NDM"!&SN6N 8X8A&HE;T!01+=@0&2A#%I'"?FP0%,A_Q
MN::YCY*S/&9CCQC'>YC3(-_OTS^VY3$V6][?&^Y?>OCBW/MMI\5E3+$3U?LJ
M9>W7)ZS0F?=-R+>G:A>^R/3/O0SR]OY^JG;;Y]]*-YXCO_/P>QGX^:"SRCK>
MLCP]BW9*S8UGWO;4(S1S.V.0W[^I7>3&,">?JAGA[2OL4,F]O1*!C)K,P<AD
M6>G_ ,@3RX-,QP[-@(1:A<?,_16#QIAV^K7TNMZ]*/3[?9K%PL<W7R<U<MR.
M;YZT6="P>;5WF-;<,<^-&1POYUHL'%GOBL7":$H=_/3\Z^E'L)^/FK.CW//V
MUEUSO)'Q5L3.#TB>NW6FVWC&DS!MC1IWS?ZGVM5B'"??AQ_M9\V1X?O'&E8/
MWG3I'Q3RTP:S-I[Z:?\ -?Y!/B&E$VAMF\LA##>&RK*L[#>-#;-:0H %V2+L
M 1;-W!,&P:L2LS+$@RL2,%[V+2H9(UB6$!!H@MK*PA%2O!UV(O.LFR;O-9IR
M %AAE2(@#AM:\9G8HUAD%U ;+;SNXAO*8;"%PPXF]W5LMV\6)XW.<3-H!GHQ
MQM1I55T;II@Y>-!E!D4*0C=*!D(ALX:-9@$V$9,1,$V6$LA=;EQ,I*L6+IB"
M+(G%,6-("LT *DQ>$LB&##1X%608C%F8 &(B4$<YW* E[NR1:<RDT*R )1%B
M\<[DLC:"I,!+ 81)AC1=&[<)":QV,!E:XDB1MO8(M(!;F:3"211B72:"8J"6
M$ 5$&"EI)_XC).IXU.6UOO>\G72AOTT[/3''<J4=-^''O$E/<=WWZZYY6S5A
MGCU&_P 11RMN$8O^^V]7GQEOZ.O&AG@CZ?NKCQL];_+0@1TCXHYX@]OY^,'D
MUB/'SVHV3F3U/NI!?+V^Z2^R/JS[4;O+]^;<:S&M^M@[2T(7S4?F*!I9*LPC
MP,2<5>>D?_'(/#+LE=!4C2I5967U2Y\;43T?'VU<+=M_Z/?C7"X'L<-^O*BC
MEZQ^UJT2;!SU=#/KM6P<#>?,O[H.%B_%?/:C%XY4,\4/.]!DX%^T5FO#SVK5
MT^?SB^'GZK-Y?)7DZ5GU/?SNT\8N:8-?B*>$UF>TQ[4KAPAZ=\4TNO)!KM]-
M0)&I/"P0;YX_-._)[PCWS5IOG]^D]3_E+0;T:/+DH@(05;7=*4O5)&!$2) D
MD$+9AE<A+O>Y*@$C)U$RK?+$RS$ D!1<AV5#!*PT,PV766B.Q.-O+B0Z'58"
M0*TKA,3>7 *S@EAIM-0B3( 90,B&PS.;RLW=,WR92DPET+,HPDW;*"IP5JE1
M.TO) SGE&[D=H1HBCT!N=G04@LW+((5?K,0UG+DV(F"91XJ!!E69(J_-3X@*
M9A;# "X)(R+P$AY, 3*$CE8L$R+AO-D<#OP(!67 $L2"CQ/)5&4@XHQ 0C@P
M7*8+C>("T#*2!'"RN".D)M*LVBYB*5E.4 B2 S$[<(6T$$)$B3,X4TA+CDG>
M1AU+6C:!JY!#A2 F<L ) 4 B(HC(Q_QYCM\5DD^.#UWZ:Q628B8>=[^E7&8G
M&<QBU[#9;4-!&I.\Q/*@8:%^?]]XJU,7'/'$=(ZVJXQ%SU\2.56S;3U_5J,S
MRGM>M?C7\-QY5F\UH7>3[$=M*M.Q/I/V5DQE@]/[THKVMUU8]J!><W[73S]T
M0G7/SIT*5L$ZF)#1JJCI*++_ /'WSDV,CZ<8$<:,1R]V:%PW3ID/:I(MMSQ;
MU$Z\:CCI^M];_P K@6^M^;PWZ;1,6.>5X?NIN1$<7M?CSK1ZNO3SC08 H7 P
M>QOS]Z-EW^/[0@YWH0<6[YY>?SB\_JLWE\E7]GH34K<R.[\UM<?9GUI))IAQ
M;L]XO[<=D"--_C[IXU1GZ]OJE<G9/@IXGAZB3[4Y#E$]GI6#S7_DD-^LH97;
MT,#2Q +4H(P(HM^:R-X5ML*:#.8D28B$F ;S01H"%  1)Z(V&ZMR5%IN$"*!
MQ.@)%.DM0*0!9*6)1AL]L$AJ9%R4E$"0 @P*7$PC)K2&3*V(6%=5'.[.N!2K
M#MP)G @B=6 K /@N(0GL*78E?\ RDN'E7.D\"VID-79#*,H&[DH\4&4C>55A
M=M$7=%+EBED14KNK$$N2,2@8T1%(60 ,D142,<A":0F"6Z$6""$281P0I%.<
MR*A$N$(C*HERY1B"1 6N!LEP-L,LE[DV@7B%\I$ M,:\$P-,HCHLW@<<Y&T2
M0:LB1",..I<EC<I'_&-AVMYYK5A8LWQW^^-RN&MP<[D;^3-6%XVT\@D_=7FV
MMIQK8VP/K3BSK;HXMZ7C2BHD'DGH^U)\O21[4<]>=R:+W$ZW^ZT=?BG+/X+H
MS,<:,G/7N?)0D==^5L]NO"K2\GMKW>]&S:\?K[H1)S]P^*$3)>7W/NDF')@<
M+IW$G_QZ.(N#"3*/!4:Q%"X;>R:&(Y^RU-'%^9/F?FIGAWMC'"]:FEO3'KZ5
M$3\:NNG+>,UBC!'5\S^Z8.+0@XM_U4%W/M0D!L>U%T-_\#!SO6;R^2A"<#XK
M5TGAGS%?-\U@3BVZ8X1??;C4H3N[:>E*(C6/@]FGAX*=YO6F-O[ZTX0.'O?W
M:>3M_P :;;@2P@)P(@,$DT 8V'U2ZD644@HB9[K@A#O=64%M3H#E5((;Z7B\
M7+CG6S5E@6+2I-B;$)=S$@9$M"I:1-T&QN +N+9.R6*JW5EE@I;$@RW7-"I"
M+L0K=E+ C(&!!2B[2Q/$8<SHJBLRIN4?#07GR03_ )*"AD18B4@)ZV(!5W&!
M,3B9OE6E@MG1+MY@NK>(,D."B,%K=(R2BWL1(DS!.#2QX!<B  5!@F+"2X"8
ME$0L3Y')2 515K!3+*DDJF8;0QQBE9F2P(FUEG050+B=#@PC(LS+:8C$8249
M%)I8PK%2P1(E=+&2A&C-WFUA,(@P!/\ AS0LB3'GLTU\81]IH3,;L\34Y'F:
MM:<^3?X]*&6#R^G)ZT9GS(?)0SS]\^]%O&I[9.WO1S&!/KCJT+,:/V?-9NGM
M^,^GW0M#H>B*.&Y:7CWUX\VLVUR/7VM6IN-N-WXHPO4]&:/JDZ3\E1C+T8LW
M.RAI"FO_ ,?$C%U(F ]S&L1F*%\:OM^ZO',?.B=JU&3XUZE0QVGF_MIX.C;C
M@.W2FD&,S:>$=9K!PB>?4^N&*.O0\\UH(E,XY49>!ZT<O3STHSR7_P ,#D>U
M9O+Y*ROM]4,<7YCXJWN]1:5FJ[PO'C6#DTK#Y;QRK&73MYUO6CK[OFOR1DXO
MK)\5F[QY\?\ %)GQVU1EN22J@5,,.8KFR/,(1=5D!# V(@Y!P(F2 +3-39"4
M("Z<%C=DNN+MYJ. $J@!9MIG,2P4O<7+@P1L"*XFY$-^2&K5(<V 5SCC,R(L
MG08230@C!%(B$&\LE\ZT<%-.,5(=1JE$4$!$4@WJ>BP_YS('&0K(6L%1/79K
MH<A4<2=ICJDP@+#="8LYSQ-!O?-&(51$B !9$9(MHDJ$Q%2* W9,]MU@@2!7
M ,"@*RLQ 7I%FYFI-% (!LNC9A:)C,!,95B29 @J)B4 DNDD7+5:%2\(!*2S
M$PK# <HB5JV#!-X +?PQ=*">XCAZ\F0J(#PG_$+O$^(IH8)'^IYIQK)LYC7<
MS:+=N=6+"TS=O>_KIPXT4.T1\FG?QIH?TMQ^#K-"[I9-O"_;:A>.?20HYX@]
MOY0N.'K$^]&X[GMX?C,Y?+07[WXYYW^:3JB1K*6]J+GSYQ[4=8POO]4;O$5M
MQ\Z=JO.WW,^]:,QF<^Z,-"'@7D#_ /')G0,-^C M0N/'Y_57N$QIC'O_ "AE
MRVY>-Y]KQ;:W*)YY:LRF=-YQIMIF:?7K\=]>%&QNO\^^M=HTJ2QCVH(L%! '
M"C:8S[6_P+!R*$KT.\U8QM]*/H7O_:]CXK'A#N^-90V>T_5-CYVC^'DTI#S2
M/CUI=T_+61YJ>:?-9O+Y/^%\<%X#09A+) K&0^_\;$GV1*8U%PLMD#18"2R@
M7D&"(PEJ7EL,S,'1=; 78%Y$3(@.4#.0(O&K,B<UW4AELE]"(9VL Y70($75
M< #DR)4B**;H(,A-H")3ON"\, X# PT5)5FZ(56;#(U&+%Z,PY6 29)_J%W!
MNW TK'L :C>^Z0M=802E8DITO&$)C6,;39M;T(,$0 C,D&W(3A8BF$$$RHHI
M+8 KQH0\PJK.!8!FS!-4/0@("U6;(4&B7$PX'$"5C4UFQ%;3C*R99ML)AXKA
M)J1%K+B9O *]"CT%!*2$*U!$$1$$1D1N(ED3#_PX]:,3T3JZ>U"^#.W.W:.%
M7'M8TO=XR6YU<$1;GC.>&=88K$O_ "SZ7H\+VGU/@H$LZ'*]SKP[4"7$1RN?
MOUK,Y?+0@OD?O\&W)\^*,YQ&G!FA,]7C%M=(GR:B&V\]/F=J,'(Q[4#1O''^
M7\FA"_',/BA\+ZE9/;JY5=<W7J_^.8&@T056X@3@J$QYJGS6#G;J3[T)BV8]
M3/?UK%R/W[U,&(MROCMKRBM/3*T95V\^*@ ,_-"".KSJ"[GVJ3I'7_ R.%_Q
M[GS6KI\U.W+;AYS[4;XP=J-@WW]O2)H7.;UOYO1L&^_&DK;?IGX^*+;DO?'N
M4,<_E?BLWSS]_P# ]:)B)M$3P% %JZO%DEC#@:+Z!67!(KD&;%78U91@D7*$
M&266;H3)1QSU9HE 1--P!*C<(;Q=3$B6C0RP[JZQ.JXF(0AML,2"2XRHQ+@B
M0-Y(IV"*S>S.9-"5M>2$;*.P(W 7)%63 @3D& E0SXNBVJ)$I/A5@<SLG%K+
M6D@ "/\ 7'+%^.8#-'!DU/<D(MP0:3'!&:FQHXW.$^SJ5%3$)]BAP-+\ 2DH
MZ*(,FR< LU!)BSY<J4-@MI[E$""5!A+I<RVU@9S,!2XH,M,<(O!>]AB\Y;V@
M:7TI)54C@" BB%X088-^"6TE2@;@9_P)(G;G1DQQY<:(LW7W]XHY8\W]YZT!
M6W[O#WK)JA]G>89];4<]?L])HW>7M?\ OI1DWGTR>]^=:.OQ7Q?'\Y[?C!Y>
MUZ$AU._\HR,;>\GU4PWTCT&B,G#X5[M#/F7Z_M?)0Q.V.U&12E++)'$4=/\
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MB[!E0A$0R2F$@R*BF*!3@8FQHD%A$+FD>@DP"CB4+ U"!P"TQ4A $EE%*_\
M,F[*C5&*-:*IN3:<!=WXYDF6J4Z(WL\RVW7GS+('6"#H0-D91+<*OT_26*TC
MJ27HM0@?4IBQ$"@U]%0WV&2R^PEG?J6+19<+P_<2!4VBB,AJ;Y,U(J>(I%!$
M_P!QSU=I^J,"Q>Z>6G+Y>A9MI\,^VM[4"%\+GT3A7HS[N8OKP:L%L=-.OEM:
MG>/%YJ%MKYVMFCV,_'S63S??\9G+Y:R=;L<9J,);9DYPWI7&LKZ5:#A/G?\
M%KY>@"KHZ7M/J NF9_\ CEMX!W>2>D3I67,?-*2Z;-(BV*\G6L^WNH?+[%8'
M(_![F?CX_P S>=J](_7S6*WZXUFO#SVKYOFLN3XK/DHY;GL-9#?&.CYMM:L7
M)Z>9K$C9SK]Z=FL77W_T@BD68"7% ?RU;Q:@,6+D0UHM*2O>T$\2;<)G&-)8
MJ/:M"Q(RJR3<1C- C0H)$8"7:&-F;0QAN+2-\1*+&@C&C2<(T"(0,1FQE9F5
MO-%F9#BL(7@2Q[I*6)S,& 2J;S!,@AD!($4@%BP[5@YXHGB%#%DIM&I$M#[
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M6"D"?:MYO%S;0@%2$)@2#""($86T62Z8BQW1:!:Q,"D(-22#2\#GB8L($S;
M@;#,6?@AF0&2!Y#"O O=9RUL<SOE3$:!UUJ>CWFVZ!IPXA@#/(B.)Y4//E@
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M'SWH^A>X_=8.?O0$<IJ2$X'<])E7E1(S'./;^SWH1M>Q@VWSWRS03B\?JBZ
M['O%:>UU\^\<J$#M8.DUD<SW_P!$#PHN#O2AGORJ:V=9G2M+M[_NL+*:.E]_
M-ZP]_A,:^%8/6]\=>LZF;59RL[[.9Q*G.KBT\OK/'B<*P7X>:7]XH5!A:*,Q
M0EAE%S"HG)D0,("+I!*P3J6.:0WN0!40+]BQ)$:(1.Y)"QBZ$2C#+&^;)/"
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MZ$[;XH#5*[,6TL'1M-3&IOSDM)Z[3IBU_P#>XX,>!#\ET;>V=:CBX2A+C"H
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M.ZZ1HI<TF[P 00HN"-[2^O*FDT3$! 1:RPC- ,DNA ZJ BJ@"M"E+"DX *O
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M7A./.U<7SC]^MYJ;';(\O#TK!?2W#>?2)HK(W2,>%0P3'/'?UJV8C0D]_O\
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M5%/!;AM-++B^(X9GS2B]S!BY+Y\TZQBWO>/O<BF,69XFFO8SPZ4W6)B+XO\
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MPQEUU:G=:+1O??M6/S3YUHV[O2/>L5\\O1P<BWLH,'%'M\P>M9<6QP9?WBK
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MA:??-^M01&MNOSV_*A&Z]$?_ 'X"%U:W@--=E:W%WE.J6:#."[CCO8F>NM'
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M7_\ >,GN'HT[?7GCMK>AB3<U[=^&#A>HVYG8T\VYT$>?5O\ ."[,X_F_]/\
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M%>@/:C:-WU?W%0[5+9\OYO4YC^><N>*CPTT[R3>?2BP&W^02AO'K001Z[_\
MY#S>G[I$NFL=?]N+K[M9N/\ I,FE1T7SS/I00!_^1H.:A:V/7S]8:OF\9]_K
MUJ&_GD^%X[Z^FW[]*XV^M1W?3ZI(7FQW_,.V<5'XQ=?=K,>'GO\ X@5&>E1\
M\GXG2N%W\]ZAM'$SYMM4-CE!'AIS?_RR#Y]OH[?X(C;SK\<:G>_+C]4$$3-6
H%XBH;O#S7TJ/O^NAW=Z#;R>C/CRJ!U(G7;EZ<6] &#2/[_\ X'S_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>silk-20191231_g4.jpg
<TEXT>
begin 644 silk-20191231_g4.jpg
M_]C_X  02D9)1@ ! 0$!+ $L  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" D\"B8# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MD?WE_.@"YN]Z-WO5/[2/[R_G1]I']Y?SH N;O>C=[U3^TC^\OYT?:1_>7\Z
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MY_\ UZY.XU*4%OE3\C_C59M4EY^5/R/^- ':?VLO]^+\_P#Z](=6']^+\_\
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MB_/_ .O7$?VI+_=3\C_C1_:DO]U/R/\ C0!V_P#:P_OQ?G_]>C^UA_?B_/\
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MB_/_ .O7$?VI+_=3\C_C1_:DO]U/R/\ C0!V_P#:P_OQ?G_]>C^UA_?B_/\
M^O7$?VI+_=3\C_C1_:DO]U/R/^- ';_VL/[\7Y__ %Z/[6']^+\__KUQ']J2
M_P!U/R/^-']J2_W4_(_XT =O_:P_OQ?G_P#7H_M8?WXOS_\ KUQ']J2_W4_(
M_P"-']J2_P!U/R/^- ';_P!K#^_%^?\ ]>C^UA_?B_/_ .O7$?VI+_=3\C_C
M1_:DO]U/R/\ C0!V_P#:P_OQ?G_]>C^UA_?B_/\ ^O7$?VI+_=3\C_C1_:DO
M]U/R/^- ';_VL/[\7Y__ %Z/[6']^+\__KUQ']J2_P!U/R/^-']J2_W4_(_X
MT =O_:P_OQ?G_P#7H_M8?WXOS_\ KUQ']J2_W4_(_P"-']J2_P!U/R/^- ';
M_P!K#^_%^?\ ]>C^UA_?B_/_ .O7$?VI+_=3\C_C1_:DO]U/R/\ C0!V_P#:
MP_OQ?G_]>C^UA_?B_/\ ^O7$?VI+_=3\C_C1_:DO]U/R/^- ';_VL/[\7Y__
M %Z/[6']^+\__KUQ']J2_P!U/R/^-']J2_W4_(_XT =O_:P_OQ?G_P#7H_M8
M?WXOS_\ KUQ']J2_W4_(_P"-']J2_P!U/R/^- ';_P!K#^_%^?\ ]>C^UA_?
MB_/_ .O7$?VI+_=3\C_C1_:DO]U/R/\ C0!V_P#:P_OQ?G_]>E_M8?WXOS_^
MO7#_ -J2_P!U/R/^-']J2_W4_(_XT =S_:H_OQ?G_P#7I5U13_''^?\ ]>N&
M&JS?W4_(_P"-2QZI+D?*G7T/^- '=QZB#CYX^OK_ /7JTE\&'WD_.N(MM1D;
M'RK][T/^-:MO>/L/"]?2@#KH[@-GE?SJR)1SR*P(+AB&X':M)9"=W3I0!=:4
M#/(Z54FN0N>5Z>M,FE(#=/NUF7=PR@\#[M %N2^"X^9/SJJ^I 8^>/\ /_Z]
M8]Q>.-O"_E63-J4HV_*OY'_&@#ISJBC^.+\__KT?VJ/[\7Y__7KBFU27^ZGY
M'_&F?VK-_=3\C_C0!VYU8?WXOS_^O2?VL/[\7Y__ %ZXC^U)?[J?D?\ &C^U
M)?[J?D?\: .W_M8?WXOS_P#KT?VL/[\7Y_\ UZXC^U)?[J?D?\:/[4E_NI^1
M_P : .W_ +6']^+\_P#Z]']K#^_%^?\ ]>N(_M27^ZGY'_&C^U)?[J?D?\:
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M7Y__ %ZXC^U)?[J?D?\ &C^U)?[J?D?\: .W_M8?WXOS_P#KT?VL/[\7Y_\
MUZXC^U)?[J?D?\:/[4E_NI^1_P : .W_ +6']^+\_P#Z]']K#^_%^?\ ]>N(
M_M27^ZGY'_&C^U)?[J?D?\: .W_M8?WXOS_^O1_:P_OQ?G_]>N(_M27^ZGY'
M_&C^U)?[J?D?\: .W_M8?WXOS_\ KT?VL/[\7Y__ %ZXC^U)?[J?D?\ &C^U
M)?[J?D?\: .W_M8?WXOS_P#KT?VL/[\7Y_\ UZXC^U)?[J?D?\:/[4E_NI^1
M_P : .W_ +6']^+\_P#Z]']K#^_%^?\ ]>N(_M27^ZGY'_&C^U)?[J?D?\:
M.W_M8?WXOS_^O1_:P_OQ?G_]>N(_M27^ZGY'_&C^U)?[J?D?\: .W_M8?WXO
MS_\ KT?VL/[\7Y__ %ZXC^U)?[J?D?\ &C^U)?[J?D?\: .W_M8?WXOS_P#K
MT?VL/[\7Y_\ UZXC^U)?[J?D?\:/[4E_NI^1_P : .W_ +6']^+\_P#Z]']K
M#^_%^?\ ]>N(_M27^ZGY'_&C^U)?[J?D?\: .W_M8?WXOS_^O1_:P_OQ?G_]
M>N(_M27^ZGY'_&C^U)?[J?D?\: .W_M8?WXOS_\ KT?VL/[\7Y__ %ZXC^U)
M?[J?D?\ &C^U)?[J?D?\: .W_M8?WXOS_P#KT?VL/[\7Y_\ UZXC^U)?[J?D
M?\:/[4E_NI^1_P : .W_ +6']^+\_P#Z]']K#^_%^?\ ]>N(_M27^ZGY'_&C
M^U)?[J?D?\: .W_M8?WXOS_^O1_:P_OQ?G_]>N(_M27^ZGY'_&C^U)?[J?D?
M\: .W_M8?WXOS_\ KT?VL/[\7Y__ %ZXC^U)?[J?D?\ &C^U)?[J?D?\: .W
M_M8?WXOS_P#KT?VL/[\7Y_\ UZXC^U)?[J?D?\:/[4E_NI^1_P : .W_ +6'
M]^+\_P#Z]']K#^_%^?\ ]>N(_M27^ZGY'_&C^U)?[J?D?\: .W_M8?WXOS_^
MO1_:P_OQ?G_]>N(_M27^ZGY'_&C^U)?[J?D?\: .X&K#^_%^?_UZ7^UA_?B_
M/_Z]<-_:DO\ =3\C_C2_VK*/X4_(_P"- '<#5!_?B_/_ .O4T>I _P <?3U_
M^O7"+JDO]U/R/^-6[?4I3_"G3T/^- '=1WP;'S)T]:MPW0;;RM<A:WKMCA?N
M^E:]G<LVS@=Z .DBDSCD5.K9Q69:R%@O3O5Z-NE %BBD6EH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M: *O_"(:)_T";/\ [\K_ (4?\(AHG_0)L_\ ORO^%6OMTGHOY4?;I/1?RIV
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M^5 %7_A$-$_Z!-G_ -^5_P */^$0T3_H$V?_ 'Y7_"K7VZ3T7\J/MTGHOY4
M5?\ A$-$_P"@39_]^5_PH_X1#1/^@39_]^5_PJU]ND]%_*C[=)Z+^5 %7_A$
M-$_Z!-G_ -^5_P */^$0T3_H$V?_ 'Y7_"K7VZ3T7\J/MS^B_D: *O\ PB&B
M?] FS_[\K_A1_P (AHG_ $";/_ORO^%6OMTGHOY&C[=)Z+^5 %7_ (1#1/\
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MV@Z;#&Y2Q@7"GH@KB-+NMPB.W'7O]:]&N/\ 42?[I_E7C^ASY$'R_P![O]:
M/0-/DW+'QZ_UK8@^ZM<WI<F4BX]?ZUT%HWRI^- %U#3ZC6I* "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "H9.U35#)VH H7GW?\ @5<OK#?*?^NG
M^-=1>?=_X%7+:Q]T_P#73_&@"CX+;_BJQ])/Y&O3*\P\$_\ (V#Z2?R->GT
M9DW^M?\ WC3*?-_KG_WC3.V*8!1113 6DHHH **** "EI** "E^M)10 4444
M *:2EHI )1113 **** "@444 %%%% !1110 M)110 M%)2T@"D-%%,  Q[T4
M?RHH 6BBDH 6DHHH 6DHHR,X[T %%%% !1110 4444 %%+24 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110!'<?\>\O^Z?Y5XCX?;_4<?WOZU[=<?\>\O^Z?Y5X;X>;B
MW_X%_6@#O]';Y(?Q_K72V?W$_&N9T;[D/_ OZUTUG]Q/QH NQ_UJ6HH_ZU+0
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 5#)VJ:H9.U %"\^[_P*
MN5UH_*?^NG^-=5>?=_X%7*:Q]UO^NG^- %#P3_R-@^DG\C7I]>8>"?\ D;!]
M)/Y&O3Z ,N;'G/V.XTSM3YO]<_\ O'^=,["@!<\T&FYR12\T[@'\J6C^=%"
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** ([C_CWE_W3_*O#
M/#OW;?\ X%_6O<[C_CWE_P!T_P J\,\._=M_^!?UH [[13\D/_ OZUT]G]Q/
MQKE]%^[#_P "_K746?W$_&@"['_6I:BC_K4M !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !4,G:IJAD[4 4+S[O\ P*N4UC[K?]=/\:ZN\^[_ ,"K
ME-8^ZW_73_&@"AX)_P"1L'TD_D:]/KS#P3_R-@^DG\C7I] &5-_KI#_M&F=J
M=-GSI/\ >--S0(2E[4E+F@!?6C.>])FCM0,7VI::OO1G- "]>M"FDQC%&>*
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M_P#CW7\:Y?XJ?\BA-_UUC_G73V7_ ![K7,?%3_D4)O\ KK'_ #H X73>DW_
M?ZUUUO\ =E_W1_6N1TWI-_P'^M==;_=E_P!T?UH CU+[LG_7/_&N-UK[K_\
M7$_UKLM2^[)_US_QKC=:^Z__ %Q/]: /;;?_ (]XO]T?RJ2H[?\ X]XO]T?R
MJ2@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@".X_X]Y?]T_RKPSP[]VW_ .!?UKW.
MX_X]Y?\ =/\ *O#/#OW;?_@7]: .]T7[L/\ P+^M=19_<3\:Y?1?NP_\"_K7
M46?W$_&@"['_ %J6HH_ZU+0 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MTM)10 <\^M'THHH *2BB@ I>E'6D^E  *.<T?C1G#4 +[T4G6EVT (***.:
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M^ND_WC_.F'US0 #WZ4O I,YHZB@!:.GUH';/-'2@ !I?K2>U)TH =24#\Z*
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M2^NHK6V\3Z-<7,KB..&'4(F=V)P% #9)/I71U4HRC\2L)24MF%%%%2,****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@".X_P"/>7_=/\J\,\._=M_^!?UKW.X_X]Y?
M]T_RKPSP[]VW_P"!?UH [W1?NP_\"_K746?W$_&N7T7[L/\ P+^M=19_<3\:
M +L?]:EJ*/\ K4M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !4,G
M:IJAD[4 4+S[O_ JY36/NM_UT_QKJ[S[O_ JY36/NM_UT_QH H>"?^1L'TD_
MD:]/KS#P3_R-@^DG\C7I] &/-_KI/]X_SJ,>U/N/]?)S_$?YU'0 OO1VI**
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M=>-I_-"VMIYH;.U?XL#N3D 5YEJ7BCQ MI))/X?U.&&,%Y)9+*1510,DDXX
M]:9X=^)VG1@M>2>4>@?&1@\XKX2R/K>8]'D\6:OM9C9>6JC)(=/_ *]:.B^*
MO.A/VE9'? <,JCH<\=O0UP$OQ0\/S1.GVS.X8/%<_)\1H[5Q]G;=%LV CV)Z
M_G19!=GL^H>*4MXXS%&P9GQ^\7C&">QZ\5OU\ZS?$*2^A(W;60A@&'7G! _
MG]:^BJAEH****0PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** ([C_CWE_P!T_P J\,\._=M_^!?UKW.X
M_P"/>7_=/\J\,\._=M_^!?UH [W1?NP_\"_K746?W$_&N7T7[L/_  +^M=19
M_<3\: +L?]:EJ*/^M2T %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%0R=JFJ&3M0!0O/N_P# JY36/NM_UT_QKJ[S[O\ P*N4UC[K?]=/\: *'@G_
M )&P?23^1KT^O,/!/_(V#Z2?R->GT 8T_P#KY/\ >/\ .F"GS_Z^3_>/\ZCH
M **** "E]^M'%)0 O:DHHH 7]:*/YTE QW\/O2=*!1[T"%S0.M)^E'K0 O\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MO_Q[Q?[H_E4E1V__ ![Q?[H_E4E !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 5#)VJ:H9.U %"\^[_P "KE-8^ZW_
M %T_QKJ[S[O_  *N4UC[K?\ 73_&@"AX)_Y&P?23^1KT^O,/!/\ R-@^DG\C
M7I] &+<?ZZ3_ 'C_ #IE27'^OD_WC_.HJ %Q[4E+GM1VH 2BEHH 2CWHI: %
M'Z4GM110 4444 %+24<4 %+244 %%  &:* %I/YT44 +1FBC- "444O% "\T
ME+10 <4?6CBC_/6@ H-'6@T '3O1^M'O2?2@!:,TG3_Z]._2@!,<4O\ GI11
M0 ?K12^E)CM0 E&31^E% ![=310:/<G%  *.*2EZ"@!<4>^:;2^U !^M%&?Q
MI.* %XZ8H-(:* %HSSFD:14&68 #NQP*@?4;181(UU"(SG#&0 ''7G/:@"PI
MHY]:R9/%FAQQL[ZQ8*B_>8W*8'UYJE:_$;PO>7T-E;:]87-U,VQ(H9U<D^G%
M '145QNJ_&/P3HL\L-WXET])HFV/&LN]E8=1A<\_X&L:;]H+PG(S+IKW>M,H
MRWV"'./KN*T >EG-%<%:_$^XU?39IM+\.7=Y?!U$-FTT:%U.,L7!*H!SU/8>
MH%8%U\;+JXN'M;.QAM;N,%7@NB9'5A_LJP.!]*5P/7!39)%A0N[*B*,EF. !
MZUXU8:Q\0O$5W$$U*&WC#;F6SLTC4KC.&\PN<=N&4U:\9_#^]U>:WU;6+G6M
M7E^S_9VL-,O!;VJ9*Y)1<,<]20S8QC&#0!V7B+XH>&O"\+/?:G&,''[L%^?J
M.!^=<=IGQ\77-:M(+/0)H=)FY;4KNZBP0#R$CB9RS8[<5Y_X:^$FDZ/-_I^A
MW5O&K+_I/V)9)&/0#>PRHR0<X;D_05ZOX<U+2])U(6>G:5#!@!GO92[3/D\J
MB^7N8\8Y*@9&,]*!'H@HIL<BS1JZG*L,CC%./:F,**#10 GXT4M)0 4M%% !
M24M% !1244 +2444 %%%% &KI_\ QZK]37,_%3_D4)O^NL?\ZZ;3_P#CU7ZF
MN9^*G_(H3?\ 76/^= '"Z;TF_P" _P!:ZZW^[+_NC^M<CIO2;_@/]:ZZW^[+
M_NC^M $>I?=D_P"N?^-<;K7W7_ZXG^M=EJ7W9/\ KG_C7&ZU]U_^N)_K0![;
M;_\ 'O%_NC^525';_P#'O%_NC^524 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !7G/QB^'Y\5:4-2LE9M5L4.V.-<F>/.2GKD<D8]2,<\>C44TW
M%W0FKGQ-K6LZK8Z?&UBWD0.VV2X7!<#I@>GUKL?#>CVW]AO+"6=IE_>2,=S-
MD=<UZ5\6OAK!_I&OZ;;D-)DZA;1J"KK@YEQV8=\=<YXP2?/_  BRZ3,;%\>4
MWS1M[>E=:LUSHQU7NGNWP^\4'Q-H,?GM_P 3&U AN@Q&68#B3  X;KTZY':N
MHKP[3-1G\)ZU'?VPWQD;)HL?ZR/() _VAU!_IFO:K.\AU"TANK=_,@F02(V"
M,J1D'GI7/.-G=;&D7?0GHHHK,L**** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** ([C_CWE_W
M3_*O#/#OW;?_ (%_6O<[C_CWE_W3_*O#/#OW;?\ X%_6@#O=%^[#_P "_K74
M6?W$_&N7T7[L/_ OZUU%G]Q/QH NQ_UJ6HH_ZU+0 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 5#)VJ:H9.U %"\^[_P*N4UC[K?]=/\ &NKO/N_\
M"KE-8^ZW_73_ !H H>"?^1L'TD_D:]/KS#P3_P C8/I)_(UZ?0!BW'_'Q)_O
M'^=1\T^X/^D2C&?F/\Z90 4E+^-'\J "CH**/QH *6DHH 6BDI>M !10?UHH
M ***04 +244M !12&EH *-W6DS2T %+2?2EH .U'8444 %+^E1R7$4<D<;R*
MLDAVHK$ L0,X'KP*XO7OC%X<T.ZFMA="]N86V.ENZ8#<Y&XL!D8.0,D4 =O2
M_P">*\@OOCA)<7$*Z='9I$W#>9(9)3[*HQS^?TK1L;'QQXHTN>.W\50:8KRE
MUODMX+B9!QF,*/DV_7YAGK2N!Z<O&:BNKR"RB>6XFC@A49:21@J@>Y-?/E_X
M,\<VZK>ZIXDUN<J,SQ27IBA^@6 )T^IS3-*L)/.@%[J&I*L#?O56W!9P?21Y
M03U[J:+@?0;WUM"JE[B% PW+N<#(]?I5*[\5:38H6EU"' [(V\_D,FN N/!?
MA_QUI(O+59[?4(3#9I/>09DB0!0(P,%=IW9+#/4Y/'&7=?#>;PZ@^TWFGSE3
MO*74OEF8>@^4#/XT =S:_%CPO=ZBMDFH,DS9PT]M+%'P"?ONH7H/7FL.7]I#
MX>PS21#7C(ZL5PEI.0<>AV8(]P<4_2]/M+[[*+/PY:AFE3<UQ)-)&$!RQ *;
M"< @?-P3GG&#4\53'6(IC<Z9KEM- B02);+BV+J23C!R0,]2,8(QF@"W'\>O
M#]QM:UL]4N8W.%D6UVH?Q8BM(?%*U>U62+1]4N9W?"VEK$LLNW RYVL0%&?6
MO/?#=_%:ZU_9NG2Z3=7>"1;W0C>0''38Q#?D17IFCZCKUO?*-7M+*UTZ11&K
M0L$$;\XXRV=V<<D= !UH S)/C%IN[9#:7$C]E;"Y^E9%Q\9-58N+'PY#/CIY
MM\T9/_D+'ZTVX\ Z39VT,4-E=6-ZT:K/Y2OM4A>2FR-RPST!8?6LC3-<ELKQ
M=/TO7]0LGC8QD2Z<!&YQ_>D)/Y?SH Z+7/BKXAT_[+/9^"WDT^90!=:AJ<5F
M!(5W;-KCI@'YB0#C'7%<[#\:/&&JW/V>S\.:?:,>A>Z^U@_0Q'G_ .M78:QI
M-YINDVX:YAU:PF9'DCO,94[,?NG50JKT/S#^]S\U<]K6FW-M:+J&C:!?3(J\
MMIMW'++NQSM^?% &QH/B3Q[<3 WVD6S(>#%';- >W.^27!&.V*S]2^(7BOP_
M.;#4[73Y+]$WO+8I+Y.#R,%QZ=<GK57PCX@N?$%^NE?VQK&F:W"S.;?4K1G:
M-@.5+$F/E6]^IQ7;ZP!<+,;D0IO486[L S1' '$S%HP.,XP>IH XNU\6>+/$
MP7^S+CRP2 7A\G:N>V70C-:!M_'<UO-I">)[*PU54-RDMQ;PSW;1],"-2J;=
MV!NQQG'O5;7/#:1V*W<>@1:C%#M(GBN6N0Y8XXCC"XQWV@ ?G6SH7A/3M8T>
MYFBM9M-OFEQYUNTEI*<1KA!('9PG(R 0,@\=<@'G5UX@\;I<>4OBZXF48R)M
M(@@Z]ODD)_'M71:7X8UW6BCGQ,S.P^=%UB4'UX6-\"NBURSUN'3[IFN?)&TY
MDG@S&%]"R,[8[Y*_B*XZRTO5UN(9)_#6FZW!D1_VAI>ILR[2V/N+;E@<'/+=
MNM M3H_&'AGQ%;W!U#3?$6I3W-W(0UG#DPQ1@'#1Q@,1C@,2>2V<KP*X>:76
MVN%BU'6M3M'9MA1Y)05.>I5"2!^%>POX5CM;,6ELLBVL;-)'Y=Y-&Z%CEE)5
MQN4GG&X#VKA]'U7PY?7ESI.EZM:17Z_\?$$%K]K+XR!O??*N00<Y.>".*!V,
MO1=+LM/O$A_X2Z\GN;UOLTPMG+31(49]Q8D&,#:!NQ]XJN,FJ6N?"/4_.N7T
M[6]>O[5)"R^=K;R!EY)'!##'S+@YZ&O2_".A_N5:[M(I&:)DGFC:(PR,0 55
M$[8W_> [>]/UCPE:6]DS/=1VVG6ZEP)I9(Q$.3PV_: /=3B@#R[2?#-CIDTB
M:K>:I"ZX$D>R2X\L>N69FY_W:[2WT+PQXATF:WTR[-[JMG"PLYKK,<L!D(QM
M!"85F !QC/3-<OH.DW6K:E<2>'=>N;Z"%F#OJ.F0W5B6!QA;CRXF.#Z9_K7J
MFE69_L.![V73A<;2LTEF@^RR\D8P>W3OD$$9ZY V/)]4\%ZEH=Q"MR&=ILJJ
MO<!G8^RJ68__ %ZU+?0=#L[*XN'\.:U?7%LA>..:%469_0-G*\]V( '-6+_Q
MQ:WEP]CH%MJWB&Y60))_8"26<,0!0$^;(?*?[ZY"DD YX'(Z/0?#JZ;=%;E9
M6FE=)8VU&"&:889=PW(Y)R 0"  ,Y.:06*J6^G:W';+!M\/ZE#"T=S D&_:Y
M(W()L ,58'.T\YR1TKG(M'32[DO;2VVL3>9M,<\;-)UY^7'(_/K7K&I:9;72
MM).WE[5^9LC;CU(/RG'N*\ZN+BTOKN-_#K7=S;QN1+J5I<&RM8VR5)+!A%*<
M@<")\\4PL='H&MZLEU#;R>'%M;)BJ&6W.T*W.6*LJ\=!@9/U[96M>%]!D\Z<
M7<VGS2%KC]^ZVB!V?<P.Y Y)))Z<XP2*ZG0(YH=*E74+ZXU -DM+>HBX7&"O
M$48(X)Y7N>>PYS7_ !)J$MU+I_A71[C4=1:-&-Q=W(@M(E8D D.&8\<@"/#
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M10 48HHH U=/_P"/5?J?YUS/Q4_Y%";_ *ZQ_P ZZ;3_ /CU7ZG^=<S\5/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MQ !/M5NDTA10 H*Q^6!P,=&/N:M^*=:;1]'>Z6Y2VV/&IDF1G!RP7!(!VY)
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ME^GIU6FZTFOZ:)XKR:*S 54NS&L?G\#+ .O SQV[]L5F1;EV2>(8I)YOERR
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M7+10.OF+ T$2S1)QC,VS<1QGK3K?]FW2/$S&ZN=4O-3*XW2+=AF)P!DD#J5
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M?S,I4HK:"^XDCN/"$:X/A[1LGGYK"(?^RT]IO"2QC_BG]'/?C3XO_B>E1_\
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M.);>3 DB)SC</0X.#T-;-<S36C-@HHHI %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 1W'_'O+_NG^5>&>'?NV_P#P
M+^M>YW'_ ![R_P"Z?Y5X9X=^[;_\"_K0!WNB_=A_X%_6NHL_N)^-<OHOW8?^
M!?UKJ+/[B?C0!=C_ *U+44?]:EH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH *AD[5-4,G:@"A>?=_P"!5RFL?=;_ *Z?XUU=Y]W_ (%7*:Q]UO\
MKI_C0!0\$_\ (V#Z2?R->GUYAX)_Y&P?23^1KT^@#S_4M*234+MR!\TSGI[F
MJW]BQK_"/3I717D8^U3<?QM_.HO+[59!@MH\?/R#\J:VCHW45O\ E#TQ2^7[
M4#.?_L=!VIO]C)G[HQ]*Z!H?YT>2.F*0'/\ ]CHW\/'TH_L5/[H_*N@\H4>2
M*8'/?V*AS\N:3^Q$_N]ZZ+R12>3ZT <Z=%CZ8%)_8B?W,?A71F$?A2>0,]*
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M+I"^56*^5-J-T&) /NG/.[A?ICGTJN647'<V3N%%%%2,**** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@".X_X]Y?\ =/\ *O#/
M#OW;?_@7]:]SN/\ CWE_W3_*O#/#OW;?_@7]: .]T7[L/_ OZUU%G]Q/QKE]
M%^[#_P "_K746?W$_&@"['_6I:BC_K4M !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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ME]G'I2&$=^15_P G/:D\G\J *'DC;CJ*3R,9XR.U7C$!G%'D]Z L4EM]M/\
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M_P#Q[Q?[H_E4E1V__'O%_NC^524 %%%% !1110 4444 %%%% !1110 4444
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M++Q4K0NHL-24D&SDD!+#D[D/&X8'.!D=QT)YI4[:K8U4KZ,ZNBBBLBPHHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH CN/^/>7_ '3_
M "KPSP[]VW_X%_6O<[C_ (]Y?]T_RKPSP[]VW_X%_6@#O=%^[#_P+^M=19_<
M3\:Y?1?NP_\  OZUU%G]Q/QH NQ_UJ6HH_ZU+0 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 5#)VJ:H9.U %"\^[_ ,"KE-8^ZW_73_&NKO/N_P#
MJY36/NM_UT_QH H>"?\ D;!])/Y&O3Z\P\$_\C8/I)_(UZ?0!SMU_P ?4O\
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M !KC=:^Z_P#UQ/\ 6@#VVW_X]XO]T?RJ2H[?_CWB_P!T?RJ2@ HHHH ****
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M(<_*+A<8*.?7 X)] .G(]#HJHR<7=":NK,^*SHTVEW&"LMA=QG;(K@@;AU#
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M3=1NI@.^M&:;2T@%S2TWO2_SI##UH]J2C.:8AU&XTT4N>>E QU&[UI%-'6D
MOO12;L9HS^= !NI>OUIO&[K06/I0 M%%'3I0 E+VI/I1F@ W4,>E&0>#0?TI
M@ HI*49Z4@ 4OUI&]N#CTIOUI@+2]*.*3T% "[J*.F:3OZT@%H^O6D/>C.WW
MI@*PQ2?P^M'6B@ I*7I24Q"?K2T?C1[4P"DI>]&>:!!1110 =***#2&%%(&S
M2TP#M1Q29YH[T@%XHIM+FF*XM'/:FT4!<=GI1FF_C1GO2 4F@^U)2TP-[2?^
M/%/J?YUSGQ4_Y%";_KK'_.NCTG_CQ3ZG^=<Y\5/^10F_ZZQ_SJ"CA=-Z3?\
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M]: .]T7[L/\ P+^M=19_<3\:Y?1?NP_\"_K746?W$_&@"['_ %J6HH_ZU+0
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 5#)VJ:H9.U %"\^[_P "
MKE-8^ZW_ %T_QKJ[S[O_  *N4UC[K?\ 73_&@"AX)_Y&P?23^1KT^O,/!/\
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M?FY^YG'W6/<#)-781VU%<=\2OB;IOPSTVTN;V.2[N+N=8(+2!E$DG]Y@">0
M1T[LHXSFMC2/%FF:UIXNX;E8E"!Y(IL))'G'##ZG'&1GH319VN!LT5SJ^/-*
M^T-&S31H/^6K1G:?RY_2MVWN(KJ,202I-&>C1L&'YBI EHHHI@%%%% !1110
M!'<?\>\O^Z?Y5X9X=^[;_P# OZU[G<?\>\O^Z?Y5X9X=^[;_ / OZT =[HOW
M8?\ @7]:ZBS^XGXUR^B_=A_X%_6NHL_N)^- %V/^M2U%'_6I: "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MZUUUN1ME_P!T?UKC-/DXFY]/ZUUMO)\LOS#I_C0 _43\LG_7/_&N-UHC:_\
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M!-13 WO3E- "T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M -N'\_\ Z] '9?V@/[\?YT?V@/[\?YUQO]M_[</Y_P#UZ/[;_P!N'\__ *]
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M ->C^V_]N'\__KT =E_: _OQ_G1_: _OQ_G7&_VW_MP_G_\ 7H_MO_;A_/\
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MB_RJ:H;,YLX#_P!,U_E4U !1110 4444 %%%% !1110 4444 %%%% !1110
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M 'L>CWPQ#\R=^_UKI;74!M3YX^_>O+=)UCY8OGB[]_K[UT5KK0VK\\/?O_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M2P_Y^KC_ ,=_PKL** ./_P"%:6'_ #]7'_CO^%'_  K2P_Y^KC_QW_"NPHH
MX_\ X5I8?\_5Q_X[_A1_PK2P_P"?JX_\=_PKL** ./\ ^%:6'_/U<?\ CO\
MA43_  UL>/\ 2KC_ ,=_PKM:AD[4 <'=?#6QV_\ 'U<?>_V?\*YK5?AQ8A3_
M *3<??\ 5??VKU2\^[_P*N8U;[K?]=/\::$<G\.?!]KHOC6*YAFF=P)%PY&.
M5/H*]FKS?PC_ ,C1'_VT_D:](H&<I>\W4^?^>C?SJ+=TXJ6]XNI_>1OYU'@C
M'-,EB<?XTO;FDZJ3WI<\4P 8''2@G% ].],9BQQ0(?\ XTN<TPY4YI=W3/%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M ,*TL/\ GZN/_'?\*/\ A6EA_P _5Q_X[_A7844 <?\ \*TL/^?JX_\ '?\
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M_5Q_X[_A7844 <?_ ,*TL/\ GZN/_'?\*/\ A6EA_P _5Q_X[_A7844 <?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MQU/-&<<]: 'JU'I32V[I1QGDT ./M2-V[4;N":09]\T .7Z4-2?7@=Z0_>H
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** (KG_ (]Y
M?]P_RKQO1.D/_ OZU[)<_P#'O+_N'^5>-Z)TA_X%_6FA,[72/NQ?C_6NDM?]
M6OXUS>D?=B_'^M=):_ZM?QH8%N/^M2U%'_6I:0PHHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MC1_%0 N3ZTI;=244 +NZ8HI*2@!W7MQ2EN>*92T *>])^-%% !1FCL?Y44#
M4?C11_2@04#WI*6@844F10* %XSQ3@WMS33CM^M% AV[=U'%)ZY'-)THH #[
MTF:6DSS0,7^='&*;^E% #L^E%)FC</6@!:2C-)NH 7FBBDYH =0>>IIN>E+F
M@0M%)G\J3/XT#%_G12?7I0>E "]Z*3_]5% AU)D]J3/049H&+Q12>N:7-  6
MYYHW<4W\>*6@#IM%_P"0>GU/\ZQ/B5_R+#_]=4K;T/\ Y!T?U/\ .L3XE?\
M(L/_ -=4J>HSB['I+^']:ZBW_P"6O^[_ (UR]CTE_#^M=1;_ /+7_=_QIB&:
MA_'_ -<_\:Y35OXO^N1_K75ZA_'_ -<_\:Y35OXO^N1_K0!Z_;?\>\7^X/Y5
M+45M_P >\7^X/Y5+4E!1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MX*J3&%;D*I.2#U'&Z@#HOB+^U=XPO/$-S9^&=3:QADE,<&8+>79@ ;CF-O\
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M]'D:;2;*1SEW@1F/N5!JY5'0_P#D"Z?_ ->\?_H(J]2&%%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 17/_ ![R_P"X?Y5XWHG2'_@7]:]DN?\ CWE_W#_*O&]$Z0_\
M"_K30F=KI'W8OQ_K726O^K7\:YO2/NQ?C_6NDM?]6OXT,"W'_6I:BC_K4M(8
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% 'A^F_\?A_ZZ2?S:NPT?[J_]=/\*X_3?^/P_P#723^;
M5V&C_=7_ *Z?X4 =79_=_P"!5H1_UK/L_N_\"K0C_K0!+1110 4444 %%%%
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MS7$OV6^G2!HLL5#$.%P,X'S.">/>OLN@!:*** "BBB@ HHHH **** "BBB@
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M_P#DN&C_ /7.Y_\ 1+U]Y4 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %>*?M=C/P
M@D_Z_H/_ &:O:Z\6_:X&?A#)_P!?T'_LU 'QI"NW?6O&,A_I6? GWL^U:D:?
M?P.U NA6NOXO]VL6^7Y6_P!S_&M^[7.[_=K$OH_E;_<_QI@?I5H?_(%T_P#Z
M]X__ $$5>JCH?_(%T_\ Z]X__015ZD,**** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH B
MN?\ CWE_W#_*O&]$Z0_\"_K7LES_ ,>\O^X?Y5XWHG2'_@7]::$SM=(^[%^/
M]:Z2U_U:_C7-Z1]V+\?ZUTEK_JU_&A@6X_ZU+44?]:EI#"BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH \/TW_C\/_723^;5V&C_=7_KI_A7'Z;_Q^'_KI)_-J[#1_NK_ -=/\* .
MKL_N_P# JT(_ZUGV?W?^!5H1_P!: ):*** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** &M56;M5IJJS=J .?U#_EG^/\ 2N%U;_EE^/\ 2NZU#_EG^/\
M2N%U;_EE^/\ 2@#U?0?^0'IW_7M'_P"@BK]4-!_Y >G?]>T?_H(J_0 4444
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M<Z*:CK(JNC!E89#*<@CUK-\4>(+?PEX9U?7+Q)9+33+.:]F2  R,D:%V"@D
MG"G&2.>] &I17D_P:_:2\,_''4M1L="L=6M)K&%9I&U&&)%*LV %V2-SGUQ7
M3_%;XH:5\'_",GB+6;>\N;*.9(3'8HCR;G. <,RC'XT =C17S)_P\$^'G_0&
M\3_^ MO_ /'ZLZ?^WS\-[RX$<UEX@L$/_+:XLXBH_P"^)6/Z4P/I*BL/P;XV
MT+X@:)'J_AW4X-5T^0E1-"3\K#JK*<,K<CA@#R*W*0!17G'Q._:#\#_"286V
MOZN!J)4.-/M$,T^T]"5'"@]MQ&>U>>Z3^W=\,M2O?(G&LZ7'NV_:+NR4QXS]
M[]V[MC\,^U 'T316;X>\2:7XLTF#5-&O[?4]/G&8[BVD#H?;(Z$=QU%97Q*^
M(.G?"SP3J/BC5H;JXT^Q\OS8[-%:4[Y$C&T,RCJXSDCC- '3T5YW\&?CCH7Q
MQTO4;[0K34;2&QF6"1=1CC1BQ7<"NQVXQZXKT2@ HKQ3QM^UEX1\!_$J;P3J
M&G:U-JL4T$!FMH(6@W2HCJ03*&P!(,_+V/6NU^+GQ9TCX,^%5U_6[:]NK-KE
M+41V"(\FY@Q!P[J,?*>] ';45\R?\/!/AY_T!O$__@+;_P#Q^C_AX)\//^@-
MXG_\!;?_ ./TP/INBO!?A_\ MF>"OB1XQTSPUIFEZ]!?:@[1Q27=O L0(4M\
MQ69CT4] :[;XS?''0O@=I>G7VNVFHW<-],T$:Z='&[!@NXEM[KQCTS2 ]$HK
MYD_X>"?#S_H#>)__  %M_P#X_1_P\$^'G_0&\3_^ MO_ /'Z8'TW17G_ ,&_
MC7H?QOT2^U30K74+2WL[C[-(NH1QHY;:&R-CL,8([TGQ'^-&D?#W4+31TM+W
MQ#XGO5W6NAZ3%YMPZ]-[=D3_ &F/8X!P:0'H-%>)S_'+QSH$9O\ Q)\']6T_
M1%&Y[K3]3@OYHT[LT* , !R>?6O4?!WC+1O'WAVTUS0;Z/4--N1E)8\@@CJK
M \JP/4'D4 ;=%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %>+_M;?\ )(I/^OZ#_P!FKVBO%_VMO^212?\ 7]!_[-0!
M\=V_\?KQ6O%_%]*R[?\ Y:?A6LB_?/M0207?.[UVUB7WW3_N?XUO7/\ %_NU
MBWX^4_[E S])-$_Y MA_U[Q_^@BKM4M$_P"0+8?]>\?_ *"*NT#"BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHJKJFH1Z3IMW?3
M!FBMH7F=4 +%54D@9[X% %JBOF3_ (>"?#S_ * WB?\ \!;?_P"/T?\ #P3X
M>?\ 0&\3_P#@+;__ !^F!]-T5X+\/_VS/!7Q(\8Z9X:TS2]>@OM0=HXI+NW@
M6($*6^8K,QZ*>@->D_%;XH:5\'_",GB+6;>\N;*.9(3'8HCR;G. <,RC'XT@
M.QHKSKX-_';PS\<--OKK0#=6\ME((Y[._1$G4$95\*S#:>0#GJIKT6@ HKQ[
MXQ?M1>%?@GXFMM#US3]8N[NXLUO5?3X8G0(SN@!+RJ<YC/;N.:]7TO4(]6TV
MTOH0RQ7,*3(K@!@K*" <=\&@"U17@/CK]M+P1\/_ !=JGAW4=+\037NGS&&6
M2UMX&C9L Y4M,"1SW K"_P"'@GP\_P"@-XG_ / 6W_\ C] 'TW17CWPY_:N^
M'?Q*U.#3;'4YM-U.<A8;35(O):1C_"K E"W^SNR<\ U[#0 452U?6+'P_I=S
MJ.IWD-A86R&2:XN'"(BCN2>E>#:[^W5\,M'O&@MWU?6%5MIFL;,!/J/,="1^
M% 'T-17E_P -?VDO /Q5NUL=&UCR=4;[NGW\9AF?_=S\KGKPI)XKU"@ HKQ[
MXQ?M1>%?@GXFMM#US3]8N[NXLUO5?3X8G0(SN@!+RJ<YC/;N.:]7TO4(]6TV
MTOH0RQ7,*3(K@!@K*" <=\&@"U167XH\06_A+PSJ^N7B2R6FF6<U[,D !D9(
MT+L%!(!.%.,D<]Z\[^#7[27AGXXZEJ-CH5CJUI-8PK-(VHPQ(I5FP NR1N<^
MN* /6**^?/&/[;?@;P1XJU70+[2O$,MYIMR]K-);VT#1LRG!*DS D?4"L?\
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M \=!T-:/A3]H*SOO$UOX9\6:!J7@7Q%='%K;ZH UO='TAG7Y7.>.V> ,DXH
M]9HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH BN?\ CWE_W#_*O&]$Z0_\"_K7LES_ ,>\O^X?Y5XWHG2'_@7]
M::$SM=(^[%^/]:Z2U_U:_C7-Z1]V+\?ZUTEK_JU_&A@6X_ZU+44?]:EI#"BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH \/TW_C\/_723^;5V&C_=7_KI_A7'Z;_Q^'_KI)_-J[#1
M_NK_ -=/\* .KL_N_P# JT(_ZUGV?W?^!5H1_P!: ):*** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** &M56;M5IJJS=J .?U#_EG^/\ 2N%U;_EE^/\
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M$-WX<O\ S(2<M!*+=P\;>X.?J,'O2 ^=O^">/_(Y>+O^O"+_ -&&O9_VY/\
MD@MW_P!?]M_Z$:\8_P"">/\ R.7B[_KPB_\ 1AKV?]N3_D@MW_U_VW_H1HZA
MT/+/V-?@CX(^)7PPU34_$N@0ZK?0ZQ+;)-)+(I$8@@8+A6 ZNQ_&O8O%'[&?
MPO\ $&DS6UGHC:'>%2(KVRN)2T;8X)5F*L,XX(^A%>"_LF_M'^#/@_\ #G4=
M&\13WD5[/JLEVBV]L9%\MH84'([Y1N*]6\3?MY^ =/T>>71K?4M6U':1#;O;
M^3&6[;W)X'T!-&H'@G[*GB+5/A3^T5+X0N)V:UN[JXTB]A4G89HRX1P/4.F,
M^CM7VK\<OB _PO\ A5XA\1P;#>6L 2V#@$><["-#COAF!(] :^._V0? 6M_$
MOXT3?$+4H2=/LKF>]N+IEPL]W*&PJ>I!<N?3 ]17T!^W&S+\ [T!B U]; X/
M4;LX/X@?E0!\V_LQ? 1?V@]>UKQ'XMO[J?3+68"?;(?.O+AP6(+]0 ,$]SN
M&*^EO%W[%/PTU[19+72M+E\/7X3$-[;7,LI4]MR2.0P]>A]ZQOV [40?!74)
M <F;6YW/'3$,*X_\=_6OI6@#\]?V5O&&M?![X]3>!M2E(LKZ\DTN\MMQ,:W*
M$JDJ>Y90N>ZM]*^HOVQO^3</%_\ VY_^ED%?*7C.-K']N6W"/@MXJL#E>.'D
MA)'Y,17U;^V-_P FX>+_ /MS_P#2R"@#S+_@GC_R)?BW_L(1?^BZ^M:^2O\
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MA_U[Q_\ H(J[5+1?^0/8?]<(_P#T$5=I#"BBB@ HHHH **** "BBB@ HHHH
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M#F_^"@G_ "6;1O\ L 0_^E%S7W3X+_Y$W0?^O"W_ /1:U\+?\%!/^2S:-_V
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M03_DLVC?]@"'_P!*+FONGP7_ ,B;H/\ UX6__HM: ,7XV?\ )&?'O_8 O_\
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MG/NS$G\:Z&I&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MSD%OU)X2&(=_<U[+7R%^R+KAL/'U]HKD[;JVFN4 R1G='[^BGM7U[0 4444
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M1GQ[_P!@"_\ _2>2ODO_ ()X_P#(Y>+O^O"+_P!&&OK3XV?\D9\>_P#8 O\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \/TW_C\
M/_723^;5V&C_ '5_ZZ?X5Q^F_P#'X?\ KI)_-J[#1_NK_P!=/\* .KL_N_\
M JT(_P"M9]G]W_@5:$?]: ):*** "BBB@ HHHH **** "BBB@ HHHH ****
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MVBFMYT#QR(PPRLIX(()!!ZYK(\.^ _#/A"::;0O#NDZ)+,H2233K&*W9U!R
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M=&!R&!"9!![UV%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#P_3?^/P_]=)/
MYM78:/\ =7_KI_A7'Z;_ ,?A_P"NDG\VKL-'^ZO_ %T_PH ZNS^[_P "K0C_
M *UGV?W?^!5H1_UH EHHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M]:Q[QO*D/HS<_K0!Z%^S*V[XS:2>_EW&?^_+U]NU\0_LSQ[?C3I)'0I<<?\
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MR_=^M6&^7K4$W;Z_UI@1-4,B[FP*L-44G:@"K'S&#4<B[?\ "I_YU'*OR\4
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M!WQ#GN[VQDN5LY_[4R;NQD; 5]Y^9EY!.XG@Y!]2P'WE1112&?GY^VUX9N/
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MM0W[F71'E9?5EGA"G\G;\Z /LKXK?%31/@_X1FU[7)&\H,(H+:+!EN)2"0B
M]^"23P ":^2KK]O3QWJUU/<:#X-TT:9"=T@ECGN71/\ :D1D .,\[:@_X*%Z
M]/-X\\,:*9&^S6VFM>"/MNEE9"?KB$?Y-?97P\\%:?\ #SP;I6@Z=;16T-I
MB/Y2X\R3: [L>[,1DDT >/\ [/\ ^UUI7QAU1= U2P&@^(G5F@19=\%U@9(0
MD JP&3M.> 2#VKV/XA^(+CPEX \3:Y9I%)=Z9IES>PI."8V>.)G4, 02,J,X
M(/O7P?\ M4:/;?"']I+3M8T2)-.61+765CMEVJD@E96PO09,1)'3YC7V[\;/
M^2,^/?\ L 7_ /Z3R4 >8_LG_M!>(OCM_P )3_;UEI=I_97V7R?[-BD3=YOG
M;MV^1\_ZM<8QWZUZ#\?/B#J/PL^$NN^*-)AM;C4+'R/*CO$9HCOGCC.X*RGH
MYQ@CG%?./_!.;_FH7_</_P#;FO9_VQO^3</%_P#VY_\ I9!0,G_9=^,6L_&S
MX?ZAKFN6UC:W=OJ<EDJ:?&Z1E%BB<$AW8YS(>_8<5J?'3X\:)\"_#\-YJ$3Z
MAJ5V66RTV%PKS%<;F+$':@R,M@]1@&O,?^"??_)&=9_[#\W_ *3VU>7_ /!0
MK0]0C\;>&=89)&TF73C:(VWY%F65W8$]B5=/^^3Z&@1:7]M;XJZJO]H:5X!L
MI='S_K!8W<XP#S^]5POIVKUO]G7]JBY^-6N7&AWWA:?3[Z"(S27MFYDME [/
MN *$]!RV2.U,\'?MI?"EM#TZWFN+KPV(X5C^QR6,CI;[5QM!B#948P,>W KU
M7X>>.? _CAM0O?"&HZ9?3S.LMZ;-0DS-@*K2J0&Z# +#MB@#M*Y?XHVUW>_#
M/Q=;V&?MTVD7D=OCKYAA<+^N*ZBBD,^!?V#?'7AOPGXM\1V.M7=OIU]J<$"V
M5S=.(T.QG+Q;CP"VY"!WV>N*^^$=9%5T8,K#(93D$>M?*/Q>_81L/%.L7.K^
M#]5BT.:YD:273KN,M;[B2249>4&?X<$<\8 Q7DL_[)_QM\ 123Z%?>;Y WC^
MPM6>)CC)RH;RR3UX')SQ3$?H3@#/'6O&/VQO^3</%_\ VY_^ED%>,?LM_M1>
M)KSQQ!X#\<S27KW+O;VU[=)MN8)US^ZEX^8$@CD;@V 3CI[/^V-_R;AXO_[<
M_P#TL@H&?*?P%_::?X-_#&Y\.Z/H3ZYXDOM7ENHT<L(HXS#"JG"_,[$H_P H
MQTSGM7=^$_V^]=L?$"6?C;PQ:06?F!)GTY)89[<'N8Y&;=CTRM=-_P $^/"N
MGIX'\0^(S C:K+J1L!.R@LD211OM4]LF4YQUVCT%'_!0;PKI[^!_#WB,6\:Z
MI%J2V!G50&>)XI7VL>X!C&/3<?6F(^J=,U*UUK3;34+*9;FRNX4G@F3[LD;*
M&5A[$$'\:\M^/W[1>C? G3;99[=M5UR\4M:Z;&^SY1P9)&P=JYX'!)/ Z$B+
M]D:^FU#]G;P=+.VYUCN(@?\ 92YE11_WRHKY+\:Z[H?C7]LJ]E\8WL%OX;L=
M4>UF:YSY2QVR,!&?9GCP?4N?6D!V'_#<?Q+@B75I_ ^GC0&^[-]EN54@]/WQ
M?;_X[7TQ\#?CWH/QST.:ZTU'L-3M"HO--G8,\6>C*P^\AP<-@=.0*K7/[1'P
MDO-/DL9_%NC364D9A>WDR8V0C!4KMQC'&*^0?V>=:L/!?[60LO#UY]I\.7UY
M=Z?#)&Y*RV[!FAY[X*Q]?3M0!]E?';XW:=\#?"L.JWMA=:G<74I@M;> ;49P
M,_/)@A!CZD]@<''S1'^VS\4]:7[9HW@.RGTY3EG6RNK@8_ZZ*X Z'M7V+XTT
M?0=>\,WUGXGAM)]#=,W*WS!8@ <ABQ(VX..<C%<8O[0_PITA%LH?&.BPPVZB
M-(K:0&-% P NT;< >G% 'EOP3_;:L?'WB2T\.^*-)30=1O'$-O=P2EK>24\!
M&5OF0D\#D\D#BO;?C)\1O^%2_#?5_%?]G_VK_9_D_P"A^?Y/F>9,D7W]K8QO
MST/3'O7P3^UEXF\,:M\9K?Q!X*O[:\CFLX;FXN;/[OVM9) 3T'S;5B)^N:_2
MJ@#\KO"/QJ_X1;X]3_$K^QOM7FZA?7W]E_:MF/M"RC9YNP_=\WKMYV]!GC]
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M\52W*%YKLRF%8 K[AN(9W<L4P2   :H1[;^QS_R;AX0_[?/_ $LGKYD^+?\
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M-P\(?]OG_I9/7B6J_L$^(-5T-KF[\8PZEXJEN4+S79E,*P!7W#<0SNY8I@D
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MZ@R#RACK]X34(&:W_!/_ ,"R7E]XE\<WJF1_^0=;2R#)9V(DF;)[_P"K&?\
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M\#?LN^*O#/[3-S\1+K4-'?1)-3U&]%O#-*;G9<+,$&TQ!<CS5S\W8X)KZBH
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MZC+!->Z=:B"62U9FC9@2<J6 )'/<"OG[]I#]DWQ=\8/B9-XBT;4=%MK)[6&
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M$NM0T=]$DU/4;T6\,TIN=EPLP0;3$%R/-7/S=C@FOJ*@9^?G_!/O_DLVL_\
M8 F_]*+:OT#KY=_9=_9=\5?!/X@:AKFN:AH]W:7&F262II\TKR!VEB<$AXE&
M,1GOZ<5]14""BBBD,**** "BBB@ HHHH **** "BBB@"CKG_ "!=0_Z]Y/\
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MVH Y_4/^6?X_TKA=6_Y9?C_2NZU#_EG^/]*X75O^67X_TH ]7T'_ ) >G?\
M7M'_ .@BK]4-!_Y >G?]>T?_ *"*OT %%%% !1110!YYX^_Y#*\_\LEX_$UQ
M<V.:[+X@-MUA?^N*_P S7%S9_"@#+NOO&LRX;[WK6E==367<-U]: ,ZX]ZI3
M&KEQ5*3ZYH IR'D_6J\G?Z5,^>?K5>1J (&J"3H:ED/'I4,AZ#UH BYI&IS=
MJ:U #:8_K4H^[4<G84 -Q4,OW6]:F8YJ-URK?2@",?ZM<]<5'(NY34J_=IK+
MQ0!49?E4^](PJ1U^3'I22=30!7E^Z>*JR=C5QONFJT@Z@<T 5Y%#9%9M\O\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH X
M3XX:]XE\,?"_6M3\'V4NH>(H/)^RVT-JURS[IXU?$:C+80N?;&>U?)OPM^"/
MQ&^,GQBL_&GQ&T^[L+&UGCN9VU&#R&F\O!CA2$@$+D#/ &-W))K[MHI@%%%%
M( HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O"OVS&V_!>3_L(0
M?^S5[K7A7[9@S\%Y/^PA!_[-0!\1VK_>XXXK81_OCI[UBVOR[OPK55C\WTH
M?<,-K<\[:R+QCSS_  UIW#?>X_AK*NSP?7;0!^HN@_\ (#T[_KVC_P#015^J
M&@_\@/3O^O:/_P!!%7Z "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MOE^S%<962;>6..O^KXYKYN:U1GW12/$?1.%_*H;I7127MXY !_K4PK=??/\
MDT ?=^@?'SP=K0Q)K%K8R=DF=EXP.[*/7]*[O3]6L=6C\RQO+>\C_O6\JN..
MO(-?FS9,'8O;W3LP'24%L?RK?T?XD^,/"L@:PU"Z\I3N\O[7(L9Y!/RAQZ4
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MIWI24@(J:P)S3J0TP(8^0WL:,41@Y<=>:=0!!MX;Z5"O*YJR1B0]JKA<;@:
M(G&<]J@D![U9:H)J *C?<YZ XJI*OS'Z5:EX)'KS5>7D@T 8_A35&T'XG:-?
MJ=JQW-O(^,]%E4GI_NU^G((89'2ORNU1_LNMV[@<[D'ZYK]/?"^H+JFAVURA
MW+)NP1CLQ';Z4 :M%%% !1110 445#=745C:S7$\BPP0H7>1R%55 R22>@H
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MQ]\?XT ?J5H/_(#T[_KVC_\ 015^J&@L&T/3B.AMHS_XZ*OT %%%% !1110
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M4 -:JLW:K355F[4 <_J'_+/\?Z5PNK?\LOQ_I7=:A_RS_'^E<+JW_++\?Z4
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M_P"O)O\ XJO'39^S4C6GLU SV$_MJ?$@?P:3_P" 3?\ Q=)_PVI\2?[FD_\
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M (JO'OL?H& ^E+]E [-0,]@_X;&^(?\ <TO_ , V_P#BJ:?VR?B'G&S2R?\
MKS;_ .*KQ[[/NR &_P![M2K9#KA_ZT >Q#]L;XA_W=+/_;FW_P 51_PV1\0^
M24TO_P  V_\ BJ\?:V6,9;<*@^SM<,0H=(QU8_Q?3B@#V4?ME?$-N1'I8'_7
MFW/_ (_3A^V1\0_[FEC_ +<V_P#BJ\>6S"C&&I6M0O9J /83^V-\0A_#I?\
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M 'KO_#7WQ!_N:7_X"-_\51_PU]\0?[FE_P#@(W_Q5>1_9AZ/3OLGLU 'K?\
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M[Q(=7:ZD7=EEGE38P)7^-ESG&>WK7U-\/_C!H?Q B/V61;><#)AEFC+?>*]
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M^$BTS:2UXK?[.#_A68OANUX[_@/\*7_A'[4] >/8?X4P-1?$FE?\_2]>G/\
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MI]:>/][%+DT!<9Y8JQ8W,^FW4=S:7$MK<Q'='-"Y1U/J".14:\XP>*DQSC-
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M K+QC-2*H[FH^P]*F7"@&@!VT>E'RLW!YI5]^:<HV_6@0BT]124HH&.HHI*
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M%,*U:;E2*A*\'MB@"LRU&RCO5AEJ$T 1,M-VU*U)MH KLM,:/\*M%:;M'TH
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M]IZ'7DBL/$4L27+2$+<*J1I@LH )+_[1Z#H*^BHY%D4,C!U/1E.10 ZBBB@
MHHHH **** "BBB@#P_3?^/P_]=)/YM78:/\ =7_KI_A7'Z;_ ,?A_P"NDG\V
MKL-'^ZO_ %T_PH ZNS^[_P "K0C_ *UGV?W?^!5H1_UH EHHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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ME ?]P4 :!^(%OVBG/X+_ (TW_A8$2]()S^"U3&AQ[>(TS_NBC^QX@.54_P#
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MR5GXVA_Y?(GMAV9@Q'_H-;%KXBTV\P(KV%F;H"V#^M &PDPV\FI%DZ'-48Y
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MC8G20M&#M^;W]>>:L0F+5(QN'ES*><=?S_$5L>29)]@^;<.G:LC4-+:"0R0
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MO\$<#XL>%B.]ZG]: /OZBBB@ HHHH **** /#]-_X_#_ -=)/YM78:/]U?\
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M+UJTNT#<02Q^[M]* (9E40,<$'C^=6+==MN@0?,5&?RIMTKBW:,XRV,'\?\
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M4 0B(=?PIPPN<' -)/'*PVQ%5]<U$NG[N9'S]/\ ]5 $C,O3<#^-0LR%]NX
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH :U59NU6FJK-VH Y_4/^6?X_TKA=6_Y9?C_2NZU#_EG^/]*X75O^67X_
MTH ]7T'_ ) >G?\ 7M'_ .@BK]4-!_Y >G?]>T?_ *"*OT %%%% !1110!Y9
M\3/^1@4_],%_F:X*Y8,Q/:N]^)G_ "'A_P!<5_F:X"X[T 9MQTK-F^\:T;@\
M&LVX/6@"C<?Q51;'-6YSUJFW>@"O(W-5I&QFIW/)JM-Z#I0!'VS332GI3?04
M +Z&D]:7OBD-( I#]<4<4F1]#3 D4Y4&EI%QM&.E+0 4H'Y4+0.] #J1E#+B
MEHH&-4_PGJ*9,I7YASBI64=<?-2=>HH$1LH*\=:AD7<M3)E&*GGTIK*>I% &
M=)'CCM562.M*:/VJI(OM0!1DC_*H&0[3]:OLO7CBH)(^#0!7Q31\K>U3E<4Q
ME]!0 GI1MWJ0.M. I5^4GB@ C8@A7//;WJPB[N,?A4++N4D<,.AI\,NW <X;
ML?6@"Q"60L!R/2K*2!H^.3Z=ZA4_-T]LTY5*D8&?<<4 6H\[034HY'I52%W#
M%2=P%6ED5L<\^E #_K3;K.P$<X-.ITX/DC/K0 JKNX%+LXYI<[).GRGO3^ON
M* *^WJ*1DJ5E^8XI/K2 HSV99@Z'#"H&_><$;6]ZU-HR?2JTUON4XX;LV.10
M-%,1D\'@TQK?:V4( [J:M1_W9!M?WI6A8<8S[TRG8I*FV3Y3L;/W3WJ]#<#[
MKJ4/J>E'V=749'S>O>F^2\;<KYJ^_44$GHGP9MVNOB'IB(W.V4X_[9-7JOC3
M4HH;?6I$( :!D W#KY0KX2UCX^:M\+/C%8:GH,\MY%:VSP2V:2#;O)E4DAD8
M9'R]NW6MKXE?M>3>*(-*TK0;>6WU"XOHC,5E.9%(9/+.Z(#!RG>@1Z?2'[V:
MT](\/ZGX@G\K3+"XO7'WA#&6"_4]!^-=7_PJ^'155_%&O66BGJ;2)OM%STZ;
M%X'US0!P([UM:!X/UKQ1(%TS3;B[&<>8JXC'U<X4?B:Z3_A*O"/ASY=#\/-J
MMRIXO-<8./PB7Y>OXUCZ]\1O$/B1#%=ZE(EKC:+6W_=1 >FU<9'US0,V?^%?
MZ/X?4-XF\26]O*O)L-,'VB?W4D?*A^N:>OCO0/#P*>'/#41D7[M_JY\^7ZA/
MNJ?I7G_X4Y<[:!'0Z]XVUWQ0Q&IZE-<)_P \@VV,?1!@?I6)NQGFHU8]2>:#
MCCOSS0 [<K=12!N,'D4VEH 1E&WKUIN=OOQ2FFF@ '%)W]**1N,T#$/0XI*3
M/%+Z4" ],=J23 ;C\:6FE23F@!F#Z4TFI6^[4- Q"<5&>IJ1B.]1GO04@J<5
M!4PP>:0I#J*2EH)$IM.IM,!K=J2E/7TI* $_"DH)YZ4E #=W.,8J,@5(V.M,
M;IG\* &TI[8I*,T %-;GI^=.IIX]Z $'WN!S2,OIQ0.O6E;K0!'24ZDZT )1
M110 4G2EHH %H/>BCZ]: &JO%9^M2.MKY4!_TB5@J]\=23CZ UICI7*WVI/Y
MLU\K86,^3",Y!.?O#ZJ3V_&@"MJ#+ Z64)S'$/S)).?UHAC$8 ')SR:K6<9*
M^9(<N?[QYJXK*<XX]:!#\TOUIO'!ZCUH/3IF@8ZDQ[>U)N&,#[U.[#L: %ZX
MP<4\#Y<=#4:89NG%2<]O\* #V/-&ZDZ8%-D;'"_>- "HI+%LCT J5L=1UIO"
M]%YH^[P>?>@ SNSD?C76>#?BEKO@B.2VM)DO-*EXFTN^3SK692>04/3/J,&N
M07/0YQZ4,1G^E 'JW]A>!_BAA]#NE\&^(6'.E:@^;*=O2*7JGT;U  [UP'BS
MP;K7@G4VL=:TZ:PGYV>8,K(/5&'##W!K%8^@YKO?"GQBU70]/&C:O;P^*/#I
MX.F:E\WECI^ZD^]&1VQP/2@#@-H;I2,-V#7K+?#7P[\0E-QX U(Q:@06?PYJ
MTBI..Y\F0G;(.O4YP,DUYIJ^CWV@:A+8ZE9S6%W$</#<(48?@: *?\/S?G2=
M<?H:3[W;Y:/PP.U !T;/6C:5;.<^U'XT<=Z $/TP:/PHZTJJ3UXH 7:=OUH4
M;6&>12[O3D#K[4N[CCF@ ^G2FMC;SR*<QVCCFDXQ@XH$)@DY!V\4O7/%-W=N
MOOZT[)SZB@9&6.2O:G+\O]<4<9Z?C2\8- !M'/?VI#@].*7MG%-Q0 GIQ2]J
M/J*/PR* #]:2E/MQ2?ADT (H&:5_F;.,>M"^YHR.<_G0 WC;@TWU%..6Q@4U
MO3''K0 W<%;)&[V%5W^\?SJ=ONG'6H6P>V!0(8<=1UJ+!D;D8QUJ3G<<]/6B
M$'&74J3V- ATD@AMY#TXX_(U#I4 :1IW^8,<_P Q4MU'YBQHJ[P3\P'859AB
M$481%Q@=*"B9AY?*'W%1E5R3T[U(S$+G;EL8VTU<=S]?:@!),MLQ\@'!J6%%
M.589(Y5ATIH8<JRY_P!KU]L5(BG*[%)4_I0!+&AW%3@J:LVZB%L@9(J)<JRC
M;N'][TJTJKMX.#ZXZT 1RIF3DCKD"IY%1ER!M;ODTSY?,4[>@Y[\U(B'G>,+
MZGUH CVF0?,.1U-*J[8V4<Y'!I>2WS IZ^]*S!0,#([@<8H AA0+][Y\GD=,
M4]EV?,G ]/2E&"I"@[NM+M8+G&YO[M $1C!^8\ GI3Y 7VD?* <&G*H(.[CV
M]*"W;&X?WJ &A4;(*_0YJNW,RIC(]:L,"V"@X_*H]IWMA<_[7I0 (HCDSC.*
M'4!G8D#=R%J7:NT<8/\ Z%36*$C*=!CK0!3NU4F(J-C9QDGV--V;E(88('6I
M)(]TD8;A=V<]>QHY9LL"H[^] $" &-E X(XS44D*R)L/.1CZ5;90O(Y']WIB
MH6YW87#']: ,N6W\P&(G:Z_=/J/7]*K12F.39,-I[-6K-"S9)&)<?+ZX_P Y
MJK-;I=0D$;9!^8H$13Q$_,O'9E[FH$99LHXRR\JXJ6WG"?NI_P#69X=N_M3+
MJ%AM>%,,IY"^E #9U8[67&X?K[4R&1=QD ^=?OQYY]/\:FW(Z@Q?.O9NF*BF
MC$>)DX8<L /O_P">:!$^\2 L"%] 3T]JCD*JWF*-K 8-,$BX$BK\I^\!ZU,%
M#\D )U]<T -W;O<CG-*)!AN-VX8J-<H^TC;FG' /3CTH 4,%QGE>XIWG!>G3
MM4)89. 11_"3_%G@4 6MXP#3LC [&JBR<=_I4R2=C\P]:!CV(VX(ZG@U%M.[
M&014GWO<4,HR,#(_*@0Q5VL"1FI1WXQ2A1QZT]0/[M 6)5 X(&"!^=2JNY>E
M,B3GYN%[FID^F%]:!DJ?+NSSN&!3EP-N>1Z4U??FG'Z?0T# _+G;T;G%"X4Y
M-.51MR>O8>M(H'.[@?2@![,'CQTQU]:3:O(QN]&%,&.03G_:I3][Y>%H  =K
M$?>!IW"LI[YY%-/RDX^8#N*7MZ''IUH D9AN.0!Z<U&ZAE!'![T94XW#&./K
M2JOS -\J>M %O1->U+P[?)=Z7?7&GW:])K>0H<>AQU'L:](A^*NA^.%6#Q]H
M*W-R1M_M[2 L%V/0NOW9/QZ=A7E/.X9^7\,4]FZ;1SW &* /2=4^"MQJ5M+J
M/@O5+?QCIL8W/%;?N[R$>CPGYORZXZ"O,KFUDMKB2*1&B=#M:.0$,I]"#WJ]
MINJW>CWD=YI]U-9WD9RDUNY1U/U%>BV_Q<T_Q5;K9^/]"CUP@!$U:R58-0C'
M3EAA9,#LV/?- 'DS1<\D4K1@J %Z'K7JMY\%X?$5J]_X$UJ'Q-;J-SZ?(!#?
MPCN#&3\P'J.O8&O-KVPN-+O);2\MY;6XC.UXID*.A]"IY% %-8UQR ?0YI1&
M>YS4FWCI3V4#./F'\J (U0HRDD&IECW,3T!YI%V[1D<TX.-O\Z  J O I=K'
MKU]::UPD8R[ #T[_ )4L<ADYP0.QH =TSQG-*/4C-+N'X^E(3Z<T (R\9!Q[
M4FW/>G=NG/I0H]L4 -V_+3@,9R,_2G>OI1M]* (\<^M+M'7/X4\J!TY_I0%H
M 3;N[XS4,EK'+RR_J:L<+C/2C'8G ]<4 94NAHWW3M_,_P!:B6QNK?)296&.
MFW_ZU;)^E-9>V* ,5KYHF N(6!_O+T_I4R21R+N1U.[MGD5>FMTD7F-6^HJA
M-IJX)C0Q,.FTG_&@1)Y>X9R!VZUFZMI4>H08*Y;CJ33Y([ZW^Z'F']WBI8;U
M)OE(*R?W6R/Z4#.-LKF7P_,UK,K26QYVXVE2<<_S[]ZZ>WFVQC+^;&>CKCBE
MU;18=1C8M'MEQ@/@YZ'%<]I]]-I,A@O@PAZ"1AQZG@#CK^E CM+.Z#;4)Z]&
MK6L[KYO+;JO3WKE+>X295EMY1)$>1M/2M.WO@=AS^]7WY/\ D4 =1&WX5,LF
M#Q69:W0D0'.1WYZ5<63T- RZL@-21R#%5$;U-2Q-\M %L,#3@QJLK<\&GK)Z
MF@"P'%.7GO4"L&IX;ISQ0!**=30>.*6@!&%)3^*0K0 PG!Z4G7GM3]IIF,''
M2D H/2G#'>F;A]*=0 5&W%25&S;J8#>U,VE>].;.*:?]Z@0=<<T;>]-SZTA8
MT#%)IM-9P.II-_MQZYH <*3--$@[\4NX8ZT ./2D[4SS/PI0P-  RYY-1,M3
M-SCUIC8_QH A9*A=#5KC%,9: *4\8DC*N-RXQUKH/@MH_E?%[PM-"X5!?(60
MYR>M8S+UKK/@VFWXJ^&?^OQ?ZT ?=M%%% !1110 4444 >'Z;_Q^'_KI)_-J
M[#1_NK_UT_PKC]-_X_#_ -=)/YM78:/]U?\ KI_A0!U=G]W_ (%6A'_6L^S^
M[_P*M"/^M $M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% #6JK-VJT
MU59NU '/ZA_RS_'^E<+JW_++\?Z5W6H?\L_Q_I7"ZM_RR_'^E 'J^@_\@/3O
M^O:/_P!!%7ZH:#_R ]._Z]H__015^@ HHHH **** /*_B=G^WEQS^Y7^9KS^
M?O\ 2N^^*!QKP_ZX)_,UP%QWH SKBLR;^+-:-P:S;C^*@"A.>&JG+]VK,YZU
M6E^[0(JM]ZJLAY(JRW>JK$%B>U QC4WO3FIHI +29QR:&/(QUQ3":8"MU/:D
M9MW:D//:B@"=2#2TR/O3Z %Q2_SI,^E&: '4M %.V\8H&(/O8I&'S4^@C- B
M%UW#T/K2#YUP>#4Z+UR*:Z#=Z?2@"K)'ZU2DC(;I6JRC:1CFJDB;ATH SI%Q
MFH77*U?:+KZU!)%^!H I[00,^E-V<X)JP5QBDQ0!6V8Y[4 ?-4QCIJQ]*  +
M\IX[4>2)E&>". 13U7CFI(5'/UZ4 );R?,$88/4'UJVN./7-0-"KIM;\Z6.0
MQ81SWX;K0!9"[9"P&,CM3MF<<<^HIK\%,>M2KG'(XH %+*0!\U/DF$B>GM0.
MHJ.X4-"1UYH MMAU//N*5&W 'HO:H!NC;*\@\8-.CE".5/R@]* )R1R#VJ/C
M<<\>E/4\<=3TI?3//K0! Q_*F8W<=*L>6,FHQ$5S05H0R0B1<'ANS#K2QALD
M-UJU;V4]]<)#;0R3S,<+'$I9F^@'6NTL_A'JJVZW>MSVGANS;D2:E*$=O4*@
MY)]CB@#@/).2P)X[5:TW3;W5K@065G/>3'_EG;QM(WY &N^6;P#X9.V**]\6
MW:\;I/\ 1;7/KC[QY]>#7"_&S]H#7?#O@6\3298_#<;;?*AT:+R#_K$5OG!W
M9PW7(H$>/Q_LQZG:ZQ>:_P#$OQ'H_P /K:YE>=+:_N!<WQC=MV8[:,ECC/0D
M'GI6_P##2U^"MCXP$>@>&]3\=:K91BX&L>('%O:)(DB8,=LG+## _O#VKYQF
MN)Y(FFN9I)[B3#R2RL6=F.,DD\DU[E^SII<5MX-DU&0?OKJZD*MP?D 1<=,]
M4- SZ!UCXM>(M6C^Q?:ETNU'W;/34$$8![?+SCZDUS#7!;D\DGDYISQK(I!
M(JH-T#!9#D'A6ZYJ;E6+096QCK14+#OVH1F7/<4Q6)\\8H4\XS0C*5)-(V-V
M:9(\>M.IO)(S2LH&6[T"%HINZF^E "M3?K2EO2ANA]:!C=U-9O6BD;[AH$-X
M*YIPIJD;:5<?C0 ZFL=IS3J8Y[4 )NSDFH&8YQ]:F/05 WWC]:12$HHHH+"I
M$^[4=.B/44$O8EI:2EH($)IM*U)3 92-2[MU)0 TY#4C^M*WL:;NVT (V3D?
MB*:PQQ^E.['/0TT_6@!M%%% "=*1N.:=4?W?>@!!Q[TOH2*15R3S3F&.@XH
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MG<--YBD891DUH[?W89B?-S^%9^I6[*RSP\$?>&<#'^10(A=/LL@*?,DAVXZ
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M_&FGZ<4 49(_6H)(QU(-:,B\>U0-'CZ4 9C1X I/+ (XZ5>:/Y?2HVA![9H
MJ>4/>D\KKGI5EH^<]J/)W<@XH KB,4L<>W/IFK'DE3ZT+&=_/K0 U5ZCFE:%
M6CVD9%2;?:EVCTH IDM;X#<IG@^E7(W#*,'.139,;>1P>,4SRVB&Y#E.#LH
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M !N\Z;(Y11^M2X]N:2./R5QUIRL>03^/:@ 4_)BD^X>?TH..#^/%*<DAOTH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M#-POTP17*:YXHU;Q-.)M4U&XO7["5R57Z+T'X"L/R7A_U;;U_NM2PW"S>Q%
M%@'L>W2EXVC'7O3-P[&G _E0 \-@CC([TOEHR_.H--%+R>* !HWC(*?,/[N:
MFCD63J<&A?E^\<TV2,$\?*?:@#%^(&H#2?!>MW@;:\5I(5;ON*X'ZD5\E6DK
M7#7-S)]^>5I23U.>?ZU]!?'K76L/!LFGCA[X;,Y/($D>?T/>OGII!9V.?[H
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ME&P<^I _K7/21BWMX(@Q)V[VS_>( /\ *@9&6["C/K244").F<BDHW9^M**
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MM&PALCN.?EJC<WVXR0V_[V4\!A_#3/M$NI3/%$/*C)P7'Y<#CW_*K,.GQV6
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M]H#^C47JOL'+@%_,_N1ZGHGQD3Q186VC_%"SA\2VL8"1:W9LT.J6R]L/M E
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M.D98$\=1ZT -VF0 *<#N1Q48._*)]_L*=\DG+*1Z 8J"YOTC79&-TQZ#']:
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M+'(DT:R0,KHXSN!R#]*]ET2/X>_&93<^%KQ?!/B4C+Z-J,H-K(<_P/R8\D<
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MY%AC9W.$4$DGVKS'2I);Z^N+VXR9) N&8YZ<?T%=QXGOC8Z6^!DS9B'XJ?\
M"N1L(Q%&P'TZ?6J)9:C&6+=0:EIJJ%44Z@D*<JTVI!]V@ %.''2FBGT "@9I
MRXW<4W^]C\*>J[5]Z  T*V[)ZCM22-MC/'-*HVKB@!:C/[QL9X'-/-1Q_*N2
M>M A7^[@5$R[L CZU(S YJ+=U- QKO[U6FN-BDDXI\CDG&*H3N9+D1=E 8F@
M18AX7)X;OFGEO4U"9#UQBFM(6P*!#Y&ST-8^J:XEB?(ME^W:@1E+.-OG89Y/
M . ,'D^F*@\1>(VTF2"VMX!=:A< F&W+; ^W!;YL8&!D\GM3M'T>+1KIKN65
MKS4I 2TLHY3."57J0H.<#/<UG4J*FKL[<+A:F+J<D%ZOLNY?T/3SIL*W>K'[
M7K#$[(2<B)>@PJDKG )W8S\Q%)JOB"WM9&_M6[9KLKF+3%+/(Y_A&U,D!B"-
MQ&.:S=:\12Z7JT%E:1QWFOS)Y@MYP=D</S OG@'E<8W _-GMRND^&$M[IKV]
MG;4[]N/M$Z@E0,8"YR0!C/7J2>]81INH^>I]QZU;&4\''V&"^<^K].R*NGV.
MK:]-+-K>^RL6&(])B<!5/0[GC(\P'!.&!'SD5T=CIUMIT*PVT"6\2CA8UP/\
M]?SJ=4/IFI<=*ZTNB/GI2<G=L*<J[C2HN[-3*H'0?C3$-6/VJ41K_=I0N/>G
M4AC=H]*-OH,FG=Z7GTH ;M'I1M'I3J/44 ,VC'2C9[9IX4XXYHSUYH B9%].
M:B>/O5@@'/K3&]* *;)NJ!E(ZBKCI@>U02#=UX%!)B7%E-9G[1I;_8;L'+&)
M1B4#HK#H1G'7/ZUZ[\.OC[JEMHT6AZO;6_B&RC7%SHFJ#<"!QO@<@;#T/R9
M+],UYLT9;/;%9U]I[S2Q3VT\EK<Q-O62(X)(_A;&"5) R,C.!42CS(ZJ%=TI
M)R5UV/:=6^$GAWXB2'4_AEJ?]GZUN,EUX0U641RRL2,B&1CM./F/J>K')KS7
M4=.O=%OI;'4K*>PU"' FM;B,H\9(XR".1Z'H:J>'==&J7,T)E-KKMCC<L6<2
M'!*OGL2J[OO'&ZO6=)^-4^O62Z+XWTB/Q?:0@1Q*[;+Z/L6BN,CD#)(<G=M
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MGR$EB"O%,A'EQHS#C:.*!#V(RP(SQPU,9LL-HP,TH!.<<\=Z%+$G@8Q0,1E
M^Z<K_>QBEX'(Y_K357. I)]J>?E7!^]0(0L/[O/IFDVYY(P/6EVMMSCCUHY9
M1DX&: &]^>*0KR"!D?W:DV;FXY H;YV) Q[4 1,H;.!2JAQR.>U2;&7'R@4[
M&.2<-V% $<:Y^\,8Z"I]HVX/X-2QKY;!G4%<4L:,3@<GTH&'5OE3FE9=K8'S
M#/#=*E =78;1G%-'(4+SGMZ4 ."C;D\-_.EXP,K@TYL",)_'_*@*P49Y'K0
MU5);#<+ZT<YY&#W[9IWWE&3MH"LYQG/^U0 O3&!GGZ8I#_%A3G^=+*P=L)\O
M/-'SK@8R.QH  I\O+#+=A[4] NWYEV^W6E;U[J.E ;;\S=#S0 GJ"O'J._X4
MQVV\@87W[4@8KELYQV-9WVB?4IF2/Y(0.64\^_?WH +JXDNI!%;[FBSS(IX'
M^>?RJW;VT5O&H !DQRV.2?K1'"EN@2(9SUXQ3GD$:;#]_L?UH '9>,\8X]:A
MY<_-\J>YI3YC+G&<]Z87W)AN!_>H 1F^?[N!TZTW=TV]0::P9L[3D+WI))!.
MP$7RGOB@ 9@=V!ESVH\MC'DCYNRXY-+Y;QLOR@G/!]:E(+-DG:P]/I0(CCC'
M\2XQ_":?M'S!N0>C"I(\QMOD *^IYJ,*^[(Y'4*: &L>0R# SP*@NY8[49+@
MCLU,N[PVK$%07[*..>U5H[9IF#S-N8](OX1_G^M Q-TU\W)*0^N/OC^?_P"N
MK,4<5O&0$VGTYYJ5L10[-H#=N.E,57VYQN'O0(15+-@_*N/O4[&& 9<>]*,[
M?F'RFG>6=V,[@.YH 15"X(&X>G2G!0.@R:=)\[<''TI\BNN. * &JORY/#=A
MCK2C'.1BEXZYP1VI4X.\]/2@8#_)H^;@J,<TJ@[N.1CBDW%>OUQ0 I7H<9S^
ME+\B#+$#ZU4.H[GV6Z^:[<$$XQ^=.:UDD_USE3UVKT'MUH D:]C7[B^81V&3
M_2HECN;ACO+0+V'!JS#;B-/E13ZG I+BZ6UAW2=^GZ4 03+!:KND'/\ >;))
M_"H(89+UM\H9(<\0]/Q_G3X;5[QA+.W'\*=1C_)K1XQ\N /I0!&L:JN%4+[8
MJ_HNM:AX<OX[[3+R>PO(_NS6\A5OID=O:J3;L]!2$GOQ0!ZI'\6-#\;0_9_B
M#X?6]N,;1KVE*L%ZONXP%D_'&/0U6U+X)R:I9OJ7@?5H/&&GJNY[>#]W?0CC
MAX#R>3C(Z^E>9,QW GIZ5)8:I>:/?Q7=A<S6=W&=\<L$A1U]PPZ4 ,NK>6SG
MD@G@D@FC.UXI%*LA'8@]#5>1AZY]:]1M?C59>*HX[+XAZ##X@C5=BZM9@6^H
M1#H#N&!)CT;'N34=U\%K?Q3:S:A\/-<A\36Z#>^ESX@U&$=\QG <#^\O4] :
M /+C)MZ4QI.Y/2EU*VNM(O);2]M9K.YB.V2&XC*.I]"I&15)I3@G/R]:!%@S
M9YS3?.]>*J>=N7@4AEZ4"+?F?G2-)5;S/F_#FG&3IGI0,GW?A2"0Y )J+?[T
MC2!>2:!$Y;BFYJH^H0KU?'X&H&UF&-N#N_/_  H"QH&C=Z<UE?VZN["Q[N.N
M?_K4@UO;P(A_WU_]:@9KYI<UC+KF&/[G_P >_P#K4X:]_P!,@!_O?_6H$:K4
M=.]9G]N)_<_7_P"M4J:M ^!NQ^!_PH&7LBC/O4"W44GW6R?H:FST/8T .HS^
M%,I6Z4 .I?QIO3FE6@0X'::?YAY%19I=U B7S#MI^>QX-5\T_<?QH FW#O2\
M5#N[CGM3\T%$H:G;JB#4[=3 D%+FHU:G*<D4@),T[.%X&"::.*5FH&+S@>M=
MO\#R?^%N>%?^OY/ZUPN_K7<_ TG_ (6YX5_Z_D_K0!^A%%%% !1110 4444
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M;IGES>(YD$T<<P/E)%D[F9AC^Z1@$G)'&,FG^(/$7]APHT=LU[JUQDVEL%+
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M&*N[TZ]3Z4LDB1KE^ OMUJI->-</M@0DG_EIC*_G3OL(F"O<$R,.@' 'Y8H
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M<99?QK98JK'J>7+(,'4_Y=_<VCUNT\6:?=''F>7V^=E']:UK>ZM[@*8IXW]
MK UX3Y\R'[S#\:M0:]?6O,=U-&1TVN:WACI+XE<\VOPK2DKT9-?B>\(G0BIH
MX^F:\;TWXA:I:\27+3?[^/3W%=EI'Q4LYL"\C%N<??W%NWLOUKLAC*4M'H?.
M8CAS'4-8)37EO]S.X6#N>:5;7>QYVJ.<&J%GXLT?4,>1J%N<]B^/YU5UGXC>
M%O#L\<6HZ_I]I)(=J+).H+'CMGW'YUV1G&6S/G:F'K4=*D&O5-'1*J(,4BE=
MQYS7,1_$KPC=,-GB73&)Y ^U*/TS6M:^(-(OE!MM4LI]W3RYT;/Y&K,"^\(E
MXJE<VX3GH.F:N1S)CY9%;/H<US7Q(UP>'?"%[J ?RW0QJN#W+J/0]B>U 'SE
MX@U3_A(/%.I:J3E)-BKTZ"-!VXZ@UZ'^S[;G3[34=7>,L-06-4 R"-C.I]CT
M%>1VZ/;Z05Y,K!@H[ECG KZ-\)Z*OA_0K:Q1 GE[N%&.KD_UH [6'4H)R ?D
M/^T0*MQ_-RC@URV2ISWJQ#?2P_==@/3- '2[BIY4\<9IZX;H?PK+M]6$G$C;
M1ZGG^E7XIDD&5 ;W4_X4 3=,TY6J%F*MC.1[\4JR XSP:!DOO3&;WH+<<&F,
MWK0(7=Z\TNZF;N<8I<^E #J, ]*3.XXZ4[CM0,2D;-.I&H C=LKQTS7@W[1G
MP[/B/26N8,"YM,7=J2&.)TCDV'CKS['Z&O>),< '\*QO$^GKJ&DSHT8<A&QD
M9_A/^- CGO@_\2+?XH^"[36(AY4TF_S86=69,2.@SM]0F>@KMJ^;/V5(9?#G
MC;QWX9+.EK9Q64D$#9VIN5V;:.>IDYY[U])4 -:D+!1D\>]*:S];OH]/T^26
M218U&!N8X[T <^WQ$TBZ\9-X819Y-06%9F=-A158J!GYLY^8=JWI+=XCDC</
M:O(/@/;VWC+7?$'C5"MS#//]DM;AEW;HUBMR2K'' =7'3J#S7M_#=:AQ3-J=
M:5/3H9H8=,8HX85=FM4D&5 5O:J3PO"3E3M]?6LG%Q.^%2-38.,44S=FEW?*
M.](UY1VZC=NIF[\:-P[4$\HI&?:FL#TI-W7TH5NM5<AQ((SFZ)/9<?K5L8SB
MJT',[<9Z_P ZL=*9G8=NJ./YG=\=:5V(4X[4B#;&!G!IDL4M4>><TYC4;-S0
M18,[J3/O29&?0U&SY]C0(>:9]Y@!^=,9C4D2\ ]ZI$2T)%7;Q3LTVBK.<4FC
M-)2T 2!J=VJ+=3XV'0T /4UB^(YA)&+<=,AB?S%;?TKEM7D,A89^=FR#_L\T
M 9%PWF&,#J6!_I5U5'(JL55IF=?N+P./H:MKC;Z&@0O'3'/K2[1Q3:=NH&'K
M3U;H,4BC@\9IW;/2@!>?6DD/0>M&<T=6Z=* %7CBEI.]'UH !TH/'-+2-C;S
MWXH$(@[]SUIK\+DU)FJL\A"]>O% R&1NO\JIW#[1SP!4TDG'/6LO4)CM" G+
M>AIDD4+&1F?INZ5.BGN<TRW5<# QVJ'6-1CTFR>4D&9LI#'W>0@E5'N<4AF9
MJ-N/$VL1:<CXAL)%N;HD9#=,(".A(9N>.G?MK7ES'I=E/=F%GM;-!LA7J^!A
M$!]20%'?)[TS1]%;1=/CB<^;J=PV+F<GYG )VD\GH& ZUG2K=:[KZVREUTBQ
M?$@'W+J3&>>GW)%/KS7+/]Y/EZ(][#KZGA_;?;GHO)=62^&K.ZNIKG5;SB6\
M*M!%@AH(?F9(VX&2-[ \?C72+'M4#//K1#"(U"JN,#BI0IKI2ZGB2=]!54]<
M<4L:].?>I(U(&#3T0>E,D:%ZT\+^%.V_G3@A]* &;<<U)&O<]*58R1R,"GA>
M,8H ;RHI"IXYI]&WUZT ,/TYHY;O3MH]*"HXXXH ;MH'%#9Y'WCZ]*7;C&.M
M #-WH.*,^O&*50.5!Y^E(%/S$]?SH :S9Y[4 Y'2CR]S9Z"D;VX'2@!1EJ8>
M.M*<[<]*;N_&@!ACY()R:B92I]*FP>.:1QDC- BHR$MUI-@QCH:L-'SGM4;+
MZ#GUH$8^K02V,T>J6D337,*A&C4$ET.1@<'N0>G:NA\,ZW!?63S0#?:7*-#+
M#D9*$X89&<9QV]:@ QTKFX;A_"NO!=ACT:<*%P,)%(2 1WXPI;/ YKDQ%%S2
ME#XD?1Y/F$<+)T,1K2GHU^IK6%K/H<ZV%S,)XB"8+D+M$G(W#'8@L!P3T/2M
MA7YZ\>E0ZWI_VZU^1BDL0+P."?D?' Z]"<$@\''-5-)NC-&(I9%-U" LXR,Y
MY&2!TSC(^M:4:JK1OU.3,LOGE]=P>L7L^C1WO@OXC:]X!F:72+UHX)>)K20>
M9!.,8(=#P>#C/7G@UV__ !0?Q3 V^5X!\2/ZDG3+AOYPY_[Y'O7CZ2$J1GY1
MZU,N-F<\^E;GDFY\0O .O?#UQ#J]BT<<W$-U'AX)@1P4<<'UQUYY KGK>,VL
M*QDACGM76>#_ (P:_P"$Y&TH-!K7AZ10+C1]3C$UNXSV!^Z>AX.,X)!KK_\
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M'^% #VSJ,BJK;(U/5N_?^@K0A'EJ$ W$#%1*J0KLC5>GWO2E+&(+M.Z1AZT
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MGL:.7]J4*/,.3@^M#@1,<M@ 9)H CFF$:LY(4*.>>M5((7OI5G8?N5.57O\
MYR*09U*8 #$"D'=V?V_G6DL8A38@"J!VH 525 QVH].](.> <4W<,')[XH 1
MLKR6R*9(VUL=.*';<Q!.!5>23'7G\: ":8-[#TJE-)@$=Z6:0 9SDU3FFX;D
M9]:!#+B;H/O-VJE<72KEW(4=.34-YJ"6_P#%F0]%!Y-9826XD+73,$/2+/\
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MKUP3@"@#S21MN% '/IV_&F[3)DAN1U'2E965F1AL=&P<C!!':H]Q5C@X/J*
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M3\6/C=J?Q02&R-JNF:5"_F"U23S&=\8#.V!G&3@ #KWKS>@!!2_2CK3PFV@
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M:S[/[O\ P*M"/^M $M%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MY/ZUP1R&4=J[WX#_ /)8/"?_ %_I_6JZ"ZGZ*T445)H%%%% !1110!X?IO\
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M>\\4:RZVUNK7%PY;RX5VHN3R?85[EX3T6;P_H<%C/=-=21_Q'HN?X5]A[_\
MUJRP;E4BZ4E>)Z6>TZ>%JT\71ERU>J7Y_H^_WGAUOK.M^!?$&UY)%GMVQ)!(
MY*.IZCW!'?Z5[SX?\16GBK28KVS<['&UTS\T;=U/H?\ ]=>4_&#7](U2YAMK
M5!/?VYQ)=(?E Y_=_P"US^7YU!\&[76O[9:YM/DTK&RY:3.Q_0+_ +0_3\:F
MA-T:KI1=T=^986&8Y=''U8^SJ)==+^7SZ=?S+'Q!U#Q;X'U -!J]U+IDY_<3
M2!7*_P"PQ(ZCU[C\:ZOX8_$H>*[7[#?LHU>$9)P%$Z_W@!W'<#Z_3I?%4&F7
M6@7<>L,BZ=LS(SG&WT(]\]*^7TNVTK5O/TVYD4PRDP3XVL0#P<=LCM[U=24L
M+533NGT_K\ R_#T,_P !*E.FHU8;32M?U:_%?-'UQYG3O1YGM6+X6U.\U;0+
M.[O[1K*[D3+Q-Q^('49ZX/(K7KUHR4DFC\YJ4W2G*G+=.P_S",=Z-WS9/-1Y
MHR*HS';CGCUS2^8<^U-S29% $OF D9'?UJ>-OF!JI4L;#C)H O*WRUH1R;H\
M8P:RXVJY"2W?M0!E^.O"4/C;PO?Z3*0IGAD2-FSA'9&4,<$9QNK\[[_3]1\)
MZA-9N3;7$8 DC=,$9 8<,,C@_K7Z7JPQFO OVCO@>/%%C'K/A_3%.JQLS7:V
MT8WS1B,8)^8=-@  !/S?G+2DK-%PJ3IR4X.S\CY8LOB%>Z=&(O,>,@;3)&B/
MG\"!6M#>1^)H,R>(E@ED'W)[>)3GTX?VKA=6TVXTO4KJUN89(IH'*21R*0R,
M.H([55C61G!BW!AW7C'OFN">!I2UCHSZG#<2XVC:-9\\5WT_%';:AX7DCMY%
MM[A;ICC]XJ\'GVS_ )-6-+\<ZOI,B1M#-<1*-IC,80=,==I/:L70;#Q7J68]
M$M-2U5\X86L#S!3C.. 1TS^5>Y^ ?V>?%>L6PF\0V']F,1G;((F8\*1D*X(Y
M)_*N26#G%::GT-#B6C4E:;</R_KU*'A27^VO#XE(;?),P?(_BQ@=/;%=S',R
M+71:7\)9?"NG_8X[)I55C)YBKGK[;C5"_P!%>W ^1D/H5Q7#*DUNCZG#YE3J
M)<DDUY.Y0LEM[K4HC+%N.>NXCM76V2FV7_0YOLOU4-V]ZY;3[*6.^#%"%7OC
MV-;T;LG4\?6B+G#X78Z*D<+BE:K!2]4CN-*^(_BK1X0MOJRR8& &MXE&./\
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M@!5;"L*/3/S TG ]UI?3'(H 3[K#%&T9I6_(T+[\4 -8_@*3@^QI3[]:;^M
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MP<4+T- Q-O09HV@\4_% % ";:!2X_&E[4 -I=O>E_2DQ0 GWJ3_(I?;&**
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M1XMO0)H8OE@M9VEW,P:/# CDDNN#NZG)-3++Z$];6]&5AN*,?1;C=27G%/\
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M[MW&.30 WFEZ]>*7[M-H 1@336YZ4\M[4P_-]!0 ULCM36('7BE.:;\W;]:
M$4;3N/(Q3#NZ#DT\MAO853U"Z,*[4_U[<J.V/\@T"(;Z_>W;R8US(WOC&:2W
MM!9H<'<[=2:6TLVMUWR?-*W4YS_GI4TC;>6X"\T 1LP2,EN'ZU"J-)AV4;>U
M2J/,8L>0W3VIX7;P"<=Q0!&%W?>X'K3]A<[5Y _BQ2*IW$5.N57)_BXXH&#*
MLC@Q_+ZXI_ELN.![>]2*!,N!PJ_G2E1MZD^E #=O<DAE[4Y/E.YP"O>D7<S
M]1T.:=YBC[W\/ ]Z &*K;CM&[T!I5:1=R[1TYI67:-^<.3QBHI&);=R* !L*
M $.[/6J]Y<+;VKDJ-Z@E:F5F"[NR\UFW5R+J\6%.3G+Y_ B@!EC'(T;S,-QD
M.[)[#J!^M3=5PW ]:?Q&=HX'<5%N*D@?K0(?M9L@<@=Z8W^EL GR+WV]Z5G8
M_+W/7Z593;(H55PB\Y P: &K&8U5=H [5)[DD,*.-H&2=O2ECW?7/<]J!BQG
M8P9E!7WYI%5MQQ\P[9IEQ?0VY E8Y'0 9S3&^T7&60"+)R&SC^5 BTTAA^^
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MB'33B;2T8?WO/4>WJ:RI?B-';';<1+&PZ\L<?D*]O\MN:KS6<4W$EO%(/]M
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MZ=8^<2]X[O-+UB;[- BR2.,EUD)P<*>,-_2L_P '^-=6\"W1A52+1SD%X0>
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M2&(!F)()R>O.!^55S:#-%5_"E7.3S4FW%&W=]:D0T+3@O4 \4H&/K2JI/L*
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MT<9)Z^M1-&6[Y8=N] %58_.O#C[H&/SQ4Q0J)%7[HZTV*/RMY_B;OZ4]5=F
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M6FW ^5O4U)1&T;R*I/RQY^[WJ5515R!G/\/I[T]<,V&X_P!DTU6W<@!,\&D
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MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** &M56;M5IJJS=J
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M1I\>Z=@/.N9/]9(?<]A[#C^=;NXHWX4^N8\;R7MQ8QZ=ITGDWUW($CD+%0
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ME&,=:=M].*<J!OPH :J]#4JJ.I&*1?O8IP7GU- "J,"E6BE_2@!>U+BDZT4
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M@X]32]/<4A_^O0>@[4 &?FH'\J-H/UH P3QUH 7US^%*N>A'/:D7KS1_%[4
M)GCFG*:3 Z]Z7K0 [;TQUH;! XZ=:%PH/&?2DZ 9YH 0XXHVYQ@XH^Z<CFFD
M!NM "<[LX^7WH+?,>WI3FY48X]Z, ]>M #4 8@GFI".I)^E-%*N%;./K0 ]?
MNX(SGI2KZ4TC<QQP*<54XQP>] $BXP<=Q05X&.6[TSD\#M3TP-XZG'% "-C:
M..1UIN[M1TQGGGD4UL+G;0 YNP'XT+][I\H]:9@-R>E29!7 &#ZT 1W4GEPR
M-ZJ0/RI;2$10JG9>OYU#?;7:.$\DL#GVZ5< VGD=J $;!W'G':LZ\7[1=10'
M[N"3_G\*O2,(U9ST49JG8YE:>9N S?+].O\ 6@"UG ]J&QM/O3L#@CK4$F23
MQ0!&R[6 [U#,VY<]".M2]CQGBJTG"[G.1[4 4;R4-^Z'WI#M_#C/Z4Y85BC1
M%Z 8J.*/S+AY^V?D'ICBIF7OTH$-[G'(H:G,>,8Z&DP,XZTP&L,T4M&WUZT"
M044NWCTHV[LG@?6@8@I?;O010O?OQ0 4F**,4 %%+]WBCCTY]:8K"=>@I?TI
M>.](%Y(I#%7\J=NQQUI,[>,9I6Z+@8I *.>,<'K3N,;N:9SCDXHZ\]: 'LO(
MQR>](S!NV*5??\J/XAZ9Z4 )2BE/5L<#L*%)ZT 1L?F.T944R3&XD#%32,/+
MX^]G]*K2W$:L1]]O]F@"G<*/X@21^59EY&HW=0,?+]<54\1>/+'P[JT5G=I(
M&DCWLZ#<$!.!D=>QZ5);WUKJD(FMKF.Y7N8SG'U'8_6H4XMN*>ITRPU:G356
M4&HO9]"HV=IW?A7'^+=0G\-ZAIWB.!@K:7Y@.0&!\P"/D'ZGN*[&[C/F,<85
MJQM:TQ-8T^6SD^59,<G/8@_TJSG.Q^)=BDVARS("WER+(A!SD$D?CPU4/"[+
MK_A^]L)OF:ZMYHQMXPS?*.GUK3\'ZI'XL^&NE3*N)+>""TN!G/[U8T+=.G)Z
M<?2N4\'W3:7?"!P0T<HD/;^[ZU\KB?\ 9L9&:V9^^Y'RYYPQ6PDM90?YK_-%
M_P )ZPVL:'#*X"SKDN,8_B8#C/H*Z2%Q@,?3G%<Q<:7_ ,(KXZOH68?8KY$:
MW'3E%0,,GJ<R=C72183#IR#@A>]?5'X"R\F H"KDMS4O <[.0*K+^\7/W>.:
ML;OW(4?>!R&]J %D^\3@8--7:>N2?:GJ5W%7Y'7<*:Q,9((SG@XH ':,LQ_A
MQQCUIB;@,NORMG:<&A%*8[$= :<V68\X!'?O@4 1Y'(Q\V>#2JJYWGD8QN-+
MM# 'HPXIA8_<V].1B@D1F"*.IE;]*BF8M&P8 ,O)'X4J.L,C'&<]<56P8T7=
M@@'[O>@8><.!C Q@^IXI-R[=J@C<><TC_*=Z_=Z[3UJ%V$C9Z>M,8Z0?,1&,
MCN6IK-\VXXV?I0WS1X0?-G[U5I&2\D,&"4'+.O(SZ4 +&JWT@!)\H'MTS]?Q
MK555<DD?)VQU-5XX_LS*J?=[XY[U:AM]K9/!["D(G@0YZ?*W"YZUZ#\"@4^+
MWA5<?\OR?UKAE1B00=JX[]^*] ^!<:'XL>%2!AQ?)_(T#1^@M%%% PHHHH *
M*** /#]-_P"/P_\ 723^;5V&C_=7_KI_A7'Z;_Q^'_KI)_-J[#1_NK_UT_PH
M ZNS^[_P*M"/^M9]G]W_ (%6A'_6@"6BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@!K55F[5::JLW:@#G]0_Y9_C_2N%U;_EE^/]*[K4/^6?X_TKA=
M6_Y9?C_2@#U?0?\ D!Z=_P!>T?\ Z"*OU0T'_D!Z=_U[1_\ H(J_0 4444 %
M%%% 'A'QF\-ZAK7C56L].N;P"U09AB9AP6]/K^M<UIOP3U_5-KR6#VL1.#YF
MT,.?0L#7TQY,?F^;L7S,8WXYQZ9J2@#R;0_V>=%L9 ]^RZ@O'[MHV7OZASVK
MM--^&_A?2<?9M$M%(Z;TW_\ H6?6NEHH @MK.WLXPEO!' @Z+&@4?I4]%% !
M1110 4444 %%%% !3)H8YXVCE19$88*L,@CZ4^B@#Q[XD?LV^&/%EF7TW3;7
M2KX;B)+>(C=\N ,!U'4"OESQG\'_ !5X!U"X6?2[NXTV-SLNDC!4J,?-\I;^
M\._:OT$K/UK0[/Q!8RVE[ DT4BE?F16(!ZXR#Z"@#\W?.Q(-AR5X=.A!]".O
M_P"JK2ON]J^D?BI^S/I\UP+S2KE]/8J?]3#&J$E_X@-I)P>N>]?,-S)=:1JD
MFGZA"(9HV9<A@<X)';/H>] %_=36?;R#@GBFEOW>[TYIKG=LQZT 3QL5QG\:
ME$G?.!5?<<BG9H L(W?O4JR?-P>,56\S':G1ODDT 7?,'K0C?-SR:KK)N-21
MMU- %I9.:DS54&I$;M0!8$C=^?:G+(> :BS2]NO.: )A)[4[/'I4*CI^E2;L
MC!ZT .5@>AI::HPM.H 7M2BFTUI"O Y)H <[&0X!RO?WIRKQC''I34^50O6G
M@\X_R* ,W4+'#!T3(/4 >]=G\+PVH>"_B-I .?,TM+[;G_GWE#9_#=6!UXQG
MZUUWP3LQ)X\DT]#B/5M/NK%@3@?-$S?S44 >4KAC4J*TC!0-S$X%0[BC;2,,
M.O8UN^%=/&H:DN[[D>'/3KN''\Z .V\+Z<+'28"4V2N@+\<]2?ZUL(NY@*8B
MB-54= ,5/'\M $GW5P*CVDL2>E.W;C37?CB@!KMV%1,VT9[=Z';%4=0N## 2
M#][C]* ,[4+@SW3X.54X%8M\VZ4#L!_6K[L3N/>L^5=SL2>]1(Z*.CN,A3')
M%3YXIJ#@5+L&VI-W(B//2D6/GCJ>*?M]>*EMXO,D&.W-49.1:MXQ'$O&"1S4
MAIV/EZ=*9]ZK.7J%)3L4E "-TJ-NE/:HF- $4TQAC) R:\-\(^!=2\8?%;4/
M%7BO3W6+2Q]GTB.X8,@5S<"1P%('S*\0^93]T<^GN4I!X(JOL6,'8H4=< 8H
M 9<$>6<\BH4VQC &/H,47,GR$4S=E10 _P P_2D+=.<TFZDSGF@ 9@S*,4X,
M1GWJ(<R9/&*DS0 _>.>*4L<\5'NI=WS9H ESWZ4R3L?ZTJONR.]-;WX]* &4
M4OXTE #<CUHW#UI<5%NVL>/PH$.8_+D?RJ/.:4MG_P#73:!A0>E+3: .3\8>
M#Y=3DAU?1+MM$\2V;>;;ZE:C;*Q !",0RAAN2,_-D?(.*]Q^%_[1&H7^CK#X
MRT^?P]K48+&ZAD,RS_.V!B",(,+L[^OO7G.!3/7(!_I0!Z!\0/VP+Z]_XH?P
M8\__  D]^WV6'4YLPM!RI:6-9X@LI"%SA6[#G)%2>%?"FMV[07VHK>>)M8N8
MU:^U:X5GEBDVDE%R6**69SM0A1O.!7CWB#PC!K<D-W!(=.U:U=9;74K= )8G
M!4_>&&VG:%8 C*DC(S7<>&/CQX\\%Z3_ &/#H>E:PY"@ZM=[L_* ,F,R[B6Q
MG[W\7MS<>7J7%V*'QT\-BQMY%*K/K8*M:V\+@3SIO8$[%.5&W>3N'\..N*\N
M^&\ESI=\LOB^-OM[M@W5QPZKE=HRO0  GK6_>>'=3OM:?6[KQ)J5YJ[[CNN)
MF>!-Q)*QH6W*H+-@;S@'O5"'7+?6=3_L3Q!!'INJN!Y3PC?Y@8A5/ ;'+$<M
M_#GC->5B\&JLO:4-)?F??9'Q.\+'ZIF"YZ73JX^:/6=0\/VOBF/%[<+J8&3#
M='F2)L8W @[N/K_"*XJ2WU#PS>SVVH02RZ5&Y6'4V&5V9.-V,[<95<L>V?6J
MUKK&K> [B.&Z9KFU8A=[2$%><GH3GJ>W:M/Q-X]M9M,6U$:W1U%-HADW;<G'
M(R,<9SSZ5C1QK3]E65FCLS7ANG5I?7<ODI0EM;9^7D_(?#-#=8>WECFCQ]Z-
M@P_2I>G'05D^&]*M;J-(TOI=,ND8LORF2$Y49#(N,XP<?,,$_G:T_4?MTD]O
M-']GOK=FCFA!W;64@,,]#@G'%>M&2DKH_-JE.5*3A-6:+\;=.]/J)<9]_2I
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MB@9F_P!FQM]Z/D4Y=)1O^6?'KBM-(C]X\YJ5<<YX% &7_9\:8^3[O0XJ6.V
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MFWGFW#)U$'S,^3Z?NT['H*N:%?#4=*L[Q6P)(ED5>N[<,U?\-PKXBT'6]*D
M*3VK1J<9QN5UR,\?Q5S'A&7[+:/ICGY]-GEM03W"2NJ_HHZ5Z>$J>TH1D?"<
M08-8',ZU&*LKW7SU_4["W;=G?E1UVFK*?>Y.01]X=JIVLC.X8J"/>K4(,C$(
M/E[5UGSA(<<;1D=_K2R*RM@J3_2E5F63!7CJ0*4MN3(;))[T#(U&\$L<-[\T
M?*RKGAN]2^7LC8/PQ^[^M,5'522H/?F@"/:V[A?E]:KS2%3W4] W0$59,I"M
MV%4YB96,8._'X8YH$,F;RP /F.>0.M0R2!FR#R>@ITYVME>9!P?3_/2JLC,H
MY4 #I0,D+_(Q;@KT7UJ..1&!!79ST-1NV[&3@]:BDD\M3(1N XQ3 DN+@K^[
MAY<CJO\ #_GFIH+=(T"QC)_B/J>YJO96[;F?.XR?-SV]JTK=&$H&T#([4 2;
M&7JGS'K[5>CC&<Y^F:BA7^(G+'CFKD<0C4AQR?N_6D ^-!M&1S7?? ^,K\6O
M"YV\&]0Y_.N'A20+RH(]37?_  1S_P +5\+@_P#/ZG]:!GWS1110 4444 %%
M%% 'A^F_\?A_ZZ2?S:NPT?[J_P#73_"N/TW_ (_#_P!=)/YM78:/]U?^NG^%
M '5V?W?^!5H1_P!:S[/[O_ JT(_ZT 2T444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 -:JLW:K355F[4 <_J'_+/\?Z5PNK?\LOQ_I7=:A_RS_'^E<+
MJW_++\?Z4 >KZ#_R ]._Z]H__015^J&@_P#(#T[_ *]H_P#T$5?H **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** $(##!&17C7QJ^
M]KXZTF5].@C6^WHP'R)QN).#M_VO6O9J* /S&U"QO/!MRUEJ@/E@@+*KA_O#
M.#S]>U6(W.X'CIUK[+^-?P+A\=+=:G8IG47AVR1O.560*C#'3@GY1U%?$>JZ
M;=^#Y\I^\L3\K*Q!=. 3Z?[7K0!KA]PI8WW9SU!K,MM5BN(EDC/RD9VD&KD,
MRR+E><]?:@"UFDA<LN3U-1EL+Z"FV<GF0Y]Z +Z/A<=ZDA/R"JN[BIXF.T4
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M08;]W?IBHXU"0H.RJ/Y5*IW<CGM0,D5?+P0<'TI?7;TH9BQ&[FG;OE*]<<T
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M#=6UN]KIEG&8K:.7'F,"<L[8R 3QP#P * ///,^:E&2<]_2HU89XYJ53N H
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M:\@9ZT^*-Y/G<;1TVU,HVCY>HYH$,3LJ@8Z4K,OW6/ ]*<WS<D89O2CICC-
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH :U59NU6FJK-VH Y_4/^6?X_TKA=6_Y9?C_2NZU#_EG^/]*X75
MO^67X_TH ]7T'_D!Z=_U[1_^@BK]4-!_Y >G?]>T?_H(J_0 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7@O[1WP>AUS1I
MM=TF!AJ:;GN?G=A)&L1Z* <$;%'&.IS7O5-91(I5AE2,&@#\I]5M9=)O)V *
M&&0^=&PY7!YX[=^M7])U)9(P=P*MCD8]*]]_:@^#$VC:U?\ B:U7S+"[=YI
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M!ZOH/_(#T[_KVC_]!%7ZH:#_ ,@/3O\ KVC_ /015^@ HHHH **** "BBB@
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M*56W8 YYYH ?NSR.12K]UB?R]:8HY('0T_;VH 7EEQTI4PN,FF].II?O?T-
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MG^3UT1I4Y*_/9^ARSK5(2MR77J>U[_2A7/))S7D=C\6[ZTPEQ:PS<\G<P/\
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MN9]@]<]:KV:,I,[YDE/3/8'_ ":K0AM6F+2#;!&=NU3U_P \5K#"X  'T&*
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MK4/^6?X_TKA=6_Y9?C_2@#U?0?\ D!Z=_P!>T?\ Z"*OU0T'_D!Z=_U[1_\
MH(J_0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 5\J_MM>&7O)/#^JQJN%AEAD;(!P'C*^_5S7U57GGQV\)CQ=\/-
M0MTC:2Y7R_*"D_\ /:,G@ YX6@#\^M)D\P*N<\8_'%:,0^9_7/\ 05B:>YM]
M0>$@C#,1D5N?\O1'9ES0!+M"D_W34N.E-V@GFG>OTH <N=K?C4MOE4.>I-1*
M"83ZX-20H=H&* +2]#3C\S ?C4=.CSO)_"@"RO-3+TJNAJ9#0!,M/J'G-2K]
MV@!?K112,VU2: $DD\M?KQ4MJFU3*W)QD>U5HAYL@+=%Y'UJZ/F*KZ_>H O:
M39F]N@&'R=SZ<'%>@1C;C Q]*YSPG:AH9W[;@OY#_P"O71K\M '6_#-@WBR&
MV<XCNHI8&^AC/]0*Y296C9E8893@CWK6\)W@LO$VE3DX5+J/=]-P!_3-0>,[
M?[!XFU6 <*ES)M_W=Q(_3% &!=2=O>J3'-2S2;F/-0T (6VC=VK&9MS$^O-7
M]0DVQA/[W_UJSZ!H*E4 ?-S40YJPJ[1CM0 GWEIO/2I/2F-][% #H_F:I#Z"
MF+QTIW3ZT"%--;UY_"E--<_+0!$QY--SG(HXW4V3F@ :HI&_.G9_"H9&/6@"
MO,U0^E/D:FT "]12X/44T>HHW'Z4 ,D;,JC_ #WIU,?_ %P^F:?0 "FMC<![
M\4ZF_P#+110!,.!TJ1:93^V* "F/\H&*?43,2.1B@!/<TG\-#4?PT )1129H
M :??I3&ZY'0TXG<Q]*3KUH 8:*#2&@"-O6F\9_"I#3&Y]Z (]V,XI*7D#IBD
MH *3^M!I/?O2 44M%% !3A3:6F O\Z=&>:9]>:>N?2@!^>*Q_%;;=(;GJ2/_
M !TUL9_.L7Q9_P @Q!ZR@?\ CK4 <M;Q(ZM$P&T\$8]:RI[6YT?4&EM29K(G
M=<6Q;A5QSY:\+GECSWQ6Q"PC5ROWB0!^M2HN.2,L>6I/7<(R<7=&59M:Z^LL
MVFLQ\EMDJ.-I1O0\8/X$CBH+JW=&S"3#..C*<'WY%7-0T6"\O(KV-Y+:[C4J
MDL9!(SUX8$=SV[U5LM<:2X^QZ[&MK)DXO%!CMSCU9C]XX;H/2O'Q67QK>]'1
MGZ!DO%-;!24*VL3>T#X@&S"P:JI<9XD"ESR1W+?6NGU30]*\;66T?.RY9)U0
M+)&<$94E>#W_  %<'J.C>8I8?.N.H)/K[5BV/B"^\+W?F1, K8!5D![@UXU/
M$5L#+EJ;'Z#B,KR[B>A[7"OEJ'275AJ'A%)5OU^T:7 <17BOOD5<]9,D$GD#
MY1V-/M[N&\@6>!RZ/RK8([9[_6NE\.^,+/Q-9I#<LHN'3:PR%R2#_M>U9.N^
M!_[,\^^T,>7*Q,DUNS%UF.<\#!.<$\ CM7TV'Q5.NKQ/QW,\EQ65U'"JM"JS
M?*.<YZU"T(;J35>UO6FC*2Q/;7:G:T,J[23W*@\XZ_E5CS"4Y&&_6NS1G@7<
M1/L\8_A)_&G,RJ=BY Z#VJO=!Y.8I"AQT]:QIOM#<;9&8G!R"<5E*7+LCHA3
M]KO(I:M(+:>49.5?C\ZV[:X2ULVD;<RX7..U8%YI]RRD!.#UR1[5OJN=/C1L
M8:(*V.><5%/FUT-\0X/EUOW-.WNH[J,&-PZ^W:KD'[SY@V,<UP6F71M-2CW$
MJ-^UAGC'2NY61(P69MJ*,DU5.I[1:]#/$8?V$DD[IEF-E.<[EXJ9'&T8'-5;
M699$#@AXF^ZW_P!>G\J2".:V.3U)9/H=WJ:1CM4'.1WS2)AN3UIY^[SDMV H
M 9\H&<G=Z5(&'\(R>]-^\,,,-2?=;/04 /5EW87BG,P5L'GTIBX\L#OGCVHW
M'< .2.M $@9?7.:<WS<8^6F,5RI-'#9'4>U #HR>QP11N'6EW#<,]*:LA[CY
M?>@!X(.#BD8@8)ZTW?C(/6DW#@T $C[5R.:KLPZDXI[MG)/7/'TJ"9CM*@?-
M0!')(3@J>*KL0/J:5FZ8XJ,L5Z#Z4R1"1NPW-2)CL<TU1R#@Y[U+P%YI 5KM
MBV(5X9^1^%7(UV  #H.!56S_ 'S22L.<X7Z?Y-75PK>W>@9*OS5:A&W@\U%&
MO^SQ[U,ORT#)../6H9F^7'4&GNV%SUJI+)M_G0!%)(.QYJNS=,4LDA5?4U0F
MN-HSGCK0(KZA)YLD42G^++?3C_&E#88+QA<52LY#+)),3U  _P _A5N'+29'
M)/6@#1AP0IJ?BH(^W'2IE]Z!(D1>< XJ>,_+4*[2P!./6IX<>GR^] R:(_-@
M^E.?"\XY-,'>G!A0,3=D9R<=Z;NX'8^U/W<'GGM33C:1QNH 3);IQ1QGCI24
MX,%Z Y[4 (V!P>M ^N?:E;\SWH/8B@ ;G'8#KBA?F;(SBDSG-...G&!0 O7C
MH:56!I%8ENF!3J %XZ]Z=MXS^=,I: %X6FLJLO(S[4O/I29H HW.EV5Q\LEK
M"Q]3&I_I6'J'@/1[I<&!8CZQ(B]O]VNI(PIQ4+1X7CGN:=V2TF><:A\)K:3<
MUG/(C]5\QP /R2LT^ _%>F<6.J,J^D-VZ>WH.U>K>7_%C H*G!-;PQ%6'PR.
M:>%HU/BB>=VOB;QYX:13<1B[B7Y?](N3)VP/^6GM5B3XWK(@6]TV,2]VBA'3
MZEZ[66L+5K.*^P)HO,0=.2/7T/N:U6)N[SBF_0Q^J\JY82:7J<]#XYB\5:A;
MV-L9[-)I%667[C*A(4E2">><].U?1WP=^$W@S0]0LM?GM%U^ZCV3!KZ"*9FD
MPPR2Z+GD\<]A7S?IWA/PWIFK>;JEI<&RN"L>Z"0Y@/&7)) "XR23GM7T9\/=
M#/@GP^UYI%W'+HMU");8EQ(Q&&(YQ@_,_8USU)J>J1TTX2A=2?XGOIU;1+J.
M4WWA"SM[,KM66.R@W!<8R/G..W:L#4O"/@S7(RZ1SV2=!^YC4=<_PJ:\AO/B
M%KOF9:YC,>[;M\I>!G [5T7A/Q7KWB*26UAEM2T>T!60Y;@],?[M8&YY?\6/
M"H\&ZY;7D;VXL) $$T0(8Y\PC(VCL!VKE/#WP\\8_%Q5N]#EM],\/+)A[V:Y
M:*9BN X 3<>C<97JOTS[7J6J>&_'ED=+\16<L7EON*AS"0R_\#]VJGXM\.V.
MFPI:Z=?%=.C&Y+3S$8!OF);."W4G^+'-.X'#W'[/NKS-(NE>+H97A&Z3[5=7
M.,8R.D-4YO@CX[AMR;?4]#OU_BS/<9X/;<@]_P J])\'ZY9Z7]IMYF"PR1[?
MO#N3W)]S6')96?\ PD4DZ8,3W!8$/G@GZ^]&HM#E$\!^-=-MU6;3[%U4 $P2
MCZ9Y857BF=&"3QM%)TVG!_D3[UU7CHRZ5I-U):S'RW5&P0& RX]J\P^ JIXH
M^'5O'JRSR6TNQU=%".#Y41'MZ_G0.YUJ3!<AOS%,:91UY_"LN6SUFSN)8(TC
MO?+YW1HS$C /8#GGTJ?P?X'\2>.KITU KI&GJ%+#RVBD<$X8?.C#H#^8IC*M
M]KMK#.D.YI)RP 15ZD^YP.X[UT/AKX6>*/$DIO'2"QT>XVR>8T^)=F#SA=W/
M'ZUU<</@SX0P;=)0WNIR?(=MQYW^T,@..Y':LG4/$WBKQBK"XGM],T63^*2'
MRP(SZLP;T]>] C<C_P"$$^&;)%?>;JNI,,E'MUEY'RMRR+WSW[52U#Q]KGB*
M3R8DCT^SZK%:LT;X&<='*^GY5R[2>&/#)VH)M4O).6DAE62'(X.2K CN1^%9
MMWXXU2ZM_(WPV\.<F.!,CCW;)]._:D(Z#5=8CTEA'<2&-F[L"SG.>XX[?I6?
MXC\=7&N6]K:Q1>7!"S$-("'.?HQ'K^E<FL:GD=_6I8XPK KUHL,NQQEF+,Q=
MCR68Y-6%C]:;;GY<GBG/>1HIV!IL'!$6&P:8%B*,=,U*H'>LJ37X8?OPSJ.Y
M* 8_6K%GK5G>2!(;B)I",^7O4OCUP#0!HJHIRKN!IJG(IRL>!0,E7&S/YTC,
M,#)QFC<<'GGTI-Q4<CF@!RL.<4F!N]S358;L=QQFGJR]: %;Y>*H2,UY<&)/
M]6AQ)GO_ )P:DOY7++#$<R.<-WP/\FK5K;BWA50.?XCZF@!T<81551A0.U31
MH&R,X%(B_-CL>M3>@' '6@!JXSC'(HXR!WI5ZG'W<]Z1NO2@!6Z<]:<O*YST
MIL>&('7%.(Y)S@#I0 G!]J<O3Y>6H0'H1@]J0'L>* &MA>G![TZ3$>.X8X%/
M7 W?2DQ\HP<O0!&S+&I)Z 9IL>([>68\HP+'Z<XITZF0(N!G.6J#4) MJ85X
M,F$ ]>0* &:*HF:XD!P&?C^?]:OEANP>".])9P"&UB1>/E&[/K@4Y^Y494<4
M 11[3GO]:5O5OPIQ^5C@<4@^;']: &]4+9R!4#,NTECCZ58;^(D\=L=:SM0D
M=E6  ;I!QZ\<T ,T^/?YESCYF) ^AP:M-\K>A[T(HCC"@?=&/RI^>IZF@!LF
M%]P:8V,]>*5EZ8Y:B3YE&.,=: &,/E(Q\M1H S%02*><=SU]*5ONC;QZYH @
M9EW;<D$'DTP,"V!DCWJ0C;G:"4'7--D 5C@#:1Q0 K+W;..U(JEE8Y^441X)
M'7/?/2GLJ\GTZ8H BX"\$BC/&<_-4BJ3PPQGH34>.N<4 *W'UI6^7'I2+C))
M%*W&.?FH 8NTJ.II=I'^[3N-O;\Z:% Z=30 BKEO:E_F*=M/;BJE[,RMY-N<
MRGOU&.?\* (KJXDN)#!!D_WF/&!_DBK5K:K;I@#%.M;9+6/RT&!G/6I<"@0A
M4X+ ].U-Q_$>E*PSG/:G#&WGN*!B+@\C@TK#;@@?-0%"C IT:KN)- "-A1G.
M0:3 48ZTY@%Q@,7/%(S;HPV,,.M !QC '!ZCUIJJ&?8"5%"X8G/>I"ORJH%
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MG\VKL-'^ZO\ UT_PKC]-_P"/P_\ 723^;5V&C_=7_KI_A0!U=G]W_@5:$?\
M6L^S^[_P*M"/^M $M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% #6J
MK-VJTU59NU '/ZA_RS_'^E<+JW_++\?Z5W6H?\L_Q_I7"ZM_RR_'^E 'J^@_
M\@/3O^O:/_T$5?JAH/\ R ]._P"O:/\ ]!%7Z "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "FN@D4JPRM.HH _,+X
MC:0?#?CC4X3P(+F:(<$<"1QW^E6%8,$E'3I_.NU_:L\/_P!D^.+R81>6)Y&F
MZ8R&FEYZ^U>?Z;-Y^EH^<D,?YT :JKQ0W<>M$?,8S22?>&.YH DVXBX]*E@X
MC'K4?\'X5+#]R@9)3H/N#ZU&V0IJ6,844")E-2(<5"N<\5** )5;FI5)QTJ!
M3U[U*K<>E #\BHFS,V%Z>M-FD_A0Y<]A4L2[%(SSCDT /M_XFZ#'2K,"]6Z[
MJJYVQJO\3'%:FEP&:ZM80NXLZKC\10!V^AVGV728BPYD ?\ ,"KK+CVJ\EIY
M5K A&-B!>GH*K3+QC% $2R&)E=3AE.0?>MWXLD-XLFN4&V.[ABN%^AC']0:Y
MZ1L"M[XAM]LTGPG?]I-.$!/J8F*G^= '$,<FFTIJ.1@J.WH#0!1OI-\P Z 8
M_6JU*S%V)]:2@8^-<M4M,3Y5ZT^@04PXW8'6E9NPZT*NWKUH ?'@$T[--6EH
M #44C=NM/W>M1,=W?F@!N?FS2;@>E(RXS3<T#$DZ&J\AJ5FSST]J@D[T"*['
M<V:*** #GUQ332^M)0!'_P MOPJ2HU_UI^E24 %"@^8!VI5ZTJJ=Y;MVH D4
M!??/6G_C2*.]#<?2@!,U&WWNN34@7%1O[#% #6Z4E*>])0 444F: (@Q;@FC
MFDY4XI,T (:0TZFF@!M- ^;FG'% 7YB>M "/]WIFH<$=14KD@<=:C+$]30 E
M)BEHI %%%%, I:.U% "_Q"G]LYI@ZYQ^%*OS<=* ''/8YK#\5,/LL*?]-%/Z
M&ML=:Y[Q4V6C0<G /_H5 '-6+?:':0CY>,?Y_"M%6&T@#YO6JEC&JKM VJ.U
M6POS']*!!M&X;CNXZK3)HDD4QNNY3UYQ4FW^Z/K4C1@*/XB>H':@#G+?2;WP
MYN&ENATU3O%@V0<]R'PS$G'3WJ*>^T_Q4IAPUA=*"?*NB%89X'&?I^==.JA@
M"Q^;M7.^)M#@NG66*/[-=9XFBRK$X&,D$9Q@<&L*M&%:/+-'IX',<1E]6-6A
M*S1RUY8WGAV\649DC1LK(J\8X[D>]=]X+^(BRQK;70)W,H#;E&./P]*XZ&]O
M["0VNKPM>:8/E^U2*/E7'). 3QQR3VS27FAI,GVW09UFC7YF6!L\]<=>.#TK
MYFM@JN%E[2CJC]LR_B7 9]16$S&T:CTN]G_E^1Z_JFE6'B:V0RJ)0!\KJY^7
M.#V/M7)ZEH6HZ';^;(W]HPAL!H$/F*#T^4#&/?/>N:\/^.;[0V,%\98^>%EZ
M' QG[M>GZ;XDTW6(5"3PL6&3&QR#P#W%=N%S!2]V>Y\KG7",Z-ZN%5X^6QQ"
MW43)OB((]-U,DF$G8YZ$]J['5O!=G?1,]GMT^<<AHP2IP.FW(7T_*N*N;'4-
M+3;J%I);CIYWWE?O_#P,"O=C.,MC\QJT*E&7+4C9E+4+R*U6-7<*2<C\QVJ"
M3Q%#$ JQ-,2!SG I+@I<3Q*V)(V/7M47]AV[3%A(^S^Z#TJ:GM/L&M#V'_+V
MYFW%UYD\DF "YW';7=Z?,+S3X)&'WT&0?U_K6=;:;9VJ@I$F_P!QDBK,VO6%
MH/WMRFX?PJ=Q_2LJ=/V3<IO<Z*]98I1A2@]#EH]3N=!U1XXY&6-)"'0\AAGT
M^E>BPE)XPP(Z;AS7EWB'4(-1U!YX%90P&=PQDCC^6*[7PK?&\T6W).65?*;V
MQQ_+%88:5IR@GIT._,J3=&G7:L]F;VX,I4#FGQ8C/S<Y]*\VN/$5_P"%=8N+
M56\ZV5\JDAXVGD8/;@UZ#9W27MG%<1MQ(BNOXC-=5.LJC<>J/,Q.#GAXQFW>
M,MF61DJ22.O2G,@ZJ./2F%EQQUIRY;MM/:MS@"1A+C P>]*K;8RH^]ZTW/K\
MOUH&%;K\M #U[;OFSUQ2?ZOD<TG'.WFE;L>O^S0 !1P>GM3F8LPP<+35QNY.
M*;D%1DXP>E #E"MST/O3&?(*_P J,'WV^M1,VUC[=Z %+*F"1N]JJ22<'/3/
M2I9)!U_2J\C#Z^U A'P.1^5-'S]:3)ZMQ3E;KD;1[T"'J JXJ&X)<K"O5_XO
M3%2/($0N?NXS3+16;?*P.2?ES_=[?SIC+2@1J% X7@5+$GX#-1D<=.:LQK\H
MR>:0$T8VX[<U)@<YH51CFFR'KS0,CFDX8#H:INWS=:DFD[ U1FDV=\YH$1SS
M$9)/X5B:I=>7'L'WWX_/-7KB;=DYK#:075ZTA.8U P<\9&#0!=4"-%3.<=ZN
MV7M68K^M:=C]T=ABF!I0^]3<+TJ"-AMXJ;MFD ] ,U<!RO3%5(QS5G=QC&/Q
MH&.S3O;IFFBEYH 5>#S3#U-.;C'/-(QSR.* ',O?\Z9UI^"5YX%,7ZT */N^
M].''7D&FGM1]* '?=.128R/04O\ #TH7D\]* '9W=.*=2*O7)I=O/'- !3E_
M*F]#2^O- "X)S2,G<=:=N'K0">] #-OMS1M^7C@T[/4^U+QQB@"+9Z]>](PV
M\@;JFPO8\TUQMH SI8^M59("WM6FT?RDD]ZA9 >HH%8Q9=/+ ]S^-3^&-3U+
MP?>MM<W.D2/NELT0!ESDDAL$GYF+=1TQ6@L8SG&137C!R,<4 =39:SH_B19(
M_P"T(;"=_NK=2(I4\\$;O:M6QT>]LI([O3M0M;EHAC]TV[.1CT/8FO,;G3(&
MWNL2JYYWH-K9^HYK-DO-4TUL6>J7]MGG:MS(1^6ZIL![;\2_VE/ASKS0:-JO
MA'5Q?*B_:;Z&<.(V4MN^3S%'+#'./O?A7/\ BC5-/^T16^D+)/ H#B4XYY.>
M S=_>O%;C21/<2SW"&>:4DO-)EBV3DYR?7FNV\->9-:PQF\C9E8DR%UW!<_=
M(SGOG/O3 ]"\"RQ7FK'[2-\<BA=@./X@.OYU/XFL8[/7I8XEQ$S_ "KD\< _
MUK$T^.6PO(KBVD ","=C@ @$'U]JN:]?7&IWGGQ'+;1T(/.T#^8I7!V9A_%+
MQ);_  \\*-J4JF>-D1S"A 8Y=%[_ .\/RK,\%^*(V\/VLL>GW,$;(LGE;=Q.
M47U_SQ7GG[0R^(M>71])BL;RYMVCD\SRT+(<%",D# ^[ZUZ;9WH\*:/;^59I
M.T,21^6\0(Z ?Q*?2JV1G;6R-:U\3:!;K(J"XM)F.YFE"@= .[^@'Y4:A>6&
MO6OV6#Q'I]L?XFEECYR",8S[TR+XI^$I+%!>^#M.FNSG>QD4<9..D>.F*M6/
MB/X::OD2>'+'3I!R&260Y[=E%&@[3[AX>\ Z;X5L[F[BUW3I+UDQ $F'RL,D
M$Y;U [5PGB3P#K7B#4YK^34(+J9V8K)''P,@#L,'H/RKT&:Q\#:IP;UK,CH5
MN;C'Z,*K3> ].F7.D>.9+9B/DC:21@/0?/+CUHT%>?8\WC\&^(+%1'+<K(!P
M-L)Z=/[M6%TR^A_UD0;_ 'MR_P#LM=7<^ _&=LQ-GXCBU53V_P!''\W/U_"H
MH_#WCR!@+GP^]W'W9'A.?P7-'S#G?5,YO]^J,3!G SA"3G]*SK'2=9UO4AYM
MVFGV3$8MQ'YCGD @Y"D=^_>O0((;J'*ZGX<NK0_WA"Y'_CJ_7\JPX[BUO=8*
M1S&S"E2C'<ISQZXJ7=#4DS0MO!.E6]NXOK:>7CYG960'KS]_Z5TGPHUJV\,W
M=]%81 0>>0D;28QA2,Y.3R,?E6=);Z@RKLU'[9&HQL*J<CTY/I_*MWP?H,MK
M9SWR:<)F,[ J%'/ _P#BO2@LMWWC"\DO/M,MTMG(<\R!,')/<@?R[5SGC_4!
M-X9N;[,=Q=1,C121OG'S!3P!@\,WYUV]U-:S!EO]!A?;U5X NWGU">M>3_%"
M[@LK=[.T!B5U1O+5S@?,?\*0>I9MY%DC5L8__74P/YU3A8*H4=*F63UYJQDX
MX;/6C<V3GIZ5#YGOS3_,]30!(,?CUJ*YNE@C+$9;HH]Z7.%)9MH]356W0ZA=
M&4\P+]T=B1CG^= BWIMF;<,[G=(XY_"KZXX!Z4U0!3\CL:!CCA>12 =<G&?4
M4;AMR1GVHW+MY_ 9H E++M7''K33AL@Y^M-VXRI_.G?Q8 )_&@!&;DC'7TI8
MU"LI;M^=!^5N.?>G@!N<\T +C<QYP/>C:NW(Z^E''<9I54L<'@>M #"-P ].
ME$:A,CKD<?6EYXX^M.4+_O?TH 9#%B1G?YMW&!VJC,WG:Q&JC*Q-G] ?Z5HR
M2+#&[=-H)YJKIL.[S;EN3(V1QVR10!=VAN3Q2,<JH7@CO3NHYX'O2'&T@_GB
M@!NU<D'GT/:HVXR.N?2GM][Y>E# +_M>] $3*J?.>BC-4;;-U=RRYPJG:OOU
M_P :LWS;;9U!^=QM4=SDXI+6!88$!&UL MZYQS0 \QH1N'![YIC89< 8(I_+
M,1]T>O\ 6D9<MC[H[F@!JX"D$9/8BF?>QNY!ZT]L*W R*9QS@<T -9=IRO([
M>M1LN[)/ /7-2M]W)'([4W[P]O0T -?(C&W@KW]JC* L5/\ WUVJ5L9P>A[U
M&WWLKDB@"(97\>.*50%;)I\BA%X^;/Z4T!2!W:@!P7<Q(.T?[5)L##(XV\$>
MM+D!><YHY;..* &;<]1FD&%8]\BGMVXP,4W:!S0 BG R>E.^AP*-HIDTBPQ,
MQ(! X'J: ([V\^RJ %+.W112V-F+:/<?FD;EC]145G"TK&:==QS\@;L/\FK]
M ";<'!/Y4E'ZT4 )_*C!W>@HI?2@ XIWWACO2 ;FQ1SN]O6@ 3"L1USZ4Q?N
MJ6.<G!7N*>5&.*;\IZ<^] "E57!'2D90V3T!I^WY<MQCH/6FKC\/2@ ;!CPO
MWP>O:C:IX;YAZBCU[#UIK?+]S)&>E "%@C%0.HP<4OE[64D]#G%$A_V>3SD=
MJ<N&7E@6_.@#GO&DT\=EB-MD4K;7]^,XS^%<_H.@I=*UU.@V?=17Z'U-=CK5
MBFIVJPLVW#!OU_PK.U:]CTJU5$09QM1.W']*Y)4U[3VD]D>I2Q$EAU0I+WFS
MAO$'ALKO>V!9 ?\ 5]Q]/6LFTP($X.Y%*G\S7:?;HM0A)0>7(#\RFL&^MU^U
M-L .Y<D =3ZUI"G%/GAL85J]24/955JCA?&@FM;OPOJJIYK:3K=K?F,<$B,E
ML=.,X'6OJW79CXE\+^%O$-RI,FH6MN\.GIS/*S+$H1 ,;CDKT'X5XM:^&XM:
M:"Q%DVH7MY((;:VCC9Y))"=JA0.<Y('XBON7X'_LYW.F^"M)UOQ5:/>:W8V:
MOI.BW:[1I[HK",8WE&8A86^=<J5&><U<XJI%Q:W%A<34P=6->F[26QX5JWPO
MN+_PQ>V.K6\NA-J$4$T"ZE&\(==^[@M@DC'..F1SS7@>APO:>']/C92)8X(U
M;(Q@A ",5^JUKX%M_%WA[[/XQTJWNY]V(PRHLD$>%(1'CP5&X'H1GITKX$^(
MW[-/Q+\"^,;NRL?"NH>)?#TLTCVNIV$2ML7>X2(Q1L[_ '$#;V_O 'G&:BE&
M*BC*O6GB*CJU'>3."@96^5N>,[JG%QY7'4'@D=ZZ8_!OX@6\?'@;6B5X):U=
M0/Q(J&Y^#_Q17F+X<ZI*O7[P7^E48'/EE#*3D[.0,8I&8R2EAPC#//TJM)]M
MT[4)].U>SFTO580#):72%67(!') SP5/'J*)9UCA+,VW8#^/I3 CO(UO)4C!
MV[0=Q/3V_D:GW%T\L XSD8YJ"QC>0.[J<2'(;T'45;7"MCE,<;NQ%(!]LJHQ
M)^;=QQ5FWA957><G.-O0T0PKP5P5S]T5?CCC:3*\^E,0L-LJE74X[[.^:T((
M_,Y/'8YIL,!*ABNTKT']ZKEK'O;D;.><T@)HXV6W(4Y(.<^G2IA"A;:XW+C.
MX=,T]=J_*>5/\0&!2?P@+SZB@8R206X8GD8YQZ5EV<+W-Q]HDX"\HI'/^>*L
MZDSR2BW0$DX+E>PZ8_E5N.-(T Z>E #)%9I P^52.<]^*[7X)J&^+'A<]&6]
M3^M<:VTXR<8[5V7P3RWQ9\,8Y'VU.?SH ^^J*** "BBB@ HHHH \/TW_ (_#
M_P!=)/YM78:/]U?^NG^%<?IO_'X?^NDG\VKL-'^ZO_73_"@#J[/[O_ JT(_Z
MUGV?W?\ @5:$?]: ):*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MY&*11G%&[OC.* )%)YYS3E;K3%QM]Z3S.N!B@!_WO>G;1BHU8A2:56Z@<^M
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MUH58AIXQS_%( :GCU2'M)&_KM8$_I4EGH/@:*.WALM8O]5OGC#.UR#M!Q\V
M8AZ?WN]=[H_A_P ),K(B""9@0/-B609XP1B,>W>I-%*^QP<5Y]H;9;6]U<R=
MUBM96_DM7H=-UR9<1^'[\YY5FMW7/YK7I4?@NXTV'.C&"0_Q2R0C=CKP=RXY
M_D*R;VS\50R-NOI8@#_RSD(Q_P"1*!G+1>&_$)7<^@WH]O)8_P!*AN--O[)2
M;G3KZ!>FY[60+^>W%=&UQXAC4[M7O!])V_\ BJ9'XB\0::WFE;?65''V?40T
MB'WY?M0!R7VB)G\L2H6_N[@#^53.PR"O'//85V=G_97BR18]5\/6^C/)\OVC
M23'$4YQG&QB<9)Z]A5/QM\*7\&6\-SI^NOJMI.Q16N+<J00,_P!_UW=NU(#C
M-6D=(8T"_-*VT>_'_P!<5>LX_)M8D/!51D$5A7:ZW!=>;<Z>KV<'S),LRC.,
M$G;DGM6EINKPZED1,"Z@;UP?E)[9[]#3&7NG+#@TTYW$8!]J5Y%[\X[4UC_'
MT/8"@! 6#$;>W2DQA>/FS^E(TW\7KP:;),88G;'W030!2ES<7@7'^I.<CUQG
M^8JVN[J5!SU]JALMK(TG5YCD^W)J?_5Y R<]<GI0 BYD7!&T4Q@S<#H.]#,5
M)4=NE.8D(,_*3Z4 13,&;*<#&.*:<KCY<4\;9.!PH[XYIC-\O/X4 )G/7KZ4
MBKALMTI5SQQUH9AW[4 1@'S,!<]P#3=S!B-FUNN*E()^?[K=L?RJ-V.X.1\Q
MX(S0 P+MSR6SV-& JD$8;M3E/4GH.?K3/-#,< <\?2@ C5FSQNS^- R5Z8/M
M1N\GA3N[FFKGE1DD=\T .;+<>G%*S!N0,"DZ9.>#3E4/\OW<<Y% #&^5<G@#
MO5)5>^NLD;8(SD'J&_R14E]*TA2!#C<?F/H/\FKEO;BWMU53G@<GO0 *N  .
MA]J3=M/'-2XZ5$P/)Z<T '(^M&*3)]:5><G\: #CGUH"D_2C=\V<49QGMZT
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M?^0'IW_7M'_Z"*OT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% 'EW[2FG_;_ (2ZE@ F*:"09_ZZ*O\ [-7P
M-8?N_%5PIZ/#G_T'_"OTE^(VD_VYX,U&Q(+>;Y? SVD4]OI7YN^4(?&2'H&@
MV\_B: -=?ENO9A4S?ZY>/K^E1G[WNIJ09,S>U $K?=J2/[HJ)ON&I$R%'TH
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MK0 U^M-SUIS?K46?E;ZT $/^K%24R/[@^G-2+R: )$&U?ZT[\3FFJ:7VSQ2
M4Y'%&[FDSQBE H #],U$?<YJ5ONFHCCM3 1J2BB@ ILGW>>E*0,<]*:S C':
M@"(44NVDH *:?TI::Q- #>-U.IO>E- $;,/7--;KR,4[(( [9[TR@ HHHH *
M***0!1113 *<*1>M&Z@ C&9-P^E8'B#_ (^CUZ ?I70+]W%<WX@8"^QT) H
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M<Q=-\0^(;6]WR6-O)9[2#N.6SVXW_2GV<,V7FN"&N)#EF!SV ')]@*T_LO8
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MM6MHC;AN ?O4V-1%$O0\8-+M9LICCK0 <-'DC)SUS4%U<FRW11_-(PQQ]/\
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M^67X_P!* /5]!_Y >G?]>T?_ *"*OU0T'_D!Z=_U[1_^@BK] !1110 4444
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M'XU(>M12=^U $#8XQ1FBB@!P(/2FN><4*::W4T %02?ZJ3Z_UJ>H'&5D^O\
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MC%,;/0]%Z4^0A, \@]#3-R;CDG.,<T -^]G-&.U.]%Q@8[4SC=M!Q0 R3+9
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MUGV?W?\ @5:$?]: ):*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M(..:S%F5EZX/O3EN@,IC=GH10!J!^#SCTJ59L+C #UF1W&W&3Q4JR@YSZ\4
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M;<*M]?)".%4$MGU&10!>TNW$-FH/WLD\^N:M;2O0Y;O3?O8&.:>B[01U..*
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M.%;*C*TF-R^_K_2D51W./PH DC8!/FY/8"E50&)'''/O3!\O %.CX?DX(YH
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M^M $J]Z&Z49%#,* &,/SIGO3C3* !JB:G\D^U# 4 5>C4C-C!ITGWJ8W/:@
MSQUI-P].!2)QG/%)_$?0T .##.*9U9AZT]5ZY_E2[1G- #8S^[7Z4^D50HXX
MHH *6DW 4FX'H:!#J*9YGS8ZT^@84M)10 4CMQ2TUONT 1-25(RC:#3%ZC(R
M* &TM+QV%)0 E-IQ_2F^N: "FD4I_*F[O0_E0 U5ZKG!I*4<'GDGWI>-OH:
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M,OVBX2V7)!/[SZ<'%6YIEAB9L@<57T^-3OF=?GD.0W?&3C],4"+T,*QJJJ,
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MU($"XIV#GFANAH A-+1C-.QMH 7HIIC?E3_QIK4 1T4O6DH **** "BE-)2
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M3W:6O3S/;]'URRUZW\^PF\^+^]L9>Y'<#T-:%?*MHOB+PA?7]AY&B:/K'AJ
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M^M)0 ?I1VI/TI-PSB@!%!#>U'/3&!ZTN.>.E)]W)/- "[>/>F9SU-+NIO3-
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MK<KQ'2[Q].FCEB.5!R0,5Z+H/BZ*ZAVR#:PP/F8#M0!U-%1QS),N58'\:DH
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MPIW^11_">:5?7TH -HSB@#=@YHS0K8XH DZTG&*:QZ9IO'- #Z1F'U&*92G
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M!+1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M<?XT"(;B3[9<"W!ROWFY],\?RK1C7:H"C ]*S]-M_+7S&Y>3YL^F<&M)?NT
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M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH :U59NU6FJK-VH
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MXSZ4 3/\IQG-)NPW4U"9!V.2.32B0'!'XT 2LWX#O3-V:3<#QZ]J8\B@#TH
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M QSG(H 3!.!3ATHQQ0WM0(#]X4UB<^E+N'X4@YX[4#$QGO1MIX7C%1L2..U
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MZ]H__015^J&@_P#(#T[_ *]H_P#T$5?H **** "BBB@ HHHH **** "BBB@
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MN^@";S3[4>8?I4.\"D\T9Q0!,TA;K56_Q):R ],'^52>8,5#=2;H7[_*?Y4
M<QI<@:W&#T_Q-7ZR]'^6-@>/_P!9K2'Z4Q#ACO\ I2CCWI*6@!>.*7@].E)3
MOPI 2*J[<]&J2-MRD$?2H4/S5,C#D9XH AO,(JOZ=<5.WS(#^-).NZ$\5'#)
MNC4]\4#"0#MTJ&0[O>IRN0<]:@]>U BO<*!L?^Z?YD5:B8%5/:J\R[HF^F:D
MM6W0KZCC]* +BL5-6%;<,BJBCO4\;?-D\'% R88)-+CL./K3-Q/!Y(IP/6@
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M3@^E<]XFN@L*LWRR8]?<5QN/LW>)]'&I]<BH5M;]>IBZQ =-9KBP 6Y_NO\
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M0!%<R'( Y'<U1FD7#9X"C@BGS3XRO?UK(U.Z\NW; ^]E1^5!0FFR&6664]7
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MLOQ_I0!ZOH/_ " ]._Z]H_\ T$5?JAH/_(#T[_KVC_\ 015^@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@#BOC-IG]K?"WQ+ (_,<6;2J,9.4P_\ [+7Y[:XK6]] 2I! 96[<
MC_\ 77Z9:M8KJFDWMD_"7$#PGC/#*1_6OSL^+FB'0?%NL6G\,-[.$/'W?-*C
MITZ4 <Q)AK[9[$X_$U9MR);C>V#CI^E5X@7OE<#/[OO]:L6T15"3P!S0(T;?
M#,6Q^-78V:-MRG!JA8Y6%<]3_C5U>PH&:-O? X$@Y]:NQW4?4L!6/& :EZ4
M:7]I 'Y4S[YI/M4K_P 9 ]JIJ,_6K*?*?6@"0C'/4T[<$ +'FF2-Y87C<S'
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M[:Q9FDNI-SY\GMGOZ5:O)3=-@'"+P3ZU7G;:H"\CH!045Y6"C:.OI55E+.5
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M78:/]U?^NG^%<?IO_'X?^NDG\VKL-'^ZO_73_"@#J[/[O_ JT(_ZUGV?W?\
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M9X@ZE28^#R/I7DNH^%/$-OJ$\NG7$-S TA*1W,SDL"> 1P.]=+)KLUX06(4
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M6N7A\87D+?O8/RC/^-:EEXZB./,)CX_B"C^M=$,VI/<\K$< XR"O#5>3-?\
MX1S7(5PJ6<JC^XQS^N*BELM0M8\W%BR^ZNA_]FJ2W\7Q.,"XBZ]"R_XU?C\3
M#C;*C?3!_K7=''4Y;,^9K\*XVCNCFY-6MHW*2;HR#R&&?Y9J:"XANE)B??\
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M45]5&*BK(_!:M6=:;J3=VQ%41KFJ]G"UQ<&=N5Y"@_Y]Z;<,]U-Y,9^0??\
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M^67X_P!* /5]!_Y >G?]>T?_ *"*OU0T'_D!Z=_U[1_^@BK] !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !61XLT7_A(?#]UI^0/.V=<]G#=OI6O10!^7T,;6VH7,+ A[>5X#
MQ_=.*MR)YGS'LV/TKI/BQX7D\+_$O5[58C#%-)-)&,8#9F?D<^BG\JYJWD$M
MCY@YR_\ 2@1J1_/,0>BBI(SM;CG<:9$H56;NW%20K\Q..!042-]Y%]>:LQL$
MR2,U7C^>1F_N\"IE0R-C^'O0(GA3YBY[U:C0R8_NBH8UWN,?<JY&NU>E $JJ
M?K4R*1C-,5?FSG%3CCDT .!VXXY["I88SZTR-<\XY[58CZ].U "JN*<JXXQQ
M2K]*>*!$;)FH]FVIS36'M0,CKMOBHHNI/#>HKR+S1[<N?]M<JW\A7$_=:NV\
M48OOAEX0NQR]M)=6<C?\##*/RS0!P;#%5N>!5IJ@93N/I0!&W<4@]*6DH 2B
MC-% "KR/3FBE6B@!M-VT_P#"DH A*]143+MXJPPJ)P3VH @8;EJ$U8-0NO)X
MH @DJ&K#^_2H&XH 8:8>M.;%,H 0CYO2F-U-/8Y)K'DOIK:^>.XR(&8!)>WZ
M?4#F@#28U#)SR!R*?YBLHP=PQP1330!&K!QD4%@M02MY;':<)[=JAE,C8V,<
M]S0!.UPN6R=N>Q--9_NXY!JM]G+<NV]OI2-&Z\ACQT% %@L>M(T@W#G%5_,;
M'*FD\P$\<F@":1\9 J$M3FX&3SFFJIVY(P#0 AZ4WO4FWWII4_6@0WO2_>[T
MM'X4 -.32[>*!GGC-+0,;_#33\I#=1WJ2D/4#% AQ;(%)QVI@^4X/3M3Z %X
MVFG4W!IU PI5Z]*!VI: &T4XC-&/EH Y:^^6^QZC'\J 3M4=LT[65\K4(>,9
M./\ T&G/LVKC[V>?SIB!6*YS4JO408<TN[N*0%E6R!3UE.>:J"3MFGAS0!;6
M3D4\2 \5360Y]J<LE BUY@I=U5A(>QXIPD/K0!+-^\7W'-*LPD4']*A,G/'%
M1AO+DX^Z:!EO?VHW5!N)I0_K023;J7?MQ4&\T>9F@98\SFEWU5\P^M+YASZ"
M@99\S&*;NY/O47F<>](S%L$<4"'M)D9[U3N9R&,:C+8Z^E.FFVC:GS/Z"HE0
MJ,D[F[L: (O+6)>.O<U5N',N4'TW=JGF8R85.>>2.U5WSGRUY/0MZ4%$.TL/
M+0XQU-21QC:,#&.*>L87''/<U*HVX.W/MFF SRRWR]?6M"WM^U0PQE<9')-:
M,*@+G% AS?)&3WQ2PKB)2>_-1W'\"],M4Z_*H&>@%( ;Z5&^0I-2;N?45%,V
M%Q3 K3?G@5E0_-<.^,X Z?Y]JT;AMJ$YZ"J-K@1;L9+4 .DCW,&/%-\O;4N0
M>3S_ $I/OGCGTH&1[2W^-+@JV.M/7 X-)D^GXTP(0O)&<&H]XP2/RJ60[6P!
MSC@U&R[N0N/6D!%M\QNF ?QI)!E=HZ5+C:IP.:9R>,8'>D SRQMR3G%=3\,_
M$D'@GX@>'M;NHFGMK&]CFF6,9;8&&X@>H&2/?%<QW..!].*DV,OTZ[J /U4L
M?&F@ZEX?CUVWUFR?1W7>+XSJL0&,G<Q(VD=P<$8YK\]/VBO&VG?$3XL:MJ^E
M-OTW$=O!,5QYP1 I?'H2#CVQTZ5I^,E.E_L[_#VW[:GJ&HWY'^XR1 G\,UY2
MJ_(2PSZ9I@1>3RO/OFIO)W+TR?6GK&S*!CZ<5*D9Z-E: (HX/)<;1DL*B2S(
M9D#?-USBKN'ZA?FZ \<4XQX/'7'7O0!FK;^7DCCV-126Y8\# /6M26W+8(''
M>H)HPL;;3N?MVQ0(RY(R49!T!Y-9TR;HR5.0IQBM.XW,P4?(#U/J:H\M(=JX
M X(QP?>D,SGMFEQD[A4$VF>7'\H+2,<# /'O6REH;="TG/HOJ?PJY:VG&]TW
M,W;TH YR/PT;< N?G;C.#5RUT5X9!\X(..<$8KI8[8LF9(PY'0&IH[/S%VB,
M ]N* ,E+%\?WB.^*/L;0L-H)<CH!6[':>7]\%:ADA?DA/F!QN]J!&.L)\S9G
M!ID,$5]$Z3+E0/NDD9ZUK26RIM 7+'^+J:IV=LS32J!]W&<=J!F-=>$+<,LM
MBWV*7.=^#)S]"?K^=+'=:YIB^7]HBOH1UW 1'T[*?;O72-;LL3=R!Q69=0NQ
M QL7O[FERC3,L?$"*%L7&DW<"CJ\8WC]<5KVNO:5JT2&.^M]QYV/*H;IZ GU
MKF[[#,RF,%0<'<,@\U@W&FPQQL4C%LW4/"=A^GRXJ.7L-2/3;G0VG!=5++_>
M4$@_C6=)X;ED8-OVGT*FN7TW4M;CCC:QUJ?RQUBD'F@G//WR?:NS\.^-KZ$M
M_:^A+=K@8E61%(YZ[43GC^5*S'=$,?AN^C92'RO^X?\ "M.W\/ZA(I Y/8[#
M_A79Z7XF\-7T,/GDV+L/NR6TIQ[9VBM5=:\)PL,ZS#&.X,3BC4-#@8_!6H22
M#=(HX_NG_"M6P\)FQ^0MYTI/\*D#M[UTE]XY\.6$+-9M/J\_18H;2<<9Y.0A
M%<=J7B#Q%KDBBTMFT"!QC< DKGJ#U4,/_K>].S8:(BUS5++P@R/.3J=Z[;8[
M6U(+J<9#,,Y"_=YP>HXKAKK39=8UN36;WB21M\$&#F $8P3QN.,=1QBNM/AM
M/,\]E>:X'WIIW:1\?5B2.@_(4V330J,3RXZ U:5B+G)7D;-&Z8)5>^*I"S+1
MDJ>!P5Q75_V:6DVO'M0]>.M']FQACMC 5>#QP:8'&_8S+>11M\Z@9P/H:U8M
M+<Y)X'3H:T--TAO.EG9?EW,%;V[5KBQVJNU-Z^@[T 84UB[*C/P.W%5;BP9<
M'=G/0XZ5U8LF*$R)P/X3VJK<68D4JJCGIQ0(XVZT\39#+O(^M9\_A^"0AGB+
MD],%O\:[.33PK#<N./SJE?V_V:W=POS _+^= '!V^BH;R1U7"#Y1G/L:EFT&
M.X+;A@]CS76VND".W4-'\Q//'-/_ ++9ND0XZ]*!G)V6BW5L1]GN?LX]X]W?
MWK0L[[7X9)%@U;;Y9 .;9.?TKHH].'S#'(Y%,L-++W4X*<%AVZ]:!>1!9^)/
M$D*-NO([D9XW(J8_)#6Q%XVU-5!DLXY/99N?_1=.CTCJ!'TZC'!I[:*5Q\O'
M8^GZT *?B#=1KDZ4''4_OR/_ &2JEY\:+?3^;C0M5"YQNMXA(/U(IUQIA ^[
M\OTK,N-+\S<)(]RX^ZPR*5D6I-=35L_C)X=OMIE-S8ENHO!''CZ_/6E#XX\)
MW[KCQ'I*'NDE]$&_+=7#R^&;&;/F:;;2$_WX5/\ ,5EW'@G2#?Q?\2FTC.#G
M9"JYZ^E92HTY[H[:.88J@_W=1KYGL=N=/O!FVU.SESS^[F5OY&KC>'6E' #C
M\0*\KM?#<$1'E-=6XQ_RQNY8\?DXJY%IWB&WDS:>*=0MTQPLK//_ .AN:Y98
M&A/>)[E'B;,Z.L:GY';W7A&.1B3 R'VW'^M9<O@V526AG"'W0G^M8JZMXTT]
M0#K#:D <G=;PIGVY!_R:O6OQ$UFW;%]X?,J_\]$N$_DJ>G\JX*F447\)]1A?
M$#,J*M4?,OE^HZ33=8L5)2Y5PO;9_P#8U%_PD6JV/RR6TDO^TJ__ &-:J?$+
M2)E_TVWFL2WWMT$K!?\ @6S'I3E\0>%[P?+JUFK'HLK;/T8BN66558?PYGT%
M'CS!5M,9AT_1%*V^(**VV6WEC..^*WK#QM!(HVR*!Z%E]:H-H>EZD?\ 1)K*
M\R,_N60G]#_G-4[KP2Z\Q6SQ?]<V)_0&N9T\=0=]SW88OA?-(VNHM]VOU9VB
M>)(KE61QO5ASAA5&;1=-U%S+!_HMP>=S$MR?;=_G-</)INJZ>PV3S$_W6&T_
MJ:EAUS4K)OW\,NP=6'_UA5PS.K3=JB9R8G@G 8N'-A)I]M?T9OWWA6\CDC<2
MI=HK%L(IW8R.P']:15\G*NK1$=I!BHM*\;*)5#W !R/D<_XBNIM=0TK5(\S+
M!N]2.3QGKBO:H9A2J]=3\TS3A+'9>V^1M?,Q(T8?,/RJU%,5'S+BM>Y\-Q3Q
ME[.[\ENW\8Q^+5F3:=J-J2L]E))&!DS1#?G\%SC']*])24MCXJI1G3=I(<ET
M&; [5:CN>/7UK'CDCD9EAD!<#)4'D?45+'))'@,#5F)L*ZLI.[%>>>+_ (;Z
MGK$C7-MJLE\1R+>\;&/92./T'UKLUN1SST]ZL)<'^]652E&JK2/0P>.K8"I[
M6BU?S5_Z^1YMH/P5FN,2:O>"!>\%O\S?BQX'Y&O1-$\)Z/X<16L+)(Y<8\YO
MFD_[Z//X#BKD=R-HYY[U(LX8')Z>]13P].GLCIQF;8S'756?N]EHO^#\[DK<
M8.<GK4<DF,]S437'H>M5Y+CKDX]:Z#QR5YMAR*I3S8.WH:9/=;>AR>U9\]R>
MN[<?K0+<EFN-K=>:HSW ( QQ4,T[-WQCWJLTG8GCM0,DDD^5@HS5?<,$G@>]
M'F$9R<#UJA<R/=S"&!R$'WV7U]/T_6@!8V;4+@.P(MTS\IZL?7]:U(X][$XP
M/2H8H1&H"@*N.U7;<84#.?6@"Q#'D@D<5=BCY7G/-10J2O*XQ5VW3C&/QH$2
MQKT!YJ9%QS^E-53P*FC4]A0 )'O;'0U.D94^]/2,* V,']:>!^- QH4TG/(S
MTIYZ>M)STQB@!@&:3-..><4S:<@]* %&?3BBDSZ'/XT*2QR>!B@!<]QS1DTQ
M6/ I=V#SSZB@!X;H31NR.346X<\9';FDW$\=J )&DRQQ_.F8'>F\"FEORH$/
M9NW:HVE'I3'D_*H9),=Z ',_S?6H9)MN<]J8TASUK%UZTNM2C,<5RD47\28.
M6^I]*F4FE=*YI2@IR2D[+N3MXBTYF(^V1 CCEL4UM6M)P0EQ"X]I%-<==>$[
MU<D20N/9B/Z5S-Y&T,[0M@.K%#@]^E<+Q%2/Q1/>AE^&K?PJIZ1=6]I,IWVT
M+^I9%.?TKRBUF1M:MF(VIYX; XXW9KT+5M22SLY@'RZQG8@/)P*XKP_X<E,R
MWM_E-O,<!]^YK2M3<YQ21C@L0J-&JYO?1?B=+<3R:B",&.+W'7_.:BBABLXS
M%"@1-Q; [DG)-2LVT%1POH*C"[N378>)=VL-5>N3DFK7AOPY<?$"^GL+*=8;
M.%5:[NG7=')&>#&A'5B"W<?=//I'HOA[5/&EY!%I:O'I?F+]HU- "F,@.BDD
M9(# Y4YX(]:]KL]-TKPGI[0Z99PV$&,E8QRW4_,W4\D]>F:RJ5(TX\TCLP>$
MJXRJJ5)7;$A^R>$_#=IIL/\ Q[64"Q+\V,X R>2>I]^]<#KNM2Z]=>1 "L:Y
M&3@]\]A[4[Q-KTNH74EK!(SL[;=BG/IQTK7\(>%_(@>XOXP@)!W2\8!'U]37
MR=2I4S"M[.'PG]!X+!X+A'+OK>)M[5[=]?(LZ5;VWA[33?7\JP6L0 9W.T9.
M .20.I]:YRW9_&&N'Q+<V\EFK1"WM[.=2)(D5@<L>.KASWX8<]A#>ZW-X_UL
MP10,OA&%2 2,1WDBD[7&0K%2K*P/*_*.IZ="BJB@* H] *^HP]".'ARQ/PG-
MLTJYMB'7J/T%VU5NY@H$2\R2?*/:IIYA!&68_3W-06=OYLAN).6)R@/;K_\
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M* &M56;M5IJJS=J .?U#_EG^/]*X75O^67X_TKNM0_Y9_C_2N%U;_EE^/]*
M/5]!_P"0'IW_ %[1_P#H(J_5#0?^0'IW_7M'_P"@BK] !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110!\C?MF>'5T>\L/$4"X&8XGZ %F,Y/3GN*^?K/"631]@20?PK[H_
M:3\)CQ?\*-0M1_K8IH)DP!U$@7O[,:^!- N&_LU$D.9%8QG//4YS^M CJV8+
M&*FC^6$L/3-5Q\RK5AOE5$_O4#)(1MCSW/-6(02I XSR34'\:1CO5R-=JXH
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M^W+&FQZ^[,5GMQ$!S][/]* .@]33&/O69;ZM;2G E(;L,'_"KRMYJC:=WO0
M;CNV]1[T]H57KP/44FU^!M_6DX9MI' []Z $CC9SNSQV!IV\]6'RCTI))HTX
M #-Z8IIC#9=SQZ <4 ,%PDDA45,O:F!3,IPH2/L1U-*BK'P* !EI!UJ3!/!%
M!6@!GX4F,T_:?6C;A1SF@!NW@4FW/>G%MH)/ '>H_.WMA!NH <4# Y.*11\V
MPGGK2M;LW)D/T%#LD:X)YZT /"XXIPP"!U)ZU76X9C@+D]N:M*3M&1CUYZ4
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MBO/-95XP9F8_A0(K21YY/ ["OIOP1^Q.^M>&8;S7]<FTR^NXUE%I:P!O(SR
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MM%(*8"UW7P+_ .2O>$_^OY/ZUPM=U\"_^2O>$_\ K^3^M 'Z'4444AA1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MCZL/\:L+=(WW986^C4#))%+#! -,QY8)?(7UI9)F5?E =O\ 9YI K2#,JGZ
M=* $\SS#B/YC2K&Y;)/MP:</W?W5(%,\]7^55.>G- #\!<Y-&[<,(*78G][)
M]SQ3_,PHY!H YCQQ'FQMCW$F/S'_ -:L>U;=!'GJ% KI?&$:R:0S+R8R6Z_[
M)KD[%_W()X8J#0!=!I0>*C5CS2EN*=P)-U&ZFCI@4S<&'TI@/D8[31')\J]\
M]:B9\KBD#_=^N*0%S<:7=V[U#NYQD8I0V>*8%C?[?I2QMUY[5 #3PU B?=\O
MM2ANF>:@YHR:5AEDD4W<.:@W4G>@"8R5%-<+&HIDDPCSG\*@3=)\S_@*!$\0
MW,';OT%.>4] ?K4&_P#^O2^8%7)Y]!ZT#)%8JXP,MC@5+&"K<\MW-5XQM;<>
M6J:,_-SB@"5L=  /7BF&3^$'D\"G/(%'J>U(L?\ %_$>32$31C:H'>I%;-1K
MCC/-/S0 %L2#TQ4PD*QFJK?Z]?3%.FD*PG\J +-A_J1_GN:L;A52V8QQ@5(S
M<@YZTQ#I&S[U6D85(Q^8=JK,PR<^M(938AKMV]!@?I3MWRC/ZU##\RM)W)I6
M8L.::&/W<G%*K9QCKZ4Q6Q]:=N&>>:8#LC:<TI(/(.!3-VTG%-.>] #]P/4<
M5'MQGBES^5'44 (,*0>]*>Y_2E&<8Z TZ,#.7R0/2@ *Y7& 'K:\$::=8\8:
M#8!<F[OX+<#U+R*N/UK(VY;GI7I'[/NDC5OC-X2B"EBMZL^/^N:F3/\ XY0
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M:3;\N:  '!J93^%0<U-V]Z )/O#':A4 'I[TE'.W!H .?7-(6*]N*<.E-9J
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MX/(]C5B?//RY]C63-&5?!&!]*8(]4B_:%EUY$M_'OAC2?&T0 4WDD0M;X #
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M^QI#<IC.[]#713>&[)U8A7A8_P!W:!^@K-E\,MYG[IDE]V//\J ,\*6^9O\
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MII\;>7M(&XCLW2@81Y:3A0Q]ZD\Y=V]@-J\!?4TV1MS9 QW('2EXX9@/H!0
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M<6V3!(^M.[=* &+CT(HW$Y'8>E2'/*8SZTT+P1G% #?\FD(_*E^Z*3;N]A0
M4UF-#-N4#H/6FLORCG- "=N:1CMYIQ]*C8#KU&>: &RR!4+$C;5+38S-(;E^
M&R0O;C_)J/4-UQ<) GRC!)[C_/%:,4?E8'<"@1(W:E SFD'S=JD7*^^?2@8J
M\=.37=? W/\ PM[PKW_TY/ZUPVWO7<_ W_DKOA7_ *_D_K0!^A5%%% PHHHH
M **** /#]-_X_#_UTD_FU=AH_P!U?^NG^%<?IO\ Q^'_ *Z2?S:NPT?[J_\
M73_"@#J[/[O_  *M"/\ K6?9_=_X%6A'_6@"6BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@!K55F[5::JLW:@#G]0_Y9_C_2N%U;_EE^/]*[K4/^6?
MX_TKA=6_Y9?C_2@#U?0?^0'IW_7M'_Z"*OU0T'_D!Z=_U[1_^@BK] !1110
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MG,O0_P"13<]<]: &[CU[4Y3G)IE.7[HH =FEIM+0 OZT4F:5:0"T?C12 Y%
M#_2D_"D5L9XS2]: $HI:0T #4QL?45)VIK4P*LB]\5"R]>^:N.NX569>OZ4
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MIRS%6!/X<T@+L;E6PYVCO4RW#!@5X8="*H^:&/+9&.IJ5)-V"#CMZT 6RP4
MGKZ]:=S)\R]/:J^XMD#D@YZU(LH7@-C/&*!%F&0*K<_/V/I3U9I& !VANO/W
MCZU5##=U^HZ5*K<'.1Z>U RRL@\PX PO!7U]Z<H=>2Q7T:H.=V0!@]2,'-3+
M)OCPO,@_AZT 3K(PVX)?UYZ\U!+"54S1C#K]Y?4>GZ4Y) .%Y_V@:G7&,,0<
M_K0,CM[H7,83I+CA3P14HS&P#-M]:K7$&W,L?R2KRNWBDCNO. $IVOC!W=Z
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MS#Z40P*&&!@5H118P#UZX[4"$AAS&6SPHZ4Y=NWK@5(W<XVK[4S=P<CJ/E-
MQ&8*N5Y;M51V"_,.OI3Y&_[Z%1\;L]\4 ),=N%/(J%I .<_6AL\#.6S]VF38
MVY"X(Y- AES,+>W>3JN,XK,LX_[0N/.F)49(5>O'7^M,FE^W7PC4GRHV^;MG
M_)%:#;8XPJC![8H 9(Y5\$\KQ36"Y.#D4-C<0/F'O3BR^9G''88H$*J[OO9&
M!FIH_G4D=1U%,C 95&<D'-6..><#^= #5Q@G<13TP>0.?6D5BV 5&.QI>@([
MT#%^Z<]#1)E<-U5J>H7[QY&*8P^;/5C_  T '"X.XGVI_1>G#=:0XV8QA@<F
ME# KD' H&*@RP3[N:1C\VT_>'&:55XPH^8T#Y6./G"]<T (JKT)S3F(;J,8]
M*=\JR!BORD<4BMO&,XP<XH$"L6C.,<=>*9PRD[B,=O6GNRMDJ<+[=Z:I^4Y7
MJ.,T#&K\S9 YJ)CW[TYB%X/6F;OFR3Q0(1SM R<TW(7J:5N%QU;TII;<I!49
M7DTQ X^7I\IZFL^W N+\MGB,[1^M374RK"VTD;ABGZ?;^7;GLS'=^E("<D;L
M&I%&]MO5NU-XZC\:DP-V1TH&)W],5,BGG!R!47OGCTJ55(SSM7^?M0,..O<U
MV_P-.?B]X5&,8OD_K7#X^4G: #T/>NV^!O'Q=\*>OVY,_K0(_0NBBB@84444
M %%%% 'A^F_\?A_ZZ2?S:NPT?[J_]=/\*X_3?^/P_P#723^;5V&C_=7_ *Z?
MX4 =79_=_P"!5H1_UK/L_N_\"K0C_K0!+1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 UJJS=JM-56;M0!S^H?\L_Q_I7"ZM_RR_'^E=UJ'_+/\?Z5
MPNK?\LOQ_I0!ZOH/_(#T[_KVC_\ 015^J&@_\@/3O^O:/_T$5?H **** "BB
MB@ HHHH **** "BBFL>U "YIN_W%-9L U"TG7B@";S/<4GF#U%5FEP.GZU$U
MQC^']: +OF_2CS?I5#[7_L_K1]K_ -G]: +_ )OTH\WZ50^U_P"S^M'VO_9_
M6@"_YOTH\WZ50^U_[/ZT?:_]G]: +_F_2CS?I5#[7_L_K1]K_P!G]: +_F_2
MCS?I5#[7_L_K1]K_ -G]: +_ )OTH\WZ50^U_P"S^M'VO_9_6@"_YOTH\WZ5
M0^U_[/ZT?:_]G]: +_F_2CS?I5#[7_L_K1]K_P!G]: +_F_2CS?I5#[7_L_K
M1]K_ -G]: +_ )OTH\WZ50^U_P"S^M'VO_9_6@"_YOTH\WZ50^U_[/ZT?:_]
MG]: +_F_2CS?I5#[7_L_K1]K_P!G]: +_F_2JNJ6-OK%C+:7*[X95*L Q!P0
M0?T)J+[7_L_K1]K_ -G]: /C+XL?">;X8:G')9Q2OIDK;58;I A"J=VXJ.!E
M\Y)[5RMG="9%W,"^.OK[C\*^Y?$6EVWB32IK&ZCRCJVUMQ^5BI ;@C.,GBOD
M+XL?#N^\ ZG>7&UIM-,IDBD6-@$!*DG)!!Y?GGC!H YZ5OD."!4BS=!Q61:Z
MDEY$,;22!SN'-3_:<[!C!]?PH T_-^E,FFPHYZG'%5%N.<;<CUS3;BXRJD#O
MZT 7UDPJ@]*F67 &,5F_:/W8)7MZU(MQE00.M &AYI]10LWKBJ2W'J*=YWM^
MM %Q9,^F:[_PZYU#X0^*K?.?L-Y:W@7_ 'R8R?Y5YIY_M7H'PGF%]9>,]+/'
MVC1)ID7KNDB*LH_G0!Q_F<^U-DD. ,CFJJW1R!C]:1KC,@ROZT 6I'^7\:"U
M59)LKDCOZT-/[?K0(M;_ $(I-_S'FJWG=\4U9^>GZTP+N_W%&_W%5?.]J/.]
MJ+#)YI/W9IPDS5.6;]V>*<)N.E("WO\ <4>9[U5\[VH\[VIV M;_ '%&_P!Q
M57SO:D\[V_6BPKEO?[BCS!ZBJ?G'L*/.]OUH M%\YR143-RP[5"TW<CCTJ-Y
MN.!C\:0$K,,\4FZJ_G>U(TW;% R5F]"*C9O<5&UP!U6HVF!Z"@1+NQGFHI#W
MJ-I/;]::9<\8_6@8YF%1=_2FM)STIC2>@Q0 ]FJ)L%L\4C2G/2F&3V_6@8C=
M<4QB*<TG^S43>H'ZT!81N&XYIC=<9%.\SYL;?UI-_M0%AOO1N %+NZ_+UZ\T
MFX*>E A,CVYI<>_-&X?W?UH/7..* $X]J,?A1UXQ0* "EX[TN[Y1\N/QI<9P
M< ?C0 G X[4;<]JD*\'BE6,GO^E $7E THC Z"K'DYZ<4>6W8T 0,H[T;5&:
MF*'\:3:?7F@"':.>#1M"_6I&R,X-)CC)89H 9M%&T4\@#^*@]OF% $>P4;!4
MNW_:%(5S_$#0!$8P>](8AVJ7;VS2[2/XA0!%M]?TI-I]:DYQG(I-W.,T ,*\
M<FF;>W-3;O\ : I/^!4 1 ]A1Z@]:><_WQ2#(SE@: (UP*.*?M''S 4A7K\P
MH ;]*3<*7:1_$*8V!U(H =NYSTH7 [TW?[BC</6@"3<.E#-46X>HH\SK\PH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_P!,_P#Q[_ZU<1_:G_3+_P >_P#K4?VI_P!,O_'O_K4 =O\ VE_TS_\ 'O\
MZU']I?\ 3/\ \>_^M7$?VI_TR_\ 'O\ ZU']J?\ 3+_Q[_ZU ';_ -I?],__
M ![_ .M1_:7_ $S_ /'O_K5Q']J?],O_ ![_ .M1_:G_ $R_\>_^M0!V_P#:
M7_3/_P >_P#K4?VE_P!,_P#Q[_ZU<1_:G_3+_P >_P#K4?VI_P!,O_'O_K4
M=O\ VE_TS_\ 'O\ ZU']I?\ 3/\ \>_^M7$?VI_TR_\ 'O\ ZU']J?\ 3+_Q
M[_ZU ';_ -I?],__ ![_ .M1_:7_ $S_ /'O_K5Q']J?],O_ ![_ .M1_:G_
M $R_\>_^M0!V_P#:7_3/_P >_P#K4?VE_P!,_P#Q[_ZU<1_:G_3+_P >_P#K
M4?VI_P!,O_'O_K4 =O\ VE_TS_\ 'O\ ZU']I?\ 3/\ \>_^M7$?VI_TR_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% #6JK-VJTU59NU '/ZA_RS_'
M^E<+JW_++\?Z5W6H?\L_Q_I7"ZM_RR_'^E 'J^@_\@/3O^O:/_T$5?JAH/\
MR ]._P"O:/\ ]!%7Z "BBB@ HHHH **** "BBB@!C=ZJW#8#59;O52Z/RL?I
M0!D:C(-LGX?TK)L9E_MRW&#GS%_I5[5&^27KV_I6'ILF?$5J,G_6I_2F(]*H
MHHI#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M_ F#_P",T?\ ##O@3_H+>(O_  )@_P#C-?0]% 'SQ_PP[X$_Z"WB+_P)@_\
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M /&*^CO,%'F"@#YR;]A'P"PQ_:_B3_P)M_\ XQ2?\,'^ ?\ H+^)/_ FW_\
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M .E-0?\ #SSX7;@/[ \89/3_ $.U_P#DFCEEV#ZQ2_F.B_X=^?#W_H.>*?\
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M9/\ A'_%VT=?]#M?_DFJ47_!4/X5S,RCP_XP!7ULK3_Y)HY)=@^L4?YCK_\
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M=O\ _&*<G[!_@*/IK/B7_P "K?\ ^,5E6O\ P44^&]U 95T7Q2JC^]:VP_\
M;BJ<G_!2;X:Q_>\/^+L>OV.UQ_Z4T<DNP_K%'^8Z!/V#? 4>,:UXF_\  JW_
M /C%.;]A'P$QS_;/B8?2ZM__ (Q7++_P4R^&!;']@>+Q[FSM?_DFIO\ AY1\
M,S&SC0/%Q"C/_'G:_P#R31R2[!]8H_S'0_\ #!W@(XSK7B;_ ,"K?_XQ2G]@
M_P !&/9_;7B;&<_\?=O_ /&*XF7_ (*D_"N&41MX=\99)QQ96F/_ $JJ_'_P
M4R^%\K!5T+Q:3C/_ !YVO_R31R2[!]8I?S'3C]@_P$N?^)UXF/UNK?\ ^,4W
M_A@SP#_T&O$W_@7;_P#QBN=/_!2OX9+G.@^+AC_ISM?_ ))K,NO^"IGPILW*
MOX?\8D_[-E:?_)-')+L/V]+^8[4?L%^ 1TUGQ-_X%6__ ,8H/[!G@$MN_MKQ
M-G_K[M__ (Q7$0?\%4/A/<*670/&0 _O65I_\DU*O_!4;X4N^T:!XPS_ ->5
MK_\ )-/DEV#V]+^8[3_A@_P#C']L^)?_  *M_P#XQ43?L#^ '?<VM^*&']TW
M=N1_Z(KE'_X*@?"R-=QT#QACU^QVO_R35=?^"IWPF?.-"\8<?].=I_\ )-'L
MY]@]O2_F.^A_89\"0_=UCQ)TQ_Q]0?\ QBO _P!HSX0Z+\&?$6C6&BW=_<QW
M=JT\C7\B.P(8C V(O'%??FFWT>JZ;:7L(98KF))D#@!@K*",X[\U\<?MTD_\
M)UX8 X_XE[_^C#4'0?/D,@81X.#WJ_"0ZY;G;6;:,5"?-SSCTK1M]P^]S]*0
M$Y_>( #@"G[@OS* 5QCD4FXCE>?8TA#.N3\N* &M\K97E??K3<!6]34C*Q;@
M@D#DTS(..X[T"&L2S9-=S\##_P 7<\* _P#/\G-<,>">._%=S\#<GXO>%#_T
M_)_6@9^A5%%% !1110 4444 >'Z;_P ?A_ZZ2?S:NPT?[J_]=/\ "N/TW_C\
M/_723^;5V&C_ '5_ZZ?X4 =79_=_X%6A'_6L^S^[_P "K0C_ *T 2T444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 -:JLW:K355F[4 <_J'_+/\?Z5P
MNK?\LOQ_I7=:A_RS_'^E<+JW_++\?Z4 >KZ#_P @/3O^O:/_ -!%7ZH:#_R
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M..:Z5-//!9_J * ((\M(H'7-:M1QPI%]U<'U[U)04?GW^V]C_A>77G^RK?\
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M/]N[_D>?"_/_ ##W_P#1AKZ]\'@KX3T0'J+&#_T6M?('[=S?\5[X77L=.?\
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MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** &M56;M5IJJS=J
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M01E6[8X%>Q+I<<L3QW"K,CJ5:-AE6!Z@CO61\1/ ME\1/"MWHUYB,R -#<!
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MJ9%$JL5+)QGM^%,1NZV!<1NNWY"<C)K 6S2WR\:%BQ (7FM61]T95CD8Q_\
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M+>7EOI]M)<74\=M;QC<\LSA$4>I)X%>1>(OVE]&@U*72_"FE7WC;4XR%8::
M+93Z-,<@?4 CWKRSX1ZQH7[0=\VC_$";5;WQ)9@21VM_>;+>88.YHD@6-,C
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH \[_:&Y^"_BO\ Z]/_ &=:^ K%1M7_ ':^_?VA?^2+
M^*_^O3_V=:^ K'.U?7;_ (4 :5CE)"A_NY'YBK<P^0_0?TJO'PH<=0/TJU(P
M:,X]!_2F!DW@/S_A7U]^QG_R2_5/^PQ+_P"B(*^1+S&'_"OKS]C7_DF&J?\
M88E_]$04@/=V^Z:CW5))]PU#0 NX4N13:*=Q#J*;1DT7%8=13<FC<:=PL.HI
M-PHW"@+"T49%%,04444#N%%%%(84444!<**** N%%%% PHHHH%<****8@HHH
MH$%-)H)HJ2@HHI"P6D M1LW84,Q/TIM, HHHJB0HHHH ***3=2&+13<T4KA8
M7=29-%)D4AB_6BF[J2@5Q]%,HH ?13** '_2C)INZC=0%QVZEW4W(I:8QV:*
M;2J:=Q6%HHKE_&OQ+\-_#^V\W6]4BMI#]RV3+SOQV1<G'N>/>F!U%(Q"J23@
M 9)[ 5\Y>*OVRM*M[,#P]HMU<71R#)JA6*-/0A49BW?C*U\Y?$/X_:[XTN)1
MJVK32P,>+"U)2W7CIL!P?JV3[TK@?;_B7XZ>"/"VGM=2>(+/4&'"V^FS)<2N
M?3"G _X$0*^?_B)^V)JVH*8/#L,7A^WY!N;ADEG;TP"-J?\ CWU%>,>&?AAX
MZ\?LHTW2&T^V<<76H$QCUZ8+?D*]=\!_L337$GVKQ;J:WC<$6]JS*GOEB 3V
MZ8I#/#_$'CKQ!X^E^R37NL>*9 2ZV[2R7*J3W"\@?@*IS> _%^GV,-]JJ#0;
M!CNBM;T8:4#G_5'G '7<  *^[[+PKX!^"^C[;JXTS0;51YNV1@KR=MP7[SGC
ML">*^1/VB?B/<^-?$5U<Z?8WUCI$8,%C<7UN\4-Q$,9=" <[R00" <%0<4AG
M-:#9Z1XHDN-/O[&UD>%#()8EVQA5X)4X^0C/;((Z<X#;@\.6^GF1+*?SC!&6
M+)_K( #A@[+]T9QC)ZY'/!-+X-^ SK&M0C5?#FM^*9F4RKI<,0M(<?PR$Y9F
M7)"DL-H#YSG /V#;Z!XD\-^$;MW\+:%X?T62!1<Z7IH^T3Q@9!9CC8X"X/RX
M(P>#0!\M:#)K_A'4[#4?!,6I7, "-J6@M.7AO]Q"O+"H&-X. 5PQP WS88'V
M=?A/8W'B>PU25H)?"MXZ2)J%F?+BM\?P*"=T0894PDX1_NC!VBG>>"[^ZU32
M[?2);.TMKI_-LIKF0Q[6W*K)O7< 5;G&!QMQDG%3>"_&0?Q"GA26 VOAKQ@T
MUM LCX_LW48D#F%P>Q(51CE@T?0@@ 'T?HG@G2--LR+',EM*H,3%Q)M'4%6[
MCI7$_%SP;<3:;+=Z'=2Z5K"P;//M96ADD7.2I=2"5)[9Z\US_P"SGXXUBS\1
M:_\ #3Q)&[:MH@:X@N 2R-!O5<9/)!+J0<<Y;I@9[[XG7QTK[)-*V+:YS;CV
MD 9E'X@$?7'K0!X+\*OV8=-URVM]<\4ZEJFK7DS^:^D"-H%4EB0)L\D,,')(
MW Y&17NA^$VG:3I<X\-Z3I'AN^*;5FL+*,2D=P9=H/(]OQJ#0/'FE:>?#ZR,
M1-?[-*:12NT2#>85;GOME ]3GVKT?S H)8\4 >,^$O!_@KQ9)?Q6[Q2>(M)*
M1W-QIKFWEMY"6VL0N-L@*-G(SE<GG->Q6K,UO'EE=@,,P/<=:^7=<\63?"WX
MH?$_Q1I=J;C1KJ&WC5L,(9;W,0/S 8.W=.3[G&02*]#^!GCJ^U#X4VFN:[=Q
MFZU*[NKC=T"H)67 '8 J: +_ (5O#XB\/^*]2U1UO/\ B?726C7 !$<,<B1H
MJ9Z#Y#T[DGKFH?\ A)K)KYK*WN(9KU5WM"KC<J\#)'7&2.?>O"=.AN[K4(]*
MBUV^U/;+*Z66AY=2)&9W)9MH!+-]X@X Q].J\-_!+7[OQV;6TDM?"UG#I:R7
M)$K7-TWFS,%ST7/[ANAXH ]BE\?Z-X5T]5O=7MHIF'F&-91GZ 9]JX^W\8^*
M=>A6U\,>&[[RKQY)X]0O(VBM]LDC.'#G@CYL\=1TS7<^&OA)X8\"V\E]+ VJ
MWL8,KW^HXED&!D[01A<8/09]ZZ+P+-+<>"/#TLPQ-)IUNS_[QB4G]: .(\/_
M  >U*:^AO_%GB6ZU21"'%A:R-%;@CH"<@L ?8=.XKU2BB@#\W_V]FQ\?L?\
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M$>0N$++C!:JNJ VL;!&(+')JMIVH/Y90MB@9^XWA? \,Z0!T^QP_^@"OCO\
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M -:JLW:K355F[4 <_J'_ "S_ !_I7"ZM_P LOQ_I7=:A_P L_P ?Z5PNK?\
M++\?Z4 >KZ#_ ,@/3O\ KVC_ /015^J&@_\ (#T[_KVC_P#015^@ HHHH **
M** "BBB@ HHHH CDZ&J=U_JV_"KDG0U3NO\ 5M^% '-ZO]V7\/Z5@Z7_ ,C+
M:?\ 79/Z5O:O]V7\/Z5@Z7_R,MI_UV3^E5T$>I4445(PHHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M^"?#4OB=E7)NY+B.TM5)]Y"&<CN%&/>O#['Q9XB\76MQ=6&B0?:\_NM5\07
MNH$'J%4*@/<>6TN.AQQFYI^H:GINH/-?>+=3UJ6Y1$N_L.R ?+GY(G*E8U!)
MY1 _J_0!@=;JVCWNO7<$?Q%\<,#=%2GA+0 R^8K'_5E4!DE7L3@_[W>N\T_P
MOJ'A]O[+\&^%+#P_;E07U2]V^6R\<;4<S2-[/LZ?>['L/!OA_0M&TF&XT73X
M[5+V-9WF*YGGW#.Z60Y9V.>68D^]=#2&<)9_">RO9%N/%-W)XLN5.Y8KR)4M
M(CZK /E/;F0NPQP1S7;Q11V\:1QHL<:#:J*,  = !3F<+4;2 F@![-33)CO3
M6;]WN'8U"TF:8BPLF#7@/Q-T^?P#\=_#OC*%-NDZULTN_D+ *LC#8"WH-H1O
M^V1KW=8W?D=*YSXE>#[7QSX'U;1KR2.$30DQ3RG"PRKS&Y/8!@,^V12 ^8/V
ML([CX?\ BCPEX\TO$>HZ;?K'GLZD%MK8[':0?9R*Y/7OAG!XX \6>![:XU3P
MQ>DEH+1"T^GRD O;R1XW84GY6 (VD<XP3V_Q:TSQ)KWP9;3?%ND2VFIVD1EB
MO?-25;@0D<M@Y5R".OWL,>.E>)_ SX_7?P3U*]\JS34=.OE43VIDV'<N=K*V
M#@C<<\'.?H0#/HKX6^&_'5CX%U*PUZRD7PTNEWB0R7>$G!V;8PR%MP&"P&5'
M"*.@7/BGB*.\U3PM'+:IF-+6,SMN7Y55BH.#R<D@<>M>]>-/VJ/"FM?"F^O-
M.U"-]0NX3;1:6S 7*R/E!N4=ADG/3 ]Z^>4\7-H^DW=LD*3![!4?<V-H;M[@
MX.1[]10!S_PSC\_Q%XUTJ(YN-2T6&*->S.;RU.?P!8_@:]&\*:\TGA*QGG(7
MR[..-1[8+G]7->=>#]?M?"?B_6]9:RB^V2:,MM96\9*JDTZC:PR3G"9ZYR6!
M]Z]:^&7@>36[)YY8]^C:-$DDZ]/M3J $MU/J^,=\ ].@(!-\+=-N?%?QQL8E
MC9=/TD174T!X6*:.".-V(_O&50,U]?M**\O^#7@V3P_I]_X@OV236_$4GV^X
MVKM$2N2XC'XN2>G)QCC->AM)[TQ'B_Q&CA\"?&'2M2LHS!'XPMI+._95^0W5
MLH>!S_M-&TR_\ %9_CCP_%XZ\*ZMHMW^\2^MVB#/SM?&4;_@+!3^%=5\;K>*
M\7P8K#]Y'KHE1L=-MG=$_P!!^-4--A^TS_,<11@R2'T4<T#-'[=-8?#NYU%0
MT>H7MHOE*>HFE 6)?^^W7\ZZ'3[6/3[*VM(N(K>-8D_W5  _051UN2U@ATO3
MIE+"XNHXX@.S1 SJ?I^Y_6M*-J"3-@M)Y/'-Q>N/]&@TV."$^K22NTGY"*+\
MZZ2-ZY30=7%Q_:EU*ZK#)>NL//5$5(\CZLC'\:NR>(PN?*CSZ,QQ^E SJ[9]
MLT>3_$*[&O'8-4N+J^@#N=OF+\HZ=17L5(9^:/\ P4 _Y.$_[A%M_P"A/7SS
M;M_Z#7T-_P % ,_\-!_]PBV_]">OGB ?^@T"+G;_ (#5>;Z?PU,N?_':AGZ?
M\!H ^U/^":9ROQ&_[AW_ +=5]J:E((-/NI",A(F;'T!KXK_X)I_\U&_[AW_M
MU7V7XDF%OX=U24]([65OR0FD]C2"<I)(Y./7K9E&]"#VXS5I=0M90=L@7UR<
M5YS8^)8;I55FVR-UW=!6I'J4,R;U=<*?EYZUS1G&6S/:J8>I3=I1.Z60,HQ)
MVXJ2.1EP 0:XN*[WL5#E7_B8&KL=Y-QAR#GA<]:V2.643K5N3M.Y,GVIDUXR
MJ=L9.!7/1ZM<)_$#CJ2*M+K3L<&/)/12<&CE?0S-*UNI&7,GR$]JLQW"/QNX
M]362=5BY++C Y_PJ6.\MY,9.WOSQ2LRFT:ODQS+M(5AZ&L75O ^AZW-YE_IE
MM=R^68PTD88A3V&>E6$NHB<+<*,_[56?-<+PX-";6S,Y14MSRK7OV9/#FIQQ
M)8F33"I)9E_>,YQQU/ KS/6_V5=>L9PNF7L-ZA8\2 H5';GG/Y5]2+=.O5<]
M^*ECOP#\R$5O&K.)S2P].70^'->^#_C+P[(PN=)FDC#[1+;CS%)Z]N:YR:SO
M]/;9/!+"Z\%9$*G]:_0AKV&3@G S_%5&\T/2]5C9)[:&4-U!0<UI]8[HYW@U
MT9\!+J<\+CYL'VJW#XBGC7&[G%?8VK? _P (:P27TF&)MNP&W'EX_+KS7-S?
MLQ^%V5-CW2,/O$R9!_2J]M$R^J2[GS?8^*I-W[S[N,<=C6_8>,H(4V2?O!_>
M;K7J&I_LLVS-(UAJ+PYSM209 ].:Y'4_V9_$5JC-;7-K<[5R1RG// ZY_*ES
M0D]RO8U*:T1B+XKTZ5#O4"HI-6TZZ7&T$=JS;WX,^,M-'[S1YI>"?W.'X'TK
MG[K0M7T]=TUC<P\[?GB9>1U'(J^5=&8OFZHZ#4-+T2]0M+;6\_J)(E;^8KF[
MGX?>&+^:0_8%1Y.OE.R#\@<?I5-KJ:/ <LI)P :DCOY%;);!I6ET-HJDU[Z,
MZZ^"NG*I%E=S0MZ2,)!_(']:RM4^!MS=*I%XDTJYP-A3/IW/>NHDUBXCP0?P
MJ:'Q;<QM\RY-"E46Y,Z&'EL>7W7P<\16:YCLXY2P!_=3+Q^9%8E_X+U;3US-
MIMV6Q_SR9E_08KWJU\?2 [7A7'][K74Z/XBT:Z;-X&0],QKT_"M/:-;HXWA(
MO9GRA9Z>L,I\V H<@885EZQI N)\.H\C\Z^V)O#OAC4F$D=Y:S-M!5+A0I'?
M'S<5RNJ?#/P_J3R V%J5_B6- @/OE<4>T78S^JR74^26TE+>U(4A0W3O56WL
M?, 7*DJ"<FOJJ;X*^&+JW*Q1R1>L<<Q.??YLUR6H?LZ6RJ9K359(F4$*DD(<
M_B01_*JYKF+HR1X?;Z:MU#(G0J>*YO4-+F6X0Q#:<Y()QTKW9O@MKFFOBVFM
M+A>_EL4_###'Z]JQK_X6^(;5W-QH5Q.C#EX%$@_-2:=R/9R['F<MO<-&DL38
MZ X^G.:D%JVW<WWF[],UMW7AV^TNY9;VRN+5&Z>;&R_S'TJC)8F)AM/#'&.M
M!#BS)O+.XW/MW*G'TZ=JSH\P2+C<#G!([UVC1M]C\MUPN>">U8E_9!2"L9P/
MXJ9+1+)(=FP(N-FXMTJBS12R*^&+?H*TXT5X%\Q2.,'UJ2UA@^7*?*1S^=38
M+'/7TD4,W"MMSR>U7;.97FC<'(QCZ5K:CH\;6NQ(P5/(/4_G6)8VOV5=I;(R
M?O"@+%[4KPW$"*H!JD(2L:D(K8X.34UTGEE%SR1G;@_SJ_;VJW5LR+]\#)_Q
MH)L9"+\H)0(5_A4]JOVUXKQ-&X;8<X([51FT]X;GY-Q8GM4D[R1I*I&=I^\*
M L5Y-/4R*1\SGG=4ETSPV[Q2PQ2)V8D[OYT^U4RR*5Z^E1:W!<>1N4 %3\Z_
MX52"Q6TRU$TPC90J \&I=:T-=VU.&;H:K:/-YT@61M@7H?2MN\\V14QR$'WO
M7WIAL<K%8S6L90S9&?NU=L2(U\LL=_I6D\:7&3Y83!Y/6LV2>,7C* 20,4R;
MW-/RYEA8QIO'?T'O7,75SY5]@1L7;\178Z3=1M"T+)E6&WDX[5AWFFQ6LA1Q
MDYZ^E,$1PRR1NA.5..2/Y5:CC,MP"1G-2+9AHU<YV]N*MZ;$OG#=C)Z9Z4Q-
MW*\\<=KO,IP<<8JMI]^9LKM##//&*U=?LUD^>/:">",UGZ;I:QQN=P1F/ H(
M98OIOM$,<:C:H!&.M)I-L(5<.F4Z TZ2V9%!)#@>AK6TF/[1:?,P4D\8'2F3
MU,UI([>3!4%#TSUJ_;74<<>TY*/Z^E9.I6LDEXJ)R0>]7V!3"^7[52)N-O+&
M"29!"OW3N%3)9W";CU!YZT^VAW2(&RI[9K7D"VL>Y5R?<55A,I:?&&F0O+DY
MY6IM0LTO&;)XVD<<'-4K6;S;C('*\YJZQ;S.#CFJL9IZ%2WT_P"RQ[1DX]:8
ML.Z4L <]\UL6]LS$[NAXSBJ=UY5O<>6I_&BPAFHV+&Q&!@'J*IZ/8SPL^\J
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M:$8*O3Y>]+_K1D+\Q.">U.V-#N0?,6_S_6@"/S"<@*#CD5W7P&C9OC)X3<X
M^WID>_-<+'&/G&[;CJ#7=_ 3/_"WO"G((.H)]:!H_1BBBB@84444 %%%% 'A
M^F_\?A_ZZ2?S:NPT?[J_]=/\*X_3?^/P_P#723^;5V&C_=7_ *Z?X4 =79_=
M_P"!5H1_UK/L_N_\"K0C_K0!+1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 UJJS=JM-56;M0!S^H?\L_Q_I7"ZM_RR_'^E=UJ'_+/\?Z5PNK?\LOQ
M_I0!ZOH/_(#T[_KVC_\ 015^J&@_\@/3O^O:/_T$5?H **** "BBB@ HHHH
M**** (Y.AJG=?ZMOPJY)T-4[K_5M^% '-ZO]V7\/Z5@Z7_R,MI_UV3^E;VK_
M '9?P_I6#I?_ ",MI_UV3^E5T$>I4445(PHHHH **** "BBB@ HHHH ****
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MP'D"_&#PHN=N;]/E)^M (_16BBB@H**** "BBB@#P_3?^/P_]=)/YM78:/\
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M]G6OSWL9?E7C^#_"OT%_:0./@?XO/_3I_P"SK7YW6$GRK_N_X4 =1:O\H/\
ML_X5/))\I^@_I67:R9 .?X:LR2':>>P_I0!#=/P_X5]@_L8G/POU3_L,R_\
MHB"OC6ZEX;\*^R/V+6W?"W5/^PS+_P"B(* />YO]6U4]U6Y_]2U4Z #<:,T4
MF10(6BF[J-U 7'44W=1NH%<7\<4N:;NHW4#N.W4NZFY%+3 7=2TVBBX#J*3=
M2Y%,5@HHHIB"BBB@ HHHH **** "BBB@ HHHH **** $8]J2BDR*@H6DYIM%
M @HW8HIK=:8@I***H HHI: ,OQ-XCL?".AW>K:C(T=I;+N;:,LQ) 55'<DD
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MM_\ JH&5_P"T'D9A$O?KFN_^ <+R?&/PC([<K?Q_*/QKC8]BKC8-O\)Q7<_
M@J/C'X3'1O[03I^- 'Z,4444#"BBB@ HHHH \/TW_C\/_723^;5V&C_=7_KI
M_A7'Z;_Q^'_KI)_-J[#1_NK_ -=/\* .KL_N_P# JT(_ZUGV?W?^!5H1_P!:
M ):*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** &M56;M5IJJS=J .?U
M#_EG^/\ 2N%U;_EE^/\ 2NZU#_EG^/\ 2N%U;_EE^/\ 2@#U?0?^0'IW_7M'
M_P"@BK]4-!_Y >G?]>T?_H(J_0 4444 %%%% !1110 4444 1R=#5.Z_U;?A
M5R3H:IW7^K;\* .;U?[LOX?TK!TO_D9;3_KLG]*WM7^[+^']*P=+_P"1EM/^
MNR?TJN@CU*BBBI&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M+:9K6]^BR*H?39%TV+D,GEOYQ'7C@9_$YK9TR-I#80)83*4(OKNXL[[Y?,[
M@G<P]NGZUS6FW/\ :S6\7]HV[^<_VN1;NV(W(BGL!SCFKMM*E_#/*+6RG:_D
M1/,L[AHF\D$<Y]>!P*WIR/.KT^;4ZQKV:\6UC:_U%+C4)6F>*YM4FCCC4Y*'
M VJ",<G)/3FH+C5+34X;F\@NM':75#]BLTDMGMW:$<%-XY;((QC &:I?:GLX
M+^>Q74K,?+I\0AD$BXZF14YZ>K=S2-KD-K)>NFN)<G3;7R E_:9_>L/OENIY
MZA1WQS78FCPJE.5]$;7ER68N;O2]-+QV<7V2T6QU(8+'ASM8[003U;)XIZS2
MZ5*@F.L7%KID0>5[FW6<3ROC #8)+ MT48&.M<[;3V:W=LL\>@W%OI]NUX\<
M3F)C<'D%4'&#D<MZFKVE:==1?8K>6POK".:5K^YDL;X. 0"1&68_,#QPHQR.
M:LPV+;R6$4BV-]=::_R_;M4\VV>W9EQE2<8''&2Q/TJ>U>ZN50B%;9]6D\Z6
M;3]6#F&!0"C*''&>FU5Z=ZHQWUQJ<$5O%J%]9R:O<-)C4-,60Q0C(V[ .!TY
M)[9Q56XOK?69+B6UGT*]GU*3^S[)YA)!O@ .Y=_!.,KPH[XH%<W9-0OII&G2
M+489;YA9VBWEBDWD(,;Y/E.[:<<EFYQG!%4_[6TZ'+Q3:?)'9R"UT^,I); S
MG[_;;D^RG''-5+N%K5;UK+39)$MH%T_3H-)U%2"&^\RIRH(+ _-SQTJE=ZN^
MGK':&YN&6P7R@MWB4N_=MW7C..,=*PJR5.-V=N'H2KRY8F[9:DRW:VHDG^SZ
M?\TDD%_YHFF."5(;+;1]1WX%2_+]A=KZ>-[4N;B]EN+-7,B@<)\O0#Z,:Y33
M;V'3_/=Y8XRH\V8_<')ZG\3^M;48NKZYMEMXI)X$_P!,N)+:]6-UVC*)MSE@
MWU ]37#1J5*E3R/3Q5&EAZ5K^\:D.JI?%K9KBV2\FC$]VR3R6[6UJ,8PIZ9Z
M?P=0:O0WE[?^5) 9TNKW]U"+:6"=;:'C]YDXSG&?X^?7I6%]HU"=(X[HZG"U
MZ[7=Q');QW$5O"I/[IB#M&<#U)! QUJG)J4=Y(=\VFPW>K_NHH[BQD@E2Q0M
MD';\W;.<JO&:],\*YTR7T4?V>6SM8[-S)]GT^"6RD3'3?(0G&".1PON:F35(
M8UB>WN%N[6*3RXA]O(-U<$_.").H7C R?8<5SD>J0R++/ID:*;I?L-@+'4LK
MY()RZ[OEW#!/ ./7K5F:\FAQ-$^IW2PH+2SW0)<KYA_Y;-W)]22!VJ2TS?SM
M6=)(Y[B")@]W,MO&_P!HDX'E*8R#E3U^7MUZT37UO:O.MW/':LJ*]W+^]C$2
M'[B)D%=W3."#7-R75K K1-);RQV<GD0I+820K/?'/S948;\%(  .:)O$KV8/
M^D)+]A #FUOP#->'DQ$-VZ]2#QTJ6:QEK8Z<$RW3(=L4K89_WL<@LXL<8X#
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ML!AX!P2,#D?G5QH?)+!@S#=LWA&QN[*N1^9K.YU./*=U_;5HS2!-2B'K\X!
M]^:N+?32*0LH8>N>E>6W>AQ7BL)TCE*]LAOF_N*,\FK-K']CVY@9 K;FVY4
M]!SCYF]J2N+3H>BQW#(Q8(H8\YP#4HUYHT(90>?EX/'N?4UYRNM3PL7CN)<
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M[;W-M?20&(Z.ZR7S-E&WYV<C&#@N/TI[?8]0-DL[:5/YET]R@6'?\RYP5[9
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M9O047(YK'4QZPUO<R23W,B100$"-P2.<X( ZG\*NPZ]+,UA#)+!)'&OF.L@
M.>@?VKE?[1FO;)Y%U.!]]QLC\R/ *Y.%'KC'7_ZU7[JZ>=;G=;6\\<:>4JQN
M V.F&]/YUJC!U#?BN4OK5$33%.9C))*'P.#PP]014]OK$C6MW!$+Z-KIPC+$
M"<@=R!T7BN:CNDM6(-M/"L,&"\7/! & >O>K]CJD>GQV\<5S()5CW,LW)QVS
M2L/VC-F2^%NET\=W'$<"T07,9V[O[IR.>>O:K5^;>WC6]:VTJ1M/A$<=K9.8
MW>0\L<<@9.>>O:LNWU0M;PS-<0W4DCEW08Y'KTZ\5FZAJ:7EN\SP1PQR2@$0
M]\#@X'4T[V+C>;L:4U\]A8H+;3+VRMK.-KJ407!DB0]<$D@L1C_ZU<#XB^(E
MS9VD"?;9IKB[^8M<"/<N>/NC) ';-0:AJM]KPU&WMY[JTL93Y;J<*9,#KGJ!
M7+Z[X22UM_.BC*(G7 XQ]*XY5M>5,^OP&%HJSJ+WF=AX?\37+:A#'=W$-T^H
M3K"_FN.!V/L!@5[-!=-J4=S='2IG-Y+]B66TO%W.HP2W!^0 +U]S[U\J6OF:
MIJBQ0>7"J[<-<,%!*J.<GU(SCWKWWPU,-,M[.-],6.2SA,B+#*1E_0 KT.3U
M-=N'J6T9X_$&!@W&=)6?4]#EU)[2.]G6YURP@AC6QC#H71GQ@,@."YP.I/?/
M>K,FM1VM].(-=L)(-(@%LDFH6BKMN'& QD ^7/\ =7N*YG1=4-O;VBO)JEK$
MA>Z.YPR[NF&Y],CIWJ]%JCZE#:6]UK2S6\\[7;)>60;<B@!5X7 VXSFN^Y\#
M*'*[%R2SLX5M+>'3-*O7TQ#=NMO*8\3%<Y"[@#N(ZMZ5EPZ+-%);JVFZ@H\@
MW\SHPF"<9$>03ECC@#GFG^6=6M3:S0Z#,+ZY\R1U)B>6!>ASU=QC-*MI)>6M
M\(M&NK2:]NXX9;JPOS_JDQM;(P O; [9J)153XC6G6J4+\CM<M6I@MFL8;_4
M;B&2<G4+JVOM+!VVX!.QA]U  ,9;G//M3H3;:]##YLOA^[769UEG7;);R26B
M=.@W,1@^@XQZU%-JFR"_6VN]<M+NXN([.-I;998HPHY=5'.#SR3WIM]K"31Z
ME/'JMA?7+B/3;>._LF&W"_.I?&2#SP.*I66QBY.3O)FE#;S7BM-!ITUJNIS1
MP_:-.U9<PVJ$;67<=J@@'Y5!/6G?:KR7[4ED^NV/]H316%H+BS6>.)5P#)MZ
ME7Y^9SW]A6/>0Q0&\OH].T:^:WB33;&"RO3!)@Y,A(^ZG))XY]Z&ANM+CFNT
ML=9@T^QMUM+6.QO!+$\K_><(2267=R6XP,XIB+TFL6\DDTL%]I=S)E=+TW[=
M9-$-W'F?O%YP>>% &<"FQQVEHS_8[72[C^S@+33TL]1-N7N''[SY6^16&6(W
M;FX/J*2UU&ZM;I(DU+4K6+3;2-3]NM%=99G#$2!P 6QD<+P-O6H#J$%M<)$V
MJ:#<'1H1<3/=VGD'[6^61AP549QSR>O%*Z+:=KFNWVS2[=HXX==V:5$((H[6
MX6[^T32#YFVL=SA"_P#%M7CIQ6=J4C6=O(+FZF2+3$"+)>:86\^ZD/#!T SZ
M'8.W6JUK#%8S6YBTK3[EK"+^T)C9:@T8-ZZ]-KD9'3YGXXP/2I[?[5HLD+BU
MU]UTV![VX:*[%RL\T@XCR!N<KGH, 9S[TVNY,9N+NCF+7PG8Z?J&H7$FI:;=
M06<(26.YN6@4WC9(CZ8V].Y/;%=AI\+Z7:HEK:74W]GK]HN5L]35UEG8 + $
M;!VC/ .T '/)JA)K']EO$VHZG>2II]O]NO5U+3%;S97 \H;NBE2WW5!.0>:J
M/<6,<G_$SE\/SK:J=2OTD@: _:6'[DMD<<$<L2>O%8*E&'PH[Z^/KXI+VLKV
M.@F:6UA6/4(]0O+>)?ME\)-.BG6:5MFR$&,<E"?X03\N<UFZC<VUHMTE[-9;
MT"RZDX@FMVDF8?N8MRG'?E26X/W:CA06L@S:PR-&S:G>1Z?K)!>Y8XCB8,<D
M'C)8A>F >E3++J%DL<<YU]1:*;^91,EQYTKD8ASU./1<#KS4R,*;NSG+B?7&
MU@0VVI<C:\]O%<F186(SCMVX'%=1#*\R7"W4=[/#C[3=.UM%,'C#';;JN-QY
M&?NM]:Q_MR6L<KWES([Q(+FYN)[+:[._W%_=@@D<#OQWJG,ZV\,4]VEG<-&5
MNIWB62*26?\ @&">548ZYQZ#->>GR-M['TTZKQ4(12U1T/V]()II[AHHKAE1
M[V7[&\&U,+Y<(^8C('7GC/(IEKK37BGS;F>&YG*M,+:Y9D6,<!5## !XS@ ]
M><5S<#&Z&YC)MW&:;=.7+.>W/8<<5?\ (:T9TFM;J2TM=LDK-8B99Y&X1/4X
M)R0!D$=1WP]I*I+W31T84*=ZFK.BU"\F:2X=H;B99(BTTD=BKA;;G]RI&&)/
MT/X5E#4/M$\B)YEK(\:#;"[H8XQ@J-I/R\#T!ZU7:2QMUEAO)M.N);>17G\R
M"6V$UZV3&I(XP.1@[OI4VTM/+M5)VM69YUL;])&FN&;!APXR HQW7H>.E:2C
M)I69R4:U.G)N<;HNM=2W$TRAPTBH"-Y1S#$!R!D;AN_$U8AF>VCCE>'R(HXV
M*[E=!#%W. ",GZ9-8D<#^8UK>0.\$;*T[75HA^T2D<+N P0O3\!S3Q>1Q>?.
MS68D2X^=%FE@::[^;:F>A4#&0,]#Q41CT.F4U9-=3H+>\C9!-+)&V%+;A*!Y
M,9'#L'4$,<].V*F*R36^^"/[*%^=5$6X1+W8['Y8]L5SGVQH[<RL?M<A8&2)
M723=)G.W+8'!^G2K%O);+YLT\MO-YGSR[K4AI9@,)NV'.!QV/2G&2%.E*^FI
MKRW$>XMN2! N[9<2/N@AR?WC!D_UGL?SI@:WAD 3:21YBJ2GR CAWP>_:L2]
MU=[2.18YO/6)BY^R3NIFF[C#'[H],]JY&/Q/JVI:IY8C4VY;=()(@6=QT&<=
ML43DHG5A<)*NG)-)(](E42-M9 D3#?\ .&&T#.6;@\\<"L2Z\()<.]T\D208
MSM*\_4G/%1PZ@T;+(OD>8V!AHG!:;)^9BIQMQZBJ>I>(C"R[9&>)2P7YR5E/
M<D,,X!Z<UA4:Y;LJA[15.6#LR[8>&;>%6.YG+ L=^#M7WQ_*M.UL8U10G^K8
M9QC;CGJ>F._%<=_PD4\^Y+9?,N)#]XK^&3BKFDW]S_:=NL]V3@D^2S$;F'J/
M3V]JSC-6T/3E@ZD[\\CTC3M!,<?F2.4C /3@X_"K]C#?7DS1V:RM$1P2.WK[
M?C4%BT^K30H')A"Y"X!5^F&SZ]<"O3/#FEQ6=HJX'099NIX[FNM1/FJE6S=C
MF[/PR^PI/ND)X;82,?\  @:P-<NM'TUA:Q7 CF4D%<[@""N03ZY9?SK>\<:]
M>1WT=A:W<6G6KK@7#8)D;DE OL!G.?RKBK>QN]4L_-@U>.[4%5?S( 5)&P-C
M/NC'ZM^-5R=3%5FMR3[0-V23_NU7FUBWT]6:64H.J$=_:K6H6[J6F5 %R1S7
M+:M&6V^9M\MSA&8@'/H!7+4O$]:A&-:U]C??Q);QPE]Z[&'S>M<O?^,Y7NE,
M1RJ9RQ^;O[UE7V@W%XI,)*,O5'R 13M)\(ZA)-]F+*S<,'7.,9]:XJE2HUH?
M187!X2'OR=_4V-)O+V:07!NWMX\[MV>?I],5T.DZO#$R-'/YSQDD+R3[C_ZU
M00_#>^$VSS3Y6T,.>IR,CVXS78Z!X!MM'8R)%%),WS[I3GGH<>G%%.G6D[MV
M(Q5? PB[6;[)$GAO4?M5O;W'^A1VZAE;"DD0G/&?8X]L9K=CD>X5;:36+DS,
M'L]T%N$Q(!N5^1@';^!S38-)AL5&);:VC4[V55Q^[;K[=?PJ_&9S\C7DF\$Q
M[HX3RZ8;!^JCIW!ZU[E+G2M(^#Q7LW+FIJR(_*5KB*=8=2D9I(;M6+D*/,!C
M9<9Z '<5[9XH_L*-K5XET57802VH$UP>5C8F('GHW7=U%3IY=U,\.[4Y(I,G
M=P%"3;B #VVE2 >JY&>#5F.!6>-VL;@DO'.6DEQAB#&X(SSA>2.AS[5V1/)D
M0?8S]M68:?8QXN8[C<\F6^="C-C'WNJCG!%4&CEAMRF_1[?_ $6>(X3Y49&^
M48/\(&2P[&M633]D,CKI,7FK!L57F&&\J0F)3V Y+9[4DEEMFPEKIZ(TTBG?
MR<.F<X[DL>1W%="9@XF'>7,JL[#6K.!6FLY6:*')VN0I!))^^1A3V%5?MJO>
M6<3ZT\C"\N8O+CMB@D(W'RSQ_ /XNY%:\TA@LV)O-+M91!"_[M<A=CX8_P"[
MS@>A-0R3N+R*-M8C_P"/]X]B6P&<H6$3'GD==W&>E:QD92B<P\#7"),-6U:9
M/[,G $<.T-E@/-P!C?QP/QJ+4--$NGW=J[:_(!80P[D<ASTSM/\ ST./F/N?
M>M-;Q)+(32:Q>RHMA,VZ. KNVMCS!Q]X8P >M5=7C6^T_44>37"7M;<?N?E(
MRV,H>F[(&ZMDSG<3"U#1V:ZUZ./1M9N5E>SB#R70"2!0.8R<X5?XCSD^G;3D
M_M!;B:.+0I&C;4%C,DET%#1]Y@.N.!A>^:N?V>EO?ZB\=KJ;M/>P;WFG(3Y1
M@,ISG8,G/KCTJ2WTT+<1AM*D"M?R3%WN>A QYN,]#V6KN0XF':>'&:ZMO-\.
MVT:OJTEV[S7A8\ E90 >6S_#T'I3X]%6WFTR6"QT5+?SI[J8R2L2K#)&P\C.
M0,GL!P*U;6S,8L(SIMO"$,S'?/O:,GT.>23C/7'Y4VWB2WMTC$.DHJV;[55\
M@9)[X^YZGU-,FQ6\.1/I-G8K,VCP'RI;B06:$+\QX()[>I[X%6EU%;6*%A?0
MJD=B9?EMSP#@!L=A[4^X_P!$ADD-S9V\/V,!'6/=MZ_-QU7T%+=7,B&\3^T2
MH2&) ([7.UCGGW)_2D,5KQH(GD2]N L=F.$MAU8\-T^][=LTMPTB_:2KZ@[1
MPK"%B4 DD<D>_3)[4E]/M:[4S7S9DBC AB'&>< D=#W-$F6:;C4&\ZZ5 6<J
M J]QZ+U^OY50:GL,/^I3_='\J^'OV_O^1^\*_P#8.?\ ]&-7W#%_JD^@KX?_
M &_C_P 5]X6'_4-?_P!&-7C]3VNA\VV9^6/GUXK5M5RR9'R9.3VK(LSN">HK
M8@8!5!.!U-#!%C;^\X&Y<\4^/[V-F*A^TQ+\V\+C@ 4TW$S-N2/\32$6&8+D
MNP([9J);I%W ?,W8#-,2U>4YE<@>@Z5/'''&VX("3P!0,K 7$[$E2B?A7H/P
M!MT7XP^$V(RXOX\$Y/K7&!2I)SPW4>E=S\"./C%X4 Y'V]#G'UH _1>BBB@8
M4444 %%%% 'A^F_\?A_ZZ2?S:NPT?[J_]=/\*X_3?^/P_P#723^;5V&C_=7_
M *Z?X4 =79_=_P"!5H1_UK/L_N_\"K0C_K0!+1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 UJJS=JM-56;M0!S^H?\L_Q_I7"ZM_RR_'^E=UJ SY?
MX_TKA=6_Y9?C_2@#U?0?^0'IW_7M'_Z"*OU0T'_D!Z=_U[1_^@BK] !1110
M4444 %%%% !1110!')T-4[K_ %;?A5R3H:IW7^K;\* .;U?[LOX?TK!TO_D9
M;3_KLG]*WM7^[+^']*P=+_Y&6T_Z[)_2JZ"/4J***D84444 %%%% &?J'B#2
M])O+&TOM2L[*[OF*6D%Q.L<EPPP2(U)RQ&1TSU%:%?G%^W!\;([SXW3>'H;I
M3;Z);QVIC2<,K2L!([8[-\ZH1U_=\^@\I\(_&G6/#F5TG6M0TE7G6=TT^[>W
M21P!AG5& ?CC# @U/,!^N=%? 'A7]M+QU82,;G5K'6DDE#,NJV* H@SE(S 8
ML9_O.'Z#CU]H\,?MO:+?PQ_VUX:O+*XDG\L?V7=Q7<21X'[QVD\EAW^558\<
M9HYD!]+T5Y_X?^/OP\\20V[VOBW3K9[F?[-!;ZFYL9YI,@;4BG".V21@A2#V
MKT"J **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@"MJ#;;4^Y'\ZH U<U1BMC(5&<8)]AD9/X#-9L<@(^
M]2&B<$T]9*@\P X)ZTNZD,L]:BDC# Y%()"/I4H;=5",V:UVG(%5VC]N*V'0
M&J4T.WD=*D9F7%JDZ%6&13+#6KGP\P24276G@8"C!>+'3;ZCV/X>]XK[5#-"
M)%P1D4@-V/Q'I4T:NNHVH# '#2JIY]03D'V-78+J"Z7=#-'*OK&P8?I7E>MZ
M*T+&6W'U7L:YYK[RWPWRGT-+GMN*Q[SFEKQ"UO8I>NT_A6U8W#P_ZF:2(?\
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MI_W1_N#^E6KK_5M]!_2JNG_='^X/Z5:NO]6WT']*74$<WJW27\/Z5U7P]_Y
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MC]Z>J\"F Q8ZD"_C2XJ18_6@!BJ6J14Q3PM/5/6D,:JU(JXIRKQ3J0" 8I:
M,TZJ) "G!?6E5<4H%2 O-%+2@8I#%4?,*O527[PJ[3&CY]^-GPET3QKX_P#[
M0U"2[2?[%''B"0*N S8ZJ?6N>T_]FWPG(!F;4O\ 5Y_UZ^W^Q7JOC[_D:O\
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M*HO*DD-RW]HW5J\ESL#31DX()PJ^@]_I5JYDFD&H^7=6,QC58PD^%"DGD/\
MK@5:1S2J%_3WF7^SXS)9W2E6EW;<,_/!4=NO)I8XV-I$DVF;6N+G+B";A.3\
M[>OT%5YK=S<2D:;#<>5:;4>)PK,V/N 'H.>M$<-O!/8[K.YM7MK=I-L9+1ID
M<@GN<BM#E<BVVHXCO&$VH6;7%PMNN]-W /&T?P@Y//L*?)K!:XORNI0S1P@0
MI'.NQ4/?G^(DYZ5FV5\RPV)2_N"6=I6^T1_-("3P?3';'M1]MDNK>!C<6=R)
MI\Y8!>G0*N.M)LVB:L=U)]JE*6\-P;>'CRI 'W$<#V&*YK7&GT]X0L=W%Y:;
MCY3DH.O./XOFHFM6F^UR1V:JD]PJN(7&64'&XG^GUIFK>1<-<E&OHI'*0>:"
M3T./DYZ 9_6LY7:/3P]2-.:DRUX;N_-M8B5DW$9;S#DDUZ)I&E)XPT^/3CY,
M36R22HJJ3+<[BN4 [D $CV!KRG[+)8_:FM]28+"BH%D7 1^@R<\YYKL?#.N7
M&C31R_:P;B%,.T)PV2,''ID$_@:\V5.47S,]OZQ"?\.6I'KMNGA&:6WMK".[
M^W%<RHP1HHQCOCJ>>GM5G2]2-_YK*EP2["/?@L<C'3V^OI4GB37DUA[1!IRP
M01H7>?@R,>@ P.G7C/\ 2L:P66QGLMB7@,A:5QCY5[*&[?@/3O792;.7&55.
M'OO4]"FUAH;>X,^H/!<-MA0NF<N1P0HZ]O2IKK6I1#>)'>VQ:U18E6XC()<]
M<\=#CL<<^U<Q9ZB]BUC =9(ED=IF6:$D^6IR1N/ ';UY]JL1WTEZMJ[/I=VE
MS<NS-C&8U(&5&/F;(//\Z]A/0^!F[S9O3:B[R1*L5LWV>+:7B<*&=C@CKP,$
M]?6KT?DVLT7DZ9<H+.W=UDB?&2WWA_X\>_;I7+/YNH6R"71U:.>Z(;[/<8"*
M,?,2#SQG@8HN+A9EN7^S:E9O=7*Q@IC=M7C/3A>O7TIDO4ZNWUB/2UMX+34M
M1ABM(&G=)&+*VX' 8>JY'4>M8M[KTT=Q9I]KAGCA7SY'= 968_=.>W!&:YK6
M/%$WV><V^J7$/VB78@FC!&U3]T#!P#GKW%:G@Z&;Q!J5Q-+<1R;L;5\I5VJ!
MTXZFN&O6Y5RK<]7"X24OWDEH=)!=0ZG-I<%U':0S"59))V&$B).-_P"O/TK*
MN-6CT'45EM[FYB:WN3="6*5E65P?E8K_ !#@<'\:KZEED1XHU:1V\O&[!8?0
M]?\ Z]<UK5C.MQ(OD2<80*'W#@8'X5Y\I5;7U/=H4\*Y<LK'<:?XL^W7$;75
MQ.H9@%X#L?8Y(P*Z&XU*.*9+&74T^S-+]NF6YLPX=%!P#Q\N.Q.>:\VT.8QR
M)YL&/+(&[''X>M=3)KANC<R/=O;S2RK;(KV_ (&/3H?4]S]*Z\&Y2;<C@SB-
M*FHJD:<,L6J6]M'?+X?FAFE?4;L*AADD5 "AR!\QZGYB/QQ26=F=0AB%SHL<
M'VF\?4+Q['4SRJJ BG=]]3@_*N ,CWJC<7VY9BLME*[XMTCFB*C.0"I'&<\^
MU5=1\BXBG9--L;M7 M@D,^PF,-]W(]#C@5ZUSY=;FW;W\TD$4FWQ!IJ7-Q-J
M-TSRK((XUR?)8\;%.WA1DG(IO]O+<):_:=3E?[1+)J5XUYIRG]PA^1 1N ^Z
M<%LGGC'%<WJNLV>ERR(UAJL23K%8Q+I]QN94!&&RV,#Y0">>M:%SKUO)#B#5
M[Y;>X<0?ON$5D/("L.,X/..^:S<CH5-]47)M0L[GR9+Z?0;M;AFU:_-Q T+,
MJG$((S\W)Y9N@/ I([%IK2UOI;"SVW4C:A>7>FZE*JM,V_RHP"!G*C..%'/T
MKD-0\?K-]J2.\BO;25A$5EMD^X."HRO(.>M5!J#^(Y9A$BV]OA1M4Y.!Z_D:
M\VOB8TW8]S"Y;5J)3>B.T@DU!OLQ2#5C=(K7\L=O)'(&YPL VCYO8 =\DTMO
M<1V-E)-J-Q)<W$):>>.6)2(RQRL8VD@D>V:Y.^UB!;5[6;2MK7$Z;M0M;EXI
M$5!QD="!C&T8ZT)=SR6()N'55.XA5!RH[?B/YUQ3G[1+E/5HT71;=3<Z*(S7
M$,8D339FA7S6AE#J6F(S&,8P%&1G\L5-8W1TF:*.2TQ%;.;J06M\X\RZD; !
MC))8 <\G&0.*YQ=:DDO/-7S;&)5^TR^=$SE8QP 3CCM[X%6I=1@N%'F7.FW<
MT47VV=I$,#;FSY6T$G Y')/IQS54XSZ(PQ,Z=UK<ZO[?<:;I$5R+O566W9V2
M+:MR\DKGJ<_.0I/3(7\*2SD,TL\=M<:?<7.G'+/=Z>8R]Z^292R\=.NT9R.M
M<]$CV;6S_8OM#6L/VQY+34"P:=QA8]O< '// QQFK-SKPT:W\FX.I+-!\\C7
M7[]S(_(5<9SMR!P!T^M;.3A'WCA455G:&QJV:Q:=N%E:63O:'RXUM=2:-KB\
MEQYI(8_PYR,ECR,"M.:6]MV=;8:O*8#]CAE=HKI6D8'=.0>R]/F(] *P=+V3
M6JI&+:ZO+8,8C/;[,2G@MP 0>Q(YJH9;73RPMK&V>6RC-K;&SNRI$KC]ZQ!)
MP02>N6ZU4)J2NA3IRIR29N36<=BRP1S1K*Q%O:K<V#('E&/,DW+T&">0 .>O
M>J9U*S@C4P/!?1[]D'DW(!E(^^W//'XTR77+EE@L[*XOK>.UM1""\WFN6YW2
M?-U.3@9SC'%4=?D>UM8Y&NH_M4H$-N)K7+$#[_S*._/H!FN>4H2^'H>MAXUH
MM>TV9;A\30:G-,BB]MF7;"BA48+_ 'GS^/>KE[<06<Q\GRU4C"QM%C:/XFR.
MYYK&L[+]R$C$*"0AF8/L(0'YCG'89J[8PQRO/?Q73E%4H+?S0RJH[@^O^-<W
MM)->\>W*A2A*U,FDD,=H'MA'%$58CRY2K"/!^;IG-9=TLMS,%?S&0KN56.=O
M%6[_ ,2S6T5LCQ)%&W.)$#;E_'M5/[5'=.9I[BSDD;,MR9(VC*@']VH(X//K
M^55%1JJS9PU*L\-+G2)-#\/7-U=/%&FZ0C*Y0@#'1=WJ36EX2\$W>DZI<W>H
MR*UQN(6&&;)3YL\9')/>NR\+:=_96A_:9(D%[-\S(DI8%CUVEO0?RJ?36-Y?
M>5)N(4[@MPGS9]0W?&?UKHC14=3EJYG6E&4%IS;G<>"]->9HPX^9AU*X_,#B
ME^)GQ1TWX?WMII8A-Y=%/.GV.%,:G.WMU//'H/<5JV^L6G@GPE?:]?\ ^IMH
MB8T) +MC"J/<GC\:^2=1UJZ\3:Y=:K?R,\UQ*9)6[$GL/08P/I791I\[U/F,
M16<-CM-=\47GQ!N;6\N#Y$,<S-'#&?N*!CKW)R>:U_#NL-H(ED4C%Q]U6)P,
M=_YUP]O?M#(IC 56X ]!6V;@O=Q1@!D9<-[<5V2BK61STIN]V>F7&H#4K-"I
M]]OK7/W<:32;';RQCA\9*L>.*S+#Q%!IUQY<OS%OE4>E6EO4NII%1]K2=".H
MKSZ]*\;]CW\#7Y:G*^I>T]<@/(C0>63'+]IX)QT; [&M:'33@-%(S2A]R%!@
M8]*Q8Y=LT<LD*HJ@)/+*<DKG&>/;)KNM/LQM2-7=V3#H4  9?2O,4;GOSJ..
MJ-C2(WDB573=P&5BV/F[BMVSB7[X6'/WD#-R#W%8+1BWC?$'&/-3<V/F]/:M
M+P_J"ZG%N @1T.].=PS_ !<_YZUTP>MCQ:J<HN1L;H[=2QFB6'K\J?P-Q_,U
M$UP8_+A-\_G,=B[(.KQ_,P]MR]N_:KGF"/K+&L:]<+_"1Q^M,CF\M7=KTNL2
M_,!'R60Y;\QV_$5W1/(F0!EDD*":\D(R@=5P/G^=3G'.,;0??!J9;=9?F$-T
M1(2Y61R,"122/4 $8QVSZ4V29&#;;FXD&_:#&O)Y$BD<=,?+[]*F41LSLGVN
M3J!R<?WQ^/8'\#VK:+.241L=@DD<;/:$L6&]7DY 9-K<=^@!_/K4"V)B$<O]
MG6Z,!"Y+2 D%3M_-5)P??%6I+==KA+6:4X; :0C=SY@&<_WN/;Z4EQ9+)^[6
MP5XSYB_.XQAANZ>A;CVK5&-C.NK66&*1(HM+A*Q3H@D7*@Y#+D?W>["J]U=,
MMV^-4M8E:ZB(58\EE9,!"?5CT([<5K?9BS!C:VD9DD#2*QR?FC()QCDY 7W%
M4;F0QVY)N+& ^7$2P4':0V&[].<#T)K2+,VCGI+H8B#ZW*8_)NEVQVFTLRO]
MX<9R@R .^/SIWLRW5O<N9]8E5[.VF A0J1\WWE.,!C@;AZ>O;=EEE^W00'68
MU'VF:/RXK?)?*%E0GGYE^]GOC%9DUU'=:?EM5U&57TX,)((-C<-\SC(X8^AK
MHBSGDB"ZM0UY/_HNJ-B_A;<9"J_=&"O^P.X]2:9:::OFEA82*XNYI,23$Y)R
M-_T( P.PJS<0JUY*3'K4[?:K=A@X4' QC_9S]['OQ45O8+'=(?[-N_\ C[G8
MR238V]MY&>5(P /_ *]:(BQ6M;5[>"T0Z3!;B&VEXDFW["2./3!ZEOPIC;;:
M&1F.E6\*Z>%60G(0Y[G_ )YC]<T0:1Y=G#"FBP0E+.5!')/NVD_P$^A.,M2S
M1^59RN4T: +9QC=(V0.>C'^X,<>IJKF0MY?):+>-/J%I;JL<7W8LE<^V<G/8
M>]+<WPCFN(Y-3;<;J.$)% "RMC.W//7N?8T7=XV;YCJ=G J/#@10[R,\\C/4
MG&/2C^TP69?[3D;_ (F*0@1VPXX_U?3IW+4QB&X$DXB,U]+FZ^78H"J .G^Y
MQ2PJ?M%JC07\H>YDDWR-@(1NQNY^Z1P!3(95DN(U,FIS2->R8;9M3@="<?ZL
M<8]2:CM[8LNG@VM_(RB=@T\I5N<_>&>2<X7TZT(D]JM_]1'QCY1P?I7@_P"T
M1\(-#^)'BC1;K59+Q)+>V:)!;2JHQN)YRI[FO=[48M81C'R#@G..*X#XD_\
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M *UGV?W?^!5H1_UH EHHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH :
MU59NU6FJK-VH P+[^#\?Z5PNK?\ ++\?Z5W5]_!^/]*X?5E_U7X_TH ]4T'_
M ) >G?\ 7M'_ .@BK]4-!_Y >G?]>T?_ *"*OT %%%% !1110 4444 %%%%
M$<G0U3NO]6WX5<DZ&J=U_JV_"@#F]7^[+^']*P=+_P"1EM/^NR?TK>U?[LOX
M?TK!TO\ Y&6T_P"NR?TJN@CU*BBBI&%%%% !67XH\16GA'PSJVNWV_[%IEI+
M>S^6 6\N-"[8!(R<*<<UJ5XI^UQX]TCP7\']2MM3FM]^KJUG#:ROAYOE))09
M!^4[23T /N* /QS\?>(M0\7^,=:U_49%FU#5+N6]FD481GD8NQ '3ENGT%8$
M.LWEF0(II$)&>O'Y5ZKK_A.PU!@]D%BE9=P5V!) '.,=",]\=/P'G^I>&Y+%
MI8]^YE8H%Z$]_NGGI4V&3:;\1-0L<>:GF\=B5-==I?Q?BVA6>6!AC[_/\J\N
MFM6AD)=<$<8)[=*@:)P,@Y;TJ1GTEH_Q0\R,,EP&C[[6R*[/PO\ %*?PO;W4
M>B7LVA"[(,QTF=[-I3ZLT14D_C7QS&S1[6#%2#PV<5HV_B74K48CNY#[,V[^
M=*PC[K\-_M)>+M!AECL/%VL(7ZR7EV;]A_N_:A+C\J]T^"/QL^)GCC2[M8=3
ML-6$4A4ZAJUBCF-L9"[+<P#'X=^M?EM:?$+4H0JDH_KN')_(U])?LU?M/6'P
MMT76X;[3YI=<U&)6LY+<*Z*WS[1)N8%0?D;C/R@^V4[H:1^@\/QB\6VGA6>_
MN/#.FZA=P@[7COWM8KKG"F-?+E8!N,9)SD>M69?C])H]OI<>L^#M4CU/4&*Q
MVNFSV\ZYX_CE>$_Q+U4=:^1=,_:VT/4O!4.AV27EO?V,L<]W(\2F-4B8-E"&
M/W65.".1&_'KZ1<?M&>%?$OCSPREGJEE)X9MD-Q+?3 QK#-M<1JS/C8WW, X
MSN ]*E3EU*Y4>^Z;^T!IE]K4NE3>'/$%A>1*'=)XK=]JG')\J9_4?G5]/CUX
M,DANI5O-0D2U7=-Y6CWDFP?\ B.>_3T/I7A'AGXQ>']4^(>JZS?:II]EIZ0-
M9V4\LZ(ET@D!#1L3AQP#D9_U@[8JSX5^(%IHOA#6=1EFA_M6Z83P0Y3>R"-
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MSXC/=3%-,@\I6X#RKER3Z#I_.F2:S6[KN8N$4]3TQ[FN8U/7K&S#>4/M,O\
ML\*?J>]-7P7XDUR1)I8"@FY\ZYD P/=<[A],5V&B_"[2M-D6:]9M2G7^&48B
M'_ >_P")/TH \N_M36-<N#;Z=!)/(W_+.V3)'N3V_$UT>B_ ^[U+;/KM^UH&
MY-M;X:3\7.0#] :]=5HX8UCC58T485%& !Z 4QIOPH YW0OA=X4\-W<=W9:/
M";R/!6XN"TSJP_B&\D*?=0*SO%'P<\+^*+B6XE@N+&XFE\Z22PN&B#MCDE.4
MR>I.W)(SGK77-,/6HVGH \NU3]F#P'?K&(;6]T]E_P!8]O=%C+Z[O,#8_P"
MXZUU7ACX3^$/!UQ#<Z7H=M%=Q+A+F7,LJ^X9B<'Z8]*Z-IJ89#0!<:?WJ,S5
M5WTFX>M %DS'UI/./K5?</6C(H F\T^M)NJ*G+0!,K'UJ56S4"#I5A%H$2+R
M:G6F1K5B./- R2-:G1::B^U6(XS3)%C6K,:TD<=6%7Y<4#!5J15I56I57BF(
M:L=/"TX<4[8?I3 ;BG*A/7BI%7'04X+2'8:J^E/5?2G*GK3OI2N,%7;3@O>A
M13J8@HHI5IDBTY:0<T[IBDQCN:6D Q2U(Q0,4M%%4(5?O"KM4E^\*NTF-'F/
MC[_D:O\ MU7_ -"-&F_='_7/_"CQ]_R-7_;JO_H1HTW[H_ZY_P"%,74VO^67
M_;&L34^__7+_ !K;_P"67_;&L34^_P#UR_QH&;7PWZ:A_P!L_P#V:K?Q64R?
M"WQBH57+:-> *W0_N'X-5/AOTU#_ +9_^S5:^*__ "2WQB-C2_\ $FO/D3[S
M?N'X'O4LJ.Z/SN^RJT\1.G,GE6V<Q'../NCWZU'#:)#9Z<OF7<!:7=M8DEL=
M0?;FM2>.&SOY9<W42);;?5 /\:()?,FTP"_VDHY*2IEI1@<Y[8-8<IZ7M#';
MS)K65H[^$%KG:/M"\<<;<>O2G2P7$O\ :'^C6]UNVQ@(X5FP1]XD_2M>WM9)
M;>U816-TIN=^>" !W_WJCNK&)K6^=M-9B\X!^SMRP!!+>QI<H>V;T()+=8[J
M>06$R&*TV*\))7&"=H'J,FET^.*&XTN+[1>P,L3N$9>'RN26/J,5=NOL\$FJ
M,);NV*(F]MI9!QP5'?K5F%S#=#_B8JP%KGRYE S_ +9]O\*M(QE-E6QDEF;3
MRFI6LPED9BTJ8:09Y"CV&:DFM;BYLI@=.L[UI+L ")PN4'1V/J,"K-K'+--I
M9DAT^YCC#,2@ 9>X9!ZU6ATN)8=,6?1'A"WAF,=O+D(V2=Y/<$^M58Y7-[$>
MI11QQZQ)_9UX 3'&'MV)>7'&5!Z8_I3[FXM[>XU#%_<V[6]NL677*KD?*V>Y
MYY_"H))[=8IBMS?6HEU H2_/S#KCC 7O3KJ]FV:B8M1ARSJ@6>,!%/ VGUJ3
M2*N2[I=PCCO+6Y>.S+LDR\L2/O'T&<?G5>&U97LO]#M6"Q%LQ-@*QY^7'J?Z
M5-.S3-J;Q6]G=@0*BHCX=AGE6/8'GCVI9=-"O,TFGSA4LRGF02]L<J/?\:+7
M-^;E*]IIZ2+I\8T^>W#.TY6-]P0@#&XFBSDA5;)8;RX@^U73,%E7YFVYRO3@
M9YK3TZ."W>W_ 'UY#Y=D9#'("<+_ +7^T/Z4^SGF=M*C768Y8?(>7]_" TJ]
M0V<<8!]>U7R&4J[*UG<M=6JXO[&[6YO/+7S$"@ =5 [GCC-376GS#[5)'9Q-
M(TPC'E2*2W;D]NQQ3]+L[AET93;Z9<IEW:6!QA0. 4S]>:CL[%I+?3$G\/R0
M/+>M<N(9R4C(_C8C@]>GM]*OE35F<ZK2C*Z8V_5[>/4GFL=09(HTBC>W.2^[
M@E/H>2:E;5(=/_M-1J-W8"SMXXMTL!=0S< CKE@0!G&,GO599H%ME;SM6M)K
MK4EP2O\ =.1U'"?_ %ZC;6GGBN?+UT;9M2$48N+;[BJ2=BC'?CD\8'8U<8I:
M(4ZDYZR9IO?RQS7"G4[9EM;10RW2A=C''S.>P.1Q[U9,,OG(%M-.G>TL&9'1
MMK;V_A'(VJ?7W_//N+B?4+?4!&VCW EN4B191MP 02K'NW Q]/:F:M8M=PZP
M3H<$WG2QPY@EVM*BG)9SG(Q@8%6<]KL;+>)8S66[2V@:TMV<-%/E [9!"KZ\
MD[C[4VVUC;]GB6;4(EA@><EF!7+$_>/4MZ#I65?S>3-=@6\T"*RQJ68D.,
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M1@\8JN7F:NRZE3D3<5=EU[&XO?+,TLDACC$<:LQ;:@Z*/:M[POI;WNIV=O\
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M4JKZ4P&K'CW-2;:*>JTBAH&:>JX]Z7CI2CFD(*<%Q12T["N%%%%,0"G4=**
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M7Z;]V/\ '^M-B1K1]!]:L+5>/H/K5A:DH6BBB@ HHHH **** "BBB@ HHHH
M\=T^W/VPG;_RTD[^YKJ])C*J./X_\*R+*U N,[#]]_7U-=%IL6%'RD?/_A0!
ML6B\?\"K02JENH Z=ZN+0 ^BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M>_%'4K5F;3M,@33G#'[L^((SCGN;5ORJM\'O"=M8_&/QYX\EU&:[GU,[(O-
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M^)KH?['']V7\O_K4?V./[LOY?_6H Y[^W->_Z"-[^0_^)H_MS7O^@C>_D/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MSH?T4U#_ ,*F\4[<?:M+(Z_Z^7_XW18"?^TE_O4?VDO]ZH%^$OB@?\O6F_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_P"@K7(ZU]V;_@/]*Z[X:_\ (#G_ .OEO_05H U?%6L67A_P_>:AJ$ZVMG"
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M[PJY4LI'D_Q&_P"1R'_7FO\ Z$:=I/0?]<A_2F_$;_D<A_UYK_Z$:=I/0?\
M7(?TI#-S_EE_VQK#U;H?^N1_K6Y_RR_[8UAZMT/_ %R/]: -KX7=-2_[9?\
ML]=O=<VLP_V&_E7$?"[IJ7_;+_V>NC\9:H^B>#]=U&,?/9V$]PN?5(V8?RHM
M?0+\NIF&%6;<5R12^7&K*=N:^;8?VG;O<Q,",!C\?\Y_2KB_M02;EW62G/4]
MQ6GU6?8M9A2VN?1GVI54 1U!(8YB=P(_"O"8_P!IZT88-D^]>3G&/PQ5R+]I
M;2I%S+"P/7:..?2H=&HNA<<31E]H]C-I!O!QCUIYLK%EX15/? KR&/\ :)T:
M;[R,HZ'@_P"%6;?X^:!(!]]6ZD%<U/LY]C>-2F]I(]0;1;)LG'MG--_X1FUD
MQME(]A7 +\;-!;(\SCV[_P"?>KL?Q>\.LR@7H4L..M+EDN@[P[G7MX53<-DN
MU13#X3" ^7*#SG-<]'\5- *@C4$P3C ;)S]/Q%31_$;094_=ZG&><8#?Y_R*
M=WV'RQ?4V/\ A%&5<JZNV<_0U$_A61F^9E;//7H:J)XSTJ53Y=_&P(SPX_.K
M,/B*QEX2^4DCC#4^9A[-/J22>%I)%^9EY]#TI&\+S3,02%#=<5-'JT$@79>(
M3UX8<U,NJ%<,MU'Z=0:.9A[%%9/"32JX?;'D;21C)]Z9_P (2JYY3>R[6?')
M%:?]I.P)\Y<^YI_VZ;G]XIXI<PO96,)O!+KAMP:7!0GGD5DWG@N_6,F(H\@X
M&2>E=JM]/T^4C'-(+R7C*+GVJ6S2,4MT><6FAZK;S,E]$K)$"$93G<#V/%3?
MV/<+MWVY*QY(.SHI[=*]#^V,OWH<FI/MF6.8/I0I-!*,6[V/.X])8K%NC"I&
M=R +U4]12QZ+(H4(N%C;<IY!VG@CK7HC74;$9AY'M3_M$#?\L]O'8"M><YW3
M1YJNGM&NV,'"'<N6/()Y&:9]@96Q"[$H^Y3GEE/522*]$_L_3VD#LF,]L<5!
M)H=A-P':,<X %5SF?LT><7&GA0-@#M&VY& 4DJ>J\CI6>;>"S;:H#O&Y*X0?
M=/5?\^E>IS>%;*50$G:,=SU)I+7PCIMNLBG;(9&SN;!QZ 9_&HE)]#2,(]3R
M6&*YAODC2R+0Q@R+.I.-AZI@-U^O'%7ETUK=48C/DLQ6,,Y#1GJ#R>:]7;P_
M:8"HP1!V7'Y573P=8\D%E;^$Y!Q51F[!*$7LCR>^TUXXP6W2",%0KR%M\;>N
M5ZBO.M:&IVM\L,?/INXW(>G.*^E#X%MV<G[0QYRN5![=*S;[X8V5U)'(S!I8
MPV&;..>O /\ /-<U9.=K,]' U:>'DY3C<\7L+><6[27 5U$9CE8JN=O4'((Z
M&EDS=*^4:0,JB5HRR-N'W6&&X/TY]Z]=;P)!&<>?&ZJ""K# (QT([USE]IUG
M9W#QMMD(&&4 $8[9XJ4Y15KFO)"M)RY+G.M9S749;,L+O\WRSR)^^7M@@@ C
M_.>:)[83,Y61PLA$\2_:$(+@G<@##C^F.U=U8^&;G481-'%E&YP./H?KQ2OX
M7U%IA&UI)NSO!7U]<YQS_6NR,M#Q*E*S9YK)8Y;?;0L(HY/M<&V.%PR'AXEY
MR,$__7-0'0XX64-;1R06YR ;!=QMY"<HN&&<$G/Z@\5Z'<^&;N#:7LV1=[;%
M" X/\0Z=#6:WAMUCBS:-'"A9(P8@/E/)3ITIW.?V9Q#:%%"H^T6J;8T^QR,M
MK(A,3?=(()X&?7CKP:HS:<RQNTA*RD>2[1R28)7[I^;OC'/ZFN\?1QM#>5B)
M5\K;M.73^[G/45EW&BBX4-)\Z(FS=EOF7LPYZBLJE[:'51C%27-L<XHDO?,
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MIUP[=)N#[#^8KB6FIB+#3>]1--[U7:2HVDH$3M-[U$TE0M+4334 3M)4;35
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MAG/J&K127FF2VVF1_/))<J4>;CA5R.AXSCMD9KO/ /P%\(^ 8X)+?3DU#4D
MW:A? 2/N_O*I^5.?[HS[FO10E>O0R*"J*K6?G8^5QO'%:6'EA<)&R::YGO\
M)?D_P*\%K':PI##&L448"I&B[54#H !T%3*E2K'4BQ&OJ[6/RUMMW9$L=2+&
M?2I5C J0+0(C6,#M4BK3UC)J9(J0$:1>U3I'[5(D>:GCBH B2//45.D7M4J0
MFIUCH$1QQ>U3*GM3UC]*F6*F(B6.I5B]JE6.IECH B6/VJ58QWJ15QTIZK0
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M7(6>3&>S&H>$\S19@E]D^]+73]/B8RK=J=YSR^<YJW'I^G^9O7R2^.3@9-?
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** (Y.AJC>?<?\*O2=#5&\^X_X4 <OK7W9O\ @/\ 2N?T?_D;+/\
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M]*!FY_RR_P"V-8>K=#_UR/\ 6MS_ )9?]L:P]6Z'_KD?ZT ;7PNZ:E_VR_\
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M=7!5E!'R$YXJ//(7!QGL:L7@AM(49N6ZTD,_630/^0#IO_7M'_Z"*X'XJ?\
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M2=#5&\^X_P"% '+ZU]V;_@/]*Y_1_P#D;+/_ *[+_(5T&M?=F_X#_2N?T?\
MY&RS_P"NR_R% 'K5%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MFH]4U,0V^!\B]ZS]/U>*[CRHR_W?F[TR2S>6XN) P;Y >E7%;:@$8P.*I2R
M@%5VG-:4#11VK,SX.*"+EF%5W!I!\^,"JFM1R,NQ< T1Z@C\$]^"*K7UYO8E
M3G_:I-B/UY\.C;X?TP>EK%_Z *X/XJ?\A[2?^N4E=YX=_P"1?TO_ *]8O_0!
M7!_%3_D/:3_URDKPS] 6Q6T'I!_P+^M=IIGW(OQ_K7%Z#T@_X%_6NTTS[D7X
M_P!:!FQ%]U:LK5:+[JU96@!:*** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH CDZ&J-Y]Q_P *O2=#5&\^X_X4 <OK7W9O^ _TKG]'
M_P"1LL_^NR_R%=!K7W9O^ _TKG]'_P"1LL_^NR_R% 'K5%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH CDZ&J-Y]Q_PJ])T-4;S[C_A0!R^M?=F_P" _P!*
MY_1_^1LL_P#KLO\ (5T&M?=F_P" _P!*Y_1_^1LL_P#KLO\ (4 >M4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 8?C?\ Y%/5/^N!KRS0_NQ_]<A_2O4_&_\
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MB@ HHHH **4*33]HI7&, )IWE^]/HI7&-513J**0!1110 4444 %*HH I::
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M4C67:_.2H/-5K?5[F^ES+"HAWY1E'/YU9DA$K<9*YR<GFD62:;;KN(",%/
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M8_I5NZ_U;_[J_P!*J:;]P?\ 7,?TJW=?ZM_]U?Z4 <MK7W9O^ _TKKOAK_R
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MY0]:0$=%2>4/6CRAZT 1T5)Y0]:/*'K0!'14GE#UH\H>M $=%2>4/6CRAZT
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MT5?_ ()P^$),%O%6N$@8SLAS_P"@U'-_P3:\'3%2WBO725Z';#_\32]M ?\
M9V([?B?5/A,8\*Z,/^G*'_T 5P_Q4_Y#VD_]<I*]$TZR33=/MK1&+)!$L2LW
M4A0 #^E>=_%3_D/:3_URDKSSZPK:#T@_X%_6NTTS[D7X_P!:XO0>D'_ OZUV
MFF?<B_'^M &Q%]U:LK5:+[JU96@!:*** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH CDZ&J-Y]Q_PJ])T-4;S[C_A0!R^M?=F_X#_2
MN?T?_D;+/_KLO\A70:U]V;_@/]*Y_1_^1LL_^NR_R% 'K5%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /)_B-_R.0_Z\U_]"-.T
MGH/^N0_I3?B-_P CD/\ KS7_ -"-.TGH/^N0_I0!N?\ ++_MC6'JW0_]<C_6
MMS_EE_VQK#U;H?\ KD?ZT ;7PNZ:E_VR_P#9Z[RN#^%W34O^V7_L]=Y0 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 5YE\5/^0]I/_7*2O3:\R^*G_(>TG_KE)0!6
MT'I!_P "_K7::9]R+\?ZUQ>@](/^!?UKM-,^Y%^/]: -B+[JU96JT7W5JRM
M"T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!')T
M-4;S[C_A5Z3H:HWGW'_"@#E]:^[-_P !_I7/Z/\ \C99_P#79?Y"N@UK[LW_
M  '^E<_H_P#R-EG_ -=E_D* /6J*** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **\+_:(_:>_P"%"ZSI%A_PC7]N_P!H
M6[S^9]O^S^7M;;C'EOG]*\D_X>,_]4]_\K7_ -STP/L^BOC#_AXS_P!4]_\
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M-?B7H_Q3\.+JVD-)&4D,%U9W*[+BTF7[T4B]F'ZUUE( HHHH **** "BBB@
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MJJ*\]\%_M ?#WXA7R66@^*;.[O7X2VE#V\KGT5954L?H*]"H **** "BBB@
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M;7F7Q4_Y#VD_]<I* *V@](/^!?UKM-,^Y%^/]:XO0>D'_ OZUVFF?<B_'^M
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M%L/_ ,36OH_A[2_#L+PZ3IEGID,C;WCL[=(59L8R0H&3BOD#_AXS_P!4]_\
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MXATQ-7LM1U?5[&:PM[&UG65_WJ%"[!2=JJ&)R>N,"EJ!G?L:_&W4?BIX-O\
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MD>] CVZBBBD,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH \G^(W_(Y#_KS7_T(T[2>@_ZY#^E-^(W_ ".0_P"O-?\
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MZ'T%^S/_ ,D%\$_]@]?_ $(UZ;7F7[,__)!?!/\ V#U_]"->FTAGYQ_L,_\
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M$?@BYN?"^C7%Q-H=C)+-+I\+.[&W0EF)7))))R:^;?\ @H=_R.7A'_KPE_\
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M0 4444 %%%% !1110 4444 8?C?_ )%/5/\ K@:\LT/[L?\ UR']*]3\;_\
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M-!'<1P/'#;;@07+. 68 Y 4$9QDT6 \&_89_Y+U:_P#8/N?_ $$5^CE?%O[
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M_P!LO_9Z[R@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M9:E'$TJ>6S%C&X4%@0Q." >#CC'/>?&S]M3PA8^$=1T[P;>R:WK=Y T$=Q'
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MZA:'=;3>*-1:\$)SD$+@+Q[@^O6O6Z** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "O,OBI_R'M)_P"N4E>FUYE\
M5/\ D/:3_P!<I* *V@](/^!?UKM-,^Y%^/\ 6N+T'I!_P+^M=IIGW(OQ_K0!
ML1?=6K*U6B^ZM65H 6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** (Y.AJC>?<?\*O2=#5&\^X_X4 <OK7W9O^ _TKG]'_Y&RS_Z
M[+_(5T&M?=F_X#_2N?T?_D;+/_KLO\A0!ZU1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110!A^-_^13U3_K@:\LT/[L?_7(?TKU/QO\ \BGJG_7 UY9H?W8_^N0_
MI0!V>F_<'_7,?TJW=?ZM_P#=7^E5--^X/^N8_I5NZ_U;_P"ZO]* .6UK[LW_
M  '^E==\-?\ D!S_ /7RW_H*UR.M?=F_X#_2NN^&O_(#G_Z^6_\ 05H ZRBB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\!\
M=?L6^"/B!XNU3Q%J.J>((;W49C-+':W$"QJV ,*&A) X[DU[]10!\R?\.^_A
MY_T&?$__ (%6_P#\8H_X=]_#S_H,^)__  *M_P#XQ7TW13 S[C1H+G0I=)9I
M!;26QM2P(W[2NW.<8SCVKR[X._LN^%?@GXFN=<T/4-8N[NXLVLF34)HG0(SH
MY("1*<YC'?N>*]AHI %>=?&3X$^&?CAIMC:Z^+JWELI#)!>6#HDZ@C#)EE8;
M3P2,=5%>BT4 <=\*?A?I7P?\(Q^'=&N+RYLHYGF$E\Z/)N<Y(RJJ,?A7,?&7
M]FWPS\<=2TZ^UV^U:TFL86AC73IHD4JS9);?&W.?3%>L44 9?A?P_;^$O#.D
M:'9O+)::99PV4+SD&1DC0(I8@ $X49P!SVJKXX\%Z9\0_">I^'=8C9]/U"(Q
M2>60'3G*NI((#*0&!(/('%;U% 'D7P=_9G\._!'7+S4M U?7)S=P>1/;7T\+
MPN 05;"Q*=P.<'/\1]:]=HHH \3\=?L>_#7QUJ$U])IEQHMY,2TDFD3>2&8_
MQ;"&0'//"CWS5?P;^QC\,O!]]%>-IUUKL\1RG]KSB5 ?4HJJK?\  @17NE%
M#(XUAC6.-51%&U548  Z "GT44 >-_$#]DOX;_$*^EOKG29-)OY23)<Z3+Y!
M<G^(I@IG.>=N3GG-8_A7]B7X8^&;R.YFL[_7GC.575;D.F<]2D:H&^A!'M7O
ME% $5O;Q6<$<$$20PQJ$2.-0JJHZ  =!4M%% '"?&'X/:-\;/#-MH>N7-]:6
MEO>+>J^GR(DA=4= "71AC$A[=AS5KX4_"_2O@_X1C\.Z-<7ES91S/,)+YT>3
M<YR1E548_"NQHH *\4^*W[)OA'XP>+G\1:SJ.M6UZ\*0&.QGA2/:@P.&B8YY
M]:]KHH ^9/\ AWW\//\ H,^)_P#P*M__ (Q1_P .^_AY_P!!GQ/_ .!5O_\
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M%XRO(+%=$75;J[+)=!I/+D\S;\N.OSCBOL>F 4444@"BBOS\^$G_ "?I??\
M8?UO_P!%W5 'Z!T444 %%?//[7?[05]\']#L-)\/LL?B'5E=A<N@;[+"O!<
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M?PC9:_#<>(TGFMFL%BD#"2(,9%R5V_*$;OVH [FBBB@ HHHH **** "BBB@
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MX4 <OK7W9O\ @/\ 2N?T?_D;+/\ Z[+_ "%=!K7W9O\ @/\ 2N?T?_D;+/\
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MVH-?M=#:5=;GUN.*Q:"7RI!<$H(RKY&T[B,-D8ZY%=S_ ,*D_:C_ .?[Q/\
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MC1O?#.#COB@1SGQ,_:H^'_PMU.73-1U"?4=5AR);+2XA,\1_NLQ*J&]BV1W
MK,\!_MC_  W\=ZG!IZWUWH=W.VV)-8A6)7;. -ZLR GMDCTZ\5\\?L<_ 31/
MBRVM^*?%L,NK6UK<BWAMI)&"33%=[O(0<MC<O&>=QSFNG_; _9K\+>$/ O\
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M?^N1_K0!M?"[IJ7_ &R_]GKO*X/X7=-2_P"V7_L]=Y0 4444 %%%% !1110
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M<"ZTV^B$L,F,''0@CL0001V((H V*\R_:8_Y(+XV_P"P>W_H0KTVO,OVF/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "O,OBI_R'M)_P"N4E>FUYE\5/\
MD/:3_P!<I* *V@](/^!?UKM-,^Y%^/\ 6N+T'I!_P+^M=IIGW(OQ_K0!L1?=
M6K*U6B^ZM65H 6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M>^?]7G.>_3BO3J8'XT7GVF&3[-=>:LEMF'RI<YBPQ)7!Z?,6./4FOU]\%_\
M(FZ#_P!>%O\ ^BUKP+XR?L3Z9\4/'%UXDT[Q"?#DEZ ]U;"P^T+)-WD!\U-N
M1C(P><G/-?16BZ=_8^C6%AYGF_9;>.#S-NW=M4+G'.,XH$?GAXN_Y/@@_P"Q
MNL?_ $?%7Z.5\XZQ^Q__ &K\<(_B)_PEOE;=7@U7^S?[-S_JW1O+\SS>^S&[
M;QGI7T=0 55U/4K71=-NK^^G2VLK6)IYYI#A8T4$LQ]@ :M4A 8$$9'I2&?/
MW@?]MCX?^+->U#3KZ>3P]%',5LKR_P"(KJ,8^8D#]V2<\-QC'.>*].OOC1X
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M'-?(/_!03_DLVC?]@"'_ -*+FOMGX=?#/P[\*O#Z:/X<T];*VSNED)W2SO\
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M &586]C]HV;/-\J-4W[<G&=N<9.,]30!MT444@"BBB@ HHHH **** "BBB@
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MY#^E-^(W_(Y#_KS7_P!"-.TGH/\ KD/Z4 ;G_++_ +8UAZMT/_7(_P!:W/\
MEE_VQK#U;O\ ]<C_ %H VOA=TU+_ +9?^SUWE<'\+NFI?]LO_9Z[R@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% $<G0U1O/N/^%7I.AJC>?<?\* .9UK_ %<W
M_ ?Z5SNC_P#(V6?_ %V7^0KH]8^Y-^']*Y[1U_XJRS/_ $U7^0H ]8HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 8WC%=WA?4A_TQ->::+!@)PW^K']*]/\ %"[O#]^#T,1K@]+MU54Y/^K'
M]* -NRC(C'!^X/Z5/.N5;_=']*DLXQY8'^P/Z5+/%\K<=A_2@#DM:C.V; _N
M_P!*ZGX<KMT2<'_GX;_T%:P]6M]WF_+Z=_I71^!8_*TF88Q^_)_\=6@#HZ**
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** /+?B%&6\7 @?\ +HO_ *$:=I,?RCC_
M )9?X5:\<6_F>)PVW/\ HRCK_M&GZ;;[0/E_Y9^OTH N;?D_[95D:K'D'G_E
ME_C70^3\O_;.LW48<J>?^6?^- %CX:KM&H\Y_P!7_P"SUV]<GX#C\L7O.<[/
M_9JZR@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ KSGXF)NUK2^<?NGKT:N&\?0^9
MJVGG.,1MVH RM#CP(.?[W]:Z[3U^6/\ '^M8&DP[?*Y]>WUKIK&/Y4Y]: -"
M$?*IJPM0Q_=%3+0 M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 (WW:K3+UYJS4;KUYH Q[V'(?GT[5C31/#,TL<FUUY4XZ'%=1
M-'D,,UGSVV2WS=O3VH YJ[UO5ESMU!E^7_GFM95QXDUQ>FJN./\ GDO^%=5-
M8[L_/V]*HRZ;G_EIV_N__7H YEO%/B#_ *"[_P#?I/\ "F?\)5XA_P"@P_\
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MT?V7_P!-?_'?_KT 8'_"5>(O^@P__?E/\*/^$J\1?]!A_P#ORG^%;_\ 9?\
MTU_\=_\ KT?V7_TU_P#'?_KT 8'_  E7B+_H,/\ ]^4_PH_X2KQ%_P!!A_\
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M_P!!A_\ ORG^%;_]E_\ 37_QW_Z]']E_]-?_ !W_ .O0!@?\)5XB_P"@P_\
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M_P =_P#KT 8'_"5>(O\ H,/_ -^4_P */^$J\1?]!A_^_*?X5O\ ]E_]-?\
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MV;'_ *!M_P#]\+_C7-_V'_LS?E_]:C^P_P#9F_+_ .M0!TG_  MFQ_Z!M_\
M]\+_ (T?\+9L?^@;?_\ ?"_XUS?]A_[,WY?_ %J/[#_V9OR_^M0!TG_"V;'_
M *!M_P#]\+_C1_PMFQ_Z!M__ -\+_C7-_P!A_P"S-^7_ -:C^P_]F;\O_K4
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M '2?\+9L?^@;?_\ ?"_XT?\ "V;'_H&W_P#WPO\ C7-_V'_LS?E_]:C^P_\
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M-_V'_LS?E_\ 6H_L/_9F_+_ZU '2?\+9L?\ H&W_ /WPO^-'_"V;'_H&W_\
MWPO^-<W_ &'_ +,WY?\ UJ/[#_V9OR_^M0!TG_"V;'_H&W__ 'PO^-'_  MF
MQ_Z!M_\ ]\+_ (US?]A_[,WY?_6H_L/_ &9OR_\ K4 =)_PMFQ_Z!M__ -\+
M_C2CXL6)_P"8=??]\+_C7-_V'_L3?E_]:E_L,#^&;\O_ *U '3K\4;-LXT^]
M_P"^%_QJU'\0K63.+&[&/51_C7*1Z+C/RS?E_P#6K1ATK;N^63\O_K4 3:M.
MFL:K]I2.5!Y03##T-7+.UV]F^Y_A3K>QVN>'Z5J6]KCLWW: (A"=O3^"J5W:
M[NR_<_QK=$''3^&H9K;=V7[M &5H]]'HOF^8A;S,8V8[9_QJS)XXM8\9MYN?
MI_C3)['=MX3\JS)=+W8^6/\ +_ZU %UOB-9KUM9__'?\:9_PLJQ_Y];C_P =
M_P :R'T7./DA_+_ZU1?V(/[D/Y?_ %J -S_A9EC_ ,^MQ_X[_C1_PLRQ_P"?
M6X_\=_QK"_L/_8A_+_ZU-_L3_8A_+_ZU &__ ,+,L?\ GUN/_'?\:/\ A9EC
M_P ^MQ_X[_C6!_8G^Q#^7_UJ/[$_V(?R_P#K4 ;_ /PLRQ_Y];C_ ,=_QH_X
M698_\^MQ_P"._P"-8']B?[$/Y?\ UJ/[$_V(?R_^M0!O_P#"S+'_ )];C_QW
M_&C_ (698_\ /K<?^._XU@?V)_L0_E_]:C^Q/]B'\O\ ZU &_P#\+,L?^?6X
M_P#'?\:/^%F6/_/K<?\ CO\ C6!_8G^Q#^7_ -:C^Q/]B'\O_K4 ;_\ PLRQ
M_P"?6X_\=_QH_P"%F6/_ #ZW'_CO^-8']B?[$/Y?_6H_L3_8A_+_ .M0!O\
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MVMMNWA:OQ1XQTH EC7@5+357I3J "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "FL.].HH B9<@U"T?7FK6*;L]A0!2:#.?F_2
MH6M?]K]*T?+]A2>6/0?E0!F_9/\ ;_2C[)_M_I6CY/L*/)]A0!G?9/\ ;_2C
M[)_M_I6CY/L*/)]A0!G?9/\ ;_2C[)_M_I6CY/L*/)]A0!G?9/\ ;_2C[)_M
M_I6CY/L*/)]A0!G?9/\ ;_2C[)_M_I6CY/L*/)]A0!G?9/\ ;_2C[)_M_I6C
MY/L*/)]A0!G?9/\ ;_2C[)_M_I6CY/L*/)]A0!G?9/\ ;_2C[)_M_I6CY/L*
M/)]A0!G?9/\ ;_2C[)_M_I6CY/L*/)]A0!G?9/\ ;_2C[)_M_I6CY/L*/)]A
M0!G?9/\ ;_2C[)_M_I6CY/L*/)]A0!G?9/\ ;_2C[)_M_I6CY/L*/)]A0!G?
M9/\ ;_2C[)_M_I6CY/L*/)]A0!G?9/\ ;_2C[)_M_I6CY/L*/)]A0!G?9/\
M;_2C[)_M_I6CY/L*/)]A0!G?9/\ ;_2C[)_M_I6CY/L*/)]A0!G?9/\ ;_2C
M[)_M_I6CY/L*/)]A0!G?9/\ ;_2C[)_M_I6CY/L*/)]A0!G?9/\ ;_2C[)_M
M_I6CY/L*/)]A0!G?9/\ ;_2C[)_M_I6CY/L*/)]A0!G?9/\ ;_2C[)_M_I6C
MY/L*/)]A0!G?9/\ ;_2C[)_M_I6CY/L*/)]A0!G?9/\ ;_2C[)_M_I6CY/L*
M/)]A0!G?9/\ ;_2C[)_M_I6CY/L*/)]A0!G?9/\ ;_2C[)_M_I6CY/L*/)]A
M0!G?9/\ ;_2C[)_M_I6CY/L*/)]A0!G?9/\ ;_2C[)_M_I6CY/L*/)]A0!G?
M9/\ ;_2C[)_M_I6CY/L*/)]A0!G?9/\ ;_2C[)_M_I6CY/L*/)]A0!G?9/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 2BEHH 2BEHH 2BEHH
M 2BEHH 2BEHH 2BEHH 2BEHH 2BEHH 2BEHH 2BEHH 2BEHH 2BEHH 2BEHH
M 2BEHH 2BEHH 2BEHH 2BEHH 2BEHH 2BEHH 2BEHH 2BEHH 2BEHH 2BEHH
M 2BEHH 2BEHH 2BEHH 2BEHH 2BEHH 2BEHH 2BEHH 2BEHH 2BEHH 2BEHH
M 2BEHH 2BEHH 2BEHH 2BEHH 2BEHH 2BEHH 2BEHH **** "BBB@ HHHH ;
MMHVTZB@!NVC;3J* &[:-M.HH ;MHVTZB@!NVC;3J* &[:-M.HH ;MHVTZB@!
MNVC;3J* &[:-M.HH ;MHVTZB@!NVC;3J* &[:-M.HH ;MHVTZB@!NVC;3J*
M&[:-M.HH ;MHVTZB@!NVC;3J* &[:-M.HH ;MHVTZB@!NVC;3J* &[:-M.HH
M ;MHVTZB@!NVC;3J* &[:-M.HH ;MHVTZB@!NVC;3J* &[:-M.HH ;MHVTZB
M@!NVC;3J* &[:-M.HH ;MHVTZB@!NVC;3J* &[:-M.HH ;MHVTZB@!NVC;3J
M* &[:-M.HH ;MHVTZB@!NVC;3J* &[:-M.HH ;MHVTZB@ HHHH **** "DVB
MEHH 3:*-HI:* $VBC:*6B@!-HHVBEHH 3:*-HI:* $VBC:*6B@!-HHVBEHH
M3:*-HI:* $VBC:*6B@!-HHVBEHH 3:*-HI:* $VBC:*6B@!-HHVBEHH 3:*-
MHI:* $VBC:*6B@!-HHVBEHH 3:*-HI:* $VBC:*6B@!-HHVBEHH 3:*-HI:*
M $VBC:*6B@!-HHVBEHH 3:*-HI:* $VBC:*6B@!-HHVBEHH 3:*-HI:* $VB
MC:*6B@!-HHVBEHH 3:*-HI:* $VBC:*6B@!-HHVBEHH 3:*-HI:* $VBC:*6
MB@!-HHVBEHH 3:*-HI:* $VBC:*6B@!-HHVBEHH 3:*-HI:* $VBC:*6B@!-
MHHVBEHH 3:*6BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
2HHHH **** "BBB@ HHHH __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>silk-20191231_g5.jpg
<TEXT>
begin 644 silk-20191231_g5.jpg
M_]C_X  02D9)1@ ! 0$!+ $L  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P@ 1" !4 3X# 1$  A$! Q$!_\0
M'0 !   ' 0$               $"! 4&!P@#"?_$ !P! 0  !P$
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M[?R/J?5.R^R^/?:,($"4Q$RLUP;X.BC49OD@0(%J*8I2C.;"I-\&8'H
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M7Q?UW[9XT\XRRF/1A\CC>YT47LZ(+92NL>H7MVO,1 F)CT)B<G)B)[F>E:
M    4\(Z,LLS2PGS"O9;5N,>             !8"_@
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MG(AZ/4:^Y_W8MRH\8?\ '__$ $(1  (" 0($ @4&"@H#      (# 00%$1(
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M6!::/W0CI"\:&)EF"+E9BCA2.F$6W64*]E1O=18DJ=O.+0$-%L1(1"4/'2R
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M/F"HQK8[S(ZAM4,@M' %[=8-R.&_?:U\1T.44>SOT41G98TOOEGD<D(BCB>
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M_)3H,)'6\G,JJ$C;4@DIEYK<-Q%C]-L*R\DLG#*0RD4^\$=O2QXL9/\ FI$
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M6"?!+#UETO[=D.W\>Z"'.[PZN15K$%'N-A^;4T(5;96R5OI5K[-29.:T4%J
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M"Y44P5NN,] ;4(K75XO"H!'@;V[QIO1B[GB!MKV+BY35REMEZ.45_D>1 K8
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M T##K]+!(ACF$$Y H'6I8O\ P;__Q  J$0$!  $$ 0,"!@,!       !$2$
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G1THKSI-T.Y-S?1UORXI,G[@E7AD4&W_.;BQ"=.+8"JQE_P#(O__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>silk-20191231_g6.jpg
<TEXT>
begin 644 silk-20191231_g6.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_X@) 24-#7U!23T9)3$4  0$   (P041"
M10(0  !M;G1R4D="(%A96B 'SP &  ,       !A8W-P05!03     !N;VYE
M                        ]M8  0    #3+4%$0D4
M                                              IC<')T    _
M #)D97-C   !,    &MW='!T   !G    !1B:W!T   !L    !1R5%)#   !
MQ     YG5%)#   !U     YB5%)#   !Y     YR6%E:   !]    !1G6%E:
M   ""    !1B6%E:   "'    !1T97AT     $-O<'ER:6=H=" Q.3DY($%D
M;V)E(%-Y<W1E;7,@26YC;W)P;W)A=&5D    9&5S8P         1061O8F4@
M4D="("@Q.3DX*0
M
M6%E:(        /-1  $    !%LQ865H@                     &-U<G8
M         0(S  !C=7)V          $",P  8W5R=@         ! C,  %A9
M6B        "<&   3Z4   3\6%E:(        #2-  "@+   #Y5865H@
M    )C$  ! O  "^G/_; (0  0$! P,# @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @$! 0$" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @("_\  $0@(< RH P$B  (1 0,1 ?_$ !\   ,! 0 # 0$!
M 0        $" P $!08'" D*"__$ & 0  $!!@,'! (! P($ @( )P$  A$A
M,4'P46%Q X&1H;'!T002X?$%!A,'""(4,@D5(T(6,U(7)$-B<AA3@I(9)31$
M5&.B18.3)C4V9'-TA,+21F6%LK33XE64HZ3#_\0 '0$! 0$! 0$! 0$!
M      $" P0%!@<("?_$ %,1 0 ! @(&!@<$!P4&! 0& P ! A$#(002,4%1
M\ 5A<8&1H083%%*QP=$5(N'Q!Q8R0E.2TB,S5(*B0T1B<I/"%V.RXB0U58,T
M1:/#T^,E9'/_V@ , P$  A$#$0 _ /\ =8,-W'.EU6Y74W-8W?)Z6^: _-.-
MR6.CW\_I+=[]R9\LGH"/GZXK.O'SKJ@1=_2%]7_/) 3ED[MPBZN"(\]T#V\(
MNY0RP/5!F=W2F'%8WO\ "0C!\$S1OA]H&N[T0?WN55@SAH@1OK._" =W]::B
MJ=]W1 "^:/MZY8(!];NNY:[<B@]UWXR0!W'=TSY)H<^@4]$XO?XJ@!& MPZH
M/QMUZN6?AW[)7;[ZH&]VF=WF@[L/I*[+J]8<[IT04%3PS>@>EWN1W/"!,KW8
MH"!AR0-[_*P.#G</CM)!IJW8H!I&W93<BZ\+Q29<TYTON@89NZC!;Y?K?59@
MC3X-Q\)=VOFYH,3\QGIW2.K'.[=)/[:]!@L1@]]_6J#"STU2F@TYQ[ZNDL>?
MRB&9=;@@+M/M8:;[RBLU]3*5JX0^D!:&MW;DK[#M$YODDP=Y NB @6^,KGDL
M;E1"]/E%U[O.Y +N]40SG?4I7W-59:RLYH)-#$V(S%T3N&.$NUR3&Z;DEW<D
M&P$[<[X6%PN*V[N_?;EN*#/N^JPW50%W1+=BQ@@-N@CNYW-*+SOFF?\ ;MSK
MH@ L]!FB^[Y)@.-]$"- [E=4 ^N.3D63;^YJLF OYO@@)S=XOOHD&=TXE-"[
MXI63?>^*!P,AC7")WK'?/)V5N0?<IPWI2@=]7>73Q27?7(H7GHZW+ 5Y1L<T
M#/SNWN6?=_62'#/QKGHENIGU\(*;LX87CU0(\<KZH!8CINOF@QW[G=D0SC'7
MX2 \KM\4[M^_@@QMQO5$&]T\4"+NG%8&^76:#$[M+^.:<"@TOLH_&FY.R7?4
M- @/MOMHE.MWBJ>[6F:0H-WN]RPC3Z2G'KXY15 [M5 >[TK^O8HNRTOFEY<D
M%66;W7DE=DMVLNN".J  G==Q0]G:F2<M+$H(NOM]P0?<'>54Z%*;ROP@5^Y,
MS@[ZL).E'TODL^-];"!VO$-U%KNJW%^/C.D4"=?.M(R0&];*(O=<E,&5W!#?
M"AZ(*$W=N6?EG>*3"[MRI=W#-!G7"$*( V\4L)2:>;L+ C=1Z!LM<;MZ5JXX
M^4/NW7P6=8A! P/?2\%CP?-U=7X7)$,X"[AHDZH&#+Z\)NU\K :W\H,G<,4;
MG! 97I91=WT2-76W(],X".71)#<^'A]O6'GMS2OLK!K+G>]!32O:M[D?=>Z_
M"4-7N<_/DL>UY:P0%WCXW8[EG7E<LEAI7N$S-\2@FT);NE^$ TZPJ%B[*4Z<
MOE #CC/PB^[BB_H,JK 7=T0#6\;XIDCG65@..^$+UR0-P>@[*_N?%%W:W.W?
M2P-+L("SX0(O5Z)"T[R0+NNXK$87GOX;TKCC>*)N#T =K<^-S19['>B&).RZ
M]4!G@] SL19GI,I-SKS3$YK>VJ @TT&Y*:.NJ8"J#^_:\$&.@G'4ZXH,[C68
M1;%T2>VZ20.;^+YK&YWWBCE>=[EA\888H% W3[/5+O<I7+CSDJ7RA>* -%(-
MVM<D6KWWN68YW>:!7=\UG*F$.7RA>4?"# 7PLK'SNA#Z0 QN^B?W7O*"+K<F
M&4+E@L3GWDDN]$#PPCE@@!7@'O)P\H^+=Q0OL@6WUX5")X/M[^(XHOETRBEZ
M7! 72KNQ3LFZX)'W%:XY7N0.!>&/W5$7!#W=_MW)8"6O1 '8@<,GE()QC3(Q
M@K&#MZ0#%^Y 70O3A]/6 XV[PMIS6!XTMWA ")7*JSKUUFF?D,L]$N[1!,&5
MONO)4=>&G6F:S-UXW! =>: C@B!2<^W7JB!;^MP0=VK2R@4C3ET3 7NQ0MZ)
M^4"OTC6JH[SWGW4K==T3C3Z08B[O%RS\M_+I-%HK-5G<+WH%=SGOSM]5KA*^
M:QHZ]RP'WXN* C/- C+"6&B3YF^^:-CN@=]N[Z)+W6Y"\-5G]O%V$&'!]S[K
M#NL18>BZQ?+! 7[W<T",G3?*%\]R;)UY8%(3TN]]4  REI*7VF%>.>[HEKD^
MIBY$#??R@8Z#=7#/?!$&[MR'M^^2U\KT08WIX&[) G(Q=%$4A**#^%*;D!-W
MJ.2S[Y6,$"<.9X0N"4X1^;X(']M>VZ#T1;M0E?=)=][DX=ABY_9 0.Z1O-,_
M+.:5H;^.EXH,(4O"\5GSAY<]Z1V>,<,?M,/H6/E!@SVE\_2(%ZW!'=\WTT6)
MN\D$S3"<HWBJ RS=S2ONZHW&^*!7W"X]4PS<;O5 V_#Z0 NZYH'S/;A>"WNW
M7X6+/*_A*<L[[(&?3G6S\H \+^DH-_/5.[@@QS&%$ <%F[P0!R^4!=+J@!1T
M>%]TQTNX)+O"\T# BM;=Q28OROAU6M\=-.R8\+I?)!F3A?W+),&L77&W*>^[
MX+/XWV^$#NP-ZZ(&?#3<A[K=T* O*\XH'?>.2)I>EU4U4'OH@7=R[K 7C]($
M;T .MR+KT0'$&<IYK<=Y1<@1I*_&"# _>_-,ZG/C?T@#C=\T2UATNXH$>M>=
MVY9UW>2TT&=(^+[IGY7>] "],MUA;#"F-$ =3X* /1R%X[_E,Z].J#$RO*R@
M/BZ[DUQOZ0(N[Z(,_=)T-')C"7U@I"SY3B71U\8(,UM)"]W?!$;_ +2D7<KF
ML,[I!TD#.W:)AIG'/5*_X??RAP/A V+QSNP]'=D_!*.<;N86?AY.: ON]$S-
M[^JF^[[IF6M-3OOH@=WF^Z#[WN'3@BT@3C*/UPX(#[?,LE+)RK[MVZ^*#4>2
M"8S$K+C),;[;DF[7$Q3$7D@PZSOH4MWB$3=]T.N^^R!@:/[ZK=-,8I7\%G[\
M/J^R![O2OE(U;J)@^[JE;-]?" [KQN:4#SVOFB#PIBE=>^?D50-?*[>L!;[\
M)2+FF?K?DR0'W?"897.QDE-W<)(/OL=\T#(G'AFE?>Y8T^^-RS0-KTX)O=A6
MO>ZJ1SA\Y+#YT==A SKN:+L<I<G)0,KO<F+L^:!W5Y.X30)TI>CU-^N7#JB"
M+[;T#$]DIO/2\%G];JL19+T"OE?5.+@$%G_7UE!ZL DT\7%8:"?VEZ=NJ(-W
M]* [LH<+^$>N* 9O!,[J? N2  7CJ$31V5O-S0PQP6'Q&^>Y H._I'#7LBSE
M\HD72E_*!&Z[YH&=WZ(N0'7RM]?5[T"ORQQWWQ3/IIPTO)!V5W-8"F5WN0,#
MH^.MOBE)[[JA8[^&=A8W".>E$"-"[FF'A"_'18('!K<P_P"4#PC\6]$7?/BA
M=BX%!GT\&[<FW9[Z?: $B+Q2.M\>2!R;?9N"&ZYK'?G<T-,/NZ(#WK<78H?%
M%A3+E8*V&5[T!.-WFL_>4K[%TNB!NYRX('SOA<TH^9.F7?"7AO#DX.D>E$#L
M\<^M$I(DZY+?,R5KY7\( ZYF:U]^2S6GE+RLV$!TA+C?"25]'.>^W9HOMU[R
MM\6Y ".6447:(FFD<W7N1!NX[T \V]8-3S?D>G!8\L\KMR7=U?=Q0,=);K\(
M?,+^D3EQQO>$H^90O%!KX4-4Y^(7K%(!=W@G=C!V%\?DH 0[.X.RZ(OX7QT0
M(\)3KUZT[(']LKA]+%!]5AG>%\$& N,?*SHQCC=XH7>'1RU_.-N@@/(87)$+
M/OX0?EPNZ(,[#*7/D]#&]Z(._3H@_-!GT%WABC[=W020?&X6$2UA]4^$"BGQ
M!.R=+^MXT4\.%PR1N?:7! Q&+C=%NGBYK.XW]H&_I!@;QW(GB(?"6\$SN=^8
MH [XER0W8\NKT3PN]RQ%XWR09]ZTU6XOO+DE'CI?!.!NH$&=2=X=4@S^?NPF
MN["S5[_%$&XW=A80IOK>"PUI\($_#A=X(,1X>+E#5 C.:.AWNQ3/L40*^7&^
M*SKE2J+W7NL(7N<.R#"W0AO3/N)\1A%*#OCTMR)W==]P0((\X)C3A\?*QOY1
M=G\TO! O#)%U!B-UT1-[[<"EOQ>,9(,1*Q'G!T$ +X='+:SERKOX/19$T!=W
M0+72[X)K?D@1VF..=P0(>L.,_M$&/&XY6Y:^-5K?>,D!?B/I#SI)9]\.X=@L
M[E;M'=T#'OP2C#PB1=X8]D!V[7XD@S\M>$$W188(7QR0.R*7KV&];76\+>D%
M*RYIC<;KQ0([SO\ D319WV)^$2):U6[H!OQO.,.*/V@1B,A\&BP^.>=$& OX
M0?RYZ>$;'"66]9V4>:#$_/R4!6Y?*:_-R2FY;[F@9F@N5P6:9WP\=N*QRD*U
MO*1W)24#C&_B6>2PWX3?R6!%Z4WHFCK\9T0$F%:5Y]=VB4Y\:7D@_P"W7<EJ
M7P&"  W>&"SKA>] 7=$SO$B@ &&!Y<TP%*0W&72DUA2)6%G=PUH@#KO[P1PK
M>."+I/Y52FFZ[U088.1+._">_3NL*?5W0K>ZQ'X0N)S.F4KU6.1QXU?K5 '>
M+OFM?6Q@@:Y9>$@SMTN&$T U=W5%D]87B@+KKC])3,W6XIR-"-7G-!V$,:S0
M*T-]> QQ1'GZZ(N^W6$([X=$!+4'5=YYI7WK](.M]\?*V.@O)!AXK@_%$GO?
MPM?9R#^?T3ODA,B_QWT\K8;D#<<+*&ET.-\$&\NNZ(OUL(=;LHW2_" ]RY$?
M/3NA=X6\(BE[N6"#&^5NCBE]U\G7-$WE<D1I?;@@SKPR?K96P^!F,T'ZQW3[
MP6!I&XOU?R0,R.[]0MENO'P@_O4T6]SWW>Y!B9[CQZRGD@_.^Z-WAKR2C.ET
M0'KQ3#ZOO) 7NY($3T%Y( 3*M>3L$BH51%B8X>9O=67#CKHB+PG?93?=PWIA
MPYR-O1#<4A._D_<L3F7OL#Y1UX/RC#<[F@)W\KJY ,U>B#.-;* /7XLH"_.^
M"+[Z?:6\4YN[J4 -TXK/6?I=N^$A-NX(*,V?G.YI"[3M=X(LG-R!/>X(,_5]
MR3LE1)ETO1:=W\2D@L3 \HK?%G@]*,'O^D=U!X\( 3;LH%!^KL#WN2<?-**9
M08^>81&_AU2@^%@>/'EH@8[^JW6\E,FL>/+RL3JZXH'?+25W- Y^$0=;N2S_
M #=+" DZI+TEAB]$U%-;YH9;H7S08B@>["B(J+@'K [MUP1]W6.>#GH$?>8N
MB+[[I0<?F7+%$=I_"!GT12W?99U(QXWF@Q/>%X9H@XO&FE]$SKROHD._KOON
M@S]=^ 0XWSBC<B@Z\?/T@+K[O00!G=ZK#O\ 'S3% S[Z3N29D_6*7??"M4UP
MZ/Y($:QS&X7<$V!Q?1R1K)]=V(@F)UTOK) WNUD[)X0]O:[FA+E7AU6?8-YH
M U=+O-$6.GPE:IEA*]'O>CEG?P4"NWRDB_6=PTP1 ^S/ZZ+&'''1!NWA9^O6
MQBB9=IV]*Z=NA1V" W?DZ+%J[RW06]K_ )O[S1([9]$ 3#?;GI&3+EBG!YP%
M]T#.G#3@_E-3OIAR6)Y0O3&2 TN=]D#/O[Y9K.UO"PEX\;WO1/.[AD@UWCT6
M^D/F_E9T]U,;<@+_  AE>CLT':[[N*;J@UNOAR3$Y&Y7@DN\HPXK"];J@-]$
MXOSDD OXYP[K;ZH'-'7=O6NDD'\.%X!*;[RP0$B7*Z(!K4=$66J+.LVY!C;[
MX=EG:X.ZHAF[YK>WZ.7/2J#)AR&=^4C_ !?"%$0;^(:H'>.%]SHLSO\ K#<I
MD\/%[E1\NEW@@Q-[["SL3CXO!9^;]TM-\$P=A;HH 3K,=^24WAE!4/;2)DIO
MS.Y 2-782E<HK!G.[W+<9NDA>:!7.P0O#F5M?)NJ':Z<T!]UWHB=^ET0==Q#
MUN.%^4!UO#G1)?>_M%^%WQHA;^6[H@PZQQR<J/&E][DE%WFL @+KN]R#I:7Y
M6=>=RX+#/YO["#'2[P6OZY(.O++RB!=X\MZ OW7)!_.]R/M6N\R@5_Q?1,+X
M=Y!Z#N->B(N[XH#E26"(%_"4%#W;HN-TX]4!=C>71!]SZHNSA=E!US@@;W7Q
M0]U(RR6O"^RF^\']L/"#H9:OX N29]Z\E%]X_/TB/$3BY!8-=7<%(L/QK-$-
M?*'O[Y(&9.6?#N^W(DXZ=TA:OBYZP+]_;IV0#W<-ZH//1RFRSQSNZ*A$MZ O
MK'1!J_B^"S(WQP3$8H$:NN')89/#XWAW"5^(.J;W9XGD@W@=9R6)H?$%B<+S
M2 ZSYW.B!V2@_*4>UX+:&^%4!G3R@+KM^";C9L+<>B!/6[L [U+W#,?'!%[[
MN:)AOWSN2 -&W7!S]4'X4IC=-V"WNSO%(3C=Q<@):USO+LGV9MZD[AA?4=4P
M';!YOP@Q-OXHLFDXTJE?\FZIF<K.'"6X(* 7NG<$&G7I@L^]W-R4G6[N:!@U
MVSA<T'\<S/7)*] 9W@@<'5!H\W.X('O??BESOX0 X6>%T1<ZE[Y( 7=N"+[G
M?A 0UA>81N&%GB@[ZC]I2UA- [[/>X0*4\J(=[KBGK'X0(@;TA3IQ5'#+<IY
MRC=N0%_>\^R87TMR07\T\IF1\7V[H'+65G6^ZDWR2OM]R3'-^D.EN0:W(OYV
M(7!!V&;_ !?1,!F.>Y 63SN\,$"$7Y/\U2@4CPB@ &#^@SLB28#A7&5%AEFB
MT<_I!G8F1OCVDY*3A?'KBLS>-XX<$";/#"Z('9/'3Y6 R* %WR3/P^KNB!&C
M*=X8+%U2<O"QP'F[@@^\$#".+]XIX1([7NJB#JL1<+"! S?RF9[=\NBG[D[.
MJ &[O!(<.M[CHX)B=\YF^:Q$^2!1O%^%OD79BLZ[SN2%V,:\$#:OL31?QN/C
M&*#OLQ0N\$&(U^*^.5$V1P[/N<((7X1&9$[\H,$Y=F-R &:!:SYTE?%!GU^I
M+.0PN.'CPF=W0(_37HZ^*8N\.2$<TPN^:!=_QP1.^^Q3:1TY)3KRO.,4#.Z8
MWKHBP7.2;W\,[P0'C/[ZH')PUL<8I7K7&[G5$#3E/?808B^W'RB\>'W/#=B@
MT=']*H&Y=T ]VO7EER1!Y6_18"^%NI@@<[LXH#G3-'=K=P2"[I;HHONMW5 7
MRWB,O" .HY718=3CER09%QTO) PN-\=4<O%RP2@7QZY(V?CR@'CJZ.-$_NUY
M% .AA?6\5G737D@#^/T[)_5%V$LW:_2#KS\HGOE<ZH,;EU2X<BC]6\6Y!VD7
M&;Y?62 &_-(IGWX"47PGJF(SOY0%SL=,NB4_%_-4P%WQ2.UI=\T#<<L'WDAU
MY7BC>7&BP&7>\4"NG]8#E])F3W=PS2WAI,H?4[L(*,BEY/C5$FEW1*R:'=\[
MEOFN=W%!GI@<7Y1"5UW82&MB_I S_@Z7<$ ;CVL+93CUX(CMKX^T&==(<UC8
ME;UK^>L%C+L,NEO0$'(YCN],>/>W1"07GAY>F&HZF] @'&];"S[[WJL#<[^4
M#>-X(,4'WR0L7>"9W>F: ?66-4_6$J8 W')+>.,KYH!J[GG6J \1<;<MW\7)
M!V?G=E>:7S>CLIH'&G),#KEI2:3AX6YYW<D#WP>E:TGE=O1\_6J!N_,D&=7A
MYCTWK#/O?*"SIW=N6-_'C@@<W>B73"]Z -SY=ZIA>OR@9^72["6'U'G\9+$]
M;A?-*!UM]\T#[M_>-:)"9:WJL^[GF4P%NUQ0&X.N%S27=ZHFMW9.*SK@@%^>
M'!-HXWT,>"0B[^$ ;SO<@=V+]#E3YGFA>=BX(76]$=V[&Z%!A3PM=O<@R.VO
MQBCO>Z^MX!CTI>7%%VNFY V,^%S6=/'MWL(&>,^EQ6ZROEI)88:06M[[YH ;
MNWY+$?7T@(7=Q6-W.WH $PI6^2&ZMZ:K#O<.>4$#-5OQQ2/ZNWCD_%%_?=?-
M*Z7W<$! YV5OKA>^"Q^_*SM\KY('XQN\$;OM]).N-W5/[L^E]D"'A\7P37\W
M002D2NW8(C[%R0*_AP?A9FB_*^Q6%RX(OOZYV4%&3RHF:/"^DU$'3XN2)#Y\
MJ>>Z# R-./3NB_7@E??6,)H7&,>7QJ@<&_K%_)$7*_A!F[SZ(\M=((#VY_5O
M2@RE>[[0]U.7"^2(R,\3/A+P@9]RGJL_6Q,)AJ4K8X;NU\T"OS.B)/-\].21
MH8=;DL+F@.N,$/;A<IA$#[3#7A/5 G&Z8Q>J7=Z)"+N^P!UP^/E >F+[<L_"
M[B\XK:[LD'UO=H@S\.W)Z(&#XV[>M/P97T6(L( #XY<NJQ:^CIV>E,7.NZ)A
M>M]T!%Y?#EFAK=_2((@B3D^W7J@ 9[0YH V_@MY=])7TO3A&" ^Z=]=X0]WU
M]R@@-:&[WK,]KNB!]V6"(&/.9HMXX&QQ2$];US0$V/B\UKG 7AX0%ONY!/=W
MU0(URP\OW([NUNZ('.\%@;NJ X8WN6W=>D$6:ZK7.^: !J[@B;C8S6<*G=N2
M&[%T0-F]\^5$77$K/EK>2!-+A)UST0 <[L(9X8WP0!D;Q&]TRLZ&5@10'A\:
MVY,Z[EW2GO\ 66:P%XY.RZ(&=E>JP.=WQH@_>Z3B5GT[WQ0,;['@L0EQNW?2
M-V"@Q=OS@^%]$'WHL19O=CO0T0$\K[>4+-V]:^5O@@[E?*D4&%,G;TS_ #/+
M<*P,DOP>OAZ/CD@8-7PHE]UWR&*/@"SW0^?KASB@W'=R1WY3^.Z('=,=>*!+
M\:I6M];W26%V5G=O%\T!S=7DG! QXP?3,*>.MO6(O1UZH'+7:_G%)6]$<OGD
M@#T$'X'J(=D#Y Q6.8?A1!_'M?='B^^'#1 !>5\D7RZPZ+&^F[>@;OJ@P\NT
M@E.7;7'A@F%WG1R4V.7V@8'2YW5&[?\ 22Z9K72X(-[KW7<B#=T2NNZHF])O
MN2!GW</A8]_ 0W0UQ6(I>$*3<@![\JIKW3/A*!OO[?X1/<>+>@;"#D!9PAR*
M%'SB<$WM[87! NYTHROL@3*_M-CPW7&X L] .M_: 7.\T7]Z.ND/A*^=Y(@C
MY08GQ*N?%9^L!TO>EUEY"9WQ2K^70H!E=W-,S?7DEN%V]9U_-A 77]23%JFZ
M%VYZ2Y7DB#N\(,_"]->"U_-YK$XP$T;W]);D&=2 TNX+'E!8?-]ZK'MW0$&M
MU6%W.P@#?W;G+7)!@?#EA\5QB@_'$>%@-?+R@9_"6HP%$,=]\();X7NHB*97
M/H@=B[R6--#VY\DCUGXH,Z]$O5W2ZK#3M>B<7*[B@![O\WO3/NM8^$K[Z7\(
MFMY<NB 2Z7>28&\^=$GQ?#3);F'^?$9H'?G>5Z+ [\.*%\>F5<D,!VX;_M 1
MAQO1 ];?QX(CK=N2ORIYZV] 09;KW)CTLRQ2FF&BS^T/" F]R ':X=."(./:
M5ZK=Y<;CP0%]!?W18'EN&>$<$NZEZ]43=YY(&>@[++6]4#U@C[]TL,@@T+E"
MQS0/B^6M$,=[M7N"8^4"_6Z#RL1=;KG-8COTN:&7>\'^$!'32%W%:[ZI783N
M^BT=>:!C>#W#Z1'*[<MA@\PWI3>4<+>4#&=Z+&[PAP2OSS^DS-1=A !?C>+@
MC>G);#<//VAGF.!@ Y >WRL,J0XWJMYPFL.N-_* D][->"4GE=\DWSR[]$I,
ML]?O1 =++L<%C]<D,8TY8]9H/[TN: X6+Z:($HNSNB(O)][T =X&D(I%0_?E
M40*1]F=Y51%;Y<N4T3.'3*M$':>4#OTQAR[I<GX+$WW1?+D;NJ#/TN%\%K%Y
MI2+N=N6!N\4# Z8H@Y##RDZ=9?4N+UGV]!0B3K?*^"4WWX(=H;_E,[=?! KS
M?,)F3I65BY)2;UEQX=T?3M\\$%". 2OSRY8SLK \,NB)-;B+U08=NSOM$'&O
M3-#)P!Z!#OB@9_*&,4EP1&)O@@1G?6* .OY[)@)>+WI0=^EW5Z(.Z^F2!@._
MCNDO3%&[/5;IC?.$$ %])T3B^EP2NM[W?:WLJZ\[F@#1\P%W19]^?*'&W=%A
M;H6Y <0^-\\$WMW.M^.J %N[+ W8L(-[<",=>7-8#Q<'CNG\)2;[Z:[D"NQL
M)G\,1'*"#KSOY0NEZH*.I>"F13H#9'5$G2_GJL_O<O"#"71 CBZ+MUYT6??Q
M>:#K@)('=RC<$ ,,N'= &\KU3 Y<[X(&X;N20FX<>FF*9UWT4S1[MR!G\ZSO
M-Z+\K=;T@\Z0R6)F@:X3WZ)7UU'/&\UC]TAU2WK?2: X7H<LLDP'*^7&CDH^
M[CU3#7"0L/0$"[SN"#[&%\5B>/.["4UTFX[C?V#YRK;N"7'6L+SR3,]^,+>:
M+$94O?R0:^O)8F6!>YUW-!;"^.B "^-3@L_CYNB(XNMSKP6.#^/-!GWC3?81
M=F'B_M(&KPL)P<+?]2PR08L]X"_M*[I65X1>F)N^G! 87>Y I\Y97R3.J+A<
M.2':D-W58'S]W.*#7K*F^&"S_C7RL_HL!\/RJ@V%W)"RC>BQ/CEGT\H!C'A#
MFF!O=>2SNEYW@] BF6[ZY8(#?1:]\G_*&&3^%W!:SK<$!=6?UP=BZ*+_ *=?
MREN1JFMZ!AYFE(I5%V([\KY(-7AY0*=US^D?=;B@?#^_;3%$><:\+D@8><N.
MJ:HY^>/!(#I*ME-[KNWH"9ON^JPT>^%]-4#B[I?E$&@G90."Z>5[I)."6\4!
MQN["!@U==, B>'"'RI'A<LJA,&KW8W5 1K<K=%$BQ"+EG\L_ 0-Q0%XX(/N^
MZ7W7]H ]WRRO!R \Q=Z20^=SM.2/!]TZYH.RG\=!! SL)9=-4 +$9RTA58&D
MTQO>@)9Y)2;=?%'W:7TXI=3UNW(,_?VZ7FL-T!\\KHL1\6*OX+.N^2!OJ6@Y
M<UGZ;S>_D@^6^_O!)C]XN[P0,^5W>"SZ\*WQ0=.W_%E8<^?.W('%\>*4B[PW
MQR0-]G#-$&P)(,[SFF9/T#E=A "[Z=D'W?1 \X2OLDY<[O!%FW7!-QK=[D""
M^%Q@JAK2[NDQE]!:[NB#-: 8.KDE\&(G\=\TQ&^^2P9G.L):H-[NVF[$H :8
MU'W&"?G>=O1 0.&J_"Q-_"F.-]]V(3OTC@Y /=VNZI@>[GW>](Z9=S[K Z7R
MTS0$\KOJD?ERX;E0'MPX)"-]WW0 %^%7W;T[5)PM^F20LWODZRA[N4\I7U05
M?I=Q0?7X[7J@_P I<WV[- S_ +Y]<$/=.MX[UB9#BA[<GX1[(,#;WIWQITA>
M_%*XY<73R1(0 Z"_'VBRS8N!0MZ!.^MN0$C*CKP\K 8$7!!_:_"+\!9J@6X4
M1[("_E-[<A=\T Y7V0N,;SY(D=+"!''IY"# W=$7I'5%>=R3/XX?=\$ ,IW\
M71&[Q2$>'=>,D1R?PRXWB!%F64TX-8'(0T4V;NFF]4)^8==$&W"_F25!\GNS
ME?!8Z7>*!G64"?IV"#]W:_A#X@@+70P?Y[H/\7AX1!G<M4"SRAA>[-!B>5[\
MTP'U&WI7_?*^:=D^>Z!6G?2P-Y<$[Y_%+R2;^?QY0.#Y^;BLZHOAUPDDR<L^
MEY2X;T#$\:Q^.J#)@_6[Q2WRO=).SI+S\SP0 #OYGE1,[/E<4I%Y/=>(1R>@
M(/P]XY6]9VFDM'<PBR.MSO!+I=/FR@(-Y7C)$UN[>IX/WW>28C[OF@9]\M_E
M(#J-SN)6"WMN^B [HBXK8C=!$A*[&_.M$ =R6%P[]]$7K W=A!A=!WWOZIK[
M_25]:8Y_,Y.1!^_O@@!-W)V*P%W<BG(LFY=9I+YWY09]B=YH@Y=^M4I,JW?S
M%'2?#?<Q! Q%[YH$[[Z]TWSAEQP0,Y7A\;T&?._E &L+\H;\_I+<+CJ@8:2L
M]HN6-;C?E!]#!U?(N*V3^-R0.R-ZQ\7>20'M].HF><\+MZ @86<><UO;T[H"
M_/A ZP)[N<@)'BZ\7R2LXC+6,[Q@@TU-%^Z[ET0.-V[2W_2&L+O!)\.EGW3
M2E=SWH,_*=ZHOYYW]21]LKI>"4W>=Y@0976\T":WQBE(Y\>2(XPN!ZX( >@,
MD.WW2Z%.!T0??V@ RR.N+X7).X8Z.Z;TN^&_JBR<M/F]$!Y7V2D3A]B"?7*
MTTT*&ZCN7.Z(%N^7TF?<CW2W=PT6-(VYZ#&_N7Q- BX]:71;'%!UY&W(&TIF
MZW=5G5'&_$0L_/Z?XMRW;"?SR09W)^G/$(\.V/Q3-8Z7FE(TY/OD@9]YROX3
MW?"*DZW\KFB3YK!]\"@;H_I58W?= 7+*:8M3K<4"#6^:V&N7987ANN:S_BR@
M ,Z2CK<3R3 Z0IY>DYW<*K>)W?<&.+H"=]EB;Y/\K&EZ7W6/GGF@-FEYXH.N
M[WH$Z=;@LSRX(#G;]4#P@8[^RQY^)06(OGS0,[@+OBL,K[ZH$^,$;W7O0%^>
MZ4D.G(5BLU7.S=4'XW1 [(CWW+>W0WDB=#QW_:GY0%JW7E!3%.=X>4UBST$U
MACRA%TJ?*###3=3Z1-WEU0=W?WAE\K% 1X@LZ_GD_NL-<3>/%&[UF@47N1?;
MKYA+A\<;JJ"[RRF@'?-+<K-T<$6L'>1]40^>CD I+0_*8'A=QW("\G(.^.]S
M0/=V>Z'6'VY87?BB-Y[T N X)G>;N&B7/.0@B@)'WNMZ#L@7X\,,HK$W"/%&
MW=4 -WE1(+Z<N,4R5]OPO@@8=;AH$":[IW+);*!=GR1-\'NY( #A2E;/PC;L
MJ=T#W/VL[A-]!?#@@%_6^7A,/N[Y(,T?*9?>:;=3'"_A +G+X3PA#AU-[U,F
M^%N^4SK?U["* T@'6>Z'C[C= MUO<+S6+/"B#;[E>:+L[Q\H:<KG18GB@5^6
MCM'!;ZOL%G].[^B#[NP4!%UR=RBC\:X75#AQZZ+'K<4!!D;WN@@<;XW!9TW9
M(O[VZR@._4B*"!%OPMQ3!J[NE4 =67S/?FCGRCN2ON+\OE8UO?Y0;=\2PG<D
MP:Y_27"]$74[WSF@+KTZ#Z6PWP<M=CFE^\[H@9_+KEY<MUK>FY9 ]JCD@S[-
M.'DHLY8=+[)2>5];<G9'>N(X\"@(.' 0T2^ZQYO!9T\CDL!>: M75$%*Z]]Z
MH#AE7J@+[\A&Y87#)*2C8=EA@@/U>?9*#RM[^LT2S<MP[<4 4#@:8YB:4HGX
MSOFAYP=Q08B<9.W7\+"NN6EYK'.^./! &G0O0,[2[BB#OC9^>*#UBSE>?2&"
M [DGCO?9'VSK<+Y+8UW3OB@!,KA?1:\)W,=$'QZTO2"8&GE\4 =>$.YXHNW7
M6JW7=!;7DZOV@8F[LI#=3]HOM\<=Z1J[XS0.#]WA]H$VZNIJM?2*S[B@WMNE
MBX(?0W&:+KN8RYH#C&]$&=7?I81?=OWK-7]WO0!Z/ES0:X7SHA><J>5L+O6(
M6-RWYH'&[?TA) W]>$#>7W#>AA9\9.\H".5*K>*<MX3#G+AE?1:[<@5]\X[G
MV$.SG793"[H;R0\Z8>$!=?.WO1=RO?@M>$K>@3)[I4F@5T_&Z_I4%S,7*;K?
MRN:;W.?N=](&:Y9/\44]3?3?O3/NMQ[K/NY( !N1)RNZ>$'^<9=-ZQXW&]R#
M>>EZT6%Y0M_E8];"WCF[Y0#MWFB+<B_H]+\_5Z(&#6^1^L/M$GZ2G'18#'A.
M_A!OH:].Z+DAKS\I[OY0"X]D#6<'<YI@>%NNJ2[L("#WO[6PTJZRC<*[J&6Y
M!V6%^<T&)N\)IN]RO*B4#C+<,^IG1,[2/'08]D&PO?N0.0LWY6^.3N=%B<,O
MCF@QH: W>*URZ?*SM]TN$UO-XW! !>5UY(NRX7PP"($X\$']+W(-\W>:!-]_
MN80'+S])C0]+XH!I67W26@1?VX?"%W<5CVKN?P0%V>&[?GC58#K?T@^N0PNJ
MP[W?! 7<A;D ?/&L$2+NN*#KX6ZJ!@9:PONE:N^?99_;@$$&O/OPIN0?OO&\
M$7RW:I0+R04?@?C-V2'N^,[XO2BEWABF=\^>/A I&Z'<WBF-Z3Y8<4,G6]W,
MK7=ZH,+%\." QMPZ&\$=V5:I=V<-)(&X7'6:U[\U@,D",G[[H@87TX(F[L)&
M38T3,F]W9!G9?=XHNPMZ8\*^4F7B;D&O+'K;D)/QOSP<F^>D'X)37*-_>" D
M_%\04 +%Q2W=Z(LV;^D#/N]=]%KTA>Y*!;TX[]M,,$ %T0^MZ:[RRF@;[=T
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MH''BM[TS[Y=U-G-]:7<T3"7.)EP0!^6FER1&MW<DN(W0[XW!8W3C;T#N[=$
M,.R;W2DY(;X10%]WU6#6<<+Y)7UY=-+HL#NO/B@Q^KBB*ERQI=\4H.7"[>@.
MX;GW<$7^.4[G!+>M^<44#,W@C;I]>:D_ER^')GSA%UV[! 'X7V1-PH@!O0==
M_(Y(#\PT[##%'#?P6 GKRSP6OI/P@P^L%MPL<P@^COF"W9 7[K=T6_DI<\D'
MC"Z10QW(&Q6=E73&^R+A6[J<$#?>Z:( ./='MH$OCM>B)[H-T%V],.!OZ^DI
M^'X1&^"U[[[H'ZSZ?:0F\$6C<87]+.H=V-.(08ULW )2:.E?3PF/#H(>%AOS
MR0:WTQ6.58R"44& QUQ@FUOP-R ^=)=NJ#[E>6X(G(6Y '@'?2 OUN:6\K?-
M-QQUDE(OXI>*#"FMY3D@>PU>43@B1N^/A ,=W"$NUNVZMV$7TL(/N^J "X87
M@B-.-Z(.SZIAAR09V3KRO)R#LJ.NYIL^8N]$&3=XH*,F6/Q!(;#I7S1+6%'W
MEFIF63G^-V:!A,K V-,TI$[O5 B.,'</-=P0-\N[WW6\CF+?DL^1T^4?CKW0
M+>^Y)KXH'/*\*HW?=!GW?T@/GHMSGG&DELA;KC\H-\COV6^"'K?/=UT0)YQO
M@@?XY)4?.,EOJ=NZ8H%9O""(N(CBB!C3 7SU1-W0(%W.%_$T?=.[W]%N%\=Z
M'S?SI- +O'NM?TM8N\9(CYZ7-!GX7>,UKO##'$K'I]( WV0,.5WDL9TN>_D@
M#R?*7.JQ\4KU0$7"Y9K92NW%;=77BBZ\;X(-E+A=X+"G"$KZ(NE/Y"!%_" W
MH-W%8-><-W5!^[KKV1"!@;PA;^ZGE=Y)B?FZH0TE'KRQ0+>"+Y_4>VB9+C?/
M+!!EKQC=%@;O!_=,-]>(F@1_'O\ 'A9_61N^K$??PEQP./GD@(N.ZS\+?5O0
MSXB4UGWAA?9 #]WS1/T[Z6OZ[;T!C?P@/'D/GX6Z%U7:8Q1=X1=]Y7/% 'Y.
M?;T.%W80Z1[4SBFPN^R /W7>]8+7QT@0L1>#[D@Q';XR<MYCS[IAH!33!;CF
M?M!/YN^R<<#5TOK- ^>:(K>2 @W#AF@34#G=RQ6%GL%N<)Z9009_Q\01%B_I
M*Z6M!ET1NW40876^Z9D4\]W_ #FE:N^U$08X4ERW9H&.^FF7+AT :^+[HEJQ
M'Z0?/ 7S^D&?6(.Z<,MX03.&-W<DIZ9W) ..6#ZYHOEK266[L@./Q\21+KRO
M[0.&L>E^$@-V.2P-.Z4GZRO"2![S0=2WO1&;ZR\YA8W\\N"#/NE.%A!TZ<!&
MY%:_M8'4\98]T&?3XY3<B^[O=% _(QCVR3!FL83OQ- MX796??*!P<F:O#[O
M)*^D=(."#/Z8V%FFN0C>M$&N$J.O<MPC"'2:#/?! OIIK5%WW@LT,(WR" OQ
MX7E),3=W1+=Y(/IT0.SIT=PWIO,APO)3'=[Q7&Y+$S=I\(";A=U2OZ#G1^$'
M(OU@YW"_M*1.00$4YWU=!'![^5_* H=VB9_._"!1N[0<@?F_JJJ61]G+?927
MCS0 &7P_YUW9HXT^,D0+CK>J!&7SW.B#82K8R2NZUX[\J+==.VEU6&EY]N2#
M 9/@%FA6^B/*GV@>L[YH,Z3I?-_29\ZOA?#@$I-CLCH]SG=H>-Z  ?-V$0)4
MY5A9@B3X2ORSSR0-?R<E@<?K>M>,>J&Z[\(-[LKL/0!X<!>+ZK$\).OHL>'V
M4 ?.[RDF%.T;R0Z&$(3=>B-^;H@-X=>G5 <.Y0!X.-_:Q-^<@@ .7:]<4XK8
MNPE'V4V%>F\NF$&=D$";PPW+$R\=DH-[N!0$'M?VK UCUDH$\ON*9HY<.UA!
MB;W2/58GX%_2#Y0MVEE8#A.' ::H"-^-)K7AA>3D3QN>B%XD(,."7@^Y(OO3
M!;CPZWN0.^Y)0>F?+)8M8[OK23UL?+I_6B##CUETSYIAO&5WHMRB8B]8($[[
ME>B /G$=))Q%\WV%,"CH23BB!3H[7*[>L#V=@B79)=W>_*!QN^TMWP\HORT\
M(7'2YH /'6["89#6],$IW3W<$0-WS\30 G.]U<ECQY7FG=VO5);LZ1S^'H%/
M*["(T<\6-ZUY<^1D]$GSNOF@#.%<]ZKPODI#'[OLF=>.ZB!O=?1)[KREJL#E
MP<L1?P@PN^R)\\C'-!U;YK7O+Y9H#[KZ1YK W#=>,TH-\MV29PX_,;D@%RC]
MTP6',W)8W6=R0WTL^$%?=I22G;K\H86_<GQRSZW@@Q-/"!&5[[Y(&\L\99(N
M\2Z>4 (X<A&/58?5+DL6K\H/Y&\]Z"F[[[)=V.'!$7A&"5\Y#YEY* M=>'"^
M* OIJ[%9_)_A"N,[Z?2 DW=E!\Y4Z\?E.6;ZI7<(7<IH-\3RNWK.N[" ZPAN
MYOQ37>'P@6\C2MY/3W2[<E=A;^=O3/T^>Z!>/QV^%ASY?")-U^^2#KQA>I0:
M\\M$K[DZ"S_B-;\)[PI<T <_DL-\;AS>L?GBZW_*WC2[B@!PO'HG[_'E9TW7
M!)?C=T*#/G?"\7HOI<[N*QJ;PCDI[H9ST04QG*$IQ-A#KQKTW+8:?%R1NK^;
MD&OK8YK"-XW<T-UNO!$W6MZ(!APSN*/SYG<%OKE;ULKO-!A?UW6?@/L=NZ%A
M'NZ^1R0;W0==WH,L_B\TPKN*04^\4#=Z73%R%WE@F-YX<.*4C"KZUO<@;XAK
MT2X91X7!U<5N7+DL_I+=P0'*[^],*W?"" N>G/DM>'R@:Z7;D0:?>E_*4B[M
MR(-^+D@%_7E #B\9\+P3A+=W- 7W=$0;ZX[SBE[TE>>]8&M*WTR0&-+O+>LZ
MX:Q1Y:"F'5*<+ON@ RMT7(NW3M^BQQU/98GMP(=7B@WFW:\I!8F=+OP]:]*[
MM'(BEYH% QQ-<;BB_O=U0^=T/,\UKWWN0'=SI>*+\+S2\OG>B_3ID$&!L<4[
M+0^K[(7@E=PC+&@T0,_4:D(:>%O,/DX?"SJ?/! !?.\$+N\T12YWPX(/E]X'
MF@+T2:RUZ+>*7)"]+D@ +KN<^ 6??E:^_P K"SUO% 1U?E>GA;E?%RPH=R8G
MG?9 H\=%NKKA#BL#>Y_E9USS0#=?AY3 ]W2MR'(OXH.G#2G'H@+)NN%Q0\9H
MG@?A9U7'E*[D@V7+MW[(V^GS=$/.*+M>5W@@6[[*C+4QIQ=#7NID]KN$D=S[
ME=$#8]W(/T^]*<T?OS?9+AKG/2B O^NGPL+L"Y)>$>M+X)A=-R $\!A@AEG*
MGSNDC>D(<H\$;U?#Z0.^'&5NN"#[O%9V^^54I.'7+P@)-W<ELXQN5Q2NT[WB
M$S)U0 ,SE>FY$GZPUO! F.L/C+MO6&^2 @WX<G=AWO@I/W'DZS+@J,W!!FAU
MM][EB<YH/?"\]Z87T'**!7>4EW<5:^'UQ4M+X\4! ^+<LUN0&%V*?"Q* 7XW
M;YN0?VUOZ3 8W=/I8]Z9! ']KX<EI\'7>JUGEQW(OZ30#XRE=%AEX^^2W(<?
MK1&WX9YV$&.><,KKR2]PF(E][[U0'5XO@@ -S6)O@9CC!:SP\\YK4TR'!!GX
MU^0L[Y^UNQ.X)AI@@'S>Y8]NDRB;\QY)0+U@/E 1SW/A\(OR==]$'T==;,U@
M;X=N* CATX06\W\H$UG F7;)84O/=Y0;YRG$16?;HY\O*9DT-W)R5H<\N=R0
M!W#Q"%]4:\^'=8GIP\+/Y"8W7N0:^0O1,;C.QU2B^B'NON@)X?%/ 1)YW"^2
MS[W1'/<@//W=$&%[PAT'*^1Q6PNBW>EVY +XW%%U\[*QZ?7!_)$\KEX0 WK>
MY;XW/[K/\7+><>*U\(H#[KY=0AWY.N&Y'NA?FZ@H"2MI;QS\K ;RZMYK'O\
M%Y( _7[[NZHOOMWQ0=>?A8]^%]$&W6^]ZQ\21?>E-,D.TLX780%FX.6./B5Y
M("\+GO1 09U+P0O?<'(/G=^$7]^@%\D&%V^(^UB+R[YY+?->5(>$<KI]:( %
MKX1XS6OSRMZVF=[XX(,Z[EHB?%[G(/Z7P0N" NO+6Z+7X^TC^W1S]R(S\VY
M>3D3\"[R0?K7CR6:/2X=4"OCI;^Z+O-WD@3GE2\%N.ZZ! 3>Z5U6!JE T$75
M"P%S#G1^$#_7A;B,KR0N"-N^4!:,OIV[)(Z[N*+^5C3-,_6P.&2 1YP=&?;[
MHA>EPYHEK>ZEVY:_'W,!!@/D9Q@L!TN\$W9YP" L7<T&?SE\;NRS^9[>?*V^
MX9<UL=Z#;W7?= ^<M4?;K)+K"[A5Z#!$7=N10RY7S0;+GI>^"S.F=W% F\$K
M_/UGT0.-_P!72:U\+W+'A3A58'?H@RUX?2W"HWTNB'.GC@710$'=3O=*+#A6
M^*QY(=G[[P0%TH2\7)#C=O3$8:<-=Z4W>B ]1?%$UTCQ%O2OK8!C'=T1!Z9H
M-QCON>Y*/&F;T3?RM>_P@P&1GI>01!OGOL(&P@"@;=AWCI)$"^BQN%_,5GSX
M>.2#<;\^"@?F\')GVZ[>E[_5Y(,[E.^>B/WK>"+[R2OY5-\T&:^,*(^;^.:S
M0[9W! W=E!GPK0=^2&+GW598=.!N8[H&?VAROB@3?&PM=]T+';EP0$7NIP6L
MROPY!]T^$1>Y!@>%')@:#CE5(6J/OMDA[KSPOJ@;RXWDY'R=;C+@@*(WYN>"
M#.6%,[^U@;TKO6?U??= K[SNB89ZK.GE<+@@;OP@(KI]HWSOH@-,5KX^$!95
M%)_1R1!;W\ F/U2\TA8=<!<^"+N582WH"#K=S6?>J46-<).6[P@@QO7X6"8?
M$:H ;L[W(!]30=U[WJB[/#[TIBB;E]H%=R?VW<5M;=?99W.]Z:_GEOU0,^[R
MWJ9[5@\Y8:^4UO@@.O?"$(_*#"W2/T@3<MVO)8YZ<:K$]_K*Y(!=Z7!-PC5[
MBE%YWDCX.''=J@=I3PH>T$0;R=\(OZH #SE=\W(FY7\I;RTW:803$W#*]R!7
M5PRQL(@[]ZVF>LX=/I*.4GPXH",,O-_"<CH@_I?6P@;W3L.WH"<;L]5@9OQO
MY\K7Q/"W)0?D>+B@9U(7EEX>B[/ _/E(Z5]J\JIK^+RF@V77.^:SMU]EON0O
MS@@_$;[IS0;B?N]R-W>%%N>&7WT2_'1T;TB@8^;BMR-T0QIA)9]]Y?.."#?/
MU'Z6%F^2WSYAU0=RC>E4#.F;O)"[M[T#OI9N*WNR^KXZH&SIG5#3F;=) CGO
MO)8>>=ZT0'XMR)QU0Y_%SDL:]=#;T!/6C[BA>_"]R!&>'!T%@.U\D&^^=E'&
M_IW5:^=RYH 86?K<8/0/[J3Y<E/#2QEV1OG2XH\96[/D@S[ROX6/CC'Q]H71
MT8ZY(D];^*("?B]UO6\.UN*4]>U,]R9W:2 ='7\H=3V=?PLZ[^L41A<'"^"
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M6^<*&%U0\$[\//) <.$[W<4']!=S3_"6^1L(!YOX368W)+RWWR3 2SAWG)R
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MA"^J'MG\7JCIE/AK8D@#-]#IHB+O/Y1'7==$K\,=7WX09T.=VYR)K>*P-RK
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MY)#RN W":!B;[<?A,*;[\*28&+JW6WH'=R?Y^R@:C2'"^"+^9UOLL/'-PN:
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M#\L;O<@^FZZQ0,^6]*#;]$!K>2QK=V] SH<.B%\;W)2T<9'[W6$P;Z=W2O!
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M\;^%@S]BXY]5CC9N119/&W!!O;?S>*SG<M-V4$[[U<D(Z6-$!!RU12C3?O\
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MW+/OE'IO1#K=! #0'G@@[QUDL1<;WK(''ATCAOT2/Q=6]\DXM_GD4F=UC?)
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MG=]((&]S_M8'HY29[^383! ^75%V[S*?9!TG_5\E,FGQQZH&PZID&7(WQN"
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M-!N3[O2JWMN5+WI?=8O@F?<SR^T (O W<%A25X:HBW'#NM<7&]4&OBF]MX6
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M7:=O6)D_6\\4#4?#B@_.Z7.J4CZK<$7<7'C"^2 C/"&,7S\HNPRE3XMZ3"L
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MP373Q]( +PL]42-+W<?"+K?;\$O6W[J(,"-V2+^_'5+ND.5N<B13N@QX=0Y
MW;D6LKBEO% 0;WS[:)G:2TL*8O?GV50<J<[>@FSI>[LD;$YW@Y4)EVNYI";Q
M^>2!F:PO'RB_J?CZ6%[[YI"'?*#9NO4(W*[HLS?G!8LU[AUX(&*:[[I/=ON%
MT<F?A3+._A ?=>5 4AOK?!"\?JW)FC)XZ7>J "XY.W8\%@9RI]\HH80YV_5;
MVV^WH#[L\H3OX0)\2>@:%:_FZ8H,;UY_25U\^2QOX3CH@S!P<[S5-NQY<K?J
MOM==\$2U.\HH 1>#WG?E@L.5\-%AN6]NNZ\$#.TC+I?)8;DKZ&>^]."&<^IO
M! [.6GPCKVN7E(,7?/U*6"/A A.&[<9Z)V'1W8XS2^VL<(99W%&^,OK@@?<+
MAT6]W7EWMR5\]RP%\;X( ;XN3 9"].!*5H7#<@#E\"M\$%1RTN2F3EEP384L
M&"SK?>:  =(RX;AR1?=V$?;=\')2>FZD+WP0-VN%%/$N<[#DZXK8H"\!V0$1
MPOKJB&;Y6^B(S\%Z-S0*!+#&ET1&#XOWG>E.@E]H^VWW]("1>>%Y)7>-+S61
M%R0*ZL4<QAO.A*8%!R @\<M\$7TI#-(Z[^DP&72X=9H']M\K@D.41=GZ3F@Z
M7Q2=:BLKW(%-R^Y(AJ_GIDE-.6GPF=KBZ[<@Q3 RI#CYZJ? [TKNL*4F@H,7
M@NO6OA,1P=(<M$K-]$MV[N@(SI19PBZ'F3["5TLKW)M=)OO&*!612_%P6?)+
MX$)1KQJF=7,9>:T\H&]V7(7X3>[-([C=Z(FY7H@)I$2<3HBR?C&OE)[KZ$ZX
M(CS>] UX0KOU6?V?E]T*6[Z+8=NY0$Y/N_I(6<O'%-+A;ON24W=T0*:7O3B0
M.[% GSN<.&\)P1K!!,X9.A)U[TW(PK"#R4#?B_O9X'J@W+/FB,;&%T0/1U\D
M75OF@(W#2.:WN^/.00=C"-_#T7WK?P@(N-BWIB1TMV(2ON^"4GC? >$!)TRA
M7ZDB!8W7T@D?V6^R! 2\H#F_R.RU@75YFM?3G3- =R4&/#2^&.J=D/AN[]D!
M9<M[JW?0H"*WE]8[EO=;[PCV0)EI<TGQUEP+NB"@:MUW-8FO:^/RE]F$CXN%
M5G;S3.^: @]+>B6<3?Q)!U[Y<9+?5W! 1TN%OXH[_H+,BDR,\461=SMR!7/N
M[E!&7?ZU1:$H0A?A "[MZ!WX.N'/HL=(/N:F>EVY$T?<+@@5[X\+L=@^>?S?
M2"P^Q#O;D"SREQL("[CTIOX[E0#/Y[/4Q>FB8WGON* P^N[^B1]W]9N1/#I>
MJ#AG*XH,<1GRS6[8WG'*2WU \'X10?S=?GL@8XW>%4.7P>$>24WWX219YRF!
M)^G) ?;25.,N<D[M)2W\SR2BLN-ODF!N\T  Y7>HDA;KX)KPZB]42SVPN/'"
MJ!1A"_"9WW25[]$OMOYKDF.^\MT4!(WUY<E-\O#N*HSI?U\)/;;T&#5W<>%+
MOI-2==]O"8B^^%O0!U_/9$(/N[H@+WRW?5$%7Z&O*'-+N'S- 'E=ZI29987N
MJ@8![[R-XZ+%G /S)N\$-;=/R^2#6$.=N(YH![;=%4W/\ZP2X7]:)I4OZ0 =
MN]+Y+.KVMR;'E)+[M_:X(&!WR$;?-;>,]P\J;EL4!*!%YQCKBB37I=4'O^;G
MB@S_ *\01^ZV])]UO)%HW?1 0;/3[3</GX28[X=/C)-*5X\<<$!-EVZ^*4M;
MSSU3OMUUW+#Y=/!UR0*6L1PP^:(.?.$N.[18"IE<\\D>7"\D&?.=BB#]_#L@
M3TY;T61@X:N?H[! +IOT6/3**:[P2D;\8W 8H!<Y7](D\NXPQR0NZ;T3;N_=
MW9 K[QT.)L)A;GWY6 0?-_VY P#\,<'9+!K5T9B=$04A%?G/=35 S[Y+.E9\
MTH@Z[O +$7?WS0.#RA'6["SZ CA=*=E-^^MWU1,IO?QOL@)N+ZXVY9]-3E?5
M*_J#T@B-0+>@SY]!YNBT.7BWH.F1A#=<<D\W:97\H%&^\$S+-OODE(^EAUUL
M=$#/EXMR3MA&X(EFNZ:SIW+Y,G( !XO3JB^WQ%CHD/?L[FB&JX7;\<$!N,+-
M7H@]'YQR[\%GWNQ1%=UFX(,_=T?<$#UN!^H(DT(#KMV*QH^[Q0%D72^E%N/'
MJDW<^6_FC%!@-[K@F%W=,DH\/E=4P%Z=D ([8=%@;ZDZF"Q-PPONF9OK>B!2
M;A!;HBZZ/EXW/6 =AYW(#G=]TK\.9X+$W=F"&CK[?2!B;J@;X9\$IT*)-OJ$
M!9MU\.:8CE?VE%W;DQN5YX(-VM[]ZF<,J9$;WXIQ4($9_/A]=$&UZ;AJC\I>
M%[L>:QMW?<@9V^&_AH.Z -W@L^\!XZ(7J@%V5A;\^*W.Z71:]*(&^+=?5;24
M+NFY!]4S^4JSO<@S)^'0I;D'7@@3;N7QP3:RUO[09WBO'REN^Z8B5Q\K/F@3
M&]^Y "KJ6Y,1AX.3_A CH+O>@/MTN^"8QW#I?TD^+S[(CAO<@SL[C''NB:QE
M=ZK"_A 5XW\H&W6$":FZ?:W#6[W+.O35_% !<;I/DMETMW >$7Z<4!C W?R@
M Z7--9KA+LF=![D"+Y<.Z '.APP6MW6.)HB-/FD^:3>>&-R[(,;=%USDF&8?
MK\<T&;PWH.D_=?5!O=8X"\'(NX6)(N&%+^Y1#T+OQ!!KNYYK4.')YSHL1>AR
MP0''ER0:ZS6PHZ!/>WH^WO;[T0=R*#$Y8993%+P39WH#W27>^=4P/UE)WR@#
MMPPPQRGX1?6*S6D0,N6KJI?KO7! =)791?\ %]*H:XTNO(HD;KGEW0;$SE!U
MQ[03#1[X/2&EWU6??#ZCN0.!;N+DI,\G1WW;UGX7;J("_GHX("#=;UH@;^;C
M58=A?RB3W$)1EQWH%%;$J7(+#*,NF&"Q9Q?A26.2PN]4#[WU@]8<>?- /W3G
M3.L^2<"^7?L@#]--U$G&P?")G/XE>:P=>\7P0!_2^&"SZZX13LY]KN"4F\;J
M@3XN^B;&9)('UNB/A#"4XY7\26S[]+<4&^>0X?"PNZ(DS"6_I P'BZ7BE')S
MN<=V<-%A1V[SOZ(876J!BZ-Y(V-+GDD?U-X>%@-U]R@=W7[O!!^EW! &@AN%
MZK#O?R@/NF,?$7+$WNL)2.%TO!$#CE=Y("_K6]PR0^(Z&]8(@]KK]+#Y^KH@
M-WV0?E*_M#5U_,T;=T0#A8,UKZSYH ?&]$5=J@S[P^DM;TFFO=&\%G8:3WWB
M@SO$<$1=S\<%KT@E O :V4 (E'AW0&#[>Y/NOSV0=G\/\T0;Q>KD7X9.CFC?
M"L;JM?&[$4!9SN*6S>MT19IUO&XI72?UWPMR!L;DL12[QR<L*718F[D7( 3\
M?67RL_=-U\7+#XOPMS[YW1 ;O=%(J9Y]G7\*B NGTIQ^%N48)7SX;[CH@-=R
M NULWDL1VN%YK ZK-'N@S^'36\UO':ZQ0?\ &+KE)RPO*\D!=0=^*#Z71^]8
MCAEAEGBM?>_I!BUQ'#Y2@U^'_7.J/E8WP=]/Z( #23[EW3 _&'P@#A=[D'[_
M (G#ZZ(*OE?BXK&[T27'IDL-]+OJ@-PTO=HE=@,N&G%/[KBX:OW(&G!!AG&[
MMR8Y#N@ZZ#5$M<.D.(0*_46_DC<?%Q0N&: :O26J C/K?E4=Y>I?>29^'@9<
MKB@4^(=^&:''B0CVSNM:(/UTN^*#=.5_2(/"$G0T0???.\E@-$![P^WS0NEV
M]8;]SN.6NY$UOF@(.+P@:NW<+>ARS6YPOX0*^5O^D;\N2BF^QW1=<C1VX2<@
MQK<HV]'VY:WX*V/"Z(EU!]3" OLRN"W6E/OX2OC]X00!E*X('X][^$'Y7!V7
MR\)KQ^^PT4R;NMT0-ID@.?F7*=4?F]%CS.,LM/,$& P&,,+G@CE+*[*(:N^2
M!,\C#!U_2#$90^HWT61?E6Y>$-!@?-UY(%&Y4?WJ$@OM'L1!% +??5$90^+W
MHGDMX*#7CPR0 \2A<,5B<.?187'=P=O0 "8=A"\4S0U==S4W\C<-);JIGWI#
M?H@#]T/K7Q%%]NH+X($=+[)A=S^$&!N5W19HW*]4'5N\%G7.\<T&M^=RZ+>>
MU./!9XJ.%\%K'SAY0#CA=S3 53 :POPD:N_I PTSE?E".=WCB]8%UY+$]J%U
MXY("&M,M.GE%]W1)NK#76F5<$1E=W1 VZ]UXK26'?#*W[D3TO&?9!B:78@D)
MO6N4(K$;NOE [X:.^=Z!@=TH\40,E(]\N:<-89\,?BJ#/YZ&]RW"^-P0)L7>
MJ+KIT?<T!!M^54"U=Q>MPN&"P$:?&F2!AH[IK>*+L>2#L*'-S@+DE/;GT@@8
M\*2C;DJ8&;_F5QT2H,_[OLEZ#$RW56(R@YW.^J.;N&>7E .\.5RHB*X^$OQX
MW(OGKV&Y P.Y!W.Y:<\%@?CO&=U1%Y_" 7>7:28=+\N#UB+OGOQ2\[R[H'?C
M;TC60A=G-$GC=T@B!K%^$/M!-]BZA$?4*7\*AO+%2 W_ %?5 [WW<$1IHY*+
MQYVY4?AV03NE[UF;E)W2Z(M;[QEJ,4N%,_C.@0,^W<[F@_=;D6CPOD:/0\WR
M0!W9,!B,K-YH#ACH,^J!/SX04(P&67/%(;E?E,3"LI7*Z)".?A!A2[*P[>;.
M:-QW+;G^4&#/5\+MZ<#Z-]U/#PZQBB&N') 7Y.OXZ)K/QA12QN$._E,Q=]L*
MH"ZE'D7>Y$'=AN0X7.<R@.E0+AG1 9K2QWVZW(/N?-%^#Q;XO0,_31ZWNO7"
M]$F%E[DO24JA^%R0._<//PA?/MS3^,:/NPE=RNW("#=5B<(WP6=D[Q=)H&X8
M1@@V_%%UP0S>_H\%R-]T&!UTOF@3KH]X^$0>73ZFL=^;T# Z"Z)#?9!VX\^'
M5.U) KN6X(NN^.:4FZ)W\Z@7AP08"CB[6]Z=9SZW8XQ2GE'.O3K- 7W<@L4C
M-^1X"H^ZNZ(%(6!GC?>*8G6'9TTH0;W3X22;KN\*.&-_#TOW>.B#,W!T@G9/
MC1R5PRY\,X)2;\H&:U-;XI0UNR&-R4WW'!,/O"4T#$XP[5O@B!E=VY"_/TG9
MW78C- 3>%A39&3K@BT>=Q6&?#+N@PP[W)!KQEK]+$V[G% G'CPPLH,*Y[[[)
M@<Y<[PJ@#X\] L<7W2Z(&-CKN<DX"[WPP1!6(H[F@ RA6\/+TX.BDSI(;X>>
M:9\ODNY<T#M<#?!(T3I+>#=A,332%Y\%,U?)XW#P@P^.T5B>L\/ARS[AU*(/
MFZH"&-+=CS3A3)EAUO%$'I=^'("3.@%F"7EP<*(\KKCIHANL6\.D@87=5@>%
M'P2',7HCCRW@7E1 W)+[>&N".<N5W59U_* C"''DF!\7O2DW>2#M7.W83S&_
MD@9]^/"S[E>"0=+X6$Q:X:H ^X.1#5C/K>:PTSN\TC_O2]R"KL7\.$;>L!T?
M\?2 :A6%'_5P6-V4##36-5F6K?<>2D>%XWB]R#_/(WS07+4[OHI>ZWB_*5_>
M5RINS3.O&"!A&8[+8\I?>B!Z2OJM[GXEU/I!F;OO1*#EQET6)FZ=()VNH'2O
M;! GNN5ZK B^1C>X+.W.G2Y<'IG#3=?AZ @W#LE?PENHL^XOT3GB@47JL.%P
M1:L%*R-'4QWH#YN$/"(-_/5!HWSO)%^Z]$!&EWS2@7?19\W_ #?-*>'3Y0/=
MWJ@3K.^2 1O.Z9(%-8B$(.=P<F==WN6&4HRX.X)2=_%QA;N" @TPR=;TSLNX
MO[2 W;^&#E5[^9\/XH$!RX?$PI;IW?VK-:Y:*;OAW7MD@V&FF8N:Q-WV0.,+
MRTA\)A>5S@@S\OC[P2FX9*A^\;S"GROZWZ(&&B<"Y<5,)G\N+K[(,[GH[R@^
MPC?WU"6Q<>*#'/0ROY6)F;RO<LZ<#80(W<I8_"#'+'._F"(%]_A8<L*N@FOD
M@4+'APW6Y #ZS%[PL#=R"#??8A/?G2FB3KUWIM;@$&!6?<M(XZ(/X7TNJPET
MPWZT0$&>%]EC*')(:W;DX%NZ<$ OG;\$#?BZ(G=KKY0\=(64!'<7=-5B+R@A
MCPY<TP&E>?B2 #FY8'I;NZ(C'7C]:(#IX!W(*%*SI]W58G&^$-$7_!%\D ''
M&9ABL!PEIY[)@<W8I@T(WVIR03//E?5 &Q<D6L:7VD@+=?% 7W(HON^B Y3M
M]\$#=+F@+)QY=IUG7!%^YVB6_C!8[^%N" B_"+^4ZW":4#6DM7<(<"F.@PW=
M4"#IPGCHB>^BVF4O!6NM]<D"W.43\CDFW3W6$O*/+P],3E3L(YH -[W8[U@=
M/OKG@L+XS[Y[EN5-U?E!A/??'PB!3*[P6/)Q* .6X20 ^.G,(D7OBCN<"-*8
MK$?771 0ZQ-,^[Y*3^2=G>Z\9H,[*+[MR8,Z];&<T/?+H_?81)W[G(,1;W6%
MB>5@OO%(?C.%'(CF1OX( 3?Q>BQ-W0!*T9V+N2=UA K,W)FKLA+]"^BSKA/6
MG= 0=>76WH<!=NX(V.%<5GX40!D5=NZ'@J 2E@+P\*;M]QW88*A^YSTZ^$"7
M3EJL#K<+Q6:,P,*%R5_'E?9 XTU^+Z(OX7U2V74WY(Z7QMR#-7V^$,9^;N".
M[QNP0?=TY9(-RX(#PMRZ\]>$$77//4H&?+YMR5G*W]ECO?P*+\?N6" C>[@@
M=)T?>]8>:'! CJZ2 NRNY8+&EZ7DC[ITOBE9&^F* \;JF9TKE=N6T=>.24M<
MIN\:U0$_-Z]9)'W9N:9^MSR@D.&=OAB(A 73O3=]E$7XTZHNQE\V[!!J\D!#
M5(SN\4&H9QWP,;HE\:#BMXTO7B@+^M](+#F_)!W!PO(<9(CONUXH&&G8VZJ!
MYO%FXH/N[=-:^_! UWDEP+G7T0'#XLHOOXO% 7]JV'640?-WO2]\,-+=P6?<
MW:(,.5WAO1)L7BL*97HEOIP=F@PS[:7@B^X(6[I?9'&\^2#$]/-C HAK3[K?
M((8:+.N5+AB@>W7?-*>FZ.1HL_6W46??P@![QXHZ=97EDC>FF2PYB%W! KMV
M6EOYH$7G=$QKA=O^$K^IY#SV0$;[\=821?,CMFD?=X8)Q?D]D ^"C=.*#M;W
M(G"[U0$:B\ EW>=-W!9]R'E8U>(<';[S*!V?.F_LMPX*2)':/:;]<*00-GXI
MJFY:.O>DPYWJY82O?X0'W3(OAQ6X/N5\EKU\I?D7N0-?1 4K-8]K?;T3P?;^
M2#0=##&F2WS"["UFD'<NZ'UR^K"!CYTPOP@_666"Q.NZ/-; 6Y >76\T'7=T
M6TE&S7A- WQRO5!F?KX3#3X\I+PPAO\ ":^&1O! IKN^>4)K#'#YX(/OJ^]$
M^ZHR0*[S]K8F3Y0YIL+H8H.Z=T#,XNZ7R2V"L_"S=N6)I>:# SIEGBY,#?A)
MVGG=,9+ \Q+M@@Q:Q[)GW?>B7+/M>BS1N[<@HR<+=K]I3/SAKT6!<^Z=-4#]
MZ"YH,/-C'1,!C#A?1*Z@>L_K*[WH"?%W)*_##ZWICN^,47;]]\D"_&D/I/OQ
MNX)/GE1-[L<+O>@UW5!TW!_98GKBL"[!W&W50,ZEXH%K6-[T"<>7.R@_M+'M
MGX0$-;M"[KC@Y8"ZVY*_O?9\D0=+PRI'>@P:XP.-W)$76X\D0R''SA##[2M4
MMWA 0;[]\$7RUB^;J$7!Z5V3@'.2OZQRO'!!0D7GD*K.=.]UA(.D.%ZX)R>;
MI:''1 'X<X6>24&1MT^R!O#R.Z8<H\'?'9!AYO7D$0)_?)!_3/AP6?=9<]4#
M.TO2W)2)6Z%?M!\99='C>L6L;A#L@SNUWT6.E?E(^LN/=4\>+>@5T][OA'P.
MU+Y(BL+PI'D@_%]V$&%9SG@L+NN2%UAKEFL#];[/3,"SUM[EG5RK;I[T4"*;
MD&&<IG&ST38>?"!-SX\EK@;X9Y(* >;P0(QEE#>_LE+4\Z2A?!,6KZY/P03]
MW?X^IHO^/NIY(&[ZV4/O?V?) ])6;FE-\B2MN '.Q5!UYX(&?]!+8W\^R8##
MZ=V[('A\X7\ +^#5$?.*#1OAQX+"]$&Z0Z+"D.6%]DQN*6W3RD@.Z[\(Y?5W
M)*.CKSU@M\\)G6*#$71;2[XINS^T4KN_*[" &_A$'+-$=%B7=D&Q"#[%YH?/
M3YMR<<(7=$"WE*?RM.][[FB#@B#TADYR!1YOYQ3#& PUS2F[T1!Y<W."!N&B
M4=^JQ:PN*U\X=7:508"6ZF[F@[45W!,3UOR@_P"=][D .&FY%]W7!3+6FNB:
M_A S^\_&YR%W>2(QN\$"=<$&'#+N<"@+OSKKGV?JMO6YWR04^1?!;X[H/Y#Z
M2D]>P=?!!O/ESN* NM)CX6\_6Y!XL1O) S[==9I4W:/!*@ZC>Y(["%<#IO3$
M=NDKR2F\'7O0"[OJL1?C-$#AC(\4H* #@_G?-%WW<]$Y&ZWRHD&O1 SN@G!9
M_P!_--2L^C]]=R5_CE?= 7U<89HD7H@S=.6:)ZYWJ$& TZPNE$M[OC%$:?5W
M587&(NF"!OIS\=_);VZ"XONDDGNTN7VC[M;P^$#/CYK?);)X=S0!6X/NP@S3
MK.: .&MT0?E;J<$12P@/OS=NCQ[<$I-UO>J$7=%.?P@#I'1^>6Z:<=*00 N\
MN"3O?V@H#3YW?&Y!HWRT0=<G9?7TI'C7<@+IZ7 K'/7XO59]CA90([F]\$&%
MZ7CG1/TU4[^$W*\$!%<_$.>Y%K?+*\D!2N=WA%,[&\<$":"5WO6\_29^65_*
M'SA90#E6\["SZ7+-9U]/M8,];T@@S7D]%GWO^]%G=-T8]D'?.+T#"[RQ6.N%
M+^T'\8W>]:[S08 0OCU3@[]4K)MV2!YOX(&.G! 3?KG/&B!-?%)?&2WQQN"#
M-<>MN\(OL]$OBX[MRU\<$!?U=NO<L"@*:0^+T6OD@=\W=N^&&*&LG6_KT2OR
MNZK'Z+LX7O* ^<<M-U$0<KS&-A*_F>UZHWPO1VJ#$68XK'O?&B.<,/C% ]G\
M*1N:#"^J:[I)(_I#>F\6-[D!?=\^,ECB/%ZH/^<EK?+X?UX(#Q.M\TK]412S
M3@_@L&:4\W<4&'76]R-_.:/MN[*#5NOC1 F<KNW(OHZP^2 OSG@%CWN?E Q%
M )V3I]( >>%\DKY=.W#DJ2WF=*( _#G".'R%GWGI<4'97,7 H 9<;QE7<@9_
M:]WRE]VZZYK7\W7,+ [GW9\(,^,*7?+!/.P.FJ1]XU&XR1 G=WF@<-6["C\1
M5;2Q=N2.Z+!J5W#<@=_CQ'(H>[2\%KY/O)*#E"W<?A _'4I?=>5AR'NQ\6[D
MD+7B[T0/W=>Y$8_-YI>OC[6QZ73) Y:'UNYH&SII5 ]N"47ENOD] 7Y1KN6T
MI<KT6 NYY(W>=E!KNYIP'\'1S[0GY2#/M*[@F%S0$]N24=+L+'=<+Y+/PN-N
M* B_E%],+Z06?IK\5" :SNZ[D!:-Z&WY!3([6^B>[GXJ@^]+U08#=XQRW(AK
MO;KBF+-7<KW)?,(0CW^4&YZYQZ2^4#;^2=IFFZZ*?UNL.09_/J^MY(ONF&]!
MW7&]:+#XL("1IQRO5*YT]-U[T<KRXTP6.A0!$GO#[DL.]OODB[#K=$ !N[W+
M#MSRW( WO^>"+I/P=4820;J^^&&2PP0(ESP=<T7WE!!@U&RL:ZBL:8(#?A"Y
M)R,[N * 7]8>$!36PY'*]W9#"]4!=GCOU\(EFX8=T+?2W[TUT-C1 N!C*X>%
MAWE5Q\=%N$M[\CQ2Y9TOB@/#M?5-A\68+ 7?(H$7VS') S1KFZX(/W9^+XH
MTW;^JQ$N2#/PO2XIA8NBF!G<KQFG-V=VJ#.G\)73,88WO*8FX9%$:/ZW\( -
M^2+1QN^$T'[S]]L=RTD"GAPPX%9UG3PG9:O2XHD]:>=_1 KZ1O"^*),+NJ0B
M[ZTK!8&\:71 SKMR<-VYUO0-Y42W! \W1ECB.WB2%W?-9U]>25HH*@"3O'WW
M2M7*@OH$C)OI?%!]B?!!L9IIX5[<4OP,[U6!NB ^VWW+!,[/Y^%FKOGCO2-=
M?%]T!?<KDC[I1._1(['BG9%ORS" #=?P%KGQX<%NMQ1:Y;N]R0 YSW;M;"6\
M.7A%]WCD@!>%!\(#=;FF8-SD;>D[X2&ES19#N<D%'/ZW6:+L^G>/""5[OE)[
MR<+\(&:9L]$&O%[OE9EJ\T27YVZ_*! :.X]2B[7K>B)'?#K<$S+6ER^T$FKW
M:8HGS>Y4;$1PNY)'7\(#=Y=4CH'2&Z4ZO^%7[\P2D8\QP0 6_P"GK$[M<>B'
M&[ABAXN^*!@>,+[_  L:WHEUY0^9)]V^"!1?GSN6/;FZ^Z6^?/HJ7?FB!?M[
M\+T1!Q,>%VY 4$(+$X:ZNH@?+&^" ,^+^0XH&]</F2UOOAB@H>J3MO69.=NG
M1RS\GO%Z(-=VY,_6IE=P2G3G91.N_KQ0*Z<\.2!%7N^J72"V6_6^B8E @%F^
M'A/GO=/2\H(-80LQA>"S7B1NYH,3/ <WI>4QORO)$7+'6BPZX:NGD@(^X\DU
MQX\;%$KZ6YR -O0,6NZS\?D:02%$FW(&?KPY)GSMTGTO13\<%A)UT?3[04)@
M;O'>E?G2KIK/XNX8?: TI#C;\4!=++*[R6&_09\DX.6._,7DIW-R!@!]7?!*
M:9T0+5Y+"WQ^)\$&==\GYJCKNM$MW>*/UIF@)9N_I3)^+U3^ZZOGQ0-W><D"
MW0(YT=>'%# ZT$EAA.71 Q:ZR?I;MZ5^,K>L1C6N&:P'=]WB@!PO"RB[Z?'P
MM6<[[:8+'C>*!G[L#<5B,MWA+\WB@,).\Y\T&?;IHEK,=+[+&SC>/9-P%XH
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M\8(NI.%91[\J(!\GS?9"[TN!6%_59+7! '3CQ?NN"(Z7P1?1UW2:#)X6>VY
MX:TGC>B4TW=J='K#?]]%C=]."!#-_*%P1N^A1-]KW+<[?SY!!M[KDZL!/-;Y
MNZH.E7.Z($WUZ1%4&MWSS5 >F1M^"G=W@F%?C) >TKMR!,C?V.&Y,ZE+O>Y3
M,W4[=D!&Z_$<I)OG@*H.LS=XYH \(7IX0 F^WPFO*EX/1=A>?!%UWD4"M<X]
M;*&<N]FE,T'7?--?#I+R@P3/EHDNDO(P1%W1 #6YQ" -^<5MT$P'UT0;"[?R
M@@1?+LB3><I5&:6W("+Y+8Z<G>$7=J=$!@+O! V\;\D#=\4.3HWY6R.6%]T
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MX%;W8'"W:HCOT0?.Y(-RUY10N]^Y-B;<_P"T'Y2NW("[C8=#Y>L15\=$/=3
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M*!YYWNU6Y8?%=Z!M/*4F5R/=&[''>DX.Y6^10,ZE> 6QW<DONN>2//X!X9E
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MIH$7=QG$WSH@-.W&WRHL[A</*!OXT1^+^4&':=Q^T>6[RE?7?A>_--VY0O1
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M%\"@P.%]I(\H?"7Z=N1?TLURC-!F:7=XE,/-,S<$'>./1!^=]K<@V6$/%R3
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MDE!RNYH"*=+NL%@,I;KMR5J,GUO?R6 R."#$X8NW4C<(+7?!8:.L(@2@[""
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MN<;#DQDX4OF$O?E![_*.FB ^XZ>+W0<A?C?81%?//<@+N\$  YR\?28=X]D
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M-Z#BB[C?&\$!=?;A;DHZ7P6?=,9H@Y.[($Y7?/!8TCYUDZ8LI\=1QU6-]/M
M+LW%8\+OX2DV;\(@].2#;K^]Z8C*P'5K-$W"[<DR/T@6Z]$S\_JW.2XQX"!X
M]EAQX#/E(<$#LM7S'$W!9MK7E=P4G6<LE@;H^^F*!]7#L^Y+/2CF;@B#.?"Z
M(&??:#],D3TLI12Y4X8[Y)@UK1];T[( 1E?UR2ONE^$QJ.%]5@[Z0(;=?1,
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M+&[O)$4\)17BZ[P@@-^%G;H=+*P*S[[^*/0 G?X[/IH@_/ZOQ**WMZ(:[^B
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M+=S6N\NZQ%XOR1-QQET09W;Q\*>^&D'9WFJG?82M;["# _=V$']N=/I"Z/\
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MQW6%WTYHF[Q6%+X^$"@707-%TUB8V\9WSIM_-!@=?O'1 <J?%7+/NB9UR^$
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M;^T"+NS@MVL73-8GL@+^T+^TH$W@8_71-AG=X *3KOZ05?\ 6-A(_5$B]_1
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MS0-SN]4 W:##!V4,$+IPN&2WWD)7T6?RC\;D&=\_&29^5W/'FE?UY&J=UW5
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MBXWN3@TYO\.Y(,#IX=CK1.[S]WJD'C.B9_7! 77N[)3;[JG\\A\I",\+O*2
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MRWNSP6O<@'W>2 -<^/9-K/%SPL&1?6YH#?!.Z=FAO!(.M_2H+OZ0#M#??F2
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M!W6PF]M?M.1K=^$8<@+\(%:TW&_A(#=WA-,U&6^FOU1*T+SN"!A8PNDDPW^
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M/NL3P&ZJ \RR^Y:($ZTZ7W0,:\<+YI77>&'):\TQG</E ']4/=AQQ?XLH/\
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M2OK=Z(NAI'&7REN\W1^4!%W>2I[IZ=<K*F*\+O1;#QR0$FDZ!^'E9V-W@.J
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MOF@Z6OW\IA?9 H^KWS1=+>_2ZH"_G5,1T^]Y0 CD8< L=3PYZF7)"[Z#X6&
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MUEV;G! 7="+S6 EI)W;DL^II?'%!FE+MW! 37P/M8#/#-#%'YZ6] 36\LMZ
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M"=;N:Q-S.%O08,X8:WFAAR^7K#+?&Y($\K^=4# 7="D?.^W!.S7%;D<[CH@
MKK=[T6:7?7MC5S[R6?UWNI.%N0&W4O1 UZR/E#V]>6=RX+"N!X_%A Q%[^"5
MV,[O/5,Z=WWHL1VZPX3U0!V%WCP2T'"/FEO5!ANC>:GED[+AH@;W>+PU0+$_
MOIS6[0&5A8URW(&&(C=S0 N0,U@U=8+.T&M_2#&[WZ(.O*"H&;I?4H^VG#<@
M1DY=T!P=96=NN^:<NF+.%]4 =;N$4SL+O%(!<;>GX2'V@5_U,\.:4@SUW;@F
M&5[[@JDN[ 99((AG<[)*1ON&9L*C]UW+)3=TQGON2#/^.A^UD2SONGP4!G<;
MA- P/?E=A$'=\_:31SM*W#>L#G6&B!R;A?;1*-]Z+$RN],5L:.D<88H,$1R%
MP%\PE-XRZ_"+KPW_  @S7:\^VY9_S=(+&XP^')N%;=A80 F]?*!Z=KFL!GU/
MUV@L!(YRU,T PNX]5G6>F11?2XQAVJLZ[J@<"%,KI;DIXSX)0U;\4<3TI\\W
M("=+P1&1C7RD?DZW\E1Z!/<<39C18*@[7PZ('KQEVH@VGDI?;B9Q\<42<K%]
MT&<[C#XQT0/3QYY)'<(9IFFI.NEA(1FZMXH 1%VL;O)$F[Y/U3NK<*1GS2AF
MKK=WY(%)NN=]ELKW^%BS.^![I@S=-.Q*  8"*S-W>."<FGGO>Y3!<YVX_*!F
MK['0QC1**X7TIHFF\7A?!%UONG!!-W.P_F?E6"1GG.RM#+&'*\'H,6:B4L]/
M!2NF+PI;T[ZW>:D3XSA7<@=\1GT&.O)%_P H>W??=TTS,-+W(!;]4P9O[N96
M!PW/WN^TC['*^R!B/E"\4I:OMY[(.X3AKA5 XZ+-,WS19$Z0ENZO2NCAKVZ=
M$&:6?/>@3WORG T0(,(W>FJ/NPA2B#9PX#EXS@N(,M&,MUT@@[6;II?%/K2&
MN!LJ3(<!I?!4>@Q%W)9D[W7N2OO*Z[GIA8S\[T#-&G?C\);NX( <K=#"YK8W
M>90%]17#YPDE?I#ZTM\4SI_?T^12"G'[Z!!0,^'<TI&:)/VL0^$M.* DPOD_
MZ2>VXIFKC**#IQW1OP@5URNYH_ O"X(W=XK! ";TZH=W=N@KP1-=/AZ&=_7:
M2 'KY*87=\UA($W/ZZ+,AUWNW("+[.O58WI=4!#<_@F)K=_: &WNI! ]XQ?D
ML:PM\8=5B?-YH&99Z4EHE(G9>E9-).\7%.:X_" :9'O;UKX]?M8'M?1'/2]:
M/0*^7W>#EKOSJCVE?)8A /(AOLI6CGWOLJ"_C1 C",*.M[D"LG/%,;LUEHBY
MTKG#B4CKNP@8^;O<B#U[WT6-]C\H;L'QO3H@86"E!I<8U1Z72:0ZC>'W#LY
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MA'*[?86SC&6MR0;"]>Y6(6?*['/@L></-T0 BD[^N28CQJB#.XE(6<+=A@]
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M=K"(9G<L/*#>VN_L@1R6.%,#HAE"6@H@/NY$2AI>Y8BCUB*[S+CI@L[1_!
M;XWJL!+*%W-;W7>]"3I/-SRXH&*#L,N?:"Q-]+>@_IYN" X.B_MX6,<L/*;)
MVN78:('ZOJ@/MQ2](<D6I1+^,LTMYWR0,A+/G]&Z(&X7O6?<+@@.'#A&N*WC
M+3>F)T??)*_@@U\A19UZ>."P.-WBE!Y61\8H&9&^CJ<%FA]89!$8)2;W2\E
MUOOZDL_5_GLE)O*]<$[KE?9 H-]_A8'A)U<;^T'W=%F:7>: D=^]YHWX>@3N
MPUH_KFMKA?V@Q/2^P0OH*841.F Z&MT*#NYO5 2STXZ>40>]W1 CQ=QP3>W6
M=WN0%DX7QF_B@T)NW.0.G;?!&_.B 6^'$P\K/O[^T"<GW>:P[WT0'YX7X0)N
M[>L>V.L+FC_'A3CX082Q^+<L1T@.RP'C ;T'X:#/E%!@+![],4VFMWK!$1N]
M D)R=<JTX20''>XH'X^-_(Q6?Y0'>5\T#D],;^4AN?1;&YOO H_%WH@+KQ\+
M$7<:H.P')%]WG@4"NI2^-Y(M&_K#58"^8L(C?>/A 1?V@^=Y<$+OY1=NM]\9
M(-[I<'W\A!_>KT!A7'.A6[][T08F_)[(WNN<,DH9NFFB/:W:=04!TRX7X1OY
MW22:@_*POKR0,1WOHL.2WW9O!%D4SN%X( :W\8/P0N=R1=,\!?+/<L_MG3IC
MQ0'4W=$-?J:WWPR[R6OXR0 C*Y\,EAIJ+Y9+7&]8H[OA!KO+LLSWOGN0?40O
M*^2SMW!WUU0/=]D'.S-Q=A5 1I6\:50!\<S/B@)I='+$4Q%CCC-%W'=VYY10
M:/&]_F" $4Y<^<M4SY7!+GO^$S/B[F@7M==R#IW1W5$V^CHF^J!^;NF2!IG*
M_F*S)MV/-PN"+)1-]I=4 +4YW"WS0%GO<-$K/.=C#NG=R?TT0!_3GY6!PRAA
M5 UO1]P69$[^M4!TOX&6E42;T2Z83\.2OQE0N0.,LOI WUZ+8&[[(X7$A!G3
ME=VY NA.*'NY]X0QAW6-\)W% P9QO+!++J]!]\+@M./7XXZ(&9-W18Z\[K$)
M7WWX31=K<KE) SKACDL1>7RL[6>Y_59HW=U08B=WN4R<Y7>B88W)];?-$@?#
MM^*#!I' W7F^J1X^+O<L:97#H@8Y]>:!9N\>-$@:Q[5KWYI@>UQ0.R+Z7Q0W
M5I=[E@.O1*^3WX97B@:[U2^X2MR(,77C>2'MC=Z6$# XWK;]RU^1Q^$FM[UA
M"5[KB@?"]-4C7P[=/MF$P./*\$C8C%SK=RW(,^@MR<-4\7*&Y39-RTW=933!
MG)!FCEP3;AE?=*'56)?=O0-G]46%O*4!U32XY9(\KH@;<^X7V6P?<TNXO\7T
M6<@=W0Y735 ]JZ=T-U;CN2B%+N*!_/:W"N&.?>-\4C4HW<TC)YRL]$%,%GOA
MS%+=')9JLT!?%R $\C#QR@LR=UG[2\K>F8M_7Y0,>7?AKH@6>E./Q@B^+M+\
MIK=O>@1TA8NX(C2%VY!YP,LUG&\I(&:N+KR1]HCP2#XWZHOO0WJ@/'M]K#QX
M\I0==UT0+65TWO05'9_"4_A+=]>2 ;R,-Z+KK@@SG[[X:I@*0RX\X(#XRF\)
MB;""9&M9]T7:9W>:#8P>BP.$CX'% 2>3J7QRP1)O?F@UD9X<$C\7V,?/5 YQ
M^$ATJ$0ANNX(#N1==RS2G=E&*;6#SSNDD"OX]/B1R6=<)+$97\YZ+>4#$0Z<
MP@R+X7< _'Y3/I- [YZ]Y]TC-\ZF759]UXYR&25K#+K?9!FCPN'E*_&&5;'A
M$<.&\E8:=T!'"E+R3WRE*Y+,BYWJ@\Z0O=W09JXSX(C1^GBX)3YX)O+N5V$$
MSQ^RA=E,[OQ?R26[A?)&HZ]Q_;D^HI<EKX=_&*0:.UN:<#KNWHL3'D;(CQJE
M!Z?#GXW)8F](=5,-4E5W2588HP=_"X1[H-&[=)8'[N?E%^2##-]CI6')4QPW
M7]*3];"9GDC6KE<<^.6"5T_F/U\(G)^%PPN* %ZWN1DQODANO"X+%I*#I\]T
M#&EW]K#FHM'4?%XQ5&9;GDOG\]468$W0\UA5T=_9;=.^"SKA@B,ZW#?!:]RS
M]UR'=R4'CNN%$% U/M?+X0:NJ''*AX/10 '%%H9??=Z(SJ:7>B4QQT^> @@0
MC"WT/8)F:3NW+.-[T2RZ0PW\+XH"1TW75 &Z<.J8 87<U,#N(?5<4#%T)0 I
M"[*(\R-\$IWOZ)MW3Z0 GX%-'I@=-(;J*?NW(NT^$%;XWO4[R&?@(EJO"F&-
M%'^2G+MEU04(N4BL.+G7'[<@?%;*+)I35W/4:.0.[IE=P2ON[F@TW?E_9!EI
M X^>-RYK?7#3)*SWK!$#==]4!PX\,_"#L,#&X)[G-8! H^L@FN!6?*%R2D'=
MDYXR0,?F:VZMR2X@RW:K&[YH&)OMNJ@+W_*'%^>-]7+,E!3'-*&L=*3=>2+0
MN[JANMWF:#$Y$[^79%],+<D)E.?!$Z<<L>J M'*O&J+(4BUYW#RJ,G.Q- [L
MK\ITM\"F02?/RC;N1BL;PE1;&^J#'MV'%9U,X;D#2$A](LFEA!GWA""QN%WJ
M@R>O4.6=#MQKY0$8:K8?>*7V:OCXLIC?8771!KNFY%JCGQ/:J!O47H$#TSW\
MN2 GX)O#>L[(UOJY;&\DX/1V_! E\):=DISN"<Y97>;U@+N\$ =WMR#]+[K$
MXPZ\!P"0-;^WW5 ]WI]HY\!;]4'\']+C1+U\<KP08)KY(/O3MW1WVZ* NOG?
M=!T(9\$'Y]=WVF.&[<4"D8S<[=FBS64/M :.OPB;N\D&'QBY GS*Z(#QG&Y(
M-#,7X0.[#+F,9K?>L'?24&<OA.+N>:!27.'7CR3#7'MD$A%].:#+.N-T<@=]
M,=SM0C+SPAO$$1TN^<DK377M6^:"?2_J@51>&Z: N(U4FBXZW?=!7+SW6^>/
MPM=;P1'/YX7! ".OS+BE)%=V._)%K:7NNW(AI^%/&J GM=ZE+)QN2.N'/X[I
M&V'AW>F$/I!FFJ=]$C3>;I2DXG[T3;%ARHZX( #C@1#<@0.\L;Q5+QZZ)/==
M\WH,<KI>>B(/07E/RL )_'1'I! 3IWL]E@>_(30.F-[[JB^\^F]!G)77?"G)
M$WON2 M\9T0,3;G<*IF1>'C@I%J^''*DG)Z>*[CB@QW7X%N0OM8X)2;C@B3W
MN^B!O=?0NU0!Y7O0 [7EIBL3AKVI1 !G9^.*+\K%^41C9>9=_A$?"!3?!Z#W
MRR377%)[<A6M?M [LG3'$7<M/OO"#]3>?5.&D$Z_'6YQ1TK;]$^.=WX2&6GW
M.ZH-R=CAIES1--^_OGY0)!P6)NM\T!?=\>2%X=K"7W7KRR1 UIX&] SJW"YX
M001?WN-]$+OXW("#?%])XH87IHB^=+O)(^M[D#/K">>5E!XAOA7@F9EVOZ4F
MV,.U]GH*/MQCO1/5]^>* '("=;Y(LSW&L_I!,]_J]Z+[%\D2<.,-96Y3:,>[
M\.O9!7="Y<'K9%9GK+@L\W<.R &%?-NW/3BNM+Q[)'2\T"+KG=Z('?5PEOS^
M$#?*,$IJ+BY$CD@%\)8+%G.\LN5%O-[TW(H,,^G98_&%XRC)#Y'#MEP0?>C@
M@)+W"P@+\:8+;[=>6"Q-\D&QY6>J+]/C[HEX<J2G*PF)X1[:ZY( ?.F/9+[^
M_%(6:QWG&BH^LRZ-Y( #>YU^4U\*I??2&&_#XDG%]]31 /B\T13SQ6 [7<UK
MG5!A6EPOF@3NC=X+</AW.2%_'&X('!W7>BQ.% >-R2GE\RXI@'WROH@QO.#N
M4D'<*7A0(>V7#<Z?CY6&&%BEZH#R\(N\7XD@+/=]\D#7A?5 S\JTZ:I;O!R#
M^_Q"W)@)XQY87R*#"N?B"S(NNY8=[O@L3WOXX/0$;X=L<KBL\<)?5\%AO2BX
MZ;Z6] Y%]/&Y(1K?CD)A'=VLX<EJW&Q!U$#6_&[*#1EUNYHAK&F]*9WC(73)
M  ;?@;U")ZX:)75$_!6#-Z(&\%'Y[6=$KIZ5D<D?!OY"!CYNY+/UY;D@I=;A
M)$C2[TWH 3\V<JK7=Q@B.[]9W&"QX7A<4 '6,^(^:(CIXZ75$#&$K\T2N[\+
MWO0%T\.2S\NTIH.QOZR1%O=AQX('+63]<DIN$[JB#7!\],#V6!WFO@:<4&?!
MV./".5$A.Y-[MWG!(;^<7/0,17X6&[JF.,, 7\AJEOR@($\H=AHF=;^/P^:#
M-=^.[>F!U0*URY_'."#)E#%^ORL<M;?3)82%_5T04)N\D&I:=Z80DICS?7)-
M=Z(%QUW6/I-#Y?NO)*[XQB)A%H<T#7>J0'&7S!V"& E\.X+7ND>+_I!1VMWH
MY*[+>@3R%NO1$&<8VZ]R#=JSN*4&5]5@9<Y/CCE-%@TN\I:(%\/O228='N6:
M\0C%]\5B+A*,4!!Y\HNG\(OR>DS[QR\(X91ATQWH,3PO@L^]=4KN]C2.B(%[
MWWO04!W.CC/O5(32=X75$CI])F;?4GH @1WB^;RG=/&'W##!*T'3G+G;D'0?
M=]XH Z=XS^%1D\ZCA'FINYI@S/SNO>Y!FMUO>E.-RI@B1K>EA$C+6ZH,_J[D
M^/&X(@SB[JE%O$8:K5-X409G?=PQ1-W?-,!CQKPP2'>9F)CD@VZW"P@T*QF^
M#[E)$987OA]!!H1UO=;D& TPW99IH7=\$OU?:".&]WCX09F_"8D2TT2O^<I?
M>!1=B_Z\X;D  PN5O6#?>]STQQ%W\I0-SI;Z;D ?U^@MB-XW+#O7='A1%T+M
M_=!-H1WW JK)W2IW[($7?3-!FOG*""KQPN+UAR[]H*0M]X3%$1<74R0,1.<4
MMR^,E0EVO4W313'4?5A ">'>MYK&Q2^Z(SO+RM[?&MNLH,^?;'HY89>./BBS
MG7<NLD:8_*!7^,!=T6SO2*.[25P6!X(!C"W(]_I8\]^3[DAASCOMR XPQPN?
ME!W+&MT6:&CHW<D3VJ@WM^*(TSX9 Z8(AJG+I\(@7*^B"?G@.LHIWB'6L+I\
M+%GORROLE(LTR<@/(PN]4!G"?QN/*B8%W;#ZL)0>-[KD@8G#)XI]+ W6^B2?
M'C<-4PKGW@@V&^#K"!I2-YHDUX][X(#+&S\20,ZAD[J*I#\(Y1%.O3@46CA<
M'(-N^K[(OM^:!-_'99]]LW\D#&^V+D@$\W7&:SZ7"9*4M8ZGM\A!0NN9K5Y2
M@RJ(WO2,M@Q%[[CDGO?D@Q.MB\UL9[\\>:S4-9% -3NW(%)+^US\)LNB+ISO
M.\%A=V$!N]>B'2[MZ4-W?>")\GA-U_ !\QP^=Z8[JQZZ(&[N#J+=9=(<OE 2
M*BD\\KHL[C\+ :^?JY)C#I&N#[Y(%=CA](F3[UN2 .,7W8WIG5B/CD@0:8/Z
M6_5 D7S<F-;U%O0=>5.FJ!AC> W+$V<;D>2 ,[Z)C=Y9("S;M.WVM[KQ2$7?
M*BV%E[K[(-=;N2'W?Q&2._7/OR3 P$)BMW!!,''EYO@JNL+,BM_6L-R#33](
MW\<$"W=)51(=<)<5GSQ^!>J7K=_"!A)WSD]8CA&[+DO+%'Q#AF@SKQ="\%KG
MRW6]:XXT^<4!<;^-4! F-W*N."P,_$DH/1_%XUMZ/F6Z^R!GY5J)!;3+3 NS
M2W#,8;EL,>M\J(#?SB!QJB,;=G<=R :M]ZH/QOX>@+Z .'&>-R1&EZ=.2QWA
MVEX\%LP^Z1H@#^'S&"#0W;KG@M>OU/!$$=.-[L$">SKRIPU3@6>^?5896Z]*
MK.W=;=5!A\PH'<WH 2N7Q\06:OQE96$KY=,]$ =/%\-9W1-ULWEF];M=T"W.
MH0!_>Q<%GWHLU=E9T^%_"#=;@_!$G/3!*RS]NR1!I6/*%O0:\A'G;D=+&7%8
MC/#??T@##/E1!GZ6(2YIGW?P^%$M]Y+#O;_" @\HW\>%FNE9(#M]<TQ+W7/M
MX0+=B^";7"?:ZH#Y/;I-9_;M80 D]N:)X7>J!-OL(D^-VB 7=ZK=LK\40+0Y
MWV3.A=)H"Z[N2#[@^5OR0)UJL_D?#G(,+NX+/TD;O[P/"^J -PK&.DNJ!_=\
M?/)V2%\R@^]WPL=^=B:#8W*#_A!D64.$:XT/%4&;KOH@3Q\;B4;Y>940WXZW
MR3"QI) "+TKNP0X]1#MDF\[C#EYWJ36_INX1W('(XHCQ?#GO0983 PU\P01;
MG"P9J@/CY6#4=;^EGW\(&-G*MT2>Z^7.JS1P+H<T@9OK<B@<&\KW+-=41C5$
MF>M[T",CC;BBT99!9VORF X#[Y$=T$W8X2KAS6:'*7TFW7G?-8X8/Z<$&9,1
MP1?D.&]*8_:=W.]$&>)W .C!!_T@T+O#X6%QB@Q/;N] &<TS+0IH*7]+.E+'
M>9S/- C0R%AR'MH7RQ=> 5"UXOQV4RT^X<T#AWV_FLUX2 RL+-$F>=78;T &
M$WK,C2PC?Q*ER0?WL7W0,^ZZY[D0<OI!G.^BS8PZN??T@9_*F=Q1O[-Y9([S
M%.R;A?-!K'(<Y)-]FX.52.>;II1?2=4&+7/#2YI +N^"H"_*E.ZSG6,;ZH%?
M?*>D.28,WGW2NKKE>JWNWF[D@2QBB!]XW<$'7Q=RW)GWG?!V: ET[T<L6A+@
ML<M-U$C_ !>"!O=K\9HOGO=RT2\KYP0(?K2FD$#;0\R?)X) <;<BZ[EJL+B[
MXTW(&![2\WT3.R,^LRE:/:2P-7OS+D# :]==R4WNN:+^^_X?;DQ/>&J! U*[
MNBQ.[=WUY+.P@]%W+P@'MKNO<F?A;UFKY6$=_#MT08#2W#DY*^]U41A7#YYC
M)9TMW+M% ,I?/1 '4N?&$80N2(6]@N[XH%]PN'6^J<W=N2>W>ZX=DQ-W;T"$
M\'F_I$&^^ZX+2QNKTI/#GE>Y 7TYZ=;P1':'2=D(/399=$4!/MT*Q#[.O#LE
M$ZXQJ1?A5?HY$+QA7%$@9^:.1=OGQTR2M&\9=.B#!O4;KR"WNO##7L@#3*X?
M/QG\!-\+X(&/GXOHD::PJ+N:8M0G]:3WR<EN[<@8<;QMZ4758"G)8=S\(1(=
MM[[X8)PUC>Z: QK=[T,^OCCV04-+NRI%F7.[Q1)XX9?6$UF>#]UGD@#ON[&]
M8\+@BTU6X8I;%N^D&=EO1=-PX(OSZY0W+.IE=Z(M]Q0_Z\K/WNC*//&J<F^B
M4&=<[^D:BKJ@I)C&64\=R+I:<?B-$Q/*]R#_ )"-Q;F$FVICIA),RW;H^8+-
MLUD*6%(;.7* 1*W7[KPL40:WW<$!=W-.T:==W#PCD0'&$+^5G\X7;T2R:.XK
M$:W;\4"LFSXRYIOE*,N>>5NP3#'KK"^"%Q ^,? 3$W?!!D\NGQ<T#?25A!O?
M>[BB_&_*1U=;^$+J_AV0,38YNO@@#;K=<5A>%\T7:$Z]$&!E>B+KG\P0!E<I
M:Q5+Y.R^4$2+X\5L!></*HY^$J]L!UW)2@F3T=/*&XA*6>MWP57XPYC?N^$K
M7:DH2^4&]L.^Y,[?ITXH8^>W=/<D$BS6^/+5%EGJ.@B;DJC[TPD@3VO<@8BE
M-ZF[>.+]4[[O[JA[;W>)H->=N3>[I'D+Q6?QOHE.N]UTZP0 WH[PF%:8NSL(
M&\?"F6KA<7NW104+J7R2]\W\,/M##'ZAR3>V\K%A 1CHL-XK?5,+%V] FX5O
M<7H"^,X;KTR0 OLL&LX#$7Q3CE\H%?=TLH'@.&7BPF G8MZQOO=$$P,G1T*8
M-6Y]]<4YOE\I+Z(",7W'@E3#Y[\OK!*@<F[[36-*7?-9JM=;ID]R4&R>: LW
M?;X0!CP?).!<]^;^$E/.2!@<;PO<F([<>[\4C^E^$PO@Y 'TK=P1#.<NZ4LZ
M!VMW!,?&=$!'&&.*5H7TOBL*C6_*)Z]_I!A?)W?-8TWW*:Q&5[J\T"+NX("#
M<,)[I>$<Y'A=ZI0,1YX(D7;T"MB\:)7<4Q/B:(0,[K<.OVI@>?A..O22'-W:
M Y3XH T$K+<7?1UT5>8OP@!DZ[AS0 ><\$Q,4G6-\UFCUZ;D#$TCEP0(XV_Y
M2C&NF-[DY.=G- & Z[XIO;VP0#73=)UT1%./5!G7OPT^5@+Y<)30)E/Y?G=%
M/W5&J!RT$638OZ2!WV=_).!<<T"^T_%QO-;VWP-4P',7;T!8N"#73[<CEP=N
M0-PPN"(OL@SOA"]=UP0[W>")Y.NOT@5OANR5&1OE=Z*37&6DIY*C(&-S08WO
MO<IOO$*MB[WE3A5Z!@<CV3$=>.MX)61UKST6PW\T#NU4[O<E!Q/<\!"2S]_/
ME5!4WX/=!VZOC[EO0=\(DSX/TN*##/*F:!II]_:'NQ<[#+YT1QD?F_"!W8W?
M1#G=+T6OBY 4?TL>$&OEHLSKYL\5B.O9!U]+\A ?;?W86-WCYP0+6.27%^_L
M;H@?[Z8K>Z@N_I8>#=X(.J>O;3@@?VWT2@W/YWA$B\_A!^L/%S0$&[O<D(?S
MO$YI@>UOODE9,H6Y P9OYY)3CT?T3#LM[=95* /$,K/RB?GH(:);AWHF^D&]
MN&*U[KWI/=PH_CQ>BVSYP0+[>(AQONB^[Z+ H>V/.4J.PGB@,\+R3^R@A#6_
M!09YW5 FM,;L(%&>-NQ6B\5C&ISO#>G)%W%3^\>:"HYOX7JL^_O[P4PUF^-W
MO2DN/9\-?'A!<:0(WCP@-SC?&G18$7?TL!7&^]O0(T,$KM+HY5?;D'4POZQ"
M!ASN^2QOZD@T73.(A@@$!!E6JQ:W(NN^J4C$#[0'Q=P1^;W!(]W*O>=$Q=@^
M\+@@/D7'FB!Q$^5Z).G.2?2QT>@%WYD@!D-U]-RSY[]\/."PO==A!@S<,U@*
M7IY1Y6%B)[D"D:W3<A[\CR1::S<<7:(OR[9A "9)2U?C5.!EQ??-3.S=6>7A
M!O;4<,7=,E09][@>: 'FPFMV,_* NP%X12@8W]]4K[C)4:OA>2!0;OF@= _@
MZ%E%DQ<;MVZ2+KUOL@1]W]X*C!<[?TN*0,RY5J^^"W2[@@=J<H7O2\WG[ N2
MQ,M>TTON\RE?) QNZV$S^XO5*#&-S3 =[O1 /:MA?RB1?$+=1&[@@'F.0^EG
M8X!:[O=% >?O"/%!G=+OC">W5-/CBI$5G\XW).^43IX0/=TG+DL1XOSV2ROM
M+LF??BZ(,!OE;UA/I\(78C](ND:W3#<@4_-^%1URT2_%_<@B[Q6" #3ZNY*@
M8QN#]^6"5V_#+Y1+5\[T 0%]'5RJIWXYRT1)EUE=U2W=P0,,[[I=,M8%$GMW
MJB:.L4YXH%!UM\KZH@TN\?I$"5NAV"Q9=0UG8N&@*3>%;YK 3N&_EO6)GNZ1
M1?@>>_H@S^_QI! C&_K@B!>EZ( 7\W% SZWSCHA?"CK<BZ#]]OJ@,>_3I\("
M-^>>=[DC[NEP5!PN]RV'F[F@1^=V]-[K?!Y\0RB@>5SMZWW8W(#='+<^7/5*
M!*'??CD/M$&[G]H 3+GI*^2;CD_#L$H&5BX(@]1T<@&-]*8HY<)<EMUTLP0
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M>/PE^OI,^5WY03:9G>^/T@!+?C-/Y(R2-=,.E[D% <+PZ]D&HN&O)!EJ#Y^
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M7:F-_21JID'WK@J[,]>DD"EGE2^J1T^GWO56C.Y^;@E)F;Z/0*18=N&9W=4
M;NCYK-''BL-+G>* LF9W<J.P3OZX7)3)P%WQ6?/KY&%*H 3WPS6&%NP/"*)9
MQB@ ZF/B\$!,88=5F1T'S)%F[DB1 V] HGQ(=3+C<UB9PW2PXZK#QPS\K$<'
M?/;1 P:K*YONM5FM'CO*RE=W=*]$S3G>='NO%!GZ3O1V*1V%WFF(PK>=YI"R
MZ\+.B Y4.%_:9D5^\'I3OWK,-<'SN!*#.PO$N1D#C3%^=Q3#5W=^/A,Y^Z4<
M [!!$#&$-U$PQL75Z9J[B4'9.08'"\*=%C1\H_)T"PPL/6-W1 7<EO;@Z3G
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M6!O="]4 :%G>B!SW.&+NBS^M.ZQ-SA"G;! ?CQN6:N+A12-;P5?;=:.=HBS
M$RR<'/@+<F]S_,I&^N"%_>:4COV=>6"(..<?$T":.\W@4SIW2X)'[O* .\97
M15!E5V"5GL+BB_K>ZB+=C?>]R4'C>&D-=42S]9]-V\K$72_I$8"\L;U6(?\
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MCI?E ]^UY!-WC\<B@%Y7+(H/C=^$<,\>@N*5R!O-PRZ00:\]N*S^W=!]_%$
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M@G+73F<JZJ;Z.Z?2H*8:(,6OJ\**;/6QTW)FR+A=D*;)POB@>6-A$M8=G\$
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M!13G=%GRNG2BU\J8X(.^+ZH,>[TS#6(2@>/CES3.Z 2N\T"-;.+W5Y7P3.E
MS3C!YY0H?"F3]=OG1!5MVG3#BZ#U'3AA&=R34.%)7.62Q'.^>" NN-DHC7C=
M$-._7ED5 ^Z$(9_:#H.NF)[>$FHPZRN:P'WK<4_NH:WND@37/XO@C8/PY8E%
M@SNE;D@ $LD2;OJL7=NU[TOGL^:#$].,1'A)%D<-XD^]$6+N\40+GIA6J!>7
MB*9WWI7L_DE)^/(19+OCOY0 'B_AOX]%4#*^BA\\.RH(8QX;^62!7:R='&YG
MNJ C7=!]A*_$\+ZZ419.>B 'EGX2C)W&[DF:Y7@DZ6'<4!'%UDICPZCXR[I+
MXW-%DW+D@T)_%E,3A.XI7$/P>_?A="MI=,$ OQ/7BG?+"Z?"1H<X<,J:JC+.
M$#TX7D@1K&-WN@$I%W=%3:4PPQN ZI'=\K[9H"+?>O9,_?OC\%)I9=WN:I<[
MY(-[J Z7=4P:@,;OFIBF3["Q.N6"#&[J@&L>.E-4PQE?+%,\0>@!%=R0&6=B
M-!G16?C'51=.,+G]H"=>_+EP3##K2Y9I2,H2O%RV#Z0[:]4!:,N%VY #"_E%
M^72].:4TCXW7P04$)NZ7@IM"_"5H]<.?/JY,RV)ZC-WSR0%WB6"VMWBMNG2W
M>'I1?"XX40-E%UN0+5)I0>NJH6=8T$[L(,.?;&]RWM^K^BD%_-Y*A;Z($+"Q
M9EDZCOA-[LY7?)$[S@,Y=$"%][Y<806!CQ<?%\5C?UTS6T\S\("&KH(8+/R(
MGQYY%9V@G&^"!/T_B(<R@(.^]^:,*95I(7,) >?VL^X;LT#'*-QO<A[J&[O%
M9W&\:K$2=KPPOH@(LUP+[=U3^Z3Q&[S2OI*4KQFE+5S^$#!K[UQ'5 TY_21]
MW)9^'Q;D#.=BZ[R")US#\*WO0-Z.6)ZZTBZ^2#/M[H7U6OC>B+Y8BM]M$&AH
M+Y(,+OHF:I>2/NXPMV*5G%V/D?:!@:G/A=R0=DZ$[EX1-,[>+P0XZ0Z20,[?
M)VZF7E$LXTOY4]*F[JF?\/N/A "9Q&\.D-+@@-QPW5^]$"<,9/BL,Q&N!NFB
M!W:'2^*+!E=$ ,-]PGBB&]7B_A!FPZZP0!QL.O>G' :Y_.Y;VXZ4SZ(%+4@\
M<'_2+KI))SII=$^S:O2_A!/E%WW]X)A=V]9L3O6RE%>&?$\^"!F9W])6A6DP
M_5#VY]M$29W=<4 XON^R<'2%RY<%,FM[GW@BRT+=?V@($C47\)V]SKMZP.,[
MX75*6KTK%UQ0 C)4?+"Q'NI/Q^H6YZ#W[N@\H*M 7AG<DH&?U=5G2C1*Z6%<
MG4.2!R,8TS&>:+1A"MV[1(T:8V)]1DL^_E X-NNJ+YO$NZ5EF.JH^W;OE C3
M41H:7<$69B!6]KZWA>B(-(YW<$&+3G/"3W=7W@,T6F:Q=G;E(M\(RTK;D%07
MZ8[_ +6?5PN3T =^':0J8:(!K+AC?- Q9\WV3.=+YW],EF6LXW"^2<M76\4$
M>=\>RP&.ZEW18?79R!R?>5]4%!(S>):65)DXON]7*K!Q@:\'*+0B:='50/[G
M:9^!3NFA#E3DI!J)PI2G9,-WTZ]((#/[ZIQD]UU2@U=P?7#,HANY(->;[W (
MOI;KN"4'*"SY\HW>*!GQA86::N["D#?5/[=\7("X_4B@^A=WX6Z:((ED8<^B
MV,YH"^NZ[?FEG+>^Z=$0)QOAU0::P'#&]R#'$9O$D36YWN0)E?(NO<B!J<L_
MK<@4?-].B#)W!Q@[%-[82C&^?&B RN\4#"<)Z]$Q.L[W.\)&C6.MY+.B8E 6
MFKO*"(.6<Q?PE+)XOAAOT0<9685NB!B;^DK.7RB^[S3>U]-V=S0#W4FZX[X5
M1MW*WK-8@?24'A'>*?:#%G3+ZD_-+A#M>A3D]NEZ)63I80$!,:P>;O@BSESP
M%C<MC"<KOH@.GB:1H7=<<M$0.^DD 7Y\OJ44&9:O%R)-[D(4QOYYI776%T0.
M[E\XIQ5(3" ?UP2AJ-BEOP0$M2@E:RCTOLC[96_HE^G&#KI5!1]TC;D UI-8
M7>24"7P@9JFER4_9@=89V;<F)R/*XK,[K$-$ #'=$-7W"?,X7T2^X.UN^*!C
MY'27%9UW<LDN-?,'?29].KT# 5KX2/C*ZPT09U=E"6.Y%W"-]T#"[MR0UN[<
MF9U,^GE(]\Y7>J#,MWP5,(;Z3P2#(.OPCQ=?:* ]7PYHOR?#A"]$!4NZ/E>]
M*6K-\$"DT=6[FF]SL>K\(I#2-8_:+3(Q^OB 0,RUSZ4NJ(-XA[_M!GI,5RO!
M%T9R>@(J_G&2##IY%:'T4H-'9<,/.J!^DUO=2M_6=$KW0 ,N"!-4 ?C4PN2J
M#*QPZJ8:N>J9AJ+AQN^"!QRC,*;9PKESX(-&]Z1UF^&4D%&'0B3 SYE(TS%U
MOORL*1&E](IG6^[@@WMA=Z43''M&3HW!%_"GWDE,KA"EN0*&O_:11V_-%L2R
MKR@$H9U[X"Y.3>W$Q[H,<XIGSOK7Z2"C]'RZ<D7:H&?#A=S2,G$(NG2CC<PE
M#.;[[H*/RYI 8]^4D6J'=?8Q=Q69./'?1 KLKKS@55T#>*(N5V]!\1.[@@S
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MZPNMZIMG6(Z3C+JLT/B6%R09X'C=9Y(SE<5M8.\&\4,<=,H7- '8OG'ZO2:
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M_5!D7AOWPPT04( EPN]R#NM\1%"ZOA#EFL[P@=JWWHL_KGFB-/J23:9 W>Y
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MS>/A WOI082R^4X:H>6947=;X4R6 [=G^.2"K;(N&GA1 EAT/6$DV0@;XYK
M:7** G')WGA])0<^=OMR+W0I%W&#D=R CD_?*J/MJ93YSOPD9MV0TE5,6>#[
M@@U"_&%-/C) F /Q=Y(O$JNK + S??') 63=2CCN/*X*;,]T*<NZ)&$"[B@)
ME*[\E9^ +G<SC<DKY=N2=F$(ZNQ"";Z2\9WDB1.8?%*^L+F!BFT^>%-4#!K&
M.'FCT U,[UF@=VZXX)61A&^*!CKKAO6."+)XPZCX<F RF_7@@F.PO+-.>&?=
MV:7$RO"\T WRD<^B M,E^Z[J4X$"_.'-WQ1)J_"_.];W7WS08&5NDJ>WEV-Z
M""F^4W]J)2V3=,>T$#/+R_=D)0JE]_,W@IB@SATL""=T^.^C_"!PQF-+Z8[D
MSW<U,X"=WR0'U&E.J M&7:CKXK4SN]X1]O$98]G\T&!'H@9FO6_I D_;K^$[
MJ.[Q2;HW]H #.JU=:0ROHAQ='E'RJLZ1A3/&\D!(EY=1*&75[3-;BG.A@^[Z
MI0<K%B-4!#.)T$GWPP0+/#*<[T1#63A!Q6?PO"* -,6^Z>$L_OE?A G%[G_4
M<)\466I7=A!O;D7:WH@!KK\=,D&FL)<[TT3?QTYH,^Z69)3?'-.R.5/'71*U
MO<_<@<Y]KP69,G2=![Y*(-X"XU3 YEV/2\4&RA/*=A%YKI2YI<[O'@B#CN"
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M:S3/TIV0 CEON+D+SY2R6J:4XIASK1W*\$"-- Y(>T0QNMX(EEU+^J01=JY
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MZ("_G?/!!6Y8_2V7#MRB4GCXE?-,TU;N[W($/-!V[AIXB@;AC?F:HX0I2?-
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MT#AJ+OC5*9R>#<-$'5L;\Z(LM<+?PNB!79V3N^4Q#N^%NW(@7=O3$7#=>]
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MOW3=K])9.X=+/PM"6M@I0,<7.N:!I;ZPY(/TXN^BF98Q.+Q*%R=D@:U[<=R
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M+R3YR,HQ(=<5F#&(QW(.G/>[&\P@<B#A O=GE\)611,!/$1SB'?:1JF&9W(
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MX_: D3S&-W@B&I#202MG%T>ZQ-'/=7"^:!GZ.N"P$_J7*\$LW\-^0[IW4?\
M?G[0$M;NF" .%WEN6Q%[T[("#,M<GG[1)C?'P4 S.3CXK?)-](,)$[KO)(3$
M=XTF'<]$YYNZ#ND=23AO$T (B[4WI@G+A%\X7T?N*+0^,W?-%)LR$\G0A75
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M&&+\UO=')\[DF]L[TCU0!_ /=ICN0]U]AI5;"-QO!8PSA&D[R0)[L!/K?)5
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M5"]U>=$#>.=R^EGW2_*W-SI?+TO*\+E- 2>.;K@A[IV*=_EZ8#L+HL1;NG!
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MK$'#&[^$"UXO#-W5$-=\MY0%J,71C6%_;D20[6(HY_RI@B0=?7<G9(<[C]H
M&9 NS6=+ =KN*9U)$7]3@C[35V[#S0H)XS=3'.*:DN'5R0F3_,/D.3LMW4^$
M&,7]H2[)6=Q=N<F(A"-,TH8=WJ>/)!5D1PB]S^*!)T .KZ< F9A1\)C+(+'
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M ODY,,W/QJ^+G<XK/=SS6+641<<.R  S>.<M]]$"U3.E].BQ%CEHB!<]>R!
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MB6KP^\$!)N\*HG@ILCZ?DF+0O..@<@#\KQWYI6FN-\7UY)GX/@]YS2M7K?-
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M=WQD@+RZ+IWR3BCA"NEPAN24(D:7>]8"0?P,L8\$ ?O=R'35$&IL2%[D&30
MN&_CR[IB^#HSGED@ :O#FG#-XN09!TI!Q*Q/6&G9]$$WQ?SR.6*8B>(ANO[0
M]WQ=]DK#,W%Y-<1@@<Y0%=?KDE]U%1T\_OX2.GA&L1#EE;@<E^&]8@83%Y?&
MB5[IN-W*JWOP!GE>&]!@!/"?VC2'WCXBM21Y30 X6Z\4 ?B## [EAF#*#W/P
M3,&<^ F]9HXOE+@8WJ@#,HXK5<^E>0U^DI,@':Y.QJY9F9?IA9PYH&#582AT
ME>"S+6581CP6.]U;H[X"4,SR$]\J9(&#4W.>]W)Q6:YNPYCFE;,LZWCBL6I1
ME PKY=5 XQ?,.&YW9 SGN?>F:.$)W?)*T)&ETSH@<#/[R4O=XG;OE,2#CAY6
M]N1S=I<4&=++*K^>J+^64(SEP>M 0D;MR)$_*!60\@C/AB;@G:$@0X&QKR2L
MAT';[Q^$S6&Y_%W% OMY?7UDG&KL_-/"0PD72X.BX9IC7L_"Y.ED@9J;M((B
MNM-.J23G;J)ST@(/I@@4TB^ZW%%_9)&.L-U/&%$K0K/*KAR?]('+5+<.JSJN
M^9&^2$HE_+=')RP,P[76_" XNB^.I%]8)B1,5G"^:#-76>F7)*V>4\#?5 <[
MC(U6?+*[?T6-=/I#B3(]D#6_M>*)% ?&>2#[ZW1Q0ZY<$!!O&^2+^WWYQ0=-
MW7IF@+?A=N0-/Y//X0=Y+^R5_P!XY&>2+1E1^%P)0.61+*W;J)36'T0YR8'7
MOS^%FF=<O*!1I<H9\EG[AUP^T";X64>.? H#VO=S*<";YQ^5)V&,J1OFM[M:
MWV0.<*'I>Y(;T>G)Z<KDI@7E>^B!G7T&4<$-V).Z^*<9806)D!O%?E_- C0J
M*.^;W+.C8OI)8^+^D[NO'6B!!@-[C7[FE]UUS6)RGC=4/:\PI;LGH'%<M\#]
M06[XB\,D2S@_?)WV@1RM\+J@!GWEOPGO1P?OSO&3L%M326,/%E"%93XTC)!G
M><$WMK4AT,TC[E>B8]LB,]"@S/ X7+NE:-.W+BF \#5UQ.B(Y_'7ZD@).,Z9
M:A2(?!Y $72&0QRR1:?!V7T7VY(^KR'P=P049$8X:_:S1D\:<8%9DQ>\@B!C
MB'K"\OO% HC.4"8<^.$$2SWY7!$F\-WA8C2,K&,D"Y;Y7HCJ=!A82NCB<$[\
M8]< [Y08@=G=[B@_+CX1&^?;"'TE?CR>89X;D#DZ]LA>*S7F?#KBID4B:.O-
M,"]XW<CT0( _=)_7@F$HB1B.,3\+%B0^"^Y)3]SX[\<4#^T2X(!F1G@+P3#:
M4[<_G5-IUO5 A,MU3+Y2LZ7?,)RTYUE]QTU2 /QB^L+Z(&!Y8O?#XY+.@Z/U
MGE96E,W(=T'5#P8AU_$$&TYYP3^V%,+[?*0OCF(_>2+)E8RE;T",C /?6^B<
MCF8]$W>]SW[D<MTW7)!,,UAPU"(&+H?,,'.W.6]F%9 <MZ9SP93A&[&2#$5C
M66DKBC[I1?2PIG+G6D^#EH0A$'G*-XH&WS,-^//050]T95ZTT@B69CEE6]V*
M7'I SU0-?>\@B[C2\8[UGRE#/)$-5YB.F2 F]/CX2C+">=_*7:'-T:=NZ49/
MC3QR*!VCNESS6:@\2>;\Y(',N.-XN6)UC=X(#[@:W?9%G'"[P0W>#\/4_=#=
M)W>Y(*-6>O)P0+4J;["#^&%+EH$'"L1?4(,.,,51H0=+% $1=;P@X\)/,[ZH
M![9<OC"W+&CW?&5YI2=W1'W4RK3(:C&2!P1)^4KPFL[7S8FD.7)UQX43'QE1
M HC"/$_">-99\$ON$*<)=W*CYYH)-$&%WAU2^V, :V_M)-"E[Z+;,Q,W=]\O
M*#>S,#X') CSEX>4SL?M,6^4?B%N0(_$;KD@3+"AN1BCFZ/7<ERSUET<@WR!
M]]X.6PYXZ94Y+$5\O"WMZ::U>@+\C'=#LM[,QQEY,XH;HZT$YW)'>\<I2O!
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M]OG! Q-7W\22^^[OB$2-==Z4\[Z3<@):G70WP3%JSNY*;+($>%CK@B;L]4#
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MTZQI/3>I@C,8"5[TSX@@0Q'BF6B!@85#XW@L,1N\CI%('B!EF7:WN1#5WS0
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M.SR1?\N=8!LI95O-,,,88/*#/O'LL3.[A3BE)?B!UC]!8'J+O% &AONI3 :
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MO,WHB7:<OC)"^ZSM-*W5!FA.G2^ZHS0F3A;\1A/!3=$/D7F<G&WIFLX0GVO
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M!1&-,\0)Y[Y("R!-SW\AY6?&'$X8)&C"6.Z4UGR,^')!B8'K71!\.SMU>+T
M,9RZ?.03 P&_!Y\8]$ ?)PGWKN[(L"?//XP6.1=W\(@])PCAPX()MM3QI>B9
MFG<T=!_;)$C0OGCXAS0WY0G1\.B -,XEPRNP@[ 5H1NNJ( QC+7%ZP-.G-R
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M! A%C3"W(L#+2^W5;L^PM[>FEX(':<(2CVA>Y$M8.N9D\J>%Z.0:P$,]<H%
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MR2@Z73""4[^4=Z EL5?&$()F2)UAOU4]W&? 41WV*>4%B:],Y&Y*9RW4NNY
M-;T'XXROL@):REI9<F]VMB=Q<D:.#J31>,90UL10,&CVQXT6?QY8:\$/=UAG
M='I216_E YS/"/WV0EWOKD@3+E8J4&A",>5O>@Q+Y81OH4K+)W3=V)3OQN]'
M;T'O,!SSX>$#C*&^M]T6:O=?A3+[J>VJ#[NS2"!G3>,<DI$G0YV53/2=3+3%
MZ!(N^7E &0/N4<\T6A@*WP=26B5EK@<KJB3&$ 7WN0*ZI&CI6%G ^<'I_;NN
M;DN_K3!R >V-Z1[#BB&K\P0!RD_&4H9K>[1T[WN0'W:8\>/TG?"MCRI%$F4R
M @+M?FJ1_P!7DF9,WOWF=_:P,J9YYXOX5S08G&#^'#<F!U/:Y+.[Y)6P*<1E
ME=4%7O$B.<+DHEH7R.E-=R H^3KO(I@'=H% PC2\<XW1,:87OA@HU%VXE/TQ
MN^B!FFCYWW3<D9\S%_:+4X/[_6'%$U%?CZ@@(:H[24=%@)NN%UJI/RI#3-,&
ML/-+Z! S3_J[S2OMYO1$M/Z7V[('3[G?P@8M7RG\)DA$KO3DG0.0^KL;OBA[
M:/WW5,='QD:[DCXC#.'1!N>&?+#X0)R'&[E!.!ICCBE=&F6[J,$&8.,-\<N2
M;W9X7>BSKQTUK@E:T?43@^Y(,2*NN+\\$A:F###SQW(C1V#N_C% X3D'_'+1
M H,'1E#<B:9W92C F&/W\*[L[AR0*,PZ3C2^R4Y.$X.O'BG)S<;O@E+&$R.=
M;J@7<#ON:;!P=?=*^A#CHXI@:@GAR<@SR]S^4=-,\EFP(;J1BM[]'T^+BB>#
MJB-]$$69Y9R5"90W0Y=T&2Z#I0QZNI%%HQ^(6[@@L^Z>=]9(:]I:/40#CNED
MJ-LOW9B7W5 L-0_-Z4LR(B,*ZK,C/B7JCKZ?'- ($ \KNJ 9,7%P/U'$)792
MB*9<I*;;;G/?S<=<$'0R>F-SGO2D2/B>^J++(@8S?\.Z<4Q#XZ7A5 */O!!H
M0?T=@'I?88C[39%W7+A(:H !"?'H@^W=-4P9O&^-4''7K9X(!#7$7;MR+;9C
M#BY$ ==]NFI5-G/YYH'V9D89O?+K>"=\P[A#=V2APR^;=S5!W^$$!<'G'Z3!
MJ48/^>?Q1.UG6L_I2+)$9A\CYO#4':LPO32*H!QW24WU&%^$6FX^<D#D^.,4
MI.4WO\\**;,W.UC.[P5#(1X=;@@'MJ\XS1]KI<4C/-]\N"?*MUL:( Y[P70E
M;\5BSOUEE>2!#S*#IX/U2M,YQ?<LD% W+.Y7#-8C").0N$^JF-FZ<<'%$O@Z
M: /W. I?RGC#M?)!U:ZSGSR6DXNXQAC\(!J,IS#DPR R>;O)*1YE83.RE90"
M+[LBB.7/G>&"!I0X#2MZ(D;Y2Y=$"L&>6$H]TS+6&\TG;\5&47NE"\<54N@_
MA=4!K@,G7%!HB)<29##"\4 <.\'Y6Y,">T</@PX()^[4P<<=4CXN(O'MB51E
MG#_TGZZW%%MG!PNG% 0S-\G6;@IL&+@'"4)$=51D\'WPD[-*!%Q%9QNP@9HO
MA'75]466L7'#?)([*52^:SW.(+WYOI0409H4&._1#VPG*AX3MZHX/<($1R^.
MR#<R9Z]<D!9./PZ[>B61AEA8<@7"[W%(]^0&<P@P-'?4J8H@"@&#JV*(!E[H
MZ'LF<==SG[\3AW0*&9SAC N[I=GJY\A75]51H2C&E4&\8BC_ *09S@71C J8
M;D!B(?/+-4++P,,3>_*:5IBLP'=JH+.F^#CS'F&Y(_-S[O)%U7O?'S!!L8NM
MTLT&;#G5O)$![^7Q<4 [=CK.^*S0E)V4'BY(#@(.S-\4SL8I S5XQ\^$QS.#
MJ7;D!+N6EW5(YU7OO@L!D"+@[KHLS,B,)&A'QF@;^7"Y5*;VXWC=4C0R)CBY
M^J#JQT\NPX('NE]T TZCM(SU1!?&A=RZ8 ($"NM@75!@U+##.X<470K WN?6
MB  IRAP^8(M0S?%[L:(,1O?=G!,Z7;'7LI@8YQ?RSWIO?,SGVEE"/) ",)2C
M<L%@UNIPMZSH/M_:Z)"*3?UE-  )WK'6*HS.-BJ1U#Q\YTQH@-F[/B]_3X05
M=WO!^%4=8P+_ )SW*8K!US6+0I&[AO0' "%O=XW(@0,07U-QZ)2R('RY,X/(
MZ=L^.2!0(.E?-&F($(AV_LL(]H.=\K3!T<!=.B!290^:RHF'WJ@\P WX8)H"
M%7_=X("_'M2]4K5(\!E19H9/N!MZQ$G![CIQN:!61-V&\9^:I@W6NKX+ 4N^
MZ+3,CQAXQP09HF#L3?'D@XO.Z#QCG;EG=0X/U@B:2QUWXH')CPE<>V@2O,Z[
MH[D=V.DG\(H'#/=''.>B!'B+ID1#I71,3O?#6-]D6[TK#$+ .AGPX6$!9#J0
M4WO@_E(2YJC(G=Z<$A=&R[726Y [M_7<E,878^D6<GSZ4WH!H3=$8]-R!F0\
M;JSNN"#G&#]^%XI@>6EGJE9+W0(082YCOR0:%7X7?5,TT91#C6^:0ET#WW\4
M#>S.$)]3P6/5_P :)80B1KKCSR3-BN./@(,_Q]89K''?\)?;+-%EK#=?) 03
MH13,]5@'R/"YT"9D5(EU%/A+PR=CYY(*$RSKXU1=*I$^)I**'NEC!PS=X0!.
MF>?'Z09IF,_@($TPJ7(NSGOY)0<<._*$$!+JRRA;E@*OE3$&XE*Z49]ECE)T
M7W807 E><2H @QB#BZ$#SBJ,FG;COZ.0)AN!@+N*! >MD?25D@89WT,@]8?-
M8)BR,*UPRP\H"^<<XCL@?OP^X30(>#%Q?"[<E!_W5<.9=#7% 0U%\I9O50S*
ML+<_A%*,@"'7K)R#.=\)]]R!X8\HZ8)7QP!-\T_M&)W'HD,Q.&'>W(&I1SW:
MCS@@[F--0$P,(B+Q'BE GNG=[D"B!<<G.[>,<DS8$.F.[JLT,H0/F_*CLF6@
M_P!Q>]IHB$ "8,[L4%N4OC=S1TOM;DHUL+%G?%SC!!F6:D:.A<$Y A7=2_A*
M6G.':WVY9\'87O0$.?'A"&%[TXQ+OC[DI/#P;<<L28)@7O!=3?>>"!?'/59T
M0^3^%_:+MP?;G:(LQB=QR0 GN=;X9(-4&(?\[M4X=PID_EVWI2R]YS@#T[(&
M9GN=A!8X.,?GAIQ2#'GNPO).=7XZWQ0 Y#/2G.W( Y1#Z[X"BSY0$^-\$6A!
M\XTF@S,C,%[SC\K'3Y%/*# W\I2.O)88\WVZYH#[=<*0#H)GRR^OM*!K@[/#
MNE.''S=$%K=24+P2AKA*5PS"+G12LF;X_$?ATYH''2ZUL*7MQGVOX3EV[ W
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M-=RI%.3#'QW&*!Q%]8I0UEI?!!9D9YC?&\%G:97EU4PUA=T5!Q?PN>B!2SE
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M3QQTLO<FW\HNZYH"0 Z!$70EBF(LW;DC0A-_'@4632M-U=V2";4Y%SH7U>J
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M,Q9L(NXNE@<M;F@ -WE<$Y&+Z/69E#C-Q0(SQR#[ZH&?E-RDT,HOU@\53O\
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M0V[7M]Q!>TRSMMJT2[_$L;+8AHO :69KC\LQ_6+U7K]GLA[MMM6-DR*MM,L
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MP2&F6<7W-$X7O[I#H7XX:VY Q%> <[BMIO?%$"7.\4&M=SKHA,B3\=.2;^-
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MZH,#AIGH[1!EG5Y^J(OX/YAP.Y,_#'N7\N 0*Z$'X'2;]<U-PI# @7H53VR
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M*CYZ;TQ9XX8T2,F59OI&^27WU!R@>79 Y$W"&&.=ZU1#7.,JR^D*1AH:4'9
MM<GPRN2#80>!5[]'H\'&&6*+GTY.@$N5\T  B.#N_P!+>V?"F").> O"Z)LS
M*4$$R*2<89;[WK,G=D);L%0"<I;]^2+XND,A.$CU0 '05-;'19]0(N+@3><4
M!TPJZ^*8]N%_"# UC1\/.*TI:1NG1*6Z/A/36\4Q9ZZ/A*^*! :.@3TZYIGR
M-'\M.62!9E<\M.*(U@/IU]4 ?-]X+!K .,7]KR&28LX8?6<0-R4&H=P03,^#
ML*IV2<LN"PPW@Z?-,TV0KPT\H)FF3^MN0]IW7PWE5W4<X71 M80XUQSZ($]]
M-T>/!R/NH[3#CQ6 H:ET#$:IG"/CD@5TR^ D-;*8"Z&QNB@3UP,#!T;+U@9N
MPCEVG)R#=1.62/N(=#"6,I<.J :G"+Q@$6*0/V,>G! 0)QY2NJ)R=6^,N"S0
MU-X(.&EX20.S3GA?5##G3+@@Y^Y$,PSKC*_* BC\3PA?- 9RE#!(V>(Z53N@
M>6H'(("0,"'.=?1;#Z@ZJ1^+Z/T?/MP1!Y<OBJ!B'?/;=P0(YQ0]TKL\XHOO
MDZ/5!-S\@Z&%]XH^TU?&G+=HJOG@3KRIY2.K&>YPEB@4#"5:1 HBT>'#=GDC
M[M':?>_<@U4Z3SF'( &LH4O.$D'/B\NW<+FA[1"<KCUR3OS%'::.0!W(6] &
MLL/I4(TX3W9&W)1@(.IGCX\(,,.!#[^$'U)B^1N:(W:I6M)\M]X('+6%>MU4
MC.E.(PQZ)R9E^6NF65$&::2=NB@'NU&]&,8RE3CW3-L#"7"&/PD#<A.''X0,
MRS\A\=TW(#H\QA>J( B?J5?*7!PA&1Y8P0,RU*%7A^#LA3!.YT;RAEW0!EOO
MOW6)OSO@4"EK=KG5*RU%\0_%_+JG9Z2!Y*9R-899BX(&!?B,3E1V:#\,87S3
M,MSZ=0D]O#YK?!!9EJ$9ZO$(F=Y.2LE]NZ90SS4VIN,LI(!JF$ZZ:ZH*NP\:
M0/(XK%K<]VD%':>K98!+;3+(9B2T0 X.B\EP7SW]B_J]^%]""?R/Y_\ $>D<
M'D;;U_IF&AC_ (?R%H[ADY!])=RUJE%8PE/F%^7&_P"\;]5/K/0_BO3?GMGZ
M[UOY'U6P]'Z9CT6QV_J&3M=NU[=F6]JSL_XV&"8--EIS,'KZ7_57^K_X_P#7
M_0^N_+?E]HV-A^/],SZG;;/9L^[;#9-M?Q[(A@D?^=M?^ELWP+;XP*7RON^@
M^I^ZE7$RMW-59C0.J=W/<OY\_K7]]6P_*^G/K_PWXOTVR]-[V]F-M^7_ "WI
M_2@%@^UIH;+9,[9MID-?XP<?>"R)/7JWYS^ZS\AM 6?3?E?QFSVK1:]FQ_%>
M@VWJO\69M'U?J/YA[0"XM,[ !\<AF:XXP7\G]+WB+R^#B7NXZ<%X'\C^S>DV
M :/J/5^FV(9G_)MMFRX#$/>-XUHOY"_F?ZH_G_7':LC\Q^0V+(+8]S6P:;'M
M(_VC^7;>GV +47/V#B)."^-_GOZ5^I]:SM&_S/[%^Q[;9%F/IV?RVR_'^G/N
MFS_'^.V#+MG%W^6T)DZ+BL^LA-:.8N_K1^Z_W:_JGXH'_FG[3^)]*0"YC:>K
MV0:A0,^[W-.>(>TS"_/OXS_B3?K'K?7^F_#_ (-OU7Y3;^I]3_I_Y]CL&V?3
M,!EEIMO:':%D0]K)&SA_FVYEX>%_-;T_]I7XAD[/;>B_6_0>M:]S1_U?Y7:>
MM]:&2X_Y_P OK=L[:AX#_P"-EHM;G+]"?HG]!& 6-GM&]CL=C_B#Z3\%Z)GT
M V@JSM/5!C_4%]2PRP2*P37F\6CMY@UHW7[?P?O#^J/]XGXK\=^%]1^?_';/
MU?Y;:,,[?^+T/I_2[;_4G:;(ED#:[(,D[%@MN_S;< R]K)?Q+]'_ %__ *F?
MN7YSU/JO0?KOJ/0>EVOIF-CZ;9>E_#[1O;;!IAH^WV>I]4R?80RT&FV@6 W!
MH $+^U_]+?Z$_P 3+#.T].QZ/\<R]EGTS7NVFTVK!))]YVA+1]X/^9;+1:,5
MYW^X#U.V_ C]?_:OQ6R;:]+^!]3ZC9^N_'[!G:G8>I]%Z[TQ]/M1M-AZ=W\F
MT8(V9V&U;!'I]H/?(M/M41.<WCY;OCS+=,Y6M$SQ_!_#K]S_ +$OV[US'^J_
M?/V/:;%G:LEKT_H_4?D/4^M]7ZAMGW;3:'9^C],T=DQM&=E_FUL3M&?<-F7,
MF+*^$?B/[5=DTSLO1,?KGYGUS6T]/M6QZS\UM&/QGX_9#8[7:,[/:^G:]-M_
M4[1K9?R,GV#;G9-O(?LV0TT!_7[^H7]8O5_D /4[#\)ZKTOI6VOY_3;)MO8[
M':[,MLM/_DVI;&VVC)_D;_Z3F60RVT 7.=^=VOV#U.TVC.R]1Z+U.P](S!D[
M%G8M;+9 P)/IF-HYMSYMM-M2+WKEW1;SO''/GK<*\2;VOX?1ZU^J?HWXW\;Z
M=CT?X[\9Z/\ (>S8C9$;+8[,[,$LL,[78;;U>U9;VGJ&!M@W_&QLV6V_:0P6
MWA?J?^GW]MOYG\VPRWMO3_\ )?QG^#.SV;CZ79,AAW_49]*RRRWM0:?SDBI9
M"\Q_2G]N_#?CO^K_ !>@8]2RSL__ &+_ "/H_P CZO:[,C:#:/V6PV89V#+W
M-!P+Q[GO@Y?IC\?_ '*>EVI:88_9/2>GV6R+6TVC;/XEK8;3:LF ]/Z5C;M;
M5_\ &" -IM@RYD ^UI=(W3QW6MY6SYDIC?/C.;Z-_37^U[\=^*]FU9]-L_6>
ML]C'N]1ZQOWR)?\ Q[(,?QL>TO(<*B*_2I_72QL]H1M=ELRSLVCLPT/9L@0/
M\0VT][+),"1(1BOPO^U_W%;': _C_P '^4_(?DOR^UV9V6RV[?J]C^,_%^A:
M;99:8]3ZCU#/IV6=LRR2?^AL6-KM#[7 !Z]=_4_T+WD_D?W+^I'Y'\UM 0V?
MQWX_U;7X_P#">G9>6BPTR UZGU<P&V]OM&&6W/&S9$%J*KSEXY6CL=8MQ?MC
M]>_+L^JV&Q]6P !M0T'!H-LLML-M;-L!MF#3(:9/M:$&@XZ>7)&'2&$+ZKUW
M]4]3Z1KTVP'XMK8GT3# 9V/\)!8# TF^9)B3%Z]E&.-OOBM!'Q=\BQQP70(
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M![Y"L2@)+KA'.XQ"!JX8WI]20?"L)2=I\I?=6R,9.[H* 3<]V<#NO1*+SN:
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MPAC*G9%H"2S3+HR=Q-W!!0WNZNQ\+-/TEJD?+.#YV/E$\'!XOI@@7E'69JF
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M>L)76J/A\)8Q/&" FEY\<T&B)8PP?UXXI1M,I2+^'U)+PA5V?4'B]Z!P'1?
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M7)&G8C(7%\]R!<JO-NL*K[X)"!R=D_*X%+)QI, %Y04+72W=QN1&!Y5'QU2
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MV(:)++&U]%ZOT6R_EV^P$&V]MM-L\CW,N9(6=>)RB?R[=B:MMUO"'U#8_P!
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M@9R\;MVCTA;B8169..>$IB\$ ,XF MZ;WO>!D)THA+K>+D)1?)W- 63'VQ
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MQ&*5]'OQA&P@ :G,\KHF>(@##.N=N09&X<+Q=)%V/"&* LT#M+PAV6 %7OW
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M!^GA_)$CF@R$&?AEQOLE::GV=5S[I19K=1U$88/Y=4#,Z<3=A,3>,(90Z (
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MSG:1!<J,M&@+[MRFR<)]OGC).PS.,1+)!B9YF3SS\)FFL(=#KT&2B63-\7Q
MZHC-IVE7RE) II7%]'K,81KUBZ? [E=DO>'&%S')3]LG4?\ ' (&=6KQ9Y+-
M9#<*$3OZ2#/.MNCS3"5+O<@ XU^=0J>[?X2>_$0?VZ]$7S&-\4 :;R?AFZ]R
MP&(J^_N*+&S? RNRF;#GNH8Y73L@#J '(G!(TTYSP&O&O/),-I ;QB_>>R;Z
M$;XXH '6)IO="'323\>B0P@(TG=O1#^^EUD@+\23#ED?A(^CGN>Y\T6F8NUP
MN\4<83-E 0.$'/[A(?K=R\(D5(UW26/)[M!H@1IK&4703@"6)QPTX)71T(M]
M40S5Y?AVA) /;*O4\<[<E=*G=R<-SES/7GFBR<Y.?A]8N0 @XR.5[]R5EF,3
M'1QC<%5\\)T,*$7Q4BS6O=\'(*%C=PC=*E;VXT?>NY &KWX_&'A%JLHGENLH
M&?&1',0@+HB3A6S"*F:E^E^4PV9C&Z1RR03::BX1S\4>BS&&<#XY=4 .4HC.
M!6PCE<G(':9E&?0)1KRW2PQ1(D_.L\PG]LH?&_-!$LV^0RIN6'+-V#C\E,TW
MW RR=<"IMQQC(4?J@NRU2,H5N!\)6S@'D=);^SD&9=0+KB4[1&'3AF@4C'";
MN/VL"<3.]<([D6FNG!GXZ)<CN(KX0/[*FN$\$NTQ#SYR5&2)<B;<@[#5W7YY
M((D<1'33$=$_N=2+I\@E H'NQG.>J=V6\X'YZH,&<8&P'K#..Z%V4Q>\.WWS
MT2%F+64'5W(":=1+=WH A[LY.U^D6J3=ABZ^"1T>TI\]4# @A\QB7[HF2#!>
M^[@F:H).!WNTA>:<9<;D]!!IF(PP??#'%9T:/=#[3FLIO%7[DO$1IXG-!2@!
MAR@@T"Z!.-!*F'@23,\!P1]U":BK[\((3<3OJ[ZE<  '5G5[X9T@J%G"//I/
M+>EX[Z;N44"@OS\77RJS=!XC$Y9=TH#H.B!!W(O6QA4 N^L>2!B7P$:Y$=U@
MQ0NZ/RS<BSHX"4>EU0::CO=9F@Q:BZ4L(PHG!GEGQ"/MI1Q @/M3&>DX9?#Z
MS09^3L[TGA!;69MT%@R_CSO<E]L?'#2* >ZCCK+/Y3C4N/+7<@!G(5OJL7TE
M.\]9(*DQRN\G)-*8.2E^1[TYX+>Z3APY::('9:I &KYN<@7/B,=]$GL@\B(,
M\LOF:8'*;OO@@=DB$)?4#<T0<,(7;MZ5] //CBL79D/K :7H@(:XG?%8F/Q>
ML9(/[TN*#4ID4?E\8[D#^[XAN3>SG..& O%(R7/+WAW#Y3,F6D;SH@!$R!7B
MLZ0E,G,QO)8F<(<8Y"XH>_7"%920&$Q/7+LY8M4$3C+1!TW"\$6A.+N3]+R0
M!EJ7"M_(R1 NY.0=APF!BB+/GG- SYQ.6!ODD#+W&M;%A2:R-=XQO!,28NU&
M, @8F<P7V[+.CDH+P^+Y7OP3>Z>+GX&,)2N45MU)/>-$!9)&KHGJL6LG'+.]
MR!,@YWCJ_JB&IDDNEVA;D!PQYNR\(%L/E.ND-$HH1&#GF&_5_!9IB7(O>Z$8
M=$!!GT\.Y_"Q$'NA#Q94OXYQ>:X!.R)A_&6F.B LAT:"F"S)XOD^F/TL3 \,
M";N:F,J3-78#OO07PP.,'O'6J#,' $8V4>Y'S86(J)"N,<,4!?RCVO!)K![G
M:7-8$Q!F.1PWB?19N8_]I>[+ 4X<4!]N/7KC-$FN$!V)0?%W%_UTWX)6,YE_
M /G@@H&J"GPI$$F<,#)P%QDF A#&(Y$0U"!-71 A_P"U8NK! ?XY<(\0FV9[
M^!H_@D9:D10/(UH>[OA/W#G>$!&KNO+NMFZ$]!4<5-IFHGOWSF_!5 SF([C!
M 83?A$4?3189:/%NHA"$J.Z2QNJSI"N4=2$#NC"8AQM]$A&M;N"8&^\.:#6!
MW82EX0 8B-WJFRI3%V-R*1\IQPA%WPF),*ESOF\)( ^WNEWQ5 ,QW(S=AXHH
M@4=.5YJCI9P(?E<T!($W7<RF:QD<O"7C'<<-%F120SF^]Z N> <Z6_RFKTC1
MT;,MRF,)%\KT18KC&0G\H,6IX/= 72>"!:LOL)V6MP&G)3:/!\;Q04?QCPN%
ME ,\)WKPJE=&'&6[YH4P$#E#'6?+-  SG$4S"8BHC#QN2Y.>Z#W3?KS'!,*D
M0AH$&+40</-/O*2#,R[!W:QP0+6Z8BZ%E!^L3N08$OY!\ .29MGI20P2$BIJ
M)7;D#M!-[O&?'@@;B(2+W:7D@3J\4SR7+M?R&S8!+>T899#WM%H #5\G?2]-
M_+_U-_&^F)'J/R&P9(!)9#]HV'3/MV3+12X]]X9@F<)_2+6D9_1K@'K\W_FO
M[G_PWIW^S_7^K+(+0'I_2?XG1OU&TV#()H\B!>7!?)OS']ZK#QL_QWZQZWU+
M9>&1ZO\ +?A?1?Y0<"R?5[=N3R7 ^U36C\LUMV>,1\7[E="!C5^.5P5GZ/GJ
M<5_-O\I_=/\ MFV#?_+OU?\ 7O0;-WN8V_Y#\XWZD,,N/^;0]/LF-D2RY[O=
M[2[!?JW\1_5DC\+^+_,?D-ELSZSUGH/4>HVC&P; ].UM?0[/W^L_@VC1_P ]
MDT 6O3@?Y;0$ .(*15!;L[IN^YM&H=*+\,DKQ1^_G#/!?QI_3_\ BE;7\C^0
M]7Z39_@&-E^.V6W+'I=JPTUM/6;78^\L?R;?9[3:L[+8%EQ:;88+9$!!Z^T[
M?^^7W-_P['T^UV>T:9+3'\K/I=BR6(GW,EO:ED@ $E[0@X+.O!,/Z6^\5#N0
MO."WOH2''ENTAO7\G_7_ -UOY/;;4L;/U&UV>S(?_P!':^C#;+$#[_\ R]I_
M@7@%L$LAXB]Z]6_+?U0]?ZMEKW_E_P N620T&=G^6_A#1?(?Z;TI:]KB'QQ$
MP]2,2.MG6A_7_P!;^4V6S'_4V^R8 '_=M&&=\2)#Y7IWY'^J7XGTX::]7^9_
M&[%D D_R>LV#,!F6Q*HW.7\5_P OZ3;^H+;>V]#^7]9M&FVF0?5?L7Y(;':D
MN#4';)S(#O\ %SG!T*^(V/\ 2/TNU8;:]7^"_$,AAL#_ -C?7_E?R!9VGN#1
M V;+1<RV<W.>(AZ55VX$3SE]7]Q/TW^I/XW\J/4'\-^1]/\ D!Z1MEC;M^GV
MG\FS8+;_ &@-C_%N1'^)(!'M>\.3_M/]3?Q7XUG^3\Q^9_&_C&"?:&O7>LV'
MI@2 \@?RMLO+@]P!.-%_(/\ 1-OZS\#ZC8^B_7VMEZ+8?E!M]EM/3_B_0M[/
M9LED?R ,M[1O:[0NVC9+#089:>\OHO2/V/\ X;'YG]O]1ZC\[^9_9?R'H1M]
MGM-GL?3_ )3^3U19+3Q_+L-B&A_#LB(@- --$S<Y6*IF(F(^C<1&_)_6?;_W
M5?J3(9:/[A^!:#8'L+'Y'T^T>&BX%DLMF9@'NA0+P/K/[Q?U'9R_:/Q6V:BY
MG9^KV31)$V02T _?!?P%_+?\/$?C?5^K_';?]S_%-;#\5M-DRTTTRULBW[&!
M[F66!M&B"#!L-,@^Y[-2GV/]J?XAELAK]J:]7M-F&O\ #TOI-HW_ !P999:8
M:8(V9;!'M<W_ (F(+EB:ZN$>?=NXDVZ_!_<3UO\ ?7^N,^YCT_K/3>HVC,?:
M?R7X_8  3)_DVL!J-Z]#_*_WY[ >T>B_&_B=J"\^_P!3^T>BV(:9H6?X_3[0
MO?,/<Z2_F+^'_MQ_ [,[$M;+\GZ_U!#)VA]7MQL=FV 2YO;['9!IMD-"?^;H
M2>OT)^H_TP8 8'X?]<V(89_V[38_CFO5[5SP [:^J.T#RZ)#('M<XO<%J*I[
M>>SY[&-;AGY/T8W_ 'J?GO4-%C\;^#_56F2P?:6OV#U/J6O<7 -$^G]&&?:\
M_P"UX>'1$75_!?W"_NC?Y'\5M/R>S_4_1?@AZW9,?DQL=IZAK;[3T[9]GLV&
MVVH(9VL66F'!Q<1 +PWH_P"@?Y_U/M&SV&VV.Q: /_7V['HMGLG@RV&Q]A;(
M9=!H.!C%?6OP7]JOK_;LF/4_DO2[%AG:,[0L!D^I:/M(:99;)99]P9(!#F@2
M0XEQ<K$3E]8GY?%J)ZH=_P#>-_<[ZW]6_%>O]=^(]+Z7U'K]EZS\?Z#8;+;A
MK;>]K\@P-JQZC^!DLM-L;-@-C^-DAILLDO<"%^6OZ6?WN?F/R/H?];^9]<SZ
M';DLLM^G]+^"898V1:]Q9=M=OMVMH6FV62T]K9C9B #S/^B_XW^@OH1^4VO[
M-^4VOJ/S'YC:[/8;,-^L+'^BV#/IMF=GL1Z7\>RS_I]E_&RTT&&VOY-J/<U_
MU(K\H_WD_J09]7^(;_%^@]&/5_D6-ILO6M^HV^R]+L-IZ;T8 V>RV>R;9&R;
M]1_U6O:6B 6'@F 4JB;3GX[(-UM^V_<]#]9_==ZK:M-;/9?E/R@:_P 0/_8?
MT_IA$$O(8<V!2HJ"1%>J?D/ZW_DVV?=MOR?Y39B,=FUL-I EPAM-NT0\1#V7
M2<7AR^/>H_5O5,M,;7:?@V=IM Q_'_J?3?D/QNU+&S9!##(V>Q?MB&1_B(@B
M/MFO8_QVS]'LV=E_K/2^I9:>YH>K]/ZSV,%J7^;?NV<":ET8B*YZT\>>Z;V<
MYF8[.[\G3^8_>?6;5EVT_8OV!Q8<&-AZOT&R)?+_ ,O9-M T)>6A*45\D_,_
MB=MZEPVNS_<O6;,/#.T:_/-;#9-,A\0TQL]D#[GD/P !>OK#?[_^*]*T/3L^
MH]-L0TR?>UL]DT&6 R\E[>SV7M]SA[0"8DAYBOT/^J_A?P7K6?2[;:_M/HME
M_J7,L;':.V>V#37M###6Q;;#;#.TVC7\.R;:9'NVHB R04IJSV_*/#M(JF[\
M*['^B?IMH=EZEK\26-K[F=H=M^2_8/4^K+.U9(]I.RV :>TS-IB#W0 "_3'X
M;]D_8O5_CO5?J_H?R^V8VNQ?Z?T>T_&;%L'9--[,!AG^3U/\NU:V>R+0+/\
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M\K.U9@ ?\H2@8*1'5MZH<)F9VW>M_K7])OR>UV8V7XW\/MO2LO##/^G]&QZ
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M 7TG](_+-_F&CL_Q7K_PC'M;: 9V7KO2;3U(:$&B0UMMIZHG,![P]?=?Q?\
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MZ+($( SO3@4I$90<Z[+H)@S]2XFWH% USC&Q5.T?&+X46 Z4,GUCBL]W)WE
MIH8"'#)VMA/[<9Z\47Y#@'??)"D_E\N,W8H'99Q$'Q-U4]8OKX%="J,E\ _L
M/M1:9?"LX<M;@@++40!',X& &OPL342PZ^%1AC6!G!QW)09]B[2:!'1>(:N<
M[*\TP9F7/WSMV$D0>4<<AHD#<-[LR@=PP,(TI86,9Y:_*0Y4>3]+4SPO6'A!
M28J)YRJ]39QZOH@^1RD^'D:)QCCT<@0@N+O@/%YY+.H0[!V5\%0F=8]'/"FU
MC"3HF^-4#84,*\P+"+,X7J,_E((4+G?>\<'0"/NR^>&*!71GCFZZ20)G&<X(
MCCI(\4<G/,/, @(+@/%99I?=(P)PODG?R$+O%)[8/K/0FKNJ#8PWBZ?288$.
MYTKK,?2#,'EQCSQR=B]V"5KXKI?) S]YECS*4MF%= IA_:+KA,*X+GYBN#N*
M /QW==+W)&1CK\ZFM $TX/UEA)!EF!(HZ#^?;+1 Q+Y'%]Y8(,XR[Z"Q@@VU
MEND[/?Q1 E3A;D#.X??5^B+35<Q3AV1#MYSF[*BS;0A"9B.KT$V7Q))E##AT
M50'[Z[[MR@3@-!\4A85&:@ S<'Q=H_K2B $NJ_=I?RD#/ 1^L]$6JS=A<P@3
M3@XNEYNJ!@Z<L=,2'XX06+CP,3EA>B1DORASS[43, C_ -JC,E]PW8(-[G0
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M=ET,UXI"S :O?$<)NP3 U@>SX(&][H.@9H,LNB(/PUZYR<AM#_VY0/+?;Y(
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M+37XOTC@/\BPUZ-L0+WEEL[(M8$_[JB,5W_HO[Y^Y^G9_*^J_;-NQZQOUO\
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MU_IR/>W_ !DL%HM?[8+X,U^#_5_2_P >R]/^D_F/R>U9)_B_UVQVK0>TY_\
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MSIB(V35'&VR?";S^+=54VSMWP_GQL]I_4UAC:-_D?ZD>O]$ T_9-;7\?ZO\
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MU-_JB6&OW;\JU^F?J6W;&T9_4_U]MEAIK8- D#\OZWW[1C^0.9(V7J=KZ[;
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MY#CK>:5VLN&6,,$2SH^I<)! '9=N6/>"+3X<Q]Q[+"K[-R2AI[Z5C?5 ^T.
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M>67^U>P?I'YW^FS;6R#/[;^+_)>HVQ(V8]7ZW:[-K;;1D?Y,L[,[+9^]H/\
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M'HAZ_8>HVNS]1LO2['TNQ_E].-BTSLG[+U7JAMFF]GM2VU_L&R]OM>W[GC]
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MO\=IM=D6620&7LP6*:IB+U1GOF,X\KI,1>T;-V7QF7^@_P!TH<*XO"\-^?\
MSNR]'L/4>M]46AL/3;)O;;0LLEMLLL M.989B6BYS+(BT837QG^V?\M^6]5^
M _$[?]F]#ZC\9^5VC!8VGI?5-^[U#+&S/LV>UVKV66F&]LRS_(=FVRRTR27L
MLP"^Z?E?6^C_ (MKLO\ 6?C=IZA@N;V?J]NQ_&P09;1@-/>)N<]ZZQ-XO&R8
MO'?LO&YF8M-IW9/QSLOZ_?L'YLM;']._3?6^AV+7^+/YO]G8_P!/L6 03_+L
M?Q^S;]^T (#OY=JR"]Y8<%ZO^4_HAZ3:;1G\A_4K]JV_YOU3MF1^(V&T+'I6
M&F3[SLMEZ380]C3<V66& T R"2 5]X_:/QWKO7C_ $^Q_<_Q7XW8$%G^/T#&
MR9:=(,^]K:^XN=BR^E%\A]%_;M^<]/MCZS\7^=_6_P HV3[F6_7;/U[/J29O
M_P!3L?4>H8><!L@!016=^>SJO]/EWM7X6COF_C]'U#]>]3Z@;-GTGZA^!]/^
M"]![66&?7>MV;MJTP YEK9[$?]0N'^P;1IP<'07L_I?Z1[/:-_ZG\WZSU/YC
MU+WG_4;0L>F9,W,>G8(8#.1!7S4[3]Z])[63^$_$_DMFR\-->B_-;)EIH#_;
M[6/7^CV!$ Z.T.1"G_ZXOV/8DL_D/T'\XR T7M^D8]!Z_9P>XC_2?D/Y'-"O
M\3@MP9_E,3/U?IKT/X;8;!EEGT_IMCL661 ;+9L,C+_: 2O*':0%.<<.J_*.
MV_N.V^S#7\_ZI^S[-J #)_ _DVS&G_3V>T9+C,AMSE\A]1_?U^/V?YGT?Z?M
MOPG[#_S_ /*1_&^@8_">K9VNV9 _RV@#;1+#&SC_ ";3:,[)C9N>V668J7C9
M>/&$U9X*?U[_ %#\Q^T?F]E^-_7?7^FV?X_]<]/ZG9_F_2^O:;;_ !OJ]I^3
MV#+.P]#ZCTK)]OJ=IM-C_+M-J&P#L]@TQ[&PTTO'?G?[:_W7\CLV/QOJ_P!K
M]!L/U]CT>S]&Q^,V!]3Z#^'9LL^QH>_\8SL?YV-FP&6-A_/M6V@PPQ_(6FGE
M?6OT5GU'X#9?E_RWYCTS?I_R/[)^0VGY/U 99;]7L?1[0,,^F]%Z;U37IPVY
MO9>CV6R_D;8>Q_(TVR#!Y\=L/Z@#\BVT/SG[0/3>D][AZ/T>PV_H-DVR^ VF
MUVK ;:9=_P"U!\UB*-]IO/AWY=?BDSU91U?3?NN]-_I-_0[\+^H,L^D])^0_
M,?GOR@:+8]!Z/\EZ_:^G9VS7_F-;39GU!V+(VC7_ )AV@F'^T%[Z_P!;#^]^
MNV+0_#_B!L?2$ ,>D])Z[8,;=IDF(VY:;8VK4/\ <RQ.2_5/Z:?Q.S8 _$[3
MT+8+@TUL=KLFVVCBVV&BV6L23.:^@G;#$.F37.-Z+5=-\KS'/EX%^KQ?R8_6
M?ZM?N_X$-^G]3^DEO8L#WG:#\'ZAMIH@/+&T]1Z+;-G:M%O_ !&V>0[_ #+,
M'+W ?W__ )'T[#'_ #+]*;8VO\8VFUV6SVWJO2-, EWM ]5LRRTU(G_)D,@A
M\05^]?VW^IWHOQVSVFTVVW8?LP2TYL,[-F+G-[1[@27 ,,^YLF 9>OAWY+:?
MF_V)EICTGI=C^+_%;4$?\P_*[#V^[9O_ -_I/Q;;'^J]6"([/:^J;]-L6B7A
MEH.*S$3'[U[;(M$>,_AVEXX>?X)?T#_N^]-^Q>HVGX[U/XUO\'ZYIG^3T?I_
M4^L]/MFO6;)EDM;1K9,,D;3W;(.+8_C=[7- N7ZV]7M6O8WM6/\ (,LO_C9:
M9#;>GN< _-R_!NR_MH_6OU?U;'[SZD^K]?\ G]@?X-C^0]5MQLMAL]IZL#8;
M3_2_CM@&/3[)O; ^T$G:-#W%S07Z,]/^D;+\@&/7^JV_K6=IZ@!L;/9>JVNS
MV6S8=_BQ[&"R' 3>MQ,S&<6W93?Y0GP</[!^>_-;9H['T&P_'>B8)]O\GJ_6
M,;7;!G$;-DA@&HB752_B/Z2M;8L[3\S^4VOY':3.Q9VOMV . V;)<ZD=R]BV
M?])?QC,3Z3WM&;6TVVU:;?)_N][R3-=;/]-?1#_RMGM=D0X@[/U&V8(= 2;T
MHI$;]L\]8]\_%?K_ *?TS++'IO3[/9 ._P!K(!@,1%_5>7(Q-*&&KI1KHY?#
M/V+T.P]"PUM6OS?Y#TGL9+?L'JQM'!D3:&U>RRSBUM&F61BOE_X#]U_._D-J
MWL_P.W/J_0,->UO\GZ_T[#'X]PFSL/4,AEKUVU'_ '?Z1EO8LF#6V!5F8Y_"
MX^[_ +EZS\/LF&VOROI?QNW(#RQMO2^DVS3O_:FMKLR& <6FQD"5^<_7_J&R
M_,^X?@OT[\9Z;TVU'L'Y7U7I_P#0>G]M6MDWLQL_4>I(<\?P>G.R:+O^J0OJ
MVT_6OR7N9VOJ-A^"]<VP063M?3[1D>X._P @RT6V?<^(>"[5>!_=OZP_D/Q6
MS:]3ZK8?AVF-FR6CL1ZS:,;;:!G_ +-BQ["2T0',@ Q<'+,QW=FWX?*2)GK\
M?(?Z%?VVC\#Z[\C^;]3^:]5^2]=Z[TNR]%L_2@-[+\=Z#TVR;.U]GI]FWM-I
MM-LVTV23M=L00/\ %AAD+]2AISWF!/S#"-%\9_HS_59K\]Z1C\FU^+]7^*8:
M@SL/6,^S:$B;0$#[(?XDN+G07V5HX!QERC#H5J(ME\[[<UF>>QT!N\"Z]ZI_
MZ,PX47&#WB-+'TJ^\NB'0#A-_'LJBH,SCBIM/&3\P8>408XP%:Y)6@\/J^(%
M]$%&6I?'#5;:$2CF'N2L4#BZK\D'1!?B-YQ#D#.\3\=>Z<.Q)F3D_7":EE&)
MC*>O1.6H.$.1X(' ZP?VU\+%T 9DCI=O2A\J0CAXS3;@7<S(1P0*27PC.SWX
MJC!Q=V=IUS2 783 0G#E>] 69T+XO$(X<$Q:>_(APA!V&/TID9].5PZ$G"IX
M==R EXP<.GE*>$'OEO[K-G"<1*9S'1*!J7",7;D!9%O^O*#35.SG9GRC$NA1
M^%99+&ID*1P^-R#;(C_(T,*JC;+G%[P0^>$U)DR@_27*XX)BUW<3CGN@@ -\
MQEV6?C#7#=P1 A)Q$)V\9+'+GE<T"M/.?*65((C*$<8ONW(D[@[7FL"(\ )#
MGV09H/<)D$Q[ZA*:QE%V+U5F])\5,X=70P0#W8Q?-XINBY,# PZ'&-U2AJ<]
M=<M4[,GETHX1APY[D"RBY^ P-;CO69)>YWMR#B7.>[>B<A$&61AV@@TU2([\
M,$%/=*NG<&(=DI,M3FY^$<0ZXN3LWQ@.#_E8P.O)T0@4 4XRX)P'.G/@$D'R
MCR=2.=2-ZS7%YAAB]Z#- =:V[1(:TC 7Q1+,QR$. T3.@\RIV-UJ@E[95GQ@
M\A'VQB=#+/H@15T,<W7+5Z8@P)W#H@P9T\X*C!E]8/O#%(R>!X/$'$3=]I@S
M2$-^OT@H73ETA"\4K0FZ\T-8XZ[T'O?'M+) OOI#KSO!;BY\Y>"YZ?VN>ZL.
M^L*(AK%_S=4"^VN3H0A1*T+$.G601!,83OI".Y(\UT%(]W50$/PAQA\5Q3,M
M.%-96'*#+9@'90D_2PJDF+W%[L9;D#BCS'%\;^T .SQS2LB=3R<#"ZE%EF+B
M=R"GLY0G;XI&?,LNJ<'"@ #I/^%@[1^Z*#&OP\Y)&BZ1J/%Z;T 9]'76";$^
MT!!@V8W9F@_(NOIU0(F[KXL[DC!+G%]9?*!@W\"=YK$\7XW6'),!F!B:F%'1
M=S0AAA"OV@#YCC+<4IF1'%U=QU1?'%\(UQ19H]T/,D .4C)TMZ3WF&-7WWDK
M.&G12:/#O?A!-L$.+B3#("D!>2LR(.$<^M]$@-6HY/#G<HIB8###!\KP<@F_
MQ&II?A,R:5RZ<><D (R,#\N3$2.&..00%HN<Z.,841#1=1YX9),7.D>&-QW+
M>[<./QKJ@9\3'EA3%2;%'S?G])VC26F<2@PR228NU=HY!@S/$"_EU%GS,).?
MU?\ 4$WNO*GPZ:4:9@0D@#(I%[I]G]T?^X$/@#>0FLZH)E)\(OD)ZUW(#$!P
MTK4H'.[QP2$FH?K>FJ<.K.$:;[[(-#D'?6[F@>4=!/)3R'WSK),!6;KGE<$!
M64G/$M.'5 S,3C&E[EMH*Z\^^6Y9DY8\/BYK P<9STC)R!&WNCA$K"0TO[=S
M6V@@0_[SHL1 8@:3!E8Q03:;<67/><Z>+DG;;DY\_P#+0W3PBRS&(R=3C86!
MHZ%P0#5U [?U-P5&B2_*]SJJ#C S\Z=$WN,2Y\71I]R=)!F1-_+F.$]4]7 0
MTE!+[HRB+^\E3B*[Y4Y8O09H%TI5UI>B0DD<-"*OS3T=$"[DD$'NI+R[Z0:4
M]+X)PT'"!^7\]:R4R:'ZOH@!$QC3+-!1T7\'\(A 72J4X\;FZS%,3#?$CI\(
M%$'OC5W%QBF9%?C7P$AGG@_AJ]4?8AN&<T"$C'A1UG!ZP,W]+WT=!$LR,'3<
M4A:D'0><K[(!5TR;TL+$T#M<\A5W!('";XP"/MDYG?;T#;-F8,\)Q\+K]KG2
M#XZ;^3NRY@;?3&ZIV70RQ/"_E ON?24XOXV$'84,;=R"8X,R$R(1[K-,U&D$
M&8I#C+/-$FD(\5-\A%_37RB";F^Y<$!%=9^$[+4W1AA8.?$)#'L8!UXHE[H<
M+H@=MH;S!UXJ!Z1@ZX*Q9<(QUN5R2AK33IP"+"8-)3U&75,#!Y?E#?8XK 4X
MW/>F#0WCC)$(6JP1S&'BB+0@2,9'FY(&C+I<CT0N'OW$RX</A%EJN^%+FING
M5Y.@N.2LPQ 4CTOP@&)=@ZY9DHAJ$N$XX7!$C<"1QEPZH.=*Z00.:9B^7=8&
M@Q/)3<<)&]RH[=CGP0 OE)(90C 3O[1=$D=Y4^2LZ@KOI.X(&?"$*.TMRTW:
M\[\IFF>';Y2$1W_*#,M4U6=,F<I8HL"9=ODX=LD6C0<L<4$P)4&1BF?EI&]V
M"49Z/I&]ZSI=\ZWW0.R(/ZFF%U2-M&8@$X^\4KYNP&%/"!'Q?9IQ[*IR%!O%
MR"B,Y/E2^^2J^4(7<$"--1$<(XIGY1AE80]M]>63DSI6(=\$ :-YX<]))&&X
MT RC-,T<,D0\4'V@9MH^-_-ZE[N-)WJBTWVGFE?3%_UKJ@=U.M%FF@]SS 2W
M7JA<=U@)X0CG]_:%TB,N.Y]8O6CEU%_:H6J0.74H/UW(,]U2Z_GRMCW-\$S(
M@_J,$ =1ES0.#*%W\H--0XTNG1!JIZ)7]]+KB@#(?(?&J8B47'MO2L-'=UY9
MS5"7QSXG#P@PEC>#I]$!O[&RLRY^4:1Y]$Q:F, 787C]H)PN=OK2JWNG3Z19
M:N&^\%/'XOL@)9?4W3OT5 P(7GSR2!F<GIQ23^1T=@4"FCONZ>%B9.=\'JM[
MC=_"G[GSPP0= KXD+WJ7NG=]]4S)RU%;X\$P&X9(%9Q[PX'BJ*=>=X8JB -Y
M7?-.'\.>?E!D72$KW(NF3'4<7]E1G8@U\H8D7OZ\47:B$L7F6YVI1 S[Z."@
M@TT>-O(^%0-TXU=YRP4]H)"4>\_B3H)@S('.R@Q,2:&?D%.RU\.GP2MLP.,.
M'TLP:P=VN&^*!BUEIEWC%,#"FEXHD569RYQNB#>W+/'=N,^2Q(,QCQQA@C[O
MN20Y/^3?<H,[#F.6NB4M4.3G.AK5/ CSR=@>J!I&,-<N*#%N>F'+/.J8\^$$
MC9,W0XSN"1IKEXN(04)QKX^G9H,FW5=FA[J@@3GS!68.>)'.7<% <B[3SV,E
MF:B$,9XY\.*SMV4I7);C+K<<$!# T[]BF-!+L+JD S, ^^%TP;E7OF@(:HZ@
MX'D7W%,R;EUMR(TP?EK>B+8P/'*&^G9!,CMRN/%'W9! X3=7"%!>"S1X2E=Z
M(,(.)@'V?/53:F\8R,7IF6<\79C(R0,.IK9CW09@3AGID'W@B_=Y^A) -YNS
M,R5@SC,<4%&LIZX](SSDLS(XTD=%CQ=;G>-5M81Y_--$ :;L=%IQAF[QW2MB
MM8WVZ* )YT,[S06:=(A^D-X.7!)L'_\ =C ?^TTCB<]%?VO^IY8H'BZ-XYC%
M6!GY90[FF&25YC!^^]YW(B/*$1(WT6(B8NPS\J!69^*YIVJB=7N=NN*7W4PF
M#%_QHL&M_2F" F/&':*/NGVW12LG@[AKU>M8P-N0.1SKAQIEO2OE.M7C%XJE
M:R@)1-N4"_ N%8 G0.B@N3G+&4)0Y;D ,X9#RD8,H&(>7Y6]ZJ [$C5^O!UP
M0+EA+&57I3L@\%Q?*,<WY!4#=P[^5FFZ&&!(F@!.!$<)CO),S*LW3NX*(&]Y
MK*/"4_A/B [%]$&#-91E1UYRT3AM\@2[2IO=)(7O?'=I\.5 (/Q%V-R#/ES-
M\ZHOEU#MPOJI/'S<Z03"4['V@8-=WUT0+6&[/,H##CG@>,UN?=^'2<$%'5A
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M_#_K7Y'\;L]A^)]/^1_*[39[+TWJ_P 5M_Y?PGY#8G:;+:^J:V[#;(_U;7M
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M<NR_$_MK#1_D_6_TGU8?)AO:;)X./NV)<[JNG^KW]Y/X/\!ZX_@#Z7\[^?\
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M^L?AMNWZ'\0&J;-C\7^,+/\ (R/]O_L2\D3)7V[]&_';;T^Q9]%^@_I'XO\
M4OQS/^+'Y#\CZ;9[/U)PVC'IMFS_ "M$@/?M&R\N5F)ME,^$?C\%^['">R\1
MEUS.?@I^C_J7IO5CT_JV_P"DWXG\/L]B ?3^H]?M/2>F:V#,PTPPSL?Y=G F
M09*\G_5;]2_"^I'XS8_A?1_C#^Y>F]?Z;U7HF_Q+3+;?HF?3[5@^H:VNU!99
M&P:]/[MBT-L(^_\ P8> O9F/Z)[?UA&T_9OV+\I^6::/N:]+L=K_ *'T(<][
M(V&Q<6F2]W^33W07U7]6_0_Q_P".8#/XWT'IO2>Z!;V; _D:9'_I;1I^T:>9
MO:,5:8G?GS\F)F(V>5[><W\GN^P?[6"T[W.9#0!>X@!X?J]SG*KX;X]O'93V
M.T)@R"26G,XG3IS71^2] UL]DTWM#MPRT"/;Z79';;=E]660(' N+EMS<OJO
M7;/9 [3;[39;%@!YVFU;9V3#LVFR!#62^8?D?ZI;%KW;+\-Z'UOY_;Q9#/H-
MB1Z;W/<[:>NVX8].R 9ED[1PD"YR^9?MWY[9>D/N]+^D?L7Y_P!4/>TQZC\H
M6]IL_=B&=KM-H&1+_%C9LN$@%\,_(_UT_.[8M>G];M_3_J'H6',-;/T_H/4L
M^H99_P#:=NWL"P(0@0R<0D\[_A]5B.?PVOKG[I_3CU_Y1@M_L_K/P'ZO^,!+
M37IMCL_3^I]:VRX ,[;U^W99:-2TSL&-F\N'N(!?Z+^$_ _I_P"//\7XST/Y
M3]H]8#_N]-L]HUL2T*>YD;/9!DY>[."XOP'YK]2+8]1^7_.G\OZH%[3?Y3UV
MS;8]SZ;!K:L@1,B#HOTE^#_J7^OLLL[/T/K?QFR9  #&P;].!PV;=AQ4[^_9
MYY->/P_%X7\1^S_F2Q[/P?ZCZ/\ #,-,_P 8]1ZS;,_R[,'_ +SLF ]IPC[2
M9K[K^'V6T8V.QV7J&QM=NSLV1M=H![0WM3%MKVT]S1)&"]48_J/^.#G^NV J
M/\HG0.GD-$FQ_J1^/;;.R9_(>E_D]OO#!VC+/^)+O<]HB+Z3R2)CC#/<]>_K
M#_6#8?@?3[#U'J&/Y6_4^HV7I]FS[BRSLQM&@RUMMH666VBRPR"T&&62TVYP
M<'E?Q8_JSZ7]B_:/6-[?U?\ 4+]R_%;+U?K/5_Z?]3_#>A]2=D?QP]8WLO1-
M;-OT[?H_1^E&T]"&6]L/6;;U>V_U&T>TRS[?8OZ??IG[%L/S7[-^P_EOR.P8
MVOZS^M[/TOX7\=ZW;,AKT;7Y;:#:;7\OM&&6PTQM/],P?3;!KU+CL]F=HVP"
MR0TOL_Y7]D;V1:V'ZWZ;]2].P2YGU6U]9L&FR#'^0;#9,LGW%[PR6BL3GV<(
MW]L^/,-4S;M[OGW/Y,?T8_X7/H-OZ[:_D?S?Z[^2'X]IO^39;?\ ._DO3>OV
MKQ[7M'TC'\.Q?M?;_(WM/4_ZH^\^X;,"?]%=E^L?H7ZFS[]ILOQ;7K-FR/\
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M=D"S[H>]Y7L?ZI_2W\9^. /I/0[([=MW\OJ=N/YO5;5H1]VT]1M/=M"U4_Y
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M:C^I^_ <@:1O 6Y,&=,W8+^=&U_XD7ZXS!D-'7U6QC.,'NB'<EX[:_\ $O\
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M;(@/?ZC:,, !ZSJQ$;9CLGZ[? FW?V?BZVOZL?O&PAM_TO\ ,;5D>S_/9?\
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M!VS7L88](Q(%OU7JMBZL5ZS^J'\)^1_ZGY7\O^>_)M[,%K:>C_)>F]3^#_'
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MC-BWZGU7\9(+;!]5M2RR/< XEG9Z4*^P>G8V>R99V>QV>SV6S9 ]K.S9998
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MP:KE31MO.MVY9=F_J=.R+<\<I^+]V';[+9L@,G9['8L,AP9]FSV3# #@&0R
MPPRZ@  $E\._:?ZZ?A=GM&_1;(?\Z]<R"/\ 1?C?2_\ ,-J6I>UL[-EK9,1J
MVV'5@O@'[+_;Q^>]8SLMMZC]O8_(G9E^T_!^IV>W_&_AML /]G\OH&SZH&@.
MU&U8(_W,%>X_KO[M_P BV>S]-^9_3MO^!V#((:_(?BM@Q^3_ !1]I(+3?K/0
ML-[?9AH.:]WK/3;(B/N+XK>M&=[QVY1/?];,V[^S\<Y\"^K_ !_YO\M#T7ZI
M^#_7_2MO_P"O^88V/J?6^T_]P])Z9GV,&OM;VB]@_H?_ &N>C_!^L_(?FO4-
M[/\ )?E_R+0;VGJ#Z;9;#8^G/_<SZ78,@L[%F'^YG_(U*^J?JW]3/QOKV&=K
MZ'\CZ7U&S<&O^EMMGM#&#):]K1.STV@9(DX&"^@[/\BRU_DQM&6@/_1:9:#M
M&22%8ZO+@E]VQ[ QM8B0<'.#G3\S@ORU_<=_0#:?L>T_ ^O]'^5'H/6_K_K-
MKZC9>F]=Z9K\A^&_),;5@LGTWY/T'\NR9VVS#3FV6P?<'!T0%^B6O4R:)TKF
M\"7=?BC]O_N:]0S^6_)?K3+?X_\ 6QZ L-'\K^;9VA'K&-J\AO\ '[(.V6T#
M(_W%ML $B%$F+Y<Y?'LS[%IONW/HOZ3^6_*_AFAL/S_ZU^K>D]$RS[1^=_6M
MKL/0>G989#Q_J?0^LV>R]1L28EVR]1MV1(17GMK_ '$;#UNUVWXW]2V _._D
M=F\[3:_RC8^A]-_[5M-LVYO:@5&P9:>Z87HWZ[^K_B?RFT8];^3_ &/9_M&W
M<R6-BUZS8_Z)@O\ _9?H-BV&(&7O9:*]]_:OZ)?AOR V+8]*?QOKO2LN]'^4
M_#[1K\;^2])!P.PV_IRP\"K&U9VFS:#PVR05SM/'*^RUIM'"UO#).>>SF%O3
M_P!-?6?D2SMOVK\FWZK9M.:9_%>A+?I?QNRJ&=H&"-KZEQ@6MHTX_P#HN*^T
M?A/P_I_2;)GT_I?3['TVQ8<&=GL&&&!*OM XF*_+)];^V?@RR6ALOWW\-LV0
M"TQ_'^._:=ALQ $LAWX_\F668D >EVS9Q)7T3]%_KM^)_*MM>F]-ZT^E_([,
M^W;?A_RFS:_&_E?3M@N]K?H_4^S:-@F3>Q_D8:@YHA;B8V;^$Y3SV7CK6;]L
M=6Q]]_U.C]*6$X]13 /,S9"]>'J-SH'C+.&*H/4/>07?XO?1[Y?2MV7E/5LL
M[39[78;0GV;5AO9-ADE@EG:,EEH,M#_)EKVDN:$08AQ7XA_IY_:W^0_6O];_
M .%OV[TQ8]1ZS;^J98_._@MEZSU?LV[9;9]+M?S'IO4;+U^UV6Q!#&R+0:(9
M'^3)(>O</[G/ZY^L_7O0^B]7^-]!LO6[7U?K=GZ1K:>H;:V?I?2#:D#^;U+;
M )##-3 8D+T#]=]=^9_.,LM>L_<_QGH=AM&62UZ;]<V>S.V(+C[3ZO;M[1MD
MN)'N88!J"$BU[[\XV3/RF/%TB)MNM/'/9W/?OR/]<_R'X0_Q_M_I_P 0-DT
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M)%F;SBX_*P(RAQA#>*1F@F8G*@J9.X(M/DX2T.6MX)WF;KN>6:6& S)Z S0
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MVN:HI X4X3P2(/R:/[W?UC_Y+]2\?_*F,_\ Y8IC^]G]:IZKU/\ ]+V8>_\
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M_P!3Z<8CW;4NP_[8XO)71L/[=?7/_P O6;( ?^C_ "F,(R$<)&@6O_#K0?\
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M:/@1UZN&_?W_ ,% V;X?C_3&$BSMW\/<Z&#YJC'_ !/]F7__  O],YQ_[/4
MZ?[G:"J_GZQ_0WT#W'U/JR,ALW\'$ ZF+Y27=L_Z(?CG/_G]61!SFMF\";_]
MN+GO&23Z)="\<;NJK^K,?I,]*K_W6C]FKA\\[7[W_P#@H.Q_^0/2O(>/_/BX
M3<_Z4F_^)\P7@>A]*(@#_';&G_MV>ZJ_!9_HE^-KM/5C#_)A\L7>8<5/9_T8
M_&ED$[3UC),V6BP71@XAET9YDD/HL3Z)="^]C?S5_*>8\^T?I)]*9C+"T?AL
MH^G4_=FT_P"*!AZ+TD<-EMB-W^>_<N/_ ."?M!P'HO31_P#E.U(J7..TERS7
MX@/]%OQ8?_GZP5)]S,*85H*;U _T:_&EY#?K"'?^DS!PQ]N/#-:CT4Z%XXW\
MV)M[IR8_\1/2N=F%@1W4?1^V]I_Q0MJ8CT7IG9^GVE,/^I-U.:Y/_@H7J"?:
MSZ+T^$-@7A\8OVM1$%\I+\8,_P!(?QC@[_6$B'_FLP = O8PH88!ZH/Z1?C'
MR]8\'_W:S(RB&*F$*.@K'HMT+'[N+_-7]68_2!Z63NP(ZK8?T_!^Q?\ X*%Z
MK_Y!]-J=@9$3 .U><P)0$%3_ ."?^ID/2^F>80],T8__ $S<Z>#Y+\;-_P!(
M/Q\![/51,CM6:"4&*S#SW4F_Z2?C60_^/U1=$ [<$F(_]H#GF+B_%)]%^A?=
MQ?YJ_P"I8]//2S?ZC^7#^C]F[;_B;>L9:(/I]CLVH0:](0YV1;ICR7 W_P 3
MKUT';/TXC$GTK+MQ+8B1CN7Y%_\ 5A^.B_TWJ6H'_([=Y[1I$$NH$1_3+\;
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MK?VCA_X?![HCYRX1AZ=OTW&MUTZO_?.3^<G_ (<_<"?]WY-IE\1_I]NR /\
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M<OPS+PW^:_&SI^$;#\HCXH4^T=)MMM_E_!UHHP9G*G%S]V<7NVX/S?F[T?\
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M &CT?MB8+])_B?[7/PNR]W^LV_Y?\M[_ &AK9>I_([7TWHR&67#_ -@/QO\
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M7\MM/RG[%M_]S37YK\EZG;[$M3>/2[-K9^G#,9#9NHY?C#\=_=CZ_P!,&_\
MFK'Y_P##?QO!VGY?T+/YC\"S_&U[3M&?RWXK9,^H9V9,?=M=F0002OK?X'^Y
M'\_Z\?\ PA]#^K_G_3[/9-;3:>M])^=#6S#+#/N]I],SLQZIC:-R8V6T#P3_
M )%?8JZ5P8IG$BJ]-.VK#CUENJ?5:UKQNG/J>+V7$OJS3JSNUK47[)FU_%^Y
M/P7Z3^*]"&=G^-_#_C?0L@. ]/Z/8;-WM#O]P8]Q<:O?5>YL>KBR'.9  >RY
M\.@Q<(.7\WO2?W(?MVT/J]HU^C^@_'^C_&[ [?U?K/RGY';>GV3;_P#RMEZ+
MW;-G_5-[:G\9(8_[L#OU7^Y+]N]?MMKL]C^E_CO0>FV'I#ZQOUOK_P CM_\
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M&_)>IV_Y#U7YWU?Y/;L;5K:>WW[7;?DMB7;39>H)>RU_*V"3%E[,OJ;/]?\
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MY']4_(D,;1MCT7YO8;7\0T6P&OX]MZ3;LM;%II@$C:?QL[-EX++!JO<?RO\
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M.U]2'Y+8O!_GV4C-L87))_S38P:&WV1%"&PXC*CLU\P/X(?^[,O]SS=.J _
M"'_5=A_D'.HM1B3P+1UOIW_,-E_[N8 +O^X;^3\G*S7Y#9?^[MG'_P!K9A1?
M*S^"9$]L/_?G_:5G\1L__=P,YM1Z[U/63PA9ICK?51^1V4';;9_^_A(?R.RF
M=MLW R]XX[L%\N/XE@?^SA&GN2#\3L__ '>/_?MW'DGK)X<]IJ_@^IG\EL8
M;;9P'_I"3ZX)V?R6QB[;,;FPX$<(A?*O^4;/_P"2!&GOWV%O^5;(?_' &/\
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M3<(:%'V])U TO1!5\X"EYK2R''3AP4GNC/ZKVY+-9O?0/@'Y].:!_<)PB:G
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MCX3W.^'=;0N'= A^IL[\^J!BW=X\ Y(6L0Z\,$6:OP<"(1\Y51 S+N-Q>@4
M4P/SO?5ZWMFZ>G".3H.6%N$--Z ;PWQNB LF?6[JD:RT$W#P_JF9J^#]$(#*
M_N* LM0K"8$ ^["9\B'UJ]]]$AE 0AI83/<)$Z3&F]!@<8=(W.:?:!PEQ42U
MN#J#?>"=L] Y_E K4MXB+O59SB]U,89W@A)SAWU*9\W1O'5 66M8V<^:1HY<
MDHD0^(.MY45'/QA+XN"# Y2\<EBT#=W%,T8?3SFD9/+)T>Z#%B@PF\'F*53,
M-4)N@&^"DT<CNG?3""S)E4F5]_M!4%SX:"]>R#6+GG*#@B1QAI\/^UG3=N?C
M<\$$\)G*%PHG JXC*CJ<EO8*\O-Q29OA*QT0/";QQ=?VBQ6LK%'W4I SGI!\
MCP<)I@27X"%Z7B@SX^,76X(/D+^:I'.B(:\_*S(?6!>[R@J6_B7.\5O<(_\
M;=Z(,Z\J) T)$A_7'Y05#+Y.NZK%AV)^)W\A!G9ND88'YO5%HG&$CC8S0 M0
M@"=+'!*,7:O^,549Q?<,,:)2,[^D :Q&!S\)!*!C< #\)@,\9>/*Q  >[[[(
M&PZ+ WBZ^25T(>':7DL!0"><ZWX04WQE!*TS&O'XE1 'C 64X&)?#<$$V1EN
MO%%$M4["\4$6S^!K/IMH ?<T2!/_ "HY\'F(KCPC#;;+:@CVM DLO(>X.G,Q
MPQXEZ_FRW_=&T6&0S^0]0"TTR([0X@ESW$?X@P]PG +CVG]UK?N# ]?M_P#
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MR?\ _<J]J2RS_J_40]S1=MGN@ !BX/GEA%#U/]TFU/\ \=;< F)_G.XN+AA
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M3GX2S'I1ITQ?V2KQCYQ\G]FV=@Q_BR6V62ZI=#>2<'5/!8[-@^T!M@O>94$
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M?Y;4,P <##.#I2=5?Q&V/]=MM[0]MY(]P#VG$M$DG_<,IQ.2VU_KQMRVR#M
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MOM2S[3M6R TR[_)P'^3)D]YB)D.#L2K]E4^_.WJ=*,33LKTQ&V9SJ?W?V_\
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M,3,S$7O.7#*+3$1\W/3M!J]=B6JHHB:IJSPXQ*[S:9F:ZJHG;NW1D_MOZO\
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M_<Y^0]?LO1^K;_&-^IVNR9_@.TV?MVS30V;3]FWM -K_ ),#_P ML?[O;[2
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MM@6F2RTTP/Y-KM&R8EHD3 HPXM5> O@?Y+\XWM-F6?YO5/:9(9][7O9?[?\
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MK8!+O_C7TQF8^[VG"$CBY)_X]VE/7;(!\_\ 1[($5'^UDQ.^49KT)C\,(?\
M4V++W_\ <'@$'W'_ ,M[\BZ 72/U]N!9]1L(N,R" ZKF*0)$,7KU>U3QI[8R
M^;P^S8.RU6S]Z+_]O:]P_P#'GJ"(>OV0G/T\ =VR>XC>\.@(K;/^H'K 2/\
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MU/X1IG8;1MG\=Z7\!M_S/K]AZ[:N:]0UL/5CV;/:_CO6;1G^7TSMKMF@SM'
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M&CZ/3$41ATQ&)BTVIOLB)JRHIRM$;]EDJTR*[^LQ,7.;S/W9SXY3M[K/QO\
MFOZK[/TGI?5;']8:_J#^-_/#9$>@VNW_ '7T^R]/L=JR?\=IZCTW^NVO_28
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MK:?V7-_A_3;?\?ZT>H_8_P !MB?R3+7XS8G8?D/QOY9AEVT;])L6FR[8>O9
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MV/XKU/J]ML?3M>B_),;+;,[#U>QV^P9;V>WV&S9VA_BVA8;]K>SV?^#.U>(
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M'I=I^-]1^*_#[#\;Z/TO\G^KV/XX^H.S_*^G'_Q3Z3UP]W\;7NV0;;V1()?
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M^I#6RVWX_P##^FV>S9&R9'K-EZG\@TRRT/\ !CW-C9;/W>T_XN>][I%?BO\
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MHO\ A#>K9]5_K&_V'\+ZQI@[0^CV_J_0;?:;;T>TVI]VT;&R=_%M6_<0YK:
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M&2]>VO\ P>?RK6Q];[O6?K&S_(>I# VGJF=GM6MEZAAAS(V8V/\ IP/3,!D
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MQR"[_3_U^],V[^/TK99/_<6_:.) H_0SJOSM_P"X\>NFSM=F\.):.U:9D7N
M#PXRB]U,%TM_T0]?#9^_9O:'N!&T:RF7  G?C52-??7_ *37Q;?L^</T[LOZ
MZ>C<X>D!)<X':O)S<ZF2#7];O21?L&9T).Z+W+\T[+^AOY)GWEGU#(::'M'N
M+_:'O_P) _CC FH+C!3:_HA^28+SZD-,AT'DY.<-\<,%UB9G?\3UF+[GP?IU
MG^LWI?:&OX &6BTR_P!TRR! /$P\22'^M'IHD;("!FT*9R"_-/\ ZG?7>WVC
M:.>/_3:@9!P<X9E[HQR1O^B_K?82-JVRT U[O\R[VS(Q?@ZG*3,^]Y-17B>[
M\'Z8/]:O3B;#+-/]P(Y/YNDE/]:_2B89(+R\$3P=AAC1?D_UW]"?R+7L+.W;
M9<8@'W?R,._VM@&3L'E\PY=/H?Z)>J9!V3;3;;R:D@&;,6G?[3#VOZ+,U3^*
M17B^[YP_4S/];_2.+3F2X0<0"<P"'5<N/UG]5_3,,L-F#.T'O,?]H,6=]80Y
M+\S[3^AOJR]EG;;1F+WB)&.(GA' +ROY_P#I)M]HSZ;9>_:AK9[-@-%EH_Y$
M,>V.+V@_#+#.M5QB>>MK7Q/=^#[=Z#^Z?TOH&VF-E^-V_P"1/J''W;+U7I_3
M_P ?M#Q#;N_E!!?_ (?[7.,UYK_W-KTP,?P'K@<O7>A XDN7XG_<_P"U_P#)
M?E-BQZ/\?M&]EZUG8;=GTVTV0;]S.V<S_"UM&R66&&#M&?:V6B1[23!Q7Y=V
MO_#S_J7!H,[$8C_G7I7/,"U%ND^R^5I.E:;35_91$X=LON:TQ.^\V37Q/=^#
M^O;7][7I7N_\._DSFQZS\>T_$?\ F#43?)(?[V?1P?\ KOY9\G?ZC\<2=/\
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M%7O7=L_[]VQ_^<_[%,._]CVP'$0_R:8.XNR5_6G#M_<8WA1_4OM-''SCZO\
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M +3 WY378Q_7W]<+@/V?\.]W_P EL,ATID 7!6-+POXF'_/3]2\/L3HO O1
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M#0>X@Q$'A[I$Q=29>]?HC_ENQ(:/L9#P1+%Q#Q!X$<@8BBEM?Q.Q+G,BCO\
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M7^+7N!>1#_NP>Z9C""_0?^AV5-F(N=_B7N<?\9.CF8XKKV?IMFX?])EP$?\
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M'^3(!!K!YC =XT7Z2:]"\LOV8(9)>]T80+J"+X5&(<H;7T0(@P ?<(%W_;'
MR$1*&2S.D3S:[I&!5EQMO?G';_A/4>TO#1@Y[J-$0FXN/A=^W_![<LM/#1_P
M) >YYH*"#ZG$37Z$/H"6?:61$"=2"#$R+Q*IB")/LW^/)!  >XB3WPD XNP,
M,$C29X1F3H]?W>J9E^;_ /P_MPR3[&W^RLR S.<,A/?%79_7]M['>UH_X/!/
M^4F:?^C4<"(K]%'\<T0X,A_M<2'/!I0.<7G Z(G\>U[?:X/ ="!/+&6$ZJ>T
M[LG.=&KV7RO?9^+\Z,?KFV]CV0T2&#(_X@%B<R\/<Z3P'@)FOUG;_P 9'L;_
M /*=$QB,^,W"(*_1(_&M.=0. @27R,8[Q('5R4?C"1[7_P#:Z4'.GN>[E!/:
M)X01@51OWWV0_.&W_5]L62?XVJ5=@Z !SB^!P"\VQ^M[5W^PA\B_*)$'BDW
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M[08!G9[ $!U-.A@G']*=E4^H)H1L-C X#_+#B5]@9V?I"\NV (+B1LZG*I&
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M]/Z=T/\ WH/ ZOBF'ZXQ%QV@P_\ 8?TT7"G^3WBI!(7WYG^D?Y6('ZO^<<R
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M;9V#8F0VPPT"!#_(%F0IJ N?TGKM@R6FMAL_3[-J31V.RV;#347_ .1899>
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MZC^T'\SZ-@%D/_F_ ?G&&_5;%C_VC^$!E[GP7WOT'[1^._+_ ,>P]5M/U?\
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M(>-IZK:^G],"7.<TRTT6F1D ]ZU>8M>8\F+Q.Z?@^Z_C?ZP?C1[6=L&?3M-
M ,[?W;$ODX#:LLS.KWKZ/^,_>O0;:.S:#0@"=FTQM'$P<Y@DF,W#BOPA^9_J
M!L -JSM_ROXID$>WVL,M^L:V9:>20S[?XP1)T9!R]4_6/ZF?B?2;5GU!]3ZC
M\CZK9;39;7TP9]$WZ0?R;)L->UIOT[+#36S;(<0T(!X!B58Q(V>=_P &J8GA
M+^K#?X1AH/\ :/\ (/?(F#WN$H:..:]+_.?HNRVSPTRRV&GC?!\PE_IU_5C;
M?F]GM?R7K/2;/T3>VVS]CZ?9L-LL?P,,!D%K^0^]IILO:]S0!<X.A'W?UWY[
MT^Q]HV_J-EL6FO<60VVR/<X1#++_ '$ $$N$'Q(>%9F.V%?EO\Y_;WZ;:EL#
M9'VMO]S!<6(S>PU[F8X.<ZB^-?D/[6-GL6SM_P 7M/5?B_4 O_G_ !GJ-IZ$
MOQ;V>S_]A]KB[:;$OQ7[O]1^Y>A9!+>W#1," "7ZDN#AN"^=_F_ZU_A_3O\
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MW9'1>D_@/0_QL@4=*(#J$>%YS\O^V>F]'L6_4>KV[&RV6S9>6FFI 0B#B?\
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MRQ!D$")BOGWZS^P>GV!]VR]*VPTTT_\ FVC9_)[0' ;3;_P>I$/^[W;;:?\
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M:+)#0+;(@TYEX!H#3S%*?TW82#;FV0X-$,O+Y@1EB*KVQO\ 7_3ES0&V#O\
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MO1>__P 6S_\ =.SBZ;+/B&J0;/9R&SV3H_\ 8R\$;MV[5(P36ZGH@_$^F_\
M=XWEET+W(G\7Z;_W:_+W,\A87OOMV<3_ !;)P_\ :&>)A\+?Q[/_ -U;,?\
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M1?V5&T& WOO1;^81)A#*F "Q/1&C?PH_FK_J7U-'NQX/XN;3_@Q?AH>S]O\
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MXG8?]WIO3-$C_NV&Q)XEB6JS/HE1NKCOH_\ <L:-.^N9[H?Y#F?[AOSS /\
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M1!C)T<4^TZX_?EF.BZ/<I?3=E_4 _P 9:?LQM_?[?XRRU_'_ !^W_=_)_O\
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MOV[;M^UM[+(@"TU[GDB#WS$YM"(3U;7K.>=C]Y-?U)V1/N8VON( ]S(::))
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MG#_M+)F_W&.,PY2:A]]_*?NH:]VS<0Q+_(,EEIDP<T"7<E^;/Z@_HGX/U_\
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M&[;=F;V\<OAS^+\F>K_2?V+U(+.W_&[7;%DAEO9;7TFR]^T9][R6-N63_%[
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MH_#%ELC\MZ4M;+9-[9O8M-D>H.S8#VFMGL2R&]K@/X_<2T0R "OS-ZO^X_\
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MP1%?4/T+^G_[RW_%M/RW['Z7T#'^X[/U+'I_6^H!:<]EMEAAIF$0/\P6071
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MD6-J(>UH[-IG: ,DN#V3"9>&9D P7,U^D_LWH?:-G^6VS;(!:+&TVHVNR)<
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M<X/)G(R&D LS6L4[WU3_ )QG_B 2:%V>IX+?\\<Z(>7>XS<^A(\+Y2U^9_\
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M^91 >!B_7'+FO0S^6EB67@2W"$5PG\B7D>YQ(C"(9E"/59FL?26_S #@6O\
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M\0.H_P G0%(!^;I)&/T5D/'\8><0]V9D_,=5OVZKCYL_9]/#R?QT:_M,]/\
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MP<W,3@XSH1Y3VVKBOL%/"_A#^0&T_M9V+PR/3,@4<Q*3W$X8& ? %R0_VK;
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MJI&FU<6?L^F-D1X/XW-?VK;)[CZ9B$H3_P#;<S'&KE79?VN[( .].'-%Y9+
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M^-'_ +B]LWN&P=B"Q![L@YXB(.PBNAG^V#90?Z<%\?\ :"_7#)[G3FO[&_\
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MIVS)<'D /=N $X:33'^C9#G,DR+C!SZN=.(AE%?U'_\ 5XQ'_I@M4/M>,7&
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MG9%XP9G#D^C]7+JV/],6RXECVB+P6?:<'3)#Q6+YO7]%S_3EF+]G[0YTG1?
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M(_QQS!R PGP4LT^/?\K:BYD,FDX@NX.\I!^,(?$^Z3())#((+Y1PRI)?:O\
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M09!?6_TO^JVQ_'AD_EMM^\?J^W88+#7\3/J?R'H&=ILV1_&TUM/?Z@_Q--P
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MQM0WZEH-M>YD,^[9EEEY#P2"5^O?4_U(_26&?_8G\C^*]0V\%MIC8EMEX/\
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M)=K%U!+=O6V3 ,0\F,"]W%PG2RJ'TTW/R[@.<\ZP0<VV]T'-/<,(O)B YSJ
MH[#8'_<0&6C_ +G]!&/0P*VS])'_ '$.C"'&?)5:8(FU4N<]^7V<'(([7:2>
M7N@='P TP<_<L-N26P7!Y@7C #VY9NSHK#88S>/#Q@2F&PF8$A_^1C/'=5TX
M*B;0+@\LYEWN!R#B*%RI[RYW^T5!J,B]V&0$$[.Q+@]P9B'8C'7G+!,QL: E
MSR/CGQD"H.C9-S?'_$;A1Q.?E=++3W A[(+G!^+SJ 8%1V>Q+X/>7Y 0=R+H
M+N8V#G 1>'1(<]\3B\X*CJ9VDHN#X,OH=;,#!>0V&U>0P]\(C+H]<'\#A[B
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MR$WW)ZJULXZN^WW!!,MR$=U->_R@0_!P,,O"4-1<[$/!ZX)R*NRRY?00LDW
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M$X8B.JBWZ 0) <(#7'*PLZVZ%U/P?--K^"9D&"S.!AQE$@4@5#_D(>7LO<!
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MWSC56ZQ3U/DC7Z\*,O!,B'E_!X#M0BU^N,P<R7%SWXX/<8;MZ^LM?C!/VD-
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MTQRFY?6C^,<?]H:>^( Z7Q0/XI]#P,/,=U$'R _K])!P?#"G&J#?X >YD@#
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MX$PD7..^B_1!_#/<75=*;GRI#K%SUS;3\&"'!D%P)MTY\7*33SSSVC\S;?\
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M<M^0_,OK?[6OPS3_ '>DV^T$1_GZG:MC0^ZD_N?AMK_:=^N$@-_BR^ /_6;
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MVQ_"_FO4?A=CM-NUM&#_ ">JV'J_3MM>QC9_R,L;/8>I8/O:8+1]K)"_6?\
M;!^(_8=GL_R7K?W+TGH/0^N]9ZG:'9>C_&[8>H].QZ=C:/V#>TVKRUMO5-LO
M.WVK1B2 R   )%6=HRSX93$=V_NF&K9;N#]9L[.KP)9.<(]HH-;&!RRPO>NK
M9EX!<XQ\;N:N=G68WTSGI\+I++P^TV,)?Y-.T  D,@^W+DVFP<0^HF\1+R*R
M?A5>PG8"! ?)^%G>\!<NT]*#$LB$A"8PA/JLS'#P'J[?I7DDRG.EXY+BVOIG
MYET0-YG)YKBO:]MZ:K@3_P"B*'@Y[J+E_P!-2&@ @*#A8@DTW'IVT]$"\F#Z
M$.+\NWRN-KTH((<0Z+B#!TY0<Z.4U[OM?1R@&GP]I$72>&LOE<[7H9LN)9]M
M2^4<'O6=0>D;3T?_ '3#P]Y@[+'%_P *#7X\0+B(QT<Z=.B]U/XVH&+LOC*:
MFUZ!XD8P=GB_#MFIJR/1]I^._P!Q A ET2YSLJ_]TB@/Q[G%V <Z0?/>O>SZ
M.8A)Q.0 >=.7519_'Y$U$YNE*\DFF1Z>/0Q,"^9@'<Z.DD/H8/#)B0\4-[B-
M%[H?0U@?="1>*DETG+'T,(,R<1"!C4N^5-6P]&9]$YS@)\"_0B$@^:VT]%\A
MT<H%V<<-5[F?QI>' .,ZUSD1E@7([7\?%U61QC2'(G12W4U>.WM>BC\>3%[W
M.)>'2J!*N4:H,_CXN QB^IWNX2DO>1Z!SP9:%^^GP@?QU0RYX->$*/QHIJP1
M5;G)Z2S^.@S%U3D9#,RF$&OQX? $O%8Q=3#*B]W;_'?[80Z5)UEO>L/Q]'&L
M8&#X:6Y8U&XG*^WY/0QZ)W_:T0<#5^!QW.F4['H: -#&=:=B1+>O>#^-P9GK
M,0EXTA-!K\8X#,_6/12:&K]3T?\ T$2'%T2'S+I!YS,;>1Z)Q<0'!SHD1."]
MZ9_'/!<"2)/%7XX#'1+_ ,N?01>[.I&YQKI!ZSJW+O2F?18LNYTH7]DX]# P
M+G8"./DZ+W,?C?\ VE^!F[45<^1CU3G\; PE6#HF@$,'\'JZDI%3TT^@@]D/
M=";@17?FK;+T@_\ 1C)PF#*KQO7MO^@,S)S@0'_!\Y!'9>@DX3BX3.(R$EN*
M$F9B'K#/I70<'.=I0_#O"[&/2$ $2!U<Z;X&,M%[ SZ(S,""YP +S*%ZKL9]
M$XP'RX6];<YEZ]LMA7VZ:Z]%W,>FB'O]T=7X.P@[F%YAGT8<9@$X2+]\%9CT
MW_I'"6(S6HI)EX9GTA) <1A\Q?S5F?2X.,Q"@D\TE7C@O.#TXC 1I5QGNA!Z
MZ6?1R/\ BZ1QSI1:FA'@1Z>A$)%\7]-9=$!Z/_:0  R2ZOSQ"\ZUZ28<\D/&
M.M*FPBQZ64'EV9WYDIJ?@/!->F!G$AY,("@<<C7&24>FR#P)QKAAOHO8/]+,
M%PH_F_=<5AZ1U#/"& O1(B=@\#_I]P,2Z.3WG+EDG_T]#)P<:UA&;^%5YS_3
M2)#S&%'UOZ5!L*.E@/,-RS--AZV-A O?-X$R(ST<J'8.>\/)=2MP^EYW9^GD
M'0C3IGFF/IO]KH.?$=,W4X)%$CU\^DJY[G%QQTTX)&M@0-7/?7$_7%>Q->GB
M'@.F;APFB?3Z8B/2$UO5'KK/IR0YH0A(/+GWN3GTG_M+QH]V)(F_/$+V#_3U
M<]\7!V&-*O*(]/7327/4U@IZOK'K1])$0#R 2<!31_VE:]*(RQ -73)WR>O8
MVO1S,09?.Z:1KTA>1"+@270AWX+6KU<]P];9V4 '1+W9#&7);_3;\'_%,JA>
MQ_Z21-(0'+1 >DF\1,GT=I+Q!2*!X#_2SPF"Z1P&79':^FPB'B@=G]47L+?I
M07"#@X%QKB*C6O-*WZ:>1=&6[#J:),<('K?^G+W.@8.A,UW)F/2N>_X$A?%>
MQ_Z.;@YXZSC&, $&?2OF'0<1>(WI;+,>#V?HY1!-!.?_ &QH73F#)/\ Z:CG
M2RUX0'-Z\T?2>!.$,>2HSZ=[N!?CEP>I%///XCQ#.P=(1,'.@*&\UT?Z8%W!
MX)<'8Y89U7DV-A'VZ$&8A".BZ&-B\OD 82B!$/=$QGG(+=AQ,;#@'0KD]69V
M#\0 '. #W&CYKR#&QT+H8SHNAC9.<)0IJ[>D".S8H#@ ^9%[E?9^G,72#HX^
M+"Z&=G)XB[@\WHNDL3 @^1 OFJ(#9"1K6_O1.SL\![A*, #D:PCN72QLO]L(
M^U^47]:\)J[&R@[L(.E?T@YOXX'$.SX&YJK#/"M?K-6&SJ,Y:1,N4DQ8D'1P
M=XQ0*&7TE*,-;P@D#I!^-,)=YKH]MNZ9 H!G* +J/?XP02<^=#(E\L;<D:V<
M08?Y3BK>QU'#*I.N'!'^,/<)"8E/3.>"#G:8FX.PB]P'>"/L+A03Z1[A=33
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MR_'"54'*61CD )^4HV,XUAGEURXKN9V57!\I1UU%/I*TS'+%S_EXL(.4,?\
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M@Z$\-W&A\+?P3?&,*.P=X.B\DRP(TB ['&\$W\<X/GQ."E6T>-8]+YQ^TO\
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M-2][ETL_CR 8&  >93N*]^9_'FHENS<=)HCT)+W!PDX@1,Y4[R5JI'S/;LM
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M_NIJ^CN"LVW#C+ C0<R_ZMZ+6SQO/XHNH[/A*[Q0&S.$-8ZCHLCC8V-(U)I
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M?2;_ $Y ?-\7$P#\M'37L+?IYP@<<H\ZT68]- OC=).PL(/76O2D@/ZQA$/
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M#9SQF_'K*5,TVF3R]TKX*S-7D"%)\^*S0RI>Y F^#A\9)0SB"XE\9.$(WFL
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MG0/^LH*KN76AX<5,LR.^B!:#B_%]1]H T;#N:+)A@1<\$'#?2Q<D6)&X_.:
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MJ0:0F#8"!W"6#EF&8N!?"=)9Q4Q%SX9W#NG+= ]\!$PS._@@#JP@7RZYK%F
M@3VL<N"F27]QCGAK1,R:/+L3>XH&W96_[1#IB$)RA=Q2OE.&)C=P3OGAG')
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MX.=  7!V&]59V='OH<GSE)^4J*[/IS.9CIP&Z7R@=FGN9= / $)PB;JY=[#
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MG718LR)GC?=9AD"D9QI.F: SQ%7US=Y3$X<XSH!77=)80=G X# CQ5,U%\@
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MR@7QQT09BKXZ='9)H2B2^!=)ZG*)$.VJ(:J*W]P0.TW1S]*0OLIL&KH!\S'
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M7:7;TA9! .HAS>;XJP':9EP. KO\)#LY^<I^46QG+E@^$ @.;Y/W].2!MFS
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MB1B^\/*0LOQ#I8[U3 'C65>^&2L"6?\ EC.KJVY,"\.<YQW%;WP(J2X0I?!
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MS,R'4'>"5Q>_=$QS@L9PI%WTFI&(9E.90 $S+IG@D PQB\T%U5&780(C&["
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M\N.::#IE[K^DC8D]T?%]$$2__: '$3H?#NSD&1E+-T9.&GTF]CX0A47>B+.
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MV,;D$P:>90$L=?/PEQ$U<_.G+HY;VS=6,)9?)"J08X/,\\^O5+[70?!UN'9
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MQ OY"Y_$TH8-15[ZQMRZF68F$*8?^T]^Z9EFIJ\0PNHD@XOXGSE/?0Q5&=E
MAQW7E%=@9?"RF!@=01#C<B@XCLJ.S#L1>B/M<X.G4O-NHNMH%P</-[LDP9%9
MY!!'9[/F#H;T70PQ0.O [K*8,0.<N_TJ,BF.Z3KP>@=EB3LWNQ\XOIHB,<7'
MXXOFB&,W:9YJOM<*$8'R@!#YD:0=81&(,\J2@ZW)]F,(:<(*I9HZ408<$&9$
M':#@+WN* 8W[H^/E4#H.<#'C>DT'%!F@73 P?)^#Z.3 0%8=YD:]4&C!T\I)
MV&=[@X9T^.: EAT (99\MR+-".D->"J# QE+A*FB0U%0(X7%!0,BM9.EEI81
M<7X0QE 5J](&A+F+L)V2]_'.\$#A[\X/TN:(<'\==$@&471O2X*D(/<Z>$4!
M?@(0CAB_?DA@<.)^T"UQGPMVZ,U)IE]:@ET)1RXH*M">+GR?+#YW+-1T&76\
MU)D0.<!]_29EJ>AR?3KAT09AH/<2\_[@,I7O1?2,95=8JBSN>Z,)7139QB*:
MNEB[H@LRT)E\ 9Z9HO!<>5<NM4&F<@ZF)?/FD&,'G.;GH&(@"YY@-*?:9D.#
MP7#&KL'9( 4&%B.2'M<(&ED=$%"QF>CLKHB&.DM,!BI,-\9Y\Y7@GQ=N[\^&
MB -')[BZ\5A2 ?G>"P.,,97VHE::), -3)V6O62"CLW?^VF<N:G"#PX"6E.?
M"*8LO<X\+WI"R*QE&\?M!4;36D!30]D[0,84U7,8/,B^7#LJ N=&<@1'ZNB#
M,TB'4C7MA!.RU*&DH8/THHM:"(TU(\51V0QXSO!!5]0-^>3^;Z)=J8NA 2EN
M'!,&\I'D.MYI6R\F /5!BSA1QO?\)WEWBZZ)69&R/"(,,7F3MZ ^Z[^UO=@]
MY.HT2BH.+\P"AH^$'ZXOD@H&MY#H)#!THS^=#"2Y]0_.J=AG&1F;X&J"S(F1
M,.XW]($Q=_[3(2P[(,F;QGOOPL*SB,'3N""C EI"4G1CCT4VB<<7'DYW1;O+
M"GB%$&1#2+IG(($(A$Q!??G'-85<#(9WRP1;9^Z><U@8 ",'4X7) P($72J[
M.^B(,: ZU=0:8J;37^P/,-SC/3L@)O<7/G6%R0.WEC'=<.:4OF'@TO-2]T7F
M6 B;%R3-&+XND1COMSD%0S(O<:W19JN(EF*[Q\A(3KN\U3--2=XA1Z AIX-)
M4GI;T#2)$.GFJ5DS%[W=.BFTU&#R,7"004?%SA'@X#LB<8'I;TGN+Z&<83X?
M").L83Z#! : .><'UC5,6J.U G8D@S4/[&7WH%*)@YP$'O= QJ@H&IPA*,!'
M/BY-[7.Z#[I])&11[KZHF+P8.&$T! >07W\#Z3EH9:.M_*:B&M3,\$ON!!A\
M8(L[EV@)2DZ#I68%("Y^D,<>7;%(^;@7Z\1U1<YSW<!6O;5$,TT^,(Y/IV4S
M!S\I\(Y8%,R#/!Y^-W22I[GS$>4>&HS@@EAOGV?Y2!J, !5TP!31ZJW 1?B*
M\:[ES$/D3$B8N*#H?YX?: &,XG*'19ED5/C3($IFC>Y_P@S!?GY<9)=SG/=W
M>^^V)K>04VB'BD78Q.<D'0W(;GZOATL+E]T\!CE>X)WY.A<U+VU-N=#>Z+YH
M Z0F#SQ+[<J@"CG NP=9?% AX@!B'TQ&DWT0=4CQQ0.TT[>'1Y\E,$4A@1@:
M0J[X6;-)FY)F)!H\.VJ#8Z$YN&?53C,.I\JA:<\R?A/[)IO6R$XF)D^9S0+[
ML*8.AF7PW\DI @R2988E\^FBP($*U/37<F&^(?!TJ/WV$!: J(3A+E\G@@&Z
M 9%YYO2LL8DB=Z:[DH9>7%F _P!I!IC\(,6Z!Y=5V!N2JZKHD/[ 7!(T '.%
M80G?-.Z9#\Q&^'!!-@FHBX$]'?2K*1K)]/A(TU0R.<]2."7<X\=+&]!1EJ9!
M>XNR=-PUKP6)$92IEFIEITP1E0&EUW(L 1(B'">.%XH'!_W2$09:6]5+H'7=
M0WX4F0/EUO56'&9+HZ40*_ 2QL\4I;P#][H3X]51J&0X6]09 J9F&&4+H@HS
M6DB,?#WP4P(XC*$+WH/#R"#Q@<]X52\/@'%V$M:N19GX>#>TP=!U\AV2[/!T
MB]^1.>7A#9MP)S<\4 S1!EGE!$*:U \N?'-[GS@B<92?(0'&X+><*Y]D6L<H
MR>^;]4%!*-PNF14&LV82C3@F)@)GME#1*3"(^RC5.T?:^#ZP($'B7/)!EK*-
M;Z.H@RT<!D\QG8Z([,D/>Z(X^'(3.WM*X:80H_E=%A,RA"=N@LT(S-!KO2AE
MSR^KS(O?VHAND_O!>'S$'"#C@[F@2Y]7;H.@(BE4Q9K4D4ETWK-,8GP:RBC(
M,@4<_&@\C"2)<9;P8\1@@T'2#@\0Q'#>]*07PA E[WBDT!]D(1!GNPOPF]])
M^T.T!\%*(1ES==%B#\U=IT"$%!(WX=3O3M'B75XN5'QT#RZN#\^:F6(AS41+
M(&E)HLRH&\>._''DE>YV^NYYZ(1C#C73MS2^W4&+WYRN01:9V]ACM90X/X2W
ME(&R\0(INNKEF1C%^3B2 Y^:++;O:"YY?!W"-"C)FP]S[=F.:<B ,WT[7D5$
MAQD75CG#GQ3-2,^* >V(#+XR&&F29L?^E,<'G&&Y*20'O?!UUAU0V8=$QCQ(
MZ!\=R!FWF&L'2''&2;9B0@0Z3\\TA&KC*$*"4U0 8P?C0"9[! &FH@<JU@IR
M>(8NPP3[1EX? N<ZZ9YI69$S)F!%P$MZ!V2($@ AZ+)_[GSB-<=ZD '" $WR
ME2\DX#G>XZ&7+N$!#)>YT)4GA\GDF:&_XQI"3U@1D03F79H-$4$*?/=!B[!S
M@X2=?-$?8$G9:8S0$124A7Z*S](ET?%U0!DSRX@U'ET>:1Q>8X;A<'IVM!"6
M!H'Y]<4@$ 7P?0<D#EF<JZ0D@RP(DPK-,V8A\H0PPO%*'U<[23X.R[3*!B:T
MAOA3N2A02BY]YN1< XTEIIXK@G9#O\GY#$;KX()MB,'$"W[LU@9.#ISEI#&;
MZI U0PB_'CDLTW"8(J'PYQF7H"V:4@X.[JP+@#%^XN#I=U(,"+Z<^<="F(TF
M)<K\( VV)O(PIE?!9@O]QR!?><SN4VYY [COUO"GN,A8X=$& CGWQ\($"ID\
MC/YFM[Y0I 7)R0[2<#EC?62!F#( SQ,0B#$U.,KLR4V/_;7DP$G@*S(<XAY.
M<;&7% P+LSNX9I2-_,:9.YK0C6L*:7S2--8"+CQZ;^"!QN!E-P=K#1!\"*S&
M69&])F9@;L=+<G:J-\3%!-@RXZY%Z<4C2LAC>"#Q0&.4#OO%9AJ+C 93@8/P
MO% [IF\-R1@OC[=[^UY)P1*(G'"RBR,# <;^4#%C+>(;[U4R.#IXY/T0+9N%
MVY8,/@(ETO"!F)2,H5K;[<B8LF )<[=>Y*@=IF)F8\<(Y4507#S [W=DF$)G
M&%'(;0S<SW+G3W32X A[GF!E&._Q-5:!=I(BD*X!().<\F+^^KXQZ+1/N=H@
MG[2Z@ +R8/TB$66@Z3XSR%*O6%,W:QK2D@D  B(/X9P0= K!\#6;T[>0!@ 8
MY.X)&2(!^6B&VAPA]5YN0-"E8.N\"D(=GH<^6E0D(F:<74A5R($RS2?E C()
M>S!X(<ZBLTUD3"LB?')3$(^V!S?.N&2H=J#( D]NJ#;1[@"*1<X#B.B#)R-1
M,%SW.L(%M[P0Z;AYH'<:)/9F]V)@(4=R/= [G$\7F.Z]\XH6L3.>Y8;0$S>8
MP/A/!U'NK&*#%V'#QOUQ4P"\&64X#F7T<F#(A)^O=4V;3G/$=!>8S* - 1=A
MC7-#WUB\;@[3NECIB(/CQ?;D?;77O3?+L@8@/>XO=;^B4%\8Z5=@G]F@R-7*
M!8-'#VGC>:"P;X2&^<-<$S9UH8:.<<ESO<X&+MSDX:QD>6N"#?PB!#YN.$XQ
MYHEF1)?2>>%[DX+A*!QI1XHE+4[W2K-Z!7B(&.?WR0:)>00Z1G3&,$62(UNP
MJ$AV(,-*SF@P:-!F=$&>':\4'T$L3UF@&W!\XS?!SZTX(&;Q$<A2=.JF6RX/
M#B>2;W&<GQ#XGC+@B,W<K?CN0 ;0Q#G%P)C7+<G#6]\X1=*!X20#+WP=$&O#
M/%$XB9>'4& 0(S-U'OO+' H-%Q>"[*FXJC1RR>Z#I:Y9*+(>X5H,<,]Z!PT\
M$1?7=G@/A;W.QCA2\T#,NE3YRJ."?1\*2UN103\<\59D0+W/=$:SW8J;(? %
M\.G,G<LTU6N4#"F&62  !P9<7&#N6X98S0'<<WB(0SI"&Z^"9[WU%31PEQ09
MAH1UB#59\HP/(_71)['E[J:"["9EIPB!*.0Z(")!SIUA 1CY69)F"<:#Y2D/
M<<1 #D<GA8O= NC![S<):(+EJ1<1)UYYKFV>T/N;]X#ICVO>0:-"6\<HJI;+
MA'R[[QH@_&$W''4<P@?',Z[M!<D"8/X#*D8K![A2)<)2&<))?=B(1C2Z( 'P
M!B9E[L)>,%@P&1)U3&1KI!$T,790C=<$6G&;NH=T"7%]D0[%XAY#YS4JF(I9
MWSW+F9;A.4'?.0DF;!HXC>'507%(C N<7[XU3'27&=S7(PT7/( =)U09P[%=
M>RC.$\7_ 'R03VK3HB!+IRPYY0JE]S@!!XN>#YN6VVS!++R3[9NJ:;J.JHM[
M(F34J.=J\$?3G(+!IX?\.?G>:?9$U<^,'P-/E!EC_'V@G#65$K0B"]Q!@,4'
M3[G=M<;R4VFH0,7B,X7P4&GE\1'E2'A8BDWD .P \H*B8,C-V2H6:O<21U7,
M62Z#6#X!V2LV#B'!VA)J_I31 Y ,'XQI"F,DGM<'EY=#!X.652H#8'W>_P![
M4&2S['_X$M$$-$.BT)", 3!=!:,G1[^+"#,FW<A<462*/K/@X+-_^CE$K,M.
MT\Y70H'(H"1CAA.\TKLCW-T1/W@[*\$O\PC/#?ED@D!*H?$7/HG;9,GUD,\\
M!BM[KP[E8$OB#+*+L.F'8#[3B.%P<B7NJ(5GNQ0QH7U,4.;I?&[) 6&\H]'=
M@_BM.7P75T2,@1GPPM^:DPS1]7:B?31!UD98#!*1-\-8OQ<E]W#6.]-[Q&[\
M( 6M9/SEWXI&3B7G3'+DZ44S\C3X=W2AFO\ W7+#) SLQE!+LVVHAH,N>0\5
M&+J=$P8C_DZ?!TEC"-+<][[<@5IF+I:3A'<].RUA=]40U'4 WD%@,H"NEP0
M-1IU@>F:4ESPR)F;W3SRIB@W5TG9@WT4RR0(RH!$H.AC W@^$$28=8I&@8P=
M)W8BX+3@=^LIU0%EJ0B)=8K-B-8F5+?R<D#.60.5R1#4P8"X(' =.[?!8 9O
MA"4N<<=R5LT@Z52$0][@1?- A9J)U!UKNJ@P9F B0XY4Y/X*SN,H9?"1H"3J
MRDXH*D_[3P@(:>9*+_\ <[R?K'5<>R]:RTWM?3N:]VR9V;3319/M=M'^T,ES
MFB'1=_M@NHBZ 'KT"D2LQ9@T^D!$S>%0# U,HN=J@[1TI.XE,P-\WW>*J.-G
M8_Y%KW&+(9]O_:Y\2!B:Y. 72TS//.1A'0R1?"&'#?I! FLX." ^XR@7'A#!
M8='Z:N68Q@YXW6]4:-'7I7[03 T\G62#>SBS(1>XQB;HL&8X_3MRJU!Y=ERP
M[()A@5WY[NB=H P[S<YR!;UBZ. H_-(1ENK(7O0.U%PI"F'=)WD[+6N:),\7
M6-XXHLM!P &9.!IFJ![GAP?#CYO-9DS!$A#'?>"S+)B^^SH(PBY]\NREQ-@R
MSC'.?3FNADO=OUO[28.?PZ5.25@@OG\B_"#-A[P[)]R"1DT(C0F0\J[0$^C^
M@ZI'3FZ1QC7QP0-(#<2XSTO5;W0+QOWR@8)"-XN5\DX%&?LU#D +?!SM?*4-
M2D>DKZ*;>_7X2>Z,7NW/^NB"X,W2?=XN6H:%XXV[1!DO)'M(= -<SPDF?.9=
M9=U"H(9.7G/=Q2>S$UIPY<$Q:R/7E<7H,RP--^."0*@X/X<+CP2ED!_^3JF<
ML@IG:2A&WO%-U$6MVLI2O!0;W<^6=RP0 (?A*5_+D1G",KW;DX!.O7!(&]VN
M%DX(AHP(K++P_>HMC&#N6[F@TU(<Q*X;T'06AQ[#[U21=(N?#3/139B!C&G,
MZN2,DOG_ (O@X5S0699>8U,NYTG@B6.ERQ69XXQP6]QP^KP0 ASG3G5,#CCT
MZS[(L_ =PO#<D>,'1C'N@J<*2RO&F$$&GT,)$F<+T2 SPY%W.'58-0Q[.0.P
MT^+H7<4P9G!PW7!*"1,3.3\T62YP._K*P@++$Q6,*7N1!,-82ZT<E,8B:<9X
M97D@E[L)"?1W?DD]\7 D3A.=7<TQ+H5+WNH,QT<G]KM8CY?>Y I9G.-8;\NP
MT3;,QG$X;H;PE]LL=\J_?PB&7.:%(/RIIG@@Z"VZ3P:R<<YJ;;1F,IT\E2+S
M2?*.-X(D@6<"4#!J_CS\I@>)TMTU-EN1RK"Q+@C_ "BO3"[" L-%\1IK2*9H
M5?\ .2G_ "0$'"F5O0+\-\"Z'C@@8B$8O()!S[?:+^LJ'71(!K'S+(41 K6K
ML(P=(X('-7"$_I;9X&L70=D$'2(E6L=8.2L5GRMP0.R]Y<"XXEXEQ!3!@@$R
MR.*G[@^;JOQR3?R/>)%T!1 28/D;=\Y24]F2X$B-?O/I!%IK+(U=?).[K*OT
M>R#-#'A6%$C7>+M-<$Q.$'I0)ES\L+$7H.8,3#IXGGO'!7]H<[0.X(N?J_._
M"9AO$$"ZH$(G#!SL=7+ Y$RTOHJ@7CQ[X+ BIOIDY!S,SD0-=P"9^<:.GG\J
MKJ@0[VZ(1;9$B(X]91&_@@D1B#O#XG-9X<^3QA"M[LDK6&[QI1ST"Y_:FIPZ
M.0!E@0K7+C7+BK XXT,G\K*'M&#CEA?VE+\84SR*!=H9#A?=%Y=6,I//TK 3
M+QE"(<E(A?%!# .,*=]R9M^$,I'PJ0D_2[HA"$Y4D7><\$"^S=QK7BD:8AH;
M[*Q,=+ <D WUQGX00#%GE]E "&(@^Y.X9KH]NX.N&*'MF)=+R00=-SY]=?A(
M!1SGUZG)ZZ61.H?'KSH>T$C0LTPY<4$!LGY]XUPLHEB$>PNZJP9P^,9(G&6/
M*5/*"+;/^T2A.CB@ZF<Z%TLE0QS(ZNY]YT2LPU'+R?M!-K9Q>Z$KZYK-,7)Y
M%O746:G RK@D+-;X%!%G8.A;X=N*SG:1RXW!4#+R'P'P-RWLCCGIE801+/3/
MZW218V5<YP$.^E5T.X<H2=90(?*DJ U>@YO;'?./3RG:#I@Y./5.0[=<^:#N
M_2/V@7^,0:A"]\8\U'V1?(UP743($5PZU^DA:%1#A>]!'V0#A-]SDA_%/%PE
M+<3= ND#*S5UPDG:9DYT*NY7T0<+3,7/OY3LLTYT O@%9MFIGD79;Z.6]M./
MBZQ0<Y$75QI'LF88?DXWQL+I=AE#J?&FY*TS3"L7EZ#F]KJ4@D# B1OC7(88
MXKI=Q$-4Q9RB^&8DZ]4'(RZ677/PK@.WS6<XN+@(WX>G=0N<'.[;\4"-"4(X
MQY'%R0'6MQ5SOG(1#X1\I&C1U9Q=PQ029#\-RHV, ?GPA[,++Z.D'8U5/;.X
MNKD@BZ&Z5]=%B!OA!\_CNM[7N#B'C'*O9#VR,R.TM_= K3+M]2!NW7@@[+)\
M7QHKNIC<KBI-,S)H^M,[>$'.V* N&$Y\T2)#H<+I-4:&_=+?ABE#$62(1D3A
M3?P0#^.>%+MRQV7.!U^ETM-1+@_?UMZ7VX$9BZXH)-,5D1./QPXI'8NJ?C7Z
M5SLSB'9\R#Y4OXGSIF[CP"!1LZN&.^ET.28BKQR=14]@@'XQQ699A$3@[+L]
M!+VB!O+48A1]IH[1\]!U79[8.X//)U,'I6J0PE077L@Y6ARN 0(D[$?.+ET-
MBCA4:)0R'R(AQNB"1&^GU>B#;.()<[>ZG*JZ.<I/ZYT4B7>-Z"09YF4G#K>:
MQ8F^F;P^PK,[-\2!,0-P1.S_ /RM7:3R0<P8B<W2"?V1B71AVC7%58#MY,#R
M@B67S^?H8((-;*9D9E\'WP3>P.$SUBKEG+GQAE3<E]L)0!0<[3,A-Y %\S@@
MZ5*0?'&_I=+8J!$YP<Z.XJ;MPQZ.P*"8V<OAYO[2ABDA;G7DKLLSX9G5\,U7
M:,?[2'0AH7(.5T.%!#<@R)/G68?2E ."LRQ-\WOE ^:.P3>QVM1@@@"^!A)W
M;>J1C"8A@^_I%D6<=/" 8F#RH.[]$%&&,]1,Y12-,X5G?9=#.CWPA?P@)YXY
MW#X03]KG#'#DK,B)TN.&2)9,X.''SHF:%8NN.]  S02H_*)?\[EB9X3QY)O<
M('B_#3NAAE+/0UO!!79M:8C#X%$\>% Y1&A!/4;OA4!)>(OU#J95>$%0T^8E
ME.EO3"<OFA<N5L%X&,(1=!_,0@)*XA,93<1@<-R"C3-!@;.B8& #\0^F5.*F
M,"]TGB[,%C( %Q>'/-[D%&=I_P"D\1A*>[NF9:Q+L/D8I*.A.+Q"]4S36@#\
M(RQ[H'V;4:GATD$P$:%W4T4&8FKO'6W)RZ $6N5YS05,XX7\JK.GP'8+G>[*
M^W=4?#?#RZ=."!H8'%\]'=>JF"\PH_2]Z(9?+/'IFBTR!&LGB4,K+T#ML0(<
MYP%(0H.*1B9A0NO-5]T#%V&LXI&'!\'DS0"E8Q<,XA$O@X$8C//*X)0V'@"(
M#X]02GSF<.^2 >Z0F"9>#1SEGAXX;_'TD:8B\:?5.D41P X_7V@H6C/'&YHM
M"1A24YZ2R%5FA1[HC*-W!(344RSN* !AWN(F9..%'(LBLSCAD!FB"'@X0QYH
MLF,XN+LMZ $E[A&483N2;W0R#G0B/#\DNF&KCCFL&MYX<'WQ04)=CN-S4_<_
M"&[A1V*+M<Q=X)2U6&GFD:H,_=1\.JHS0N-PA404/<)3TMSOIRL2)#C)UWD#
M".ZFG5RQ-(N@,AF*_"4-#.\[Q2$S=CQQAUS06=4$&;L]=_)3#6(AD!UP69!B
M'AQH^O;1$"$Z.RL(,&\(OO@Z.Y!SA@<Y"^*8@.=_\T('Z"BZIB(N&)F_=,(*
M>Z$;[>$T<!./0142U)U2YV.N'A.6I/D(9ZYH"TU23W&-X+-,N,ZTI82-A[GP
M=TZ)@027@.? H'?2+GW>:S+,\ 09V_5(2"Z)G2F/!9MJ&.=R?TF@P=-Y!UA]
M8(OXT=S^**6#ZN)=U=86?A>N#J(*.@XFHW($N,! 0<)1'>OA*305KAQJ@6A$
M1)RX.?)R LLQ!C* DZ^:5\QB\#++#-Z<-O@XCZ@E]E'0,=,84^:H&9EB\E[N
M^%A$X9=<]))7Y.T$J71*7#*.;KI5 [3+X ]M[LUO=)]'/[.RRI5*6QB*5K0[
MW\D&#%SWOH^6:!@U-SQ$S<IO= D1?*3E5O*64]Y[*;( H75?-][IH*X.#J@F
M&X!)KQ=*@>_&CD#.X>,TWO=71D7NW(&?D)8QW=DHK-W:D.B'MQZ>+P6=7'#E
MO0!ONXU@ZRBR<'AX#Z T4?Y 3XQSPH[PF+)AO+L+Q,*H*$3@[&7 HN$"*1 =
M5]<G+"(ESRMR&.,>7+R@4F<#_EUDY.&H/.F8<I^[")QIGNJE8,JXFD+F$%6C
MKC#,(,MRJZ#NQN:! >8.@Z+Q\7%3D^+GR=CU@@JT"'\(F/PB^CGCA*MZI"UO
M-<;U>F!?U<[MSU0*V9.<Y]+BF:B^C]UN[H,L5WPD12^"0DT#M>IH@+L>>51P
M4O=(O,X;S#[51C"1U /2/%!K3Y(RZ>$%=J*GE7XS4 9XNW"-,4Y:SD[+<ZPI
M,F@>[/O5W) [Y'49/^TWNA31URYE3:&4B").UP1>:2?&B#,@DN,H.+G\^R?$
M4C*%YK?R'3CSW.CV19(>)>;X50(6).YEV71!IG04<,KDLTU?G+!2 /<YF9W/
MXH+^V<HP$9Y@8Z52AIP(]KG.D8DR?>:#XRU Q=-,3;^V4W&&-4!8:F#%XES<
MIEJ9=&@[7,\4WNRC[80@^D+<IN<\X]-/"!W0X/&?P_1*6C(<Y$82^W+&5'PL
M;WHAMU<GD'6OV)()OB,0^,I4 Z*D0(AY,'0A]8K,NB15Q>[/D1!#:-8/$W@3
M=S" !J3WF3P'V[-5#.3A42C&X(,DS(T>(WCCP2@F)KAD@=\CKGPPZJ@VFDXZ
MZX%18)KA"CO)Q18 K%TL']D#M-8_&EQ2OU^TK@1&!OA#"29_82PP'! "UB'A
M_+[3%J#GB#G#?#?N4R.^N?-*"XDFCK!"+8S+47#/(0Q[0503DY[QID/*B[4A
MJ>F<X P3L"#S4N#_ (G@B'#)T.8R>'NYA2+/_<#QERI4JSX<75I%^.6 W*38
MD\0!YYNF-R!7B&31E)2:VCY NQ,A2=4[34Q1[L*1E@-$H-"3#&3J0^T&:( S
M<Z$R<!GVB5F7AW?OIU2LLS:>\9\G.DJOK*FN[A-  <8"&3\">L%T 8".'GLY
M189>\TI)W&F?)*RU6\"[R]QH@):G DOC0.R*80=#,?/A-[N&<"7FF20G$0[\
M8H,V7@?Y;A731 .<7/+Q,QG?9#V@B#V781AG\>4H9(<,J2C?TBGV8=7&=PWK
M X1):WPY;U@88!^$7Y!%U'&&[PB*/<]U:CLI,D:_'0\DKIZP D,_BJ;9X5 ?
M\<$%&3E"8ODD-7%QT$!IR3!K>'R<[B_Z6 G33S;^""1!<0^$A)_'FE98=N(K
MSB]4<Z$2Z.](R(A[Q1V,X;D% W.$Y9OO1,#"LAHIL"9,A!WF>[Y3/R>"_=KC
MN03]NL27N."J\2W NANRYH%T9AXB1A#D4F F2A==EKA%P.D\U,. #HSTM\%B
M8Y.<(6Y_5 "@H^$Q&KT ?+(0IA<59ED2,'A]C-29+G.=G=-$66GYN/2<,)0X
M( YT'#=AW2LQ?_[34R&3E5H_?/CWBI-$2H_6?"#\4#!H4?0;[FM[= *XON*!
M(G@:.-_2;VO?JY]?A H#JQ?+'OIS3$<3I"-Z42EG7_&6<*[L$P.3W>'@ON.2
M!6FJ.,PX/N$$T@[ OGB8 )!J7\\_A9D/'^YV0(YU!?- [C%^HQ%X;TS#<#C!
MTA,8*?MR:AKAAS[(#4%_9!2+Q03\)FFL3.N>Z,4,=,H@8^5,M.DX$G,>2_)
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MC#7ZQDJ':8C=ECXJ@TR\ ASN)0:R!0T?@$ON=E$1^XOA*"5G R.#L]UZ)A7
M1=6%T0$$B>;A]<DN/3Z527Q=2EQ"1PHYV.L\=7\8H'#(@*+>[I0YX2PXJ;I$
M"3[SCBE?B-:O?#CE@@H#3CNY^%/W3@'#,.XIW5F#<,=Z?VXC0P<[- K\Y2#K
M@$P=SJ;EX4G!\(>'1FF/WA#":!O;-T097>2QV<0\.JZ?-T$[)PAPU?>:4E^M
M\4$2S%XERPLIC(4C#P_!%EAVDP^;\!2*=IB4>?#6EN03;9O+)(\T#X61A>JN
M68"Q1#VY1-;O)!%F,S#A'+HY4(#@Z>&Z60=K%#VNA4_551TC64(4OR@E[LNX
MU1]HCK=R2M&IQH.60*H^;CPZ!!, X:"^")T^//9$F^#]RS3,N&_F@F3@S.W7
M5!D2?/7"2HX/>]]-,'( ;Q-R"19F9OH[#HF#<PYPX;N2LTSCD99=DA9JXP<X
MWP0*69/UPGEN0A@2<,OA.V)!W4?/!;VQ?>F[-  S-[KQ\H.BX8&W<N"HR 'X
M=<.%$'1#G0@<2_KJ@0,4EF_DE:9P!C!T3<+<N@Y%[^5YJ#4Y%U9.?D@1H<LU
M%L&CP)R70T'"<1$UC=$7.QIINP039!CWQ,(WR0+JS#_K$XJKS$7>B! $3C \
MIH)M,OUX/AT[K,B0=$NG%.3@[N[KO3G%UWG! A#J1J_ <B5-QB\N\NMTL%T"
M- >P[] @6#!!SEE^Z5)2[:)V&.-8[GC1,R*[NKG9P2N,^:!FN]+IR2>S,Q?&
M6[ZYJIV;ZW>_>@!$0#J:WO01_CD7.+K\CPB&91?1U8R^E9QZNNA699H1\Z8.
M02]M72K@_&X9I8/A)V[)V]4Q=\9IV73OYW.\!!J(SD'SS*1MDS=>6<59MJ]<
M^W-,&7/?,XT#N]T02&!#I[[\H>V>8D\W952SY=?VE#, # G?<$$C/.D-+<LR
MQ'2>MSP3NC"48C *@9E#'!]\W8H)E@!T3AA5) Y!UO3;;,/?2ATTJL6<H1AO
M%O01]HH_+YZ99K>R>-*&_"ID0Y\'W-$B@F)'QUY((.BZ/9Y[XI@!.3NFY,Y\
MXO-].<TY9DZ4SD^W()%Q%9RS%\4K&LZ5I#56:9P !Q$D!LA#L[&\\4$7?]TY
MG['149:A*L;YJA9RS+S8YI7<#-T-"@0,\(:\/*D1(\@>?PND,<9NNF:F&8SA
MAV^D"?QY3AY<D+!!RE>;OIZZ"S..8%,N.2#+._,XH.<L0!=/C<*H@5ZC X]E
M<W"+\K<BVRYT9Y4[>$'-[*4,_'PF=#0'=83^WIP&*(ECNCOUH@B&0(3+IFW7
M@B&=:0?7A&"(9!(?*KN5\((.X#&#QU0 N>)HLL OPOZ3# \>QQ^]5@Z0=TGA
M5 C0H(AP 4PQ\0D9Q[KHK" J_P"JK%F#\(AT;S0<GMG0X\WO3LG>SC5]T5@S
M1\#$O#X+!F0!A+G6\9H$.RS?UTP@L0+='Z^4_MF,:O@,+PFD:&+XRURN2 NG
M(:NXK#9P!>Z.LH 05,W9'4=<EO; 0I,W'[0<[\=V9TP563N@Y_!#>_G6'RKL
M;/&)X"$G(%=#,LO<_OYJL1)[X\X/$$U<MU,?&*=U+N3I()M,@NP D<1;L$P9
M?$CA<$[%'QAA#G=%@P'.&.K_ +N2 AAV> )^,N*&SIG'#<=/K%-[9O!\B_B"
MSX]!5U-\."!VF.SI83N:4BDS"71V?54:D )^+\)1-YA$8H'!F#)YR<@69 @1
M!<9Y[NB++7/AFMI8RX YH&V=0Z[BBT,,*4-,X\D '3WX!]^58&\D$"UE@(7Q
M3"CJ<;RIHF+._I9%N2/Q $ZT?VF@0;2IG!_S;EU0(PD<\A\*?M$,<*.N2):Q
MF;D@;9SC6%,[SJ@6G_XB>?0.ODD$8 A_=R+)WN+B71E%PP^D#,4UD;EE5,84
MH3%[GX>%-DRA*+^<<46VL:QACD@F\S+G.&I-!&856:QC74QDCLV8?Y&)R#AD
M_MW4R,1%UG@@8-/F]PQ[Z%5 ^-^-S4QI.;Z^/"V57WG!!9LNG-Y=]YR2&7+-
M]TY+--9!]W!*:&#JD\W(, ?G0*GMJ'OKUOPI //"5?CZ3-&&KX#J#UF@#H1W
MUMRPP^?=ARA1+[2YU!#(7]JK#6_KH@SHS=J.6BBV^0>,Z.P5 8NKC&FH6,'P
MG"XUQ0(R).M\M%6#L#*WS[I2^H=E48 7DBVT_D#,OT[H(^XT=&/QJ7;I*I;Q
M$Q3ID@ Z@GJ]*T9NF_-P>+CV0,8>/%]4[P7&1P"B#B!+%]^%9F8!K=FKD$VL
M'POD>23^6)!!R??!,6AA'(!VFN:0;1_^+J0/8?:"VS )?)P.IPA\(@D6'C+P
MI N+C,]!;U4"1P-\;@@/OQEG>"4##'E<DP._*'/3)*-7.=*Y(':9F^%(<@,,
M\DGL@ZI=E 5,HHDCSWO%3?3"LR@S4YT<)1OD$K;-07F]U-4H8=(O.9OCR1+4
MI#*!KYDY!@YX+1)J!33-._'/@Y\=%G9%SY]3JE]@UN>2!FBYP$RX5W/0+=(R
MA=7K%F6 GU<] $&3G\799H&9%32(CV*9K/08#(543&7B5[UB3 TPX7P0,T*L
MS+KPZ+.=&'NJZ$L,/"P9SR#J7FB6'D85SPW<G(![YG.6;H#JF][\0X1RRU19
MF9"M*7O21>2YXQN)AW05T%SEU?T4?>'@UGB0/O!$$B9>9[K*Q8J8O$M<T#-.
MH_..]8M0@)[I&&CUBS1\,[DD:,  )?XO&9?7J@).0%-_#FBVSB"'"!\ZHD]!
M+B[DM[\L^6&YSD E6$Z3\=]$@+WX9O''7"-$SJPZN[P2LLP.Z/9 6B(DSIGB
M'=E@=[H2WP[K',3F"9Z&B4-?]KLO!*!BUCA#JXW%8&1#@X:QRI@X)FS P?)S
MJ/I>*D3(\?$KD@+3\0+NF:H^GE3]P<,!+O%&<:X"$*.09IL"42;>3>2S1>X0
M&,;?&(2AKB(AW!.VR]Q)B^,A1!-H3Y'GS3DN#R98GQ1(:F8?KI>]8BADZ/=^
M'= P:@#C]*C(#GP!!KA?%1J]\'"F%'R5O=1[^$'XWB@#)I!^$W#%W18MO>0!
M00$<X=>25@N_R@]TP.E8;D&CND_5 N;WW+3-Z4-_]W_O.>>0N"#3Q(3[P$>R
M+4',N(^8W! &H[X;\+JF(=!\<YQ["2+A EK".%]4FTB^>L(\C% /:(C"N./P
M5O8X.><(N$_"#+ '_I1!J_-'V/G$X?*!@-)4I8D5A YDQTPWK%C 5^7YA!D"
M47P!0,_'L782&_JD<^1C3+=D$[3<]8'YY(^X#O1[QQ0'VXB+L_A -2(%<([M
M;*@\/>"78OA?5,_VNC%J4IU &GE!4EX,P'N?A&1^)H@8%_G"6" '##%U=V%4
M6#,$AQ>+P*#$2R#HXW1  ;Y.%,7IB99U&DWU^DC0 A7.;S4YX(,T"\.,']I/
MP<F?(;LY*;!B2XN$'SX2?V6:$B_#0("X:X9/PO)8"!+R.G;R]*3)P&M0<$?<
M* Z7=$#"3C2.9#[TY*A,R^%*<:E3UN4R([D^V;J #T=VX/03-!%T!D:[M4&F
ML*8U$Y>5F3"0I(40]T>_,"&: !G&%3"%]43LQ &P,[@J,M 1,GOC#B^/BB5I
MK#=F_'%U$$VFG S#B! 1E ;J(,M0))=0 W'GT5&C 1!G2.K\.CD088F5#$X'
M&4D )+L'8ZV$2P^/U"FF"5V9W7?-4'*EV]Z"0:A(Z5XCIP68-36)RR%/E.YS
MW1B,B+D!O2%J6(C+H+JBR8X@SX1$C%3 #W1A(B>FF"TW$N%7#J[H=$WMD0(O
M<3CFB"VR8.(J;MR9EJA=#CS[I6@_H#TA/5T'HLP@XDU)'2W("VU"$,(2N1I%
M2>T(@,OS$3CA!79U(#]QOJ@<!$XSF9&B$0(:A%S\I'*,<*I03*P'2W?"VUV9
M'^0F'/%'>1BB")@3K .R19ZLRAEX$-V?A!IK$5+MU.05!7*!CR?TJD::@8$8
M TSWHC,/D0.+QO5&A(/ATN3QH@R7.<X6+[J?N>X.C+0:840$"<7OJL3$%D0=
M'=0.Q3$B1E3*ZH,M"8.1ON@3W$Q=!W>-GHE9%0\"@/0.QFFR!>1%PSG]OW+/
MB(N$G/?J@+516F^"VS$PYT XSYI6H',4$HWS1V=8!SC*KZ(&;!H/=#B,:0A%
M*9 $0+G@8T>JDP!,P\#C50::YN@^X]D#^T"#M\G]GN\IFC!T)9AY%S69#X9B
M!YN0:(C!YXN=TP0(62<WR<]^Y[J(C"/1&1A 4X/ET0.Z4I6<I( SFYT2[PMB
M(#,@=+*8" J]QMTU@S6$Y[^6:#>U]PT"26!+J898.S5L<]QY8N2DO@[RXYW!
M 61E-T18WJ+3+Y8A^1\\E<Y0'.]TDI9D7ZU?=4"-,3UH7;\L\\$'.>X.+C"L
M,YJAA$?8G9099B21$S-!\("R>$WFX2T5/:Z,!CG=4A^7@1X7!,T,7ZR<0ZXH
M'VAG0F .ZPH@UB->PW)VS4Y3D1=!-28#WOD:3<@+6SC.&1=QFD+,BYSZU,IX
M\$6F)T)#G8W5R'MD\2SAPMR AJ4W1>3XJG+ +R94(IIT0I_E#+?6J=T/\3D#
M+D@5DB0T#^3L?*9_'#'OBINU?49R1?0EYTZYH TU"5W;DO\ [:\'#H42_ X4
M<78X6] $B8 YPH(<D#9AYY1A+(/3 8O&73+1$GF*0+W16)&<M8R"!&C!QY\P
M0/H*;+;IO=0BHD\EW*755]M7/,R_/(HPI%U/N@01#4X%VDU5ED3C7%W+Z1+0
M@'@NFZE4&FP)/<9!T)8H*.AB=;AE1*IL-O? TUG)418F."K+4L7A] /M4,/D
MQ-\E,AU)D"W=,'!(Z#L7[]/&Y$*V"\5G)R?VS(J'EZ0LO<Z8@<UF3!V+ZTPX
M/0-[GN)AECA'+/FD]DYPDX=D=(NIAH@QGO+\8H'<:PS <;NB9ID.9P%<KQ42
MUOQT=GBF+9D74A&CNH0%P@:"+\3NL*@;B7<?A<KB\Q+C*0 R?HKL, !S,A&;
MYQG&Y(&(B:0A&3LQ5<S0>[_*1>)@WE(JK59F%*9.KS4B\1WPY#7'/5 VQ9,2
M2^LG%P0:,0##J7RZ:!8MDO E-QEG%-.)?D00]P>XCZT06+(G(NSEAN2-2(QX
M&W1P"4$0+WP Y\.*JT(;G'"4']$$&_\ M$!A@,LE5EF,3G'.&Y<XVA'^X5="
M5_2Z?< Y\R_ 0KIH@( ?&<8# X)6]I)T0(<XG+53V;<VB00S)S@[4ZI6=L*D
M/P?EP ZH*,UTNZHL$8GAEQLHL")J'%0#6KQA*/5 [9 C7"D<10HRJ0<-;T$T
M&@\/!DYP,Q>*+(?-TG?5.,:H)M$D Q<]W!\S@C_$"X-/#HSPDY,T(0+J"+_C
MB@]T&GEX@=)/N* $'_(@?XU?59DF!(GG(75,V)3 =8-R4OY)AS0BY[QRF?&]
M!U UU KTO<E:$"Z9[EUZ)&=HZ ,IE_?/).&I$8PWX]$$R''$0>*/RSU3.KN
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M!TD\JGQ92/J_+CBIEET(Q$TC+W&+X[Q1WA!5F#S1[K/>BH&GNPZRG7!9MJ
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MVR T\";AAFX]N"4.+W2B-_BF: ;39^7 U\8"J5ADN_RC,B,ABG(D)/PRB ]
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MF[)U$!V@S=*57],L4 S)V+M](0BBT78O,SVE]"25LU?KRK5!3W/>'Y^7J/\
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M,[JSE@IEISXPA-%EM^)QW2B@N #.#L<NN14ZG"KGI0#C*F.>;I)\Q7K*%.*
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M9&$>WU\H$R!%ZK$P+I/?\:C ("3$"O7.^:/NGN$JWY4V3@#.9RA#)-A)P.]
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M3R=SSMR#8QW7D@S"!WW?AGXFM<D ]E#?SAT09@\\*<IQ0:;\:'Y*+6GR3<T
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M&]Z?W2D*<D#!G=O\I"PZL*:+':$OW;Q<$H9?"3J7! I-:;G/^MSLT/># #A
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M&ZM @<EU-VZW9HLM;L]<N:FT(N?C6<OKFE+WN?I6W(,#,"D/O+NF=)_ &?!
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MFB6JDUHZ A.4 D9 GP DZ5)(*-$TD[/GUS0&&=,,G(\02(.EA+-9JC@_*^*
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MK@$Q.ESX>$!(G*Y7P0S>[ <MQ4Q2(.3HZQ5 !)W5 37AEA96;&\XX<>"Q:=
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MKS0!= N>7RZ]L^"<$9O=V4RYXJ<\+D@9G-SG?'-%D3,R<)3NPD:P?>]4#+X
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M?7)-\FQ8=%2:-0:USEP3DPX%_P T0$ESG/ISZ)"T_P W]I0U.,: X2==423
M/SI) 2QBX5Q*#X%PA &[R2.>\D%PQP^:T3$RSB)O^'004&F1OD$C+4#*9[\1
M)2)(@8R?,)WQ/= X,@]]X60@T'3O.ZI675,JRYT*JVT*"('+N@BU*472AQ2,
M?[9DF+]:Z9H^RM*;_%<$<R*0Q=4ZH,67SF(AV"SW"0SF/HH,'[E \+"U!JZ.
MM=R!VMG0F+IGMK7!R4!SL<SHFF^4[=T<I-,U[3N/>2"X-1#OBZYR2@9[LDK
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MIJG_ (WQC#E><4GLTY0O)!1IK"1J$AF)'#QEO0(H_+"\D6=H! @3PPA>* X
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MP($'">]!D.,]!=N08,!X>_>:SY+>W7CEV^D]V?&]9D3?"-NH@5AFKG1M]^$
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M>FY3-"2Z)M\50-!Q ,'0C"]4$R?^ZF6DB^:JR:X2X/KWQ2/$IUE Y[DH:_\
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M"KYNO>G;H]PA/MVZP01V6SQF/,('!'VNG%Q!\:&Y)FA5Y#G2N3TY$C#/=>]
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M^(W"C1E/ 4TNJYR2"\O,X2O#X05&SFZ(!N]4I#W/A01I59F9S$*SY3XIFF9
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MLMR7:&,=(&28"HI\D0T1(GB0-]PC3<@0&<*;_I%B;L,X42>VCZ46V3,[O,H
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M[H_KF@ 8 D*XIQ+C?PHLLR@/KSHG]TG"&X;Q?5 SZ=YZ97&282N-TJI>VO7
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M@+7_ *+J=[@E=B)2GP3#_P!(Y.OH](WEU@^]R#!G/O\ 7=4+H0G2^') 0#S
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MI(Y( 'NC-\([OB*ILZO%(2$3<'*1@8@NAH(?:):)>9" #W9]>FY&JI*XR+Q
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M:&<G4TS".T8?(N?$8/%-Z# D.@2#=Y*O\T'M!SH.SIQ7."8!SS&6!QO15/\
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MZ_"5\\!ON"!'W1.&G?%V$K@*CYOPBV(72B!SM)%_&.2P:G!UW.#IQ4F&*2A
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M8_)T=V*+347$7@I^Z0 +M7C-W0XT6]OU75V&2"@E$RA#&^B;^. ?0\+XI"S
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M_:H3D[@YVYWA0:RDY[].6[BG]T@,(W5]<)(&(?2$/&[N4NU(=$_[>FF. 5)
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M3/,B3XO%R!PRXEPGPN\4UW;@E]V=^!59_P!0P0'6\4X&$L,;B4CX0SGQ*9G
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M'I=.:81PW>:+$X6<+S0 OP@H0X'/.]V*DSC=O3E\MZ!<>PO1 3QGQ4VGB4<
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MY^$Y$LN9QS@C4VR#^,0S^.OPBTS_ -KN%<KUP2EG$OCSPQC5%H3S@,G(R 8
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MAB.1EC]\G:JH$W6XPFY39H[E\V%=MT'SC]OW(.1[SA=>R)!@XB.[XX)/:/\
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MYOCCWX.Y*1OZMP3,ZNIGH@#3.$.&D(I6,3?AZ?VXTSCN2AES]0;O@@5LE^O
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M8.(^^,D#$Z1,#IEF$.@Z/P69 A#/&/?DHOG/3??5!5KY<9.,^'1!EG"?R@P
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M7"WK!K/IQC<DL<8R\?4D$HTN^V"(?4PN6;U, QWD97+3!4]L(4?*X($]N_7
MS59NPR>ZPE#5# T\;\"@S"?SIX>@K3A=RW( /JZLNER4WRSN57\DP!FZ_/5
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MO*"MLSB(B#];DE9:,G9@&JF#/'*XQTS0(69NQ3!@7IU[JK5":UE-!MJEO[!
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M6YR!V"#!^$^(5-K5SI#?\FBXF0[>>W#=\*@:I*[TP0.VT^(&$Q//DD8$GQ'
M#/>4_P#)3IP O1!F#Z!]*0BX! &V02\.>YQIVW)V1AB(<(*08PJ3?"-E59A
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M?=QX3['1$QE/?>2"-9.,L1<SS71LZW3QR7,VP>GP[56$)OB[?F>71 6K??5
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M@@R+O>K NQOMU4_GXTPU56,)QM^>B# \+WW 8*/N-<7#JJ%J_BPD:(IR-_2
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MD]KI"L'NO>G($<\XQFMLQG7EU>[<4"NH X"6=23<TSIO,!2+OI%HQA+0S0J
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M[K>LZO/"4!C]( _"8BM#<B@YP9X4G?E69-8OSKXBE$)"MWX5-HW_ +<Q2J"
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M*(P$:M%U[G(+"FGU"GA.#E&5WG519,W3KVAG<D[+3I;Y?$B@<"CXT?=O6:/
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M9'HE]W9TYWA1,6LL;O<L!=Y409]S.5T6!QII?!*,!TXIQ\X6_P"D&=,Y(/O
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M.^?C5!EF]_1%\-+>@FQFF9-,Y3^U1D_5[^:.T$B,ON]$#.= .Y7>20GJ \)
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M6Z8S468SP50:8];E3>E99Y0T??! HSWP6!G-T'YV/*=XC/#+<2I^YSKT^?E
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M>.2Q'U/1_1 -9:YT3,9EU]0@G[;MQ*(%_%]5M$2<$&9'TF#4\GPX3O&B49_
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M+XB%-;<H^ZDH]3WZ("SM)@ ET#A*F5S3>]V4MQO<E+3J0)GGNY\D33,TNG)
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MW3%L#, RI?)!)MHRJX.XWNW)W$!D'_(S/8;LM4I:$W1[>;FG)DXT=>?1 CC
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M<?OL@JRU?E$"W/POX7*RT8 W]KIV=;\H&>Y_;FE%7:?2+1$97?Q1(R;KYO)
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MA"6?=.63!W6-ZRT5@2<9Z!^&[!5 H,#?GB%O;2\MV:8TQU[7-0$"W<[FE?\
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M0'>W(\ !?)!DWG>" GOQ[0O%;*/3G@APG?:$UGTHZO"_I!CG@)_"4910NQE
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MAI+(=J8/0%H_-+AX0<+I]HV?)R\H 84RXSY;D :-^?'9.^D;^7#<D)^3=T3
M5O1W9!,L'K.XQ" '&\%0&8RO<F#,W\OM C9YW#PI/Q'"C_(S52U??S7FE+I7
M'QD@5@_%+Z.<@*NDF<.6/?J$K)<<>_7&F&2!F1@./37DE#.[SU5&C>0N.Y(R
MU1V@Q04&',2PX*30PSLWA5.W?"RF+NEYH.1DX[\5ULLPAX.7;<H^T#14+6 R
MY=4&+\?$$S)O2-\4O\D(SO1#W5[<+H@H3AU%PICH@#)X=NNY)/<^4NGS@F>(
M;^=8T0%HUEYS?2B+(T^[MRFUW^;R4_?0?8=R\H*D1C#<Z]R=_;X'?JHAO'=N
MAI\IO=APUOR@)ANS0]WE_P 758A\M$P=OKC?=!;9X\+UNB5HUKW=C7PE]W3G
M3.$LGJ?NU'"XH"UYBX0N>])EORX!.P7[J7]A3;$:N%<Q'=D@9K#YB;X22,F.
M$9&3_B'%,-[[=NU2 <?,GUN*"[5[\;BA[X2>XN.5^$M_:F2ZR@++6$'RH ND
M&#M-U."Y7WV^U79]OJY(&9S[=>B+;7/E4_'! Y7=%%LREANNB!F"9JQROZ4F
M3'JJND[400;MQ?"^2F0^\5KO/!#'S"]:($]KGUSN2<-;\/-P6=NN^BV2!FAA
MP@Y39.[6^JH#6\M$@N[H@8M;OBX( 8BZP-$GMI+YUO>B<+X7B@Z*7N46J.EY
M='X\IO=?E2)D#OOAS05#3].>0T!HE^+P2D\W])YK.NWTMR"[51#*Y1W*0<_I
M>](3/MR<E8/WBY!U&I%QMT%/W0CUXWV2-;2D*<$'8\;J@H.O ?$D@9QSW8<)
M9O1]W"/S]A!^^?U>2 O,@:]D2S"[^U@Z%OO!!LSOR@##+C##6EN3-&E+?V^5
M-DX/[.EY5V2+?&Z()>VIF90W]9I2U#QCDNKW=[O<HPOSXD@#Y?#]55MOC<3J
ME=?5Z4\>YQ=><$# U+J=[>F.TP%GLH-M:X0O>L,+WGD@I[N\-<+U0 G3KQ19
M%RR1VE<[XZY()BGFQ>*<'3Y41K\ISE=\IH*.N644@9LON%$\)XPNGPBR0::8
MYQHZ: @T)N%O4BU$Y=2BS7+KT%4C1YPL9ON2!_>^4G]T*;H?&*P=]%SI!;2W
MN0.SRSGG<HH;24/%]$-IA#.[S2DS=I5UX( #092\H>XQUQMR8,.W_6[LD(P%
M;O<@SWY1^D[-7U<ZS\IJ#(Y_79RCVS@@H*TH'>:#)5%!OOKN4CEC?DIR'#SI
M.\((!B,>7?-(2[..#M^&B1K$%TKZ[D6KZPZ?2 ,M1=3IYW(F='WU2%F7#=ID
MF:(XR OF] S^+^%Z)PUR-;^5-@5.6N_7""9D3)\_,"@S0<#B7.<Z? (>V7"^
M_9!HR%RSNB<LX'E;D$?=%Q@F$X#ZN* 'B\N:QACNW=:8(&+=!'D^^'),&J5J
M^[T2!C"Y3699<\UPS05!PTN#NR4M.GPA7"XH;,.YE+[ _'Z[H&9,X7<D6C2H
MCEG#A-;9A[Q3GI\I"8FY3$.LD#,O^M7<JHEHI297N1)J;X=$# R&\H&KLY/D
MIM,USX9WN19Z0X8W) A,\'WQ5&FZ.F(<NI\H%Q#A\(!F49.WTG90,P)R,\XN
M2D[AUOX3^Z@N%N0+,L)W\:% ,G7\Y]'IFCA2,-T=W-2,X;OO+X5B,XFG2]Z#
M>Y^/9]/.KTWNP>#ANWPK-39;BXQ@_2]R<B)=#"E.J!V3PZH-""@R<GX.A?+D
MG?SM]U02!="$87CT1V9FY\[*#+$2;B>(T3F$A=4!R,\.FOTITUCEP3,;IGB_
MHBU9Q-^9("R?CG44A1,SB7!X%;U42UNR'A-[G@ W=T04]TL!;L4K;3H"L3RZ
M)'/?1Q&@#^/B:9D NGNY.UB] X;CN=&N]3::H,3%4++\P)"\JGJ5)IE[G& %
M!!!1DTQ%-U;>D!G!T8Q0$,I7HF$W0Q[OT0.,1E]HM-T&^B7W2<+Z^4OO?\#-
M [X/HX@2[K#'[+X.6][Q"0OA96)%W//X0(1.$!#FE?1T,[XJSZ.I'X,[>E8V
M=2?&* UO[\J(B6IN'A6:X!Q^K#LU(/XXZ^-R!S*1QL8WDA[WDPHX?(Q3-=+Z
MH;,N?#6[.Y K)+Y0ZON"=DQ+W"%8OS3"+H.=W,(4XO4RS=TH@QBXB0X2E\+H
M:#@ *S?V4&3A+C]JS1A?/J4"DTQKE>*YVFR^#L'TS=RCC!4]OQX[K$0I(Z$B
M6F:!6(F--V&J9O:<!&[G1(9!TRL6<I1NXH,^ F]XY_'-.R*&X8H&@%;Z(DN=
MD_(E S$:.A7*X8E -Y1%.,!T*7^2@GTR.ER2>[<8H*M-SA*80>_)[O)\GF@Q
ML_C7NF:V@&) #G9B<>#D&/&KH7802%N#P72P3H.D\/-W%(>F65O6)@!?'%!U
M>-F3D"G%V['Q;D/=('3"_'*K0#5'8\,9;D@<8'0&Y1^$$OX\(BG@WHG8!$C
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M7W7+) A^;^X:)@SK?Q) W>+T/=>$)7J@Q+HUYW90!^X3N2Q.A\5IQ3,\+O1
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MDU=&.ZAT"0B=?NB7^2@>^Z40':,]^"9D=[=XJE:,NOBX[D/=>^=Q06 Y<],
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M7CO""VMOASX(@7=9S0=7(CGWEDB^S*R@ GO/QHJ;M<)>.#D!CC5 Y9[L=_E
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M5Y2X)Q6_K)Z"C!XX;T?=?7RD9/U?(J;XOX?5N0 &,>MQIE-RNT,A<M>JD)B
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MPN[W(,6KNJ(;>ZETHIEJ=QT6&,KO#@@Z']:7>BB6XN[7')58-3S=HE]M7<D
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M>J#(P<8]/E9_&^]Q0._=>!W%(<=.F'=%J5Q2$XS$SN[("RT;OC@G9$O%RQ2
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MT'<P85W&W*;1^3QK\+>8Y[NFB+ B['[<<.J#3^[<>29D2,HWRHE:,M_/ZBJ
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MROFI>S@>.^YIV<Y8UWH&)PZX"Y;H)7Q'W!R5\Y==-+@F9T04(^ 3#3APDE'
MR36)97K%*9[ZH &N%WQ1%FN6Y XY<H<]=463&5\H(*!KX==>RP:QI=^5/W.Q
MY<^"<<IRR^W(%;/5 '#+2%\X)RS?-(8%VZP@'MZ4J[N-RS+7BX650'A%3=/E
MUO1Z"C/,8&Y12MB]'5Q3,LZ..X8OI>J#9G>FF=$!!AI;T!=^46+WWX@%G6+A
M908G2M^,.24-SO+=AI%5+"@T.V]_=!0F^,<%M^%+MR;9F&G9 _/2^62 >ZMO
MN29G(7=>"&Z7TBS09?-A!F@^[X*#++GW>N,%<M3RO=HD''6?US0.!]1@_D@3
M?C@F9:=*W><$A;X<]93J@)-WQQ2,US<(S>YW%.U?(V=RF#;[ZP04,P_+[W84
M5!T!L8E]='KF:,C9%P5V+^KD@WMF+CAG@_HF F[GSX><$IO*7-T0A[KX7SB$
M&=Y/E\:42.^AIV^$]W6-P4BU3@>VIRF@!3@>9;GJ9Y?"(-B4$%@;\NO<IOEK
MOS.B)R==R6#-WIO0#VU'%.P/JZA%G#3XO!(3ANIRY;T%B.$IRTA!<[;6%W<$
MP:\7HB61J:<(.\( PWSC?S7<G(Z<NB5ECZW)]>=T$T"CC'XP5 !NXEV3E/*]
MVZJ :G&?#?X0,UNG>24M? PUW)G;L+SI51=3K=+>@SW<KC)-[[-5-H90UO>E
MW=-4'0SUZ7AB$P'!U\X*#/.>L^JK[G"R@9J@A\5Y^%,-3@]\MT],5@U)]NE=
M%@<.&F/=!0#"%1T/.:8QMV3S>J0:NENRS3-&MC7D,JH)/KVZK.W1C=$0*Q?U
MX\5B.&ZYT0!IG*5>KI+ W\1N"W\E-+OY6(O#,(&9:EXX7S3C/Z^N*C['1SA"
M]4S\78"\T"M>,H3??9 0C\T=?)5(Z7?9(6:97! ;S%GY0+?A^?TG Z7X4FF9
MPW7>2#/?4WR5&3?;HHAF>_KS3 QN_%4D,6)SOL_!4 WSA=[T&A=8G) &P^%.
M=4#9[]U?C229^5^7_"S)T[S2/P%W+@@Z <K$]SOB:!:UY7!)];N?#@E!O 3<
M=]N09MKZOLILLX7GNHB3?5,#SQN\4&+.5XZU=HE=67Q>JHV=-;SLI?=>ZW?2
M!2SO(PPO>%F3EVSYIGWYMRF^Y.WQ^(H*OUN!U[J8.6<3N^'I1]W?-59%QE?9
M 09"];R500ZF5NYI3#YK<N:FS6^=R0%HWO=Q^YI66W=+N:+??N'J+JSNM]4%
M_?47",>XT2M&Q\WR4V3YK5U->"<"]SO"!P=W7CTP"4UX\KTJE-97?-*1AG?V
M@J^^1O@E!Q,KU0&%_71,>=_2"@:I3P@U?&\E,GN,^:P,3*W"R@WOO"=:]DS+
M11#L;ORDQ?;[Z(&?5WQ!,&J873-1)G7I"^Z ,G.=WUR<@Z&JGHD]W"E[HXI2
MU\.DD ^L-4%68X9/INPP1-+O))[LOBZZ(M7Y0$#"OE4OSE#!1!O*$1\S0+?
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M/(%!1HZRFZXA 'P>/92$]\/K'HG?XO- [L\",=UY(>[*[KCFE#5^$GNYY6]
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MTOBK>Z#I<9)62(N$WU0(TP8N<[JY4V3,'/QZTZ:*H:@<M.ND%)_#"+N%<D&
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M_A%TL\JUCR0*T<.T/M$2H_I\(.U-[MV.BQZ0STTK'<@P:U!P.8QZ(EK"[K1
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M@HDWV^?"J'7>'!(6>'D2=85\@0T=_P!)3WY[ZH;($/P<^?1-M(&%W05+DGQ
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MGSQ?R5!M/K.W+GC$7C*5Y)V3=!C.J#J!PW_.G5$PRP/%1]_7YUKV0]_"(O%
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M0L?%E!ML7R4FC1^<*GZIX2,@UPW80/9!7W=ZWCO@A]\9[LJ(NW<<K=BA]\4
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M"U2[[0P0;OS[^%8"S(0RLKE?AU%O3ANWY?: -N\/-QU3,Y?>KE$CH_LY]7K
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MDK0=+HMYTEGPZ51]SZ1C#OXX(,6MPH89>%$M^8Q/P^H3WNS4P*2GGOU/#*2
MB.\\:3Y.P19M\." RP[SW1S<MWD9WJ@9_P (6^^?A,SPPPC7>%B?J8=>X("&
MN'%3]WDRTW=@L3+X2 9[B@Z&3VARFB3VX/2,G+G.$4[ZUY#3J<$ ?$5Z\NZ9
M_P X3=N@^"D_AB_NM[O,^G#N@HU5V_OIHD?RN93>[ZWWE!ZD#=V$#/ZP@G!T
MP^D +^4'Z7D@Q;N/"W9H$QN]Z#0U=>[1!]Z"[" M.F#YMU<742LF]W/D%@;X
M<\<D7=;-P079:YS6;-X_?)<_N=C==4?Y*/05?+[-5-UWO1#6\QC7<,<4C3>&
M5WT0,+AU&6<TY\WKT7.&[^K<JB\('QGV0.R-/N:H!?.]RD]URQ-?B"++72'3
MX04]M^5,EVLN^"!:X:\!.#\4F%R[_:#%O.\C;E1^.+Q?E2-_&2SW7B$#DW<.
MJPNS>Y)[J0TW7N"!/5 S66<:/^!P2 WQAV1.?B5Q3>V_E [+-C)QW)GN^YN'
M/X4@<\H&&"QN[>@L#AVW'X2GP+"FS\NN66:H6J7I<$"&Y\GW@@,/G#I](>[<
M^%BD>:+[Q^$#-'DX987DE!XX*1K?')*6L#B_Y\<$%B>UZA6#H5Y+G!R?].O@
ME9-Q OF@Z&CA+YY%9EJY5P[&:E[J4YB*S]7\--810=@;WEW6%(<5!IJ]?CRE
M?P?CPIQR6SN_M I:^+UW)P(924VA=XO3,A Q8O'I<TI%OZC)8M4#R+?N?W4R
M<7W?!!8?7P7?2(/'K<.BC[J4=P6?K/64+.*"C9^<Z<,$HOA]:)6AESNGE!D7
M?;N@I?*XU<F?>(^$A-WTH@3VYW- Q;Y:[[P6?]=LHI ;\6XU39ON<N<\$%2W
MNU&XW53://2_"!-,L;MR1\M\.R!P,9/K?15AWG/'X46#\W,>8*A:O&6_H@JR
M;$+#UC/?R[#!0!Y],)2\*ON\"-R^$"-=/LW22DZBHTW8E=D+>U]W<D$LA=\E
M9R;VN[7Y4BU-UOSQR0._"&EUMSDGN$C'K\\'*1)\7R5&16WWX08&68Z01#7Q
ME?PB!(?&#KR3>SANK;T".GE<\X/\+"]2 [F_DF)M]RDZ2#_@?%.J#/\ N=]5
MB3]RFF#-WU2M'G+ON0$:U(YS\*A&#[N,()!I]8_"9DR[W80+[;J_)!V6G?XF
MJFQK>5'*1:X7+H[) [+6-1+OV3@[NF:B_"1,?N:'N\;\'7'<@<F_JW02D;^.
M'4YI7UQAR3 ].3^%P0.ZF U%^(I6CSO=ER1+5]8< #@@6N#^MRD4 $[>+XU3
M"]?BN25EKK=Y)KTO) 7;J?*)-;=IFERN^"9\QUN5A ASNY8(=]^[>L<9WSD@
M3K=U04#5-'97\IF@_P"[?I1*!NMT,,QJY$&R4&#&(^;N:I[?B.^Q1)[N#N]+
MY)F.]WD@F[YTSTRFE:X<ET$8<GW+@N4GE;^&""FA(KINI*'A,#\9>;Q4O;TI
M+#[HFNCS6%YH&!N5^4W.=X:I;ORF!OEH@#0OY2CCG><$PL><OA(2[0ROL@1H
M7A&]5-H\C?%5::AXCQ*@69],,;[H+,-\.#[\)R/(^1BN=DN^^=[E47S[(&]Z
M :IOTO"BFS.E;$OA4=TO1!9J6DLJ<U'W?7(IB;F^]ZB6N_00NLH(+%OGP^$
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MP;PPN%R6=*YW#>E99PN[Q0.3Q[:W1;V\JPOXR0:Q^\A]]%-O;.?=F'!!V,-
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MZ]%@*G!T>OGG@D';HZW<2@HRUQG&[HE.]URQ\)!II<BF'*^R @ST?VKG1/\
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M22 R[_%O*);PI;D#7WXY5<B_2_%5)IK-V]]9*@ZX7Q0.#]W@@V>$<H<.54P
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MYWX\O2M7><\7069&&_I>Y!H&\KT"#-'6\.CU)Q>_(9V_M%,_X%(31)L7?0&
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M@8EV%U<@33I2D[S0PWYY7@E:,Q]WH@=U],Y8*?2D*W\(^_,[KN:+]+^=R#,
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M<Z?*=JE.U]4&_EER6'%_(5).-%+[^>>]/[KQX91P059\U3D]+N55(F1RIWN
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M^#UPP*J!.N[G>]2#-8TQAD@#=RRW<4^S&/R^5Y.4P2_*QI.ZJK30#N!QW7)
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M>\*/Y7==R+OKO>]<UZ8JC#5Y?#M2@L[2X/CPS0)^7.O?N1?O=NSW/4FCG?)
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M4MUP2OPBY!=@U?<K\+/RNY*;/UE>"8-7*L7WP<@). PXW\H \KX8K87>L^B
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MW[O%';D",-+RNJ!@U&^NZ/),]_& +K>D98QOZY(NP%]NB!P.V5YG&"!G=O\
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M!N[*/N[@RX:O4S8Z;N27KCHZ^%'(*$XF^24F^WE &ZA8GGP>[XI5!L8:Q<J
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MX[T%?Y>,KM^^2M-Q._Z?F]1<K,LTNKG(#.&6J"5IJ( N\TR#R!?&"+/F>0O
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MIE"_"HR.EZKG8-]+[J_NW85?!  91ZZNEOU2MF>[1[^W)/?2["4>1'#I#E5
MC,*]WWBLV.U;YH!KYB[Y?).1#MQKCV0,SA=Y0X+-"N<Y_.F]2]VOP*[^R;W7
M2] @S1OL4'S^JZ)2T*/Z<X43L^;MZ @TGK<T7YW6"U\<E)]O<^+N,2[1!5_"
MY82W($_1X4P4R*4CTXPK\I@@H^EP-]9)2U&KC;W4T"0-=+XU1==_:"A/GE6F
MGE,RWN=<*12$83!EU199X6-4#$WE)ST6<9]<7^0HM/CC+C3E3%!AK4>8UA>2
M"S^$87CXJJ _(OZ4+MRPNNO! =HV>=N"0-8CLZ,X2?3PG:9^NU\TH9W76"L6
M#%F6DM\/*PAIXKAN3&GU>J'ON7"M=QU4 +4M;NBS!E82NKRZ)@:N&6GA_! 3
MCSNW.Q2'O"';KT3.^-7=/J"1_'+R@H!"_O'2*S8N[DE][G3R@Y^.[!Z8G"X0
MU03:+MVO'C\+,M/L&R_<LT,*\ E9,]UY/[%!TW?GDIF?"#H_/0+>]^Y\.^=Z
M(79P-<:(*:S/.'(+'O=T2WVY0RJB;&#KG*B >WP_!WDVY*-G3?>"P:\C!._#
M&^:"@IOGYZK#G%[[X;E+W96)<**=SNX(.@B[QX*35':C=K-,^Y\$K6G/+K<T
M#L-2I\SLR3%KEI3HH.K/OX5&#<IW+>@<'[@[12/%U?CRBU>3KTP4"USX8/0=
M0IK"''#F@:QXQ$NEP2,M?'/?1%VN^]=T9(-[HZ=Y1=6F"4_-;UT0<_OVMT%@
M<KOP@P%OKD()P;/Q])'T?SG2%YN6TUMT4%3=.E]%,M<(\+X)WX]HX<+FI$7G
MIO0 M7PO),#\)2+\=EA#Y@+*"C3?.;Z/PN#T^S/BWR-T4O<^]./18,U?\Z],
M4%C<Q/NIRE"[FB1NO'PL^>XRP0!_'3=VX/409/[RCSX<$Q-NN2(=.I[W- "+
MW](I#]98WFF(C\_5Y('G(U=?+@K <&EO0:8WOE?)RYRUD<)\\)J[+2LQ&0($
M;E?VB_.%Q-NQ0Y5KSUT69/?7FLA_?>2P:E$WI8*7VU@ZY8[I42/OE/)46]V.
MD+X46+4M^'//HH@SL:WN6!WRJK-MPJ"ZWTEP\IR;Y1[5$JJ1O=31(_APO)*J
MKB_N[6Y9H/\ /?BHC?WWUS^D?==/B\5D58,OF]-ZS8ZF^'PI,M:W#HG]VO9
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MCOM\-R)%YOYVY'VV,?JWH.ZW?A S-][.Y$WQFZ\DAOR#U19:G9.00*^[H2J
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MSIP\(#OO*W;D0U35V.%[U+WTMV%R1]U=V<$%/=GTONE#>>_"\*34FCQTW/\
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MA>ZG1!<-2[X[^*9KIITO)2/QR>IEO<(7=58@=C!4MHRI,MZTNB);E.'*Z^%
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MY\';U05ENP>]VCE$'''C+#3LC[J1GT\(+/= ?-S6!EXR=66BD6KR?909:K+
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MN"#K]V&CJ_*ILVA&=-7KD9;[1RRODK,M9 <^.:"S;64(Z.SN2FTS.SI"QR3
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M"Z\]+JN9G>.YFJ#:<\^'"J"AS/UO4AICN=P=]K$\L?&Y^&B5D2Z8=D%0U>]
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MF->4+YO4VV8PW:X:?:+L]]Z6$'2S+<[A(9J;8TGJALVK/GM+BCM&K=G,:>4
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M,W25#[G>'I@::PO*20'-UV[!$&[$[FH']W3 C)Z1UX6:I2:UCC+2^:<-6Z_
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M<G#Z\]%#^2_*7WW=A2)NDG!!4-'$W&;X?:J#>/U]+E&(NEE6]V&3LONM7H+
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M*31OI+[Q2L;O&?#DMSG%^&0Z?= N&*YVC;XZ7\H@]_O+HLT'OC,Y3F^W4*Q
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M=IX4%P<N-THL!WZ1\8J):^+[\$PVE*&/WD)H"UOX!U]$P;[<Y<9<H(/W\9)
M-8'=P04+6MWH@>MC2*ERMRWON5ZNGF@H".G&^"#37W?/DD]](Z(<8Z9/<@4'
M"^G%._*9PHL+ON@2+KAWW("&LG](8.@F9-^!I+-39":]#"'R4%(8QUJ[CN4V
MKW0KRIFA[^+Z7EY2MM7=%8D.R;.-RXJK#<GTB%R!J<57W8/I\RNJ@LTUG*KJ
M>4AX$9W&WI09?;EAPC*MV\*W&#,\OJRG[CG\HCA'GE2\TP'.[*3-P@'2?3ZP
M42^8I&%\%T>X>(\[Z)6G0?QO%03#5B\Y:+,M;IRO+>IM3@_33,4X)F#U?"B"
MGNYRPO#) ^,+WIFOJ^4)J!\\>[D%&=_F*=I2?E>%U<G]U]^%4 #5[L57WWUP
M=*!I)(;QO1)V^GYH+/SW7"0<B3NN_"07PAX1(YX4RQ0/_)E,Y[OJBQ/B<.&4
MRD]KH8@7AS>F IK?E N'W\7!/[->6_CR2 77GHJLGE=ODK$V"M,?-T4W73C2
M)706Q>BY&SYS^')(;3F@#G=RDD]W2]<>R(LFZ^)(+/'C%U\40<<\M%,_67?<
ML&IUOAF]05+7'ZSN*UP^Z9YJ):N4#\HAJQ<"@9]T6(X4O$)0:O[:&ZI3WXE
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ML.@&?<O@%BUUXV%%EJQ/?CA;EB:/NBDP*>^G>ZR3L-]ESLL]I:?%O5W8.N_
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MB+N<:)'\G3A>2R*C#<^GC%,_EQ^%/&^3D";\H+AK/E?!*^NLN7#!1#?PG?\
M!W7J@++7"^\L'*H;Z0E.4^JY2UVXWP1?WN-Q0=H/:?6^J3^2.\V,%#W4E<=,
M8U4VF\3?:R@ZCM-^?RE#>3L1EF=%+W?*#5WB=7(*EI]>-;P<D!PRL+!I]NO=
MN2D1>#&=ZJW%!VRICAJL!TM[OI9DX?&CLG)6^KWRN.^,U!3W7X2DT?KN\\E!
M\I3?,WJB#QZ<T%09/OZ^47VZ?G@E]W;&[<HDSJX7JK$#J#5ZSGI/DL#G"_O<
MH,DUW=/G).")5IUJH':'FQXHLRSH_P"'/WY[TS_(SC9U2^]WQI?V@+L7G$"7
M#+Y>D)'C59IK.M+NBBTUOO (']^A'QDJLMYZ72JY","[CTS5V=+[WF@J_D_Z
MR(6?2&>$?*1GC>[Z3M'XA/XIHK<+[N5RO@$[+4^7W&?THM-=W]N'3)*RU]='
M!0=!:^3Y4SM+@X<9V$HOA)V?!(1,N?I\]:+I%8=\\W8K/\8I =V]],/)P1%P
MZZF"EY@=#+5BFNF2QTD_5_2XI&2CVN%\%D9V!W97R4GW\S@K/>_S=R4FNTNN
M_)+AV6OCOOLE/< ]SKBN9]WS"<-W?TH,T;IG]R<FV;7#=A3 *+1X2Q<^[<46
M6MY^G\U;B_N^_"E[\WU#K>L3QOM<E/3Z6YF-GAVBWN\?&Z;DGN\7K-9\'6?O
MFD:'.A(=]*S-HZQ=C:4U$\IJH;WK@!SB][J*P-DWNZKG([ >+SESZJI:MT N
M'WX7"_M=6S:O.^:@Z]CM,_%^(KMVAA<+N"\8PU*^JZ2V^5?&&[<@FR,.0O[7
M8Q3JY<C#$+O5=+%PN=R0,UZ=\9?<LBBSLQA>&ZPF.TZS.[CHA[Z<*7RY(!M-
MG" TW]PO&M^FB^]U(KS0OMO2$"-.</CN@\./3XWU?E1'_3WN7DBSXEQ>N8_7
MT=UP03'ISA"[+HU6.P=CC*\-<EUL-6_6(Q0:V@0>)VFS<[5_4.@ER,QA"_M=
M[>SAP?QI>JY6MF= ^^PC1!-@/NXW)=0V/@?=O6V+-X?*\LPR*X7Q.*#P.T!'
MU;E%]^>W!><VVR!?!]^5XT["3L8X((%N=TPQZR3!L8/=/IT5_P#3ZR.%;@E_
MT^6^%QWH(AN[A-RY]HW>?=V*LULB.?2\7KGVNR+KP[Y<$!V;6>72^:K[9UZ.
M[+E9V9PC?T%=EDF=_*!PQSCYE--Y%99'$HEEW"L^5E0&TO+%\OM!6\[R28X:
M4EK'!."<L2D;;OXRX("_?E-\*WD%-H<KO%*&[PKS1)EE>Y!,F5\XW%*-]R#O
M*MCNL/E!*T,#7X/QH@HQGC/=,]#@F=>2#)SO//%%HV_&Z:(%'/XN!JBTU>5U
MP<IMM@5N//DO$>I]>XN%G#HK$#RY:GXK;[@F9.DKO@O"['U!,SP^-."[66I5
MUDH.UK:#$;MW3Y*7^41<[C5\-ZY"+[WT46B18B[GD]!Y4-=N;^B;W>:6[JO&
M;/;4)X[NJZOY12Q=$%2?(/7=3E!%TSTPP7,SMWEP)<_*^V*Z0T+CCGN0'VRA
M'%_>N')"7USOFJ\\OE3)O(W#<@ RCPST0?UI'"^86/>OQS\*9. W\)7)!4#X
MXS^E-JIX>$ W?W?$(/J[Q'#N$!#5BXX'FF9;O?I)2:--^F3_ *?5!D3Q1'4-
MKROBY*=KE*/E1 SRRA<46F<8:(J[#4\<..[-8M8;Z7!<[[&0OHA[]_7?31!T
M9\/.[@D)RP^Q<$H;EG#7">:5^^L,H<4%0UE2_C%$-<AI]!<Y':GFN"=G",X^
M?BBL52"&K=QO<B/!@L!<OE9IH;])B?G>FT(#N^^BFTWG.SP6.>Z["S(UN/WX
M4&9:+\:UG%5]V;_@*3K-.%XIP8;@,@'0\:HDS:W@JR<Y1^[WH>ZD.O,V42<@
MZOSS42?@(KJ8/*-^(IS5V5::;U -<QOWWJG#5'^8_")!@.$X=[DF[ <#IO42
M=]]$'[L\,.<]R*H1/"'SP1]SJ"5WPHH^_=VXOXU3$Y\Y7YHC,7SOL!IL3?IF
M+WX)#M-<(\CHIM&ZG<B!C2F/W8%"G9,[^DS5V(0Q4F326#W=*[U8M6_A\H7V
M)AF5ONO!78$X1RRE.Z(,M>>:7W".N'V]&*^8,3]\]^5A*6J=)\>WA#W7=:8+
M"D*8W<$:IF^X#=WE!8<+Z1X9)I9NE+"P@6KTYHTHR*W3@L#A8?RO=,-WWW*;
M1XX#1SLWH+%KXI"W+ W8WJ+\=\[W5A@F9S/G&%O07!RJ;^%(MB\YC$V,4&F[
MD,GG'@N=_&['E!1INIJ*PA&SC1,QG*&=WBE9[#EXCHJ##YO26",ZV=E;JG)M
MW>,%)VHY7U&B5HN@#F,!QLR1HSYW?TB;^\150]_WG47Q1!OZ0'W<GWG;D[+=
M>%+\U4B<;L"* :F^\+D4'5[^GU6620&=:[WTP4YPW7<TS+;I?=Z2HB+^WA!W
M2'?D@[S?2*F6KI&-T0#=Z\[BBF:-](J9._'"YV42>-WC@E]O*E$&9Y"=C#%8
MF=P?CFB-VMV\8(LY3ZH!LSA''J)XE6(Q%.5P2,Y8K--0\]_/"K@9_.QHY*#;
MX\H.Q4?=/XMWE2.T, -UO=+&."),]3L+6_<B&N,;\8+A#1N^79=;!+CTNG1"
M)/[I8N^H=\<D0>72Z:J+1CO^\H=$"W+E3XMZ*M[L#E?TE+6@XW%*^_&#SYDF
MOAX^D #66[YISS5 WKPOPH@7@E]T.[SPQ?R06)[0,N5+BF]WQ'-^0[KE$[U^
M.B-NO/'>@L6K=OZX:(,QRYWD)32'Z%\%F3R&3KN:"A-\7]D63=3@Y2)SA/AC
MX2LFDXRJ9<HE!<"/,;K=D$6MXKX\Y)63.Q?P@TU+P._62  ^=-.<U0$3[X0O
MPD]PZSN(2%O=*4^R!SQ MYA+!9@WK<%,GK?/FL&M\<\+W(.DWANS?;D66N-\
M]% ]>MXK,F]U.[D%"<XI7WHD:;F<%/\ DR*)3-UFCTA+-(6^EQLR4VVSENSK
MYX+G]QA"W7Y5L:V=G46[\C3EN5MF*&KI=5S,L]>(SA].6]Q$KUTPFH3U9.QN
M4-+X[US^V??L)*?OG;\\AHJLFS<?I6\<&=C T@+$4O\ +ARA=<7K$X<>'-3'
M<E_>X8JU;5ICKNL36N&HS@X*9.67GK+-.^$S&#^QSR4VFL3PQCRSHY92O88?
M9OIB@3OAE<%(G-\[ =+PI^_E&[F]4B9RX;WD& ^0A?PF:J;^U'9%SKRY6%FV
MK>H1.?P,;=TN"QX7FN<-T^IR=R*H&Z9.YJQ+9RS>5UX)0S5SKX[D2U=Y1[(L
MG? _"@<"^WR@_#NE.O6G3I59HNS=G8XH* _9ATO<E)TW7R4FF[B]SL/E3]SN
M7G@_%"%C<[?;E@/$,.K\P@R9Z#?=P2M7\7!R!P>M,NZ+(^KL*8O<Z9Q1:.F-
MU0.;I0 >%5CA<KK!0]T+RWK#:7)QG>:#H]V&6)D%%K3%[^D+JE!EOB_MJD:[
M=+P0$-;\L[DL6CCNF7KF:.L=SCGIU3;,WIEED@Z&164H'M@L6NQMU7^4K;7C
MC=9*)/#E2=;<@Z#M!.[SCBI_R<'AVE^5 6#=XJ@ R=Q07)R$+$5/^2;Z_4[>
M$/?+FI#7A*[P0=#+6 &59TOHF+YP=S%82O<I@2=UQW/T=T5R87?SS!/?@1=-
M2L_!U([["Y6JQD_(:[H=$S)E$N'"^Z#L]TKMV]Z!;O+KQK*"A_+C8OBL6K[Y
M'D$%2W8OJE#?UYZYJ!;P@<W1-[EF8QB[O<NDT'4#=,((G#GH*=+<H@RA>](W
MM*"49WOSX(+!KX[FXI?<^Q' 5"@T>-W]H,G/M?=!9O>^]R79"0U.[HL_*4G8
M7O W)>;L(?>G&"L#H:YSE&/UD5(-.PF^6%Q3!JWSXW12VC,SPOI#FM5[14-:
M3G=[DK?3Q,9Y5DE8[7>"QO0468D"6\/?=X)F&\^3KW)"-W40O2(6 D_O>Z"Z
MS:19NX=^6F:5_P /MZ0M.Y=,"I^Z.^'*YYI.RW.0[61!YR^865SD]M[^1>M[
MX4A\52LG-]7WPT7/5% W?2->"Q-]>?PI@N+XY>.$TQ:SO*O=6FGC ++.7"O:
M5%60A _!LJ3\%)LGJ8:.E&!4MMZATDB>'(8C+FE]U_-XKF+7(=K>$^S:QGRO
M&PLBN6F=>"NP<<YW\O4@=2.%YI/?J[OC?E!XG\VR7%IEYA2[*]2]#[BV&P\'
MA(UUXKZ TYIX:#P^5:WJH,^D8?[F1G 2O1:IF!U^G:> ]T(O5&FAJ+Z2JN:$
M@(=7YTZ)FC*<KL+(Q)IUG=S1]SIW=N2#KX1:NK^DD#EN$KUPY)A(T,L<OH*+
MK!\JK0IA8&M(H)EH\!ROL];9FMCE%*U1U[\4&CQQOZ0.R9DYX'3B;>E:;Q\(
MOP@H/RRKASC*BU3$#LV;5*WP5O:^<;OEDN398G7SRY@+H9VHXR^0."<;QF&:
MA6H=3'IU7.6[/<Z2\H;9JFYTA8Y!0;-.4CXCT4'0RW4FG60'7HJEL<OMP'10
M=)R5JF%W3)0.2'PQ"NZ%[OM<3,(G6=^#N73_ "5CNP=#P@!9RMT;&B;9NRI#
MB*5?J9K%F$?%_"0M.A]&[<@+;=Z/&CE!\GXY4KX.Y5&) I8^5-\0Z'#I@@J#
MCAO@<:;IJ;>3J[XX)B*_;_&,$&C2L=-V]!F=K3A'Q!T]RZ1XD^[#EQLC?1T1
MI?)6#7G7C80= :G#& O<5SAI[R<L+T4FCAF[QWRXK,;HX]+AJ@J=\1N?;GJK
M!TX4SUD5,&76^&?% ^!3I72J#IVA#B!'+#=JN8,W/086))BV[N^8[I07/?E?
M0H'<>UY!*F,=)QAQYYI4+/)DFW7#! -;A6NYWA%L?7UABI!JE/$N&:"K_'@Z
MA5?IG<W/'=0!ED.-U5":RBX!U[T!]TU$-?73Y1?33X?X,$KK='.Z!!3W?/1,
M6[Y6Y)E?>.N:1JE@Z(.IEJX+J89F<HQ[] O&AIV[E2_A=#&V=EA=>N"#JVO7
M1U\UPLF,8.O?N5FMJ_?2;OI<[];&-Z005V@M\M%SM'/H;\H-;3##H(NORE!^
M(N^L$0P/QO$GW%59-=_'HN;W1[0Z)@WA6YY52%5+6.GUKP2%F).?2%Y*?NDZ
MM]$6=H+ZOIKE@K,]8LZ\Y0RR/9,TW0WAPQ4"W?UJB#N=<<;Q4L"USOD[KBE%
MNE\ZK>"^BIG.[Y(%%>GSVDB^,>MW$I2,KAAU2$\G/PE!_;<@Z6FJ.WWR=R0?
MPOEW42?&'PF#0X6>=4#'XC#A<4GN[/SNN*9JLN-?K)2)$18?9W( 2;GI>:9[
MG/%SCN1!IEUETMR-ZW5 H:S#G7JARC]7H5)K*6+I5E0R^E@9OI*ZYK=.?,"S
M^5N^YH-'3/3M<US^YV^^=>@5 7Q QG<5F8L,)U=N,KC@JG:4IA*>.KIJ)%*Z
M=DN_QA>>"7R'0,>DWWR>HM82Y?>&LT[#6'FGVY9MD&5\.;E K.TX7.^BN"^6
M\TO'&:Y_9E\G1 -.AA#*\4'01EUW75)DZG6C^9*WNNZ=(A(U%\? T2X;Q>L]
M%GF&#]V:HR,;L1C*:QPK.*#G(IXD^W*C[O1W%*T+$7^." -+L'<@=FZ1O=).
M2HF^/'5/<!SX2Y*W2Y\-3X,Y]D"UKI"PD?76G761=6*WNQY.W=(/2%$-Z7CS
M3!J40_7@H;N3T _C@3/SFM35<5)N^+U0-7)<X,K>G9E=WDLRB[Y\Y=TI,8]I
MW\)17002%L>"-,>2BF]N4JWBL"[*GG&Z)66^\)QSIX1<*;[[;T28*(S$L=9_
M&*9G&WQ#O'1)+?I>B9^&5,>TU8MO51^^NENH@+OPL6MSN(PU" ,G98=-VY:O
M8$RSTOEN5&6L7R?2SK!2]TC<H7HA[J]Y'/ME)9D$XWFA[ISWXU@A[J7H[GQ1
M.+OD]S508&6[(O\ OBL^<\NL8<I9J;JW"GE%EOZA/O<$N*,8X7TYSDKEO!]X
M=5SAK=?1&^@2)%/?]0Z8#J@_B]WSO6=\/N]$C5STW+4U7#@S^..Z@4VAEIX^
M]%GNBX3U=3IN[ MTPO?&M I(PN.-NR."(/UNDMRGH@1+?=ZIM+JENZ^+?)$&
MWT(TMZB3<K?0(L-<_%[E Q/;[I-8-2%\_J=%FC\\+>I_R2EGX^50Q:O7/KR5
MF-IC"4W/N"YW6)7T0$*5E>%R3QN.\M0+\KG]+E:.XPCOZ9I2>%,?B\%)EN-V
M^PH.@#2&&ZW?:(:G;KR@D9;N7SQ@MOKU'=6)2),W\Y5MZC[N/:LQPQI!8M5-
M>7'*BFT>=?'A)E70&\8],KT3-D93O*]'\K-D2AK]'@B#=]/*@HZ<)3=SC7+@
MCRP?"\\2L*NO.3^RF6Z.KF_=XZ*S%@^T,[Y75ZS+6DZ)0UOW2S&2)%91TIR4
M% U>#L/"H&KN?A2%:Z3RC+3."S;3MS^G-!4M=ISE>Y -[KUZ+E:;G>$KR2,M
M_(Y<OM6!W?3D[/#ARO%<K#7"FN?-7?I]7FH"1DE?]7CDGR?=\U(F7&)N/T@9
M^7>[,4&=>T[[*8:^' QUP18/W73QP5B!;W3AE>0G@@6\*X6X6%$M\N G15%.
M<KU28"LM4,;Z9)GW*\TK.#L+C>*)ZX9GD% X.J8G=;]9*9.[)[[%.:WO\?6Z
MG&2 O/3Y\04_/%8M:2LW@D+6<3A#.JL5"G8SW+,M>7WC52]_:[DF!N,-,](*
M"QIQ+[O@E O*^*U@NO/NLSUG7ZIQR*!LM+K-,Z[\+ 87K>2!-W<$ ==\<LTI
M/3'E<TWOG+""D2^YN^NR ON\/E-[KIS<^4,%%G>.KX0N%%5TWX7?!!A\XTJL
MT,']W7N6)&=WN<C[N$(Y(%!L\;SBF]V.3OFXI&C8Y@8XOU<L+=I*5E!5EK.Y
M3RYIF5RG?UG?&"HRU2X1A%R(J;\W$+>Z4?F/P[@ARNIEFY0+6N,/%!T15^LL
M*/2/G#ET41M,]'<LOE9K:7,B#JH+!KN;U6-W711 W=I5IHJ^[?AYX52)!]V?
M#7B@=I<,$#?:\5,'?J>.3L](*S(N-I>%S6+4!=?G<D9 US\IA07O4&OB8"LN
M:(%W+HD?*X=+%$S)O"\=7(&=]4?EJB#=[SFI%N[YD<$ U?Q3-!;W<O-V$ WW
MAE@[NH--7VSN@08.,?.M\$'5OO!UX50 [97VDIAK3KD.&]\'(^Z_OI@@()%C
M=]JI$L8^-X4?=+7*]*)P;OC":!6N0L?'RB+OBF:OYC>]2)C0877Q!6:A5_RY
MU).W"XK Y7A012C._EUP1>*1??"ZJ!GWB,M_- M7IKPR4SCEWAHD]U^:6-4%
M#NCC"*F_7C"RF]W3E13-SGTC]H+,M8&W4-O2EK#=EIXDH"^@5 <>T<M_3- P
M,;.X>:],_AXE\C13+<8[^WWN6?A56)S%V3'P:_7"*9IVF/>>&Y2#=X$7Q1]\
M_N]=ZW-8<8^.J5]P'U82^[Z1]WF\[FN=P0VJALPZW)<W-W-^%Y)F:=W7'E@@
MZ6=I%]WG)>7V,0'BD<?C62\"<<XWAPT7D?2[6F-PXH/+,C4:SG1,U?99DUN"
M8Q^C'H4',T?.Z\."%X<Z@JGP@V=*AU!NJ@4;;$96$[&TOXZKD:#KI.N'-(-I
M/*_NNY!W-;6@G8A;TC+C>/367!<#6U)K7":MLC>$(:WB@[G.R#N'RN/:&@\2
MFJM-91\=%RM%\[ACUU07V>T$C=_"J2+DN,#CC<[@D]_#I?T@ZW.L3U\)OY'7
M=N0V)>_Q)U\=$Y&ZX?$T"L;7$7=N5B!]<HUZ@/7,1ATZ7BM\:RX1Y(.ID"D[
ME>B#0RUO'/PEV9R3-Y7>&""?M%]NG-1.QI\?'"2N&A82--\9Y(.;^+<Y_4&%
MQ."KLV/$+O<E#?:\O*NS\!UNX]D$FV!)P[[EXUO9QX+RQ.4+Z"M%P;28ACO=
MB@?9;#B:>,@DVOIGZW>^";9[=SG+H8V@,[A5!XP^G(Z1O=FH_P 5)/SXKS[8
M&)':N_)<.T8PY2RO')!RL;.A?XL4P4]IL_#H65U@SRA=,_I:>_')T'S&*#E]
MF+Z72/->+]7MB("';CIJO8&V8'<^L'6(+U[UFQ]T.,[W(/7-KZUHO ::&D[I
M-!C9--9E[WRNNFB]AV/XQDQ]O(3H1FN]CTH$A#GK>:)Y/&^EV! E9[5WKR(P
M=NONN[9;(5%.O5.WL;^LD5QC!QK>3K>L=F*C3K?RNUG87?)3:8OK=$'B-ML;
ME;^SER>V@W_"\_\ PZP$.D'2[<USM;&KLI7R0<&Q8,,P^8=>L7KR @,,/+OH
MBBD&74YXWGU5@P_//.7UP0,R9/OXRWK-"KCVR(PCQ2 &F<)C?*YK%JF_A>YV
M*)(DT<Y2)Y83NKA0S1VIZO\ KRO'M;4O) [V>2U;9UJ\@[<,J)WZ?.,.JXF?
M58B.6=ZIV=L(9_')9F$ATM7*&.7VE)NNNJDUM!&6E*.NHHE8;>Z%W5%6V9E2
M,-YPQFJ>[X'6A6[/?VT>IV+P0%IJ8[8]7),=!YO')'EEEQ=%3:-]K@=$ +5W
M]*FSPGWS=#3[7*^._@,0NED8#GY1%B><!H_IUD%C7ZAV* QG#I&-T@@3<QOX
M]D4?=N\75$GE(8;KR4OY>5]4??K=_"#-'%W'APRH@R9/AJ[2?353:,7GP>%(
MU3ANG8=33IJ@9^LMW+?JG9O@ID[M/E*_C+3/.WHDQ=9KZXT4GYWA\H%O.6KI
M;DOO\<JHJP.$.':0R3,G*QU^E/9M##@F)W8.T[21#AK=?RC_ "77([NDE%C.
MX/&F*#6GS%U_*$2;WSO*GTF9."YWW5P[)F3NRH+@BK/YWJ]9_;)XP2OOKIH-
M4"7>)HQ5E:1:TY3O@B&KNX)"UXO5*^[>B36M[Y0TRS2^['X@7/4PUE=W1 -1
M\/Z(D1=4-RA?@(_R<ZNN^"CR\YX)'XR=K\Z(N'O='NIENP=<4ONWNGKXT@H
M_/=]N<^JJS;H1PSX<T6+[.W,Q/UWQUI1,#?V$#I(W""P-W3.NY6+;UF9ZCOP
MY^+P2^^E;ODEO'*W*1-SD_O'-1*JK2N^?D7\X(.T&#G5N-:KG9,1;[<]=#-F
M^#Z1*+M@<WNN\Y*K)E&B0\KI@E+>3M/NK]ZMTIC?SW*MM:TY!W3RHDTN]-:K
M-:7A-3==+<9J-J$YY92N4$PINX[IPZ2>I\QQ\4Z(EK"'/C>B)$9S*HIWNS-+
M[G=*8PA**E_)>-X5I59IKS>7="ZWNN?R@R=:.P\KF]UUSXJK#65*<T5<Z2GI
MECGP4?=">,KQ3$_6#W9_20F])WHC-\[*,M[^'+'?)$FHRNX')0O>_E]T3>^=
MB6.B+$K@X\,>O!)[N>3KL) ;NF"0M<+</CFBNH'F;Q6:.EX=PN1G:1S.Y7+4
M)1P.-!U?P+D">[EEWU0&&6FX>3-*7/N3JZ)2<;%\ @KPN^^"HRU(.?$Y"73+
MDN4M987>2=EOOUZV%<DW\^"S36[25]<D;(@I$W"(^$ONW4U458&]_)9EJZ<.
MN"YPW*7FIM[W(LFN!)T@_+Z0=1/<0GA3!1#6[=>$%@?H/YE$U?<K=! VZ\.U
M$-(UL\DA[\.&'1,.ISZ8YS0'W7=A;W=1ONJ!,^KH4OBH^_=2KI]Y(+>ZCM1"
M))GV1Y#&^M9)1R%S[<D2=-/.?A [+7;3XWH%J?QNX*#KF_71!K+._F8JB6.&
MXUX7\JH.?7@N9DY7*Z8*C^%[[**H+ROBG8^[-N4F^L)(!O!UP0=9/T)9EQOD
MI'K8*7W7VQQ[I"<(5RY]%90"U2.N$;Z)@UNC#YKNU4O?RGO@[>LR<L<8D89*
M'/XBVUI"0QRW)!=R\H--UEEXH/M!AJF4//CRM6V<PQ;BZ&6NZQ/#I<=<U$U<
M^4(]KHB,QA65X+,MS)VFA@-_F*H&K=.].2YFL'?&[NL)<A$G#>C$1GFLTU@]
M]]:( 9.EE<.R1EKM+@._E5 X=NSN*'"-_D+3<_B]:S6!MUX>4I8QIAI/Z@J
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M!$AT[P2'"_K%;G*+<_F*!K$W>*9FO-W.\,5S/X.[A58,1PN]5F9N*''Y-\D
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MY\T0.TUK3KTZYKG:;/SC]I_=]76PDOP@5A[XPTMYW\5U"F=CZP2[/J_2_"Z
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MGVN#^1W>F+[JGV6WXXR\RH@\LR>[A?')<WJ!2-]_&BS.VS%YYI&FP7O$ [&
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MQ>Y)%F]HY[H;^3L#R7$SZAY@3N/?Z#ES[5LFL*2CJ[FCLV71G&,.%X(/-,,
MA[L[MRCM@(WAKGU2L;6#OGK/M)1VC3GE\7WT&B1L'$WLGF+A<+Q77L]B(0W\
MW>8.X)!MQ"3QS/6\DXV^[*$\I=>*J7)M&1+ESY?*Y6-@_P"S?)5>3OC8IFN_
M9L.#]>E+Z(KD_P!+",A&_C)<^TV>':&?E=FVVKH3BZE5Q!N-_?T@E_$3+/PN
MAC9D"[N#EV;,C0P?AY6;;$NT1IG80>&V[1%-PX.[N,^O*'YOE!>;.P?2,[Z4
MW)MGZ<"@RO+[0>*V6P:G%=30<'UI8SYKR30 <[2EQZR@N';MON2);?Y([-LE
MV.%;ZO70X_!Y3DZ,5'8NYZN%X4)7EF& 0!#DZ=D=D2;;^9>(;VDH/YY8_2S.
MUR?H?A>0VOI ^Q>.$TA].X3Y<\4NU9RC:"#M^^[@C[A?GJA_%< !\*S.RI 2
M==YA'.*>*);BZ0EG>D%5EJEZ7W0:V,RZ+C2>EZ+F;!^"Z&'.GE&W02)/XX4?
M\22D^790N Y.7 =J<[[9/T2G::SWOUPLP1BJ+YN_W<K"L=INC,'&G->&&T-"
M;J<2]='\Q#L:PT\=LD*HV;N=[M]UX7]K"HMU*[\5Q?ZJB/\ JI/=.N[#EX1G
M5ZG:&J<[XU[HOO/K ;JKC_G&#M ],SM@;?+#3Z1;9Y1;M6!PAC7+>.Z(;I#?
M*["YRV*8Z:><,TV%QQE!"F;7RE<M5MV712-AU$";,_C+)*^;G>=/!1=<[^XG
MQY22-;6;KA;^<$",A\J89G'D,][KFB:TR(.[*OBX%69\.GRNBYS04W)V&N<K
M\[I(W>T9JOI>_P"-\0NE@]/BWZ%<Q9E'#X^>*Q:<Z,Y"LZOZ9I=RE1IIV6;I
M<U(DT^9RTC)(6^U#PDC@[B,%JJ<VZ8R[1]U!UK348<%4'",,G^<8!<[\%5DU
MZC" I>:R51LL9JW>>4*9*!-;OPJDXCSCV@I/A)V PK+,7 (DQEY) UINF[DY
M49;O./7&50D]N<[K3'"2>7.(E<^R),Y=9_?=Z[T_OH+R@HG>';INCJ^XIV,[
MA+3'<A$[-C?RFSQ@C_).=(&^BFT+CA-_1(1?#BK?<ZWA?WWUO)Z+ P^@;^US
MAJ;CC&;QO"Z&36Y&>7THS,7GJ7?CC<^;E!LCG"@O5 MTN3\U$M[Y_>['@B13
M;N,3CIU=KT>$??X4WG3E;R4>],(.1JJ<A+=SN@X+%KX^NU2E.O;&W30.7&9A
MUU0C*T*@;W\>:J^<+NW+G!UWN+O#XA;W7#IUFB_ [1SA6-+$\5-^;K?E,XI2
MW/C\8H#::9B_F,)*Q)$B^/&\_E -6[I*^"Q.Z,):6$S+&ERZ/Q2)XK=@UHY8
M_6^Y52MEW33/)(&]\+N."19B-LY3^3L8A&,M]_:5MK"\]WA1#=)8N6.TQ+\M
M5);5::POK> 0#4+=*Y]%(-:0+I?'3Y3/P>.71].JM/6"_4.'R@6KR<_6:B6O
MA]W%*^F;W#F=W=)9F+N@-/?S/WCC1.6U-[N\/N':E4AVNZX].*0L3Y*/X<^.
M2<<H6*8+F]]Y9T<F&TZCM?A+D2NW">_-VOV$66[ETX+F;VGP[3/HF8VF==U\
MD6ZC;=_64TF/<SPS^4&VL.W6-P4V1.<^&#GO<HEW4RU#+XX\M0D::,!-^ZMX
MI'WUO>D+6X<7YZ<U;[E.S&I,'YZ!4!DZ\;=V4&3K.%+C5'WZT^:\UJN1V>^5
MUO6B7:'C!TZ.CS7%_)@Z[U<K#:2\Y65@,R+A3&\TNT-,;Z;]RDTU=\."F\G[
M?ON*"K!GK._A6:VG3=]8KFV;.[#+5^<E5HUN$S876+<\>?F@-&F-9'ZS1#7W
M&]2I%K3APUMR=F>_2Z:JREMJWNSXYNGVQ2D8SCPG>CE-IHR'U1V$'<TV,*7?
M92N6KJAJW_:1O:T\7X7.VW\7>Y2$[RW:;UR1TL-/T%Z?2;W\1G=7/$TNS/@N
MQR-P@BV1H;Y<T55G:S!^ ^Y(O+\'P!SO.$7+E9-=,*3E1T3@J,MZ/UCIIT1+
MNL-2WQ[H':?4<[<5R--WA?-*&MS[Y:HKL#3ZW<GHM,XZ_-Z*#+6^#]7?!XI]
MIM*'K;T$_=G73XN* VN;[[8;U-[[F$S.O1W2.[1!5B>GS>>JS36["?1(PU?G
M'LIMM<^.]4!N@@/B<=>:ML6'1.MTBI;)BZ8[U<-X=D@,TSRPMRDT><980%\
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M(.3KGB2[=HK,D>+JL),]63POJP:1NZQ5?QP,'SX<17-U5Y%O9OI/&Y8*VQ8
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M*6V.$>K/SFK,>IZ<L^.7%2:].!3/GIAY5=GL *R@^W941=6%6=MB!K'!4_E
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M>*D/CU<BTTSCHZ<I;I("12S\9K Z<<G"]\U/^01CND[?3HBZ4M!AA<T%R=<
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MOW5:BKL"@RN]Z;W9U.#G0A=4'2NW_(2NE0QAEVGY4JVBK_CSCNW)A@)7+>H
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M$XZX+,; 2XWSR<[!&+6GMR>.C#/'A<A!4CP)&<G[XQ7E&/3@:]:RP"GM=@^
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M6EF*8>0=E#2%S^UO;8O?BN0>IIX,<Z)O]1R@;[\9*Z\K$1P7]HD+N2! AP=
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MFWPN-C@IABEGGIT3,@5A-SWC!&9C.QV=FZP["1Y.@N7:-'[H71NBHWMG#I'
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M.KJ+QGI_3W5]^,%?U3#A OA">@L*14DP[3MP7#IUA;UCKA6-;Y+PNR!?OG.
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M><8J]OAB^\5Q,;9G$<8V.27:>J&(W?=."MVXBV>S=^*[0C@(2Z\"E+,<(;G
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M+KPJ;[)K2+?S'&[DY8;=K$SQTZTW+!H5&4G/.=8<53W# <?%.;W+6M(DSM3
MOO45,CDL-LT:OSO1RI[Q/N,=%AM!B,<+D[&;\5?6=22F6SCA3'E2<MRFTT<>
M&'08B*Z_Y X2W'C>\52!L<;=#NMQ5/#GP-6'$SM3IC"573ZKNV6W-3]9<N+T
MC1&6'R<K*D6AE/'6$,Y+6M/$B+.\^L=65;L.46O7'&F9UA>"X&FYSA0PH(_*
M4'/XA2N&JSK*\G_K,_K4<E':>L+H<>D'PS(7(-H*W?5'W@P.7%QF_)8UI'CM
MKZHO\3\/"Z_2^J:\=#OY8)6V&3"C\':<?"KLF@' .I4;L,EJ*\N=X\BSMS _
M<<_,$IVIT["D9?:?9M@NX;^GE.V!>6-N6=>>ZXYSM3&FFXY3JE_E.%NT^I(M
MM#(OTCD==T'+FVFV NW&45N)'3_.<)_.^Y)&O4'3+XMP7&?4BW![ZE_2BFUM
MA?,8Y\TUK<<QV,^L/>-<S;E7_69[_DW1>(&U%SPK>*8;893[89!9FOJGO'E?
M]<167+=GJD;]:81X%_)>*;VH\2PL)#M ;$(YTQP,5J*M_P QWG\@<3+&FLDC
M7YB@WW3SR\-MVK'1>+:;^W]J@*:_ALVI9[/_ ,^,C!SG?=ND579_L.<Z0W[M
M-Z]0.Q?&.5,](X_:C_IB_#?6?#'A@GK2SZ&S^:&(IY[S56/S E=QA1>B;)@N
M$<<>#LJ&7-=C+!IUX_>-5GUO-R(>ZC\P*;ZU?RQDJ,_F6>&8.F_[7H[3#6^\
M==%SM>X.$XNSX2\)ZQ7OQ_*LSAA/S]*?_-1B-UY..>B]$9+4B^-<\'4C/B53
M_*$XO\O=PG*JL8@]Y/Y-GIPWU/)$?E62[AD<KW+TEIIKG,FER!W37,WMFL6H
M7,PC]R4]9U,ZKWYK\JR)])?6"Y-K^=9H2Z;G\CG>*]&VFU:@Y\7B',O&D<5Q
M^QHNB78X0^O"UZ[GF%FF[WUC\PR3 X:WP%5Y#9_DQ)]]\E\Z9V+0C'/63P5;
M9MM4K2.Z\5N,>.":O,/I^S]>SB[E]X]5T,^M9 _W<W_$9KYPSM6A&+].6&(*
MYMK^3:$GQN IH9).+'/Y-/J+/KF<1TG6]$X]6#4%V=Z#DOCP_+MYN),'<-=)
M+R^Q_(FK[H+U@IZSK1]':]4SC4Z4N,,5AZ@?^EXRE6G-?.S^0-']G8/Q>Z/%
M7V7K6LY5K'>?"L8JOH(VXQ#G&HN8Y)3M1_Z0J!9C>Y>E#UQJ3'&>#H7@]./7
MF1IRB>&57A7UGT9F+O<1M1>579A58VXQF[>ZF'TO2SZXY[ND90KDE/K3\X/3
M7LS%#WG^88C<,;L)?YA(W9HO3&?7&SAI1WRA_K3T .OP58Q.QTE[G_J6<9'7
MEHE/JA4B7'/=E*"]-_U1Q,]W"]$I]4<<O@ZUR@DU]3&KY/<SZ@8RYI/YLQIC
M\_"]2_UF)U[7\(L^LD[6HURNBFO*U1+VS^0<W7'X<BRWF)=.6>"]2_UU,,W[
M]V$D_P#KLZ.U^^":_61&3VT;7-Q^(7)R;^8!Q?N?2-=<EZ=_KSQ<^LL?C<A_
MKSB[?7 X.Y.5G$9FF;O<OY)1=OQ?WK-Z?^6'^[X^?M>FCUYTWO'/=TF@U^0,
M2^)A P)'S5S]RD5[[]QJ/;SMAB^X<\(+!N<<_MU1S>O2QZXYR-3UF^Z+H_Y@
M9>XTJXTQN2SZR.><EIC<]I!>^L=,_I$-"WE^[K1>I#UYQYX0H@?R)QK OMT(
M/6O6<W6J+O<AM!>A W\D?Y:=Q<^@7I/_ #(U+\74?<<E1G\@<;NKTG$CF?P2
M*7M;;;WB^+HGHE9=PY_'A>L_\PS)PC+'=OP<A_S.43UMU."NN30]LX=<G0MR
M> W" K;J+TYG\F<3QPE)-_S3,OK!SM[XY&FBS?ZK339[6WM,Z&!P=>0ABN=X
MQK7 .[_:]?'Y$FO.S<DO_,:OXZ/UC-6*DBG.[V/W.SCP</'RF.U!!P.;KE1>
MK?\ ,3>9MW5'_F)G77#DI-43+5GL;>T[3=IQIA!#WS><?I>MGUQQF>5-WVB/
MR,HQQQ-0/I-?/Y&=^>>?#V(LUF-ZF3D+EQBO!G\I/<,0'##/!1_Y@;=A=A:B
MMG5>?:VF&=Y]D/Y<]<H^,5X(>OSR=U)/GPL/71="[AR4FJZSY//SP(I=N3,.
M$YOO<_BO#;/\A(O#LSOW/QJIM?D=,,>O,Y/4IFR1&?P_)[,6]\,8'+&\$ON\
MG*E%X'9>OTYG@NEGU^GSA16J8EMYCVB?0];DJ/#I0>8UGVIDZ!7@FOR;GW\:
M^5S-?E-.@@_&R0K>)EBJ'EO4[;/+)W ;\I+A;-QHO'->O>_$\W$6*(#UHD>L
M/O!8FI;;+<P\ELV(Y708TJO("'S!^8=)>ML_DHQ$2<>8/0=D[7Y6&)SKAE*/
MVD-/)[5I\!>^ZI0U66)?/?->(9_(UQ=*X'NY9K\@/(URUXJW1Y)N<LM<7X;E
M1AF3X8=('2J\2S^0%Q.>&Y=>R_(">^LGY1Y345Y9V6G:ZI7TIC!UY+B/KQ]G
M#"@U*F/7"Z9/XR5RLS,.YMJ0RZX1P>^5%U>F:IR^L/I>*'JQYP=;AT7=LO5@
M?8LNW912)2=^7!YC9MRTKULQ5V=IC(=8 A>$_P!:+E"]P51ZT#-_#!^^O5=8
MJA<OD\MWAPP=! LB;^W5>/'K14]WZ=EAZ]F$9[S&ZS5O#$Q;8[V@(1T\R6#$
M(8Z7EN*XF?6LX\\>B;_7,T-:\W5Z)=8I\76&9'7I#G#3>KC.[MX*\?\ ZUF,
M8Y=GTY.6_P!<->"3-FW2VQ/6$^FY38V5F^<Q5<Y]8,7>;@Y$>L9D_<,)WS2Z
M1#I]D1YPA=$[+(IS$3HN0>M9-1EK7PF8]6'S%XXSTF%5M#R+.5T<[K0)209U
M$.!AGE)<1]4S0V_C&W+#U+.(,+A1$CLMN5;8E3=B)?:.S J?J5ZNBN=KU(QR
MQ@906&V&+Z?5T0B+.X-V_/LY9OB-+/A<(VXC'*<D/]2)/WOP=(\+G)E9=/MG
M%PMT,<$H9LP>Y1/J Y[ZXXVZ(@D_U QYP^.E%2[K+$^+N;IR(RR2'92Y8\>4
M5,;88CZ%,X72G\PQ<[2S;U+]:50'L'/@_<[L_)5-W++6%% [48]HTOX"!VHQ
MW=],-$B5E1HX[H'??6"4LZ^=';PD]XK>4*5N _E&,^?'<."7(9G9>8P=J-);
ME9EG/LI?RRC"NX:Q=1,-H(2C<<]V:Q-6?4DC_'$R=8?>2!V?S"E]DIVLW'?.
MR7H?S9@P=VA<8Q70M'@5IB5)870:*K&SL.B^3JQ/SBI,[2WV%0-]"[@YZ76(
M1VK/3+KS2,;(3F?'3RJM-<;E+X*'NF-[^XZ9J0JOLX:3K"7"B#>S@_33<Z^*
M4-=G4 L.C+@L6^M]N2HA6N]Q@'=,>RS+(?6>7/"3L,TPTB^/SDB&Y.$)0QQC
M&,]R(L#PW<(<*A.PT($0K='8?2YO?1^-Q,RB#RGQPPY(2["T#.DN$':[^*\;
MMF'WR.G E=!:^!)\;Y)2>NZ^A1.I'8[)TWW@)/CNQ7D!V%Z]%R"'T'Y\50''
MG*5YXHMOHZ7_ #2B\=MV+N1L+H+=[O"B3Y,1W[9H3N[4-FQ+$7O=6F"\D&(;
MI_&@7(R*NPS@JC:[WON,W\D2QMHS###/Q>:\;M 2>HPWYKR7OI-_A0: [\;[
MHS.V$]EL9.RF[*'=RZW9X9RMR@RW00?#FG_D^H>.%46T;Y(SLHQI##?3/-R[
M# .?(2RQW8KD]V'.''" %%4M4KNAA>]&K1&Q/VO(./0QOJAM#S\8T5&3#K+K
M3=X4VHX\+XOU1*=CF9V1,3G&Y[]5TR=IOETZ:I@W0.WNI<3N2M-9W<D+9W:;
MGEUS&*Q9=4:X7C' )@7.SA3O(75*TW.%OXF&X<4*G)MP3![P[<(.D+U3^G8K
M@;RXJIIU/QP'@(C)VE\D6'<&Y<,!JH;://ZY)66^><=UR1+7QXON@CLH2=C=
M)JXVN[ESZBJYBU<$[+L/ T&/."*JWM,]]94Z9+CVFQL3E0V.*Z0;#N%N<E)E
MP#X0Q%Z(.%K9G,.XX;PLR''"7:)P\JQ/.&[OC82-'1YA8KTK121=G:<-YEP+
M^JY?4FE3&0PPR@ N3:;5V6]\KCX1&UIQ?;\UG7')M6=\8<XYG@D]/LGQ,8C?
MG/3**[F@#>LX.C2?)1<Y\*@8C&\YKG,BIV0$1K"$I0TSFO#[=HF4GZRIHO(-
M[6FDJ=G240R(2RS%,]70P6IV#>B>'/GPE&F6$."\KM&@YXWDW+*J\6&W/^-#
MPS[J@V[W"/8:O&/A8'(VP22\EU*@C*%R7D6-C#Y?='8.T7.1\ZN#M/*H-N!!
M\J9>;?@%!LN%\=4S8A!QOKAE-)_J(.[=,-5S?S4IETQ?EA!=*!=AB)/?GEX7
M5[\[ET7/L]H-79X0%Q7/M-JXB/SV<I&_/SR%-KL_<03AA'7)Z.SV;B/.OWA-
M2V>VC/*.-+[JY+G'@^[D%:9V_(=FU#V0.EN)-XKPXV(9+W0P\<XR<]>18V\
M+,"]_BF2EM]TK[]5F1%HPW9\7V]<#6R)B<XGC*-T74#D>+G.RF_E"JZ"S#*)
M<<QB9N^5(FP38M.XZ3[YR70R:U-:NRIYHO'MMT#\#B_>Z5'=U?8M7\[MTUN9
MF [;(?S^8_48+-$D<.&0PU6+6_E&AEP5]@<GPX?/16GC/<$]/L?_ $HG'4+R
MGM<'TLS>]WT%R>Z4]16-PS56-I1^E[\Y9+6\!X)%P[^59AA\[WX=YP4">@>2
MY9G:[H5R\ASN,E1#U.5'V5)C9O<^3YQ+CK17VA>^&[+I-;9LROCT=2B#K].R
MZ+W2I7YJZ:Y]ILWGG"%\Y+I8+O#HX03 Z'#IE>2D2 PRZ)TPOZT3%D%Y,Q&-
M-:>5%O:Q=2&6+^&"KLS!]F.5(+G5$!?900=&Y:.P56I$7]9[U/E&_A1]]*\>
M73BLZN00; /)(T^N'TD70_'A2\UE9C@/<BU>.[GI)(-I?'"8Z*(:Y4X_63GI
M2WRC#/"]%D7+>>.[5V$>TT??'?>]<[+6&16? 2W#?UID@ZO?K <NOPM[N?#X
MQ<N;W;LPXX0& %0E]_#)U=5!U^[KSKN*WNG&\,5RLMRO*2/OI<$N.@-4G\X\
M<\%@?E<^E[J#JL6KI.)PA807ZXRPX>=$ WG09KF.T\\<83E*:4-^<,L-V#U1
MWANOW7'<Y$;2[A 9:+A]WQ?A-[^!YETZO<I,CK#7CP9U$\D?<9:5TCP@N(M<
MS/2Y]G+#;9V.;N:#M9;NOV9<TWNLYXWN7CQM8=(55!M+TMS^2HZBU4QQ&6"7
MWW6'9<K6TE@ _K2]$OOEI2&]YC)!VDZ\4IVE'#X^5RAL3?-_S>JQ:K3AY+[R
M0=);Z7<$?Y,NEF"X@W-^$*Q[.J\U3?R2MQB_[PD@Z_Y,,'3KC<"G#?)]XPLK
MA]W* I)W)VJ<-]3#H,W/@I$WV#J.TKR[Z8X*9:^5SAKGTUHY8M\N>6D4%PUB
M:CE'K<42U=YUH%S>_7$.C#--_('SPDJ+AKO/F!A&3XIO=+M!V[6$>"YPU&)R
MYPWZ+!KM6]W1!T--WVW?*Q:X<G;ESM-;Q/&,:W%Z3WZ>!7X4ONWCH.TNLQ/!
MXA%;W8\]<0N7W9U=GO.] 7#<ER[I]W6DWF(CIT3!OZ/3+NN;W7+APU=Q2!MS
M\7;N/3JK ZB:BFF#A?>*DU.\(PS=R2%O63X6-W%)[OOAQ4N*^^$./S80+6'"
MMG'&BB6I^$ONWPK"_I8FO@*M&]5,-?$>'2J3W9P=2>$K?HD]U\"XFX9)$WBP
MZ63#COTW[EM=(TO@N<&?CII<U3W^/K"]5L,33")Q^(1.ZJ4-97YQ?19\[O/<
MD[X0IU69SRYYL*^ZQ'G2"4M;\8NA7H#2*F6I=-W/Z2$XZ1SK<ZU35YXCK8:R
M^ASAY3^]V&L,<*\IA<@VFARY1QS6&TQ^A*&2L>(Z_?OY'JL-I-<7\F%'.SK?
MTBRUIN^^/A28OU#K]^5>-XODLRUPP\V[>N7^1^E;IWX(,[32%'TN(JK?GN'6
MT;NPI%O6'C"O93.TKQ@H^Z,XV_A!U5*K3W#K]^#^G.CIK>Z@Z3TP7(-K2^[G
M31+5#5U<J=W*:W58=7NI0]KIF@6Z]:+E&TQ.GB.^*0[2$/.7RMI=VAN':KKA
MO2_R3I'XLG2JY WF[7G&>:4[3%UR#QA/Z4CK5VEN<<1'EQ4_?+YG>3A-<QVD
M'AUY9I?Y)1MPQF4O$CK&TE(?1B>SHIO?G=-SODKQY;[??CE5,-IGIE"YU6=6
M,AW^[.[^TX;^]?'6"X#M?K ?-X(_R?%>BV.S^1V'B =NX)";G+L<5R#:5PTN
M\50-8<>?%9JE(OO=#&UX4'00ZRP6?@ZF2Y0999UF]\98?:)VFG3M.>:DS$[U
M=/\ )+CG.],%O=VOS5<_NR="W\^ZF&Z81A(Z4X;TO%K;!U$Y;[LI2U/?VX.4
M3M*X97+LG+6?$0O""6R@<.W$QV@[?C@K>D:H;OX3-@)&"ZFC^>]9C>.XM2?@
MZ,Z[OM#WW<%SC:;HRGCCA'CH@TU\;_%!\IJ2*FM*YETKXH,-63<7U4O=2'.O
M)%_2D(:R-Z+43MCG9M'0=I++AYRHE+4[=IB>7;G::K,QK0TUY(LE[^U;S6>_
M9S(K_)J77Q3,MX0/F$IAW5<_NLW3C"";W;L,N[NKWK4SESN%O=W'CZYI@UJ+
MY@=US^[BZN4/B7-,RU*-,(8B^R4U;/,=;#<X</%\TPVF^+\W_"Y&FYSNNMU7
M/_-4='5MZWO'E&=L/-R^"];WX1=?+M@O'LG"O NSY_:NPU)_*,^]%;CI::XG
MDZ\'4HL&[^,^B@6O#X?<TGNW\W_+Z\$%R<M-_>WHLM<;O$*!VE]7/WA+[\..
M>/CY0=;Z<'ZS+W00]U./S3X7(-IFZ&Z<+$]$?Y)=J9G<@Z_=N?KO^DH:WP^'
M.&=-5S%OG+&\*1R1::KK)]SAIN4%WTR@:7\+/GPSO#HH RA2/G"$WK%J>)UM
MZHZ/?R=\K>[[WWX7.32>>F.](=I'+S!\>@0=H:W1SO'<IEKQ=P7.-I*GF-A8
MM7WUZ(+>[F*80Y:.1+4O@WT@N+WU^YTX.YI@U]D1^\U+#H+7)]]T?=E8[KF#
M=:&E,][YEVCD08#*L=Y\2@I.5N Z"U<AIINRD4I/3O@I^[0=]Z#]+A9JM"@;
M^S*5\-40UTD'/N;](KG)E3 5R.#A+FL&L#I"+[PBI<=!,^,(.H,[BE?.[Z37
M.TW3DZW7! M<;>Y6XN6HX&L;W.CG1 M]Z_2AR=34RQHL6A?FW(G%<'Z\[Y$2
M0-<:KF?1VZ[*(VDW]:X0R68G.5=#)A#/K'+3 (M-Y3<)#E>CU(-X1Z71]4'Y
M]1=7;EH4]W*NDI3LIO=+M<I]% M8>8ZB]$CZ1[QIDI(Z#?QX2>_?7EQIW2%J
MFG3ZWJ7N$<9^1Q6:9\(WCH WSC#DBTUTX9.QS4/?NCG<H(%K&&,N'A6_7^%A
M0M<<\7WU3>[/!_><K<N9G:7<DP;PE3&^::VSK%_=AE9W9K!J=5#W[GT\X_:'
MND[=!2:A9^?G=J$HVE"[J_QAE10]^<+YX56)QRNZI$WSW#I#5S?QUW+ Y_(-
MPX+D]U,K\]%4;3API;L(I,_EE<=+Y"G*]9+9OTTZPZY*/OT@'P@<SV&/%9_'
MO]*1-\N?$4+4\\;<_JF]U'\MS^RC[Z>:#PD]_'Y'9;OP'2^6,NNYV$W9*3Z7
M8YJ1;P\;]+@A[N/.\USF)M'@+"]$WND87T@'GY4"UAQYTD1(?"4GI=NP6YX"
MQ:TPRO62FUUOZ^5/W:C+#7'%*_DZL@?FX+E>8%O=U=&G#'- G@XWOH](&KGD
MANS.+]U1.6J7_#J%/=>>*J&^(+M+^5R>[=IU%<93>C[O&)J!D;"WKP.DM7RT
MWK/\=89:ZKE#4[AOD[Q!4?X?>74K?6+/S%^9R[(]<Z7/)0#4L'WX6]THXZ#C
M4\5SWY1N'0^KHSEA>YR/NN<_&G=<_NW4O$4AJ@&Z[AJ>;SY4B,\QUAO _4.7
MTG]U_-TDN0-NRX.A#@F9;P,,,7XCD])FXZCRPA+=3/'-;E#A?0O4??UEEA];
MUO=I;H?-A%AU/OYY409-1H^>L.RY_=3="X4WK':5?''Q3+3BM[-LCK#=7OGR
MRDN;U34)TTNW)66[&D9X1G51V[<#TG2/E36RZQX';M1-PT4BUA(V=>F"/J#,
MWQIP7(6^G&C\'$S7,=+^59&\N*(:TAG+#".J@6]]:X4R\K%O=IW?U'R@N^';
ME*7R4O\ (*SGV&CL^"Y&CWKR&7R@&K?43GP5BV\>09;S%7_-S3#:Z79U7"RU
MA "SF^6BI[N=ARM4W%RW\[U3^2CR^6>[0+D?VH(?"):L8WCFIS\!V!JZR@_#
M75 M3N,K$ESANWO<!.ZK%L=.G/JEQT>Y^H<_1TO![K>[2,Q7YPWKD]\(;W:]
M.B(:W:1/'3J$UI'23X&._P K,;3QC]7HN8Z[XF';RL#P<,C3CNW)<=7N^^KL
M-3$T0)^).,?B:YO?<:/=DM[N7*[DEQ9K/I$8:8I,(8OTW_: ;Q.>5YK!JR3A
M'B;DH'!<\&7&<M"M[M[CJ-]7YPS7.6[=Q^*HL-[MT887!!<'/348'N4[+=@O
MZPU$:*#[<\Y9 X8R1>_!TN'?P@O[Y7=.JWN._P 2?VUQ40;JX/?]A5?C(TE]
MB$4# F)?GP<Z-'3^TGN\1I=*HC@*.GGKUYI">&F[J_6D4#AI]NX7!9]SO+BI
MAJ,\/DC-%_*_E!7WYXV[+"I6]^CH/BH/\9WG) ',9G6^$D'5_+GEACK&L9N6
M]_V7S=?5<[]TL':'MP@F?G9FZWH*EOYZ=9O2>_.O'&Z)/=SH^?VD,XS[YW(.
M07]]ND[*PBQM"=]QT\OR@,89.D3=S3/X1G+@*6Y:UN(O_(>5C*<%AM,]3KE"
M.*BTUUZ2C\)0W@(C1U_"7W=8L6N5C-^?PD+6L(=MUC!3>-;OHE;/T;G3PLAO
M=0=;WK>_.\],5(F_-1<D?==(CES* --FY)3M2,;[A9LS)QI2&&*@T>=\QX6H
MJL/(;+U1A.S-V%A=!]:^KL><*3'PO#/H#A''[NB#39J=PO3BFMU#N:]5,OQE
M& %QZJ#>V?&+W.,>N7,8.7%[Y2=$0<:0OPD+6DA'SO?'=FI,CI.U^7#DD.T-
MS/&Q5<Y:Q\SGOPE!1+6#N,7QY]YI,CJ.VSWWGN2G;FAQ#JV;@N1MOA OOGY7
M,UM)TW0?\=%!Y'_4WAY^%/\ U!U\<MQU7C&MM/73@<U$^JF"<*Q$]1\HEGD]
MIM]^]\A/.-%S?R2/; X=IK@:]4,1QD,9\,RD_P!2*0<]]3'/%W1)5Y=CU'*F
MN?%^"<^HTI8I"D<\%X+^6E($O(Y]<RF_GE'*8E-YIVXJ2/8=GZD5.^\N@7D=
MAZGAGT[KTG_49X&\^5%W;#USG1&XPCWE1('N9VXC* EG7CG@*+BVGJ!&7BCB
MO!M>KAXG?TIL^H?&KXOGQXTB4[AYUC:B,7X91KKV>F.W&KN0^>:\$SM?A]]T
M/Y)1=R.+Z?2#SH]2(\NN#LM-RY6MN.(-8#!T'==R\8&S#EWY=EBU26#QWSKN
M0>1&U&NLMRML]L!-PZRC?PO%/=+0V<*X*#;6^Y";L7J:L#SO^I!PRX$?+E;9
M[0997T7KS#7S2W3T=F5UC:ESKRE3-6!Y\[5F4-U\%!ID&^MR"\,=KG&,L;E(
M)V/4.Y0Y/>Z'A4>5_P!$S5UO?H)*W\3(I+EE][EXUGU9W1$HRJ^+NJ;_ %+Y
MDGO?1!UM;,4I]\7[E;9@3Y7U'=>,&T.)?"3A"\>CU9G:>)W]20>1:/&,+W>%
M,'?'5V6:@&X95IY?/IBM_)5_.$GCZ0>19:&.[!,2,!B_"C^>.2\1_-JZ7W>
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M6Y.&M^F<CIHN!ENX6_%/_))^-TD^HT5'8V;IE\H>ZL.+ES_R<'<]#EJ'*?\
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M1I@8F96:\*J.=RQ+^HC7Y(-2:!/&S;T[/K9/.\.Z4)^S)?S\]!_<3LO<!_J
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M_&7^H'XO;[/;-$DN!($P[(U<Z6(.*]>#1$QG>>IRF=NWO['Z'_&_U0>"YID
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<YAK;S+],>-DH+PFW]7.(<!-^\[\G)UJ*96[_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>silk-20191231_g7.jpg
<TEXT>
begin 644 silk-20191231_g7.jpg
M_]C_X  02D9)1@ ! 0$!+ $L  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P@ 1" "[!]$# 1$  A$! Q$!_\0
M'0 !  (# 0$! 0            (# 00%!@<("?_$ !H! 0$! 0$! 0
M       ! @,$!0;_V@ , P$  A #$    ?[^
M
M
M
M
M                                                         %4G
MR/AY=.9^O>CV;]H
M
M                 'AN7#Y'Y_G\++['Z?;]/[>H
M
M                                          #YEQ\GROAX.!)]3[>O
MZ_W]V[=9       !@U9.+G'6UO?M       P 8(%<G)G/3F>WKIT+L
M                        ",2H
M                                   #Y[R\_P ^Y<--CR>/'[_?KV+U
M]EOOT-;V;KI5N6[-N3(,&"B34C1S.<G)F/.XX5G-Y^?VG7V?2^_IHDU2B2H@
MF"N(@K(I!(2148,$),V\C/+EL;3I['?3U>^H
M      'Y\\GI\]ROZ>]WFNU
M                              /%<^'SWEYH'/G/O7O;=Z<EAO6[I$F1
M.>SHYLB*V:59FLFDS"XFSV==?FOF_+>_Z_H_?]_H1DLML7*@96,JR*2,K$P#
M*C!$U9CS$YRG3VF]>VZ4                              #!^2?A_3\U
M^<^I^T?W?YK;Z9
M                    'D.?'R'/SX.+GEJM]B]Y6[5UNDJD:B:DFG%:7%A'
M*^V&\R6Y-NMZZ\)Q^7Z??T^WKM9=960 ,&!&168&25"$3J1 \;GCZ_>^A;ZK
M6@                               /@?Q_H_G[\I]K]R_NOS/8]/(
M                                                          #!
M3&# (F")YG'+C8\\Y?.3'J^GIOMX>9K)4S1E0O+BK6>SJ]A=K2.+-OY5-?E[
MEW\Q7[;Z>7W&]V'%SQZMWZ*])K:#)DD2,@E&:R2,@R9,$A7G<XZM;-OI-Z
M                              'S3Y_J_&GX3]-^POU'P_J?Z/Y>0
M                                                       #YIQY
M\T@4R=)?6;Z6&#! C0X^..U.=MOGLXVKWY\:USHQE+[92]#;8;KU=@Y>><D^
M;9W^#.7L\=KI+.?Z3:\7U[K)QG6IR=N[M)$@9,B@,1%28)@B#!$P<5C=:V:]
M'N@                                :G/7XQ_%?H^9\KU?L7]Q^<]/]
M;Q@
M8/D'#G9J[)R,O'>>^LUTNJZDD#%89\YGR=MTZVW QRYF]^AZ:Z#74NH+K2R,
M%VG:69YW/'PG/R[EW1KO^/<>KR;7["GD^O\ 359Q<W>/>]=368,5F,4C! B1
M!A"C!$B1*TY<E=SV&O;=-                                  >$\7I
M_)'X7])GR=/UA^H^)[K]-\N_ID
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M*(T32G*9.]+M=;LW<NI5;&:S2,T@8($1"LJ$5(*CC3GT.N]VOL&^H
M                                               P     #(
M                           ('@>>.@U@E7F^>=_6\%D8U(Y4E)Y+'F]'
M<8ETV.S=\N.39.3I-=)J]:4AJ6W<-6%LB4%I2:U2:TS%*$X^)K35ZV4MR2!
MR8(F"!@@0*4IEUTFMK.9F-Z76_I7T=@
M
M   !@\ASS @DS6SKHZLTFHB$P?/^?G]1<9:^9\O+T*V]]^I;MM;35$F6N/)\
MNS-KI;UVY==*LK-56Q+?6C9S\XZ>F_+U%E5D2M&21E28(D1;B,$2! E&+->9
MV7.;73NOL_;T
M                                                8@  !7S_ )>>
M^8W+KY!Q\/&FOJ77V[]NU;8L(IC:HG*DTLR2]"W<NL'.DX<QR6-:8@FWK5L5
M:WL-66YENK)DE;DD9(F!&*K00,1%*$C.=EO6O3[#U[@
M
M                      >!Y^?RG#R]_?3Q6/-\XY9]MV]V_=3N]@N2Q;K;
M4F;2WV[5;-N;()3)QN..[O7D7B^,</SOV/K^EZ^M7*5+@HN-:61945C$UL7:
MSO4N(V2LRL#!5,ZTG%G#U._3]>[^T
M
M        #S&.?#Y>;O:W\_Y</)NVM=2MVSMW7?UKIV]'5VC9K86VIF2LUXU9
M.+,U2><SP^;<?D>_Z_2^V^CZ(          YV<WV[5H
M
M                      'GL\_-<_)Z-V^7\O-N[]?H=;]!O7>WJ\
M $#)(
M                                                         XN<
M>&Y>/UVNO@\<_L/H]P
M
M                    &O)\GX>+U>M<JZ^E=?4
M
M                                          .'C'/SCT'3KN6@
M
M
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MV6XZ-!-&8I:="?\ O\0Z969M+LZ_(U:C(<0ZC[#U\B53S;/+;#31&\40D)V
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MU/_:  @! P$!/P'_ .H1T<_1L&M#"'-\ZT;P@9@$9_MXPAU&#$/-EML_%$R
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M9=]:+29'WJJ+G-)D)$9,^I3;H#OU*DW0;WZDW"*'FL U@R_!&+/*P$W]PA%
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M%14@J(4A\B2D%1",,%%BB0*=A$U%\&@.I6NF;1=_LL#@.AV?0&07?P]%MP0
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MQ@>J]>23M,ZT';0J0M3HK1I5,'^7?Y^]R=ZJW\ *&?\ ,;"^#\$PYLL(A N
M\2*WQ8K/T(C9.')F.D%8?W'1H3C&X/B.)I4YPJ$+")BOQH=6#QOTAB(FTK!^
MZ#AW@IQAX5".&PF548@<S"0T54L4X91SMREIT&2P#NOX'PRBQ\;)8YJ,*-4&
MNL+_ #?]X&<BAQ(<5H=#>R(TYBQP<+P3^;TQ:IBU3%H4Q:%,6B]4FVB\*DW6
M%X5)NL+PJ3=87A4FZS;PJ3=87JFW6;>%3;K-O"IMUA>%3;K"]4VZPO5-NL%3
M9K"]4V:P6,9K!8QEJQK-MQ0<9F0J5*VI4A:J4Y%N@Y]G>T+G7;1O4MH4A;UJ
M0M4MH49TPX-K,^9!\2KFSA5R!!D42X1@20?$ZIIKS*4P@[/U*=I52F%,*8[!
M4N53Y5/8J0VW*:KW*B[/1J4B-!'+WJN38G:)R*#6ZO651;9[\R)8/%H#GK]Z
M< 1FTSGR(&:#E2"F%-3"I<MQ5,;;BJ7+<52&U4N6K8=RGRW%3Y;BI\MQW*>P
M\X*GL-Q5=AN*GRW*<UVS*:FG&6:M-G,59^V95V.Z)W*NQW1=N3XK&>49<QW(
M16.S&?ZKMRQC=MQW+&-V]%VY8QNWHG<C&8,\^B[<L?#%<W=!VY"*PB8GT7;E
MC&[>B5C&[>B=RQS,TST7;D*\P/1.Y47:KNB5)VJZKT2@UQKHNZ)5%VJZXJB[
M5=T2J+M4W%2-AN*D;#<51=8;E(V&XJ1L-Q4C8;BI&PW%2-AN*D;"I&PJ3M5U
MRD=4W*1-4C<J+K#<I.U2I&PW*B[5-2KL4C8N92-AN4C8;D01H7,4 3F"D>]1
M-BHFQ438J+K/<J)L]R-6<*1L5=GN5:GL*KL-:D5(_=,(P7!L*;0PF##C-S@/
M:'2-K3G:=HD5A_<=P?A7C,<6$>2V,W*&M_1>2W"66>+'D+-"B=S'#O!SW1>#
M\)PAO_MX^.:1MA1C C[*(CQ.=-[HNZ?@UP;A(AX4V<I83!=@L4_MFP1.S[>^
MU0^[V@ <-X*PF&/.="$1[1SM8]@%GVU0.[G@&/*<6+"GHB,'N:]QZE#[I^ H
MF;A""W_U ^'_ !M 3.%.#8DJ&'X(Z=F$0OK(83@YS1X)Y(K-ZQL(YHC.FW>J
M;-=O2"ILUV](*FS7;T@J;-=O2"ILUV](+&,UV](;UC&:[.D-ZQC-=G2&]8R'
MKLZ0WK&0]=G2&]8R'KLZ0WK&0^,9TF[UC(?&,Z3=ZQL+C&=-N]8V%QL/IMWK
M'P>.A?M&[UCX''0OVC-ZRC!^/@_M6;UE6##/A$#]JSZRRO!!_M.#_MH?UEEN
M!_E6#_MH?UD<.P(9\+P8?[^%]99?@/Y9@O[Q"^LOE' !GPW!/WB%]=?*7!XS
MX=@G[Q"^NOE3@W\OP/\ >(7UE\K<%_UA@?[Q"^LOE?@L?^88'^WA_61X9X)&
M?A' _P!NS>H_='P-@[*;L.A1+&P9QGGD:R=YD-JB=W_!H>YK(&%T1YSL'BW^
M(UP]I-[ON"#Y3XL/-.>!X9_<R^*P/A.'AT-D6"YKF1!-CI.K&T&1:;0X3!J-
M:INUFW?%4W:S;CO5-VLR[_N1>[69T3]993%]5U[UE42O[W5L.]4W:[;O^Y4W
M:[.<?%4SKBX;U3=Q@N"IGC&W!4SQ@ZEC/6M]E4SQHN:J9XT>RJ?K>IJQGK>;
MQ5C/6"X+&>L'LK&>M'LK&^M'LK&^M_A6-''?PK&CCOX=RQK>.ZV[ECF<=+G:
ML:SCNMJQK..ZQN6.;QW6-RQS..ZPL=#XTW_!8^%F,;VECH?'&_X+',XT\LT8
MT+C3>5CX>B*;RL<P_C'7E8Z&//-[ECX7&.]I"+#UG7N6-A:[KWK'0M<WN6.A
M:QK_ $OH*QL+TKG;UCH.>NYZQT';[6E8Z#R7HQH/::QT"SV2L;!U3T5C8 \S
MV2L; U/96.A9BT]%91!U#T5CX8\PW!&,SBS<-ZQ\,'[T;@LHA\4ZX+*(?%.Y
M)!92SBG<X:LI9Q1',%E+>+-P64CBG>SO64>J=[,_>LH]4?964CBC>%E-D+K
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M*HK&%R)G:#:$#;6JM 5)4D:RG&05.8E7.4LX0,E.W9I0=+^<D73T=?8!$ST
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M=**CI <F17-UEL/$XB>%5F6 D+.TX__:  @! 0 &/P+_ .T&I:S)*$E2B<P
MF3%]DAED[F+LUE.92B9U5C= %W28UQTZ^U/9B4E)3I$L9<-8;?;,T."8^_Q;
MKNV<;#(XWEI:\"H2E%)) .; 9H(*S)2<_%#C=9,VA2!/-L$&73]_A<L]JL?_
M .PBD7=D3>S DXQ(@IPQARS.3Z\[KM\ JFI24ID1FH@11Q/*9'I_B>R<0.6O
M-"1-Q14JZ+K:L>,R$&YB,0<?XGB(VR><15Q ^,(*>J6R1F2;QZ(VRSQ(,7V3
M, R,Q(@_<!4@<?WBB%8:^PKN7 1TQACZ4BJEB4S3$PE;9*[.PA,TD"\5KF!7
M"Z E7#,B+X03I!'TQ5UQB>F=SG'C@2M#;@X?3QQLF;XTHO>14;-MQ/,?&#T1
MMY<:5#Q1L7$'XPC$?O<8JX@?&$;IS GQ1L4K7R#RQ1M*?A*\434^VT#A*71.
M9,;.T..?&('-3P1UIM:^2Z.<PV'=9:2I8J7.C"IXN>&4I*2E86A4N!-X=(C$
M15:><15P<Q/BBE\\23XY11MP\WEC<N=7T11M/.?)&U1S'RQV@^*?+&V3W,;<
M=R(W3H$;L>B-W5&[.<YBKKG=&-NONC&*CRQGYS&U@W4RXHO #3@)\\3NB'1P
MI/W ,VS(2@JWY+>%K19'%N)8M24R*T+#:DWE700B_-.R-!M@L+0\Q:+$H,Y3
MR?: >JLG/9SI>LQE>0H34$\H"7&U!:%":5"H(.!^\0H'W:.@P(PBTWL"&J\%
M1XXNIVO!'H1&$C[V:?!%''.>?AC%*OA)BK+:N$4B9LSE/<[+HB2D.HXVU>**
MK<3FP4*B#UYZF8)<49Z-C.M#S&)GJ[@E9K2?T(ZW9\I.<5E>'YTHV.2\HGX:
M6F\_OG8GZWK3_O'DB7'=!BC5F1\(J7YL2+S:?]VWY9Q);KR^ 4C BF=5?V$R
MXX$Y*5H36L40L_%4)<UWPQ96$T6%H6M%:"LJU!G7Z,[(G)=_-0RE**S)XY^&
M.VYXPG&$8?Q!0TB&TK4;ZJ74U52F$2+=IV.)UA9KP2%>2']:GL0V2")$3O9O
MN!3J@U-OG)F7K+LTEN8:M4OL3[:9)=0O H7/WI&=>1\K,>MV665'JG);ADFT
M@4-LR8I="E>V4S>GC-*34AUI06A6<=(.@C.,WWAY>_2>:LN64#U'I;&^D)GC
M=H9*Y,8"F[2AP83N2!(&<>&)'6B= O)\,;)E7&DA4;*:#[]"O#*73&P<2KB4
M/4QBL;)2>64;*T6?NT3K$D.)<I/8 J$N-*2.F!<:77.47!_?N^"*R'+/P>6-
M@A2SP1,E+/'4QLG5'AE+F'[( O $X%2JFH3GX5 <9AHJ;OS52:;V8QL6E#XB
M1%4*[I(\L=5ER[1 N&NT]],3XO0I=O";:@32LLX&C]_C&,9XS_PEK6NI#3"$
MSS *<,QQWHPAS6T!*G!-1';7:"?W!!U,['E6S]<L=O8.MOM.C:D.)J/&*&$Z
MGM5B>I<H@W+-;5["P99;!D@I7M6+;= O G9DTF,+[2J]NV=N@^^'@.!S?=_M
MT]T(VZ><1MT\\;HGGC=$<\;HGGC=4Q=0L*-X&0T5'JGC:$OA$^2));">+AA1
MSJI/.):(V+SJ*SH1Y(,[65)G0%*:#C$HV;[1/).73&QO*/ +HZ?)&QNHXR5'
MQ"+KSSRDTV*5%L?X=T\\XE=IGO%1GQS->6<40.)('B$;!J7)+U-G(GC/YH\<
M3O(9;&@ &7+"DIM;-KM=Y+;;"74E3CKBKB4E9-UL [=1D$CAD(M26A8&7#97
M+0PV\+J FSJ+G65*I:"^W>2#?"7KDT%K$@6QI?512E+]G:?1U*74JLK[*=;.
MO+2RA,]=:3=O+55R,G6U;35^V7UMH05)FI*EA(V4[J5!,YS.F!UBPMTK>>6N
MLLT@G/!F[DY XG5>,0EMRTV9*M<OWV6U7=9IL5!1V^-1(<$"=N*$A:"NZV#K
MJ0H$M^]"\"149OXLI?NFP.GU/B*\7W!N6'*EF2X%#K;P$GF5YEMN#9)(.@P&
M\I"TY:U-)V-FRLPG7<HY/;G1%J3+V39TC;*,W  :'$-6AFTLNM.CK=I95-A?
M K.RYI;<STG.GW<NH:2V$MJE43)J1/'@C;HY&Q&Z\R$^2-W5S >*%:ZXI2-;
MFE)PVV,8?O\ CD/5&::F^@DQ50/$9^")(0I7":"-C<1/E/DZ(V;CBN@=$;2,
MT4/-$W+T=<6V%:%&\LYA)-5$\0@=3V6U/WL[=G4E.,C-3EQ(PTP+EF:9$JZ^
M[LAHV+05R[(0E5J?%U1E=901FT[)47D.))GA/#Q^.+]B5KFM34NR.;E:@*D*
M*>N)5L;J"CW5:8(M.6,GOM:X%O6*RMLLMD!H ,M@*2M:V4.5<O#!(3>PAF\I
M]SJAI#Z&G;)=4BRG>NM3O**"D+%R302B2AMI0G7T/.Z\ME]Y^YK%KG(:ZTRA
MLK:E+8!9[9)5.=(LAR<7M:8?4"S:%WK2RX"H.(<F2I,UA2DC0:4I (;5&XJ@
MK4+IG*4>]&/\-7^ 2=((]1/$K[A%-/-I=;6)*0L!22#P&'<M:@[6,FVM9+EJ
MR0[LLEY0SE*V<&W%8!QNXK3>@9'U1V5S(&4QL>I+?>Z@M!PG8+?(I2%YFW,,
M+LX 2O6W")A#DA>X6U;1P<*">$#[MWU$]MXSZFUBZVPI]:Y];20G8TO**C@$
MSXR<(7U+8;,VTVK6TJ>=5>6@8JDEM6?-.>.$3NV!,C_25'OJ= YXQL'<N>=&
M[6(?@U']+TT1ONR ?[A5>/9QV0LR>*RS\+D=D6ODP\Z*Y30#I%F3RT*CZ<<"
MV6VV.VEMI*UOI" !=2#=UMM&*JX9_"DI8?-Y((H)UX)_1$U-E,Q.5X3\$=1B
MCH:UW@*-D@U]Z2GGC$RX/%%VZ*YY5GIX],"28S)XXJX.2.MLK</%Y8V+*4?"
M/DB:WBG@12+Z@%N>Z7LE<A.%8SQM3"9"J#.N?3$P%-JEMAL3+C&:)*.N#AQE
MZ>ACJ:WL I4 +U4$$&8"'D26U701/"H,.6G)]J-ILQ0D,M/N%3S2&[J6V4.*
M!26VT3NS4C  SF3 :M/5B<I!RR!NZ NQM)U]*G'W;20)A2=="&&]J4;(J"Y0
M^W9PE"K7;U6TS O'K8O34 -@F1(O87I" =<: (GMD^6*OL]VGRP4.VZRH7>2
M+FN@JO+VH"14D\'@@-(=25+,@FH)GHF,W\63P'Z(4)[513S0D?"\!^X95DRQ
MD^SVUI0EUU *T<*%[9)&((,*<U&Y7]<\G"?^K^7%E;:4BH19K5NC>A()NC1G
MA-@U4V#*&IZUB2%)R@TX_DI2M+&4DB@/]*0D<,(=:>:6A>#K#J+0R9Z'&B9#
MX24Q-"TK&E*@?!]R^(C$<\8CGC;#G$;9/.(VZ>Z$;='="-T1W2?+&ZM]VGRQ
MNS7?$^6-V:[XCRQN[/?$>6-\,]]1Y8WPQWU'EC?#'?4>6-\L=]1YT;Y8[\WY
MT;YL_?F_.C?+'?4>6-\L=]1Y8WPSWQ/EC?#7=B-\-=T(WPWW4;NCIC=D\RO)
M&Z_W'/-C;J[T]YD$ N&6/6'O&V(<*&=<:)GMDIQK@8Z\PIOAE?3SIGTPI0J$
MU/:^&&;19Q-*'+JE(1KO6U2#L@/<45QC/6)4( !"AVTQC3#]YB.>-L.>-NGG
MC=$\XBVO-HZH6P5S:Q2;EY?!,2;499Y2AAS6U&^VVYN03(* ($A(TT3Z(%H;
MN":B;C@!Y+HAIHZW>5D^>P3+K:GDI,ZYB*?1 1KC2I73,'!*C*L@*PXXHIZV
M#=K14A,\\(]DLMS F+R0<VDQ-5J0OXZ9#AQC=[/W:3P0/93(GALQRP/9+=9Y
M_<X^G+A 3U2FLLQE4RJ94@^R0<U$DSXHEK\YZ$&ZD2O$J5M4@#$G.",8WU6=
M$A*BHXX"513E,@)DB))M&RKL:7L+VFE#G@[FN8$D%8+DCB2A$SG&/)!+-C4\
M %$I%^=)DR-TB]('83G42TP@BS6UDK_E;.O6\/Y= 6R>Z$;#9)SH-4\F@]$3
M;DTYG0L;'TXB(ZZJ[?264EK$:Z+NN&<]D 9)V,O=3QAEOUQMZ@VB[-2T7E<*
MCK8\42-LMRIRG-T5&C:TX3C2%VVUJM-NGK9L[=H>-QA<@EU76RC7+Z4H'7;P
M2D74T)AJT-M:RY9'V7T.-K4FK1[<3DI*D32J]B#"2<I6(8"MJ9%=%58P?JC8
MY;,I/5+-U01192;TE7.VEA.L2]=+#7^M->?%_P!<K#=K7JIG-CVT"64[!4R'
MLMFIT;> GUSL,S.G53/:X]M27#$CE6Q3K37TYHN>N=FG*>V,I2G.<I8</!C!
M/KE9Y"9F5713'; >F$21E6PJ)(3=%I;O3.:[.?1!*LJV.DZ)=2H['&@Q\>:*
M95L@G47G+DP-%^7[:13*ED,S=W3/.4N.GH(N^NEEGHO\\]'+$D918)NE=;R:
M#X21S8G,(N>N2;PS!BTGIUF1'#"I923L9SO-6A)IG 4T"H<(G2N$=E;-6F*I
MUJ*79Q>]<V)#."H^!.'#A$SE%,J"C3YVPG_)X:3F[:1B2\J(KH:?('"HAN0'
M'#=FL-NU]QV:4I#3Z:A)7BIM*9&[2M3#V3K-9+?E.VS8<=L]@LY=+"+2!=<>
M6;C:$$^_PK+/";':[/;["I"'7'>J;(]?0&R6ZM-)=<NK5.XJ[)6*9@SC?C_Y
M-RG^IQ+JM_\ )N4A_P!I%+4]RV&WI_.LPBCKOR6U?,Q1;Q_%+5\U&V?^2VGY
MJ-L_\EM/S43]D?);1\W%3:/DMH^;C[8T[U?'A1'VQ\E?\R)^R?DK_F1KCG5E
MS2BPVMP]RAI2NB):YE"?_",I_JL;?*'Y(RE^J]&,3URWR_X5E$>&S1NEOS_[
M*RAF_%^;3FG&Z6W/_LVW9N#6(GKML_)UM^9B8<MLIR['6W'O$3+EMY,G6U7@
M9,;I;,W^S[8#7@+,XV]K^06L?]*-UM>,MX6OYJ-O:_D%K\.M2B6O6J?]AM7S
M4;I:LWVC:L_X/]F>):[:ISEO&U?-X<.$&3MJIC[!M6?\'"I/6G8[;V'::?X<
M$Z[:I#^HVKHZU7DBC]JQNUL-K%>5H4X<(2-=MA*C(7<G6U5>$I9(2.%4A&R=
MM7)8K23S!L\_D,$Z]:9#'V%:I\VMS]*Q<U^TWO[#:N#/K4I5QP.:-UM7R&U#
MPM\/I(Q6TOCCLEH\R-\OTIO.T_-Q+JIZ=/M2T9S(?8_3'")=4OU_JEHX,3K=
M,<_#H,$FU.T_JSQ\"/05PB\+8[=T]2ORQE[CT%<(F+3:)4,^HK4 ;U!BUSYQ
MGE&^GODMH\SIPB?5+TM/4K\N>Y+/Z2,;Y=/%9GE>!)C?3WR5_P %R-\O?)GI
M<]V44M#_ ,DM \*!&^'_ )):,\_><%=&?-&^'_DEH\R*6A\RG]JOYM&PKP2G
M/-.+NO6J?]AM7S?IR11^TXD;RM(PIG;I&[6G"=+#:CSR;H> UX(J_:\+W8^V
M3EQ:U.?O97LTIR@3?M=?_EUMS5KUFG+CFBMHM&$]YVBLY>\X<-$S@E4MW?\
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MI 1? D@*F$@)E%1+"8X>30?4P/-&U5S05.)(&FG@*A 2RRXYHVB!GSJ4-'#
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M/P3C=$"DJFL;JHY]CXI"#)I]>B\%$&6B9\,4LBO[HC<$I^,(^Q)Y3%7$<B3
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M21/X59 </\7F6DS)GHKR1L$!/"/OE/\ $/SA#' Y+HALZ"F&5R)""BB<2,X
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ME%L)ZA&MQY,$!9ETR$.A<1(G22 P,47KHY)W-3[K!C"OYIJ7U_+PA*@D85"
MWH<*0F#HNF++UO6NYPX&A:B9MD(&$R*&=]A"-XGS3&LP*C9S$DIDH22#.W%6
MS/$3ITBRZ8F)WK^$\\9N-:6ZE&G01;H+6$<&EA =CP436T 6D"9<E,#-2*DC
MO9<:(=(LF(2(.]<"7:*(L0HC,0)C@F-U;X&=QM$?L6(2E2 V$L)V4BK WJ@
M1(E+MXX84,%":8@2A8BW72R+ 5@.2$@45)C0IAW'-.) M0@1%VKR Q(_^TY(
M!2,B?"/1(3C#L(G7255<A!4]\@0NDZ8X"N44$S!H>-,;;I\SS9VMZOSYSQI"
MC4U@5>JR/(X6P^(7RK?&.JSJ_LU\8:BY9]-_P-WTO]Y]U_>?=?WGW7]Y]U_>
M?=?WGW7]Y]U_>?9?WGV7]Y]U_>?5?W_]-99@7=KL6K#_ ,%O0XY+)?0?WG]8
MWXQ+?R/P8A^L7XR.[F0TZ!>2N1D K'55>O7&V;PG@QV*@9 H)%FAA9')TM#G
M1'S)<<H#D^V>.>/1O4RGQ=/[L/PH+WP+AK71,.0"AC GBC#U5PA-@(!BDJ5I
M,5)00N)[2^F/@]];C[]\JOVP^5_.=A^_3[60[+TOR\24$<PGK/\ '(P3W_I8
MLL.$FOF<P:)_/T_>:(:];]LC$S]7?1 &$Z<<[Q*5$ZQQBF6S3G:4CBB?3'5+
M&G:/Y*[>N(RCA,PQWH8B;*GLFVOIP)9;X];X:^N1;^ET_GC%(8I8F,DXW'HV
MY"WS5572!*=E[XGN*8G_ #XDGR>WN3M?$,ZS7R%4?6OSD0K#,3")"8$Z+#DU
M6:%L+RUN2WTP0OGBVNUI\FKUD@Q#<(54PR^_.6S M=3Z>>,]JJW4U%X+@N+S
M^.;Q/"HY?5$.)TVJ=\W WCMID;')S@6L:20Y.N3DRURCOI,CVB<,5,;X77<-
MG$W5KB1+UMG$].B/A'&%8PQ)T/(Z)MF'+&,B&<DOBDR:&U2#G5>^76^YZ]&F
MZSEX2)=0L#>DU,SAA\<RWCKZ5V*U@'(EAUKVXK*4+HR)E+ZCD)&J9!8#F"\
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M(0.F(]8G-/<.4B**!SK'9@*M;% 66B5E@2+<LQD5J9,4A*D#!E(BXI#V@($
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M#"T+,#8))!C-8(F*D> GA+B,P@-]+&A8;2R3@0!?$PK *@N!R9O&C J%+45
MJ>DLR-/E)KD!-XMA*:)7N/-5'0T*=Q)A!L.O*%3*@A!3NH,06W;,5,P1*S>B
MX,(26F9@<@L@XXBUJL#(7U$DAT)1Y$@L!&$ )T'VO+D!9*@2JK!.:!:%"S3G
M [FPZXPB-;0:*ER)H T3;DDST<K#NQY$X"F2C/(+*EB."JJ8&P@MF]L&1$LD
ME1F-10  $;F^TL!]!<([,:CO:0L@!IV3DN=T#%%<D A%@622$*D"CSE%+R98
MVXFW#,PC&5R!Y$J,HB#DI0-*0T*\2";L&Y" T!MIX1H"2Y,AG*9W733'3E+I
MK ^X6R1X 3&M[.$$C.U!"TA-JDU6,9:2.L$SP;HN:(ZB8NS8>=P#[,SS-0G0
M,),RS-J"MMR/HS>/$.U:E#3,6AHC%)I1.DB, :&H$-[9$$*%[6DB&;=_%1<A
M\K62HI1ER?B"-9+",IC78U^'27F\"G:Q+TB.6'#Y"(UDHD-)3OFY^CQK-?"
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M8CT?:S:"'G_9N^CVQ2_&\_BJ()UQWYF\N;99<DCI*"VBIDW%O@PV)004Q/\
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M%Z0G5 %-(=F\B@J VO=+3E?_ .9O_]H # ,!  (  P   !
M
M
M
M
M
M        .J
M
M             !BD
M
M                   3#D        1^       "2"+P@
M               !
M                        !]V+8=B 2.O$D@>*TO.6T C S0
M                     0H
M                              ?2*25[)_X,:F/!&SD27 6P2:Q
M                           1X
M                                   #DLZA#G.:&R3+9T0" ;3;"8 :
M                                  T
M                                     #/( #J<)430-J%49VE 10:?
M1210!]                                 <^
M                                        !!7,_"9\;X[PG#'^1X8<
M2#0  R4 2074                                 :^@
M                                             "8)98)YWA\?G)A7
MY4#ND7911;:0S(275                                  ""_
M                                  220!+MM\T);P$E3[(240Q [BD2
MRVZ[W TR\2@LX*_.QH?J:2PT@0WK:7AU,1Z$\!/HM.C[;M;[J+<R@     4L
M$H9YO_T$#;&:AM<Q-1D,&<X7 V8RS9;#!LC[(FX(U4J"PAD:U ],.M^@Q+FI
MTD0SIS ?"<2?]SCI;!5G0C$D.=LU#,@S"'D.J9O8Y*T69=./?A@*D\XA1Z
M     <ZE4YYK3-)1D]9&/^ZWG%7\B^,"\"^@.AC] =\F8I[='.YV21) 8(HR
MW9*1)F7EF=AUGN;#4UN)6M;+:#>TK@IX>,
M                            "222220
M       "%>)3%L39= ]PW 9RP0YV&0 65?DU=?\ P
M
M              $T!*84-OW0FYE%&_-7B/\ 7+:N9DH#$60
M
M                        DEMIR3 .S31ZP9(2/:$&P&+$+;T9,
M
M                                 #F*"&]CG!:Z*OCU%4B%EWC0#SP
M
M                                      !/<."N@SK7< ?
M   T
M                                            #S=_        (
M
M                                                  2L
M
M                                                       /W@
M
M
M #\
M
M
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M<ZG1+X]M]2[/CY^F^A,(^3M_G(90\ZAR>NI2=N][_?::E*X]6'K5PG6)V=(
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M]/Q^M]41+]]_M;:4F5><??6>F@D20PK,>N)Z:5SBC;[7]SKNEPS9/$:ZV,I
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MZ9]YQ_?.K3,HSQ/1ZO.D!!=L/7<8W^NL56#,-\"3"]3^C*0$8-,XI^28[Z6
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M,3IP(DQ5/E&'Q/&D@Y#?Y(][3;<U$2[*W^O139&>-2V!RT_Q0/V;4F1+JQ?
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M/DY5/:OG:*A(XU3$>FU9C"^.IC3!-2N"'&+AJ??I>E-1L#>**CIOGK)>JB(
M9,VIX!@]NLHH!8XLLB.'WZ:R,4=RC[\QHVMS7GS4_,;2C;U.:Z7?/76(K[L_
MQ>+X#?B]XOL.(O>B"8N2&%WQLLAWG,S;:C&L[+?,L;<QF=^D#J8@AXB-A]2X
M<<]- 9:&^#)5\>Y9C4 F],U@@C$;5+O>I+J<<T01FW/3:(J&>"MZN:+_ %C>
MR=3U,BYF\FT]0\::(F;V:](]]" W..1^G,U'72YB =H'WC^I@TMU$/%1YKWK
M\2</2\>D>.-=3^9BZX;Z:&-X-_69[G5-#N/Q''GK\5IDF "5LK-8-[VV8W$@
M6A8%VU6;G[>H2R#FJ8BF&X&?SDG_ )[%[<3]VU%;5ZW?F-\QVT;XQO\ CKH!
M,E0J]3GO5]S,:S', ;Q*$3!CGSTAJYYD+]O:_&H8,SW7GERY]-DCF9G^'QU;
MWW(3/GZ_'&D%W8VN)RYDQ$%9>FGDT'.4<YV^3I&@ 91DB;8C8YBN/;544BJ7
M-37Q[\+,-=6#K]G2!P3ZYGUF?CBI )/-V4U]SURHI&MIB9_OIU[Q1;KDXG'S
MO6@*PDR3N1[<T15MLK*D2L7^><;YTP8A(7#,;\Q%[5U=99A!._H\3M.=M<HJ
MZ!J:F_COHD2R9JC(PN]Q73-!0U"G%1@[;=]_&C9/!,X(C;MG:]L+D8,):5&.
MOQYT-;GM\='WAPYU(WOA#;\\='2*)4XD]CM/HWJQ&[$!,[V#$9WYC,+WAUXW
MJ!G>JGK9K.>">L2\I8YPP=Z#*,[E;4XG'&==3TQZF=26!,<.?$_=M 1E/=BX
MQS5<^NHA(90 ()O-3(%[/RFT2%@3M&S.?)F;E)8B4NYGC??MF8.=6,-YK:,]
M3[&)R<?)KO\ ?8_\[CH/N_UJ6>DY_OCIZ'4)MG'7]_X1^8O?J;1Z^NHDPQ]W
M/WK'-??/SSJ%+WKCOUCKW\0-N'OQC)W[NGM/30Z'8G^##[ZO+ 0HSU'C^'B$
M)9"4H-B<&(#C_GR"J$=M_6IXMKCC !&;8\02\YTR$ >1]>/#OTG70/,^=NT0
M63TTA8 PU-&X[D2S?/32YRX'$Q\3XQG>N"7A8](]YQJ1AEF.%O%QF[.VD,S.
M^/@GN>[KJ=K.]\3O6=]M">(XDZ[D1Z:X([(Y[8?LZ4H102,^6XX,=F] A<$'
M+9.WGMEC&C*12'2JPJFYES&&-)(914[+$N8:L)[Z(;%C(=@([J,!GX$P1(DD
M5PDC-WL[^-2@DPD8J>99GQ+VJF6%\4\RQ6>*!7.GN16-W<V_;MJ0B?1>"^U'
MBM2FACR-]6JZ;<NA"!38@$2W$D3O,1OC2HC FR4D;I#-$#Q5)2&A*AIG&(OC
M&*XD%EF<<KF8;O9?,ZE)#'#!OMX1Q'74SMKM6E:MC?&W.=%44*UG<N0Q&6SX
M#/)YD.BJVW>4)"!TL$3,DANN1?!4KSIA MYY$F^,;O.;0%S-JK>XGRRV](U"
M3,RT28N[G#@V,J@0L%@4'DZB8]=]"1)XD#),RB2\%YNZDJ25)%7"L5486N>;
MQ>>DX\IG0-V3D[U^S[-*&#;^?MZ[]OU/C^-=_P!YW]/C;K?2_;[^X[K]QSU^
MSJ/7UQ_7742;>QQMO<9Z\:QXWY9W\<:[O;1'??G/B/&;E[:3NW-1U[5?TTG9
M9VO%_@H^NH\_Q+_?GTTY RT68K9_6#9K2+1-<XVPML7MC&TQZG,QCQ]Z:0$A
M.^[V\=NLZM(FU]7IM^.I.ECB:^_N/%YU^3;FLX]]Y-]) 8F)+W;5!F=YN7@C
M0HO,',]OF>?^A0.0=0<'H:@, :@S!/,:@X-09@GF-0.0?'^(ROE%2CGI^M"A
M!/6N^$B+KMMHD"692:Q)$<1,<>^HH9D&=^.RJBLF^I BH04AM<71*I'5W.IO
M<1Z3&^R:!N7O>+;[;>.[H!L'-^F<Y?ZUG">S>WWXTC.!N839MB?L[:;0^A1G
MK1[>- "91,XO-_P1&.#26">*/R,-7N=],*'<(/;:^_1F=,,9XL$>EGV]%2 Y
M1'M=8V',+K;%>O&T'//'75("#W1YF#TCUU5T]*+\_B]0RY Q3574\\^#2I,$
MQPQ70Y]9U":3%"1CKMZ=;W4.T>DE/ZVSI%H&ZO'>/'&I3>]KCMST^UJ A,.>
MN_%GYQ>T0$,F1VCL./QET#:."_L^((QI+/WZ3YK4' QRF>3[/Z^D_=M!W7/I
MZ?R_.DN?O>-=;VC[[ZZWLZZAZQ]ZGQKK?/XU/([R?/FO.NI\GWJ_&NJ3SO?4
M)Z<^CJ&9K^>,ZHSMM^/7[#I'/'._$7/IWG7$_/ZYU';WG\#K R[3"=MG-1&U
MZAM/F.>GF.V^GECI/R8O]==095:QXQ\3&VL$ O%3$*]OE??_ *3+Q$^_O/?M
MJ( $PB[]S$ULDG?5&>:5J$B>OR2]M0065RL6B',)',XT!H@4!BW+U*@BCO+8
M+2LB^#"USM)H@0A<;N)=\GSC.J("JK>OJ:EY]*]C4-Y@B>F#S& KQJKK.)<?
M!ZZF+-^(X%!S&[4#7.MD\P.^^Y?C/34]4QWZT;5^0X((S7(WWG0#(K?+#Q;+
M$1GI.HBQM$UX<\/V-#B%V<KSND\?/!HL4'6)OQO'WD8O]HK$D4Q.QF>8C*47
M"-TN^T8KC4A=Q$MN6#IYJ.=(2>$9,5UWHW.N-&$%DDB",&U_KSJ=B4%FL2DK
M.?CTT%%AF2LE8P<5P>SH#+DSA(QMOCG/1H-65F,[^ K^HP.:VT3X>AGF-M.0
M.SOS+]9Z:AW^.4VKR_C3%@9.?F#JBW,B\Q$;O%/>Q],'4-;X+9:CI[^SUH:2
M#O87.W\7G4U=RE.]5TY[:87$HJZ\F+C[OJ3;>1P)EDOBIC9(U*. ;P/A-^*:
MS&@J9O$,[5V@-K\:D"[S;HLYOIYW)YA&U0'G[UT.-)S,9^V[XTGN]',3!SOZ
M:/LO7$<_Q6MOS1CU_D-\Z4XQJI.O/[[;0$#=QWZ?>IB0I$"Y>1D(3/Z<G*04
MT*[76".69J:S'_2B/0AF)]>DQ[3H 'J/"JQ2NTOX(TE1MV[X""2O70AQDG$U
M>.O<QO$Z&%AIC)\\1>/&I(4CCH\$7S+%\Q<5&)9X9S;B:E>C1I;@%6) 9CFM
MX_G&AL/(7.)S+'I[N-"$,#(K8]0GK6_.C>!XGZ_U.MLIB=@SZWZW>N97=_0&
M@V85NU;^?37,3WUTWH>W'C70>AKH/0WSK-6=*;5Q/'TZ4:Q5AFX>^3?YYTKQ
M/;MU88H=IU,E]+9+WC'KX;70 1@5_-7Y[4Z63F8R1$-8STKS1I#+/),U5 8B
M;(Q&^?\ YUV42Z!@1_TKXGR:,*$+&W-><X'59?=K)KO\,1HL&V!6[RF+<49V
M8C4LV&0:C8=]LQFH(* RCT,/J>8\:P$O5\T3OJ P1_W0R)N:##0C@Q69]]N,
MH1%)&(,P7>\9[U>=1!2@)')+/>:>W_>$D3D334M1&4.12\<;37?2R"$0Q)<E
M;F2-KZZ98R%#&5G>-C$<\?\ >2@REL"7@9R>^TAJ2S8(0)/7+#H  $!_^9O_
MQ  N$ $! 0 " @$# P0" @(#   !$2$ ,4%187&!D:&Q\&!PP=$0\4#A(#!0
M@)#_V@ ( 0$  3\0_P#Y!KE\07FJ N;T/)A!.USR62KP802(')!1FDXT0+%R
MN'&B3H"'8FAU_?C%5&3D*$%I2!7.^6>!(&A$2",<$2B S\P95T,62I#K08FR
MR@A6X8*M"$A_?=";D2TVXT#M M0!&4QXS,S!$U*0TJB]RW2]!4E(84)2I.FR
MQ<ZEBO3((I)H41/I>^P_'!A$>D$?HBC_ ."A:"=U"?6\JP0JW!W$6_ GT<*,
MLKI[\FY+'2J#KI BAS$(01*(S_P*>S\G*>S\G$-0'M3B/9?4OW>)3Z@'\;P8
M[4(#Y7/%)?C /803I%102LX@)%FB8NZ!![+\<G190P1XC0^2)O\ 0'9M&BG5
M!5\!7@CHT]G]B3G0H0A 6#4J &AG*,RF@!=36+-H%B NDEHK(5.  68*EHMZ
M![-509G> IR(8JB"D@:'NT%\I+7%A DA[Y J5E)C"0;Z< R5@4?"0N-221*H
M'J%U#S0WB0C,80[T2/L?CAJ? 3[Z[(\]+TO(=9T 5^X/Z<_CRGI>4]GY_P":
M>S\\^JEX3WJ<[)/0GI>M]'W\<[UHH4)Z6'N8N\#; P6:_)1[C=ZQCZVC4WDU
MWRR2"KP:FU2[X5Z4+5PE*NVD6"./=M/ 06-/#2-HR+CY/9J,>X88Q5(BRF-"
M79"N&5#?I%\%Z@:0!3G\>4]IS\8UW\"=\9OCE40GACWXGCWPI4-A-?Q$N7_!
M>/\ 240KUMBYWCBK,BB?V-8O9OJ[0!^_#;[@<T>OB\4X=_RZQAX0YJ+&R6>N
M[J6'T;B*FAO,ZN8T^_\ )XND(/[&8_.]9P?+SQ<_+#GZ\UG&V 7T>)ZP^O&S
MR()-^"">\ODG<^+GU2^)TF>^MF<63RXFO_K]_IS3NA.D?E?6AC^SP*@6S^J(
M,SQU/G@@UWJA8ZU8>WQ>^ U-&W=*0Z\=K]77B!)&H2ANFQ&/I(A#Q D;"+5-
M%'3Y:#HH010IJ"M-%T$%81GRBL"M7*@*!?Q_0 E[UZ^#TO. <!D>TX2:>&R@
M'!*&?\@S* 1']?[$"[?8M SYR'FN;.1%1L4E #I.KC&"\ EH8]_4Q[8!D1'+
M1YE.$12$[.J (CA-5FH6]"7PP*W5I6P A9(!L%!,M,[V11)]08IE"T0"LAJ!
MP>5IHZ#[+Z8=+D6" B^1=87DQ1*=A[X+'=&D0*@\@,5]!>!Z(%J 7S" "ICA
MDSF,4AL< (Z84O=(AGD(P))6]I#'0E9Z)O)+#1@I2S((@@"$M&91 E4-#P78
M0:D% M/8I4WDH=1:T*4Y2 '5-3@B@1* Q6'R&S JT(?&!B##0^0?!Z($2YU4
M=H@"HNH46 NM<-E:E^L&6@*%JT++GE0D-00QF(J</RZ.( 9W,(B ""XG%H4T
MQ$$6+BW6<#EI\P/,$@OJG%MI&.29%(5) 8N)*B%5U96A*ZR?XX:M"_D;*J>_
M$SH >T+K:V^%&%[-E;PUG9A([M9VWO@#0;W /\<5,%>LLWSCGXZ\4X4HOH"?
M&F'S^OEYIZ-P#[?K?MQ>U?@#]."&/UJ]_&GKB#8;N0??]CD0.+KI\\NZCYD/
M^YRR..S#N_!_[^>*UH=N^6^,YCZ#T5MOGQ_OFTT/ES[_ #RBU#VJMZWX_P ?
MA0M[,UJ?G[<4NKQZ_(7]^)T01FH&MOH,TO#@L( 31'(DD MJ&<TD[84B%JHU
M(WA(X8J./?:@)(@D/_SX)""#HCB)Y$[''C\@7$+F .6@7%"D6F4P_:1"2\A_
MDW-5$PNCQ4!/[#O$D183;Z(AW"U&1U;8 1"?">9%#OLO:D0&):0&US4>Q$[I
M'EA9,,OV\RB$003.Y3JA0,02*"BC"6J1M $%48:'%LR&0G^6]5)(6:'#0;@.
M44(TZC2:]* 1(@ ]-1T04+3I7F,!+"CW#$'1XV5[;.O;6*@J!AX)Y!6;:\&%
M%;5)&]C>@[6R\/T,6H6 L54,% !ZX& ]DPIT=BFJ"^)P.ZOS=-+""" #&/AP
M IBH,Y%&E"VAQS.@@EU5^;P""F4D A0LKPH"CZ0>C*R *5E*&@2E40*\*C43
MR2M3*U$ Z[G)J2@J5%":Q0 !)I8PC %4,"JX1)J,M)M[-  B%CI2C$@H,<]A
M()J9!:JAPP38.JB)1($%#$\!YW\Q@F34JH@^2 #:=G0QR4G4OVO:KD9+\RG8
MW\G[<JX7Z]>OY/GYY7S)"OS=_3KE-4 ;*7WYCYF4Y0*@X=&7O%MZ[^W,+T'M
M<9WE]>'@F=L03"? WN[]2]@2$=%#$>!VW,[OYXI*AZ@'UUL+N>X>>"(H3V ?
MHOKSG D!M#.H3?5Z/OS :R0WOP7SMX)=*E2D\_H?;>^">NOSGQVS[<O8/#CZ
M_G^N3MDZ*=9[>_?QSMBJU@".=:E8?KW>"T,(=31UQPOS/C3E[X]85_+^YPAY
M40SQ(;_._$YNG ;1[ /D:(X' &@+P1>TZF]22\<AGY@)'8L+U4[?Z"%!99L<
M-P631R#&O,<LJ2+?PJ#Q$:D(\T%I5Y?Z^%1#50!]WB"B*,1J/I.KR7^Z_;A/
MO^3\\3[_ ('SQ/L'UI^+>(=^_ _L/$-?R'[<-]A%2T8("@:K[<A$A!8+8=MH
M7X/MRR.@B=/4@(ML+AR 6\.Z&#J'U.*%.4BHG38A[16A5M7H3@,$)"P073S>
M[TGV80'5I<"8)T=F+W=!P%P@IH0X!T&F -R 7"4$IL<VO%I#1$3I,*3&(!3%
M;=)9V.$(:#(&Y. 8X/L@I5J:@9*';!=4.X(/<%Q-"R*RA+ F-T!"@%H"<QSH
M%I6+42(1W?-CN'6+!.TD^K:G8,X3Q%(J.P45001*<\(N$H!&,(0*'O."Z(XZ
M$"H,]1Q5GERUZ'!PE9'B2/29("3$SVD%SA'I/[8Q$ \T8EJHP UM*T JHH)U
M IP*12(T(Q2 4I=-01%L?=,4U5E6>Z)R(T"JMY.J (J]3M:$E:J@O"2$$(ZI
M7?Q(>\U.4%%/A\?K]/SV<]7?>FK\7>=)'YS)^?\ ?!.3'Q#[93]IS0T^=_P9
MNO;[?CE%:QAZS\[[_3A\/O:?Y/\ ?-0#?'?Z5Y)3'5SSGT?>^.#ZD\Y/+UC\
M]?IT<IZ[G0?KXGE_;@B$G0^+^O?U_P"_7?A_E/AOV\<\.WQ_V9^AP)V_H/ZW
MB#7Q)._PS]N$18[#U?'9^_O>)VG/C]MSOE2&59W]-WX]O?/+3X4L7=BP/59*
M\9.NO'[9Y^_KB+C%'<C&ZVOZ_P!!QC=4(*IFB_&%YHYZ>1IMG.JH$/?)Z'>&
MV&2XX D "#1'I'I$T3$_K?KA=V+BPDFD" :LX)8+/H/5$WP+<JD3*:4 '1_5
M:=G2S>45%M;@#!"$ -(P[2*UVYEX% DJ;S@!0?'P,SS.OCDM+SR#?5_BS.!^
M6_'KTG7\^G$C>R$"M_UX^_%+7/\ 2?=.:#MGV^K_ #>6/"]$?Z_8/SQ@"Z#&
MJFG?:G@KT<Q2(Q?0%\1ZZDV8\A:="(MAU]<^GSP@Y4K4#[ TAD:;#4=)0D'#
M3XIV5IG+J2PAZ0$XCY]" T]D4.J/<@:]#:D*4JUCH( -S"A0/8,8L%.:D428
M0A])(@ITK8073N 3R.;4UH$6F!!"A,B NPBP-%BC26&^0@I1IH!#@]5?2""2
M)"/."E]A<DF"!8I$.(F[*TFB\286)B\K3M1_L0P)V!4#"GT- A6$E*':[%MS
M8K)($2M>?-7$15%]T7?$7&PV7WJ$65+;XQ'/?E<,JD.1/D</<Z#V.9-BHX-
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M-,A T& H7:^*;/080GR-4AKS$9 P!0L2< 0@XP"X( !YG*EF%MQKJEV*8.
M:#AJ@T@'@] 9?$3X#@H:(8[;C1JK=046PJLH(2>!84:A4&#:P)*LSL%-#C-J
M80RTL7>2YQX7&+!T&(T0..= Z@AHI<H@=$RR<KE,IE0"CR*"KEL9 Y*\16@
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MS#9N2T\:K$)^R2F\D2HK#H!6@W$5"B'*9(3!EJ ]J0&<9K5&.<>H Z6V :\
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M#%&IYW@M=22$ @0+$C!S]G::\5M0$]T%<.U-10$V&-@@0"!A&Q&""6AZ"0"
M\W@,"B+. 08%!;T-4V8;M$A $ &95X62$FCI =Y%*5IP]B4':4IVM2$@37R@
M4%A*:,BH5@*(=N+'\C\T*"(IA $5IB-H0)JS0,$03CMLV"A'2#& (&:KB0AD
M/=7S<!(V$PX[(D:1D2<B!H-V%B=$H7QH%B<[X$0@6+ :K0$;#5)0*:I>'8 <
MQ*HD!%U6:#0E!Y(03B^=KG$<H;%:04U.!<##7H@+DT!?(#CQ2T @8 N: CR
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M5!44!'E?A!9E +O9\!?@<-1WVT+JS(/.2C9AX^.20JM*" 8 H>+8O'<, =5
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MPD[AY1OJZ?"UPFPI&H%OH" 7K-A,X1N/X!2H1;T4,N'@"P&T$H+ AZ$HB \
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,R05*P" !_P#K+__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>silk-20191231_g8.jpg
<TEXT>
begin 644 silk-20191231_g8.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_X@) 24-#7U!23T9)3$4  0$   (P041"
M10(0  !M;G1R4D="(%A96B 'SP &  ,       !A8W-P05!03     !N;VYE
M                        ]M8  0    #3+4%$0D4
M                                              IC<')T    _
M #)D97-C   !,    &MW='!T   !G    !1B:W!T   !L    !1R5%)#   !
MQ     YG5%)#   !U     YB5%)#   !Y     YR6%E:   !]    !1G6%E:
M   ""    !1B6%E:   "'    !1T97AT     $-O<'ER:6=H=" Q.3DY($%D
M;V)E(%-Y<W1E;7,@26YC;W)P;W)A=&5D    9&5S8P         1061O8F4@
M4D="("@Q.3DX*0
M
M6%E:(        /-1  $    !%LQ865H@                     &-U<G8
M         0(S  !C=7)V          $",P  8W5R=@         ! C,  %A9
M6B        "<&   3Z4   3\6%E:(        #2-  "@+   #Y5865H@
M    )C$  ! O  "^G/_; (0  0$! @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @$! 0$" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @("_\  $0@(< Q5 P$B  (1 0,1 ?_$ !\  0 !! ,! 0$
M           ( 0<)"@(#!@4$"__$ $00 0 " @$# P,"! 0$! 4 "P ! @,$
M!081$@<3(0@)%"(Q%2-!43)A<? D@9&A%C/1X4)2L<'Q%T-B)32""ADF1%3_
MQ  9 0$  P$!                 @,$ 07_Q  V$0$!  (! P,"! 4#! (#
M 0   0(1(0,2,2)!401Q$S)A@4*1H;'P!13!(U+1X6+Q,W*R8__:  P# 0 "
M$0,1 #\ W^
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M  !^+9WL.+M.7+BQ]X^/<R5Q]_\ 3RM'?_DYX=JMXF:6KDCO^]+UO'_6LS_T
M^ ?J'&+.0
M
M
M
M
M
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M[3#MX\D>6.],D?OWI>MX[?\ \LRFB_4.$7<P
M
M
M
M
M
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ML7PY,>:D_M;%DIDK_P!:6M'_ '=EWX<?L'#SA6+=W1R
M
M
M
M
M
M
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M $_U^#SAT<Q2)[J@
M
M
M
M
M
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M[8C'/Y_L3DKCM6-O!L:WZ<LS7%,Y,F*,/\V:V\/YGZHB9B.WRG.IC?%G\_\
M/AS2Z0^1QW/:6W$3J[>KLQ/?M.#8Q9N_:>T]O"]I^)B8_P"3ZOE'^B;CD.,7
MA7N"H
M
M
M
M
M
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MP
M
M
M
M
M
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M4[@J*=U0
M
M
M
M
M
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MJ'<
M
M
M
M
M
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M>>*]<E>\?O'E2;1WC_7O_D_1%O\ ?_LF.8
M
M
M
M
M
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M]I_HLF4OBRHOV#KC)#EY.CD
M
M
M
M
M
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MX_R_ZN42"H
M
M
M
M
M
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M_>)CX[+99?'*#F.,6B?]PKW=%0
M
M
M
M
M
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M)B?VF/\ 3O'^;L[IN*@
M
M
M
M
M
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MM/PLE1=HIW.X*AW
M
M
M
M
M
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M,I?%E^W\E=CN'&MN[DZ
M
M
M
M
M
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M_'RSDT[UQ[5:4SQCG)&O>U:9;XO<QTM,?KGO$O64R=X[_P!)_:?B8G^OQ/\
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MOB?COWB>_P PT2_TX0=HX1>)_P"3FZ
M
M
M
M
M
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M[\<HN8X^3E#H
M
M
M
M
M
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MK34FNO>,G#\A_"=^:<GO3CXG%.++.[HY-G8T*VY#-6N7!BQTK,>?S6%R./\
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MX6(.0IY0=P5
M
M
M
M
M
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M'<
M
M
M
M
M
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M$
M
M
M
M
M
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MHO2T1-;TM6U+1/\ 6MZ]ZS'Q_26G'*7F66?,NU=EGF:^[](I%N_[*NN
M
M
M
M
M
M
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M_P ERMV"D3W5
M
M
M
M
M
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M-RZU>+O[7E5<+/:O?#AYQ_7X_P!>ZODL1<@
M
M
M
M
M
M
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MO'_[59F._P#EW:<<Y?%E^UVKN-GF6/T#C%X_NKW2<5
M
M
M
M
M
M
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M6QTM,1-^[U];?W_S_O\ Y?T_W_W:)E+S++/T56.P4[G=T5
M
M
M
M
M
M
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M.EN3%LU)KK;&++DK?7R3BV*6Q5O[D7P98G%FK-(G%DK:F3QO6:QZ2<G;X_\
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M#D Z
M
M
M
M
M
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M?,2[XLL1<A3N=P5
M
M
M
M
M
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MK-S[?.O+ZHXQ;O\ _;_-R3
M
M
M
M
M
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MQYI^/Z6O:O?YB$9/4+Z!^C^:T\VGAC)J8<U:4OAV-?4Y3![>/+&:N&L;6/\
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MS1Y8<F/+7^^.]<D?'[_-)M^W[?Z_$KY8K?J'#SAS[N@
M
M
M
M
M
M
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M_P#O]O\ ZKMJU12)[_[_ /14
M
M
M
M
M
M                                                  !3M']E0'"U
M/]_M/^__ '6[ZT]).FNHJ37G.#XODY^(KEV]+#?8IVGO$XMJM:[6*8F(F+8\
MU)B?GNN. Q_]?_;MZ-Y73V=/C=SE^'U]FEL=]#)FQ<]P\X[V\\F.W&\YCVYC
M%DGXMCP;6O3M\=F.OK3[/6;B]W^*]*8-+1WJ[<7_ (EZ?\]RGIOSLZEZ1BS8
M+:U,NWPVQDM6/<C)ES8ZQE[1&*8;"CCX09>KSK+<D]4QSXEEDUE+)-R<>-<>
M$L<KC^6Z]^..>9OC7//GS/;Q&NIAYOZD.C=JW';/4VGR/#8\ML/%X?6GI?)F
MQ?B9<OAAIN=>=,5O@_(P4CPC+LX9MF[^=H[SWB^'#?7CUITKP=>>ZZ]+^6U^
MF=7?KQ>[UEZ3]4Z'J#P&+8B?"^YGZ=SU_C6MHUF(\K4U\M,$WB+Q7O%F;B<-
M9B:S'>LQ,36?FLQ,=IB8GXF)CXF)B8F%A>LOICZ$YV;6W^F]"N:\^5MGCXR\
M5LS>._:]LW&9-2V2T3,]O=]R+?M>+1,PQY?2V:_#O99K=WEE<M6>9GEEA)VR
M_DPPMRO=;PLQZDNIG-XSVF.&-]]^K'''*_PZ[KEK5\W*U%7TN^Y?Z5]49=?#
MPGJ3T5R>QLUO.OQG*;>7I'G+6K-:1CG4Y>M<-\GG/C:?'#$VGQK2(_:<6MZC
MZT5K;;UMW3K>E<D9_9C=TIK:L3%J[O'6V\'A;O\ HM><?E':?&(0:]1/MT</
MRFK?4TM_C]K1G)J9_P"$=8]+\+U-HVMIY9SX<==RF#C>9U\?N=IFU-V\Q^\Q
M>?B8 ]7?;K]3>BM6^UZ7<KU5TIS./).;+L]%]:Y^6Z;VZ9<^39S8;]$=61'X
M^'%$QAU\''YIFE(C%CF:S">7XF.NV_B;NK+C^'9+XYF75F4G/=EE>GXW,>=2
M6./3RO-N'&_^^;^+==.S]L<_V;"'%=1:._3W-+;U=NG];:VQBS=I_M:,=K36
MT?UK:(M'[3$3W?7K?NUS.K?J>]8.A]K#AY33Z=]1\>#7U+[G_B?ISD/2SK*V
M;+6/R-;1V,$5XG<RUR=_;O.;'-X^;QVGS7XZ/^ZAP^CBTXZPZ<]3_3N^QFG%
M.;EN#CKGIF;=N_?%S'"3M;E<,3VBOE:OA7]ZS$3:8=/ZSNO;^'U)>?&&64U+
MV]W=A,I,;?%RN/'.M:MA.C;^6R\;UXR\;UVY3&[U[26_R9OA#OTK^KOI_JW%
M3)T]SG2?55,DS-*=/=1:>/E(Q^/G'N\)R=\&SCR=OWQQGFW?O6*=X[+^Z_J=
MQ7?QV\F?B\DSX>WRNMFTNUI^(K[^2)U+3;_X:TV+3;]XCMVE?AUL,N<<I?;B
MSS\?='+"SBRS]O;YTN./R:F[BSTKDPY*9L=O\.3%>F2D_P"EZ6M6?^4OTQ:%
MJ#D*=U0
M
M
M
M
M
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M;5U]C'DR4\H\HC)BBWNX[3'SXWI6W;^G]&B92^*JLL>H''RA7NDXJ*=U0
M
M
M
M
M
M
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M]_LOEWXY1LT[!3NKW=<
M
M
M
M
M
M                                             4E3Q_W\.0#AX1_^
M.\?_ '6LZW]$NDNH[1DYKI[B]_8K:+TW+ZN/%R&*]8[5R8>0P>UNX<E._P"B
M^//6])_568E=8!C@]8/ML](=48=Z(WN0C/O8\.+);J&F+K'!3#K9/=PX,5N=
MG+R.##[G>,GL\C%[4MXUFJ*?/_;;V^F=+9R]'<)L\3SL[]=S4Y_TVZUY;IC)
MIX,&*E8UO_"7-9LW"9Z[5ZWML:T;62EYOYQEK:E:LY:DPHZWT^.<QF4WVZ[?
M%[=9XY^G<LQWEA+>V3BY3QGE+/IYW&[QXNM<6R6:LU9-2S5\67Q/B-=KGO5C
MUPZ,VYX_E=WB>L.+V<FO&*GJWTGGZ<Y/4O&*9VZUZEX>N;BMK4I-:X\.Q%)F
MU[=^]N\S/L.A?N7\?IQL_P#B/HWU#Z&OIYHIM\ITW:O6W1E(FOQEI6L9[UP>
M,3D[4U:^-)CO/=GIV]+'GI;%FQTRXKQXWQY:1DQVC^UJ7BU+1_E:)A';K+Z2
M.@N:]R^3@<'&[.6MZVV^#R9>&S3[G?SM>NC./6S6M^TSGU\L_P!NT?#/C]'<
M9K'J9\?.6^.-3G>I-:G;V\7WTN_&QOYL?:?EU.9-;\2;M]5WOU;OOI9+TB^N
M'I;JJ<>/IWKKH3J[+:+_ /!8.5KT_P ['C$3%,FAN6RT]_\ O3PP_/>/T?TE
ME/JCJ:]*WY74Y#AXGQ[Y-S7G+J=Y[=NV[I3M:_C,3WBU[4CQ^;>,,87J3]HW
MIK>]R_%Y>&W/*F6N/!U+PF*=FDYN\>YBZ@X.W'\GAOC[Q..9PYI\HBU[6F/F
M,&G]'_K3Z9Y,NQTCU%UQQNICMC]C#QO*X?4+@*8:UGWL67@N8B.7C'>U8M$8
M:5C#CGQK>;=YB6>?5Z<E_P#R37.L;CE.;))CO.9<:MRN>/OQ+PA,<<KQZ?C=
MWOC>[J2SWU)CESJ;]YL*\3S^EOTC-H[>MN8IC_S-7/BV*?\ 7%:W;^WSV?6\
MH:W^A]87J5T[J<?R/6W2_0O6O(;6QMX-GC>DLW)]">H7$4TLE(P;FYI<I.#4
MV*;5+3;'CPVI'G\5M>(F4C>@_NL="SLUXWGN>ZG].^6M>*5XOU,Z>R[?&S?V
MYR=L?4/&UI_)M':)SY=R\Q':UNT3$NWZS'&W'/TY8_FG%D],RL[\;ET[9C9W
M=N=US+S+$.GAW_D]4W9Q,I?3=6]MDSU-7FXSPS9Q:/[N2+/IK]2?']0ZM-KC
M=C@.I-:<<6G<Z/Z@X_EXF)_:9X_-DU]W'^J/\$3F[1^U[3\3>?0]3>&SY*X+
M;L:>S:L6_%Y''EXW8[3\?&/=QX?.._Q%L<WI,_X;2T8=7'*;QREE\67B_;Y_
M9&XV<6:>_'3&3O$3'S$_,3':8F)CXGO'Q,3_ $[?]W;%HG]ECBH
M
M
M
M
M
M
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MTO6+UM%J3'>MJS%JS']XM69B?^4K95;N'&+=_P#?^?9R=
M
M
M
M
M
M
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M/^7_ .%J#F*1*H
M
M
M
M
M
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MM,?UB&C'*7Q=J'T!Q\H_W,?^JO?_ '\)"H
M
M
M
M
M
M
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M%WC)3M^TQ:D=I^)>ABT+U:H
M
M
M
M
M
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M./Y_IWANQSEFY=Q19[>_P]L.NMO[_'_7_P"[L2<
M
M
M
M
M
M
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M8MVC]WOXR?[_ *3_ *3_ %_Y+9478*1*H
M
M
M
M
M
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MJK'KQP]R/V^?_HY1*;BH
M
M
M
M
M
M                                               ./BX^W'[_ #_]
M_P#J[ %INN_0OI'J7O/-\!QN]FF8F-NVO7!O5M$=JVIOZWL[E+5_>LQF_3/S
M'9 GU5^U/T+SF3-LZ-XP9\WNS;!SW'Z?4FE:UZ^-8\]FN#DZ5K,S:+?GY;^7
MSY=^W;*>I,.RZ\<>?Z^1K[ZWVUN?Z#C7OTK/6'&5TN+W<=]STZZVRS;D.6F;
M6XW<W.FNI:1@KKX+?&SJ:F;+%Z3%*VGM'>V6'UQ]:NFIXW5ZHQ]&==;$ZG?)
MQ_4?'[G0?5>MLX\O:=+'MYL5-;=VMBDQ;%FQVIK7M$6K;]FRIX1_N(_]'P^>
MZ;X_D\%M7DM'4Y#6MW\M?=U\.UAGO'C/\O/CO7O,3V[Q$3_FJO1PRZGXF4W>
M-S&_AR\YWQTYCNWOUN[].'3QFL<;+9.KE,;CQ=^_4WU-<8R:[KO&3MWK"X[N
M65MYXPQ].?<CX3A>0S\/U9QOJ%Z;\OI8ZY]S1YK2KUCTWK:WC3).U/,:$;<X
M-/\ 7$3EG8Q^W3OWFO[1._TZ^K?A^?QZV;A>2Z<ZOU]G'.3'FZ3YK6S;GC6.
M]O<XC;O7-2_S'Z(V/T_,?JGXBG6'T-="\E.SEX_5WNF]C:P9=;8R\%NWP:^S
M@RU\+X-GCMJ-KC\V":_IG!&OCI-9_;XACL]5OM&98U/'I.>FL>[AS:^35YS1
MU=OI+J[6P8<LWMJX>2XS8OH9?.LS%LF7'@F_?Q\:443I]3&6S.74QUCV_FMR
MRF4[MSLF.-PRGISN6LIQ=2SSSZ?.L,I/:]TM\3FRSG=WJ=\DXW?-9@\?K1P,
M1'Y>SGXW+V[SK<EH[FKGK$_U\;8;TO6?Z6QWO7^T]IK,]C!!P?I_]1'0]<O%
MXNJ^NMG6G)-M;'RW2'&]7Y-;!3_!BQ<WK9KTV8[7_5Y3%X[5\HB9F(HJS^LR
MQNKA=ZEO;,LIS)=;U-V;U?;<JW#Z66;_ !,/WNK^\U=?SK8X >@Q@
M
M
M
M
M
M
M                      "DJ@.OP_[_ -OC_P"DP[
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
(       !_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>silk-20191231_g9.gif
<TEXT>
begin 644 silk-20191231_g9.gif
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M?XUP6C\CG$&) QP$E^56S 5) #+*4,>7F6CD$T$!#?!PG ,1G+'"(Y'DT 4
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M0(R]<C5 IPUQ^FF B,N8;+T(/7X0Y)"S5,"]$/70 0,,Q : 5(7+)<D*#:W
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M .D<TL2!!% @R&#  !CPE@P00 4#L(\8!)##&*)0+51;81@)<(!^$""'_3"
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M^)I6N!$I-R9E6K!08:L#$0&7, _)1UTK(*( H /Y<+%Q@:T3U /Z %)[D@]
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MG)&3W=274E_ H,'9'8,9$1QP#YTM$I)P# YP+Z_,0N!AXK&!##TU./JG8/V
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MA8@W@CI@K23"53QWJ01LGCOS.I=^J(&/OHC @"^XD*_7RZLZ4P 5EO-<I9[
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M@.9)P!&;3^0(N 2 'Q;2L>2H&!9DX =C_W:UE^,!7G, ZG;-:%)(B.0=V7D
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M0 ]^8:81 _W4UL%]'"8@P  ,.+ "60N:J""( NUEG0#<,01 #V( T !#>PF
MC&$#]-.  V*0"-:)04X&R0 "#0!!!",8H$)Z4$UBP!<+0&68 'P-(,F-'0AP
MCU5">LF>"H8EU.)(*KSX)9IQA5ED00.<"5*7:<HY)YUUVGDGGGGJN2>?;P4$
" #L!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6810517504">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Recurring Assets and Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">$ 104,095<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_MoneyMarketFundsMember', window );">Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">34,363<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate bonds/notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">10,176<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember', window );">Asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">5,181<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, Fair Value Disclosure</a></td>
<td class="nump">104,095<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">34,363<span></span>
</td>
<td class="nump">$ 10,495<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Commercial Paper, Not Included with Cash and Cash Equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">9,919<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Corporate bonds/notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">10,176<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | US Government Agencies Debt Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">44,456<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">5,181<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Redeemable Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,091<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, Fair Value Disclosure</a></td>
<td class="nump">34,363<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 1 | Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">34,363<span></span>
</td>
<td class="nump">10,495<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 1 | Commercial Paper, Not Included with Cash and Cash Equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 1 | Corporate bonds/notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 1 | US Government Agencies Debt Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 1 | Asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 1 | Redeemable Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, Fair Value Disclosure</a></td>
<td class="nump">69,732<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 2 | Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 2 | Commercial Paper, Not Included with Cash and Cash Equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">9,919<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 2 | Corporate bonds/notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">10,176<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 2 | US Government Agencies Debt Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">44,456<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 2 | Asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">5,181<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 2 | Redeemable Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, Fair Value Disclosure</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 3 | Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 3 | Commercial Paper, Not Included with Cash and Cash Equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 3 | Corporate bonds/notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 3 | US Government Agencies Debt Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 3 | Asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 3 | Redeemable Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,091<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=99377789&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109979856&amp;loc=d3e26610-111562<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=82897076&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109250915&amp;loc=d3e13433-108611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperNotIncludedWithCashAndCashEquivalentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperNotIncludedWithCashAndCashEquivalentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_RedeemablePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_RedeemablePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6951409424">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - ASC 842 Impact on Condensed Consolidated Balance Sheet (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Jan. 01, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other non-current assets</a></td>
<td class="nump">$ 3,644<span></span>
</td>
<td class="nump">$ 3,982<span></span>
</td>
<td class="nump">$ 1,029<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued liabilities</a></td>
<td class="nump">15,034<span></span>
</td>
<td class="nump">721<span></span>
</td>
<td class="nump">9,448<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other liabilities</a></td>
<td class="nump">$ 3,700<span></span>
</td>
<td class="nump">4,469<span></span>
</td>
<td class="nump">1,069<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember', window );">Previously Reported</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other non-current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">139<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,069<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RestatementAxis=srt_RestatementAdjustmentMember', window );">Restatement Adjustment | Adjustments Due to ASC 842</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other non-current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,982<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">582<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_RestatementAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_RestatementAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201602Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201602Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6794828400">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Stock-Based Compensation (Details) - Accounting Standards Update 2016-09<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Jan. 01, 2018 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption', window );">Cumulative effect of change in accounting principle/treatment</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember', window );">Accumulated Deficit</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption', window );">Cumulative effect of change in accounting principle/treatment</a></td>
<td class="nump">$ 13<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) to equity or (increase) decrease to net assets, resulting from the cumulative effect adjustment of a new accounting principle applied in the period of adoption.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201609Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201609Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6801508272">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Redeemable Convertible Preferred Stock - Schedule of Redeemable Convertible Preferred Stock (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Shares Authorized (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">24,069,615<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Shares Issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">21,233,190<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Shares Outstanding (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">21,233,190<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLiquidationPreference', window );">Preferential Liquidation Value (in thousands)</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 121,144,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Carrying Value (in thousands)</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 105,235,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember', window );">Series A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Shares Authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,629,629<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Shares Issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,629,626<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Shares Outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,629,626<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLiquidationPreferencePerShare', window );">Per share Preference (in USD per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.70<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLiquidationPreference', window );">Preferential Liquidation Value (in thousands)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,400,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Carrying Value (in thousands)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,369,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=silk_SeriesA1PreferredStockMember', window );">Series A-1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Shares Authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,111,111<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Shares Issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,111,109<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Shares Outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,111,109<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLiquidationPreferencePerShare', window );">Per share Preference (in USD per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.38<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLiquidationPreference', window );">Preferential Liquidation Value (in thousands)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,755,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Carrying Value (in thousands)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,723,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember', window );">Series B</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Shares Authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,264,470<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Shares Issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,264,463<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Shares Outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,264,463<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLiquidationPreferencePerShare', window );">Per share Preference (in USD per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6.11<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLiquidationPreference', window );">Preferential Liquidation Value (in thousands)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 38,276,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Carrying Value (in thousands)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 38,014,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember', window );">Series C</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Shares Authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,064,405<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Shares Issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,227,992<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Shares Outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,227,992<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLiquidationPreferencePerShare', window );">Per share Preference (in USD per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6.11<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLiquidationPreference', window );">Preferential Liquidation Value (in thousands)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 74,713,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Carrying Value (in thousands)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 59,129,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityLiquidationPreference">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate liquidation preference (or restrictions) of stock classified as temporary equity that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.28(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityLiquidationPreference</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityLiquidationPreferencePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The per share liquidation preference (or restrictions) of stock classified as temporary equity that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.28(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityLiquidationPreferencePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of securities classified as temporary equity that are permitted to be issued by an entity's charter and bylaws. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=silk_SeriesA1PreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=silk_SeriesA1PreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6795085680">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments and Contingencies - Balance Sheet Information (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use asset in other non-current assets</a></td>
<td class="nump">$ 3,400<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liability</a></td>
<td class="nump">769<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liability in other liabilities</a></td>
<td class="nump">3,700<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total operating lease liabilities</a></td>
<td class="nump">$ 4,469<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888419&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888419&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888419&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888419&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6958866960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Financial Liabilities Measure on a Recurring Basis</a></td>
<td class="text"><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following tables sets forth by level within the fair value hierarchy the Company&#8217;s assets and liabilities that are reported at fair value as of December&#160;31, 2019 and 2018, using the inputs defined above (in thousands):</span></div><div style="margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:37.743%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:12.583%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.441%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.583%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.441%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.583%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.441%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.585%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-style:italic;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:9pt;font-weight:400;font-style:italic;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="21" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 31, 2019</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Level 1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Level 2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Level 3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Assets:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Money market funds</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">34,363&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">34,363&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Commercial paper</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9,919&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9,919&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Corporate bonds/notes</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10,176&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10,176&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">U.S. government securities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">44,456&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">44,456&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Asset-backed securities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,181&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,181&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">34,363&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">69,732&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">104,095&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span></div><div style="margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:37.743%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:12.583%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.441%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.583%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.441%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.583%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.441%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.585%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-style:italic;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:9pt;font-weight:400;font-style:italic;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="21" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 31, 2018</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Level 1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Level 2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Level 3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Assets:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Money market funds</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10,495&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10,495&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Redeemable convertible warrant liability</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">16,091&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">16,091&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock', window );">Option Pricing Model Assumptions</a></td>
<td class="text"><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Additionally, the model&#8217;s inputs reflected assumptions that market participants would use in pricing the instrument in a current period transaction and included:</span></div><div style="text-align:center;margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:99.839%;"><tr><td style="width:1.0%;"/><td style="width:80.182%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:15.818%;"/><td style="width:1.0%;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 31,</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Time to liquidity (years)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.57</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Expected volatility</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">62.5%&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Discounted cash flow rate</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12.0%&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Risk-free interest rate</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.6%&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Marketability discount rate</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">14%&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">Changes in the Redeemable Convertible Warrant Liability</a></td>
<td class="text"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:84.057%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:11.943%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fair value at December 31, 2017</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,185&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Change in fair value recorded in other income (expense), net</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11,906&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fair value at December 31, 2018</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">16,091&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Change in fair value recorded in other income (expense), net</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">21,030&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Reclassification upon IPO</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(37,121)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fair Value at December 31, 2019</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)<br> -URI http://asc.fasb.org/extlink&amp;oid=99377789&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99377789&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=99377789&amp;loc=d3e19279-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99377789&amp;loc=d3e19190-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6794596896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events</a></td>
<td class="text">Subsequent Events<div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">2019 Equity Incentive Plan</span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In January 2020, the number of shares of common stock authorized for issuance under the 2019 Plan was automatically increased by 1,250,210 shares, which was ratified by the Company's Board of Directors in February 2020.</span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In February 2020, the Company&#8217;s Board of Directors approved the grant of options to purchase 92,885 shares of common stock under the 2019 Plan with an exercise price of $47.20 per share. </span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">2019 Employee Stock Purchase Plan</span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In January 2020, the number of shares of common stock authorized for issuance under the 2019 ESPP was automatically increased by 312,552 shares, which was ratified by the Company's Board of Directors  in February 2020.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI http://asc.fasb.org/topic&amp;trid=2122774<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6716374976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Redeemable Convertible Preferred Stock (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityDisclosureAbstract', window );"><strong>Temporary Equity Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityTableTextBlock', window );">Redeemable Convertible Preferred Stock Issued and Outstanding</a></td>
<td class="text"><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company had the following redeemable convertible preferred stock issued and outstanding at December&#160;31, 2018 (in thousands except share amounts): </span></div><div style="text-align:center;margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:99.839%;"><tr><td style="width:1.0%;"/><td style="width:23.040%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:11.964%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.602%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.964%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.602%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.964%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.602%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.927%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.602%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.933%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Shares<br/>Authorized</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Shares Issued and<br/>Outstanding</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Per share <br/>Preference</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Preferential<br/>Liquidation Value (in thousands)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Carrying Value (in thousands)</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Series</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Series A</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,629,629&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,629,626&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.70&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,400&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,369&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Series A-1</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,111,111&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,111,109&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.38&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,755&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,723&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Series B</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6,264,470&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6,264,463&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6.11&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">38,276&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">38,014&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Series C</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">15,064,405&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12,227,992&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6.11&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">74,713&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">59,129&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">24,069,615&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">21,233,190&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">121,144&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">105,235&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (27)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=d3e177068-122764<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6958878448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Option Plans<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Disclosure of Compensation Related Costs, Share-based Payments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Stock Option Plans</a></td>
<td class="text">Stock Option Plans<div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In 2007, the Company established its 2007 Stock Option Plan which provided for the granting of stock options to employees, directors and consultants of the Company.  In connection with its acquisition of NeuroCo in December 2018, the Company also assumed NeuroCo&#8217;s 2015 Equity Incentive Plan.  In March 2019, the Company's Board of Directors approved the termination of the 2007 Stock Option Plan and the NeuroCo 2015 Equity Incentive Plan and the adoption of the 2019 Equity Incentive Plan, or the 2019 Plan, which became effective immediately prior to the Company's IPO.  The 2019 Plan provides for the grant of ISOs to employees and for the grant of NSOs, restricted stock, restricted stock units, stock appreciation rights, performance units and performance shares to employees, directors and consultants.  A total of 2,317,000 shares of common stock were initially reserved for issuance pursuant to the 2019 Plan.  In addition, the shares reserved for issuance under the 2019 Plan will also include shares reserved but not issued under the 2007 Stock Option Plan, plus any share awards granted under the 2007 Stock Option Plan that expire or terminate without having been exercised in full or that are forfeited or repurchased.  In addition, the number of shares available for issuance under the 2019 Plan will also include an annual increase on the first day of each fiscal year beginning in fiscal 2020, equal to the lesser of (i) 3,000,000 shares; (ii) 4.0% of the outstanding shares of common stock as of the last day of the immediately preceding fiscal year; or (iii) an amount as determined by the Board of Directors.  As of December&#160;31, 2019, the Company has reserved 2,366,251 shares of common stock for issuance under the 2019 Plan.</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The exercise price of ISOs and NSOs shall not be less than 100% and 85% of the estimated fair value of the shares on the date of grant, respectively, as determined by the Board of Directors.  The exercise price of ISOs and NSOs granted to a 10% stockholder shall not be less than 110% of the estimated fair value of the shares on the date of grant as determined by the Board of Directors.  To date, options have a term of ten years and generally vest over 4 years from date of grant.</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Activity under the Company&#8217;s 2007 Stock Option Plan, NeuroCo 2015 Equity Incentive Plan and 2019 Plan is set forth below:</span></div><div style="text-align:center;margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:99.839%;"><tr><td style="width:1.0%;"/><td style="width:32.670%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:10.841%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.602%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.841%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.602%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.754%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.602%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.199%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.602%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.487%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="21" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Options Outstanding</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Shares Available for Grant</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Number of Shares</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted Average Exercise Price</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted Average Remaining Contractual Term (in Years)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Aggregate Intrinsic Value (in thousands)</span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balances, December 31, 2017</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">328,290&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,308,890&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.09&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7.81</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,073&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Authorized</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">223,664&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Options granted</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(629,716)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">629,716&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6.51&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Options exercised</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(438,578)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.50&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Options cancelled</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">135,651&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(135,651)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.56&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balances, December 31, 2018</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">57,889&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,364,377&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.79&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7.36</span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">33,132&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Authorized</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,317,000&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Options granted</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(848,023)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">848,023&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">22.77&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Options exercised</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(873,786)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.77&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Options cancelled</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">27,824&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(27,824)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8.71&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balances December 31, 2019</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,554,690&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,310,790&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7.91&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7.27</span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">140,234&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Vested and exercisable at December 31, 2019</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,514,891&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.27&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6.38</span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">90,854&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Vested and expected to vest at December 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,310,790&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7.91&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7.27</span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">140,234&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The aggregate intrinsic value of options exercised during the years ended December&#160;31, 2019 and 2018 was $24,867,000 and $787,000, respectively.  The aggregate intrinsic value was calculated as the difference between the exercise prices of the underlying options and the estimated fair value of the common stock on the date of exercise.  The weighted-average grant date fair value of options granted during the years ended  December&#160;31, 2019 and 2018 was $10.17 and $2.93 per share, respectively.  The total fair value of options vested during the years ended December&#160;31, 2019 and 2018 was $2,221,000 and $569,000, respectively, based on the grant date fair value.</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table summarizes information about stock options outstanding and vested as of December&#160;31, 2019:</span></div><div style="text-align:center;margin-bottom:12pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:21.444%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.437%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.832%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.597%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:13.311%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.597%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.875%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.597%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.832%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.597%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.881%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Options Outstanding</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Options Vested</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Exercise Price</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Options Outstanding</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted Average Remaining Contractual Term (in Years)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted Average Exercise Price</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Number Exercisable</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted Average Exercise Price</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">$1.35 - $3.16</span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,072,765&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5.86</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.84&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,770,060&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.71&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">$4.73 - $8.27</span></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">919,355&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8.23</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5.81&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">383,077&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5.72&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">$11.29 - $20.00</span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,192,804&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8.73</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">16.63&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">352,383&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">14.46&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">$36.47 - $48.53</span></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">125,866&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9.69</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">40.50&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9,371&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">45.57&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,310,790&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7.27</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7.91&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,514,891&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.27&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">2019 Employee Stock Purchase Plan</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In March 2019, the Company's Board of Directors adopted the 2019 Employee Stock Purchase Plan, or the 2019 ESPP, under which eligible employees are permitted to purchase common stock at a discount through payroll deductions.  A total of 434,000 shares of common stock are reserved for issuance and will be increased on the first day of each fiscal year, beginning in 2020, by an amount equal to the lesser of (i)&#160;1,200,000 shares (ii)&#160;1.0% of the outstanding shares of common stock as of the last day of the immediately preceding fiscal year; or (iii)&#160;an amount as determined by the Board of Directors.  The price of the common stock purchased will be the lower of 85% of the fair market value of the common stock at the beginning of an offering period or at the end of a purchase period.  The 2019 ESPP was effective upon adoption by the Company's Board of Directors but was not in use until the completion of the Company's IPO in April 2019.  The 2019 ESPP is intended to qualify as an "employee stock purchase plan" within the meaning of Section&#160;423 of the Internal Revenue Code of 1986, as amended.</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">As of December&#160;31, 2019, 61,648 shares of common stock have been issued to employees participating in the 2019 ESPP and 372,352 shares were available for future issuance under the 2019 ESPP.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span><br/></span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Stock-Based Compensation</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company estimated the fair value of stock options using the Black&#8211;Scholes option pricing model.  The fair value of employee and nonemployee stock options is being amortized on a straight&#8211;line basis over the requisite service period of the awards.  The fair value of employee and nonemployee stock options was estimated using the following assumptions for the years ended December&#160;31, 2019 and 2018:</span></div><div style="text-align:center;margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:62.903%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:15.147%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:15.149%;"/><td style="width:1.0%;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Year Ended December 31,</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Expected term (in years)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">5.00 - 6.25</span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">5.00 - 6.25</span></div></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Expected volatility</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">42.4% - 42.9%</span></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">38.0% - 38.8%</span></div></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Risk-free interest rate</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">1.47% - 2.54%</span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">2.68% - 2.98%</span></div></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Dividend yield</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;%&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;%&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr></table></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Prior to completion of the Company's IPO, the fair value of common stock was determined by the Company&#8217;s Board of Directors, who considered, among other things, contemporaneous valuations of the Company&#8217;s common stock prepared by an unrelated third-party valuation firm in accordance with the guidance provided by the American Institute of Certified Public Accountants Practice Guide, Valuation of Privately-Held-Company Equity Securities Issued as Compensation.  For stock options granted after the completion of the IPO, the fair value of the underlying common stock is based on the closing price of the Company's common stock on The NASDAQ Global Market on the date of grant.  The expected term of stock options represents the weighted-average period the stock options are expected to remain outstanding.  The Company does not have sufficient historical exercise and post-vesting termination activity to provide accurate data for estimating the expected term of options and has opted to use the &#8220;simplified method,&#8221; whereby the expected term equals the arithmetic average of the vesting term and the original contractual term of the option.  The expected stock price volatility assumption was determined by examining the historical volatilities for industry peers, as the Company does not have sufficient trading history for the Company&#8217;s common stock.  The Company will continue to analyze the historical stock price volatility and expected term assumption as more historical data for the&#160;Company&#8217;s common stock becomes available.  The risk-free interest rate assumption is based on the U.S. Treasury instruments whose term was consistent with the expected term of the&#160;Company&#8217;s stock options.  The expected dividend assumption is based on the Company&#8217;s history and expectation of dividend payouts.</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Effective January 1, 2018, the Company made an accounting policy election to account for forfeitures as they occur. </span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The fair value of the shares to be issued under the Company&#8217;s 2019 ESPP was estimated using the Black-Scholes valuation model with the following assumptions for the year ended December&#160;31, 2019:</span></div><div style="text-align:center;margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:73.961%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:21.238%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Year Ended<br/>December 31,</span></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Expected term (in years)</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">0.50 - 0.63</span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Expected volatility</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">44.4% - 47.8%</span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">1.58% - 2.45%</span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Dividend yield</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;%&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div style="margin-top:18pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Total stock-based compensation expense relating to the Company&#8217;s stock options and 2019 ESPP during the years ended December&#160;31, 2019 and 2018, is as follows (in thousands):</span></div><div style="text-align:center;margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:69.314%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:11.942%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.943%;"/><td style="width:1.0%;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Year Ended December 31,</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cost of goods sold</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">179&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">51&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Research and development expenses</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">426&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">256&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Selling, general and administrative expenses</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,372&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">604&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,977&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">911&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr></table></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">  </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">As of December&#160;31, 2019, there was total unrecognized compensation costs of $8,539,000 related to stock options, which are expected to be recognized over a period of approximately 3.04 years and $219,000 related to the 2019 ESPP, which the Company will recognize over 0.39 years.</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 50<br> -URI http://asc.fasb.org/subtopic&amp;trid=2208855<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6795095904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-term Debt<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Long-term Debt</a></td>
<td class="text">Long-term Debt<div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In October&#160;2015, the Company entered into a term loan agreement with Capital Resource Group ("CRG").  The term loan agreement provides for up to $30,000,000 in term loans split into two tranches as follows: (i) the Tranche A Loans provided for $20,000,000 in term loans, and (ii) the Tranche B Loans provided for up to $10,000,000 in term loans.  The Company drew down the Tranche A Loans on October 13, 2015.  The Tranche B Loans were available to be drawn prior to March 29, 2017.  In January 2017, the term loan agreement was amended to extend the commitment period of the Tranche B Loans to April 28, 2017.  In April 2017, the Company drew down $5,000,000 of the available Tranche B Loans.  </span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In September 2018, the Company entered into Amendment No. 5 to the term loan agreement with CRG.  Under the amended terms of the amended loan agreement the maturity date was extended to December 31, 2022 and the repayment schedule of the existing term loans were changed to interest only so that the outstanding principal amount of the term loans will be payable in a single installment at maturity.  The related fixed interest rate was changed to equal 10.75% per annum, due and payable quarterly in arrears.  At the election of the Company, 2.75% of the interest due and payable may be &#8220;paid in kind&#8221; and added to the then outstanding principal and 8.0% of the interest due and payable paid in cash.  All unpaid principal, and accrued and unpaid interest, is due and payable in full on December 31,&#160;2022.  The amended term loan agreement also provided for additional term loans in an aggregate principal amount of up to $25,000,000 and allowed for the conversion into shares of common stock, at the Company&#8217;s option, of up to 25% of the outstanding loans under the term loan agreement in connection with an initial public offering of the Company&#8217;s common stock which results in market capitalization of at least $250,000,000.  In September 2018, the Company drew down an additional $15,000,000 under the term loan agreement with CRG.  </span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In June 2019, the Company entered into Amendment No. 7 to the term loan agreement with CRG to reflect flexibility with respect to permitted cash investments.</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company may voluntarily prepay the borrowings in full.  The Tranche A borrowing required a payment, on the borrowing date, of a financing fee equal to 1.75% of the borrowed loan principal, which is recorded as a discount to the debt.  In addition, a facility fee equal to 5.0% of the amounts borrowed plus any &#8220;paid in kind&#8221; is payable at the end of the term or when the borrowings are repaid in full.  A long-term </span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">liability is being accreted using the effective interest method for the facility fee over the term of the loan agreement.  The borrowings are collateralized by a security interest in substantially all of the Company&#8217;s assets.</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company is subject to financial covenants related to liquidity and minimum trailing revenue targets that begin in December&#160;31, 2016 and are tested on an annual basis.  The liquidity covenant requires the Company to maintain an amount which shall exceed the greater of (i) $3,000,000 and (ii) the minimum cash balance, if any, required of the Company by a creditor to the extent the&#160;Company has incurred permitted priority debt.  The Company had to achieve minimum net revenue of $1,000,000 in 2016, $5,000,000 in 2017, $15,000,000 in 2018, and must achieve minimum net revenue of $30,000,000 in 2019 and $40,000,000 in 2020.  The liquidity financial covenant has a 90-day equity cure period following end of the calendar year to issue additional shares of equity interests in exchange for cash, or to borrow permitted cure debt.  In addition, the term loan agreement prohibits the payment of cash dividends on the Company&#8217;s capital stock and also places restrictions on mergers, sales of assets, investments, incurrence of liens, incurrence of indebtedness and transactions with affiliates.  CRG may accelerate the payment terms of the term loan agreement upon the occurrence of certain events of default set forth therein, which include the failure of the Company to make timely payments of amounts due under the term loan agreement, the failure of the Company to adhere to the covenants set forth in the term loan agreement, the insolvency of the Company or upon the occurrence of a material adverse change.  As of December&#160;31, 2019, the Company was in compliance with all applicable financial covenants.  As of December&#160;31, 2019, management does not believe that it is probable that the above clauses will be triggered within the next twelve months, therefore, the debt is classified as long-term on the balance sheet.</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Future maturities under the term loan agreement as of December&#160;31, 2019 are as follows (in thousands):</span></div><div style="margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:83.256%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.943%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Year Ending December 31:</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Amount</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,454&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2021</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,442&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2022</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">48,256&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">57,152&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Add: Accretion of closing fees</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,205&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">58,357&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Less: Amount representing interest</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(13,339)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Less: Amount representing debt discount and debt issuance costs</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(139)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:36pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Present value of minimum payments</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">44,879&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In October 2015, CRG purchased 327,759 shares of the Company&#8217;s Series C redeemable convertible preferred stock at $6.11 per share.  In addition, CRG received warrants to purchase 163,877 shares of the Company&#8217;s Series C redeemable convertible preferred stock at an exercise price of $6.11 per share.  Upon the closing of the IPO, the warrants were net exercised, based on the IPO price of $20.00 per share, into shares of common stock. </span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In July 2017, CRG purchased 163,877 shares of the Company&#8217;s Series C convertible preferred stock at $6.11 per share.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.19.3.a.u2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>225</ContextCount>
  <ElementCount>452</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>84</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>6</UnitCount>
  <MyReports>
    <Report instance="silk-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://silkroadmed.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="silk-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1001002 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://silkroadmed.com/role/ConsolidatedBalanceSheets</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="silk-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1002003 - Statement - Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://silkroadmed.com/role/ConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="silk-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1003004 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://silkroadmed.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss</Role>
      <ShortName>Condensed Consolidated Statements of Operations and Comprehensive Loss</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="silk-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1004005 - Statement - Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders' Equity (Deficit)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://silkroadmed.com/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit</Role>
      <ShortName>Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders' Equity (Deficit)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="silk-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1005006 - Statement - Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders' Equity (Deficit) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://silkroadmed.com/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficitParenthetical</Role>
      <ShortName>Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders' Equity (Deficit) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="silk-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>1006007 - Statement - Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://silkroadmed.com/role/ConsolidatedStatementsofCashFlows</Role>
      <ShortName>Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="silk-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>2101101 - Disclosure - Formation and Business of the Company</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://silkroadmed.com/role/FormationandBusinessoftheCompany</Role>
      <ShortName>Formation and Business of the Company</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="silk-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>2103102 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://silkroadmed.com/role/SummaryofSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="silk-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2119103 - Disclosure - Recent Accounting Pronouncements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://silkroadmed.com/role/RecentAccountingPronouncements</Role>
      <ShortName>Recent Accounting Pronouncements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="silk-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2120104 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://silkroadmed.com/role/FairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="silk-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2126105 - Disclosure - Balance Sheet Components</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://silkroadmed.com/role/BalanceSheetComponents</Role>
      <ShortName>Balance Sheet Components</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="silk-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2135106 - Disclosure - Long-term Debt</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://silkroadmed.com/role/LongtermDebt</Role>
      <ShortName>Long-term Debt</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="silk-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2140107 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://silkroadmed.com/role/CommitmentsandContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="silk-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2147108 - Disclosure - Redeemable Convertible Preferred Stock</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://silkroadmed.com/role/RedeemableConvertiblePreferredStock</Role>
      <ShortName>Redeemable Convertible Preferred Stock</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="silk-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2151109 - Disclosure - Stockholders' Equity (Deficit)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://silkroadmed.com/role/StockholdersEquityDeficit</Role>
      <ShortName>Stockholders' Equity (Deficit)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="silk-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2155110 - Disclosure - Stock Option Plans</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://silkroadmed.com/role/StockOptionPlans</Role>
      <ShortName>Stock Option Plans</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="silk-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2162111 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://silkroadmed.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="silk-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2169112 - Disclosure - Acquisition of Variable Interest Entity - NeuroCo</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://silkroadmed.com/role/AcquisitionofVariableInterestEntityNeuroCo</Role>
      <ShortName>Acquisition of Variable Interest Entity - NeuroCo</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="silk-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2171113 - Disclosure - 401(k) Plan</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://silkroadmed.com/role/A401kPlan</Role>
      <ShortName>401(k) Plan</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="silk-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2173114 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://silkroadmed.com/role/SubsequentEvents</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="silk-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2175115 - Disclosure - Quarterly Financial Information (unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://silkroadmed.com/role/QuarterlyFinancialInformationunaudited</Role>
      <ShortName>Quarterly Financial Information (unaudited)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="silk-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2204201 - Disclosure - Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://silkroadmed.com/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="silk-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2305301 - Disclosure - Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesTables</Role>
      <ShortName>Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://silkroadmed.com/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="silk-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2321302 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://silkroadmed.com/role/FairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://silkroadmed.com/role/FairValueMeasurements</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="silk-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2327303 - Disclosure - Balance Sheet Components (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://silkroadmed.com/role/BalanceSheetComponentsTables</Role>
      <ShortName>Balance Sheet Components (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://silkroadmed.com/role/BalanceSheetComponents</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="silk-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2336304 - Disclosure - Long-term Debt (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://silkroadmed.com/role/LongtermDebtTables</Role>
      <ShortName>Long-term Debt (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://silkroadmed.com/role/LongtermDebt</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="silk-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2341305 - Disclosure - Commitments and Contingencies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://silkroadmed.com/role/CommitmentsandContingenciesTables</Role>
      <ShortName>Commitments and Contingencies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://silkroadmed.com/role/CommitmentsandContingencies</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="silk-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2348306 - Disclosure - Redeemable Convertible Preferred Stock (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://silkroadmed.com/role/RedeemableConvertiblePreferredStockTables</Role>
      <ShortName>Redeemable Convertible Preferred Stock (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://silkroadmed.com/role/RedeemableConvertiblePreferredStock</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="silk-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2352307 - Disclosure - Stockholders' Equity (Deficit) (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://silkroadmed.com/role/StockholdersEquityDeficitTables</Role>
      <ShortName>Stockholders' Equity (Deficit) (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://silkroadmed.com/role/StockholdersEquityDeficit</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="silk-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2356308 - Disclosure - Stock Option Plans (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://silkroadmed.com/role/StockOptionPlansTables</Role>
      <ShortName>Stock Option Plans (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://silkroadmed.com/role/StockOptionPlans</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="silk-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2363309 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://silkroadmed.com/role/IncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://silkroadmed.com/role/IncomeTaxes</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="silk-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2376310 - Disclosure - Quarterly Financial Information (unaudited) (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://silkroadmed.com/role/QuarterlyFinancialInformationunauditedTables</Role>
      <ShortName>Quarterly Financial Information (unaudited) (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://silkroadmed.com/role/QuarterlyFinancialInformationunaudited</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="silk-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2402401 - Disclosure - Formation and Business of the Company (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://silkroadmed.com/role/FormationandBusinessoftheCompanyDetails</Role>
      <ShortName>Formation and Business of the Company (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://silkroadmed.com/role/FormationandBusinessoftheCompany</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="silk-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2406402 - Disclosure - Summary of Significant Accounting Policies - Adjustment to Prior Period Financial Statements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesAdjustmenttoPriorPeriodFinancialStatementsDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Adjustment to Prior Period Financial Statements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="silk-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2407403 - Disclosure - Summary of Significant Accounting Policies - Cash, Cash Equivalents and Restricted Cash (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesCashCashEquivalentsandRestrictedCashDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Cash, Cash Equivalents and Restricted Cash (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="silk-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2408404 - Disclosure - Summary of Significant Accounting Policies - Property and Equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Property and Equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="silk-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2409405 - Disclosure - Summary of Significant Accounting Policies - Deferred Initial Public Offering Costs (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesDeferredInitialPublicOfferingCostsDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Deferred Initial Public Offering Costs (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="silk-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2410406 - Disclosure - Summary of Significant Accounting Policies - Leases (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesLeasesDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Leases (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesTables</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="silk-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2411407 - Disclosure - Summary of Significant Accounting Policies - ASC 842 Impact on Condensed Consolidated Balance Sheet (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesASC842ImpactonCondensedConsolidatedBalanceSheetDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - ASC 842 Impact on Condensed Consolidated Balance Sheet (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="silk-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>2412408 - Disclosure - Summary of Significant Accounting Policies - Redeemable Convertible Preferred Stock (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesRedeemableConvertiblePreferredStockDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Redeemable Convertible Preferred Stock (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="silk-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>2413409 - Disclosure - Summary of Significant Accounting Policies - Revenue Recognition (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesRevenueRecognitionDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Revenue Recognition (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="silk-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>2414410 - Disclosure - Summary of Significant Accounting Policies - Advertising Costs (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesAdvertisingCostsDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Advertising Costs (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="silk-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>2415411 - Disclosure - Summary of Significant Accounting Policies - Stock-Based Compensation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesStockBasedCompensationDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Stock-Based Compensation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="silk-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>2416412 - Disclosure - Summary of Significant Accounting Policies - Schedule of Earnings Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesScheduleofEarningsPerShareDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Schedule of Earnings Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="silk-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>2417413 - Disclosure - Summary of Significant Accounting Policies - Schedule of Potentially Dilutive Securities Not Included in Calculation of Earnings per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesScheduleofPotentiallyDilutiveSecuritiesNotIncludedinCalculationofEarningsperShareDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Schedule of Potentially Dilutive Securities Not Included in Calculation of Earnings per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="silk-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>2418414 - Disclosure - Summary of Significant Accounting Policies - Segment and Geographical Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesSegmentandGeographicalInformationDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Segment and Geographical Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="silk-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>2422415 - Disclosure - Fair Value Measurements - Recurring Assets and Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://silkroadmed.com/role/FairValueMeasurementsRecurringAssetsandLiabilitiesDetails</Role>
      <ShortName>Fair Value Measurements - Recurring Assets and Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="silk-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>2423416 - Disclosure - Fair Value Measurements - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://silkroadmed.com/role/FairValueMeasurementsNarrativeDetails</Role>
      <ShortName>Fair Value Measurements - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="silk-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>2424417 - Disclosure - Fair Value Measurements - Fair Value Assumptions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://silkroadmed.com/role/FairValueMeasurementsFairValueAssumptionsDetails</Role>
      <ShortName>Fair Value Measurements - Fair Value Assumptions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="silk-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>2425418 - Disclosure - Fair Value Measurements - Changes in Redeemable Convertible Warrant Liability (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://silkroadmed.com/role/FairValueMeasurementsChangesinRedeemableConvertibleWarrantLiabilityDetails</Role>
      <ShortName>Fair Value Measurements - Changes in Redeemable Convertible Warrant Liability (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="silk-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>2428419 - Disclosure - Balance Sheet Components - Fair Value of Available-For-Sale Investments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://silkroadmed.com/role/BalanceSheetComponentsFairValueofAvailableForSaleInvestmentsDetails</Role>
      <ShortName>Balance Sheet Components - Fair Value of Available-For-Sale Investments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="silk-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>2429420 - Disclosure - Balance Sheet Components - Fair Value of Cash Equivalents, Short-Term and Long-Term Investments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://silkroadmed.com/role/BalanceSheetComponentsFairValueofCashEquivalentsShortTermandLongTermInvestmentsDetails</Role>
      <ShortName>Balance Sheet Components - Fair Value of Cash Equivalents, Short-Term and Long-Term Investments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="silk-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>2430421 - Disclosure - Balance Sheet Components - Available-for-Sale Investments in Unrealized Loss Position (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://silkroadmed.com/role/BalanceSheetComponentsAvailableforSaleInvestmentsinUnrealizedLossPositionDetails</Role>
      <ShortName>Balance Sheet Components - Available-for-Sale Investments in Unrealized Loss Position (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="silk-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>2431422 - Disclosure - Balance Sheet Components - Schedule of Inventory (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://silkroadmed.com/role/BalanceSheetComponentsScheduleofInventoryDetails</Role>
      <ShortName>Balance Sheet Components - Schedule of Inventory (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="silk-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>2432423 - Disclosure - Balance Sheet Components - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://silkroadmed.com/role/BalanceSheetComponentsNarrativeDetails</Role>
      <ShortName>Balance Sheet Components - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="silk-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>2433424 - Disclosure - Balance Sheet Components - Property, Plant and Equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://silkroadmed.com/role/BalanceSheetComponentsPropertyPlantandEquipmentDetails</Role>
      <ShortName>Balance Sheet Components - Property, Plant and Equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="silk-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>2434425 - Disclosure - Balance Sheet Components - Accrued Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://silkroadmed.com/role/BalanceSheetComponentsAccruedLiabilitiesDetails</Role>
      <ShortName>Balance Sheet Components - Accrued Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="silk-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>2437426 - Disclosure - Long-term Debt - Term Loan Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://silkroadmed.com/role/LongtermDebtTermLoanNarrativeDetails</Role>
      <ShortName>Long-term Debt - Term Loan Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="silk-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>2438427 - Disclosure - Long-term Debt - Future Maturities Under the Term Loan (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://silkroadmed.com/role/LongtermDebtFutureMaturitiesUndertheTermLoanDetails</Role>
      <ShortName>Long-term Debt - Future Maturities Under the Term Loan (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="silk-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>2439428 - Disclosure - Long-term Debt - Series C Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://silkroadmed.com/role/LongtermDebtSeriesCNarrativeDetails</Role>
      <ShortName>Long-term Debt - Series C Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="silk-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>2442429 - Disclosure - Commitments and Contingencies - Lease Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://silkroadmed.com/role/CommitmentsandContingenciesLeaseNarrativeDetails</Role>
      <ShortName>Commitments and Contingencies - Lease Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="silk-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>2443430 - Disclosure - Commitments and Contingencies - Balance Sheet Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://silkroadmed.com/role/CommitmentsandContingenciesBalanceSheetInformationDetails</Role>
      <ShortName>Commitments and Contingencies - Balance Sheet Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="silk-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>2444431 - Disclosure - Commitments and Contingencies - Operating Lease Maturities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://silkroadmed.com/role/CommitmentsandContingenciesOperatingLeaseMaturitiesDetails</Role>
      <ShortName>Commitments and Contingencies - Operating Lease Maturities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="silk-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>2445432 - Disclosure - Commitments and Contingencies - Topic 840 Aggregate Future Minimum Lease Payments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://silkroadmed.com/role/CommitmentsandContingenciesTopic840AggregateFutureMinimumLeasePaymentsDetails</Role>
      <ShortName>Commitments and Contingencies - Topic 840 Aggregate Future Minimum Lease Payments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="silk-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>2446433 - Disclosure - Commitments and Contingencies - Purchase Obligation Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://silkroadmed.com/role/CommitmentsandContingenciesPurchaseObligationNarrativeDetails</Role>
      <ShortName>Commitments and Contingencies - Purchase Obligation Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="silk-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>2449434 - Disclosure - Redeemable Convertible Preferred Stock - Schedule of Redeemable Convertible Preferred Stock (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://silkroadmed.com/role/RedeemableConvertiblePreferredStockScheduleofRedeemableConvertiblePreferredStockDetails</Role>
      <ShortName>Redeemable Convertible Preferred Stock - Schedule of Redeemable Convertible Preferred Stock (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="silk-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>2450435 - Disclosure - Redeemable Convertible Preferred Stock - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://silkroadmed.com/role/RedeemableConvertiblePreferredStockNarrativeDetails</Role>
      <ShortName>Redeemable Convertible Preferred Stock - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="silk-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>2453436 - Disclosure - Stockholders' Equity (Deficit) - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://silkroadmed.com/role/StockholdersEquityDeficitNarrativeDetails</Role>
      <ShortName>Stockholders' Equity (Deficit) - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://silkroadmed.com/role/StockholdersEquityDeficitTables</ParentRole>
      <Position>69</Position>
    </Report>
    <Report instance="silk-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>2454437 - Disclosure - Stockholders' Equity (Deficit) - Shares Reserved for Future Issuance (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://silkroadmed.com/role/StockholdersEquityDeficitSharesReservedforFutureIssuanceDetails</Role>
      <ShortName>Stockholders' Equity (Deficit) - Shares Reserved for Future Issuance (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://silkroadmed.com/role/StockholdersEquityDeficitTables</ParentRole>
      <Position>70</Position>
    </Report>
    <Report instance="silk-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>2457438 - Disclosure - Stock Option Plans - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://silkroadmed.com/role/StockOptionPlansNarrativeDetails</Role>
      <ShortName>Stock Option Plans - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="silk-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>2458439 - Disclosure - Stock Option Plans - Activity Under Compensation Plan (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://silkroadmed.com/role/StockOptionPlansActivityUnderCompensationPlanDetails</Role>
      <ShortName>Stock Option Plans - Activity Under Compensation Plan (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="silk-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>2459440 - Disclosure - Stock Option Plans - Information by Exercise Price (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://silkroadmed.com/role/StockOptionPlansInformationbyExercisePriceDetails</Role>
      <ShortName>Stock Option Plans - Information by Exercise Price (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="silk-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>2460441 - Disclosure - Stock Option Plans - Stock Option Assumptions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://silkroadmed.com/role/StockOptionPlansStockOptionAssumptionsDetails</Role>
      <ShortName>Stock Option Plans - Stock Option Assumptions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="silk-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>2461442 - Disclosure - Stock Option Plans - Stock-based Compensation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://silkroadmed.com/role/StockOptionPlansStockbasedCompensationDetails</Role>
      <ShortName>Stock Option Plans - Stock-based Compensation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>75</Position>
    </Report>
    <Report instance="silk-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>2464443 - Disclosure - Income Taxes - Components of Income Before Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://silkroadmed.com/role/IncomeTaxesComponentsofIncomeBeforeTaxesDetails</Role>
      <ShortName>Income Taxes - Components of Income Before Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>76</Position>
    </Report>
    <Report instance="silk-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>2465444 - Disclosure - Income Taxes - Reconciliation of U.S Statutory Rate (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://silkroadmed.com/role/IncomeTaxesReconciliationofUSStatutoryRateDetails</Role>
      <ShortName>Income Taxes - Reconciliation of U.S Statutory Rate (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>77</Position>
    </Report>
    <Report instance="silk-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>2466445 - Disclosure - Income Taxes - Net Deferred Tax Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://silkroadmed.com/role/IncomeTaxesNetDeferredTaxAssetsDetails</Role>
      <ShortName>Income Taxes - Net Deferred Tax Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>78</Position>
    </Report>
    <Report instance="silk-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>2467446 - Disclosure - Income Taxes - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://silkroadmed.com/role/IncomeTaxesNarrativeDetails</Role>
      <ShortName>Income Taxes - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>79</Position>
    </Report>
    <Report instance="silk-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>2468447 - Disclosure - Income Taxes - Reconciliation of Unrecognized Tax Benefits (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://silkroadmed.com/role/IncomeTaxesReconciliationofUnrecognizedTaxBenefitsDetails</Role>
      <ShortName>Income Taxes - Reconciliation of Unrecognized Tax Benefits (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>80</Position>
    </Report>
    <Report instance="silk-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>2470448 - Disclosure - Acquisition of Variable Interest Entity - NeuroCo (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://silkroadmed.com/role/AcquisitionofVariableInterestEntityNeuroCoDetails</Role>
      <ShortName>Acquisition of Variable Interest Entity - NeuroCo (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://silkroadmed.com/role/AcquisitionofVariableInterestEntityNeuroCo</ParentRole>
      <Position>81</Position>
    </Report>
    <Report instance="silk-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>2472449 - Disclosure - 401(k) Plan (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://silkroadmed.com/role/A401kPlanDetails</Role>
      <ShortName>401(k) Plan (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://silkroadmed.com/role/A401kPlan</ParentRole>
      <Position>82</Position>
    </Report>
    <Report instance="silk-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>2474450 - Disclosure - Subsequent Events - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://silkroadmed.com/role/SubsequentEventsNarrativeDetails</Role>
      <ShortName>Subsequent Events - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>83</Position>
    </Report>
    <Report instance="silk-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R84.htm</HtmlFileName>
      <LongName>2477451 - Disclosure - Quarterly Financial Information (unaudited) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://silkroadmed.com/role/QuarterlyFinancialInformationunauditedDetails</Role>
      <ShortName>Quarterly Financial Information (unaudited) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://silkroadmed.com/role/QuarterlyFinancialInformationunauditedTables</ParentRole>
      <Position>84</Position>
    </Report>
    <Report instance="silk-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9999.htm</HtmlFileName>
      <LongName>Uncategorized Items - silk-20191231.htm</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/role/uncategorizedFacts</Role>
      <ShortName>Uncategorized Items - silk-20191231.htm</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>85</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-K" original="silk-20191231.htm">silk-20191231.htm</File>
    <File>silk-20191231.xsd</File>
    <File>silk-20191231_cal.xml</File>
    <File>silk-20191231_def.xml</File>
    <File>silk-20191231_lab.xml</File>
    <File>silk-20191231_pre.xml</File>
    <File>silk201910-kexhibit231.htm</File>
    <File>silk201910-kexhibit311.htm</File>
    <File>silk201910-kexhibit312.htm</File>
    <File>silk201910-kexhibit321.htm</File>
    <File>silk201910-kexhibit45d.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>silk-20191231_g1.jpg</File>
    <File>silk-20191231_g10.gif</File>
    <File>silk-20191231_g11.gif</File>
    <File>silk-20191231_g2.jpg</File>
    <File>silk-20191231_g3.jpg</File>
    <File>silk-20191231_g4.jpg</File>
    <File>silk-20191231_g5.jpg</File>
    <File>silk-20191231_g6.jpg</File>
    <File>silk-20191231_g7.jpg</File>
    <File>silk-20191231_g8.jpg</File>
    <File>silk-20191231_g9.gif</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy>http://fasb.org/srt/2018-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2019-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/us-gaap/2018-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6808295776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="num">$ (52,415)<span></span>
</td>
<td class="num">$ (37,630)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization expense</a></td>
<td class="nump">712<span></span>
</td>
<td class="nump">517<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">2,977<span></span>
</td>
<td class="nump">911<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Change in fair value of redeemable convertible preferred stock warrant liability</a></td>
<td class="nump">21,030<span></span>
</td>
<td class="nump">11,906<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments', window );">Accretion of discount on investments</a></td>
<td class="num">(309)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts', window );">Amortization of debt discount and debt issuance costs</a></td>
<td class="nump">46<span></span>
</td>
<td class="nump">68<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_silk_OperatingLeaseRightOfUseAssetAmortization', window );">Amortization of right-of-use asset</a></td>
<td class="nump">582<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaidInKindInterest', window );">Non-cash interest expense</a></td>
<td class="nump">672<span></span>
</td>
<td class="nump">1,555<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment', window );">Loss on disposal of property and equipment</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">159<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Provision for doubtful accounts receivable</a></td>
<td class="nump">23<span></span>
</td>
<td class="num">(123)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWriteDown', window );">Provision for excess and obsolete inventories</a></td>
<td class="nump">118<span></span>
</td>
<td class="nump">23<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in assets and liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="num">(2,241)<span></span>
</td>
<td class="num">(446)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="num">(4,696)<span></span>
</td>
<td class="num">(2,565)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="num">(1,471)<span></span>
</td>
<td class="num">(1,128)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets', window );">Other assets</a></td>
<td class="nump">552<span></span>
</td>
<td class="num">(62)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="nump">615<span></span>
</td>
<td class="num">(309)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Accrued liabilities</a></td>
<td class="nump">4,964<span></span>
</td>
<td class="nump">5,023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities', window );">Other liabilities</a></td>
<td class="num">(769)<span></span>
</td>
<td class="nump">406<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(29,610)<span></span>
</td>
<td class="num">(21,695)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchase of property and equipment</a></td>
<td class="num">(535)<span></span>
</td>
<td class="num">(2,276)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment', window );">Proceeds from sale of property and equipment</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireInvestments', window );">Purchases of investments</a></td>
<td class="num">(69,421)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(69,956)<span></span>
</td>
<td class="num">(2,270)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Proceeds from initial public offering, net of underwriting discount, commissions and offering costs paid</a></td>
<td class="nump">109,352<span></span>
</td>
<td class="num">(233)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Proceeds from long-term debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">15,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock</a></td>
<td class="nump">2,590<span></span>
</td>
<td class="nump">656<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromMinorityShareholders', window );">Non-controlling interest</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">113,757<span></span>
</td>
<td class="nump">15,424<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net change in cash, cash equivalents and restricted cash</a></td>
<td class="nump">14,191<span></span>
</td>
<td class="num">(8,541)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash, beginning of year</a></td>
<td class="nump">25,300<span></span>
</td>
<td class="nump">33,841<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash, end of year</a></td>
<td class="nump">39,491<span></span>
</td>
<td class="nump">25,300<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental disclosure of cash flow information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Cash paid for interest</a></td>
<td class="nump">4,234<span></span>
</td>
<td class="nump">2,738<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract', window );"><strong>Non-cash investing and financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Accounts payable and accrued liabilities for purchases of property and equipment</a></td>
<td class="nump">32<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForTenantImprovements', window );">Landlord paid tenant improvements</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">794<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_silk_StockIssuanceCostsIncurredButNotYetPaid', window );">Unpaid deferred offering costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">717<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Right-of-use asset obtained in exchange for lease obligation</a></td>
<td class="nump">3,982<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConversionOfStockAmountIssued1', window );">Net exercise of redeemable convertible preferred stock warrants to preferred stock</a></td>
<td class="nump">37,121<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConversionOfStockAmountConverted1', window );">Conversion of redeemable convertible preferred stock to common stock upon initial public offering</a></td>
<td class="nump">144,140<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=silk_RedeemableConvertiblePreferredStockWarrantsMember', window );">Redeemable convertible preferred stock warrants outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromWarrantExercises', window );">Proceeds from exercise of warrants</a></td>
<td class="nump">1,784<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=silk_CommonStockWarrantMember', window );">Common stock warrants outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromWarrantExercises', window );">Proceeds from exercise of warrants</a></td>
<td class="nump">$ 31<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_silk_OperatingLeaseRightOfUseAssetAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Lease, Right-Of-Use Asset, Amortization</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">silk_OperatingLeaseRightOfUseAssetAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>silk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_silk_StockIssuanceCostsIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock Issuance Costs Incurred But Not Yet Paid</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">silk_StockIssuanceCostsIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>silk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=114775744&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCostsAndDiscounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Future cash outflow to pay for purchases of fixed assets that have occurred.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalExpendituresIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockAmountConverted1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The value of the stock converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4313-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4332-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockAmountConverted1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockAmountIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The value of the financial instrument issued [noncash or part noncash] in the conversion of stock. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4304-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4332-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockAmountIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAdjustmentOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (income) related to adjustment to fair value of warrant liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section 25<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=109262497&amp;loc=d3e20148-110875<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAdjustmentOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfPropertyPlantEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWriteDown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 35<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=68049868&amp;loc=SL66093879-108312<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 35<br> -Paragraph 1C<br> -URI http://asc.fasb.org/extlink&amp;oid=68049868&amp;loc=SL66093883-108312<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=66092785&amp;loc=d3e4542-108314<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWriteDown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashInvestingAndFinancingItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaidInKindInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Interest paid other than in cash for example by issuing additional debt securities. As a noncash item, it is added to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaidInKindInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForTenantImprovements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for the allowance granted to lessee and/or direct costs incurred by lessor used to prepare the leased premises for tenant's occupancy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForTenantImprovements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of all investments (debt, security, other) during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's first offering of stock to the public.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromMinorityShareholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from a noncontrolling interest. Includes, but is not limited to, purchase of additional shares or other increase in noncontrolling interest ownership.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromMinorityShareholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromWarrantExercises">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from holders exercising their stock warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromWarrantExercises</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669625-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=84234705&amp;loc=SL4591551-111686<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3000-108585<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=84234705&amp;loc=SL4591552-111686<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense related to write-down of receivables to the amount expected to be collected. Includes, but is not limited to, accounts receivable and notes receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.5)<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=82913815&amp;loc=SL49130534-203044<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=77888399&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=silk_RedeemableConvertiblePreferredStockWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=silk_RedeemableConvertiblePreferredStockWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=silk_CommonStockWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=silk_CommonStockWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6807013952">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Parenthetical) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Shares outstanding (in shares)</a></td>
<td class="nump">31,255,267<span></span>
</td>
<td class="nump">1,135,310<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">31,255,267<span></span>
</td>
<td class="nump">1,135,310<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">100,000,000<span></span>
</td>
<td class="nump">29,879,220<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in USD per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred shares authorized (in shares)</a></td>
<td class="nump">5,000,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred shares (in USD per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLiquidationPreference', window );">Liquidation preference</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 121,144,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Temporary equity, shares outstanding (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">21,233,190<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Temporary equity, shares issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">21,233,190<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Temporary equity, shares authorized (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">24,069,615<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityParOrStatedValuePerShare', window );">Temporary equity, par value (in USD per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Allowances for accounts receivables</a></td>
<td class="nump">$ 45,000<span></span>
</td>
<td class="nump">$ 22,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an unclassified balance sheet, a valuation allowance for receivables due a company that are expected to be uncollectible.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=84173941&amp;loc=d3e5074-111524<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityLiquidationPreference">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate liquidation preference (or restrictions) of stock classified as temporary equity that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.28(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityLiquidationPreference</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share amount of par value or stated value of stock classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=d3e177068-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (27)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of securities classified as temporary equity that are permitted to be issued by an entity's charter and bylaws. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6795085968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Deferred Initial Public Offering Costs (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredOfferingCosts', window );">Deferred initial public offering costs</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 950,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Offering costs</a></td>
<td class="nump">$ 2,481,000<span></span>
</td>
<td class="nump">$ 233,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredOfferingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Specific incremental costs directly attributable to a proposed or actual offering of securities which are deferred at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.A)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011391&amp;loc=d3e105025-122735<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredOfferingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6795016384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity (Deficit) (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfStockByClassTextBlock', window );">Reserved Common Stock for Future Issuances</a></td>
<td class="text"><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">At December&#160;31, 2019 and 2018, the Company had reserved common stock for future issuances as follows:</span></div><div style="text-align:center;margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:70.596%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:11.301%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.302%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 31,</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Conversion of Series A redeemable convertible preferred stock</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,629,629&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Conversion of Series A-1 redeemable convertible preferred stock</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,111,111&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Conversion of Series B redeemable convertible preferred stock</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6,264,470&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Conversion of Series C redeemable convertible preferred stock and warrants</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">15,064,405&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Exercise of options under stock plan</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,310,790&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,364,377&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Issuance of options under stock plan</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,554,690&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">57,889&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Issuance of common stock under employee stock purchase plan</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">372,352&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Warrants to purchase common stock</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7,527&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6,237,832&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">28,499,408&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfStockByClassTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's stock, including par or stated value per share, number and dollar amount of share subscriptions, shares authorized, shares issued, shares outstanding, number and dollar amount of shares held in an employee trust, dividend per share, total dividends, share conversion features, par value plus additional paid in capital, the value of treasury stock and other information necessary to a fair presentation, and EPS information.  Stock by class includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. Includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity. If more than one issue is outstanding, state the title of each issue and the corresponding dollar amount; dollar amount of any shares subscribed but unissued and the deduction of subscriptions receivable there from; number of shares authorized, issued, and outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=65888546&amp;loc=d3e21300-112643<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21553-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=d3e177068-122764<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21538-112644<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21521-112644<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21488-112644<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21506-112644<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21484-112644<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfStockByClassTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6808367024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Formation and Business of the Company (Details)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 13, 2019</div></th>
<th class="th">
<div>Aug. 31, 2019 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Apr. 30, 2019 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 191,526<span></span>
</td>
<td class="nump">$ 139,111<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39,181<span></span>
</td>
<td class="nump">24,990<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Available-for-sale investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">69,732<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1', window );">Reverse stock split</a></td>
<td class="nump">0.3704<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Payments of deferred offering costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,481<span></span>
</td>
<td class="nump">233<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,601<span></span>
</td>
<td class="nump">$ 6,382<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Issued and sold common stock (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Net proceeds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 109,119<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Stock issued, price per share (in USD per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20.00<span></span>
</td>
<td class="nump">$ 20.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=silk_IPOUnderwritingDiscountsAndCommissionsMember', window );">IPO - Underwriting Discounts And Commissions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Payments of deferred offering costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=silk_IPOOtherExpensesMember', window );">IPO - Other Expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Payments of deferred offering costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,481<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=silk_SecondPublicOfferingMember', window );">Second Public Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Issued and sold common stock (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Stock issued, price per share (in USD per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 39.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember', window );">Over-Allotment Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Issued and sold common stock (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">630,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109196051&amp;loc=SL49130549-203045<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109979856&amp;loc=d3e26626-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash received on stock transaction after deduction of issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedOnTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Ratio applied to the conversion of stock split, for example but not limited to, one share converted to two or two shares converted to one.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SAB TOPIC 4.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187143-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteStockSplitConversionRatio1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=silk_IPOUnderwritingDiscountsAndCommissionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=silk_IPOUnderwritingDiscountsAndCommissionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=silk_IPOOtherExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=silk_IPOOtherExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=silk_SecondPublicOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=silk_SecondPublicOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6795078704">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Components - Schedule of Inventory (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryRawMaterialsNetOfReserves', window );">Raw materials</a></td>
<td class="nump">$ 1,203<span></span>
</td>
<td class="nump">$ 1,054<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsNetOfReserves', window );">Finished products</a></td>
<td class="nump">9,119<span></span>
</td>
<td class="nump">4,690<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Total inventory</a></td>
<td class="nump">$ 10,322<span></span>
</td>
<td class="nump">$ 5,744<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=68049868&amp;loc=d3e3927-108312<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterialsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterialsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6800820352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Changes in Redeemable Convertible Warrant Liability (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Beginning balance</a></td>
<td class="nump">$ 16,091<span></span>
</td>
<td class="nump">$ 4,185<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Change in fair value recorded in other income (expense), net</a></td>
<td class="nump">21,030<span></span>
</td>
<td class="num">(11,906)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_silk_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityReclassifications', window );">Reclassification upon IPO</a></td>
<td class="num">(37,121)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Ending balance</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 16,091<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_silk_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityReclassifications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair Value, Measurement With Unobservable Inputs Reconciliation, Recurring Basis, Liability, Reclassifications</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">silk_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityReclassifications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>silk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized on the income statement for financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=99377789&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99377789&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6807854608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-term Debt - Term Loan Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="5">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2018</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Apr. 30, 2017</div></th>
<th class="th"><div>Oct. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_silk_DebtMaximumBorrowingCapacity', window );">Term loan agreement amount</a></td>
<td class="nump">$ 15,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Debt drawn down</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 58,357,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_silk_DebtInstrumentCovenantMaximumLiquidityAmount', window );">Minimum liquidity amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_silk_DebtInstrumentCovenantMinimumNetRevenueAmount', window );">Minimum net revenue target</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,000,000<span></span>
</td>
<td class="nump">$ 15,000,000<span></span>
</td>
<td class="nump">$ 5,000,000<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_silk_DebtInstrumentLiquidityCovenantTerm', window );">Equity cure period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">90 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 44,879,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementScenarioAxis=us-gaap_ScenarioForecastMember', window );">Scenario, Forecast</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_silk_DebtInstrumentCovenantMinimumNetRevenueAmount', window );">Minimum net revenue target</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 40,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=silk_TermLoanMember', window );">Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_silk_DebtMaximumBorrowingCapacity', window );">Term loan agreement amount</a></td>
<td class="nump">$ 25,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">10.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_silk_DebtInstrumentInterestRatePaidInKind', window );">Interest rate paid-in-kind</a></td>
<td class="nump">2.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_silk_DebtInstrumentInterestRatePaidInCash', window );">Interest rate paid in cash</a></td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_silk_DebtInstrumentConvertibleMaximumPercentageOfOutstandingLoans', window );">Percentage of outstanding loans</a></td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_silk_DebtInstrumentConvertibleMarketCapitalization', window );">Market capitalization (greater than)</a></td>
<td class="nump">$ 250,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=silk_TermLoanTrancheAMember', window );">Term Loan, Tranche A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_silk_DebtMaximumBorrowingCapacity', window );">Term loan agreement amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_silk_DebtInstrumentInterestRateFinancingFee', window );">Financing fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.75%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_silk_DebtInstrumentInterestRateFacilityFee', window );">Facility fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=silk_TermLoanTrancheBMember', window );">Term Loan, Tranche B</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_silk_DebtMaximumBorrowingCapacity', window );">Term loan agreement amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Debt drawn down</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_silk_DebtInstrumentConvertibleMarketCapitalization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Convertible, Market Capitalization</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">silk_DebtInstrumentConvertibleMarketCapitalization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>silk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_silk_DebtInstrumentConvertibleMaximumPercentageOfOutstandingLoans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Convertible, Maximum Percentage Of Outstanding Loans</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">silk_DebtInstrumentConvertibleMaximumPercentageOfOutstandingLoans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>silk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_silk_DebtInstrumentCovenantMaximumLiquidityAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Covenant, Maximum Liquidity, Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">silk_DebtInstrumentCovenantMaximumLiquidityAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>silk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_silk_DebtInstrumentCovenantMinimumNetRevenueAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Covenant, Minimum Net Revenue, Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">silk_DebtInstrumentCovenantMinimumNetRevenueAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>silk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_silk_DebtInstrumentInterestRateFacilityFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Interest Rate, Facility Fee</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">silk_DebtInstrumentInterestRateFacilityFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>silk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_silk_DebtInstrumentInterestRateFinancingFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Interest Rate, Financing Fee</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">silk_DebtInstrumentInterestRateFinancingFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>silk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_silk_DebtInstrumentInterestRatePaidInCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Interest Rate, Paid In Cash</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">silk_DebtInstrumentInterestRatePaidInCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>silk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_silk_DebtInstrumentInterestRatePaidInKind">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Interest Rate, Paid-In-Kind</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">silk_DebtInstrumentInterestRatePaidInKind</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>silk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_silk_DebtInstrumentLiquidityCovenantTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Liquidity Covenant, Term</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">silk_DebtInstrumentLiquidityCovenantTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>silk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_silk_DebtMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt, Maximum Borrowing Capacity</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">silk_DebtMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>silk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109500613&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109500613&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementScenarioAxis=us-gaap_ScenarioForecastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementScenarioAxis=us-gaap_ScenarioForecastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=silk_TermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=silk_TermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=silk_TermLoanTrancheAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=silk_TermLoanTrancheAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=silk_TermLoanTrancheBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=silk_TermLoanTrancheBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6801557648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Option Plans - Activity Under Compensation Plan (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_silk_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardsAvailableforGrantRollForward', window );"><strong>Shares Available for Grant</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Beginning balance (in shares)</a></td>
<td class="nump">57,889<span></span>
</td>
<td class="nump">328,290<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized', window );">Authorized (in shares)</a></td>
<td class="nump">2,317,000<span></span>
</td>
<td class="nump">223,664<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Options granted (in shares)</a></td>
<td class="num">(848,023)<span></span>
</td>
<td class="num">(629,716)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod', window );">Options cancelled (in shares)</a></td>
<td class="num">(27,824)<span></span>
</td>
<td class="num">(135,651)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Ending balance (in shares)</a></td>
<td class="nump">1,554,690<span></span>
</td>
<td class="nump">57,889<span></span>
</td>
<td class="nump">328,290<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Number of Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Beginning balance (in shares)</a></td>
<td class="nump">4,364,377<span></span>
</td>
<td class="nump">4,308,890<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Options granted (in shares)</a></td>
<td class="num">(848,023)<span></span>
</td>
<td class="num">(629,716)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Options exercised (in shares)</a></td>
<td class="num">(873,786)<span></span>
</td>
<td class="num">(438,578)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod', window );">Options cancelled (in shares)</a></td>
<td class="num">(27,824)<span></span>
</td>
<td class="num">(135,651)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Ending balance (in shares)</a></td>
<td class="nump">4,310,790<span></span>
</td>
<td class="nump">4,364,377<span></span>
</td>
<td class="nump">4,308,890<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted Average Exercise Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Beginning balance (in USD per share)</a></td>
<td class="nump">$ 3.79<span></span>
</td>
<td class="nump">$ 3.09<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Options granted (in USD per share)</a></td>
<td class="nump">22.77<span></span>
</td>
<td class="nump">6.51<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Options exercised (in USD per share)</a></td>
<td class="nump">1.77<span></span>
</td>
<td class="nump">1.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice', window );">Options cancelled (in USD per share)</a></td>
<td class="nump">8.71<span></span>
</td>
<td class="nump">1.56<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Ending balance (in USD per share)</a></td>
<td class="nump">$ 7.91<span></span>
</td>
<td class="nump">$ 3.79<span></span>
</td>
<td class="nump">$ 3.09<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Contractual Term (in Years), awards outstanding</a></td>
<td class="text">7 years 3 months 7 days<span></span>
</td>
<td class="text">7 years 4 months 9 days<span></span>
</td>
<td class="text">7 years 9 months 21 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate Intrinsic Value, awards outstanding</a></td>
<td class="nump">$ 140,234<span></span>
</td>
<td class="nump">$ 33,132<span></span>
</td>
<td class="nump">$ 5,073<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Number of Shares, vested and exercisable (in shares)</a></td>
<td class="nump">2,514,891<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, vested and exercisable (in USD per share)</a></td>
<td class="nump">$ 4.27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Weighted Average Remaining Contractual Term (in Years), vested and exercisable</a></td>
<td class="text">6 years 4 months 17 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Aggregate Intrinsic Value, vested and exercisable</a></td>
<td class="nump">$ 90,854<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Number of Shares, vested and expect to vest (in shares)</a></td>
<td class="nump">4,310,790<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, vested and expected to vest (in dollars per share)</a></td>
<td class="nump">$ 7.91<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1', window );">Weighted Average Remaining Contractual Term (in Years), vested and expected to vest</a></td>
<td class="text">7 years 3 months 7 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue', window );">Aggregate Intrinsic Value, vested and expected to vest</a></td>
<td class="nump">$ 140,234<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_silk_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardsAvailableforGrantRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Awards Available for Grant [Roll Forward]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">silk_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardsAvailableforGrantRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>silk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of additional shares authorized for issuance under an established share-based compensation plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)-(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price of options that were either forfeited or expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)-(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6606545056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>401(k) Plan (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jan. 01, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent', window );">Percentage employee contribution</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanCostRecognized', window );">Employer discretionary contribution</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch', window );">Employer contribution match percentage</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent', window );">Percent of matching contribution of the employee's pay</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanCostRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanCostRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of employees' gross pay for which the employer contributes a matching contribution to a defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage employer matches of the employee's percentage contribution matched.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum percentage of employee gross pay the employee may contribute to a defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6809002432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Components of Income Before Taxes (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic', window );">United States</a></td>
<td class="num">$ (52,415)<span></span>
</td>
<td class="num">$ (37,630)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign', window );">International</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Total</a></td>
<td class="num">$ (52,415)<span></span>
</td>
<td class="num">$ (37,630)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R9999.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6667138672">
<tr>
<th class="tl" colspan="1">Label</th>
<th class="tl"><strong>Element</strong></th>
<th class="th" colspan="1">Value</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201409Member', window );">Accounting Standards Update 2014-09 [Member]</a></td>
<td class="th" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption', window );">Cumulative Effect of New Accounting Principle in Period of Adoption</a></td>
<td class="th" style="border-bottom: 0px;">us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption</td>
<td class="nump">$ 87,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201409Member', window );">Accounting Standards Update 2014-09 [Member] | Retained Earnings [Member]</a></td>
<td class="th" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption', window );">Cumulative Effect of New Accounting Principle in Period of Adoption</a></td>
<td class="th" style="border-bottom: 0px;">us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption</td>
<td class="nump">87,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201609Member', window );">Accounting Standards Update 2016-09 [Member] | Additional Paid-in Capital [Member]</a></td>
<td class="th" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption', window );">Cumulative Effect of New Accounting Principle in Period of Adoption</a></td>
<td class="th" style="border-bottom: 0px;">us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption</td>
<td class="nump">$ 13,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) to equity or (increase) decrease to net assets, resulting from the cumulative effect adjustment of a new accounting principle applied in the period of adoption.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201409Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201409Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201609Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201609Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6795011104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity (Deficit)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Stockholders' Equity (Deficit)</a></td>
<td class="text">Redeemable Convertible Preferred Stock<div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company had the following redeemable convertible preferred stock issued and outstanding at December&#160;31, 2018 (in thousands except share amounts): </span></div><div style="text-align:center;margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:99.839%;"><tr><td style="width:1.0%;"/><td style="width:23.040%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:11.964%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.602%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.964%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.602%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.964%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.602%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.927%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.602%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.933%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Shares<br/>Authorized</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Shares Issued and<br/>Outstanding</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Per share <br/>Preference</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Preferential<br/>Liquidation Value (in thousands)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Carrying Value (in thousands)</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Series</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Series A</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,629,629&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,629,626&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.70&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,400&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,369&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Series A-1</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,111,111&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,111,109&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.38&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,755&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,723&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Series B</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6,264,470&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6,264,463&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6.11&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">38,276&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">38,014&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Series C</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">15,064,405&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12,227,992&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6.11&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">74,713&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">59,129&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">24,069,615&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">21,233,190&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">121,144&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">105,235&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr></table></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Upon the closing of the IPO, all shares of redeemable convertible preferred stock then outstanding converted into shares of common stock.  As of December&#160;31, 2019, the Company does not have any redeemable convertible preferred stock issued or outstanding.</span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Redeemable Convertible Preferred Stock Warrant</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">s</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Upon the closing of the IPO, all of the outstanding redeemable convertible preferred stock warrants were exercised, or net exercised based on the IPO price of $20.00 per share, into 1,945,365 shares of common stock.  As of December&#160;31, 2019 and 2018, warrants to purchase an aggregate of 0 and  2,672,502, respectively, shares of Series C redeemable convertible preferred stock were outstanding.</span></div>Stockholders' Equity (Deficit)<div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Preferred Stock</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">At December&#160;31, 2019, the Company&#8217;s certificate of incorporation, as amended and restated, authorizes the Company to issue up to 5,000,000 shares of preferred stock with $0.001 par value per share, of which no shares were issued and outstanding.</span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Common Stock</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">At December&#160;31, 2019, the Company&#8217;s certificate of incorporation, as amended and restated, authorizes the Company to issue up to 100,000,000 shares of common stock with $0.001 par value per share, of which 31,255,267 shares were issued and outstanding.  The holders of common stock are also entitled to receive dividends whenever funds are legally available, when and if declared by the Board of Directors.  As of December&#160;31, 2019, no dividends have been declared to date.  Each share of common stock is entitled to one vote.</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">At December&#160;31, 2019 and 2018, the Company had reserved common stock for future issuances as follows:</span></div><div style="text-align:center;margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:70.596%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:11.301%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.302%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 31,</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Conversion of Series A redeemable convertible preferred stock</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,629,629&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Conversion of Series A-1 redeemable convertible preferred stock</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,111,111&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Conversion of Series B redeemable convertible preferred stock</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6,264,470&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Conversion of Series C redeemable convertible preferred stock and warrants</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">15,064,405&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Exercise of options under stock plan</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,310,790&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,364,377&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Issuance of options under stock plan</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,554,690&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">57,889&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Issuance of common stock under employee stock purchase plan</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">372,352&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Warrants to purchase common stock</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7,527&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6,237,832&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">28,499,408&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Common Stock Warrant</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">s</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In connection with the IPO, the common stock warrants were cash, or net exercised based on the IPO price of $20.00 per share into 5,968 shares of common stock.  As of December&#160;31, 2019 and 2018, warrants to purchase an aggregate of 0 and 7,527 shares of common stock were outstanding.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6958878160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Balance Sheet Components<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock', window );">Balance Sheet Components</a></td>
<td class="text">Balance Sheet Components<div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Investments</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The fair value of the Company's available-for-sale investments as of December&#160;31, 2019 are as follows (in thousands):</span></div><div style="margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:31.974%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:16.750%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.441%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.942%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.441%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:13.224%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.441%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:14.187%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-style:italic;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:9pt;font-weight:400;font-style:italic;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="21" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 31, 2019</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gross Unrealized</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Estimated</span></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Amortized Cost&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gains&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Losses&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fair Value&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Money market funds</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">34,363&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">34,363&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Commercial paper</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9,919&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9,919&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Corporate bonds/notes</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10,180&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10,176&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">U.S. government securities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">44,450&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">44,456&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Asset-backed securities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,181&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,181&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">104,093&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">104,095&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Classified as:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">34,363&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Short-term investments</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">51,508&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Long-term investments</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">18,224&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">104,095&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table summarizes the fair value of the Company&#8217;s cash equivalents, short-term and long-term investments classified by maturity as of December&#160;31, 2019 (in thousands):</span></div><div style="margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:80.211%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:15.789%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-style:italic;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:9pt;font-weight:400;font-style:italic;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 31,</span></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Amounts maturing within one year</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">85,871&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Amounts maturing after one year through two years</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">18,224&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">104,095&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Available-for-sale investments held as of December&#160;31, 2019 had a weighted average days to maturity of 291 days. </span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table presents the Company's available-for-sale investments that were in an unrealized loss position as of December&#160;31, 2019 (in thousands):</span></div><div style="margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:62.102%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:15.467%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.441%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:15.790%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-style:italic;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:9pt;font-weight:400;font-style:italic;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-bottom:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 31, 2019</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Less than 12 months</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Assets:</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fair Value</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Unrealized Loss</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Corporate bonds/notes</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10,128&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">U.S. government securities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">19,067&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">29,195&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Inventories</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Components of inventories were as follows (in thousands): </span></div><div style="text-align:center;margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:69.314%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:11.942%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.943%;"/><td style="width:1.0%;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-style:italic;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:9pt;font-weight:400;font-style:italic;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 31,</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Raw materials</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,203&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,054&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Finished products</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9,119&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,690&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10,322&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,744&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr></table></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">As of December&#160;31, 2019 and 2018, there were no work-in-process inventories.</span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Property and Equipment, Net</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Property and equipment, net consisted of the following (in thousands):</span></div><div style="text-align:center;margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:69.314%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:11.942%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.943%;"/><td style="width:1.0%;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-style:italic;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:9pt;font-weight:400;font-style:italic;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 31,</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Furniture and fixtures</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">657&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">517&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Equipment</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,295&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,217&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Software</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">18&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">76&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Leasehold improvements</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,991&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,978&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,961&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,788&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Less:  Accumulated depreciation and amortization</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1,550)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(946)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Add:  Construction-in-progress</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">323&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">38&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,734&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,880&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr></table></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Depreciation and amortization expense was $712,000 and $517,000 for the years ended December&#160;31, 2019 and 2018, respectively.</span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Accrued Liabilities</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Accrued liabilities consisted of the following (in thousands):</span></div><div style="text-align:center;margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:69.314%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:11.942%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.943%;"/><td style="width:1.0%;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-style:italic;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:9pt;font-weight:400;font-style:italic;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 31,</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accrued payroll and related expenses</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9,151&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,157&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Provision for sales returns</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,419&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,862&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accrued professional services</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">682&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,014&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operating lease liability</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">769&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accrued royalty expense</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">470&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">313&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Deferred revenue</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">304&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">137&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accrued travel expenses</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">431&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">270&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accrued clinical expenses</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">241&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">244&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accrued other expenses</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">567&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">451&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">15,034&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9,448&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -URI http://asc.fasb.org/topic&amp;trid=2122208<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalBalanceSheetDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6795061760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Option Plans (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Disclosure of Compensation Related Costs, Share-based Payments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Share-based Compensation, Stock Options, Activity</a></td>
<td class="text"><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Activity under the Company&#8217;s 2007 Stock Option Plan, NeuroCo 2015 Equity Incentive Plan and 2019 Plan is set forth below:</span></div><div style="text-align:center;margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:99.839%;"><tr><td style="width:1.0%;"/><td style="width:32.670%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:10.841%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.602%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.841%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.602%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.754%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.602%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.199%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.602%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.487%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="21" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Options Outstanding</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Shares Available for Grant</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Number of Shares</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted Average Exercise Price</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted Average Remaining Contractual Term (in Years)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Aggregate Intrinsic Value (in thousands)</span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balances, December 31, 2017</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">328,290&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,308,890&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.09&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7.81</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,073&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Authorized</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">223,664&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Options granted</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(629,716)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">629,716&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6.51&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Options exercised</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(438,578)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.50&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Options cancelled</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">135,651&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(135,651)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.56&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balances, December 31, 2018</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">57,889&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,364,377&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.79&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7.36</span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">33,132&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Authorized</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,317,000&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Options granted</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(848,023)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">848,023&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">22.77&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Options exercised</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(873,786)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.77&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Options cancelled</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">27,824&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(27,824)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8.71&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balances December 31, 2019</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,554,690&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,310,790&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7.91&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7.27</span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">140,234&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Vested and exercisable at December 31, 2019</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,514,891&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.27&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6.38</span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">90,854&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Vested and expected to vest at December 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,310,790&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7.91&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7.27</span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">140,234&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock', window );">Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price</a></td>
<td class="text"><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table summarizes information about stock options outstanding and vested as of December&#160;31, 2019:</span></div><div style="text-align:center;margin-bottom:12pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:21.444%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.437%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.832%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.597%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:13.311%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.597%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.875%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.597%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.832%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.597%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.881%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Options Outstanding</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Options Vested</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Exercise Price</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Options Outstanding</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted Average Remaining Contractual Term (in Years)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted Average Exercise Price</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Number Exercisable</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted Average Exercise Price</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">$1.35 - $3.16</span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,072,765&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5.86</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.84&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,770,060&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.71&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">$4.73 - $8.27</span></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">919,355&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8.23</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5.81&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">383,077&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5.72&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">$11.29 - $20.00</span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,192,804&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8.73</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">16.63&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">352,383&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">14.46&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">$36.47 - $48.53</span></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">125,866&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9.69</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">40.50&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9,371&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">45.57&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,310,790&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7.27</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7.91&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,514,891&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.27&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions</a></td>
<td class="text">The fair value of employee and nonemployee stock options was estimated using the following assumptions for the years ended December&#160;31, 2019 and 2018:<table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:62.903%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:15.147%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:15.149%;"/><td style="width:1.0%;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Year Ended December 31,</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Expected term (in years)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">5.00 - 6.25</span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">5.00 - 6.25</span></div></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Expected volatility</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">42.4% - 42.9%</span></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">38.0% - 38.8%</span></div></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Risk-free interest rate</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">1.47% - 2.54%</span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">2.68% - 2.98%</span></div></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Dividend yield</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;%&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;%&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr></table><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The fair value of the shares to be issued under the Company&#8217;s 2019 ESPP was estimated using the Black-Scholes valuation model with the following assumptions for the year ended December&#160;31, 2019:</span></div><div style="text-align:center;margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:73.961%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:21.238%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Year Ended<br/>December 31,</span></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Expected term (in years)</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">0.50 - 0.63</span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Expected volatility</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">44.4% - 47.8%</span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">1.58% - 2.45%</span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Dividend yield</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;%&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Stock-Based Compensation Expense Relating to Stock Options to Employees and Nonemployees</a></td>
<td class="text"><div style="margin-top:18pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Total stock-based compensation expense relating to the Company&#8217;s stock options and 2019 ESPP during the years ended December&#160;31, 2019 and 2018, is as follows (in thousands):</span></div><div style="text-align:center;margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:69.314%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:11.942%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.943%;"/><td style="width:1.0%;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Year Ended December 31,</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cost of goods sold</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">179&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">51&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Research and development expenses</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">426&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">256&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Selling, general and administrative expenses</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,372&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">604&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,977&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">911&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the allocation of equity-based compensation costs to a given line item on the balance sheet and income statement for the period. This may include the reporting line for the costs and the amount capitalized and expensed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6791119760">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Adjustment to Prior Period Financial Statements (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Jan. 01, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems', window );"><strong>Error Corrections and Prior Period Adjustments Restatement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued liabilities</a></td>
<td class="nump">$ 15,034<span></span>
</td>
<td class="nump">$ 721<span></span>
</td>
<td class="nump">$ 9,448<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RestatementAxis=srt_RestatementAdjustmentMember', window );">Restatement Adjustment | Correction Of Provisions For Returns From Customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems', window );"><strong>Error Corrections and Prior Period Adjustments Restatement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,860<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_RestatementAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_RestatementAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis=silk_CorrectionOfProvisionsForReturnsFromCustomersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis=silk_CorrectionOfProvisionsForReturnsFromCustomersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6795040256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders' Equity (Deficit) (Parenthetical) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfStockholdersEquityAbstract', window );"><strong>Statement of Stockholders' Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Offering costs</a></td>
<td class="nump">$ 2,481<span></span>
</td>
<td class="nump">$ 233<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfStockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfStockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6804990016">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 39,181<span></span>
</td>
<td class="nump">$ 24,990<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Short-term investments</a></td>
<td class="nump">51,508<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net of allowances of $45 and $22 at December&#160;31, 2019 and 2018, respectively</a></td>
<td class="nump">8,601<span></span>
</td>
<td class="nump">6,382<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">10,322<span></span>
</td>
<td class="nump">5,744<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">2,878<span></span>
</td>
<td class="nump">1,408<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">112,490<span></span>
</td>
<td class="nump">38,524<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermInvestments', window );">Long-term investments</a></td>
<td class="nump">18,224<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">2,734<span></span>
</td>
<td class="nump">2,880<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashNoncurrent', window );">Restricted cash</a></td>
<td class="nump">310<span></span>
</td>
<td class="nump">310<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other non-current assets</a></td>
<td class="nump">3,644<span></span>
</td>
<td class="nump">1,029<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">137,402<span></span>
</td>
<td class="nump">42,743<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">1,898<span></span>
</td>
<td class="nump">1,252<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued liabilities</a></td>
<td class="nump">15,034<span></span>
</td>
<td class="nump">9,448<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">16,932<span></span>
</td>
<td class="nump">10,700<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">44,879<span></span>
</td>
<td class="nump">44,201<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_silk_PreferredStockWarrantLiability', window );">Redeemable convertible preferred stock warrant liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">16,091<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other liabilities</a></td>
<td class="nump">3,700<span></span>
</td>
<td class="nump">1,069<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">65,511<span></span>
</td>
<td class="nump">72,061<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies (Note 7)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterestsAbstract', window );"><strong>Redeemable convertible preferred stock issuable in series, $0.001 par value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Liquidation preference: $121,144 at December 31, 2017 and 2018</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">105,235<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract', window );"><strong>Preferred stock, $0.001 par value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Shares authorized: 5,000,000 and none at December 31, 2019 and 2018, respectively</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Shares issued and outstanding: 31,255,267 and 1,135,310 at December 31, 2019 and 2018, respectively</a></td>
<td class="nump">31<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">263,384<span></span>
</td>
<td class="nump">4,557<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive income</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(191,526)<span></span>
</td>
<td class="num">(139,111)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders&#8217; equity (deficit)</a></td>
<td class="nump">71,891<span></span>
</td>
<td class="num">(134,553)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders&#8217; equity (deficit)</a></td>
<td class="nump">$ 137,402<span></span>
</td>
<td class="nump">$ 42,743<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_silk_PreferredStockWarrantLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Preferred Stock Warrant Liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">silk_PreferredStockWarrantLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>silk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109196051&amp;loc=SL49130549-203045<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669686-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6801-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=82911808&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=68049868&amp;loc=d3e3927-108312<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6812-107765<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=SL98516268-108586<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 305<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=84242212&amp;loc=d3e2352-115587<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(g))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterestsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterestsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6800642624">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Leases (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Jan. 01, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use asset</a></td>
<td class="nump">$ 3,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Operating lease liabilities</a></td>
<td class="nump">$ 4,469<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201602Member', window );">Adjustments Due to ASC 842</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,982<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Operating lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,190<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888419&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888419&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201602Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201602Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6807389712">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Components - Accrued Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Jan. 01, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedSalariesCurrent', window );">Accrued payroll and related expenses</a></td>
<td class="nump">$ 9,151<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,157<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_silk_ProvisionsForSalesReturns', window );">Provision for sales returns</a></td>
<td class="nump">2,419<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,862<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedProfessionalFeesCurrent', window );">Accrued professional services</a></td>
<td class="nump">682<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,014<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liability</a></td>
<td class="nump">769<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedRoyaltiesCurrent', window );">Accrued royalty expense</a></td>
<td class="nump">470<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">313<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Deferred revenue</a></td>
<td class="nump">304<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">137<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_silk_AccruedTravelExpensesCurrent', window );">Accrued travel expenses</a></td>
<td class="nump">431<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">270<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_silk_AccruedClinicalExpensesCurrent', window );">Accrued clinical expenses</a></td>
<td class="nump">241<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">244<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Accrued other expenses</a></td>
<td class="nump">567<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">451<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued liabilities</a></td>
<td class="nump">$ 15,034<span></span>
</td>
<td class="nump">$ 721<span></span>
</td>
<td class="nump">$ 9,448<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_silk_AccruedClinicalExpensesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued Clinical Expenses, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">silk_AccruedClinicalExpensesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>silk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_silk_AccruedTravelExpensesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued Travel Expenses, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">silk_AccruedTravelExpensesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>silk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_silk_ProvisionsForSalesReturns">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Provisions For Sales Returns</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">silk_ProvisionsForSalesReturns</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>silk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedProfessionalFeesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6911-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedProfessionalFeesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedRoyaltiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for royalties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6911-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6935-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedRoyaltiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedSalariesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of the obligations incurred through that date and payable for employees' services provided. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6911-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedSalariesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=82913815&amp;loc=SL49130532-203044<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=82913815&amp;loc=SL49130531-203044<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109196051&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888419&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e7018-107765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6800144784">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Components - Available-for-Sale Investments in Unrealized Loss Position (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Fair Value, Less than 12 months</a></td>
<td class="nump">$ 29,195<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Unrealized Loss, Less than 12 months</a></td>
<td class="num">(7)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate bonds/notes</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Fair Value, Less than 12 months</a></td>
<td class="nump">10,128<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Unrealized Loss, Less than 12 months</a></td>
<td class="num">(4)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember', window );">U.S. government securities</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Fair Value, Less than 12 months</a></td>
<td class="nump">19,067<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Unrealized Loss, Less than 12 months</a></td>
<td class="num">$ (3)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=82897076&amp;loc=d3e27337-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=82897076&amp;loc=d3e27337-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6806972672">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Fair Value Assumptions (Details) - Recurring - Level 3<br></strong></div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Time to liquidity (years)</a></td>
<td class="text">6 months 25 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Expected volatility</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Measurement input</a></td>
<td class="nump">0.625<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Discounted cash flow rate</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Measurement input</a></td>
<td class="nump">0.120<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Risk-free interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Measurement input</a></td>
<td class="nump">0.026<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Marketability discount rate</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Measurement input</a></td>
<td class="nump">0.14<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=99377789&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=99377789&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputOptionVolatilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputOptionVolatilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountForLackOfMarketabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountForLackOfMarketabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6808512288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Option Plans - Information by Exercise Price (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options Outstanding (in shares)</a></td>
<td class="nump">4,310,790<span></span>
</td>
<td class="nump">4,364,377<span></span>
</td>
<td class="nump">4,308,890<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Contractual Term (in Years)</a></td>
<td class="text">7 years 3 months 7 days<span></span>
</td>
<td class="text">7 years 4 months 9 days<span></span>
</td>
<td class="text">7 years 9 months 21 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price (in USD per share)</a></td>
<td class="nump">$ 7.91<span></span>
</td>
<td class="nump">$ 3.79<span></span>
</td>
<td class="nump">$ 3.09<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Number Exercisable (in shares)</a></td>
<td class="nump">2,514,891<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, vested and exercisable (in USD per share)</a></td>
<td class="nump">$ 4.27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=silk_ExercisePriceOneMember', window );">Exercise Price One</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options Outstanding (in shares)</a></td>
<td class="nump">2,072,765<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Contractual Term (in Years)</a></td>
<td class="text">5 years 10 months 9 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price (in USD per share)</a></td>
<td class="nump">$ 1.84<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Number Exercisable (in shares)</a></td>
<td class="nump">1,770,060<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, vested and exercisable (in USD per share)</a></td>
<td class="nump">$ 1.71<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=silk_ExercisePriceOneMember', window );">Exercise Price One | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_silk_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice', window );">Exercise Price (in USD per share)</a></td>
<td class="nump">1.35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=silk_ExercisePriceOneMember', window );">Exercise Price One | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_silk_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice', window );">Exercise Price (in USD per share)</a></td>
<td class="nump">$ 3.16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=silk_ExercisePriceTwoMember', window );">Exercise Price Two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options Outstanding (in shares)</a></td>
<td class="nump">919,355<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Contractual Term (in Years)</a></td>
<td class="text">8 years 2 months 23 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price (in USD per share)</a></td>
<td class="nump">$ 5.81<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Number Exercisable (in shares)</a></td>
<td class="nump">383,077<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, vested and exercisable (in USD per share)</a></td>
<td class="nump">$ 5.72<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=silk_ExercisePriceTwoMember', window );">Exercise Price Two | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_silk_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice', window );">Exercise Price (in USD per share)</a></td>
<td class="nump">4.73<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=silk_ExercisePriceTwoMember', window );">Exercise Price Two | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_silk_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice', window );">Exercise Price (in USD per share)</a></td>
<td class="nump">$ 8.27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=silk_ExercisePriceThreeMember', window );">Exercise Price Three</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options Outstanding (in shares)</a></td>
<td class="nump">1,192,804<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Contractual Term (in Years)</a></td>
<td class="text">8 years 8 months 23 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price (in USD per share)</a></td>
<td class="nump">$ 16.63<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Number Exercisable (in shares)</a></td>
<td class="nump">352,383<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, vested and exercisable (in USD per share)</a></td>
<td class="nump">$ 14.46<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=silk_ExercisePriceThreeMember', window );">Exercise Price Three | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_silk_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice', window );">Exercise Price (in USD per share)</a></td>
<td class="nump">11.29<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=silk_ExercisePriceThreeMember', window );">Exercise Price Three | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_silk_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice', window );">Exercise Price (in USD per share)</a></td>
<td class="nump">$ 20.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=silk_ExercisePriceFourMember', window );">Exercise Price Four</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options Outstanding (in shares)</a></td>
<td class="nump">125,866<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Contractual Term (in Years)</a></td>
<td class="text">9 years 8 months 8 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price (in USD per share)</a></td>
<td class="nump">$ 40.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Number Exercisable (in shares)</a></td>
<td class="nump">9,371<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, vested and exercisable (in USD per share)</a></td>
<td class="nump">$ 45.57<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=silk_ExercisePriceFourMember', window );">Exercise Price Four | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_silk_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice', window );">Exercise Price (in USD per share)</a></td>
<td class="nump">36.47<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=silk_ExercisePriceFourMember', window );">Exercise Price Four | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_silk_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice', window );">Exercise Price (in USD per share)</a></td>
<td class="nump">$ 48.53<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_silk_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Outstanding And Exercisable, Weighted Average Exercise Price</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">silk_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>silk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=silk_ExercisePriceOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=silk_ExercisePriceOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=silk_ExercisePriceTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=silk_ExercisePriceTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=silk_ExercisePriceThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=silk_ExercisePriceThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=silk_ExercisePriceFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=silk_ExercisePriceFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6950206240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events - Narrative (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Feb. 29, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Jan. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Shares of common stock reserved for issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">848,023<span></span>
</td>
<td class="nump">629,716<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Exercise price (in USD per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 22.77<span></span>
</td>
<td class="nump">$ 6.51<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock reserved for future issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,237,832<span></span>
</td>
<td class="nump">28,499,408<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">2019 ESPP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock reserved for future issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">372,352,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">434,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=silk_TwoThousandNineteenStockOptionPlanMember', window );">2019 Stock Option Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Shares of common stock reserved for issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,366,251<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,317,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | 2019 ESPP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock reserved for future issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">312,552<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | 2019 Stock Option Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Shares of common stock reserved for issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,250,210<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Shares of common stock reserved for issuance (in shares)</a></td>
<td class="nump">92,885<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Exercise price (in USD per share)</a></td>
<td class="nump">$ 47.20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of shares (or other type of equity) originally approved (usually by shareholders and board of directors), net of any subsequent amendments and adjustments, for awards under the equity-based compensation plan. As stock or unit options and equity instruments other than options are awarded to participants, the shares or units remain authorized and become reserved for issuance under outstanding awards (not necessarily vested).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=silk_TwoThousandNineteenStockOptionPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=silk_TwoThousandNineteenStockOptionPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6625121136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Reconciliation of U.S Statutory Rate (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate', window );">Tax at federal statutory rate</a></td>
<td class="num">$ (11,007)<span></span>
</td>
<td class="num">$ (7,902)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes', window );">State taxes, net of federal benefit</a></td>
<td class="num">(2,270)<span></span>
</td>
<td class="num">(1,582)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationNondeductibleExpense', window );">Permanent differences</a></td>
<td class="num">(4,731)<span></span>
</td>
<td class="nump">289<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_silk_EffectiveIncomeTaxRateReconciliationWarrantLiabilityAdjustmentAmount', window );">Loss on Series C warrant liability</a></td>
<td class="nump">5,330<span></span>
</td>
<td class="nump">2,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Change in valuation allowance</a></td>
<td class="nump">12,797<span></span>
</td>
<td class="nump">6,197<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationTaxCredits', window );">General business credits</a></td>
<td class="num">(319)<span></span>
</td>
<td class="nump">136<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationOtherReconcilingItems', window );">Other</a></td>
<td class="nump">208<span></span>
</td>
<td class="nump">376<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="nump">$ 8<span></span>
</td>
<td class="nump">$ 14<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_silk_EffectiveIncomeTaxRateReconciliationWarrantLiabilityAdjustmentAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Warrant Liability Adjustment, Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">silk_EffectiveIncomeTaxRateReconciliationWarrantLiabilityAdjustmentAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>silk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109238882&amp;loc=d3e38679-109324<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=84176650&amp;loc=d3e32123-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationNondeductibleExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationNondeductibleExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationOtherReconcilingItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax exempt income, equity in earnings (loss) of an unconsolidated subsidiary, minority noncontrolling interest income (loss), tax holiday, disposition of a business, disposition of an asset, repatriation of foreign earnings, repatriation of foreign earnings jobs creation act of 2004, increase (decrease) in enacted tax rate, prior year income taxes, increase (decrease) in deferred tax asset valuation allowance, and other adjustments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationOtherReconcilingItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationTaxCredits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax credits. Including, but not limited to, research credit, foreign tax credit, investment tax credit, and other tax credits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationTaxCredits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6681257872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Redeemable Convertible Preferred Stock (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">8 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfUnits', window );">Conversion of preferred stock to common stock upon IPO</a></td>
<td class="nump">$ 144,140<span></span>
</td>
<td class="nump">$ 144,140<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits', window );">Conversion of preferred stock to common stock upon IPO (in shares)</a></td>
<td class="nump">23,178,555<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueConversionOfUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueConversionOfUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6799892064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Schedule of Earnings Per Share (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="8">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
<th class="th"><div>Mar. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss attributable to Silk Road Medical, Inc. common stockholders</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (52,415)<span></span>
</td>
<td class="num">$ (37,629)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Weighted average common stock outstanding used to compute net loss per share, basic and diluted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,956,679<span></span>
</td>
<td class="nump">960,882<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Net loss per share, basic and diluted (in USD per share)</a></td>
<td class="num">$ (0.27)<span></span>
</td>
<td class="num">$ (0.26)<span></span>
</td>
<td class="num">$ (0.42)<span></span>
</td>
<td class="num">$ (20.12)<span></span>
</td>
<td class="num">$ (14.12)<span></span>
</td>
<td class="num">$ (8.49)<span></span>
</td>
<td class="num">$ (8.16)<span></span>
</td>
<td class="num">$ (7.31)<span></span>
</td>
<td class="num">$ (2.28)<span></span>
</td>
<td class="num">$ (39.16)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109260490&amp;loc=d3e1337-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=114873765&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669625-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=114873790&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6795034896">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Narrative (Details)<br></strong></div></th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Fair value of stock (in USD per share)</a></td>
<td class="nump">$ 11.29<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6958823664">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments and Contingencies - Purchase Obligation Narrative (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PurchaseObligation', window );">Purchase obligation</a></td>
<td class="nump">$ 7,097,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PurchaseObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Minimum amount of purchase arrangement in which the entity has agreed to expend funds to procure goods or services from a supplier.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PurchaseObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6791559680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies - Lease Narrative (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRenewalTerm', window );">Renewal term</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease costs</a></td>
<td class="nump">$ 870<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating lease liabilities</a></td>
<td class="nump">$ 721<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted average discount rate</a></td>
<td class="nump">6.50%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted average remaining lease term</a></td>
<td class="text">4 years 9 months 29 days<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseRenewalTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseRenewalTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=77888399&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888419&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=77888399&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=77888399&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6958775824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_silk_AssetsAndLiabilitiesLesseeTableTextBlock', window );">Balance Sheet Information</a></td>
<td class="text"><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The disclosure impact of the adoption of ASC 842 on the balance sheet was as follows (in thousands):</span></div><div style="margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:51.685%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:13.224%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.441%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.903%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.441%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.906%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance Sheet:</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance at December 31, 2018</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Adjustments Due to ASC 842</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance at January 1, 2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other non-current assets</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,982&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,982&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accrued liabilities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">139&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">582&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">721&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other liabilities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,069&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,400&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,469&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div>Balance sheet information as of December&#160;31, 2019 consists of the following (in thousands):<table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:77.647%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.441%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:17.712%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operating Lease:</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operating lease right-of-use asset in other non-current assets</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,400&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operating lease liability in accrued liabilities</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">769&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operating lease liability in other liabilities</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,700&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total operating lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,469&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Operating Lease Maturities</a></td>
<td class="text"><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table summarizes the Company's operating lease maturities as of December&#160;31, 2019 (in thousands):</span></div><div style="margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:76.980%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.436%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:18.384%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Year Ending December 31:</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Amount</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,037&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2021</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,066&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2022</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,096&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2023</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,127&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2024</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">904&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total lease payments</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,230&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Less: imputed interest</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(761)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:18pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Present value of lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,469&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock', window );">Minimum Future Lease Payment Previously Disclosed Under ASC 840</a></td>
<td class="text"><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The aggregate future minimum lease payments under ASC 840 as of December&#160;31, 2018 were as follows (in thousands):</span></div><div style="margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:83.416%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.441%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.943%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Year Ending December 31:</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total Minimum<br/>Lease Payments</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,002&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,002&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2021</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,031&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2022</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,044&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2023 and thereafter</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,920&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,999&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_silk_AssetsAndLiabilitiesLesseeTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Assets And Liabilities, Lessee [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">silk_AssetsAndLiabilitiesLesseeTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>silk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of future minimum payments required in the aggregate and for each of the five succeeding fiscal years for operating leases having initial or remaining noncancelable lease terms in excess of one year and the total minimum rentals to be received in the future under noncancelable subleases as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6805088592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock', window );">Restrictions on Cash and Cash Equivalents</a></td>
<td class="text"><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the balance sheets that sum to the total of the same amounts shown in the statements of cash flows (in thousands):</span></div><div style="margin-bottom:12pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:69.314%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:11.942%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.943%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 31,</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cash and cash equivalents</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">39,181&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">24,990&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Restricted cash</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">310&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">310&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total cash, cash equivalents and restricted cash</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">39,491&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">25,300&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock', window );">Schedule of Cash and Cash Equivalents</a></td>
<td class="text"><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the balance sheets that sum to the total of the same amounts shown in the statements of cash flows (in thousands):</span></div><div style="margin-bottom:12pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:69.314%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:11.942%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.943%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 31,</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cash and cash equivalents</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">39,181&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">24,990&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Restricted cash</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">310&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">310&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total cash, cash equivalents and restricted cash</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">39,491&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">25,300&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_silk_AssetsAndLiabilitiesLesseeTableTextBlock', window );">Schedule of ASC 842 Impact of Adoption on Condensed Consolidated Balance Sheet</a></td>
<td class="text"><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The disclosure impact of the adoption of ASC 842 on the balance sheet was as follows (in thousands):</span></div><div style="margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:51.685%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:13.224%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.441%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.903%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.441%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.906%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance Sheet:</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance at December 31, 2018</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Adjustments Due to ASC 842</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance at January 1, 2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other non-current assets</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,982&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,982&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accrued liabilities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">139&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">582&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">721&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other liabilities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,069&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,400&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,469&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div>Balance sheet information as of December&#160;31, 2019 consists of the following (in thousands):<table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:77.647%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.441%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:17.712%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operating Lease:</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operating lease right-of-use asset in other non-current assets</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,400&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operating lease liability in accrued liabilities</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">769&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operating lease liability in other liabilities</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,700&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total operating lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,469&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Net Loss Per Share Determination</a></td>
<td class="text"><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Net loss per share was determined as follows (in thousands, except share and per share data):</span></div><div style="margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:69.314%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:11.942%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.943%;"/><td style="width:1.0%;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Year Ended December 31,</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net loss attributable to Silk Road Medical, Inc. common stockholders</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(52,415)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(37,629)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted average common stock outstanding used to compute net loss per share, basic and diluted</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">22,956,679&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">960,882&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net loss per share attributable to Silk Road Medical, Inc. common stockholders, basic and diluted</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.28)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(39.16)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Schedule of Potentially Dilutive Securities Outstanding Excluded from Diluted Weighted Average Shares Outstanding</a></td>
<td class="text"><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following potentially dilutive securities outstanding have been excluded from the computation of diluted weighted average shares outstanding because such securities have an antidilutive impact due to the Company&#8217;s net loss:</span></div><div style="text-align:center;margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:69.314%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:11.942%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.943%;"/><td style="width:1.0%;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 31,</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Redeemable convertible preferred stock outstanding</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">21,233,190&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Redeemable convertible preferred stock warrants outstanding</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,672,502&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Common stock options</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,310,790&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,364,377&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Common stock warrants outstanding</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7,527&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,310,790&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">28,277,596&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_silk_AssetsAndLiabilitiesLesseeTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Assets And Liabilities, Lessee [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">silk_AssetsAndLiabilitiesLesseeTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>silk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of cash and cash equivalents.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of cash and cash equivalents restricted as to withdrawal or usage.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=SL98516268-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6795045008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>401(k) Plan<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanDisclosuresTableTextBlock', window );">401(k) Plan</a></td>
<td class="text">401(k) PlanThe Company has a qualified retirement plan under section&#160;401(k)&#160;of the Internal Revenue Code (&#8220;IRC&#8221;) under which participants may contribute up to 90% of their eligible compensation, subject to maximum deferral limits specified by the IRC.  The Company may make a discretionary matching contribution to the 401(k)&#160;plan and may make a discretionary employer contribution to each eligible employee each year.  Through December 31, 2019, the Company has made no contributions to the 401(k)&#160;plan.  Beginning in January 2020, the Company started matching employees' contributions to the 401(k) plan at 50% of the first 5% of compensation deferred to the 401(k) plan.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanDisclosuresTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of defined contribution pension plans or defined contribution other postretirement plans, separately for pension plans and other postretirement benefit plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanDisclosuresTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6958878880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Formation and Business of the Company<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">Formation and Business of the Company</a></td>
<td class="text">Formation and Business of the Company <div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">The Company</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Silk Road Medical, Inc. (the &#8220;Company&#8221;) was incorporated in the state of Delaware on March&#160;21,&#160;2007.  The Company has developed a technologically advanced, minimally-invasive solution for patients with carotid artery disease who are at risk for stroke.  The Company&#8217;s portfolio of TCAR products enable a new procedure, referred to as transcarotid artery revascularization, or TCAR, that combines the benefits of endovascular techniques and surgical principles.  The Company&#8217;s manufactures and sells in the United States its portfolio of TCAR products which are designed to provide direct access to the carotid artery, effective reduction in stroke risk throughout the procedure, and long-term restraint of carotid plaque.  The Company commercialized its products in the United States in April 2016. </span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Liquidity</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In the course of its activities, the Company has incurred losses and negative cash flows from operations since its inception.  As of December&#160;31, 2019, the Company had an accumulated deficit of $191,526,000.  The Company expects to incur losses for the foreseeable future.  The Company</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> believes tha</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">t its cash and cash equivalents of $39,181,000 and available-for-sale investments of $69,732,000 at December&#160;31, 2019, as well as its expected revenues will provide sufficient funds to allow the Company to fund its planned current operations for the next twelve months from the issuance of these financial statements.  </span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Reverse Stock Split</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">On March 13, 2019, the Company&#8217;s Board of Directors approved an amendment to the Company&#8217;s amended and restated certificate of incorporation to effect a 1-for-2.7 reverse stock split of the Company&#8217;s common stock and redeemable convertible preferred stock to be consummated prior to the effectiveness of the Company&#8217;s planned initial public offering (&#8220;IPO&#8221;).  The reverse stock split was effected on March 27, 2019.  The par values of the common stock and redeemable convertible preferred stock were not adjusted as a result of the reverse stock split.  All the common stock, redeemable convertible preferred stock, stock options and warrants, and related per share amounts in the financial statements have been retroactively adjusted for all periods presented to give effect to the reverse stock split.</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Public Offerings</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In April 2019, the Company issued and sold 6,000,000 shares of its common stock in its IPO at a public offering price of $20.00 per share, for net proceeds of approximately $109,119,000 after deducting underwriting discounts and commissions of approximately $8,400,000 and expenses of approximately $2,481,000. Upon the closing of the IPO, all shares of redeemable convertible preferred stock then outstanding converted into shares of common stock and the Company's outstanding warrants to purchase shares of common and redeemable convertible preferred stock were exercised, or automatically net exercised absent a prior election. The exercises resulted in the reclassification of the fair value of the related redeemable convertible preferred stock warrant liability to additional paid-in capital. </span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In August 2019, the Company completed a secondary public offering of 4,200,000 shares of its common stock sold by certain selling stockholders, and the exercise in full of the underwriters' option to purchase 630,000 additional shares of its common stock from certain selling stockholders, at a public offering price of $39.50 per share. The Company did not receive any of the proceeds from the sale of the shares of its common stock from the selling stockholders.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI http://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6791033744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Quarterly Financial Information (unaudited) (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_QuarterlyFinancialInformationDisclosureAbstract', window );"><strong>Quarterly Financial Information Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock', window );">Unaudited Quarterly Financial Information</a></td>
<td class="text"><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table provides selected unaudited quarterly financial data for the years ended December&#160;31, 2019 and 2018 (in thousands, except per share data):</span></div><div style="margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:40.467%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.441%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.262%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.441%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:13.544%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.441%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.019%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.984%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="21" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Three Months Ended</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 31, 2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 30, 2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">March 31, 2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Revenue</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">18,634&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">17,026&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">14,928&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12,766&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gross profit</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13,913&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12,856&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11,231&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9,427&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net loss</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(8,291)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(8,007)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(11,959)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(24,158)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net loss per share, basic and diluted</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.27)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.26)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.42)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(20.12)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div style="text-indent:18pt;margin-bottom:9pt;"><span><br/></span></div><div style="margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:40.788%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.441%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.621%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.441%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:14.025%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.441%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.820%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.441%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.182%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="21" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Three Months Ended</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 31, 2018</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 30, 2018</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2018</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">March 31, 2018</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Revenue</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11,470&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9,614&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7,767&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,706&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gross profit</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7,803&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6,732&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,376&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,772&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net loss</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(15,618)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(8,953)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(7,651)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(5,408)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net loss per share, basic and diluted</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(14.12)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(8.49)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(8.16)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(7.31)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_QuarterlyFinancialInformationDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_QuarterlyFinancialInformationDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of quarterly financial data. Includes, but is not limited to, financial information for fiscal quarters, cumulative effect of a change in accounting principle and earnings per share data.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109225645&amp;loc=d3e1280-108306<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>69
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MMWF\81AU8\K(XK%T-8943OTJDH\ Q:X831F:3LTXXFBD(3^ G/,6+V2?$9/
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M'WN?N*\35GV \:E@[Q/W=>K^OB",9Y,KL?<E]W7J['.W".-3P=Z7W->IVV,
MX_NME-C[DOLZ=39*NP&36DS5[UF],IY].S=VFKHR/68VD9%"IG(9>QI:XB5
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M;Q>E.W3]:>;/FW'[9;SHZLNTM13?]K?6_P%02P,$%     @ ,(IB4$[71 7
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MSW *A%LG4 0HM8'H;-,@$@HT#"&[Q8-;,;A>#,0V8W!-UN%Q)3,\N!.#:\5
M;"\&UV,='E="(Y)D"<0W>' C!L2)P7;B7C3;T7.R*1#NPH#8,-@VW(O&[1K%
M[L\=D:G_!*>C@]'A1)\6?[#FF%>MMQ52G7/,:>0@A.0J)7E0R4[J@#I,"GZ0
M>IBJ<=.=TKJ)%'5_ @V&8_#Z/U!+ P04    "  PBF)0F:7_FG(#  !P#@
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MVV0&1KO.!8,!A4B;RGL&=R52ZX#TN1>7D)P2&$CH$6W 06+&033M$V/?05"
MM)3IW3,Z>3/1O+7[(RO?UMMJ\%S4=;%IWT2\%D5M;-;HFZ6],MGR>)&;U[KY
MJNWW\O"V['!1%[ON3>#H^#IR\C]02P,$%     @ ,(IB4"S,P0S9 0  8P0
M !@   !X;"]W;W)K<VAE971S+W-H965T-BYX;6Q]5-ENVS 0_!6"'Q!:A^W
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MNTE"9=[J,S6TR)0<D J7U5,W$]$NL<TL7=#WSG^S;K6-7HIHN\[(Q0F-F'W
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M$ZC$1DIHI 1&5"7+TE3"L2R5$RN*E!F%"^AD 9R(<K*P3LB=O;J#%:LBBJ[
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MQ[KN4N_0?>B]/:?JX72S28_=<%GVU\WA9.MPT]7[XZG=_'1T>/L?4$L#!!0
M   ( #"*8E#WZ"R&L $  -(#   8    >&PO=V]R:W-H965T<R]S:&5E=#@N
M>&UL?5/;;MLP#/T501]0)4JZ#8%MH&DQ;, &!!VV/BLV;0O5Q9/DN/O[4;+C
M>IVW%XND>0X/*2H;K'OV+4 @+UH9G],VA.[ F"];T,+?V X,_JFMTR*@ZQKF
M.P>B2B"M&-]LWC$MI*%%EF(G5V2V#TH:.#GB>ZV%^W4$98><;NDU\"B;-L0
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M.;LW1=ABIAI<D[;)D]+V)FWR(CHO[!U/=_*:/F[[5^$::3PYVX WF^9?6QL
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M:-O+1DUNKVG:I$TVU[3]S.JHY,"Q@.OUWQ?0L[;U[@LPP[PW;X8AG] \V@[
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MOO-G,X_9;#@<EA_$UF]<_@902P,$%     @ ,(IB4+ES\,2P 0  T@,  !D
M  !X;"]W;W)K<VAE971S+W-H965T,3(N>&UL?5/;;IPP$/T5RQ\0[QJ:5BM
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M/+YL[']EC >4LKG"$6KP@\V&@LJ'XQ[/=ARST?"FFWX0F[]Q_@%02P,$%
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MT&(S2R4U&"^M(0[JG#YLCZ=]C$\!SQ(&OSB36,G%VI=H?*IRNHF"0$$9(H/
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M,'LYM?YTT**?IQI91FO^%U!+ P04    "  PBF)0UV1O1-(!  "<!   &0
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M]2>ID=* +26ZLPUW]JG8 @Z-<=-W=JZ6"[,$1H[K6T"V!ZG\#5!+ P04
M"  PBF)0MH^7M+<!  #2 P  &0   'AL+W=O<FMS:&5E=',O<VAE970R.2YX
M;6QU4]MNW" 0_17$!X1=UMVL5K:E;*JJE1IIE:CM,VN/+PHP+N!U\O<![+AN
MZKX ,YQSYL*0#FB>;0/@R(N2VF:T<:X[,F:+!I2P-]B!]C<5&B6<-TW-;&=
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MH+^-9VDBLJK4/8=!]6) $IH"/QV.I\SB'>![#Y/:[)'MY"+$JPT^U04.;$'
MH-)6@9KE!L_ F!4R9?Q<-/%J:8G;_5W]@^O=]'*A"IX%^]'7NBOP(T8U-/3*
M](N8/L+23X+1TOQGN $S<%N)\:@$4^X755>E!5]43"F<OLUK/[AU6O3O-#\A
M7 CACD!F(U?Y>ZIIF4LQ(3F?_4CM7WPXAN9L*IMT1^&^F>*5R=[** ES<K-"
M"^8T8\(-YK BB%%?+4*?Q2G\AQ[ZZ9&WPLC1HRT]3OT"L5<@=@+Q7RU&NQ9]
MF-AODGA-$H] LC/Q8?[32>HU23T"V<[$AWGTFV1>D\PC\&YGXL&DP<Z$;*X@
M!]FZX5.H$M?!#?XFN\[W4^BN\!_X_#A\H;+M!X4N0IM!<->U$4*#*25X,*?:
MF?=H#1@TVFXSLY?S5,Z!%N/RX)#UU2M_ U!+ P04    "  PBF)0-])49MT!
M   !!0  &0   'AL+W=O<FMS:&5E=',O<VAE970S,BYX;6QM5.N.G" 4?A7"
M RPS7J<3-=G9IFF3-IELT_8WH\=+%L0"CMNW+Z#K6LL?X1R^RSD(9).0+ZH%
MT.B5LU[EN-5Z.!.BRA8X50]B@-ZLU$)RJDTH&Z(&";1R),Y(<#@DA-.NQT7F
M<E=99&+4K.OA*I$:.:?RSP68F')\Q&^)YZYIM4V0(AMH ]]!_QBNTD1D5:DZ
M#KWJ1(\DU#E^/)XOJ<4[P,\.)K69(]O)38@7&WRI<GRP!0&#4EL%:H8[/ %C
M5LB4\7O1Q*NE)6[G;^J?7.^FEQM5\"38KZ[2;8Y/&%50TY'I9S%]AJ6?&*.E
M^:]P!V;@MA+C40JFW!>5H]*"+RJF%$Y?Y['KW3C-*W&\T/R$8"$$*^'D?,AL
MY"K_2#4M,BDF).>]'ZC]Q<=S8/:FM$FW%6[-%*],]EZ$R3$C=RNT8"XS)MA@
MWA'$J*\6@<_B$OQ'#_STT%MAZ.CAEAY]\ M$7H'("43_M!CL6O1A0K])[#6)
M/0+1SL2'B?TFB=<D\0@D.Q,?)O6;I%Z3U"-PVIGX,/M_0C9'D(-LW.53J!1C
M[R[^)KO>[\? '>%W^/PX?*.RZ7J%;D*;B^".:RV$!E/*X<'L:FO>HS5@4&L[
M3<U<SK=R#K08E@>'K*]>\1=02P,$%     @ ,(IB4$2>X!.W 0  T@,  !D
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M_=E,8S893O?S#R++-R[? 5!+ P04    "  PBF)0?_:*9B0#  !8#0  &0
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MFMM8WU?MNWZ[4/)HOV."[F-J^1]02P,$%     @ ,(IB4,OTE>'H 0  ,@4
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M&Q:O"L3_;=@Q7C9L&[NS0_#D,III\I6(2]U(Y\R5OM?V]I6<*]""[I/6JO0
M&P,*I3+;C=Z+_C?N \7;84+A<4QF?P!02P,$%     @ ,(IB4+R^Q0,: @
M;08  !D   !X;"]W;W)K<VAE971S+W-H965T,S8N>&ULC97=CILP$(5?!?$
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M(5H-!K6VVX/9RWD<9T.+87EIR/K<%7\ 4$L#!!0    ( #"*8E 4XVCJ]@$
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M(?NLO:K;@:!-]PSQ^K=0^@=02P,$%     @ ,(IB4*TQ'^   @  7@4  !D
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M\3 [K1UXO>S.2_7^><V%@,Z%Z0<_-],EFPJGA_1^R/R(ZS]02P,$%     @
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M%WXV&-3&7;_8NQK'?C2,[*>-QO/?2OX/4$L#!!0    ( #"*8E#/QZQ*N@$
M #X$   9    >&PO=V]R:W-H965T<R]S:&5E=#0T+GAM;(V4VV[<(!"&7P7Q
M ,'GMBO;4C=5U4JMM$K5])JUQVL4#BZPZ_3M"]AK;1(N<F.8X9]O9CBXGI5^
M,B. 1<^"2]/@T=II1XCI1A#4W*D)I%L9E!;4.E.?B)DTT#X$"4ZR)*F(H$SB
MM@Z^@VYK=;:<23AH9,Y"4/UO#US-#4[QU?' 3J/U#M+6$SW!+["_IX-V%MDH
M/1,@#5,2:1@:_#G=[2NO#X)'!K.YF2/?R5&I)V]\[QN<^(* 0V<]@;KA O?
MN0>Y,OZN3+RE](&W\RO]:^C=]7*D!NX5_\-Z.S;X(T8]#/3,[8.:O\':3XG1
MVOP/N !W<E^)R]$I;L(7=6=CE5@IKA1!GY>1R3#.*_\:%@_(UH!L"\B67I9$
MH?(OU-*VUFI&>MG[B?HC3G>9VYO..\-6A#57O''>2UMD>4TN'K1J]HLF>Z$I
M-@UQ_"U)%DV2!4!^"T@^Q0%Y%) '0/&B@O)5E8NF#!H9-$D\11%-4;Q)D19I
M'%!& >7[FZRB@.H=359OFDSS5SG(S='[E_63ZA.3!AV5=;<HG/6@E 6'2^X<
M:72/>3,X#-9//[BY7J[T8E@UK:^5;+^,]C]02P,$%     @ ,(IB4 =0,P^\
M @  I D  !D   !X;"]W;W)K<VAE971S+W-H965T-#4N>&ULC99=DYHP%(;_
M"L-]^0@AH*/.K.Z7VIW9V4[;:U:C,@N$)E&W_[Y)B"R$C/5&2'C><]X#)S&3
M,Z$?[( Q=S[+HF)3]\!Y/?9]MCG@,F,>J7$EGNP(+3,NAG3OLYKB;*M$9>&#
M($!^F>65.YNHN5<ZFY C+_(*OU*''<LRHW_GN"#GJ1NZEXFW?'_@<L*?3>IL
MCW]@_K-^I6+DMU&V>8DKEI/*H7@W=>_"\1I)7@&_<GQFG7M'5O).R(<<++=3
M-Y"&<($W7$;(Q.6$%[@H9"!AXX^.Z;8II;![?XG^J&H7M;QG#"](\3O?\L/4
M35UGBW?9L>!OY/R,=3VQZ^CBO^,3+@0NG8@<&U(P]>MLCHR34D<15LKLL[GF
ME;J>=?R+S"X 6@!:@<A]31!I0?0E@%<%4 O@K8)8"^);!4@+T*V"1 N26P6I
M%J2W"D9:,+I5$ :7+Q=\2=!U2?NQ0R.+WW2):KO[C&>S"25GAS8+I\[D^@S'
M0B6"RUG5R.JA:#TF9D\S"-#$/\E(FIDW#.@Q29]9#9FP)7QAH?4!K#[F8* '
M_0R+(0%!VF?N;<RHSSQ8F"CH,X]#!D5]Y,D6)NPSSS;&*&MI8XQ<J_^^G/55
MP[WW']G[(%(!HFX*$-LC0'L$J"+ ;@<,NJ1A8L54BOD6 QC&1C46+$I0YTOV
M_,1V/_' #XR@X:=A4"<1 *,8H<1HFO40'*$@38'=$;([0A9'1NGSADF[I0>>
M^1X7=LI8M_=6"AJM\V"A0."%!O9HP4(XP)XL6.I!XW4^6ZG0\+^T4(EG+K*5
MS;]G[@QK"Q6-NBF;#^AW-LX2T[WZOV?.AAPK+I='9[8]4MP!N?$:\_-PO PM
M\RMQ!&E.#%_AF_/+2T;W><6<=\+%AJ_VY!TA' OW@2?Z[R".3.V@P#LN;Q-Q
M3YN#0S/@I-9G(K\]F,W^ 5!+ P04    "  PBF)0<\H?YG,"  "X"   &0
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M^@TE)ZF7L5KS=I:V&\GJ[CO!ZS]6TK]02P,$%     @ ,(IB4.)1;!7' 0
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M_WCB%==:._!&-E?>2>MG> X$U"YLO_B]&5_R&#C=34-*YG^*XC=02P,$%
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M3YE_ZI-M?;$Y'Y3^I1N^#B6P.;VA/QUT]6'Z]4%V_@G$ZC]02P,$%     @
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M":T/YF>T[?A@1L>;?OH+=/Z0U5]02P,$%     @ ,(IB4/LK/S$9 @  #@<
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MAI(P&-Q_A0L("W>56(V]%-H_@_U9&UD/++:4FK_W8]7XL1OXKVEX AL2V)A
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MUS)9106Z:J(!L[68:(()1P12[&.)R%5B&RW29P5V2T06NRO$3A.QR8_O3'Q
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MM3;*IHQO;;*]RC?GAU)M37<[L_?-\(UB>##Z,'Y_B<X?@5;_ %!+ P04
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M8KB>AX'B_?CTB*;WS_HO4$L#!!0    ( #"*8E!O=JSG>P,  "H0   9
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MJMN]=A=2;/7.W#O\/##]!U!+ P04    "  PBF)0T2!A_R "  "8!@  &0
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MBWC%JWV&LZFC,XTBG6'Q'KW7:L/7!;M&T*0YC)ILH7G<[68-0_Z<)+N;)$N
M? '(\O\ \KN / $>_ZER\Z[*4;-.&I,T6[[;<L[?)6*+T<27]UVXLS2>G&S
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M'Q$@L"A-DC.RT7/D#LA(-CN7?< +'#Y1X8"7.(QKG!$8)F]<PC"):<3.'$>
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MK1:-N'A-]_/6K'V+\&VHN[]M-TVSS3/='JEWSZN8T$5P;HEZS+K#D!$&#XA
MLP\I")1B39SPF(33%!L($TTQ]Q FAH50L%9J".B$(($)0I @- 3AN!'(JF3=
M86*#J0PF0N9C5>/B$"PE J5$CI28I):4#I.,4]P@A"TA[Z$F8F)03 R(R2PQ
ML5,O1@CLC(LD69IDA,PT* $U):XF:F5:)Q]JT'NHB9@4%),"8JPTZ]0IFV(2
M121.+#TN$&,:43S3G@Q4E#F*,OOUR3XJR 5>%801[$0(:!*QK:@#1>\?&SSC
M=QC(XA@>=BN:R0):WATFKE/0&:_"L%GA3[@5ANT*NWY%T\BN-70Z2JQSLKF.
MF4J![0H#?D7#&0K89'#\B8; GH!=4XA2Y\=/KCAS]\(#D"2:U0); H8\(9JA
M@,\PSC[>$0(?.@(<.F([4P^:_*=E<6HE"D8C1\F;@QGGI+<5I\K,DJ/=862\
M,U-4\!_>S9L_6'/(*^D]"Z4''S.>[(507(M!-_I-.NH1=U@4?*_:VT3?-]V<
MURV4J/L9-A@&Z=4_4$L#!!0    ( #"*8E#:>;E:V (  'D,   9    >&PO
M=V]R:W-H965T<R]S:&5E=#<P+GAM;)57?X^:,!C^*H0/<- ?M&#49.>R;,F6
MF%NV_=W3JN2 ,JAZ^_9K 8EGW]ZA,4+K\SX\[X./+?.S:E[:@Y0Z>"V+JEV$
M!ZWK612UFX,L1?N@:EF9;W:J*84VPV8?M74CQ;8K*HL(QS&+2I%7X7+>S:V;
MY5P==9%7<MT$[;$L1?/O41;JO A1>)EXRO<';2>BY;P6>_E3ZE_UNC&C:&39
MYJ6LVEQ502-WB_ 3FJTPMP4=XG<NS^W5>6!;>5;JQ0Z^;1=A;!7)0FZTI1#F
M<)(K6126R>CX.Y"&XS5MX?7YA?U+U[QIYEFT<J6*/_E6'Q9A&@9;N1/'0C^I
M\U<Y-)2$P=#]=WF2A8%;)>8:&U6TW6>P.;9:E0.+D5**U_Z85]WQ//!?RN "
M/!3@L0#1=PO(4$!N"J)>6=?J9Z'%<MZH<]#T=ZL6]D>!9L28N;&3G7?==Z;;
MULR>EHRP>72R1 /FL<?@*PQ^BUBY"$9&2&0$C"HPJ )W]>2JGJ(4)B @ >D(
MZ!L!_*:-'L,Z3-5C,.$IN6W&Q>&49AF-/8HHJ(@"BCP$"4B03/>$@01L@B?,
MZ36^<<-%\ 1S6 <'=7! 1P83I"!!.MV)#"3()CB1.7U2@F*>W?H!X1@EW&,)
MBN'8Q:XD&GLH/,E%TVU!<.P0GF#, +KN&"4)98XS ##A:>JYU0@.,G*3C#CR
M4,#)0_0.8^#LH62*,8G3+^&8),Z?HXOSW6DXR A(,O5Y F<0\3L\@5.(TBF>
MI!_^H0 0Q'!FWAXY<*81$&J*/8L.'$(<3S<%PR'$:((I ^@]4P (ZE\>.9YU
M% @T]:W$<  QN<,4.( 86OL<4^C'IK@0AAFEW!,?#(<9 V&FU$,!)Q"S.TR!
M$XBA9= QA7]LB@M!26P:BI,;/='5'M!NRG^(9I]7;?"LM-E.=IN^G5):&M;X
MP7AT,,\!XZ"0.VU/N3EO^LUP/]"J'C;ZT?BTL?P/4$L#!!0    ( #"*8E"%
M_]37Y@,  * 2   9    >&PO=V]R:W-H965T<R]S:&5E=#<Q+GAM;)58VX[B
M.!#]E2@?T(DOL9,6(#6@U8RT*[5FM3//:3 031*S26AF_WZ=2]-@'X_@I1.;
M4U6GJGW*CF=GW?QL#TIUP:^JK-MY>.BZXW,4M9N#JO+V21]5;7[9Z:;*.S-L
M]E%[;%2^'8RJ,J)Q+*(J+^IP,1OF7IO%3)^ZLJC5:Q.TIZK*F_^6JM3G>4C"
MCXEOQ?[0]1/18G;,]^IOU?US?&W,*+IXV1:5JMM"UT&C=O/PA3RO>=P;#(CO
MA3JW5^]!G\J;UC_[P=?M/(Q[1JI4FZYWD9O'NUJILNP]&1[_3D[#2\S>\/K]
MP_L?0_(FF;>\52M=_BBVW6$>IF&P5;O\5';?]/F+FA)*PF#*_D_UKDH#[YF8
M&!M=ML/?8'-J.UU-7@R5*O\U/HMZ>)XG_Q]FV(!.!O1B8&+_SH!-!NS30/[6
M@$\&_-. #]4:4QEJL\Z[?#%K]#EHQG_O,>]7$7GFIOJ;?G(H]O";*4]K9M\7
M@B>SZ+UW-&&6(X9>81).;C$K%_.)B R#"PV*:"RI8\Y9;(5P,?06L781@F$6
M#!:##?;LIA@".^#0 1\<\!L'TDICQ(@!4P^8E*<Q958N+DS03!(/G03220"=
MU*(S8M*K."1^(A;IM8NB3YFGM@)R$8!+9G$9,<EU%$I)'%LK8>WB$I%=PV[X
M2,A'NGP2>\5)EP]/A5T;%R53B:FDD$H*J-CZ2ETJF;29N*",>&2802:9RX39
MZS<#"Y/)E-EB='$TY5G&XQ0S(C%N4#&H#K6[3^QDGB8L\P3R=$(" C$[$ )Q
M3QS8ZEX(!2X2CPO<I\@#C8K@3D5 JTJ$G2T">98VP2V(@!Z4^%8 [AQ$/) M
M%CM!:G>R12#?&L)*)D#*PM.6")8@R>[/EF+)4" 983<4"**>.%@Q%(A!V(J!
M((]B*%8,!8H1'L50K!CZ@&(H5@R]1S$()'QQL&(H4(SPB(YBQ= '%$.Q8B@0
M@[#.#DL(\BB&8L50H!@9VW'0#NF+@V5%[]C:EM3=LSCCSOEC!7!,4I90[QF$
M8:4R($)I*74Y@:ZCD3Z2-Q96*T-;E[V13J";<P;Q5)IAM3*TO]E= 8&DI_LP
MSV&=.2Z(=/)A[FF%F$.POWA8_ SH6OJ^+;"N67*_*!G6-0.':,GMY2+<@Q<C
MTEW%$&CV@,1S9&2X4[![.@4"24\+9[A3,-0I?/7#38 ]L+=RK%A^CV*YJU@6
M(\5&5Y_IE6KVPQ5(&VSTJ>[Z#]FKV<LURPOM/_.M^15Y7H^7)9]NQKN;O_)F
M7]1M\*:[3E?#I_Y.ZTX9GO&369('E6\O@U+MNOY5FO=FO#,9!YT^3O=!T>52
M:O$_4$L#!!0    ( #"*8E 7D'VS$@0  '82   9    >&PO=V]R:W-H965T
M<R]S:&5E=#<R+GAM;(U8;8^;.!#^*XCO%^RQP6:51%H2G>ZD5EKUU+O/;.(D
MJ(!S0#;MOZ\!;TKL(=W]L(#SS,QC>^;QR_*JFV_M2:DN^%Z5=;L*3UUW?HJB
M=G=25=XN]%G5YI>#;JJ\,Y_-,6K/C<KW@U%51D!($E5Y48?KY=#VTJR7^M*5
M1:U>FJ"]5%7>_,A4J:^KD(;O#5^*XZGK&Z+U\IP?U3^J^WI^:<Q7=/.R+RI5
MMX6N@T8=5N$S?=HRTAL,B'\+=6TG[T'?E5>MO_4??^]7(>D9J5+MNMY%;AYO
M:J/*LO=D>/QOG8:WF+WA]/W=^Y]#YTUG7O-6;73Y7['O3JM0AL%>'?)+V7W1
MU[^4[5 <!K;WG]2;*@V\9V)B['39#O^#W:7M=&6]&"I5_GU\%O7PO%K_[V:X
M 5@#N!E _-" 60/VRX _-.#6@#L1HK$KP]AL\RY?+QM]#9IQ>L]YGT7TB9O1
MW_6-PV /OYGA:4WKVSH18AF]]8XL)ALQ,,'0&R(RWF\A  N1@6<.]P$V/B)A
M]Y"M#V%IC+-@:$?9X(#==53B#CCJ@ \.^)V#U!FI$9,,F'K Q$)*![7Q40PD
MI 1G$Z-L8I^-) Z;V(L#C I"'-P&P0%+$H[S25 ^B<^'NWF4>''^D%P2<.9Z
M@^ 22 5-<$(")220 :(.(>$' B&!.WP0&&5Q$L]4@43Y2(2/4P>9] +1..9)
MZDZ8CT/2;.NC'J59BK)._:J1#'= "2XPY -U8T%3KIPEG+E2M$&!Q/1]IE=T
M1O7H!]+5@GZ?KQCP4<)25">?*2 IPEU2@) 23,C$)84 .9/QG.A17#8I^T =
M6=!O"PG#/:HDBBLQ1:38JR7JJRQGE BOF% @DGM;%/@H]W#EIC%24S-+&<7%
MEB)JZR9 9D%R6O\+M_(V*(JD,W1PJ:68UGK5-((HO5MF%GZ%([AD,9LAN-A2
M3&VERTCZD2A""(7-31@NHS1%^'@BF/J!Y$)0,OFC+CG$QI";$1[ )1H0B7;+
M)+.@::*(1>KR05!^TFU1U%S2 2[A@$BX2R=#0=[N$P-Y^T\,-+-# ES? ='W
MR1[6,AY!\70^N5ER7"E%<(Q1!BYM'Q83,;." [X$ +($I*[:@"_M$%,NT[FC
M B[M@$A[ZDJ)!4W3AR] S 3"51B0#73J*@0*FDM37*K!EVKA;L S"YK.4DID
M/)=>N J#K\+"U8L,_+VLNRK>Q\+U%7Q]%<1=@2UH5C'N ^'"";YP"L+<0(BZ
M3JK\_G"(2R#S)5 0=^]E00]J<PP530[?E6J.P\5&&^STI>[Z,^RD]79Y\@S]
MX=UIS^C3=KP"^>5FO)'YG#?'HFZ#5]UUNAH.\ >M.V5HDH4A>%+Y_O91JD/7
MOPKSWHPW(>-'I\_VEB>Z736M?P)02P,$%     @ ,(IB4 2\VY.O!   ZQ@
M !D   !X;"]W;W)K<VAE971S+W-H965T-S,N>&ULE9G;CJ,X$(9?!?$ @$\8
M6DFD3D>C76E7:LUJ=Z_IQ#EH(&2 [LR^_7)P9P+^:T1N.H'^7:ZR_579SN):
M5M_JHS&-]Z/(S_72/S;-Y2D,Z^W1%%D=E!=S;O^S+ZLB:]K'ZA#6E\IDN[Y1
MD8<\BN*PR$YG?[7HW[U6JT7YWN2GLWFMO/J]*++JO[7)R^O29_[GBZ^GP['I
M7H2KQ24[F+],\_?EM6J?PIN5W:DPY_I4GKW*[)?^,WO:Q%'7H%?\<S+7^NZ[
MUX7R5I;?NH??=TL_ZCPRN=DVG8FL_?@P+R;/.TNM']^M4?_69]?P_ONG]2]]
M\&TP;UEM7LK\W].N.2[]Q/=V9I^]Y\W7\OJ;L0$IW[/1_V$^3-[*.T_:/K9E
M7O=_O>U[W92%M=*Z4F0_AL_3N?^\6ON?S7 #;AOP6P.N?ME V ;B9P/YRP;2
M-I"3'L(AE'YL-EF3K195>?6J87HO6;>*V)-L1W_;O>P'N_]?.SQU^_9CI2.U
M"#\Z0U:S'C3\3L-NBK"U?NN"HR[6W&G.QQV\N(I8C"4;5R)2A;T0,%#1&Q"C
M0&-L0$(#LC<@1P;T9*0&3=QKSKU&"A;I-)H$C'2Q%'IB;X-T49+<V1LYKJ#C
M"CB>3!QW-7$ZG26DF4X3TDCL; R=C8&SZ<3909/<C8H.4C;QUA6)0$\L;9#H
MKKN1OQKZJUU_V62VU]J91:Z83%*"H@1VE("1G2Z_Q E'!ESC7E+82PK"(=QD
M$4XHT7S0&)&3V S4K&@TJI'F.B:R H/)Z9GQ&70@$>-$/SC],#%C85O1_02R
M("'X83A-,9"GG!7)W,3"M&XW"T1B83BS,(2[,U$*!*6I186S @-I@0G"! :5
MZ0?6)4:0N0QJ)J?A#B+&1O$*:E5B#!GBD##!,8?\ 0XYYI ##IUXK6B<0QG5
M$8:0([XH$Y@O_D!]YY@</J?"<Y><E*5"49.#P>%S:C(2,2*;<\P-GU-.N5L%
M59!06SQ,%Y]3![E;"$4B(DW%A"GD<RHA=TNA"C21LCF&D",($VQ"8 C% Q *
M#*&8 Z$5C9*.##21(06F4" *B<V0(#;9#U H,(4"U2\G7NE,;T+N= 1F4 "\
M.%'_!,9+Q ^$B\$1 !PGZ0@7',92GD3$UD!@<@2H7T[602).) .!P1$ '"?K
M6-%H6Q ',;%D)>9+1C/2CA6-TH[B;>8ANL(<2I=#-^U(MQ@R&4CJG(DYE(!#
M3J0NB3F4CYQVB>/N' ZM:+S980$GLH;$)$I$(C4[F$3Y (D2DRA1"7,"'D1J
M=.H@NL$02L07P;'$?,ET?K *@Z, .$[:42XXC*LDIKK"X"ATFG/N'X"($WLJ
MA;%1Z"0WS3I6-#HB1P'5$89+@:.<DW2L:+1/%-2I1V$$E8N@FW*46PJE"A11
M"Q5Q180(I*89$Z@>(%!A M4< JUHE')$'$@J8$RA0A12)C"%Z@$*8TQAC,K7
M-& K&DUP$JAI?@SO;GP+4QWZV_3:VY;OYZ:[.+U[>[NQ?^;=C?'D_9H];89[
M]Y]FAI\!_LRJP^E<>V]ETY1%?VN\+\O&M%ZV#/G>T62[VT-N]DWW5;??J^'Z
M?7AHRHO]:2&\_;ZQ^A]02P,$%     @ ,(IB4*N_-O#R @  %0T  !D   !X
M;"]W;W)K<VAE971S+W-H965T-S0N>&ULE5?M;ILP%'T5Q ,4;+Z2*HG49)HV
M:9.J3MM^NXF3H )FMI-T;S\;*$O,H4W^ #;G7I][\;E<STY"OJ@]Y]I[+8M*
MS?V]UO5]$*CUGI=,W8F:5^;-5LB2:3.4NT#5DK--8U06 0W#-"A97OF+63/W
M*!<S<=!%7O%'Z:E#63+Y=\D+<9K[Q'^;>,IW>VTG@L6L9CO^@^N?]:,THZ#W
MLLE+7JE<5)[DV[G_0.Y7-+,&#>)7SD_J[-FSH3P+\6('7S=S/[2,>,'7VKI@
MYG;D*UX4UI/A\:=SZO=K6L/SYS?OGYO@33#/3/&5*'[G&[V?^Q/?V_ M.Q3Z
M29R^\"Z@Q/>ZZ+_Q(R\,W#(Q:ZQ%H9JKMSXH+<K.BZ%2LM?VGE?-_=2^R::=
M&3:@G0'M#4CVKD'4&42.0= R:T+]Q#1;S*0X>;+]6C6SFX+<1R:9:SO9Y*YY
M9Z)59O:XR.AD%ARMHPZS;#'T#$-Z1&"\]TM0M,22#LSIY0*K(2*-\ H1#")J
M[*-S^SC%#F+H(&X<Q!=9F#I9 )@H= )!F)%<)9!( APXV5HB3.0009@8$TDA
MD10X2!PB"),Z1! FPT0R2"0##MP-BC#.YUL!3!QB(A-(9 (<$(<(PKB;_7W,
M!9$I)#(=.$C3D922$(L^O%XP9*1ND"LD@T#QB+()+!X/A%ZA" 2*1[8[P26$
M1%=L> 2*DY%U<*4AJ$0,"BX C7X?7$@(J "#[0I!(WN1X#I!A@*/PQ%=$:QP
MDMVP&[$V"1)5YD8[!,6A\XE7'X NR6!]DJ% LWB"75 L4'J#0"D6*$7:<U,"
M0=.1=;! Z5![<3BB/8JU1V_X?U,L*XH4,X@6@!+W%_X!Z)(,UAX%LDK&6B8L
M*YK>D!(L*XK^>(.4 %#B5H#@K)DLN=PU?;?RUN)0:=NVG<WVO?T#M<VH,[\T
M/7_;H?]WTQX8OC.YRROE/0MM6MVF(=T*H;GA&-Z9=.[-&:4?%'RK[6-FGF7;
MJ+<#+>KN$!+T)Z'%/U!+ P04    "  PBF)0L?7,J$\"  "1!P  &0   'AL
M+W=O<FMS:&5E=',O<VAE970W-2YX;6R55>V.FS 0?!7$ QP8\Y%$)%*2JFJE
M5HJNZO6W0S8!G<'4=L+U[6L;PG%@JO1/L)?9\<P2[Z8-XZ\B!Y#.6TDKL79S
M*>N5YXDLAY*()U9#I=Z<&2^)5%M^\43-@9Q,4DF]P/=CKR1%Y6Y2$SOP3<JN
MDA85'+@CKF5)^)\=4-:L7>3> \_%)9<ZX&W2FES@!\B?]8&KG=>SG(H2*E&P
MRN%P7KM;M-HCK!,,XJ6 1@S6CK9R9.Q5;[Z>UJZO%0&%3&H*HAXWV .EFDGI
M^-V1NOV9.G&XOK-_-N:5F2,1L&?T5W&2^=I=N,X)SN1*Y3-KOD!G*'*=SOTW
MN %5<*U$G9$Q*LRODUV%9&7'HJ24Y*U]%I5Y-AW_/<V>$'0)09^ XG\FX"X!
MOR>$QGRKS%C]1"39I)PU#F^_5DWTGP*ML"IFIH.F=N:=<BM4]+9)(IQZ-TW4
M878M)AA@4(_P%'M_1& [8A=,TH./!^RGB!C;3\!6$]CDXP\F0CM!:"4(#4$X
M=+@8B=RUF,A@JM;&,DE&3J:@)9HI5F15$DV5H,A.$%L)XL=KD5@)D@=JT6+B
M@4V4+$>EF&*BF4HLK#H6$QU)-%.)I95@^7@ED&^_'/X#M>A 0Z-A$(^*80$%
M43PC9N:F(DM!YBBL-W&+@O\HB?VJ(?Q(2?#TKN!D?.LMJ-@?J_$&C:P$?C$]
M7S@9NU92MXQ!M)\KVT WPE%\I^>-:9#O-.VP^D[XI:B$<V12M5G3#,^,25 :
M_2>E+E?SL=]0.$N]3-2:MT.BW4A6=P/0ZZ?PYB]02P,$%     @ ,(IB4!RZ
M$"T) @  ? 4  !D   !X;"]W;W)K<VAE971S+W-H965T-S8N>&ULC51=;YLP
M%/TK%N^K^4X; 5*3J=JD38HZ=7MVX":@VIC:3NC^_6Q#*"%6M1=L7\XY]]R+
MN5G/Q:NL 11Z9[25N5<KU:TQEF4-C,@[WD&KWQRX8$3IHSABV0D@E24QBD/?
M3S$C3>L5F8WM1)'QDZ)-"SN!Y(DQ(OYN@/(^]P+O$GANCK4R 5QD'3G"+U O
MW4[H$YY4JH9!*QO>(@&'W'L,UMO4X"W@=P.]G.V1J63/^:LY?*]RSS>&@$*I
MC +1RQFV0*D1TC;>1DUO2FF(\_U%_<G6KFO9$PE;3O\TE:IS[]Y#%1S(B:IG
MWG^#L9[$0V/Q/^ ,5,.-$YVCY%3:)RI/4G$VJF@KC+P/:]/:M1_U+S0W(1P)
MX40(TD\)T4B(/@BQ+7YP9DO]2A0I,L%[)(:/U1%S)X)UI)M9FJ#MG7VGJY4Z
M>BY6R2K#9R,T8C8#)IQA@@F!M?J4(G2EV(0W]/ ZP?86D4;N#)&SB,CRHWF&
M^,$M$#L%8BL07W7A?M&% 9-83&LQ7Y(P#I)%+0Y8M$HCWVTG<=I)''8>%G8&
M3#K+XR^<?(:X,I$Z3:0W)H)H4>PF_;^>.&"NGN#9I64@CO;_EJCDIU:9ZS&+
M3B/D,327?A'?Z-$R3((/F6$N_23BV+02[;G2OY2]^ ?.%6B7_ITV6.M1.!TH
M')39KO1># -A."C>C;,.3P.W^ =02P,$%     @ ,(IB4$OEWDA_ @  . @
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MS31P/7LOA.8&$=T9N*,9X].FX7MMEX59RV&6#1LM^G%.)].?A=4_4$L#!!0
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M0  *!%8@O!.()UE[#+&8QF(P2C%.$4*P50A:A8!5,EGZ<&:U8$% "P)8I+!
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M+]K31#NHS+D[* 7]:6WZ'U!+ P04    "  PBF)0=+$+D.(!  !M!0  &0
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MGKI:KY$UUU&5KE,8ZC9/XZA(]WA50227C[B^&O]U,9W1=R_&XRC91["&%!G
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MFNU#"G_L8#<Y?)R<A2@0O<!O2@AH+96V3P0NR;.9U>'AHJ*#'I'++(3-VJ;
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M2?OJL#2J<JHBRE*4#&X+0;!C0H^H'!J8<@XGB983M( _?9;A?V-:=U)U2_X
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MF4\Y)88>42ZKY ZCYU^./=E[, 9\,E,P'^;X1&7J$Z[*W,H@I 47O102Y#H
M'IR$@OFJ)K=J73KIVT'V60 QT) +ZMR@6"3M1<*32BC8!W;9\=NF+"8EZ\)(
M:9A*FVD=N_\ ;\IM*3YC]QG>K@:'3GS]IK,>' A*ES!O34O9M_N.()$\\5ZX
M:\01U)?'V^/SRZF,3DR?TF^PV]^,"<5R<PQ:.(0K(2 Q>TG3,2?08$V8[-5B
MTJ<9I3!) LTY;%O,TEF2SMWAK+AN)XR(4W%N^\)(.5OA;3FABK@,+DI1D;,
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M7/'$/)[ 6_=%41QHEAKP1B5&.SKGG9(2US79=@Z_/-@Z]X+'PGU^8-#QG2<
MZ!6GI/6MH#5@HVU&VS"T.>1_[*BC../8/-P'(3GW,7Z?>M^Q$+H,^]KM)R-U
M$?%BLTQ2@Z*K!O3)-:?3WY@E4+O(M3\6WW0XX^\>]NS\(B>3"A-_BHTOV(1]
M_8(DRSRFJ)\CO0N.9G&@3:$$G<Z$?UL]8.Q?5H!C,D 1OJR=E>#PW6'6^8$[
MQ<O ]"7$R\T/ 3G^[[1N<MP8B'JW"(-,8_?&97Z(F4%FSZ%"C!N/V-"_8 54
M(HET;D5-T>Q:'9Z<-K<.^_V(5^WTT@;135:LPZ#O8R+0\#QUA1OI;6E-7M5>
MLN9<K6W*<<;>?4E<L6U^J!42#K_V!'59<$U6EN'I2WVVJ:9P7GW-Q54U>TA]
MOTKT+OA#-UD?1\T1=]Y0@C%R.5R1MGQ6+J?L/PB1\F0\&7:'"\ZB"#_I5*U5
MNCJ$AXD-*9(J;8'-:M7AWM4[MZFE9S.8X36.#.DD1";LA&6(*2Z]V^M!%[;9
M.D9MP,+\*_+OUSUBE] :WO4Q@[Z>IUU,XB)Z,1O'T]'L)?XX6<3S\>IE])<F
MS^CEBXSR4BK+ZJ!CO0NL43*UC\?Q:C:/YXM5M)H/X^5RW+6;OV%=71^%]8T'
MXR4O=#48S5\VFF(]A^>9#J<M98/WPC?>E.^W&+'2O1E6;Y@X_-VG%8\$K[*;
MFF3C"%9JU]W1T^CMCW5F$;"=HF)ZC$<Q8G&-J'/6\VI0.X<#:AC'L^%8M820
MDT]C['>U6"'ZQV0._ULLP@=/#KZ(9^.%-/+R(XV7\7@!?UK-HYOTWJ4;_)R6
M]U6R>Z"8SAL#^VH9)ZN$J0(,8HR5$7(=6!>Z! K5/%TC10\O4?,G>\ )'K(4
MH2:! NBHRSO0[["5R.-#J2*$G_$# I-C$P/=190(PP!EML^'7TQ9A"60OA&.
M%=T:#:=8J#02Y4BF;X]@,/:]DX[;9O6P]#:LE>] VMUJXVWG&Z27:@^\;JBU
MD_-P15])3V6-=4R<$SP*6T1I9HI-*."$28V9:T9]L]TZ EPWVJM795&BX4M&
MR8EF[M=B#N*D7E,3[VON]TW7J+_#^U.?C/@!8(U7I\##WA313^EM16ZP'I?L
MS:_&Y1H@B4F30(SGII@JQ.!#0_?(X#M3)J[XVG;L&D'T8&,/.ZZN)@"CQN?6
MZBV$$_<%L8AQ9+#.\-^^TW>@,9E:6L%D:@(BG5LB^[M G_6F22;4:8/T\M.@
M:+%-STXWS?QL:2],00FN#E7,'!A"X3]=ZP<?&P]@/6JI%!54C[!L^D[Z1'2-
MIV]+*C\6FPJB4I -YH>P[PT\T;XY$0\ FOWW [#J?GHEXAE-8E \@I1N:0GV
MUKDV?#SRQOB;R(7--&D:Z;1=4ZA-:>4<=>-1EGXIX*R6@?N>T<Z;)LUPO*>E
MIXVQ2?O:;C./-4%]P=PP#VE."G-B(DE2#:M@'/X/&P<'+>N$/V'G$&?#<"XN
M.T$\QB'?!&HZP<CT#"!&?=REUM@^$A9I]ZR;L]M=[+,)JAW=5J!"8C$NA10H
MV=:U]C8)=N)4]AM.+C[JYFV^YW-F!I922)';:FU"]L7''YT"T> ;XV$/<(TD
M9$<.Y=,BPU$S!40=<F48%$)L-E;P,'9A<^O *0KL\'"/[2-\[*+C'BSI'ICN
MV[]8'[*4<)$,VHCA[YS(%E>;HSX^)&P\T>2Y(#A@2N!#, 1-S4)V2FXRGQ*J
MH_O]7_Z?N/]"M1)@LJLZ_UQF<72=EP?.LS@P>*6I"O=\'M-L?,3;GHB#R:5X
M&4J?K0L):(X0+.S$9USL/*P9_N:O">-@!N]RO@AMK2[O]H]4=PC?*Y#=F[WX
MOXL"G-*)"D8O#:PN1^,X#"]JU'HZ?/D]&-"8;LDW"(=HA)SLBTHL:?$@K3*0
M,_+[:)!J]YNDWFGQE3!ZB6S8X*_;FB!: M0AN03TN,N[C?F4LZVF&B3A-#62
M: (?.$">//IJ9E38+_?E)8DBXM/4H,GE$36^$,YW8/>3(WE 2>A'8JG96+-;
MG8\BLN+V->/8G3(KA%>KP\&)5J0+PC,H=32(7E-/"=^SJ_8I ^W2P["7G0<:
M=2"W1,5V(<^FTJ8]T2TA6I:+>>R5'^V$G=(S;IA_P'_P%3%^)7UQ\29"$W5$
M/W"EN"02F'S;4\U7/1'Z (I)KK#NB3X'R8#EJVMV@K@O7S/I)Q]'0<=O'YEF
M_F01N:5#34G%<F3N,PIQQ9FEZ#32(F:+Y\:X.%1ZBA:$*5G4\)#VMU??*,WY
MBHLR8KN3!+[*3U]JLIO7H-G>>] 9=R4F$(C*SD23.SXM:SX0L*]+/;/+-:O#
M! 'JKW"Y)^B4CF[5S60!"L)Y_XBJE)GKTF7FB&?/(5X0C9)(+ZX%GY;@55II
M_<*;0@S.S>=[3@R8_^ Z@4LN9?3W0\DU@)KDEHA925M3FU:;ZUZ*_Z$Q^MB-
M7MZB!!?MEQ9A6C'3IZFLZQ^=GZ:E/_/3$_?I0]'Z^$"A]YLWUD-$!%>W47.8
M.4"[ EM5[!LY:&CP4F\1G >6S>$W(^TH94N\Q,':K;'V-)\ED]DFL?D!UVS#
MV^8N\NU3WR')M:_]8IR9XZL\7+Z8MJ1QY1!$M*[>T[7#TNP6O2OFIG1Z)KOZ
M+G]3]_HPG&3Z4K'_1*A<[WO%F%U@O'U.*T92@ E4])BVZ"-_BK0"_)(Z3J!^
M2U)$C;%'QUZS6X10I*B-4T*9T-HAOK-Q\[K5X?E$E^;HU\'-P+9(M'\.]PX8
MC=Y&38(SVV(*-;KVAG.G!337FONM6QHW.$AX:?M'T4ONTB90.9:AQ3Q+<V'S
MGME1W5CV]T-JP1<HU=A<+^$TU'G9L@#VHO$RI0/I+;=W+V]+1E0"8]&\(L]2
MZ1-73EB'&I'B(1<X;H5S(@8S: 2#R/[',G/F:D YMT=A% 8&H9.NNUS-/7J'
MVTJ7H-)@9T_";7EGH^PAIH)0\/$62*X%!]\>2F^J4IXR98Z6,/?]/OJEU4 =
MP=PQ%C,)<-X-XCO_\;IQ5]P3JW@%7P__==UUW]PSHV$\6LR;_SQQO?3)Z32>
MSN;-?U[UW%E];!:/EJ/&O\R:YZMX,1D'2QX-I_%P->M UO\-FPS+G,*8W9LL
M?WSK2>K[OFA<&ZRU9\@YK&'D?Z"^&*CN?&&NZMZ/Q:@_];7Z%#BPI7/,YTC/
MP?_]OPGT]ZD<AVY\W3YA.SDE;#N[U8LWZ6Q0X>[Y6+7]>+H21 I:#)0CT3_!
M*E$D3Z8A.HDZ&<SE/(4ER]XD+,4X$#A!5]W)LU?G]$77#.$4&G.[]-_&LA$>
M=C08KWK8^I(]\X6U%'#7&$M$T,01,%V\Y.2-\6H QZ,]RI6;N9*'TZB#PF6)
M4Z6YF[0($M]0[=N-,)9+JD5H!KYT"Q;?B[$O#53'IBVKEM$G!)+9EX(\3)F/
M%)I]&0T'LT7T6@,"7TK,)Z,SG(\'LS^0;T$VT/6>8BS]T7@P_$/T,:L_7]YA
MU[VP&<)X,/\#%IC :I4H]"SD]>D?F,IZ(+*?9(_$@IPQTRBN"KT(&OG:<<,Z
MU^8, YFPX3G)\\%OF$X?Z7<SB2 _U&0/AN!GV;YWXITJEP^0D0NF++  /PB?
MFZ(,C/1+X@R+A686V1^?P5L9?GZ+6 W4C")%&FGJ3\8QT]%"9P%B<PJ*PDS"
M\ UQY+'#3]9L1J-1O!K.G_C64@7T;_K4>!0/)YC!TXC)DIGQYL-[R@D;C4<O
M;<BG8S8KHT-\\KT$B]+@"*KWJ%-I%F/L^76F30=AT/"(Z(!Q91K/15^W^?=@
M[:W3?_UN)Y@QW_6^3"V4-4&]6ZIXBGLBO[U7I^><S[Y&3NT7?J9FC[_Z9/O7
M3C)=N2ZAA,?R,V7A2YC:>E!_-ZT^U.;/T>I1?5\.W:,OIB_/T.A)=1]&*R#+
MET_I\:'^WM3C65?'92+IOEB\-/K[M37)OX^NFRX/MPTW")5W*1UJ_ G/1O%L
MN.2DI=8?0>L:CZ?F:UU,T/&A^C3S[77+Q SCQY_G\HNNR1A=\I9ZBN/F'7M)
M]&F:O)(B*1X*JW:EMYUB,UY$RUF\7(S:3S(RI7M081_VCZ6P@M;.79V^:)3
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M8)0/@CGFHFPJ4MPEO," XW*Q:OOQD,=H^Y1--!DOXL5L]02LS4W*<9"S$8_
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MHOO[8Y F'. F] A"2YFG8W.-2]$5K&L>+S6-O"SOJ&Z92VU<8A;1LN1$2IG
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M AZ^11LGD[13O)V$TN933EVRS8"U*$'4+"U/0^-8.R=PY6JX(/5C4/IT11T
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M37$QOB@7 "8?^@AMM_LP2CWH(E:<5K+F[K;".=ZEAZJ\+H.LQS;'9O!3A/^
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M@^$J6@R67'\_7$RB*W5I8..[23R?3]VF*&V^0 -T@2WIY =RO<+%U@<]?_>
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MLS%Q@YN16)M,XNE\;#+;24X'=0F*AT'-;)KJCM"<9T=-YW@\UUYD?J&2Q<D
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MLX7AK_*<]V:MOD@E3W*JVG[TG@FD.;?OX36N+0VT2.M7CCR^EH++EAK?_+M
MVG@.A>E>7>3"7T;- O>/&)#C%=KT+F@2I1WI4_<IMTNJQE+JKT\<T@ZTS..5
M-&H?V]3TP,[PA4F3I^;J?SML[NE?U P!ID)6EIM,D+X27.(^[H**2ZT.,SB"
ME)S=:-^46/[$5/+%PBIT5D&POU_J5*C-59+3?(AUQ+V5H;$#<M:"@GZXZ(ZY
MM)Q SVS_$M8A4#(1DK7?4!@\0"+0W$W>L()X \)I<"%5FPXHSX_*&WSQI"3
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M8UXA$QP#D7K0(\U]LLEK_B0-UNG?#R7[=(EL&8_VG!8KG2&4KMFC-ETAWZ:
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MP"SQ]"RW$10!7!IG8%YPV=9$F.K;6P-OM=:(.*.3_P#S,*?7V+.H>(*:SF0
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M![*N:YOWXWCL>^(V:27Y:QKTY'&,O(4ATP\WYHB%=Z(IWTO>>&_V^P?-O6^
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MEQ\RE_W"-(5F?DP*5__><P$"(L072;^#,[,3HP%6=OEM!KJ,/*8XG7N26_=
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MWZ+QY:6LR@LGPDNX4I)FDW#I95=5)[[LL_E@92COK_'PM[YW_P%02P,$%
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MP    !,"   +              "  0    !?<F5L<R\N<F5L<U!+ 0(4 Q0
M   ( #"*8E GZ(<.@@   +$    0              "  >D   !D;V-0<F]P
M<R]A<' N>&UL4$L! A0#%     @ ,(IB4(S7A*_M    *P(  !$
M     ( !F0$  &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ ,(IB4)E<
MG",0!@  G"<  !,              ( !M0(  'AL+W1H96UE+W1H96UE,2YX
M;6Q02P$"% ,4    "  PBF)0K"M32FD#  #3$   &               @ 'V
M"   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @ ,(IB4,3N
M3+ "!   ZQ(  !@              ( !E0P  'AL+W=O<FMS:&5E=',O<VAE
M970R+GAM;%!+ 0(4 Q0    ( #"*8E!.UT0%P (  !(+   8
M  "  <T0  !X;"]W;W)K<VAE971S+W-H965T,RYX;6Q02P$"% ,4    "  P
MBF)0F:7_FG(#  !P#@  &               @ '#$P  >&PO=V]R:W-H965T
M<R]S:&5E=#0N>&UL4$L! A0#%     @ ,(IB4" H3D-T!0  FAP  !@
M         ( !:Q<  'AL+W=O<FMS:&5E=',O<VAE970U+GAM;%!+ 0(4 Q0
M   ( #"*8E LS,$,V0$  &,$   8              "  14=  !X;"]W;W)K
M<VAE971S+W-H965T-BYX;6Q02P$"% ,4    "  PBF)0,DTKGUT%  !&'
M&               @ $D'P  >&PO=V]R:W-H965T<R]S:&5E=#<N>&UL4$L!
M A0#%     @ ,(IB4/?H+(:P 0  T@,  !@              ( !MR0  'AL
M+W=O<FMS:&5E=',O<VAE970X+GAM;%!+ 0(4 Q0    ( #"*8E 9-AC*M $
M -(#   8              "  9TF  !X;"]W;W)K<VAE971S+W-H965T.2YX
M;6Q02P$"% ,4    "  PBF)00I;VAK4!  #2 P  &0              @ &'
M*   >&PO=V]R:W-H965T<R]S:&5E=#$P+GAM;%!+ 0(4 Q0    ( #"*8E :
ME!6*LP$  -(#   9              "  7,J  !X;"]W;W)K<VAE971S+W-H
M965T,3$N>&UL4$L! A0#%     @ ,(IB4+ES\,2P 0  T@,  !D
M     ( !72P  'AL+W=O<FMS:&5E=',O<VAE970Q,BYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( #"*8E![A,N5M0$  -(#   9              "
M ?,U  !X;"]W;W)K<VAE971S+W-H965T,3<N>&UL4$L! A0#%     @ ,(IB
M4/T'00FV 0  T@,  !D              ( !WS<  'AL+W=O<FMS:&5E=',O
M<VAE970Q."YX;6Q02P$"% ,4    "  PBF)0:QJU";,!  #2 P  &0
M        @ ',.0  >&PO=V]R:W-H965T<R]S:&5E=#$Y+GAM;%!+ 0(4 Q0
M   ( #"*8E HQ''IM0$  -(#   9              "  ;8[  !X;"]W;W)K
M<VAE971S+W-H965T,C N>&UL4$L! A0#%     @ ,(IB4#3#03ZV 0  T@,
M !D              ( !HCT  'AL+W=O<FMS:&5E=',O<VAE970R,2YX;6Q0
M2P$"% ,4    "  PBF)0*C)(V+,!  #2 P  &0              @ &//P
M>&PO=V]R:W-H965T<R]S:&5E=#(R+GAM;%!+ 0(4 Q0    ( #"*8E!>TA?N
MZ@(  !L-   9              "  7E!  !X;"]W;W)K<VAE971S+W-H965T
M,C,N>&UL4$L! A0#%     @ ,(IB4&E)/DOI 0  9@4  !D
M ( !FD0  'AL+W=O<FMS:&5E=',O<VAE970R-"YX;6Q02P$"% ,4    "  P
MBF)0UV1O1-(!  "<!   &0              @ &Z1@  >&PO=V]R:W-H965T
M<R]S:&5E=#(U+GAM;%!+ 0(4 Q0    ( #"*8E"XO1Y5] $  ,L%   9
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M970S,"YX;6Q02P$"% ,4    "  PBF)0HC"U3=P!   !!0  &0
M    @ ' 4@  >&PO=V]R:W-H965T<R]S:&5E=#,Q+GAM;%!+ 0(4 Q0    (
M #"*8E WTE1FW0$   $%   9              "  =-4  !X;"]W;W)K<VAE
M971S+W-H965T,S(N>&UL4$L! A0#%     @ ,(IB4$2>X!.W 0  T@,  !D
M             ( !YU8  'AL+W=O<FMS:&5E=',O<VAE970S,RYX;6Q02P$"
M% ,4    "  PBF)0?_:*9B0#  !8#0  &0              @ '56   >&PO
M=V]R:W-H965T<R]S:&5E=#,T+GAM;%!+ 0(4 Q0    ( #"*8E#+])7AZ $
M #(%   9              "  3!<  !X;"]W;W)K<VAE971S+W-H965T,S4N
M>&UL4$L! A0#%     @ ,(IB4+R^Q0,: @  ;08  !D              ( !
M3UX  'AL+W=O<FMS:&5E=',O<VAE970S-BYX;6Q02P$"% ,4    "  PBF)0
MI<12?MX!  #Z!   &0              @ &@8   >&PO=V]R:W-H965T<R]S
M:&5E=#,W+GAM;%!+ 0(4 Q0    ( #"*8E 4XVCJ]@$  /,$   9
M      "  ;5B  !X;"]W;W)K<VAE971S+W-H965T,S@N>&UL4$L! A0#%
M  @ ,(IB4*@?GSGK 0  8@4  !D              ( !XF0  'AL+W=O<FMS
M:&5E=',O<VAE970S.2YX;6Q02P$"% ,4    "  PBF)0;25D9WL"   7"0
M&0              @ $$9P  >&PO=V]R:W-H965T<R]S:&5E=#0P+GAM;%!+
M 0(4 Q0    ( #"*8E"M,1_@  (  %X%   9              "  ;9I  !X
M;"]W;W)K<VAE971S+W-H965T-#$N>&UL4$L! A0#%     @ ,(IB4$D)/KRO
M 0  T ,  !D              ( ![6L  'AL+W=O<FMS:&5E=',O<VAE970T
M,BYX;6Q02P$"% ,4    "  PBF)02Q>6)MH!  !B!   &0
M@ '3;0  >&PO=V]R:W-H965T<R]S:&5E=#0S+GAM;%!+ 0(4 Q0    ( #"*
M8E#/QZQ*N@$  #X$   9              "  >1O  !X;"]W;W)K<VAE971S
M+W-H965T-#0N>&UL4$L! A0#%     @ ,(IB4 =0,P^\ @  I D  !D
M         ( !U7$  'AL+W=O<FMS:&5E=',O<VAE970T-2YX;6Q02P$"% ,4
M    "  PBF)0<\H?YG,"  "X"   &0              @ '(=   >&PO=V]R
M:W-H965T<R]S:&5E=#0V+GAM;%!+ 0(4 Q0    ( #"*8E#B46P5QP$  #4$
M   9              "  7)W  !X;"]W;W)K<VAE971S+W-H965T-#<N>&UL
M4$L! A0#%     @ ,(IB4.D?VA8,!0  #B$  !D              ( !<'D
M 'AL+W=O<FMS:&5E=',O<VAE970T."YX;6Q02P$"% ,4    "  PBF)02&DS
M&JD!  "< P  &0              @ &S?@  >&PO=V]R:W-H965T<R]S:&5E
M=#0Y+GAM;%!+ 0(4 Q0    ( #"*8E#[*S\Q&0(   X'   9
M  "  9.   !X;"]W;W)K<VAE971S+W-H965T-3 N>&UL4$L! A0#%     @
M,(IB4(LJ(U0? @  Y 4  !D              ( !XX(  'AL+W=O<FMS:&5E
M=',O<VAE970U,2YX;6Q02P$"% ,4    "  PBF)08([DN'<#   0$@  &0
M            @ $YA0  >&PO=V]R:W-H965T<R]S:&5E=#4R+GAM;%!+ 0(4
M Q0    ( #"*8E!=B)=MQP$  "L$   9              "  >>(  !X;"]W
M;W)K<VAE971S+W-H965T-3,N>&UL4$L! A0#%     @ ,(IB4'$6\M$0 @
M8P8  !D              ( !Y8H  'AL+W=O<FMS:&5E=',O<VAE970U-"YX
M;6Q02P$"% ,4    "  PBF)0S8X<%^$!  #I!   &0              @ $L
MC0  >&PO=V]R:W-H965T<R]S:&5E=#4U+GAM;%!+ 0(4 Q0    ( #"*8E"
M&X[8 P(  %@%   9              "  42/  !X;"]W;W)K<VAE971S+W-H
M965T-38N>&UL4$L! A0#%     @ ,(IB4(M[2#>6 @  /PH  !D
M     ( !?I$  'AL+W=O<FMS:&5E=',O<VAE970U-RYX;6Q02P$"% ,4
M"  PBF)0?5"S#XP"   +"0  &0              @ %+E   >&PO=V]R:W-H
M965T<R]S:&5E=#4X+GAM;%!+ 0(4 Q0    ( #"*8E!O=JSG>P,  "H0   9
M              "  0Z7  !X;"]W;W)K<VAE971S+W-H965T-3DN>&UL4$L!
M A0#%     @ ,(IB4-$@8?\@ @  F 8  !D              ( !P)H  'AL
M+W=O<FMS:&5E=',O<VAE970V,"YX;6Q02P$"% ,4    "  PBF)0=]+$XTT"
M   4!P  &0              @ $7G0  >&PO=V]R:W-H965T<R]S:&5E=#8Q
M+GAM;%!+ 0(4 Q0    ( #"*8E!':++Y^P$  &@%   9              "
M 9N?  !X;"]W;W)K<VAE971S+W-H965T-C(N>&UL4$L! A0#%     @ ,(IB
M4.<WX_O1 0  C 0  !D              ( !S:$  'AL+W=O<FMS:&5E=',O
M<VAE970V,RYX;6Q02P$"% ,4    "  PBF)0\EW?VA0"   H!@  &0
M        @ '5HP  >&PO=V]R:W-H965T<R]S:&5E=#8T+GAM;%!+ 0(4 Q0
M   ( #"*8E#JM, R[P$  %@%   9              "  2"F  !X;"]W;W)K
M<VAE971S+W-H965T-C4N>&UL4$L! A0#%     @ ,(IB4#87->&B 0  7@,
M !D              ( !1J@  'AL+W=O<FMS:&5E=',O<VAE970V-BYX;6Q0
M2P$"% ,4    "  PBF)0P:_]Z;8#   T$@  &0              @ $?J@
M>&PO=V]R:W-H965T<R]S:&5E=#8W+GAM;%!+ 0(4 Q0    ( #"*8E#1+5@$
MK0(   P*   9              "  0RN  !X;"]W;W)K<VAE971S+W-H965T
M-C@N>&UL4$L! A0#%     @ ,(IB4,(1+O'E @  5 L  !D
M ( !\+   'AL+W=O<FMS:&5E=',O<VAE970V.2YX;6Q02P$"% ,4    "  P
MBF)0VGFY6M@"  !Y#   &0              @ $,M   >&PO=V]R:W-H965T
M<R]S:&5E=#<P+GAM;%!+ 0(4 Q0    ( #"*8E"%_]37Y@,  * 2   9
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M970W-2YX;6Q02P$"% ,4    "  PBF)0'+H0+0D"  !\!0  &0
M    @ $6R@  >&PO=V]R:W-H965T<R]S:&5E=#<V+GAM;%!+ 0(4 Q0    (
M #"*8E!+Y=Y(?P(  #@(   9              "  5;,  !X;"]W;W)K<VAE
M971S+W-H965T-S<N>&UL4$L! A0#%     @ ,(IB4)<8I?N: @  BPD  !D
M             ( !#,\  'AL+W=O<FMS:&5E=',O<VAE970W."YX;6Q02P$"
M% ,4    "  PBF)0<#K/VL<"  "0"@  &0              @ '=T0  >&PO
M=V]R:W-H965T<R]S:&5E=#<Y+GAM;%!+ 0(4 Q0    ( #"*8E!L/^!!'@(
M /T%   9              "  =O4  !X;"]W;W)K<VAE971S+W-H965T.# N
M>&UL4$L! A0#%     @ ,(IB4&+_B8]E @  I @  !D              ( !
M,-<  'AL+W=O<FMS:&5E=',O<VAE970X,2YX;6Q02P$"% ,4    "  PBF)0
M.+&O0^4!  !<!0  &0              @ ',V0  >&PO=V]R:W-H965T<R]S
M:&5E=#@R+GAM;%!+ 0(4 Q0    ( #"*8E!N@E[Q#@,  (\+   9
M      "  >C;  !X;"]W;W)K<VAE971S+W-H965T.#,N>&UL4$L! A0#%
M  @ ,(IB4/N9;0UN P  N0T  !D              ( !+=\  'AL+W=O<FMS
M:&5E=',O<VAE970X-"YX;6Q02P$"% ,4    "  PBF)0=+$+D.(!  !M!0
M&0              @ '2X@  >&PO=V]R:W-H965T<R]S:&5E=#@U+GAM;%!+
M 0(4 Q0    ( #"*8E#ATC[@XJ    ^' @ 4              "  >OD  !X
M;"]S:&%R9613=')I;F=S+GAM;%!+ 0(4 Q0    ( #"*8E!A\7[#60(  $8,
M   -              "  ?^% 0!X;"]S='EL97,N>&UL4$L! A0#%     @
M,(IB4+7_O4<B!@  6C@   \              ( !@X@! 'AL+W=O<FMB;V]K
M+GAM;%!+ 0(4 Q0    ( #"*8E#";GS=G (  +0R   :              "
M =*. 0!X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( #"*
M8E *4FQ/- (  $,Q   3              "  ::1 0!;0V]N=&5N=%]4>7!E
<<UTN>&UL4$L%!@    !> %X Q!D   N4 0    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6791471360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Property and Equipment (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property and equipment, useful life</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property and equipment, useful life</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6808182768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 63,354<span></span>
</td>
<td class="nump">$ 34,557<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of goods sold</a></td>
<td class="nump">15,927<span></span>
</td>
<td class="nump">10,874<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">47,427<span></span>
</td>
<td class="nump">23,683<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">12,272<span></span>
</td>
<td class="nump">10,258<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative</a></td>
<td class="nump">63,220<span></span>
</td>
<td class="nump">34,820<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">75,492<span></span>
</td>
<td class="nump">45,078<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(28,065)<span></span>
</td>
<td class="num">(21,395)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income</a></td>
<td class="nump">1,656<span></span>
</td>
<td class="nump">189<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(4,952)<span></span>
</td>
<td class="num">(4,361)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income (expense), net</a></td>
<td class="num">(21,054)<span></span>
</td>
<td class="num">(12,063)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Nett loss</a></td>
<td class="num">(52,415)<span></span>
</td>
<td class="num">(37,630)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net loss attributable to non-controlling interest</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss attributable to Silk Road Medical, Inc. common stockholders</a></td>
<td class="num">(52,415)<span></span>
</td>
<td class="num">(37,629)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive loss:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Unrealized gain on investments, net</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Net change in other comprehensive loss</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_silk_NetIncomeLossAndComprehensiveIncomeLossNetOfTaxAttributableToParent', window );">Net loss and comprehensive loss attributable to Silk Road Medical, Inc. common stockholders</a></td>
<td class="num">$ (52,413)<span></span>
</td>
<td class="num">$ (37,629)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Net loss per share attributable to Silk Road Medical, Inc. common stockholders, basic and diluted (in USD per share)</a></td>
<td class="num">$ (2.28)<span></span>
</td>
<td class="num">$ (39.16)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Weighted average common shares used to compute net loss per share attributable to Silk Road Medical, Inc. common stockholders, basic and diluted (in shares)</a></td>
<td class="nump">22,956,679<span></span>
</td>
<td class="nump">960,882<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_silk_NetIncomeLossAndComprehensiveIncomeLossNetOfTaxAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net Income (Loss) And Comprehensive Income (Loss), Net Of Tax, Attributable To Parent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">silk_NetIncomeLossAndComprehensiveIncomeLossNetOfTaxAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>silk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109260490&amp;loc=d3e1337-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=114775744&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=114873765&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=114873765&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669625-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=114873790&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669619-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=84234705&amp;loc=SL4591551-111686<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=109228884&amp;loc=d3e1436-108581<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669625-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669625-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=84234705&amp;loc=SL4591551-111686<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3000-108585<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=84234705&amp;loc=SL4591552-111686<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109196051&amp;loc=SL49130543-203045<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109196051&amp;loc=SL49130539-203045<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=109196051&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=68048583&amp;loc=d3e3636-108311<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6794620576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text">Commitments and Contingencies<div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Operating Lease and Rights of Use</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company&#8217;s operating lease obligation consists of leased office, laboratory, and manufacturing space under a non-cancellable operating lease that expires in October&#160;2024. The lease agreement includes a renewal provision allowing the Company to extend this lease for an additional period of five years.   Operating lease costs were $870,000 for the year ended December&#160;31, 2019.  Cash paid for amounts included in the measurement of operating lease liabilities was $721,000 for the year ended December&#160;31, 2019.  As of December&#160;31, 2019, the weighted average discount rate was approximately 6.50% and the weighted average remaining lease term was 4.83 years.  Balance sheet information as of December&#160;31, 2019 consists of the following (in thousands):</span></div><div style="margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:77.647%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.441%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:17.712%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operating Lease:</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operating lease right-of-use asset in other non-current assets</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,400&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operating lease liability in accrued liabilities</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">769&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operating lease liability in other liabilities</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,700&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total operating lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,469&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table summarizes the Company's operating lease maturities as of December&#160;31, 2019 (in thousands):</span></div><div style="margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:76.980%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.436%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:18.384%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Year Ending December 31:</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Amount</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,037&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2021</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,066&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2022</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,096&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2023</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,127&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2024</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">904&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total lease payments</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,230&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Less: imputed interest</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(761)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:18pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Present value of lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,469&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The aggregate future minimum lease payments under ASC 840 as of December&#160;31, 2018 were as follows (in thousands):</span></div><div style="margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:83.416%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.441%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.943%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Year Ending December 31:</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total Minimum<br/>Lease Payments</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,002&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,002&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2021</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,031&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2022</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,044&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2023 and thereafter</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,920&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,999&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Purchase Obligations</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Purchase obligations consist of agreements to purchase goods and services entered into in the ordinary course of business.  As of December&#160;31, 2019, the Company had non-cancellable purchase obligations to suppliers of $7,097,000.</span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Indemnification</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In the normal course of business, the Company enters into contracts and agreements with suppliers and other parties that contain a variety of representations and warranties and may provide for indemnification of the counterparty.  The Company&#8217;s exposure under these agreements is unknown because it involves claims that may be made against it in the future but have not yet been made.  To date, the Company has not been subject to any claims or been required to defend any action related to its indemnification obligations.</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company indemnifies each of its directors and officers for certain events or occurrences, subject to certain limits, while the director is or was serving at the Company&#8217;s request in such capacity, as permitted under Delaware law and in accordance with its certificate of incorporation and bylaws.  The term of the indemnification period lasts as long as a director may be subject to any proceeding arising out of acts or omissions of such director in such capacity.  The maximum amount of potential future indemnification is unlimited; however, the Company currently holds director liability insurance.  The Company believes that the fair value of these indemnification obligations is minimal.  Accordingly, the Company has not recognized any liabilities relating to these obligations as of December&#160;31, 2019.</span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Contingencies </span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company is not involved in any pending legal proceedings that it believes could have a material adverse effect on its financial condition, results of operations or cash flows. From time to time, the Company may pursue litigation to assert its legal right and such litigation may be costly and divert the efforts and attention of its management and technical personnel which could adversely affect its business. The Company accrues a liability for such matters when it is probable that future expenditures will be made and such expenditures can be reasonably estimated. There were no contingent liabilities requiring accrual at December&#160;31, 2019 and 2018.</span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Legal Matters</span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In February 2019, a former employee, through counsel, advised the Company that he had filed a charge of discrimination against the Company with the California Department of Fair Employment &amp; Housing, or </span></div>DFEH.  The former employee&#8217;s complaint alleged sexual harassment and retaliation in violation of the California Department of Fair Employment &amp; Housing Act.  The complaint did not allege specific damages. The Company and the former employee participated in mediation on July 30, 2019 and reached a settlement that required the Company to pay an amount that was not material to its financial statements, which amount was fully paid as of December&#160;31, 2019.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6958869056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Recent Accounting Pronouncements<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingChangesAndErrorCorrectionsAbstract', window );"><strong>Accounting Changes and Error Corrections [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock', window );">Recent Accounting Pronouncements</a></td>
<td class="text">Recent Accounting Pronouncements<div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Recently Adopted Accounting Standards</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In February 2016, the FASB issued ASU No. 2016-02, "Leases," that supersedes ASC 840, "Leases." Subsequently, the FASB issued several updates to ASU No. 2016-02, codified in ASC Topic 842 (&#8220;ASC 842&#8221;). The Company adopted ASC 842 on January 1, 2019 using the modified retrospective method for all leases not substantially completed as of the date of adoption.  The Company elected to apply the package of practical expedients, which allowed the Company to not reassess: (i) whether expired or existing contracts contain leases; (ii) lease classification for any expired or existing leases; and (iii) initial direct costs for any existing lease.</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Recently Issued Accounting Standards</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In June 2016, the FASB issued ASU 2016-13, Measurement of Credit Losses on Financial Statements.  This update provides financial statement users with more decision-useful information about the expected credit losses on financial instruments and other commitments to extend credit held by a reporting entity at each reporting date.  The update replaces the incurred loss impairment methodology in current GAAP with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates.  ASU 2016-13 became effective for the Company on January 1, 2020.  The Company does not believe that the adoption of this new guidance will have a material impact on its financial statements.</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In August 2018, the FASB issued ASU 2018-13, Fair Value Measurement, which changed the disclosure requirements for fair value measurements by removing, adding and modifying certain disclosures.  ASU 2018-13 became effective for the Company on January 1, 2020.  </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company does not believe that the adoption of this new guidance will have a material impact on its financial statements and related disclosures.</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In August 2018, the FASB issued ASU 2018-15, Cloud Computing Arrangements, which aligns the requirements for capitalizing implementation costs in a Cloud Computing Arrangement service contract with the requirements for capitalizing implementation costs incurred for an internal-use software license.  ASU 2018-15 became effective for the Company on January 1, 2020.</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">  The Company does not believe that the adoption of this new guidance will have a material impact on its financial statements and related disclosures.</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes, which enhances and simplifies various aspects of the income tax accounting guidance related to intraperiod tax allocation, interim period accounting for enacted changes in tax law, and the year-to-date loss limitation in interim period tax accounting.  ASU 2019-12 also amends other aspects of the guidance to reduce complexity in certain areas.  ASU 2019-12 will become effective for the Company on January 1, 2021.  Early adoption is permitted.  The Company is evaluating the impact of adopting this guidance to its financial statements and related disclosures.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingChangesAndErrorCorrectionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingChangesAndErrorCorrectionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of changes in accounting principles, including adoption of new accounting pronouncements, that describes the new methods, amount and effects on financial statement line items.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -URI http://asc.fasb.org/topic&amp;trid=2122394<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6795057968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">Income Taxes<div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The components of income before taxes are as follows (in thousands):</span></div><div style="text-align:right;margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:69.314%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:11.942%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.943%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Year Ended December 31,</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">United States</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(52,415)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(37,630)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">International</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(52,415)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(37,630)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">A reconciliation of the statutory U.S. federal rate to the Company&#8217;s effective tax rate is as follows (in thousands):</span></div><div style="text-align:center;margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:69.314%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:11.942%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.943%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Year Ended December 31,</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Tax at federal statutory rate</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(11,007)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(7,902)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">State taxes, net of federal benefit</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2,270)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1,582)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Permanent differences</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(4,731)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">289&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Loss on Series C warrant liability</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,330&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,500&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Change in valuation allowance</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12,797&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6,197&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">General business credits</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(319)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">136&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">208&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">376&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Provision for income taxes</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">14&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div style="margin-top:18pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company's provision for income taxes are included within other income (expense) on the statements of operations and comprehensive loss.</span></div><div style="text-indent:18pt;margin-bottom:9pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Significant components of the Company&#8217;s net deferred tax assets as of December&#160;31, 2019 and 2018 consist of the following (in thousands):</span></div><div style="text-align:center;margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:69.314%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:11.942%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.943%;"/><td style="width:1.0%;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 31,</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Deferred tax assets:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net operating loss carryforwards</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">44,574&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">33,815&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Research and development credits</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,287&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,944&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Capitalized start-up costs/Intangibles</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">16&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accruals and reserves</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,227&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,169&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Property and equipment</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">188&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">82&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Stock-based compensation</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">568&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">274&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operating lease liability</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,133&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total deferred tax assets</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">53,988&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">40,300&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Less:  Valuation allowance</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(53,126)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(40,300)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operating lease asset</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(862)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total deferred tax liabilities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(862)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net deferred tax assets</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr></table></div><div style="margin-top:18pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In assessing the realizability of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized.  The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible.  Management believes it is more likely than not that the deferred tax assets will not be realized; accordingly, a valuation allowance has been established on U.S. net deferred tax assets.  The valuation allowance increased $12,826,000 during the year ended December&#160;31, 2019 and increased by $6,197,000 during the year ended December&#160;31, 2018.</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">As of December&#160;31, 2019, the Company had net operating loss carryforwards of approximately $167,948,000 and $148,380,000 for federal and state income tax purposes, respectively.  The federal and state net operating loss carryforwards begin to expire in 2027 and 2028, respectively.  Federal NOL carryforwards generated in tax years beginning in 2018 are not subject to expiration.  Federal NOLs that arose on or after January 1, 2018 can be carried forward indefinitely against future income, but can only be used to offset a maximum of 80% of the Company's federal taxable income in any year.</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The federal and state net operating loss carryforwards may be subject to significant limitations under Section 382 and Section 383 of the Internal Revenue Code and similar provisions under state law.  Federal tax legislation enacted in December 2017, commonly known as the Tax Cuts and Jobs Act, contains provisions that limit the federal net operating loss carryforwards that may be used in any given year in the event of special occurrences, including significant ownership changes.  A Section 382 &#8220;ownership change&#8221; generally occurs if one or more stockholders or groups of stockholders, who own at least 5% of the Company&#8217;s stock, increase their ownership by more than 50 percentage points over their lowest ownership percentage within a rolling three-year period.  The Company may have previously experienced, and may in the future experience, one or more Section 382 &#8220;ownership changes,&#8221; including in connection with the Company&#8217;s initial public offering.  If so, the Company may lose some or all of the tax benefits of its NOLs and tax credits.  The extent of such limitations for prior years, if any, has not yet been formally determined.</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">At December&#160;31, 2019, the Company had $4,320,000 and $2,860,000 of federal and state research and development credit carryforwards, respectively.  If not utilized, the federal credits will expire beginning in 2027.  The California Research and Development credits can be carried forward indefinitely.</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">As of December&#160;31, 2019, the Company had $1,436,000 of unrecognized tax benefits.  The Company does not have any tax positions for which it is reasonably possible that the total amount of gross unrecognized would increase or decrease within twelve months of the year ended December&#160;31, 2019. If recognized, $0 would affect the effective tax rate.</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company recognizes interest and penalties related to uncertain tax positions in income tax expense.  There was no such expense recorded during the years ended December&#160;31, 2019 and 2018.</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">A reconciliation of the unrecognized tax benefits from January 1, 2018 to December&#160;31, 2019 is as follows (in thousands):</span></div><div style="text-align:center;margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:69.314%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:11.942%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.943%;"/><td style="width:1.0%;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 31,</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance at the beginning of year</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,348&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">615&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Increases related to current years&#8217; tax positions</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">88&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">118&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Increases/(decreases) related to prior years&#8217; tax positions</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">615&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance at end of year</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,436&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,348&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr></table></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company currently has no federal or state tax examinations in progress nor has it had any federal or state tax examinations since its inception.  As a result of the Company&#8217;s net operating loss carryforwards, all of its tax years are subject to federal and state tax examination.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6623528224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount', window );">Increase (decrease) in deferred tax asset valuation allowance</a></td>
<td class="nump">$ 12,826,000<span></span>
</td>
<td class="nump">$ 6,197,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_silk_OperatingLossCarryforwardOffsetMaximumPercent', window );">Percent maximum of federal taxable income to offset with net operating losses</a></td>
<td class="nump">80.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized tax benefits</a></td>
<td class="nump">$ 1,436,000<span></span>
</td>
<td class="nump">1,348,000<span></span>
</td>
<td class="nump">$ 615,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate', window );">Unrecognized tax benefits that would impact effective tax rate</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense', window );">Unrecognized tax benefits, income tax penalties and interest expense</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Domestic Tax Authority</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carryforwards</a></td>
<td class="nump">167,948,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State and Local Jurisdiction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carryforwards</a></td>
<td class="nump">148,380,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAxis=us-gaap_ResearchMember', window );">Research Tax Credit Carryforward | Domestic Tax Authority</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Research and development tax credits</a></td>
<td class="nump">4,320,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAxis=us-gaap_ResearchMember', window );">Research Tax Credit Carryforward | State and Local Jurisdiction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Research and development tax credits</a></td>
<td class="nump">$ 2,860,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_silk_OperatingLossCarryforwardOffsetMaximumPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Loss Carryforward, Offset Maximum, Percent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">silk_OperatingLossCarryforwardOffsetMaximumPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>silk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwardsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwardsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI http://asc.fasb.org/extlink&amp;oid=84176650&amp;loc=SL37586934-109318<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=84176650&amp;loc=d3e32123-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAxis=us-gaap_ResearchMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAxis=us-gaap_ResearchMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6808659456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Option Plans - Narrative (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Options granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">848,023<span></span>
</td>
<td class="nump">629,716<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value (in USD per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.17<span></span>
</td>
<td class="nump">$ 2.93<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue', window );">Fair value of options vested (in USD per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,221,000<span></span>
</td>
<td class="nump">$ 569,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Aggregate intrinsic value of options exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 24,867<span></span>
</td>
<td class="nump">$ 787<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Compensation expense for share-based awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,977<span></span>
</td>
<td class="nump">$ 911<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock reserved for future issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,237,832<span></span>
</td>
<td class="nump">28,499,408<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Compensation expensed not yet recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,539<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Compensation expensed not yet recognized, period for recognition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years 14 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=silk_IncentiveStockOptionMember', window );">ISO</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_silk_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExerciseThresholdasaPercentageofSharePrice', window );">Exercise threshold as a percentage of fair value of shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=silk_NonqualifiedStockOptionsMember', window );">NSO</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_silk_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExerciseThresholdasaPercentageofSharePrice', window );">Exercise threshold as a percentage of fair value of shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=silk_IncentiveandNonqualifiedStockOptionMember', window );">ISO and NSO</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Option term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Option vesting term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=silk_IncentiveandNonqualifiedStockOptionMember', window );">ISO and NSO | 10% Stockholders</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_silk_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExerciseThresholdasaPercentageofSharePrice', window );">Exercise threshold as a percentage of fair value of shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">110.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">2019 ESPP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum', window );">Percent of outstanding shares of common stock</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent', window );">Percent of purchase of price of common stock</a></td>
<td class="nump">85.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock reserved for future issuance (in shares)</a></td>
<td class="nump">434,000<span></span>
</td>
<td class="nump">372,352,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_silk_ShareBasedCompensationArrangementBySharebasedPaymentAwardNumberOfAdditionalSharesAllowableUnderThePlan', window );">Number of additional shares allowable under the plan (in shares)</a></td>
<td class="nump">1,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Compensation expensed not yet recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 219<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Compensation expensed not yet recognized, period for recognition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 months 20 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Issuance of common stock under employee stock purchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">61,648,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=silk_TwoThousandNineteenStockOptionPlanMember', window );">2019 Stock Option Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Shares of common stock reserved for issuance (in shares)</a></td>
<td class="nump">2,317,000<span></span>
</td>
<td class="nump">2,366,251<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum', window );">Percent of outstanding shares of common stock</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=silk_TwoThousandNineteenStockOptionPlanMember', window );">2019 Stock Option Plan | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_silk_ShareBasedCompensationArrangementBySharebasedPaymentAwardNumberOfAdditionalSharesAllowableUnderThePlan', window );">Number of additional shares allowable under the plan (in shares)</a></td>
<td class="nump">3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_silk_ShareBasedCompensationArrangementBySharebasedPaymentAwardNumberOfAdditionalSharesAllowableUnderThePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-based Payment Award, Number Of Additional Shares Allowable Under The Plan</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">silk_ShareBasedCompensationArrangementBySharebasedPaymentAwardNumberOfAdditionalSharesAllowableUnderThePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>silk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_silk_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExerciseThresholdasaPercentageofSharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercise Threshold as a Percentage of Share Price</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">silk_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExerciseThresholdasaPercentageofSharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>silk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the expense recognized during the period arising from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average period over which unrecognized compensation is expected to be recognized for equity-based compensation plans, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Unrecognized cost of unvested options awarded to employees as compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period which an employee's right to exercise an award is no longer contingent on satisfaction of either a service condition, market condition or a performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of shares (or other type of equity) originally approved (usually by shareholders and board of directors), net of any subsequent amendments and adjustments, for awards under the equity-based compensation plan. As stock or unit options and equity instruments other than options are awarded to participants, the shares or units remain authorized and become reserved for issuance under outstanding awards (not necessarily vested).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum number of shares that may be issued in accordance with the plan as a proportion of outstanding capital stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average grant-date fair value of options vested.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Purchase price of common stock expressed as a percentage of its fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=silk_IncentiveStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=silk_IncentiveStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=silk_NonqualifiedStockOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=silk_NonqualifiedStockOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=silk_IncentiveandNonqualifiedStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=silk_IncentiveandNonqualifiedStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_PrincipalOwnerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_PrincipalOwnerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=silk_TwoThousandNineteenStockOptionPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=silk_TwoThousandNineteenStockOptionPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6795051920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisition of Variable Interest Entity - NeuroCo (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 17, 2018</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
<th class="th"><div>Dec. 31, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Value of common stock issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 109,119,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestInVariableInterestEntity', window );">Carrying amount of the non-controlling interest</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=silk_NeuroCoIncMember', window );">NeuroCo, Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Equity interest acquired</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Shares issued as consideration (in shares)</a></td>
<td class="nump">33,462<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_silk_BusinessCombinationConsiderationTransferredNotesPayableForgiven', window );">Consideration given, amount of notes payable forgiven</a></td>
<td class="nump">$ 1,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=silk_NeuroCoIncMember', window );">NeuroCo, Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesReceivableRelatedParties', window );">Promissory note amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 498,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_silk_NotesReceivableRelatedPartiesInterestRateStatedPercentage', window );">Notes receivable, interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.74%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_silk_NotesReceivableRelatedPartiesTerm', window );">Notes receivable, term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Value of common stock issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 154,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_silk_BusinessCombinationConsiderationTransferredNotesPayableForgiven">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Consideration Transferred, Notes Payable Forgiven</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">silk_BusinessCombinationConsiderationTransferredNotesPayableForgiven</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>silk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_silk_NotesReceivableRelatedPartiesInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Notes Receivable, Related Parties, Interest Rate, Stated Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">silk_NotesReceivableRelatedPartiesInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>silk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_silk_NotesReceivableRelatedPartiesTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Notes Receivable, Related Parties, Term</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">silk_NotesReceivableRelatedPartiesTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>silk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of equity interests issued or issuable to acquire entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of voting equity interests acquired at the acquisition date in the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestInVariableInterestEntity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Portion of equity (net assets) in a variable interest entity (VIE) not attributable, directly or indirectly, to the parent entity. That is, this is the portion of equity in a VIE that is attributable to the noncontrolling interest (previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestInVariableInterestEntity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesReceivableRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an unclassified balance sheet, amounts due from parties associated with the reporting entity as evidenced by a written promise to pay.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesReceivableRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=silk_NeuroCoIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=silk_NeuroCoIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=silk_NeuroCoIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=silk_NeuroCoIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6800138848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Option Plans - Stock-based Compensation (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">$ 2,977<span></span>
</td>
<td class="nump">$ 911<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of goods sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">179<span></span>
</td>
<td class="nump">51<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">426<span></span>
</td>
<td class="nump">256<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember', window );">Selling, general and administrative expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">$ 2,372<span></span>
</td>
<td class="nump">$ 604<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the expense recognized during the period arising from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6791568736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Balance Sheet Components - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleTerm', window );">Weighted average days to maturity</a></td>
<td class="text">291 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcessNetOfReserves', window );">Work-in-process inventories</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation and amortization</a></td>
<td class="nump">$ 712,000,000<span></span>
</td>
<td class="nump">$ 517,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period between issuance and maturity of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=99377789&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcessNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcessNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6810623536">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Components - Fair Value of Available-For-Sale Investments (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">$ 104,093<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(7)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">104,095<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_MoneyMarketFundsMember', window );">Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">34,363<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">34,363<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember', window );">Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">9,919<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">9,919<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate bonds/notes</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">10,180<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">10,176<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember', window );">U.S. government securities</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">44,450<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">44,456<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember', window );">Asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">5,181<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">5,181<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CashEquivalentsMember', window );">Cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">34,363<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ShortTermInvestmentsMember', window );">Short-term investments</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">51,508<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=silk_LongTermInvestmentsMember', window );">Long-term investments</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">$ 18,224<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=82897076&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=82897076&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=82897076&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109979856&amp;loc=d3e26610-111562<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=82897076&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CashEquivalentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CashEquivalentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_ShortTermInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_ShortTermInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=silk_LongTermInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=silk_LongTermInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6794962384">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments and Contingencies - Operating Lease Maturities (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2020</a></td>
<td class="nump">$ 1,037<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2021</a></td>
<td class="nump">1,066<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2022</a></td>
<td class="nump">1,096<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2023</a></td>
<td class="nump">1,127<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2024</a></td>
<td class="nump">904<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total lease payments</a></td>
<td class="nump">5,230<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less: imputed interest</a></td>
<td class="num">(761)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Present value of lease liabilities</a></td>
<td class="nump">$ 4,469<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for operating lease, due in next fiscal year following latest fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for operating lease, due in fifth fiscal year following latest fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for operating lease, due in fourth fiscal year following latest fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for operating lease, due in third fiscal year following latest fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for operating lease, due in second fiscal year following latest fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888419&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6723275984">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Long-term Debt - Future Maturities Under the Term Loan (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2020</a></td>
<td class="nump">$ 4,454<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2021</a></td>
<td class="nump">4,442<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">2022</a></td>
<td class="nump">48,256<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_silk_LongTermDebtGrossBeforeAccretionOfClosingFees', window );">Long-term debt, gross before accretion of closing fees</a></td>
<td class="nump">57,152<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_silk_LongTermDebtAccretionOfClosingFees', window );">Add: Accretion of closing fees</a></td>
<td class="nump">1,205<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt, gross</a></td>
<td class="nump">58,357<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_silk_LongTermDebtUnpaidInterest', window );">Less: Amount representing interest</a></td>
<td class="num">(13,339)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet', window );">Less: Amount representing debt discount and debt issuance costs</a></td>
<td class="num">(139)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Present value of minimum payments</a></td>
<td class="nump">$ 44,879<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_silk_LongTermDebtAccretionOfClosingFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Long-Term Debt, Accretion Of Closing Fees</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">silk_LongTermDebtAccretionOfClosingFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>silk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_silk_LongTermDebtGrossBeforeAccretionOfClosingFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Long-Term Debt, Gross, Before Accretion Of Closing Fees</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">silk_LongTermDebtGrossBeforeAccretionOfClosingFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>silk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_silk_LongTermDebtUnpaidInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Long-Term Debt, Unpaid Interest</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">silk_LongTermDebtUnpaidInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>silk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109500613&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unamortized debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109500613&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=114775744&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109500613&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6809115760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Redeemable Convertible Preferred Stock - Narrative (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Apr. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Oct. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Temporary equity, shares issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,233,190<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Temporary equity, shares outstanding (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,233,190<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Stock issued, price per share (in USD per share)</a></td>
<td class="nump">$ 20.00<span></span>
</td>
<td class="nump">$ 20.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=silk_PreferredStockWarrantsMember', window );">Preferred Stock Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants outstanding (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,672,502<span></span>
</td>
<td class="nump">163,877<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=silk_PreferredStockWarrantsMember', window );">Preferred Stock Warrants | IPO</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesConverted1', window );">Shares of common stock converted (in shares)</a></td>
<td class="nump">1,945,365<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_ConvertiblePreferredStockMember', window );">Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Temporary equity, shares issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Temporary equity, shares outstanding (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockSharesConverted1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4313-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4304-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4332-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockSharesConverted1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=silk_PreferredStockWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=silk_PreferredStockWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_ConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_ConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>84
<FILENAME>0001397702-20-000007-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001397702-20-000007-xbrl.zip
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MB3!^\29A\&3P?H#V"]\ ?$> \ZL &R<)BQ2U=)"A!<QL6@9[U;*48N$M=37
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M;(LCREN,"-?2FN$6<H(9YJQ!F@!Z_"9ZKZYZM&6( 9P3%ZHW?R87_'551S<
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MWMQ_&%AH9SV")P*,^_"0JKM#JB8T)>@B%B+5BU&&:9# 1C/'=0K>27!!PWQ
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MT"D.T[4K)REN.)<3@TX;PES:VTDI%D/0U!(AX1_":3V3GC=^?4J GX2#/;$
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MI?7VUDI[:_.G"VGJ.5$E&-U#E=SKI)0+BCU(RV(!O,S):+]FKF9>2D;I6R3
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M'68,URW\>_VOS6S1-6&%*>C@G0R%\S2NQ/"C2$%M)*3O:4XZ99E=CO:_2G+
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M#XO5"_.&?!*ZM(G.8DE19TH(J,)B/$KSSV#Q:%LAVEBQ7%DX/+3?.WZR8C3
MOOE< >K'7<KO5V>IZ:@14ZT'?"M,/&ZNS3  *A8V;JI&RJ [7939E0*13%TA
M'[CW5$M]]N?TSY$HNF!6*4-Z\#X+(.(T8RN-.ES2(,(,+)[*/W2I'3SC$J6$
MO0CSY?\QPI;WAI Z^?CPXO][ SOS)O'^7H*5PC52W%YE;8>QAM>^BDC&*GS)
M=$6'9)8@[3=OV9CEQY^_Y<?[;>Q@V$"?!^T_)LK0UAIW0)U5+ 8T0496D,Z
MB#M&=6.)1&CFA8#8FP$!$T2)1274J,<C/?@\\2E8LC;S0SO!!9H>>04LA3"4
MLL?J?O-E&B#^!0'C3_VL,LF%GR@]5<'G47JCF;WB1!\OWIB:N+DQY]<_4_%O
M2N!I&--N3:B)X)HS+!<=A5DEN@':4D#+%!:FCX!9C=KJ\EEEASVF?J;'/<.%
M1\$V.N/O(/@2R<[#TL_G"J<5)5(.&7OGDKZ$D]E=LP,WWM0N,D_>R!^CSO#T
M>)<,NW6<J05VM+O[ORHCJ!L?F1?UT #4"4E>XE(TQ\O<&_4&_"'H!T(S,,U\
MA'CN7[%F9\;FH!P%[%A4ZVP;\NV _43O\)+1_U0UJ$AD4"M^PS*0;"V0O.H&
M9ZQ"&87;,0 -T-E%F21+L!I N;T$D0'GD5 ],#V93#LR&7#J6@V/LM7.TH?C
MZTI[AKJU <S1",BE* >9<"R_,8:^7TUR.QY4-A*601(O8+FV'Y,#ZJ^K63:P
M#5;?2IA%5V0IZM2D49$$;[":G1MV3L9]>S0#+@D_TJ2^=A.X!]6XW-S^B@9)
MA*D&<IN!![S3_A/;Z-OH %?1$)U3M\<!5%7I_,9<PLEKJSS\3BU>J.FG%JID
M.XWKY15:#MY;N-14S6,QE.2VRUQ#LU3E\+ =8F4W< !TF3[L60K:$M@?;]$^
MZ@ N?3F+$I\6]W<?6/( _30)Q9N4>%@!M9AN'BQLJ,8]$"&@KV!"=%Q@\N%3
M!TXA%(YY8V,&>B]C/\_)#M,$_XK=81Y=].;EJ^Z@KR^WAARMN"$,?)#Y7!QB
M&B4N,&2,<N25*97]*'?Y;]CC!3WE[06B@/1/G[_Z^-]PSO:*<C:C+M2B,)K[
MF$O@7I*+Q#$F\SQ\0_X'QMRQ%2^05WGY]@+':83*@EHWH!1&\6#)QG*^ -*
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MO&8%58GU2HI2IC.;S''MC _4T>0P_1<L3%#45T^>&NP;B52!G 5Y@3#8Z-V
M3U>S_YO)F[5)2;00T=0;BR@1)&136DLVZ$_'H]Z1:3W2Y(P>D,>AWA6WKQ:-
M_&ETU#OF]-TM[G':2#B9P5R2"!P]Z5C(S(5 .G.T\:?QT%HP_FJ78DL_C4YZ
MQ]Y\=R-(+8>4KSUIW%U]7#JW$B_7=S%;%S T55#.2W940H43-0H*4_TT.!OT
MQG6JP2M_&HS.>@-]MHV'[CVF"6S(2T&<Q<3-!<[UOBQFZ\%:]EC&V6VH53:J
M/G]/ P=HL#T,'(&Y(7FDJKH_L#8MUYOF1G4_/DVW0S!_\#,_C"[GW7P63:4G
M<*7BC^?;U\ON#.R,53&P>V?B"3H,PF<:<!HI$43SVYC<56V%W4&""H_@.1-U
MW5J55A6(1K;I3;B.'N.Z4J5-(K$G8S&M:8XEG&6-X%//%YH Z;'TG>CJSPI*
MY3HE!"&-]O+LJ\!>.EN@O;0!NXC98A7+/0#&"SZ1NFBY119A%,EDQO.%PT#D
M $J[5XNB022"A#!)0RKJ,N%TTP=?PP^JF6\")H1N)Q?;()03TU!K8ZKI[14+
M?,6POA'S9,MN0B<]'UYZOJSJ.U=HB9K:@153Q*/0A&4Y2;MW!)\:;,IYH$SI
M+!.+3JIWX:092J-FA9)*LI3:I_T@ S_ RXDE8R[QZ;;6^$C1E-=:-&6*:IKU
M4SKU12E1<L9T>,#4F^ =L,!*=3F/$'"9T)O$>P=KU['U,<?6K8S_2B6,*6BB
M)].^-!J;3>U32\D3B8E-%4]V8H&W!%;YRNSS'42T,%=N+5Y\PMQLWK)9F22]
M!"CU[=(4JPBE67 B9>!4('Z]#1J 5-@U $=RS.W;< (T_P7#3>:KF(Q*W%8K
MO>[K8A7LCFT\34IS;$^XK7FR(^V>OV/ZPF0S$4].$&9$TNLI@]Y<P6$%L#8R
MAG6>=U%JF'WIB86+@*5DO$FM[EB*PTQG+6I=>$$E\PR#9>U&@OB2^YBQE2R1
MGG340=:L-0%1] AM]09 S.H"HES8GE*EJ-LQ$IC76PA0"=ZL-\E0- Q)O$<%
M)Y*28>]!NQA<?L1<7+UC,Q.]79[3:;^'UWZOK9QLO8T9;O"9^0S)IB2;SDYL
M4T!VMW7A:BZ:0Z>U1+3), /'\(L3CG=O-7ZK,ZTZEKP^1IZO29/>1Z)CC@*P
M$ N]Y)R!G96H^8)U%R!I]%))FH)VH^99U>Y!*BZO2A]:LB(60F&][*)V(SNL
M+\-LT*V3>?'5W=I2*=93X?I+4WZ"A[:F'=\NA?VV/=\4)G<)[R8;'KN$MTMX
M/R24NC,G'B\4:5P&79]H\*,YWH0!&!,[DB1$SO5..QV"?%_%CZQ"U#K^D64*
M4\:;(F$41B"?L=ZZ$.5MBC,O(W8VM9K3&+X"(X3A1$EL-Z)_MG;C$*#!Z[9C
MP7(:)C^9@Y$0S.P9C7.!G 2;XI(\1"I:13,03'I$)=K0AX76?S>==LN\4K?@
M --)<- 0;LH^H@G&F9<BS,R$'R&(GAEEQ@-4P;Q$\M&,=P'60E7$VO2E).&A
MJT=KE;JX^14Z$V:#P7OC8*:@F9*U$M%PN:5]?FN:\"P\)'+W=1@C5['5C;T
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M3I%1*X_/D572<A3/% 2>9E3VQ@GHF\EO@QL]D"!&-+_T\BQX\4,>Q9^[6+X
M'MS@7Y>#WE^+RQ\PD;;NJ[I3/SP;+;Z(5P^4!7]'YW^/N.*V2O=5S5;Y2/-I
M0$1\  EWS2,QLT=0Q@\$K6/,T*I?^&T:EKE.1PH4YAI##9U,'<BCX:PK\]?K
M>#2B2VX8^$(Z;OUTS$&O"N7Z(7BG-ER9N0L[KS3S(&_&'ZW8(\^@;:QZT)P:
MWT!&=\'&&^GJU 4;7;!Q9R$P'TBXM@FXDY[WH1(_U6QW+9_T?,!+, K^3*94
M-L%R:<IU0DM3V[+)UY]FE*>E(8(62C!EXL *(%]<US9S1$5^564-K4'8;RJI
MVC+RRT;^7Y7KA"^GIQQ)]F;-N@F$ L%FV [$YAM0Q02V8 (((M.YSKJ2ZBS'
M:ZOKCU96A_N_RR5A'PQTY=9[IB)R[B:*(SOPCZ5509ZDB<$4PMXCV"VENXLH
MGJM!2#/KREI9'5-%C@'<2VMH.X?!D2*C!$G*9 U]KNV,:BE)ORA\Z5?Z].8<
M<_FBY:ER%.&I NM)"I3AE9E,/CSR9N!['Z2+AA 6K2#>/ %$QQ.Q]M>TYY /
M5@T2,.5H?E7WBX5U*DVD'"*D[')$R"V:!.KM976*,F#NDJ;-=9*6<53]H$BS
M6I4MA0:D VP&STG1J9._4-!SGG(="'73UT(5] D[6/@D#.@#E4Q43K%BX(")
M*F@&0S,40GX@43X&)'A2#J/:4O$!X9NH2^,!^E8UM=WDSK?":&9!I<[LWU6;
M33F!8KF0-C(:7BG 4MS]111O-C[V)Z@!\;T);[;&?QZ8JIF?(\W1("\UC;@0
MADJMF=?K>\ZU*I=P8!P[UD$ON/5*0(D/4<)-JQ<Q2(+ XQ"U (^CI40P7'P+
MJ9B"M<RQ+-L495'>"U2[[J QA0""@\)/RVN/JP.BZ.&Z6J$<'"-?M 'Q(VP8
M"50@ZRL*!YBILW""MI3U42QRQ+%.:P*#XU>"$MA8>%>&T"*ML@BE-E2P('+4
ME%Q>9I,JQ>"$^&A9;*,M.2^X)K[*<=+JV;=D""V)"*89_FKK<CO'XUN%+,;J
M0$HF/2-#/6^P,P3]V.P;<^ 6(-GX;*6;+[6":[["/J8?-M/L>Q(Q-GEL97%T
M*JQO.L6%0%-Z))2G<<DD+8BC<O<J1"=6)A;ZE C))$H'#N,RXVKVM6+/[GIA
M+<31=U1KE _$)\XU[#?0I18[=4PK6W7!!5&F8]L@N-%8"6;P1@'&"L&6#*1D
M,$B[.G-IUX"S>JVJU:7S+Q(E(&^'06]-N]M9=4S(/((YU/::V?(ULX=->H!+
M,7.LW,_FL"]E40>S9/$<1U-%!.G-T[ ::V+>3=2VAU7V52<_53ZD,1=ML7H&
M-;[$;B^5F..+HP6FZU,<UU1@KC>@[/T$;,6YST@YW.5<K-%6VAOJ;,/ .9$
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M() "I9JAC#3?I6G$=,^8 ^T@*4$ CAN8I]5 B"!0"XF3JAR'BDIKJ%F"M8!
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M7<^B8.;%O#7TD\4B2V&K\2<^[&26%A%J"'AK;YIF7ID3F0 Y)2&<II>7L E
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M,O((*,_/T"="MR'ISF!;D&=D7;F,>6F,F/&>IF%(WX$]W.^=]I][9^,G+]_
MW\>GW4%O,'CN+5[T>X.SG_FEUTU-,]-\F@]N>R[(T*>#WN@)'2*]!3J09>X-
M\<1E^M!S[Z.6OPB)CBLZ,HL;G>*-^KV3,UY?OS_XN;=E/M1)Y%V0R/\+9&JD
MCZF_V%UQ+)&AEF1KXE, 25L-4NH0)3.:TV4;%B3O,/ Q!_\+XV?-\IUBN1#6
M:JFTZ(CA004T=K8-/O^K%'^_%:(&UOYA5=;0@#\C9S9-9#,1YK7"""7=N#,X
M[EL3OA)/86$3#ZS2<DH[W%C>07.SU@J46FF*/5_,EC%M^]!9-]8K":UY8%L/
M UN5F98XO]!BMV-M9VJK%58C4C.B=1[M @\.FRG02U@5 U1N*8^3)S>-K4.R
MH*(=FE2V$LC#8-S'UQ>?>%V9NL17 \HQ)4%K;MM4:ZWK&Z+PQCT##?&D.29L
MVYE@3B;OFDQ^R\)-$P,&P('VJ;R/ NC^@FJH IPDN-QIT[E*<(A(K4HEI* P
M-&1+H6?*M$VC:8%YKJJ>(Z=*N$YEB=D5%Y<JP1FU&&^^3DTU2,O5L?*OD/<F
M"C@6>6M.-5VH1\!FDN L6E<@?UA I%-<4IK$2[U>G#^;=--%E$98$0></U>Z
M#HVK,>*H*."EJ:2,QBFB=(4=!-+(H@6N+S##=T$99&Q;T=-[QME8=3)(@'6\
M\>B)'3#5U6PT$A!N!IL)Z^'P"[QU0-,IP6"?J3SR98QBR(6=G2I&;LQ=N'.F
M_+A[G6;Q'6LF(]!NH6KBZ+.*HQF&X;EJ5-Y;^(('4.K*5)#AE<GKD_.COE!2
M"//!"4[273;5B&\K$B<B]T=$?ERQ2G0)<11D*7B\*=Q<$F][("&!E2[!^J1E
M<ZXN3&FF+:6(1 ),TZ!D$8,*H<Q)_EE9-<K1%I2P#?P2*YSERGA)&9@$4TW:
M'42/[\UYK@=K4]4V[ >E:[ 6 O=2H76(/$S,IVTGL9^)GWF2,.VY7KTLAK)W
MDB?L2.&NC_Y[1TIK>8VASF#2%/&J*AZM<WZ)1)49' +82&Q7<H90&^!S!7(6
MG>T<7B5(09:0- T5OKNN1)A3C;(N%8>+0<;ES0QT,__\JF9'?OCX_OWOC8A/
MTYHD-3$X?<(S7#'O&M;D5>[)S%_M3&#C :RIT+GE7.:K4Q5><\J[&):RK["?
MUGCVCA[72Y7]2#.U6 M]S<E?I)AH.BWQ<4*;\/,Y$(?"R>>POC0AL0T&R"7;
MJ91 UJ4WVO)<6;I.">L]T14-X@I<&\&K2ZZK@=&L9L0*:-3?U^?Y<G"#E&K;
MY38)F07A>V,9OY]<TLJ/QD_P\:<G3^J='?4#L397OZ%3#_NC'B[(U_7#=,$#
MG=$@X=Z&V3*/P*$'7L/#!D) #MUE#4&#KULCOQNC '_WDQ)K.(;]8;\9]KV*
M%)IBH\[1^'C%DJR,2)#,1X,3L"4C+/=94+L(KH":0 IO<'+J<8P7I<,'PTB*
M2M;2<D&!6C3G48#&"KS0W)M0 4RY$/%6'8=8D%A3@U4@^#;$DK0\"4^C.4],
MJU?[#(OP(_CITT%W#$(/3-B?,3R#'3-@E:,8>GK<'?;-5Q0$PE*GI\-^=Z0_
MY[(_?'#A/?W;9?'<?-/SWD_M&K^<3>7_8)7'T: A0?#%M0"&O9.E5:\(E_0W
M7U);N7WAV>;KS&M9Y$UA@1N>)^]<7=6K39I/TGJDA-](BJ6"F<G;D9(RNC$M
M"Y#T*+]S\P";=BH]+!HA IU#PMNX6)7O-):30$YU->?;UU\<N_H+5W_Q0/47
M>VOL:!D&^@1,3%0ZRY[IYV'/ATQY<IC8E< @-=JR(!K7!S+(W\+T P8IT.K0
MJJ"F0I\.>N,G/]?"$6WB$G]W](33:V?]GP^O5+!1! +ROXR+7!?QU^)?Z/M)
MTJ+AG))^0L>2TCZ-PYBH C/1V9KB ]8TJ(#8XZ!4POI?-](0;%RAVX:GW=IO
MO;;MM</URNAG69J;2X_14:1;MZ2Z[(Y='0S$JVQG!M0P+16LQ:AR=M=O@5I*
M/ V)D&U(O^Z1-?N<E0D8F$,RAX)V7N4]I\EEBK_#_35^-A^GKI7]QNCB-7R
M_1I%E'! ),QP<^"3J:Q(-VN8"FLZ['*!=0SFRM#X#/O(9[<M-_N-^YN)XMY3
M13L6H%T4_F<U2V/L^][#3=@L;*SX-_7TH+2H4?#$VI.J$?ZZT=_/7@GV"TB:
M^<J/2U*=F!U8O1FYGFW-]&MJV[X'ZON@]V,/WW5KC2:$8II2!)LCK'(5V/Y
M/0:70 82],-&!% &Q1(A&#"]5$AL5SK4IMI<6>T;:<F3:YKRO-^6E<*1WG3I
MFVEO",Y\D@JD']DY,YWH6EU1.X2T(=$WHN(*64R4<"Z:P#3TLU?N0,TYG"A+
MJ,D#FX=TH]'Z56!   XZR<NY5B]\6[+()F4&I).G&$$U27;LT:C7H^EV)EXK
M*O3KQODQI GZI'KG.1%KSB:N)_Q?M>;-6@KTME!L,Q.Z-55Z_I7*P'-K=L93
M= 1_/L'<Z2;CE-JJ5":ZE^^:6=?>*D<'%FL@,#FU_!LG7?6Y2?ZMTQ1X7,Z3
MJTI48G!AIN*%N1L1IYAP96':T*),9T_AY+,4-COP%SXR#9L9T1?@ $RTSI0?
M5HUG3*1)2361=BQI%55EF]?A&',@B4BT7'%?IA$&T3%%@(D)Q:QOWF?5C@+'
M+0$S+:AV@4Q':3/SJ49'\B2U_4=3+6&+L%' 1-E2A$M(,U@J7 N; P\7#!31
M0UBZ.<G3;")O#'<\XVJ3RSB=8 $"", TS U\"AR$V91,17/@L%SWU'V2QBNX
M319V00#!01!KQF 2UZ"73(#1O+:=?R:JKI (D/*-/JTGI!NU/<21[4D%8']2
M"J3IL;HT2A:EJ&50)K-FUB'Q!1;(9$@TS]7>FFLJ>\W3M#P8;O$SKT>YB,J
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M$VZ'VBSDZ'B7Z7C0.W.$[ AY_PG9"61'QX= Q_>"?.H(V1&R$\B.CAT=?XU
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MB*@Y^FTJ"1=I!'O?2BM"O;,(1&P6S&A74(RF1(=44HC&0@<(SL<:P\R;+],
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M&.0WJH,^Y!9"XF[JHFCC GB*R&1>*3/'DT,11G.'RW1(=WP1_$-D.!"$0RC
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MY)DH5H$H2@E_Q(F20AVN"?T\&06M8N/#WAYGMQPA&_=DO)\4Q;.G&-7@R?B
MM9%O2L:'@BWO"_F:L$B1Y 5 *)M)528W,IA+4$R"J4C2JO ^DA:Q\]ZXL[\1
M#T?(SCT9[ZE&T+OZVD;&WD>R1ZWD&)TD1BMINDHFJZ50*I@58EHFC^QCYVW-
M_=B:@STV:#U"KN[)>#_*R?E3Z-B>C ]8.?$N$^\RV::<+&415:7(9%ZI6E-)
M,$\6!^'YJ56M8NS]L;<ZVV9U>C+>).-^9W_M:#P9>^=)V_238W2>7,Y!&4FB
M()^HLJ@BBNHLJW3!&HK/-VD?5S_?XZ"F(^3JGHSWY0/T9-PR,O;.$^\\^:;
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M )//]-+SO"@1/\NMKP?6#4M?P#FJ:![23_(X5@&1Q3H_98!,9'DK9<8[PTW
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M#X*QV[/'\#%C>%L#.<^-6XE*SXV/',&>&Q\[AO^H[3R?L-M$7F#_U=*' X\
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M#5K"B4J\?.YNDB4(18$<.=U<&Y=6:"G6R\(='G2#&"R%AOD)K.5D6>01&-[
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M@_]!.'ZI_@AJ=HK2AN4+&1&?P6B0</7SE433A<,S>'=.8KE$^\*5*?JUR"/
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MET?)U<'MM6E$.+BCY$;8_]9JOAU0-&6$FPX$S45$MM+V<4#=GW&"(AY18V/
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M,F%T9U*M2#'&.!_Y;FD%V"3 'Q4P;7V!MI&D^%6"EW29,/I@4Y=@A(!&G0$
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M< 11]470RQM2O8:C#4?-Q0V%!.C7TQ7&T$'M-TLZ+F=0I($V).) H,8JD6K
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M:4S@!)Y[%0SPFY8Y3S4R*4[R,;N^8WS&@(G"\35I0D/>8E5W)+N"6<("6;C
M)"UIN)0;6LO P=6H(PW7LNYYB:C\;3;D"!3-[C6P67,/U(W0?PWNVXQ-&J0=
MLW6%P.%LUYX%0\4UE'MO<*X=FS8K"G'%2=0=GH"R0_XL4Q0:_ #K3^NZVBLE
M!@)6Z61Q>P-"$L(\DW:)A)MA:/+C;F'%=L'#CF$8^8?EIUG-L)?C<*VHFM_7
M-MO]_:?;N1&V:>0UDL_C]DGMTAC6MI\=5J$:J7X1K8!X/>7[14[ R.S"0Z#:
MHNO];Y:?,,;$'>9^+66@]L$XKZ?.X^U]^AE[T8.SMB^N]>P'.[*+ K]4W4UK
M<<5$HMH&LEYON,]@ $?S&2]N<FY@"QO;7:^&S=CPPO^"]:!:YMX )8RRY!@!
M5!K71R^4VN>% *;P5'J^X2ZGTX$\7;T 2'R580;T@.QW5-3TZ9G1"]BNK1.R
M'>J=N#A^*4$70?[S']KK*(7^9:&R1J"K$,%J$QE?02,Y6"/ZX+MJZWP[?$5N
M$6%9QFL8OUUC@SS&_5ONKH(ER)6=9@-1IV<7YX]FYQ.(B$2$9,,T*BF QAK)
M/RK/G5M$_"7$9 ?3*G,Z9'+7 2JV'_^B+DXP'!1;5M>(W)0P8^EW=)LL!<(F
ME/;:2 )BJGT#;12C(VO7F(&,N)/"['L2DO7NAYQ W7CI9;BR=P<_N-V3510;
M,9@LO$+V:TPJ,VMO85Y&7LF/QSKC\E@@IL6)S%UTK8K<VTPJ/WFLTMCAQ1_-
MGC=2C'C\Y*NTK#UTF<D;PJ$OH&BUA-71D?G)'C@.57_D:V;XPQ[IKZ*C!**6
MN!(*HI!!;V!KHAW'96'D%X?$=^92M?^;JSK>85PS1%2':B=K1T0!M7:)#FFW
M3"^7CK0*(?)-V[V1>_,BG*J.F?[6*64/K)Z%)FN(=ZS5=7EP-\GW#/:J!17G
M:1M?(Z]MQM%MS#3)2;Y$]!7D(I^U6\6R6J2;JO(^B4VI:XMV1VHE9GK&%T X
MB_I@W6<%927/N(7Z'?#Z%E2"6M'%TQE4X,@)OGLCPA?-R/O4&98Z&:G)6I8J
M862/O'MD4/)TQP,6Q*X*?]'.KVNK1%?4 YN^$@FM' O:^-^4"R7<AR.>Y#:I
M=(^MEP8'HPLVD<^ZZ\^N&U&'"O] DR(FUR_*B$06/_$VVT67 A]BU :*U[K9
M5X,[#_?^67RY";D=N3(M\N==/;5,&"(C,;_6>)-,U73G2!DWP2BV2S(.DZUJ
MF6  XV$@@0?#N K^5/T;D27\\4C*Z"-\]=LMZ[=1(X?)D.WN")]8#)V$S(^J
ME0.$HT6,QS( @[@G4:\A+2@D:>*CX+N[8W7)6-L,=ZMJSERR&7A0)&6<JID_
M][5!4=654OWP4KF4AU@X0%.:.GDTQ:GD]Q8EOT]/);]3R>]4\O-G NZ: ._$
MTAP<C+Q@<N3)EXJCV,5J04GKMAQ;Z8R$U^$MFIQ;&=ZTH!K(L!!<PNMJP(,<
M;++F1"090@>MWB!9^,S %'4_3)@,RXR@BC9 QD ,BXF8LLOE&]R_6Z._2A-,
M1$IUW^\K9A?_SJ2UW";A)I!L913,,$FRPLM:9_\2<Y+:BJ:.FCX05(IPD_8-
M?<_EF-Q4+T;&JKW>GBTI!0BQTLC-J,\9#%X'VQX<T*[6'KEE5]Z0[#2M%?J?
MRGJM"X^!B2)KXT-IQ^TJ\_;[ZM'EH^+8I/R!/R9]@NU.LI*??B$;#/+85)U3
MKT>5^X)+<Y"T<GB?PGZ^7%[7/3IK,#- 2E6ZZ)8UELW)\I>$^@@^G*8J]2;2
M76R]B/8TMR3JHNHN:3*?@KD(2188S26##(<KLK^OM>4Q.MQP9>K4&NVI,NN=
M6UFMC,X)<=2UST?5VR$;38IJQ>W<]J"3/OS^HH3G@E30#:J=F_*-Y*VEAO%1
M0L1OMWLO#>@ZRH_G5D3]S6$#UT0S1LSF3A&B9Y'0Q+,F.[\.ME=%$#YLB1=,
M8:_3$#VF;9C;3[J+@AV;5[L;''T(>XLM0T5*T^'8)GA?IFBG[/"@2D-(7"'L
MO79*[Z@U:&A^F* #/G']OO\!'N]#<6H$RCN'#$\CB@R^V'R7DN*I^>S]#_"6
M988!(Q(_T_\TY14M0HY8]H4]7 #XPU:D7-]@2!U^V@[O?X#'MT-^)5GA$(F)
MV)<<30)\*[/U6/R,U04[Y]1H^/X'>&<O,?WJF'!DA:WJ8[$HXR!+G<8>T>E"
M+1B3A^<U.I!)E4D9QMXG)R&1)?HD6-1>GR@^%:$VTN$4_QIGR/Y!  R,*,,/
M":9GW^\%S=BRB("8+ZG3I+A"ZY2J@[*I2"O7=DNM1U8+X(&DT=B[;BEK^3."
M 8H&X6];83>TAZ=@4L&1B8@VDT^.M?KS<;[48N@LUZWQLU93679/F%D'B\G
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M4^(Z\L3EWPU&ZAO\K7XXD1K7O>"47-)<<X^:0T,;^EA)X(HV_"+^-/C$PU(
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MYPIC>_9*.D+9C8A0Q<LTXD.N\<R8:70*\.-^7!\E,^_;ACA2P40=31&&+T-
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M*$5;<7E>:14^$L+YM_LV3&,UNUB7]:9'XBN?"E$!9ZDBONI$;L#E$.Q?F2[
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MY9)P5]5SA/=TM5.7,[OYT$(CCCG44AK'*X\0AS[^F.>&'!VC>M9*'2"Q#[V
MH^QH:X,O?9B9#0B>54-6NU%;) _"8.SBI+F6."M&I>:](J_$-/SH=76T8B>1
MF*CY.78DP=;M=P^T#?E;KI2DBHJ!9?WOL$0A "Q<=?"G1_\=ENAK70DD29X^
M?O*X\ L)D]DK.C!6*^ W]^18E&HGL!VU(L_QETC1Q_)7*BDOK\/*!Q_+=>+R
M2KDINV4$%>9(9W1Z8OW6+)5PYUK2;Q69C=J\>\31F<%--VEFX:\6:4PATW;O
M#F2"NMGZD=0"PUMM!8%@Q_<=PO\P+KLCIB<2@7S6C2+$7$-*KMM60G ]T_VN
M(&RTAM<1BL?]JM%*NSIQ@[X6<%Q6+%16Y(;%YQPNHNTNPPG_1YF(I5R]W[ +
MND\>WDE*2%LN?W[O&H^=D!&QW9%5ODR S!(P0C]9 ,MJ%6RC$SU*>GLN:M(.
M24&-2;5USM I@.I6)$8V6EP-SL +RT6\&C1GHR^A& K#E*'V15\P)1.U%R[+
MFXF==C^RGARY9%@Q]CV)[>/?DTGV8]Q0[\00=L'H4,[79!]Y)#3^"&?DCB93
M>UW GSQ?-$M%QFQKY:>+[U]'<M15.$'$+J$<7JG;+;@NJ@%(!>8Z' K#SWCW
M!3?0%Y_S7F*;L6\='-Y!"M6.0[71:8&IGR[5C^K2UJJ\D%_4:P05^@4,J!(.
M1USXW^EA]>*^D()8"W;A*"52X85P/2IS0S9F3VIFE" 510[#?!AO7V3K>' [
M"WL%F%6?<[_<@PDT^K,2V8&CY-*8HP?@3YNX# ":J)!]250NX$LC*?!RRVR?
M\2W*J8Q:#C+>\F C:]%FIK3U/,)AL^]W\N@2++!S1:2FO1'5V.ORLFG9' %4
MA54 E;!HO:;%5:+([E 8U1&\KFMEA53_R?*D87NN8>SQ-M"_0*HSJIWLKMIE
MXHXWN(I$L3K7Y%!Q+-1"E1V>'%\T7XEK.=QS]NA#DR(_<BM#==(GJR00B:T>
M1Z9/D1O+R>YRX;P4FTL/[N!O23-3:*?KC8%E*'Y!]NR# QYC0]ZRVRQ/:V#9
MM!F2Z*4KR4\ATG(DFOK*" ,>YNFF4Y:N""_/5B\3'1::LS3\NX[(]D\B%4%"
M/9D]C\@(*Q OO EO1=)D=2 P$3"BADS?#E)!"UTM#=E%,AKYN2&_3!PM#N=6
M/$NEQT5GFPPR_!L"*F%TZBK[[A+EO'9KI?(T$=S]N#=NFHGIF+@6;#]G%<6M
M_*-69*UBPAHB"*/6]66M/F&XOK@!90J4_AX")9>M$;&XL_2C,[J%F@M^4\J3
M9'\8G/V#E'5D-E >CLC]G+LSS5E$H<SWR\MJ)^XLTFX8P86>9#UHI?@(VDNV
M&@\.\.?IL<' 49*0U!%R^M2596RTKV*2 @[P\.MB]R012CGQTDE)M"JZ\_#.
M+@(;G%]CWQB6Y85AJU7(BE-,5!,,6[OK6N&(M1N9+$'X,YLP4^LGO+-,'V'6
M[=<*IC0JLI1P$J-=>*_R$*\P2T*1I-DA^?;-<BP\74KTEF !9J5)]29KK84^
M^6^"7S!V@5Z)AVG8!" ]TS45[COL5O-W;T,^>= Z@M,M;(%MVQ.C[5M4#[\Z
M50]/U<,3H^W;YC>RBIYB0E]!"G#SX.ZUBQ0A>&,L<4#L=5'+O[?H7C5N>/GM
MC=;<L&#N\ALHQ*@6 2\J8F=2UM8)-;5.0(_E3G%.:)RUP^>=1EVD>XL=5NKL
M*"\CTGPD79(8<QCIF(3CQ,!<3RC\Q/.+<]\8M$Y1&&Y+R)*Z(:.M@ 4'B;'#
M;KG*V]S$4S NE9Z@RF)8[HJ)RIYC1(DB7.L''5"^G:/*CI4-O%)D/P+%M5W.
MAI)1VELH>5T-O1X4/]J>$O6MOC]?WU-K2?$8(2]:%C7-A*53IW20PNTK>"<^
MH 38KD:B!&]ZSMA:M\"F?&/DA&11B7GB\5R$R* B+XL)W\ ]]YUUBJC6GD2T
M B,K,+D!Y9620I3X]7"\E+(5#K+&)QEKJ[2.,7F!?S/]23)T;4OM4V,Z'IM_
MO 7]2F13;U2H':V7_U$6L%C*&HY$0*/(ZZ70'\<2#9HWU9 @(VGCQ0334%,#
M_[SOHZ[3X+S@-VUBA+TD'%$^1P)<6;],H"UKO8RPZZO4UB;=B>[%]/U)<QSK
MK\*>DI <.IEJ/U+FWRP% [K823U\FP=W-?QX=4Q!>*)U8_* #;B>D=F4@Y,E
ML+3BJLN(7">A__<VA[FU57@P-T)U1\-(9D+-?$^]FRCG3.?,R]G31Y_^1\Q'
M5+^ AW2V*W^1=/G,RI7A'ZJM!EI*G.9:Y_S()+&Y$6C\!32,I<GD>3%[_IRO
M]SS\[TC\&L7M2@(E;M!I?!)^:Q[B>S"DSOXK_"C;Q:ADR_Z.3SD/JN7F:&DS
M8P\Q3@U4\1/A9=D_U^_[K:@#8A#A85_$RD?XPU>2;7Y6+43*%W]52!-YFC0^
M9ULA!2@LBEVU#5M%'SE8325)3.WFC%_2+WPJK_35+4O+?%SL^0M. ];DNC+5
M/8GUI5+:N*!WS#41LS=$F&C8'D?&=#7Z&LMN<568SQ$-D&6JHN PK%7O 0%)
M(7Q;KZ5-D=%VVR02O& OK!FA:L!?#LOM.H<&K4!1K]+(@?+\^:*ECK=FBNU*
MXI5)A('AX2TA-\6:::O/H;GWW+3AF(_[!8[9%I9$>!'B'$UE\5(5,J4-M5S$
MK@<Z+M6-=0^=2?42#4?['3*A??#O97'0_"4M_:P;BYIZD5@4*'ML*NS&R:#<
MXV[E%Z8X>W0+K&%*:"$L&1-+8O8I:0!1FN!#M9,64+FJ@C.D5U3L?IV:.C;;
MTX,;((TB*5=B\?Y[V&M$4$AK57/962L#S/9Z75D&TI:\9 *KO^5:B%0(8?F(
M570M(^F1M-C1IN37<1CG]\%3E?HC_EIZSLY=?DP)5 2.@M*T#IV.#/DKS U2
M"NE<P'!RV$ZO8+[?<0',D._:0JV2.%&4@E=*L!?.OJ%5SFQ<'-E>&B#/M_A^
MJNA]#J7,NEOL:^B7LW</?_VLEO2<?E&R@&G!'58FV$NB]6$^]PT\>'&..-7B
MG&_D_/!LTXZU4[^A5!_LUHZL#=+DME'7=<S\B)A'?#(*C,/0DY(DC&0==G(P
M0C=BZ*U%@"E] ?A1_[%*K8W\0:/GE8ZL*KX#YSK^)#=W/ 69)VLQD"D-1I3&
MQPT]?0NI4)E(?VU;T)).O,0*E>J0*4*SKZVC?-*@P!9+,(A^/>_?X2M?2^WB
M0K"_1B@0CL&3(^0 (AFRE& D-ITQU>X2R>F6PM/^@WU\"J8 DLQ:V6ZT![9U
M9<7S8+'7F8>#MRUFR[VU&=H^G'9Q[)RHAH9RXLMIH!R#_%)R=)Y^!9 :D4+)
MVN7F5.T0M#V">6JF+\)-V 6 MOU8_B)4H*_"U5>MW)P^G9Y3B>N6HTGL5=ID
M,M4^Z##.-2:C>LY*K*"I88<1MLMHQ%Q]@>>6T2.OT.FEU'A*E7Q7F':!!3ZX
M@_DSSEM8O.LJ&N].B7"L9A;)+RQZAU:X;DC(%L!M;S68'BL36HDSIF ,J#"@
MDU6+RKA?@OT;TOND-(.[4R;00$@_&.(H,M&H68EQ,QF+TM;W.T:AA1UC$<<%
M9'"G\*S.Q*MNS[99#[_5(T=USC+"J.[SM#'!5'">&RJ)\X>&\SB=AQEG'!S<
M(B$LZNH8&N(=^7E.-;%['\7/'Y]J8J>:V&^TH^Y(P>L;HRY\<!?O.2^&44*(
M3&Y7Y7+V].EGC*7/0/&0*!PE\!Y>V48A9ZG?:)9YBPEI8V&T(X49;U?"*'<D
M<]18AK>HX+)JY$9,TB/\^ ]4+UKEO)+*I9'HL:AZ0*+)L*FC-%*E#$WRB^2B
MU.S8/*R9AG"1YMOB\^Q=_<\JQL]J0Y!^# ,\NE$^M'UQC.PM4I^GF/-YZ@5X
M<.?@9S X,BR.I.\L>SP+BRN$CLWL>Z:_GO*(//XC&FM>U^LWLU=M::#^=1$F
M:?&(G1N)RS2ITK#UR)IDVX7DW7:S)T]#S/6\:?IYMU^\F3WKPF<+<-PTA^L2
M@6,(Y;_Z[/&77Q6QMV)7K:OM%4Z!EAM#J/3[\)$_S/[X]/'95X\?/Y51W%3S
MX*E4454[?.SFYN91'P8.B<I-"%(7[>91^'50)+5>L*PW7K6FW1D''+9#$]:*
ME0)UR9*_Y9M%D!O<&_<BGBN U]??7$#=7N*P;2<IOW4EW.G^"^Y8Z3L4UL 5
MW#ID\C&(!9NWY(C.%R4Y5GZ68EKRO8/)0,TM?(1:;3,6W];,E9?:6 .2I 73
M0S5;=G30A=/]B?2O,HA@5?8[K9VC8_)0C$F%M>< $G:1A#8QSTK./*.EV:+4
M%_XS&V%\!?&(YX 55IO(!AC7(6LT^KER*6[W/N+F^W?2M;8RKFQ[]UX2$%W7
MU<T4D8Z-&%_XMEQ4:-">P3F<_?YJM]OV?_KD$^RWE?X3-MLG.#4X-.',?/('
M8;"Z@<A'!S+09?KB3OZ6WW$;]@^/6*SP V$ZITL BKDU9S$\9]Y!7CT>!Q;Y
MIR99>8(S.S _B) 9MQRS)\S5G0M/TBMA1 K#^!8!S9/'9_\MSX^G!^-Q*@*E
MHWF[]3$384N]_/__[6YO[,D7_W:*=>X3ZSPYQ3JG6.<4ZV0Y<A18GYP_FKT"
ML?NWTH7S$/T]4:Z6LF6M>=Q5"WDN K])N@X[#F^'&;VDWHH[YNTR4\546NHV
M,@--F(69NA&56BDEBE<7 ZOH$H )-"EEQM0CWT+NRV,OM(RMBB'$@329<K)C
M.JBIU3:2BL0=+H\B=X#<AHHDBH16^?0AWG*XQR,C$%9A!FWK@]*FACMVW\<[
M';3BDDR$6J=%8B+&LXDK()/A(/E2M.&RK \>-?=K5\4M!^8C!*U+J?NIOK&Z
M3QNX<KLVN/0RM&!YL!6MLC)>*?'O#^U>(&;,$Z]9136/X9!\9*FH/F]4PUNK
MM>E1>(SZ("K4O:JBM.M83$,19H;VNM4Q\741>5=8@+[RR5?FW1,)(WV.2H*)
M,&TOZ?/+P/HJTJ%>B+ "&C1^P ?#CULE.OPXZ"3._AK<2$82\?DF]/RQQ]RO
M>#Y>Z42!RC),[=>Z5=_: N_:[9^^^) ,\MNBS)7:$])E$'P/WT=885&)L$?-
MPCXEGC8<C:;:J4)&X0 5;!&'%H&>9/;W448C!S5JFL>)=%C)!0S#L#<$G_36
M.4Q@+1-7D@O3Z\ P$'%<\5?+GLFFR,*A+_(@:WERM3:TV4NW,%HZ%QNF:#]V
M3$IFY?'C/VK)' O#4N=,X'*C!"772]B6-5-9QM_!9OC=YT\??3;;0/2M5132
M[S[]XZ,OTE\%(Z_=98:)S#:-+SO*!O(5NXD=) *$MR9300T6KL[-7D[XDFW+
M-.N_>_+5DT>?V^  /6IG@*OH5Z^KA()OTUYFB=F4_F*!'2T%.U.SF>\2?%2O
M,'9=&I"?.8M@WL/-7;?X"W8^QBP&;]]*Q4I H;8HNW97AU?I=A7[%Z[+GDSW
MVI_ .)QM: (IU)GB33SQZJIT8*] S(7>CI)/3OHAZ=+KXZ2095EXV- UFV5@
M"I_R647>A2Z95VWKCV@RG3(^2A0>TRT7X6H#''\"3/>.1L6I4F]1SJ<R56D$
M#>E?#<4C@()55_:[;D^(JR$-'RB/P\^"T#MD#2ZZN>/FF\3GDE/[R1>6CF,5
M.4( S0@#\G%_"SR;O;A6#%<3YC/"0&B BN-F(6P59$;+;)LFV@-!QHMHO1!%
M$T,PT=.3;P-%T1)MI)AR'LHQ8T 1\:A$G<KCIYN9"[^YO2ESS089.HJ3U50W
MX.>RM*OF.6_4MF=M(%3S*3R]H0.KA>EK>@N>2+^]M"P;#&OO])#3HIPO%@38
M7JX/MRS"D<O=(#?8'<&_%)A#=M,OD,G>P7G&7\)9MM&Q6F6W?G;5#WP&#4](
M"WG#33BO2!L0&V_$@/.!QWR' <N3_:YTD$U\93 &/AOM/)3UY5FH464 6SE!
M0[PVQB@)+!2$:OLK_AN!HM4EZ-'8M0:#%D%C[X#$F(RLU'@>"ZXH<J-$.;"0
MM\13/'T,IH;[UJ9RJ-P'>%?6$!:V9,675H1^!UB>_'"OK^S:_.\;/!Y_Q;<W
MX@_!@^\J9A 4!QYC>/:J^;41'Z,P6P5'\3)RW]RDYBGG;)NK[2RZW+$P%%W-
M]$0",LN#K7/_#6Z277Y4*K"#LU??0:'28IM0FV,VBVD <:Q:" /V^HFX-1QC
MBY ,,*/S\*[TZ+$J28)O#$-_@OAV%6J;RZ&_78_,.JM<_*S9NP8X:>"NBRD7
M=LIA-3<4EV>MUYFG2I+KE:ZA,4*9=HJR*UF#WL#K7=:]7-& ,_#VDA-?>!T2
M5(T;!4-P"%:Z=0ZJW-JV6?E31SY*62ON=XDSTD_B<Q<:%&L3H$Q%=DCFG9$F
M7S;)4/''L#CV,?\!1XEI;46#QMDFN!XJS3$Y[#Q\\#V0X-J_5,%#JLGNNXGS
M'/VC.$=%O.KN?W1U5HZ?7LRHZ]I5XBD9/$O_^QU*=^DB$N@V4@7\[WJNS3"K
M-9QWO=&TBIH,@=X*+JKXTPF6>/]2W=-3J>Y4JGL/5!UGO(2W\#";R[-UM=K]
MZ=,/RBN[_=PP-_Y%S(U_: /,YO7)9X\^YSPFQ2_8;NN\"![!1AVM:0%O2HY)
M=_L@>!X*_0JR;:?^H.O[Q 6X06O+^!=XQ4EBJNZBJW"\ZG#:1.]Y$_$RE,1]
M9)57M$]D@T-IC>F-(E(>A[7^Q.O0P8/77'4QJ1W/C:'4^95)64PQB_[Y%ESH
M:;>\W]T"-M"^7%7**I(U)0<O+T0(370)Z]Y'EME^T'3;R2J\_P%.K_-/#1*U
MI.MD'6(-;IU$!NSS_RJ P+]>E_MF<56=S/T',,#IA7V1MQ)$/1X?$L)QF*O&
MA/'^)")*=&*7U%,!;D4+-\%HGY;\O0]P>LF?V>GE/9XROT4\MEIOV;8@2S'J
MG%HXO@FC=WV+)L_=4Y7YM.CO?8#3B_X<V1=MA1?8QTUV_3J>K951H[.".YW#
M4UHU>&Y5RD6-0@LKBVL6^L%E;Z4YP154?7IM(GEV5WY;*?A UF)Y<6,EPV^P
M"& )/T^6R):LE(O+@((H]8C[C:+=1KBB!EPEQS"&BE],/ C2(])2E&10UBFM
M#ZBK1+=3^?D4F+  #<E&*,1CFB_19TALJH4D&J98'62]41MQ'%3/VN98$2\\
MP$.KJ*,<HN$):U!:><0C,^/L3F-BW177LD&JDLL>7W^ >]G7 ^>5E!6Q E*O
MS[DGLVJ%*];?6E4P1.,ATO(/[<6H>E\*]63?KL'4B9^1CGP62 IB0;/$LZ<8
M3TQ[PSBC$(:=I)P=&3S#GV*%))41WJ6I_G^]SOG^]]/;%C8S##99>TCKUNRH
M8\$-,$>WTG@;!+\C$HE(=B#FGC[&B;MO23"#R% &1WGYW:9V"*E4-S0B'BL&
MTL EF&6Z*8[-*A1*<X%%+0N^2)>9@NPU6>.@%FN@ M8'7=]^HF,YPG7NK/S)
MM@!<(YAU^V<W3G($AQ%.YY>BY&A*4.9Z(J/$9'C%E^GIAFN=^ GEX@G?/@C@
M5G&OD>6J4(V6024N0N+"&I=%K!&BK0Y9E#A0?PD)R5A3K@^$Z<9F:D]9"_(;
M[)AR51F;GO9GI]IMN5;5MFMA+YEV[L(4? .)#;F _;MU)75;XTH)2U!:C8P+
M<%<UUFS9BS:(> 3J<]2)=C$-<!M%SP7QQY[$<.77. 3*UEL=,>I\HWSZ1*U#
MB]/XYU+D<^00B5C0_2J+I_#E_88O?PT;#5!VDY?0)N>K>JNTR"F+G*18B=TC
M#=U\GUP$(7PVDDJ]X>ERH\EY%ULOJLT<I#KXT*Z2N,DX425""N^XJC9M1TG)
M["#Q*23Y"Q^\.']]2H9\  .<WE@7LF]$#:7JM] '5OR4UCZP7SSJF'=I1ASG
MS:KMA!'$.VZV4R[T_0_PB)$)(\-Z#L%%(]<BKVSH)6F8$RI>W4@R%='LJ7SU
M(0SP2+$3-4IZR.O:W%,D%ZS) 9'N<=;Y+(<VJ%F>EOR]#_"V0]Y)>5J67H\]
M$CLDH-XYFF58>14/-R0$^B3.X.2K"X\,>+@9LGX7(S8\[8/W/\#I??"J NR0
M^5>G)=)B:^!XWW:V3_;\_0_P%GNN&>YQE(Q;>M^P]:>YO5IU I*.@*2?GH"D
M)R#I"4CZFS"C/X*U$HFT>A?)'/LWPD:9<#Z>-TP5V:1!F$@1#!%"]+M#RA"K
MNL?QCHV'E\QWR>3M&LJX6?MGUXJ@CE<&%Y$4M***OK@F,*,03,J6'D_A3O38
ML%WOL.5#TR,D@%6V[)@\%>7=*%_#ZK(.0SK)5NUBKY4YT<IQK=M(G87%S'MT
M4[-Z^$O+C 3/N;NLHHYL66_8E<(O5T*\0K$XEU2V/-W$(Q:H9X?%O*PI>P9R
MF?2GIMIW@S_9-Z7\KDWMDH#&T)';R8ODAG3=MEM5-]?I4S8A>OR2'M)BR7?M
M346!D?LWSDH!+$U@:T5Q4O-MQ6&5O+O4PK,1#Z43ZE54O,_G43.A'0H\O=9$
ML$*'\':U@,');+.071:3Z$9S1 H!I?@TK#A+(58Q$=J<^#TDXM.O1X0)]^!4
MA[84A$6E5Q\A$H_]KBJE"[JOJC>^MK$STA\U23M5Z!'*$Y>B2Y[\L N6 H;;
MO/RSN&I;P3SL=S7:[16XW C-D]3H*N4E1%5CUP)T/[%9=&BIGB0FD.,6D$;I
MZF$I"=63 <.*S=>B13$CE6\GO<OQMP5O8S.&G;"NM%4T+&=XPB[B\2^^.9]M
MZN69;R[S"QC;"BD 9B=;82O6&CHS!N-R8XK-77JC;P4M2$.4MQ.Z'ZUW\2=Q
M?)0G,IR*MGO38PTWO9>#<H5?3IDFWSBI6J6*E2^6(#?0K-&&Y7(7QR''5?E7
MPZCDW'6, E%AU#DLQK5HLY8>AV-O0(HOO&Y7;NLELT?"_FK8V30__\(V<;'9
M1PR0P?"S2&G")!VS0D?K\K/9.=$9L;%\\I=0TPNC[%<'ZU-I.]_0OZE*W(JK
M_7IJ!-R1TI NO9=4I>HVQ]N-3R".=P<%^9Y6E<JSUM;HG?C2G)A>9T\IW;0D
M@QKK_S C_:*#V":%&?$#JHN,.?YN'S;$[+6IOKT@#;21YCUON*IAM_Q%[FX6
MVUX\_XN,\UD%>.I&&YO^*PRR7DCCRK,7_U6HO$D9)K]KJD-O][_7BC(A6U81
MH>46GN"U:$S(8TQ&08H(=7/7Y0V<D7W":%SNC:%9'F:7WT11TU?683@:I?.I
M+TOE@%+(E9!2\$SH-'(B;GM5GD2^Z,0[&>0IYWZ()RN*O3W$_;ZA<*Q0:\\%
MUNFV,)23]BKUG%1>C#:E[L)WP?D_H+7>A/U'<C3"XU5U$H\AU[Z9T/^O]VE'
M+! :M"M%?M2]AF2[JBI,IB8L[FHE<4+L]X.VLAPBT7VD4V@,D^) 1WHEY6X;
M1'#,M\CN"B[)OEM<(:9@UW;P",/S7ONG](*F\Y+<=STB,COB0^';;"CQI95L
M]L(D9?=*NLPB[@67FN1RH]! DGK3YH7LU:'OF88X&J <.#DJ.X=+M,L_84\)
M5?4:GA-OH-I7F;>2GD ?Z 0Q_*= #,^'WIIAT(@PW%IO8P;"$@_N=AQ6D6,"
M\N\[!=EC,"[Q\FYE5?T8E^=NI6<)"L:MQ9)3.DY&LBH7*,<:T5!"[ 4S&*S;
M-5()=;,*YM%$[K,U@?<9+""9_?#]U[HNL+M_L]S!:V0 G._"<86_O*["*:<U
M>=FUQ-<KRRO<F_ #(32!\<+2BS:K-J]J5)G8!S6.PFN)-O7R;->>X7_3:'>8
MZ-[<!E@'US'MVS*$F0W?P?Z)*F0.XI9@3 CN!'J4R'M,?'T*9SVI%'BAJ:57
M(R@+UDZE.V;?A]OI,K&FG?>'S3;LRA+>DCWA]:Y""J*?W2L-^N\K_I__[=WY
M]$/-R?[;_QGL#NQY3^0L*#?;5NKP_6!"SE%HF"=+W&G;!;K%)..3=^L"]Q*"
M+F;JP^[!$H?M(W[H//B<T<1MTH*SR*419CQNX"<*(]C$D+MJNN!^\ N\/J.T
M W)4> ,PWZVA</FT$$&->A-OL(1E5L$3!3-36 F')/PO?GVG>5,^TVG*KX)I
M.0,EH;)LG^VWF@MUY-? \T N5%/:XQ>%JG)E,6F?4A[PG\MMM<=FMQ'K\=-^
M>'<$_16?$CK6IM <.YC?UGHFS=$'7"U38B3--0"/..3DAC;IZ%.!\_X%SL].
M!<Y3@?,W*FIQY$P,G92AIX;+P?2<:(.8Y!0JYI^:57D=)I>3PQ )4CY$1@_<
M9]KSZI?P;TR%Q,3=\->S*V_?CPVB*:J:/2Q4>BF<K2UT\<RPLE70LA\C5WY5
M$V3>&\+/DNRKSG3%?2K^U!WVS@J*+JLBO:/>F[_<U^@[AX@&E<"6618@+,IE
MV:@[ZOS>NUS](M$8_3-C$O;(X-Z=CDSN" Z'JI#WC%8N;..^U*:9V5_BG#%[
M\?IOK[._TF*='%0^$J+*7<3 Q?Z[:JKFF!P2A'62)%-^B/R'S)5Q[A/J-Y-U
M:A6GZZ^$L%+TW+7E%^E=YAX1[^ Q6"EK"BWO508OPGG;.2QO^.O%/OBZ<&R/
MM'ALJF#2EIF$^0K=2^BMZ\+>D*I3)+W&7SIO<S 3^B:I^2PVG]:K.Q=:%?!8
M,=.T0YOH'J-.R(BL=7NT?:W+N$*1IYHLR1ROZ?UK:U9Y1!IF[$T%7O*:FJ0A
M%F#[!?H4'4&N0''EO1:2DFL'\S]\W^)7,3!'I?%!:J=:?HPV^Y^;;F.N==L!
M/.],]ZX3L5A-BC9A'?^'+*3V#Y*K0)(DK%W<^U90#_X&R,)ASV2?35KQWV"F
MS:D(9TNAPL%FE@7'I?8J8VNSPO[@;I,NW$P!4^^@,,M7*N^(-+]?;5TL:=>,
M(O4=#LXLF-JKIOX?V+8(,:K3OIA1E@EG*W/XR#MC'PDW<3B+AR'<Y48WT4"O
MD^4(5KV-G<+EZ+_YX=6+GW[\9O;#R]=^D&'VUNW!;B__0;JP'MR3\2 *PDE[
MBB$ VNY[U^AJ.LD#"N.KJAE"*R+9LY8Z+O>@6=I5FJ0HR8V?LS!J^5N=B*;"
M=@"D!TBGJ,(1]D2;T%/8#(+.D5_/%Q^>R56]KJ1,!'\EZ]C>H<57"O%RP"1S
M:2\9'G/9E9M9ZQ9.RIKA^:*KF@@^C!YX1"UI S/3?14NXPU>/#Z3L)6PK.CF
MR-NW8Q.[_(+EF[*M%'>;7)8-Z)79V8W7VVQW?G+4 7J^.CI 8DDV$$55#;:Z
MST,?4<H-U\BZ#!X?=S[VAOJQL965S$N.3)G@DD'3LT5?/(6<B-;X%->"Q9M\
MT2+O>(\&U8LX#0=,[3/[G*;!HN)M*ID/(C;4GH,+56F!\)*MN%6?N9)U;T0<
M_/D1?0?W8T3U.VA.!-R)TTX*0ORG)+DG+X7[>_3OT]$Y$N1(<H^.7/K$HJNH
MQ%BR0]7%3%*.C3"M=+4BDB7A:U^++'N3[Q(]M*-=GJ=(T[F-%5B[Q;/?<Y@R
M(*9PK-;U&RQOY&TXPMP^3IF>0NMW=]-FT+BI-N!KK;8U_TO<X!USF:)'B:B5
MM_6^3P%4K"B]^-OS9V=0Y:*)Z<)NO:Z[/:&_ASO<K?OU2WU84WP'3$2 V>\T
MIP(2'(0=47]['$8 HAK%T408K10- <K/U(V ==V*I+6Z"2OGM%K#9W_>AR,?
M/G(5SL@CL;_\5@P-!9(77)?@?U^NV[E)@A+%&7[IVVK>[>%5/'W\]'%!&03]
M-*X?*$)]_GA&-:..*;B<03I3I3(@B232. 6>E GN4;O$;V::!.%VW8/S:4_S
M%B:UVRO+L,03X1G!AE1+1XR33KM01H5'>OOBM4]_O6#-P">ESRT3A!RQ+LVT
M2E<^ V%QL<B0E^_JA<HC\%:TNUW>$*T5<K<;"E/*4H>L6X/IE& PP"@'O\A"
MY?!96/L?)WXLEI-D1L6KC-1!'DW.+Z_5!Q&_</):&8@CI7==53=5-W@D554U
M:AD0"0YPVPF#*C/(T1(:%7'+;;^#4Y5PQ*FPSBVCS \ 1ML2 9=4$S-]*J/=
MOXSV^:F,=BJCG<IH_DQD#(G,6P][6Z1'9<I;8*+!6S<:9 UR).&#Y'$(7,\2
M#"B7F7['6R(WU=/$BCJ"O+M'GYV3JIU[N?,0"[:TS'K1+(ZCX](ESLJ-,MS=
MF,Z5[W'[&#WYN]-ZT9_4]AN)RZ4@X[T)ECD; P&9(I]%:Y(5HEI?E:1 \N]0
M"9/5C+C/!)<;O)=MJ2T69%%#F$UF=Z'-@ L7OZNX6Y%X3X[/D? B[=3DM"X&
MOH$4<8V>1;-QD79:./?(4.TS)\@XE#?1M>NEX@%WHB1F"$"J,LSE(RWG0!,2
M_U\)\?>.FME\M_ K6C6$$&X2GD\/;K/?E2XU$R-EPXF"YAW]H07->4:GH<YJ
MOSM+U'TV1.K,-YI*56.AU-N'.."!LC*TFL%JHWJ @R>')5V7"X-QB77R*MX1
M7PCQ2/P _H7M%ZD8I  D^6)8]07 SSF]8Q?)_, CS!?LQ-GBHGO>U2,R->+K
M$:]V'3M6U8G/-P+7#[NA[F.=:YN17N/S*"(9PCZM6V%6D&9)FP6K.#-Q*QC4
MOZ_\HEL'J*#2D#S;;YC]2'S0M@3K@YP,%=T)PQ4K*SLL!G%J9/L\2+R1%NQM
M)3EYQ4DX^QV--G*&5\&4A!%'1F<9@V23YY714T-6,)U" ![".04SM>RU"!X-
M6Z6CD#RIKRR>H^BO'LOA*T127[7RJE58ZB[U'[5^4&9&Y=4+[2]C9O$WD:49
M*G3F/$.#9F27\1SA. <:B)DSD%4QD@Y/K)%_C!-]^R7ZPAM9QT9M1T6:4IE/
M<?E?RTA:5<UQV>:@B&E=(P7E#A4@_6H,/*88PRK"XMMGYW!WZNJF'S<;'5M]
M2#C4TD#I]%W376TMXV9:?\3%QPBLR)K-=E>=0>>#&]?>-%8QTRQY>EO5D%0#
M.R2WA>ID>D:P]K746LI>+)]H68Y(>B9(;-7NUKX7'>D>5?*6?XH_;[4*7!Z*
M<=E%HG#6II/5???C4\3J_R9<8ON.&3;)D@-W8G4;.\_AC6\]TB2>PTVSZ]HW
M\O[+8!.ODO=;*J@;61I%U$L>BH[<M6)D5K'9RP%VTB^/.,J4Z]S2(;Q@1RUN
M]C)OFK"2$W+"@IX3RW[$QNRW3!$V%27BQ_W!/&X[%9P)AD7^V[VKW3$YUB>]
M;EZSE?8XP@U=LYEG(2 I-@M%0STJN:U/M8=W:_E)KTK/<;#M7-U[:#ZUIF25
M:R#I3$3C^/X=PN?*W:@F;ITUV2%*3SQV\ IIWT<K?'_GF<LD5"8I+<"+T^^.
M4%'DO3O:?9' 9@/#H1.UJ2K_L@;+\"H6AC8;/$"KSJY?<G32D=B''?:Z;JP!
MT&8/!:%%_2GVJ?B5YP_>J';&98A3=L/NV!AWP&B')5LR"2#$\R- 6T)S^9F,
MX^F/71434AX@%P_AV6\#JS5-EA$%OV(!=XUP0HUMDGDR[4?;_)LY&(HB_G+0
MJS:U_^O5H%LE?'!1"^'#I@V1TL%N<?NIV!B\+0\:W<AFSNAH0%TE,;%G5@H>
MP%F[.MNV"^!8$7GU[+/]5U3T/\+-=(=55]*4!+3D&K%U"VAA"S!SC9])B7AU
MC"^8JI?/2">A0LWD#^@95-J'0K,HO72!V0^'YY"MQ[FY89=4'3VV)"S25#L2
MR3B0"BPV]Q]15>0^F.BBN[!-^$RIN:ROX?E$X:YP"4FA<I T)3T,R6"&HY8S
MI5AH($6+&+CO#EN%/,_)P2*41N6,#+,):,P-+7F5"@F6 4GQD&(%J@?(N_D3
MG:;+'%Q;B"*N0C'[&U[?W2WG2]"4]<JXPGCC&E;#K4/=6#-^I.(OC)& YJ9J
M)'C*X"UI@>2C&,@9RVID(\O@_NH0-S)'N<)#\"E+9(06M'"GRMW]*W=?G"IW
MI\K=J7+GS\2R8O9XOJXTSW]FKL@0YB&]:$H>0K\D B=OM?L:L!C_R"C30Q&V
MC"\3UU9\]NCZ0UCM:1]3A2XZ>'>X<D/JE?&= 5<@/%2 A]8Y=$M63-';$9#]
M\!RDB 6?@O446E^JX7*$4U83+KQ%Y]%!L%NWKL> <2O+4?3&C66,D./KG=W@
M1W\ =$:JAYAS/8G*"9XA#!,'\O@A)5<2-Z5/M)2>U 01.4A^RO\&(=#1)1MN
M4#_F_'O3Y:@N;>3A;HV.09SL 6C>R#;GU3C^\8+'*03RL4@^NO 7[C&L?R[3
MQY'HHC/CG*&RZVKEZ#1B1#U/6JZBVR<Y7Y$00:,$64O5FP[>1P]CE*_H H ^
M X-+E0[EK.80^\72YU?M(,OE@K88;J6G*UF2,C28^O. /:=SZS->W<IO%N=*
MRR^+$& ;/ DKS)[%\IFKF<4/1\YAY9O2@J,55'O*-V 7RY=MH 9VLU!UBF4*
MJXB]+9N^EY)WA>HOK6W830.6J6P1XJ;,=XEM-Z&@0C:#+*"RYRIR0MD_6;+G
MV'&H)6(Y?A1RC-QT$!Y;#^6(P%L.1Q@6S4Q7L"1[*[/J]I3;+.+[XK &;39Q
M#*-CB<V</I=U)19&BYHPAG4WU:%;C#.T-Y7F<5Q*L8Q8>A:?!7M8D?-R$OMY
MR@2\>S%-5(]T,RQSCF?"=\\B"RZK4N4^V*A((D1L0\XN[(+[83Q9*>$)'VU7
MHB2*47Y.#QME'-Q#WR[S$ [DUZ;@.#B*KD*>:C@N<5N,67!H2W_A7X09^N/G
M_^&[HMVI'4QJ&+6-\I,X0AJ<['E/P_/&WYSR#B_TCGL9._Q^I%'&/7,0P;J7
M/P*$L]3!*+Q F6Y3,SXF\SP\'AY#9(,ZUT0$<P.@@_K^7 M0/SUZ_6AZ\O\S
MN-!_GDK\8"S?ORZ2I&:?ON0Z%]4C3W*;6)S]NA18G9JU^,57"L8[D[5]I>'_
M[&^D6GP=7B)V_X1;HA]^ )Z=#.W5WW["?'Y(E%:8YS#CG[P6%%\X%]9@_NIO
MKV<_;=G =Y&12+[ZZ:*PZ[-7R#W)C'+^.N"BOW]M!;[PZD)-V4N'/?X)M5XA
M8(")7/MB[QR.25JY&$%]P 1<SW,DU6W;+EY[X_M6"<1)*AUWIS!@AWDW5R^?
MZP]L2TTOK??CD@&,LQ2I2#-*:+?RL^<?[MK?@YG!"R7(\O86!L,JB"=-KXI5
M?]=J89ZG^4F9:;HC^0P7%&6\2DLD?>+=AX-F%:W_Q49%\4\3THZ=3,4=N5]#
M]P)/6B[_#B9<W0A:BT5@9F@,Y_0>.U3@6Y8P9%KZ(E4"LYIJ82U6;('4&J/Y
M!H#4[.>D>B2 $ &Q( >0\)%8W11E/=.MMDGZ<I3GT>7C70Z?;?@I@7^4%#TK
M7MW:0RERR,KF,720P3_'I-[E@$QRW'/J11;B,]4EYVY>$:<SJJG-EM*&A<A-
M. 3#3FK1"A=AA[N#RNV%FT4*[^@$UDM53H],HUD-WP*K;V%^I,.(.GGOJ_T
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MY%&X@OH<3AJ2^HLKT :%O3<Z*UR)?5_XL$$MF;-\B0Y2]_!*4,2@8SIX[,,
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M@SD[;97W/\!?N54<IM/)O42U%?A BUIZ?Z_;]7Y3I>!$8I+3'GC_ _QGF@O
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M7Q^]Y.BMCMQ>GM-CM&Q=SD4Q.><VS)P/RO6#V/7,@J:NMRSS6VY$OZ^?3R"
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M7.DN^SG\B7WT<W3>JS KE9#U\WWCV@F\R)&$>\#'<&V*06/*@+KZMUV#F=X
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MF*]38S.8T)YI'XQ>.3$KL>0M\')IIW28.9#,9=.E7V*NJ^=+/U:XS*'L,UR
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MYB3Y\.1?)M]>V!)S,*,BC7_)/ZU*84/@1,>:NU/JUN>+R%>U3O%U"9)R:WE
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M.83T4:[(H6IK;B"0RDX(U\N=M0@I0[0G_R<YI:C[J/JGSKU1[CI'V2E46$@
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MSDF''N^>L25V5FE B(AKFB#^/N8 $UP(=YI"'!%/'Q0G2#E*]WU5EL#7';"
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M.=6UW-0/\T,.[YK2>/V9R?+C&.#\2O]PH2[,'$$E 8]ZQP6P%0X7PQR&I8[
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M>.51_-[9;# 0ODS/T\I%HXW9$1A1&,A3$<X@\^!7-/Q*>[Q?6EUN8==?CB8
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M\^/R-PY;-[/_ +EWSBG;,@J.UE=U=5UE*0=$_N&4(K1+7U8WM(M..>N<Q:F
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M1 >NL),*346>6JJ/--7FTA%KIH.C5CYZZZP\H?4@>'*_U$0<O_;-4G9+Y[O
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M;KNL):9:!^M%-0$ (KY'*VR]T0WY"?I*/QG]XK$203PNWC=-Q%UQ0#?OR7@
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M76&E?(W' 1,38TU<5!,YV]@-UPEG%>A,2/?A$5N'\,R6$/Q"_BPR. '98FH
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M.9=SQ =];R,&>J1X/ NUF]#S,@UC6-U8 K.IY96 'A%N'*Z?*)#M.#%0BH[
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MX?"0""L.P^QUTKROD_OS3IJ[DXL=3-]O20[&+EE+MW1>\9%D;\].W/'%W@/
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M:+( G4KH5,*C)46&%YU*:*&+=M1)D9(ZXP&.FNM,O"ST&04C1#[8UH&8/ID
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MFR_5(N<S%YQI=B";R>M?$Q% \S$-4^)Z5W#%%0R+(L0<OL2E!B,>8SHN,HS
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M7VOIQMSQ,F_<F(_ JK7O78LQZE.O]&Z9VCHQN)\8G%?$8.] '#N;U"=&Z*"
MX7F!!ZMA_"WFU*Y#-)&3Y?TX&9\"IN[1GO_4G(Q?Y>2T#!?NO+7;L:1%]; B
MA2H7VX:CM:=%:\D*/2H0Q4,@LMH")3&\<$\'CPLE<:3(8=W>[?9NR_;NP#W=
M*[;[P>S=O0<;A^+!O*<#YT?P8#JPZ_WHA-,+]^*D@VT_#$BY3I(W63=W>+9/
MC+.#$>0N/-]R[MZ516JM#<\?2R4<(\SU8#!RST[..IK=PXE8.W'>(,XG[G@X
M[J3Y,&.XUEJY7ZU>.^>Y[F'[EG /O&SFUA<?8X=F&E+1,'[?-D^Y':>"'?AR
M![X\&+N#BT&K:8J/!X"YTSR=YMG_!FF)YGE^[IZ,!QWJ>X?ZWC+4=_0XJ6GC
M=RY"<LHZB-?KB98V(W-L[MXPU592;*6;XBH)I1(BJKU=[.O0%VW"'%C!T2(H
MF.'%"A*72R!N(9]5E=@<V,--7=W(6T5=Q2>UR%Y5Y%*\P%K++%,:C6$%;Z<>
MRR=.XA<D%_X, 9;YTN')"GS>*JA(TW.K8"-!48=FK_'FI3\:595+S:(QH]4+
M")U"R)T2$8UPIJE3U"_2%'M Y9'ME50+\QOW%(-\&Y!KTY/:)O&MEQ&]>EEE
M^1;>DGJO2"1]/RU@2T:A-Q'4.U<O?Q[.0\8 @"O*[MRFZ1!16Y/+4JQD\R#^
MPK2"Q.<ZS:#)YG[K:%6E9,FC-!R?-*77(&2LHP4*MGH)>5/V]M\.I7-\J!EW
M-#>W0:V)(AWTSNZG2$=GJV"(M9#0U?5LU*QK+ 8H#+6*= WTK 9:M"V*=$MU
MM9V*(&U0/JK3"U^-7GBP UZ6\3R- ]X._1C6%"]M2]@!?F:;G A4U6?]BN)K
MKY.6Q+8-064DL$&,J;09UD0@Q,85H,?*#18I:C !D<-SBX6&V?OF9'2"L$2'
MN,>?4+:UZ5^%@%U3^W7+5S_[AXG8<V^]^K%LJG+**I+C3&Y8#60VK--]-"I*
MW6 P6F.8:P9]M\'8"'ZMU N$(+41X(J\P"E!QI7(Z 0[ZU9O/+0HZ!BOC%P&
MP3W3(&G9BBHJ\?[4?!$E2Z7D.H.2MH@\UE_B?%BW8DAV Z-^Q!KKL>1'M!:X
M_^,FM;59>BQ2-EYE3$"O(R5O!")V-0Y\B6'/.G$%B<X Z\&WMC UN/H\41A3
M8/@6:,^U"0=12+RJ'#^/(4*WI*@[P*YUP*[3#K"K ^SJ +LJJ%:H-W]&O?E:
MZ\VC,V_O8^>#GR>"IG]"P*VT'4EM"PYX'9*]35R2*;]("0Z[!+I'S,959&RD
MCBP6SO-G;S[]^.Q;5TPJ6@+"7K2>HS&#B<QQP;P]?9LDL 0<9I*9V)^A-Q*;
M\6K VIAM8^:@B8+'Y#-MJ&O1C1'(MDHPL#XE'MC_*=S'@TN"N6!.-AI:>+-W
M]//7^N<N\RQ(%JA*/U#>@K!V)9@D>VS-0]5Q@$_ENY,*82OR]'V!/1D8(%F^
MGP"N\5U_(0[)X07Y)F=XS4]%K,1CZ;N:BI$!.>W[S;V<%SW <=.]RHF#*^%^
MPP%>LP+M.1P*;F_"$^CX$(8AAC0GU&CM#C,,VP)$O1;G]('\$Q_?_VL+VHDV
M98%*"HSV)G^.,YHQB,HH*>MJR1:?#(,)58H9H5RG)*)3!X+?_M\(T]J+XV(.
M.G(6^E:BG'Z'<4ZJB((7'SF :./D;XX^J2;4<8HQ(!P@HA/6))(#7QL<Q9\-
M3YD6*2F/ZM/ Z5Q_&G&DS>>&BVM#Y U:Z _4<TN"^*8 .5)^+N?E2^&3EK'D
M,UC<*S *J&@G$!_J!QAP9-BGYHA'<^R41Z52QJQ_B;#(C*B9O40]L&'5SGLG
M]EI4[C2F[^!^KXC!)[4FHN8^C;<9TLK1;>CHXP&3>LMS>+1DA\LYPE,AREG(
M7/U50.P)WBJQ:WL08GJI/@.J5Y_>'$_#;@N)JX#3$-I63JN*F );O79NW<#@
M[=>LG9$B/F];-C\?7N9FEN!M4J*V@Y=D</EXB2=BJF6D.&^9=&:%38F8T.GX
ML,H?+YP8)=M?E>+(Y63PRCD;<QK&O.E*PJAZSZUQ/',O4$[U(,\<*PK35W64
M0YOYHSI*8@K),A2*;]:8I.GB095+$?>R>>R&0^TZ9JHG(]C;BRWZ@&>XH!NN
M!']]LPN#O(Q7L.\]F$M.PC$BO*3W&=0=/%($'IYD$%5X*9THPU]_PARR\^JK
M18GUKOU.^#>,*ZY<!^)T]^%1&,1CPWN!&I($F<>,%#A@/E!W+3)O_%3S8).D
M1&AD"M2<<D11\ER4A09XE4P'O$KC*^MW+%^=]22,%D<LQ_P1UGHUW Y^_]KD
M%W$'W,CQ=U']'<^ ]>0B ^E#3@9O.@W3.3/44C4$.KKXAY]<JYBYP\OI,!\R
MO4 4SI%F)S6-/#P/DS(ZS.J'DR<NJGV<8(XK9I@5=5DY.;A=)A"ZQBJ#SXC!
M'!ZE,*\Y5^D5J6 T:E@*#&L#GWJ?*^=[+C*C+!+.C.I%I1]Y_E]%R(G"C/T$
MV*LA[$[,WZ;\FP Y>S'#RS\"NZ!3[9QDI3,I5!H<<.I5Q#@W\WR61S92,+<1
MTNG1FS&JMD_WN44&_F !\*(LT>P(Y#8AFP_]&HF%YV">(\-U1>N!-\$,,9>!
M*)1;75%89I)YF^@[D.;5 8QY%F\G-&T@X[#&Q!.S7K6R1B)$$;K.>+-Z1]89
M>''BI- /1=^"B!^8IH/4O)5 P,D"X]S'VTWQ)E,OC*C,!40SFRXK+[!R+RVA
MY'S ^&V.-(ZLF?X&8WC41\RD)L2\F!3WX)^H)%(/Y$1HV_3-LUF2YE-4&&%L
M)_9QVE#@R3. Q4W2 'U,HJ*:<+H%OKCH@P^]) 61%20*D4+:'38XY%^@ TU\
M)>9!B<_F&G=ZIMWOTA4'-^<U3\ G115 ,'OO$M" @_Z+?]&;$L,*F>KY H01
ME]EX4.5VWJ@_C\^Z_=9@*& Z:[4DKC^K=BTAM-^$[;=>EV&!DG@R^BK2 \A4
MEGH^Z<=4":R^F#'K&(^,A9'F\@9^FF39"_TW:P5CGTJ]2;<RWY3\."YL]OAS
M6BQR?RG,:J!'X2GP9_D0<^&?17"U\@8_?'I_^=KZV]/$@<S9DZ=)9&:)JY[+
M8037*LT,TZ#\2@<'+.DQ$S,AH>*U5%SHNX'^B0+9K3I/"+,)<5]J@AO\;&O'
M )[\.WVOM; ?IGXQ1^? )SIL\^B5J!:);;S% H_78G8@K$=:?(_D 6UZ)6:G
M,N$6W1VTB4?J;HP!ES=)KB4/"0\,?8E'K>&@.Q0[O\+/R%4=C-W&U&@6?MDR
M-5IF +U2"C$+E@;ZY3#JP;U%_AIEBS/-#@O> FH_.8E%WBZ0<!9 MA&8QBS)
MR%9&V1T-WN%H\*P[&NR.!K_2H\&&39&1FKVKGB/'2DW#DA2W]'W7T MR=,RG
M& LZQ2(@5P_^^A).;B'3;-L,-K$AH0>;.3^'/F5ZCOJ$U>1XP!SUZ\Q1)+-0
M/39$<6F:)E=.6/EK^+^%;%>ZDC\V6?D,/,4;M,TZ0";/\ T96K"<_Z.\*)_U
MG(]%BA5F1I:;GRW?0,3*L3/&<^ /.C=)&@6@UQ7[IA L1D4&1A1"W&0)#UF^
MF$ @@M9=O[$5GV*)6Y[5IT#L^GH<VL=//[QY?_G#W_]K<#9^!7LG3?(0*^3M
MJ9-Q!\[[C\R*2N$S/.T:6X#A+XA>=<6MO@/EE3%BSY@@F\(82DRFWK67^47D
MI?R82@I)_":+1Q!\QHR"NTF4)(%S#7^I*#.G!$PO*)&^&1)$Y%Y/3RYFC.,D
M+V>J^DK4.%.D^FOTA%04<$9$.D*69;B0!I1.7MJ>(ZDJ\6>;EOH8#V+_0+YJ
M<'@IG2\O[H&7K5Z@NVGF6WU1/B5HG*F23K;4./XLB9C<8<'FC).^&WKL9>PM
MIQ40%65A=M<%0%B;R!?6:6Y22;@O""O.3;ANI$!3CZ*209I8^WG8]:+(MRX/
M4#AAT:/P2+^YV=(4N#2-#-ELHT@30&OB71!^GV>+C_5D+C"M _L*2P3U/VDV
MX-^8=\&'$^LF)FD786I. 5<$GI,:?(?C3!DTSK8DSC)4M#!-H&D_.T:_PD*2
MJE(A;7@MAOBO>!H5>/TOL/*H8WY3_BR&][BBZ/]][/><Y]/O/G_G.;\BXS-$
MUF\5:".I$GZ3S!>P,RBJQ]]^ZU;NZIH3C0 <HBA9L,C.O;B8>CYEX_$NV#O&
MO7>ULMK#'-R&H?L0N28Y1?YAS UB]A,H84T/J+V[2<9E2GW&(B-+&UJW2<OC
M)3YN1=IH4/24!A8KP8,[/L'3&I$2D?@%V0^P7U><S$6[.56;'1)I0H1_F5PQ
M[%9.%E/Z(FT^%"F3FYQ)EW1-XZ/0-$Y8?TH2%!2+"! OK*1N3#*DB/EHQN2)
M,%(%72*$VHEU*0V=M5IFKD,Q/Y7DZO,$ZYOXWY27D R<=E'XUBKCO6+EPG3N
MJ'S8L7CQE[S_CMJ)M\HD![6)+YZ#J@O?,#]5[QU5).T_<!C]E?M.Z=!01YG4
M9, 5>WC13P7<%,8S=)W7H+0B_/>(OC%_GC>Z]>MCLKQZW/S4+BL;R5+OW$+-
MOK3M=\-O(C!%2,*^A _F=)HCJ3QNBL7#['!J_&1VKC>Y\DXXQ]83GLH??OWT
MX????M!./HZ2ICQ4'%A7OC>.-OH\L)[L7J.OK?_(42HR5U>)DF4QC<YB2ZJW
MQ+U.3+;)?(Y=$9AS!!^L9^NJU4GE/*ZQ7(U>4ND'07P$K\2L]YBNQNE^'GYK
ME)V5A&[2CZ_@ KC"+EARPJD44(%%TV*WP(PJ&7I62;8UI'O 3>8%Q6':&%JC
M>(6+\CR\K@YML2)L7(J+MU=AO'FJ]J/519,_1%<?JE*3,^ RI"E/,IK6"(,>
M?53MF0/2ZR0JYL9GK^X:/CR-EF33T;,SQQB8EYB$7*I5RG^,9<5XX(EQP%;B
M;E #UB_!H.)%GKQH#"I<W!@;W1HM,WB SGM5JQ8*1M:'>WQR8MD%/G&2J*/T
M%1L<_G5IV!S]KHI;S_F?Y 9V>TK+)#^B;!;(E?3&-3W*=8I%$J]4;<HM.'+E
MW*L59W /0E-XP'UX6,FQ$L^L/-;T"9+*D2>F*B<IJGC86\\:%OAG6J-2"3Z8
M1CI*UK,0P$0D/>?7)$>K:BH@"5XB2=550I67-XH=CZ30 _O[?YT/!V>O=)#C
MDA*FV#* #>/G.K L)ZDFX%N)\6(4\RL5ZR-3DY*@"=&Z&GX+>X9*=U)]6DMU
M";:34#O%O>[T[BZG=^?=Z5UW>O>5GMXU1*T_4W+?F)GC@Y#YPR[MC.AMT1#.
ME!=(ZI<<FLLBCI=XW@B6$78LJ/8X]"HNO"=76ZU$7$&FG72ZCX3&NE=L..8"
M0XIIO4H9FT 15#O)^!'D#W ?H/2G@>Q-08?S;9=VD3_?A0K_)F63.@)M.?.$
M2N[@L8.A5&?#?,TR >*"AV49?Q]C88E\6>FP6/<CK;H8'*8,PS0I\@N$<O2#
M8=67$.T<3/YH@$ N3H;3KO D(>^M0+,>Z![Z,)V^^*<4=5[.X+V<UUA4=O4U
M["@2;)"E!.9 %[9F- >>-0<N1PB8I\C3@MP\7:\$&X[\'&J/2:F,F!*GE)-/
M$ T,AERIPM)?'T'&$,]2^73W@U72)J<-NN7UZ 0(VPG*AB2[F$] BDS*P>#]
ML5K1:2>M;=PF@#D+:A D+-+=T8SYMRSC=JNQ6"LR:C2C@($NXB:# KN/*DVK
M51P<5[)AY7I62Q05YF%8E;_<O)RW>XLRKHJD$R2\5^2)OH01N.D30>V&-8V\
M1:9>ZG^L8=;;XH0KB57]D;=\&<:TAO3<TM?M]<7?%;X6&9!\W^/O5@#,^<O1
M2>^DO^'[C1?W>X--7Y[V-WZ]X<N-3[WHG5Z<=R/N1GSP(S[KC[:\]A8RIBU-
MR4X9Q]HUFN'9@YBJ;AVQ&(7'9ZXZKW%7;C'Z]Z1B^*A[3=^R2?Q()G$+/AAM
MB\"FJUM$H?MI[4]WP*VV^SVVG;P:ZA#Z907\\?$96NC@+2G@3D&V1M324LVT
MXV7>J)@V,LH<AM;Z&?,DOU$>Q?FW\M*G7O5'F,).)!Z9(N[%B$3A7N3"G2P<
ME2R,7IQTLM#) LG"+YAR)U/1R40G$RP3OR7@D+:+YWAGLWK1Y)H_^JQ^6,D-
M6PG7CE]TJV5MP2*VE3UT>W+0IYLK/#T];34I<2OU1$<YW*F$8U4)0[=_/NQ4
M0J<2.I6P?^%NATH8N!>#BTXE="JA4PG[%^YVJ 1J;!B^ZI1"IQ0ZI;!_X6Z'
M4D!2S;-.)3R"2MA%,E=@ZW=?2O%T,_=;'1<+]=-]^O%>*G8'<[1>TO78R[AI
M-]PRQG;HC;$[/AD_OMZXWTRU2L ?X"UTHKP7$SAT3R_..UGN9/GP97EG,5XG
MS)TP=\+<"7,GS/?U,L[<P<D.#NF.4Y;W7AEU&,'TKRNMK74-K6W+6SZ6CKA;
MBND@=,3(/=]_,JZ5@M[.%'PGRAM*4H:G_4Z4.U$^?%$>N/U1)\J=*!^!*+>D
M!* 3YDZ8'[Y@9V[_HO.6'R>@WD^6:$_/?[(3^8UU#?*E/&T$WP=)@4'\5U-:
M<[?4U>-,9IL4V 7$2#M08/N;UI8(:3MSXYW6Z;1.&R;S!/RF\0[BV4[M=&JG
M4SLMW![M4#M#]V*\@X:D3NMT6J?3.BW<'NW0.BTI(>KT3J=W.KWS%>F=TPOX
M<P<H+9W::4AM?T>P]-\_A!RA@7KI[C=JU'Q[H]!>I4"HJQ-#*@9X)7BN3;]0
MH1EC2@HF@"Q9%'Q#B'WX3!QI2-O(>>T3I3J(O_,1=HT?"OGW#UE.-#;'1\;Q
MBQ=[S-(B!'B9$X297V09DO[@N\,/HB4RU M%-?.V(&$+R O3&='O4I454<X_
M6PCC'7$43CPD)!(&PO+J+(<)%7H8IE(B,IF)4DB4IQ8>,_\*>2XQRU##X.^]
MRY[#I'I$GNW[:H&4G5ZY=L(N$BE-Z\'WLXF,D$ZD9BBKY/)S[[-RE%Y]GH\L
M*^8+?CM- 0BW3U(:Q!S'0)/ !-ZN$X7>!.E*B-$F1<;60KG(K(3TFIE,'?-E
MX\Q'25:D-'#D2;$>G:KJ3,Y@JR8IB2W>+ U5+$RZ\ .DS4G@%7C3(K5BD@KM
MX W.<12J:^8\3967)3&IA\*0GOIAZA=S)$_T<=3\BF9Y>;7@W>?T#8Q*")]@
MMG#Z_RR"*YY-;X($BW1'+TV7^.6U%Q6JG!\:L#5%/$8<&%);PN "U$S> L4!
M.1?39"XOE<$D^#11KYES18\0B1N#<(HT[?1S7NUR)ODU^1=$%F,M:)*64BW+
M'2^9O4A? ,_4!+V:P?'XB$[_F(41,Z5EX%@0"R7.E+7%C'I,%3.-(9TS3+S*
M_#2<\-;]-<F%LVRHM8=7P.0:]J>5S0>[-BH"S;4-0O6:*'.=3[2]4*[?H= -
M^B_^Y=IRG%>8>VS]%00@%;C-\-GS!(R;KW5]S<MH1>01<1IR41EII&O#.8Y#
M".'NK@OY&](OY7A0K$(??HTD69,_D9_U6@D7]QQ4V)=R.QVBF-'C*IC\FTWQ
M)U:0L.1^ H*'$W> ;WT[VW20D-&R'(Y+I*KUTB!SWB2!X7TE$K37EV]<Y[=D
M$?K.:?_4Y2V%]GK8?Z4GC%2=IA032ODW!9B(N4HSEWX\> 56+10RW#D]1*%$
MYFF"'&PD>',%@A\PS1\R]R:&UBJ3S7&C1#FS?)+5R]BJPEX)8#,+/33>[B</
M-C XBTR4==YS?B?E"R]$;Z+MH4/$P+3B_U'"S>XYO@S?22;,&4Q#22)\V )>
MEX@.KY(D(+T-JW$=DKE"IR$64ZSISJ?(?,RLP^3F!IJ35U@<9\([1UR\_-,$
MAZ3P+9#Q^HLP\[+)1]VP]N0>K!$H0&:$5.;=TE*4Z>J.L_<.G+T7'6=OQ]G[
ME7+V-FP*FUE3')18*R^C?=@Q0RM OI1R,A\\$9P0HWO!@0+?Q+CQI0.%5+,8
M^2^RE\W*RC:^+X:GO?-S*TE+"<[1Z>&8Y.>A(?-IV^"J2>-SFL$0ISV<+K4]
M(P/]//N6S7YI.5]MNWX7O<%A+]\!KY]L0LIPV+RALG'U\FZ[EJ-!;S0\\,4\
MK-4L73Y<+UBL.(/U0G=OD8)?V$QPO;INAZY#KP]JV3RP=SZ&*[6KIBG0M]Z=
M&+)OK6U/3P]ZI0]KH4UD:4(R"C"?(T4]V$PK]LM@<;,II;4:%OX0<S"WTW%;
M83AGUBE%)\E3F!5VI1,B[DZ"0L)CB((7F-GAS-9<!917X[#);)#?8\KW7>:4
M>\UG\+Y7F$R%1<GISACY+U*5P644]&)&]U-S6L#>@V7"&A4P9]W-CF1?2'M"
M[ _K]0UTIB_Q_2*5;(E1 Y@YAEM9V8;5-S=W=1T54C:Z6(#BR&;A@I -A<!<
M+L$<0: B>+=TN?J5:!F3ZN!7HL2KY(/DW3@CJ%/3/9T#PO^U9FNN/#P^H)0,
MWE>2(/PV=M9#29YC8YI#)B/5.2/*>!S?#GB'.1R21)"P5!F97Y5,9X:+("N9
MF25D68Z6>BWUML!EKVZ*ZI9:O;TY@,O3(OX,4Y3XG\OS5HK7UC49R9T6+BW5
MYKXL!(LD!!G _1C.1?=IV=9+G*T*(FQ">UIT5AQO6GGAC3K ;=Y3O.\\/ARB
M<<&WY?YIW# B^'BJERHY)W*F14J;L,E63Y9XG"=G=;4KN[H-*8U4CH%WI6QU
M29'B>.%6O>V,_B'M!\Q/TZFJ$?%4Y44:TWJA:L(3%OB(3E-3)ZQJ--!"@=+Y
M7P_/RN("#R!1+8%4_4%'<1ZL3C8SAW(!7GT=9N9053_0G'@VGW96%1LJZXUG
MGGY21(%]J@5R',X7:##PU5@K<EH<1Z"WE#4^%#H_\K*,\^>28X$92PM5/<N4
MD]J)%Y%(9C.EC #_H?B\6T7\/)! .1.F;;! G8NOASHGPC_\),/C4CHE*U+2
M\7&@C\QP!>9Z*/A+G A.4&=)A//^/I:TM>]E1M/=H-*_3D)_\T.K%N\&\TI1
MI.=@:1D:6##XALV/5U:(X&!$81U\K<A/'_YYB2?.]M'-#[B&QWA2]3JCW"*L
M^Q6^)PSH!GTJ6%<\%B_=KY^*^0(V=9I3T<(_\90)29,O\:-BD=%\@0P,^X,A
MR0]N(=B/5R$F:5'W8IF%%US#=O2NR!3X*L4S']@3RA1;H/'4A0U<<8&#DA-5
M.QV*E@$/L'Q/[L\J85& UO%E^&NU!O5O&9(_JC=K"/ON.L';+LW&Q6OA$=ZU
M%T:XW3,57:M,FRTS?AY^K&X<4F_7='AEG4%GYO@/_I\,9ZI $RJ7[2X?#6L[
ME7E@,+>Z5_; =S_T[?I)H2\"R_4^RXKJ@>O'-(GAW[Z(SM%M7ON8^?*-<SZ&
MO2>'QC\C9V9Y*@S263VHO=CZH!B-M0?&@%@X,Q(FD%44P#RD^JSU4V+%A\08
MK.'P,*@N;:)E#G$+2X84YE/TP@)#.^,&!*%=/X8)G1NXEDNWI'X(JS^RE\[S
M\%M^"!@^VA!P>8A&-,%_@G/!UDX?=>._4/WP:[UR,,',US/=J+;_?$C/LQ O
M:V^J;X%VE5*;?)\03X3A-2029D-;WL>^&!30I5)43>.,UDM/Z@IH5)0I-O&W
ME]*(PR7[1(M,I9S.WBC'%__M?')14S?.)PGJ4N7ES*_MDUN>4;,B8?"/9[>?
MDXY'S[HRA&W*$ ;]K@RA*T/X2LL0&CRK]Z 7G;/7/>=_"S3VDDA!*P<?1/KO
MMV5)L_.:JH%_\=+/H.T^A=GGH[,D?TAH\P64(3LQ<W[;%-[6I,23- #[0BT4
M&"[H!/-$PJ8>)K?@8[ZF;,_0H3Y^;DK&X1$AZ@<%(3^F[3%#AWKXFC,0N!P8
M18 B<2AK$/O+,LF[<L'R$$W[70M,W^O9^H0O?ZQ2./,"3/3,7/I?!T/D:R\R
MO3R85<ZD_P>D[YM!_[QWX< ((JI@I@_?@D<XGX"G/)*8X)6XV=(FI"@%NM4Y
MH.Y?V_%[3[SXLQ,H<D0@*)@GL5KJ#3B%T<!GW#R27*LTID1SIF!72&\&:/M%
M0EMBDL"/OP._##^F/H47^$[PQN7O=8DV1,[D*"Z\!67-N=T$]^S2270]MVF>
M*2?>P3A&[U(Y=*"4='IM,IF^QP<)^*BL6+#CQS>*0EC2 ,\L[?R'=(W8R]NL
MCYR@H.3(-"JP@<(<:U?TB0FNL.7!H[I>>1%X=U;W5#SFA:F^M^GPJ+[P$08.
ML-$"#C3Y> =F+JE,OIRBX8DT%0I#\%RP3XV]>+@HF>1;KSD14U F)\9"OC2\
MYE^6P4@89WE:2*8+US*FJ)BFV;8!M+JTZ&!WL4'&F2T7F ?BR'G0_YLC%F!M
MN9T;RH_C6&A0GFER,5ER-F*5528E0QMB5=LDZ:H8-*F70Q2/NQJ?-ZF"/7N<
M5N=U95DYR:'7EF0#&P#<6\2%F@OF7DC9%SE<<?*;9&43A'E1J<*I%!FXW 2'
MSR&/)S<V@91A%'Y6Y$VA'X19:A@UW)-.S:-P'N9VPA>3JPIS2J3DZK("IIVP
M,BX<@3YQ4AXV&"1\PZS =I]0^L[*!CBMS;GA@@_2\.Y6)V6C\Z@=1YXM<+US
MC#E2/!GU6>!((<"M"VTA;O4*/,INX-_<CC6#I899X\J0.LO:)D=@QU:^K;5/
MS[X_1!UZ>W62I,XR*53A5G83%G$DQ'4L5BO4XQ8NP;;YM3P$+:L'X =H3;'2
M WL@=9-CS8"]3>H1KJ?VJ -<OKN:P'<2C;[1T>A1&L,/5CR/%1$5D 640]:J
MI*B")(J\E!J9P?&S"E'ED$Z:C2L7KL3T.H@@5U17,&B38[EP2AQXKDNH[5)U
M+3.G4[K4%HT68QHE-X_BQS>!;FR9MS[M\M;;Y:T'CYZWONC?+6]]3Y25+1/@
M!/^RDCBETE^OR!-]"2/9T">"?N/CEEMDZJ7^QQK\DST@?.,@S!:1MWP9QC3/
M]%R9AHM!;S@\IYD0I'49C\Q2CV=I!0=(KCWO]?L;OJ]<O -VM'JQO!,6EMR^
MF<%],X17BW;5>+O$]V48?78^)5[@_,*>@^N\C_U;M.(>7VNX93X?A/T+&HUW
M1O]?FC!G18TTX"\=]%'&>:_VS<E%O"P6BXC^QLCKK9=[]S5=Y\,ZTW5?];>M
M9CT,10KVQ&C#.VO2\XO>2?]T2TUZIR]/>^.+\>.HZ$?5OP]FW]B)P1 AVSV]
MYMG.P.8^@C_T/#,M3MLLK-8G:$+:M<@[&]E&E,$[#+ME7LW67DN["BSZAU-@
M<=M0MR^P.#_! D]]+(8.S$*1I7$^J2L\HL2<[D>N?+4*/]^%Z;RF#N.)%>5C
MR. .7<Q./!]%/ >#48.H;6=11FTU*/L<V$&:C'JOIC9$V8U;4Q?=O+P/DG<[
M5KD%<MC:@1WD!K%SLO8%CY(VZ,S9P\W9^;/O_RFMC)?8RMA8RD$YD]5/SSN7
MJU4+?[0R.AC\?_;>M*FM9%D7_BL*[H[W]HY0>=<\=)]+!&W<?>AHP -N'_A"
MU&B$-7 D81M^_5NU)$ "C!&#M"1R[VXW6$M:2U69SY.9E0,'DPL8!1BE]MIJ
M^-KZAZE4JMWI;LFO>YV3?CPJ&>I?8^/OWN"JY?I9M/U!H[C[-ZD&"&@9Y&1E
M19H0 00$! 0$5'MMS1]UG8'>QQ!CISH-?=WK5IM??GZ;/S)675<^5'V9JE/A
M\M-1KYUO//B_C3?_>UH2>'_9C"7!=_AO8"I@JMK+/B$2J JH"JAJ"=157J>J
MUR4E]X^2DOL8KGFZ3P+6JI5LK:X:$** M8"U( ^G-DIIUM9+!Z7!C_.'@1IJ
MM+6K*X7DAV8(4 -D8L#2P=+!TM7A"6O[8+!TCUNZZ8JP9ZYQNF?-E8!RX?N5
M"],G+Q?614#N7I@'%XS7K=+RM@JE6UM2/[!BX8EKIY^Q>>AC5NT'PKDWZGS^
M>Z^,Q"E)AU7?Y#+AX?I17'GU036Z2]AGXF;7\H5LW:Q-0'9/6MVJK\2HU<K/
M*XYAJ^:C91=]K^QIJ+K?5*,]_'C@0T&BJ5DF=ZE:XY?RWG&_^=>C#QCWF__W
MG7G#HS9A%XT%+_J<3G?<ZDVGB?FI-+%V;S!H5N-YIM[3OSK8]Q,'^R>7!_N#
MRX/]P02:C*<R5<VRRO%^N#C>KYJ,I8F^*->.3H9ESE)U?M(<MVYMC3OJ7WRG
MJO74J$7KS<YBC8$_BN&T71J6733A*F]N567Z]N0DWZ1\X&@(1U7!3D3CERP>
M[5'/R:HUTOBKE6[ZHUE0XPVYK979Q>Z\*K-B2G^8WDA+FS]N?C;N@E2U?VR?
MC2:OM]M7_6;RR]4P]>L?<=589M3H?"P?,\G%9>^::WW2JDYFI87_SS>F40W+
MZ9:9465O1\-S)_NTYWUKG91Q4:.I>&6>P6@RTM5^3,^W*_.5.[',*0*NF3?7
M_."Q7U]VNIR:_3'>6MBE1=#,QJ":(78Z&(P4J9J^0"^FV]P&-<TIG!AU+QTA
M0<=VNU7OU7&CVM;PJO]:4?SQ9)+\^K)V&5V*#9_5!/S=#EJC#1H;@[ Q"W&K
MJMZEMY+[15?J0N*EY7<UUN[L&F5?#JT<-2,N[WS5&(V4G7I7:S"><-<O'?'R
M(O2F78#K'W?K$UU. ZR:+!83=?"J,>ZY;R]&7$T0>,IN<WZ02\?Z<LSKV,.^
M@),)8M@MHSW+ HT]S5^F^/W?C5_>OM[8_7UD_97;CKMO5R:6&UEG%QY]=;>Q
M!70!;1=W' T,[/5#94Q?/E?5#S#%,LVP/=F%M&V_#2Y-GXG19OW3]MB"S-^R
MZBQ=+*#Q#GV8[F+ZYJ+K?WZ&3FLPJ#J]CS^R^E( C8MRN:Y:.UX)]E5CX1\,
M([I5@*XFOXV%8+2SC;UJ]./5JV.QO9R.>9*]NDH:QB-41X(V>I R$\E5T[#*
M.*U>=]S.='#:K^YMJZD>%V.U?N@J%&5)_5CU2+WT#XH<7ES2O/R,<5_Z[+J4
M[N%E:FY^DFHJQI7^#,;SO:ZTK_BMS?RW_5$3Z3+AN/O9?AZ]./Y:Q7\8?:T+
MQZ'J?MXMW5][X\FT7^/D_*?+.8.O&MEH.;%7'?C'JS.>9CCY)./5RK>JG+-J
MU0NV5(VF[WF[ALN+6K[BA>\R[A=?/F2,HJUJ6.=U(!VU^,S^7W?<VWH"=O[O
M;-^WDJ_\8WLT?/@"O+N]QN"TS,X>W1A@8R&PL7LE@I>#R<92/O)=>SZ&:NQ.
MY?R7*7@C-J^FROQ("2\$YG83_$X%;4[BQ_5'*# SL@C"B I[%P-N7C4^G([F
MZUY<?#5G[7M>KF[^J&81;ML8EBD%KMB-S4;\V@K5".!,?+9_&5JY&$-;#>J>
M&#TT=M9O^UHC<V6\E+8]Z$T\0!ER8(>7'WYK:& \LF%JIO#E8.-B%X58!E!?
MV4>EV7C6IW:[_/?:+8HVE@C*U7#JJR#)[0__Z6JT<;7*$]!4S2P.Q32: &YW
M:7=/A'B>L:5O#57G/X/_E " C]^*"ASU\@Z^[I4(TJ#Q]]]OET+[/^3G^2OK
M4+/Q.CM<>3>[K9LM*6OXW-NVGY6=EK >Q2]*Z"XBZV7 SVC(XVUN3Z6Y95),
MJV ;Q80]>+AC:84PUTZC]SE0E^QE':BS11RHW[&;[-Z[^<2?M*2]O1_5DK;V
MS;WO[-7Z-.V]?]#U[+:>U#]1OVE=O7?7LQ]E A21G>YF=+/?ZT.Z6R^]U$KS
MBI'[]CN>[47RRG#ZP#?C5^2N%R6^\^4[7OSY([/[O_D6S;W8IVYOE'E?CTN7
MLMKG=C"YS0!['BSYI7(CL[]@JY%797Y8@<6C*OX\<G['OP4[M-,-I"?7V4 +
M[I^L]&0*P#U:5-93QQ:BN?7*2EZ8V?*8MN2+%OYR3CWOOJQ/U<T=Q. IQ4 O
M+?;]!*7J^=#+=.DS&'#_Q_L84UHIDVVC&K+Z$#2=;35^B#>/!\^Y[-,"5N9)
M%N?E*.=X=.XJ*>?K\7SFT23D!_6B?XYE@?O708>6EPO)*RIJJW(_&KU^7?D6
M9T?48)7^];RK44G$3Y9C)#6CZ.*BE^._6M^+POW1'\TE;IQV6\/WI2O'Z2"L
M59E$^;M5?]&2RG/#+5/$8LXPLU%31Y@2TA+*DCG<*MYM_I&L-4+TK8YM#_[?
M&LK*6M)&[#!_Q/?AK]W33N@-QZ^O-;JV$\O-T&=K3WXM(KS1#>4_;Z[D=V/X
MVO;[I4;I']L^C5GY\]+&"@:J\]+ _CESF[VO?]/W7_?9]FDX?O/UX$]SO'O\
MD1\<;XL=^I'O=-YW#C;?=_;/WQ_MG^^T=C?WQ<ZGG2_;YV_.ML^/VG^SG?;^
M>8_L_KE_OKL7VKN;!U\..N_P06<;[W_:/M\__DQW]_XY/MC<_KY]O,T/_M%\
M][7I^,X?W=WC=V<'?[YO'1RWCP[V_+?MO7??=C>_\)V]CVSWTS;=W0SM[;VC
MUL[F/OF;Y?MWOK=W.V_.=\Z_?#_8_"P./OUUO+WY/E_SOK7[YT>QL_G^R_;>
M&[K[:4OL[/W3OGA/OM?I ?TH]_>VV>[>'U]V-]OM_<[VMYT_/W[?^7.+'^Q]
MP3M_OON^O;<O]H^_D)U/_Z2=#_C[WWMOAML?\+=#X[622E.D6)2(B\B0HS$A
MA6V4R@JL UY;9Z9)-/FO_TQ+QOIHKGE=M*<F:'+[HBS:T@> KX.(+AW DR1Y
MH#I9&C#G3ACB!-4X"<]]Q-%7 *\!X.L&\.>7 "\DQ33O'#)2*,2#4\@*&9'E
M,BHFC6(\ SSE36,P /R3 OS+<9\>X9;6V7WZ<-3K#]$P]CN-5O=K' P[M_E.
MEXM(GWH1[Z,:/Z#_I6.:.;@2U7;NY=W<NMI,()99B*5UZ3G0[<TOARYRZ[-
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M-50QDO=>)X:X41R9J T*1G,N)"52\+5U*9J"U"]&L\*)A2\@4/VB$'&^&=>
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MU\[R,:@,9_5;(U9<WO@EQ-3RK>&_?ZVM>0CW?WE*^&)JT-Y.%YL]K++LR>J
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M1D10; G7/"51$(Y) @BWTN;M*D9N=X='L3\.VS9^&=NX_VXVNA':6-37TGW
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M.F7_Q%FOR18O^E#F00-3:[+G54+.CQN0/J^/]YB% T%X8K;OY(N6"->7)O0
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M#AY5W7(LGB'C;_ES+#HG[=Y9C*,$"^1LQH:\X)V3V!W8(K'/FVLQ6_;04M#
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M]CN];ESLR?T*)G!!-B)D(X(P@S O6IBA2P*H&J@:\ 8(,P@S"//+.[F?+-B
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M6V4U$UD@B0^$&809BL9!U4#5EE750)A!F$&85U:89PG8J&2%LYI'P;A-Q-'
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M!4OW\9"]?PG9$8O 2K<AGRA!7!*%C GY5RD)IQS'0'R&["9AHLD(&+JK#=J
MC,]BZ#X,%F]V:*N&R1_UVGG9!B.#%F+ <\'+SY=X*9R0FF&/E$\RXR7GR# J
M41)6J6BUM%'<=I *. DX"3CYL_9NBB:C. V!)DZ]U5$J;I1U3O*(%7V"@ !
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M],1@R"6)$9,BAM+90(GB>C25YL [*]#^9PZS(J S4>V/>%9?S\"^ _L.  0
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M+BTB9C302I&$F80P:F,BC H(39. :Z%HJI!'.NY9 ?O \28"W8IE1O0 =S\
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M0AU:&1,KN25,FY (*4,2,AK#RUK3Q&UM1_0B$7'//=E'#];'JQGE."6V. $
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M+9<\54&(.;I+$G1[9-LT WCC@\+VNRUT5O&3%M98>X*-WA&__#/B[Z>%=;:
M-RO3>' FBT+V5>H/I"Q"3ET461U)&S$=<>E",))I0&.64$JCA[*1_ZE6]4TM
M#WVR\BU5R%Q?#N&4D\XP8@U/">AY4"$AC4B4Z"1F(I"@2;:VPV'*^[[.??CX
MF2,>59S;4.L0M@;3)A".!BP-TS!2-J VO:^"Z1[L[A/L6GLY30,><.%(Y!B
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MYCB?V'(@"V00]5U(C@H,'<AB@F&(R;$M;</C"Z^7$SFI"L=?7%RJ]9J)$(L
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MU)H&%J9O WS.3U4U^FRYUQYZ?05*ZS_CPRW%RFK;H>&,X.'=2_0$JY@DNH.
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ML\C',VU^TO;3WOWR%X7['X;&618:21AC 6'"!409RHCFFB74I9Q%FW#^T4C
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M_#V*\7_,Z"GW4O&20)5V>M$/(=#*?W75F"[]E.2H3;Y)80N+'0?*4A-D'JN
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M<% 9.[E4X2_)PG7E2N.'7HI;'A02#HKMCZ) >DL=1T/@Z$HTJGQ-'E: @7>
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M&6PRV#PCV&C*I+5>2,%CIE"H*,7<2.*%4*%-E86;!B/.O'!#$18$>0=<45A
MH;- $UD 1:@*2"3""O,LW#30$'([4W1XY<NQ@JS()_M8!'PMO3IN3\ +B2WF
M$A%D,%54:L6AL0);+ARD\I:F["PM/"GM_KQH"L$4^@('&0%3!H.T@#Q00EL@
M&7<DR L:0IX]Q;*G6/84>UYI82TWQAVD!:X#@1+8".VI=%):SYDH('5*$Z6S
M*:3)B#,O+7@?U@PC!KA# E#.@J" % >&%DHCB0T1:.,U@IN(%QEP,N!DP,F
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M !+) 750 L4%!U!2S N*A$9/:@U9!X*3P2:#30:;AP4;XY5&#$ML/2V85(7
MQE-#'(12PVP-:3+B+%A#-#$(0P(X9!I0CPJ@&%/ !\@QC'N*"YF%F\<UAOP$
ML1\-Z,%X01[3='=-W1;='U@W2 V$16F5_6['MOXK#:&Z4C=%PD7;'P7*5UU=
M6N F3.:#5MRZFP7T1^?QI6(N\UY1+YQSHJ"!1 OOO#;$&TF0E^Y!,LY$<V3Y
M3G4&?ZGNR+WIE*;;+T<#ET'V3B![N&BS@HQ#B)P%1'L&J$44:$@]\%(S3Z72
MU(DG+,WU' >N*90K^\9EW[B,_1G[GW\>[R)O%]A BPJO/:&B( H12KTND!+8
MFN)!\C%D['\H[%^P'D(A-+(,& ,EH H;H)FV0 ?NS10%5-H$["_D)B<X8W_&
M_F>'PXS]&?LS]C<&^XGW!10:%T0B*D5,XT$504YY) GFM]2U7VG8S;#_0+"_
M8,D5PE@"C0=8"AM$?FYB2)L%0D>632L/+6QN7%O&_8S[&?<S[F?<?T9]OW+0
M,P0#5@19WVBA-"RT+D*#F$J89?XF@?^\S(^9T4XY!9RR'%"",5 6,X"1DE@5
M."RFCTD7Z2:4+(/_LYCC?QU&[Y+PO^U\?_U_Z9_9OM[R_?.=NF$$-XR_V^DY
M<%1]1SA1K-:DW^->COMWJ@:'G=YX*60UV6E("W<D'%&C8?^W^H=J>=(O]7J&
M07356>E>C3\L05SZWNE9UPND-+1E.^595UV\ZO12IU.[OYUW[/ H#"U,#*SH
M;>WR4'>HOKY575O8U]5%PK<X)5=?O_;AZR_B+2;N^V:XA:Z[2.FUEZ^YF+O<
MC"ZS6SY\5T>>U43C=@SDCWCVR*O(:[KS56<86C)/Z^KSK%U:[?LSE0#1#[F#
MWKC*)M!--WB"=>:/!J-OG'&GV@U:!&VV N<IKIS,Z7$8HT1@;MSL^5K'6YM'
M&1[8Y_G'-OG5/.4/Z$R>;O?_TWUWW19Z<,[\QDF]'Y_>2 IR@Q;ND<[*O3=>
M/D6/=(IP/D7Y%.53](.GB.13E$]1/D7WW@'[_2!PYC/4_*1O=S*Z/6@TU.--
M765X>74?^O-01LA[4IP'Z]ESMY]G)L_,L\S,\R7&? P:^7AVNW:_YRY:IVIP
MXH8M'^Y?2HOY?#/6A/EY4)>,'XF[?GFN%=8*H;C7A&E#M?9:>DF]=9Y!&_]+
MKA4BIR^X@Z<%V7V_ _>^_-G9/?WS=#<\$_K7W7L?VPV_[7_L?MT_N#BX/+Q8
M]K0P\.#X POOQP>G!W#W^./)[OLPUC#&\!O:??]7=_?XS^.]-SL7_[YL3R,K
M]P](+%6C-<.!40,0Q_(!6D.@!=6 $RT<-!*I&%F)X"9]$D>+-<U?D//E_*3Y
M<C+$-H(T-.4HW!YBM3388<Q\(1DML!%,P\)[ ZW&Q'-^.XC-Z>B>&ETOYM 5
M"UH4S%G@G:& (D&!@E8!Q;@2I @?39'3T65XS?":X37#ZQ/"*Y4J4F NB!?4
M$"FPY1A9R(W1RJH,K\V$U]UYX14A2*@G!7 %(2#6: =">0VP*Y16M#"</&F,
MX#J0V RO&5XSO&9X_2%XE=HI TE1%"1(0(Q)4CBD*2$0FYA0/2N(&XRQ\R*L
M+:A56$L $2L E=(!C00!PDK,H18&4I05Q-GQXXE\]SI*=[KI8#^M]\>-4>8_
MKRD_3TV>FB>=FNP!<CMB^=%9YTY32'/@SM)0XN=S-1BHWK#5K6GIQ;.Q_3][
M(H^[,3/KG:X#&U]XPEA1Z%1_25'BE&<"!@)#B$ _II%[$T;Q70T[W]T,!Y%%
M@_OZCKPQ</?PFR7:6>PAD 6$@!))@=1>@2 4%,9Q2GR!FZM^6Y-<'%DYEY5S
M&:4S2C\-2G.&G-(&<RD)-9Y)" 75%"O."))69)1N $I?S*&T-P(9X12P*.;2
MHIP#[;D#@@LM4>$PY TNB9A1.J-T1NF,TAFE[X#2L9HD@\XAR L:\%AA%; 9
M::Z8++ @#V!^RU#]H/XL%50S1BU5Q@)D UY3'3Y)Z@@P!''JJ5 &15M;L0EE
M\XI)9J3.2)V1.B-U1NH[('4@ZD(SI;VUBEJB!!3,8L21EASQV\K3&:F?SBNF
M0FIN"^V5QH!B70#JC0.*(PJD"+L$N<*B@F2D?O(LU/5,[XY.0UOFQ6>E1GAY
M]ILQ@NVRI0)!&E.6J2UYLS4\<JW!M9;GLG7N!J[5"60Q]*1[$6XW<4O:EAJV
MO.H,6M]C.OV6ZMGJSG*DCYT9MH;]<.NI4S'%_JGK#>/]3IFCEE9=U3/AQB/G
MPFY60[?5:FWW+EKF2/4.8U-S[XV='[ARU!VV^CY]GGWI>;@>>W38"S-BJ[M-
M__2LWXM7PP/],,1!>&?XT;5^<7^?N5[I_K'9ZH6V0TMQ LIAZ$-\6YD>.',#
M%8]^F<847S9P1^&I-'7]L@R]W0]/_1$NJ-Y%TL7QW\H;IG$ZZ:G+IJO*LN,[
MH<OGG>%1Z$B=Z"SV(/9I9@:..J%# W-T$1I^^7MQV!HGUZVHQ#C#[N;BL.N)
MN-.T6C=T@]/0JFWIB]:H#*0Q+&)8T@3M9X',Q%].^S9,==B?83_W35C[U- P
MYLAJI21@X<;2U=T(M\6KW]6@TQ^5K7+BJSI>N.&*O6#464SQ'*9^,#+#L%?K
M/?.#P].J#",+(PG+?)0>=^4PL!'#\.ORJY<ZU3\][<?MT#<G\9[_OH[U^9<;
M?#I2L3C&/ N$*?486EM@1UU@A@SDJ"@\BO4ZC;G"\+^S^VZ1T4DO_U=8D&GY
M#?A"N9NO_SZ"YO2OGOHB1WNG;\G>^P\77X_-^<'QT<GN\0>ZBS]V#HY_/VGO
M?\ '^Y__;N^?L/;[S^>!4_F[_>;#-\-TF"IG@%9< "H\!PHK H@DC')?:.I@
M8$_0%I9+W$DD>&$I5Q^I1+_"NL9=D2A:M?/#,>F4)A""847$PX8>1&+9.3WK
M1H)49Z$)1#!N\J-.(-EAK::;;TRI.KVST;!<(DJQBW'/='I5HW-DZJQ?=N*/
MKP:NF\!H6D?A?WZK*06OB=>JQY0N^]W1T/U6$SHX^_S\,\NI_1I)$%%<U;GY
MF_GW:##E- \=T .G3H#R83"O5/=<790;O\Z-N7ZUC&U?.3$KBVE4/="#7U_?
M$F+D0R",]W>84'R;"4VK;B.+DC;?JT#4 N<3;XN]52^EJZVC0:2W_]5APA/)
MG2BLMT%RH<H0+0K)C"6!R@KWC6^\WD_P$<C 'Y%4!S;F_WY5KU=MJH6369%;
M1* LH'*.!>*N$10T"D3,2R@@++"=B,@UH[Y@8S;.2N\Y)113I*PTD&*G,#'<
M4H'YMS>Q<!-$$(%I!:=Y*)B49*H2!6[W[(SLVZYX/;O7^QB1=Q#P.]RPV^\-
MQE]_5V6G_&M,XO:=.>IU_C-R99J5_=#1WP/(G_Q\V$+V]C]\HQX)JK0&R,A8
MCQD&T1=[ C0ID$>&(L'I1N B L,22>9@Y*ZC%0UF*X,8')<_2B@5)YF@;L+[
M5%@5N"W?#;))$A3*T>E9Q>8/CP(*UJAWIJ(0WCFK))_^J&L#&YEDDC'W&%_>
MZ47.+@D@X8J:0&@0'3I]VQH&WJVLF:J(P4'ZZ(Z"R/3J2MJZ#%:-+7DDY98@
M\GX5CP3<0@(_2L4CMB60N/W#*US1?X*B&#_F=_^S57YY@J(O><^LP9YYH@)!
MZQ5V^'C:Y_W.:5+;= ,;V+%1=_++A5.#\A^W6*,'FL3[Y9*_?635L\_Q=2(!
M%4YPPGEA'*-><^&4*)PK:"&L#?+"K(YHQC 6.F1>V=$@KM6BB/"EUD4'UO]C
M'%FY%[BY86"MPLSLN\'I"^7NQX5;#RX/+MO';^GNEP/:?O,!'NQ_B-P[VMU_
MBP^./X1G=\C!EX_=W8M%N]B[X]WC]D5[_Q!]/3X\WWWS\6CWC6&[;SZ'=KYV
M=M\$R>#8'GU]_YG\^W)GXFS:WOY&81#23(& 1,P &B0S$"ON N^$X$%Z4TX5
M&Z_A%N-+=IJ72>G6,6;P[=]GE33SO1^U::O" U>XQSS0]/T(<#?=]M\;11YP
M0?>-#!:26D=8H&78*%V$S]00[UF0HS5>K?LF=Z%E[:EE:R=*K!/=.,"9Q-V"
MQ+5G21PCC$FA$6#6"$ 5,D!A:H"$7CJNO==4;;PN\-9R*HS_>6ZK?S/IS:T+
M"341 -:1U7TS->0851ZU?+=_G@PWCP4#=V1UUQ$&.)7$(:UHX&RCOEQKJQE#
M!9%:RN(J+[ , T\( Q]F80 SZ*Q1'!3$6A!6S  !&0-6"XL\DE9A%<UP6_ I
M8&#Y &48R'+ C^8.Z90GP ]<-$P$8NS*X:."0)8%.H4/I*,HA, N@ "T MJ"
M"8,]QQ(:?H4?3 :!)P2!S[,@P(6#A%@%8,$@H&&I@'0& 4H(YI0*AE0  ;Q5
M9%'@)\" =10%VLE^/?86''MX96'@D84!0AASAFF)$$4R  +SE'!.'$%$P&(U
M#N", T^' P>S.$"X<\K+( QX'JB_%AK(" O8.590+P4541B@611H(@SD^)%G
M&4'R7._T5/?._NME'9]11VPD]^'X5 SZ6'!3_]]R'&/2.AOI;L>$Z]Y%![_H
M8K5]-NATHU.SW&K=OSM7N=.OCCR8=FS.<UX-JW"!:&4.=W:&5W:\[FJ_V^V?
M)\^QU*^S0?][Q[HJK"5TTH0.5>Z8=;O:A5W1JT(7;,LE$!@'S93+G;OUD%4*
MSCD-NRZ%RF@7E86_I B&_BAL$%O^XVH'M97N:$_D%WJ].VCR__S<Z^NPO;_'
M:4@H^7%N:G]N-]"=;[; 2F.-@$94!?''.B"U9( 153CDL,90++F!-L'9$,%
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M]WT)?0I];>]OTW!/IWW\[J@=VFY?&M;&!^<'E]W.[OL#]._+';K[X9O&0L/
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ME#?.X .Y CW=A-TZP];/OOT?)8#K"5%5=7IEL\[#@X3=K/M)>7"^(9^A>^^
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M!8P!FW03RJ<H)/8X1ZTI5.D&<2ZC:D;5C*H956^+JMD<UP \71!)%>5!)B5
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M:\/%&$&,MTXX93"EF"NFHZ^5$@AS*Q#/7$QCN9C+12Z&6RBA8!102QB@SA5
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M-L=+/^M;<CW!:FX.@9@BH-]+20#"(>Y,1U:E U!EG6&@7(SN;UTY]&7P6].
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M7)[]C',6CCN?X',+&]!['?-X 2!RM7B\S+DO[+)H1DAAEX=EEY-S[")B ,U
M4F2#C8B+P)'&WB+,J39*>VJYSOGNM*2%75Z^K?&B]WKZO10'&41LNP%/_-[R
MES=Y'HH/7GF^E)^W-J[T/'V<F;KWL7B@?M6TR!ZH*(UWT2*A6<[XASFR!BB
M41M\<,:R$)=6I7X*V']5"5-*^J?%@[.G\[$7I'M8-3?765%>8Y@I%"D!I!.6
M(<<Q049HH97$7/)<DWH9DZ?(LO&JL&X>5=R7Z$[?.HKYP%)WK]'.)5W/SC:<
M%'?'7*NW9_-65>*=G+(Y*:#_,Z#_::K>;N_\V (5UR0:3>0H.:$03YP@&U)
M.M)$?,!"*I'+=Q>_>?&;%[]Y\9L_W#K1E-#?"XB\.-WQ);M'^[T3VQZ>3,+?
MBV-TKC7'\:Q]KB:MQ.3]NLJXMFLQ80'SA&Q5^DEXD^M>"T1XL 9C$1W62ZM<
M/476LU?E)2@>T<7#L0<L_E1P["%P;":VF&H"2"81P!9'7,$/E[1%#E.L8F"
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MD?#T24_'X-J/;>@Q4'?K1SWV=8/ZDV&8:6W\WQ&TX5J( B2!(;J 4DI9BV/
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MB28@5Y\$TC W\$/P1*CFP+=U6.IUY'HSNLVXF%Z"%^[/43?F-6'N[(!3=W'
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M![HY.!2;Z^_HSO:F^+;=;NT<_'FX<]#L -V )K*W*P6HAE+S7%I%(LZY0\;
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M[6&E4\&-,\T!I>P*:S"WR_K_';4&K>$XC68SCOJ]MSU0\\_TMRO*U@.I]AI
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M W .:ZT_WO6H5D9[DD<'1F;^;3A9A.<+;@1,V:N=;S*"I?&-KK_2* /OPC4
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M0BUK_1J-L)][C=:+*4KT:(DM*JQ66.V&9J,CGBMT]F ZFVXP>JE<2L8B2K%
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MELB/%\2 M_,DU&&1/ZN3^"E$57?5\&;C\W'Z88GBF!/0FXGB2"I8SS!%PE,
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MJ[A3,N;P9;)"S7,%2@2G%2?!:PS_"D^L-SY9FZO6NZ2]+$);A/86H=W_N&.
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MDUJKGY=6YHA\-//$*%#NB4I H=2$J!S1TF& 50PZ?6-\#I!9MMIDM$9CJJW
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M$2APRB9/]3F[;D!Y:'R-/R(8H?"8H9H(8K1<KNYX6#W'RA43K8YFV%J%G.L
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MO/N::)ZMG337U\A.Y)H1K",RFGO$110Y<)PC$IU)E$A!,5]:%2O3,(J)@=Q
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M]EOATD7X,_?*F)1A'#]]__JHC=F;7X:";RM_K30V<R.#8QBI-D!C__BP6I<
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MG,IA&1_Y&<]G>! )%VN"X49@>(*J=)95G5'%8D?LO,- *-<?V$\U$NHHS^&
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M;2Y>1_]/ U H(H=Y=NP[$6@5+(A]L+3#P#'3R.=WH/\#'WQ-A]S5/Y1[M6<
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M:/N7O>C[]*7B;;+6-D0J/G_8,&@%\("?KB$?A6C\L]OA0HG'M<2C,1\.96[
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M:J!%K,IBZC:59-C)<YW>'^K>Z';*S2>01W2IW%S1V/V6D5.K(S[[,G*?E3E
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M4; ) !*&@_7A\MAH5)S3&8\NR#-6X9L D!-6TJH:.+:TMZ,=S<K.)@BW3G)
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M*+/ 9MH SJ)M=R^H8JF ^W4"[K8*N*N NPJX_ZH!]V.*CR/S;NV-E:X"L(%
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M>LFRY'.P[()0S$%Q P0#)2WA):]S](A1*AZH(+-L*JB,3T8L%BHY=;YHKF?
MZ_ H%]F9(A-@&9!%\ LKWF& /==R?K[&@5:R^,3<TTZ3&TQ N%C6L)C2#M4U
MLL=?X/(;'KOB'KT(^9%1UCI,.ZIMD<K>)L2WZU>6D-B\;CH?TP!>B^$V)(*Z
M^4:GZ"+U]9XO0P/DLZ+2YI]_?E#7S1Y_@<LQZV/C?J=$.9FU#+]22&FN_?FU
MT:1[B4C>K44_ F:@MP(2LYJE?E4GCW&Q%-'%O%+8\_@+7(X]'THL>U0SFGFI
M! ^+<MH+M**P$Q).*"H+">\"5[#XQ$4',Q0&//X"EV/ 09%CP6&1IUR*7.><
M^K?)&QYXU:$E=H$2),=: J]?K@-\1<P31?>;L<"KI 8>>IE5W[NB NEVIDYO
M Q:X_/3V:\<IU?FI@^NM?3W,RC9Q&#V1E$)V?>'?I^8F=D#UOB=3*>TQ4"B-
MM,[WM19 ^2W86:.2SEE06,M<X=8&+'"%/)!7Q3N84N<GW0R!6KY":>^J"L'C
M+_!*36!9+<MU(GG((5I=89U+!2I]9S%]QU7I.RI]1Z7O_*I5!78Q=X(L<9%\
MD>OBMZIN94,Y\1%OLSOPCEER1NQ:U@Z]5M2-)<6$2GQJYR7=G:S3159GBPCG
M(4:WSE@V$G@G' #G/ +6O)6Y\]<-%;_NNFZ?;L1XOB[LTM!:6^BV%S5><;&"
M8F'_]S],SW@Q]^'R(/+*89:NK5=W=WF0>#Z>*6,WBU>=NC$[BB[UR[9W8W:]
M^$XO<WI%B*T96\;95F2YT%T$J8T5^8JE/G_U&[4E6#%($T)2H:-M4\MWY1WO
M3J*]K!TMHTC=A"<F?7 %75G-SL@M,.)G\N+ 7+!)D.@EY?/QN4C17^Q8H4SX
MQU_@M3!FS+X+SPP5F<X3&4Y<63]7F'ZR9']]^^BZ&%2SO:7A3E0O%(IM(XI]
MO%O,:JHQ=-%#N8LV9('+4> (^S5RWLBC!*D<W8%U5*%IL8M.!21K3)QYHE6Y
MKQ*BU-QUTG1,!6(8SD3KZ H>DU''OL]QQWERNHI;RL004.N(^5-9>KQZW[^6
M)Y@RWA] Y1=#M;RD/CND7K9J@\B7POG:3BOOFJ/LF3X?9$+4I9HZM:^ENE+X
M)OP[N,1 H"O]6-T.2\@#R.9?H_OS3%Z*Q?)[8!!G=&N7Y6QT\;-&P=YG )"3
MDHUK./5$$VE3DY+JUX"ZQ$>BL]!\915Y8Q+SM-Y0&R^&-S<H*XR2"D4%+6S:
M@>W&\A.Z>"EAE;&ZORXUJ1Y-L.<O'Q63)2L=9J,"\PZQ$3#5)1=U#TZHR3O\
M..&\KN22B5 \ BN=8Z"XW'@(5/1=].>3I1@H#L.JH7#<"B+M?28!4.-;YQ9&
M@W15I]!,&V9J$@/KN]UCD0#97/G<N9T;8E6I!N6-@$4>]J]!++M"_82=%)>D
M_[:^@%6Y[=>]03(WV26.B^N.?'S=;_Y+F?3;ISJ1$I"E%S+.VO2NZ;5HE;4=
MKFQ$]^(N"[NK<[[+<VXT.+)^5UI#=-N6:N74675U7ZBDW^JFU[Z+B0(BO--:
ME<9N7'WM332%(ANPP%4H<J>&=#>)2W3;(7T2%'14<Q4>;, "E^.!M 4HL7(V
M25KQOR8/65YW!6SQ.)N,ZLHK,E-,E)]4N/#X"UR."T7K6:&"3V=L-.LY7%?T
MPVX9_KW:._^1TO\>H#P27B2+I]=7T<DK@-;D$EN2+@N*VHB9=(YT+LS5U:[I
M.C< N;WLN/MI;_>ON2ID1W3?5)BMXIKZI*GE7\\GC^QZZZ]K-ZVT9U4]I.LD
M5'DJH4HE5*F$JJ=6#VEE6HY(5'U5)ZJ^[B2J[E.BZI-S?ZWE5ETG@U>4!46!
M*/S*G6H\C9]WKAI/QS_<O?U?5)W01..C&O&Y).'F0I',45MGD9=X>JD>Y_GY
M3I6-OI<%2\8\V0&Y.E]V4]Y=XE2#ELJ=]&ILXB*:2K_G+#N3'IAL6O52AP;S
ML_=K='8OSLTI&N(.G;@M+^^Q=P>6KD""9]71_)I=)DF)P,EDS2D1\M<^B@M[
M\/Z;HAQKIJ'_3WO5ONTS0VF"U!&=DJ%DS]C+AQ$I5!0I$JHHM3]EPL:D@AI#
MH(*3X7IN]TTCJQ6LY,^FM3;N]\^L;K&$YX;];<9YV_CI@$VQPM:39"W7;F-$
M-P)9EE<+79*H6[DL"-WI6-6O/8PL8ESD?(K5#A(V!M6LH<UT-@+2F=8T-L$8
MWE16OVO:.<$_0$*OL4'#OV>4KS>8FT+V7Z=$6N%\HZ =+JHNHZO) %BOF];2
MI=6MTE%]%.ZX- .FE=$[,W+*=WUW ]D^H ,"&$'YZQ]_@:L2JKI'N[2Z.)PR
MX3%(2#:"'U<BD,II>OP%KCYEANX&.+1Q)CRG0FZ*TLPIHTMPTH60Y6?%Z(RB
M;?(&)-YX K5"JBO41.Y[+GJ+GV7%J/'@ &]22/#X"UR.!'_G<#P@8K0)NVBR
MPRE"!Q*P$KWAY1NB\1OHK[,2-#AJ<H%==T KF,A"+5+ZR?((GV04Q_2=FHTT
M\NHMSWD)"/2Z(T+_!#R!(54&W.,O<#7#Z#2E$K>L12Y*K\44L/WLC+0GK/1:
M8E&=1N6H4XJV,4/E]B9I?@/-DI(-EWT545O/@6PL5I.>5#NQ#T3)6XL,J^Y*
M!?YB2>.+VG"E2IPD^*D4Y_55T)7:<R2;D&+EY:5++:)1=D*ODC=;7.]"CS@U
M'0.88(X53=GIJXC_)U,/.Y?")+=!HWN$IF^WGP<34B\3]AS=]N>)J%.5)W)K
M%>HRV/X*:X>B&5C-ROHZ2L2';)36(\G)!\V*!HW;H.UP RJSK*N&G[0Z,"NS
MJNZ7B!F2;?^>NNM;)CNX-?U\1,V#$9K"\$5=Y1"['U _&)KO'/LT"BU?'E/O
M\*G0G9A&Y#S.G6!=(YL<N>3GER7N8GFE N^[S[CHRS#%O9,]S4Y*WC;N6(%K
M@U5IG/.9=?T+1-'%BC 0+A>5E.5]RD2EVL[")-XU75JZYFQ:=]CC20_KA'\'
MH !&T$G3<4GT$P8+N"AS?M&TM$O)6U1WWL&N=>C3H1U6?#J51:]AJ!DNIX?3
MW3K8W1P9RO%<CK)4&KLJ4E8BO)9MJ,8U,L@DMBTMC8LU!3$'=1YM+JM*+8O@
MC"C94J9S@&Y0S>3E&R+! C"VH#<:N[CM/8:8VB:34G<-Z@\ERZ&NZGOZ:?_U
M0%0VG-\S.LI.T R?UA4:* 9,?;#@4$M1'%2.VM^^Y*,";4J."Q\ K#BZ@&*.
M1K*@C5X+$W%<Q-KFBY?/+ZV#ADAK.4='$MK+2#O3*6:,U@5&8 .=U*@:M O)
M,/5AR-XER%C'6'D$/U^K 6/+B1H.]_3$\C%Y7EJW5MIEP$O.J7.,-^UI?97(
M)DI#CRR,#K)ASM^"2E6$EPI$#W+\8(9WHR5>KY;=1/$]LSTK^WZ9"^%F%1WD
M"&& ^\QB+MU3WP&UAX7HB$PZ',53L4XL"F:!Q%<M CC\&4?Z(M\H*CRQZ/N(
M_<U$A@YH$P.P'.&,FHX\LZJY.3#7E>?-K$1Z'%#!].9)XX8 JQ1@*UL)$/L"
M!H+9!-B0E?JK"S[6:R0E= XP>*3ONQ)63Y=#HYM?^+KN@B)6!#VU+/E_SZZ.
M5GG.,Q7W7BON[:NXMXI[J[CW+Q+W?C?E8\TT=SH7MKK7M+8]%O=I-J;BU[VK
M9X2I3U!'RZJFE&\WF 8:S3G:?*.B^"[3U.K2NR)P7W:JL].U,GD1BZY>#IJ:
M%:SN7$UF;*>N=*];>J]DO^A-N?1"W0[:"S.J&;KLNEWCU*",/*'K@2I2PH]X
M6Y3";J3EM;4U*&&9.J[75_:P12R>?[:6B_"!4A1_UL93[[ADT?NF[0,<4$G*
M*RSQ'(SS3EOPN6X/TA![?_3JDS#!I"L(HQ!]SQ5=\ $=L$<,>RW&X%GNXE7(
M*L/FSG&CA@M7QJA1!+O]1ZD ?\Q&O>+-ES706+ZS[&GDGQZ3N3X:B0B.Z O0
M..JZF1 MD2  I\5TGA+0#FF*-Y5H!I6R:--H5+NRLL;[AZ8Y*SMN'IG%36U"
M5MTOGIX7TA<S!O5=&\)&1IU;G;W6M8U]=#XL ,-*+A:'UE6U[+5DUA2(OH"5
MP3MDR.V!Q4Y=*&QSH%F&&=)BX(> "M',N6UH'DJ$!4-PZ6H02OUA+D<BH6>>
MSBJ\236'1IY (W%H?3%'+GPVFQ;U)R4=.OTEHJ[FB&8C-JGX'_4/+SH3XO<O
MNEB,Z(0^U1&[^"/+"9%HWE9-WC&DJCPMX?^3>D'R^8YX]OLT6?+0W_%-\Y+G
MEWUL[%SRI;'C.)<^ONFL]HYI!5NU8G?'M:TM6['A;AM6A%:X52OV=IS0WJH5
M!SN^[6_9BHW0V[(5.^9VK=C?,>UU^?'O)*"$D +9A]+W_SVSG[6>(A$%GQ:3
M/ZS)CR8J+H4N_FFELC8O0<_07PRZIOR;&&(NSM[):!!"VES4#EN]SEMB1EZA
M%/8UR#5MOV<O#T&%(2WE0Z.9?9!NQ$9ED;!> L4' =$E\]_1*4H'WS:?XQ?0
M9M6!;=&!?6(C5EZ0Y_CY__GMUSFZ6R]Q<X(7RY"E9WP;LBUR/KLBE7[C]]!!
MT6HV>9BE@9Z]SN+F< G0$]=KXGIGD\8/_N3IZBFP1$I"W46O<*48X]-GC$>4
MS%4?N&*0#\H@K5^-0?YZ]'58Y/J^J(G85KND I=KQ5*W8Y-;1WCVKT9X3T S
M04KZJ\G:W,/;QF5;#55$QO99B76I?D'-Y0D<,/:I.:*88X\UJJ/<OJ,\QJ#U
MTI.[#Y=P''.^]BG+F"Q. ,#2JF*4)5J]P5M!EVYQ/0Q\]TO8F/9^1_M8G'1K
M!%R'-JX%M<>AC<4E7DH;#WBTSKT=+:8L;-IY;BAQ;L1Y_9_YP[I;8-%YW 9:
MXD!%4.[QH>58YL#T?-&J:RL@MS&(MAQFBC4HUO T6(/G#%S#4)Q!<0;%&38#
MP3>%,]!M1.N%8@V*-2C6L!D(OBFLP1KXMC,P74<Q!\4<%'/8# 3?%.;@N.'
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M?I+]46[,)9QHHAO41K7AN3.!\B$&;=?Y6\_Y+;H 1'>=G[,E8-L?/><'L"]
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M*^ LX3^IL_)2X?BA,YXYXG\S+W"VL)@-O,O;PI;3Q'62;/$OL20D6<(U/\P
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MX"L;G_QH0$5 _' 3>@'!Q+WT(^ (QMOA6S4KB&/\27Y5 .=9%1>M_"1)3M:
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MPK7D#G0F@$HL+,H@CI;+C$1)LTJ&CK,FK-!AD@.TL<,0;-8;C;[+,0J#0-U
MJP8HY=!K@@J'_&+A;Q=P%$+Q")#C6S_;4H0&=T?A*U1T=LY&> $LW@^3C)%-
MQJYY>POE3S%3(*0X>/?QA]_.E2!8E^5'F7<;P@@,@95TG.= K3D._4B9$B3
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MPCHD'9HD2'3FRLYL,K1N).N;4OR:=K45::W!+CT),N&!.)?BN+?IE[ 0>5$
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MW6B(O !C@',7.I ;?X.%>[_L^!I#\*8<EL):VI8CWRNFOX<W9KZ?-V:;;T1
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M[DM SXZ5Q)0K8I0#CF/]B>KY*2?[^?_VM'\+N!D]M$+M30?(11C R0G32;@
M[%VC;H;H'J&/" /K^M<\BZM>U-9)(CGG'"%L9IR0]DN%)&9_+R]5,GTE I#
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MX%GCA@%V<&3\B_P)V-;:3^5/\K<$]'C>[]=3&AD&-^',:!-C\7+IJA]>2D3
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MRCX2]#3N6(/D.R@=HJK!/"2(W >!D?O<0%(;E4DD,JQ=I_Y1DBA-X 0<EI9
MKO,M=,H$*.0^5Q?#KM:>[+G3O'9#[T0Q<<F3 *A571$$%#LW6):K%2/\>T5K
MDK3RZ@I-#UJ47'1U:]2<DBJA644KC".-"O^DU&!2XZYD2BO[]([.?OC8;"D
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M8J:Q7!*FI:GVL?G7#TD18I 47NIB14"$K0B7YD":@J**\")I*[&_*<$BD0S
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M FP>V/"2#2\]A: ^#U>QN'(^]YSWWJ7?,8OZS%K476-LP]','8UL-,G:T\>
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MGBZ^5$![V /E@.U;_&.00!.^WS;'7KV[\;EG*F.8UI..K"+!S"<1)IQ>\RF
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M1[ 35\^?4./7X-)G$?J R5HGN_E#V/5&ZABZ3;H>74'[ G,LI-E9.!>KH/S
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M3$B[M-+Q8N\:9=?DT_H[]H\I_ Z'W_(F4T<DKT%9V2Y($UXUC0:.;:%/ V4
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M)"+?N_#8;\('QEY'TXEH X8]&"/\2.-KZ)5A<C98+ "5S+.!.HJWI/ &;*T
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M WR7*^!9C&5YCVX<5YP 2\+/N*S]1PESP,E9#F"6==Y4>72X8R+1< I'[ D
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MGD$PF>AFO+5FL_+)".!:RYUO#\1V#[4!;3)[^+<W.6""^::ZJ. J%!.FMS1
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MR7U7&IHI.++X])>Q[>=[^'SJVP[3^_)I4W8.7_#1B_QP_(PWJ!?TBC<*1XE
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M/H$XJ=7;X8]ISH -V;#@LMXW6XWEFJZ("H81@ "+1P'  HE2SETW E1Q*Z:
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M :9F&5=H+:^$Z(CP;]U'N+2C2_CW@,*NL-4D%%RBSE##J&&$@HM'P;?> +K
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MOUP4+<?3'%+/[)/4NDLI2/^[ ^ROQV_R$L]F%)JOKH2_&>.A[OH27"&>_G*
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M9IJ]-REM[K+P'$Y3L)RHK#SY+:1%UUM.GH2':[%Q;^03 3G2OP@6$&]Y,)Y
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MSS*-L#'?@PU\]^KC(.H-)05ON"5@)L@$QCY0?'D''GL8J031]P4=!KZN1/@
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M>=MAA\6#GWQ],9XLYN-/\!XP9%X>;__6S2_.V"&-I\^OY70]F(_'5VEEQ$_
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M5O1#H"K4W;W<VM[F:>B-4$92^Z2!"^(TU2@<DXD+#L/C)(7VPAN36U7BK3*
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M&OP4>,*(#7+9O#,8=UDHUW2YDAI"##'1G6WLH]T.:6&MQHZ-5KBN%NHONQM
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M[ YU2)'PL$BWES*?*!1^N^CC&8[G39B,3Y?]-,ZMWJ+#MJ'NKB,^..OZ'22
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M^BQRR%J9U*2?RP.83H\I?2F@05^#5^/NSCU5 ;^M(<;/=.C=)&<$B"&)S%+
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MU<O08U0Z=9W%N[^6[_Y<7E\V[AW>.:^(%EM5D[<LO19+DEJ =B*!45$#1I]
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M'GA9^>8C-8$7[W];7E[^S-)_YN6TW;#?.3471ALDVU@WJV9/G5VL4)5BP^>
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M'1@P=HCU[D^\^N?R^J*\_O 1\]7?:J7<0A+^R(:J0'GE H<1KFB6VF!A%*L
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M<"SC=&.JT!5LM")%$:LJ78I,3H26)S*)3P.6,3;H[BA8DI)C6%XQ!4MDG%6
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M6!^>$S1GMQ<,COBFSM'[A&[=6Y"*#47Y&R4_?_"8M=QSTOV08MSBKHZ(YAN
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MA?H+A77ZH3%6LL ,JM,^')&(PZ!Q6*?O29A_2,A5^(W/\H-OAG)R_EW ]$,
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M0JC9RR+A*@YPA"1"%1I2C@H*]I(JR@A5265E616D UP5:2^C^"/]?AS<G3P
MR.E7YP("!X?R^*DY-54%>U5'946H=LJ.4)WD%."2]HKR2$FX@Z*2K(*,BJ*"
M$O)';JOSVQ[]>Z[D6B&@''455!2U=>7U9%3E9)149&55%?8IZVC+:LO**NU7
MUI:#:O2K3(H!#JD'4HS\[_Q?IKV&$,%,?Y^@H:Z.DJRJDI*DG)0L><:L5L,
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M@GL];R7BQ2%N$;U8;S8ZE*-K68MIBHJ=>WOJ^_7LSSNG*G"N<[LK"S=U+L8
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M;P->AP7"NM=4+D.7/X&\XDNXL[\3@ZRGS8(X0<+Y-TE%U9&@^S\6*[O7*+9
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MZA: M)[RNP6@MN1.#+_;IK*E/3X9+_211+!WA/)UW@*ZE74]N) JM"5""W:
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MBY'K4-!H=]-,QP0.HRF9BG:FZ#R9[-$8>]V4EM;6])UJUK%^25?ET>Y^-[@
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MM+T8[E\MC1#'MQO*;#PRR6=%Z@.U114"3]_Q?HX9/GHH.X,]3;HK(6%N%<!
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M_E<@D#'FE81=K#Z3&C]2[V8=/IQEAJ3;910OTM#0&!Q\ZW+.:D\3B7%8W2
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ML^*]X>1!:<O/JJG2O0[<0==$7$[#*'\M&=]C 93,52VM@ML)B'2\(@S31::
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M_3%MYX'5!9"H5W#\K!NI&^U:E@*2MO,VA@[\'IFA.51P=;1WF1ED<'TF$N,
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MI'M645"]!1ZE N>?1>2A?1F(<*2*R_U2 SN&GP K?- $3ZJ3!>D]!1J1@:0
M>+QJ^._7]<ER$Z'K"JD'H&,"VZHW#IY7>AR;VB8Y*!3K5V\5$33@S?V$\#C&
MOG_2<_EI_^>+GW9//\<1P"]<8;0C"+H9U($_X5@V. V\L=:3,]58.E\M0UA1
MI+^\R'E *3A^>HAK7%<$^91*;OLH#()"/3,M6I\G,D=A+"QF="Q6WNK\U@$
MGM.RJODU9R7)[&IUH#M=4;-I/XZV)YZ 8O%U42V*S+8<A=UD"UEL??,$PG/P
M6'O!SI 8."DM$9KVD%EGPD]8=F"D>JACF>@IB[&5%5Z^EDB@ME*]]BEZYB^
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MQZ-SQD8J.<\,W4M->?BBVEL!%K''K.T)#) [1*"VT.)/_2<#;\^WY6X>]&]
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M0]"7<O%KQZS/J3VV H678OQ /)H7\L'L]2N70^AMN>!1;V4"K#-+0:EUVZ_
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MMH2KU?Q!W(,A*)4*L;^; 1 >;>,-KELTZG\]TDD\<C'ZR4"CQ87\%)1UWV_
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MQU/_LUAG@!- Y;!U2+_KKAN<G2E;"30JQ#YSY?+:BHY[7>&BR(Y&,ZPKP\^
MVBZ$@>/#C'.1Z-J85]1E:^F<K:76@OC/$-A;G7/0&IOHP,P'QE^4PU]5](;
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M#U*X5="Z500_&2U-!6H9+RM^6*@!TD,9D/<"@I/45))3=1$?CXZ^OQQ^$.N
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M?Q>6@JLV?\;14*\7?L.,A5WW/N3I_9Y,K5GCEF^(.D^<::R=>_'D09ZO".L
M[*SL;3=GLO'T3$!;:Y_NZ)MYP>W+4FMSN*$HX;ERM_9X4>U$ W]%?WTK*C>#
M2*6YH"FTR&FW,MB?#[Q_+>IG,27B(@5?,=L3*">QF@&./MUS#]LX%*E!R38G
M7OQ6OK/-)I37*'-*<K_Y?:_2_GP($N:, W=8%UE,8]"NG]Q3EO5I&XC,X%6[
MW25H6UA#6^F@1Z;]VDC&VJ^>>4PZTXAGG=P[&'N':1_YRG:+G#>%XD!JZ-5H
MBA"6^WTP<U;K562#EZ(N!U1>V0.B7MY.DB_Z0OI?/$P)U',\#A%1(84^1V8E
MH_UB[GM"*P[W+O>6-ZOX!R7, F,K1P#V8_$)^1E^:/OL60$&%%21H3\_242W
M#D0JSWB<)E5\+50IVKE\,E$IB])8.EWWN37]PH%-P+_)$TH?.ZL7U+CKWE%[
M\[R?F\K[7OH=5>S:=$_A%J<URIK,!@E%L!:)1$4_D5%8A!!F$Z0-_;^]T=#[
M&$\VA#RIB%R(:.2/REM+&,N"1) [GCLV0YSFVFNN7WYD0'3=DQ]?"/.=>&X2
M_]G(E<M:3:HT"7#3EH"W<I$M64P+5]&Z*1? L2;%!]/3DTDL>J2-LWA=<IA,
MGC@^=]62GI2/K1*SF'NF$:GG9QL]>OZ/ZU+:/'&JS$GCT4<(%!EXV9.R%S]W
MGJXL^753(EAG<P@E-<(>V#LH;(=$)4_E\M6:9L__H4B[\'TRR!E$/%4>"B:W
MNZ!V35D30UQ;3>J=_)[7@:H#OJC9.8:-OWX3JH%<L3L(V^>9I93]0V$39N_<
M26(U!0RMV$VY-'F_ZVT8'MKKI=%ICLO3D*2NW[[#7&II:_#EI%-%"2_>JWN.
M.]&OKI$U+^-^]^#(?5V'N9_J6*1</I^GXL66T(S\VZ?GW9^\GTSR907]/@<J
MN-GE>O@+_/3U+TP:/.37RV3@R-Z@' P^3/XE@QHNFCO OOHLARS=#4*YI;"G
M>8!QO[$]TF$7\87N'*4'-G%>X)RSXR/> 8?0C]D6*D_J<:7N1B;,+4M_*\IR
MNR'1Y96H'.8E)RI(>F39P[!B2/R/V]H2X-Y@T)G0'PIPC(12T?E;>\RXW[G%
M4 [UGAG^323IMA<(RA@RX'I:=:'?:9,^VK?<1BQ238A8S)$\#T+ $$SUTG$0
MLY[PAMAWM&#64?5JJ5L45#_RV#TQ\F]KQ53B,E5N5#@DDF,W3ZYKZ#D8NPW<
M=MH]X=Z]__272<-W?.>:UGP8=>.M[\OE$,!-*PN Y65O:$:%I!HZ6TV<T=!.
M#0,Q7VT=!C-/JFBTA-?*B,&5M]VG*+J2)8MB3)I?5)AOFQ#7 PG"?;5/U]2.
MWLV@'C9\^T,!\I\/!LLWQX*7.[BDBM"L<DTV_2$OU:2;R=RJK@W#9)FC^5YO
MBY8\E,&G$"$_#-V1(G6"+?+TSFOP%_/&?HXOM'''=R O4WVHN^$^LH^[QY12
M?5[!3-?6HMUS6SOM!KU=ZA+_KKJQ8Y]O7;7UTBUL@P=/;N"[VX80HQ+L_-!C
M&NMTC7#GT+CD=M!L0+)=4X[IESF+P-8M#_ZK7)+XSUFG1P^9:3MVD"^LKNG/
MA2:3>X-PPT?=-K-"1,$P05W!VB\ST3=N".HP\,7M:MY$J*>T4,L7U,]K2#H^
M=S<UR^A\-N+BT5B)3UK&OWG@=[EI_QPF(I+K\&5:[J2.;7?$\9_B5.;NWAJ;
M9N&H-:3T>:9O51OTM E6F+! #\R]<;F155:< 0)0.=C](LE_J>#?D&Q;S?#C
MW+3:(P=$AB57 5BT:===.A%$>X#*D[E63'!R84N>*M34YTQ',$><+PYA99>F
M-KQW;&A^NFNHGM(&2-,JFYIW=GQ&]0E@&8T_L4D$-?:S6DJ**Y4=BY^J(Y!C
MF,'VK].@P/QIX7TTE50'%+#,-^8@XX:+2U/<K@-G3C,*=^^MC6Y<;MC.$'-J
M,KRN6%9_Y_*OBEA9BZVDC$R;C)_8QBHWR''15 /YN7VKU28U;N8_$$G!)HZK
M\M4P]M3T_+90S*:_#IW)7\$K)>WO$Q0L 3SY>WV_-]NVY09LH3H<X'1,'[:Y
MV@)>O_/MEHIQ2Q$8ESNTG(L01F.Y&KV098/4RMED9/Z'!OY!<8@0_%_5<)H3
M#9YXBJ/SL73A!>6W266N(=T,MB<]-1OA1H]'R'!K2; +$H6$043W"%]9?!QX
MPD DJ7<D14XMM@4I(^BHSQVQBI.M;G%+: X#.U\.55[IIN'##XPW7G[__$WR
M_E.NV2S-T6C,P9%1J<2Q';ZU.D/)TM5M0&9KP.:Q0$-&LM,B,<+Z)LU2?S!;
M\RYF*U>G*$A_3:-?W8.H9C^#Y<MYOEFG\"%<7I@D?5M\1LID=B'?L0J ?IY)
M1O%ZSJS*H!O;9WNEFN5ZR3T<BN/37-)8.O?D/Q3C'K5[PG7JD@ED:Y^5SL#1
MC[84V+1WY+(7_&PU&ZR=:=TY0QGZB4N9F=3J2\K%O!X/X"JR4H$MRZSQTA_!
M)THVU7Z=RH!N?=D7'C3LF-3&V/UF!2F#ZQ$7/4WM?@7;4S[%S&I>MC9?AE>F
MB3DZD9AT)^_1XYS.CTN*B%5)7^W?]7H@RM;.G%^\_]2B.@'41-(5ORD<&1_*
M7YXE^>N]'J"V\2&9NEC4T+\,2RKT6BD3@9-ILPP8&H+C78KWE[Z[-&UEV\:[
MN-N_%G/Q8G$;7>E[MIR0U0[=\B&+Q *]>E4=\OMQYW.V=2$NJQT<\OE7KH+[
M.ZF_."-P9U;?STSY<1FR,JB1^JT@!XZ5L$-T.TT8'[(Y;%;.(6QAU.#Z>Q79
MAB'?.]=%ENR.YERL;'%\JT#QN>C3WD1!3_<H:/3 ?SP;J?I?:9Q[MAB_SG@V
M>^9X8 :OS/GM5*%PN7ZGSP*H\\VS$DKCB8@<FKH=<E$KG5V=\9@_[&+6_K4-
M?MLO<V5&ID^Y[N$IV-:J!+61C%/Q@$.!11)"N!SP%5S-W^5WEBRT2XQ.A<HR
MDO,)J^A^V?<P@R'I9,<@-7_*RSO*8OYRWCI5"A%0I_4'52;<TV?"X'*)2%!>
MO;?M@-8P]O*FQ]H\PHR75MR^*:92I'.*#R5C,1)I8N]<_U(9Y=39!&3H=A.G
M..*F__]SQY_&*^&>I& 2JW*3B#,IYPZ3Q%UCB< '_GR9KG\HAH!6)-1VQ,\(
M(VDPODS:06DU\[(W>__-DM6Z1]P'7]R2Z"'L #-[+HHBYWDWEG!UN!)I7_!.
MZ =(:.L<U\6X/7&D.^O07K(D1*\'7(S/=2M!O;?FZBN03A>OC]&3[KE-ITHC
M=(PRE<R*(8_F#BH[Y)6)=FN-,IZ]Y4KAZT?E?I/RR_;FD:3E8IDAK2)*Q[E4
MT^=SY"+9U*Z]U#MZI99&0$TB,K.D^UT[[Y!8#Z'?LKDX1RZ;-+G7P]V8,O^T
MVQTOH6?_9-F=O.'"RYK>M<!3XPI]'!#=&6PI;1_78DSM_'[(2E;T\?6)Y5>T
M!1GE#ZPD.S-%^VOGHFTB)<U[/X(3M2B\<??\:KID&:,W8$L*_N/KW9(Z7@<2
M)F?-AWO_N,)('QO&Y#Z@:IQ73E\SMI$#"S/Z,,%IY4=(,WCYV$)NNN\4R(#!
M?-4D GU4H7/,+#Z2,E0+JB4N8_F(X@NW\D@JUJL6>I(HG"E5QA'TS$1^SM+
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M/_Q2-6%U,#\$%RL\/U-6SG*<S9/X0\&[4:7# AUD**\5VC"43IKI=F6Y$R^
MN99A-K6(1-=$W..RRTF^!)]Y'V9_M5E_4#R;MV+>*QJ6,CS.&K1UE5DA97G9
M21-N7.Y9B']@(C%1Y>(ACT#E)F"0&;XEC^Y@_A?\'_]9[$ .90[?7LS)Q.2Q
MWCM,]0:J.!)<""OV\'"_\B52%*Z*GFL(.5!J#JHFPE/I^N(&RWV4,:N25R;]
M14+F<RJ2[*U6(7D<<[6;JT@R3Y!7PPQ,><8$PXP,B<X)\5*R6WFK W$MD!AL
M^6E(&%K<<A).Y^FC0P_=6$5_:?E#D<Q6+5KQ6"YY4I;EREO_^PE8!_R3H]>N
M(2[GEF7%,<3SA*@4%.<]&M\8OB31&%!XB@[=EO^Q;SED %C]6PL_YKK^3MBO
MS%G)KH_EK27OZY_]/ 7'[+7(.6O$@W>_=IO1 <FF17$(19@IDU2$SJ,+O'I/
M3?M[CF&V-XYU.5)4V?&"-2PKRQ;'LA7+@\)9%"&)[OM9=T;@BP)PM]DFRQS.
MF&#H#&SAMSO;S/\^M#+99<V5R^!(D0\+592>6-HGA$LX3:_*= W,.H+3K/DV
M\*T)=-=U+_1+Y"A1TMGRC<(D1^1<,F?[#$FQ"5R#3*31:-,J3GLA/3F+;F]+
MW2+\)&US1:>)MY;6%2$4>$J#MH]>*">O+/[$R3EB >T2"T-3:[-/SA@:76Z-
M%HA;>MFE@N7C'4:-85IOQ3-E##-K7I7C2G_<V;RO3<\KD^E84/C&XFR>2I&"
MRUFX,R9.6KTI*'O?<S:E@057G 6^_E)E4B@>7"EJQWSG[?7C<J"$H;\0;KL)
M]1'Z@+!_S(!%J,P]=L]<K>^7I+:P:%.&5(IPX@([,S:RB@%I.=:N$(JJ; #'
MA0J]KC:X4VNCOQS%+3)L)WR5PGRH>XKY)!,@3)NY>DP[[%4$=EM5VJ_]*?\L
M^_TB#SP,2./CT7.3W228%G*<5DW8.T+V%A\M+E^@ 8.U:91M( ?*+,]O>VG7
M$[T'!7?E=DM>C;9=I,/6^R4E^CQR7?-MGF1)%45]6H@J+W[K'!>;LS5<HEE4
MNF],#SL+_I6?;72W?(J2BO%8X)N==R>>O*W-7?KS6DL05X/>(V"ZR5UK\DS^
M\Y*6;XU!9K!N-:]1<08E X%J/I-HC>LOGR4+6#-3B N\9QOGMR_]D+8Y3357
M&656:)QN J$4/[O_N93EYP>&-^/%R-FN)[\:J*P#-R?.O"'M:\BFX?BK'_LT
M&CJTXWY?--)_S0Q?B$C=AXJ95:5GMEG=VH':(.=2]_,4BO#'>;Y&W:8&#BC9
MFN%D>S+3Z150$[; >\WK&K60S^X_)U9MF>-XKR!"8R_96'(I1K4D'B2RL+(\
MW,\_YUS^&1=9QL&;+&?20#"6SL/FC:-9 \;_EO"F],YQIGZ9LR$-];E*QPQ-
MOV;G?CI2<+)8AUH?@QVO7-KF*UB=E[W/(>[X_6/6EV[Q<R<O7,>F33"ZTTQB
MR"7Q[/Q5UQC'M]ZG=TV9>NA:R$\ )L@E=^^ LI]3"URQI\BO ')H5$I+F71#
M9]3<[!==\Q8$1Z_/Z'11&\V.E83*D KC+4:<:6R\_?UB>_+OM%%0ZJT%/6)$
MT[U"GB9O=G?&$F;HV2L('F&4;"\)LGP[!1KV<I*"$RSVJ"S4A&"K=GQV-Z$:
M1&EJ_R@D/F.(7V*YE\$N23-'+,?IB;YBOW)!&8!>TZQIXH@0RFW(7:[ODVVV
MS'3/:DXEEO/&0R=.KYEEX^KGV/:H*2H^7>?^&,;3JM]UA/G%F:K'P\T?TF25
M,#'D6LVW:MF9-!GX*=K F'<A-W_HR$RZW#1W7'9MYQS#)$> BF.OYN"9%17Y
MT7(+X?POK@N[N*NQ7>.)B[M_&_ST!^4=%7M[B% ,3]&0MFY)CVE"ET^L6^=L
MC)M%PWO8PF4IX,T;-PJC:F^?;_?J \ZOVKHE])SR!H""YM#MSB8#X=?.'9A>
M N.]=*,27O<IP?H)GGZ]1YT9QT9M5PMG!H^3"[,ZFH:7.$X#AW;[W_$ZG2=\
M&';S1>@+FF\HL>=@K@-=21(:)^#=R]GQ5IE?*!-@ZVSMR.)><2(>_S9EL "B
MBX<9[M'.0MQ?T8B(1E(/3O=UFKN;E2-A_?)5V.2:!4Z5=%ET(YH=Z@X96=O-
M><UI<G+2U%11A1JKW7<?I?F]^".X2P_;'\!N.7=]WBT,"XSDF&,TGQ!K@CA%
M$0ZYS7NJQY 9:$'YP#$V$-I/!0)H=U0Z,HV[#XF"*2&F=L2GU!_I2BP,>[.=
MY9NM<HHM7:I62>K)ITEJ'=(B4$TQ*0#VRPG/!V*3B2PBA5-''%@4?<T\^YLA
M4S.790(A92X;B9/O)1\'L(_16.!:*R%31Q$UFVYPSMY;#9MPMX=;CUX\?_?R
MY<GWF8$3ZX1=\41MUI="GQ/8"N74.4%&VN2OI5$9PO0,W9%]>_#D%^Y\77/R
M&?:2S=N2;<O+^T4^,^&/ZM68\\%.RJ5"J"* DD,TW/8T]>5+0X)GY&53G=H/
MJ*F-D<BQ$8I\T[#$;RU"6ODW-V_5(L^<&DT^AD">?K48KWJ+FY^>CJ-=_=8;
M4*>='677L9MY!R/QU[NFQKCW.HK F.OQ;$]G\H0C,W[N!QV#F(9P/)]\13,<
MW^3'OC:^^[!H(8K\JAYRR]9M6OE[H96@6N4">>H-OQ(?328$=.Y4(?I_:$\0
M 9!P&<T"I_OY:=M?8]57>/5PEB#[)':BU;JJ-I4QY8CU%Q!:$IO8,*><JCN7
MGBOL5,(;;:))M8I-SSPIJ;!)E0^JW"<9J)U9#@2&-(S1.F"/[5Q2Q08^%@W.
M/*,/;]H#P?_5X>/9B?:U_0&3DJM0(O@'X)I:%*//TY4K'[34W?&)5&%95+EI
M=LTN-M;/0*R+@ZQH4N:N+:_T0[B*PO93JAK@YFUW6#^W^WDEFX[!>,X749=]
MN=@A5..7F\.@ZR-4,I;J=_ZM+(YT,XX"UH@?_JQW^\;QR4;<A!2-D[*#PJZ]
MQ[]R9YM>J/<6N,.KY^E=C!4ML?A#@>TI\1QC&YHK8@W=$]@($KZ1Z"?$^31J
MNEV' *>J/>)_+V)]'SJNM^+%:^LAF4[.[B$WC$8(X?K/.2!M1R"?%/VEZR_M
MXD^_'3 6>S%IE'D(%1LYE8]A%/K@@VR!@X+#+OPN1ZE(4Z']1QDL;/B/&8[F
MSR#OW1YZGZ0U<V_8UX@J-A/*FZ'-@N(]+,F/_T-'-N2_SM_XK(,S+TC/4W(L
M7K_N3HG7_O?T!P:><:E*,EA[N((+074HDSY%*4E[F<E&9V;DE$PYW% ;JA$>
MH;DS-7U<KR+>ZGW5Q%ET"7'64J#\O6JP@?CBB3&>RY9.L3M[3E/>6T6T]-H?
M;@$&3> R]E<&'S;?=QR0D&US"#VR>#O3_2CLP[0H%G,EW]3FO9E4>M56!9/0
MK2'-20X&*:ZYS-P^%@='IL>N(^H&;+F[$5Q# WM^V1XO(M*#( !>U*/#!NQ(
MEB-GHN-F?'&KV&BSZ]/?0;*.!*$8[36EO$'>?@F"FU^6\*80<P^\;]$VP_3?
M4TZ+4_;5II%'#1:WF!2ODCIGRSR%G4VX8"MB^C7&@RK;[I?KQOK_(U;T_[LD
M'8032M3C*06'MT$.MCRGUCZL>H,>0Y4W.)TORDH65.%@)W&V<KCJL.L<'4:V
MQ.^@QGD8>'O;+3TC2=FVHVM<R3YQWR0;G1J^VGZ6^O+D+U+G6H<*0*.A"S*@
MXQ?4Q763BI?-N)945=F&E5V/T3EE/?0#_;F5/Q1KK"'^DQ[DS! ?]M/>V0-N
MW<4FH8@T^KT1'@;4H#2@-A#S%W4(Y/QE70QY>=>U]"Q48V-8GWW?;)\E/6IF
M\AY3BF[.0<M22#1Z*'G77>HL5&9Q;5H&^R74-_I5N9$7]B>S<"_]=85O(Y$R
M#X]34F]E&&9-T!@)USPP67,!QYSYNQ/>D$=@*]*!;2!]"FJ;O]A8 R$F<;2Y
M)* P/MWBSJIR>%OZICWEKW#-8_EQ 3BKB2)*D@DGM?/I2EVT32@#$[_E (7+
M@6E=K,N_44.][TSTD@:]SHC2'LQ'..#.2\FCT]$['2>_W#KM)WKMFKFY*X9\
M[=N$$0057F0E=R,7TY4 8TG0M!- G24FS^ZS-SQJ=W/6ZAPGTNZ5N^QD+%CG
MH?GH<.<CRA4VP414!U3O33S]WUA[#Z>FVW!;%#\%5$!%I#<!:4)0>@=1Z4U!
M:N@=0H 0JE1!05!"[TVI4D(G@5"53D(-/71(D%Y"K^?;L^?.W-GGG#GGWMGO
M?_#^YO<\[UJSGF<MQP?M4%$GN&] :8WW&9IE*5;<?>.4&G.O4(E4RRXM+:-$
MRK_0S</EN7/$6J(%<P"=7Y]<8<2E#.]U#60_'@T;#JBZOY]@'/Q!/PR:G1%$
MK&UB6ZY=Z1.W0H?51_,UR4'O<IKCLE\IT?Z\Y<E0,ZGN9!EN<2]OK*(C_>++
M72D6?BW#+?/%D39*:(2A_#NF/Y2=3 ^;G6-4[L"SC,S''X^C(V:T1"8RJI.=
M1!\0FC(7-. 7[HT]"Q%3X_4F()[:U!0]OP\'H1Z_.G>7$1#,D 3,['T_<XYY
MN<6.CK/?^Y]C)-8S2%<48''EP*HB8;4\W\1F:$!,K$(^W-MP/#W+Q[QLM%+'
M%#F(E;9]\ZG\<=CUQX/&VKA79A&4]?DUQT&YAC-3Q4)"H(V*?*^/G,[ I_EN
M\)QE]4H!MKMX^37:VE2Q3N :X.$OA.@-B3O*^4_R<8O7E1!T*>>C&^;7CFWJ
MD:B!:19(5Z2_^Z]8R([&Q>3'<Y?KU@4%H[F3-_@78RR*O*VXJRU#79Q7\$/5
MT^/<FF]5,GS_M9;R@NO;=-PU6YOK:FLJZIV^+D[XT+VH&\TV&[69Y-ZP2+H8
MC! P.^F/1R*T [)64AP@9J8):_+5(FXFINQ,P<4W)#JZEI8%1N]7-D]4Q(.+
M!S_Z%U?,;\6.\:IS-=<F\J(=LNOZ/S;F@Z!7"O?0MC "\[Y_DAE1A OR#/92
M3+[Q2OJ&9)4?^Z NY/6Z)/Q6_"&H5#\089)\Y#F!8.6<0*K$=6^K$Q] L)*C
M&?1]HG,I+;.[Q*U/L-G(T:[Z@?KM^A9\=B>]3ZJ',A3D#1;\%T[B=!E2*+[Y
M+W-7VLZ\23M.N/LT_"WM\/^/.9S_W?$FGZC\-=N&+5:I_;XC<+KM[?8C;)=O
M= 7CU%#K'WY#8B-]Z2H;K",IV=\>#GE&];0.E>4+F3-'=C#LW9!D)LXAT=V[
M1@NJ+Z81QB? J(%&+!G#1FM@(.!P3M'>$I!AZMKSWMPQVVRL(DDWC?'@"@#V
M6>L% ]R><6IU9)@F/ON<.%27XVA$.W9R@@MG<84,.,.)*[[AK<=E(NZBYG,G
MU!H7#7 \N%5X?;'88VTM=0 9,$=G:7V;V9M;]SRPI>*&!%V]<+*3^VVS2N@Y
M2GI0='5>!$VFCB<@7][= LR2Z:>&^ML?J KJ0JD"GV)38:-YWB,)<HYCN&FW
M3356L7FY[CVB7'8U\9KL4TTXR3^EEU*-MU6<7VP\E&P,-[]2F-OVVF90V%&)
M,[&GMU8,O$B9GW0GNFVVRD]=V!<WS5YF?A0\+=Z*M/)T+2(J#( ]+WPD"6X4
MQGSWD&A7$UWA14D2AH6H'V:UX7T)LS[:)QX7^!E-9MD /H[>@_XNJG)!^_'Q
M5UY@JN+Y0LK8G[RG*N.FZ##4>NMNNB_C5<MWG]P :/GHIE148:/"AW7/K&B1
M46:Y_0P'Z3(0,GTAI6>7]CD@IT*N@>>&Q',^:D5F:.F!DH.L0+76W\FT<7\:
MU0=;M)/F[VXA'>[$A-<;F#Y=)F.1K]9GX_LZ:="48^8D8#JL'_*;+D.E9BG;
MO)('U=""S= XG[_G.CM5SU::2A2YA$F.J3LZ$)@&/JK.Q23C90TI:LR#%E[0
MLT'[62*HRM^J!'5J\R[59L]#E]P+\^UM-O )SG.T8&\6R5AHK=G!?KO#=#.L
M.%O"-G (_Z:MS[DCF-N^!S8+*:I=69[NP[H?G4!I870]=_>^PJ $ D"X0&1;
MG,:B'5<^L%UPLNM4]ESNO4G=5;=1R+P/L=$NDK9ASFY(;,D]<A?\@P_4^5R\
M.2CZA<SST/SAM\]K1()CUM_N+3;8B16QJTX4.43O&]F9IP6\5ZE!Q#78*<RM
MO]6J ))MN-\^X2]]7L'![!3,KO%9X&[HK,#^[\=T;GF5M'G\=SUIJILDAJTD
MQTI&:,JK3%(*L8TO(1AB,V)DH$18AB#-*Q]V5S/;TO,-=YKGPAY.9!CZH,:9
M66_)F<XYO>$#M,L-YQ0+LF_T$%-<TM!"P*<(N=$VC&#F,0;Q+UN(E'0RD#.+
ML(P)]![[G0GA@SCF)PDU20$W)'=I3^ZD%1AH73C_!CO\S15RT_@GFJ,HNBHI
MPQ6'W'K_H1MN9&"O.%'3TT'3:71<<5:.6B2Q))U]DQU*4R63)+^1BAMG@KA:
M]1U4EN]E\\AE&!.]E6.*?%,U62,J^OSA;C.+Y.EB4IJV?F0\_ ^C8'D%AA<V
M?T?_VJ7'M!"C3RMDCV(7V%P1NK]L!G\FQ\9,I"<G-F?UO$@IS[B7&9G6S:+E
M)@[P[+/?]_*OMN\Z*)$#Y]"L7)6A,], UBF$#:?M[27K!&>\[S-(%1B:%0Q[
M[F@"NIC4U:XV.?"8!Y="8RR]>90+?J0(\/H)$7FA;]<Y>),'$]Y?IGV=.YF;
M@JO!A#3I%NAF%C(;,H;XKAK005@FBQZMZ;-W>@'3[9*I@V!V_MMG[V]_LW4C
M[,Y 5(J"NLYVRO=@U!=0UT6CQK=HR^'R":+K^6.N+B?$M]Z\A;FM)T7V(2PA
ME/(;U.657+'V2CM3WYP?-=Q>F(_>3V+S.]GYM:N<\KCIL:1A@_YZ7L[; 8:S
M7(WC +":WE1%N1>L1)>[\&U>HJ""=_:4'9UN:UM<1#3B+H-2SH[+AS<4#T>W
M0VT^5$;^)R/OEQ=ZV5]3COW%F"@Z>RBSP(GT!V>G"8%X8RHJXTD4/__;(E\L
M3[U4'^E=2&0;[.N(!)X-;1^_R;3^\AW$"9/H>0)VA:@RW[:%242+?[>:(IG*
M8PG)JGG?\TK1_K%+P8#7EZWWMV(470!_Z)7JWL'XLIZ\.P"J7=7+.4<.PZE_
M4L.-S]AC0!<TP^G[QFH'ZL?;^GRQM&79T>]6NKI1%Z;?$VCB\=!;OU[ .V/C
M?S2=JYCS"P81UVL<EW$^V=> F _IY8? S8,(PA"(Z'8VK4 10LA]J!KUH^ZS
M-#@<RM)-<G%!J-_OD")2M90HV-[Y>6$7/R]];T&C;.@^KW]#YN[?&J_8EGX
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M@92+@]60$34'\TO_MK.A51BU$2-SM]CVG8EZ']F@0V.AOL#Z%?<GY342)LE
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MK"2!=2./,+\R1F^V ]A#9)8R+:MUR7' AHHN!=9R5H1E+VM99'8N%G[>D.@
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M)1/E8$3)B3KUGOA@'\(4?!"_Y9KR),J6/C#)4_P5=C]S3T]W:) 8&;]D7<R
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M' >T<$CED3O< -1;_AJ]/O=_ZEEA^9OO(W/)40]+\H#HJD9\[ZJ%V+KF+FN
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MR*S#?[?#<B7G#:T<#R.']]$7R K[V'@G?XW_U:%H!*WZ<P-X>)[HRR%9OJ0
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MY+R$VKC$GM97K^?";P$MRH71,5OZ/\06(N<-8X]<=:5^22_2!>J^0X_8F_.
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M!BEC,[G&)+-NJD&RSG^WV_FL[TK#'W??P'^IZ!R4,",B/)S-VO\B:.E94L[
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MDYJGV/)XABG:2 F2);1O-=!JA+4;.G5SV!)FN4-J()@QV!LG<B+^$D?3L2T
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MK @3O1>6S.:-EA8)HU!9L P.J=65T%6U!S/T+GMAKOY!=CZZ+>K?*PDK5<3
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M!1W-S7/7-:$:PG$ )N\[I3EJ ?G3S,JPBM52']>C66'01$YNF 4I#K?IWTC
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M;,Y?Y.2:@I??4#((F:DU> YSFW"P6^GS)8]O=?BDY)DQPFHX'F0_*&Z6N(J
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M9OV'CK>A=:K 0\OG\>(CE4TN4I4>D?F-=9ZOUKP\@LT';L&IH:S:SW[6%:!
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M98%-7QP\%;+I5RWNW1EN?/=WFC0&+.4B]^<>GB0(1!=G:8R027ZYP8)@V5I
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MLB:*1._?;9U+B*:055][C'ZN&&K<[RCE^WV^>K78/&DCQ[""4/P!'SC5;9A
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M.'X>V.L$_!)7*\((P!Q2;'%JEM3I&WL;/G]NIL1\% Q &_<V;8/>!CX*SE-
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M',T7V;Q9F4U-S;$5)YJ/YOB'O:KJ<*!MK%6@J:6__O4^?QU8-Q#->FRH]FK
MNN[O")P=AJ4ZW2HZFME/+RY(Y[#7@BCI+"LW(H^BJ'5#<<<JIG)<3'L6?#J+
M_\TQSL<6OWJ<4T)&*!QKU%&E6G?(6;NL)HGY;]7Z&GIKC0IJI4=;XG%.8."^
MOYYR/Q-_TBT+W9!?N;_<@DW LHZWZVJN 1]XG7;V9B'%6$OU;606?/MXL@-!
M9'YWD7 YDTV/V=<KI3E<VPAQW6(2)+<6%_NTQ0I,-59CCDG<\VV*B3CL29&4
MO-BX#+?&;[F&)L.$_JT]D(5AY.JW-KO+S73IP*$N(6CM$!$%FUC\Z[ BU14'
MF;/DMHL3[I-QS]DU[[44.W8Y) 1L$_?-\?*XRE6:0OBIB6T O"^/ES1K2(QQ
MKT1NT%6FQ:PV.:2F.6E%J5.6*4I#7^A1/&]V]GY^>&7&]02R6/$8AR<7\QU:
M%M8<-5QR8"-)3?8E4WN8D$P,K\MB==;%,-PM?SGQ&A ]Z^[,GV]2'56 >6F+
M:?H>GX(87^"86PW$2Z%%9"5)TCU;$A(Q<GDF6>HZ/.P4 9\BHC38:A*JG^@^
M0)B#$R:]QIFE=E?0/FI2Y5=S@<Q_H_=U@MS!/MFF!-MFD5EC03ZQRXX]3[.K
M92Z2LD^.B.BI8?O84,.+RMDK"CJ!87&D5J TIA@]T#0=[^",C[*^J"L@#"XP
M(C"8F941  "02_F)$J34+E[!"+@#H(R6?2-5],'V\>/'M#_+-BFUP(4BLN7C
M#F)STI4(-'A3?6ZA?YR3DJ,3T[;?>%NHC=4@@\^$5?I4^<WO;55Y.#"DQ+4K
M]E]:*22]N)_QXJV=UPSQM#91_?%?9K/SJY%M0KC.:9%?CIJJKWBT^-SC66:Q
MC33+\L.,A=8TKG2HC&<Y ]^QGJME+%UWR)I#?[ZMZ[YD9#WS&V\Z?\2E*" G
MA:79T=?<-;3/I$OO%;I3\S/_,X O@9J95_3]NW]> =I+OI@K%:U^,J3M+XU[
M4AL=/GL-<$(PJG1VVC^4(--MZP_%WY%9RJ;Y<N*RG*!?28"G=!U!:*6ZU"8E
M\G:>#W'E"L0)IMGO<=Q8.RNM&,@ A:#G\ JB>B#*@LI_J0R%1EE%$73AZK/?
MC$**H?EAJVQDL3Q0U@RDR]&@91!ZQ.V\Q86Z_3*'/GA0)\S^&A!9^:I>^X\S
M_7:[T6.=>U+U]5'TC6Y<3DFC/;;O'D:(RY@ZC/>2ZTC,'W:D:G%Q^Z)\*>.R
M.PIWD_AT.%9E<K[9Q'(7!6G#Y,^#;=UC!2ZXIQ9,/RS%)VENJ.F*9G&DJTUY
MSJV274"?E&YW:LDT&R)"HD06'1N4%3#<Z#F@7+'&80MR4\)(:PXI$1N1*ER;
M..A &4X:/?WQ?I</,M]3T8@P1O;,PO<+9I>E(A]:S2B!?:V%\Z8=2+-[T>F2
MT.).Y? -FS<)A0/-O,Z=Y^)14ON&.H/:)KWF)C[5<ZOS3.FW>8S:-[+E2K'&
MA6,7(ATN=5@YP;'9$ UYO9;U/B,Q"Y XL:(6B"3];GT_/<"=Y Y=8Z">P1-T
M>PW25(Z!\Q',GVW,XETQC))PPN"EO,%Y41PODNQ".,*3K_A,^XH6%L"6*A2-
M+2O_1^Q<3_U75N;K*(SG7*K6"JRW< (&-_^Q3E:$6JZ9;/ME6N!7<;HZ2:N0
MRM:A.FV,$-*3,W1^GE[!I"BAH]Q&*U/I5NZ)Q*4ARL"E(+A0WG9 7L#?LGKB
M-/5UA7A6G')>_8BJ@R]!8^.F1?.!\6IZCOC@+(L0&B=<J0K5GMH3NS@D MU^
M+]<^*D"-JQ\4C;-_EO$:=JRLV,LRV$BR7/E39^[4J.(#EWG$T[32+"\QQJ#+
M".P^JB;Y[(Y-8ZN9+UH,MSX%O/C_: 1BR+:+&:DU([Y(#N_)L/,+-^&*>UJ.
MJ@\J&V#[L@'CW^SSSA86)MMU)+J1ZL3<:W_GV$[NX2H\CU>9PAU3=)X^634Z
M#3<1-]<;0E<NV.^I!TB +30:VYR;W3$\:4<Z'+I;?]3,(*MQ#"KFY.^IIH<2
M_TI7D$UR>*)RM@8M0:GQ F9-L,. X76!XS/8GH[3J;*'@JO0KXD: KNL/'_F
M&X?.HS:V9'62@9KJ.^[!=F7W!0H*(/LV<9R-E0SN.<.XHPQ- [4OL(U0Y8@T
MWK[TS\?IE5P"0>9AK@U+A@5D[6U/XBTCQQ<1P9U&#$WH@B9RT;3Y4T,=/9JG
M HF0ZAN?!?XJ>-2Y,-=\!:IJW@"6U7_LLY?E#<3N@(S\\T@K"8X4T1I<PQGM
M\^.\#4X$>N"5W>R)LB?'$$JG-;L)A) T\B1Z^IX] ;&JIX2Y7 /\IY'N=JB'
M!CLNN&IT<%/5H3+]*7]^!2-%^-/N?63\O(_3Q$!3FU\3JRR?A"KG@ME&'?3/
MZ&=E]1NA$TC^P+G8QCQ&G,L1T>(P?AX9S6>R."VJ$=C+"IH)VI3@B;;3;@31
MI3*35"347;MC @97=E=@$?>S9\WS39%)G:!F%#.KDDE%EBF.TYYY&)VI(87E
M")]$V*ZKQ1YM]#9U-KJ2N^8_;!2H1^WA:90_%W4TJ.C8:2T_/3B]!C!=50XG
M'99-2+[9WK\;30G&SD642 M8K!D*;IQQR#"'2*3_[?XH$2\1D9VA\@;YUU'\
MV.4U +T-;,.+%FE#5K[OU_H[;#7+QT.O 1,[#@A%&S+A#!VTQ535Y74-\.%O
MA4P/"O2)';3U&:$4A/Y#8BK0-&0PQ'S._#!D/%X'" DIMC67F_:?WQC5,(1?
M _0W* *C9FTHW4)24V7",Q[LA4P$8F6SX _6P0CS3=CW"P[C:T Q?S)P]AQZ
ME7UXZDZ,W(/CFH/Q.<+R7+40AXD@_M3.\34S>^$(YJ 9')=MHA$$(,P[Z',T
M8B8<)[W@,'\67V]== U@]47CATK'H(;0J3%XJ-0LU9Y&B?NS7;,>:$_:\LS*
M85 F9C@>.(P!^E1"_*"F-Q>IQ2?D3)[B=HWW55\\QP97M;F@;;7=<CHKP\4,
MD$X=HD8:[V\]#/YF\BW/RFVX;<>CQYT"+B=T]PGSG7&W$SX#&I%Z<_I-D::H
M]1$?/FH86V_R)_)SZ[9^8N 8=;:]8]2K(3Q01_C.\KL[)S-OP5(?'%?:\,'W
M'.KH3A6'D).4H3,FLP S3D?&DVBMDIT>1]M3V(L$$V>\;*"^28%!C^_<4L$7
ML.OSCF>CX>F4Z-MXQ_@X?WW931<L79T'.69XYXX ?4)6;M 9N%"BG :"I[T&
MB"7/KXVW/FZ->!;9S1)9V.C6/=F;LE@"(6T$)#RNAYQSFR%TMLJ9@@IH]\C$
MRA'KV83NY88J]+\<)8HTC 2WR?/#&9)OWE"2O:U0&!9/1_)[DS%01*Y_,+5K
MZ&V*>B@)K@ =E$_5$'KB,Q?5_4S(5OU=.C63E9?1+KT5AU;<'/Y%::ROX%O+
M4\V,D67Q/J,(9]#"<I]&^ B%_53++C E.=7SDG/]T29S,LGGH>L@3F$.>>,T
M4<120F)B!_39QPF+B2<-'^M1\,,.KP&@C#-/1.^.3W# U4-A2^W=[_Z7T)5]
M+38DGJ;I.>O<7$J^1F?]C.RTSMPQ!1?_D6$2!Z)AQ 49IX DPPKPA;Q+2[]!
MS<7<.8+-<3Z]I%J(^ KVB9/)\-PGQ] M14U7X6WA(:#,)H>W8@,FB+NESEVR
MI\YD:>NR =086-]UGHB]!CRRWA;9KBFLHR%M4"DM7 .H4&K/1AG./J]S&7^Z
M0<7V'LW"Q%W331TUN35V#<#B U"'PNK7 *^(KU<5(9?RR&O J?F_2C"@Z<Q4
M\%<.]#\]$/R['DC2'QU#]V?_'\[.\ZO)+ESS\;5@ 14%E*Z"(-([2%-I(B B
M"H90E XAA-Z+E2H@(+U)EQ9*((&$(E("A( 0"(0$D))0$Z1#0IEWULR:-5_.
MG#GG_@?VAV?OO:[?M>_K?JP[V,:J1^5(9)*53A^-+KGX-M9%-/*YY:Y&<2/.
M\]:'1QR/_AXP<,=)1$QQO)G/ZI41?^LLQZDK3:-<F?0JO*7UGC\QOXQF+V5'
MRFG7PL,GV!7;\K+^]KA3XG]2TN]^95%B(06]7<M?ZF:@'//@#;F)#Q^LYP =
M\\JWG9Z%&\HW*1&4<KWQJJ^0"I/I8I]SDN :#3&?#PBVUQ\FO9N91/8IRQ!9
MVGK/_Y=+9;%B<K95<QA8^MWY&_0=),V<N/)&-1YO3='T/*^>U%B3^A/"5KJ=
MM"6>Y688[S4*<85)WTT.G/$+7 66?NV=][#M<S?,K44I1:G$%Z>T^EY>;SX@
MTE&B!KD:5W>TRG;STTFDZSPDGG\W-,UY=_-5GWV-9.?JD)?\M-9/PEC[1=BU
M0#5AI7MN]'"I9/V4GHRS-B\M11___0")VNC#-KA[%G0\TGOX-HJ50_(:L:$S
M8LQ:[3-:-Z);E&Z5#DY<F=&TC4N@IQR)0[8.^9N6R&\<FAO0"SC+Z0U.N(MF
M*G;J 2KM.*+</4BU7O[=[F0Y#C/$]51HEC];J4PQO4J#I/&#XV+O*[%[5?V<
M%UUB[XI^R/C4)::>F[%W%/NB(6FF%D(B?[3!R5>5W><CYKG:V[>GS<TI8>&^
MBE2MLV*(@?1#=KGYJJ&*R6>_FQYI3#MLO.-*H]0U[1I[6HK1S?2ZLR7VP J)
MAM&H&(+[)D;/S0I[&S_T!2F9-3)"GQ_*J5^7/0'H>OQ]R_;&4[HR%/1XGMFV
MN!D&5YH32>$:T"^E":W[2Y<R1:1F9_S1ZN/FQ#8IE!;:N36 >/G31%\U_>V;
M@TBB\C>%RX%_0N+OW1>Z["7:&D3HMYN(WM88:@XWE\H+9N3N#5MSH_H;IBW
M.2O<Q4U9T^*''5_E@(8U4"'WD88VRNC??X18TKVWI])NDFC5&#Y7X#;V9P@R
M.)Y^ A!Q]W>]KD2RI<04>V[,KWHKYC]K:"U1I7E(YRFAZ+/DJ!. HPZ/IKA3
M2XXND[SGF9&H[0['>J^U%J0I<:6] XB?8:\;I86I)G;?)[2+&.ZT.0'/I?,O
M[*6L5T2JON3DO:?U"\!(_E$6R]=(VBZQB'[I[K FV-ZL(58LQ7O%&>G];<R_
MU__-636-?LZ5OU;U4D-%:T\+4]0M3'L>G;ER]>:U^^)-2>V<EW1ATK\9-YXO
M'QEF.QW$$ZPDH)F^>(C=8GY&Z)Z K[0,U_NKB=?./IL4RZPR13<-Q4F)NR-$
MZIY)V;*>]J>AFWZX&FT^X[6N$'E5^-WLFLCYAJ?WN:[J\'#HE%9\=OGX[==;
M/>IK=\A40)@7]*W+3RMF)3/:O3KCMVJ,7S<^HR-2[<5RG.1JF]W$1F9THGM-
M FG+=K.6I#RE7AV#"DL"^NU9!M=L;WT?J%W4,.[SN;34_+$>)TU= 4U[3FZ:
M25Z.OO[4_E;!9!/;XIC&1WMY#VL<<HJOCG# 5&!:DQK#L\.@TV+^).1,0M^Q
M^F@W]' [OX[ 9L+(V.[OQ"4:^&Y9KJCR:-U?5&S"REW2;^*YMO2Q+#N]Z97?
M%&9%%%K?GDI:Z)M5-D9@YJ68=4?GUHFN&MBPCRQ?@#<6,G9&2&ZK]+(C(U1C
M^-VX)]M,'5?_!Q_$JW#$TN+6N+B69D%6X3R"J:=:_NBSQ3![<!27EFKUEL"D
M-FKW!/#;I$S6R)J,S([OPMQ$%G'"5Z-1ZXT$?L>5HE'EY]W=;84K_D6(VLP:
M:O_V0C5>%2J>*!O7UW>(3(M_]T![&M7#7/%@MN$U5_81$9%]2T@B1'.OT+\&
MWUZ(EFP%24W%0J-'#I.VH%4^U3NQC-L=F;YSZKL4_-.#TM;H(8GQ:WT*(QH_
M#8>$X=<6KQDHB@:O$!_0VYR6,S,7Y8%,O^!SFM$D(%<7B)W]271T](Y>?-5T
M[46?B^X_JR*D?JQ\E@\?FN-3^J*9*OMEY3,+-8GE(-P^:,GDKK[LS+L_992B
M<E<I,.^INW_,KD=SE%VKU^,,GHUL&O6OJE$<D)QCK6+Y<['E;6PATOMSB^H^
M.N!NMFAKV$-VHK8BZ03P]^&X8($C$N*W96CG/,S)S%C'>:BL8&7= Z=DV6E9
MRE4I.CO:IM$S7[?';:D;_?37E+J1H-&O;2TBH<;0$:2LOPTE_S >8;@ZZSC3
MW.715L8(<93GQ1W/\&'$X4!;1[>%P%:UX*])\4FMUU98Q$[AJ/U9OP ])8E?
M!?VXUD\ +]L*,JK<-YE:C;^F&$G;PM9X#1+T^K'6&AC8;OR@O8Q?R.<X;8=%
MXNJ'9<=L0Z>1GP2:E#Q)7^C*\=VB_-H]2/L!Z7_&MIJU/AFF3H99;[<Q[OB'
M82#)+46229I]&6GQ2BZK0MB(LV,?*_>@-)A$7L@ECZQ.Y@W>\.E#'Z,T7%M&
M!I.\*[&_I>LY=>,$$&FWCG+TXG)E+:Q*4T9\Y&J%\3=]J MM\\1:/D-)\_IP
M5%$\P9/^C3]5V"<O7TQQ^)LQ#/;(R"(II-];$JCSDR_UJ8=<@LF38Z_^671T
M;PFC&GCR@/N\4FP.OE[U%S!7V(69( -@ZY-2*S1FW 9FDX P*256A26TSH2G
M,)Q70"*#S/KNO(C\LC+A8#F08>5R9L!BJ> /WYS=@X#7OCD>,>0D]*NE'V0B
M=RWOETYC<LL'I?30JL8_(ZTW&H[+K%]WSWA&[!O9ADU0(Y;SS7ZU%9\ 3'9?
MT# CO,TQA' ]JN\V,&MBUX^T&LQ?B(HJ0*6F(E5^6Y;=&R6$%N"5I9M=V^N%
M7V(R*,F;Y(>S+08W^2OQZ @?VA2)98C67(V#:F82M+JAW0)-H4?3QWGK^<;T
M1><9_V:E\<W51/]U->E8DF_PW>;3M=7[GBW"X5VV6<F?8I_?,S1<$7VA 'W:
MT#@(&^>&R[547%N"O'&6();ZA=^T%7B5_'KT04@4_LW?AL \*I*S8$H-U@EW
M7PPA2R_5*T3/^^U%2"8-AO<N%F4P(I8'-W9,?)$-NT9FZ9*34^H2&$>_]KMD
MR7H-^*^)S$#D.-24@8$%Q43N#>"S+DDWR3N@E"9G!S]MJARHEA;E9EA//Y\U
MI737*XUWA5Y?D:Y _@L8CLOM#!!8!#$7@^]?7=R',86^^81E;BLOCSLS!"'C
MD=FYQT]*C;MZ4!MPUHC9^1- UOI<WK,Q!G"[V,.^GY$[YMX0IW_>A^UNH?3<
M[?$W[^_"PLJK2SC9^00A3K,6;P[.WL.3VQ(8\A42]",J3B$GL%1EWS99797D
MOC&O>47BR/3HY9< !X;SLE7>H?D ,]MYEN(O(2_8W7^8U F"$.JW&[+P;P"*
MU>"'8$M"@KEL/ 0 > XX"_@I#0R=+%'X3=*^VSTP#"+]&CDHR]/K9C6ZF6X@
MM 30Z3+""0$]TR)&!SH?H,)SERDY>^,IYJ)46O0^CXEX2;U]K;W^T8'+.<)G
M63Y*:R(8DK2E+/_D[[^@UUSODI ]Z3I')JF$R$,,Q.0UJ8^=/OS2WR]6HJ??
MP"*S NQ_O=<9$M'H6?$.27.%SC #Y3+3ZO+F-MW3]2;8='-Z%G7]0O<R&NC&
MMP1$G8 ?P50-]&PL#';F<Z2W>;#7JI9#L",79$[R(#MS"1&HOV%2J,5MG+K4
M2PRY'%(..P&0L^+C^=+E:[^42?@92/1Y-]_O?0>[IG(CM]',XUZ-C<$*>BU1
M1SS=)\"DOX.?*\@K?\-$JQE][9GP:&XQ#9CU1J=K^&I!8%9AP9U_6,U]<BE!
M9[\A#ZKQDK.QRD^XGZ_&'+"0D5'@&!6VL>E40APPX3 %[V!NQ9)&I.9:CR;@
MX$H&SB7>F:$_JCL\P1G\@Q)V_ACC6P5-7]T%V)MM/ZE>*IW*$XA3;%N?;&^>
M<"VMPTIF'5 :L575\^[N<KV]MV+O$?7T!MW> 'Z>-<B(KFHB0=J8Y>QC\C0P
MYN6#G>-G>?U0>-0U_<$V><=4?2/5W "-2SV_5$_]>+D*2],-IT8DX3EQOB!*
M3UA^J_EDIZF5"><@)/L1A -Z1=7<E.U61&2>=??:L7+\@@+KRRY;>5#9&&N
M=>1$MA<)N)&G^<,Y\XSIQ]X.L\;!#95_^=S+(CHZC6=@0^</[)M8RZ$:A]?8
M2\[?]WOO;?^CSV[ESM^AL\&1VVW)?H'S1>JOHD:C)PU)C5/-1DNQLEM*WQ,V
M9G2HAC8MB2Q>/>77(LLSNH>@?MR8O'^%>-Z]:/.$"TBC),WKE]5^#YX M"/8
M)[$_<%?V"@L8W[23Z*:"<L0$SZE'!;O[0O$V>A09DW-.N&W/\MT.G5(5)5"
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M29?:ZBS=QF*'(-9)EJ4+11J*K2)<]XPTTXYND'M6ZSR4+$Q:/RK:'ZI*QIP
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M[0C';!_H')V2)Z:(+;V73Y]#&IP PCVV'QB&A64NIJ<X 5MWJ(YAGGN:<R<
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MJYXA8!U%U@2>KJV<IU"TPMM;JY/_A1MKSEU79E[F<1ZCD0BU+,(:Q1]8^Q3
M>5D:^OHQ5&Z=)&?"BX;K^BIZV)[WB$3QC#7DM@>L6ZO[^J[*E?*Z4%R"1E<$
M*Z;>+H)' VU=,JSSOWN,!$^&_QONZJ.M#0;IN$HF^.'PC? <%'O^O]>D6:Y.
M;^).Z)9D;KWA,#]G]J_7Y&.@D"AVE/N+[LSP]Q]A#<Z,+^^+%DC> H['GVV+
M1Z=>#WIK6;65-1PB49<D!P8#?M,NE-_RZT3%ETMZD$\ 1QR*QHTTHV;C5*SA
M9I,CRR(]>TLNHCA2-EC0V>4_SG*JWST*V?XRKID3#!S-#NS@N5%1YX!<!X.%
MY(X"DG%OQE6^!)W%53<I*E1&<?[6>EX[L#N@]N,$T-EGL&U[73!4FQSQ.,"?
MM,.UBI@Z 21^K-!0@<7LCBR'OE\D'JG_LM7+RK%^=!37O>E 2*I<#;UI-U&U
MZ4F YID$+W-S1*J<NCU"^-R!UC:9;*2CR#8[DU-_R)C8M4G[/?>-1<W(^K7N
MNFN]GIP;UT*?J6%S7_70Y7"34U(1KD@XGV^7V881Z1A24UZB-$MJ]6SVR/RS
MZ$DJC96;YOD"7F?^,UZLX[8@2^0CDO/^IE]V?GMXBYG.C<Y5\ X!CIO_E;X3
M>VO9$0P [.=JPS_,EDJA5D"7O>7G,8X>&9_A<%5G82!(TWH:C!$.%9]4+L\Q
M_W>IT<TYC-J73(4.AZ&<Y8O02,H<,OW7N9S0IB=OU!_=-8/UXOD;MXL6J&BK
M S'*)?_#.+;;'PS+UGTJ9FU&7@Y0\F.#WW(1$<@_"&@JWGC^LU "KU,6'O"$
M\P^7V$%$M[R/W03.Q/M.+_,%:FR=A>JQH/'%\TO8?;O]Q \33+R*!TJK,I31
MX'904AT'?NZ@,&T4%W#."$[95:'U2#:V^#$M?0?B80'I'FI8@ 8V">&1'VOE
M2" )GJVR[KPOWC_<]JVG1098E;'QIDTDYW9,9E,6_\>K",E<'N1C(O"5N7+&
M[XMY:QS@7I2=D,72,$-E)UF@X3@W/-?'S-M#WOI"J?.R2*B@:*:"\I$2VC^W
M#M(AC,XS0JGQ)K*77V-QOQWFRH@@"S4=B3;T64[%SJ0&E/%M8PY;Y5?#P<<-
M_B"TX(J^=^=38%.;,E>@D5-"<]DW6V7]\N4Y.E3B/[%2H5HUYI4?7X67'84H
M+7 MHR79BQ<D V2V-L,DW47X/ZDNL/=4=APW8+DU"W FLW&07>UUP>'X!EJ[
MB?^K$T!73OH)H#OT>%&0(=%[MV&9[IC3OX)4&;!<=8K_P.MIKWG\Q@+4X8[;
M4B^\(ZA[I!I7Y*HJNE]&#W@\?8'5[,EO0U"_N)$LRT7)'['&UAC7L-P;]BA7
M>8NXXW(H2-1LZW7B##*DR.?9V085I3B0L/F*?C:VK:CO1H!:V3<=4\+//UIR
MEM>\P"IL$_?Q^Q#/ZPI[L&=XB46>NAS9F@Z=;L1!Y?K"YN=#]KIO/P6$YT*X
M>*F.V?QII%_<*GL!1Y66U-=S_=W:3T<!RJSFC0RWH6L#I/3GGM6G&$J2H*4^
M"#!#./+VP '/V?MN#[7.EH1:^X[<SB.MP>>RI$&9CQX*)0"C%<XI>:J9MTYX
M5'MD?#H&\^E*QJ!_HQS'#O/[&EDA2KWAM77/U&4WIE[J0;I/ !0BS5:.K]_R
M!KG^JNZ]GO&)*A__F[.<EK)TV'Y-68%*_T+0(:DO1_F=X3-U3E%UD "M-F;2
M.@"3[/C<4:EHG;M8:'_Z:1G5V^3B(S4CJU7-;Y=MG91TK2>27[6% ZF)V+?1
M^R_C4[^+?)6'LFI>W,B65*G<E,'\_=4? C)%W/P+F]7-&LA4(;Q>[XA4T9'9
MN_HH4<*]%)=_%NFX9Z)4O;_Q-SJ2*_!VP1VEO74&U[1Z^M]*FT/_0%FYNB8:
MK]Z9!$JSX\A8VT3")=$&Y,7QS\_H.WDB53Z7'9=$DE->@='>;[<@WAG=7<6Q
MC?#!?Z7J]5_??50D+R^&#JHI(4*!L.BR;V")#$];%-E^DE@UXZM?F4V2BJ'(
M&, V;P9IC2R8R]MJHGG>?-&^HK1FY2\EN-J*0X</02$(O[;4;>V&XZ)U2:*_
MA'71&291Y$[.\E6Z<5>\;_(3X] ^_L<L_.\#/]E'5W6UI'/X$B%Y5W]9-]QT
M=E4X]XWXGEHX,SGT#.2(A8B62:;PH""CBP9O,\C14P;<H1XW'W6A1'T:G@>P
MQ2T)X/+D_"&M&V7H*]]#E +;X7_:5+8[S9?.MK;Y,-*.\[JK;ER=]L,^I3I=
M/?W>$>%S=CU#_]P#91_^4?&&,"U\RHI&#D8]S81DD7C<ZK#,D \+@QOD(J"(
MB<2U\$_8I47JS?^/[N)W[SY^#'L2[+=L6S$8OZH9Z9=B@OFA\*P!FPO6$DWE
M@B0Y)9T6,:U0&#NLBNBG D,/D5SIIV"G.I/U^JXOQ,_^-<ES.*XX 3PZ =CX
M(PG7#7,=ZE! [[B]2U7MVL'12_''=L,!:4ZLSEFD$$2D+%(F7\D*+IN@6K15
M>-704S P/$W#Q+>(<$6G(<":H9JKK#B2!?N-6)=N\I484D@K:K 'Y;G0S.RO
MYVX2/W^"L::F2B1%JD7SWVWYW?]W[<%_/K[A_RXV\1\\]9(WBK=R=7:[]B:T
M.?R3!N8FB@>D/;CM[8B&C]0_ 'F6[]WGN?"R+T(W)>*C")]/BC!P7CHS/F#T
M FIXG%Z[XQ^$Z['5#!!Y5#IMF-=;;Y6E- %\,-E(L?_^.?'[]*:%_GI(?G:R
MY+%K3>4G#?'EUN*WW<I#?YEMS80('],&K[0YU\O2J%"O^(4+SF=_7D>]]Y3_
ME3#,1AO8\$YDRND-=[ZY^+5%:HZOZHV:MN5EW'?_^_W#W2#OQ\_-#=U&8"<
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MPA-. B^HE5T!WO=<;LYVT9ZC_/,[1KR/9/' IW<7!!.F*3VQT$=[96["A6)
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M4![0"6_P/"8PN]?X5A,K"S=NH+.!@YW?J8.BJH(#%C2\1=CJ2"/\00:=UT[
M$/=L0F(SR@NN?_[B\+L!?ESO9?#7$$PAX_Q"YRZM,^]4R3\\+ \%6!F.J)>B
MS_1N!=@G="6(C>7:ZPX/FF;='NYRJ"\=)-63+++=IA8JP^[\H4C42MTD?$#9
ME\L._^F6W6 _2.!,-Y;U96ORY8;R&KF9\.J;K039Y1X@S:DJ]WV*\5,EO>5^
M5M 9Q$#V0/FO  ]([).(22224$%T$]YR78A==XO3JJ4[%@,V@8!$V;.[")I
MV )"^7"@]JA5GP;A<K>UR)]*:7TCKYY@@!HQ\3*TRX][\')R33.+=1Z?_/I+
M>(JHAX4K&,;@=MAP9'3)FDST]A>,2#V;36S!VB4BC^Y>- &Q7[B/M_8)WD0%
M5XF#S(+_)$R,BR,M16)82KWT:OGQ3(>6'N1VW(ODQ6-4$*F4'83V,(-]U;R(
MB<E' &%1C'L6K@'V3T[87 ([3K'O#F)=U3T&Q MR^TN6O1C3IY=<*FEG=$1.
M4H*@-@*7<A9@BT*SRH?&4>#P=B(GP35XN3%(INZ$C3)GHT-#D]F&V\H%LV>Z
M3B'51NI,2G>"J$RP81BPTP>:M'A4C6SNEIMTP>IXXXUI_+R7D@WSIA51"^?I
M*PXSW+=!6\A?O$:[GK;*)Y<_(52X+-"?#X*./FX$A^8&U^WZ(4$+RQ863&=3
MED+!U*QEEYS(I ]YJNS\\@?X@LB=[M_.'N)3^F8F# 1:\2R^E<O<+2-!VUAI
MH5Q?=EYV@\UB(\'8=[W, 2.-D7ZVLLB-CL#87^Y%1A7(R;@@\Z8M_$-_ @XD
MT1 ^>/1VXS98S4ZR7!;.PTD:3NNGE29G%0PX=XL!NNO+MQ[1''23X:7^.'#$
MD55:^!WPX_M!N+>'8_418\D1GV_/Q5#(=0HXC3CVNE4U.'*WZH0T&BRDE7I<
MX![FK U32DHD>;VJ$'\<Y$1K\!P?.:A1ZO-G=>$AKPMQV[@<&_@W3 H7J1 I
M5Q9(B$E\7=XADV;0E2K2_]=E%DW$[KRA]DB;-/CL/*\]L.["3@1^,;A8FE'X
M%H80KQ$_'W&91/$3R844Y<1^^DPCN)?,&Q/9C9]%,\@RXF(8"\K7WK?<IB%R
MS;?\)TQLX@'R&4$Q4 =Z[;$[B$/P[+^",N^W!2_?8V[1WC_"'WL/_JA.EE2"
M)[L:@0RN\2'$*<5]QK K'PB$*$@<K^],O_)3>[YS">R7WY>I!/!9</O607-J
M9&>_X;'-F7G92I ,I*"&CX^G*JJPG9A^E" UT%^V%,!WSOGY!+)6<898H]E+
M"4@(ZD&#L:QH:V^$1N=E[K;QV;)W;Q/&Q56S*[[O*:^ZJZBR6"6@6\WKTT..
MCY MO9H:&U:3L8Z@^+!X/N(R\H5X*[FS^UI3>G+AJFG_N2[[?0+1>*PR&F<Q
M=7M!;]^G;*>KK_L'E+="!]J<XMG^QF+WG;IA6MQ+];IK3=4!',,GD*PA=3)T
M=%\N:E43->24MXMV6K&[ JC)5O!>5LBGBZPG2]787?"N500NC;*#T@=H,\TZ
MGGE,GU\[%C*X4&C#'U#,EL9IJU\!DI<_AQ3+IEB?RD@\NS2EOP($R&ILVP5=
M/S^3_&]KB2>Z%\$A;X?+1<K.)B"%F](T%?@3W^8#^IS=  N&0CP<W! -=>"K
M^Z@_2ZX2+ALRZHZ7RV7Q][-%-D)[/"E7.$X+LNJ=3&N'+2S$>3/'2+<3&C,9
MQN #)+?3Q)^>&HHG8M"#@;8RPK@RF$.,ICAHQK1]^8; C]U!#JV>_YZW]/\I
M83_2/I.];NH24)N,K*[+VIKK_N'*L //E[P"0/.5\6HF V[A/5> #]"8V0]!
M'US8K/R>-S#"RV=<P*J,$2)E-58_; \7(S\.SPO0$Q2!%84S-0?6&)L?7:TM
MI,LTXD!3=+#/H/I9]@\T>5"4:$_7CXL>'J;."XPU,_@708\]5K@UX7#J.R_+
MN9GBCA<TWDM3S5$(\/[T<8D05?*<]?#A#1J#U)Y3]S;G#ZVN!MZNP'^YF(8\
MBXW/5E<,=/056G+MF:8KE[ML3HF-EH$I12P'<U DW],7M44I#-\/+Y:^+V6>
M#\AVK*G!D2ZL>:G?(G6 +Z:FF:R0Z.CA05O1JI@1B3@624G!B=CCWECB0H82
MND!#6JB)=1<>[B$B.RB[S(.KE>Q1$'>ARV<AN'>?P.[*9?\JZ=>=$%G(,.;I
M)?,W<#\Q^OL]C9[W]@>7%1DDC.NM;\5""BIX-'7Y9H7)N?-+.82U2C[*,VG#
MZ\:D.Y?[O"ZC8H,O,5:!_MG7@Y+0A+,?Q2]4B7>>CG[-_WD(>V9TU_%BA1\B
M4H82KF^J;JU!-E?W"RS6]?.[6=F.&Q[6 I-! 4W&KV-5)/7O+R$BRX]WR#4;
M?N"H<O1S86&CU"QAX4&FETL#*)S] B1H<M<F%4TLA_][*JE5R]R)3<1!="_#
MN?OF^L4+E3<*!T1\;D-$L[*D45+)AH_*$J97@>B*1I1E)Z$!;J20;'Z+,BY(
M=__6F6]3@\\_Z3M=]ANR;JANCRN >"LITR;)0B<X\[)N@42*JPER\+89$$.Q
M;X>F#/V#DG6O.;D"],?YA$0F[ G C:HQ<2]Q;I6[@2/MBQBJ)J;\&DP5.G3?
MW264@V5J3O4E_DL8F7Q<:T\DHP19*K!!B7F= RB0\')>Y^7(J9 $/\M "Q%,
M2E[J2)XR P\S&@?5+M 9I:;.R3>D.'O?*^XG/KM/OE"M2GE/4,5Q')QGL8#,
M%">[K@5MYN4CCP2OYS46 "4W2_8KADXS6XB@1S+C0OT@YD#<__NGA[\WW#=E
M%)%-0@5!B97YM9?:)Q.+B^7'00QF[!?Q9#E=F@7'K!)___'-,+S 6B9&M4C0
MC 6\F^F5+*/1>1)#]3.H?]!;Y,:1%%P2:\F'<0U&GWHU]MMT-$9+\88VVN0$
MT2-@F[X3_A?"IV?5R@04&P;V"+P0/+6=61A-?(B1A=;/@I\GS_0Z. 3('C)J
MH>I/6-&LD0$!S5DL+\1N"Y!K!5VBBH]*W,U*Z3U!3 *IZ&8>PK<X5]E2J+=5
MKP_+_#I/?2J&AU@Z)PSEH<+I_5B+TFP;KPQC':$T&7*W<J>P#*06O.&TJ5ZS
M@JE;6,R'"^!0Z=(YR '?6D(W^(<34335F7_V!7X<\'MF&1Z3I>=B8OA#)_AX
M2DOX)U>!ZZ1$ZJ7;VID':"%H^%\\84G8! 9A@>0S'Y8C)H44^A3;)H*K9@.+
MD7_#_D"VP&+#*)O3L$X@V(_!F,82RF/S)%H?2U^A25#WF_RM5FP6 #M(&6EZ
M=HF\ CP<"DV!DC:0%7M35X"W_R4OM,R>:0\U(&>7< Z]2-DE3^_5E6]^!^-Q
M8^)'#$=,0H5F3+*B?1R,EQ%!RK4V3&XC5,$.3X:KY 8##J42+-28@9T^0G+;
MB%*9 ' &A\X\O"E\H)=9-1-I&!>N?YHUMQ]^ZCP]<+@MWS"M9(S=/0LHJ"4G
MBHO%ZC$H.YQD+X[GCYJ@C!U.DBO&T]*N /K.IO,.IO9^XU"Q%-B1I^2HZN">
MVKQ]SUR$A,1=YM^,\6X!R>##^<WQW?4:,L8%.J%E'Q28V\ZIMG@*LR+XM"!L
MXI"'S;Z'9X&Z&L(+J(+) R^T'TD<[6 ,=SPI\%FGD.LZ' 2P*B0OA*K=+,*"
M&QW>8J<(Z9X$^I'MZI]DT?78HK4F@1MX <ZB TS= )<+O_=6.JYP0"@+*_._
M*'O+L";<\&UX)BJA=(,"@DB)=(N24BJ2(Z1!%HZ&$8I*,Z0;E)26VH"14N+H
MP8AMI,2 T3GJ_3W'\;[OQ^?Y/_?W^\M]7'&>YW'=UYFX[/*$3N>^V^D>02&^
MSMZ*506/UEKQSR H 87$L'\GRREG_(->X?1$^ IH Z^'(B[*9.K+PMK$1L#-
M\AK_O?PQD#E7Z-=%1HCVB"3FH+BL1>,4G[\THSX2>S>#96E[(SZ%LFC>KK#L
M@\.XI.S6NELK= ?,.IRK=8=-#LTXUUX"DD&DBW/".<NIK<2Y^\5W3Z?,0UX-
M!Q+*/!L'#"+M9,D7Z\11UYCZ=U>!I2&(D18%K"F'1'&3F=%J+']R=?4DB2B9
M G1B?ZM<0;MG?>,7#Z@H1Z%((KZ75;Y*NS.<#L_T#F_!8L$EAA3F=9DY086T
MS1P9C)]>+&6<]\"74;8)I";2P="MW2@-/ZFMM+OD&<G)FBZ_NH/DK%0V>U]A
M;+PV_?JI#\'*JOMES(H1\?=OV< +_4M 3GV9;\+PW-W)DDY1HQ@Y).K-G]RE
M)I7$@I_[;;)>%-LEGO^>O"6#93':+HTZHEO^3L.-!#O.=3["P4X8Y?1'K*YO
MVPU:"<-H,R*/<BNE1"M:FVBVP^!&KA:^?53X?CT4?HM<_#Z#"=VM/:@<XO_R
M.=\L4Y@-UC;O9\9SF/C:19?PG8WD\6YU2>K)7!L5]%O2HX@T:V3=SPKWL.VR
M4GOOO*7Z0AVEM5M']PJE="TMGO0^'/B,_VSE%/'F!VZ/S+-H0C\771GE/7%>
MB@0':ND)T_)"W&_#F!.F>G>'T'8ZD;'41:J/5HXJ">:S+:(&9*\8:/!H44*Y
M@>FHS:3F&?Z4[1+0ZTT=7!//@#+ _@V*>4O)-, G" X][:&W_.0Q$6]T[F(B
MO6TI>U(Y#_K%&J0Y:MI+?0)!3BR).?FUAW">:(_FQ1R"4(Q_<]+M!-9ZGD^?
M6 0[J8A@!G:WP[GQ5JY)SHC9U*S>Z<53\DM/.-<"U1(KH^V*W >"XD&.0W>=
M[*BG)?X%(X<N+1L7[#&R"R@EI8AYW_\?3G46CT!.%JJ>.#\5,RGUB*F9%:[!
M&EOW@AQ%4X#*G?VJGOU)#V(!;QI$W$Q%\4%(X,K#$V%;>6<U K=!\_*)M<)N
M_CMX.=<UH^/-'/KHW5-J[R8*Y1+@]= '. [J"77'F4L>5%$P[I!7/@GX=ROP
MTF+;Z]WG38,L!P%%P0>R^Q.OB!S+&<D%7%8X50JYIR'#'^$.VS0Y2CS9D.W=
MWSD?Q@"]BOECPJUGEWT1-PNT5D4G-]R?6TXH_3I.&G6)J9XE>(9<UPBJ0 QI
MN+FS(G5JTHK@M);K?0)-@)U_2;L3S<+YEN<SR\<%Q(V1>LF*V%#YC#_YKOD.
ML14(602M X#WN<RRLW--+/Q5J4QA\->'KZG ]TH99(47 J6ZN8;;J+I%. 6@
MUZ$.OTR:\% DN$F$\:^?F-.$A9<MPGD*P<BH&P>TS-29I&+WF-]%"!9=U:L8
M<A!9@'9]S??I9#* P5NMVJHQ]EM*45X0E4N :G ;,SFV_/#N&4SIBFDN=4^'
M=;>ADD3O/^>!.&6_WFD"6)QK[EJ/X.?T-@[LH1@:DL.P"*GAGW?F]U-I +%E
M' D;]UG=@[_23MNH@O;67U= ^QWE/!).7<2KUYU'2JH[\CQLA'4FW-Q%HI5[
M%Q:4GG68Z6946#[O_.^&C6-Z,L)8X,,R*W*K#M60/.CHLQ"@+;WI^5Y;A#JB
M2*:0.:7;&_DONFJ>6D6X>,,KQ8C%Q'%1JC%F @5U!:%0D"M5Z>T@UV(13BLJ
M-^%NA5KKG MTR^MYVLQ^,E>(1X;D@T&_P[G@CTGW]N!&UZQ;UAX]W$,;R#J\
M_.X_1L6X4_K@KGP(ZT4ZP\>,<"CVH&2L].;[&,-A-\0@\^,;_()K6WC;3W=<
MO]!T,=S>[#JM?L7C[1;96R_#?&V][I2GJT3C8)YH5&+YZ^NS]TS)&F 3A##0
MUIE%P<L&?$Y@B2&NZ.!:"-=A=QDC"1QWHHOPP6+4HJVG)8YFP[][,YW]D^F,
MDIM$[(TNNO:*^MRHIVE%P/:S@T&^K#>_&I85S\>Y2R_6#.V)3_PF!M5V9'_4
M?Q!AU21GY7%78;A^(*+ON!F)YOA0VMH\691\Y/?X.Q_#[MXKJ #M(D.1G07V
M\\>:Y4M 4T!5NFU<?PUV09VSC1;4^Q?_"=TM#&_YZZ MG!"L]5ML)62Q=\.3
MZ==GQ(S XI0)3SB[97GNO79ZPSMCY:Y?$Q>NMJS)E+J9OQ+CQZ^91I8^?/F&
MG683MHV\G04'1"2^W:=GM/3OC DPOQVM\BVHUPH?EN5J)(+@63(3(K@ ^?]:
MH3E_/O> ]<<XYX?P$O('1(Y/N$9[ZZMBR6+Q"$#]!MS?II?N^KL\8TG=LB+%
MR%RLS.!/;(UBL6A+Z*)XB4RP@2^CM2MNSSXPT3S+/>RV<\X665L%E5/1@CJ>
MP)OI["W?VMO8E P7!P>JG=KU1,?T[0P561W*5RJY_&7K:,K^^CHA&N^[V\PQ
MVKK$+-P7A^05JN2E_BE6+Z@)&]#Z=)&'>R<W_X8ZQ2]C+KHMQ3)($K*5YV<+
MG:;P[POEJ$FMMB:$NF6+;F!COI(E?GX]X?G1_U28;7D31J^UH#6L:>9-3O4&
ME><:S4I(;_GL^^I7JTJJ3H;[FIY&_?_:Y_C_M?:YXTDYO2A.Y;883YWY$J3F
MDFCC:B"4 YP^P+[ZQZ@:<G3TZBF^)U,UW:FJMB13H@^2,>%,Z^;;[ZP/>E !
MCI-I#R!1!(/3[@4(D5@O8JR!?Q:@)9O5CBDU+BE'WZJ/K!\-HPR=[5*]UL8W
M2YS.-D%F_J=XHR&0Z>=T9#"H8S/A?[^VZV[8T(G,_O*$;L!O$J_Q/"PV^\WJ
M%Q_V2&].SCW#G#6]3![G^/K?HY1)1N1'VH\2M\Z-IL]:C\)ACB'948FD&E)<
MD]UA&P6Z69VZ2I[I%"75$?I[CSVF&/]CDC4G.8$UL\W-)M_D;E(%8>-FKOD7
M=2^C#!KR$LM;*#,MXT0K,<2=D:X_?XK$SXSD<^;JH:T0#_-JH,O--YQ%SQ\?
M>7P4?CG<L$G+B2L\-,#J 7T<4=PMOK6X4/=AFO&PF63'9\<%9'_.E"+=6I84
M=]]H9XP'Q+L/"-I>44WI!'&RN[-=>R8/$#84>4,AEC?2^.#!_V&->_^X$+9-
M(IT;5H;+,Q!;=U_!\VNE'43;:IA93Z7E(/5''9.RAR;JG;PAUQ.\7F2CKRPK
M<T:]>;N&>/G#U$)L+D'=-&/;^,XL[0OI.%8.6.\":ELO9@CLKI7M,<T*ZPIR
M3ZAQIQ,_7F@GRET+1XJX<!H+Z-'L+ #IQ13BK@\(ID%>*^LLENXR""_<:(_1
M=/L<;E^GQTTQC!M>V7^U+A6 H7CO*^H6>C6B]"OV$-]<>!PO @=27\R<*"BD
M%*3L.7F:*WS??!!D3?$DA&SRZH*+@D5ENM4V#7-W!ZH&U294^U02#T1"6+I%
MB0;H:*^B='M4R! K9:9*?'?WP?_.1<-,!;(^/[JE?5%X<"0?2X'F9;] ?UKJ
M:$89D]#1G-HR/6DG-379=58A/@,GP5.Y<KN+Z$T?B0*D[1%OR6DPYA(@I?KH
MP%MC:.KN7S,1!/!L433R7Y/>QG2/D,IRUE93BSN7U=86JWTKF "?K$3(1)[:
M%@(MM59XD[#;0;<F@<A!K$1M;!VX(KNB]MD9W_14]=U/KE9?X[%.R&,-[1J>
M'^ ZI-AV/M48NKBSF&SG$&T-NT_']^FWY+7&B(5:6'V7KT@3;/\8TR'F F$O
MV?.8HQ)W2?]U$_%*3R*+:T4.MF%I1GS9I;SU,%ZA:+WYXK#IUM7/!*K):L]2
M(414124/.>VH)$FCO_)%H[K ,'AK@YJIVUC*P(0\32)0K['16@X./K3ODW1T
MZV;I^I<QVY$;^O'*,X#JO:NC334$E(YSQ>&=V(8@)5SA#F/Q9YGR ^3\RXON
M7L?"]Y/UR:#XGE';^^^*KC?<F9^NAR#7*T<?#\CA'>%8G1W=<V><E,[)BO<C
M3K:? L)GE;JY<*T*8N^->+T@TJXAH5>Z@9=4?E;]<26)P^'7\,\L>='CS3(N
M",H_Y&^OSD[2PH1"YLE1;&0QA]0UPJ/J08/Z-MIZ@TG?*;7^5O[A^"EC0RE;
M@P>3VC(J^X]W<D+"_H0)3W5= M(3G"3V^QOKEE>^3;"R;IF>3!5_O1];A,\I
M<ZNHP8&^5EX"Z"N[$_![0^P.:#J<O&6//EYV[(0^BZY=1#-G*%NM6PR>#Z6W
M2;-;]OXY1>-U":!;K&5N=.G/D1)S7[G+AF2+S+VIELS[[OL""A3=/#UA[;+;
M^8UB5&28/^[O)=D^Z 9Q0,CM3OQ]]XV]^(B&JN4=\6"6A;R1#4F3/?6;@<#(
MY;'0)OX1YH7#]0)+&Z7R/6%,OV%"IP RRNU?S*O;? "-%?J:0F_;L9SU2X +
M)9@8)I)?)8=>D1RTQJ\/G+?D_G(@IQ4IUF@;%?''H.N_P%)WQZ)>903US-T4
M688'%*U&+$E<B?8JODE.M0 2ICA)B_ 7]Z_$\#!P 3^O'XKOX"MJ3OE.&U\8
M]I^4#["!TG!6_FE_;*4^J@6\V"[A3'$]+@HD3KA##>7W)6MXS&?\)'O_([>U
MVMVTJU']+XJ)[K 4=^1H/2I,,OSKC#CDN6K]QB5 =\IP!'I4)N%$<1[,&>'Q
M3A6\^$;O&5QS+OLIYJZSR3"M\XS= KU_!MUJHO685W/;@4^5#85E)O?G#G#>
MZ1*PW^I]"3#V#:$HY,R\/C'_C^=4-1UL5GV*@[[_GT\\2DM::8HR=G-M&W'.
M9["G3?%E"'-8"+SIV7Z1,:?CJ?.#C8GWYFRY+6FJ+,3H[BM%Z+AOD>W:M'%>
M4YN5Y7MKWG12N)Z[]W!PY;0U%X5;"@RCN^>TU\>X5;>?)A/CB), B^4%M0?I
M!">'_$Q)/5<_5YE: TYY$/(K@U3BQ+'9X)$4A*,H:O#?ITYQ7"-WNG+GHT$\
M4RV>)MC&Q\HB56VIJR:\^.?_7-*4#BZX>LY8\N[Z9\^$Y6& B!GK4N+K5BX8
M7S2+>Q-L8(9F4G0=PW+<JEZG+!<W1C3LK^K47-:T2W),2/OSX>3G[>:F'YRZ
MWK>]S;0VV?G.V-PN 9'>$Z=.I*!<5@QA4X1W"0A14<ZK-,%^"]DPO#.<5<.I
MIRO+84V4)NK?A48SUL/0D4>!1<XA5%+UR-3_DD!4(V#% LHR4.F03>[\YPBX
M\XWC[]@5@FG!=GZ 0JTO9*FV(5C@5M:\>N3\AHG\8-GVUPW^W7PAM]@OI],,
MSC4U/Z]OO!)<PB/^GCV/BG0M@'+X+ [4> F,XT99/K5A0B)S:9ZOP"&&S8QQ
MV8F'>J&;YA2I[IVSUX<]B*[]1(6>2X!1__GW9=G[.TQ.! ,*K^%!BV]T%71G
M&\,3><8U\3+0A,N) >W2HF\DT,O$L?E84)GN=E>2$CRDWE(FZJ%7WX?#WE $
M0^1"DR/ZUC15O4E#!>-?LYB,NI(KIDZ,3-FL!KYW/YW_$5IF,GX\FA#_?.'J
MU5NAEB\R]*QNW0]5OPZZ_U75-2TR2J_T'+(?CS6LZ?/.>=[K&N0M977T/C!J
MFC=IP*6(ZO6_=EFE4*.9G*=]?HV8HG/U?2.W+:Q2=,CA:?HEH*M&NBGD0&S>
MMTC8MW!-33.X_%QWWQNY <T=W' P2DQQ*?US"1CI*Y]: N&&'OGKC0^]/'<A
MB0YE2F&-W\<JDZPP8./\!TV#'BMCN:*V%K\[/5UWU6A&L)__[K0>[(>$;"2.
M9S(M=TL5Z;^6 ZY'(,I<L$Q[04;[N6OA([FF%B-(0L\$C-ZBHR$3-KN"]1K2
MTME#NB_1E3I_[LO&I?YJG?;AT 7#J<G+#I\FC\6O6=U2?DYJ;)E:[6/*O3T:
ME' @5A>(X9=E7T/U3$5&'G3;R=I6U"/2W9PS<8IE1ETWKEO(Y@UXK (J7/^(
M%;I3-?Z0/**]P!H4!::U=03ASN.EY;@3:WV%JV!3<P0CA+ZIK>H4L@SE/5N1
M4K\;T#$61CN@B)9-_K[CFJ']ZO K]*+Z7#UN;M8E[A) [;ME?PE8$QI1R*>T
MY+KX7@(6%^.:'O10JH#OS]V5Q+US*L::D'[;40;:V<OL;<DO+P&/1?JX>KA\
MZK\?5HKX$^3PITU')[O.:9> _M;UDM7RD2DE,R<R=TI?[]1AFD_*$%LGHM][
M?Z":4;71=>L;%1N9/.]ZG57G\&;/!)C)73OB:X63Z%&9T8MO&/:G\&KF/73X
MX=^;_M.WO4ENLWV,U_P2HP:<#HVV@RJLTI[JPR?.O^&D*G0??C&$92?679O_
M0)MZ=XX_).#?+WN4Z&C2:5:P;7J4B,W/[94U3^W"NSI$DX.J$HA+GTNFIA?T
M?K^%2X5B8=#[DP>@G6;5=?U5M"Z5N%VF!^\]JC[4=45?TQC5S_MMHTJM!ZFE
M:L6A?4>[^B$8ESUKH[>>_MIK:FNI3A1J-Q;'2P!A:P]HI>2:892BC^WED<\]
MJBH40T"+>;X$^*QN%8'O#W"/G#]T_]8A"H+ 2\2[S*:Q9L0KNA+U6OEP#6QC
M+_TUZG=Q#OP "7]R=K'=U.$.:M(AFC^; $4/KC<,Y7^>SRVYJ-JZ!%CXWMY4
M>^62A3(C]'+8=_-BXGBIW18KL(-6?TC7U&5**/#0?R4+Z][IV2P>5CY84G&C
MT??Y;KN'PYQT*G4O/>+C4M89XQB);SEX:K-D\<(M98T@SS(CZ5"UW:-FG#&5
MV;N=.Z6.HWR!@NR'^VM-4RN@4P?36&S?A9'4T.ZHZ[!&+!3<TOE#X.[VMQKD
MT8B<0ZV @N9> RXLA\#DILVIL_R=))^Q.9WSQ90_-+, P*#CZBJ0\*S37^!'
M^:^]%?^W$IZ\05?BF[_WLGL-73\?P=SRF;FC6(%XVNR D2P(!O3'?.2$BTQ]
M8G8GLG[[3<7Z4IUGFZ%:^0$W(X>U)+6"E/O/;>]"-,^S)8?-3(&OO71O_GSB
MIS%Q7FJU,E*KYLT>S&D_['"#M#]V;O+\$979:"W,O7)#IM7O>0"L:[16-=;\
MM$63.9JF,>SGWXJ,#K.:45[E*!I+)]@2OK5$!CE3MLRG['4&9#N<6$87LXA4
MII\W:%502Z\C8O[Z9_2ORP^L<+5KIG2 +(W<(\6X'K]<K/4U"*,5$GI[#-P*
MFE:Z.42B.T!/_.L1"83FY)(/7ZBW'CSPV(0EDDX7W'26!CP1IMCH[[40)N*"
M5=#YH6";$#-V?ESZ],&0'>4.7R*:@.>1=$H^A>0;HM?#C3VO:E:04RQ[%7^D
M^,0U)&3><&SP7'-KOE$6XK6I(%V3HIUD1DX5BR:I%2,I_Z)WAXXJ"^!\#R*#
MR]=:O444:LFZT@C?3\CX/I"RN<=G:@[A&==?UIDAB6?]*+C;D>P&^1)@2'8@
MX!T.>LUF30=NIJQ]'=-O;!I/3ZX6?=@?[!YP&C%5W^]I3_GTFKYQ<4_B$A!E
M#AF: J<CB4B%2X#'M%1*MOR8F2@(98E73%/VO$9S%,=&[K%0E1>M5LH]P[34
M3+3YX_."B$CY2X#/+ '3.3JE);5FH"FYT4C#Z9=1'J]4:2%^B+$A'V)3:&RW
M.V5N?HPBW#TX&>OBKK5MV%C@&*[:\XWG<$)/CZ-E1R_D890*9[$:_YHC*J!'
MX\ E8#HM'UUU_+7=MX4?1N#SPOR'4S]S3\*#S0LG\U28XYJ M)7@G&EE55&T
M0':[GW^-R#N?5\<+KO+ER"WX%R,V-!:ZZ?:/;)UW7#!P&/#4:&%:] !9$/M=
MMUC,\=H.4-T7''ZSON(!V(+@"^,Y?)2K84U+TQ)>WX\;Z,(O28$NE@.X85(=
MK %P^? K9L^XY8]D!MR ++Z<;7',(ZNP$SAM/.\(83'7,#>F!O8>E&?I7X6N
M$TRSF;)Z_MB'SF-4-;D6LD=+< ;O=W5J76";4?/1T$L [8AHEYRL+W_&S-KT
M!Q]_S_\%!6_)4%C@3RU".KR,*HJ#:8[K^IQP%'L3C-QIH*F!><+NZ=WIMV_G
M4I.^"DD7\((D-UY]J=OH19%O/=@I-)R=#.6OG9]D^EWST9M6/N3]UT81F5,U
MZ%A2R7*#PZ?VJ,^'I1332&NM:SZOBP%)V\!2_RJ'A,\0(CI2*?CKD\B,2N4-
MD>VB:?!DTA?^%83JVMG5-]?#_NL&P8/[CPL?_G'G6M!D&UU+;#<1H6).+OL3
M69#E6(Z0QU7)7)O+DQ<D992=9+=\G%A]$VLDQ]TP07[Y5T9[B*QTD0MBJ,E^
MM4?2A\N.&SB.21V>R=(PO1V_JQ;)^8'YZ,M8DO)<,-M%U[VG"'[(O^])?T4L
MLYX4,RO'FI</J=3_50ZWT?;_9S  C'9W$[?[&$HEUIO\9GI3.J]P0K/9K)9Y
MBB_ 67I)47( %^"VG(O;,)]3:'2&S_MQ2H(^.DSF+ULL4I_%7 (P(C]*/*B^
MW?1-9M IIJR*U/I&&EFWJKUO$Y(1P:KVT>7_L508]$^^.8: YJ(*@2B'I#.,
MLE%RZHG+U&,C' >$PS]]$U@7=Z,]*4OA)R>WKM*8H7[PD[IW \IBR0\J=Y]R
MK9LNIZ<^6%+C3R'\^7NH=]]=NWG$;!GXMW8-N-L8$I5"<6;:)=IEN8S:H!Z,
MIL;5UL?_TLQ81KV:LK R>CGXI\MI\(/=]X?H,2V]S2J#UOHJO'TWO4*-AOYN
M1'G-)8"_5 (3'*)4\_=[X</Z/]_WQ&_[L,T2)Y(N 5^C CR,NJ7WA5GGD"H8
M0=(.^NC%0[MBCZR62\ 3C(.W_U=/FM_:-C.IIO6,0S8VRQ^9%S!@G$PN^[C>
MGF,;,;W 3RM^PSE28"S!B#%22YJ>[^H=.09_TXFGJ+0F)?^9]A$SUAH^<PZY
MC+FK:7-1IJOAO/M'>@/%'OZ54@"ULA7C,_*J?-.T',,Z_#EY$Y"J=MH3!>3L
MW\D4 +IT0N)75DXS,]M/58@_Q[]^2>H)33MD5AZM_08K1AXP:']F.,7 X#RV
MRU=\'Y:C*J):)9*C3-M)2HT$P&+<]2COUY!TTOJ2I=F@>86VYZX_'>P#+;6H
MD+O;F;'<7RBN'#DSTWP(7,8UN8'_N:T8M&Y>N!RF/,?]GOWY\]_4)JNW2_&7
M$/?X:1]XT.-?HPAJX 9E2"1%Q$A\^1(@U>"2#DU>VHG<LF7V#SSA?#6Y6+7H
M?^VK";15#!MS+.70[;TCY\;2JS!_WEJH(P76WZ6QU$$J(MND,J=?R-S&+_U2
M>H>/*B<&2:/(CB=^;GHU<#[KMVM9$[_<+>IIQQ/+*\6@/^KZ*ZY-2>7U;=D[
M.O68;X>D;.J^'W\_P$>*TTN;[F[C$T6Z\ZA"DEPV04V?E>,KZ6)/ZO<R#C/J
M!^1N(MPXHQ9V#:#I>ZEVW8QLY+A'#C>'\FMGJM?Z#$S,7=4/IXOC=>P/1/.F
M@R2R0#ZV&;J0HZOJNY5Y5<)*W98?.J.&PH$2M7^%)D>)VEI6%H&"#OB[GB&&
ML9K,N*2F/OWB3)'!>K'ZYL Y:?R*#X[][)F6UGT]VL4,RQ#&7]-FH T+Q4-K
MKHWTN-X=K[NE'\XJ21.8A\BA^6.59U:8BHC_=X;Q$O=_*6>JSYNM!U'2:T=\
MM:BT*$8Y-7??G+OW0<&[P#+.L+-+@%Y T(>5I<:VUP]WAY3E)N@8)O\Q+ZG"
M7=#N<7]./,*3U7;.SY\8M@X]G;5I"?R3[5E8MPF%"1572&8#FTS7LJU3K)LX
M-RN<GQ!"!>K^5EH(L,L]@:6<)U@?JQI2&?(ZN?X?.*&JL=J2Y.ADK6%\@.GZ
M-7MX;F% :AG%/^#PH^4[7).5RXG?-^S-R*<6R R3=K#-:TI)&'@*[(OL0<YZ
M)V]'5ZQ= N:#Y"XR?%\G-ON*8Q."\#L6&?P]L-D1-6>=0/N6=CK3.<#W:U<,
MYYH5;9WP]+_EQ8H:0#37QX>\7W!(>L;9%P#EK#5F$PBOQQ6''NV8_8H=^F;D
MJ:U[S'\F&36OWNV \=)L83OV.ZXA[PQ,!&Z<^6L_@OJ(_P3+OKK1[11K-:@P
MDF;W@PE?[8Y1J4 _S(ASK;I;[0H!ERO0UH^E"DSK7+L" ]A%WJ?19F@(3%G7
M\62QIF=.-LJZ"W-"TW29=3V)+786?\U&8FYU.RH[090U?>A]>[QK)<O.^T(9
M[1K8L WE,CRP:)T<_>,8_=2Z4O= ^P;6''='^HJ^4O#C1"EE"SX^^<<W3!;L
M([C<#TLTZ@F#:K=_HV&;I=,=8ES;(Y#I%W$A= 0S(807S$+^EYR!8)O1Q&%%
MLV?^RT,.K45R(\BDQ"<A/G_^E*F_3%J#>RYG<'#I%JDH[A?TN/= :WJE^**(
M(J%<<W:A5[:?:@RRAPGR.Y0\]24%]HV$?A!+%44N X*?&"YMS>8#\9#I+7B0
M-_+40SMOE91+L=O)I121S:8(<#-XQ!&T-_$Z!=0D@=IHW7)8 \,=_HW\[^3-
M!-Y*9U3BBXNTF8*B,-O'U@:)_Q0EBWGOC2F&3=^V^,1I/B%>?^!CT3DIU1_"
MI-DZ%5YX\0W,[TOY]"MR8HGH?0G8QDL,\A:>A!P$%^R?BCVH9 U WX\=^%!F
MU6/[U$SZT^3XW%CY"(6J&E4%CYKE7-R"+R^>=*8Z\3R[V'I/S&$*B*VNJB@X
M4!CTL4[N[K=T]&>C_:V8\AE9Q_;:]MB*U3O#VD@N[%Q#9MQ_A._K2:N[B)&P
MR]<C(+7A_5"ZZV(B%V+<U"JJCA2G K,[9D$F_K\&F"?=$/_UC3=Z;B;F'<GC
M?+%N[3"5,N;IY_PS3;6_V>6?J)ZW)'>[.\YA:+HXM0;0AQP5[HM:_1\<OX[)
M'K=,?C)\'=U*;0HC>KVA5ZA>P)&LU?W]/>>1$;WLEP"98P[>$O?9:!85:,90
M:'4N+%-?4F?'Z1TF74AD<Y-7I.VC_.Y$ *Y-!G<)2 6SBTWC?5LR2(V9'RWP
MGY8T>K[Y?*/^1;9,/<-?*)2]G^R($G;4$+<.I-:E:\]X!=F\DROREIA3W0U9
MQX8)Q+BCUXS9?E0%+VQ2:Q-5QKOQ/C%W,&P+'"BG5F_+]$)YA[H-"WN\R7J3
M'51(@0ILX#-!MY0P+4FT,-?E2I)?K&G),NU&679ZI^I+)K0O6MVE&_*8K%EF
MKW%RV(6FS\=R&MQ]-V/:Y1AM7],M7S@SJQ<@5IZR_MKH-L@41@WW5?B.U+U5
M%KG,Z3LF3#XT7/%6J)R'SFS::OG\&4"CX8%N<3K;Z0'G(RT*XK:)F&P"*L%J
M+OSY]+>M1+NS5I_#K.?;O.-TIRY>6[4U'3*UX,U+0,L@(H[RE;BQ:;WL,UF$
M?'<4%$@@K)[M<-E^8.>8I=OPJ9+K<"2FB,6^W\-O9HHU-1-RI3A=BFVHFXU"
MT6W4'Z2)';[GK?+=-:1"P5S/N"EMF\.I1>8/2:/^B0V;-R;)9^;,>M[CJ_+E
MA=5W$C0Z0'K3>EFCF]+@Q[=X7W8GBI[]J9E:3FMU$=5L+E*I3#^('<JAK'TM
MCWGQD,O=,$0J27IGPV9E_TLW,0_C$'>H@B8U1&R,T,\?*Q3OV]0%;:USBVZC
M^B$&I%.S/J^U$.%8[(F/]:#PQYMZ85<N'F[PJG<-C54;FE>>YJFQ#MBN>9PZ
MD#9&E%W$IV>M@%+'JDNI#:VT__-5D# C*T41;.YK:Z$):Z:U0?6;A</<+_Y4
M>G"KI^C][<OD*C!P25]*U5# '>',:*)V>TB?<Z@C\I-S!*_S7O'/COM9-9QY
MP! &MQ#?.XM^E#M4G3T#L2@.N 203E\[<]5.6X6%]]*.@&XJ '75BI=Q%?&A
MK@NQ6*I9J'K3(C;W3="#X2 H2=:?Y_NP]8L_%;7]"?O^H":DA"!-K^  .=_S
MPN;B]U*BA2V>E9%I1Y==**5 P?M_[$I^,W*,G:,_2?)?V,N316_:QQ,6.G2<
MVZ4=#<=JT)LX[-GT<?!17YM!Q0TRRJ3*YOIGF36ZPA@&M70ZJ_]2*IR[L([-
MQ(N'M&D;SA1"IQ0\\?/PL5-OPX#:<3KD4"L6HTUE=-,S^+"A->@%8^FP]1=1
MT/V/<K3K+V"*>)!'A ?0.F!KIRFXY]2U78JK:]B3'FS<7"?UFZ4%6R#G$+4N
MY6F/@1 6U?\-8T\':4TBQE5!6?K;FL^>T?<>A0EXT+:4LIA=S37"1EW]=/4*
M#]ZO^$IBGWBPZ7DL[*PL_I_\)IU@=>)6YPS*A[W59H'/S[IXTVUK)Y#8W ]#
MV<XLB:;*9 H,E$N9BPPY?9CBZ; =^'@,X9,F+#.PVJ55(E )?S".4\K$]E!7
M"'FN&>F7,+/&5GD?;O B/SEK8*H9I%)OWES8KF]0*TOLH7K'$%%4ROS&A.&_
MS J[8Z=<=GMR5YA<K]GUOL&Q3BDX6?)G(\,=Q*Q]GFEDAA"K1,2<?X;:[:F=
MM^F99M'V9*'IIO GH2ZW^G:7E-@H= X=B$EXPE.- 7F^,SG\5D_U0BL=IVKL
M)>"&C[Q^)*QBN2F7'X? -H7B.$'Y3T 2?5)I)],B(O\USM&MV]!T4X6!'VZ%
MFG?JI<N<B<V.'7N2 Q"$Y&E64NDX/=_MM*-?";T*!5$\;S2UKQG\T-?OO>$\
MB8XQZ22^'.:0,"8NL5H6:Y'$U)T$VH328A:-S*T'I"5\Y?BK%*['L&4HY?R
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M^7SE)C'N;H ^=8IN[?K%&#!J3D?^3 F>],I@^8H1R[7@?]_#T^23^6Z^WEZ
MOWH5W[$!-^R]>HO*M>A?MIU,\0T)Z;J;VP ?@-RC^5L+G])R5/%7;[$;05'O
ML_WNY.E3^1[>_Y1(-Z8Q^FJ%?,PT\LB31Z7U@/&?F89"Q&1PSM]B)A.AM+53
MLX6,AW0NW*$M[84ONV O3\-Z1 3BM83CT@Z?W)/C\0CGH1$C7V0Y&9SW: B_
MC!Q(S$8PS\"9 ZKW\G8@;L=\6R:6_T[:C#H_.2%-X"*E/<C.1W(>BFDIHX\.
M'Q^\0]@Z*#O,Z,/2XA3RDM)SLJ*D8"RQ\<-AEX!E2$T9%Q+_D0=,@G#73>9L
MG,D&149+]8]ZN,\S2JDYF+2LB;64-9?G/^A[EYC>V7]/TVN%NR-,MKY@I_#M
M*&F>GA8M:V;-C D<JHQ6#<Y;R^/FSL:"N4+$$J7^>2Q?,T(S9<7RU]65>6F<
M65[,4(=L'%),1<@I?52&!]W[H#C)\=C:3Q6T3A7U X3XKME34!0>$W-ELEAG
M]$&4+]S=&6EAL5,@-R",7>>6]-KXK=]S*MNO[RRKZW%4,TU0VFH5"7;HWVO<
M$LQ,;N@$JFZ>C6#I63KCR\+KF3SRWS1%E;Q(\YVW8AK5:+Z8M<R)%PZ!0N;>
M?#.YGSAY^&BN?*W@Y(G\.7!PS$"86EB@?;%;EUXS,=OR4#@TD"5!L:4W#E<F
M[,J8,%AHGI$#C+T;_)=+W;O5HS=4_I723,DE()9W/K<E1V9J*'GG$J#_\X!N
M%4A*7ZS@]O<$0T;.GLD/"+7+..=0;XA5+@@J:& D"L &E9E]\Q_RLUVG9F0=
ME&(:SMY^"%,9)UILY<IVPCPP(GIE4U>\?'QV"2W?[>>IJ4^T_0&/^T<%S4&(
MLKS)E<>*0+&@PO1^"0[NK!5EU%1R1X_Z"IV?:-IB!(*%I;Z"S;0H"JG)5]OC
MG0)"=4_L6VSC"[1G5=,A'Z( 0;/@MW]K.W SM4Y@2 &##E5\MN.(S,J[Y>B,
M4<O#T2\EL?8(,SOO#_N7 -'FI:&G?4]CID\E$K?4/46TF*Y39;P*4C*\ 5,
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M"-@9G?FY*EY+4D8!O=9?3[FDTSG<3GE.XJ_OWW71\(=4>-.]/6('+7V9Z&=
M6/IEK$B'MD37^0839WU\H*?.YGV(U7UKL'SWX0[2(=MK.ST<8_OF7&I6-6ZS
M44ENC!/^:Z57.LIT_:FI"'BR*H+4!Q[I++8QIE=4A9Q[4S[VM[SP+E9(%1LL
MBBOB5FMH&6U1P8@1YMW]N6,V/ROB&*4RD['+<K0P!])KR.0T[6W;)^?P@[=!
MVK/0+-5#/%@JCL:,F&$@WF?(W.IGQ),6$?SY(N8BVVAX5ML>Y:TG=WJ,4EU;
MC5B/;.*#S64V["\@[9';ZYE%WOY3)5M\U8B7U@S/I"4<K#YP&IA93'L[IB%R
M'<9JYI # 2W5#"W[;:05&PIF'6DP2OM 9!>4\HCNQYI6,PIA9KFJ<MO-8]*3
M!J?55-UZN-1EN92RJ9;Y83Z<GT?[1Y#4_@7DH!GE%N8L%@=_B&6.!JVHIL^#
M/%/3+GX$N?^B4/]RW *N.PCJYL2P5>2D#V38.^/=SE+.+,01++TQG1M[1=S2
MPRV,)%PB25M_U[R&EC&OIJ&F.:/+HW5M:2"_JC9KF?2=,^;WH8U[-"9UX83+
M1UKZ;AX2J(*"3B].@<56NQ'"]$?]Q_V#M<JSV4'KS4=J/]'(X).9FD'PX *I
MZ;11>W<*%$*;HHUVJB[0"  Z3@!,B]"^\P3DCVZ<4U3.OPFP')@0GL@HAIOF
M1J\?E$@O]_9],/ =S@KN^J&;MOTUL[ "IB2"6%)4+RSS52R&/);1?C.]% J'
M1]#QN?O/WZ=_(Q"!#$7OO#05?HC2MV;UDS?3D<^Z! B[>5LS\D*.0M9O<7-&
MRH.*'C>L4#XLHWC/*F9F08WB6V^7=@Q!N\<K@UO35A- IPI0]?/#J'AO/S=.
MX>8$USP/33=([;]%L8[ 7I.+#;^A>2[+(KMLHDJ5,RRS9J02GT@J1@)S;"!0
MP74Y']JYA7Z_1Z36K2BW5? B?MW*=.)T8GN_N\W3JF&,,>6LR 3,8PQ:JWLZ
MD:&WCG"(S"&/QP\JK=9H(O$=]<[3?W*:$R=4 _G')FJG*NH&(@;J-?\I/&QI
M%Z\'GT8.2,F!ES"[/3C_R OQ5R,M'6Y;IRD8I/T)FA#O:'1KT7MV'A5S/@,!
MUA\2+P$!A&"S>OLL+"]33XK%2M#>)GYU<9Z.L?\ YY;[9QV41'!L="@=D:=A
M;\$8<@VF><H"M.<1E1<'9KK$<^/FF?[%R=X_O8L])P?;J/&JS-%#7BV?BRF0
M\Z8G9];(F>)9F<M(SR7 8"SNX:!ZT<:41(X8_F%_<0:PI*^A*;G7?=933JI/
M9=WH)G556R6E?X@]H_^\(GOS8AUTXG.*[(D'N=&O1HQRH9,=QVF6P3YOL>$!
MR]M@;FWO5IRW!T*S0 **,6A!+7'7_J'Y0+>"AC:( ^D&(7$^*A!4\V;:COZ!
M=54XNT>1[?>-'^[!$#?G8*H4 %]$R)@ZC,+*[SS$%6AL=BT5[=*G^D^S-=NI
MP8)$J,3E6,=PX7-% E<V.MD?U^*CN9NZI*'$E;;8O37LI@O[-?-IR1\5G3?K
MI.W.<1]9#-YWR*27ER'Y.X\.?^B8T4>!*"K[AC?X2LXJS[,DE>]\Z=+@,7.^
M8,MA$PYU5N!Y57S-ZDD7+"^CK.<-6[?LV[AR<H<I)"-IQ]CSIKS]M_I'B4FT
MQ-.R35-3YY\I=9N]> X3(X&7\5=+.!+O7'<PJII+&G[Y[.@0/%__]I6GS\5:
MF7^T"^TB+WA,W4WT->;LS^0E8$>:07ZT5/P_?FHBZ8T[D]*,29']-UXARD__
M][TPX7W9;GD.37RNT.V,"J(KYZ]0D5]1'(].O%3!?L4(.:T/RO5$-**]B"^B
M"8P>>*N(-E3)W"&;E2857V_'0F8&A=^^_+!(KF8N9/Y\Z@M/"/T>0MMV-:.H
M6/824+N6]_[M"OEP(2GAIV>AP#B=UX]2;8Z"O, $D^?TLV3-]VM)9WC&%R\R
M6Z0-(]Z>LVT7[;[F>,(ZG2]4_0U_UI5Z5+_$HF!EV(:N.LJD?:'MGL4L>.HP
M&/@@HY]='%'Z1ME%QR)FXJU-@L=9Z,QO1D/=6O1HGXY:S#3PJN83Y<+QU^.!
MV\B<Y*)^ED#?B3/)XS\>9 M/V[2QE/^'LK>.:JO]ND734FC?8N6EN+5 D>+N
M4$%:M'@A2'$)%@)! S6D:'&7XNXD.$4#A. >@CL$B@;G]'?/&??^=;_S?<__
M>XQG[3WV6G/.,==:<$]D$@_JH9C7Z#3[4D[2,-T5>0HB%.^4<C*\;SSO,&,1
MT2PUF3)?YLG$.6C[P6:T@<#T9W J]'X!;R5=0J[H4'(U9B\%) 'Q&.O.DO:R
MU:F+7<*D[?U.<N/G)[G479\=8J#&M+=_][C,H?U6=I+?R-OOX:_;HALS_OI1
M,5'N[PZVR1P4V_<W=X#X>:V+66[<;<^@S\$'D=?]<6L?;)ZT$Z&HPOE0RJO'
M-'KGP<6_),4_GJ("]2Y!9V]:Y.2&1(P(AXJ&"U*ZOWX*-L2J2B3^L+V&WP'&
M)A0/JJVB,NKCKQB_Q3GXA[P@%9?RD(=HR#LN$:<5,LL[-2MLWY.J.W(1L3G?
M'^\4#5X8>]?#%O[XB)/^L<MS#L(E2<-=[4<98GJ@D+D";7DNFNDP>_WW8_>J
MHLLU5(M3_%20A/]JZ&$E7"XM@L<R8V.SMXL7H_<4>\/XXW^">TNTC8RE=0)]
MP[S+LC=Q5)<Z1<#&A:,8*LGZ\(CJ(\?Y2FDG' FBKU8=KF8Y/K@*@3#NI4I
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M@G_\6.:]RIR>:UX8$V]==(V&1/4C7B2NU?"'NR*]]),PII9;R6'J6@554R+
M<]Q>6O^2?5!+N4,V*0A ZJQA3T,>3M,^O@/U08FXFL[;&7E:F3M*D2>S.=7V
MK?:3MC:;\O5TCRF@OA)[IX7G^?6!Z(7XGY&6UD-O*A+R3>1WQ4"4HH<IRQ1#
MMOYL$9<L9EF%G/D,KN\#THX82Z5KPN0K3M\P(HKD/@V:,VBLP\'),W"3Z+<U
M[@1!\/?V9[\M9UQ,W8ZDHEC487RS3GNM)?->*J<U8]=Q0[7TP"VX:&&D>3I+
MJ8+)VN7BSGQS!(WZ'CP.RE3>4H"R6T1I,AFYA$U?L,XL'8A.,[S:E[SMF5FP
MV820R_6\!.G6-D"?HPQ80;&:G$MZNQU4?ZRRQ+QP>'^] M;4@?F63'GL@%B\
M^CEWDM>?$FT**K4W._=T-$69!BQ$@Y/2=].S7L8"U=AN0&(1TG #8:$18)_\
MUJ  :+U;,BP)R@N),TNS*@ET<2X#RC9:UNYC5A6^2\:.:?%M@!IH+Y@O-A(7
MYAQ8$?^BG\<-.)4?TO;80VE(SXO#84,I$!HCH#2K0Y=9(,XFMP%=*SC?+!"$
M^V;E?EU!SH'-/HA70M2/298J55.\"Y(6LL0?G VS8$;F:RK2L.^&%:2:HWJ)
MA,90)&06'A^J(/)JX<7<C,[VQ1 $R7M=69YE) JODF;(<3N37$OBJ8YF&[+[
MKJA<*S(@U70P$:TCK?5. US0I&"3M)FR1A8[=P<P7E 6<(]H>VWP;CZ]Y0Y0
MEE)X/?_\H9WT\=#%Z10CC6GM7CPJ[OMZAA,\L/'ZF%F!//\O!7E_&X<G6[=I
M'=^Y:';]"MN%3@UK E<C_/OO %WPP*35K/VF%A'U19T-B)WQ-Y&VH5H_!$0K
M,'E>WB_D/FB]JOW1C (Q+8'R4I,<PL6K<1/2W.9N[L50D3I<VBF;JU*VB)@Y
M*\]S\H/R"%K4!B4J*OK:]?K;@D16UM6_$I'SIC[^.9=*OY=-L$5<LW>V'S./
M][?'$85N5^0,L05OKIDF?6P1ZSP6LEHBMR@,(W:719Y]>NB(P\AC$\_#B\>9
M1:XR;;!79].DX]:FTUY!35=VWV6>QWC< ;@&WC+QD%FY+^C8-MD_J>]Z8@5W
MH77A9Z_PHAZGYJJD.[X9BFO:3\L8'%0\ 2XSPLKW>3Z,, P0 +\9C]!/12Z)
M?B!WGUW/C=S4WWU&X"D^_F J]6G*2J/3,^?E2!5'CFI&*LR3Q5.=%JX$Q8&B
M3[,'2"BC]C_?5!H8%=P?+1'Z@2NA8[]$.OB''6\</\0W^-T@F7H(66$(+@T]
MXN)H,J:T4;$@&@727QH63__H'@-DH)\*8VOI]=FR0G_A#MYIO>"4-6BM6\7H
MK85Q-:F+7XL79V=O3OB#+ZOV7RL-/;25D8%SKY?P/"9<G#4-^T?;*_#3E=XO
M=7S<&:L.B\O3#T\9N0H^3>1\+Z#2^:%A['KY]/F3#QKZ8B\-,;O:.D7ZC^)5
M.3Z<YQ1Q4>2D/AKE2A5,*?"S2U1%"<Y6'AO]%F]4BO/'S+[NJ!D@HE QK9'_
M8K";([HJ3Y+\!QLKW0!DW PY0Y'S&Z78DAZ?:CH-UO1]78VUP6O4AOR,;H0%
M'+$\G]^H&S7,N:IO<F"F.*_IF3(J6%@HOG68@FGWO]N!411:"AK-&PF*UX>\
M_#8<L^GC7T8;U]UH'6Z)?>Z*<CE&N_PX19DT[O@CM 0=KL-6CG1\C*\^7Y#)
MD*/F".X !>[B?+A1)T.Y0XKUFQ)F<SW(GLEA+*;=2Q3ZU %I)97/E74;W75S
M<78'L*QC$H!UM<P?RS<VQ2QPB@,V8Z%90TWL5UW:-%YDD4)&%%<^XB Y@ORR
M;^]0D9B.*WRMO&-,^T]WQ)9R*P;;<P?HT7IK#:^JKKT'3S1(_.UTQ+=B<5ZG
MKV:V>] ,W$\YK6Q1<>!LB2^I#WW4&3\3LQ*Z4LH0Z.H>E%0VPQU]H&FY(<O=
M67_%%<O_=HM4J^K#,QM:0[N#A=#\IQF"L\B0D>_=D \>&'!G_3GW=$S.C]3F
MW48-[NX4'8]"^[F<F-]!(OR#@5Z-L@/<TL;3JX<R(TO9FV<WW,7FA)Q2ZF]D
MQPQ*>AQ'Q3+SZ2B-2(O)T?SEUF%$Y!1PZV%2&@'[Q29QW O%<_B97V"66/L2
MW//XZ&;[A#\MCJLVP,)__$97F-2OZS!V;G8QF14L>=QRGG?.M00_!M.Y;-4N
M(W!9-,^%ZD7_4K/*-,WG@93<)[HS>>4D$;PSWCF@_MC(.I975ZK?!><0G+>-
M^<?IU3FU&G;L4S-ZX:46FQV:1W-^8W1NUA<^Y>WH306=HX.,,4/W\5B3&@-S
MP$=&%9Y&3HL*MON.U?M\.SW\H_#V7+G:_BF.U;?-]O@5&DKA3<K/"K5?BQ $
M_2T.Y<_:[@!:@KT1C1 URZ3/&U2@Z"=4*R#7=-".9?)V^P".<WS */.+W;%#
M0*Y-;<U;I_.#!YJQG\;HI^;;T!O*S8^I*7_,D'KQJ[@&]B]:HLQ7HB_JKDWX
M#\B'<< (2F0.#*X^O'0Y,N[S!5VW_S95"NU7RYC&V^8WL[0AA3=0SUBO8% R
ML3?T]]$5_3].@[O1_YDP=E1_!WB^.!%W$U=0<,(T.G@'B#,$J<.'A4_),]:]
M9&NW<93)BICYI )6;W(1_MH&E("(@7Y^(SCXX3^L@^PD9"XW]P(U@B^]MA7-
MRB];?_HP.>V:987??(NW39Q'M$IL,UO3^=E)Q B6T17DW.=!Q?J[S1+;*W ?
M+70O74K\WZ_'DSI=/^AG?":77P'Z##&9?BQ5X?#[J^"S7UT? _3,:GUU!=ZV
M?O2-VF:/H<T=D;/?87Z;5%?5RQ+;4^S"T>=".ZY% G?]JDS_H?YWQ.,+SE8<
MIQ46#Y3Z6SI0_BJY)0YGVI?1)ZX>B%88#Z:YO/W\RLE0Z[R)E3]:?U1P5W@E
M([-&VK9;*L/$#:3\8FB>_JF'QO@[@7X7&=^*.P"(V]:8F+/%BX"111_84D;'
M\\<R6KV0B=6*?P-&?3N/@37ONZ02:*'>]F:E;F02N*\>1'AOFOL&()\[;0S3
M^R7>E+6F"[WY\]8G75,@,!*Y8-"F5M'$A>D*898J4VX3*6L4X(Q_@ITAD2<.
MG@>J2, ;FU_MU(,177'U;M45H:*K5WH=CZ-BQ<DIY^9Y5EC;"453EA\U[5I%
MC+H>5U.^ZUI7F'=@6RD_JMC,I1FJ"6""/5+=SNQZY_.0YF? YQCJ[D-U]#&]
MDAR?KO"/!59[Z-[L2?F>A,HC>SOXOO.;I2>FP2L(W%24 +NZ8!(I:W/KPO7]
MV1KCI,EHT0H>F0>''Q(2?EL$^5&5IPHM4ADGRGT>6=H)L<"G*C_#EYU9YVU-
M](>U)6WY73*>AM\!E.X X^$Y$0TQ1[:M?'':'B%B'G$^8Y1Y(FSBJAKO^5C&
M]O<(C*$ [J^7N2>[#0&!VQJMWLL[/0K[0UE'@PK2[2;-O&>N$S"<*,*3VH5O
M+&L#>! X[#QLDN3M\^2_,-VL@6X-Z/KIR<=L,XX?43IB_=)#O\';%CGAU9L0
MF0=Y!$H;[46(.X"*LQV^(JN&1>T.4,BK?3&TGM4Y"+UR2;EF$3'[AB/)4)^B
ML:8WMO]%]WL,8=2MP7P'(",>=+O6N5+8#OV+II/7[59.W7L%=X,E?&":R\JK
M".AZIEB23P9?RM$5UN#4)ED8Q8ZV9@VYY&MMI.+C=\)'Q8<Q/F(VX\O7G 2=
MJQ7BFYNL)O&HWA]YPEJB(:"-F)E_H2TC>K@#XPD/3&6FHTEO'>[R97PP0X$M
MY?$3LA$ \LO3^9RPH[*?O=N+NMJTDA;U!KM-5IHO@4[K_^D>WO6&BI(0]13"
M)J: B4;]Z8B(3P"JFZ^EFA>;?&E\P8Y3@EP:CSBW.^S7F\K.,!H,I*7 -V[W
M&@P#;WBBVVS+BT*#;4DG)%U6O+_6"]C5QKUX4JX!98$9_)-%[?H&5U?X.R%J
M7YJ^L*@D7U1IX:4+&[QA+-GKWTH*7D=^T8=1D]Z1^NV:O/Z%#D@F3!NQK H1
M\?7'1C2H)OF>?FT4UW23983B)@M,/J@>I'/AQ3!:H<6TGS=T3$>[,RO.]<N;
MRJIE@^ 9>-X8<%ZAT+2944&'HKP6P3D[N5[0F&=U8N7D7;6.W/DJ5OW\^;UD
M7E>PZWRC6L8NOK@X7I3855'=]\*F@;W,N=T7TK]4=\^J07\21'6:[#GZ&9KT
MRQD.>DM&[@W.CCOM;(!>R[7&"Q*%)MNO]CD,F:X08G8[PZN=A#R<5TLC=I;X
M:Q93)GO]YTA/<D!7Q2^/&"02I=!@*_L5&1YCOJ+,2@P: _VX@FZMSKGM?$G
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M!:1,C8M5GK0!ZK;6$>6S>NQ4D3/JWHL325Q\>'\,E3X'5!6:V*!H<#$K/I$
M(6 +59A8'EO:=(2W7SN)5L%VR(\ !$PC;KL]6\)''.^QN3#H#!X$_T"9IW@$
MACPUW2J3[W4Y8!&-1;&A\F(.$E7H]8?!_)"J%</VP4'4\1C&LB_<:J13ZR\$
M7ZS=?5=)$)(?DNH[H8?KG@9KO=:BEGY/SM2L-RD6^H'S["J>1T0XZ5\'I%>
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MP5 4D'"_0?39'[$]?-[SL;;2;8/UQK;L@>LJ7I%PM;3=^\9J#[R<(0N]7^X
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MAOQXR:)VI5L21OO^^&0YC4FI&7N1$'I5Y)^*G\W4K@&ED2R**@=F>_#5V<%
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MF\W063F>F6[H#MPZAMOJCZFNV)M6652QZS+5-=\4M9=Z)KK Y6KS?"_>9 ]
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MHU46R !,Q=&IGLC+2>F!3T*_??Y#]NAC.LT!IMT?:"8IEQ#('';RZZQ%(L<
M-*M<\;Q4UEC],(U41X@DS"%WD*]'*W*\%M7@0@#!A!#6^I_B<O;!>;=DTC/I
MP-WR=:]6YC8%T/;FR)D'I%W3]_E!3&R_!56O$7N$AVU%M??G^L%HZL:6E@JR
MWNR$A6;8'4#$)NP.L(^<S47)P 7BYH]7;V_&=U+*8/OS?$C&_RVUW8W_#V3%
MUU:IMCXN[Q,WI(8@@78)-G1*D0MVJ1LID8/B/@' Q!E@T\[E[>71$ESR5S"'
M]'MKOV_&(R8K@!</-X=WFR?L]!6,!"8HWYWD_OIIMN%+A-$>'AO6\B']W81
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MNYY0G7%W7G.THF<X"RMGM (X[Y6,<D+7;HO/> LEQM^J"%S?NS'5LC*];;7
M$:?(UE _,NFY$_^"\JE8>%SL> LW(CR#O=G#XN-Y_7@S[(V7QXGG4SV7>.F$
MG]\*XK2E0;%#5?J4%@[=9G113QU]DAEO.<U_\SJ!+Q*\K 8LM"WEW5Z-9(XW
M,WLK]6[1!S+?H,OGM?1Y(;_Z#A! ?/5"V*+T8XU]=$\?/FHT#?IJ$*G/I)&6
M.3Z^[=4IJ)2"!4J;6C5^+K7%_2"9B0]BS(01ML4$<2FYXY?8! :NR/7"V&$'
M$U-W!AID-W_K@IY@<']V@RB"\4ZAIWBQ6M7O0!.[&<1ZH=[F$Y#Y!3R,D9GM
M\C"Y5NE[G[CXH"*[N888%TTT7$6 WY33E;D9]@UU:IWNGU($T8M<M/#%SI6X
M )U.X+.$@2DI0C%B$,3\$Q-JT$WX(O/Q7QRQI?K7$5L[F0<FR)UQ!>CRT_^S
MJ+@-@FY/R[:5KU43O!Q[M!8LME!39XZG*2OR>>F!:2O-0Q9B3>CZT/9AR9J\
MCH 0P;, _ Q&D;6O<>Z0/*=(['=L%IH0B<X\T*LYSQJ,XZ&<_(.F0_7G."GQ
M\*2P3ZA9Q?_/7]S.%> *P$W4DQQ^"^'"[NJQ^W5HD7#"WWTU(YR"8_9DG@_H
MB8IK??A&-]4J>JCHS1 8RE@2=H]77Z=]X@J@>R98"Q%NQ1N=8T:J$X03Y^]+
M7[#.L(2EJ#A+$_TOBX:K;P=]NS8IC+1UN7S(U>D_V&!THSUJ/%Q?729#/^%(
M_P_Q(N4<,2SLVD\#5J0P[\U(#F.LG-B4\E6,*YA]>]":?V@4ZEC7;[Y^ZS3&
MM[*S=KQG>+_*\O<BGCBE)@<=MZQ6(LGZO]!/<!SY#:!CJ2F?V,^@4C)\I<\M
M]X4.UUL)YL47;*C>=ND"7"\^%VBLU2S84_(J6ZI]ET:,K0LX5WS4_M+"+]V:
MJ@OX[WA[JH=%3TX#6Q-'(7UAQB<9N?%\)-WT\]:4%E3<2T+0(EK='.E5BIUM
M]%P0(N_:=$5N3%105K.:^'VK(BZ%L1A+#1@9=8?UB+_0#2KBI8JUU<I[-!3P
M#_/N@GHZEQ6CL412@H#7?+,C,NZFEAVA1/&7A;'8?"=.7\M*+,5@PZRQ[8#C
MC+J_6 9LD_F#H)LI1^&MY'\%:,"B#5I'O-K._$>BEKO7F?''&G XI!8KB]_!
M55X^./PX+!2'IJ(L@TIH7>^(_-AHK3XK*YGSM+<AZLT<B(1.3U*0O__<3!L8
M3A=OOXD18+POYJOI&Q(M6$D"967[>EO]/,Z5R@JL$"9<YMR2X]0JL,]GY8]Y
M)W*<AHR<R^&L2E0E8([E6&QZ5@B<UP58!A]72=V_,7AF(@EUCRN;.GMS:&AI
M0"TK<@5@FM[I=%Z(F0$><[)( 47]="]Y:QM*=^6N,^3;<,B&/ J7'B,/8)5E
M=(Z?*X]I=L&W."E^_BJ\Y?W5Z4EGL+-_']9)R7M 9<V_?="O=XD;JX!!%T.T
M_K&QD-JB40($OCU\"M$>#=>I7)]>W<U9FBPEBD).::\ J6CQ\Y$CY9X+"I_.
MF[!#W^P3N$C'AK.^$(8U-<0>?2!9Q963$^2-\@V9:2^]D$7D0/!SLM-DBXOJ
M+ZKC#<-7 /,0_WKFT-P4&]V)]8W"-96"(J_2T3;^/7.^_Y5M*TPB"GL201Z>
M</BV1S60T-!:WQ*IF&/18I&)D7TT*;-_2T)SV3Z.O>\CZYU_'KP.@UP!OL^7
M4!=>)EFW-X2;G5[CGLM?)_F6K6S,E[82*_,MD3R0XC_,Z")P+>%FD)"*PY0N
M\"GT)+=@;_;5D=;3A6_D_;6E\9<?#O/6<:767U$A7$_0A] W7&/,D"/*IHZ1
M;*QP<4G%R/0W%]=]CZHN'!W4/O0L\+E/[XE1KV8 Y+]*0+YUS1\G(-\.&]QR
M817URP]W?!X-[\E-.HZB-,[?D([Q8>&'YA2 VWWK ,=U+1;\GWG0MPZF;\C.
M-,*IE8N8JS[CB6LD)B4"[U;4]POE0!OGKA5:=G1QP_.6V:9F7\MTA2][Z^>C
MMN:X9[@2['4KS\=)\']VY?B@?+#/J=C?"O/<Z,PK $$%7X_&<??OY^I?<M/V
MEB$7/*CHOTY;RU'O?1/O_-C/(WMDUNZ*8!*)M'+0E,,Y'KK/S9#\/O=1E:G<
M[:V7F+ISVK34!2C\..!L2S(8%'3.I<88RA7'84 )>;F3PM%#:]GW[&[F]@Q1
MWNCS57?3!\"9!W@UW28G;+]E,,79Y#D]5)(9[:S:V[)XPMI9^3[_=6\B[4IR
M20Y](5K=2<G?ODI"PXGF]GY6]IG/#8G6C@OI^!<)>S*)(5',\0&")C_6JQ\9
MZ>#1A<5^,C((Y/2+ZE7_8C33/CFQ.H8,CGB?3$W6=+5T;P0196UX@CTGIL^8
M+=I@0]#*<#I(N]Z87T>Y3):,G=W#H2W$16V+5/_J344<Z)U2Z]#H=9>]SD]X
MIB>#72[WLBMMZ!%6[OZ(D_11/Y2JFW83Q?*^HB;H:R@#6?8_XS5Q:"')%[O&
MS45;2B^7/O08MQ;_Q.@B#?TR;6'IVA[:>^OSM.XF9D.K_6Z73R+&1_)'HNPR
MLWD:1U=*5ZP8U/T])O2N^1))C/T"(^]#]3FAKHOBBZ5:$8;VIF:*P@XO4 ,F
MTRJ-PK82%J@<&,4@7U#L4W6E)!NVMX62ABG2'W5)<3D#7HL4M6P]9K2L"R9V
M,2]<\JI*M]_J9]=;=5(+-A65CB3> /&R,=TNZ7YS'D1/I]<Z?7OY9HX[3N\N
MOUK0Y-'VSP9#@TJW-JY4MS/1#$S!'NF;^^=TQWL6^P$1B2V8L'.'BS7\!_R_
M25)./=GGM!9!OE ]AH]GQ@?CI'YI2NJA _]]YQH_C&]1K*#B%!ZHVC^KT*[=
MS+[1*1K90H\"=LRV1*RKM+'X,B+%F6KT]2QX1*+W8RI-^DP73Y3'LCTO<N"'
MI/C<S*+1X&&CY<X4)#H$*.P+#B]M)BH!\2PQC/8?3[C:B2+3@4)GB@4IT#,X
M6:<[Q"X16UVBF)8W6;-U5IQB$<CHO5PM@/?PURC?Z(IM?',_FU_%?'K_;K@8
M,EGY<,6W5L[+G"4H#E1\9#"XC):] J1YX%=_JC8>$$^]-H[]30JJ8L43XV?7
M[[%> 9X1#%Z2;#TA);[K4U-YENKOLF\MG6NO#Q?(RH#:,V8.=,,LK: 0&;QJ
M1-=^Z6$]THG8488?E>A1E?3/B0LEHAW<.;;51S8"7VD0K:K\1E9RGX 6C#HX
MW 0V8L<3!NNUA=)_S]EHFO\D:=J]N^D>H_D]]M$V4?'F@4,/]'SRP(QC>MTK
MTC=OWCE#Q1\;9VM?YNY(XQT)T&5Y>2E_?Q'<O45WUXZ_LAG#*-0)%%X:"@?I
MJ8V:TZ50N^;UG$N8.U;3EY!U@U62./H^FG06-\\9-^T,EX0';OL*/6JADC'\
MF FX :#3HY:-NFG' DP%NC>003-I\A/6H<%CAS97@&\];:LO3VVS_A[1B]#1
MX?X)YN0AXY:+#ZG6/]70'@3;G559'>DJG&FB/+M]CK[**7:C^BQ L<4$U'(%
M\/8+-US[S\ XL,9E\<A?:0%NFSQ(.<!>7@'2A\O.+E4OH(H5G^C_KF!L/,Y-
M7NQV.EP!CM$%,$K=4.=DS:V%KR*^K>K#(7$KOG/:^4?-RQGRW<FKM(:Z6F76
MLH[UD.%*STP$/S-DKOKVBI[><O#+ V#>:4Q3G(U[EB^5[$@(R^ISUO0>\O3J
M:Q*<0SNW0__5[HF,,!>Z&?-,;E^#ROI>SIJJ#D0PW#<:3]ITFE,V2K9/:W^T
ME].6R'"A>:';>= 8HN^^/C@+0M1;>>"Z=UJ>^K8'X1(G [+UVX,]=5V);%\<
M@TVT'+("<K!FW/7"$KDI?$@@/"&7\EK3R^$VKFA"NG/R$:HJ)$9PLL:V!]D%
MHGS4DVY!%V?'3W,6M)O1KS@XM]T$VO-$GH &<X0FSK:S\7Z7- LT12^3*%>W
M\=MS=8VC#(!PIYD(OC%)/'>R<Q2!^_T408@N3K)&5=2O3VK_^MZ [UWBK<5:
M&RAN]6>HA1R2R5N=RW0GG\IU&E$Y^D=6#@DJ&&#<Z27(4&1(?!0;T"#,7 H8
M/7QCPJ,:*\@N!!/UA)UW^&S?62!Z3/_=Z?OK9 \W5>K%D74#+/(D<-'A2SOT
M1BE%Y'CR;#J>?6N\.H/^N"2CNP\FZG8QZDG"[1A/--B7?RK^^?XHM32&4$P@
M;Y,%@FB6^"E3G^:]?^A5!3!Y][;JL[GC7,F@E2+<!\*?,Y_^B]'3DU(^P&;
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MO[<>U2943?/+I#@*]?7:- ]OC3$QR5@5[ 5> ?[]Q>*#=B<Z5M9S' 3K:ZR
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M5PKN,7*XY5DPM66@^G:?I#ZXN%L?!1W[<*8!S/4I],D65"GR RNGNB2(YCO
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MQ_'1.R8R)0CV__43^NM3?HB U[UFL>)'@5E4 <(\<VY;L+61?9ZQ(-!D3T4
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M=RIK;0\Z&$SWV9U?:X_!S#T?DXAR?\72ZV+>ATOK_>26[NFHURC1+!9I=04
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M\GOC%W;>\@83H345?5NA!^]]!E]S"ZV$AG.OCI%08E.[CL\CUG$\B$ _5I8
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M]+2;-R-:=4O"Y#@8R33J7JGL7G46=VIY=&_U,>Z>^U0WV4OZ'$!>ATHX5'W
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M:/ZA8BUXE#!MT=L0H\+\(QC\I<DTF*9J!+>O1RD/9#2S"\[AO?4>RA223DS
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M4.,<(#0[G#7J(4J1V&P;53JU(K!>GT<H'"/0$VW+.$>?-C "YZ5*10CQKD_
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M,('7M^GDN>-C^_+OSN1;,_=CZJHM-:0C?T0:NN#LG^AWQ IBG"?F"K^T __
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M^'+7,;T <9.EV%GG#FP[3WE4J >&U599)G7'INW7WNJX!\U.W#-\.2)B<ZL
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MVSPF98;=+-.>IV7*OT$B(D,.H^// !4AF.3<U.C>\0$EUPD#RM+K]8TXB+X
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M;-M1RF\FLBL'3B3R/]LP$^VT%VR)P]84H]N;U\\ #8*_.MHJOR'?3=1VAS3
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M00+FVGE =!<]9-H[T*>CWM0 LZYAG*@G%'31P\\8'P,%W77_<LTDM>%=6VO
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M1-V^E-D?0BAUW'HP>9;S51%;P4R\0Z=_#3B'Y+F@AN?<G*RMHU+[NLU.I4C
M -EF^3%;ZI_+%8%:+0Y#B[4..->)@WC'G5&VK<\+"6GS\S=^"T*^S<5!>-[Y
MSNZI #<B\8Q5CDUZU/AIIB?82&%->LNKWTHRHXH,YLJ$E\O2!@FS'4Z5/\0K
M MA>3I?<A>;D<O=6@%O?V46B^D46PY'-WTPM;TM]2OA]CLZKP:#>M.Z#*7%$
M63/#%5=!>"8#<^-@_"ZSWA(YB;;D:.&Z16XO6*1W:"]3KXS6VD^V-8 ,@:Z,
MB6!>-V!DU4=Y077RZ68)#QZ=3R=)%E>-=R3R[AR55QCMCR]_GO![,Y!MD-=
M33385=)W.V+ ]Z@ENI3XI4L=D<,%U3[USV=)J;'0_S7J12V05LF4C)Y?">09
MY7)L(FUL/^K$)*"S95+)W!]+D7[5&>O2PZ_;:E1\(J +'9U\\)]/\90O+WO]
M#FF20P$-Q*55O%%?;*\B@J3;K'B'#E]/T]:\)Y2[K=FSO0E; 5SHGHU1OS,
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MI3NWX3R%K">__T/HTJRYXZ.'5984L@WW-%&(5A:2#BOR\UE,93AGZFI-7T&
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MF@D#4M<V&/[=BIX]Q5I9\K]*H9],/N\, M/'9FW@L=6L+U]9#Y'-=]&^ 1/
M8J7B13()H)4#]^L"</WRVM+8%PBI*&PE%=5^DF"+&WB!!P/->"R=]UG.)80&
M,..G9]N2SC0/211Y+"0$H!E[\QL 5ER<BL%KTK?QG8Y:^@Y!GG\M$0XM,3$T
M-G//C/:6WGE9\\%P/:9NLA+JN['T#OI(NQ9?FZ-T>G!H)]*#P4/MC=R1^<#0
MP.-[$5%RBL.:1/F-I!FJ8&"7ON+<,FT1%;I_A&9/J>[K+%,@IQ&W<T^!2VGD
MF.]T^*.>)S=I'R4I]*->*M+> 5R\R%5U3;OBT#-YGF8T4SXNS/+BV64JB$'\
MU56(L?-.WQU QW:E+;][_B&7_%$.:71>$/O*TY:-/<A2XQ?,H1892RSZXK6+
M:%3FDQE_/0Z5-)B: ]!P#3FP\#WA:]3HHYGS!NB</R)9SU$X:_Z%96/M$$^/
M=6SO_!L:_(+8R0"WA)L5_?/X&I!*)-QP+S+*E"#&V7H,*?@4V/?[S+FCZ[E#
MBR6Q(Q((S'^M;DKQ5OFZ;]6BD $IRC"F0,?Z,\U8C5@\-OQ9#X$7:PX;(J6;
MT9O3TL:,0T#Q 0PD2FHI^$9%F&T@>ZBDM'Z!O,2E:\,FU#2WB31W<$^>E>3\
M*C%/QL!"AS12 [=2BT5@RD,&Y?48^:J?_<#M%S>XT[ <78T)OT'NSA72%'#O
MH'>C'%FXZ9Z?O%[5>:?[K37EG(,T[>H&\5RJMB70G_S)A>$2>D^'@;T"I)D^
MRMJWIQPLE![8];DIW,$J/-2D6S;"99D?E"F-V:V:7LP!_D5FJOG7-OA X9N!
M+6P'J?9U1!5QS.VQ>VEJB;8_8IO\B069V)ZXI#T^<_)%#YKA5T]A8 IGPY:^
M$M[[+EZ'(D/:5\&.DC(C!L)55B$S9_6'?5U#R-[#(61UE_W+B>?5C2KIBY6H
M"/V51YQ-%C^ZB(-P#"EUYDJO&.87'@FQ4AT.GESKNBY#\7N5GU2=3;(G\U9P
M>X!HKXN%P]<$6N8[KSB&>0ZNKQN$Z@._73.U]Q#$V>NVTZ=S(R@-*QKDT9Z^
MW3VLTHEMW$WPBW+,[GHQ*U=%6_]!6W]T1:YNMXR0Q,5X5E<>O?66DG*MLX^L
M_);_-EW>Z1B, *6.15R&I0Y;XH'M:F"DREUI8H31JY47<T?>FON-N^G"%Z)#
M(!D13;CI1J:MM%=0_@W]*2MQN4SJS(U*PQW@K%Q_^.P.P&IX[CXKN]3&>_IA
MFOL2>X0>O?<ZM4:1AG0:^E%)D@$;"L&;KSNTKDS<T;$& 3W= UT^W3^52SU=
M'S_7/,9<;AEL:U#9X:DW?P$^MI-\OZFFO,M=JS9 ND9[=0_B.2V[3WKT](>Y
MQ@W+/&3O)IK(*<DD;06W>@>@2%!.__>MRQ5=)]X:'4N72;S<]JM!HS7@RYN8
MW6L9,Z/T3"LD;F'2"<E#CZT;K0%M75>"K9@S]I3X,8K]-(?A7&E'A :VT14Y
MI,=JU3:URW"CC^+?C-^%4\8O'3K6TB1U5'8A-N5LV.?LO6_LN<WX.6U$?<M9
M'-@ X#!:<-,K(O*)YGS><9H,?S3'JR'3-&/QIB*]AT,\T,,0V(MB#T<:T^K%
MB81OY(J2;7:ZKCD\UX:5HU]YFJM5Q@.RE/R*C[<SU2J4W3DJW*,S:R47X:0"
M8LL)MW9"^GMEUPG:M*\>WG?D-]KN;W(V<?.TW*H88VRH^E=#V'0=N+*:4>P#
M&$R>/3/.V=2?63YQP VF[*Q"F-PXD?2E$F<4N<(KZ1$NW3"B=K.1XW9EOWK_
M"7H!.L?N>*A:QIYGG*Q?0Z<TJ4 W%9F7'30Q)D@Q1>:QIR,/Q@/2WC2R9U-%
M5B;^G!7+S@KZE?6A4R^31=9G*OF @ZS#APX-O/Q )V16H[IB[L@Y$AEI(CRY
M</4G[<!$:,([CY3T86;PH,R.3PFYM4_#_OL<=8VA[_KA6XL5)/UTQJ<3"/M_
MWOM3(LU-=\IKPLDJ8E<=FI'2T4P2+R^*.H%1P>[W7;0%L'?5,1]+?%P^/B,C
M$=72:"LFZQW<-<B4!=YGW^%>!;^"H$S.1$1R;.5?4HOO7>V7 %P6JX0CQOI-
MO3*E@% 9KA;9X%G"(TK-WEP9W#3?:])]3C'#W_PXJ(@3PTE$VKH!K6?W2(*"
M\8V%*I,!\-GG/4DBR0DF;5O@,+?(U/-&Y(WJ)KQV8,2V3?)E%T]_[' AG;&X
M'%9/K7Y<O&:E0'__2?DG/Y%M6OOO4';+V.HN,EJZ#T* F5G&;Q7VU!97>OF=
M8AR"@H*B'G:+'^W7W.SMNQL7YPA47O_,%=))/(2M[>6]-P)_6"P![V4V'(OQ
MWP&(4.V/R*I^N(2;!3?,#0F(U E7V , @'\O__T05^50S18#PAC7DJ)3"1;-
MK;6I7CS,O/J@[XOZO0J3Y7\.[6//B-M5Q?U">2P)1<Y3.+HR)].RYG?$L<DU
M&=N0M1_7Y]7(XL$1C\<3X1?[C!>^&)''?R,6JT?U#BL3SD;W;&]S>(2:]VMD
M VYBPP9Z4;RAH!DT$O*DA"?&\IR^*F6=2FS_=9F\0O,[BFG3@%-3X91Q3HA<
M>-,0+TO*F9'\!PSF%PQCIFXBL'V?WS5EIU=%Z0;FWZ>7GKMDQAT!+<]0"A>_
MF4^>:E)H(8TN2VT'#K'C5SEO'"%1R*/XP#YCS=XZ_W&>J=KRHITD((I&*31(
MACOSFX8;VSPXJD6--#/#_@U+P03>,[WZ>:X69YW!M[^*R3_\[J!3)X"HQ0+*
MYG?,F?OFUNE,5B)U2$@*6&WMC'3?R+U.5")PR7!X00"L:U:Q\;>"BL2HY9R_
M!V0))S+9.M 9SXZZ")(:%0NL^ Z$W0$,VM?K!HS,D81O$EUE&P%2^C)-"#7F
M::D7;7IP<(8#CF9T+[1+\WKI6/#JXCA55W)U]-*D5)3@C4WR:P^ 3Y^&3\F%
MU]1%%28N&T7>0R\38(>^RB3XH.!":_&5??%;F@B[X4R^_8X5X-EA47R/H*!P
MMLT'5<*0M,6Q>N1CZ#G=<PO>>@8%VSL K], W@ =]<?Z]98T<?2#?#@14VMI
M4F+?>#E\:=!3GZ>X6*O5Y7:QK<F'UZ"H%@P;FVAJ)['17XS]'-GO5[DEK%-I
MMQ0IHP';3GJME QFIP1+ENH[A;-9L.:)[0E*PF+G.<1?F+L':P<P[VK=CB^L
M(79"%;.:<NF0VG:I=F0X]#"#.;XC$ QRYAKL+)2P]1VZ08["%T+HJS>G B6*
M:;2T:A..;'81_O0Z+-<H,ZEP(@./%UG@ QWJG:IGEQ\N8E"=#AMCZ2'<@SQ=
M"FV@U$[:Z "$I'?"[Y!!W<V(\:CA\U':8C37TM+5=]'KEZ)W@ _:/TTTS]VH
MD]D;TGX!>^V$%)3\BMY*M?/F\-\Z 0K!NLDH<Y]HU8%\_E7XJ^'\ESD&(*'[
M#YP*F_U?$58*K;J>>W/.'B@5YG)/L\P'!PI?&5="GMP! AR6F3VR&<PSE-=O
M*3O[6HH:8^O+0OP3O0:=+G6L[P"[?)&'85P_==*$<&CCVW=>/*T_EL]D5/LZ
MYN\/N]#02H(SI.H]KWX:,!&2!/UQ:_2JB,<.CWJLN'04@O<K-^>PZ\K>SE@7
M_:,%SM&9K6^_CESV=W\1)"L%/]]-.EHC+-KZ;'#/E,D4QI0$W+8.1P2[]+QE
MI8']*&F)>LYU+#N^^TN(I6KH'3;<0Y/+!<*PBEV:E+6*G0].IT0>>B*O)Z]I
M![US.GTF'083<OAT9-5:"H:KFK-SW/6:O.,&:BK=9;:/8];7?N-Y*42:%F^"
MN1H'@[]5,\S>(A4OYR\A_):WX+7 !*V>7::]*M'_CB7!=^/_(\)W<7!;)*TW
MN5!2O%4P'W]2N7T)5X*!RZ/'[P#*!(IJ626P69GOB5T&VPY!)D<2XR9S3BC!
MQ,/OP3L2[/A9H"<O94XNA<>S6?ZT)7FNY'\B'5WU#%?WM,T9DP@BG7I:,'AR
M9L1@2H];2=?TS_S:Y>;!<:C"-7].ND[Z+O'/_Y+R9=P!!F3?(F7"3X8GE"'A
MN18EIS*PUF:PDNB@[8N/0Y"T\SL E!2P:R9Y6?]5EJ\>TPVF,G6!<_V5^74'
M4$-OQIY[[$YKIAK9'#*X">6V'E8SS^+3OX;BK!ZIL'W>-6,F$1U5=TN=2<4Z
M2]I>U458?3SF*R2+!P%DD^G-KS_2;UO>9HF<*#% "((%O9+6AK3[ELQ;&PV%
M*XK9RV(YEQU5]DV<C=*7U_B-(+7%C)0+3@>]'F*?_W"J" 'N];B==P]MK%:D
M18.ER+.]A-'1$+S7'\>F>:DM&@9IKR8O>9"59C*$P9E)4B>0DX;LA:;ZU7@E
M)P4\(>B/@,J>/3:RJ#^8!7%I!B(EAZ@A*>'T%2G,#TO'7M3GRVH35@V64<O%
M_F^1,#)V4T%7X9^+>0IZ\IG)'NK(YDY;[C6BOV<N<_!J#9KTO%_CE:#H< +7
MRU1FZXT5ES &C0+OC_"*Q<E^.A;GL3B?#MM(,)8@]#'"F^0.4(07%9EBI$QG
MO 3%4"P[]CM]6-!"19?> 2X)+U=/VBM66Q.[>.\ 8SI,XT:[W9K,=X"/-(<C
M8Q>9K-WZ,J!?Z_<=EO!K VG;[P#P0+UJK/KX0B8D5>O<W3_IO&7[5*<F>"%8
M2Q+I$FVY?0?@"P(Q7_UU@"V8(\[:%0O/U(ZZ__-PQ2UL+959H<R2/;C(.)SF
MBF6K^YA"E8W6D5):L*WOC!1,X!:V6!_>'Z>5P4FSE0W9QR17MTC$':!89DP:
M?2KJ4 A!]\P6#^)ZK&X=9;2/8&12+K*^'Q:7&JPTI;>[:U&K0UJBF[T@,!0\
MO%"9(")>X]-TZ.>NN>TO1L<,L8+RL\ LUWV5)7]W&T0=9-^J=)SRI.UF]-8*
MFGD4*(A-=_JU?;I<*6,XXXDL!X&*S00EY+6%JV9Y-49W>UKSF;C!ZL[W1NR_
MR]@H>SQ>&N+?U[]L8W+K58X%4^0$G3CLI/DAS8?[1;NGVA9 85Y!)D/[G.T#
MUK$U-4=3ANK.#*3+G$@#-_#GEWM<H[]6+\3S7[O!0=3%>9;KN1)53(@^0?],
MT$_K4.F]1,&75Z>W%N#VYVLEI7M73F=V/51&POGIR !S)W6)_"TUN3L XD0W
M_5L+@\V> MV:CW!*RJQT7^$"!_7MNQ!>VC"Z@D/3LLW6$Z?S:NAF89/L%I1A
MGO &9E3+IW0<>)VC2<N&-AF$N'-)D4JPD3YY-.0S;__RHU*$VT,^W:Q6_5.C
M3M,P-!.;J=%C00#@DK(5M3P;,?ZK+4S&^3+.=<>PLMG"'U)9WO(\ZEZ+OVZ%
M>NIVF31,X.S@_CVV?TX=N6GLQYNV. I)&,X*(_DB])/A]K)"<B_G^2CU,E-Y
MJ-OG1>^IY"+Z;>/M.C/NJ!I"*X>W'&WY?DOSOX8&;!/R/F(;5["_7N<E"!0L
M A=.H(O%B0T*E-KWMU /H+2(7T80E&+K&-D/^TVF)@NH%L?X/5H;Y%'!.JD<
M1_%!B]"UODK:I@6"(8?/09H#O'^N&54#SS%>,*X>@KWZ$N:K''9V3UL#Q&*"
M=Q#?J#ZS/(M@9%_:R+;H,8TN0O\R[10Z5;<_"=:8?^$^Z"(\F1!#0D5?$_9Q
M6C*2>;F9=YO.*&?;S +#/T*//5/B,%J+EPD89/5WW'CA_C"&]D'&Y2]&]ZW
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M&^,L':UF?Q:F=[^WU-]+?4XE/$)8\:!%#E/1O?+%)-=A(2!Z;;!1S0J26N3
M^]/4'M,]Y(X9&!ZI03@T-.6(I%<,EZ\,)".(B'HJ\>M +4B28[>1ZG(E"20>
MQPNG8KW:<HD74\%*?+^&*SUXF#/5I)S728TU9U97_4%K;]8 -$</GEC0*@-"
MFGS:QDY#K;NHS[U1(S(+?*+"=7O57JWBD--FN=P-K$(A+R.E1ZH:^8<^*ZIJ
MX=$Z/R(<1?QG(YT/2E\BN!HMYB'G^M.$D[E/E]<.;7I@TOT6RQYR/[OH!X[)
M-(QN"++X:$OV+Z]@]8?Z8!>H>C?IUS'H !'#:7& AE%S7DR+SM>QM_><'RY%
M3;;-:16FKNE3C:EJBH7L1E3]J:^,6*PS%Z3XMO*:%:%<-5["'[552?_!!'SE
M\[$,J'#]YV5SOD71@_DR0056WA1!DD('\[J2Z!;\B@.=@+>9'#/\W64*E_EY
M@42+E]K3'JLT<"Z.UQ[<M6P":ZK/@Z= C^?FNWLS/M0@<?T:!76[/?;[S$4;
MB,FM' ;DB^8>%-#3;4FFU6I6.+RI&208.>OO5W@OU-?$=*G;0Y#Q.V\^]M#3
M^F*J-]F3Z*:NV:-7C3F.8M4OIK*9"-SR>U8\;:%%/&.K_O>9GB=/[Z>]??B-
M4S,K"S+(6$9)O;=B0&JQ>Z/ @MMS/3D;,TRQ*KWD93HU)S*[7KR8;=4?!ZG=
MKI@&C_77JI54?.POPOF2*4ZWQ72/)WMCH<66J]ZI/8W.TQF\:%/O+723UNZ.
MJW-PMDJ&Z7%+CJ)@)]$T6:S^&7>JJ= ZKP\X'-<])I+]2]2 ";=RM/A2B&9L
MA+7R+Z_V/(5H4U[?!E3PS*])>T[&3DC[2U[=GH[GIL#2$58]"+8" SU9YG45
M9BIJT?HT'#62"99HQ/:J8I7-9VWV,_0CYL"O%PG8I30+?7FP.?/.S=6]-F'7
MAT[^F!_T/BDJD.0:4<"ZGYORGHD6/VLETO9WXWZ)MR <SIWC[?5IK6;V,EC*
M>M2S-\$H'"2HJ&^8(XHGFB;Q-9F-M-G%I5\EDRVSV93.?ML9]"3X/<^R!VC@
M1@6&A^=K;+R=,"1Z[ZRJ5B:^S?TLMGQ4TNDJIV=:]L8$?AO,NG]I[BB3Q=NS
M_[;9B#]IN @Z\(H/ %AQ(8ZW?[Q/^)A^>W-^VL? N4L6&XY+G1:[-9C$=@[H
M7)Z/PL%_FZI=FK__+V7VO[56=SJ#3<.+2Q[,D WFAG.O*&\/\_V;-A^2AZ_+
M![4<G4I-,L6JXU?D>%K&!1!ENHRY<?D5X))VE?;)7_::W]<$#3<A@A/EZ]]-
MM8=XV\>,UNG9IT4/NHKKL2A"<:<9Y.JGZJ]9O>S&<WK=+V^(WO_'U3SE]2\-
MVT@"7=97=MR_GTT0W0'R;2<IU-_=2U^;FA(YQIIBNL 0"-E:QK*=B)AE[.?$
M\SY7<NH4%1@(<NAJ5KC-F]7G#FK5*:EZB:)Q9%46V!Z:5U1(LRNL_LLKL%-=
MN7YDKC58%8M6!KM)9,9.\;1F^U46!-[&4=ZB[')]@@<[G+"R/EFC?"#D7NME
M]42K:FO3@(0O7[E J72XU' Q@;7^O%7FL1L:J9SO4++J+,SZK3>Z9-^_4F/H
MNL4,E^MT.T]TBD90TF=7IXJ>"@0F;-SL_; Y2S1LQ-I4!$%RS)7/@AN/-?U:
M!DNDM F:J?[ 1/=EW!\H]G1A?0P0+GC2T-FX3S?.5\Q_%MSI)<$IX5K,N<&9
M)HPBY\)-!:EDZCO*7_,2>E$AQF-S)3*D_22"5V@U0*$<T2']XD1L7FEB/WZ1
M:$8* YK"5^"#Y]0!XUR)H*%U1!Y"<>#<?Y)-\VF$'N&#:GTO=74/W?=UK'HI
M)WGD5793R:$553RT_BX\B(MP,1G=6#?K>'6\K_;6SCRN8A,L#L)B/93B7A.)
MH)YCMO133QFW[[PY5'[N79*N^1V/PZV^$8VGNA6PSJ+TCGM\?;S]IX0ORG-C
M?5=:6?@G/8Z/D'S#-,27M'"!U?IZUH'C(Y8UV4XZX^4B+-@EBG<\U3=PL D4
M28_PGH \BQ]D4!-MH#D+Y"1M\ AL^U,,+5DIYS^GK/)TAU.&N$%D1V8M:?"Q
M!A("BK_O &3$-&7=?\N AB@4_H89.B(_0Q;!+/[3NWXR?\9?[J=>6L$6/(G"
M:*33 U_PKR740-GG@2@.>4H!!(Z73Y>2[Q@R#PO^_!8,/$OU7;F>\2.^S2O:
M#V,QS/VT<5K[)H#"@4M;[X$WL?/X#Z-03*F%411SGU[=6ZE<@_%DDM6SFZTQ
MP2<3JV>7DWGR?GC$EBG: <]7:3M#7QK=).M_^\&7VK5YJ<NL&R8SL+*K&\?$
MJ@VSJ+T2^R$XH!TQZH+8SHL'3MNY=?YD>[[(SYYBVZ4QV;48=3CIV>=M@6"8
M!))SMD+IWA1/A]-'Z:V.X@QJ;/9=?R3.O5.QJ& /A@HV+1ACYO;VT>::(EK4
MUU;#Q2US1DVUG7^79$,O))6^7^8^^;K /5HL8/QYIKSVJUKNDP<IL(L(M-PO
ME3J7+HH9[N8AN**ZCF'N7$ZJVOS9==I^>D0A9O=FQ-<J[4Q >7Z6*>''83]M
M2'X"E (\<[8HM_-^V4&EH/2! E!8-=\D6?A;E_7W[I2GD?JD.C;22+M/&;K+
M4Z=K,2CL^S^?4$49<$H3A]C (L%8CNS>L_ +;[^>_ JT/YF& TM=D61$%I#8
M2MD8/5Q$?S;-.^A!@83-UNS+]W!MQK)*$[VK._\_G/UE5!1>]#Z*CZ*B4B(A
M,8"2TM(@99!2(I(#TLT,W:5T"$@W2'<-,,!0D@,, ](QA-3  #-TU_W\_O'F
MWN]:]_[N/J_/6N?%/OL\^SE[/UMMTPS?"CE!8])/TQV0%G< G\'(P@LC*IAY
MM^6!X^2WW.WJJ!,6 [=$0[0:N$R8W=<S_IN,E40=QN-76^OKT<J<?U)(WRLM
MJDE!L?N,[WJI#IL\<:#8N39DW8(\?Y\[]QJP.HX&+A)Y%)![(W3"V+,-0<+V
M%F%;69*5SGY:YU8!4JXK[JDZZ'P_.G:S@2)+IG A9<*4WS&S!_/-7NG03>OS
M D6S&VZ?W1W= N)N?(\BRK[JK5&FL>2;41_=,@A?P9#\;B]1Y=HG*_+GU] 3
MG".&6N3OD"VF7R/2T[A8IAHO'63-R+_]#VXO7IW-O>9P!R"^21QAU+Z,N50[
M7MZF%E]P9/9HW?4XGFM!D$^)(H@$T3UL\4,-\.65'(W"3C6FTK-BXR_P;U+3
M"(,-!O&IE._RI3Z^D\ ]SL%&4@VWL;6$)?UU"S%8G'B/I\/J##%P6K*[?11Z
MHXR67'H\&'2."#S0]^LU8@I!A/2L&E?> 51DJBZY_27]EXB:Q#FNV_OI^3L9
M#C:5TJ%[]'PSW58B'CIW@*IY7ECQIL9"MC%%^2S^D+8*#TTE_\$TN>I:("SI
MS=5*E7*"GG*8EC+7.^W)#U!TMKP#\$NI<[?Q149WKJ1%VNY-,>C.O.SY9<FA
MON$RU?G6X,J,Q8.19VB7T$%V0ZBYK AV,)6Z@7MCG^!3TG-%>R,YME#>_S[-
MSKYD&X@:.6*-Q/^R1"4TLAL+'7&\W/,&[*MW?$8D>OM=-1<4R\SP0FE68WYU
M 9T^TI#$TNC-YL>T!K.8 ,A<*KZX9XQ2$TB.\$(5T$AO1Y<=Y76!07='FN24
M6(+NBUD!$ME>*DAK@?X_F)2N97JT%3>P)/-AUD8*O'B(Z#KJ=G&NVE@?VKK%
M9LKSZ_SG\Q\1]C#J9JY%E5782%VWOK-%JZ.G@KUU,8Z=#:1N#1[Y[XIB@]!O
M:]F!(\-!XVRF&T(*I&RQ\R2ON8J1E_F)_52H\ T-;3A:BJT6#L"TQ)FX08#5
M]M]=OSV^JC8O?[RG:^(\XCN.$\IL.7I/G"X_$:.: LPGE+KEY&7ZM\?[RK@<
M)'[F78<5FF(,;"_*R;5?B$C%WBAN]LZG=!UIS3=_M[L7M)8AA.><<CBPONY'
MLZ<[%%[*VBJY*WX5-!_,L+T#Y)J_$<PD;$USJ,DU4Y(^_@22&D7N'MI;3I[<
M'LL>?QFAD8"X9?U8##N5\LVEU:1&1 6R65R+W0PPEAO? <ZJ^&\WX'> 0[O%
M9^I#RYM7"3EE& X\UO;)'6 ZU7H[1E$CHS.^*?L.X!*2_05%&SD!CFJ>UN?[
M?@>8$&9%DZ.\YD!#=X 6A[=EV4I*T1S?9TPBZY5 ZG])?+^Z]>XGW:H [<6X
M2(NV!2(&V261<D*-A1,FS&]_M+,/IE<:!FB0'?DOMW_X5FRW]@XI-O_#H"7E
MR\ EPW+6DJ%DLC7E*%%I&]A)SE[DI%2^IN:_X[8;GVEOL1XI/KP2/(\F^\?\
M^/WOM<\5A^Q>B]SJ1.8@YH$3W0-+L$]\4>4RBCTBPU;-N[AC^.$ZGL-65I!L
MLO@-Z.EBL/281OINE/_P<+8#,C]"C&<BMCY)N"XV1<7Y@4E&@CF,Q'GMW8>&
M-3ASREBLJ)CJ#-M4'+I/0=J[N!XZ)T+MGMG63.H IU><L^1QMU^]L'ZK>)HJ
MH;5A) N<&6@E-?0Q@;&,N.<NH'E/&%-2J'N2,?J&FBO(!XZ69542BD*,=,I%
M B)<-\)1<IIE 3PW1OK, <=\K*0LR7\:HJ9*T@N![VTA#ZC>OG&M('<6TIMI
M7W81E5'4HD#2\,L^>RXUM2;L+/->:CY<"F+K-B\Z3291EP6B=1V Q3%2U;08
MS*5#V;V0B:/DL/GK5J]%69P+=ZS,4=W'F @M=*?U7)-9FK8S9.&].*[D:1+<
M3;7^C1#YMY$%*DLIV@@Z0DLR=T)'G_0H.>(&WK*'W3'7+$S7ZG*N5GE4!'']
M13K""6Z6S%2[59*(UJ#(52BNJ@3&96876I@2 #&U]V7I2;<FQ@71,3WLO7UA
M.&/Y48HE]%,DK$E^8M +GJ)6-QI7D7"AK\D)R/_%J<HFT/SNHX5G: U[T)M=
MXN^.O#0_^N00/RBKR\"XM<;07W*/S>_U]=?X9GGGLL8N;=*E,FR\M2UDAV06
M0RN3DIZ^?OSX\9?G\7N725,&//\:PN8F!OJG?5,O4L7(\C*L[PU-IT+,Y0GT
MWCRALQ_1R2S>ECM<822*HOO[](9KP(3?=<NL62+ ",SGFAZ',=!/N1 M<#TB
M0G@Q,X15[WZ%GZ\XZ.A7]0DY&AU-./X\.E84E9CWN1(O.&%8H[W'ZWELF"6Z
M]/?S=*INH7<]'=!VB,J'KW4M]RL_;27B5M5^3<I?LYNVPB&<I3YZL'$0VFS>
MGY>B<SW*85_XJRF]=X^UHB]%\7$8-W0#;N\^(=,H(8Q_+U"9+OVC)RGESS0=
MA=899Z,BLKY+(%/8":ZS^6D#< 2*OGHA_)F>IQ__U+E (F)W-I=OR8#CB-96
MI4PF+41!.1WTR^5&):W_K_TZ1N!]NASN&/-+9,U#"DWE8R5N).LC Y$XWXW3
M"<^LX%D@AJ7KN#Z>=RA.Y&];TR1!")&1M3UO88GAV.6$M8:@ZC<K_2/#2NJ"
M>S)!QNMQFPXF&.K-C84SA_76X/00CP1*=\2!+585C,\]Q/ ?!V"G<IJ:8:W6
MF;;.#R<#$8[<;#:[;"$32U6(8"!:%,47Q9U/B0C[(":EN_2&:R'6+BH_<X2>
M,EK92*,P8 HX$V'*'YY)7$EU ! +#JX(I=H,)4>92FR6=L?2OV&Q>D+W_JW!
M/\8BX^L11VN3"6/L:6>F6LY_N+),_=5O/QT5TX%=!RQ";%3B*IMLF\].B-<X
M'4%?0:J_87E 7I\CZKHH3@ZK8:68;2:YU4AO3MN Y+8O^D+X4QLC-STZ6WXO
MU2)MG1ZJS"Z+"MP!*E[)F-M(([^(-_'%N;O3]]8IOIYC=?#Z[X7,&WK^YW'+
MB6?F#^J+>S94KU#^?5-/5C[0:[C,58EFRXC=_!W#UCAOWQH&^L&:R\*]Z34>
MUDB!$O4J.T("-51_;<AD0+D18LGST5^VL[96SH*%[L7W[_DZA+[X?2-IK>$
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M.\!",?23(\^9+OJAB$[9Q7/V4BGXE>]D>')'SB5XM;BXU%N[E&!7NC3JO$C
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MEI]'P#G7GI^I3'#L;-1 .05Q MM')1X9F^PQOPQDRZ6YH=%L4Z<H&_+,A3N
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M?L/J^HC5*B-JW:KC6,,K+364>[^1E\+V3*,_]R5OV\6R!MXC$4'MG:M]"M*
MH7,?!9:/H"\"JT091F8G7!NB[=<\@$TSMR"<_W-^<[_F_\D5$I1IB5U4N-%
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M]L^3.:@\$)T>3Y[I<,I_[OJ>GR3W140#&1KHTL#RL]@\FSYXS=D>'<'[)U3
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M(N_0$4E@D;_V\=#CEBK!*Z3?'4 VP+KRN/4Z?@"I:.TQ-VUPI7/_85)\0X/
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MCK9 MLJN1C;<LX:8K EQ!1)_+"9]WUAAO%]0]#L!S33 OJ[J=Y=9+F5W%8F
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M#FOA!>89^CO2[D@G'%?J\[  MZ%'A91)LZ)RPIEWD.Z9-ZTMUU ZCOKN3*Q
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M6)6F80\%1K0P2SU[F;$U>>,H<%M"2SR2Z5@?^]*^N=F# ^/.[?@ .!HZXWL
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M(Q"+*[<Y)[4)K-/_:,;3, 24BV)N)S  I\&88T1'3#"/[_I^KBFM"(.T-Q\
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M^/JTS^V3+\:?AQU)J6S5:&K[C/,-L#(N%0K(?$ZO8P_H=8=H_@Q%U89IQSE
M).F797F4&/C57R(_87G?T%(W'N\YK:PXO;. 9S!3PZJ'6<[1A2K?3@S&DV=3
M[YH\^*:;-]E2':BVEN;)%PSB9W!N#7]/^D_HLH7"Y'N:&K(A-QW0L-%YZY@E
MT(8[]NY ![FH.OG&G'+:6#KK6TU28P=GLAR?-1NGU&O!FGK\^)I;O8J=/H%3
MO\U'S?M'%%I,M99+D@TQI@,B>45\G_\YM@[%;T^2MKP[=X#<XQ?:[VT^T@>G
MGD":W3S+(U!8^11Z<]_:=L0)\[];V/W(776ZPJYR6-'Q*%X(5<SUQYF^"M>4
MN2,4SXZ1\Z^D8!!1 OW,=/<S7S,7:>[P@$:]HB(#JR7QWU#5.RX3*V"#GR7P
MN+HOMR4EUB__%+7P=_%VUO7,A*NQ8^)NQN34Z@% ,Y+L6)AM],T^[1PQ2I@I
MXQ-F9S,O,%Q)&3O7[.'HW+&4ZFM05ZOJ(5QC5?]7)PC@1(U+/;+1LP:SVA'D
MU<L;XYI0VO+?7Q]V)/U]U4:_@Y=!K?"^AG4OW]2#\OM^DG''M?K, V!:+]U6
MB%?W7G?H ;#CQC.Z70>%";9X>:&OVS,HQF-'3T@%7GTN)?D::KNVK\2Z7J>D
M7UQJ_;5>:4HQL6AU\?SCOUQL6>.N%CY$D[%:Y5"(29LT0YVD(RRK%7>032O>
M%$C;02RCQUW53)9(.,)?(3KYQ_XN>YD,7YI6:/-ITT029&_UYFN9Z\>>!=SZ
MHK2N%BG,N_K"/;_\U?=]'MS'\G5CQP'&]CB?T(I=^F3I3LE_TNU\!5*@^%%+
M<\>-&7<":5>H>+GI,'!SM/=6B3![C-<5Q!K>L&"1XSPW U>PI9B?-KC,PM4N
M=+".4<)3S5%8: ?,$+4C/*XVF%IL0TT5.M[?DM^X.)C/FL0<M& CK213],R^
MV]\;.2SB92J*)<>IS5(* G93H'1GR4L=:T4E;23N C]26(;OK?IUOF&J#8:F
M32QG *KX620_H^T/ X73OA#(D7V-K+:L2 HOHK2$#36A.=-14U0J?H1J@WQ[
MV4*,]<?_R4CZC^5?JEBX58FFX:=]9FNNO"QS.>V/H99 \JLLD\S0VW-9QMMW
MJX&^93E,K]S<FB?R.X!"ECKM2#4KU$,5=8-3_HJFKU9V_-2]4^%8AZ%^N!9X
M*BP/]1CWEG?[(MIIJ6F#URD MZU1_N\VO!_EQPE1:7Z+IB'R4+ID PY!,'-@
M$V.M,"%[;&>)3 -(?J_R&DS[XT-<M0$LLS#/E?" 5,9I9;C[** 8M9"+JR:,
M2XG&(U$/4%4:W*["\]MON3G48"WB7^BQHFZRW]?X]S,D0Z[/1N_)DS$-'U7W
M, ]CH!#X0.QSM.D+L?QL7>TJ:AIN0AKY/?5/A;LALOS DU<#G/@9^-$X3'%Y
M&0A;R; H:<WJ;BUB/A*> <-@TM1$%6W98:$(I U>P()-4129F;WC6HMK7WY.
M0NJ<&-S5[AHO.79CH5N25)VRON?%BC9'2TH0T[EJ-85<M1C+X6F5CAP_&?.'
M9 K@@/F0$>UB*Q9Q M()L$[[_/$\)-O4$4HW8,J"Y5G:,*@(G^;/(3?T%!&?
MBT")F1_%/M?_9EW#NYJFX__2T\T.^Y($CVA[KH+@2;(6[(<X2D6ME^9Q6(N^
M4?Y=?$:U3.]RJ('?["D</:>&&XH3VPO6-?T<]D4"-4[ZB2CO^S5I 6_QV\(+
M![R5P GY_45UQSV=,!6[_@58.8NW@M,%54D6B<1+RS7&EL;L^2^TM$/JP2M[
M&W%U)0="I4.ZBI@,W[F=D,+;%4LO\%4TAL3R_+CSO&EFI*7!LR$\FH5D:(7
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M)%4X2,AM&:CJX$HBBE@W-J!.C(TTWDDW[2-.ZVD-_*'/280Y(ELUAI>6&2I
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M&3V%Z-E?J4QOWZQ>2%X[[K7$+%Y[BV:@V=H6K1 TK@TCF6ZC586;.BYR!OS
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M>/*/G'46*;S'R]D:%['?-I(N5J]?N_(ZY/IEB?,C'/*C+WRYIO1/"FN.Z4G
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MZ$CF_\"CV9S?P)31[?<K1=4UN,K6Z\O9N]SK6X:\]A275(JH&'5%-'DX>]G
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M#'SP>0#($1-E>%4([+'FQ]/8&E?U%\49KOK4@G<%F+E,D^<4_9M!J=QG5M[
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M#Z'N.7!ZX*+DL^+^[!#]CV)?_E$@"GD552=G]*O88"UEH7K@54]Y$>4=0"L
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MY>KTK,'HS18FR!F@_M& (T&2E8Q'SC,HRHCN$I1K4[QHI3R9Q/ =H+ M0Z)
MEGBS,,J#E7&021:<M<5O<"2MH5+\:;#605F!",;$\T*LB[!3$W6\/M;:)F-I
MBP-SJ^7V--T!#N?WM6KJ3N1EY=KWD0$:)\EN>^-;:"]C=$RFD/5M9M:TQOR^
M87I&5]QW!MX<MV? @-*,R".EQX6R[INU,8P#]I.G;R'2D*O1.\">4N"XO(@
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M1XZ\0+\M </&&I_8[X,K[_U'V-2]CM(E::<_#G>C%(>7A"RX3PPLTV<AQW<
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MZ3Z=ZV@I5G#*$[NO\/?73\G,XYU*P+>-Z1H<F6 ,V1/)J[]=0K.>#""^= I
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M][FKU4ED]$0M3[4(U3FZUP7SE)^,M!\XJDI<G=:EUT'M!%F$(@3AY?-(5!]
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M>2\FG9L$SIE*?4Y:2A5I='AD.2W.QBQ%=OCE$]61JY#I%& *$?NCY&PI])L
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M9\#T<!RC/LOYYH;;:$ +1#YE,*:J$<-5,T5LT?-[NUN?50;('K&HP+HP4U1
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M@2,;U]I][')58F\ '*_\^NO(^EA8*5;B;CW=94*<UEJ'>1SX'=EL^TK;=S?
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MZ9<0)*1&N.[/S$M8CP2Q[[//<@PIKBPC6._/;$\YQG>8[.E:F^ZLY\#4KUP
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M %R=!!XL-SX55A$<A[9D((]SUT9 LH]1CUUII(;$ :\<W MELR+ND=UJX%V
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MA\K/)"(6Q+?S%'6%3^9$CX71R9?4]+AY6/KI(;I;";6\ 1,"N?<$>7;UH&D
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MPA7=$ 4*REA.S/"(GPM],[S&K"*,@G&(^PBI^/[NR9"30CL-W>8=1V-LNU;
MB#3SW7E;K7]#R]_*,%[%?+DC6ZN,H+U$54_OROR\SRI_YS+=!&.^UV#T!9/?
M/P7"8"_6PS^FTEKZI%CN%TCM@/)9N3#[;@; SCL&O\@-NN^\O:?ZD_F7;B8E
M_L+$N=LE9HWYJ>AO[9ZV#M_9WC'KUH%,T_K=UPE:7=LF+O8!@]:*6%:AV=EW
MEJ(?/LL_,R8JP\U^OGE*$Y4RLY!&R^.<Y0=A4Q!\I*,K4JXA -G5T\QS3*(@
MH5U)>R%0*_'.HI*D/;.4]L>]BWT3AP32+V%_J[D'B!]?T/(^H1-)>[&X\"EU
M^8%.R2/^=>,).KD''W1(57_"PB9N?V%I:^)V_2%AP?DTYL.+JFX'OI+NP(F$
MS>^*C>7?,^^Z/$WTKGTZMB&#5Y,ME$\R]B][\5YBQY!+3[YV^NL_95AC#5KP
M18O(F_@W.X;5MS,)*G")X[F2C]2&2;?NA'L_>2AR?/XFJ.[\2["=8M &VV3;
M:);9X!'D:_I,5,48;E+$AT+M:V:G7^6AR]K=46H:2D=']LVOGAP# A'GD8W
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M/YH#$6N#FZCM\^\W?G,#<.WT<YE&IMJJ"O376@LB]WU*U<4#'.5RA)I@<[U
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M$V^'CG1PA 07":J$21G+@-.,XM#GR!PI:7>^&\ CO"+]YDD;WP:T_BT^2SK
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M>R1QJ7DGAIAX(YJN#@/S/,T$"C;>$C!.NAZDYRJC]11$S(-3]A]]-A(O"?P
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M XHF8._W0Q\3V#?\8^709])%;OKC4(2;HJV0FDI[/=^0.8.%4\]H7[ZY'C4
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MBJ@TQLG./.JG,79J<70=]PP7CB-OF%0>FA6W;+:$88C![<_\YNVNASDJN>J
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M-)T4R0&6-&A,>Z5L#!K J+*3+/1 Y2!(MHS$,N6%@P/U<%\.6J B?#C/)8=
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ML(U@U2E_A9RVB)JJ+>_-<X5GOST[>D[4B<U.['[UZ\M7[TJZ=A<%%9=V$Z^
MT8JKM9+ Q*.8YBJ\'VR]PB8]?:RN:7T=Z3!JW(Q[$/]"._ "IX#9O\^"Y5HA
M30QN\,:ANXI6BA=N_22CH M?;7-MVUS+L3MKKNEB,H^7?_(720!-/[Y@B3\X
M_]JT/7=VY9V7$F_SIQ^=D"J-UI03<23H[TMM%+_S. Z,.JGI5LE7=+9@.(MK
MNP:LDT--=_4L7>+],1Z\HBWH&A6;4]83F F^&M"C^K=C6#.DE^H*_5O*4I*H
M\KKCL]AB5O&?0FTB6ZC7H-'Y(&]A+G%7&5A#85M!F=@F:$R_NFO-+.G4X6H:
M*C28586TX1:'PEQBC6T(W B:P:/5S:/6P: 2(@SN*J";=N-" 01U8UGN?I+2
ML)Y4O<U2(+Z&3.Y16*-?@<7L;1;/UJ._FXD:OK^B>0KI(&J9EP>!<]T<D']V
M(X;V;[N($)TV"Z_F)JV=73DP@JY/P0]^V[JC'OH+.HA(;YMO"\5.$N.S\\T?
MN0TQ =M@F,O-<H<LO^(GI)XX @J@_(19Q"MC>:S?ISUAWOVM'E.>&"2<<:!A
MK*7WT1U#4*\1WJ[;(7U]/Z^QW>2AMH ?_7-I.E<?-Q/3_DS8,(F22G:8=(67
MDVR/Y^MA"7WEF; \P"="XB_QT6@5HZ_ FQ+,]+R(>H__?C$Y"R^/:2&8&JNF
MJG<.67905Z6?[?;>K-XZ^E8T_4+L/ =7[Y2O^"^#9#R;!=YB7N< ?5Q[06)6
MXURJ=1'*GCSHO3?&C(1LTLC_&%4<3_Y9HKW.<F-4ONEW[?$'[-7%1$W/#MV!
M4Z6#\?HY[TLY[J9]GA_TD3.M3']<IM]5;<,X%N)C L1VM1%O78NJ QU@60U$
MUFU%]V&-3<^S FW3OF"?&UCMHD_B<A.>Z@2"R1[#&PMY04C(8XY_='A8#BK>
MQGIO"T\6VR<O\O^0=V&EJQF_&2S]*&"036/?LG*PC>%E0T[7'&WIPS@&."_H
M4MM@7:/Q.YV];#)''>65D)QH7"4M2XI!5$FI]!(/I[),6UEM7WBJSK=.OD4J
M?1O\9.A32D#\ EWLMLLU8-:V28;H>5GO&W^VD]&&]>'M]YD;K^))%AOW_OJB
M9>3EK]-;4$>@M,>CABS[K>G+;<H**+UDFB6S0VB&* 57?7<=+-;JJ<WS+2JF
M%*DCFVS:?NIW#NI[;M,[36EZ'1B #5@=(,(6-:4_F#FC;4'.+:TA+0/WLC#]
MP.H4>*CMZ"(-%R2)T'\"'95S UU,YF5K1XXO#%4')9J>#2R<B.O% O!'RT<5
MZ2"BT%*!QW%6N/?E'>OA'BY_>3+%@<@^U;]4H&:KRHGRGM^X,L?NU6Y-D)<9
MWZ^KR_,7F][GH+U)PV0]LN9<WJ7ETNQ[5IUQ("/IRPV6F"HB?,AEF.Z)E_K.
M2H%SE@43LPZ#+?UXWRK=BRE2242VI.#$%+P_\\(48E/CM:MZV)6]U:#@;6IO
M@_#L_E2V#NQ"SSD=/WK'XJ%K\HI;DEF5IUJHIEEP?N^RF8K1#<EW9F@=LT=$
M#OIJ*DP'0*XR9877+;4:6;JKD?P5\TE[UBOTA>"<-IAM<++>$A5GYK+F-\N7
M 5RHTQ>5A&*)9L/5A,UK@-<UH.'2)Y=@CUS.B,37%&<&5"G1@7W=_M=@_?\@
M=D?"*;-CQ$85+FE?<<^_]V 23A3"OWX_D\Z4CA)97\XV;ZR4V33Q39)["-VY
M</ J.9Q_W:H\IH<=]OCQXNW&'^#B:E5R\D?@@Q)$N<K[K;46;^L(#'_=-S;E
MY_]E6**"C:).JX_7Q#7 L.8/1 9S:A!Y2OD,0F[!&7V_('D5L3YH^I[9;C\T
MX6]]\):%S[R4I9Q?ZK;19=\A]!J0665Z!@&=!A(BYI>P.\3-Q2TD!X'?#V)4
ML1 _ [C%#C&:!51QP%Y]WWK,$E.&G5TAVLPH/XO$DF^O?>&)&J>CW-^_SZAI
M4PW^ 3(CQB?.44_5=./F;+-\33=3C6-M-2GBX!!&QAZ1_)#$FA]P1Y80ZXQ5
M++7YLT=7C\]$=O0S=NV0$X\@OP)7:%?['R)B]MFX.J:60&$NU%(W=\[B7PP@
MQ'XA9S9ZU\CV@%#VC+CX#LM][T)-FH :U8,*Q+^%UI;%K_?4=^J)0_/=.P/V
M+!O(3:=\&U27$!.,/2[KEM&=!XP@RT\50Q4USD^A!,V6P"9.]4]&]^GO0CEY
MMBVG)%4DTV7P"4#O%]_#4P6/(<SIQ5.;);&BU:C4YP142DN+'"VD[)/GJ-P7
M,3/L$"33+YOW=7$-FL;Y@^CI?22$65Y'YF\#]87@=,+#XFU9D6Y=WH4(2R.6
M%Z&;[WPR@/WP0!,0ID/O@AM>IK&_J]QD,#\36U(M<<+)G:+Y'HR1E/U^]%=-
MF?;+0[B^O3QM2%6]B [C,^/*2F)+8%C1'?NF7+0\^E7\\ ]-?QV11S]QTX2M
MQ^5JX2\A-;<);N(<(?0!?#K"D;9>M\7);H3<2D.X?PQ74BV^_>&[^D=N-@NV
MJ6(=OM"-X^?/1&N5V7^RSD^55=&^K*C7"^?#E-UQ_"RO5_>,KX#PN4[YMH$R
MMU[(UH>9PN+BX2(+<8-7*,(=OE%I>M>CN>R1S*S.;^R%KQZR/RHU>*];=B_D
M>8A*$?O[QY]OWLNW%G;V>YC'9<5[&9F>0#=,MQE%(7+(-G8Y!5*>S>3_:3"4
M_H )_F,\-5GYOMO%LQW8K2C^'P$0)R^K:P#EO+]"VC5 ^WCX=W-1"FYU,<]2
M>?18_F3=PIZ1X#M#D73R,OS;3^YO0M!S.,E";K8:@\&LLXJ=0P/X8R20?C4L
MAKXJR[^W6;7)BZ-E!%4]0OU%I.@+CEE*ZKT(J^SVLY]@^ZF!&4TV6PCC%>:"
MXRHQR0? 7R&( *DMHWR>Y!=I&SO:ZUD_ TU_FIN-5OH(P-J2^[T$J/$AQS+<
M+EM-#G>#Z%(\^7P!K:X'Y1Y>S<35 5_+^,%EG/-X7JVE[#6@E'7>16MXIKF^
M9@>$3:88/G:M%8H^VSJW0$NTZRQ&'WWI]U#] '#9.7^>R#R1H=D_O3OS88)6
MU3AA2\^D$V3 V.U!/NVCYL=;N0-8Z>#I>+)OUF!-0JM(+,<]_B/-I_&Q3CWL
MN]N4B%SPG/J_^QZ9'PU6J71(U6&Q-Q&=JXS2H)E\&U ,5R;Z/0=+- *=.?Y&
MO6+4-YQ43Z_&"9!,#KX551:]8=Y1K:PB4OC^\QVJY1FXA=OD>D5%98%T7LD&
M'PKJ-/VP^C&Z\.88^3NS&U0NG6/Y?*WX234K05&&@N:D<UXLSV">&",ARV84
MZOK4@?BLJMM'WR[F8#V]W,!-0],I4S@C(N>J<%(Y/8:_;VYC@!,E"(D3\7@U
MY??-2\_(0D0#+3@1F5!B8B)%=@U0"6YJR.SKR1G_3>8 R!,]TRWO88;VU]N=
M<ENFB8MV]LR,W'CSN[-'^F_Y.B9@1>4#9K-LU%:EBP)C,%LW!R$@P'JR&QGI
M"Z70--&=0:>JH"0<YH\1S)3W&C 1WI XE2@.:IJI8KH-%8''Q8&80HUZ1N&W
MK!S_F;4I.^7^;B!A9"]Z;RFN^%N2#C9>/E$*ZW8+&<QO4C3@;9^8J1MZ6O6]
M?)MSMP\200D'Z(G"J[5Y;Z$B1OCR2ZU<[*HD>4*F*,$?,D8B)\I6TX* KIRA
M:(YVOKOXHGW%N\%RCR22P ^7B8:97<5[$%/1'<EK@'!2151#OT 87HUY?I%*
MW%@@OC3CKTW;)X'(-0&7=U_?]8,]LM*0[_H57(R4_4]-36J?SG<RN]W0( [(
M\#M_BY['#DY[FYS%1"U!6)D&79UZ$OC&@!A')DM$QB M3 R,36W)_ _3TL;Z
M18VPVVX_1]MO'2F_6;=;<]^J;FN..NG_:.M<EFIBR'7K>@P(^C%X_[NM_D^Q
MN(D9TEK W?M>H]2J0*1+<]D:/41@5:-G\^Q%J&J>,'L/F=*D@4!1DN[B+/R\
M7>SIBK/B+4@U?%:''GI!:(1H[V@_L(4(BD']MST"+8;\+P2B)J]X%U<HMF"F
M[EG,;6-2$CM1ORY:^=>(>V.BRQ?4-N">F+>N6<4NN2ZZLU"[1"?11R\:S:/D
M._8;N_<9#4R_+)FI &HN#$77G>M 9CU&=D7'MT]1"?N"VJ>YJA>]M26/P.'2
M7TM,*W%)XLB988EB0_(=04Z,RTOY6OU0JE?\RO0]8_5. @4JQV7ZKKGO!Z-G
M,/,^I"OTD,]3%TL1Z,J#I#DIZB_A.&1=D61<-')W-/426%%C3.S^:E>U<MM\
M55?9VFE@%"-%EECQ<PX_T9,U41&Y<<";NAX;Z -F1:K/$5-3D4<UEP1'8W+M
M1STCV3[)^FJ96+LD@@W!9NIWMWFNTSPPNIX"U=+@-G?_IL@Y+3S/V\ZT'8,:
MY5^C;FYWX2N$VR?6U.Q)CR;6#$,7&&7B=.^/27QT@7T>!C:GANQ9]OLN^61,
M+758C X\<9'2K$:[-CN9*TCHUX"R/(04YYU;['4UM7/<_-=OR V)<PGFD#NG
MF]BG-&#=ST5BS&\CAE'WGOF(98(OE #% YY8C Q8"MW6K@OKY09_LZ[E[2\&
M>"RY+7PL5F PR3T0"RM3WQ<@+X7]9+?J$<@?'6OW/1U$W>W!S>#_.1__6]LF
M$/3$)$AH:9BOB[,>J.QNFTE^EZUY4*!N[GB12=NMU'@+9X TKCBHP8_ X-$#
MHL_/OPS*//[^]'WRU9/PQOA^Y*?*+RQY$FFF>UN9)XWEQ9\X1#?L$6,S=%KN
MFD&E8G[RQ;ST;_(1(3LWM\\6"4RT+<_VU9<<&<=0DB=5PZFSTB=$\83YC>4_
MT&8X.LN\]3RVG3)13+$9)U8(&UR/*?C$\QS7J!FZY\O ^NJK;:J)D%)=-5F.
M3+*OH%@4,U1TU=#"#M</&(E.UO^3#C4.I6UP6G124B$MR\^]:1@.W'QQ'IM'
MNR^FT&81N4CE:FRD]%\[Z-BN)_X_%)_C@X.@/SO7@*?I._=/":"SSQND-S;7
M@%5)LZS"%Z_;AO=@JE?4#HF=&TX /:M79_?^+Z;ZA(@?3<^\#_P45,FCSK'.
MM@'!IYF(JM;.5?V69:LXDM]-57(YI#)PIWSY5)Q2 N/>7&JAK"W6+YWR+^F-
MZ/%N?S^?.W7LKF2YF3Y)B@H,"0PY]FNN6C^B;-VGG3$/Y#TP]=%OWR-2<?_Q
M=A.C!%KAD/BO8X5?R?YQ,7-PP$J1EAS0!_/@0>>I4F:;> A>YH/Q52JVMM^$
M=7"0H4"BF\HQCH^*R5!"S$DK$W:U)M'0Q137>K+*3T.C,I2GZWF1"3%V:(2D
M&TTAR'-?*E/*=[W1(G?AAK4%;1OQ.+>VTV6]GJE8/DRL/W91N%P7MXTT0]CQ
MSL_5F+6\_JYOPB6FK-KK>S8NI(Q[*^==AJER$F)WI-TZP_.7H'.G"H7H^7OK
M08VI'*$B:9WKK'\!UX#!66E&@^R:R8?5YA*9DC4$<[JOU=;-UB5;^>,9E? L
MX.I ]XQN+C'&X'37:9JBCF,[4X_Z\WAS')-W[]W!Y#[VEO"I'3:_KTECW(^]
MEPU&!&C0J(A$+^N-!RJ(O S<](<B[)4JZKOX]ZC9D?U;X6]8WB@/D80JI8_D
M+,;.EI%F!>-;,9?8[_NFW(!3XX_G65:OW&C0#/[<H74W=HR;(]CR$$U]?W%C
M,\3I?6^4*>L#4?I)D3C(!NL=5BI\4T-=/#9FV/P)J/B3/YM1^V[BAG)#S(2#
MRJH?>C@/-U2TDDB7(/#KSTY=&XP3FGP<&F'!^G)NQ$?(XY*1V*MU;BT?5)*D
MN(H,.K'D#BK3(GCAO0,/7>^=3@D>X&=3@W9Q^+-VB]^G%/\YC'\;;E15,'WS
M7)B27*C9?P-.J8^#/AO"K 00<13.TC*C'2PL&G>[HM<5C1W^S'AV[^((50MG
M:9?BWAG$RU?[JS/=&O/7@-O*-57A+FF8K-MI:7#(#8^UG K0VYG6V>^@KD][
M<CLQP&:N679NRQ\9J[-RL"82.\'>[H^#2JVW[9D+O8:F]5<RV1*_>"I6@OJI
MV&;.SFKS]I)#]IC"\2";D<OVG$]LVF18HW.CF4P<P3;I26M-:KS-C-PW9D;S
M=F9'0W5D7],9D:I<+N:O3:$FMZF"-8296B(6\O)9X0@ MAY5Y<)?;X.<)6BG
MR(-"8[O\B?Y$P?L;@CK[,OXKP:>)/:<<T@^87S;Q908^?4?%#U_IDM[3&(LG
M3A^;,[ [A*V3EL^)>HV0V$?UH2E#KF'4<?=7B\E-IM>;*HF,&!E79?O*9,EZ
MH6EYD5^[.I%[8;;'XX(X@H^Y7U_)KC+/=#G<!UC?<)2F%$2!N:QW_T#YT%[I
M15>2C-H/>1;MN<:<5A$7[I:B3B4M#?T]=T%3SS'Y'L/D]-'>FVL&67*&,LZ[
MLI/J@6-+8L9BXKF:37((UX]F_@I4-FJ[L@TC7QL"%YL1+ A/Z'G+S-'29KNF
M=0]CB;0'<)MU<N1)PP*TLV2[,B5!W(YX^*YFRWN\B=W+Z_,1S'7'-O/UFE1F
M'.<6T\P_\_.N4.==_V8%F<MZ'PVC-@OZR-%:L$#!&H);]:SIN<5\E#<S<9#,
MJ7U?"C*8L+1X7KGD9KT>+R5_ZS"GBCCNJL>BBUWRRTO[;=QMPL%EI^;$8)\<
M; >W]9JBF/,8!EM< Z:0-74D:>C?+/AFGN;,Y;B/98EW^[>M$Z=<*17SN:S#
M\Y^;<OSJN%OM,#G'1@L7'POU^,]DF?U,9F?.P+L%(7RMANX+<#RH">*I_$$S
MIUH>FY!<7QCNV+;]".TMH%^A3&MRZ\X-'V8H+UJ2H +TY!=BR#/TU-!BQM1B
M"K%Y+RF94G]M!F_YRJ4X.<.16RGM8::>6'_V:?<7")9&J2/E"W;!I@"#P?5>
M@<3:]8O4/WUCO;9(;<^07U\,;EC8^'E74<R:TZWU2T)HO,:/6NC\'F_+D"*O
M =U-N7AX23:AI5>DU9%CGP+(>;.WC@5NXL?T*=_5@6B ,5C.A5J^R7!7[4N]
M&ZH[-B9<R?-(?:&M>/8BKD0)VHSNL4$*M3DDIX*NC,2_/W7MWN5I]5#4W!&8
M.R(((B&2RCS]72[ +%&,AJCDZZ+Y!6B5ZT?4IZ;T9=P);SQ8P&N=-8 _TM%<
MB!-_+!+QHOM[,/U]5G8 ,6H!N8LQ95Q7U?7*V-/)Z1@#B!23+4>/#WO9YU(T
MY*?B#1JC? ;II_AL@?$IO=W^;ZC0"7=R8,];,S4=DFG3<TW!!7#P/3 /S+%D
M"N4#I=_%J"1K/SAMM7"^*;:J3:[:,1:]\[=F=K 2VW;Y#(O1[3\(V&XZC)&@
M3#W9C\"+45C)?X7UES>:(^Y&![?*_:$BR@T=1K#STU^NGQ>0TOS.Y.SDXHZ8
M;,03/@7^<6/3WN./4RMW-RN^ER?>&.\ ML>+*HH,[9?<-1%C' W.U*V;CCZ;
M!X56<:4[)]SS<X41IPE^!IIHG"K:EEB9S:%=?X0=<>;&THYI4GZ-#!,E_&;P
M3T:EI?2H.<^LIN'C?SH\WP5I4/'_42"$[IT+^+8 O_P.P@<,^*'&"=@5"$W2
MGP0E[9TJ,B'@FN'_I>D(EG'6Y[A8&:31;B@C$H.5"=(6)=J,JJ>RYD$TJBP8
M5*AT4I.T_]E^M82Z,/8*2>8[S/C.G?H9)_PGMWK0JFI>)@Y9U._1^)(XN-?H
MRQ/@]S# Y;_ _Z^/K<J@0L^V@@E85I<H22)QM?%P/WNUFMRLN.?=Z2^/GWRF
M#+?J0=BD6>E*K ^YC7V CH%Y&Q.*8:O#@6D[!H034^E+_8RI:@K'FX/'G>9J
M+59A\;#L@7U#B318*Z[H6=C?!_E[YG/O*I$H:).] TYV>.8X+I7?N0V(6JQE
MY_B7'9PS_\&@8X<]3,%<%^7R2*82U!5.C:N;B@N:=B&\4I&^F;[RL#1%Z1H@
MZ-2YP):!*3S]0G:30G*\"-Y0*4[9DZV.#I@M"!.;=KK0PR9Q9P6T;CX>E%?Y
M_#J@6>IGA@7[,XC[F9()3F7 E$9UAAS+KWFB+[W+\]GJE@D>!>B)"/EUXV6I
M:(M**$UVWD%-0^*I#UZ[Y!'/S11BO3)"C N/IS]=Y\Y?(0PZ/'RZ1;D/FR,;
M_1!U?/\:()JKL>Y]$=# )_JQ6%UC5$ 29%3IOKD1S-[B7)@5E.@^IZNVY?5/
M*X*&YE'1C(;9X%C*+0I]?M[O533Z'S+H;9.H:U^S]79+3EB4:3PWN_IP-!E7
M%7Q1=U!U90$*>>J\$D"IA9;_B?;4M5G5*?%FW9DM[>"=6%(B>2_O%N-0[I_N
M1Y=_EA,IQO[L%2ZCE!MKB>:3(+1^H7V>0YNYX1? *_N7]I5J[FLWOQ-> VN]
MCTI%#P.^H(U->,A0S/_FBZ5(34NGQS]$40]5QY55RR8>3U"C16MU;AT_5RJK
MT\V;2NR.Y^WA&\VWUW^='B&^:.RK[WAYN?&,>0)P=&Z@=?NO$M5P;=GH*IJW
MLXXO3I(_.=]*@<GG@@:K]FTI=[[UQ3]]A2I'S\OX7*I0+O_ HAR+:)\7F12]
M5-)XIOP\_7ED860BM?;-R,Q[.F(F:E,!#4\K\']WMD^>46.-X7,!LX^Y[?9K
MSOY(K/T,3*/OC0C:21MW:)V/@U\#H-,A W*.4'.V30:D8,=$Q0&QI))--3"D
MYQTR8$P@-ST['2)_1=X@_WO]63SU+=,H'Z :\[!'F8@':L+W&N"UT6;O<,ZF
ML;6%8LF1/(<-%YLO]N5@71F6?OF.O#>TV3CN@3<7^63@!KQI?XWX-?!UL_=7
M-.X<G&&)SAN3_ C0H#,">*NRMA_M+T5W<V[NZ DCZ?=>%$OY:)"6X*FB#L'I
M&K!DT\_Z,S+]//?%V7["OF+)M+N2X=YY7.O$?D;3]#EW0N#+A=8]-IKAS**;
MO#JO'[6,& ;S+/";% (AE&G(5/\)M@SQ,:HUV6A[+XLAUI1^6M;Q+IOHC?2E
MHH%\!P/5\+C-T*<-R0YIMRMO+T=:%Z,9A[[<RS"R&X5Y/VFX8?0F\F9PXQ6[
M"MK P9RA!BT0WG&SI%47@DZ5YKYUQWC",UDQZ3[5C+MUR\0B<+G4TX#IPUTX
MZTZIR;3N'T$&S,RY3;'S:A9W4G?CYQ+$UO3+4DWC)4]U8[.[N_'2I67R*\\^
M-T/BMQY1OS=%A?R4_EI$F_+*Y>Z W]@7P^ART,J4M--)M@Y-6=7SFP4;K'^+
MH[OWOL4SJ=C4J:<I<RDMDF:*J"6L/+Y<>67[Y0R93Y&':G?S]Y01>_CBLD-7
MZ$G9VREK%&J>7QSE'_D6SY&K;3,-KWQ(>Y*6R0P@2V.$JK-J4%[.2HZF#9Q1
MQCG2^A'K1.!S?KK\G&/2=0*;LJB!:\ 13X9.)0B2NE)_UT%U=S'3NGO[GUVG
MH=2SJ:HF('X'I#=VRC7DDV&V&: U]G< G;0R%N^XZ"AA&V\-UW1DY$712LWC
MV 2'3=))&WE9:1-4AOVUY1EKR1*8@M\-J7'U2$YJL(O".L?)$%FU@)ZL9Q>G
M0:NAE&3G%,'$I:=A*7$UIKB"=HLB<S'-YT/0X.1O4M]=Z?NL_&G5"W9R"8OT
ME.L3JODVTSEV/9]V]-XDK>R3*21AF5HZ^8U(?TRN=$76OEZ968%TS83))0F/
M5]H'%%T1L?7'C<MW^3R:MR_W.QD58OKM65T*L<;]'KXCY]*V@NSX$;&4,+*M
M&W40LG:P)MXUPT<YCR*@+;!NRQL7/9R1O-1LO/<W0>F-2]A%]YC]HQ-KD-G@
M^RUR#O"NN@J=B\E^H6?7)]Y=@0QLNB4LX5]R,S,6'/+ZLB(V5S%J_@[--EI>
M-;Z\J?&-X3B=G@/#;YD[8>'%3T)A_,I*$L^.'^T_0#.I4K)U^]'"BY"'ZFD&
M%XGQTP>H>TOQ,_3P_,?1]PC,5DL;XKJ5\EICOA5B$BY*2F#*()GDX0!XN8JX
M!D8@Q_VM!!3J#_4>R^ZMC<;_+4O;%&%]A&CXMZR+*(H6O8_J!P:"3_YA[CS8
M^_7@!'2'&!W([+5[GKB[.AF>:&F&T/()FNXL9Y*L8'AV.E[H' J,918!Y]IL
MW=NB+P^Z(S]ULG+P^K#WGRNT^J1R*?;GFH?&9I_3DA]A_^&I((22["Q*QNR8
M,EVRR Z92)NK(</M0(S_Q#D4^J[6E-MJ<M5@$5O)JMS,YT82_\>I$J7]V37R
MV"F!K9;.^PLF\\PY_%BY7H+U"96)#]_ G&BGB=SJ?FS/G\QZ3$3G?,"SN&M
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M0P&5.F=/O :(=ZVA?DP[#$[-$V&5\6H$\MF1.V8\WP88(9?X>ECN!LF&%8M
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M\U3BO'/BG?(JB7OS0C(PZH!47_[Y^Q]BYV]##5_IZFJ',$\NE%JJC5$5/"F
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MNQ]\-IY(P0"1!22M0$"&?S8[I7CA'HU1HXLY4'K9EG Q/^)0+*(JV-1HA@,
M:<8LYC2&(@38P+'^#UP+,7K3L4CZ)T:M4YQ)A<!_?1$H[I2$M+?QW+!+O2'B
MBE-- GDXNA+2U(T-80G5=U7.DXPR[XF*0O,6D!*]%NH9B%VK +C#5+C9^D=O
MRO<NSODYH12?0(ML]]2S?'NXM,;VL7@-2)T,6-#]0-:$8&&W1R!RH%X/K,Q]
ML<NAS.JC]2RN(NCEL:!S-7\UK2T\H_;SR1P91\Q^*I=/IG]W99]8RM)&,^^C
MOL[%DYI\HL7.$ .NJ.XYF@CK^Y14B:DR![?6GJCVN&=D#K**32=>9'74G?Q
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MUC_+'/RU</=+!W5+."F R1@DLG0BDU754L@X/G-A(ML^9;YE4MLB[U![:BD
M$7C0M^*C%,\5*!39U@"@H*!7U 8"O:"%X_>5^/U*)V8%""#N^UK-$&?'G*TS
MNF<R@OQX^_L"Z/=)7W9%93Z]6"4N41"><?\Z>-R6MBY)88ML<D'X2:M6AQ?4
M#71!1Y:96AR]CD>/!$_ ?PEY)S966FQ9FY2*MFG2+A82=IG*C-(+P:*BC/T/
M.A+2^EF?K)Z)?[\4FGL]];8_]D_5!85JRO PRJZ%^[_)-RPW8_^CX+2"VT[(
M"T9TO+,R..'[5@ONX=^,4WQ ')=V?F+FN6;H17M#-/MT>)V<Z/LA[IK?E\'Y
MW'2+H'?FZ>T\09ZR C0+/-[$2V?AX/]$,/0\7^'H^7GEOT/D[M1[^^O>7U,\
MC_/T@^@$EYU4Q.4P/'0?_D&HD,:]KV]]7)IZ)3XQC;"T<W^MS,L "+*9$;9F
M2!M6*&-X.'<2,T:A$^02K[SP5]/?X8KABG7/ZB2X4"9H3: 2$S5OK//UM+
MM+X[/<9_0Y0_%[UV&%&)X[?]"NO-)GOY\O:RC(#/ &(C5WBHF_EDCJ#9:SH2
M-S(/B-ZI]7>\IW2\9]W=*)<L13WBI<R4NVW#*9#5U-/Y6-?,:\ZC_.PJCQL4
MY&)<3S%TDJOEV 4&P%)\H!-20:KN[8-20I)!77\Y?*4<XMS+:%T7D1&ZDR3Z
MB8NP\L5PLGPC8#2&I$3L5OQ8:Z6Q9IV2%D]39-$'X6I@7]A9F%ID2?1&YN-
MAX:]7*UHUI<#O6.OA66#9#1Z L9R9Z)$7,6,F5F8CRH"AC[.C-=VQ";OEG%V
MZ'4%_/,6ZL!]=+0_F8]"=OFS/,,TA%XSRM68 $T+GNG&X=S[/,3KW4<U"+>L
MRT3.2,KHO!F5?<W6GXFH99J[=C;,0,I-):;U^72R@D&>*EJ6.8Z2#?WZ)QTO
M?3X1R?0-+3(51-=;YUA$/Z-.,SED*VOVR@:(M'O2C#9&?4D_@_>,QA:VPI/Q
M)BVI@GDUS3C!)JUKA:RZYIEEG::UC1F9K,98C+!EL*P%IT_':X7?V^5GP;IR
M1'^'!+Y(9(FBQ,CZ085U/BZ*2K/@)J\QYYPLM;ZQB#M,#''LU$<*F_!C%&Y\
M!AS=7$KMG'E8M,F,7"_=1H &,!WO$:8N=26H7D#B;/Q2)4@^\\#ONH70W_N?
MD<#D=Z1:EE5R+EQ1-71&FBKR,X],MG%95":CBBW]F7@L/S5G"[=A/S2F@]<Z
M<$'[Y!SR,^>&:!)C;@ 3B =O;HT#02NGXQ,G.B/B:]9NW *BP#1)$0_Z$*7=
M0*99PS],2#XTQ^5:!^@HS<86?,&4:CKX*^)8I@7-V-K0))=RZS*]^-O.14]V
M%#V+WUGI-D,I=)XO8E%RV*_ 2CK0NBFZUFY45 O(-H&_MRTM;R3T@-2%:I[V
M)4\C[%)?O''Y:X*.K6PU!&I@X4FX-!F*9["%7%>XGL88TS7"4Q #=< DRK4Q
M?/8:MA_]7A/&5%#L=1KO]V(8QS*>!_ '.]OR.=Y.*;MKO51>]J?%LA\4,N.*
M&,8&3(Y7E0]/.X%\7M])&TFY^$S>R$YQ\4QO5_3*OR# ?L^/R[;6QD;29UR^
M]^Q>DLT@#LI_'Z6V]-!%7E^9_CPOWP4LI-QB.@0]T)GI:1_R7#W3'<C^M9*M
MSN:\XFD^IL;\YW&8PM)SR(Y)H?C$!MR1PJR^#F/'ZVD8WY8SM:;Z:\F"(;I5
MZ=FKL,IJWYG&X304T*XA9.0'@'$NY7?**OK7TLG@B3I;!&>5;Q7+>S-=3PL!
M]SE389K],&S188^T9.TBJ<N^I&<<XYOYIA$41D$\4=+TFL%>[< M9SOP$!_;
MEFT?G^25NUB=-NCP_:[HK?!0#RD#E_D6YVFCTQ[*?H=ML6CG:LD0EG*<B=VD
MQ<?!9OUD"Z$5"^&AYWE2D(PS*#U:-GRT$31#1E*))]6UB?"8;U/=R)V-9Y[F
M\AI@OO;=0-P0-<PN7O-6[$ [2H56,#ORX%ZEE8S,T</#X];1=0%YF?Z?3*WI
MO[UUH4&9K@TC6EC]/=O2?!GK6BA!,'=K^6?4/D^=M\GBQSK@P]-#C279#L&D
M7?4UYGL7%V\,6B1 OKK^WAC_=KK*<\,X4S#N\*OWQ/*^P=D95Q;7JC!&+%WO
MS"%39Z5>_Z*5^MH.S:A[Z(;<[\F1DUS3M6/ZB&9$@0"9/9DK#61W^@)MEY\H
M' GQYZ00&"HX6S?6@[+:A:#9HA3:Y5F!/\\--D*'&S>O7TNW#KP@%*8VCG4M
MT!C_%&0Y+QF](5*KPVCXS_F>M0X=W<;4!*HW9409?8SM>173X[G$^_8QHZK$
M8%42%K;9# S@F#J6] )0]-4[^BS<85_C8\R?="@5^M/:XR$!F*2H;A-0E*OI
MSIM9JVP_@D^-(7*J?)T=._I.@KZV8*"2UIFS7=.(='EG@M%L6KCRQ_6QWK16
M1)8C>>]3_V?!R/D"F0#K=B^8.3&(;7VL HAW!+MXT)MS,+,*4U='4&NUY2DP
M:P?M#'W#6$C@D"H:?3!//H?O9++](9]'B"@L%1J\F(YP GLIS/")J39]E-'B
MUTG7N\1QNM>B=7^$S3#.;;,NU2\_# 2*'8 RYE&U#;Y2-$)-O7I5;LP4<4>S
MQU+.D=&[L?Q?X<>7PPF0Z$\F/<$Y[SRXB]XO61)4IC-+&G;,&(;6!0!5L;Y*
MB@T8T?B[IA!FEAU/3(79]ZU8^X!32XLTN[CKO ]3F75#GPZ;56Z((B=Y-_?0
MN5U,\9N7'JD*L#Q<AY;7(G-9X,._7,"XV3F^YM/K$BN_/29?O^S13:X2:*#*
M-G'8+SQ^)1UKG\I^]L'PD_;X9NO;Y-@4WZH>K;^6=;/>:?\:^4)*A\5OA4](
M^=\?ST*MJ4=L(J'8GNE7\JC#;#B&<_!PIV @.S7#(K;$"CQX:^A>-ADBJAZG
M$E7M4_L+:6L*>1 1;W.H[]4XT#*_@@5FXA*WJ_*TT*(*_L\K._\-W[;_P.7%
M45:XML(*&V//E9C^=>$K^</%;A@I?(O%$.Q270*U*40QG[C=_7YU][]NE*KS
M7C:N?+LFEL:=*AMH)QCT&CF<8:[41"17Y8OK!0I3XL!T4S$U7PEMK96)()**
M7X^CK=F&R63Z[ADKGD<SB?;KK"%V_<+'I4'P%I9#K )8=FT,SH\26ZMK\V4.
M3$$5HSJD;RV8YAR:-Z0LC0LQ/C,=A6H= Y8+&_&P[3IV0L2E1>CX+ SN45R9
MQ=]+[M,0!/!D8O=:^]JN9?YP84&OL74*E0$,= %! IN$>GWUC.CDWZ6\N\4V
M@FALR#F>%C9;:*:U"]"N=&^GH?<)@9V@ IP&@#)^@8Q>SK6^+K%CO]@"E(A3
MU0?7*#0>$2HI7TUF:>B9768$Z4U+[UL.I+47IILLT$BF,X4)4OIWTI9O-1M&
M.U<EZ;RM-]*3;K<1;>U7VU(53GPBQ" ]]!;V4:Q(Q#/8SZC.]LRVFF 1S LA
MVL<&7&JE%@;$.#JX5G%4/?(K80O+#=66D1K>7C9$Y:PG'\]@7\UHO?V0.[MS
MY@^/$2+*-95L"I\OV&72[1+VDINU8UB\ZU(^[[C4I]=<E<WHGUQ2\$W)-P_3
MWTIU8&3W1#X^4MFIK/AEQ6MJGD$WJPBY'[1)+/"<UO=+V> 2&6V92%Q4 DVV
MJCW\R/%/AOF7]^4\)<3I@1UDY0,.QG^^5?Y V$,G0EH4O'$UJL+OG8\OJ,<T
M*L@B&76%TGDK> HQ39H\L=1;D5]?<^/P2DNEXLJV/\2")AGM+$7*;N<\_7&[
MGK?O_3V1W$??V5EE#8FJX2Q4 MKW_=I^>&A2+\I2?L8?<1O9B:3KZ=^*GYS5
MNB&:@QERR!'-%)0]H2K,-*>J^!Z1H$%Q?%+AQEW\I(#U0T%B".NGNXM'95S:
M/)_;</=XQIL/#4$@O-*8J-@XM:+Z;#A\\BG,,'..D7B5T8>OC.%G3F'8CB0[
M2HK7X&\U_H2GA.;LZ\9@[?"T!+MXD[9N%O KDF@LS:YVP<._Z:G+)MQE/S(/
M6)E>>=8$[F%!>L$O7"(NK:A,A_76,MH=L\V9_6,P$L,$4'ACX%F=;#=@LXA]
M3^!;HG$\Y'^;A7J(XM,6+. S?7'#1ONU&.>(PXB(2P9@^B=%/J]B^C?L:*C?
M%L,L+ #; 2DRG(G))&3.2Q!'OG,T?1PF;/Y 8,$_[5;JH!8$/93EXNZE):P<
MM(<WLZ]:B^VWSWC)PU KK,D]*'&2$F"LOQ@5N*4MG5&E7IW&!>S0<F;C+#N"
MI-DKQTG(O?H]UV)@H48OS=;:\3G3XV648DONNW)I?[.V.QM,];LR5TU-UK47
MI6CYG<##0YUI^667G@V2XP3Y8X(\GRX+%F[/<?T++E==<,VVM=L?C;&B&33+
MJP@T>)G0GWLUV1]I4C#59S+-#$*V.$0]'[OFHL_,JY%ZZPC3;YH4H\+NZ9JY
M6;)EE[5-=#?F-2@'T!3;_T8^9?%QK*5]3=QPT+K\EWW?MI;K1[NF&ZOY*M(+
M]@USZ:'P5$:5FKJX/:41IT.L.E.I+YOQ0>&Q\V##9"(5L^/!<1<-X"F9F7HO
MS1=+-A>YS94V'N2*Y,&[.\\))O:1Z/H>LU9EZJY0]:%&XWNB?7$HY\+@FJQ;
M\?9(I[:&E3Y/T5A7/CQSET54,ZR(2@$R1VW*:J 3S.A3EEY*W=QJ5-WYVYBI
MQ\Z GQD$E6'*%[?]*G)P$>SN6^%YJ,'..).$[R^#B6F[?%&60-?1'U\?N<"X
M'VEEK]KPHW/,7?>6YW+TTFML!C?)";.-E'T/TRV4'<T\[EAN<<>:['8D<[:U
M_!R$V;9T-(>,3U&8"@BP@]UB%[_GM2XWP:AE0A"O%*E&4G(8K3@KAAM"#^<<
M/TN8)BBMJ_J7 >.'FK(?=Y";4EQ\[3G(5D$/ECC:&EWSS#K/BB'"H^,;% Q$
MR#ANH<]-8U >0N_8/1CMX5&;R)1#[+Q0FHZTC-FXOP8@:OMJN_[K[A"0Q1UE
M?WS<V X$/JO.>C5Y,N*)BE_+<Q3O<5ZJ"\V,%%R59W#8K/E$Q_3S4>5QKU[J
M)@OX3,DCKR9LNX2S2;Q9O-B1@EE29Q\YUU^3D5LAW&-/LE/[$#ODC+H%;QZQ
M)N\%($_R:UEB5PAJ$DGF(E,8MNYL7S1Z&1KJ_B':W2Y'O)I<7WCU$JXJO2Q@
M^:M6ADD.:(T :?7&0E#FW^X4D4)".(-)P3-3.[@&AU64M^GA*@M"DA^!Z2=Q
MI!\^R.L98TQ(61=.2WXF,?ALJO".Q_-KRDNV**19T#Q=":_\NW<96BLE@_.I
M@+XW4-$'MU/*/X="EE(B)JDR,E4?8Y32$,YU7[\!B -Z9@Z<Z9ZK4K)1)ZXY
M[<3)57$Y]OBIU)D>I>EH*@'Z?8(6R" ZF$ML[]E$?F^0<Z[Y>CSEDB ,2V@!
M>M_Y\OJ1NX7:YO'UGCX-KU_IFE_A01Y !NR+\Y"G2H0*9_N^8#;I]9ZHU/\S
M Y<^J]*2_]+!/&FX@02*ICM'FX:FW?\5_[AQ6BRCF.L+[4-VL#&<M3U,9BUA
M<ZQZ53ABEP](QB?IBIL78XH-@45AJU@6J4\JK(0K53G<5!\>5-BZ54D%:L2@
M(+J#0<I3L+YINYI&H[S4];"6Y2Y;Y(&7C]#:*3?CK(J8*I6;F&Z-RJ].:BH0
M+;T\K((1!6SGJR]2AMGH:K((Z%OK!3F=)<H56MM:>5)<LQD&^"EA5Z:'8%.S
MR^+'HMFP#Z0.WUWN0'UU9>G67ORP'Y?5>NE('<W5S'_WF^^N'9CL.62NUB8"
M/3Z%DF=F\;M>+"#](96E;5(Y0RSE\Y'LSH)&O99+=>9$<?*A[?-5>&UH:QB2
MK([Q4+N3;GC'T!Z09!)1^?-;]QXG;Q-@2.[HK_MA3@W@/B6I2ELNVURUA>/B
M20V 4KM\60'ZY7XZT!TWZN;X,9A@?"\NI>JY_ ,%_@:%SGD=1X"4&VA2]D5Q
M\[S>;.V"R"17F&;W40:S 6E"S61+(TPISO$2*;>\?P?QAV8YMOK+3R;!S2J/
MRB.!K,WC^#K)IN/B8?SAA<L',^3\/_4FO;TEX?LAH(O6L[8U2D2B<9=7@%1:
M=!5!P^_2['A5M[$VC75Q<W:U:$2)P6<JK_<T]R,"F?_JY#<KE-!I&Z)A' XJ
MRH55SAZ!@-SV5Q;;5?GM\P_W1.FL+!WP9<R_WJQ$'RZYD/WX*Y>+IADE_8C<
MSO605T#<3X2270<M-V:?E5X*#\[LQ_?[#C7P.A;\=T9V,_X_RD.+B,L(C\*4
MH$R_J5Z%9"?M\K]9'!X@':$W97$%*_(71'ONY&W!_0P<9\$J<FX3'-FE$D>2
M.78OUF^?'@JD.OJ7H'^^NNID%F>(>ERT\F\,(=UE(6$YM-],II><5E5Z56T'
M8:?P@N8GV)FV7A8!L/8Y4I//C 2#I7J&:9Z=^9.IR\(80@YT)OFS50+\(^()
M?*55LWG=\;7!Z'#/%DGT114F$'?9'E1VB." CUX98?%IW]H8)R!#'BUJ,=F5
M*<.@K&&GM59TD\^>XSSVB]N8+-?,.0Z^GHZB.8CT>Y.BC8F6LG4L\U!AHXBX
M[[1;)Z<[R8@EW#WZ&.E+MCVM&:P]->OM#R&C2\<8V1./5?DSOZ%FF.HG:9NM
MW=,?;&_$:,OA6Z+9U&,M[G]%^11+@F7>[.I[ZEF(,F("!.@7AF]U!JUJG-;V
MZKIV-:)/>(8)EJP\C2"IZ980I,C0D];((GW\#N^]PR&P8/K\F]-*_:X:L.ZW
M4(,8[KJ+V]/M#BA;56+M)V]<=E062(S.]L&]#K_ZT</^WI1]'UN^FAYT'WVQ
M!W* L/S1-LH7DC:678U\>D/4?UJ HRXDU/.F>&?ZCWNK'KQ0!=K>?37EAQ>U
M$2,,^[[LKKJVXZ>I <9ZUEOVVM4 J(W]<W]SSIK(A=LDOK,,BF4J5!7:O/7X
MJN@"KH%9.,$D\B"<VP(C<<(US,]\)Q1.N(V.-K=B/F@U=+%@,MF%^\)+%VIM
M^ID-@48XCG3+.;VPN=VMV[C%PRHK6F=R,:KO/P@QQP&MTZ:R)4%GGGSP@%:$
MZ:(@3.<4?12)>&55'?@H=_R93O*ZM+$N&-+3X\)@EV56Q]%8&V![FLZ)$+E_
MZ[/7HQ.%L=WER2]>&$YQN V[3O*F#EA>]H9(/R>M%(JYN*H3:\?\'':'U4U2
M[F3*ESV#M[__OQV'I\S1;51LN+*'PY<R.P3_!^+LD<S%D+?0;U,JRRJ_E^'1
M58%:P3J09N;)<P;X&<YXJ:4[:".O'2C5KN6>=]0,5W\@(&H>!D_F1#PCHW:3
M"IR;J+ZU>\8-;]_3O&"U*KGJ#E)U* T-G!I=^@LJ3F4\RT_^26PV*PS[7BQ=
MIB;3OD&R7K7(HA <U5J5<1D8GQ)4/:\/05/"IC6O%Z9E<>X2;&QA+XH+(]:>
M"RAX2:#<L47#5X<;M*]*=M/_3+^!J2,A;6XR\01@W-OD*+'C/O/)89:O^*"]
MWAWN ][0YD&75P$*S_A-8^LM5A8$L]G@@M3[G4M$Q0]!CVO,UP;WTIQE.7IL
MXBJN1 C3IFON]GX_MHST[XO0T"PM0(0:^DKAC56PYHRAIN8 ^P._:3 &\\7.
M1?HO8CLZ%0ERM*&X_9*5U+6[_<.M[ :&,)S?"H+NX[#W!V01@ 5R_U[BX%KS
MYK("WEX$PGE_;+?X8]KC7L77 K(-YEZ3M5PSDT//<*_<"S5&JN5=SKUK/R<,
M@A2-"/??2Y*SF"V[6XF*K,$;EYFE,I9Y]:;5Z&B+R605>M4Z[WVASC'^2\AP
M7LE ,.(8LZ8L_)GU4U(MU?BSZ.ZVZRLNTXK'S+G.MR @'8?^&K8GW/WV^W'N
M6Y@L0>PN*(IS<[%TF=]?9DK"ERS.+F=>;0I@8FH)U/8L3:DQG06\.EQ:LW32
MB[%V,YN&5+6(]3_VNUCCJY7])WM3'B/@%C_P?<>SP0].6R_S#[M@=6G;5Y!*
M\1&'3?N.R?,TJ0G* ?8XCV@/DFDM,(Y"C"PZX;OQ(^N0<WV;*'\HI.LG\I5U
M+290E*+R?*WV;Y:WC+]S]$<Q.*O<MVY5:^!O[COJLXKQ;GVV+1*FN7PU\"Z*
MXA^X%P[*+*0V/M_OD-/R!%QF?]3WQMWMA\/L!_DC*Y7W?X'>3OOX3[V3-.7>
M Y&!CJ5* 7*SAZ9)_A^"I0)0C3TYW]/(#VN1@RCF]1;HEWM0!M\2';]1%N*W
ME-0]=Q-24W,P77]V)\.N*SW0'DXC,:E]4_"VAT$B%AZ%'C8J\![]?RB8-E7D
M=&R89G#W4NWBP%CFT"6G_/'4X&97>T_6&00>-(U6+=7LGR.HS]O5W!!)\@T#
M19\X^=H7%K#]C-T>":K'K/4<<4ROGKHK63C+RG*@@PV\,[ROSJ&2VRXF)X'D
M'T>7"K,X'O/^+"/)AV9QK0XCZ=]]!PN<K#$PY\6T3\TC>A;Y.#!$M%/1O^KZ
M1#1UZ)L"T!3B:2]7A%2Y$6L<G1TYWV.47SJI!AKSU_:AG=L%[@>F;F0<AETO
MT9&"J?)]RYB*JKS/<I_^85MHMJM<ZY]=K(F.R'GA8_,1U!4LU)DF!B:B3VQB
M*CE&E3#LY0I3ZKSS@ #5F[E*')<ZX#$ C-"MYG;\9#7U1'4SOM^Q&5CGB1!8
MRJAZ:CB/2Z$3$[_86]!Q^]/4ZM.N+5677>^.W=/SRK@J)^>=FOY[0Z0]KLZ5
M?M#);%9E5!,->1<@[L'4\OA T^F/0/YZH8;CNZR(>09?*-W7DG8!_["GYL*T
M]?PW1$4RLB>Y5^'.07!3.:@?*XA"/LWGW :AX[5[;),.2]V6+U_<3E/Y ]KE
M+*\HRM1;_BS@YO_#%6-X!.=SLTNP:RV(+X$?JS *,W*S>,IAKSC]M"]0P8%5
M5;">RK_].KS\)1Y:-BC!.3;&N-DO#V'>=_:8$_Y:#E5XR&3$\L7#K1AOB,KW
MRO$],SL[C;LG)]*L0%DPXL+J[38Z[V'$O[& _1]0D(^?*&B3O?)LR 6/_KI.
MVF)#J]3;?B%B\B\6\Z[T[+PABM)37[;84'CC^5_H  TBZ&6,S<$?M]M?'.[F
MI!BVA$PYBONRG9?_72)%%M'=UW]>Z9L:.?%[%?IXE6.=9T(BZ?/;L? T#RJ3
M)!UF$EB@8HC 7+_)LO,8<SE4L%A2%'B^PU@-MY^F\ODRSF4&-#6ROG4;L"'8
MNIW=L'L E-:<6C!?HWDJC6.H,(IY_;SJ<_L6/$T5T6U9C"GWQ$)8^AG:DQIJ
M!@C#/<^'^3-_565SU 1<CIVV_[W5UZL_'/>EE=\<+;D<DWJ.N?!!T)CV!"4,
M'1-"O<@#"VIY9ZW(K2F!XL^FCDO>?5_O'Q];5:5LOR%Z:DY?$4T.3MVD]QF<
M13 $&&MQH9\L^Z-\":/"CEBY=%S;>K(%,"U-Y.?NFG-L"NU"YWI*KD0JAGHH
M0#59?R\U>P]X)30KNBYZ^I;F3-* ,$A[]RQ 1YP,3EKSX;[U^H',K<^R@YSX
MV.SF]HF^MA[!AYOQ_'190=';YCU]Z5NBU&[\@=?6GJZX7TBQCX6$=.=3X:MO
MB!7HL^",)'R&W>(&Y5>RD;*\+'((YX@B8D\7+7OQHURNW]=D@ DNO9*'F>J
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M@2G<%1;7;YZZ3OVS:U("\?:0[HT_'^6%8=TBLO0LW#?6=1B"M?-$%R8&0"\
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MK=G5'3?(RO,SVT+X_%MCO=U9UN*+'4=S3Y;")Z[&&2WF,WVSWRU7;@%-K#H
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M8:M70V\SSAIGDXZ+WVP,<#?0-*O\GS.U,\9;0#R[^6%0<4%=-S__B;/VM=
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M-+K4CAIO 9T'RCYI61,',F6G?8'E&D&E-CJ/::1F)*(T51[401CSW-;\LEJ
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M&]8:T:(ZD?*16C+%9R@@<Q;7&"O/!G(571%$*(\?HI3/8:('U/\1G30O^EM
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M,T#D<WOB!-J.+S+W8-SMTB$.>;M:DU(7F,[5JP.@SA#@2&O',GIG1NXH=/'
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M(I%GF^8*ZEO.QZTSKA!486O#6N159&>VH6;C<';BTGGOZ![Y.L(Z7A)2P>K
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MCSLVFL%/L>;55HW5))/QOU@_C=]!%7[]-O-GJ)&]%N.A9A=22Y8NX 6S,*\
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M,;F&O@$\<E&:[,@Y3M!?34O".S?5BC4/K :]A,_^$2448!3&G[R/QY>",UV
MHAJ._:%WD2-0))^=0>9V6CB+QYB86!)(X<_9%*TR+$TKDD+ZBZE=2L>A8TI_
MK#@8B%BKE0O*W-TM?#IJA2TM+@&P6%(1/B5A%9[ MY8D&RNEA8<@0"Q#)'[T
M:LZE2;O$+-BTHKST:NT/_\!RC>(&4D$FR 2%.RM.4]?/N7Z(P:J+ =F361S9
MCB=M9XCW0-<@!;*^Z"^L'"0QP?KR&$DRA]'!ENQ6[+N$NU=$;3 663O?/M?<
M0[2-7B& ;.1=P7T7)=H9?7_N.K5\L:B+0]C4BN _F>;,*]3YIBU'+U=-#Z0K
M(BF\TN^ :9V\ZTCK"]X"#*@82;1J=/P%<9.3E>4)IPGCY=*^.E:#3R1HSTD
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MB/YL^OK>+ :*2XZ"T7@I"5>B&+ )/N"QXO8Z1;4?*79.(TH9VE[Z,68!:,M
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M[Z\G"_FE&^4L/C"NHC,K$0YOT##W-#*[=9@+%+F ?,CJ-+:(A@O$SPN@DY:
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M*EI"4WS*<CQ9>.%PC&!-TUL@8V2>][FI?*9@X8%-C4PW-9=N6!,];W9Y=YH
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MF[>.BS(<%,K]]H=[ONQQ"%T<>A#LXP8ED+*%!X/ ZV>$,\=RRA%VNI#>]AL
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M2?[X3\][$EE2@'!Q4$BK?)"#C!4X[4(P:H5LG$'W:M<OR:46:O5O.?A&7O=
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M[FX?\W,QNIX>?_337UW)S'%(IH_J>#>L(/>7\ SQPGD,F8Y-FCYHDO.\ ">
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M'=<"O5#!S(V6WX]=?B0-#=LZ=*]NYKAM8=WGZ2,S@+]JC?>,IV3L(M,RB>\
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M#L/Q!9FX#K-UXUW[I"K27?2C)MY3&6@E!@^ZG)>H/0,%->UI<^J1<+0^.K.
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M(B?$C8Z3V"7B;>A5'FJ-Y!<C*K*] Z39,0FC-ZXR'KBLUH=_>_4@3O"5UF)
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MCEU:;$?NL$VUS6)+GW%5T==)^J='Y_)/)$>=7G5'?CSG:0^[:&5 ,CO-7A&
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M2/U)/DU"AR'AS"!\N&2PVR?>W-3)XT;-\I,YWW,UF;^]5I9RM!!/RC66^J7
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M-/4#?Q[9Q65/70-1Q?*>A1*C8,6^UVWVSFLW=4<_+IW_O]?Z_S58<T*!QK>
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MZJ)G)T*(5*R_*Q_(3'-&/\X?3TT:'@8X7=T;F:Z>R**'.ZB,&[R@]W&JG1?
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M_T4?[=3]!<O#9_.;D-<GT:3C[<I2_9"%]?]0:$]>86115JS0,=&! -HVK5N
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MY.*;.S41A=="D[-MAL%2+\9FH@;*P7WF_F>/1 5K]U\W?@R VD_AK"*E_ [
M^6R[H\ 9!T=7_VU4RI53Z*4Y\VR,C.1*!2C)+T5BJKI>P+,_VBMT#OB+V2A%
M AGROHI?<F[UO+&B.:/5#Q8NL%U>(YP7L&.!27\!G_FV&@6KY*NPW =0<$?]
M&RW:H'MOBAB]PY>?$/*R!E'*;QC<_O7UT\KS9 1/:"PLJ9,&=3EM^R)[Q\3X
M'P'4/!M.'RVO"\+CV6$[Z ?+N)JS;^5YE,+W1J)*%0#K7F'H#12D.0*"8XT,
M_5=O_*'P>,8]NO'$Z#_@T,;$*;'4MY&4SH=Q2>W^5]_I6Q.G.QNV9?JJ\^W+
M^ON[?^V<:"@?2MSY$<%'^9F>Q%F 3YA1BEH>QIQ88&?^R@A4A<7/T++';9P[
MS@G\]'!^$M7ZS<P3&? JBA_IG^H'":JTINFZ)LL7O[Z"<^W7/(V)#B#[5DB^
M.],(+7PY19FV?X'<TU5E;4F24/!Q_D07<5XJ%SJMH-1J[,/IT&TX.G!OOW!J
MNB!$CZLNVX!3P?>*QGB@^W1?E5N,6^2G&J50IW:9+(4WVLL^D\RHO[6=T\<S
MJ:DEN!XN3SC(\WP1Z;27V7><BGQI BWP#7!8Y[>Q0;$6IWS=MO)RZ;);+HAT
M%WS8'[FW33@K[7XGV4*;3.F.6]MWR(O3\/9F4)RJMMS7V2AG#>!I"$_W_A0S
MIL_\55V\]$',([&Q($BM8$FHILUDP3<K_6J*[0[.G+I]0TNE?X@Y.UYTLQ6;
M]&U?U\XTLDK'@O ET\&,<!>=<G]]>8_%T+!*XC=]EY>_Z9PT'DRE?1C(5D))
MCQ12'[& .:LU6LB-Z?P"4<)9=L5F1S]_ZH9.4]!GYVN$'S\/(YQT<O^M4L,_
M9B[KG;5US8C?S(2T!]X"MO73PY_WW[=Q4YO2?NZ%E%70XS C\6D;5W\RA?TC
MGU_$O$##JK.$G@WKTBM.=JH\(6B%O^"C.X$DOBHPWR':PAD7*XD _>UTNYJK
MN3Q^F-W;/U[.-.-0C<^G$:ZTF='**<Y[)>D@&GF?:;/.F-5@*"TX[SKO5<D(
M):D$'W?+G9CV.H/2;L$#S7H6IX=U4_HY=.=.@N+[OYIIK$$Y.!$CH,[F2O#U
M2C!*I='V6^X:W6@BNH&Z[-"DH*EL01S/ZV@98&_<_V:I?_O+_$])%U4B7&1T
M@:QKMH>A.ZY]KO1U[3N1.<XWG"'$I.[*Z\&?36WOC<+O=*IRE].N-H';Z,X@
MI&=/79C2QQ,JGZJT>MAV91Q-O9@T&#X$V_9O(^LK8/9+L9OW_!&];%!HHR6?
MM$3RG6/F!;S#]I #+-KS"'Q=ZVN^$>(65>G;BZU,,VFH0=X"8IC;'>M.I.&M
M7LF<MI?34TY$KF86K6C4T:D3AMZ^ R]&N_UIVR,*_V\#4E(Z.0[V9G8;''AE
M>#SY?+9J1]"$.C7&H-W]LZ=$[& \!OG]D?V&<EA!BL-L/?P$A6 R]!,QOII:
MH#H@9*MML+1Z#K?ES1]YE5_S;=IF*,'R19+TW3,Z:8RQY5)!_$?E<HYL@]+!
MHSYA1&?OUB^=-G'1MP#:S>DSOO!;0+!'=O7D33%AZEKA"'^*6$VI\#=42(BY
M>@\M9;P%H!V #?V3!\%#=D(VM5GB.[P<%L3U?X]W6+F-'4,V0]JB-PUA5LU
M),R?1M!?4WU_S,-.<$DP#UWB883#U>!^:(^^YPBF T6L>MJ%,MQ_4DZIYZ)5
M7Q<[2MI<P^*J242L!E_YHGC879RZ1A*ZSO-1-5__Q\WX8KF(@>V%3$F._";5
MG>M<)Q*P80Q;[<[,+NZS;8N]*P-PR.W;LC3UFG>TV.\5Q9XIZ?BJ>]&0G[ZZ
M$08\7D=(M<W#!>O'@U<D+]Z+T#^0:GQ7VV^0I3J&.\)8=028=5I4E%7W?!]S
MOS.0,7@%(^XQ9/#Z:+9GRE7)R+EA *G?6ETU@&ALQLG601Q&_#MU[M$MG4#B
M\RCS]'V'Z44IC;FTZ?MS]W1Z*>6_M2,+;=SR!EX&\.FZVVF,'%WZTW)F*D]H
MQH=L$W+*^L;#)[76+H!9JR6J<#]]!7W= *Y78D&VVAO4&0IBRQ0$[7YMW5?&
MKS^#L"A"O-,@?'AI1[>7$O4M\?C3?CB5:Y"@\"STZZ'XU1O2%Z['@D,4:I59
M$L_%TT2!K-F>:J[LPB/A_1P'CD:3\0-B+]2)=FECEPL=!70I03H;HVPHNN>"
M2DI!@HO/1"W>*@K A;6([?_DOPIC:32/\RYJBB)W#X49,YHNVP+^J7A1JF!D
MH\$C:M;E)3V3\?'C+:"WQNX6P#=3N/OW?%""&DP>HWI\"[/O\K8#+W;V5FA:
M'7E+0XMDT_;G74#E]15)2D!>_V14K 1',H7JD%2#9^O7+"-\0U-LTK P!,Q3
M40" !D]@H$AAI+C<9XQ'O]K0,]=H1!JL.;)0R2KZ]7N>:O^Q=/.!YH2#+QQ\
MPW/@&&(_[X%^H8*8G[MCMX Q4YF7P[1-ZUI6RTR&)6[3D+[G#>')$L"DA-=+
M,=[>I1S]+_Y9!B\_)U6GD#*$$_PH8B,.09#DA:Z^A0593V;G8S&/J\F@7HOL
MC95LWPR^]E.37]*;1S+N.V7_A2'X?Y[!_>;M^9GO\\)WMP"S_EP-\:L,R:")
M]2*G),&03H;%<?X)L$1U5/FT"<>@/&3.?E2,FN6'[W]3^4TNNL6BZ>"+&#4K
M.JH7LG3&7,2.E=O]V&40@.6<!Y@4.KEQ1GSY-#US7JK&J5_>TLE07@"N_8]
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M$-&<0]ZXS=FO8ST-@YUS.X3K%>>Y\LJCRK T]_JOZ IV"_R"'IQ'5C= JH7
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M=DJA]^4I2RR- 4Y$GL2+(HSGGLW?X$]8W@79!SWB^%^LO5=04W'7]AU%!45
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MJL;(?0_7$VG8$,(TA?'JIM:#<<ZY6+UEZ<C=2@O)[5LBA<,%E;YFM=+ NJ/
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M*]Z+49.OQ;U-?5;,B[EM#1XX)^]\1Y^]RLBMY-ITV%J.?,W>OLNBC25X3^(
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M>J=MM>*ZOCJ$ZRNQ0]5S$XJ@;NU@[I ,<Z@L64?V"75A9*1Q\\<@&UQ40G<
M-_S[1\T'D'EQE.[C?)2#O1FWC\-@;LB$6WD>K,SVH2;NMQ?W]!NIY VRU@5,
M8JYE?.%*+&Y6/7^"*Y3?L D4@[PLE''CJHM_;JW4G)0\8X7$/_-*(L/\+KOL
M"0/(' U!P QR<X6>J6KVNJ3>]AM2F0K5&)%>/#*N?3S3&_F  'R1.7M;IGVV
M7K%4DYK#\M_Y/3"T?*YBL9L.JN(3(OKV=,46W.RF>-E[:\X;.$H"IR>,Z@PO
M%&!WLQ4KAI"S#S/K%I87M!03F&H#4([NVKR$6>OI44ZP(<R"/ ==B6CTXDAQ
M(G(]4'&5>5Y!;,^V:S(,[\*N[C2H\Z1M\(P6R*H;=4YZ:5M^*6\:K!-5=;T[
M4CDQ$CD"'W1;5QD^I.'SYHD__$/$5&>P8L@L!1>O-&^ 7F9<8FFV'/WUO97V
MLK7^BI/O87\1AE@$<<XY88MT!SGX7HE+<VV$DLHJ/:W::KJ\ZMK^FL^]G$'<
MX7Q-#X#(LJ'!ED\8-G?&#&:KD>PZ39'HBG]WS"A>_:?7B4=+%1(EWU^[,=@T
M#/5'&U>F#UW/-TMET/=U_7>D_H]VTJ_ECK[< -A;<S+_4;*S"N*+,W&&%WKQ
MO:%(UD1S_9ECN)%=YOH X</!KU?G:!Y8!@5_SX_;C+,W *; GV2VYQ#[&+&-
MLZHM,;WSDA],=)ZF1.X\4^3%@H)BMT4X^/?D\.G_RY^,*>C^(2MSJKDGW_'0
MCN*(_AWM18]>R;$ '6=)U?RP3M5M.TCM3@2 FMS&W >J<DUNZ5*ZE6/NV"9Y
M/&4?4;Z4X:9T@5"7UN8SN:+ )Q-&)]0+&H99/9W4F)&XBE9,!9SE]GG@4;QC
MY4$E-45#XK(#D0E0W\4<B#'Q*U7Z=JSY<&A<9KK,ETC QK;(;4NN2J3<9%*$
M^B'5S[D68F<1#$9@1+K567[6?+H!#AY,X:#VM 5:X1T(X?(^=[XKD[KPI'V%
M$<,FGZ#Q!LM;TYE:R]FU_5G?'<I/N7AXK.%6KJLAX:LJSST4H%J66<RZB&YQ
M+[&5-4KA8Y'JW[N2B:IW.:(*19B/+KA+^F!<'5^77(:\HZ%,V(&R'D3'(27R
MH>A!T=VH&P"-L5UKK OQDX!!LW6P?TH>@.NJ-*%,[*<I3&21<!=FUX+@RQ-9
M"KN>5&U.>U%O4I>.>TIV _C0S=]/::@/_H4U#8[DK[<*=EDQ6\!NBU.Z.0L%
M=@C@B%T?<(FP;RM:;&KF0\!,(UH96X9K=U$FC#W#E3_R\NVLCR'K(FR-]SG%
MTRO]X(O2E+  D#%\8WIM5#K(KU&S\=&[OX.?_163B &;.=%N%,459^.F.4PG
M\-K^DA,.#:4R83UKXN^SMC!B$^-P@+]K7>:M"P%2I4;<BCL\ [16SH7L=-H
M>S;;2/A<4PBQ-\3/V5<463@F'\J(5?\^(F(HB=%_C<!4+Z*D+,9!\!V^#(X4
M6DE?G1/(E/-;)HOJ'0Z%H_4UGT%>ZWY/<I6 1TCT>:_:_,C@MV'98K=3;W,Z
M?\=X.F.5YTD5\6)$[_'HXQN _R*!;!C9$C.1_L'2$[ZYGWKIX^JI6=8:N]MF
M!"U#:OKV3EO[EB/84ZQ:7UCRP7TT:BD9V=DM+4[(\MM6\W+= [CL019;2(G
M&AH\70S<O/+PPC$>.#97UTZ-S4^149'<7EE4W!4/TN4W#V._*K\<\6CE(G0-
ML_#B;P!HC5-R_&;W/.Y,9-R6:GCBJ  KXBD[P7'Y55K>02I^ [2E%S\>P!6
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M(CAZ0+#BG$\M7)O,=A@<QT,G'U"#';@)QI[XU"_%&6?(VU\/\T!M2N?QZ9'
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M0^*Z%T^S;WQ#_WJG-VJ*S>]33G"J2E2LV+T73F 3_48SDIN$E=$;3<UWQK]
MO7F>I/K%Q8!,6,D@EZ"(6!=N@ =F)=.F>GV?@C.>I.)RY _O-E,AJ-C^X-?.
MMV%->QW7N?CXNE;;U"U\^6+5WZ\?C)\6+GTASEFI]FS9 %Y43*?0>R*D\L9
M;;X6Z.,KY+#3)<JQ,:T@#90A?@>(X$<Q]B.MQ-/,!G<]^[E+*&8F:QY)C QZ
MK%LGH=T]+,6;"Q)QKAM7V4Y >!LKNU@\4^?56K7VDP  ,4 /P*E._(D4[N$M
M3,'G3J_\PYE:++":W"PZZRQ#/@J]FSL7O0/Y:0[VF=XJ1ZU<VNU,;)'JI,#$
M#CT9S<8M&-+LWE</KSG__?A1H=C+4GDO,+YFFVM?A,X(?,D/.4258S>^NK+)
MSS?,Q_4P2E\NS<C+'@>U]/T^.Y6$M]T!VE?C4D)J'*:OK!1>!S%1;5?&+]?
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M 0R=6V[59@?#G%&GS8HCHU+S,I>]2:0^P&0 /A5,,BQ7%#,@F3Z'+)1U+)K
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MQ $1/= V*M1=\F+-722;EU 3\6$"@']KGM'EX6SN#NZ6!'MKZ:<(3S4(AH4
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M5KFG^F=.P&>X$=1+W>[TZKV.3Z2!VN@?H)*!PN@^.FHQ9SPV12BJ4E")R5N
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M\'Z\B?Y>U.>!(D\-HT\^B;%/.(!\!:Y\,@;Y@3%6L5?@(S<&@0&GH"YK[3L
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M;;G:3Y!K7_/9,&9'H>K%LED^J_6F++W%A"7[+,I-9TV6""MS/ML.W0<B(_,
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M&W''!3+#5:J?EPOO]><!H*#IS&U'62=@#[ST&][#.6PWNW2NYSD+O;)7+U)
M $#T1[.:W\"0^1_UJO"JU&G0.^(0K%LREF*BHA#\K@EG?A-/+ZS.!.FQ10P]
M"?_ U.I4RBX8?]1FRYS*WB01?9]C.G]:;U;7LVAG7Z'7N:KT0E=Q:K6#-PV>
M%M25SS)30A'=9W#>1>[F1JXL-$'0P6$6]WP%T%M=@6JE?6T7!,KJT*F<G=@5
M\#J!!1DT4E%0K^T;AY9'$IA,D];<>\?O1EM0X+B8UH,A1-=DLBWXAS72%!F@
MG$UXDJOY*.]C7CT.,<MSP,39;Z8JID5]X7WWM6 X/]DZL(B_/DH]9VTNNAG
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MX,SU9#FMP$X+Q2!P>I[6IS*B5@-'WZ_%#QH]'ZOUM<23F4KS;EKK<^7%H %
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MCTPE+/GM^KPU)6+!R(2R%8JX;B:V3CWEBBC_O#7[&PE=CFJUUTM02QKEWE\
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M@2-?*Y^IGCI1*_-WIF;+_Z7K^U_&[YBV4YD &'UBA?S#PZ:$A=/T$,WZRFN
M04-#RQ,C3A<L5/ P6]@:2C<C'VYH*S[NP](W<)PQ\OTPY@P8\/X:@#$]9-M<
M*(3 6<:.##(XIH!;&P5Q_2T.37@^V&1 :,_%;V^-5-1>^EO()=+HQH?[LE?_
M,;I69]L==HY<-0D-5HJ-L\G::<,6]'!R*71S(:FX&@1%0Y%LBAAT<@[-*;C(
M;^%^#6AP/0]O(A0>%@#I@<ST!Y&[&9WIA.SSQN.F2,S"A*.L0 5&H6SS+_IU
MM!F$%+49!EB*REN/32*LG'D]9-:,[5+TZN1JZAE'6?#I) _C^&U582#(FY_W
M1%N:]ZOR6[<S!Y-\S2\MO"YT>]B&%)EL>V"7F.#":0CMJ3^'D'V.L:9RG8*Q
M%MN$+^?H@3?[>'JX4O!O4_Z&(V08R\-OR"RA%8;\E(_;G;1STN'+C:#MF*7I
M/5QS?]GV6NI4DU$APD[@D[D#GQO0J4]&VE\UVEP40;I]WNZT$.Z6(Q[!&2??
MQ&92\"=X;0ZS5IMTD#.\%.2^[E3U\_+JZ$V#/TJ*;&A[B5E44/J;JX+^%QCG
M.](SGN(B7<G9[P?N+>*-!XN(2N46OI"T/>1@R'3EX^@I4SLV9*A$N/FLQ=W8
MCS]28&?99>-[25U=*E_+#R"/SE-$0R;71)>3XIZ@5-/39%K@NZI7TA;+LIWZ
MZEYZ[LG<?.[$-SZIY$I<E*Z3(Z,.Q_>R2TWR.,N((JDX(O\OFA-C27)ZO36*
M7[]U+O]@ZEK>9>C<%(L+,.7:=OWUB#S*3%74\B2=YY$X5;N1/N5R&5K52F"6
MJY?RD9\3.2(NTLVPR6\?V)#5F.HM11#_Z?&3!]^@__X"?(X/?2??YD+!'08&
M'X\A;Y?Q9*8V9T??GLO'>#06LN>]NV>],)?TRL,M2MME@MZ6,)>D2L>E*Z-O
MH*2#F(TL<[?RJ"0WZ%#H)';>?N4Y./Z3FR*<N^"[D-.#QQS%CB,[^@7T;*\*
MRNX_>!WULAOX;DM5^XPF?T<<H7MT!Z669)[:[@BXN2XQ+/J,)9U:H[BVJ*G6
MTO(-UVM-?CNW"TS4LX_5R<A,YH5&(AU*>W[VS\"%!#J7N"*@V 31RG5I/SB!
MZ+61UNP!%<A9@H;B!R>&TL[\CC3.DM7<2INCO$ODA<[$6WV,Z1PR:_SB2K%V
M?1I=O^?F%)8EXN*SOVDPGKR-N1OW_'C2/VSVO!L+QFC%.<+3\D36UX/V#_U4
MDT K@E+S.^>IXS3&<D-,"%ZVW*P_PUF;2V1&*X>X$0_-#$7UC:J8#<U<Y=6.
MV;VF+\?Q#%]V="W-4_3%QF<N9Z#8R]XUML&FY+G8 J]PE<D?OFTE[^V&@V7W
MM1P2_WA&0,]8J/E1<G]JS-]4)J[+Z- Y^5=9,[Y(6)38N?6X.44C;R; '<.(
M??1T?+:61 )5^S&L[?&WRD"CV)EESIC,SKIF9U$R97DQ? I^_NOF^<^#9S]2
MMOC6./(3:![8O -?6=J,=7R$S+<W9EW6]N8NI<?U,',?]?1(6.G:1XZMF;M=
MH2A.#(<UTGUY7H3.LU#@4KT@;"$=$Z*+D9,.%HY3L::@;\WD4TQ>@6 ,"?#Y
MR'SANGNK9[F;.W^][XK(YGU"<Q _4R&(6*O"7V515ZR5JC,CH%'O5CT/B2T:
M8_0%)BKPVLB!H WG/'^^;*F^%:P/=QP#LHD-P[:>;W+ <BX47NJGK;LF"K<&
M#@:?I %UM4GZ!/LE9L@5R(]1JSM )#-I#W]KO.47\+F#@]&L>;DQ6>SGJ01&
M9Y4G-^24HH".(<A,CY&(>QY1"*N:7ROEB+LBTT2.Y['>\T!A4B>0?Y1W6&N_
MN6,SZOQ/I[G_#[2#O VP_# [>V[+MM(7V%5]JB7I2%IDQ?>MF7.A[5)Y)\4"
M7/N4WD*!\,8B9Z?%=GIU=B9H\OUJ##=.SG&BN*''#6SR@_AC =IJ)<IG&\>S
M)>D_6L.,&(G[?M+KM5G^VD&0Y7QZ0%S @P%^^G7>P;'_*]/B?@;5%C:40Q:8
MO"ZI,WM:=\3,NE!QDE:9<:AIOIT.SKOJ0(O7(ON]97DUT?P#_$6U;?T[A.\M
M-:UU35\ZO9TASIY,C#5O.LS^S(].W7QYFVK@;^7-'^7@%J1J?1.<A,@ Z3D
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MB%>0;UC6QK5USA?.)3'E9IE!-2GKUX"WEITS[GB"K/,U8 PN'Z\ZO*"+&5E
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M%K O>&Q6+]/"]0H'%M;@71<XF.'?W/:&'-CGUG[=Z?*+1#._U$(Z<2$PL,(
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MWQR=/;CU\0[R)0E>1E/C(/[57+"5,(8M9OA2]9_2/+\JK@QRQGF1@.BF,/.
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MQ1-?VJLV<=FW&ZG/PYY+&4%^%-SUV5K+-.#V;XJ?C/(878W\S+EJ#2_T/=4
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M%V4;?C6NW8$V.4/@:HWZ<1$9[TG"TJ9_3P/V+TX7D1N)LXO6#7B4B#;9-UN
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MA6Y[AO=\:AD>/[,<].%ME\2'G(O43 L?LHT,;5X!WI/.P)81GG3S><>+\"O
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MT&=6$O^62)L>3[$HXJ$V-=SD=>?^]#Q=-YR'$J.2J/=S<LCZ0O&):V@F1X?
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M$!$?%CRRMHHO\J!)3MI<P3YH,#D#,-ADPTMC VC>C1_<OKV-&\O/RU1><&8
M&&7\$0LU#IAGG"U[S.]R.2LM"K:6M9N.LBJG.#:.O0A=6#P###'=D?>7-_4@
M1K;OZA/&IXY36KS\%X$WV=M(U0HI!-ILXIKGD2Y!'<6]LTW)M3)?3"C62VDC
M(I]^03,PD%05'::LE] )N<Y)SKN65?*M3^4^>]9BWK?JQB!#:H9':WH0"LC]
MHD[,H6>GU;ZRN"I&?&Y,/KM2]*BNR@IZ*(Z!9>SJ-Q[[\+ZH+GX1Z)>'FX5E
MFFM]E>M^VZ'TTSM')P!^(B'1?Q#YK$LCBS(Q?S\J@S5J:[8NJ9O!/B_$D'ZQ
M"[-U8\LUL794:G,3Y*X[K(VQ+W5R)IKG/MUB#B/+AV#KG%;]0.KJE\'???H#
MB_;Q>2.Q_B2J ']<2_,LVGSG2"FQ..=;@[%#1C4&-/GRL&F(P?FKA*-+SE78
MCF&%DUZ^N .FMB2E28+%1(NS]*&([C6)"[20)LR)3J+:+)ZZ.C[=)&Z9JK$A
MHX.C9;EC(,P\JY#*JZ%1NSE=L>@0UN]4\&<$Y4"?#:R75W6[7RR7<6:Y,K:-
M6Z]T)Q+;-=]3DUK2(V?JZRF;3,Q<.(AHL_=9*I3[\&-T''2E[9\DJ:_Y  "+
M.1 OEM!\$891@#8G\"7!4ENKM*<M/'>&S9B ALJ!'BU@'N.;'X>&N9 \$,LP
M*LZNN1DP/Q,4TYPI6LE8!1$4"Q4^,,T-:E(OSJG&]'-#!_E.=:@TF0:Z3'.'
M\K@MZ2TE;-H\#'9?K-!MPCEQ/>7GGO6DGP_AO7TD'ZU\WSV7'45N^N83*)I1
M[IWX5.ZD2<)WS.;[4O1R$\. M2GYH\!!],9BQ><9FU>3A3<R(K)%5\Q>?"8U
MSH)V4F>?C1C:\\$7*?=_BVV6I05L%R0994Q._/[5;\$US%A_;8\W#XHZR5D(
M8SIU A'@^Y*MJLD^E-7@N=.O>.S"*9J,6)%%.]9@A(AE8GLV2E[I45&YPJI&
M5GU3*QZ*-!T*,X [ 3'Y%?S1UNM\*1&29'SE[^?<*3A>=-4R=W7U^:>'JJ?C
MQO=X>:'G'U]]6<[05,4D<4W=/)'12ET_@+]M*C"Q(?[M&<"W8/!0P2ISNNJ+
MK8TG:/8,0,'WG Z%G<C+BI\!]H9AQ6> 3_9G@ J"I[E(D_- ?<J"RKU5;Y44
MH>;O(=<^EEX,I0V,?1,1<&&=?>\\^-7Z5@:YU;#UU8Q/)C*[?HTP_LW'U"SZ
MN3 *E?6>MO92N/EW,'$8*H:-R0KK2C]A@9.0.@(ARZ+N6JJMU>"G>A4\0A'L
MBO;?S@!,/TU]AR"UO4%N(>%<(WILI+Y:QGFC-R.,F2][6+2N%=;F\Z<LV-L'
MQ0.G^E-3\NGL;Z<N@2)L+E477]?Q-AQ*7:MC^S6O6?K+L<+YS?'7Z*; >9<O
MW#UAL8L@Z&P9ZT AFQ^B,_.J6!AC*C_<EB&?FW974*G(3N A:3/C>EV0Q6'
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M"SP^/A5'(^5K8.M8.['QF>C%W/D$=7'GGGAT1W"1C4Y=R$DJQ-XQ8PZ+V#M
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M\GOSU6[/ NYR"=S1,)OV_;KV+_T@<4<6"ZW"=;4IP(K>-W#JTKX8L>6M6$S
M'1/WF;?; A +4F3UY9HO<DB7<T@7%L"Y[Q>9_O/E#\(ME:I=U0W'ZL9G%&7(
MY<7\]F5/V%>:EH?CS^?5DW8_?M]E_7FBD>J)P%,3Y+LP1T[HW6=XB7YS-;]
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M-ZR([WQ63Q:!%5U%D.UA:EN!H505Q6/MU[Q.FOPXN90K%M1/N]X+V.R+XLX
MI[<7)5+_ #--1#ID<VSH89LG@LD.AV826/@XMFH Y #BSL8KWV&Y_GJ5?G*6
MQ18U#EQB>P;FL9+26C X6*,X-/FF0A#@BD;G-G@&SGE8&I=&8SI^Z;(F_-KP
M$H +P(YXN*4K])B_]=&JA_JE*Y^"FKS>19F]5,OUXBN!4W:#=5/*\CSKM&1-
M<8VA(4[684U-9I/Z.$/*I(QM/T^X<V"3?'QMEN7 \Z;GY*H"]SG&]KF*T]<*
MK"$GDR+?YW/\*+ F6%/$2RHP^ Q0!B1MMCKN&1W+FU"SK+;=>]PJU=/*GS@^
M^U(F56KRYA'KOL>D!KBV3,A!P=BLZV9UZ!IYIV2&Z!;>RD>0"KF[&2E>&_0:
M!CRUW>#U*-4P6;@FS=8V<,R$/@/HMDUCJS3+DPI>V4-_C; ;37S F=E6]>.S
M=A]^G. H]I@<*Q*N<6D! >-QML>WT3&[*EO7<@-K>@DPON_83G:KS>]G@'%\
M7.YZJ]E,2/O5'"GZ@#>P;=Y#U-4Q _5W[P&?DVT"KMZQ^/9.#_Q/(XQFZUV#
M]!;C5Z?$>2L,-SAF\['/@HOFI65.BV5="SG6IX FFR>EQ3^9Y#(BQ?6,,HAW
M6(.#P[6SWT>:UN)DK#KL]6I,DX"+F'"XTG"7QUR0^7SGC4L?V\:4\AN>M57S
M.=E5B P%:HQFUQ2YIIERC897-;S_,(Z33R/<\1\5/,%N--N--J?E.1%KY61>
M'R3='B7L'@7SH$,S)BKXNY"$8L/\>5Z1$BBOKX01W/N.OI9DQ+NN=%=#UP1F
MS8"%FEA_::FB< 'Q@^U)KZ7$HU#7@03%(^HQ;(?PME.MBLK\T1D_A9V(EV[1
MBDQ*7L</J4GO.OK=SH[Z?]\ 4?^W$O'^9S-=3SG<#]3H"7EP2!@(109JDRDR
M!3AJ+KH$>(>DR>UVPK1,IVO=G+6L W-^Q\MG^<L85H*\'_2V !=R!DCM)?KP
M6O(68\OJ8TE[!:=IO@OB(9\YDF6)ZN0&@]^KXQ=\)DVVQZ&HH0/S-[?L(EWU
M9#@OJVQQBF0YXV^S< _]QUO__['N@Y907#8']\43T&%Q%JJO[P]W8'MU&,@K
M^F)PTL%8HHA2V,O+BE_H%!84K8Y[6 6W.&;WPM?5!Q,F@7 9BGM22-5'59F"
MPY5;1TW;O/6@\<9$LEV[K_C8<:?,$LINA7_8<8-)S3!U>UCV- FY":D2BDC,
M3E+I]6I(]*-XB'0H:[HV-V#+(L;4HD?_9,F;6G&$3M98U2S[OGW0Z#AT#MLE
M/46?]3U]]UHBK<Z/. .K&\6F/NOR;^W=4"]5Y-\^K1V\XYWQF[^SPH9;&#QG
MN*;&1U_[7NS89,A!CZ"<<Y6\AIK-G<]U6&&X?A-A5_Q61V%,* :3?-'3DF&%
MJQ(NAZ#QDM=?)8B(/_["FE>P82'P@*V]6M8,NU=LI&ADVK@,9^YY>/\,P'H#
M #=1>H(&%Q?'H20U26]N=,2_/6]*7U&.@:(R]>X3O  & 'J&OB'1#:F;9=S.
MOH;7Z<ZAFEA!A4F&C@T@)_2O.^F+#R4O,&2Q<7[%.FPZBK67$)BWQ8)F'HZ@
M0"5NBFZ:K84A#[!0F=1-:>"KN7Q'8<14#>I9S^56+!D:-* QZWTYQ_0'01=Q
M7L20Q5SPXD:C"W8^/U(AJS 5>YKO^58/ENY1.7.79C'<QJE>3W2>WUPJ_-!M
MX7@S4VG&N7/3D_4+X3M2!9\UJ\?W88Q015":P[GG HD05QBK2JU]14?J6W2#
MRV3J42TQ"0V/_+T'BWPA]>+1#X0[S5S M1RM%7XJ:3$Q(5=Q[C4.(O*DA+SV
M,H?>#7<^W]%C$E\K[&7*5P\8^#ZE-@1*J8A"WF M#I3J82%$59YGT<I$*Y7/
M 3BXA-W8( (N!*\.V^@OJ[]J0-1LCKV-OOA/U_^6W3IGE,6>__>MZ:ZU9B\R
M-MF4)OIL/]Q3MF34.*$5F_@3Z>-?)8.^ME'9\I>N#"P.[L6EX)>LB*H?23@2
M,.0=G [1FMDM9XO7E-8W[! KL]@3+?B1C0\+)+;&?$K)ZJ&NF5P[0'[V&$<]
MR4DI?YL^ %.K\1]XY<2WF)<M%)XYQ"W;QUC%FE:KGC]L=)%D9;<<3VF2U>_R
MXN9-_;UX\*[?D930[3XR<#+J&)4THFP&.LSR4T#L4I&9AH;JT_-30;N;'K F
M,8=^KR6E=8S"D;_J][J.UD:3$F^0U<'6&-M6)J.P9.],F[++MY:<Z3I?JX1Y
M+SAFGW\:$](86JS[L[[)LY%,I>[#<%4\,K-JL@$U0V9MLO+&/%//W >4PK]0
MS^U6LMQ?+]U5;3D#;#OI;!#4O9<,"HS:"<S3O-ZMEM\Z8;L6>YH/(.Y4O:_B
M?V[)&HX1.H'>T!)KJ]C982M[K3L?U8N#/?I]=_2V_[X GWX&,-V>[5TY P"V
M#L%Y[T7ATE(YFD\9FE*'L^OK/S?.[:8Y-LTCXFM.%5;/ $6\J4VO[ [47ZQM
M[#L3=R>E%R+::_^[T[K?1L<IJAX!PTHRO:GA76< \>%#K9=*ZRM"ISN=<0<Y
MF8LB&W>.KWOVT*8^W/Q7KQNWX8L\Y:>1IU$]!1):=P0*A^J,?OLF#VIWX+Y6
M1G2JF=I_=%TJ_QP(SW._\-:ZV3[-4NUP_@X'+RMU9UR\)+Z:T?GY?WQ4=S.
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M%?>I]*2+&7%=N8;6;6WO=;R.+O"_0_Q6H_[GWI__/8+=S@ =DX6W@8IK>6<
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MSZ+/+%IC+#X$&=MK]3'N' PW=1 0YC+HG 9)KK7$S<S75N#W#.3H@6-!<;=
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MR8'E[;^K7J=@NOWAV=MQ*97W*_4FWO$5RH0*,_M63WK7'5$Y3ZNNE'6XYJN
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M$O$RYJE,;5"G9VM"E^7 Z\U)"1RZ_MYL6NZI0C</J(&91\W;GN:H)LEXQT?
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M85L[)=_:;3O'&^9@W>\.[RPDW!BZ0"P:+!^3D!FK\T 6)'E6_Z/UH*_S[=>
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MU'=V[DE5DG,JF%(N1(T]*4A Y)B/*:,FCO+Q' K6$,2=86]9U^3H^%CTYS6
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M>T) "_T<QE;#4-99YN5^T<CSH(+!_;51%I&Q*@N<Y^<)3(EFZ2+7&B*W*4E
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MT'SO?:_X_8/*_D"1=+#K,MQ?Y8 (E0F-0$.@N'1$,,LAZ2AK\]+ 4(!=^=[
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MIL\@:]0$<\-0L%$_<GY'':VF#:<U%=QGC!X94["J\DAQ,[UQW !F>Y/G'/J
MRW'RH:&S4\^J4IE8Z\P[/X.S[+7564P.7(BWS%,[:TVEJ="/C=/8V]_^&!VU
M,]%\<Q6J=PW0:3Q4SC7:.B>PO0E)M7@LGYWCZ\QP_%AT62-_*B*SO'HI+?\C
M\.-]DM%C$96Z+0?5B!=K&:>V<?45'"5RQ2E53=Z# VO"!*'A-BI6<JR@ZYFO
M^[*W#]J^JP.GWL1+763Z&(K:?U:"#UR7)&D*X[[;ZAV .E-R,G<XO :8M\K5
M.K:0N<I)WCL4NY#%GQN.MED?NGYW"\RN&+L&>/P^AT!_[4,W)HZD40XN4=>
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MQ-?XZ(@>PD3RP:<R"KD76#RT/@J"Y(E^R_GP:@I/(FCFZSU'V-$OM4/,-E[
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M6N,EB1Z?V5/GJ#>M^,:DM"5B:@8VKDFM]H"&D.K!+@T'&V*&%\*$!OZ#GFJ
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M?_T>>MY;Y_B=>K#+S?453.FZ*J6N8 5:G.V0$VH;\T%IM'0!-IOUM6NFW>F
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MVS$RV=M'8?B(A\#V6:ZZ"E%17=M2!N#)E(9MY%4J'B'Q$D;#P:X"LT!I$W2
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M/&--KR2P-12[CAUQO+,Z-'TRU8_S57!:TOJ[GJ$N-L[DY?[LU!?^KK'VWSU
M<5_ ^V,V(QQ2OF]E3RKTJC90OJ_CYYYD)=+19U6$67/.(=,7N.FV=2;!,_%O
M"#'N:0#&VNOZUQ44^"N>2NV05SF/V/QVKYAG5S&N1O'(E0"+:N>X%]:,*0ZL
MAMVQ@ZH*H=NKUX_?-M_MMSJ*B)LFI(P W>),Q4X'$6?W@&)A"7'3* K5L1N]
MZXEM+-/O,%)+*<Z)2]=,]TQIJ&R@;M-P:[F]X1U7PZ-4#UH&WU12#TAI<4Z8
M):J^=M'QO 0]\+R'@:^6YK4E;S5^[5O]V7P+>0I[>P AMW?&H7WW)R>C\)%4
MMH'PY8\1-YQU'LUL;J%<(&$(48X(_-=Y399' I/19ST#B^;9K?!CIY;J5)\?
MX1FC9(/(SH6FCG;-^?1[ $;08<*W"E=0/8?WK([K<O*/NGU'W $JMJ?4L^LY
M!K'6+,7LZAE2TH6T:0]KU;2.&M*U'?BP(&QALC@ Y(>-]H?&:LHO?0AX+%3&
M^A/*T#$_&A 3:1'12?[]^SEA_$D(>7>DD^+&=,%U/>H?!P,Y;_[RA@0QC,@S
M8*7JYHU\.!'SJUE#FL-9P"^M?GUC\B\3\Z364J4O^M$&P1BDXW1E) _M*:$N
M$I[_MNIY133%;QY;J>[26,X1@A'F4K I.ZBYCD.(W72;=WN2[*XD=?M9GB>=
MVKZ0%_KH2GDK"CSGP<=0/7<N?FEORC*2X@=(:?[8BZ01.:\L;2OT,T$%S*HL
M,VV2N%ZG#QL*?ID.2A;-SHZJQ&8;)Q)I3I?FB/]4GGTJA1P81$0NXH/#X7;[
M"ELR#JP[U*"J2]676]9RMN.&3N[3\$AS68F^Z"J5J\_]T9<.N7_#[P$93+17
M/0GL];O.%YMM_FG%,M1-$*3RGZTGOQ\]>OP21I''\?AM7EY>H:PA1=K_@+_[
MXY?A9((J#]X .)4 Q'^S !K#46"Z-M=60^L#.V;M6^N6D$[]"O=/8D0.O_UL
MKO#U'%.DQB:NQ^)-3H\=IY'A(Z?"1SN!H7>Y%]"H0(+%P"(DQ]SM@_G=?KKE
M2!>MK@U3][$S994^0T!TXF>M_2\D ,HI/N>3P<:]C==LE6K?>\:\##='B0)V
M@*K#$OZ#"2@HB['TN4%_XE).6E7FI\DU#:*6$0C8M/%9C##.<U?+4T4^ RZ\
MJ.6F:[O-5.?N4/)XF"WA=@ULN(\M(ISM8-J)[S\X]"@_00S*6^TPJPX.FOY;
ME-DV\31N*68H)FJ18<)D^,X$7/$/M]W&!J8R*5V_EJ'^>5>Q<1DH;XVX/%Y%
MW(%S[Z@G7IS.#(871^05YA7F?VS_.A=[Q_H\:7=QT=01IIC>^-U(>A$C720^
MH6,162K859M;8TAYK'3=&IF@92;;'GIXJ%DB^$>C'G?N440NL%:,NTW&+?W@
M18S35'$5S:+2N9<-[;U^7^EX]99F\T3RB45%4Y\=$PH*0WSV66NG7SN=<QZ!
M?E2^(^6+G24S8-Q0^O@ME"6N>Y130+-.+GKF7?IPZ'@R^'!8]FA]<:#C(EQ#
M<9VC8NBZG-R1)H>&5J^1.;TY>:,JD*/0_LWNX]F)&DTO'3L72Q*VL.=J[&>_
M#0KT2=/OD%YRYHB$L_&9X!#OXOC"0U&H+O+S1^+ZM'1[CX^WQ'F5TI]\58%!
M/9(&T%7"DGW?"X\#3JHP!KZ-M;TK)L>!VM:F#1:R#63O&O#/%\^*K#0@J%B2
MM1$[>BD<'_1V"P@,X8@ZQ%MX2P5L2(&XA1P5EU-^T7GNWV[.5N'*P-J>X?IA
MT/8F[5#&RX(#KV5,K89"/M'=[TF'M>T;SZ7&!N<]"/.J[6I0CG!^4E,:"<H1
M/EI6K_/<%Q(VFI?_%=>]VCCY572*3:PX*ZV/\?B\JDE(^.Q'E]V33B7(91W
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MD\NJN$#V67@CA]*EQZ)T9NO6M=5EUU78PB;R%KJ 2*[PN]Y%W(B68#%G(+V
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MC R)(_,F2R$/@,<CHJQ'FFX]H!4$49X81;ZDM<3]&?=/XZK3"Q^(IC8SF7*
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M:0W:5X."I1R 00& .GLN?6277#,N,BPJV*\ED_)+>HZ;P2BX76\M->D[R@<
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MM3D*NJ07,<4=G)/Q9[^ZX8L\:F,TK6]=XCVP%K9M$+,<_M%EH[G0XUM=U2-
MP=<*-W6AYFV<&W2]B]5'C,WPC%$PC\.6 [8!-QMF]6,NM0]R[]<7D&8G?UA9
MRE<^PC;?'[->"AICPS$N,+RK^V8DN\YN<\HL:B6WI,QVP=[N#623O9!Y\O;'
MT9*BIJB5>[E^C*#\1$@=V,RL=0\5>\-N,FP<ES0&"O;@&"-WMG.D<:1Z(2&B
MZY11I/,FEDTE3U@WZ929B9C)B+V8_0-E?-T(FQ#%H-FOM;@Y!:/9.)SLA$_"
M%]F<[!QQ;8KEF/I "Y=E6KUC.<-1JQ.D-PX[/._)*, ]_BE8EYZ_:IZSV^L]
M@*/UXW16>9V^_U75YA=1L5H''D\U4Y&7;IRJ\C\U&_E#L7Q8YLHQ+7G'E(^
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MI3U188Y)65OL"&W98T3-60EU9?K["@O3X+L?V//459\51E8O/O<<OZ0W)BB
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M?M%>G9H1,7U@)GJH ,--1?6]M:H+>&] 4H'N$W='9Z[3&5G2,/BH>Y:GTB/
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M1Q08"]F0*UO]>RXX8K2(<5%V F.F/ +1?257YP> @'5IO75NIA/&XJV?.-N
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M"'"UB,-I">Y-9#IHM^#,88YL,=[@ +MYF8/X?O!&?[_GVM)<(+F^M;ST 4?
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M'(CHC/"=+0X@CGLG?MO_US]R-<^B+1,1=-##U&L<9/E@\-QNNETI->[>2MC
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M7,1S:6B74NYI<4)&S_?:)4^DS]_)-S+ +L5^/-:Z+*$C$O5RILA%%Q3,>;I
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M?*$2YB*?68O Z8Y[SFCVXX^-2U-]ISQ)D:0'"J^'2<7>T.%FCW5\75VS[X^
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M=7&)OZ)%]]P>)E,C"J<',><S<O-V:*ILV##LUPG*NL4<&,Z(2-W-ILWF+S;
M'9C)[J.(W*6<$7V?SMY:U_TQ@-&OZLQRC_H,=$Y4TC(U_L6DE'[GUKTY?\?;
MF.\\FZ=U>'JC;]4IR].$IC"EU@B):PD3]EPSL4Z3[>8O<R](8?UZ\^>>\Q$
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MU??"/U^?E WS+H2VI($D\SQ)O6!>\;N#[KN)3W=A=H5&@> #EK*$QL19B-%
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M'%08NRT-4RYUPY,&IV;%M!IFXMJMOF]GF.UG._NK1_+&]<R=$Q8%]T:!6LR
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M.!F7".>IMD+^('-,QQ+;04/[K:HK(9Y DIK*ZP&EK/+(S319PIPNTY<39+U
MD7'B@WS>2S59KN ^B:MWX]71!GPH2SJ%/[G.,?KM<&G=V(2F.5Q5"_YWQ65Q
M\Y(M41*K.$1T?[.5&2F].?C"!JMB,__.6G+8'CT6X8A2Q9]M ZQ(4/>-EQ8@
MF',A?;J*W[LLJY!*'XC"HFM>O.3Q>9:A[:T=G#V@RFB%9_+%%>@6OCB3\7U:
MB^$4CY/L?+8K1RLQ[QD]'Y.,_FS5Z'0\@4GN(FM@DN0\DH;#S?=#R&5M7#BM
M X!J_BGKS^ CE3_$G1;P_/+"7!GFW=RG2B^>S[ (NS^JJ*::"&;AAYY3]PJ1
M3Q+>N$]7.OD#Q5+<]M34B"N!7(M5^<14LJB+ES,!^3]Q?7VZG^018?0<2K'7
M,1I);$G-#P <J2F!]Q]%/J(KL0HQ2M0H-&*Q0)5+G!\*WLOM&ZO+'U$>UC-E
M@=02[9"3'TI3$+=N'(1EQTN8>^>7BY36B?^G>T[W-'CD=,(G#V]F5>#5F(ID
MB5DMK>A VSP7:?;/ZOF%(IU0AY(V%G<M::WH]%??"1]E\/)F=-JML\@.8!_7
M?4'@[$B]WW#=ZX3#=UY5MM3#Z&S5HC<-A7N#-"=@\(OI,GOM"'*[5%:\(Z=.
M,H?*1U227L,K?$ 5-E(%Z?>"\5MDS]]O>'OY_,G2T,Q5L-\O]4R5:MI$#-8=
M8J0?/Y/HBB%Y(T"XG?GEY/GR@52'Y+O5ACK3CRN:"F:#[.F-4'Z=2B>IOE$>
MK1>Y!"&R!"PH4XA?[N,0,R/6R<^8]C]2H_4_(@.FS7YK]HWDFW>V+AZI9;IG
M;'QSO=\_';56'*X%/F)>W/^2]ASF>@-5N&02R-Y 8P\4@F .]P-JO/[XC8T?
M%S* [UD9G[!CJU7?G5_\?9C^?X^T/DGDNN#_)^.+A'B^G.X6)"F^F]:CTEH_
MMO ,5=CQKD"#>V'ZK,]]XV%6KM/\B1$0BP#MT2.YJ5ZJI//J-C&N!X!Z^HA&
M@5@:C*!_@C+#]T*[<;M$U=T%] !0XKYIO-DO<<Y5%&SQX1B66M1+3QEVVN6O
M$J(G%D3F$\!^;]E..P9R^"0N'I,,.H_^$Z+>W3E_  CU9KJT*.?!925L^!8R
M>N<Z0%BL9VN,'M?88L>HC+!(91BFYL>"A/-FO]MKN)=-N%IN=4U:;[4K8N(-
MN'"L(92S9O"84#X/)BRR23]4T3C3-96(T$I:/XAZL1R9+1@E=<$;_ON9R_]]
M=\[Z\,ZBBGSD=<&9</25='A_LZ1+R&SDL[@K-6HON(C:,1:(=,=?(SJSZCN@
M&H#E\%@\ $J,"UME]WU\Q^"E_#3(M 7(ZAV[V:%+_=2^3>=VX4KNC*L79_&6
M7T00RO>Q6S&_O@K!'P^+NIJ_YVY[[:8;3>PH1T?BP^8;P+HC4MJ538E^W;15
M,<.G?SH%..*:M,<W3\'6%UU1X?/&$+R>&PNLQFF<UW1!O=#&!LB%H+G8VK'"
M>"YSG<)*1ST373A5.!V9K7K5IE^9^K-T?_-W4FT/C :\^ZDGVURE\#G&_^CJ
M3YT856A^FMAN5GUBB?VEG!/D;=< \]>DK@'5'#B-3>IG"!$\58K]RY0ES_&)
M+SE0H=5([EZXZL0\K!ZY#!_=M8*ZM""KR"S_#JP_3A^JCQQJ^^+NAP]J1'9'
M?VV!%]<<\(,/6^!._;(3&"/4%6* 8)@(4L3Z9Z)*+6>"7;2YW\T>/Y&^SLX4
MHOWE+"M?I*E\(^YP!# -'BUQ ,T<D/XH60U@.\'45N9IB2JU7D /3F3+_W/3
M693JW8(N4H/D!835/QY[031."U5AB\>]Y^RBX[[]#*A"2H)=*\TW5)D/ &>E
MPR59'NPJ-V\JUGU&9IT+XW9$=A6KY&:W3*R::*P0?Q_6K'1\6WHABGKGZ""F
M(7A5"Q/WC+A)NT\5YU83':]3)8@J=]-JB#)WSM+9L/6ZOWC_#0K^QL_V )AW
MFS_N!_[G'(5N9XO>,+5,DY 8%O'TG5#B&?U;T*&NRMWOCCCQ:KWM;RZ\=_-X
M "2Z50?6#5?>%-[VP%/ZU0T\*JF2**G7<#DTXOG&=5L.;,L-TT4? !2*S14H
M1='YQ:'6 <:V"&IL>QL6MSM<B\FN<:7!:IH#QJ_Z)MT6&4;<D')[\$Z]-$KV
MUB,D1!LB5#1.RA=9]AD36>95=):__9.._JL6 >WO7X0QUKR7K$L)QUK$"BN
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MJL5NI3V>J\IIF"\Z]>GX:["2H&.1X\6W4NA\EK0E!L*EY\[23=A=_33.1'2
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M:'H<8VZD&K2:G+6@"#[/1T!D4)%'^JFLYO5QY 5#W0OS%1WB$>9F8<'N@&,
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MOAP8,[!@F=S=^4\;9/]$050<E"="(ZS]N)SY.E=J&*\S#B<BW15J/QT.&V8
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MV+8R+G?!2I>NKWG,0[4S_3G8%%[)6DGVLJ29HPP,ZV%/VICLS4B<.\WA8'"
MCJE%/I!^-RX'YO6Z(_24G.4WQW&$>$;45)6QN:'AO/0FWQ"7$\:#"\DKZI/V
M6XQ_)%^2UU6H&% >-(V6_M.M,]27P*9TS@VM^JI6,[$+9NNC0$K6-KK.<Q.E
M2_;9$.3=;U?ID8CE__MQ-BX-YY7))O66Q;:J'UO\S=FFLFO]T@)8?9)*"NM?
MUIB0#-0-1PM&V0($1,<;CL0(#LEGX93=.SUB14L0 [4FXFZ1%(SQBEYPD00\
M+]CBG434HC?0^$6R=_W[>_C'06_8Y,0CS\B-HSS TAC,+] PK\C.N4MOF62W
M7^,UD,CW-?0Y3_$L)P02=?(5*BQ^W>[X->NZV,>V6RY_%(U;D'!5B0WDO2PO
MQB2I?21]6LWR64D&RNZ(?*C/(:BO.K1?<EW6L)X2./);HJV^C(W4KV"_>"*A
M22%57^M$(G[IBU@HS$TG)Q+F@W=5?YX \ST\)^.@,\1O+Y[0IVA(VW0>M37V
M$03CH^F\[_,7U<:T2!K$;D!$>CL5^'_ "8@X5,Z/-(4."TE.^- 'LG=OEHH7
MR70_9!UA4'7^-#^&\7W/)DN^A" /9)^%N,R&FCLOO(Z(Y#\[T/D@)X[ [Q[@
M/L)^DLNZO.))8\L.K1+>ZWA%9U^BL534VFX,J94[64_)80XFJ^K4).MA#U64
MSDB6;2L@AK]!%CKM-MXISICQYCNA$W,O*1AX^YVT::V3=,O!0-(=XG:'35(_
MNNJ^.5!-0RQ,5K8WHT3%<9D3113\&I;WC&%)FUP398F.GY!M5=&[+RV5B602
M+V)LKULN'B:^'?L?L8+>R4ZWZP8G-M_992^FE.([O?-= &.3> LHR64>=CBF
MJ5/ UG4S4^-B)Q%K6">>2$[QOTBJ(I"< ;_Z(T\-8HB+B4Q!0@7Q!+NIXH[H
MA#Y\NGFMD$;Z1NV$:><6H*F^J#,YDMHQD,M9<LFCY =UG(WYT3@,I_G;YGL9
MONYM98L6D]*]%KL%K'\H$#[_PY#HOR]N_GDZ*;#2*,7K%L!1!T[0/.7N*G5Y
MM".B:K]H&K&CZ X5Y-3/:N@9":S9J.XS()PT-X+9-"V:6&:MS\7%NZ38(KSG
MX@U@&^G>YY?.-NF+[WFX#BIXX:8711&&"S-]7,[<'DH>RO?(*/_K68/_#1G)
MT<E-%13/]3LITYJQ;\Y7**CM\@1(L*5H5- 2< O8-2O',I:[J>=J'^3W<8TB
MF#[ERQ2B&@>O_.:V_TH$@&\!$;OPOPQ^6&I2\X>>GJ["Q+;W2.K<=ZX%2?/'
MN-MX(9IG78:--;#9&P^B;Y/' _?M'XPX41!E6!V$*1\ZK8UZP:Q7UO"SVW :
M1<'7RT'7C7 9__Z")CH_IM3HU6JOAJ?O?O2YZ38G/QWRD?OYOL.5*=+.TI '
M89DD]GU62>Q@M@&W.DAN^N Y +U?8YG6K::G]3E9??)N63*- -J[N2K?LG)(
M5 ?2Q34]I!&SM2:TA)_F+*H=!%/& AZ'N!#I2T"I8_233.;DJY*LJ/<@8]GA
M]?29$M,-X_.(F%XDS?C7OW=[JNY?5H:6_6X$.K[CI!N8/#2+(%630I';;C3K
M92SJO"_O$4K5^7R6]U6G1Z&H@7R^HJ(P6"S\C1GI\SP-YCCO<L4'-.'#]N59
MTQ KTP_!#630;!)!,&+:,^+!KD1U^ B(Q6NP\V4MINB#^3@%3JH2E%='SX]=
M<S\XFU;KUM3MX_2R*FP9QGVY5&5#*QR<.&N\I%]!I0T!T<!;@ "N]# "?GD^
MEW\EMOHKQX??W4:4])O+P4;*_O'J84W#PK^P'F3*J(CZ4X^;L^F_!0Q90X_C
MR/,&]I9?(@";EJLA4<GU67H\"S;ML;5S=9WQ((KIP)F5.(M\8QJ.IN]W#@W+
M!7L:*'IJ"K0X9G5_LMHQM;@!F^1B^2^\N1)I].+M.F6'*H?N4Z@:.B\C/7U)
M5 P>ZY NZ>70S(Q">I4Z2@M!9IG/EA%N:$%NU0W%?AY:#K,8*S0'EX%&5*9H
MFF0?;6%J33*1!>5;H^QE"%N]E6K6.P"X;-2.QGARV%,[62AR6^8J^(_J+0"\
M-!99S),T3.1J"_,H>AM\HM7P+4IYZBV,H$Q8%/;[#@]X?_TH74PW E)5?9.^
MOW1657R620U1S]C/;._Q:?5!"_SMO98]"+FVNIIH\@FP15B/!AK!@P;9\T8O
MP=$^)!XC6?\?S2J[=F6,!M*YK72>N,W2G._^X:GV+4GIS]>A.MDG5W6&V&\*
M+-1L<1,4#<U#/)J"!'^+_#XV_#2!6GY]JQ#9DU!)/$TZU;XC7]Y7S*MFK&K\
MYQ902#-R8R:3[-G^3M$OZ]2CW'58_V'#-/@;H1*W3=1;Y6/31L1P(I0V0.J$
MV:F"6.,6H#YZ<;@-)[TFK#!OL1H4SJF,G<="V8NS:L^XNN2VMS.5EZ4T1BJR
M@",XPQW"#7UWND:*M%$12[(($<+)$9.TC3F13\ 4&PH*(WV]U#FTS:6M4=I\
M)S!]8RXHA1M95U-3VP "1E#E@X"0U_,TTY^G/P,>\OXWT[5>Q9.Y)5S(/&/@
MK\%AA&75R:Z?25%MM%(2Y^L=R^"\$:##,XKJ1A+:-_22^8,V-'/6"=$XS,@(
M)A(SP[I$%'*DF1)45QS;9W$54F-S()'KCUBI#<*WA*!<LJX3J[YJ1C:UN4 W
MFRIMLC>-PD? 69N4'K;4E0[^MP 1W-6QCX>ZT$C'LZ? =R : F."=T]&:M?[
MTRX'TT!>$T90[%DL%3_X$!UVOP:<UL/$G/+AQ?E'+CVG;E^N(F@B_[C2\C2B
M(+?DSNE]91C<^'TOC]\">\KSI6,KF:]@8E>)2;7?4=!I@_L=;]S,F3M?>3G*
M-' ^;\YV##@2"^YY5!3=04"@DHW)WJEC9?-]T_!UI?'IA=-BN4 _C<.3-%&\
M:Y5_F<,J=/1II13V.Y'"0+A1SD>U,C3ZK:/R2V[;Z3I+CR_XOKK0>)J!U",;
M-.-K;#&&2C2.[RZDSM,UU#8F(V^#W$MUA&>I[4?^9]J[<$=]@S%Y4P>M<-^U
MV>)(,G60@NRW+ZBSXD*CB6'O7X<==\PE[!4=89RB/'-474@[Q/JFO!?T4_=O
MB0L\,MP^X3Z[T91_AT@VZG6(5?L/D_).PP!+2/R;8H*0.60-QUUGK:.J:A6F
MMD=/""WWEOZPE<N/%VW-N\V9RM2HJ:6FLG\POP>L#RKM2_)/&2+_&;9?; 61
M-01B!W=.))\]'PU7ER05O;"Q[SB3L-=@O]#-MT]IBG=)E9"!/MFB>]!QQM@]
M@?@AUUMNXA6D)/T+1X;9US/FIM1RQ N(NA330%;M\Y+:M3'3K6&/<5<OZM74
M7C>C\8UNC-ILM=]W'=?>2\.FA#B%3)2=IX7')2,:XCQRCNT)WI5R:-X[O6CX
MM<\(53U))V(:$"6U<5[Y&EY\"^!G]KD%>'&HOZ(8-:_K]/*PGUOE;\NGJ9DL
MA<B>,XPU9T-:J#VSJ1X1(6M17"'A1Z*W *O[&80_71T2:O 79 5R!K,5:D-_
M!J9''LS[-?F"C%^Z!=X-.WGI5\(>]^R1=_.@5#()[D)XX>3U<P.!^L]*%B&9
M;O:T[R\Z_\Z!MVLZK-[-%\U5AD^/<SY:CE?F7D$-5+:@_699G$2%$^L7.Z[A
MS):$5O$TIO4*J;6@)W;-S+R;BFQFGJXG[_Y&2SR)H-K#::ES]I*2TOU)X<:Q
MUB5ON!"8T"Z8@5V'P(MTH'ZSOE9]8!8O>()T@FO"^@?A8^>BE_B+-Y7I_/P+
M-DC7H7\ZHHB20O*&VE \PPAM_GAZF@?"Z2F'YN>,#>/+%*G]DBP^O1<ATN/:
M@3/"J;X#6?<][R/2)'<XM^L149]!5\;M+"7&6CO=2:S7@MOGOZ/Z""C?MOY4
MOR=Q\Z94W[Z(UG>_<HB\D']9]9X!R5MJ8X8^R/. :E>)J/G'%<./Y7HKK+6E
M_S$,N__J!0M=6KH&HQ_JGF#CS4N1%WD.;SO)$?[.9S]L1U^;SJ%L6BJ)*EFZ
M>*-3*J<H067@39?/C+1/UOQ>]D5U)/_R9H04# NGPA&XYQT[1#_':47J!S[D
M\LFX[L45+I$A61/?#LQ8#O+C?L[PC0@$2$*4XBT);&TRC2AA9O3.=".VVGFI
ME6\2<\F6X)/F^Y5K&WB$VG:_=%;S8!6PWM,O/'95S(1YT'D9ZXFC*ZKP^ )W
M].8<464+0N=/\74="YH<S7GJ#!AE18AJGK"G9'#Q.C-%A$'#1WQ$,[7^<"X9
M3E/M9>3J.#J3G;LN=<JI6R7UOQ%@%.6OCYI(HRJ$=M#=84YL[0MMX"!5X("8
MD>P:(-S$#=<H)>:]*2X%J?F*W1M ;\L+J>\P,WK38>(0S^C':0Y4MC(*'9.'
MF(XBOGI0UD4N8_7C+&!RT^0QI9YCR)RGQ?BJ1=WC,@ZC*=>E)>.C^2(*V+'F
M(4X_3E>7[(Q176_MUV3( C/*>;@QU5Y[WQ+H)NL!ZL(21$L0AE9>I2GE< GV
M34=\5(M#H81N 7I^'/?V^?N6;1?WR N0?3VP9Y6K$J(YX^1>\K\/[4ZI1Q7
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M<T#EGFU9_1@WN!>%8M%R>"4"%>P#,]XX$)!?9OVFL<(9W1&O0.>J.YA.01S
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M""%Z=Y@ B8+ 13V[Z*VZGF:]7+VDW53RGCK.\4AHOY?#@532:FV.GZ<<YM@
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M26S*>C;7Z5'::(Y-+)\-0OI'?83&6*[-G@.)@'G15F"9".(TCG%XJ-;0R)5
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MW*-.H]'!MIC&X6**7AO2L9IN'OA'XF,U&Q.@IO8/?%6"X=,T#+3)LBCIZO?
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MABL/CI8,2;TF>VS1BJ YHWU?D_=9)B_-"'7OK/DL=WE$3/3!I21]=:@%N/B
M>'.>#4X$K^(*S\1,!<=:M2,NH"_BRB5$&%;$6D>NU.;:!=(K;T0OG$K(A,JY
M94$<SX76$5!_P(N&D!7"#K7'7(C6S=2\C%X$TVPVJYPR6/5<0UF(6."7>XM
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M?.-^23NB5B%<+*>\QI.2[D^#DL=X,B$%3TM/*A[(5IU^REE:B)T18QBR ;?
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M9&Q)C47QR:5Z]O,?_/X]9P 3*@G8UF?]<P$Y0_FZ81E.3TX^O7PQU^5HMKD
M.U:]NPV.X&GD15!$:\<'CZR47=D:GSDX0R4<J![J'$K'MOD 4_C:C%)=,9&&
MC8H8'@-167US5V8\$FN=EMRB5X),AW706:%Q3W\ZK\]AK7_N3F3[FIR]A4C2
M3D;X<;C+O71[HHZMZ=1IR0_]=JMM+QQ;O\YBQ9P.L*N(_TMVR<ZE0(P>6-"=
MR6S>;-P_Z,/RPN^VFI6!V/0+#OB;-[ V^Y]S>+3\^A^T5X)LUYD>WDHI[)TH
M:P>@?K$GIV/.<CVL*C,WYHV,(.!\,2$2@<X((%9/H*,$2],E^*D3N4-5HCK
MI'UX^)N])(!#Y<QK]4"FI&XMS;LX572O-X@XQ> AQ6"ZZ*W9B?R X>3<M-(_
M[C33]^6>##J%;MYI*WQ"X(;=.\M=RN>SP%7N(QI-P9<276524</$%1(##:W<
M]1(CRZM;D)UZX/!JEBCF&<RFU0=(+GR<NDRV(40J<55Y%6X$]!\V&MT5.];
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MH#CRIBPVGO@8?@^@M07MN5Z>Q3:TBXL9EH_ /39;9YIDXE_LDZK=.I\"-2+
M/(JLYI5N. *1T:W'0X7>,YAW_F5[/=_WEC<4MI;U,%Z,QN>9&9_0J2A7ZR#1
MY*!NQDB58:G>3;MQ^GX[UAZ^F?7LM6GZH&O3.?F@4,N%%KRM_7S?D3]U0\X5
M)PS.?,QJ%85@N0)9 \L!YVSCXT\?7!C<0<+[IHOUMW:S,.1+FR:O\Q&N.YI+
M<QH_^Z.*TRO+4T7']!I(6=0>^P:\Q97!>V/A3&UX!&CZW@="O)LXU+*;L"1)
MA)$*@^[@'NI*TJ;;22 (J[N],+SUUTPW[J^ TJRLK&RC GDC@J"VETJ=2;,U
M%ZN045$L0TJ:QDRG!GNZ=+VG/>;C&NIK[.Z&:]%?)+"]U*N1N:_F!W'OXD*I
MD/QHSJF[#(U=?H#N!!3&[!:8N4U4=75T]/DF#FQH38)5_#-&2IDW[]9#@FT8
MNFG8S[ZTE7O%,>.UF+F/H<\(6K'K9CSN&IDE36HT[Y_!S_Y(1R:$-WBN-*!$
M)Z54P=4!36_BD!P1FSL#0AIM(6,2?$X_!752D30T>D=N2UX7BG\;HGJ4U1/<
M&IRVPLHT*NSG<H,)Y)^L4^ETO_E5Z;-4V[2W?LX3**TWO>_@&^QM-#S5DNU5
M^^(!/[;.>*$X9>L;9A32I#&WZB4N>2?YW'&+^(<O=AEN/*Y2TSD5/=9%/KE7
MGIDKFV"3R&:_,54_U-D"RQX/\"O<O@?4_@=]_7]$W35K:(QC6Z5A!D'G$5E3
MGU6G__9>\% ?\RW9!(#"B[ &?!9KE\%-5Z]N,/R+R$=/BH?4LENSZQZQ]6\P
M<O+AR%8"_Z6))C.PJUYP]DPIS(G5-F061=3[4[(9J3H\LXFX[#ZS<+U,G9]Y
M_Y"1E6\@/ ?TE=-6@LM9JEEW1GJ^/U%6'PBE41(AP)F8@&<XLSLWF5=.^/+\
MU@0_K_BCGC-9]A+L!K7H>UC7VVJYLJ(1BXA)AB3E(XMU62][N=U9H,$7IW'Z
MHGF*@_I6]BCHB4 \XU;\R^#E9(R20=)?HC[,!;@E:B'[F4_1R@DOPQ:>,IXR
M@!^ ]P4/9,:"0,/6_H@R&$,P.LJ<8Z5Z8.$L59*8L4A$7:'(>LX3Y0/KK7'=
M>M6C\A6'ZV$&T$7CD7=XY5RN9X+\IL*GD'!&3-1C+<&T2HMG?)&?#WI:=L 9
MYX"_=$MSI?+Z5I2M>^FVFVN7X%/Z]$^_9#Z>CF@VKJCX[15O;6 :L@?6Z@?5
MPN(3]LMTZ5X%GP_&)S?O52 O:A;/QP\"BD\"%_@#N#"NYAU#]9SREYA)H^/)
M;GTQ'66-_O>#XS^R!;BCR6K%'$Q>FGAA&"?^1V7V:I:H,;]3JSO.?!.3))47
M.3T2J:G[;JKGKSAA:]%"%5!\=;FF-6E:P0&^UJ<A+R_PHJFO(J\2RN(J_#-U
MS/_C@]EZP4%_ ;)_>6;_VNG<3&$5=GM6SC8AJ3^C M1[?=ST,PL&9+F@FZG9
M[<5Q-T&=YRJ$Z=YEO(2'G]A[G>%,<SS-6KU_QT8\@**#1RG7B^8!@":Q%OQ_
MGLO2/:OY:8_F,7VVF<%DJ"^.YUFS, ,(9N0N,?ND<V7D%^3?54B07>BJV*T[
MKSXO%A7VQKEKLHN%=U%G<;_=^.$3S$EQL?SW3KJ TZN$2?X8]$RV&V71PX*)
M94S8>8:V_S 'T5W:OE[Q\V[CMB%T"UHDQQV2*W)#MG)E4*<ZG, #'^R_^?.X
M".68>YK[D8\F\/CLUUI*:CG%33\L2_SO=6N"A,!EEG.R]67 GFNFK3ZU@D92
MQW9DI\@0=+EJP,D"I)+),[G>!Z;B,-:=V %D4#JW,7"QL:KD8D"1@V/,4ZW<
M1N[K* (B.Y9S-2:,%<I4EHRLK'EVVWF+/M[&7"+&0[:#[NXVXT"ITOW:B#JF
M8XF(GC>SSPS(,LL8[)?U>?AO[Z-QO^S)&5?5Y=WJ:6G)O6C8[<RJ;&J^C$%5
M8 K4?=QS<2]#?U,@M.]\([L-1A3P<LI_>;T5M06MW&* \.9,-:6+330V?^_%
MN:N@E#&:*QKQEHZ/X0L"QB(QU3F/1E' VYYMOJ'Y13&L- Z\L\Y05'FV,%2S
MB_'&[ @ X7_6G;1;4U<]+@<;YO8%7"LWI)VO[P&6QD$I;K&UT:*5?BD:$7D)
M,D.5[ $TGQ<6+/)PLR/*->H+_^ 8I12+_*'5!+W=-?&0H0]XRX-R;AJZZO&Z
M&*A4W@+<NRS3ZS!2._M _+@FW45*!V>P8KZN [33$!XU:T G*5=E<*J!8.Z)
MN5P'6]T>W1Q>\6>"]2^:GGSSO$G--.R;Z1.K]:(?L)K9/F_L5+X';&+'^[U]
M36(3JMH2I$!??A6NU+MV?I29-RDHR'4)2CH\SS\0G\K(^?OT5B6VUSGDZ_PB
MF:$7F^J<>,K!$C'!7(4&944=NF]H1D;,43%9,^CQ;.@>5V(GN QZI%#A]N<G
MS]KO/6&I]XOPM</."BAT8V6=NZZ@W&&%T);.$<7MTEA8@^$9XD"TMVT16;&/
MMOI3LS;CA>_DL-&?=AO!O9FL>TEHSV&_TF.2!RM>W]UU4RH6X+,2_ CKQ0\5
MIM!,D(BF(V"CT0E\RYX:)CV%-)]K?\_3!1%I;VX?$:9L+]=2TK>=6:F[*WK;
MD>2E,]1^1,HJ>8CSDBD64&??JJA^D99:-K&1M3 !R><6[%/+#IAA+W.;"&OR
M#UV/::,MKH!B:\-MWB3> Z8@.4I-/O:(%(1D)35Q>=7!IX?O+(T%\NE_-\[\
M*NNWC4E2[1D64#3IUI3=IA]VF<>GZ%)&>G@71XZQD:T!%TP,_)AX'"B+Q(0.
ME#5^FE6^O0<(I'X.XNR.%9ZF#:_77/$QC%5_H;^Y_*1+(B%[L#GT.>S]$][9
M&PV=?)=OVON46DGNJS+K:Y@_@CZ@>P 1Q:GBXY"B(?>7!E9#28,^*W<.),(+
M*YDZNA[='F9UU1_XGW<1B.0QXR_89^CD.SPA/DTGY:KXB1-_SL#@0BLMHJ.4
M:/MO*<8VZ1N#>4I"L.(Z1GG)M$'WNXP@HF$M>V/>!=%QV_%E^;$]Y3V ;$]'
M0\0W+X'M%8PW!VKD)OJW\5"L(0-6P!RE7EP$F%\4S5]?SDU)QLJ/[NE\WF!/
MKS@P[DOK(\O[65<>N WMQ$:#""8%K)!!\)AA/O/OK5K<-Q+6ZQ NY6/Q #B6
M;%BI=4\S>MCQU=>^^/?/V?95O*=C.% )+-R'<L62FH4N-U!:C_:O/+5.S#>&
M\0<:L#A0:5K>:R0!2G0V JN<;/*$Q;ZCX8C&+P$LS>Z'[&&)1T'BWSWO?28?
M%2K'<W$FSIZ:ME7K,6C?^B"'?H+VXA'Y4HNZ>=&NFHV(6M_I+6VPMG(N\P[G
M1 EG>C\;C=?^K&X^O5(7VP^(QJ[R!ZX24A!SCV)/>_<>6/$N58WY:R5E=1.2
M,!$AA+ZP"!^;_OZ8XDHOE_S599$#.BE++2*/H)6K*.Q:=MM1Y_.D2.I2BN'B
M9SG!+?%'I,%3_!H0<[[QX*Q2C:!N=_IX9L"K/J[OG)L9)FH",_RY:9/VF6#.
M%083P)58D9K^UO?WC'0D(S!?C\+BKH#,=/ZS79W//PWN)_\_"NKOWI=NJY'E
M^487')>33=!S%7FV1DUX.0\<W_*4'/FWR8U?#D5^DYAJ3-)*4^0F%\P1)ZP:
M_2VN^473O][W[!X0M9<QH2BQI9AS<[6H9$=ZO+]W]:CB&!SN47=36-.Z6-2T
M=3LV;S/BR4$9ZG99/H"]!V0AOY=;D'+(B <6,O[ZL?FI8O8O KF9:?!+F#<U
MCM:_,X?>%>K@X!IOO1O32S^B?)I?GN7?-/5NVC^A7KVY_^VCL5XPATL,X;1&
M+N-DT-BKBG259WE%<Q/VB/(!*&/0J%F>BDTL.$A6?& OL_#M,;U=%@:5N/_"
MQKU/B GO7/2L>_Z+#,__6HOEY"V[? QL:I<O35069GXRW!>GJ3O5J64NO_AS
M>_BNO'-RGKNMERX@665!3N7<W0XT &\C<;AV0IU+YXS4!DAL4DH1?0*;=D04
MV+1W;V,@&^G?C[',(?< -L1J+:0GQ<* /AD_$[,O[K@\>*V<U"NVKM.Q]?2I
M 66O*>H\8TIFG3O31QS-/[9>C3H:)GZ8]MP;OJSW,YV@!N>5WO /I1_O4_B'
M]TW*,R\Z@8I^'J*#0?G&2&"Y99FI0W_\I:$N/$D?7<_#5:W3UV?4"-?VM( *
MU_)6BJ#I5\23\*($J,K$@/XN25W6W;!NLAV0:7ZY:WF>Z*K">"!A1[7&T.%U
MZLY-\^98_BZSH[U_,#L[^\JX*4;_"9I/XIKZSFS.^Q/!)I?FNW4?^F@Z<#NH
MC56##\33X.)>@I.AM=]ZT,<OU_6RY=*M]T=UUE#K8J81@7VZI&[-1ZTOO!24
M/>DOZV:/5<<5)M&FM3UUNO< T#JN+6%KN29=U*):W?^@#SH.5M-+_2EX\,DJ
M9AJBU/L(L3L5J&N# B$WS!V!F42)R4"A]46#P5%U4,1[3+4^=A@G6=C\1L(+
MR.<UIXY<^7,/J'8KN0>L@S]X-=R^=QS>]UR91]E4W1F=%=$P<Q7=J0:MNA+.
M5P]ON$K?K:_:5$<OR]O/5[==K2Q(F9YQWMS<"9WQ7:HE!#VUW91NT$]2ZVS>
MV3'<X#5:%=JQCFH=$XZP)'1(?ZII5.77YHAH;G9LML#(^_/GW$I9_76P[X_>
MXX@XTCCD\))IUF@GTHF9([WUC&0\()W)GLA>N=9+=]%1></1Q_/E'C#P:3^\
MS4+9O%^+[$=F3/2)/8 QEI*C2D'.JE)=:8-+?B5Z*=JJ8Y4S(BU+5:8.Y%HX
M]-.Z?F!S"+'9.SQS]F&T4>>1 P6SRTV]T_EWAUZ/B^I/9]X!X=ADD;Q+UW&'
M V'28IUU-1^D_X!#1U9!0E4[O41SE3JN5@+;!:@Q0C7M:;<';A#(V%I:7\RO
M !^5KDF%6X">S(,_(:%S3#*;><:[:Z:,8_5V$W6!1BDJ=:- _!_<D U/+F7]
M"-M!;PA<IW1LHB]P:\_5+D_/T&-077K\":MK@7_G,K9*RPD3,%I03?;/P13>
ME[:6VEAE9"WP2:$7GX9=8(UJI]=JP,D\$*7RZ!S4R[ C+_I8$$8?F2.N^[7M
M&6$5L,%5?*C'>ZIFMF;G2^/0 1209@6KT&"@Z0WY/M2XLO:L4NT!T'"(OX(@
MWTGJPV)W>-?&O$/WF<J5QLD]X/;KO^3"KT-@VRD?1,FTN]M4_D;J1-+9>OMO
MS<N7HR1;E"<:?]'F_;=B/WK?8H-N##26GU^DG_HUW /F99NP.J%$KBO1YY#P
M[/I-WW=HO\%O#_\?095Q+?>GMEXM=4M&(]-&TEW#.DD'9S0<D&TKZJ.@EF S
M528XOXCS*;2X6$*%B@9OLB0IU.6]>/?^V',;>:<@0[E)->P;]&^#M69[1#/G
M>,=F"^J!V2:)<MBNGQ)32U0D"^&?B([Z_?5HN+;&A2>):SM)[YLTW69TH=P$
MYK1@RSI ;8JZIW!"4@8U_3+N-*)$R&0S*^H?^I4)Z18UGWH-UV.@LU >#]ZE
M5T95$.ZHZ?3P5>K? -#5TUNJ6[8K1ENM,L9X5'DFK,9)J*TT\WW_SAHUB56[
M@<IX%,.&AD,<0?8ZUGW>%O!*>-$'>O3;=^]_'>L(CNKN;BEH/H>Y=T+ D&>H
M5V)B+VIH_?R\#:W3?' QH=61_]?"!_!"C4*UNUK,5#A,K1[K.0JI-LID8HX<
MZ)'3O<OC]45FR:DXI!=;;BY\\MI/7L=%S:4+?DL9]O3"MGYT?>DJKBN<RH"_
M0,N8?5ZQ*[63S?;L'J \>P^ ^]L-=,@$1IM<V54!YP[NP.Z4(_[@VS]WAL=W
M#J<*L97JM@F"(>"P]F;8TS->@HI9IZU>$PWZ9F@:++3V:9SW[C/[1=.^7@5U
M.D-+NN1]<JQPS6P%KKY6RDSN&0H_R$(W]<!XI@+9[G]<D^)%G$#[ZU=_@9Y1
M0L<'+\9YEUY*I<0Q\D&_T 4LAD(]IOG3<VDI+M-:J>V98E/' <=2?HSRX<[N
MM1YOG,VK/S3$7L3-:FH<FL5=N?D\O$R*(;<]C!U<(7]6VYGEN[QKM+[XR91^
MUU6]*+2)"0U.5\<F7,3HV9#I'1/:4Q#4W99PIBPU0F00#%OL6ZQ*>TNUT4,-
MWB#7-<+]/UM_1:(6E,'2%*EA*\@P[&(L=Y1G>?W,BLB+OMN-$.3#,B8N&,.S
M9B=KJRCZM975[P*<TE,%E/AM 1H+RG]"<-9D34H9U+0$O'O8:X!.-WF^OH=A
M5Q]?/F2H4X5G%292ARR1R!!5X[\*KG/HA+=13'F[V;3OT(JE/2+#*?^28T0%
MI_6_,#$5G"VGX$O3>*8I6G D9=L>17 46_$K-==/!5;=L[)V//]':I9(;K<7
M6Y4HLDY']G(;V%"CYMKQPYF^6!NB]^)OZ)()^)WH7V<.79V)!G O(PPB4*!7
MNA1E)?*]T[07(@;=T3)F8F(+1JM+^WF[ZAA^8F\ ;YXL>1>OY9?6JR_.%)58
M*H4E6KYV>;U"QPY;^O18OP3I-*H^YL^(WWI#LK8\1-TC%NW%L.YS:+6NI+ >
M'<1]$(1[TYVSDYAN3H0^=^&TVJ>TE:BP2(SOZC-T<>DN IOPN]//D4R4Q9;I
MOY2(V1!]#CFN!/U:'&",L*KU[D<Y"# XA:01?Q);GCW0FZHSJ]7R\)<*Z'<@
MTF<)1SG+K-]\HZ.G ^SC117K2#.1T=GJV43E2 SG$#\:%NZ(HA31Z@ZP;Y_K
ML+:>CA-%-/IE<(I^Z%0@V=VRE5"HY49G'%L.&P]@?-93OS3A#&0J<DH_$C.M
M$Y)ZG1K!543B7WVRL:3[..#!&U6M@K?F1T/*>V=02S^L%#H4+YWR[.J/BJTM
MW@(D(:HILG9T2>P)/CWZD>&8@_2LG6%E<,<*@6DW.1OL+8(XKN,V+ZF@,S4G
MMKKS:=06DIRFDOR5@VPQ\)/P=]SP8:Y4?<"TY?I\E04+''WQW0CA5#_<(M3S
M/(ZG03=M2<R+4U5HKAU'K?LJ4$SA82=!_R)11-"W!M">%CE_+08R=PRNK$$'
M5P-X_RM276>$W5J!P\-5[_FB$A:EB#QUSJ19),1L!CI8%@&8'A[K6W[X5]!X
M:?EVW:B^J6-J48W7:2?F9=V.M[NILDQA3DB8"-&SR33I'PLCT/^8TNY&?6=*
M?:N3HJ4K+:9;,58DRD?P+Y:PKA)T.;.LB4N[56[53I.OQ+C8$ZOW^STRRE1V
M PE)_7H<2OL#CQ2QXAA[TT"KR7''J65@M%2KZJ!?"L*92:[<'36/H6_?\I:K
MQ1._CCV=4Y^L3)(0$SW?GI3T]J52W7C9%KCHMEICB#N[M&5?YE&#SLX*O]65
M%I=,&<?O;YAO^+=QUKCBX7D/D B;?^]Q'!G+^/:\O=W5YW!<T6[6MKQIA)!X
M2_2X<<*!)RJCZRE-,[R"C552OV((-608YJH/8DQ^Q?[[;^-D@01"/';/1&&%
MU=:TR,ZSVNEC)#)V8XB^?JKNSB-?/Z-LAEC4JI;WG*?I'J K$2%7&M#0+)*M
MHS.\U3,W3]I"/"!+BH&/=XNDEQ_^8&F  VT_WU%_OU$_? 6JSPN<!\-7][/4
M0?1U4Y1NJ&2%<PN\+$<8X9(.ST03<S]ENS76>B2C7DJ@C\>8/^Y'8Z>W%K5M
MPH'\<EBK77?5!SF!YM97?YMU0-]=G7> XL>#P%(5V3%>].?\>C37>4WL4(3:
M(S5.J<=<TN:&Y37C&>XTIB0*8RW&TRV"Z!#^T32D2!_3!H/GMU>L_FFW.<&@
MYKX]G]U%)., 89V[:6G3.?&WD;4:;'0_:_W5;J9LK_[5C\V]$>QN^!X:+*1(
M4J)]<6).T<0J(UODT12P'3@49]@YR2-Z0;1G*GR5_+G'QAE7):P44 1E' 3<
MF/,([%CM!R!/"3"% C!_X?5C 9>3H?A[0*=L43QL9+1T!1U=>$ZY<80<8AN%
M&L)])7>C55J;V'[1L/V:=3Z%$)740+2L1X=<YFMVHUNKI$P9;!('!MRAN!TF
MPS3Q%^BSD:":/:H[Z !/(RB3S?"DE^JTLQ==:;?7$B^WCJY?N&VY:<K#HH<Q
M*_58\G7!97.CQE4W/I5,JT;WL%>SCQ"*7]XVV/GL5IC]^R<Z(;W<[MJFO2CJ
MQ3.B<0A\>0_H]OB8=2O3#34O]PLR)^)#L]V\-(4M7+:#*S9BAZW5+-_&7+8>
M@ZO++6::=60N=J-LJ]>O%\TA.T,>4Q@',_?EY>>#<W,C7^-\Q[Y]H2,8^JW3
MXDKM-FLL+R'%;U, 1>_?]7B/B4?#G_X-,6Q$X+NR6%YFFLE.J!/E>A95]_C<
M',D:B.3.!ZOC?0]-+/C$A?(=@<>739*3TVC+1&E/3@Y:/6K.%]?_IEVW(E8>
MD9NRH4_K.427U727])KDURE"YXNSJILH>6AG66[,]!*Z=[,LZ 2Q%W0"N0?L
MQQQF3Q>'[034L]T#^IW_.Q \@_])%@7&AS<FC@EGMJKXDY&&<DWC?&0MX:H&
MW0%F=^.-[PK>%K::! VZ5(* 58V+5IED1LM/5BVB:JGB'%>\&L9?Y"FIVM<-
M%O$;#>)H5-B??^P:$/N:'\#"--<GIDU>5UZ+"N8[VGU-&@"[5*L06=G152\.
MS^?>H=E/)/&41QW);ND8Q])F+A<ORV<S/@121JN\M6<G: _=TG1YFC&KF[$%
MTYRN27?E)$CJ6T,'#/*+URYH,.\5T5K56:Y90[Q6=ON/*:9\.%ZIS?D9&2L^
M4PU]34WG1&R_V"\:WY6Y#EKE/I3^"6:^]OM!8U72[-@S+YY$UO4%]DPYV-L>
MV2Q]]ZEA5C@O!713[YWAAV(!A8LLM=$J$L]S-.I'=)6O#1K.RII-"<$\6R+O
M=#T7N4/PU):-F9H.])WSQT22%'EK@P8QB[8Z3[".AVX8+P30L#EZJ-ANI4"
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M)ZYUM%\?;=<:S)-0%@**PQ+T*1\2?A=;[G3-T5%V]/1F._)Y_RO( :SRY;S
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MKX47X%%%8S.2G_V>1WK1;2AL%4UGAMHLO)@6+1<QA2 ]"!K=^W&HMH&&M$H
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MJ N/JUH)^O*;ZJ,AMYR-6+;--7'G:%_@EGK1O8K!PD7#S4F%A/6EQ571S<2
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MWZ4A\!21-IV"[M1/'I(9D=C2O;'HL;_4/8ERZ(+:O9=^6:,G0*(_2*QLGX;
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M*%/DVY0_'I15YHK+10,DQA[LP@:W:QWT]N6\N%W/WCD=ACI>L(_/'26QECX
MV.SA\(9S#2_A(3M:_=:E"'DGMXCRF:A*$HJ^YC9\:^(1AE.5(NSUA0,S?%(N
MTCORSY[^N.T5P[[NKRBP(GWSM_T]A8@RV!A):5)K>8T"]\&@D:A0R*,H\+!T
M:.*>AVU:$8&&XAIG%<SE^HMF@%ES5J)F<#[2];]'"+1\DF"?;!$EW+@V)#?C
M;)ON628P0)D,+Z]_$K#U+H':VJL\7L)/(M1<94:F-RI! ;#V'M^9RJ$T"-$]
MCFGLLU=^\Z1!.=UA==;SH@Q*]R6M?)R:[8TE%Z'ISWG%FQ%6J!NRN'P JI#[
MS]>X@^3YSP/-\'2.JI5=[5RR9BMG(GS&W=G$\KP*"QG;+SVEPR?LRM5%]=J-
M3 GB!5@I3*EM.HOSJ][+I0N&SCZ71[.F\*#P*5*R@(&5D=#X3U<-![R*AAQZ
M@2:?NC^7J4< "\O2T@?#+ -4:)F5;:6?S<\0_W4I=4Y49:%*QDA>I%FP/ "&
M#%1!KPZXRXV?X8J(.A61)ZA".P(\N]6I[/&,QQ9<+LQ_U%U5+TVJN(T2=I2;
M8DE I+?D3FF+B'ZUKQ4U3?A_.NZ6-QG>IN3\$ATPEQR_ZQBMBGWUML5*_O*1
M<X>^(/AZ:PO<3E[;_/KO%4_WA9."RBB*M^ I(Q<> $QU[G@8O=6IQQS$M0%A
M791'-;'04@R2<)*Q!'R+-\1CX-I<:C5/M:Z!YFFWA>E#A&?<-V+^$= &X =)
MM1Q*+N ZER* -/QH7=3NW<")#-OR>RZA)R0:GY X35I_1U]-.[E6S2[,KIXX
M&"IC[+2P'[<? /S]-S'W1MM3E07Q0B<A'+0I'P;))Z[V!EL:G9Z^KE\*H6V@
MT]^?BK'(=#%&E^0?FD@Q=,RUYM/9/M6=,[.]1$F5WI*S#^C$OLN?CNNOT_B]
M?!389\-1LMIAI#MJ-PID<MBK+=M$B^6E==WO.A02+P6 FYW!YA8C5.=ZD><M
M5L@/R0@8O86SSXBU@S/YD;QJTG.@JF.PGW0(E.&Y6G RI[M.LB#2N0S-98SS
MH>?O I)AZ57X1:.+3+=\#PTW/^2V/X>OJHE!7-;)"N[5Q47EO.'2[4:S2NX4
MX5W[K$\ <3Z*[$B!K0$W,.A^V[UL;R 70HU\4Q<RWQL_3 T1[0RZ8FN"IH^O
M4@_VA<7C2[H@##Y3T):GV<]E,]E="')>O&D/C_7>W>#\==0]*I31+V3EEU26
M0#_62Y>]!+,\S+'[#I-2)2O/Q!.*I_EQ."]9B?_8(V;J5_R\<@[:"M:EI4\=
M5!X77--!VAV0^*;[KS3DK _2IVHV!T_;44@!;"LS]39^UU#]2:)VV%C>(',$
M]ZW0BU"Q72X_.NX2,""(-+RX')FN3NH9.9BEI$_!K;4_DXOI"'2#-7%%LB1(
M#?B=ETE>Y+CWMGVO)EFEI3O/M-%YD>$T9CGD!C=J.\"N-W"OV);/9+O'&81Z
M*@?5H((T5FD7E=:DY&543X]CE3-N^X:V>G9R9(2!WBO?BPL CQM]*.GAU*%<
M$%_!Y9'YQ5[:R"O]Z917"ICP'KL1]A4ZJW0!&2]^,<D#D("16-=)?M(#8"6Z
MG@BA?:(WX6,1\^6\_OR*Q1[%^0 @&[K^5:.W\  H0-JI1T"^\4G<JKD4F4>6
MW^>/ANX]L2RDM<CLO#;(_DPCM2,O/&^*]_P<W%P&8U=P62P<"J2ZB* &.,?4
M84],5IQX>MPD)%@@S"G2G\(6,11H$;<8AK1Q.C<OB6QL_*JBC5VQ,TMBY723
M!(1=P6:X/LO7(8$)ZJT_0\<+FJ)MB*@0\8 WB]%GU=*(2.F:FU+92TZ!U$YF
M*4E\,/P;>QD.$=I09NL?FJ(^;W-H.VR8OSE.A7PUA^58L(+U+BUFQ(4RUX#N
M!3%-"5EQVGO!48\%WE!)+LRF$R7IN5C]2XMD2@#=IKJN74UFUNHB4S@N1R,_
M#O6]%JP@MUE@ W[#^6?@":F9[L\7HO70$@B+N%L[+,6T2><)0;L? &"&H?OD
MSU?-"0B1UU,-<PQ1P:=,WT\@E*Y"10^ 9\"V^W2].Z.]D]O&M;VFE9S**XMC
M3!F9OY37N8&E'X^EV / VMD8(3_<JGA55OUA,E4,^,XVE41?9Q'.1(5B]3HV
M,5H%W<2F!$7GTKH,#@&;ZSDF"L/"T\I+%.^+!#?PRNNCJP5I/DMI##.'.G<]
M"<\G1RS&MJ8* BS>_\6W8@] Z%0DZH\ROXD^45B>G1TW]+W!A\Z2N8Q)JJJM
M5#;%SWM_DTE)(3RVD%[7E[U*.I"8'!IG0T @+/XV5ALPCV_",4.\N.9E(OJ=
M.H3PB ,JK6".,NW<C<!^A/ ,>KFP;/I=4-,0D'50C]?($$<GV^E/0!)YVMHV
MKGZV.)/C!DWY<=GK365?KS?-J&2/Y*:UXU4['RY[#92UF6*V$MK^"*67W#T1
M^WRYA,](S[8U:&TIM(N^E$W[]R)"H*OHCA<V<%7CI8FQ45Z(F?]L\V_?[:;1
M-=5PD:7F+]&9(>MDFI^\*6;]J$^XKW KTI_2Z1K?X6H4@8+0@)D%3?@VK&K]
MEZ\R?O38T7V^C&6S8PX/J &)$.(3C[< "QV;'</N^^8P&C&S#;"<IVOL%C[#
M)?%@/>$D$IDE_JWNZ*2^?[K[D1#)V>T<*<+4S;=]K7PQ(&:#1$8<2]!!0[:Y
MW>")YF>/Y)S97)[4<>ZPTX\S>O8[8R)>& [N&+F[/PAF?!PY2HFU .07M00!
MCF'D<:3%9 >6;OG'&O4#@-"4\#&ZBZ2 )JV,5+&HE(K@0K/W<&4EX*/O6#S%
MONBFE*.(X/2\5]?.Q(2*"=<6:N*63#II#(/'YM\>U\=R?[9O5,..AA\] (J<
M%BXGMH&Y!\4>%YZ;@P^ +TUI(\PTX*R[0>_^KF+)31Q4[<Z'#Z.7\$R7V7"#
M-E74^3=H;1.+F5 1;EF.VEN7@^5<I6+Q3V&(1VLQ/>2Y%@&8<2V_(6!7E393
MF4Q):-,^H2FW=QC@.1@5PYX+,6>J%0>YG-7N)$,+1YKY_NZ>39\[MVVR;;_0
MJ$EKE^;-!"_>*/Q#S1J!.U\(>LP%02J%(E[1T)UL^FOZJHL8>3CLI4#)H]*8
M?!OFI!B'/4H9MD[QM]8-(-+%4KE]Y>.[5-PQ='O]\7-K[D<U_2N]!_@)O/(;
M4L\L+?0H%^P_[?<,1UKZ4])O>$W-613:]X&D;25'%D1@O?9Q?;LGR;]G\"(2
MW@M/_K6([; Q@ED-&,0P41P;U4WR5:9X!&F@I,.6$[,%<B'_HIE-/HXH5M#7
M"+\X$FU\ &Q]K'.?B4"J+I+I-1JV3!Q[3O0*'TDD&S -G-A99L951.J5[UOF
MQ]5("S.#C^/%,EKSXZH=S2/]: NAW-(N(CT\#5D:72;5VHF<Q.YJ#G*@@LH-
MB1X\H"WO.!2<A,XNWLXO$<>^6;9+IW/^==@HXK<(-%_0(O*N-0!-R/_YKT4(
MX5L!OR^ 1T!N/2490K4T@Y!!JD<VGC!9,:/!"Q1X(Y7%\U/$("K2W'S+-?L3
MP2+6"WX,FG1\Y"K:,*'J[FQ0L4):T-QTH+*A<X+W@HEJ=IG&J]^EK]I5MVJ.
MN F%V4!UTNWD'BLW9G,6-7'9Q"U^0E,=?0E<#_"(7M!ACZ739'DSA:3>+^]>
MV(WY4-AA!^K?-WF/T^(377@(145@^NSE\?$;!VFFK?[ ]83U'+$9SEO[J2#>
M4$5I"7BJ,2TJ%+?)TFBXT[K?7M6LW2I91T2EG-JWS>2/_MR3HW!N9LFX.YGR
M.!(Z?4K+[7%V1F\;9/]K!WH7K)%4_>W$(#U\A=3YLJ3\>"S$7&Q[N.=I>$NY
MA>X"B-/&9O_GS1=-*Q(2$H4O&T)S>_/Y\C_VSGN>>+%_4OJR)_H<GD1W1K;$
MU>+9YCFGM.?]H8LH:TMQ/:8 QQ\BK&3)[*[BUH%1"I;D#V][D>46NCZ+&?S=
M+,VF@\R D9U>_HNI?*KL/#2.%:#CNXU6D'+*)&S)>TZ#(Q,6-JTAJ=4E2U5C
M5\/N I\C(E+NPK(471I]"%F3%8KY').V"9P]AM=I7)!F0A6NF.A3:\GUFB2E
M@,D;%/X1(DIPL![=L?=.O:QEOCR]3MR<09^: I,9+5OOI-D\F6WVJV:2"=-?
MHJ9L?L]]V2K?0;H]8JX/]MG F>1/WN_AU]Z\"LM^GBN^-F@\@0SA\&3G+V8^
M[S)/E7R.B,H*I).%WI QE69K%/[&!6I]^+3H-\4;T?V..T0\G"4X8WM+5^+[
MDS(M3<=@4O^4FI\8F=WWM\U_G#$KX(+%YV<&QNS^Q0:93"''KG O^,$O$,<V
M^U9"*6B"H&SF/U; D?I\+UMW#<?Y[?/$K=A72->@E;2A1"*KZ ;1%''%);6!
MS]KJJL6(R8WGB,'*=?R1H>SYW2L;/5IY#R&E]&[G(.^)8;VF=ZCV+"Y,O^"]
M0W=F*GTFXJ="LQ=SKG2X+[&.-3D!ERD48;<1*HX:C5:UDMIU#OGPXWB7"@Y@
M_VW*5AB64:#[J;<=(O$J8MHZH,R,3GBM=J$H],EXB_:3+Q54?HO/H?SI'_/,
M6-&KFC_ Y#)T'U[O@CS9_VZGL[XDODMEG/VANI"8E=*IZ/;IE]>M,VK0964(
M#Q^):VD3FN#%T/?)=:P.Y*49-WN^K.X)'B-O8U;5H"2$4+X<=ERK:LT<2ZB]
MBILA/JT,^-JB0\@[ *1=\US4Q^; A%?J550*640[W<BEZFT'QER-/^EK,2S5
MR\77NY>" I&8Q<(WKRC,NCR(2B?!M1TJ?4JQ,8Q.N&3&[Q[^_M^6;O\7:^?1
M72K4R3LP%*84@*44@I/UKZ8[EWBV[X.$Y[5*J9U2&),<-K<)/"TC!2(HIJKU
MK<$SR;LE?-U]#*:,; QE[>^7]+,3W/I@!N/9^</7)X6"4^C:\A2AK=J#4P\3
M06]$?S)M:EV%B;-U:_I+ SH=&OBY=YHA/6N_02V >DG1_YCJS&X+S1]:N(@0
MS,3X35 3+9W:C]](1M[%S3APVZ]?&41Z+\PKT#JD*SO)>R5?]23PO/NA:=B3
MFLCXY3[.7TM:[KY^CW/OFF\JLX;+3;(Q_2"_>;-_[.YSE;?%B2-3I"KV%05$
M-;A.P' =2=DP5$R<2O?28^71_V_A:XD?)1(,JT+%;(3Z7SN*+J-+/JYX1V?I
MY?JT>R/OI#/R[(0? %_]_L%,1"=>A][KTGH\.L/M7._<2Q4Q=N0<$:P"+:6H
MUA6S(@/&^X.'3#$3&>%N>W3];/1/G3<K.*^C*;)FH?IB$AX:[C)&JVN$,Y^:
M*CP2QQ^Q=F(G20\[H.L]I RG8H82&8@9^N''#P!%*?X5KFHJ1E)]!70]='U>
MYI9;B]*U>1YV%ZVY)M_SSDL7V)DHM/*QSM6!.X9W@_<"R!W]KG+!)E[Q]J><
M!/+%7(_M4H,KA=.M55B*+)T_1]U;0KY?HLOU^_-7(O;[#/;NZ=Q)MQ'9H**8
MLX"]>K-J)^?<X6L)QEM4R/:QCU*7A'Z79&LO2(N(>>#%.FCE%B=@&@6M0* D
MDLBR"L3@!BT1DV.9X&=SVM5.[MD:_(E;UC_$'(Q511HR1,I%[/,R)+/&O62*
MLUC%I&@_Q)+VF&5E5?=4.[GU+U<AQT5BKD)3F:'N!?6O$^1V'Y?R[_'U,!L_
M0U_0G8@8Y8/_*RF&)MMTXGNG=%AIAX0=<S"B> F"BCXU:/_4NG9B!$0](GJ>
MPR(=\L9_! QKLW*Z[PXN+'RU^F*M+(0CQ:S)6T1TIZ*MKF(LKJ&EH3H*'C:O
M*FJOV\[C?F(O=T'GP_<2F:#X\L7&N68&*LD?N$88MV 1#.:'@M0WB#*\@.=L
M697QTOODTV4B6R*.419W\[YD&E<F5#(73]>T476%:PQ=G5D9'_UT^KT];E>_
M+!4X_XP]YQB9,29X "P(KO8JYQ\Q#Y!58.%EZ/H)67]I.ML&OUAB)YY$&_]&
MX&E05BN)Q&+QM-^T6+-*S3;<2YN8Z,?CO\+/G;7\YAOWTITM^MJV!F'U:Z76
M4)%'MX@B*VG7/EJ(UU+'_:1@90H29WFV1F[^7<C>1:I@LJAL??=?G#/R:D=T
M?TF"+[8?#67R'^A>4WH1@.YK.+;96/)J4)9\J\ZS8;%24M2MX;B&%FVYV1=*
M7DO>HDF^5R?"#"9T-130,6QZ]^FP6C:_O\1/J@M4,^IPU3T_=4Z[J%X]MSB=
MVCH54S.91+APTB%%4M+4$FL2Z\SLK!X-"^ )86H&B>0OY,U/G?+@<3%#Z))H
MB/GLJ5SM^=C* Z"4?F!W#HYZFL456:->:%VX5,,Z?\;N$9KP?_(FYIMK<TG<
MNJUX (!&:U50;_M=RQ0K3U261%H;!EU;&GKG0@PB!V\[CX8BJ/)LN'WB04+_
MRYIB>:8\]NK9U_>GEP)&P+_MTE.,F@B?'4B[/(1H0%PUR5BX'#OT-0ZD)<)K
M9SM'Q0]4_F,%J)YQEGC)*$(O=^9T77Q?]77DHE"<N\_ UN$=3 )W5+Z9-7G1
MYCYN75A$D\2!]?/)3L9WLH8SG.1-[<U7,@S2K(-O^? KLR/;UY0+72T2=YP,
M)3\\ .!+R#\MDF1;:F;>R=#B:)F<=^7B4>>?_#T)%"W/YP2%?6(=+(98S;JE
MLII5Q]H23YGEK#"@?S/J@K$JIV P$%KD#E>TB+?"NO[N=ZJDA?0V8[>-/UNC
MFMP3E [(XB6[$^F2_X>@TF^!I7Y%OC)ZI_YOX+(_5'%G_CNU_ - %7DXL!#0
MJ=^]>W_/*2_T*<.:]-#G6U/'6"\6%7Q /XT)X4F)-43*96O<3ES*2\M(\$Q@
M(NYW<C8AX5$4:K6W$[?5#X >4-Z(V:J?2X8AQG#!>-%0/17B%3TT(Z#J!MSG
MKCC@MN1?,#)2?\/MEKTI-NH=_C9>;6IS!B-B)((12IN&> [=7R#TK!IW(_EZ
MF)CB2#J91&5X7ZEP!K.?B$4/@W!(M6K:.SMZ+-:VK58JA40=HAQAPX.W.\@
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M^/\.]7L9)#\9NDR?L]TL5";F;S.%:GDS!C0%EK6E[(<N->A&TW'$W0),!U9
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M&#O2*Y.!_U=-WU)L7*:.WD:)KXCZ+E6<5R279-?_JOCS?4:&"7"#@R7UB,X
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MH>KIY?0(,*KH>;EAU.4*Z&681$#W]H1<?P3+9?PKK&A83XQ$$:_X<K23'??
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M69P17L.V5=_8PRH:*&G,2P4"L;K.K7^S<#=->CE-?.^Y<A45A58;B<P2K#T
MUC\_ZWU?O-F,WHI($JL^OTS=71$"-RPJG"B@MV \HXN%EQ[53D.M7Y=08D8)
M DCOPXL'P/%^)FVP=X9+;;9\:T(9C.IRU7+6\'(M<BY&@=$I)V7]I^%ZW6/\
MIX_)-#9SFTW1USGG-Q))Z%!CIM^TGAI4]@&]H-IP),.ZUF8T21;\Z#*%%0],
MB06L95$<-2A+:G"WKGH #, 4L>##C<]THI-<!$OJ:GPXM"6;>>^V;J1K,[$>
M 'Q[ DA:Q_L-!@,;&E)$2I*6?SC@79N+P9_&9R]GY4I_G-25474+I\ 0KQC@
M$9,*^@2$M%^YC"!39@<N<)&!0T>K!8.H!%EWLW\NXINP$M_/=6-TIZ6OM"O1
M2.E!BB1?W!#Q$2D]7[01MP]4/U!?6G'[TI^PWSPP=9-P&*V4[_9E[,6Q9;C8
M(WF9OR,?0L)NE,:&C/*K!4\2&:J2JN=#?WC_[D+\$2QW<7\D>+BDR.)/?L$)
M4>FLYUAGDR^!T)O3K4=-DV-'I+>Z6!X973;D<^!+2T[*QXI=NIV+,OR>-QVG
M?KH=E;3ME!D."UY+Q.\_HU$=L/RA;4_5 Y>X84S(##OZQE6=?L$2)8P7Y#:?
M6K^^1WDC/%V[-;KCE])[67:W 'Z]]0#0\Q&'7Q=46>_>9'JL:X$7><LEX%/9
ME\=AHYL;C@-2&5\S2L:N=Y3M[X"Y)^0G(,%BUU25#:8!!C?U=%O(H#,WI.:2
M.6AN>$X>;!7IIM@&&UQT"_$(0$TN>%6NAC;,'(7=6GY'LH5T-NXEG-0>N)[O
MW67R".'F]^\=-DA(6'Q-M4U34?[" WSD%@JDP$W[=.B/Y:#4O^EP;>C]SMA6
M2+.+LJFT^6)T",S0Q%,7H:08&7*INYZ @E:..D4S(U%49*J6=CV1E0 <P3)"
MT'*]7KQ5%(>R,&68;:LG,?0=6F#7D4N F[J<CME>41:\K=':"J/BW /$G&N:
MQ%LW60WW<PEIVQ6'(M(.5>8%MZ+X.N;15<_+RCHB8DU,Y;?6/1:344S[W RN
M8%4V0MPMIEFIAB_%?=6P(_8F(AHE?'>/*0*/-CFR,)FZ@PNM(M77Y4/A ?I@
M>,%B0^W^AU]AC2)+[XK:=#EK2YGMS;_KB!DPA$+<Z@3 F/SITD[ZFP90ZD:\
M]0G/MI$416IYNNT05VB2C8GB>"6236+DPS,S;]="#/[2(KT_3Z;X@N?<Q?P"
M-)V%Z_342%(Z<+\B!ZZ-OH_:@RG!)O<J5:Z=$.4V?A@7ED1GW-DM:^ Z,=40
MW2#Q7'?X"!BA.F7$ZVBWRRMD(-C@?E?'S5AGF[AD5?$ >&J3=,B=W2&D+O:1
M9R#<GD@JGQ3S2?D/PK.P(G+/>9B]VH!TS, B]2!I=.:LG\1UZZFS1.3C$&!)
M(\6(;177-@;IO3A6ZE.F]U&_H0!:X&GT:W5E'[/:$KQ6M>'CO-FMCBO1ZWQ=
MDI43+HV)6=0R6JBA&>KK<I6$#R7/P<\5).!^$Z^76K+[1:0R%_<9+B%7+7,>
M"ICKV=:J@8,*I_S&AB^OY^:D8Y-'A;L8TM@H66<MFB=W<HIMICK/C3SZX2QQ
M'TD8]>"K,OT_2OICWW/MUM-]<7_W6HK7GSHWGB1^B[!@[E<]:[W$Q9ZEY0T*
M'K8/"RVX&FUUML-AWM?+YSVIC[-N(ATXWOL=3M[]3PC(;'2MO@&FGY!TZP5U
MU*A&6&X#V\[!N/VF@L):3\W:)7S;3 ?3.G9M/]R$.Q"H!I5?U'&8?/7!<AKY
M0UQX[.J8[*4E1^F=^KPM8M=7_D6^XQE\D1*T[/, N!6Z&HH=D5;S38JZ6V@5
M;8(WJB:J7DP%JZ2!,2>38@?1:]'"@W %R[XVET/E58#"@'+:]/EXHLX$\C4D
M?N6F]!?A,6@9N)V>P):RS^>M[_-S'K2"!TAC4ZVSJ$/G-XA^'GT#8^:]D C:
M?5J;ZQGD(N#AU5RWW_B=UQH5U9,[3S/%8G6>T%8&]K:)DU!<>D;.U?]NGK"M
M8V/!LHQ#KY=STD56.2\RQ]V!PW0"6-8B$.I@E$D]I><4_"-U';Y:7YK"%5<@
M#B[P"NWR<0\#=3N"G;M>KSB.WHJG1,\:/\+'SYI6HS6<[0J'=I@Q?\X@ZLJR
M$7:J2'S#-+02!OS07E#K^OE=YY!.'6K0-Q.RP->_^H8J5FGTX$G1D,!^VY]N
M!=[=]>N$064,?76["+2&JVHKXX<OVXH4H73$,<QVTW)T+4H]T;K9<0IJFYQL
M@MPXG:)O"DQ:.]<23KS;\7E:]L\%C'$BZJ@,J&UNAJS%0\9\\AU#]U,++\H?
M -PL<7X25T.'E_(M!%1WLM?EZ/W&K8P9=]Z9?,R-+:;Q <#.+*IPSWB2Z?%=
M>0PN\_>3%7,!,&U.56U4C0,!QARK,B@:/Z,!F,-K67/[_+@;L1&OP@L(QSP0
M)(_-W\SL31<8_GX7<7X3-VH;FB;KTM%8JZX>SKR)*7TKHH]VC?8(:#;%*4-0
M7G[AG87I7!,:Q'=\>>(.-)PB0CCOJEJ=]E5_V?WK2#P'GDTIX:=AS\8+3A72
MB\=N5F(VU_US[CRO1JFC4<K\RL/"11R[616G'8P-D6QDJ]%DP])^_NG215I)
M"Z>=_K%"+<QE5Y7 (\ Y$4D8TEV+R8K*));X9I):4FW]KDO5(67 98* ,3(@
M!TP9/*'%O<;6^56<M\/6'1+TXCM&,LE<M4E\Q&Y$))H ?1[9^"K^ ^&2D+;-
MJIRY;J7OM>_IB9R-I\R?:.M'\X?S.J?T%DVZ3S_>2#5I1Q/;4Y$\8?OCW)Y^
MJUO$FGRB2[@"3T_?(@YBWK?O>/]4JQ%H##2I+0;KV=CH.?=;$IR 3&\^14G'
MWQ;0'LA5+Y51"2JH%SUR X."UEH%+!\ IJ!O;BY96$<@ZAJ]T._N)HZPD5TS
M.0%M1 8;^?D#P"4 ."L4[15?0M2F;W>>1YQ;X ='%1)?/R_JDF''P<MRDLQ.
MHBZV4[6F.+\ B;N4XU@0,LD)>6 4&DD$& S8Q=_?I=K]PF+D?DKPQQ%3\2I%
M2V,=W=J2]J[+2"94KPDFDKXMEI4]"KRDDXCG5VT@5Q#?J3.O5'%7:R+D)\P.
MN;[);%F?D;6#DD/W<3U%T=CU9NI*U?P2NLNU"(2@Y9,,AY=5KZ]>B%]%C[\N
M_&%?*K/4Y+%2X_R$.,PH7XO,,L1^-K_DZ^7O0<@N&D%S'6]U^GO <[FQF8CP
MN1M>[OW"!%ONX?N65&E7YE_M1;B#(BMJ![]QCA7-.J#G%R,XP /IAXG_1I;Y
M_OT'QE]( >=P/;[/>98Y,:(44TA&9V>.Z7.QK( 73PEE7D%CM]5/O>ZD)37\
M- 8$/63X)+%+>6YG:"L:^#:OK8N"QJ=12::&5N '@.( -Q7XZTRY[E>,1]8A
MY;CSK?EU^J_;>[<MRPI#-]/IZH$,],>S0.Y4>0<;F;YC@YD=:K'^N8;KY6G-
M*=(WCD8.RS4A&2,;#X RX:TOYQV0!X#&W;MA*"6:\@LJ*Z3D#A#U?(@M8'(=
MG&EO9"88$+)F';"2\)U4-*M&DOST[ ' LI]E+8-D.Y/;6E%WN/D/\ 2J16P(
MBZF+6JGDF+A)A4Y$MU0WIF/R%M1 EK3"\Y:&=D_F_-3_Q?/8&MHF6BVMVF^R
M;F8?GVKY_ !P<!]$W?$U!GRRH_\VF\KOG0(QH%KIF=YS*S(V">(%?1POS13M
M/<,WL$ZW>E-NE&$U$\%5WW_BF'$]Q=_/L[<8:%O56N6&B0].DHQFJ'WVZ3_
M!.M-T/N+PJ1B"WL.K;^0($,5'EWL]W@NM%J1I#_R'&\TX9FOX@X->0Q;AOWP
M%U"M#F&UGO4..[S_TCDQN7X3.^I/DQD[?N7\A\."IB\E([CR<MB?7>PN'IW%
M$UF,)'9]F/%DG$BZ@"&"3,.,U@L;N8EO&B^U=S6':ZQ/M$5=I(/C%D-QJJ-$
MR][$#9K\]9;VU#Q>=D[%4>!$[E_LZEZY( 9/M"%&C8FM'>??KW15;#0A>J(E
MO::''N>L:3I!.4)-6E0E?F]I5FY(6"A&4E&?9A31O>CWSP^ZPZ7,8A;%O'5:
M<P/O#<.Z$8.9)/RQ#X"O-_[3)<?+O"DZ\[&1N])/TUQ:_YUAL<*$=*"K/5S^
M19>61LFN[D&HFA9/[\>OP-A#\2Q6@6[8[FP'T]G@]I$4+:H(9^?9G+6RD[A!
M^?F!)W.^$T21TDF'6J+D]P19MSIJC+=72JZ\S8$MWS7U5Y$!EM(I/X[?VB]C
MTP"*(C27DN?L0DZ?/0"PQW/6% +\WH6<DOX;#!/?%JX]O^WA(S1^$[K;Z:V[
M0E%==V3,SV#7$1/2>,$6X:#F)S@'?4=\"/ <PU20GYDW"O!IK &T.TXU' T8
M*/%FC/0R^I_P*RL<+Q-ZQ^>W=U. J$LL2>):F KJ^^_8HLG8N*:(_^LGELOW
MY5X!FV;OJZ)WFAVW'P"JU[KQ#2RHI]<G!E9B-LKG55G(^)GU:J3@W/> 23D0
M532XK8SE*0V7U[<'P*^IW[X)M_M&HYRMA0LY@D]I++DVQMY0I1!]E,)PTI(L
M%$VI(%KPUMNJ#58]-!N"4&!G-A?/H,D'P!6!U^U.M\W7D/<"D[\V3<H]Q$M=
MO1O?VQ=YI4_@KKCI_7BV<5V,FPJUX6H7Y9L+GOSBL"XB'E<C@I"[CY<N0524
M?;0M]T(EN&.SP5LD!K:Q2T >F6MDHC[-_8'S>,'1@Y'W.<$T[U]J&EE%( ""
M95S$63#)K8Y[OHS,&FC_286VB<5DNC7*XGBC?N3Z]4PZ__#<OT9R[>(J,]DG
M?:&3=RUC\H +>O](Z=4%(JLE1I+?RZRO6WN8)O3K0=Y1*ACHGF*/DG80E+=_
M8D<Q</%Y\6H&_D4.._SZ7'LVL)+U_[+#VG\5$VR&DNJBOM228J/YP 5(WAU>
M/PC^"^!E_$W(+Q#RHZ7D^OZ^P"%DU8 )G?Y;H&MNV&H$W73L0#7Q;?)"]#;2
M"=\<:V1F:K]3N8N:8U:, +JOW3QT?#1T6IHNL7'5ZI&8]^]&JD'L]E*=,U.D
M*V($[W==$0^ JI.Q.#%+EYE, 9=8%.P=]QH-Z_'EBR.)!X#WOK&@A;03-ZH"
MZX3>NDDU^"V44CM2-&WO +R@U,%O4,(H)\*JN,LVTQU.&A1W(D1*UC22-?S(
M^-/T2'<QLUR:]SZ-8^T)#3OE[<LY-G2SEDU5O]//Y,'+P]\Z2LGM-3.==^&)
M2H<!V;W/B\@?PV!"2R5\O4XAW(/T21X1\CCQ5B>?Z-:(%X\$EDB\I[[OVC)
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MCZ@.D?:T'9HV/B%)14-=<^U?"H;>6?_Q-Z\9G.)Z-EX,P8IHZV30_RPZ- Z
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MN+AW#(GEUX!_OY9J2MH-UO!J']K?] ^1*(_B*Z:JB&L#K='J1/P.RKU3>@
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M6^<'&$[T)%A] +QO^+3%[L^.\2[,)@F.3\2H_1S(<; 33GOI2X-!\S?^.9_
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MW.IR8=<56U>,V[^D?T?6<JWG>?*QTB1'X3Y'U6ODWE3MY:J@VLLU?53U'GO
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M7)9[6ARQH#:G H/ .J[CKI$C^;5W%R>L9XI^%O'@WPUQ@S]A_/Q)__TBH^F
M.D_,)!^JQO?8N8 X?-^F[ FE:ZM5\.O#-VDG5@+[%CNZ+%B7" E8@<&T^./D
M78:H&BC0\#$E"J+;D ] U3L5 \H03,3,..00^H*#^4B(<)E/P,1[B-4[&"D'
M^*M#>A=D$ <[]3IC!SF_*?E[Z0-9]@ ,8XATGFA.[D%6@[3>7.97=>DE!Y?*
M+,RC%BA"KK!@NV:4;PQ16XP5!=X;W2+]M06S3U_UTH,*S93]174OU]//C8@N
MVL+O'O7PI#9C.3;(V<__R02I/M%^V?0T>KOT_C4Y)W,W7IQBQ^,;>LO9BK:8
M-H8RT62GP4K>!%-UM7E(+ E#SZI@!85#7UVX975+8\;P0GYZ7(H<K +($#!"
MW]+0Y:G[TFD@X>!9G#"_NRT2$L]7<?@C,MW<.=>7P6P=+><T-&[\R@P;F7G3
M/PO?,#HRF1(GNIE+7<K9NF#?CJ,J-K/FW1W0W$Q582CR!$JMQ%!BS8W2CAV4
M+"$2C)0C.B<"@8N][(??O@((.M3"WN@WM^C;SHE5W'W@NXL^O= 7EG,3H<HT
MV#0PTZP%>HOR*\5DG/=E>(M=V5*;K!O+N;RO)W\N*?BHE7.+?2$QVJTZ_2)O
MJX_H;A:26;J5%G5M)AX$.V])P7J)'?^]X*C=(QL)&Q/STNN$#8W1K?@_E=G2
M]C%Y6PQW)'&=+H$4U>4'XN\$:U(N\U"'*BYU%><S)<T[9FVTCWGL*4MTHTMG
M.>_(5W20WK%[7MCI7-]AM%WQK186?3X4J!J\[3PB=K,CENM0^&^R9ML?  VS
M!_]T]D=EOR66)I68&B3?U#JDL:TU_8),JQ_X?KRU9R1Y?4VOL0F+=#!]G/MQ
M@<M:Q<_W<D0HL*.^XXW,+(M"FT?<LUCV.&T><?WE:IVF\:3ZDQ=:2?$:9\GV
MV7P6S2PZMX2 556J<I6L-T#Z!GN;<L:!D,<J7C=;@NSE[&[ISFD58*7WO]>%
M&JS.P5':YT0M['NZR@ZB$L[X>/ =[N4H?L>US[3S^CM'-.5>:'HK.;J$J\J*
M[W39O"#GMR(@KRQ\5Z,T:&'SB5L3%KH8\<$A4T\A *GNWLEJTBC4F\Q4S9Y>
MV+B]=BF8B=F]H%NYV;RADZ2-\2"\$<@S,'4!._\OZM[Z*PKG?_]> PD%1$&1
ME ;I!I=0&J2[NY<%EEJ05+JE82FE&XEE@24DEUJ0%%B6%)!84I>&[^O]/]SG
MW.<SOSQ_G3,SYYKK,6>N&6;TQVB_&PL?\W$3L_3,H*C\%D^_UT34.RX=PZ8&
MT.3REL(LW&30M8E373 =[Y7HOP[^O8,=^K[=Q]\71%'P%D'E:"/:[5NN\DK,
MNQ^"I9JT@2_%+37CQ=5<P;)4),6:M[*NGP0\<&?,)!Z,]Q+)[@!>865 L?VR
MD<-W#_#[$C13V;CWS\1I[LO4SNB^5EJ)A'Q;UN$,.?17T"&Y,7_Z^],9KH<X
M?/=0;U116S=BEO2J7YST-_FG-X95\8<UZXPYO@\DR 5+K@GT3/_4H.'K",F!
M)*GD3%ON" &U$Y<?TZNUJD95RRI/T(>WFA;!;*&)-3%^-R?EEMX$H%XVQIRQ
M96*'",'$05"8UNT+SAIEX>4UA;K;[^NRXOQAAE$)J49ZOI2&G 6YI?RC*^T=
M%SE@/R+P_*+-S::PX"I"<1K--+J\INK-??8K(C$!_.VKM8ZI5\2@C#=GJ%IS
MK?E>I1@Y_5@)N.ZU7\5NT0K?HG_Y*T-+4HU67U#\"LLQ!WTIMXB68@%);4,#
M6!+\NJ+O1?CAP)N"7+N(-T2\N3&?*=3<$I')7DE%F2C6&>OYP22&1Y\E;._[
M,K<7FW/]XZS)F(HQ4'2@DJN(*^%_0'(M:PNGJ.F5YR#?US&.&&B2TL<R872.
M>Y1U;>?U?+Y"@%? JJ*.S*)%LTP%E,I9BQCYX,8[KOYJA;$_&BPFF>SJ@^N[
MM0W.(.[$I?6$LCL 6V&L!@NL05CV(6O<,F?AEMJV^1)%PG3J.A:5DDN[H)!S
MI*5^G '5L.3HJFH2@ND9<*A:7',2DO7]+6&72A]%'%Q)5"N457[8^WN['P)W
MS?/Y,+%/(1/6C?&BE(RCE,^^H=35W@**W[ALZ8"E;SI;G@U)'I> CX?\=1(-
M8V!_XOH_9JX(9IM_.OGYV#AIN,[94OF%PDI1U2*WM%Z/L!OUQ@24-2M5GQ'M
MR_+0PTT>D'$T*<WPMAR&I]4T9DY0];QF:8D :!&JCIXIN^HZ"(NH4M6D29D[
M$C0.MP AB1VT> ^H*SR(8EJTIC'O#C O\S4C1[-C<HMQ\9TN.QDC_<I\B29]
M$YT,?6Y&D;5R7G(,"L\M9R/AW\=8%=Z@JGPW_?_'Z<O_E^T]H62MBW<,R/1Q
MWO93FKE/NJI P/N3Y%WA"KW+A'_154WS;.*2CS[D YF&W@VRV].8*IN:J?7$
MW#<2^O!9:9H-6O_V(+=^[)!_>(0]Y4\B0^=\BU4Z[OS[_[+JL] R7Z\^XR$6
M-S=*D*+ \D9\?O1SW=;8 LT!BJ)PK.EZ<&NDE6AV3>_>YC>V<)@+4=PC,%_&
M_!,)TE(%FM[(VN[1=]3;+X<VMK28^KN,;K89T#UV[:"W0B8>ZCK:L"#IEHI\
M)I]RQNH_QF6NV>J$+2-G56.-"CI 12U$>S7=>:D>15A_'D$(7#7CFTNV&E/D
M=]$^-*QCYJI7AJ-C]7[,1H_P6YW0+-/'9GZIY+F<Y/[+Q ,)!_=T'1L]HTQ2
M3F:0+_-7K0D$0,YE++#CYV@*^GGO-OK'V7[>WZ,%X2C'V>=<LQ8Y >G1%FH[
M>(JG1W*DT&;P646EH"5W;FR7N=!C/]$SW<GO[R:5&HK=4N\U?&.6'&%W*=H=
MZ6E9[3P06AH)*,N?SY+8&!DGI4W7F&71Y"FVHP3$D19#:B$#!E*S\JZ$-A(1
M_\'F/50RTN]-P#>]S-S.76U85*[,@] V$4,' 3 TT/-P/<-H*EL\40P_O5I4
MH4X#M4EN4"#C2?"6[JFEGNTGFQ4P4&T:%BQMYN.==TSW4KX#J"SJ3U)(G=?;
MV<'>G'DS]"@E_7A:57Z 55"4[R.O58/+Q<3%,#5AX \S,)%*UU ]TIA(V60H
M#;/^$BY=UJFUB#(^#">1WTW%')_?$KV#P<1%5&0Q8J_DGBM$'.OIF>CQ'6 P
M^A5EYN*%S:6@'A[IF7%DQIQ :\PBX?C8M*8A\ Y@L>%Y[73L2>*BX4 S@7S<
M$C4XV! F)"8B6DL-&-PG@<^F\I:P\=_OUL)7U-J\X4MMOJ("<9V8: 52/AC$
M1U.$TP04N/04X]28F]=;7EJ" BXL)W4!_L4Q&YK$?0J##0;,)VJQQVI^<3\]
M#BYG%,IA)X*-A;H%Q%;?]:?]?A>]K*'"_X#,?VE6BM&B>R[/UC'^8,P%  XT
M5S1C>==/,:!NE**2SP$S;]Q2?<56VN<"<0ZJ?(Q'DU]XG>1_32!I'A"-6+!\
M5GGBM2"%SKKWN_54PWI#90G:-7]+Z.?VAMNXI/;%& C$ I9ZF0+,;(T6,RX
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MZ8,W35['1*>I(+BBWM,\FMN1X!B8?UTQ%3:*M@M^_U8,[]9_=/A&8;PS2CQ
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MBJ=R@8(NM#;'+P%T9S//>5(!&QP"5TN8]]04:M;(YKW_X(1+)<:R?5W"G!F
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M$6^B!39P<,[LFE(A@/^9VWF1[4*^ T?N 7Y=]SM"_3]:!5=2ZLQRQ=M*<.;
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MM^9_P4*+,GY&^\7F0ZIPS(C$^'IC%#R$S"@K>I)<9].%3$ $ "!U!3@6 #P
M;H8GIB'D*FU$S!,,Q-C8R7Q# 7R2'(^NS\!N0?F297GA$3&6Z%D83 C.4Q?
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M;_L'72\X;HD?=%?1'(R,]_8YK<V_M,^<+'+X[C7^2A;;F7;L@#A64?XIR1T
MHW:I,)L9G=$)M\%DKG)F7SGPY!%SF;*P?R:AXZQ0*ZL(<&]H9/ (KU9 T YZ
MSB>1DYE.9%3^6&[RS?[2M(&C8LY,9*0,LE\"4F"T=8Q7B]@_:LL4!4\T,L@8
M:=A_+9D@IS#+)A3YZ=GKSR.+>F]TL4$T,4\S,3K7KN\$%-.B,65F"Z'/&WZ&
MHD3!?#SG MD"Z.N=J*W_,A#[T?73?73N:Q2KOZ=)L'(()%/.G1^1I "E&GB<
M'QG%P*=C_]BI'85N)K5,038/#X!D0<PTBS28^D81 ;ULY%EU4A+,4_/0:I\
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M\)9T6?>F&U@08Y?X[\A;,R^#R$1*\[)L,\_MZ5>W:TT_!5\OZM<T[X/SMOE
MM>O(L8*1OZ5IOZ ^68S:>W'?)J!/+3)5G-B:DL3$Y8XW?HXM;V\&Q+R^7V<)
MVU%"_B$[/]&S@7IXLQM.[^?MD!JG;/-)5PK)J@7D;<QUG%EZ?[6_# 83L_^
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MP/E(^GZ_T @1*[>AX/+ @!QD=P@Y/]&GI)5L'LP!&ZCV%C%;-%68SR^*[.X
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M%+BD[@\!_FE)WXL=G8R+N0?4ICX+=>?44\W"UI1.I,?^X2S'/EI?2?L6/=S
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M!6=RW"G4^9O&-W7F_ K'7["E[GLH/OE]^T(&;*P&7[-8BK=YZFIL#+8FQAA
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M>!1'S[DDT<#[0%):@=%^P^RY6U"UHEVR!T4X,U@^FE]7,DG!_$B#V@A!=B@
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M>7;9_AAV\NR%,[W.:5O@V7]Q+?O9J4UFAP.S';_+ZE"[KM[O.G'N.>B=3.>
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MBG(C0!CB@MUXT^ZW]S$LR35>%:K;H)\<>%%=3B5F#K,[DKNAA$Z#:%$(EKX
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MW]!CU?%G0V/>5+GA4FG)J/)CZ,E_)$AZ:\.$?GF"?9<WU3BV$ZX*NST!WWA
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MUE[=/VV(<('=Z$;D=8-.KNR"%UU .G4 @)7>&<@A+*S%AHD"YBZ5,PGCHXR
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M*&''MI)=VM9?X#73(4WK0:&F:TP_)WG,W[6&O#539]S*#N<L_24MS,BWZ"O
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M]6?Z9"$@X=F;9!J0IZ_*Q.:GO(2 _F%U%P&5(>U,2&90.+E!ID?NN:SS%RT
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M;AK!)2S$V=\IH_0MNZHI 7;8Y$+@6,EF(WR09J0-8^XQI'\B,PF]=5[#B'Z
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M,#;[E_##5/./^/;R19'40"?Y5 &>\418I)SSBTL]JK=SS_YRRM/+K3H#>?I
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M;58F D.\+'QTV^4+>H,'D#76=$\C5TL/E+:P]\4O0"?>DP>G:.5B.&M_3+"
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ML#0..A\'VTQ GTQ \B=@-1/PI7%:8S"26'7P5Y!99?SRU*V2+?]#D>AX^AN
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M5QD@X&5JO^7]9HJ>;O?O+<,O@GYT4%X&';P6^OSGL%_M6?#/&=V7YP?U442
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M0YXF">-=8DUVP\W[O$.78\G5<2_*<*YN8<[49Z-&#!SG[[IS%I8FW6[E!$U
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M;SEW<,S8S#"/F.T<&])K;45I =$LQ<2^=K%7>;?1(2E"8U3:/,69;YQ>J7$
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M9T8"SF33\OX+*NPL0/PC0700(8,=KJ(?$*G!V+\F>K"&,(2(-J0Z12UO"$3
M[F/?*@%7P;]0,_"K_1(+X+RAOQ4+_X;X-!%/>58 !0H1UXA_V#G/#EB ";+I
MXDL8\[2Y&]WF+Q3D7Q<FPZA/PMK9B4!#=#N)!YESFS.]\("= E*>"\+9M-[$
M(G2@!R,%+"YD5129%4W&B"^<1^1<$:50(JY>?..!UG$#);8FM*NS;)Q %B-2
M]25OJ"V.0*0N38$A:-D-"QW,"922^0"A '8X;SJ)@AR%_ZZA! ]<8FUM@2><
M@*(Q?+]:4V460C<).:<"F&7)G+?MJD>O6I03>;2@IR!J"!;8+S&1TP+HK/GV
MA8$#/:R<,)&G/!)4K2DWJ\EU!FWI-?GBL&:ZM:;L.[X!+>YEY#N0)0NZ:1P[
M$T&RX^9NACQY,%4"4. V]L+6"E)@RT;$_S<(4><E2]$[L.FQF@:'_#GGH.O,
MA[PI  ;([N&]H'B._0B0JW4B]0#9% $HL6'!BP2<+!%*6P(J)R^P:,01K&B!
MJU#.?\%PU=@2:QBQM)-W=3FPRN7\."Q(M4$3TOEEX<==3DXRE^!X7P7$".,(
M.<DU^B_Q /ZU?G7@?*H$1'O)>P,,Z-H1!1$ '9"D$RM@2(]4VBFI81>X @ J
M)??.!") =9JT*[:TG1]NVV%Y)G(F#QPF5QVFFDC4<$&P'M8:(V#O_E6+0.39
M@0#\Y 6N)-R5*ZK7@"LCGS?*L3P#?,S&],"*)BUS&LPL[.5I^%'],&NX^G^C
MCKA*(H"&@O]^W##K/^"\#T41?K)AU10V#$<XNLX_7CY.J'G?O^!.M:_@*&A'
M!)5H@GV-#*3)DQ+:-4V1U(M:L$H(ZC]#" *(< X%T$Y,'$3Y3",#V&=S--E9
MO?"/.FC_%N]U1F(V-K&F@@P*2 #B1U6#02#A=9SL%;3 I_,: SD440-\251!
M%%G"7BH#28):6"LP &).4YO\O.>6J!) MVF\^1OE;#)!Q"Q":U+X#IDUKM^E
MJ*%[_DV<HMF6G@<%;)9CE;;M#9BP.#!2*>OV3+R]%-4&+V^$5W=^C136EA&H
MJW? A0I'7%E0[W,(WKU_M<99C;!EZ*LM"R9B./E?91,S=S4A$T !9Y)*.82D
MQP4"] TXR)_HTFHHB,^OD B)HX^/4F6Z!:#B252<LP'+FZ8CSA1'F\]X(XYK
M*&'!3K826!\>0,F8NL./,-,I_/1^+##9_V4@;-^!0F6$ RB!B)ZAP*@5KCY-
MVR?J>^KJ*957/72T/H%6S&FYGT[?USJY1"$UB-2JHH >P*-%[*D "@:<*'?#
M8,R?S';Z^[.M_,'(KYW"BM>(; F;7X2W3(/5K_JA9H!R&WHGD\Z23BJLW!"!
M'PQX@ZM4P4;P^6LX=*8*@B'1?[Q !PJ9A4.<-U4[^>]:B$;4QAEW0\Y_V,/M
ML SMKLJWUDP'-*'"HD!\PK2R]HPO@6+Y'MQ;R'31UGP9#]%SUOJ"ZF7;.7]?
M"1T G8+$-@A:(K_%^)AH>:P->07=_B.)'** /L,OMB_*N2WZ.2,+,G;#,1,+
ML\!"<28),([]:BS<&R\$UBI3]2> *G%^1^&'4U&"^X5JG9H0MW(UZ%)[73]Y
M %*J=2FF]%>T3R %J*,S%29/<8 EGUK\'/A<8XM5NA(*=.I":-TV"%^T;HE:
MF&DJ<Y+7S+:J_Z.',(<*OLM9:NA_T"G,R36+^VNKO-*_AC -7A-B;G ZUMLH
M 8\GL,V:0TUY9N<K'/XER0&KC@/'XWUTOO-/9\^"G;1+^@^TBIUR1A^<V4I=
M,:4'YU(C^IQTH*K"'OUV$:L-FKO0FCD](KCZ[2=0KFI[YH;^ +>A^.)<#E#>
M?Z ?3K ;(]?0&"SKV-=LLU](+J;^,&'ST-+CHK[R*4N6G'@-J](H#A@7-SXE
M_<0L[%WY2K:SRJ/>^[OM+.B]UZY5191W7N,=%#_3D0)?$LCX_P!98CP'D:?Z
MQS_1]EN$.8B2^T4D30/H8+\TLUS 'AB!NA!K>Y5!93<P5&&S?]75#F//62B&
M@[Y\Q43NVOG!I7]%28O<CB[NIJN%?M:1:YW>4+YN*LS@MZ8))4N8ZW@J!PM%
M<&BTON>![$ TK?DC:EWC) ?W0)],Q?,^?Y1,Q:"?YF QU4QN%>0X\?RH^<^B
MN_V@SFA3^>N'LD1@.FR,L6^A@G%S@MQ>L V6K;%IV.2JC2NK$08[8]>O8=4]
M-!8]\J$#D,V5_J\C.=3!N3@XUC:;Z4 #U)3#CZ3G31U2Y^KAFBFO!0574Z&Q
MW#+:!W/HB,JKM3QENS\N(2HH:2#\<):?'+):7$WW&3?2?^",W>O*1R4Y-6R(
MN,@?T)>AR>3^KP"?%.^@"]-"UR+\D<[(!2/Q>=']O*<@Y#5BT>V(=HF%1](\
M+M>D-(7)%RH4+KQ%W["@U T)4.=P0YL,$HR5L]/J*WW=,20"#%3$_W> 0!(%
MQ7/CF>*G463LIHS*9/;TI(SBNK.X8$3"K(RF0L2:/)83L#+]J-FQ7*+EIJNU
M964Q4EZG/G"Q!-=QE25_Q-J:7Y^26-B"O35I?0TJ<#Y]XZEE=AU,T&^M]^T+
M==+B=#:D^67^Q5FQY_K4>;&6+%;CQAU5. I=X3$T)MHD0 $&:,%FO!$%2H*]
M\;6T]ZEYOH3=:&Q<RR'Z,Q%/[B>TVP)Z&"$R%C!\E%0G\.WB0]3T_FOC&[XX
M9M&3WTVY,2_O43;G>K/4$5CET[5?VPHUIQTTV=TX2E*IL=<]2F)L=KCC'\O3
M[.CD'RW5?/^1?SBHV2FJ.<*DV?GYT1/;Y@=E_D^\FEU:Y /5FUV'_8-2FMUF
MY/T*F]TWC[SKFSV.CQZ&-#^DO.']H=F3]=&#U68OH1M.!\W>-QX1+GN;?71;
M'!E;?.\<SZ%:_)P>C:%;_!^U] /'#Y.33+FFW.-;'L?="'S^*##M1M#+EL">
M1T&O6H*&;P2/MSQY>^/IS*.GGVX\^]SR]/+1L[V69Y0*1(;6$!J%4-: 4*1"
M&'=KJ%I V/76,%V%<*/6" .%R#L!D:8*0=^A?C*#TQ.IT4D*,<];8UXJQ):U
MQKY2B&MIC>M1X*.HL(Z!?:U+4UAJ3=A42-QK33Q62+IL3:)43&9H2V953.%N
M2Q%23+W>EGI#,4VM+4U7,=VH+?V.8L:]M@PGQ<R';9EBBLO-^/\%(0G>]EO4
ML'>/>7TD+6IP6E:(.9FO>6^8.8]M1KRRN9S#1N[F!':O9SW_/PP"S+(];\<]
M<\4!Y ,]Y'E."'6GWH8)6"D"+#I7\G.F$'IG,:%V=(_$1K67ZM^@2P0_&P"?
M3T0<"#KKXH1V:$3;> W53;&S<1NPI0.W;3->PX-SA6KW- !14C1&-WI$1 "W
MY0.D1P0W+P44I'67<&%.</=4J'FRP&=.(&A'(FF8ZELZW$O"^L-\2("7(D"<
M[N:8Q$$#J$ R58,M H _O-'%4AT$++&ZY6C"AJJ]O>_Q[*:$E'NTQ$$/Y$$/
M7$!:1T , (I9 @ A5"L^L*<$/,X\$, [R(,,]BN" M_430X-R*;8, 1X%(4)
M/!6;)I%99U!2%N.GR2! )TN9Y(0Z_^3E)+[(7/(:>Q*/$?R>:"HLR_XG*MZ:
M5&  %E!*-3 AM\\:P92[MB/NUO1N.&OR.3W5 63TLNVF# +;Q7>/"3"$&E;*
MS.($>*\%LO=)->S+UCU! _!+">S+UF\]+1B 45X$P.X?0$* @"+@K4% !(Q2
M4L;#\ &M/TQK/QS 9_[H.XP:;JJ1-Q-  HQ:/ARK,LK:V)A24ZY1SG;)%!#!
MXB^^!W@ !5  $3 ^Y4< \)PD,8WF.U,N+R7 ;7"JV8LEYRPQKQ'KKF* &BT+
MUYC2.]B#(@NT;(KD=?Z?MR8 )J)*!*" '2B(0J!#&_"^@D0 %.R#9]I#,AD8
ML(TG,"%H1/] P>5X<YR,UO.J #YB@#]LTSPHO\'[PT%JC2E9</"%9D3  ZJU
MO0 4W^7$@PG4&HO(@U&^ _%KP/J/IP.64@,8@I>M26I>#9>%.4 T #"08$&#
M!Q$F5+B0(<$X)=9$+!)QS81#%#$^ =! @  H!P@0P'# D+J!#0PE,$0  #LH
M$1C$08!A'P(&  C0 V! P %"[UA*.)#@@#UY !@0$*!BYY=J#51(8$H0"@,,
M-P4TN&G 0$.O7\&&C>"! H5!93-D8)/!;-D[@WI$B(> $#Y\""2P8[=3*8U"
M[Q  *,3 0#P5^W!B&$A#P4 "C0D* '#@0!@%/ &HT&"O)0:F#!K_S(.0KN@!
M#/94* V[FG5K %LVQ):]P8*%V;([F&!@ @,!" WR<C9@3X"]0@*ZVC0@5;(*
M@9F?V[-Z0#(A"1@TJ(N'\P#HK=40*)# T;&_=P(0X%/<<^\[K0(P5%/1&X#D
M _LD$-) ?IZ\>5U="U# @E0@)"%__!F0(= 4;## :FBA!8H)H7BBA!(DG%!"
M6IX2""9Z\!$) @8..&F>S/9B  $#&(!"A0/VDRR,?':*YP 5: C*'@),4*$Q
M=NZ;"J=\!-AG+X(0>$>!]L@#( X'H61MBBFG)((L"CP@@LHI(ZCFG<DT.  "
M=@B(YPL('". L(UV$T I!$ " (%Y IML_ZH#&M@.@GP.2,< IFB0 $T5(/@,
M 3@98"!$J!B@I\0H(?4J A0HK?0:VK9 09U*48A J\G\&8D=%1BHQ\#,#M@.
M ,_R),X  DJL"L#4[$FU'NSH(: J .C)!S15H2)@G4]Q@H<@>A1CH-#ZM(H'
MBE='RHQ7"82"IX$OK6(@@DBY18B&1P\*((!N!WK')'+178C#@30Q"(&EO@7)
M'@A^<Q0 >;X$0 -".(*O@3 UB(" !?RAT28(>F*J.Q4.C><=#>C!485XJHF'
M!A7\H1.*@1"(1P&L$"" '0;3+=F@$XBXX *$WAW($!5H3 P"">Q9@",&['E'
MG@,"@PHI=@Q9I__.PE1@1X O4@7-- /VBLJ?1@&(9P$5J@ICGM0@>*>J^4PN
MN=UV >A ['38+8B\+UY^U#FE"%#!! U4F#CD>E:UAT45L)"@3D(%^,F ",C$
M!\6"D8N;3 '"N$XRG#0@@ 9YWA5 [WTT4X<!:N-IH($P6L+IXEJAD RTGKJ.
M%-:$ DB07))+;STA PA1S(!JN#+@"SDY'L@ DQ10;".>!\+S23GCX*J:@7X;
M" H,(N *  @"JV<T=0QH0*>!:-^V3@R><]W[@C09>D7=CV\ >+H.,.GXW)\W
MX=""(,"@D(&XWRD.3;J2SRK=(7@2SL"J40^!8 !-WS/@0.I1IVHT;R![#"1@
MS^BUK?6%;R>_@<+ZLE>(.L&I*YK@G@&B1XB-F6]%=2H$ ?&TD<0!8'D(*$3%
M1+*3;6W+ .$[0')PAX#N'= UM4J(!C2 +M;QD(A%+$CQC)A$);*P3DMTXA/#
M0C:#- ! 4(Q4@0ZDNFX-T8I=].(7P1A&,8Z1C-WZ_Q;JQD4N<Y61C6UTXQOA
M&$<Y1HEK"/%'&K>XL3GND8]]].,? ?F]TR$$B.@2P#S"  \"A(B1BW1D(R'Y
M2$E&DI*3M&0E(YE(?"22D_#H9"=A18!$.DJ4\" E/DC9R53"(Q_X ,DK'17+
M?,PHE@>H9:]F5$I5@F24O&QE*O,ARF#FDIC#-*8PD5G,9!Y3F<UDYC.764IZ
MF-*4P;3E+/-Q2UORDI6H?.4BN3G-4?YRFZ5L)3EAI<U5 G.9L?3D,*FY3E.&
M<Y[2K.<H[QE/>LJ3G^'D)B>%N4ELTG*;ZBSG 5Q)RH-.LZ#?Y&9#%5K+4$+4
MH8D\J$7325&#\C.>'9WF1_\]&E*0CE2D)26I.+,)HP(>!$'H@D)(0A(B1\Y4
MIC6-Z4UIBE.;YI2G._4I3F$:5*$&5:9#A6E1C9I4I2Z5J4UUZE.A&E6I"G6G
M4SVJ4I%*5:MNE:M=]>I7B;K5K'9UK& =ZD][JE.UII6M:*TJ3.E118.(*Y!U
MM>M=\9I7O;HN=7OUZU\!&UC!YK60@S7L81&;6,46L:6+=>QC(1M9R3:$KI.U
M[&4QFUF]WE&SG?7L9T$KQL*&EK2E->UIT]58U*Z6M:UU[4(J^UK9SI:VH.UK
M;7&;6]TN=K2[]>UO@5M7U0:7N,4U;AEC>USE+I>Y1N1L<Z$;7>FFJ[?3M>YU
ML1M]EN%FE[O=]6YRO1M>\4;WMN,U[WF-6UWTKI>]M-UN>^$;W]."5[[UM:]F
MGWM?_>Y7LNKE[W\!'%A_!#' !3;P7C40@W6D+G4(<O"#(1QA"4^8PA6V\(4Q
MG&$-;YC#'?;PAT$<8A&/F,0E-O&)49QB%:^8Q2WF,(/O&( 8! 0 .U!+ P04
M    "  QBF)0K@I'@(W( @ 9+0, %    '-I;&LM,C Q.3$R,S%?9S(N:G!G
M[+P%7%3;VCB\Z4&)04!!:5"0'IJ1;I3N4!&& 8:.01"E% FE,4"Z0;K# $%!
M!0%I"1&03NF>;S/J.9YSSWGO?;_O_?Z_^]X_&_8S:SUK/?VLM7-M3#_F"P"]
MJ*2J!.#@X@ JX!^ &3U%K.B)L@( =76 $P  "$"$<P+  TLXX!^ <QH@P)8!
MP +GS&]E6QR.'WUP00 [A  #N+OB"&#+5. >&80"\'_TSP#W#N#8GA\ L$-_
M_LI:.ED@F;1LG-!.;C9.SDSRN@),ZN8(E.-A'1#@YQ>'PP3@,!@33!B._0<
MO!2<[W(Q& !(P?W)']<H!>]G&><3\'TCQ,'[H2/AKW;@,/QN!\ZY7^T ??*3
M!R_N;[RINW[P4_EA"_87\ZLO@1^^7 !(L#:9R:L#N)A%@ Q; RS]L!2#0 !
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M1DNKG%J:%/ P4[&RUS;H&W8\'O=HRY/FE/G2UO/==AR348PO5$Y&/*/O-<8
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M>& "8)3U#K^>)@07%.?A%X;S\V,5_[7GGWBH.UFBK&[\%8_#_U]Y_-+SSSS
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M+D6QPB")?\A\VI<<$&A)K0^0(/1VY6_7K /S(IG&'V]TE/$YF%L;NP(S-/Z
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M[V=KC\<2O4U^ADNQ'U$J3K-]38X101<J1-LDG@"19^XX\/%*@,C<E( WFTF
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M]RI0+P04KM??!@!W)A*E4SAW$N628$%&*QDS<0^9<J+1LBVOR2>= PIS4$1
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M%FU[0.H7DU9):5D0K,1$2.O6.$?5?_$D)+9['E@& 26*HZF81%2@"G> 5';
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MX,+M%"T 46!Z:1ZK:E*A\*DD^\D1\SC?ZAW\(6@86L#6XK7-20\PM$1O945
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M,(#0PT.>L< -"DYF%["T9I01-M 1 TS/N&!U32J820N934<THL3/P>I& 7H
M8D>V,(8PTEIJ$VECU>74@_4MK9'J#<.A(SRRPLZY\KL>B2;;Z=( -%4'NOG&
MKIX5Y6L-QT0O'CJ^[96,B3^^6O5*<@@?%$AV8$,CGTPA8[@VWO\ ;I7.\K9X
MZ^&H53F[VY]UM][$UAUOB< .^A7"J^^09F^NTWMWOR>>+\RQ4NT*Y)Q94-R)
MV0OSCR1J3A\2E];L?#KB2LXY(N6[U:25#2VZ9\-.H'Q-/!+/+9.(;->AH($M
ML:][7 4^W#X+J-8M.<J<[O/PM-K &43$+!!V^)/W8YPR=XD<R@./ZUT6:#T[
M9I)\P%!X# ?;1+?=/SY3.W'AN;O::DA4)IAZ4HU*IR%>BN?J<X4I;BH9^FRD
M*4L]!B0B\\[(JTJHJWA>]SI'"JXAL]^E<Y"N-QRX"F484^KTJ>T5H:EFW"=@
M0HA25#:($GKAS/83!IE<10=BM=AZ+J @"16BMKD:1N.G>O)S"(*0=Z"H%:3X
M:B(,? 1Q$.+XW4(P4D86D$%<^^ZFUE2598OZ00H3$A-,S534T%$KE3ME)EU1
M&H3)O**N@V@XFMINWM?I<[JJUOVVQNMQ*/PU^]=^NPJXY'N;^FYRIQO..B>J
MW'SL_.RS*E+<>9")53J@D1)2EP-N @"$58Z_:R#<-BD8UH+K< @]<1B#W!>5
MMQMW;7RTU)]-P-.^O5?+/9M3>X_YFJMJO(4VW3[EJM!B8I3Z"YUP2Z%I,"$M
MH*2,<\W=K7:VD=*KT-Q:=YM[60C'0&_8,UT>MVLS#J64%2G!\ &W.(2=IRC
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M10PE*DK&UR(3[/ Z@9XC)Y'EN+JE3MKYB&NQ"0'ZF%.ADKVJ4D[51@ -I,1
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M0J;/)4 1D8P,3F8==<.V/<0W%1KV@.=0=4[Y6:"8C?$&!C', E.4-,/&O<'
M@XIJZ-E*AN*<TG,)*1L,89YPT\>O7#R%[W%P<<%%R$ZW G %+LJ]&'Q9P3I
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MIC"W(-5LU:II8EW0E8!,8YZF!RS)CGAQ!@35:Z34&BJM>M1>FIGY=L^HM;A
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M14+MMZ4M^YUK4S/R\DOU:=,%*OA>D%*5Z[;73:L1!RB<1=V&MD:UAJ T#]/
M8*;MRXATA-"7$T\3533^PI "G 1$9#+(Y&&><1AL#6@3[UCV+"_0)9QI;:VD
M+WC:$J@I,%9*!01M6"DD$$$&/AA1S T5!*T,CL!F#@? KG[=/;SQ[_F$W0KG
MI*F:-4W'9NV*K)SS]/?D"XYOG:(ZMI?H*1*N'<QO226%!(_0<:^I,S^4XU3!
MY9MUQZ3M7T3LNX]?V*(N1>TOC6BTYZ<I5P5UMYPD2S3\W*SC(7#<@+WRZ'%H
MW=0H849?31#2]H<>TE.HY(Y#Y7>7M59..Y:9XOYXX<]"=+CU)YAMB=:FDM!L
MA$T:-,*4EM*UB V'KUTQ.[%<O&Y>L1\P;\--"N9<\V_ZAM[H)\M.S\;,:^%,
M%]%'U1VY1GOTXTJ<XV1)W#PM4'VWRJ#;K[ I,V$ALP(@EN/OQ8?<AA_J-QZ>
M+7MBD/<7 8>"J'LD_3*Z YN$@^PU_8JOS%RTB1)"'$J4$PV@P&WPCY8Y<QK@
M3J"]*1Q''34E1U<=]L+_ +$J5**MR0E$  (91(RT\=<#GEIH$Y;!4><D%,6G
MRTY69X*7N+95$H(C %4?QTQH]SI-()2HB%*:BI\I$C+T*2,PL-@M,[\U0"$P
MB22?Z4 YQZXD;:,:<U!WCC4DFJBZMW0Y>-05*RSBQ0I5Q*P"2A4Y,I)_NKTB
MRVK]"=.N):!V;0U0[V DN*=%(=:EDH:0$Q2E.[]0&1S.'L;0'!_51=T ]AZ4
M4HTF<6%(6A>L(B(A[$^8CA_&[2,LU#7#* 8J4Z3/Q*05;2,B.I2!$>.<</XO
M(-%*@J*F8#(W%2=1JD3Z:PN'50\H?EB2AN"RH#0H:=E'OHI8HU04H(\MIR)B
M.D(>6)B(U;50EQ"\M<:8U4MT.H9I"B8@PRSUAXY8>V\AJ6TR*A[B/ 5-"I<H
MTY\+:8DA0@8PRAIYQQ+1.+I&X*)N64D-#D%*M)>26XC^D0,<LHZX>-S44]@#
MGFN84B4IPP9C #:.F8CEYX?V_P KO%1,O\QZ?DD,TYPB8C[CA^TU 4<^<M<X
M:< 4\Y,E24JZQ@1G" (SC[<+M^8)B2:)=;'CF?'"Z0ER;XI71DD)RC'[0TT&
M-V,#JU*1I5;3<2@GJ##KYG6,<*@4%$D[,I5EP0TF(@3F?O,,96%GP(0\<"$4
M/M_/ A#W><?/ A#QTC]Q/\<"$>!"++WZ?8X$(_M_# A?_]3[]8>/7,Q&66@B
M.@P(0AX0/3SR&4-,Q'QP(7AQ'J(4VK122F)ANS&4/,$X$*+ZXV&'UH=A\) 4
M(YD&(!&F1QD)1F14?U,%Q&UJ 2 80CK&!Z:1PW?\Q3AK&EH)&*CJ<<>E7EN_
M%%*5C+^I<"$B'MQJG08'4 &*CJI3DV%.$I6A;P;1O5$#8B)5M*AJHG3&" 1B
MMS"YF)(HG%0J\)BIORA4/31)R$K+B.<6FE>KEI\1&?CAG=@!F&27MP0X'I5.
MM,R6RZ,B4JW'Q@22,CY8@93I8"TXJQ0 $FN2U7*@D=,H1RZ>/74G#.1[O3?C
MT4H "0TC K1<GP&B8_U>.>:_/+/$<YSB#4I[$P AM/*FY-3Z25#<#M=<.1T"
MLO*)@#AO,T.C+B,0%,P11AS:-SS3-J4Z4@J)R43U]P!Z9D8CS.UD0K\_^*G[
M5K:MP_2J:4Z^5,^KNB"=(^'3PAB*NGN<":XJ2LQJ<6UZII3TP0 \F"1HL@P!
MR(S/D,1I<>I4OZ-,7.J HNJSK:*BD#:0I48 GPRAF(F!Q%3 .?BI:!K'VK=8
MJF-.S)3-3[8$0 "(PZD=8QP@XEIH#@E7 &)KJ>9-MB>_^Y05?H2-#D(G4::8
MT#BT$-- L2M >SM%"MEE\CTA'X5I2MM4?TF).>G0^>-5DN<<"4O-.)7L=$=R
M-A),<U",80.8,,-IF@%I Q* EJ7=)F4*00/4:*8)\4C4Y:8;]JS*QKXVEPK2
MM$NRZUP3_5$$*(Z;1 > ZXQF$@ZKBVN8R6\PM2)5I2B00HP@,PF.733/&X<=
M);A3O_9W]@360N,HHS42:8]._P""UIVZ[:H94Y4JM*2ZTJ@Y*)<+\THP_I88
M]1T;AU(2,=#XI[<\XY68V\:XM?73'T\XA+8_$R/(: JGOO,^+<<=(-[W^WBT
MC(&KJ]FGKBF^.9[396I+$O6)QDDD^A+-IVJ @#!Q])((\QCJEI_;)[DR>?<+
MK:+,=1<7L+7#Q#3@.SJN<3>]/#7L)MHMQN'U-',MGZ2.E,%1WN.74JMS9PMS
MSQA3)B5KUENN6_>/S4W3Z3,SM ;G6JO;<^P\_/(;F9FD5,OLALG>IN: $0F&
M)B'^V/W 8UGTNX[-=EA)9Z=[$2#W"HKCD#FJ]NON]PZXU"XMKZ)SV@.]2WD&
M6&/91(WU=:5;?<#9ML\J\9LU&KW/4[?E92]:'3J7.?O5*K-/EA\O/I;:9)>4
MA!(#C94(M#"O)_9?W/LX('W'$+A\VC2\Q-$HPR-6..?<H;A_N+Q!NX7-J_>X
MH[=[B6^H"RA&6)P^W-6R[4N;F>5^WSBN[[EF$4>\'K9E*%>M,K2ETZI2EWVP
M30*\N8E*@M$TA-0FY'YIM1R6V^E0)CC@FX<&Y=MUPZ*ZXWN#*DT'TT@RSR:>
M[->@;#DNP7< ]+?K0R- J?49B#EF1]RGV8N:@,%2G:_2$ 9[OW*4.73X4N$Y
M >&$(.&<RN_+9<7W"1__ /+S?\*7FY'QVV'_ %&^VH';ZT0^XN2(_P DV8TX
M4KN&3<4D9F62_,9#/5EA:2?8<\6JV]E/=B\;&Z/@>X@.I0E@ -<L#0T\:=Z@
MKCW,]OK74V3F-GJR^;(_###NP01R/9<PD(1<4DVC(M_,)F98;NJ=\PPTWNCT
MW1QC<?9'W=L87ON>![AZ8.8CU'/L87.^Y:VWN;[?W!$8YE9ZS_F Q\3@EJ2K
M-/J" N0GI.<03^N6F&G_ (3"!@TI9C[ACFU_LF^;8\Q;ALL\$@K7U(WL(I_J
M KWTR5UM;VRO86SV-_#/$1FQX=]M,J]%LK<"#'=D28>.ICD1YXAZ@]<4\;6F
M*UEK3D1'/=^?A'QP)5KW5 U+P)H-$Q( $3GKI]V"H;BX8)TW/N6H:HTAQ21M
M)42H1ZDYPURCA-\C330**0-NQT>IK<5[7/I0CU#M23$".HR]L# '&S"2*G-,
M_0D\51ON=O\ EI>E3[(=;4IIIQ( 40!%"A')0S*L:%[B\5. /ZE(V,,@/E-,
M<5Q-Y7GGFZ[9M7F-S:6'IUDN$G,3C\L\%J/_  LF'EAU:SM?%=M;U"DI+<B4
M%V+5T)XWJTB_;4BLH9>^!MP;TI44+V0WI)!VKVF$1G#$7%-Z,?>7']B7BC;5
MWE4P6W7M\^6F F 6/A2,\B28 C",EP][JAW1.FL:!@%/<LM4XPDJ3T,?(@ Y
MPSP^B:"R-Q&- LZ0$3LDHH*P%$IT($#XF$?;A1_RE:$T4.W[:TC6Z?,,3DKZ
MK:U()!$%M+226W6700MMU"C$$0PD'$# ITYK9H?1D:"P]H_:N<'+MG7W0*I+
MNTUVH5FVPK=L&YYZ64-NY+BD0+B$P,"1'&X:UXJ\8J+ELIK24>G#^50%55NN
M8-.Y1L^JS#:VU2=3M>KD+0IM:52ZWV5F*DISC*0RSTP_VR0PW@+3@(G'[#^Y
M5?D0UQWQ+:.,33\:4^Y?0!]7 3\_>W9!RM3&B\N].-7*0V4Q<),]9/[@$AU!
MVE:RR3[L7KG;=?TMT1Y9;.(_92GW+D_M \Q<CDM2<!+,!W#2XT^U<Y))NL3*
MMDQZS3A!W!W<<XF,,SMQR221Y=2N 7K&-H8P.:,2G]1+(F9M2%*2OXD@DD"$
M?$9&,<)YXG-:/<ZN"EJF6RQ;[(??*$ ?$2YM 2"(F))B$I^_"]NQKW4<VN*;
MONM-6]0H4Y OD5Z<=MZ@N*^2'PU"=:*AZJD*"3*M&,0V1'<1DK3$G&T-- ,%
M$N_,^?%8*(PN592V(I^#40!B ! Y#(0PYC)#A0I&6*,,-&)YR;BFU9P,?A))
M(R&>4,\SB5;DVBK]R &N 3]D)U*$MA)((5$YD & TZYX<MP:"HI[6O\ F'12
M'2IX%:5[C&"21& (R(_/#ZW)=I+CBHV9C-0%%*%'J>8$8[B-3" A',CK'#Z/
M,E1]S$QC2YK:$A2O0Y_<4'=H DYGWZ 1$,2]O(\QXGJH*7^62ICH4]!: %?"
M4B(\]<H^'MQ*18-#@,2% 736]F:F>AS<=D2,DI@(D$$PP^B>ZFJN-5"W36AQ
M-.A4Q4282K; @"'CJ89Y1Q*1U+02<5"OS*E2E.;MASV[1 91'ZA#VXD;?Y'>
M*AY*^H]2-(+W;8 ^_+*&'[?E:F;HHRXDMQ3XDP   ,H1/MCYPPNWY@HR7RR:
M0/+BEUA"E *A$%6>>9U'E#/SPMU2$N0\4J#,F(RAUTCK&(TR&%XLBD0E!A!(
M1E$'/7,^TZC&Z2=F4J@ 0 R R&OV.!87K A#[?:&!"(^_P!T?X8$(_OP(0P(
M1'W^Z/\ # A'@0BA'QR_/ A?_]7[]O&'MAJ<XQZ^.!" C#/4>_H#TA@0@-,^
MAC&'O.7LP(49W8D.S:]D5*2A*5PZ*"3&,/".,A*,R*BZH!QM"X+/B4P@",X^
M>$7 ZC0)]$6A@K2O^*CNJU)EI1"PN"($D"/7I[!A-S7:3@4IJ J=28=7J4H\
M@D.A4 8"/F>ASW#KYX1TO:/," I*!['1@U!3&I]0]&X9%T+*4%XMP!$#N$ /
M><(7 )A=0)<#\QF&"FMU[:L*/Z7!$J$81T2!GX8K$E6DU) JIRWP#2<DCS<R
M&E?&<X_H&9(,($C6&&+W  U<INT;\Q+?+5(TQ/CXRDP"A^GS R&O4XCY20ZO
MX5*LCUD"F':FI,54$P*@A2@8@Y9QAY$X92S1UIZ@4U# &- :VI37J504$J0I
M0"($@Q$/OCYG$==/:ZNEP*D[6U<YP+@0FU,3A7*[0HG(GX<^FH]OMQ&2/ 8[
M'HID-T::M 34FYTN2SFQ8.R(*8_TZ&/@<,3/)7R8.[>BE;=L3FELHJ"/O42W
M#-/,3C4T@*<; !<2E28HRAU.0]^'\-G:[M)# ;H0[DT&A.#7U[\O_%,;VYGV
MN)\[K?U;&OFTYM[#]GZDTGJU+33CKJ'$[\@M).UQ )R*T',1^[SQ$;EME_M$
MACW&U=%4X$@Z7=[3D:]R=V%]9;G'KVVX$L8&./F;V@C,4.":SDR6ZFIM*AZ<
MPP2!'X5*,2,_SQ %U20"5,-C=Z#-0Q#L<LDLR3IF*<ATJVNM[DE/@ 3 C[L.
M2X& -#O/4)C(")XQ3-PP3CI3X>:1N)C I.66N?C".$XF.>R0 5/_ (HG(;-)
M4TR2JN=8D5-.S3[,LALPWO.H:20#%0BL@$^0SQOMVV[CN]PVTVJPFN;IQH&1
ML<]Q^#04G=7=K8V%Q<7]U'# !\SW!H^TD+35R&P[-*D;?IDY7IU>Y#7RJ5MR
MJ%)'ZWGEICLS_I&TP/Q8[;MOL9O-O9MWKW"WJPXWL>D?_DL 24"VO\&[=A4Z
M+6,F341\M0"32N)7*K_W0VNZE;MG#MMN-ZOAF8:LB:<O-<&C* YBJW&K=O2Y
M957[]7$T*1*BIRD481F'$$_\MZ:W*"A#4;G!'IB6AY?[0<%C:WAO$';YO$>5
M[N3"8P[^**V815O89!4*%FX][A<GE#N2<E_IFW28"VLZ>H&]DDU"#WT.*=%#
MX_M*G-;VJ0Q.3:5;77ZD5S;JSKO2AR#39S_I0!Y8K'(?>;W*Y5'+#?<HN+:U
M.#8;1K;>!K?X0QH#ATS*F]H]N.&<=N!)#L\<\P_YLQ,KW'M.HD9I^RC4I+2Z
MFVY9B7 $-K+#;2(#]((2D [?OQSQ]Y>S>:XNY7O.9+G8]YJ>JMS;2".HB@BT
MU_"P- [@*)A<K\<V[RYQO=O'%?:;33+LHDY2A.H2EJ=I,^M*7J769&80/5EY
MBEU)EF80L9Q;@<B0<6M[>63B^&\E::UJ'N%.\8]$C-MMM=QO]>UC)TG M;C]
MR@3LOHM,[B>V7F3MYNB0E[>[A^+EUZC2U6DDJIEPR-P6X%R+PE:@P6IAR3GG
M&6WV3FEQF92L9''>>*^Y7-K:*[MK'E]^QSV-+!KU5TYTK5>>^7<1V9NXMN[C
M9K=UNUPU-(P./8.O8N4W8#S/=![F^3^UGN3N*L5VN33<V[QI-W!/NL3K5>M=
MV:-8MMB85Z3KSE7H2A-,MK"EEV1<"3%4"E=^_P![PV#'"WY=.Z2,D$.BB>[_
M .IM<.Y6[;/:SVWW>"*\/'8_2D ^5[FZ:=OFZG)=R97CBR6 =E";=,"-TS,3
MSNXB/ZPM\M].HABI77]PGN_N!,<O.;YCSFV)L3#\&M;6JLD'M3[=V4QFCX=;
MN<T8F1SC@,L2ZBQS,CQW3$[)N1M26V*"=DRF0*DF,-'%+<&>&<'(/>[D4@-G
MO');EQ.'I^N<\JZ64^S!24VS>VVS1Z[[;MEA!& ?Z& [*.=4T^U-Z=?XE=!2
MINWT@G=ODV)IDB @I25R*!GX'/RQT;9;#^ZVV8V?:F\FUMRUM<X4ZU;* /M^
M"J.X2^PMR#'N#MCQZL#&GX%AJFC,T7C&8<+M/N9ZF.+B4N?,%Y+:B?ABNH2O
MS(RRR=!&+]!SO^Z&SB^GY-[='=["E'-N-N#W4Z^:,5QZU[ JE)Q+V1O)?4V'
MFOT-V,08KT,;4Y>5QIA]R\,R=7DU$6YR7(3R49HE9RJ*0?%(2B:=JC/Q:02A
M!]F(6]Y3[>;A&;;W)_MPN=M)K6>QCGA->TM(P[SU4E:<;Y=:.$G#?>2WO7?^
M3=21/![!K!Q\*U"WW+[O"@[1<U)8FY+=M,_*A,N%*(3 HG&%OTU9B<@Z9:/C
MB(;[/>S?N(RGM?[ARV'(*&EEN(]*O^4.>!JH:-U XYJ2=[A>Y/#I&.YWP5MS
MLU0#=6#O5PR+B&DTPQ(Z)VREWTRM2I7(3)^8"1ZLD\@-SDONR!<:*C%!Z+3N
M0KH<>?/<#VYY;[<[@-KY1M,L+S_+F:T^A*.UDF+7#LH5VKA7,..\VLQ?;#NC
M)H&FCF5'J1GHU[<P?@MN20I9#SQ24)()))U/GYPQ0XPZK@1BNBO9%'$UK7 D
M@X)J7W=*J7(O%A4"&UA)A$13I C&QJWYC0*/CM)'R5+'#!<PN5YVMWE7&J8E
MEPLS#BGYER!VI:2HD@J@0D*5#+KAM)=%E:G!6ZPVL4C)&.!5#.YN552:3)CT
MTH=E%I<$"8195M@/8E1PKL\VN20$4::T/;X)UNUNV*&5V&M2YPU==0F;/I2F
M7'%%QIL"*>H3 F/6$<,]R.F:E:* M,(R'?-579XEI%3G'S.S$5)0I*22%?$M
M2LMAZZX;P/:21JKBG+G,##4@*X]*E"VV L) (Z#.!\>G7$NW!HQPHHTSR-!
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M85)'>-RF=T%@Z)3GG[!'#0M,A+&8N)H/%+RC4&FM ,TUZ@]Z:G')<^HTZH+
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MEX:J-M\+6)>CDNI?[7?W[0\YM^-E%;HDXZVH*A^E;M* S(UQ.[=MKH\'TJ5
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M:\#K:R8[M;;L<))6C_.X:LZ!(36?N!R$M9?[I!L^VNSC@'J7+AV.E>#'&?\
M2'43CHE%I5-(=;EDN3BE%2Y^8_ZB;=5HMPO.?\O<.B D8J>_>Y?+^4CZ"]W$
MP;$T>6VMVMM[<$94BB# 1V%^IQ'S$FI,SM? ^,\?D?>VMDV?<W#&XE)EG)ZU
MF>2ZE<:-(9V- P3X1,)24E.8C^HDDDGQS,<4QH#0X,P!.-,*^*F:X%H.!2@U
M/A7P*A$1.L0=1'VX=P&H=@$B^-E0:$GO)/ZUINSI8F/U!7J".>@'Z8>!QI)(
M]KR [!*-B<X!P"T7YQI*_B@(C7<K4=-=3'+&GK2_Q_J6^6"3G*EZ"28Q4K*
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MUC?.*R#]2F&C4AH););]J@/PSZ8D6Q1M(!;BHBXN]-&M.>"=[R):58.Y*1M
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MD!1MK&37JT)'^H[BPZA?2? D?M59;OXUX,]$M(X'XMIR @I#ELR-QV=,)20
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MFKNI,D5DB+5S=UBSE ZJ[K!F<2D%_:&FG;(Q\3^Y0\^UW[=6K>Y7? ?O4_\
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MF76L)^&'6'@=,^ICA_%*6@- P4--$"X.+DWMZ5*&X+*C$@1)U'3+08F8'5#
MH&\;IU %;+"7/5!2DA( CF<SG'\\6& UHWM58NGT+NJD*@-%3Z6TC4[BI7Z<
MP!Y@8FXF^F 1G15V[<W2*FAHK$VG++W)"MH4DI AK_3T\<6"S <P-[2JI<R'
M52F"M/9\IZGI @9 *B#U5".7AB9@;IICDJW=2$EP[U:"TJ:7ELAM"E*(0D)
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M_]3[]_N^[Q)\,"$.NGO^QP(0AXP^WY8$($1U AEK^.!"B6Y6_EII]D ZE:?
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MSS(5^[4?:0E1_P#<Y+=N,(*B7XY',XK[6W=M,V)S75\/\$_N!#)&X>HW4?\
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M]!;*/+"#;+DL,I>;MKCW)\^7A%Q$&/MVM=WM)/QH>JB6U[-^IEQA=],JW/\
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M_P!N!"'00_+[0P(0R'NRZP\?=@0B.0,,B(](>?AY8$*-*\LN51T9'8O9$G,
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ME5>^319#_P!PF+6FZ:W(VYZ3+RII50E'YE,XZJ7:94M+X;7*-J&?J:XXUO\
M[C;!QW=7Q;I"^2< O?$QI)<U@U.<#@*-ZU(RH51G[-N4FVQOFW9D<DA#8R_
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MHI"5(2L0 T^!64<LCD-,77;8::03BN<[G,TN(U_XJ[W;=Q OEZ_VI:HRZG+
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M-K]/TWG@'% $%D$$9#'#>,MW$'U/Z?.) ,:QNQH.]M,5ZRWG>>(7]JV9W(;
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MA*CM*JN/A4$]!@M[7<'0Q6[[28PLQ +'8'[*IA?WNTV]XZ=E_;ETC<:2,/\
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MM2BBJ%YM*2X@A(@-H$5$90ZPA[\%!V+00LC.H.Q\4<O4B%*W I&0.402?&(
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ML+E'Z9?=>J6FN.N0I*K4VQS5%?\ V#-52LS5.E77E ":I=2<14)12(%J"E"
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MNK9+[?F!Z>Z.>+&Z]OC$R6.:K3W#]RI?$?9WVZW6"Z?N/'CZD3P-(DFU/!J
M0 \8"G15?L?ZC/<^Y7*Y<-]\[\SOV*W;=2M]RGVU=;:)FAW3-4>8;H%VTK]Q
MDD3$Z]+U=IMV8EW7%L*:4XE*,TPCKW>KV&VG#)R)Q&XU ;Y33 XBF?:IG?\
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M%"5EXRB!"NQ]/KM^Y!X:HO='R%RO1FK5Y"[KN\7FKN1J-E-52FUE=D6G6_\
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MED @9;RW$>&D.F+1/;A]@3UJ?U+FC[GT]T;0X$@?>J^U&5,I.-SC>X*0J!@
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M#PWDT>U\HLMN$ ^FG:0\@FCB!A]X62\FI"W:BPU+S7J4I,HNF34Z-J)%3DX
MY+J6 O>V\ZE?]S?D7!$:XH?T;K_;81"2)HG%]!C4YT_Q7I6+<(I8G-(_,=0M
M;6A\OF_8M?GUF>G...#K^8DVTREZ6O5+8JE2VMJF:G<O$$Y*6=-3+L\-I<7/
MVW,4M2TJB6WV2L9+Q?\ D_I7VR;%-<6])C%0N&8+:847GOB-['L_,^<;$Z:C
MX[J.5K.C&3M+Z4[-5<<U$]A7LNI56E6K/L+F'IA]<E*O-$*W>NE+;84V2"VI
M*X'<<B1''+KFR;;ODO+=GY(&(\%WR7D<&W;>^6[FTQM87=IP%<5<JW^.:7:7
M--C\>U2OS$G-5]$L[/SC3[LU.R:9ZFSM1$U(RK2&GIF2GFY4,EHK(]90@0G'
M,^1;G<;\Y]C%(Z&R9\T@!>VK<0T@>&17DGFWNK-RC:-Y$,;W6GJ:&M)&-'4J
M"?+2G;C1/F[:_6J1PYQ],V]<E6DZ+4+YJDM=S%4J2V6Y>XT3"&5,KG9AY;SC
M-58ET1#FU'K !)@#BG6&V/\ I7RS6[G3N<Y\CFQEH Z=*8C$?8N0V+["7<)H
MKL0B[]-NAH?5QQ%:"O05*V>RZ[:?2J\[)J=4M2+BK$A4U.%):-0$Z^ZX0L$-
MIV;]J(0W%)(RACTALS@_;]K<&NH(&D$TQ%<L#@4_VZ*8,O[*@'YKB!C7+].J
M^BBRJPU6+1VMN12)=)23#X040!\SGCHC6:MOT!O35_@N5[PV6UW2-SCYM="/
MV_>F)4I-$PAQ,1O;7 P@3YF$>IQ48F:I9.E2?UJQS3.T-/0@)%::>3*S,NEM
MQ4$J5\*"J&U,<]H,-,/K<@3,J5'7()@DH/TJFU_D]HVS+/"OW?:M <?"&$IK
MEQ46DK]29=0T/[=0G9=9V[XF ) !..E;##)-<63&Q%S"[' KC?)IXH(KY\DS
M6T:<R*_K7;:W.YWM_MVUJ!1J3?#EV-4BB4R1"N.K0OCDF7C*R3+9 F["MJXY
M-(*T'XBX$CJ1COL3=$4;:4H O+]S)ZMQ/)7-Y/WI1XT[LN,.5^2U<4VS)W>S
M<8M6NW@ERMT:3I4M^TV[5;<H]03.2*ZLY<M&G%3=TRI81/T^43,(#OIJ4II:
M0HD5P=X@^N[RW:_:M8/('*/;3</<3?M*[7>:.\KGJ]..+JX]XIMFT>#^,.[?
ME7@*HO4JV+GFW9NO7?2*!9TI-2].DR?W1278NRY&XB%)U6^MYR#Q/>/=-1^6
MNWZA5:3HG>O:':[VD4VC\BT2RT7=3*[VT6UW%UBJ\QW?6S7J?9R*'9%016')
MYF2>"UUJ5I*)5<Q*3,VL0GS*_7=H]PVQ<]ZV5V9<Y5BU.,^R"J][_--3N2Y[
M%L2:XLM:BS?.EMS?'U0HEP3 K-R794K]X/?I]+>I;,S)3\A/HJ6]J6:(<$)7
MGOK:3M!M;F07EV>W+8'*W%]W]K5'I?'E[]P/"U!MVX;/[O+2NN\^++VK')KL
M\[2+=?DJ59-09J]"DI.N5EB=#+<HS.(6XZR(3[[#?J87'WU=SMN,6M0WK*X%
MO;L M7N$IU@7-2Z:]?-L<OL]U/-7 M\RD_==-FG)>K4)EOC-+<FEMMM#J0)@
MI;6XII A+U%^K!6KB5S]R#0>S?E>M=J_"LWW26O2^Y*4Y,X9I=*O+D'M+F:I
M1;]M^JV3=]U6M4N.K;NJ[K?J-)MZO52;,I,S$HIR=1(2ZT.J$*OW'7UX$\I4
MRUK>L7LVOB].<KJ[H:3VMT[C"RN:>,*U:TU7[G[<JOW+VS>E+YAJ2+?M6IV:
M++H<RQ5'PPVJ1F&'%2_SR/2+PA;5U_6VK]1LR[;GXZ[4;KIEH<DV3WL,]DO,
MUY7_ &/,VKSGREV6VER!<=\TR\./J3.M7CQG;%2E>,J]/468G'5KK$M2%M."
M0>F9>(A,?BWZQW+<E3)*?Y0XCG[[Y>Y)X6^EPQQ-VZ6)-V3:UOUON [\*;S1
M/!B0Y=K57G#1[/J-)XX-9G5U>7<3;TFR)=E4],+62(5ONS'OSY7O[M![T.YK
MN,L1=*N#MM[D>\NT$\4TJ?L.D5RW[+[?J_/,43CN?N^<N6G<=5.XZ?+R*Y-V
MOS%2E*9-JVS+CC+1.T0JT\=_7G8Y.H]!HMF=F]]7ES?<?<]8_;%2N+K'YJXL
MK]M5.N\F=O%W=QMEWA2>7ZC_ (]:%0MAJUK,G)6LN^FA-.F&EKEUSS:4%T0H
MPI_UW^4^,K?OFG<]]KM*JG+T_P!XG>EPWQ'8=E<J6U;5$?XD[0IV@-WI/73>
ME<16Y1_D"CSMUTRBR#,M+):NFJS7J,HI\LA:P(4[U#ZY5.F:;R]R%9O9CSA<
M7 W;]QUVP\J<V<KURY['L>H6!:?<Y;''MX4V5GN+ZY,.7U.W1QM;]X5";N24
M:8^6DI6@O.?-'UV$J$+J/VI]S=*[K[1Y(Y!M:TJE;]BVCSQR_P +V3<L_4Y"
MIR?*U+X;NR9L*L\GVR:>G9+6E6[SHU4E*>'%K<>:D/7CL=0,"%:#+^/WQ_E@
M0A_(99^?CXX$(?RT_/ A?__4^_?W?;+V8$(\"$7ETC^'AK' A:-13NE)H?\
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M.06^J3&.8 'NU4/VKY29VVIFJ4YEQRH2=/9;9^3;F:BV)N6/[9-%*$ORH/\
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M=U4&UI"F2M8JUYW!+6_3Y*92V)5F0NGUZ8DS2E#*59G7Y=XK2#Z:$E0((QZ
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M@#&@#B:"I*;N!)."L,R4S$KZ2MNQT)0B)"5%P0,!ED0D'!**$-.#J9)9KBT
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M<F%I6%(65'%JV[8X[.*=DMW#YG$X&M,J@KG7(O<>#<9+6]X?[=;XZ1@ ]66
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MTT]Q36F*B4LDE<"00$Z&/_B&4 88:&VE&)I1+Q2-F=H;6M.J9\[4 \3!02\
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M/D=QAMGNM!>D'T!&TX,:/*'N)K6@ ."JFT7<6R<WAW2XBD#;9E)#72R02X$
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M *FL/6Q8DY.S'ZW/G)&GS=L55P*4=P*YR2BH'Q P(27QA<EK77(_X)?L $5
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M*)&SV$D")CB#NF EI)5BLW1]7*L%V2^TNJ<ET+ "RXI.2T'^E04##].(N:
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M]<%4>DSL6D[ZB0=AR(.X$YF&L(@PR.,I*5C6THM/YE:?A @(G/)7GUS.!($
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MC"U:XDXJTUL\KV;>,LDK<DD.+ *FWBR"%*A_]0".6,K=/06O:=6 6&9%:5P
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M7FD5@Z2SM&ZZ>0WSFF5XP\SXF:3C2E55B]N_^C56NVXBQ^/:Q>+DR5)HM_\
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M5HM)&AS1V*9;=JA0I&YP@*$!GG#V==<1ERPMT.Z*<80^C0I[H5PJ;2TE+NZ
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M5SM.?;?=Z!',TMPK4T\4UJ7?E$K(*).>E7EI^!QEN8;<>:4,B%LJ"7 4'4$
MX@[G9+F-OD:YQ\%:;7>]ON6U%PW5XHZM4FF99;S)+I$2&VT+"H&.90L 988,
MM)HR1)'@EI[B&0-<V10Y4ZTZX5Z@[E00HIW#7.!R$<.1 T4%?N303NZC[TSI
MNHNO!P[3M0DK6XO:$-I2"2HJT2D=280&-@P C&M#DFDTSGU-,N_]**0+'X?Y
M!O2WO\[E:93;>XV$PN5<Y?Y)N"G<;</-3""?5DY&_+G7+RMXU9L _P#MELL5
MZL+(VHE%*(&+'9\>W&^C]<PB"TZR2'0VG: <3\ J5?\ +=IL+GT?6=<WV($4
M(]1Y/0&F ^)^"D>3:X1M$)1+IN'N'N)'ZGYL75PAP!)O)U")!AZF]QO*\LA6
MBG7^-I=X Q:>;.;RO&MIR#MPO!_L0@_K</M3=K.:[[FYFT[<[H/S+@C]3#]A
M"4+AOF\[UH4M:=<J<E(<>2TPF;D>)[(H-(XZX?D9M'_+G/\ MM:4M3J!<%5;
MZ52NBLUI9^)R=<42HQ>X\CW2];Z'JB&TIA'&-#?C3$_$J:VGA^Q[8_ZKT#<7
M]<99CZCZ]HK@/@/BL,@V&PVT$I@ E"8  (3#:A"1" 2D: 9#%>R!5O;'\KJX
MI\TS:T1$QS"=!D/&'EA!S=;2U.624<#1292)A*4@$@@[0DY#\HCIB#N8_FQ4
M_;R_R\$_*>_L6B"OTE.@'YXA)HP&@U5BMI"'CRJ3J-48%L[OTDC6,-,_&&6(
M>ZC)8VA%:=<OBK%:R N!(PZTS4RT.JMA*2ZH!M,%*<60A,$@F!)R!R,/$^>$
MK2PNKJ^M[.SB=-=24#(V-+Y)'G)L;6BI)Z9):>]AM+:XO+B1L5I$"YTDA#8V
M-'5[N@[>@4FR5;FW&ERK4P[393="9>^(3)W-E89VM+2^V^XG1AM0F-OQ.%E.
M9]A\#]GMLX5N6SP\TV-V^^Z-V&R6G'X2US(0<6W&Z25TQQ,J'.C(K@5Y0YO[
MK[GRZRW67B&Y-V7V[MM3+G>IP0Z8Y.@VZ/ R2NH0R4.H*@@%.:1M2:J]-7.A
MMRFT<)W-J6&W)^I*1GZVXHV!DF.:4AA!S:2I7][%Y]Q?=JTX%<S1Q7UIOWNU
M WTVN:W5MFRU&,-A!C&Y\0\ID=CJ&"IG O;"[YC!"?I[K9?;F0^HYID/]2W4
MUKKOIR \1RY^DW#3A51/R';TA=EF7193B4-"H2$TAC=%1^>#15+3"U*BM;JG
M$ *625>)QX;WG?-^Y!O-UO?(]TGO-UF>[U99'%SGAQ\P(-0!B:!M %[.X]M.
MU[!8VNW;'M=O9V430&1PL$;6Z1AI ZFGF))+L2<UR,L)'./%,U<O-ECT=NNL
M2-(G.-*\Y5*RXW53-,3 $S3Z=)*(2]+2<FZE#B5*0E27H#J,>;_<+9["UW"#
M9[N]=:027A="YHS$C0' XX5'5=/GGMMVO+*6Y89(3:MF:.@]-W0_Q:AE\55"
MX7K@IUB<[\E2DJU;]YT'C>D7H)1J99<4W1Y6^)>I46KK0T2N5G9:M4Z<9=0D
MD(2XGH<>T/:/8=JY)[(7_%/7=-9B6>W?KQQHTM(\6T*\L>[EZ..>^-OO!:YE
MG.VWDI4EI:6T=TP\U6GPQ6U+W>_W.<>BLWV]2)>;NJUKE4BT)-V>E[M_]XMB
M9:MZYPW-,,!VB*J<@PV/22[O4ZD1!(CY0VCC=K[?\OL+.PNW"VAW&!CI2/RW
M4DI(RHK1P8?-JH%Z#YWR&^FXS-]-$!+<6;I+=K,2X"CJ#_2!4]5RPXQN*?N&
M@5JS'8IFVIWTIZ5FDS*)AEMT.(474*4 CY:86M.TC(G2.6/4'.-H&W;I:[E;
MX1R&K7-H016N8[NQ=,_M7]SXN<['OG"]_=ZD4MDZ.5CSFUT9;0@CO^"@SDWC
M6O(I4W?DHEZ<DJ//+I%QEJ36CTY%@ 2E5;<0E+7IRA)"LHP6F.F.T\1W=EWM
M=LR; @4%>J\'>]/MK_V7N5U=,N=<$#GL8X 5T:M36FA.0\OWI\V'>L[1J-(E
M2%M+3)O#THI5\TSN ;G-T5CU T8:@",,0_*ML;>UMV.I&<_BNL>PW,Y=EL[3
M=(W$L,=#\:_J5R>W>73RC=$R;IEJQ+6+3YI,O<%S4ZA-UE-'?J#3S=%I$NAZ
M8D:<*K5IY(0PS,3+'JA#NQ>Y$,<JN^+[?MQ;)<ZVPZ@'Z0"1V=<G=5ZDV[WI
MY)=64QL9VR7T9<(F.>0'-'S5;0FHS':5]1G%MB]O #) S;_<:]JC4W9-F+J/
M/-4HM-I\Q<#TQ2Z7/6O+3'R=;K\O/T1B9J#U5FC,LO2DFX9=GYA"]XBIOUG.
MBW;N&\<V=TNVW4<%Y<V^G4XU((;B.ZG1<KVK>?>;W0]W[&+E&Y$>W\,K))(7
M AAC#=(#:D4J35]:U\"N"W>6S5:U7;7X]X\D:W5YV\K]MZ5DK:E&)ZIUZJU)
MBNRTW,*>HJ?7F:A-IEV"MYQP$K;"U*.1(X+[4\6WG?>93LL!]7?7!D9%'&-3
MY-57 ]V.).0&)*]:?W(\NCX?['S1[Y#:6D=E/"897O:R/Z=I;0 @8@MP#1B<
M %*7/]N6A(=PMQ5:]N;K%L%,D_)-T^P;514>3.5*DW*(84Z4<?V%)OKH4Q,S
MJCZ;52FF'TI_I2! >J.,?V_W6SW#&\\YG8;;N+WN>;6WUWMZW&F@QP L::?Q
M.&)IT7S\L?[H+1W$G1\-X%N6[QS-K]7.YEAM[#EA+/YI&UKBQI/7J%,,Q1+=
MN6VZ#.3W!?+=QTFEH?\ D+IYQN*A=M]JS3,RI3JIQV4J5136YJ7F?4_IF/6(
M'CCT99>V7&;.Q9';\ W+<[>I/K[E-'M\'2KM#BZ3X_<O-NX^]?*[R^G;<>X.
MR[2]^!CVV";=;JF/D#_)$",?PX=2:IKU28XAH-,?-(J'9/:)DI<SE<#=L<@\
M]5"299.U;:1)5&HTN9<&28KF=JU=,\-''A/'-7JG@.W$'$"*?<9<.A,;FC7W
MN%"<PL-O.4\AMQ)"_P!P]T R<^6VVN CM;K:XAIS#6Y#+%1[RY>-K\/67PYR
M?<-]RS]K<Y4&Z;GXJK'#O9CVV4M$Y3[3K:K9N'?/<B3US5JB3TC5&/3+4S+)
M<6T02!D!(_\ ROPG8A#+:[XR>.3\%KM%M$W_ -R8OI3/$8Y*H/\ :WF7,)]V
MM[G8'0W=I(UIFO-WNIY6:QJ _*:QA!;@<?O54ZW]3[C6UZ@JCS-%[EYB886A
M3%5:N3MVX^EIMHH2IM*$65PE-&3#J%1+)>#B8 1.)VU][^-EADL[/=G.IB"Z
MSB!\!'$/VT7*=Z]H=\VJ?Z'=Q8L:'FDH]>5A'>]\O[%(5@_5QLNGSJ&JA8?,
M[DDK;_[G/<TT:X6@V1$+FV&^,)0RJMH&XEDHZQPLSW[LJN9+LVY"/+&XA.'P
MB4#_ /&7IAPBW&RU5P/HR8]X_-R5BZK]33A"\*4A53H'(II*]J''_P#'.'N4
M:4E6A;?D:Y;5'><5$9 /MN=8C$I8>[W$+B!S+_;K]CCC5\%K,*>/I-<X=]:G
MMJF%Q[?[W;T=:75M(>Y\D?V#4ZGAT3GX0N7M2Y"GYZ_K68X3-?N"4K-BTZ9G
M[$O3MPO2;8J_R[%UTDSU,K][<>SH32DJ:]9AAA*G8ME:$J5B2?=^TO)PQ[/Z
M4;HD >HR2RE'@[SL!.7F..0Q*9.L>:[4?4<V^:QN;HP)V#Q!TO(\!AGT7=:V
M.7;%^0H<Q</$MB2S%!HLC0J1=5L2<G;M7EI*GL(EY9<KR'Q^])SQFD-H'Q^L
MAPGPQ";W[4<5MX'WS;F^VVO_ #'1F[M<JM_,B)<!UKIRS3BWY=NLE+?Z>&]D
M;^$/$$W^Y*!4]P*;US565ON<1,6[.5*[969?+<FGD*3X]YCI<FZ([@]=W+E#
MNZ\* PP007):L23J GX2,L<5W[VZ]SX)/K.*V%GN^Q@"LUK() .TOC);*V@I
M44J%==MW_B<@%ONT]Q:;C2OIR,+#CV.-6$5ZC JM/.'<EP)V\T!V3Y$YCLU%
MXJ40+/X(Y(Y7MFK-H$2&&V>1ISN.L-VHJ$ $4Z@2,LHY H&*5=<1LKQA=R"U
M@CN0?-1TD=",QI<03WYJ5AY%=6DI@L+F0L/RC2V0D=*%H/W433X<^I5PG=-#
M<DN/;>GK%NYM2FI"].Y[M:J?*,O4W@H>E,&\^*.5:K5')<N"(=;X\DR1GZ(T
MQ&1?]D;0\Q4MZ]HQI\0%8&\>YSN\#KN*PN#0=:#[02%NU#G#ZCW*=3=IM.[U
M.WRAVL\\4R=O=M-0M2S[R?E5B"&O\*[BE\%7TU-*!$&Y2DSZHY)*L23]X:Z,
M?T"WL[BG3U0T_90_?11D?'9&2AO)KV^LZ',6[GM&.==79V J_G;YV9]MMY6K
M1*SWF]S7=NYR%/S,VBL4'F_DJ\>";9FW!-*3*OT>912+3M^ITV?EMBVU2E5F
M4G<0%'7$Q:[C>OMV_4V?HW!S;F!\1GXJ+O\ :ML9<RLM=P=<6[3Y7@EA<.]O
M0]RZ@<<_2G^G%+2\M7:%P9:_(S#Z 6*[=-]W9RE*3"5 J#C4S6+HK%->"MT8
M@$9X=MNKG0 7C+L"C?H+5IP:3XDJP-6[?.Q/M]MA%S7'Q)VT<36C)U2@T<7-
M=-H\?6W19>L7'6)&WK;ISU<KTLQ+(J-<KM3EY*3;<=]28FWVVD!3BTI.OK3'
M.1;^A!F(6U\ IPM:J<,RUYW'QC9E0XU9O^RJ/;]>NZPK97:[%UVI0[K-21:U
M6N&W*5LJ=$IMQFCS8D'IAEMN;^5=](J#:X:E[SFXE;-8QM=+&CP"E*$=-PAD
M ,H>[=#&JV(/0X( 1A[ ,X:><3UP+*,]#"$(0) RST.>F!"'30Y9: :D>! P
M(0^_*.@'4QTCH<"$#U&?7H-2.D"(Y8$(G'6V6W'75H::90MQUUU26VVT(25K
M<<6HA*$)2"23D!F<"%7Y?=IVN,T6Z[C?[BN$Y2@6'95I<E7O6)SDZS).G6CQ
MW?Z5KL2^[EFYJLM,T2SKU2VK]IJ4P6Y.HP/H.+P(4JV7?]C<BR%3JE@W=;UX
M4ZBW!6+3K$W;E6DJNQ2;HMZ9^4KMNU)4F\]\A6J1,P1,2SNQYHJ&Y(B,"$[X
M>&7^SI[\"$/'IJ2?NP(0A^.L#_ Y8$(0AIJ81\_X1P(0AGEY1^VF!"'YY1^V
MF!"__]3[]ST]OW0ZX$(C]YZ C33.(CI' A ]!'QRAGD<X'I# A G,#^7M\0(
MC A)M6K-(H4M\]6ZK3:/)^HAD3E5GY:G2OKN EMGYB;=99+KFT[4QB8&&!"%
M+K5'KLL9ZAU:FUF2#JV/G*5/RM0E0^T 763,R;KK/JMA0W(*HB(C@0E(^?\
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M(\QRP6[/SC]:$G2:3)NRLBQ- 4RARQ7-NOS;R@V)R;=V)74JK,@_$\J"&T?
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M!C7.[AFI/9_<;@7'=FNG[M=D;@]Y$4$3?6N)CC0-C%*5[7$#O2=WN\_<,\H
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M7QM>\$R$8D]:=1W=G2B\-IC!.0@,^@@-?PQ&/P<_'J4Z;FT=Z<E,4 0!';$
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M%CW3;-AVMYGWV4W%QF((C0$C_P R3]@Q\53]FW?DN\,%IQR$6MF<[F<5-/\
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M0C&=(/4K*/:(]0=1F?;#7,XQI%*5-/%"\+5L25;]H&9)_2E($3$J^$0A]V
MM%&M+NP(J!B<E$%R<U6K1ILT6B?N%]723L:MJS)<5B;2[" %1GFR*71V ?UK
MF'4[1G Z8L5AQC=+V/ZFY].RVVE3-<$L;3KI;\SSV:0:J)N-XMH2YL ?/-6F
ME@KCV$Y#'#')-!RP^1^55;^4JRFT;0<4%IXTLR?=3,U&7C$RUYW8V&IB<0L0
M"Y:2#3)T*SB1;O&P\= CX]:&YW(8&ZF:"P$_^1$:CP>^KA3 !(BTO-R =N,A
MCM/_ "68$]1ZC\\/X6T:>M5.U#H-%MFF2=&M^E2-&I,@REF4IU-EFI638;2
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M&0'@%U78]KVS:(Q9;59LABIC08NIU<XU+CXDIW;6VGWH$@O;$;H*W;=B=RQ
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M8JUJJM\X- KV*8+==<E%RTPV5>HVM+B#FG* ^!4.BM#'+%GV\R13QOPT4_\
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M:X+Q*SRY<HAN0$ 0))!.GPCV0UPVZ@]4]8\N#FFE%.ME7VN5+:4O&,4@@N$
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M R*5"E927"-?CTE-4*#G]O?=0[$$.#.M7VZEP(E+QN$F/?R]-J$]_&!D7?%
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M7%PWG.8+:S"GFG,O@W? C#X,[\A>/N7\0#5%<MO @B^M NE"RP2ZV$Y(.T:
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M=7QV3!JR+.:TDE;_M:4;(R9S[ XR89V]W4$8IBRX\R& 3AYV/;$0[(Y!1XD
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M9(,U^Z)4:#?!W"H3_SB@5)]K4%N#=A"DH"33[LO5ST)G@#1C*/%EZ?L HB1
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ML_%DJYN#4&#$V\%E"US.BXRDZJ$[W".ZV4W='X$OE/Y"!W!VDBJ80X9OIB/
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M/+O/>\[N>0_N7]_U;7/U3$]W=?VJNJNKJ^^[N1R[G %N/925EP5 R,0.8@>
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M+LM"5"-M7AN%A6Y:H[D$6@RA(YJM&"+ F6>L/>SXK5J;'KW,UZ3XW%52IH!
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MI7#_6&M]<-? C*Z\T3R$B0&T4E8E?ET\H9MS&!!E1\[Q4F).'G*<+(5.+PU
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M\R)@$57S1=C%??:O*<1C*6Z;;ZZ[WP 81,(#3N35_.A?IZ*"NUL491;A]"Y
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MNE"8]5-7++QB?\UVBXY-@X2#!02#A?B9XSYJRUG+=:54CO>O[[73=C]+?8;
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M'W99!F2]G<,+WVOC6FP]&>7(=&O?3<_E2^C.>7-83WR*6NLV* G.XO/+'R'
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M2;S4MCUR,9Y&M@,VUZT=?RTY8?=\][#3C76.J&G,Q"3=E<<SE4:\-E,);C\
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M#D0B8D?S^YPT>P%YCT1N+:]4=2D*!*P+WGS0?3,O6$2 N#@_&K8&)^?XC1
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M7J84<C[5N$0BJ/=[ EGA1O2V8X/31,6ENNE&-?""(*Q+2]6!3A11.>,["V4
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M3(SC[.H!O(\P.=UROZ<\4=V..?SF=:$FO/3M%HX0!QJ.4BARN"^,B(#X]B,
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M?G.D=K0J.TL&YYD5FO!H;L<WR>@^1"L@R3@-BCSU_R=-?@0[HFZ>]=.<C(#
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MX7KT7Z89')=6&R^[.&1F;;JS0$1%&5MM:L2S9@IZ-PN+JAS4N<FK_7=B.N>
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MV\#ID[@@R9,O#&2*IR37BLZ]&/=[9')'+;^,)X8LFIU;YUVZ+8U9-;[-KV8
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MB09/[&\NU;VY&V<Q.SW>SZ9K!2.=!CN<[.]^-1T?\YK:<Y[>%A_-L*98"#L
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MWZ'C"A@=KY1HZ1^.#0,UE#8;4).OS9X8I<PM7R!!*I6L(G:8Q]3KL.4M/7\
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M!:!'0%^4ZY40^YG!@DH:\<(:+[&=:M*#!UN_]OWC6^ :B_*YGG1[<DP%UTD
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M:9F3<PP_\QF_@6:C(F?L\7=_ TD4<[R*FU'L7DJYV6L22,504<]0"K5-:A6
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ML><8]0?)A@>$/WA^[1_R@*7^U']!;0"]+>LS -C$^:?C^?\)W=I0"W8P('Q
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M!C2W*X= 9--^Q!F^?8 X-O_E0>B3/GEUZS>1GX]:B,%\IIFE/@(N7 R1LT4
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MHAV4_()E6#!?<$HW[K/Z\YR]S,?W->E\S-%--W)8)?%).6WZN6IIT 2E]'%
M:R;-]G>OW'Y_,W)*ZRHT(2S/& M81<IWZ>J+.4HT3YYC>:1VB6Z?3'Z:TS+C
M_9+BARB1^043B,#3$B1A]>D:5])'L,$MZZ3D$AM!2BU6=&R>7/ H[D+O.FYJ
MS_)ZLY*OR;;&C0;19$-]A).>#E_5.8Z-::O<P?I"V@3%YK0P.JX?R;?><$5?
M=\+R0U1>"GIVZ-01GL0));$@C7$JSE?$V--RWA7L+&\'8P0$0CW5A36NO15%
M_0K =YEW\>>&%#4*B=E:<AN\%(?1\,U7, 2US[\CU;RA_ZX:&J<7)92'TZ1K
MU6FSG[QN)J_JHZHGLB;GFM[1^"[FHNMUQA?F[V1V82'"/#&:M*SYGCIFXYW%
M#^Q7[U9DEU#RBF]^T0=;FZ45US<W%UB++R?HC/*^/L))0T*^1?Q4U%ADEGUE
MHAM1GI7XP<,,WKLMZI>PEVQP"]R,@PXWVI95Q#A'M=>X92?<;!)N)]ALA8I\
MMZM@W?UI,#HSK[N<L3D=?$[RYR*6:WR8$,/>,S:66Y*1<\-).?4"S$XMG<[R
M&_YIWQ7*<L<75;AMV1L3G05:!719JK'+^E+KLA'6EYX>G#K"W_(2?OG@Z2GO
M\ 69U&G!%Q6Z>H).RYQ#%B^B4HR^&:CKLX4M]QGJLZ8;*'RKJAE5T%BA.Z75
M6"$P<7'98,[>1UM/P<'>K4F_7>S*O:C?(/Q2HO>59GF!_7@6+8Q@&>2<(DU<
M_G1WC=!G?^>!C([\"P\"4]CP&A:?D'2F2YH7!YX_+FX>.^O4;] OBUK7$60T
MY/GND_,++)YPY>F!VE,-MH_))<QW3=;]Q6.<T#M3#QZ$+>L//;'.%*T\<V-N
MB5YHPVKAG2VGO/YYP:7F@U6?)JFS#3\]7A_ES!%N7V40Y-QPL\X!AY<_2:75
M35!^F.]DP3C\?+9/0NZ:>*6OV\P5CGL"USXN32GN[IK$CW__#4*HA4R>B-9A
M#.]8>F4:*5KZJIHM7$RYHRKY8XCB%_M7ZQ<[[Q/.X:PG:2S4O)6D#[[$^M7<
M&KOR]>=FT/6[2:@)MK%P2MFW$=_%U(4/_$OOEG;'V9EW*QYZ_XJR>?A!UD^C
MTX']GC>6A/0CE/RTO__Z:^&7CPS[J GF@7!*4T'NS_>OEA+U+B#7AHV@,>5?
M&B8O%;P;LH1D#&_-+_29VAER1^6^1ET3Z_P-ZA21^L@H"*_:A6)HUT7+"PZ$
MD%L7D%M&AN^')[Z'NC0W[V98:L'6TIIMLU1A[I[/CV*#T2O) O=W?^HMM<!<
M[EX5*]@E%F&D(T56U?N_;>FMZ)Y&;D'WW(768O)SKO?YF>0K@-5%+!W$<YOG
MKGJ#)P_<FLT%)+DB'4/?,%KS)L-2\7TL1O%COT%<(P+0Q%==OT'QHQ>^BHG?
M@QZ<&]861J[L-60:_X1$#"[V1EA.+:UJ":;::2WMY/KFR\O_S,W[2%UZC^!=
M&@Y)Q2?P88+VD1!G;1:C/;@Z-DTYM2<C,$%,((T)3"7QJDEV'0(1,196E["H
M:E>2_0WZ(-XD65ME;/T&TFJ&S:6R:F</D]7!8VA'S04M-&E4*)U6Z+!J R^?
MZ'.KZT+?L@6F07^#+.&#8JZ^#E_>-KZ?J^ 44!=/EUWM P\CS84E+[T1;U3/
M>F_PHUD!4F(!?])GQ!CP.*VX0'_8O<?J!MOGTLXN?;:(-.A;;NQ](1G8:3;2
MAY&$UN8APXO3^ B5FH-ZLP.A'Z<J"!^WK)=M2BP\D[@6S;D_.@^H%GX8=8AK
MCL1<;!@S@Z\EJ.C270BXT]-W0*K\*5"7H^58;7O1L3K7+LS>]/0;M25IKV;S
M2_VGW $<DG7":XSJVY?K(Q6FS3Z_:R7KNS:W6OJ]PN_E"PEGRK_[_7QQ_<R
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MQF9%E[C_8+]1]F$6YN'B:B9;HL7ZZ,82K5<UE&0ZH]B^,!9_X%TR/C[*^<S
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M*PSUB$[A(N^M#G.8<<DF+JT\NLF<-+EH^67;KQ?%TC3(SQ6H"6$T*=JZZ]Q
M3 Z;9?2??6""KWU^WV<FO@5R#FPU'Z\:O%W03L0N7#%&GG.\U-1UQ^Y/6,1
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M]/*BIM'#&ZBIAYG=AV59T_[5!5Y)^]HFN(2[02%2=6E#=M^%MS#$ N+]N.#
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MT9+MMDR)+>(Q7_MCPH6::PL?C+R*?F8\%_MQ5N30.O.^T*UDS(1?2/NJQ9
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MV\%6FYEJ3!Y$?)C39.-WH#^P/0BZD(EW1U9I/?C>$VHBKLMNW2[HN$]PFU\
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M:W%*(61E.1%0X8D$58"=0PKF:K)+)$#H6,GMF -CL:JB,_&++\599%2L,M\
M<]&Z!EA;7LA7"67-,PNO;6?25-H9F++?&'5TQP6QQ$/D+]2?)72QBV^JWW=R
M1+MW5<YU.W-J@Y=O0 )'_ I?0HS)G "LNIZ#C0;'_7ZK8&/PH7P;7K=VDCZJ
M"1M=-$I(-'5Y8B']0,1A!!<L)EFJ%%L6FVLRLE'<0.7"[9.07R@L2L<LLWHV
M,.FJ4;:T#T+WW_IKI254DEVUZ1-2N_UP8Q@<]_\R!$_#PU2WW:M_3D(;[FNP
M.#G=;ADMOY?+^2[0]4G0[6B(C:)I26.[,*_;456RH1&_%R,*J?VUIRKO\-^%
MP<LJX.O6Z.B*L:8Q?N>;DZ8^S@T)K!@R<L$W8&,#BQ9\F>A#@UUYX[!9;O"<
MS_"_1RY]I<')/0$\3Z2*7(3SS>RUM [4$J8H#W<K?P:I$\L=>&1,7#5N4&W,
MR_F2Y#E*9K,6M$D[ZHHSZ/YD%,UH,L=SKS&IG'PI8=H9-:FO7:LI"J&%3KO<
M,;CN.]"G2<I0;,G+B85B9R1,=/>O7"?AKD9\  ^P>K92*<;K3-14LW: JR,6
MR) V'L2>[F5 X[T]X^D=HS+X/-6LJ#[2R;6GP:=T-"0:>LY,)Y' N]N8OCF6
M(&OINWE,LPZ^%S+?&3>+T >?3@N+8#2(+704I4/T'^DVICJW/( ^[8$0+0'\
MRSV\9FKSOF=AW4YD@NI-[H^@FX[C(9H77"NN"(Q1B;M1Q;>Q3_NAM=I!SM?L
M?"C%KTB3VD[Y*S5V(<#8^$/%ZI$C79QO[FL0'-%@IZ>,?KG@;&" C YR?.AE
MDYKRMNN09>@@7\&D$6/\SE&W'3IMYYRW[27<N?'1L<F'T2,1/&(!&GSE3[(>
ME$(E464S>D>Z3<$N%/W@ 65@-^U5O_/ O1;+-4I[.B*88%JUU-Y*4VCFS'N0
MSV5Q(5&%=E%U9 G%R]\@;)IJ9N%383/M=,';1#/$2J2AB0, 1\K\A+G-/$N!
M,[RJ,D,J60+#9V*71JMKX5_>P\Y9+V0D$;]X[LG?-"^GO0:)7!B$)^#E_)"3
M/\H7"'L16HUB:M?X^BV=G=XYWJCIV60GQKC$'3\1(3#Q"ZL]?(X]/!/4UR2T
MW56EHP+PH"=%7%Z-=A%KH!E2>HC9C?6PA4_-^!+NV-HZC,K^]#UQB0U;\;Q]
M!QGN:7Q/I:<#+L"B]Q"C4(Y/C9!QR7L,[-M**[00?* 3/#  Y3VID#>NW(P+
M.\TDH[[[5!5@D I%*\2,3^[N45._X:MH^]OQIX%AF!&\;/RAY@6W! ?Z#/:5
M$9%@*IZ"9_3.DZCV[*K''B9U%N7=2'@9>(=%T&P[66/2%NBFA%_I&]U]^C=Q
ML$;,CR,O#\7>VK9X-PRV;++RL-*1 BTML921TKFAUK_,50A-50KJT8WYBGZA
MU(@?L]8PAI6TM(J=F>(%1ID&=D\'FH;TW?W[]CCD<V^<IKV7KT?(+%MQS@0+
MEAHA_$18I6/Q2 "?X $PL58C8X[&SI.L+O(HZ>(AD52L#"E^CD.,RA50Y1MY
M!@AS]F.X6 7'Z."/](<M?50B9YP-I^JT$M9[Y]PT5@<6TF_QH8WB0R]$A6VP
MQ>WFS^LLL?N")@G)!(2Q3*D$975;]C9Z'U0/2QP#6&E_)TZEYN%2#U4.CQ0/
MS^7EZ)(3[MHV Z1$"I: 8%P(ZA""6L 'IA:F.1Z]FYQ9*,XH1XKOM?$YC%R2
M1.?,:<WHS-TTG2I;KJFL,[>I-_OM7MLS7!,*K\&/"2U],#Q8JOUN_:)%C5<P
M"GR!.$=-6=\#R-<!Z\0&2WAYU8AG6:EW3&+23N6>))I5<O,U^+7<HT06Q?JT
M9%?/NWR>AZJS)7CUB7_T=,YOQS5]3=PHPSL]^_VVP^EZMP1 ^9)Q87!QVU0]
M8V>O%:B_Q*<+#DLEP9)_WTLDGG_/$@=,;L4E+B,OSMB>?&#VY.6%"-8KDR(J
M>'+U<8&&CZ<<CS5YMNQZ'@7""CNFHY#X.1AAPG=3+NAYD+%6-9M.%-6+V_\9
M;4U+UN69O*"HJ#IDLW/]E3'0NY4:-F&5U]<* E^H[?#*?8["_AG6[QL^?'P-
M:!0: /3(C+CO-@WF<J,F8U,V72C+19YT3HPNK<690,&IS-[UX$U_?\9.B=C=
M_;^WU,JS";9^PL*]'V20C0CM6OA#XY;,"I?P*9/5QKA3D0?R7Z[23ADQU,"'
M$[]-K<V5A)'W4@R2404PTCZ*S_S2;U^8)*I&\VG)\DM:[B7)> 9;&%;FS>RD
M[:G$+==+$H[Q)<?T'[#\S?%VE$9D44/MCD.@:W$YON&-^:8BRL%7'@9DDI*
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M0KS?X "9R8(;K;_KK5$'O*9JL.A\KHZ5;MAP45%N]SH*7_4J@YPM<?@1@/9
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M^X<.D^ZBP!7T?N59<'2D")Q_VX@6*VY0"8P)D]04Q2*(!#86HT$1%)]D3GR
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M"NS79ZK3ZS[6-,2%A:4;@1";4V=HW. >N8-9$']<P0$[.',,H_MD6:C:/>/
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MPRF2(S)8)JWO'V^6\;R66Q"I/X64=,=TM/\C(*F?ZL^Z2AO2F!)7JGDN^!'
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M$*0BF85FSV- )<3')EBJRHI;V=<[7)/UOC1,&:'ZL,1<B,5NKE*-;-D,.%:
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MVZH_2/'T#CB%6ELM#3/.";=>5,%(+<3UC#>DM^8NO*^(\GG<7J:KJ[V)BI4
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M-?50TD"\9)G"_HJ/.=OS$#,>[&T?37$A>#9ZE-0VH\NJP5B^=%3@[S6XJTA
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M2;CZ\9%E<F83,_9ZB'4E_-+C77\U.)[SIC:LM!4TU/&3N+0B0-P+ROY[VY:
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MV*U+,;U\*#LP3,??U X1RD]H<%?6]G"K^\^_Y!]CC_I.=/Y3+:\7[MV!G_\
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M:J*ZG7U*V\WCP&.EVN,F<P4"M<45, 5'*:8[S#Q.[NC&Q-&:/(U=ANO4O?\
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MYX)/>IX&WD?@;?&1Q<;\4@61#HR@XZV1->_3_ C!>S772YY<,0U&XUPW:&A
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M1O(QOR52QQ65+5E7453F[3S22F_Y[$_0/DRR"C\NS>B@*[R=:))!_1Q>Z/\
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M0]90U W[7DIWLM1&;<XSQ ^,MUMK<8JC:^)I;8ED!YX=SK@R'#2*PLX5QW,
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M'[]^*W@<57$XS(;U%6+\:FJ%]L3C#:$CN)^3/8&3K=F,H/= Z?U)I%^S"#W
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MBF>5<7P9J W],<L;#[<4)X8S1/<T:W(XD.ENX^S'3[3^3;4;.9B.R9J;=O\
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MHVJLK AE(.A!&A&.DK9G,>B+;JCVOV=#1916U7E,&Y[U!(6WJF@DMIU;C>*
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MH:A \-73RP2H>!612I]E[XZ*ZN38W;?,]EZQBD4M3-068FUPYDHI=?C"VO\
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M2XQL_7D=6Q/:0[K_ %'"D, PX$7'H/\ /2,7;T:_L7P,*<5,N['N#B_'YO\
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M40'BT3!?I(PZ[CNAXJS*?T3;^?7/^/\ HYS 5^R&32EMYXJ8TTE^30.R*/\
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M9^=Y-KE)=!6J8F&FR$J".:;QJ5GH@&E2*FF6,6/)*DY&79>4A3S3++*U(%U
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M,0?-U$Z]6&:$WC4Y0MP#FHA*"8LZR'INBCXMG6X1BKU!K]8X#?$M*,2B+C*
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M#=X[\HY-3?AMBR#QZ6@2A6-><D4^ARA<O313YB$I_P!WOA6%3NB5P0HTU?\
M'LBP4::UD+U)4I9_921[:?/.O^&V@Z[FVDZ-O9<1A7]HU(W&'S=3#2<:G;%B
M2FAEM,H>,?QX-CHCKZ77Z#K8M"M99I7-'UJAY1\S@/*W]<3+VH'$PVBN)BQ[
M)\)(??']W2< ?RJMGJ#7MR@    4 % !D!^+6M98FDE]D /I&(_.@:O6&H]1
MW$%!QJ"#0@ZB-1&T04A:=\3DBP^E;;[2'$J2I"KR0KFJ&*=M#[N$2=E/(G)-
MV80R!9;#[+#S2CI)D/<P*?01@6V4A.*C56(SI')5[0<I;,<J$I4[HU'+!Q)'
M>8^6]G06M9DPE*W#:=FS,@ZVB\"IMIU#VD"AT5-:2]7S2H91\G4X'['T-:Z$
MTJ-9!*%?R_0ME59V8/VJ=@"?=#F772)?ZA7VD^P1R7;_ +XM>QI?>I-/8?FM
M>9\%D'E@T6L:-&V\O"HX#&)9-!6)@U-V)*7,P^RR/*4*[DC%1_=';"4A*0D8
M "@X#T&VK/>"M:-!\<Z*#["=:N/F[^$/NT!QQ]_P82"M53%DV:J==QJ&$4+B
MMOV$GSCKV#'9"$);2E" $I2 $@9 #\8MFS+X,W+IYPQ>0/* \M(&L>5M&.8Q
M'-,+2%B%)*<-42#NAM"1>. ;F6%$[DN)CY7FG%V/9DXQ,2TF0MUJ8FYJEQJ1
M<EE.S"4\U2M(X)=+: CG+*K@SCY-Z2KTRRAQ:I=U]TL:1!:46W$I=0HH/.2#
MSKE=7T+2YTP^K_47_,8>U#?7OALW9=.T-^[XK')9-'9C<V@=JE?=\W*1^\[+
MRP/1&E6-YYJ.Z] YK<$WG/C=')YBKCKY'0%Q/K*Q5W =OH-F'T2[2W5G!(RV
MG4!O)PB:F%ON+></.4?W4Z@-PR[]<.DN*W")&3<FGDLMC$YJ.24ZU'[M9PUQ
M*RS<JRAEL42D=:CK4=Y_&K9LW0*\)9'B5GG@?DUG_:K5L5AK%!A#J*Y=L= I
M5L*3V&L?*.Q_:GR<%]#*'U,MR,ZE#@O(.A6VM5\"G-I6_0Y5CD1/.M6P^S-O
MLNSP=:<>T"[\ND*(!0RJN*$)(2*5 I2N'SG+JB>Q6Z?]15/WC#W33U^R+U&4
M]0WX]O5');I3)^PU[7/FM![3VB^NM0%E"=P1S>\U,.*HCJA&>>N+&9T4@T:8
MNU=.^\>;_#3_ #X?H?:TUIW="@^*:)K]IS;^SD.N']@KC\4A#1K0"I)P &))
MU :XLFSQ),54/'N@%P^;L0/5U[34_C;B$.(4VL7DJ%U0.L&+0D%2CI3B6U8M
MJVIV'[2<CMSUQN,.-U& B1K:7()35 L^ O-%)_T[PH>I(A?)Y<O:+,]9JDM$
M.H+J:W5)0@C!)R6V<BA6(U$Y19\R)J4:=UW;J]RTX'V5&[YCD>!B9%=)ZQ]I
MA[ZQ.P5]AC25;H,,NJF^L<E\YKU6C_/$PX&6'G3Y#:E=@A*JN$G$G&O$XGMA
M]S"D-)OE*1FH@#>5&G?#:4LLMHP2EM"4[ *"D3%LV?+U"IA*E#R6_&'^&H$.
M<HV$B\EE11S><M;:>EBGF@J7CJ%*Q_VF:"RVXSHUCR5*NKKZBPE604H"EY02
MJB<,6+>E'Q47D\T*QI6AIJS.!!J-1!UBK4W+/_5NH.ZHK_G1_0V>?++5$_6+
MP3]D:U=6K?"T:_@F"S4U.<6-9X4YX4XGF-FC0VK\[@G5]KA^.S<JB;:+:L\T
M*UA6KJV[HF)=32U(6**2:'^F[+'9%VN<<A%::PYR34>@XXD#8EU/]51,L:":
MF&?S;[J/W5$18<[X._H%GQ3^&.27,DG]KHG]GYCD>!A_IK]90]L3."^$)4>:
M*ZQ]\<ECXR:'V&O:N+;<T=GO4S7=1^\<>ZL:6Z8<=OPVY=H0:$4((VB)JT9N
M:P>?6I.5P&ZC]U- >)!@5V&)_DO+6E-2EHM.OV?/2[H>3,2G-4^XU@T)@9/(
M36EU5#6@"@VI<,:.S99;%JM-3LRMQ3S\RM#Z@Y?*PT2[=0F\ZVEMVXW>2U5*
M $@(ARTEN//^#@HDU)T:$.A*UD5"E'2W0M-% 4H0JB4XDDDLO%YL3$N_5Y%"
M_(5:TC@36JY8JN+45A*+X45X)HDH%5(D^44S+:-$TEPWD(/."5:12[E0W=>*
MA0JO$!/,17FJU2%KR=H("F7*$@&ZL%!YPJ,% '$8C:*$5!!/^;C]#":"IU0\
M"ZLK/ #8!E"F=T(E2ZM+8UG$[!K,-MI:0EM HE(H/QW9UQ:LGI4:=(YZ!S]Z
M=O[/LA35TUCD ]<FYN6_/-)7UIYOL5'*F4\&MR>3=NI6YI4\'!7VUA-0=8ID
M=?;%G37A<JA9//1S'/6&OK&,'*)K!QT;'5_SF)D>.XXPD&]P]T<E5?WB9&UM
M/<H_?'*9RC##=>DX5=24GWD0O.OS))WPADKZX:E<HL^QIV8*%2TH\YGS@A5V
MGK'F[14USR-T1-\BK3M"SGY?P=M"G&S<TK@%USI)43SS@K7LKU?_ (5<MD@4
M>LVZ#71^$J"*\"SF=L3/R:\K4NI4[*-W GG.2[Z7;EW&H3S5DG4 ,XD+*M*0
MF7!::'FV@VJZE^^D%=0H50M)4"G,85"J9Z[13:%GVBDV/HT*2EP*EW2A-UQ5
MY:5DI=(<9NK45M!236BB6@VVB.2_+:5M0>#NNMZ=M1;<2%87D<U2F"JA=9KE
MY8'G#G%*DK 4D@@X@CT!.<[F]L%N%-Q+LAL7O*5[-GX\G(;C[8*000<C@>'_
M !$U*:-Q2:89IX:NS*.3CW@=LRJC@E:M$=]\4'?'+^4N3\O-)2:/,E*E:B4'
M ?NQ2ABQ)G0S.A4>:_AN"QB.T5'S6O/"5M%QA8%RKSKJCFA&EN)4$9J3?4-(
MH?5I-XX0^?&I@)HL]L6%-LR4RMQY12@LJ& )JJJ2D8#C%K6B9YW2$74)%UM%
M:T&=3]HZ^S>5*@&IAAO(F+#Y+S]K75I1H)6N,PZ* Y5T8S7Q&&^&[(Y-<FF=
M/:#K*W0.G-%*E']4P.'F]<3ORDV<QXNSY:^$FZ%N4;1^RVC'O&^'OE&M)5\W
MFF45H"ANM.LA6K?7%)RA'+B>4"H3A44<XBZC$56G##:BF1NXXD")?EW-5%]3
M+O-O72!D0".AETAJ-#@+V<,VI8/*EKP.>90V\<$A?-4%><RY@I)RPPS&"ZQ\
MH_)Q7)A^6M!Q4[,V8^XEI4TCG>"T9+2=)3I//(-V\4I0[1*20HK)I(4FC8+4
MS+333GA!EIT)8FTO"ATC92:7%('-3L(CD/RQ;M1A##[@TXJE8I=)*.:LW3DM
M*OK$CUA&>(R] !@""(N5.X?C[8JE6X@Q=B;9OI"J8CV'[C"TEAYMU.!0M*NL
M$'".530M"P9:=3B6@VY^RH +]T."A/7$Q:"Y":9<6IM,NI3" M3B$*0\X[<;
MHD\YP$]*[T4U4<,Y9X3##3R<G$!773'OCENM4E;LU-.%K1*E%--Z2\="IVG.
MNIRTJJ-U.%=D2:W'927+W^(;2$/@BBD.I )0H:E $5[8.==D:0C7"W"86ND,
MN+6\AII"G7'%!#:$ J4I2C0"@Q(KL$<E^1*9=E-HV_<24IT@E5* :92,;TPK
M $@>3T1KV1RF^4QF5OR')M+:U("FS.E/B44PI+-@<ZFI1H-F1B:M"TK0=4]-
MS+K[JS>4MU5XU^SJ2G7= P,!MS.N/$PE+B<E8X' E.(UBASSQXPE3J*$>22I
M-,*$BF>L98*K5(I@,_"%9JH54 J1E15X8$8BM,J#70JYT,6@^VN\'%!=X*OA
M5*??34.K=')JV)/E=9<Q8=K(:F'0T4*2X$JTS60< ->>E0!O9UHO;'+RRIZQ
MN5<]*S=_PF8?,XW,7/!V)EI1")9<J^1HM+<2&WI12@=(DW$W5)BS)[^]E82)
M6;8=#J;C>BYZ11PK1K#GEC74Q8%IMVA*-*2M*ZH"DE)J/M)K]D]WH SX?,?\
M@E\0Z/L5[#%W9"D5PVQ-LYX18*DVC8<Q9[E"IH+:H?-54H/5GU1/2ZF'G&E@
MA;:U((IK!I'*A@NR2"& ]HGT.K<*J&7;;4DNNC$8W#05VX<X".3KX7*EH*O)
M00MHUK>:<%Y)VZ^R/E/0MN8E7 A"V7WF6IL+H$N2ZLVRHY"^V@A0Q2<12+!?
M85/6BS+LEH+#,VZD.%QHOJJA9;O5Q4@-WZ=(B\1C!A4+72&VWYM]N6EFUO/O
M*"&VT"\I2E?&>0CDIR0L_DI)*MFVEM>&I:TCCKE-')II71M5S<U%0YQ. PCE
MARWFN4#BY.3*Y:R$$@(!NKFZ8!QZGD>:UE3I DF$H U0(!@& 84D$04T,6%:
MCMD6E*3K:B-$X-(/.:)HXD[B(^56RI*VN335LJ:+[#26U3&A0EQ\R3JD%U3-
M>;IFQ5;9."5TK4"D,S$C)3;#]MM3"FIZDO**+NCGK/#?U"G .;.*4@)2Y>I>
M!)&-(Y'6P^F:6V\@-(F%&:D[J-&VMJMU26T:@*&HVPA06E*TY* (Z_0!_7Z6
MOZ!_%Y05<6-K+O<FONA(J$[*5@IB:;SBPI[^SK20%X,S'BG*Y D\T]N'7'+6
MR=#,"T&QXF8II% 8)= YJC3SM>\&+7DU.RNC*4N7UD$$Z.Z<TFN*E!*DI)2E
M"G;U+J#=6E7)%"Y-]<LI14+M6U%Q)4XA2B7%J14J;T;QT022: 9YA/RB2#DY
M,R$RU18DU*TC2VUN-.FXJZDT(2@\\^-6%MHPJ*X1R:<:F+089E)T#1B:G)V5
M#B6PZM*%LMW$.A*W A!*@VV2XA-"M.!(,+-!"&W9EU##*%./.J"&VT"JE*5D
M !\#/*.2G)61Y)6>NV+84VB<T6D>><I=E44KHF_MG)1&*CA'*[E9-<I)DMMJ
M6Q93*CX/+Y%VGY9_:I6:4G! WY!/SCY@8!@B"*&.2JD<H^14[9,QSBEB8D58
MXW%H.C.WROX1%J6+:%E7VW66[99N!B??FI=)=D5H=2PIYI8*BAD***/4;4@J
MHH&L6<ANS'UO)F%HF;)F&F3*KF ]*+E'*..N2TR"I"[J5!=$FETFN,6%.HG)
M)"D*"P %((-:H5B-9RR] 9R@#YA],_BEGT\*0#Y27$]90H#OAKH)PU>R%#")
MA-1\?TB;;S(S&(W'[XL:>E[>LY=ESU/"$(N&N!6G)+B3YPIGJ/&.5EC3]F2L
MRRAN_=2K0N)3@M-2+R1B-(E%$FHO5K3,Q94_/2,QI:J(!JI#N:JYT)J4WJFI
M&VHQAVT?[7NW'F0N]==EE>)=2HWKQ"E8K!KS]:DU4U<6F^&N2<M+VBS-J2SI
M9%]Z;0^J\I^^^PXTELNJ04Z%#3CJ54*KIT1TJL0MT $4.H'4,Q7($T^^M,*0
MQ)3=HOHE9-AR8><("4-I)S-*G4D;2<(Y+<D)+DK++MBV7&C.I;OK<61H9)%*
ME#9.;AR4O,G!(CEGRQ=Y0S)88*F[+EU^):RTRA^6=&O["3@G//(&L4BD4BD
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M:S6,L2=?7 KA3*,!NB1(5/2J=KR?OCEB?$R*?MJZN92L4/ ZH#:)Z6+2Z:5
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M\*1*L(ES,3!353KBKM<[I-0@; ,U4SR@5==I7%1Q6>B*"IZ@-6J)QW^TYHE
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M%)R-013%)&"D*&HI,3<NEP$;>@KXVQ/V<IP\TAJ914M+IS71^;7[C$G-A/\
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MB2-NZ'$!)YB@4[\QNBP)?36BTHTHR"LTU'5WQRFF])-,RH/-8;OJV7G#A7>
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M'7O%894[?T+[2FU#!6!NU.1&JAW0$#KB7K6Z$E5<*?&$>"K50FB!LS53=#+
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M9"E#5?=->HA(IUPHW4&!"1%D,Z.6OD8NJO?LC ??Z,WE:5]US:O#@,!W"L'
M0LPXJ/D]E0U*3UHKPOJT:5'4AL55CQQBU)@SUISLT3];,+N[+B3=33=05AS%
M0&R$IAI!6I*!FH@=IAM ;;0@9(2$]@]&4VYHI=U6N[0<58" 84J'%0H$D 01
M_8?(Z@JETRM,1CI7_P#_ *[JPE-(S43 BRFM)-).IL%9ZL!WGT9VL[1#;5>D
M2H\$_P!3W1>A2H)K%D2IGK5DI:E0M]!5ZB3>/<(Y>S0;EI&STFEXZ1::^0V
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M0_V#5M.,)%3"13YAOA1A(J=<,MQ9DM56F4.:C!&]7]/;P_!6M9:9]J\BB9E
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M!]0#B<]$3Y:1L\\=<<L>3+<^S_;=E +64!;[;>(?12M]-/RB1^\-^1J#C@1
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M>T[LA!, $G;#3 2*G/?!$$T@F *PTU6)*04^:]%H=)6W<GXPA#:&TA" $I&
M _$R 10X@YB+5LOP99?9'B%'G)_-*/\ L.K9EE2"F#4&H)!!S&!!&1!S!CDK
MRE9M-C^Q+8NK<4@MM+<H4OHI2ZJOE@=N><<K>2SMA3)?82I=G/*JVO/0D_DE
MG9YBM>6>8,-K_I$A.*E'DN"I3DM/G(.?6,QOV5AM:7$)<0:I6 H'<?0I,3#4
MLTIUU5U*>TG4 -9,6C:+L\Y554M)/BVM0^TK:K?JR&\F$@K- *PVT&QOV_=\
MRE4@F F&VJQ(V>7J+7S6NPKX;MI[(2E*$A*0 D8 #\54E*TE*@%)4""#B"#%
MIV<J447&ZJEUG#7HU'R5;O-)X''-4 K;6EQ"BA:"%)4#0I(R(,<F[?E>4DBN
MQK6"%3.CN<^E'T4I>37RQKUUYVVO*;DY,<GYPH-5R;JB99[=^;6?/3_$,=L)
M5"%Q8<]0^".'FJQ9)U*S4GKS'7Z$YA]N6:4ZZJZE/:3J VDZHM"T')UPJ5S6
MT_5MZDC:=JCK/P282DN'XPA" VG?&?N@JH*03 37X^/CN;:UQ(V;>HZ\*(S"
M#FKCL&[,[AF    * 8 #\7<;0ZA3:P%)4*$&+1D%2;M,2TOZM?\ M5]H=XQV
MPI,-NNRSR'V%J;=;4%(6DT*5#7\9Q9-HR/+2R'+/GTH$XA%UP87KPZ+[6S''
M#(U&65LV1-6)/.2DPG(DLN4YKS>I0_W#482JD-.%)2I)H4D*!&HC$&)";$Y+
M(=\KHN#8L9]N8W>A%UU#+:G'#=0@$DF+1M!R==*C5+22=$WL'G*VJ.O9D-9*
MEPD*<500AM+2=\5O&L7H)K"4UAMJNK$FE!G78(D;-#='7Q5>!2C4GCM.[5Q_
M&IB7;F6E-."H4.M)U$;Q$Y*.2KJFEC+%"M2TZB/>-75"Q%GVA,V5-M3DJLI<
M;4*C4M-<4*&L*&$3+,ARZL(/-74SK2:I.%]B8 YR%:[BC@=HYV8,3$N])S#L
MM,(+;K*BA:3J(]QS!U@PA46+.^#S 0H^*?HE6P*\E7N/5L]"!( ). &),6O:
M7A3FB;5_=VSA3\HKSC]D>3VXX4<7 !6:"&6DLHJ<X4;QSCA&<(1#$NI:@A";
MRCD![]@B3D$2PO*HITZ]2=R?><S^.6A)(G6;N3J:EM>P[#]E6L=><.M*;4I"
MTE*DFB@=1^.T0M,<F[>>L&?2Z"3*ND)F6M11YX'G)V]4<L;!8MJ01;UE@+=2
MT%K#?Y=G/5Y;>K7F(![8;7%D3OA<J H^-9HA>\>2KK&>_P!!]NVCHT^!M*YR
MA5X[$^9Q5KW8:X4JL%,2K&C%]6<.N:HK&<(;K$K*+?7<;&RI.21M4?9$K*-R
MJ:)Q6>DLYG[AL'O_ !ZV9#2H,TT/&('C /*1MIM3WC:0(6(6(Y!\I/!'O['G
M5_W:8/\ =U+R;</Y,U\E6K57".7')O\ LJ;\/E$?W&;65*"<F7E&I&P(7FG8
MK"$F+)GO!)E"B?%K\6[LNG)7[.?; -149'$>@V=F4RDLX^KR1S1YRST1UF'7
MEO.+<6;REJ*E'C[MFP8;HSAAF\;QR$/.W1AU1?4HPD0VV8DY)<PH 8('37J&
MX;3NAAAN71<;33:=:CM)_'\XM:1\%?J@>)=JI&&"3K1]V[;2%I@U2H*22%)-
M01F",J<#')RTI?E98CUE3]%333>B<KTEBE$/)KK]BN)BU;-?LB??D7P:MJYB
MM3C9Z"QQ'?6$GX^/C.+"G?"971+-76.;O*/)/N/#T&\HYS2/)E4'F,XK_6*&
M7[*?; %82B\H""0VBF[XPAQ5]4-HAMJ)&15,*\UM/27[D_:]FN&VT-("&TW4
MCXJ=I.L_Y#.RJ9MA;2L\T*\U8R/N.XD0\TIM2D+%%()21O'Q[X6F+(M-^QK0
M8G62>8JCB-3C1Z:"->&6PQRKLMCE-8S-M6=1<PRUI1=H2XW2KC1^TFE1]H'5
M _ICMW^^+,G#)S3;OD$W'1]@Y]F?5 (4 H&H(J#N/H+F7A+L.O*R0@GKU#MA
MU:G7%N*Q4M143O)^*0G"&4TYQB8<U:S#::PTB)&45,.71@D4*U;!]YU?TAMM
M#2 V@42D?%=^T_Y';DE4>%MC$<UX#6-2^K([J;(6F%ICY/K>\&F%6--*_N\R
M26+V2'=:."]0V[HY;6%_9-I&89323G27$4'-0Z<5HW5Z0ZX!^/CXSBP)WPB5
MT"S5R7H!M+9Z/9T>ST%\HYFZVU*I.+AOK]5.7?[(NXPA-<-F<*5='"";RC#2
M(8:*E!(%5*( &_*)673+,I0.EFL[5:^H9#=_DBDI6E2%"J5 @@ZP8GY0RKZV
MCT>DV=J#EUB%IA*ELN(=;)2MM25I4,P4FH,2[C'+;DPIM9 G6475><W,-CFK
M&Y>>^IU"'F7)9YQAU)2ZRM3:TG4I)IWZCL-8LR<,G-MNUYA-UP;4*S[,QP@$
M* (Q!%0=Q]!5JO\ A,^\JM4MG1HX)P/?6 .^.B(<<PI#8K#*(LF6JHOJ&".:
MCUJ8GJ& XG_)K6D_"I<J2*NM<Y&\>4GKU;Q"Q"TQR,MK^Q[60EQ5)6;HR\-0
M)Z*^HY[L(^4*Q-"\W;,LGQ,S=1,7<@Y^3<_:'-)V@0(L&<\(E="H^,EZ)WEO
MR#U='J]!,VZ&)9]T^0VH]=,.^ 2I1)S))/$Q2'%817&&40RV20D9J( ZX8:#
M+*&QY(QWG6>W_)[9DO!W](@>*>JH?95Y2>O,=>R%IA51B./QPCDW-M<J.3;U
MF39"IAAO0+KTB*>*<&-<,,?L[XG)1V0FWY1X4<8<4V=XK@1Q%#UQ9,WX'-MK
M)\6HZ-W9=5K_ &30UXQGCZ".4+VCD='K><2GJ'./LA$' 5AQ5(;%3#"(LQF^
M^%:FQ>Z\A]_^43TL)N66UY5+R#L6,OZPX@@D$4()!&^N(A8CDK:ZK&M=AV]1
MAY09F$ZKBS@HXCHJQZH^4.R4UE[;ETU0Z$MS!3EC]4L_RUX0(L6;\*DT!1JX
MSXM>V@Z)ZT]]?01RE=J]+L^8@K(WK-!_*8:$.F@AS$PPF&4X19;=Q@KUN*[A
M@/\ *;:8T4XL@<UT!P;*^4.T=\+$'".3,TWREY-/V7-<YZ7;,NJN=VZ=$YQ%
M/X8F99R3F7Y5X4=EW%-JXH-*\".<(L.:\'FTI4?%O\P[ JO,/;AU^@BVG-+:
M3WV+K8_937VDPC 0\:P<2(EDPTG(#A#*-&TVCS4@=V/^4\H4<Z77N6D]Q]T+
M$*$<C;7-DVPR5*HQ,D,/;**/-5U*I'RB62&9IBU64^+F@&WJ9:1(JA1IYR<#
MM(ALTI0T(Q!U[HD)D34JT[KI=7ZZ<#Z!YA>DF7W,[SSAZKQIW0B'=< 5,2Z<
MHDF[[S0^T">K'_*N4'U<OZY]D+^.V%P"4J!!H0:@^^)-:.57)!;+F,TTT6SM
M#S(YBAZU!QJ8HIM:D+!"D**5 ZE)-#%@3-UU<N3@Z+R?72,1UI]GH&F%Z-AY
MSS&EJ[$F!4F$9&'<:PD5,2PBS4U>)\U![_\ *N4)YLN-ZCW4]\*A4&/D^M7P
M6TE2+BO$SJ: '+2IK3K4,(Y96;_9]M/+2FC4UXY-,K_Y0#9CCUQ+.J9<;=3T
MFU!7WCK&$-.)=;0XGHK2%#K'H%M=819TT3K;N=:S='MA.<)Z,.0V,8EQA%F)
MP<5P3V?Y5;[E9AM&M#=?WC_2%PHPJ)687+3#3[9(6RXEQ)&U*J_TCE2RFVK"
MEK49%Y:&T/X9]&ZZCJV?9ALQ84SI&%2ZCSF35/J*^XU] O*%=VS[OYQUM/9S
M_P#;"<X'1A6<-#&&!$@FC%?.43[O\JM-S2SKRJU 44#@G#VUAQ5()K"H!CD'
M--VA9TW9#Y!+=Y38-/JW,"*'8>RL6G)+LVT9J47^2=4$[T5JD]F$67,>#S;2
MZ\U?BU\%X=QIZ!>4R_%2R-KBE_NII_NA&<:H5#(AG5#";C3:=B1_E+JPVTXL
MY)0H]@ARJBI1S4HJ/$G'VP^8O0I45CDA:7]FVU*.DT;<5H7?5<PKU&/E!LT)
MF&+1;&#Z+BR/.3BD_NX<82?Z19\QX3*-.>52ZKUDX'T"<IE@S#"/-:)/[:O_
M &PC."=D'.&,Q$DB^XVG:KN&)_RJU'+DHH:W"$=6ONK#@H(>S,$P&W%(4XE"
MU-HZ:PDE":Y7E9"*PPHI4E0-"""#L(-1$P1R@Y'H>I>>:9"MI#C(YPZP"3!%
MU1&^+ F+KCLL3@H7T^L,%=U/0);[EZT7!YB$([KW^Z$08UPP/;%E)JZ5>:@]
MII_E5LN54VUL%X\3E[X?.%-D.12IH,R:"+-L]J5L]N64@*OHJ^"*WUK'.K[.
M BV;._LZ<4VFNA<\8R3YAS3Q0<.%(;,?)_/!<M.V:X001I$"NI0HH#C%LRIE
M)^99RN/*IZA-1W'NB4?+#[+P\A8KO2<^ZL A0!&1 (Z_0':#FDGII>UY0_=Y
MGNA$7<(UPSJBR3XQ0VH]A_K_ )5/.:28<5JO4'!.'NATUK#T6+*^%VBR@BJ&
MU:5S9=1CWJI\W*:3\(D=,D<^65?_ .F<%]F?5#><<F)WP*TY==:!9T:N"ML<
ML);^\M3:1S7T73ZR<1W&*4PBR']/)HJ:J:\6>KH]H] 3RM&TXOS4*/8#!)6I
M2CFI14>)-3"$P<(IC#/W19JKKZ/M5'^4S#FB8<7L2:<3@(>.!W_!A4/9F.2T
MIHY=R;4.<^JZC]6C[U5ZOF<0EUM;:A5*TJ0H;E"AB985*33S"OR2U)!VIKS3
MUB+#4RBTI/3IO-Z9 H<JWA0GKCE'+(G;+<HE-4MZ1O <U:!JV;.N'!0Q8+]R
M86R3@ZFH]=&/>FOH"MEW16=,'6M.C'%PW??"!C"!\<86?9%8:SZXE5W7&U;%
M)]OW?Y3:KE&T-^>J\>"?ZP\<85T8#:GWD,HZ3BTH'6:=V9B693+L-,)Z+2$H
M'4/GY42EQYF<2,'1HG/63BDGBFHZLX964*0M.:5!0X@U$2C_ (;9S:JU"FDJ
MIMO)H>^+1ERQ,/L^8XJGJG$=Q B7>+#[3H\A:3U#I=HA)"DA0R4 1P/H!Y3/
M4:EV!7GK+AX(%*']I0/5"$P$T3"XI"/OAHY1+KOLMJVI'^46B[?F%XX-BX.K
M$]Y[H6:GB8=P$<G9333BIE0YDN.;4?E%Y=:4UKQ^A:DH)R2>9\J[?;W+1B/N
MA(IAB"#3LCD?-Z62T"CBRHMGU58I[/='*>5T<RAX9.@H5ZR<N[V0L4^-6N+(
M?T\BUC53?BE?LY=U/0#;CVFM!:1T64I;&RO2-.VG5#285A']/F3#9BS%WI>[
MYBB.HX_Y.ZL-MK6?)23#ZR;Q.:B3VQKA\YQ8TIX)(M@BCCOC7-M59 ^J*#Z-
MK2O@T^\D=!TZ9/!>8ZC7NCDK->#VAHB>:^FFZ^GG)]XCE!+>$R2U 54$AU.V
MJ<^T5$.YUCD\]==>8)Z:;Z1]I."NT4] #S@9:<=5DVDJ/4*PHEUQ %- K+]N
MJS<6I9XJ))AL0X<8^-L:H$(/Q[XLERCBF_/3WC^G^3VH[=9#>MQ7\*<3[A#I
MJ:1D#$E+>%SK3?D@Z1SU$&O>:#KC+#Z/*.6OR[<P!BRNZH_87_[J1+.EA]E\
M9M+2OL./:(;6F9DPH8@I"AKYJDQ:<OX--/-:@HE/JJQ'9EU1)/>#S;+M< L!
M7JJYI[*UZO0!;LQ<EDL \YY6.HW$XGM-!37"$[HI0=4'$D_01$HO1.-KV*%>
M!S_R>TGM),*'DM"Z..:N_#J@ZS"\HL"6NMN32ASG3=1ZB=?6JO4!]*99$PPZ
MRK)Q"D]V'?%TH4I"NDE121L(-#WB.2LUIY%#2C53-65<,T]T<IY.BT/@9'1K
MX9I^[KA0I7X^/Z19[VGDV'*U-P)4?M)YI[Q^GU:8[(M"9\+G'%C%"3HV_53K
M_:54\*0TB'N:GC%?FK%?CX_K"*X0U$FYI&$;4\T]7]/\E=6&FUN')*2>R%DJ
MJ3FLE1XG$^V%90$J=<0TGI.*"1Q)ICPS.[&&6DLM-M)R;0$CJ'T[98T$^I0'
M-?&D&RN2AVX]<<EIHLSBV*X/HJGUT8CB2,(MB7\(85]M!'!8R[Z0ZFZ:'.I!
MXC#VQR>>JT\P?R:[Z?57G3]H'M_3ZVYWP65N)/C7^8G:$^6KLP!VF&L8;31,
M3*JFGS5QXG ;8184VMD.7D)72H:-;V6 *L@?9!2I"U(6"E:#0@Y@Z_C9#<-1
M9[E%%&I6/6/Z?Y+:SMUE+0S=5CZJ<3WW8K#APBQ)?23"IA0YK0HGUU?^E-?W
MA^ Y0L7Y9M\#G,KQ/V%X4X5H8DYA4L^P^@\YIQ*NJN/:*P%B;EKXI0I#B=>!
M%?CA%MRO@\TI0%$N\\>MY0[<>N+%=T4\$:GDJ1U](>S#C^GI( ).0%3P$6E-
MF=G%N ^+1S&A]D'/]HX[\(81B(<5<3U0M55&*TBQI;PF<22*ML>,5LO#H#MQ
MZOFMZ5N/HF4CFNBZNGGC7Q*?9#<-0R;JDJ&HU[X!"@%#(BO^26B]I9I=,FP&
MQ[5'MPZH,.*BS9;P:4;211:QI'/65]PHG@/P$TR'Y=YD^6VI/73"$@@E)'.2
M2"-XP,<D7T3$@$.8KEU%I0KY!Q0?:.J.5-G!;#BT#G,G2)WH\K5LQ'"&E:)Y
MIS+1K0KL/W5A)O)"AD0#V_IY;DWH);0)-')BJ=X;\H]?1ZX0C&&$4%?CX[HF
M5ZJ_,H]^ BR)+P.42%#QKOC'>)R3^R,.-3\T]+B:EG6M9%4'8L8I^-<(20;I
MP(-"-A&!AJ&]42RN;=V9</Z?Y&^X&67'#Y*28O$U4<R;QWDY]\*.$6>QX3.-
MI\A!TB^"<:=9H*;*_@K39T%H/"F#A#J?V\_X@J.2T[X-/Z$FB)I!1G^4'.1U
MYIZXG2'6JG' H4-H.WV1.R_@TR\SJ2HW=Z#BDCJ-(LUW2R3).:4W#Q1A^G:E
M!(*E&@2"2=PB?>5-S"W3T:W4#8@9?>89;J871"> [X6J\3"LHL.1\*FM.L59
MES7'RG,TI_9Z1WT^A:DKHIC2I%$/8\%CI=N?;#0AN&E75 ]O^1VT]=:;9'Y1
M5Y7JH_\ =3LA/](<.$6'+W&%/J'.>/-VW$Y=IJ?P7*%GZB8&HEI77S@2=Q%.
MN)9U33C;J3SFE)6GJ-8;=3,,H6DU2^TE8XD9=2JB+>E\4/@='Q:\,:9I/NBQ
M%\QYK8H+' X>[].[5?NM:!)YSG2W(_\ <>Z+D--W!6)I>J# 2MUQ#38O+<4$
MI VGXQW1(RB9*6;83FD56KSEGI'M^A-L"894CRASD'8H??E#::8'@:[80(3#
M2JIIL]G^16BO332]C?,'5GWUKPBD!M3SJ&DYK4$C=77U0TV&FT-IP2A(2.H4
M_!6JSIY%]-*E*=(GBCG4ZZ4A@7HLB>*9;P=1Q862@D^0O&G *KVQ:#J70L9W
MQW_\Q9B[DT$UZ:5)/',>S].B0D%1R J8F"7G%+.LX;AJ$);QASFI[H<Q,+PC
MD](U*IYP950P#_&O_:.OZ4VQ<<T@'-<S];^L($)A!H?\A6JZA2M@)A22I14<
MU$D\284B+)8O3*G3DTG#UE8>RO;^#(J"#D13MA"-!,/,G#1N+ X5-W^&AA4V
M6UT:3>4>;3><NPQ9G([E);+'A8\0QTKRU:.HVI112CB==W;E$Y94Y8<[+^%4
M5?= 0XDU"N=0XT%#0Y:Q^G4VO#1C7GP@HBY2'ZF%BE88EES<PAA'E'G'S4CI
M'L[Z0TTAEM#38HA"0E(W#Z3J X@I/5QU0$TZO;"1 A)J/\@FS1E0\ZB>V+D*
M1%FM:-B]K<43U# ?A+:06;0OC /(2NNU0YI[@(0:8C/.N^.1EJ)M&RI-Q5*E
MOP=Y(U+;\6O#54<[KCES8Y?E)@(3XU@^$,$#&J*F@]9-887I&6ECRD)/=^G!
M-,87SB2=9@IAR'!G#HBQI/0M%]8\8]E]EO4.O/\  /(HJ\/*SX_U@0(3_D$U
MB$IZX*(4BL-)N-H3L2/PG*)JK3#X_)N%!/V5C[TB$&/DYM4L3K]G+51,P \S
M7\ZWTP/61_+%L,":E$/TJ:7%]GO&$/2W@;SLOY*'%%O]6LWT]E;O5^G#IPN[
M<X(@B'!#B8E97PF82D_5IYSG 9#]J *"@R& _ *3>21] ?C[V*N @B$HJXD;
M_P +:S6FD)A.M*-(.*#>]T-&HBSIQ<A.RTVV:*8=0YQ /.'[2:CKBS)ANT)$
M72%-S+"7&_VDWD]]1'*22+:]*!B@W%>J3AV'].#B:Q2#"Q"TQ)L:!K$<]?.5
M[AU#\$H45QQ^80/Q]>*C!AD>,KL'X5:0M"D')22D]8I"06W'&SFA:D?NJ*82
M8^3FV-+)&16KQLBNJ=\NX:I_=55/".4<DEY)< YCZ,=RCGWXPX@M+6VK-!(/
MZ;+.%-OSD0H0PS?<J1S4X]>K[_P:QAP^80/Q\_,R.D>K\-::-#:4RFE I06.
M"T@D_O7H28Y*6I_9=KRSI-&75>#O;+CII7]E5#CD*Q=$Y(K;Z2D"^C7A3'M&
M/5%NRA:?TH&"N:OUAEVCV?IL<36*?,1!%8;1<2!KU\?PFN!\=\#\>.1^:D-C
MF\?PW*1NY.,N_G&J=:%?^X0VJHAM5(Y%6OX?9<HZLU<;'@S_ *S?-J?63'*2
MS@2ZD#FN"\CCFDPI)2HI.!22#Q'Z:'YSE\R$U-=0]OX50Q^<?CIRBD&$Y#\-
MRH;\1+.TQ0Z45W+3]Z1#1PA!QCY/+3,O/N6>M5&YQ%]L'4\WE3>I. X1.M>&
M2-[-;(_A_H?;%LRI9>TH&"\%;EC[Q^FA^B!04_"GYQ^.J^:GX>WV[]F/'S"A
M?8L5[H:.4),6?-KDYJ7FD&BV'4.#]DXCK%1UQ8TZW-L,O)Q9FV4JZEC$=1]D
M6]9W.>:(P5BD[#FD_&<*24*4A0HI)((WC],C] P@8U_#T_'S^(V@WI9*:;UJ
M9<IQNDB&S"##:HY 6CI++\'6KG2A*DD_FJT(X)-*>M%MVU+3 0W+I*W4"ZMT
M]##*[K4=6S")]LJ.GUY+]Q]W9^F1BABGS@4'^7TBF/X=0O)4G:DCM%(6-$^\
MWYCBT_NJ(A"H08Y+3"D-J2%$7E*:50ZE@''=6E?F("@014',0Y(ZVU?LJ^^%
M)*"4J%"/TS(@?H#:[>BM.;32GCBH<%\[WPTJ$&.31OEQH9Z1L^[W0?F0TZX:
M-MK61F$I)IQI$[9TQ<TA8=24#,H4 1G0FGZ9F!^@/*5NY::E?G&FU=>(]T-F
M&S')18$^I)\I IQ%:>WYI9EMB7\*?(2E65<5J^RTG6HZSDF#,SDT;C \'9U(
M;YM?M+6,5*.O&*SS1J)HE0QNE157J541:$NEYDS[2 A:5W)QI(HE*ST7DC4E
M>2@!1*QATJ#T9\K6_&2CVU"T'B"".ZL XPT8L%RY/MD'R5=N!'LB3;$VZTD&
MB7*'JS(ZL1#C?ALQ=0/$LD,,IU!*<%&GG*5B=L-2<O)R]]ZE *G8/OB8DY::
M8T\H4WT\[#RALA#(5..2].;,RSH<1O";P[% &%INK4G82/1GRI:OR33GYMX?
MQ@B":&&E192[L[+J_P!2G:*1R;<"IK0DB_HW=#O)0:I&_6D>MKBR4!+@0?(J
M37SM\6TP^^U5LDM@<X),69.3$C.KD5DE#@\77;TD]HJ.J$-Z,3MH/"Z&Y=Q"
M/76DC#AG"S>45;<?1G;C>DLR9'FI#G[B@86,H;.,2B[KK*O-<0>Q0K$J^J7>
M9F$&BFUH<!&JF,2SZ)D"99P*T@N)&I7E4W5K36(9TQ6,Z:ZY4UUW1RF8\'F)
M>?8%-&X$FFT&^GJP*8MZW6IF6:DY/):$KF5CH@J2#HD[2/+.7DXX^C2:;TLL
M^WY[2Q_"8=30D',&$X'X^.J&E4I$LO22["_.;0?X1$G:,W(FLNZ4_9S2>(-0
M1'_:V?N7=&Q>R)"2*[Z T]VZ)VU9R>24/+&CK6XA(2FHQ!.LT]&UHM:.:F$>
M:ZO^8D=T90@_'Q_Q%CN7[.ECF0B[^Z:?.3Z-N4+=RT'3J<"5]HI[H,(,<FW+
M\@4_FW5#]['YSZ-N5+5')=WSD*0>((/L)@PC..2SF$TUO0Y[4GV>CGE,U?D$
MKI]6ZGL5S8,#5')ER[/*1^<95_"0??Z.;6:TUGS2!B=&5#BG&# BQ'-':,J:
MX*44'@H'WT]'+B;Z%H\Y*D]HI#Z-&XXW^;<6C]U13[OFE'-&^POS'6U=BA -
M0#M%?1S;3.BM&:32@4N^."@"3VUBD91).:64EG/.9;/\(KZ.>4[-V::='Y5J
MG6@_^[Y[!<TEF2^NY>;_ '5&G=Z.>43&DEFG /JW*'@H??2%M&N$!';')A?]
MV?:UH="OWTCWI]'-HM:64=3G07A^R:PN7W1H-T<GZMONHU+;!ZTG[CZ.5"\E
M2=H(A<OB13(T[X,ONK$DC13"%<4]HIZ.G6N>K?&BW0A%% ["#Z.EIJ8NQ<@9
M#T<GYQZ S_\ +SA_\P&/H[R/_P M7P/_ .A@_P#_Q !D$  " 0("! 4,# L&
M! 4" @L! @,$$0 2!2$Q01,B46%Q$!0C,D!"4%)R@9&A!B S0U-@8H*2HK'!
M%20P8W!SD[*SPM$T9'2#H_!$P]+A)51UM/$'9:06->*$E%5VH*7 T_+_V@ (
M 0$ !C\"_P#Z+/C21KY3J/M..-5TX_SD_KC^WTO[9/ZXXM;3'_.3^N.)-$WD
MNI^P_HSO554,/,[C,>A.V/F&"*>.>J/*%X*/Z3\;_3P>MZ:G@&XMFF?[47ZN
M.-72(.2$)#ZXU!]>.RU53)Y<TC?:V-I]/M-I]..QU$T?D2.OV$8XFD*GH=^$
M'HDS#'':"<?G(0#Z8C'@=<T'2T$O\CK_ #XLTSTYY)XV ^DF=?21B]/40S#\
MW(K_ &']%1DGE2*-=KR,$4><X*4<;UC^/[E!](C.WF6WRL$</UM&?>Z8<'JY
MY-<A^EYL9F)9CM+&Y/G/Y?,C,C#85)!](P M6TR#O*@<,/2W']#C 6NI"GYV
MG.8>>-[$>9VZ,?BM5$[?!DY)1TQO9O5^B4S5$J0QKM>1@HZ->T\@&L[L-%HN
M+-NZYG!"],<.HGIDMY!QPE7/).V[,>*ODH.*H\D#N6XU$;"-1& O#=<Q#WJI
MX^KY,GN@^D1S8"5-Z&4_"'- 3S2@#+_F*@Y\!T975M892&4CE!&H_H@N=F&@
MT>%JY]AE_P"&C/2-<Q'(I"_+W8X6KF>9MP.I$'(B"RH.@:]^ONJ]).RKWT+<
M>%NF,ZM?C+E?D;"Q5X%'-LX2]Z9SY6V+H>ZCX3 92&4BX(-P1R@C:/T.FHJI
M1&@V#:\C>)&NUF/-LVFPN<-%'>FHMT*GCRC\^XVW^#'$&_.1F[N A?A*>_&I
MI23%SY-\3;=::KZV5\6C;@JFUWII",_.4.R5>==8[Y5_0WQ^RU+CL-,IXQ^6
MYUY(^?:VQ0==C453YF[U!JCB7Q(U[T>DL=;$G7X #HS(ZFZLI*LI&P@C6".4
M86FTL?DI6@>@5"C^*H\M>V? =&#*PNK*058'801J(_0QP<>66ND'8X]T0/OL
MW-XJ;7/(MSAYYW:260W=VVD_<!L &H"P MX#":YZ,GCT[GM>5H6][;F[1MXO
MQ@*BEDSKL93JDB;Q)%[T^IMJDC7^A;*EI*V4=ACW(-G#2_('>CWQM0U!B'FF
M<R2R,6=VVL3_ +U :@-0U?D=?=@J*5['8Z'W.5/$D&\<AVJ=:D''"1'),ONU
M.QX\9Y?E1GO7'00&N/T*-/)QI#Q8(;ZY9.3F1=KMN'.0#)4U#9Y96NQW#D51
MN51J4;@/ Z5--(8I4V,-XWJPV,IWJ=1QE-HJR,=E@OVP^%BOVR7VCMHSJ;5E
M9OT(R5$S9(HE+NQY!]I.P#>=6&J'NL8XE/%?5%%N'EMVSG>=7:A0.X-?=$=1
M YCEB;,CKM!^\'80=3 D$6.-T=7$!UQ#_P R/EC;TH>*=Q;]"'X,@;L4#7J2
M._F&R/R8M_YSR/!<=53/DEC/F8=\CCOD8:F'HL;'"5,6INUFBO=HI=ZGE&]&
M[Y>0W _0<SJ?QF>\5..1K<:2W)&-?E91OP68DEC<DZR2=I)Y?R6OP$M1'=HV
MLM1#?5+'?]]=L;;CJ[5F!BJ8'SQ2KF1ON(W,IXK*=88$']!MSJ UDXDE4_B\
M78J8?(4]ONUR-Q^6UEW>#NL9V_%:IAD)V0U!U \R2ZD;D;*VH9C^@WK6-K3U
MMX]6U8![J?G7$?SFY/"' 3->KI $>^V6+9'+SGO9/E#-WX_09/,#>*,\!!R<
M%&2,P\MLS_.Z@\'0U<?>&TB?"1-[HGG&L<C '=B*HA;-%,BNAYF%_3N(W'5^
M@J=E-I9_Q:+ES2@YF'.L8=AS@=0>$)-%RMLO-2WY/?HA_$'3)^@J&B4\6ECS
MO^MFUV/DQA2/UA\)0547;P2*XY[=LIYF6ZGF.(:B(WCFC61>AA>W2-AY_P!!
M!)U "YZ!BIJC[_,[K?:$O:-?FIE7S>$YM'NW&ISPL-_@9#QP/(DU_P"9^@BL
M<&S2)UNG+><\&;="%CYO"E+4$V3/P<WZJ7B/TY;Y^E1^@BBI?'DDG;_+7(OI
MX1O1X5I)2;NJ<!+O.>'B7/.P"O\ ._0/P>Z"GB2W.Q:0^IU\*UE$3XM3&/\
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M&P :@/T#4M:H[8&GD\I;O%Z1P@^:,#N+2W"6R"MGSWV9<YOZL41AMP4E93E
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M5&![C BO^LM=SYW)]II&3FIT'^J3]WZ#I#OB9)?,#E;U,?R5+IJ%+RTA,4A
MN;+V:._-83+TL,9AR7&/8WIL-EI]*QQPU=C8==4O8:A6YY("]K[25PDJ',DB
M*Z$;"K"X/H/4TL3K7KZ1/V92#^3&AHX[GK.7*/(J*AZEO,JWQ['HE%A^"Z9_
M/*O"G]_\O$3JS%AC(#KR$^CVFCX845WJM&Z0B"L<JDH\+#7NMF.&HGS:-2:J
M593.S2F(J.R/KRL<V0\&.==>/8I5U-1> 4]?&]1,V7*I3L:F^RZQZARZL:;T
MWIF4TXTM++)2^-'31*8J.PL&NY4.%W9FQ S=DBHR]7*VXE&/!_2<@CH]K6OR
MU*K]&,'^;]!TT1]\C=/I*1@J=H-CTC\CI?1Y3.[TKRQ+^=A'"*/G9<O0<5M$
MXL:>:1!Y%[H?HVQ411DBJT941:8H?\I@*E!TI9CT'&BZC/GGI8DI9M=S8(KP
MD],3+Z#@GD!/HQ5^R+7V;36E87!&[KF1XI$/?#<>3%55V!ZVH[687XT\? @^
M8%M>XXT-#\%HNA3T4T?MQSC\A!4; M2%)\M3;[,4D.;W59$^I?[O:>QV3+G$
MSU]&1>U^'CC(%]URFH\N#V.HB(>F6,56N4!2JZ]0S+O7;Q;7QHNCK4$LE-P4
M\?6@SQ,74-\S+VK ZL/H&CXD0=9*N)N/P,T8LL<4C"X%NWMJS8GTC(O9*Z6R
M'?P$6H>9FNWM:H_WUOX,/Z#ZE-@+\(O1)Q_M)'FZ@]N0=AU'HQ6%8\M-6%FB
M-K"Q[)';F$;Y/F86=-UPPW,C@JZD;P5.(M&S$K3Z0ZYHX2>UZZH6::$+\IZ=
MI5/D*,54A][IYG^C&QQ5R507BM)-2D<L]4K1M?QVNRL-N*^56(CD>EIG4;P7
M#Z_HV'3BB7Q:2G'HB3V\!\8LOJ!QP=]JMZO;U\N^GDIYOHR '[<:$U_\:B'H
M<,OW^T]C;6'_ .D95&;9F:G.37NLX7%/4UL\,Y5V"E3=EL;Y7^;VO)A*FC$B
MY8@];6!Q%&(2+9@LG&9B>*H3;MP>,TL];4K$I;6W&8(I-MMAK.*2BB%DIH8X
MA\T:SYS<^UFYZV3^%#^@^FJ@.V!A<\Z\9/47]'Y*ETW%'>2F/!2,!KO'>2._
M2AF'F&+\U\:.TK2IDJ-$Z>J-*#<T\4<@SE">V&2\;#D.*W2T#AJ>HT)-5QN-
MF22D+C[<:(T=PA4U<E #3$:[QLU5P^?D9%RE,*EV#3UU,+=XZEHT4>7GO;FQ
M OBPQCT(![>EEV6JPOTD?[QB"+-VY=/J,?N]O[($ )/X/E=;<J68?9C1,H[S
M2-&?_P 0E_2+X!Y1?T]70TK]HFDKMRVX%]G/R8T>!$RNKRN[LK9FX<!TX64Z
MB2@N@W"^*>AGE7K6@@$<050K,H]S$K>^<'WM_MPU8ZWBH(^$UCW]^+'KV7'&
M;T8!P/:2?XR7^'%^@^=0+N@X:/RH]=AY2YE\_P"2TQH_()':E>: ?GH!PB_2
M *?.Q5T;#W*5P/()NOJQ-15,;O%HVLK:4"+W0PUB[<F]$8W8[L>R[04TH:7V
M/4M?31O>^;1\RN].XWY(^RPC4/<B-QM[%*!=<GX.2MJ-6R1U2**W^66\XQHB
M.Q,TVFJ**2[#@U DC X%;YGS=]):RFX&%Z!]GMZ=]G_B5,/2'Q01WVS-_!D]
MOII/&T=5?PF.*9O$J86^C(IQ W+#$?2@/5T2BC,6TI&H7IBD^X8I:4),.%=:
MIFFDN[.J\">Q]ZJVLGR<6WL?5B.0K:2M<U#&VO)LB'T1?SX&KVLW-62?PH?T
M(3PVLF;A(OU;ZQ;R=:=*_D?MQ6+%$1!5.TD.53K2;LT0 &VV8Q]*XKQ/DCX*
M>2:5E7A':*?A%AG"90_!<1G5CV,J<UA&;C2B:/DO1Z3AGIYH6C<1/2SS+)(I
MS(I[(AF"E5,H.1(W:V</1*_"PZ-@T=0QZV;(JQB5H[YI#Q#+EVGBJ-IQ['C!
M3Y(3IB@C$NH!AUU'98UN;CQFWG?^0HAODTO2*OHD8^H8T:O)(Q/_ .[R>WTH
MGC4%6/\ 0?!/BM?T&^*-N6EIS_I+U='U$D@B6.O!X4J9.#/ 3 %4';/KLF[-
M8G9B2J<N8XU2"G#VS"%-A>W?L;L_.<(O-BB(%EZVAM] >VJAR5K>N"']" JT
M'9*6^?G@/;?0/'YES_DM&Z;2G,[1.**>-2J-("_"0#.U@MQPR9BRZR@1DD*2
M(9^%66.6G*:2*@3Q]@F6U&\Q 3K@"KUO3SO3C+) *2P2KDCDCD<(D8-FLNWC
M:\FHY!Q%Z"=^-(U/&EZXTI.+H,Y8*_ W )V62YU[+D8]C$#JPD.GJ4Y#9N#0
M5*ZG95LLA:Q*:LMRJZA^0T%%\)IE3S\2"3^N(-_!13L>:T-K_6]OI#_!U/\
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MT#VYCO\ V?1])'T%N$D_FQIJH\:2FBV>*K/M^?[?27^"J/X;8E'+JQ2+R4T
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MV&\K&F9B/=-)(@YPE-']Y/4.#[?@*@DT,[<;?P#[.&4>+NE7DLPUK9@RD,K
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M>7DT?.WT5S?=AX_&NOI%L1OOB=?-F6Q^L,:9@O[I24S@?JY9;ZOGB_M=/_\
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MAK2Z4JXH0N\Q0GAI3T<55^=AFY>HD^6Z45%4S$^*[9(T].=O1W)GI*B2$]\
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M@H?@T.WRVW]&S&6+8=_^]N"]3,=7>(;RMY^U0?6PT5/E@0_!^ZM;QYNV//K
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MK4013*>:1 WW^TT+HX-JC@GJ73GE=4C)\R..I?FQH^B S=<Z0I("OR7F0/\
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M6=W9W8[6=CF8GI))[IEJ9CQ8QJ&]F/:H.=CJQ+43-V277S(NY!\E1@J#Q%)
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M/J=<5%#+JE@FE6*^QE5OMP58;.V7DZ.;GQF7C"VS>/ZX)&W!(UV!]/)C1T4
M][:HJW8KV:LD[9B=I$8XJKWN(X9J*#27 $F'K@%H:<MM8K?(QY"P-MV )M"Z
M'9MI58N-<[\PVG[,>Q'V*:&T;3TT]7*ND=(<%F+FGBD#QQNS$V7BE[:MF)US
M<621K [K:ACV/IE+\+I6HF=K;H*8G-S!>3?BGJ" 9'::J/RF,A88DJ9KMU\>
MN%DVAKZFZ.#V9< \F >4<OKP1M]>S!L.?!N.ILU8-NG$-=2WZ^T3/!I.F [<
MO2,&FC7]=#GC/,V*'2=.P:&NI8:J,C9:5 ]O,3;S=U#%^[P>0@X0\JJ?2/ *
M1_ TL2^=FD?[&'<4TF[+X+_"-%'P>CO9$[21%1V.FTVHS2P-KXJU\8X2, !>
M&1[G-(!@TE5 H87RYN;:!S@[L,DT>9;$?*7G'1CL<O#1-VK;#J[T\XPLB1<)
M/4.*>@ISJX:=MA/YM.V8\@QDJ)SI;3E1KDIZ!A+.SGO9:CW*AI8]EMMN?$$^
MEE1:!'X2'1M.&71Z,-C3-V^D)N5G['?=C0>D(;9J5X4XEAE-,056RZAV.XMR
M8I-*1=J5B#_JZA1(C>9M6"!R;<0S'4-2MT/Q<(R'+,O&2Y[8J=6OGQ5Y(/Q/
M2B&K"E1D@KU_M$1\7A/=(SSD8G&754-UU"X[7))K.7H.HC&8;?6,<?6#L9?Y
ML9UMFY/]ZL<EMW/SXRQO(@)N0&-N>PPC-QC(&9KD\8;M>'F<!8H(WGE-MD42
MYWU] U<^-/\ LYE5LE-&*'1B'WHS76.,;KQ4P+R<C/CAY%XRM8#FY?/RXT!2
M)EB6.ATM6RR2&T,<,>1'8^,^O*% S&XMBFT7//'PDH9-'.=2U8'': $[)P+E
M4-F8"PUXI<JVX*J>,\JYEUKS:\'FY<#',=N-6T;<9AJQRX(]'4,3'BLP-MQ5
MM3?;BMT%(>R: KY(80=^CZO\:HB/DJCM$/U?=0P/ %*WC4\+>F-3X!KC>^61
M(Q_EQ(A^L#W%'#[Y4R?4CV^NW@NLT-7KV.H4-%*ONM+51G/354+=[+!*%=&&
M\8TC1,Z)[(_8]5/0Z9@ALDC<%_9]+017)--6Q9)7L6X%V*/CCH),NHNH[=/E
M#QK8=WM'&&,DE]2HHUM?D&$K,TU)0*##HZ*-<M1/$>*]0A/N*R[!)MR[,#A:
M9%D?WI>,S7[^>4W>1CSFV,L=2\5/JRQK[VOBH-@Q2*@U)I$+G<\9^P-G8G$2
MMKMHN%M?YMM7JV8Y+[^3%O,&'JQ")<IEA58YK:I$F34'._*ZZ[\N,TL]DC(D
MX7A,BIDUW9CR;^;$+43B:FHXNM\^SAGOQGCWY1N._&>,_-^YN?&>VKOAC.AM
M<;+?;B][/T[L#-_VM@+&3V!2Z\FW6#S'&EV55CFJ4CHXRIUD2GCCF!&**BC7
MLG6?7M4V]ZJKXS/\U;*.0#&K7JMZ-F/8K4D,$;KFEE(/%R\-#*5(YU%SRX6?
M0TBT5;&!*E-VE)5E0I1E9;-252L.Q5$=K$\8:SB;V->R2-X=,0DPQSS#@Y34
M(.QQU8[7A\ON50O$J4U[<20RC))&<C@_[W[L<_)BS;L<_P!N+VYCTXMCU886
MY\02;LX0]!QHXYLL'L@T1-027[ZNT:W7%-\XT\D_F7NH=.%\ :/;EHZ;^$O@
M&MD\>KJ&'096MZNXC"#Q*2-(OGGCOZR!YO!GLC%1'4T=17Z*T=IS16F=&OP6
MD:.L@+T=:/$JJ1HUIN'I90R/TXRIICV-Z2-K U=%/0ROSOP9R9COL+7P)].U
MFCHJ3.LC:/T07/764Y@E1.^L0$]LB]L-1Q=(U:0Y(U6)/<HP++8#M8U&K&8V
M+D>K!+GB@%CT#&B-$4MS,>&KYTVE7JNPTBL/(N]N3'6]['+3T2GQC[YYM1PM
MLO;6\V+6MQMW)@34LIA>UFMWR^*XV'[L-PT[LDG;(K$)YUV8&9+:N)J[9=UC
MCD;E&P]//@G7KVVV'S8)4F,[T.\_TP =1!W^KS8M>_/B3/JSP*!?<[=KFZ<2
M9% E32-,"-FH[?\ MBCD!!5Z*F5HB=3Q\$NH8#1F7*X]S*;#R9N3$,:*O":/
M?KP#>J/:)AZ!FQ3U$7&>BDFT=6KWR3TSE1F'YV++(AWXHM/PIP551S1TE94*
M,IFH93>EDEY7I)^*'.L*UL:*T@MC+4TK1U)W&6$Y3\X[1TX-]MKB^+\NW_?-
MC[+8\K[>H<!O]^? (W-?T8T+IE39M#Z5T;7,?%IVE%'77YNMYG)Z,*Z['4,.
MAA<=TKTX3H\ :-_PD(]"V\ 2.=B(S'YH)P6.UF+'SFY[A:1NUC5I&Z$&8_9B
M>H;;-+)(?G,3X,]B6F<IM4_A30$Y&S+64W74.;=[M2* 3XUAMPQ'$LV79WW)
MA 7&5V(A)VWW<3>+ZKXM72\#56.9VCN'UZAS:L?BP::1KE.)92>7#RU%1:RO
M)4YS;@XH^,X ^J.<XTY[*:H7#SM!0*=QMD!'-!!J'RFQHO1X.L/)62CD55R1
MWZ3BQU<E\ C;]HPQ&IK6-\<&XLVSFP*>1>,!V)\%&&5_JOT<^+'BGGV7Q:]C
MN)%_3BTA!Y+:M6$$<;.%LQL/43NOR8LPX\AS,.?O1T#$5.PO))I.,KRE57*#
MT G?C1_L6DJ-'U\%5HTUFBJFI!06A3A)J-9>V$D>:UCNUC$77142]K-$DG"K
M"_(LAUL#NQ*6[)"S<"1N:-1E=?/QL2:$K9670/LHRK35;:HXYW)ZR=MV>-SU
MO,V\%;XK=&U2!XZN"2F8MWC-VDB^0^5UYL5/L9TB.R0U4E.JOQ7I]()VJWW)
M70VE@;86U8'!F3ADOQ7V29>V0^*X]>+C=JUZM>RWFQ;DQT8ONQRX/,<'&D-&
M,;\+3U-/;D+Q$Q^A[6QH&N?W271M.)AR31H(Y5/.'4W[I7IPG0/ &CS^8R_1
M9E^[P!I!P;$4DP'E,A0>L]Q59V--EID_S#Q_J!O!LU:#D?1%=H_28D^#2FJH
MS4']@9 >;"4^B:Z;352C-,XC&6E5W%U!;9J)XQ.#4U4SRU9UYHW*)3B]U2!-
MF5>?6<-#)$G7=LDE5)=Y&3\Q'VJN=A8[,13,W%X1(N!+<3K9CERW^%';Y^75
MAH2JY](31TW"C4PIUX\C'G.J^*>"A"5$<0;A,C ,9&-V+<C$6VX-7+$W!R (
M)=J #M8[]Z1R<N+[AY]6+$W!W<^+Z^<# )4$'OQ]_)@-V\9W[UYQS8X.0V>W
M8Y1_OTC!CG7,.\D&PCE'],>,M]7*.GFP%[ZVIO\ ?JQ !V*,#/(=[,?&.UG;
MU#%IJ&::4WR9"26&X$#9B@T*DD<ND)ZZECG@A82I2&IE'!T[$:N&CB4O(NU=
M^-%U\CMFT,U6(X\ONPJ(^")S=[E OSX>4Y0502(NSA0@L0?EX:J1LT60D^,D
MC:[/S[=>)Y8T/X2T,?PE0Y?=9(8R.NHUMKN%[*O.M\4-=,QDK*:)*'2&]UDC
M4"&=AR31VXW+?'X6T0ZP^R&"-4RYN#@TQ!$<T4,[^]5D!%Z6I^8VHX:BTA$V
MBO95HY^#TAH^J3@C5-'JX>,'5PA';A=4G;K>^)H6%DE;AHO%>.3;;G1MHW8O
MN.KIP>3FW>?%^JXY<31WMK1^FQU^K&D]&W-]%:>TC" =T-2XK8+<V2H '1W2
MO2,)T> */FX=?142^ *@7L97@C'[97(^BA[BHJ,?+J7'3V./[&\&Z5T3* T=
M?05-,0?SD; >NV.":-(YJ:62CJT1<O9J=VA>_+QT.+K;EP=V(4U'LB:MVIL:
M-T<69>%C)=D-B@>14:QW$@64X-7['--ST,YL.MZALR3Y!8!R;QMTNH//CK/V
M6:$$D+=CDJJ->+)NS-$;HS;[QM?FP-+Z&FZ]T/,V7,ONU&^^"IC/&0KN)&+C
M"E3K%O\ 9P5 OJX\7WKC5QHN3>G2.;&>/7&=?0<9)O,>3'C(VQEV?_.%\4@_
M;C@B>, K93R\O],+0Z/T@V@M%TRJ]17I_:M(U$@XT4)![#2TT=S+*=K8K-/T
MSU%7H71]5)!H.6HOPFFM)KV*NTO8Z^M(&S1PR'W5M:G SK=FV+R<K-]V(*9'
M8U$S9LOB0C60W)F.!P4ST\C'=VC](Q'.3FDBE4-R21R<65"-ZNA((QI+V*,;
M4NE*1JBD3:IBF'7-.+';P69D .P;,'*+:]@V?]L1Z2HQP&G:1?Q2J0\&]0$U
M]9U#C;?WB4ZXVL-F/P=I2/@=*P)(]+,19IS3G)4*?%JJ=M53'LD6TJZCAX)A
MEEC-B-QY'7F88M_OSXV8V8;HV8!MM6^(M@$JY=>/9-0;JFBT/I8>4\<M)(?]
M!+]TKA>CN4_DXQXD\Z_7S_S> *2+QZK-YHXG^]QW%4V[6#+3K_E"S?7S>#M)
MA4RTFF8QI:FU +PC]CK(TMOCE"RM^NPT3[5]>+C?MQ3\G"IYM>-'<LL $?3#
M-=_5CA+YB'L=6N-CVI'*#O&)8YHX^%L08F :&9;:QD._G%F4XFH')_!.E4*<
M')K76;(#?WRG8Y0^UHC8[,2&EL\5R0A.M?DCFY,%3Q2-14[OZX5@V61>U-_M
MYL7N(JJW:]Y(/^^"K+D\>,[.E<<)#QDVE>3HQ:[9;]J=E\7&O^F "+O'[F^_
M)XC<MMV-)0T6;KRKIC1Q6:V3KAA'*X/>Y(BQOBDBC7+24M'34$ 5>*BTT8#.
M!NX63,Y\8ZSC- E35U)UJ-BYOEGQ1R8+S&\K\:0[<G"G4@\E0/3A-5@@U=('
M&/1R8J)ZINMJ*@!FJY'.Q(]9/2UK(-I)Q[&?9M61]:Z-T_I+K#12RZI/P?2*
M:>.6VU8F N&/;'$L;Y;!C<W/'UW1AS8R#ENO3?&E)M%Q-,NB*R/2-<8Q_9\Z
M)$^4#:DHXLPWWONQ15D8(%3#FUZCD=0X!\DZA@B^W?@G%\''1<8H9!X]L:*6
M_%TC[&:V ZN_HZJ&5>-T2/;H[I&+> )E\2L?ZT41_KX T?%XL<\A'EM&H_</
M<+2-VL:/(W0BEC]F)93MDD=STLQ/W^#DTU31YZWV.RFK(47:71\@R5T6PDA4
MM.%&LO$HP)H;ENW!'?(VL8RMJ;8<(_B,M_3C1^DHP1UI4+*&7?3S6N>B^HXB
MKX!PT4].KF,'4V9;ZN<'5B,+FA<'C"06LS"S#RAR[\"2A-ZVE;KFG52 TX [
M- OYPKKCY7 &(Q)144HM83<+(LD^34<T 4M'4+LECW-?=A.N;Z,E8VX4\>GS
M'S*Z _*&K :#+5#MK(XNRG7FC/:M?DOCK6H;@JA=4,C<4AAMBDY#S''!5&I@
M.+(-OF\8<V+AL\1UW&M6'.-V,R\1]I\7%K[-O^^3%]_^[''XLZQ5J^\E@@G'
M*E^*3RKMQP=5!)$@[9FC) Y[8S&KB;D2&-\Y^:0 O/?'#.#P9D4YMN91J!U<
MPP*>#4;<;7K'E>*-YWXTA%"DD&AZ">!*VNEU2:7TA/(%6FHHNV:GAS6:4\7-
MLV8_^GZJ@6HHI8KI\%3Q",L+; $#7/IP&UG@P%D(UV1AF1^=#N;!RD%K&QY&
MMQ2>@Z\5LLLRUVD=(UDE5I"J*629&8Y*94.R&->7:=>&9$"RTQ7M>U0;,H\V
M W_QTXOBVS'FP^*=P=22@D#;YOOQ[#91NKZJD:YM9:JDDM?I=5%MA-NZ1BW@
M"OC\6:%_I(P_D\ 9?@:6%/.2\GV..X:Y[V9XQ O3,P5A]"_@^6"90\4T;12(
MVL,C@JRGI!Q7Z"D5NM@36:'E.R;1DS$K&&V%Z1[P.+DA0C'M\9U%FYL#-JOJ
MOCK"7*5:)H;]]&S#8>;-9L56@JDVK-%.ZQ@]L]/?O>7+J/0<-64:\*(>R3 )
MQK?G+=[SX"9V5Q8M&3QE8>+OQ%[(M%N5J*619JV#*#'41[&G"G4)D[\CMUVX
M@GJ(,XJHEE[&+&-B.,!;D.$269JG04[\&D\ER^C9V[59CNII-F;O#@:2H]7:
MF9 P-_%GB8:I >486GK==N+PG?KS^;! /"PML8;QSXX0<1?&&SYPQFL,NYU.
MH]/)CGP+;=H8:B.@X$9J'E4:K2\;S7.W#2E%!(R\3BZSJO;")#+(@;4<IW8*
M31\)!-;AEOV7-NDC?E'(=1Q#1O+(8HJFGJE5E[9J9^$6)ALL3MQH&I9<S"?2
MG$&I7009EAU<IL+XI=&5,\M%+,B+2+7:S3O*N:*DF9M4]#4=K#)KX)M5\%*V
MABIYP3G:+M;KJ/%QQ2"&.NVZ^)K*V:6%KE=4:JOCC>U\'F]?4)Y\'!\^%V;<
M: =S98=,T+^8RA/6#;NJW4/=U?'XT,+_ $'<?\SP!7MMM-P?[)%B_D[AIH+^
M[U)<CE6%?^IQX0ZYH$'X<T-GJ]''8:A<OXQ0,?%J8Q9=RRA&MJQFRLIUJZ.,
MKQNARO&ZG6KQN"KJ=8(P0=HV89[<)32V6=-ZVV3)SKWPWC%+[*=$Y)Z^%%E:
M.'W/25$!Q@O]X1+AE/;#$>DZ/++3SQF"LIG[>%R+34M0AUJ5/:$XZ[T<6BBG
M)ECR^]2!M:$>+]F&CSJW"P&*KI6MPM/*RY9"M^WADV@C9@TU547IJ7.RR=_P
M1-T3RALY\34-13Q0TM6ACI&;C9VW)4JVH\)M4^;%53TCU%,^3@Y]'%V>"FD&
MRHHRW&5'V\&"5QV5>R#6LJ]I,HWGG\88%)4-P,W>.>T)Y#@Y +GO3KBD'R3N
MOAAE:#7[FW:W^3N*G&O;O QSX4A]UF!Q%':P[<^;4/7AX\]N"8#IU:Q?%FCM
MJW[2IWWQFBOEV\XQ35/;'1U<K_Y=3&8F'TK8H=(TW%TG24<4U+*/=3P%EGI6
M.WBE<R>*VS%$\LH,LM/":E@VO.% )\IM_/A8IZQ83[ID96DD"G9FR[SML<&"
MD8M"WNM25RM,HV1QH=:)XQVM@WW[,'T=..77U#A01OWXCE!LT3Q2J1J(,;!P
M1R:QBFDV\)!"]^7-&I[I'@#)\+2S)YP4D^Q#W>3R8GF^%FEE^FY;[^X:2G!U
M0TV8CD>5R3Z55?",WLLT5'DH*ILVFX8UN**H.H:45%_X:3M:\ <354:K2$M#
M,ABD%CD.M71M:RPOLDA<:U=;ZL<JG!T97\:@D;-!(=?6LG)RJAW'%1IKV+G@
M*QF+5NCO^%TI'MS+'L6>WT\)&JFBTG V<T\NH%K6D4 ZSR&,Z\9\LE.?&C9@
M.<HXVCY!UKC+4333+NX20LOG&_SX&5BC @HZZLI4W4J1LL<1II2ICCK(T"+(
M4X(R6U,';M6.\'%*E//'42J_9LFL)'RL=F8\F!+3ME;:+8%+77R[$9M8\S8U
MY6!&H]\.C!*'A$W7U.!]^+&ZGGP/1Z,22L;K&+#H77]N!PO:-*"X;G-K]&&:
M,9GC\7Q".)YL<;7TXJ:&>->"JXFA?FS=HXY&1[,,:6]BU?JJM&U#U%,3[]!+
M[I8':+6?TX>!(Z6)8V*YDBXV7<W3@N[9W<W+MK+=)PU]V#ZMV+'E_P!WZK?[
M\^(^88(^1]V-'J=HHJ8'IX%.Z5Z<#HZH[LH&Y9N#_;(\7VOW?63?!4T[_1C8
M]Q5G)&4A'^6BK]M_"+Q2HLD4BE)(W 971A9E93J((U$8>MIXI)_8MPC2*T*M
M)6^Q1Y#<V N]1H%G-W36='=M_9=<(68"6)AFBJ(CFBEC/:NC#401C5K!_P!V
MPNCZQS%5)_89R;"=1[PQ^%3O/&&,\KM2:07C0U\(R2I(O:F4#5*O*>VQ^!_9
M)1I<:Z>O@(45:]KPZJ=3-\)E.8'MAAA ^=-W+;D(W'U'%O4<6(S#'%V';JQV
M(W&^-]GFP(YAP3^+)VM_DMB\+77=8[//C@YE$J_+77Z<7:,QD^+K'HQFCEO;
M<=N->IIB%]/&;U8O?4RY;CU8%',#UY"O :NVEC[Q_*7ON;#,Z=L,SR+LOR1\
M[;\2!;77?R6W=(WX]C_LJA41S%&HJOQ:E(=6L;RT)(\V#44_'210XY<KC,OJ
M. &%M=M?^]V+C81Z/_G%CJ.W'GP/]VZC:L,VT* HZ;WQ14UM=35T\ 'ZR54^
M_$:>(B+]%0.Z5Z<+T=4=V03? SQ2_LW5ONP"-A%QY^[JT[Y%2$?YLBJ?JYNX
M1TXJYOA*B5_2Y/A)D=5='!5D8!E93J*L#J((V@XGK?8@D31NQEJ?8W52%*60
MG6\FAZ@YOP=4';P!O1RMJM"6+XF7@IZ>HISEJZ&JC,5;2/LRU$.]/$J(LT,@
MXRL0<:CK4@BW;*PV,IY1RC IJ\9G066;89%Y_P Y^]CK8G@9898ZF@JF"\+3
M5"GBR:_>6[65#J==V'D:E2BTS0N]+6&E $77$7?$#BO2U(M)&=J9L,DBY)D8
MHZ'<XY#R;QC6,:CYN3%I%O\ ;BPE5AXKZF&.Q2')XCG,N+5,.7Y2[,=CG3*=
MF==G-A5SQ."VU>3$,.NR)FL/&/\ 0# "CC7N!S\MM^(*N(]J_95Y5[X?[V82
MEI:=X1;+PC>)OMS\^!$@O),>#3YVHMT#:<:*]CU)/'/4Z/45ND) 0PI.$3+'
M$]MDTIUB+M@NLXHHY-:R4E-=MP)08EDC'&B[)_7&O9L/0?Z8N-W[N+>CGP-O
MW='4;?@7%CVYY=?+YL:.3+GAT8'TC4FUU7("L 8_*E8%1\GNI>G"^ *&:^8F
MGC5S^<C'!R?74]W4\-_=JJY\F)&/[S)W#/)\'!-)YUB9ONQ?E-_"@:LB:FTA
M$I6ETM1Y8J^FONX3*5FBO8M3SK)"]M:X>IEIFKJ $D:9T3"SJ%Y=)Z+7-+3M
MXT]+PD.HNW![,+(^66(@E9XFSQMJW,-AYC8C%/-?A$EA4'?VIMKY\2/#:.24
MW8COM67*X[Y;:M>O'7?!Y4G81R$#B)+WI/('W'&4^O&KS7P#9QSKQE]&-80G
ME'%;&5A);GXPQK?)]GHQJZVF'3E;%Q$R9>0@C7AY!(PNVK,NJPU?=A,Q4@W7
M5J(OR8!!XM\-*[<1+"[=](=2QH.^<[A]V#0^QX<%&+(]9'[HC'M^SGL<879=
M==]F(^O:]*S3VF*^**-4=I.#DE-I9YY6N\TV7>=2[@,4U.QS&GIXH+^,8EL6
MPP:UQ"RL.4#5?^N' V!F4CFOJ]&,E]7>_>,9E_\ @XRG;;TX-L7VGO5^_P V
M!F)9SO.W_P#Y&)M,3I:JTRX="1QA11:H1T.Q:7YP[J'3A? $]*3KII\RCDCG
M%Q_J+)W=14_P<#RG_-?+_P KN'2#?W5U^F53[_"UCK!V@[,2U=%PF@=)RW:2
MIT<%$%2W]\H6'6\U]\F5)K;)!AXY*)M.Z-4MDKM"M^,1IMO-HZ4YP5W<"\QP
M\8</+%J=7C,%7&1WM32N%D1^>UCB2DJ(\RU4;QY2+WU7##D92+@XB$I5F=+L
M!VP"G*I;D)&!8YEZ=8Q>%P>5&Q:>'@V\<#4?/@@2%3SX][<>:^.+93S'+B1\
MS7R6!OO;4,6X5^;7A-=^CDY<0/3LKI9<]CQD;O@5VXT1H6&<T:U+U5345:KF
M-/#%%E,@7E).4'=<D:\:0]BND(H@- F&2"KI!KJ*2LX\4LG?2-O+'7NQ[#ZE
MI;T5/I0BKJ&4QPPY^T:1FV:]YPZ9>$L69&B(E62,FZR)EO<$<F*Z?@G$5/1S
MOF=2I>5ERQ11J=;,6W#'"O<,?=5V68[=6+=\/7R$8,;ZG'+LD7E'WC!4GH!W
M>?&6.YY3@:KOM\W(<04* BFC*RU\X'%BI@W&%_'D[2,>?78XBIX5"10QK%&H
MV*B#*H] [J'3X!$)/$JXGB_S$[(A^JRCRN[JGDA$4(^8@)^NS=PU?RVITZ>R
M!OY?#-]):+I9Y!VL_!B.H3G6>/+*#\[$G6>D-*40D5E(SPU;*&^#DJXI77FU
MG$CZ(TE%I&^M>NR:2K^=*@>GD/(!%&,-P^CJQ4!U2=;F:+RN&I>&0#G?)SXL
MT#-E[Z(B37S@:\6DC+#>KJ1^\,<=."OB\4N +AM8VXAB4;=;6.X;/7C?MUX5
MM976I UFQU>K"I&@8G9F.4G"U#T\><P\")U/&6,F[Q<VO;BKTBF<U5=#!#4,
M6# QTPM$JC=SXTCHT*C330%J<2IQ>N(>R1@V\>V7SX>6@KZ[1U93R*51:A\D
M1MDGIB+YH^"F4ZMECA4]D!DK]$U)*K7#LS4DFXW'>GOD?I4WQ^%*"H@F( X4
M1N.R+XV7:&'..;'R;<4\G,< (#PO>Y=M_P"G+C/4EEU[-K'HP J<$@W=^_.Q
MP*/1T5[$=<5##L%.GC2OT;%'&;=RX6BI1GD:SU54PM)436[8\B+LC3O5[K'@
M&"H7MH)HY1SY&#6\]K8213=7574\H87'J[MJYOA:F9_,9&(]5O:C\H!XU;%_
M#E/ARQUCD.):6B6.%=%4T5,[TPX%FJ'[-*7:/+FRAXU%]ECC54F5?$J(TG7Z
MPS_7Q:JT72R_+IG>!OH'.GKQKCTA1'R!,@\\1/V8' :6C;Y,JLA\]QJ.#P51
M3S6U#),I^_![#FYU;$,\]'.R+(,X5<RLA/&'HV86>CG_ !>1DGICEM8:KQ,.
M]93=2,!D;,&6[1WV-;C"W+C+E8^+EUYN; *\0GC>2>3S8BKTM^!_9)>*K6W8
MZ320VL!WHFU/SF^&0P1212C*XE :&0>2?2#B>K@DJJ',=<%(3P,M]=B'U =&
M/?'B.LC>.8VW8&H?>//CE.$KM+<)HW19UJEK5E6OYM6'88C\*XN>\0]N$HM&
M4L=+ FY=;N?'ED-WD<[V<D]V#!\ P F[TUZ9O\OW/_2*=V5D_P '33-Y\AMZ
M[=Q0#EK1ZH7_ *^'*ROG8+%1TTU0['4 L2%M_1BOTE,29*ZKGJ6OM'"R%POS
M%(7S>TFFE52B+<YAJXHN=O2!AIYJ7*\KEKPO)$VLWVH1B]!I*OI^2)Y>N(Q^
MUNWKQQ*FDJ@-TT)0ZN=;CU8IJ-_8T:JIGD2*/\'5:9I)&( M'*$MRG7ZL6J?
M8Y[*:%=68I20U:\Q_%99";]&K?CL]1I:BD0W8U>AM(0K&?EOP&0'SZ\=D]D%
M)M_X@3P$= DC6^)M'U?LDH LO&BFC=V:FJ%]RG7B]ZW;#>N)M%:4KJ9J_1CB
M".MA2>HATG3>\S4_!HQ9P.V6UQA.L:/3-<+6/ :*GIXV.XB2K$"VQQ-%PT$9
MVR:0K$:3]C3"39Y>.$TEI&21M\5%$(8OI29W\^K"RTNC8Y*A>UJ*O\9E4\J\
M)=4/.J@]W#%O -11,>+41\*GZR';;G9&/[/NR<#;.\4/F+YF^JA[B@/)6KZX
M9/Z>'*FE1\L^F9H]'H.6(]DJ=7/"K#I/F]J$V-4LJ>9CG?U:L#D5<,!YNH*Q
MUO#HF!ZB_P"?E[#!TZC*WS1U+,JMT@'[<<>DI7\N")OM7'_Z/HO_ -U@_P"C
M%XJ2EC/*D$2'TJH\!C%_ %+5#WF96;R-D@\Z%A@,INK ,#R@ZP>ZZ&FOVTDD
MQ'D*$'\0]Q*?%K8O7%*/#E#H6-NQ:*H^&E /%-35G>/'CB0:^27VD:>,P']?
M5?%/'NBCSGRGV>@#UX)WD8/3U'KW4B72E2T@O\!#V**W,2';S^"%\!07-Y*>
M],_+V/W._3$4[K2+=!3(/G2%G/J*]Q5'YN6GD^OD_F\-O(VI8T9V/(JC,?4,
M::TKFS+5U\[1$&X,$;<%!:_+$B'S^T3D07^E_P!@?3AF\9]7DC4/4,",'8,7
MQ!31 M)/+'"@&]I&"#UG%!H^,62DI88/.B ,?.USX(7IQYL'P!443'BU$?"(
M/SD.WSM&3]#NNODVCKAD'1%V(?N=Q:16U_Q<O^S97]5O#>G*M7R32TW65.=_
M#59X%2.C-?VLL^\WR_N+B_B#!'/U*$LMXJ /7R:M5XM45_\ -9;='@E>G \G
M!\ 4M5\%,C-Y%[2#Z!; (U@BX/,>Z9I3LBB>0_,4M]V&=MKL6/2QN?7W%-%\
M+#+'].-E^_!'(2/1X:T)H"-M<TLND*@#Q(AP42MTL^<>3[0?[YAZ\01\NL]"
M"WVG#'EPQZFDM+NO&JIEI(21[U ,SD'D:1['R/!(P#\GP%2N3=XEZWD\J'BC
MTID/G[IK3OD00#_.8(?JENXQTXKH;6"5,MA\DL2OU2/#6E2K$PZ/X/1T.NZV
MIUXY4;KR.P/D^TA7Y5_,NO[;8 \153^OK.,N+XMO.K&BJ.UG%*DLO+PL_97O
MS@M;S>"1A3\G!Z? -90D]LJU$>O>O$DMTAD^CW324P]]G:0]$2V^V3U=R-):
MPJH8IAT@<&WK3PSI#2$ALE'23U!-[>YQLPU\YL,559+?A*NHFJ'N;G--(TAU
M[[9K>TS;HP!_,?NQ?EUXMU-%4-KK)5QM)O'!Q'A7OS95MY\ #4 + <P\$C#K
MS:O 5',393+P4GD3=C-^C-F\W=,,(/N%,M^9I&9_W<G<E%5@>Y2/ YYG&=-?
MS6]/AFNA4]DTI+#0 <L;MFF_TU]JTMM<A_>/_3@]'5K=),O%HJ;@HS;WVH.N
MW.(U]?@H8?I&&YF[M/M+[P;XI:CX6"-CY67C_6OW1727N.':-?)B[&/W>Y*V
M("[+'PZ>5"<Y]*W'AG06A4((@BFKYA?6LDIX*+5SIG-_:6&UK*.EC;$2\U_N
M&+<N#U!4L+2:1J9)SSQIV.+U ^"Y%^2#ACR@'NT^U,)VTL[I\R3LB^MG]'<]
M34'WF"63Z"$CUX+':22>D]R6.L'41R@ZCBJIC[U,ZCG6_%/G6Q\,::D#%HZ2
M2.@B\BF2VKY[/[2!.<N?-J'K;U8Z %]'_>^"/$'42--;.RHHY68V4>DXT=1*
M+=;4<$=OE!!F^L3X+3D;B^G"R?-;JCN^IICLGASCRX6_Z7;T=SSKOJ'B@'G;
M.WU$/<U/6@:JF/@W/YV'5ZT*^CPO65CD!:6EGG).SL4;/]V*NM?MJNJGJ#?E
MFE:3U9K>T>3=& OT1G/[P]&+\U\.WC-]G4T33D!DZZ6:0'9P<'9#ZU'@Q>8@
MXORV/JZH[OH9-W#K&WDS7B/HSW[GH:7]9.P]$:?S]S5"@7DI_P 9CY>Q]N//
M&6\+Z:=6RR5424,?+>J<(;<^7-[7A-\S?OG-ZEP>C _WMZE;7%=5)29%;=GJ
M&L1TA5\&VY$!P1W:?: C45-P><'$$PV2Q1R#YZ!OO[FF6_%ITC@'F7._UW/H
M]J.X;$74BQ'*#J(Q54NZ.4Y.>-N,A^B1X6T+HL'75ULE2X_-T\=EO\]]7M#;
M:UD'2YR_?B"/D7.?W5^_ '+U:BL*V:MJVL>5(!D%N:]_!J\ZVP1SX'@&DOMC
M#PG_ "W8+]3+W*2=@%SYL5-1\-/+)]-R1ZCW/2UZCW1>MY?+3C(3TK<?-\+)
M0(Q,>B:*. B_%$\_9I;<X!C!Z+<OM*:/Y><_-&KUMAODA8Q\T:_K7Q;JZ)@(
MLW6J2OY<O'/V^#!CHP? 53#?7'.'Z%E0#[8V[EKIKV(IY%4_+D'!I]9AW16
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M;Y%0/0T1^_PE[(4\;1%</]!_:3#E2,^E&P>GJC$//2U(_</A.63='2OZ7DC
M]6;VD-8HXT9X.3R#K4GR6U?/PIY<7\%11=+G[!]_==3I%Q_=H?4\K#ZB_2'5
MT:?\2/X'A+32>-HRM'_X=_:'Y4$1_?&&Z3]OM*3GAJ/W/">D).:GC_BL?N]H
M\3;'4KZ=_2#K&&B;MD8J>D:L6\%.>3BCYNKNH*HN2; ;R3J \^*:EWQQCA"-
M\K<:0_3)\W5T>?SDX^K'_3PEI0?_ &^L_@/U!BW1B/GIT_>;$HY)'_>/M*+R
M)_X?A.K?EJ@OT(D/\_M5J%V/97\H;#YQ]G/@>"6;FU=.[NN"XO'37J7Y.QVX
M,?M2GF!]I0G^\2#TQ_\ ;PEI(<M#5?P'QY\+TC!Q3\\ ]4G_ 'Q4#\])^\?:
M:/\ E<,O^DW]/"9/CU4S>@(O\OM60[&'_P 'S8*G:IMX)"^<]U7Q/6$<:IDX
M-/U4-QZY&<'R![2D/)5_;%)_3PE6+XU+./3$V'0[5=E/F-L+TX?H&* \L;K]
M9#BI_6M]OM-#G^\D>F*0>$Z8^,]0?]>0?=[8.-^H]/\ O[/!)/=5N75;IQ2T
MH]YA16YWM=SYW+'VD'-6I_"F\)2#EC<>E3C2"#8E=5*/FSN,)TX;HQHUOUH_
M=.)N<J?2BGVFB/\ &+^ZWA.BYUD;Z4TA^_VQ'HZ?B'1Q]Z)>%;R8>R:^9BH7
MS^UOXM5"?5(/O\)-Y)^S&E!R:1KA_P#B9,)TX.-'/R517Z4;8;Y21'_37VFB
M7Y*V(?2.7[_">C_\.I]))^_V]^7X@'J5,^Z&GR?.F<6]4;>UF^3+ W^H!]_A
M/3L1U9-+Z0'F-5(1ZCA,>;%(_B5D?U@5^_$!\:EB/[WM-&D;J^D_CQ^$]'?X
M.#]P?$FHG(US5&4'E6)!;ZS/[6NYDC;Z,T9\)^R(?_=:KUO?"8&&/BST[?ZR
MXHI/&@R_1/\ ^M@=6A;Q:NF;T3(<*>50?2/"6CQR4=-_"7XDT8\96D_:2,X]
M1'M=(K_=93]%<WW>$_9&G+7\)^UAB?[\1]. <59\1.$^@P;% _,X_</M(V\5
MD;T$'$!Y88C]0>$J,<E+!_"7XDTL?B4\*^B-1[6K3QZ:=?3&P\)Z<OW[TTGI
MIHA]V$\H8]&*U>6GD'U3BE;D<>N._P!WM:-QL:F@/^FOA*G')!$/]-?B0%\9
M@OI-L <@ ]J1R@CTXE3Q)'7T,1X2G9??M'T,C>5E=/Y1A>D8'DC$PY8W_=.,
MN^)X_O3VNBVY:&G_ (8\)1#DC0?5'Q$/M*5?&J8!Z95]OI!.2KG]!D8C[?"5
M)/NJ-%0V_P J65?OP,)Y.#YQC2,7P<\UNA*AOY<'VFAW_N,(/2HL?L\(@<I'
MVX7H'V?$0^THO\5!_%7V]9\O@I/IPH3Z_"6@)=S:.J(_.M0&_FZB8/,<:9IQ
MNEER_.19/M;VNBN:$CT.WA&,<LB#ZP^)-%_BH/XB^WBD^%I$/G1Y%^RWA+V.
M2VXW"UL>;FR1-;T]2W(<-BL3X5(I/VD93^3'G]I2@^]SU*#H$IMX1IQRSQ#T
MNOQ)H_\ %0?Q%]OH^;]?$3]!A]_A+1-1WT&E"HZ)8'!_='49<7Y1B!OAJ9/]
M)R/Y\..<_;[1X_@:R8?3L_W]V'N6@7EK*8?ZR?$FG/)40GT2+[>.2VN*JC/0
M'5U/KR^$FEWTND:.0?/+1GU-U%'+@8T9-R\-!^[)_+@GEL?2![324>\5B/YF
MA4?:/".CA_>X3]%LWW?$E&\5U/H/MZX>+&LG[.17/J!\):;_ +O'#4_L9T/W
M]2,\XP.C%%-\#6I_JJ8_OQ&W+$G]/::7CONIGMYY!?PC0?K'/T89#]WQ*7R1
M]GMJN'X2FF3SM&P'A+V14_C:*JF_9(9?Y.H,)Y.)FWPR0S?LY%;%,WR"/:5R
M>/1@_0D_[^$:7Y*SM_HN/O\ B5'Y"?NCV]5#\'43)]&1AX1TC3'9/1547TX7
M7[\.GB.5^B2.HN*R/QZ>3U+<8A;DM]9<'JQC=)25"GG[0^$;^)2S-Z2B_P W
MQ*C\A?L'MZX; [K*/\R-6/UB?"+*=C*RGSBV-*4H[6GTA5Q#H2=P/5U,O1C7
ML9"/2+8FA^"=D\T<C1_=@]71=C;/(\9YPT3_ -/"-6_BTMOI2I_T_$I/)7[/
M;PR[IJ5?3&[@^HKX2]D,2C*OX1ED _6A93ZV/4& >3&E::UNS2D#F<"4?O=4
M8T5(#8BM@%_*D"GU-X1TBWR*9?293]WQ*'0/;Z/GY'FB/S@KC]T^$JR3)E6J
MI:2=3XQX/@V/I37U$Z<>;$H.R>&!QZ&C/[H]I3O>V2>)[\D @$!_OY7!^[$3
M;<T:-?I4'PAI%^5Z=?0)3_,/BCG^!J8F^EFC_G\):&K;C+/0206WAH9BWK$G
MJZ@QYL:.F\=)8CTHZ./43@^G[\'JZ-E4W#T<&OY@'W>$*MO&J[?1AC_ZOB2.
MG\AI >+#PG[-E?\ E\):&KLISP5LL!;<$EBS6/2R:NH,6Q1U&^*M6YY%E5D^
MW+B)O&C7TVM@XMU-&GX.-H?V;$>$';QZR4^A(E^[XDCI_(5J>-2SC_2;PE6N
M-M)44M3YEDRMZFZ@ZE61MB"S_L763[L4[<V7[_:219K\!5R +O42 /Z]9'A"
M#Y4M0?\ 58?=\49%\9&'I4C!'(2/".G*3)PADT=495^6B%UMS@KU!@8GB.R2
M%U/G4C 1NVC*WZ1Q#Z_::4I=Y6"?T7C/A"BY^'/IJ)?BE.O)-(/0Y\(RPMVL
ML3Q-T2*5/J.-(4EBO6U;4P@-MRQS.JW^: <>? P.?&DZ3Q:B<V\L\.OJ<>T$
M1:PJ:::.W*RV=1ZCX0H/(D_C2?%*M')55 ]$S^$M-)KRS3K5)<6XLR*?.,P.
MO PIOA3AMRU,,,GE-QHW]03##D/5T9/FRJ*J-6/R9.(?M\(4'ZM_XLGQ2TA_
MC:K^._A+1FD0#:MH#$[6XH>FDLJWY2KWZ@PN-&U%^^D@^E:0?PSZ<!AWR@^D
M=5'7MD97'2IN/LQ1U(-^'IXI+\Y07]=_!]#Y,O\ [B7XI:0_QE3_ !G\)4E>
M%8MH^O7,5V".I7@SFYLV79LZ.H,+CA!M@EBF\R.,_P!6^('^1E]'_P ^T@0F
M[TCO3D7N0H.:/HNI\'T7-PX__$2_%+2'^,J?XK^$M-T0 +O12R0W%[2PCA4-
MAOXNKJ@8EB.L/&R^D8"'MXB W2.(WK'M*K1S'BU48FC'YV'4WG*'U>#Z;F>H
M_CR?%*N/+65/\9_"3*=C J>@BQQIG1Y5@(:Z8IF^#E;A8R#JN,K@7YO:55(W
M:3GA8^B7^D@/IQ;!ZE)6IMIYE<\Z=^OG6XQ%41'-'-&LB'E5Q<>#H_DSSCZ]
M_O\ BE5'EJ9SZ9&\)Z/TY&O8Z^(TM0VNW#T^N/FN\9;??B^TI:Y?>I!%)^KE
M(L?FO;TX25=DB@GRM_M)-$S-V6D[)3WVM3L>,H_5/]5AR>#G'BUDH]*1-]_Q
M1/0<2-XTCGTL?";3,+O3:0I&B/(9'X)OJ,>J,20MVKH5].P^;4</1RGLT#%-
M?CIJ/TUXPZ< XOU*:NBVPN"R^/&=4B'REOY\0U4#9HIXUD0\S#9TC8>?P;5+
MXM83]**/^GQ1G?Q89&]"$^%*6G%K5>DHE;EM"C3"WSE'5/FZD%<EQ'4%8IN0
M3+[FWSQ=#SY<)(O:N ?ZCTXYQBW4;0M0W%DS2T9)V/MDA^=VZCES^#=(IR/3
MM](2@_NCXHU[^+23_P -AX4T+HQ3QH8IJN47V&0A([KRD9M9W=4^;J2T[>^+
MQ3XCC6C#G5K'#T-1JGA<QL#ND3[G%F7F(ZG3U(YHG*2Q.LD;C:K*;@XBJEL)
MAV.IC'>3*.-\UNV7F/@ROC\:&%_H.P_G^*->>6()]-U7[_"=3I"ME6&FI8FE
ME=C;4HV#E9MBC>3BNTM*,JSR98(S[U31\6&/IR\9MO&8Z[=7UX'/@8ATK#J2
M0I#5V[UA[C-_RW/.I)U825=XXW,W_?;CGZJM(QZRJ;152[E%^+,.>,G7RH3S
M85T(96 96&P@ZP1T^"Y$^$I)!]&2)OL!^*,H^$F@7Z^?^7PE)//(D4,*-)++
M(0J(BB[,Q.P 8.CM'LT>A*63B[C72H=51)^;'O*'RSQK6Q?JC%NC$D$HS1RH
M48<QQ+HRJ;7&0 Q[^,^XS#I&IOE ]2XZOX$JW[- MZ)V/ND VP\[1=[RIRY3
MX+H_E\-']*%_OM\4:6/X2KOYDC?[V'A*3V.:(F_\-I9,M=41MJKJA-L0(VT\
M+;?A)!XJZ\#VHZB5],+U-'=LHVS0'W6/I%LZ?*'/A'#795'SEW'S;\6P1U(:
MJG<QSP2+)&XW,I^P["-ZDC$59'82CL=5%OBG XP\ENV0[U/@J@DY*N"_0SA3
MZC\4='P\T\A_TU'W^$6]CFBIO_%*V/\ ')HVXU#2/WH(UK43C4NPHEVVE>J3
MR?D%>/\ L58Y:/Q8ICKE@Z'UR1_/'BC"R(;HXN/O'FQ<;>JDK$FAJ"(JR/Y%
M]4P'CQ;>=;CDQ'-$XDBE17C=3<,K"X(/1X)5AM5@PZ0;XCD&QT5QT, ?O^*$
M4?P5(GI=Y#]EO"$M<^62MFO!HZFOKFJ2#9F_-1=O*>06%R0,5%?6RM/5U<K3
MS2N;EG<Z^@#8B[%4!1J'5OR^V&O UC#TTIU..(PVQR#6DB\ZMKQ)HVL-IHFR
M\@)[V1?D2C7S:QM&,IQ<=4>Q^ODU&YT;(VX[6I2?7%YUY/!6CWO<];1H3SQC
M@SZU^*%7^;X*/Z,2G[2?!\]74R+%3T\3S32.;*D<8S,Q/1B:O8LM#!F@T93F
M_8J8'MV7X6<]DEU7[5->2_5 QJV#!]KMP-> +^O"5U-_:J8<91MG@VLG.Z]M
M'S\78V$D4W=5&;E*\OFWXRG!ZBRQL4DC971U-F5E-U8'<0<#AF TC1VCJT\?
MQ*A1XLG?<CW'@E4^ J)H_I$3?\WXH5\G+5S>A7*CU#P>OL1T=+K.6;3#QMK
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M4].Q&=>3,.VC.YAR$X@K*5Q)!41K+&XWJPOZ1L(W'P#3_K*C^._Q.F_4T_\
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MEEGE;QI97+NWG9B>I1T%.N:>LJ(::(6)XTKA 3;<M\S<B@G&C]%TXM%0TL4
MYRB ,QY2S7)._P!L<5;JMH-(JM;%LRYGXLRKY+K<^7A<20'OX^+Y6U3Z<,IU
M%6(/FQI/13M<TLZ540.Z*H7*P7_,C+'G?NM1\)3SI^[)_)\1Z1?%I+_2E?\
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M"6.X+E=1SO@84?[MBGK5VCL,O1M0GUC&D='D]I)'5(.9QP;^M%]/==%)X]+
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MW8:;V74;9N2U-52_\F^(VY8T/I4=S#X@5Q_NE1_"?P,?#,VKMFS?2UXV8CD
MUHZMZ#?VD,UK]::<H9K^+GBJJ:_^O;SXH)/A*.F?Z4*'N;S_ ! K_P#!U/\
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ME V/!6M2C]"B4:E/CJ5X*%3?Q*K[ROWF:<HXLP=-:@E0U\S8*XJ7YT79=?\
MP7_B?-+O0E/H-"Z:8#PAK6BB42B42M%2G2I4J5*E2O#6J-TPJ2I?694.\YRT
M-XOI*LA\#""=(U/2]^BO_!:FPE/F)]66R]E)8S>5!0:!>H:5K4IE2I3*94J5
M*?%1*E2I7@31!*93@89D%2F\0;S'RA%I,W-"JAY@@B0S;HL.XED:.WKJ*_\
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M'=#2_!<&A.-%;"C>S1:.$8+ 6"]W'L6=8LIF]F=R;LW%9F_'W2E/=7DX//\
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M6R)U!_/0U$"O-;>D"X7Q=Y$?[:86[9BS\V7,B-Z!AE;;G)U4="M6W'9_XF2
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M$O1PE8N+SC?AOU)E=1RAHLI,KLTZ-,U[FWM':%5VV"T[9$4F1GD&K^G%N?\
MAXVG2IV!^C07D--U*PA B1BD)S4XW/Q:(0>+1."M[F\V #<[R+;=-G_DZ'$>
MU]7$;!%B7H/SEKXA9#QV33_4N_&",F7X[ZQ?.KYB7Y]:B\_.8*99OO*O;2MF
MA1IBATI2.LS!FM9\_G!Q+.@HP&5?[3#%8+:H][REJS,Z;":%+I[FC1IGT!9#
MJ[EN^[+7;84=X,0X5W #SR__  SD6.X+<<]TZ4!1V68H6Y0KO*D"@@T!6EC
M%CBZ'2C,6,Y.>A]E,KYN]=[O:!Q< /.>.0]*XF FUK5'R7[2J7+;.X2B[[WC
M-8%B,J0KG+'JFWA6(&#+LZQ,\1=OH,4N(S2AT$7V)6[0.^3[3%X' [;W7Y_U
MM,(^J& KOA/CFA]H+4WINS<E4&EVCR^&*0-XX?6+ '(EDI5]!T\' AN6O+=-
MF=X;.=H/4$/_  H*V7!*NP 578F;L9Q?E$@4>Z4NSB5AB""5C2QBA<+NYN&<
M1Z ]Z,5 QK?!KWC!ZUS!6R;W+49U42WVF8FQJ@5V^_65MAM<<1U5MQY^)6 1
M;!$\[N8I3Z"0[5]E)DGO5S]*B&!$AV];GKZD8'>?63W^7-^8:;_,?>&Q<(JP
MKD=DM\/?08E]_P!:6:;T3B.BV=:=/0J\%!3%=79&\X_HR<EF9?:K;=NK?3FA
M!/31;[M7O_X1G9V2-LCDN+B-R;DQ*!B4!.&CC2S"&RNL&*Y+YO?@G9)O_(!Z
M >F77E*&@YL.'A2FVRIS'AX+&=*]1P[JA"M^JK;V!][^;P@VRVZY-+)<67K6
M&=!5I5ZM>:5!1-QOBP8,-QCLROBE-62&[G>+%PU^K':_GUCV[JGXG6</2@NR
M:7NZZWC-^;\W)OQT9?I6>,2"QX(X9?9L5$&T.D?GUQ.;#P;3:A   _\ @O<
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MN^&? Z:$QAA[8RPZ0$>A%<D99M/G$^=_!O+]I\X\5+=-"_2+B^D9$4?KK/\
M:!*D70[9ULO_ .\,2IT5AU!7L5<B((B.1,B=1_Q*M;Z>5K"QUZPS,/R&2\(
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M'#5,QP)H7": [=A!N$85O(;.R5@MP2TK:JO*5;50$ ?CB+H_Q,_.L:+7-O\
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M33&=F-"R5&"@RXC)Q&42(XC*IMC=Z=PU&8Q;TRMKD#(C_. SE$&;J #E6IG
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M0IHWL^;_ $WF?NM7'MO"!A7JZA!4  *K1"WEGF*8WPAQ1 (^@[Q@! '0^N?
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M+O\ 776X<^?SY],V2X',ID_JT&0#N*2T! J9%MF 4JFZ8;JY.ZLIL =*ZS&
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MYBQR]5M^,PN#O_4"_KV-Y!3)+8O](),_4A!M@CUS/U_<+I>BSWZKEE_[1ES
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M52'MG\P_A;,5EZGUDEQ[\3ZX9M0WFZ&9"',&-0,:%'8CN/,=7'%R]+AQ"&M
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MG@:XT%MQO)+TJ<$B!S4UZRN&TN0F3IY0_$7=ER#8!P_U_4(<NGJ*]^Q<8\C
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MF&C*YZCI.([;TJF A%-?*O:)U?&<>3TB4'&+X._G';HS)L=D4 ;>%@?9-^[
M!J#.;;@\Y08J%>/'WHW#Q&*%/;'"'0 Z2H1@$,==Y S<4&*C$381W5]UYTW
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MZV6',C-8V8J=AA7V?WWFPK^]O66JJ\-<]XFXHM%Z1;<6Q6'$3)=/>R"W,[.
MM*+*8%F?J,Y?/:..+6L8_GG%''K&3U@M>9MQ8>D>*FYH_L2IFY%O.6@[SG.6
MFP]F_(L^G\%7-$B=4/0N\Z@R3839H$VYMPT?HW-VE:N[.=1@F0T!*E0/T "H
M/VZ8 %*%6"L^;G!D59#!M=%CJ,5&*ZL>7K$K0XW(GG]I;T!SDX[]O/M'\5R5
M1YQ%N2@W5ZYF:*Z,[.]XI!D (&,WHJ!VRVZ-$ON2V':W-L@Q Q41XY/8+MLE
MIC 1RZ6MG&J=BW3:,<;^>T,^*MUTWE^:^+(F<@2->LXZ@'9NO9A!XK90^[TW
M[Q&UYXQEYS*U6,\=.VY^9LC@)T[])OR:(I99;"^N@,&^NC)_J!<SDA0[]!4I
M"6Z^  6[=A5>86DJ[LK[OK.O+=Z?7VR$540_R'=V:*;I*T%0=X+G^U4O+.(4
M<5]68!1>B5DE0%XWE;??IUEIL!?=Q_W_ '*"JS6<<=>Q*EQOE2RDSN^B8E!!
MV+7Z WF ^&+RMJPD5DC;^H^'=SI8Z''''%/KIO\ I4V!,V\H1_9;TWIN>"\]
M9QMP_/\ "0V/X&X[D1YR^QZP[3::6_2VILZ'CK>;&XBB=1C]VH:&W!#^A 1A
MAA^W) $S8GD%&\U2E)-D"2V<!YB,"2I AFUYEKXZ&-D)'07YDV>?4><F[ ):
MTKS=7^T(D6)7L#"LLHO-2A[IK75#V'N',-B]A)4["5.&3<!4!N@S$%4S#1C,
M39JVUSMH[I<J[[LHWI6UW1.'<9B8C+V \XXL)2",2B!JL*G&[F=7Q16%"<*I
M/: (1RV6_*Y7 C$3<#FYLX=8LD;!3C!AL[D,CGL ['BZOK<=64& UR6XYPP1
MACT^0T%LZ<#./DXIH?(ADCB> E(Y,(9-N&=^ Z4&(:78V%@FSSL0N:G6XE5W
M;NOI,3)$9*I[EO<$=)TN+]^IWEP=,-R_97_8UXL.N3#."DPZ)QZ])9UCC'S;
MI%"A@]_^3<;F\3&NFG9&Q_Y%G6.U.)Z'6/M%M/G>[SO'W7ZIRT<M5C.6A[Q;
MQQ3Z@F+2*IDWEL.CX:_2=IF9O3>T<M'+77_B W/^6XO\#3#BDZ/81M!M-A!F
M;$VI@T/%6B IYE8\-W=VFZA#!-N55!!H'B@@PP?N3<]4BS6PKB0*O9>\"D56
M^XF[TFRUA:X?1-TK(V$<-D2]#O4MT;'B6O#;J+LPJC.:$9R6(<=U#@\<Q84H
M_+ILI*Y^*<0M&R 480KKI(QG#WU10;EV=X5ASF]F MWRRQ!*J2^Z'4',$*+S
M3,=*%DYFA%TW(6Z;S;(R4[H3.:_U^Y*VGT%X'#7)CUBLR@WRMQDY=\8A>G B
M]J;TZ/$1IX>-=VP7U*@+6T,SX=5<A*G\V<TXN1S+<$OZGOL%.ZI[BCF;5@$X
MONCFT*<G.,(MZ0^22[+- QBXR12 PKHP&1KD&G!L\XB-P6D+5MU\XP;0<F_I
M\HB2V.!D+XY]^LVH;J.$NJ1\MIGC*KQ\]X)6@56WOGI*1%F57QT@7KN44/'#
MY1DV07@OU,B9Q=XC"WKJVM''ZKSG.?TU6.VGE.<>MGYW]3>S>8K,F@[:/Z[Q
M%O'%-\9SG+P?X#V??^!J*CM*B>D8VAP3A!I;<-"$/":5 @'3)KFH5Y+$((=+
M:TA"$,/@",.D'[G:[<P"J2YW@C<;W)$9'F9KP(S?A>"F'%CDKS@9(2=R:<!3
M!8M)8&!L\/GWQ^+AR\]8&W]-+0<TV*NDZM^L.0&[#7;DOEM%S\1WV-YQ R.5
MS#HWQ,0W!PF#X?,COF53)9*I"C&5R]R/!3@2# Y6X,3@_#0;,<FP^'DQ,16-
MZ5YEOYH+N?,UY]/.4])FV#_C;K,)O5Z&*@0Z2Z.IM?GS<-J5*6+Q73S&^0&I
M.+M;VAY#;MCBGF^<%JN4U8FXQ@:KQ5M=KM  [0'$9\TK!*=R"SHO!%G\J!RA
M5SB5U1]Z<4[UO6S+4;*9[./AF*Q=>QO-<>9!+&.7V# WDI#D\W%;DRLS>AZ?
MW4*[3=MWZ?\ ?>;:,UZU\Z2ZG>.V2OHQD"(< KMT@Q;TC]/\)OG.<ISG1I=H
M[:>?APWY:>@2&E-\6TO!H[?KJABWBWT<X[3E.<YSY^FGO0OI_P #GZQ!\OA#
MM!@T#:;$V<0P0\1H0/=F88:<56^=KWTCP5':'0((?%1 _=CKH4BV.!E-V,HX
M3.@.9XG50%JQ!U>\--=H8GO-4P S") J/1X0.)6D4BF3A?3RE2P(5L-^[4(S
MD)EO2EM\#<%D)LX.K'<J'2/GUE]&%[W7$/)1@HMH-5Y\,O+QZL=N\VQ4C5JL
MY =W,*#7W*=A8:^T("8[M<'=R(!'260\7Y<+.,-=@%^RXJ,-:A<!\VQ2.6@N
M#FCM76NL)-YFRK3L^B^D7+4QGC/?''>9Y*IH3EXII.9SZ$8+;XJZ;F< *6SE
MUJYRU<>M+1[VD&"**QL&QS,-2 98KU.'T!4>7E#KU&WK7D+.WE,(EE 5Q^!9
M\IARI1DSC;/SI XNQST!MGOS+D\\!DOF6=RT:V#I]H:WA$LZF'^THTF)YJ_K
MQ!YK6W=16>3!D[1?+9S9(QYB?I?A-S.>GG\Z3X^NEVC.>CGI4=Y])AKR'VTM
MT>TO&CXG]%3>]8]'..VCG.?SIJ7#_D_P_@#^BAE?H1_J9!OJ,&TV$$&30QF-
M#QF^F&U\Z-3VAW;:O*/80A#H;4VH(-1@AVA@TJOWEOHA3F6[6PUL7FHKAW@#
MEOZXXC<L1U ZB68%%U^P:A(-*.CK%M>9@H:0YWV(1>E@HUQ56%?, F"4,F:;
M'*=F=Y?+03E17IO4A"O!5U;*=/M R0M=<%%?+YFZ-Y$N^G%\LZS=7?J/,YF;
MB.TFUO"</,8H62\&<]'5*0+S_8/#TG(NNT+Z=G2-0-5T"=VQR\7O%J&.P*\A
M9[.(DI I(H*[!_W&M; MID<UX/H@H]SHQ6A]PE$Z-N#'& U*8"!9_-D/T.BB
M1<V@<ZGS;>J0-[DLDSMG*-HPX,%$J.*9=YY;AF,!,JWRLUD.$0Q89(R RIO:
MX91 VJN_;WZ]87<W8Y/F9929'U[2RQW"T9O_ )+BHW.];7_<H.L%Y=PF#,Y;
MI0>P^A)S;:+>WH6.OZ7X:-K'O'O/CZZ':/@//2SZ9]Y\QTGY(;S)%8?L7O'O
M.?SB;V;V.CGIY3<P N/<>^O\ >W O3Z(\.8=H<09F8FW*!XS0AO*E:?47)B"
M#0V)@@A"&#Q%$/WE$:[=4'@>\#.P> SQQF:Z*,R^OQ%'1^--*-U=X(VVMBO%
M7GHV65GM$!V"H.5]E2NS !5JS#O'(5+P\MQM=TP5P8@#XILA2'&<*J\I:P:7
M)U./7[Q;]1I9 8/(F]!M^1Z<RU5 '(=/R1ZETFGI]3J@<V1NAX;Z0"_D\DQ.
M<;QGT_?+CZ(@3DZ,G0>^]=T+"K&\V<D;&T+PXL)SB#EB]L15JO!I"TA6B:0[
M,+Z_.$AV0%-[Y4,Z*QWE(SU/*(MPOF%1<[>-4.#T+B:VZN4#RLAEQ39N#.$@
MPN8L2V<DADYZ85!#N[O(4?FPQU*_N#<PQ*RCB6<CE])ALJ'\']IMK8;S3Z2P
MM8<F,5UKJ0\U8V+Q77K :4*87Y[QWQ:MP!P]7M 'H[BU*ML:CBJ&#]+\-'Y3
ME'JL=HH]]5QCIOA<]()OTR1V/V#M'O.7GIYSGKYPZGP,J?;^ HKS#+]5!>TW
MD&T-1OF0FQ#1H?;PFA#>4.&<QG+(>2G.80:6QH'!#H0P>" 0_O0UB=8[:D58
M;)3'('D'++ON*4:SY,:#<FG;W]XPV5U;J$'M<JB+7OAO*N!#?E::Q9!:K<E2
MWQU,<R[38>VUH,SOBR[W=M;%M9F;/[Y_UU.\*A2MG'D/O!,UNFZ?*DVBR7?#
M[HW/-LP9QS%9-S'24H*?7<(NW>!]@7QG1\FY OG,5M5O>S,*7K9\BBKVW3/K
M8!0CC>(*JV+@NLSI;DME;Z5 1BK5U;$]APW6"4/:<MJ#8%G9FYQ+LJK:>2X&
M7#7F+V*8ZS<)5?$O%0Z\*J*8C+5G+-7L[7AENB^VP<NN>W!6D#,'?K'^+-[0
MP5!*XP^LS!])8U>]5?/X/'28DPN[>/GTG6&^>/?;YO*_:?5Y9YG8HPV[G:-5
ML*X*9*KG$,6!6L)6;S>T.ENWZ;E/RGY:>>ET*/?P5WCKSB>1A#.8\Q6/+5_5
MV:'/YQ.4YS?H9S@S/CZS=/\ J=_P!S93?+W#]05YU#:38@P@S,I-C4\)MH0R
MAUP>N)35;'NP!H\TH;P38FQ!!#";H(-+:@T!^^=O6MK1C#F\;FEV 9(V%X<)
MY_>!%[_L_P!QO-UW.S].\?57:+!KZWL(F"K_ "R%/*L,9E*0W"&6PBGD 9<Z
M\R3;>"%LI5AH<!0>;;D[]GE+*T4U8<WL.Y!>2XGMU+HP( ^=LPZ.$^B;^'J?
M+;4[]&&P'L65N;.\!-#D\-COL]92IQV!Y<*?<]8_BV6^A^ERK:,70O,;NES#
MO4I2QD%.N2S=,T>$J_5_&4JW/ ",FJ,6RUSN4E0!X/;90*O=B*$:V<2>B]X
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MKS9M';5:4&_];QP[39I5Y/1Q?U)>"K%5=KYC@\XS*R3?I;W)]72$.2W(K/\
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MQBF=@F(XD= &2>:(R#:[SVS5--XL]IM,*]':N8=BN;-\L(_AHMV%<" LU@X
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MD6&H^^F26!@G-H/]X%+L*C8SNR+#@?&'1#-*[<2/GC,FIL(.YNQG\;T/ .*
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MDIU1E"&:F,1KHB41M/KE\^^DQLC)@&#S3/N?1X)2+\SRG8_Q&P6Z?K=JK_P
M":;_<D%<XE?<) &E5%T1_WV*RX<NX3ON!3Z>]D@/L-Y:OPVN _<-Z4OW?=D'
M0*6.SJGM),O0W!$*^U@97K;#!EDA?5TWB.;:+AAB_C(S$6K+#0OJ 2.K-"/(
M(?[J%KG(X;"BH'0RAQ%VP5\TD:H-P&*YQ-$E<&A;RT6TK6,=50*B]2BWJ ;N
M,[<MJ3,LG/G?:=S+LXOI<31[.F<T*#^#2X\+G9BZZ0F=TTQUW(P19=T0+7 "
M!9PO:+3;O+?\2:_^]_)96IZ.^0^--1TYI,0_5.K(K%D>5WX=R2^9$@84V,[C
M(U1_W.7RA$D()<729KYQY^!F;A*T=X\*TM;+:?*SC-81>(8. &TPD$Z><W7%
M;8+-B8H2N:4^YXAF+(I1QD9?I\$*Y-=8/F'8=%UDVQ9+:&FKAL8*N@-E[HZN
M8E AV+(9LW<OCBV#3>G JRDW$(S/-M_2=(8YH6^XFW\R<&:[#!HKJ2(EU0&-
MV2Z"WI@[Q>VNZX8+X(>H4NG&[7+N-82&A8=]Q ^,]'M^,+''0]TV_#+L6?:K
MOW/+\5K"*,OTP\B=K(ZB<XON/D/[Z3\I4%FULW?CFD.%;#MB_>D?P]VD?$Z]
MNK:92%^GI-3)"<N%%<&XKH!GK'HIS*2QZ4A$CJY53S'Z?_\\#(5)'FL,'AI\
M1$Y.EL=V*R3=,.$YBJ00/W^0W(^ZK[W'UJ2$J:BTYT=KYJ&_;7O&M[95O^=2
M=CM= -:LI&VN1LGZ))6(A#,R7LN 8E/,J6ZOH"R\:$U_&$L9*0VLMJ!B8[O)
M D:S:Y1Y^D\QPOU'LUH.Y^\'0(5NJK!_V&LB>\*@CW=S3<H2-KYOPD B7:'C
M66E, @MHK2%#5 PSQ^<N@/2AZE%M-!&]3M3KE,G)OYAF.7!C1E'/ FH->O;J
M#.2?(V.^5:!(SW!#L=3/  I46#AYCU_>6*-.-1R1CR?TZI<L9-4U\]NBV0[H
M'V'D!,!_+@3ZHM/T7_!"]S#OQP4,'-];THW KS)%M:KKR198/LS9Z22\Q0_^
MA>2T#]?ZS:FT\SET3?].0_7F&^PNIVYT R47(RH.G3.^>;MTG7G_1)!RR)17
M^2.G<H+1'PP:SCD2D@?6EWGV<EF 2PZ?FQ+@2Q4TANB&DX<;B7$!U1B*3/8+
MTK7:]M=:K.(0:8A:RZ@7VNRTNWLW+F IZ!):K<.E;#=O '3<S_44$RJ*\3V-
M$94X?=^T(*&<C]GYX)1^TIUZ(#96=SN466V.:.UWI^^9<>QYSVQF[PX7]_SO
M2)40C\]R=W4:=VG/@N[1DHY?O@K4V_N#[RPCG^-Y_7RWA1$74T62>SI 1/8F
MBF!(M;]]][%M>1];Y.O?/0 &P<KOK^)VFW.4 I4490V9,Q]M:JM,U:!9;67%
MD!*W_@)F.OI>$X%ISZYMAP1('*1^%R[CIDC1$SGLL5]3E@^/&]=N##Q(56O)
M.I#?G_<_I33'>0[^"V&))6"-(F"9@)MTWD2>7>;<^R:>#4C7/@#()8X7=K[M
M?]XRN*GK9^BG9W */G#C51@ZH:@D>*DW&FE'T[!I] ')NW3N@^7^ %![^6HL
M.[DAY6/2>L2)A$Z=ZW<!)I0!10H<R>D*^]<8;G27S,BXJO[EI6#\C'$DXQ^(
M^$* -Z9J5$J1UC**"?MU2K)OO#@4:(Q!@'(YPFB9'1Z=)CYJ+&1;O)H>)O>Y
M;WTM[;'RB2Z'.'HI$\/\J3[ET^XLZWFSI#[#7CIDC_;^CYH5M:;]@_? 0B='
MUFIQ>?D#31NZ3^O01N(!T-#WY$/)N]F7'XG2GNK%%M6OWL=5$[8Q'!UKO/>V
M.9"%<T0QK;XGVN*^8<Q/B=FH/Y3$YCJB%2TB(E/ ._W%>3:9DJ>K'1PTL#OV
MV)7(L2#@.F5U_,M-Q';1>>SIC-8J0XAR2^Z/I6N!VXC$_ AJHZ\X']NP]AW<
MDC<D.>TDA:>!RR$(CYQA&@1%<^#MX/.:,^0LWN!Z/>&0CT_;&_D'0.$#X%,C
M<V7MWV YLYY[_<0!KY%&) (#D?NX+0=OI[]4]2MBOZH6'""))J+,B)7J6!*]
M!S?^>'4'+/M[SS[S&5Q71.O[B2W<3)%L M(DR\-=1LRYUJ9+[2A4"Y"TH16/
M)X(]-7#*K)<<_FAF_KG8QOM@Q"GT]M?G0@>,UH;OY1+FGL F!V+/Q8!O$$=7
MT1KSXP-VC=L.-,"!YSPV%7$M4"H57FIUE4KVUE/=-W.TD>AU+>VS.)NUS^]Q
M,45$@GVX9 KY#DI5XTD[=E($M3T92V&PP=#N SA^:7:<&G06#[J7'R/""B*X
M.)TJ(^8Z%L1J!4RJLI6L3\0QUBR>7[;[6=UG\?I3V3!MJ\K+A2BV=& D;@<K
M+5;I-(/1EUFC%Q<@( ^C_>"MEUN$J6O,8NM/Q$O="D_[I8H5U%P.UF+H+4(N
M1/;J]O+G*C:1R=^*F8RNY96)! 6LK2QE8).:U2K3^I3@0/50&)-[L/9CU?60
M1-\VH9[LQLU %3(9+AX 9+YWR^*[DV1]N%*QT4IN!#K]7G.FCA;M0K^B<"W=
MF><2C:(1=K?M&T=2,9H0&P3((WD^2/9J")TN31;\ 'AW,((8#T1WC*$'NY$4
M(PMW^HFWE]!TQN[@(-BQJ#]M5]YYB;QW;M=;6N;WH_R9?Q?$,57<Z>_C;R3*
M7&Z;&(]"P1[4$DL[<N'EY?UU3$ ]RLAQIOOIQUE'Q-+ZD@(.D#D%<SVAOQI[
MKM9NXCRB+VUVNMEH6:+(E!2&(F*1,1L5_9X3+="XHYBO,5;*\EB7@YY/U&C]
M60@TL ]YQBU"D7M0HT_<.ZT2-V%VY#/=5UPX-N]?/LFZO'F;C-X)*+VR>VLK
M\3Y(M+6U6AN/)+RFTV^PCC*17EZZ04QV88^*34DS7L+ L':Z?4R?T7V6N>R:
MF@U5!N?<WQ%IHU+39'UJ*BC!R\A9.;4G37((;=)Y@D<02@W-2%G$E=*N]SY"
M<=U$]?Q^K&L*^F9-0*A,02P!BWSLZ>/.Q"+C=G4W[NP/N#G5NVWIQ1RH0^^.
M+N/-<,O.N&G/;Y$)"<\S#U[IB",7*??##W^'[O$B$./&?COBN5PCR/@X4? #
MX/"HJ<GTH 7$%#R6!V]U&,/0#D14K/W0^L_K1YT6]IOC[ -F0_@_K[]Q;ELL
M2P5(Q[7QNG>BB@%X,@P<^ZY=V2+\J0*SW-Z^O%>N9'U$]-K?UFGW!)VD^/>N
MMR6[00,_97//"3%EH'^8@57/V$>%(G!FQB+PVEL'S7HF:0P=&?H1.#H0;&@0
MLY _/ZO5QE927[=[Y;@K"P[==+,1!UN )*)=NG7!+N-+";W\?X[Z#J8LM5/Y
M[[WX@@3"A]2AK[KNP6&6"6^%71+_))D;!G\-+F90Y<X?W^[3Y 6[2(6="O-A
M?6T0]"7?^><7&EE3Y%JO'$4KS%YVMWQY]XO.H8ZI_CINKV_STU (?6VZQN"[
M",N&"3.' O%? ':5U\9;GAU$J<7-:0N#QBI2AK-<WQ#O'!0R\^FZIF.'?-D(
MXC,XW_BK?L%\5\*E3),>("G;J&J)Q)4:O]T!7/= -]!."CM%!Y56L01DCHID
M,S$2D_UN,DIBF")C7WO#(US"SW^84%U_/7(RT*/=KX42Y(<O:GJ^B;M%UX>G
M!LWZ7T4;6P;=7B7WU/0 )3,:/)?0'62N&NRVV[SY YZ 4XJ8@_PM0>DD-S7P
M7?B;^5=+-AYDF/!9>XY.MY^A:[,F!T!WYE^\P_X*W &?1K,[SJ58TN.YG)9_
M),SXWQ[8#B3U3/-4A=>-'X<I>@Q?I<F?BGK\&R-=$.SK(E,JOBF"UY_:E\YY
M8:4Z/^XUJ9*XTJF_/FI/< "7@"R21.:%J(33RM[&])6-\PT6W@XBK;=A9F16
MVKN2OR1*G+L<>3]'<=0MK!MGN=:)W#E/N@D/&5XPA)\?D%3=-PZ]55PF6?^O
MFS5K($D,X!]KDO[J?4/#3500U<%K;Z3'/W+:N8QF0?XF!^OM+*!<Z*@\?/E2
M+M0_'O3F>9V[=\5RCPW.O:K,&0/)"I]0[U(@TX84^M:V)@P<NN<]'4!=E1?W
M\JW7MZHW(82]&SO_S4SH+.)%;EFMJ80'#=.*G,?;?%@#33K<A)NJ7:K.3%DN
M$CP* "N!QSIK1;];14<HAHO)YTH)3LO'&?!>DX^HOM:<S#VA*K(WML<I;J#@
MB/_8,!.VN7Y=$*8#-8Z$A\^-!SV6,7@7O+$.UF6R'/QUFXBB&CO)--A(<;M4
MMB@&6J!,8]H<2?MJE-7*KD9/6^S/-KQ<F1V6 J+][RBD]*=>B\;ZS;\GGV0C
M.CSJTM98<'Y"$&4P3(7#R-HLL^OM35*J,/W'EHPZLV%LU%!UM%MG//F?.\$H
MXHVXO?7EHD=7/8B'FC.J[NO<"I BT!*W<\&BUR)T_026,03T>5P;$MJ4ISFB
M$KL@:XJ:(CL^HH+\5U*AJY89-;^/Q*@#X+X_3Z:A&5_FCP\LA(G2EMPSN:\S
MS4.:;V^[L#+$'P!^L#I*6>924)VZ1I[4#P->LYEE@<G!J6I!-J%7!SOIX";F
M7X:A43-226^ZS['9OTAQ!5GOS2]VU'38$<^(_N5V:6_K.,&58HM>]]L:3SU9
M_5AR=W*"#"L(O@M%WVKNXOL(&U+-!\3E8Y+*65:9T'0S^W1P[[F;?V5K:.DP
M=X<TD.:<V@1+Y"/?<'H]RH@5/:$Q-ZA K#N<<_PX$RK >Q.B!B3BYS9>&J/A
MRVB:[7%WB;K<ELZ SS"+,O@782[W.,$;'R1BT?TNO(V@"WU[CWB_LB0K9SC[
M1/^+T7G=YV*3&-VT>8)>]W_'EAB1+\5.]LM4J3D&O9O^"6P3P8"$[#<++D)L
MEL157D)<@O4^"F;V#J3/40I'^N[!@"!3KI ,?%*HS(YM"2VN$J'8&U=5]E_G
M#0GIR:\ZG2E?QK1>O678)R7UGOQ+OWSO!Y5#2IEO=<(V1F"3 G=-IX\BJ$!
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M\ZE@,&JXG.Q84:_-]_@!4'-/#TW>EAP?4&KR==B21!](:NMO[8&Z\L/C%/3
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MX#T2!)<+K>BFVM9O<Z&._%B^?G#SD<=+K.[M5;'6;)SM\OER)F[0[-!R2)R
M<F#A##=.#4WH4P;*E+H63&?F\]"Q!X#R1.LTW..,G7%[7>4%>;9X$^..P@)-
M"6A CI-_NE^V:$8&KQ3%H,BHR.C<UC+]BQF+8&&%1YENWN4UI+6ZUF\V*:!C
MI/KPLM)C\2/3L"^>\(& ]JK%VI2[[RUR*N16XTE$$?S)Z=NR["41(T:<&UMY
M+ 5KJO@-RJ?46#)P=[Q]XG1J!N_Z-<3LB_E+[[8V*FF^UPQ=$[(?E)J9RXNB
MN[_B?T:8*GSNB\:Q-,K]TGA!NYFJM.IS.3TL);-G\NN%H(+0%,-B+V7@U<]'
M%,<WF">/F.O795ZPYF^"F9\B;R<'^NQYGQ \&=ZL;7ZJ"GNTU1+-VH%)X]MP
MH^Q$VB-H63&9RXC/_=A"$T64_5JB2H,_++[%YH< TX^$E\H5;Q6))2DC\=^Y
M"=.$3BPWM"R86F6=&96IEC/P;9-P;$BN]"%2S=?!D=N,>B<T24Q%ZSA]Y%&\
MLN__HYS$$\3YY'9&:X/FH]O:+?L;1^]?N"A %:BFI/KT1EN.;F-][+-7H]!\
MT?M_4G11AF8/@-7YS'-QM^]7* T/Z6./(]A82;A4."P[DX_>E2^M-3)IZE0X
M\?X%ZUL 55H@K/T"0LGR1I]1.C_ W-M9/.'YOJ<T!\GHKX6.JFG3MK5=D()R
MP<ESE/E_1728C;@^K%B"T0T.4KSL^?.,\/\*LJZ&PH;*$(PARDVZI\S89+%Y
M](%[YJ_3-TJ.J@YNM#Q>U=R'^X3-W#X ;&I;8'G)M>.7XNX*,PK[/9_EW^'%
M1WHG90Y8#*:([@PMJ$*"15.AKPDL#",RL]8[C >U#E^/?+M=OV73R+^4C?SR
MC)+-/V$'P'"B-R9-TLN_EI"JN"K1FAJ(QJ&U/)UYK!@.PW\8W5<6@3<6%3$A
MJ15/;Y7%"I,<N_ C)F)6B!FY'L>MT!)93W]N=P61."'/0YFD<"O)27D<"*[H
M9-]>I R)^869KSEV&KJB@M$'.)2!.!#:9O[T+  @'T <,7__X@$PP7"//.?
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MAD$D@U#[.,OV05Z:T;E=0 S*2L"S9,J[&9N\TB$<TKS;_"780V=4;DKQO8;
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MD"PL: 4HZ;Z-,7B8@,/B_S8RQ 8N(J0>PP![E!#0^9 ^O\][HEI L#$&3AI
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M_",HF A7N(%30LG E0G50/X?04%Y@*\&%*@F*0Q73W;_,V1@R#\R4Y* #",
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M)U%=Y/1>M0%0N"RY. "QI?["1/]@;[84J1"WL]Q5V=/A<_4(CN11#"#=KI*
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M"$UEI79MN1@\:Q8X%\N]!V[L//SW/JGJULW%T* 0DM&692= F^$=>$"@DP,
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M! F-\PY3U^-@*>; KXP]K,5S;7IT0 *);RS:W"!D*8#D!0+_GARPJ6SRBK"
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M<&4N@C<E1V1(T.E@#Y< N? 4Q-HZ>N"2_L6""KO#M<:R5EA?GTGI0"W[XD=
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MO03](DW$^NS7#\,;@$2>#9;*(0_[BI V!!L5$O&%O>[8B:SG!\HK&VL!FLB
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M +J)4?=[])22,P2/QT=*"4*E)ZR,X5S(;!M'?95B)P^)[!(YC&BG=86^\:,
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M_WI5,X[ZQ%'@B/Q8T&7>FI&P1HWF4;'S>4OK;-$ABR-7IT0&EM>"+[B'K&T
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M2,&AUCLY,T)D6L@8HFM0@EHY6K668R6807-_%.C@!C6# Q@2@\596"$BSM'
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MDS)!2X@ ]!Q(*&]<K14"Z6J\D) $I$*K6, 6- "E0RRI!5(KG@AH,!6$4-A
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MJE0Y24!%C*K:HD,X,B(4$4I M&8FO*A:^(?0":D4D.H#4J+RG!J&**@7LVO
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M$,]>F5#"(ZA$Q):@:#(SL1$%D*(C6!MGI(+-XBC@HA&8HR0L16:T0--,2-6
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M%0%:V2'%RP107REHN6<JP,*3B^B%@0T3++9Y0!P4N+L2V,]PF9:6)B\<P4Z
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M3-\S#E+,@2\&@R50BT7Q'%5!,$<J30L4/PK: JRL+PI)K(0:6P=KT$JA(O+
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MAJLV$  EN Q80IB%0)9%]A?$A"/;7*<FC%R&:9& BHXD#%HM[I2TUK@"0HT
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MEE>"3'(L2#"*"ODVR2"B "!MK<0N(<S[!%Q'Z4*4O&@BS&[.O(T!)1>)T]%
M8MF)7<5B2I&\=%5\V]V%K*QOA3K$Z8;#^1"4:73LY;KFXXRJ^AE\Z3#76O$#
M<IIV U=D:>LW.PT8U:\[OAPFX8A!)!F8=_N=@EV.J#YGC?2;- :*Y@C 'I=M
MSAB3'&ERVB3(; AMO,EJL.0,LZO+WS2H%ES\3!.!,..TH>DBI@\*9^LN,/%<
MEE.+U9Q47?HVYPQXS>Y/;U&6G-H!]F)=5,/\DWC6KNY1Z13*B+"XF.KV'(9\
M8E:#C"U@@U,G-T;_52:",KF&^4\E-CP/!0#-^N2>S'4"]/6S3QYNSL/Y7^>6
M<MBJ$N^:G+.)+*^H2A(AL\-K61%EYUUO7U@_#'V.?]U)> C7[2L9$*IX;,<C
M$=Y7![&6Z.3-K3NXNW\<%?YR=%$3^D0HC;Y*NU*/-OMD;3?0%?_EQXT483C_
M^>G.P,(E"^X0K.H(P>(F7J[M2I_M:9UO*1]A9[I^R$L3EJ>OFBZXR67IF)$(
MUKC2)P#F*6,5J&89G,0GFBL]I^+3!TB+1+E&(PA*2\;$FF8^^Z6.AA(\3Z:O
MI$49Y[2OSJD9URQNWFF<G*(V_$ ,'%O-"?C^/MI+?C2'2(49)-;:X*L&ON-H
M1D<>*Q7=2)JR!#5/8P>U#];2D-E$9!&9&3$9T%5&'&::](H^Y4N%JFNRFY'1
M?ZO#:=D429O>X<Q4'W)#<TX':XYO&Z;>$VB!\BV7V,36<R4_%Q8@)95KUD7I
M! ,=HY/%@$J W=P1:NCRD"%5*;^^=GZ<?D0WE;$*4?KSE/X?Z-?%HIS#CS4$
M/\6V1<8JO4> -1RI.$Q<;'4!R/=TRK5 53+31DK?ST8Q"/;6[ HWM'OT%K&
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MU0#]4KZ7$\^!B7)%1/*,=C[WZ<<L 25V"6]Q%3B-$2IY\+#<_(+12",V1D%
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MWW^MO7?Q;_&$X@-;20ZS/Q@PV:GEF:5Y]B,&A.OK%^\8S.59192LE08Y73%
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MUK2F#2C]+GYX8V' QJ8GW>_[WCWXWCU9\=[W3Z!3U]6?#A_,.N@^7][Z_P#
M;T\W6]K>GDWOGG]3;QI_.V-[_?T+1GQWOXQOTW;GAKPU[)^'_!*(Z84*8ZB6
M#IH;HC7%:.E77/T]FEYR9N,E6^1-K6UQ*P$@TP$F:P%+I.&&FOER678C$*.J
MWY/<X$8F>"A+HP^G<DTD1Q)7A<KOAA $B53.<[(<XPD*:,?>;WVQ\8V?0<J3
M+VX^.WG3X^/^$=_CKC>]_&"O[\U)XGI/Y^/L/UNL;RRQO<^0IW?6OCO??_&,
M*T)&H?COPQ4UF*9UD@C.^ 66B(5I-W+09ZXX@<I $IE"\"9M"*&0:<B'OR\
M"EJ+/.M8UXUII@P+JOJX4&YW/YR/; X,NRGW6]GA/Q)22==\O)OWWESR^C%9
MZ>WXW3_B]_GPW_=_O[O>^WI_@\5Y[?T =,20DL.D S:>%XKB1-$&"V:G,+=5
MOACPH9J*ZM60+$G+"+*VUD>AI$)M0OBQRX:+&:YM_3!?432L.;S)Q%%DS.42
M^LGJ=.)MG).NN#!4!Q:(/[X_/J^&MN':*[MY+>3>]O\ PE:^G[\-Z^8TX'/L
M4^+Z8W[8W^W]:]OJ]-Z[T\,]Q7^;GS[WNOAO>_G_ !!!\ !?0>EK8D,R38K
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M-?Q,],<_MN>4[C7>>/QIR[<OQAUF.//TO%Y_P9AU;. )T&3UO>$(+C2DK,Y
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MQ@6!FT*\I>Z-"<FA6%D-V9LJ*1,\)K0F*X-C)3(R+<-*J4:/3#2QVVB-P*Y
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MI5M*4"*-YC2C,1B#A(F:2LDH<>#H1=Q"N(ZNI9B8BU;MBG!(A160"&V>9-<
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MM5[OW.]W_;IXSWT^<1RTMEI[?C&]-U\^]]O3PY<J;R_Y[E];;]LEHOQ22*@
M!A7SY4@04RU70!"( O$!-8"%&6DT<Z3A(K"! DKFE6U4E@FAE$&(D$H"DFM?
MR,Q.$-:RI*J2W*S)?A&A@1JC5601)6+L]+4<AC&E77@22-))K&5L#5J75KI+
M:3..^6 <AS=:TSX/Q>DHS 2#1-2F?<*12I0E@62JDHDB5K1RH:K,X"!*LR01
M&J2UBDQ869E<!FJBY!!E:K+VJQ5 !0'D$K$,)4)DJ.@J,<)2HB@B*0E5C@!0
M3#!1+\'44HU))P*0PS1#2F5:5?40X-&(/>\5Y3J&E#$"FU'5=(B,YI69APLT
MUZC,G$2M%%=;[;E^-\,>WKOV]OF_TM[[>3>]/^8W^J_KZ?SXWY>^-(M\<,4Z
M/S^?)^?G?O\ ;1S0E  4*P%,D#,6:H!-0D(M!2]",K7C$I2Y<L@#+0K6[2D5
MM)*@1K-*&>4PWTO2CD+'I$M?E$31K)!HBMSJ7OQ"$*6PF$EI6"LM5"&MYGT@
M)S(6FS,N;8K6U^&)PE(Q>QE5SM,1&1?$\"9G.>SG7^#B25.96A6V7:<4R,,*
MUOI6L5KG.'0-4:LF3%5BNM<@IB)2R@-9BY:M:1'PPE$PI= JTG,M%<DUP+!G
M$A"B!B0+,:2\QX$(G9:@V+LP%2*!:5BM,LD#*GL8B%:JWC*E2CG$:UQ"%DFT
MP\@L9Z\;I!#-#-EB: !KI,D+M10H!K;0!E$$?MM\>G2<%C^>&_??\_Z/>_3'
MS]?A3+M;\Q[:_<G\@8$Z,]$))<I AQ9P!L[+"H=9@! S11(3C:"J&<$5J#*-
M$@FE X<:Q$R5<'Z2R(S:S$5$U6IJP!6L 6U7^074X=PAI*2UN>BTG\&(S+ 5
MSQ-HFM<\ND8@(+$P!<8$(Z-7D+9Q(% MDA"C71(@PQ+$Z",F2"H0)#%!+(:<
M0"BI@*S-".9BV5J@"E8D46+JR*0O/(IJDSUJ1G,<,)!4L-:DA9I-B;Z9N'2T
M$:7RK#E-8EHS8*EF9PK"@B4I4A+@(CTT.#6D0VJ&@B@@W%X2UY0! 2!%A206
M:1G2;:1$C$Y$_)%O,QP:$N1;FMPE2X1/16_.3C,,S(HG:4FC7"RL9<2(HD)1
M&XZ/VF][^?#>N$F_EMO6GFWOM_U7#7&]SX'#EVIC\[]>7>_VD2[4")-+4%B+
MC20F(++DI2H(FQD6PDA19K/!E4K:=,-^T!6ZUI2O.LA$"X9*%BLM6:$Q>\JY
M2&$N)NVI+K,7X\[T*T*M%*DJ7A(5R6\IB*A05NTLK#+=ISH%\3SP60;)J)(;
M+!+XO&=24*JDJK=6?(DQ 4I0B,1BMD. @")!3:2249:!!(T\@0R)1K4%IVAK
MG!J.F1)#22$+?,<IF2!FN%.5A*0L92YTR5*B-3BR68E<,"XTH8+DP\J4)(8#
M(LF(&6R*+#I.3SHCPC%"+@!>'!JA Z2Z6P*I:B3)1TDGNMPQI*++:J%"YI"A
M@S^TWO?QC/<]OK[WW_Y7??\ .-_GZ[^/?AO6GD.^OAO\?:#XX*4(V+%$*N!0
MW/,USI0A,@ .>)6J88O,N0%Z:4BS:<5*DC)-(F8HI,DZ<,Y$%8(F;9T[$V.Y
M#$5%B]6+L,10:LP9Z80\#IE0(.!<*CIK@ V89NRK6@BJ)5F[#3  L+#,X$$6
M]B1 "P$^FPJHJN1,!8"#S(7%BK)">D@2:& 3B27 ^$!.U),%YK H N%Z 4K0
MBLJYTI4A)$JFA%(3*U[<ZK1E,]/B"JX"X56? @>?B6'BA/4:*N3!X%)LLGH2
M:WO:C!621C-EJRVLL9TB<FM#&CTTS)I.B*$+05Y-[2C(9((2(%@KY%"%&<U,
M@+(K"/VF]^GV.][^?^9WO>LSX;WO/Z6]UQUVV_''R%CD6M;+ASQO>\_LF\PL
M(# 6)95@5 . ^%/1$2$3.1%*ZA8&6%58*C,72)S:7;31PR6<VL*05@DH>J8:
MX,2R&#+2<IK%4TMA:U:WF9&M69.,%&>$#+):Q=8"E>0*&>A47A!<746:5U:0
MTIB/E'PI' 8J0 ,H4-G4ZR)"T0E4H0!7S@[3 @B[2N-=G"]"#]EH(K35P$+3
M@ LQI-HR0RRFXE&,1"T!2DMK,$(C26<Q&&/0-3!!2:5%$& 83GPA)VH]5P&$
M@NR(($T:&10;E8*F*4&1AF(28%,UI-6\TG$^-&LI3(L51^";1B"-D3*O0HA*
MI8$B(;/T51(0HW5E"4?MM[W3R[WOG]#\]K?W_F6M/7\4WV^MO>_3'SC?JQOA
MUQZXW7;]D@\X2\'2H  54#!)3.7& 899#(I8P-+>*A1H36J<QY"YJU5F8)*"
M9@O6+N;>5<"8W#HI6+3=UDU<B *BA6. /+.^1//" P0+"",K.;#EDQ5KB7H@
M)2!Y-E=")TI.!$)6:2S*!(DM9X%I9G%T@F(B$161"0J2Y^B1!$V9RAB #90C
M'22&E@YDWJH#I(PB6G+UI_ I-XPC[LH>8TJ68HD <5%V4CRY.R/*"KB.( FB
MB+(5$2&(EP@*3)#10;CE+I"0TP4[-51-\DN$USD"N$8B'AG[0Z-Z$%$9ZLJ@
M5"$AV+!0)/V>]_K.F-[Z^&][KP\V_P!>&>][I%9_Z3Y_OM]'>?'?;A]F"9@"
M@@"52@ *K!7"R"'"%!9!B+BF5%,#9E"8FC<R"]HK2&F'0A!"L!WF"+MHYTPA
MIXI0JBQ<IK2UIC%,B%2N<=;5FE#6:,XA1I44-")M=H/4Q(PDR(I7G.;:*&=&
M,2FL":5FM9$JMFVIB!VDH18U#,@2  -.@B5)(FJAARP!],45Q":*H5D@2")7
M"S@T-%-"Y"(B,XCD2U*\,F0OEWP-B"PC%3E(@S2)K@=2E07"TGT@(#'P$X/B
M0,R;6%29"D*L(1 C0HTEF9SGE!.3AZA*+9K3D+3*Y4KF0@%"0E$0HD1&$J),
MSFC 8ANR"*F4:5D6;]C%9SMX[_FS_H=]OM][[?8'4<,H( E4H "K0P<EH]"
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M1!"MPQDB.NH:%&L J6:22P12%:3:J%RI)4Y8P-18A,J0E5X7V6592J*\BP4
M/M082_ *0 $1P;&Y!!T,D #-<B6"U%:WOG.O*#@TP%3H5)(E &9O-"N'U&YP
M[@26P*D,3B(: $,$EC,J&6,1)$B:,<>EMS>8K\2C'I2*/'E5C"5VT"FC0*JD
MZ9) WW:A?^O_ %&_?/?KY"Q\6Z8/:GH/S]("<R@A6W58P &N#$0T  R)9DHI
MBD&#004D)*NG5RKQ<HPU")80L" .FLSG?! 2!L<)4&&;U+BBU<)""T457,Z,
M0\)FQBHY"1C2U9)JTI>LUB,1Q%,J0"YJA2:DRZV,"J8@EE#:LTDW*!-;$1RE
M8%8F)(H11%Y4OB:4K,&2,NU4:4UA@2M,QU*14657[="+;@@3&0ERA$1P'D/\
M#*IF1,IDM.#)$)+OWRUI69PAXT2,61@RBH 1,/FVAD-"YM,$[B+)H?AQDX"9
MFTQ F$U;?J2;Z6<S%;;2)D-)J &%1,+^C5 PKLM(BB26_P!E^:]OY:??Z-8R
MGTX\?^6WOW^IO??Z'[WZ_GQ'X:5OM^B1H-E5PI8LP0E(&,M'Q]$PFD/*!L$(
M%+I>W7A%X)Z3B=   MR@%&@$ZSFR87/) "A)P"#-X3*1@8,H( G,5*!HUHS.
M!-RRT1-:J5B)X'0N400,,/"IG*N50EK2(:1 "MRMR.<CG N"\\QB(8GT@!-
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MHRC4I?CF$+P*1E8,D@9VB]0S2&:@("K0@)L+DN05AK PALBC65!731=*QI@
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M#1$Y%2H$$TIN5O;@QE1Z6P!,Q10T1**9AA*F 4J^0R$DD"1-A*"A:$.HI"0
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M&R(V)&99(3,1_CI73F)+-D=#P,M,Y.FT/-(8Q]Q'T4T=FNYI!-PCR^6H[7Y
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M,Y$^_VBVGL(/M#-)JON.@5>'0="8-J#)DI.&*X&%1D=8INRIM4X>7P >\QN
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M2,S%5HUS08;1G%-\GT3PM+1 9KU=^$TC2XK"I-M:^/Y;[T\#5%&2H,.9M 1
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M+4Q$'&(_()I7\L7",><GZ(@%Q<L0R/4E<<?;IXJ=TR%0^-?O^VDWA0N[0?>
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MG$#<2OU_%)UG4!/,%H9#(!BJ)"1(4R&T$'H Z=(10D!ZER8=I*,@**%#Z)U
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M-\U AJRD--?@FNA;"28E7GLOKU_+Y+CV?3H=)4TMV:Q+]:WFO?Q]^.E]PE]
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M_4Z< ZR@:N,5\Z&:S/OM7,:SW+F1N@#3^C2KP/?<#M1JFTU1E!1L0X"JD<5
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MZ &- #15!>PF.1@#+@"EB;R=-7R(<Y7LCA'4WHFYI\Z.O^9^%Y*@=$-VLQ1
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M6L PBSG,5-[XB6#]$ACPZ8Z.@;*T4-I)%MD]+2K_SHIU"/)?J P7[XOE5Y9
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MGWKSZZ[Y^G9NMV>_.<Y7<):O=*UO_;+$MO3M2>=\.^T.N=S.0T]?LZ&MGK^
MX-#"9DI2==W/B*E>R_)LLX/[XCV+(7<,]OI"Z7IO";R>"P4DVUB<.V<JG/Q\
MCU>W5Y!G O4#W87,C\WD7NZ4;/J6C(2(A'/3  /6NL_E%1[&7?SF$BT+JRG>
M?Y#NX<.*?X0 I'H^SQIBTNL2R'NJXMC*S94 ;AUTB_VDDX_U&X;4J=TK#;*1
MKX<SQ;&&*Y%K\2@59D!-XW+"*/M-P5 &6Z-!YW#C%FV0ECXF[JDN@&M ,Y'#
M2=2CG7> "0"+TCH2?Z?_I4H/!T@UJ;#EPO#Q<V !-WRT"$O=."8F?9566-$
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MK%_-]T;)=8BJ><DAW'66_F,W]^K7T4B+(^K?]F5"%-4M\\-N%-8\@ )10'M
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M-D'^3PZZ@FVF76$<.X$G[VK-ECB^CPD>K7%:#(BW-+<H.2^\'+]M\Z(*$\>
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MOOM ^"<PIV/4J[8C-9Z@49T'>=[(6&)<SF1-N8ACI^'Y?G-Q6D7EG_L@^R*
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MM@E@#EL]:1.9YU;DL_6"Z:(9W79=X>,T?S%<K:-YZ3G1 OU$N(GE6"BO,MH
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M!(US3A'2."=#[1^1I)D;11F8: \)2-L5H*,P=HBO1K'2 R"QB$0^G8OVIY8
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MR/H>WMHA.2N\GE^CVUHS;SC2OT^34K]0IWG'H$!#5$I#IMUGUI1?3Z/4^0-
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M%L3M1UA6:MX55FF:L*P99:T9.0O9&[D6C,K$!MW^.WV\2@X_Y51YY-0R5X@
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M$0$=-4X=U GC_ W^=PW@5,NP? :?/GIW?/6VG!7;0]A#8TXS9P.QD4HF)@2
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MN,FG,!"37'9KV?(GW6W/AUTBB24K"KA4F2:Y//]SY5]AB(Y-IT'D/ABO(A8
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M6-K9N_ZT:!2CJG'A&$HBVF*RZBF+U0_)O ,76+;]<P(D(K$'-^+<?(HG'H5
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M?'B<N7+F\R<]'JN&@M&2NNDTF]-*-B,2,P12A>'3:VF^+R41K)L9M8S$M D
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M3L0#3-;JW5JM7[-  !$!$:(C1$N89G9P$B8C@KE!L;!F6DIIO^\X(Q$102!
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MY@JG8(FYHD+LZ#*!C$BP("7 ;HS:)JE(]2.8Y>_"XTPD?.!-P2%"5$B8.(,
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MQJQ=BVL]9R.66$S"3EG2U6F<T<[6H3AHETK4-6H=M*E4@%(I-M(_CIB/7I/
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M)9B<7MY??[%_DZ_\OO?K]9G+?J>.],;W/E(FU@N%7ZLL 1>0'T;W9TUAK@8
MK8LL6EFM(X16]<5*D,Q2D7BM.M,\G#*WHAE1DB):UO@TNJ"SG-(I;UQDHRN:
M2O"K_DL$"E:!(UZX>A0F8?5@@P-")YH1E#KGTP6,LZ+,3KPU^' )/1B;?N8T
MOBIK_)I/*DYU*1A8%^L0H!#.6E8$N7*$O%40D-@E56>*F&I#:J%I'09G=<%)
M2./-6K6!%O<DKX[V_G/F>&_;\?5Y>.]S_P O\<=UMWI]#GO\>O/R6\_;]_WR
MS#9/&4 =R-?[.%)@+\<W(329MB(U5.!0_.5NYAM!1X)5Z]W3,F'$*D3,UTXY
MU@#MA(^Q,DV 31"&;4Y(006*'^3$:  F)53JTV8)'A/]US+5PLYHBB1&@MYY
M7UQ4:M.-"*4]>_7"7=!::  NTHHU&(P*9_A7TT5R<0DBRB A0*,.?&,#</<1
M=$JC F:"4)S<)!%"_3,K?2S1+!+7)@.<D&8OA\>.4_WQWO??R;_/T]_G_E-[
MW\8]<6KE]'?X^EO9T\@&)$U,V:RDE52L%'!JS-+6BW H7#"HS=MH.L=,IURH
MPBM;\+UZYVL98BB8<C6<IAX99Z4P;A<1-E$](?\ *A9HY\2'V#&!E*@EYO3V
M<L5BZSI!1IKGI>6=90BP NJP!Q5C #(R0#8TJ Q$H!A#2FJU2%695-265E7
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M4B)H#6+JJRE:@(]GR;Y\_P!>%_&/UPWZ<J$[WMR\N]W_ .4WS^CO?[^GKQ_
M?'GW.]UQO3P2HADB&)S+,?EAFM7EQ(->%BLYQA0D9JB9K6$C7AJZX,K6<M0Z
M'&E\LZX'(<;049I VFM)Y7Q(5M5%EAI5GWG6U<5QI!UX^MM<!/S5\P!.=/\
M(IR1$(3,=P?=C4JG$#\9X='A'7CIQYXK$K%())!FB((:&IY('%9$FZS.L*")
M&,\/)"!"6:$<Y$AXB+7!6)XMB51K 4(I,,G"%HBNA77>!6S-X4;81(7&G%?
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M3LY$SB5+?;;[?OPWNW_.[WV\5C7H3Y42!"-@)5X 3AG2C,(G28I<;D@XFH0
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M5(29 C1I9P2VC2S!1<574FF*?] *S3D@Y+:9M)AN (F66+*8"9T&IBSK&6I
M-4'*HN55P,DEFI]+?X_YO?Y^T2*PUO3(:U:\AFF,J-,O<WKR@)B.+H\^\9<8
MG#!"UB:W9;+JI%*UP.@M;T)F\ENENN $::)2N6( *"9L16<$P*#((EU6ZYJO
MF%XE)6@JN%:/!PR1(4B,$"\S;AROK4ZRZ=*=L^V#;C+VI3OP_,3J4?\  A1J
MH-15YTR^,,)H9Y1Z\V#*U<7N,\YLS7*=(^)! <2^Q02<_J*IZ^*=7D235(Q,
M*12)A@E1(:,4+80+1</!H$!253.%F+0$YU4:@)S$NA@$4AJ69'FWO??Q*_)T
MMZ_\WO>_;%CE]F 50!5X&&SZHA6@%*Q%#^8ERG3+YWWP(*&6J1>W2WI><3J"
M*1PK6F2-+G&,,1:GS;+I3(Z8.-3$-P9UA8J:Q Y_0@ I1#,>\+R94K7  [WO
MNF!3*G2"GJW<Z\,4NDT1URZVY'&7_ F%FJUI0Z5;5IB#B9A7W/5IRQ((,P"M
M6P5K7)3.$M@02(D<8E]5^I$PF JU 4N1*Q<B6F)@C4E(GCK<GG2+88**E0.%
M5A<@I5N> B"C0U" K:,QD5X/#)00"@2*08@M33Z'+AK:?>_I/AO\XWR_YC/O
M\?:T08NY#+K@7*G>:MB\AE$<:2T9K2F<1VG,>7.<230W7O$G]Q<I'&!]GKK,
MPYXA@JC:MZJG$G*,    !0 ( - H>7>XCQ* XG/=XK>*X*),TJQE'QVP<>L:
M^F!L&<K6QZVMS*Q7"D'?K]_$R) )F*U4R.G7/%^E23WFW8BNJXI51/"S-<Z6
M@IGQ/J0L+$2\80Y.$)G893.D?R\,166'0X-1K-(6.A52F"U1,A)""&!E+6&9
MM&)51/%0MLPD5&)R\WSE2EO;/&WUWT\-[W3Z#EN_[C3_ *90%;&*Y%5X-.LD
M<Z\+883$TUBT2O2V#2:\[_EY32YH81&T\'.\5O\ %6N3*@78"LY]V*<\&  D
MN9/!&,C5?I3C%*'%BO*%I$?@I2,OYOXQ8<076=>L?-<.D:5_7"OS]_4=6F3
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M_4?9%"5-/"%>"A/$,(":'HOJ8(32!]S*OMS7#'-(*6D-%RBM<+#DQ9[)"!D
MYD& _AF'6JHKK++.1QQ,TYB%$AD(HDD6:\'"8PPE,!@,B2:6 6Q+(XFE *37
MP9F*K3.2TE;TRK_T5K'Z/'>F>^?CZ;[>_D?Q[_.-G;>GYWO<?=;WO]^?>]\O
M)^_3GYM[W3[F/B4KFAE>)_.()%JG6FZ8$$9Q!&4L6I2(O;CAS&$9LQ0NDQ%C
M2F,P4I% ,#-*P634:P(G;88JC(L*IDAU9X2G!%28 H425=2CA@Q6Z 4J62HB
MS%1PLA29))D2ZV@2+6_Z'>^^./DWRQO?+Z&_QC+\_,_/F-_HRW,^;>_;_8!
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M\\\?-6=TR_N+_5WO?Z_T-[V_]=236L?.W&]L;X?3=[A]O)O>WR''$>E-]O\
MR>,\Z5X3;KC\_.SCZXO%S/\ 3?9<^D[M\_0WOGC>_3_P_>]Y_<ZTK6G>.^-)
M*^S&OST^Q@;D_P#BE_M]_/VDWX7^QWM_QNNZ[Z>4H!I_VV^W %U HK_3WOM_
MY0\-]N.-_P RTUY?1Y\>VXG_ ,\WOMC>^_\ XIO?;[W/AI]M^OWOA_\ !^M=
M,M>/#E@F(;ZG[]:<L9\*?,_'_H7+_P ]WO7_ .=<!/&_U:^_ZWK:G_\ &]?_
MQ  N$ $  0,"!00#  ,! 0$! 0 !$0 A,4%187&!D?"AL<'1$.'Q(#! 4&!P
MH,#_V@ ( 0$  3\0_P#XLE"ZP;M'HQE (NT%8>V)YO4 F3"_)=.,I0%)0.F,
MQ0$0!(RAPNJ $ W%")N))_\ F2&+(#PW3;+K8%IJS=?%&.TY .BEZ=GF'[2F
MAB(1#,PM1RP%E$-X(F:2[3*T@09#3.=4.DTO"6W6U<3W?NI[_7[I1E'7[:]U
M=[E"&0**)<OLO2@#T(@PT3<[NU*@>C 1D'$Y5,X8M5@<R%OC<K='P;Z5:,(X
M6,QHL6")0*!C!)H'#L_ADVC_ /*E"<+$*W?@L%6 6I0KXV"@3;'F)%-KN:,E
MC.! B?;"!*(T7N5#.5DU)F?OA&?6MA.]ON_K2HW8M/O1J+SM0F@<_!4]CT^J
M\$?5+V/1] J6[U^Z<CT?<9ZYVK1CYCW]OUEMYW/;HT+?$W\'T:49&^#YO3:X
M FKBEAN(/&HP1!@"0&# C3+K#2[Y02=KDL<Z-"T6X#I83 )Q%,^,,)__ "63
M1X@,,D&+ XI(%&A(@K;DJ&9)@AT58%2%)9QW2 !,&6NK%N!URZ<>=(Q-C:(U
M[^ASHMGC'WIW3.*";!Y:\[:<"?E[1R;<IN^IM3M$.5^N9I=3TGU9>U)M)N>U
MHHGOUG^5S>M>+UL$^O778FU]&U.%R9P1[Q3;''8Y[]6U.&6V/8QQOVI]L><C
MH-]:CTQ.;\LS\?3DV8Y2=G/1:@TUTGU/KO2[Q<]8\_E,GT8A"N%"4"-R$(@9
MR0<:O=+ Q-BM2I=**SHWXLMQ/>C0E<!D*DBD)<?_ ,@>BH\.5  "J0 58H-!
MW9:,/P7NFFIA[ 2S B@"+1.RJQ/Z[Y]NU31!/L=/"=J1IU\P/7G6&;#'6<?J
M\-[T<EL?V8Q/*>E6&YV\AQORTKA=K^<<4VG,IY.=V--);:(FY!\1ZTJ\8X/S
M)X4+6W(O[4)Q/K[/C1N.PSUFW:F>%'&?7-0E@^>G+6HR(WDC3W^[UZ:"W.]^
M.>G7;E?;77]8UTIK\VF>VFP9]N'W.6<S?%.3:W+^1QN!B]1Z=?W'2$I]2?<Y
M?9VBE:/>E:GGWZTR>3BY#/,4@R1+:<%0'#(-VT18H0*!<T]&*RD)@1%/_P =
MFE,[*EM9)"@T?:RK:(.RDC=/ETCT\3(;9F,PXCNS-M:2 =DWTGIVDNN*DBRO
M+V^B_'6K0QF=-8LSOFV0A9I,)JB(B)ULFT-^L4UKIDD(9VG;4C1T29D2V>'T
M'4@X<3M;I$<(TZ:\*(B9</WO[\Z(TB_;E-]KQ^@+Q/(7I-*['2TOOQM^J&^=
M/1/FA<7O;L_=<9[/NN$\=J7-I#:'ZJ6R3S@M[UP\SIML.OWQJ^]5R+L9T>$5
MFX&+1GEJMCR8Y8GC'2^#EGGF@O;E;L)F\^^E!./;WXO;!-,3:?-M\ND<:A<0
M^:^D/>EE);CQW/"M4[?5)N>>:4T=Y,TO&$B6$%<0XS.D^SEA$I%__&I(@RCR
MD2%HUW6Y<#HQB(HS)1"0-[$3>);&9@&T\7=@IU%Y;MG3? Q<BP9OB78M%S55
M-Y'7:#A?)(MB>1B>#V=+; B3&""6?;EZ4K APA)GBVFP"ZL$WI<2LA@M>^M]
MYDM?>G9$AC&+,QOO)I=X0A9)DP1/ B\WROH5&$VBR=MI>FEF(M0D2/8TCG+?
M'#G0M(O<(]+/*3M:@&CPF+&U[6Z,4"T':+3@;'I?.;4:X] ?MZ5(WZ'#ATZ6
MY"=^T>[3IR<R/;XI&W35[?-9+//GKB\<VIY^O#:Z[ZT-Y+WY6P[>A-!>5?AV
M#4G-KYM1%P<NW'Q'2)JZ3[T)_?W2Z,,Z>G&V^#6B1DACZWQUSRFC) WY^<".
M25?@DX7?,>12'.?6D.6]'];\6!G@)002D)L<GW<!9,@0#-(&O]H$D4#@B*?_
M (PU;>&80R!O$BZA+<EC_ +1 OKIRV;LQ%M.(S&L9G)=F@M;!A!B?6][3C.U
M#:W;MRMJX'&]21"SM'"=^'/+%(Q [0$N.QMRYU)$PUOU2>6CRL46)-=MEWYV
MUUXT&/&/G$1)VHC$GO@UMD\M2HL[;!\]:283>"_.\CUO0)N1RU=[W>COO0!G
MESZ1;A'6D%@AT]XS!.^E!+Q,:STQ^J@V.Q4!@#_!30]O:E/C#'GC3KI/+Y/W
M%M*=-M_$T@./.B9L>3IRVF^-:.*%Y8TCGJ1GM0+GQD>ARZWMQJZ9<NESKF->
ME2"AR_3X\(JPHV?-]_GA1R1#YI\<][*D'"^M:IV^OJDFS4.480)@CO*C4XP@
MZ(,:DERDT_\ Q8;'WF?CDA1"-5(4ES=A74H@#:N._P"DBTXNWE^IP:YI6(/-
M>;N]L-.I)Z8]][[\J$B3;RQC3KPBK!'!,9;'+:UU<%RHX4BS;6W!OZ-DXE.$
M)AVM+NN(TFZ8P5$-DMNNVAS[<2OT,'$X\?&L63?6@&#\0N!:$T[^34^C,[-_
M3XIB+WI<FW.YM?<KF-;BQ&9@;[RNV*'>WHOOCI2S(=OLKD>E(RKU*CN^GU3M
M]?BU*-&D.>^M23'MY;@3C2C2Q[=HQTR!3IF><GF_63E4\,MM,OOO>^(F:E-C
MG&,OKQUOI4LG<X[_ !.I2I?9WGY=+SI0R!#YYS.%.D]_/-W-.0D3WYTAFY[T
M]G2*0:%\FK!0H.$?9ED@B6!/_P"*".WO\!INL @0&"OI1^E L" 4Q2\$:%T=
M=_T8XWQ>L,[=WLV[S8X5:"S83)B2^DCNC:690 ASO&)F-B[C0+)+0Q9F[G&C
MA.<0.!O206N2%MIB]V+_ %>C(DG&;<9WGV(N18H8--!F+8C0W]<EE!%HWB/O
M6*%?7;COOTY7(J)@XN%L<YW@CI+5EQ80&C:YB[-IK7,<G]X=Z$"FS>8;]8J%
ML'=/8^:@G#>R4I<G,\.V_I1!(*:6TB=V_P 9J\EL;^KB<:X?O]U#GU]NM+SG
MD#Y'&HFY-XB)C?;AC3UBTB.'UTR6SPI/3^[>1Z4UV$==M?6>-(F:,ELE&<0Z
M\.W*_;:))CEOPO&GF":<&18F+3VYSP@F]B@9TY'/O^[60J944Y>N]K^E$S!#
MHQW^D[<<@+Z.\>?TS'9+>><2H+-Q\[TARW^ZEDW 51?![&-D%10"],H2C8%4
M8_\ Q*NXJ^XF$+!%I/3*ZP4"JY#*'(P=(F>?D?+_ "F@!P\\V- 6)(8F/OC-
MHTOE9#T;<;A$\(L1P*QR9+VY7[!OI>A"+CGEU\6>,4UK6X&G33EKMFEM/._+
M2.Y[TY%NOP'G.DA+G3KKMSEY35\S&MNIZYB@QDG8YUI1G0)6=WGG3O64+&VN
MN8@U<UAU#.3322_'79X5FE-[<.-' I<)G&\1>>7[J-86JS;.+09X3>=*9H.$
M1%O5/NB;F9NH8T)0L.!G8BG&"O 8N9<\HVM8HWRA,:S?K#5]9B73%](O20R3
MOKMPS;9=*AL8-SE=[VN1IQQ67BCB^P7X3%6W/"WMO\GJVT\(UW2+6GKZCI9-
M/[K0.;,]>5<)F^(;?7#/*@1$6[-KG6-V8MPJ:8+7BWG VAAI2[=I]Q/%+'0A
MR4WV\N8TG&:)F2Y?F;^/)S.<3][#CA#VJ.SCU'[\W*@LW&A#PTJ?%2@-T2_7
MH!B\ZZ "M32=A6W_ /$4R75,LC9)$A5)$%$)) OQM][L;WO3L0!BQ@G;>_!<
MN03 B%Y^N7+JQJ%HX&W+'':_.H!&CR<=CEO+84W.N]_G3A8W4YVX9P3;VKA!
MB\#]8Q;7O0ZWW>UHG>_RP4-C7:+3P+'.9BK03$[-_KSBC9!9YBVS)::BKSI@
MMVO;%HQ5]23F20YA#\<-:TJL;1A)TW"QUH" .N VX/"7>IR1U0>]N=-]$<37
M[YQ2FGI4YPSCQI 8'&H,WC0G79^*/4$M:# F0L,6OCH48XU9#C.3;:]KC0WM
M.3VN8]#CS.]D=NC-]_7:;4&F;[2<,W7CFTTHQ+6T!;2>O"H)MZ3/?.)UX-06
M?7EH]3-N-3:YO/GKOO3Z+Z\B?UT:02&C6\8;],\.,VMK%12Q:?3?;?GK+2"S
MEWM^K[W(J5"1YC<(\@B%8)\_L.NO&29 CSM[7(R.<2YA\\Z-02/GTUD'H_-(
MC#0N .RJ ()Y@5%>INQP@%@!#19OR_\ X?;PN4JYF9&2AB>B3(@EYY"^>4J*
MU-"+"1I,:K).A>)CI3MG);U_=E=KT[%K6QQXZ!Y>*.,EIPS?5GAC>C4A,0$3
MPB,1;KVH"(\]_P!5?E.D7=OU3!YKV3Q36'@W8QCEL>7J:$CIZ;S)Z\*. -MR
M^V.#WS$A4#9T"UM#OCV:>""W*#ZMMCG>INAT+7[/IRIEXN</U\U,WB.GJQ\[
M4,"U<+&/W??TBLL$]*0T!Q'/MU]*"$!;@/&T0G8XZ5-I/06?4--L5,XON&UT
M^5FK#!F<GI??'+E27(Z1WO\ =\E1Q))+HM[8M6VWTU_5L7P5&-MSA%\3=Y^T
MS6^23M/2+</JU,+%S7AMRX.'WF(XVWY7P^_M SQAY[]?,T@YJ0;3TS_/;A0,
MMO.6/UB2B9DSY?/1VG2IEEKYOF8ZWQS+WBZH;\H^=N7,*RV\^]MS5J:=S7AO
M]^]JFMJ8\V:29&DABN-RZ& %G$)*(:K9C6S<*+%0! <__#0WE"7ER "A !5@
MI9=.+-D12KT90J5'M,]>DZ<;+4V%[<^4>DOTT,RD()8F-I9UMY=,",";F"0'
M2^FS-@NU"N0R);BE] B$9(TQF75Y7\M>E,]"VNOUIRO0R2,V@AG268MK;O$3
M6%N;VBW;7CICA44$%XX0\'SE$4Z%B. ^:>13$^2]_20Y\XK$NF%(CD9O.=WE
M,9:-[7[:$Z?-TB\1Z>6XGM03"=OW7"]6H#!'YW">W:@UO.IFQYO27%O7YI6W
MM]_V@>,[?,_N@<6R3IC6Q+[WFDB0N\,Y]Z",#)N1OF;P7@-LXIXAJSAQFVU^
M&-(I%DW,6OI[\IQI0$IK,:7=VYO?XBI;&\V(BW'?A;'.E&'/IM%M'F6DBDY/
M9H2)VJVQHQY\=36BOXOEGWF*>?9\6]-I-<1X6OOZWM9S?/ *AEC.>/MC;]5J
M&??^^^MVM<MFW'4^NI4DNNIO'S0D]G:E&>^E&7!1S3A- B+'_P#AM7%39(=/
M[=G8E62+H?$7U8VTB^NTTD(Y8'WY\(OU*5-@F"(OY=V-J*T!Q6V->!G%U:%L
M9)&U]<[<%,6H&V#@>=VK;;,1Q@GGXZ5%$%XSSX8FV9QF*9 $+J3F=.<1JRDR
MQ48:3,1I%^3OES3+9;30FV/;UG,D M+&DQG3ZG,T #%C <,W])WZ5!!8#0\U
M]+= #'^E:MSM'2-N/^",B:$1"^X>?PO1,P'-HEOGCII9DHI2:NAW?C;M! 1.
M;!SBP=(M?;-2@C=F=)YWB=8S[67.%9B)VA9ZL<:85MQV>,$(BZPRVJ%D-<1C
MSTH$EG!U)M37\/.DWX4+/[SD]_?8*?1YPVQGK8LPS;>_C!:]MBH)-+]M==H:
MBGCY.=XM6IJ9Y>7Y4TR=>%)(F])D?.)[E( TZ&!=(F[5A)__  L* J@ JK !
M=5; &6E)6P4 +L7;@85,4<%KH"=M)D]M: !>"9C+%Y75F9H@2;2F+Z1$8U@M
MO::,#+;(<;$I%S99P8:P!W^_-JUT8VE9<^X35P@+;Y-[\#U=7.9K$.WQUZZQ
M4$6&_..FVG2:QSHP=&>M_'4P&"=TEEST/WPJ"%,E\[WVM;C[20"1/$MGVX>,
M==O7ZVUJ/'7KMR[-*,2]/)Z?Z4'-0>><+VY?X)(F]$B L=4UX3O;CK42F)>(
MQC-S69<%J=<#.!TTMKJD,R221<2^>MH/IH9;<8Q;WDC>(VQ0#PD]1F.4W"AE
MWEOQWC%&R1F(;"-\N&S:\I:9J.3F<1M)?98ZXBIA9N'M\,?S59;:^N_!OT8K
M88EU<*6G0U9U-K"BX]5-8 L#C,<,T@WTLGGF*$*:?=+FQ;RUZDQD]:=#& &+
M4E?65Q25H( NP!F:JL4$/_PIDEB8?4WA0'D1.$C4-Y^>? .=,)-"8TM^HPSM
MJHW#%G2)+;;;CMF*BT0$LF)RLV6YQO:*BC7S3?RS-.IW?WRQ:F(77A&TR9F\
M'"4F:3$7=C%_11XQUI2 )UVG3L<=*:1JX8[X)-LZO&$@DL9?[FVF3N5=&/18
M/F6%[U EIP[3_C(S?C!/[G3ZBD1C_0@Y\\BD.+:;V/,YI1Z8OGUX7_(DCC4D
MB"9S)>T;X>4'2F1(EVUYS\3Z7<UUDK:)VF\7F_SFM%F>./I=IH9M]VSRM1AG
M1J0X>?4\*)4AQ,R7F_E[3BL,,W&,.V+ =LNU7&$(NZ.)@WG.93-\6-TSC>V'
M;9X[U;;7+"D6;1N!*1O,FM1J,X18EO,+'"_!-Q4 .N&V(8SK\>]37,GK6MHY
M\XTTC)>EE=$ -++8 A_^$W7J]D162::X% LP.&!EM?R;2&G&L8-''U\V..AB
MPE#:^YMW+\,U8!#JA%O(M%[\V1GM\OGU16'<TRIAUV7;&I4R/K!G=^+V.L2Q
M9XYWP9C-UO5LF$]].WJVVFCLCB6Z&WIZ6K"1!EMY>[_+4(<+]9ST\Y_Y()T?
M4Z_/+_4D\'$F?/"F<LWY1W\[TO3-_P!<G2+G&E&>/IZQ4K;1_)ZVGM1H=Y=?
MG?&T:U%*:II/",F=]ZLIH/SR\C%8%K-^MGUO9K-P_GS0D=./G"U,SN1\?04-
M[[E]Y<<[VG+4PVN/ ATR,.BQ8Q0)FY>+D+!=U@5W78H[^O61];UPRU\%TR]H
MO5YG4Y8M/5AB&[;6D11R?@(Y^^9I6F&8.@FV:&3ZT8:904LQ4&25_7'_ /"!
M>J>A0\X$*Z!0]H,0$!%A.!<$K4HZ<.^+]=,4J8;&L#//V-=DJ*3MMCN<K\<4
MXO86C#VCYM.M,L-<$,G/W_M3@(-Y(S"9Q,:S92VD5"63.-+&-\1RU):9B"+V
MDNG)-9-+7AB@))-K<\&EPZ^M):!F8CTMVW6V"B :!C[WCU]_\U!_8],\G_=8
MC(EN]N!GA45P66>.WQPYU(JUYQCTO#DCK20S!+:"T.N;QMQZU,32]Y#9W[UB
M1O'Q'#;3\9GS9\T<;+]37'ZRU-,VRZ9)^9['6:2.G&WS 1QK/YRS/#6T]:.>
M#^O7/W1PSI\P3VB*0;VLI'=FP8@M:QQ@"W\^JBMHG7S:D&>C]^<*GX1>*!)7
M9Z2P  A/_P '9R(;P0"(1JN1<*F8<#&=(])USWVV8GK\=N-6*$6FSI@C?SGB
M!GXS>^.MWC2L8Q'%8S:]XSK268<6T&;1PC7H<V1GGU>WN;WIT39CO.?KU;4U
M@A&&VQT(].E7 '?M;1[]5HS '3S^_P"E#GCZD?&E)%N_/L?[1(G:HQ0MD8/@
MM&M7[2RMS1DSZL;T@KB[RWA->16;&OR:3N4!7>U]<%)*H2\.VUM)V&#W! AI
M>"=/<L\]J;D9U.>\\P=8@OFTAGALKYWI+-O!X7O[UGQ?A[<I.U9.WNG:==:.
M;9//:A.B3#M.UMXV[V171@O'6YPQ^V:$B=J'J1U/JW:D<QI=Q" P,0A(01!$
M1!$PC<3@G_X/DO!EDCYA2DFH8M8QF)3@YOSCEQFTL6+0&.UUMY&YANWQB;QT
MX<]:)0F42E[6+9F=7$MJF%M&=<O/VY;2;*)Q@_9DQC7G31<$[+QN9EVM&^:U
MA%I=HV/5_=&+&,[S%_[G6D218C&)?60XLDNA_J8O.U^507DCM^NW;_<;HFTG
MA]2S&:E35D=F]FURYC2]91G+:,=[W;9%FD2\<87"N'ZI91C0O.4PXXWW2=1"
M\W[^:U<(]Q^:!":W)]!?6](,)61C*WCQC5)ITNEB(@)-O0;1OF&KPQH3QFZ3
M;63C3IDB/;.F=3:32C>313Z^:Q#I[F9I0BSJYSFT7_C,?B8G?W/LM11=)P\=
M^8WDX,TT2^A210MLM5ZRE_\ @TSU<1"W4PB(SC)I3I;S$$S@C360D?JXL[3"
MR'N1?7.N]0%9C2"&>&AK5\:K?:#K>74W(N138#-V.UNFDZ*[S"1TB,K99]F[
MW"B D-[')C"?,]9,F)C;ERV[W_!CGKN>>'^M2W=XWX:=RV^M*VC;:._==Y8J
M5[8SX[Z:\*EUVU.9U_UP#@^=XFK4R,F_]OO$F*D;&^H?>>G:HCPTZ6ZS%C9J
M),02GGKWXT!4C7VQ1@DY6'7<EM;8<!K5Q:+VM+[)T:''4]N]R]PH7>#X*SI:
M"++,$L1KCA\K(M(F(S-W&9?=@+O?R^CR;)_*$-]<\RS\5 &Q$O',QNW7BS%L
MM2-QP]Y/:C9'2_;;[K(]?O[:LO0+40G4IEB!:#)+_P#!V%5#(G,A$P"(:#NM
M1PA8[N//;I%L3ARWX\6=\Z9SBI@<?8+<JF&+Q$EW=-8SUHEL,&1>,F+>ZFU
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M,5-QN.^+(RQMT"J+(8 *A@:3=ZZ>L=G6 X-\]#)P*N>!YZT2A(LV9ZH#A/\
M^'$/"$KED6&C&5+!"U"@V@9O*FG;QQ5N^UC,K'72[JGI0JG8_OVW=J@L:C0$
M"34X/LYQ2V6I#D>7G>:;;6['E^+6NW7CM\T H B(W%61,)>^Y;F]H5=1'&>+
MA]NK.5 XJ$%$<0I!I@\]E2E E'*0,;?E*]'PK $8A#DO<2H!<;^5]((#V%AR
M<Z]9B^%E;!#$!_IT=?BL0\\O5QW?9H7>?N36'('U2C$B[BX7&)E(B_6URMC
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M86TTP@J:Q30I!+ -P<XH/M+-T1>6D13["8L![3)(@E'Y4H,DTD",M5811,P
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M@24RH<&Z=+%HJ1X'K^%(LZ\I\/,UF<O/:L=K>/&M>N;N\8G;ZX461L*3V #
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M ES!?]>L4#9$C>8C2-KVNNX9LZS $7350,A,I)CK318D-I\"R818F%(C(Q
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M]3-W=X>3HXS8DB\H7_NGMVI/,),FD&&=:%L(*%/> RUSHZQ?,%F0HY9P9IB
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MJ&G,C$:421=D LX,R02MC2\PC)G_ $QY@2+5)N=_Q.9>=_>I-SO2&O:GL+Q
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M%;J$60RUYE=O4 $,O-@;T/O,((U/3@!/@H$:=0\GUM(4\&GU%5[JVTFU005
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M8.-RTS=MI<US%.%X9X$<<<,KUH&8"7.YYB(HEPM/$T[>VE+.;%]/.$^U ]V
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M'[B@P9VRQN^9YT4"Z;6SMI/>M5=&>5XCT[=2$W86P<7N^E10B\%XV^6;<=J
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M]E9&GDON_>O1I; M_P"</G',@)+ML$Y[3;G0 $2%KK:\/Q4$!I&F;<M',4$
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M]_Y0"0:[Q;/0]\4BX;_/[H"H[OO1W06MKS\WRZ5) V\_G'CJ2LNKK^WEKM?
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MX[=YKIY:<HVJ%K<7.7CRKE\=:"9 Y/Q/S5P8%MH<;:;W]ZA>Q?@??O4-GI0
MS#AC[J$7CT^!]Z#-V.'JY.4>U.X)O:_7Q]Z'(OW>1GPQ-Z@B0#;5C?QI+BSZ
M?J@<AY>:Z_HH+V"4FS2,<.Y+F] C%B,D6<VVB\GK&$D9!9Q\Y-)VS&:MD+7-
MQWSQR5*F,YYG#WR[[5DX?=D^KX9VJ!F\<77W[T *)'-$F!$FV,\.VKZT0;BD
M!^K/?!UC9#EYY[4Z6:ASXRK;),*!H,^*')7"B@11/_54!5 !56 "ZJV +JXI
M5'1+H9S@HF(I$JWF'8+E-D(%0Y#29K$#)*4DH*LJJR[:R8BVAPZV^J1B1;FE
MMNA;7UJ0+9)IG-_.EJ(&*SB.IF-?Y0:X"]B&.&?.)4 (!8B#VHM3MQR[1U*9
M(K0NE[;:4RW7YQ&Q'3/;%.ZN\O6)GM^UO?KW[7X]*XWOZ:]@LTJ[^<9?:I32
M.7U7&]#ZI1=#YYZ>6IS"\.WFASW3:7O:\^1ZTOE4X8SI3\(\[!CM6%RYN6TG
M-_8U*@4<-DV6V=-J,J@ J  NJM@ E<1>HP.$#(^9$1"07!)$-1QRQ8H5R%,"
M+"<O*'W 62$6L4RRR26)AX8((P(H1!LHQ-&>P*"P(NV3%+X*'<,I.95ADM[A
MS4*;Q?D1:I5$"8@0! (  ! !8#  $$0!PJ%>[I=^Z'BV>K]>M.EI;R/D=,^D
M8 +1:2'>?0T,XNZ=0)!(2VP# D"$<X,L5+;)&B,HA#/"M2VN+B 1T)&02RET
M0B\MV(LC,3:BF;,)6"9.0+MH<1J2"CFA)&^)P\.>\NLTJ*)(&,XD9>R^CI1W
M_!DL 4:*)^ >T^8U:^<:AH1=)ZPK)%K&F='0K%@R3@%3!*$E)[]_ "QG O%E
M4\0KW!+J I13\YZ;K/*QC#8UYQFB6'*3/:+V9=#[9MERTQ>\X=;1,NK>]*Y"
M3<1MQUX8X-"Q![RC\N"HBS5HD!A)$W  +P8 NPK%FEC*'<RM,2MD2(J)F*3S
MV <(' )%$"%4L[.(('8 PO46+DRW;0ZWUYO(TJX S*YV2$W&_P ZS1UNDH(D
M=B!%4!IQN0N@&8%%"54 8 4+I#"7EF +3,S-/W ZL0H$C!=M@1H-RZE2JLSE
MZ*,,-#-X',&LL&U(C8=S"5(]YK,/:SPZ3+[Z!^L32).([NEX[]"IEEPN]]&<
MDS\TTYGEQG7YNTS,MWA83'O[3:*B,W>\;_'\I(6Z\OPB9/P@YIV]OW7]I\?2
MAN;>M2W].VO+O2MSC,EZXKGYPO7*];^E28OT?JI6)M>2QQXARI$$1<.GKYTF
M70P:SG$F'I6"QOST9TGO5X1 "1"$$1$81D<.;KQ12AD'9$8T)DU7HG<KM@<8
MHQIF-)"4LF= 3F"MDN9I<)001)"PB'&%88NZ%$2(+ S-"9L++)T$AZP0B"C%
MU&%$W+U,#8.W3?CVY5"P*3H_+?)4-GN%1T'OWU_E0UMP5SORX>M1VYWSREMY
MBM-O:]YW^_:#?+U/OSA20PZSK?>SS[T@+DS:6W+GKI:H1CQKCYJR$2>6_;YX
M5'>.!CUHS0OJVMG=F9Z)I2>S 0,^\XTB@ W:W\Y30C'J/O\ M+UETG[K.($S
M$D8J*\-\V<D;:7AUX4$&\397CB.X.@FM Y,DD+DDO#OC>_&IKH)6=M=MM=)S
M4>&%,<[NA>T&=6*64D$P[S=/K;;-9!N#$IY>.U0<M//)TJ:(GA?EL\O[0L"6
M><V2,=8H6XA84Q?KWWTQ3 #7A_(_E+=1*ZB"=M@6VJM_ZDP!X"HZ" L(53W:
MVA'4 D0&F"N8Y2363^VCYH7X/$Z_VB1J>6N_4C7:K8VA&FFUO6UN-7:!YIRT
MR<H()<,6C33SYJ*1'$QC']J<N&-]>O\ ;;4LW&;#-XYS&(F;T@RTF)XVMHVX
M<+4HK+UVZ7UI!K[?$TB<_?G*D=VT7]9[PT#VMRXQY.F]*OIYJV[35BT<8X<_
M)IF&,Z>-.&-F^M^_K3F#SC'K\5)M+H?LJ72_6;]6E2QJL8Z&NE%IL0S ][^>
MM&&((?GG:G5<*%RB L0&5L"L4,=FTET [+889"B2,;F!= PEQ(08E(&BP&7-
MI+R",Q@1!>@6S ,'XDH0"$%2V6XQ^,%,RE&L41YZ =@206])7/8SYWI4 9C2
M[._B$T6I'CG[^*0EW;U&/+T^/LCB<W]\V^MTY8YQ[7^JR)CZVQ%N$TL6<E@@
MX70XOEW+$O,QH1,;SQ,9UJ!UF0V!PK"BEEU-D?@EB:9")0.-2%%@QFS&D$%K
MT(AN/ZGTX'.H@%TDWUDG@^X1A!E1;-_^Q"!I3JSVWE%+SB2,,4)(CJ1WH^BI
M=$@Y*GK@D APN$H&Z4 90NE@"009H9R6"%:0LOE066 5IH&6LSC)).@H$K4I
M&I#RW#VZT%R4(%NLZ^M](H5,WEMPV8]7$T@AF9QKTH6$0E$B ENP09B+;4KM
MQ!'P9 $Q)8J(H!$O8X8<B7)N+*"IQ101"*TJP,09"1V@P$QS=/!64A2JR"YE
MBUUX&6_6KBVTML%K=CCB<E.2'<TF;=;&=N-JL2T!6$R0,.S5LAQ$AE01FPS&
M!UU$BH( $8)0F+H6!EBT7"!\Z-11J>*&)89M1WG@8A<T(M%DAM"#S?\ 0 :J
MJ4K,K>;3WETRVG%2+=7G;GMZ;5*JKSG/ X><:.\,V[WW\Y5EEECMMPI<K2KF
MLU%P/2:OQ,<II<_1/0HX._[2@Y"?7ICVH$7'G--VAF0+;#^RO**>4-).<V\%
M#YCM8OZ$=:'KZ<]OKI1T]6/4*&#=VL=_W01$/77K::X+<;_4J)<'"R7Z_P H
MD8<#;&)Q;36E!Z^/$\F2(<K+)]8+BM6",B!%4*NA P+1C&+$-KMKD:E!8("$
M#I @P[F<VI"X(8Q%H3 9MD8E+5,F2)6%&1MLX3%#H8U?G?MSKC.S]%=[D=?)
MK<OVSVKM<B>Y7*[%=[E;H:5'2#IYSI$N.[49Q&LV^EI.@.SMB6W[HX3L'W0E
MTCU>[,4;.[]U/<J>YZ_5/">OW%(F1J_I[G'<_59-F>UO2]FC VX7=-.NM&.L
MW WUS,VTWWU%FUX1T&=.+USK>XF&^[),O..IZU99A^,G7;>'A2,)?QU]GJ4L
M8+#-\]'AFZ?+XKN3Y\^&E3(XA,FBG$+[7WL!;0DG&VCY/I(*# LUT8G  1BK
M\4\%D9@@"0:#?_2&Y9D/*5A\?8QKM:25H8A$&P0@GDEMOOYUTB,P"0!=CTY^
MG+8F '+7]_/+%Q,6OI\\,4&!)C?]-!1<@FTO70YT&CQV(ZL3Q]*1##QR?WMT
MFEA)22SOOL?Q:<L.3*[:-_U@"*28Y7;\_/:Q";BZ>-2 !/-Z1:'K+-*1$9G3
MWOGR*A+A&UI;9OK.<5'0ZQ#[-+<$[VQSB'IPH,H3O]C0'F\Y<KT1T;[F/.&V
MU2P0YSV]3?-%L.6]^Q9W',TA8)&W;SA02\^>+'>:15T%U)N\IDU :M-*YP5V
M6HQ NQ@M7&E(H)1?"17(441&U.F2J"K"S*Z@*@U=(H*$M*!%@$LI20&ZDXO%
MTZ;$!A <PP:<-+AYU*=$6:*::\P/:W L]D<+9Q;?A10&C/IBT>EMFI+H8SPY
M<F\QZ3%R'A%^ QGWOWC"'H3VMB.>UJ5+0&%U[::>VE R97BYKKSSP/:C(DN9
M""W#A/A*50UO&=W,_P!ZSS!V)]&G4LT$M7)4#"-1+&\BJA"EPW'5+]="RP@P
M*.@( MYGIZ,:/V-,)+ZZCM[>_.AT/ RIYHC=A%I=A! R0@-RN*SY]:U 50)%
MEIAHL.,.B<Z!84(2D.^<A-"$ B$R%PS1?-BAW?BS!NA#:Z0O,EDV9(;:"RBB
M+WBR1$LYOVQ-2L$E]^,O/1RV-:XM=T/A<[;^CN@<.^=^3^YM2[QSEQ(P!-86
M8S2SU@*=RJVZ56I*7\L2"0Q$J*2R5:+(4H(0*HE8&$RD(% 2028ZDF/ 8IIO
M)>6A#>%KN8SB,2Z:?"(( R\?Y]8(HL0:5R+/I=$2)%*$4$LNZ92:.)0$I<(0
M0D-$HJ(()\P/C"! !(@"J%B?3.)EA$EU0L(*& G0P1RW[+2,W>0WG6YTN1LY
M:5F%,SL<_ES.T7WSKR_?:]+J8_;Y'XF<3+FU^E#N-N':=:-5)M'[K!;C=]']
M5 F7 9^?U>E7!#&D_H\F* [M,$3O;NG;2A6W7W8ZFGS?-+:SKE\T<Z\\C+B?
M,$U*WQK /Q1:(QHP[PP>E^%!S=.@_)-)L'G[W/:HA$;:DSG>#WQ3+7V\M8]Z
MA&<[P>U$=3T"VQM>H28#QB?UTS1':')]I0-0F+OQ9Y>6HBPZ_+Y+0R'KROTH
M[D*ZX6&9AQS#5^RL"\DM$EXFVR$B31"2^2(LF<S+CO4]LM9B",Y-)<^K3(.D
M F]L,::F;,ZPD"6W-O[G\!+$QQHYW7ZKA>K]UPO5^ZX7J_=1<$]Z\I_=>4_N
MO"7[XT+;EE[SCK2;%X?KMIGL</<^WGOI2]CQPFG*ST/FI),(<\^Y[4_I,6=/
M(ZU"SQB)9G>W>.1)>K!"MC@QID,6MK:\A1X=^S)V-/>IRD1-^<:^]N&E')-9
M6^;0FQUA]:"0EI4F=9MQG[8K8&6.'+YYFEZ[CT]"^9]=/Q(K1:VTEN=K1;CB
MCXLR1$Y&^?"B$$2Q!;-IOK]WB@%(Y$/+ZMJ7:NP@0Q-1(AH+D,HWAP&9UD[U
M!_\ 0A-EZ)EB4:/@<:F./X'*@Q( @VH*5 $Z\VV/.>M)AV>VV_+31V( 6G?7
MS8O4$6"V2V?.EVIL8J0:QQ/EJQSF/#SC&6UV\UTOQR=:BL#!G];XTJ>U\S?;
M,[SSI]N3@/GEYJ6_LT(7NF=;:U&-IR)]I\=HJ$8+\M>/\HC,RFZMK^ML1BH-
M.\^\D]"F+<SR9=L9?(H%Y/.L_%"L1EROUY>A+P3QMZ?&^E :>=/F: ,$30C(
M1MXD?-$F8+G#J[6TXWI\2%*==MJ"\]Z<8=$)2(!A;GM)"+56-)) TPD[ 6-4
M15JX!3+&_%;]..FP:Y67K>(A%U&^E-P$(G@.FA308("HMCSO.<SI-ZBBQA^M
M1]LK?2@M8\MY^I#M9?EIJWY_+FHQ0>=]_,M(X(.Q4S!=U:%1369U\WTT*.R@
MWVX=C?;G=)&PGIUW"UW7I1@09'XOK?#?XHDQP.7/U0X3M4L3LXYZZ[Q4+J^=
M&E LY90,>6Z4#D/"NA-.P01 II6 T &MD(@) J <,)GA^GT>]$@+L$68N.J"
M$D"D+=1#1>@'J-D(AR^U+27@2.\S(E;34+\LOE" !+0Q;,-EF0B8P$2XA%Q4
M7QCD" G1EB;I)1F'0'UD+B52*F&0[Q<TSKY!D*D+Y>WIGE&\4P =3?S2FL[,
M3'#]7PEY:*5Z:!65&]:(+D14D&2@.*ST4,QAC$T[)72Q98BREF+@C$(L#P5;
ML)X0D'%TPA#&C>("$:$+RZ4LS4I-\YUGS>GB"M"_A(%2Q0E;31 $194!#QW8
M$P87A)3)T$R&)H6X19R=<%H+,2<4M-8EJF W20[(A2XAL6'I%C!'#;6F&\\9
MY]_9S2EOKU\Y<J*@,:U<$?/M-(T7U]HJ63Z>T4CDX_M]:<70=M9DP>W.AQ>7
M;XDXUM>M]5E*+ZR^D8OY%)&'& ?O3WJ1GPS?:""U*7M^NUMJCS#?7JV"VH6U
M)J#=OYZ]7>MENY8ZYJ#!Y3AXQ\SPJ<P=00=;GK>D=$7G^77MQV:218S@F]NE
M0,3[>Z1\=8I#@TM/R>U+?V/8J)@G9D[Z/>G*+/''D4A= Z^T?%""R!S^[T((
MZ?%&<V?.O2C2.=/TT]5T,";##JR +-FK"8&PFI?2TYNE\ZQ=D77<TF<A9Y:<
MZ:X?BU\C:+98C2] Q+;EPTP1SAH#AZ>?%",48R<W]4(W*DNX^:2+%O.M =%X
MX\]Z6.6@3Z[]Z(:=TMV_= ;<;3VEKG/G"*BX3WK;[CWF:Y7U\X_JF.0=OBLJ
M#7)/G)G,[3 MGDZYOVMAX5=QGN9U,I;.FABH@:.+>QT>7 A8$NEGWQD@)YS5
M\ELPX%\6F$PS>HEB\,>\3F,1WWJ:0==+EY6W?VJ!Q;$8SRY1;7,4D*?$>E"3
MA>>O'S3A2*!9OF;7%S5@%X]+[?JV^*B6V.77I$]BIKD>./73ATS_ +A,3K(4
M,1_YZ%)5_."2"ZH05 H(G>)*#$%7(*'4#2F<08_;&^\WJ1".5OWF<\-Z  W$
M:3GGQ]LXHBX1H_'WEG%1EA&@$0]/F-<4BLKMM//+K-,YYK>EB/F^M0EN+0Z6
M9\Y4,A9QGY:FL:+1C6]YO[^[*9YIH*"XV+3I;/;G29B,Z1;MKV:)B<$TBVG3
M?A0;0G6T^9<5<QV7K@GO1&D:;7\X^S6:Q?1UO-F/OC0:';]1WC;E2';SI3"T
M/2/JFVWKK387:G)NWD#3KY--%MXEWO?B6M3_ &)P(+ +,4&4 )HAP:+5Q'.Y
M2VE#0C*)M3(!)!.8955D@5N2LVG!NYE?N^5(ZIDDYPI Q1<#0*CS!<@" E)6
MN2')QMYU<]+4."&#UYF?-+A:TL77[S?Z(*$BV/?;G_,4(+7]O->-"6.K4EBP
M>E'!;4USU-];Z\BK:Q.F_0V/C%Z*5;C//'?7M>:,# 0FZS-WXSRK+F/GYIVC
M.?OX^IHD 6O$_/KY-< H%Y&=N&^D=4* ,&YZTN8075W DE+3@-65\6BL-S4\
M268PR%C< H;"+$,X,AHJ.Z(%E0@6S&R&OG;4S/NQ,:1*5AD#I+),!IT!A+ 4
MF##T!&&=(X,.$BQ-R.3@F"[2"@KH;YO#(X$$$0CX@L1$,+'6R+4H2PN74[^1
M49D20,\ QSQK0K$& .%IL]233DTCJ"<D165NJ.V"A,(;P\I>MBW<JY(1.5C-
M].2,A8; !H^7'@8T PX$@WE%DF<#1+  !!:*2Q<L&O/IQWO4E&OAF2YNW0,,
M2'4/" "Q*VN %KJ Q(T;2ONI=4)O+)S-X0I*[W+X)PJ!Z-&$?\Z^A90+J7:3
M=>T(]8Z5+9]?JIN1ESCEFWWVI;97LF?0O$<Z=L_;MYBG8[NEIT,\Z61!;E^T
M[4"(%P=8](EII'J])[25:PN_VWKN]J%T]GO>U[[4$^H%NW\XZ .HTCG@TWM.
MU":6V9.WGO4 D#O/H%NM0V [/N_-!UCEMV-:WU[K]5%,7G?3EFO :3MZ1/G>
MDFG>2H(L6W+:ZAZ)QHL03HR^]7D&%O[GUZ4X+9?/JHYWROFK199B;&M,=CF_
M%JAK'KSX_P!MFME>C..?GI0_E9OSC;A38F=KMK[3/A:@J#&2%I:MHOF<EKSJ
MEL!-MG03U X32VEZF(G$Z<?>I^#K%E]I@DT3T7 NQD9\XS[4A:]]O/;M3-G3
M7XH*P;>?/K6$X]W:_K^ZMW#/IP/.=!6B?-#3WXT(((.K03-_:H-CL5!L>?P[
M?XR%K1VO4T.,LWO-YXIDM)TBH"Q)>VH[V&S?C.(EHD@C:<[-NW62^*N43=DC
M$$8<R:YQU:!A,)CIVW]*!%WL\\CWYZ<*ED,FIKK$[V[S2DB7O&^>]OU42+69
MZ7]IQ0DY:[;S^ONC03K8+Z3T_5%*+0A[?&O2HJEA7?F;7Q;2>5$5>UM)R>WI
M4>($)$XB24HJ,!C@*D!_:1 T</\ YS7.C8V50L8RDU"F2HQ""@<78U^;5--4
M&(Z]IU]:$A(-C7I<Y3][()YEN&,YN]J9^'W'#E4%5.5YTUWG2<<*A+$G"WGS
M0>AT(^:#T]OD:CP#O2VGC0Z'P_3UH9N$:3"\L/CTH,H7AG^1'9K0.WGM%((C
MW\.=!]B_O/Q1O$]N>L9UBHI@Z6C?QT3-:BOGUO?@T0,&^_KFU+XGK[?-<K@_
M?GS3%PSI]?5/H:L<OUZT;N4#PN0 56;4HFGB,);1APA>E<:8+C]P UG21(D
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MK!Y'O2.@ZM*@WMZC/'_R0; :6!,/ O:1.JEK,+Q4O6C>XGI%2!QN\OY[T9'
M%Z8UTW[YJ;'3AC]#\9JRZ<S![S#N4&!;R'EJCN^GU10_/N>?NT^2?KPO0AY*
M>>M-A=J4[%Y@[>=:4+P/W\TC;3UZTY8T*6!=J65=Z Y[?=!#>5S'3$9\FIM>
MTYO!RUS'$JRWOJ\=CY,>M LK;WZ<,?-:"QRF?.U+BH&<$:UF#(G82AL-D$%]
M)Q8R1&UXFAF*H@)>6R/&X$;SR;(>A*3C>38NLHA5N4Q;&>G._;>H"-7/UTH.
MJ]/RJZMB/GLZ:34 1EQR?2^:E;+I+N3YI/&2B %@"=^7O2*608S$.DOW?2@
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M0"X&-SZX]=:*9NQ8=+M^NN<5&'#AMF'9>44,3I?U_=ZG13/">KPCY'-1!B(
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MN..O*A (BWS']I0$CK[5<YXZZ^M0M.(UQ:?G%>E_?FA$$S;I;'+[Q18#8/\
MAAM(@!:LR*'@T8+3$L9$BQ(S.29G83J2)*77@(PQO!K$JJ-HV+8B6]@@LVU%
M:-TB#NT*0*A-$,1>\S8&2)C7*C$2ZJ)'G5:%#)@,2)Y(E L%"AD$!5H0815B
M0AM$J[!RP&2,:B;:1!+T_N>$7(>$.A.[1*,7+;.+H&DJA0LA$!(J\44;*X "
MC4P)8.(J2'NY:QL5"5)>*9CXUX:Q3%P1O]7OWHF(SK>_HR:[U(LWM)JGSVF_
M&:,"%(TRZ^F>/0&GMR!+?AOZ1+$;U.!F3&;FL[_6T3!S:YSUB.SJ3?BDM3.8
MX,R.'JYB*ME+$1.M^,Q$QI%ILT(47PD,3AF 4EDO$5/O<9!K"6%D6,ALF^9)
MUR'@(S 6%6ES'+"$-%FVR)_ZS9M9(X]'WO:_*F-@XQOSYVO5D,;[SQF&%=+.
MZ6DY%]9]/;O2<C;#YI>^MZCY''-KYZP36B6M)Q\W][T$>?W_ (P1:GJ?+R<5
M-))NB!N;P7>?&\TNU=%@.EAY<S&*E+7+ZI,LXYW]+4+8&)X=8B/3;2HS8SSY
MW^'6A$\WW$]Z%^KZ@^>AM9$;ZL--R&!LD6C_ ,DIRY@C(YRB#T-:PFFIE@^C
M8]J$'DGI;SK67,SX7??I%9\Y[%&2/,M2!H9><>3M6#CT@-OCI4I,QM48GMV7
ME#TOC%-IG2B1-IUDPGK5B>#T:EF+&L^6H);!W]>$'XB'CB=.?2\<5J06>_6Z
M;18L\M*@6^G?UM/K;0:0F_=SM!:F7.F#QC:>UBL<7]*TNKYZT $WU;]0.O\
M<4DQA>!RQ\:;&E0FISSUQ-CK1 C@')]<E&YO/I'/C[4-MFS,XM@[[T9,:=>'
MIKRH)0HT,>Q0D'G7A6 *&=A=;&N?"Y>U 2B\0;9<WUM-27B(?/W68Z'W];3B
M.-.1NA;N5CU^"IB;SB-YTX)/W_Q9  ZA='&*WAJ:23([U$+F2;(KC6 Y&06J
M.,B&]QBQ)E03""4892RR1=X*C@J*21=FVZVT9'C1+TL"$N,(F*'"VY,<E%V'
M1[OQSAC\PHZEU $HH$&C'%$AH)&8( IAK?,=&(@JC 39PZJ"",T6$U>KDC!3
M 6SA9F2+1K(H@DH;$ %D E\Z"9 1C;?^^F9J$@A"7G.'7STH0PP;MGGO&+9W
MC%!,6YW]9;.,^M#U2X@ A,X[4O1-HD;;9+)? H-1&"@_<L]CTA ^,%Q 0#-Q
MF=<WQVUVH<C.LZ[,8MBWI$3\@YVB)YD7P6P"IY2B3C>V>NINS$7AV0I%&BP0
M3XIK,*"?KUBPV$$ R$-*64G):I]>0F5U8RCCQCJMUY&2:0.<\M^M2"'_ *UC
M76-^,<_(K5)G2TDW'&,CQF[HW\^Z,WHE;6)B,QSP)&=6VI1#L?N/[?\ Y4$9
MORSTXT((2AQ,_P!T;3'"H)2+L6S.J8VAX;9OH=94=XMB[;XJ^QO9-YZX_M=4
M][NI&"W.A=W^QZ;7X4/A^*4DL*;W4,A FC%KR'_D99:&W0.TJ$\(^/Q-8^7U
M6?/\UEJQTL7]^%"4-_ZHTK.O6-5U_5*I/+CQ>%O-R;:!_**'KZ67L[<VF]S;
MC_%JT:HSYQVK5XQ4=I(W^./3E4DN]K[1YWK2TR^:;U$^=K;?%6V\>9?@QSBI
MUM]VM^\7J(VZ^=:4L^_ZI0+!;G]TF:\5\XWC^Q% MA([9UU+&0NMZD53F#B[
M^:T)'G#YK$OT+^30,NN>B<-J@L9]OWS[49][<W]4;KM\T9>5"Z]#SM1E?+M&
MX7N+ZGQ>D(< H8MEGI:A<#9]0^6A8)H"<Y\XU<<WS13)=[V-=3?72W_$6^&&
M2SA)DZ9H@F(L"8%Y&(NNSBU0P)A*S*A,6(2"S!@IW5$F@2468L+8"=:<\/*
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M<1OF72SK>]%=,#4&ZV882RP6S&B8&=L25!#(979LM): "!+T2Q(FRIB6E\A
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MP'(J"+8N\_[YFE NM@^:./GH>U"9)F XW6HQLU^:P+Y'Z^*-!W&_K&VOSPJ
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M(N6Z(2!>R@MUXF4PGP. ,<PX8E@A DA$#DA]HM<20@BADXPV+XFZEIQ4@8+
M'$;+N;X(X,U!40M"PUS*CEUM;6@9,]#'*(0D2FCA* N&F KQ9S(HB5[)0F]9
MPP!,*D4M#,U"Q:X62*4A4@4RT))6(42HA8;W(T-;M$N,E8&8,'$LHXLR)&$K
M20LZ7DO>=9*DSE)&721OI.XV@B:.?#$IB)PDERM;_EL"1K"CDVMG:=J4S[OS
M:@GN$=;^M0!B=#A_=^,5#0;ZNIQQ>7!:P;4865C+RY3Y?*5,N-I4XV<OIK#.
MO$C3DYQEQG]T%U=998FV;ZOD8H"R6+0+F37&,WQ02;J#;4OZMYY7FBXBZ*:W
MRRWA"_/CK"3K#$V3@:SI.+35LEBVN#8C)O<TN4.'Z?L]>M+G'%O?7KCGO+$"
M]O=S!;3/M::<(Q?3AL3JWAB[ILFN8B8U,SP6]M 6H7!/^UXL"/+QOQM:/P95
ML6'>U^T^]]*88&N;3"Y>6OC5MF)LEV'!P)Y:.]0K<SDT<;;Z5FUB<;V]#I5]
M[=,'?.U-))2I#8VL]($59H1!$1!$PC<3@G_C 8!C,*%@RV<7NDD33B!>3A;O
M;R8B:B"YM;30OW9ABC(X7K3S/=J;1C'%L1VFKRMI;AI!OOWJ<(GGMSWY49)=
MHOQ_1V:B5\A^L5*.SFV+^I2 M[>D>]CD=J*068G3M[G**MT.&F?CYK@!F^VT
M1SJ,$XF^9F>.33K-0S?PC-[KJ<.[>9ZO&>RYM3[W?0\\O-"!#7TY4H5VCY\X
M5*XA+[U)?4:=B^?D&#K68[A[-*_!)]JN.0]RC$N&>=SYJ!8,''F<..<T;SM\
MC0@XOD4$ ;%8//(S5R1>4XS>@MMMGAVMV:,D]^$?%2<,AQ(OVBH"U3YY<LM7
MCZF5O;VUM5M:+&D6UM_/?_B4">@G@@";*%KM7=)7:%P(PTG%54[0E$RP$RF0
MF<YOI+2RF2*$ "K9S,6D,)<%*LB,N0@5)#$MM:-W .$@$"Z&S"R+Z2M6">);
M.OG,N+%YG1M"R+I*6#=%MABS+AJ*JQ0LI1JKN<5>*L R04KXVDGH:#9<UKF*
MA>B;!,,0RGW+$2+BE@0)0FG+AGD"6H:,SJ(EJ9HAKTB)RNUJ389B1C++!I-P
M4:4 EK0>W/119 ;4$T:;"H%;."C05-VH9)K_ '*C4+>0:?!> !,(F14-:X,3
M4<)2Q=@82$E@6B7#0,TN( H-)M,YB)YS$"(+,@* ,*NRT7SPH@L!$*Q0H( 9
M -''-1F!0 G+TA*8PGL>;1DK:BJ6HP[)T 70N)D<B@"@## 0+)+L!$BI.>@S
MN$) 7SRL74?S$)3=VDU21M$MQ'<0;MW4-T;;<=II,2!?A:9F-#4RK>6G81(=
MF!!ZN.$.L?\ (X>5+%V<<6_I;3#:.(!?Y]L/KRHR99B4M&V,V^FTS1 K;3A!
M:!TO?$YUN5[HRR3FQ!N03:)O:AE>\WS;3.[:?5I,-RK&_*W2^>%24DKM;HS-
MYXFE29,Z^NY;'6K#,VRXG.AFT[6ZU@P^NQ%MY)X1$U.$BT/-S&\1?AAJVT1#
MT\X24 &7(*OG6#GQX4 (G%\18V,1[T)&6=(U-F>\=:&)Z6N27+/7YTI+:X)O
MF)LVEF;TR7O-G&^!O,%SC,8"KRW<S]5>-8GI/W6D\_2/O_7EHVPXXK;2=8X2
MXJZZ]G&X_KIG2LXB)9-.,$89J=AK-N9IR]??0,+G%K='E:,5@7Q\N4W+O6LO
M&?W'(L=<4$22-X2R.2^B+Z4-YNR*AZ-!F@3_ ,:_TB[<6I>21"6@ZU;*,9VG
M;;'/ABH"QB6T>72/BLWE\E9GG@K+ O[/WV*%C,ISNOQGA4(<N+QZ<K<*,YT"
MSR]\24#-B.6/U[;8J^&YY^H;<*V3'325-6_VWJ&<(R,9R3/F(HQTGJ34KGO&
MM,S?L^'2.=-U>O3UTK&#=S_<><*@L%ZC$Z[34%S4U\YTSS-:4H\_9IDG0[63
MU[5AT^JQG@.^/:CJT/6\>U!@(NZ.*^<*A,8,?/:L5\\O0E#OR_)E&+?'SCK1
MF'EZ'VT,N9Z:_'6I[M_=&=/JH(9MGA!8>&?MJT)SMB=;ZTP)V/7;L.N?^(YP
MH"N4$YXB_:H>,@ !P$"$FV;M6@]@GA+)1)$A=7TO22  ,('T.B+D&9J:507D
M80:1>=(NQ>DF94(%67$)4R[BRB3-2PT%IG +>8DQ2!"#)."BR(A.LPQ4<174
M$7!;JC+AURMLM4 @1-Z(B!8F6D4TEHN&^8N*7,:RE,TK(V,#QT),))I"D.R?
M6$R=A FMDBAFA0WC&&:X"$AIF:A7=20Y,(@N%0A=5] %$Q)N" JBE6Q6@4HF
MG<<&$0V*EQ;>1<B9@69911N=B*!1E"!#.!*1%/)3+S[BV;BBV]JG:2F!"+0N
MK/8BT)>KN*1ODVYC8DY58B"/>23AJQJR),(QW(46-GA$!:"F@(C+L)<0:7"2
M[5\[C/LH B1AE$<ZB/A,BE 3,B!C7DA@(2W2 2 ERD+G"T_NY(EI,($ J""A
M%WB6J2%X@4G 2EG \+QSX.8G%$=.IHB(7;(7!F+Q/_(B/-2+=]+0(M/#''0W
M:,F_,.F;]MG5O"RB ,SV\_<5!(1=EO*XXNS%I[D\RW6^]UO..$X#%2J+:8O8
MM>;XQ#>XQ6HN+CI&D1&=/W3*)2;79MQR9Y4/(<2_ZY]ZA(DO!=U98W]ICNBP
M,Y->/@\'E2*<D-YMUPQ.O&H').-="8! U8M3$-XM<".'O&ASI YVXZ9X_-9,
MG2-M^5RXVV*!K'+CIWX#;,48UDC,<DLYSFY.;S06+DH9F[>88P[>E[A>^(DB
M2>(%SEVDKU<6D<XZU%ID];>GFG^L3',Z?<XCC3ETNVV^JU3;*&M\3)B<:=J)
M4MI?FQ']NZU:>$!WF>'*?2FA;F=,6WSBVO"N<7G2-%YU=LZ8MKYFHEG(_/[H
MI[S=7R^0_ 0@NG_QEL_]B!Y,"!%F9;K&'9#>ZLO&\?>E0'UYRZ4;3O5B<I]1
MI@!)PYC2IN*T/.)P]*M+:8C;]Z6.%1&(L'77XH%FT^>6H(GG:._M/L;22$P1
MYO)OB*1KD7F87:,_&],7DORR;;_=1I.98WTQKG[LTRUN7MROF/)H24YT^.>G
M>G8S$&CYUXTI,+?SP]/Q]3W^Z4(TN-S'+S/.LC%O9_5&#A#V(.\E23TCJQVB
MK5B]B'C#?AFI1SUVTOP]J $<NWRYZT9!YOQK-W\_7Y"XZ>NGK4 >%O?SE6E?
M!/6[Z]N-1\\<9B^O:+%7!C2>6I]6_H(G5]/TE"#OX?'_ !"Y \,2G& "2X"5
M0^BJ FH7!LN#-BQ6VKBR %C264"D-=F<T*-RW$2( BV O9LM4).JW  88)+C
M>;4=C!")F6 BR$3(*0S:*8J)"B$H@(%96,7+05!T(18(FP1=E>TWD$@<V"8%
MUE8',[TRPRZ*,*)DV+L3:D ;=X6A,0@2&!O3#$XD!@R6ADP30MB@LJ2SF#(-
M6<[E-#@BTEDH,9:1$H>0MH.-F)+@FWEP#,F);1)%7A@RF D "8(F4 BJQE"@
M(3 F;JQ%$VR.(6,%X<1D1I(;5R6 W4$85R7&+%!B,RL2.D U8G?G:M)[1KP(
M.(R=PJ'V@ 6YB)(14M*I?&$:CB4"BME\KE@0%>"Q((Q>!.]XH-C"N<!%SF;M
MD0DQ2F>8( 6"Z3R%C-W9/(A&Z"L)(DQREQ2RJ!>P"(K# 0',S:8:#;-F$;&$
M*(,8)HH-PR#F[DFPA &:9!E<:PM=\B>NO_&XY7]-36EMG(1P-M,P3ODM9*1$
ME_.CQXE1MV"U\.W//+:)J45A5"4&/B?73:F*N=,'/FXNVG%*L#O=<S=D,[&D
M<Z1M+&<XVC?XX0Q<WLQ\=--W>"KX3#Z<=/:V;;EXDN62+Q'\NFT15]OJZSG4
M-M=<=*22&+O?G>>%[SEQ2PC),8XWU-N$44HO,1.KPWU'20HP&,\81<D.1Q/9
M2@0AP^FIKF@Z2^MNE G1S''1NWM$%YV*1B#,CZYQ VEL\KULOHO$3%M"]O>B
M!1=CMHEW^5$R*6AU=-TY:U,(AWF<O'8Y8IRZ?ZG'GV>Y5C#TM$^12Y+8/?U%
MIRD'?:;W/B8VTA<A+L<&_->$QQ*O+2)CK^[[>T*V9OZ;QC3$%;: SK+MYVO5
MY]=R<^KZ4CS--M(<3E[!,7V+?^(_@2^).I #FG(IWENE)4KI15U9O2A1:3-K
M':9ZM"8&Q^WYJ2 T*Q<88X&#C/F*9!.IG&(VF>#VH>@]A-L^^[4H"6#8M%R_
MM4T1C9//WUH7 \X586;,7CR_-]HH4(R.F_7,VWI'9$A/ZCB4U&3C/>>56 =.
MD)GTB)XU \66<<?/2L%=YMG2GECO\=/"I7+-.\;^]%D=JE8::)OL^>?-$+-I
MY/ZF_P"J^#'<HRAB]MDF5^*)-V9UR)% W4AOK>.T5B\UHXU@+\_U/S1NO"._
M\_ ECSXK"6ECC!I>^.'#C4T;1KSNQ[''K1SP.&6U]_?:K30P:6UG3+4,1J1W
M2Z^9Z5@YIC-B_76L#D?\4B5FDL^6SX$$HTT5Q2[, D 21R8EYM10  (I(R+#
M"RN^TTC:3@M.!& ,RK>47:FD#>&)0B%Y5X'66:*]:"@JUF"WQ:)3R0HRP!6
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MUF]N5]:O1Q[7<]SR*(SPG<)^:.8G"\YMISJ*?/+%J59J5;"%FX):P:?^';V
M+>7EE5H51 D(INQ//S;E! 46@BW(]O3A^#<-8#K8J1+3+^KS;?.?:1A>8@?;
MG,1ZUMS3>-B\,SQ_=1 I8"^G3G+B$UFA #0DA /*Y;6Q/'&;34RQ#$,J6<?N
MK;>GF[ZU!,ZQ'G&IB>G73Z>%#;&# N=#S3%31;B&_$OG>VE[4,5UZWAOPL6]
M*R>;^)8C29ZT,'(H2 :K/G*C$ZO#PMTJUGVSW^;7G:I40@A9G2/0XG[ A@CC
MKIT/&:!T;N+T<MGUG]T)3G/:H(>$_![^]"[L$>=J%BVDSS_7M5_&P%^C_;ZE
M1."Q?67MG]QFN&:&'/S/68AO6+%XN:WVMECUJ*+8+S9SQVC':U63&/0SW?NC
MEZ>>G_&1YH8 >>1;S$7HF$T@5DMBT3,$3?$TCUD1"M@N!8C==(M5H4 YG$0P
MLPXE=LZ@LTMAA*R&\03,D;VID5>:&&85O*9#&"PW")%BZ" "'1F7VFI3D-%&
M1,"I"#&5D@K$N;U!)I9-4F>#:@BKE*B+%UK9<,YQ0($V29"-TF)&LSK$Q1P"
M$0"R$3F1!!J.LBB*JYG.87&U9GB#H0L/L@ B(M,=!@:GI908 0,U;NQL0'=[
M!)$-3W6)UUU%21!>6A,0GM4D=]S;*Y/)# "1)DF%@,)T5+2JD5>9=FL:)+A-
M$,,DD<W)-RPP;%V*DQ<&)ERL$W (%YN,$1:#-V814)+!FE04PLQ"TA5Y#-3<
M&8 JDI 0X0 G2H)M:B$XK*6@WI2*/DDPK@+I!7SB;4'JS.1_<*(AG)#32:.B
M;I+XB;(J'IR@S(;PP3H"HO,!("6X.8))G2D/$2(Z0N)(AUP00V,35OLHPN7*
M$FU3QHQNHTEQ9C7_ (#2!@;N)VGE^ZL)(RJ:Q!F;7G!M0*UXF,S&_2%SRI6;
MJ0Z6[\-=\FLC$K-\&-O.]65,HNG'%X?JE3+>ZL]CTX/##3)7EB^A;O2EG27I
M@OT#AZU!)H9XUEN2=<YZ =R*LZ\W/0Z%!&;]=9S/CI2"7UWSB;]=2V^*.%YY
M]PWUNVYU!N3;I=GNT5G%F2Q(6B(9]S[CSCOK4$H6ZVQ^]S%)%G_)$+$\SXH;
MW+W[":N2\_%.T:W=9Y]_J2?]0ZFV/?APN<*X6_PN\;S2E5\6]>;"VQC2+TR=
M-<$Q#B/YO6KKVO[?IHZ&N'2[ZE&5M-]I.M7E\ \QRQ07TW\ZM8W<%FKF= O_
M (<*16I$JFW&#1,4-D$@_'KHYSU,<H=LC;\"5PA]_FI$>D971Y1?&\'!\3BH
M7^)OKSQ4DD!B)MF(XWUMC-V@$@PV#C&N\]8VJ^R4D=CEOZ4"I.I>][CG#TP:
M5RI)UC\"2.U"=+;&B-N$.#5H5P%H.'73%]Z<SNSS%K/X"4./IK1NNQ[^-21R
M/7+[U% ;7YW.AVJ1X-KQ:WQ/+-ZB1BTDO4]/48OI1M9TYM!>"";?5&+-_3'L
M5GT^J,G&!WIG&L9X:OF:A,<-'D7--YSO6"Q!!QG;XOIK7"Q=T[VR>BU,@!8#
MQ<[7WP::T?%M>_#?-3HQG6W[Y$7VO4 6SC>/WGC00!M_Q@(8)(07%"! )B4!
M=L6?,  A9X(-[-KQ,T)!)>L8(09A-F),N :9K,%1P"\K1R8UH90(6 8(N#T1
M*%YJQ1<V@6,QN1@PYDHE:U^-T<45U9*D_!A9?L##,(YG&M(HR%" ,$S)<NC,
MCJ,!"(N7)(O$80PI&=6A9NK(,Q,!J(O:H6-53VJ2Z*)R%:88C_+CP)8+&0+8
M)(D,4:04)*01"*UJ5,K%S+[@",4;%5-+!(:5B 8,MZ+H8*(@P#U$*%A5-J.R
MT21.%!@NF6:>0(<(:(OB-;B$2UZCRY=39%"0$(PD$PQ(D.BT!A="$&9+MS=@
M(KVSY@0<3=LI:@QQ0R6S#(84PE!@GFDZ7I;B^622-GR*2;;\,@BR/:LG^85$
M4J R09,CINPTHC5HY!(+_55\@2RE$S$V^*.==K"G:<B3 2S0?0K>=]X'@+&R
M8\8R:HD;C=G6CND:0%?<)9M%LPWK1B@C!S4$)7$;,93()&% XJK@EJ0E\BC4
MQDV9IW^Y!0/EIO4'=.A%HQ?/*U[5J.&'.$-9S.W'>*Q2<26@C!W[/*=:!$O.
M#2>-NUC>^:*1K8F=#+G?@FFM6+HSQEO,<+3WB=826;_.=I9X1VIZ6N[QX.-(
MI08Q-N,ZXX3&A60G27GG77WFM'0O\=9=^%9[L:8F.,>QFF.%>$'O?QJ%+]RU
MN.G;-10<.<[>C]E!)99VO!PY>M0E$@(UFVDFAM%_R4B\VCM_>+_FRL!B%>$X
M.<>G*F8X#N._[OK3\MNU,S?/3XM_H]SX=JNBNNL'*]].?&+5.'1Y:$N>6X4[
MMM\1&E^4B'8:W"][$<>?&-?G&S=CA+&I:]\O#82\W'GI;2+\*%TV'RWCKFC=
MSK,YG/Q?C-3&@0^Z2<[W6W_A.W#?LH=!4O$?K>7M]V2WJ$>P=;,>U8<A\T$H
M;U(SN^G'M4D<[XTU\S-&Z'GR\Y<6K#Q =;$7VO-O>HA['#QH&,D9G%]L2O F
M@;M#?..N][WX_P"/%),>^=;-N.=*2*9/&GO?C%0^(NSS/B'K^3(X7\\X4)ZH
M>=ZF3FKRQ'N]Z=B>7L<,(6XU/P-D[=\:5'Y:9M?><GC:'9MR/W[<:Q+T//2L
MN8K5T^:L&VO2P5VRT1GQXWV:U,QY/E[!K6#%O5_7[B]*1B7IPGX_DU#%LAQY
M/3!J\*M!;23IR[\+4@;6])OOXQI5Z=#W]O#_ )&(0AI+#J*F*($$J>X<;@?7
M,H$KWBS,U,S G*6#-(X2D')J9(Q-M$$P2 VOG=B:.@EI@%*^PQ*JMK2T2K"5
M3<#(,R"+MH;6DI'?%=8/(DMDQK:: VV.56 DG9==2@D))5)! 0$I<!J.4TT]
MC0%9B26+P!I1KQ-(Q.'99'PY9(V['G+ '; TM3"3'<JQ$:CY<KK)XGVBC\M%
M0F%2H _B3VLBH+K=FEF!@E637278D<@,6IY5!E!FXM+,BZVO!20((RS$:D9D
M)=E84B'(C<B95R^@(N3JT0I99-$DOJN,PPAF)&@7R%P^S5<"UZ-C1BE$*6%G
M,1.D%/B)^ G<I+1DQHI_9%0<M(0S)@7J%VFI1 E-.OLLT-!\[+E,R"(9*57)
M<B"&0 66QB;6B@/%XO@<D! E4#FDC9ES?=$IUE%,-2,KDFU*E4N ;:11=(E5
MRZAFX5AB")#"7HIF.06$)#;&4+JU')A,R6$7.(;DER;<*506XWL 8B'*$9VM
M=H6JHB^);$X75Y!\I862)C\EABH?[,?/,Q^LB11F[PQC@Q<@]BKR\3AEA3>\
M0QMUHDWNSUF#]_-'8%)6\SV-(OVTHE@&77(%Y=YUUQ><2(G5#)'#E!IBD5M:
M#I[TMVWK.+=#LRV;TH.Z_>_W>LO&_0QWY^]&#?IOI:V&^+7HR97CP]>V&+<X
M)9T\<6\UI8ORT.YD@\^V<[=YH5X!OR#!?/#C0FP#!#9FVN+FESC0@$PTD1>D
M'-(F2/\ %Q.UZE,ML+:_S5)-+S=UM><;$+T+FWO'^E0^4[6YOQ>DX[VF(;R0
M-^$SPS5[,NVNM.D.<<>%)%EQK>>/-X/:K#DVX./URHV.O>6I]_KY%!D']VE;
M^7:-WS,_=\<ZNX@S&L8/#N ?_"4\).8&=4.@6;N*="Y93UF>>>Y0A.1TR><:
M-CL??W1LX7\ZUBF-7Y]K=:!-5B?=TB.=;>UH@V-.3-HQQ: PP#K=V\L^P"!C
M''XC/S0Q"@&(W',-3&\T3>8S:-N/'_'1.0S11 PB;69G#IN$7KGASWW9T]/S
MFOGEJQ<">KCT]JE36&.=K3P^ZVFV=])]1FL;! WL6UWOIS]* +:)UV]:P!\V
M\YT99V]ZR.9[T#N!Y6^ZFCD6O[:W=M]ZEBVW/^ATF=J$B0B#1ZO7Z=JAP/#Z
MO/+,40Z3MG6#EUS>:-AB>._2[\;7H;,&"7US'OJE0@!>.QYG6:" -O\ D>]K
M%$8,D"B$6R5#6UO*GTR_95M<7MIEJ#<%$,+FF1%0E)(27 ,C+=:=@Q1='!92
MD:Q$Q%)0A*YI@R)8N&1S-2M%$9+$7P$P96G6D6^$+1"0#+,$L3I92337,0A'
MC2E^A%]VC>@/QI1L])@%?6AR*8D6LX%=Q\D%./(,[)V)O$",-Z3A*51)<)$&
MVR:KFE)*Z!:X1-"4@2@%7O(F&( +EJB$9449!1@@1+6(JEA(*48+$20%42F$
MAB@0X,:BL)'$EF-*(A0053J9 0PP'$I%#_F@@C(7+@*8 NJT"4SF),TI&>E^
M#+@A27=),R$1 /&H%P_K"202 #*4GK1A&J0A'R+(=*""F;LQ4U RFP+H0"C(
M25V)N*ADL-KN+TLA*=A:LF9(21$O&IO GA,+)XXLMZ33*#T2RCHXS%R"A6OQ
M,@+* A-@Y6A-W3"(BB+&0M-L$TK88"W  @#0XI9E:L4.YBP+!$B1U%!?&P+$
MSM.D>VY-3L/E0:,(20Q:85HWHYH (9>I%V6_VYO./Q3ARA>R.N;>IKUIC.@X
M](XL^V+U.,HK%ISKVZ]:4"\HR3-K<>!I/*G52P#P_?KOU5F;RK/!GSK-)NA*
M^<'M4YY;9\SM-\THRV/OYDYUE\Y:]7TJ.6?.'%(>E-<GZMSVQVTK-?RUOLY%
M7LIPLL:&Q'.^::*N'N;:S'2T%2P*1OKB;\.<T4D3#%P$)UC?2I!,N7;3&D6]
MZ,/!QP_7XT=?C_*"<:6(M;T<G*EB3C?.DV_U)""0L*WUL;TJ+PVTNWTIR[+H
MZW"_;^4VXEY)C-[=4F(TX36O,WCM/OBA <[Z^;9KJ7QYO0E7?:VN^7^Z>U?G
M13V%<SXF-\?^$SPT1N.*A"%%DVSQG]%9VUB7?:/WIRK!:+1VC/F9HWZ=)MT[
MU/!G ;W_ $^G*C2!&";^8G.=Z1)@L6C.K/:#IM4XB(.]YC,D>NU%AG#ZIIPS
M/2U$R+E(MB,WFX_Y"1,R)4B&B!?-]8/Z'*I\D7=(PM\;VY<Y_(DYOG0OZT9[
M^A>IXMSGV^G^U([).A;;>VU$ XDVVMOC/ :$BP?;B9V]Z:,:WY^9I)3K4D+C
M3H^U+((YEX;>TTS<%X^/[)JF;TL=X7SGWZUL%R/5#C,;\)WK&C2'71L:KKSZ
M5CM@VOX=LNE8[&AQY\B+.8OSC"3]XM]O2F+NI;E_R@7 A(!S9$AJ-,8.!(VL
M I3,8(OBQ#!; 3B<VMN.E,2U(Q8DR*X)42;9:<CH[%L'0"+EDG+0UCSR$H[.
MH@R4*(*.#! &P&;QC#2C5%@7*Y*KIB-F+(T**C"8"+>1*L,,)I3,&K*8LG!\
MPHJ.(0R%Q',;]-284:TAX//X<=$= NL^W%F<$KL"F9PPT"(/2# $B(($"+36
M1(W $T8@)N@"Q%.DV" M]5T& $7F-7> R4&BQA:,&"X%*FH7 #CG!4J)AB"I
M@7+=C  '<;+AI*R'"@UJF1!3+CCO1W+C @2(90$R-HMFAN'8@Z=>;!&YT4HZ
MF N%,2NCF(*)2+Q +(% BV$9Q0FA,"\3C>R-KG-3IAZFS6<NH<D7279LW3.&
M&PXADR)I_A<BKL29"\7:AS(JU!*,%J7,1A74>,E+@VDO &_,E)$IH2,$"PQ)
M;K=IN6+(2RL"]YU-Q6;4V$A 2H2!+;1LQ:8S1.DI2!LL!6Z6ASIC,($I$%E@
M1RPPB7L9F6H'(&D(YCD@! 4:"+,L"@*_/Y!_V8_J?YSWBE#<^8%OCE12W+3&
M8S-]\.)TUJ^Z\$ONV,Z=]HI2;X<:W-]NO<I)87[>;W1M?>]39F[=9Z7]&M&;
M2VB<._"7INE6=M)TUX\S/.:C']YZ-#7C4>7CUTZ!4L^W+3T>==^^GFM7N<9\
MZR3=YTDS+?C$\>&;?%*$EV<^4_W:B/FQEVB9[YM9YT;  ,AA&-).,T9PX",&
MABWU:NHQROY>D1AHR/"Y\^G^5Y8RMYF,YN1BS'",33K:+F]\WOCE]-:1S]8^
MO]) G);2\>VW;E84VN0$.VNAY#%2V.5[7"[B?0O66B&,6=P]M8HS,](V?U41
MJLN<>NCG5UH\TK$03>V,?%!PW9QK$?&T8>(S%_W/RQ0NH5)B%%/ *\,[?^$_
M-@;;:W<FQK4/1>V=,;<KXHQM6.TT?/&_FE&8M-Y>\?5M:G>GU'I[5,R&X#RU
M.%YV=(UK#B<<.NBVCY=H$B+;1;EU:#%R=L[YFWDT1IPOOM?7UKQR]KV_RBDN
MMD+3L<-S:G@[DD8S.8Q,]:EMT_4_@0G O\^K3*6[F[+Z6ZWBK);:.6G9_=2I
M&VH=']5$%HB&,_&.N;5;)+SIOGKH40+#'S]T/7;L^=*Q&V6*FAMDZ%H.L^^:
MM&ES]&^2_+JXK.F=>&VW9PS5TL20[LS]O#>*<"UX_O3?C:\5%IIPWO$QC7=<
MUB8LARCXVXUB-L_/_.%T1]N\K)Z^ #0G"88,0V+D9B(9N4(XF ,0)>JJ9.DQ
M=J)F5%@. (JWD,0WU@QR$IDIDE-Q0(BSE:KW=D%5Z4.$9ENPQ:*(&QBK,A>2
M54M9RU;<\5O!H<!%MR0 7ZR6%,2=B2*TA#18P\$^YZ2,K91HDLV5D$WM$"@'
M)R0E%;W0H9&C<9 8+;*9R V&;6\[7Z^PMR$M8(,"HZ2-B0F)2FP$A>*-3<!P
MS0O= W <7<*&SE*=A)"V;C$*AIFT<S94@JK*)71BTB9O1 'C28*3O O.8GC>
M*09$D@!S"R,(O47-G&6'#S,',T4.Z+JS8<FJ83#:CIVE[X1-X;XC3Z@!,B<,
M7@BA=.9*%6JM!X-\-9,!4&*(H"(0 XW4\$ZTA93($"A;U'0 8+4+:<17. MH
M+*7BQ#A<T95@$T2T1NK+H-.36B(P$ 00<(B5F\U,"0#A9,F0D$8,7(Q*F1""
M&(LER$CFTWB9TJ+A0-I$PX31;B!=AO4>H=LI,7*S9(D%=X(I!-UL(,DB( %D
M7NL:]./ ( C"R<"?Z\>;^_BM6D,<_J>W*IWGT#6?':^M9=#XI9C">PVUQ4V[
M:\SR[P7QSC:5[[=MN_EZG8./I6#R=BFPG+X^VF!]>;*]SM-6&]\'.3YFI!^=
M-/9*FGH=[^Q%3.<Z<-/;3C38IM#SO4HI9)M.UNE\PC2PBC$2QPW<\N+FM<ID
MOD])\[EXS8?/-J-QX1V_M-QY/^40S,#*]'CNNGS-+(WPP<K[6VQMW_T-A=JB
MA.)MCAM?UMBI\LR:VB;G/S%26(VF;L^0')ZTYG&3KEMOI[T,Z0Z[7@/2.%&9
MS8FUMN7I'"C?1$L<YOYO1)=\Z\WU\BBPN^NV/JN4\)9FVHU*4IN#W)_\$LN#
M[0F&%45I&$M%,](^)[S03H/2P5BHR-0-^W.B8MFP[V^LL<L5+IO$_,6DB[IF
M;U$*" (\B]NF2BP&P5"^1B]S&H6;X^S4Y001OU_K_D*++VB>[UAI!R85NDO'
M2>,<+R2&L)B.]H8^0S8H_C^4$H<:,O-CM=J=/C3#/2WK3R,&29^HWQ&E#-D]
MO-HF]8[;;7V^.[4&FQS7/QRM0!8H%Q2JS$6W[3%8K?6]_FV^;Q?QT#TV_KPH
M[6TUC.L]F.LYN=C$0SO?AN;SF^:G>T<#/#:8UYU+I;'33!.CC;E6[L1NA\;T
M !U3P_YU,NHRAA&%%6U*:\FM*.9P<%&D:?/!(Z:1C>9:@;U9B6$&"%NA"28J
M6L$$N,4*X 9N"A)4MI8%D$N92)N;Z$4@+[B$W!"X W9"A6X>1<--AHV5H\L.
M&[-&GH,)%&RNA<I%(2$0 @DU!));J82I*5'2QP"00SM=2!9$&F90(&^*W$ 0
MET*-[PX\:XC2$!%&0KK0+!S"8V)NH?#"0M&TC2B248H2,B1'N'##2KIF"F1C
M6NX(WD0Q$&U-O("&#$,<.2,$6*BZU$G&*&0X)W[PC]V?Y /)F#>C1BG8WGDY
M8%@(6J!H8%J1$?&7)(%Y6!0I-&4O@0A-21PQA!R2+"X2'<F>TKA:,1BX;+11
M3YG&.ZRIDI4)+%6A9!>4;"<@SH=RBF,+8 :@229<4-5",L4R!"<AD(6W.C$8
M*>%<&[DA:96(J:0%BY!"#*-RZ^+9D;C%249B2DL ("0TEN.DV*FL@M,DA#-[
M+-[TB)I"))5_"0X=6BM)CAF6P#$+R)%S)-JI0/A)EO(H!?\ 7HZ^>M*9DVC2
M)]XXYX4,^?:W'C6+C'73<B.?:L-6+0FD1QQGM:A=Q$SK?2'B3VHQ,8QZQM[1
MO6GK\5@\FGNB)B^LI_.FU.[P![Q;T^*1U3?SG9VS:MYK!R?Z=BII\RQ[15Y#
M7;8L=_,T[ \KU^*'+$C"&Q:^>,W]Z91+ ?R_O^[N"Z)#<.;>3;7+:F"59M\1
MTSQWHD+MCN?@Z[Y\\T_QN;XVTZVY.<^K$6-M<9MHZ:_M8M$\9^/]#A/#STHB
M%T;<A>FK9HHRXW4<NJ:Y?2ID*NGZ4WWN4I8FUV_'7EU*$GJTXO:]8M]+NG"U
MVYK;EM"Z&;Q/+'$M-R*.>CZ+0L^87:WQ7O\ )X"C+9!W<#>S_P""L@(- 3YK
M=,E.O3[N^C,<Z5V$!.?K;A08.AX\:*%N5^VNYK1-DXQX8B;Z5A1%ASF((M^B
MB"Q:.I&]K#PTK?AZ4FZ%L6"6SGT5[%[7,ZP6O&^A;OT_Q"WO$VX^,_K\."D$
M-.\RUT2Q=O>+WX8JZ.+]'G.C>=OGQK!YGZ,U*C&77S#AJ>XV_FIF?2]&#&TM
MK<HT;[]Z3CD?U'8YM11P-]7/S\?C&'"7ST/W6&(LZ'+?QYWJ,Q?3NYOK?;M4
M48M=R.E_?6TZ5/%MK[\.>'6_.HC98/F\Q?AG3-0&+V-KNFUMNMJVS3L:>G'6
M*L[8G3IK<OM6/^A$@C)Z+U:&(>2Q1GB\%Z@FT@9*=P$K#7"7F! LV(T;9DQ(
MH&D:NRI0VH6(PPD0?&(P2)HPYA1$LCDWC2U2@A'#$SJ @RJ JV8R=#1FL6!8
MA8/[1)$2T[I03&8*DUR4,"!VNY:.UJ6(H2A5"I >EB%@PND&)"E(%" LJRWJ
M#!SB\EE14E 0%)4;^4F^D"R+; 8>I8F$"7O))O<DB+TZ"4PD&4)"YDDHQA4P
M5 *CO 20+@E<[ULFA9%Y0(L-TELD5.CR.2R4:99$*VI9I!#,9*LQ,)WN49^6
M6P]B)I 83=J]I87YU,#TH0J8%)&<$D95X-7)ZL;'=\&NLE,5/1+%G-L\3,(#
M!CX4,]I#J98PU069C(!1 S=<02,MHI#M ,62'"\L,CU)D<;$@4*^"<21BS(4
M:9H;P%0 W4!BTDWHP "H(C>)"9M.7I5^@$*FYDBV40BLLM""$W!9+'$6Q$78
MQ0_$"D2H8,2WSH(E1+'3%M9B'2689-G27* &RYD]>*T'^IP<07P\]*;*;/6R
M?=7G%/7'OR.105W1'5CI6J@N[07BR_MHV>?HW^*Q.?W63S6M?/W6GU19Y+'M
M3T:"^LG.LFD>^/<IW8TE[$?#3B>!'?\ M&#N<G'Q\4(J"!GC!.W.>E%)//E-
M]]M*P;&N<\/-=JXDQULA\QR=JS>:_B<&VOQ\_P"*L@2[S@)>5_BF8Q92^[>?
MGEL?Z8EN&>>3MK0S?>'C>]M:>7GC>-.5GOK5YXKTB^G+;EEEW<I].%]+^D5@
M\O,>;ZU80R:VT.?I[U/+^V^YK-Y'LT&':_S?U*-V+0_H[35U9N6__@D3,B20
M=^P.+KF,6VL=(^>_&G&X<L?>>M!]V_$J1-GW])O-N%'9"UL$6TYQ<UZ4FE6"
M^T<N+GMBN2".<WGM&EYK5+IQW,QY>A!?=CA$GWPQK_B)3AYT]/P)AT:@L:M"
MK+@V1LDC6E8XT8)W\_?6L!NST_A4\9S[_KWJ6/2WJ7ZI>]1B(TW]L'.H@M;X
MX<'/".T/H[8_I^J$ :ZT=>E)9CS0^>%'8COCA/.^,U(EMLXSS[6YQ6*23U6T
M8[]=ZA B]O76.]IT(JYBP0^DZ]]=M:50#GSUZ_HUJ*[MCGO\<M2H.;GSW_Z5
M?H3*O6!5 R7B#DZF%D]\IA=F,HD)0Y8"MB@+NJ#I?RQZ)X4B(=6K?=EH2H U
M3.4)TM&$+2%HA2X"V)B-E<&"1%";B"[)BD(Y99PH 2E@8X,S@L:LG5B JS8E
MJV%E:!(E(1&\LLK:*F34"KDO6,EKR0(C">R3!FQ";-;"FCCUB=8-4<!4@&:=
MO,;3!0&I!KD-0G0T:"3)P,@ Z)>Z8"@B&+(DL66D+ 2WHH!011"20;DD1?"U
M7#040!3#>1?5@Q4))@682)7X@'A3@5,S0$"^NB N; PJVTHA"$J76CF*-#(\
M 'I+!Q1466IE<F$"D)=A2;*7T+W(($>PY0BC $"I0@]V3O$\T4\%2T!H%QM5
MQDR*-+>Y4PHK."R#$TL14$!5W :1!+D9*>,<0%3L4P%B=9)BA(Y&[*24 8+Q
M!$)H%/6!R0 K"B>XAQ%#.@EHANB9D=121VBH]*(A9) AWTA!LUHD[)7HI=B;
MDN;%#!C$,&&9X@K;@:T[$,+5&XIZPP$$_P!>OF^:=Q:S;FOU2@ERSB[\&.E7
M,,9/5^*,\@/4_M'.I2.1:DLQF8.8)6;U\YQ63E1SSGU6E"N+\?$T[N_7%Q[#
M?C.U.W1CT;T\\ .[]-.Z<5]Z@.9/UGPGXH51 MSD-)Z:\Z[QY?K,=*<%XG.\
MU=DV08XW.=KU(3C?68X\?,?C)_BY+P2:91;3,^B:T]C0=G7[=\_Z4T$7>46O
MIOPJ7))O,[2M^,]B>3)<FL;*3\Z4F7IO%\Q.\\ZE,MGY\Y5DHJ"2\]XN]:^2
MA<< GTY6X;YJX3<H;O%7U#XKB-%YN*O+MN_^"X<[C5'H(][5;,68_4]^.(B*
M8&&QQL>=:N9V)/&]"N$V2W6>LEXFU,W'ZF(;==ZLAT%[]@S;6C ;!I'FU0UV
ML6]VQZ]\F"/N,SJ8=??_ !,$[Z>U9H0 T[:+@'";'JU*>:Z1&:%R2WD&$2@P
M'*IGTZ9>Q2*6<\+> 6SGI;+/FVW+/"@M:<1QX.B_JK,,9_7$B?,L1S%Z9^N?
MXP'?Y:WR\^K]$<*VLH'33L%))J2/I:]YG1WYUA$S"F8XVQ[=2M:-"WMVCT9M
M%6L3._??97K0R6;X]+\W2T8BHHMB[\'3X?\ KL6#OW]R-? AYP[9K8F2IJF%
MD04)BH( $% 9KB$"'6*Q2#(00@E:-#J,NO.YMDC(6;T\BW)49 $V )98PWD"
MU4O ^!BP,Z!>C>JADU@8-$0&!H ($CJ!F0;$('&D%]D )0L%L3">J_BA8,JA
M52"XL-ZCIZ@L !MLN&8!DLP?LB02PND-P1+HLT&820,$@"Q+:+"6B0*VPO "
M& +RR-J$E.2@()-):!;S>*1E(!2K+2$I.&]V*4)-.K @-V5@NA)C%(ZP28DM
M+7[*,#!1Z&^)FSK!BHL%Z%BIM6_L97.I;Y&6]OL!&,!L=^.*)?"BR5 S *DD
M2 THUZUY""US$14:/%L905*;DM.&GLL19+)(!@FZ@6*<P&$3A!; 5EP;ZQ19
M(TN4;"L& $7AK5@2:$&: (O=C*ZM:L&I41!"!6MFYFS&#G!1" 2XDR0F;[1>
M@6,*2ND&R&;!B;KL-,&\%0$97 +C#:VM23 1L(,,Y"$HQ8Y28E-C 8&C6Q)"
M4!1VTJ0%D6$R,_ZM?-\UD>8:QY_2'%9O+W+?JL.1]J9=?F@SS'N?NLW3WK!Y
M-0B&S/G.?;E;.DO<;?$<[VICS3'HW[/:*6>3IBV?2/[5CNOGF*<J?-?FH)ZO
M9G]T =\][(S'L[WMF8^,YTN^X%.PW3T:&0)9.O#USAF*N!ID[6/Q</+_ !0D
MGMU_=][;4 WF>QTMV]/],,[-X>.W&S69J^ZU^9M4R\\;2^?-(OT]&'UK/D^7
MSCSM63S6AG8F.6/>O#R:RYGWH")X??T?VA=Z>MWVI&,BM?#_ +_\!XH7G \O
M)6KUJ-NY&L*>V:EVX]O[UH;L(7YW^:92-PBT,?5#<,XX_OKM0J6A0M;VWB?G
M:B$P@UX7>=^9V_$%;%PFTZS!IC/&YC_(P6CAM6+\/6@OQ^K61O3A'@W-!H!#
M0 THWG8]?)JX</F[Z34B6UX=6=QM%_L0L(\[/+I0A9LYX7Y0XQ:KQ![>7AZK
MO40^_G2@E#CZ:T9<//@>N<](O6P:%M9;^D=*PR2:0<H([7BV*RHSGEIC&^F)
MH;6-"]F/2Q<]*&UM">7PQ:QES4T;0!QOSDQ>TT0F(VZZ<?C!00>__7.)TBB5
M-D8)(Y26BHO6(Q(2H+M6T- '"4*@B 2$BQPET)=>+EQP@P@ATH>;M'5 9CH
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M4% PBM$R@26L&MZ'13C@I3]LAU,V:?[!%[5 (D2L8FP%W,0L H&!_1FQ:#4
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M;Q/%=IZWX5?+2>^]N-_(JV;H:8#7Y[?]X,52@4R&9&S4D2U/?2::YM3NDMD
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MFU1&[/IRUO?[*AG@-IUB/7/2N0BQS(CS[JX]OCYFG,\A[M>PXY>3Q_'D<"L
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MDV&4Q,*8)L%*: Y<<EN4(6;,8*>&B6R@OD;RN,ML32Z99 (L(D2I=2_'2B$
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MG1\>DB-_;/S4B1O;F6CM4S9)>,FV&+\(W;5$(B" P\9MBWF?P!F6,7M;O\-
M6OC&"6,[X?\ &$W8S[<:.''RWXB.P:D @ V@;4FD21D;^D).L4<=NQ1ORMVA
M*&-\>GVT<9Y])]RW6KY&;=M/C/#%6IZ_-^OEZ" -B*P&]WSD=Z&-;2=8^]:Y
MC<(X;^C+6.-O>W3?O4T3:X>E]?-ZM&;1MCGS\FL"SF>7WQ+YH0-K6#IX?^&D
MMM!<&R*.0*4IU/L"(2H)L!D=^OI=N1'(4]QH*9'*/84. B$"1!!CE@H$0QF(
M7;'(]-O&*8(39H&HY9)=X2E8%4.II220H'(@R,)H6(").2T)<@+B:7WJ"Y[Z
MCZ+AM&2R"K1.D"[.22"T0 3<B$PP&$@H7LB,JPI*F83<1!(3%"8O>)FX4<G2
M42A:82U],MG5PW9)A1E@9T9D S2?! :0 C$ L19#0F5N4"1*VBK.%"I<%X0,
MZ#!*B%D:5,Q5^[(-"B!2Z;:(JAM,XB7O@: R:T3=2KDY,SOJH O!2,M@!IBA
MMAC5ZA8@A($"L)D%+ 7;20$4P)R%K,TK.B4M6C&"0J2C!!5+( L<J6+E! 5E
M(8DI.4)ODH "!1C# I@9E5AG&*E>L&<P6YDC)1A&LQ0CPV"! IFJ&,-/MXLB
M$J;$2:LA#.;VR%B/*JD0#,2 "6!A=1Y&)RU83FP 2,_U9NGO2AYGIN>#IO4P
M-UZV?K/&H'#,YU^9M2F>N)U'YSIOK2OIG[?YSK/I]TK/(ZWFV]0[B.M\SI--
M*3&GI;K.U,U9D]5^N]*5O/\ ?H*>>OJQ6>F/)XT$H<?36ID7?K#;M$M3V<$7
MS<].G&CD9@'!V/?RT46K/I]\#,12@!UO&MP^XIZNB/.OK7HC\9]/O_!0SP?(
MOIRI(UOMW]3^/^F6=/6TVUZNO*H,&[KUOC)?TM-2"0SI!Y\SF$IV9+P6CG.D
M\9WTK+9FYZ7TWO$?%80,;QZ;VWLZ9J)1+,G73'OM:]1S;&/6WUT:FVY$P0<]
M6>/\7 WXSF>''>*W!MC3^Z5"H.KEU]"?&H6 CT,$O .FC;_N0ZEIO:3F1(&'
MDHFQ99Y[P[$3K1PXVCCI_1WJ +QGTX<:#!..$WSVA^ZTDB2V9) ]=ZA6$L:R
M:>N>_'\*!G!ZKI^B.-IKCV\T_P ;F-$OOO;MQHB+8_$R;;B$NS:V9G%9*)F9
M43JSSHW/,I'IBCCS?XK+K]498&6(.#KPO6'N;\OOIK%6+[QW?CW_  9 >:5(
MXU]L>KBCL!>3,;_1ZN]%!:TKZ6Z01MMO4>^G7$7TYW)I(09A^^?[J(Q:)+;.
M==[.:" .'KK_ .*KHU' -E#P R4$ "O-;$I92JBDIA2K!70I+Q,A!!N*  DR
MT! C,L"-%0?/I=P% 1*4,%BD(@B%(+"0Q8:N%=!A9;5G<I,W@I4R.1NLQ))N
MPSAS.[XJ+!';)S ;R0D+>:!*4"E(AE%O<U,,5E@%*88!FPV"21.A8U+(0@B9
M/<7*CM25)H!PYOD61$;)(DP?9J.C "D$TEV;!4JUZR((J8>):95!H1+IH&Q0
M%Q>+P6BG: 47$BHN6;VE!K:IVT.JF23DD(2*4&0?S])#"6:+KRR^R+6\QI'4
MBHG2PAYN&VFP82*@1-NU()!",C'.:.^-S,9N@+L+!6)36PCY0;IJ(IDB8X40
M$CG(K3!*(2H@E-B@6 +*K6^E/3)O>MQ"I/NI(B'#6\C4K3Z,8"<($BVY3:U3
M;MST$@DBP&8,MZ@WB0#N^"0DP)0?ZE8VN]JNRS?MOGO[4<<!;CMR_=-/!?M
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M?>G'J^/2=K[UVDZY?WDXE9HUZ9U.F1_N;S>VO$[14B\X\Z!63S:D<03=\UK
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ME+.QF8=J,IRX#$Z^>NCB;SY\?F<,=>5,6C-Y=_.7^T++F_1&/+_K\2-RWO\
M@)0[\J 8H)8-: <]Z8&TV>E7K(Z?+$7+?=9T6XEOGBQCL0\K'&=_-\ST*;"
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MC,:6+E[U@MAQW;;6M,ZS$9(<B0<.E]IL-K]2.TT'&==-F,<;4Y+E-YB(LZX
M)+<)_P C.)V./'A49=_0)N9Y0^/^.+K[_C!SKA@:X*5;ITT>;9<MFD9/>>G+
MH]:E684SL=9LO;K4PSK 4ZMH\Q>G)(Q6J"OE-F]8NONT[SO'=D]Z>'EULM\>
M%.P<)_7F]*(WM[!\UJXOQ-?(]UHN#N%:NGS5Q;-CK<J!.<>R>M-DYP+C1_O.
MD0!M\?8T]'>#KKZQVK%T7.'7U;7K Y@>$SC?3VK28'U+%8'(]O\ P7&@LWQ<
M=$S,4 F9^V:,=AN?+'D%7.)S'!^?[M#9(\G+C;-SUQ5A5N>&+N;D";8-ZR)A
MF;1<AGKITHV1E+0PC#(,,Z[9VDILN"\;"(MJ#T*@XA>X#969(@Y;@W?]JF6Z
M)[UL0Y+]T%B>] _U'!S/S/HTY&[,IST.M*P<O2_S3P8WYL)6/MB[-_3;O%"X
MT"W1<]:%YV@Z1]^7HV>%_.E#/(>S]'X2%-OP(!Y&?:B;C7J_O4BK2:"9.F&=
M>E'.DG631]!HW>)^O(K,Y4".!MW_ !!!MQSPCE-6<\C@GG;A0(9V[\>ISZR4
MS%\1(XSOY>:M29LP-NOKVD:*\40\06=B9NT#BV7:<$#.<<N]#.!(N6P[[%VW
M?!* ##KTD]-?R0 ./G'XBF)L1PS_ (P72_'3]_G58Y??C^!N;>>;T 6C3UW]
M*DY3=^/-Z!8"_K6N-<?%J"9O\>K/XD9BTX<^'2@ @H%8* ,?B3./>DD3A;XH
MAA+?(TEQ!;D9S;K5P,@<YOV]+=_^$T!+XL.#)"0UQ>8O<X&&9G;,=H=R@$+Q
M$< /C37FPT9W-C+B\VU^:&$;EDP26 M$0&>1FH'5%N/ES6C'.%YV^(_R!F"R
M<:E+H3OEGIKP-#?_ ",'(MM;'XC+RW\VJ'#%I]XQ>Z3QMM%),4M>9B>/R_HJ
M99O/$FWI.LS0RM#F3O'IGM3HG6)EB=C7EF\V"I-O$5YNYTT%9.]8O/X*S\:*
M5SD>L%+',.T=\5IZ46)U/6#[IXXPTQ=?>LWEY[UHX"^M9;W]SSI,E[6F^ODS
MZU8G9.V?FE<<R$\<SRAVQ7U?4>A_:Q-HMG.,[:RVM3.= ;VF_P"K</\ PIQR
MCN/S7QUDLP.V%?GS-9<_PT'[-FWAWO%00RJ"S,@G*YIS9H8\X[1P^M:M$T3T
MN]\WG$8H59$D,Z::7FW?6D-AVXNI$<5NS:W_ %.THPZYET>EK5<-6R.'.G=X
M2QRGZVVIJ\#\EJPSG3K/K\5<IK\L5A/ ]_W7N>[]-'#T\]:2%-JS=/8_&;C_
M #XHZ1-T_77XH9Y<\-^Q]T+S&OOE[VVHL]7UO[%"(X*>U<@\]WWI8%VIBCY+
M:F(ZG8L]!BI#B0_/S\TB3<F^G \,7J,S'7)XV]*6">Q8#//9X;TQG0R;R]MZ
M0M US"D3K#WFB!9D2SK&-^J=V_Y$"6;MNF=,=N[4I9S^//.U MB@F;OIYS_
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MC%0C/FTSEW+-FD5Y>6)WU@<)IQJ 6;WO?AUV9HS5.I"0:8L@"Y9$D/R0'FH
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MNQC6C.P0%"&E<!MN-F66F:$94@>,60D+!NYL<"EAMZ;'2?4I;& -N7*T\Z$
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MG!CO_;U@=?AXZ>&*[[??MBL;MNM\[^FM9/)0N6RDO6 KV/C3A\UJZ6UU_P#
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M\NH\/D2Y]Z01)P:(G%78^,6C&-J<\<=9DW5><$K.1F]>$DARUN=4UFSJ4L9
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M%N!ZU^Q]SRJ2]#5.7R?Q:G@'V;EU+[_R\2#3+\WXPLZAN3INEB Z-S#-3)U
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MV-I[\<U9(H#Z42!^T/!$""/E:VEZM$DA/"!9C3_ 68WV(KTG7\?!$H$X\3"
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M39CM/Q\S5A=KO"+>WK5Q=_9GYM27\N?9BAGE/;/I[T)>9'O0LF+3VO1CFO\
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M:2?^(R3J>-3EM;[WO)UTH;]-.STQQW*E'3?AQ[Q)3W'=]^NN>5LU89X]1O\
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M7S?-8$XMNF.$7WVXU*$[NVGI2B(UCX/9IX>"G>;UIC;^^M.$#A[W]VGD[?\
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M"RIAUN@SN+28)($BGD ", RL%THOH>1%"$1,N*B%$YCS5?A(224)_P!Z)F
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M   #_I2Z[0_*B%,1P@'3ZN<J1$6%K5,X)L]=+CM%HORS?<2"&@V (Z(#,%$
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M+#FEN2&SI(JZ-TF(?[!V>;U\ZUFFYB.]GL>35Y'U\X3UTH(EUC=W^CM3E;S
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MEH"MSANN86,$8]VE1'(HBD77E G7M+>@$)^;2[0 _P#@ [E$3R$,9<106:-
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ML7G\%8NM*(U(:Q<X\*T4=N#VB:Q/-(^$X5=#P?KSZK1S/=\\*=TW^/[_ (*
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MX6]BB+9!&IJA$R&S,X1)6HU92F80+L(;R!5,K 3)D<CMC;*L%@G@HRPS(
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M'SWH^A>X_=8.?O0$<IJ2$X'<])E7E1(S'./;^SWH1M>Q@VWSWRS03B\?JBZ
M['O%:>UU\^\<J$#M8.DUD<SW_P!$#PHN#O2AGORJ:V=9G2M+M[_NL+*:.E]_
M-ZP]_A,:^%8/6]\=>LZF;59RL[[.9Q*G.KBT\OK/'B<*P7X>:7]XH5!A:*,Q
M0EAE%S"HG)D0,("+I!*P3J6.:0WN0!40+]BQ)$:(1.Y)"QBZ$2C#+&^;)/"
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MZ$[;XH#5*[,6TL'1M-3&IOSDM)Z[3IBU_P#>XX,>!#\ET;>V=:CBX2A+C"H
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M.ZZ1HI<TF[P 00HN"-[2^O*FDT3$! 1:RPC- ,DNA ZJ BJ@"M"E+"DX *O
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M7A./.U<7SC]^MYJ;';(\O#TK!?2W#>?2)HK(W2,>%0P3'/'?UJV8C0D]_O\
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M5%/!;AM-++B^(X9GS2B]S!BY+Y\TZQBWO>/O<BF,69XFFO8SPZ4W6)B+XO\
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M'F:M\)Z]?H_=1O%OTG?VJ63C?IIYMK4EC'O]5%)B,OK:LIIOPUZ>:TO2WO\
M52C,M&]/:@9=F_U.V_IO5D^9S^NO*^1HD'%T\F71DJ.-Q/6><,YX#4%VD8X:
M]GGI40:S&NMA]&H2\K<O(_#$V(X9_P!,.WF/>U%\M^''CGSU_P 1.* <]Z$:
M%3"HDI)JH%**3*B6Z U5@;FMVX78*C 7A2%A&!,F H)$@+:!+(EM9U,S!0@D
ME6QE5:(Y<80/=^ZAN]O//B.Y+X0;0@!%*(@,#0+CSG3 &;S2,0UD")Q*;6GM
MB@EG;2FUU=/T<3G21YQ3XH D3BI.D^>U1$<?/IY-(*3IY?TIN(PRWTQLG2(X
MU*8-5#I1C/&>IO.D>O6H\U\Q6HE]G3STI!T.IW[U#8U]>UN'S>F^S!YQJ=O5
MVZ=O6H@3F.2_$?N__P #Y2D>U"@LI+B556-+_>M"T+R&>8>U$(=W);'KWX7,
M*WCT"C ;-G2"CCS?[J<NT>NGS6GIPI@<R>=O.]9VV>6J0FUX[K9[=:.3>=M>
M>UH[E3:9<[1IRQ\%'#B#U?/;_3YW_(HCK:.T'I1-W;/'AQGM3.V+1$Y!Q@-#
MA9$&O7K<O9O"<]03FM&2V\2M;.-'JDA5X6B\6N8M;%IGNI>@L;C97CZ$73$F
MDTKA*.EN$B8;=^=,.\%F,9@G0VVWM3O<IDMT"VV] !7O$$QM'IJ11HB0PV]#
M7;%\TQ2I>+X[8C!$U-$II,O2^-2Y^Z!"4BVND"^KTO1EQIMMG2UOT.9.>;=+
ME$<WXZ_NF,ZZZ=<=ZQ[8_3PQ&U62?>\\)U]],4F2.CF-LXZTB=E)[Q[-:)TC
M[G6?36DF.&KGM%+$G4<3YK7)ZUR>OZI3;!YFN8=J4/K.ODA37EXQJ_+Y:IU@
ML;MK:Q4,Q=</'Z+>9FF?V^U?R'WX5M6C6;>]]M*FG3C:+:ZS:<XJ5WB3AS*5
MN/.+0YU.TV[?7O4EL/OYM2$(F;<M)]C^TDEND6-7TV+S7M/:A)+%K><7TH2]
M8G:2H($&[:+PNG3UK5T^?](+BC?]6^'S.,?X@N"@Z]J ,?@-4?2G#!L.8JI%
M$  +D6\][)LY#A169K\H;2@V9 UO<S#2-5)0$Y#) ,ER&E HNAYYZT<#$='A
MI:>WXO(=&FVD9"P2H-' ,MO(;:?5 &/.="1Y4P!WSPX>](LZ1=[]:@;4H^*,
MP](YT)-.OQ21/!AV\S4F(E?CRQ2)[3IY;\PS&N* (ZATG?SG4I+TK@5"UL?,
MV]^.U)Y>>O6H^_2?J@$6EY:U_2R"_P#P!+,$YM=_2@039/DS[]=<5<'"/EH,
MD+>3M-G#&775J=UHM&]]^U8_-/G6C;N](]ZQ7SR]'!R+>R@P<4>WS!ZUEQ;'
M!E_>*L#C9[?SE1Q@L8X7Y7/Y2VWM\;\2W!["R\CM_?\ :"XT)Z<.5!9@2D1V
M6_V;\ZSC2SK.4T&9F\"79WFQJ,H,S:=73C:V1%AF8;VO&5SC*.$(L:$5?.;8
M(",XN7C)(X<0X0QK.;!D&_SG2"2IN"=LS&>&IEMF0QN80UR1P,1 :TR71G.,
MO0]_EKTPLC;3 R\>^M'R-F[$!;R(VI<UK;[]*" ;)Z<,>D)]%$F;FN//-*(%
MC?EY;/69@DC9)X>6Q]5T#60,GEGG6/&(WSB^W+%M*BRL23JGFCX"X3JV>/U?
MYK>LX\W\X4VK)'G+#PX4UH>7+GCI?L42-N,3Y/*H<(ZSYTI$6]/V%<4-[R^=
M*"\-YAWGD^[[T5Y;9C7K[_=3ZQ?6(Z;\ZS>\W;Z8H-,]WZ[T3*LQI/#+Y;&]
M9MO3TSY%#+.G&U^K$_JI=>A)WGSA4-1]_J@+:1\Q4T.4;]Z=S2Z+QLSVBLPX
M/7^5$F+)VO/O;KM<--R[<TC$1QGU:5YW2>T_%8]0](K%?/+_ .82^>VM&][4
M 8"W^,.U&_M01C\C>!YI0N'PD%T-2910!D\2; ,Y1);-\U$+(TD,7&5AG=2;
M,.$+R$P@F&)0NP@;TV4;-2*2)LNL@5FBRZHB<%VD$M:N*-X A,),G!_(2)2;
MZU*4-/7'W2">M)"E%E8LWMZS0D8B77J4D*;5%QVGSW[TF\!A[^?QH.O]QGK.
M.] &#CW]J)PN&_UWH)8H 1G-^>V8J#;2.69C:9O4??;ZTTH/J,<M\\9QRH!?
MA_7K4DV5W$]A;A_\ Q$R4F1&$XE#!>+\4SMF'S2L#D3W?$4<9U]8>S[42W!D
MZ36/.48.C'#!6'7ZK3S\>E8G7;CU^-M:<;3.VB[]<4;<AIS/)H<XDTX!\Z2^
M]#'3EIZOG$0.4][_ .Z2(C>6<[>L>K1?4B<$2$G M;2-&[3%G?-]2_:6)+RM
MZB)-")2TKMH:2+$8"FS?.L6+.N.<@,HDVKA-BY@U;V+.QKF(LL+8VC.IB+7V
MO< -D")F=NL8FT+C=#-)&9B$'5Y<WC2IK;S837#;C:WI0B' M@XY(E)ZXB],
MY1#'3KQS?>=:B"MOB'&+]VG(W)K.EOUJ4#!.VT9O;2W\*$$.O:.>NY9>="2O
MF6,SK- W&KUK<)SRXUHO4[]NDWS6S,GMWYS$1UK=QWWR0?%':-;^2?-8ON_'
MR]'%&MX^2.@US^M$7OKP^)>OK-)XO5^8K++&U^I8\XU?5[OUGYHR;N;OFMV-
ML6FTTY@ZF==6_#[KU].NWVYG.O7>EOC3'I>D?M^.'D'XDW_"@3Y:H(:7OYRJ
M$RQ+/:B(-L3JR<9PZSZ583=F8CM_/Y7 !-MP+X8G7A>K4L-K</WG@1FM6;V,
M^6=N-*>I/G?\[^1<_ F-G7K%&_Q\]0<25!YIRVY'^,+@FAZL>M &#\B>6K03
MCS^OR.-%@! 6@)Z592% FR-\IP&UBP8E'.E,<1/V'2+ N&=#:@/N&.X!/1J'
M'?//?2@@]Z& O<S "$+Q2)&$T#+*<D3 [*T_P$B=N?X@F,1/WVX_#3),1KN\
M/./"DR/)J!(VXZ:TDD.'[_5(<K\P^N/>*1-/(GVS4-K9L5"RZ4"XJ" S[T8S
MQM[><:VB.KZ7J/AR^GO7&_O;EZUSZ;<O>E*V0Y)[B_MG_P" BK(O\*$-EHLV
MV=@CE6<PFJNLBGIY$5U&;<Y^I_60PQ\.O")]+Z4;'!/JO@^:AMJ=3;7CIWH8
MQD?5>^G.L?&BL#G\*M&;=[)ZUAR'O1C@A'GI:BP&P?[IM?!,6,VS(VN^%B>@
M3C'[M-N!9DYE@LL7X$69+1B-1SQ;6Q'<AD"&"=8B""G4FVDX.&YJ.D09F8UT
M);(N1UUWDF+*XK-F3G9B>!8WFQDPE!(2KK;C.6<S,9BZVF$,R09YAV'9X-0!
M0D+;+P+W]XO2+1AM%W9OTSK)K2F1O9C.Q?&>NEZ1;27%LZ6^R>U75-L+YOGD
M6IU)#:(OQ\]-ZFC78(TCTYS>C .SQWSPVHV)=G)'*SJR?=Z(/?3R;<]*'&^W
M$Y^V?:&"T/#'?]>M2;VWX\?>=*;1XS,1K?'')GM75Y/OSMLYHA@CO\5#=[/N
MDQ>8XB*8;7-6)]<<:D8DOI>+>_,GCO5VZM[W[V+#Y%9[Z[XVM,'K3LQGG.=L
M1TX;5D&D&:$G%MV_;]T!O?J'7;LT%QCO/)*LSHY,]L</QK.U^LQU/NH X1;T
M>]7R=<[%XXM[>]"B>3T<<OU1)$=2QM:.GUKHHB'#/K;SK16SIT-L^#3QVMKM
MWMU_"JRT)X9].'O06T),V.7FYG_(%P4;_3'M0!8_(G'?2@F;_D3RW\S06D\_
M(J#]7K$M?#=#>3%JE/#:P'<8Y,3[ R3<PW-;VL-M(W9:,F[)40GG-^2D+"UP
M.#UX_@R#9R5I+#"HE+,G19@(X05M$K+4JN5G\RVW]-].3>DA3:D0YEON\N7#
MU_ A>=%DU<;K3<3>H+G*(?-N?.DNCQ/NH],?@3X^>6FA![^?=03.7T\^*$X[
M_%8^>1KN&BTLX^'WZ-)'GW^/2;T/Q_\  -%&$A<Q24981ZVVH9Q$A%[9:<U>
MD8S!'JWSM-^>U%*,Q/.^=C6V:4#C&JQ)?'5B8UKXM]O..^E"XS*I;:%]Z.+[
M>A*<KQ5T-WX*QZ#Z'KJ<)=J.)TN9X>QBL3GQW[?-&VN)X7\OR/\ @N<X!QG%
MN&W YL\1G8O/"7/",*&K5Q>[TF,P_7&+4D8.=N)Q#B[A#47)7LWOTANDL,WU
MIC8,,+OI%Y!F2S="+S:)X:G,09+$X(T"\UJH];$SN,#LXO#12<K,NR,[C!^X
MM0JEMB-[R<NF[&:RAD6$QG@FF8WQ:KYN V:3PQPY9T3C$J M.01K&.LTJ5"S
MG/G]IVX)&NS[Q/:U+ +IEO9Q&8\M5D-UO<UCC.^=&C8.";CG^ZR;<#"QQK:-
M4MK#_6@N'U]ONA&GQYZ5=RG/'O;TH O/O[X]:,&#>7V'VJ4YMO?[\X4<3/'A
M.XQP/FD;O=^#^4JQ<YOS/L4IK\_KTI&KZSQ\X\:=OK6@O0^?"K?(,2WWY<>^
MY0DQZLC;WZQFDJW3>TVGWS2!=GY\Z]DT!9G7KPV>M^RL.WQY-2F^USC:GCB1
MV_E3DFT:F4[D6F&,WFGM+&TLD3:#3)O#>]2W2$U]S%NUVA.?ZQ%N$WY:5*>
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MWTH3'S#@.?,Z4P3DF[$7GA/&]IKYO<_W$7EBW=V_!&OI02QTQ/UWMO4FK?5
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M(S4<#:9<3&H:1BZ0,2M0#=-XS8,DN)X3%YH"0Q<D2[M,[[ \6K$6C+'#E4(
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M,/MH&:%5-8O#8;1G$:Q-WL+J8MSXX+>_#_29,*S:/,?,5".\I&A[X:@TE<O
MT3S8F:N(7;RVF_/2[32D6O#TR#>>5&K 3KO.\KDQ62V70O[=Z;0@O:T2<V/6
M_>*/I=]<=ON@VY6<Q<(ZZ8FLMF)@@O'._:]3E[W;:'ZVM!%^$F28TC'%8TSK
M&N:MK&\1'U;5G?G4VF7.F>.O.9]IIL$Q-BWIF8S:^<5-DA*9@(Y$:-.U6F]?
M4.CH"WOE#0Q$Z?OTY8K#;A>>6L:;=K5%!V,DD'IU^VF(MY%^/#A?+48>3B#K
M[1K0D6MJQ'2WWQHV <\_*5VQUB^Y^_?1+2:WY&_K[<*.'=]EHLG.>D>SC^UA
M;UVF\6WC/^4-K9N4)\V\UM4^%&][>>>E0:4 8#_I$.GB_P Z=#_*1)Q?SSC%
MR@^7Y0B%I]\WZU!$:VZ_/;\J$;KT1_\ ?@(75K> TUV5K<7>4ZI9H,X+N..]
MB9ZZT<!?A.+:^OK1#VA<=JX,=(]6[3P,VT'R]_BD3"7[OW\T/C#>QGCK6Z;W
M8?37VM)#G@2G3.(\XE9H[],=]MZQ^AODOZ,U !E[QO%(F1.=0.2:DT^/:H:+
M[_5+TAJ#3Y]J1,B<_P < [4[7GFU1W?3ZKF]*EN5PO4K@>U(F1_R@L20ZIFW
MF?JM4/[G@2E^^:GN>M3W*EN<?-?2I;E2T3V^ZYO2N;T_=<WI^VD0P1:=?NIY
M6B)OYY:*26-<<.-MP9MSH[V->K??1G^5,V))OB/N,:U/Z0:[7VW^(S 8UVC?
M6TTF)P+J$3G%M:8PENY:SIFK$L;W7]VY]JU#E8T<V^L\,EQ@UV2^#KL.KM%<
M+(Q;KS-2.5KW1+(\;GMXTUR+LZ3[7CWQ7!Y^01;6#G>N$Q6C6>SYI[V]:+[_
M (UH;3!ZZ[&[.=\4 EL>2Q;>UIK#($0>?$VY6K#)FQ?;UXO2MH]?5X\.#:K)
MG@;\>]_TT3A7/U6/8YWWC^VH-[-\?KSVH7X![\_.E&.88YY[4;=#US0DDJ6Y
MYGS7A4=WCQH!^]:@V/\ K$]?3[(\"],1=K[Z 6L0E.\\O.5_P9.7ZKSV^_\
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M)PJG.(,'",[BPEH7[>$P8I<9DTI[H KA^:'IBD>:7N7#O-*(!XAP9?VW"7;
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MK522_=Y>'4(2@5:WL@12S0.:>0%AKF@]':)>-O9,KGZ@-E? 04.9MFM2(UG
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MC-4?_Q<$658*'N#*PUSZ\L?=]P08(>2YN1\_Z_O;/ELW.576UL\';"H.2O!
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MHCW2->4"HE$!;1\<T(-\!3?7D,]$O%5\JPVV6XJS;!Z]DZWH+V =DB*.$=)
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MLF5>M3<Q\H*R-_5II!1?B2U_$F]9N&G\3MJ7*/O,](UM3]5._[363$NYI+"
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M,YGE+]B)F!F"H1_IV.$@R1LV-LP9LE+9UP <ZJ=Z6.KRAX R5P/52\^\T6M
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M3M&=J4HN.W51VE=)9@@IL2"XR@JZJ$T4E=>HCSO2:;M#9A:V9V>K+1Y79LY
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M/DO[(ISA=:GRP!TNU;/.3>\YL!UB-&Q56$RAG-;^1,B?E6)+EFV6## B;"4
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MLF# FV"3KF%K\C/MR[E#8I!S+=9.]+]X=@D%V]J^W')Y&]AIWXWX*]"THZG
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MS':SP,+6L&;DM9Z7,66(KKP'2I\,A.KB03AZS0%%H@*_&S'MD*.(Q\L23\D
MPY837<>D?92:-K2SH]<B[_YNAQ#RR?NFR],HNU4R,#F5[$D\Q@'#2\)(E]52
M_=PR%W?VU=[96]J>".T=/!/$62MT^AQ=&E+EJ*:;/>-LU8N[JKQ8C4H+.4.I
M3TI7:;)1,G@:7"M3]!A?O_L=F><R[L45!R+AF@T9T8T.W^DD=]$WMNFNRU5+
M3**>RHB2@7+;&K8>F8/1D9H^^ZSKK*^7W[6FSE7<^"],9E7!=D#P':<J3$2
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M&$_@!/%/O5>7D1W:,!I_M8P];)?VYXI,_/-;>UWJ+8:+4&LS587(I370LY:
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MO!)_;4+9M'201+<;@Y+P3ES8.>"*.S!4F2-<#7U<,(-BW/?AWDOV4C)3[QY
M9@$H B54XAC( QJT06(9(E.Z!0YVE+%>3Z;7H97;"!OP97[G$G35K&;603'V
MAPD-DAZX(MR,^X$>?HRK64K?O[*-7PU>!;)@ G "9OI36UOSS I3 P@@V7XC
M(C(9_'V^+VZ1),I<@,;;GB=>GAC35W--'78W4RX*//CPF?IU];TN5Q5.$%H7
MR3#LLPRFW;&-'IDV'7;B$^HQO\<8#+OFBL-/D!?(?@LB!,2F?&WS+-T;JC!H
M+<1V14<]S[VDYM+=@1X!"B_+=RU=7%%GYEW*3&.-/LL-1!KC*G9?IUWHJ[*D
MD&T.B#4U)?#-!7^_$BB9(D8][&S0YM%.SQ9JG_L?S#WY"?M0^;BUN9;CB(5B
MY_[)+A)-TW86EFY99,?FZ[&>)YYD=Z&KS!,N=28D!>782J1Y=L$/%N8ODX]3
M4"T?=?_H4FZ7K'>JJ]J4^>;,^8T60<?_\U+<M!AIQS1.#W,.B!S7BZ2UJ1[/
MT/ I&Y$> ZB<B;F.1.&9)Q<5%+R+5RZ\B:2\F?B4A9X!<BLH$W .:%4F+_ *
M!S 60/9UCT6+CAB:38DI,"LDJ_]57%"A0]IZ=L["["N[1*,[=H>/_VT7!>]/
MEDP9I*^&$R]H_TGW^KLZK,FK@T*.],G$L!+6JD(63Y=L_NXN0 "?0=[K0OL1
MY?M1S70$E0F9P?>ZHWLH,>E>D<_2IWD^5)5E\OR*CR4BAF%/A1?^EF>,-8OB
M;N';?9MQ2[7MG8KF4#K#SQYGOE[4L4<>5$'$Z+V;Z=CWZ'+U[?W+IKE1P#M(
M^\^E >@6TLVF\F8Y' S/0WB(>[\ZR'8"P<1\]/:=>E[3T% 3M;V^L,>GQ5(K
M<8>%OY#O0MF05!3^9E!TFBUJV<?*(Y;_V<#>NY\T_$G3AFG>(&P\FJ;CBI_N
MZ%&3)TM3U9=.S@4FYH6@N QFR)!4PDZ7:S3GD<,.E].SOK^1*0I%?R-3LE*I
M<B/:Z7\5!-/R,SJL(2-!I0RI1>:#?DL+[_$<_&^0,S685(LG6"V*>9JGM);[
MLX'*5?7UP5V+VA]3<VJ")>K^? [^&?<, C#<H$$)EKST-R/F, /IGH@_*7;(
M[_9Q.!09IPK>U-"]3)'0.A/O&F(:;5X*BMNP</%8"6!R9"2D6]?&QP6$W:5H
M5=I!DBY >YMY<%+>]8TGHBM I@MW4I(>,LM3[/S12 J9<.;_ZMZE0ZDTAI G
M& 5XX$5)XVD+ZYGL9[<$TV990<)JKEPLYM_O49%F3O;/[IG3PUK5K,?Y,; /
MV:'OBT6C\Y>#0-OT(7W7=DX^3%RWKB&0)6M+N9FY=TJWW,^WL%,:$^WKO39O
M^%/+_<X!11SG +NBG3AV[YR':&C(^Q_>86=(R)@N=;))S@%/-X4K\MY6U+HR
M)8Z*Q)K99LZP"0&E^/#4INW'^I\J^U"<L<T=Z>DKW_._/*9\WQLZ!YEP<:[$
MI\O9.3D7SW]6OTY5+^E9VX+E*^.X=]'*'E0!:@-Q=LGPHYLS10S5!F)7M>L2
MKZ6#.YJ??^!#=_J'XXW]^="(5C"K=X#_#3]7E_<>W$F#UE,*:Y5"O7]ZBD_"
M5DPXE"SY.?>O8D&XE.5>3A"#-W;HLKKEUU?SL\Q M\)?4BVKX!@/$ /B]>8O
M@BH;?!7.*-9H^>GQI&S?G*#%\/Y;6&K0'H#C.$MC[!P ]- >?-^BS#'AP6BH
MVS@N6B)F.*81:70.>.:PG#E]<44!%F.<ZR:OD:*6(6VP5$&WY CTOPT.@H_H
MZT:QJNA3 1B"FQ_@ON$9MKW,).LP0+).9#39''2]76MB4I!\U84/E-Z??+=#
M7)"*VWU(B&J./-3##,,K<8&+$F75ZLD6MF+ZC%;IO0FWKC,0U!W^ *</ES?:
M@5%LQEUQ*R@Q!21S.SC3H1GKS6GB]O/2S]PH+@=*",=IMT7W-/(" 53B#5J.
MC<O"9>K&&4XZ?5A91UG[3.H<:NX<]E!Q\PFM>78_/L6OQ.V">'_ =7YYLQM_
M?&B7*P6S612FS79[CZ]C9-,?1J/D=_UT:6 KX!FO)?,/[GXQAL8CU\?==USK
MM3_&&*!>^,%*UC):W!Q&H:R$>VCS0&DY%VJC3J>\;2OGZ/B%7K<D_UH# R]G
MB4U7\SLOH6W*"E/[6>:LN,G.7SF.>S5I?G6 _4K-0@KE.L+.#IS,/D#IS-!F
MI@KT7M0M_)5J38?()[&[3XTB-^D4EP!*@"Q@!.D_&KHS&G,QW/^V=CEFI0*#
M_R=3^']Z#@ 4^I\4%#>;HN5V&U;@]*1Q.3"36-45GB,M&27U(Y-VZ?P-J[8!
M1B>)"SV'AF YRV"'[7]Z'%58EQ'5][I;Z\"[-VA(@V9_S#CP5K!>CB12&^,_
M)27Z#<3]MJI5B\/#.8(#PT+SR;+QZ!$L#Z#UKGW]'.!9+G[- C%??._?0FG]
MANN1>[HTVPSAYX#K.F!2T^HY8.21V4_.?XG/_T_#0!3[L5_^1KBNNN!I:D@?
MA#>0.$$YPH0XGGPJU&" $@;6>H)@5.; ?6RO=R]5\RN<_7(S<2O5TH"?NTQ7
MD]OS8F,#%D+,]'^$%B0Q9Z)V%L3V\8:[S1"L8[DR4GAHH<'?+N[X8[0-XG$
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M 4(-)(0;_);W^[[W=^>><^9W9\[,N7_L85;6VL]>3_\\F[77.D7M$=U&JC(
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M#@?]_S[T+?#J?^/&EV3Y>M88?61.QTB@Y)$\\1$1TEOVV)CX* #26YG_[^U
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MB'3M#^;3;KBMP)LK%! %1N%*BA^7H>#O+GA+O_N%12]&R-)?34<H5.;]V@1
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M0\W@(JF20F,(GI9CJG:>YV6]CH'=;! )DN$<-5Y9X/X,<(B3%HGI8V#SW#&
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M_T_D2H+[VR>(]\1\3R#O5F+U-5^V#S?7GR GO#N'PBT%5OQ/<U_N-[,DX8U
M60<BZ_X,%:G ^0,@DQ!/P&52,?0W\+Y* MX]>V8DM1J?8-Y_/ B!<^CB_*<-
MM,FUK?6G6NW!@-TNG,/D/_NR_Q,O%W#C!8MZ_6,/_]#K(N(8^$N5NB0D/@$A
M+OQM+>_\$4>'<LTG$(8TVV.@Y2BMC_:HXD_%;C32'P,W=O[VB7<DC: #VHF[
M *S[J$#N\F_W^<.^_V;@#[.LBEFKZ5 <AD_\D[>N?Q/BGU+9@GS%BU[Y=@S
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M#1Y#.Z('A*%+^ZFKLU$ZHUYW!'PY+(R[G2\M*@RLW_R@T,/Y'@:6X)7 C)8
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M-SC%9-TXQ1G*TJG7[Y<3O$L37N<ML$V]?W;E+;9UEIMJHK@$YT>+M>-4+ZY
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M@=W]P_QQ5:9&D;RQPT"A4.&<K,4S2[<S_E#T5'UHLM<C^Q.CE,$B4TT_H86
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M8=80Z:0NA\J'JLGT%VG]:3OR'\/C5XLC$FYGOU^[8_86BO;%$/1*94@<5:D
MZE1@^]XS=DE"1'JI!/BGT7/YEZ@OVW0<D['^ /^UCNPK7BYT8Q> PU@WY%V
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M7M0<T>GN^R T8REWSEBM64M8>N=*L$MGU?B)X=8YE^OCAS>CWW5;:6\ ;!>
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M(5YZD3I+0=$DM*9AD2!G)J0Q'99U.O0N,G/AVFJ@+1FL0'Z73DE7M?2;N/:
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M_/KCQX^/%[>6W9+!D96DG-MT7B&JL#H-$#*"KQ:*S@IQ6Y8#.L(+=/V1/%$
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M!Z18=>@26\+!U(HP7A_O?--E-""Q42:S7P@]<CLB!.W.7@"TO/!P@*5"?6K
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MT8?<X1&JJ;M#(*K*X/*0W=<PBOG!VXX(:;H]+(005ZYV YQ,O'Q^/_RM+M:
M^<+FW @QD'XDC'G?CKE%VC+1 LVOG9Y CRK&X&X=K[H8@S'\FA[7:?^?Q?.W
MO@5/T +#73S@A:50?2^&@9@F)__/)L ^INBD<'7PH["P V'XV?!3U_F/VM)*
M3 R#K-GA#^-V]&!+6;Z&#5>YZ^Y.P$?%/JY"7)'N8 -DN?YQ=KPOP20\LD8T
MC,NP+X?*\35^]*LZZPOWPZP;8*-%DVNHA)?J!V[ Z:3+6;K.5I:NF,)\6O=I
MQ>[G=OE$,KKFT71'*G10#,> 730I_G[',;+6^%#*<%$TI&2#092LPEEHWAAO
MLMMZ ^!+C0LNP;]*+"V2NSYY#E["ZTON:CW1@_ &;)0)LK8)D*VD/]Z3PO-Z
M9I5D&$9AX/AJ B(!B.REE[Z-9_1'CYUN\UDOF+!CN(XZBP-!R2.KA^%R12 *
M>NB1#J\%PY:.^]?5P-;OL7>>#\3-Q1F6!'8MQ:.#:^Y5#-R1E+OF5>;O(&;^
M($J5,L1/#XKE&6BW]?0YH6-^IS*'/ZLA6GN3D'5,(.L>?8KN0/*YOJF+098)
M_0A79'JIHXCTO '\(T6I E/M^J]^CR@+K/P>Y:"P1QN$5NK*Q,C++7X('-[D
M)MAA%X;I^.S+\=BD)L:-29 X2?Z^YW.VB8R"-%6RA+X9I052.XDB<"0"*QQ]
M.R/:?+4WP-? UI+IS!O@:9VKC"[QI<\ZC'Z("@8;,GN71E5J,XLK_.LH;V<8
M:? P5"EXK;GSZ$ZZ\JV'Q*4^\DHSMMN(=ELZ&.$I[=#QY7N6(_KS7A[1H>"&
M7"%@(M371(I&2GUW#.SAV/"UQ-<PV5;2KTIH*'78'%[]U\ 3O$%JF1 O^5V]
M3K7FTR,=562^<9K?\JM27Y$/'>O%KME&L1'70UR9T5)RUPHCW(1=ER6?*<S+
MU]TH;=CLL>>&KMLFXD<<3Q8+O/!!O ZNT_2_BHC ,9KL_IGRKUJ"_MY]ZOEU
MU43)J)S,Y5#A\N3O++B7VH#I"0JG:0^*_J![<3(EE0HJ-0Q:DY/SF*-;+VD:
M1"-2D*@XWQU)[_8<^[(;X!=H&?S)8V_?JNDZM1A\ 7,N9[=30$>XQ?S]K[[O
M4J#V\BO[CL;0JNGC6[0._F9GG=1D:_:^<_X>'[G*]+R.:CX4%!$LYMS('^4(
M+9[S0T+^?D"_>C&0B^S;6%>2>;T$U0/]4^J_HUY?2/Q>L4+?G>R<:44D83G(
M&G]7SK:!4;SVHL[G. IS3-# ,4.YLD=X'M;Q\..BY017Y=/?ZBQ>M-F[DA<6
M^Z($\*&7/W$J25XS#/))K-<E=9(*"_GJ,MZB!$)O35F*^H706;"I$$G6#$:W
MG>'H,9(*"5FX?+5H:L>>\9^S#^Q1GJVF<H6$?;&L:AQGR,_"TJO&QBX'&1,8
MU^8L="'AFVXI=?,OP0M>V4X!@J.R 6.$UP$&R<-B/[?4<5P78T0_/% 1QP5>
M<9N._LQX6B"RS=V\]-R$C29%[/7UMF]AZO,[DK<+Z(Y_;QM4#\D6=K@1I6(X
MP6SHQU)(V"MZXFY>7FI*+[E2\%+04QO0W-,&S93)O'\3UUX@#EW5(Q1U^M,W
M;%"/*BMOFU;-SF6L4T\#.A(ZQ0_6OE,SC)XA3I!\FS[\>(1\ *Z/!C]HCE)O
MPNK7#4.B3O&2DRY,#WWP3K>&QHTX1T 7*@_PF=Z=;;$AV"+C&^!/"1-PMO(M
M;58J,<)Z<@SDZUCQ&VTSV!#^\P;0IKU5@:TI^NIGKRS^*ON+SI*4_AO[E:M5
M]WR2725Y\3%E*/T-X*4P$IKUZS<ZZ373C.C3I?W?IA6<<.VW#TB>31[ W^I?
M\ZYLF0^QK\=+J19 ;C_'?7>3^&K"'$(;UU\ACNB9S2SP_9.:<IV,O0'@1F$K
MH?_B;P"-1OWYZ!!8CGW(.NF(]*6Q<[Y"D/QY.3?.8.*=2TO+Y%.%YH<W0%1)
M)4X%94_TH?7E#> X<3N0<R?FG6F/_)GWGOY/UTL3&;]TM>8>M-*"Q"9#@2Z>
M-Q_19<)%<58[$M+\4X";2#$7PS/30C'<?LU+ME<&[?6B1"BR(7L]J"H.YU7
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MYZV*TX@2B%-44"?,1O1LVV]ZZ;LI1![FHP^O$B#W7O.]KI7C2?>(ALG]9?"
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M*+NPPA(E_\Q/9&7B25NT*[ZSM)X@4#VWW28I'42ZPO;->KY"]C7!RU;I<YZ
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M'Y."1&JAU#<'1'!<+8 D(:70DO>E@?!/3S**(&Z%3:+5*X25$Z?MFXPW+22
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MU1U8?DDH>D[_2GCMH-_O][JPCC_K:@*JLO5QX).I9N'3O15MA9VT@*79+>F
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MDV3?&7\J3Y/+P0WNF1?Y2MJKEFI.)D[&JC70;HZM4B#?1XC$2LH:#[S[Q($
MY7-:V@X,R-0S'ZDWK6^$:GO/;LM12Y39>9=0;NF;5SD,LI9"4?-":F:(H^&G
M/&L]#U&I1+T:NFN:*$0G;;M"YI/_232B331XT$U<*?H+76@W+!']89CPH:]H
MJMQ?'$_>.NQ!<GSTV*, P\1#GL02R.<0<Q_,EGX)6"/.G[:?;M7,QM[K7SUU
MKMGF7HUXBZVM+W/1J1R4$399&2&*KWH_[\7 D\\91.P>_9<+2+'JPGY7I3U(
M.LCILVUACUF=GI.Y4Z$Q[28YA6>9>![8!T:@P_RA("H(H"!U'(R9-PQI0?S*
M*JD)^@N(\KGU;\H8J,W9R'IIY#JMP![D*C2[V(<.RTYZX$KBH6./K'>7C+2:
M*LDN)Z/;U[^C)\>$RO$GYLXQ4>J2R+[5C+>%.NN:<0]M"3[G*'_RL\QB:G5<
M:]%6>B?G$>6L9D$82A/W<VQ:OJC\R>=#_I2=V5 &3<FYC3=9NL 2%:MN 2_-
M7;^8ZE2VVCK8*Z>'P%?701>:.I)6E]>OWQT&&%8'L?(S8LO7DBK$> CXG^8F
MCI ;;RJ%95"=B65J1*4UR;RO-__:F!%K5?%CUWKL^*C@5QVTZLJJLFO[WXQ/
M*3F_BO@R"'UM%(1HTRH^\>^\<]^QJ'7^T?!%RV"4/7N9R9"#E"VFRR9M>+I9
M62"E1-'6D=DW#=>_3NG?\8=90?!9%L&:1TP[[L_. %:>7C.@H*4ELT;F%+-S
MO_ )I(=P@X,@^F13?<],);WP8C.HM\R"01<$?O/Q8K3D>#NJ,0A>5J']=';A
MBN\!/4+]<[NQW)V-:(0@\_T(XL!54U4;I(7C6*GXV)-F#4FS&2+<"6[3^SDV
M+86%KTS@TP56O1]=B>3=%2UL^FG(&SH6+-HE9G-:],+Y>E:O_@QI0(_.1<6T
MAG%F+J1D:P!NXUB5<:Q.[J0>D7CTAUS[6L=E'<GUZ)-UV.-WUCI.7(@6,S;F
MRPDF%(SGAULA@]HF+Z8 5*/(AIX)5>1\TITX;;_#:'$=L<U<]5GE"='WRK\J
M'C,*9="]S@I$8WYMS(/(DCF+\X@!L>Z1S\74[:$]Y\RAE<<*G)!G$V+KPPPN
MI]WVUHY[HE6ZKK+)=4+B)_'L']7P#WK(#2!]?2,D+W*'X,5T:!ZN)]Z_3S,M
MEKDB@Q^K>2M$F&>?!M?4]WLO4YOH,_^H8G_,0+\C>8$HVNSE;)[1GZCX8(%U
M\>;CV18C>\]94Q^=VZ.&88.K?OOKA(ST'B^V'"9/G-VJE9ROLK_'?*\BJZMX
M]ZJ7J63Z0W:,X=:TYO?S135$]VEL*+/&SH]+^>[O]7VK5/',F?\'>5_]%M7W
M?3^$=*B TH."TMTY@"^ZNU$!Z6Z&%@%%NIM!&(;N[I 6A@9I&&H8NH?\^O[^
M&Y^?[WGN.<]]]MI[K?/<O=>2]- QG&"<[\I+P*;N^RC"^&?_^IJ /JKT"2#@
M9_\)(:'7O.#4L[5[7B67M4&<]K/^KV!7Q&W3/=/<&^'APG%LXY1J$9%_['.[
MB ]G&[5 ?9Y7-^8D$#]&)B=A53#X-N4+PQF>)+%7GIAZE_\V4MTEI?5?UH]I
M/=48#]+TR,1A0S1]W-48$H'CI*O/$H:V-9$?5I:*(.YF *6$7NO@*7ZG84;;
M?5MS:3B%B69&09BDDL@#,>!#T?V4$B]-&  7?<\NG="T#10^+^;<? '116K?
MC[Z-]H$\<RP-BVZ"<OBR1R!0B@<8'.JDGV5W0)GJWS2QFEBP>6Z!Q@Y?LAWO
MZA=FLQ+._:F%*<;%_#6QUMB[J9X MB3)EU^6YHE7\VTXP_57<CMGRC<L%Q7@
MTB^//GSU1<#>)_@(K3\!WMXF::7X(L8Q/NJHVW!$ ;?AHN2 K7=9"=4^] VL
MGPI]Z!Y*GW$SNB  $U/X--<V8=)D5*_CPSB1*!D+QF4#SH?%;W4%#&S\2W1[
M=MXU3"G.61YS(>_EB;J$L23'W33.<:9(&26HJV@<T5O;BD@ETHQSRX0%:D!-
MF_=*09RQO'M%"%_7:K'>7Q62;H]#I1T;@I@V'],K""%-""YM=I#7LZT1SH7U
ML- $> 5'XC/-#/0@N )\QD'9_::UYIX%T]\C_6OKH29O<Z;L[T8\WMLHX2-I
MV+;YEH[Z#DU=0K8F5DXR#_LYR;I;U(\%CWJ/_Z)K>7CO.^OGEPNMO"#825+F
MWI\?)#N"<^0PGAFX=0_.Y7'DO7GWG;V?[\7V0'1?3$$4MN3W44S^06)5ZU'B
M BP!"%FVQR"8O(8Y-%J3ETKZ#L;^<&"1%CJT>SNMYQ%2F&?OAS; /=9\0TAZ
M=([,5&O9BB8U-JMH$D',Q1K)J^/88G2@-^.K&$(3'A:3K'<0\2PN.3^PZ&<P
MR%@<U[5+:=U%#[4=OPR./!.GW,H6_BS]8J#EKH]RCRVPP)ET?::F*K4G1\94
M>R!:'9=Y*C12'ZV3J6]6$7I.=++"IDEG%C&9K:/P1O8\=S49L%[@K$%\C_3M
M'EF?SL+DR1N\+R;HD?>CKP?,:IL0]]Y.COM12MY9YUPG6QU"V$4'/!YG =RJ
MGVSRBEA)3S^K!^=PE--5YW%+3)Y7XO")4P,P\[@Y^%8B&R0Q#]%I+DW&^I='
M!5",QONQB7-I_'V"TWWQ1_)!I_;0\.M#1<I*$]%!2Z,UVSSMC$10XG/1+Q)W
MU]<0S/U-E1)L_;M,CO.WN;CHW;,R[ZM)DP$(P&J0,U;I=I*6U3GT+17<G%?=
M#]NN^N%Q\!*"\=<73HF8R]^&CYW!6J!2EEQNV==%KY?3G7&OBS&H.H/;0J<K
MA'W4.F2*JJW'I^,[D$SQZMUR9[DW$(QTN@4JC\4XSF@_QIV#YJTIM L-]P@^
M''<.RE!GE5,N*96,%RLR>,K%>_\^KSZ@IP6W@"!18F!I"U!5LE- <%<K2B>;
M"7"@_\#0#<>$M*6*:R6NQXZIMK4+E<MH?JR-%3W4*VBT2Y<8:XE3[/H6G(>2
M_KTB>.ZN_ $5UPG*^R?&R_MI]4_CR>PN=C-3:LC%A4)6FI&J>H$M QO'TM_T
M.!9 ;(ACG9H(C#3ZBP+QH,]GF3ZI/I;B(4>V&!2RZZ'-8$_8,RS(,$SIO D7
MJ!P0A8H%0'!*[ULDA#_'UA?0;EFDQ;;TT)7HA+5?7$ ^@88+=M:+!P5*28Y$
M*3>3W,R[3#4Q4_;<LA^3N]X2U6"A]$@*6JY,JC(/>[ 1P!S1"JND!X\42>\J
MF<.Y$":'A?DC[G2%STD/;.]B=S9BSR:X/_>4\2Q]G]Z6DX)A)FXBG3ZO, ?E
M00$R?#WV;86T3P"_6J5[-KS/B9=-(U1OX,\O[H-SI&@,VC]S' Z>P+3BSAP4
MH@.:L9#2+\KMR\(U.Q?*;KD:BGW='\4/^<[\"8<>#^;.*%R*%%SL"Y?J)K1?
M^I]*TY< ^V-(!R8>\C9)(^>N$#3R'5"V'G#G$<\KC4'*"T$3[1OF]R76MVFA
ME[82GV&E1_Z^()] /$1DR)F?R! *:6[UQP<3#-9-I8;NQ 53K(3_F?-QRSD=
MQ0ZG"^PC20:,EODY[B;BKR?B%XB;LY*7O:'[+DELD!!9&>@PXQ0D:.1;*G+0
M^6:/Y^:KH-G/,J-0E^+_Q+":/RG%R0^V"-+-]S@$DR^.%0=(S+\Y%6PE/H;"
MOPM2*@0,N-*2'G/K3% #SA#O5Y,'DEHD6;W8'2K>GIFH+!F5'UF(6T5L\L7"
M)DJH*)2@(LP@;F-L0WZ;[.F 8W,V6$Z++WF$>3)>TTZ09\P[_7,IE[Y,MZ0B
ML"9?X%HX0_P6ICWGXT4,@[D2Y+_MYJ*=4JE\@LN (!R(DS7E4EC;^3^"B#D0
M6N #$TQY:&VKKCE"5 ;?SH29+'5_#U[[^&"/X["3)AC=ND/YN/L$H'\"H'0B
M.IX JB' X^#+XA>E,Y['1GE+/Q[@\T^ "NVB"JQUY\'UX-[0M%H6>(=TDY;2
MM0GSGKWCA60,0"SZD7Q$'RE- KVWZQ"%&F.+T!7E[=#+R66:S>"E_1&W0Q_X
M"GX4>!@\A> WD5RTZXJWQ?KKG,O\EU^R5,HP<SC3':^]4Z /8QTF#TD2.-CP
MI7R?*0*UAEB<AZ+,NKK/@C><?0T>NY)NYPF[*GQ 6$I/@/"6C8^WCQHH:6 ^
M^?^M>9B,")O[F.$G@/GP_6+[P$9KDGG6:1WP))VYZJ_EHY/Y1U>W?TBT&5=?
M'&M&'1N3^<]Y]:#CR#%D$2*.>L*'!M;'NC!T<R%?!HBUV JE3R]A0\=69M-%
MP3''1#RCJVTFP#G(X#6F.#:NIMOLN%/K/%B@SF8L8&AF_*P[/MGEVGY_J)9K
M6Y1B=)5ND$*-.17.37C@>(NE=9CM(]959VEDGE5W3[*4.W-JZBG%WA;V0^\=
M\  &^J/? /O)4>E*6\_Y!% 3*G[T<JO ]Q)E_^);RG8D;&Z<Y66,4FMLES=Z
M(VMRTQC]!&!+I!GB LVJT>8=50N^<RI,V!G0@;)74(6]CGC;,%.0PVBT3K5"
MWBRZCL"B/+XU4(#=:/2N,J4O*8]]<97YO/6[5&3KO/KN48\2I<2!SX,QX.HN
M6I7]I]:ELM)>T$RT(G-I)ZZP=W>VQ%@PC>]X_A$_J3+@V2E%89Q09OR:46B+
MH3K6B>CX>D?/?;]KVJ)Z 62H0DRP;/=K+68@N*3*?CK J-@6===HI.<NK_D*
ME;M0F;IF/AG@0V-B3M'0BA7>'"_7!N+B;<Y3SVTXH8SV]D@2MR9/478XE+]&
M7]R_N*:4&$EE-<_JVO'5B QB=WBD:O[I=)"6>EK],/:G5BQ\-T088^V"8M]8
M8R".X*;HV4_36LSC(OH_8A?#2Z-N\> [ ]93\0V-*\Z.@1)804/MR[.8/^N8
MNIA=W.I*6_-)$I_\J5TX1IJ_)O9KF5:U>]JA<Y?M9&MW%+K,;*DI9B>HA2H$
M#(C/.80Q4CD\<E^!U/.4X8^C<_5H:CK9?I4J*:>ZJE09Y'46".JKD3I1[1L[
M1T=JW(8;+2$#;?9W> @'6U N5<TZS/1.C-5NCT;\+DTXU +U%(SW6_D&&%\C
MJ@(S4).H5^[JGXTT,CL,[*ZNKBF".KU.]:'%-V6&3CI::6.=7W3YV)YM*-!B
M1 D\ <@<C%6"-E&$QR_IT8^'@2E$O04PH LY= ZN@C9%MRO@7>8;;,WO=PW=
MLG<UB(-2?'.J^IV\G^=O-<9CW&MYW+XP3LVCK)Q^E'*R#+[=?O$$V$2UBBRJ
MGK*YSDGES@7%/6*@1"H-!G*?T?-^9]Q/\XXJ^)X<]N*:?4 #8>0=_%H F>58
MH_;B6@_K$KS<>'H4YREMDOSQ>DOF"5"GGU@B7[KMN!%!R-NMJ_<9I[!U<3?/
M+ABP=B<3"RMA_UN"UO^KZ'.[]3G8^)*8M*_5)^)0KC/'CJX^<"0NH^-O:])E
M2?Z<H[/4]C+G14+P0'GY9-=* LV>#$PYA0W<G1WT.=TR<%G%VXSSRS7)HV?R
M$V @M37N>6Q\=&SR <D,?3W&ZU210S7>>'52E/;M1%GW PM&5)5V&;UX(&N/
MAW:A)X9DQ7W"^JMER6'!0"^\K6['DEM]Y\F;J4,(L3K3P&),$G9L@](;ZRW=
M?&C< T2R&%.'\N,&9E9<%N *:@)U20DEQP0>58,^2-.[G2Z94W_\IE;ZZN6J
MTM9SC('Y6!G4/GOWD9/:]EP.3.&Z\D@;(!:(B$.9'0]6*!VU^[C B/Q>74TJ
MRHNNM, _%NAI?#-F\PT;'/F"/0C[S26C+4^K1/41U0_P/_YV,?WKQE*IF@'+
MQ8%<@3Y?&E3I8"]Q'JI**4DL*7TL3:HMVJ\XF&<<S8O%B).7M!A""SLO^98S
M9K""UHU:]H3@I]1=%M7I^&B_@F![#TYEM9T56E\436!E1-B)WK.VQ7#=3V!:
M"M1W%B4U8$D%/)3<DY:@<@F;TS[$]Y0I"&@O_JE%J]&\9OO-L^U!([)^S9@O
MN+]&_,BP<*][HIZQF2-H+,XIK50K'#?ZY2_[@(QIMONW2\E@@IE3^=36QBPF
M[)?NA9]NJ4](PZ4$FFY "(>\R";]0Z<">[)WA^&_?_:.LD2\P$]8L$HUHG'&
M[T$M8$K%%X*@G$+QY$=.1EF>EB?EB'F*9ON<_E_5'-G"<[7)8@43!=^;VO@%
M+J]@41H<!4[.Q.+.JT^ %*M8)&DT=6(F+$KM-\]%&8]M/*_YMS#]7ZU$TLZD
M2-UKK?O2)-L1SYDF 61G9^ZEG+7O>?UTYT)?,3#E(Y\H'17G#^<WYZ\9C[F5
M"\7BP=<EB^A6)V"*@<TYY=&Q4J8LG_*?*-1.-,N^<;F>VAH2CU35!CW;L)D@
M(T=NTP3^]9]4?41<;V+H,_DQY!#4^E!KYZM,G=Q[MP$[84W,";&+(@_DF*1^
MJ*3P\Z9M^<T5U@WIPS$NWT%[;\9TYP')DA[%0VUN0A7UW^>\61I045^HZ:[
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M8RDT?XDR-/ 0X+?:'I9D7( D&F8G+5%$T!=TU9:T2@8L86FD6)[D]:6BZIX
MC',!2B?6C_-J@0Y]KZMOVOHZU'9R2;.>[_[X?#?D2EI,=VH>$ T^/9M=(_1M
MTS\)*FRZ%<H7RO/L,'\UL)$;+<9S)4J!9$=PX]QKO DP^O($P!OO8L8RGRKX
MPU>#X.^[_^LGU=NFD2Y1GKA,4C'&MN&.HWQ]63D] ,*_[,)9*H)@&W=&<H_]
M_Y' SHCEN-:@CO.O#C\9=YC;?"#8<:ZHX5)AU2]=BO 54S+T$^!R_S[F[$NM
MFZYGMYFYSO6/;F *P-SZ/-2R-W0Q?;E8(MNS!,<[WO]6U[^]D4:&$H&2QBM?
MBNQ@;>Y9F:D"4,MK#TX@WD?'%B1)$Y 3B3))^7L6)GQM-!!Q)K&US&EK65+7
M9X\7>S$D:8NA+UMLNHXQE;7[ZIFF51/3=/!L]>=N2;M]DYRN4 $ ^UM>:25S
M-"HS6G'$;2;.6%^K.1?:,L8^9"Z1ZW86)DUJ=U79-^0,NRAXN^V^Q@9CI'AY
MWZ(O*8HUEP9BQ0W_/.$%P<W 4IA)[/(A7]BV9@[]ZL>YF&#(R(Y17Z7QX;^N
M#D<$+I4 !O,29J/B^"KF9D*SYL&:J(2.,";&..)#X]Y,\S!NG#( N+TM#%CV
M*F&,+]UZ A +6K,W8_1YZ:CNC03M67@<2K\L[Y75)#$]/]14U8$;GBWYK6BS
MTST!N$]R\8NM!A=)^(PB/- [(< =X174'K'H-ELSLBVN]P<3'P.=(D*@O_<K
M_FX#0*0YN\:QW&&"NT(PRWW=AGTJ')V\&P*>-B#H#HWI>+#%J.5=4&=E3")H
M:R'@C>*B =<PXC;MRL84BPSW \13T#_$2\HUS .18PO"]G+'2.FP'557C(]S
M:=['R:09<:*WTZY81)ZP,@K'*DUW8BRR<''WX,6B.P*_/E[+^188OS.6Z[@(
MH@+ [\'E=]>7F;:=!3CYB9S+;%E4>%NHC0.^[R/'L\:RHDTQSZW?FSA"Y'DL
M9I>_M@-\A86IC^_ P3AO&_%ZM[BKP D>.6N#AXJ4]"&[%S"@K#NNA":62:6\
MW;Z1PE2J*.E*#RK;(LD5E\W7F1C G4X3>IU5(>E&+Z]"LIG1EM24TR&)5$2'
M#BB1 V97IFFG[R?*AK?;)J:<U<%1GWH3\9%PA/1+=OQ:O%[2\82XT1 E+*BH
M%6J!IZ?0K&2:T0XEC4_EKD +SIU1<ZVYAV>_>_=[I-BL>9$_<W3YMHS^%[D(
M\FLPG!Q0;C63Y2O^%DZ+ .T*^G\_8:0$'IRJ+[YZI[%A#GA@[?06H64/QO_W
MMIW:K=R?<+I];@EQ'BJ.![ORA4_=&QY1EDHU9P5,M'%@;)#[P,+PH)M>=/0?
M+9R@!D8LQB-7]6/E>.&C$P6L*$",B<5VBS4"J?W\O2;$*0:<NY/]LXEMF:2!
MPT^/D9*(QY9RK*V@>YCPVC8NR"V6%#LS%;2RSCUBT%7!MQ&*KO;)]9 F3MR@
MZ SR/HWV*K\;_56N+^5LN"V]CO'HH1+H.]SPF=[J0#PZ%!TDH.!</> Q2I8$
MUY'^_KG>-MAW-P!V+.3Q"";(4:)DAFSIYKKIOY$G?P+@%Z<=6[FRAIS<Q6%Q
M+>O,!C32^(F@0PN)]"+6*NV> /W-6TES\2]8V+MIR0;LOU@V[:SG*5/5T5-N
MR]%XUS!# =R<9W'-!5(777W+""B!JR3&X6J\XAO-W]^P2B19*,O:IJMTD"I,
M/ZBW;P@/YTK5?.=)&[&9\M!VT56[ZG=XZ>S+9(PD(:ZXVU$ ^7:'Z'1YDYD3
M%I/7"6'CVS_V\VM!QFW;Z3,,>V($23E_L:K( 4,S R)Z>O1?<]HJQ1JX%+02
MU#*UL%W>!^W!YT*HW,2,N*Z9Z6[&]!H:_+;YU:6N>2ME*$&/K0'/GP"VPHM<
MY#GM;R\0]YD3@Y2'TA%'Q]%Q*-EBK^X-.;9BY 0U90J"5I/OO;CNM7%T4P=M
MG'V$'2EC!^"E(D7(+MU^?=SRE)+PIGW[=$![+FNBF%$'OVJ8=I9&<^SFHAWG
M$:-XHF%Z&>LEMJ>@MDKBU"MS'/%9T?=+(:22>U0'0B @C7E-I,KIXT\7!#LV
MS<M3>%*Q-&@AVSW0=<4_,S,XK!44>^YQ O^MM5^;PK4*G,UPJD+LN[;TJL3I
M2;C-M2L[[#G-I,6_>MQC%-26M-Y3K36*^)%2F[C^M="3(:S_30Y]0^&^.<V,
M=?4L1Z4 :@$.=_&@BID_D2P3,I-GX6\Y\8^FON#$O8J8<2Y_+7\36K08(#.I
M,%(6X+TJ+6G1C.4+,LWE33">N"<\J?JMV+_;E_><LNICTD;7\^JO>V1QJ:Q!
M6]FYN)182=+T'QYJ://V^W@N_]?XG.G,S85WUJUU.7A9.6APX^&_02=3WE A
MM=][ZL<[#G675*"-<^L7HU$LV#  _H HO*-/"'25L0$)/PB4U=R8RP^F!Y^N
M!T.]V->FXKW&12#6'.;4,88ORVX0]VP7QD3BU4,M3P KTI.*=SKU\7QL<NH
MJ7J,[%5@&(AK QT<+A\@U9%U^8\AZH]Q,O"2A"R'C-[D/3;PMHNSDW8 =X)[
MFV9H9T;:%#IX1"-.VM=6OC^"'NQ_M+.+>VS]%_S"S#F0=30*<Y",.6SG\V\F
M_S*64GY?\[-7XH3,<S(/[).S:JH%4("?4>U,1:TP^X-IIEYG<^0/"\K+CT\
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ML*M=H#2-Q7W.3P#KE.<4%BL=>QA6%FTR:'7PM'76:,S/>/+8EN(CIL7077'
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M\9WG"6"_=^:7\NA,L[1:K%K[!' KFV>Z<7!<X=JZUZ0N$^X]67,_R"NWO'?
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M"_4 JA#'!,G9_HJ2^[_GUI[W*!8\M-YU>0@\MS]KB>4W+SC=J$'\DU95AD^
M+(/D/X/,T^08\LA6_8#!U+(T(A4]_+\M6YK/C&B**8SE+TH*.>$2L_K,/L8
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M:^?B+JVG;3YRJ5>T&5J249S90/ME0ASUW3FAHY<VU,2.H[/]HH;KI+1'370
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M:[L)/-%.R G2E2Q](H]SD2=O**.+@FO#^Z@]/=6YQL_#K<7V_.^Y:$Y_0%0
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MOA+UI8!AE$0M7'LY>4<3=CMQG1'.$L2L12&:=RHR(E(8+K&=[$V9A5M-#I=
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MRAX3/7%RL,L!9_EES<NW((6=*SUP%YA ]<A\-7/N_%(3BM?4W)8BQ(=,>G&
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M(+E,T,XLL=BV^GD\O?NL'Q$XW?F ;254JC&&9L#/U1*47J"XN6+:3RI*0 X
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MI;G:[W[?V=C?7M ZN0G_@$J^0<:&?B,S94(,]$QL#DR8/]^S@R'V"#Q/;0?
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MT!]CG:[KY;#F^ +72V'DW/,=?I?1G*77^O+=Y<NG 6Y9XU-Q1[DW0+X>(*_
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MG[-SQ4BZ-NA%9 ?H""#@"[;Q4$&8B5.MF;L"&7UF)O.Y@3];-))/;-LSQE5
M&:+S",-:N[:C#YY;6-97#B$35J!V2T7)'4WX>6*5"Q?C9.PGRI66WM[59E(=
M#?8&77^KYA0._Z "',0LHM%R753N"=J$BE9N:^\WM-_6ZDYZPZG-HA<'(IL>
MV6ZVG*QICW,P3;?5_6E1J[D!*.YF,WNW<,EVT;4XF;#F+FZ],&71ZW<BKQGH
MHUTW;&K"SK@;*(E8"TA8>C#5H)6'@@4U?//;$;>!#M8.$8HKK_H][>NVP]R6
MHTUM9O50ASAS]6MU(\3[%K0TY&FG>@H#Y<<>F(4IGXE\R50I4)"?Q3UD+9Z
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MA6$%$Z_5!?0^ZFF%F)NK9/N)FR>:#UMK%,KTU/NTB6MU^^N?LW57VE#];;E
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MLMVK I'T-4Y&+5L?&<>1RG\3:7-:*;NW#8, COL.?9.0D>"=\1S&Q'![O!O
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MIB. 74_''DY0\,8GQS'[NPWY(9P$1RF5;AH#N' &<2\6WM(["-3/T^@ \4&
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M:0'".$7]1PSL(D(PX3)2Y'15'99Y$&B+GXH-;)1 6?6>GP^+=Y-%',%)IB4
M/1<67#=\C;4YBSA>@7(=LAR@/\T'[8A#2*X34D;I@$$_6.SQ&GR7H/*,;^ZY
M2G;*)<T$["F0>:AB."-PREL(=DEX%H9X#TZP.5%*V<_3'FS5;W]("\PVS9OH
M#Z>ZBE-U%,R8?6-8B'YRC7.V)@."QI:F%[CGEC\4]SUI+)SA3-K^"NN9^B(-
MKN"QE8R'JK6;3L]+T )IQ[^W-'H"=-J6&>AI=_A=*#,CSG5 ?M/0JSB2TGH6
M-=3!@'2A6"3#-E@=4$S!G>F=V9QRT:K1'_SH"P\8:2BG#77MNCT@ZJ-V"8J0
MWL5&%@-I'?12E6%'S!!_>&_L;YUZE?WW!@@-.UVM,V1]O_;PWF^YJM9+[;&^
M$G;UT.2#)#7AD)]2U /RR9[C20YH^Q,59!A*_YYHY)=*ZY$0]C3PIY.]C7N=
M>R7'FLMY3]N4&T/9I\?KG)YZ8,S:3'LN>FUR@UE"J'?+0EJO";5\-6IJ:N(7
M!NXD,_1+)4C'[ITRMHTW/"TX#0:+%-H/_:QH[V3>RU%?1!DU2A1VO17&"4IH
M-M_3'<H[XV*1R3F[MC,M[AAJ[:<7((;U%P=*C(?\O!8PFU*+C+H!- Z4%5;U
M^=U#2>4^#U?^52Y\1SN=Q%]0!FQENYLI5XD?FU<MREH_>VE25:)GA4[AL.,:
MI#Y(/_(=8Z/CKOF5HX3:<_EB'RPP(_=ZU<8\"- \.I_0P!)=V+62XPQ<4_HE
MRNZ<.W^S.'O"QGB82#8Y"VUR,(^^0%SR@BE,;P W/\X++3;(#CAE-F1.L.[X
M!)W6%E*!16D@KL#SPBM75:VOG4.F8BJ.XD8N8^7)YS3\OT]JJCIP5D.5,,QP
MT1&3:N_%.KHRT.)N@.E;Y>YW%WUBYQILFI]:R]S/CLJ.)\@_B&>F,#SQ;P]2
M/"5%$SC_ [&@Z!R2ML_HGTDESA6]R'VRB3DI-_H5#2L@KAW05?AS(*??85Q;
ME*BZ%AMEB-LR^N;#\%@S:#XML4.^JV1M_]JKB]#ST TE G0QG4X>;AG8VAIR
M\>H<5/J(7/T&69Y<5('0Z;VD9*@<)$&\^H5[-K6.D]SV(A8F8W-M4O5!V)G<
MJD>_96>NPDK7;]Z>8?^<FQUUUB[TQ>C#)X193M99EZSD#; YMIX\%I[ P94_
MY]B@LF)(S$[G,4Y94D9EX4N+9SOO4=V#>9^/[HCC(ABS@3G_34SY7^R]151<
M7;0U>H  00(A0((4$"0X!/>B( D:++A+\$(+IW (D! DN!<DN'MP"%JX2X*[
M.Q0N/U_C'^.-\6[CM=^XC=4XK;//WFNN.><^6TQF:W7K\4TL,,1\6)Y6@?S:
M\\CNH&L?@V^R\W=5NG-6_X@JP6)O"V>0ZPD?SJY:XO"E++:RGXMX:3D<&4A>
MEBR'#'%[)%/?3N.'M?)L/M&R/E+&.];KH!>[JX&4 #Z'__OO^O\=&,F7T<MU
M33I+!LX*,9CI&U4_/A37B[:ORU[,O6J%WFX<"R1<<S9[Y@X@U*=.>W$T=^,_
M$YZ4C6^H]$FN4;,MO9U);"]:AGP;&PB77RA.1+[&)V?\86RZ+1$E7@NCB]+_
MA!O8E"\VX69SL@:;*7Z7QH.H_^]>R%2;,N;%4%T$.>7E2-#5!.L__<DO?2=^
MK%@*L9SP>RI6*[-G=9&>J,(VC:KXMCQ),M9+"]"C*SZ"?H#$:V@X'-Z[,FYB
MA/NJHUGP#LG DZ&5O%'+!:.I-]5H/#[+:O#/F;I)WD42N%!AT%N&L:I@83'<
M\++DWMM\M,:/ENY+K%9:[$$T[B6"&$';O7ELI$/BIR#"(?\WR=]9M(>5ZO8-
ML(/WO'<K:/4["R7$0Z.V;-)=N9#!Z[,QBG""4(O?"='^PJPX2ZY_,@ENE"&V
MEPY%'=-[[N5S=X*!&6/U["F[WJ3W\3F7B/Y[N/6&8TNN #XDW<F3!.BE*)B3
MJZ:&=@[KG/;6I0#?4AF+#&5-_7\X(@&*E"H43JTL<>6C:]A"SV&^MHA)I^:1
M/.S"Q!+7!(-9\EMJ>-_VAT'+H%),F7O>=9DL>QXY]FGJ7\6-NI-?$:0+D>PH
MJS)O@D8P&&Q]H)#F19+*YTH07:E5OJ=D]QK$ M@U;*#83[T2SWO^;115^;JR
M)^<3+FSX$[788Z]*CWZ4M48C66S'UM](B%%N:KZZ#TE(PN0/41_/-_TM'NC_
M9&@T+-5!",PJU( 1EN!/< >AT&7)CFCI]D?OJ.C-']8EK'E\L>)_6V2DK\PW
MH[K3&S>0-=RAMK$27[?SRL3"/'.O5;C3./@;4GY<JRM.^1/_=[G"_#!(92(.
M,$OY;W+(,.[[5!C@#C=2LHY[ ):[ "$$_%B^D+),?*(/;IH"=$Q4"Q>O>E:K
MG5OWF_]4P7<R.XTWK04+(X_"VB=;>GV>>OY4I+B+%.]@<UU:*DK#8HK$;OU9
M>EI;XNPK,,:!XJ"3B793R-Q+!E[0XOY]O1J(,VBB&<[&)D<=0DAEA"$.5ZWH
MX&CZ(4!%_A2U%+8M)KIRTRQ@E=D0?>!RNT\;Z?96+!*'R@NNQ4M0P-'DV%88
M?)(4_[$+&_89SM5/W+::-W]15*5[Q?HFHJE'W_[)<9T/A.*J\)(UC@;,B[JM
M_>I8'P\I6HEQWWH WK=,5)?0=$7G='<V/JW[^+4?AW98U)T%'W*]N5 77#'9
M).K27R##^3-W;7^"7D+^7.43SWQ#QJ&JU35J*(*^N768',+'B;06HA>C\1MK
MM&/2K#Y^PB"-P8M?TQBH57$ +#T K#OM&R(GFG/'O)'$^F7$_E/@1M!@R83[
MCZO?51R=.LAD2BSJ5;ID%_0!4IGU2\W@BT"*H16]9FIGVUFA<;<HVJ\T[6@J
MV4OX:2C^8)LBF2+9S[-KAET#Y99N(W#OO\"::5Z)SQ.S[-*H_AW5=!8A19W$
M>&7]B>--Z]Z-G_I%ILVR);5S*5ET5MT'.,A<JU.L^;]_<HFKS294!]?+%*+D
ML6*],&0_QSXY1D M8R/%6^4'$*O.+UAGN:V.A-A%+O*_S\UDV\:2TWN7=@9"
M(Z(..1D8G!O#[_EUP2KW)RSBQV3/-%T>46*[6;H#BXEIX$VC$K2F.$HO2@#O
M2%G.([$G-*Q.U$&WN27=/-"OC.:X&A)S/C)0&]J;/B=P05\S;@:4T&2\G 1?
MJGN!0!G^BOTO%9AYMJ;J*DRSO=:PZ7C&_UE;552<Y:%;SFQM"7Y>+A>+1JTQ
M@>>&/TVC6*04Z]T4TPDJEWDM8&3\_#P3<SV1BD4-+SS%02DW\=#OO00!^USX
MZ>[[< $2Y\B)3T-H-(H3@-U\CYA[EGM_P(2JI4,-U>G$HZV]F,4.4+# _DM0
MG=,XSF +NWRL!P$[DX8ZS4(TNLE)Y>+Q\N]X8!+/+'H94BPYNF&(N.*.Z(5H
M=12X08W!J915-,3R$ZX @X-2W0- EY-?;,JC8.G@:I2GBV44QA_\CKD]K#JS
MEE\'3H RU[,7:CO/YC&G5#:$*G9>=''YJM=G8O7T->]D"2SD'>?U,JY LV.)
MSS+1-LZV=>Q>U[5XW_83*I?1+&MRECYYSGL#\M5XMRBN$WN9(PQ12'EB$+71
M.\2[JU;6'Q;(24)=(^[$_(*ZU0M<V,Z,L5CRG@P,Z]*)</>Q8N;>LMY-S[9,
M(?=N$4F!?#4M 82=D28?=]_[S"@@ZE;\"=<5&5!4+.YFJI;A*D^(M6?GP@<=
M2!"_9-ON7:65<:UY8W3;23X[X=N4WR>5Z(-6^5I=G63D/U<*;S<Q1F_NN2>^
ME!DU_Q%U1U#P,=LC83#J7XTG9XCO[H<@U&>;TJ4TU"V+C"]S7?VGGHYBCS#D
M>OWHVB/YV+U17LN<W&HR>%%Q8U?2E7ASU".S6=E /4DR]4,?QL[=!Z:2S'-A
M$]_P%F<=W1"5_HE>FQU5?B]#FN7@XP"[+UP1UKH+Q;[2-)\..BL:R*A$$M.L
MA/%AGW99RBTQ2 ^6EN3K/@"5,<=7 /,(>+7 .H:[/EG%94Z99-VX/]ZXX^;/
M=)I'5D?#0;KMFR"MNH901\R/I-W.PV_/]A?JIR;%E'/6JBO);NS3,M90HQ3J
M:V7#EEM.0S6R\G.)AGDUAV<_]4_D!CVIHKH:=Q7>=!7S.O?._7D4)MM\PV%P
MC5G;AL<*8[JX&=M:.;7XJ>@-W"TQ2^NF]A8?4FW5-5.RNI/><M=*7'?JL9)6
M&1".L!'I5ZV8R)*N;CRM#<\_^>=\-17UU]XMY*3%R*"]GE6U0&X&9C-QD*>;
M;@YW4AZ-G$>DC9\>JB<O$%<?^5:WP,BQKZ:DNP9&&T&66/G\&U.[.BD787NW
M8+,+]QA/:*'LE?8F&=D2R)4F'7 QB5(8&>[9$YUF,EWIO]G%L]GBR^ 96W*0
M$Q_#[D<0/!VFK]&+ZN)VJF4[=[L_^.A'*T'Y^"TIIO+8K]<TO2G2W*V\$WMH
M/BG?R AA\*$Y#,S'*')G7RF;SA1YML3UE@IT=X60>HU@E')VLM5G&*.&=<LL
MPK.'KF+4QL$!#P!CT3M*S:3J(%NB]$9UU ,@IEG>O@1@CWSVIU 8,XW(O,,I
MD&J,'@CWDX_A6TW1C+5Y3%:UE-?T<0[",UX9\N;%D14?BIW2>=44(R5WJR<_
M>O*"PI3GF:X>T6"-Y7&3=5*XSRB,E9FR)46MO>R%*E$FO+1X +I>O:.4/<F1
M6ZSW<AZ)WF'&2ZZ<MS-J#D#E=ICG[^!+Y41T35\DT]L5@C^:DF[_ACP[RR"8
MGQDNFNMU4Y6R_,V=KXE6%=1!((%<-0CM8C,@EHS\UP3^/3-V"&^-?Y6@SOSI
MGY;PFRBE";33_4Y>'7UPT\[G9.YZ0MOPL>Z%O)3YX\1_AU@9S@Y1_!HQZ[]/
M_N(6.@=L^=AD:%RL^',PA$*\2$7D3@+24@J_JQ;2=/MSV,\ODNP$HPU!S4GP
M-9Y$!R'AGA9KICEXW4+=\/%D9?MJX$_>(7&TTCPB8R@QY$I*T'X&<+I!I(U>
M-.=_"B?(C4YBK1)$DU:N 03D$IZP;SZ*]VKNFK40N1 U"%VM OP!>-N72NW*
M\MWR>:?CJYM%H['JK*CU]G#3,, @@QEPS?,T.]M5EJ)"6_-213P#Z,H,8=O*
M^FD$0:W-C(M#:2*X@/ S?R&J;3=$<X&CLE+<_'P^&GF+H?!YML)^/VCU!XL'
M%39?,Q(.."R<#])GT#&R>V*<YJ5=/+*%.K&%S=<54*:PZ748D.=)KSLC(!QC
M6N?<L]UE)?FTMB9" JV<-[*9-:?3#SIA$F[,RC),8[@8;%5Y!)MM!M[S_%Y,
M/%0M.[C7/_WK\O.T">Z:8]ZV60((QCA*CR(\=Q6COSK$V2%S9'W--\.LU6KI
M,W8E2.W)),FCDS +4^#QH0.."N&>P_I^T<I-#X!<LIT,9<CJ&7F1GMO="#,Z
M;0R./;B0/L%07'*6WPQY:@HN9(P(/!UQR7PJ8.N0='R[)1HZ3WY6$.X5YXP<
M^\&R/8(+1%E,]J)%E<$I>.;<J0H6/9YC*?M!I5%,&;J \97SL-!*M'J/M ?J
M(H]K2_&M[7T<,):CAR=+4CXH9EX/4O59R @&!,<QQ%O.?#SHTB_T4@0V=\\R
ML3@]AY4F4KD\MY5>EV&%,.23  /$(SZ8G'.<\!N+1.R:MV4D0%AHBL*2V;'R
MS&J:;TV&J^.X< B!7]._;K3';AY!@[F,"\83?+2T-M^_]RS8M_O BD/^XT0/
M-&IC02LAV[NC5U^DOZ_*C"X0CLHV= (&Y6)'5%GWA$'GF=AT!T,'69E\@'CR
M]K8\UH)<[[826_0>,SHX1*#W3G1,_"-Z5F1[]F<=62IL(ZC4,!G&K@362$%]
MHC-Q4.SP5 J]Q16<"[6KBCD?_]B2L1.&?FK8E#\E.5Z'(ZS;2^O-J@-A?YG^
M-D*E[52L@&94^9'+:(8:MNFOHL10V2<7YA4!T^A5!9BJ8L7;'2M,(?F%'2[F
M"W)VRW?"_@8)4Q5+=E05?RZ8KJ<4$566I8QV:YA?KWX:8T1UM"[K^#U'.50/
M4GV1(4*>RLH<"PAA;SU*?F?K5[_=CA8\.:/KYF+>VL./Q^HLO\(RV$G'P#/D
M9JS+D_)CU>NUJ*F;].(1I(,]?3!Z8>V\(2;,D*%24)QBDBS7HC9$+M/HH*<B
M)MMK;2HD=(7M^_< :Z=^3LE9>L)4^@K42KIK%,_*?/>:0]QF6F!6V$&>*C^]
M!^(EXY<C%(C5'H[\OOH=24/X:[(DWI[^A_PQCQ//SXG5/->S4LMEJM'(G869
M3T'X >3*C4)M!:T6Z9H.S[U94M\U7>6.C<;]EF,89-@367.ABC"[-)0>O:<S
MTL6(U]OS54#6>!^8T)B&Y>FX0FR7<?MYEO<L=#CTB6/.O.[-[=Y_]".\?7_,
M@"F6?_CFQAOJB';Z)ND%]BCVNMYY\??GSJ'VH?6%1N1O;/S"J%^YH*D^ (K<
MOX6&$S<$_([O4?P_<6>U-CX+JQG)UVA!\.(\];YOV<FT*,=1RP@M6>1)$]VM
M!D6B[4'35.V,Y3:GBF7;3I"Q$VK/IV(D)WX0/MDLT:C[8=]>ZA9^0".?H.,]
MD&9''5BH@+37^MF3*:435&7_Z0115SBTVM_>HE=_ #6E5=42V@Q U"A9)\Q_
M]']Z^ B?D!VMY$X M79#$/<!O4##B(.0; \RS$^*,%/CO;L00JW>AE6J1[2%
M8(-4N(_?C>YS+K[>CG2"X+:^='^;X($$G4$V20T)TS6<XZF<9\ITNDZ?8U.E
M!+RB-:@P;W$#.T^5OL>)!7SN6T)^_59NJL/>U<Q2HV0!P]HRS8XROQ^",M[/
M+F2K[LD(H2Y^^GO?NQSXGG.!(P"V<LT9$C-WTK_>+['O7R*#9^EI["1O=R-M
MX_&QL,6F/QXIN=5==BV[&KX01<U';F8<91*._#]_W?___F2&_\_A771CYV%^
MR'!T7T11^I+<)+H2[8]'WPW*V4A#"^'M=I1T[-XQ^&Z>WII3J_\D,/8! &<Q
M^1-XZ *WUV-FI^BESMT0D&;X^PT__0= 4CO%*]5'<OEU."]1M%[&R9F,A?[(
MD\9WL7?CJJLY@E9,*>YE8_Z@^IG%B(\.\>\1V1/R.%^NER9^_)S!8D8?.^-;
M/>6BB9!1BA+MO65&[SM5>RM?&I+[7H*80_SG)C_KW0Q@5$*BRFNG:H7&$-MO
M5$;*46BGQN8$B][7^$5MZU\KM>8#W;H**RM;R,2;44QN;D +[9V[=H09!I#-
MAN/[L*4=I>=;6?K.!OZW\ZC,@.*V&FWJEM=X@3WDWQ!]0Y@VY98I9 )WG5$S
M(EG;)&XI"CYUE+Y4>2P0+RRDWA#E/NZ(?38HN2KJ5^Z1JN'O6.#,N'CA_@*B
MH(*%.9'>O!,+FJB2JX_B?P;0VF6Y0[LMYCJO3[50. +=Q#>+=]#A3"M6#<![
M;N)]2GE1M6D-P+2@ZP!F598W]=E3P<BZ2LD6#TQJ<LESN1ZA5>1O]KQE4>0?
M[I<@XEX;=TX+$YI7C$T!*'Y%MXJX^>&&2(.MT)L&5:[5UJ!V -Z$ZA**9'2'
M><XW#NBEY,E_'*3M">0#H"^>G#<"L)1$_/$Z5LI] /JE2-"XEEP*7B8K[X<!
M+%$G 6$^'P9DUS[[$\^-^3U[)G,T@OY)BM$*+6\QA[MAS85OQ9W[+'MWRI_,
M*G., HAHMFZR/"IXQEU_D?GTPE0H.V>-("D[$SWV>L0:?#.&)L5!HH*F1#*C
M:_SV-$_:,]?',Z_4AQGM:J7B5G/6)62S@/X!H.*OR!BJ\-9Y %YW4E<^2M'(
M&L!IZIB^Z,,?.S&B*-T^Q-2FS 2%GJI%)9-K5X4]*6PXH8G3TW386[.3G5Z+
M[>(;X%O#RBE,S^X)539HYX&Y2VNDZN[NLL_8<)_HF>6O6DN?B1G?/XEDQ2MR
MEQY@Z!#:ZG/TN2)U5ADU;FH*.Q>,F3G@9XWIEJ0'>QC+.,\V:U1.4WR,JMBM
M*"E.%FI2,:T50EE /)8;".6/CW6\;;Q&1S,RS9K4]##?X,YT+HR(OZ;D*H<6
MZEM^0T\4BYZKG6KP47L_UF1G7NV]5V^6KL(>G484_\8#_ "@Z5-G97F&:7OO
M1F;&[NYK_Q9_W7+4O)A,#)3X:_R@7IJ.4";2P^#43:7)7.%I:ORVY:7/MI[O
MDJA)$?I%5:/5J-K:$23E4=8BI8^*97CAB;%.%2&^<$#9\](#U !A_4O_V^O.
M)N?H,)S]5M'BQUSE]U#%8IY7#$'WTS5FNRW8]P.GA]7<ZWV=O?R-W*Y)FV+X
MQ&G$?^AK? 1H2)4:FI21SF*)I/$3CH75K%7>66F;)>]&0G84M6J:K;-8V)7M
MW/)LWK/N,URP$@KM7FE$<<6MF;3J[HTB,.<^W(B97LK=6@_TY7U>(PB:*9K'
MCDW*9H:-3U7DWKR'_9;^[.B$TV7.XK07^57MO+$GITB6(R_.;-TH:NCW?NF+
MJ<%LNX$Z_=4:8T/K"_;L)TNH7NK)EJ)T<3Y;DU^X?S?3U-4VIM][OP]:G[H;
M%/7*/\C"$B1HF2]<HVFZ"C(%36/F&E JRH,[\Q=K0CR0\@>:'\)?6LR$\2AJ
MB"!&;4:&B4+/7\B)YNI$Q&V*)H8E@^S(0)-Z.@D?")YZI![4/I;-C+Z8IQN_
MA<%R9M=4"[G1D9/8PE2GLDGVRKJ>-TUKM<;,:!G,Y+WSVZI8-.T\7N.^1QWX
M_$SSMF<D ,I\/G@E;8"TW/,LEU.L7'0S"BI(]8= =E?B!9:1_D;:HB#9E76X
M%JLB2$#FT[X$03@"^>13G6O.G"#^66YQ:-V5SQ;:4E!0F/1K8T3U_&4/V%J0
MX!GP0GRR9Z.HBB![!;&?%CLMYL.*D[3/BCTH0=1+*\3J4;@G<9VB:9^TDL6N
ME7FMQO!.>D^0G\ZT8I!?YO729O/'/X;6:+K[WS^3+F=$7VKT3!L#!$$!&K8/
M@/>8?$?:LF_&VN1D>VTM'$N^E5_WB]W2Z2?IUKWC0[6W_1*]0JM3/Y-;]%VQ
M$/O!P[H%[*E^Z8 40U#%8W-<NMAC2(W4U!GK9G@1(B-T+3^94AD^L=RSUXY'
M'><\"\'K?D4J/_2>/49!605X "#!>J$<C#(,J,QG9([O4C+" L7G7 H2%P+H
M/A@Z$K!Z#/>KE([](8[218#@WBUG^"GTI\;7:AEX0\)\;0MI9"K<@F:63%3;
MC7544340=VR$EYJ20'3W#J"0L-T%LHR,BUMJ@V,@)H"(@+9=B>O-F?A6WH6@
MOV$ 99H;1BFS47(E;YC")M]J9)JQ"CIJ]6>.)E:T=L)V@%(FYFH9W&V!]VJ<
MQ0K-0]>&M?*$=__C< ZC%7K$4*(Y[*37!H]&C2)C6QL>ZG_FE=,6\%F\@NZM
MPX5- 3TN3*7:PU#XP'H^9LPR#4J#4Y(]-^7<$S7IC00(>]GX+@F[X)8O1;)8
MK]^[;>]OB6H5>?IUA>/BIA'K=1!ITN!'6B];35S^\IPO^];DN9RM!B-K_.9K
M=/8]ELF6\,IZ7Y/A<J'RM=Z\ /=;MS"B\1W#1AT;/,VJL!MTJZ9.*F'ZZ9&;
ME,G/]H="N7?XOD5]]2:,B07#[U>3FC3R]?[.DN^-69.:)Q[P_*254\793#O;
M-Y+QIKI47!HD5*F<WJPV\-T!QV*U!+(D9W?@QVS5KQT/FQ@);B\0'RTD%WDV
MY.2T5=:Q46\Q"/L?)S+\0%]EB$5,GEEVS.-?,G7L>V8;(#F_NSY-^)OX@IOL
MLW WX<!=A/-$"J* BF^9V4#NGJDE7>]#0Z2:SS*>J!=/HZ;V7N;<*[*>JR%1
MM^)G']O%\:?I.:.'S=*Q#TP_34/:<YM"3E=>-FZ8EYIR'\S6]AEB.8IJ22U#
M2'<7Z&+TM,UK.*A'2'^LUX&Y[_>-[1][,0HW"FLW83JZN:[\QQ/B#T]-,[C"
M([+*J8KBCBXZALEN]34:1]9KQ\7$*DT.+>JM<C_7$0"*R"Q8_$ZKPHUA3J&'
M S)!YN,Q:5J%IT-=OC,.?NL1Q*W0E^-H/S(55W=[NLMEJWNM^I3(WR$I80C/
ME>FR8E TH&/.=[BA:9!NVY S1.N+?>R^EI90-X_(>_6-2_K5.KO>VHDS4=0]
M^S ,06C7\]]IAV<9V+L)<*,9NPWC\E[JQ2;1V+D,9VTGG4=N:Y=BV XBGGOY
M1-R#:?=0^M?(.O$?7_YQNTF+\3T#=4#A152NIXG&2O)HH#*E%)-B'O85\:&!
M5F1X@V:LZYMB9+^K=!N:?W\4])30OQ#!?.GJ0%U<U6O'B=22>KIT]8EH?_=J
M1#0=JO"*MI5;P3K.=?.HN-X6E2KZS3B"OOGD:IZ"]P47H;'PYEC>D5_ K=QJ
M49ZB1&ET7KYJ1[]5MJ,2F?=61R8D*9>GY+S1!G^;8"/&Z<\3C1WE^C\'HM/O
ME\N"$<S'#+G'8WA4U*NV"%/E;V[&I\'SPS0EKK".I>$O7'9C*@L[3MZA=LCT
M^Y$> M'HF4I70F*/HF[6]A4O'UZIV,OLT'YTWIT!RO'I9G3!1];_0KR<RJ"U
M8%]4P-4K4ZOC2</FU--\NEBC.B'F4^H1ILS($*5<M5.A6R5]28Z48=N^TN(<
M\S#M8(+BU'SL%;:FC3<+I0^**7YZ(+.L4^LK-,E9<AMQ--N1EK2D$ F>91IO
MA;X3>::E'25G0M49(F"_AR<\Y!4IZAN?L0*ATK=)./]=(;7>AL?][#7MD&^X
M3-FV?DIW7O3B5$XD5S$NZE<')Y+<@GW (.I-TMID<-14JKVO/H)EV)."Y2^%
M+8CH)256TDNZ<)=!^4SWX@+^2Y.;HZ&L>F8LB&Z%98G.@NP+RJ\I[WC7#U4O
M47_XT'X5LO0U!N06].2Q46-BO-&W'=Z4'>#B@:4(@J@]S[+GU)V$,['9"&!R
M 8USXQHA>^X@"T1QLQ6:WOI*ONR@I^-G9905C-'K 4BCB+G78B_O=*9/$_0F
M/(%.EM35!JL3^'V]3@%<8%\T-,A41-5',VW#EU3I;O_NP2<6_!VQ=0'HJA"2
M+I('&ZZQ [MP7HAN.,O$M$]#Y;UE2SO+18:\=NT2BI0; K8E<-K.\]XJ)R;\
M1-N2)H1*>%$_&I'@[;9#I5BBU3K3 &7]9XOR"MY9V&\EB*K8H7);6-85*Z*>
M%F)9Z,CM(9;Q@A]T2Y;"T""5'QP%P1X\)H\6$1>P"/ME4?<#A.4+R4 5K8?L
M43\]E+,$0J88#,4_-8K7D6P>J)O+D*"1>"EYW5GK3;;BPJZTEV"RXK9^NH"#
M.D=:@ HOYYCVZK8FY>4W,3>D[M $@YN&/UJ#)+(,-(+!=WEQE2ATE?1#/!2K
M1+!O(;3YZ2^A]H +:0BK+QR1ZT_)^&J.PM04[)%COAVI^TW<G&R5R@HM7%R5
M^V3""H-;138OS1WLPZ)W$-$$W_!_;6$PZR2)':N CV=L%@7_$5$_@R,YS?</
MT!3"L :IH%=>V*[6T!68FV;$?:+&H7)>!+/L%?6>;8<!W_V;7C /DP\/JK+&
M=N!;_N2G%MDD 4J04_$M^G!53AXYDI)NX:M\M._5^3O6;M'W^Z(1S:TB5BHB
MKGQ 6+T#U&B#95;9GC5G;Z!D;3:MSPM%MOEH=]B*OG$R<$G&WFV(&?O%L$Z6
M%,[F ETB4_\X3$]&C"W!4'W<)[1J@7_.]A61Q]1QQ;QIYWGX=IMUF9\Y">F#
MY#OLG]+PH[T+QW6!-G[C R*"R8<DL_]\BJS>0(/Y=PV3A,]F/0OGVI7 )OL#
MHLZ:2BDD/T=75ZG[[+R0S792&"!!E-#Q'/X P./E7Z[%\"XD9G#MD6OLZ(:8
M-#IB6"^I ']?)V)35W\UB/OA7 T__REK3KZ)"*J!.%5QKS$*7?"A;2C^Y+\(
MX[3+9C<]Q8^</X_-&%CS=9WEDHKZ#& )^,ML:R+(?J98_R/%_QZXW_8'9'E:
M)GC\LHKQIR\U$PN(B>BY+.30E[_C8%G-Z_<PK"$Y.XLJ3FOU < ^X8 N4%='
MGH@6V4U5%848BV]O/JJV:(][PQQ&.7.S'NI;PFTMVUN%&','(=] >R0"E5KP
MHB&0:WT>.-\U()EC*,,8ZNRN9LC2T[-U,:I2[-"^U3S.B18*V1E;\(CS&^<B
M;0[EF0J-*%F4O6QC[\0,6W$UGYV(I=A$0=?%R,L("6Y5CLX.1MO?\IJPU2HO
M*-K+J+6U4UPH?ULD7)]4C/IJFH#G\7.>SN>7M!JG *!N^L0[Z^<!V\"@M4@<
M25:3KN46""UI_,]&;)[.38T)\^V9S4GMP,GB#/J[<@]!355U'4F11I8VRH0W
M-$.Y@<N:DN2]L(6J%FZHEJ ?KJLD?VTR1]:'BFKFOS/F7^&G(Q.ZBL=UM8%F
M5Y,K6@QGPAACS2*$*7%ZXO1\V?FKT'$#2I%^G41'C!^>Y$5O63-00>M[-B^%
M WLH'S-:HSJ)2V-(@K]B_653]\QA1@/OI:9W+$-J:B93+1PA]ZDV;1E8S6,L
MO J_PL>:NLD^LGI"U].HX]]KB$T:Z]T/X_H.0CE,E<PIT,K,C\(SNHNVC^D2
MTMMX( QWCE;D8N'T&O;Y<Y\3P(VA YT7)(O+V!E"&8U_-;Y..YW4N:ZA<C$;
M7?'#\L75+HZ[H7?A5F7K/U\3!Z7DV(68#8-,UZ\UFXN9225ZYCRO8;(?\M'K
M57U-NJ%[E()VO?1E@Y^0+Z<&Z)W*%H8A?<4"I$'&MOL2O618# VW67GRRLGQ
M22 [\EL6P"#3>5HHWQ4O?SD<X>@A(1(;!N1XN55!_DTF4RL1"%U/9WIC1PKY
M,E\:O$IX]2T!:<CVI<*_\&JHE2\MT GLU]WX  1Z&'VG)@-9[O<\BF&?B_]=
M(_,_1&X##DD1?HE(&'#;?AF13?/L<E7MR]'K^A3:-A .R/U:(]BX[0V5B)_(
MOA]TF/ !,+M<.3%YE< 4G;L='I)B"+_1RMBN\KS6%7=Z3[,I05'8I#*/+"$Z
M)1MDR/ PK<_$$5CA!+-J"X7#)_S:+M7+[_JPY)2"#@A+I/_A0K6[253HS/GI
M0.IL:<>J84"\7DJ\'%(^0-D0Q5I+'0?<AGVKXC6!P\<M8B]5UH=-5#L;2<)/
M(Q4!\<7+U$RD?!4ZRKZQL-2MN^A6 ::;HH]E4Z3][H!]I^Y6"G"[ILK[YY+T
MG< ,[0'@8MWE!!>>Z'IJEM.2_0V PW%+>([#59Y\I/T6/[$<MT8#G[^L?.]1
M:1-':=H8PA9\389$8=5O4Z+7MM#6SO)EX"R>QRH])][Y_#GO:@3[.9(Q51XJ
M3,8J"L>0(''(7N3"R"2[@]:P<;LQ3<4$1$4X37)PBVOL*F=**@C-!TS%IY;O
MOBM=>-0%QTO$2H/\UE8 /TG$; G$O>0#TMW7"JW^JDJNCCHNO&Y0D ]?3H2B
MC+9 IVI8&1JH=/:T%.EL$<:<B9&AKZ;XMN0-(/, <+3BQF09H?*V5570W@5M
MH,W$P\<*T]<;W3)Q2# OAG7]5F6SFI\AQ_R)^2E]#NKY7^NK.^QQ2SRSCXO+
M:W[SF'%R*<!7;GN<K!0E]958/B#DQWC!(^$J8FQLI,$DC)(0U4#4!=SB9QN5
ME/Q: %(WO *L"+QA9+'*?H2.&I"354,"M':RW%6E&.^F^9(4_7>1(LCY[T;Y
MK7K'7GG>'9_:-<4LE0WB6,T\2[+W#^2:%'#6Y#@/M7YZY8&\NF63TK9[39@Z
M5:C=7=@H,9-5HX=W2C,6@#5:9R]:MU/=^TN.I'NW7MD0IFIWOW4]$4&&"_F*
MR'3+)'!:E&L^VEC.::#B5SHV_H<-[O'F?0$;7_B%N%$^5DURG'HECW-2^E63
M? F6D;=I())OC$>36N/<PCBRU.":P'P_Z(I@_,[:N63*0)1F[&B#6VVB*U8E
MDQ<P "/WT9[\R<;G-)T@B*!JTI$VBZ!DHRLC6ZVG1BUZO%VAZZ>8-4!WY_&?
MC3.-ZABKVW)PV&,0:&CB\,PE3-Q79;[2 L7Z*X.<E&W'#*VL>7QJ)=,M(GPM
MM"G%4$A#(3#;AHUQX;+Y/O-.U"S/_9L_EA.:Q-S54##GN=_Z%75KH;4F->/O
M]ZS?)&C8BC(2A<!1-4[PA.#\+;=[VXB[K*>V6 &$29EG5Q+=X-.%^C+"RXV;
M]Z:8QPGB'CIP$+[EP73>=@O#N.M7=8:C"I-82E#0'W"7V[(SYELWKPRV=,?P
MK8524D-Q/="[^0^]+71/S^858DR83!%?SDN1FD<&Z6<*YUXN5TC:K"<%?[9K
M:7T@K"NEMJ[/. 1V7L;H12+<%[0.;\7P<2],A?I-3RFJ63\E<LC^BZO!ZRG1
MY'?'E>NY14(#E8G>/\>MX.L,&')DX<355W[QFR$BRG#RU3E5HX*V[ VD@5 ^
M!3&^1S%R3G-ROF'7-9TL%F.,O@F;-5C(X&H:7XH.793\X6>TJS,U8Y=>&!C-
M^ # 8E@'9E#!F7?[??8T[7FP.S96E[M8I]2YK3*=SW$F\H3O$Z+4ZD=<92*%
MR4WEGKJ(A9"?76O]:E?UZ$ 7L0=-)WJ$J@1]FJ#V((WC(I_CCA&ZURZ=;J_M
M/I6J95B/]\X]1]+TDX90:*9E(M();OMB7:RGH<,6#O;X.1(;&2_I(8+"9V4"
M=<>D#T"PZ_?O&@XB_XQ88Z@%$-*$]L_@S]+'#/]UP2AA=&QE*[P&ZKNL$<A"
ML0$E @^/;KL%GG\)TO(QLKMC:3TB^:MC23HPI*[3>J,=N,C9G\&$DXO+:ZS(
M+CS_9J%Z[OJV51>+M.&V&D#M-VX,ZZOZ%:TYRR%%/7/LD64W?  FB!HQL?%Y
M@,NQ>K+[0(FE'E-:B0NN@A''YCQR,TY^@OMH7;E\SJ\G%&:U;]PS,=D+ J4/
MH04,::"S8?D$.6RCL:*>CMU]B2_>!#+KBC00705$29>P7JGTZ*%$:#YN7;X]
MCE-YF=;]6P7UJ-<?.'T/>!6J->U.RH69UH<OO/Q$3#F8B?)5A PQ/[[PQ> G
M![EL%'>W,O=N_""6%EBMY6?$%OZI;IIB&UK&AQ]I+60L0I&[?^I:P!A;SB]M
M+> ^9$4$.B6*45[63LF93J1NNUB,&N:'K]C]$RX6^&%@6/UE@Q\#6\S,> 1S
M$IU/?0BV4/K/2_-S:XGUW[O1OY^3*%1N)N;>R@<*4'H4-%K\()3@U4+K.^M2
M#W?6=(>%FQYGFE8IG6^G6.5L^)-ZB(T3JBG9<P_SA3OWK/B#^A=/<UWSEN(W
M Q2,2@#FFY:S9:2A9"YBPH<9;=%E3=64?D3U 2"4?Q4[+ ^XN;NLI,L633,F
M.H@Y2V *^[$ZO/^X.PAPX@S2,\&FTNO@(SB'$OBS^X.4OH9"?'LH\8DFV*-U
ML"PS/ L7.,':2<7[>ZH(^^W/FQ-5HA&#OC"9.WJ;';OPTPP[/U.3VWR\'V/N
MGA\2P@_^V'914C,X%$U_D##X'$M_+8;R24;R=U<J;ET\LB%8M*)'6P^2!&WB
MGXT(Y-M+V0>@FK8\_7YG7C9,_;2-LKE($RG37!DCVBRJ4E-O%0)QF:V*CGK_
M-^64,IT':V'W11'"/7/FWW6DC<#'035%6YV=Q/-_F]"Y'IGUAMP_7@Z=K3-J
MRT--(U8S95]<8=[YK=8M(8XK JJS+<K<,NS<0^(7R_H/0!B_(F2?2&\;C^&(
MF>"-T&8L D/0#WZL%\&@#&._>&J9HOIQD%'[MY*2DX]GZ6R'H=E4>;<#O84F
M0X^!.^;P/+WP8=K-.,9($QZ[5DK%C>PB*.R5L=#]:Y%[5\BW8M.JZ9S(-YT*
MCVF[=OP',E7!=[E>WA2V,B.!SL5DZO_T"8T1M+[,2!_JCO"6X:AV>7U:3;C!
MHD^5''K\L3/A<<#$F&?B"BTCHD'M7["$70P?@$/"OBJQ5RM?9SO.*Y%Y<VV4
M=+WK=G-*GWS\ADDW,ZIY+K\;&M#(A76?;,QGQ0Z<C%2"2.@9\ D;=PU3+>%B
M+%FS5YK6HN]?R*PW243Z^[W(D"^)3J^IY"_Q5LS4*PX+7!FS$$W.P<66$&W-
MI(FG"%X/:;8YUQ:3R9NE6;$VCTH+Y Z_&:>[S%MF85<QO!152MG;]"(G@<5&
M1J_FLDY&?;VG@%Z]\'!"*OUP(G_S8[/6G,1*5+G.P^N/B$.P[8']RK3+]EL=
M;D NM*^#@3@!A5'CB& X(JA9>:9D<\7_E#/7[7.E# W&:X(.[,S;HA&+BB.!
M@K9F&QX1TOHZY%9[D>(26,1\*'HUF2,I*D8@1AICQ/MD=2H"T_-<; &"=1G8
M]<%IKMC?4: =[G*_KVW <TV#BL9Z +R<'H"]FLFY2\)NMP'%C*\KD^KG#X ,
MS>#P]%%^UM%%U&MC3F_Q"]B%F8>2'^8@#=>FCYIPZV(A-Y<EAM [)3_YH8HQ
MUW0'56J[&>MS!6F.3E]3A,3K-1:JFXLRB4#*?*>&C%#.$L*++YPR]R*M1GWE
MJW4US5.X,MQ5N.I95'W.R%)6@Y&)6#Z.)N(<O=FZEM\(0W%+<S/L,HC?M@%3
M>P1TMD/0?53[PQ-J3QQ*N7 3V2$E97J:>$LYAWR>TD&9_>C\[O9")["P>$9?
MK3=-9K^-)?C$NMV"MYR5Q/G/ [#2S,Q>Z[.*U_M6?)QC[%^/\T  EY.R$_;)
MOOYF% I-,,3>H8JJ:T(A@B2Z!7:**886U"&X:= \,56%I7>']6IVTA!H]$3A
M[!HJ'[\[P&-SKZK&>N,J?3(YA#W@U_X#GF"WID.OV0VY<^6"I*L%!^9_&LO5
M 7L6D0LM5TU%#,8B$/&$R8>#D $4']IKY.K4K_H&;7IV:;U?47#]93F+&;"B
M1NW[? -R9:ZW\U3?R#:O1N@64BWL.D33QX0VCXIV(]&V%54P(?05F::1KZ)E
ML?73+"<^U=GUDI]G.>UO'I%GXGSDG$125X^'] A?C[NMLOJ)N!\;H_M1 -+V
MLD@C>>T)-A;[Q73L=7OABSQ_RK13";R( <\_%UG0_9[=;1FJ;FN-CR!J[!*
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M3JDIJ3"^5#%):J%2.BQ)?&;AXS.]4-(MLD_A>K4#!0::#%&:NY"8T89BNJ[
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M*VQ,5>T;O."6WPRH\$CZ!56V9OI98'&9T_H)@1[WT#K'B7VO^T1PK,AP)YK
MTMHX<V9=_6QB9<*56<I3TI?^K'5]9^<%*\L'?(=R54TSS[C7;YJ_3)ZX\$'I
M.7)4E_H@CP@WRVF!MJ EP7@9E,:R&-UE5+2N/5 V\RMO*FOV'<)_IDT.(F4G
ML$^4H/>5,")B'SKRZ%LZP^FJI&C+&R$[K]BN$EZ/4XVV,ZR/)9F"WT?G;15
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MA<'F.$6HXR*U+IY758PI-+D[J4:0Q]=R5U*4(H5M%>)K>&I(I]X5<%1XR<6
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MY27/]QZL0U[L&Z8$1?J/,VL#DAJUA20(,S(/I1T=1P(?1<L@=4(XIBX[/&*
MO[/-X8R\+W')[!,S+I_H:9;MO['<.(K M2T]$<?$@!T#Q0*'R0BVL?2^(Z_
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M%O Y-LXUB0+733'RO]&+1P6DS!>.IWF+IE*;VZHSLK:@<(#9$T/F?+*MZ.B
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M*^S0!=(CQ#\U>31M1Q,B&%@(%M/(WD+5_MWCGV%>W_XLS?3Q9269$]W&9PZ
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M\4$E;CM@6HC*!RNBF&D0I)'J)=R5?--HAWKMA3?HVO=[BD'&1C 74<5#IK@
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MY++L/<QJ;<PCV_),+_E4PIO):FHF)^07![G_O3G9B_PA)_*/G#TV>R9W5?C
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MH!79L?+$[^9*_.RK*O,@!0M6E-TD)9])^*.W\H</AX-@/S6@1QMS]L4+CVX
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MN]*<PG"N^<5*W@!S2C0W0+7)HQ9\LXG/08CQGL'(\1VOVRK*M0U6^,G1O(!
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M?$9?QA&V_1EA(=J67XAC9/0911WGW3;3O.1T(!]9X%V:I#X[X#NT=9L!MVX
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M\Y_] -&SBBB\?,(1O;NB^BV.A46 WZIL96]L]/N,6, +\6>/PZMS63+SJV^
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M!O#!?]IC%[E.XW[><SC(L218Q3K,F6&=<LIUS%WE;H0?G]0+W6"@%&EC&*+
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M_.Z=_W!;,62P4X_>0X9/]KW<8,F>U[-._F8NM*LO3^/4HX[-)9%ZY 89WU_
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MK*8X^QP3D6P:L1J,=N9J(Z9SNTZ4I1;:KOV3B</=M/-D4.Z]]_5X<*WR/SP
MQA^RJ\I\#UQM8+C=-',RF1@,6DOI<XBHEO@9U?,"$1LX"@)6>\PJ(/^>B-8\
MP&T>!_.\S4]H[&<?_X@A1VT<O>Q-<AU;*YL78?N(G8ALH57QI-H8.YS_:E7
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MNY7'=5_\I23)!VZG=1B?I3I7)$]AVZXFL;,XH<8&\Y=<-1.)_6Z9!>:;5J\
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MHC)#Z7D5G=IT,L[RRP^@PH?4^'";C5^8'^=?HIE(/*YH\_&^P;M6B(BT"=6
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M$I%_K<!+3QJ-+LZ:I8RN;&DM3G17EPZ#5]BN_X$9AR\F\A(@V8+'3R(CE_'
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MKC?B6@5V%QMU<:P:;[EL%GC^QRB)T$GTF8-<,_.$:OV)"_>-^9.&V'J]I_N
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M"['E[.#D1#GL][\);Y'D(O"+6D5%9:OU"HT<88>7@Q\HOXOKE!WY75Y6^6U
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MQ5F<DB)3K C 'V"9:468Y@7/IU''P/JI^%)#B]O17(LOFT7AGF1Z\EM5$!Y
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M%WT*,WYUL:.B9"]#;"@< E*RL&@^5S,6#C G6#X=93I.R\5B_WLZB'1XSJ%
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MEU!IVWR=Y;/SW2.0ZZ0D2%*#(\W#1NWW8@%<N=@I-IWU(YB%A+YXT)4WT_9
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M+B]+9N$Q'-@IZ]66XR .8<]O*(QLT##9UT&Z"^#Y8H=@6\#DQN'N0,E&;J$
MD YV\$$DR2&R)^WB J3!?G]/[*6$>-\?*BFZ\HX"XM#TK0A3A\XH4NS]X_=
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MZZ&OG3\ Q*:LD6IK.$G=I1)A\O\X:MTC0'Y*I_+RN9Q0&>V>K/.T$Y1_5$H
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M8FW27@#H?>C5B_>"9D&V3.T_R>W&@RGY5<TGBCYR^3#HJC;F$-!H4])L:PM
M SECKC4%\$S\=+BZ7^N':HX]%S&NY*(JHZ2O*J+ HO+95H+)(-;YIS-Z+H2
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M#H/L"A; Y$X%)ERF/..;T"0">ZC?>.?VL*0Y7#W)43S'TO:RB/(BCP)8]IM
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M1]SQ;MYJ=N%[ VLB.,+XSZO]9?6RZ/4:'B1FK.&T\(6\(F07;KJKFF$*,R5
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M'^T]S)_0E^G./UWQEGEQ:3Y/]]T1&3M"=Q!,.Z+V[,G^BU@)4FCM,8$CWX&
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M-**XKDJC@F*3-I$?ZF(-]/!=;[W.NE'7"O,(@HZ6%J76E#V[DP5MK(%%G1'
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M^-M_'7\8,B[:?..DP+H43YRB!X(&TZ$#Y##W ZM/-ZG] IO+@E^XIL^?XMU
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M?M>N2;#[Z\LYA\B$5,N1/5/)RAQI0GO=3^>,&0PNI+GS8]_FZ[M@W>S0POP
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MZ"C@L2@GD<JY-;!I6VB'K@;+7Z&)N!4\4!KR,7X^>F,Q!SY5.&G^TYR'X!?
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MH'7/N20(BQXKU\)OE4.P+.^H*[&?QXQ#4SI(2BR,+?Q:0!Q@Y1Z$GQM+BQ/
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M3F&AS;6H)W_&]DOJBLRC>XP;*]16HC0)\'R^-,W.=/"6='/4+=H7=MN=M@7
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M693C*^GK,%E-\2C3R7<4[@ILKZD%NX-([Z(HFVZ%[,:+?K4VU,:L6E/.DKT
M#&5R/$XA.C697GIBUV/0QOS]MU!AWLS5C&^_=R\8?IN0]6*]5C<;H)[E^"Q(
M.MRH^;1413R!+6!%%U7DV-U[Z)7MDK?OZ9.8^KVNDRRF+G^]-BVS>^(7Y739
M@H1VEJF1P^]N?(YKQIWO95?TZQR]\5AOD(Y14 ^%%!)V,C_=(B8EOL^5)QZ^
M&DK+;4HWZFE$0HG,A9&*ZDH4<Q<;FR>F0G@-+._12W^;5_LMDGI'6UR\  2
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MM)&5;NSOESP9/!2ZPJ8O "U>]7[3KVW:W9F--R41P(>V]U9]+'3%?1^-<%X
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M9<>9E6KJ9B[N0SYI/']M;(8$K^"WIXI>OY:,JX@_##A'(LU3!1;E=#C^ENY
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MW*&KPQ%8&^(,&A1P[XX0*(Z4YV*!!Z-OW'%[G9-MMRH;:L?7H^41(<X^5GD
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M<$1??(B[]Q5PK?:/VO6K=*>=L904@^@*;$L97QCE2M[._KTM#&TA+,G6G71
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M!%L0>UYI3=M5%VP<5CQF/WV@=UG*BR& =CNV-@[KOC4]K_O^!) F1<4A44\
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ML=MOOY)E" [J@,3ETTO6W"E1B<@4Z:W'>!3MDN">?0=2@0(=]@TV%_+350Q
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M6B341T>S&-<NW1$N2TD*(=[,)YO?U7YVE..0CQAP]W7%SZ\%OQ,X(B+Q29'
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M7N2FM0GW O_=ZEC(>2N16\.]<.&8(P.O0"I/68T8M#$A^$L@K4@?#P=,[PE
MF:!;QTOKM/K/U)]UM.&%6M1_Q;]/&\C21-^ZW33E01 VH+=2BJ0(:,GBEO"0
MO !(LEO$S>3_,Q 7ZV/5E2 ?'*FF5;@>CT.YEGH TDZBO#^X*+<%7*M=]CM=
MM[*W7[P(>@)LC!G+VST!JF?+'^<YLF*D=[#ON D?< [ZN<R1T33M:PH6>R^5
M?CIF< BM+0DSFA89$AJZ&E#<!*Z2RIQ!?</7@Z2R'\)\O%8>%P,OU]L24)>!
M:\]0M,^Q[X1V4BCH]C/*_1;NG@L=7W\2@=][/0&0O?YO4+AJ+!U2S %21GQ;
M;8Z9'Z>@O?+K\O#*(H%*3QZ0:,O/,.6(SEMBJ8*\.I,5_:.:!#+RZ)C-1H1>
M\0;-P4]YJPBL%,1;OJ'6'H=HUVX(4G-QA275[1JZI%?VL;) &OM&5S(N>\<2
MV=(EXK 1<K3'#-5\:_3!U(=6I,CI7XSJFB,72XH\$6M&B&X!_\J>]OH4 N%B
MVH*_V5M[4]KG;ZO5=_!!##3ZGJ_960_5^6!=5<ONTJKXPUN74&)&7QGD]Z8^
M"8.%*3[L8B_$GWV*3VG PI:E/>3YCS$./ISWFN-Z&\'Z?^"D$QPCEB>1VYB'
M(G#),9\Z@NQJR<-X8\-NZK#W9UM!<&R,^ZN\WS;(Y&&/F8*F8<W%.979*W+]
M_+"2FP][(6IJ?;7EQT&@QO0N7>O+A0^;_7@B$GZEB<^8IZ"R!T-4\\9X(D+/
MH, F^$K5WF1Z57XW9:]E*J6+$JE*Q9>?0>4'L86H0G#.3/3OLN]X/EP6Y@W-
MK;6P23-\=C'L.$ZO@3Y%BMW:E*N$)1!"7[*W;'3?*F,TK.>P<348+NDS*35"
M_9WN%W>.S67:?5<_!C5&/(%7KZ+@\!79;1)B9?Z;%= BTM$,[^]FR-S QD1)
M'^WXJQ&,(5L=/# $XBV$F:(+#J,0;UPEX.U3$[05+YYV,D_<O\5)#J]55\.Z
MT.D3)CA4DYI6(B/C\A7?]4A-F.]09ZIOL.B.Q\$-NAPX&(6H33J2+1PNVNI$
M.J U))S2$,CCCHQ^XH,@WW,5V(%6?O>7T*DFN,TUOH"";GK<-X*S>K;KW?H1
M'\S0]53RG[<U-]2TW?B-=H1X\ESNW<X*%BP^ >P$6TP00L<[0,0FJ/F+, /;
M(;;(=L6"4NK)&&M=]:_*S8]GG$>4;T_?4^_,!G>4[_6?E4YN3QU07MKUUL54
M7I T3#';0#DRM-)%-C03OV+8AO .#$B*%G$+*JM^HLKHYZ[U2-4"?JE1Y((N
M(8@Z53=2^AG).RA*3&Q]1=[M5!DI#?LU^<E08'Z/+9#]Y.,#<U5 ; I5&S?9
M1;JX+9C0,S\4!/IT'Z?L>^^3>,(%Y](EV']L^1/5;0U8<CN>MPJT>$#\$\?M
MW=^$P+^*ZR$Q7TU7>Q663>QI9/\\>$W69/Y^RS?#/5.-8P,@A,.)YZ8>'%LW
MNJ!F"?,8DO#![VW+<IR-H_[T!>SL_>PS)#1AR">]-=]F5MT_:AF$=_!\.[GR
MR+RJC0 -D$!A">21<,ZECK4=%N)J22%2J!>>-;"[;W><EEBP@ED:6BCV85.;
M5P&5H--'%=K/PQVR=))&4QR .@1FP=*L@]00:(:VCV<)[XJAK;.L$UF.O]7;
M2N<)\.=)L@\DC(R.'2(THBSU$&W'=^47:=S,=5DRK5D:27=2 ]O$[]L !%LK
MG2*#)[EMK*0C\X)X>WDV$UQR%$X_]1%<6U&JF_1]-U*:S39PYHQ,*TQM(-)!
MC+I%T^94WHJ^;G*#C?D/?U;[@J-:=29D1*LYO%SGHJQVGDG9^K7:9/:$.RE]
MQ-UP\6 ('L:9*UPIW[.T#5J%H,J( #T[#5E:USA>@KEOB&S0<.!6:VUX>*SM
M*K4T?G&<MU6!V=DR91W>!HXPQ9O<_+:)Q=&@XJKUEP]XIGSZ$(ZX]5J>:FQH
M35D?,>S/=LYZ)RT5;?=CTLEL\O[*&QQ==&8)=';QR>IYK*LC;VIKK =YY4$Q
MGP J#8F("[ [@B\2)FJZ\EE2U7F\6"-?C7&R5SW_:[[=75^>6(D)6;W==_.6
M=%[)!:934%U=41]/88%/(/9GVW/A5-BC5CS%Q/[5U>?O-J:_''(VKM)$1B%9
M&SNS^6;^N9]_,<;N[CO7'=0M];B X!#2%G:UHY^AM5884_'2<(/"M_DTFU_]
M$/;"/NU'OV/7^Q28E4FXXCWNEVHR2U#IYV.X.RJIX_*7WO9(<(TKR_SY-7-U
M N^D7Q@+.6-"UUUZFJ "6 ^ZO.:(_)(T],V_)=3=66WT>5*1,0^?_U?24?F2
M#PQ#4FF4;$TF?^;P:)0Y-D-<#IJW%GG4 !NSY?KII]80 ;7B)4Y6+LXKZ52.
M;;H;^Z6!"Z9@1%[MR#U2?T)AIR'D+:$GWT+?$\ Z*7B++3HT63+ >,EG7/"B
MM704Y@JW'8RZ<GF\Y"6F:XB,U_5460TU7$S5^</Q<0(T1),)_<C&%19?=@4'
M"FF9M3^C!Q!89_146A+>RBA?OL3( )V\F/V:1(2_4*E!2,.N7V91'IOYBFOR
MS0))>43@,IR^YCLU.*BC4=*;^N+WVQ_>S_\,8":6"K8XX?WNIF-*12@L>C/2
M4YY]K_R6@FY>W9:PZ;4XX@$32AC;41 E2M'N0#ACGY5SO"/2W]>9-%2%.%9E
MGQT?,<7:F0X^/QU7$+F-OH48+J)2$JSR=7&,PTCV>_-&VSSP>&"6,=3$7\+S
M-,P!KHQ'&(6&YN<YYG;]&@I7PV5;6A548_2KL'[X<\F.>P[&.\4"&W#B%@8?
MSL6S^E:->E3X8!_IK$C /<']F:*W.]-8*](<EJ@0Z5\/Z:^?6>$]#7TSJN=C
M?C;9:J+ZR8++[9VA$?F<V<^M>G=VBZ2[$HJ XP9![0J,+UKNZ8(.X;EH;4Y'
MA2.SA8)9#T4Z3O%"63C?11.V/F!B%/?A?KU=G>HZ0XY0@Y)<"W:G*Q@"&8CB
M5N+G[*&^T.3AB[G#J"T/BV)NVE&U"Z@&Z\";.0:K=K6T&$6G=:I^<U;NN1]4
MCY[8%(\W3%G9)3@V I?.>5_6B5AX!7N\<&(K>O4N#O&UJV"Q8^PPF6TYYG7%
MS()5/DIYSDRT6$D[*ELW*:V*M,D/ZR/JYEJ6NJ;\7U7,:3=14?%>Z^ W^O;C
M#:+=IO7BP6-#1ZJF+,FNE%1?N"46;YB%E":AIU5R=/02;C3%U7W$@LS:W;]R
MG=WX@9I!W6'GG9+[!F_YQ-YLX%$$6=4GO*?S!G33KKH0;FA61I[#K);<F:1-
M7]55G>\9>QB(5CZ^9XIX_X?<"QLSFD!^1Y>2CNF/Z;"P_3)157-UA?RVG?BO
M3Q*%[@]UUB/TJDIO#LZ"I*^V*[C.)]CP6,T.H,E;,!]JW:@NMUB-UFJJ[<?U
MZ%/;D;) \,)/"O3Z[85DP#GUQK:3K=+Z9,YNU2(?KVD4^5DFAD:,=ZX,Q?N=
MK574D;^J]^"!9E?O1D,JX'[7L'YR=_'BLLBD%Q'-QSVV;$5_I/+HE3_TY7C8
M)_#RT(7^F=07_W;^3X\+,!=A1PW7A?OUEEL@F1JEI:^Y(W_GPJ-(67-[I($]
M6HJ=#0PC>&MUYX+N%PNWT8C-VI8^@@I:>Q6O2IGC[C7Z7(Z"@CHTU-#S6QO^
MM7 OV3Z,DKF\+&K[/<0T! ?/]5>O]"*!;U3WY+U3H9$!4]G$?(1FS_7@QBSF
MS'+&NH@CJ0$><O7T^2A;7^X2'_N:P83UZ9+5I:8U#4%R!5RLS"+M72YOLR*4
MQ*&_\T*2(Q1%V/$$>.45H/\Q'BY609A%[L16S<<#.;X)-='J]7$D4C3_X=%9
M.KY/4'6(*W-W"F3?BV6WV??6YD-H7+M),21UWDXW#.FWB?FO96Y,WFC;U,9H
M"*$KVP0M!343*&X&"%Y&Y.#_F@H:L7,$2=3( 37U)JW3-8Z\RAD)L(G?V >*
M+1P$R ,O3:[B?G(]TER76$3(352DO%VUHJ.7'-QQI@OW:#+I>I ?2E^V))N]
MG'T^OLB/#6OXYB*M'C'JLT,#Z?6YFKNO5L#&/,4^*R6:S^EGM"^],HS.U-'H
M&=C]'FORB0"YV%=59<1A!W^N_%8DOE\IC E,KY6@/]#$-L[2W%SEE_QNLV>P
M,^+3)P(LA2O K'351_[X-I#SLND -B+#]3F55:)P Y1HZQ53,U$N2P6 _L1?
M7 =7_D-X<G0X3,A%V=)QXJWF9;.XOQC=LH#?UG,F+*8=$<E2F97WH*)M:X%Z
M-PLC.82JC"5[S4[R?&9QYT6O2N&AT+)1R]PI80:FD+-%M.D9G=1T#OYWOW+2
MT!$F>^Y585=3/SAWX22%!'7T.NR[* MZ;"G3F(-OC595M?(WG2/"ZC[F)(Y0
MMCZ>^1U,5WWG$:?B:B5N[BVM!*OHW&JT4&CHK$34H?;OB61PE+]4'X?\G5*9
M<PK0TO[K7J8?_)A 9 2,6'AO)W"92AGS6"EFRX8W0I,]R+DB /KI_OGY,[C?
M"UQM1E'F_D.[K[]8A9':?U=P=H52RE\96",]F<22%H^A?K7&/M7]NA)HDUM[
MHSXS6['1,X%FT39-DID*LSH6>$>(,I>HT&N8\W!AE4!_"Y D19EBHK*0#^3-
M73,ZU+ANJNM,W@F.^^D[<WQI)S"A2AMG6WK9X#B0;I_YIR<.EFVV4+7>;-W(
MFL\XUG,GJN687BTZ?:=0$UUW&998_V..IW+):X'Y!_7CE@_17)3_]-D'!U^8
M44W8=U]]OSDDC'2@T\7GY0X]I-?A0^&W@!'B!>OZ\:.F>B+63;;-9\:;JZ]-
M3DH\7Q.2I3+2*"O"P 7=;Z\W%J.T?HWM;=W/F7PP2I"XH4"$#PUXH%B^,=5K
M3ZU]H/:PHB?%?-_<(#)Z-%_$Z4AA&?;+\?1L>,I1J/=2HX0'.'V+U/#)C,[\
M4N]8F2(IH]=>/R,8IQXL!,?2<_KLE^(85L_?_(<QO91T-7V_']]X7<NN.1G!
M55^*Q&9UEMK?*=Z7M8W6_Y6WCW5*P[TO>F$9@_ <ZJVMP@S2\Z!;(DU@&B/(
MSU.H7-?'%-)]K??^E-@UYGZUW?#=75UNLYN'L$/10:(\?GA/FR$$["5*-2_=
MAQH=/V3_SM:2*$HAH=0X+K-:CW[,R%CP8@[.*$%H.TXA-![XJ271B8&I:C;)
M,=V">+!7)JEO0K$SE?K.LF(1405S3KE-89QL^0-NIII*"'G-0M7Q^.ZQSMQ6
MF'B/9S_^?:Z=6$BGU0OKY<#;PX0?<BQ%8\/2.YC:2YK=]8BPV[2,3XWQ1M^X
MTE0/Z'FC7T73);MX'SE;U__>9@5=!X! \U] JCK6A^<]]7(-4^]CKOP/K:[A
M,G/(R7RG90/RM68,-31P?>RRY&SY(@&:)!9D3#-JYTA@C],=7T>O12I1<FNK
M]8^P3U#W[V@L^G.,BN5"T1W2PF*#>5LE<&/=9+UB,:MYRD8I.RJ3UH3Z\&KD
M&9M>5<D>RJC;G^32&>F56V-T54YA81:"1N=9Z?B)/2)G;81!J-EFM?H;GI=;
M@XZ1G.P@3:,&?^>-_*=/R[;(UI&Z\WCRV-@#YC,A==B.%2.Y"#=0R=<_[K.0
MLKB-YDVJFDNPV<H9M[-NO31\V)]-K^++UV]O)LL%0->8!L!DEJ2";IK>R2*+
M_F<47T4!Q"3N<,'D(KV]*SY;.58_L1'&[OPN6AN3YPV#(II3#B8_:!?3]]:L
M*\DZH?NCD&U%SR< K3>UU3/7*\BDIZ:V@&!+Z*$J=R%FK'GZI1E!)N,BSAM_
MN$EQ@>J8/4Q;CQ$7\#F7R@=,BB)$7L5=Z]&2L11>NCX!=OLJ8>5/@(UEB;/3
MV#FD"7Y@YWNNX967$FQGIOB"UQ</![I)4Y=J&6M0$0_JB'UYB>EK;JL&CJV*
M\4F(04[!0IYM-!;NSNU,;_L8#(J/_K'4IHG'Z#L0IE1'6@:Y#R+MV$C_@M_.
M?6@UD=7 CCKS9WLN&J'B>633K S 6?,&3 R$76+#\MD?SQ+ECC6E,5)6,4XW
M@(\E1VT8?70;V&&&SET/(A6DW\R&P X>*^B6LM<C:Z2C>BL%0 .LN/'!_V,2
M^+^.26!)JO!'X@0B:'C3>D%#TD#X2@.UOZ^.3Z;[SH$TAG>%XIF)U+#LY_3E
MO9\)[GRW#@GM?;5R;!ZA2MT\VRW37-<@&/Q.J? F*D+23CM"NF]5"?M$PB[T
M!A!HL)@.V,#4<>^%SO13:\UG,]>AP-S/MMHDS;]"GP!+DE5' <F-5OY.1?+;
MH,'JR@^QN7.QV0]V2=;R*EKX]N/#;T/D0MSW&*AILU=O8[&QPN9HEDA']P+8
M\-D7]MG_*+G60WH<#EVO/@$QXIPY?I>\_&?Z.OZSLMG_W]:+BL?NNOTF$<=Q
M&W5J9T*XEQYMFRI$=L;=$> 5?%ZICTJ]C[J->W!Y_-VRH'A7_ 0PA)^7R%BP
M/;ZXUM4*M=W3N3S4HNDOA[8-<T2@K X7\,J^JFH#V)\ !*[P.PU_CL7:)T 3
M<)%NHMPHL-0I^_%'T+5GSPJF.U)XF%'Y5SQX6YLVZ-+V%GPI-N[H1A>17E>W
M2 P:>*CA<$APAFQ*\]]2[@G^G)#](58:*V*6@&B*^_I2WNGWXO-<O<[&+S*L
M%.*ZZ8"]BL I22N=F+';KV7[+_]9(OQ:"NJ*38E!-$U)_TK*-Q<M*2I5-3],
M@Z\_HS6E"DIX<,YQ>\0I_:E'R4GM HUM##W8X*\4_UH6*M-F9)P6(Z1;18K2
M-RH%(L3[P[5"@H-7C[8S)QU*8B#'VIM-&.T'TF05%%8QN<ED"@LE?_H%=]I8
MKZE.[GIE/@3^-^K>.B:NZ&L7'J!%6J2E:/$.4KRX,Q2*>W$O##ZX.Q1:*&X%
MBKM[81C<M;@.[DX'9_#A]GV3^^5[<W]_??_<?,E)5L[*/LG.SK(GS]EK;8CQ
M6?KM;DZ]MN=0]3]#T.]E0:H3CB9F\'@$?%(UODO;E*=-56I_:RJ5[[L5H7Y=
M%M#?3N1U;* *APX++0=LJ])K]+Q^ GA^L:0YY;JJ)CZ[_MNU58U]G*T2RDD\
MCQ[@SZ=@^)YL)\=,?LP+V_#4->+>E_XZ/^W\R$)0_\]R0X#L](9@.5^W/,AF
MK$71Y 84?NOM-+6T/&KO2I0,4VL8LC\&<@U1!+K_/">H+3FZK-8_Y0Q]4/:D
MFJO=0+!J-T5[%,#GU)4.Q= LZ%^<F5 &]&=1S"88Q.+:D@90MW0QV_.DIVL+
M[GN^>;=]C2OQM[C0;\4ON-[A0#']U&I?D$.X>[;>67.9QKWL"0 :N;F+6@\6
M'/"Y!)$$C >^:J5QJ1W?6+BR-D+*NN=A>$0%KJCOOK\V1V]\.6Q3?]]D[["1
M,'=(LD#_)E=6YI+%&[/=IXJZ$LLVWOK^+X?(RZA8?NJ\E'PQJ2Z:>GAL*QZN
M]JEM>=F"3.YGN*:JD"9:$(:Y(, #+X9UH17GWG')2)FJ([)>W;RRQ\2F,)/T
MZ(U%[27XLCJ>F;4LQB*B9RG!83A_YOPL0RP97'4X*=]>+GM4?.1Z1=,M+C0A
MZEV<OH*A!9MEAZ,])-_F,^6X"UJ(4N>X54Z;)"UB1;AGOS""CD66K1[PU/3(
M6XA\TL7(X)_B%HOV'[T7>O"#WF3F]!1!2..E-X>_:.LNV05"U!/HHSQ%9$>P
M)'$Z,=L[T-)[B!D4\G92UL>'ZE;?5"9U;3J=[Q7!CEO79%J? !B+X?F\Z=]Y
MT^Z ZP#8CM(RZ^Z*U)8[/#2 W_;.'EFX:_ RA&RZ,.6X5Y#@;;8%_=:1\;UC
MN;2O/5XO(5O<G^!/[J+<\7&V0#[VF(B?%BK+*\H\=!CTF[\XG^'%N3Y". RV
M8MON9O4XKCW+N9B]KDV4,1<I\I\E%&PT;%%(X9?I9HD%#@'[^-9H;&%3\KCO
MXQWMRW?0QWBF8YX *>=[*QX+MF?MZ:7]B?/+3L-TG=I_.Y'B6W--]R<$>C:D
MA"_]Q;$9HB-P"&G)D&,^=Y[7!6^I><#KT1!C1_[;M'YN[JGQ9-=+P[V+JN#Q
MC;%8LU6[?LA O^2?&Z68&[)'5=N_C':X) Y-3%E)'PLHPH=Q _&% [./)/KS
M"MN:/SZ3QY6PUYUTPLH9L"WG6EFB=;[S*+2)'9U>@FK$1T1A9/E8T:3DH.JQ
M*YWY=^@IT;WWEJ)06M_![E05KDN?;N]%=_0,R-%JUOT![F1(9*5!LO(] 5JL
M,<CDZ$:'M3RQ^/ @<$1[FN#=]AX9J'/OX,_>8^Z!!*4_/,G&MVS %9^]!NQK
M[7V;TR,%>]P? :^Y!KP-H)K6^5S;/"7=^4:_;,@"%LM;RBW9,P.8ND21FBBH
MDLR/0E@.^0^7LMY50EVZ-6_S[*B+Z?*I!IW$6#.:YE*44,-S%7K)@C5J=+1L
M2BZ3R31N_7_ 2+U7/FI8=?OB[V S;HK@W;R5P5$VM1,*&$%[#G5;($!:F;WG
MMT+YCR:N<BN14 'F@2*YDUL=\H(C]"43R)=(" 5G-OTP]8R>"_&,@')%(9F/
M6Q_W=>\<C.1L0>G<8&65>XC25QX/VGX@U/494ZR+"!<^ WUI$"W)$*X$>QWZ
MCI_C#:2*C O#00[X[ G@&['S(+!IPUM)XD\V*GY$D1)!4_=\6$;EV##X@R?E
M*[3.HZFF4:D!#5L2GWKX[Z'B3+$$4OZ$6D%<G1A9(>I9</=UI#O]8N0P_9W_
M",GN)!6,_T'0Z=6;D#B>HR.)F&2X9EN\^:NR)>],\^=9EI<,\XG*L;(15->D
M>,VJK5-*+MZ'\@7)F_X5KM3I ')V?@PP'*O0=7$@Y@&4WRV["()6.<=A>(>
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M+(<-/?C/_'^+?/<60)=5(R >#+0FCCG^U#ZO68$Q\NT+):HX>ZJ:]W?_PA-
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MV;J@\=.$1ZRC0C*P)[G !]'L)6-CCZ@ MMP[&_Z)>IT7!6X7SO+QU<KD_"R
M@K 8$OX%K@4/ *G$VMN3F,+YMN>H)S$S:CZ^)?6^X>;:!W0>P*.>  K]-7IV
M5K_G4X(&]77(;G5^AR)N"%2N%N3K4LBU5*CO9RZ9H:&AJ^OC):*D> U$'*G#
M\5TOA)&7I570TD\"X52(6HBF;I(#D#9%S'5 *F: \EZ'RZJD+5*WTSV!(7[1
M4B^7_M;616:KDZK-&UG^>DW>IZ%JO'"E<'2XCI_KU\S7)++;=-J+AZ-Y5:EU
MRQ-^1^62EB'""NU1I%=#2GAWJ(<@L!KCV=55^>0M?YWT]D'*>S;$RIQ<-CG[
M=1A*U!=Y8%AWV_S]-XZ;N_5>,UW[N'-0!-<%(8&HU=<(#@X2BZ; .EMM1W>7
MVN!?*U"O<172:A,%\S:5JC7=6$4#+W8^=AFR2EJ;%7JS/TM?.TT/FZAD*\U6
MCZ9EG2VS(:%>&R;BLFZ8VN!K%5\G&4C:G*BZP,(>_UUA+\@ZQ0PG_YF]QK5$
M5Z?0T;)V<4AN>N_;I-ZI95G&O_8FS#JV7Z=CBAHA<SN&Y:ZSW1L,G*ORUFYQ
M1E*EHX5=[E0%/#C:\DRFWWXD1O\+B""%/XVS^1/NQ,FKN[N,L"8!2=U""SU#
MFJ2()\"K=:? M]6E%O'4[V<+/,[/6IZ'35P] 8[@?)6Z8S!"SG@F,HG<:WQ,
MK UCOT)M^,RUM49WD\N? >?BFSH$_#5TMO>0/,@8HQ8I!$1OIHA6$"Q2)'?G
MO>=11!XD[XX(NJDY$=!PB+S)@HS6"T6Y,*5CBO[&_.M\XP/78&QTB!Z)]4!>
M*+(LO6OK 'R-50F;N08I''4UR<. (8+1++8L\<6XM;;)R,DUSK#=4!L3]987
MH>3TFH#<01JNPP S$.5GO85,2;+O8Y&4-#:M_I)G?]UY_I0%17CZ7PF"6-9Q
M8WWRG?V;+%G9?U;=P.1V?Y2,2;#(DH^+S^JHGW.\RTQ4KFW109^GY_G+^&'-
M$SBQ]=48.IYBD.YQ?2'_[+/]&69:BL ;6P&E\XI@03C3$+B_3\1+/<&%N6-I
MV"FYPV9F)[!>D;'0"Y[FDKU,=_OJ=2-!LY,!4Q97GZM/59U5X? [OM!R0I5:
MW=YF__Y=S6>FO^<[;R68LJ"YKM4&0_BTLR?)JQN]-.T;Q''GZ#5;@J);[1 !
M8*Z&O[J+O>38WE#"G3\FPH$<"KEPQI <*7/&!H($F)(=@DZ9@;4VE>R.A35U
M2^Y 6](4'X="EG*EI8>23EHK%IX8(M?+*BFUL[M19$',.>N2O.XG;0/S^Y#@
M?-9!H2,MS!P4,-F4D+VMG<A>(_'KT>W;"\@F6'G^^D.3O7ZX\G[,% X?YCV7
M'!_8+0)^/N!([X*Y]Q*P*.[X!<LO4='1F2KZ9Z*M *'ALJ2^]U8RPSON 5:R
M13EZ7\LF$839<ZBO7GUEI;.PPPR[@S'S:S7G^(FO4?9D1Y)&XPP_&#=F-8_I
M-"E+$#>Q>X8:V?6*/Z^L)]T,W 6$WT?!7_73*_-;?O>;"U4[U#?C(>O_0&1N
M==ZG#'9S2\V+4522MML]_ CQVQIICJ]!BTK011MG(L>(V"/53U <Y_-;(DL*
MF.;,?".D.P!X$R/BNZY5ZD[&0>2=(FR_/"F-7%C\](%_=SRIGM!)B#+Q8(!/
M<TO\1\\;84_]Y4/4FG/1P6O#R#:MY)7,!/9REW.%O=+Q,<G$:;K %XI"N%/C
M5/_BM[-K,67=RL$N]W5U@@5;J]M1O16PTG42N "M>XQ$X$$(EJ@5E25J;)9-
MP4O+ -=Q#$K+BN6C'AG8N0-^0=W'BT&X28<K\)S8.0,Q2(DV?60@)"B[*JBI
MI;=(\;8!0I+9J*>O)[)(P\$'G4GC;VQ-H;:ABSW= S+$ M'K=Y.1*YGVH=7,
M08\QY$9YS=KQ7U>$L'Y?WOZX1*]Q:TO4+Y-AKZIF#R&+0MYS,:_# *]\"87*
M0@V,1&L::AN\[?+Y&_K'_I82-CX>O9+O>I;5Y !52TMH)CKXDY%@N3WG//^[
MBW*RHD*ZK6QYGAOK)W@DT>62C"D.L%?M4^3.*@C4P.CRIWZ,\Q:@)9>[1XR+
M!O .N0\GZ[+]K>*LW()"7P5?>%<99$[YK:BH8+I&.6NZWU+/S0F]/01!%9[Q
M;T(,:S%.'OZ(7.QC0K(^?VNG#JL,B[:&(O@M&OV4,8MY!_.0"REV[W/5@Y\
MWA<WU^4IL%=Z(W[9[)I1;/8D_+&;=C%[:?UUOQ\'Y7K?T].EAORE0[N-<9ZW
MK)KOH:P6>]!14=?,@5U(L90<$U3?P 7J$XW/$'^^OU>8&2J(&["FGI<EDM:-
MY?A< >RZ;;;B2W'[O3Q"_- OV9*DN^=([/ $Z*TSD+:+)92F< U_Q;_SX*L%
M@LJZ[=H<LVW'U[$/)?!'E6!=VV*O7QS=:DG+E-59X2G4]2AFOE,FZ($+Z*@2
MV31+<C=) @:D5PZ5;;P4NP1\5$I=/4L&*YT;OX>2_];8'2>G3%QMX7QIL[:@
M3[-H'O[\[QK/.P5=$C&/Y$N:/\73NJLFWI\=Z%3683@75C,"?E9753\FU6=V
MRE/G?EH\+^;?<UYOX]NU[HE-#?O<^-"YF;)IU4<EL/&(*$JF$TB1%CU "FJ\
MS4 @9BX&<JZ)RQTK]+V8NG46_X7QNW3K\&@<0 OX1?YR%NCM+9/Z7%6K<I61
M+>R<9]29.4'[K_Q?,<P/XDD+,MDB,[=1TE9X,=-&9])[O13I!L,AVU*4(Y,]
MY/<1F,+73$QI\-/CFD7L9&D@*8V[;@:N)\J]9VFMGILYZKGV.L%' \OUMF7U
M(')RI]5E'?.\2G/7J?2VA8.4MT$S%1.EUTM'AH_+-KSI5*VU,33D+ ,QK-P]
MO6HV<&K##B[')-E"?8.9YC1IV<4I-V!)M7@;:_]C;""&27(QZZ'Q-)Q6],>$
MM_D YZ(7$Q4%1FVEM=MTT*3<Z'O_0;4OX*E:<(K=Y# ]2T0._?D?%X4]\JTE
MQI9*\1%[N=F5A0_[:@!R?]81]::3L?R8DODIH/<[+;>53@NS^=N6B)6Z\( ;
M7=?K.!X7 F===C)8]!D6V86&*WCW$EG)27#XLK2O$?OUQ(F*)^X3@!2T5^G6
M=03N*\O(V[9SB%E1),_3]7DH?< ;N.![8TCVT*A\<3OBP3$HW!K(0V _O-1A
MV[2+?3?\MK_-J:-;EJ:26Z@5Z@F9.B)\Z)0=,A=R'/%XD/;\=,XH06X>EY-V
M+LG]==9)/#!3Q7F,JY[&[VVJ_9S)+RFW3]^:]"BC<(@2Q"2>@:GJ#I03S+\L
M.3C04R!#WIY[$S)3N@T,GTP5J5/P_/:O4LEQ<7X\NT%BG8J56]<EJ%-0!<M3
MVB&_U9JV&:M(F"\N>^ZC/=S-O#0S>SW\F.D0]8Q#40[GN<K:J&8&C9]6*3L<
M\@V:IA'::8.],OX+T_7Q6*S]9PJ)(M/Q7)<QSR[GV!:9:4MQKH-8N288+'PX
MIVL6_RY2\5N%1AX.*0N^%(?LM6]-V;6.$LPQ^O,< Z3DAU8L0U(B&LX5>")F
M61NV$/D!#+$A3Y"88J7,3N/&Z1<20O/O4V^*&W"0;ZP-NG4F[/JX*&7:<KF'
M,9$VQ3::GY6P;T9[MUP$8CSP&+"IKV-]W.AW":'%OWDX6!V!:5]S6,TQZ-0U
M_,)6*Z416-6(PA2D""NNME^P2$%,2+C_FO$OLGYHK#PW>:^GEA5@<;]P$J5M
M#E=?L;FUUU%/,E'!I0_&B^[Q&^,6!.]#\MCV$FB;H7C>H#N.DOF.[S#R%]4K
M9*RHSF,Q^2)]F_+=9!)"ULBF@M[$-PDN H_8&!@UY0*ORHT5E'QF$,AR#S)!
M-2>N6*3K=>U)G[3CE]H5.M1HRQ,@MFE^B'Y^:<F;?$>N$^-?.:;_CDT;"O7U
M8G]U\,'@AWWAICSL+WV,V >?Y ?FZ(9%<O*8),<7!QO:DBZO]IJ> %G@J]%7
M-M1&&1^*(I\QL.U\I$P\7E0]?;.OPCU3)[NC]V>'UQI]H5] ;@$C*RJPD6N@
MM*PI#I8R9 V+%L^U<2BG-/%@2QIO<'&=]YU:7L/>;8Q15H91E&S@$ %^-_#
M1*^._:-)/:/3=X4S,U[$XC]3.P&*GO/,9("G8A$?]%+N562> .$1DL\\>F)
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ME&#Q,/(M(-99E?::^MGW9+SQ"/-F"SH]O,+FX[WJUW=F11VM;;/O2'G&0J]
M'BHCYIC .&SJMC*C3WPD;FE)^Q##BF^49R&:=E";2EU+\+LG@(=4V@Y?J3MQ
M;>1?5\GI.L"G'W+[\B>(.SA=E5=(G\<' VAF(72YXGN!6G0_U_3N-=^WLH45
M"IETZ^M(*GV*;O0&&AJGN018H5]MM9_J&7](R?RGY ^_E3IY?LP3BP0-BK0=
M3?B]/CM>W#*,E#RC7A$_-M>&M?;/F]/'U_Y6F=L*F=BCI+20(L;A(\W9D;0Q
MHIZI3(/DV$T3M[%(++5#EUV)BL(<W^4 H3;RU!N:A9'$0!9E0-PK&4CT&6=8
MZ^B4S ?_\L:R:_Y-<]JH&:AS%H/HA4V=:V8._&/>T;!SO</>D4ZKSL9*UPII
MS-7NA3Q_I!ME8/FHZTK70I(#>-'N^%D$J\(' KY.+Y->><^WT3U\RPLC].HA
M1J\]/WF3=*OO3,]EU\QB?^L78VY7^\O2WR-?,\'=\5/L_?EW94698-;;=XE#
MQ& B^X=]](XXT&#!O>!EN6#!XGMTV$+*5.+?\@-M#Y1FBS0)>O&"YA4&;[:9
MZG'LGRK[?'L2]-AY#1HG3>6B_K7SD0"M NW@>EU>;O%A]JQ=:(*BAYA?$6OV
M'QB;GU\RLDA,@5QYD9*  >M$MEH0<!?U! @**F3L.I#)L5VZV9S;1F<[GI[V
M4MV_TF<>/4A0;*!83B 56N3ICA$F*&[36D(H3FB\3F7,:KB.IG_6OY+&$W([
MDUYMD U;V5O<^%>-57&'C#(ELR@PTS28/P%ZNZ__U4_9#Y#RTW2E.>[;:7DA
M0J>I)O"$)U\0\*HJMH>U8<KDWY*<HF\"_2;GK(>@J^&[B M[IN/B1U>:J3:F
M_Z"L_U17,8W:?P(X!2I _U4U[2%W6D:@X]AKK,MR'9/#I7U0(4=.C*/VP7_5
M.64WOD\ 6KV.HXV.2^(JG?^@+.J-"3U"B:V6##C29Y)BS,QE*T#D2.(_O9XO
M>]QJ1$D6Z4YQ-N=HJCJ)V6(U'HVBL]<OV3(UBD6K)^SC7D1471O_1/-1C/6I
M9I@3F66,3V_C69Y^;7H<?J!6'[76)S]*.8&NGJ8RH_'JL[HL+T#]?_S0\!\%
MO+NC0;*+"8&'&[<U&M:-=#9\_;CE[O&'H%'C'_YY<9^[ HY>E=7=DF8[WGM1
MABG/5(/!=YN]!2):OMGJ%U[[<4(TX%IFQ-<5%>=7T*F[-8C:M@T_@?%=-.UX
M37??B_\6?P($G[KV6AJO^/'.KI5/<L*WP1-$M6@?Z2_SVBC603U-[71>YV-+
M?]C!&-XPSHSG4:];SKH OO$FV=/%+'5J,7\?%]M\O&P_5VLM<ND$ H\#OXO3
MB!/=N.;8?,=U)"ZKRSVL6./"VE<!O3A4G&%GY\J>@1_5'Y0Y19$,Z:(T>K63
MW]4?J7KSKXTN[[:S>#&N;8*"H-'H;KC7KQ+1F"@8U7\M@4[0;BP[N'8:&J?<
M,8*0U]I3]MLN":R!/ZIGJS_H=)G4Q_8L=> ^*,Q6I0HLV":*/;QQOG T&P-A
MT@?(MC%7%4XF[U\[?F]G>?L$"-VB=D"&:^:**=EQ0^=Y;W;;P8^9#Y+V[D33
MJTK>=@?_S!\#O>=?[4]34IU;T$K%$_%+#$N?/VEN9 J2[6- I:9WR)^8I<VL
M->\3Y!K1E7QC5?DY78WR85D[3&C%JVS&X%"COX+<T^*#-XLW32[QV&-24W?V
M%Y^( X2?]\:-'TUQH+5AF:U<$7<>OZ6%U/D>QC059-Q]_,>X.Y<R-P&S0=!Y
ME6'BOG"@L'G:J,-14^0WC9G+@:8JL :\PJ['6PK!_02HZ\XN/5$V>7Z3:!C/
MF(P>[.!WE KHO#8\IE'2,<U[X)BJ7R"!S-DKN*/(9=[1G%+_0Y@@!<#Y"4(9
M;-C(?^=&J H,'!8Q'Z+>1CXHN_EP=MZW*=K=(>[U,;>7##8*'@RW,2XQV]SU
M!<&Z6UK11*;J,@#J((VWCMU!0BLO-SR_BPIX4JTDQ^*TQCYWX'BI=-AS$WHN
MF>V.7M>J?NK:C7K?F+RIR\'FP)@REJ#X,O2'"#A!X^?0H<IR D\6%,[;,Y=O
MLX\Q#%5=".GT/"(+G;M6M7@"Z"*OI:/:6UH[_X'$H*U*=V.R&]4- BQ#*=?"
M?8])H]Y&Q517MO)C\O"N._!4,W_:+W->-.?BZY*161U_QHTC"1*E@;G$,7&H
MB=-5_KL@Q@O52L;#B(QZ-.[:JU*M.C7: ^W7UJ_?G=NZ%\E S00O)(: ^IDD
M:9$(;6#4-+WN7$5_??R -G& H=H'K5)B&RU;+6/F'[8#JB]5*#4:: H_4$2X
MY(IYE1([3V@$3U&%EMUIS/HS_\FJ/REDC2+VF Z^SI46_A4<P:R=^FXZ.<Y5
MY2!""=Q46(!!! 42X7Z>E%;[_E]$_7^S]8R\WK'_@7Q_?W;]$&V"/.RX>YVO
M?)^/:GH"?.=RY^_X'T3[TA,@V0397\OWSV>OAA^LR:&G:T6Y3P"[)P#2%G:F
MIY3]TL\L5VO8&A[$Z@9J#,#3O'&<5OM?O'UE4%Q-M^X02$A"@$ "9' +! _N
M#"3!'8)K@."#N\S@[@27P0D>W"78X"YA<'<97 :X>;\ZM\ZYYWQ5]\^M^ZNK
M5O7JZMU[[U[/TTOZ$5 'O>/6OJYX!-#6]](8_V5Z^%:CL2)_ >XU^07SSZ/H
MD>.J$D4\ 4?Z!'!ZMV.4R,[5OG*7><S<[N"67H>VWKQFG Z9V.56+7T4B>#-
M]^$IJ<1Y;R5<9,X+K_Z:#K;+N"@9F10+"4S^0W]-A\RD&O;YH=09]:B'U]K;
MYG>?D' 2^_V)#&8B_$> .3179]%F_MWS5:U?DDNT]TSZ2S/2X$--<6.G@FV(
M&R7:\OU>U%XO76V;RZ16^ C:G:!#QVM93V+=[,.T,3]9YZ@]]Z<!?48U?RI>
MO+?W<_'=X[!PNEX+6I<-/R3ZQ=%]A)<4/+"1*))+X+)_<")=_#'QZ$\.W25"
M"Y.4@.QV.EFWRPFT9E3ZM-RK\<>KO\OBW=Y91@.43[ V232='+!4KWYA8LK"
M^"T/N/'A$EA$5]O06)5,)C!RD=<,>)[.JN3D(I+[I!0!9YZT,)5RNDM>?]6=
MA9;48$)>JTW&^CY83NM<,H!E-1ENR_J)1WI)T4ZQ3"U*@[>2//^M/;Q4^C[#
M#8V]EWPQU-V^]RMY\L./N[1P3\_(ST17/(>V-I7?9QD;*9C,&K=AG5EQGLYA
M1O6\,SEZHMELHT,"ZQ%/CQ6:6M-,<XRFO@T*9&FMH[T]X8%IQTN5Q!TEV44)
M#NHD10TUTPX.XHL@SX'P;;75VN^>;.>"ZEAXUMU_7L)A2>2%MU\GJ^40:3VV
M9BX8+\-"KEV FYJ7F)G"1=\G/[4,T\'XOE8S;(FQ63OD+B-S9GFW-ID0%KO4
MN\A($4^[D<F$R"L,RE<V=.'\5&I5FK:LE'=JDQ^U-+; C0/G*V:IDY.Y?HN'
MCP!O=]PD$Q/VOA=_F7/MP]C?A^3?<IG(U3/E_W9*;K#<B2[3^MF,U)!"?]HK
M2*5\8,:5Q=FRH;VR62=ME,6K^R6 ["O.=A2GJI[%&6ZM-%FZ/(T<#?G7,%F7
MC<L#>\6)@R.@TW>>V^\#WQ?S?7O?XJ#)W;O_/#C0EO5FIS]!Q0C5ESFL ?NE
M^AYX:/QG"^LG*A*X31V+)R+*D^<O/-TNZ%/A2B9A7&&\]?QLS7ZJ.^YT^6 5
M,M"=O$2NJR'SX7JXTR\BI>$.FG+-U\_L(S(OM$Q]P0DMA]H35F72=G\QM-.&
M,RG](T _%VRQ';8]."LQ5TOUUFAM_H@QSN4#',(O9.C";1^F3:60MUV:4G!U
M"N?NS%"82YP9_\PR$?@'3L&9V;%A?ZPNQW'31SBID''(#(P=KZN[?,#K0Q3.
M+I^--C3 E.JG,,"Y"R]L5&BU)!8 8HSP9COV\\L"RQD65YQ?"L$82TZ57<GO
M$1,YZ8F.Z1&&AFKIE\TD+&N:P]^;9<V))Q;3N50WT>O$7K:UQ#?<J8)K(]O-
M0DVGJ#4-W?M-GSITWZ]/U6?M:FF<N7/J^=IR/2^M+#*EY>L 1!<P(+SB^FF/
MZ$WX-*>E,%ZN%VDK)\2><]F]+13[ZIE:B<C?TQJFR[O"KAZ>__@^F9>J":F'
MDZ@J;RO"D!UL8CUOLF[_&\[_#K7/.>*JU=<0*&?YD[?@H[?T,,=-H7GMNSFN
M_3X"XX#/M/,04]#'^$R1S.E( =VS+5,U>\A(?/X;ST-5O32>)(7Z-&M;7MBK
M#H_8^DS'T[-TSVES.2OL+ %PMV!"><;4,1QCY39^]U@+$1CQ$U$"[12:D*A#
M:G_>6#BPB(F- 37E4NB^]+L:_"501'C;TZ)>5ZDM 9ZWL^LV&\!L-UK:F,TW
MWEY(J;2U!]O,V)#O_=D\PDT.8/PYNG1^UPKJ+847E\;K )WY6-]3E4/=<2:K
M^50/A,\R:P-=BS\;WV<%JS?Y@HW"QH!&2^CXSS2:&WN%JV7=?PKU%X5<A-/0
M4I,(+8@'2@H[V+F^&<&4B[+H77SAX+"P&'5^7,MR#W.D(U\ISF@$WDB-BL#8
MR6N6!;?J7*IPPLH<[XJNSE""[C<-Z/-+OYP51<2G@2SGH2E?>"JY(G_!D@DU
M1!9_N*(LDL:C:PVXM*412VHU#N*.?GW/Z4&+Z&0"TU(TC1 ]GE7C,_R1373,
M%%Z^S>HK2"MHQ*)@M>P09[\Q)\&X'T=D]]MN9BY-JU+3%$%>XPOR8M_"J&%B
MFO0/&U6/ &?O^^'WO56S;X9?[A&%7X97@HE2GC-FH['59Z*-,GLWE"M\38L3
M!H$9Q%43^SK;3 )%X[[;?OC@SEZ#+TGJ.2N>K2>6KY,4.YOID@BW'$A3CU9C
M;$>XG+),3[H+@G]A2+44;Y"G>\$;5\8+[X. *[1_#+A&CK<HXBE)D?W840*S
M21HX^4P+MQ[ ]-8DYL2N"[#Y<LWXNWKWB,KN$CJ>QA'-.S0EJ(6>UAY129V.
M.] HC%<#@V E+BL*1Y)^J?J8FRAU;V9G7AN3<0*:*WVZ#D"/./66)Q*H6ECJ
M*&WXP:K5;/0K/8-H(';Y4[I][);UH1.9C-7=SB'=5$&]9Q%?HO7K'&XS&^F.
MQ0BS"IFJIGH$/NB\63+H5)G][@N56"1_K_T4&BP96=?PVVV4.N0H@D\"TT8@
MUL?]O"18P]?IAE(VS>(X)Y*2Q17X4O944L$!;<5#PYDXS(*<51"+\<VL3;":
M+?5BGH-P$(Q3FDEOD$N5X+W&O>;=,H^[$%*+N"*$+4G%=V'4V$YSP8B!EVHC
M@IV4'&7<4#KW1ZX^I&Z&%Z-8DUJ<7X)L47KTW8@HZ9GROOJAVV3A'"O5J[6W
M*>^?AKTBF]O#1+_(5Q?:E_@6!*O.0#3.6SS0W[T,3TMYPH&ZFX,H7\!OMBIM
MG/==XXA2P1SN8'@RB6WBDB/IAEGAN\/4LTB-;HTSSHYZ_%YRQ::O)\_<+BGN
M+2=/VMB /1L#AB1Y+LXKAAJT.H7DJCMF/LX@C\4X83TAL$,J\R7=X)6,BFZW
MAE,<AX^HL-TS@5ND^$S^6WZ+S+TO4@%XN1\_Y*7'818]), _>PV$Q.CD=\N?
MA7Y&1N6^V_^TZ^HHJ/ ]Q:C?H>T;C>OZH9;X4?#S@J.Y9M8*X2N4S &&N<G]
MG 5-/T)R^-IP5@<']G(G9^;V0]FBH4G$7'<L$$>@3N#>8S;%.PLQ;*-]]/V.
M&D-<\\8('B6Z@42=Z3P"$,0SV=Q#+F<Z,JMJ;W5+WL1?A;]VD,!]5[RY97G0
ME,#_QE[C^VQE0^OIT$0_510[J>60CB5.F'")9^>MSM*>B\LC8!<O\!M7;(O,
M^*^=M[ BS#VFS%C(M#/=#CCOC%93+&RGY'DPLU3?J'"@AV*7#I1U8%\M\06E
M7ND@:02M4<FDN3X_Z3KW^$OV@J-H_#I&Y[7<]SG<0LK.+T=8<JVD\1?M-X9D
M*KU./YO@B#TI./&0YNYVN3-1I[<=/6/3C</-YNZWU&X>=AM@G='"V?JX]+NV
M5Q'P<=W/P^S:0R/+2]A/4-.T)>&3V$N3F!M13(-]/3U<_NKH^_P6$Q.8]$E^
M7II1O9B]4VXS7@"%#^TCH",XWYV+1(V0&]WH#*9M%EI;B*0/K977UCB3.^.D
M<1#1#_>!SCW)J5;>)(/'S[1J*VWZ28ZJ%QTR\EA(%DF:.<'84@'[\]PL4;7O
M6T[QSH"XKQ1ENMSKY437,K:\.K9CY<L+:N8:W3U&W=M=/\LL,8;+QM$W9!@!
M1X=[14LUFM14S[P6>]TK/B*Q-X\O2V/U^FB_QQP *9S2?6$%?.7:5=*:MW+U
MF,Q?KZJT8=_,-=@7WMGX!N8FO9Q@'XB->GZQQ]0X88,9[W?(U(5B]WEAD.\&
M[70_,CEYG\Y+V[I'I%(Q,GWV0A2ZPM?CD11T\8(@RX+TEW4NF-13(_2DF4),
M)>.X:(F+JMYHF4K4A'G!47576=SR@#H(X_F<ZMC*_<%#K0)"C,OR"ZNH47KF
M4KN,U-',S*J_1+;(;C^&\5)-5"3GX \=!7KE-P0#?3-[Z!SE2Q#5*RAQF6N)
MI"4OR?3GV7LM/D:)1\"0^JM,:CD,K3+_.E5S?L'@^EK5EBERJ>YX@^Y?)4RH
M6#/_WZAAYUX-OO?B<,>2J#UN?MX*NH7MP6C* \%1&VEU"OV<L@]8'9F[ ;:C
M QSS4E"%9$%O>*LC,4^3?%-I4V$F\G59B,M&-N,*\JAV8GY!XMJTZ4>),8"A
MHXO 9BD/HE46ST>/_SW0R 6TJ_K4&AL^=GFQ^@AXW3:5*76#.V?R_IVQ4_"U
MCCE]IAO_=H4'N%G<D;@PPYYRA*0.HA) "H'J$CNW-IR*SCO\CK&G,2XV/MF]
M29WC3.DV0K@S\FA]*@_+LHVG?[YMNR,]VL:(5>).4^\D=7[=V^^#SRJZS12[
MNS"=;5KOOFPR;[+8((@,$LOD/,#<E[L3E/HLG%_%^7%QB^>X)=EF(1.PWU?V
MAL-\)'%-//F?@Z'IU[H2R\UR<:7)@/0+^NSS4G<V0CYC+>Y&S7"KP$7L.F#*
MNR<=4'=1&K)]TQ59LO:TID[:%X2T+V6"U+O,QM F)U/]UEPMXM!+X&^ 6Q',
M=A%Q$IOZT! <[_VO0\3LIBDF49L],V4\FW4)7V1KUH7P8J.@(:K$XR)_(IBY
M&6!WGQ279*G0.%*69]_S=5QQ"_>LR9M+3QW3@XPD%VUQ%GP6&MZMAJZ3_^@O
MFR[/?\IMZMP6V:L9</,#1] :R%\6&\[ &E]'8OX(J.RLC^4";X^F/W'7%SC:
MA\E$KD*K^T0&\Q )OR(84GXKB?&I@Q8H9DHE\R6TAQ5B.3'B=@FV85LO'?LO
M7O&1)Z!K-M2J"=C K$'5+:WUG+:_5:]>["BYBERX<IJ#+TZ"#^.@YKMU=_I$
M"Y5'E*3D$N[TUQ:FTW5]F[40B:S*@*AEEV=\X86S+(<S<:>[V7J?/COFSE/#
M,4JHX0U7M/4_US=[B(BSM$QP2V\\;:E$8^>W27RZS:+7'B[4QGE(2'.LPO5F
M!7Y$7S;Z/A$NB0&%TQP!W.#:968O^^H 6GL1O0P/%GF(K_&P=+,X14691,'
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M?\QX7[Q#BES(.D8)"WQW0C>XA"(+*M<JPF&$8+9:X!&X!BPWK]UQFBB54-B
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M\,YYYA I4@EFV2K&XXTX%6#</H*/N!WP%^X2GLS#L[/]M6J@'!9"C139P$>
M%ER!KX>0%VDS\<JC]@#,N2!;Y1;.&3CRF135;'\[2;>FO8<TH.82F(\5*9@7
M&H3P5-!1'?J)6&8$G I7R;H6##/7;XE6]18O*5%TL@]&&T!:I@04LF9=!+2(
MNWD_220Z,OVNZ<NJ$Z7HJH=!$_/JXJ0I9#R#)LQ2#%,EW)*?D;DD_S[LZ+_D
M9G(8L-=96)8N3/HUR9J;I.)^!:=_'L(7ZWZ35G0<84;PM#4$V_34O%HGU-:T
MV2[IZ0R/:E?EJ& SVTQY5T%DDU-T3K=7N,5F>#_L"8_U)I'%MMWQO)!3Z3Q8
M@$G0ZJV ?AF8K#R%Z_<W[VMFQ:/;;[ M6J?]0S46M7#_38M4Z@.NN@IFC<3Y
M\)$OEE*=12 >0?O)D](2/9V#7W_8+C<'G]8F(A_&K66ETE>3HT0Q,]K^G!>)
M_*E3WU3(+IXO:TO49.FT>4X6! P&VDFA(CGVU32_-:O/3'NEO5,.N-P.LOMX
M^'L_,Z/]Y5:$.XUQ@3.9EB.'IV=?5#C@#ER[5$CZ3+%&P!W*]":HE^,9.[S6
M6)JDMY*F-CV<[)?>>)9*Q[T NH:S3C1[+8@53+7$9UPOWJ#TD00CV%:A@4S
M7GE9<VOMAGBB4QSW:57(9I=Q$2:MX?H[@E%&6SU%]4#-@O)RHWUM+W4!U]28
M<G5A?V-CH^W"?<U4X:FXH6V6CI>?[7UUR&G"5,JP<%F%KW5Y' "E(8>)R_0@
MIJC%_?ZBDJF[" K&P EN3EX$L5J,-7IF;PW777@T5Q*3T'?_)WTOWNT^>.\_
M6_]*%%-JUZT\C[7#5YXDYR;'A"]54;VY7F8\RFBUR%LBD6#E6)*&;90&W@X;
M 8HZ"F6\+3$.NA)R+>U_<Q#;>;([J_1\)<Z%,.YH*,+E\(H/>%Z&M;]J6U"5
M<\3<[)(9O'^HB;>[TF5?UWN!SDPX,'-:39:U33.&PYF^C2R_)7BO(H(\_7,@
M9/Y5@80]=@>ITV?#^CW%,(KRZ/WG=GH ^I[[]J[VF#1V!%$,8M0F,, NL$$U
M<DA2US]] _*UOP(W0[AJCZCNV=JY1) ;&D:!0[$"1#5A>_=8!>Z.,6H57J)7
MM<"5G")R(I8XOR-)>EGFKC:4'U:DPN,PUI!ZNGLF2VJ/Z,<?^"7QJX^C842,
M#.W=KI*!I8;J,)54.<O$FBV+NJ!_I(_W>E0*W%:[K[[^C,K/29YG30NCNO]2
MZR.PRC[BK'\E?O)9?A!?38-ANL5$7LR\4+M9??(O4^.!]<:^B])\,M1(&+?+
MU-))>9JC.T%WM="<EESXMLA:"X!]AV_W6%O;II4N"<C@;9-M:)%G%:+Y)C9@
MY#EZNH9PX761=6XB=]0NX N)&H?#\N=Y4+XL6PC!5@:T-AY_@?9E%2(1W79)
M&<Y_45RH,+M%3I=K\2%#B%??I HS6J&Y,8H@ ')F[%[EK'H_)FG3RO1GI3I<
M_L2[]<?'D4&:XH1Z$ ?U68R"-WNTQ\DAH>(AMOZ<K$5\J*W0EB".7=;3WZ/,
M[$NMN=W*[0G&N)=>5](80OU6/+.1H<"5BW>8\0_<5:YF21\:RA0<]DX&W201
M"Z5F(GKG7N6"9O?K>K!09^-5MH!Z#CJJS#6V]T*E]]M\?:@7W#W:30NZ6E]L
M"K#LJ6VB]CX.]_<_*X.,I<;!"]V@TI*4-='LRAU47S\\ L8> 3(33*G2I!?"
M" >SI#\(KJ&WN#$.BODL4YW,E'RC^59S/RO'M49O9\C3PS9833EUWV2R^^H/
M*:97YI(&V_>/:F^A]-:VQU'-GN"@/?'1$<Y:#_1HW4< XT(]O<U3=W@XETY\
MJ?XH#2K?7V)XT8Z/0L$JL67!./N\D9PXDP;/LIF&=;];XRI\<V%1FDM/2_&S
M?NB*,*O@'^S#";C3AE_$"@_?!4A9W\RL0-;>\Q7MP5D4.J^8_GR614F>!<],
M,63M5'HC\Z)'WE%8L6Z842(0HVAG;LF-3870586)(LF/:$&C='=V26;PR3 Q
M.2T6!8O_OC[9ZLUZ]%>?ODVE]#?7&B6[ @$NCCH-<1^N_"*WOJ>?V&'NZDZO
M#]+T=8IXN!RX5NLQS8V4;+,[]749PVP_:]7',2/[>H=E^WQ#$YK]>\6_\[0#
MJZ.]N[A\+Q,C[7!G)T_*.7O;!.O&#KX :I)4;?#\/'!5-76/<@,S/,(RN$N$
MGR'V7*?(WQGZ\80F2I-4KMAG;J?N'!%*'79_LOHP79^-\XSCV5?CF]D?7FRP
M.\7#P!S>V6>+)@ZZ_A&H8L756^*+M)_+UH[O\TM>[PR]I]G$#*+T6 =I'Q4T
M9;I\%U\M;N+]4[]ZUY.Z&W_W":'&"E3GZF?L[_4>9 #!\IT> 39A:Y0JCX 7
ME%0N=)!3$T@6;*+A$?!*GJ4M&__II+&(=A%6UP<M=GA5$"CTJKQ\2>M/D[1P
M$P&((<+F'7;T)KRR+#HSUD"R+F[I=$V].5,SKXL2Z]Q&N!(V-+-J^!<0<G>G
M>=CO+%<LP5>_IC[PS6^WZP-6-?;:1RD29"\#XPCH]DP%(><6447IYY?TR)ZO
M6AD2&T=P[J;>W1!66LH53A'(?J8BZ/#-^5N6]A_!@U7BB+=LR8^ 10?,"B,I
M5%%5,4=?]Q*[X?HFK;.:C;" H6<< VVD"?[3JKC/=T/N<88.Z,850)H3[K(1
M?96$M6';5Y62]S";?#I$%<6/C_PJD@4X.OMJ!6WFV^IZ,A-\VFL<RAKVWTUZ
M.?>&_7#K& MJM^%%@+K$2DG:9,$TE\,!M#X42":A, [+U PF%Q"2[5C+"Z:,
M68*QB;8%<^?I]14I)M O%+T?LW(.D]<WA5*O<F*WOX\-TGSEK)]YH2^M(I&!
M&E9?!YFFJ*E:KH,ZA4>9F22L5B]W<AZF-6</\<4W2]$3&1H8A$-6[K:JS!JT
M2BLO%U4V2,CFL\*M>&9^?^L@^0NA8GNHQA"^]L"'P3;F^JHUV5"[9YNT[?I*
MY^CGQ11SUHDGV>,LV= J>:SW0ZLGG)UW07ON:^7#SRU,C<%% YU'P*!=*=T$
M=!KZ0*!@L(P?&?O,&MI]V,\2H76O)"!CZ8LE8<=TXUH+AY>G^'6G&^:782QX
MO2LD-KBJ>_Z5!4N6OD\7"C7J R0N3]D2GJ&8C($7BWVCWV0O7:/>!<\Y-1M9
M+Y&R+SGPO\1U.K)DJ(B.YQ?(2&B_I1[07B+[+1,'_/WP?@< ?ZL;2Z)R?X8Y
M54$'K?<A?,>SPL,.7$_8'Z;E2UR;N]R;$-"5!S++5%"FUTD-&-J'@4=RZ&1]
MFGZLKKX>#??T0I5- DG]ER?BY/TL0!OLS)7ZDA]>=-Q4^@BKEGMSBG=[@G_.
M@U_W?O1Q<$0TX/ZGXUW?'_?VGZ^'#)*PO8P/W> M> 3,TCV8MIQ[M+YL8D-5
M/@)\H=K[Y\O-%.OW5C'_/9U;/I1X_)Q"^U>MOHC_OCIAWC^<^G]<C8E<%%FX
M_Y71?CJA\+#5U$K'4<SW #HI#6=28N7\=7]U<<$];E'Y37) <O3A+5JE>0NT
MHT2,,;_)1\"U)%P4]__E1:4_3?03N-D3?3AMJ!;KRXSTM([FNUS+4Z5NG8LY
MM8/@2UDX-FM72H%/)!T%&#.R6/G0ZV6&&J9K$T;F][-'LQX!+_=,*[$S*<I4
MTF2Q,VGW'SR5,!EO9YKC(S^=_7.)Z\MOL]S'M\^7'CX_ D++8VOL=^EO4 SM
M?]8G# 8? 66BI-N76ZV/ #&2Y3XHD@MJ8[5\CM>*"GX$O-$CNOQPGG3Z"-A7
M@1I''PW>0"]^HF<^+,RV[]!XWN ^T$4?#GL^^/&VQSP"UJRR'^ 4B__JK7P?
M!6IFVWP$S&3A>-XYZC\"LB*/-T#7J:#Z_S*3X#M2J,N_IB!YR?=PT)[T"-#V
MX2^8Y3Z"KAG_:_AB/:O4RYF_?2.W;;K^4:F2)S5$53T8W%OF.^=&EIT.SM?_
MH\2'K:$[Z_)WI#=8(\N=;<L'TP9/]XE;X='G(=NM#7%TC:(# Q\A+1KR);LT
MUNW,&<W>PB6\G1YVP7!M'2/%Q%5<T$,QX);XO^3?OTPM2/A>KCEL_'-N?H]0
M%4!;UQ1J$MG!CY;@BQF#*Y)P5M^#^X=M=3::4.L\>?.D["[]N(;<&B.QGXY.
M),"'X <.7T7^ARS<@>6PY1-%6(@^ME5:)-VPD%I!UL+[287O\\WFJFA=B3M2
MHAUF%<_:#&>%WGCF+LJ"/<U8:KN_P*FE\K4T25^+;;QVZX%<SS*L1P>*O+Z.
MMQEW2^MJ@I3+&5%QG?AR4()_JRL'*\=!=LD4B_*_P?RN!/A?_7F5R[\-._O[
MNQ1S:LJ3XV(*X5A=A,.73^27GUD-,S^0S%34 #,R4.$_='Y*0/;8%K^C%V@V
MPO?/1L,? 2MI('RNLLB"\J0*3'HF,[?768?-(WC1@\(,FJQ>8F]Y66CR6["9
MA]_D639LAL6T+5HUM_R:J5GV\Y"/+,L8-%A<PDPEB&AD[];!B!958>MMC>\"
M5;5'HNC7"AIG460E.IJ:>9&TA\8T70T,Z/@ C2),%WNX]KG\9_&QQ$%QZN'$
MM^(<J)3?-GH* H9L_!=/JM*JQ;M/V\-G8P;7*_SU<7WSFVNJ&[\TJ6/BOG#+
M[A=IB-*]MRJ8:E%?HKFOY9(Z7#6VS=D5-(T-[97CE,&==.[^O/?45GSU3TN?
M,R;CE85-H_EB\$@7UNEVT-(*16&M-$7PLAP2?Q^K;F]U &'$VVM$#T&C$;1_
M1YINQX35[!6)K\$!P;Z.,\"'S$#?<B<$YE97!]]]K+3A9>IZ3G._:KU]4OP(
MJ$J*HNB_[EH?_ EDMCG>:'G.#Z)'T#M3B%%#G"=V!&C;B*>X2?;-C>\@/WLM
M\D()A2<H;3-.T&Q3#>T4'66SW#S87KG)JHZ#G?JT)Y7.R,V-Q*6F393QF ';
M ;;E[-++:C8]3.3@DZ3N^&O%2UKDQ?DX1_A\>(C1 ON/5#Z6*UQ#O7;&6B2Z
M?O,)](!M51;X['*Z@@I'T8!E.^Y0<2ID]JS\\JR+B:(K1(B<ZR>HRF1+:MH>
MWV]+B7U/6AUEJ4CJQNP&ZTS%]3NJ:8 I3L:]C90VQ A]'?DDQ@,PQ+!LD%QF
MXO (J#FS5/("73.LO$;7TY-_VFQRGOC!V >WP(:XR2 \:7)_N8Z^BPR[0-G,
MUO@^*_O'FU9]=Q+@+JRZ .)7B_J6QQ;=XKT:7I*&1G])MHQ@^>["*(9/4_F.
MCP:/BD(F2IAG4O.Z(5.@L=ZL<1),&[3H*SC^I(G#N%"+%A1:U%S?!P8:H'%;
M11,\3,.(G.O1C'ZY3+Z[75T/%8&QY'X%58Z&242?V*YA1K'JE9<;-S8V9^3Q
MLVWJA(Z*'#+-1/LY)0N1X$9=!-9;81WC#[V*_S2RO(MCR@\4^E8P2EYK_'N)
M8**- H4W[<7['9U+8*Q!H]Z"!,;^105,'WOZ"KFK\'?SBAB=,U.>$F*XH[KN
MT@M]&'8PFJK%DO;=9I\/P'X$>'=#&4>OC<M@SQY^BU#-F+AFZDF,(#\.0=1C
M'WH;SH& ![JFGUZ\5MF08?AO96GN5#UQV@_A=.]-XEQB.T0"9<W^I%:L09_.
MZ4!&/,Q\RI84*Q>8/QFDN_MZ=8E(4BR_%'#B,C!()L6-%!)S7UG^ ^ITJ>HF
MJ/7<49YMB#QZWZQ.OB$!NYJVA<Q,2F=YX5Y_6TE8%"GC7JQA_/F";4,[&?8(
M($\ "4Q>%Y[,S/9D/K^&KE@<;47-RDGA?XT27VRDUC0VO?$ F!QPIBY=EV4_
M CKMD4P=#J5QU.8:6$X%O  1D\A%34-DW=-CE$1<XNB4"^<CP(+,0W YZA'P
MU(E/5MK1UOMR=UTNXLOL:T;>2781[T#-ZZ+BP5+(GV4L)_X\C<E#I_[CQ(]=
M3.QO>!37,0QB"ZWT@>'=RS6)_FMUIG_W=;(TG0\8;TW8^USQ_@2G_Q.JE#6!
M8C(K@TRF!D=];TZ5J*ZR\C1?\(I-4 L-N_.:^-M#*]^3+48S_O-T=$B[#0QO
M?I$'F;6C?!^?^99#5 IU9(*Z+_J+EFM[D6:'GDA)E5I3L*"<+]?V*\C!M1]G
ME&>:.JJX_O?QBWE-E#%R._K]E&DS3%60^DP4C<H""X#CCF8<@?M-X?K%ZM6)
M0CV2IN?J"DA\O](6QZU/0SE,\V%C^]X.?5=^$!JC8S1[,%TL5NYE>3WLT3>A
MIVUY;'49+/QU01=0,L(3&,8ZMS\;%GXIB'SBUMS=3B"D"+"W*-K765O( O .
MTW&FQV%T_3Q'T=RGGJ.=-'=D?FAK: #+*C>UI9[JA+XQ'@SY47S!?Q-^]C#^
M$VKV",!:\GI_3;,FZ&:;4%&8>72*6%WOG65GI)-P[RHLP]%!^5?*7CHB ]97
M1WO^J>"##"]I;MZ_$!?TX[)O67EM/UY 0^J]_#D5^OM>9O:O0?WU" CA3C$]
MC7Q(*>H;@C]HPS@6,=>4,=<U,XFNO>U7VN<<#4ZFB)NQ%CW65.A/1^PV\<6Q
M,H/XTC,]WFB+?#C1L:"H$H&MR$I[S1U3^6K;V)5^)U+PMH_YZBTN6#(_)+,C
MJ^=QU@7Z]0KA1UC?F/CG;*S&<?D0=#7EX'Q5'MVC[>]&?PD\*\T[U0:3#T=3
MVCLR2XB-UHR B+=%>-QL51KOT[P85CQU^EC8NM65]21N7M#:=?)&/8/./!]5
MZ*P#68QB#9=Z$8RCJ+(7>BQ(75V0-QR5:(>KH;\* =NO:$ ^>7EI^M9&*)FI
M,I3@W?,_"=]L9HG5?_05BR[2#&)$83Z(0-&_0D3<<@Q>0'I%7M?(94\93ASD
M+;1$B-*A7IB+HBS::S']Y[6O)5<5T7?Q ^Z$I^A @K3OL@)S7]KATO;!8LMP
M$;F=5U \+M#3:X7N^7F$2'$2?M^&_SOQTZD/Z!.FJ$"\N#'N*=M#G6(]E/!]
M4@M+'FVS[J+%K?6=J&" 7;/](^!)H.*J_'T5&^5)Q6\0NILEPN \OFA^OC,#
MP7>8%Q%[SD:QK7#_LX7)&<FF>NV:+>F(;Q%:Y'Z%Y(SID94(&_@HX5+3,%JA
M7[.,>--U!1&YKCW)Q'**+*O1.:[7>R'='3+1+07 D7K-X[C'(%Z&MJQR=>A<
M*LT;+H+C9BVELJPY@^"/%:4*NGYSKF5P5O PUD8=KWZ?TX9]K3[.R=VRC'"H
M1"?72GGW\&EZ=/TKY*.;F1+RZA!X,J/6Y.L$Q?7UZ&^X\?/N_<0>81B2<RR[
MQO+DKAM6QQN$DB7N;8($YG/G-4</]>0F'Z$7<-J57"L[7^.J*O:(?(A6OV\0
MHL^?CV>8='*Y4]++DNAE2@2N"X7&GY'7FCW@/T-*'C:S^*QZ\>8RV*0'1;SV
M]EB,O5;']3T7+($AKGJ7V 1)Y)/D=3Z$@@3Z_! \ZV/),-*I]A=>@L7R=S)>
M4LB"O).03>5"'6;Z8PG:EWEW@?6*0^-.;:N6-M>VW2I[!G6%$=8F,4*$Q,P0
M%:C3CQHAZ'(O:M@217:=XFE_I^HEF3G@;B U.8&E57:UQAO#*.$@&&.4A%FG
M6&8/0D?Q>U+ ;4/;.*9,\,-W6]* "57D"P/7J,0/P:M:RQBK4T[8GFM7X4O=
MXC@E3K9@RK//G 1G&XR*1G+^47.YJ;/U,1ZP7 1KI57%+H]'1D2.)U.?RAI0
ME,;AXZM"S-@82>VV*L/9 >B)XN"AJ_RUU!()DF!0T=[,F;E.$ :9-Y+LAXG>
M1:-PR4KVPH[#530D2,RUK#FF^9,L2O#Z_TS2ZY;Q4)<XJFU%")F0)PB2OOR6
MAYGNMO[Y+-M5O M'K,<-%,Z25QMKNSHP^ 9R@KMMH+I/:+2VZ+L?=F) ;O%I
M8D]T\*X(39U@6%U8GG+$?]4@,DFI]HO93;#VI8Z@+_43_K4VYI.19OH +[5+
M%R,JT[[S'F_5E7MG9RR^/SP.C$4R>T.,$HC<.NS,\[8$?7X1?6SYIB:Y8!4E
M317"\ZT8N(J*31[;KDR'0#PHM* :\C5B6I3UL.MM(WDMN7E?%N;115[![7B3
M+Y9T?TY<#%8J/XJ!%\)E<Y'U),J"5\7LK "]6E+&QCR+F=4JZ^08Y3'XKY")
M4=,F7&S8N19T^<'/AQ/R09:9 O=BCLHE2JW.J+15;*W->L+YT*X8VMVY?Z_Y
M0'#Y"#!M2[J.I4A;D0?S;\T%$ZP0L_YX">^&[07;%M8^X2IU'G8U[,UVO<(\
MJ:B_XS9=UYWUJAO)=A^#/O]'MZ;FGA9,P0RS<[GU5&O.H+^2<^F_DORK"; 3
MJ&LN1V-#R;$V0U_>0:OUNTZ(CX[..HFBW;GB!]C2G\4 [#?A<(#G;-K>K=(\
M0_>_V,@4Y.7\/:RS7O8,]WP6Q'L7.X8)+H+"(]H5]S5)9Q[R_]IPCGM0F>/!
MIR+:%1SIXD]&9Y+<6Q">^QPA@A7/Z&I%R&W^,E)GU[*:X+9N)>O.9K1690Q"
M[=:UQMT=GN>F[8TIVE#WXW.II4()SV7$C0JS-WNS!<C-N-5.R!D'^AWH*%LU
M>URWS#D3I1IQ::!9A"/EFM0$R[^ TH[*3E\,"W9=YFQ_G6)QFC>:%]KO3Z1=
MW&T, >[KLF8C[SI?7_LKC'/=7<S85IB^#JJDEC*B]0%ND!K#5D<];J([!.0,
MWD H+5V6\;S$75]Y.+?$R[(,CXFUTGYA:+Q6/B,''.JWYGH97<N>M"&=1K%V
MZXD<Y-3Y60]8KH[XX<.T$< F6-/S"OQ,L- G-39BN];6;7=!=PH-G6"&E?F<
M7($+,-1>^^6^;/_2_:6&L'&7JPC+%'?H]O3A@=,]*R<M@Q6>:6P?4R@OWB25
MSV[,7,>Z,)A=5RJL*^%;K.P\P05>-&/MD1>V])VT'FWKDS#!K2C+(?]_ E/X
ML]#_;XW<F@]1*K("4;+F!<.%O!LV+C#@+@SU$GT$&%9ZNO,,8^B2I 72),P!
M$:1.<9J-_00'$F)C#E:K;(CF7F)H..3C0IF_-.4X2U L4QT/5S]M-(.BH2[5
M!;OGR],S9HWICQ.IR]_W1O-7#VI-4P(^C*YJMXL_>))_)K5X945J7MGKPY@3
M < $H(G9(W+8CA5K \N/C -%SNJ83A?UM\\[)[^8NG5]C9>>*%U]()DCEGY+
M[D+W!'FD^1<\<0\,TJT %;Z>\^<A$W\U'8>8)>)#^I^_%L6](HIXH*='%L_<
M$&8KGF0R31?*=[[())!YF"G-JMMQ67X!^6 )>^5E5K!'F#3Y^]MER,.\=1Q!
ME'D]]F\?/B'3=CDGV]=:U^'2M5,U=P$--8T1TJ0A'7[/+[EOJ(=O-!:@E= (
MBJ]_H47>T-#H-[9^V%%Z].23MFC&\E75/ZVP+8A]C^:[F>R+A@H/DIO"PI71
MO"4O\EKT!<^U$J'E0-')E[?5I[[.3#IZVM.'%2SK3?60RJ'L'W<K5Z7W;%VW
M$GXE]QF%VG,QSQ=?B?(*.RPJKED.RJ>&YE]P$;A:.3'77+R1\[:L5F D3/4E
M3/VVGQI:>%X\_%[") L+F_WB)T(F>*C M@"C5\8VY5AYFTL)(X4+7?[MA;8H
M"PB8K5*@V5^ KF9I$CV367FXWU^DSC$%F-9.Y-N36KTHP0+F8=C##]6-HQ$9
MI&I&?#]?Q\)5BY6*5/.<NJFISDOPX(<RL5-[R5EH-'#M!/4$]0+QGH_/9_)Z
M $9YXO"99!PUN +#N8]1GMJ1Q5OJBC*1,*6: #2+*64Y,?&WJJ^5:E1_ O+)
M+!@&!"?>U91(*Q8!"E4UR@2*T%]^R$G^SS(.L@P4@BB':6XF4(@56?[46,_E
M\S^EEL]'+K=CK-#E9YV'<Q_HB SV'@%-;<L'LWK(Q#Y=MQN=OQR&_(.(P16B
MJJ:5UOZT_Z%D<O=0RAA:S[W,]O")"+K7WM2.DC>QU-YJ]/_GC*7B KIH +VT
MJB%6/'HX@.VU@FZGPXLM:"S6%"_T80:6@'V06?/=_FJ%=]V:UN4]S"P9T.LU
MM [PU/!$,BHRK<Z&&0BZ[&I(\HV '!:;9TE.6&</NG16@XYICJ'S,@</M&3M
M."@E!PFNDG+1_D> RF+S&&:W8,M^>"[IS$:XG5>C$HXGOC?#F%:NO(G*#.&W
M%\!(9(TQ!5N]]G@<&LO<_^+M+8/B>**WT2608 &"NQ,([NXAN 5W"P[!71<)
MD&"++A("P1V"NP3WQ65Q%@GNNK!<?N_[X?YOU?OQWCO5IV=JIKO/3/54G^=4
M/WW:=;)-T6F$9^-V;W_\'909W.,9R;ZIM"N,S7W$<J^R/?8SX .L[@^ZHP?F
M#S0HN;>0N-]^]^.^H=3\!<G)&C+AD-:>;-8&S&5F'5K=:[O=B\PFB#8J.5:V
M#)J=7JFK$(R[&8@M.%@"T\B;AL>GN"=[Y,S3)EU0ZHTX&E X21B0^W7#UQ Y
M$>Y0LZ@3VKGWB1N:@>U-X"6AZD]M>IFJTN\6E91R<9N,S=T1:SD1'SWGX)_B
MP4+V[%P0E*7A*XWE0PV6P,%\&9)_'S64;GGH:W%7/[WUX<9W&?0ZA,#&#>N_
ML>H/WT1:T];6,I,_@*8;*IT0D(#B%*.AV678UW#WMYZKIPA"RHH0"7#/@S#N
M4MKM/YT<FFQQ;@35;(N:[6=(Y&H1D7OUXJZT*+-%B-2$[V"P2!"S87]1$Q9_
MC,!R5CA*N*0Q(O4WNX^L"P)DR\(^S$#OA"RY\ RHU#!>O.<:PALX'8'K2[8D
MN]'DM,N;B[-,\^PY9?G$U17O+TSWW2:^27]'V+*?A2/=[]'JE%P?Y\%V=)BJ
M22T,,?4P32PUZ@O_;/"^.5Z27\^S)JF%QIRS1+CH&6 K:]/T+QDJ&DXEMM-3
M+4X"HSQDUG+W$3^2L'[+3J4P<!2_-K=;WXK;[WRBX1Z_X0PI?= I'R4P.R8E
M5UHS1"&-5*G;CHWKS*\**AOO#P4>HR1-D#[V?202_LA[/N!'H6ELN'U 7E%M
M06VC24:TFBV/P;WPR&HW,#(8:IA?*B@XF\_>:L0_978L)*#/$H8.)5Z>BI0T
M5*^/\2.(,]36F?$AS&9[!BQ_#+B%$1;NGC@F<3I7DA^5R:=WL5BBBOM?#VU]
M7QEWS?7"=*^TO+4!D0Z*@BAQA*D+-28LUI=&>>4SOMKT9V_T>]<(3;@]K:6
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M#["Y[_PSP9#/=.)B<0[R=%!%$HAS,+#CTK8$&N"#O%9A%$[@9OSS)U@GI-1
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M*+-65TJT'%=)#-!\Q1==K-!=2B31K3TU&#\+Z /-%\>+;6774"ME"SV5?E>
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M-]S"SAJ&_(=ZOOZ3]8E3 2_3*8W%CBK.V.* &A"WG__KXV"M;VX3$KK,CH
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M[5V,3BOVZ6;C<HNE):ZI)&N]TF(T?&3W-XIP@9*1X[A+C<.55=[:X ?G;?@
ME'Z6Z91-8P_$%\!X\$2+%0UM:!&QTG/414.WNQ8O9BZC'J_>PIR/'H_(1,\
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MR0E.T2E7(MV0*ZUK%E/<VH9+L_DX53@R4<H((Q=XT.O3GR\ R($$(:]"BYM
M#PA=K:\- F44'RHO%W&.$+C,=[1@#>S%D3 PO^:"()_:16J[55:8K.$I>+X^
M)WP!F*<2VS2'9?U:_7,.:-7=WF5(H:RH[XOJ3CT(7/.%R]A J*=(Q"NM4CS,
MN%=N):#&/7-2UWCM;#W#2)7"(R)-+X!T]R:*[A/,JO<$OV0Q!2>VHG>%.AMF
MZ@)5;.=8IW$[U]A][^P#1AQT+WWPN.$SPD79Y=E)Z$$*7:KCCQ)C)@I+^W9I
M=KXK.X\A+E[!@P13LW_\D%*<?6GIW.C8E,*:%E&KJ?JHB#MQ?AK71([*UDI/
M>]CIQD41^VU(C_[;.VGJ,!Z@*?DP,#O:55N:8-MD9^PRVP9MF.N-E.*2G8ID
MD>@[O81O"OJ$#BJL^1KH=4KW3L@1IN3=>#&_Y1CKO2HVH31@^N7$%P"J3*F;
MW&&3UED_7MY3]N&KBP3@=OKU7L/3>AJ# ]J<YF\;Q,:U.N0$I%<[45I\:6AM
MFOW?LOKXB>ASG(N\0 JQ80Y2;+0;[QNN"ZPF.&0=W;IS@PL7AOJ]WE9^0I50
M26V_%E9=F;U!J_-J8"*7$A)D.)IHP3H*:W,G38HY2@3_!,8R<+\-TVF)%(J4
M-JJP#F.4<'F'-JV@)$L>2A6(6J^Y8)\F.N]*7>).K2?194HN60,Z>L/W6+70
M^X5)WR%U4C*I-&V\=+;C-]E@O+"_&U&NEU]<!5K%^X?8G7B5:6FJ%IP'D ($
MH1(L4M$M2A=LR <WSS$"P-/=]AXFM[/+"T3X@CE>N_D%-SJO\%Q0W:W.?[@V
M'_.L@>DKA>.5P<6>?AY?H%6.XEOG,!<1Z>R:TXADZTJ&!<JHJH9RNUUD'^+O
MTI?<8=13YYI&#4%WU+)48SWHH8(QX<&%7_@,RDC5MB:UEY2^C48/J;./?)1P
M#^C?;M%K!D%\\SO>..MZJ^D)DX'[D>+:OFZ2JDE8=[P7/XRD;YW4Y^^ 3J!V
M*)910L_J2C7RRP1A07F6GN6]H[G'?)1[(TQ['U=UG.V]QWI32E7)EYAX'];"
MXZ:B^H:(-3L-D_EWR@ O .$9'N,=2Z[Q]NF\X)C8#8?N0Y8=_"/:=@TEH@AU
MQH:%*5)_06(M+L>R6 @"XW=MSKZ%X"7#H-4G@9LR/1MX4:+>=))"_]?E[=1D
MJ">Z6]>I9F:V9[5SJ(0F .R(N?4< 7'M[>8?)?2LLBD'6L-.1%:#:&W#YZ-4
MWG<>7_P!U(\[2?2U.%QQ4;_[/IVQS;_Q7TWM0\ $Y0II.('7DE,EL+GM3$A2
M,('!!]U,MP9*D*]0"-WA"9*7ET.*PY-E)>?8&:-RE5E2/SA^!8J&FA5S9 N-
M($ /#O[NUM<!>G)0),/DU_JH(TF#O_..!&D1NDG_OMXPY:W#?4"W.]EHD/7J
MO/YPE$MM-RHFUAEF*H9I7= 2.)0WG/2]%C7R.Z!*OWPJP^+.M=F;>5S%_ ?Q
M0F@XL)>:I?C;9[D;J7=IR%ZN!QV%7)"ABB8IF0')Z"/2Z"]Q#WG;)V$.]TDG
M%)(D']TTOVL,+%1O33XTC"IIN1"_KU><\-S]7N6LLZT_)+#/Q)A0&ZQ&V"WM
M8.400M-R 4B3TE=#4K/NP3?> 7">U<.E<8S*1$OE1HO'T[)4/V72+J&GA!5'
M8:X^1([4K%:YJD!8* CYZ4F"E[Y@2LJWR3ARA#:$()GSEG]IA\=[:M5'<)^R
M!$LBI@4+V60O#%K11?#3^GU$4JW56U:A2(13YD=\N"ET<6>HK8O--XZGU23L
MJ63=0F&4!#XYW,[8<O=I!I!B9Q90:AAMI#>G(G/!0DN R[J$&W=XSMCIS0V[
M ON,;HZ\N5.FJ9$B$]:LUAN-DO&N"T/G03=HB8!5C-4(=\>;$K\\(OKE_)'T
M@R!PB&AUBK"%*!E7RI,[3"%R W;Y1+?N1>(R#W;M)UQJ$"7U[24+\B'>$18Z
M:^0O#:_[5DPBXRP4_2G4\Z.(:\\'X8N^XIC:L*LMWZ+OP;#W$F>'=4)SU=R+
M1MB4J*TJTIM2B6'^*HBV'T1\<DSW[C\R*XL[<4,X!W]FAR?".>U8NX=%[BPW
MAM,K3PJ+0E-YCTGJG;=@1 @<86$;07W45,4\9?-4QDM490/% R<!D8WMI&'D
MP5?#9OP,FFNY6Q)G%C/'#D,^KOH,GCW@'=1H1YHRN&"10$<@SL]OIM4_J[\U
M6WME5Z9]Q&AI^UVEH;# 'L\^'BC<HR7%##PGZZPO4L<.%<B* KPO\EU38?YZ
MN1J1+G\9=C3K"9.8440">P;M0,LW(^Y&<T^&-* Y\QU%$!=BI_GCVL;OF2:@
M)6H*6 5/J+D3DVOV.VL$X8BG<$M7LV>1.*)6\U%2HUR-L7HF:\^A9?*8SF>Z
MEDD;G$'VOG%KD;.QR/R.1\LIX"BXP-R\M/"=&OKHV Z9C\P."")M77U" 9G!
M5_2?P<_7/.HW(BQ3,*P[SW4UZW2'I><M=CIPL(_P,3,W7XRJ3*:<'>E-G<E8
MP 3.B)A/+Z?-:"%6C3\ZL[LF^ZA&IFT2%C5T,B'KL,_E/2?:?:<+.OL:&*2<
M1JK"/>XSF<-96;._!\/'-X"7@H-9 @QK>5CAFNM.<MQR/DTV KWR#.OODS;,
M^EJE4!P0^DL#%.>L9>+@VD?I*@W_K"C6C"BR=G0:KV*.PYI F01UR<DM1U73
M_<%?/-D*>6+OU!F@=</U$6BVPC!Z:II[]>V(Z&)+N(A]/=\AX_I8MG$/'T9\
M7.P>>E5[H,M;:5_ O5,!=+@ZX5V45:[!<H,Q2R!Y $\L]KYZ878Q9&&1I=BR
MD9#J0=CD.M%>VGH)I"+5F/(&H"W+^262ICI1*!EX)0$!3B4:5%1/ULJSC/!B
MV0-K\./ 68NO6$N3!.C<$*I]?X0AVP6"#":J8^^(I3;"^6%R=17>ZWO6?% H
MO\RW^(/Z]"1):TF5?J+UNNHK%X<MV5S&Y)]K"W7T1N^9&T0T2=/:E2'.O)9F
MEE0LR5AI5X\=?M44L?X2DO(U>*EGJ25T!,2\?4?;C1M^T5+JZH<-U"PK*+"6
M]_N1R24TV1.LFOM<E):U4]S5?ED-C>@9<2;,\*V'9@B_-I(FGR>B^67(C(9I
MELQ>6P6C>)!&U96-H"[LC<KT);G45*2PP$)QV??*"SBQR[EB4A?/B!39A;93
M\RT2L/<G:5RTY3M<4#6G[??A_3^B/QUND ?@I@6S=1W^2>:L)8;2ST#+QGQY
M5LX;U& P*28ON&V9?D_UN.PHK0]TG9OEF+L\(?$@;-6@O('5OK]X3.Y?)%GJ
MQF0^7*I%$'?<KKE*(8 2YC -V(']R9S7J+AF!X;77]65IE2"YDK8YS3@<DA=
MA*&7P*E20]J<X6Q-'=7P\-8BMA@?;K>H\M!6H#PG%P4U>5!5YJ1OC1]!YX//
M6-ITX%+/4TCX>99#'PU"VAQN4OPOA&$?SD5+G&(^WCK1=T@:E@#V;+@&5"+#
M!;S78FWF&G+DVZ(8CP&.,?9X,RR,]Z4*2QG=D<T-/JQ&K([):KQ1H^2+4ITV
MZM2-<.U4A?ONT9S+N%.E>9_,2Y6%--W>V_+N$-JZ;]1"*MAFG_O*H+FSS#:T
M19Y;([]=WBE[I,"KPN1NO@4EV\#+.4]2I,VU]F*.D;KT6H%K/D9K)XG*9&U%
M% _"A+D39@ABQ*'V6]:(R9L)YM!.>AN!]E$%"UA%%?%GJTPTS=;^]X;;(%6K
MS0>*T\)&:'=K;OXPTM2@PZNZJ&RO#.BQ9%D]C_MBX5-J3M#([$C0O-Q)2RA
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M:IB#I/+G1I( >!J_2,Z)MZR5RN)<_NW\]8;%J8^K%() ^V51;=L;'J?$7.+
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MA%;US-60@(.B9:R?VMR<@6S6>2S-;7>277U3X>>1KD'XB1?RB4'%0^I@[EO
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MPT88<<B&REF8EX?8S(!=_(567.>8(NU0XJBS"OY&JFH1+@\S1@A,63$G=#*
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M3B*T74TU60#1_^#V%K&$E!770-93' T3[/7]$00KTSALNP[W+KAQXM](H5V
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MW5&4(Z>N2/D@3:Y,9'X^3!\_TQM9$AP?&ZB=4R=PX5N[ET,-P8'**WR182_
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M,EH'6]&G2[B;8XRWB.RYKE?A7>?L9;AJHIU]S9$PDW<)[!%9W69ZOX<!5-J
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MPD*/6E.-[N<]@S2W/J66_%X'"CZL\"T'S7?GN;SG0WSOX;]$3F!L?HJ_[2<
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M!!-M,!<QN-FX[#FU4PQ*]D>CG@0Z\_-?^GBQV;A.ZL)-&3BJH<U)(K2FI?M
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MBG)UN?[BWS?<T"+EAH"7O]OZM:7^O4\5&W97K?(_N*&%K4$NB$Y!E\NV0WS
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MR6%PSVNHD./@[#C:SLG"Y]5"=SI.S:[+\A<DCBX>3[ "[+2OZ9\..-]T% N
M5"UTB-VC1&B ?JJE&$F1T?N'K&Y^D_N*_U! CE>%J\%0+GS2T-[%G!WC;%/_
M7>9MB%D&7(B< 9? &G>,J:Q$?W#E#0C@<7O4\\&(,UO7UUM3_^6J3"*YGWM3
M[C: 5B'T8,7;H:?EI@1MX#96O0YG4IEZZ:^_T^)[U"O!4ABNJ_(!K9,;IK3S
M[\3(*T(O48'@N)184 ASK9VLSA^]4B53]DY.O\"BPM CH;[_O<3HA6QF#!,!
M,==FRS\DIZJ8;FAT];O@!5MOYOB4;)W+FL#;"]^!U>I[N.[P_?[G",X1DFJ)
M;G_A.CM?_NX7UK<_;0SH3MRF/::US"H1' OL2D=@*J'1"(:-C,STI\4;+][4
MJ<5LH0LC%SP9+HV;O]RF5U*FB&[8?@;!?A&A0DY""! V3#*/C*XNZ32^2D\U
M.NLA)@M9'-<645Z-%/Y=1&$AQR/X S6.)+J&RZHG%I6-MX(Z/K!]U+D']OC3
M8Q(S%[)/Z FT"W0+%)U-*"JZ @@!7$=@G D2GA+/D10)D:&2!]]?G'^!O'C>
M\-UYF$@]M./.<=FW>[7B:BN?2!)$#I(,MF\Y0-9B;J.?_VM9L;>0;%:!Z%V6
M?9$DE\.O%XY)A 26S"<RG-6W2[@FYO7AWCTA@#;[HQ/8]<;Q4/HJCX0L_IJ!
M@]XW&X:&(9U-9L/+UY,;\K+I&JYTB:E_9G49:T-%'IFU4@&&[H49@<7=E:_*
M67;G]O)ZZK_K?RV*1W"/#VH>#RSL])A0;(/RJ5E3SH[Z";E,'BSH,_O+MJ5L
M:3UMO]ZM=C16/:@)N8IL;Z8((P<<.T"^X/:@ ET7_DE:FPW[WJ'E;6WFKL*"
M:@K--FX@5Q/LUF"E?:[]1$J:+LU#@(X,E!9=R/^O7?K_+^W2EUC=^=M=%V$:
M3W,QZDA0R">BL&B2.?QBB?4FEE)Y@5TMX5EU@]+)V58L%W%+/0$1";8+@4#^
MT?N53G-X -3[-Z1<MU&@S?SR)AM\:"2&$F?YP,T4]@HEV*BN&(=Q,0JX5I.J
MY"YOY"UQ83E#E3W_D:;5Z7D>NL4F08K0UI+T$;^<]'</RMDX!N)H+&F^N9E0
M2SP36-8J[4>?8?PV(Q%2)=^%"B[2/: IO[NK*L$<,=M,(@0MN4)BA!D'28:%
MX>D-\<=,!4^_FCIGP[A]+^+BD0F]G@Z<'Q>RA$RDJ,#OH%JR@/KZRJ'4A:VS
M5A>9)?W*D_<,19;UVD][*BR)9*(H?)#N:^S!:E8%5, UK4=PM6O3=\]_=?A=
M%<VA _>NX^9<-MP'Z]%Q$:Z^J'SN35O-I^BZ-W=>3E^_N^HX4? ]@$-CVS-O
M!_!D&_7][P?:FZWH;7G@& C$I<=E#]Y\*Q_R>C_E]@2]W;/'%_I(NC^;^Q#=
M GD.P59J< 0&6*<:7STH[6Q:F'FQVKVK#-UA_[S6]DHX4H?K_]EVW>Q ?HUT
M<4,N(9.D]R7-#(:?2&[M3TC?-X3*!CFDBP';#V5BV)8E?A7]O?Q#)VH(4WHI
MRMBY+5[>>+3()QMV/ZOBBAY? 6,I8UF/WD2,TF)S]Y^;A_\\AT0B@.9#_%<H
M%; C@WFK,V-"OR;T9T*%>Z]_*X"H!8-#!C;E4&P5W8M"%C:1O=D>%6V-O #6
M_,73MT^K8X0D6N$2Q/,D(T)?7NLBE",PWJ)T-V;!QM+9L<X/ZA>[;Z*U]'9^
MGZL#$68*H[6&TQ.VL(IW*S]CRSYJE+KOB6D3S__,3Q(+RS47 ]SZ[X1G>^NC
MZ^&R9#0(2Q04N='M5O4R>I+2P:>]8K\R\?GMXZ>9+\U65SLQOZ&&$"+;&NI(
M:A2CN0;\CUN1_^?'5H]H!'\T0F$@L+;;#)642F]+R5_8S%3MFSI6=;M>U)E>
M.1[QN+:9CG2MB5",16OC;N6X'2_X2050S8)NLY:;6?I=BAS!(NK!F<#.!_1K
MZ'PV:E?7UX/(UDX%\@_E)RC=T%UWX5-4H+:??#DK3#WW?Z,L_F^XI(/>XI]B
MC=<<+\DN!$L%%E#/&W4*=>C&&OP^9EW83LM4>*#9?EPDI?^A1!OR\=S4R</%
MC/A'V+DX2;D9A>U?BL[#YA)=J2K+54^$IE9$TUHAOHGY)O0C^Z8P#<HHI(KW
M>3,=%6B3)$<X%,Q0 1=R\7?*4*S>U,\@5?_-%!G*I\JW^%^:$"U3ZX V-CY;
MDB;!<6&.W45&BV4[ST4\7?6>0X)YZI6<&!&OZ<S?1'PRN:31!HM<?#0K-%BU
MQ;/2(VGWUB"4KO_\*EU*6IJNTGXV6\F'/^LB&C0N@=U0FH.<;]ZA DECVO,H
MPH5SB^LI4X&][5?TGE@]JE4Q5&E4CY'1O[7MTS6/J-J40+F8WI63]#'&*20Y
M%OTR\YIS'DN)R:Y[_M/&6)L*C*HE1C46+HUM*6?#6<U+'M6&.G;(=J]T%UY;
M.';F"YOH_!9=1!B-N)!,WYFL7AWX)4PMM*-/"S%52) U#+URFI<GX_:^6M(5
M?=[AZF#Z-LA4H1$NL=HQEX"Z'BJ\NZT3Q?29QWDAB"^LJ">A-]6K:[NI8;@\
MJ>A#;JSV28F5N<E"?"I.L64+>>W30(GOFSIT:9:SH&F4V8.O!!I__4;[,?DE
M4\H,BNMG@HV:3';#E:\5OPZOLZ]#D;?:- YSFT]2@:@U0C$5N%;SY_0O(H8"
MA9DA^JG J6I4+)3YB9IVV<34^/J=WJMJ"I_4G([IW_,L^Q9,,QO'O!\L\7..
M%C%B>PFGN"7K@]W>,!X<UDFZ,_(DLN/*5RE_JY).UJ6+UJB+/KN'2L>:<_\)
M9W,_74HZO89AA<O[E6T<%CL43B6:[W[OSCU[\%@]C*(Y<(+,C6.+!3.K868E
M'TLP;$N/\7A[?3(GJ #IG5(1N51N?R"?-R]-N"#:4Z3CNF3,JN/JLNHZYWSS
M]_.C5V]3]<H$18585!F("K&%^2YX2TJ&ZT?G,=/9<1O=BG8O)G>#4_'A+-9_
M+DS_FSIYG=N=I8!P.9B@^#,//X(;27>O_4D-"U=D?&JD3-FUK=\1:,3!],#?
MOP?\\Q)J,J[3EI_\WJU9:/+7D>I:A4NP7TI=)K_1]][(9_73YYA25FHT;-M%
MQD;N J8P*8(@/A=G%H-Q?H.*#K!$)&9>#L[*>R1U)LK4IV+F\84 _AO+OPU1
M&?4MW ?<_TEG&_X[12D1TH@N@7D+JUU"5NW]>;]X@T^\09SQ_G1#*HL]?-Q#
MT9W$&5$KI(0N;82BS0EYVI]^[/=&-@SOV%G,OV;5EF!.ZA[Q5S,YD<#=#]?&
M'>]^UDBSZ.;==S9UY^:PE(>=0:M,93>G2A00KGO7D0X2C-V9L/J3#MU"2)M/
M8T]\W^B7N*4Z3=V*NOOP&^%,[9=I^V$NFOTT[I]S5<A.(3,01=N523IY5A/3
ML]T^S&=5EP.27%,9VRK>4N1W2S%;/W$JNU>Q@3[M>]E*DD()P\Q'7NJJ-(<S
MW%@_]-;!TI;"HFQ)H)EN(!\5*(Z5B/-_H+*0J2?4[7*4-(_LWF&#>P^=1]UD
MLRNR?(IODEIXFGIYWT%T)T?-G>^0-I8NV(^[BW2/4)I-$L969:XTR5YV:/P@
MF2-84/>"[IG6/GVJIG#UKM_AUL^EA. C!RPZ?//F!9\*WZQ=S::KLU;G9?=)
M:_R'0MPXCT@P02PCRS[4-%_%OO7L3*[H?2\KEN+;LYLO#C5J:V[!SCV_W&B1
M/>XJ\"1!/G)?0HU#[DED2I369 N[/LNE"V6JBZ#RED9 2+(XWN=5:]F9A[>J
M93N%ABIUOS'P/<CG4-[4 ?SES%K\YVIK.WK[YARQA]&.4X>-GR72NX(=.4=
M\3X#X4:NW1_ 8&$!5*#[U[B9QD%NLS7Y#15P1IV&6Q*>'T&>^QK)&@]WOJP]
M9F5HL!BZ_@7H_=(.D=F:+$8,48%J6!R"F:1GS+;6X!_G]_C)P_H]Z?G7R]/?
MYN/SBV1V$T>8CRIBBPMFY+??.'LN:/>>U&\-?O1!G'L/NOF9:!I8O.38P:*M
M/29'%AX:FKN9>@ SCKJ;W-#+ 1A^;>=+QN^O)$-,374\)V%=.W2NM@I(A@E7
M['1@@GCF1 G/15K&L\R/K-.F=I^YDS_0UO_+0?[7:;:K?W.9P9N_,1UA$D[J
M(J#Q0UINR?77\RZ17>/^8CP&3OS_YW9G&!3Q]VOO]EG@Y+_;O3U WUY#!4[N
MH)M9>I:(9_>L)M9WG6L_@<;Q=O-=Z=.8:T-74<8O1L9F(!72W3(XJY:E&R.K
M,XMNW#P2":LK]=&Y1MO(R*8NY'.S<\23:WC;,P3Z11M9TUK#STQ]+HN,\\D.
M-@*3TZ>0)W\O=0BX-Q%%2,$&F[W]KDR_:[Z3) ]>O.6RWPB[>W0U(C'MFDK_
MGZGS=#=!2@LHZ7[I](4.SV-^<_I"CK"U5&#0%8::JRF,K=HY'4ALR\2_4$05
MSA%<9IU0S2R=W^\F?F/5$GI^%J,)YZ4"9]TCJ( M#Q4XDG2F^4U<W/FMP0#=
M= ?%W2#.;.TGPH[D7?E#GFTR E8],'EO='5T*;8S.^-KLC5'^%5T2M6V*$M*
M8CTWB.%M^>0/5&"5^,=1W^NF CUR+?MSA MZSWVKL1Y1^[*7/4H5<O"=\:=L
M1,R7=<7\:%YG"']F*PCFW;0HM/Y%!2KQS\?.O+0V]E&[,9/\M07A8$!R;8/3
M$MD(O9VV9Y/N$.(^EA:\QQZRQV&J;:WM"0&[16R'M9Q;,(]?*C;OHPLFG2=#
M&RS-)Z^7:]'9,PE<H+D; AP7@2IA')&G+> T!-P'=-Q]_9R[=4/N998*CVN1
M\L:O[CY*>87U>A$EGDFD EJ$POD=+MVD?$*A/F9NT*XI'C-0YLTF&JXZ=AR7
M@3?#(KM4NT>VKT\J-+:<&+GL19QF9I-A:'_ [!C1LDK+/1\\1^+$6$0'#:G9
MVP=TF7J4"K.UI#F2< 03^NF[9JMF;9B8+"5RIH;$%$&OXX6U$&1+9FKV5Z7!
M2D=*\[$^FJTP;7@=\PDV=:B.$Y^9("ZNVP [MI#QO/%Z-\?$9&VRTLKCWV<A
MAU/2"YF;Q4MHP@7%#C918^QAA.1R^_?N.Y]-]*:M\[77C%\AY\^&J>7AW0@B
M<WQJLCC!VY_CIZWU"M^XTB<OOQG5<'IRE"2IA7\YEH=LU2#!W79(.O/%'T_^
M+I*7N&X??W7A/-^!2!=R_GS3#OC*;"2)G?#@XR7/;Q^:&&^I9@>J_@3"0MOH
M8 06>.12ZEPE:LO73S^Y\[U4=NUZD9)"!O_>/;UR9ZZ0#^]%]Q\V<^!XMUXL
M)=&1''"2D=/EZPTGWGR<F]0I9 I<>LPPE"_RA=>?EDZ\_F2HZ_:'98,\ U&_
M5$6:M)?+5]09--)^S\T+L8YUP&KEM]XMN\K1=DP6='6;M%09>5W"479/ZK-0
M 792(#FOBF@.U_8IF'$6D/MV\GKF)3[=I4B6)DL=NI3XE+=)EH=H7OA-0NU"
M4KB&\-@#K%]SSI)5<57LGF%-95T#>XM]2F-7H@)S0EH\>RK-$S\EX5U-=5UG
M)_[?,*(&8;4+R49R"/E $ 1=%#;59>C7CH<D>OQ]PQ1CJH)TQ7GF*U\CQ)96
M#KF/E$'?/7L6%]T>*FJ&LWU!CD9/!\TYEQ/ETBGW)][=.?3F:+]0-)WED_7,
MK ORUR5I<8L\M>)1C;2+;K8<]VV@-^L_Z]KFY,6\@GPS$8/WX?+PC3BFP'7C
MXW#IX6%33-0=CW.[+>ZV%M&SYB9>D:V]IWPB6FC%$YK)V5 GR#-9RW4-A:&$
ME;3+3V_,F7>>=DLYI$NFJ?Z4JNA8J!TN$4].14@$RBY GS=JE09^VM8A#>@=
M?YD\]?HY\[=ACA!(.K3,**2P4WJR?\&X@RT:<19+[$/*SED8<$F<BP/.3]XT
MRAKW+-08:3E$/Z,"G/OHN%FF2IQP2H-2P7GEK671T,;>A,$:E261B.E3(6/?
MYZK'MEB6D,\P''(SHNV6+Q7\99UE9AJ]+;LO7N5_?]N[)>MY8\A]"(GSL_4K
M6T*_WD.CSWH>_G$3YKRZI%88<:5>^B] )Y4SL.:7-"F[A.[XX'Z .4;PWKB)
M';G9=E%2[F>#O^F8Y-ER_X/Q1E^T)SF-<@:N34A:<&TR[DKG&33/F+*#B^Z>
MKVL]L\?'-\E&$Z7\I75=/;I]4@@=Y2L$-:A(L*OZ]%1R\;I)]J4/M$EM5<!)
M@)9V*$SC%I9MZ\R2-#OB!Z\M;6-F7R-4N/BCY:5SY1Q!GI=7H"AUI'_]P4K3
MSI)T!U,_Z%O8_*#LYDXO-L9XBM@F%I3NTI<D!F_:%@*H[!X(/TF,"KS8;Z8"
MY100JG.WBW>,?.X/5PF=W3'Y499=,>RV)*EV>)E'SO;MB^[:9B]-"/LO)!_&
M&19SW_X>=O;=N>8W9R2YTC.?,'$R4P':6X*>AW3[1S_ZF2@3PAJ$D"6Q08T+
M3NV;Q!%K64M!UP]<J(-8^J\;B2T^B2PAW-U;.=@7UQT^58VX.]34FIY&/AR>
ML;M'2W/W5".@U-)= .\CPDB/0: S[&>:(3R8-O!Q$/IFYFUM]2KFOLRKL'X3
MAHR]]_1K"4T=9NDX8Z:2\J\Y0SK*S/F/V+=B"?0+XB14P2$Y^@!#YO6#.9'X
MTU8)T'D+,;?O1]QQLL++4X7RN( VX]]0PQTBVP;R2&H]&9+M:ZIS!D5/!5JO
M55G5(40(KF8./O9>!>0407JG5&6;5XXC,7=VT044 <K0'!LI),?\:Y;(\'ZH
M5BY,U0CSVFU6G'9%9U;S@2IW/^1YV? B?7LI[6)T]*-!N,Z#VM&;4V/OT)QA
MFKYV7\M[EH.3 ]$9< ,J0+=3G6KQ: !N+\>^_+)VY$E'M-#3%'[D_LF'&I@*
M3/5(-J>E=;L?HQ+'M86Q/>Z'&'F*")R;D$"4M+$@)':;3SD-,PS?&7+P.TE*
M,S -FP\+5'VYW^]"#,$'$0K%N]@B)]TQ?@*='T^X6OV(MU-;5KJ<5_[@WJ<I
M?U43V3\[TF0[#$"I/R5P:)O*4Y]D..+[>27RUK!((I/C);:'_DNXLMH." 3J
M],[,&,EM[I1A*1V%6[TT]8M)#&%FTO&EY*?7=]S3N:?6H+25E)JR)M?QWFJ,
M-W(,*EG#[^G.\ M+.-@1PEWW99VF:FG=9>*];NI]1U7T;^E NPS*&J&+@H&2
M<#U7QKI$5Z\:B0]/:9IO!WJE)"N)I *M:/A8=2^$>:UVLJ;0LR8S]*6DVAY4
MYQZ_.!4HG6T^3N!V_+-NPNW7?B_-LH5V\3H^AF-_-U4UH7A?D'<7G0-U+PUV
M@\Q;35W?C+@S4KJY/#6C&>096GDJGSX%1@&%.:_&E<!4?/]"5.QH.L_J);LJ
M@Q7&MR?2ED_(BPO)K%_URD2U8ZJ[.Y"1",G:P6:)M7[)DL\W4ZN+IJ9S.9/D
M%8!4:>LPY2X:+BHPD81/(+AAHQ?<REY\[ EBK57O&./M8WGM^<VZ"-[^@;TH
ME%$^B6@!#R:$XMZTJK@U1QW>WJCAS37/KZN66>31Y9!:6H=7)N%UKFBL#1\P
MN5D9US17OG:7E'IHD9,IF^;[X&0Y7B0")A1XB']%:%J4?CY9& EG6;"HZJDZ
M?!024,FK:*6U:,#X]6P60TOW-XW'\V/EB*[,Y<FQ32J07;)<.6&@GFT_<U]7
MXK<$#>$^*A%T'I H&'/UU&<;P_LQU?WI$J]\B8\S[6J5+/AU3\QT_Y1,>=$I
MHN$ZBE"F#&(8%^),<8^S'O^W]MX[KJEMVQ]=" **&$$%J5%!46D*4J0%5$1$
M!!L=HJ(4$1 !:2%!I4F+@(""$!0%%1#IG4B7WFN$$'H+))002'O!O>\Y>WOV
MN_><]^Z[][S/CS_&![+6FFNN6<?W.^<<8W25?4O5PZN )20.&'ENP[<]>.&E
ML KYA@A7! NK[5-(<'"U]G66&%A\$.JT]!X0_O2M\846QZRJ<03L)BU+XP 9
M@TL+.7WL'CIIE@'H)PFYQ3<\7:\%O=1M.^";IM'3RAQT9R9MD*-L]R)J%7?Q
MMZ/RQNG/EI)W03!Q]1KRZ!X9JJP/C@G,R">:# N*LGOAM7+KRT+7+GG5EA5,
MZGI>147W=U#D85#RI_<S5CL(%7$CJ +R\=7MA;X.E*.SE\\=Z1) M1HOT<\N
MN89QEZTHS&!_,89E5I8U:ET)Q(G 3-%C#70T9UU0OSQ"! = A#6.%5;["E5"
M=E'5I3KMC\M;SEX=I+TMU%7+ 91 TNS"H%>\%Y6SG'YU;7&5LG_&:! QOYQL
MH<7[OJ_+TL+BI'!IZ',Q-@;PS5J+B<N>>8))#40F2:#:Q2O58"X4Y_%R+M3T
MZCEX/0#I['Q[TT]XS%GL;5;)[7C5X&LFB7>?=\N5"*>S?C^XMI^H0]UW7:\@
MZ 9!\5UD0&E1X-(.\84&H;/?(:R2=/=5@\KB\1+RN1&O#Z[B.79&,O/>48[M
MT9HBX?NN7KS]%_R#'?P73D=7_VH=]B7+P,ROCD=O_.,2+#"1_U>1RRPB_L:*
MYBH$F6_?C=A8=Z9MMV/-^ NZQ=J,MD>N'ZQ09&HK'\3T6?1)MX_N>@>NH-,R
MVE,37#F5OK[QVJM("DVJ6;^B0\G?\*5<9A(F8B'MV2:%VK\T-:\W$JXT"GE&
M/T'V,$+ZQJR8P>[Y":4XKT1]0>,E 9W.]&1D&@.P183%,@!!#9'!V0?3)3U?
MI/,EW;\-G 3#0 M%ZT&C$/\^OS\[C$C_3A<E)YC3HNBJ%OWW1\_=B?*-OAK.
M@G%YP,05N\>WB?BL6DV67Z?OY/EH?K\7S.W\8$HO0>_5XF2@7>O-CH!/1ASM
MSRZ"WOWB<J+B)*T8/5YNB>C78'Z_E@(),=_& ,3Y*R$D$)3&V5<'+E2BQJ5G
M43@PB.FC\3]4P"DQRQ[X:L*:=D\%SS#Y+?Y0D'FGC5^]YT>VG)3OV0>8+;9G
MO7K7"J8>1H#\T9/OTF(H*@\:RIP6[*74I#_8'6UMF.(]&G>GQ46AYME"G&_*
MH4?>P)F&Z9-^&ZPDEKXOJ^" DKH$57G,S& DWT3N4D9PQG?UPGL57QRJ^@RR
MR4B*X_ ,77)]9=U]+L$CXM'C[U\Y3,3.S ];.$3@LJ%0>@N"\QY9GE"'N5A^
MU]=JUJ@<S:R'>[< 39^ FU>G+XJ[9_'0/D+NTA U5K+%Q,(GW19#%C'QBU=,
MS[M*-7(LWKFC>>;;D4>['UUP]7-GG9OS\<R\'7' ^N+ML.V;AS&2W8#=3XO1
MY)MTYM3LWRB[_\N3.TF'0A3#G:,.9BV[6T=P68?7. &1;P3)3M@Q6SR(,,KC
M_ GC((>I45:I>W&/C:5A^9*3\Y>QKCFK. *"1%#I+79X[SEW.;\K%M<KWO-
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M 51J,(#QL#D("9RPZ;P]O9R66K%3AYB FR\@9:=1Q54>SX4K&HW$UK?P:$0
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M&WJN,.3TD>8[IQ^' <VEPF,20J4VY8++]!U]=]<2,F'N+MRIB![]5"ED& .
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MOBPRIM),IT9V%]1.<.)K:5?67H<O#QNU&G.2FCG9P/?7JZL17QU1_E3?M^3
MZKKK^05Q'\VQTHFM25^6O*ZES\OMV+<+7_?8I4_D(ZO.KVY3+%'SK@S@* X'
MHC"GALZ&.0?24[(T ^#"5!:8<9#:2."!5;8*BLX O*/TP:.C+:5=X#GY-Z29
M%D>8$-GUMWBZD3@#/.AG.%U5FOSWS7"ZMG$+3K^'_$FV;481KJ+6T]!K>Q@
MYOZ&\Y_GS"^RI# :L_)Q".8TP-2 ^T$D$,E@$#+1A-=P3IA =)W'("6QJJ5W
MRI4J-829: -26;+["0F9SP#NF9CWTU)LVI0:PZ_#?[RQ=7*)#EL]S5+X-R/%
M_];XK]C__OBO+)/0O'KJ"Z@0HE\=O7((JO'G/CB-'N37*^^MV$FNJ+^2ET0G
M^?!=S,R\8R\>F:-\TU 7<HF [9>HU#A,0% EH)B-W9_>TE+F-0Q(,6]BZ4[8
M/"=,^0678M>(UZ)Y&RS=] $HJTZ-,SMJK[VA$Y'O^=Y3-\ *+1^;U. 37DS
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ME%NVXB#U1*#OX:JQ:STK"35)DCX7XTWO,B>RQ[.?DZ-[3,9RKG:#=G=E93(
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MG]":[?I.IC"ET?W8@R,^MX)C*S'-7(5<^3FN=5U)+_TH(2''?C'&_^^./\\
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M /HX?3_Z[V\'#R!6F,Q<A*F/V]DY_I.O,V( ?W\_XN^Y:AX $V(\0^G/0 P
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MH(8&-GW?%6G,$-&0D8*2R:"Q9$N,=3EL_P)^!)2T((M5WP*?Q/W+D#QY>O,
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M- MRP=HX%%^[V1X=:V9O*_Z,2ZIU::/W]K;_R4>AE1-+8SP3T\/9NQ!)K0J
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M'H'*%>@<OUCS5(5B8N=J]M95A>>XWY&I-^@T7U*B_FM@&16G$>T4_9J3;$H
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MKP;.OB778#0T@/=1LS>8S?14>K^O'=MYL=1T-\@6]/!ZT<)4]#V7N! <[">
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MISR[0WKZLFQG@4#')9#7;'EI*F7U/MRL5!BSVMX&&/+.,,R^0Y#RR=(46Z-
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MA+00SD?=1Z]Y\16EC$A ;A-Z!M\D7RGY,YR1[(>I4"K\S/J1E#2^$'5N^2?
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MIC>YW$[T@XYW2Y&^)XK=A28?=X%72XZ\\$M75_ABNDHN3WG]I'&^S-*?9ZL
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MU9OO>9I#'4MF9-CWOY#X_+Z8^"K0O1+0>C*99_S-R"[N<JSKDW5R5MDPKP:
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M<AT/\]FRTQ&,-'4B?.UV("3.F-R^-Y7'E&TAH!"O&*4K/<BHX8^6NNGIV3=
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MKYA\;37+QDYR75\*+] +PA*-.,@><=,A[M>SBRR1K>)&Q7QK/1G_:RP,8VD
MXL#1"@R_E!FQ0Y/N%R%GDLOZ^FX6<H:C%W(@!4VJ)W@+$$>Y+W;T-TJ7Y=J?
M-@32VU],%K8@A$_8J3T@4GXOVV'1\=A_];F5U("[&&HHX[YTB<3GJ8,W70 =
MAD@GFC9."$O_B>ZZ>0J[ P5\&ZZQ>;%%,I<+Q;W&)^RRO"2%_(^"&SL.<J((
MARH4*:I :Y- D(U%1AT\-18#U@ D!>U@'6^D3]G;,;4 =KZ$50#?)P+3/S3Y
MD18:Q4O(.WMR,^+WN2=<6F@T)\F@+W$H7A+;8[+N/(S\"@SUACPN[N47=4C%
M%+9N)]O[0A@RF]HNN)CHQWGJ*Z9GXB??,61",.Z&\GCD-/BT+3G]>M)4$_V1
MO  SKMT ]>P/Z//U%+=A<&4>R8I"^E^3UU-:TC"<FL]!KC7?1^?TNL3+9E9
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M^W[@:TZA*/R6"Q VPJG1X=D7.@=,.C9W:P8E@D//5TR5/WPWVP+[[;/&A''
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M +3TZ7GT?%H<;M]HW^#6UN^\#P&3$0B*4 +',* A6Y>UTE[$02>I^D[3YEV
MD_K+T#]E]\*+%*=UT00CI^RN(_!JTZ6?.WX"EROA:X10_UN%4,RZEFG#$%G>
M=^<X 6@/P@E*Y1L33V$5I64]A"&!G9) X#>=@XJKIS$XT64.<MX*:BR9M92G
M@>K],]=!YU3<?1]M>^U#K3IOM&>%48AYH6BIA$F\<7^#GPQOKQT'ICV=BX4Z
M5%<9XH^/\KRZU@E0Z.VAG>./]58Z:^\7O+1[K<85Q'B8Y=HHQGBSH3#W$Z<[
M37<1/\JQPM6B4GIZU:GNTO.^;,/9U%QR"0V%]!^Y79&S M19FZQ](/:NEVNC
M**WGOM=SUW<1-(I$? X4&2%M4H\L";E)ME_MU6-<#K4K66^@_[ED:MVX*3V7
M 6&#:D67]@8M^S[C:8!HKN.6@&5J^G;<\DREOO1@?_EUY0YP-$?8$VPF 1CE
ML5#1^PS^0[!6W-*F%52A[]U2*U?@LHGR1\H<VQ8T*=[@E"1F 4U*M^MRG*/_
MA4:<Z0(^LU6\,[IY:;4ID^#P?&YBM8;6OS[QT*&7^^9K.5/G0I;2=)8X%&=O
MNP0_LT]/[>7I'5W>>12^T66XQ]AL[D!>DR'3<W:KIYI!I3J\@GPYRU!^Z1XC
M%AH^_1 29WNJW.ZZ,+ J(2]XL:&ON8P&6;DKA(;?)T G7:>S6XX)R%G;T<IX
M*":D_T %Z)>SZ5#+WL3_BX&>QZ1>(^^&O4E2'S%B4\6?<,CQ0[M&@)4?PKJ3
M0N:HI'0M6V*R]]G^B5-^/4@BRJ%I7?MBSO\ ;VF&'\XX1A$P5"D=GO:KZGX(
M=F*4L4&#]&O(RYS[2+[J6&;B@L:+[M?\W??I-;")&>D89$#3CIB,[@^S]P)Z
M[:3KON(6N%7KJU9^.T&B0KX&:6@]W9Z7T"+4F#YI.R'.Z99 4&<%"#>WE=0O
M3,C/ZDLVUM#C;UG8$;LXH@)"$U7?/ZEU7.HDMAB"OK'HUZ:CUHZ927DS%>_+
M,)L+/KLWNE3@3!\'!DF@!GE7I1-AX_!3F93#\!=KH.D\=<JP3YUQ-('NU37Y
MA IDZKT:)GMO)H<;F_!]O\.KC,#Z[\Q:O?[-[CP4-5W)PQ0>FR1JW"EDK.3K
MFLV$CQO8R7L/BB7=PTX5;T^8$,+I8K4D<R239%.>IM*TN=YJN6\D+C_VBFQY
M$6B/-\P]D;$$O\&D %T'0SEMRVG1C@$F%(F5#?_RN\^\,[NH4B1\(2;T35\2
MPD.W@<[/($"_34P_BV5A*UN8=A7%[2.A8^?C3Y F.2J9S)1QZ2FNC&RS]J/^
MUW(PLLSHDC4T])D]K$=\#]V9NE_P9[)-5VE?[., \"I8:=2$],!#G+.9K)SA
M>\$ 7RGO0 PZ\5RC*@0RW4S4/8_Y+@[Q"I0!=7B*1(CR=)Y#%:.'*AW X7]Z
M/SX>D^OL3)_\(+[I0L)+$#9R>.E5$U<V2B0DQZC<1Z9[RV +MKKZA#@[YK1#
M!5O,#S>;8A[UUA%XK=[UY8A9[;19QE:%>EOU_NYWWYTJ,,*!LM5\)R#3CAH4
M:J,WD[;+VXT41Z5S'4-Q>#?#Q1I/# MHW]/-.E?AQG51,*:1#:I*W$TF+94E
MRHT.8XU6[\%?528W]D)2)YR&E[/4=@+?B-%[\3WG/H5V49U8N$NRR+5-'_6!
MI#^A$=45_O?X%4\?R:YR\?FZ12)NT=NA/=N;T7/P&BG=9B_IB>85$E&BG_58
MI0=HO\"SJ-+W8"J?IC/VC6!<Q)7#< SZG?H[+J+L[/POIZX1-^'E3_,JLQ77
M-2D&S8?'B+(_S9R^!8R+)>DK2TS,I+QD:&Y_LOE+BV.R6RCKOJ\#QK'J)1L.
MI;T9"739>1#0K0SXN5_#$72O-MJY$<('..(%8XHQUX"IUTB1-S%0;Q2;W'^[
M=WXK?0Z)^'F-(UZEHY%PM#TH\E,;*9_I_5WLY I1=#S4M>9<2(3&=7X<]-J3
M?;=0S-JFRDZ'V>7!Y>0T%(1E9>"[9JJO%O3?38\CR$"DBS4+2Y/E$E^NS05.
M544A+"-K/L\6]WQSFNP_.M0OU?G/]=VGJ9]O*QJ;(]I9Z>TG'6A-X*)U)\E#
M[>4_=QNI,RG,HJV69R)XGKZHI95]OQ-DO<%(,8]FWI%@GGC?]D?PJ<"MYH5=
M*-,EFU4Z)+"D&=APEU+2]ZM#FQ]6+[/K<+28JBOL#4<Q42#^://BG->730)N
M)JV)TR,._]RAQ#P6>>D$C$(@U?1).TQ2I<YQ+NS5W8GM.%+>DF\;?-M+DA-0
ML2U34.HWD[+K[X&NP'3G>VZH,B_]1L8[*I$*QNS[#!EY8X8BQ^!CZ\\0:W%K
MZ-3??X/!>[K4@BY'^(Y/\+S4>!_$%S.] H@EPS5?(G97TP*F\J#79O>J=QY-
MX6O42"H>)DVD>/APOYW<OL[]'8JV"XPTN^Z<T) \>R HZI!*)Q^,W!D>DQEP
MQ M)J<_#*TH.0QM5R'\F+E\_6SS/'=*7^DGEYRWJO3SFG/.P8_C7NQ:UGW[_
M^P>HX7:%KB;3-8Y(!XNC(GO-L 76O, E>-VFQ!.S&&^"[H7?-;C$>MT'=99_
M@%YPQ@';BP)9,ECZ4!!U_-9 E7HI,%LXU?3Z[)HH1(]I3LH'7)'VSW^:4C+^
MJ[3KT1N^HL?64%CESZ8W/R?V'DF@#UZXCDDX;3H>GMN*A?H2@MSU0<YD[D47
M?+#$T.A2J^AGD/GAO>B>TVU1TWG1$ WQB'&F)PT8:WN;7UB^9V3VE>&77XQG
MWI'</SZ']11N$'POHFI5I%@$2:DCF7IJBW10Y>E\*'<UV?XW;1#:#7.Q3[)B
M^(/82U9.A._>*MIIP?Z8IWZ?[[2THX2%Z3\47K[W!+=_>'*AZEBU!$/3KLB+
M[E]+RBSLF[4>9HN)>\>_^1ET,Y>(CK%M2TGU'EU*Z5E:"I3AF&#&+]/IU\Z<
MJM.'_1,Z;LA/0L^[QGA_-WR_THGVL#7OV'WQ$%=$#(+GV[SOV/9 I9!%-;NL
MV#B778Q/\/,^/5F)=J-PTMN]8>5JUY<BAJO].[H'G+2MK])X?1-11IK'*[ZC
M25SD==&/JHZ?PJ\L'SMYTUI;(ZK94?DD;\UPU@[5#]U'OFV\F8M7;^L"J+D$
M41@)D:LYQ8O^&PBZL$;<&6XV]DDFR [W-(Q_:>]5''4)2 ")NF#_QL?,OL_P
M0$=WUE89/4:*JN6"7&<S28;+GM:7D8QZ7SY)7U].,VOVF9IW(DZY*8R8>-L-
M5EW=;AI O9(8<<F@<TC^LGL\15AM^FZR!C#@*GIR_90MO_.0V' 6TS!26C4\
M8:7TUMIO):7#:-%HF!*6C_OKU&Y#V4K">_S)!"']+^B)1C@_L7C^F,7+%A%S
M\*\J"DB]5"K=3O=1]&ET2_8&XHKSY^@S/LL'P@B'IDD)DTV,%\#NX/1U7#;U
M8HI??F3<I74$*-"*>2=A)5;OSGY@#-MY:N2XA>7F4HX-#%X96P<S'$NYZ#97
M1 5RVTU<L+2_D!&L,:>.-N8X&!(9_R7P!83.F+>=Q!#$*[65)M2,7^GH/YO@
M?3RR=Y_4_4%*M)SF_ 5?$R9)%)X0%_)KQ _H6L]-2@SY9=,IMAU6X\?O+AW$
M-]C7*YL:T@#'JMZVU=F:K%;#9Q]NS$#]VEB.03>#8\#AK2T(=18_S9K@-O54
M:OH]+,[9W+8#3@4(?2BBNCE_;ME$(H0:BFX'WR6G;SK*CMQK,B5U25V1Y<ZD
M5#2!'=6'%S\H#*AW?+4K:WJ/&"[>K)[:1(3'&85C4(BA3/FL(/7IPG_N/]VC
M!Y]&U6,N\1&X=F>;S=7WJKCSO=$.HW-*$1VJK#CGZ&?09Y_'H@6.!?]M=% K
MAG8"04"*+5BAJ>JT(RBZUZ"I=1</W4>=BG-H&1EQFJR1"TF>@U459<05##3T
MJDXWZXE-QOJ-V9/V]_42I2L6GFF(.)I?02>]"RH<#38BG$;;A4+$?9*^]$=>
ME>,-D^)3-28D;LK:[!4$F7OV/=)K9W3=<Z"R?#:;4S2?FM%NF9TKH8V4#)XS
MS$UO*FJ#VB!G,G;XJ=_N#>WJ2&3(2%HV&F))1M*V"H:]894W[J3!*P0[#C_?
M/)E*99C"J;?^W@=+,\,'E'MY_0CDYOS\1?*I@A$MBATLRND@U"_7Z9\V>1?[
M6J0'XEU(M?+ETZ3H#I7F+$1E^[_-QZ ]P5-6<.5#DRNN#==+!3812H@? ;%_
MB%MC SR$0<RDFH$;O &*K"2WK7&?JY_S7K&#H1A=3G>WJN[KEY;Y&9+*F$[<
M=%1?_"XU*WXAUV\^^QUW]OEHW0&D R"ILA_Z&^K\5$7_^T=R6L*(+L @G\B4
M^!] N<.+R\O7?3$6*",SZ?5@_CYSPBK*ZY2;H.L47BOB53LT8+*">O8D[KCQ
M#U*LCYEPROSS52!;*@8?,Q]0FR#YD(0_80PU/J%Q/Q.]%KE3 BV4D/QVO2PO
M[%(DB6+P1FE2XI6P. NRF$4ZG%NWLE0\%-\HQY#1*+*9PR"O</M+XH][#Z ]
M3L.K4-.M;FB?LHSV]@=6X:ER:%*\9*,"K''-DIADF("$V.3=#'E-+OD%V:*,
MK(('YXM#<:%/6*F2JA$UF/T8?LM2RYU+O!H)4U&-/5".FK44X? ?65I9UJ7*
MA?%6RQO5IY?+HRG$E-"!)6BKBX9DTQ-5N2 B5(W7+'%44Y(.-O:_[[('N[3P
MG"D.Z1&#8>'0_:%"'MHG=C$>NMR)F>:&'7N94!"3*G>V] IZP3(D!*@4D)@7
MPCB3>LI0P366$0;ZO=B,6,-Q_=>HUAA->G$E0VGC.R":*CX8$N&T3U:$:#1S
MOBI'].?C=:2=(R*E>/'=H&Z_?/'IOSE./Y>>K<S)U(X*J4NJHHMQ!(68.(%C
M'#.V6D%96HEQ.)41H08=LXAW9G"_ZB/I_;XO00MUPW[-UBAWZY\XZ-#:;T'F
M,FULMA*I"=^E31(3AQOF#['ZDI"N2F:=@&23Q5O3R94Y[2/1NI0W75C2\0Q_
M8:Q#DR>A6AZ+?KY4.FVE!UE/K==:"H2ERA=[RR]9BVZE/%S8/3&\<L6JQAT2
M5RW_/T"G)A@2//K:CIX@A*JE/\!]@R<-;8H-TU^AOBC9/5]OT[SYOFO__D#I
M9XYT3+SXLO,L:SVOYHHK[:9IC1QWY<HKLD"WK__Z\[VD.W]A0W):'!!GAQ^8
M2FCZT GZXV8PC!=P*J&Y5 (5H_-G[K_9@Y?+#_K%C(+RJ+<F3&<?_SU9BD+]
M"NCK[IA(FM6D1KXZRVL:WQ<O 4S2DO<BT>4\R,6;PV,?)"UCN$6CZ*8-]_%E
M\<__AF,]E$8/R$=4(CI/-\U_\P^XJYYG=6\SY?E['-@>%C$8NOTXA!U.&M67
M"6<9_I&QD="HXV2NU.I45<7(0910E$2#ZKR:4QY[JT6,\,WDXF;-;S68R0_R
MJEEVHBB';>2-/X!/(MD/GNZ\NYFG&1#C*<[RJ]17+MLKO3G>IUW4\1'<+SRA
M:QFD+(L,*R/-9!)CG6C6L<YTPW="A,+PT2J:P1G3[)>'7G!)U"5].9/<2Y%X
MV67KFGVNR$EWBYQU;)=.199HK)ZP+'3@B>G[@T]OX&C&]^=8AMZ):-_=2!P8
M&#B@D%OH,JCFQTA39,9+8[7CC2O;,?.M%SK/K:2*_S[,P1"H%U^V<"0 9'=N
MFATW'$@L*\#260U73;Z(BR<RBGZ:.B[L7)HO\66Z?P6.R9I6'CD.0:^VMJPM
MEDBH\BBH2\YH+B=8?!(:T?U!=E>###;6P 3=L?8CZE90;LRGB<5?/]3$,Z_8
MZKC6"4\%=B\$Z=MG_N>A(@K<'&Y)Q0RLG;;2MG>QGGD$0&[X:*G-/Y,=?()\
M X9,OD+>4[L;2=D[J387<:%[1+8RYV":(^'65_L[X(KZ $?JW,_>F>*-9EQ8
M.0/=>4CARW)R%)$Q[UX:$QN]]'SRA\JFC&"@=_[8IB#.]BR_!+E\ZQE$+GK
M:J:*#;3;/8&CLR6TXP(\<-ML&A#83<B8[S[%,' >[&XP;://)!<@+[G7SY+2
MNZS^Y/)[]&W_3 .1-9[J/_IC?X,M$4^Y;=<I<W+U:31)6@<[X+J:%J0!#@X8
MN+^2Y<H5S,+SZ,X_;Q^[E9K9Y[9Y:5]_#[Z08L7]\JQ&TRX)T@#LA43.%[(&
M6.=VO!BK^14_-.;T9"6[7:FFI$"L2M=^GMJME.0'*K C[(YOT>GKD5?-$E^K
MO\Q7I%$H=;#8]4L>!C.+.\D]\N/H^0V6;=]1O"OD@M58OB2Z:3H#K[;TIBC
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MU$HV%G!&.;Z4/'J0KN1WIXM'?\#],LK<[WU^EK609%43\[?Q3<V7\R607/B
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M<("--,NS?3?&&=VZX8RDTKQ]Y[KQ)?7RL>0CT:!(& H>JHI\B"LL;8&$4#*
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M=<7C:*Q[@--ZB[/IX]GXX19$<H'R+AEDR$/7*EC-0L.FDT@V 6:$0[_AQN/
M:!@*MH@>49X-G\.IKJ_,9FKZMKSD9R6[6,<LN8-I0\L95"C:W$"H9LS5V'L2
M[:DT60%U]I>VT:V+:,$K+TA.#9LL8F5ZG%X,+>L:LY]K?NS==68)N+7Z7I:S
M_;GTUR26%S7T1UF%,DI_[C8QH^> XA36AQ;-%KKBB>Q3<Q*]32;[%\M"[0UA
M>9J#![E@/HN1]WE?CTJX;SEBSFC0'Q$1B:&)Z*ORP[S4"18R?X>TY/"XZ"].
M7(^Y>%.[^*.#8?-3&,V0!!40L0RJMQ,Z3Q,T+OK?'>8-&J6GHYMF-0ZR'"UL
MD%<^%)SL@:YNU1B7MFJM"UN;FL9U_[TD<*YC&)-H+IORZ)\4E?6_,>K]_K6Y
MKXGS8_H=D>H_D[2;@2_K]>"D1IGH:$[]EY-F<;8R)>K2K$J=0KK8D9_;;=H9
M4_[G!F1AOBW1F?2?^_1-X;TW<7ZVM++PU(DH1#?A!]BG(4\(?0QXX1)&,)3"
M/<N8;9/19F%!@9/=X,WF#0965@:-D0.B"#.XA]2T=+4@59CJC22K%_V)FO)
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M#QQOH2T])/IE''IE5^:6\3[A9$/!\Y4EMQ:-T_1-R9BSI"WO/Q5%M,,^E*R
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M#GD,;<O41!+G:2*?!]VC>C[(2:IMGSE6Q;A2@;%^203BD#-SKX9T+F!_322
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M6^ /$>VBFX<.D4,*-)J46W?@G ?9.W0<CJ;+LY,HR,$0:R0#*B02_DFQ>?Z
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M7,KYG',#ZW#5'X:*CVKI05**2\;+.!MKD/LC$>^(KF-$_X+/'>\+^Y9RLQ-
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MEBQQO>=]((U?Z=N\%F<P0B) 7NJ(1U.#7?:9#?:X"':Y*?S/$C3(<..6JIS
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MLV^5=#_[H6MH4S0$7)K/Q\*N&7??Y!%FQ:6($\01Z*#?X]R>MZ9_RM$0Z8+
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MV8!0OD]6C/"6SL61]R&W0N9#A96;D<<ZY*"+P_"UC2#]?.:VF)I'%AP!4/]
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M5*Q?@!E^ +ET9DE28G)",\Y1.,;@SB,3+T:JY3EJ.)6H OH8MYA[.6X5=EV
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MAW+<V6T[V;L0.K=.Q.Q_A1GDQ/J4(--$@W-JDS+OQ7E\G'XL%OC'_ _]R@$
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M[Z;*OAD_$\0FD--"!-DZ>2!DD^*2P S7W/*  X&SU,8CH*-!$3T#.*7DQU9
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M7K^@'%U@LUY.W9UC,(NQ_M/TEA79HQ:>#GIGTW'4*@24!XU?#T,2Q=VZ3?0
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MK(VT_/Q5=+F96.%$3Z0F8IXNJGZ)>)$!)O)62O@FEE.B9RI24U3FO=\V!Z^
M@/\P;PI&#55G1OL^+;:!4!\@+[?IGDE 4.\#W.H>+( ;K[)FKRC[)L;CD&1+
M0?HV/UJ(@[F&M." H7]UMG7F!46:2FLDA!-_MHK^0=^^8L)[$(@ME>X/=1^7
MF1&&0]Z&J#:9'K[>]8!1V]08WWC =\L&#))K3:I]@NXF,LV_]J]4,:%:J0_)
MNU/RMYFJ,?X.4J$SQ8<02)O*Z/8!1 ,5B5:2U/2R]IYX+=3E7A4-JY/*[[$!
M4LEA)+]L1<-:K SB;*O7SRMBU]I7C1'#!W@F0$SQUR]].[P1..!?QXB:(S.Q
MM[%EK;J2<H(Y?=:Y2%W/BQP;^+7F/7G'6GLN_HGWG%NV5A(U7PT_HZO&<$$6
MKAC!WC]P"<73OTH>L*(K]D49 RMMJLOP'XRLS)+N]LZ7^KG"7B6>:W]D HJ>
M,48(75]R 20XIG4/1;X/RU9' MSN6H.SE[)W9R50'BW;.LL#Q+!UN9%@I*XD
MX<W;6***]MY8C>L'B]1Q7F]$C&/U'(WD>V>U?*F#L-]U(V+R*LRO5%;L<8A.
M;ZBWNGTQTHRD:@*:9#A)DH/[_XF.?=5QPMF=,MYFS"&5)_H=NBTAEZ@=7.M+
MRI1IO"ZX\8>'HKDX;7E&,\Z524/J3C)02\QA3?Z@C!9X92?.Z?M:SD-HV:F$
M"-O6I)LP-^*_$[P;#WY9IU'WY:ZI@^YU<&\-:28TB7, ^R7[W87\ ,AU,_9Z
MR,$34@97F^YTBE_41$T'!4KG+B^9CM\S*$3NIUOC=YUB\CO9[U)@ J/G'N%_
M[4+<8M<//J* ILQ3#RY,( >NX!H!:P+,:R5]0WONL61S80+3U>O!BN(ET,S*
M+82H<""8=)IRK"T9R,EH)0E*7[9.R[XR-Y </[-@+R6\TM:B>#D>*O48=\U"
MRE$D(3A+G(NZH=,VHT$Y+7NE>6 T$TRI$C,H3X[(4I(E;Y.G0,8R]L^]\\1_
M&THQ7(UZ07XY8.HFQZ[@I)&WM@[N\$+>$?#RV&/%]*<%-+2O6\W?:^_-"V8R
MA)"/-ZC[8C)EFZ%G^GP#*!H)0/[!U)=[:27(!. ="O(]E9'[3].Q%0O"ZLDJ
M*AGK3&@N8,0F44'?2X5A.)//GR)"KW!S-]H=-' C(IF@$*STFQVB+<^9?.1=
MR)0"KW5 @E.EU&J,M>PPF>SU[%D)7FJ9XT;[V>57MLU$(4E;. GFX@:4&^'I
M][%3WH&&*5Q)N.M\YN#&\\@R^Q2N_D,D+WL7\K0SD.\$C>VCE[&4B^A1D/[*
MK+2#QO%QQ8=+:=;G@\OD4I.94C9Q[6KC@'77P,\_[,"')G/:&UW3_H"YY:,W
MJXH"4OF,/L4N:PNN_4FL#_)E.>?-Q2"M*5%ON6'PF7N"AL,Q[Y+QW[ELB*;.
M"W8G([%Y;_5>"JP+#22O#S(-^;&-,N*F>\;=[W+M\%<%0#.&T85"+"&C7\/L
M?ZYG3+J"%0&QH":$,[<U.WU,KZU4+F%U1#APLDI^@E%^2_1"P*.H0XB9+1WN
M+XL19^'%--()5*7X>&:MJSC-RUUI72KF?43P/O6VI#O/,7=G-O3;J )QGG+/
MDB" _"<D+44@#J>/#A:ZH_^.2P2:KB5?:[JM,<X,7'Y6H0\;9#YS)#@\M1S0
M^*ZX+IH\)ZF@LO$PK3**EGB!M#,LBPHJ0:\B'+,Y,D%O[@3R3."JO+6"392B
MW)? -; )O)::J_GO=<$@'_CZM]>2(8LG?[I]#IY5@N.!DMG#",^UY];<5=DK
M#-2M4]+N=>+ZB9257'OS*;7J^\7/$GID/UN-?+D0+RC]YD\HM?YAENX6%)'G
M2"(4AME)?O=[=M$$3T9*!CO1X7_S<7%3!:B_\5M_07\V3BA5X0WA"L&&Y0L[
M7,]8:- KHAD"=2?8C*\70.B$!MZ6F5X!DY AA_J<"BL*^!J&<'K:%&RO^.-R
M?6U+^>NQ O]S >B)46&4!/-7_Y<MQ^:!<B<JVJNN<(@<Q? E);FC:G(]"2@@
MN8KQ477"E)85MT'YO4LC.D=T7_$W%B];'T<*CXVZ#X#MDLK.44.+\CAU<B'$
MU[Z#1<4,4I0C)RXOME1N3DMJ.7X+*,%X]LQA($M5X[N2!G.KP7EU_=49TIW8
M)-GY)RYQG"15BA;)..2JTJ%_X7]"ZEKL-(>+\P3$7;,_<<QKE"LDF[ Z(;$6
M7Z_-?N4ZKE5#RH7/#!>HLM"+H[E+&_];MS^9LPZ5S_SS57'JM4\WA+MO":V3
M-N'NR#5O%\J,"YN=J>F7 !PA/7HR W@ 3G"2W>W#+Z59/AK2R?\+YEZ\7"23
M](G5HWD;,$(V'S24C/ZFAC=!/1H/2WJSPHA7C* 9_PL$8W8+R_N,19%9;9 $
M/*O.-D4"X5](+'%(FAF!O&KT7?9 XMVB6U%PA,Y3FT$V1,ZB!4X_VP0OG]+\
M%-/'NX#& 3]2A3)W?])/;I7ANRWNOYZUZ$;8\3$3.\:]DM3CO8TG=LN%_A>0
MT2MIFD%FHSH_!03,YX4V?T0#0ZX0CY5T>EX:7ZV $8I)->II&M-V9GU?")WZ
M'4R6F-?S(83(I2[T@)$5?MT)NO#WZ;^-6P.Q&% ?]VPWM<2]EQD[%_&RAH4'
MWOLWPO>7__D87,KDBDG1YO$2W<DV -T[:B0GR^L39^<VE%"[C?GOA?,+&>VZ
M_0/KRM+KXQ;KI_PA&N[M[-*]G$_8.J\-[\?[IJQ2$=0]^-G74DM,)<YM.[X'
MS$7M8V!'KY!!Q:T,("/UH8(8$UV4G5,0?,_PW+Q!9!Z $CK"Q<$;X]HR'1IA
M[RI:7N3_-2<Z9.HG=GZO@&KXLV!X,=URH"\,G')>[X<NDH9%USAC'T[9'^Q"
MI7I*MANY44ZN@8QI*=4J6=8'?1"G;+\>)Q$0&POQ/+[ ]$+1G"\;%'WZ;,%:
M(C\!+6B.N,@RQ)R7&/;JF6? A*1/ZRDJX)/&>'-L%%U,[*9M9Y[]M^MT= 4Q
M=B9CDH7\*B38(8U>2XA4_K2_E;N#G)4XET#(^T2R05%44AC8*$=!\27U^H0N
MJ]<UID6 UQ5!K35_WK%EQS$R3LDBH?>1CA)A:GU50#.9S2JY2ON)@%:[5[FC
MRW+WVTF@'B>A.08[?]])DYN ,;T)T4"63I)J1'_TJMTX(V^8H7H-!6Z915DH
MB>UZ<!0%>9GF6 N8G# .AU>ZVCVXN%?I>4N4Q/\*^8?Z8M^]0#>W)/-U,A]X
M9/KSBEK6FSVZ"#R[-@O]/[-:W9;!6L"S#*%MEZ?-PX";_<_P_KQX>N);.]I[
M$7 L228YINV)G0DA0,[GHKMQE>R5=MUFF0EZJ.)/C(QQ#3A>=BRPR2/>PY.#
M PZ7D_6?T_(W,A_5?_6/)ZI<1&ZG@1)C')^0D%63JYYF^'NP1Q)^41FRH ;0
M',]9\U&*&5XD"@?TS.K'SJYE,V,31H1393M/.U&A=HK=37OOQ6 X\ A"]A*!
MF<_0F"8@3%ZB<S [B;=6A0#]]OGQ6Z:O@.UV+J=MFHYJ)RB^JM,L!QFUURO/
M=[OUOOT9,]8\(M)3P7RASW/DAZE71P5NBB9>C^)[\#56CWC*&O/E;$@(+P1E
MU"O)68]:ZCCX[-'$K,YB;Z<5@1=51.Z@",Y/-H,.0Z<D5Y']&4+.U,@S=K"5
MLJH7[BE5VO\$VU ?R@@*YF>-PEF-L8/;2V<<)&/(&<"HE?=;#R]!.N!$4)/<
M_F*:: +579E2/:&VTK'*S@@*3T+^5%1CFOT$IX/RI#FU#A68.<DC"(N5B*@.
M1W8];50\10J<(2_P8ED0ARU8LMRLNC(-[.)M-,U+YG)BS*S$*%KNJ"E"_OF]
M%Q2#KT;J?QPJGWV;\B[3I9F]^1YRZ6-">990,^AFZX24*GM[16@=7T(RJM:4
M],B 2<C3DHN%G 2AZ#E]/J?[EN@>,D.4N;C^( T<S--F>A,6"Q8PY4<Z%>LA
MAE=8,>0R:+@+U,XPL_D$GB24B!+)04*K;_=Q0XS#H]O2.(+WICMR<D59\+B%
MT@\VJ*M\97$R!154K-8]<_QU1_?M)!&:HACZ*0BEP]R,[0*:<JX>X# V9.NW
M5C3YFUX[\W-]YS@42R%9[%B&T*3QUJNA!CUC;"B.4GP:[E5S4W@2-2,C8\.2
M=Y79'[+684[X436F_TY\5,^!R/M_WQL1?D@;,'W2.\B^)>I_M7( K!-'+CY#
M.W6O[,AA\&')2A3!,!R97PQ G>-,6;"(PZ]IG?8W>BY!I$DG5D!+^9[GS;GU
M6@D-]*&88K,_]"^2YPAC^$\A9B-GH@>#%2/B=]F-I/..7ZF_-:*SFN%MF:+<
M>,546.SAU8W_A'K*W#1BR6GV>]L=K>,CPWBF_/5 QDR=+$,AQ2@%V;N97E'U
M5K1[-YX'=ZR^^)^0*_X GV56-/OH+"ZN-?;\P/[(%6I _00S=_WY#JK8@C=W
MI&];D,^N8!/R=.(H T)XJ*P*(&')7LG R!]4=VTA0]+ [.5VV?XJZH;H>E,)
M* ES QFNTA6,XT""9YP+:$ZR5M"G)1<=)G\%'1'*#CSD-MV"?<XL?[QNMIVX
M]#P(=GNE88DQ)2Q9X==?-S'F=;A0C$Z92S4:):=79_US::4R[N(RPNP5JQ3
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M6*[(E>G,N&J52"AMQ:YI)+]]].KO3=U3EI,?;.O?E)[IR6*2_]H9VYSJ5O2
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MPQN\C+*%;3= ^U"QXR9AJ63)V!M\.?Y15Z]1I['L#.MVW8A8GBF@E+>H'CT
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MP\[-F1=W8S#*@1DS$U]"4 *5:-WZ!*\8C-O,6'J'(9W,IW#TCKB4M5Q5CL4
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MO/"+RP SYCNIKL#Z3;J35X/7[#ZFN60-;<U?M1Z)_N28\%JW3TCJ"=9?T$5
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M5#A$)]^%UPU*62P\OKX:CL.X:;<,3$J/D,X9Z \#'Z4 [V_A$6I6#&K7V<
MA97DA L=?Z6VB)-31O$=@^1&8]HR7RMTS!+VII"DWSE]4E!P;X8&NEC\8RG)
M6&\*S8EPZF,]C6)$8K6)6Z?)GM)F8=FK%U\8T3-^ J[5;,18 A/":_2BL1-"
MO-VB+(3!D*P2-(\G'%\FL?IHMPP5K$,\N>^4X 9/8*!^4E87XS_YKH4WZ Y^
MM^RN8T)2SPLBWY?/^G]:"D/1Y!!\1Z!;G^;@-! 8E39Y\0R\GN3I.$9@"LEY
M=]'5NA.37E.O5PD8:=9+@/T0-M6KB1,69M!VB7*"3.@V'3F7%/<9Y9]FUU_
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M%0P852.*HIG>%V.CUG/E-VV5<4>^8V!LAIP>J@#8.YLOPYAW,UI=NDQRJ#Q
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MCG>\PU97$1Y-^U,"]JXCZ2SO'/"W:X6+C-3)JSD'EC$VO(+Z]S$'E-.C D_
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M2;>'0TK<9EE>HX$#J '*!_T(!$LK4*-:X'#][P)_D5'D36<LRYX[QRG3S:?
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M (R@Z*OS ,/JY(1=%37B<\\ 47\^G@'"?#5'Q8F25-$?F&=4507%5"@=5_4
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MYS2/P%WLE/;C._!R,JKLO[;F*]1;=%M"B5M:9YWMA"IK6J7%B;NT5#]@LC4
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M:Y_-?&]?+4=-]GO,O=/:0!ED$+H!!!YK&\_\RJRU9JU@V>>D(L4A'25 C<6
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M70BFYF#[SW^HR>/0L65T")A9FMPI'9X3\$&]-FBO8PB1$OMFTS?11DR+(A$
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M@,X\;I 1SHP\M_F3K9 :"=Z,Z[<3="T)[V6++[21NFN:V+_$X]9\FY"6E_$
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M\X%<)>(6(B< <4"/ 6@11@0A=PLKE-GQ: 9&1#&2= R-?TE["ZE^U+;:8S)
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M8=F[YBV?5&7&@#A3 <+-2%@GQ)EN2C$X,@V,>.R*YQW$,8S%%KG8L<+\F"%
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MK@ISYN*I;;X3\]$B%RMFO7G&+H*S_S[%+SIP'*WK)7<=IA_"*D8K[/)W8+<
MK>%[*>E:=SGGU6VB:IX,%^3'L>EV6+_UNX%!?LJSHR<IQ!)[V3_IG5@.WTT\
ML+7[PW^V;QU%/ /[9+ ./<N(%_A\-RG\P&:[GL3.!W !?Z6]F3),M3Y#WGLZ
M5:90/2S\9A1D*@74N?[(*4B@6[O=(61]9]G*/SF2,Z)=(^[^RW5E5J>MM,9P
M3)NJ'660C>!.[V89<G5TGI<BC5UXP,YQ@8Z&$#I6ZOHV6ZMUU<,S0&V^U C#
M@@.QUR8!>0@K ;\;.+T;T3)1.<2VY.5=J0%I9XM0: /[^([=*,B[CN/:G;*V
M'?/<_P3],Z4 QX'U92<"/Y#8"0K%WJ%=0 ?F=?$S--BS=*_(\_8R^-)+TR;M
M>HXKX>"$)^'^>W5B@WMKV=/?GW &.4!+3'O7$@[Q<S-*$J+ARMKAJ*U8DO$S
M:H[:6FCUIO!LIVZ3M/I:[$W'80^TD1)F3Z(QQ:3-\_:)(C,,=<%K+\ZWZ=JU
M3>U00HF?M[2_W@#8]_O38>$+^>&W-K(^VZQJA5C,JTZNRPOW]JBFY42%RAA0
M@VZ27C!44DH_KL7:0 [WH<D$HE7L!W16F #U0?F:ML5OO.QWA4CL*,8O]H>F
M>AOY*2E?_<#Z*@QE2:.9[!,+'*XL#QU?U8GTH"6D[<0D/=M)-\8^QTCQ?J"J
MOF.F1V(Y;F^<W8\.VI]@?4S2P+^&A'NEYONFAG >(Q1F,]XFW9YO5 E1WTU?
M*G&8*#.G3FUSZAI2M-,,5:(^;N]&*/%GM#([)J CX:/)[ 9G9![V'NI<$T=/
MD4[K8OP351S=&G WG0\9=V-&-&BK^"RPG!97\2S]214+)6/09+*+"6BKX3::
MI,B+G;3]F%VM\[TN7]W(JV.$W4R!0NGY-6NGG0:JEQ5QAAOQ J*A"\G_"9?G
M/_VWCQ2WF!.LW3D4PM6&I+QT,=/\KXO%>R@.(3EVER3KOL5/B$_+RG5"+MZ_
MNIU)0$W0W)#-S-MXK>QAWEYOT7&OJ"RN#+>6\+LXCU3L3OJ\- ['UT*.T;G:
M[CTHQ[Q!M_JE"\((LE,R, [WOJ]B:2H3MJ4]:XIJYHQZK3B+S9!(-IEX1O]0
M<(7A)#E;Y#;/<"@06;N>H:J5N+L6DZ!AAQ'*6CL@E+#,V>&'DR:OU#?F5FFT
M:Q0<-'A .,1R#TM\ITPA]V*C5W=1(=BT ;>/4,9J\-J_\0*@.N=%0[=W<=TD
MFS:P3SH<,3K$]^2@^,_6E>V,9D(OETG_A=W(GHYRJ2Y!0S38/[[?GQ9C.GK]
M+JVH#,FAM1M&"VB'N .][#_)($9/&UY\W%-7GF3(B^H9-<?6G$YS7[S!G-)]
M0YU5K>*Z=C?QT'Q6&?-.9_3DZJ4AABZ'%.EQ<4']%S[Z!<X=XF FPL5_F=5O
M0]^ #;WG\AOS>R6EFMR1!=;=3&,HO:9W/1K9R/.ZF:\ZP1Z+(934<WND^7J/
M&L]@5O__V#.YI<:M&E9QO^/X86R_!54)_ A)]4]"8?UV"4N1_6/B\UD25$1_
M''34YVG:G1Z=Z4=1U.=B8/UR9I>RI)1+-49J-Z0+\GF?L,K!H=<U&J=QTNZ3
MQZ*@T?D9QV#\9%520[9D/>[E)DU5O-?^9H/O6Y?G PCDJ^^Y %Z;BH&?UOH%
MNT@+DR+ 8/B0^P0S&._NX&=MT*.K"X7F_PDTGQQB<)@^"9/,SZ54VBB+C>,L
M5L-HC6-]3F:(34R!:(#XP#SP41#M4Y4&5:*O4S"'PY^@FL3!RSB:=5LK/O+N
M4/KWRAC^\=L RJ@T\.&?Z1U<#ST%6CX%>-L9YHP&(DPB[)UNKZ.Q\0;,'&[U
M(I_8P?+EKF'QGM#YK&C"ASB%"K>56+.#28C[C"R]6UVHBX_.\Y>,E*->Z\N<
MW-U.:S5X.$6>\_<E6:0B(^@+*LSR##Q[C=G%^@"^*9_NTB>Z/J*C"*AOOQ['
M/?PIIV)VOTT(57 AZGI&&Q8K*K%[D98_14&OI6V^7=SP>XG@N92]<\[#9WKI
M73>#HXJ^!Q6/QK3UI8EX'G88'21=]=1MZEF<C\DH5"_-_FK-G)\\U9+OT'R,
M&(HXPX*OKZ:.55Y 1*<!,HF\AC<L677"/#RI#[W"0X)N#OZ2?5(ID</U//>+
M@E%?=MARY86 D?DK7LJ&X<<PQUU"XJ! R-%=9S^#!OHH_9-U$'35@D %:P%1
M>:OB(>C1Y;_,_UDDQ^Y0(M4V&:;^UPM-!D3P'IM!+.(#W2?.0:CY,>'T)\.6
MM:*^;V+6XDV=B;3#2D)/3D'CL71*.6G@<HW-2SKSC>C]$\?[]+T+\$2*O"B?
M*F_W1GKF&_TO!^UW3INH[(_4YUO6JQDP)N]6K"Y.F-\8I7:^9'-BGCO!Z@+W
M_,EU[3Y*P%"-CQD8J;G=G9/C?#& ARM0--"<#*]TB[0/H\_"O\..2R=7@.[<
M!KOMAKN6=I*]4R50TA(AYQ_D8BR[CKN0T=O*DG<AP+#/[;FQW5L3[/36A(14
M[ ,"T=*P::I_B#N4=FX%1P>XH<$0K%WYJA>[!''M.H]_B'E%LHBGG##?U>-;
M9[(#VZ@J=^*:U%R)/^8'K./SP+M3W&\BJX-T4DC>\#VAUG"8,X.PK1 3@@A;
M%K&[+ACTBFKANUB"-0#H07F7N@2>\V*.S&=;.UBB75PFO,5>GB/>$HL]Q[K[
MUG/XE#P,?M**?P2-;!A*?IJ-Q'YI8_:\A55&AU=?0V,4)0J4@2$N_#=GN/2$
M0X5>8N6>&SO<SJZD//YVE+]KOYJ9U_0MH-J0#K6LY7O&@2==^^YZ0II6TDH?
M^\CV0"=$.R7TT/58]B1=9T+G]IU/.S$&#^5/YNC)NM.L&;G?JT9(T#$SCL*;
M8?:=%TSFFJJ45B@(2TZ*_&5NR>SGF2)G+7<T:LGBBGR9KU'"G.4VM1&*?Z\'
M+<3Z\WG:]'HOA:9LIG+^KOZ]BX,94=203I;KA^%8^W^\5TX>MERWLG.,/JI1
MZ]DZ@K(. "*L-$F\FT(Y7_@CVY\F#H(OQ1 J J#?RM2%.E6-.Q<+>W4,&*-;
MV(V*(G*RIJ\Z:$HA>9 D)&1#RWXM])Q'>5<-MYAAHCZ46Q<EV9C2<R]3#?\H
MWHN7^/>3TI*6#9V&V;B^S6M .<UV_#TC1==$[1E0Z)&9J!&AD18CTKQJ'I-+
MG[^S9V?G"CMK!VO,ZW>:R.=]1@1);SAO;,2?ZQ_ ;MU>L@/DC-WA]P"9.USI
M96L;YEI'ORU^S4R?^UZ^RVY,+>'V6SU<"!V4<_$HW8CU+^R?U*B<:F]CR]K^
M'PNH2R*Q5\BX;?FA@J)2_F),W/]8C*=92%UG@NQOMD\"[,3%UNWKQWTR='0)
MD3>^K8>.:&&;QF83T_2BC;;/@2RC122ZS3X_@M47M2\N=\%BTU@/>C,BP%)#
M6G+JHRK"A>_+% X#?'ASUY5XW?'(^K1.(T0CS%)3-R3<HGGC V*9+TZ6,KKK
MVH*:X/)6:YB]G*;3WJHV\*+0/.7K[VC:1;J[1K<\&77]0L_-CF/+0>A6?"@Q
M]1_?VK$G-R:J^%D\&*#?L3I?K5="S$N)AO7<ZKZY!>PJ.S/&#BQHZO5/-'R1
M!TW3^G\L:6LQ[*'/DR)LQV?ERI?TRGW0P"L,$8:,)0_:B#+D"UOJ2*@_D\2^
MY=L'Q?&D[0?P"LB"+EO8OQ\MH$EN)AXJ:T$""ZPLHK.)PBZ21/,>>9=^T[NP
M!/7C*M3UO*6]^#6MEFH1# ILNN%!!#)#GJMFRB.#[B+R'N_$]%3_''3,'59M
M"JE_%#)LMY8;M!W'?6VIRSY_4.3S,# +?0=(:9(7;0G%JZT^_D,G] JB?)'3
M WR6[0X L>.%#P(T.ADZ(:B!BQ@QT 8%=;%I:W>VWV5]0"<QS0X"VT*@L9=^
M[$%KZ-W&^K?(R:"J^XEX#Z!^/AFQ\\' Z('[^21#/4DS3]RC,(<_[#3RYV3*
M:+.4UPB;QK\\FOH[W78V0^?9("\V"#R/\T=?4#\HU!)%HD\[H-:C)@OMM)?=
MZM@X$A2\\1JGF!%EO5HIW4%D& BERU'&CB/1FG<O(O>%.SB-#UPF#Q9C5OF2
MT@6]>3M5.G -AFO%V?5--JPLTIZC[(!E%1F[+@,</$%<HG*0A<#+'NG!*T$(
MR3GHJ?$3 &WBE^.Z3^8.S+QGU(.<YRF #@>A/%WB,+(SM2JDP%#!6&6'KJP[
M,K:NT]ZY83>B02!N+A159A"J8G*S8U,K;>:+BO^.FLN26GUNJ?,NX-CV#Q+T
M)G24V; 2R:O ;GC05OVT_M@7<T__J%WXP:2@1%,JU^/?G3A9@&8EQ/#< =0V
M;&0J0*)R,9&$M;S280W1Q109<34NR,I\/&MR-]VJO.(.WBC.,08'S_L:0*@#
M*4-4X]C6PR4=VZ%=$M',,^PHH=L#*/2Q= 6UD_<O/>ICQUKS(Y7 _KC[MW<+
M0_;7M*P1A87"MZ+;SD+C.(0*@/F]=^=>(I9T(8>M03 =(FD:$CNY%O\ZTFP]
M3G8'A_7]/9,4'2UH&E+ 0XY 5VV>!/'/]-LY6BL5%-6$>DLG\[;3E27'GT@%
MV604+K-3/M.$4)G]LC$>SFJI NF4A( QZ;C%_ &)D1[U+%B326O].6D<<^;(
MPK5<&[)%\2?'GR8$X)Y,GU_DPO'-A(':YPZL3T57<!2U0"@\GS*D=#$$-OO6
M35V74,42M%/F/ 9PULT,;MVTD_&_GG9JA.?"#4%<Y37SD4%*(8N^D,Z--!'?
M^5G!>-ZM:VN!%9>W[J/2(I6,PG?BV9'3,I="I]F?PS5AN\OAY0X@CP_#?.-2
M'AK=IIR$SL>(4RQ;E3-"2HB=TN2D.9LYH_JDT.T8]FF(9/LV%O+\:>5J A$H
M>X0=VYQ9[? =LT0,;<3H_\!C% FM".B7Q^%38]T<09 VC7:^S)$NEJG]] /8
MS;Q/ZSE7'QZ<D)P=;W/R^R[/$B(Y1F9M:$4?-X>E9?ST(G[#.L:"!Y<.&K9Q
MB]@O'6-BUX<^D"S)!Z*^O!]Q.*,C6@PD^C[FVJP3WYR^QRFGFOS?I7-B"R?T
MSG>?:TK/@3XO1$RKVU3;J9C\\D.4&4];(.P*7+-2N*O"'5VOI"877G4@I'CE
M^/[R[S1%D;-;A%PI+IYLT@_\,1CJ_=5Q5RI7FI!#CMJ-##" )W#15][1APP/
M)_U+YSG4F?7#2&/Z?-SYZ2E>X6G[T?'@3;\^0V2"OKF/:,@BRD971-9\9_3Z
M!7?6=&K7(%E UU(4?@:^]0ZUK+K'D%BICP[1<*2^*)Q*91L4+)"Y<-CV4-C>
M DE,?7'2\Y'[NG-M0@PE'0B*K&G/4JU=_G,WR2DK0%DPHM^.]/VGJ;12NL/-
MF9,F;]-50;&(*T'1D+UGVQ9M,69D/H5?W8Q?S[I*DPUN$(5_>Y07/&89YR.
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M@G+C^$G_MML_,%GA[4Y09.;LQ4X%\+9M+T6#EMQ]FTM4*:(Y.K!'(#H9WV\
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M;7989XZG"N%K*(F<&HYD4A0/USF8N:%K+7#6[%\X_*W@)U[NZ2:+6'X/V?)
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ML-8C_.]4U"0"L LW/BHE4IP>Z@3Q>[XKHT9%D^$3>=$S[5#,P@E7079P*-&
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M<C5R.[LO"6# TH?(E;&OC!WJOQYQ3AH6RC'QT0)1YUS^2^P49>$LDKWZD&.
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MXOJ6)+-@,EU \KQ/2M1Y_:!R?<!>A)0OVX/N.DNY>L. %$0?C0YQAD!G=!O
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M[6_RW4W"QWFR>%@Q%S@U1^ZQ\IFLNJV GD(FDAQ^$'"YZ\\:V4"Q/B-; Q2
MW/  1A;#J174F51,R*9\S6K1#W_&++_=^#*E%.[CI;*'[@F3D#EEMBI$5*X<
M)/2&!=TS4EK3=!)XKT\)R@XWQEA*Y)C<24YNH0QR9PW9V3*SR_10KZ<'-DGU
MZLKQA;2_U/92D@-9(P::R1OZPR;CH4B)HU28,V=LU!X2]TWS&?AL3JZBBG7
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MDUC7A\&RB7&<:^N!?7+\>(VI6IH#]8^N2?KC+_M/C"? >@Z*Q!!7,Q3(^WL
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M7=L PL7>@8)@8.21_D(LA\X!Y4VQ^.5&8E2#RF8Q3 ,.%>7CJ1-MQV@W &"
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MO5&@:^$G#6.Y@.;5>,S"0#*286]15B!P7 ,^-?\BUM+<AL3 >JC+?5N?B#>
M*5+RW2URT<MQ@!+8R[ZS[AFQA([-R8_OJ7Q94&<& M9D<B?:29TPK2RLALZG
M8W7:%S_W/+1XGUBU$^I0XMG(P_\YD0CIEI(^8YGP7D_]28OKVJL%[MR/93LS
MI'^T%6@(\$<=&P?.7%5P?C&]%3NK>/PF5P\=/E[;.]YH0/^5<0@4:#Y:F'%R
M,$=3MH@_*5;?JK/)FTGCC%PO=LP5BU% ,96J_G-HEG#_!KK"BA7*TD=)IYI?
M"-E42NK[T&BN4^- +[03.!Q)G;'"DD\3&EN**Z:I  <ZS&(NR0N2;,ZM0<#9
MMO%U ]'_J#YDRZV4F+[>[SV^@=F6.>@/%X8B#+\3BKZ]KT*,2C00@+GR,FL'
ML_;.Z^^G,C+O*_[I$K?@&NM^S<,3>H25$]4&,7U$O+_YX2U\*PN>MQP_RY[4
MX(;JN3_$HF&,CEGZ9KENGF#M:K1Q'=TY+< \MK8)F711 "'8_GH%[[OD9793
M03W&.+7DJS%&1O[LIV6\1YV=VDY^[RSL6(X2_%1H=C![JA<G"^DU7L'GR)K(
MX<^6<EKZBT[3CPVJV$V5L0AUXQ*KHX3ES7\FA2I/RI<B7.WET)__G:QE/7@[
M14)(&J^7@/G?B;S)2'BC-5P4":KI@39)/KY':=KCRD9$:TI)3 UR"#RT3%+<
MN7#<3-94N/='*J1:X2/61Z#TCMSMP[72II;-VH?WP)<*5[#636IQBW%H'U\3
M)5P(:46=T2'H$5]&8#KN87[L[0U-5ZAPVX,8N!KU-(^]E3HX$*NJUZ0I")[!
MZK;6>JBNL+3%\:/EZV8XF8*V-GF)1*U;[>Z5N%_Q FJD^JT$#Q]V]OI_LK90
MF&]>;?T(=1Z?GK 'UA*,WMUWDM0--("#?5  !F<I6X'M>DH7U^^8C#))1KBR
M<A6D<,\!:';J :S.J;2"(C=CZM4=CF0&@FB$="B)\K\J*X=%AU%W(FX;HRO!
M%R  @^OSW#HT[G%I\?TL!F_*@X#@+J\$H4\SUYR/QVDGU!A%__KZ?U1O$.IT
M;Q);WM(W,C]EY76+@;&_,.?F+(*@7>NHC-JPAAPRM_^C>G=U9&KX)+-%CKP2
M+6\K9!28$\/-S?*KA-_:WFDFL:4D'2@X.(=_8:*;A]%^(/9\61.?-% D5E4:
M#;)188 &$S]$N=P,=/C?7K9.-PB1^7[O$F[&UJO +H5!H;O#HZWDAM:C'\>_
M;(1B.&Y>[B FY'<X*T0&S-[?+#A6=(O?J\-:/O[NL-WF%7C>=4_^=5IT9LM&
M0M/VFBN;1I?4D&K=68CQ?U396@&#W-[F%R!O]X',D&FJN1'\M.R_Y/08<@\[
MW,69#\:)&:6NCE'>&W2ON+L1\TGXXNDB@.KJKB9H2=.U\"M\DWG-=U%%<YZ8
MIJS,P3[0ADWC.J,AXK:)([S;1'X3T-,K]\/%;8$?R_[MKU@B'UKH*HXZLAU\
M6-TEZML]+(GJ?QER;DWB^?J9YF*,U_K32-R;;^Q1J]O:;*L56%=Q_G$ZY2WW
MGK+7(5L6#_?':*.ST&LI'[@?>@:\N(&\DY5$]3HBVCU:%;XO,+WNN+M? "OH
M,BHUF2G,#U/-^[ :3]W/'SQ<>G%7C]\FP9L9S??;+/,ZI#L7TL6/MBQ8XBY\
M/OPK#<T'.S\Q(Q9\B%__'9>G,P0)%Q?,G=&7]^8S0GV9G@H-^!OS"^W5-NZ+
M$OD^A96!V#LHA-5_5+&QW[CFB:] ;'P1?HZ<4;/M-,!QIZK8:6G(<!]<34OS
MK/GHWDDB$S>*))GT!9$E+3)EL%6.8ML1,='TYX8S9GR&-#"-)[EJNAH193_!
MU! 3/.6JW*/?DD/A3N*B.<BY:.OV$3'97+:$LYKA#N*E%,5_)LUCV]KK8'3<
M(N/M'H9#KA[.IA2B*:W3HC3L,*?$RC %>YFFGG7/ ^PCG#I-1LMSF@%$54U5
M*^7&:\. 'JSH="#P]:&ZRG@,.MUN73"G$ORRV@R2P*KI<SDHHAP^K)%%WO-B
M<::<P1M?YV(\FRTC,@AS9X?F06<$,]G5RU2=8_WR+K]+AW*1XSZ6BO;,T$:Z
MRC4?%?:9:EGTE[VJS9?=S3O&6V6  U)FBMV<O+V-BVSY"B/PVHI!\8PY*Q#>
M[)^XL=5$YQQU6:^QX6*3B 5CWPH2.],!7]]$U"IO;0$Y=&^=XS@\%Y*4Q[%F
M@G="O]G6T,9C%FLI%:#5BWF\ ?,Q8PB&&RW[1(@<YRV6A2\.5<-*,XK,[H3?
MJ>WKEF-IFKGL\BC\X]\Y' 2<T]!1/#1@$HYB[(_FB,4$;1'4) HA>XZR:EN,
MKUPN%/ZH3FY\G'1*>?0K-U/3"?O-DN^DW\)\5O6L="C=[5#\2DOM;+CPF_>K
M7CVS6M<6J]6,MK[^!(2?,5$#Z62IJ=.;PG371<F6ZB4D(J#6WW_8X@4UM?@C
M,M^#:J_.-49FO8:WV(+0;EI^4<&CE2><1VV/S>+X,+*0NG4CT,-W\H.\I?W6
M28@]R74&'5R+,;/_8;2EO/A*3D"'Y%1UP0A28*SJR? O%E41@$++=B)G780S
M)Q0RQ$5 T+60C9A!EE_Q2?*F[K9U@Y-O+P\6_PD9,(LS]Y7@YVXTK7']-WB6
M**]Y^H_5L]S@&?IM85>N<\=<C_$*"=>DR='O]>,3W&N4S1Z6W1*JM9WNV^HS
MRXG D 5;XK+J3H@I\,(TXL3@D[0\)^(]'8-\ZS"MZTJ.DCPHUHB6]DE2P-N-
MQ*L AX*4;N2Y0RWBU;I96WPI&WM3Q7Z46?_=K*<N$)&1?/=,&=="MX/ T05R
MO$E58=%&Y:^*EHU<XN:4NFL#I%B,D>,0RSZXT];I.L,:@!^/#/@B2XC*=7<\
M%^6.LN#((_QZ[V;^"E7!"7$@M\6A2/ET;V&2&*%"DF':@5 0G4@ERU2V,38$
M<>^' CSIF:O9*%";4,S(XVF5:K62T"B[,G/7X5774%I>B@,H+&[%3+A+T<+%
MG*LJ%Q4]S?OL\N.7&KM#A+'/)0N@2S "F9OCV>LB4BPJ;$ISTVPA[<Y2UY<W
M4S=+#!PA/5\YY(&D=[/LJ1A-+1O-E1G+J, <C?B*E; -H<3Z!-\QLHT**J.K
M=GI-Z0 @D/\?5=;9C#RWZ,)P+5O#0\*FV_C.K659%=Z[AW)2XJC)QO^9_-0\
MK39HSA'WFGI,=^&:^= GBS)E*R"J.;/Q:FNX:!%>*"J^MUIZE2-CLE.^S=)Y
M2BS!DRWE;LS83<G6JNT(PX[L-13-(S<ZL"I%I%%JBBG74'#7:NE[MXNGO_J+
MD<=GYB'2G-_=4PWHR,2]2],?.WQ>Q)'+#W7@$X<WD^1?<?'Z[_+S?IJ]9<[9
M]7]0VH_<BJF*:__63T(M3P+RB(E;?H9O[B""X&(>N/V'R+JG36UG"8@G@IXN
M/BJJ8@R$%=DVS=/,=#MN2@)X)?N 0]XI8F!M-4.\EH\_R !(SJ#H,WO0NB<A
M;6O8!C"^D3(\$="68')>/)<KRR'&/3.0;D0(LE1,N:_6HPZPK9&6B_G8[Z-
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MH=NKRF A+&B!>)6TLIGZT-W6G(K>,999N&]JE.$L[2.'\A1YL1P^6Z70B&E
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M9$_CJ;6Y;./L6@R(EBG_%4?U:Y\P^>NK.!ETIZ?(\(CL^<GUZ+M'_KR5_!^
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MD9S<ZP;RK=SB[AP[[+:JJ)6/@V9DAQ'6L7,TDSVD0@/KV/0IZ0:JGQM($YN
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MVA4U_T8V=0';*ZCS3+4VP6TCFZ*R_05!T)O3(49.SSB2SW=3'(MP3:49C#G
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MAI[4\S^+E%I4O6&P3G$N*! =^4!9JJ\+-DP>$#TAE-!@XA@CB$LI.TS_9K\
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MNMS3YZC%A%'S^N%3)/JM%8T\-3 <S!"W&GH./7TLU!54I\[<L8Q3T*WUDBT
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M.V2.0._#6AK+NA:_+,<CA M,9%/Z(\#=B\3> PD:+=FJ^1V^INAOEER^HY'
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M0B,S,]\C54$5.DV;] J3CT-JT*8-L&SR3LI"EH&1+015PT=?1GE ]Y.90@,
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MLVL>[Y!UKWB 9">?37HT+8#' T5??V]SF%-=XE-MC%QNHX1^T3Q,R5\SMO$
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M",KD4@&$!SE>"1E](YXY9.JG&$J&#HR0 U#\*;Y6$!.(FX.TY98IV69<!?E
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M:$Z=+[JC-"9.%OQ&$\%-T0^1>9R<;>F:SA"?:\"@/''ZOHMN=@'R%$C)C64
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M^CX7H@8M0GI6XW1*^[SF%@*S&'QC]H>V$C/65\$# :EU).X)O;21ZO-]4C-
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MP5/9OEP^KD@V!/PLT9=J;K>EQ%-^^Z(O[GD[4=D##-UW<4C\<;L(C*.II>]
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M1@7>(7U09&1T<^_I8PL\J]]"@+_'R3<(K>TS$NN^6B4=:8TA629G#?6G3'%
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M,NO&2#Q PFZ]:H,M=(/1,I0X:H,Y[G2NRB^\*6 IUC!T<#+H$PRB'ASM>MA
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M9 YH':P%\LT';L/FW8HOH]\8XFJ+\,2[IRC- !A&.2-TLY+,B7"[@@U$1/9
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MH'YIP90#O#@_PET=OX:/3$\GN^=R '2.+GY3Y:IA?##PDJ\RRY!%DTA3@^2
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MM$N_Q+&RV(:+P&EF:X_+,?UB]5Z_9[(>[;;5C9,BK;3+ &]HC>YY>OB/[_\
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M[=_SC6:+1<<NF=]D!]X^)IB80J-+N"!8QKT.[247HM-;Q6\D!64*HLOZESD
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MG.Z12W$\D[(EK9T4VF<)SW5T%0@;A4/O#&:$='4=/4H#2#G/[IF8"!?OK?!
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MYSIPO#/LB"Z%:_5[DC9C#ME;D#,C-Y[_  B!-^%,,3?)*S+@/,\D7!YCH_5
MX.[6\ %-IL"N&JI@)DZ7NJD]F5>L?E XZRNXH$\KY+$]+>@<ZX9@Q?5 PQSW
M/,CD>*=G<X/KK?!1=+ 8.NW8)GSWUZZH"#&CJ;N@%%MH72GWO?5;V[NI^DC0
MN5Y("Q>5X^4Y:E=;FIC##//&>2I[97N\\T"@=C9X/X)P9Y#EC'?'5 #.&%9\
M48?8=/'&R@P:OK\($Y];WK/X;A]V^"!&MZ(&?*Z.T\+$4=P?>B4]SSLH%K'@
M,1<D#7>&24EQW'7+3PB#=]D0-^%GEJ@#Z$26)W\GQY:B4$[+L7=DI%0Z^G!
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M, X<;LH@Q(K]4T6&YTQ<P@Q$_$R(8;HJC/"/Q]%!N\.%YK \*.OB@PA\X^$
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M'I=KZ9C8^FV7I?P^T;VVP:8:/M]GJ?5,GV$,M!IMH%@-P: !"_M?_2W^A/\
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M_P!RGI=J6F&/V3TGI]ELBUM-HVS^):V&TVK)@/3^E8V[6U?_ !@@#:;8,N9
M/M:72-T\=UK>5L^9*8WSXSF^C?TU_M>_'?BO9M6?3;/UGK/8Q[O4>L;]\B7_
M ,>R#'\;'M+R'"HBOTJ?UTL;/:$;79;,L[-H[,-#V;($#_$-M/>RR3 D2$8K
M\+_M?]Q6QV@/X_\ !_E/R'Y+\OM=F=ELMNWZO8_C/Q?H6FV66F/4^H]0SZ=E
MG;,LDG_H;%C:[0^UP >O7?U/]"]Y/Y']R_J1^1_-;0$-G\=^/]6U^/\ PGIV
M7EHL-,@->I]7,!MO;[1AEMSQLV1!:BJ\Y>.5H['6+<7[8_7OR[/JMAL?5L
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ME#Q)<!HGIU?K?6G);X^9$GSR*> YJFR:(UMD#X\Y39 :29?KBJ\<Q?TX QB
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M33Y6_O.K^5IMCX7H&:".#GTIF,6GLF,.(Q@V4GCL!7EE>_,Z:3_"\30_^)&
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MSD(6\4!3M%50FV]W\X&%>JI@M^(<5)I\J56SD&Y".G>6]=68=<]70U;6L>
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M3^F@*1X"4S%^J)_$_*CQD*0B0>8VP@XXC!.%VP)%>8^> 733]7E:-($K=8R
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M-X]J%G<&+\^)T1)D:HRA*!"-'-W;/3T.:YU%FI J"K;RBUQ1Y"<01Z0GKI
M]83D-];2<KTVCSC "*CZ4:XT? -F314%K4,&8VN,1P=7/WT%OSF=4=]M[45V
M=KCD)(!GD0-19#0Y>#',N--]DKS30$ZYCY@6_C4>&V,GJ3W=UI[/[1APD!O(
M(,>3[4428(<B?AVYTC$S$9@9*S^= >Z RG*=!F$W4^RV6O0&QFCG9*ZT60=)
M;!S)U]9/56_I\I9-AX0U[._P^R">3NWH1OG4^F1.>Y38N]>8WMA 9E#\4>-^
MV"DPAL/O*#PF1VRDBS_RND$$%]^OSF50;4B!/0T*,C\QUK7/9\;ZUA.VM_NZ
M_"#."(.V-*EYY"5RUC+57B[%">$VXH<D ='A;1"1">&_7Z&*7M/P.V%R3PFT
MIH/6G-)FX:Q*+(M>1&8\=Z'80.XXK(+D9-0)M;8\9<7Z02SRBOQH3EZUOIZ=
M[%UUN._ ;EN75!&T)3<@7LPK'Y(96QT"V@A>ZA[<;K$N=OO''/5)V_5IJ)#[
MG9#*--@A%4%+JL6<YP%ETEX;C&LL!&[:A@TYKY,[WPE-7%;#/13,]([Z*;A)
M6UWWW8[*(>@H\AE7UQE F'H*$T;:;X(X>RH(\'2B7J[WW(#/>?YF.C<DI_.J
MG.[)9F\<E;?KY;E6A^6X61L5Y1'J2QZE(D(4-UF^$VCG^6!<<:A^7:R.@(N<
MSH0#UW65%2!HCW5JDV[^2(PCFV7,49/)&6!-A??65GR_A'U>!3H3\PE:? (E
MDZA.M/R0O%]H(G)#8T-;<1JI52OH4DN9P/DB"+A?(3Q'K65@Q$X(.*L,T]!
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M07WTOZVV'_/N#P;I;T TI:3(%P/U3<L+RK=F-1 WM[<V(I\\Q2$SB[YR9&_
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M]<)JX_:;5[(.XOZ7A)S4T*^$60IS+1ZYKFEV(MWUZ;H]+UUZO?CPYD"/ 69
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M8&B8;=#7<_*S?Y\>_$$N!@Z.NV_>PL\@4Y:0^!0&1G]0T77!5K^4"4,VOLM
M?LHM+F2 J,6(D%9JZ,)U^0Q;<$-YF=T02 *2"/ZBR$N'@2'"?!%T#?($G"Z,
M]\T)K0GKAZ//!4#G25-CW50:W-:.&CPX4%X5 J/6C0""*EV?7;KS+*G\RZP^
MQV5DAQ/G@W7D36W">HYAJB&<Q#1,-WH4%EH3$"Q%YD[JS6 /HQ4W7 2>!+9V
MYA _@;R7EUM<0C<;&^HCUC"L:H=5DNRKQ^OOM/[,:$G\@G_$C<Y^=,3BX"];
M",=EB$^^T&)7S(5X+LA"1]#&'\0JW-A* !?W&]K/NK6L/W(VZ+OQ];?7)PPZ
MR978M^*Z[2WK%)Q\O(IAN07XVF!N [E:8VU&+0X(@30\!G,1*P?[8-D,+&4+
ML&.3?(.&JVH@M?GS5CQZ)7>4$SXQ86^"TD]?QWA 8MX(I:(ACSB0-&&J?]%D
M,T<C6-4_H24>D%M!&5&78<BLO9)S?':\2ZS/MZ[B1%\#10-/CT\SY00Q7!3N
MVE =5*P[IH:DCF"7-_;YN79=OKDZ^R+,#B_PVL@1J/2#L/\[WMA+Z&@<:8C:
M E"J%I'-Q3\%QN<U@*S(F$<;IUU[MP"%D!'P4C2P<XEL+/!<@F$\5^N/@NJU
MR%-;  T>X>)\@Q1P00U)":&6,8A$>BZ)<D=5:N2&75^/Y/&E\4_;A0M)DU=D
M_^]8%=2AI<#JP?\-=?W&)ON"4XHZ%.\>/7%@91PO[A_> IRIXT"(XNLHQ58^
M!%K&:2P(9+J95[$%,J!>!IQ43"<.5]]$YGA":S-N#_&^%47F41[>7PW/7EKM
MXK4)\L5K6!23Q<6^$+_%Z$,KZ?P,IC_^5C4=#]G<Z6@0W0'UN\Z%V4X)D='!
MV0P +?\H&0_.%(YSRDFD9+'G^OAG/K+A&C-D?!5^EMW"0U?0+2L-B-5!*6GP
M)9!WF/ &=PN0]!PR7\R/%)T2&N<'C/)NX8NVGZM>*P>.*D(FHW 7:X=!P&H8
M_+9S6\CA%C<)8KA1=.;,^+(C/VS1%OK'%ERF8=R!PK5:\EI!,/-YT%@^#.E+
M@)(0FVH(:&5H9FY%1]$Y0ZGEJ%V'O(O6<O^@<EZLUQ:0_(7_A/&AHO,<#<.\
MH?7Q2HQC7X*HX Y63Z P=)MF:.%*72/6(8)I!@GH+@M-F<^ CD</>L 0\9BM
MJ_\6(%>T.,#/S(!4"GV'AE 9SR2V *U#'QEP4/2^]76FDT!S[N3QC;8_V/PE
M03<SC&?<7J.)IH+3F#OIAXW$SCF'BFZ[FN0_.]["WP+,8YH H#S\NG;.[=;V
ME/\=CF$N5REE*C5:I1L(L4K\*KM7JX%8W[I\U6UM/;%E"^ IQF'VYN88H+!G
M%K8 QTGR-=Z,_\TP(I=(S"-F3,> ^?8=/T[ 1-,JCJN02"%POK&RD@),%-KX
M54EM 0R$/G;9N"@'+CRAN8%H?Q";[N/PAN\RC_T,)\M7&Z @KCSW>INCB;5D
MK_D&<Y_@'!T5F;]I1$FEQ[)_CX_:@C?2-K4R!@C.U$4Y5&O3(V *FWFK#$ Z
M9ZC2 !HHSSGZ4M^"0OBJ/X5XXP+Y.2<E0 FW .5B0-MD@V];X! YM Z<RC2A
M.) :$GET\:VZ&C-TL;"5.M(4$7CJ/_Y3W)S^3,.#[1;8S<.WBUU[,;J]8F H
MZ:$0TR*"5G!\M!I_-L1'[R0Q[]G:-6>0X*E,']N\@?<T@QK;"M3J6+J@3%CO
M8S(NEF3")COT!U%=N'=!Q39CV$4X!9;B;?I^'4+; BS3^H#M,*RO<) *GT<_
MF":-%2/FME>/6L:V,<QF*(N30A=!T2" W5O\5! IVR##E@!KRGM]6>OO.)+U
M.DAS3>@INBU.%"NN;@$^B9W$RASJ=S[D,F_%M=HN9P";3R?6TN'>#-BP75E8
M[;!9]WA(C[Q647]T;NVS$!4_<JXV@;/2CI65LR2)(/UQ4C"S0>80"BEKM!&=
M'<AW=M2I.<>U&-%3FA'UB.*A58@^5-4"20Z%=QLJ9FI5-.?_;[H,ML0(J7:(
ME0?\=I,::WS$P\_I_T:*XWOYA%]B*QK?MJZ$S;0M8@94<^3-J]DS[Y;%1T&%
M[U:@P;(&6X!#@'V[ 9(S=XK^8E_K6V$/@>6)3%.Q7?%:)RJE1"J8 DEFH(PO
M5TE0#6###%8VTY(8_0S*.'RD,9OGZ5T96H3$D/_W0D6Y>@N@\I(VP%>\1I'(
M$F1MH-!)T?I?\!O1;[6E_GBQ$*/8#Y!"DXX Z$(.%*$"QJV)"PG>"[;=T=M4
M$=@ZG AE[8W\+AS8-&8)!NMJV"Q,<;4H'E[),*^Q@1.F5<$I],HI%KV:N@YW
M63?K,7Y(_W9"$'O$1MD3:KL%<#[Z$HKM9>/[MQM"!(4-%6P!K@H>O&?6+K[1
M#:H:KJNF@Y K$D4:XFODM(1X>F -\U!F Y7[BNPFUN"?X8_7O&KG2 /]$8@%
MBH'EDHX94X%;R3SR,R.^66H$W'I\;>6]F(XU)@([-B$4L6YOI6WC'W0T)K/?
M&B]XB\PY/"(M]>9AUO&.*I&9T*IXPW01&R$,>!;I SXSQPS-UYPU&VP+;U),
MC3RLN._A->/OUDNXEO+/?^AD9ZPWUGR.[,4F)PN+)\'*O#]TACAR#9O"*8<[
MNH38*DZ#4F @<0&-E25O\;_9'2PN5.Q!MR1"0]1U,L[SP0MX,JP!6BHD3[VA
M ST7R,J;QE=Y@]FA^32[?%0PR,<9[?SC,S"<!B7Y"79%&^Z,9T@LKLW.@WO!
M36+/(1923NS)Q76C(.[;V;M<$S8@=AR D0]6,[0*]'#NE725)-\VW"/_(O(/
M,X#>H_'%V45PCO!X-*(;DU/%P#B0V^%T)I^+]EKGLPB%G,YMCLG&7>N03REE
MLY94Z2E$0(W$\&<SJ3,WIVQ'#*M*7S(YT_.B,L$#3@IJI1.%.U?-QA30Q)X#
M+'28(>FZAGM.=$0'(I!I:.)+H9ON6#;>"]$2%G-7-@V?&5KRR&=_@]LKAPI@
M]@TS&=WMM;'@Y9)D+^P<N1$S.T\7$CZ*B.%MGQ"#6P!9N\1>5H,L)C%H'ND#
M1%(VD=HYO3!N#A*$*:GOK^FFA0J?$E8WHOT:,@>QWK:IT &6\Y 0VQ; 0Q<Q
MX54AU1 6!YBFL5-"_AQA(C]Z,CNBYF^CL1PU:1+/K^9HJ)!R[O)&*[IRL[<
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M^?-&"^SP?2B@%V\T7N-6<06;";G0W7:':7,K1TID]9$-P>F'@+HLB0;\&'5
M)?DTG%QNH^A2S9X*K0H(:6T)J*8+1!>W?6 68RDFB(3$SS<8]<.QK\U$9='.
M+WOJENUF+<Z+U 1UO]&>)<.*F]!/=DE#2QH:GNX+LG9<;<<<.NNZL;QI3>"7
MC\^4&DV&)K'AP^9+T# >L'UI[$98$(D]$4>;=+#KT;[[_<Z=SKM9K/5EWOT\
MQ1?B ,%+CGM*"3O'&6EC6X+8MGWY4#_7(R<4_W"D2>@"$9X=_T2S<:] GU.5
M,,S%^ PM,>AF3?04_+3M Y[#I(V*^C",L:W$D?(.OPE#X%?"[F$IHBB3_["5
MGFA-OLQ+(S+D&')F?V((@CRR-69 ]!7K1K;:MJ*+:.-/PH,5C+@6Q_[:A89#
MTC7JX.G>T!CT;V!$:+J,+76WJ>U;JR*"!K<5X20ZSG_.0W@OL7UQW)5^LBKM
MS'C3T#1:)A_6KDP$F*^@->E/UD5 'G9N=DKD*E='$I'7[#[ M<28G'6[S'!U
M;I89Q:4_M5<-?$^X5K,%>+JRZ(-TA<0)6UO".Z#!(/?<,NTR.%'C*#,L>) :
M)BQL2/> %WFN5;?\F)2 F(@BQ5J^96N8XCM(<(HHOA^K,M!07"#$O1.N%+)G
M$FX$W &]2\E@TN#M=%1&3E!#$>5."SR:BX"&M'TI;O^&67*;;=2=>L2WW-\&
M-!";3HN?H3Q9!:MB0E -VP?;H=B^M 5(R1^D!M6R61;=U#NKGCP5AARHY] 6
M@'5$27:LL4MDP :_%$8:B.OFD3F*;7R<IUC#^/20"(04@.S_QZ,=D8;R!49B
M"%3<*9VZ&Y*^!2"!YUU*A8AIST],L2[7V'U3GO0S%S=#UMLD_%IJ\"SF:&@E
M&6KEV*7WP=!V5/_Y8<0=IEU7PD]"P!$XJ-Q\)92$6P8/8]W9C<3A\8_#)F/C
MM_]6<>2P">,!>90[E!R_N;NW;J/*T=]:QY"Z?\;[5WK0"DQ$#4>;W(_I_/^?
M" 7PKC5X4/Q)7)/!3M 0_YXM:PN@9J"2!&'%\<PA\2)(WQ9 FT(3IV_B.EC>
M^CSR$ Q9+E.SK5FS%BZ;2KLCC1\'DYU1Y/G9\BW %(2^;;"JF^#8Q'XS->"V
M5>WWGVG9]_<DX:IP7C@^18+SR1<%P-]OV(VY^&E$Z&9* K5GJ47R2-W"_\9Z
MXL=0%8]^+$T1#1M8X<Q9L&?.H,P*)"OHU?@$UGD8!0D#F WVFR#'>C3;Y;8
MM TETX['V WPHLQ2<B5X@ 7: KPP9#EWD-W:\AE\]/;N0 \8)6Y;3$<:2^J-
MH:2M?43@*Z_CX#55H4L1$^BYN1,,7.3Z@$@YVU?J\< ^XH(> =?=HK47-\,P
M:9$*4??/WX:H%?B/2O7@X\MBO"!7>'":Y$BK6B ;\QJ*2^@FS&WHVE8F1G4K
M/96YO?>&!=7Y25+<2"WN2R.3NQ3N=7^[6AT,^DGRC>:R5E8L4?53V1B$T.6W
M+70:C.O?)CP^JZ+MSEB[)4F/<+'*CT4JAY&DX.(<&,WG*+?+A"85.%N-3DE?
M@AW8^(-U8H-CV?6>5(PKK:I6.SZT$E;#Q'R(K6;P4_#%&@$US&B2 <N6>8%F
MH+2=GM@05=P+/*N> _'>E-I$8J-%L03O.HX\*J6NF(%B$8H#$*30#.] %L@.
M'S!/(3DDN&J ' W,AC:M5[!##5!NNK@@4)V!6=G<Y@T>]LIU#>Q/5$,I@V](
MJ*JJH6=X,RR%Q</,0_F@<A#%62_+\*?RWJ$A#L6H_9=@_6SR7_P_21O@6TOJ
M046J\*R$;'FSD#\Q!O51]R$ZHOH^<5!*6< :!K^&(?>P%->U$J?5HJ,-":*Q
MEJ-9X?XK!IF3C;5S:)WA)9)=;L8;>.[+CI2L4,(&<"K01/V.X\C-=<?W7[,/
M1.7_#6\_\"5H$]$O=APTVR4DS]DE#<#>3M4*?:)WYDCTVGVG&()W33=J"%;8
MT6QP]Q:@1SA4)*0NCA46B$<K:(-\D%K(GQ9WF.QAHT?<_T3[[P,BS)^:R0Z
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MVUMR^(\<^40O#OVJ&!#+M_<>K?4;'CT8$HC].K,B$9=("IF9"\=]YT/;69U
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M*SA5[6W?T6V/23RQCY'C?BW=UMX^UH9O!>A;=Y \2_:$FO6U#[8AT8/+**4
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M' :IUB\ZI>5V(Q%@1KFW8G/^CM6SP,S+%XW^CO3*B(BI>$TM.=SR+.ELOP=
M^LWBW>93MIMD%=MVBW_='IZ:98*/RT4#4IVM-VRF^I2CX_^^<@^I<&Z6J22Z
M> Z]$/H/<?7)OB?O1)-7#GEF4:[8X%\'QBO]&S+E?4>!,%55M#/S^$KLW3.^
MLWN*!0T7;W[TS"SI<*#X5F2U*^TW:M#GG1DWMKWF=T1N@J@4*D?=-[U=/'S@
M7E/WCU>KSKJ/"AVN:'P83V'GW!<J=-G>3U.=2ITF]%:XW#.<(M7*']9L&$'L
MO0&X.%Q>JT^)P;^4O6M%W6685JIY!Z/]J*=:8'$\MIOB/%B:J1 2SLG4&#@[
M[K/N?.6OMH&?FD^B=O],3O(@WB"#$]YL":.2_KV*4)+SKO,V/#7YDM/2PU%[
M\0$5&%=O.S 6&3MV\9J>QN;>0\WW3_]]42;F3=K#TVNVA3>[/S^Y_WWK[D6O
M5\7\"?<.4B5H)(HL.D#'"["SYO+(1)J!\6+>V,?A\1V[&?S6H;SCF#HE.66I
M 5LN^-[$OP:D657:8T1J#3X$;&"F%CV8NSE+RL8,0K<S^ 8Y&S",P@(Q:I9H
MIU]GWS& =+VZI![T%&,XD"U##CJ?8L"RW6\,C1<#*AF3[BSK+Z?J OT7( J+
M*6,B:)\(2F5Z!3\^VJV50F7EA=5)Z="=2R_TQ1G>7/HVA3UK_ES$1"\+R:)C
MZQ1_DEL[ P;ANI=#.NFSJQ%'RCZ9;$!UMKNW<*ON@RRO,1CD 'Z4[^9+E0ZO
MA]71#4Q^7WQ0] UN_E5J)6(;?W([D =<^D ?9#E",H5$DAO]0D9'B4#O+:<)
ME15WC6H@DTOC.Z>7^S>:=(I<K]<%/;X8/@!%"4]R@*-"1U#OMAC0@G9<+TH9
MV\L1 XHBUK'5:*O4+#CH03#):Z22X^UAYA5>Y@FO[3(\KN_\#\(!VIU>8'JV
MFQ,["ZD4-8PD$D-G,<>6A';R.P3&XAC]U(+5:7F5N(+@QR,58T9K&MV^)8D%
M.GV YT0*7U8(I*%'EHGNOS!'=J1 J6QTN?^BER!.&S,2 5_LZT=&.2$^!(;6
MR'^1R56HH_N3MLR[PA\"?X@!Y\6  PU[2'0Q('H,;5O]82"UC/[[W$@Q ,>!
MLSS\B[UHZ3W(WO(R=D_B6)!QG1C@NN@=9"KJ  ]#^QF+Z?-$%^JFMZ0V2'4"
MR#(T4Q!)\=_&NO) WUGF<6#G)3'@8(,(^A5M%X H,,"]BX@DP](Y\#@;.HR;
MFAZ].R$LA:)&@;/435/H(8R.D)(MUY49OC-_OESH'<CG4M:;(.?H:+SD13L1
MT!1!G $_FW1LH6,CH3XJI-L@]1%-IN,]G85XE(UP/OL<58*6$N@MBP$9H4%6
M#J4"\"PQPMO>W-O<0Q#Z$W*,M[^39C2%URH=9(H!H(4G 6( >B!3-OL5AY_
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M[]]%40,7TB6Z^AQR@%^J#G*A_5YL9Y\\&N)'E;!U3R"U'D]'.X;I_G)X2SL
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MIUC*7=XK=Y838):DE';6;/62=<F/0\\?F=TQIESF=TU=H&_%I6^:XLAO22)
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M&PT-Q+S+U8L<P]PDND"O1ILT_\EHFZK^=:6EDLG9M;]\";2^4ZW^P%4/<^W
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MTCSO8+9,SL%/;G,LC.Y=O:;QW^F$K:T'QV."[QWZ\G#]&J]B+SMTZJ:GA,1
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M7K+B<?P0*/<;V".XW[5T*#9QRSR3LQ4,HA=]G^CE1B#@$]3J"TM'![\ZF?2
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M>5Y=FD]1V "82TM^O]Y ]^QK335LL4G1.=*Z6!GBM4HVR?SV,B,1.R4"3HN
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M$SGX6=_]#U#]G4\VC[\I'#Y4TQE-D2B(6E2;VB UP7%/R*[?=[UU>8Q<W<)
MR5YZ?09P][-'PV?O('7Z!LJ(@K<($TW&5-OYJ"-#]*"-]?JS(=:: D6]^S6:
MKQ:U)JI%G:U%8>?[?7A9Z_($)/F&B.P:RFAPV-&G\5-+%BW6W(I4DV0+NF2U
MNBOB&Y<U=?R\O'TU6M OA*=]18],?K>?7O-3:;"M1JI36)G3$UGPXE6,I*KV
MQB-PIJQ$'I]W--9CGA.,8#U[9,O\G\<BN8SV3538=3!CZM--XUO7;7<)L/,I
MY,7WARL(R-FXR]SW0>>]7=;,':ID.F+-P+?U%J8-F<D+II*42T^<VE!&0.JX
MR&92'E!UJOVH83!\9F5[OO]-*7[^'1;=(*)P 2PRI<QA17-=E-@1G#'2F"ZR
M>7T]6JYF^:+6++^Y-Z#1T.DX>_X^O&J!%O7Z67&I2VDP7Q/4/CO.ON^&0#KA
M ?J#]>7 C)?+3WW\'[+$4;_>+4WX.A]W].FX[98KI^QUQMDS9S*$>S@B2H\^
MG'?GNVPL025C( ?2<+@1JDO+0$J"D+Y)?*.P1E_S%]O 4+4.JP1G/8:/$WY<
MNH;[T VQL]38\K"0)>ST^GKTC,.(/>WFM=6+$:R+<C>\I=2[;[%HW:U;6M30
MLEOU_W,H>^9P2WH",C-0EBH=TW'%P#%:YJTD8Y\*V3SPLA8WGP7O*KBYQ@V0
M;ZUIT@6_<YZ:O,U!QH(=.49YHI^75)I0";0>C.D&M\>"@G:++1'*U9C#B$@K
MCGSO>'B,FS80C.AK":+RYRAO9C8]=+R54+C3/N84[8AJ,S!D%7>EC/?U"_H9
M^[@9$-APCQ_D .:I$(%HV*-Q38"6/T%#*=>0/=MKT19-04:RAP)O#CB 8&Z0
MSX.;23,+]P^0X',4R23W#V V3!=BM[21EUS/D9YHE<M$5"UJ8'M'J!BUP' A
M7971C6YMILYY2B^ K@X/P=OUR>*B";B "(SXS2OV2:1&!EK4$T2[[([][J-%
MZ;Z9O3Q>(T"F27UB,D &@GX.3\'$%Z@^X5>=Y+C7EKA.\Q*Y6O18]UON/\+*
MM8A-%/OL!*< U35@UKQ!J-ZZK,XF^C^OT4]=23#&8LZK$_<LZGAU^#4KV,=\
M!G3-0_XQ[8G^U=%8)^0 <?BY6I3D%?G^J6!X>]V_#W5'Y7JZ]<;%@RB;K2Y_
M6^,Z-T&+I!VM<'#5S;B6IO QM^QFCD>D"CW>H?LM=FAV=\6MZ.B5FWJZ5E_T
MEMD\&85>F6M1/YIJ5ZL\I07@%TOP(:5,=9&C<6,9F:H1FWZ])%! ?-F1P"HQ
ML3[QZV.]>/V2ZS%L^9;S8V]MPG0\-<CZ]NY_]D!SK_O[$_/D)#BY/[3O:]FO
MKFHN.%QU>&AEH'1]@.C\Q$OXF128J8@K9HJ@72IWV$!7&:Z:&X3_);)'\..B
M<6B[#LP4X*#5[WX]6M0TT /.HI_^PV%?. HH'A27*3^ 3TP2-]%\)TR,%S:N
MS4BJKOE*@9] JY)4M+_]T'*K]>^E7E1'$GJ^ABFAC5>1_XTW^U+XU85H"Q2Z
M@TUC/=QNDD>2DI1DM^'&*PQ[Y'J%_M7'TLX0SES5LJ2C+BL&YD:UJ)/^MX0:
MSXDB[&CPOR8+ZF>.<:2[/U'@@S)LJX!N\"^YP?+E?A7U$[NI&2:X=WFH3DB+
M8\/G5P^4)4(04H:'>75HBK1ES1Z)L/'S>("RU$J+,H!R0"UJ.63S"!3+$)<:
M"]_%IKX$'>-U/L=CR[9LHH.ZJU866_R;%<M1;9H? Y30V54QN;QWR]A0S9OI
M#5M5VSZ]BZXMI4UTD#/L=[$5/D#8*_0?$K("D>G'8E"IT_,NB:*9KW'GJ$Y%
MP68=AK?&XW<DZVAB6ZCJV+A2]F+J>-9H)$,6K#\;.-L\%-B,Q4/K-1$A!@Q9
M6@;&9X^A\\I-6<[7'SJ.5SBD7+9@I6OZ-"79<Q+T4^I?8=;ON^<)1:)>B(<(
MRMTE)JD]+GJ9@^G",?8E9+6^4AF_ZQ9*NY&T:W=JU[E11M:>@1$=:)WF#*A4
M-9R*[WB?[74[KU=?&CGS[-O^R:57X0S+BZT"RHK^HNX3=T;3-8-Y<27;@1F#
MGC>\.[>,>^/13#EUYD]^-L5)E$\MX7OHJS*N''R%A?]G^-R,SRF4SCL&^*/7
MLR-/KL+MM&A9H44= ]=_G9;]DPS^H*.,%\HMGR0NF$A0.<VWMO?_@8;X'6F%
MZU_\LV-\MTGJY3WD*8LY;UD8<,PD\X1XZ003S?U);D8F\81$@X](^?FW'AB@
M)/XQ"_]>=?K7U%0Y^JZB@D!]MV[$6-T^B[XJ+5HZD2L"Z 5BV4EK.Z_P;4MV
M6\Y].<X6F8V>U8>!TWZK5GY>$P3(;XYEU[!_HSJI#+\TP^>UJ!?!7([K?A7E
M>Z,*"/OU,/3DAO $D=P.\V0):]/*6*>WP6T7]R.%0O/3)4 'THY+7]9&FR<_
MN/==::A%>:'OI4+[7YS7U=S[,L:(6.7Z?#6::]%2KT4]Y3]B9]=?3#EP&=M7
MD$B17RNP@5P='JD\[7;5)VM1VQ#N$#RBON1HL/;7,ML#D%0H#<%J4877OFQK
M^V4/G&^@PNL]%JU>TF95'_?A(O6.D@"Z ;]_!3])%D0:UX;HQ;P_>]R!HPH<
MW[@B,7[!@N]-$F8^+CGQ;7EK4?YRS1[L!K@8\+??PQ :NB1_^0_= UD*->Y(
MT->UJLA[(L)XQ -=\9N+!S3N[%WS%?24^](\ ^^C<53C64M<[ADXFV0(P'ZG
M4';$%_\N [[MTJ+^B\^2#G0?># //?J\C$\L.)R@17U)WJ3Y)T,6]P2\A4MG
M3^V4<GK:V'+5'U<]Z$KT4XKF!'(]5&S<04<DRL2>B 6FKMPN!D>BE:=,VQ=:
MFV2%P&^Q:Y7/07>6T2D-N0/5C8<$+IG_F,8/LN:NG/OZ[#7\G\JKT-Y@T[=$
ME]KP,6NWHD-=IB>Q?5-WX,5@)]!;1<*+SH'OPNM6(WCA*+W A;<)LZQ"6BW<
M*Y[9G.L$FVASJS<5%X#*$XWZ$./GO5ODR\$J;]$CK.KOD3G[HH:X1T%C^P[V
M7=?'0ENEG4M\3![I5NH='YG_H^7"96N_+8\/&6KL_90:7AE7_R\Z]7Q]FHJI
MX&9,Z8%-17.7])@K*)#YK46AL/[=&0FBB0ES+3J13(.D&57T4_F5V-0? @O1
MNGK7[MMZ\06B4Q>;WLRFG2*"SXPVZ#O1%<?B8J/,_Z@Y7)]_;O].^^6?*N!)
M&T%4F97(^YDGD?LS"$:KR*L4G24:%W8@BCHF6. A&=0-0CCU4NM=]Q*-,SMP
M)5E(& D 1?\#%?O#9'/3WM F7F(N'M+Y6ZYF^KIGAQ9-A:Q7(ZE[C>+FUC;4
MN[_(=-6I1J ).XIQR\K,0;=H45>KL@PKCYM\TFP>*Y-C'<%_*!9E#-(1T5'$
M-6S>OQ->0*+TL^DXW/Q=N!X_P3ILJT699UBD)L'M]Q(,FZ]!)9HC8,!>8-(^
M8'4FOW#KD9RTY_X!+*,(:(=4[4&WPS:1XI^$J+,5A*W'H_>D9GQ[5\!1':\,
MP+B,Q,99+MMJ_&!%I1_L3HF^[!ZZM(07K[\:#*'\C_SJRN6Q9P96!CUGHA%4
M-_'K+LO+F$//[-3TUV?&4A_*R*(EZV6+F;=6:U%FUL,)=V7.[)%TY: ZWH5F
M>16^GJA%15+/+2EC]X"'@0T,@66LD"+MM!WB44'(TM6I4._X@FFR0:FZI57]
MM\8N!7U/REW#JURJ;VL9\SKZ1XV+RV5WVB';JQ[K/JO^4V%[!E?_-A(Q/_A?
M!][J7-/%[.3DM!K "C'%.VI]* _T&?%#GW*E>J,V_7DN&/7.!4&=%*'X53A]
M(C[@<IO,[M@"I/0+KR24?E?K(DI,!.[P&/;L>]*G;\WFLVW(?YL-7X1C5+KS
M^5DELO**^6FW]CCSU!"PAU<3YU(+#^<OB%YYJ9.$/LHU<&A#M_\50 KMV>?M
M[M"7_J@9$'K770/,R;OA;>@*"3^6,Z#J'\QP*J_K3CR[J3MN0>$Y_T6Z;SXE
M4,6Z\"9<93;:<R((22C-)N4E^0(=25R!U6XAX 07D'\G&$50E9$F3R4^^,C7
M,CMG:/>*RHVFMAS5Q96?5BW:JAAGM5%$[,)(C:]4BRI?%Z'?1DJV;X#['[DQ
M_,(_J?8&63SICG/^4"BP($CV7$YZ:FSEO.UR=TFPA[M-E&37J^W$.G.#:W7M
M+C'#>EH4"%3:*E14K^/Z6Y2LZ[\:POQGK?JC*<";(OC5P*/2%?)^(:R6$5C*
M->U?_?9.0=M;I64S77K@4XU-3$AZTB1,CUK1U5?H\]'4\[I]DK1VYBL*T*]
MDOXLK0_:;=U0_N;!M0EOTN43:13%(3#3;/AJ*ZW'/Z\KONY=S4B02TNR9AY
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M<BZ6W--N'146\-GTJ+],91/*T!P)#@&-&)K==CJ5 96MI5']5LQ%%'F5!B^
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MOE>P>]COIL_.^]&>2\5DO )[E/."1Y!W(I#EH<&. %OG*HE,(*._6HG5%/N
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M30]BP$?2F^JD43!<;_^$SG8S_&L-IT0N.7QU_G6\5RMAW+Y$]]X,!/))ENT
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M8-RD9+;6C_FA^C6/P%XA<)<P<2H",3YF#S$VK1;^N<7R^W09]GTR@F2YF[D
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M/OQ$?R@S]K]'?=?<?0PA0'Z &#<KUXX)S\CK/"B15K9I?AP1$XQFI00E9@J
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M2?ZRJ;I[ WX0.[#0)CJ1@^Y*)1!P-Y#KQV8^&QR,=>AD2358;HYZ1:&&2AP
MR:R_+,'B/U.9)IR-7SLXC:PE3CRFWS)CA0HK&#>?@'!.VR+S4?LUMQ\97(%O
MMN29H2U[G\:O6 S=NSF0O05K=ZYA 61F@HTEO13X5+)@1)TT4-^7ZM!WUY3W
MC0[B,SW$VS*M9/,MC($3%C+?B>"VRF'+S'KT.GF Z\-YP\N#YF]/S0D &%Q"
MVS/0[/F,K_0$R_()@A\YG. 9/K*2B+$H!2Y!5[635[4NW^+_8RB\:CS5/M&&
M6Q#LBDQ0"#Z)[/D]<^<"C=BD3JS/%0!-=5*6L\QDPG;L@</)2ONJ>$+SSM>0
M8]PN*_M\_D0(<^X,.88);13;\LWZ[R4@$+O^#$*RF.?<7^TTV%:&DR>4(X>+
MUL1$[AJ>SE3SGUDH ,\F\&=X-@E!M9OH-GF']_L%@*YEW&+I1_X,A,@X;/G=
MT>ZUXWG>F]XFL^0?)Y&_CESA''V,WO\!7XK=%@ SPA8YU>)!Q.NC7$EVI8U^
M:]+H3RF<9\$&#VGA6_P7DIC+=0G"; LY,S2*#=])0#>IUS0''PXQ,SD,9JD8
MP94RV4.S-Z6J:U:E0L'(D\%'*4X))Q60Q>MVT@[W%592)[UC4?^X.VTG7?U6
MW!?Y'42!<6&+YPE8@F^;!?9=/9P_#J@_NB!6.@RB\D28Q-$(L59G=,Z(,: F
M;9SX3M<-+8>'CB$:ZRT:GUM\M2B3']+&L*3+%)Y38<L=$_@N<ZL>_'5TZK$<
MUZ99;W$UJU.CD2OH';ZTJ^-V$IIL&]2!@N X-W&\UL&$(?AH!+KMP*]Z>-2]
M [*WQ39O;19")X@:'C<97L",QCSYY/?]RFY<]W5"C?#2&:&44WQF "A$ !B@
MMQ]DK\N#3W0CB#5>UR^0\4- +K)8ZK7340O'1VD_X6]JZEKXR$MQE]_J:(V[
MKZ'#5'F-@_6D\SR7[SIBNQZO@U\,2QAX%]<PUVRE]!IH3.G_N@"=IX0#Q*4^
M3FV<XCJ-"P"?F#\+NST%^N@F>8OVDAFGUJ0]WV5]P6-H[Y@_=?;D4CHY8:\
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M0V-WW]XO6^@[\4J,@8W'23XT_ V]A[(->'17;KV:Q^N,3UL^&MGLA1T<[KH
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M" _K\3+P4H7>&-:O!;216O$/]P_:+,(J!0 ,K?F1@AC?[HNK3J%$D,=Q0K6
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MT36#+,Z.%Q<HR,E^,X5$,7@E.@YYM>Q G<DW/<%?$-,H9=_ 7L!?B;JGRQX
M-S&(<!^A]N(3K:%DT8,?.<.M21K87ZN,%K)%H-L0P1+$^LMKA ][^U^20Y+$
MZMU*IRG4-*H.[$5B_]9E"ZA/OQYR>E4H[Q4O%.>S@B&1V@TRSX2,R/GFG=5B
M-EM1Y<(&X[:*BDI?V2^G-VII3\#WNA_TL%9$+0$5H$L>VJ]I'+,$S76_:?GC
MR$*LYQ0E K*$6%HG*2N]3$QP/RBL[4]@G:PWEN6GFNP;&&[KF)KJJ*DX5_M]
M6PNCG/4_7GS!V#-I01(/J:E+X ;^U.]2WU?N<]\U$!UR*1N=$E"SRP7-VO0
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M%54@+=G^0SXCKBR?L1WZ.3AZ9F'X[9:Q-A^[_<[^2?[>!XF<GB4Q< ;3@FT
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M4J0X2'6U1.PDDH<D)<A7IXE5.?E[K^Z)6%GFSQR0H3(,!.K9=\ 11?']:L8
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M)%3L+E!28B2;\X;SA6X3BP?R,KB8X*.*QNI;==S!RYIG3WU>:^HLE;'%PZU
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MY>I<F1O@Q584EP[*="ZGU:PQ$5DH1AP51PSYO#,],TA;P(E.CWVCE-.6HF>
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M".$1LL!VXR]J%]1;0Z)#CNI)R=>[-0)A_7IRG$AUQ<MF[$W,0:.&C:\HP:T
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M/^'+_<Y#&K ?#KR$IIL8$5ZH%?W1=<AA)Y%U$;1E]XNBYK*1A,EZ::ZP$2T
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M>[/@-0A)X9S4=Z@27ME( ^M38('F9RB?_^NKE*$V5]0JH;(*V.B;,W,"K 4
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M,2YJIA""7R^+(UWJ8O=K,Y2,-WN]61747%9M9H?F*["MT.-E/U4DL;&C3^W
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MO@4%(.C2_O90_+.^UY1CQZUB*O7T>D-_PUTVW\F[3QK=_) O;]ANS#$W7!(
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M":W'+:OO(;[6[3YHC.+ZJ(HO$?M?P%W@W]Y]/+U^PM8],)WQ"%[GE4^/Z@N
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M(R8T/>S+<U&993#Z+&L#*-M&OK)_RAA[W-&;6QE%K_D9)G4 P7IQX8=?O[S
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MJZ>YI\3"!%' 1G&\6]CE2TR7&(^RD5A'/Q\"A0WZ^C[>&,)CR%H7P,J.4JK
MFFOF+\QSQVQ@S_3_A9)X1^E0E-&/EOTQ0*Q0FFIKUQ?4W!L.O' DUED$LQSG
MD3IF?O]D"Z+IZ0^MBZ0W2\,UE28">D_#3CPH?[&&V>4:^?$QN0P39Q_>RWB=
MTN=;9(98;^Z(T]SV8-?S3C(\!B$;<G7E")A/I9D$^+<U#X:OGZY4U+KA%7N#
M#US=GKBX1( :'76/E8^ AR1I!W6-E,Z:?&&X?4#Z83D<_>EZO<YZW#QS/"<B
M&KXXVO.>47<]F8E?9'H2.GW7Q/U#STO(7I]&WMK^U$ =,%T6P!*]H6!C/%W;
M;8EW9FBLDAH#GPV(1;:3.<4D&4\9=?>&2';/J@K.-9*J_P]5ZJB AK(Q%&Y>
MKY(8.9"K\M8&6@^E^@J86K\?5PA-+4:^KJ^N\Z9>L+ Z&!"'XSAY$4(C(K/:
MQ_ ZDQ3'KUVM%2L3;=2*A:./DC?@>7S@W+(P,IL;[)+A3[4ZMHQ(IM#L#T(W
M!)$[!D.7\P$'[OH;JA&2'!#JF0'WU7FL=GCMY>&&!SM\8((HQ76RS_@4*)BA
MGN:O*R7-+JEL2<3D6&$3MG"K$P2LX"1I*F/=)=33%'+)*A1<MJ=U/&1$.DT
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M3^G FM[IC(JEWK;9$BJNW7PBZD+\N5X"4<!+=Z2@##89#;VG-YO'VDP@?KC
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M6AZ!^^L3G@<?0$PT5W;B_ ID]FP\LEJXJOWN V%"XWE<\UC< O(ZN9WA098
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M?3_;CQM,]*HF(_!Z'M(#@3:NZH6(ACHD#1'3ZXMZVX#O%/:?\JF(7[+;@']
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M/'R-SZ6\#?J>Y%+_<U.6>F:YU91!@.-#B%$N# /!I4U'Q<11:#&OL(MD4YS
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MSY9Q,4''WO9R/KAIF2Y$W2*<Z/]+!/-#:N_WU4+8P*4F074]_$_I#,)T[?F
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M]K[&_QZ_?U2%5T2=LQU4[,*D)7]Q*SV W:ZD9??^JQ!UWMSN A6CQL22AWO
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M7X]V[RJ)6?WQOY[BVV#+X,&(ORYH<?Z:^J])6GR@I[O"COOJJ]SY8OO^C<(
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M]U<5F4[8M33II$%;E_ ?UYY+N-!_Q/-@O;P%X[V'8UV'JY ET%N6 \G;O_A
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MT)%1TX]*!P8\Y]2C;()G*?J".5D_-T#GBFI'4CG)AT:"G.@2N>Y>;>\?@K.
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M0M0GFAC7O))SKY*F'9?=]'H:SDB9B$M+ZQR#,XH=4.>P%=,F?)[5)7EJ_Y-
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M+# Z"C 4<3@GFT+>>P9,;W#,2][C 69P+3C7 ]/7T]QRYM8 R]UI Z?*!XS
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MJ>@>,FBDMK"7*#0U@A-G>=20GILHPGJH)XCU Z[9%98UA ;(H$@O5M'>:\_
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M#3T);=3M96DDX)AV^45$V2(+E*TGW5L3WGFZ_D9DI4DB9DN@#+)DM*UVA/N
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M=RC',,/E!$17JKLZ3-F%KC]G_AVXLY<&,1+:%QVX(!LU)@J,&(GI-FZ6L86
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M!NG=(H?UY)G25P5SO;J9LX47=62E(@$ISJ-M[SA*51LV3/39RX$WOSF04?"
M7B9OLNQ37XS.*=] NP]79ZRO;BN;:-?A_579UK(-[W.EHCNV-=.5-=,_$1OB
M/VW3IAPO 0ZBM;1\&D\")DMKSAB7!N9/@K&59#WH'M&?!N!<EA;) .?[3:^N
M7[+!R6A"(%BJW6EEYGCA+7G*IM*F#&-$8?FHYUZNSIO1'F)>7TB2D ;0?8SZ
M\I7150QJCZ7:WOAE5K>!*<Z+E209+L]X<@4^&.P($QU'WR*&GGIK%741H&+I
M'7NSYGVZ_IG^^<!7PZ]3OT@L3BD[+1!C",/\#B?0[@<0B\#;;1CH^9VXYT?!
MH[!)XTO X(4CX7O+J'*,=>0GEO0/NUGFK^7!76&GJMUST PS[CQCM0'!]DO
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M6V$W/&E=/0-791&M[0-JPQ+(?1?4%^\FE,J?G:TM*VTKG>M%=%X(_5E16G;
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M;4)BE584-=1&!+:<V#V!-;N),3]C7>B'@^E7N:0S^YFT2: 0$/) ,<@ZNG9
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M>)V>V^YS]?0>LW^!3SZ.4\Y*8(=#+&\9-?\JSA(C./% +=8\][]HBF3WFYX
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MS<,@+DNIMBI,Y"\. 2YTD_-]$'-_%*%#+6XP2C8C,5#Y/O<NR3@?_1@^9\)
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M, <HNPPPX[D'C_X,H73H@-GYOYH0N_:,<H<HN^$?;E*1K*J#C.SP!CCIUH]
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MO]+Y&1SZ2BIGT<#B^(A$Y#N@]5_T+\GX2-\5O])-ESX.,I9:3LKV7_2P:/\
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MDV?I@"YV?2_*LSZ5P#XOF/@=U!Z:U^.B7RE*X+AV_P"(!FR.T.P'A>__ .F
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M<.,$0*.GHZ""3&S&H<_QHE89?$B.$GA=#+#HFITONFV;(B^$Y]-WE!PG90:
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MQ$:0"+)=..1G+% Q'_<\N-ON:)=_B82GOQW?28-3%'R?+XY.2@S&$ #3X=)
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MN-$S6P A[7&3SG5X0>#;]-$.<^0PCX%58[)T'0Q K&.Z2\N-E-^8Y0YI_P"
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M=/O$4DID_P"T1C$T&[NCLWN#XB-^,%FR'SUG#7S) 6BZD\)<.&*8O-(5.&2
MRO+*%.ZWN@Z4'#2J .@<+C%.T [#,Y^;*4!^,K<$I:_[08S\C-!1IF357P Z
M7N0#+XF+W\LN:+C!Q#[MZ#+=327>W(":B0[9.Q$U+,/]H$I7A]JK\Z2AK>*
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M"-QX30<)V63H'6B4;,X.X'A<EW_Q%Q>7&@QODILL0A(0G*8A;L$'(-GO+LG
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M* #^T5*XL@[E8*1D<7SYU[.+.2.ATWS"E=M:W?9BIOV0#^PXH8#JAZ4/GY-
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M"2G<+@+UD!_SN:;(;\_6]D?$MZK2L+H8>*W]EXV/\V&13D2LQ.LIU084^S_
MVQ#1?P!.4F[_>H+Z/#@A4IEK#BQ8UWO2U)(P(AWMQ*% -;VC<7M&[@_D@D]^
M^R03%J1"K3D)V&2_\-:9H;#D,.[I^'R_:'=):8]D620=@??XR5[R1?.XV[=
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MR(TS<8#SR@1P7HRPT](C$%%[+YI>ROH-D8G/:ZV$ZCE7K:&XB<=@>F5&Q.?
M8(:8]O%^M-D)9K3%XGSX6508%ZW^_0RL*OO171=,^P1>JV$QL9#[D.IP=[1X
M1';.*QLJ'&N% H"I;6P<R/=C+<> "_[!\>J*:C?>1+FW_[HFB\ME88V-#HB7
MLSI.9N#]-27X=I-<&;4GX%H%B13:4$3Q8,>+'8'(<ZM,-YI^XJ8P@V\O!J8M
M&).T2+'3=2!/XQ&U^0+!*&@74ONH9/*B\#1B-\UK"?M,[?Z T,N<D6A"ZP$;
MZM)1GCV O1L\(%.[3S5$X7 %$M$2!3>9\7>;L7;KAGV)UY)M00$/J05<R=UV
MDI:2K$P!!BY>%8RR4H$F*9\IK7T+6^+P-+YA&;"^-4[U;3F1O$2KY=LC^3FK
M"MAE!1J!AVSHE-4YK*].,EV1?8>< 3Z7=>$S+SU".8)#T(*UYZUMJ- X<]\_
M "'=^,%,.4J_2DQAD_;Y*1H(3BIA*,SY]K!+K"UKO_"E9TOJRZ10'I?9ZNT'
MA]HS15%=57&7"N=+GK\UYB:2N4#&V:S.EV&D(KFG3.]XZ!:P$7U@X^;%]_W'
MYI[5F+XUF9A#$\_-(\9-G6#+1,,-P![@.*K<87!L7N3Z@U,F[3NC5N)$2Q7@
MO.@M&'?75Z8'5]E3H'0H5[(GK3-?R6=P;JXZF)AS1P3D$+;T#Q!JXM*P]^2,
M:8I25KU\,CT9*&E+]4Q0^V,21$9@<=#&U"51I6%EI>')'P6-FA&CF?%[:I&#
M)#[G6.:VZ5;>A45&U6 ET2Z)$\@$_;E+%$:O[ BADO#-9>A7^H0RM6CH&]BF
M@_X:M#ZI;C?.064F?A7GQT^NCG%O99$J"S,PV=HE> \!'=N>32T2SUXK$!#W
M-)(C60^[EPNRH%._ LO#9+&?M"RA3!GR/98?$?RGN$]*,Z&]WI<HJM<NEYO+
MB5I&_-L&?AN[FC+'LF=!^+*"?X!%OQX^Z%Z_B7[#H^I8HG@(PS5D2S$S->^5
M42E8UQDRO7#:L1!I[2:>DQ4==%OIIF/0''PV +"$=9".J,VE!,BQ!43N%IC9
M' [F%RXJ'U<*R=_3G2>&L8SP088C-$@[SJ!@%;A&7D"B5F0RAV @S\J[E: ?
MPG- UQ>0A(#$L?A/ A:-QWZ8<2O0TR'X;%=$$PK'H=38Y4#M$\TO[CO@=W<,
MM6L1K;ZTHGF"B2E(F.7P:JF6='/@44^UV+BB'5\7<CW,(/%]'S82$C&^,(9
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MIM"<GO<AU]CK=5%RX?1P1MS(&HMDSPX9EHR+M)QYGZ9OD@[??V#EA:WL-/D
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M#.>LG".)41K?&"LND"<LNN-E,3')"=4.-]LCNI=3OBW6[.IO1Z_%6N\8<G>
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M'+)!D2J;R.!,('(C>P<]W=]WYWMA_[V+H?&:3J'DU2N/BTNXBI$:3.@4Y3F
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M/?&>(T3>XP,[=+&BHTQEICGT42S-W#J=4%'O!%<KG\)@R)UG\+,B@&_' /\
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M7M@[),R9XU@_)!LQ#L:82PZ)36,>-.: F'^WA*PLW][N2D>;N?C16'2=;[H
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M))?+P@)H[>^&[!Y4Q%^H/TK & ,0[ZN2BU"0.%GL@Q$ZD-.U&].Z3GR?]XH
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MS(]Q!!Q^^^YZHVUA2CIC6H02#.,'4$1S@F=,OS\W- @<:/?QRSR2M-.<(.B
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M*FN.B";;(<)Z'*>;O"=B,@Z$-+IX3@#?I7I')("7AW41N71  Q,QB\S>L[,
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M>:9751::, !..0$))F3CX!QD/MR"A?NB'YXZ==% BHWOE&Z/1$8/(F2*O?\
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M\X:H,X$. =&68Q\I=FQE+<)Y8K N,9&N>!TYK-DNF[.IXB:!M8O?NU[8)G"
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M,&EV$INP=Z)=,\XWV"4LR]K\9/F(O0 ,/B<;T572%-TT!)U'V%B:<-T>,_*
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M ^-'RWI67F0C2 ZZH,"(1DYPS[E#:-B$W8B+M1<5G3!<_66:Q <7/C.%!G1
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M4,<U)MKS8Q5@ YU>M]U-J%22[@-_5 &6B7.$BJD;@<$=DU2%X7R2AKONI\%
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M^6F#\$^)=\!2(L^%4&MW]H"PWC\X21:QI/SQ"D--\H6],T_YA@@9]'2KD*7
M('?'$T2LU+S+ORS3&0IC\WH@!9GKC<E,-&$,8R-X*A9@>&;L>ZFVR)78AI2*
M ON'=,^Y$H>P0.%RZO1:#G'2D$#"NZ[@X(@UX]'.N*A[SC1[EAM);I7CQ""C
M0B_&B7W7DB&2:@XUQYQ698^X7;T"^U]74$H?.*)#J;_'!.PR-U][<F:EPO=&
M"!&#K'I333),T7@.'C%]U2 X>3RO>AIGG>I0)YCAKR3@TY7EPHB^OB\U-[Y2
M?]YH*FD+HZYI0*Y\+@D;!=_B9=<=Z8&E\'(&?.&]V$)>47BGTE9+X<'6\I,H
MAP=SKK@@<F@'9U]TK+&78;SV5"0X4=OA?A$2\W80(1B.!RP/"%4,C!W#A=<4
M6VM>]XI2.\)[QXER09_3?KF@R:2)QY(NRC+#6\4'C0XSR/'Z0%G:.WYWQ1+,
M9[M$H9IE'?=R35ARZH"QG2F75_-8]^LI3N#DC+C?>7=,R'9WR0+[-[N#^C]$
MS.7C-^&716V9%7C#Z0;I$0SY((DW</I%]7F5<8WP4/4^E#;GEH>UH-.9:=$=
MCA@FR!C7N@Q;H*Y;GNXK,#5P\)F#++HJ!WSR?E90*.5<<N4D!7ICB%8"D)]+
MW)*Q'6]*H%9P$!FZ/%$B3XBY^$,7_?RL6<W/WF^B!0]V$7WK]+ F ^M>&"+
M./UTW[U0C1PIACG.2 ^^[DC/00=0[K<INI)]W)*TUP$Z(&::GEVQUX)"=VFC
M@L1-8"A^]^-U08,TROZ3-"F/;-%D9.PJ;S3DW2J! 8#K1U]B@_RZ^7!!HO6
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MICW2@&( A7C</*!WNTRTAO2DYT=.=9*7MF'_ %,PFKN<(3W.0(^HW"B8"4'
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M!WQ$L7X?:S67S*]%!DSP?O57\#D_<@#A"&!'?,V$[1FZX=/I*)W7C)8B(J[
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MAXW.PB1AQMUO4FF-]C.\$#-:NUO5R#(&_*1E?)*7T>1CWO!,R,-\+G1Z#.=
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MO'>.2F]]7.?PW52@G@'SJL!*W??) [8AHZ_M(70.X:USU5"14?/P@61SWC)
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M%KXP>.HC-8-4(.-(G)(1*$'Y;T% (O,Q)TMVN/-.T7"&MZ;TC^)P-RDY9F6
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M+$'>/')*9C 3/V@84<>*=IJ64<\[U4_=-SYFQ?99_,#E.ZH*!OEGY^E-J,B
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MB3W9X20%HN>_KPWNTP6:V@#JON\5,RTL[T[!HZ'=U-R!_=6]UOX),#F78ZH
M"7+ _4T2SJX>;CD@+8?#*8K!.<;I&X%*-I3H@^<^U\D&+4N5YIQ9F<ES\'D&
M:LRUC O%N\20 M;^NAKDB,QQOJ@1&FO+ZYHD_90!IHTXF[@IADUC6\]-4Y:S
MR<^X)0WC&-BXH"75Y'AEP0#66F=A U=\(>_1URUB@<#B;O +&0QDZY8+,Y;K
MO%;W7RYNU0*6CSGE<$S.TI)PXZ[HK Y3A=Y+-5IY%R08%\Q*6=C@AM.,7.[\
M.::4!K<W%3?6+S?+CJ] YH._1R85#OETOG)(^(?2N2H^?3!][D$_:*OT\(!K
M #[EI<U1TA5UY20_C=PA>%A!(,@Q(>1@79*Q,I.K8.J#,'OK<']TI=,/Z#@@
MBTP,]V= JX'#M>H2NP<'8QE+G5!D0CJ'71 PF3DZ5[E9ENE#*\2%+W7N19H[
MGKCS0%X>28QN\EFQOUN5N<IAIYC(86[S)%LQRPQL% S+ WSE+[3T?!^.'VIM
M-Y'XT6:)A9RW7F@-(O!G!PY71*,';^Y2/C.5+EV"LV('[E?5!-Y@-[[D%4LZ
MTKC<<%/MN3,G"-WN0*74D^585\)'RI]W!/[)<^+T-H=VZN/T@FR\OD'91QW8
MK%\).ZO1.53E?"9P1]IQA=Z(,#B#X->%$!CC /??)8C#""=D$9FW7D@P(<Z8
M[A+%[S)\ [I@F&6)HLU%\773=P0,<97-UZ(>ZZA^(4@)SRR=ES3-!P!GI7(H
M"3(EY?$ \$0U,O<.I%\%FP]SX$0=KX3_ /M(&>CA/5!(%X=_M?R&O/BIR=[0
M_/I])W8DNA?6"HRSP?#SX0!W+KK;D'0(TCEYFBV8ZG=\7HI^TO@+QT-N<@ <
M'3)P[JN\/AQ/QAW46=SR-UT0C)T,2[">+D%@U&I!A\]LEFRX0K<<-"DV<^AC
M;^RKM&YNKF:\@@DSB7O%+O%.6H/W 73..]9[XY1O=Y4RU4CZPOF@</J'!U(D
M7](>PP,XO?V2!O.;@!GI2#GKH::#@^!Y7F@!(UE$Q1 W"FNM,744WB+Q$1"S
M<?$(/G/H@9IJDW\[YKG+.XATLKX)FF@[.6CK[/3,FCP<W9U^D"L-%Y!@[K)^
M4/&"#3;G1F82G@*O56I[HD5H]]\$C0X.KVS09K=##.X8)F6N.LQEEV2^V&EO
MIS3LT-WV0!O)SAO>5,-O=Q=3?GR$%1LR&)A!XR2N$<9YWAQ0+_(\0/AX\5-%
M0&L^EV%,LLQ$IRA&K^75(V>KKQ07(%9=8UTW)#LP"^E(OY4W)F1!W#I]@;DQ
M$#"1(,81PP03]]8B-1PY13;5L0?.0&.DHJ;G/#WE\B7.J)X32LL1?/ F3YZQ
M0%G*$9>']%5D /=/SE>29D.@<:USUY9H%H2$>#WX::2.2 ![HS?".[XBJ;.K
MQ2$A$W!RD8&(+H:"'VB6B7F0@ ]V?7IN1JJ2N,B\0(RS>)H,F0@(E_&X($Q@
M"\PY9IMF)8RP''#>B24!Y)!D>.OPG_CU>33YYI0U03$R^O)5::Y"0/!!,B,)
M.?AQS/VLY[B<(9>4Q)+G;OK#[2@XE^;G9.R>B[)[ ;9PL=\PG9V=:G@YTAHB
M^(J >@E>BJ&IASGQY.1)GXHSSF<!QX89)0*%SJ@C*Y)VCNI%T1.5=4A:J1!Y
M?V=5Z(?VZ/Q':^2!:AJX<)O[X*1;E1\MTY=$S(MY=%"Y]K*#NS@L6(LN@'1E
M'QO2LQ<(.9B87$J@,=*".[-WT@#I!P$RZYGAJ@6)2A7A63["Q9B3/I>-$[)$
MH1\7T>@4NDY\ [)^?)2!B!P^>$,ET/&40XTX9<E$XB!ED.^]%':%SAOQC\)1
M&+A"$9N?Q?/RBW3(NCI?1,<)BCKGEN1"M _Y8.#O*9@0#A.?!*"^?&N7'>J@
M1%NAW08&<*.?<%)JF$)ZQ(^5FBZ&7%U0:71!ED.!+JQ?1TG205E1V_'E>B1\
MB*2POHL[(TC?1!EC"!EB-XQ0;^26$C N^ZH-%QKUQND')]FP?^Z$Y2^QT3M,
MY0#W5?OG! C(Z@2@-W+-9T' 5I,^%L ,-V+]Z)(?S^;^$!+,  _'!YO- ,UJ
M!R,[DDT)>.#[T69C,ORZ^4!!JTYXSI1!F3S5UWJM[(1%3PNY($2=(NK>YTD%
M'!SYF0?V\IA+2.N^W(- 2!R&6^PI!O\ [<7PH!-Z"A9,07.>(3W7BL"!"4'N
MRODY3+3HZR<]2]SSQR?D<$'2"##?#"B4Y [J) RZ,LA'4Y.X)CBY[ZGL$!;Q
MF_ZI5.RV]S@(/E :/A-2+J3C.FZ]$H:=/D*XN&"+"K6M1#2;J1Z)20"(.S<^
M.!BL-H_S"(%*<!O6#7QI2G!$4!@8 F<0_<,^B8MB>4L!7Z7.3&#,,1(<:E8-
M1>][Q'O]( R)Q@]^Y\(=$P#WLN>#'2/A,V\9E\!(F\$H,<G&D$#.=(.<YY^,
M>ZFTV^ +CI?VB32EQ6<X2O*L:H*,!PK(.)?&,+P09=$ES\>$<UB84<)',]DK
M,9/PW#+N4&;%*PC)SZ.XN?)3+F:F)=%])#[5L8/ST@'JHT^AW02(E&0?DY83
M&,Q2&_@BTW.%,8NP"F* LN K5UT08S>)/>08OTU0+R:1NG"*-' YOIJ'H,-$
MYN$<^ST'6!!SGN >^F.J@!-XD8.,PZ?359K: 2)%29!T-90=X6!#@[.H@@VT
M&4"Z4\PY+[3G1[B\#YU1;,A&,-!V-4P#GLX5W:<4%&CD7RPYVY(I%J+.H+WP
MC"PD0=Y:G\2E+'!(V:#$'%[G#EX3;3(5O3+@I>YX=6E-<(.KT08"KN^GV[XU
M!J_XN2++6KI/>^]Z5IAY&\SD+BY!@U/-[H.+A1!DOA(NA35UO3$SUF<L-$OM
MD<7'$_&J"QPRYG/>H^YU)4J/A%IN+G1GI=,$K36'&HB(&]4#L'"&'%]\$@/^
MYDAX>\8_7*B+1BX.<0]_8=5OX\(==>*#;-IQ<8.C24WC)%T0:QK2DI=E'$%P
M))=IUC5'VQ_QP,XW.""CQ 7G/NG)_P#1J_C]5475,&AG)U-,PCM&'R+GQ&#Q
M3>@P)#H$@W>2K_-![0<Z#LZ<5S@F <\QE@<;T53_ +7&)-,Z'1 C3="#NB[7
M!69+QQA6W)&6X/+H.?=YHD.+A$$ B#L4#.$69]G*; Q F]_PK-!SL*<GZ&JF
MT(QR=08/0#&$NGVG)$-:\P]<KXPB'F5,G85C54)D('Q<B@#HN-8PI>&*NP0;
MW2PAX4F!RCON/!%[HASYZW/D@9U,)ZI# @/^+JD:VA+]::3Z<BC["X5(GB_5
M!8-8B!>)WV3@S+JWE1$[I2@_#0*#1F(94+[Z( W,.KYGNNJH&C#F7UT4P9/Y
M#%4:8PG"7/P@L^ @Z#]^5PHN5IJDXTO<Y,6_]HG&NF5X)"=7R<.WE!395=$1
M?[N".+M_Q<4KX/%2'^3AAP4FGTKC@]VD!*J"CIN+C%V-_:=B@,C/+-0[0D_=
M>]-[B88/%8Y[@@Z6F*B-S\)!A$O=@_?U<@RT:2["X50_DG@ .EV]!4M0&$AT
MYI7CQK,<)6%,# OJXT3 ROX0.#@]];JZBHR:.#KYOZJ#XDOATSW45O?%PKT<
M@DT)NE"#MQ2AN@WP\VY$LND]SW\;EO0)D1 2OB@=HP,8N<+PP2,-3YWDF]M
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MH&?@(BG;4SCX1>,'0K?5(S-]/-^<$6VX!XB^F=S0#V/R='=BBTU%Q%X*?ND
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M%88T/<4O)  94ZFK_A."^432\%,BM.%+DL!"#X#2\8(+%F4X=^R4Z[L1?-#
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M&5[O"1@Q<1)Z#1.\2E/'1R+&$CWN>(0.UQ'/Q@D_D^HH;1DTA>,NZ'\?9_1
M&@)Z 1=G83:9/!%_.Y;^+?\ &'5$T@]WCI&&" DSWWO@-%'VQ>^$_&^RG+6
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M X/UGIN"F36> S^$%7XW&_I2:&?8:]D&7O>;^$P$Y\H<4#L"$:%\>:#1>7?
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MR0Z$#&\[P7.R9"C\,.J!RS*;W#ZOLL^6L<8>,4&6IPC/L(8K#0NC'H@Q+YO
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M'&4>7>"5ID/PB^%OO).=H#!\?%51H;WB>=SKE) 6A+ QJHM0<#)QUW)VV\>
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MSN[)4O?OXWGO3,GAI?G<@ ,7F]$6XWEXL)VF1<;[J+35+TW(+,!SZUW_ 'N
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M@;C&GA!8CD<4K3-[^+M$O\G:FYV"T7@NO+/) Q$M3OE82AF+Q6X*GN2$RO5
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M !@\W>B+34J_-7>4 -"9 /+JZY8G[61]G V_AN$$$#A_F-SNJ4:OR19SR?\
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MP'S,J^%,"II(W=4XD,1Q0'VS(D]UU\*;8,.'C0JS66IYWJI%IX+IZ0PCA!R
M,M3S[5[9([,9YQ09&(U?="J,P=765C% 'SOD@"\%T,N$">B4'%[HPA#-.0*8
M\I?: RC?VEVC6!PQ?/D_DM[XQECT>L1@YV[X^,D#;,O=&EWP71[P)5HN$"N3
ML)7Q0;#YSGH@Z6B^,G]:7BL^=B5]%!EN#K.F?Q1%]W*R@P9>82NG*BH0Z+Y)
M6+II]H>W&3\WH";NX!(\ZYCRG9,W0<8O6 SO!_ H)LB[RIN1:$LI*C#7",7J
M0U>_AC90(V).FZ-500&;CA+P@T(\+N6BH (\)7<D 9-FW7Q)8>'Y?5]$''LF
M8DZE$$,L]SGVY.R9SKO">$.4+AY0:%^<.V] 6<Q3'AQ^,D0-9?>E7*+#9K*W
M>5<-7ET^$#87PNCUB=<,4N%NP/#RI$1UGTCVXH*;C77=WR1+NO*^B0-.AS&_
MAJBUA6Y9(,(1+Z?"S,=(FCKS4&'UE+G<%<,RW?'*B -PI;N.N* 9D1KO3--9
M70*/O=O=R&-XH+M2[]!=40SNY=>%$-FT9X0OYU3PNAW]4$0"#D<^"<DTT3-U
MCOZ;@@0^1-+^D&!U^KT3!KC;OC);*$MVJ U!PQ=2]$&9,<,._/DL=I0BIO=T
M0!L\?K%;RYW6\,T$RWA>J1HEQ+GNJ%T!B;L7\%O<-XG#ENQ0+LB]Q,+O#"KT
MQR&&Z_I9DX:=7OMZWNN[HY!BQ]G6%[TA8UG6^N"9K:D9PS6]SX:_/'D@)+A.
M-_2'OW<EB)8:WS2-&D+W(*^Z[C\:)&F?/;LILOB^5Q^E8L_68OP@1DOW(-9/
M+@ G0-B_W7N5'7YN"B")\KX/WH'><+O>Y,'QTWW@ILSKX5??,$_5$ -)F4+@
MC[L[O>F-O-W)0#0YH'8SX8?,E4M/>X/Y&^RBRV7OI071!J<ZY:WD@K[Y7QU\
M*C KRQ>I C#//X<G-.=Y8("_A*\/"%8"[F>RG[LOM-INRIP0$F!??A3V;?77
M>] LO!C7"WJK#(K"3D .#WYN2D])'"5E,!(YF]Z5HSSE=S04#?BCY7T4]_.P
MALZOZS5?9VUAT0'97Y[:IMGG?%9[I6+X!2+3J87>*!R*C3X6]^3U)[YOC#Z5
M6F:/CUL3QH@5LRITA<^2P;SK>_H@[&G#/[50ZG+3/P@FZ9?E?3DF!Q$+=O'9
M"%'W+3!+>9IND@++5OY7!.T-TO/QDHAD<>,.6?2*H&GNN%[T"/B+T=GC@JM-
M%T!+E?11]@?SXT^56+BZ?QG$7B@I[Y$''CT*1IJ<9P<_#NIL-._Q<>Q2@1<>
M'U=4%]D,;L)BU%VX:7=%,-Z/XI6A6Q*B!R<>=Z)V:]/.KZ*).,(A^/#<F:+@
M_'&].$$#OW=O&7-(8.JZ^BS+;XND_14!E)W.47[G(%SRZW96!X1KP4F\*87R
MHJLM?>6EO0-\!2+'7DL+NW)V3+5]RU0(RQ.O96XZ;DH:K#XNM5BU YZ'CNCO
MQ0(T\RD^/>%U"5F]\+X)R8:Y(LM<KWZ\$"ACK+[^T0'2>L_S.Z53CGTW\T +
M-9 BQIBF]P\3A"\J%9_"5[[BHMP,[RU06#=+EW^$ ,[\I-GG])@U=1A<T&^;
MODLP,1"[<BZEQMZ(:K\WG;@8NPWOKBIM-5%]NB),C\<E,E].TJ#R@LR9]KBD
M!Y[]+XJ8+OKQUW)B3\.0%^N_1'6W=M>B1_C+@F#=,\.U$&#3ZZAUCG@B6I1N
MXY)&61\&> YHMRATP,D#AE\0B,QGR4V+O$5\/5#1 Q,L'3?R2BZWF@Z[L*)-
M*O[4JY!:F5WBD9%7F@=.]$S,K[=2L2Z3\+KP08NK*PB6Q\99J0-3N%]TWB6M
M^$#B.Z=NH@Z[Y#5*R?%,((A[SG8?\20!SHK8'"G?X3X:.Y7!$#?B@7W7'C<$
MP/?HI&KS\8"]RQ/._G%!9IJ3HE(.L#A?TL_HMION%Z(,#I?*XK7>B#S)V%NE
M;UA>90%IG2\'=$/=E?;5 ZNN#]_*,TCM=?A!0F5_:8-72,+HH8//&]VJI[LH
M<-VB!W0#\\+MZ0/UNMN3CCNOFM[71(=B^L.DLWH,][Q#.\\5FQ03X83S4F6Q
M-SH1*>===;@@ D]WG([II?; /Z4SU3X#3E,=(X(OOM=$$PUAQN$54<\.\<J*
M;\.5-PSX(#6#KNA06#-)7C==4K3#G1N6Y3+5W]HD&8>@J6]>1%\E$FX"2SZ&
MYWT>J%TATO?!!GP=IN<**1J7'1U1P0K$/"+_ *OJ@'O@"YUTPQP6#<'X7*B:
M3Q2&>B!.#G=/J;T!>]U\.'RG/#Q<B%(B '+Y3PY82=X0.2X8ZW<DIZY/I7>I
MOK>=>:+,@!AB\7X0-[J2SZ)PUP2@#A?1*#1YOIOZH*%OGG=A!D2MWCJGV6SR
M?K*=-/A*V"+KNAX0*3@^%\NJ(&>E!]T!U2>[YTN/TJ"%;N2 EE_2\-$ PZO2
M]%CKOE>O5%K:"+C=W) GNYY8*C_/32\$H(I-UWFD)N2!GSGONOA8FX==$M'U
M(WB[@D9TC<<(8H*BEB"++64K/A1(IC%,P:ON5O0-6<<L,K>G)K+X4C/@$23,
M[_* /?(PCVQR1&;P;L_2FXS$CWENJK@>3<)4"!0+ZC>-RLTS6[=<%,'GP1)Y
M2%4 :C=[OA*Z61&^:WO?7S@ET<ZHT-P0'9UY(-?6#E-O:&F??BJ XOW6\/S0
M$0[.N440UFY[[U^T"U/C]=!X6905?.\+R40W8N;JX)_F>*0M4OC1 C33^<^/
MA#V:[DTWOGI?PBR,8Z.ZH![97OO4*@$\IQK+I5(*G/>0+\.1!@_COE?E "S%
M^$H[MZ4SA+Q\8(^^3^%XW! \^AIPD] A:EA%WF]$S$I7FM[9&<G:<OE,URD\
MB"!RU!T[E<EO;5Y\6\)!UO).&G.QN\T# NA&EOUKNS1(QN'=(&A/.M\$IC<(
M_'!!@UE&APPN2 ;-FNE,G+.D^\T[0P<+OZ0%SP^LL;Z)=WF65R1]U)GQ-%BM
MW! CJ7;I+-%V^]Z+6FBB1$1NXH']AF_&Z)_?@.<4 :$NONA[NJ![X2X]E*4;
MC8UDF!J7_2!$+O/D@=S\7) T*4I?9)[2Z3NKKDIM&@K.\"@Z3*_AUU2OUTQ^
M5+W'75'W\8\4%GW=E(70 L(^Z>.6=RWJ;&N[3X05)N\*^$'2>9F^/TD]TA2I
MZ<?"9HN UOB@9TS@Z73Z@5GC&#KX5"DV9 8.[.XXK!GZ*!F3(N+CP3,G+$1X
M;NZS(W.LQMR):ZW=$&=?P^ZH@=@D,I1*S+7+J@ F9TY)F6]<ONW(#/.F4$!'
M%SY0B.V1[H*-M"F=[^RFPR<7\M/N28F>>_C7<D8J<'W"W(&: YVY49$..'!R
MFT)..%,/NPL#%Q<!XYZ('@Z>2FS#IIB[M1,3GGHZ^55FT".GUO'Z5=GF^./?
M@[DI&_JW!,SJZF>B -,X0X:0BE8Q-^'I_;C3..Y*&7/U!N^"!6R7Z\!GO5,L
M'/UNJ5G%]WJX<B#YNL:(*$SE"4J=E "6>4GI@7OI&.-W@L3Q)0.1AA+XN4YJ
M3+?7=?14\CZ*7H^X71!G/[7D).3C2$L[A%19#JU^A%4]T[N'1 I$07PF(7-;
MW3C*NN5'O0:P%>+X< [@IG9NU+M^6] 1KA#OXT50.FXWA5!V3X1K&^%$K1IU
M0%XF3IF^XO2EVEWV6<,4'94=K>?9 6FW@EFAA3*\=R0;,&)?HB_0PIC2Z*?O
MQ@ 68:(.GVRSZ^,NR#R!B,3WO% MT=NOZ2M S?Y^$#/>]TG9[SEJB2Z%D8B\
MT@QEG@E<\N>01"<,4%?=0;L!2["!:=&L1VO!2#!?2)CEG!5]L,+KG7H@P9$H
MW"RJ%@ 3PY:)-[WQ-R&G!9EI[GU?](":.#Q3ZGIDB"XBC\+W/2>POR![H-4
M%9DS0,-T"> DY8M/&+A6& OFE98B"2X3YHEN;A"\:G@@9\=PO>F SA2.Z%YQ
M4F"\QA/<[GS>B3!V<<AD,4!::<YVYYOFE8:FZ>-_6]*VR*DNZ^$Y9%,9.>[Y
ME!"ZC#JG,]O*EM(FKCT%\%H8C/.ZIA)\?K1 6&1N=O&3[WJFT$I.,+\54&"_
MC>X8RWI@:%T^.^J &,:2O<E:C"E]MR#8>(9[OE,&(1=+'#&Z(-[C(#6NA^%0
M-2QIUIR0#(F-+Q2,B0!QX^2@<L/()?4;R/'!*>64-1H4SY Q.4M]Q6:D(F<?
M#_A!,RKH2-X5&7D.<7O/"BF)3U%>*HP:2SU\50)!P@(8P$8>$I,^N:+/(%]C
M"YK--OKX'U@@.S%=:2Q=>BH6;Z/O.J4-2TYXE*V9<(:Q0,VU1P#B7G53:)IC
MW1]F,8U!RE%,U2$#XR^D&C6LL%C*+YE'W"EY)"9QF>T-!D@MU^,ZJ#5,S$GI
M#&::,IG4#?EWBE]N)QXH,VUN<!(FE,M5F3J'8B&Y.U$0W'*%!="D.XF>8-R0
M4:+HCEG-(T0(R\^>SDGND*UN\*)F@^+M<L.-R0(_4O-1(;OI49:X8G#Q@]*0
M7N ,HD]GXE9\S!T0^X<$!;,]SL]V(E@F9#A%]8ON54CWT?04U0:C1PNEO0%A
MHR<2/'G!,V8%^'66D,$^RP?GB2[*B.U<^1=G2%Z(),TA*!?.2?V3-'!PY?&K
MT'P>Z3@Z_G@@\D/CNZF]$"ECGTZ/[JC)RA(#2?'+NHOG%\1RF[.W*H9@XC[X
MR0,3I$P.F680Z#H_!9D"$,\8]^2B^<]-]]4%6OEQDXSX=$&6<)_*# !B9B#K
MP5&3/E\]<<D# .AEE8@IC7!U;JB=08H5PIF.J##:81+C&;KQ0+<8 N$!KX2M
MM4$8;IVY-[IQ>'9;QF@5ILQ,'/=">6J4.J)B9C&\DH8)A6;S(8.561B99U=<
M*H-[9.%,8*GNAGA#"SHD98SD[+Z^4IVH$&H4&>00'^(UT$>7PJL,N Y9>"IM
M-0!)W>>O%,-I'(!Y?5\.+D"-[2<XD YWP2,L1K'_ &Z"\58.+@Z+^'E+O@^)
MN44%7P(=4<%-EGG ]OG!,R9@OC9O>LYVAWSKX[('9%OPO>E@]\IPE?9;9DT>
M7R?030.T @8 ]Y[B@9O*]-,-Z7W0ZTQG1QJZ/1+[A( PF[3X4_:7;WF]*(*%
MJ9PHYXI<-Z4&@< 1OT=;EF#2KZGKE93 "<N%.<:% 6&M'NG0;_"ILV8$Y[[H
M7I./ 3%$^T;$&0,'E\8H$)B[$"'5,UXCV<IAF+R/\?-Z)VMLX0K!YQ?>D$ >
M(OI+I6,>*9<[#-6C(Q\[O*R"SIQ,98;O!3%T7S?.4'3P3,P?*MWT7/[X@&6=
M+H@Z"U"$72=!SI1O!(6GSLESHYGFA)XD^65+P"JT YF+L4$Q,Y:<G(;-G@_6
M2F!@]\0[XR1V;/\ NCY$?LH+-")J)R09;C@!+P>RBR7&+Z3+K^E;9%Q,(0G.
MXON %K8S=!T2,,[T4W3)Z\;HK;?;X3,.!=<ESOBY\C2&&&:!@T[+O7[R@E]H
MBZ7^[,&[@LVW_P!H&8IG.O)'"GP@9BL!=+FG<^6CA-()3=N<[[4P\%YCF^67
M+N@J&'2$8/#\KX)C6<18N*3^2,G0S3BHS'#XR01+4*T<Z*<-/!$G850=%PC<
M+")&\X2LH,S4'1^(?E@F K4RT>I,0SN_I6V@PPIB@F!%[M^2QB8Y&RG8#@7/
MQC+@I,M2P ="X.<@HU#.&JE&0.>+P Y4G F#^MOS4B!2[F@8!T<WYZ)F6J\(
M+G]ISG!^#I1EU5@:NR(Z&*!B,#PFKOD(9G/+A)<N1WA\8WN3LD2!WR?P05)E
M0Q>Z>J#&)C@Z^NB ,WX0=QNB#+L[EEX05#50X.SM^BBTU-XG.$;D$":8SRJ;
MHLUQ&M:2IU0,RR2\@O(X#"]ZS-8OSCWPYP0V;1!=21T/!*68SD\D7T0.6I5@
MYXUK=%)MS\S.>[[Y)AAC2[AFG+,WXZ0^T"LM3+HB!!NRB331TW_/T@6(Y<LD
M1"!F$&;Y9<8TMRTWWSKD@T.$COK<D 7.P-]MR!@8C.E'R3%N8 AG%Q$()6LH
M8!Z!'"]Z#%J+J<(/3#:96^"7V[GNO>LU4/OH@Q?'@#=?I68QJ)]X\USY&KC=
MP5P82%#>+D!:JX[^6N]1_CC[AAC?RJLB?'C?4*+34@+\"ZH*  Y.^.I2$P(H
M3SU"D_B'AUP&B 9-7CMAH@H_*H'TK[-G&G:LNNJ@T)AV!Z7""+.V<.3\KR0.
M6J$?-O2,GH<Q8S1+3YT#^%V$OMR>;PX(*[(5-NG>]+M!@1!3]T2)0>77RS3,
MW=O0 0Z:(M0=!XKOKX0%9X98P??)$;I;WW75 Q./93]L>VZMZ13,B7#X6:&<
M^'*:#!KAI'-.^IC(""B6>9<_6/9,PS3=J;^4#"ID_E5P[:HBF,;MZ42)I'-0
MB7 <Z=$'0TYSWN+[S^%B(&5RFE99@0\FWH-;,S$#"4KF@=YK"%>UO@@P=^-R
M1)D#XSZR6V>YT=7C*B!IR=<.6:85=E+GP3.%(?-X*0+J5@_3Z0(1QI>0E59S
MH8=,MR)B=+ECB>*FVVZ8G '/-!<-/#W.=K<)HMXC+?K!(RS4$]DI:F#C#%!T
M XZSN?VIAQRSE= I^YYTK!U]<EG1&'6P@K[H3K?VL!AS.O'HID1C /W1O>7(
M-M2 ^X^.4D%3,0$;BL_%SA>XH>_Q<> 2%\+C<]$&)HZ&(P0:9J+[;DQ&!W8I
M2W0_'- -)NXY^2BPU U/Q;E+W&3H6^_A%G%U#NTUZ('9:D3O^54F,1#G]BJ
MV>,\8)"S*Y7]H"1O[V],PSWRK _"#CE2M4".?/O].0.<H=LM3O0#4P1'?-9G
MYZ.6+4;YC7.2 &;QH4P8Q?CGOSH@T:Y^'<>2(>XW>.:";)RW(^^(>,I97PW(
MNR#@)7Q0)NZ'J@+43A3S?A.[@;G;UREOQ>*NRW2XA!1EG>:3ONB>W-]<+>L&
ML^G&-R2QQC+Q]202C2[[8(A]3"Y9O4P#'>1E<M,%3VPA1\K@@3V[]<#-5F[#
M)[K"4-4,#3QOP*#,)_.GAZ"M.%W+<@ ^KJRZ7)3?+.Y5?R3 &;K\]4#>SEX[
M\$EX$7]IO=E'I]Q^EB*O0#W.ASG\)=DU0!SAWF^BHR08&,$P#@>L4"DTO>LX
M'=TNZ)?<_OK.^:<PN^." L]I"E_:+^7BW/H4CP(RA4D8+>Z(-+X]D%&JWP0]
ML'\GW>JSW.A*[[)/?0: <^Z"@%>FB0'=)WRIRUOZ6>,.-U05::RB)[CP&(09
M/%^4JI>M+Y8A(_EP<+YH.DP_VX<"D=B':'=SRJB,2,][_CPF ACA>)N2"9%Z
M^4&(GEPNJH_+?A<-$'[K[5QF@:^U):[TIPW?-[UO?/<X54WOE+ W22!BU+[%
MA9T;W<%B.MOX+-LU%+=!!FC&H&4LU5C%^$+\J()B+EE5%YB)7NY('KKT';50
M]O>^>')49@3XFZFB<"1YUR\%!'VNCA(W)498D8XXXCPJ>S)XGE8S6=[9C"\3
M8F@FWQS\Z/EO4]F)OKUR.BZ<N>>O10;9.ZCB@5HND(/I;DSGQRE=;D@!3@_Q
MO<H-L1>^(G33YIB@[1I>_FB29CANO[69;A?WQQ@A#ZZUN2#,L/Y\X\I#"JWL
M.>L^"9AJ5SJM[Z5QZOUY( (9X)WY/'>X*;8^/'!0VC=><I204+9,L=T+GAFH
M@T-NZ*C!>(?-QZ+>S/3D@:]<TX\2%>WA2 QH3"2JPUOOX0!_$]Q+-,SG36D4
M"!KK;R+"!$JN,+RWQ0.60.M\/*/OTOY^%,FWX_?RD8/QUWZ(*!K'E?#":D6W
M4?&<OL.3OYC#O\(!BAY\G:\$#?RR@Y]_2FT?-V[C$M;"K^RV1!IPS09G:8UR
MTIRX(LY#.%\<-')?:*[WX&^Z=C*W><T!?B!!U[J%,"8^+N:=X\0O1**GO>3O
M"##0$W?1 B^^82D?Y8.Y:9*L\I7]H)$.$*Y7NU3LBDC<.'1*WA.^6X+-8WQ0
M,V([I7@E,='0Q6+41<'7]*A(Y/XH$88/4X46=C3SC>:<-3Q^'2MZ#,<'4Z\Z
M?" O$7W2_A)+A=\$Y&7.#Z7Y4B*";MP068/:XV4A#I5?<E+W<57WAT<+G*:"
M;3$L8RUOLK R%(WN4WO><,[<MGQO') 6B*97JML]<;[.2DXX NUYE-LP.6[1
M 6]+NZ)0=_/),WRSN,7Z*0%.'3J4'0&L+ P4FB"Y] ):/Y*;W7(9A4=/'ZG\
M30-LS7+ZY)R.\KF.^"DR(1SOCR6Z7>Y SZH@TY81O<D]V-YE/G7#% S])CZ[
MH8"Y=4K.:8&,IW%!@.%R3EKI+?XY*;33H9[_ )^$ W-_UNWN04%,W/W#M\HE
MF^<U,$P=<$&FJ:RR049?<X7X6)C&5]*I&'\H7T'%*&H\KP04???66:)+[W<T
M :86,'54V6IOQOC@@J6KZOO)*V*P%S>A7K&W]$[<885OOH@4WTNJ8!W:["BU
MEQPQ^$[+6.]R /?2WP0=N=OO[5V0)]\TK8PIIPU0(50%1]N&5^4[([7J4&+3
MG[WN[IF3"X7-!IGZ>]* Z%+CQW! @B_./R+Q<G]MZ"=TB$'Y(,DQ AT0/"AO
M%.-S^6_2FJA*+\1=')BU]>/"!P?"S\,+Y/U*B#&E]"L^GSRZYH' O#M+>F#4
M<KXYI&&'/+^*&G)!1IF_CPBT(&^'?P@+=RO%'ZO6W(-LVNN.$Y931;U<(.2N
M=2'2YHD2-86>]$$B,.G?1 G"Y6]6:@'Y9W&*0"!^KU0(^+[P P=%.-H+OCHI
M!K+=3!XX)F8=4%6!WTRBD:;^L+IN4WN[<;FL^,M3?T$%BS5V\( F+I"IC929
M4OAW3.N*#/"1[HOA55&SS>):*7MBYV<ZUX("3>2H+O[4/:Z /WCQX)P;N'9!
M5LX.UKRMZFSE<(H#AC$B?2B9[I'#"\\4!=BX>;E@F)@>LKWS2M? -QT2EN^E
MXS0%V XTUP3>UU3?CDI^[=OSPT\(X9GY09JKC'"^OE#9L8FEWV6ZN^/I'H]!
MT,;4" X=0DVA>897\J;-_.^:#3=Z^<$&++OC"D-55EQ?*&5RHE9:QCRR1 PK
MARX($;N"9D='V=W!!H.IO?VYK--4';#B@9TG&%F?+FE%>L$GND_6],-R#W7A
M?E \8W*G#JL!TTE6"S!GA6FX6]%D7>=$!!R&Z_I#VS-W- 97GJ_<BTWE?9!A
MNOPF::QU^KY*335+LYK$:B#W7! S3<Q2?0<[F@&CC!(^G6^B<-7X\($.TKNI
M%.&<Y\HYI"SC<>WVG+!Z2UH@WMWY7T3=-+BION4+Q5!$9WIS03]FNZF6^KY[
ME4@81EFD!=F>SLYO0;;QW.UO>@H*DH"=N?G1*=Y6<XW;NDD#>ZF<DA:PF)<N
M?1ZH _-#^-SS5 NKGW#548&/'K="Y @1W5ITWHLM8:^#K1 660'PIQ42--Q3
M-'*-_?58Z1[B4D"NFZL^"F&'S,#>ZEA5.&,#W^TI,<K[(&P&5W*2Q:S^I6]3
M!WCFY]NS3<K[2T04?>+L;BB2'0=(:WT4_BQKR6#,SA'XS0$'#=&^ZS GA<[A
MO1]V5W1%EJ=V$!]^ERS?<TK0JZ3W2X73!-T$[O)*,'NI!!L7:\K>E>:6[YN*
M#6(OC;E)YDY^^X(+^[%SL\5/W3(E]UKJE$!"< [6CLK<F&8&:!&C@>>)KI3%
M$%XSC7#EJBTSGAE>*S+H.W\G;T!9.F-W!4]SRE=/CGE>25^5T""I-Z?+A;E$
M@_3LPJ/=?2YH,B_&""(M];^DPV8PWU^D_L=>-OU0!/!!BR90A*^:3VX82G"\
M^2<EPW:\D SNS^+W( Q.5](=:)GZ.[:NQ08SD.';BG%;^4#- 5F<.^"4S=UX
MO\(.OA-9N N>';! 1GTJF/+&^!*@RT<-+Q^52F&%SMR ZRL_2S(Y79S#T(N=
MCNEW[.0E)\;?'#D@S3MY%\46#UW#O]J1:GD"Z-9)MG3+! S1C.S8CN1'G+=K
M<TH9F8S@^F&Y+!]=,G(+D<N5RQ0=7=\]DH(AC1VMG59\@Z&.,/&/= 6A-W/H
ME9Q)?3*PLT):(.O@@?:-/&F27#'+(GM7LC[,^=T0]U ^YN[(,[.W9<ABE,7T
M=*_"P'WA'JF9$.)CG*ZS03 J9T'?),!4.\ UU[+-9=7T@D9&Z>4KF@S4P!A$
MNPPRG!.!*4G:.#MZS#8$_GS>:)/U>6:  XQ!W6Y$M<;^DLYPR/%W%(U DNC?
M;H] WMR^))CSA>Y(6N=\[@@R.=WF@HP(O'6R46S6;N06$*WEJ@T2.OP@WN-2
M!2-W)2B><HG<;A%8O,:.[K,DB&KKZ<4#M]!QOH@SGNTR4O?%PJ9U3^^(RN],
M$%2X"Y[U.-)TONM[I@ZV:)6WOTN%P0'VN()TO&62&T;-'.^7I20\/N^,$_N%
M\I[D&8)B\@PD$ S-UXZW1 G 3KW6V-7X_7W\H*DF3HZ7PP0RIXZ9]D'D1B:9
MX=7<EAI"^\-<D#B#@.KSOT1+-9X.%8V$F=FY>5@9\/"+,F?40 $L=+>HDO,B
M/.O;BG?QA-U!N6)ZB4HW*B L"#X[^ UT6;,'C>Z5ZH^XN('!U_*S4L<+N*(#
M(JYSG=+Z)\3%U";GV=@B).NP@3+28TOL@Q9F'@_'W-3+5!"/(6_%9]X:!86^
M9S[(L%$GPR>+@G9%(/@?&Y#:. @(B%WP08D,90PR@A,W4)=F7Q^+HB!"$33C
M-(1#?!R+]PZQ[X(A '//2.GQ)$F'*(CI#CQ1,'YU*1DC&&6."!O=6(PP>0G#
M-;#X7H]*#0#/6YILH](4O>@9MF6O!9D0C#N?*)I;KP4[\.?,H%CAARZ\H*VS
M.(B(/UN25EHR=F :J8,\<KC'3- A9F[%,&!>G7NJM4)K64T&VJ6_L$"O= !P
MQR=.X+$85.\2@E(X=_N"SW2?0P[H"3*IE&.].*$XCC"]9)2<B(F=W+!(TP2[
M5XU%W! 6V\)RE+AO1.@>^^#S@IFA<)=*PY*Q+W/PGP@@#1?C#/NG$'#[O-0)
MB:BKN2<->;N:"O/0<$AGNMVG2: .I<'2I\A,&Y<,]_E!,,_[C6C](NR3,M4(
M@*O?;NZQY1G/@=^25PAO[;K@@5[\AE,X;@G]KW##J>H[)"UA6 T-ZA. ZN>N
M[ ()MM&$)0?\8)F1&68[:K-"@YQ<[YW)C1T8.NJ ,MS: \[M]4"V^H,(7T^$
M0RZ!.9?5]N6#.5 _=]/0)[8 8%Q=R.>&Y5)API#-*6G2&_/Q<EFA*;\<YH$]
MPP+YYO\ JJJ^$>6%D?21EPUB7UOD@TR9R$];PJ@HP:B@=OIP2D%P<9D@G?V4
MP"7U(D!#Y#JR5FC3&]4",L[L<AAY57T%?H^%(-O=*3M]VY#^02?'*$O*"H&]
MSH9>7H OK+=?PES?.5[OI-42%NWXX2J@D^<]<Y/S* S<, _C)9LT EXO5* ]
MY%:81X^.:"K0JS.>7#KQ69;<'ESY@BAD8U2,[,AXD'5C$.?]4<C[?]HF28NJ
M!AO0=.S+Q,2O52(#P7/<,'SSQ3OHR(2PEWO-+[93E0AW9"6#R7\LKY)??D(E
MSQ#X=X1:-1,PRI8585,>U.?!!%O&3K&^Y(4C,\MZ.T:Z\- ?H(L1<=2.R#"L
M='D4MRWOXPD^:($,''?$]^2=EAQQ?PI6^Z#,M:ONX(&-,LKN2.,.&N<.Z4'X
MR=.%Y10!HQ- _=?%!HS P@_L42<91+Q"';Z6V>]T7#YT08LX_P#O7"$T[+,X
M4A*3IWHE]\]1OS'R@R][APPNO) 7'K65X(>^;WEV[A#<F:>^6I') ,@\7VZZ
M(-M&G!T_^Z$)>$C0!<<*9NG=,T&VWR-7;NV"+31#GB702W])H 82!A-V.1^U
MD)Q(<!3D88/104+1F8/+P-\](P3;0TX@<K[+,S)="8T<_P"M4C3(?"%RO*B
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M ,&9G>Z%,>*<97]% K1N<=.QU6?)UY>5GUF["\**A$'BN-/*"9.1 \TU563
MDX#O;ZO4PZ >[*\K>JM%PN5(()%K 5Y:Y)AGIE,WHB.,(NGEHIAH4[VYW9 K
M0P</'"JJ(:XI *4<^^^*<,OQCR0![X2UN9N"Q:W1K?VG=,?=Z*;;4IWED@=T
M,+QO!*!NC2ZFJPB^.@ZWJI[,'_*-' 4ON@9K*M3P6(G//."S0,(N=#2%]4S(
MAEIN=QW502>XSGNYIFL73ANN*#3'*>%X<'%*!1\!YZ>$"-@TWR\;DS+,(WUT
M2@]:]=**N <_AOLH(;5K<#Q?R@J_QN K7ZY33!VIGON28&7 7UP03+<@ZRJ
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MS0.6N7A^3^RDT8Z8H@SU?RN/T@R*SZ?"!O=VYS5 [7-(!2WTYTZIGX=<N_)
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M5@)&SG"PL^CH2%Y)72A3C=P05(?%[HV[.N],R3J.;],>DU,9T-NT1V;4QO\
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MW(%:+[OAE"2/&;KOF];W7*^R &L#=QF@4FF;KKKN1:[7OK]K&F^[P1([[O*
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M@^4>+[\HF@C#E=." C'%]XWQ4,D1W#+Y^DK&TNRBZHEENYOA! 1#/.^<$)Z
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MT-'WVWKH:H[%Q4",+O)!5G9R,KO0K-,[LS\418/$.?K?*:VT:A"^-4$RR[C
M7;D 9F6.-W1,(W'58,P.K\X4RO%!0],>KQ<GA*6LK[8/0F]URZ(OEO=*7GL@
M+H:;Z<PG%\9\]RD6_%\$?=5U_7) 2R)RN#EGT-+CH]^"Q:X8X_"6^.%N>@;9
MC"W7N1:OYU09#I9HOD_IP0 &[JLR:9.\\>80GQB/BP@&>CM+F@N&JX7\)'K,
MYX7Q0:/QB_(^4!#%PO>$"U2M'NXXK%N!==G<E\]O* GA<]ZS+4(Y/O3DB6G0
M^;MRGEXCAN@Y ?<_G?RG9KKVXA+LV>/VY_1.&:(&>[?PN])/K=_2S;^*SO%]
M8H.K9;4.[8J3>TN[>D9IV-NAS@D:%YWR04+6?;KTWI@:Y.O)<Y9W1BF'9Q?B
M@S4<,W7$H'M(NWW14&SX]G>5-D/W/A]6Z"!N'5V*#)I#M=A(6I@W>."G[9[C
M=YO07;9O.]RBPSC"?WK]+9DXROJB+NM$#-M.E=XC0)V6KW< DU-;=>:+Q=NW
M( TUG?UT56&G;YWFN=IG3'MQN*S%XQO6J#H::P\7V43I?Q@F.<.V%YIGB)J^
MWVZ$T#,L6^?QQ*+,'0X7AS2?R4^[=-,&I1,C/,005:IE>2YFB7^.F'95+77?
MUZ+E::P'Q](.ID\WWX1VDYU[?:A[I7O3--7>:!@Q#PJ>T0R^B5SBZ7F:A5#4
M'#1U;?U0.T-3RI'HIXV/A;Z.>2=DZ3YH%!RA&6=W!$"3KSZ\%O=09OO'B@3?
M% 78>>7A!UYWV6]]PU0+5W#3I5!=EJ_BW*;1GA;LO" -RWWP2M9! KK&#[W+
M7''XQX)@,.F-^4?99[7P08!^->/@H/\ %;[9I@,*W]Y)"91QO'L@9YA<\[WA
M5]N#_!?;^ZBR08;J0WI_<ZY.TQ0$LW=A(R1>"/NX/OE(T2EEU\R@J1<])Y*;
MG<=UZ;WK,M2RG>%X*NT:%X2$;>@0 TTX]^DD[L==-?A!AL<(7<:HF]W+5 0U
MBZ[XH.Y/L=]ZG[G)BW>&^XH*,F]W#5.787A\KF+6Z^R(:K?QXR059:YPO!*T
M']TH.&'/L9923C2W7)!-EC=.=+^%4LW<K<AYOG!$C=SO6J"=*=+H@P88S&5Y
MB"<,T^3=5$F5\1;GH'8+[OLF="!=3QX2,\#=;@GR=A>ZB!601'&\>NJ<'*Q]
M[DI-\/HHM') S]SNE_"1KMEUGJ4AVM.T=+HD%B^2"GL,30SCD@R?CQP6#4\?
MKL[HE(,7">^\D!==WN4V@:)V6H7<$T)GOTR0(R3<<^"LZM;G=<E&X4NZ)SSR
MAA<8X40,T*8PQ0]@W:<+,D633CWL06?&M9<LT&)"8-S@>6"4C7X=YXI +R=P
M09H2.5]L]ZJR;X#MHIM&GS\=$63NO! X$?O#KX*+5XH--;G4[*+36MWH_%!3
MWWC]X+>+O!(R,)IQT?YGP04=?'JG#0OG>"E[L>-1!2#9T 0=8N/#@L&N-_84
M&6KRG*''1$_:"A-SLI.@?"$8WJE=?QUY)G9;KOF@+&^Q<NB8[HXN[54GBY?&
MGE4?>*#$_5\=5-V%F^29HTL7!9EJ\T$R>(CYWHAKG]_0HF-W?1((T=')!47A
MQZ8)"-1/AOOHHOW)FB^[-U0-[NM99ZIC3[T/!<Q?\7U5&+X8=4!:#N<_#_A,
M!7322>X=K>E.'U'#H@3:&6-SU^D66WS?K=AR0C*WPO!,+UPO>@HV'OX7BZ2
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M]P4Q-Q!RQE(J@ND!\20&Z<=Z ,L"+Z7;M')&1!_",P]V[#DBV)NE,UL%*SM
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M=>U$& \O,A+//)V:FP'RAB2Y[M*)V1A*+N#LM8T0",A)\<]_9=):<&3K#-Z
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MPD-&<^H%BZ*;04^:HC??4UPK4JM>FM$HK\_*OB!!8448EX-,CS4Y1HN5OT"
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M'L21K"<&9F&CY=%V"ET6KNU6W2-<P%\0!U$'". 7"?6\DQUVYY&X(=/(!7Q
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M2. =? 46S*%@OYP"[H[+ \W_./UY!Q\143D%#:0Z;=Z')/WU-U2M#39J!<D
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MF6M3:IV/0/W4 P/4RNIB86>C9U1O_@SBUN69702%<9_AV96YA/WTG3K?@H"
M00JNCU+)7;.,A*%8/=<Z;2-)(S+%GGN\CH8WRS-\GSKT(A%T?[\#FJ1J>9DV
M@\2IJ^*48$^N/'+D_#8+:3-^SS)TF1=*A7F]]R#SM#0+3J>++YCZ^15,<GY#
M5047DY]B"4<9!P7*IH?M\^D?K-A] Y5@._C8"R)NG((%A0/60V>(W]-Z4$D
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M"E(8V7X$FD7]Y3(MBO'G]JQP2T7%('9\ I".D;:7/M;YFNAV#%D)V$ V$Q<
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MA$U?4+'?A:E0OKC,&(:T)_.PT]:4V>LLG.G'CL&#G5H#_*$ZH,2[_T2]?"M
M/AFFJ\+W7&]. ?3#.3FR <7T1Z4\VM"L9W"KO)EUY].QXPV]BXJ_2V9<(Z2\
M OQH7],_GH02!]^.<OU'H*IRV,M?'R%)^9O'TNP_5E/%GO^-QNX%\6ZC\4Y9
MCH(]5/&S9#B1N=W5# 4?7'\>Q>-?S3OG3$LLW![*/''7]6XOZX;TA;:K'N?T
M)':*&3I'?ZPT.^3;SV)N/#(1&+.T6\O\[@Q0=1#@NC\92;5[R@Y\'CK ;SDS
MF<]I#!]]R?MS-Z+YL%[ZD:/6EI*#.%^RH=.9*UG@2S686RPF[IJ29QXW];U[
M6@*8?QB99LSUYHDQC//;9WB0;7G7CY/W:"/-I^[<\I=_H_ZH2A5*U;*J_^']
M1\#9"#0ASQ?CH0!\71H%_*?_)2,H)@VMHZ .!#+MY<4\\77OP_7 Z]E$P%-D
M6&1KC=F;/Z,L8Q4$^T#OQ'%)R1\U9,&OJL] C(.LIYV\B:]]HC<1ES6R1-&?
ML2\%O-SI'&R@ KZ<\IP9BJ]Q,,<%XUC<1N;:Z:QVB\KC6,Q)(97\-$Q PM2H
M'2/ +A4NU9;3;PU<C99WV1Z\66WE[95AI66XP.:>(C@SW$=QYOW=2V;2:=*7
M8T#19.,%>#DT/0B^\J*8"S) IA][:/K:^&(UZO;[[FM?HVN$GD&A*G)EAH7A
M1GH(X \Z^/;W[,*$K :\6C\<7X [S,W@C_P;$@YG8IO].07@TY)_UER-.ZZ9
M>1>0ZJ/)XE2O+*/WLH]P*[0N))>9HW?R,5>W]0VNS)P"/8O=C<H(+?$N_#W=
MD\L /!T\4]<0<;A?7<"*NMEH;A#9RV%\2Y%Q!,>0K)BI\E (+<D+)R!TF%7
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M3F[6&UZ/>DG5.Y[OT#D<^^S0*0=S;&\^UJA3E0+?:QM'2"PR5=E#" O16Y.
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M/:)(1L6YX;=7YO#*(WW6&QW-RFH'&2:!$VQW.DE"EV!M688,7.%Z2.4%B2O
M"\DUD)#W0L[BB^C&_49OQZUXBR7EP F=62;LX& =*1@]_E+'OMKO4@OH1M;$
M57ZEE1-X'28&00@&7 &UA1 CK,5L'S@84[YG/\A.<@&WI"$GX.^82S4N1 0W
M%'5FRM]'[C?@FA@^-Y"0$TZR_6L_*5J!<SU&PR$JK6'^\SSQ%%Y@Z:#7MP+-
M0$>:8,X;KV;/W[%*'M_Z*"@Q<_^L:+9112I00GZIZ&Q26S7[YZS%+@<I[9B
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MI'9H>1(@5BYPD$.GQ\)?9#/IH=9<.W^#DO/DJP:OC1-;5(J7#AME#TB46X0
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M,U5[<@J<4B!D,0+E*;U&=A),&%CZQ1RK5&>MUFY#^ZGD&M9R[MZ+O$]PG(T
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MDXO>O/X.\Q0-W,A/:^]6%?2\FD92F1X&)B;Y@A>YN;>%K>VNK8AW&4KQ6P'
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M_4.X*ZS^7J5H4<D,BU^4[7T6C[Y?/OD^1X@>J8H9H2EK-6!OH4>LF=!N[<,
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MVZFH]M]TJJ&$ (.J^@BO#W]R*U7TL&%@/=NE&Z5>1FJ[>/3N([.L@SZZSUO
MLZ.XC.B?+:-.;I?Y!?>RW':/XJ@/S@>IYKV-7'*I^3<:IL5<P >@I\"-G9]J
M9:3H%;@L\FS9YL76;Q@-V_3\CJ), ^6-E8_W.GIW@B"1 <G%Q_JR]HR,/_>2
M$@BZM'O=>N9Q'*(7R@+!3B9W:;UV#5";[-#Z<IC=_(: T=6.US/,_E31=H<B
M2E2G,(D\L"OZ!O_G&$2<I+J/#;]#'"5V;A:JQ7!&=FT$@'!$ZI*\-57X[G$[
M;,AD$7R*_-%*=XY); O2JPH>%1&M9 P-O=4-D^1W<^"^_L'//&/?RB6$LR 9
M:^+9D\:9]RZ,5JFT0W_B&#0'-_?R6!P5/YPWZ5QY@$$ZZ)#.S/4<A(P+'<.3
MXP^!YI=<WP"/7/YHB0[7EDH%7[H6.0S^-=TS1)3<$6<E=JBB7UT/WN<]J28"
MZ^#Q).*Q)2NIASM^8KW4<? (M(&>0'=S7I*/NG4?,VN'=#;3>7JXJX)6+/ZC
MB-J:[;-XK^G:Q;4Y7-I<X+E\-45_T&7745D*7&MC\$+:]CW3/;S0PQ![/]<_
MZ&AC-!**/C,-D.L&>&J:=E2O]E',;<RO)P)#UU=<#[?C+E'?0(O&,:3$S_J_
M<,1H3GP. S-= !),:KF[FW=Y81,4P[=H_069!D1!Q9)'^^551<96Q21/JHXL
MZ:?3QJ(XS%506NL.4)Q BVJ F*Z?Y7\4Z6[K#+2C5_?2GB2 P,K_2X(HIYK>
M&"4R/G(</'<SW@TH.%W)S<(JCM*3A?#V9E:!ZDCX9DE*K#&7 E\^?>?SEI_E
M(5G(0J<+092@NVI*#^VY7N"KH."N$TBNX@>\>-PI I]L3O<?A02%E,O'!(AJ
M$Z6'#'$+$SUN=J[(#D]L93QK=*1)KLEDO=:39;UR33HW/;B T+Z( E=S;L9[
M7[CR2F#]_E>*THX6QDN8W@)JU=JV'$ /9N^Y]?>@.PP>^O'#F(T:<RCAS-SB
M=L5N>)2$/&5@H<K:43P67KSU_"!OZ7(S43YPJ[@(5&:)=&.0$T@)OS)3;?W"
M);IAL;4OY]-0*$+;<HJJI:XW:UMOO(K2^27%;^T7N9VH"O/_Y69"6]'-^P!H
M=<^'92\:WKD5;2W%(A%FEU""##[O;&0==A?93O@Y&W2@51M@!.E04YE9+L V
M#.T!/GH[O I3-/[5=8R0380DG]GXO1O]'Q==UH"3YY1T;T=K (R&8TS,W-R9
MEQ,RJY10$0Z3D9WB'JU@X]>9QROK0MA BPZUT-T_*3\?[;2T=H2M)VIB"]Y&
M2 !"!R*+G#E+/&)5F"Q5SJ(B3D'[]UDF;B)LWY@T]+)0=D][M3YG?'AZU&C%
M-,N_$O\4?-8+FY$3RA&*Z$L]WK"PHC5%(L+A?$Q!YT^"CPHK5?N/^^ZL3A#3
MI)V!Y6^BEX@,EV@Q<=SRFI'OV5%-"#LQN!E5O4[3\00OE$#S]UBHCX+E0?):
MXIP@6Q'^,97Q>6\R:.E\$7L[B;9@DVCRIF?.3C=\K94L'M[EEJ8I$@@]@!N<
MG2 "[.A6:]R,TN6J,)AHCPE?(3Q4TTYJ)?[ETQQ=J)U?"XN7]@TZE_7%]69/
M%WQR8"C^>KLJ=?4XQ.ZVUDW-R$Z"*JI!.AX?H%^1W6RRNK#3H*0Q)H1;I\="
M:F29%".WG+!SK'7.@TFA!A@$W#O2S>3--TN$E^+85&Q8R!I'7/KM;LSG97:6
M #6NS'JI'B[8.-V/AT:#]Q$**:_/0X4=E?@)I^\LKDKQU=O2@OVGV#[OCQ.W
M%7<:!5&K2;PWH+/^LS"&6X-7&B$6I,F!=Z2BM^18:]OVS)A.^!T4FL?<4)FD
M2V522:^0Q[O^X8OEK4H.8*]SR6_:WC)LOQ]E%;J\A^*%5"\_H..<_?U0.LO7
MNTK#VIC/TO!_P-FWO@VMC=";WRCQH$WT=VT$693L/)HW*%,GTUH^^<.PU/&%
M(B>V#V*^C(7>RRKUI,!'.0)>:4PA7R3<'![/#)WVX&^'C#G*4%OH=?_K5'<:
M9J;/0Y]%ZI24:B_%M;EX=+=9/W[6^V,OL2$E;@3OO,91ED!.>S+),YF!1@HE
MR,T/_V9YFE$COZWIA>>;I.T8[@L][+/X>M0SL$'S1HFO$^I @$V;"\#P7!]&
M0AYNO @!M9H5U(;]LL0HKSZHE/^!9A]++96@78/0R=4^2=K579BV^NW VG?N
M[FI]2VICZ8-;AV*6#%(=^@C;STW IT?#ZYN'>\4IJ@M%MM.HBI"X=/&1Q8KS
M]%AP3S#[04+6+52.4*7#"U9U:*4;?';@705^<$'8VIYQK3O+FF7HO('\,(HS
MY2 \\'_Z.*:!%0F3H-)5$+!3C?[UYTHD-8=1X*5W+JSZA_3.#[T+%PX?KC%&
M[6?W3;[X??,S.3;KD+P) Z#GRC,@&RS?TV$S9^\CX82@? ?CC"2\/0.&3B$8
MV67WXJ?P502F,?WM.^'/N_7<-0,,J&2(7EQVV2I>?L+V]Y>Q+L=GQ$D>R=KG
M,I,"T0##K[:*,6SH#LMSOS[RXQHYC:A*U%WGW"V(GM_@8'_;V'@77;*DTD')
MYQPOY3F551B-B!A3*/1_5EOQ.=;U1S&VN6?4?+8,Z3JEY+7L%S7_7)CN'[*X
M7Z>K]:):D7O(<L)^VO/HHR<J4EU+E]<[1>C"GQOAXC=FA1Q.G]1#11YZET<F
MOF6PO'H7OQ!)AI]##N4NX#O>7XI7-(1G95V]Y%H;O440TP0GGOO1RGS3U)]^
MQJT=D;[\DR6N<,,' CO<W&/]7L8A&CA'JP15JG;@?M.<K!_P:(1."*&5_1]%
MD;)>F5+!5A$1]+-L]%:E>UAK7P4!N%4_.:/UCUXL?9K<C]+"*1_[><[6JI+1
MNLW+'R'YAOJ/<"O[JM"_!N]ZH=OQI;^_K1H[MT<R9HJ9MGF7YV*<M^:<*/Q9
M8GZ@1U_VY=XU([W;+*-E#IN<Z $VD#WJ?6K%&31A 5B)1($H5,\/N!PBZ[IV
M*CPFN+HHEYCW5D0=K^\EM"J7:X,Z.TJDG>UMR+ 2>AMC_R@XIG1 J)Z#JY]H
M7>O-'W+SX3#?T+E,3$[94H@SG+OG,6*6':K;KO\?10AT+7\K2*0K6WB.VK5:
M:QEB[91GH>'N]4]9B*&&K8X<0 B!G^D>YN;TJOB)3[7@!#Z3.E5X(THL%]Y#
M2J=LLA+1#$"T^E&-A8/?._K V-G\K[-;T:Y%XH6&[-V3XI35GU,N]RJP=[H6
M5,T FB05M;N86IGG!-H!ZQ@K=$:LI&W(_HYB*[B!;HDP[)S/]@U?VE#S]&A8
M<^Z1]^Q[])'YX$18N%Y59ML#3GN^B<^[(YRS8JGL#;PIT6T\H \LM\W.'GN#
M7"[D@E 0F[BMX'&*:#+IZ-U%9M?,B5T62DOV0:MR-X?-!UW9$+-L[;;14$7H
M,H<OFFNH9(/RV0#T2D:W?*'GK_,O@GMZ@T!OL6(WA]V?5;)U7F.8_\FU]6M4
MO;*Q&*R/EA;KUF&QK0N3^UG%TNUD[U<&&3T'3+1Z*_4FOR]^\KQ%PR6_@$\0
M_"<NI2XBVH.GZKB"1!"SBWDR 91X%"5_#GBV<ATF$CF?]C4"C$%:015EW!BX
M-,.2IL2JULQV$@VW$F]X&%'X_(>O=-<3E5[)36E_'VL5?X&\>UMXCK*N,N$9
M]+%?6_3NT4??D.XJK*RW7;%"C[6*/:J#AH; X+KR;V,3XFGC!D2$0VLUS-W@
MKO855&&YPP*U*X20O'TK9[X<\.:E8XS=ISD%/@M;S5((1WX_\53O48Y=:B:5
M7 6LFB  #MI(MC+H67Q4]5?/,1H&9!*_(#&7FI%:_9W_Y8Q5(1\/;BOY.UT+
M@I=;!H*1CJ.@G[<?P1;%7ENNYN3UT8/4S*?RAED7$C:$W#D&&LW@? -&!X>,
M (?QE\^3N.Y_3OR(-I47VOXH3$9>KB<,L<-^G)G"T)P;\ML%L&!CMLL>CF=S
MK ,*&N.ZI/231[[Z"OMCSQ0CIWPVPMS6=>:RA96.[1MZ!HI1\#;AO<MS#9:[
M\4ZO+["NTQS!W;K<UP-5V;X=:P@:ENGS^96BK#O?[BYU_;7S\4O9/M1S2)[,
M7G?;);G,L!P++5]JW'VT"U.E/K^_&F7W(%,+;Y_3R-E]NT<<[%@SRI8BB-RM
MY#$3XQ>E.E=P1E_9*<TF'5R QC-6*8.<?F-8M,<#H%=;(]Y?L$(3TLP;L!+]
M/5'AS\CF7E/A&RTY%EIP*7Q/WH[$:B]\V< $PJ[%,B0:8T<H11JJ]VRP,'ZP
M'=D'=E*#K9G_<A3_9D@]?+,1^K_,CSD#UD"-F"=FZ527,R=/RER.K,E8$8S(
MKO+LZL2-=8A*=,WIB+=^@^9!BJF+US#_R7HE+H;#Z1=.",U[]])EMDPU-JQ1
M'M9 _),8"1XZM?:SRL"KMJK*'SW"*3A"&5CN9TT:!9D0%Q0?2%<[.=:RQ!^:
MS:B!5MRUI/@DY$9+=S%]YC#3FV9[G85 7.*MU*6-(Z::0]QNOOBR5YP1UI*[
M>Y21(FQ=0>-]9/.89;:=5,WX=N4:BD"I6O\^^-RD?:E-4VYZ8R(UHO3E[F$O
MA/G?R;[(MD/[H9)PG>!/<S%?K(A#0M@(P%O@0=SD6G!A],(4B@&C9FBYNWU]
M"/H>(N(JP2E5Z9I[>-_#7B!Q\6"C]CDLGU$Y\,=B<2B'+PYV\(YULQ#%C&[7
M$TOP-FN"Z6=5H&+6F1TD$Y90CB*^19?MH2'&K >2AQ:G_?L_;LVS5W*IU,R(
MN_NW4#QG$<%\8KK\B#AWQJ:JA'+FP<(M&#R*O&26.>RP%O.[T[*?1P\C^ H=
M8H<% +;CP9^.A0NHK8 -MV"5X2>U%48349< ! H&6TCP?DJJ.'%IK1A.J#LC
M-R0DC*L]R,+%V"J#"2V*G*C:BL#^[^J 3E_([-IQFXP&&N>W:E*,,"ULCY%.
M=Q<:IQ3W..VBLPB<IBOKB7C QDA1O1OCJUE3R#[Y(I,]<899>5YP.*,+H!N@
M8ZVAT&\9VK&<(;7)B69D/.L&#M X^;-.]_P0J$MYJ7\4R_](W*2S)%J\NS)A
MKV)MD.]*^V'D_JCY:HY9&^./B\-B'E#CQ9%IX-EJL!5NLQ%\!%J+OKJ6^S$L
M[5'ZW?I/48$\RV?<F]&'&^& 9^['"P;NU7P'734Z"\7I P,'T ,]D??D *>4
M>K'3H.T/>ZC&?^T4QHB;"8/-+^N?EO6(RL&-2OU8>?_B."JF^"8J-OIN0Z_\
M#AH#^ UDR9#.*T =43B/3C2R6?BMIN6G$:4+8-\< P/N36\Z;4?X(/E[8]C\
M=KP"C#9YULU7%7RDSTQH?"<]!LN65?4;D'8[ _SH0CUH&]4WDI,\+J=_P3S\
M]<WOY_0O;BNTV[*:64K5OO.[:A^E93DLW@]^[%<-^YN+,/Y%[+!8WXO1 M"6
M>,@IW(O9)P<KZ2/"3)\4 =VX]#RQR_.2>1\,MFHSZA[E6.#LP*AB7SFY4:YN
M\8Y'LM >(ZRH7\_,R%9D=3R^\W"O8)?!5ALV2.%) *]_?+D*'J<5T%$;6WWE
M/WIDJW/<8'-Q:,\C&56_VVVK5:1(D-8&4W\"/W"ZAENK-%F>W;VQ[?9 FCZS
M:GR,7: 9.NPMI,Q#!D8=Z_"4:>CF=[*U/-3JW(@L8I'U/ )-YE2LO'EYSLI)
M5_.'&NCZHH/LD<JLIE=-<$&OY"!<80_*)5T^HG<LU/HNX.*X[:@N7D.$-LR4
M4<"_8>N>;?B]CD"0H3]O&RS31MP KPWL"U[D*CK0"S7(/$6\R&@C0ZWE32^<
M"U+:;I1!C_BLI%',B6\]&5*Z($>^B0<SRW$AT:?+99.)B+6<F'LO?B[OW5-6
MZ<+QCU#(77N$-5>CBM[L8VKS^/5^ 9[Y%%>2W[;="RB,"1EC8]R#I;-@L0^]
M!8\^<B$\5..0I'B]8(O+=@G9SL'[8.*%3#'IMM*J!L!QF8ORE^7*18,4HO].
MJZ+C6B!HQ:MR0U$D-[2N-M1"(K'C75>C'-Q00AC2K>+4YE)7_LB*PZD1K;"<
MJ+/86^W8<^OS2/!G_%-) 7 M4W%'-X;J\@A^N5NMC?%.K%?3A36:ZA\V01^L
MHU+B%7O-B!Q<-A4(KP0*0IA6-</E7@#VF*+4%><K4HS^UWB>SXM7<(-)ZC?3
MTL<N&H9+WOVSUJ>[9A>X$HC#TWZRB[7-U4:TM=K09E[Q!RPFLAL\.6ZMWG!P
MOOQ58UF"K=!4,2P8(7?NH(S>IL DX[EO+G3Y7(/*S0XC<V&O%;FYY1_\,0&5
M"'7GIP05;;8(= >"]J[-^*YK,8[,M1:8_11F536LT!SU)X])*F*?&H;)Y_[_
M.@>KGV<UBQUEXJJ.MB_S7?@6?5C^UE_L&--?7;B>0-K(UD+I,CJIH#D2\L#Y
M Z%:^70MKSRMH8(/O[>O]GT-GX2XPW3YW:1YNY81;-O\[&EFA)%O,.:N=Y$=
M/39D6Q=R%4<('9%DWU9=NFM 9Y$Z+]/S>X(,",U6T)[1)5)Z9SNFUB2)Y%3Z
MY#-12@=N#=(E=IDLT+1#\Z)S?7^A< DICK$2,@*$K%-30;B 9^+!P%>5=/J_
MIV/03BE6K[:J2^G(+QC9#P[R9A-H#IM&1#!NMP6 QRH/0GJW-#OO?8HRRB:^
MDX%%<UYZ1362ZIWVF9RW;]%2*XLL3(*-S[9] TV(,T>/? -'5;^[<PM<F.:?
M14CT9G&##\X,?CV?</6,+U/L;CTR]U^"RI173_1*6'\ASU'AA;7#GI2]>=(P
M2!WJ5?8(*]NS3<&I'822IE[_>S&H9>&E?5+K*IO,H=*&X.M3V69S46U\HU=-
MK(H9Q>U$'^[V4=(1D+V^EVWVO0U ,-M&%LEN3$.'_-M8[JH%Z"9[:_Y6],1R
M[:3TH8BC$7*\CTHE "/"A<;IUXA_$(;IINGR#2ZDTS\(&_R[#M_%>LZYEC!W
MUD5;6[N>VDE6R\^:FNQ*^6D&&Q3<00E&;2=2:J7:"SXW=ZU.N) ,C0EO72P<
M9>QUXPNP%=^JK7MB="]H6MK_YW/F%6O?0W31?<N),D.V:/K*V:6 #_W]H1;8
M$2)HGQ5;%>!4$%637^'Q%SQA;+I6R_PYW$HE$F7Q-@QZ**&,55_9;6N.+3LJ
M<K?G92'V\J0_F\A)HA<K?[BT5;E1.RS_0RC49C]8[Z+Z:*?PM4S$^LW[R"_=
M(2L);UMP5<CF^3U<LWOHF<NT7XNOK#@?/7VX&2;ELI_)XT, ,R34RE^QWYB-
M4*"U&>>3PV9IA(V*\'B<X6AN32&_:,*!4QS:Z/*4X-,,7W]-@ XD!:[O67OB
MNC7_)+EF+=O$,KXLS6Q<K3O4 YSMLMT$&OSX#"$$,3II$8] *UW87;-SL]ZO
M$+O?P)"+;S/,2C"\.'?T'-W7J@VGDY:'8?ZIZD%V^# -VGALV!S?$BG=(3#'
M+P0B0;[5=J-'>T-BCM"+<$:V,CGU=XU05=Z!]=B[M)EZ]&] G[P6"ZH[;F20
MQFBK5'3*Y.]]'AN5!V:JS;RTS'N#[H)_!&]QIB+%1-/-K\%C&><M'9]#Q&2C
M1Z69C3YO7@'%J1"-L/1@4?LF\/: K$J./OU20%@<,0?%WEN()@GT;LB^MR"/
M4%\V#ZT=?=3E%+ZY%=(Q^B5'G&EZX+/N-&?=111@WX*(S<X0S9VTD!7YH>1O
M':B1&7'W:3_Q,T@0AE;+9[TUMKD=/R@1\*'G/IH?!S$5[-'-CWR7D+2<_*O<
MKNBZGIZX7K:\.M8T0^<M4"_/,+"FRQQ9&ZY;QSJBE]EV 1"O9;MY*FR_Y*V2
M;BV"1.CS2;8U7+T]A)977&13$<:U=#Q0LL2$%P?<72&/7\SQEK$W.2_76Y!
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M9GE>"YFBM5:S1[57BN?A_\&@3)[BV(KR.XPS\@;;/3<W8>C>M(AZ]5X$_C[
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MY3$Q!)#D]Y?]IR J?&!6<<A:4?\/ZQJ.J;%M!?6G+7ZM7<!JQ*(EWZ,IU5]
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MVCRV+ZK*XA<]2Q]]K]2/T6_JY\.PM/(*IS32K:/$(Z"6^#\23U0(UC,G]"8
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M^OYW'LDQ^N[DE\2JLATT#,*VVKW!J!G@X'$C]9JSEX%IJQ+X($9F&0>6*_'
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MXV8U-ZD3>6Q?2B6_4-;4>0TPX>-2^\K:N<D7^@)B:@H]+CBWX47RU#ZT7%%
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M^.W"S[MBN ;>^<-A,V0MO]75H1WSB)PE0_T?YH=;[=#IE7?'MC)+9Z*X2W9
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M^Y'"A!SD('5IN?>SU?R/H#@11B99@+$T,T_H_]:D5)#+"9= IE%X$J$7GJF
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M?3'51 X-HA+W<\5$DBPH).=J;.WUY[!=C;H<ZYJP(O8X*K)OD:-/MY^7?&X
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M0A_[#TZZ5Q=@C>/+B[V$KSCH/3<JZC?7BTK&ZZ,"8-,*C*K0T\=;F!T$-_=
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M;E:^Y9IUG25P CTK"*U>Y]_\@O@)(1[S/ZKL4K Y+99#9NM\5. <<)ZF=^M
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MO='TDYO8-'8:Z4\F,_24GB>/8-OSX<(<H)1>/0OL3=<?Y>V_Q%\X)B/-BR%
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M14\%;ZF\STH<%)SAS=0B^#!N#T;]U1] D<6 Y$AC/@>V@>/UE80X+-:Z;VQ
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M*2J.-&;:3)VK=?'0=-*GBXGQ@?LMGS?82! /]/]HKHF77J!V=,_U3)'@)_K
MPS!KBX5"3?^9UG_@!]"5O-;D [L8F][J/3IP_:3?#CFS'1LA'[O>4 *U\4'H
M;H<"%D)1]AD&83AV8Y=%FTI2SH-_RBHNJYM$IY7'[ANZ45S3J3]'"8::/LG1
MSO7M --\_TP.6T^4=>U@&$J@@RI46;8R8;?R:N>3U]+?:X#^)*P'E!%=Q,G.
MY?8H,L8D,/3RB^UA.K/N>>0WDKTW89IVBEVKB(LZ$CL?Q<S=O6GQ9BL:IO,;
M..$D7=QS'!$Z+*UFMH&B12T"&Z14/R%7X<O^V#?;O$HT9;W5G4@IMVONZ-W.
MC '?CO=N''3K:L $*F"58WJX)<<\F+.^:6WMCW/-F<?>+ISZ1AZIDT_R5>JS
M?6P^M=3/44ZV_4AL'SNR/$;^@W(M,#1EO1)S5A?@GRQDC+<7,D\?@HSU)[7#
MQFW:UVH*Y.:J>&J&2W>C<C[QII8BP+_&J[W!)#L_J^[RSSHRL<9B,U4R@PRL
M]>YK[LL%GT#J1R4^C]X,?:PTEKIH%PH=EG$^7M]XJVY:6O?[[BTN.+3:>LED
MQ)$V9#YNPAD^&QXA[\O.G\/;\LEK2 LV2:VD8&.66/S/YG3F5L,0B+WB$DZ-
M-">,I D5]WDT9836QM\PD[X<4\1'@@$696B1BO9Z<C^3>3G!0I[Q44(X*5TW
M[6$@=)Q@Z/3H\K:BPNCOH.@KYLD;<I#,S0$ZUND2SO:[2)B&2$#C%+%)5I%0
ML?7^?U2.P $S[#*;@^'9!(E *Q!H82$NQWG,/I%TO=AC%_&B1]3EYUD-O;8X
ML'8NNM5 -ME@UK]%3]HM2HP^]9\HJ@3DHTXQZ,EH+$N/K4_'OX>C8K_7ZO[S
MM,3QDD#SZXBUA(RMW3OF8]O38KQ"D;[N<.>\(,QEM!3Z?&K$Q'*>I1Y(,*1M
MZYG]Y<;Y#;IU]9/S[W5NZ5V>Z%R_;W9E,Z#,C]BUVSV-518ORDW(\#F.?":E
M'Y>6/#76,W]TU4(8(T&8AB]?0>G,B6-GH2&^5F^;>2+"\#19JB<BB1\:T$2X
M='1 !FE-SGHZ=I3O'C%K2"TLMY0M)7F1+<4YW/1_5 5RDB>)%E]TN\:O.9G=
M.32$AA'L)L22*.SL[86'@]=SQ>#1\#W=_%4T,2R_8;(-XOFV2;,Q1]I+Q-H'
MX=- 8@/,9W\>$;H=+5^D[2 ]>&*ZVY FOK_^/RJN$%M_%I'@[8@&ZE%<_:&=
M[!+O6C1<I#SSG]=<G^J7?[1Z<(P/*E 0WO&_ @7@WKF)A[&,P_<0IT>I2&;*
MN'^0@?T8";6K% (]78HJN+_%'+I5<;)A5_KC._1)'.4,<FBZ;(M/'F5CY ^4
M=(<S_/VHU"U4D(5\$&9%V@?3WM1]R..CV%<%Y=!XG=W7=&DCVIG1F?DC/,O:
M@/7<@<ZJ4.@?&+V1D'78Y*4])2#$Z=/9P<7^@CP[HH( M55%J\T3_/XFG]C(
M#9FO=29Q>8^F+>Z>M+A\U*'/WBW*OX3YR2XXJ1T7":'HK:<X*B:?U!X>[8B+
M8=?$G.^*GA\!C"PV"<K4MT6!,?:E_C,\C/@D:F@*%V QZF4F<Z]#R!OFCT/W
M:VH%S ,'A^-=ZU<2WQ=7T^(%'0!]S]Z40L*-7?I>QZ/F1STY32^VX3*M!B:;
M_33@>3EK+<V78'H;;LN(<?8PBCX_2;!#^M$_(VJYFV.TU*K)6/B]UT#UP!G;
M[@6'6H^ER&9%31*6K4!_3Z#^JH6-)]54W >#5EU3J6^3#=1?/] ^-I_%1CR[
M;3SO+D0^I+F!#XDQ?CCE&&RU)S!'/;Z2UT"@7ZL$HVA_^7_%)%-LR7WHY/]1
MZ9G]\SLIP,7S=X%1;MA!#=/#[)O$\L*!;/G#$Q)3F<P2\Y\NKT/01@)=_=UY
M-QM6OS3YL+?S+;83'QAPCJJ2:RC:V)+,#CS:=#Y8Z[JJ[(=;VX0* OZ-A5#<
M).[?%"=_;)[XC6>$H>=/)/.7Y,=:OKO[8CD7"S=U?@>F!"@963W%1O]XF\8Q
MOR; H'F7/-VP3FL)Z<BW\T8*UW9J:+""@TA)'#9X72X=/ \^:E,2$M8W&%P/
M\>2\V3N:S6GVZ1#:#6B#NT7)6F7$0K]1RY&6UFB^9X;T:[QNF+X%/H#!1_Y<
MQ+S2%,(-ELGYOF]O4(03CNK&!M>%$[Y_SL*KEO[V"FZ%UVB?A%^/F[_]@7$'
MZ@^T%@H=#]S&061&#DMMU4(FQFU0/T%\8/V]]V1LA&APBI/G4VGD'T_YD'^J
MP(@F'CR_58DW%/<RCF,)^>.M CH_35]5,F@(9.VD.GNV.?]4AZZTG^XEPLHW
MI*#+8F\TU9!% \0;3+#?>^_(IJ9M+Q"HV<8_A22DT_]C)7K!6\.BNYIWO@%N
M$;G"4QO>^' ZYSS!8N,]WJ_&KRGUV9P(9:?E"*+,/20XB;1Z6V/.Y&-C-07.
M#<N^VD6Q/GQW!IU0X61=JVZP[F?*S"YIV7R.-R-V$K')GC14?$\[.HJO;/_U
M0S[MAXF1Y_;$A0V#MMD<]#,'4?B(MI_[KG_B O[(GT$*\M@P 3G>+%,\D08)
MDTR;&I?;*#-LYY>.ZS'4DMF,R*3 GC7DNK7&=J;V/#3Y3L^?_2T&E4J8BF?%
M(K.G8&%58.@J\:'\+*WGX$823,1JEF#.^:W^_GRFS-$[D=KM(+5%$S.;UBS4
MCQDQ5A!:]<E2["LIJTJ'ADH[)=RFFS1GDI>BSP*W,^&E/8O%AJ0.=W"5F^>Z
MU"?*FKS*AKFU5_O3=XL\^<QZ25X1E)9J/='K0GE,%V)WX,;O1Y'+"?J+]WMJ
MU4U.#BH:8I">*A\JEIQDN%F<B_/Q[#(,_JN]0'/_TZ@/)'A0.UC(GNJS''"K
MA^[9;40?0H*N@\^?<,EQ)T<+IL69VG=ON=-PBK* U:W.NPPY2HA[?'TX)_-(
MGF@")8*.$JNR]X3?E<MS+-#\EL=V"NLQ*\WO"2A@>@R8#AB=E;&1>A\!\^#-
M_/=5#)IZ.C=Q9")$:S/J7GB0ZDB:=-NT>@BS,!ED!H4;/*CYY_EN>5-<-$2/
M/O+1>JV?!3EAH/,^#6E(X$]"0MGF9LM0N<<% 6Z&+7H;5%,Q16309$".)A38
MA]>&]YA?5-&T^T_+PU38AFP;O^^-/0PH+MRJWIGN3S9B'0?+;0G>[=5Z<G]X
M@7*4X5C0:<[)[$9Y?B+TN'10,.A/?%O$5[/Z@?MRD%"\H7O'Q1+(.S&ZMC'R
MR4(#H]5DH#M'Z,5?&.!Y"/(@\49@QV/&@9[#D[R36(TYGK+B>5>0M3U6T_.)
MTA+# 9H1G_.*,/BG[LEFPPG59XB"V)=+<='+<">#/S?'F53P&NB<P963"^55
M_'V0+5GW9&WV^:3G<:>YM1/FZT7SN#6R5 S8!Y$](RH-4,4*J86OG')X7Q_E
MZ K>N0.$BPII5I)5J#+P<]+LBTXX_[2<Z87U^,W[CI[R3%^"_ ,!#6IHQ[&)
M\L]Y@Y"#4J2<S$.^FS1 Q[\9Q\E?ES\:% 5,NW-[DY=*O\5"U[M>VZC5)Y0L
M.VEN9&_;W"<5'MF[8K-ST9Q.G^4HH=,U:<H?VXE.0D<M/6\&JQ%XDZ"C\K(-
MX87;+7FH'[/W*4%]^2T="L1]H'/U_ZAT*$U95^0EO3KHDE7&L+=#HD+9?-1D
M=@,%(JVT"&-[>_7[K_ZR<@6>9GVC99/L* "S40]X.]3 O<[&WZAX@<E!PO"8
M,VD5(.6HAB4#6BK26';VI,'O+J_A/;L@"-"Y1??=ILQZ/.B\43%^9._DZ3)X
MKE4O=[3RA(F_&'&WLXXTS>!E8BSM _[Z_/V'Q(L-:"X/_A5]N#%Q+4=N5^>+
M+6A8XSX,2XNB5L)4^16M9ABYR1-:4I'$;$2#MF <.@<F\C^J-O3M>*&K#M/L
M3L^;G"L<SR--U6CV/H,-V:W88TS%FTC)BR?/1$!"#;0_3WK%8\AN/.KJWGMT
MZ]/]&C3ONG9>7T2V9+@>5)".<I -:F-/S[2W(Y/2<#(C@KH.T%^40;N^$BF%
M&'O((4?S5D4!80EH#5(-09:R1"X):XA#*[O@[<0]']?]&J9']Z9#TKZ4T:?Z
M//]1)T&HV900I8 !CHZ(/!CQ:/.!'R+=;T>!@+3G%6QE/BK#SFR#N90DUG*R
M%4PCPGG^"SN)DY2W[P)2O)GZ.W_G\AP?TC[U<$QA$,".V\98F[H4_0J#*UNX
MCXZMP$LK<&ZYH.X9?/7@1=L$&,*C**2UZ<7MA[,JJP\&S+D@>4I3T6[H3_;W
MG6^P= Z^%8J<-Q0R5P5+CNVJM8Y5^7R?<"Y[B^+B"_BCX2Q%/;&62?J/("4+
M6MY=OA=/.77ZWAY* 0=HATS,0G-N.8O)>45YY)MN8T\ SY<$$++\C2.6Z'2%
M,'"(ZYF,*X8#=(<)L QS,*]<:^#>ND>\,+Z SQMRA6ZFONJG38UM_Q^5G9-:
M\EI]NI@0+4E*$$LX>J?\ M/ 2C)\HTL_7,@4 <PZL2 NWL(8\8QIZ#DNF!S7
M'R2=Z#-'IEF5R$]P][3M"G8P\BO,3PX<.>-]TQX"CX_GC"](<G.P:D.(UH=F
M<*'00TBN^FM=_RKOE1/$$L&B% J8ID[I,I\>U<HI[(T--_7&#H6PEGH)3(Z;
M'QQ:A'$ O"P\V1_4M@>6)N[/PSBA4[#E0WV3P[NW88UT#E]\X:7J0+6L 6Z7
MME"T0#X]0&UZE;]%:;XQ^'# ^*X K)(+T):K;)$-CIBD7D2)P?EU2&+?8?<:
M583$\^J'KSBB/Z=FWJ(+(O5*?P(-#=*1?T+/,&E*.6]/)M)S'VUY)@5-*X<<
M)/RV[4S%)E>!^WQS54$K/3-^EJ1NW%08>CSS:,/G)I8\0).V/[C5A9S>?X$7
M2-[JXGTV$L[!,\%>$@1HV!+<,4N^NCWI3LZAE4@"<L"TGK3\(^B,?IT@%"TL
M4U$+*=_;RE4MEP81UUO*V*;#D'P\(<[%9$P,CQX:>8S^EH%<[99R*>PJ89G7
M1 %7ZD?RX*Z+4)5.'4V1W@#M/0\SZJ+97\W1M<!S;(T"##_'Q-WV0@G72!S)
MO3 AHDM?BW21GH)SH3)P6M3OG\=CYA73/>/&>L*<%TYJIT?Q7V!S%7.WM,:W
M<A#3S"&X/8558RG6HY0S"5:M<O?"L ?/EPJJ077<<E#SX/I"%M9Q)PEOW,YK
M>^A<MJ;0;UE^^&;)  !L5K0\=RM'^*ZS],6A\;RCV0#M;P9^HU$YVZ[("+QN
MJ>CLZKEF/%U8EN0F37UK3VA(57_%%T("7J5?<,81"T#D=7Z=4WU7OHTP%N8Y
ME)NVPS(3XY.1142'H4G,CVQD(SIW*W'3>#?B"6T\ZG=P;9%"X6%ZMO*48WW2
M,++@.E>7.Z;I=J5.TVFB[3CF(Z][=IJBW_?&R%:=F12U_C@[(4U9ER]OGQ(]
M.'A$=L.B+*RP&.R1!;&/3A[P\3A6NGM.T&^ I2L,<P2XX=^GR@Y;SUL^$()A
M;C]:M(.B%%][!"8P*RVYP9?S>!S7=1UU*/#,]2:6C[LAW?&E_:VX1 E$T!>O
MC0F5B!.X5X("\AP7#W\L:&A:8&&7FA534(Q,G.,I*"QK?R%/$5&+ #FI@KGH
M,N>[Y?[N/V;6)>3(1 %&-$9=BYL]R3? JHEVHS*@-*HU&NX;![%3/+-TR6#4
M;Z(Q/TKKLL9ET9.![Z*3Q\)O.5T_%-G];E_!*HEE=X%C6K:#_UM3=&?RG>CS
MX,;80DY98B<P.O>O&[<W'F_R@-Z86.(:/6,H&-Q(0_A@-D]/PT]B'C,YR@6\
M6%B+K+%D)Z4*WW;;%[[+X\/-CT0S:)J,B%Z?Y#M2YA-85:O8^?]C!7F34^A&
MJT+%D>FR,_YWKL8@*5]WMT\JKAO+3/@+0\9.CA(DU2UATD^$@3TK(B&+]&$+
M]S5WLWX:8.M )/??8G+XK&^:5:=LG*M= =I]@%"E9?+FT+;R:7U$1I#^YDYQ
M&*;I6^,,LC17K6CN==O+*?OSG?C?/+\ITG>2,]L)RA8>W#&<2AIZ%4@$<Q<N
MZ(Q87M7L?YJ?-I&UFH%%ZC;)7A1;;L M:L?/FM? :MZ%G\XB,N%AZ73[F(D]
M">_+ISD)ZF(8T=U1M]>%O,+O1IE(F,2FR^;/;?A3>& XL01MPH@1C=.=LIW$
M,U/M 9%$>7T^'TL8W&^ZP6DT J O?1H!M "; JVOGWJJ ?.'_$'H;P_.?$H?
M+Z2&-/QW]ZYCPW;ETQ<,@FH@<$5(S8O9WNWHA R-Q1!M!VI7A%'VMB%UC')U
M.%NV24=0?$/D= AM6_;)W63-/XEZ%;>=O\^/&Y5F;0MG>)3U5B,O(M*_>[[;
M'C"WLR07+O"A2R0M;OS=#A0\$PTE'(Y+%61B" +-D34%%IZ2X5)"M2EV\&!C
M[3G77-]5P68"$<W ]??$(%:[:^JNM&Y@TBBH0:&H L\@N$]-\2[#D,.G5JNW
MW;8;?688^-PU#<1XH4^V"J AJ;2/2GGG1N,*87WNXUP J_6EX=/'ET8CIAY[
M\+*$P!AA-?P@<Q>F-J)%KS)L4W5D\I(PK'84HNF13&OFB)\ZR2$ULLP5#$UQ
MFKJ@K>8^ <P5/*02P;KI'L2NO3@M$HV03L>9V#^3@Y:3"LCR#NOUO%JTI^NY
M",LAVG12.(7FFZ\6*O0.U"$\$*D>!+ H>W2UP0:.Y,IP#D)6FG@.X!7&J#6H
M F+]5=AW@0>WJ%%;_\%/<M'I4O:I".69COW18="7!M:7 S<?Q4QQ=.=^UD8^
M]G^4%8Z*%&/U K[+5BBECYTJL507I1VGGBQL>X]1I)BS=56LQK_G<?15,ORL
MHPF<56_?*&BH_Z3N&6$R]TSD!0:HZ<9-1JA>]#,:8VF<7U86[_A,ZO.1^LV5
M[,7GPJ:8O)&.\<7 82]^#W<TATU!]B[,00_IV;RUH>>K0.G,>2=.]IRR!]A%
M[W_KCHF6UB5:64XED Q9@I)Q9.F4EX%H2W.+M5)]'\N28CZ1X"3"Z3?,+6^S
M/Q.Y<HYY4T=.GZ$=#%).@YN0'6Z)\V#*@Y@]UJM[RT^#!J@O^C3S>]=H$GBD
M<>N@\R*E2:FA02I:J<,)=BZF:K/H<WT15L+I1%3>;YR:.0=(UU.A.-0LODU:
MSOZ]TIE\)??Z=R'*X^N91_-_&)@PUZT$NLR/,?O!F2I/CD!K9&BNL"+:720M
M #:Y5<.F?0D:>[[DFI/WB]9%6W5 Y*64Q*N)B*G+%W4">WM]XJ/Z0+9!9T\0
MV_PHKQ_(1JUBJ^3MELI_>>)3HEM>UQA4]JFWN;A:.78DD7,*I<7)%=/9<'8%
MOV\4BEMOC'7VU+;%].[DWHU=+)9Z9_!OBA8BV/1:L#YHY:/ZB&L'L\,;MK&4
M/7Q%F@BQTX2$CRY7;V&-6"[,U8$E=>8'1B2)D5]Z)M6-X?G;%AC_*%&L?:>
M#1%?_:P;OD!(ABXY>GI"<]&]#.AR#FL21&'XL6C5(XATO)VTSX86>;2N T#+
M["1&SW/+ \_,]#)G^I_\'G9)F/J+^+'H]_!#V]\S3Y.N^Q[0M3Z -G-O4JM5
M-W%#,JVI=:Z4*.;#/W?-K259^FBX6?U3977/9"^BUYAYI<QX_IR6!HP8;&G<
M>&4434 +:NL\%[U B/GY"SVYDJ&^'PN5B*]6%J1XG *"AYK/K5\=HCGRG-3&
M>7X> RR:\W:NSB?" TKW\:X%__Y((HQ9VLDOPK-OA9_PW+SS/:*?T:)/*E9'
M^H'9&JW1(R0QXE!_HZ,@*4#PCM*/^^HC;H^-2GFD["RVZ%HG/F"':-B),<3W
M?OGLY[%O0'9>;?*0[E+QUL&;_:_XR-*VW5+9&%U[9J-W1UEWNI>8=Q=H2QN*
M]Y1KG@O=6+V]ZW//?W"K(;P4(0B4DGH:<.8:,' I&5TXH$YJ$_+A+H.%QHB^
M8@35CSO;V5,)1KMQCD#DG69MR)"/^I=J8?B3E@GKC_7C9D7_$J6A)YVZP7T<
M;J_3?!MX/72Z;;2<GZNOJP=9/BI$"WLGJH@CU!@;(2E$TD34IG^+<7]C;/TS
M^2C7&:?T<3:M8<7O]:;S]L7LYHG?^%,73XB%SRFA<V1QB/I+[4;"-A4*9_UP
MI"00%\^'0]VBCWE[][? &8H6@-!9&J,>[>#::;CN#M\1%6B$!N\EM*L^8-/0
MQ=/H_+KDS%F)JAERJQB!BXCU(SN,HT5"Y\&_Z84\#X%V$B\B=^)TEB#<_FBU
MM5+)*M=A]G_*0X/6UU+ZA.,;V990SS7*$"(L%4L/SO1ANE&:9  M]$HA0?B*
MC)5!.)953(?8JB!7UUE)R 39][Z>O)[YU9J/=6WH2"S66D;@HCDSI<6=M5+/
ML'+-]KI)J4B/)N8WAYD1A&34?2%Q1_)TR MMNXJ!^W0'2;I2"0-H35/M)0#^
M6.;^DV_FX[VOR1[['%:OY$_L6/^$HM.G<>J:0DWP";6P\AEK?@^7R%*63[N@
MX&\_C4=@[7_-HW,J&>3)V3!(OF;LH\N#%GW%_G+[*S+4MTV_Z?9F$[PA3#<I
M*M06TH5.*X]>ZD%SO,P&0T4S%/9\O<^;\[VR,E:Y8\<3&F5P<<CUC5N?\,:0
MFEEL?PM52&:T:[<5:>_^6F)+H:HL;85*C>U7KQ(YZV<'R)3;KT#1N9+,"]="
M*'5UQ.[*XR8J;O>[Y45.K[//V!LB FWHKO<:H&2L*\.#,X_D&\;X:;%VU<C+
M"'W5M6XZN=#4A2FIE%[I\F.()(HCPFOS*SZ=;CJN?DQ+#IEJO$R65LTX&;6G
M722COFE)[/*.AE@O30>FBU.G55I794W9^'?T$C<VY&5G!OO=0FU>(84.K4@:
M6ID(VD>9N;J3G6SMO^SI"4NL/%+R;1_ZV:512VA:VHI!4HTN,:^":,>Z3)E:
M_ZR@AF,:>5S?B/G$)P;=CJIFN0PBKG]H(A0._ZD?BH9C5UHFW"*][?F;&S.Z
M.8="C^%.&=G=UNCT&VV$0Z@#ZB %0/Y;37/:B[$!:RL:+.-.I%2PZ,&; A78
M(HF/S#P!P:E2$I1^!6*<TJ+2[)*O:7*[W.SDN 1IZE5WH.X0)^<K7+9@[2]%
M/?9-V<5PI\?.3Z=,$MO)2 (-ZE]ZRYS96W_PAG6XE:V?4L61U8I9>&^=F>/2
M @,AHO;VW[A'%*-:&BYO0HR#@5/J1$FFH[HFY+(%?; ;JK_1N@$R'UC,>'<Z
M'R3TC!R>2'*;"5=-[O\,#U(UZT(D6K4IH7UEWO<!@21^;13UGM62.#A]+<H@
M9-.W<) IVJAQ\.#V)'T@XM,^E'-LJ'VHIG*LS^\/N.8K$BTENXLVX=<&#.:F
M^%-# _6DBIL1Y$#]@;YKZNW9W3OHP_'5NB=1NX$'*4+6(&8XJ?096NL,8OL1
M;!%1\ZO^.)4/12/LDXQ5@[OZ8G\8E#_<R64L"4YEGIP(6AMY\ W^VXO?IXAH
M/ %&E-!TS'/L&*1HW^8.2-*U9W'99+.=5TUTAS4CA@]'0X#<'';8N7\I#:P!
MD ,;5@_U3:IWJO&\I$73KVX6_T(L]^J]$(;J$U,[=E&UYF@>;=':_9$H:\#Y
MK,13XT"M&'4V*=V>QN%O\OZFHRP17+X6__B?5&^KQ.S,619?F])LNX_GU$_$
M_N#1>A."?P&Q=N+72R8R8A<Q2@=P9^#[Q]>XELLIQRE,PD^/W2%#'02"(L)?
M$L,VOZ^'-*UV5TY,V9W@5)U((FUKP8%+^<5S!V$4_>GMF?"G]3BM0CY)S8G-
M/K5&OUIT9/5PN:YP&]U=1PMKGI-$\D:0_O0?FL 0!>A:,LK\\WR+]9*L S=T
M_.3!=*^[*@9N MN$/O-I__5<'E(H1)UL9 .X(@J=-:=T5HB7!H:#8SCX[!\+
MS;X^W9T-?;0D.;C)R1Q:!PD%O"R1+,5M2&3IPJTVG)[<$XZAW11C&]8"(40#
M=S"<OUY[\C"'^%V^/$FD5CY>=): X N(1^EE+GZ#>R+GZVJ_GHD\?(TW.=2_
MQ?2K)</HW-U.21=1^)8+YA;UHNBXZ^+,_#H*;+("Y@4^:_YNA\W>"PVGP W+
M>H9OOPR:B31^R@Q[T;91-,S;CKYLO1$KM%XW!']]@6DFKBI-P(KB!A"6)RE:
MQ=!YV&!)CK;#C5Y"%8M:M=]V!F*S;#U74+[T:B71F3T1U**_$$I1:I^E=Y40
M/%PR8_(]#PJA6CZ8;N,<R#K9XM 05=+W0VX.&J$[&P?S]/0BEFB$[K75!_7-
M"T '0KL51M()SHR3:\))KPIA4N%H_RP$C6?1G9<M;IX6E.\AM IHM?YN1UQ0
M^M.O/CXN_V:/N$PP:QS;R;G_-)[JVAPJO+4?(1N_A_9\<MOK0UY_$HFD#<0T
MS,:6CJ<I:I-+(*(3]OW(=\9CZ+/U]15FKN_5U?6X3Q8M[P) I.QULVAB=.L
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M4^L6AV6=8BF7B0O<+A4%N?J=R \/XCP#%F0V4K3:\<S1US%&IM^9 CSDT5P
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MT/APL74A2:'IL>>AR!*^YI0V#T9&K)1/U2 S=Q[KZD7%!JV().3.#=SGWE"
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MI)PL*ZB4!7\[.29"P(\('I1:2!S,8M>%GH#]0UQ$U3C,P"ZARDXXQ3;$Y+E
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MG GTYR*B''XE3R0:VF13]#6U1M#G_(Z:H<4#S;.*>Y2;%'*SUY"[J_%T%O-
M]+8<,$4S4:^%\Q6E7#2S30U_E-R0Z21)M^BLVTV7[6SU38I45Z*CW*#4CX2>
MJ[<>U\D&+9E1.)DF<Y:YZ$B=:54:J&^8F"J9-Z*):^"HUYP]73I*1-H+=]\3
M56XN97$4M'D"R>\^*U'65&P(_=8*_VJ,9%5#=AY4G"]';%GF^.?$S]._FEI9
M[@X</K3T%0WO1B;'.6D0P8SRPPW/QZG?1H6A%&W<PP(L: ,XCECIL>Z&%;.\
MEQV#0^:,N _1CY_?CW+'%14W+JVMMTO/E,TM9\5X:M#2C]Z4Z2(9!*Z^R/S
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M(8L]+3I<8-RFZ'E1=9FZ47:[/Y@IT1-H6$-9XO(7]L<'7XGMW_EVNIG",(-
MOO#[ZI<\>9!U4,.T+U;KN )N@J!;MX6L90 VZ$.C& ?8$"6YY7J@\/AX?DSX
M@&,!K_>UHY22</*OC*7YZ4IWTL[J'CN 4&R8O2C7$5[SEUOL[:L!!J9VV/M-
M7+DM-J/TQ=0H0H]:"TUQ5>4'*7).^\P9:+R!OG/Y<ON>3 AV42?ALM9X^?WP
MG1UI=18[B*?N4&NWCN*C*2+<)6KC"C7,T]Y/72B'OU43=1Q;?5*1M!B0YG<_
MR(Q0FG_13ZEYWZ)@24G$"ZU1_M[G\X)0]O/4EO78VS]# *'Z'$=D"QJ8FV3>
M'Q5K%36K.UX[3B^6/A>%V@^H$@PQE S(_5'*N!K1KL<=34#7#V,T7!/37;EI
M^WY<5=Z]J+(1OQT]Z'%G/*6],Y(=M!GLN#*)5N(&5\)?$WSH$@@7]>PDQ\X9
M8V@K]W*6&V8#7(T(O7Y1*%_+1-(M]!V=MZ0$^FOK^]3,9 8&:14&?W 9%5NT
MU3:/EE-OB)6W.\J2V1=YN%0FBMX"]]>&33>]+;P8G/:ES^K:W'Y)"+HTVZ;5
M\K! -;8*,[]P$9Y0'%,*'#7YVC0=JJ"%B]X7_5BI44QLU]A34;V^VW42*<#P
M]9*P5V&W'+F:P&)((S0D"W_TR-2:T)/U>NKR$>.A_I_J'O_L3ZH$ IFKD4*R
MC</T10"G]VQ,&8OQ/"IDZ$4#YK#U;;EEYC";.HM'44\PLL&U$B*S.58I<@ )
MBATH&6#,Z*D_BNW+76KYR/.30S(M0G#@"%K[5NLG08M3G?A**UKA;%=OP@1?
M$+R"RZ9_2I(4FF[0N>6T^[/:K7*G9LE&#4C%2X% W.Y=< "I2X=R)X1ISZ\3
MYT[SQD0I36SA07;'8]-ZCP[.1Y3%V]48T>KE?%MS?\0UKA]O@K7#\>4$*"(A
MS+/BIGW1L[#;,XMNJS<C790>"AG+L-TR_CPM<;_V]=^ _7DZV[=O"3'B>]PU
M)TR!A[J]O#%B1N&^P>;>#;?0H[0N\'W,@X\U91NI):[AOJ4WQ#L&Z8_ 9+EM
M-\?-#8,GRYX 35IJF<C/)?(7RWG'("3WL*BJ@T_)QI55/VSEXQG"Q-5DJ?,%
M(2FU[?@83\U]WXED.(I>>HJ]7Q.E>'>;N33Y']3"**2F@1)5 \_F+@6N87:C
MH[<.&>!GD7G=09WG\?%/&%RB7L[7/)4PZUQ!)9KF.3WP_SI873J@,@A;*7A7
M>A48V9Y=!C^:H2F:GC*ZY_+^V:_/DQ=_G"AJ_9J/'*M&FC<GE?J(:OSW%^L/
M[GE7^N/^O/9%LDR=6'"Q[4%6IO&O0S1?/?F:ARR)_E5ZM=1JU4IT>1*LQ>5]
M06EX^<A3:![(EFXQ=&+)<SSR%.,<5^F%E?@(K7Z3<']:+>+].]('G1PY,[1B
M/^U+A;,OB2*R$@M97(]HE54O!#L%?_:HEK_^#26,_A&6.I3M^44U_2FH4.^+
M_M_>L0FF!-O(-L@LYE.BT\+ !-3T@_:3N3I5?CJJ>\?1;-\V=@?B!7T=:O6U
M97V@]P7*Y7@(R;R#S+&&@;;<JWS<N8N+RG_5-JVH.I; -IO(3YB3IP=H@=V1
ML2#!Q!$5@8Y'M"7;JD"#GY,2#R/0DP)>"XFF!N+'Z:M][0PV='P\QQ;NT/Z%
M]"/QM()G+6N!M51LGLH R*R![+!2@[7]38UP1SH/AUII1Q:K;L?&H(A<3S7H
M9P+$R=3%<8Z&*6&SW-YO].+2LNB&"NGD4M;J86,9>GY_2]S,E(DX*2\5GJ;.
M+V8/#$>O5'"7)Z9A#GG,0[H<!7:/8"X<?HA0B<A#V-+//T7]5Y#9,3IV\> +
MM&-NPA3TTVJ@%:GLYM[+F^$CF:^EMKC1-1R;$1[IVY&_[/ J<.L3+DV>1KED
MN7H?1^\(2I'<7JAN4JO"3.F>AD5D9>A>I !7<UA]5VX),5$ BE@3<U!.]*SU
M[Q)L\KF80[^:1#H2<K4?.R_WL-DI)4Z^%% %NSC\^L.TF7>E0FNTFWKN0'H3
MY^ \'3-?).QCC]@Y%U7XA?Q<Y1'YDM8&,>6?9&!,@.26=8_8/)B!][%QYD2<
M3EHI":S ''S\>I6&'ATY''8+[))<*QN/ZCN\G@?/[7[,)^M+MF9W2+VEU5 I
M[WCG?FMKCV#X3EY-]=F(\+?-;NRB2S1YD(INZLT%=X7E-#\BC:WX<8R7[4Y2
MWO@-<&R31H?!GX(9G +/V6QWTT^<PR&,DEP=KY!Q\AE)VO@LR3O-H/+P)I'1
M)[;Y6*9;!'0J8_O:?R>H^-<B#?B($-><D]0Q9PQ1TGDU,85JN7K\RKO.4+W]
M!MH'_'ZUQUE)[[7T^9ON0I\]_1HKZVO]Q.=%O[4M\[NE0XN(R#J:SC7JTFU3
ME4"RUF?HH9/:$T*A9OL&@],RCFH%81LV2JNCAV7>#JOR-/VU/RON/W&[0HC^
MGZ96VM+J#1#$/0CAO1Z+JYEO*?6'%4>HNK_M[*D&['1(Z4\NS=(T_O7?2>9W
MEHF[9G'Z+).*$DF?W<I5N%J($?\0>(;G\-/BI^5=M"P1KC#JF2(_(H7Q*ZF(
M=7HFM,SY%=.1,?MB0?1WQ!F\]GFCV#Z$Y&=&N=^6N,,$.25FY^E5&:>>&ZNM
M62BZDA"W!;BK(W<.[WV<-:,C(.DCH:+M"U/AB%MJ7!_XQ6"H??Z[V@# +&>8
MD9N!L[J5RX]EN0J7F#)$B(6  [:XTG#-O[W[/\<]H*.48G/J\.U"'V#M;,7T
M.?YS1%;L3YP,<V'$X(?6_CQ6LM^>J"2S0T(I.\.1DIJX((*#[A'C+2)*IHJ>
M@#^4'DTJ8+F&"ILP'*/#I?;?KP,F_FK+HN?F#N[0QNVOZ@Y.NJ;WL[@=TS=\
M10\>W_,Y1!96$K9!)557O\,; EM(CE5>Y7Q[JP&95IS,:X17,T+ /OIY=QJN
MZ2G"95;(1UK5[6Z0-&#^RM645L1\^;82MC*7R4GZ#IB.,JRLY.-#%RY&Z0;!
M2V)<'L5:U.A4D:,F5#1X<B&;#]M):5.)I7YN\#3!U#XE-)GL7U)6=",JY)CZ
M62#*B?T!RYI,!(9(G]P9W8+6EUK9V<0&W]JX(LAJDR)7.A3P80S*R;VHZGYT
M+'<+&CP1Y1]C_-.W.\$&;\#A_MGA 4E8Y5*-GY_N(8?\F%@9-KU_F:W;V_D^
M$"QT>SS^,"6'Z(#F>AC-_[)@$?SM]_=-%!6]3M98@;MV?NM4?3$7'G?W?63W
M=HQH1R<9-F2L=^8:>FIC] (-N\'X0W^HS^IJ3RRM^5K:.W-NF<6NN)<7_@(2
M'/P@HHZF76B@7-V4M%3^GKUZT&A<!%3Z=KGB\[S#'-5G'#=9&U0I^U069".D
MT[-Y4.=0'EE18QH'VE'4VH/^' '4]S%EIS:^6#6./A=A5!NV%:BT@5?O>'HW
M'92NIRNF+Y]:>DV%/@+3QXBD1%48C&V.:B=('V:[,4I?2,T(=GP!6WC72O^:
MUKV!K;G);/>YE7/@!%-MO<R97V_PQY@<L@.[CH[.HWP5B"TE%V6SE?4X'30-
MVO9BO%?UKKQ_$(S[:R-S#RP&JD#85_HZ<:VTM\58I6AOC>"TBM%+SF_.!*:X
M<*<591W1CLV[W-QS% E[YA[Z_G$?;GH,X9RPICI#F/JBM CWX#/M,10SD.\4
M[^K@$3E%2*)TOQ$@@V=0Y*!BCSY\\2:W1-_W7TA<89)=3G9A L!AQ=%7.0:K
MT;H<@E->LG/;"5%9H13 U@]<GO%"_QJ#,#8-U=^RKJ-OR_09'+!0ZV,5/88)
MC(.6[X3VXHQYLZEHF6L!5MZ(\1H=W=H,&;CC762TZF6H=L+//V.5X!C@"""Q
M:Y;&3JPK03V<.$?=N\;1:U)SZ0HYTHL=6!5.I_ON]G>=SGX7;JGPR@VH-@[.
MN8:J>_&5<(X8M;[EO<\3LO:?(.$+JX9M]9T0@E;JPC! :P7'Y=?_@]55W[YX
M?KF!AGDL*X4&1!J2S@C[YS4S-([4M* [T25"M8LW4"X"1###I5M ]O/%=67
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MSD -<6%7(.F727 [:Y)K3CNYV1G\S6U^@EVA5ZOM8_[UFS!-OB1%$P'_()B
M_SM<0,)!7+U1JXFE/Q:ST78?PV<N(QZEL=&F;,ND_?6#R.;0C.B.[,#^#S5J
M7B8Z!YT>I[4VG\.X_5$'&2T:U,CW,)(U2:UAE>2$=V+M",</#HNJVJMNOG>,
M+^$5M#%CD$V)B0[=_CMC<L1ENSU$^<6$]+D]]9VSS=SKQP:V:V$$[F-M:S-I
MCC71_).Q36FF?H.H8.HK.8N'YCFK5KR273D$=14Q]LK9'6DC&E=<R-UQ _U'
M:C4&HH*!HK%3@W6*!K?SF0H*>]4>;6Q3,>_/GHTQ-P"7B'@S- 3)/*170Q1,
MJ!.=B3[?#*N6@1P-4G$.G8VO@?*EK)V4!3PUE?QZ+53SWL?WK2HA3-0TR&(*
M<ZGU9UK7UP]M"D1^#IJ#!ELZ)9)HYVT2"(WE7/IC%)T^TFL!!C+IX^V_>0++
MUY.%@/K?M-P.FDZU\MRJ#TJ2G"3?*2TUADF_\>)Y(Q)*WV[UVG,I):[NY4DD
M-OOFN>9+*;;>9:>,G4&+-M6Q[C!MG=,"OGH>5172+8+=CAX,T$]-:8JY.NBC
M0UX>"$[?>!9C>+-&9 'QJM']=^,-GH?[T[A^@?OS('[X5@ED=JQ!KP%(E!9G
M2@!\<Z%RV<!D<2VM"/T15/ESM"E0*>5BUI1#;@_E!W!0/S(D1A2;+'TIR.5]
MY!W#=Y<\(<VYP )+GBJ(:&2'=ONMQ?;.=NLG[&_'66]:-A0_/.'H@3UIV8IB
M8Z<Y>G)784ZA?S&C4)1,4+=@='PD79QEU76*TM6QJ7+;!&>MADPWO'&?H2"A
MC]8A^4BVVZ% ^X=_H(>K+H(!\_RJ^D524 D.L5'NXY,J1A3U#9+?^1GT 3,#
M*81>(?@Q,AF$(D?WW>),P_WU['[4(R,R22C1:,WYR+@0JSU#6":PLDT=.U4"
M,JGOSBL%7=B.C,XBS5\'CSNOJHVWQ1/Z#11H=G&V<QSS)V=G6O^[,6(_N",W
M)$\;_ZL.VKFOP2-\8B>#F$I2Y4_]$E;D5&F9J*&I7)5?(JUN5;P8!!5 _BB!
M\+29='FY;9:>2[MVHLM\*W+T".$J+L*\(CVK_NM)W@?+TJ3Z]-^A.-T5IX4>
M%D<>HD1&G8(_[25PE,;#X^/7UN%0%II6M5&9(T?7*)*DV;*2)J,%-\0OIY^Z
M]P0QI";\+#P8@.L-1F['V1R+X>ER>3&7!(($#<)V#B"+]HUJ-QTTVR%OQ557
M7#W>D^#/36?*(QR>K",OJ7FV?7LE3/292']CGX =V^8>5XDAA#"LNF50"]X2
MV1<$X(M-@!9H9&=_B[%6_2+ B$@(0M8;M#CJQ^KR,G2>C0>[ZB+P;SV+LR,1
M#.CR6L5G/'QZ*^!W*XPN\/67[I\F^FD-T5%UG_;%G/P^#5%(^8=\L]46D$N+
MW*3:#MQP^5!)6Y^ CKY+.;=@=NM.?A\;YZ'6]V^(3:84]Q96%5S_C7<SB"+K
M%AN&<G!:)Q$9MLRJV%F2OLP6/[O\L4DM=*0?<C.^UB+,2$D-;!;#=#I+Y][
M:7C9T,:/BN[IT +-I@6 />P/L<UL/T*WMJ!N?M9ZF>9UTZ8DQ4E4^FG*:]\-
M3L]5K?W]!WL*1 '";4YU?J/M&4$E>Q@'X3";KM/?82I5?O%LY:YSH7_%-T*,
M$UI!^V%1( _9D-1(KM+#A8DI^%<A#PV'B9P'ZU"5H;.WJJ"?TO=;0M.1JBYC
M B3R>,4D+5)>Q=0?:MZDU3+9I.RY9"?.*GK5$DK3$I*::^U%#"4Y,9 $I'AD
M2V3 CF^.FS$-4IU1.H37DZ_16TT!]Z1"MX]Y4'(+-@" "]=9=S7^=9VJCMVW
M\U7I%_9*80%TKHW(,!'?INLZ,H".*WQP\Z,>X;A^FL\(DE\['7]BY>6)QO@K
M-A*8%G[A:PNK6?"WI[YG[TI+$U?*4=K'F=%]"@#P= ^^]VR[Z*-\*O1;0,BH
M<3&3F+W\N"DW##;Z>A71UUY'^H&=:G7<0P^$U<0XOILQ5WN5)E)]?$NC^-PQ
MBU&3<EHK'3O <$TQEZ8?_:+0%X%32.SS;<N%.,6?Y^9U]\'C.(\<FON#R.?!
M"$ K<G(VA2YN\;XSQ1M5XD^UCY:,NR3D@2YDP77K+GKI_X^L9(H_!TR:Y%=*
M^ML8/_K/O2;7OM-]C3-'LD5EF?WA96AVJJ;R"%_RU>(_8/P8:OP!K9DX(V2.
M:U+78PY&>F;KD#ZRSFEA]GQ=4CQB58?^)(JP7\I$Q/ANXOTMM&@WCM>2%/:S
MEC]>V$59R)L$7\P'6WC@*B85L.YO,'[?=J.L4BU#_D*K2.&K*0CDS;+1U=..
MN9<)E1E7RP]A?XYC0"Q*@ZV+4^UJ@TX1S[=J_BQ,SIAY+#@H41?Y'"3023R=
M.ZB;O'*TD=\>CE<3H6_=1V0JRGDNO" .*<$IAM?E;J[7S*QO.Q,,))F'SK6O
MB%;O41PN7L(D?V1O=^-=51U[OQ^.-<ERD #X-GCS+4;+T5HJ</@:*BH][B@;
M4VA5/@,-2)Q@T]X'XBVQIN&Y=*,]TF*]UU'8>ZP%QJ>&"D_\#"<R\HL@J%;=
MZGH[:&!VTJ+9&F9]A?1DM\Y<>>S3\9J\ WU^]E:M']Z?KHF7$J[B5U*!'P.>
M]K 5J817M7!J:\PL(7URZ9P#MCH"M&%O"H\<!ELC'F;G1E_4L:+CC\73+AVO
M;WZZ6UP;3[0:L4&5Z=[G&N-T"4[G=.9Z  S CE,(I]LAMUA, W"*VE$11Q$N
M_[5E '-F#OW/4RC'X\^>VZA/OZEQ"#DL87%'C$$?-&FU^>:#+Q]%M^Q)30_X
M4$9O.M^\8\I TQ):RL9!*ZUD*$D;_?$P)=EWC7Q@_"3W<R;FF1>]PQFMBVX_
M<AD_[%@>1SK,UE*,1?=3T]NCMV)WW0SJ 5 I(LRYI=1+]-;V\)D R@4XG6T&
M$JK@<:LQ U#3TF\/J1T5#J32([?N2G<#E]\GM,<8O-YZ^!8;6]5A^?9A+X/@
MD;G%_1%[1 ;^26NPQ%CA9^+:A;.SQ=<Y]+UDIM&.]/&41L;1DR3'V/HA&W3<
M]K%$ WA2L:1A)]P@[ YD&)/+"8*Y#L@U+PU [\NK(YMJ"2J7%<KZI58]*(JI
MO:K) 8I9D$;;2YE/5:Y1'/K=89EJ6WFUVI?^]Z@&K654O#JD_$I:I7;>F3*C
MC(>4'[X^C1(%EQ(  P>CE#AZ3&%K(_YV';]Z)(R:$[LAMF@1;1,_-WJU@(TW
MOS%'&++!@@*"R[V%$PY[[X9>1'M)7I(<A7F2U5HNA3D&^.X(E;*-LS%?%AIO
M(G926=<"5G/'S'P_)W$D*M7<+,+FTB=BA_HU.YP=SHX,J!=*4YI*;?RSOSRA
M0_$KZ2DY*<^*!+,/;<&X-8+.  ;O5,J9@(!L,Z#1 M^/U(>[:P:2AS@.%S;M
M$?5.2TT[X'*;3PB2LU?;8H&_B2#AJ+%=ZB/2F,L\)MC(<3.V+-@V@ZWGF;G/
M]2)W@R4V6<L%@W5=;*"</8JVH.-0_ENA<<WQMTEO:-PV(!$T)HSA.1-&JSUM
M>X;N*S*^(R[O'[*;< 197+9HISIFS1R.5>D(6QJ+!?U:\Z]BI51RCL27&_PP
M2>B*)X%I&'< !W[)1K9&K5XE++R32&S*I#SR#NBO%G(7U7?ON7UU231;(2(E
MR!\8/6X/<V3/X->7/M9!VQ!'I'[_M7QRX<=FE_-BBOORS(Z9@*B8WHUKW@W,
MPD4%&\4O_523^C&2!@.)QY'&SEI<_8%^';9?=V-H[>A^O_H,0=\E^]^H8<0T
M*OC.F^Y\?,+$N!DAXK5;I7I68;-<>3]<PHP_-?=>0V.:/6*]I-2/*:X;0=7R
MQ?G;>NR+3VU;-*#Q%7:I$)RK7GZ36;2R0_[#3+B8K-C_ 31 R[_OIWNLD[#?
M9<[+/:6GQ;U=V#KOP$D.>4?ODIX6$0=]UEQ.=5FF+PQO)Z@7WY<!?RK!O7[?
M#EQ2,; ET77(*^U]/"-[[WO03_D&F^ESJF(%)]*:7DN=ADO-1";G.N2[2P;W
MR\H.8L]J\?M8F\O"5IEW3/#F9K!A]WXQB@S_ (-]-"B!?1'V$5=N2-;3I?E
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M=4OO=\:7]H"[%YQ EPR^7I"1XU6::SK2[HHM-;[P"!_?H1\9*K+>>ETJN0C
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M,87A@46!=Y0MZ<W?96G:,1!SL#.F'U1'9GG<L@H%O&HX#!Z(;QX7<ETG\9[
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M+Z[^VKU)HNN+[[)"UB[/1(T9>::Y9(+#M?6?"J48;L[YJ;)L5=D.2(%T0.:
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MZ)&]I-UY^5/W6]+N@[?>L**U4V!]S[Z:88JP---SNTE!V3]W"'ARI[G<7YY
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M4?55%].4L._A4]U(CIPX:42/TL<SAO1#L-6.4.:LWKGQZ+F!P^'7W5BU O\
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MO>N1DPRMU\8JS+7U>:!VFJ/<_=6&^/=RG[LOK#AO3>X1%WBHM&WRUZ#D@?\
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M,WSX,Z5_-X(/XWP\I"U$"_K-*-H]_.+R=$EH29<:?9UY)2UB,;LI3KN-V]Z
M$J=N%,'K5,[,B\*,F3[W\H)GNK>5S7.S"\;[JO##Z%QHK522<-<L.A+I\E1D
M]>P><ES/PUR-\XIP?FM\%F8A5_?? 6,)+-'3OSEIU2/6?R=8^5E+F+7'I"\@
ML6OF^]:.4?=A>'RCW=F.%!<$)6RXU-Q#PB#UCC?10#0>!;DX:PAFZ&EU150,
MTK_BE^)( XW3D@T<'6-/$4#"\M<.T)*S+5\,L]ZXP;SE<<$X;[PRY8N.FB)*
MK;4KR=#KDD&E^7]J)#]0A=A,R?C?XN2*=IJ;TH;.)$!KAKP2$X?&%$&3\Z.M
MVN*(Z"UNTB8Y2.J5\_I(<MT:8*?NN\)\4(=#-7WR@=$"WASW6[>IAN^]S2^[
MMK?:2!RWGI6[*WNTJ_OV<@<]^7>2GN,\<O"*K[K\XQX)@UQMRY"=UQ&0DKLG
M>ZDK(1.84)^[S[J8G?&"=]N=>]3(W7C?=%7%PIY4G>.$OM8-R'"[X+$][^,5
M;3]&9GAFP:D'1,ZON9J)JC+70]*=WJ!:H(5SA<4 UK"?WGY22:H=1,GWCIUH
M@\1NF %\5'W9?#_GAT!-OK518E3VSQUQZS1J[B3U\*8;=A&^&."J^W:4[Z(7
M$?8ANB^H0-))21P#C":.MY_:*=@^.SMWVG:X8XQON5-DSUW2N6]8MSR<XN08
M9NU-ET<M[DWNPI#0X*;\<.5N4R9F@YW1!?W/?<=T>"F:W>2F&^M,9$HEK#=C
MKH@J[7SO"+._M]9X)&6^'!WTB=IXJZW50,T[/Q\)78#6GU#<D?>^'2:'OF-U
M_<58MO18,YX9\A@%-WUQ<]%D\?-S2%JQ"RM15$>/DH7?RJ ^='7EHI6ZZ)F6
MN<-VZ6JDS Z"=7SOD+>I-7OTWK>Z8OZ2M-7?2@4W))AEN\>7Y(%JN?&MY342
MV[PZ?#!+[N;_ (Y^45T7C,>$K+?*_G&BG[M:9X_-E)[K\&RNE<H[0UWO7) G
M&\?+XN7,-I8HG)P?U%]5R53?(ROD-Z).%_2A[^VE+S1?VX1Z4Y*WD5?&IE@@
M["[^T&70XBG*\5A>OB/=0-[>7*%.IJE+7:W%)[K!Q=XQ2-&=9Z9YH*#4;SG<
MD66NFLKB\*3_ +[\>%$'V+JA+J!%;N?A%HY8Q%]%SAKQ.&6J;W<+?% Q:W1W
MQK$)O=K*W:SR4@U\ONP].3KA##&Z('9;Z]J?,TQ:W3OY7/[;YN^T;L=*HB[^
M%ZVX*1/2Y+ S&^'._*FT<(RMW?%%.P92G?R:*SZ:9[OE<@:F9=M]R*?W/KK?
M!$F>HS5;WVY48I7/6],*J'NPW=(8=51@[ZY82178R>'&_"KL]I&&)A7Y7+_)
M*[=+@K;$/,KC >>2#RS&UY6_)4&TH_IPMZY7.&!4PW>[GUY(/*/N>$,5S[0[
ML.WG19EJY.NL%#;;1]93=>*# R?3GIV6)=?-V7-%AB4'.XY9GBH;5N>?CR@N
MQM?J^'-=;#=;PODO$[)O2Q)=C+<MPKOX=4'7M-H+NWKQ3;5Y*S1,A&F'/Q-<
MC3,Z..?-!;9<A;KFNP&M[\,@N78L\AG&Z*[;<Y?-]8H(;7:2WOH5/VOC=UL)
M&FJW#6WYKG:VKL!KY0=>SS@8KL]L'\Y]G:27B-CZAY,Z4YW#)>69VD.^["YA
M 'NU%WY0VC>-B?RI/BX2-N=93M"%7X[ZU0<X;GK*MQ74-I01C*XC?!>+:,80
M!Z6]79:PO? (.LM9WKA<T@:C"QI;WOFH^_@!@ZJ0[2L+N2#L:;N["B#QX.%[
MESC:82?6[@],PUOH;RPWH/("\7RZ)F=ITA7750!O0<M>"B6STE>^J#I:;OI]
MX)#=YAZY6FC/6&;[XI1M+.N%P06;#H6^,]W&B+#.%79Y7N2;L0G8Z=+GF@[-
MDUQ$!E .Y+I;E1]WV7)A#A=@H-;6\,"[H@1O9E]_;[$%T[-<QVGGE-[E5ANF
MATW(*M'K9Z05&2+C>?%<FTVCK?><LE+^;6HYR?*ZH+;5H7NX[L5%AN+ZW*RN
M7:-YV>V:Z=B;P0=++6,8=W<>:H687&\X8K 8?-W1'W:GD[&]R#A=$;KP7?LQ
M"X.N"Y6L7W0A=&S-+E#CS0,X>.G-3]]/IUS6VAG.Q?9<H'#3>]!TM[3##MAB
MO'ELOK/2]5TAFEO>_DIM,.PE8R=\P05V;5WRXH[5J%] N([3O?/BF&U@*P?I
M\:(%!C.OQTQBNQG:"$H/UAU[ KQFTWW?:*B-J1,4TOJ@\OM#A7*X?:FPWG;_
M (7 =J3C*48;I/&J;9FIN^Z#MVDN[UXTMQP<:7SP72WM8 3O"607CWQT[\7C
MH]2P\SL&C /PX?"KM@^&9="-UT7C]GM'.E(< 3*XRJNG^30PW)(Y&X=[AOPH
MAL=J\TXKG]0V^4;CJ/I+Z=FN?/<K$CS/MKAU^.JB6 'TSJ+HLSM7"]-8J1VF
M+_JX!!WL-.N-((-M/[^=%QC::<;>L-KB<1B@#>-B*@&OFW?$E7:-PSX<Y :T
M7 /IS[W[T'<Y]W3<NC8=34/NGVN#^1W>F+[JGV6WXXR\RH@\LR>[A?')<WJ!
M2-]_&BS.VS%YYI&FP7O$ [& N2#DV;!?KE*<;"[2U"#Z#A139(CE;U<,P[X6
M9H)'ETL;ES%H/QYUZ5YKM+#A!^[3S)>+VT'SIH]^/+H@\SL'.'"]53:,B<,P
M[&YKQGI]KK7/EE]+I.UGNQ03.Q%W#+FD9].)U[T#H[W]5U,-92LW%ZH-J,:W
MWH]"R8].,/.BY=OL!&#NVY=W\HB-.KS+5<VVKXR=K+IBD#Q+6PSG?2N2.S]/
M]F^ [RHTR7OQ=RAO5V&G /O/Y42#,[!UUPZQ2-;#G>3O$5TL[25X5M\%+:-U
M>X.OR%5<6T]/.XWV7,QL#AN=<KBO)?ROG6]_E.S&W7W"#E.SJ[O\O^UX[;DT
M?E%T5YYVMOGCW2GTSXN'"EQU0>LO(QXTDJ[/U5'D\7ZC6\5Y;;[ 1@)6[IY7
MC6?3OH^XQR"B679VKY"DR^6FZ&\I_?E]T5MCZ:%\;DEV^R=+&%3OO-+D0FRW
MKNOBJ Y.W7QZ/1V.P-<ET-[+IIG"R:*Q(X@V)/\ BYXK/OO<E,^G)E#/=<M$
M#LB,93T>;LHDTNL&3^%_81=>GG@_BO'--N>)"R=.:ILVNY^A<T8JCOX.P@4R
M.KUOI1#1NQQJ$C6VC5T*=\D9M.QV/I'#/MY2'CI/++4<5S_S2Y5>8]MSHHG;
M4WY9ZX:HW%,PH>=,[Y<T7=OH9XJ(V@PH-)T?;U=AH&-Q1J)X]P.SX97718F_
MN ZHM-C0#GKCO2?R#$/>;N=$6J<B>Z1MZ+'>-WW4F]H'P+[AT.BHR91PCQO1
M"\'+5T69:U?YN,TKJ<QE%VXW!$#BA$PK[]V1A?= M=^5,KU4SF1KX2F_@A%,
M#GGOGTX)R<\J0SU^5/?2[W(^[$[OC7[1F:K*@XQN7=Z=^!O6W&2Y[RS^%0%_
M="K8S67U8GR4"=<N/CBG::^E(WG6.. JA?X;#,&^BZ&6NA7,_GUZ0H5?K1W>
MJ+?8;WV38T0#>O?@I\,-'=^2W"$IUN'!&9JB#\:5OP)H$^!@'3R0?=[TK6KA
MT&Z%[D)JRZS!JWR2$WU^T U/.S2ER19&,87=1)%IV,#NQ.;[PF@6[O*62+;.
MZ-G=DIM-83IJ$2JGG)=@9Y;M$[NL(\%SLM4IEW3>[D/$G851::;.L#=.!TOD
MHM";G]X7..:B=IASX6$HVB,WF.M8WNNE4I;UKVY4Q"'NG-W3'6D-4U\/I$F9
MG)-\\[TR<F]U]\;<E+/#O*"FV9NNXOPU1NC8L&KN6A6+4[QI@N<&Q\7BL-?N
M/R_)'.J<]BS/#K;H:)P;^\G.P7/NK7%QDA[LY2%<<,$:O;):X0QOZ3@RN,5Q
MAOEA"N.I5F&KEI?TC/5MXNC*/;Z\!!TG8WQRRQ2LM8X6Z\D WP^PEUIC*ZOC
M=XUU>E(PCE?=(6NUWO69/T^N$H(15U=1W.@/F^J/NSFE;(^\KP?@N<'MRFZX
M.5R:F8C<Z2U?QAGS4 WXQOHM[INX]QI*JB>(=9PZ;U:IC<S-6>2Y:RI7$Q<*
M><DV%N=.Z*0:Z<D_NKPX<NB4\2:=ZC1STNBF&IXNFBVU)V TUO=-1;;G+3KG
M<5ETIG)3^7[N7BBI[G7RBN('+E,CQN5 *ZOTW]%94S3772.M(7%3'R(QORJ-
M&\+SDILD>.?216J4E8&WR\5@J,$<I7QGR7&=KAK>:I[[D!Y4FGP(F\.EIOB^
M<)PWJ7OPN])*;+69TSI*25IK+C*K^SPLJZ"=>U0.B9AK'@Z4%R!HZC1V'VJL
M0C*S>$4'5[H/%NP2>_YQ?>Y)[H8V_P"7*0:XCN\\E;"HUGON LI6FL^;YY>5
M'W\^_;ND+4]=//=2XN_=SD.!EDIO/?+"\:(OT=2,D0UNPUUN#EJT<4B#!H_+
MKI5!\).X68+%K!VG6"D6KN\5+$3DJR<N$S)U]$Y:XOPX=^Z@&JN=3ACTS>JL
ME]W+%)BRF+5(7XZ)@U;JWY4-HT[A3&X%(&N,)R^=R0.L-7A\XI6^0PY*+!Z\
M!B7F."9IO60X:]U9CGX#,F,]\/L:U5PW1^E%Q^]TG/K?QN3!O-_6\7[E)@=!
M,^IN#TC\+-.-S6?WUT2%JW8),C')]W%P1-X8FY*++7F$7A\OE':;3=+=C>44
MB+B9:G-W&[<@&G]/K/[4P7_-_.Y=3A/?"6O.&:LQ8+[=^/9]]E5@][Y904"U
MENQ?2$K*=ANG#I-;CL\R5B'<G=/E+[\LM,Y7!%IKQPNRN=IK"D!"O'7NLU3Q
M'2&O.G*$GE%TI/WW!29.&[AKR6#=C6]ZP*2O??A4V9X%<A:S[@+I9;NLZ]E9
MBPL\5R!KX2M'KU'%W/<HDEY+Q=NR0:-:9TX3C"$8*"XP'* P>\W&$DH:[V>V
M2#+3[>ETAE1_BB"Q.7P_5(UPCP>E>-\=7:6Y#W\+OR@;W.%UH>JF6W^!IVHZ
M84PW=_8R3,D5=EI6<LD"AJGCDKLWD!==5R Q.7%UOXJS6TX<-SN2U$0"VUC"
M I77IFF9TC6%9"?5<+6TQD.A56-MPOAD,%)'4T,*OX=+U46N3JG/F^F.";WO
MPWUX6Y*TU==[UO5R[ C+=U^5VB7:,Z17CW5X0RZS@K,MR>]V^?FF:Q<=@P$>
MN2E\W?% -5 IOW:5SDDTIPEQ2XJR>^4+W*GB_O%<8,CK+)6+<-+S^% [3/&F
M4>=O5&>73[,C5<9VD^GCOBL-I,<<(98(.LF.( =2["F6].T?A1]]7N^MT-T4
MA/3CP6J;;T7!?>[*G$J9+M>%G/!(]TJ7>"1_*ZJ=:@^L:A\#A>Y-[^PS^-2B
M2)<Y>;DH'*N8I>HQ6XG*+[DY^*C^.)=07+<KD=,@[F_LH,,B?66*)VFDKT[;
MEF<^\B;NEEL2K"\-X72PV^M-VY>, H)3U\JQVCH#*-]UE76WMI94\]%-EIYT
MY8+E]\C<3<>2;WS(-Y9WJ'2VTZ7WJ+>I-''ET=(04!M7W3/3 9HEK32^F2!V
M3/R=9J[+6Z1@(:<%R,M5+[[_ "LUM!D)2$SE6<D'1[^-8.Q.N_1(T9F^W/<H
M>^E[NXJB^D>1L9U058&-E_EZ80Z?$4K)T=Q=B_*BS;?7"^*"ON$ON(ZYGJLN
M5]\-W1\4R#V%EO*+G;N>2#36<71Q466W@GB]T+>IG:.POFEDNH-K@?A,TWVZ
MWSDN1^MQ?EW@F!KRAQ[.0,6C'-^D^ER1:;\_:SJW1W 65$<H[];PQ15@U%_7
M$4"H^]9PN*YWR=#7#)_)$MW**!VCJ1=Z+!N=RY:E0)Y2J^.?1*6JX\'T@@Z0
M:79IX3AJ]U=_!0]WU<8=5GY#$?7P2] 6S+MTT-5,;2Z.3M&5WNDH^>PREP5B
M=PO[KU$E1W'3FN0G<'8\+XJ^R;\\,IJ)+%O'>'NPBL<JF<,>EX*>T^#&6'TL
M^W7RA5%./N>/(JP\X7.W* ;M]=W).V8:9RWT1)-SZ7AP6:.[3AV?R,%Q_P I
MX$@;E<-/C7+/"CCY12^W>-7)F<OF\4A:%:5$$/Y)76-U0=++64.V=1@B-:P/
M109:YSAYICC@G+7#&AXY;D%/=.X)--<M^"YRU5]\\T WK,9C6.G-6$A=LV+?
M84_=G]#+'*JH"^> XFWQ@D]DWP-)4UZI?Q^2W,R:PPNL^Z8&Q 7U4F69>+EV
M57<A>ZF96HK23$_ ZQ4">Q%/E.UXZ24B<.1RQ6%=(;ACPGWW)"W/#IORZ+F]
MU='2O%R4MRUD.V-)K4=0Z/>*[Y0LH%H99ZTO)<X:AF]TW:I=SG7!SX]%O5@=
MC+5TT?BF?G\3@.ZY&6W4-'2.JNRT^>/-9KB4XBW=UQ2,LVZ(L)BUQ[7GHLR9
MB-^5(V*!:(CUY/OHF9VF)I#ZNJGM#(7?5(6MWD2Y<U!T]<*$WR6)F]SLM'/Q
M?G@N=EO$UXW3@J!K'Q>CDL'#5RGAPY<,U6W?"F_XQT^,D2U/3@E46 9W:;H=
M(*I&$C=^%S^ZO+=]*K#=.T<.EU6YF]MMDE)IK*LKO!,,<N0^>.BGMAPY0E>]
M*PU__,%N9R+Y+C#DKLW8O!<C[W?%E5#68POL%QC:;73[N A\.O-!H\LLK<-Z
MY_?-USUAFF?QSAG=%%'W<G7SEW4R;PFZ\4I-+G=.RS)QO3NMTVV\]R;]_P E
M6&[S^+FD::B]SNME!H=OE^]3;-FNO;%*MMQ8&\EF1OK.;I6=RC].KN'1T\T[
M+<G'X\Z+5HM;O9C:O(![YUEY4RUQD=]A^*O!W;2^2Y6J4NL/M8MFU,Y*>Y,_
MXO&BYBUYF'P-Q6&TG=BY+>MU27=K+=QY73- MTC/CW.Y<S.UWZ94WT1?UKT\
MU*YIK0N&[O"6I6]U;=ON04"*OU?E,9:H@W1199HP[7>*#)P^;U0:L[^HX*8L
M56HV2E.QT%J[JG#<ZW"E<% F? QGF#I\)7X<,+NI66G0;=#K%3#<H_;Y^%F6
MOCR+*DU"NF>:W5"3.U1HW=P6?3R\/HN<M6-:W@J, O>>;H9+-LKIK99',*P=
MRU3!I.!YY1U&E5-J@%OND%%%HWS\U3@XY='?>*Y_?*=X3W\DS#4S&<8X2\[U
MN(MGSFS/#G9"[[Z?6*S+<IF$\KBIEO<+UFIAKPZD,31;IV,USFZ&CQ=#)2CX
M=TD_)!@R=?W\JA-+^IC.86-6W7'-DB=Y/=1[\.?/)4#5W?-<QR[\-^*P+G.W
MQB[#5-WCDWE/4ZR=S\TA-YY;ZJ'NPT^88=7*@-R!=>4'JWR^,[2J,BAK<>H^
M!0KI9;G67P,5R-"S*Y.H1-$-F9/D9W\+%VH=+1\7AS0#<KT\+G_DPPQ^OM8-
MX=G_ "HKH?1V_@.>>_%;WZ7UR4@UETA?VL#?'K@K,AG6Z[DJ,G7B+S4V=W:Q
M<DS]0-U9QP.J@M[KU.*S[NRH@WOIC+>G]W6_KH@8'=9PNB)/&YJ'OXQRUX"J
MP:O&'/#C1!6[TI@5GY:XK,T/3G\J.T,3>[)[MZ!FV]+\!9AJKYS-V%P%L]]^
M#NZZ&&\>L]]YH.MMK?WP<8\E-IJWW5+[J4P^.F^B0M8]+>B1)O=?;*2HRV,;
M[8CPH':5,*B5RR2^]V&.[I\P17:RWO\ K) G<_#SQ7*PWST^O)5&CGRR=Y1)
MGJ,^?02O>G#>XWY7(T8QREXZ)F6D'8&Y>:Z(OY./"Y\5$$0OF9:+%JS%T^.0
M0%_>J+^73,[W)&CCS=S=RI5%D\=VD'WS1F9SL#OFAXA&$9YWN0:/P[EFE&6@
MW=G]5;Y6+9\\5 U=XX.FAH_#Z0 P<;IK\+ \I?>[BHU.P3EIO./S6J;W4NQ@
MY#@;Z*;W<=:(S1'BM[LI]M1!%^IX2[RWJ3+5X%'W6Z QW<'(U8_NPAN-Y.3^
M[/B70MVJA[I\_,4WNZ72O)%N?W<ZQR1)X7;Y=%(-;[[<4P/ 9!!KTPAS.*+]
M*?,9I6OK)]N6!O#Z-4#;X]BE]WST[\$K37GA"\EF&NL/D5NJ"Q$,:Q6.IT$K
M* :&65+Z*7OUEE'6:(L==UNU4SQW1>>SDIVDNQD$A;Y.STAFJ3U+,[G97\(O
M^J7)3#>/04W?:5IO#=ANKXA51(BRX;G3(_%\5BU>7PN4-4^M2>R8G.$W$JS%
MECK4)QI+!T5,M]H4Z<4I:G23AGQK NY+G;:GC6WS!CQ4A+<\R[/=\XWT6)\W
MKR7(#URP\=U7W2^*W\+>JJC)IOY.MZZ&>/6%S7 &Z<H1CCTRDNH-W,\DU%B5
M6A+70Y:_"5\Z4G]/N"B6XX9<ZH!K(1Y7<%A+NI\I4O=S2%N[Y* :SKQ<Z&:F
M3RSEEQBA+I?A*E(6($H$XV*12L&E<$K6^^_U)6%;^2<91ODM_)GOY;KP4<[W
M^4KYPW4^:/S*M4<$NZF&Y YXV-<4WOU?EE3QFN=CYXX8A,_+XE6YK)=8-8:1
MX[G/3%H\A%_7*BYP^6,\S;D66K?TW0U5A73[O@/XB/T@6I]:8$1L*!:M\'YZ
M\$C3=_'50=(;['#*YO0?T.6=T7+_ "3QGGCORX(?R2=NIT1)G@ZW_#KCFL6K
MZ=LNBY_Y-<0^F=O0)G*\ KVD+M-7Y?;HHLMNP>,WPU7.&IPN=]Y*PJ^[YA15
MOY#"<9QN&"[/3-7IOMR\1MO4 84%W#DK>E]8"YSINA&^*(]A:,)/^9;PH?R8
M\.N]R/\ ('"(!ZXI=HQ/.XT[H67.VIA$8Z*?\P>^PN5YS[NAV\)"-W2]SBBO
M,L[2$;S7)MFIX=W2SSDN5G:NW2Z.\UP3/>^^=A!1D1W.GPODNYD]H&=."\5[
MG7"W172PW72O>^"#KVNT<^X8_2XSM,Y'?AO^G*.W;,A>^LC*+EPM$V1NW(/*
ML;6>5QQ?<D[>TNP^DEP;%^_BZ\>BZ">3LKD@WNWB@XKE;/.[\JWO<_.5WBIM
MC#7+>@VQ8PQO7RO)/AG2\*Y+QK\7PW7R<NO9;5\Y^;XY()M;6.&.D)V]ZJ=M
M"M/%OQBY+M&<IYWQ4&B[BZ_&] 'S==_(3L[2\*?+USF>?#DF]N?8WD@Z"7P#
MOKOBF QW*6SS?7M%.6[PW7N0 #'2[X*K._YPO-0]V-[KR2#:?$<9_#MZ#R1;
MSIRETYKG+>;I<+Y*36UZ:=5'W//G"#MXX50>199?A.XW-3VC+J8R=<^'5MB:
M86.J7U GX[=>2!1M.PAU??!ZJRW?FW8+Q?NFZ$9;^ZLSM=U*9.C80>58VM*I
M&A6ENCD>"X6=I&-"'>3\074SM'ZWRQY202:;-G"KG<J[E1AO&Z7JD;'/I<HK
MG_EC&Y_$<T'9M3GI\/S46?G?<P((,MWP=HYY=BF[CA>2"+3,[AKR5=DU00[9
M9E85C\[KR3^V5.Z#L8VF%.\8WR2-MX:_*39F\(8^%1IJ]R#D;:S3;/U%\:=I
M+-!^%XT7*WLYSYB],T'EAM.-F\$NT;Q/FQ1>-8:(N[HF.TT=C]6$'0?47C@Y
M!O;O!L<-^B\<V^5.F5E#?NO%!3:-S=D,(XZZ)V+N=X+D:LX/O31=>STQOD@=
MJ1'7A=-ZXS.!X:NKS>8*FV:S$>$>]X+C?G'O3=GP0>3V6SEOJG;8DX<)^%R[
M/U#MT(WN>JG;C"G&Z((-LG"X_-N2LL0=A,TP%X)V]HZ&'"7!29:?O-PX\D!K
MB.7Q/@JM[6G"^R:&?#*2Y=J>!@/,4$?Y.5[EW[(_&&2\2S;[W8<UY'8LN<7]
MQTP4G<.SV6%%H<<(Z?+ZC!=3W4Y7JY<>VVFN6_/"JH0-O>%F@73WZ65 -Q.,
M.LKU5?Y(7UP=;D1$[2ACOW_#UF"+/(7W7/M.K[\T0V9.+KSQZ(KR)Q-<,I9*
M89<9WWC1!AK.1QG=P3^[C?/>@Z]DUPY32[4UNY89KE#=Y9=U4MX\@@E_*7NR
MW?;MZ[]DV9>:TCBO' B_*Z=GM@'9/XY<=:HEGDWPP@/"\3ZHV13GF[<%U_ZB
M$O->:X]IM'QZXU^.:";+5D1FK,[5Y$;\KF+6$[S@ALV#>>)**\ULC">F-X*#
M<^%[U-@PC/"4JXR0_DW1A)!U[,=I>46^-8U2;-N\_A7)F_Z[6^B$.9MGYQ7.
MW#QT7:6N7$&^L%XC;M^/F-A!;^6G)%HOKQZ\NJX=D8W?:2\BR01GEE7?C)!/
M9TCB_(P<KOOK>*4;.^N]W*,%0CZ0.PUINQI>"Z0:;J?1[+DV>T',:/TM^BL"
M+N74101V[+Z;^FL%S,#CPSM_=-MMORLW2#EX\>IBZ==>E-V3U(+O+,GMYO2$
MD_LKCI2]X7 PU)POS>2J=N>OQ>Y)%F]HY[H;^3L#R7$SZAY@3N/?Z#ES[5LF
ML*2CJ[FCLV71G&,.%X(/-,, A[L[MRCM@(WAKGU2L;6#OGK/M)1VC3GE\7WT
M&B1L'$WLGF+A<+Q77L]B(0W\W>8.X)!MQ"3QS/6\DXV^[*$\I=>*J7)M&1+E
MSY?*Y6-@_P"S?)5>3OC8IFN_9L.#]>E+Z(KD_P!+",A&_C)<^TV>':&?E=FV
MVKH3BZE5Q!N-_?T@E_$3+/PNAC9D"[N#EV;,C0P?AY6;;$NT1IG80>&V[1%-
MPX.[N,^O*'YOE!>;.P?2,[Z4W)MGZ<"@RO+[0>*V6P:G%=30<'UI8SYKR30
M<[2EQZR@N';MON2);?Y([-LEV.%;ZO70X_!Y3DZ,5'8NYZN%X4)7EF& 0!#D
MZ=D=D2;;^9>(;VDH/YY8_2S.UR?H?A>0VOI ^Q>.$TA].X3Y<\4NU9RC:"#M
M^^[@C[A?GJA_%< !\*S.RI 2==YA'.*>*);BZ0EG>D%5EJEZ7W0:V,RZ+C2>
MEZ+F;!^"Z&'.GE&W02)/XX4?\22D^790N Y.7 =J<[[9/T2G::SWOUPLP1BJ
M+YN_W<K"L=INC,'&G->&&T-";J<2]='\Q#L:PT\=LD*HV;N=[M]UX7]K"HMU
M*[\5Q?ZJB/\ JI/=.N[#EX1G5ZG:&J<[XU[HOO/K ;JKC_G&#M ],SM@;?+#
M3Z1;9Y1;M6!PAC7+>.Z(;I#?*["YRV*8Z:><,TV%QQE!"F;7RE<M5MV712-A
MU$";,_C+)*^;G>=/!1=<[^XGQY22-;6;KA;^<$",A\J89G'D,][KFB:TR(.[
M*OBX%69\.GRNBYS04W)V&N<K\[I(W>T9JOI>_P"-\0NE@]/BWZ%<Q9E'#X^>
M*Q:<Z,Y"LZOZ9I=RE1IIV6;I<U(DT^9RTC)(6^U#PDC@[B,%JJ<VZ8R[1]U!
MUK348<%4'",,G^<8!<[\%5DUZC" I>:R51LL9JW>>4*9*!-;OPJDXCSCV@I/
MA)V PK+,7 (DQEY) UINF[DY49;O./7&50D]N<[K3'"2>7.(E<^R),Y=9_?=
MZ[T_OH+R@HG>';INCJ^XIV,[A+3'<A$[-C?RFSQ@C_).=(&^BFT+CA-_1(1?
M#BK?<ZWA?WWUO)Z+ P^@;^USAJ;CC&;QO"Z&36Y&>7THS,7GJ7?CC<^;E!LC
MG"@O5 MTN3\U$M[Y_>['@B13;N,3CIU=KT>$??X4WG3E;R4>],(.1JJ<A+=S
MN@X+%KX^NU2E.O;&W30.7&9AUU0C*T*@;W\>:J^<+NW+G!UWN+O#XA;W7#IU
MFB_ [1SA6-+$\5-^;K?E,XI2W/C\8H#::9B_F,)*Q)$B^/&\_E -6[I*^"Q.
MZ,):6$S+&ERZ/Q2)XK=@UHY8_6^Y52MEW33/)(&]\+N."19B-LY3^3L8 !Y
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M+=IO7)'2PT_07I])O?Q&=U<\32[,^"['(W""+9&AOES156=K,'X#[DB\OP?
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M?W4RN]5A=:9SEN4QAI?W"LD&VZ'4&\:9HQ:-O8JUA'=;D63NI+!RD&IOESE
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M<^BY&69=>Y5@,;'+LZB"#Y1CERW4[+R>Q:AAT,I<UX]TGUOCJNP& N$D'?\
MRN<=#,Z15&FJRW\//E>*:;ES^^&BZ/Y.5OX!!#:3RC=ZIV6^0G)^^63UR;1N
M+QKNQX22C:Z>;Z11BV?<[AM,<H0P'$R4-JU)WT[13][WG6O-3#>6!%YHUO\
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M$%5GQ(<#\(LRX=N-U]%/TS,7S/U++<NSU #AD^7;=\+AV>TC9N4$29>P,,N
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MVL(1-Y7.UY+EVK1/0UB<*!=9NO!3:&%']G<]\4;F7/Z>#\S6W#*<5Y+^2$)
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M>_O,"#GN^U(EV+I3BB6O$:5)O<B1!O=ENGOTQ<@3,5OH/E*&NH=9E#!$G*[
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MUOI%1!OP^PG=9\?2U?F5'K'B.6\4>@T8'28>]8%PR"EMVH<HS=EP2!X3U9W
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MF9V1,3G&Y[]5TR=IOETZ:I@W0.WNI<3N2M-9W<D+9W:;GEUS&*Q9=4:X7C'
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MH-'S-_"X_P"<:7<.Z'\OUD%=>1W?ZHYO.DL<97!9GU!E&SS?0='+A.V'+"^
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M,\L.I:9,1(+]!^S)RU$\\%>E[7!#+6)NESNH?("I7+AP;T9[L&LX?M7W(']
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M5DBY\QCZ$?]6N)),]HKPG2[\5##VN_,RIE%*?IFV]BJS_B1&I;B%IX\;DE6
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MM-YVM= 5WR)@4M-)5W]JX)?;=> U5ZB&$RJ;.J:5Z7(X%:V(%45Y&D42!;[
MY(X&40:=GH]; Q-]&#:QO'FL#T(1XIX5DC_FDP^(CJM!DM.55DT'.0T;X6VM
MB,0)]J)[""[HB>Z_WR^* -7)J*;S=4_9Y";15\3$(X-L$Z6.+^&,J"(OD$%[
M%A"JOSW/&2S,VSN[=<RX5ENPV+&9,#XB^+M3H')QNMD]!(BJ@S57;4 WC!D'
MZ+?SBIWY^_!E2;QK8;A.<VXNL_IN,-DUAA30E'Q0[!C3ZNXW@#, V_YZ/C;\
M_<D2RM^H_UO\_$4\2F$A&4=!"K0'*DC":EL GJ!_:>(5K+]>CR:^(.=U@FLE
ML<K/P&KLU<G,)<4%&X=IFA!DRIC$/KCWN>H:*6\O2A<55U-2#F=WT<#R(:1*
M(8J:BOW3D-99CI:VGB=GC'5?\.<ZJY3GA]HD'':T"^"*#LSY'J?'I>IU"8KK
MY7O7:8^HP\8%E//J"%CG"M )A[>!1:-WJTL2R.-B=)%[HC'8P/:E.>81]^Z?
MB]L\M\@"0\L-=4S7XTIE%&C$9#ROGG%/SX"C<2?;I1[#0/LP8'%3S1TO8!GW
MQ2@RE?AIR#U$W!4R\@B/U@;54K49IS0A#',9)MO= FMY;>WH/+M0WX.FD@(:
M>1MX%9EH2.!1ZP%.+7M$Q4I6158P$'I>>CIOIU/O"Z1BF KS5E);<V+R+01Y
M;+H!OFC=L?[1KDM-/^2?*C/_@5H.78*4U3(RE-FHUD@Q1"LBTTWL5JD';'UW
MS.8Z0 NU3^?\Y[VM+F(L3O2_S@(<7"2.67KOQ4_Q;$C6W-K3SI"-\%N[GM97
MHBO@1>S^%X!\#C:NN,N]CN-IUA1Q5@SRRC.4IHL.+R8>/ EP0*-&!-)$ [8#
M]K?:E8]A/C9H_5$1M.5($X,P1#6EH.'8MYJ-@G.+QKM 58=T[YDO")+2!4U<
MRZY NLBAB*P_CW<E@4-DSFXW4.WVP>Q02$I? 9Y[?Q+@0WYG-:P9(F9C[ #S
MN=E+ZLG$=$T]=GZ8\V$OJ905/@@J'[^ A C'-;ENT"YTU H0^L%LJ:5AEFL_
MIMBF16Q>B>]!=&!!@B]@+WAJ=W(!Y,B8Q%U%I97M!*74L;GEX^YE5W_@=//V
M\+EAB#C;ZMW;W6[-36/ \$JI+?_2<QV;Y9';V8D^I_LIX];J[(;GNA-=J(S=
M>\L\:N[IAQZI#'8JX+7P^M;!39>>MKL0*/"<*OYTF2_/E_K-$&+)O>_]K&#3
MR0D>=(@-(S@Y*?M:<T("3 <2+@0:2Z$]_'! DX*]\[>H?)7K*R7+<_E2=3=[
MYN;T@L]L\N*7"!PM"[8=/_4BOCT"SCOL'!/[1:>1D*U!JRXFAO@[JYWK6"<5
MZ15:/9ZU2^ /Z-L?N15K9M_ J4H]W+'TR>XIX*"Q665%%6O*RG?75F62D>IU
MRGET^;\_-<IMD6B_XCNN 3B#7>/?QJ<1-*, =3G$KY"8Q^DOPH6MP/A[--OS
M@F )6..BC);XY5#)G3CHIC50=#[\F8Z]WY9[YF(K\ON)P %R%A"VGDG7/G7]
M9C L,P958EP43#K5/V2(T67X#)3ZV#TMN7(90W^@WRO5XBG ^25L]Y8ISQ4F
M"Z-@\[@"%L=RY94OG(9P_(7P,-+6*@4'%T[)5C(N.B+:MYR_N?J7SH,8"?P6
M/>QFZ?#;$NE\Z6'^FL=']K]TPA>$U T"(S:02OGFN[>45JVOA&-S!%\\4PC@
M+%H\70J:N!\54;)/"XUG]- ?&/J6Q\Y2WWSV?+$!VY7;:#5.QY"'S[%BNMQ@
M,;F)K%.ILL;3:N0O6NXIQ](5?BN9[UO\=1$E%<TF76M%]C\2&-PIW@W< G[G
M?K_1-B@BQ8D7D//*;T+2G\TZ+SP\_1,W.--QW6/Y4-<O:/L(MH<KXK*M:;*Z
M.!V]HE8X9?*7[E$(_7&(J]B35:YV4D9?YX_W<XR+06 <ZN[UH")K>;7T.4;9
M29T]I[=+.R'V2./S#65<.&VBVD91ON=F?VAPRAGX9'V\XN$CN="B=]:H/ALZ
MMQP!0'=(/HLV=;2LKX$;+3-H>^C4N+J"X^SAEIC^2S<EL24W;;?(LJBV="$F
MEHEX_<SJ)K'NHMR ZI?)[-/#8^0BMW.B]E.%Q<+]KA@;:K_^V0]#NV"W (QB
M'3%]&SO'G,)[_RW$(3KQX*H\CL_V<>?<P&G8PB.H=X'65&K;/O=+/YMK]N]M
M5UJ)-B=LWVD?PRLV,U6:LW86_ MC+]_&%M%4CRVW^P<<3 5&1D+^%'(EJ;S7
M?(D+FC_Z2[?%@'+A]I[@_$NW^Q3!;.A0>?=ST$*^ 6-QA_1QMS'5TW4<>B_K
M]U\Z;:K<6Q;F2]?X<FAYG?VH6:V?>WP>LYH9\=Y58_73)RZNA>VZGH_L%UFR
M'M<Q-Q[=!%SQJ&4LISH)KVX'W:9WYS=H_2K\'&RB1@5WD-E1)A(<<CV**H0+
ME@_P3CVFAI?T6++J(0O.1P>Q#W#N;VQK7 2Y!^[]D,OIJR!"7ZNFNVUW*A;[
MO?)C(10OT27D#?5ZC7$6'?RE0T5"WV^+(%,NU>X*\" ]DWO;G/W>W7%'Q7OI
MF&7(.U[C1W?],VR<Q<U#@BKY$-CO60YT=)LS&P/=LM<9NZ'Y=NR=/K.':,:N
M98=+ Q7!(Y);!ILX2%"- -'7=186!N:&#3BVCRG8:KH:.+:/C,F._IK4;)6/
MAJ?D',R(7(=$3@..QQL/@OBKQZ:5W2/,2QHM9--(G=]RBNFGQJ;\/1 7O\1/
M^,!Y<LCN[[S(8".V(CRO=COB41:SL]>P8:U9O2&^$5NW2*QI_^>-@,&J] OH
M=_KCLZO Q<B,*RJ]7T&]CCUO#?<KU9ISHF;@7:Y-2]0E2L=G-;]>Q,6 HO V
M9WE?036%7!P8(:#$6"L)Y3\;ZR=,7FA)M:<PV]^XO<0;8OR">SSO"2S09\YD
MZNO-1ZF<\;QO$S*U6^!)O,X+D)2&&JNN)VO .>F _5[O*Z?$1$+I.F>"O2/"
M)PL[E,ML-:"\&O_*!U0>I;#R-/V5,NFXS%B#L_:^=W+Y1..SD/2?]_<$+WT!
M-BQ15*[CF:0>M^SHU$\;:X07M>O-*ZBPE(A-&D)T[.BPB.2P?Y"WAA_2K:G.
M+6-/>#C/!C/^#2;HUI0R2(R.>[FF2?G_&PB6D)X.LC2Y!WFA,,;[(]@4V4"@
MO-Y/I;) DL0PM\7T7CU;WK&M5'^^8. ;]UJ9@GU8N=K&@X:R!'<:GA(D3T,>
M%,'CT<4!V,Y0,<V Q'/'#:8EZ[]T;39A.,H!Z,&N??C!E;BRPGZE7%0/RSU2
M)N+5WAIPWIO2JTG?+Y?,IT;1D.X2Q;;!?>OE;Y$O.?WH?+>=PP'1>-,P$+'<
MEHG6%G,408;N).["\'VR5\S70M)>CLDL"1.[=,MPOT_;Z_B])\3QXL$^W^*:
M[T.OC/E!E":\6ULR"9';:Q\7XR9G29Z_<;'I,1 URG("02>E 0-\/="I("((
MIWIAQ&_,-VS8%BKA(I4+!V17SZBCQU$]>ORO?SEV_^SAWMN7<D\=4ROL*LO0
MX#M].#;YR_%BL+1\K^"@KI[-6&:[M)"@V$3Z0,\$.=SAV(4[D^RWGL-#2'CA
M5\UY"6)6>A1G)-TRMG0 +ZM_LA:T:D3% ?8UY[!US OB]_^T.V6OMV>AU0%E
M":-83:5L2 !!"\?S@+G,TLBCZDH=!\KDS5H'MQ/7DW[V,GN\/\L=WN_EQY/L
MS35']6WAOGI&,56).MYY*NVV/^T^U&]#= 5^[J<_\#*C*G;.O-]1$A=LJ@Z-
M[F$A#DU.JJ:\-'ZZ1 EZ\@$_*-LTY^J=Y;*53G4\/$I>%3,-,7"OC^HHON+I
MG?L"V/^/8%TQ&3ZOGS3CA'67MCK=T,.):;ZDGBM_Z>2RB*L;X4BJ2/=9&G.0
MVVH;PU2"3S\_V[D>)'8Y'(G5K]_J[W0UV95-M_B^U:8^KVADP@=*??*DIM;W
M&3%*YA^M0D%\HH%)O!;BWT/G&PZP0PJK3@>^=W@W$Z[_6RO!IBN)?<4P5<^9
MQG(,M7'JO0TE=ES5FW]HK9"[:O^,7X,J(6]5NU;NI)0;.,]")J;B]6I-6L&]
M%Z6J(L%W0>6.XJ8?+ >\7E+V/8KG/QDGB.$>"4#M0M'6)[$4:$GX(*CLD5](
M]B1;TUC6LDO(/7S_W&MDE\[37L>\I(095K]++=Y&\1"X70K5CKRAAV7BO&1F
M\2/LEN^X/]-N.RZ6U4]@#0,RUUS0)TV!*:.^XX0U((<E#DQ6'F '.*5@0 =9
M*;P# 68F^PFB/1)JF,(E(B]>MF=N.KM4/.OI<X&UP3#I>:^O&B&(_:@!F7)'
M$\:O>] \&I S&[_ T)+1\^A; 4CZZUU0WO$* RBB67/:!";(!6^J) S1IH]S
MZ$DOO!L#G_]X9T'LAZR ;.$(O='!D%O#EW_P ,8A8:M.3E K#45E041%7 O;
M]H,5DC!$+7"?U2M3T>E-P,^EI;:0U,W"=H3%2^9EOP^>52OA2 SW:\(2_(\:
M55 L .*1UZZ:W#;H>#LU?_KROX<4'V/!6OUCS" 5R83W44X+>S?YG5X/D#H'
M9ZG6Z52'?? L7B7IR9)9&HQ+N]\KA^,<VB;_+Q'0Q@D0TQECL*%DT)8R.3%X
M7UJQXXI2 =K>8GJ^)]M,/WN]+7(^R3,/C^11V#/9#=@0S]XH'; DNW4:-C;A
MKKFCLE:='.> 'H61DCE3<=5D.8)&BKWC \^!P,Y)21C ;8 ]8)X1HJD&]1FX
M--5H1I51MH6W:$*T_7N-3+:2:NI!A9:?E?_U-?$=J<CB0<@,,KGQ42@AF>4>
MK3%01JI#D#2^_G+IL -HH6JWO#O1ZX.J?V/;$=6QV05P^._@4-F-JY 6/N(;
MY= 6DM*?NV(^!"9;^%[<3@9.-Y$#KS'+"DG1<D]=_5?%2-6VC_;HQ\RH+OHH
M=JZL6[MBC*UJ0.%(<C 7:.'QVK_'5GLI]EZZHYBV[S>N\\BM%&K@P_&[KK_@
M\_KU@'.E)^-A> AT*&.H7PUL^[;LW-0BI_1W>#F5Z?!C. %>&&:-!<<JF"03
MF==WC]+@.65F_=*>'VX1U<8<'IJ=PBN2W><4U9[0]R]/O/IUO5V+)9B7C!$[
M#0/VV(!\;,JX]YXUH]QDHX1KWYBEWM+>OB[$)Q-FN$2L?:JD3HP 69S] 5UH
M6TQ#.^?07,<!+Y0LG_>CO,1]+U"BT+SJ>9>6SYOY+AMX26WQ[VOGB5\?,C@)
MO]+?Z.JIB1V4X.O?3@Q.NB /2U?PX"K8@9@%2H=H>!LXMT?CH&U!"IIYAPE9
MI0#3KN/\U$L.3B7X =DQ7N_SZVTOM!:=DI8OVYVTN^W&OYP=V.S=Y/WB[IW,
M$H@I3 3?P_^9#NU>+'_86-GKG$?IEP<6^T?.L)N[![<Q_TY^J*$T?"JW(OZJ
M<_KT4P#SH3B(,X$>?=6^XRW,C'J/)R@^=$&$=69B$Z(=[)+TR9K*_7!L=CR)
M-=YZ3<68/<!E)1#5&U]QBD,I]\AW\%@WOCH&6<#NH&"Y.<VX5[N/1$920OSK
MN&E[$S2U:(_-L"U>^Y[CX<,W]U7R+V<<F]K)Q6.K16NW)K6Z2I_EK[EX,^;6
ME % A(G:P@7EQ[O\I.N2Q=O<@XG5C3>.%;5A$K' '9^]2<_30L[MY>L3+]T"
M"L=_CHM\^TLG7=[Y3/4"6-W[U6=B366QQ^!IA&-)\T#P9]4T*,S;?=25N5F
M+[@T@^O.M(M'@MCI4/GGQ49]YC0_.^]9C*??-R^CZ".N*!RGHL=6ISQZG:C"
M$.Z)-[9B@GB;Z=A UR^7;.A_&6O:]^S8;2'NS1G71DLW!]_E<OGD(PYJF2Z1
M $PW9/-JJ +<P),F<:>_QOQSXYJMCJI]E6'!UWGDB?[/-3!3)AV!92<*6_8.
MI#O'$.8WR4(/*4KA8FWZG!H/;O%D2O82![SP(:F=*E)K6[86+_[2#>D\PRB3
M:QG9N(EBSS1\NM%ROT<7F(A#L^Z;"\Y6J+@!G*]TDT<A"RO0N]$<(E9SGW@E
M\'?R[)?J/>=*MYA5V3S3?<-WL[_[ ZV)AP9.'\[X^1@)%,XA36=S:?1%^L5-
MD\JF$:4"!XW10/?1QUP_$"GPY'#(?_&<$7?O*8C(-N>8P]U8,_JN7H]]O4KN
MKG"\IKI7GG9-UTG#=]_=0OK,PCYRCX_L7WX2_7@5%%L0]P=NBK9)*099IE\F
M=!P ,3S$*_)U7,IJ]5$!W9A>,S\]P@/8$%?3?_"NFJI\?KW]Q),O[Z".,)10
M'>L<5BG6)L,3PW(54)%&X>LSSZA^_^ZW9_30.L_B"%+'=T%8XFKKD4>T*WOP
M(5)(Z.T76Y>_"_\#4$L#!!0    ( #&*8E", I)O]PP! &@; 0 4    <VEL
M:RTR,#$Y,3(S,5]G-RYJ<&?DNV5474&3-GJ X,'=W26XN[L<.#@$=W<($MS=
MW=W=27!WUP1WER !+LG[SMQUUYIWULSWS?RZM<^NKJJGNKOVT7[ZK/VV_/83
M@"PC(2T! 'L7>C!Z .!M#2#ZU_N_D3^#_-^. ?;6"T"! 71 ST" H0# 4< @
M4,#>^@$$ #  .,0?'/!O\NY^@(2"AH%]AW'_K?>_HP P<(AW^&T5\!'BO2LR
M!/)[Z/45\/\W 5$-/W@X[_MT'=[;K?YO3N1NJR,@>?#XF[Y[Z.C^1;"E]']S
MLL<4(JK1!W<N5&_%EIJ3EY>U%LV_<;  -05&A\7%7V=_728P?TA'1S-^[NS-
M=F?&[__Q6##]_P>E0AQT=KX!!/;ZY&.H8HB^_:@QO+O7OIA>O+=M![793K2Q
M?,2F3@"R.7&/C*3>M&YI3AP<W&=YY\A>'.7+ \-HB5/I0OWK:3X$QBD'?""?
MZ(R\WJMK/#IUFUNX^!?%@#W>C!S=K-<<7;BEGPG]]^L=<-JZV=0SQW^<ZOJR
MYE9"$7S742@=QWUZN#\<OE*DF3Y2.,Y(.66FZV.U_[OEV\F3H.^/0PE9ACK'
M7!,CVN'"R$HY"%HFL874&[3,$D6+KB^VB?]BIIY'JJT70?;'J;)GR5^^Z6M'
ML?_M8@E%<XA(IJ8"(K*UJNX_>6@WN;3+%%I2%J8[:.EH2-*=!=]0M'&<>)[T
M.CSZY/@JME0OZIH8 YCT)<1-H:25 A4*A:[:=DY^=0=U5VC]JSD>B(:>!'.^
MT=Q_<WP]N>&/423^[]78(Z?_G50_;-]A+"J&;^\F@;"FI/C9W2-]1(7-1.1Z
MN\JLH6)9MXHL@N,5Q/[X)<67^7/SDX?WX"^#@2G"JA_Y793- 932J"RP$E;D
MD0&4<J@8!T[15=9K1YRY_V)"L!O%G./?%@^*<SZ]+Y)]3SF'KWI"_XV"(?8S
M/6ZDT$=F/VMV)V,S"44A"G"=*;BN'31$5?S(P5WB84[L7I&=7C-HOW-%U/,8
M$;#)>OVX=WJU>D1_\"1?@[74/C+H4C:RUM$81VP\G,N, M1/)?V(PN2@L6%E
MVD5X^*_FQ<V\>QBZ^ERP[U6C?OIYW<=I[L4.^[]1M_XC-**KY6EF9*=;]M.$
M<WMU82RSAMFDV<B:\XG-]R%&TU^'GE:Y2\!C^"KZ2"R+5<UL-SXO*D'&O0W<
MBX=?A#642Z<TNT]O 'DU!R>WF"]+*IH!&*D#9!]@XJ"0"SY(Q=$IZ"2MW^/>
M;[#]RQ((T0:.?L<]?)XU&YF["SD6H&I_X1S[5OR?/OM@7P%0'_2_,^GWH'V0
M8R2# ONJ#X&Z74>)26[$KNJ.J'EN S%B)O!<=<0H]Z'*,%4 ;/?RT9;?>\IL
MROWJ6;!@;>FP0K.N7)IV0M-E3F,IN2(&,!5E=#PG,#&+IF?H=-.Q)&(UJ/=9
M8O*%LH6[4ML!3I*K7!HT6-1*AH/IF)O,;I(YEVPA9U?<Y-U08WCF],. D45D
MS*F\P:D,C\E<=M]SA\.D#*V!983<Q)8F@C:Q,]!P/6G  L)RG8+9!812*IN8
M)BM-95(LI2:7P&1*JY.[&+K69#*TI/]^98A8.37[2&,O.32/-65V_-YTQ^X^
M'7=\_#%%^QM/^!S>^&>;3IIRJ0 <(+HA%!B.<@#J$+ULF!$V,R.K4:))8+N>
M;4[:-]Z[5Z.2&4'Y:T'%Y]]UI$TC5TB"Q:R?'6\?C>,TXNA"&4G7:+1V# LP
M4FF3\R7@AHM8%E4;DTP@D\39B\HL28$@D+B)&&F:@59]+XV6<?&\A(SK>-.
MW$ Y15 L,\8"1V%U17AX434M>_G\CEE.J<<#@R>"X^\;YA>:>^=C(^7(!&JZ
M9J"[@,]GFZ,A5J2I33O!_4^?:HY?LWTA[QUN5XY&]#Y)NY90\1RL;.$>6&G-
MX9OZ7.^\D.^<G,B[9G2S_THMH=0+$)R:;&C+.+RK4@W*+#U@/U%9G;#6UE)S
MI+8;JZRC3Y9N<[HYRE:=.GZQBF&]CGIVI3B[/#ETB3C+9K1>F;REK-HT<D"?
M3[\A:- RC3*60.T?;ZC$T41C2:77*)0EHZ0V9E0ACZ1D;* P_3A(#\&R'9<
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M%0B=4E3HL6H J>/<F+;>&$]0'(MX5K"W>D2+@;?*)S1Q/;:-H,>VFSL?NR?
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M7%H&27+]PYP,:)8>6 ,C>XP(%LP!?SC0%%V?'"-_MLE*_PD0$E0[^%6+@":
M.P3!V 2+EWIX]YX[FL$^(5C)IV?'Y_1:VLS5>/8(EH\P-F#2@U9M5XT&DAP7
MQ0Q889D_YI_ 3H?>0CQC&9_G00O<CHION-)3TP_0*7B@E^Q=">)>K ="@UK*
M/TBM&+8\**W)Q(H>8T)L0?^,!CPJA36UK54E#'N?P/00;UWV:X@WD(U\,4D1
MB[@P54YJUB@0#@/;B\,C2]WGZ7F&BMHGYH;PJ@H5M1DM:P!Y+FAV*7-6@,J=
MZMQ&"S$(9 (ZSE4](&#'RU.A?'(\RR ;"&ZHEH]D'&F]9HMM%2HI1^!O5@8
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ML79K%C\2S6>M!3S"WP5 WY&]&Y ^M=_OB+J@WZ\RXTD\8%*A!U["D=F-( E
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M%)=744UBD#&0EY>C"6(J1N]-58$SD*,IEXD]5_YBIQ"^8J*TN4+\4V?%N\B
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M+WTW2$@_3XF0C//!EZ.>UTU!*"&OIJM#\L4#@2); H!P@H\OE=TE,9WB4.V
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M[ E7Y^"[R)#JR=C-NMB[E7> A;"#1]1S4'0'9];V'1ED+=PXP8./-)/O6.3
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MVZ*,-T#DC[=^@!7RG_M2("#@X>$1/L*"0_^]306 0O(!E1E26!D*C92%E<W
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M\D=OZ$&CH+^:'QQ9(,213?49!K_\\%.U/#WP8$L)WQ27UO;W@G3QO1$>9J(
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M=WEVH$0(HS&$-_E5*35:P:SRQ],YA7[%2;-Y$FFD-GI!!<HX$X/%Q%<,8H4
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M],K_AB_=JW;J-?D7V\Z\"*_F4=6ME?,Y$6I/_?,WOH!MF5!?B]4[$;VRGJ>
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M!$[R.$QEK8&L#*O,B0UJ,V*"4GLDK2,40G(TX$$Q:+O?5>LOFKIGH$A3DSQ
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MXEZ@OI1M^@AGZ^VNPT/8O+(&0&XS@WK%?(W3.X7=8R2,+-#+I'&7[>K\FT%
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MG<"*6A7SLW#JNIMCV9R4.V"]-+'XY<,O-T@3!@CM2O,S^328S1B!OBT'=2O
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M""$^S8/.(%??O^YM>ND5R _XVPV%%%N]#1IT \J]1Z%;4NV97B)[GZMGV[-
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ME"!L<<G(?0FHBF$6C<QM21[Y0^RR(V"#IVXT7Q!A\HFIA%UP;]S5F$MEK_9
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MY'*Z;IGY" CI+GF N)U5E(2'WGG2&Y#W\&W!0+J8]8Z$E?O5*=43GT@)OSH
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M*?.ZTLO?LN@/-NE3F1SEC1R5[TW8([YE9/2$SGQ4I1+]&[KYZ?:/5LJ>^3]
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M.C]7PSGUM'-' $"V+/Y$H!X_9P<R-[$E+T@8P$0AH9N(@@O,6,%R<S!K2H;
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MZF*-#O$?FK1=]3#0/<W31U2 :F6*X9H)?!'%M[CE.!-I SQJE6DD2&"YTOJ
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M"EH3"<X,5,EEJ416(;.A9+2Y)#F*TB(8R@XHM1^91V0GM?AZE;!SDMDJ3G9
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M&M0?V0",1*'X,)EWU;))>' TP]^_<&&/L1II0IN@2DR0Y-NXC0E[VIEK-!V
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M1J-C)5@J"X7@89V"UT@=+.@,#1$B"B!%"HBQ&;6Q,\N7,07AR(NCT]^T4<8
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M7R#95B;,,*UPR&O3W.'\C>$C9_C$=2BY%W4UIKLA^PY>(3 "SGSK%%YDD=6
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MGG\]$FKWXA^_MU'\1V-_^J<#S]D"K1$P!/FT>L77^<?'$\78\;G.?AZ,W$[
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M[&C%/%^_E9G.5L+L]ZXM[5;G7M5//R)ABM8\9^"E/@VY?9 I][:Q!S-4>O6
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M__M?S8-_:_U'U-N_D=/^2-LU\5@[AQ9D/=LBWMRU8]G<6R;<YT5J@>BN!&?
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M[H_NHTA9^ NE[Q3^>XR+\!@65L;,!+/V<+/L$JV,/O:W!Z:"7>/.7#UG6['
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MU+YXGS6P%X+^O::W=N"'G_MU
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MWML[7A*3&^-J[!#F *ICE]:WV6QC7F4&3SV#5VG,4S>.B=S!CL0@KS* IQ[
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M8[LOOHU^]_P.@/+;%F<!/GSZE(R." -*M5#X5BC$>%9PN@-K$@=^9-YWYW2
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M[(V Z#8 PAQ,.1IRL'+KJ$\$X6!Z;O'J)_B>D7@YRBA@/>T'5]#APTRFV.
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MP$YNMO\PWH.6C$&LQQT*%/RX]-<S[I-Y!1Q7L&^E\OI5K\K=)ZY&SY+SMR?
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MD]O+*%FNL_Q<GDMTI FU>GH*+(@RV,J+E073)>3YSC\B^-D='4@%GQCA_2C
M%D?V;>21,Q.4AM$+69VFF<&FL2*$8,F@\Q<S\K= !,9&W"/67:WJ1K:/2*KW
MXUO._)UWY"3R#498NZK$B%#1[\E (E #;X);$ZA<?(U\'DZ3@T@1E0X"80(
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M*84ZWL=#6?MM$V5L2C:T24DU%2=NWTH\.'1YM#.0I?4M54VL6/:3"**I<F$
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MW?ZWO$T$6NTN9R-GL-NHQE3YAVDI-VZ.-7X:,!*"@]]7E1@I3Z40?8( ' O
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M#!*FIJPR"2#!/()$)"SRU+L4,VH5U#P.[JFY2Q^*7#P\+HIG(=IX-ZC/2W+
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M2R04R.=^&@5^B*S231FU.K4Q1:/2!:N;\G%;VYTZGD"])'GWP36EOV\_WLU
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M_$AI(+=+.'FN.9O/;YP\DRNTH"8_ &GP_L4Z__YI>LUTS!5E RO6FBN%$[1
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M5NI)577#_K7,VG7UCT*]+7E-[L6=_'NA@R16%5W;JTK!Y[X7>HDND1J%@NK
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M4R(0T]6"$ TD1)SYD.*(0NX'4F\%4TSE_+%)G_>Y)F5MII*#8+7YZO<1#R<
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M>#][G@\>20F>=)V5JPYVN'P;S,1S&GT\L.X>'BM9V=F%R%QQ#'J8!*G#=\N
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MTF:UC$"BRWM[4<@CY:UR:5>CS:;QJ<G[.Y*5X.]Z1UB[I[5>ZUWAA\H J"T
MM[FNR=8,S7:NJE6WF#FK0Y$]^!A ZZWD5K,MFJ6BN=(TMQ'>PV1BZ4.;2Z?5
MJOU1W=8^S.P[KKV>T4_I/NE"P7?R:R4:/;VC.@V2KI+Y]H>:9>;WNM%37H!
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M0YC::*#A [DHOE=M 2NY@@[(&KN=JO?H%C/I'I;L@?59@0<-UROX>FK_D[9
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MT3TCYWG9/@FT?&AC:O1>"JL%_WNQ4(_1F:ST:-=%)\X%H9+&)%):Y%&(:))
M[&$/QH)[L>\AB;C=;O)HT*>F<2NPX&F-=K:*71\I\8=]]QLNJDVR4X=>H[L^
M%<A6AMPM F9@_:IL.&A<T-DJK'L"64%Z=]TDTH/8H_]CY GIW2O.$H;T1]"S
M-'V1W^M:>'I'=-Z4H:>(0R\B.O9)CUN$($A#/PQ%(CA./*LZ]%L/G]IXHK%!
M77&^V5^W+#N_35KLD2B.U,1#YW:#B.,($A'&,*2<"A^'&(=JB"]JLAB8M'43
M0TXT1*4%>)UUY2'+F\-CCUU]D"MX-!LK^[(S\&BV>9O>G'N;K,>78^:Z' %V
MGC^J1A^S;%]%CU[3,SFW>G'53=]T@(!X$HNB*5;3!4+-DU3$TD<2DC@-(8IH
M"O46D?Z::8"(\'EBE4SE;&M34\(5V"[8: W7,GGV68+-/FYGM W\M>\PMH5T
M%7#I,+>U"2-.LU>?;7#<_-0FMA]DH#:ZJ9^&-&N:6[D_= 'U95GJX[,L91Z3
M,H"<:B? %Q+BR",P]9A() DD#HS.#%YN:FKJT2[C+S90[63C#*=FFN&&J8$%
MHR5I"^4,;'"Z4XO+7+B4BC.MC:H3EZW>%PF#.WKO4*PBM8X&64F44I&2 %+D
MQQ#%*(3$CT.(B;*;!JGT96"Y27&NO:EIQ1;<_= LZWV*LSP;;U6X8F_XW8I3
MQ T0TV;(B^.]BK--CKU=86+_D1T+H]MZ'JS0R<=>$?:[>NBZGE'WNGMQBJ47
M^9#%5$!$]!($I;%R1@(=N1$Q',569RE.MS4U26F@0MI@!=4:K.4!B3/<FDF)
M(\8&EI$=LC8X!Y 0 SZ<'G0XT]RX9QLNVWUPG,'@EIZ2P?_/LBL.^*6XX3S3
MJ\ED\9%D_#9_31ZSFBR.+U2_?7A<%,]"-/*UJI+]L2SN2_+P21?'KK):?!;E
M4\9$F\!:AWK<YTT+<TE\1N-4IZ8-=$"_[T$:11Q&..2$$1HG@967\T)V3$WJ
M5L:TP;W=EAC;LM92]%[H[3 4U.GW^=!BO6&@J:2^Y@!H$G2)@XZ&&3BUESH#
MZW>F]177!>\[/F9@S0CH*.D*)X M4AP."R_;JTZ'G!<R9=SA[&7[ZV"H?&$X
M?4ZGD$JO1>K_O%7-/)&%1K_>Y=6'%1>%SB#\*ZF73?9@J<:2NUS\4Y#RR[>R
M6-Y_^_*]T'^KYB$6<<Q#O<!((O5'BB%A00B9B%+!U"]\SRA*VSFRJ0V5;0AQ
M!1XZZ(!H[$#G]GI6>$'=P@?U]Z+Y!YO\E4Y[]/Q@^*+]-/22ADX,K.QJ,P1O
M6;83U[.Q3@?O=)W9& B4A4 ;!3H;@3*R^8<7ZTR;\SXOU*ECG1%Z@<ZU/&$T
M0 ></Y7DLL$13S(-P-/NZ:<A&KBR0,MM_KBLJ_=Z_S#LEH$2AE$<>"$,&2<Z
M70F%5)  R@"'7L!][,>T5[F5P[:F-I@VV$#8L\[)$2[-9H".&!IX&-NN0=("
MG8&.L &6U0PX&:0RR)'F7J;.QVF[3U;M.'-+SS" $R7@210Q&88!]'G$=97I
M&*9QE,*(4X_@A$8R979Y+!R4@A\GA\4FI?:BJ?+>/QS@!+=1RHG0JXF)"'S%
M+98P12*!"'L)99'O)8EO$V3I@-DQXBV_Z#:VD^T/PR[#L1K+2 AQ1#%$C!%(
MTS""V$^\U.<RB<PR);AD=Y1C<WO1K /1:QC(<CUI0T>Q;!+G:XBS=4#+L\,0
MEO,L.(U?.='4N,$KY^T]B%RY</E !^*J4\<5FC^^J%:5"_]1O2P?U.OSIG@@
M63Z/"8Y#$3!(4D(A"KB2%Z'<9L8D3Z(PB&)J%5,[!,BI*9*> =7/[?DF\%N+
MT;+ X"!]::9@+]U# \N?7>>X/TIV!7NC'AKK@W-:Q\.N8-KZ(-@U;?78C_A0
MU*+Z))C(GG1NN4]B06K=;JG=G=M<B9RH:GV\['/=_*(MKT+NQ9S$H>])GT"&
M8N4D^E$ "?(1%!$- C_U$)%&*R#7P9B:8C>&@')MR0QD'7J@!NK3)P%<]HS!
M)L(H? ^LORW5G[:H[LP G1UZ!:;COCWNVQH#-M:,TAT6VP"C=,M(:_Y#=H_=
MVO[5K)Y=R.__]/%6[:]F8&>)_OJGV5?E>IO7RMEZW4;E?Q*/.N5O?J\;6%;S
M*)5AQ-(0!K&:4" 41C"5C$./1P%+=&9>'YE6Z#K7T-0&FQ8KZ,""-5K0PC4O
MW766W?/#B4O.AG;8>])E5=_+A(LK:GV=??QH=;],C-RN 69T?;^UBB_B03V.
ME,_M=.S]JK#VG.@L7Y$703] *42Q2" )$8:"A)P$RGM-A-4.W:F&IB8*:YR@
MFZ :E;&WX]9L_N^"L8$EH1]9UG/Y2TRXG(^?;&O4.?4EB_?GQ1>O[Z<.;X14
M3U)S[;PN,[IL<H>I%Z#+E7*3YTNRV/YEI9R556S@JA1NA&/!]<S6DR2&2.JS
MO#1FT(M"B4,AD6^W&^( T]0T9^/B ;&*,&9;)MC)CHM.,U.HD;MB8#'KK ';
MB(&V9YWH"K0F[5Q1Z0G7.C#<887C 4AVJ9,N8(TJJ0YYW%=?EX_N+=3- <DO
MY$=S *I2/[Q6?\_J[5+/U2J=PYPE"4HBX4,/(Q\BW_,@B22!D8^8B)+$2\+$
M4I1MVI^: )_*V0)88X/EQK5M9QB+[5 4#R^L[0EKG;RZQ3YK?F[A[Y2,K_0Z
M5VN!4PGM0YUCN;2",+8T]N'GB SV>DP_R?L@OM^PIC25F@M_+(M<_<C:/2 =
M /M-[PA5M_GV-:NTSILDS,P/$Y8R"D.I,TC(%$$J)8*QA[TH"!,4R=!&!UV
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MQWA;;MN[*D[L'QFXVGDJE:EBIFSK//T )/.FO %,@&)-G%/>EDQRK?6!_+
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MRD(HB 3"D%0YAE6A"LBPK! 3$N4Y">V&<%GLV+AM+\Q(MSJV2[N=&"/>([C
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M)%4<SHA]F3(.EW$X6<?!X]:^*83+53V5*ZV.GT >_VV3IIO;]5*F#()VV51
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MA4:PXB2'F198V1F?((/"^O1$T<OK,QBTE4^C+=BJ"YR^H2Y!G#'S8Y7AQF'
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MV[O54_; K5S#$#GL[!IX?\]&K_:A.YW/E:BP*,L*%KEL\OTEK$I<060TLO]
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M94D+9:?P3-K)G%0LAY5!!!:5RDI-J6:$>$5*A4H>':]\N@,0[*J_"7A< FL
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MA)8%RWA90<Q);I?\.H><<F5_U*)04C&L@N*4P\2/C:>WVK<=:-S9>/.7'0M
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M4%EE[CA+E79\2J*A**K,NL^,YQFEE).\&Y^W<S6:T5GK,N38Z+;5T$ #@[E
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M7$+")T%TRAJ5'RY9?$@/%Z_ONYLE%[3(EZ8@*:?EJFF(EX19S*" 35G0..6
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M#C1\97X?#O\VR=\=1G;F?W==W\\#-'W3I/Q5TE*6M>N^#5>32I+8=&-G620
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M3(8G;/5)?;O#CTIT)^PZI+53E_2MBUBED-,J\N0#7=&VXB>*,8QEE 'MZF"
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MCMTM\GDFLZ5>TFSR6S9V!CN&]JW<ZF76+;>,WFPNA]YK\C>-3;FP82*9AIF
M8<JS>M'PC>JR^D2WNR"K5RG]/AYW"\V2LFR;$<^08C04- &*00X01C&@&80
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MT,Y2VYS:']'U!=(G[SGK,"H-]D7HD!5[C].S]+YDJ[M%N2K6=4QI'8/S17N
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M5MRT(#"UP@25,1&$IBF<+>0C74G+4AK]%+%ZWDG]O.^J,]SCOK'#'(^*1OM
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MLV!,_GSQ[K_LWO[GG??_(3?OYM[[GS>_O7SK:GK?&^EC^<__\S]^_9B^X%F
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MNWXU?[@$.UGR+^;S\S#[@%\7R_4D^!(B+X4BXLQH.Q.A.L (-J+*G@FR9VG
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MA)RC9=\!D&[Q\&IQ%J;SB6)<8- "O#8(RI@ +E,L51)S#)W,2C?I1'XO-9T
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M>'+,1(A,"YZ#UJ%1L?:^%(X_[Z6/ .%@K?4+QTW ?H.O(K.20F7P@==9V%Y
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MQK@7)8O?)PE]XHP\4D=1,BA=+-2>%2!#M%Q;Y6T;Q^T(FD>^GSZ)L3N52CM
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MS(K76"CI_QC^F11KE"^* [(HZ=AQ9/\H(VA6E);(,:4F]S>#4-_+0OF1H=Q
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M*$[EY* D,J35,)+(500N,17F+'.IR6S=32)>0A!XG-,[4"%GU5!X9P%0V%@
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M..W5Q(JL3O/& T&P*\;VUT@'^-JHXM]\HZ-?7^#Z5GL]77SU^UN9GZB0A*8
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M"T)ADZO9)VCJ9]'F(>I^=(O]\;(?>UOTF@_^*".9*>6XCI31!$IP?*A7RQC
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M]>^#YG!6D2,NIWEZ;DHN>32<.0<-?(W&U@!@XK0K@\DH$^K@FI1N#;R.7JY
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M+-4&>Y&V4N0F(G?&A^\FSTY]^6&Q9_9LD'41(8P*L\>LNTT9W5OJ)'LM@\$
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MI/FLX3MA KFRM#,-&=V@BG'@:XFH4CJ&K%"B;C,E\&22QZV2ZPRP1\FOTQS
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M#?..E=94IP*5*^LC&M\-I2CRI!X++F1'#J.CL-WVYO^)W_"/NZ[NA6__=<T
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MOQ<,Q;<$6.3V)Q;JN$J'5/[)=T$2SP;AJG3(WB9\PSDQ:0J&'&#2PR;1'#-
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M]5_71M_6:U8?TNAAJ&0FXG(DN51=-0R/&NUV,/M/:I7:<<_7O:JY?ST[0'E
M$\:GW5_O60*:W,"$W,F$BE\#C>M7UJ#8P#?4[+_0K3=0-W<Y\?J^Q7$X$U#.
M]:_7VU;CJ\<1"YDAS7JE\52IG57;V2 1+BFHYVZ1BZN[^_YU_^+\OG][0VZO
MR<5O_:MK<MV_.;^YZ)]_P"*LO;I[_AJ?K"C<VJSPITSIC*)X1KX8G3Y#E"D$
M-1SQZC$:43$$<AX9<I=Q+*HW:;G>.J+'A(J8U-NQOPI>C/KGFIS',K40_$)7
MU_(5:=8:1 Z(&0'Y3%5(!>CR[2.'J5MKK&G4:HWOUWHSH/T@U*KM9I)^0#YD
M$=7D2X6\S^P=3T5 (E"&#:9H(6I>OVJ?]+9HM4UC0T,.,Y43JH9,E#D,3)=F
M1O;R D<&OB24*@9E+<)IJJ$[^]);LK7M[Z^9B-'N7:MAS'3*Z;3+A-/-S;N@
MYDHMIV>#4IIX)E!>7_%U51.O5S8JM4YS>_57^_Z8@4\ZE9-Z:\?.56<0;Q2T
MM4ZI>%=JEK[S)EU=G+&]:R+*\[)0&B.37DKC&'=S?OWKN&:S K_^MF1)Y@W2
MS-H;F78;Z>.\OQ_?%7V_P'XGLB(QSK"CN,N/]#<>NIT?WJ?/_(XJE<[J\^?O
M;S;AIC4_2 OVR8B.@2@8,Y@@]9D10QX4(J.<W$$J%7*"(-=2):1>*__+$L1G
MQA]0 !J3CQ!;_0/2%U$%L;+3>[(>[DFK.EPJT+- SP(]G]FSWRC0<T\+OJ<:
M,1,!,IF2!R$G'.(A!!Y$E4?/6.*D0AHTKC"4"72?IB031F46YJ@!%_Q!6*4D
MP2O%$'@'U&[%%9$)LSZ(;[?60$ $6E,UM4T2^@!N4S\?4V-9C,+@E-Q%CO)=
M?\14E"783&!WE 3ADTQ&+!H1G=F/1?\)*,@'L0HD3'.@=CW(A)D1*JA3="KL
M[';<%$63]A["A46CA--E,Q3D4)!#00Z'!&W-@AS^*G( ,F "X=<B^0)N Q=8
MDUBMENJ9&.#>F[K0#1,1SV(<$R%]"5L#I .F^)2DB,B63"S)<+Y@BQRH]<K4
M2$BQRV$$MD7&L0%2A$0<=]-I)T]$]8@,N)SH&7\H&#)ME V/45OHY48I@R4:
MT#-AUJ0MF*!@@H()#@G'6@43[&G!^R>P^?K52:/^MJ=SK,_CS79;+0<#AI<.
M4/N$*G#0C5#,+-HAQ!+0%H&8'MGFMEF"+H5U*^PU8E7$I<ZPGW4V%"Z3:Y,J
M&4&,Q9H<(63'@!S@<7E;GJ=]!$MY'GMU[*9?Q7]L,0$707H:*?]I8;U>K[0[
M;PX+UVN59KU>X/K/!DJT4N#ZGB:\!(VR(Y2ZR,FWX3>P09V(9GKW+C:Z$@)B
M=CZ3C]?(3.$ N-4>,^TV\-@*A!O'IBT76_]E]T$!QR_($WG 9@'D0>Y:V$J&
M;@#*HB5GL3N/I+-0LYA1Q:P"S(>5G$,C[$B9MJ$>1V7:Q87<=E]J0(&,.TT0
MD)3:M<XXM5X*JN6$6(2,L(</0"W'S?!;"+8A.A+8'^+"<2@8IF"80X+'L&"8
M?4UX-:8\<S!L\1(& WN*9PP"](9XS-RQV(%6_.7F$(VC%^R(E*!]("B4F=DN
MP2[$1^>MP4:Y!M].&9!P%C]S5 G>$BB/(P([04$&!1D49' @2!859+"WN^%Q
M=AVO;4HY#^2XFHVDP.QQ3>'C_A:CB47=I72 '\MOS=&%D%&4*8O*2_OU#:,F
M4ALLMX=!<2R-%B9_9+C=QZ&/MG09(+V8T;Q9+G&$:._2X#9#[HX?>8&.O3@C
MJN=>#3H1U/$0Q,ZC<H:@6@J$U2GA[ %XGA-?:1_L;9N">XH,QL]"/2\G@]$N
MJ.>'9##<T=)XQEK!8D=O'8QEYEAL[BT%[(S&P7HH:RX:S6)FI/*>B&WC"G#(
M)&'& 'S%?0HE5<Y'B1G*YP8Y0II!;T5;;PC_VJ#:C!3ACXRA^(X ,^%^9*&/
MBW1(X9_\%"3Q8A"N2(?L;<)SSHE-4S#D )L>MHGFB &"=AYPFJ<E)D ?; 0)
M]&S[[Q,<[M#K[ #2=U%!GD'P.?,-O@"-L:.&N2NPE39"QIEQ71#[$4\#'\;2
M.B Z2Q!ST;Q.F=SWVGA4JW 3"@HH*.#0\*O(5^Q/ 6)*!@JWV@$",CCO "'=
M_7H@Q_[ QW.8&$L^!AO4$728_PA"Y0X%)"F74\#:R4AZ+X(^819D@C\EU%79
M&Y^WUZV =GY_=/R2/0=8;W0JC6;G_T/USLF<$?:&R.*)^MH3]?I5"V]I][G^
M:_7UV_>9F#F_7^U<:%+B3I.0F>Y_ZAJ\_1O6X'#L?G"W]\6(P8!<SZ'YU@>0
M#MS S_[5%T>?%$.#IVCQ-=L?K[S3:#LUKA"878 WBSOL$%\)<HF[%!>[(Q^I
M0G^R$;@7;FTE]U3ZUX!U_>&Z,2R_&VOEK5FES3UIB.B8&>CE]VMM_?5:6^WY
MY-._Z<N]<^SL?U!+ P04    "  QBF)0=&']_U8%  !D'P  &@   '-I;&LR
M,#$Y,3 M:V5X:&EB:70S,C$N:'1M[5GK<]I&$/_>OV*#IXD]@YY S"O,$) G
MM YXC%PGGSJ'=((;2SKE=!C3O[Y[)T3\2%(GX[38M<?6P.T]=G_[V\=9W1?#
MR<#_>.+!0B8QG)R]/1X-H&)8UGEM8%E#?PCO_/?'4#=M!WQ!TIQ)QE,26Y8W
MKD!E(676MJS5:F6N:B87<\L_M=16=2OF/*=F*,-*KZM&\$E)V/NE^\(P8,B#
M94)3"8&@1-(0ECE+YW >TOP"#&,S:\"SM6#SA037=FTXY^*"79)"+IF,::_<
MIVL5W[N6/J0[X^&ZUPW9);#P3861,)BU[%JS43]LUILUNUF/'+=Y&-&6VW*=
M(/C3024MG%ZLR>4ZIF\J"ZK.;M==\["1R<Z*A7+1=FS[UT[EQCQ)KZ1!8C9/
MVUI;)8YX*E$-@=L6'^_L_K55I7Q&@HNYX,LT- (><]$6\]F^VVA4RS^P3?N@
M4\CV;/W341L8$4E8O&Z_\EE"<QC3%9SRA*2OJCGZS\BI8%$Q,6=_T;;CHFWZ
MZZJP]Q#WB5E*C8W]CM-0%GM7"S9C$FJNZ=PTZMZF?1F0[P0K0'=3L>MH#;Q3
M?W0T&O3]T60\A<D1#-Z-O"/P/GB#,W_TAX=#*/9.H3\>;F1'HW%_/!CUCTO9
M[L/1O!\:)V>GT[/^V =_\F1L<IIP9D[-@0E3;Z"\#$ZM85>?C'W]*?2'DQ/?
M&\)3=%_IM);]6D6G_\Z#:?_T;7_L38W)AV/O(_0'OI*XMNU^O]4_F,X>=-F.
M9,CZ+0>T-/ZC% *>IC10_02LF%R 7%#HI^F2Q'!*,RXD\ BF++[ \T@([VG(
M A)7890&)NRKV2_WFJYK=P8\R4BZUM^<S@'@AD=<).#8QN\0<:%WCEB.JV%-
MB0":AMAS#&E DQD54'.JZ&:G5062X[P895N%IC18"FQZT'*2AN!=!0N2SBGV
M)DG"\EPIC[]J9HB-#"RHH*CU=>T*6TKE4'T(J) L6E<A6XI\2=!'DL.U?+(!
M1><3I1()>:::I.O3RTF*OWB@5I6(&4EI;DRN8KJ&?J !5/RMHIS(JEJ7K.$B
MY2NT<4Y?[C6:G1^OQPQ13&7;<%3(920,L84S8AK)=NUUMCO]S&W^E?G;+*W;
M72UO@-K2F/KHZ()158B6<;S&,$JR6/%SRUE!/RV9H*HQSG4,;0FU3S ZQ.>!
MQGYXL*7/9Z9O6;[AD-.JU0LF)CITD#BMCHJ'_RMYW,=+'I9B1DR(]C]F8$EP
M78BCF@.;O!L1)I!9F:"YXE!5B4D< RY#53"+HB!##N7536I-21JH<=PPU#=$
MG2QQUC(N*,@S*O29>4FW3=(VOXM"WY9),HMIZ8R$B#E+"^O)4O+.9D#?2(J1
M&1<A%<I7,<ERVBX_=*X56K6^<YVQ-B(9LCR+R;K-4HVZ/G=S/ZPU3+=6TU=$
MB4K*L-1G<WTTB^NC)<.[PE;3M.UOR&\LMO3VQ1&H>(Y@OJG4*N6*TON29VTW
MN]JR8<:EY(D>NB==;X-QJ:H7EM+-&!YPDVK.M8 NP';N!O0_D/G>07$SENYI
M4:7W<J]^V,GU$SR!UL!O)NX^IR+?\FK70-ZP59V%@$+.8Q9":?F#>N#P7_#
M8T']T5%[L& TP@J.U5RR2PJ3*&+8<#X#_%  [Y\(AM4NPW)W!^6#NS!;NCH\
M2'W;W5ZCTAMB:Z#O$_">B& !;E7_T_:YNC]7]_^TNA\O [RWG)OP=JGN-"3=
MV43XM.K[X\']T=&[J/!'VTO7<X7_>17^#LK/%?[G5?@?DVTYS8N7TVU!8Z*:
MLNMO;&^]RZU\>2698=9=2MK9Q(%]]Z7O5S6Y\2S>/^LWX;V_ 5!+ P04
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M3W-Z4G@?[[G.E)%\/GRB959<"6_S86GJ;,1!)3P;Q9NP'GWF^A[2$%3%!V_
M4(A,S /D,2TV#[@)]'>;:R@3&!,$0)DI$I./3B0E"$)VHXO;8,<&0IC'\^R
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M@U+S+G+M @K-[NQT7.-]5L.D70B71Q/!H]F"&<XK3@&"H] W@%ET ZA[#+5
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M@S=W?=IR33==A.MH$VP\%Q$!S8W_,+#[O7A7)!BIR$6!.PX>'MCPS<ZJL/L
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M,#$Y,3(S,5]G,BYJ<&=02P$"% ,4    "  QBF)0-YYD:T,\"@#6OPH %
M            @ '6+A< <VEL:RTR,#$Y,3(S,5]G,RYJ<&=02P$"% ,4
M"  QBF)0R,<QF=#=!@"N+@@ %               @ %+:R$ <VEL:RTR,#$Y
M,3(S,5]G-"YJ<&=02P$"% ,4    "  QBF)0MT!X$4(\  "M/0  %
M        @ %-22@ <VEL:RTR,#$Y,3(S,5]G-2YJ<&=02P$"% ,4    "  Q
MBF)0\@\29VS%"P 0TPL %               @ '!A2@ <VEL:RTR,#$Y,3(S
M,5]G-BYJ<&=02P$"% ,4    "  QBF)0C *2;_<, 0!H&P$ %
M    @ %?2S0 <VEL:RTR,#$Y,3(S,5]G-RYJ<&=02P$"% ,4    "  QBF)0
MS_UK$V+1  #C;@$ %               @ &(6#4 <VEL:RTR,#$Y,3(S,5]G
M."YJ<&=02P$"% ,4    "  QBF)0#[*CI[TN  !++P  %
M@ $<*C8 <VEL:RTR,#$Y,3(S,5]G.2YG:6902P$"% ,4    "  QBF)0?JT%
M(B(A 0#2]@L %0              @ $+638 <VEL:RTR,#$Y,3(S,5]L86(N
M>&UL4$L! A0#%     @ ,8IB4-PDJ@3$M@  -8T( !4              ( !
M8'HW '-I;&LM,C Q.3$R,S%?<')E+GAM;%!+ 0(4 Q0    ( #&*8E!JN&U*
MU@(  #@)   :              "  5<Q. !S:6QK,C Q.3$P+6ME>&AI8FET
M,C,Q+FAT;5!+ 0(4 Q0    ( #&*8E!'17>IA@@  #Y-   :
M  "  64T. !S:6QK,C Q.3$P+6ME>&AI8FET,S$Q+FAT;5!+ 0(4 Q0    (
M #&*8E!?H6>=? @  ,Y,   :              "  2,]. !S:6QK,C Q.3$P
M+6ME>&AI8FET,S$R+FAT;5!+ 0(4 Q0    ( #&*8E!T8?W_5@4  &0?   :
M              "  ==%. !S:6QK,C Q.3$P+6ME>&AI8FET,S(Q+FAT;5!+
M 0(4 Q0    ( #&*8E Z@&$PPQD  *K!   :              "  65+. !S
M:6QK,C Q.3$P+6ME>&AI8FET-#5D+FAT;5!+!08     %@ 6 ,H%  !@93@
"   !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6795084288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Advertising Costs (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdvertisingExpense', window );">Advertising expense</a></td>
<td class="nump">$ 362<span></span>
</td>
<td class="nump">$ 186<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 720<br> -SubTopic 35<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6420018&amp;loc=d3e36677-107848<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6794646928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Segment and Geographical Information (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2019 </div>
<div>segment</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments</a></td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of operating segments</a></td>
<td class="nump">1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6717918304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Balance Sheet Components (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock', window );">Fair Value of the Available-For-Sale Investments</a></td>
<td class="text"><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The fair value of the Company's available-for-sale investments as of December&#160;31, 2019 are as follows (in thousands):</span></div><div style="margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:31.974%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:16.750%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.441%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.942%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.441%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:13.224%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.441%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:14.187%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-style:italic;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:9pt;font-weight:400;font-style:italic;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="21" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 31, 2019</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gross Unrealized</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Estimated</span></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Amortized Cost&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gains&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Losses&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fair Value&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Money market funds</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">34,363&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">34,363&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Commercial paper</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9,919&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9,919&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Corporate bonds/notes</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10,180&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10,176&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">U.S. government securities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">44,450&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">44,456&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Asset-backed securities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,181&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,181&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">104,093&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">104,095&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Classified as:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">34,363&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Short-term investments</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">51,508&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Long-term investments</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">18,224&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">104,095&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByBalanceSheetGroupingTextBlock', window );">Fair Value of Cash Equivalents, Short-Term and Long-Term Equivalents</a></td>
<td class="text"><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table summarizes the fair value of the Company&#8217;s cash equivalents, short-term and long-term investments classified by maturity as of December&#160;31, 2019 (in thousands):</span></div><div style="margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:80.211%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:15.789%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-style:italic;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:9pt;font-weight:400;font-style:italic;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 31,</span></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Amounts maturing within one year</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">85,871&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Amounts maturing after one year through two years</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">18,224&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">104,095&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock', window );">Available-For-Sale Investments in Unrealized Loss Position</a></td>
<td class="text"><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table presents the Company's available-for-sale investments that were in an unrealized loss position as of December&#160;31, 2019 (in thousands):</span></div><div style="margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:62.102%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:15.467%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.441%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:15.790%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-style:italic;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:9pt;font-weight:400;font-style:italic;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-bottom:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 31, 2019</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Less than 12 months</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Assets:</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fair Value</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Unrealized Loss</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Corporate bonds/notes</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10,128&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">U.S. government securities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">19,067&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">29,195&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Schedule of Inventories</a></td>
<td class="text"><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Inventories</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Components of inventories were as follows (in thousands): </span></div><div style="text-align:center;margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:69.314%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:11.942%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.943%;"/><td style="width:1.0%;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-style:italic;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:9pt;font-weight:400;font-style:italic;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 31,</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Raw materials</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,203&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,054&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Finished products</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9,119&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,690&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10,322&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,744&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Property, Plant and Equipment</a></td>
<td class="text"><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Property and Equipment, Net</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Property and equipment, net consisted of the following (in thousands):</span></div><div style="text-align:center;margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:69.314%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:11.942%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.943%;"/><td style="width:1.0%;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-style:italic;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:9pt;font-weight:400;font-style:italic;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 31,</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Furniture and fixtures</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">657&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">517&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Equipment</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,295&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,217&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Software</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">18&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">76&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Leasehold improvements</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,991&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,978&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,961&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,788&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Less:  Accumulated depreciation and amortization</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1,550)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(946)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Add:  Construction-in-progress</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">323&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">38&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,734&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,880&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Schedule of Accrued Liabilities</a></td>
<td class="text"><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Accrued Liabilities</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Accrued liabilities consisted of the following (in thousands):</span></div><div style="text-align:center;margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:69.314%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:11.942%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.943%;"/><td style="width:1.0%;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-style:italic;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:9pt;font-weight:400;font-style:italic;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 31,</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accrued payroll and related expenses</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9,151&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,157&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Provision for sales returns</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,419&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,862&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accrued professional services</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">682&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,014&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operating lease liability</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">769&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accrued royalty expense</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">470&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">313&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Deferred revenue</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">304&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">137&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accrued travel expenses</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">431&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">270&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accrued clinical expenses</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">241&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">244&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accrued other expenses</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">567&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">451&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">15,034&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9,448&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI http://asc.fasb.org/topic&amp;trid=2196928<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByBalanceSheetGroupingTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109250915&amp;loc=d3e13467-108611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=99377789&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByBalanceSheetGroupingTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For all investments in an unrealized loss position, including those for which other-than-temporary impairments have not been recognized in earnings (including investments for which a portion of an other-than-temporary impairment has been recognized in other comprehensive income), a tabular disclosure of the aggregate related fair value of investments with unrealized losses and the aggregate amount of unrealized losses (that is, the amount by which amortized cost basis exceeds fair value).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=82897076&amp;loc=d3e27290-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6795014800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Quarterly Financial Information (unaudited)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_QuarterlyFinancialInformationDisclosureAbstract', window );"><strong>Quarterly Financial Information Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_QuarterlyFinancialInformationTextBlock', window );">Quarterly Financial Information (unaudited)</a></td>
<td class="text">Quarterly Financial Information (unaudited)<div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table provides selected unaudited quarterly financial data for the years ended December&#160;31, 2019 and 2018 (in thousands, except per share data):</span></div><div style="margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:40.467%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.441%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.262%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.441%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:13.544%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.441%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.019%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.984%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="21" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Three Months Ended</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 31, 2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 30, 2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">March 31, 2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Revenue</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">18,634&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">17,026&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">14,928&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12,766&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gross profit</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13,913&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12,856&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11,231&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9,427&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net loss</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(8,291)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(8,007)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(11,959)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(24,158)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net loss per share, basic and diluted</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.27)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.26)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.42)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(20.12)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div style="text-indent:18pt;margin-bottom:9pt;"><span><br/></span></div><div style="margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:40.788%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.441%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.621%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.441%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:14.025%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.441%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.820%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.441%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.182%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="21" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Three Months Ended</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 31, 2018</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 30, 2018</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2018</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">March 31, 2018</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Revenue</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11,470&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9,614&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7,767&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,706&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gross profit</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7,803&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6,732&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,376&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,772&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net loss</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(15,618)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(8,953)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(7,651)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(5,408)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net loss per share, basic and diluted</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(14.12)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(8.49)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(8.16)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(7.31)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_QuarterlyFinancialInformationDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_QuarterlyFinancialInformationDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_QuarterlyFinancialInformationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for quarterly financial data. Includes, but is not limited to, tabular presentation of financial information for fiscal quarters, effect of year-end adjustments, and an explanation of matters or transactions that affect comparability of the information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -URI http://asc.fasb.org/topic&amp;trid=2126967<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_QuarterlyFinancialInformationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>silk-20191231_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:silk="http://silkroadmed.com/20191231"
  xmlns:srt="http://fasb.org/srt/2018-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2018-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="silk-20191231.xsd" xlink:type="simple"/>
    <context id="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i8cac1e6fdc7c4cc1b0a6c0885ea13522_I20200228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
        </entity>
        <period>
            <instant>2020-02-28</instant>
        </period>
    </context>
    <context id="i67c494a371a04303ae82b13756a123f9_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ib1a82135571248368e03bddf4304bc01_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="i6e1fca0c7e7e4562a33eec6ef093c73f_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="i81d78a9636e34b158306cb1e7cf203a5_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="i0980ae5f9b0d4a1d8d2ded0faf7fb77e_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="i875f802c129642f1ba841126240b68a4_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="ie3817a2997b54e13adbd3f8f1650b444_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="i517a0560ef9f4f6a822a0a124dd39744_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="i24fdf32d0a37459b9db5fc564063b7f5_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i70437b3fd9084ab18848599576d75854_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i532518b8a5e649659408304a8b441189_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i078a473226e5469f8b43b5c341ea2777_I20180101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201409Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-01-01</instant>
        </period>
    </context>
    <context id="if3906640531a47a789a69ee035108cfd_I20180101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201409Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-01-01</instant>
        </period>
    </context>
    <context id="if7fa5ba84e534af1b2d35b63277a0541_I20180101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201609Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-01-01</instant>
        </period>
    </context>
    <context id="i3d970a6f053141c8adef36f595567ea2_I20180101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201609Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-01-01</instant>
        </period>
    </context>
    <context id="ibfd8d47f8c2e498f97e7e0e1de986a52_I20180101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201609Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-01-01</instant>
        </period>
    </context>
    <context id="i486e6203c31e4389a7bfae59308a9fdf_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i9c2de9078e6d4638b12de94ce89dcf8f_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ie5422de912814b909007e41dfe62434c_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i372f9742dd2f42ca8e67497abb64e072_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ide97ade70a5e4b9fb300e7cf6f1de815_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i67b8527276b74fc8b42f80e4649752f6_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i32f0795bc684401e95ede404c8ba027a_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i034315faec014251b182a3d66bbaabaa_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i0e663b10e19444c782441b76f73225f8_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i30323612426c417f9cb96084012048a3_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i128760dd6ffe4a6bbcffc708f475df73_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i0872d194a51d4edcad754b82ad9b0396_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="icc70fdca20a04c6ab43a9d230a3bb9b3_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i1ef328d4a82d454f837101558bfddfe2_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i2a50ab8679f64d4e9e5c5ef5f5850abf_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i1fa63ac295464df58c38a6649e35436f_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i4e66b2f70f744286ad2b2575bbd8de82_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i92a29de035d648249198240ca0cb4b8b_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="iec5a27c85b024faeaa754c4a163a1274_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i52088a0c6adf42bd8f967682ae5eabef_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i7462368c462e4bd490bca37af6860f56_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i183f22ec2ae24c28af10423035463332_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">silk:RedeemableConvertiblePreferredStockWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i3b88e1cc16544cd09f30471712be03e7_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">silk:RedeemableConvertiblePreferredStockWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i6392e7d9184e4e68a1862ac1a23c3c37_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">silk:CommonStockWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ief833aecb87341158807940d3631f438_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">silk:CommonStockWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i61f1ed462e8447ffab9c8334784ff07d_D20190401-20190430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-04-30</endDate>
        </period>
    </context>
    <context id="i6ed3f43f8f3b4ec3b256ad182faa9d25_I20190430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-04-30</instant>
        </period>
    </context>
    <context id="iba3487b4fc2c4dce923c5b7f62c0537c_D20190401-20190430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">silk:IPOUnderwritingDiscountsAndCommissionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-04-30</endDate>
        </period>
    </context>
    <context id="iee7e39f90c474f35b760d777c5110c8f_D20190401-20190430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">silk:IPOOtherExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-04-30</endDate>
        </period>
    </context>
    <context id="i3ff09a6410f6470c9bc375b415065a88_D20190801-20190831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">silk:SecondPublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-08-01</startDate>
            <endDate>2019-08-31</endDate>
        </period>
    </context>
    <context id="i2cf16617a08a49c5ba94c598a0c73b8e_D20190801-20190831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-08-01</startDate>
            <endDate>2019-08-31</endDate>
        </period>
    </context>
    <context id="i8c8377ba457f49a9969abe8f8a528e68_I20190831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">silk:SecondPublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-31</instant>
        </period>
    </context>
    <context id="i3f5cb6d7533a41b3ab5c731853816aeb_D20190313-20190313">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
        </entity>
        <period>
            <startDate>2019-03-13</startDate>
            <endDate>2019-03-13</endDate>
        </period>
    </context>
    <context id="i733162f186ac41fb8f9b99aa842ef13f_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">silk:CorrectionOfProvisionsForReturnsFromCustomersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="iec135774dba44b3cb207fe343988137e_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ia68f07ad6fdb42d6837b98ba4cba8d55_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i047616b3b96f40259dae391a81638613_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i5fe1f6eae7624d96b5070b1632bdf4d3_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i0f51c2607db4468eba9bb514ae0e4471_I20190101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201602Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-01-01</instant>
        </period>
    </context>
    <context id="ic94e339422444d219c38d07bb9e37715_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i2e1fe8d050bb4a7b9f6556eaab0f6abd_I20190101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201602Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-01-01</instant>
        </period>
    </context>
    <context id="i2fe97d6c47914971bb09d925222705a9_I20190101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
        </entity>
        <period>
            <instant>2019-01-01</instant>
        </period>
    </context>
    <context id="i098a8c90a714485c88e5e439c93fd1fe_D20190501-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-05-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i2658f65419d24aacb4ed4233d75211b7_D20190501-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
        </entity>
        <period>
            <startDate>2019-05-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i2a4cd45d3ea346e09975b91b19f7932f_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i9b9b073cbf81459fbce0e491293244fd_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ibd915c83c8b6404bb5a637937ffca6c6_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">silk:RedeemableConvertiblePreferredStockWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ia72cde864bbc4dc18c35b893b41f4dec_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">silk:RedeemableConvertiblePreferredStockWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i869e207d48f649aba79d5a398971f471_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ie37285cde19b46798cf9ecb3d7e8e7ce_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i41b8867a9c614370bb9151a0da07f34d_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">silk:CommonStockWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i8ca29bbf162449f8b42d0edd6cafd993_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">silk:CommonStockWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i11a85190a9064adf9756e907b72ab81e_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="iea42b3ddd43e48b7ad739160a6355912_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i8eda7181425346cbb7f781c8cd52aefd_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i3154f26e217748508ca43b15910d4ab7_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i82c527872b3d4fd290ad3917440837f9_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i515b5eafffb247339a3b64d3ae67d43b_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i7a1d59cac7d948139b04deae23e13fb8_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ib459ddf8987d4fc0a4427c93f88a000a_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i692d279131c24a49ba70cd82d78e0497_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ib7b24582c8bf49e99df758604eab3abb_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i506cf4e4add641df967ba7f06a1bfa17_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i34e6e9e2e2974a8f804997693d613758_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="iadf6d107d54849849c8bd9ee571aaf22_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="iff1b3fd1a5a741808c1bfd931652d7a4_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ia337a287632c4d2aa7cecbd25f4f1784_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ie66ece3747d34884887e66fe24d152f1_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i8de1bb3daed54738a88a86d2689b10ce_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i19e0a6db758545d68ed21b0a945cc60f_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="id10e93e4a6cc4706bff1d8eb9e0dad18_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="idcfab15292df4659a682cf4c3e009b01_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i5ffa4f8eee864a558fefbc3fc931f9eb_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="id62c0d16fbf34863a1344fb61a82dc68_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i3ff608b2639149898494a31eaf193271_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i5fae0f510baf4fbcb8ab06bb60002490_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="idd88a7fb35bc4bbfb9f94fdef50dfdef_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ib9c2e225f695462c85b06ffc0db23f77_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i49a7a83783f84c3982d721d07ccbada7_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i9beac03666384655936e1b43302c9e0d_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i2cf6f35566bc4706a43eaf580cce3381_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i751eabc279934cf590084b42a75319d8_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i682c50ee10764018a2a9d81b7a596283_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="if488b5abfdda4d3a8085d2171b9717d8_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="if244f20dd62e4eb5ac07166f1d16fcc1_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i48e873776ce54fb78ea86ee6468dd7ce_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i1c2894de35e642cab6de34c3ff5418b2_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputOptionVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i7493e1ba4b784b10bbdb551639b996d8_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i6f1f166882e84b0d80d658c2f7290c71_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i73355ec5b9114196885f43773e313806_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountForLackOfMarketabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i75704913843f46ea87de6f08f1952574_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="id719d5cbdbe541ab86698a19fee6fb0d_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i02820e2a66c44977989d03b1fffaede1_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i2f9bf5b113a1441481893ba9f910f9cf_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i507134e9c9aa43a28501de3b98f309ca_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i0d613bf9b2a14909a35df00d8a23da58_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i24c078f64bcf4a558a6eb9707a027214_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ic83cfde8eac24427a5b7c49a8127d817_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">silk:LongTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i865a5a03baaf4a64b9eb712f44655277_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i5b1c140e3f174d628388c3f67f069432_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ief7e81456214489ba291e117b1b06060_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ibf79c9f5d41a43c0bbf17c7e0f0f94d7_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i2cdfbb16655f454e85b113e66702358b_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i54b13dd93afe499f9eda02e58485e8ba_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i3eb7140b29f74c85bd43c66d2cab8f1d_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ibe305b8c4cc94fa5a038d2f95ad17a9b_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i9c7143f51286457db347c4a2163a630d_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i1ccf70059f7d4165acf299107d6c8761_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="id62906738f144d84bc9d557ddc169284_I20151031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">silk:TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2015-10-31</instant>
        </period>
    </context>
    <context id="id77e08ef6b1e4d26923913e53db9186d_I20151031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">silk:TermLoanTrancheAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2015-10-31</instant>
        </period>
    </context>
    <context id="i16c13b04e0bd4554b32d832a2eee0af3_I20151031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">silk:TermLoanTrancheBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2015-10-31</instant>
        </period>
    </context>
    <context id="i1ad5b6c72b9d43eb9409533a1389160e_I20170430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">silk:TermLoanTrancheBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-04-30</instant>
        </period>
    </context>
    <context id="i77aa0ed0241849f98e4736227590410c_I20180930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">silk:TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-09-30</instant>
        </period>
    </context>
    <context id="i96c7f06d98d442a59802339444e89dae_D20180901-20180930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">silk:TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-01</startDate>
            <endDate>2018-09-30</endDate>
        </period>
    </context>
    <context id="i54b82514b8694d3b98494d64e98b4745_I20180930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
        </entity>
        <period>
            <instant>2018-09-30</instant>
        </period>
    </context>
    <context id="i7ac0d334898e4fb1897fd7e5822858ab_D20160101-20161231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
        </entity>
        <period>
            <startDate>2016-01-01</startDate>
            <endDate>2016-12-31</endDate>
        </period>
    </context>
    <context id="i28c5cd5abfce4c7aa5c44b0f651c9ad8_D20170101-20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="i24d31e2c272041379e7662e50a4130b0_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">us-gaap:ScenarioForecastMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i4225226f93604e02af259bb86559e5b8_D20151001-20151031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2015-10-01</startDate>
            <endDate>2015-10-31</endDate>
        </period>
    </context>
    <context id="i5675339c673448139076ebcb2b762771_I20151031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2015-10-31</instant>
        </period>
    </context>
    <context id="i69a4c0c247dc496998d701bc90ebe115_I20151031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">silk:PreferredStockWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2015-10-31</instant>
        </period>
    </context>
    <context id="i6665fb41539543faa5c665e0459d1cf6_D20170701-20170731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-07-01</startDate>
            <endDate>2017-07-31</endDate>
        </period>
    </context>
    <context id="i4c8c2ee5923d47dfb022beb8e861a8c5_I20170731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-07-31</instant>
        </period>
    </context>
    <context id="i7f1961a81c2146ba86c1873951eb5d0f_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="idef65aa8bbea40b3adcc724c6f06297a_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">silk:SeriesA1PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i4afaed3dd6794f36b67d203a6ae5b570_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i12798862adb04861a6ae8feb9c091437_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i0002f1df204e4ba9aec2b7e505502fde_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i4be1e55866334204b2d9b1643c2315e7_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i85f16463983d4272b900d0242c5a7b00_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">silk:PreferredStockWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i3fd781122bcd466f8d1f4fc674767318_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">silk:PreferredStockWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="iea7780a1616443f08f0fda6ff705a8ec_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">silk:PreferredStockWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i7e4541352c2a44929295cae86c4b2a1c_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i22fe2abf909a4987bfe246f58fedaf54_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">silk:SeriesA1PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ib7e1120b4a744e978a8b7a345369d7a5_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ib86a3e190d06442abdb93108d5a238e6_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ic4860da07e274940b7dda28b5b824fd4_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">silk:IncentiveandNonqualifiedStockOptionExercisedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i447ce34fe05a46278994221dbd0e0819_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">silk:IncentiveandNonqualifiedStockOptionExercisedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i3dcad0503bdf4e5eba8e00589d3e2a59_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">silk:IncentiveandNonqualifiedStockOptionIssuedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i88bdc53e6793436cb3ebaa916528f65b_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">silk:IncentiveandNonqualifiedStockOptionIssuedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ib065e570d4804ab887f6bb6e1fec5a75_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">silk:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="idaa6eb381396400786f1ca3efdf5b014_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">silk:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i7c6d2473a2234f6fae9d4b0c9b650a4f_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">silk:CommonStockWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i1add56f0eae7469e989ed855f525f96b_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">silk:CommonStockWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="if8633988d4034e2c837d8cfec30261f2_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">silk:CommonStockWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i9b5314b8f65d48ffb39568a32e1ae70e_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">silk:TwoThousandNineteenStockOptionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i5c3d2d26b9a1456fa6a38583e15b0dee_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">silk:TwoThousandNineteenStockOptionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="id374ce4879bf48d69346a02ab7b52f9e_D20190301-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">silk:TwoThousandNineteenStockOptionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-03-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="i188f88bd74544c788b5f388916b2ffd9_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">silk:TwoThousandNineteenStockOptionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i4579105f1eae463bbc80b9182ebdface_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">silk:IncentiveStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i09b415be50aa4620acbb4b68a3d03255_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">silk:NonqualifiedStockOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ie740d91c6b54459faa35c174c4cc3dbe_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">silk:IncentiveandNonqualifiedStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:PrincipalOwnerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i0ca865b5bbab452998af805b9a59eb9a_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">silk:IncentiveandNonqualifiedStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="iaa805919be064beda12a6545c3d07fcd_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">silk:ExercisePriceOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i8d08513aaa4d42039e2e5145986ff348_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">silk:ExercisePriceOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i9168c8a79f074245b359c1eabebd2867_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">silk:ExercisePriceOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i6cf6ea883ee84acc9631ce618bef5f1c_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">silk:ExercisePriceOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i6e1de668b6f54e6f9e86b8d5f1188b44_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">silk:ExercisePriceTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="iaec558563b4843c5b260f5fe73e22f01_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">silk:ExercisePriceTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i0e5c6cb252b942de9df54fcafdb03c57_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">silk:ExercisePriceTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i8e43b208e0754e78903aecd89161bdcb_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">silk:ExercisePriceTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="iee86434ad814473fa2012397d08d7c63_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">silk:ExercisePriceThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="idb8741dc808745c1ac9cfaa8b95bf8c6_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">silk:ExercisePriceThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i580ea82051b046c086a55b23cbe96b48_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">silk:ExercisePriceThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ia1a2680b0c4640b4a319ee060427817d_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">silk:ExercisePriceThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i4a6ce09ec8ba42acab7925c328fd9e56_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">silk:ExercisePriceFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i36d7682595324850a7a7a098e56bcdd5_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">silk:ExercisePriceFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i80e1df55cd6f4ff3a796ff102aa5ac3c_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">silk:ExercisePriceFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ide54ca5d5c78499cb82e54623e321d1d_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">silk:ExercisePriceFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i7d7592590c814df5ad461b54e146b3b9_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i9e2e6766734d4127a261bbe5ec027002_D20190301-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-03-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="ib91f8a2aac654fce98f1b02f8c99f196_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i8b3d2f66951844b589a808406d5fb193_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i10afc7fc69ce46cd8b9478e8ac0d56b0_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i0804bae1f65e4f6196a788f2e067af2c_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i859497a16f11489db5d922955dbeed5d_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i8918167e82b447cfb3b692315e36731e_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i0ac3add721de4c95964529b527a87faf_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="if3367b49450540498cf774db610f6b6b_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i053d16b53cd8429ca7577e64137c4073_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ic9a24cc8c2884fee93b26726701eda19_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="id2b8c23dfe7b4a01a7eab1d91fe07c43_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i679bcaee6cf74e85907dc8a0359cf4fd_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i7a5998ad299245269f1d4f24167005aa_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i67c3f66fec9c4c4387a07595b56bd76b_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="if8375b4a63c74b3f9a8c71549841fb7e_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i7a626cb9bbb248679c22a7a00441bdd3_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i43fdc98e9d1c4ea183dc2c37ade70da5_I20141231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">silk:NeuroCoIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2014-12-31</instant>
        </period>
    </context>
    <context id="ic91bbe5141184edf9c4a395e69721932_D20140101-20141231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">silk:NeuroCoIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2014-01-01</startDate>
            <endDate>2014-12-31</endDate>
        </period>
    </context>
    <context id="i0e7714d1fef74572b8628cbea233e040_D20150101-20151231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">silk:NeuroCoIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2015-01-01</startDate>
            <endDate>2015-12-31</endDate>
        </period>
    </context>
    <context id="iaf615eabb3f14a45afa67326aa12db72_I20181217">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">silk:NeuroCoIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-17</instant>
        </period>
    </context>
    <context id="if64e9115ac9b48a7b91422658f25ee6d_D20181217-20181217">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">silk:NeuroCoIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-17</startDate>
            <endDate>2018-12-17</endDate>
        </period>
    </context>
    <context id="i129f46ce6e8d4fa98d362bb8455a8c28_I20181217">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
        </entity>
        <period>
            <instant>2018-12-17</instant>
        </period>
    </context>
    <context id="ie7d5bfb4355c4753b62069b31a28328b_D20200101-20200101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-01-01</endDate>
        </period>
    </context>
    <context id="if8352f2dec42436aa6815358749e14c2_I20200131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">silk:TwoThousandNineteenStockOptionPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-01-31</instant>
        </period>
    </context>
    <context id="i8e407444496e48f09abc6f0747a028bc_D20200201-20200229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">silk:TwoThousandNineteenStockOptionPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-02-01</startDate>
            <endDate>2020-02-29</endDate>
        </period>
    </context>
    <context id="i36441150a0d742e990ee101edcbe8518_I20200131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-01-31</instant>
        </period>
    </context>
    <context id="i4e27136927b743769274f523ec2a41e7_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="icd407c3335324384be91497048cf5f08_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i88f7bdc9a6e24592abadfd8d6f1e1bc0_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ie6ccdb76509c4f75a0d36602c75f6151_D20190101-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="i3efe8595a2ad4f2991c93a7d62cff16f_D20181001-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
        </entity>
        <period>
            <startDate>2018-10-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i93f9aed079644f15b2c34904c4aaa35c_D20180701-20180930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2018-09-30</endDate>
        </period>
    </context>
    <context id="if2a4604d433c48d698f29d76aa7a770b_D20180401-20180630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
        </entity>
        <period>
            <startDate>2018-04-01</startDate>
            <endDate>2018-06-30</endDate>
        </period>
    </context>
    <context id="i4209466b8e53444e9359f5893b730654_D20180101-20180331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001397702</identifier>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-03-31</endDate>
        </period>
    </context>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="segment">
        <measure>silk:segment</measure>
    </unit>
    <unit id="vote">
        <measure>silk:vote</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV80L2ZyYWc6ZTRhZmI2YzM3MzZhNDRkODljY2JhMTMzYmFhOTQyOTIvdGFibGU6Mjc2Mzc0YzUyZGY3NDAxZDg0M2RkNWNjNWZiNDI1MDMvdGFibGVyYW5nZToyNzYzNzRjNTJkZjc0MDFkODQzZGQ1Y2M1ZmI0MjUwM18zLTEtMS0xLTA_be9a71d2-90c2-4465-9140-16e0df67110e">0001397702</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV80L2ZyYWc6ZTRhZmI2YzM3MzZhNDRkODljY2JhMTMzYmFhOTQyOTIvdGFibGU6Mjc2Mzc0YzUyZGY3NDAxZDg0M2RkNWNjNWZiNDI1MDMvdGFibGVyYW5nZToyNzYzNzRjNTJkZjc0MDFkODQzZGQ1Y2M1ZmI0MjUwM180LTEtMS0xLTE1OA_90c54837-2187-4928-9c3f-4c7b3b2e61d7">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV80L2ZyYWc6ZTRhZmI2YzM3MzZhNDRkODljY2JhMTMzYmFhOTQyOTIvdGFibGU6Mjc2Mzc0YzUyZGY3NDAxZDg0M2RkNWNjNWZiNDI1MDMvdGFibGVyYW5nZToyNzYzNzRjNTJkZjc0MDFkODQzZGQ1Y2M1ZmI0MjUwM18xMS0xLTEtMS0xNjA_55e66505-c609-47ff-8b28-f7567dfb7011">2019</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV80L2ZyYWc6ZTRhZmI2YzM3MzZhNDRkODljY2JhMTMzYmFhOTQyOTIvdGFibGU6Mjc2Mzc0YzUyZGY3NDAxZDg0M2RkNWNjNWZiNDI1MDMvdGFibGVyYW5nZToyNzYzNzRjNTJkZjc0MDFkODQzZGQ1Y2M1ZmI0MjUwM18xMi0xLTEtMS0xNjA_ac724f30-9e7e-483a-a1d8-b3316db3c011">FY</dei:DocumentFiscalPeriodFocus>
    <dei:AmendmentFlag
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV80L2ZyYWc6ZTRhZmI2YzM3MzZhNDRkODljY2JhMTMzYmFhOTQyOTIvdGFibGU6Mjc2Mzc0YzUyZGY3NDAxZDg0M2RkNWNjNWZiNDI1MDMvdGFibGVyYW5nZToyNzYzNzRjNTJkZjc0MDFkODQzZGQ1Y2M1ZmI0MjUwM18xMy0xLTEtMS0w_72aa21f6-d268-41f0-be53-adf55b3bc62f">false</dei:AmendmentFlag>
    <us-gaap:StockholdersEquityNoteStockSplitConversionRatio1
      contextRef="i3f5cb6d7533a41b3ab5c731853816aeb_D20190313-20190313"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8zNTc3L2ZyYWc6YWNhNWQwOTYwNjFiNDAzYTlkM2U3MzRhMGVlMWY2NDkvdGV4dHJlZ2lvbjphY2E1ZDA5NjA2MWI0MDNhOWQzZTczNGEwZWUxZjY0OV8yMTk5MDIzMjU1NTk0_566543a4-ec2d-4104-a87d-ee131c0a5b8e"
      unitRef="number">0.3704</us-gaap:StockholdersEquityNoteStockSplitConversionRatio1>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i047616b3b96f40259dae391a81638613_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90ZXh0cmVnaW9uOjZmZWQwNzhkNzVjYTQ1NWU4OTcyY2RkYjU1Nzc0NWRkXzMyOTg1MzQ5NDkxMTE_2fc458bb-3e66-4101-b8da-1c4fb228a229">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i5fe1f6eae7624d96b5070b1632bdf4d3_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90ZXh0cmVnaW9uOjZmZWQwNzhkNzVjYTQ1NWU4OTcyY2RkYjU1Nzc0NWRkXzMyOTg1MzQ5NDkxMTU_fb1b7f55-5035-426c-9941-0c64a4cba092">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <dei:DocumentType
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xL2ZyYWc6ZDc4MGVjNWIyZWRlNDg0ZmFlMzU5ODlmOGEzYWY0MjYvdGV4dHJlZ2lvbjpkNzgwZWM1YjJlZGU0ODRmYWUzNTk4OWY4YTNhZjQyNl8yMTk5MDIzMjU5Mzcy_e865568b-a7eb-409c-844d-8ef36e9b35ae">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xL2ZyYWc6ZDc4MGVjNWIyZWRlNDg0ZmFlMzU5ODlmOGEzYWY0MjYvdGFibGU6NWYwMWE1ZmE1NDk2NGQ0OTk2YWY1NDcxY2I0MzExODAvdGFibGVyYW5nZTo1ZjAxYTVmYTU0OTY0ZDQ5OTZhZjU0NzFjYjQzMTE4MF8wLTAtMS0xLTI5_1fdd0a1a-88b4-4458-bd57-87754fe0f458">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xL2ZyYWc6ZDc4MGVjNWIyZWRlNDg0ZmFlMzU5ODlmOGEzYWY0MjYvdGV4dHJlZ2lvbjpkNzgwZWM1YjJlZGU0ODRmYWUzNTk4OWY4YTNhZjQyNl8yMTk5MDIzMjU5Mzc4_09297cd7-b6b9-4a8d-8729-bfe3fd1d5653">2019-12-31</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xL2ZyYWc6ZDc4MGVjNWIyZWRlNDg0ZmFlMzU5ODlmOGEzYWY0MjYvdGFibGU6ODFlOTg2ODc3YjIxNDY3ZGFmYTQ0MDYxZmNiOWU4MmUvdGFibGVyYW5nZTo4MWU5ODY4NzdiMjE0NjdkYWZhNDQwNjFmY2I5ZTgyZV8wLTAtMS0xLTMx_1d8d38ae-6f2e-4caf-9bec-c8ce199d3468">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xL2ZyYWc6ZDc4MGVjNWIyZWRlNDg0ZmFlMzU5ODlmOGEzYWY0MjYvdGV4dHJlZ2lvbjpkNzgwZWM1YjJlZGU0ODRmYWUzNTk4OWY4YTNhZjQyNl8yMTk5MDIzMjU5Mzk2_9e18b081-9f3b-4e13-8733-0720b1565d33">001-38847</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xL2ZyYWc6ZDc4MGVjNWIyZWRlNDg0ZmFlMzU5ODlmOGEzYWY0MjYvdGV4dHJlZ2lvbjpkNzgwZWM1YjJlZGU0ODRmYWUzNTk4OWY4YTNhZjQyNl8yMTk5MDIzMjU5Mzk4_90daeb3d-2f74-47ff-a3b9-0389bb80861d">SILK ROAD MEDICAL, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xL2ZyYWc6ZDc4MGVjNWIyZWRlNDg0ZmFlMzU5ODlmOGEzYWY0MjYvdGFibGU6YWM3MDE2Mjk5ZWY3NDc0ZGJjY2MwZmM2ZmM4ZWNkYTkvdGFibGVyYW5nZTphYzcwMTYyOTllZjc0NzRkYmNjYzBmYzZmYzhlY2RhOV8wLTAtMS0xLTUw_37377075-47e1-46b5-aafa-7f80d558b493">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xL2ZyYWc6ZDc4MGVjNWIyZWRlNDg0ZmFlMzU5ODlmOGEzYWY0MjYvdGFibGU6YWM3MDE2Mjk5ZWY3NDc0ZGJjY2MwZmM2ZmM4ZWNkYTkvdGFibGVyYW5nZTphYzcwMTYyOTllZjc0NzRkYmNjYzBmYzZmYzhlY2RhOV8wLTItMS0xLTUz_d8c63871-000a-48ea-86ab-e43ce3c70f7f">20-8777622</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xL2ZyYWc6ZDc4MGVjNWIyZWRlNDg0ZmFlMzU5ODlmOGEzYWY0MjYvdGV4dHJlZ2lvbjpkNzgwZWM1YjJlZGU0ODRmYWUzNTk4OWY4YTNhZjQyNl8yMTk5MDIzMjU5NDIz_fbf61baf-ba58-45a4-bb8c-c415b80efef5">1213 Innsbruck Dr.</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xL2ZyYWc6ZDc4MGVjNWIyZWRlNDg0ZmFlMzU5ODlmOGEzYWY0MjYvdGV4dHJlZ2lvbjpkNzgwZWM1YjJlZGU0ODRmYWUzNTk4OWY4YTNhZjQyNl8yMTk5MDIzMjU5NDQz_99cc0b41-a791-46c4-996a-d9bcd21a5bdd">Sunnyvale</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xL2ZyYWc6ZDc4MGVjNWIyZWRlNDg0ZmFlMzU5ODlmOGEzYWY0MjYvdGV4dHJlZ2lvbjpkNzgwZWM1YjJlZGU0ODRmYWUzNTk4OWY4YTNhZjQyNl8yMTk5MDIzMjU5NDU0_c6d28b3e-9a7a-4c7d-86b8-8473fd94f66c">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xL2ZyYWc6ZDc4MGVjNWIyZWRlNDg0ZmFlMzU5ODlmOGEzYWY0MjYvdGV4dHJlZ2lvbjpkNzgwZWM1YjJlZGU0ODRmYWUzNTk4OWY4YTNhZjQyNl8yMTk5MDIzMjU5NDU4_259482e4-bc64-4e5d-a610-959ec0dcc533">94089</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xL2ZyYWc6ZDc4MGVjNWIyZWRlNDg0ZmFlMzU5ODlmOGEzYWY0MjYvdGV4dHJlZ2lvbjpkNzgwZWM1YjJlZGU0ODRmYWUzNTk4OWY4YTNhZjQyNl8yMTk5MDIzMjU5NDY1_b3d8e34f-121b-4111-ae36-2889a1372f2a">408</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xL2ZyYWc6ZDc4MGVjNWIyZWRlNDg0ZmFlMzU5ODlmOGEzYWY0MjYvdGV4dHJlZ2lvbjpkNzgwZWM1YjJlZGU0ODRmYWUzNTk4OWY4YTNhZjQyNl8yMTk5MDIzMjU5NDcw_ccbd7f36-0e21-4d2e-9957-14f0c8208a5f">720-9002</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xL2ZyYWc6ZDc4MGVjNWIyZWRlNDg0ZmFlMzU5ODlmOGEzYWY0MjYvdGFibGU6ZmIyMGU1MTQzOGNlNDExZGI3NTgyYWVjNWYzNjRhYjcvdGFibGVyYW5nZTpmYjIwZTUxNDM4Y2U0MTFkYjc1ODJhZWM1ZjM2NGFiN18xLTAtMS0xLTg5_bf900797-f1f8-42a3-95da-eedbc0921764">Common Stock</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xL2ZyYWc6ZDc4MGVjNWIyZWRlNDg0ZmFlMzU5ODlmOGEzYWY0MjYvdGFibGU6ZmIyMGU1MTQzOGNlNDExZGI3NTgyYWVjNWYzNjRhYjcvdGFibGVyYW5nZTpmYjIwZTUxNDM4Y2U0MTFkYjc1ODJhZWM1ZjM2NGFiN18xLTEtMS0xLTg5_ab16aa04-c7f4-4636-a0ee-9c454147a304">SILK</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xL2ZyYWc6ZDc4MGVjNWIyZWRlNDg0ZmFlMzU5ODlmOGEzYWY0MjYvdGFibGU6ZmIyMGU1MTQzOGNlNDExZGI3NTgyYWVjNWYzNjRhYjcvdGFibGVyYW5nZTpmYjIwZTUxNDM4Y2U0MTFkYjc1ODJhZWM1ZjM2NGFiN18xLTItMS0xLTg5_ec205080-a0e7-450e-ac66-c958afc0669c">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xL2ZyYWc6ZDc4MGVjNWIyZWRlNDg0ZmFlMzU5ODlmOGEzYWY0MjYvdGV4dHJlZ2lvbjpkNzgwZWM1YjJlZGU0ODRmYWUzNTk4OWY4YTNhZjQyNl8yMTk5MDIzMjU5NDgw_8fda091a-320c-4131-8110-d2e364e2b86c">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xL2ZyYWc6ZDc4MGVjNWIyZWRlNDg0ZmFlMzU5ODlmOGEzYWY0MjYvdGV4dHJlZ2lvbjpkNzgwZWM1YjJlZGU0ODRmYWUzNTk4OWY4YTNhZjQyNl8yMTk5MDIzMjU5NDg0_d9a9ec7e-0977-45bd-b420-1d364d9d9831">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xL2ZyYWc6ZDc4MGVjNWIyZWRlNDg0ZmFlMzU5ODlmOGEzYWY0MjYvdGV4dHJlZ2lvbjpkNzgwZWM1YjJlZGU0ODRmYWUzNTk4OWY4YTNhZjQyNl8yMTk5MDIzMjU5NDg4_c050a95e-b55f-477e-9d7c-62da049824af">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xL2ZyYWc6ZDc4MGVjNWIyZWRlNDg0ZmFlMzU5ODlmOGEzYWY0MjYvdGV4dHJlZ2lvbjpkNzgwZWM1YjJlZGU0ODRmYWUzNTk4OWY4YTNhZjQyNl8yMTk5MDIzMjU5NDkz_bc3eae4e-cb48-4024-86a9-fc3e6ccdc916">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xL2ZyYWc6ZDc4MGVjNWIyZWRlNDg0ZmFlMzU5ODlmOGEzYWY0MjYvdGFibGU6Y2E2N2IxOGMxNWFkNGExN2EzYjYwNWMzYjg2ZmY1NjUvdGFibGVyYW5nZTpjYTY3YjE4YzE1YWQ0YTE3YTNiNjA1YzNiODZmZjU2NV8xLTAtMS0xLTEyNQ_fa8c3c15-174a-4318-9f77-f402fb1e87d4">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xL2ZyYWc6ZDc4MGVjNWIyZWRlNDg0ZmFlMzU5ODlmOGEzYWY0MjYvdGFibGU6Y2E2N2IxOGMxNWFkNGExN2EzYjYwNWMzYjg2ZmY1NjUvdGFibGVyYW5nZTpjYTY3YjE4YzE1YWQ0YTE3YTNiNjA1YzNiODZmZjU2NV8xLTQtMS0xLTEyOQ_1a4e2b99-d8e6-4597-995c-a3d0a9459ba2">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xL2ZyYWc6ZDc4MGVjNWIyZWRlNDg0ZmFlMzU5ODlmOGEzYWY0MjYvdGFibGU6Y2E2N2IxOGMxNWFkNGExN2EzYjYwNWMzYjg2ZmY1NjUvdGFibGVyYW5nZTpjYTY3YjE4YzE1YWQ0YTE3YTNiNjA1YzNiODZmZjU2NV8yLTEtMS0xLTEyNw_63a35599-3d7a-4e0d-aefd-3ebeea3e1a9c">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xL2ZyYWc6ZDc4MGVjNWIyZWRlNDg0ZmFlMzU5ODlmOGEzYWY0MjYvdGV4dHJlZ2lvbjpkNzgwZWM1YjJlZGU0ODRmYWUzNTk4OWY4YTNhZjQyNl8yMTk5MDIzMjU5NDk4_256e50f3-ef31-4f96-82db-db84c6af46b1">true</dei:EntityExTransitionPeriod>
    <dei:EntityShellCompany
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xL2ZyYWc6ZDc4MGVjNWIyZWRlNDg0ZmFlMzU5ODlmOGEzYWY0MjYvdGV4dHJlZ2lvbjpkNzgwZWM1YjJlZGU0ODRmYWUzNTk4OWY4YTNhZjQyNl8yMTk5MDIzMjU5NTAx_284cee9b-ff2d-4997-9660-43a5935af3fb">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat
      contextRef="i8cac1e6fdc7c4cc1b0a6c0885ea13522_I20200228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xL2ZyYWc6ZDc4MGVjNWIyZWRlNDg0ZmFlMzU5ODlmOGEzYWY0MjYvdGV4dHJlZ2lvbjpkNzgwZWM1YjJlZGU0ODRmYWUzNTk4OWY4YTNhZjQyNl8yMTk5MDIzMjYwMzky_8968b99f-da47-4f0b-af81-f2ba38864d0e"
      unitRef="usd">818000000.0</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i8cac1e6fdc7c4cc1b0a6c0885ea13522_I20200228"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xL2ZyYWc6ZDc4MGVjNWIyZWRlNDg0ZmFlMzU5ODlmOGEzYWY0MjYvdGV4dHJlZ2lvbjpkNzgwZWM1YjJlZGU0ODRmYWUzNTk4OWY4YTNhZjQyNl8yMTk5MDIzMjU5NTA0_a129f2c6-a2b3-4d72-9f34-0dfd7b07edf7"
      unitRef="shares">31353906</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfNS0xLTEtMS0w_9c876782-73e6-45e3-b2ef-70ae67a508d0"
      unitRef="usd">39181000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfNS0zLTEtMS0w_562024b5-9657-4db7-a56e-a46e73697340"
      unitRef="usd">24990000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:ShortTermInvestments
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfNi0xLTEtMS02MDk_be4ac000-4a6c-47c9-ae94-5a722ef4d8f8"
      unitRef="usd">51508000</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments
      contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfNi0zLTEtMS02MDk_4bb54916-88b4-4cbc-a4ec-a72e6f2ebbfc"
      unitRef="usd">0</us-gaap:ShortTermInvestments>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfNi0wLTEtMS0wL3RleHRyZWdpb246OWYwY2VmNWZmZmRlNDA3YzgwZDMzYjQzN2NlZjY4YmZfMzI5ODUzNDg4MzQ0MQ_acd0916a-148b-42f1-ab43-d462d2293fe6"
      unitRef="usd">45000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfNi0wLTEtMS0wL3RleHRyZWdpb246OWYwY2VmNWZmZmRlNDA3YzgwZDMzYjQzN2NlZjY4YmZfMzI5ODUzNDg4MzQ0OQ_05b41582-8867-4567-be18-130711ae7dd4"
      unitRef="usd">22000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfNi0xLTEtMS0w_4856396b-0067-433e-9506-712154864668"
      unitRef="usd">8601000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfNi0zLTEtMS0w_477bcedd-04d3-4553-805b-f165252a99c0"
      unitRef="usd">6382000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfNy0xLTEtMS0w_6a25fb60-4c33-41e6-8729-7a8637464921"
      unitRef="usd">10322000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfNy0zLTEtMS0w_f8022f46-7e15-4f50-b4be-b7ee07ad409d"
      unitRef="usd">5744000</us-gaap:InventoryNet>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfOC0xLTEtMS0w_1e4d1333-ed50-43d8-8e8d-bddc13925611"
      unitRef="usd">2878000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfOC0zLTEtMS0w_3e00aacb-5cd6-4890-9f42-5a383b15e1e0"
      unitRef="usd">1408000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfOS0xLTEtMS0w_0e0f83bf-26bc-45c4-a38b-0bda8a80d7fe"
      unitRef="usd">112490000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfOS0zLTEtMS0w_dd9e78e0-5783-4df0-b729-9f7f4e0501f4"
      unitRef="usd">38524000</us-gaap:AssetsCurrent>
    <us-gaap:LongTermInvestments
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMTEtMS0xLTEtMTE1NA_a276d77e-7277-4cba-90a0-7fbfa602918f"
      unitRef="usd">18224000</us-gaap:LongTermInvestments>
    <us-gaap:LongTermInvestments
      contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMTEtMy0xLTEtMTE1NA_6555c30b-0d7a-43ac-904e-8a530e38766f"
      unitRef="usd">0</us-gaap:LongTermInvestments>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMTAtMS0xLTEtMA_1a9d05cc-588c-49a3-8793-5b6dc94dd43d"
      unitRef="usd">2734000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMTAtMy0xLTEtMA_528535af-cfb9-433a-ac5a-da8aecb0f0bc"
      unitRef="usd">2880000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMTEtMS0xLTEtMA_31b6edc5-60c3-42f3-aa9c-fa7381aa93ff"
      unitRef="usd">310000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMTEtMy0xLTEtMA_06d97578-eb39-42eb-8563-390d9c042f34"
      unitRef="usd">310000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMTItMS0xLTEtMA_7cf8b81e-20cf-46c1-9286-a82c93bd5b78"
      unitRef="usd">3644000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMTItMy0xLTEtMA_e417b86c-4589-455c-98c9-8a82047c64d7"
      unitRef="usd">1029000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMTMtMS0xLTEtMA_e2e1c96b-a28f-4a7e-814c-bb39faea3e81"
      unitRef="usd">137402000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMTMtMy0xLTEtMA_8397a049-c38f-45e2-8afa-bb6f7557c344"
      unitRef="usd">42743000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMTctMS0xLTEtMA_afd98cd1-2ae4-4fc6-bef7-3931d8e005d8"
      unitRef="usd">1898000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMTctMy0xLTEtMA_e04c677c-4255-4d38-a216-fc381e47e85c"
      unitRef="usd">1252000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMTgtMS0xLTEtMA_7a2afc73-95d9-42fb-8cfa-5fae835e6f6d"
      unitRef="usd">15034000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMTgtMy0xLTEtMA_14b74377-216e-4c05-bc5a-913784c09518"
      unitRef="usd">9448000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMTktMS0xLTEtMA_fb365d77-bb1a-491e-a80b-c11c513a853d"
      unitRef="usd">16932000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMTktMy0xLTEtMA_7763a787-270f-4fcb-bd68-f5535bdd6e97"
      unitRef="usd">10700000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMjAtMS0xLTEtMA_c202f47d-5518-4923-8be0-157a501ad1ae"
      unitRef="usd">44879000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMjAtMy0xLTEtMA_4c1a8fca-8ffa-4c6c-8514-eb08de244866"
      unitRef="usd">44201000</us-gaap:LongTermDebtNoncurrent>
    <silk:PreferredStockWarrantLiability
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMjEtMS0xLTEtMA_9f2585e3-4d02-4393-bd68-0754c4fcd1ff"
      unitRef="usd">0</silk:PreferredStockWarrantLiability>
    <silk:PreferredStockWarrantLiability
      contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMjEtMy0xLTEtMA_f3220c4d-51be-44df-a463-4561f4b1bf03"
      unitRef="usd">16091000</silk:PreferredStockWarrantLiability>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMjItMS0xLTEtMA_2dcd1bb2-200b-4f03-9fb1-ac4152f91bee"
      unitRef="usd">3700000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMjItMy0xLTEtMA_18e27628-6f84-46b1-a775-ce1d67748285"
      unitRef="usd">1069000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMjMtMS0xLTEtMA_ea92731d-c8f3-4974-9e89-d98445621654"
      unitRef="usd">65511000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMjMtMy0xLTEtMA_32d1ee30-2b38-4ef3-8191-71051ffef3d2"
      unitRef="usd">72061000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMjUtMS0xLTEtMA_fa87819c-8d30-492a-98b1-8aa02da5425e"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMjUtMy0xLTEtMA_702de309-f8b5-4943-a906-541399c2d4fe"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMjctMC0xLTEtMC90ZXh0cmVnaW9uOjhkMGE1MjU3OWQzNTRkNjBhMTMyYTIwYTAyYmQ5ZjY5XzMyOTg1MzQ4ODM0MTQ_ec3d9f5a-d8c2-457f-b3ab-b0aa898e7d17"
      unitRef="usdPerShare">0.001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMjctMC0xLTEtMC90ZXh0cmVnaW9uOjhkMGE1MjU3OWQzNTRkNjBhMTMyYTIwYTAyYmQ5ZjY5XzMyOTg1MzQ4ODM0MTQ_f0b1775d-2bdd-4232-a60e-895d53dd2f44"
      unitRef="usdPerShare">0.001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMjgtMC0xLTEtMC90ZXh0cmVnaW9uOjY5M2UzNGI4MzI5NTQxZjhiNTExZmM2NGVkYmJhNWJmXzI3NDg3NzkwNjk1NDI_283e5154-4331-43cc-bb7c-9a64d9d3135b"
      unitRef="shares">0</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMjgtMC0xLTEtMC90ZXh0cmVnaW9uOjY5M2UzNGI4MzI5NTQxZjhiNTExZmM2NGVkYmJhNWJmXzY1OTcwNjk3NjY3NTI_9af0d346-febe-4012-b221-627d41448aea"
      unitRef="shares">24069615</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMjktMC0xLTEtMC90ZXh0cmVnaW9uOjk3MmI1YmVhYTA2MzQ0ZjQ4MWQ2YTFhZmM2ZjNlZTQ4XzI3NDg3NzkwNjk1NTQ_49765644-1198-4e6e-aae8-d5dfe7f714c9"
      unitRef="shares">0</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMjktMC0xLTEtMC90ZXh0cmVnaW9uOjk3MmI1YmVhYTA2MzQ0ZjQ4MWQ2YTFhZmM2ZjNlZTQ4XzI3NDg3NzkwNjk1NTQ_d496093a-a22d-42e9-acbd-5d582f390844"
      unitRef="shares">0</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMjktMC0xLTEtMC90ZXh0cmVnaW9uOjk3MmI1YmVhYTA2MzQ0ZjQ4MWQ2YTFhZmM2ZjNlZTQ4XzMyOTg1MzQ4ODM0MzY_697c984d-21c2-4869-830d-1900e8ffb674"
      unitRef="shares">21233190</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMjktMC0xLTEtMC90ZXh0cmVnaW9uOjk3MmI1YmVhYTA2MzQ0ZjQ4MWQ2YTFhZmM2ZjNlZTQ4XzMyOTg1MzQ4ODM0MzY_881c0137-70c4-46c4-aa2b-11850ac851dd"
      unitRef="shares">21233190</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquityLiquidationPreference
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMzAtMC0xLTEtMC90ZXh0cmVnaW9uOjExYzM0ZTdkMzVjODQ4MjdiMDNmMWQ0NTdmODA2Y2MwXzI3NDg3NzkwNjk1NDM_43339976-67fd-4d57-b3c9-b6be6f635bf6"
      unitRef="usd">0</us-gaap:TemporaryEquityLiquidationPreference>
    <us-gaap:TemporaryEquityLiquidationPreference
      contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMzAtMC0xLTEtMC90ZXh0cmVnaW9uOjExYzM0ZTdkMzVjODQ4MjdiMDNmMWQ0NTdmODA2Y2MwXzMyOTg1MzQ4ODM0MjU_30dc7539-a692-48ea-965e-0e72d01c037b"
      unitRef="usd">121144000</us-gaap:TemporaryEquityLiquidationPreference>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMzAtMS0xLTEtMA_ac48c241-bf65-4a4b-b904-79696899d778"
      unitRef="usd">0</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMzAtMy0xLTEtMA_3484ab93-5e99-4512-b71c-97a3d5c2e446"
      unitRef="usd">105235000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMzQtMC0xLTEtNjY5L3RleHRyZWdpb246YWQzYmQwMmRhNTk0NGEzYTg4ZGYzYzc2MWZhMjg5ZWZfMzI5ODUzNDg4MzM3Mg_472f89fe-be9e-4d5a-8a7b-daf8e2fc32c2"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMzQtMC0xLTEtNjY5L3RleHRyZWdpb246YWQzYmQwMmRhNTk0NGEzYTg4ZGYzYzc2MWZhMjg5ZWZfMzI5ODUzNDg4MzM3Mg_5d50563f-bfbf-42c0-96b8-226f165dd5cc"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMzUtMC0xLTEtNzA0L3RleHRyZWdpb246NDFjMzdhNmU4YjU2NGE0MjlmZTg5NGUxMDRhNWQ1MzRfMzI5ODUzNDg4MzQyMw_25e2c3a3-1c71-4293-a72f-6eb603cddca9"
      unitRef="shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMzUtMC0xLTEtNzA0L3RleHRyZWdpb246NDFjMzdhNmU4YjU2NGE0MjlmZTg5NGUxMDRhNWQ1MzRfMjc0ODc3OTA2OTY5MQ_7445b496-5c93-4330-b03e-9c191f037b74"
      unitRef="shares">0</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMzYtMC0xLTEtNzA4L3RleHRyZWdpb246MmQ4ODk0ODk5Y2FjNDBjOGI3N2JiYjM0ZWExOTk2MDVfMjc0ODc3OTA2OTUxMw_1918c77c-8c9e-4a49-8ec4-720b5147d16f"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMzYtMC0xLTEtNzA4L3RleHRyZWdpb246MmQ4ODk0ODk5Y2FjNDBjOGI3N2JiYjM0ZWExOTk2MDVfMjc0ODc3OTA2OTUxMw_248d08f4-d922-4ad5-b37e-b920e0b3b1ed"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMzYtMC0xLTEtNzA4L3RleHRyZWdpb246MmQ4ODk0ODk5Y2FjNDBjOGI3N2JiYjM0ZWExOTk2MDVfMjc0ODc3OTA2OTUxMw_531f3faa-c504-4405-b860-74a824ab81cc"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMzYtMC0xLTEtNzA4L3RleHRyZWdpb246MmQ4ODk0ODk5Y2FjNDBjOGI3N2JiYjM0ZWExOTk2MDVfMjc0ODc3OTA2OTUxMw_6c878701-ddb9-4aea-bf7e-a768834e0ca4"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockValue
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMzYtMS0xLTEtNzUy_f757541e-cfb8-4cb7-8d72-d3f0ec27c4fa"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMzYtMy0xLTEtNzUy_4f12ec19-fef3-4dc1-8d75-255af41a45fd"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOjVlNDE5MzI3ZjExOTRhNDRiOTIwMGQ1Mjg2M2MzMTJiXzMyOTg1MzQ4ODMzNjk_d8127b1c-92c8-453c-a3bd-66207ff909e5"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOjVlNDE5MzI3ZjExOTRhNDRiOTIwMGQ1Mjg2M2MzMTJiXzMyOTg1MzQ4ODMzNjk_e5e38ca6-18d6-423c-a8cc-002cd4e86159"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOjUyOGJkMGE4YTc0YzRiNzNiZjY4YzZiMjM4M2RlNDg0XzMyOTg1MzQ4ODM0MzI_9434ab46-6fbe-43d6-a298-aa9d225e592c"
      unitRef="shares">100000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOjUyOGJkMGE4YTc0YzRiNzNiZjY4YzZiMjM4M2RlNDg0XzMyOTg1MzQ4ODM0NDM_4863ad7c-ed7c-43f1-95c3-48413d662da8"
      unitRef="shares">29879220</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOjQ0NzU4MmY1ZTNhOTRlNzI4OTMxYTg1NDNjYzNmZGE1XzY1OTcwNjk3NjY3NjM_72054368-71a4-4d1b-b605-5534c31fbc39"
      unitRef="shares">31255267</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOjQ0NzU4MmY1ZTNhOTRlNzI4OTMxYTg1NDNjYzNmZGE1XzY1OTcwNjk3NjY3NjM_b5185c27-c069-4052-915e-44c0d1fd3c97"
      unitRef="shares">31255267</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOjQ0NzU4MmY1ZTNhOTRlNzI4OTMxYTg1NDNjYzNmZGE1XzY1OTcwNjk3NjY3Njk_319984f9-21f1-4ab1-9028-14458326afe1"
      unitRef="shares">1135310</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOjQ0NzU4MmY1ZTNhOTRlNzI4OTMxYTg1NDNjYzNmZGE1XzY1OTcwNjk3NjY3Njk_c5f1f8c0-f7ea-4a0e-bd45-b5d9b9960708"
      unitRef="shares">1135310</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMzUtMS0xLTEtMA_07bbb82c-bd65-4e5e-b0b3-60c5c1017824"
      unitRef="usd">31000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMzUtMy0xLTEtMA_793e1d7b-ceaf-44d9-b716-2a8677dd1aad"
      unitRef="usd">1000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMzYtMS0xLTEtMA_a702a4f8-99c3-4077-bc68-ed457f6c0536"
      unitRef="usd">263384000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMzYtMy0xLTEtMA_0a7d2601-e299-4a35-9b6d-ac25ce14957e"
      unitRef="usd">4557000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfNDEtMS0xLTEtNzcw_feb44c31-565f-4f14-9828-b38c438406e6"
      unitRef="usd">2000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfNDEtMy0xLTEtNzcw_854fa8c4-22dd-4384-bf9a-ad78cee86dd7"
      unitRef="usd">0</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMzctMS0xLTEtMA_c77f0281-5bcd-4fc8-9658-31df194dcd58"
      unitRef="usd">-191526000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMzctMy0xLTEtMA_5a7d9f60-35dc-4e46-bf78-2d1790558611"
      unitRef="usd">-139111000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMzgtMS0xLTEtMA_227f8b2f-7151-4000-ba35-ac5f0c650ca0"
      unitRef="usd">71891000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMzgtMy0xLTEtMA_c6b8922a-a6ce-477b-9afb-f03293f4bced"
      unitRef="usd">-134553000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMzktMS0xLTEtMA_716b4cc9-8fa6-47e7-920d-f824d84a7058"
      unitRef="usd">137402000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV84OC9mcmFnOjQyZGRiZjlhZTcwMTQwODk4NTU3OWM2ODdlMThiNDY1L3RhYmxlOmEzNzkxZDg5ZWJjMDRlMTRiOGU5NDRkMTE2OWI5NTVlL3RhYmxlcmFuZ2U6YTM3OTFkODllYmMwNGUxNGI4ZTk0NGQxMTY5Yjk1NWVfMzktMy0xLTEtMA_bb297a98-2db8-4baa-a44e-b77c4a67f512"
      unitRef="usd">42743000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV85NC9mcmFnOmRlYjQyNzI0MmVkYjQ5M2NhMWE2Mzg5NWI5YmIwOWM5L3RhYmxlOjg4OTQyYzhjOTI5ZTQ5YmFiNjdiYjkxNWUyNzhmMDk1L3RhYmxlcmFuZ2U6ODg5NDJjOGM5MjllNDliYWI2N2JiOTE1ZTI3OGYwOTVfMi0xLTEtMS0w_b2d5bb02-985a-493f-9cec-104069a7ecce"
      unitRef="usd">63354000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV85NC9mcmFnOmRlYjQyNzI0MmVkYjQ5M2NhMWE2Mzg5NWI5YmIwOWM5L3RhYmxlOjg4OTQyYzhjOTI5ZTQ5YmFiNjdiYjkxNWUyNzhmMDk1L3RhYmxlcmFuZ2U6ODg5NDJjOGM5MjllNDliYWI2N2JiOTE1ZTI3OGYwOTVfMi0zLTEtMS0w_e1d99d6d-c932-490d-b3de-0818266cd412"
      unitRef="usd">34557000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV85NC9mcmFnOmRlYjQyNzI0MmVkYjQ5M2NhMWE2Mzg5NWI5YmIwOWM5L3RhYmxlOjg4OTQyYzhjOTI5ZTQ5YmFiNjdiYjkxNWUyNzhmMDk1L3RhYmxlcmFuZ2U6ODg5NDJjOGM5MjllNDliYWI2N2JiOTE1ZTI3OGYwOTVfMy0xLTEtMS0w_58f6785d-03e8-4d02-af18-98ae6df0a003"
      unitRef="usd">15927000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV85NC9mcmFnOmRlYjQyNzI0MmVkYjQ5M2NhMWE2Mzg5NWI5YmIwOWM5L3RhYmxlOjg4OTQyYzhjOTI5ZTQ5YmFiNjdiYjkxNWUyNzhmMDk1L3RhYmxlcmFuZ2U6ODg5NDJjOGM5MjllNDliYWI2N2JiOTE1ZTI3OGYwOTVfMy0zLTEtMS0w_94f21b11-27a2-4f6e-9f7f-5a417fb776d7"
      unitRef="usd">10874000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:GrossProfit
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV85NC9mcmFnOmRlYjQyNzI0MmVkYjQ5M2NhMWE2Mzg5NWI5YmIwOWM5L3RhYmxlOjg4OTQyYzhjOTI5ZTQ5YmFiNjdiYjkxNWUyNzhmMDk1L3RhYmxlcmFuZ2U6ODg5NDJjOGM5MjllNDliYWI2N2JiOTE1ZTI3OGYwOTVfNC0xLTEtMS0w_d8b1562f-8950-4bf1-8928-2302dd3b692b"
      unitRef="usd">47427000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV85NC9mcmFnOmRlYjQyNzI0MmVkYjQ5M2NhMWE2Mzg5NWI5YmIwOWM5L3RhYmxlOjg4OTQyYzhjOTI5ZTQ5YmFiNjdiYjkxNWUyNzhmMDk1L3RhYmxlcmFuZ2U6ODg5NDJjOGM5MjllNDliYWI2N2JiOTE1ZTI3OGYwOTVfNC0zLTEtMS0w_d82846b7-e976-4105-a43a-0627d715267d"
      unitRef="usd">23683000</us-gaap:GrossProfit>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV85NC9mcmFnOmRlYjQyNzI0MmVkYjQ5M2NhMWE2Mzg5NWI5YmIwOWM5L3RhYmxlOjg4OTQyYzhjOTI5ZTQ5YmFiNjdiYjkxNWUyNzhmMDk1L3RhYmxlcmFuZ2U6ODg5NDJjOGM5MjllNDliYWI2N2JiOTE1ZTI3OGYwOTVfNi0xLTEtMS0w_6bcd35d5-c21b-4509-be08-a45167a0b0fe"
      unitRef="usd">12272000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV85NC9mcmFnOmRlYjQyNzI0MmVkYjQ5M2NhMWE2Mzg5NWI5YmIwOWM5L3RhYmxlOjg4OTQyYzhjOTI5ZTQ5YmFiNjdiYjkxNWUyNzhmMDk1L3RhYmxlcmFuZ2U6ODg5NDJjOGM5MjllNDliYWI2N2JiOTE1ZTI3OGYwOTVfNi0zLTEtMS0w_ca6e7ad7-5d06-4e7f-a8c5-9e4df6d31b54"
      unitRef="usd">10258000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV85NC9mcmFnOmRlYjQyNzI0MmVkYjQ5M2NhMWE2Mzg5NWI5YmIwOWM5L3RhYmxlOjg4OTQyYzhjOTI5ZTQ5YmFiNjdiYjkxNWUyNzhmMDk1L3RhYmxlcmFuZ2U6ODg5NDJjOGM5MjllNDliYWI2N2JiOTE1ZTI3OGYwOTVfNy0xLTEtMS0w_af6a9d5b-c292-49cf-bf22-be08a68f8e40"
      unitRef="usd">63220000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV85NC9mcmFnOmRlYjQyNzI0MmVkYjQ5M2NhMWE2Mzg5NWI5YmIwOWM5L3RhYmxlOjg4OTQyYzhjOTI5ZTQ5YmFiNjdiYjkxNWUyNzhmMDk1L3RhYmxlcmFuZ2U6ODg5NDJjOGM5MjllNDliYWI2N2JiOTE1ZTI3OGYwOTVfNy0zLTEtMS0w_c31f4570-47ed-41eb-885f-d8e66d9c5d51"
      unitRef="usd">34820000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:OperatingExpenses
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV85NC9mcmFnOmRlYjQyNzI0MmVkYjQ5M2NhMWE2Mzg5NWI5YmIwOWM5L3RhYmxlOjg4OTQyYzhjOTI5ZTQ5YmFiNjdiYjkxNWUyNzhmMDk1L3RhYmxlcmFuZ2U6ODg5NDJjOGM5MjllNDliYWI2N2JiOTE1ZTI3OGYwOTVfOC0xLTEtMS0w_663d9098-b9e0-4d8c-8899-696b8234af6c"
      unitRef="usd">75492000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV85NC9mcmFnOmRlYjQyNzI0MmVkYjQ5M2NhMWE2Mzg5NWI5YmIwOWM5L3RhYmxlOjg4OTQyYzhjOTI5ZTQ5YmFiNjdiYjkxNWUyNzhmMDk1L3RhYmxlcmFuZ2U6ODg5NDJjOGM5MjllNDliYWI2N2JiOTE1ZTI3OGYwOTVfOC0zLTEtMS0w_4f83cac2-ea6a-498d-a3b9-1f58be02c658"
      unitRef="usd">45078000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV85NC9mcmFnOmRlYjQyNzI0MmVkYjQ5M2NhMWE2Mzg5NWI5YmIwOWM5L3RhYmxlOjg4OTQyYzhjOTI5ZTQ5YmFiNjdiYjkxNWUyNzhmMDk1L3RhYmxlcmFuZ2U6ODg5NDJjOGM5MjllNDliYWI2N2JiOTE1ZTI3OGYwOTVfOS0xLTEtMS0w_bdc534fa-3097-42d4-9d57-228c1c5398d8"
      unitRef="usd">-28065000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV85NC9mcmFnOmRlYjQyNzI0MmVkYjQ5M2NhMWE2Mzg5NWI5YmIwOWM5L3RhYmxlOjg4OTQyYzhjOTI5ZTQ5YmFiNjdiYjkxNWUyNzhmMDk1L3RhYmxlcmFuZ2U6ODg5NDJjOGM5MjllNDliYWI2N2JiOTE1ZTI3OGYwOTVfOS0zLTEtMS0w_7452215e-d3b9-4a12-8aca-1711356bc407"
      unitRef="usd">-21395000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV85NC9mcmFnOmRlYjQyNzI0MmVkYjQ5M2NhMWE2Mzg5NWI5YmIwOWM5L3RhYmxlOjg4OTQyYzhjOTI5ZTQ5YmFiNjdiYjkxNWUyNzhmMDk1L3RhYmxlcmFuZ2U6ODg5NDJjOGM5MjllNDliYWI2N2JiOTE1ZTI3OGYwOTVfMTAtMS0xLTEtMA_6892d8c1-754a-4882-9110-f76c1e3c61ea"
      unitRef="usd">1656000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV85NC9mcmFnOmRlYjQyNzI0MmVkYjQ5M2NhMWE2Mzg5NWI5YmIwOWM5L3RhYmxlOjg4OTQyYzhjOTI5ZTQ5YmFiNjdiYjkxNWUyNzhmMDk1L3RhYmxlcmFuZ2U6ODg5NDJjOGM5MjllNDliYWI2N2JiOTE1ZTI3OGYwOTVfMTAtMy0xLTEtMA_dd69fdff-bedc-4c84-9280-6e1aa1e6bb73"
      unitRef="usd">189000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InterestExpense
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV85NC9mcmFnOmRlYjQyNzI0MmVkYjQ5M2NhMWE2Mzg5NWI5YmIwOWM5L3RhYmxlOjg4OTQyYzhjOTI5ZTQ5YmFiNjdiYjkxNWUyNzhmMDk1L3RhYmxlcmFuZ2U6ODg5NDJjOGM5MjllNDliYWI2N2JiOTE1ZTI3OGYwOTVfMTEtMS0xLTEtMA_66684829-f690-44c1-b4bf-ae9bdfd79a3b"
      unitRef="usd">4952000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV85NC9mcmFnOmRlYjQyNzI0MmVkYjQ5M2NhMWE2Mzg5NWI5YmIwOWM5L3RhYmxlOjg4OTQyYzhjOTI5ZTQ5YmFiNjdiYjkxNWUyNzhmMDk1L3RhYmxlcmFuZ2U6ODg5NDJjOGM5MjllNDliYWI2N2JiOTE1ZTI3OGYwOTVfMTEtMy0xLTEtMA_51959093-c81c-448c-82e0-1520a1484ff5"
      unitRef="usd">4361000</us-gaap:InterestExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV85NC9mcmFnOmRlYjQyNzI0MmVkYjQ5M2NhMWE2Mzg5NWI5YmIwOWM5L3RhYmxlOjg4OTQyYzhjOTI5ZTQ5YmFiNjdiYjkxNWUyNzhmMDk1L3RhYmxlcmFuZ2U6ODg5NDJjOGM5MjllNDliYWI2N2JiOTE1ZTI3OGYwOTVfMTItMS0xLTEtMA_2cb0431b-4d36-4e5f-a816-02651f3c4d25"
      unitRef="usd">-21054000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV85NC9mcmFnOmRlYjQyNzI0MmVkYjQ5M2NhMWE2Mzg5NWI5YmIwOWM5L3RhYmxlOjg4OTQyYzhjOTI5ZTQ5YmFiNjdiYjkxNWUyNzhmMDk1L3RhYmxlcmFuZ2U6ODg5NDJjOGM5MjllNDliYWI2N2JiOTE1ZTI3OGYwOTVfMTItMy0xLTEtMA_d95c990d-f90a-479d-806c-58063c22b187"
      unitRef="usd">-12063000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:ProfitLoss
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV85NC9mcmFnOmRlYjQyNzI0MmVkYjQ5M2NhMWE2Mzg5NWI5YmIwOWM5L3RhYmxlOjg4OTQyYzhjOTI5ZTQ5YmFiNjdiYjkxNWUyNzhmMDk1L3RhYmxlcmFuZ2U6ODg5NDJjOGM5MjllNDliYWI2N2JiOTE1ZTI3OGYwOTVfMTMtMS0xLTEtMA_56aa056d-10b2-46b7-8d08-da131799bd73"
      unitRef="usd">-52415000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV85NC9mcmFnOmRlYjQyNzI0MmVkYjQ5M2NhMWE2Mzg5NWI5YmIwOWM5L3RhYmxlOjg4OTQyYzhjOTI5ZTQ5YmFiNjdiYjkxNWUyNzhmMDk1L3RhYmxlcmFuZ2U6ODg5NDJjOGM5MjllNDliYWI2N2JiOTE1ZTI3OGYwOTVfMTMtMy0xLTEtMA_a7d243a2-9ae5-499d-a2e3-76632aa7acba"
      unitRef="usd">-37630000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV85NC9mcmFnOmRlYjQyNzI0MmVkYjQ5M2NhMWE2Mzg5NWI5YmIwOWM5L3RhYmxlOjg4OTQyYzhjOTI5ZTQ5YmFiNjdiYjkxNWUyNzhmMDk1L3RhYmxlcmFuZ2U6ODg5NDJjOGM5MjllNDliYWI2N2JiOTE1ZTI3OGYwOTVfMTQtMS0xLTEtMA_1be7ccd5-9181-4ce6-b6c6-30a757d5d587"
      unitRef="usd">0</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV85NC9mcmFnOmRlYjQyNzI0MmVkYjQ5M2NhMWE2Mzg5NWI5YmIwOWM5L3RhYmxlOjg4OTQyYzhjOTI5ZTQ5YmFiNjdiYjkxNWUyNzhmMDk1L3RhYmxlcmFuZ2U6ODg5NDJjOGM5MjllNDliYWI2N2JiOTE1ZTI3OGYwOTVfMTQtMy0xLTEtMA_91f964b8-e444-4b4c-92b9-9105d8f78789"
      unitRef="usd">-1000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV85NC9mcmFnOmRlYjQyNzI0MmVkYjQ5M2NhMWE2Mzg5NWI5YmIwOWM5L3RhYmxlOjg4OTQyYzhjOTI5ZTQ5YmFiNjdiYjkxNWUyNzhmMDk1L3RhYmxlcmFuZ2U6ODg5NDJjOGM5MjllNDliYWI2N2JiOTE1ZTI3OGYwOTVfMTUtMS0xLTEtMA_b01213af-4c55-47cf-a91d-92f598e83323"
      unitRef="usd">-52415000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV85NC9mcmFnOmRlYjQyNzI0MmVkYjQ5M2NhMWE2Mzg5NWI5YmIwOWM5L3RhYmxlOjg4OTQyYzhjOTI5ZTQ5YmFiNjdiYjkxNWUyNzhmMDk1L3RhYmxlcmFuZ2U6ODg5NDJjOGM5MjllNDliYWI2N2JiOTE1ZTI3OGYwOTVfMTUtMy0xLTEtMA_f71df9d7-7710-441c-bb2d-4747caa4f880"
      unitRef="usd">-37629000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV85NC9mcmFnOmRlYjQyNzI0MmVkYjQ5M2NhMWE2Mzg5NWI5YmIwOWM5L3RhYmxlOjg4OTQyYzhjOTI5ZTQ5YmFiNjdiYjkxNWUyNzhmMDk1L3RhYmxlcmFuZ2U6ODg5NDJjOGM5MjllNDliYWI2N2JiOTE1ZTI3OGYwOTVfMTctMS0xLTEtODQ1_63297d63-eb2e-496b-8099-5fcf19ebc4c4"
      unitRef="usd">2000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV85NC9mcmFnOmRlYjQyNzI0MmVkYjQ5M2NhMWE2Mzg5NWI5YmIwOWM5L3RhYmxlOjg4OTQyYzhjOTI5ZTQ5YmFiNjdiYjkxNWUyNzhmMDk1L3RhYmxlcmFuZ2U6ODg5NDJjOGM5MjllNDliYWI2N2JiOTE1ZTI3OGYwOTVfMTctMy0xLTEtODQ1_3a639919-8146-4431-ae4d-53940668a61c"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV85NC9mcmFnOmRlYjQyNzI0MmVkYjQ5M2NhMWE2Mzg5NWI5YmIwOWM5L3RhYmxlOjg4OTQyYzhjOTI5ZTQ5YmFiNjdiYjkxNWUyNzhmMDk1L3RhYmxlcmFuZ2U6ODg5NDJjOGM5MjllNDliYWI2N2JiOTE1ZTI3OGYwOTVfMTgtMS0xLTEtOTQ4OA_732f6213-0fa6-411b-8159-91ba88ebc94d"
      unitRef="usd">2000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV85NC9mcmFnOmRlYjQyNzI0MmVkYjQ5M2NhMWE2Mzg5NWI5YmIwOWM5L3RhYmxlOjg4OTQyYzhjOTI5ZTQ5YmFiNjdiYjkxNWUyNzhmMDk1L3RhYmxlcmFuZ2U6ODg5NDJjOGM5MjllNDliYWI2N2JiOTE1ZTI3OGYwOTVfMTgtMy0xLTEtOTQ4OA_7a1fe4c1-ae90-409d-97a8-002e274f389e"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <silk:NetIncomeLossAndComprehensiveIncomeLossNetOfTaxAttributableToParent
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV85NC9mcmFnOmRlYjQyNzI0MmVkYjQ5M2NhMWE2Mzg5NWI5YmIwOWM5L3RhYmxlOjg4OTQyYzhjOTI5ZTQ5YmFiNjdiYjkxNWUyNzhmMDk1L3RhYmxlcmFuZ2U6ODg5NDJjOGM5MjllNDliYWI2N2JiOTE1ZTI3OGYwOTVfMTktMS0xLTEtODYw_481aca5c-a836-4e76-a6ca-cf5ac5d00ef2"
      unitRef="usd">-52413000</silk:NetIncomeLossAndComprehensiveIncomeLossNetOfTaxAttributableToParent>
    <silk:NetIncomeLossAndComprehensiveIncomeLossNetOfTaxAttributableToParent
      contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV85NC9mcmFnOmRlYjQyNzI0MmVkYjQ5M2NhMWE2Mzg5NWI5YmIwOWM5L3RhYmxlOjg4OTQyYzhjOTI5ZTQ5YmFiNjdiYjkxNWUyNzhmMDk1L3RhYmxlcmFuZ2U6ODg5NDJjOGM5MjllNDliYWI2N2JiOTE1ZTI3OGYwOTVfMTktMy0xLTEtODYw_2be9e1a8-93b2-44b7-9360-f042424d4600"
      unitRef="usd">-37629000</silk:NetIncomeLossAndComprehensiveIncomeLossNetOfTaxAttributableToParent>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV85NC9mcmFnOmRlYjQyNzI0MmVkYjQ5M2NhMWE2Mzg5NWI5YmIwOWM5L3RhYmxlOjg4OTQyYzhjOTI5ZTQ5YmFiNjdiYjkxNWUyNzhmMDk1L3RhYmxlcmFuZ2U6ODg5NDJjOGM5MjllNDliYWI2N2JiOTE1ZTI3OGYwOTVfMTYtMS0xLTEtMA_f61e9123-d18c-4685-8217-7ceaef21a2cb"
      unitRef="usdPerShare">-2.28</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV85NC9mcmFnOmRlYjQyNzI0MmVkYjQ5M2NhMWE2Mzg5NWI5YmIwOWM5L3RhYmxlOjg4OTQyYzhjOTI5ZTQ5YmFiNjdiYjkxNWUyNzhmMDk1L3RhYmxlcmFuZ2U6ODg5NDJjOGM5MjllNDliYWI2N2JiOTE1ZTI3OGYwOTVfMTYtMy0xLTEtMA_c2070a05-fdc8-467b-89a9-e1e9f0499e9f"
      unitRef="usdPerShare">-39.16</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV85NC9mcmFnOmRlYjQyNzI0MmVkYjQ5M2NhMWE2Mzg5NWI5YmIwOWM5L3RhYmxlOjg4OTQyYzhjOTI5ZTQ5YmFiNjdiYjkxNWUyNzhmMDk1L3RhYmxlcmFuZ2U6ODg5NDJjOGM5MjllNDliYWI2N2JiOTE1ZTI3OGYwOTVfMTctMS0xLTEtMA_0ac01e45-dbd8-487d-95cb-278500cf812a"
      unitRef="shares">22956679</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV85NC9mcmFnOmRlYjQyNzI0MmVkYjQ5M2NhMWE2Mzg5NWI5YmIwOWM5L3RhYmxlOjg4OTQyYzhjOTI5ZTQ5YmFiNjdiYjkxNWUyNzhmMDk1L3RhYmxlcmFuZ2U6ODg5NDJjOGM5MjllNDliYWI2N2JiOTE1ZTI3OGYwOTVfMTctMy0xLTEtMA_39aa3ef8-52ea-4528-9a94-a4fc9ca122a2"
      unitRef="shares">960882</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="ib1a82135571248368e03bddf4304bc01_I20171231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzE1LTEtMS0xLTA_0874e3a2-2f99-4a08-ba32-76143a529d26"
      unitRef="shares">21233190</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="ib1a82135571248368e03bddf4304bc01_I20171231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzE1LTMtMS0xLTA_dc0098d7-1e56-42e8-8108-027783819ff6"
      unitRef="usd">105235000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:SharesOutstanding
      contextRef="i6e1fca0c7e7e4562a33eec6ef093c73f_I20171231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzE1LTYtMS0xLTA_0af2612f-a5e8-44b9-b5ef-fde26830b400"
      unitRef="shares">663270</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6e1fca0c7e7e4562a33eec6ef093c73f_I20171231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzE1LTgtMS0xLTA_0336e68d-4a41-4bd4-a40f-a462d9b51bf0"
      unitRef="usd">1000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i81d78a9636e34b158306cb1e7cf203a5_I20171231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzE1LTEwLTEtMS0w_1c587bdc-01ce-47bd-b9c1-9ad20407d950"
      unitRef="usd">2977000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0980ae5f9b0d4a1d8d2ded0faf7fb77e_I20171231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzE1LTEyLTEtMS0w_3a3a0cb6-f85e-44dd-97c0-1a7905668c0a"
      unitRef="usd">-101556000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i875f802c129642f1ba841126240b68a4_I20171231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzE1LTE0LTEtMS05MTk_352bfbc3-1259-4b48-9690-a05387dc8ad2"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie3817a2997b54e13adbd3f8f1650b444_I20171231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzE1LTE0LTEtMS0w_9a000718-f988-4a5d-9afb-a1bcb0b2eae9"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i517a0560ef9f4f6a822a0a124dd39744_I20171231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzE1LTE2LTEtMS0w_58f41035-fd7b-4dd9-a044-b54634a60537"
      unitRef="usd">-98578000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i24fdf32d0a37459b9db5fc564063b7f5_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzE2LTYtMS0xLTA_90446859-18c9-428e-81fe-b1dcae1db807"
      unitRef="shares">438578</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i70437b3fd9084ab18848599576d75854_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzE2LTEwLTEtMS0w_6d1fa0e6-3b60-49a3-a12c-82f6f7053e06"
      unitRef="usd">656000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzE2LTE2LTEtMS0w_da4b7199-b3a2-43aa-b1be-24efd1b35f14"
      unitRef="usd">656000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition
      contextRef="i70437b3fd9084ab18848599576d75854_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzE3LTEwLTEtMS0w_1a69ab75-2cf8-400a-96ef-19188d28d6e9"
      unitRef="usd">728000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition
      contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzE3LTE2LTEtMS0w_baf3b417-3bc6-4298-b581-c3e7398bb94a"
      unitRef="usd">728000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="i70437b3fd9084ab18848599576d75854_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzE4LTEwLTEtMS0w_2cbb2344-5e6b-4e5f-9d2f-57621fa722ab"
      unitRef="usd">183000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzE4LTE2LTEtMS0w_ea324f7d-6d0d-4f95-bdd2-3a8a17b2f450"
      unitRef="usd">183000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
      contextRef="i532518b8a5e649659408304a8b441189_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzE5LTE0LTEtMS0w_6138f33e-dacc-4634-aadf-72e874ce7f3a"
      unitRef="usd">1000</us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance>
    <us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
      contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzE5LTE2LTEtMS0w_acae1742-8a7c-41d0-b32e-0f0f8fd93efd"
      unitRef="usd">1000</us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="i24fdf32d0a37459b9db5fc564063b7f5_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzIwLTYtMS0xLTA_d561a9de-e6f9-4059-b0b2-103823dc1a52"
      unitRef="shares">33462</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzIwLTE2LTEtMS0w_f6ed81b4-90e0-48a6-96b1-3d8d76ed5639"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption
      contextRef="i078a473226e5469f8b43b5c341ea2777_I20180101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzIxLTEyLTEtMS0w_b3505260-9d54-4994-b4cb-13b3ca1345be"
      unitRef="usd">87000</us-gaap:CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption>
    <us-gaap:CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption
      contextRef="if3906640531a47a789a69ee035108cfd_I20180101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzIxLTE2LTEtMS0w_719a662c-ef01-4b18-98b0-e960e8219a40"
      unitRef="usd">87000</us-gaap:CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption>
    <us-gaap:CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption
      contextRef="if7fa5ba84e534af1b2d35b63277a0541_I20180101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzIyLTEwLTEtMS0w_dd40051f-d5d7-4682-8910-d341fb092894"
      unitRef="usd">13000</us-gaap:CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption>
    <us-gaap:CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption
      contextRef="i3d970a6f053141c8adef36f595567ea2_I20180101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzIyLTEyLTEtMS0w_120b4d87-6b98-4863-8b48-b73ab5c0a136"
      unitRef="usd">-13000</us-gaap:CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption>
    <us-gaap:CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption
      contextRef="ibfd8d47f8c2e498f97e7e0e1de986a52_I20180101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzIyLTE2LTEtMS0w_df9abf38-6ebe-48aa-9c2c-4c9955ff8132"
      unitRef="usd">0</us-gaap:CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i486e6203c31e4389a7bfae59308a9fdf_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzIzLTEyLTEtMS0w_e5c5869f-83f9-41df-b803-eea1bcad1bb9"
      unitRef="usd">-37629000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="i486e6203c31e4389a7bfae59308a9fdf_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzIzLTEyLTEtMS0w_f1efa857-6afc-425f-9953-3e76d9a7511f"
      unitRef="usd">-37629000</us-gaap:ProfitLoss>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i532518b8a5e649659408304a8b441189_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzIzLTE0LTEtMS0w_23e47d5b-51db-460d-8e10-2d41da10ee2b"
      unitRef="usd">-1000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="i532518b8a5e649659408304a8b441189_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzIzLTE0LTEtMS0w_611d4619-8fdf-457e-976e-5aff72095e5b"
      unitRef="usd">-1000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzIzLTE2LTEtMS0w_78e77cb2-5589-4e86-86f5-d4dd234c862b"
      unitRef="usd">-37630000</us-gaap:ProfitLoss>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzIzLTE2LTEtMS0w_cdb5b19a-19f1-4c75-a99e-e81eb1a1784e"
      unitRef="usd">-37630000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i9c2de9078e6d4638b12de94ce89dcf8f_I20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzI0LTEtMS0xLTA_709bc8da-50f4-4e48-a36c-19cedcf97128"
      unitRef="shares">21233190</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i9c2de9078e6d4638b12de94ce89dcf8f_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzI0LTMtMS0xLTA_b82b2be9-8190-4ad8-b5b7-874fb791d470"
      unitRef="usd">105235000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:SharesOutstanding
      contextRef="ie5422de912814b909007e41dfe62434c_I20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzI0LTYtMS0xLTA_e05d3910-cf21-4617-99d0-c6614240ed1c"
      unitRef="shares">1135310</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie5422de912814b909007e41dfe62434c_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzI0LTgtMS0xLTA_5b56830c-7cf6-4644-9326-f5a77ea86ae5"
      unitRef="usd">1000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i372f9742dd2f42ca8e67497abb64e072_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzI0LTEwLTEtMS0w_9c2d7163-c2e6-47a4-a6b1-595a8bda4326"
      unitRef="usd">4557000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ide97ade70a5e4b9fb300e7cf6f1de815_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzI0LTEyLTEtMS0w_a5bc5e91-c153-4c25-b76a-4c5f4164a170"
      unitRef="usd">-139111000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i67b8527276b74fc8b42f80e4649752f6_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzI0LTE0LTEtMS05MTk_c6ccc6aa-5918-4a3d-945e-2a0069b58de2"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i32f0795bc684401e95ede404c8ba027a_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzI0LTE0LTEtMS0w_606912d7-d9e5-4270-b1b3-f83c3112d7f5"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzI0LTE2LTEtMS0w_ca1227d8-f0bb-477a-9531-a8741546cdba"
      unitRef="usd">-134553000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <silk:StockIssuedDuringPeriodSharesExerciseOfWarrants
      contextRef="i034315faec014251b182a3d66bbaabaa_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzI1LTEtMS0xLTk2NA_1ceea147-0abe-4ef7-baef-28b1a4655cd8"
      unitRef="shares">292361</silk:StockIssuedDuringPeriodSharesExerciseOfWarrants>
    <silk:StockIssuedDuringPeriodValueExerciseOfWarrants
      contextRef="i034315faec014251b182a3d66bbaabaa_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzI1LTMtMS0xLTk2NA_10bc88fc-f9a2-4e83-bf60-365edb19a75a"
      unitRef="usd">1784000</silk:StockIssuedDuringPeriodValueExerciseOfWarrants>
    <silk:StockIssuedDuringPeriodSharesExerciseOfWarrants
      contextRef="i0e663b10e19444c782441b76f73225f8_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzI2LTYtMS0xLTk3Mg_57ed43a7-c0fa-4435-a781-fe8600ea7c66"
      unitRef="shares">3764</silk:StockIssuedDuringPeriodSharesExerciseOfWarrants>
    <silk:StockIssuedDuringPeriodValueExerciseOfWarrants
      contextRef="i30323612426c417f9cb96084012048a3_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzI2LTEwLTEtMS05NzI_970268bf-597b-4512-b4d6-d4a5329db4e7"
      unitRef="usd">31000</silk:StockIssuedDuringPeriodValueExerciseOfWarrants>
    <silk:StockIssuedDuringPeriodValueExerciseOfWarrants
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzI2LTE4LTEtMS05NzI_d2627966-bb87-461c-abb7-7f9cf517201b"
      unitRef="usd">31000</silk:StockIssuedDuringPeriodValueExerciseOfWarrants>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzI3LTAtMS0xLTEwMzYvdGV4dHJlZ2lvbjozY2RhNTAwMjkxNWQ0ZGNkYmM5NTM5ZjIyMWQ0ZTRmOV8zMjk4NTM0ODgzNDU3_de7fca63-61cf-43fd-9dda-6b7785d79895"
      unitRef="usd">2481000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i0e663b10e19444c782441b76f73225f8_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzI3LTYtMS0xLTk3Mg_6068f55b-fe1b-4fa8-b80a-8462d9a8d226"
      unitRef="shares">6000000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i0e663b10e19444c782441b76f73225f8_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzI3LTgtMS0xLTk3Mg_86fed58a-2531-4638-842e-1b8441f56693"
      unitRef="usd">6000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i30323612426c417f9cb96084012048a3_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzI3LTEwLTEtMS05NzI_5fba8759-0404-4a41-993d-41356e586967"
      unitRef="usd">109113000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzI3LTE4LTEtMS05NzI_9f10eff9-f076-4d6d-b577-2dfd0cf8bee5"
      unitRef="usd">109119000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits
      contextRef="i034315faec014251b182a3d66bbaabaa_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzI4LTEtMS0xLTk2NA_d940979a-331d-4cbd-ae22-0cf73ec4b204"
      unitRef="shares">-23178555</us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfUnits
      contextRef="i034315faec014251b182a3d66bbaabaa_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzI4LTMtMS0xLTk2NA_d45e5d72-a94a-4df6-be97-ce6cb50a6bd6"
      unitRef="usd">-144140000</us-gaap:StockIssuedDuringPeriodValueConversionOfUnits>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits
      contextRef="i0e663b10e19444c782441b76f73225f8_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzI4LTYtMS0xLTk3Mg_2795e1e8-8ed3-4362-a1da-fda82614754b"
      unitRef="shares">23178555</us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfUnits
      contextRef="i0e663b10e19444c782441b76f73225f8_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzI4LTgtMS0xLTk3Mg_9460d81a-4b88-4fb6-8ebb-3964c98abaa2"
      unitRef="usd">23000</us-gaap:StockIssuedDuringPeriodValueConversionOfUnits>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfUnits
      contextRef="i30323612426c417f9cb96084012048a3_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzI4LTEwLTEtMS05NzI_62d16787-9d50-43f7-bd0f-2878a47f2381"
      unitRef="usd">144117000</us-gaap:StockIssuedDuringPeriodValueConversionOfUnits>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfUnits
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzI4LTE4LTEtMS05NzI_fe1825f4-e3dd-4137-814c-7635169e7eb2"
      unitRef="usd">144140000</us-gaap:StockIssuedDuringPeriodValueConversionOfUnits>
    <silk:StockIssuedDuringPeriodSharesExerciseOfWarrants
      contextRef="i128760dd6ffe4a6bbcffc708f475df73_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzI5LTEtMS0xLTk2NA_42a193de-48e9-429f-9814-1d293192406e"
      unitRef="shares">1653004</silk:StockIssuedDuringPeriodSharesExerciseOfWarrants>
    <silk:StockIssuedDuringPeriodValueExerciseOfWarrants
      contextRef="i128760dd6ffe4a6bbcffc708f475df73_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzI5LTMtMS0xLTk2NA_56c9dee6-cdaf-4a9a-a9f0-55caa1326c52"
      unitRef="usd">37121000</silk:StockIssuedDuringPeriodValueExerciseOfWarrants>
    <silk:StockIssuedDuringPeriodSharesExerciseOfWarrants
      contextRef="i0872d194a51d4edcad754b82ad9b0396_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzMwLTYtMS0xLTk3Mg_a6c29883-3e11-4317-8f9e-69d9de26ab14"
      unitRef="shares">2204</silk:StockIssuedDuringPeriodSharesExerciseOfWarrants>
    <silk:StockIssuedDuringPeriodValueExerciseOfWarrants
      contextRef="icc70fdca20a04c6ab43a9d230a3bb9b3_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzMwLTE4LTEtMS05NzI_c7d4b196-f830-4f67-83f1-4df5b79337c8"
      unitRef="usd">0</silk:StockIssuedDuringPeriodValueExerciseOfWarrants>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i0e663b10e19444c782441b76f73225f8_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzMxLTYtMS0xLTk3Mg_9582a799-82b7-4733-9903-024c324c11e3"
      unitRef="shares">873786</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i0e663b10e19444c782441b76f73225f8_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzMxLTgtMS0xLTk3Mg_afc5edfa-47be-4ea2-a274-6dadf806b85a"
      unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i30323612426c417f9cb96084012048a3_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzMxLTEwLTEtMS05NzI_ee4d4627-ce6d-40a2-8f86-70512025a008"
      unitRef="usd">1541000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzMxLTE4LTEtMS05NzI_bcc5cbe4-0572-41ca-a93f-af27e0d314d3"
      unitRef="usd">1542000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i0e663b10e19444c782441b76f73225f8_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzMyLTYtMS0xLTk3Mg_d0066eb3-2041-498a-b2e2-8f9999e32737"
      unitRef="shares">61648</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i30323612426c417f9cb96084012048a3_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzMyLTEwLTEtMS05NzI_73b01ed7-2fc8-4273-af69-b899a4a6bde0"
      unitRef="usd">1048000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzMyLTE4LTEtMS05NzI_e7e2e13e-a1b9-459c-8eb1-6456ad474062"
      unitRef="usd">1048000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition
      contextRef="i30323612426c417f9cb96084012048a3_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzMzLTEwLTEtMS05NzI_693412c4-a0b9-4bbd-aedb-9f5ae9c3bf40"
      unitRef="usd">2887000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzMzLTE4LTEtMS05NzI_1f565a84-bee8-4795-861d-9a90b8c7e8aa"
      unitRef="usd">2887000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="i30323612426c417f9cb96084012048a3_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzM0LTEwLTEtMS05NzI_1d35ada4-5459-4ec6-a5ee-9eedec6b3961"
      unitRef="usd">90000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzM0LTE4LTEtMS05NzI_56fffee2-f522-487c-b70b-124d324c1673"
      unitRef="usd">90000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:ProfitLoss
      contextRef="i1ef328d4a82d454f837101558bfddfe2_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzM1LTEyLTEtMS05NzI_7723f493-c3d6-48c0-8df5-6f20f9322dba"
      unitRef="usd">-52415000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzM1LTE4LTEtMS05NzI_16fdd335-2f1a-49f6-8437-ac114b1e888e"
      unitRef="usd">-52415000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i2a50ab8679f64d4e9e5c5ef5f5850abf_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzM2LTE0LTEtMS05NzI_a6305b99-5440-43e8-a3e6-c2256177a489"
      unitRef="usd">2000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzM2LTE4LTEtMS05NzI_a677a549-d1c0-4aa1-98cf-e365ff4551b1"
      unitRef="usd">2000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i1fa63ac295464df58c38a6649e35436f_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzM3LTEtMS0xLTk2NA_7aba0aa9-7bae-46f0-83a6-ce32d2730866"
      unitRef="shares">0</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i1fa63ac295464df58c38a6649e35436f_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzM3LTMtMS0xLTk2NA_0db7cbe1-32d7-4815-b8c9-b6412a54e6db"
      unitRef="usd">0</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:SharesOutstanding
      contextRef="i4e66b2f70f744286ad2b2575bbd8de82_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzM3LTYtMS0xLTk3Mg_06f56f5b-5135-4b84-99b3-89bcddca581f"
      unitRef="shares">31255267</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4e66b2f70f744286ad2b2575bbd8de82_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzM3LTgtMS0xLTk3Mg_a114d983-2120-4e15-8c8e-1540da07631b"
      unitRef="usd">31000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i92a29de035d648249198240ca0cb4b8b_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzM3LTEwLTEtMS05NzI_154802fc-b05d-434d-93cf-840821545280"
      unitRef="usd">263384000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iec5a27c85b024faeaa754c4a163a1274_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzM3LTEyLTEtMS05NzI_d79865a4-4a9e-4b32-ae44-1037e231bdf2"
      unitRef="usd">-191526000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i52088a0c6adf42bd8f967682ae5eabef_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzM3LTE0LTEtMS05NzI_c66867ec-ea08-46e4-af0d-5c0ecba10963"
      unitRef="usd">2000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7462368c462e4bd490bca37af6860f56_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzM3LTE2LTEtMS05NzI_5e35661c-a742-48f5-bf0b-f7d438af381b"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDAvZnJhZzoyOGIzNzczOThmOTE0ODVlOWQ1ZDRlZjE2ZjAxYWIzYy90YWJsZTo4ZmU2MzY1ODM5OTM0NWE3YjU4NThkZjNlNWEyMjM2ZC90YWJsZXJhbmdlOjhmZTYzNjU4Mzk5MzQ1YTdiNTg1OGRmM2U1YTIyMzZkXzM3LTE4LTEtMS05NzI_b25b6b0c-ee97-43df-a4f9-0de43a17fe69"
      unitRef="usd">71891000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzMtMS0xLTEtMA_3fec88e6-35c9-4a8e-99d1-5d8328fc4e38"
      unitRef="usd">-52415000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzMtMy0xLTEtMA_1693eb42-3a5c-49c8-8891-73109619853e"
      unitRef="usd">-37630000</us-gaap:ProfitLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzUtMS0xLTEtMA_3f8885de-bcfd-4b6c-9006-8a0ac1c81fcf"
      unitRef="usd">712000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzUtMy0xLTEtMA_869e29bc-0638-4d4b-9986-0b706e6bdaf1"
      unitRef="usd">517000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:ShareBasedCompensation
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzYtMS0xLTEtMA_754dd843-94a8-4c6e-816a-7b626ad4d01c"
      unitRef="usd">2977000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzYtMy0xLTEtMA_8591b428-9634-4543-89e9-1f866c9da4a9"
      unitRef="usd">911000</us-gaap:ShareBasedCompensation>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzctMS0xLTEtMA_3663d307-5bb4-4703-86dc-fc162405df08"
      unitRef="usd">21030000</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzctMy0xLTEtMA_3a4784dc-17c4-4c1a-a609-24b6d32b6ded"
      unitRef="usd">11906000</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzgtMS0xLTEtMTA2OQ_35e3ea85-88cb-4a1f-af1a-fcf55a1393a6"
      unitRef="usd">309000</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
    <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments
      contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzgtMy0xLTEtMTA2OQ_c9fd59a9-19e9-4070-b7ed-2d3985910f8b"
      unitRef="usd">0</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzgtMS0xLTEtMA_e5dcfd38-ea8d-467b-9643-3514c029ac6d"
      unitRef="usd">46000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzgtMy0xLTEtMA_1ade05c1-499d-4541-ac04-d74cbf3d169b"
      unitRef="usd">68000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <silk:OperatingLeaseRightOfUseAssetAmortization
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzEwLTEtMS0xLTEwNzQ_2de95f29-8201-46ec-b6c8-67613c933971"
      unitRef="usd">582000</silk:OperatingLeaseRightOfUseAssetAmortization>
    <us-gaap:PaidInKindInterest
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzktMS0xLTEtMA_7665241d-2dab-498e-a507-5cb2764dd275"
      unitRef="usd">672000</us-gaap:PaidInKindInterest>
    <us-gaap:PaidInKindInterest
      contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzktMy0xLTEtMA_822d7984-0441-4874-bd1c-ae0b3a51cf1b"
      unitRef="usd">1555000</us-gaap:PaidInKindInterest>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzEwLTEtMS0xLTA_1e96bee0-3ac1-4eee-9da6-33fd135e4a5d"
      unitRef="usd">0</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment
      contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzEwLTMtMS0xLTA_fb25e629-635a-428a-b886-09aa8df32008"
      unitRef="usd">-159000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzExLTEtMS0xLTA_b85b7399-f018-4635-8d5a-72603337186c"
      unitRef="usd">23000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzExLTMtMS0xLTA_df5858c2-f74e-4008-af76-5dc503f530bd"
      unitRef="usd">-123000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:InventoryWriteDown
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzEyLTEtMS0xLTA_caa6eb0f-78f5-4585-879c-cdc1ee2a92d5"
      unitRef="usd">118000</us-gaap:InventoryWriteDown>
    <us-gaap:InventoryWriteDown
      contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzEyLTMtMS0xLTA_7c20bbe7-ee5f-4529-8b55-11379a946858"
      unitRef="usd">23000</us-gaap:InventoryWriteDown>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzE0LTEtMS0xLTA_124fe92e-6a9e-4b53-9ffc-3a463519b5cd"
      unitRef="usd">2241000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzE0LTMtMS0xLTA_c8a9fdcf-af01-48b6-9d93-bcaac6896a81"
      unitRef="usd">446000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzE1LTEtMS0xLTA_d975f91f-0ec4-49f7-9124-d99b8907a361"
      unitRef="usd">4696000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzE1LTMtMS0xLTA_61495ac4-3093-47d7-8e66-59dcfff66c57"
      unitRef="usd">2565000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzE2LTEtMS0xLTA_2357f7c5-e8f4-49e9-bade-207a9ba985ad"
      unitRef="usd">1471000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzE2LTMtMS0xLTA_c4015c58-0531-41ae-8cd3-aefaf6ad75c8"
      unitRef="usd">1128000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzE3LTEtMS0xLTA_15430cbb-64d6-43e5-9db0-37608c9b37b1"
      unitRef="usd">-552000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzE3LTMtMS0xLTA_6f1f1fb2-8bbc-4f6f-a992-3949996230b5"
      unitRef="usd">62000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzE4LTEtMS0xLTA_0487f096-ab30-4d68-a9d0-464f81594193"
      unitRef="usd">615000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzE4LTMtMS0xLTA_e5281cb4-c95f-4229-b9bb-19df20060415"
      unitRef="usd">-309000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzE5LTEtMS0xLTA_e9543c75-6864-4ef4-99b0-248fc3b7ce7d"
      unitRef="usd">4964000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzE5LTMtMS0xLTA_a543785f-67dd-476a-98bb-41781cacba6c"
      unitRef="usd">5023000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzIwLTEtMS0xLTA_14a71c83-eaae-49cc-8744-6f04db7bb6e7"
      unitRef="usd">-769000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities
      contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzIwLTMtMS0xLTA_be88fded-ea63-4243-a068-1fb93d793b10"
      unitRef="usd">406000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzIxLTEtMS0xLTA_4cbe7550-9981-498a-9c6d-21ff343c013d"
      unitRef="usd">-29610000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzIxLTMtMS0xLTA_f1fc7534-9892-4915-9048-e6b11c47b88a"
      unitRef="usd">-21695000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzI0LTEtMS0xLTA_5668dc0d-84d9-4165-b380-56d4e2d0efac"
      unitRef="usd">535000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzI0LTMtMS0xLTA_8452fbef-16cc-4d38-8b6d-9dca36f43341"
      unitRef="usd">2276000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzI1LTEtMS0xLTA_e9f8fcbe-a275-4195-a456-37618cd19176"
      unitRef="usd">0</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzI1LTMtMS0xLTA_81d4a5be-9c83-46c6-8369-2baf5971f38f"
      unitRef="usd">6000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireInvestments
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzI4LTEtMS0xLTEwODk_81bdb566-8acd-4908-88e0-4ce5625d10a1"
      unitRef="usd">69421000</us-gaap:PaymentsToAcquireInvestments>
    <us-gaap:PaymentsToAcquireInvestments
      contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzI4LTMtMS0xLTEwODk_3358223f-d01c-46f3-8632-8e1e92ba1c30"
      unitRef="usd">0</us-gaap:PaymentsToAcquireInvestments>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzI2LTEtMS0xLTA_fb820983-820d-4d97-ab84-6e475d5cba0a"
      unitRef="usd">-69956000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzI2LTMtMS0xLTA_4ec24c8f-e5f2-45e4-856a-9e74f86880c1"
      unitRef="usd">-2270000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzMyLTEtMS0xLTExMDE_9d4fd417-e932-4dd8-990c-9f0af72eca39"
      unitRef="usd">109352000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzMyLTMtMS0xLTExMDE_891c1ea5-ea8e-4cd1-9aa1-1435ea5cc36f"
      unitRef="usd">-233000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzI5LTEtMS0xLTA_ca51036c-3a2e-48d7-b8a0-1d63384ff8d8"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzI5LTMtMS0xLTA_256b70c5-4984-4010-af84-04ff6458e3e3"
      unitRef="usd">15000000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzMwLTEtMS0xLTA_cd76f8c8-5eaa-40cc-a12e-9af98cdb5b27"
      unitRef="usd">2590000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzMwLTMtMS0xLTA_ceac81a1-cdb0-4c50-92ed-a21e8a87b01a"
      unitRef="usd">656000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromWarrantExercises
      contextRef="i183f22ec2ae24c28af10423035463332_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzMxLTEtMS0xLTA_9fbfafd4-ed87-4b80-9132-26c65490a1e8"
      unitRef="usd">1784000</us-gaap:ProceedsFromWarrantExercises>
    <us-gaap:ProceedsFromWarrantExercises
      contextRef="i3b88e1cc16544cd09f30471712be03e7_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzMxLTMtMS0xLTA_7708089f-2f47-4675-8c99-1f4d31ec2726"
      unitRef="usd">0</us-gaap:ProceedsFromWarrantExercises>
    <us-gaap:ProceedsFromWarrantExercises
      contextRef="i6392e7d9184e4e68a1862ac1a23c3c37_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzM2LTEtMS0xLTExMDg_8702f8f6-2f91-4008-9dde-03ae85f7fe39"
      unitRef="usd">31000</us-gaap:ProceedsFromWarrantExercises>
    <us-gaap:ProceedsFromWarrantExercises
      contextRef="ief833aecb87341158807940d3631f438_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzM2LTMtMS0xLTExMDg_27de0df8-b210-4fbd-a1ba-a36e36fd5c91"
      unitRef="usd">0</us-gaap:ProceedsFromWarrantExercises>
    <us-gaap:ProceedsFromMinorityShareholders
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzMyLTEtMS0xLTA_b6253a85-b965-4d64-8449-d6a7d0cfb157"
      unitRef="usd">0</us-gaap:ProceedsFromMinorityShareholders>
    <us-gaap:ProceedsFromMinorityShareholders
      contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzMyLTMtMS0xLTA_99e4aea5-c9b9-4923-8001-23f7eb0a85cd"
      unitRef="usd">1000</us-gaap:ProceedsFromMinorityShareholders>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzM0LTEtMS0xLTA_0f531537-4d99-467a-8f06-13460e37c867"
      unitRef="usd">113757000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzM0LTMtMS0xLTA_8d20efd5-44f7-404a-8070-4ba7a86f9294"
      unitRef="usd">15424000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzM1LTEtMS0xLTA_2c320a43-ed39-4aca-8165-a03791732931"
      unitRef="usd">14191000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzM1LTMtMS0xLTA_2e72f499-4ade-4fff-9ee6-9c49a5f643a4"
      unitRef="usd">-8541000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzM2LTEtMS0xLTA_273df366-8f3f-47a8-ac24-d6af92c5a123"
      unitRef="usd">25300000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i517a0560ef9f4f6a822a0a124dd39744_I20171231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzM2LTMtMS0xLTA_ddef9c8c-6b06-4e35-8048-9a9ea5fe77e7"
      unitRef="usd">33841000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzM3LTEtMS0xLTA_90cea716-9828-4198-b7b8-acd802342d1f"
      unitRef="usd">39491000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzM3LTMtMS0xLTA_308d2323-d67c-4535-b6dc-011c08729d48"
      unitRef="usd">25300000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:InterestPaidNet
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzQwLTEtMS0xLTA_933b83e5-c57b-47ee-b4d0-9c283348dad6"
      unitRef="usd">4234000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzQwLTMtMS0xLTA_d871036a-40b6-4cbd-8328-ef5b279360fe"
      unitRef="usd">2738000</us-gaap:InterestPaidNet>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzQzLTEtMS0xLTA_ec55e5e1-a767-48e3-8d23-702939d0d460"
      unitRef="usd">32000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzQzLTMtMS0xLTA_5b0623a8-35e7-49a9-89a6-228d1120a176"
      unitRef="usd">6000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:PaymentsForTenantImprovements
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzQ0LTEtMS0xLTA_e6114f63-d752-4917-ad9d-1fbaaba99442"
      unitRef="usd">0</us-gaap:PaymentsForTenantImprovements>
    <us-gaap:PaymentsForTenantImprovements
      contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzQ0LTMtMS0xLTA_a72e6f3e-14d1-407c-b737-770cdda341da"
      unitRef="usd">794000</us-gaap:PaymentsForTenantImprovements>
    <silk:StockIssuanceCostsIncurredButNotYetPaid
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzQ1LTEtMS0xLTA_8e8112c1-2cc7-4837-97df-7dee4e72caa6"
      unitRef="usd">0</silk:StockIssuanceCostsIncurredButNotYetPaid>
    <silk:StockIssuanceCostsIncurredButNotYetPaid
      contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzQ1LTMtMS0xLTA_00f2b420-a90a-4a96-8e5e-038579489419"
      unitRef="usd">717000</silk:StockIssuanceCostsIncurredButNotYetPaid>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzUwLTEtMS0xLTExMzE_eb66ca21-a665-4fbb-a278-8ee620c5c46a"
      unitRef="usd">3982000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:ConversionOfStockAmountIssued1
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzUxLTEtMS0xLTExMzE_dec5c07a-8277-4e70-be2c-e33c515ec93d"
      unitRef="usd">37121000</us-gaap:ConversionOfStockAmountIssued1>
    <us-gaap:ConversionOfStockAmountIssued1
      contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzUxLTMtMS0xLTExMzE_a8029bbe-606b-4027-909d-3ba353985156"
      unitRef="usd">0</us-gaap:ConversionOfStockAmountIssued1>
    <us-gaap:ConversionOfStockAmountConverted1
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzUyLTEtMS0xLTExMzE_33e2f459-8786-4f72-ae4f-e4dd44997e82"
      unitRef="usd">144140000</us-gaap:ConversionOfStockAmountConverted1>
    <us-gaap:ConversionOfStockAmountConverted1
      contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDYvZnJhZzo3NDkyNDhjNjM3MjQ0MDdmODRlMjY4Y2ZkNWVlYTVkYi90YWJsZTphMzM0ZDI4ZTY1YjY0YTE5YjU3NGQxNTc4YzBlNmExYi90YWJsZXJhbmdlOmEzMzRkMjhlNjViNjRhMTliNTc0ZDE1NzhjMGU2YTFiXzUyLTMtMS0xLTExMzE_7d6ec168-4dcc-45dd-8332-d49521df6de8"
      unitRef="usd">0</us-gaap:ConversionOfStockAmountConverted1>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDkvZnJhZzo4OTFiYTkwOGFmZGM0NzBhOWQ3ZTdmOTU4ZGFhY2IwZi90ZXh0cmVnaW9uOjg5MWJhOTA4YWZkYzQ3MGE5ZDdlN2Y5NThkYWFjYjBmXzIxOTkwMjMyNjg1OTI_e33e08d2-abc4-4bc8-8af6-160de5a2e4db">Formation and Business of the Company &lt;div style="margin-bottom:9pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;The Company&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Silk Road Medical, Inc. (the &#x201c;Company&#x201d;) was incorporated in the state of Delaware on March&#160;21,&#160;2007.  The Company has developed a technologically advanced, minimally-invasive solution for patients with carotid artery disease who are at risk for stroke.  The Company&#x2019;s portfolio of TCAR products enable a new procedure, referred to as transcarotid artery revascularization, or TCAR, that combines the benefits of endovascular techniques and surgical principles.  The Company&#x2019;s manufactures and sells in the United States its portfolio of TCAR products which are designed to provide direct access to the carotid artery, effective reduction in stroke risk throughout the procedure, and long-term restraint of carotid plaque.  The Company commercialized its products in the United States in April 2016. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Liquidity&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In the course of its activities, the Company has incurred losses and negative cash flows from operations since its inception.  As of December&#160;31, 2019, the Company had an accumulated deficit of $191,526,000.  The Company expects to incur losses for the foreseeable future.  The Company&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; believes tha&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;t its cash and cash equivalents of $39,181,000 and available-for-sale investments of $69,732,000 at December&#160;31, 2019, as well as its expected revenues will provide sufficient funds to allow the Company to fund its planned current operations for the next twelve months from the issuance of these financial statements.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Reverse Stock Split&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;On March 13, 2019, the Company&#x2019;s Board of Directors approved an amendment to the Company&#x2019;s amended and restated certificate of incorporation to effect a 1-for-2.7 reverse stock split of the Company&#x2019;s common stock and redeemable convertible preferred stock to be consummated prior to the effectiveness of the Company&#x2019;s planned initial public offering (&#x201c;IPO&#x201d;).  The reverse stock split was effected on March 27, 2019.  The par values of the common stock and redeemable convertible preferred stock were not adjusted as a result of the reverse stock split.  All the common stock, redeemable convertible preferred stock, stock options and warrants, and related per share amounts in the financial statements have been retroactively adjusted for all periods presented to give effect to the reverse stock split.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Public Offerings&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In April 2019, the Company issued and sold 6,000,000 shares of its common stock in its IPO at a public offering price of $20.00 per share, for net proceeds of approximately $109,119,000 after deducting underwriting discounts and commissions of approximately $8,400,000 and expenses of approximately $2,481,000. Upon the closing of the IPO, all shares of redeemable convertible preferred stock then outstanding converted into shares of common stock and the Company's outstanding warrants to purchase shares of common and redeemable convertible preferred stock were exercised, or automatically net exercised absent a prior election. The exercises resulted in the reclassification of the fair value of the related redeemable convertible preferred stock warrant liability to additional paid-in capital. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In August 2019, the Company completed a secondary public offering of 4,200,000 shares of its common stock sold by certain selling stockholders, and the exercise in full of the underwriters' option to purchase 630,000 additional shares of its common stock from certain selling stockholders, at a public offering price of $39.50 per share. The Company did not receive any of the proceeds from the sale of the shares of its common stock from the selling stockholders.&lt;/span&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDkvZnJhZzo4OTFiYTkwOGFmZGM0NzBhOWQ3ZTdmOTU4ZGFhY2IwZi90ZXh0cmVnaW9uOjg5MWJhOTA4YWZkYzQ3MGE5ZDdlN2Y5NThkYWFjYjBmXzMyOTg1MzQ4ODcwNTI_6fdcae2a-88c0-485a-907c-fc1e67285411"
      unitRef="usd">-191526000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDkvZnJhZzo4OTFiYTkwOGFmZGM0NzBhOWQ3ZTdmOTU4ZGFhY2IwZi90ZXh0cmVnaW9uOjg5MWJhOTA4YWZkYzQ3MGE5ZDdlN2Y5NThkYWFjYjBmXzMyOTg1MzQ4ODcwNzg_6ef6bb01-f957-43c2-8f8d-15a823350c48"
      unitRef="usd">39181000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDkvZnJhZzo4OTFiYTkwOGFmZGM0NzBhOWQ3ZTdmOTU4ZGFhY2IwZi90ZXh0cmVnaW9uOjg5MWJhOTA4YWZkYzQ3MGE5ZDdlN2Y5NThkYWFjYjBmXzM4NDgyOTA3MDQxMTE_a773eef9-fca0-43d9-8ce4-1bb75b744a17"
      unitRef="usd">69732000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="i61f1ed462e8447ffab9c8334784ff07d_D20190401-20190430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDkvZnJhZzo4OTFiYTkwOGFmZGM0NzBhOWQ3ZTdmOTU4ZGFhY2IwZi90ZXh0cmVnaW9uOjg5MWJhOTA4YWZkYzQ3MGE5ZDdlN2Y5NThkYWFjYjBmXzM4NDgyOTA3MDQxMjM_e33a2438-d422-4bcf-b964-048160544f19"
      unitRef="shares">6000000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="i6ed3f43f8f3b4ec3b256ad182faa9d25_I20190430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDkvZnJhZzo4OTFiYTkwOGFmZGM0NzBhOWQ3ZTdmOTU4ZGFhY2IwZi90ZXh0cmVnaW9uOjg5MWJhOTA4YWZkYzQ3MGE5ZDdlN2Y5NThkYWFjYjBmXzM4NDgyOTA3MDQxMzE_a4903343-efb8-4751-adcb-19111f745184"
      unitRef="usdPerShare">20.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="i61f1ed462e8447ffab9c8334784ff07d_D20190401-20190430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDkvZnJhZzo4OTFiYTkwOGFmZGM0NzBhOWQ3ZTdmOTU4ZGFhY2IwZi90ZXh0cmVnaW9uOjg5MWJhOTA4YWZkYzQ3MGE5ZDdlN2Y5NThkYWFjYjBmXzM4NDgyOTA3MDQxNDU_ab445d3b-524c-409d-8640-255e4bac1921"
      unitRef="usd">109119000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="iba3487b4fc2c4dce923c5b7f62c0537c_D20190401-20190430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDkvZnJhZzo4OTFiYTkwOGFmZGM0NzBhOWQ3ZTdmOTU4ZGFhY2IwZi90ZXh0cmVnaW9uOjg5MWJhOTA4YWZkYzQ3MGE5ZDdlN2Y5NThkYWFjYjBmXzM4NDgyOTA3MDQxNTc_b94d75eb-9825-4e59-a0d9-314b2f1bef97"
      unitRef="usd">8400000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="iee7e39f90c474f35b760d777c5110c8f_D20190401-20190430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDkvZnJhZzo4OTFiYTkwOGFmZGM0NzBhOWQ3ZTdmOTU4ZGFhY2IwZi90ZXh0cmVnaW9uOjg5MWJhOTA4YWZkYzQ3MGE5ZDdlN2Y5NThkYWFjYjBmXzM4NDgyOTA3MDQxNjk_185386f6-064f-4fe0-a1bd-be344f18e7f0"
      unitRef="usd">2481000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="i3ff09a6410f6470c9bc375b415065a88_D20190801-20190831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDkvZnJhZzo4OTFiYTkwOGFmZGM0NzBhOWQ3ZTdmOTU4ZGFhY2IwZi90ZXh0cmVnaW9uOjg5MWJhOTA4YWZkYzQ3MGE5ZDdlN2Y5NThkYWFjYjBmXzM4NDgyOTA3MDQxODA_a0f0568f-7a93-4f08-bb3a-cbb681ad15d4"
      unitRef="shares">4200000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="i2cf16617a08a49c5ba94c598a0c73b8e_D20190801-20190831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDkvZnJhZzo4OTFiYTkwOGFmZGM0NzBhOWQ3ZTdmOTU4ZGFhY2IwZi90ZXh0cmVnaW9uOjg5MWJhOTA4YWZkYzQ3MGE5ZDdlN2Y5NThkYWFjYjBmXzM4NDgyOTA3MDQxODk_4d8522c5-3b5f-49d3-a88d-5de925a4fcc0"
      unitRef="shares">630000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="i8c8377ba457f49a9969abe8f8a528e68_I20190831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMDkvZnJhZzo4OTFiYTkwOGFmZGM0NzBhOWQ3ZTdmOTU4ZGFhY2IwZi90ZXh0cmVnaW9uOjg5MWJhOTA4YWZkYzQ3MGE5ZDdlN2Y5NThkYWFjYjBmXzM4NDgyOTA3MDQxOTc_6868d927-33a0-44b6-b082-14e27a86c844"
      unitRef="usdPerShare">39.50</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90ZXh0cmVnaW9uOjZmZWQwNzhkNzVjYTQ1NWU4OTcyY2RkYjU1Nzc0NWRkXzMxMzM5_a3794ccb-1efc-4d1a-8939-c5eda03e7aa5">Summary of Significant Accounting Policies&lt;div style="margin-bottom:9pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Basis of Preparation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The accompanying financial statements have been prepared in accordance with the accounting principles generally accepted in the United States of America (&#x201c;U.S. GAAP&#x201d;).  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Adjustment to Prior Period Financial Statements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The Company has adjusted the accompanying December 31, 2018 balance sheet to increase each of the accounts receivable and accrued liabilities balances by $1,860,000 to correct for an immaterial prior year error in the classification of provisions for returns from customers.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Principles of Consolidation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;As of December 31, 2017, the consolidated financial statements of the Company include the accounts of Silk Road Medical, Inc. and its consolidated variable interest entity (&#x201c;VIE&#x201d;).  Disclosure regarding the Company&#x2019;s participation in the VIE is included in Note 12, &#x201c;Variable Interest Entity &#x2013; NeuroCo&#x201d;.  On December 17, 2018, the Company acquired all assets and assumed all liabilities of its VIE.  All intercompany balances and transactions have been eliminated in consolidation.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The preparation of financial statements in conformity with U.S.&#160;GAAP requires management to make estimates and assumptions that affect the amounts and disclosures reported in the financial statements.  Management uses judgment when making estimates related to provisions for accounts receivable and excess and obsolete inventories, the valuation of deferred tax assets, the reserves for sales returns, stock-based compensation, and for periods prior to the Company's IPO, the valuation of common stock and redeemable convertible preferred stock warrants.  Management bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources.  Although these estimates are based on the Company&#x2019;s knowledge of current events and actions it may undertake in the future, actual results may ultimately differ from these estimates and assumptions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Fair Value of Financial Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The Company has evaluated the estimated fair value of its financial instruments as of December&#160;31, 2019 and 2018.  The carrying amounts of certain of the Company&#x2019;s financial instruments, which include cash equivalents, short-term investments, long-term investments, restricted cash, accounts receivable, accounts payable and accrued liabilities approximate their respective fair values because of the short-term nature of these instruments.  Management believes that its long-term debt bears interest at the prevailing market rates for instruments with similar characteristics (Level 2 within the fair value hierarchy); accordingly, the carrying value of this instrument approximates its fair value.  Prior to the Company's IPO, fair value accounting was applied to the redeemable convertible preferred stock warrant liability.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Cash, Cash Equivalents and Restricted Cash&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The Company considers all highly liquid investments with an original maturity of three months or less at the time of purchase to be cash equivalents.  Cash equivalents are considered available-for-sale marketable securities and are recorded at fair value, based on quoted market prices.  As of December&#160;31, 2019 and 2018, the Company&#x2019;s cash equivalents are entirely comprised of investments in money market funds.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the balance sheets that sum to the total of the same amounts shown in the statements of cash flows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:69.314%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.942%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.943%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;39,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;24,990&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total cash, cash equivalents and restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;39,491&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;25,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;    &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Restricted cash as of December&#160;31, 2019 and 2018 consists of a letter of credit of $310,000 representing collateral for the Company&#x2019;s facility lease. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Investments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Short-term investments consist of debt securities classified as available-for-sale and have original maturities greater than 90 days, but less than one year as of the balance sheet date. Long-term investments have maturities greater than one year as of the balance sheet date. All investments are recorded at fair value based on the fair value hierarchy.  Money market funds are classified within Level 1 of the fair value hierarchy, and commercial paper, corporate bonds/notes, United States Government securities, and asset-backed securities are classified within Level 2 of the fair value hierarchy. &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Unrealized gains and losses, deemed temporary in nature, are reported as a separate component of accumulated other comprehensive income (loss).  The cost of available-for-sale investments sold is based on the specific-identification method. Realized gains and losses are included in earnings, and are der&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;ived for specific-identification method for determining the costs of investments sold. Amortization of premiums and accretion of discounts are reported as a component of interest income.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;A decline in the fair value of any security below cost that is deemed other than temporary results in a charge to earnings and the corresponding establishment of a new cost basis for the investment. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Concentration of Credit Risk, and Other Risks and Uncertainties&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Financial instruments that potentially subject the Company to credit risk consist of cash and cash equivalents, investments and accounts receivable to the extent of the amounts recorded on the balance sheet.  Cash, cash equivalents, and investments are deposited in financial institutions which, at times, may be in excess of federally insured limits. Cash equivalents are invested in highly rated money market funds. The Company invests in a variety of financial instruments, such as, but not limited to, commercial paper, corporate bonds/notes, United States Government securities, asset-backed securities and, by policy, limits the amount of credit exposure with any one financial institution or commercial issuer. The Company has not experienced any material losses on its deposits of cash and cash equivalents or investments during the years ended December 31, 2019 and 2018.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The Company&#x2019;s accounts receivable are due from a variety of health care organizations in the United States.  At December&#160;31, 2019 and 2018, no customer represented 10% or more of the Company&#x2019;s accounts receivable.  For the years ended December&#160;31, 2019 and 2018, there were no customers that represented 10% or more of revenue.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The Company provides for uncollectible amounts when specific credit problems are identified.  In doing so, the Company analyzes historical bad debt trends, customer credit worthiness, current economic trends and changes in customer payment patterns when evaluating the adequacy of the allowance for doubtful accounts.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The Company manufactures certain of its commercial products in-house.  Certain of the Company&#x2019;s product components and sub-assemblies continue to be manufactured by sole suppliers, the most significant of which is the ENROUTE stent.  Disruption in component or sub-assembly supply from these manufacturers or from in-house production would have a negative impact on the Company&#x2019;s financial position and results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The Company is subject to certain risks, including that its devices may not be approved or cleared for marketing by governmental authorities or be successfully marketed.  There can be no assurance that the Company&#x2019;s products will achieve widespread adoption in the marketplace, nor can there be any assurance that existing devices or any future devices can be developed or manufactured at an acceptable cost and with appropriate performance characteristics.  The Company is also subject to risks common to companies in the medical device industry, including, but not limited to, new technological innovations, dependence upon third-party payers to provide adequate coverage and reimbursement, dependence on key personnel and suppliers, protection of proprietary technology, product liability claims, and compliance with government regulations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Existing or future devices developed by the Company may require approvals or clearances from the FDA or international regulatory agencies.  In addition, in order to continue the Company&#x2019;s operations, compliance with various federal and state laws is required.  If the Company were denied or delayed in receiving such approvals or clearances, it may be necessary to adjust operations to align with the Company&#x2019;s currently approved portfolio.  If clearance for the products in the current portfolio were withdrawn by the FDA, this would have a material adverse impact on the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Accounts Receivable&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Trade accounts receivable are recorded at the invoiced amount and do not bear interest.  The Company estimates allowances for doubtful accounts.  Specifically, the Company makes estimates on the collectability of customer accounts based primarily on analysis of historical trends and experience and changes in customers&#x2019; financial condition.  The Company uses its judgment, based on the best available facts and circumstances, and records an allowance against amounts due to reduce the receivable to the amount that is expected to be collected.  These specific allowances are reevaluated and adjusted as additional information is received that impacts the amount reserved.  During the years ended December 31, 2019 and 2018, the Company did not experience any material credit-related losses.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Inventories&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Inventories are valued at the lower of cost to purchase or manufacture the inventory or net realizable value.  Cost is determined using the first-in, first-out method for all inventories.  Net realizable value is determined as the estimated selling prices in the ordinary course of business, less reasonably predictable costs of completion, disposal and transportation.  The Company regularly reviews inventory quantities in consideration of actual loss experiences, projected future demand, and remaining shelf life prior to sale to record a provision for excess and obsolete inventory when appropriate.  The Company&#x2019;s policy is to write down inventory that has become obsolete, inventory that has a cost basis in excess of its expected lower of cost or net realizable value, and inventory in excess of expected requirements.  The estimate of excess quantities is judgmental and primarily dependent on the Company&#x2019;s estimates of future demand for a particular product.  If the estimate of future demand is too high, the Company may have to increase the reserve for excess inventory for that product and record a charge to the cost of goods sold.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Property and Equipment&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Property and equipment are recorded at cost less accumulated depreciation or amortization.  Repairs and maintenance costs are expensed as incurred.  Depreciation and amortization are calculated using the straight-line method over the estimated useful lives of the assets, typically &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90ZXh0cmVnaW9uOjZmZWQwNzhkNzVjYTQ1NWU4OTcyY2RkYjU1Nzc0NWRkXzMyOTg1MzQ5NDkxMTE_2fc458bb-3e66-4101-b8da-1c4fb228a229"&gt;three&lt;/span&gt; to &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90ZXh0cmVnaW9uOjZmZWQwNzhkNzVjYTQ1NWU4OTcyY2RkYjU1Nzc0NWRkXzMyOTg1MzQ5NDkxMTU_fb1b7f55-5035-426c-9941-0c64a4cba092"&gt;five&lt;/span&gt; years.  Leasehold &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;improvements are amortized using the straight-line method over the shorter of the lease term or estimated useful economic life of the asset.  When assets are retired or otherwise disposed of, the cost and accumulated depreciation are removed from the balance sheet and any resulting gain or loss is reflected in operations in the period realized.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Deferred Public Offering Costs&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Specific incremental legal, accounting and other fees and costs directly attributable to a proposed or actual offering of securities may properly be deferred and charged against the gross proceeds of the offering.  &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;As of December&#160;31, 2018, there were $950,000 of offering costs primarily consisting of legal and accounting fees that were capitalized in other non-current assets on the balance sheet of which $233,000 had been paid.  No deferred offering costs were capitalized as of &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Impairment of Long-Lived Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The Company reviews long-lived assets, including property and equipment, for impairment whenever events or changes in business circumstances indicate that the carrying amount of the assets may not be fully recoverable.  If indicators of impairment exist, an impairment loss would be recognized when estimated undiscounted future cash flows expected to result from the use of the assets and their eventual disposition are less than their carrying amount.  Impairment, if any, is measured as the amount by which the carrying amount of the long-lived assets exceeds their fair value.  The Company did not record any impairment of long-lived assets during the years ended December&#160;31, 2019 and 2018.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The Company adopted Accounting Standards Codification (&#x201c;ASC&#x201d;) 842, "Leases," on January 1, 2019 and used the modified retrospective method for all leases not substantially completed as of the date of adoption and the package of practical expedients available in the standard.  As a result of adopting ASC 842, the Company recorded an operating lease right-of-use ("ROU") asset of $3,982,000 included within other non-current assets and operating lease liabilities of $5,190,000 included within accrued liabilities and other liabilities on the balance sheet related to its facility lease, based on the present value of the future lease payments on the date of adoption.  The operating lease right-of-use asset also includes adjustments for prepayments and excludes lease incentives.  The adoption did not have an impact on prior periods or on the Company's statements of operations and comprehensive loss.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The disclosure impact of the adoption of ASC 842 on the balance sheet was as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:51.685%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:13.224%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.441%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.903%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.441%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.906%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Balance Sheet:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Balance at December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Adjustments Due to ASC 842&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Balance at January 1, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other non-current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,982&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,982&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;721&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,069&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The Company considers if an arrangement is a lease at inception if it obtains the right to control the use of an identified asset under a leasing arrangement with an initial term greater than twelve months.  The Company determines whether a contract conveys the right to control the use of an identified asset for a period of time if the contract contains both the right to obtain substantially all of the economic benefits from the use of the identified asset and the right to direct the use of the identified asset.  The Company also evaluates the nature of each lease to determine whether it is an operating or financing lease and recognizes the right-of-use asset and lease liabilities based on the present value of future minimum lease &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;payments over the expected lease term.  The Company&#x2019;s leases do not generally contain an implicit interest rate and therefore the Company uses the incremental borrowing rate it would expect to pay to borrow on a similar collateralized basis over a similar term in order to determine the present value of its lease payments.  The Company&#x2019;s considers renewal options in the determination of the lease term if the option to renew is reasonably certain.  Variable lease costs represent payments that are dependent on usage, a rate or index.  Variable lease costs, which consists primarily of taxes, insurance and common area maintenance costs, are expensed as incurred, as the Company has elected to account separately for contracts that contain lease and non-lease components, consistent with its historical practice.  The Company does not have any finance leases.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Redeemable Convertible Preferred Stock Warrant Liability&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Prior to its IPO, the Company accounted for its warrants for shares of redeemable convertible preferred stock as a liability based upon the characteristics and provisions of each instrument.  Redeemable convertible preferred stock warrants classified as a liability were initially recorded at their fair value on the date of issuance and are subject to remeasurement at each subsequent balance sheet date.  Any change in fair value as a result of a remeasurement was recognized as a component of other income (expense), net in the statements of operations and comprehensive loss.  &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The Company recorded adjustments to the estimated fair value of the redeemable convertible preferred stock warrants until they were exercised. Upon their exercise, the final fair value of the warrant liability was reclassified to stockholders&#x2019; equity (deficit). Subsequent to its IPO, the Company no longer recorded any related periodic fair value adjustments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Redeemable Convertible Preferred Stock&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Prior to its IPO, the Company recorded its redeemable convertible preferred stock at fair value on the dates of issuance, net of issuance costs, and classified the redeemable convertible preferred stock outside of stockholders&#x2019; equity (deficit) on the balance sheet as events triggering the liquidation preferences were not solely within the Company&#x2019;s control. Upon the closing of the Company's IPO, all shares of convertible preferred stock then outstanding converted into an aggregate of 23,178,555 shares of common stock resulting in the reclassification of $144,140,000 from outside of stockholders&#x2019; equity (deficit) to additional paid-in capital.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;On&#160;January&#160;1, 2018, the Company adopted ASC Topic 606,&#160;&#x201c;Revenue from Contracts with Customers,&#x201d; using the modified retrospective method applied to contracts which were not completed as of that date.&#160;&#160;Under ASC 606, revenue is recognized when a customer obtains control of promised goods or services, in an amount that reflects the consideration which the entity expects to receive in exchange for those goods or services.  To determine revenue recognition for arrangements that an entity determines are within the scope of ASC 606, the Company performs the following five steps: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-26.88pt;padding-left:36pt;margin-bottom:9pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;(i)&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18pt;"&gt;identify the contract(s) with a customer; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-29.1pt;padding-left:36pt;margin-bottom:9pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;(ii)&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18pt;"&gt;identify the performance obligations in the contract; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-31.32pt;padding-left:36pt;margin-bottom:9pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;(iii)&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18pt;"&gt;determine the transaction price;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-31.88pt;padding-left:36pt;margin-bottom:9pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;(iv)&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18pt;"&gt;allocate the transaction price to the performance obligations in the contract; and &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-29.66pt;padding-left:36pt;margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;(v)&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18pt;"&gt;recognize revenue when (or as) the entity satisfies a performance obligation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Under ASC 606, assuming all other revenue recognition criteria have been met, the Company will recognize revenue earlier for arrangements where the Company has satisfied its performance obligations &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;but have not issued invoices.&#160;&#160;As of December&#160;31, 2019 and 2018, the Company recorded $102,000 and $128,000, respectively, of unbilled receivables, which are included in accounts receivable, net on the balance sheet, as the Company has an unconditional right to payment as of the end of the applicable period.&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The Company&#x2019;s revenue is generated from the sale of its products to hospitals and medical centers in the United States through direct sales representatives.  Revenue is recognized when obligations under the terms of a contract with customers are satisfied, which occurs with the transfer of control of the Company&#x2019;s products to its customers, either upon shipment of the product or delivery of the product to the customer under the Company&#x2019;s standard terms and conditions.&#160;&#160;The Company&#x2019;s products are readily available for usage as soon as the customer possesses it.  Upon receipt, the customer controls the economic benefits of the product, has significant risks and rewards, and the legal title.  The Company has present right to payment; therefore, the transfer of control is deemed to happen at a point in time.  Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring the goods.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;For sales where the Company&#x2019;s sales representative hand delivers product directly to the hospital or medical center from the sales representative&#x2019;s trunk stock inventory, the Company recognizes revenue upon delivery, which represents the point in time when control transfers to the customer.  Upon delivery there are legally-enforceable rights and obligations between the parties which can be identified, commercial substance exists and collectibility is probable.  For sales which are sent directly from the Company to hospitals and medical centers, the transfer of control occurs at the time of shipment or delivery of the product.&#160; There are no further performance obligations by the Company or the sales representative to the customer after delivery under either method of sale.  As allowed under the practical expedient, the Company does not disclose the value of unsatisfied performance obligations for (i) contracts with an original expected length of one year or less and (ii) contracts for which it recognizes revenue at the amount to which it has the right to invoice for services performed.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The Company&#160;is entitled to the total consideration for the products ordered by customers&#160;as&#160;product pricing&#160;is&#160;fixed according to the terms of customer contracts and payment terms&#160;are&#160;short.  Payment terms fall within the one-year guidance for the practical expedient which allows the Company to forgo adjustment of the promised amount of consideration for the effects of a significant financing component.  The Company&#160;excludes&#160;taxes assessed by governmental authorities on revenue-producing transactions from the measurement of the transaction price.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Costs associated with product sales include commissions and royalties.  The Company applies the practical expedient and recognizes commissions and royalties as expense when incurred because the expense is incurred at a point in time and the amortization period is less than one year.&#160; Commissions are recorded as selling expense&#160;and royalties are recorded as&#160;cost of revenue&#160;in the&#160;statements of operations and comprehensive loss.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The Company accepts product returns at its discretion or if the product is defective as manufactured.  The Company establishes estimated provisions for returns based on historical experience and considers other factors that it believes could significantly impact its expected returns, which provisions are classified within accrued liabilities on our balance sheet.&#160; The Company elected to expense shipping and handling costs as incurred and includes them in the cost of goods sold.  In those cases where the Company bills shipping and handling costs to customers, it will classify the amounts billed as a component of revenue.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Cost of Goods Sold&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The Company manufactures certain of its portfolio of TCAR products at its facility and purchases other products from third party manufacturers.  Cost of goods sold consists primarily of costs related to &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;materials, components and subassemblies, manufacturing overhead costs, direct labor, reserves for excess, obsolete and non-sellable inventories as well as distribution-related expenses.  A significant portion of the Company&#x2019;s cost of goods sold currently consists of manufacturing overhead costs.  These overhead costs include the cost of quality assurance, material procurement, inventory control, facilities, equipment and operations supervision and management.  Cost of goods sold also includes depreciation expense for production equipment and certain direct costs such as shipping costs and royalties.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Research and Development&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The Company expenses research and development costs as incurred.  Research and development expenses consist primarily of engineering, product development, clinical studies to develop and support the Company&#x2019;s products, regulatory expenses, medical affairs and other costs associated with products and technologies that are in development.  Research and development expenses include employee compensation, including stock-based compensation, supplies, consulting, prototyping, testing, materials, travel expenses, depreciation and an allocation of facility overhead expenses.  Additionally, research and development expenses include costs associated with our clinical studies including clinical trial design, clinical site reimbursement, data management, travel expenses and the cost of products used for clinical trials and internal and external costs associated with the Company&#x2019;s regulatory compliance and quality assurance functions, including the costs of outside consultants and contractors that assist in the process of submitting and maintaining regulatory filings, and overhead costs. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Clinical Trials&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The Company accrues and expenses costs for its clinical trial activities performed by third parties, including clinical research organizations and other service providers, based upon estimates of the work completed over the life of the individual study in accordance with associated agreements.  The Company determines these accruals through discussion with internal personnel and outside service providers as to progress or stage of completion of trials or services pursuant to contracts with clinical research organizations and other service providers and the agreed-upon fee to be paid for such services.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Advertising Costs&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The Company expenses advertising costs as incurred.  Advertising costs include design and production costs, including website development, physician and patient testimonial videos, written media campaigns, and other items.  Advertising costs of $362,000 and $186,000 were expensed during the years ended December&#160;31, 2019 and 2018, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Foreign Currency&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The Company records net gains and losses resulting from foreign exchange transactions as a component of foreign currency exchange gains or losses in other income (expense), net.  The Company had no material foreign currency exchange gains or losses during the years ended December&#160;31, 2019 and 2018.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Stock&#x2013;Based Compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The Company accounts for stock-based compensation in accordance with Financial Accounting Standards Board (&#x201c;FASB&#x201d;) ASC 718,&#160;&#x201c;Compensation-Stock Compensation.&#x201d;  ASC 718 requires the recognition of compensation expense, using a fair-value based method, for costs related to all share-based payments including stock options.  ASC 718 requires companies to estimate the fair value of all share-based payment option awards on the date of grant using an option pricing model.  The fair value of stock options is recognized over the period during which an optionee is required to provide services in exchange for the option award, known as the requisite service period (usually the vesting period), on a &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;straight-line basis.  For performance-based stock options, the Company will assess the probability of performance conditions being achieved in each reporting period.  The amount of stock-based compensation expense recognized in any one period related to performance-based stock options can vary based on the achievement or anticipated achievement of the performance conditions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In March 2016, the FASB issued Accounting Standards Update ("ASU") No. 2016-09,&#160;&#x201c;Stock Compensation (Topic 718): Improvements to Employee Shared-Based Payment Accounting.&#x201d;&#160; Under ASU 2016-09, entities are permitted to make an accounting policy election to either estimate forfeitures on share-based payment awards, as previously required, or to recognize forfeitures as they occur.  The Company made an accounting policy election to account for forfeitures as they occur.  This change has been applied on a modified retrospective basis, resulting in a cumulative-effect adjustment to increase the beginning accumulated deficit by $13,000&#160;as of January&#160;1, 2018, the date of adoption.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The Company accounts for income taxes under the liability method, whereby deferred tax assets and liabilities are determined based on the difference between the financial statements and tax bases of assets and liabilities using the enacted tax rates in effect for the year in which the differences are expected to affect taxable income.  A valuation allowance is established when necessary to reduce deferred tax assets to the amounts expected to be realized.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The Company also follows the provisions of ASC 740-10, &#x201c;Accounting for Uncertainty in Income Taxes.&#x201d;  ASC 740-10 prescribes a comprehensive model for the recognition, measurement, presentation and disclosure in financial statements of any uncertain tax positions that have been taken or expected to be taken on a tax return.  No liability related to uncertain tax positions is recorded on the financial statements.  It is the Company&#x2019;s policy to include penalties and interest expense related to income taxes as part of the provision for income taxes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Comprehensive Loss&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Comprehensive loss consists of net loss and changes in unrealized gains and losses on investments classified as available-for-sale.  For the year ended &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;December&#160;31, 2019&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;, the Company&#x2019;s unrealized gains and losses on available-for-sale investments represent the only component of other comprehensive loss that are excluded from the reported net loss and that are presented in the statements of operations and comprehensive income.  Accumulated other comprehensive loss is presented in the accompanying balance sheets as a component of stockholders' equity (deficit).  For the year ended December&#160;31, 2018, there was no difference between the Company's comprehensive loss and its net loss.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Net Loss per Share Attributable to Common Stockholders&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Basic net loss per share is computed by dividing the net loss attributable to common stockholders by the weighted average number of shares of common stock outstanding during the period, without consideration for potential dilutive common shares.  Diluted net loss per share is computed by dividing the net loss attributable to common stockholders by the weighted average number of shares of common stock and potentially dilutive securities outstanding for the period.  For purposes of the diluted net loss per share calculation, redeemable convertible preferred stock and warrants, and common stock options are considered to be potentially dilutive securities.  Since the Company was in a loss position for all periods presented, basic net loss per share is the same as diluted net loss per share as the inclusion of all potential dilutive common shares would have been anti-dilutive.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The Company allocates no loss to participating securities because they have no contractual obligation to share in the losses of the Company.  The shares of the Company&#x2019;s redeemable convertible preferred &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;stock participate in any dividends declared by the Company and are therefore considered to be participating securities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Net loss per share was determined as follows (in thousands, except share and per share data):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:69.314%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.942%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.943%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Net loss attributable to Silk Road Medical, Inc. common stockholders&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(52,415)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(37,629)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Weighted average common stock outstanding used to compute net loss per share, basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;22,956,679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;960,882&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Net loss per share attributable to Silk Road Medical, Inc. common stockholders, basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(2.28)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(39.16)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The following potentially dilutive securities outstanding have been excluded from the computation of diluted weighted average shares outstanding because such securities have an antidilutive impact due to the Company&#x2019;s net loss:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;margin-bottom:9pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:69.314%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.942%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.943%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Redeemable convertible preferred stock outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;21,233,190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Redeemable convertible preferred stock warrants outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,672,502&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Common stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,310,790&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,364,377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Common stock warrants outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;7,527&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,310,790&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;28,277,596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Segment and Geographical Information&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The Company operates and manages its business as one reportable and operating segment.  The Company&#x2019;s chief executive officer, who is the chief operating decision maker, reviews financial information on an aggregate basis for purposes of allocating resources and evaluating financial performance.  All of the Company&#x2019;s long-lived assets are based in the United States.  Long-lived assets are comprised of property and equipment.  All of the Company&#x2019;s revenue was in the United States for the years ended December&#160;31, 2019 and 2018, based on the shipping location of the external customer.&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90ZXh0cmVnaW9uOjZmZWQwNzhkNzVjYTQ1NWU4OTcyY2RkYjU1Nzc0NWRkXzMxMzQ3_8154f54f-ce00-4046-b7fc-69e9c7fbaf0f">&lt;div style="margin-bottom:9pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Basis of Preparation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The accompanying financial statements have been prepared in accordance with the accounting principles generally accepted in the United States of America (&#x201c;U.S. GAAP&#x201d;).  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Adjustment to Prior Period Financial Statements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The Company has adjusted the accompanying December 31, 2018 balance sheet to increase each of the accounts receivable and accrued liabilities balances by $1,860,000 to correct for an immaterial prior year error in the classification of provisions for returns from customers.&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i733162f186ac41fb8f9b99aa842ef13f_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90ZXh0cmVnaW9uOjZmZWQwNzhkNzVjYTQ1NWU4OTcyY2RkYjU1Nzc0NWRkXzIxOTkwMjMzNDMzNzQ_db39ce40-e3d0-4ed0-a1bd-c5d84d789990"
      unitRef="usd">1860000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:ConsolidationPolicyTextBlock
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90ZXh0cmVnaW9uOjZmZWQwNzhkNzVjYTQ1NWU4OTcyY2RkYjU1Nzc0NWRkXzMxMzQ4_7eb0ccc5-ee8c-48e3-b330-e1475829706d">Principles of ConsolidationAs of December 31, 2017, the consolidated financial statements of the Company include the accounts of Silk Road Medical, Inc. and its consolidated variable interest entity (&#x201c;VIE&#x201d;).  Disclosure regarding the Company&#x2019;s participation in the VIE is included in Note 12, &#x201c;Variable Interest Entity &#x2013; NeuroCo&#x201d;.  On December 17, 2018, the Company acquired all assets and assumed all liabilities of its VIE.  All intercompany balances and transactions have been eliminated in consolidation.</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90ZXh0cmVnaW9uOjZmZWQwNzhkNzVjYTQ1NWU4OTcyY2RkYjU1Nzc0NWRkXzMxMzQx_1c41c7f9-9e94-4287-9d4a-5e14cc30e201">&lt;div style="margin-bottom:9pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The preparation of financial statements in conformity with U.S.&#160;GAAP requires management to make estimates and assumptions that affect the amounts and disclosures reported in the financial statements.  Management uses judgment when making estimates related to provisions for accounts receivable and excess and obsolete inventories, the valuation of deferred tax assets, the reserves for sales returns, stock-based compensation, and for periods prior to the Company's IPO, the valuation of common stock and redeemable convertible preferred stock warrants.  Management bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources.  Although these estimates are based on the Company&#x2019;s knowledge of current events and actions it may undertake in the future, actual results may ultimately differ from these estimates and assumptions.&lt;/span&gt;&lt;/div&gt;</us-gaap:UseOfEstimates>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90ZXh0cmVnaW9uOjZmZWQwNzhkNzVjYTQ1NWU4OTcyY2RkYjU1Nzc0NWRkXzMxMzQ5_7d56b839-8482-4da2-a34d-a805bf3367bf">&lt;div style="margin-bottom:9pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Fair Value of Financial Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The Company has evaluated the estimated fair value of its financial instruments as of December&#160;31, 2019 and 2018.  The carrying amounts of certain of the Company&#x2019;s financial instruments, which include cash equivalents, short-term investments, long-term investments, restricted cash, accounts receivable, accounts payable and accrued liabilities approximate their respective fair values because of the short-term nature of these instruments.  Management believes that its long-term debt bears interest at the prevailing market rates for instruments with similar characteristics (Level 2 within the fair value hierarchy); accordingly, the carrying value of this instrument approximates its fair value.  Prior to the Company's IPO, fair value accounting was applied to the redeemable convertible preferred stock warrant liability.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90ZXh0cmVnaW9uOjZmZWQwNzhkNzVjYTQ1NWU4OTcyY2RkYjU1Nzc0NWRkXzMxMzMw_445c7a07-5c8b-4cb8-bdeb-133d00c9584f">&lt;div style="margin-bottom:9pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Cash, Cash Equivalents and Restricted Cash&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The Company considers all highly liquid investments with an original maturity of three months or less at the time of purchase to be cash equivalents.  Cash equivalents are considered available-for-sale marketable securities and are recorded at fair value, based on quoted market prices.  As of December&#160;31, 2019 and 2018, the Company&#x2019;s cash equivalents are entirely comprised of investments in money market funds.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the balance sheets that sum to the total of the same amounts shown in the statements of cash flows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:69.314%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.942%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.943%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;39,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;24,990&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total cash, cash equivalents and restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;39,491&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;25,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;    &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Restricted cash as of December&#160;31, 2019 and 2018 consists of a letter of credit of $310,000 representing collateral for the Company&#x2019;s facility lease. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Investments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Short-term investments consist of debt securities classified as available-for-sale and have original maturities greater than 90 days, but less than one year as of the balance sheet date. Long-term investments have maturities greater than one year as of the balance sheet date. All investments are recorded at fair value based on the fair value hierarchy.  Money market funds are classified within Level 1 of the fair value hierarchy, and commercial paper, corporate bonds/notes, United States Government securities, and asset-backed securities are classified within Level 2 of the fair value hierarchy. &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Unrealized gains and losses, deemed temporary in nature, are reported as a separate component of accumulated other comprehensive income (loss).  The cost of available-for-sale investments sold is based on the specific-identification method. Realized gains and losses are included in earnings, and are der&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;ived for specific-identification method for determining the costs of investments sold. Amortization of premiums and accretion of discounts are reported as a component of interest income.&lt;/span&gt;&lt;/div&gt;A decline in the fair value of any security below cost that is deemed other than temporary results in a charge to earnings and the corresponding establishment of a new cost basis for the investment.</us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy>
    <us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90ZXh0cmVnaW9uOjZmZWQwNzhkNzVjYTQ1NWU4OTcyY2RkYjU1Nzc0NWRkXzMxMzM2_a884c050-a2cd-401d-a443-321f3a9a1d7e">&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the balance sheets that sum to the total of the same amounts shown in the statements of cash flows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:69.314%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.942%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.943%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;39,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;24,990&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total cash, cash equivalents and restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;39,491&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;25,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock>
    <us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90ZXh0cmVnaW9uOjZmZWQwNzhkNzVjYTQ1NWU4OTcyY2RkYjU1Nzc0NWRkXzMxMzUw_a7205185-2d26-460b-aad8-eea4b182458f">&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the balance sheets that sum to the total of the same amounts shown in the statements of cash flows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:69.314%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.942%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.943%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;39,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;24,990&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total cash, cash equivalents and restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;39,491&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;25,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90YWJsZTozMjExMTlhYTJmYWY0M2MwOGVkOWMyMWRiOWM0NGQ2ZS90YWJsZXJhbmdlOjMyMTExOWFhMmZhZjQzYzA4ZWQ5YzIxZGI5YzQ0ZDZlXzItMS0xLTEtMA_af6e98a6-8b94-4161-b09b-04b7092e100d"
      unitRef="usd">39181000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90YWJsZTozMjExMTlhYTJmYWY0M2MwOGVkOWMyMWRiOWM0NGQ2ZS90YWJsZXJhbmdlOjMyMTExOWFhMmZhZjQzYzA4ZWQ5YzIxZGI5YzQ0ZDZlXzItMy0xLTEtMA_74796bcb-87e9-45b8-b398-1a0c0d2fd170"
      unitRef="usd">24990000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90YWJsZTozMjExMTlhYTJmYWY0M2MwOGVkOWMyMWRiOWM0NGQ2ZS90YWJsZXJhbmdlOjMyMTExOWFhMmZhZjQzYzA4ZWQ5YzIxZGI5YzQ0ZDZlXzMtMS0xLTEtMA_f2f672d7-8b27-48d1-88ad-38b8467c8dfd"
      unitRef="usd">310000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90YWJsZTozMjExMTlhYTJmYWY0M2MwOGVkOWMyMWRiOWM0NGQ2ZS90YWJsZXJhbmdlOjMyMTExOWFhMmZhZjQzYzA4ZWQ5YzIxZGI5YzQ0ZDZlXzMtMy0xLTEtMA_b612df3b-f3db-479d-b6fb-a547170ea4b2"
      unitRef="usd">310000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90YWJsZTozMjExMTlhYTJmYWY0M2MwOGVkOWMyMWRiOWM0NGQ2ZS90YWJsZXJhbmdlOjMyMTExOWFhMmZhZjQzYzA4ZWQ5YzIxZGI5YzQ0ZDZlXzQtMS0xLTEtMA_707e3707-f024-4cdd-adc5-14c36b08b882"
      unitRef="usd">39491000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90YWJsZTozMjExMTlhYTJmYWY0M2MwOGVkOWMyMWRiOWM0NGQ2ZS90YWJsZXJhbmdlOjMyMTExOWFhMmZhZjQzYzA4ZWQ5YzIxZGI5YzQ0ZDZlXzQtMy0xLTEtMA_25324cfb-ba91-4c6d-8d4e-c00cea8aa982"
      unitRef="usd">25300000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="iec135774dba44b3cb207fe343988137e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90ZXh0cmVnaW9uOjZmZWQwNzhkNzVjYTQ1NWU4OTcyY2RkYjU1Nzc0NWRkXzM4NDgyOTA3NDAzNjA_2df307b6-aa4b-488d-8b63-08df00874be2"
      unitRef="usd">310000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="ia68f07ad6fdb42d6837b98ba4cba8d55_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90ZXh0cmVnaW9uOjZmZWQwNzhkNzVjYTQ1NWU4OTcyY2RkYjU1Nzc0NWRkXzM4NDgyOTA3NDAzNjA_db4035bc-e246-4aa2-b0e9-1f8e225b787a"
      unitRef="usd">310000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:ConcentrationRiskCreditRisk
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90ZXh0cmVnaW9uOjZmZWQwNzhkNzVjYTQ1NWU4OTcyY2RkYjU1Nzc0NWRkXzMxMzMx_6222c9ba-49cf-4b0c-bdef-dfe89cef3f17">&lt;div style="margin-bottom:9pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Concentration of Credit Risk, and Other Risks and Uncertainties&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Financial instruments that potentially subject the Company to credit risk consist of cash and cash equivalents, investments and accounts receivable to the extent of the amounts recorded on the balance sheet.  Cash, cash equivalents, and investments are deposited in financial institutions which, at times, may be in excess of federally insured limits. Cash equivalents are invested in highly rated money market funds. The Company invests in a variety of financial instruments, such as, but not limited to, commercial paper, corporate bonds/notes, United States Government securities, asset-backed securities and, by policy, limits the amount of credit exposure with any one financial institution or commercial issuer. The Company has not experienced any material losses on its deposits of cash and cash equivalents or investments during the years ended December 31, 2019 and 2018.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The Company&#x2019;s accounts receivable are due from a variety of health care organizations in the United States.  At December&#160;31, 2019 and 2018, no customer represented 10% or more of the Company&#x2019;s accounts receivable.  For the years ended December&#160;31, 2019 and 2018, there were no customers that represented 10% or more of revenue.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The Company provides for uncollectible amounts when specific credit problems are identified.  In doing so, the Company analyzes historical bad debt trends, customer credit worthiness, current economic trends and changes in customer payment patterns when evaluating the adequacy of the allowance for doubtful accounts.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The Company manufactures certain of its commercial products in-house.  Certain of the Company&#x2019;s product components and sub-assemblies continue to be manufactured by sole suppliers, the most significant of which is the ENROUTE stent.  Disruption in component or sub-assembly supply from these manufacturers or from in-house production would have a negative impact on the Company&#x2019;s financial position and results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The Company is subject to certain risks, including that its devices may not be approved or cleared for marketing by governmental authorities or be successfully marketed.  There can be no assurance that the Company&#x2019;s products will achieve widespread adoption in the marketplace, nor can there be any assurance that existing devices or any future devices can be developed or manufactured at an acceptable cost and with appropriate performance characteristics.  The Company is also subject to risks common to companies in the medical device industry, including, but not limited to, new technological innovations, dependence upon third-party payers to provide adequate coverage and reimbursement, dependence on key personnel and suppliers, protection of proprietary technology, product liability claims, and compliance with government regulations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Existing or future devices developed by the Company may require approvals or clearances from the FDA or international regulatory agencies.  In addition, in order to continue the Company&#x2019;s operations, compliance with various federal and state laws is required.  If the Company were denied or delayed in receiving such approvals or clearances, it may be necessary to adjust operations to align with the Company&#x2019;s currently approved portfolio.  If clearance for the products in the current portfolio were withdrawn by the FDA, this would have a material adverse impact on the Company.&lt;/span&gt;&lt;/div&gt;</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:TradeAndOtherAccountsReceivablePolicy
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90ZXh0cmVnaW9uOjZmZWQwNzhkNzVjYTQ1NWU4OTcyY2RkYjU1Nzc0NWRkXzIxOTkwMjMzMjQ3MTU_1dfe41da-4440-49f0-bd34-c8c463f7842b">&lt;div style="margin-bottom:9pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Accounts Receivable&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Trade accounts receivable are recorded at the invoiced amount and do not bear interest.  The Company estimates allowances for doubtful accounts.  Specifically, the Company makes estimates on the collectability of customer accounts based primarily on analysis of historical trends and experience and changes in customers&#x2019; financial condition.  The Company uses its judgment, based on the best available facts and circumstances, and records an allowance against amounts due to reduce the receivable to the amount that is expected to be collected.  These specific allowances are reevaluated and adjusted as additional information is received that impacts the amount reserved.  During the years ended December 31, 2019 and 2018, the Company did not experience any material credit-related losses.&lt;/span&gt;&lt;/div&gt;</us-gaap:TradeAndOtherAccountsReceivablePolicy>
    <us-gaap:InventoryPolicyTextBlock
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90ZXh0cmVnaW9uOjZmZWQwNzhkNzVjYTQ1NWU4OTcyY2RkYjU1Nzc0NWRkXzIxOTkwMjMzMjQ3MTY_27554467-eb03-4e30-b42e-dd32fdffafc9">&lt;div style="margin-bottom:9pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Inventories&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Inventories are valued at the lower of cost to purchase or manufacture the inventory or net realizable value.  Cost is determined using the first-in, first-out method for all inventories.  Net realizable value is determined as the estimated selling prices in the ordinary course of business, less reasonably predictable costs of completion, disposal and transportation.  The Company regularly reviews inventory quantities in consideration of actual loss experiences, projected future demand, and remaining shelf life prior to sale to record a provision for excess and obsolete inventory when appropriate.  The Company&#x2019;s policy is to write down inventory that has become obsolete, inventory that has a cost basis in excess of its expected lower of cost or net realizable value, and inventory in excess of expected requirements.  The estimate of excess quantities is judgmental and primarily dependent on the Company&#x2019;s estimates of future demand for a particular product.  If the estimate of future demand is too high, the Company may have to increase the reserve for excess inventory for that product and record a charge to the cost of goods sold.&lt;/span&gt;&lt;/div&gt;</us-gaap:InventoryPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90ZXh0cmVnaW9uOjZmZWQwNzhkNzVjYTQ1NWU4OTcyY2RkYjU1Nzc0NWRkXzIxOTkwMjMzMjQ3MTc_f67e6c0a-b2cb-4b32-86dc-1838991d1b6e">&lt;div style="margin-bottom:9pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Property and Equipment&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Property and equipment are recorded at cost less accumulated depreciation or amortization.  Repairs and maintenance costs are expensed as incurred.  Depreciation and amortization are calculated using the straight-line method over the estimated useful lives of the assets, typically &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90ZXh0cmVnaW9uOjZmZWQwNzhkNzVjYTQ1NWU4OTcyY2RkYjU1Nzc0NWRkXzMyOTg1MzQ5NDkxMTE_2fc458bb-3e66-4101-b8da-1c4fb228a229"&gt;three&lt;/span&gt; to &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90ZXh0cmVnaW9uOjZmZWQwNzhkNzVjYTQ1NWU4OTcyY2RkYjU1Nzc0NWRkXzMyOTg1MzQ5NDkxMTU_fb1b7f55-5035-426c-9941-0c64a4cba092"&gt;five&lt;/span&gt; years.  Leasehold &lt;/span&gt;&lt;/div&gt;improvements are amortized using the straight-line method over the shorter of the lease term or estimated useful economic life of the asset.  When assets are retired or otherwise disposed of, the cost and accumulated depreciation are removed from the balance sheet and any resulting gain or loss is reflected in operations in the period realized.</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:DeferredChargesPolicyTextBlock
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90ZXh0cmVnaW9uOjZmZWQwNzhkNzVjYTQ1NWU4OTcyY2RkYjU1Nzc0NWRkXzMxMzQy_6c3fb3cb-7f8c-4249-acab-1796d1d1cf72">Deferred Public Offering Costs&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Specific incremental legal, accounting and other fees and costs directly attributable to a proposed or actual offering of securities may properly be deferred and charged against the gross proceeds of the offering.  &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;As of December&#160;31, 2018, there were $950,000 of offering costs primarily consisting of legal and accounting fees that were capitalized in other non-current assets on the balance sheet of which $233,000 had been paid.  No deferred offering costs were capitalized as of &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;December&#160;31, 2019&lt;/span&gt;.</us-gaap:DeferredChargesPolicyTextBlock>
    <us-gaap:DeferredOfferingCosts
      contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90ZXh0cmVnaW9uOjZmZWQwNzhkNzVjYTQ1NWU4OTcyY2RkYjU1Nzc0NWRkXzMyOTg1MzQ5MTQ5NDk_283dd04a-5b7e-4961-afaf-b8fc4009192c"
      unitRef="usd">950000</us-gaap:DeferredOfferingCosts>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90ZXh0cmVnaW9uOjZmZWQwNzhkNzVjYTQ1NWU4OTcyY2RkYjU1Nzc0NWRkXzMyOTg1MzQ5NDY5NDE_f74e2e0d-e9ba-4ee7-87a5-88326b435ba7"
      unitRef="usd">233000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:DeferredOfferingCosts
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90ZXh0cmVnaW9uOjZmZWQwNzhkNzVjYTQ1NWU4OTcyY2RkYjU1Nzc0NWRkXzIxOTkwMjMzMjQ3MjM_d5f73093-1ff1-4d05-8fd2-21711edbe635"
      unitRef="usd">0</us-gaap:DeferredOfferingCosts>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90ZXh0cmVnaW9uOjZmZWQwNzhkNzVjYTQ1NWU4OTcyY2RkYjU1Nzc0NWRkXzIxOTkwMjMzMjQ3MTg_fda5a6f5-66e1-4f0c-b961-8be160a2bded">Impairment of Long-Lived AssetsThe Company reviews long-lived assets, including property and equipment, for impairment whenever events or changes in business circumstances indicate that the carrying amount of the assets may not be fully recoverable.  If indicators of impairment exist, an impairment loss would be recognized when estimated undiscounted future cash flows expected to result from the use of the assets and their eventual disposition are less than their carrying amount.  Impairment, if any, is measured as the amount by which the carrying amount of the long-lived assets exceeds their fair value.</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
    <us-gaap:LesseeLeasesPolicyTextBlock
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90ZXh0cmVnaW9uOjZmZWQwNzhkNzVjYTQ1NWU4OTcyY2RkYjU1Nzc0NWRkXzIxOTkwMjMzMjQ3MTk_d3adc324-acb4-40e0-808b-b472a0f24d3e">&lt;div style="margin-bottom:9pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The Company adopted Accounting Standards Codification (&#x201c;ASC&#x201d;) 842, "Leases," on January 1, 2019 and used the modified retrospective method for all leases not substantially completed as of the date of adoption and the package of practical expedients available in the standard.  As a result of adopting ASC 842, the Company recorded an operating lease right-of-use ("ROU") asset of $3,982,000 included within other non-current assets and operating lease liabilities of $5,190,000 included within accrued liabilities and other liabilities on the balance sheet related to its facility lease, based on the present value of the future lease payments on the date of adoption.  The operating lease right-of-use asset also includes adjustments for prepayments and excludes lease incentives.  The adoption did not have an impact on prior periods or on the Company's statements of operations and comprehensive loss.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The disclosure impact of the adoption of ASC 842 on the balance sheet was as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:51.685%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:13.224%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.441%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.903%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.441%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.906%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Balance Sheet:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Balance at December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Adjustments Due to ASC 842&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Balance at January 1, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other non-current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,982&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,982&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;721&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,069&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The Company considers if an arrangement is a lease at inception if it obtains the right to control the use of an identified asset under a leasing arrangement with an initial term greater than twelve months.  The Company determines whether a contract conveys the right to control the use of an identified asset for a period of time if the contract contains both the right to obtain substantially all of the economic benefits from the use of the identified asset and the right to direct the use of the identified asset.  The Company also evaluates the nature of each lease to determine whether it is an operating or financing lease and recognizes the right-of-use asset and lease liabilities based on the present value of future minimum lease &lt;/span&gt;&lt;/div&gt;payments over the expected lease term.  The Company&#x2019;s leases do not generally contain an implicit interest rate and therefore the Company uses the incremental borrowing rate it would expect to pay to borrow on a similar collateralized basis over a similar term in order to determine the present value of its lease payments.  The Company&#x2019;s considers renewal options in the determination of the lease term if the option to renew is reasonably certain.  Variable lease costs represent payments that are dependent on usage, a rate or index.  Variable lease costs, which consists primarily of taxes, insurance and common area maintenance costs, are expensed as incurred, as the Company has elected to account separately for contracts that contain lease and non-lease components, consistent with its historical practice.  The Company does not have any finance leases.</us-gaap:LesseeLeasesPolicyTextBlock>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i0f51c2607db4468eba9bb514ae0e4471_I20190101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90ZXh0cmVnaW9uOjZmZWQwNzhkNzVjYTQ1NWU4OTcyY2RkYjU1Nzc0NWRkXzMyOTg1MzQ5NDkxMjc_e6aa646d-67b5-45ee-810a-bc3e20340f0a"
      unitRef="usd">3982000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiability
      contextRef="i0f51c2607db4468eba9bb514ae0e4471_I20190101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90ZXh0cmVnaW9uOjZmZWQwNzhkNzVjYTQ1NWU4OTcyY2RkYjU1Nzc0NWRkXzMyOTg1MzQ5NDkxMzk_76704d09-d685-4143-8158-94cff8c03a97"
      unitRef="usd">5190000</us-gaap:OperatingLeaseLiability>
    <silk:AssetsAndLiabilitiesLesseeTableTextBlock
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90ZXh0cmVnaW9uOjZmZWQwNzhkNzVjYTQ1NWU4OTcyY2RkYjU1Nzc0NWRkXzIxOTkwMjMzMjQ3MjE_de41b5aa-c1f8-43e1-8f27-a06fffc5f87a">&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The disclosure impact of the adoption of ASC 842 on the balance sheet was as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:51.685%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:13.224%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.441%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.903%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.441%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.906%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Balance Sheet:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Balance at December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Adjustments Due to ASC 842&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Balance at January 1, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other non-current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,982&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,982&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;721&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,069&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;Balance sheet information as of December&#160;31, 2019 consists of the following (in thousands):&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:77.647%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.441%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:17.712%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Operating Lease:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Operating lease right-of-use asset in other non-current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Operating lease liability in accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;769&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Operating lease liability in other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</silk:AssetsAndLiabilitiesLesseeTableTextBlock>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="ic94e339422444d219c38d07bb9e37715_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90YWJsZTpiYzg5NjFlNmZhNTk0OGQzODUzNjg1YWU2OGE2MDk5Yi90YWJsZXJhbmdlOmJjODk2MWU2ZmE1OTQ4ZDM4NTM2ODVhZTY4YTYwOTliXzEtMS0xLTEtNDEzOA_1e1ff5f6-18c4-45e8-8886-7872e7c35efc"
      unitRef="usd">0</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i2e1fe8d050bb4a7b9f6556eaab0f6abd_I20190101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90YWJsZTpiYzg5NjFlNmZhNTk0OGQzODUzNjg1YWU2OGE2MDk5Yi90YWJsZXJhbmdlOmJjODk2MWU2ZmE1OTQ4ZDM4NTM2ODVhZTY4YTYwOTliXzEtMy0xLTEtNDEzOA_358c9bc2-1a8d-41e3-b855-056bcaf2d9c1"
      unitRef="usd">3982000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i2fe97d6c47914971bb09d925222705a9_I20190101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90YWJsZTpiYzg5NjFlNmZhNTk0OGQzODUzNjg1YWU2OGE2MDk5Yi90YWJsZXJhbmdlOmJjODk2MWU2ZmE1OTQ4ZDM4NTM2ODVhZTY4YTYwOTliXzEtNS0xLTEtNDEzOA_8d8b08fc-3383-4e4b-b052-622239521572"
      unitRef="usd">3982000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="ic94e339422444d219c38d07bb9e37715_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90YWJsZTpiYzg5NjFlNmZhNTk0OGQzODUzNjg1YWU2OGE2MDk5Yi90YWJsZXJhbmdlOmJjODk2MWU2ZmE1OTQ4ZDM4NTM2ODVhZTY4YTYwOTliXzItMS0xLTEtNDEzOA_ba53f061-0b50-4a55-85c7-11c946662857"
      unitRef="usd">139000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i2e1fe8d050bb4a7b9f6556eaab0f6abd_I20190101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90YWJsZTpiYzg5NjFlNmZhNTk0OGQzODUzNjg1YWU2OGE2MDk5Yi90YWJsZXJhbmdlOmJjODk2MWU2ZmE1OTQ4ZDM4NTM2ODVhZTY4YTYwOTliXzItMy0xLTEtNDEzOA_7934dcfc-d208-414d-bc0b-a1ecde57ef44"
      unitRef="usd">582000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i2fe97d6c47914971bb09d925222705a9_I20190101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90YWJsZTpiYzg5NjFlNmZhNTk0OGQzODUzNjg1YWU2OGE2MDk5Yi90YWJsZXJhbmdlOmJjODk2MWU2ZmE1OTQ4ZDM4NTM2ODVhZTY4YTYwOTliXzItNS0xLTEtNDEzOA_9ba5a9f1-4997-46ce-912b-3526cdb28be0"
      unitRef="usd">721000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="ic94e339422444d219c38d07bb9e37715_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90YWJsZTpiYzg5NjFlNmZhNTk0OGQzODUzNjg1YWU2OGE2MDk5Yi90YWJsZXJhbmdlOmJjODk2MWU2ZmE1OTQ4ZDM4NTM2ODVhZTY4YTYwOTliXzMtMS0xLTEtNDEzOA_071f2c14-a115-4f6a-bd8f-1a69c03218ed"
      unitRef="usd">1069000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i2e1fe8d050bb4a7b9f6556eaab0f6abd_I20190101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90YWJsZTpiYzg5NjFlNmZhNTk0OGQzODUzNjg1YWU2OGE2MDk5Yi90YWJsZXJhbmdlOmJjODk2MWU2ZmE1OTQ4ZDM4NTM2ODVhZTY4YTYwOTliXzMtMy0xLTEtNDEzOA_a86506d1-fb4e-4676-838d-cf50b9ff6dcc"
      unitRef="usd">3400000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i2fe97d6c47914971bb09d925222705a9_I20190101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90YWJsZTpiYzg5NjFlNmZhNTk0OGQzODUzNjg1YWU2OGE2MDk5Yi90YWJsZXJhbmdlOmJjODk2MWU2ZmE1OTQ4ZDM4NTM2ODVhZTY4YTYwOTliXzMtNS0xLTEtNDEzOA_85c5f910-6ea7-4583-9e8e-5731e9076fd0"
      unitRef="usd">4469000</us-gaap:OtherLiabilitiesNoncurrent>
    <silk:WarrantsClassifiedAsLiabilitiesPolicyTextBlock
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90ZXh0cmVnaW9uOjZmZWQwNzhkNzVjYTQ1NWU4OTcyY2RkYjU1Nzc0NWRkXzIxOTkwMjMzMjQ3MjA_d4ec6ad4-cd07-4f09-bc24-a1744f375fb9">&lt;div style="margin-bottom:9pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Redeemable Convertible Preferred Stock Warrant Liability&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Prior to its IPO, the Company accounted for its warrants for shares of redeemable convertible preferred stock as a liability based upon the characteristics and provisions of each instrument.  Redeemable convertible preferred stock warrants classified as a liability were initially recorded at their fair value on the date of issuance and are subject to remeasurement at each subsequent balance sheet date.  Any change in fair value as a result of a remeasurement was recognized as a component of other income (expense), net in the statements of operations and comprehensive loss.  &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The Company recorded adjustments to the estimated fair value of the redeemable convertible preferred stock warrants until they were exercised. Upon their exercise, the final fair value of the warrant liability was reclassified to stockholders&#x2019; equity (deficit). Subsequent to its IPO, the Company no longer recorded any related periodic fair value adjustments.&lt;/span&gt;&lt;/div&gt;</silk:WarrantsClassifiedAsLiabilitiesPolicyTextBlock>
    <us-gaap:StockholdersEquityNoteRedeemablePreferredStockIssuePolicy
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90ZXh0cmVnaW9uOjZmZWQwNzhkNzVjYTQ1NWU4OTcyY2RkYjU1Nzc0NWRkXzMxMzMz_c4628660-06ec-444f-8aba-d236958da036">&lt;div style="margin-bottom:9pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Redeemable Convertible Preferred Stock&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Prior to its IPO, the Company recorded its redeemable convertible preferred stock at fair value on the dates of issuance, net of issuance costs, and classified the redeemable convertible preferred stock outside of stockholders&#x2019; equity (deficit) on the balance sheet as events triggering the liquidation preferences were not solely within the Company&#x2019;s control. Upon the closing of the Company's IPO, all shares of convertible preferred stock then outstanding converted into an aggregate of 23,178,555 shares of common stock resulting in the reclassification of $144,140,000 from outside of stockholders&#x2019; equity (deficit) to additional paid-in capital.&lt;/span&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteRedeemablePreferredStockIssuePolicy>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits
      contextRef="i098a8c90a714485c88e5e439c93fd1fe_D20190501-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90ZXh0cmVnaW9uOjZmZWQwNzhkNzVjYTQ1NWU4OTcyY2RkYjU1Nzc0NWRkXzM4NDgyOTA3ODM4NDU_3a891ad1-d24d-4d9f-9df3-74b30aed33f3"
      unitRef="shares">23178555</us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfUnits
      contextRef="i2658f65419d24aacb4ed4233d75211b7_D20190501-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90ZXh0cmVnaW9uOjZmZWQwNzhkNzVjYTQ1NWU4OTcyY2RkYjU1Nzc0NWRkXzM4NDgyOTA3ODM4NzM_e7b3993d-bd27-4c0a-9971-1a3cc2e48063"
      unitRef="usd">144140000</us-gaap:StockIssuedDuringPeriodValueConversionOfUnits>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90ZXh0cmVnaW9uOjZmZWQwNzhkNzVjYTQ1NWU4OTcyY2RkYjU1Nzc0NWRkXzMxMzM0_31a541c0-e500-490d-b6a3-39966fa5bcf7">&lt;div style="margin-bottom:9pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;On&#160;January&#160;1, 2018, the Company adopted ASC Topic 606,&#160;&#x201c;Revenue from Contracts with Customers,&#x201d; using the modified retrospective method applied to contracts which were not completed as of that date.&#160;&#160;Under ASC 606, revenue is recognized when a customer obtains control of promised goods or services, in an amount that reflects the consideration which the entity expects to receive in exchange for those goods or services.  To determine revenue recognition for arrangements that an entity determines are within the scope of ASC 606, the Company performs the following five steps: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-26.88pt;padding-left:36pt;margin-bottom:9pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;(i)&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18pt;"&gt;identify the contract(s) with a customer; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-29.1pt;padding-left:36pt;margin-bottom:9pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;(ii)&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18pt;"&gt;identify the performance obligations in the contract; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-31.32pt;padding-left:36pt;margin-bottom:9pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;(iii)&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18pt;"&gt;determine the transaction price;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-31.88pt;padding-left:36pt;margin-bottom:9pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;(iv)&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18pt;"&gt;allocate the transaction price to the performance obligations in the contract; and &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-29.66pt;padding-left:36pt;margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;(v)&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18pt;"&gt;recognize revenue when (or as) the entity satisfies a performance obligation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Under ASC 606, assuming all other revenue recognition criteria have been met, the Company will recognize revenue earlier for arrangements where the Company has satisfied its performance obligations &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;but have not issued invoices.&#160;&#160;As of December&#160;31, 2019 and 2018, the Company recorded $102,000 and $128,000, respectively, of unbilled receivables, which are included in accounts receivable, net on the balance sheet, as the Company has an unconditional right to payment as of the end of the applicable period.&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The Company&#x2019;s revenue is generated from the sale of its products to hospitals and medical centers in the United States through direct sales representatives.  Revenue is recognized when obligations under the terms of a contract with customers are satisfied, which occurs with the transfer of control of the Company&#x2019;s products to its customers, either upon shipment of the product or delivery of the product to the customer under the Company&#x2019;s standard terms and conditions.&#160;&#160;The Company&#x2019;s products are readily available for usage as soon as the customer possesses it.  Upon receipt, the customer controls the economic benefits of the product, has significant risks and rewards, and the legal title.  The Company has present right to payment; therefore, the transfer of control is deemed to happen at a point in time.  Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring the goods.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;For sales where the Company&#x2019;s sales representative hand delivers product directly to the hospital or medical center from the sales representative&#x2019;s trunk stock inventory, the Company recognizes revenue upon delivery, which represents the point in time when control transfers to the customer.  Upon delivery there are legally-enforceable rights and obligations between the parties which can be identified, commercial substance exists and collectibility is probable.  For sales which are sent directly from the Company to hospitals and medical centers, the transfer of control occurs at the time of shipment or delivery of the product.&#160; There are no further performance obligations by the Company or the sales representative to the customer after delivery under either method of sale.  As allowed under the practical expedient, the Company does not disclose the value of unsatisfied performance obligations for (i) contracts with an original expected length of one year or less and (ii) contracts for which it recognizes revenue at the amount to which it has the right to invoice for services performed.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The Company&#160;is entitled to the total consideration for the products ordered by customers&#160;as&#160;product pricing&#160;is&#160;fixed according to the terms of customer contracts and payment terms&#160;are&#160;short.  Payment terms fall within the one-year guidance for the practical expedient which allows the Company to forgo adjustment of the promised amount of consideration for the effects of a significant financing component.  The Company&#160;excludes&#160;taxes assessed by governmental authorities on revenue-producing transactions from the measurement of the transaction price.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Costs associated with product sales include commissions and royalties.  The Company applies the practical expedient and recognizes commissions and royalties as expense when incurred because the expense is incurred at a point in time and the amortization period is less than one year.&#160; Commissions are recorded as selling expense&#160;and royalties are recorded as&#160;cost of revenue&#160;in the&#160;statements of operations and comprehensive loss.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The Company accepts product returns at its discretion or if the product is defective as manufactured.  The Company establishes estimated provisions for returns based on historical experience and considers other factors that it believes could significantly impact its expected returns, which provisions are classified within accrued liabilities on our balance sheet.&#160; The Company elected to expense shipping and handling costs as incurred and includes them in the cost of goods sold.  In those cases where the Company bills shipping and handling costs to customers, it will classify the amounts billed as a component of revenue.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Cost of Goods Sold&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The Company manufactures certain of its portfolio of TCAR products at its facility and purchases other products from third party manufacturers.  Cost of goods sold consists primarily of costs related to &lt;/span&gt;&lt;/div&gt;materials, components and subassemblies, manufacturing overhead costs, direct labor, reserves for excess, obsolete and non-sellable inventories as well as distribution-related expenses.  A significant portion of the Company&#x2019;s cost of goods sold currently consists of manufacturing overhead costs.  These overhead costs include the cost of quality assurance, material procurement, inventory control, facilities, equipment and operations supervision and management.  Cost of goods sold also includes depreciation expense for production equipment and certain direct costs such as shipping costs and royalties.</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <us-gaap:UnbilledReceivablesCurrent
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90ZXh0cmVnaW9uOjZmZWQwNzhkNzVjYTQ1NWU4OTcyY2RkYjU1Nzc0NWRkXzMyOTg1MzQ5NDY5MTU_b8aeac04-b8ee-4c8f-ae30-1285f78b1dde"
      unitRef="usd">102000</us-gaap:UnbilledReceivablesCurrent>
    <us-gaap:UnbilledReceivablesCurrent
      contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90ZXh0cmVnaW9uOjZmZWQwNzhkNzVjYTQ1NWU4OTcyY2RkYjU1Nzc0NWRkXzM4NDgyOTA3ODM4OTM_e95df534-3cee-4b03-a3b7-bbd3a16a59f1"
      unitRef="usd">128000</us-gaap:UnbilledReceivablesCurrent>
    <us-gaap:ResearchAndDevelopmentExpensePolicy
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90ZXh0cmVnaW9uOjZmZWQwNzhkNzVjYTQ1NWU4OTcyY2RkYjU1Nzc0NWRkXzMxMzQz_90db7b4d-5d90-4714-8419-0c8b54e4b6c0">&lt;div style="margin-bottom:9pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Research and Development&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The Company expenses research and development costs as incurred.  Research and development expenses consist primarily of engineering, product development, clinical studies to develop and support the Company&#x2019;s products, regulatory expenses, medical affairs and other costs associated with products and technologies that are in development.  Research and development expenses include employee compensation, including stock-based compensation, supplies, consulting, prototyping, testing, materials, travel expenses, depreciation and an allocation of facility overhead expenses.  Additionally, research and development expenses include costs associated with our clinical studies including clinical trial design, clinical site reimbursement, data management, travel expenses and the cost of products used for clinical trials and internal and external costs associated with the Company&#x2019;s regulatory compliance and quality assurance functions, including the costs of outside consultants and contractors that assist in the process of submitting and maintaining regulatory filings, and overhead costs. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Clinical Trials&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The Company accrues and expenses costs for its clinical trial activities performed by third parties, including clinical research organizations and other service providers, based upon estimates of the work completed over the life of the individual study in accordance with associated agreements.  The Company determines these accruals through discussion with internal personnel and outside service providers as to progress or stage of completion of trials or services pursuant to contracts with clinical research organizations and other service providers and the agreed-upon fee to be paid for such services.&lt;/span&gt;&lt;/div&gt;</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <us-gaap:AdvertisingCostsPolicyTextBlock
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90ZXh0cmVnaW9uOjZmZWQwNzhkNzVjYTQ1NWU4OTcyY2RkYjU1Nzc0NWRkXzMxMzQ0_ebcff87b-6b76-4bc0-b73f-c6a79250c771">Advertising CostsThe Company expenses advertising costs as incurred.  Advertising costs include design and production costs, including website development, physician and patient testimonial videos, written media campaigns, and other items.</us-gaap:AdvertisingCostsPolicyTextBlock>
    <us-gaap:AdvertisingExpense
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90ZXh0cmVnaW9uOjZmZWQwNzhkNzVjYTQ1NWU4OTcyY2RkYjU1Nzc0NWRkXzMyOTg1MzQ5MTY2ODE_33c40a03-eb0b-4a10-9a94-21c3534a9e1f"
      unitRef="usd">362000</us-gaap:AdvertisingExpense>
    <us-gaap:AdvertisingExpense
      contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90ZXh0cmVnaW9uOjZmZWQwNzhkNzVjYTQ1NWU4OTcyY2RkYjU1Nzc0NWRkXzMyOTg1MzQ5MTY2OTE_8a3afcd2-57a1-4f01-85d0-a792eb375fe5"
      unitRef="usd">186000</us-gaap:AdvertisingExpense>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90ZXh0cmVnaW9uOjZmZWQwNzhkNzVjYTQ1NWU4OTcyY2RkYjU1Nzc0NWRkXzMxMzUy_1090a717-b98a-4e22-8a13-d54fd5ecd1da">&lt;div style="margin-bottom:9pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Foreign Currency&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The Company records net gains and losses resulting from foreign exchange transactions as a component of foreign currency exchange gains or losses in other income (expense), net.  The Company had no material foreign currency exchange gains or losses during the years ended December&#160;31, 2019 and 2018.&lt;/span&gt;&lt;/div&gt;</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90ZXh0cmVnaW9uOjZmZWQwNzhkNzVjYTQ1NWU4OTcyY2RkYjU1Nzc0NWRkXzMxMzM3_98d6d2e7-ad4c-4bda-b3f1-b30f90b33dfa">&lt;div style="margin-bottom:9pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Stock&#x2013;Based Compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The Company accounts for stock-based compensation in accordance with Financial Accounting Standards Board (&#x201c;FASB&#x201d;) ASC 718,&#160;&#x201c;Compensation-Stock Compensation.&#x201d;  ASC 718 requires the recognition of compensation expense, using a fair-value based method, for costs related to all share-based payments including stock options.  ASC 718 requires companies to estimate the fair value of all share-based payment option awards on the date of grant using an option pricing model.  The fair value of stock options is recognized over the period during which an optionee is required to provide services in exchange for the option award, known as the requisite service period (usually the vesting period), on a &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;straight-line basis.  For performance-based stock options, the Company will assess the probability of performance conditions being achieved in each reporting period.  The amount of stock-based compensation expense recognized in any one period related to performance-based stock options can vary based on the achievement or anticipated achievement of the performance conditions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In March 2016, the FASB issued Accounting Standards Update ("ASU") No. 2016-09,&#160;&#x201c;Stock Compensation (Topic 718): Improvements to Employee Shared-Based Payment Accounting.&#x201d;&#160; Under ASU 2016-09, entities are permitted to make an accounting policy election to either estimate forfeitures on share-based payment awards, as previously required, or to recognize forfeitures as they occur.  The Company made an accounting policy election to account for forfeitures as they occur.  This change has been applied on a modified retrospective basis, resulting in a cumulative-effect adjustment to increase the beginning accumulated deficit by $13,000&#160;as of January&#160;1, 2018, the date of adoption.&lt;/span&gt;&lt;/div&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption
      contextRef="i3d970a6f053141c8adef36f595567ea2_I20180101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90ZXh0cmVnaW9uOjZmZWQwNzhkNzVjYTQ1NWU4OTcyY2RkYjU1Nzc0NWRkXzMyOTg1MzQ5MTY3MDk_368b2f71-ebff-4e2f-99a1-fb51bc0d59bf"
      unitRef="usd">-13000</us-gaap:CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption>
    <us-gaap:IncomeTaxPolicyTextBlock
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90ZXh0cmVnaW9uOjZmZWQwNzhkNzVjYTQ1NWU4OTcyY2RkYjU1Nzc0NWRkXzIxOTkwMjMzNDI2MDk_14d708f2-1528-45d9-9b09-713f355ddb40">&lt;div style="margin-bottom:9pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The Company accounts for income taxes under the liability method, whereby deferred tax assets and liabilities are determined based on the difference between the financial statements and tax bases of assets and liabilities using the enacted tax rates in effect for the year in which the differences are expected to affect taxable income.  A valuation allowance is established when necessary to reduce deferred tax assets to the amounts expected to be realized.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The Company also follows the provisions of ASC 740-10, &#x201c;Accounting for Uncertainty in Income Taxes.&#x201d;  ASC 740-10 prescribes a comprehensive model for the recognition, measurement, presentation and disclosure in financial statements of any uncertain tax positions that have been taken or expected to be taken on a tax return.  No liability related to uncertain tax positions is recorded on the financial statements.  It is the Company&#x2019;s policy to include penalties and interest expense related to income taxes as part of the provision for income taxes.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:ComprehensiveIncomePolicyPolicyTextBlock
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90ZXh0cmVnaW9uOjZmZWQwNzhkNzVjYTQ1NWU4OTcyY2RkYjU1Nzc0NWRkXzIxOTkwMjMzNDI2MDg_79537c5e-5b9f-483d-bda6-2da8764dcb36">Comprehensive Loss&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Comprehensive loss consists of net loss and changes in unrealized gains and losses on investments classified as available-for-sale.  For the year ended &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;December&#160;31, 2019&lt;/span&gt;, the Company&#x2019;s unrealized gains and losses on available-for-sale investments represent the only component of other comprehensive loss that are excluded from the reported net loss and that are presented in the statements of operations and comprehensive income.  Accumulated other comprehensive loss is presented in the accompanying balance sheets as a component of stockholders' equity (deficit).  For the year ended December&#160;31, 2018, there was no difference between the Company's comprehensive loss and its net loss.</us-gaap:ComprehensiveIncomePolicyPolicyTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90ZXh0cmVnaW9uOjZmZWQwNzhkNzVjYTQ1NWU4OTcyY2RkYjU1Nzc0NWRkXzMxMzI4_8cca239f-8960-49c6-b65c-84f3704faf7c">&lt;div style="margin-bottom:9pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Net Loss per Share Attributable to Common Stockholders&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Basic net loss per share is computed by dividing the net loss attributable to common stockholders by the weighted average number of shares of common stock outstanding during the period, without consideration for potential dilutive common shares.  Diluted net loss per share is computed by dividing the net loss attributable to common stockholders by the weighted average number of shares of common stock and potentially dilutive securities outstanding for the period.  For purposes of the diluted net loss per share calculation, redeemable convertible preferred stock and warrants, and common stock options are considered to be potentially dilutive securities.  Since the Company was in a loss position for all periods presented, basic net loss per share is the same as diluted net loss per share as the inclusion of all potential dilutive common shares would have been anti-dilutive.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The Company allocates no loss to participating securities because they have no contractual obligation to share in the losses of the Company.  The shares of the Company&#x2019;s redeemable convertible preferred &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;stock participate in any dividends declared by the Company and are therefore considered to be participating securities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Net loss per share was determined as follows (in thousands, except share and per share data):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:69.314%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.942%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.943%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Net loss attributable to Silk Road Medical, Inc. common stockholders&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(52,415)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(37,629)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Weighted average common stock outstanding used to compute net loss per share, basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;22,956,679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;960,882&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Net loss per share attributable to Silk Road Medical, Inc. common stockholders, basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(2.28)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(39.16)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The following potentially dilutive securities outstanding have been excluded from the computation of diluted weighted average shares outstanding because such securities have an antidilutive impact due to the Company&#x2019;s net loss:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;margin-bottom:9pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:69.314%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.942%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.943%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Redeemable convertible preferred stock outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;21,233,190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Redeemable convertible preferred stock warrants outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,672,502&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Common stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,310,790&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,364,377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Common stock warrants outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;7,527&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,310,790&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;28,277,596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90ZXh0cmVnaW9uOjZmZWQwNzhkNzVjYTQ1NWU4OTcyY2RkYjU1Nzc0NWRkXzMxMzQ1_13ec7bd0-e436-483b-8cf0-70b19ecd12ab">&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Net loss per share was determined as follows (in thousands, except share and per share data):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:69.314%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.942%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.943%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Net loss attributable to Silk Road Medical, Inc. common stockholders&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(52,415)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(37,629)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Weighted average common stock outstanding used to compute net loss per share, basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;22,956,679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;960,882&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Net loss per share attributable to Silk Road Medical, Inc. common stockholders, basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(2.28)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(39.16)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90YWJsZTo5MWI2OGNiMDkwYzc0NmRiYWViOTA2YjE1MTkwNTIxNS90YWJsZXJhbmdlOjkxYjY4Y2IwOTBjNzQ2ZGJhZWI5MDZiMTUxOTA1MjE1XzItMS0xLTEtMA_434aa863-32ec-449f-bb68-56cd234788e0"
      unitRef="usd">-52415000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90YWJsZTo5MWI2OGNiMDkwYzc0NmRiYWViOTA2YjE1MTkwNTIxNS90YWJsZXJhbmdlOjkxYjY4Y2IwOTBjNzQ2ZGJhZWI5MDZiMTUxOTA1MjE1XzItMy0xLTEtMA_f5e63e5e-510a-463f-a58c-be36fdf268f3"
      unitRef="usd">-37629000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90YWJsZTo5MWI2OGNiMDkwYzc0NmRiYWViOTA2YjE1MTkwNTIxNS90YWJsZXJhbmdlOjkxYjY4Y2IwOTBjNzQ2ZGJhZWI5MDZiMTUxOTA1MjE1XzMtMS0xLTEtMA_d9b49e64-d0c0-45fa-aad1-3a82d7c4c1fd"
      unitRef="shares">22956679</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90YWJsZTo5MWI2OGNiMDkwYzc0NmRiYWViOTA2YjE1MTkwNTIxNS90YWJsZXJhbmdlOjkxYjY4Y2IwOTBjNzQ2ZGJhZWI5MDZiMTUxOTA1MjE1XzMtMy0xLTEtMA_72c083d0-bde7-4ea2-97a8-af32914d3023"
      unitRef="shares">960882</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90YWJsZTo5MWI2OGNiMDkwYzc0NmRiYWViOTA2YjE1MTkwNTIxNS90YWJsZXJhbmdlOjkxYjY4Y2IwOTBjNzQ2ZGJhZWI5MDZiMTUxOTA1MjE1XzQtMS0xLTEtMA_34d74d63-d359-44ef-b841-630cfb3e4f8e"
      unitRef="usdPerShare">-2.28</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90YWJsZTo5MWI2OGNiMDkwYzc0NmRiYWViOTA2YjE1MTkwNTIxNS90YWJsZXJhbmdlOjkxYjY4Y2IwOTBjNzQ2ZGJhZWI5MDZiMTUxOTA1MjE1XzQtMy0xLTEtMA_cff85dae-cfb5-46e1-9af8-9fdd8f6997df"
      unitRef="usdPerShare">-39.16</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90ZXh0cmVnaW9uOjZmZWQwNzhkNzVjYTQ1NWU4OTcyY2RkYjU1Nzc0NWRkXzMxMzM4_2490877a-59ca-41c0-89e0-5bb33bbfad2d">&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The following potentially dilutive securities outstanding have been excluded from the computation of diluted weighted average shares outstanding because such securities have an antidilutive impact due to the Company&#x2019;s net loss:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;margin-bottom:9pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:69.314%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.942%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.943%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Redeemable convertible preferred stock outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;21,233,190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Redeemable convertible preferred stock warrants outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,672,502&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Common stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,310,790&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,364,377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Common stock warrants outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;7,527&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,310,790&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;28,277,596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i2a4cd45d3ea346e09975b91b19f7932f_D20190101-20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90YWJsZToxZTI4MzRiOTZmNTY0MjUyOTRjNjY5YTMzNzJhNTgyNi90YWJsZXJhbmdlOjFlMjgzNGI5NmY1NjQyNTI5NGM2NjlhMzM3MmE1ODI2XzItMS0xLTEtMA_b0418f60-87d5-40b8-9ef2-2cba2fdca4d8"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i9b9b073cbf81459fbce0e491293244fd_D20180101-20181231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90YWJsZToxZTI4MzRiOTZmNTY0MjUyOTRjNjY5YTMzNzJhNTgyNi90YWJsZXJhbmdlOjFlMjgzNGI5NmY1NjQyNTI5NGM2NjlhMzM3MmE1ODI2XzItMy0xLTEtMA_848a81be-3a21-4e5c-a2b1-e1952023252c"
      unitRef="shares">21233190</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ibd915c83c8b6404bb5a637937ffca6c6_D20190101-20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90YWJsZToxZTI4MzRiOTZmNTY0MjUyOTRjNjY5YTMzNzJhNTgyNi90YWJsZXJhbmdlOjFlMjgzNGI5NmY1NjQyNTI5NGM2NjlhMzM3MmE1ODI2XzMtMS0xLTEtMA_28956940-2644-4e71-952b-5c92383b179e"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ia72cde864bbc4dc18c35b893b41f4dec_D20180101-20181231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90YWJsZToxZTI4MzRiOTZmNTY0MjUyOTRjNjY5YTMzNzJhNTgyNi90YWJsZXJhbmdlOjFlMjgzNGI5NmY1NjQyNTI5NGM2NjlhMzM3MmE1ODI2XzMtMy0xLTEtMA_185e7cf2-0d04-4aba-935f-b95024753282"
      unitRef="shares">2672502</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i869e207d48f649aba79d5a398971f471_D20190101-20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90YWJsZToxZTI4MzRiOTZmNTY0MjUyOTRjNjY5YTMzNzJhNTgyNi90YWJsZXJhbmdlOjFlMjgzNGI5NmY1NjQyNTI5NGM2NjlhMzM3MmE1ODI2XzQtMS0xLTEtMA_913f678e-4b47-45a6-bcae-9af77b83f60c"
      unitRef="shares">4310790</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ie37285cde19b46798cf9ecb3d7e8e7ce_D20180101-20181231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90YWJsZToxZTI4MzRiOTZmNTY0MjUyOTRjNjY5YTMzNzJhNTgyNi90YWJsZXJhbmdlOjFlMjgzNGI5NmY1NjQyNTI5NGM2NjlhMzM3MmE1ODI2XzQtMy0xLTEtMA_f23c97cf-03b1-47ea-be08-92b2a6d2f021"
      unitRef="shares">4364377</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i41b8867a9c614370bb9151a0da07f34d_D20190101-20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90YWJsZToxZTI4MzRiOTZmNTY0MjUyOTRjNjY5YTMzNzJhNTgyNi90YWJsZXJhbmdlOjFlMjgzNGI5NmY1NjQyNTI5NGM2NjlhMzM3MmE1ODI2XzUtMS0xLTEtMA_60ea80bc-5ad4-44ee-9b93-f538a06af69a"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i8ca29bbf162449f8b42d0edd6cafd993_D20180101-20181231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90YWJsZToxZTI4MzRiOTZmNTY0MjUyOTRjNjY5YTMzNzJhNTgyNi90YWJsZXJhbmdlOjFlMjgzNGI5NmY1NjQyNTI5NGM2NjlhMzM3MmE1ODI2XzUtMy0xLTEtMA_03504753-4cd5-4c18-9402-a23db81c2246"
      unitRef="shares">7527</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90YWJsZToxZTI4MzRiOTZmNTY0MjUyOTRjNjY5YTMzNzJhNTgyNi90YWJsZXJhbmdlOjFlMjgzNGI5NmY1NjQyNTI5NGM2NjlhMzM3MmE1ODI2XzYtMS0xLTEtMA_637f011e-e288-4a74-b3d0-3add14ae0c06"
      unitRef="shares">4310790</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90YWJsZToxZTI4MzRiOTZmNTY0MjUyOTRjNjY5YTMzNzJhNTgyNi90YWJsZXJhbmdlOjFlMjgzNGI5NmY1NjQyNTI5NGM2NjlhMzM3MmE1ODI2XzYtMy0xLTEtMA_9137e328-d155-40cd-ae8f-6655b726090e"
      unitRef="shares">28277596</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:SegmentReportingPolicyPolicyTextBlock
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90ZXh0cmVnaW9uOjZmZWQwNzhkNzVjYTQ1NWU4OTcyY2RkYjU1Nzc0NWRkXzMxMzUz_edc58ccc-4883-422c-9acb-9964248bcd95">&lt;div style="margin-bottom:9pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Segment and Geographical Information&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The Company operates and manages its business as one reportable and operating segment.  The Company&#x2019;s chief executive officer, who is the chief operating decision maker, reviews financial information on an aggregate basis for purposes of allocating resources and evaluating financial performance.  All of the Company&#x2019;s long-lived assets are based in the United States.  Long-lived assets are comprised of property and equipment.  All of the Company&#x2019;s revenue was in the United States for the years ended December&#160;31, 2019 and 2018, based on the shipping location of the external customer.&lt;/span&gt;&lt;/div&gt;</us-gaap:SegmentReportingPolicyPolicyTextBlock>
    <us-gaap:NumberOfOperatingSegments
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90ZXh0cmVnaW9uOjZmZWQwNzhkNzVjYTQ1NWU4OTcyY2RkYjU1Nzc0NWRkXzMyOTg1MzQ5NDkyMTk_958e6082-3b0b-45b1-97ac-c7b1f40460b1"
      unitRef="segment">1</us-gaap:NumberOfOperatingSegments>
    <us-gaap:NumberOfReportableSegments
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90ZXh0cmVnaW9uOjZmZWQwNzhkNzVjYTQ1NWU4OTcyY2RkYjU1Nzc0NWRkXzMyOTg1MzQ5NDkyMTk_e8f82ab3-632a-4371-ab8d-23a8585f1be5"
      unitRef="segment">1</us-gaap:NumberOfReportableSegments>
    <us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMjEvZnJhZzo3NjU0MWU0YjQ0ZTI0YWEwOTE4MDg5MzdlZWIzMmY4Yy90ZXh0cmVnaW9uOjc2NTQxZTRiNDRlMjRhYTA5MTgwODkzN2VlYjMyZjhjXzcxODM_50a08e93-38bd-4076-aaa3-53accb31e086">Recent Accounting Pronouncements&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;"&gt;Recently Adopted Accounting Standards&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In February 2016, the FASB issued ASU No. 2016-02, "Leases," that supersedes ASC 840, "Leases." Subsequently, the FASB issued several updates to ASU No. 2016-02, codified in ASC Topic 842 (&#x201c;ASC 842&#x201d;). The Company adopted ASC 842 on January 1, 2019 using the modified retrospective method for all leases not substantially completed as of the date of adoption.  The Company elected to apply the package of practical expedients, which allowed the Company to not reassess: (i) whether expired or existing contracts contain leases; (ii) lease classification for any expired or existing leases; and (iii) initial direct costs for any existing lease.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;"&gt;Recently Issued Accounting Standards&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In June 2016, the FASB issued ASU 2016-13, Measurement of Credit Losses on Financial Statements.  This update provides financial statement users with more decision-useful information about the expected credit losses on financial instruments and other commitments to extend credit held by a reporting entity at each reporting date.  The update replaces the incurred loss impairment methodology in current GAAP with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates.  ASU 2016-13 became effective for the Company on January 1, 2020.  The Company does not believe that the adoption of this new guidance will have a material impact on its financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In August 2018, the FASB issued ASU 2018-13, Fair Value Measurement, which changed the disclosure requirements for fair value measurements by removing, adding and modifying certain disclosures.  ASU 2018-13 became effective for the Company on January 1, 2020.  &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The Company does not believe that the adoption of this new guidance will have a material impact on its financial statements and related disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In August 2018, the FASB issued ASU 2018-15, Cloud Computing Arrangements, which aligns the requirements for capitalizing implementation costs in a Cloud Computing Arrangement service contract with the requirements for capitalizing implementation costs incurred for an internal-use software license.  ASU 2018-15 became effective for the Company on January 1, 2020.&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;  The Company does not believe that the adoption of this new guidance will have a material impact on its financial statements and related disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes, which enhances and simplifies various aspects of the income tax accounting guidance related to intraperiod tax allocation, interim period accounting for enacted changes in tax law, and the year-to-date loss limitation in interim period tax accounting.  ASU 2019-12 also amends other aspects of the guidance to reduce complexity in certain areas.  ASU 2019-12 will become effective for the Company on January 1, 2021.  Early adoption is permitted.  The Company is evaluating the impact of adopting this guidance to its financial statements and related disclosures.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMjEvZnJhZzo3NjU0MWU0YjQ0ZTI0YWEwOTE4MDg5MzdlZWIzMmY4Yy90ZXh0cmVnaW9uOjc2NTQxZTRiNDRlMjRhYTA5MTgwODkzN2VlYjMyZjhjXzcxODQ_b53aed5b-f135-444e-930d-3653db1e1916">Recent Accounting Pronouncements&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;"&gt;Recently Adopted Accounting Standards&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In February 2016, the FASB issued ASU No. 2016-02, "Leases," that supersedes ASC 840, "Leases." Subsequently, the FASB issued several updates to ASU No. 2016-02, codified in ASC Topic 842 (&#x201c;ASC 842&#x201d;). The Company adopted ASC 842 on January 1, 2019 using the modified retrospective method for all leases not substantially completed as of the date of adoption.  The Company elected to apply the package of practical expedients, which allowed the Company to not reassess: (i) whether expired or existing contracts contain leases; (ii) lease classification for any expired or existing leases; and (iii) initial direct costs for any existing lease.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;"&gt;Recently Issued Accounting Standards&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In June 2016, the FASB issued ASU 2016-13, Measurement of Credit Losses on Financial Statements.  This update provides financial statement users with more decision-useful information about the expected credit losses on financial instruments and other commitments to extend credit held by a reporting entity at each reporting date.  The update replaces the incurred loss impairment methodology in current GAAP with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates.  ASU 2016-13 became effective for the Company on January 1, 2020.  The Company does not believe that the adoption of this new guidance will have a material impact on its financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In August 2018, the FASB issued ASU 2018-13, Fair Value Measurement, which changed the disclosure requirements for fair value measurements by removing, adding and modifying certain disclosures.  ASU 2018-13 became effective for the Company on January 1, 2020.  &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The Company does not believe that the adoption of this new guidance will have a material impact on its financial statements and related disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In August 2018, the FASB issued ASU 2018-15, Cloud Computing Arrangements, which aligns the requirements for capitalizing implementation costs in a Cloud Computing Arrangement service contract with the requirements for capitalizing implementation costs incurred for an internal-use software license.  ASU 2018-15 became effective for the Company on January 1, 2020.&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;  The Company does not believe that the adoption of this new guidance will have a material impact on its financial statements and related disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes, which enhances and simplifies various aspects of the income tax accounting guidance related to intraperiod tax allocation, interim period accounting for enacted changes in tax law, and the year-to-date loss limitation in interim period tax accounting.  ASU 2019-12 also amends other aspects of the guidance to reduce complexity in certain areas.  ASU 2019-12 will become effective for the Company on January 1, 2021.  Early adoption is permitted.  The Company is evaluating the impact of adopting this guidance to its financial statements and related disclosures.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMjcvZnJhZzphNzhkMmY3MGI4ZDY0ODdkYmIwZDE0NmE1MTE5OTBlMC90ZXh0cmVnaW9uOmE3OGQyZjcwYjhkNjQ4N2RiYjBkMTQ2YTUxMTk5MGUwXzM3OTM_93636668-8b40-491f-891e-0a4149a32c88">Fair Value Measurements&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The Company measures certain financial assets and liabilities at fair value on a recurring basis, including cash equivalents, investments, and the Company's previously outstanding preferred stock warrants.  Fair value is an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants.  As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or a liability.  A three-tier fair value hierarchy is established as a basis for considering such assumptions and for inputs used in the valuation methodologies in measuring fair value:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;&#x2022;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;"&gt;Level 1 &#x2013; quoted prices in active markets are identical assets and liabilities;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;&#x2022;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;"&gt;Level 2 &#x2013; observable inputs other than quotes prizes in active markets for identical assets and liabilities;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-18pt;padding-left:36pt;margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;&#x2022;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;"&gt;Level 3 &#x2013; unobservable inputs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Assets and liabilities measured at fair value are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. The Company&#x2019;s assessment of the significance of a particular input to the fair value measurement in its entirety requires management to make judgments and consider factors specific to the asset or liability.  The Company&#x2019;s cash equivalents are classified within &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Level 1 of the fair value hierarchy because they are valued using quoted market prices, broker or dealer quotations, or alternative pricing sources with reasonable levels of price transparency.  The corporate bonds/notes, commercial paper, asset-backed securities and U.S. government securities are classified as Level 2 as they are valued based upon quoted market prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active and model-based valuation techniques for which all significant inputs are observable in the market or can be corroborated by observable market data for substantially the full term of the assets. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The following tables sets forth by level within the fair value hierarchy the Company&#x2019;s assets and liabilities that are reported at fair value as of December&#160;31, 2019 and 2018, using the inputs defined above (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:37.743%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.583%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.441%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.583%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.441%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.583%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.441%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.585%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-style:italic;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:9pt;font-weight:400;font-style:italic;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Level 1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Level 2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Level 3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;34,363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;34,363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9,919&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9,919&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Corporate bonds/notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10,176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10,176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;44,456&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;44,456&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;34,363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;69,732&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;104,095&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:37.743%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.583%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.441%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.583%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.441%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.583%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.441%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.585%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-style:italic;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:9pt;font-weight:400;font-style:italic;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Level 1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Level 2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Level 3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10,495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10,495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Redeemable convertible warrant liability&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-bottom:3pt double #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-bottom:3pt double #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-bottom:3pt double #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;16,091&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-bottom:3pt double #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;16,091&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;As a derivative liability, the redeemable convertible warrants were initially recorded at fair value and were subject to remeasurement at each balance sheet date.  Any change in fair value as a result of a remeasurement was recognized as a component of other income (expense), net in the statements of operations and comprehensive loss.  The Company&#x2019;s redeemable convertible warrant liability was classified within Level 3 of the fair value hierarchy.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;At December&#160;31, 2018, the fair value of the redeemable convertible warrant liability was determined by using an option pricing model to allocate the total enterprise value to the various securities within the Company&#x2019;s capital structure.  The fair value of the redeemable convertible warrant liability was based on both the estimated fair value of the Company&#x2019;s common stock of $11.29 as of December&#160;31, 2018 and on valuation models discounted at current implied market rates which are based on Level 3 inputs.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Additionally, the model&#x2019;s inputs reflected assumptions that market participants would use in pricing the instrument in a current period transaction and included:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;margin-bottom:9pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:99.839%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:80.182%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:15.818%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Time to liquidity (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.57&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;62.5%&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Discounted cash flow rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;12.0%&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.6%&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Marketability discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;14%&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The final fair value of the redeemable convertible warrants was remeasured on the date of the Company's initial public offering in April 2019. The final fair value of the redeemable convertible warrant liability was based on the fair value of the Company's common stock at the time of its initial public offering. The following table provides a reconciliation of the beginning and ending balances of the Company's redeemable convertible warrant liability are summarized below (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:84.057%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.943%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Fair value at December 31, 2017&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Change in fair value recorded in other income (expense), net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;11,906&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Fair value at December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;16,091&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Change in fair value recorded in other income (expense), net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;21,030&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Reclassification upon IPO&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(37,121)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Fair Value at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;There were no transfers between fair value hierarchy levels during the years ended December&#160;31, 2019 and 2018.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMjcvZnJhZzphNzhkMmY3MGI4ZDY0ODdkYmIwZDE0NmE1MTE5OTBlMC90ZXh0cmVnaW9uOmE3OGQyZjcwYjhkNjQ4N2RiYjBkMTQ2YTUxMTk5MGUwXzE5NzkxMjA5MzEyNDA0_c0be6920-fc06-47ce-90db-d5012e0c7738">&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The following tables sets forth by level within the fair value hierarchy the Company&#x2019;s assets and liabilities that are reported at fair value as of December&#160;31, 2019 and 2018, using the inputs defined above (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:37.743%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.583%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.441%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.583%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.441%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.583%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.441%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.585%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-style:italic;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:9pt;font-weight:400;font-style:italic;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Level 1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Level 2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Level 3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;34,363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;34,363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9,919&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9,919&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Corporate bonds/notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10,176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10,176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;44,456&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;44,456&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;34,363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;69,732&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;104,095&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:37.743%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.583%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.441%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.583%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.441%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.583%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.441%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.585%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-style:italic;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:9pt;font-weight:400;font-style:italic;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Level 1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Level 2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Level 3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10,495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10,495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Redeemable convertible warrant liability&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-bottom:3pt double #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-bottom:3pt double #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-bottom:3pt double #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;16,091&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-bottom:3pt double #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;16,091&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i11a85190a9064adf9756e907b72ab81e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMjcvZnJhZzphNzhkMmY3MGI4ZDY0ODdkYmIwZDE0NmE1MTE5OTBlMC90YWJsZToxMDJkMGM4YTk0N2E0NTk4YTI0NjZkZDBkYjRhZGY4Mi90YWJsZXJhbmdlOjEwMmQwYzhhOTQ3YTQ1OThhMjQ2NmRkMGRiNGFkZjgyXzMtMS0xLTEtNDY5NA_de90c0ff-0f23-4c3c-8e17-deeed27bdbe6"
      unitRef="usd">34363000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="iea42b3ddd43e48b7ad739160a6355912_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMjcvZnJhZzphNzhkMmY3MGI4ZDY0ODdkYmIwZDE0NmE1MTE5OTBlMC90YWJsZToxMDJkMGM4YTk0N2E0NTk4YTI0NjZkZDBkYjRhZGY4Mi90YWJsZXJhbmdlOjEwMmQwYzhhOTQ3YTQ1OThhMjQ2NmRkMGRiNGFkZjgyXzMtMy0xLTEtNDY5NA_21ed35d9-8cca-490c-98c4-2df68c428ea8"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i8eda7181425346cbb7f781c8cd52aefd_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMjcvZnJhZzphNzhkMmY3MGI4ZDY0ODdkYmIwZDE0NmE1MTE5OTBlMC90YWJsZToxMDJkMGM4YTk0N2E0NTk4YTI0NjZkZDBkYjRhZGY4Mi90YWJsZXJhbmdlOjEwMmQwYzhhOTQ3YTQ1OThhMjQ2NmRkMGRiNGFkZjgyXzMtNS0xLTEtNDY5NA_67d287ba-c262-4f04-bda6-613c3748f602"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i3154f26e217748508ca43b15910d4ab7_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMjcvZnJhZzphNzhkMmY3MGI4ZDY0ODdkYmIwZDE0NmE1MTE5OTBlMC90YWJsZToxMDJkMGM4YTk0N2E0NTk4YTI0NjZkZDBkYjRhZGY4Mi90YWJsZXJhbmdlOjEwMmQwYzhhOTQ3YTQ1OThhMjQ2NmRkMGRiNGFkZjgyXzMtNy0xLTEtNDY5NA_8a7f04dd-ec9e-4dfc-ba7d-cb6623349787"
      unitRef="usd">34363000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i82c527872b3d4fd290ad3917440837f9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMjcvZnJhZzphNzhkMmY3MGI4ZDY0ODdkYmIwZDE0NmE1MTE5OTBlMC90YWJsZToxMDJkMGM4YTk0N2E0NTk4YTI0NjZkZDBkYjRhZGY4Mi90YWJsZXJhbmdlOjEwMmQwYzhhOTQ3YTQ1OThhMjQ2NmRkMGRiNGFkZjgyXzQtMS0xLTEtNDY5NA_427ee6dc-05e9-4338-9052-f5d7bd605d04"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i515b5eafffb247339a3b64d3ae67d43b_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMjcvZnJhZzphNzhkMmY3MGI4ZDY0ODdkYmIwZDE0NmE1MTE5OTBlMC90YWJsZToxMDJkMGM4YTk0N2E0NTk4YTI0NjZkZDBkYjRhZGY4Mi90YWJsZXJhbmdlOjEwMmQwYzhhOTQ3YTQ1OThhMjQ2NmRkMGRiNGFkZjgyXzQtMy0xLTEtNDY5NA_7a5bc4aa-3a93-47b6-930f-9fdb7c6ef1b2"
      unitRef="usd">9919000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i7a1d59cac7d948139b04deae23e13fb8_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMjcvZnJhZzphNzhkMmY3MGI4ZDY0ODdkYmIwZDE0NmE1MTE5OTBlMC90YWJsZToxMDJkMGM4YTk0N2E0NTk4YTI0NjZkZDBkYjRhZGY4Mi90YWJsZXJhbmdlOjEwMmQwYzhhOTQ3YTQ1OThhMjQ2NmRkMGRiNGFkZjgyXzQtNS0xLTEtNDY5NA_c840d5b2-e3c8-4c5e-ba47-038ac2119b56"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ib459ddf8987d4fc0a4427c93f88a000a_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMjcvZnJhZzphNzhkMmY3MGI4ZDY0ODdkYmIwZDE0NmE1MTE5OTBlMC90YWJsZToxMDJkMGM4YTk0N2E0NTk4YTI0NjZkZDBkYjRhZGY4Mi90YWJsZXJhbmdlOjEwMmQwYzhhOTQ3YTQ1OThhMjQ2NmRkMGRiNGFkZjgyXzQtNy0xLTEtNDY5NA_412831fe-e66d-40ed-b396-a34ad5b887d7"
      unitRef="usd">9919000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i692d279131c24a49ba70cd82d78e0497_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMjcvZnJhZzphNzhkMmY3MGI4ZDY0ODdkYmIwZDE0NmE1MTE5OTBlMC90YWJsZToxMDJkMGM4YTk0N2E0NTk4YTI0NjZkZDBkYjRhZGY4Mi90YWJsZXJhbmdlOjEwMmQwYzhhOTQ3YTQ1OThhMjQ2NmRkMGRiNGFkZjgyXzUtMS0xLTEtNDY5NA_240f625e-2450-4c1f-a8bd-957e3ac2b007"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ib7b24582c8bf49e99df758604eab3abb_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMjcvZnJhZzphNzhkMmY3MGI4ZDY0ODdkYmIwZDE0NmE1MTE5OTBlMC90YWJsZToxMDJkMGM4YTk0N2E0NTk4YTI0NjZkZDBkYjRhZGY4Mi90YWJsZXJhbmdlOjEwMmQwYzhhOTQ3YTQ1OThhMjQ2NmRkMGRiNGFkZjgyXzUtMy0xLTEtNDY5NA_ffeab215-7e18-4756-a1a7-c46ab192c381"
      unitRef="usd">10176000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i506cf4e4add641df967ba7f06a1bfa17_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMjcvZnJhZzphNzhkMmY3MGI4ZDY0ODdkYmIwZDE0NmE1MTE5OTBlMC90YWJsZToxMDJkMGM4YTk0N2E0NTk4YTI0NjZkZDBkYjRhZGY4Mi90YWJsZXJhbmdlOjEwMmQwYzhhOTQ3YTQ1OThhMjQ2NmRkMGRiNGFkZjgyXzUtNS0xLTEtNDY5NA_e48d6c2b-6f3e-4259-8f73-8a3d5fe594b2"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i34e6e9e2e2974a8f804997693d613758_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMjcvZnJhZzphNzhkMmY3MGI4ZDY0ODdkYmIwZDE0NmE1MTE5OTBlMC90YWJsZToxMDJkMGM4YTk0N2E0NTk4YTI0NjZkZDBkYjRhZGY4Mi90YWJsZXJhbmdlOjEwMmQwYzhhOTQ3YTQ1OThhMjQ2NmRkMGRiNGFkZjgyXzUtNy0xLTEtNDY5NA_7788db42-63ae-43a5-8cfa-e071e096c293"
      unitRef="usd">10176000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="iadf6d107d54849849c8bd9ee571aaf22_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMjcvZnJhZzphNzhkMmY3MGI4ZDY0ODdkYmIwZDE0NmE1MTE5OTBlMC90YWJsZToxMDJkMGM4YTk0N2E0NTk4YTI0NjZkZDBkYjRhZGY4Mi90YWJsZXJhbmdlOjEwMmQwYzhhOTQ3YTQ1OThhMjQ2NmRkMGRiNGFkZjgyXzYtMS0xLTEtNDY5NA_f539b151-a69f-4efa-9b1d-7c1137ffe05f"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="iff1b3fd1a5a741808c1bfd931652d7a4_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMjcvZnJhZzphNzhkMmY3MGI4ZDY0ODdkYmIwZDE0NmE1MTE5OTBlMC90YWJsZToxMDJkMGM4YTk0N2E0NTk4YTI0NjZkZDBkYjRhZGY4Mi90YWJsZXJhbmdlOjEwMmQwYzhhOTQ3YTQ1OThhMjQ2NmRkMGRiNGFkZjgyXzYtMy0xLTEtNDY5NA_de8b8875-3cf2-482d-83dc-5b519344ca5e"
      unitRef="usd">44456000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ia337a287632c4d2aa7cecbd25f4f1784_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMjcvZnJhZzphNzhkMmY3MGI4ZDY0ODdkYmIwZDE0NmE1MTE5OTBlMC90YWJsZToxMDJkMGM4YTk0N2E0NTk4YTI0NjZkZDBkYjRhZGY4Mi90YWJsZXJhbmdlOjEwMmQwYzhhOTQ3YTQ1OThhMjQ2NmRkMGRiNGFkZjgyXzYtNS0xLTEtNDY5NA_b52c4bff-9d2e-4a39-937a-bdf3b61bd49b"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ie66ece3747d34884887e66fe24d152f1_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMjcvZnJhZzphNzhkMmY3MGI4ZDY0ODdkYmIwZDE0NmE1MTE5OTBlMC90YWJsZToxMDJkMGM4YTk0N2E0NTk4YTI0NjZkZDBkYjRhZGY4Mi90YWJsZXJhbmdlOjEwMmQwYzhhOTQ3YTQ1OThhMjQ2NmRkMGRiNGFkZjgyXzYtNy0xLTEtNDY5NA_54e14962-34b8-4d4d-b27f-1390fe2a40be"
      unitRef="usd">44456000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i8de1bb3daed54738a88a86d2689b10ce_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMjcvZnJhZzphNzhkMmY3MGI4ZDY0ODdkYmIwZDE0NmE1MTE5OTBlMC90YWJsZToxMDJkMGM4YTk0N2E0NTk4YTI0NjZkZDBkYjRhZGY4Mi90YWJsZXJhbmdlOjEwMmQwYzhhOTQ3YTQ1OThhMjQ2NmRkMGRiNGFkZjgyXzctMS0xLTEtNDY5NA_973229fe-622b-4d84-b731-b928a433f8fe"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i19e0a6db758545d68ed21b0a945cc60f_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMjcvZnJhZzphNzhkMmY3MGI4ZDY0ODdkYmIwZDE0NmE1MTE5OTBlMC90YWJsZToxMDJkMGM4YTk0N2E0NTk4YTI0NjZkZDBkYjRhZGY4Mi90YWJsZXJhbmdlOjEwMmQwYzhhOTQ3YTQ1OThhMjQ2NmRkMGRiNGFkZjgyXzctMy0xLTEtNDY5NA_e9178e73-b45d-4bd2-81a7-ce106a0f7c46"
      unitRef="usd">5181000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="id10e93e4a6cc4706bff1d8eb9e0dad18_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMjcvZnJhZzphNzhkMmY3MGI4ZDY0ODdkYmIwZDE0NmE1MTE5OTBlMC90YWJsZToxMDJkMGM4YTk0N2E0NTk4YTI0NjZkZDBkYjRhZGY4Mi90YWJsZXJhbmdlOjEwMmQwYzhhOTQ3YTQ1OThhMjQ2NmRkMGRiNGFkZjgyXzctNS0xLTEtNDY5NA_fe33c2e3-0397-4e09-a787-094276418b1b"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="idcfab15292df4659a682cf4c3e009b01_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMjcvZnJhZzphNzhkMmY3MGI4ZDY0ODdkYmIwZDE0NmE1MTE5OTBlMC90YWJsZToxMDJkMGM4YTk0N2E0NTk4YTI0NjZkZDBkYjRhZGY4Mi90YWJsZXJhbmdlOjEwMmQwYzhhOTQ3YTQ1OThhMjQ2NmRkMGRiNGFkZjgyXzctNy0xLTEtNDY5NA_5b3c1203-705b-4f16-a55a-f094c57f4269"
      unitRef="usd">5181000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i5ffa4f8eee864a558fefbc3fc931f9eb_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMjcvZnJhZzphNzhkMmY3MGI4ZDY0ODdkYmIwZDE0NmE1MTE5OTBlMC90YWJsZToxMDJkMGM4YTk0N2E0NTk4YTI0NjZkZDBkYjRhZGY4Mi90YWJsZXJhbmdlOjEwMmQwYzhhOTQ3YTQ1OThhMjQ2NmRkMGRiNGFkZjgyXzgtMS0xLTEtNDY5NA_057001ed-3bf5-4d14-b04f-f9b5f49ab4e8"
      unitRef="usd">34363000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="id62c0d16fbf34863a1344fb61a82dc68_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMjcvZnJhZzphNzhkMmY3MGI4ZDY0ODdkYmIwZDE0NmE1MTE5OTBlMC90YWJsZToxMDJkMGM4YTk0N2E0NTk4YTI0NjZkZDBkYjRhZGY4Mi90YWJsZXJhbmdlOjEwMmQwYzhhOTQ3YTQ1OThhMjQ2NmRkMGRiNGFkZjgyXzgtMy0xLTEtNDY5NA_e088b1d5-cc09-4a2c-b5bd-bfbcc660abc8"
      unitRef="usd">69732000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i3ff608b2639149898494a31eaf193271_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMjcvZnJhZzphNzhkMmY3MGI4ZDY0ODdkYmIwZDE0NmE1MTE5OTBlMC90YWJsZToxMDJkMGM4YTk0N2E0NTk4YTI0NjZkZDBkYjRhZGY4Mi90YWJsZXJhbmdlOjEwMmQwYzhhOTQ3YTQ1OThhMjQ2NmRkMGRiNGFkZjgyXzgtNS0xLTEtNDY5NA_88cd30cf-298d-4d7c-bdfd-8b82dcbaf0d0"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i5fae0f510baf4fbcb8ab06bb60002490_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMjcvZnJhZzphNzhkMmY3MGI4ZDY0ODdkYmIwZDE0NmE1MTE5OTBlMC90YWJsZToxMDJkMGM4YTk0N2E0NTk4YTI0NjZkZDBkYjRhZGY4Mi90YWJsZXJhbmdlOjEwMmQwYzhhOTQ3YTQ1OThhMjQ2NmRkMGRiNGFkZjgyXzgtNy0xLTEtNDY5NA_25cbeaea-ead7-4322-ad25-21a92a62cb8f"
      unitRef="usd">104095000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="idd88a7fb35bc4bbfb9f94fdef50dfdef_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMjcvZnJhZzphNzhkMmY3MGI4ZDY0ODdkYmIwZDE0NmE1MTE5OTBlMC90YWJsZTo3NGI0OWJiNmJmNDY0ZDRlOGZkZmJiNTRlZTYyYzgyMi90YWJsZXJhbmdlOjc0YjQ5YmI2YmY0NjRkNGU4ZmRmYmI1NGVlNjJjODIyXzMtMS0xLTEtNTY3NA_dbb52700-022e-4bb0-b84b-73b8e0c91ae8"
      unitRef="usd">10495000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ib9c2e225f695462c85b06ffc0db23f77_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMjcvZnJhZzphNzhkMmY3MGI4ZDY0ODdkYmIwZDE0NmE1MTE5OTBlMC90YWJsZTo3NGI0OWJiNmJmNDY0ZDRlOGZkZmJiNTRlZTYyYzgyMi90YWJsZXJhbmdlOjc0YjQ5YmI2YmY0NjRkNGU4ZmRmYmI1NGVlNjJjODIyXzMtMy0xLTEtNTY3NA_284665ed-fec4-4184-a0da-a57a8360dac6"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i49a7a83783f84c3982d721d07ccbada7_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMjcvZnJhZzphNzhkMmY3MGI4ZDY0ODdkYmIwZDE0NmE1MTE5OTBlMC90YWJsZTo3NGI0OWJiNmJmNDY0ZDRlOGZkZmJiNTRlZTYyYzgyMi90YWJsZXJhbmdlOjc0YjQ5YmI2YmY0NjRkNGU4ZmRmYmI1NGVlNjJjODIyXzMtNS0xLTEtNTY3NA_11034f36-e633-4849-8afb-2e6aba46c730"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i9beac03666384655936e1b43302c9e0d_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMjcvZnJhZzphNzhkMmY3MGI4ZDY0ODdkYmIwZDE0NmE1MTE5OTBlMC90YWJsZTo3NGI0OWJiNmJmNDY0ZDRlOGZkZmJiNTRlZTYyYzgyMi90YWJsZXJhbmdlOjc0YjQ5YmI2YmY0NjRkNGU4ZmRmYmI1NGVlNjJjODIyXzMtNy0xLTEtNTY3NA_d64da2b9-0156-499e-b183-8d9270b8c041"
      unitRef="usd">10495000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:DerivativeLiabilities
      contextRef="i2cf6f35566bc4706a43eaf580cce3381_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMjcvZnJhZzphNzhkMmY3MGI4ZDY0ODdkYmIwZDE0NmE1MTE5OTBlMC90YWJsZTo3NGI0OWJiNmJmNDY0ZDRlOGZkZmJiNTRlZTYyYzgyMi90YWJsZXJhbmdlOjc0YjQ5YmI2YmY0NjRkNGU4ZmRmYmI1NGVlNjJjODIyXzMtMS0xLTEtNDc0Ng_d3bed2f0-9600-4394-9bfa-b8c6ce743f62"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i751eabc279934cf590084b42a75319d8_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMjcvZnJhZzphNzhkMmY3MGI4ZDY0ODdkYmIwZDE0NmE1MTE5OTBlMC90YWJsZTo3NGI0OWJiNmJmNDY0ZDRlOGZkZmJiNTRlZTYyYzgyMi90YWJsZXJhbmdlOjc0YjQ5YmI2YmY0NjRkNGU4ZmRmYmI1NGVlNjJjODIyXzMtMy0xLTEtNDc0Ng_fc81c8ea-d1d7-4477-bf7e-878b916e207b"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i682c50ee10764018a2a9d81b7a596283_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMjcvZnJhZzphNzhkMmY3MGI4ZDY0ODdkYmIwZDE0NmE1MTE5OTBlMC90YWJsZTo3NGI0OWJiNmJmNDY0ZDRlOGZkZmJiNTRlZTYyYzgyMi90YWJsZXJhbmdlOjc0YjQ5YmI2YmY0NjRkNGU4ZmRmYmI1NGVlNjJjODIyXzMtNS0xLTEtNDc0Ng_554d4acd-1dea-4bcd-94e3-c3174f48ac11"
      unitRef="usd">16091000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="if488b5abfdda4d3a8085d2171b9717d8_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMjcvZnJhZzphNzhkMmY3MGI4ZDY0ODdkYmIwZDE0NmE1MTE5OTBlMC90YWJsZTo3NGI0OWJiNmJmNDY0ZDRlOGZkZmJiNTRlZTYyYzgyMi90YWJsZXJhbmdlOjc0YjQ5YmI2YmY0NjRkNGU4ZmRmYmI1NGVlNjJjODIyXzMtNy0xLTEtNDc0Ng_7d6bfab2-42b6-4fce-a714-98bac1e6d163"
      unitRef="usd">16091000</us-gaap:DerivativeLiabilities>
    <us-gaap:SharePrice
      contextRef="if244f20dd62e4eb5ac07166f1d16fcc1_I20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMjcvZnJhZzphNzhkMmY3MGI4ZDY0ODdkYmIwZDE0NmE1MTE5OTBlMC90ZXh0cmVnaW9uOmE3OGQyZjcwYjhkNjQ4N2RiYjBkMTQ2YTUxMTk5MGUwXzMxMDQ_c5bdecec-ba78-48f7-a2a3-393547f6b4e0"
      unitRef="usdPerShare">11.29</us-gaap:SharePrice>
    <us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMjcvZnJhZzphNzhkMmY3MGI4ZDY0ODdkYmIwZDE0NmE1MTE5OTBlMC90ZXh0cmVnaW9uOmE3OGQyZjcwYjhkNjQ4N2RiYjBkMTQ2YTUxMTk5MGUwXzM3OTQ_4f184abb-1c99-4a0e-a2f3-b361f1c41874">&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Additionally, the model&#x2019;s inputs reflected assumptions that market participants would use in pricing the instrument in a current period transaction and included:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;margin-bottom:9pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:99.839%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:80.182%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:15.818%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Time to liquidity (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.57&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;62.5%&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Discounted cash flow rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;12.0%&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.6%&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Marketability discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;14%&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock>
    <us-gaap:WarrantsAndRightsOutstandingTerm
      contextRef="i48e873776ce54fb78ea86ee6468dd7ce_I20181231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMjcvZnJhZzphNzhkMmY3MGI4ZDY0ODdkYmIwZDE0NmE1MTE5OTBlMC90YWJsZToxYzYzMjE4NWY4MDQ0YTQ3OTQ1NTE2YjQwZDI3YWRlNy90YWJsZXJhbmdlOjFjNjMyMTg1ZjgwNDRhNDc5NDU1MTZiNDBkMjdhZGU3XzItMy0xLTEtMA_40ea2c61-915c-4191-ab06-fe88723caea6">P0Y6M25D</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="i1c2894de35e642cab6de34c3ff5418b2_I20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMjcvZnJhZzphNzhkMmY3MGI4ZDY0ODdkYmIwZDE0NmE1MTE5OTBlMC90YWJsZToxYzYzMjE4NWY4MDQ0YTQ3OTQ1NTE2YjQwZDI3YWRlNy90YWJsZXJhbmdlOjFjNjMyMTg1ZjgwNDRhNDc5NDU1MTZiNDBkMjdhZGU3XzMtMy0xLTEtMA_535598b1-5dc8-4a1c-a24c-90f9e7bffb4a"
      unitRef="number">0.625</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="i7493e1ba4b784b10bbdb551639b996d8_I20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMjcvZnJhZzphNzhkMmY3MGI4ZDY0ODdkYmIwZDE0NmE1MTE5OTBlMC90YWJsZToxYzYzMjE4NWY4MDQ0YTQ3OTQ1NTE2YjQwZDI3YWRlNy90YWJsZXJhbmdlOjFjNjMyMTg1ZjgwNDRhNDc5NDU1MTZiNDBkMjdhZGU3XzQtMy0xLTEtMA_250edca7-63dd-4b1c-8055-db8d1f19da2a"
      unitRef="number">0.120</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="i6f1f166882e84b0d80d658c2f7290c71_I20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMjcvZnJhZzphNzhkMmY3MGI4ZDY0ODdkYmIwZDE0NmE1MTE5OTBlMC90YWJsZToxYzYzMjE4NWY4MDQ0YTQ3OTQ1NTE2YjQwZDI3YWRlNy90YWJsZXJhbmdlOjFjNjMyMTg1ZjgwNDRhNDc5NDU1MTZiNDBkMjdhZGU3XzUtMy0xLTEtMA_78e033da-0650-458c-9ec1-4332744851aa"
      unitRef="number">0.026</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="i73355ec5b9114196885f43773e313806_I20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMjcvZnJhZzphNzhkMmY3MGI4ZDY0ODdkYmIwZDE0NmE1MTE5OTBlMC90YWJsZToxYzYzMjE4NWY4MDQ0YTQ3OTQ1NTE2YjQwZDI3YWRlNy90YWJsZXJhbmdlOjFjNjMyMTg1ZjgwNDRhNDc5NDU1MTZiNDBkMjdhZGU3XzYtMy0xLTEtMA_37eeaf97-6f71-4b8b-93da-2ee564f9848a"
      unitRef="number">0.14</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMjcvZnJhZzphNzhkMmY3MGI4ZDY0ODdkYmIwZDE0NmE1MTE5OTBlMC90ZXh0cmVnaW9uOmE3OGQyZjcwYjhkNjQ4N2RiYjBkMTQ2YTUxMTk5MGUwXzM3OTI_d62ab2b1-b14a-45de-9b95-53a6e1e2b208">&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:84.057%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.943%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Fair value at December 31, 2017&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Change in fair value recorded in other income (expense), net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;11,906&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Fair value at December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;16,091&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Change in fair value recorded in other income (expense), net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;21,030&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Reclassification upon IPO&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(37,121)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Fair Value at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i517a0560ef9f4f6a822a0a124dd39744_I20171231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMjcvZnJhZzphNzhkMmY3MGI4ZDY0ODdkYmIwZDE0NmE1MTE5OTBlMC90YWJsZTozMzYyZGJmNGZhM2Q0YjhkYTQ5OGVmZTc3NDc4NjJhZC90YWJsZXJhbmdlOjMzNjJkYmY0ZmEzZDRiOGRhNDk4ZWZlNzc0Nzg2MmFkXzItMS0xLTEtMA_89201195-fb8c-4e71-9888-0d991d3d18e8"
      unitRef="usd">4185000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMjcvZnJhZzphNzhkMmY3MGI4ZDY0ODdkYmIwZDE0NmE1MTE5OTBlMC90YWJsZTozMzYyZGJmNGZhM2Q0YjhkYTQ5OGVmZTc3NDc4NjJhZC90YWJsZXJhbmdlOjMzNjJkYmY0ZmEzZDRiOGRhNDk4ZWZlNzc0Nzg2MmFkXzMtMS0xLTEtMA_a4c6cbce-8003-4bd5-a00c-9ee4292099dc"
      unitRef="usd">11906000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMjcvZnJhZzphNzhkMmY3MGI4ZDY0ODdkYmIwZDE0NmE1MTE5OTBlMC90YWJsZTozMzYyZGJmNGZhM2Q0YjhkYTQ5OGVmZTc3NDc4NjJhZC90YWJsZXJhbmdlOjMzNjJkYmY0ZmEzZDRiOGRhNDk4ZWZlNzc0Nzg2MmFkXzQtMS0xLTEtMA_b1522e77-f516-4100-98ce-11d36f8cc954"
      unitRef="usd">16091000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMjcvZnJhZzphNzhkMmY3MGI4ZDY0ODdkYmIwZDE0NmE1MTE5OTBlMC90YWJsZTozMzYyZGJmNGZhM2Q0YjhkYTQ5OGVmZTc3NDc4NjJhZC90YWJsZXJhbmdlOjMzNjJkYmY0ZmEzZDRiOGRhNDk4ZWZlNzc0Nzg2MmFkXzUtMS0xLTEtMTU0OA_483e05fb-5aeb-4f6d-bf1d-a2330ba81902"
      unitRef="usd">-21030000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <silk:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityReclassifications
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMjcvZnJhZzphNzhkMmY3MGI4ZDY0ODdkYmIwZDE0NmE1MTE5OTBlMC90YWJsZTozMzYyZGJmNGZhM2Q0YjhkYTQ5OGVmZTc3NDc4NjJhZC90YWJsZXJhbmdlOjMzNjJkYmY0ZmEzZDRiOGRhNDk4ZWZlNzc0Nzg2MmFkXzYtMS0xLTEtMTU0OA_a5872cf2-96d0-47ed-927b-7186fcdaa6c0"
      unitRef="usd">37121000</silk:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityReclassifications>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMjcvZnJhZzphNzhkMmY3MGI4ZDY0ODdkYmIwZDE0NmE1MTE5OTBlMC90YWJsZTozMzYyZGJmNGZhM2Q0YjhkYTQ5OGVmZTc3NDc4NjJhZC90YWJsZXJhbmdlOjMzNjJkYmY0ZmEzZDRiOGRhNDk4ZWZlNzc0Nzg2MmFkXzctMS0xLTEtMTU0OA_dfdff853-b2a1-48d3-a89a-813c38e98bdc"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:SupplementalBalanceSheetDisclosuresTextBlock
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90ZXh0cmVnaW9uOjMxMWRhYjU4MTA4YjRiMjFhMmQ0Mzc5M2YwYzliNGY1XzI4NQ_b28b0ae8-ee8d-4276-8428-046485897bb3">Balance Sheet Components&lt;div style="margin-bottom:9pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Investments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The fair value of the Company's available-for-sale investments as of December&#160;31, 2019 are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:31.974%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:16.750%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.441%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.942%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.441%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:13.224%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.441%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:14.187%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-style:italic;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:9pt;font-weight:400;font-style:italic;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Gross Unrealized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Estimated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Amortized Cost&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Gains&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Losses&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Fair Value&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;34,363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;34,363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9,919&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9,919&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Corporate bonds/notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10,180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10,176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;44,450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;44,456&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;104,093&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;104,095&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Classified as:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;34,363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Short-term investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;51,508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Long-term investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;18,224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;104,095&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The following table summarizes the fair value of the Company&#x2019;s cash equivalents, short-term and long-term investments classified by maturity as of December&#160;31, 2019 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:80.211%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:15.789%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-style:italic;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:9pt;font-weight:400;font-style:italic;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Amounts maturing within one year&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;85,871&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Amounts maturing after one year through two years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;18,224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;104,095&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Available-for-sale investments held as of December&#160;31, 2019 had a weighted average days to maturity of 291 days. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The following table presents the Company's available-for-sale investments that were in an unrealized loss position as of December&#160;31, 2019 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:62.102%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:15.467%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.441%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:15.790%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-style:italic;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:9pt;font-weight:400;font-style:italic;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-bottom:1pt solid #000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Less than 12 months&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Unrealized Loss&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Corporate bonds/notes&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10,128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;19,067&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;29,195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Inventories&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Components of inventories were as follows (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;margin-bottom:9pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:69.314%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.942%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.943%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-style:italic;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:9pt;font-weight:400;font-style:italic;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,054&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Finished products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9,119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,690&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10,322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5,744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;As of December&#160;31, 2019 and 2018, there were no work-in-process inventories.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Property and Equipment, Net&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Property and equipment, net consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;margin-bottom:9pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:69.314%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.942%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.943%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-style:italic;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:9pt;font-weight:400;font-style:italic;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;657&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;517&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,991&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,978&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,961&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,788&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Less:  Accumulated depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1,550)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(946)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Add:  Construction-in-progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,734&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,880&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Depreciation and amortization expense was $712,000 and $517,000 for the years ended December&#160;31, 2019 and 2018, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Accrued Liabilities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Accrued liabilities consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;margin-bottom:9pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:69.314%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.942%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.943%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-style:italic;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:9pt;font-weight:400;font-style:italic;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Accrued payroll and related expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9,151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5,157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Provision for sales returns&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,419&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,862&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Accrued professional services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;682&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,014&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Operating lease liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;769&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Accrued royalty expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Accrued travel expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;431&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Accrued clinical expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Accrued other expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;451&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;15,034&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9,448&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SupplementalBalanceSheetDisclosuresTextBlock>
    <us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90ZXh0cmVnaW9uOjMxMWRhYjU4MTA4YjRiMjFhMmQ0Mzc5M2YwYzliNGY1XzIxOTkwMjMyNTg3ODA_d396574c-df78-423b-a6b1-c6cc2cf68f2f">&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The fair value of the Company's available-for-sale investments as of December&#160;31, 2019 are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:31.974%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:16.750%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.441%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.942%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.441%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:13.224%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.441%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:14.187%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-style:italic;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:9pt;font-weight:400;font-style:italic;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Gross Unrealized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Estimated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Amortized Cost&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Gains&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Losses&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Fair Value&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;34,363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;34,363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9,919&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9,919&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Corporate bonds/notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10,180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10,176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;44,450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;44,456&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;104,093&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;104,095&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Classified as:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;34,363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Short-term investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;51,508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Long-term investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;18,224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;104,095&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i75704913843f46ea87de6f08f1952574_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTo3YmMzZjhiMDhhMGI0OWMwYTg1NjMyMDFiNjlmZDJmNy90YWJsZXJhbmdlOjdiYzNmOGIwOGEwYjQ5YzBhODU2MzIwMWI2OWZkMmY3XzMtMS0xLTEtNDU0MQ_a12709f9-3ca2-482a-aa0a-3c09b605ee83"
      unitRef="usd">34363000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i75704913843f46ea87de6f08f1952574_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTo3YmMzZjhiMDhhMGI0OWMwYTg1NjMyMDFiNjlmZDJmNy90YWJsZXJhbmdlOjdiYzNmOGIwOGEwYjQ5YzBhODU2MzIwMWI2OWZkMmY3XzMtMy0xLTEtNDU0MQ_dea9622a-b237-42c5-a99e-ec738b96fa05"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i75704913843f46ea87de6f08f1952574_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTo3YmMzZjhiMDhhMGI0OWMwYTg1NjMyMDFiNjlmZDJmNy90YWJsZXJhbmdlOjdiYzNmOGIwOGEwYjQ5YzBhODU2MzIwMWI2OWZkMmY3XzMtNS0xLTEtNDU0MQ_0e98a683-6174-43e4-a29b-5b4f27baea94"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i75704913843f46ea87de6f08f1952574_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTo3YmMzZjhiMDhhMGI0OWMwYTg1NjMyMDFiNjlmZDJmNy90YWJsZXJhbmdlOjdiYzNmOGIwOGEwYjQ5YzBhODU2MzIwMWI2OWZkMmY3XzMtNy0xLTEtNDU0MQ_ba95bbe4-b13f-44d9-8fe9-3892cfe5c455"
      unitRef="usd">34363000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="id719d5cbdbe541ab86698a19fee6fb0d_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTo3YmMzZjhiMDhhMGI0OWMwYTg1NjMyMDFiNjlmZDJmNy90YWJsZXJhbmdlOjdiYzNmOGIwOGEwYjQ5YzBhODU2MzIwMWI2OWZkMmY3XzQtMS0xLTEtNDU0MQ_99f5891d-be70-4fb0-beab-3abc618400f4"
      unitRef="usd">9919000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="id719d5cbdbe541ab86698a19fee6fb0d_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTo3YmMzZjhiMDhhMGI0OWMwYTg1NjMyMDFiNjlmZDJmNy90YWJsZXJhbmdlOjdiYzNmOGIwOGEwYjQ5YzBhODU2MzIwMWI2OWZkMmY3XzQtMy0xLTEtNDU0MQ_478eaa6c-9aa7-4849-8974-3dfc5694e997"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="id719d5cbdbe541ab86698a19fee6fb0d_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTo3YmMzZjhiMDhhMGI0OWMwYTg1NjMyMDFiNjlmZDJmNy90YWJsZXJhbmdlOjdiYzNmOGIwOGEwYjQ5YzBhODU2MzIwMWI2OWZkMmY3XzQtNS0xLTEtNDU0MQ_71c88e18-b0d2-467b-8dc8-77dc1eefe7ec"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="id719d5cbdbe541ab86698a19fee6fb0d_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTo3YmMzZjhiMDhhMGI0OWMwYTg1NjMyMDFiNjlmZDJmNy90YWJsZXJhbmdlOjdiYzNmOGIwOGEwYjQ5YzBhODU2MzIwMWI2OWZkMmY3XzQtNy0xLTEtNDU0MQ_2844c67b-caf8-4d8d-8ec5-da01fcdb8796"
      unitRef="usd">9919000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i02820e2a66c44977989d03b1fffaede1_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTo3YmMzZjhiMDhhMGI0OWMwYTg1NjMyMDFiNjlmZDJmNy90YWJsZXJhbmdlOjdiYzNmOGIwOGEwYjQ5YzBhODU2MzIwMWI2OWZkMmY3XzUtMS0xLTEtNDU0MQ_30c8b575-4909-444c-91e6-801df9915a23"
      unitRef="usd">10180000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i02820e2a66c44977989d03b1fffaede1_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTo3YmMzZjhiMDhhMGI0OWMwYTg1NjMyMDFiNjlmZDJmNy90YWJsZXJhbmdlOjdiYzNmOGIwOGEwYjQ5YzBhODU2MzIwMWI2OWZkMmY3XzUtMy0xLTEtNDU0MQ_856a1443-56ad-4b77-9d24-0e4101d8b783"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i02820e2a66c44977989d03b1fffaede1_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTo3YmMzZjhiMDhhMGI0OWMwYTg1NjMyMDFiNjlmZDJmNy90YWJsZXJhbmdlOjdiYzNmOGIwOGEwYjQ5YzBhODU2MzIwMWI2OWZkMmY3XzUtNS0xLTEtNDU0MQ_c0cc647f-2abe-4ea9-b067-38d576da2ae3"
      unitRef="usd">4000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i02820e2a66c44977989d03b1fffaede1_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTo3YmMzZjhiMDhhMGI0OWMwYTg1NjMyMDFiNjlmZDJmNy90YWJsZXJhbmdlOjdiYzNmOGIwOGEwYjQ5YzBhODU2MzIwMWI2OWZkMmY3XzUtNy0xLTEtNDU0MQ_e98fe96e-f7e0-4289-8ae2-f2d600f7592e"
      unitRef="usd">10176000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i2f9bf5b113a1441481893ba9f910f9cf_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTo3YmMzZjhiMDhhMGI0OWMwYTg1NjMyMDFiNjlmZDJmNy90YWJsZXJhbmdlOjdiYzNmOGIwOGEwYjQ5YzBhODU2MzIwMWI2OWZkMmY3XzYtMS0xLTEtNDU0MQ_cf928f5f-fc21-4b30-8654-23adea52cf6c"
      unitRef="usd">44450000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i2f9bf5b113a1441481893ba9f910f9cf_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTo3YmMzZjhiMDhhMGI0OWMwYTg1NjMyMDFiNjlmZDJmNy90YWJsZXJhbmdlOjdiYzNmOGIwOGEwYjQ5YzBhODU2MzIwMWI2OWZkMmY3XzYtMy0xLTEtNDU0MQ_d35f1183-c713-46f1-bc4f-dc84a0612a43"
      unitRef="usd">9000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i2f9bf5b113a1441481893ba9f910f9cf_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTo3YmMzZjhiMDhhMGI0OWMwYTg1NjMyMDFiNjlmZDJmNy90YWJsZXJhbmdlOjdiYzNmOGIwOGEwYjQ5YzBhODU2MzIwMWI2OWZkMmY3XzYtNS0xLTEtNDU0MQ_ed7c2f5b-b7a6-4ed7-8c76-3068deee1fbc"
      unitRef="usd">3000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i2f9bf5b113a1441481893ba9f910f9cf_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTo3YmMzZjhiMDhhMGI0OWMwYTg1NjMyMDFiNjlmZDJmNy90YWJsZXJhbmdlOjdiYzNmOGIwOGEwYjQ5YzBhODU2MzIwMWI2OWZkMmY3XzYtNy0xLTEtNDU0MQ_d81212e3-bd9d-4df5-af2c-291ca06a2f87"
      unitRef="usd">44456000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i507134e9c9aa43a28501de3b98f309ca_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTo3YmMzZjhiMDhhMGI0OWMwYTg1NjMyMDFiNjlmZDJmNy90YWJsZXJhbmdlOjdiYzNmOGIwOGEwYjQ5YzBhODU2MzIwMWI2OWZkMmY3XzctMS0xLTEtNDU0MQ_2fc9a76f-6cca-4361-9d1e-8d0f51789a37"
      unitRef="usd">5181000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i507134e9c9aa43a28501de3b98f309ca_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTo3YmMzZjhiMDhhMGI0OWMwYTg1NjMyMDFiNjlmZDJmNy90YWJsZXJhbmdlOjdiYzNmOGIwOGEwYjQ5YzBhODU2MzIwMWI2OWZkMmY3XzctMy0xLTEtNDU0MQ_a13c1094-b147-408b-b887-85c9f9c9f35a"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i507134e9c9aa43a28501de3b98f309ca_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTo3YmMzZjhiMDhhMGI0OWMwYTg1NjMyMDFiNjlmZDJmNy90YWJsZXJhbmdlOjdiYzNmOGIwOGEwYjQ5YzBhODU2MzIwMWI2OWZkMmY3XzctNS0xLTEtNDU0MQ_dcdb739a-4b1d-423c-ad5a-2249b3381b87"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i507134e9c9aa43a28501de3b98f309ca_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTo3YmMzZjhiMDhhMGI0OWMwYTg1NjMyMDFiNjlmZDJmNy90YWJsZXJhbmdlOjdiYzNmOGIwOGEwYjQ5YzBhODU2MzIwMWI2OWZkMmY3XzctNy0xLTEtNDU0MQ_17a4efdf-d691-43d9-bf68-65de6cfc8d89"
      unitRef="usd">5181000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTo3YmMzZjhiMDhhMGI0OWMwYTg1NjMyMDFiNjlmZDJmNy90YWJsZXJhbmdlOjdiYzNmOGIwOGEwYjQ5YzBhODU2MzIwMWI2OWZkMmY3XzgtMS0xLTEtNDU0MQ_ef46cb9e-68ac-4cce-93a8-62bb3476e460"
      unitRef="usd">104093000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTo3YmMzZjhiMDhhMGI0OWMwYTg1NjMyMDFiNjlmZDJmNy90YWJsZXJhbmdlOjdiYzNmOGIwOGEwYjQ5YzBhODU2MzIwMWI2OWZkMmY3XzgtMy0xLTEtNDU0MQ_1a474ef3-80f5-4a0a-8d9d-582dfa2535e3"
      unitRef="usd">9000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTo3YmMzZjhiMDhhMGI0OWMwYTg1NjMyMDFiNjlmZDJmNy90YWJsZXJhbmdlOjdiYzNmOGIwOGEwYjQ5YzBhODU2MzIwMWI2OWZkMmY3XzgtNS0xLTEtNDU0MQ_d22fd191-2985-4409-a066-74b7a5643303"
      unitRef="usd">7000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTo3YmMzZjhiMDhhMGI0OWMwYTg1NjMyMDFiNjlmZDJmNy90YWJsZXJhbmdlOjdiYzNmOGIwOGEwYjQ5YzBhODU2MzIwMWI2OWZkMmY3XzgtNy0xLTEtNDU0MQ_576d0e2a-b62f-47bd-80b7-83ecfe2d9e10"
      unitRef="usd">104095000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i0d613bf9b2a14909a35df00d8a23da58_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTo3YmMzZjhiMDhhMGI0OWMwYTg1NjMyMDFiNjlmZDJmNy90YWJsZXJhbmdlOjdiYzNmOGIwOGEwYjQ5YzBhODU2MzIwMWI2OWZkMmY3XzExLTctMS0xLTQ1NjA_567285c5-39fc-496c-8edd-05aaa9a694d4"
      unitRef="usd">34363000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i24c078f64bcf4a558a6eb9707a027214_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTo3YmMzZjhiMDhhMGI0OWMwYTg1NjMyMDFiNjlmZDJmNy90YWJsZXJhbmdlOjdiYzNmOGIwOGEwYjQ5YzBhODU2MzIwMWI2OWZkMmY3XzEyLTctMS0xLTQ1NjA_124ece4e-0d0e-434a-9373-b4f9dde271cc"
      unitRef="usd">51508000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ic83cfde8eac24427a5b7c49a8127d817_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTo3YmMzZjhiMDhhMGI0OWMwYTg1NjMyMDFiNjlmZDJmNy90YWJsZXJhbmdlOjdiYzNmOGIwOGEwYjQ5YzBhODU2MzIwMWI2OWZkMmY3XzEzLTctMS0xLTQ1NjA_7d090854-4d35-4ee6-99e7-d2a97bdfd738"
      unitRef="usd">18224000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTo3YmMzZjhiMDhhMGI0OWMwYTg1NjMyMDFiNjlmZDJmNy90YWJsZXJhbmdlOjdiYzNmOGIwOGEwYjQ5YzBhODU2MzIwMWI2OWZkMmY3XzE0LTctMS0xLTQ1NjA_6ac2a790-2e4a-4794-a33e-f043dcdccb29"
      unitRef="usd">104095000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:FairValueByBalanceSheetGroupingTextBlock
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90ZXh0cmVnaW9uOjMxMWRhYjU4MTA4YjRiMjFhMmQ0Mzc5M2YwYzliNGY1XzIxOTkwMjMyNTg3ODE_b7ad419f-89ce-4a29-b782-2960bb2bbcc8">&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The following table summarizes the fair value of the Company&#x2019;s cash equivalents, short-term and long-term investments classified by maturity as of December&#160;31, 2019 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:80.211%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:15.789%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-style:italic;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:9pt;font-weight:400;font-style:italic;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Amounts maturing within one year&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;85,871&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Amounts maturing after one year through two years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;18,224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;104,095&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueByBalanceSheetGroupingTextBlock>
    <silk:CashAndCashEquivalentsFairValueDisclosureMaturingWithinOneYear
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTo0MzMyYjYzMWYwOGE0OGY1OWRjYmI2MWUxZThkYWZmZC90YWJsZXJhbmdlOjQzMzJiNjMxZjA4YTQ4ZjU5ZGNiYjYxZTFlOGRhZmZkXzItMS0xLTEtNDU4MA_36ac39cf-1d5e-49ce-a0be-b18679cfb1dd"
      unitRef="usd">85871000</silk:CashAndCashEquivalentsFairValueDisclosureMaturingWithinOneYear>
    <silk:CashAndCashEquivalentsFairValueDisclosureMaturingAfterOneYearThroughTwoYears
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTo0MzMyYjYzMWYwOGE0OGY1OWRjYmI2MWUxZThkYWZmZC90YWJsZXJhbmdlOjQzMzJiNjMxZjA4YTQ4ZjU5ZGNiYjYxZTFlOGRhZmZkXzMtMS0xLTEtNDU4MA_c1cadff9-75b9-4a7a-95bd-43b7ff43e801"
      unitRef="usd">18224000</silk:CashAndCashEquivalentsFairValueDisclosureMaturingAfterOneYearThroughTwoYears>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTo0MzMyYjYzMWYwOGE0OGY1OWRjYmI2MWUxZThkYWZmZC90YWJsZXJhbmdlOjQzMzJiNjMxZjA4YTQ4ZjU5ZGNiYjYxZTFlOGRhZmZkXzQtMS0xLTEtNDU4MA_fc3aa3a6-c748-4209-9949-b411808e74cb"
      unitRef="usd">104095000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:DebtSecuritiesAvailableForSaleTerm
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90ZXh0cmVnaW9uOjMxMWRhYjU4MTA4YjRiMjFhMmQ0Mzc5M2YwYzliNGY1XzMyOTg1MzQ4ODYwMTI_4a31ef8c-9c88-410f-8b70-c7f5fb7977f7">P291D</us-gaap:DebtSecuritiesAvailableForSaleTerm>
    <us-gaap:ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90ZXh0cmVnaW9uOjMxMWRhYjU4MTA4YjRiMjFhMmQ0Mzc5M2YwYzliNGY1XzIxOTkwMjMyNTg3ODI_19bc8304-f6a0-4896-ae4a-576893e26347">&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The following table presents the Company's available-for-sale investments that were in an unrealized loss position as of December&#160;31, 2019 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:62.102%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:15.467%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.441%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:15.790%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-style:italic;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:9pt;font-weight:400;font-style:italic;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-bottom:1pt solid #000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Less than 12 months&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Unrealized Loss&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Corporate bonds/notes&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10,128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;19,067&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;29,195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i02820e2a66c44977989d03b1fffaede1_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTo3ZDcxMjg5YzdjODk0NzRlYTViM2M3YmVmNTRjYTI4NS90YWJsZXJhbmdlOjdkNzEyODljN2M4OTQ3NGVhNWIzYzdiZWY1NGNhMjg1XzMtMS0xLTEtNDYyMQ_6d227332-b81c-492b-872a-82d2eaa7d449"
      unitRef="usd">10128000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i02820e2a66c44977989d03b1fffaede1_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTo3ZDcxMjg5YzdjODk0NzRlYTViM2M3YmVmNTRjYTI4NS90YWJsZXJhbmdlOjdkNzEyODljN2M4OTQ3NGVhNWIzYzdiZWY1NGNhMjg1XzMtMy0xLTEtNDYyMQ_c077caa3-9a6b-4206-9fa1-50cebf5cccfe"
      unitRef="usd">4000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i2f9bf5b113a1441481893ba9f910f9cf_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTo3ZDcxMjg5YzdjODk0NzRlYTViM2M3YmVmNTRjYTI4NS90YWJsZXJhbmdlOjdkNzEyODljN2M4OTQ3NGVhNWIzYzdiZWY1NGNhMjg1XzQtMS0xLTEtNDYyMQ_d95170ba-7647-4338-8975-88ce90edbf22"
      unitRef="usd">19067000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i2f9bf5b113a1441481893ba9f910f9cf_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTo3ZDcxMjg5YzdjODk0NzRlYTViM2M3YmVmNTRjYTI4NS90YWJsZXJhbmdlOjdkNzEyODljN2M4OTQ3NGVhNWIzYzdiZWY1NGNhMjg1XzQtMy0xLTEtNDYyMQ_aaec8811-b933-4f8b-9928-e9903fa30e7d"
      unitRef="usd">3000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTo3ZDcxMjg5YzdjODk0NzRlYTViM2M3YmVmNTRjYTI4NS90YWJsZXJhbmdlOjdkNzEyODljN2M4OTQ3NGVhNWIzYzdiZWY1NGNhMjg1XzUtMS0xLTEtNDYyMQ_0547ae6b-6b57-4f29-a4c6-fbb5de8b1efe"
      unitRef="usd">29195000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTo3ZDcxMjg5YzdjODk0NzRlYTViM2M3YmVmNTRjYTI4NS90YWJsZXJhbmdlOjdkNzEyODljN2M4OTQ3NGVhNWIzYzdiZWY1NGNhMjg1XzUtMy0xLTEtNDYyMQ_58328439-e0ce-43bf-b2b9-c90e20ec5565"
      unitRef="usd">7000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90ZXh0cmVnaW9uOjMxMWRhYjU4MTA4YjRiMjFhMmQ0Mzc5M2YwYzliNGY1XzI4Ng_fd51b496-3c86-4ab3-bd64-2d9d728a3094">&lt;div style="margin-bottom:9pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Inventories&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Components of inventories were as follows (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;margin-bottom:9pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:69.314%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.942%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.943%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-style:italic;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:9pt;font-weight:400;font-style:italic;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,054&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Finished products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9,119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,690&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10,322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5,744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTpjM2U4YzNiNmJmOTA0MmE5OThjZGVjNDMzOTM1N2MwOS90YWJsZXJhbmdlOmMzZThjM2I2YmY5MDQyYTk5OGNkZWM0MzM5MzU3YzA5XzItMS0xLTEtMA_39b1a59f-7163-4e10-9f23-f50c55f6ffd9"
      unitRef="usd">1203000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTpjM2U4YzNiNmJmOTA0MmE5OThjZGVjNDMzOTM1N2MwOS90YWJsZXJhbmdlOmMzZThjM2I2YmY5MDQyYTk5OGNkZWM0MzM5MzU3YzA5XzItMy0xLTEtMA_2bdca060-56cc-4910-88fa-82e4328ffec9"
      unitRef="usd">1054000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTpjM2U4YzNiNmJmOTA0MmE5OThjZGVjNDMzOTM1N2MwOS90YWJsZXJhbmdlOmMzZThjM2I2YmY5MDQyYTk5OGNkZWM0MzM5MzU3YzA5XzMtMS0xLTEtMA_7c46ade9-427d-4bd4-8c26-72c3fcd88728"
      unitRef="usd">9119000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTpjM2U4YzNiNmJmOTA0MmE5OThjZGVjNDMzOTM1N2MwOS90YWJsZXJhbmdlOmMzZThjM2I2YmY5MDQyYTk5OGNkZWM0MzM5MzU3YzA5XzMtMy0xLTEtMA_01a04b6a-ad40-4e6c-ac6f-0444b98835d2"
      unitRef="usd">4690000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryNet
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTpjM2U4YzNiNmJmOTA0MmE5OThjZGVjNDMzOTM1N2MwOS90YWJsZXJhbmdlOmMzZThjM2I2YmY5MDQyYTk5OGNkZWM0MzM5MzU3YzA5XzQtMS0xLTEtMA_4a446b19-0cfb-47d2-8a6e-8d255b4bce1f"
      unitRef="usd">10322000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTpjM2U4YzNiNmJmOTA0MmE5OThjZGVjNDMzOTM1N2MwOS90YWJsZXJhbmdlOmMzZThjM2I2YmY5MDQyYTk5OGNkZWM0MzM5MzU3YzA5XzQtMy0xLTEtMA_dd329170-0eb7-45aa-87c3-5c461bc9df93"
      unitRef="usd">5744000</us-gaap:InventoryNet>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90ZXh0cmVnaW9uOjMxMWRhYjU4MTA4YjRiMjFhMmQ0Mzc5M2YwYzliNGY1XzIxOTkwMjMyNTg3ODQ_1d5219cb-a365-44c5-84d9-2f84b54e5795"
      unitRef="usd">0</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90ZXh0cmVnaW9uOjMxMWRhYjU4MTA4YjRiMjFhMmQ0Mzc5M2YwYzliNGY1XzIxOTkwMjMyNTg3ODQ_a3a8f531-84c8-48a7-946b-8ddf80a336e8"
      unitRef="usd">0</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90ZXh0cmVnaW9uOjMxMWRhYjU4MTA4YjRiMjFhMmQ0Mzc5M2YwYzliNGY1XzI4Nw_58f651df-0725-4361-8d6d-c3828af9d3ea">&lt;div style="margin-bottom:9pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Property and Equipment, Net&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Property and equipment, net consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;margin-bottom:9pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:69.314%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.942%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.943%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-style:italic;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:9pt;font-weight:400;font-style:italic;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;657&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;517&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,991&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,978&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,961&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,788&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Less:  Accumulated depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1,550)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(946)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Add:  Construction-in-progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,734&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,880&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i865a5a03baaf4a64b9eb712f44655277_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTo4N2Y2MGY3ZGU5OGQ0MzYzYmExMGU5MGJjNTVmNDZlYS90YWJsZXJhbmdlOjg3ZjYwZjdkZTk4ZDQzNjNiYTEwZTkwYmM1NWY0NmVhXzItMS0xLTEtMA_cdee7c10-d45c-42b3-ba4e-c031a3415285"
      unitRef="usd">657000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i5b1c140e3f174d628388c3f67f069432_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTo4N2Y2MGY3ZGU5OGQ0MzYzYmExMGU5MGJjNTVmNDZlYS90YWJsZXJhbmdlOjg3ZjYwZjdkZTk4ZDQzNjNiYTEwZTkwYmM1NWY0NmVhXzItMy0xLTEtMA_95b83fdd-fc08-44d5-84a5-db4e837790a2"
      unitRef="usd">517000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ief7e81456214489ba291e117b1b06060_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTo4N2Y2MGY3ZGU5OGQ0MzYzYmExMGU5MGJjNTVmNDZlYS90YWJsZXJhbmdlOjg3ZjYwZjdkZTk4ZDQzNjNiYTEwZTkwYmM1NWY0NmVhXzMtMS0xLTEtMA_7fdc80dd-a326-4b17-ac9f-c0d2da0e4fcc"
      unitRef="usd">1295000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ibf79c9f5d41a43c0bbf17c7e0f0f94d7_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTo4N2Y2MGY3ZGU5OGQ0MzYzYmExMGU5MGJjNTVmNDZlYS90YWJsZXJhbmdlOjg3ZjYwZjdkZTk4ZDQzNjNiYTEwZTkwYmM1NWY0NmVhXzMtMy0xLTEtMA_cf948db5-ed06-468b-9da2-03964bcc0e87"
      unitRef="usd">1217000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i2cdfbb16655f454e85b113e66702358b_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTo4N2Y2MGY3ZGU5OGQ0MzYzYmExMGU5MGJjNTVmNDZlYS90YWJsZXJhbmdlOjg3ZjYwZjdkZTk4ZDQzNjNiYTEwZTkwYmM1NWY0NmVhXzQtMS0xLTEtMA_59d59ff6-4efe-4293-a893-ffed3613d365"
      unitRef="usd">18000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i54b13dd93afe499f9eda02e58485e8ba_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTo4N2Y2MGY3ZGU5OGQ0MzYzYmExMGU5MGJjNTVmNDZlYS90YWJsZXJhbmdlOjg3ZjYwZjdkZTk4ZDQzNjNiYTEwZTkwYmM1NWY0NmVhXzQtMy0xLTEtMA_9016984b-d37f-4c19-b925-c4f2f81daf4a"
      unitRef="usd">76000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i3eb7140b29f74c85bd43c66d2cab8f1d_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTo4N2Y2MGY3ZGU5OGQ0MzYzYmExMGU5MGJjNTVmNDZlYS90YWJsZXJhbmdlOjg3ZjYwZjdkZTk4ZDQzNjNiYTEwZTkwYmM1NWY0NmVhXzUtMS0xLTEtMA_5e5195f4-7bdf-46f0-b3a4-8f1924215601"
      unitRef="usd">1991000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ibe305b8c4cc94fa5a038d2f95ad17a9b_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTo4N2Y2MGY3ZGU5OGQ0MzYzYmExMGU5MGJjNTVmNDZlYS90YWJsZXJhbmdlOjg3ZjYwZjdkZTk4ZDQzNjNiYTEwZTkwYmM1NWY0NmVhXzUtMy0xLTEtMA_a5f266ad-6085-41b8-8682-6223c067a674"
      unitRef="usd">1978000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTo4N2Y2MGY3ZGU5OGQ0MzYzYmExMGU5MGJjNTVmNDZlYS90YWJsZXJhbmdlOjg3ZjYwZjdkZTk4ZDQzNjNiYTEwZTkwYmM1NWY0NmVhXzYtMS0xLTEtMA_d1b64a52-187a-4a01-beb8-316329aa5746"
      unitRef="usd">3961000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTo4N2Y2MGY3ZGU5OGQ0MzYzYmExMGU5MGJjNTVmNDZlYS90YWJsZXJhbmdlOjg3ZjYwZjdkZTk4ZDQzNjNiYTEwZTkwYmM1NWY0NmVhXzYtMy0xLTEtMA_4579de23-aff7-4741-88fd-b229cbfef5c5"
      unitRef="usd">3788000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTo4N2Y2MGY3ZGU5OGQ0MzYzYmExMGU5MGJjNTVmNDZlYS90YWJsZXJhbmdlOjg3ZjYwZjdkZTk4ZDQzNjNiYTEwZTkwYmM1NWY0NmVhXzctMS0xLTEtMA_58089f2d-54cc-434e-ba76-fe828da7b480"
      unitRef="usd">1550000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTo4N2Y2MGY3ZGU5OGQ0MzYzYmExMGU5MGJjNTVmNDZlYS90YWJsZXJhbmdlOjg3ZjYwZjdkZTk4ZDQzNjNiYTEwZTkwYmM1NWY0NmVhXzctMy0xLTEtMA_0171a6b9-65b8-4dd0-8679-7c49ee942332"
      unitRef="usd">946000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i9c7143f51286457db347c4a2163a630d_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTo4N2Y2MGY3ZGU5OGQ0MzYzYmExMGU5MGJjNTVmNDZlYS90YWJsZXJhbmdlOjg3ZjYwZjdkZTk4ZDQzNjNiYTEwZTkwYmM1NWY0NmVhXzgtMS0xLTEtMA_b13be333-94f5-4a70-b494-ac8cca0a3b2e"
      unitRef="usd">323000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i1ccf70059f7d4165acf299107d6c8761_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTo4N2Y2MGY3ZGU5OGQ0MzYzYmExMGU5MGJjNTVmNDZlYS90YWJsZXJhbmdlOjg3ZjYwZjdkZTk4ZDQzNjNiYTEwZTkwYmM1NWY0NmVhXzgtMy0xLTEtMA_2f67093c-96cd-49f6-83bb-2022a7aee9e1"
      unitRef="usd">38000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTo4N2Y2MGY3ZGU5OGQ0MzYzYmExMGU5MGJjNTVmNDZlYS90YWJsZXJhbmdlOjg3ZjYwZjdkZTk4ZDQzNjNiYTEwZTkwYmM1NWY0NmVhXzktMS0xLTEtMA_cf31399c-9254-480d-9546-056cec79c131"
      unitRef="usd">2734000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTo4N2Y2MGY3ZGU5OGQ0MzYzYmExMGU5MGJjNTVmNDZlYS90YWJsZXJhbmdlOjg3ZjYwZjdkZTk4ZDQzNjNiYTEwZTkwYmM1NWY0NmVhXzktMy0xLTEtMA_5cca43ba-2a0e-4ef0-886a-a40ada880bf5"
      unitRef="usd">2880000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Depreciation
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90ZXh0cmVnaW9uOjMxMWRhYjU4MTA4YjRiMjFhMmQ0Mzc5M2YwYzliNGY1XzMyOTg1MzQ4ODM2Njk_4eabf89c-ba5c-4625-8439-38106698f0ff"
      unitRef="usd">712000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90ZXh0cmVnaW9uOjMxMWRhYjU4MTA4YjRiMjFhMmQ0Mzc5M2YwYzliNGY1XzMyOTg1MzQ4ODM2Nzk_1f1f08c9-cff5-46d2-b283-a819237b4b51"
      unitRef="usd">517000000</us-gaap:Depreciation>
    <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90ZXh0cmVnaW9uOjMxMWRhYjU4MTA4YjRiMjFhMmQ0Mzc5M2YwYzliNGY1XzI4OA_8172a42f-7df7-4ba0-9e64-ac427a15f969">&lt;div style="margin-bottom:9pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Accrued Liabilities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Accrued liabilities consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;margin-bottom:9pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:69.314%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.942%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.943%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-style:italic;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:9pt;font-weight:400;font-style:italic;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Accrued payroll and related expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9,151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5,157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Provision for sales returns&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,419&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,862&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Accrued professional services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;682&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,014&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Operating lease liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;769&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Accrued royalty expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Accrued travel expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;431&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Accrued clinical expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Accrued other expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;451&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;15,034&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9,448&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
    <us-gaap:AccruedSalariesCurrent
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTplMDQwNjQwOTk0ZWE0ZjVhOGI1NDIxMDRlZDdiZmQyZC90YWJsZXJhbmdlOmUwNDA2NDA5OTRlYTRmNWE4YjU0MjEwNGVkN2JmZDJkXzItMS0xLTEtMA_a31bd9b9-ecc0-4335-8cfa-6e77d5ebca79"
      unitRef="usd">9151000</us-gaap:AccruedSalariesCurrent>
    <us-gaap:AccruedSalariesCurrent
      contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTplMDQwNjQwOTk0ZWE0ZjVhOGI1NDIxMDRlZDdiZmQyZC90YWJsZXJhbmdlOmUwNDA2NDA5OTRlYTRmNWE4YjU0MjEwNGVkN2JmZDJkXzItMy0xLTEtMA_14385fa6-f416-4305-823e-7c4550dd5e19"
      unitRef="usd">5157000</us-gaap:AccruedSalariesCurrent>
    <silk:ProvisionsForSalesReturns
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTplMDQwNjQwOTk0ZWE0ZjVhOGI1NDIxMDRlZDdiZmQyZC90YWJsZXJhbmdlOmUwNDA2NDA5OTRlYTRmNWE4YjU0MjEwNGVkN2JmZDJkXzMtMS0xLTEtNDg1Mw_df95ced0-6813-4fbd-89a4-6b0ffbcabb20"
      unitRef="usd">2419000</silk:ProvisionsForSalesReturns>
    <silk:ProvisionsForSalesReturns
      contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTplMDQwNjQwOTk0ZWE0ZjVhOGI1NDIxMDRlZDdiZmQyZC90YWJsZXJhbmdlOmUwNDA2NDA5OTRlYTRmNWE4YjU0MjEwNGVkN2JmZDJkXzMtMy0xLTEtNDg1Mw_5ed67c62-adae-45d4-80ca-0428978c2a48"
      unitRef="usd">1862000</silk:ProvisionsForSalesReturns>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTplMDQwNjQwOTk0ZWE0ZjVhOGI1NDIxMDRlZDdiZmQyZC90YWJsZXJhbmdlOmUwNDA2NDA5OTRlYTRmNWE4YjU0MjEwNGVkN2JmZDJkXzMtMS0xLTEtMA_1e69cbea-5838-4d04-a9ae-32adcdb9a3de"
      unitRef="usd">682000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTplMDQwNjQwOTk0ZWE0ZjVhOGI1NDIxMDRlZDdiZmQyZC90YWJsZXJhbmdlOmUwNDA2NDA5OTRlYTRmNWE4YjU0MjEwNGVkN2JmZDJkXzMtMy0xLTEtMA_d7c805c4-e218-45a3-b401-958587604645"
      unitRef="usd">1014000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTplMDQwNjQwOTk0ZWE0ZjVhOGI1NDIxMDRlZDdiZmQyZC90YWJsZXJhbmdlOmUwNDA2NDA5OTRlYTRmNWE4YjU0MjEwNGVkN2JmZDJkXzQtMS0xLTEtMTYxOA_19f2e9e4-fb57-4f41-adfd-8e2f1cd05675"
      unitRef="usd">769000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:AccruedRoyaltiesCurrent
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTplMDQwNjQwOTk0ZWE0ZjVhOGI1NDIxMDRlZDdiZmQyZC90YWJsZXJhbmdlOmUwNDA2NDA5OTRlYTRmNWE4YjU0MjEwNGVkN2JmZDJkXzQtMS0xLTEtMA_a013d04f-a4cc-45c9-8685-14da9005eb08"
      unitRef="usd">470000</us-gaap:AccruedRoyaltiesCurrent>
    <us-gaap:AccruedRoyaltiesCurrent
      contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTplMDQwNjQwOTk0ZWE0ZjVhOGI1NDIxMDRlZDdiZmQyZC90YWJsZXJhbmdlOmUwNDA2NDA5OTRlYTRmNWE4YjU0MjEwNGVkN2JmZDJkXzQtMy0xLTEtMA_128113d6-da94-4794-bf8a-b0207ed34cc9"
      unitRef="usd">313000</us-gaap:AccruedRoyaltiesCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTplMDQwNjQwOTk0ZWE0ZjVhOGI1NDIxMDRlZDdiZmQyZC90YWJsZXJhbmdlOmUwNDA2NDA5OTRlYTRmNWE4YjU0MjEwNGVkN2JmZDJkXzYtMS0xLTEtMTYyMw_0428258b-4721-4a3e-b991-dacb49464c73"
      unitRef="usd">304000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTplMDQwNjQwOTk0ZWE0ZjVhOGI1NDIxMDRlZDdiZmQyZC90YWJsZXJhbmdlOmUwNDA2NDA5OTRlYTRmNWE4YjU0MjEwNGVkN2JmZDJkXzYtMy0xLTEtMTYyMw_21b79ee5-2025-4018-81d8-e6175b1604b0"
      unitRef="usd">137000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <silk:AccruedTravelExpensesCurrent
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTplMDQwNjQwOTk0ZWE0ZjVhOGI1NDIxMDRlZDdiZmQyZC90YWJsZXJhbmdlOmUwNDA2NDA5OTRlYTRmNWE4YjU0MjEwNGVkN2JmZDJkXzUtMS0xLTEtMA_774d7a9d-dc92-43c8-a0f5-eaeaedcc1a9d"
      unitRef="usd">431000</silk:AccruedTravelExpensesCurrent>
    <silk:AccruedTravelExpensesCurrent
      contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTplMDQwNjQwOTk0ZWE0ZjVhOGI1NDIxMDRlZDdiZmQyZC90YWJsZXJhbmdlOmUwNDA2NDA5OTRlYTRmNWE4YjU0MjEwNGVkN2JmZDJkXzUtMy0xLTEtMA_c65703bf-1432-404d-8962-1ec1da3c0418"
      unitRef="usd">270000</silk:AccruedTravelExpensesCurrent>
    <silk:AccruedClinicalExpensesCurrent
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTplMDQwNjQwOTk0ZWE0ZjVhOGI1NDIxMDRlZDdiZmQyZC90YWJsZXJhbmdlOmUwNDA2NDA5OTRlYTRmNWE4YjU0MjEwNGVkN2JmZDJkXzYtMS0xLTEtMA_ea674f0d-4cc5-4c26-844d-501f5ecc8a18"
      unitRef="usd">241000</silk:AccruedClinicalExpensesCurrent>
    <silk:AccruedClinicalExpensesCurrent
      contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTplMDQwNjQwOTk0ZWE0ZjVhOGI1NDIxMDRlZDdiZmQyZC90YWJsZXJhbmdlOmUwNDA2NDA5OTRlYTRmNWE4YjU0MjEwNGVkN2JmZDJkXzYtMy0xLTEtMA_27b819f2-c33d-43ce-854a-1d1868fa2fed"
      unitRef="usd">244000</silk:AccruedClinicalExpensesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTplMDQwNjQwOTk0ZWE0ZjVhOGI1NDIxMDRlZDdiZmQyZC90YWJsZXJhbmdlOmUwNDA2NDA5OTRlYTRmNWE4YjU0MjEwNGVkN2JmZDJkXzctMS0xLTEtMA_d19c1a98-0d06-4d65-a84f-5db7ea5063ab"
      unitRef="usd">567000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTplMDQwNjQwOTk0ZWE0ZjVhOGI1NDIxMDRlZDdiZmQyZC90YWJsZXJhbmdlOmUwNDA2NDA5OTRlYTRmNWE4YjU0MjEwNGVkN2JmZDJkXzctMy0xLTEtMA_c591d78f-cc3c-419c-9e84-bc17b41faa25"
      unitRef="usd">451000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTplMDQwNjQwOTk0ZWE0ZjVhOGI1NDIxMDRlZDdiZmQyZC90YWJsZXJhbmdlOmUwNDA2NDA5OTRlYTRmNWE4YjU0MjEwNGVkN2JmZDJkXzgtMS0xLTEtMA_2d27fc87-0979-4eba-8192-b8d2794a2cd2"
      unitRef="usd">15034000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzAvZnJhZzozMTFkYWI1ODEwOGI0YjIxYTJkNDM3OTNmMGM5YjRmNS90YWJsZTplMDQwNjQwOTk0ZWE0ZjVhOGI1NDIxMDRlZDdiZmQyZC90YWJsZXJhbmdlOmUwNDA2NDA5OTRlYTRmNWE4YjU0MjEwNGVkN2JmZDJkXzgtMy0xLTEtMA_f910009a-562f-422c-b4c1-94d214938699"
      unitRef="usd">9448000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzYvZnJhZzoxOTU5MjdlNmJiMzM0YTFlOTUzMzQyYTNiNmRiYzA3YS90ZXh0cmVnaW9uOjE5NTkyN2U2YmIzMzRhMWU5NTMzNDJhM2I2ZGJjMDdhXzUzODU_57da87ba-b580-4085-b98d-4f41ac2496e4">Long-term Debt&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In October&#160;2015, the Company entered into a term loan agreement with Capital Resource Group ("CRG").  The term loan agreement provides for up to $30,000,000 in term loans split into two tranches as follows: (i) the Tranche A Loans provided for $20,000,000 in term loans, and (ii) the Tranche B Loans provided for up to $10,000,000 in term loans.  The Company drew down the Tranche A Loans on October 13, 2015.  The Tranche B Loans were available to be drawn prior to March 29, 2017.  In January 2017, the term loan agreement was amended to extend the commitment period of the Tranche B Loans to April 28, 2017.  In April 2017, the Company drew down $5,000,000 of the available Tranche B Loans.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In September 2018, the Company entered into Amendment No. 5 to the term loan agreement with CRG.  Under the amended terms of the amended loan agreement the maturity date was extended to December 31, 2022 and the repayment schedule of the existing term loans were changed to interest only so that the outstanding principal amount of the term loans will be payable in a single installment at maturity.  The related fixed interest rate was changed to equal 10.75% per annum, due and payable quarterly in arrears.  At the election of the Company, 2.75% of the interest due and payable may be &#x201c;paid in kind&#x201d; and added to the then outstanding principal and 8.0% of the interest due and payable paid in cash.  All unpaid principal, and accrued and unpaid interest, is due and payable in full on December 31,&#160;2022.  The amended term loan agreement also provided for additional term loans in an aggregate principal amount of up to $25,000,000 and allowed for the conversion into shares of common stock, at the Company&#x2019;s option, of up to 25% of the outstanding loans under the term loan agreement in connection with an initial public offering of the Company&#x2019;s common stock which results in market capitalization of at least $250,000,000.  In September 2018, the Company drew down an additional $15,000,000 under the term loan agreement with CRG.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In June 2019, the Company entered into Amendment No. 7 to the term loan agreement with CRG to reflect flexibility with respect to permitted cash investments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The Company may voluntarily prepay the borrowings in full.  The Tranche A borrowing required a payment, on the borrowing date, of a financing fee equal to 1.75% of the borrowed loan principal, which is recorded as a discount to the debt.  In addition, a facility fee equal to 5.0% of the amounts borrowed plus any &#x201c;paid in kind&#x201d; is payable at the end of the term or when the borrowings are repaid in full.  A long-term &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;liability is being accreted using the effective interest method for the facility fee over the term of the loan agreement.  The borrowings are collateralized by a security interest in substantially all of the Company&#x2019;s assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The Company is subject to financial covenants related to liquidity and minimum trailing revenue targets that begin in December&#160;31, 2016 and are tested on an annual basis.  The liquidity covenant requires the Company to maintain an amount which shall exceed the greater of (i) $3,000,000 and (ii) the minimum cash balance, if any, required of the Company by a creditor to the extent the&#160;Company has incurred permitted priority debt.  The Company had to achieve minimum net revenue of $1,000,000 in 2016, $5,000,000 in 2017, $15,000,000 in 2018, and must achieve minimum net revenue of $30,000,000 in 2019 and $40,000,000 in 2020.  The liquidity financial covenant has a 90-day equity cure period following end of the calendar year to issue additional shares of equity interests in exchange for cash, or to borrow permitted cure debt.  In addition, the term loan agreement prohibits the payment of cash dividends on the Company&#x2019;s capital stock and also places restrictions on mergers, sales of assets, investments, incurrence of liens, incurrence of indebtedness and transactions with affiliates.  CRG may accelerate the payment terms of the term loan agreement upon the occurrence of certain events of default set forth therein, which include the failure of the Company to make timely payments of amounts due under the term loan agreement, the failure of the Company to adhere to the covenants set forth in the term loan agreement, the insolvency of the Company or upon the occurrence of a material adverse change.  As of December&#160;31, 2019, the Company was in compliance with all applicable financial covenants.  As of December&#160;31, 2019, management does not believe that it is probable that the above clauses will be triggered within the next twelve months, therefore, the debt is classified as long-term on the balance sheet.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Future maturities under the term loan agreement as of December&#160;31, 2019 are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:83.256%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.943%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Year Ending December 31:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,442&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;48,256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;57,152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Add: Accretion of closing fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;58,357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Less: Amount representing interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(13,339)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Less: Amount representing debt discount and debt issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(139)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:36pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Present value of minimum payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;44,879&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In October 2015, CRG purchased 327,759 shares of the Company&#x2019;s Series C redeemable convertible preferred stock at $6.11 per share.  In addition, CRG received warrants to purchase 163,877 shares of the Company&#x2019;s Series C redeemable convertible preferred stock at an exercise price of $6.11 per share.  Upon the closing of the IPO, the warrants were net exercised, based on the IPO price of $20.00 per share, into shares of common stock. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In July 2017, CRG purchased 163,877 shares of the Company&#x2019;s Series C convertible preferred stock at $6.11 per share.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <silk:DebtMaximumBorrowingCapacity
      contextRef="id62906738f144d84bc9d557ddc169284_I20151031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzYvZnJhZzoxOTU5MjdlNmJiMzM0YTFlOTUzMzQyYTNiNmRiYzA3YS90ZXh0cmVnaW9uOjE5NTkyN2U2YmIzMzRhMWU5NTMzNDJhM2I2ZGJjMDdhXzMyOTg1MzQ4ODk3MDY_9baba33c-d28b-4479-90de-2cafec5869d0"
      unitRef="usd">30000000</silk:DebtMaximumBorrowingCapacity>
    <silk:DebtMaximumBorrowingCapacity
      contextRef="id77e08ef6b1e4d26923913e53db9186d_I20151031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzYvZnJhZzoxOTU5MjdlNmJiMzM0YTFlOTUzMzQyYTNiNmRiYzA3YS90ZXh0cmVnaW9uOjE5NTkyN2U2YmIzMzRhMWU5NTMzNDJhM2I2ZGJjMDdhXzMyOTg1MzQ4ODk3MTQ_0955bf4a-716d-4d75-835f-d9cd445a5249"
      unitRef="usd">20000000</silk:DebtMaximumBorrowingCapacity>
    <silk:DebtMaximumBorrowingCapacity
      contextRef="i16c13b04e0bd4554b32d832a2eee0af3_I20151031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzYvZnJhZzoxOTU5MjdlNmJiMzM0YTFlOTUzMzQyYTNiNmRiYzA3YS90ZXh0cmVnaW9uOjE5NTkyN2U2YmIzMzRhMWU5NTMzNDJhM2I2ZGJjMDdhXzMyOTg1MzQ4ODk3MTg_da213811-2dd9-418e-9956-8d3ab59ef5de"
      unitRef="usd">10000000</silk:DebtMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i1ad5b6c72b9d43eb9409533a1389160e_I20170430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzYvZnJhZzoxOTU5MjdlNmJiMzM0YTFlOTUzMzQyYTNiNmRiYzA3YS90ZXh0cmVnaW9uOjE5NTkyN2U2YmIzMzRhMWU5NTMzNDJhM2I2ZGJjMDdhXzMyOTg1MzQ4ODk3MjI_34da79ca-bdb1-498c-9e06-31c12059fc02"
      unitRef="usd">5000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i77aa0ed0241849f98e4736227590410c_I20180930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzYvZnJhZzoxOTU5MjdlNmJiMzM0YTFlOTUzMzQyYTNiNmRiYzA3YS90ZXh0cmVnaW9uOjE5NTkyN2U2YmIzMzRhMWU5NTMzNDJhM2I2ZGJjMDdhXzMyOTg1MzQ4ODk3MjY_6ed94941-3bea-4a4e-975b-7fb07b63ff1f"
      unitRef="number">0.1075</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <silk:DebtInstrumentInterestRatePaidInKind
      contextRef="i77aa0ed0241849f98e4736227590410c_I20180930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzYvZnJhZzoxOTU5MjdlNmJiMzM0YTFlOTUzMzQyYTNiNmRiYzA3YS90ZXh0cmVnaW9uOjE5NTkyN2U2YmIzMzRhMWU5NTMzNDJhM2I2ZGJjMDdhXzMyOTg1MzQ4ODk3MzA_f1f79637-6b78-4b87-b327-cb6039de1064"
      unitRef="number">0.0275</silk:DebtInstrumentInterestRatePaidInKind>
    <silk:DebtInstrumentInterestRatePaidInCash
      contextRef="i77aa0ed0241849f98e4736227590410c_I20180930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzYvZnJhZzoxOTU5MjdlNmJiMzM0YTFlOTUzMzQyYTNiNmRiYzA3YS90ZXh0cmVnaW9uOjE5NTkyN2U2YmIzMzRhMWU5NTMzNDJhM2I2ZGJjMDdhXzMyOTg1MzQ4ODk3MzQ_24c1e796-f89b-41f7-87ee-537ed98933b3"
      unitRef="number">0.080</silk:DebtInstrumentInterestRatePaidInCash>
    <silk:DebtMaximumBorrowingCapacity
      contextRef="i77aa0ed0241849f98e4736227590410c_I20180930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzYvZnJhZzoxOTU5MjdlNmJiMzM0YTFlOTUzMzQyYTNiNmRiYzA3YS90ZXh0cmVnaW9uOjE5NTkyN2U2YmIzMzRhMWU5NTMzNDJhM2I2ZGJjMDdhXzMyOTg1MzQ4ODk3Mzg_bad2442f-2d5a-4bfc-a352-2cdaf2436fa3"
      unitRef="usd">25000000</silk:DebtMaximumBorrowingCapacity>
    <silk:DebtInstrumentConvertibleMaximumPercentageOfOutstandingLoans
      contextRef="i96c7f06d98d442a59802339444e89dae_D20180901-20180930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzYvZnJhZzoxOTU5MjdlNmJiMzM0YTFlOTUzMzQyYTNiNmRiYzA3YS90ZXh0cmVnaW9uOjE5NTkyN2U2YmIzMzRhMWU5NTMzNDJhM2I2ZGJjMDdhXzMyOTg1MzQ4ODk3NDI_bf215310-2797-4ed3-b65e-e4a43f5e518d"
      unitRef="number">0.25</silk:DebtInstrumentConvertibleMaximumPercentageOfOutstandingLoans>
    <silk:DebtInstrumentConvertibleMarketCapitalization
      contextRef="i77aa0ed0241849f98e4736227590410c_I20180930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzYvZnJhZzoxOTU5MjdlNmJiMzM0YTFlOTUzMzQyYTNiNmRiYzA3YS90ZXh0cmVnaW9uOjE5NTkyN2U2YmIzMzRhMWU5NTMzNDJhM2I2ZGJjMDdhXzMyOTg1MzQ4ODk3NDY_b4f02372-d7c0-49af-a3a4-978252783087"
      unitRef="usd">250000000</silk:DebtInstrumentConvertibleMarketCapitalization>
    <silk:DebtMaximumBorrowingCapacity
      contextRef="i54b82514b8694d3b98494d64e98b4745_I20180930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzYvZnJhZzoxOTU5MjdlNmJiMzM0YTFlOTUzMzQyYTNiNmRiYzA3YS90ZXh0cmVnaW9uOjE5NTkyN2U2YmIzMzRhMWU5NTMzNDJhM2I2ZGJjMDdhXzMyOTg1MzQ4ODk3NTA_753b3e42-f2fa-4cf5-8b82-8b54f12844bf"
      unitRef="usd">15000000</silk:DebtMaximumBorrowingCapacity>
    <silk:DebtInstrumentInterestRateFinancingFee
      contextRef="id77e08ef6b1e4d26923913e53db9186d_I20151031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzYvZnJhZzoxOTU5MjdlNmJiMzM0YTFlOTUzMzQyYTNiNmRiYzA3YS90ZXh0cmVnaW9uOjE5NTkyN2U2YmIzMzRhMWU5NTMzNDJhM2I2ZGJjMDdhXzMyOTg1MzQ4ODk3NTQ_8e333174-7a88-411c-95b7-a19af91a86c6"
      unitRef="number">0.0175</silk:DebtInstrumentInterestRateFinancingFee>
    <silk:DebtInstrumentInterestRateFacilityFee
      contextRef="id77e08ef6b1e4d26923913e53db9186d_I20151031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzYvZnJhZzoxOTU5MjdlNmJiMzM0YTFlOTUzMzQyYTNiNmRiYzA3YS90ZXh0cmVnaW9uOjE5NTkyN2U2YmIzMzRhMWU5NTMzNDJhM2I2ZGJjMDdhXzMyOTg1MzQ4ODk3NTg_88a2e4d1-8330-4b6c-9aa9-244feaa0dfe0"
      unitRef="number">0.050</silk:DebtInstrumentInterestRateFacilityFee>
    <silk:DebtInstrumentCovenantMaximumLiquidityAmount
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzYvZnJhZzoxOTU5MjdlNmJiMzM0YTFlOTUzMzQyYTNiNmRiYzA3YS90ZXh0cmVnaW9uOjE5NTkyN2U2YmIzMzRhMWU5NTMzNDJhM2I2ZGJjMDdhXzMyOTg1MzQ4ODk3NjI_1c517d73-78c6-4de2-840d-0e9d2716a4de"
      unitRef="usd">3000000</silk:DebtInstrumentCovenantMaximumLiquidityAmount>
    <silk:DebtInstrumentCovenantMinimumNetRevenueAmount
      contextRef="i7ac0d334898e4fb1897fd7e5822858ab_D20160101-20161231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzYvZnJhZzoxOTU5MjdlNmJiMzM0YTFlOTUzMzQyYTNiNmRiYzA3YS90ZXh0cmVnaW9uOjE5NTkyN2U2YmIzMzRhMWU5NTMzNDJhM2I2ZGJjMDdhXzMyOTg1MzQ4ODk3NjY_2e8eea7a-4507-4287-b7d7-efde2ad363cb"
      unitRef="usd">1000000</silk:DebtInstrumentCovenantMinimumNetRevenueAmount>
    <silk:DebtInstrumentCovenantMinimumNetRevenueAmount
      contextRef="i28c5cd5abfce4c7aa5c44b0f651c9ad8_D20170101-20171231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzYvZnJhZzoxOTU5MjdlNmJiMzM0YTFlOTUzMzQyYTNiNmRiYzA3YS90ZXh0cmVnaW9uOjE5NTkyN2U2YmIzMzRhMWU5NTMzNDJhM2I2ZGJjMDdhXzMyOTg1MzQ4ODk3NzA_76358b0f-b1cc-4651-90e7-4e06373ec5d7"
      unitRef="usd">5000000</silk:DebtInstrumentCovenantMinimumNetRevenueAmount>
    <silk:DebtInstrumentCovenantMinimumNetRevenueAmount
      contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzYvZnJhZzoxOTU5MjdlNmJiMzM0YTFlOTUzMzQyYTNiNmRiYzA3YS90ZXh0cmVnaW9uOjE5NTkyN2U2YmIzMzRhMWU5NTMzNDJhM2I2ZGJjMDdhXzMyOTg1MzQ4ODk3NzQ_395fb00a-3414-42ca-8bf0-fdccde588011"
      unitRef="usd">15000000</silk:DebtInstrumentCovenantMinimumNetRevenueAmount>
    <silk:DebtInstrumentCovenantMinimumNetRevenueAmount
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzYvZnJhZzoxOTU5MjdlNmJiMzM0YTFlOTUzMzQyYTNiNmRiYzA3YS90ZXh0cmVnaW9uOjE5NTkyN2U2YmIzMzRhMWU5NTMzNDJhM2I2ZGJjMDdhXzMyOTg1MzQ4ODk3Nzg_e37d771c-f71b-46d3-93e4-ec299f1d6c61"
      unitRef="usd">30000000</silk:DebtInstrumentCovenantMinimumNetRevenueAmount>
    <silk:DebtInstrumentCovenantMinimumNetRevenueAmount
      contextRef="i24d31e2c272041379e7662e50a4130b0_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzYvZnJhZzoxOTU5MjdlNmJiMzM0YTFlOTUzMzQyYTNiNmRiYzA3YS90ZXh0cmVnaW9uOjE5NTkyN2U2YmIzMzRhMWU5NTMzNDJhM2I2ZGJjMDdhXzMyOTg1MzQ4ODk3ODI_5752aa82-a2ae-4eda-9552-dcf8cb3063c9"
      unitRef="usd">40000000</silk:DebtInstrumentCovenantMinimumNetRevenueAmount>
    <silk:DebtInstrumentLiquidityCovenantTerm
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzYvZnJhZzoxOTU5MjdlNmJiMzM0YTFlOTUzMzQyYTNiNmRiYzA3YS90ZXh0cmVnaW9uOjE5NTkyN2U2YmIzMzRhMWU5NTMzNDJhM2I2ZGJjMDdhXzMyOTg1MzQ4ODk3ODY_8b66d687-5ffb-4a44-ae50-e7870d016df8">P90D</silk:DebtInstrumentLiquidityCovenantTerm>
    <us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzYvZnJhZzoxOTU5MjdlNmJiMzM0YTFlOTUzMzQyYTNiNmRiYzA3YS90ZXh0cmVnaW9uOjE5NTkyN2U2YmIzMzRhMWU5NTMzNDJhM2I2ZGJjMDdhXzUzODY_4ba8a593-79a0-4190-b0ec-b55fe128d568">&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Future maturities under the term loan agreement as of December&#160;31, 2019 are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:83.256%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.943%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Year Ending December 31:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,442&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;48,256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;57,152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Add: Accretion of closing fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;58,357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Less: Amount representing interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(13,339)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Less: Amount representing debt discount and debt issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(139)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:36pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Present value of minimum payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;44,879&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzYvZnJhZzoxOTU5MjdlNmJiMzM0YTFlOTUzMzQyYTNiNmRiYzA3YS90YWJsZTo3NDgyNjQ4NzllMTQ0M2E4YmUxNmRjNjI0NDVkNWNlNS90YWJsZXJhbmdlOjc0ODI2NDg3OWUxNDQzYThiZTE2ZGM2MjQ0NWQ1Y2U1XzItMi0xLTEtMA_a1ab850d-9da8-4b82-a3eb-0b8c0b5528d3"
      unitRef="usd">4454000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzYvZnJhZzoxOTU5MjdlNmJiMzM0YTFlOTUzMzQyYTNiNmRiYzA3YS90YWJsZTo3NDgyNjQ4NzllMTQ0M2E4YmUxNmRjNjI0NDVkNWNlNS90YWJsZXJhbmdlOjc0ODI2NDg3OWUxNDQzYThiZTE2ZGM2MjQ0NWQ1Y2U1XzMtMi0xLTEtMA_328d9084-5760-4f47-b54b-63c4c38941ef"
      unitRef="usd">4442000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzYvZnJhZzoxOTU5MjdlNmJiMzM0YTFlOTUzMzQyYTNiNmRiYzA3YS90YWJsZTo3NDgyNjQ4NzllMTQ0M2E4YmUxNmRjNjI0NDVkNWNlNS90YWJsZXJhbmdlOjc0ODI2NDg3OWUxNDQzYThiZTE2ZGM2MjQ0NWQ1Y2U1XzQtMi0xLTEtMA_f42d5c55-6c87-4ac3-8aa8-461c89f51615"
      unitRef="usd">48256000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
    <silk:LongTermDebtGrossBeforeAccretionOfClosingFees
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzYvZnJhZzoxOTU5MjdlNmJiMzM0YTFlOTUzMzQyYTNiNmRiYzA3YS90YWJsZTo3NDgyNjQ4NzllMTQ0M2E4YmUxNmRjNjI0NDVkNWNlNS90YWJsZXJhbmdlOjc0ODI2NDg3OWUxNDQzYThiZTE2ZGM2MjQ0NWQ1Y2U1XzUtMi0xLTEtMA_dc5aadf2-a20a-4875-b05c-0c20e4c76b48"
      unitRef="usd">57152000</silk:LongTermDebtGrossBeforeAccretionOfClosingFees>
    <silk:LongTermDebtAccretionOfClosingFees
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzYvZnJhZzoxOTU5MjdlNmJiMzM0YTFlOTUzMzQyYTNiNmRiYzA3YS90YWJsZTo3NDgyNjQ4NzllMTQ0M2E4YmUxNmRjNjI0NDVkNWNlNS90YWJsZXJhbmdlOjc0ODI2NDg3OWUxNDQzYThiZTE2ZGM2MjQ0NWQ1Y2U1XzYtMi0xLTEtMA_7e03ba0e-3d42-495c-bc17-2e25fc93cf56"
      unitRef="usd">1205000</silk:LongTermDebtAccretionOfClosingFees>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzYvZnJhZzoxOTU5MjdlNmJiMzM0YTFlOTUzMzQyYTNiNmRiYzA3YS90YWJsZTo3NDgyNjQ4NzllMTQ0M2E4YmUxNmRjNjI0NDVkNWNlNS90YWJsZXJhbmdlOjc0ODI2NDg3OWUxNDQzYThiZTE2ZGM2MjQ0NWQ1Y2U1XzctMi0xLTEtMA_38876a84-46a5-4384-81c3-6fd150861c4b"
      unitRef="usd">58357000</us-gaap:DebtInstrumentCarryingAmount>
    <silk:LongTermDebtUnpaidInterest
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzYvZnJhZzoxOTU5MjdlNmJiMzM0YTFlOTUzMzQyYTNiNmRiYzA3YS90YWJsZTo3NDgyNjQ4NzllMTQ0M2E4YmUxNmRjNjI0NDVkNWNlNS90YWJsZXJhbmdlOjc0ODI2NDg3OWUxNDQzYThiZTE2ZGM2MjQ0NWQ1Y2U1XzgtMi0xLTEtMA_06ea7926-c17b-4f6b-945d-8d73dd8f92d6"
      unitRef="usd">13339000</silk:LongTermDebtUnpaidInterest>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzYvZnJhZzoxOTU5MjdlNmJiMzM0YTFlOTUzMzQyYTNiNmRiYzA3YS90YWJsZTo3NDgyNjQ4NzllMTQ0M2E4YmUxNmRjNjI0NDVkNWNlNS90YWJsZXJhbmdlOjc0ODI2NDg3OWUxNDQzYThiZTE2ZGM2MjQ0NWQ1Y2U1XzktMi0xLTEtMA_6ee95b55-3683-4fac-b5e6-63128c971d2f"
      unitRef="usd">139000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:LongTermDebt
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzYvZnJhZzoxOTU5MjdlNmJiMzM0YTFlOTUzMzQyYTNiNmRiYzA3YS90YWJsZTo3NDgyNjQ4NzllMTQ0M2E4YmUxNmRjNjI0NDVkNWNlNS90YWJsZXJhbmdlOjc0ODI2NDg3OWUxNDQzYThiZTE2ZGM2MjQ0NWQ1Y2U1XzEwLTItMS0xLTA_7023e9fa-0ffe-432b-a1c7-a92ee05dc221"
      unitRef="usd">44879000</us-gaap:LongTermDebt>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="i4225226f93604e02af259bb86559e5b8_D20151001-20151031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzYvZnJhZzoxOTU5MjdlNmJiMzM0YTFlOTUzMzQyYTNiNmRiYzA3YS90ZXh0cmVnaW9uOjE5NTkyN2U2YmIzMzRhMWU5NTMzNDJhM2I2ZGJjMDdhXzMyOTg1MzQ4ODk3OTA_bdc40c8f-5964-451d-bfbd-0ee964a4c662"
      unitRef="shares">327759</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="i5675339c673448139076ebcb2b762771_I20151031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzYvZnJhZzoxOTU5MjdlNmJiMzM0YTFlOTUzMzQyYTNiNmRiYzA3YS90ZXh0cmVnaW9uOjE5NTkyN2U2YmIzMzRhMWU5NTMzNDJhM2I2ZGJjMDdhXzMyOTg1MzQ4ODk3OTQ_96b1b111-044a-467a-8629-9538e1b78c73"
      unitRef="usdPerShare">6.11</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="i69a4c0c247dc496998d701bc90ebe115_I20151031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzYvZnJhZzoxOTU5MjdlNmJiMzM0YTFlOTUzMzQyYTNiNmRiYzA3YS90ZXh0cmVnaW9uOjE5NTkyN2U2YmIzMzRhMWU5NTMzNDJhM2I2ZGJjMDdhXzMyOTg1MzQ4ODk3OTg_7b79eaaf-a97a-4313-80b5-0507034d8020"
      unitRef="shares">163877</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="i5675339c673448139076ebcb2b762771_I20151031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzYvZnJhZzoxOTU5MjdlNmJiMzM0YTFlOTUzMzQyYTNiNmRiYzA3YS90ZXh0cmVnaW9uOjE5NTkyN2U2YmIzMzRhMWU5NTMzNDJhM2I2ZGJjMDdhXzMyOTg1MzQ4ODk4MDI_b5b1a6ee-1aae-43cf-8b53-9084473af430"
      unitRef="usdPerShare">6.11</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="i6ed3f43f8f3b4ec3b256ad182faa9d25_I20190430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzYvZnJhZzoxOTU5MjdlNmJiMzM0YTFlOTUzMzQyYTNiNmRiYzA3YS90ZXh0cmVnaW9uOjE5NTkyN2U2YmIzMzRhMWU5NTMzNDJhM2I2ZGJjMDdhXzMyOTg1MzQ4ODk4MTg_a4903343-efb8-4751-adcb-19111f745184"
      unitRef="usdPerShare">20.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="i6665fb41539543faa5c665e0459d1cf6_D20170701-20170731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzYvZnJhZzoxOTU5MjdlNmJiMzM0YTFlOTUzMzQyYTNiNmRiYzA3YS90ZXh0cmVnaW9uOjE5NTkyN2U2YmIzMzRhMWU5NTMzNDJhM2I2ZGJjMDdhXzMyOTg1MzQ4ODk4MDY_f6c3ca47-6ad9-4cdd-a260-7924c9c3d18c"
      unitRef="shares">163877</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="i4c8c2ee5923d47dfb022beb8e861a8c5_I20170731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzYvZnJhZzoxOTU5MjdlNmJiMzM0YTFlOTUzMzQyYTNiNmRiYzA3YS90ZXh0cmVnaW9uOjE5NTkyN2U2YmIzMzRhMWU5NTMzNDJhM2I2ZGJjMDdhXzMyOTg1MzQ4ODk4MTA_05eee9e0-91d2-4b01-94e3-f7dcb7a986b1"
      unitRef="usdPerShare">6.11</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzkvZnJhZzoxMzVmYTRlNzEwNzg0YTI5OTAxNmEzOWU5YmIyZGIzZi90ZXh0cmVnaW9uOjEzNWZhNGU3MTA3ODRhMjk5MDE2YTM5ZTliYjJkYjNmXzM4MDg_65045684-3416-444b-994b-75d025b73943">Commitments and Contingencies&lt;div style="margin-bottom:9pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Operating Lease and Rights of Use&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The Company&#x2019;s operating lease obligation consists of leased office, laboratory, and manufacturing space under a non-cancellable operating lease that expires in October&#160;2024. The lease agreement includes a renewal provision allowing the Company to extend this lease for an additional period of five years.   Operating lease costs were $870,000 for the year ended December&#160;31, 2019.  Cash paid for amounts included in the measurement of operating lease liabilities was $721,000 for the year ended December&#160;31, 2019.  As of December&#160;31, 2019, the weighted average discount rate was approximately 6.50% and the weighted average remaining lease term was 4.83 years.  Balance sheet information as of December&#160;31, 2019 consists of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:77.647%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.441%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:17.712%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Operating Lease:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Operating lease right-of-use asset in other non-current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Operating lease liability in accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;769&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Operating lease liability in other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The following table summarizes the Company's operating lease maturities as of December&#160;31, 2019 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:76.980%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.436%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:18.384%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Year Ending December 31:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,037&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,066&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,096&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;904&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5,230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Less: imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(761)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:18pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Present value of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The aggregate future minimum lease payments under ASC 840 as of December&#160;31, 2018 were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:83.416%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.441%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.943%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Year Ending December 31:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total Minimum&lt;br/&gt;Lease Payments&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,002&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,002&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,031&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,044&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2023 and thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,920&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5,999&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Purchase Obligations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Purchase obligations consist of agreements to purchase goods and services entered into in the ordinary course of business.  As of December&#160;31, 2019, the Company had non-cancellable purchase obligations to suppliers of $7,097,000.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Indemnification&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In the normal course of business, the Company enters into contracts and agreements with suppliers and other parties that contain a variety of representations and warranties and may provide for indemnification of the counterparty.  The Company&#x2019;s exposure under these agreements is unknown because it involves claims that may be made against it in the future but have not yet been made.  To date, the Company has not been subject to any claims or been required to defend any action related to its indemnification obligations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The Company indemnifies each of its directors and officers for certain events or occurrences, subject to certain limits, while the director is or was serving at the Company&#x2019;s request in such capacity, as permitted under Delaware law and in accordance with its certificate of incorporation and bylaws.  The term of the indemnification period lasts as long as a director may be subject to any proceeding arising out of acts or omissions of such director in such capacity.  The maximum amount of potential future indemnification is unlimited; however, the Company currently holds director liability insurance.  The Company believes that the fair value of these indemnification obligations is minimal.  Accordingly, the Company has not recognized any liabilities relating to these obligations as of December&#160;31, 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Contingencies &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The Company is not involved in any pending legal proceedings that it believes could have a material adverse effect on its financial condition, results of operations or cash flows. From time to time, the Company may pursue litigation to assert its legal right and such litigation may be costly and divert the efforts and attention of its management and technical personnel which could adversely affect its business. The Company accrues a liability for such matters when it is probable that future expenditures will be made and such expenditures can be reasonably estimated. There were no contingent liabilities requiring accrual at December&#160;31, 2019 and 2018.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Legal Matters&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In February 2019, a former employee, through counsel, advised the Company that he had filed a charge of discrimination against the Company with the California Department of Fair Employment &amp;amp; Housing, or &lt;/span&gt;&lt;/div&gt;DFEH.  The former employee&#x2019;s complaint alleged sexual harassment and retaliation in violation of the California Department of Fair Employment &amp;amp; Housing Act.  The complaint did not allege specific damages. The Company and the former employee participated in mediation on July 30, 2019 and reached a settlement that required the Company to pay an amount that was not material to its financial statements, which amount was fully paid as of December&#160;31, 2019.</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:LesseeOperatingLeaseRenewalTerm
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzkvZnJhZzoxMzVmYTRlNzEwNzg0YTI5OTAxNmEzOWU5YmIyZGIzZi90ZXh0cmVnaW9uOjEzNWZhNGU3MTA3ODRhMjk5MDE2YTM5ZTliYjJkYjNmXzIxOTkwMjMyNjczNTg_e1c396a3-2b0d-44d9-a8b2-1a154817d486">P5Y</us-gaap:LesseeOperatingLeaseRenewalTerm>
    <us-gaap:OperatingLeaseCost
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzkvZnJhZzoxMzVmYTRlNzEwNzg0YTI5OTAxNmEzOWU5YmIyZGIzZi90ZXh0cmVnaW9uOjEzNWZhNGU3MTA3ODRhMjk5MDE2YTM5ZTliYjJkYjNmXzMyOTg1MzQ4ODgwOTQ_03767b85-c487-45af-a0bf-c5a9729d6dd1"
      unitRef="usd">870000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeasePayments
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzkvZnJhZzoxMzVmYTRlNzEwNzg0YTI5OTAxNmEzOWU5YmIyZGIzZi90ZXh0cmVnaW9uOjEzNWZhNGU3MTA3ODRhMjk5MDE2YTM5ZTliYjJkYjNmXzMyOTg1MzQ4ODgyMjM_e49ddef3-24a3-4a27-b5da-496fcc24b087"
      unitRef="usd">721000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzkvZnJhZzoxMzVmYTRlNzEwNzg0YTI5OTAxNmEzOWU5YmIyZGIzZi90ZXh0cmVnaW9uOjEzNWZhNGU3MTA3ODRhMjk5MDE2YTM5ZTliYjJkYjNmXzMyOTg1MzQ4ODgyMTM_a89a99f0-00e4-410f-ac51-e15d0b5d5496"
      unitRef="number">0.0650</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzkvZnJhZzoxMzVmYTRlNzEwNzg0YTI5OTAxNmEzOWU5YmIyZGIzZi90ZXh0cmVnaW9uOjEzNWZhNGU3MTA3ODRhMjk5MDE2YTM5ZTliYjJkYjNmXzMyOTg1MzQ4ODgyNDk_f8a060c1-5db5-4a78-9e2f-04157e5661b5">P4Y9M29D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzkvZnJhZzoxMzVmYTRlNzEwNzg0YTI5OTAxNmEzOWU5YmIyZGIzZi90YWJsZTo1NTM0NjY2MDgxZTg0YWYxODM0N2Q4YTliMzE0MzA5NS90YWJsZXJhbmdlOjU1MzQ2NjYwODFlODRhZjE4MzQ3ZDhhOWIzMTQzMDk1XzEtMi0xLTEtMTc5Ng_c09bb0fc-73c6-4015-abb2-f86cd0ce1c93"
      unitRef="usd">3400000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzkvZnJhZzoxMzVmYTRlNzEwNzg0YTI5OTAxNmEzOWU5YmIyZGIzZi90YWJsZTo1NTM0NjY2MDgxZTg0YWYxODM0N2Q4YTliMzE0MzA5NS90YWJsZXJhbmdlOjU1MzQ2NjYwODFlODRhZjE4MzQ3ZDhhOWIzMTQzMDk1XzItMi0xLTEtMTc5OQ_86d17ef7-9077-4432-9b7a-476ae57205b3"
      unitRef="usd">769000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzkvZnJhZzoxMzVmYTRlNzEwNzg0YTI5OTAxNmEzOWU5YmIyZGIzZi90YWJsZTo1NTM0NjY2MDgxZTg0YWYxODM0N2Q4YTliMzE0MzA5NS90YWJsZXJhbmdlOjU1MzQ2NjYwODFlODRhZjE4MzQ3ZDhhOWIzMTQzMDk1XzMtMi0xLTEtMTc5OQ_e3043960-e486-40be-b8c7-3ae9eda12aea"
      unitRef="usd">3700000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiability
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzkvZnJhZzoxMzVmYTRlNzEwNzg0YTI5OTAxNmEzOWU5YmIyZGIzZi90YWJsZTo1NTM0NjY2MDgxZTg0YWYxODM0N2Q4YTliMzE0MzA5NS90YWJsZXJhbmdlOjU1MzQ2NjYwODFlODRhZjE4MzQ3ZDhhOWIzMTQzMDk1XzQtMi0xLTEtMTc5OQ_7671a70c-ba9b-4105-9de2-224a40f4a2fa"
      unitRef="usd">4469000</us-gaap:OperatingLeaseLiability>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzkvZnJhZzoxMzVmYTRlNzEwNzg0YTI5OTAxNmEzOWU5YmIyZGIzZi90ZXh0cmVnaW9uOjEzNWZhNGU3MTA3ODRhMjk5MDE2YTM5ZTliYjJkYjNmXzIxOTkwMjMyNjczNTY_89fa738b-a998-4555-978e-faeb177d7ca6">&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The following table summarizes the Company's operating lease maturities as of December&#160;31, 2019 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:76.980%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.436%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:18.384%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Year Ending December 31:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,037&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,066&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,096&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;904&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5,230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Less: imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(761)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:18pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Present value of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzkvZnJhZzoxMzVmYTRlNzEwNzg0YTI5OTAxNmEzOWU5YmIyZGIzZi90YWJsZTo3NzY3NTg3MDE0OTk0ZTYwYWQxMDIxZTk2ZjY3OTkxZi90YWJsZXJhbmdlOjc3Njc1ODcwMTQ5OTRlNjBhZDEwMjFlOTZmNjc5OTFmXzEtMS0xLTEtMTg4NQ_203afe91-1577-4fc1-aca5-f372945244f8"
      unitRef="usd">1037000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzkvZnJhZzoxMzVmYTRlNzEwNzg0YTI5OTAxNmEzOWU5YmIyZGIzZi90YWJsZTo3NzY3NTg3MDE0OTk0ZTYwYWQxMDIxZTk2ZjY3OTkxZi90YWJsZXJhbmdlOjc3Njc1ODcwMTQ5OTRlNjBhZDEwMjFlOTZmNjc5OTFmXzItMS0xLTEtMTg4NQ_20343808-d473-4db0-a1a7-34c2b340d727"
      unitRef="usd">1066000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzkvZnJhZzoxMzVmYTRlNzEwNzg0YTI5OTAxNmEzOWU5YmIyZGIzZi90YWJsZTo3NzY3NTg3MDE0OTk0ZTYwYWQxMDIxZTk2ZjY3OTkxZi90YWJsZXJhbmdlOjc3Njc1ODcwMTQ5OTRlNjBhZDEwMjFlOTZmNjc5OTFmXzMtMS0xLTEtMTg4NQ_b9bd1dc7-f2b9-4a1e-87b7-ae436db79c5c"
      unitRef="usd">1096000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzkvZnJhZzoxMzVmYTRlNzEwNzg0YTI5OTAxNmEzOWU5YmIyZGIzZi90YWJsZTo3NzY3NTg3MDE0OTk0ZTYwYWQxMDIxZTk2ZjY3OTkxZi90YWJsZXJhbmdlOjc3Njc1ODcwMTQ5OTRlNjBhZDEwMjFlOTZmNjc5OTFmXzQtMS0xLTEtMTg4NQ_2f8a605f-c9f2-4489-a7c7-9b01559066ac"
      unitRef="usd">1127000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzkvZnJhZzoxMzVmYTRlNzEwNzg0YTI5OTAxNmEzOWU5YmIyZGIzZi90YWJsZTo3NzY3NTg3MDE0OTk0ZTYwYWQxMDIxZTk2ZjY3OTkxZi90YWJsZXJhbmdlOjc3Njc1ODcwMTQ5OTRlNjBhZDEwMjFlOTZmNjc5OTFmXzUtMS0xLTEtMTg4NQ_5a97ae2f-83fb-44d1-8c86-a0f623d94579"
      unitRef="usd">904000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzkvZnJhZzoxMzVmYTRlNzEwNzg0YTI5OTAxNmEzOWU5YmIyZGIzZi90YWJsZTo3NzY3NTg3MDE0OTk0ZTYwYWQxMDIxZTk2ZjY3OTkxZi90YWJsZXJhbmdlOjc3Njc1ODcwMTQ5OTRlNjBhZDEwMjFlOTZmNjc5OTFmXzYtMS0xLTEtMTg4NQ_1934f6b0-b804-41fb-92b5-7b81b5cc4e37"
      unitRef="usd">5230000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzkvZnJhZzoxMzVmYTRlNzEwNzg0YTI5OTAxNmEzOWU5YmIyZGIzZi90YWJsZTo3NzY3NTg3MDE0OTk0ZTYwYWQxMDIxZTk2ZjY3OTkxZi90YWJsZXJhbmdlOjc3Njc1ODcwMTQ5OTRlNjBhZDEwMjFlOTZmNjc5OTFmXzctMS0xLTEtMTg4NQ_e3d5844f-8536-49ca-8d7a-75a3da228eee"
      unitRef="usd">761000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzkvZnJhZzoxMzVmYTRlNzEwNzg0YTI5OTAxNmEzOWU5YmIyZGIzZi90YWJsZTo3NzY3NTg3MDE0OTk0ZTYwYWQxMDIxZTk2ZjY3OTkxZi90YWJsZXJhbmdlOjc3Njc1ODcwMTQ5OTRlNjBhZDEwMjFlOTZmNjc5OTFmXzgtMS0xLTEtMTg4NQ_d7dc6cde-51cc-4e95-8212-b18fb7eaf0dc"
      unitRef="usd">4469000</us-gaap:OperatingLeaseLiability>
    <us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzkvZnJhZzoxMzVmYTRlNzEwNzg0YTI5OTAxNmEzOWU5YmIyZGIzZi90ZXh0cmVnaW9uOjEzNWZhNGU3MTA3ODRhMjk5MDE2YTM5ZTliYjJkYjNmXzM4MDk_44e87016-4702-4463-b9ad-9279e46cad0c">&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The aggregate future minimum lease payments under ASC 840 as of December&#160;31, 2018 were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:83.416%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.441%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.943%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Year Ending December 31:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total Minimum&lt;br/&gt;Lease Payments&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,002&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,002&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,031&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,044&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2023 and thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,920&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5,999&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent
      contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzkvZnJhZzoxMzVmYTRlNzEwNzg0YTI5OTAxNmEzOWU5YmIyZGIzZi90YWJsZTo3NTUzM2Y0NDJhMTU0OTliOTAwNGMyMzAzOGU0OGJhMy90YWJsZXJhbmdlOjc1NTMzZjQ0MmExNTQ5OWI5MDA0YzIzMDM4ZTQ4YmEzXzEtMS0xLTEtMA_8546d274-386f-4a92-a7eb-4bf6b23c28bd"
      unitRef="usd">1002000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears
      contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzkvZnJhZzoxMzVmYTRlNzEwNzg0YTI5OTAxNmEzOWU5YmIyZGIzZi90YWJsZTo3NTUzM2Y0NDJhMTU0OTliOTAwNGMyMzAzOGU0OGJhMy90YWJsZXJhbmdlOjc1NTMzZjQ0MmExNTQ5OWI5MDA0YzIzMDM4ZTQ4YmEzXzItMS0xLTEtMA_72b6e859-d4d4-4708-82c4-3e0b3e5dc170"
      unitRef="usd">1002000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears
      contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzkvZnJhZzoxMzVmYTRlNzEwNzg0YTI5OTAxNmEzOWU5YmIyZGIzZi90YWJsZTo3NTUzM2Y0NDJhMTU0OTliOTAwNGMyMzAzOGU0OGJhMy90YWJsZXJhbmdlOjc1NTMzZjQ0MmExNTQ5OWI5MDA0YzIzMDM4ZTQ4YmEzXzMtMS0xLTEtMA_9e9a6d3b-e3a2-42df-80d0-484bc0fd596e"
      unitRef="usd">1031000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFourYears
      contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzkvZnJhZzoxMzVmYTRlNzEwNzg0YTI5OTAxNmEzOWU5YmIyZGIzZi90YWJsZTo3NTUzM2Y0NDJhMTU0OTliOTAwNGMyMzAzOGU0OGJhMy90YWJsZXJhbmdlOjc1NTMzZjQ0MmExNTQ5OWI5MDA0YzIzMDM4ZTQ4YmEzXzQtMS0xLTEtMA_c86317e5-a400-4e6c-bde3-d5b52a6b871d"
      unitRef="usd">1044000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFourYears>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFiveYears
      contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzkvZnJhZzoxMzVmYTRlNzEwNzg0YTI5OTAxNmEzOWU5YmIyZGIzZi90YWJsZTo3NTUzM2Y0NDJhMTU0OTliOTAwNGMyMzAzOGU0OGJhMy90YWJsZXJhbmdlOjc1NTMzZjQ0MmExNTQ5OWI5MDA0YzIzMDM4ZTQ4YmEzXzUtMS0xLTEtMA_803b56a7-e658-4046-9098-501e1a788557"
      unitRef="usd">1920000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFiveYears>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDue
      contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzkvZnJhZzoxMzVmYTRlNzEwNzg0YTI5OTAxNmEzOWU5YmIyZGIzZi90YWJsZTo3NTUzM2Y0NDJhMTU0OTliOTAwNGMyMzAzOGU0OGJhMy90YWJsZXJhbmdlOjc1NTMzZjQ0MmExNTQ5OWI5MDA0YzIzMDM4ZTQ4YmEzXzYtMS0xLTEtMA_3a97f9d2-1a3c-4801-a05c-edc4fb8a2db4"
      unitRef="usd">5999000</us-gaap:OperatingLeasesFutureMinimumPaymentsDue>
    <us-gaap:PurchaseObligation
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMzkvZnJhZzoxMzVmYTRlNzEwNzg0YTI5OTAxNmEzOWU5YmIyZGIzZi90ZXh0cmVnaW9uOjEzNWZhNGU3MTA3ODRhMjk5MDE2YTM5ZTliYjJkYjNmXzMyOTg1MzQ4ODcxODA_cc90fae2-6f56-43bd-947b-e4090c846be1"
      unitRef="usd">7097000000</us-gaap:PurchaseObligation>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNDUvZnJhZzoxY2M4ZDYxMThmYTQ0ZmViOTNhMjY5M2JmMjUxNzc2OS90ZXh0cmVnaW9uOjFjYzhkNjExOGZhNDRmZWI5M2EyNjkzYmYyNTE3NzY5XzYwNjk_59478646-ee80-4361-9788-eed193de74d7">Redeemable Convertible Preferred Stock&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The Company had the following redeemable convertible preferred stock issued and outstanding at December&#160;31, 2018 (in thousands except share amounts): &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;margin-bottom:9pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:99.839%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:23.040%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.964%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.602%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.964%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.602%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.964%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.602%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.927%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.602%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.933%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Shares&lt;br/&gt;Authorized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Shares Issued and&lt;br/&gt;Outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Per share &lt;br/&gt;Preference&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Preferential&lt;br/&gt;Liquidation Value (in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Carrying Value (in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Series&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Series A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,629,629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,629,626&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Series A-1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,111,111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,111,109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,755&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,723&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Series B&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;6,264,470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;6,264,463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;6.11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;38,276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;38,014&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Series C&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;15,064,405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;12,227,992&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;6.11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;74,713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;59,129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;24,069,615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;21,233,190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;121,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;105,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Upon the closing of the IPO, all shares of redeemable convertible preferred stock then outstanding converted into shares of common stock.  As of December&#160;31, 2019, the Company does not have any redeemable convertible preferred stock issued or outstanding.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Redeemable Convertible Preferred Stock Warrant&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;"&gt;s&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Upon the closing of the IPO, all of the outstanding redeemable convertible preferred stock warrants were exercised, or net exercised based on the IPO price of $20.00 per share, into 1,945,365 shares of common stock.  As of December&#160;31, 2019 and 2018, warrants to purchase an aggregate of 0 and  2,672,502, respectively, shares of Series C redeemable convertible preferred stock were outstanding.&lt;/span&gt;&lt;/div&gt;Stockholders' Equity (Deficit)&lt;div style="margin-bottom:9pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Preferred Stock&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;At December&#160;31, 2019, the Company&#x2019;s certificate of incorporation, as amended and restated, authorizes the Company to issue up to 5,000,000 shares of preferred stock with $0.001 par value per share, of which no shares were issued and outstanding.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Common Stock&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;At December&#160;31, 2019, the Company&#x2019;s certificate of incorporation, as amended and restated, authorizes the Company to issue up to 100,000,000 shares of common stock with $0.001 par value per share, of which 31,255,267 shares were issued and outstanding.  The holders of common stock are also entitled to receive dividends whenever funds are legally available, when and if declared by the Board of Directors.  As of December&#160;31, 2019, no dividends have been declared to date.  Each share of common stock is entitled to one vote.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;At December&#160;31, 2019 and 2018, the Company had reserved common stock for future issuances as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;margin-bottom:9pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:70.596%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.301%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.302%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9.5pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9.5pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9.5pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Conversion of Series A redeemable convertible preferred stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,629,629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Conversion of Series A-1 redeemable convertible preferred stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,111,111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Conversion of Series B redeemable convertible preferred stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;6,264,470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Conversion of Series C redeemable convertible preferred stock and warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;15,064,405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Exercise of options under stock plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,310,790&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,364,377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Issuance of options under stock plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,554,690&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;57,889&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Issuance of common stock under employee stock purchase plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;372,352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Warrants to purchase common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;7,527&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;6,237,832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;28,499,408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Common Stock Warrant&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;"&gt;s&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In connection with the IPO, the common stock warrants were cash, or net exercised based on the IPO price of $20.00 per share into 5,968 shares of common stock.  As of December&#160;31, 2019 and 2018, warrants to purchase an aggregate of 0 and 7,527 shares of common stock were outstanding.&lt;/span&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:TemporaryEquityTableTextBlock
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNDUvZnJhZzoxY2M4ZDYxMThmYTQ0ZmViOTNhMjY5M2JmMjUxNzc2OS90ZXh0cmVnaW9uOjFjYzhkNjExOGZhNDRmZWI5M2EyNjkzYmYyNTE3NzY5XzYwNzA_1f68b5eb-5cf6-4a77-b266-ab343e547d9d">&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The Company had the following redeemable convertible preferred stock issued and outstanding at December&#160;31, 2018 (in thousands except share amounts): &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;margin-bottom:9pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:99.839%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:23.040%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.964%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.602%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.964%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.602%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.964%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.602%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.927%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.602%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.933%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Shares&lt;br/&gt;Authorized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Shares Issued and&lt;br/&gt;Outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Per share &lt;br/&gt;Preference&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Preferential&lt;br/&gt;Liquidation Value (in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Carrying Value (in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Series&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Series A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,629,629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,629,626&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Series A-1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,111,111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,111,109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,755&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,723&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Series B&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;6,264,470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;6,264,463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;6.11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;38,276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;38,014&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Series C&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;15,064,405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;12,227,992&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;6.11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;74,713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;59,129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;24,069,615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;21,233,190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;121,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;105,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:TemporaryEquityTableTextBlock>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="i7f1961a81c2146ba86c1873951eb5d0f_I20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNDUvZnJhZzoxY2M4ZDYxMThmYTQ0ZmViOTNhMjY5M2JmMjUxNzc2OS90YWJsZTowN2UxNWY1NTUyYjM0ODlmOWEyODAyOGI1Y2ZmODUxOC90YWJsZXJhbmdlOjA3ZTE1ZjU1NTJiMzQ4OWY5YTI4MDI4YjVjZmY4NTE4XzMtMS0xLTEtMA_7eff8a58-4beb-4fa1-ad42-4e3f4281cccd"
      unitRef="shares">1629629</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i7f1961a81c2146ba86c1873951eb5d0f_I20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNDUvZnJhZzoxY2M4ZDYxMThmYTQ0ZmViOTNhMjY5M2JmMjUxNzc2OS90YWJsZTowN2UxNWY1NTUyYjM0ODlmOWEyODAyOGI1Y2ZmODUxOC90YWJsZXJhbmdlOjA3ZTE1ZjU1NTJiMzQ4OWY5YTI4MDI4YjVjZmY4NTE4XzMtMy0xLTEtMA_1e6b6163-4b6d-4384-99d1-5cae7d830eb4"
      unitRef="shares">1629626</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="i7f1961a81c2146ba86c1873951eb5d0f_I20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNDUvZnJhZzoxY2M4ZDYxMThmYTQ0ZmViOTNhMjY5M2JmMjUxNzc2OS90YWJsZTowN2UxNWY1NTUyYjM0ODlmOWEyODAyOGI1Y2ZmODUxOC90YWJsZXJhbmdlOjA3ZTE1ZjU1NTJiMzQ4OWY5YTI4MDI4YjVjZmY4NTE4XzMtMy0xLTEtMA_33b8a757-a488-4eb9-9958-706f485826b0"
      unitRef="shares">1629626</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquityLiquidationPreferencePerShare
      contextRef="i7f1961a81c2146ba86c1873951eb5d0f_I20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNDUvZnJhZzoxY2M4ZDYxMThmYTQ0ZmViOTNhMjY5M2JmMjUxNzc2OS90YWJsZTowN2UxNWY1NTUyYjM0ODlmOWEyODAyOGI1Y2ZmODUxOC90YWJsZXJhbmdlOjA3ZTE1ZjU1NTJiMzQ4OWY5YTI4MDI4YjVjZmY4NTE4XzMtNS0xLTEtMA_edd82fdc-693d-454f-a04f-120eab13f8d2"
      unitRef="usdPerShare">2.70</us-gaap:TemporaryEquityLiquidationPreferencePerShare>
    <us-gaap:TemporaryEquityLiquidationPreference
      contextRef="i7f1961a81c2146ba86c1873951eb5d0f_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNDUvZnJhZzoxY2M4ZDYxMThmYTQ0ZmViOTNhMjY5M2JmMjUxNzc2OS90YWJsZTowN2UxNWY1NTUyYjM0ODlmOWEyODAyOGI1Y2ZmODUxOC90YWJsZXJhbmdlOjA3ZTE1ZjU1NTJiMzQ4OWY5YTI4MDI4YjVjZmY4NTE4XzMtNy0xLTEtMA_7c474796-11b3-4d63-b6ea-e4fbfc361ff6"
      unitRef="usd">4400000</us-gaap:TemporaryEquityLiquidationPreference>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i7f1961a81c2146ba86c1873951eb5d0f_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNDUvZnJhZzoxY2M4ZDYxMThmYTQ0ZmViOTNhMjY5M2JmMjUxNzc2OS90YWJsZTowN2UxNWY1NTUyYjM0ODlmOWEyODAyOGI1Y2ZmODUxOC90YWJsZXJhbmdlOjA3ZTE1ZjU1NTJiMzQ4OWY5YTI4MDI4YjVjZmY4NTE4XzMtOS0xLTEtMA_3b67ee1a-1d3a-46a0-b78a-476bf327fa4c"
      unitRef="usd">4369000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="idef65aa8bbea40b3adcc724c6f06297a_I20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNDUvZnJhZzoxY2M4ZDYxMThmYTQ0ZmViOTNhMjY5M2JmMjUxNzc2OS90YWJsZTowN2UxNWY1NTUyYjM0ODlmOWEyODAyOGI1Y2ZmODUxOC90YWJsZXJhbmdlOjA3ZTE1ZjU1NTJiMzQ4OWY5YTI4MDI4YjVjZmY4NTE4XzQtMS0xLTEtMA_f9e8293a-6406-4701-b781-b72f002f46d6"
      unitRef="shares">1111111</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="idef65aa8bbea40b3adcc724c6f06297a_I20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNDUvZnJhZzoxY2M4ZDYxMThmYTQ0ZmViOTNhMjY5M2JmMjUxNzc2OS90YWJsZTowN2UxNWY1NTUyYjM0ODlmOWEyODAyOGI1Y2ZmODUxOC90YWJsZXJhbmdlOjA3ZTE1ZjU1NTJiMzQ4OWY5YTI4MDI4YjVjZmY4NTE4XzQtMy0xLTEtMA_74417e5f-d728-4767-bf04-369ba33e30cd"
      unitRef="shares">1111109</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="idef65aa8bbea40b3adcc724c6f06297a_I20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNDUvZnJhZzoxY2M4ZDYxMThmYTQ0ZmViOTNhMjY5M2JmMjUxNzc2OS90YWJsZTowN2UxNWY1NTUyYjM0ODlmOWEyODAyOGI1Y2ZmODUxOC90YWJsZXJhbmdlOjA3ZTE1ZjU1NTJiMzQ4OWY5YTI4MDI4YjVjZmY4NTE4XzQtMy0xLTEtMA_cf3e4991-c5d9-420e-a6d3-d422025977b5"
      unitRef="shares">1111109</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityLiquidationPreferencePerShare
      contextRef="idef65aa8bbea40b3adcc724c6f06297a_I20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNDUvZnJhZzoxY2M4ZDYxMThmYTQ0ZmViOTNhMjY5M2JmMjUxNzc2OS90YWJsZTowN2UxNWY1NTUyYjM0ODlmOWEyODAyOGI1Y2ZmODUxOC90YWJsZXJhbmdlOjA3ZTE1ZjU1NTJiMzQ4OWY5YTI4MDI4YjVjZmY4NTE4XzQtNS0xLTEtMA_f73dbaaa-0e38-434c-b8c8-b643cd685d4c"
      unitRef="usdPerShare">3.38</us-gaap:TemporaryEquityLiquidationPreferencePerShare>
    <us-gaap:TemporaryEquityLiquidationPreference
      contextRef="idef65aa8bbea40b3adcc724c6f06297a_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNDUvZnJhZzoxY2M4ZDYxMThmYTQ0ZmViOTNhMjY5M2JmMjUxNzc2OS90YWJsZTowN2UxNWY1NTUyYjM0ODlmOWEyODAyOGI1Y2ZmODUxOC90YWJsZXJhbmdlOjA3ZTE1ZjU1NTJiMzQ4OWY5YTI4MDI4YjVjZmY4NTE4XzQtNy0xLTEtMA_5bfdb187-45b9-4d84-8a56-aa103286311b"
      unitRef="usd">3755000</us-gaap:TemporaryEquityLiquidationPreference>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="idef65aa8bbea40b3adcc724c6f06297a_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNDUvZnJhZzoxY2M4ZDYxMThmYTQ0ZmViOTNhMjY5M2JmMjUxNzc2OS90YWJsZTowN2UxNWY1NTUyYjM0ODlmOWEyODAyOGI1Y2ZmODUxOC90YWJsZXJhbmdlOjA3ZTE1ZjU1NTJiMzQ4OWY5YTI4MDI4YjVjZmY4NTE4XzQtOS0xLTEtMA_a7f46a9d-6f47-4bd6-8fe3-76537c49786f"
      unitRef="usd">3723000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="i4afaed3dd6794f36b67d203a6ae5b570_I20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNDUvZnJhZzoxY2M4ZDYxMThmYTQ0ZmViOTNhMjY5M2JmMjUxNzc2OS90YWJsZTowN2UxNWY1NTUyYjM0ODlmOWEyODAyOGI1Y2ZmODUxOC90YWJsZXJhbmdlOjA3ZTE1ZjU1NTJiMzQ4OWY5YTI4MDI4YjVjZmY4NTE4XzUtMS0xLTEtMA_59fcc3b7-100e-4c69-b0e3-43b8dda1d5c5"
      unitRef="shares">6264470</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i4afaed3dd6794f36b67d203a6ae5b570_I20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNDUvZnJhZzoxY2M4ZDYxMThmYTQ0ZmViOTNhMjY5M2JmMjUxNzc2OS90YWJsZTowN2UxNWY1NTUyYjM0ODlmOWEyODAyOGI1Y2ZmODUxOC90YWJsZXJhbmdlOjA3ZTE1ZjU1NTJiMzQ4OWY5YTI4MDI4YjVjZmY4NTE4XzUtMy0xLTEtMA_a03796bd-331c-4174-9351-fc812910bdc5"
      unitRef="shares">6264463</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="i4afaed3dd6794f36b67d203a6ae5b570_I20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNDUvZnJhZzoxY2M4ZDYxMThmYTQ0ZmViOTNhMjY5M2JmMjUxNzc2OS90YWJsZTowN2UxNWY1NTUyYjM0ODlmOWEyODAyOGI1Y2ZmODUxOC90YWJsZXJhbmdlOjA3ZTE1ZjU1NTJiMzQ4OWY5YTI4MDI4YjVjZmY4NTE4XzUtMy0xLTEtMA_fe6a84ae-970b-493c-ba80-bf07c85418ac"
      unitRef="shares">6264463</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquityLiquidationPreferencePerShare
      contextRef="i4afaed3dd6794f36b67d203a6ae5b570_I20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNDUvZnJhZzoxY2M4ZDYxMThmYTQ0ZmViOTNhMjY5M2JmMjUxNzc2OS90YWJsZTowN2UxNWY1NTUyYjM0ODlmOWEyODAyOGI1Y2ZmODUxOC90YWJsZXJhbmdlOjA3ZTE1ZjU1NTJiMzQ4OWY5YTI4MDI4YjVjZmY4NTE4XzUtNS0xLTEtMA_542e0d09-45e0-4e6d-be11-dd4b94485859"
      unitRef="usdPerShare">6.11</us-gaap:TemporaryEquityLiquidationPreferencePerShare>
    <us-gaap:TemporaryEquityLiquidationPreference
      contextRef="i4afaed3dd6794f36b67d203a6ae5b570_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNDUvZnJhZzoxY2M4ZDYxMThmYTQ0ZmViOTNhMjY5M2JmMjUxNzc2OS90YWJsZTowN2UxNWY1NTUyYjM0ODlmOWEyODAyOGI1Y2ZmODUxOC90YWJsZXJhbmdlOjA3ZTE1ZjU1NTJiMzQ4OWY5YTI4MDI4YjVjZmY4NTE4XzUtNy0xLTEtMA_f0e19e54-2567-4382-b6ea-7d4c9b646161"
      unitRef="usd">38276000</us-gaap:TemporaryEquityLiquidationPreference>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i4afaed3dd6794f36b67d203a6ae5b570_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNDUvZnJhZzoxY2M4ZDYxMThmYTQ0ZmViOTNhMjY5M2JmMjUxNzc2OS90YWJsZTowN2UxNWY1NTUyYjM0ODlmOWEyODAyOGI1Y2ZmODUxOC90YWJsZXJhbmdlOjA3ZTE1ZjU1NTJiMzQ4OWY5YTI4MDI4YjVjZmY4NTE4XzUtOS0xLTEtMA_2baebe6c-a176-4edb-ac22-cd4df8a40801"
      unitRef="usd">38014000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="i12798862adb04861a6ae8feb9c091437_I20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNDUvZnJhZzoxY2M4ZDYxMThmYTQ0ZmViOTNhMjY5M2JmMjUxNzc2OS90YWJsZTowN2UxNWY1NTUyYjM0ODlmOWEyODAyOGI1Y2ZmODUxOC90YWJsZXJhbmdlOjA3ZTE1ZjU1NTJiMzQ4OWY5YTI4MDI4YjVjZmY4NTE4XzYtMS0xLTEtMA_a26f9948-41b1-4a22-92cf-7c49711b3959"
      unitRef="shares">15064405</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="i12798862adb04861a6ae8feb9c091437_I20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNDUvZnJhZzoxY2M4ZDYxMThmYTQ0ZmViOTNhMjY5M2JmMjUxNzc2OS90YWJsZTowN2UxNWY1NTUyYjM0ODlmOWEyODAyOGI1Y2ZmODUxOC90YWJsZXJhbmdlOjA3ZTE1ZjU1NTJiMzQ4OWY5YTI4MDI4YjVjZmY4NTE4XzYtMy0xLTEtMA_9030f5ed-722f-4df6-a503-32f7237d00a3"
      unitRef="shares">12227992</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i12798862adb04861a6ae8feb9c091437_I20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNDUvZnJhZzoxY2M4ZDYxMThmYTQ0ZmViOTNhMjY5M2JmMjUxNzc2OS90YWJsZTowN2UxNWY1NTUyYjM0ODlmOWEyODAyOGI1Y2ZmODUxOC90YWJsZXJhbmdlOjA3ZTE1ZjU1NTJiMzQ4OWY5YTI4MDI4YjVjZmY4NTE4XzYtMy0xLTEtMA_fd506d5f-35fb-491b-9fc6-b3ff5b2ca7cb"
      unitRef="shares">12227992</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityLiquidationPreferencePerShare
      contextRef="i12798862adb04861a6ae8feb9c091437_I20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNDUvZnJhZzoxY2M4ZDYxMThmYTQ0ZmViOTNhMjY5M2JmMjUxNzc2OS90YWJsZTowN2UxNWY1NTUyYjM0ODlmOWEyODAyOGI1Y2ZmODUxOC90YWJsZXJhbmdlOjA3ZTE1ZjU1NTJiMzQ4OWY5YTI4MDI4YjVjZmY4NTE4XzYtNS0xLTEtMA_2045bac7-eaa7-462b-b1e1-6fe169995908"
      unitRef="usdPerShare">6.11</us-gaap:TemporaryEquityLiquidationPreferencePerShare>
    <us-gaap:TemporaryEquityLiquidationPreference
      contextRef="i12798862adb04861a6ae8feb9c091437_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNDUvZnJhZzoxY2M4ZDYxMThmYTQ0ZmViOTNhMjY5M2JmMjUxNzc2OS90YWJsZTowN2UxNWY1NTUyYjM0ODlmOWEyODAyOGI1Y2ZmODUxOC90YWJsZXJhbmdlOjA3ZTE1ZjU1NTJiMzQ4OWY5YTI4MDI4YjVjZmY4NTE4XzYtNy0xLTEtMA_b8d07496-2ff5-4039-9b0f-04c1c9a363ef"
      unitRef="usd">74713000</us-gaap:TemporaryEquityLiquidationPreference>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i12798862adb04861a6ae8feb9c091437_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNDUvZnJhZzoxY2M4ZDYxMThmYTQ0ZmViOTNhMjY5M2JmMjUxNzc2OS90YWJsZTowN2UxNWY1NTUyYjM0ODlmOWEyODAyOGI1Y2ZmODUxOC90YWJsZXJhbmdlOjA3ZTE1ZjU1NTJiMzQ4OWY5YTI4MDI4YjVjZmY4NTE4XzYtOS0xLTEtMA_2d5a5be9-3cde-4ef4-97f6-11ae41fe54b1"
      unitRef="usd">59129000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNDUvZnJhZzoxY2M4ZDYxMThmYTQ0ZmViOTNhMjY5M2JmMjUxNzc2OS90YWJsZTowN2UxNWY1NTUyYjM0ODlmOWEyODAyOGI1Y2ZmODUxOC90YWJsZXJhbmdlOjA3ZTE1ZjU1NTJiMzQ4OWY5YTI4MDI4YjVjZmY4NTE4XzctMS0xLTEtMA_15130904-43b5-48e6-aae4-2b6ff7f9b152"
      unitRef="shares">24069615</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNDUvZnJhZzoxY2M4ZDYxMThmYTQ0ZmViOTNhMjY5M2JmMjUxNzc2OS90YWJsZTowN2UxNWY1NTUyYjM0ODlmOWEyODAyOGI1Y2ZmODUxOC90YWJsZXJhbmdlOjA3ZTE1ZjU1NTJiMzQ4OWY5YTI4MDI4YjVjZmY4NTE4XzctMy0xLTEtMA_17224ae7-9a51-45ec-bf34-3bd332f7d61d"
      unitRef="shares">21233190</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNDUvZnJhZzoxY2M4ZDYxMThmYTQ0ZmViOTNhMjY5M2JmMjUxNzc2OS90YWJsZTowN2UxNWY1NTUyYjM0ODlmOWEyODAyOGI1Y2ZmODUxOC90YWJsZXJhbmdlOjA3ZTE1ZjU1NTJiMzQ4OWY5YTI4MDI4YjVjZmY4NTE4XzctMy0xLTEtMA_a1d4d1ec-fedf-4cbf-8e63-898326c54aa1"
      unitRef="shares">21233190</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquityLiquidationPreference
      contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNDUvZnJhZzoxY2M4ZDYxMThmYTQ0ZmViOTNhMjY5M2JmMjUxNzc2OS90YWJsZTowN2UxNWY1NTUyYjM0ODlmOWEyODAyOGI1Y2ZmODUxOC90YWJsZXJhbmdlOjA3ZTE1ZjU1NTJiMzQ4OWY5YTI4MDI4YjVjZmY4NTE4XzctNy0xLTEtMA_42478671-1978-4f56-8b54-3afff7369fe7"
      unitRef="usd">121144000</us-gaap:TemporaryEquityLiquidationPreference>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNDUvZnJhZzoxY2M4ZDYxMThmYTQ0ZmViOTNhMjY5M2JmMjUxNzc2OS90YWJsZTowN2UxNWY1NTUyYjM0ODlmOWEyODAyOGI1Y2ZmODUxOC90YWJsZXJhbmdlOjA3ZTE1ZjU1NTJiMzQ4OWY5YTI4MDI4YjVjZmY4NTE4XzctOS0xLTEtMA_1d1f4b70-1cb9-4ab7-9838-90295942fe83"
      unitRef="usd">105235000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="i0002f1df204e4ba9aec2b7e505502fde_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNDUvZnJhZzoxY2M4ZDYxMThmYTQ0ZmViOTNhMjY5M2JmMjUxNzc2OS90ZXh0cmVnaW9uOjFjYzhkNjExOGZhNDRmZWI5M2EyNjkzYmYyNTE3NzY5XzIxOTkwMjMyNzQyNzE_8fd77f27-f276-4adb-9b5f-1ce3f2c8a3ee"
      unitRef="shares">0</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i0002f1df204e4ba9aec2b7e505502fde_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNDUvZnJhZzoxY2M4ZDYxMThmYTQ0ZmViOTNhMjY5M2JmMjUxNzc2OS90ZXh0cmVnaW9uOjFjYzhkNjExOGZhNDRmZWI5M2EyNjkzYmYyNTE3NzY5XzIxOTkwMjMyNzQyNzE_fb2ceba1-e5ac-4661-9ac9-d7d0ad82636d"
      unitRef="shares">0</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="i4be1e55866334204b2d9b1643c2315e7_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNDUvZnJhZzoxY2M4ZDYxMThmYTQ0ZmViOTNhMjY5M2JmMjUxNzc2OS90ZXh0cmVnaW9uOjFjYzhkNjExOGZhNDRmZWI5M2EyNjkzYmYyNTE3NzY5XzMyOTg1MzQ4OTYwMTU_6c07cb01-4df0-49e3-93aa-b5896c6c2f0e"
      unitRef="usdPerShare">20.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ConversionOfStockSharesConverted1
      contextRef="i85f16463983d4272b900d0242c5a7b00_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNDUvZnJhZzoxY2M4ZDYxMThmYTQ0ZmViOTNhMjY5M2JmMjUxNzc2OS90ZXh0cmVnaW9uOjFjYzhkNjExOGZhNDRmZWI5M2EyNjkzYmYyNTE3NzY5XzMyOTg1MzQ4OTYwMjY_eff83768-62fe-40c3-a3c4-32a7320891ee"
      unitRef="shares">1945365</us-gaap:ConversionOfStockSharesConverted1>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="i3fd781122bcd466f8d1f4fc674767318_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNDUvZnJhZzoxY2M4ZDYxMThmYTQ0ZmViOTNhMjY5M2JmMjUxNzc2OS90ZXh0cmVnaW9uOjFjYzhkNjExOGZhNDRmZWI5M2EyNjkzYmYyNTE3NzY5XzMyOTg1MzQ4OTYwNjI_cf048bc5-5241-4471-bf9e-5cb2823acf99"
      unitRef="shares">0</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="iea7780a1616443f08f0fda6ff705a8ec_I20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNDUvZnJhZzoxY2M4ZDYxMThmYTQ0ZmViOTNhMjY5M2JmMjUxNzc2OS90ZXh0cmVnaW9uOjFjYzhkNjExOGZhNDRmZWI5M2EyNjkzYmYyNTE3NzY5XzMyOTg1MzQ4OTYwNTk_58306bd9-edb0-4a42-ab27-319454330af9"
      unitRef="shares">2672502</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTEvZnJhZzpiYzNmZDczMGFlM2U0ODFlOTUwMWIzYmUwMDZkMWIxZi90ZXh0cmVnaW9uOmJjM2ZkNzMwYWUzZTQ4MWU5NTAxYjNiZTAwNmQxYjFmXzMyOTg1MzQ4ODQ5MjU_6964241e-108d-41ef-81e7-c54dff6ea3ab"
      unitRef="shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTEvZnJhZzpiYzNmZDczMGFlM2U0ODFlOTUwMWIzYmUwMDZkMWIxZi90ZXh0cmVnaW9uOmJjM2ZkNzMwYWUzZTQ4MWU5NTAxYjNiZTAwNmQxYjFmXzMyOTg1MzQ4ODQ5MzM_faeea9d0-ec80-4b90-bc67-07140f80484d"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTEvZnJhZzpiYzNmZDczMGFlM2U0ODFlOTUwMWIzYmUwMDZkMWIxZi90ZXh0cmVnaW9uOmJjM2ZkNzMwYWUzZTQ4MWU5NTAxYjNiZTAwNmQxYjFmXzMyOTg1MzQ4ODYxNDQ_59b2367d-379c-445b-a5c3-97dd0f99da06"
      unitRef="shares">100000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTEvZnJhZzpiYzNmZDczMGFlM2U0ODFlOTUwMWIzYmUwMDZkMWIxZi90ZXh0cmVnaW9uOmJjM2ZkNzMwYWUzZTQ4MWU5NTAxYjNiZTAwNmQxYjFmXzMyOTg1MzQ4ODYxNTI_626ff06c-1d31-434d-a546-fed022784202"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesIssued
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTEvZnJhZzpiYzNmZDczMGFlM2U0ODFlOTUwMWIzYmUwMDZkMWIxZi90ZXh0cmVnaW9uOmJjM2ZkNzMwYWUzZTQ4MWU5NTAxYjNiZTAwNmQxYjFmXzMyOTg1MzQ4ODYxNjQ_3b8fa04b-a79e-4f3b-95c6-506fc9982ce8"
      unitRef="shares">31255267</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTEvZnJhZzpiYzNmZDczMGFlM2U0ODFlOTUwMWIzYmUwMDZkMWIxZi90ZXh0cmVnaW9uOmJjM2ZkNzMwYWUzZTQ4MWU5NTAxYjNiZTAwNmQxYjFmXzMyOTg1MzQ4ODYxNjQ_3d1118fd-1985-4dbf-9a5a-f8342494aaef"
      unitRef="shares">31255267</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:DividendsCommonStock
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTEvZnJhZzpiYzNmZDczMGFlM2U0ODFlOTUwMWIzYmUwMDZkMWIxZi90ZXh0cmVnaW9uOmJjM2ZkNzMwYWUzZTQ4MWU5NTAxYjNiZTAwNmQxYjFmXzIxOTkwMjMyNTk0NTI_2a8cc5aa-566b-4ff2-8dbf-e07caf4c3ae9"
      unitRef="usd">0</us-gaap:DividendsCommonStock>
    <silk:CommonStockVotePerShare
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTEvZnJhZzpiYzNmZDczMGFlM2U0ODFlOTUwMWIzYmUwMDZkMWIxZi90ZXh0cmVnaW9uOmJjM2ZkNzMwYWUzZTQ4MWU5NTAxYjNiZTAwNmQxYjFmXzIxOTkwMjMyNTk0NjA_6d86283e-8352-4091-971e-c9c3c3ac4718"
      unitRef="vote">1</silk:CommonStockVotePerShare>
    <us-gaap:ScheduleOfStockByClassTextBlock
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTEvZnJhZzpiYzNmZDczMGFlM2U0ODFlOTUwMWIzYmUwMDZkMWIxZi90ZXh0cmVnaW9uOmJjM2ZkNzMwYWUzZTQ4MWU5NTAxYjNiZTAwNmQxYjFmXzEyMDM_3d0e52c9-6d95-4ae5-ace0-467452e0d837">&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;At December&#160;31, 2019 and 2018, the Company had reserved common stock for future issuances as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;margin-bottom:9pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:70.596%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.301%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.302%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9.5pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9.5pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9.5pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Conversion of Series A redeemable convertible preferred stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,629,629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Conversion of Series A-1 redeemable convertible preferred stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,111,111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Conversion of Series B redeemable convertible preferred stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;6,264,470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Conversion of Series C redeemable convertible preferred stock and warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;15,064,405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Exercise of options under stock plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,310,790&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,364,377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Issuance of options under stock plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,554,690&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;57,889&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Issuance of common stock under employee stock purchase plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;372,352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Warrants to purchase common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;7,527&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;6,237,832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;28,499,408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfStockByClassTextBlock>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="i7e4541352c2a44929295cae86c4b2a1c_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTEvZnJhZzpiYzNmZDczMGFlM2U0ODFlOTUwMWIzYmUwMDZkMWIxZi90YWJsZTpkYjZlZGY0ZWExNjE0YmRlYjQ1NThiMmNlMjU5NjRmOS90YWJsZXJhbmdlOmRiNmVkZjRlYTE2MTRiZGViNDU1OGIyY2UyNTk2NGY5XzItMS0xLTEtMA_a7e31752-7f7c-4244-92aa-c4f2a65aebbd"
      unitRef="shares">0</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="i7f1961a81c2146ba86c1873951eb5d0f_I20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTEvZnJhZzpiYzNmZDczMGFlM2U0ODFlOTUwMWIzYmUwMDZkMWIxZi90YWJsZTpkYjZlZGY0ZWExNjE0YmRlYjQ1NThiMmNlMjU5NjRmOS90YWJsZXJhbmdlOmRiNmVkZjRlYTE2MTRiZGViNDU1OGIyY2UyNTk2NGY5XzItMy0xLTEtMA_deca01c1-e56b-4b1b-9d64-5054559ccb3d"
      unitRef="shares">1629629</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="i22fe2abf909a4987bfe246f58fedaf54_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTEvZnJhZzpiYzNmZDczMGFlM2U0ODFlOTUwMWIzYmUwMDZkMWIxZi90YWJsZTpkYjZlZGY0ZWExNjE0YmRlYjQ1NThiMmNlMjU5NjRmOS90YWJsZXJhbmdlOmRiNmVkZjRlYTE2MTRiZGViNDU1OGIyY2UyNTk2NGY5XzMtMS0xLTEtMA_eb1e8dd0-6875-4fd9-a610-73df6a667c60"
      unitRef="shares">0</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="idef65aa8bbea40b3adcc724c6f06297a_I20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTEvZnJhZzpiYzNmZDczMGFlM2U0ODFlOTUwMWIzYmUwMDZkMWIxZi90YWJsZTpkYjZlZGY0ZWExNjE0YmRlYjQ1NThiMmNlMjU5NjRmOS90YWJsZXJhbmdlOmRiNmVkZjRlYTE2MTRiZGViNDU1OGIyY2UyNTk2NGY5XzMtMy0xLTEtMA_c2912053-64e8-4040-af8f-9bed66226030"
      unitRef="shares">1111111</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="ib7e1120b4a744e978a8b7a345369d7a5_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTEvZnJhZzpiYzNmZDczMGFlM2U0ODFlOTUwMWIzYmUwMDZkMWIxZi90YWJsZTpkYjZlZGY0ZWExNjE0YmRlYjQ1NThiMmNlMjU5NjRmOS90YWJsZXJhbmdlOmRiNmVkZjRlYTE2MTRiZGViNDU1OGIyY2UyNTk2NGY5XzQtMS0xLTEtMA_90891bc2-b93b-4d1d-a02c-884a6d41f0eb"
      unitRef="shares">0</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="i4afaed3dd6794f36b67d203a6ae5b570_I20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTEvZnJhZzpiYzNmZDczMGFlM2U0ODFlOTUwMWIzYmUwMDZkMWIxZi90YWJsZTpkYjZlZGY0ZWExNjE0YmRlYjQ1NThiMmNlMjU5NjRmOS90YWJsZXJhbmdlOmRiNmVkZjRlYTE2MTRiZGViNDU1OGIyY2UyNTk2NGY5XzQtMy0xLTEtMA_ab45c2d4-6d79-40c9-be72-5dbe173e7a09"
      unitRef="shares">6264470</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="ib86a3e190d06442abdb93108d5a238e6_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTEvZnJhZzpiYzNmZDczMGFlM2U0ODFlOTUwMWIzYmUwMDZkMWIxZi90YWJsZTpkYjZlZGY0ZWExNjE0YmRlYjQ1NThiMmNlMjU5NjRmOS90YWJsZXJhbmdlOmRiNmVkZjRlYTE2MTRiZGViNDU1OGIyY2UyNTk2NGY5XzUtMS0xLTEtMA_74109b30-3e0b-4cdb-8d9b-9b3d790cfc5a"
      unitRef="shares">0</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="i12798862adb04861a6ae8feb9c091437_I20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTEvZnJhZzpiYzNmZDczMGFlM2U0ODFlOTUwMWIzYmUwMDZkMWIxZi90YWJsZTpkYjZlZGY0ZWExNjE0YmRlYjQ1NThiMmNlMjU5NjRmOS90YWJsZXJhbmdlOmRiNmVkZjRlYTE2MTRiZGViNDU1OGIyY2UyNTk2NGY5XzUtMy0xLTEtMA_fdac2070-b449-4821-9fce-b72b8eac3448"
      unitRef="shares">15064405</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="ic4860da07e274940b7dda28b5b824fd4_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTEvZnJhZzpiYzNmZDczMGFlM2U0ODFlOTUwMWIzYmUwMDZkMWIxZi90YWJsZTpkYjZlZGY0ZWExNjE0YmRlYjQ1NThiMmNlMjU5NjRmOS90YWJsZXJhbmdlOmRiNmVkZjRlYTE2MTRiZGViNDU1OGIyY2UyNTk2NGY5XzYtMS0xLTEtMA_372453e1-8573-43a5-b293-6b7f23fbd682"
      unitRef="shares">4310790</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="i447ce34fe05a46278994221dbd0e0819_I20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTEvZnJhZzpiYzNmZDczMGFlM2U0ODFlOTUwMWIzYmUwMDZkMWIxZi90YWJsZTpkYjZlZGY0ZWExNjE0YmRlYjQ1NThiMmNlMjU5NjRmOS90YWJsZXJhbmdlOmRiNmVkZjRlYTE2MTRiZGViNDU1OGIyY2UyNTk2NGY5XzYtMy0xLTEtMA_e5506397-fc4a-42ea-85c6-5967f208df25"
      unitRef="shares">4364377</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="i3dcad0503bdf4e5eba8e00589d3e2a59_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTEvZnJhZzpiYzNmZDczMGFlM2U0ODFlOTUwMWIzYmUwMDZkMWIxZi90YWJsZTpkYjZlZGY0ZWExNjE0YmRlYjQ1NThiMmNlMjU5NjRmOS90YWJsZXJhbmdlOmRiNmVkZjRlYTE2MTRiZGViNDU1OGIyY2UyNTk2NGY5XzctMS0xLTEtMA_42b7f501-6463-40ff-9e53-57ea35245674"
      unitRef="shares">1554690</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="i88bdc53e6793436cb3ebaa916528f65b_I20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTEvZnJhZzpiYzNmZDczMGFlM2U0ODFlOTUwMWIzYmUwMDZkMWIxZi90YWJsZTpkYjZlZGY0ZWExNjE0YmRlYjQ1NThiMmNlMjU5NjRmOS90YWJsZXJhbmdlOmRiNmVkZjRlYTE2MTRiZGViNDU1OGIyY2UyNTk2NGY5XzctMy0xLTEtMA_2cebc1a9-ab21-4ef9-aa2d-14d9dc172785"
      unitRef="shares">57889</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="ib065e570d4804ab887f6bb6e1fec5a75_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTEvZnJhZzpiYzNmZDczMGFlM2U0ODFlOTUwMWIzYmUwMDZkMWIxZi90YWJsZTpkYjZlZGY0ZWExNjE0YmRlYjQ1NThiMmNlMjU5NjRmOS90YWJsZXJhbmdlOmRiNmVkZjRlYTE2MTRiZGViNDU1OGIyY2UyNTk2NGY5XzgtMS0xLTEtMzAxNw_fe7740e9-7c25-4ed7-9417-05f9da299eca"
      unitRef="shares">372352</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="idaa6eb381396400786f1ca3efdf5b014_I20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTEvZnJhZzpiYzNmZDczMGFlM2U0ODFlOTUwMWIzYmUwMDZkMWIxZi90YWJsZTpkYjZlZGY0ZWExNjE0YmRlYjQ1NThiMmNlMjU5NjRmOS90YWJsZXJhbmdlOmRiNmVkZjRlYTE2MTRiZGViNDU1OGIyY2UyNTk2NGY5XzgtMy0xLTEtMzAxNw_cbba9010-95ac-40ba-8e12-d75a08975734"
      unitRef="shares">0</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="i7c6d2473a2234f6fae9d4b0c9b650a4f_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTEvZnJhZzpiYzNmZDczMGFlM2U0ODFlOTUwMWIzYmUwMDZkMWIxZi90YWJsZTpkYjZlZGY0ZWExNjE0YmRlYjQ1NThiMmNlMjU5NjRmOS90YWJsZXJhbmdlOmRiNmVkZjRlYTE2MTRiZGViNDU1OGIyY2UyNTk2NGY5XzgtMS0xLTEtMA_f6d9a6da-3fd0-4af3-87f9-bdcc4e770114"
      unitRef="shares">0</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="i1add56f0eae7469e989ed855f525f96b_I20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTEvZnJhZzpiYzNmZDczMGFlM2U0ODFlOTUwMWIzYmUwMDZkMWIxZi90YWJsZTpkYjZlZGY0ZWExNjE0YmRlYjQ1NThiMmNlMjU5NjRmOS90YWJsZXJhbmdlOmRiNmVkZjRlYTE2MTRiZGViNDU1OGIyY2UyNTk2NGY5XzgtMy0xLTEtMA_9e8d80ec-a212-4755-b112-87a66435810b"
      unitRef="shares">7527</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTEvZnJhZzpiYzNmZDczMGFlM2U0ODFlOTUwMWIzYmUwMDZkMWIxZi90YWJsZTpkYjZlZGY0ZWExNjE0YmRlYjQ1NThiMmNlMjU5NjRmOS90YWJsZXJhbmdlOmRiNmVkZjRlYTE2MTRiZGViNDU1OGIyY2UyNTk2NGY5XzktMS0xLTEtMA_ca985bd5-629c-4fe3-a76e-30195ec606f8"
      unitRef="shares">6237832</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTEvZnJhZzpiYzNmZDczMGFlM2U0ODFlOTUwMWIzYmUwMDZkMWIxZi90YWJsZTpkYjZlZGY0ZWExNjE0YmRlYjQ1NThiMmNlMjU5NjRmOS90YWJsZXJhbmdlOmRiNmVkZjRlYTE2MTRiZGViNDU1OGIyY2UyNTk2NGY5XzktMy0xLTEtMA_74ec168c-8a24-4f80-b066-a5605eb63671"
      unitRef="shares">28499408</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="i4be1e55866334204b2d9b1643c2315e7_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTEvZnJhZzpiYzNmZDczMGFlM2U0ODFlOTUwMWIzYmUwMDZkMWIxZi90ZXh0cmVnaW9uOmJjM2ZkNzMwYWUzZTQ4MWU5NTAxYjNiZTAwNmQxYjFmXzMyOTg1MzQ4ODcxNzY_faa44ab6-93ae-49da-95a5-66a8c4a27632"
      unitRef="usdPerShare">20.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ConversionOfStockSharesConverted1
      contextRef="if8633988d4034e2c837d8cfec30261f2_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTEvZnJhZzpiYzNmZDczMGFlM2U0ODFlOTUwMWIzYmUwMDZkMWIxZi90ZXh0cmVnaW9uOmJjM2ZkNzMwYWUzZTQ4MWU5NTAxYjNiZTAwNmQxYjFmXzMyOTg1MzQ4ODcxODM_77db5e17-657a-4993-b139-d36a58bf573a"
      unitRef="shares">5968</us-gaap:ConversionOfStockSharesConverted1>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="i7c6d2473a2234f6fae9d4b0c9b650a4f_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTEvZnJhZzpiYzNmZDczMGFlM2U0ODFlOTUwMWIzYmUwMDZkMWIxZi90ZXh0cmVnaW9uOmJjM2ZkNzMwYWUzZTQ4MWU5NTAxYjNiZTAwNmQxYjFmXzMyOTg1MzQ4ODcxOTI_5936bb04-2574-417a-a9da-78fc24270618"
      unitRef="shares">0</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="i1add56f0eae7469e989ed855f525f96b_I20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTEvZnJhZzpiYzNmZDczMGFlM2U0ODFlOTUwMWIzYmUwMDZkMWIxZi90ZXh0cmVnaW9uOmJjM2ZkNzMwYWUzZTQ4MWU5NTAxYjNiZTAwNmQxYjFmXzMyOTg1MzQ4ODcxOTk_70340c9c-ebb5-4cdb-acda-d92c9ac6d0ee"
      unitRef="shares">7527</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90ZXh0cmVnaW9uOmY0Yzg3Yjg5ZmY2NzRjYTQ4ODFiZWU1MWY3YTk1NWExXzYyMDM_65184d3c-a88c-4f87-a562-0792ada2dd33">Stock Option Plans&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In 2007, the Company established its 2007 Stock Option Plan which provided for the granting of stock options to employees, directors and consultants of the Company.  In connection with its acquisition of NeuroCo in December 2018, the Company also assumed NeuroCo&#x2019;s 2015 Equity Incentive Plan.  In March 2019, the Company's Board of Directors approved the termination of the 2007 Stock Option Plan and the NeuroCo 2015 Equity Incentive Plan and the adoption of the 2019 Equity Incentive Plan, or the 2019 Plan, which became effective immediately prior to the Company's IPO.  The 2019 Plan provides for the grant of ISOs to employees and for the grant of NSOs, restricted stock, restricted stock units, stock appreciation rights, performance units and performance shares to employees, directors and consultants.  A total of 2,317,000 shares of common stock were initially reserved for issuance pursuant to the 2019 Plan.  In addition, the shares reserved for issuance under the 2019 Plan will also include shares reserved but not issued under the 2007 Stock Option Plan, plus any share awards granted under the 2007 Stock Option Plan that expire or terminate without having been exercised in full or that are forfeited or repurchased.  In addition, the number of shares available for issuance under the 2019 Plan will also include an annual increase on the first day of each fiscal year beginning in fiscal 2020, equal to the lesser of (i) 3,000,000 shares; (ii) 4.0% of the outstanding shares of common stock as of the last day of the immediately preceding fiscal year; or (iii) an amount as determined by the Board of Directors.  As of December&#160;31, 2019, the Company has reserved 2,366,251 shares of common stock for issuance under the 2019 Plan.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The exercise price of ISOs and NSOs shall not be less than 100% and 85% of the estimated fair value of the shares on the date of grant, respectively, as determined by the Board of Directors.  The exercise price of ISOs and NSOs granted to a 10% stockholder shall not be less than 110% of the estimated fair value of the shares on the date of grant as determined by the Board of Directors.  To date, options have a term of ten years and generally vest over 4 years from date of grant.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Activity under the Company&#x2019;s 2007 Stock Option Plan, NeuroCo 2015 Equity Incentive Plan and 2019 Plan is set forth below:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;margin-bottom:9pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:99.839%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:32.670%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:10.841%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.602%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:10.841%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.602%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:8.754%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.602%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:10.199%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.602%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.487%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="21" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Options Outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Shares Available for Grant&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Number of Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Weighted Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Weighted Average Remaining Contractual Term (in Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Aggregate Intrinsic Value (in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Balances, December 31, 2017&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;328,290&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,308,890&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.09&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;7.81&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5,073&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Authorized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;223,664&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Options granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(629,716)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;629,716&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;6.51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Options exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(438,578)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Options cancelled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;135,651&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(135,651)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Balances, December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;57,889&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,364,377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;7.36&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;33,132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Authorized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,317,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Options granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(848,023)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;848,023&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;22.77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Options exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(873,786)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Options cancelled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;27,824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(27,824)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;8.71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Balances December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,554,690&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,310,790&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;7.91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;7.27&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;140,234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Vested and exercisable at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,514,891&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4.27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;6.38&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;90,854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Vested and expected to vest at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,310,790&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;7.91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;7.27&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;140,234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The aggregate intrinsic value of options exercised during the years ended December&#160;31, 2019 and 2018 was $24,867,000 and $787,000, respectively.  The aggregate intrinsic value was calculated as the difference between the exercise prices of the underlying options and the estimated fair value of the common stock on the date of exercise.  The weighted-average grant date fair value of options granted during the years ended  December&#160;31, 2019 and 2018 was $10.17 and $2.93 per share, respectively.  The total fair value of options vested during the years ended December&#160;31, 2019 and 2018 was $2,221,000 and $569,000, respectively, based on the grant date fair value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The following table summarizes information about stock options outstanding and vested as of December&#160;31, 2019:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;margin-bottom:12pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:21.444%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.437%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.832%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.597%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:13.311%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.597%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.875%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.597%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.832%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.597%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.881%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Options Outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Options Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Options Outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Weighted Average Remaining Contractual Term (in Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Weighted Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Number Exercisable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Weighted Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;$1.35 - $3.16&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,072,765&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5.86&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,770,060&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;$4.73 - $8.27&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;919,355&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;8.23&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5.81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;383,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5.72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;$11.29 - $20.00&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,192,804&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;8.73&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;16.63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;352,383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;14.46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;$36.47 - $48.53&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;125,866&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9.69&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;40.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9,371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;45.57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,310,790&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;7.27&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;7.91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,514,891&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4.27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;2019 Employee Stock Purchase Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In March 2019, the Company's Board of Directors adopted the 2019 Employee Stock Purchase Plan, or the 2019 ESPP, under which eligible employees are permitted to purchase common stock at a discount through payroll deductions.  A total of 434,000 shares of common stock are reserved for issuance and will be increased on the first day of each fiscal year, beginning in 2020, by an amount equal to the lesser of (i)&#160;1,200,000 shares (ii)&#160;1.0% of the outstanding shares of common stock as of the last day of the immediately preceding fiscal year; or (iii)&#160;an amount as determined by the Board of Directors.  The price of the common stock purchased will be the lower of 85% of the fair market value of the common stock at the beginning of an offering period or at the end of a purchase period.  The 2019 ESPP was effective upon adoption by the Company's Board of Directors but was not in use until the completion of the Company's IPO in April 2019.  The 2019 ESPP is intended to qualify as an "employee stock purchase plan" within the meaning of Section&#160;423 of the Internal Revenue Code of 1986, as amended.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;As of December&#160;31, 2019, 61,648 shares of common stock have been issued to employees participating in the 2019 ESPP and 372,352 shares were available for future issuance under the 2019 ESPP.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt;margin-bottom:9pt;"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Stock-Based Compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The Company estimated the fair value of stock options using the Black&#x2013;Scholes option pricing model.  The fair value of employee and nonemployee stock options is being amortized on a straight&#x2013;line basis over the requisite service period of the awards.  The fair value of employee and nonemployee stock options was estimated using the following assumptions for the years ended December&#160;31, 2019 and 2018:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;margin-bottom:9pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:62.903%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:15.147%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:15.149%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Expected term (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"&gt;&lt;div style="text-align:center;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;5.00 - 6.25&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;div style="text-align:center;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;5.00 - 6.25&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div style="text-align:center;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;42.4% - 42.9%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div style="text-align:center;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;38.0% - 38.8%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div style="text-align:center;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;1.47% - 2.54%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div style="text-align:center;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;2.68% - 2.98%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;%&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;%&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Prior to completion of the Company's IPO, the fair value of common stock was determined by the Company&#x2019;s Board of Directors, who considered, among other things, contemporaneous valuations of the Company&#x2019;s common stock prepared by an unrelated third-party valuation firm in accordance with the guidance provided by the American Institute of Certified Public Accountants Practice Guide, Valuation of Privately-Held-Company Equity Securities Issued as Compensation.  For stock options granted after the completion of the IPO, the fair value of the underlying common stock is based on the closing price of the Company's common stock on The NASDAQ Global Market on the date of grant.  The expected term of stock options represents the weighted-average period the stock options are expected to remain outstanding.  The Company does not have sufficient historical exercise and post-vesting termination activity to provide accurate data for estimating the expected term of options and has opted to use the &#x201c;simplified method,&#x201d; whereby the expected term equals the arithmetic average of the vesting term and the original contractual term of the option.  The expected stock price volatility assumption was determined by examining the historical volatilities for industry peers, as the Company does not have sufficient trading history for the Company&#x2019;s common stock.  The Company will continue to analyze the historical stock price volatility and expected term assumption as more historical data for the&#160;Company&#x2019;s common stock becomes available.  The risk-free interest rate assumption is based on the U.S. Treasury instruments whose term was consistent with the expected term of the&#160;Company&#x2019;s stock options.  The expected dividend assumption is based on the Company&#x2019;s history and expectation of dividend payouts.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Effective January 1, 2018, the Company made an accounting policy election to account for forfeitures as they occur. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The fair value of the shares to be issued under the Company&#x2019;s 2019 ESPP was estimated using the Black-Scholes valuation model with the following assumptions for the year ended December&#160;31, 2019:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;margin-bottom:9pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:73.961%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:21.238%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Year Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Expected term (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"&gt;&lt;div style="text-align:center;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;0.50 - 0.63&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div style="text-align:center;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;44.4% - 47.8%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div style="text-align:center;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;1.58% - 2.45%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;%&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:18pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Total stock-based compensation expense relating to the Company&#x2019;s stock options and 2019 ESPP during the years ended December&#160;31, 2019 and 2018, is as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;margin-bottom:9pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:69.314%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.942%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.943%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Cost of goods sold&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Research and development expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Selling, general and administrative expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,977&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;911&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;As of December&#160;31, 2019, there was total unrecognized compensation costs of $8,539,000 related to stock options, which are expected to be recognized over a period of approximately 3.04 years and $219,000 related to the 2019 ESPP, which the Company will recognize over 0.39 years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="i9b5314b8f65d48ffb39568a32e1ae70e_I20190331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90ZXh0cmVnaW9uOmY0Yzg3Yjg5ZmY2NzRjYTQ4ODFiZWU1MWY3YTk1NWExXzMyOTg1MzQ4OTI3NTE_1bd84c01-0125-410b-ac10-a570926b6e08"
      unitRef="shares">2317000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <silk:ShareBasedCompensationArrangementBySharebasedPaymentAwardNumberOfAdditionalSharesAllowableUnderThePlan
      contextRef="i5c3d2d26b9a1456fa6a38583e15b0dee_I20190331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90ZXh0cmVnaW9uOmY0Yzg3Yjg5ZmY2NzRjYTQ4ODFiZWU1MWY3YTk1NWExXzMyOTg1MzQ4OTI3NjI_55291cbb-4177-414f-a5c0-737ed61046f5"
      unitRef="shares">3000000</silk:ShareBasedCompensationArrangementBySharebasedPaymentAwardNumberOfAdditionalSharesAllowableUnderThePlan>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum
      contextRef="id374ce4879bf48d69346a02ab7b52f9e_D20190301-20190331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90ZXh0cmVnaW9uOmY0Yzg3Yjg5ZmY2NzRjYTQ4ODFiZWU1MWY3YTk1NWExXzMyOTg1MzQ4OTI3Njg_0e4f4e95-2af6-4a21-b20a-7292282ddd2e"
      unitRef="number">0.040</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="i188f88bd74544c788b5f388916b2ffd9_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90ZXh0cmVnaW9uOmY0Yzg3Yjg5ZmY2NzRjYTQ4ODFiZWU1MWY3YTk1NWExXzMyOTg1MzQ4OTI3OTk_8208b388-24ac-4890-8c44-f594a5dd9834"
      unitRef="shares">2366251</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <silk:SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExerciseThresholdasaPercentageofSharePrice
      contextRef="i4579105f1eae463bbc80b9182ebdface_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90ZXh0cmVnaW9uOmY0Yzg3Yjg5ZmY2NzRjYTQ4ODFiZWU1MWY3YTk1NWExXzMyOTg1MzQ5ODE0NDA_8eb60c63-de2b-4ff1-adc8-862a4c96ca21"
      unitRef="number">1</silk:SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExerciseThresholdasaPercentageofSharePrice>
    <silk:SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExerciseThresholdasaPercentageofSharePrice
      contextRef="i09b415be50aa4620acbb4b68a3d03255_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90ZXh0cmVnaW9uOmY0Yzg3Yjg5ZmY2NzRjYTQ4ODFiZWU1MWY3YTk1NWExXzMyOTg1MzQ5ODE0NDQ_2e51231e-cdca-465d-b26e-ab1fb439bd4b"
      unitRef="number">0.85</silk:SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExerciseThresholdasaPercentageofSharePrice>
    <silk:SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExerciseThresholdasaPercentageofSharePrice
      contextRef="ie740d91c6b54459faa35c174c4cc3dbe_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90ZXh0cmVnaW9uOmY0Yzg3Yjg5ZmY2NzRjYTQ4ODFiZWU1MWY3YTk1NWExXzMyOTg1MzQ5ODE0NTI_46f89ab6-69cf-4589-b075-d895f68e35c9"
      unitRef="number">1.10</silk:SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExerciseThresholdasaPercentageofSharePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="i0ca865b5bbab452998af805b9a59eb9a_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90ZXh0cmVnaW9uOmY0Yzg3Yjg5ZmY2NzRjYTQ4ODFiZWU1MWY3YTk1NWExXzMyOTg1MzQ5ODE0NTY_9d25a097-816a-4e5c-8b81-c3b85b1ad67a">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i0ca865b5bbab452998af805b9a59eb9a_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90ZXh0cmVnaW9uOmY0Yzg3Yjg5ZmY2NzRjYTQ4ODFiZWU1MWY3YTk1NWExXzMyOTg1MzQ5ODE0NjA_a8156d97-8a3e-41f7-96b9-7564c5abc458">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90ZXh0cmVnaW9uOmY0Yzg3Yjg5ZmY2NzRjYTQ4ODFiZWU1MWY3YTk1NWExXzYyMDQ_4bee9973-e168-4dc8-9326-c0b5f3e8e8b0">&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Activity under the Company&#x2019;s 2007 Stock Option Plan, NeuroCo 2015 Equity Incentive Plan and 2019 Plan is set forth below:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;margin-bottom:9pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:99.839%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:32.670%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:10.841%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.602%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:10.841%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.602%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:8.754%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.602%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:10.199%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.602%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.487%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="21" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Options Outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Shares Available for Grant&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Number of Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Weighted Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Weighted Average Remaining Contractual Term (in Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Aggregate Intrinsic Value (in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Balances, December 31, 2017&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;328,290&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,308,890&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.09&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;7.81&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5,073&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Authorized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;223,664&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Options granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(629,716)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;629,716&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;6.51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Options exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(438,578)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Options cancelled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;135,651&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(135,651)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Balances, December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;57,889&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,364,377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;7.36&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;33,132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Authorized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,317,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Options granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(848,023)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;848,023&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;22.77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Options exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(873,786)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Options cancelled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;27,824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(27,824)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;8.71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Balances December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,554,690&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,310,790&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;7.91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;7.27&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;140,234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Vested and exercisable at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,514,891&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4.27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;6.38&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;90,854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Vested and expected to vest at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,310,790&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;7.91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;7.27&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;140,234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="i517a0560ef9f4f6a822a0a124dd39744_I20171231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZTplNzIyY2M0NGM5ZmM0NWY3YTM1ODE1YjY3NTlmNzYyYS90YWJsZXJhbmdlOmU3MjJjYzQ0YzlmYzQ1ZjdhMzU4MTViNjc1OWY3NjJhXzctMS0xLTEtMA_74a59ad0-671f-4154-ae0e-3161814bc171"
      unitRef="shares">328290</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i517a0560ef9f4f6a822a0a124dd39744_I20171231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZTplNzIyY2M0NGM5ZmM0NWY3YTM1ODE1YjY3NTlmNzYyYS90YWJsZXJhbmdlOmU3MjJjYzQ0YzlmYzQ1ZjdhMzU4MTViNjc1OWY3NjJhXzctMy0xLTEtMA_9c4982a5-76b2-4255-ad34-486e3ec887de"
      unitRef="shares">4308890</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i517a0560ef9f4f6a822a0a124dd39744_I20171231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZTplNzIyY2M0NGM5ZmM0NWY3YTM1ODE1YjY3NTlmNzYyYS90YWJsZXJhbmdlOmU3MjJjYzQ0YzlmYzQ1ZjdhMzU4MTViNjc1OWY3NjJhXzctNS0xLTEtMA_4bbdbc3c-d137-4357-8261-38e3c0e097ec"
      unitRef="usdPerShare">3.09</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="i28c5cd5abfce4c7aa5c44b0f651c9ad8_D20170101-20171231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZTplNzIyY2M0NGM5ZmM0NWY3YTM1ODE1YjY3NTlmNzYyYS90YWJsZXJhbmdlOmU3MjJjYzQ0YzlmYzQ1ZjdhMzU4MTViNjc1OWY3NjJhXzctNy0xLTEtMA_082947b2-452e-4e15-82dc-49cd84d3ccc5">P7Y9M21D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="i517a0560ef9f4f6a822a0a124dd39744_I20171231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZTplNzIyY2M0NGM5ZmM0NWY3YTM1ODE1YjY3NTlmNzYyYS90YWJsZXJhbmdlOmU3MjJjYzQ0YzlmYzQ1ZjdhMzU4MTViNjc1OWY3NjJhXzctOS0xLTEtMA_2f275264-ac44-4cec-b7d0-44d1488af609"
      unitRef="usd">5073000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
      contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZTplNzIyY2M0NGM5ZmM0NWY3YTM1ODE1YjY3NTlmNzYyYS90YWJsZXJhbmdlOmU3MjJjYzQ0YzlmYzQ1ZjdhMzU4MTViNjc1OWY3NjJhXzgtMS0xLTEtMA_75fa4d22-ed41-4c40-8c5d-a5f4860185e9"
      unitRef="shares">223664</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZTplNzIyY2M0NGM5ZmM0NWY3YTM1ODE1YjY3NTlmNzYyYS90YWJsZXJhbmdlOmU3MjJjYzQ0YzlmYzQ1ZjdhMzU4MTViNjc1OWY3NjJhXzktMS0xLTEtMA_ae169960-6244-4069-8f88-41492e4ca9a5"
      unitRef="shares">629716</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZTplNzIyY2M0NGM5ZmM0NWY3YTM1ODE1YjY3NTlmNzYyYS90YWJsZXJhbmdlOmU3MjJjYzQ0YzlmYzQ1ZjdhMzU4MTViNjc1OWY3NjJhXzktMy0xLTEtMA_20f83985-f008-4e61-9d8f-d67cfca5a3af"
      unitRef="shares">629716</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZTplNzIyY2M0NGM5ZmM0NWY3YTM1ODE1YjY3NTlmNzYyYS90YWJsZXJhbmdlOmU3MjJjYzQ0YzlmYzQ1ZjdhMzU4MTViNjc1OWY3NjJhXzktNS0xLTEtMA_d2332efe-2179-4502-9cef-23c4fbc61055"
      unitRef="usdPerShare">6.51</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZTplNzIyY2M0NGM5ZmM0NWY3YTM1ODE1YjY3NTlmNzYyYS90YWJsZXJhbmdlOmU3MjJjYzQ0YzlmYzQ1ZjdhMzU4MTViNjc1OWY3NjJhXzEwLTMtMS0xLTA_91cea72f-58a8-473b-96f6-1ddd72428507"
      unitRef="shares">438578</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZTplNzIyY2M0NGM5ZmM0NWY3YTM1ODE1YjY3NTlmNzYyYS90YWJsZXJhbmdlOmU3MjJjYzQ0YzlmYzQ1ZjdhMzU4MTViNjc1OWY3NjJhXzEwLTUtMS0xLTA_4c0652b0-1e5c-4391-ac5c-e381d14e0b6b"
      unitRef="usdPerShare">1.50</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
      contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZTplNzIyY2M0NGM5ZmM0NWY3YTM1ODE1YjY3NTlmNzYyYS90YWJsZXJhbmdlOmU3MjJjYzQ0YzlmYzQ1ZjdhMzU4MTViNjc1OWY3NjJhXzExLTEtMS0xLTA_0630b444-2ebd-4bf6-bed3-feb7088b6c57"
      unitRef="shares">135651</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
      contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZTplNzIyY2M0NGM5ZmM0NWY3YTM1ODE1YjY3NTlmNzYyYS90YWJsZXJhbmdlOmU3MjJjYzQ0YzlmYzQ1ZjdhMzU4MTViNjc1OWY3NjJhXzExLTMtMS0xLTA_3d7e2590-20dd-41eb-8031-6a5b284ed4bc"
      unitRef="shares">135651</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZTplNzIyY2M0NGM5ZmM0NWY3YTM1ODE1YjY3NTlmNzYyYS90YWJsZXJhbmdlOmU3MjJjYzQ0YzlmYzQ1ZjdhMzU4MTViNjc1OWY3NjJhXzExLTUtMS0xLTA_3fdfc04e-deca-42cc-a82e-bda4b651d522"
      unitRef="usdPerShare">1.56</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZTplNzIyY2M0NGM5ZmM0NWY3YTM1ODE1YjY3NTlmNzYyYS90YWJsZXJhbmdlOmU3MjJjYzQ0YzlmYzQ1ZjdhMzU4MTViNjc1OWY3NjJhXzEyLTEtMS0xLTA_7949cc6f-217b-4520-95ff-1c0cfb7a5830"
      unitRef="shares">57889</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZTplNzIyY2M0NGM5ZmM0NWY3YTM1ODE1YjY3NTlmNzYyYS90YWJsZXJhbmdlOmU3MjJjYzQ0YzlmYzQ1ZjdhMzU4MTViNjc1OWY3NjJhXzEyLTMtMS0xLTA_c67bff9a-2205-4098-a68b-1794216915c8"
      unitRef="shares">4364377</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZTplNzIyY2M0NGM5ZmM0NWY3YTM1ODE1YjY3NTlmNzYyYS90YWJsZXJhbmdlOmU3MjJjYzQ0YzlmYzQ1ZjdhMzU4MTViNjc1OWY3NjJhXzEyLTUtMS0xLTA_09cd306d-61bd-4b7b-8476-079c0d85c95a"
      unitRef="usdPerShare">3.79</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZTplNzIyY2M0NGM5ZmM0NWY3YTM1ODE1YjY3NTlmNzYyYS90YWJsZXJhbmdlOmU3MjJjYzQ0YzlmYzQ1ZjdhMzU4MTViNjc1OWY3NjJhXzEyLTctMS0xLTA_995eb542-801f-4e4a-8c79-a244c0fd7237">P7Y4M9D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZTplNzIyY2M0NGM5ZmM0NWY3YTM1ODE1YjY3NTlmNzYyYS90YWJsZXJhbmdlOmU3MjJjYzQ0YzlmYzQ1ZjdhMzU4MTViNjc1OWY3NjJhXzEyLTktMS0xLTA_bb21ff08-6c3f-4cfe-9a4f-ca18c72f96ee"
      unitRef="usd">33132000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZTplNzIyY2M0NGM5ZmM0NWY3YTM1ODE1YjY3NTlmNzYyYS90YWJsZXJhbmdlOmU3MjJjYzQ0YzlmYzQ1ZjdhMzU4MTViNjc1OWY3NjJhXzEzLTEtMS0xLTA_666ae073-8da3-4a5e-a432-0799d49d0b19"
      unitRef="shares">2317000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZTplNzIyY2M0NGM5ZmM0NWY3YTM1ODE1YjY3NTlmNzYyYS90YWJsZXJhbmdlOmU3MjJjYzQ0YzlmYzQ1ZjdhMzU4MTViNjc1OWY3NjJhXzE0LTEtMS0xLTA_fb92ee51-c7bb-4f41-9cc5-a413d16a5839"
      unitRef="shares">848023</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZTplNzIyY2M0NGM5ZmM0NWY3YTM1ODE1YjY3NTlmNzYyYS90YWJsZXJhbmdlOmU3MjJjYzQ0YzlmYzQ1ZjdhMzU4MTViNjc1OWY3NjJhXzE0LTMtMS0xLTA_13494431-8381-4c88-8b8f-be238a0a9be5"
      unitRef="shares">848023</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZTplNzIyY2M0NGM5ZmM0NWY3YTM1ODE1YjY3NTlmNzYyYS90YWJsZXJhbmdlOmU3MjJjYzQ0YzlmYzQ1ZjdhMzU4MTViNjc1OWY3NjJhXzE0LTUtMS0xLTA_7b1bb28e-e9bd-4507-816f-f04158de4f94"
      unitRef="usdPerShare">22.77</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZTplNzIyY2M0NGM5ZmM0NWY3YTM1ODE1YjY3NTlmNzYyYS90YWJsZXJhbmdlOmU3MjJjYzQ0YzlmYzQ1ZjdhMzU4MTViNjc1OWY3NjJhXzE1LTMtMS0xLTA_09018d50-4064-422b-9542-c4b6210a75c6"
      unitRef="shares">873786</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZTplNzIyY2M0NGM5ZmM0NWY3YTM1ODE1YjY3NTlmNzYyYS90YWJsZXJhbmdlOmU3MjJjYzQ0YzlmYzQ1ZjdhMzU4MTViNjc1OWY3NjJhXzE1LTUtMS0xLTA_4e7a0eac-166c-4c71-96db-2c3ff1371222"
      unitRef="usdPerShare">1.77</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZTplNzIyY2M0NGM5ZmM0NWY3YTM1ODE1YjY3NTlmNzYyYS90YWJsZXJhbmdlOmU3MjJjYzQ0YzlmYzQ1ZjdhMzU4MTViNjc1OWY3NjJhXzE2LTEtMS0xLTA_b95f034c-8bb5-4160-ad19-aed52af7612a"
      unitRef="shares">27824</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZTplNzIyY2M0NGM5ZmM0NWY3YTM1ODE1YjY3NTlmNzYyYS90YWJsZXJhbmdlOmU3MjJjYzQ0YzlmYzQ1ZjdhMzU4MTViNjc1OWY3NjJhXzE2LTMtMS0xLTA_109ec7cb-f1a7-4f6c-99ca-46c0098cdcc8"
      unitRef="shares">27824</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZTplNzIyY2M0NGM5ZmM0NWY3YTM1ODE1YjY3NTlmNzYyYS90YWJsZXJhbmdlOmU3MjJjYzQ0YzlmYzQ1ZjdhMzU4MTViNjc1OWY3NjJhXzE2LTUtMS0xLTA_8bda3d39-b06f-47dc-9ed6-c08282a7b30c"
      unitRef="usdPerShare">8.71</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZTplNzIyY2M0NGM5ZmM0NWY3YTM1ODE1YjY3NTlmNzYyYS90YWJsZXJhbmdlOmU3MjJjYzQ0YzlmYzQ1ZjdhMzU4MTViNjc1OWY3NjJhXzE3LTEtMS0xLTA_1b6f4382-4477-4555-b732-7b779ec16f65"
      unitRef="shares">1554690</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZTplNzIyY2M0NGM5ZmM0NWY3YTM1ODE1YjY3NTlmNzYyYS90YWJsZXJhbmdlOmU3MjJjYzQ0YzlmYzQ1ZjdhMzU4MTViNjc1OWY3NjJhXzE3LTMtMS0xLTA_3bcd0d0e-a7fb-430e-9361-9bdbcbf12832"
      unitRef="shares">4310790</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZTplNzIyY2M0NGM5ZmM0NWY3YTM1ODE1YjY3NTlmNzYyYS90YWJsZXJhbmdlOmU3MjJjYzQ0YzlmYzQ1ZjdhMzU4MTViNjc1OWY3NjJhXzE3LTUtMS0xLTA_8ccc55e1-f8bd-4f44-b4b5-2b1044c44656"
      unitRef="usdPerShare">7.91</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZTplNzIyY2M0NGM5ZmM0NWY3YTM1ODE1YjY3NTlmNzYyYS90YWJsZXJhbmdlOmU3MjJjYzQ0YzlmYzQ1ZjdhMzU4MTViNjc1OWY3NjJhXzE3LTctMS0xLTA_d817c7f4-9736-4b67-9776-1fca8e5a466d">P7Y3M7D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZTplNzIyY2M0NGM5ZmM0NWY3YTM1ODE1YjY3NTlmNzYyYS90YWJsZXJhbmdlOmU3MjJjYzQ0YzlmYzQ1ZjdhMzU4MTViNjc1OWY3NjJhXzE3LTktMS0xLTA_58a1fcf4-4765-4479-82d8-3fe6a8ca89bf"
      unitRef="usd">140234000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZTplNzIyY2M0NGM5ZmM0NWY3YTM1ODE1YjY3NTlmNzYyYS90YWJsZXJhbmdlOmU3MjJjYzQ0YzlmYzQ1ZjdhMzU4MTViNjc1OWY3NjJhXzE4LTMtMS0xLTA_39e91df8-ff2a-4f94-8831-e0ff24b145b4"
      unitRef="shares">2514891</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZTplNzIyY2M0NGM5ZmM0NWY3YTM1ODE1YjY3NTlmNzYyYS90YWJsZXJhbmdlOmU3MjJjYzQ0YzlmYzQ1ZjdhMzU4MTViNjc1OWY3NjJhXzE4LTUtMS0xLTA_b8532f13-97fc-46b4-8e78-4ce29daa8a82"
      unitRef="usdPerShare">4.27</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZTplNzIyY2M0NGM5ZmM0NWY3YTM1ODE1YjY3NTlmNzYyYS90YWJsZXJhbmdlOmU3MjJjYzQ0YzlmYzQ1ZjdhMzU4MTViNjc1OWY3NjJhXzE4LTctMS0xLTA_37fe6af4-5de6-418a-843b-a4bfdfa37425">P6Y4M17D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZTplNzIyY2M0NGM5ZmM0NWY3YTM1ODE1YjY3NTlmNzYyYS90YWJsZXJhbmdlOmU3MjJjYzQ0YzlmYzQ1ZjdhMzU4MTViNjc1OWY3NjJhXzE4LTktMS0xLTA_5959a37a-3314-407b-9a88-2a53b77f2236"
      unitRef="usd">90854000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZTplNzIyY2M0NGM5ZmM0NWY3YTM1ODE1YjY3NTlmNzYyYS90YWJsZXJhbmdlOmU3MjJjYzQ0YzlmYzQ1ZjdhMzU4MTViNjc1OWY3NjJhXzE5LTMtMS0xLTA_5673668c-702b-499b-b6c3-d1314fe70e37"
      unitRef="shares">4310790</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZTplNzIyY2M0NGM5ZmM0NWY3YTM1ODE1YjY3NTlmNzYyYS90YWJsZXJhbmdlOmU3MjJjYzQ0YzlmYzQ1ZjdhMzU4MTViNjc1OWY3NjJhXzE5LTUtMS0xLTA_2285a630-27b6-4379-812a-c2074208e394"
      unitRef="usdPerShare">7.91</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZTplNzIyY2M0NGM5ZmM0NWY3YTM1ODE1YjY3NTlmNzYyYS90YWJsZXJhbmdlOmU3MjJjYzQ0YzlmYzQ1ZjdhMzU4MTViNjc1OWY3NjJhXzE5LTctMS0xLTA_75b1f8fb-d72f-43cd-aee2-ea32589d34d6">P7Y3M7D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZTplNzIyY2M0NGM5ZmM0NWY3YTM1ODE1YjY3NTlmNzYyYS90YWJsZXJhbmdlOmU3MjJjYzQ0YzlmYzQ1ZjdhMzU4MTViNjc1OWY3NjJhXzE5LTktMS0xLTA_ee3f5bd6-093f-4931-8caa-82c77313398e"
      unitRef="usd">140234000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90ZXh0cmVnaW9uOmY0Yzg3Yjg5ZmY2NzRjYTQ4ODFiZWU1MWY3YTk1NWExXzMyOTg1MzQ4OTQ0Mjk_80de1a52-ddb0-407e-9788-f59ef4c76f93"
      unitRef="usd">24867000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90ZXh0cmVnaW9uOmY0Yzg3Yjg5ZmY2NzRjYTQ4ODFiZWU1MWY3YTk1NWExXzMyOTg1MzQ4OTQ0NDc_50b11972-9b62-4a9f-b440-4434b75e9438"
      unitRef="usd">787000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90ZXh0cmVnaW9uOmY0Yzg3Yjg5ZmY2NzRjYTQ4ODFiZWU1MWY3YTk1NWExXzMyOTg1MzQ4OTY4NDA_ad3287e8-8e36-4300-95c7-be62d0a83c47"
      unitRef="usdPerShare">10.17</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90ZXh0cmVnaW9uOmY0Yzg3Yjg5ZmY2NzRjYTQ4ODFiZWU1MWY3YTk1NWExXzMyOTg1MzQ4OTY4NDc_6aeb2402-6c4e-4285-83d1-50a6e7472153"
      unitRef="usdPerShare">2.93</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90ZXh0cmVnaW9uOmY0Yzg3Yjg5ZmY2NzRjYTQ4ODFiZWU1MWY3YTk1NWExXzMyOTg1MzQ4OTY4ODI_0e94af28-32c9-451f-87ef-17874ba2cc26"
      unitRef="usdPerShare">2221000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
      contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90ZXh0cmVnaW9uOmY0Yzg3Yjg5ZmY2NzRjYTQ4ODFiZWU1MWY3YTk1NWExXzMyOTg1MzQ4OTY4OTI_fcc2e769-01de-4c49-bc8e-a9933c3b8df4"
      unitRef="usdPerShare">569000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue>
    <us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90ZXh0cmVnaW9uOmY0Yzg3Yjg5ZmY2NzRjYTQ4ODFiZWU1MWY3YTk1NWExXzYyMDU_d7dfb659-83be-45b0-8b95-4fdb8f93404f">&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The following table summarizes information about stock options outstanding and vested as of December&#160;31, 2019:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;margin-bottom:12pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:21.444%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.437%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.832%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.597%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:13.311%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.597%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.875%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.597%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.832%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.597%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.881%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Options Outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Options Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Options Outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Weighted Average Remaining Contractual Term (in Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Weighted Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Number Exercisable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Weighted Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;$1.35 - $3.16&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,072,765&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5.86&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,770,060&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;$4.73 - $8.27&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;919,355&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;8.23&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5.81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;383,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5.72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;$11.29 - $20.00&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,192,804&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;8.73&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;16.63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;352,383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;14.46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;$36.47 - $48.53&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;125,866&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9.69&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;40.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9,371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;45.57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,310,790&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;7.27&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;7.91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,514,891&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4.27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock>
    <silk:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice
      contextRef="iaa805919be064beda12a6545c3d07fcd_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZToxOWY1MzQyOGYyNTc0ZDU5OTQ1MTA1MjdkYzk0MTY5MC90YWJsZXJhbmdlOjE5ZjUzNDI4ZjI1NzRkNTk5NDUxMDUyN2RjOTQxNjkwXzMtMC0xLTEtMC90ZXh0cmVnaW9uOjgyN2Y3NjQwMzBkOTQxMmE5MjM5ODA1ZDRhNGQ1YzU2XzMyOTg1MzQ4ODMzNTU_f7060e02-bbfd-41f4-9301-f02a1e162444"
      unitRef="usdPerShare">1.35</silk:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice>
    <silk:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice
      contextRef="i8d08513aaa4d42039e2e5145986ff348_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZToxOWY1MzQyOGYyNTc0ZDU5OTQ1MTA1MjdkYzk0MTY5MC90YWJsZXJhbmdlOjE5ZjUzNDI4ZjI1NzRkNTk5NDUxMDUyN2RjOTQxNjkwXzMtMC0xLTEtMC90ZXh0cmVnaW9uOjgyN2Y3NjQwMzBkOTQxMmE5MjM5ODA1ZDRhNGQ1YzU2XzMyOTg1MzQ4ODMzNDk_c121df4c-42dc-4104-95e7-ce394a51df12"
      unitRef="usdPerShare">3.16</silk:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i9168c8a79f074245b359c1eabebd2867_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZToxOWY1MzQyOGYyNTc0ZDU5OTQ1MTA1MjdkYzk0MTY5MC90YWJsZXJhbmdlOjE5ZjUzNDI4ZjI1NzRkNTk5NDUxMDUyN2RjOTQxNjkwXzMtMS0xLTEtMA_8cecfbab-6d18-444a-8298-ce20e0aaee38"
      unitRef="shares">2072765</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="i6cf6ea883ee84acc9631ce618bef5f1c_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZToxOWY1MzQyOGYyNTc0ZDU5OTQ1MTA1MjdkYzk0MTY5MC90YWJsZXJhbmdlOjE5ZjUzNDI4ZjI1NzRkNTk5NDUxMDUyN2RjOTQxNjkwXzMtMy0xLTEtMA_4e308219-a7de-43fa-b3a8-58ae508468ff">P5Y10M9D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i9168c8a79f074245b359c1eabebd2867_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZToxOWY1MzQyOGYyNTc0ZDU5OTQ1MTA1MjdkYzk0MTY5MC90YWJsZXJhbmdlOjE5ZjUzNDI4ZjI1NzRkNTk5NDUxMDUyN2RjOTQxNjkwXzMtNS0xLTEtMA_78ee53a9-8793-409d-87a9-655435ae2136"
      unitRef="usdPerShare">1.84</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="i9168c8a79f074245b359c1eabebd2867_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZToxOWY1MzQyOGYyNTc0ZDU5OTQ1MTA1MjdkYzk0MTY5MC90YWJsZXJhbmdlOjE5ZjUzNDI4ZjI1NzRkNTk5NDUxMDUyN2RjOTQxNjkwXzMtNy0xLTEtMA_d5991bf5-ba30-46b0-9ab6-48cf0a36022c"
      unitRef="shares">1770060</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="i9168c8a79f074245b359c1eabebd2867_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZToxOWY1MzQyOGYyNTc0ZDU5OTQ1MTA1MjdkYzk0MTY5MC90YWJsZXJhbmdlOjE5ZjUzNDI4ZjI1NzRkNTk5NDUxMDUyN2RjOTQxNjkwXzMtOS0xLTEtMA_c4eeec4f-3531-4728-b48e-8f08eba5e2f9"
      unitRef="usdPerShare">1.71</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <silk:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice
      contextRef="i6e1de668b6f54e6f9e86b8d5f1188b44_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZToxOWY1MzQyOGYyNTc0ZDU5OTQ1MTA1MjdkYzk0MTY5MC90YWJsZXJhbmdlOjE5ZjUzNDI4ZjI1NzRkNTk5NDUxMDUyN2RjOTQxNjkwXzQtMC0xLTEtMC90ZXh0cmVnaW9uOjA0ZmM4OTc0MWRhZDQ5MGI5MDA0OGMzYTVjOTRjZmVhXzMyOTg1MzQ4ODMzNTA_08414f24-d1ac-49fc-b5e3-12f928532a66"
      unitRef="usdPerShare">4.73</silk:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice>
    <silk:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice
      contextRef="iaec558563b4843c5b260f5fe73e22f01_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZToxOWY1MzQyOGYyNTc0ZDU5OTQ1MTA1MjdkYzk0MTY5MC90YWJsZXJhbmdlOjE5ZjUzNDI4ZjI1NzRkNTk5NDUxMDUyN2RjOTQxNjkwXzQtMC0xLTEtMC90ZXh0cmVnaW9uOjA0ZmM4OTc0MWRhZDQ5MGI5MDA0OGMzYTVjOTRjZmVhXzMyOTg1MzQ4ODMzNTc_7c164254-a58e-4546-8953-8e963f47f200"
      unitRef="usdPerShare">8.27</silk:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i0e5c6cb252b942de9df54fcafdb03c57_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZToxOWY1MzQyOGYyNTc0ZDU5OTQ1MTA1MjdkYzk0MTY5MC90YWJsZXJhbmdlOjE5ZjUzNDI4ZjI1NzRkNTk5NDUxMDUyN2RjOTQxNjkwXzQtMS0xLTEtMA_0d086fe7-5d6f-43e6-8473-38e777403731"
      unitRef="shares">919355</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="i8e43b208e0754e78903aecd89161bdcb_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZToxOWY1MzQyOGYyNTc0ZDU5OTQ1MTA1MjdkYzk0MTY5MC90YWJsZXJhbmdlOjE5ZjUzNDI4ZjI1NzRkNTk5NDUxMDUyN2RjOTQxNjkwXzQtMy0xLTEtMA_6d52165f-0fb6-4a9c-8c20-5d2981905bf2">P8Y2M23D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i0e5c6cb252b942de9df54fcafdb03c57_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZToxOWY1MzQyOGYyNTc0ZDU5OTQ1MTA1MjdkYzk0MTY5MC90YWJsZXJhbmdlOjE5ZjUzNDI4ZjI1NzRkNTk5NDUxMDUyN2RjOTQxNjkwXzQtNS0xLTEtMA_f7dac302-5c26-418b-a46a-f2a08501e05c"
      unitRef="usdPerShare">5.81</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="i0e5c6cb252b942de9df54fcafdb03c57_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZToxOWY1MzQyOGYyNTc0ZDU5OTQ1MTA1MjdkYzk0MTY5MC90YWJsZXJhbmdlOjE5ZjUzNDI4ZjI1NzRkNTk5NDUxMDUyN2RjOTQxNjkwXzQtNy0xLTEtMA_a89582fc-0016-42be-96af-aac7663f4dd1"
      unitRef="shares">383077</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="i0e5c6cb252b942de9df54fcafdb03c57_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZToxOWY1MzQyOGYyNTc0ZDU5OTQ1MTA1MjdkYzk0MTY5MC90YWJsZXJhbmdlOjE5ZjUzNDI4ZjI1NzRkNTk5NDUxMDUyN2RjOTQxNjkwXzQtOS0xLTEtMA_b465e8f9-d973-454a-a8be-c7b0d338eb3b"
      unitRef="usdPerShare">5.72</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <silk:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice
      contextRef="iee86434ad814473fa2012397d08d7c63_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZToxOWY1MzQyOGYyNTc0ZDU5OTQ1MTA1MjdkYzk0MTY5MC90YWJsZXJhbmdlOjE5ZjUzNDI4ZjI1NzRkNTk5NDUxMDUyN2RjOTQxNjkwXzUtMC0xLTEtMC90ZXh0cmVnaW9uOjAyNDY2MTIzMjczMTQ3MjliYmU0N2JhNjQ4NzZhZDk3XzMyOTg1MzQ4ODMzNTM_969f28a7-855d-4e7d-a669-ea2ea74b76ec"
      unitRef="usdPerShare">11.29</silk:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice>
    <silk:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice
      contextRef="idb8741dc808745c1ac9cfaa8b95bf8c6_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZToxOWY1MzQyOGYyNTc0ZDU5OTQ1MTA1MjdkYzk0MTY5MC90YWJsZXJhbmdlOjE5ZjUzNDI4ZjI1NzRkNTk5NDUxMDUyN2RjOTQxNjkwXzUtMC0xLTEtMC90ZXh0cmVnaW9uOjAyNDY2MTIzMjczMTQ3MjliYmU0N2JhNjQ4NzZhZDk3XzMyOTg1MzQ4ODMzNjE_98f9b38c-c5da-4be0-bebf-76a88b35b7ca"
      unitRef="usdPerShare">20.00</silk:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i580ea82051b046c086a55b23cbe96b48_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZToxOWY1MzQyOGYyNTc0ZDU5OTQ1MTA1MjdkYzk0MTY5MC90YWJsZXJhbmdlOjE5ZjUzNDI4ZjI1NzRkNTk5NDUxMDUyN2RjOTQxNjkwXzUtMS0xLTEtMA_02265539-2818-444a-9158-a8bc30e92722"
      unitRef="shares">1192804</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="ia1a2680b0c4640b4a319ee060427817d_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZToxOWY1MzQyOGYyNTc0ZDU5OTQ1MTA1MjdkYzk0MTY5MC90YWJsZXJhbmdlOjE5ZjUzNDI4ZjI1NzRkNTk5NDUxMDUyN2RjOTQxNjkwXzUtMy0xLTEtMA_b859a02e-aa5e-4076-b84b-812b3835dcc7">P8Y8M23D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i580ea82051b046c086a55b23cbe96b48_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZToxOWY1MzQyOGYyNTc0ZDU5OTQ1MTA1MjdkYzk0MTY5MC90YWJsZXJhbmdlOjE5ZjUzNDI4ZjI1NzRkNTk5NDUxMDUyN2RjOTQxNjkwXzUtNS0xLTEtMA_f534d379-1e7e-4d1d-af51-ea2f24b5534f"
      unitRef="usdPerShare">16.63</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="i580ea82051b046c086a55b23cbe96b48_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZToxOWY1MzQyOGYyNTc0ZDU5OTQ1MTA1MjdkYzk0MTY5MC90YWJsZXJhbmdlOjE5ZjUzNDI4ZjI1NzRkNTk5NDUxMDUyN2RjOTQxNjkwXzUtNy0xLTEtMA_96f00829-f004-4151-88a0-3d2d98ff2f8b"
      unitRef="shares">352383</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="i580ea82051b046c086a55b23cbe96b48_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZToxOWY1MzQyOGYyNTc0ZDU5OTQ1MTA1MjdkYzk0MTY5MC90YWJsZXJhbmdlOjE5ZjUzNDI4ZjI1NzRkNTk5NDUxMDUyN2RjOTQxNjkwXzUtOS0xLTEtMA_915be9b6-4b6e-49f2-89bf-e2f9a79899d5"
      unitRef="usdPerShare">14.46</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <silk:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice
      contextRef="i4a6ce09ec8ba42acab7925c328fd9e56_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZToxOWY1MzQyOGYyNTc0ZDU5OTQ1MTA1MjdkYzk0MTY5MC90YWJsZXJhbmdlOjE5ZjUzNDI4ZjI1NzRkNTk5NDUxMDUyN2RjOTQxNjkwXzYtMC0xLTEtMC90ZXh0cmVnaW9uOmFlOTZjMGQ5M2Q0OTQ3MDM4NGNkMzk2ZDNkMTI5NGZjXzMyOTg1MzQ4ODMzNTM_91867fcd-2784-4021-a02f-f171acd00c40"
      unitRef="usdPerShare">36.47</silk:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice>
    <silk:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice
      contextRef="i36d7682595324850a7a7a098e56bcdd5_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZToxOWY1MzQyOGYyNTc0ZDU5OTQ1MTA1MjdkYzk0MTY5MC90YWJsZXJhbmdlOjE5ZjUzNDI4ZjI1NzRkNTk5NDUxMDUyN2RjOTQxNjkwXzYtMC0xLTEtMC90ZXh0cmVnaW9uOmFlOTZjMGQ5M2Q0OTQ3MDM4NGNkMzk2ZDNkMTI5NGZjXzMyOTg1MzQ4ODMzNjE_40fe5b5d-1869-46f9-aaeb-eb104974caec"
      unitRef="usdPerShare">48.53</silk:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i80e1df55cd6f4ff3a796ff102aa5ac3c_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZToxOWY1MzQyOGYyNTc0ZDU5OTQ1MTA1MjdkYzk0MTY5MC90YWJsZXJhbmdlOjE5ZjUzNDI4ZjI1NzRkNTk5NDUxMDUyN2RjOTQxNjkwXzYtMS0xLTEtMA_adaf0b67-39cb-40a6-abf3-8b7a598f0543"
      unitRef="shares">125866</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="ide54ca5d5c78499cb82e54623e321d1d_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZToxOWY1MzQyOGYyNTc0ZDU5OTQ1MTA1MjdkYzk0MTY5MC90YWJsZXJhbmdlOjE5ZjUzNDI4ZjI1NzRkNTk5NDUxMDUyN2RjOTQxNjkwXzYtMy0xLTEtMA_89a553fb-43ef-4087-a18e-3ad74f9e1c17">P9Y8M8D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i80e1df55cd6f4ff3a796ff102aa5ac3c_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZToxOWY1MzQyOGYyNTc0ZDU5OTQ1MTA1MjdkYzk0MTY5MC90YWJsZXJhbmdlOjE5ZjUzNDI4ZjI1NzRkNTk5NDUxMDUyN2RjOTQxNjkwXzYtNS0xLTEtMA_e1501d8e-d91e-4bc1-9ff8-b8c2fd4f4d48"
      unitRef="usdPerShare">40.50</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="i80e1df55cd6f4ff3a796ff102aa5ac3c_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZToxOWY1MzQyOGYyNTc0ZDU5OTQ1MTA1MjdkYzk0MTY5MC90YWJsZXJhbmdlOjE5ZjUzNDI4ZjI1NzRkNTk5NDUxMDUyN2RjOTQxNjkwXzYtNy0xLTEtMA_f4b2a959-1677-4657-b345-e619be783df7"
      unitRef="shares">9371</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="i80e1df55cd6f4ff3a796ff102aa5ac3c_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZToxOWY1MzQyOGYyNTc0ZDU5OTQ1MTA1MjdkYzk0MTY5MC90YWJsZXJhbmdlOjE5ZjUzNDI4ZjI1NzRkNTk5NDUxMDUyN2RjOTQxNjkwXzYtOS0xLTEtMA_83429a3c-af7c-4169-afd6-5f448e1696c8"
      unitRef="usdPerShare">45.57</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZToxOWY1MzQyOGYyNTc0ZDU5OTQ1MTA1MjdkYzk0MTY5MC90YWJsZXJhbmdlOjE5ZjUzNDI4ZjI1NzRkNTk5NDUxMDUyN2RjOTQxNjkwXzE0LTEtMS0xLTA_fd3f0eb3-814d-4b47-99be-b8747557299f"
      unitRef="shares">4310790</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZToxOWY1MzQyOGYyNTc0ZDU5OTQ1MTA1MjdkYzk0MTY5MC90YWJsZXJhbmdlOjE5ZjUzNDI4ZjI1NzRkNTk5NDUxMDUyN2RjOTQxNjkwXzE0LTMtMS0xLTA_4ff55030-019b-4d07-b116-caa596cfb5e6">P7Y3M7D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZToxOWY1MzQyOGYyNTc0ZDU5OTQ1MTA1MjdkYzk0MTY5MC90YWJsZXJhbmdlOjE5ZjUzNDI4ZjI1NzRkNTk5NDUxMDUyN2RjOTQxNjkwXzE0LTUtMS0xLTA_ea9a363f-1409-4a10-8d3b-dab2e68d1384"
      unitRef="usdPerShare">7.91</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZToxOWY1MzQyOGYyNTc0ZDU5OTQ1MTA1MjdkYzk0MTY5MC90YWJsZXJhbmdlOjE5ZjUzNDI4ZjI1NzRkNTk5NDUxMDUyN2RjOTQxNjkwXzE0LTctMS0xLTA_f651e8f0-9667-4483-bc33-b8dffd15940d"
      unitRef="shares">2514891</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZToxOWY1MzQyOGYyNTc0ZDU5OTQ1MTA1MjdkYzk0MTY5MC90YWJsZXJhbmdlOjE5ZjUzNDI4ZjI1NzRkNTk5NDUxMDUyN2RjOTQxNjkwXzE0LTktMS0xLTA_e865a109-97f2-41c1-9342-53f33b8df722"
      unitRef="usdPerShare">4.27</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="i7d7592590c814df5ad461b54e146b3b9_I20190331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90ZXh0cmVnaW9uOmY0Yzg3Yjg5ZmY2NzRjYTQ4ODFiZWU1MWY3YTk1NWExXzMyOTg1MzQ4OTQzOTk_62d3395e-a6f3-4d4a-b023-40fcc704afb1"
      unitRef="shares">434000</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <silk:ShareBasedCompensationArrangementBySharebasedPaymentAwardNumberOfAdditionalSharesAllowableUnderThePlan
      contextRef="i7d7592590c814df5ad461b54e146b3b9_I20190331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90ZXh0cmVnaW9uOmY0Yzg3Yjg5ZmY2NzRjYTQ4ODFiZWU1MWY3YTk1NWExXzMyOTg1MzQ4OTQ0MTA_2eab0b58-6e16-40c7-ac8a-02d75e0ad448"
      unitRef="shares">1200000</silk:ShareBasedCompensationArrangementBySharebasedPaymentAwardNumberOfAdditionalSharesAllowableUnderThePlan>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum
      contextRef="i9e2e6766734d4127a261bbe5ec027002_D20190301-20190331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90ZXh0cmVnaW9uOmY0Yzg3Yjg5ZmY2NzRjYTQ4ODFiZWU1MWY3YTk1NWExXzMyOTg1MzQ4OTQ0MTY_c83f2ae6-58e3-43c3-a784-c1938fe86e37"
      unitRef="number">0.010</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent
      contextRef="i9e2e6766734d4127a261bbe5ec027002_D20190301-20190331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90ZXh0cmVnaW9uOmY0Yzg3Yjg5ZmY2NzRjYTQ4ODFiZWU1MWY3YTk1NWExXzMyOTg1MzQ4OTQ0MjE_19c83a30-65eb-4cc4-afb7-13c8bcd0f092"
      unitRef="number">0.85</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="ib91f8a2aac654fce98f1b02f8c99f196_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90ZXh0cmVnaW9uOmY0Yzg3Yjg5ZmY2NzRjYTQ4ODFiZWU1MWY3YTk1NWExXzM4NDgyOTA3NTg3NzQ_65a75bba-ccb6-4cb9-81ec-68e1b235a682"
      unitRef="shares">61648000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="i8b3d2f66951844b589a808406d5fb193_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90ZXh0cmVnaW9uOmY0Yzg3Yjg5ZmY2NzRjYTQ4ODFiZWU1MWY3YTk1NWExXzM4NDgyOTA3NTg4MDc_e262c9e5-e349-4e6b-a710-47e5317a6b9b"
      unitRef="shares">372352000</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90ZXh0cmVnaW9uOmY0Yzg3Yjg5ZmY2NzRjYTQ4ODFiZWU1MWY3YTk1NWExXzIxOTkwMjMzNjA2Nzg_5a5b22df-446d-4203-9a8d-6bd0ccbaf3a2">The fair value of employee and nonemployee stock options was estimated using the following assumptions for the years ended December&#160;31, 2019 and 2018:&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:62.903%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:15.147%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:15.149%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Expected term (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"&gt;&lt;div style="text-align:center;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;5.00 - 6.25&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;div style="text-align:center;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;5.00 - 6.25&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div style="text-align:center;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;42.4% - 42.9%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div style="text-align:center;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;38.0% - 38.8%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div style="text-align:center;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;1.47% - 2.54%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div style="text-align:center;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;2.68% - 2.98%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;%&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;%&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The fair value of the shares to be issued under the Company&#x2019;s 2019 ESPP was estimated using the Black-Scholes valuation model with the following assumptions for the year ended December&#160;31, 2019:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;margin-bottom:9pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:73.961%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:21.238%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Year Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Expected term (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"&gt;&lt;div style="text-align:center;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;0.50 - 0.63&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div style="text-align:center;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;44.4% - 47.8%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div style="text-align:center;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;1.58% - 2.45%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;%&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i047616b3b96f40259dae391a81638613_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZTozYmVjNDY2MDk5YzY0ZmIxOTE0NTJjMzBjYTJmNWYwZC90YWJsZXJhbmdlOjNiZWM0NjYwOTljNjRmYjE5MTQ1MmMzMGNhMmY1ZjBkXzItMS0xLTEtMC90ZXh0cmVnaW9uOjQ4M2NlZTBkNzk4ZjRmNjI4ZGU1MGE4YTcwY2NlNzBmXzE5NzkxMjA5MzAwMDA1_e483108e-984c-45e5-97f4-1eb9f2165204">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i5fe1f6eae7624d96b5070b1632bdf4d3_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZTozYmVjNDY2MDk5YzY0ZmIxOTE0NTJjMzBjYTJmNWYwZC90YWJsZXJhbmdlOjNiZWM0NjYwOTljNjRmYjE5MTQ1MmMzMGNhMmY1ZjBkXzItMS0xLTEtMC90ZXh0cmVnaW9uOjQ4M2NlZTBkNzk4ZjRmNjI4ZGU1MGE4YTcwY2NlNzBmXzE5NzkxMjA5MzAwMDEx_9d000e66-fade-43c8-842e-395ec14d0d0f">P6Y3M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i10afc7fc69ce46cd8b9478e8ac0d56b0_D20180101-20181231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZTozYmVjNDY2MDk5YzY0ZmIxOTE0NTJjMzBjYTJmNWYwZC90YWJsZXJhbmdlOjNiZWM0NjYwOTljNjRmYjE5MTQ1MmMzMGNhMmY1ZjBkXzItMy0xLTEtMC90ZXh0cmVnaW9uOmYxM2VmZjFiMjdhZDQ0NWY4MDNhZDljZDhkNTQzZGI3XzE5NzkxMjA5Mjk5OTg3_6be1e7b4-3a16-4f36-ae4f-c766689e70da">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i0804bae1f65e4f6196a788f2e067af2c_D20180101-20181231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZTozYmVjNDY2MDk5YzY0ZmIxOTE0NTJjMzBjYTJmNWYwZC90YWJsZXJhbmdlOjNiZWM0NjYwOTljNjRmYjE5MTQ1MmMzMGNhMmY1ZjBkXzItMy0xLTEtMC90ZXh0cmVnaW9uOmYxM2VmZjFiMjdhZDQ0NWY4MDNhZDljZDhkNTQzZGI3XzE5NzkxMjA5Mjk5OTk5_ddde7a45-402f-4539-b09b-935950241949">P6Y3M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZTozYmVjNDY2MDk5YzY0ZmIxOTE0NTJjMzBjYTJmNWYwZC90YWJsZXJhbmdlOjNiZWM0NjYwOTljNjRmYjE5MTQ1MmMzMGNhMmY1ZjBkXzMtMS0xLTEtMC90ZXh0cmVnaW9uOmMyYTJlYjc5YzFmNDQ1ZmU4MjQ2NWVmNTg1NzFjM2Y0XzI3NDg3NzkwNjk0NjI_3a37ec16-5b17-4683-b274-6bd99f72f8fe"
      unitRef="number">0.424</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZTozYmVjNDY2MDk5YzY0ZmIxOTE0NTJjMzBjYTJmNWYwZC90YWJsZXJhbmdlOjNiZWM0NjYwOTljNjRmYjE5MTQ1MmMzMGNhMmY1ZjBkXzMtMS0xLTEtMC90ZXh0cmVnaW9uOmMyYTJlYjc5YzFmNDQ1ZmU4MjQ2NWVmNTg1NzFjM2Y0XzI3NDg3NzkwNjk0Njk_02f5d0a9-9fe0-4a46-887c-bf81ea12b6fe"
      unitRef="number">0.429</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
      contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZTozYmVjNDY2MDk5YzY0ZmIxOTE0NTJjMzBjYTJmNWYwZC90YWJsZXJhbmdlOjNiZWM0NjYwOTljNjRmYjE5MTQ1MmMzMGNhMmY1ZjBkXzMtMy0xLTEtMC90ZXh0cmVnaW9uOjE5MzJkZWNiZTQyODRkNmJiODYyNTY0MTZiZjE3NjEyXzI3NDg3NzkwNjk0NjI_56990614-7bf3-4be8-9ef6-1fb75e83acc1"
      unitRef="number">0.380</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
      contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZTozYmVjNDY2MDk5YzY0ZmIxOTE0NTJjMzBjYTJmNWYwZC90YWJsZXJhbmdlOjNiZWM0NjYwOTljNjRmYjE5MTQ1MmMzMGNhMmY1ZjBkXzMtMy0xLTEtMC90ZXh0cmVnaW9uOjE5MzJkZWNiZTQyODRkNmJiODYyNTY0MTZiZjE3NjEyXzI3NDg3NzkwNjk0Njk_06596320-3e94-4f02-a6dc-5938f495ed37"
      unitRef="number">0.388</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZTozYmVjNDY2MDk5YzY0ZmIxOTE0NTJjMzBjYTJmNWYwZC90YWJsZXJhbmdlOjNiZWM0NjYwOTljNjRmYjE5MTQ1MmMzMGNhMmY1ZjBkXzQtMS0xLTEtMC90ZXh0cmVnaW9uOjYyNjE2OTFjYjY0ODRiNzg5MjAwMTY1ZTk2ZmE5NzllXzI3NDg3NzkwNjk0NjI_72d5621b-63c1-4888-bd19-0339d784bac1"
      unitRef="number">0.0147</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZTozYmVjNDY2MDk5YzY0ZmIxOTE0NTJjMzBjYTJmNWYwZC90YWJsZXJhbmdlOjNiZWM0NjYwOTljNjRmYjE5MTQ1MmMzMGNhMmY1ZjBkXzQtMS0xLTEtMC90ZXh0cmVnaW9uOjYyNjE2OTFjYjY0ODRiNzg5MjAwMTY1ZTk2ZmE5NzllXzI3NDg3NzkwNjk0Njk_3b136740-c086-4e3f-a473-626781dc76cd"
      unitRef="number">0.0254</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
      contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZTozYmVjNDY2MDk5YzY0ZmIxOTE0NTJjMzBjYTJmNWYwZC90YWJsZXJhbmdlOjNiZWM0NjYwOTljNjRmYjE5MTQ1MmMzMGNhMmY1ZjBkXzQtMy0xLTEtMC90ZXh0cmVnaW9uOjg0NzU5NGQwNzA1MzQyYTNhNDc0MmRiNDY1YzVkZWNhXzI3NDg3NzkwNjk0NjI_25acd42d-3754-45a0-8b2f-8d5bd0dc51f8"
      unitRef="number">0.0268</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZTozYmVjNDY2MDk5YzY0ZmIxOTE0NTJjMzBjYTJmNWYwZC90YWJsZXJhbmdlOjNiZWM0NjYwOTljNjRmYjE5MTQ1MmMzMGNhMmY1ZjBkXzQtMy0xLTEtMC90ZXh0cmVnaW9uOjg0NzU5NGQwNzA1MzQyYTNhNDc0MmRiNDY1YzVkZWNhXzI3NDg3NzkwNjk0Njk_c4eeb8c4-d163-488b-8e35-f93ff9a6ca50"
      unitRef="number">0.0298</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZTozYmVjNDY2MDk5YzY0ZmIxOTE0NTJjMzBjYTJmNWYwZC90YWJsZXJhbmdlOjNiZWM0NjYwOTljNjRmYjE5MTQ1MmMzMGNhMmY1ZjBkXzUtMS0xLTEtMA_5ddde67e-44a2-4236-9915-2ccf1cf50eb7"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZTozYmVjNDY2MDk5YzY0ZmIxOTE0NTJjMzBjYTJmNWYwZC90YWJsZXJhbmdlOjNiZWM0NjYwOTljNjRmYjE5MTQ1MmMzMGNhMmY1ZjBkXzUtMy0xLTEtMA_2d7ef2e9-3818-44ba-8e3c-6519de493502"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i859497a16f11489db5d922955dbeed5d_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZTowMjE1OGQ2MWNjODU0MWZiODUyZDYwNmY0Yzc4MDc3OC90YWJsZXJhbmdlOjAyMTU4ZDYxY2M4NTQxZmI4NTJkNjA2ZjRjNzgwNzc4XzItMy0xLTEtMjUyMS90ZXh0cmVnaW9uOjAzOGY4OTZjYzkwYzRkYzViOGE3MDVjYjBiYjMzMmQ1XzIxOTkwMjMyNTU1NzE_269d7b70-fd8c-49e5-9138-af8eb1104715">P0Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i8918167e82b447cfb3b692315e36731e_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZTowMjE1OGQ2MWNjODU0MWZiODUyZDYwNmY0Yzc4MDc3OC90YWJsZXJhbmdlOjAyMTU4ZDYxY2M4NTQxZmI4NTJkNjA2ZjRjNzgwNzc4XzItMy0xLTEtMjUyMS90ZXh0cmVnaW9uOjAzOGY4OTZjYzkwYzRkYzViOGE3MDVjYjBiYjMzMmQ1XzIxOTkwMjMyNTU1Nzc_936ffba1-537e-4d0e-a0fd-8cbbedfc1142">P0Y7M17D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
      contextRef="ib91f8a2aac654fce98f1b02f8c99f196_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZTowMjE1OGQ2MWNjODU0MWZiODUyZDYwNmY0Yzc4MDc3OC90YWJsZXJhbmdlOjAyMTU4ZDYxY2M4NTQxZmI4NTJkNjA2ZjRjNzgwNzc4XzMtMy0xLTEtMjUyMS90ZXh0cmVnaW9uOjZkMWY3ZGRjMTc4MzRiOGM4YjI0NjcwNWNhNzBjZTk4XzE5NzkxMjA5Mjk5OTkw_2917a645-4298-4035-b9fb-41001ed6662b"
      unitRef="number">0.444</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
      contextRef="ib91f8a2aac654fce98f1b02f8c99f196_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZTowMjE1OGQ2MWNjODU0MWZiODUyZDYwNmY0Yzc4MDc3OC90YWJsZXJhbmdlOjAyMTU4ZDYxY2M4NTQxZmI4NTJkNjA2ZjRjNzgwNzc4XzMtMy0xLTEtMjUyMS90ZXh0cmVnaW9uOjZkMWY3ZGRjMTc4MzRiOGM4YjI0NjcwNWNhNzBjZTk4XzE5NzkxMjA5Mjk5OTk3_7ceff1f6-f72c-4031-8ba2-9cd9a3ae8218"
      unitRef="number">0.478</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
      contextRef="ib91f8a2aac654fce98f1b02f8c99f196_D20190101-20191231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZTowMjE1OGQ2MWNjODU0MWZiODUyZDYwNmY0Yzc4MDc3OC90YWJsZXJhbmdlOjAyMTU4ZDYxY2M4NTQxZmI4NTJkNjA2ZjRjNzgwNzc4XzQtMy0xLTEtMjUyMS90ZXh0cmVnaW9uOjdjYmE1MGVmNGY4YzRmYWFhOTgzOTYxNzcyZGM5MWEwXzE5NzkxMjA5Mjk5OTkw_bdea0b14-1476-40d1-94eb-6f6f1ff97ff9"
      unitRef="number">0.0158</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="ib91f8a2aac654fce98f1b02f8c99f196_D20190101-20191231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZTowMjE1OGQ2MWNjODU0MWZiODUyZDYwNmY0Yzc4MDc3OC90YWJsZXJhbmdlOjAyMTU4ZDYxY2M4NTQxZmI4NTJkNjA2ZjRjNzgwNzc4XzQtMy0xLTEtMjUyMS90ZXh0cmVnaW9uOjdjYmE1MGVmNGY4YzRmYWFhOTgzOTYxNzcyZGM5MWEwXzE5NzkxMjA5Mjk5OTk3_db3194b6-b302-4a91-8ae2-bdf5508f7ff0"
      unitRef="number">0.0245</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="ib91f8a2aac654fce98f1b02f8c99f196_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZTowMjE1OGQ2MWNjODU0MWZiODUyZDYwNmY0Yzc4MDc3OC90YWJsZXJhbmdlOjAyMTU4ZDYxY2M4NTQxZmI4NTJkNjA2ZjRjNzgwNzc4XzUtMy0xLTEtMjUyMQ_507b0a26-4da7-4b5e-8121-91e8c48fbb10"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90ZXh0cmVnaW9uOmY0Yzg3Yjg5ZmY2NzRjYTQ4ODFiZWU1MWY3YTk1NWExXzYyMDg_82c9b47a-b549-4c74-8f2f-b4c8d867e951">&lt;div style="margin-top:18pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Total stock-based compensation expense relating to the Company&#x2019;s stock options and 2019 ESPP during the years ended December&#160;31, 2019 and 2018, is as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;margin-bottom:9pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:69.314%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.942%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.943%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Cost of goods sold&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Research and development expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Selling, general and administrative expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,977&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;911&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i0ac3add721de4c95964529b527a87faf_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZToyY2I0YjgxYTA2ZWU0YThiYWI4NzQwNGQ5NzUyMDVlNi90YWJsZXJhbmdlOjJjYjRiODFhMDZlZTRhOGJhYjg3NDA0ZDk3NTIwNWU2XzItMS0xLTEtMA_694f5c7a-7524-4211-9ea9-3ffe88924d9d"
      unitRef="usd">179000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="if3367b49450540498cf774db610f6b6b_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZToyY2I0YjgxYTA2ZWU0YThiYWI4NzQwNGQ5NzUyMDVlNi90YWJsZXJhbmdlOjJjYjRiODFhMDZlZTRhOGJhYjg3NDA0ZDk3NTIwNWU2XzItMy0xLTEtMA_c4276ffe-d70c-4761-8f15-7cda35ef3476"
      unitRef="usd">51000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i053d16b53cd8429ca7577e64137c4073_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZToyY2I0YjgxYTA2ZWU0YThiYWI4NzQwNGQ5NzUyMDVlNi90YWJsZXJhbmdlOjJjYjRiODFhMDZlZTRhOGJhYjg3NDA0ZDk3NTIwNWU2XzMtMS0xLTEtMA_f2d77c37-7b69-4db1-b41c-f3d261e09a07"
      unitRef="usd">426000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ic9a24cc8c2884fee93b26726701eda19_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZToyY2I0YjgxYTA2ZWU0YThiYWI4NzQwNGQ5NzUyMDVlNi90YWJsZXJhbmdlOjJjYjRiODFhMDZlZTRhOGJhYjg3NDA0ZDk3NTIwNWU2XzMtMy0xLTEtMA_0257d33d-09e7-422d-9155-a379b0f01692"
      unitRef="usd">256000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="id2b8c23dfe7b4a01a7eab1d91fe07c43_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZToyY2I0YjgxYTA2ZWU0YThiYWI4NzQwNGQ5NzUyMDVlNi90YWJsZXJhbmdlOjJjYjRiODFhMDZlZTRhOGJhYjg3NDA0ZDk3NTIwNWU2XzQtMS0xLTEtMA_8284f75d-7752-4436-83b3-7840674f1275"
      unitRef="usd">2372000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i679bcaee6cf74e85907dc8a0359cf4fd_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZToyY2I0YjgxYTA2ZWU0YThiYWI4NzQwNGQ5NzUyMDVlNi90YWJsZXJhbmdlOjJjYjRiODFhMDZlZTRhOGJhYjg3NDA0ZDk3NTIwNWU2XzQtMy0xLTEtMA_7783071d-1530-4621-94d9-1dd7644988bb"
      unitRef="usd">604000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZToyY2I0YjgxYTA2ZWU0YThiYWI4NzQwNGQ5NzUyMDVlNi90YWJsZXJhbmdlOjJjYjRiODFhMDZlZTRhOGJhYjg3NDA0ZDk3NTIwNWU2XzUtMS0xLTEtMA_3e6821be-2f00-4277-bc7e-eeac4daef28c"
      unitRef="usd">2977000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90YWJsZToyY2I0YjgxYTA2ZWU0YThiYWI4NzQwNGQ5NzUyMDVlNi90YWJsZXJhbmdlOjJjYjRiODFhMDZlZTRhOGJhYjg3NDA0ZDk3NTIwNWU2XzUtMy0xLTEtMA_9d76e1c0-c22a-4827-9429-137fc4064da0"
      unitRef="usd">911000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90ZXh0cmVnaW9uOmY0Yzg3Yjg5ZmY2NzRjYTQ4ODFiZWU1MWY3YTk1NWExXzMyOTg1MzQ5Mzg3OTY_3442f2d9-934d-46e3-b5c4-939d6019015b"
      unitRef="usd">8539000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90ZXh0cmVnaW9uOmY0Yzg3Yjg5ZmY2NzRjYTQ4ODFiZWU1MWY3YTk1NWExXzMyOTg1MzQ5Mzg4MDY_2750c6e7-bd07-4268-8938-f0ab31d8bd76">P3Y14D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="i8b3d2f66951844b589a808406d5fb193_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90ZXh0cmVnaW9uOmY0Yzg3Yjg5ZmY2NzRjYTQ4ODFiZWU1MWY3YTk1NWExXzM4NDgyOTA3NTk5MTU_9d875858-57fb-43eb-83c0-9f7556e819c1"
      unitRef="usd">219000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="ib91f8a2aac654fce98f1b02f8c99f196_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNTcvZnJhZzpmNGM4N2I4OWZmNjc0Y2E0ODgxYmVlNTFmN2E5NTVhMS90ZXh0cmVnaW9uOmY0Yzg3Yjg5ZmY2NzRjYTQ4ODFiZWU1MWY3YTk1NWExXzM4NDgyOTA3NTk5Mjc_e4737f54-5bae-4dc2-a3c9-c8d2cfd9bcd2">P0Y4M20D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90ZXh0cmVnaW9uOjEwNmFlN2EyY2M2YzQxNzA4MTA3NjE0MjhhZDUwMTEwXzU5MTQ_3877fec8-00c0-44e1-877f-5d63ff8601be">Income Taxes&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The components of income before taxes are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:right;margin-bottom:9pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:69.314%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.942%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.943%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(52,415)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(37,630)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(52,415)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(37,630)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;A reconciliation of the statutory U.S. federal rate to the Company&#x2019;s effective tax rate is as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;margin-bottom:9pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:69.314%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.942%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.943%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Tax at federal statutory rate&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(11,007)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(7,902)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;State taxes, net of federal benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(2,270)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1,582)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Permanent differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(4,731)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;289&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Loss on Series C warrant liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5,330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Change in valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;12,797&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;6,197&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;General business credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(319)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Provision for income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:18pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The Company's provision for income taxes are included within other income (expense) on the statements of operations and comprehensive loss.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt;margin-bottom:9pt;"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Significant components of the Company&#x2019;s net deferred tax assets as of December&#160;31, 2019 and 2018 consist of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;margin-bottom:9pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:69.314%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.942%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.943%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Deferred tax assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Net operating loss carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;44,574&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;33,815&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Research and development credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,944&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Capitalized start-up costs/Intangibles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Accruals and reserves&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;568&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Operating lease liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;53,988&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;40,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Less:  Valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(53,126)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(40,300)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Deferred tax liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Operating lease asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(862)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(862)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Net deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:18pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In assessing the realizability of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized.  The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible.  Management believes it is more likely than not that the deferred tax assets will not be realized; accordingly, a valuation allowance has been established on U.S. net deferred tax assets.  The valuation allowance increased $12,826,000 during the year ended December&#160;31, 2019 and increased by $6,197,000 during the year ended December&#160;31, 2018.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;As of December&#160;31, 2019, the Company had net operating loss carryforwards of approximately $167,948,000 and $148,380,000 for federal and state income tax purposes, respectively.  The federal and state net operating loss carryforwards begin to expire in 2027 and 2028, respectively.  Federal NOL carryforwards generated in tax years beginning in 2018 are not subject to expiration.  Federal NOLs that arose on or after January 1, 2018 can be carried forward indefinitely against future income, but can only be used to offset a maximum of 80% of the Company's federal taxable income in any year.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The federal and state net operating loss carryforwards may be subject to significant limitations under Section 382 and Section 383 of the Internal Revenue Code and similar provisions under state law.  Federal tax legislation enacted in December 2017, commonly known as the Tax Cuts and Jobs Act, contains provisions that limit the federal net operating loss carryforwards that may be used in any given year in the event of special occurrences, including significant ownership changes.  A Section 382 &#x201c;ownership change&#x201d; generally occurs if one or more stockholders or groups of stockholders, who own at least 5% of the Company&#x2019;s stock, increase their ownership by more than 50 percentage points over their lowest ownership percentage within a rolling three-year period.  The Company may have previously experienced, and may in the future experience, one or more Section 382 &#x201c;ownership changes,&#x201d; including in connection with the Company&#x2019;s initial public offering.  If so, the Company may lose some or all of the tax benefits of its NOLs and tax credits.  The extent of such limitations for prior years, if any, has not yet been formally determined.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;At December&#160;31, 2019, the Company had $4,320,000 and $2,860,000 of federal and state research and development credit carryforwards, respectively.  If not utilized, the federal credits will expire beginning in 2027.  The California Research and Development credits can be carried forward indefinitely.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;As of December&#160;31, 2019, the Company had $1,436,000 of unrecognized tax benefits.  The Company does not have any tax positions for which it is reasonably possible that the total amount of gross unrecognized would increase or decrease within twelve months of the year ended December&#160;31, 2019. If recognized, $0 would affect the effective tax rate.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The Company recognizes interest and penalties related to uncertain tax positions in income tax expense.  There was no such expense recorded during the years ended December&#160;31, 2019 and 2018.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;A reconciliation of the unrecognized tax benefits from January 1, 2018 to December&#160;31, 2019 is as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;margin-bottom:9pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:69.314%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.942%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.943%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Balance at the beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Increases related to current years&#x2019; tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Increases/(decreases) related to prior years&#x2019; tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Balance at end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The Company currently has no federal or state tax examinations in progress nor has it had any federal or state tax examinations since its inception.  As a result of the Company&#x2019;s net operating loss carryforwards, all of its tax years are subject to federal and state tax examination.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90ZXh0cmVnaW9uOjEwNmFlN2EyY2M2YzQxNzA4MTA3NjE0MjhhZDUwMTEwXzU5MTU_09fd3ca0-c116-4828-be5d-e52f527dcbc7">&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The components of income before taxes are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:right;margin-bottom:9pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:69.314%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.942%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.943%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(52,415)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(37,630)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(52,415)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(37,630)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90YWJsZTpkOTk0NjBmZWM3OTc0OWZkYmY5OTgzOWYzZjJmZmU1Ny90YWJsZXJhbmdlOmQ5OTQ2MGZlYzc5NzQ5ZmRiZjk5ODM5ZjNmMmZmZTU3XzItMS0xLTEtMA_71cc7bab-9a62-4028-9b92-aa87fadfc1e4"
      unitRef="usd">-52415000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90YWJsZTpkOTk0NjBmZWM3OTc0OWZkYmY5OTgzOWYzZjJmZmU1Ny90YWJsZXJhbmdlOmQ5OTQ2MGZlYzc5NzQ5ZmRiZjk5ODM5ZjNmMmZmZTU3XzItMy0xLTEtMA_0e01511e-7c21-4773-bbca-b706bbc66eb4"
      unitRef="usd">-37630000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90YWJsZTpkOTk0NjBmZWM3OTc0OWZkYmY5OTgzOWYzZjJmZmU1Ny90YWJsZXJhbmdlOmQ5OTQ2MGZlYzc5NzQ5ZmRiZjk5ODM5ZjNmMmZmZTU3XzMtMS0xLTEtMA_41efc564-bb63-415d-885f-9e10bdc51ff8"
      unitRef="usd">0</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90YWJsZTpkOTk0NjBmZWM3OTc0OWZkYmY5OTgzOWYzZjJmZmU1Ny90YWJsZXJhbmdlOmQ5OTQ2MGZlYzc5NzQ5ZmRiZjk5ODM5ZjNmMmZmZTU3XzMtMy0xLTEtMA_27837327-9e36-4799-9f61-91d55dc13aef"
      unitRef="usd">0</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90YWJsZTpkOTk0NjBmZWM3OTc0OWZkYmY5OTgzOWYzZjJmZmU1Ny90YWJsZXJhbmdlOmQ5OTQ2MGZlYzc5NzQ5ZmRiZjk5ODM5ZjNmMmZmZTU3XzQtMS0xLTEtMA_93a47ef0-e732-445b-9edf-4da1c56ea1b9"
      unitRef="usd">-52415000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90YWJsZTpkOTk0NjBmZWM3OTc0OWZkYmY5OTgzOWYzZjJmZmU1Ny90YWJsZXJhbmdlOmQ5OTQ2MGZlYzc5NzQ5ZmRiZjk5ODM5ZjNmMmZmZTU3XzQtMy0xLTEtMA_e06d641e-c32c-4328-9ab9-149737fff0f9"
      unitRef="usd">-37630000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90ZXh0cmVnaW9uOjEwNmFlN2EyY2M2YzQxNzA4MTA3NjE0MjhhZDUwMTEwXzU5MTY_3c4444d6-4263-423c-929d-3c0b2fff4f70">&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;A reconciliation of the statutory U.S. federal rate to the Company&#x2019;s effective tax rate is as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;margin-bottom:9pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:69.314%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.942%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.943%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Tax at federal statutory rate&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(11,007)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(7,902)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;State taxes, net of federal benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(2,270)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1,582)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Permanent differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(4,731)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;289&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Loss on Series C warrant liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5,330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Change in valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;12,797&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;6,197&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;General business credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(319)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Provision for income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90YWJsZTozNjg0YTZhYmE2ZDE0MDYwOTJmYzM0YzAzZDQ3YzJkZS90YWJsZXJhbmdlOjM2ODRhNmFiYTZkMTQwNjA5MmZjMzRjMDNkNDdjMmRlXzItMS0xLTEtMA_a363256d-27d8-4271-bd4a-6cdb5c521455"
      unitRef="usd">-11007000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90YWJsZTozNjg0YTZhYmE2ZDE0MDYwOTJmYzM0YzAzZDQ3YzJkZS90YWJsZXJhbmdlOjM2ODRhNmFiYTZkMTQwNjA5MmZjMzRjMDNkNDdjMmRlXzItMy0xLTEtMA_431e1eb1-e2b0-4d61-a1e8-19a085e6cffa"
      unitRef="usd">-7902000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90YWJsZTozNjg0YTZhYmE2ZDE0MDYwOTJmYzM0YzAzZDQ3YzJkZS90YWJsZXJhbmdlOjM2ODRhNmFiYTZkMTQwNjA5MmZjMzRjMDNkNDdjMmRlXzMtMS0xLTEtMA_dc6a3e2d-8a28-4510-95bf-4fbc6f282c5a"
      unitRef="usd">-2270000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90YWJsZTozNjg0YTZhYmE2ZDE0MDYwOTJmYzM0YzAzZDQ3YzJkZS90YWJsZXJhbmdlOjM2ODRhNmFiYTZkMTQwNjA5MmZjMzRjMDNkNDdjMmRlXzMtMy0xLTEtMA_1c9e965a-392c-4f7e-8b60-5c2b84c531bd"
      unitRef="usd">-1582000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpense
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90YWJsZTozNjg0YTZhYmE2ZDE0MDYwOTJmYzM0YzAzZDQ3YzJkZS90YWJsZXJhbmdlOjM2ODRhNmFiYTZkMTQwNjA5MmZjMzRjMDNkNDdjMmRlXzQtMS0xLTEtMA_5012cb9e-8224-4f92-bc8e-35cfcbfc4c05"
      unitRef="usd">-4731000</us-gaap:IncomeTaxReconciliationNondeductibleExpense>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpense
      contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90YWJsZTozNjg0YTZhYmE2ZDE0MDYwOTJmYzM0YzAzZDQ3YzJkZS90YWJsZXJhbmdlOjM2ODRhNmFiYTZkMTQwNjA5MmZjMzRjMDNkNDdjMmRlXzQtMy0xLTEtMA_6d1c0d92-41b3-433c-b25a-f6b7d53c0976"
      unitRef="usd">289000</us-gaap:IncomeTaxReconciliationNondeductibleExpense>
    <silk:EffectiveIncomeTaxRateReconciliationWarrantLiabilityAdjustmentAmount
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90YWJsZTozNjg0YTZhYmE2ZDE0MDYwOTJmYzM0YzAzZDQ3YzJkZS90YWJsZXJhbmdlOjM2ODRhNmFiYTZkMTQwNjA5MmZjMzRjMDNkNDdjMmRlXzUtMS0xLTEtMA_c0fb733d-aede-4a71-a813-7696790cbe92"
      unitRef="usd">5330000</silk:EffectiveIncomeTaxRateReconciliationWarrantLiabilityAdjustmentAmount>
    <silk:EffectiveIncomeTaxRateReconciliationWarrantLiabilityAdjustmentAmount
      contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90YWJsZTozNjg0YTZhYmE2ZDE0MDYwOTJmYzM0YzAzZDQ3YzJkZS90YWJsZXJhbmdlOjM2ODRhNmFiYTZkMTQwNjA5MmZjMzRjMDNkNDdjMmRlXzUtMy0xLTEtMA_bbd03f06-a7ba-44ba-bfe2-2be4f32b8293"
      unitRef="usd">2500000</silk:EffectiveIncomeTaxRateReconciliationWarrantLiabilityAdjustmentAmount>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90YWJsZTozNjg0YTZhYmE2ZDE0MDYwOTJmYzM0YzAzZDQ3YzJkZS90YWJsZXJhbmdlOjM2ODRhNmFiYTZkMTQwNjA5MmZjMzRjMDNkNDdjMmRlXzctMS0xLTEtMA_9cb0fe0a-b3d9-4dd7-8bf8-b5b377266da2"
      unitRef="usd">12797000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90YWJsZTozNjg0YTZhYmE2ZDE0MDYwOTJmYzM0YzAzZDQ3YzJkZS90YWJsZXJhbmdlOjM2ODRhNmFiYTZkMTQwNjA5MmZjMzRjMDNkNDdjMmRlXzctMy0xLTEtMA_27dbe2f4-e3f6-4c99-afff-2cb4f8417809"
      unitRef="usd">6197000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationTaxCredits
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90YWJsZTozNjg0YTZhYmE2ZDE0MDYwOTJmYzM0YzAzZDQ3YzJkZS90YWJsZXJhbmdlOjM2ODRhNmFiYTZkMTQwNjA5MmZjMzRjMDNkNDdjMmRlXzgtMS0xLTEtMA_6ee59761-bac2-47cf-8ffd-ba3a3166aa19"
      unitRef="usd">319000</us-gaap:IncomeTaxReconciliationTaxCredits>
    <us-gaap:IncomeTaxReconciliationTaxCredits
      contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90YWJsZTozNjg0YTZhYmE2ZDE0MDYwOTJmYzM0YzAzZDQ3YzJkZS90YWJsZXJhbmdlOjM2ODRhNmFiYTZkMTQwNjA5MmZjMzRjMDNkNDdjMmRlXzgtMy0xLTEtMA_e5e26ad8-1e73-4618-aeef-ca382c5f3791"
      unitRef="usd">-136000</us-gaap:IncomeTaxReconciliationTaxCredits>
    <us-gaap:IncomeTaxReconciliationOtherReconcilingItems
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90YWJsZTozNjg0YTZhYmE2ZDE0MDYwOTJmYzM0YzAzZDQ3YzJkZS90YWJsZXJhbmdlOjM2ODRhNmFiYTZkMTQwNjA5MmZjMzRjMDNkNDdjMmRlXzktMS0xLTEtMA_9fb667f5-f677-4605-ab32-3f53fd0adaab"
      unitRef="usd">208000</us-gaap:IncomeTaxReconciliationOtherReconcilingItems>
    <us-gaap:IncomeTaxReconciliationOtherReconcilingItems
      contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90YWJsZTozNjg0YTZhYmE2ZDE0MDYwOTJmYzM0YzAzZDQ3YzJkZS90YWJsZXJhbmdlOjM2ODRhNmFiYTZkMTQwNjA5MmZjMzRjMDNkNDdjMmRlXzktMy0xLTEtMA_04a8aedb-aa5d-48e3-b8ba-c15031452cf3"
      unitRef="usd">376000</us-gaap:IncomeTaxReconciliationOtherReconcilingItems>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90YWJsZTozNjg0YTZhYmE2ZDE0MDYwOTJmYzM0YzAzZDQ3YzJkZS90YWJsZXJhbmdlOjM2ODRhNmFiYTZkMTQwNjA5MmZjMzRjMDNkNDdjMmRlXzEwLTEtMS0xLTA_5364846d-4813-4085-a0ec-46204facc847"
      unitRef="usd">8000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90YWJsZTozNjg0YTZhYmE2ZDE0MDYwOTJmYzM0YzAzZDQ3YzJkZS90YWJsZXJhbmdlOjM2ODRhNmFiYTZkMTQwNjA5MmZjMzRjMDNkNDdjMmRlXzEwLTMtMS0xLTA_80ee01cc-cfc6-4b25-901b-7b10a71704f8"
      unitRef="usd">14000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90ZXh0cmVnaW9uOjEwNmFlN2EyY2M2YzQxNzA4MTA3NjE0MjhhZDUwMTEwXzU5MTI_79be2884-52cd-439c-8e2b-1d1d05a103bb">&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Significant components of the Company&#x2019;s net deferred tax assets as of December&#160;31, 2019 and 2018 consist of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;margin-bottom:9pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:69.314%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.942%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.943%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Deferred tax assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Net operating loss carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;44,574&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;33,815&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Research and development credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,944&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Capitalized start-up costs/Intangibles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Accruals and reserves&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;568&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Operating lease liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;53,988&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;40,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Less:  Valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(53,126)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(40,300)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Deferred tax liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Operating lease asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(862)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(862)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Net deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90YWJsZTplZjllZjc1MWRlZDQ0ZTA0OGYwMTg2MGE2MWExN2Y3Yi90YWJsZXJhbmdlOmVmOWVmNzUxZGVkNDRlMDQ4ZjAxODYwYTYxYTE3ZjdiXzMtMS0xLTEtMA_94824926-3cb1-48ef-aa13-bd47eba305b9"
      unitRef="usd">44574000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90YWJsZTplZjllZjc1MWRlZDQ0ZTA0OGYwMTg2MGE2MWExN2Y3Yi90YWJsZXJhbmdlOmVmOWVmNzUxZGVkNDRlMDQ4ZjAxODYwYTYxYTE3ZjdiXzMtMy0xLTEtMA_432c8bb0-7fbf-484a-892e-da9fd0b6aac3"
      unitRef="usd">33815000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90YWJsZTplZjllZjc1MWRlZDQ0ZTA0OGYwMTg2MGE2MWExN2Y3Yi90YWJsZXJhbmdlOmVmOWVmNzUxZGVkNDRlMDQ4ZjAxODYwYTYxYTE3ZjdiXzQtMS0xLTEtMA_26ea60b9-9bc1-41bb-b3a4-432c29ed1699"
      unitRef="usd">5287000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch
      contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90YWJsZTplZjllZjc1MWRlZDQ0ZTA0OGYwMTg2MGE2MWExN2Y3Yi90YWJsZXJhbmdlOmVmOWVmNzUxZGVkNDRlMDQ4ZjAxODYwYTYxYTE3ZjdiXzQtMy0xLTEtMA_5a1b1074-b490-414b-8548-eb96cf431e46"
      unitRef="usd">4944000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch>
    <us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90YWJsZTplZjllZjc1MWRlZDQ0ZTA0OGYwMTg2MGE2MWExN2Y3Yi90YWJsZXJhbmdlOmVmOWVmNzUxZGVkNDRlMDQ4ZjAxODYwYTYxYTE3ZjdiXzUtMS0xLTEtMA_94752cf7-7dc0-40b8-b83d-b00239373a5c"
      unitRef="usd">11000</us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets>
    <us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets
      contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90YWJsZTplZjllZjc1MWRlZDQ0ZTA0OGYwMTg2MGE2MWExN2Y3Yi90YWJsZXJhbmdlOmVmOWVmNzUxZGVkNDRlMDQ4ZjAxODYwYTYxYTE3ZjdiXzUtMy0xLTEtMA_e97e2d85-43e5-4051-8693-8699ff4754d6"
      unitRef="usd">16000</us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90YWJsZTplZjllZjc1MWRlZDQ0ZTA0OGYwMTg2MGE2MWExN2Y3Yi90YWJsZXJhbmdlOmVmOWVmNzUxZGVkNDRlMDQ4ZjAxODYwYTYxYTE3ZjdiXzYtMS0xLTEtMA_73a38d54-924d-4cb9-b050-22d1c5030b32"
      unitRef="usd">2227000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
      contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90YWJsZTplZjllZjc1MWRlZDQ0ZTA0OGYwMTg2MGE2MWExN2Y3Yi90YWJsZXJhbmdlOmVmOWVmNzUxZGVkNDRlMDQ4ZjAxODYwYTYxYTE3ZjdiXzYtMy0xLTEtMA_d266ae22-faa0-466f-acdf-b646acbea988"
      unitRef="usd">1169000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals>
    <us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90YWJsZTplZjllZjc1MWRlZDQ0ZTA0OGYwMTg2MGE2MWExN2Y3Yi90YWJsZXJhbmdlOmVmOWVmNzUxZGVkNDRlMDQ4ZjAxODYwYTYxYTE3ZjdiXzctMS0xLTEtMA_3ff7f08c-dcf5-4441-bf41-35ea41a14e7d"
      unitRef="usd">188000</us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment
      contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90YWJsZTplZjllZjc1MWRlZDQ0ZTA0OGYwMTg2MGE2MWExN2Y3Yi90YWJsZXJhbmdlOmVmOWVmNzUxZGVkNDRlMDQ4ZjAxODYwYTYxYTE3ZjdiXzctMy0xLTEtMA_1f21855d-67e6-4c75-b4de-284c790347fb"
      unitRef="usd">82000</us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90YWJsZTplZjllZjc1MWRlZDQ0ZTA0OGYwMTg2MGE2MWExN2Y3Yi90YWJsZXJhbmdlOmVmOWVmNzUxZGVkNDRlMDQ4ZjAxODYwYTYxYTE3ZjdiXzgtMS0xLTEtMA_022cf173-d828-44c8-9d06-8384b5155d0d"
      unitRef="usd">568000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90YWJsZTplZjllZjc1MWRlZDQ0ZTA0OGYwMTg2MGE2MWExN2Y3Yi90YWJsZXJhbmdlOmVmOWVmNzUxZGVkNDRlMDQ4ZjAxODYwYTYxYTE3ZjdiXzgtMy0xLTEtMA_1f27f031-fb15-476f-828c-f626d92ce2df"
      unitRef="usd">274000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <silk:DeferredTaxAssetsOperatingLeaseLiability
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90YWJsZTplZjllZjc1MWRlZDQ0ZTA0OGYwMTg2MGE2MWExN2Y3Yi90YWJsZXJhbmdlOmVmOWVmNzUxZGVkNDRlMDQ4ZjAxODYwYTYxYTE3ZjdiXzktMS0xLTEtODY3OQ_7673f9c0-1c15-4d0d-8c97-da8da663271a"
      unitRef="usd">1133000</silk:DeferredTaxAssetsOperatingLeaseLiability>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90YWJsZTplZjllZjc1MWRlZDQ0ZTA0OGYwMTg2MGE2MWExN2Y3Yi90YWJsZXJhbmdlOmVmOWVmNzUxZGVkNDRlMDQ4ZjAxODYwYTYxYTE3ZjdiXzktMS0xLTEtMA_825dd3d2-2ea0-47d0-adc1-64c36908045b"
      unitRef="usd">53988000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90YWJsZTplZjllZjc1MWRlZDQ0ZTA0OGYwMTg2MGE2MWExN2Y3Yi90YWJsZXJhbmdlOmVmOWVmNzUxZGVkNDRlMDQ4ZjAxODYwYTYxYTE3ZjdiXzktMy0xLTEtMA_e5d2770c-ea61-483f-b579-c3d4d415fe83"
      unitRef="usd">40300000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90YWJsZTplZjllZjc1MWRlZDQ0ZTA0OGYwMTg2MGE2MWExN2Y3Yi90YWJsZXJhbmdlOmVmOWVmNzUxZGVkNDRlMDQ4ZjAxODYwYTYxYTE3ZjdiXzEwLTEtMS0xLTA_d51a2abe-b523-45f8-a66d-b696a504fe7a"
      unitRef="usd">53126000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90YWJsZTplZjllZjc1MWRlZDQ0ZTA0OGYwMTg2MGE2MWExN2Y3Yi90YWJsZXJhbmdlOmVmOWVmNzUxZGVkNDRlMDQ4ZjAxODYwYTYxYTE3ZjdiXzEwLTMtMS0xLTA_eb48f420-6f69-4bb6-a861-aa1a4c57e666"
      unitRef="usd">40300000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <silk:DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90YWJsZTplZjllZjc1MWRlZDQ0ZTA0OGYwMTg2MGE2MWExN2Y3Yi90YWJsZXJhbmdlOmVmOWVmNzUxZGVkNDRlMDQ4ZjAxODYwYTYxYTE3ZjdiXzEzLTEtMS0xLTg2OTg_1909678a-cfc2-4782-8ad0-3625f4f6a88f"
      unitRef="usd">862000</silk:DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90YWJsZTplZjllZjc1MWRlZDQ0ZTA0OGYwMTg2MGE2MWExN2Y3Yi90YWJsZXJhbmdlOmVmOWVmNzUxZGVkNDRlMDQ4ZjAxODYwYTYxYTE3ZjdiXzE0LTEtMS0xLTg2OTg_7f04fd58-983b-4bae-a409-1ed78cfcd025"
      unitRef="usd">862000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90YWJsZTplZjllZjc1MWRlZDQ0ZTA0OGYwMTg2MGE2MWExN2Y3Yi90YWJsZXJhbmdlOmVmOWVmNzUxZGVkNDRlMDQ4ZjAxODYwYTYxYTE3ZjdiXzE0LTMtMS0xLTg2OTg_75d03909-ff92-43de-a18c-06b97c34ff7e"
      unitRef="usd">0</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90YWJsZTplZjllZjc1MWRlZDQ0ZTA0OGYwMTg2MGE2MWExN2Y3Yi90YWJsZXJhbmdlOmVmOWVmNzUxZGVkNDRlMDQ4ZjAxODYwYTYxYTE3ZjdiXzExLTEtMS0xLTA_c96d9e37-0ec2-437f-a327-a50b9e14b517"
      unitRef="usd">0</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90YWJsZTplZjllZjc1MWRlZDQ0ZTA0OGYwMTg2MGE2MWExN2Y3Yi90YWJsZXJhbmdlOmVmOWVmNzUxZGVkNDRlMDQ4ZjAxODYwYTYxYTE3ZjdiXzExLTMtMS0xLTA_3e681890-124f-4369-b3be-253cf6c9ddeb"
      unitRef="usd">0</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90ZXh0cmVnaW9uOjEwNmFlN2EyY2M2YzQxNzA4MTA3NjE0MjhhZDUwMTEwXzMyOTg1MzQ4ODk2NDg_8c4e06dc-b549-424c-95b8-cd1df366b500"
      unitRef="usd">12826000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount
      contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90ZXh0cmVnaW9uOjEwNmFlN2EyY2M2YzQxNzA4MTA3NjE0MjhhZDUwMTEwXzMyOTg1MzQ4ODk2MzY_aa9e849a-f556-44ce-a9a6-096a8c3bb6bf"
      unitRef="usd">6197000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:OperatingLossCarryforwards
      contextRef="i7a5998ad299245269f1d4f24167005aa_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90ZXh0cmVnaW9uOjEwNmFlN2EyY2M2YzQxNzA4MTA3NjE0MjhhZDUwMTEwXzMyOTg1MzQ4ODk2NjI_64210714-3805-4357-b0ea-224955a344e0"
      unitRef="usd">167948000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="i67c3f66fec9c4c4387a07595b56bd76b_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90ZXh0cmVnaW9uOjEwNmFlN2EyY2M2YzQxNzA4MTA3NjE0MjhhZDUwMTEwXzMyOTg1MzQ4ODk2NzY_4ba22953-27a9-49b3-9bf1-1dd991be57c8"
      unitRef="usd">148380000</us-gaap:OperatingLossCarryforwards>
    <silk:OperatingLossCarryforwardOffsetMaximumPercent
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90ZXh0cmVnaW9uOjEwNmFlN2EyY2M2YzQxNzA4MTA3NjE0MjhhZDUwMTEwXzIxOTkwMjMyNjcyOTQ_f16e8c49-c725-4dbb-806a-4dac15e8e2a9"
      unitRef="number">0.80</silk:OperatingLossCarryforwardOffsetMaximumPercent>
    <us-gaap:TaxCreditCarryforwardAmount
      contextRef="if8375b4a63c74b3f9a8c71549841fb7e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90ZXh0cmVnaW9uOjEwNmFlN2EyY2M2YzQxNzA4MTA3NjE0MjhhZDUwMTEwXzMyOTg1MzQ4ODk2ODg_f2abc3dd-9943-4f6a-b994-3abb82ca4d58"
      unitRef="usd">4320000</us-gaap:TaxCreditCarryforwardAmount>
    <us-gaap:TaxCreditCarryforwardAmount
      contextRef="i7a626cb9bbb248679c22a7a00441bdd3_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90ZXh0cmVnaW9uOjEwNmFlN2EyY2M2YzQxNzA4MTA3NjE0MjhhZDUwMTEwXzMyOTg1MzQ4ODk3MDA_b2fab44d-8b9e-4331-ad36-d077c889a14d"
      unitRef="usd">2860000</us-gaap:TaxCreditCarryforwardAmount>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90ZXh0cmVnaW9uOjEwNmFlN2EyY2M2YzQxNzA4MTA3NjE0MjhhZDUwMTEwXzMyOTg1MzQ4ODk3MTI_6e59db40-c54a-4e96-828f-a97443f8ab2a"
      unitRef="usd">1436000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90ZXh0cmVnaW9uOjEwNmFlN2EyY2M2YzQxNzA4MTA3NjE0MjhhZDUwMTEwXzIxOTkwMjMyNjcyODE_d9aba9be-b7ac-44a2-8061-22ed9e18de1c"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
      contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90ZXh0cmVnaW9uOjEwNmFlN2EyY2M2YzQxNzA4MTA3NjE0MjhhZDUwMTEwXzIxOTkwMjMyNjcyODQ_0a50cc26-c481-4efb-b557-d24b067f99b7"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90ZXh0cmVnaW9uOjEwNmFlN2EyY2M2YzQxNzA4MTA3NjE0MjhhZDUwMTEwXzIxOTkwMjMyNjcyODQ_5fbac096-7d5e-4fe6-a2d6-9fb2ec44e69b"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense>
    <us-gaap:SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90ZXh0cmVnaW9uOjEwNmFlN2EyY2M2YzQxNzA4MTA3NjE0MjhhZDUwMTEwXzU5MTM_a4b85e83-89c9-456a-89a8-84c9a859a838">&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;A reconciliation of the unrecognized tax benefits from January 1, 2018 to December&#160;31, 2019 is as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;margin-bottom:9pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:69.314%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.942%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.943%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Balance at the beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Increases related to current years&#x2019; tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Increases/(decreases) related to prior years&#x2019; tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Balance at end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90YWJsZToxYzQzNTcxZjQxNDA0NTkzYTgwNjU2MzJiYjBjN2UwOS90YWJsZXJhbmdlOjFjNDM1NzFmNDE0MDQ1OTNhODA2NTYzMmJiMGM3ZTA5XzItMS0xLTEtMA_684f3b27-15e2-4dca-9177-b847eb49b22f"
      unitRef="usd">1348000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i517a0560ef9f4f6a822a0a124dd39744_I20171231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90YWJsZToxYzQzNTcxZjQxNDA0NTkzYTgwNjU2MzJiYjBjN2UwOS90YWJsZXJhbmdlOjFjNDM1NzFmNDE0MDQ1OTNhODA2NTYzMmJiMGM3ZTA5XzItMy0xLTEtMA_7fd3ff8f-8104-40c4-bdf5-613f61ba96c9"
      unitRef="usd">615000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90YWJsZToxYzQzNTcxZjQxNDA0NTkzYTgwNjU2MzJiYjBjN2UwOS90YWJsZXJhbmdlOjFjNDM1NzFmNDE0MDQ1OTNhODA2NTYzMmJiMGM3ZTA5XzMtMS0xLTEtMA_ef25ccec-3c9f-4d99-921a-dcc59387dabf"
      unitRef="usd">88000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90YWJsZToxYzQzNTcxZjQxNDA0NTkzYTgwNjU2MzJiYjBjN2UwOS90YWJsZXJhbmdlOjFjNDM1NzFmNDE0MDQ1OTNhODA2NTYzMmJiMGM3ZTA5XzMtMy0xLTEtMA_93cd0e38-6675-4140-8456-17bbb42c4137"
      unitRef="usd">118000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90YWJsZToxYzQzNTcxZjQxNDA0NTkzYTgwNjU2MzJiYjBjN2UwOS90YWJsZXJhbmdlOjFjNDM1NzFmNDE0MDQ1OTNhODA2NTYzMmJiMGM3ZTA5XzQtMS0xLTEtMA_44f9e0b7-5332-416f-afdc-342cedbd6607"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="i64541b4a073e4ea798f842f64b83bbf0_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90YWJsZToxYzQzNTcxZjQxNDA0NTkzYTgwNjU2MzJiYjBjN2UwOS90YWJsZXJhbmdlOjFjNDM1NzFmNDE0MDQ1OTNhODA2NTYzMmJiMGM3ZTA5XzQtMy0xLTEtMA_c965523e-c235-4cee-abf9-600934290540"
      unitRef="usd">615000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i67c494a371a04303ae82b13756a123f9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90YWJsZToxYzQzNTcxZjQxNDA0NTkzYTgwNjU2MzJiYjBjN2UwOS90YWJsZXJhbmdlOjFjNDM1NzFmNDE0MDQ1OTNhODA2NTYzMmJiMGM3ZTA5XzUtMS0xLTEtMA_eacd9df6-8740-4294-8ab0-f7724d8e1efa"
      unitRef="usd">1436000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjMvZnJhZzoxMDZhZTdhMmNjNmM0MTcwODEwNzYxNDI4YWQ1MDExMC90YWJsZToxYzQzNTcxZjQxNDA0NTkzYTgwNjU2MzJiYjBjN2UwOS90YWJsZXJhbmdlOjFjNDM1NzFmNDE0MDQ1OTNhODA2NTYzMmJiMGM3ZTA5XzUtMy0xLTEtMA_4815116f-db42-427a-a0f8-e4bd8a33ad02"
      unitRef="usd">1348000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:BusinessCombinationDisclosureTextBlock
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjkvZnJhZzo3ZGZhMTkxN2ZiNDE0OTFiYjVhNjQ5NjhjNDg1MjFhMC90ZXh0cmVnaW9uOjdkZmExOTE3ZmI0MTQ5MWJiNWE2NDk2OGM0ODUyMWEwXzQyMDc_314c66a0-3e08-4d0a-98ff-75a3e1170ded">Acquisition of Variable Interest Entity - NeuroCo&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In December&#160;2014, the Board of Directors of the Company approved the sale of certain intellectual property of Silk Road Medical, Inc., to a newly incorporated entity, NeuroCo, Inc.  In consideration for the intellectual property, a promissory note was executed between the two parties for the principal sum of $498,000 with an interest rate of 2.74% per annum, payable on the earlier of 10 years from the date of promissory note, or upon the occurrence of an event of default.  The intellectual property transfer was recorded at its carrying value of zero as of December&#160;31, 2014.  During 2015 NeuroCo issued $154,000 in common stock to stockholders of the Company.  During the year ended December 31, 2018, NeuroCo issued common stock upon the exercise of stock options.  These common stock issuance amounts, as they are related to non-controlling investors, were reported as non-controlling interests in subsidiary in the Company&#x2019;s financial statements and are offset by NeuroCo losses consolidated by the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Additionally, NeuroCo incurred research and development related expenses paid for by the Company which were added in to the original promissory note.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The Company had identified NeuroCo as a VIE of which the Company is the primary beneficiary.  Pursuant to the accounting guidance for consolidating VIEs the main consideration was given to the fact that the amount of total equity investment at risk is not sufficient to permit NeuroCo to finance its activities without additional subordinated financial support.  Additionally, NeuroCo and Silk Road Medical had the same Board of Directors and senior management composition, determining the Company to have the power to direct the activities that most significantly impact NeuroCo&#x2019;s economic performance and the obligation to absorb losses and the right to receive benefits.  Accordingly, the financial results of NeuroCo were included in the Company&#x2019;s financial statements.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;On December 17, 2018, the Company and NeuroCo entered into the Agreement and Plan of Merger (the &#x201c;Merger Agreement&#x201d;) pursuant to which the Company acquired all assets and assumed all liabilities of NeuroCo (the &#x201c;Merger&#x201d;).  The Merger closed on the same day (the &#x201c;Closing&#x201d;) and was consummated through a stock-for-stock transaction based on the relative values of the Company&#x2019;s and NeuroCo&#x2019;s equity.  In consideration for 100% equity interest of NeuroCo, the Company issued 33,462 shares of its common stock and the above promissory note in the amount of approximately $1,600,000 as of the Closing was settled and canceled.  As a result of the Merger, NeuroCo merged into the Company with the Company being the surviving corporation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;As the Company already controlled and consolidated NeuroCo and retained the control over NeuroCo&#x2019;s business after the Merger, the Company accounted for the acquisition of equity interest in NeuroCo as an equity transaction.  Therefore, the Company did not recognize a gain or loss in its net loss or comprehensive loss for acquisition of NeuroCo.  As the carrying amount of the non-controlling interest as of the Closing was zero, the Company recorded the consideration paid as a decrease to the Company&#x2019;s additional paid-in capital within stockholder&#x2019;s equity (deficit). &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;As part of the Merger, the Company assumed NeuroCo&#x2019;s 2015 Equity Incentive Plan (the &#x201c;NeuroCo Plan&#x201d;) along with all of NeuroCo&#x2019;s rights and obligations under the NeuroCo Plan, except that the number of shares and exercise price of the assumed options have been adjusted based on the Merger exchange ratio of the Company&#x2019;s common stock and NeuroCo&#x2019;s common stock.  Similarly, the Company assumed outstanding warrants to purchase NeuroCo&#x2019;s common stock such that the number of shares and exercise price of the assumed warrants have been adjusted based on the Merger exchange ratio of the Company&#x2019;s common stock and NeuroCo&#x2019;s common stock.  The options and warrants to purchase shares of the Company&#x2019;s common stock were fully vested upon issuance, as they were replacing fully vested options and warrants to purchase NeuroCo common stock.&lt;/span&gt;&lt;/div&gt;</us-gaap:BusinessCombinationDisclosureTextBlock>
    <us-gaap:NotesReceivableRelatedParties
      contextRef="i43fdc98e9d1c4ea183dc2c37ade70da5_I20141231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjkvZnJhZzo3ZGZhMTkxN2ZiNDE0OTFiYjVhNjQ5NjhjNDg1MjFhMC90ZXh0cmVnaW9uOjdkZmExOTE3ZmI0MTQ5MWJiNWE2NDk2OGM0ODUyMWEwXzMyOTg1MzQ4ODc2MTk_2ae30c01-9be3-483e-b3d0-7e4226914b77"
      unitRef="usd">498000</us-gaap:NotesReceivableRelatedParties>
    <silk:NotesReceivableRelatedPartiesInterestRateStatedPercentage
      contextRef="i43fdc98e9d1c4ea183dc2c37ade70da5_I20141231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjkvZnJhZzo3ZGZhMTkxN2ZiNDE0OTFiYjVhNjQ5NjhjNDg1MjFhMC90ZXh0cmVnaW9uOjdkZmExOTE3ZmI0MTQ5MWJiNWE2NDk2OGM0ODUyMWEwXzMyOTg1MzQ4ODc2MjM_b71b6006-d3de-429e-a9b9-f740e9bc4ccd"
      unitRef="number">0.0274</silk:NotesReceivableRelatedPartiesInterestRateStatedPercentage>
    <silk:NotesReceivableRelatedPartiesTerm
      contextRef="ic91bbe5141184edf9c4a395e69721932_D20140101-20141231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjkvZnJhZzo3ZGZhMTkxN2ZiNDE0OTFiYjVhNjQ5NjhjNDg1MjFhMC90ZXh0cmVnaW9uOjdkZmExOTE3ZmI0MTQ5MWJiNWE2NDk2OGM0ODUyMWEwXzMyOTg1MzQ4ODc2Mjc_d21e91c2-eebe-4425-aae5-520d21715ece">P10Y</silk:NotesReceivableRelatedPartiesTerm>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i0e7714d1fef74572b8628cbea233e040_D20150101-20151231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjkvZnJhZzo3ZGZhMTkxN2ZiNDE0OTFiYjVhNjQ5NjhjNDg1MjFhMC90ZXh0cmVnaW9uOjdkZmExOTE3ZmI0MTQ5MWJiNWE2NDk2OGM0ODUyMWEwXzMyOTg1MzQ4ODc2MzE_e4beaf46-2a72-43bf-a7ad-358ecc9d9b24"
      unitRef="usd">154000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="iaf615eabb3f14a45afa67326aa12db72_I20181217"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjkvZnJhZzo3ZGZhMTkxN2ZiNDE0OTFiYjVhNjQ5NjhjNDg1MjFhMC90ZXh0cmVnaW9uOjdkZmExOTE3ZmI0MTQ5MWJiNWE2NDk2OGM0ODUyMWEwXzMyOTg1MzQ4ODc2MzU_96f82791-6590-4a39-96b8-d78a06e2f330"
      unitRef="number">1</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="if64e9115ac9b48a7b91422658f25ee6d_D20181217-20181217"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjkvZnJhZzo3ZGZhMTkxN2ZiNDE0OTFiYjVhNjQ5NjhjNDg1MjFhMC90ZXh0cmVnaW9uOjdkZmExOTE3ZmI0MTQ5MWJiNWE2NDk2OGM0ODUyMWEwXzMyOTg1MzQ4ODc2Mzk_9634af5d-0665-4f9d-aafb-30748d6f6538"
      unitRef="shares">33462</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <silk:BusinessCombinationConsiderationTransferredNotesPayableForgiven
      contextRef="if64e9115ac9b48a7b91422658f25ee6d_D20181217-20181217"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjkvZnJhZzo3ZGZhMTkxN2ZiNDE0OTFiYjVhNjQ5NjhjNDg1MjFhMC90ZXh0cmVnaW9uOjdkZmExOTE3ZmI0MTQ5MWJiNWE2NDk2OGM0ODUyMWEwXzMyOTg1MzQ4ODc2NDM_0756d3c2-0744-4f69-9fd0-e8e2e95d8c85"
      unitRef="usd">1600000</silk:BusinessCombinationConsiderationTransferredNotesPayableForgiven>
    <us-gaap:NoncontrollingInterestInVariableInterestEntity
      contextRef="i129f46ce6e8d4fa98d362bb8455a8c28_I20181217"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNjkvZnJhZzo3ZGZhMTkxN2ZiNDE0OTFiYjVhNjQ5NjhjNDg1MjFhMC90ZXh0cmVnaW9uOjdkZmExOTE3ZmI0MTQ5MWJiNWE2NDk2OGM0ODUyMWEwXzMyOTg1MzQ4ODc2NDc_512958bc-b42f-4f52-8f10-1cd924938ffd"
      unitRef="usd">0</us-gaap:NoncontrollingInterestInVariableInterestEntity>
    <us-gaap:DefinedContributionPlanDisclosuresTableTextBlock
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNzIvZnJhZzo4Y2ZkNzk1ODRhOGI0MWQ3YTI3Mjg0Y2IwNjI5ZDY1Zi90ZXh0cmVnaW9uOjhjZmQ3OTU4NGE4YjQxZDdhMjcyODRjYjA2MjlkNjVmXzQ5NA_8b453eec-db4a-42b2-87e1-1a650a98dc0b">401(k) PlanThe Company has a qualified retirement plan under section&#160;401(k)&#160;of the Internal Revenue Code (&#x201c;IRC&#x201d;) under which participants may contribute up to 90% of their eligible compensation, subject to maximum deferral limits specified by the IRC.  The Company may make a discretionary matching contribution to the 401(k)&#160;plan and may make a discretionary employer contribution to each eligible employee each year.  Through December 31, 2019, the Company has made no contributions to the 401(k)&#160;plan.  Beginning in January 2020, the Company started matching employees' contributions to the 401(k) plan at 50% of the first 5% of compensation deferred to the 401(k) plan.</us-gaap:DefinedContributionPlanDisclosuresTableTextBlock>
    <us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNzIvZnJhZzo4Y2ZkNzk1ODRhOGI0MWQ3YTI3Mjg0Y2IwNjI5ZDY1Zi90ZXh0cmVnaW9uOjhjZmQ3OTU4NGE4YjQxZDdhMjcyODRjYjA2MjlkNjVmXzMyOTg1MzQ4ODQyNjY_f90d57f3-acec-461d-b410-eff13c93bd79"
      unitRef="number">0.90</us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent>
    <us-gaap:DefinedContributionPlanCostRecognized
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNzIvZnJhZzo4Y2ZkNzk1ODRhOGI0MWQ3YTI3Mjg0Y2IwNjI5ZDY1Zi90ZXh0cmVnaW9uOjhjZmQ3OTU4NGE4YjQxZDdhMjcyODRjYjA2MjlkNjVmXzMyOTg1MzQ4ODQyNzA_710e3ee9-3af2-452c-8605-34f3f465f5da"
      unitRef="usd">0</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
      contextRef="ie7d5bfb4355c4753b62069b31a28328b_D20200101-20200101"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNzIvZnJhZzo4Y2ZkNzk1ODRhOGI0MWQ3YTI3Mjg0Y2IwNjI5ZDY1Zi90ZXh0cmVnaW9uOjhjZmQ3OTU4NGE4YjQxZDdhMjcyODRjYjA2MjlkNjVmXzMyOTg1MzQ4ODQyNzU_ae1cd68d-ea56-4c34-960b-8d85ff63e83e"
      unitRef="number">0.50</us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch>
    <us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent
      contextRef="ie7d5bfb4355c4753b62069b31a28328b_D20200101-20200101"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNzIvZnJhZzo4Y2ZkNzk1ODRhOGI0MWQ3YTI3Mjg0Y2IwNjI5ZDY1Zi90ZXh0cmVnaW9uOjhjZmQ3OTU4NGE4YjQxZDdhMjcyODRjYjA2MjlkNjVmXzMyOTg1MzQ4ODQyNzk_d472f25c-ecb0-43dd-ab76-17aa6d6c1942"
      unitRef="number">0.05</us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent>
    <us-gaap:SubsequentEventsTextBlock
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNzUvZnJhZzoyOTlmMWJjYmUyMGQ0YTY4YTE4OWQyYWM3YTM0MDJmYi90ZXh0cmVnaW9uOjI5OWYxYmNiZTIwZDRhNjhhMTg5ZDJhYzdhMzQwMmZiXzE0NTI_c16b95ee-8f5d-49f3-9f58-80fc8576de11">Subsequent Events&lt;div style="margin-bottom:9pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;2019 Equity Incentive Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In January 2020, the number of shares of common stock authorized for issuance under the 2019 Plan was automatically increased by 1,250,210 shares, which was ratified by the Company's Board of Directors in February 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In February 2020, the Company&#x2019;s Board of Directors approved the grant of options to purchase 92,885 shares of common stock under the 2019 Plan with an exercise price of $47.20 per share. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;2019 Employee Stock Purchase Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In January 2020, the number of shares of common stock authorized for issuance under the 2019 ESPP was automatically increased by 312,552 shares, which was ratified by the Company's Board of Directors  in February 2020.&lt;/span&gt;&lt;/div&gt;</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="if8352f2dec42436aa6815358749e14c2_I20200131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNzUvZnJhZzoyOTlmMWJjYmUyMGQ0YTY4YTE4OWQyYWM3YTM0MDJmYi90ZXh0cmVnaW9uOjI5OWYxYmNiZTIwZDRhNjhhMTg5ZDJhYzdhMzQwMmZiXzMyOTg1MzQ4ODc5NDI_5d8f80ad-6685-4398-ad7b-8c2c317ea025"
      unitRef="shares">1250210</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i8e407444496e48f09abc6f0747a028bc_D20200201-20200229"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNzUvZnJhZzoyOTlmMWJjYmUyMGQ0YTY4YTE4OWQyYWM3YTM0MDJmYi90ZXh0cmVnaW9uOjI5OWYxYmNiZTIwZDRhNjhhMTg5ZDJhYzdhMzQwMmZiXzMyOTg1MzQ4ODc5NTk_5ff0ad5f-0d59-46f5-be4a-c634056188e0"
      unitRef="shares">92885</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="i8e407444496e48f09abc6f0747a028bc_D20200201-20200229"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNzUvZnJhZzoyOTlmMWJjYmUyMGQ0YTY4YTE4OWQyYWM3YTM0MDJmYi90ZXh0cmVnaW9uOjI5OWYxYmNiZTIwZDRhNjhhMTg5ZDJhYzdhMzQwMmZiXzMyOTg1MzQ4ODc5NjY_8eab6619-694b-442a-b7b8-10f71cfe20d0"
      unitRef="usdPerShare">47.20</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="i36441150a0d742e990ee101edcbe8518_I20200131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xNzUvZnJhZzoyOTlmMWJjYmUyMGQ0YTY4YTE4OWQyYWM3YTM0MDJmYi90ZXh0cmVnaW9uOjI5OWYxYmNiZTIwZDRhNjhhMTg5ZDJhYzdhMzQwMmZiXzMyOTg1MzQ4ODc5NTE_ce40f68f-9f3b-45be-92c8-cdbd84e71920"
      unitRef="shares">312552</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:QuarterlyFinancialInformationTextBlock
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8zMzU0L2ZyYWc6ODkzMGUxMjE0YjY0NDQ5YjhhOTZlYzc4OGU4OTg2NTgvdGV4dHJlZ2lvbjo4OTMwZTEyMTRiNjQ0NDliOGE5NmVjNzg4ZTg5ODY1OF8yMTk5MDIzMjU2Mjgx_3e15fde5-63be-4c65-8130-79c5c91b174f">Quarterly Financial Information (unaudited)&lt;div style="margin-bottom:9pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The following table provides selected unaudited quarterly financial data for the years ended December&#160;31, 2019 and 2018 (in thousands, except per share data):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:40.467%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.441%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.262%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.441%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:13.544%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.441%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:10.019%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:10.984%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="21" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;September 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;June 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;March 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;18,634&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;17,026&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;14,928&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;12,766&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Gross profit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;13,913&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;12,856&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;11,231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9,427&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(8,291)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(8,007)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(11,959)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(24,158)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Net loss per share, basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.27)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.26)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.42)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(20.12)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:18pt;margin-bottom:9pt;"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:40.788%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.441%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.621%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.441%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:14.025%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.441%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:10.820%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.441%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:10.182%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="21" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;September 30, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;June 30, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;March 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;11,470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9,614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;7,767&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5,706&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Gross profit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;7,803&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;6,732&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5,376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,772&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(15,618)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(8,953)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(7,651)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(5,408)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Net loss per share, basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(14.12)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(8.49)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(8.16)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(7.31)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:QuarterlyFinancialInformationTextBlock>
    <us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock
      contextRef="i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8zMzU0L2ZyYWc6ODkzMGUxMjE0YjY0NDQ5YjhhOTZlYzc4OGU4OTg2NTgvdGV4dHJlZ2lvbjo4OTMwZTEyMTRiNjQ0NDliOGE5NmVjNzg4ZTg5ODY1OF8yMTk5MDIzMjU2Mjg0_3854cdf1-5864-4c79-a733-7b131aa27329">&lt;div style="margin-bottom:9pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The following table provides selected unaudited quarterly financial data for the years ended December&#160;31, 2019 and 2018 (in thousands, except per share data):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:40.467%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.441%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.262%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.441%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:13.544%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.441%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:10.019%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:10.984%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="21" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;September 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;June 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;March 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;18,634&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;17,026&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;14,928&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;12,766&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Gross profit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;13,913&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;12,856&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;11,231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9,427&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(8,291)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(8,007)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(11,959)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(24,158)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Net loss per share, basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.27)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.26)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.42)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(20.12)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:18pt;margin-bottom:9pt;"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:40.788%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.441%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.621%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.441%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:14.025%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.441%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:10.820%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.441%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:10.182%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="21" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;September 30, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;June 30, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;March 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;11,470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9,614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;7,767&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5,706&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Gross profit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;7,803&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;6,732&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5,376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,772&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(15,618)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(8,953)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(7,651)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(5,408)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Net loss per share, basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(14.12)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(8.49)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(8.16)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(7.31)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4e27136927b743769274f523ec2a41e7_D20191001-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8zMzU0L2ZyYWc6ODkzMGUxMjE0YjY0NDQ5YjhhOTZlYzc4OGU4OTg2NTgvdGFibGU6YzVjNGNhMjA4ODAwNDM2NTkzMWNmMTEwNGYyYjQyNjkvdGFibGVyYW5nZTpjNWM0Y2EyMDg4MDA0MzY1OTMxY2YxMTA0ZjJiNDI2OV8yLTItMS0xLTM3NjE_dc102c1a-8b91-4d68-a623-0cad678b4881"
      unitRef="usd">18634000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icd407c3335324384be91497048cf5f08_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8zMzU0L2ZyYWc6ODkzMGUxMjE0YjY0NDQ5YjhhOTZlYzc4OGU4OTg2NTgvdGFibGU6YzVjNGNhMjA4ODAwNDM2NTkzMWNmMTEwNGYyYjQyNjkvdGFibGVyYW5nZTpjNWM0Y2EyMDg4MDA0MzY1OTMxY2YxMTA0ZjJiNDI2OV8yLTQtMS0xLTM3NjE_808be4a7-3141-46a6-baf7-758a37e61d49"
      unitRef="usd">17026000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i88f7bdc9a6e24592abadfd8d6f1e1bc0_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8zMzU0L2ZyYWc6ODkzMGUxMjE0YjY0NDQ5YjhhOTZlYzc4OGU4OTg2NTgvdGFibGU6YzVjNGNhMjA4ODAwNDM2NTkzMWNmMTEwNGYyYjQyNjkvdGFibGVyYW5nZTpjNWM0Y2EyMDg4MDA0MzY1OTMxY2YxMTA0ZjJiNDI2OV8yLTYtMS0xLTM3NjE_649d8255-627d-483c-9738-0a57be3a2157"
      unitRef="usd">14928000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie6ccdb76509c4f75a0d36602c75f6151_D20190101-20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8zMzU0L2ZyYWc6ODkzMGUxMjE0YjY0NDQ5YjhhOTZlYzc4OGU4OTg2NTgvdGFibGU6YzVjNGNhMjA4ODAwNDM2NTkzMWNmMTEwNGYyYjQyNjkvdGFibGVyYW5nZTpjNWM0Y2EyMDg4MDA0MzY1OTMxY2YxMTA0ZjJiNDI2OV8yLTgtMS0xLTM3NjE_081e0cd5-595a-4b50-b5e4-aa39e602362b"
      unitRef="usd">12766000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:GrossProfit
      contextRef="i4e27136927b743769274f523ec2a41e7_D20191001-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8zMzU0L2ZyYWc6ODkzMGUxMjE0YjY0NDQ5YjhhOTZlYzc4OGU4OTg2NTgvdGFibGU6YzVjNGNhMjA4ODAwNDM2NTkzMWNmMTEwNGYyYjQyNjkvdGFibGVyYW5nZTpjNWM0Y2EyMDg4MDA0MzY1OTMxY2YxMTA0ZjJiNDI2OV8zLTItMS0xLTM3NjE_c95c3718-8d26-48e6-a674-22a9c8c1b3ef"
      unitRef="usd">13913000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="icd407c3335324384be91497048cf5f08_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8zMzU0L2ZyYWc6ODkzMGUxMjE0YjY0NDQ5YjhhOTZlYzc4OGU4OTg2NTgvdGFibGU6YzVjNGNhMjA4ODAwNDM2NTkzMWNmMTEwNGYyYjQyNjkvdGFibGVyYW5nZTpjNWM0Y2EyMDg4MDA0MzY1OTMxY2YxMTA0ZjJiNDI2OV8zLTQtMS0xLTM3NjE_b6976e4d-a282-4153-a2a0-6f7f42b11c18"
      unitRef="usd">12856000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i88f7bdc9a6e24592abadfd8d6f1e1bc0_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8zMzU0L2ZyYWc6ODkzMGUxMjE0YjY0NDQ5YjhhOTZlYzc4OGU4OTg2NTgvdGFibGU6YzVjNGNhMjA4ODAwNDM2NTkzMWNmMTEwNGYyYjQyNjkvdGFibGVyYW5nZTpjNWM0Y2EyMDg4MDA0MzY1OTMxY2YxMTA0ZjJiNDI2OV8zLTYtMS0xLTM3NjE_3945dd9a-56c2-476a-942a-98d067692516"
      unitRef="usd">11231000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="ie6ccdb76509c4f75a0d36602c75f6151_D20190101-20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8zMzU0L2ZyYWc6ODkzMGUxMjE0YjY0NDQ5YjhhOTZlYzc4OGU4OTg2NTgvdGFibGU6YzVjNGNhMjA4ODAwNDM2NTkzMWNmMTEwNGYyYjQyNjkvdGFibGVyYW5nZTpjNWM0Y2EyMDg4MDA0MzY1OTMxY2YxMTA0ZjJiNDI2OV8zLTgtMS0xLTM3NjE_fa56c466-da6a-4987-8fdc-d2035bdf5458"
      unitRef="usd">9427000</us-gaap:GrossProfit>
    <us-gaap:ProfitLoss
      contextRef="i4e27136927b743769274f523ec2a41e7_D20191001-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8zMzU0L2ZyYWc6ODkzMGUxMjE0YjY0NDQ5YjhhOTZlYzc4OGU4OTg2NTgvdGFibGU6YzVjNGNhMjA4ODAwNDM2NTkzMWNmMTEwNGYyYjQyNjkvdGFibGVyYW5nZTpjNWM0Y2EyMDg4MDA0MzY1OTMxY2YxMTA0ZjJiNDI2OV80LTItMS0xLTM3NjE_a58e6229-d640-4d57-8472-ebae129684fc"
      unitRef="usd">-8291000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="icd407c3335324384be91497048cf5f08_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8zMzU0L2ZyYWc6ODkzMGUxMjE0YjY0NDQ5YjhhOTZlYzc4OGU4OTg2NTgvdGFibGU6YzVjNGNhMjA4ODAwNDM2NTkzMWNmMTEwNGYyYjQyNjkvdGFibGVyYW5nZTpjNWM0Y2EyMDg4MDA0MzY1OTMxY2YxMTA0ZjJiNDI2OV80LTQtMS0xLTM3NjE_f4ed40d4-bc73-4d07-9ef2-55c5a5be95f7"
      unitRef="usd">-8007000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i88f7bdc9a6e24592abadfd8d6f1e1bc0_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8zMzU0L2ZyYWc6ODkzMGUxMjE0YjY0NDQ5YjhhOTZlYzc4OGU4OTg2NTgvdGFibGU6YzVjNGNhMjA4ODAwNDM2NTkzMWNmMTEwNGYyYjQyNjkvdGFibGVyYW5nZTpjNWM0Y2EyMDg4MDA0MzY1OTMxY2YxMTA0ZjJiNDI2OV80LTYtMS0xLTM3NjE_2610789f-1f58-492c-a65f-a4adcc5740df"
      unitRef="usd">-11959000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ie6ccdb76509c4f75a0d36602c75f6151_D20190101-20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8zMzU0L2ZyYWc6ODkzMGUxMjE0YjY0NDQ5YjhhOTZlYzc4OGU4OTg2NTgvdGFibGU6YzVjNGNhMjA4ODAwNDM2NTkzMWNmMTEwNGYyYjQyNjkvdGFibGVyYW5nZTpjNWM0Y2EyMDg4MDA0MzY1OTMxY2YxMTA0ZjJiNDI2OV80LTgtMS0xLTM3NjE_8d420c42-6071-4169-b419-e72d6499c164"
      unitRef="usd">-24158000</us-gaap:ProfitLoss>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="i4e27136927b743769274f523ec2a41e7_D20191001-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8zMzU0L2ZyYWc6ODkzMGUxMjE0YjY0NDQ5YjhhOTZlYzc4OGU4OTg2NTgvdGFibGU6YzVjNGNhMjA4ODAwNDM2NTkzMWNmMTEwNGYyYjQyNjkvdGFibGVyYW5nZTpjNWM0Y2EyMDg4MDA0MzY1OTMxY2YxMTA0ZjJiNDI2OV81LTItMS0xLTM3NjE_72debd59-e561-4e89-bcef-42ce6eecfeb6"
      unitRef="usdPerShare">-0.27</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="icd407c3335324384be91497048cf5f08_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8zMzU0L2ZyYWc6ODkzMGUxMjE0YjY0NDQ5YjhhOTZlYzc4OGU4OTg2NTgvdGFibGU6YzVjNGNhMjA4ODAwNDM2NTkzMWNmMTEwNGYyYjQyNjkvdGFibGVyYW5nZTpjNWM0Y2EyMDg4MDA0MzY1OTMxY2YxMTA0ZjJiNDI2OV81LTQtMS0xLTM3NjE_0769c988-ec34-4a7e-b290-4063141a52fc"
      unitRef="usdPerShare">-0.26</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="i88f7bdc9a6e24592abadfd8d6f1e1bc0_D20190401-20190630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8zMzU0L2ZyYWc6ODkzMGUxMjE0YjY0NDQ5YjhhOTZlYzc4OGU4OTg2NTgvdGFibGU6YzVjNGNhMjA4ODAwNDM2NTkzMWNmMTEwNGYyYjQyNjkvdGFibGVyYW5nZTpjNWM0Y2EyMDg4MDA0MzY1OTMxY2YxMTA0ZjJiNDI2OV81LTYtMS0xLTM3NjE_3ac638b5-c079-4662-b3e2-c570000cdb17"
      unitRef="usdPerShare">-0.42</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="ie6ccdb76509c4f75a0d36602c75f6151_D20190101-20190331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8zMzU0L2ZyYWc6ODkzMGUxMjE0YjY0NDQ5YjhhOTZlYzc4OGU4OTg2NTgvdGFibGU6YzVjNGNhMjA4ODAwNDM2NTkzMWNmMTEwNGYyYjQyNjkvdGFibGVyYW5nZTpjNWM0Y2EyMDg4MDA0MzY1OTMxY2YxMTA0ZjJiNDI2OV81LTgtMS0xLTM3NjE_bb711cc7-b796-4334-b24d-833d01fa2c76"
      unitRef="usdPerShare">-20.12</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3efe8595a2ad4f2991c93a7d62cff16f_D20181001-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8zMzU0L2ZyYWc6ODkzMGUxMjE0YjY0NDQ5YjhhOTZlYzc4OGU4OTg2NTgvdGFibGU6ZjY4MzVjZjQzNzg4NGZiZjlhY2MxNTAwYWZmNzBiZDIvdGFibGVyYW5nZTpmNjgzNWNmNDM3ODg0ZmJmOWFjYzE1MDBhZmY3MGJkMl8yLTItMS0xLTM3OTU_a9e46602-c0e1-4d74-9973-da967f7c1982"
      unitRef="usd">11470000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i93f9aed079644f15b2c34904c4aaa35c_D20180701-20180930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8zMzU0L2ZyYWc6ODkzMGUxMjE0YjY0NDQ5YjhhOTZlYzc4OGU4OTg2NTgvdGFibGU6ZjY4MzVjZjQzNzg4NGZiZjlhY2MxNTAwYWZmNzBiZDIvdGFibGVyYW5nZTpmNjgzNWNmNDM3ODg0ZmJmOWFjYzE1MDBhZmY3MGJkMl8yLTQtMS0xLTM3OTU_026167ca-85b9-4174-ae96-be81976934c0"
      unitRef="usd">9614000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if2a4604d433c48d698f29d76aa7a770b_D20180401-20180630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8zMzU0L2ZyYWc6ODkzMGUxMjE0YjY0NDQ5YjhhOTZlYzc4OGU4OTg2NTgvdGFibGU6ZjY4MzVjZjQzNzg4NGZiZjlhY2MxNTAwYWZmNzBiZDIvdGFibGVyYW5nZTpmNjgzNWNmNDM3ODg0ZmJmOWFjYzE1MDBhZmY3MGJkMl8yLTYtMS0xLTM3OTU_0a98aa95-3d44-4336-a29c-6afe8a68a7b5"
      unitRef="usd">7767000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4209466b8e53444e9359f5893b730654_D20180101-20180331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8zMzU0L2ZyYWc6ODkzMGUxMjE0YjY0NDQ5YjhhOTZlYzc4OGU4OTg2NTgvdGFibGU6ZjY4MzVjZjQzNzg4NGZiZjlhY2MxNTAwYWZmNzBiZDIvdGFibGVyYW5nZTpmNjgzNWNmNDM3ODg0ZmJmOWFjYzE1MDBhZmY3MGJkMl8yLTgtMS0xLTM3OTU_086e3ed7-da29-464f-b70f-1d09a750241d"
      unitRef="usd">5706000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:GrossProfit
      contextRef="i3efe8595a2ad4f2991c93a7d62cff16f_D20181001-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8zMzU0L2ZyYWc6ODkzMGUxMjE0YjY0NDQ5YjhhOTZlYzc4OGU4OTg2NTgvdGFibGU6ZjY4MzVjZjQzNzg4NGZiZjlhY2MxNTAwYWZmNzBiZDIvdGFibGVyYW5nZTpmNjgzNWNmNDM3ODg0ZmJmOWFjYzE1MDBhZmY3MGJkMl8zLTItMS0xLTM3OTU_40b613ee-6e99-44b7-9242-b97a8ca59424"
      unitRef="usd">7803000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i93f9aed079644f15b2c34904c4aaa35c_D20180701-20180930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8zMzU0L2ZyYWc6ODkzMGUxMjE0YjY0NDQ5YjhhOTZlYzc4OGU4OTg2NTgvdGFibGU6ZjY4MzVjZjQzNzg4NGZiZjlhY2MxNTAwYWZmNzBiZDIvdGFibGVyYW5nZTpmNjgzNWNmNDM3ODg0ZmJmOWFjYzE1MDBhZmY3MGJkMl8zLTQtMS0xLTM3OTU_c637e750-273a-4221-9a99-bb2274a26c05"
      unitRef="usd">6732000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="if2a4604d433c48d698f29d76aa7a770b_D20180401-20180630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8zMzU0L2ZyYWc6ODkzMGUxMjE0YjY0NDQ5YjhhOTZlYzc4OGU4OTg2NTgvdGFibGU6ZjY4MzVjZjQzNzg4NGZiZjlhY2MxNTAwYWZmNzBiZDIvdGFibGVyYW5nZTpmNjgzNWNmNDM3ODg0ZmJmOWFjYzE1MDBhZmY3MGJkMl8zLTYtMS0xLTM3OTU_366f98e8-8f56-4937-872a-38f9414c3a53"
      unitRef="usd">5376000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i4209466b8e53444e9359f5893b730654_D20180101-20180331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8zMzU0L2ZyYWc6ODkzMGUxMjE0YjY0NDQ5YjhhOTZlYzc4OGU4OTg2NTgvdGFibGU6ZjY4MzVjZjQzNzg4NGZiZjlhY2MxNTAwYWZmNzBiZDIvdGFibGVyYW5nZTpmNjgzNWNmNDM3ODg0ZmJmOWFjYzE1MDBhZmY3MGJkMl8zLTgtMS0xLTM3OTU_804f0bc3-2da0-4327-9dfc-171d6c7804b3"
      unitRef="usd">3772000</us-gaap:GrossProfit>
    <us-gaap:ProfitLoss
      contextRef="i3efe8595a2ad4f2991c93a7d62cff16f_D20181001-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8zMzU0L2ZyYWc6ODkzMGUxMjE0YjY0NDQ5YjhhOTZlYzc4OGU4OTg2NTgvdGFibGU6ZjY4MzVjZjQzNzg4NGZiZjlhY2MxNTAwYWZmNzBiZDIvdGFibGVyYW5nZTpmNjgzNWNmNDM3ODg0ZmJmOWFjYzE1MDBhZmY3MGJkMl80LTItMS0xLTM3OTU_d8e7319c-5aae-4bab-b13d-57da9da4f9e1"
      unitRef="usd">-15618000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i93f9aed079644f15b2c34904c4aaa35c_D20180701-20180930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8zMzU0L2ZyYWc6ODkzMGUxMjE0YjY0NDQ5YjhhOTZlYzc4OGU4OTg2NTgvdGFibGU6ZjY4MzVjZjQzNzg4NGZiZjlhY2MxNTAwYWZmNzBiZDIvdGFibGVyYW5nZTpmNjgzNWNmNDM3ODg0ZmJmOWFjYzE1MDBhZmY3MGJkMl80LTQtMS0xLTM3OTU_51e47615-85bd-4c9a-880d-6c1766a219df"
      unitRef="usd">-8953000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="if2a4604d433c48d698f29d76aa7a770b_D20180401-20180630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8zMzU0L2ZyYWc6ODkzMGUxMjE0YjY0NDQ5YjhhOTZlYzc4OGU4OTg2NTgvdGFibGU6ZjY4MzVjZjQzNzg4NGZiZjlhY2MxNTAwYWZmNzBiZDIvdGFibGVyYW5nZTpmNjgzNWNmNDM3ODg0ZmJmOWFjYzE1MDBhZmY3MGJkMl80LTYtMS0xLTM3OTU_6393b54d-0280-46e4-bd14-d7db7e8488aa"
      unitRef="usd">-7651000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i4209466b8e53444e9359f5893b730654_D20180101-20180331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8zMzU0L2ZyYWc6ODkzMGUxMjE0YjY0NDQ5YjhhOTZlYzc4OGU4OTg2NTgvdGFibGU6ZjY4MzVjZjQzNzg4NGZiZjlhY2MxNTAwYWZmNzBiZDIvdGFibGVyYW5nZTpmNjgzNWNmNDM3ODg0ZmJmOWFjYzE1MDBhZmY3MGJkMl80LTgtMS0xLTM3OTU_18f1b587-17d7-4c9b-a06e-454762125db6"
      unitRef="usd">-5408000</us-gaap:ProfitLoss>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="i3efe8595a2ad4f2991c93a7d62cff16f_D20181001-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8zMzU0L2ZyYWc6ODkzMGUxMjE0YjY0NDQ5YjhhOTZlYzc4OGU4OTg2NTgvdGFibGU6ZjY4MzVjZjQzNzg4NGZiZjlhY2MxNTAwYWZmNzBiZDIvdGFibGVyYW5nZTpmNjgzNWNmNDM3ODg0ZmJmOWFjYzE1MDBhZmY3MGJkMl81LTItMS0xLTM3OTU_03e4a1f8-7ab5-474b-b939-1fd5fa7fbab5"
      unitRef="usdPerShare">-14.12</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="i93f9aed079644f15b2c34904c4aaa35c_D20180701-20180930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8zMzU0L2ZyYWc6ODkzMGUxMjE0YjY0NDQ5YjhhOTZlYzc4OGU4OTg2NTgvdGFibGU6ZjY4MzVjZjQzNzg4NGZiZjlhY2MxNTAwYWZmNzBiZDIvdGFibGVyYW5nZTpmNjgzNWNmNDM3ODg0ZmJmOWFjYzE1MDBhZmY3MGJkMl81LTQtMS0xLTM3OTU_87bf30b4-ef69-4528-a180-4a9047f62cd2"
      unitRef="usdPerShare">-8.49</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="if2a4604d433c48d698f29d76aa7a770b_D20180401-20180630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8zMzU0L2ZyYWc6ODkzMGUxMjE0YjY0NDQ5YjhhOTZlYzc4OGU4OTg2NTgvdGFibGU6ZjY4MzVjZjQzNzg4NGZiZjlhY2MxNTAwYWZmNzBiZDIvdGFibGVyYW5nZTpmNjgzNWNmNDM3ODg0ZmJmOWFjYzE1MDBhZmY3MGJkMl81LTYtMS0xLTM3OTU_91ae453a-e4a3-49ee-b3b4-1bb0936e441c"
      unitRef="usdPerShare">-8.16</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="i4209466b8e53444e9359f5893b730654_D20180101-20180331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8zMzU0L2ZyYWc6ODkzMGUxMjE0YjY0NDQ5YjhhOTZlYzc4OGU4OTg2NTgvdGFibGU6ZjY4MzVjZjQzNzg4NGZiZjlhY2MxNTAwYWZmNzBiZDIvdGFibGVyYW5nZTpmNjgzNWNmNDM3ODg0ZmJmOWFjYzE1MDBhZmY3MGJkMl81LTgtMS0xLTM3OTU_fc104088-02c6-401e-8b2f-c2998624c425"
      unitRef="usdPerShare">-7.31</us-gaap:EarningsPerShareBasicAndDiluted>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6810895440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity (Deficit) - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($) </div>
<div>vote </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Apr. 30, 2019 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred shares authorized (in shares)</a></td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred shares (in USD per share) | $ / shares</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Shares authorized (in shares)</a></td>
<td class="nump">100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,879,220<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Par value (in USD per share) | $ / shares</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Shares issued (in shares)</a></td>
<td class="nump">31,255,267<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,135,310<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Shares outstanding (in shares)</a></td>
<td class="nump">31,255,267<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,135,310<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStock', window );">Dividends declared | $</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_silk_CommonStockVotePerShare', window );">Number of votes entitled per share of common stock | vote</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Stock issued, price per share (in USD per share) | $ / shares</a></td>
<td class="nump">$ 20.00<span></span>
</td>
<td class="nump">$ 20.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=silk_CommonStockWarrantsMember', window );">Warrants to Purchase Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants outstanding (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,527<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=silk_CommonStockWarrantMember', window );">Common stock warrants outstanding | IPO</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesConverted1', window );">Shares of common stock converted (in shares)</a></td>
<td class="nump">5,968<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_silk_CommonStockVotePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common Stock, Vote Per Share</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">silk_CommonStockVotePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>silk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockSharesConverted1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4313-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4304-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4332-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockSharesConverted1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid common stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 405<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6957935&amp;loc=d3e64057-112817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=silk_CommonStockWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=silk_CommonStockWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=silk_CommonStockWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=silk_CommonStockWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6723166784">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments and Contingencies - Topic 840 Aggregate Future Minimum Lease Payments (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent', window );">2019</a></td>
<td class="nump">$ 1,002<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears', window );">2020</a></td>
<td class="nump">1,002<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears', window );">2021</a></td>
<td class="nump">1,031<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears', window );">2022</a></td>
<td class="nump">1,044<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears', window );">2023 and thereafter</a></td>
<td class="nump">1,920<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDue', window );">Total</a></td>
<td class="nump">$ 5,999<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for leases having an initial or remaining non-cancelable letter-terms in excess of one year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=82846649&amp;loc=d3e38371-112697<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41502-112717<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=82846649&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41502-112717<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=82846649&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=82846649&amp;loc=d3e38371-112697<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=82846649&amp;loc=d3e38371-112697<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=82846649&amp;loc=d3e38371-112697<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>92
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "silk-20191231.htm": {
   "axisCustom": 0,
   "axisStandard": 27,
   "contextCount": 225,
   "dts": {
    "calculationLink": {
     "local": [
      "silk-20191231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "silk-20191231_def.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-eedm-def-2018-01-31.xml",
      "http://xbrl.fasb.org/srt/2018/elts/srt-eedm1-def-2018-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "silk-20191231.htm"
     ]
    },
    "labelLink": {
     "local": [
      "silk-20191231_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml",
      "http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-doc-2018-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "silk-20191231_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-ref-2018-01-31.xml",
      "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "silk-20191231.xsd"
     ],
     "remote": [
      "http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2018/elts/srt-types-2018-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2018/elts/us-roles-2018-01-31.xsd",
      "http://xbrl.fasb.org/srt/2018/elts/srt-roles-2018-01-31.xsd",
      "http://xbrl.sec.gov/country/2017/country-2017-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2018/elts/us-types-2018-01-31.xsd",
      "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "http://xbrl.fasb.org/us-gaap/2018/elts/us-parts-codification-2018-01-31.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 602,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2018-01-31": 3,
    "http://xbrl.sec.gov/dei/2019-01-31": 5,
    "total": 8
   },
   "keyCustom": 38,
   "keyStandard": 414,
   "memberCustom": 25,
   "memberStandard": 54,
   "nsprefix": "silk",
   "nsuri": "http://silkroadmed.com/20191231",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityRegistrantName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover Page",
     "role": "http://silkroadmed.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityRegistrantName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2119103 - Disclosure - Recent Accounting Pronouncements",
     "role": "http://silkroadmed.com/role/RecentAccountingPronouncements",
     "shortName": "Recent Accounting Pronouncements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2120104 - Disclosure - Fair Value Measurements",
     "role": "http://silkroadmed.com/role/FairValueMeasurements",
     "shortName": "Fair Value Measurements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2126105 - Disclosure - Balance Sheet Components",
     "role": "http://silkroadmed.com/role/BalanceSheetComponents",
     "shortName": "Balance Sheet Components",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2135106 - Disclosure - Long-term Debt",
     "role": "http://silkroadmed.com/role/LongtermDebt",
     "shortName": "Long-term Debt",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2140107 - Disclosure - Commitments and Contingencies",
     "role": "http://silkroadmed.com/role/CommitmentsandContingencies",
     "shortName": "Commitments and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2147108 - Disclosure - Redeemable Convertible Preferred Stock",
     "role": "http://silkroadmed.com/role/RedeemableConvertiblePreferredStock",
     "shortName": "Redeemable Convertible Preferred Stock",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2151109 - Disclosure - Stockholders' Equity (Deficit)",
     "role": "http://silkroadmed.com/role/StockholdersEquityDeficit",
     "shortName": "Stockholders' Equity (Deficit)",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2155110 - Disclosure - Stock Option Plans",
     "role": "http://silkroadmed.com/role/StockOptionPlans",
     "shortName": "Stock Option Plans",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2162111 - Disclosure - Income Taxes",
     "role": "http://silkroadmed.com/role/IncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2169112 - Disclosure - Acquisition of Variable Interest Entity - NeuroCo",
     "role": "http://silkroadmed.com/role/AcquisitionofVariableInterestEntityNeuroCo",
     "shortName": "Acquisition of Variable Interest Entity - NeuroCo",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i67c494a371a04303ae82b13756a123f9_I20191231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001002 - Statement - Consolidated Balance Sheets",
     "role": "http://silkroadmed.com/role/ConsolidatedBalanceSheets",
     "shortName": "Consolidated Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i67c494a371a04303ae82b13756a123f9_I20191231",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:ShortTermInvestments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedContributionPlanDisclosuresTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2171113 - Disclosure - 401(k) Plan",
     "role": "http://silkroadmed.com/role/A401kPlan",
     "shortName": "401(k) Plan",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedContributionPlanDisclosuresTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2173114 - Disclosure - Subsequent Events",
     "role": "http://silkroadmed.com/role/SubsequentEvents",
     "shortName": "Subsequent Events",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:QuarterlyFinancialInformationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2175115 - Disclosure - Quarterly Financial Information (unaudited)",
     "role": "http://silkroadmed.com/role/QuarterlyFinancialInformationunaudited",
     "shortName": "Quarterly Financial Information (unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:QuarterlyFinancialInformationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2204201 - Disclosure - Summary of Significant Accounting Policies (Policies)",
     "role": "http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesPolicies",
     "shortName": "Summary of Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2305301 - Disclosure - Summary of Significant Accounting Policies (Tables)",
     "role": "http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesTables",
     "shortName": "Summary of Significant Accounting Policies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2321302 - Disclosure - Fair Value Measurements (Tables)",
     "role": "http://silkroadmed.com/role/FairValueMeasurementsTables",
     "shortName": "Fair Value Measurements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2327303 - Disclosure - Balance Sheet Components (Tables)",
     "role": "http://silkroadmed.com/role/BalanceSheetComponentsTables",
     "shortName": "Balance Sheet Components (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2336304 - Disclosure - Long-term Debt (Tables)",
     "role": "http://silkroadmed.com/role/LongtermDebtTables",
     "shortName": "Long-term Debt (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:LesseeLeasesPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "silk:AssetsAndLiabilitiesLesseeTableTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2341305 - Disclosure - Commitments and Contingencies (Tables)",
     "role": "http://silkroadmed.com/role/CommitmentsandContingenciesTables",
     "shortName": "Commitments and Contingencies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TemporaryEquityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2348306 - Disclosure - Redeemable Convertible Preferred Stock (Tables)",
     "role": "http://silkroadmed.com/role/RedeemableConvertiblePreferredStockTables",
     "shortName": "Redeemable Convertible Preferred Stock (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TemporaryEquityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:CommonStockSharesIssued",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i67c494a371a04303ae82b13756a123f9_I20191231",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:CommonStockSharesOutstanding",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002003 - Statement - Consolidated Balance Sheets (Parenthetical)",
     "role": "http://silkroadmed.com/role/ConsolidatedBalanceSheetsParenthetical",
     "shortName": "Consolidated Balance Sheets (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:PreferredStockSharesIssued",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i67c494a371a04303ae82b13756a123f9_I20191231",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:PreferredStockSharesIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfStockByClassTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2352307 - Disclosure - Stockholders' Equity (Deficit) (Tables)",
     "role": "http://silkroadmed.com/role/StockholdersEquityDeficitTables",
     "shortName": "Stockholders' Equity (Deficit) (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfStockByClassTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2356308 - Disclosure - Stock Option Plans (Tables)",
     "role": "http://silkroadmed.com/role/StockOptionPlansTables",
     "shortName": "Stock Option Plans (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2363309 - Disclosure - Income Taxes (Tables)",
     "role": "http://silkroadmed.com/role/IncomeTaxesTables",
     "shortName": "Income Taxes (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2376310 - Disclosure - Quarterly Financial Information (unaudited) (Tables)",
     "role": "http://silkroadmed.com/role/QuarterlyFinancialInformationunauditedTables",
     "shortName": "Quarterly Financial Information (unaudited) (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i67c494a371a04303ae82b13756a123f9_I20191231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:RetainedEarningsAccumulatedDeficit",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2402401 - Disclosure - Formation and Business of the Company (Details)",
     "role": "http://silkroadmed.com/role/FormationandBusinessoftheCompanyDetails",
     "shortName": "Formation and Business of the Company (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i67c494a371a04303ae82b13756a123f9_I20191231",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i67c494a371a04303ae82b13756a123f9_I20191231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AccruedLiabilitiesCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2406402 - Disclosure - Summary of Significant Accounting Policies - Adjustment to Prior Period Financial Statements (Details)",
     "role": "http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesAdjustmenttoPriorPeriodFinancialStatementsDetails",
     "shortName": "Summary of Significant Accounting Policies - Adjustment to Prior Period Financial Statements (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i733162f186ac41fb8f9b99aa842ef13f_I20181231",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:AccruedLiabilitiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i67c494a371a04303ae82b13756a123f9_I20191231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2407403 - Disclosure - Summary of Significant Accounting Policies - Cash, Cash Equivalents and Restricted Cash (Details)",
     "role": "http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesCashCashEquivalentsandRestrictedCashDetails",
     "shortName": "Summary of Significant Accounting Policies - Cash, Cash Equivalents and Restricted Cash (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "iec135774dba44b3cb207fe343988137e_I20191231",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:RestrictedCashNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": null,
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2408404 - Disclosure - Summary of Significant Accounting Policies - Property and Equipment (Details)",
     "role": "http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails",
     "shortName": "Summary of Significant Accounting Policies - Property and Equipment (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i67c494a371a04303ae82b13756a123f9_I20191231",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:DeferredOfferingCosts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2409405 - Disclosure - Summary of Significant Accounting Policies - Deferred Initial Public Offering Costs (Details)",
     "role": "http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesDeferredInitialPublicOfferingCostsDetails",
     "shortName": "Summary of Significant Accounting Policies - Deferred Initial Public Offering Costs (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i67c494a371a04303ae82b13756a123f9_I20191231",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:DeferredOfferingCosts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i67c494a371a04303ae82b13756a123f9_I20191231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2410406 - Disclosure - Summary of Significant Accounting Policies - Leases (Details)",
     "role": "http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesLeasesDetails",
     "shortName": "Summary of Significant Accounting Policies - Leases (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:LesseeLeasesPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i0f51c2607db4468eba9bb514ae0e4471_I20190101",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003004 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss",
     "role": "http://silkroadmed.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss",
     "shortName": "Condensed Consolidated Statements of Operations and Comprehensive Loss",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:CostOfGoodsAndServicesSold",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i67c494a371a04303ae82b13756a123f9_I20191231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:OtherAssetsNoncurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2411407 - Disclosure - Summary of Significant Accounting Policies - ASC 842 Impact on Condensed Consolidated Balance Sheet (Details)",
     "role": "http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesASC842ImpactonCondensedConsolidatedBalanceSheetDetails",
     "shortName": "Summary of Significant Accounting Policies - ASC 842 Impact on Condensed Consolidated Balance Sheet (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "silk:AssetsAndLiabilitiesLesseeTableTextBlock",
       "us-gaap:LesseeLeasesPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i2fe97d6c47914971bb09d925222705a9_I20190101",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:OtherAssetsNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:StockholdersEquityNoteRedeemablePreferredStockIssuePolicy",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i2658f65419d24aacb4ed4233d75211b7_D20190501-20191231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockIssuedDuringPeriodValueConversionOfUnits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2412408 - Disclosure - Summary of Significant Accounting Policies - Redeemable Convertible Preferred Stock (Details)",
     "role": "http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesRedeemableConvertiblePreferredStockDetails",
     "shortName": "Summary of Significant Accounting Policies - Redeemable Convertible Preferred Stock (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:StockholdersEquityNoteRedeemablePreferredStockIssuePolicy",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i2658f65419d24aacb4ed4233d75211b7_D20190501-20191231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockIssuedDuringPeriodValueConversionOfUnits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i67c494a371a04303ae82b13756a123f9_I20191231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:UnbilledReceivablesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2413409 - Disclosure - Summary of Significant Accounting Policies - Revenue Recognition (Details)",
     "role": "http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesRevenueRecognitionDetails",
     "shortName": "Summary of Significant Accounting Policies - Revenue Recognition (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i67c494a371a04303ae82b13756a123f9_I20191231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:UnbilledReceivablesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AdvertisingExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2414410 - Disclosure - Summary of Significant Accounting Policies - Advertising Costs (Details)",
     "role": "http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesAdvertisingCostsDetails",
     "shortName": "Summary of Significant Accounting Policies - Advertising Costs (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AdvertisingExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "ibfd8d47f8c2e498f97e7e0e1de986a52_I20180101",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2415411 - Disclosure - Summary of Significant Accounting Policies - Stock-Based Compensation (Details)",
     "role": "http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesStockBasedCompensationDetails",
     "shortName": "Summary of Significant Accounting Policies - Stock-Based Compensation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "ibfd8d47f8c2e498f97e7e0e1de986a52_I20180101",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2416412 - Disclosure - Summary of Significant Accounting Policies - Schedule of Earnings Per Share (Details)",
     "role": "http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesScheduleofEarningsPerShareDetails",
     "shortName": "Summary of Significant Accounting Policies - Schedule of Earnings Per Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2417413 - Disclosure - Summary of Significant Accounting Policies - Schedule of Potentially Dilutive Securities Not Included in Calculation of Earnings per Share (Details)",
     "role": "http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesScheduleofPotentiallyDilutiveSecuritiesNotIncludedinCalculationofEarningsperShareDetails",
     "shortName": "Summary of Significant Accounting Policies - Schedule of Potentially Dilutive Securities Not Included in Calculation of Earnings per Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:NumberOfOperatingSegments",
       "span",
       "div",
       "us-gaap:SegmentReportingPolicyPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2418414 - Disclosure - Summary of Significant Accounting Policies - Segment and Geographical Information (Details)",
     "role": "http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesSegmentandGeographicalInformationDetails",
     "shortName": "Summary of Significant Accounting Policies - Segment and Geographical Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:NumberOfOperatingSegments",
       "span",
       "div",
       "us-gaap:SegmentReportingPolicyPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i67c494a371a04303ae82b13756a123f9_I20191231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AvailableForSaleSecuritiesDebtSecurities",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2422415 - Disclosure - Fair Value Measurements - Recurring Assets and Liabilities (Details)",
     "role": "http://silkroadmed.com/role/FairValueMeasurementsRecurringAssetsandLiabilitiesDetails",
     "shortName": "Fair Value Measurements - Recurring Assets and Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i5fae0f510baf4fbcb8ab06bb60002490_I20191231",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:AssetsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "if244f20dd62e4eb5ac07166f1d16fcc1_I20181231",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:SharePrice",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2423416 - Disclosure - Fair Value Measurements - Narrative (Details)",
     "role": "http://silkroadmed.com/role/FairValueMeasurementsNarrativeDetails",
     "shortName": "Fair Value Measurements - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "if244f20dd62e4eb5ac07166f1d16fcc1_I20181231",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:SharePrice",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "ib1a82135571248368e03bddf4304bc01_I20171231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:TemporaryEquityCarryingAmountAttributableToParent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004005 - Statement - Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders' Equity (Deficit)",
     "role": "http://silkroadmed.com/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit",
     "shortName": "Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders' Equity (Deficit)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "ib1a82135571248368e03bddf4304bc01_I20171231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:TemporaryEquityCarryingAmountAttributableToParent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i48e873776ce54fb78ea86ee6468dd7ce_I20181231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:WarrantsAndRightsOutstandingTerm",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2424417 - Disclosure - Fair Value Measurements - Fair Value Assumptions (Details)",
     "role": "http://silkroadmed.com/role/FairValueMeasurementsFairValueAssumptionsDetails",
     "shortName": "Fair Value Measurements - Fair Value Assumptions (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i48e873776ce54fb78ea86ee6468dd7ce_I20181231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:WarrantsAndRightsOutstandingTerm",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2425418 - Disclosure - Fair Value Measurements - Changes in Redeemable Convertible Warrant Liability (Details)",
     "role": "http://silkroadmed.com/role/FairValueMeasurementsChangesinRedeemableConvertibleWarrantLiabilityDetails",
     "shortName": "Fair Value Measurements - Changes in Redeemable Convertible Warrant Liability (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i517a0560ef9f4f6a822a0a124dd39744_I20171231",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i67c494a371a04303ae82b13756a123f9_I20191231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2428419 - Disclosure - Balance Sheet Components - Fair Value of Available-For-Sale Investments (Details)",
     "role": "http://silkroadmed.com/role/BalanceSheetComponentsFairValueofAvailableForSaleInvestmentsDetails",
     "shortName": "Balance Sheet Components - Fair Value of Available-For-Sale Investments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i67c494a371a04303ae82b13756a123f9_I20191231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueByBalanceSheetGroupingTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i67c494a371a04303ae82b13756a123f9_I20191231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "silk:CashAndCashEquivalentsFairValueDisclosureMaturingWithinOneYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2429420 - Disclosure - Balance Sheet Components - Fair Value of Cash Equivalents, Short-Term and Long-Term Investments (Details)",
     "role": "http://silkroadmed.com/role/BalanceSheetComponentsFairValueofCashEquivalentsShortTermandLongTermInvestmentsDetails",
     "shortName": "Balance Sheet Components - Fair Value of Cash Equivalents, Short-Term and Long-Term Investments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueByBalanceSheetGroupingTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i67c494a371a04303ae82b13756a123f9_I20191231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "silk:CashAndCashEquivalentsFairValueDisclosureMaturingWithinOneYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i67c494a371a04303ae82b13756a123f9_I20191231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2430421 - Disclosure - Balance Sheet Components - Available-for-Sale Investments in Unrealized Loss Position (Details)",
     "role": "http://silkroadmed.com/role/BalanceSheetComponentsAvailableforSaleInvestmentsinUnrealizedLossPositionDetails",
     "shortName": "Balance Sheet Components - Available-for-Sale Investments in Unrealized Loss Position (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i67c494a371a04303ae82b13756a123f9_I20191231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i67c494a371a04303ae82b13756a123f9_I20191231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2431422 - Disclosure - Balance Sheet Components - Schedule of Inventory (Details)",
     "role": "http://silkroadmed.com/role/BalanceSheetComponentsScheduleofInventoryDetails",
     "shortName": "Balance Sheet Components - Schedule of Inventory (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i67c494a371a04303ae82b13756a123f9_I20191231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i67c494a371a04303ae82b13756a123f9_I20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleTerm",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2432423 - Disclosure - Balance Sheet Components - Narrative (Details)",
     "role": "http://silkroadmed.com/role/BalanceSheetComponentsNarrativeDetails",
     "shortName": "Balance Sheet Components - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i67c494a371a04303ae82b13756a123f9_I20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleTerm",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i67c494a371a04303ae82b13756a123f9_I20191231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2433424 - Disclosure - Balance Sheet Components - Property, Plant and Equipment (Details)",
     "role": "http://silkroadmed.com/role/BalanceSheetComponentsPropertyPlantandEquipmentDetails",
     "shortName": "Balance Sheet Components - Property, Plant and Equipment (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i67c494a371a04303ae82b13756a123f9_I20191231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i67c494a371a04303ae82b13756a123f9_I20191231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AccruedSalariesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2434425 - Disclosure - Balance Sheet Components - Accrued Liabilities (Details)",
     "role": "http://silkroadmed.com/role/BalanceSheetComponentsAccruedLiabilitiesDetails",
     "shortName": "Balance Sheet Components - Accrued Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i67c494a371a04303ae82b13756a123f9_I20191231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AccruedSalariesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i54b82514b8694d3b98494d64e98b4745_I20180930",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "silk:DebtMaximumBorrowingCapacity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2437426 - Disclosure - Long-term Debt - Term Loan Narrative (Details)",
     "role": "http://silkroadmed.com/role/LongtermDebtTermLoanNarrativeDetails",
     "shortName": "Long-term Debt - Term Loan Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i54b82514b8694d3b98494d64e98b4745_I20180930",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "silk:DebtMaximumBorrowingCapacity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:PaymentsOfStockIssuanceCosts",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1005006 - Statement - Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders' Equity (Deficit) (Parenthetical)",
     "role": "http://silkroadmed.com/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficitParenthetical",
     "shortName": "Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders' Equity (Deficit) (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": null
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i67c494a371a04303ae82b13756a123f9_I20191231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2438427 - Disclosure - Long-term Debt - Future Maturities Under the Term Loan (Details)",
     "role": "http://silkroadmed.com/role/LongtermDebtFutureMaturitiesUndertheTermLoanDetails",
     "shortName": "Long-term Debt - Future Maturities Under the Term Loan (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i67c494a371a04303ae82b13756a123f9_I20191231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i69a4c0c247dc496998d701bc90ebe115_I20151031",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ClassOfWarrantOrRightOutstanding",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2439428 - Disclosure - Long-term Debt - Series C Narrative (Details)",
     "role": "http://silkroadmed.com/role/LongtermDebtSeriesCNarrativeDetails",
     "shortName": "Long-term Debt - Series C Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i6665fb41539543faa5c665e0459d1cf6_D20170701-20170731",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i67c494a371a04303ae82b13756a123f9_I20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseRenewalTerm",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2442429 - Disclosure - Commitments and Contingencies - Lease Narrative (Details)",
     "role": "http://silkroadmed.com/role/CommitmentsandContingenciesLeaseNarrativeDetails",
     "shortName": "Commitments and Contingencies - Lease Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i67c494a371a04303ae82b13756a123f9_I20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseRenewalTerm",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i67c494a371a04303ae82b13756a123f9_I20191231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2443430 - Disclosure - Commitments and Contingencies - Balance Sheet Information (Details)",
     "role": "http://silkroadmed.com/role/CommitmentsandContingenciesBalanceSheetInformationDetails",
     "shortName": "Commitments and Contingencies - Balance Sheet Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i67c494a371a04303ae82b13756a123f9_I20191231",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:OperatingLeaseLiabilityNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i67c494a371a04303ae82b13756a123f9_I20191231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2444431 - Disclosure - Commitments and Contingencies - Operating Lease Maturities (Details)",
     "role": "http://silkroadmed.com/role/CommitmentsandContingenciesOperatingLeaseMaturitiesDetails",
     "shortName": "Commitments and Contingencies - Operating Lease Maturities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i67c494a371a04303ae82b13756a123f9_I20191231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2445432 - Disclosure - Commitments and Contingencies - Topic 840 Aggregate Future Minimum Lease Payments (Details)",
     "role": "http://silkroadmed.com/role/CommitmentsandContingenciesTopic840AggregateFutureMinimumLeasePaymentsDetails",
     "shortName": "Commitments and Contingencies - Topic 840 Aggregate Future Minimum Lease Payments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i67c494a371a04303ae82b13756a123f9_I20191231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:PurchaseObligation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2446433 - Disclosure - Commitments and Contingencies - Purchase Obligation Narrative (Details)",
     "role": "http://silkroadmed.com/role/CommitmentsandContingenciesPurchaseObligationNarrativeDetails",
     "shortName": "Commitments and Contingencies - Purchase Obligation Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i67c494a371a04303ae82b13756a123f9_I20191231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:PurchaseObligation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i67c494a371a04303ae82b13756a123f9_I20191231",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:TemporaryEquitySharesAuthorized",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2449434 - Disclosure - Redeemable Convertible Preferred Stock - Schedule of Redeemable Convertible Preferred Stock (Details)",
     "role": "http://silkroadmed.com/role/RedeemableConvertiblePreferredStockScheduleofRedeemableConvertiblePreferredStockDetails",
     "shortName": "Redeemable Convertible Preferred Stock - Schedule of Redeemable Convertible Preferred Stock (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:TemporaryEquityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i7f1961a81c2146ba86c1873951eb5d0f_I20181231",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:TemporaryEquitySharesAuthorized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i67c494a371a04303ae82b13756a123f9_I20191231",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:TemporaryEquitySharesIssued",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2450435 - Disclosure - Redeemable Convertible Preferred Stock - Narrative (Details)",
     "role": "http://silkroadmed.com/role/RedeemableConvertiblePreferredStockNarrativeDetails",
     "shortName": "Redeemable Convertible Preferred Stock - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i85f16463983d4272b900d0242c5a7b00_D20190101-20191231",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:ConversionOfStockSharesConverted1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i67c494a371a04303ae82b13756a123f9_I20191231",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:PreferredStockSharesAuthorized",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2453436 - Disclosure - Stockholders' Equity (Deficit) - Narrative (Details)",
     "role": "http://silkroadmed.com/role/StockholdersEquityDeficitNarrativeDetails",
     "shortName": "Stockholders' Equity (Deficit) - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:DividendsCommonStock",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1006007 - Statement - Consolidated Statements of Cash Flows",
     "role": "http://silkroadmed.com/role/ConsolidatedStatementsofCashFlows",
     "shortName": "Consolidated Statements of Cash Flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfStockByClassTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i67c494a371a04303ae82b13756a123f9_I20191231",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:CommonStockCapitalSharesReservedForFutureIssuance",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2454437 - Disclosure - Stockholders' Equity (Deficit) - Shares Reserved for Future Issuance (Details)",
     "role": "http://silkroadmed.com/role/StockholdersEquityDeficitSharesReservedforFutureIssuanceDetails",
     "shortName": "Stockholders' Equity (Deficit) - Shares Reserved for Future Issuance (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfStockByClassTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i7c6d2473a2234f6fae9d4b0c9b650a4f_I20191231",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:CommonStockCapitalSharesReservedForFutureIssuance",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2457438 - Disclosure - Stock Option Plans - Narrative (Details)",
     "role": "http://silkroadmed.com/role/StockOptionPlansNarrativeDetails",
     "shortName": "Stock Option Plans - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231",
      "decimals": "2",
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2458439 - Disclosure - Stock Option Plans - Activity Under Compensation Plan (Details)",
     "role": "http://silkroadmed.com/role/StockOptionPlansActivityUnderCompensationPlanDetails",
     "shortName": "Stock Option Plans - Activity Under Compensation Plan (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i67c494a371a04303ae82b13756a123f9_I20191231",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2459440 - Disclosure - Stock Option Plans - Information by Exercise Price (Details)",
     "role": "http://silkroadmed.com/role/StockOptionPlansInformationbyExercisePriceDetails",
     "shortName": "Stock Option Plans - Information by Exercise Price (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i9168c8a79f074245b359c1eabebd2867_I20191231",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R74": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2460441 - Disclosure - Stock Option Plans - Stock Option Assumptions (Details)",
     "role": "http://silkroadmed.com/role/StockOptionPlansStockOptionAssumptionsDetails",
     "shortName": "Stock Option Plans - Stock Option Assumptions (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R75": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2461442 - Disclosure - Stock Option Plans - Stock-based Compensation (Details)",
     "role": "http://silkroadmed.com/role/StockOptionPlansStockbasedCompensationDetails",
     "shortName": "Stock Option Plans - Stock-based Compensation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i0ac3add721de4c95964529b527a87faf_D20190101-20191231",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R76": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2464443 - Disclosure - Income Taxes - Components of Income Before Taxes (Details)",
     "role": "http://silkroadmed.com/role/IncomeTaxesComponentsofIncomeBeforeTaxesDetails",
     "shortName": "Income Taxes - Components of Income Before Taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R77": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2465444 - Disclosure - Income Taxes - Reconciliation of U.S Statutory Rate (Details)",
     "role": "http://silkroadmed.com/role/IncomeTaxesReconciliationofUSStatutoryRateDetails",
     "shortName": "Income Taxes - Reconciliation of U.S Statutory Rate (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R78": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i67c494a371a04303ae82b13756a123f9_I20191231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2466445 - Disclosure - Income Taxes - Net Deferred Tax Assets (Details)",
     "role": "http://silkroadmed.com/role/IncomeTaxesNetDeferredTaxAssetsDetails",
     "shortName": "Income Taxes - Net Deferred Tax Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i67c494a371a04303ae82b13756a123f9_I20191231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R79": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2467446 - Disclosure - Income Taxes - Narrative (Details)",
     "role": "http://silkroadmed.com/role/IncomeTaxesNarrativeDetails",
     "shortName": "Income Taxes - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2101101 - Disclosure - Formation and Business of the Company",
     "role": "http://silkroadmed.com/role/FormationandBusinessoftheCompany",
     "shortName": "Formation and Business of the Company",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R80": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i1f64d28fa2d044b591b5280f5c4ce0ec_I20181231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2468447 - Disclosure - Income Taxes - Reconciliation of Unrecognized Tax Benefits (Details)",
     "role": "http://silkroadmed.com/role/IncomeTaxesReconciliationofUnrecognizedTaxBenefitsDetails",
     "shortName": "Income Taxes - Reconciliation of Unrecognized Tax Benefits (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R81": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockIssuedDuringPeriodValueNewIssues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2470448 - Disclosure - Acquisition of Variable Interest Entity - NeuroCo (Details)",
     "role": "http://silkroadmed.com/role/AcquisitionofVariableInterestEntityNeuroCoDetails",
     "shortName": "Acquisition of Variable Interest Entity - NeuroCo (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i129f46ce6e8d4fa98d362bb8455a8c28_I20181217",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:NoncontrollingInterestInVariableInterestEntity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R82": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2472449 - Disclosure - 401(k) Plan (Details)",
     "role": "http://silkroadmed.com/role/A401kPlanDetails",
     "shortName": "401(k) Plan (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R83": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2474450 - Disclosure - Subsequent Events - Narrative (Details)",
     "role": "http://silkroadmed.com/role/SubsequentEventsNarrativeDetails",
     "shortName": "Subsequent Events - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i36441150a0d742e990ee101edcbe8518_I20200131",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:CommonStockCapitalSharesReservedForFutureIssuance",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R84": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i4e27136927b743769274f523ec2a41e7_D20191001-20191231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2477451 - Disclosure - Quarterly Financial Information (unaudited) (Details)",
     "role": "http://silkroadmed.com/role/QuarterlyFinancialInformationunauditedDetails",
     "shortName": "Quarterly Financial Information (unaudited) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i4e27136927b743769274f523ec2a41e7_D20191001-20191231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2103102 - Disclosure - Summary of Significant Accounting Policies",
     "role": "http://silkroadmed.com/role/SummaryofSignificantAccountingPolicies",
     "shortName": "Summary of Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "i7ced9ff7434241ad9c042ea23c7d4827_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9999": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "silk-20191231.htm",
      "contextRef": "if3906640531a47a789a69ee035108cfd_I20180101",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "",
     "isDefault": "false",
     "longName": "Uncategorized Items - silk-20191231.htm",
     "role": "http://xbrl.sec.gov/role/uncategorizedFacts",
     "shortName": "Uncategorized Items - silk-20191231.htm",
     "subGroupType": "",
     "uniqueAnchor": null
    }
   },
   "segmentCount": 84,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://silkroadmed.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://silkroadmed.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover page."
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://silkroadmed.com/role/CoverPage"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r424"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report",
        "terseLabel": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://silkroadmed.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://silkroadmed.com/role/CoverPage"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://silkroadmed.com/role/CoverPage"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://silkroadmed.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r423"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://silkroadmed.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://silkroadmed.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://silkroadmed.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://silkroadmed.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://silkroadmed.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://silkroadmed.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r425"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://silkroadmed.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://silkroadmed.com/role/CoverPage"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://silkroadmed.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.",
        "label": "Entity [Domain]",
        "terseLabel": "Entity [Domain]"
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://silkroadmed.com/role/AcquisitionofVariableInterestEntityNeuroCoDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r425"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://silkroadmed.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r427"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Entity Ex Transition Period",
        "terseLabel": "Entity Ex Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://silkroadmed.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://silkroadmed.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r425"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://silkroadmed.com/role/CoverPage"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://silkroadmed.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r426"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://silkroadmed.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float",
        "terseLabel": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://silkroadmed.com/role/CoverPage"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r425"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://silkroadmed.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r425"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://silkroadmed.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r425"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://silkroadmed.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r425"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://silkroadmed.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers",
        "terseLabel": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://silkroadmed.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer",
        "terseLabel": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://silkroadmed.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]",
        "terseLabel": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://silkroadmed.com/role/AcquisitionofVariableInterestEntityNeuroCoDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://silkroadmed.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r421"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://silkroadmed.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r422"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://silkroadmed.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://silkroadmed.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "silk_AccruedClinicalExpensesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://silkroadmed.com/role/BalanceSheetComponentsAccruedLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accrued Clinical Expenses, Current",
        "label": "Accrued Clinical Expenses, Current",
        "terseLabel": "Accrued clinical expenses"
       }
      }
     },
     "localname": "AccruedClinicalExpensesCurrent",
     "nsuri": "http://silkroadmed.com/20191231",
     "presentation": [
      "http://silkroadmed.com/role/BalanceSheetComponentsAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "silk_AccruedTravelExpensesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://silkroadmed.com/role/BalanceSheetComponentsAccruedLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accrued Travel Expenses, Current",
        "label": "Accrued Travel Expenses, Current",
        "terseLabel": "Accrued travel expenses"
       }
      }
     },
     "localname": "AccruedTravelExpensesCurrent",
     "nsuri": "http://silkroadmed.com/20191231",
     "presentation": [
      "http://silkroadmed.com/role/BalanceSheetComponentsAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "silk_AssetsAndLiabilitiesLesseeTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Assets And Liabilities, Lessee [Table Text Block]",
        "label": "Assets And Liabilities, Lessee [Table Text Block]",
        "terseLabel": "Balance Sheet Information",
        "verboseLabel": "Schedule of ASC 842 Impact of Adoption on Condensed Consolidated Balance Sheet"
       }
      }
     },
     "localname": "AssetsAndLiabilitiesLesseeTableTextBlock",
     "nsuri": "http://silkroadmed.com/20191231",
     "presentation": [
      "http://silkroadmed.com/role/CommitmentsandContingenciesTables",
      "http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "silk_BusinessCombinationConsiderationTransferredNotesPayableForgiven": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Business Combination, Consideration Transferred, Notes Payable Forgiven",
        "label": "Business Combination, Consideration Transferred, Notes Payable Forgiven",
        "terseLabel": "Consideration given, amount of notes payable forgiven"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredNotesPayableForgiven",
     "nsuri": "http://silkroadmed.com/20191231",
     "presentation": [
      "http://silkroadmed.com/role/AcquisitionofVariableInterestEntityNeuroCoDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "silk_CashAndCashEquivalentsFairValueDisclosureMaturingAfterOneYearThroughTwoYears": {
     "auth_ref": [],
     "calculation": {
      "http://silkroadmed.com/role/BalanceSheetComponentsFairValueofCashEquivalentsShortTermandLongTermInvestmentsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_CashAndCashEquivalentsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cash And Cash Equivalents, Fair Value Disclosure, Maturing After One Year Through Two Years",
        "label": "Cash And Cash Equivalents, Fair Value Disclosure, Maturing After One Year Through Two Years",
        "terseLabel": "Amounts maturing after one year through two years"
       }
      }
     },
     "localname": "CashAndCashEquivalentsFairValueDisclosureMaturingAfterOneYearThroughTwoYears",
     "nsuri": "http://silkroadmed.com/20191231",
     "presentation": [
      "http://silkroadmed.com/role/BalanceSheetComponentsFairValueofCashEquivalentsShortTermandLongTermInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "silk_CashAndCashEquivalentsFairValueDisclosureMaturingWithinOneYear": {
     "auth_ref": [],
     "calculation": {
      "http://silkroadmed.com/role/BalanceSheetComponentsFairValueofCashEquivalentsShortTermandLongTermInvestmentsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_CashAndCashEquivalentsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cash And Cash Equivalents, Fair Value Disclosure, Maturing Within One Year",
        "label": "Cash And Cash Equivalents, Fair Value Disclosure, Maturing Within One Year",
        "terseLabel": "Amounts maturing within one year"
       }
      }
     },
     "localname": "CashAndCashEquivalentsFairValueDisclosureMaturingWithinOneYear",
     "nsuri": "http://silkroadmed.com/20191231",
     "presentation": [
      "http://silkroadmed.com/role/BalanceSheetComponentsFairValueofCashEquivalentsShortTermandLongTermInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "silk_CommonStockVotePerShare": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Common Stock, Vote Per Share",
        "label": "Common Stock, Vote Per Share",
        "terseLabel": "Number of votes entitled per share of common stock"
       }
      }
     },
     "localname": "CommonStockVotePerShare",
     "nsuri": "http://silkroadmed.com/20191231",
     "presentation": [
      "http://silkroadmed.com/role/StockholdersEquityDeficitNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "silk_CommonStockWarrantMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Common Stock Warrant [Member]",
        "label": "Common Stock Warrant [Member]",
        "terseLabel": "Common stock warrants outstanding"
       }
      }
     },
     "localname": "CommonStockWarrantMember",
     "nsuri": "http://silkroadmed.com/20191231",
     "presentation": [
      "http://silkroadmed.com/role/ConsolidatedStatementsofCashFlows",
      "http://silkroadmed.com/role/StockholdersEquityDeficitNarrativeDetails",
      "http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesScheduleofPotentiallyDilutiveSecuritiesNotIncludedinCalculationofEarningsperShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "silk_CommonStockWarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Common Stock Warrants",
        "label": "Common Stock Warrants [Member]",
        "terseLabel": "Warrants to Purchase Common Stock",
        "verboseLabel": "Warrants to purchase common stock"
       }
      }
     },
     "localname": "CommonStockWarrantsMember",
     "nsuri": "http://silkroadmed.com/20191231",
     "presentation": [
      "http://silkroadmed.com/role/StockholdersEquityDeficitNarrativeDetails",
      "http://silkroadmed.com/role/StockholdersEquityDeficitSharesReservedforFutureIssuanceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "silk_CorrectionOfProvisionsForReturnsFromCustomersMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Correction Of Provisions For Returns From Customers",
        "label": "Correction Of Provisions For Returns From Customers [Member]",
        "terseLabel": "Correction Of Provisions For Returns From Customers"
       }
      }
     },
     "localname": "CorrectionOfProvisionsForReturnsFromCustomersMember",
     "nsuri": "http://silkroadmed.com/20191231",
     "presentation": [
      "http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesAdjustmenttoPriorPeriodFinancialStatementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "silk_DebtInstrumentConvertibleMarketCapitalization": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt Instrument, Convertible, Market Capitalization",
        "label": "Debt Instrument, Convertible, Market Capitalization",
        "terseLabel": "Market capitalization (greater than)"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleMarketCapitalization",
     "nsuri": "http://silkroadmed.com/20191231",
     "presentation": [
      "http://silkroadmed.com/role/LongtermDebtTermLoanNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "silk_DebtInstrumentConvertibleMaximumPercentageOfOutstandingLoans": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt Instrument, Convertible, Maximum Percentage Of Outstanding Loans",
        "label": "Debt Instrument, Convertible, Maximum Percentage Of Outstanding Loans",
        "terseLabel": "Percentage of outstanding loans"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleMaximumPercentageOfOutstandingLoans",
     "nsuri": "http://silkroadmed.com/20191231",
     "presentation": [
      "http://silkroadmed.com/role/LongtermDebtTermLoanNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "silk_DebtInstrumentCovenantMaximumLiquidityAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt Instrument, Covenant, Maximum Liquidity, Amount",
        "label": "Debt Instrument, Covenant, Maximum Liquidity, Amount",
        "terseLabel": "Minimum liquidity amount"
       }
      }
     },
     "localname": "DebtInstrumentCovenantMaximumLiquidityAmount",
     "nsuri": "http://silkroadmed.com/20191231",
     "presentation": [
      "http://silkroadmed.com/role/LongtermDebtTermLoanNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "silk_DebtInstrumentCovenantMinimumNetRevenueAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt Instrument, Covenant, Minimum Net Revenue, Amount",
        "label": "Debt Instrument, Covenant, Minimum Net Revenue, Amount",
        "terseLabel": "Minimum net revenue target"
       }
      }
     },
     "localname": "DebtInstrumentCovenantMinimumNetRevenueAmount",
     "nsuri": "http://silkroadmed.com/20191231",
     "presentation": [
      "http://silkroadmed.com/role/LongtermDebtTermLoanNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "silk_DebtInstrumentInterestRateFacilityFee": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt Instrument, Interest Rate, Facility Fee",
        "label": "Debt Instrument, Interest Rate, Facility Fee",
        "terseLabel": "Facility fee"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateFacilityFee",
     "nsuri": "http://silkroadmed.com/20191231",
     "presentation": [
      "http://silkroadmed.com/role/LongtermDebtTermLoanNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "silk_DebtInstrumentInterestRateFinancingFee": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt Instrument, Interest Rate, Financing Fee",
        "label": "Debt Instrument, Interest Rate, Financing Fee",
        "terseLabel": "Financing fee"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateFinancingFee",
     "nsuri": "http://silkroadmed.com/20191231",
     "presentation": [
      "http://silkroadmed.com/role/LongtermDebtTermLoanNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "silk_DebtInstrumentInterestRatePaidInCash": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt Instrument, Interest Rate, Paid In Cash",
        "label": "Debt Instrument, Interest Rate, Paid In Cash",
        "terseLabel": "Interest rate paid in cash"
       }
      }
     },
     "localname": "DebtInstrumentInterestRatePaidInCash",
     "nsuri": "http://silkroadmed.com/20191231",
     "presentation": [
      "http://silkroadmed.com/role/LongtermDebtTermLoanNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "silk_DebtInstrumentInterestRatePaidInKind": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt Instrument, Interest Rate, Paid-In-Kind",
        "label": "Debt Instrument, Interest Rate, Paid-In-Kind",
        "terseLabel": "Interest rate paid-in-kind"
       }
      }
     },
     "localname": "DebtInstrumentInterestRatePaidInKind",
     "nsuri": "http://silkroadmed.com/20191231",
     "presentation": [
      "http://silkroadmed.com/role/LongtermDebtTermLoanNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "silk_DebtInstrumentLiquidityCovenantTerm": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt Instrument, Liquidity Covenant, Term",
        "label": "Debt Instrument, Liquidity Covenant, Term",
        "terseLabel": "Equity cure period"
       }
      }
     },
     "localname": "DebtInstrumentLiquidityCovenantTerm",
     "nsuri": "http://silkroadmed.com/20191231",
     "presentation": [
      "http://silkroadmed.com/role/LongtermDebtTermLoanNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "silk_DebtMaximumBorrowingCapacity": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt, Maximum Borrowing Capacity",
        "label": "Debt, Maximum Borrowing Capacity",
        "terseLabel": "Term loan agreement amount"
       }
      }
     },
     "localname": "DebtMaximumBorrowingCapacity",
     "nsuri": "http://silkroadmed.com/20191231",
     "presentation": [
      "http://silkroadmed.com/role/LongtermDebtTermLoanNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "silk_DeferredTaxAssetsOperatingLeaseLiability": {
     "auth_ref": [],
     "calculation": {
      "http://silkroadmed.com/role/IncomeTaxesNetDeferredTaxAssetsDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Deferred Tax Assets, Operating Lease, Liability",
        "label": "Deferred Tax Assets, Operating Lease, Liability",
        "terseLabel": "Operating lease liability"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLeaseLiability",
     "nsuri": "http://silkroadmed.com/20191231",
     "presentation": [
      "http://silkroadmed.com/role/IncomeTaxesNetDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "silk_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset": {
     "auth_ref": [],
     "calculation": {
      "http://silkroadmed.com/role/IncomeTaxesNetDeferredTaxAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Deferred Tax Liabilities, Operating Lease, Right-Of-Use Asset",
        "label": "Deferred Tax Liabilities, Operating Lease, Right-Of-Use Asset",
        "negatedLabel": "Operating lease asset"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset",
     "nsuri": "http://silkroadmed.com/20191231",
     "presentation": [
      "http://silkroadmed.com/role/IncomeTaxesNetDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "silk_EffectiveIncomeTaxRateReconciliationWarrantLiabilityAdjustmentAmount": {
     "auth_ref": [],
     "calculation": {
      "http://silkroadmed.com/role/IncomeTaxesReconciliationofUSStatutoryRateDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Warrant Liability Adjustment, Amount",
        "label": "Effective Income Tax Rate Reconciliation, Warrant Liability Adjustment, Amount",
        "terseLabel": "Loss on Series C warrant liability"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationWarrantLiabilityAdjustmentAmount",
     "nsuri": "http://silkroadmed.com/20191231",
     "presentation": [
      "http://silkroadmed.com/role/IncomeTaxesReconciliationofUSStatutoryRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "silk_EmployeeStockPurchasePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Employee Stock Purchase Plan",
        "label": "Employee Stock Purchase Plan [Member]",
        "terseLabel": "Issuance of common stock under employee stock purchase plan"
       }
      }
     },
     "localname": "EmployeeStockPurchasePlanMember",
     "nsuri": "http://silkroadmed.com/20191231",
     "presentation": [
      "http://silkroadmed.com/role/StockholdersEquityDeficitSharesReservedforFutureIssuanceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "silk_ExercisePriceFourMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Exercise Price Four [Member]",
        "label": "Exercise Price Four [Member]",
        "verboseLabel": "Exercise Price Four"
       }
      }
     },
     "localname": "ExercisePriceFourMember",
     "nsuri": "http://silkroadmed.com/20191231",
     "presentation": [
      "http://silkroadmed.com/role/StockOptionPlansInformationbyExercisePriceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "silk_ExercisePriceOneMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Exercise Price One [Member]",
        "label": "Exercise Price One [Member]",
        "terseLabel": "Exercise Price One"
       }
      }
     },
     "localname": "ExercisePriceOneMember",
     "nsuri": "http://silkroadmed.com/20191231",
     "presentation": [
      "http://silkroadmed.com/role/StockOptionPlansInformationbyExercisePriceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "silk_ExercisePriceThreeMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Exercise Price Three [Member]",
        "label": "Exercise Price Three [Member]",
        "verboseLabel": "Exercise Price Three"
       }
      }
     },
     "localname": "ExercisePriceThreeMember",
     "nsuri": "http://silkroadmed.com/20191231",
     "presentation": [
      "http://silkroadmed.com/role/StockOptionPlansInformationbyExercisePriceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "silk_ExercisePriceTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Exercise Price Two [Member]",
        "label": "Exercise Price Two [Member]",
        "verboseLabel": "Exercise Price Two"
       }
      }
     },
     "localname": "ExercisePriceTwoMember",
     "nsuri": "http://silkroadmed.com/20191231",
     "presentation": [
      "http://silkroadmed.com/role/StockOptionPlansInformationbyExercisePriceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "silk_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityReclassifications": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair Value, Measurement With Unobservable Inputs Reconciliation, Recurring Basis, Liability, Reclassifications",
        "label": "Fair Value, Measurement With Unobservable Inputs Reconciliation, Recurring Basis, Liability, Reclassifications",
        "negatedLabel": "Reclassification upon IPO"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityReclassifications",
     "nsuri": "http://silkroadmed.com/20191231",
     "presentation": [
      "http://silkroadmed.com/role/FairValueMeasurementsChangesinRedeemableConvertibleWarrantLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "silk_IPOOtherExpensesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "IPO - Other Expenses [Member]",
        "label": "IPO - Other Expenses [Member]",
        "terseLabel": "IPO - Other Expenses"
       }
      }
     },
     "localname": "IPOOtherExpensesMember",
     "nsuri": "http://silkroadmed.com/20191231",
     "presentation": [
      "http://silkroadmed.com/role/FormationandBusinessoftheCompanyDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "silk_IPOUnderwritingDiscountsAndCommissionsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "IPO - Underwriting Discounts And Commissions [Member]",
        "label": "IPO - Underwriting Discounts And Commissions [Member]",
        "terseLabel": "IPO - Underwriting Discounts And Commissions"
       }
      }
     },
     "localname": "IPOUnderwritingDiscountsAndCommissionsMember",
     "nsuri": "http://silkroadmed.com/20191231",
     "presentation": [
      "http://silkroadmed.com/role/FormationandBusinessoftheCompanyDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "silk_IncentiveStockOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Incentive Stock Option [Member]",
        "label": "Incentive Stock Option [Member]",
        "terseLabel": "ISO"
       }
      }
     },
     "localname": "IncentiveStockOptionMember",
     "nsuri": "http://silkroadmed.com/20191231",
     "presentation": [
      "http://silkroadmed.com/role/StockOptionPlansNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "silk_IncentiveandNonqualifiedStockOptionExercisedMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Incentive and Nonqualified Stock Option, Exercised [Member]",
        "label": "Incentive and Nonqualified Stock Option, Exercised [Member]",
        "terseLabel": "Exercise of options under stock plan"
       }
      }
     },
     "localname": "IncentiveandNonqualifiedStockOptionExercisedMember",
     "nsuri": "http://silkroadmed.com/20191231",
     "presentation": [
      "http://silkroadmed.com/role/StockholdersEquityDeficitSharesReservedforFutureIssuanceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "silk_IncentiveandNonqualifiedStockOptionIssuedMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Incentive and Nonqualified Stock Option, Issued [Member]",
        "label": "Incentive and Nonqualified Stock Option, Issued [Member]",
        "terseLabel": "Issuance of options under stock plan"
       }
      }
     },
     "localname": "IncentiveandNonqualifiedStockOptionIssuedMember",
     "nsuri": "http://silkroadmed.com/20191231",
     "presentation": [
      "http://silkroadmed.com/role/StockholdersEquityDeficitSharesReservedforFutureIssuanceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "silk_IncentiveandNonqualifiedStockOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Incentive and Nonqualified Stock Option [Member]",
        "label": "Incentive and Nonqualified Stock Option [Member]",
        "terseLabel": "ISO and NSO"
       }
      }
     },
     "localname": "IncentiveandNonqualifiedStockOptionMember",
     "nsuri": "http://silkroadmed.com/20191231",
     "presentation": [
      "http://silkroadmed.com/role/StockOptionPlansNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "silk_LongTermDebtAccretionOfClosingFees": {
     "auth_ref": [],
     "calculation": {
      "http://silkroadmed.com/role/LongtermDebtFutureMaturitiesUndertheTermLoanDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Long-Term Debt, Accretion Of Closing Fees",
        "label": "Long-Term Debt, Accretion Of Closing Fees",
        "terseLabel": "Add: Accretion of closing fees"
       }
      }
     },
     "localname": "LongTermDebtAccretionOfClosingFees",
     "nsuri": "http://silkroadmed.com/20191231",
     "presentation": [
      "http://silkroadmed.com/role/LongtermDebtFutureMaturitiesUndertheTermLoanDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "silk_LongTermDebtGrossBeforeAccretionOfClosingFees": {
     "auth_ref": [],
     "calculation": {
      "http://silkroadmed.com/role/LongtermDebtFutureMaturitiesUndertheTermLoanDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Long-Term Debt, Gross, Before Accretion Of Closing Fees",
        "label": "Long-Term Debt, Gross, Before Accretion Of Closing Fees",
        "totalLabel": "Long-term debt, gross before accretion of closing fees"
       }
      }
     },
     "localname": "LongTermDebtGrossBeforeAccretionOfClosingFees",
     "nsuri": "http://silkroadmed.com/20191231",
     "presentation": [
      "http://silkroadmed.com/role/LongtermDebtFutureMaturitiesUndertheTermLoanDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "silk_LongTermDebtUnpaidInterest": {
     "auth_ref": [],
     "calculation": {
      "http://silkroadmed.com/role/LongtermDebtFutureMaturitiesUndertheTermLoanDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Long-Term Debt, Unpaid Interest",
        "label": "Long-Term Debt, Unpaid Interest",
        "negatedTerseLabel": "Less: Amount representing interest"
       }
      }
     },
     "localname": "LongTermDebtUnpaidInterest",
     "nsuri": "http://silkroadmed.com/20191231",
     "presentation": [
      "http://silkroadmed.com/role/LongtermDebtFutureMaturitiesUndertheTermLoanDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "silk_LongTermInvestmentsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Long-Term Investments",
        "label": "Long-Term Investments [Member]",
        "terseLabel": "Long-term investments"
       }
      }
     },
     "localname": "LongTermInvestmentsMember",
     "nsuri": "http://silkroadmed.com/20191231",
     "presentation": [
      "http://silkroadmed.com/role/BalanceSheetComponentsFairValueofAvailableForSaleInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "silk_NetIncomeLossAndComprehensiveIncomeLossNetOfTaxAttributableToParent": {
     "auth_ref": [],
     "calculation": {
      "http://silkroadmed.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Net Income (Loss) And Comprehensive Income (Loss), Net Of Tax, Attributable To Parent",
        "label": "Net Income (Loss) And Comprehensive Income (Loss), Net Of Tax, Attributable To Parent",
        "totalLabel": "Net loss and comprehensive loss attributable to Silk Road Medical, Inc. common stockholders"
       }
      }
     },
     "localname": "NetIncomeLossAndComprehensiveIncomeLossNetOfTaxAttributableToParent",
     "nsuri": "http://silkroadmed.com/20191231",
     "presentation": [
      "http://silkroadmed.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "silk_NeuroCoIncMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "NeuroCo, Inc [Member]",
        "label": "NeuroCo, Inc [Member]",
        "terseLabel": "NeuroCo, Inc"
       }
      }
     },
     "localname": "NeuroCoIncMember",
     "nsuri": "http://silkroadmed.com/20191231",
     "presentation": [
      "http://silkroadmed.com/role/AcquisitionofVariableInterestEntityNeuroCoDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "silk_NonqualifiedStockOptionsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Nonqualified Stock Options [Member]",
        "label": "Nonqualified Stock Options [Member]",
        "terseLabel": "NSO"
       }
      }
     },
     "localname": "NonqualifiedStockOptionsMember",
     "nsuri": "http://silkroadmed.com/20191231",
     "presentation": [
      "http://silkroadmed.com/role/StockOptionPlansNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "silk_NotesReceivableRelatedPartiesInterestRateStatedPercentage": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Notes Receivable, Related Parties, Interest Rate, Stated Percentage",
        "label": "Notes Receivable, Related Parties, Interest Rate, Stated Percentage",
        "terseLabel": "Notes receivable, interest rate"
       }
      }
     },
     "localname": "NotesReceivableRelatedPartiesInterestRateStatedPercentage",
     "nsuri": "http://silkroadmed.com/20191231",
     "presentation": [
      "http://silkroadmed.com/role/AcquisitionofVariableInterestEntityNeuroCoDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "silk_NotesReceivableRelatedPartiesTerm": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Notes Receivable, Related Parties, Term",
        "label": "Notes Receivable, Related Parties, Term",
        "terseLabel": "Notes receivable, term"
       }
      }
     },
     "localname": "NotesReceivableRelatedPartiesTerm",
     "nsuri": "http://silkroadmed.com/20191231",
     "presentation": [
      "http://silkroadmed.com/role/AcquisitionofVariableInterestEntityNeuroCoDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "silk_OperatingLeaseRightOfUseAssetAmortization": {
     "auth_ref": [],
     "calculation": {
      "http://silkroadmed.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Operating Lease, Right-Of-Use Asset, Amortization",
        "label": "Operating Lease, Right-Of-Use Asset, Amortization",
        "terseLabel": "Amortization of right-of-use asset"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAssetAmortization",
     "nsuri": "http://silkroadmed.com/20191231",
     "presentation": [
      "http://silkroadmed.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "silk_OperatingLossCarryforwardOffsetMaximumPercent": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Operating Loss Carryforward, Offset Maximum, Percent",
        "label": "Operating Loss Carryforward, Offset Maximum, Percent",
        "terseLabel": "Percent maximum of federal taxable income to offset with net operating losses"
       }
      }
     },
     "localname": "OperatingLossCarryforwardOffsetMaximumPercent",
     "nsuri": "http://silkroadmed.com/20191231",
     "presentation": [
      "http://silkroadmed.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "silk_PreferredStockWarrantLiability": {
     "auth_ref": [],
     "calculation": {
      "http://silkroadmed.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Preferred Stock Warrant Liability",
        "label": "Preferred Stock Warrant Liability",
        "terseLabel": "Redeemable convertible preferred stock warrant liability"
       }
      }
     },
     "localname": "PreferredStockWarrantLiability",
     "nsuri": "http://silkroadmed.com/20191231",
     "presentation": [
      "http://silkroadmed.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "silk_PreferredStockWarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Preferred Stock Warrants",
        "label": "Preferred Stock Warrants [Member]",
        "terseLabel": "Preferred Stock Warrants"
       }
      }
     },
     "localname": "PreferredStockWarrantsMember",
     "nsuri": "http://silkroadmed.com/20191231",
     "presentation": [
      "http://silkroadmed.com/role/LongtermDebtSeriesCNarrativeDetails",
      "http://silkroadmed.com/role/RedeemableConvertiblePreferredStockNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "silk_ProvisionsForSalesReturns": {
     "auth_ref": [],
     "calculation": {
      "http://silkroadmed.com/role/BalanceSheetComponentsAccruedLiabilitiesDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Provisions For Sales Returns",
        "label": "Provisions For Sales Returns",
        "terseLabel": "Provision for sales returns"
       }
      }
     },
     "localname": "ProvisionsForSalesReturns",
     "nsuri": "http://silkroadmed.com/20191231",
     "presentation": [
      "http://silkroadmed.com/role/BalanceSheetComponentsAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "silk_RedeemableConvertiblePreferredStockWarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Redeemable Convertible Preferred Stock Warrants [Member]",
        "label": "Redeemable Convertible Preferred Stock Warrants [Member]",
        "terseLabel": "Redeemable convertible preferred stock warrants outstanding"
       }
      }
     },
     "localname": "RedeemableConvertiblePreferredStockWarrantsMember",
     "nsuri": "http://silkroadmed.com/20191231",
     "presentation": [
      "http://silkroadmed.com/role/ConsolidatedStatementsofCashFlows",
      "http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesScheduleofPotentiallyDilutiveSecuritiesNotIncludedinCalculationofEarningsperShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "silk_SecondPublicOfferingMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Second Public Offering",
        "label": "Second Public Offering [Member]",
        "terseLabel": "Second Public Offering"
       }
      }
     },
     "localname": "SecondPublicOfferingMember",
     "nsuri": "http://silkroadmed.com/20191231",
     "presentation": [
      "http://silkroadmed.com/role/FormationandBusinessoftheCompanyDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "silk_SeriesA1PreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Series A-1 Preferred Stock [Member]",
        "label": "Series A-1 Preferred Stock [Member]",
        "terseLabel": "Series A-1",
        "verboseLabel": "Conversion of Series A-1 redeemable convertible preferred stock"
       }
      }
     },
     "localname": "SeriesA1PreferredStockMember",
     "nsuri": "http://silkroadmed.com/20191231",
     "presentation": [
      "http://silkroadmed.com/role/RedeemableConvertiblePreferredStockScheduleofRedeemableConvertiblePreferredStockDetails",
      "http://silkroadmed.com/role/StockholdersEquityDeficitSharesReservedforFutureIssuanceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "silk_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Outstanding And Exercisable, Weighted Average Exercise Price",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Outstanding And Exercisable, Weighted Average Exercise Price",
        "terseLabel": "Exercise Price (in USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice",
     "nsuri": "http://silkroadmed.com/20191231",
     "presentation": [
      "http://silkroadmed.com/role/StockOptionPlansInformationbyExercisePriceDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "silk_ShareBasedCompensationArrangementBySharebasedPaymentAwardNumberOfAdditionalSharesAllowableUnderThePlan": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement By Share-based Payment Award, Number Of Additional Shares Allowable Under The Plan",
        "label": "Share-Based Compensation Arrangement By Share-based Payment Award, Number Of Additional Shares Allowable Under The Plan",
        "terseLabel": "Number of additional shares allowable under the plan (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementBySharebasedPaymentAwardNumberOfAdditionalSharesAllowableUnderThePlan",
     "nsuri": "http://silkroadmed.com/20191231",
     "presentation": [
      "http://silkroadmed.com/role/StockOptionPlansNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "silk_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardsAvailableforGrantRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Awards Available for Grant [Roll Forward]",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Awards Available for Grant [Roll Forward]",
        "terseLabel": "Shares Available for Grant"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementbySharebasedPaymentAwardAwardsAvailableforGrantRollForward",
     "nsuri": "http://silkroadmed.com/20191231",
     "presentation": [
      "http://silkroadmed.com/role/StockOptionPlansActivityUnderCompensationPlanDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "silk_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExerciseThresholdasaPercentageofSharePrice": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercise Threshold as a Percentage of Share Price",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercise Threshold as a Percentage of Share Price",
        "terseLabel": "Exercise threshold as a percentage of fair value of shares"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExerciseThresholdasaPercentageofSharePrice",
     "nsuri": "http://silkroadmed.com/20191231",
     "presentation": [
      "http://silkroadmed.com/role/StockOptionPlansNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "silk_StockIssuanceCostsIncurredButNotYetPaid": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Stock Issuance Costs Incurred But Not Yet Paid",
        "label": "Stock Issuance Costs Incurred But Not Yet Paid",
        "terseLabel": "Unpaid deferred offering costs"
       }
      }
     },
     "localname": "StockIssuanceCostsIncurredButNotYetPaid",
     "nsuri": "http://silkroadmed.com/20191231",
     "presentation": [
      "http://silkroadmed.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "silk_StockIssuedDuringPeriodSharesExerciseOfWarrants": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Stock Issued During Period, Shares, Exercise Of Warrants",
        "label": "Stock Issued During Period, Shares, Exercise Of Warrants",
        "terseLabel": "Exercise of warrants (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesExerciseOfWarrants",
     "nsuri": "http://silkroadmed.com/20191231",
     "presentation": [
      "http://silkroadmed.com/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "silk_StockIssuedDuringPeriodValueExerciseOfWarrants": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Stock Issued During Period, Value, Exercise Of Warrants",
        "label": "Stock Issued During Period, Value, Exercise Of Warrants",
        "terseLabel": "Exercise of warrants"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueExerciseOfWarrants",
     "nsuri": "http://silkroadmed.com/20191231",
     "presentation": [
      "http://silkroadmed.com/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "silk_TermLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Term Loan [Member]",
        "label": "Term Loan [Member]",
        "terseLabel": "Term Loan"
       }
      }
     },
     "localname": "TermLoanMember",
     "nsuri": "http://silkroadmed.com/20191231",
     "presentation": [
      "http://silkroadmed.com/role/LongtermDebtTermLoanNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "silk_TermLoanTrancheAMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Term Loan, Tranche A [Member]",
        "label": "Term Loan, Tranche A [Member]",
        "terseLabel": "Term Loan, Tranche A"
       }
      }
     },
     "localname": "TermLoanTrancheAMember",
     "nsuri": "http://silkroadmed.com/20191231",
     "presentation": [
      "http://silkroadmed.com/role/LongtermDebtTermLoanNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "silk_TermLoanTrancheBMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Term Loan, Tranche B [Member]",
        "label": "Term Loan, Tranche B [Member]",
        "terseLabel": "Term Loan, Tranche B"
       }
      }
     },
     "localname": "TermLoanTrancheBMember",
     "nsuri": "http://silkroadmed.com/20191231",
     "presentation": [
      "http://silkroadmed.com/role/LongtermDebtTermLoanNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "silk_TwoThousandNineteenStockOptionPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Two Thousand Nineteen Stock Option Plan [Member]",
        "label": "Two Thousand Nineteen Stock Option Plan [Member]",
        "terseLabel": "2019 Stock Option Plan"
       }
      }
     },
     "localname": "TwoThousandNineteenStockOptionPlanMember",
     "nsuri": "http://silkroadmed.com/20191231",
     "presentation": [
      "http://silkroadmed.com/role/StockOptionPlansNarrativeDetails",
      "http://silkroadmed.com/role/SubsequentEventsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "silk_WarrantsClassifiedAsLiabilitiesPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Warrants Classified As Liabilities [Policy Text Block]",
        "label": "Warrants Classified As Liabilities [Policy Text Block]",
        "terseLabel": "Redeemable Convertible Preferred Stock Warrant Liability"
       }
      }
     },
     "localname": "WarrantsClassifiedAsLiabilitiesPolicyTextBlock",
     "nsuri": "http://silkroadmed.com/20191231",
     "presentation": [
      "http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/StockOptionPlansInformationbyExercisePriceDetails",
      "http://silkroadmed.com/role/StockOptionPlansNarrativeDetails",
      "http://silkroadmed.com/role/StockOptionPlansStockOptionAssumptionsDetails",
      "http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/StockOptionPlansInformationbyExercisePriceDetails",
      "http://silkroadmed.com/role/StockOptionPlansStockOptionAssumptionsDetails",
      "http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Range [Axis]",
        "terseLabel": "Range [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/StockOptionPlansInformationbyExercisePriceDetails",
      "http://silkroadmed.com/role/StockOptionPlansNarrativeDetails",
      "http://silkroadmed.com/role/StockOptionPlansStockOptionAssumptionsDetails",
      "http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Range [Domain]",
        "terseLabel": "Range [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/StockOptionPlansInformationbyExercisePriceDetails",
      "http://silkroadmed.com/role/StockOptionPlansNarrativeDetails",
      "http://silkroadmed.com/role/StockOptionPlansStockOptionAssumptionsDetails",
      "http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RestatementAdjustmentMember": {
     "auth_ref": [
      "r123",
      "r126",
      "r127",
      "r128"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Restatement Adjustment [Member]",
        "terseLabel": "Restatement Adjustment"
       }
      }
     },
     "localname": "RestatementAdjustmentMember",
     "nsuri": "http://fasb.org/srt/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesASC842ImpactonCondensedConsolidatedBalanceSheetDetails",
      "http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesAdjustmenttoPriorPeriodFinancialStatementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RestatementAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Restatement [Axis]",
        "terseLabel": "Restatement [Axis]"
       }
      }
     },
     "localname": "RestatementAxis",
     "nsuri": "http://fasb.org/srt/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesASC842ImpactonCondensedConsolidatedBalanceSheetDetails",
      "http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesAdjustmenttoPriorPeriodFinancialStatementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RestatementDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Restatement [Domain]",
        "terseLabel": "Restatement [Domain]"
       }
      }
     },
     "localname": "RestatementDomain",
     "nsuri": "http://fasb.org/srt/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesASC842ImpactonCondensedConsolidatedBalanceSheetDetails",
      "http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesAdjustmenttoPriorPeriodFinancialStatementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioPreviouslyReportedMember": {
     "auth_ref": [
      "r126",
      "r127",
      "r128"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Previously Reported [Member]",
        "terseLabel": "Previously Reported"
       }
      }
     },
     "localname": "ScenarioPreviouslyReportedMember",
     "nsuri": "http://fasb.org/srt/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesASC842ImpactonCondensedConsolidatedBalanceSheetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingChangesAndErrorCorrectionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Accounting Changes and Error Corrections [Abstract]",
        "terseLabel": "Accounting Changes and Error Corrections [Abstract]"
       }
      }
     },
     "localname": "AccountingChangesAndErrorCorrectionsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingStandardsUpdate201409Member": {
     "auth_ref": [
      "r223"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accounting Standards Update 2014-09 Revenue from Contracts with Customers (Topic 606).",
        "label": "Accounting Standards Update 2014-09 [Member]",
        "terseLabel": "Cumulative effect of change in accounting principle - ASC 606 adoption"
       }
      }
     },
     "localname": "AccountingStandardsUpdate201409Member",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingStandardsUpdate201602Member": {
     "auth_ref": [
      "r352"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accounting Standards Update 2016-02 Leases (Topic 842).",
        "label": "Accounting Standards Update 2016-02 [Member]",
        "terseLabel": "Adjustments Due to ASC 842"
       }
      }
     },
     "localname": "AccountingStandardsUpdate201602Member",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesASC842ImpactonCondensedConsolidatedBalanceSheetDetails",
      "http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesLeasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingStandardsUpdate201609Member": {
     "auth_ref": [
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accounting Standards Update 2016-09 Compensation - Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting.",
        "label": "Accounting Standards Update 2016-09 [Member]",
        "terseLabel": "Cumulative effect of change in accounting treatment - ASU 2016-09",
        "verboseLabel": "Accounting Standards Update 2016-09"
       }
      }
     },
     "localname": "AccountingStandardsUpdate201609Member",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit",
      "http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesStockBasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r45"
     ],
     "calculation": {
      "http://silkroadmed.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r24",
      "r222"
     ],
     "calculation": {
      "http://silkroadmed.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection.",
        "label": "Accounts Receivable, Net, Current",
        "terseLabel": "Accounts receivable, net of allowances of $45 and $22 at December\u00a031, 2019 and 2018, respectively",
        "verboseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/ConsolidatedBalanceSheets",
      "http://silkroadmed.com/role/FormationandBusinessoftheCompanyDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments": {
     "auth_ref": [
      "r101"
     ],
     "calculation": {
      "http://silkroadmed.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 18.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Accretion (Amortization) of Discounts and Premiums, Investments",
        "negatedLabel": "Accretion of discount on investments"
       }
      }
     },
     "localname": "AccretionAmortizationOfDiscountsAndPremiumsInvestments",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r47"
     ],
     "calculation": {
      "http://silkroadmed.com/role/BalanceSheetComponentsAccruedLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://silkroadmed.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "terseLabel": "Accrued liabilities",
        "totalLabel": "Accrued liabilities"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/BalanceSheetComponentsAccruedLiabilitiesDetails",
      "http://silkroadmed.com/role/ConsolidatedBalanceSheets",
      "http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesASC842ImpactonCondensedConsolidatedBalanceSheetDetails",
      "http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesAdjustmenttoPriorPeriodFinancialStatementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedProfessionalFeesCurrent": {
     "auth_ref": [
      "r6",
      "r7",
      "r47"
     ],
     "calculation": {
      "http://silkroadmed.com/role/BalanceSheetComponentsAccruedLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Professional Fees, Current",
        "terseLabel": "Accrued professional services"
       }
      }
     },
     "localname": "AccruedProfessionalFeesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/BalanceSheetComponentsAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedRoyaltiesCurrent": {
     "auth_ref": [
      "r6",
      "r7",
      "r47"
     ],
     "calculation": {
      "http://silkroadmed.com/role/BalanceSheetComponentsAccruedLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for royalties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Royalties, Current",
        "terseLabel": "Accrued royalty expense"
       }
      }
     },
     "localname": "AccruedRoyaltiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/BalanceSheetComponentsAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedSalariesCurrent": {
     "auth_ref": [
      "r6",
      "r7",
      "r47"
     ],
     "calculation": {
      "http://silkroadmed.com/role/BalanceSheetComponentsAccruedLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of the obligations incurred through that date and payable for employees' services provided. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Salaries, Current",
        "terseLabel": "Accrued payroll and related expenses"
       }
      }
     },
     "localname": "AccruedSalariesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/BalanceSheetComponentsAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r43",
      "r182"
     ],
     "calculation": {
      "http://silkroadmed.com/role/BalanceSheetComponentsPropertyPlantandEquipmentDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "negatedTerseLabel": "Less: Accumulated depreciation and amortization"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/BalanceSheetComponentsPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r67",
      "r68",
      "r69"
     ],
     "calculation": {
      "http://silkroadmed.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive income"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r66",
      "r69",
      "r70",
      "r318"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Income"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r25"
     ],
     "calculation": {
      "http://silkroadmed.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.",
        "label": "Additional Paid in Capital",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-in Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsForErrorCorrectionDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Represents the types error corrections made to the financial statements.",
        "label": "Adjustments for Error Correction [Domain]",
        "terseLabel": "Adjustments for Error Correction [Domain]"
       }
      }
     },
     "localname": "AdjustmentsForErrorCorrectionDomain",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesAdjustmenttoPriorPeriodFinancialStatementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": {
     "auth_ref": [
      "r122"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by new accounting pronouncement.",
        "label": "Adjustments for New Accounting Pronouncements [Axis]",
        "terseLabel": "Adjustments for New Accounting Pronouncements [Axis]"
       }
      }
     },
     "localname": "AdjustmentsForNewAccountingPronouncementsAxis",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit",
      "http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesASC842ImpactonCondensedConsolidatedBalanceSheetDetails",
      "http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesLeasesDetails",
      "http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesStockBasedCompensationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase in additional paid-in capital (APIC) from recognition of equity-based compensation for employee stock purchase program.",
        "label": "Adjustments to Additional Paid in Capital, Share-based Compensation, Employee Stock Purchase Program, Requisite Service Period Recognition",
        "terseLabel": "Employee stock-based compensation"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) from recognition of equity-based compensation for stock options.",
        "label": "Adjustments to Additional Paid in Capital, Share-based Compensation, Stock Options, Requisite Service Period Recognition",
        "terseLabel": "Nonemployee stock-based compensation"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net loss to net cash used in operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdvertisingCostsPolicyTextBlock": {
     "auth_ref": [
      "r109",
      "r177",
      "r178"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for advertising costs. For those costs that cannot be capitalized, discloses whether such costs are expensed as incurred or the first period in which the advertising takes place. For direct response advertising costs that are capitalized, describes those assets and the accounting policy used, including a description of the qualifying activity, the types of costs capitalized and the related amortization period. An entity also may disclose its accounting policy for cooperative advertising arrangements.",
        "label": "Advertising Costs, Policy [Policy Text Block]",
        "terseLabel": "Advertising Costs"
       }
      }
     },
     "localname": "AdvertisingCostsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AdvertisingExpense": {
     "auth_ref": [
      "r271"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.",
        "label": "Advertising Expense",
        "terseLabel": "Advertising expense"
       }
      }
     },
     "localname": "AdvertisingExpense",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesAdvertisingCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r231",
      "r255",
      "r269"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Represents the expense recognized during the period arising from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees.",
        "label": "Allocated Share-based Compensation Expense",
        "terseLabel": "Compensation expense for share-based awards",
        "verboseLabel": "Stock-based compensation expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/StockOptionPlansNarrativeDetails",
      "http://silkroadmed.com/role/StockOptionPlansStockbasedCompensationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivable": {
     "auth_ref": [
      "r57",
      "r154"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "For an unclassified balance sheet, a valuation allowance for receivables due a company that are expected to be uncollectible.",
        "label": "Allowance for Doubtful Accounts Receivable",
        "terseLabel": "Allowances for accounts receivables"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfFinancingCostsAndDiscounts": {
     "auth_ref": [
      "r100",
      "r347"
     ],
     "calculation": {
      "http://silkroadmed.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.",
        "label": "Amortization of Debt Issuance Costs and Discounts",
        "terseLabel": "Amortization of debt discount and debt issuance costs"
       }
      }
     },
     "localname": "AmortizationOfFinancingCostsAndDiscounts",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r131"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Antidilutive securities excluded from computation of earnings per share (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesScheduleofPotentiallyDilutiveSecuritiesNotIncludedinCalculationofEarningsperShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r131"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities [Axis]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesScheduleofPotentiallyDilutiveSecuritiesNotIncludedinCalculationofEarningsperShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesScheduleofPotentiallyDilutiveSecuritiesNotIncludedinCalculationofEarningsperShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r131"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name [Domain]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesScheduleofPotentiallyDilutiveSecuritiesNotIncludedinCalculationofEarningsperShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AssetBackedSecuritiesMember": {
     "auth_ref": [
      "r164",
      "r225"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Securities that are primarily serviced by the cash flows of a discrete pool of receivables or other financial assets for example, but not limited to, credit card receivables, car loans, recreational vehicle loans, and mobile home loans.",
        "label": "Asset-backed Securities [Member]",
        "terseLabel": "Asset-backed securities"
       }
      }
     },
     "localname": "AssetBackedSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/BalanceSheetComponentsFairValueofAvailableForSaleInvestmentsDetails",
      "http://silkroadmed.com/role/FairValueMeasurementsRecurringAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r149",
      "r389",
      "r407"
     ],
     "calculation": {
      "http://silkroadmed.com/role/ConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r3",
      "r4",
      "r61"
     ],
     "calculation": {
      "http://silkroadmed.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "auth_ref": [
      "r326"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Fair Value Disclosure",
        "terseLabel": "Assets, Fair Value Disclosure"
       }
      }
     },
     "localname": "AssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/FairValueMeasurementsRecurringAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": {
     "auth_ref": [
      "r162"
     ],
     "calculation": {
      "http://silkroadmed.com/role/BalanceSheetComponentsFairValueofAvailableForSaleInvestmentsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax",
        "terseLabel": "Gross Unrealized Gains"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/BalanceSheetComponentsFairValueofAvailableForSaleInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": {
     "auth_ref": [
      "r163"
     ],
     "calculation": {
      "http://silkroadmed.com/role/BalanceSheetComponentsFairValueofAvailableForSaleInvestmentsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax",
        "negatedLabel": "Gross Unrealized Losses"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/BalanceSheetComponentsFairValueofAvailableForSaleInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": {
     "auth_ref": [
      "r160"
     ],
     "calculation": {
      "http://silkroadmed.com/role/BalanceSheetComponentsFairValueofAvailableForSaleInvestmentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Amortized Cost",
        "totalLabel": "Amortized Cost"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/BalanceSheetComponentsFairValueofAvailableForSaleInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "auth_ref": [
      "r158",
      "r161"
     ],
     "calculation": {
      "http://silkroadmed.com/role/BalanceSheetComponentsFairValueofAvailableForSaleInvestmentsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale",
        "terseLabel": "Estimated Fair Value"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/BalanceSheetComponentsFairValueofAvailableForSaleInvestmentsDetails",
      "http://silkroadmed.com/role/FairValueMeasurementsRecurringAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent": {
     "auth_ref": [
      "r159"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.",
        "label": "Debt Securities, Available-for-sale, Current",
        "terseLabel": "Available-for-sale investments"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecuritiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/FormationandBusinessoftheCompanyDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r232",
      "r257"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by award type pertaining to equity-based compensation.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/StockOptionPlansNarrativeDetails",
      "http://silkroadmed.com/role/StockOptionPlansStockOptionAssumptionsDetails",
      "http://silkroadmed.com/role/StockholdersEquityDeficitSharesReservedforFutureIssuanceDetails",
      "http://silkroadmed.com/role/SubsequentEventsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Preparation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r121"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).  Accounting policies describe all significant accounting policies of the reporting entity.",
        "label": "Basis of Presentation and Significant Accounting Policies [Text Block]",
        "terseLabel": "Summary of Significant Accounting Policies"
       }
      }
     },
     "localname": "BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/SummaryofSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/AcquisitionofVariableInterestEntityNeuroCoDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r305",
      "r306"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/AcquisitionofVariableInterestEntityNeuroCoDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued": {
     "auth_ref": [
      "r307"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of shares of equity interests issued or issuable to acquire entity.",
        "label": "Business Acquisition, Equity Interest Issued or Issuable, Number of Shares",
        "terseLabel": "Shares issued as consideration (in shares)"
       }
      }
     },
     "localname": "BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/AcquisitionofVariableInterestEntityNeuroCoDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]",
        "terseLabel": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/AcquisitionofVariableInterestEntityNeuroCoDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired": {
     "auth_ref": [
      "r304"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage of voting equity interests acquired at the acquisition date in the business combination.",
        "label": "Business Acquisition, Percentage of Voting Interests Acquired",
        "terseLabel": "Equity interest acquired"
       }
      }
     },
     "localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/AcquisitionofVariableInterestEntityNeuroCoDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "auth_ref": [
      "r308"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).",
        "label": "Business Combination Disclosure [Text Block]",
        "terseLabel": "Acquisition of Variable Interest Entity - NeuroCo"
       }
      }
     },
     "localname": "BusinessCombinationDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/AcquisitionofVariableInterestEntityNeuroCo"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessCombinationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Business Combinations [Abstract]",
        "terseLabel": "Business Combinations [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CapitalExpendituresIncurredButNotYetPaid": {
     "auth_ref": [
      "r105",
      "r106",
      "r107"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred.",
        "label": "Capital Expenditures Incurred but Not yet Paid",
        "terseLabel": "Accounts payable and accrued liabilities for purchases of property and equipment"
       }
      }
     },
     "localname": "CapitalExpendituresIncurredButNotYetPaid",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r1",
      "r39",
      "r102"
     ],
     "calculation": {
      "http://silkroadmed.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesCashCashEquivalentsandRestrictedCashDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/ConsolidatedBalanceSheets",
      "http://silkroadmed.com/role/FormationandBusinessoftheCompanyDetails",
      "http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesCashCashEquivalentsandRestrictedCashDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsFairValueDisclosure": {
     "auth_ref": [],
     "calculation": {
      "http://silkroadmed.com/role/BalanceSheetComponentsFairValueofCashEquivalentsShortTermandLongTermInvestmentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents, Fair Value Disclosure",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "CashAndCashEquivalentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/BalanceSheetComponentsFairValueofCashEquivalentsShortTermandLongTermInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy": {
     "auth_ref": [
      "r11",
      "r103",
      "r109",
      "r151",
      "r388"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Entity's cash and cash equivalents accounting policy with respect to restricted balances.  Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.",
        "label": "Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Cash, Cash Equivalents and Restricted Cash"
       }
      }
     },
     "localname": "CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r96",
      "r102",
      "r108"
     ],
     "calculation": {
      "http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesCashCashEquivalentsandRestrictedCashDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "Cash, cash equivalents and restricted cash, end of year",
        "periodStartLabel": "Cash, cash equivalents and restricted cash, beginning of year",
        "totalLabel": "Total cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/ConsolidatedStatementsofCashFlows",
      "http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesCashCashEquivalentsandRestrictedCashDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r96",
      "r342"
     ],
     "calculation": {
      "http://silkroadmed.com/role/ConsolidatedStatementsofCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net change in cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashEquivalentsMember": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash Equivalents [Member]",
        "terseLabel": "Cash equivalents"
       }
      }
     },
     "localname": "CashEquivalentsMember",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/BalanceSheetComponentsFairValueofAvailableForSaleInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/FairValueMeasurementsNarrativeDetails",
      "http://silkroadmed.com/role/LongtermDebtSeriesCNarrativeDetails",
      "http://silkroadmed.com/role/RedeemableConvertiblePreferredStockNarrativeDetails",
      "http://silkroadmed.com/role/RedeemableConvertiblePreferredStockScheduleofRedeemableConvertiblePreferredStockDetails",
      "http://silkroadmed.com/role/StockholdersEquityDeficitSharesReservedforFutureIssuanceDetails",
      "http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesRedeemableConvertiblePreferredStockDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Class of Stock [Line Items]",
        "terseLabel": "Class of Stock [Line Items]"
       }
      }
     },
     "localname": "ClassOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/FairValueMeasurementsNarrativeDetails",
      "http://silkroadmed.com/role/LongtermDebtSeriesCNarrativeDetails",
      "http://silkroadmed.com/role/StockholdersEquityDeficitSharesReservedforFutureIssuanceDetails",
      "http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesRedeemableConvertiblePreferredStockDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfWarrantOrRightAxis": {
     "auth_ref": [
      "r118",
      "r212",
      "r213",
      "r230"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of warrant or right issued.",
        "label": "Class of Warrant or Right [Axis]",
        "terseLabel": "Class of Warrant or Right [Axis]"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightAxis",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/ConsolidatedStatementsofCashFlows",
      "http://silkroadmed.com/role/LongtermDebtSeriesCNarrativeDetails",
      "http://silkroadmed.com/role/RedeemableConvertiblePreferredStockNarrativeDetails",
      "http://silkroadmed.com/role/StockholdersEquityDeficitNarrativeDetails",
      "http://silkroadmed.com/role/StockholdersEquityDeficitSharesReservedforFutureIssuanceDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfWarrantOrRightDomain": {
     "auth_ref": [
      "r114"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months.",
        "label": "Class of Warrant or Right [Domain]",
        "terseLabel": "Class of Warrant or Right [Domain]"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightDomain",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/ConsolidatedStatementsofCashFlows",
      "http://silkroadmed.com/role/LongtermDebtSeriesCNarrativeDetails",
      "http://silkroadmed.com/role/RedeemableConvertiblePreferredStockNarrativeDetails",
      "http://silkroadmed.com/role/StockholdersEquityDeficitNarrativeDetails",
      "http://silkroadmed.com/role/StockholdersEquityDeficitSharesReservedforFutureIssuanceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfWarrantOrRightLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Class of Warrant or Right [Line Items]",
        "terseLabel": "Class of Warrant or Right [Line Items]"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightLineItems",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/StockholdersEquityDeficitNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfWarrantOrRightOutstanding": {
     "auth_ref": [
      "r118"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of warrants or rights outstanding.",
        "label": "Class of Warrant or Right, Outstanding",
        "terseLabel": "Warrants outstanding (in shares)"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/LongtermDebtSeriesCNarrativeDetails",
      "http://silkroadmed.com/role/RedeemableConvertiblePreferredStockNarrativeDetails",
      "http://silkroadmed.com/role/StockholdersEquityDeficitNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ClassOfWarrantOrRightTable": {
     "auth_ref": [
      "r114",
      "r212",
      "r213",
      "r230"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure for warrants or rights issued, which includes the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.",
        "label": "Class of Warrant or Right [Table]",
        "terseLabel": "Class of Warrant or Right [Table]"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightTable",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/StockholdersEquityDeficitNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommercialPaperMember": {
     "auth_ref": [
      "r189"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds.",
        "label": "Commercial Paper [Member]",
        "terseLabel": "Commercial paper"
       }
      }
     },
     "localname": "CommercialPaperMember",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/BalanceSheetComponentsFairValueofAvailableForSaleInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommercialPaperNotIncludedWithCashAndCashEquivalentsMember": {
     "auth_ref": [
      "r225",
      "r333"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds that is excluded from cash and cash equivalents.",
        "label": "Commercial Paper, Not Included with Cash and Cash Equivalents [Member]",
        "terseLabel": "Commercial Paper, Not Included with Cash and Cash Equivalents"
       }
      }
     },
     "localname": "CommercialPaperNotIncludedWithCashAndCashEquivalentsMember",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/FairValueMeasurementsRecurringAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r52",
      "r187",
      "r398",
      "r414"
     ],
     "calculation": {
      "http://silkroadmed.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies (Note 7)"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r186",
      "r188"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/CommitmentsandContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": {
     "auth_ref": [
      "r55"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate number of common shares reserved for future issuance.",
        "label": "Common Stock, Capital Shares Reserved for Future Issuance",
        "terseLabel": "Common stock reserved for future issuance (in shares)"
       }
      }
     },
     "localname": "CommonStockCapitalSharesReservedForFutureIssuance",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/StockOptionPlansNarrativeDetails",
      "http://silkroadmed.com/role/StockholdersEquityDeficitSharesReservedforFutureIssuanceDetails",
      "http://silkroadmed.com/role/SubsequentEventsNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit",
      "http://silkroadmed.com/role/FairValueMeasurementsNarrativeDetails",
      "http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesRedeemableConvertiblePreferredStockDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r23"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (in USD per share)",
        "verboseLabel": "Par value (in USD per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://silkroadmed.com/role/StockholdersEquityDeficitNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r23"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized (in shares)",
        "verboseLabel": "Shares authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://silkroadmed.com/role/StockholdersEquityDeficitNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r23"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, shares issued (in shares)",
        "verboseLabel": "Shares issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://silkroadmed.com/role/StockholdersEquityDeficitNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r23",
      "r202"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "verboseLabel": "Shares outstanding (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://silkroadmed.com/role/StockholdersEquityDeficitNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r23"
     ],
     "calculation": {
      "http://silkroadmed.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Shares issued and outstanding: 31,255,267 and 1,135,310 at December 31, 2019 and 2018, respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CompensationAndRetirementDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Retirement Benefits [Abstract]",
        "terseLabel": "Retirement Benefits [Abstract]"
       }
      }
     },
     "localname": "CompensationAndRetirementDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r73",
      "r75",
      "r311",
      "r321"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "verboseLabel": "Comprehensive loss"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomePolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for comprehensive income.",
        "label": "Comprehensive Income, Policy [Policy Text Block]",
        "terseLabel": "Comprehensive Loss"
       }
      }
     },
     "localname": "ComprehensiveIncomePolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "auth_ref": [
      "r139",
      "r403"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for credit risk.",
        "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]",
        "terseLabel": "Concentration of Credit Risk, and Other Risks and Uncertainties"
       }
      }
     },
     "localname": "ConcentrationRiskCreditRisk",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r109",
      "r313",
      "r322",
      "r323"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Consolidation, Policy [Policy Text Block]",
        "terseLabel": "Principles of Consolidation"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConstructionInProgressMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.",
        "label": "Construction in Progress [Member]",
        "terseLabel": "Construction-in-progress"
       }
      }
     },
     "localname": "ConstructionInProgressMember",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/BalanceSheetComponentsPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "auth_ref": [
      "r216",
      "r217",
      "r222"
     ],
     "calculation": {
      "http://silkroadmed.com/role/BalanceSheetComponentsAccruedLiabilitiesDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Contract with Customer, Liability, Current",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/BalanceSheetComponentsAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConversionOfStockAmountConverted1": {
     "auth_ref": [
      "r105",
      "r106",
      "r107"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The value of the stock converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Conversion of Stock, Amount Converted",
        "terseLabel": "Conversion of redeemable convertible preferred stock to common stock upon initial public offering"
       }
      }
     },
     "localname": "ConversionOfStockAmountConverted1",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConversionOfStockAmountIssued1": {
     "auth_ref": [
      "r105",
      "r106",
      "r107"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The value of the financial instrument issued [noncash or part noncash] in the conversion of stock. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Conversion of Stock, Amount Issued",
        "terseLabel": "Net exercise of redeemable convertible preferred stock warrants to preferred stock"
       }
      }
     },
     "localname": "ConversionOfStockAmountIssued1",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConversionOfStockSharesConverted1": {
     "auth_ref": [
      "r105",
      "r106",
      "r107"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Conversion of Stock, Shares Converted",
        "terseLabel": "Shares of common stock converted (in shares)"
       }
      }
     },
     "localname": "ConversionOfStockSharesConverted1",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/RedeemableConvertiblePreferredStockNarrativeDetails",
      "http://silkroadmed.com/role/StockholdersEquityDeficitNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ConvertiblePreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Preferred stock that may be exchanged into common shares or other types of securities at the owner's option.",
        "label": "Convertible Preferred Stock [Member]",
        "terseLabel": "Convertible Preferred Stock"
       }
      }
     },
     "localname": "ConvertiblePreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/RedeemableConvertiblePreferredStockNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CorporateDebtSecuritiesMember": {
     "auth_ref": [
      "r225",
      "r228"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt securities issued by domestic or foreign corporate business, banks and other entities with a promise of repayment.",
        "label": "Corporate Debt Securities [Member]",
        "terseLabel": "Corporate bonds/notes"
       }
      }
     },
     "localname": "CorporateDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/BalanceSheetComponentsAvailableforSaleInvestmentsinUnrealizedLossPositionDetails",
      "http://silkroadmed.com/role/BalanceSheetComponentsFairValueofAvailableForSaleInvestmentsDetails",
      "http://silkroadmed.com/role/FairValueMeasurementsRecurringAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r80"
     ],
     "calculation": {
      "http://silkroadmed.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "terseLabel": "Cost of goods sold"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfSalesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primary financial statement caption encompassing cost of sales.",
        "label": "Cost of Sales [Member]",
        "terseLabel": "Cost of goods sold"
       }
      }
     },
     "localname": "CostOfSalesMember",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/StockOptionPlansStockbasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) to equity or (increase) decrease to net assets, resulting from the cumulative effect adjustment of a new accounting principle applied in the period of adoption.",
        "label": "Cumulative Effect of New Accounting Principle in Period of Adoption",
        "negatedLabel": "Cumulative effect of change in accounting principle/treatment",
        "terseLabel": "Cumulative effect of change in accounting principle/treatment"
       }
      }
     },
     "localname": "CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit",
      "http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesStockBasedCompensationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r195"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "Long-term Debt"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/LongtermDebt"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "auth_ref": [
      "r16",
      "r192",
      "r391",
      "r405"
     ],
     "calculation": {
      "http://silkroadmed.com/role/LongtermDebtFutureMaturitiesUndertheTermLoanDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.",
        "label": "Long-term Debt, Gross",
        "terseLabel": "Debt drawn down",
        "totalLabel": "Long-term debt, gross"
       }
      }
     },
     "localname": "DebtInstrumentCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/LongtermDebtFutureMaturitiesUndertheTermLoanDetails",
      "http://silkroadmed.com/role/LongtermDebtTermLoanNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r49"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Stated interest rate"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/LongtermDebtTermLoanNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/LongtermDebtTermLoanNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r50",
      "r116",
      "r203",
      "r206",
      "r207",
      "r208",
      "r345",
      "r346",
      "r348",
      "r402"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/LongtermDebtTermLoanNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet": {
     "auth_ref": [
      "r193",
      "r347"
     ],
     "calculation": {
      "http://silkroadmed.com/role/LongtermDebtFutureMaturitiesUndertheTermLoanDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of unamortized debt discount (premium) and debt issuance costs.",
        "label": "Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net",
        "negatedTerseLabel": "Less: Amount representing debt discount and debt issuance costs"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/LongtermDebtFutureMaturitiesUndertheTermLoanDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months": {
     "auth_ref": [
      "r166"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months.",
        "label": "Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months",
        "terseLabel": "Fair Value, Less than 12 months"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/BalanceSheetComponentsAvailableforSaleInvestmentsinUnrealizedLossPositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss": {
     "auth_ref": [
      "r166"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months.",
        "label": "Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss",
        "negatedLabel": "Unrealized Loss, Less than 12 months"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/BalanceSheetComponentsAvailableforSaleInvestmentsinUnrealizedLossPositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTable": {
     "auth_ref": [
      "r167"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale [Table]",
        "terseLabel": "Debt Securities, Available-for-sale [Table]"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleTable",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/BalanceSheetComponentsAvailableforSaleInvestmentsinUnrealizedLossPositionDetails",
      "http://silkroadmed.com/role/BalanceSheetComponentsFairValueofAvailableForSaleInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock": {
     "auth_ref": [
      "r167"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale [Table Text Block]",
        "terseLabel": "Fair Value of the Available-For-Sale Investments"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/BalanceSheetComponentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTerm": {
     "auth_ref": [
      "r330"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Period between issuance and maturity of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Debt Securities, Available-for-sale, Term",
        "terseLabel": "Weighted average days to maturity"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleTerm",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/BalanceSheetComponentsNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_DeferredChargesPolicyTextBlock": {
     "auth_ref": [
      "r44",
      "r109"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for deferral and amortization of significant deferred charges.",
        "label": "Deferred Charges, Policy [Policy Text Block]",
        "terseLabel": "Deferred Public Offering Costs"
       }
      }
     },
     "localname": "DeferredChargesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilities": {
     "auth_ref": [
      "r17",
      "r18",
      "r290",
      "r390",
      "r404"
     ],
     "calculation": {
      "http://silkroadmed.com/role/IncomeTaxesNetDeferredTaxAssetsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences.",
        "label": "Deferred Tax Liabilities, Gross",
        "negatedTotalLabel": "Total deferred tax liabilities"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/IncomeTaxesNetDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredOfferingCosts": {
     "auth_ref": [
      "r60",
      "r176"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Specific incremental costs directly attributable to a proposed or actual offering of securities which are deferred at the end of the reporting period.",
        "label": "Deferred Offering Costs",
        "terseLabel": "Deferred initial public offering costs"
       }
      }
     },
     "localname": "DeferredOfferingCosts",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesDeferredInitialPublicOfferingCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets": {
     "auth_ref": [],
     "calculation": {
      "http://silkroadmed.com/role/IncomeTaxesNetDeferredTaxAssetsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from intangible assets including goodwill.",
        "label": "Deferred Tax Assets, Goodwill and Intangible Assets",
        "terseLabel": "Capitalized start-up costs/Intangibles"
       }
      }
     },
     "localname": "DeferredTaxAssetsGoodwillAndIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/IncomeTaxesNetDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "auth_ref": [
      "r291"
     ],
     "calculation": {
      "http://silkroadmed.com/role/IncomeTaxesNetDeferredTaxAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Gross",
        "totalLabel": "Total deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/IncomeTaxesNetDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsNet": {
     "auth_ref": [
      "r292"
     ],
     "calculation": {
      "http://silkroadmed.com/role/IncomeTaxesNetDeferredTaxAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Net of Valuation Allowance",
        "totalLabel": "Net deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/IncomeTaxesNetDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Deferred Tax Assets, Net [Abstract]",
        "verboseLabel": "Deferred tax assets:"
       }
      }
     },
     "localname": "DeferredTaxAssetsNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/IncomeTaxesNetDeferredTaxAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "auth_ref": [
      "r273",
      "r298",
      "r299"
     ],
     "calculation": {
      "http://silkroadmed.com/role/IncomeTaxesNetDeferredTaxAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards",
        "terseLabel": "Net operating loss carryforwards"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/IncomeTaxesNetDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment": {
     "auth_ref": [],
     "calculation": {
      "http://silkroadmed.com/role/IncomeTaxesNetDeferredTaxAssetsDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from property, plant, and equipment.",
        "label": "Deferred Tax Assets, Property, Plant and Equipment",
        "terseLabel": "Property and equipment"
       }
      }
     },
     "localname": "DeferredTaxAssetsPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/IncomeTaxesNetDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch": {
     "auth_ref": [
      "r296",
      "r298",
      "r299"
     ],
     "calculation": {
      "http://silkroadmed.com/role/IncomeTaxesNetDeferredTaxAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards.",
        "label": "Deferred Tax Assets, Tax Credit Carryforwards, Research",
        "terseLabel": "Research and development credits"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxCreditCarryforwardsResearch",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/IncomeTaxesNetDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": {
     "auth_ref": [
      "r273",
      "r298",
      "r299"
     ],
     "calculation": {
      "http://silkroadmed.com/role/IncomeTaxesNetDeferredTaxAssetsDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/IncomeTaxesNetDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals": {
     "auth_ref": [
      "r274",
      "r298",
      "r299"
     ],
     "calculation": {
      "http://silkroadmed.com/role/IncomeTaxesNetDeferredTaxAssetsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from reserves and accruals.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals",
        "terseLabel": "Accruals and reserves"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/IncomeTaxesNetDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r293"
     ],
     "calculation": {
      "http://silkroadmed.com/role/IncomeTaxesNetDeferredTaxAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "negatedLabel": "Less: Valuation allowance"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/IncomeTaxesNetDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedContributionPlanCostRecognized": {
     "auth_ref": [
      "r229"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cost for defined contribution plan.",
        "label": "Defined Contribution Plan, Cost",
        "terseLabel": "Employer discretionary contribution"
       }
      }
     },
     "localname": "DefinedContributionPlanCostRecognized",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/A401kPlanDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedContributionPlanDisclosuresTableTextBlock": {
     "auth_ref": [
      "r229"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of defined contribution pension plans or defined contribution other postretirement plans, separately for pension plans and other postretirement benefit plans.",
        "label": "Defined Contribution Plan Disclosures [Table Text Block]",
        "terseLabel": "401(k) Plan"
       }
      }
     },
     "localname": "DefinedContributionPlanDisclosuresTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/A401kPlan"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage of employees' gross pay for which the employer contributes a matching contribution to a defined contribution plan.",
        "label": "Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay",
        "terseLabel": "Percent of matching contribution of the employee's pay"
       }
      }
     },
     "localname": "DefinedContributionPlanEmployerMatchingContributionPercent",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/A401kPlanDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage employer matches of the employee's percentage contribution matched.",
        "label": "Defined Contribution Plan, Employer Matching Contribution, Percent of Match",
        "terseLabel": "Employer contribution match percentage"
       }
      }
     },
     "localname": "DefinedContributionPlanEmployerMatchingContributionPercentOfMatch",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/A401kPlanDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Maximum percentage of employee gross pay the employee may contribute to a defined contribution plan.",
        "label": "Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent",
        "terseLabel": "Percentage employee contribution"
       }
      }
     },
     "localname": "DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/A401kPlanDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r100",
      "r180"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/BalanceSheetComponentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r100",
      "r147"
     ],
     "calculation": {
      "http://silkroadmed.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization expense"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLiabilities": {
     "auth_ref": [
      "r62",
      "r63",
      "r339"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Liability",
        "terseLabel": "Derivative Liability"
       }
      }
     },
     "localname": "DerivativeLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/FairValueMeasurementsRecurringAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r214",
      "r270"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details.",
        "label": "Disclosure of Compensation Related Costs, Share-based Payments [Text Block]",
        "terseLabel": "Stock Option Plans"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/StockOptionPlans"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Disclosure of Compensation Related Costs, Share-based Payments [Abstract]",
        "terseLabel": "Disclosure of Compensation Related Costs, Share-based Payments [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DividendsCommonStock": {
     "auth_ref": [
      "r209",
      "r401"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK).",
        "label": "Dividends, Common Stock",
        "terseLabel": "Dividends declared"
       }
      }
     },
     "localname": "DividendsCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/StockholdersEquityDeficitNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DomesticCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Designated tax department of the government that is entitled to levy and collect income taxes from the entity in its country of domicile.",
        "label": "Domestic Tax Authority [Member]",
        "terseLabel": "Domestic Tax Authority"
       }
      }
     },
     "localname": "DomesticCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EarningsPerShareBasicAndDiluted": {
     "auth_ref": [
      "r130"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic and Diluted",
        "terseLabel": "Net loss per share attributable to Silk Road Medical, Inc. common stockholders, basic and diluted (in USD per share)",
        "verboseLabel": "Net loss per share, basic and diluted (in USD per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasicAndDiluted",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss",
      "http://silkroadmed.com/role/QuarterlyFinancialInformationunauditedDetails",
      "http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesScheduleofEarningsPerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r109",
      "r131",
      "r132",
      "r133"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "terseLabel": "Net Loss per Share Attributable to Common Stockholders and Unaudited Pro Forma Net Loss per Share Attributable to Common Stockholders"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/StockOptionPlansStockbasedCompensationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r256"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average period over which unrecognized compensation is expected to be recognized for equity-based compensation plans, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Compensation expensed not yet recognized, period for recognition"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/StockOptionPlansNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": {
     "auth_ref": [
      "r256"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Unrecognized cost of unvested options awarded to employees as compensation.",
        "label": "Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Stock Options",
        "terseLabel": "Compensation expensed not yet recognized"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/StockOptionPlansNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "An arrangement whereby an employee is entitled to receive in the future, subject to vesting and other restrictions, a number of shares in the entity at a specified price, as defined in the agreement. Although there are variations, normally, after vesting, when an option is exercised, the employee-holder pays the strike value in cash to the issuing employer-entity and receives equity shares. The equity shares can be sold into the market for cash at the current market price without restriction. Options may be used to attract, retain and incentivize employees, in addition to their regular salary and other benefits.",
        "label": "Employee Stock Option [Member]",
        "terseLabel": "Common stock options",
        "verboseLabel": "2019 ESPP"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/StockOptionPlansNarrativeDetails",
      "http://silkroadmed.com/role/StockOptionPlansStockOptionAssumptionsDetails",
      "http://silkroadmed.com/role/SubsequentEventsNarrativeDetails",
      "http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesScheduleofPotentiallyDilutiveSecuritiesNotIncludedinCalculationofEarningsperShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tangible personal property used to produce goods and services.",
        "label": "Equipment [Member]",
        "terseLabel": "Equipment"
       }
      }
     },
     "localname": "EquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/BalanceSheetComponentsPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Equity [Abstract]",
        "terseLabel": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r202"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit",
      "http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesStockBasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis": {
     "auth_ref": [
      "r126",
      "r127",
      "r128"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of error correction.",
        "label": "Adjustments for Error Corrections [Axis]",
        "terseLabel": "Adjustments for Error Corrections [Axis]"
       }
      }
     },
     "localname": "ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesAdjustmenttoPriorPeriodFinancialStatementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Error Corrections and Prior Period Adjustments Restatement [Line Items]",
        "terseLabel": "Error Corrections and Prior Period Adjustments Restatement [Line Items]"
       }
      }
     },
     "localname": "ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesAdjustmenttoPriorPeriodFinancialStatementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAdjustmentOfWarrants": {
     "auth_ref": [
      "r100",
      "r196"
     ],
     "calculation": {
      "http://silkroadmed.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of expense (income) related to adjustment to fair value of warrant liability.",
        "label": "Fair Value Adjustment of Warrants",
        "terseLabel": "Change in fair value of redeemable convertible preferred stock warrant liability"
       }
      }
     },
     "localname": "FairValueAdjustmentOfWarrants",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/FairValueMeasurementsFairValueAssumptionsDetails",
      "http://silkroadmed.com/role/FairValueMeasurementsRecurringAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r325",
      "r326",
      "r327",
      "r328",
      "r334",
      "r335"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about financial instruments measured at fair value, including those classified in shareholders' equity measured on a recurring or nonrecurring basis. Disclosures include, but are not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2. Nonrecurring fair value measurements are those that are required or permitted in the statement of financial position in particular circumstances.",
        "label": "Fair Value Measurements, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value Measurements, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/FairValueMeasurementsFairValueAssumptionsDetails",
      "http://silkroadmed.com/role/FairValueMeasurementsRecurringAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock": {
     "auth_ref": [
      "r329"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.",
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]",
        "terseLabel": "Option Pricing Model Assumptions"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueByBalanceSheetGroupingTextBlock": {
     "auth_ref": [
      "r326",
      "r340"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.",
        "label": "Fair Value, by Balance Sheet Grouping [Table Text Block]",
        "terseLabel": "Fair Value of Cash Equivalents, Short-Term and Long-Term Equivalents"
       }
      }
     },
     "localname": "FairValueByBalanceSheetGroupingTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/BalanceSheetComponentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r225",
      "r226",
      "r228",
      "r327",
      "r371"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/FairValueMeasurementsFairValueAssumptionsDetails",
      "http://silkroadmed.com/role/FairValueMeasurementsRecurringAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r325"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/FairValueMeasurementsFairValueAssumptionsDetails",
      "http://silkroadmed.com/role/FairValueMeasurementsRecurringAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r337"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/FairValueMeasurements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r225",
      "r226",
      "r228",
      "r327",
      "r372"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level 1"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/FairValueMeasurementsRecurringAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r225",
      "r226",
      "r228",
      "r327",
      "r373"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/FairValueMeasurementsRecurringAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r225",
      "r226",
      "r228",
      "r327",
      "r374"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Level 3"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/FairValueMeasurementsFairValueAssumptionsDetails",
      "http://silkroadmed.com/role/FairValueMeasurementsRecurringAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]",
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/FairValueMeasurementsChangesinRedeemableConvertibleWarrantLiabilityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": {
     "auth_ref": [
      "r331",
      "r335"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]",
        "terseLabel": "Changes in the Redeemable Convertible Warrant Liability"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [
      "r325",
      "r333"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Provides the general categories used to describe the frequency with which financial assets and liabilities (as defined) are measured at fair value (on a recurring or nonrecurring basis).",
        "label": "Fair Value, Measurement Frequency [Domain]",
        "terseLabel": "Fair Value, Measurement Frequency [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/FairValueMeasurementsFairValueAssumptionsDetails",
      "http://silkroadmed.com/role/FairValueMeasurementsRecurringAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings": {
     "auth_ref": [
      "r332"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of gain (loss) recognized on the income statement for financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings",
        "negatedLabel": "Change in fair value recorded in other income (expense), net"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/FairValueMeasurementsChangesinRedeemableConvertibleWarrantLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": {
     "auth_ref": [
      "r331"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/FairValueMeasurementsChangesinRedeemableConvertibleWarrantLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/FairValueMeasurementsFairValueAssumptionsDetails",
      "http://silkroadmed.com/role/FairValueMeasurementsRecurringAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r325",
      "r333"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "This item represents a description of the frequency with which certain items are measured at fair value. Items measured at fair value on a recurring basis generally include those items for which measurement inputs are readily available and which are measured at fair value at successive reporting periods.",
        "label": "Fair Value, Measurements, Recurring [Member]",
        "terseLabel": "Recurring"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/FairValueMeasurementsFairValueAssumptionsDetails",
      "http://silkroadmed.com/role/FairValueMeasurementsRecurringAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueOfFinancialInstrumentsPolicy": {
     "auth_ref": [
      "r109",
      "r336",
      "r338"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.",
        "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]",
        "terseLabel": "Fair Value of Financial Instruments"
       }
      }
     },
     "localname": "FairValueOfFinancialInstrumentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]",
        "terseLabel": "Financial Instrument [Axis]"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/BalanceSheetComponentsAvailableforSaleInvestmentsinUnrealizedLossPositionDetails",
      "http://silkroadmed.com/role/BalanceSheetComponentsFairValueofAvailableForSaleInvestmentsDetails",
      "http://silkroadmed.com/role/FairValueMeasurementsRecurringAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": {
     "auth_ref": [
      "r109",
      "r341",
      "r343"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.",
        "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]",
        "terseLabel": "Foreign Currency"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.",
        "label": "Furniture and Fixtures [Member]",
        "terseLabel": "Furniture and fixtures"
       }
      }
     },
     "localname": "FurnitureAndFixturesMember",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/BalanceSheetComponentsPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainLossOnSaleOfPropertyPlantEquipment": {
     "auth_ref": [
      "r100"
     ],
     "calculation": {
      "http://silkroadmed.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 17.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.",
        "label": "Gain (Loss) on Disposition of Property Plant Equipment",
        "negatedTerseLabel": "Loss on disposal of property and equipment"
       }
      }
     },
     "localname": "GainLossOnSaleOfPropertyPlantEquipment",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r79"
     ],
     "calculation": {
      "http://silkroadmed.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "terseLabel": "Gross Profit",
        "totalLabel": "Gross profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss",
      "http://silkroadmed.com/role/QuarterlyFinancialInformationunauditedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IPOMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "First sale of stock by a private company to the public.",
        "label": "IPO [Member]",
        "terseLabel": "IPO"
       }
      }
     },
     "localname": "IPOMember",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit",
      "http://silkroadmed.com/role/FormationandBusinessoftheCompanyDetails",
      "http://silkroadmed.com/role/RedeemableConvertiblePreferredStockNarrativeDetails",
      "http://silkroadmed.com/role/StockholdersEquityDeficitNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": {
     "auth_ref": [
      "r109",
      "r179",
      "r185"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.",
        "label": "Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]",
        "terseLabel": "Impairment of Long-Lived Assets"
       }
      }
     },
     "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": {
     "auth_ref": [
      "r117"
     ],
     "calculation": {
      "http://silkroadmed.com/role/IncomeTaxesComponentsofIncomeBeforeTaxesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Domestic",
        "terseLabel": "United States"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/IncomeTaxesComponentsofIncomeBeforeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign": {
     "auth_ref": [
      "r117"
     ],
     "calculation": {
      "http://silkroadmed.com/role/IncomeTaxesComponentsofIncomeBeforeTaxesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Foreign",
        "terseLabel": "International"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/IncomeTaxesComponentsofIncomeBeforeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r117"
     ],
     "calculation": {
      "http://silkroadmed.com/role/IncomeTaxesComponentsofIncomeBeforeTaxesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.",
        "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/IncomeTaxesComponentsofIncomeBeforeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r184"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/StockOptionPlansStockbasedCompensationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/StockOptionPlansStockbasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "auth_ref": [
      "r283"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by tax jurisdiction.",
        "label": "Income Tax Authority [Axis]",
        "terseLabel": "Income Tax Authority [Axis]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityAxis",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority [Domain]",
        "terseLabel": "Income Tax Authority [Domain]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityDomain",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r303"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r113",
      "r148",
      "r301"
     ],
     "calculation": {
      "http://silkroadmed.com/role/IncomeTaxesReconciliationofUSStatutoryRateDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "totalLabel": "Provision for income taxes"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/IncomeTaxesReconciliationofUSStatutoryRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r109",
      "r277",
      "r278",
      "r288",
      "r289",
      "r295",
      "r302",
      "r419"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Tax, Policy [Policy Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r276",
      "r279",
      "r280"
     ],
     "calculation": {
      "http://silkroadmed.com/role/IncomeTaxesReconciliationofUSStatutoryRateDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.",
        "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount",
        "terseLabel": "Change in valuation allowance"
       }
      }
     },
     "localname": "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/IncomeTaxesReconciliationofUSStatutoryRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r112",
      "r279",
      "r280"
     ],
     "calculation": {
      "http://silkroadmed.com/role/IncomeTaxesReconciliationofUSStatutoryRateDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount",
        "terseLabel": "Tax at federal statutory rate"
       }
      }
     },
     "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/IncomeTaxesReconciliationofUSStatutoryRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationNondeductibleExpense": {
     "auth_ref": [
      "r279",
      "r280"
     ],
     "calculation": {
      "http://silkroadmed.com/role/IncomeTaxesReconciliationofUSStatutoryRateDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses.",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount",
        "terseLabel": "Permanent differences"
       }
      }
     },
     "localname": "IncomeTaxReconciliationNondeductibleExpense",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/IncomeTaxesReconciliationofUSStatutoryRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationOtherReconcilingItems": {
     "auth_ref": [
      "r279",
      "r280"
     ],
     "calculation": {
      "http://silkroadmed.com/role/IncomeTaxesReconciliationofUSStatutoryRateDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax exempt income, equity in earnings (loss) of an unconsolidated subsidiary, minority noncontrolling interest income (loss), tax holiday, disposition of a business, disposition of an asset, repatriation of foreign earnings, repatriation of foreign earnings jobs creation act of 2004, increase (decrease) in enacted tax rate, prior year income taxes, increase (decrease) in deferred tax asset valuation allowance, and other adjustments.",
        "label": "Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "IncomeTaxReconciliationOtherReconcilingItems",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/IncomeTaxesReconciliationofUSStatutoryRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes": {
     "auth_ref": [
      "r112",
      "r279",
      "r280"
     ],
     "calculation": {
      "http://silkroadmed.com/role/IncomeTaxesReconciliationofUSStatutoryRateDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount",
        "terseLabel": "State taxes, net of federal benefit"
       }
      }
     },
     "localname": "IncomeTaxReconciliationStateAndLocalIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/IncomeTaxesReconciliationofUSStatutoryRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationTaxCredits": {
     "auth_ref": [
      "r279",
      "r280"
     ],
     "calculation": {
      "http://silkroadmed.com/role/IncomeTaxesReconciliationofUSStatutoryRateDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax credits. Including, but not limited to, research credit, foreign tax credit, investment tax credit, and other tax credits.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Amount",
        "negatedTerseLabel": "General business credits"
       }
      }
     },
     "localname": "IncomeTaxReconciliationTaxCredits",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/IncomeTaxesReconciliationofUSStatutoryRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r99"
     ],
     "calculation": {
      "http://silkroadmed.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r99"
     ],
     "calculation": {
      "http://silkroadmed.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedTerseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilities": {
     "auth_ref": [
      "r99"
     ],
     "calculation": {
      "http://silkroadmed.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.",
        "label": "Increase (Decrease) in Accrued Liabilities",
        "terseLabel": "Accrued liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r99"
     ],
     "calculation": {
      "http://silkroadmed.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedTerseLabel": "Inventories"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in assets and liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherNoncurrentAssets": {
     "auth_ref": [
      "r99"
     ],
     "calculation": {
      "http://silkroadmed.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) in noncurrent assets classified as other.",
        "label": "Increase (Decrease) in Other Noncurrent Assets",
        "negatedTerseLabel": "Other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherNoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingLiabilities": {
     "auth_ref": [
      "r99"
     ],
     "calculation": {
      "http://silkroadmed.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Operating Liabilities",
        "terseLabel": "Other liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r99"
     ],
     "calculation": {
      "http://silkroadmed.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedTerseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r77",
      "r146",
      "r344",
      "r347",
      "r400"
     ],
     "calculation": {
      "http://silkroadmed.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "order": 3.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "negatedTerseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r94",
      "r97",
      "r104"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Cash paid for interest"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryFinishedGoodsNetOfReserves": {
     "auth_ref": [
      "r31",
      "r175"
     ],
     "calculation": {
      "http://silkroadmed.com/role/BalanceSheetComponentsScheduleofInventoryDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.",
        "label": "Inventory, Finished Goods, Net of Reserves",
        "terseLabel": "Finished products"
       }
      }
     },
     "localname": "InventoryFinishedGoodsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/BalanceSheetComponentsScheduleofInventoryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r2",
      "r58",
      "r171"
     ],
     "calculation": {
      "http://silkroadmed.com/role/BalanceSheetComponentsScheduleofInventoryDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://silkroadmed.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventories",
        "totalLabel": "Total inventory"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/BalanceSheetComponentsScheduleofInventoryDetails",
      "http://silkroadmed.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryPolicyTextBlock": {
     "auth_ref": [
      "r9",
      "r59",
      "r109",
      "r134",
      "r172",
      "r174"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.",
        "label": "Inventory, Policy [Policy Text Block]",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryRawMaterialsNetOfReserves": {
     "auth_ref": [
      "r33",
      "r175"
     ],
     "calculation": {
      "http://silkroadmed.com/role/BalanceSheetComponentsScheduleofInventoryDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.",
        "label": "Inventory, Raw Materials, Net of Reserves",
        "terseLabel": "Raw materials"
       }
      }
     },
     "localname": "InventoryRawMaterialsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/BalanceSheetComponentsScheduleofInventoryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWorkInProcessNetOfReserves": {
     "auth_ref": [
      "r32",
      "r175"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.",
        "label": "Inventory, Work in Process, Net of Reserves",
        "terseLabel": "Work-in-process inventories"
       }
      }
     },
     "localname": "InventoryWorkInProcessNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/BalanceSheetComponentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWriteDown": {
     "auth_ref": [
      "r81",
      "r169",
      "r170",
      "r173"
     ],
     "calculation": {
      "http://silkroadmed.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.",
        "label": "Inventory Write-down",
        "terseLabel": "Provision for excess and obsolete inventories"
       }
      }
     },
     "localname": "InventoryWriteDown",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeInterest": {
     "auth_ref": [
      "r84",
      "r145"
     ],
     "calculation": {
      "http://silkroadmed.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.",
        "label": "Investment Income, Interest",
        "terseLabel": "Interest income"
       }
      }
     },
     "localname": "InvestmentIncomeInterest",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "auth_ref": [
      "r181"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Additions or improvements to assets held under a lease arrangement.",
        "label": "Leasehold Improvements [Member]",
        "terseLabel": "Leasehold improvements"
       }
      }
     },
     "localname": "LeaseholdImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/BalanceSheetComponentsPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "auth_ref": [
      "r356"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.",
        "label": "Lessee, Leases [Policy Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeLeasesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r363"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]",
        "terseLabel": "Operating Lease Maturities"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/CommitmentsandContingenciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r363"
     ],
     "calculation": {
      "http://silkroadmed.com/role/CommitmentsandContingenciesOperatingLeaseMaturitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://silkroadmed.com/role/CommitmentsandContingenciesOperatingLeaseMaturitiesDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Payments, Due",
        "totalLabel": "Total lease payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/CommitmentsandContingenciesOperatingLeaseMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r363"
     ],
     "calculation": {
      "http://silkroadmed.com/role/CommitmentsandContingenciesOperatingLeaseMaturitiesDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease, due in next fiscal year following latest fiscal year.",
        "label": "Lessee, Operating Lease, Liability, Payments, Due Next Twelve Months",
        "terseLabel": "2020"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/CommitmentsandContingenciesOperatingLeaseMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r363"
     ],
     "calculation": {
      "http://silkroadmed.com/role/CommitmentsandContingenciesOperatingLeaseMaturitiesDetails_1": {
       "order": 5.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease, due in fifth fiscal year following latest fiscal year.",
        "label": "Lessee, Operating Lease, Liability, Payments, Due Year Five",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/CommitmentsandContingenciesOperatingLeaseMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r363"
     ],
     "calculation": {
      "http://silkroadmed.com/role/CommitmentsandContingenciesOperatingLeaseMaturitiesDetails_1": {
       "order": 4.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease, due in fourth fiscal year following latest fiscal year.",
        "label": "Lessee, Operating Lease, Liability, Payments, Due Year Four",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/CommitmentsandContingenciesOperatingLeaseMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r363"
     ],
     "calculation": {
      "http://silkroadmed.com/role/CommitmentsandContingenciesOperatingLeaseMaturitiesDetails_1": {
       "order": 3.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease, due in third fiscal year following latest fiscal year.",
        "label": "Lessee, Operating Lease, Liability, Payments, Due Year Three",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/CommitmentsandContingenciesOperatingLeaseMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r363"
     ],
     "calculation": {
      "http://silkroadmed.com/role/CommitmentsandContingenciesOperatingLeaseMaturitiesDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease, due in second fiscal year following latest fiscal year.",
        "label": "Lessee, Operating Lease, Liability, Payments, Due Year Two",
        "terseLabel": "2021"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/CommitmentsandContingenciesOperatingLeaseMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r363"
     ],
     "calculation": {
      "http://silkroadmed.com/role/CommitmentsandContingenciesOperatingLeaseMaturitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "negatedTerseLabel": "Less: imputed interest"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/CommitmentsandContingenciesOperatingLeaseMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseRenewalTerm": {
     "auth_ref": [
      "r357"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Renewal Term",
        "terseLabel": "Renewal term"
       }
      }
     },
     "localname": "LesseeOperatingLeaseRenewalTerm",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/CommitmentsandContingenciesLeaseNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LetterOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A document typically issued by a financial institution which acts as a guarantee of payment to a beneficiary, or as the source of payment for a specific transaction (for example, wiring funds to a foreign exporter if and when specified merchandise is accepted pursuant to the terms of the letter of credit).",
        "label": "Letter of Credit [Member]",
        "terseLabel": "Letter of Credit"
       }
      }
     },
     "localname": "LetterOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesCashCashEquivalentsandRestrictedCashDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r46"
     ],
     "calculation": {
      "http://silkroadmed.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r29",
      "r392",
      "r411"
     ],
     "calculation": {
      "http://silkroadmed.com/role/ConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and stockholders\u2019 equity (deficit)"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "Liabilities, redeemable convertible preferred stock and stockholders\u2019 equity (deficit)"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r48"
     ],
     "calculation": {
      "http://silkroadmed.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r16",
      "r194",
      "r391",
      "r408"
     ],
     "calculation": {
      "http://silkroadmed.com/role/LongtermDebtFutureMaturitiesUndertheTermLoanDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt",
        "terseLabel": "Long-term debt",
        "totalLabel": "Present value of minimum payments"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/LongtermDebtFutureMaturitiesUndertheTermLoanDetails",
      "http://silkroadmed.com/role/LongtermDebtTermLoanNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": {
     "auth_ref": [
      "r120",
      "r190"
     ],
     "calculation": {
      "http://silkroadmed.com/role/LongtermDebtFutureMaturitiesUndertheTermLoanDetails": {
       "order": 1.0,
       "parentTag": "silk_LongTermDebtGrossBeforeAccretionOfClosingFees",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Long-term Debt, Maturities, Repayments of Principal in Next Twelve Months",
        "terseLabel": "2020"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/LongtermDebtFutureMaturitiesUndertheTermLoanDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": {
     "auth_ref": [
      "r120",
      "r190"
     ],
     "calculation": {
      "http://silkroadmed.com/role/LongtermDebtFutureMaturitiesUndertheTermLoanDetails": {
       "order": 2.0,
       "parentTag": "silk_LongTermDebtGrossBeforeAccretionOfClosingFees",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Long-term Debt, Maturities, Repayments of Principal in Year Three",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/LongtermDebtFutureMaturitiesUndertheTermLoanDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": {
     "auth_ref": [
      "r120",
      "r190"
     ],
     "calculation": {
      "http://silkroadmed.com/role/LongtermDebtFutureMaturitiesUndertheTermLoanDetails": {
       "order": 3.0,
       "parentTag": "silk_LongTermDebtGrossBeforeAccretionOfClosingFees",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Long-term Debt, Maturities, Repayments of Principal in Year Two",
        "terseLabel": "2021"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/LongtermDebtFutureMaturitiesUndertheTermLoanDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "auth_ref": [
      "r50"
     ],
     "calculation": {
      "http://silkroadmed.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt, Excluding Current Maturities",
        "terseLabel": "Long-term debt"
       }
      }
     },
     "localname": "LongTermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermInvestments": {
     "auth_ref": [
      "r40"
     ],
     "calculation": {
      "http://silkroadmed.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle).",
        "label": "Long-term Investments",
        "terseLabel": "Long-term investments"
       }
      }
     },
     "localname": "LongTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r50"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/LongtermDebtTermLoanNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r50",
      "r191"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/LongtermDebtTermLoanNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputDiscountForLackOfMarketabilityMember": {
     "auth_ref": [
      "r329"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Measurement input using amount by which value of business ownership interest is reduced to reflect lack of ability to convert business interest into cash quickly.",
        "label": "Measurement Input, Discount for Lack of Marketability [Member]",
        "terseLabel": "Marketability discount rate"
       }
      }
     },
     "localname": "MeasurementInputDiscountForLackOfMarketabilityMember",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/FairValueMeasurementsFairValueAssumptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputDiscountRateMember": {
     "auth_ref": [
      "r329"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Measurement input using interest rate to determine present value of future cash flows.",
        "label": "Measurement Input, Discount Rate [Member]",
        "terseLabel": "Discounted cash flow rate"
       }
      }
     },
     "localname": "MeasurementInputDiscountRateMember",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/FairValueMeasurementsFairValueAssumptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputOptionVolatilityMember": {
     "auth_ref": [
      "r329"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Measurement input using rate at which price of option increases (decreases) for given set of returns.",
        "label": "Measurement Input, Option Volatility [Member]",
        "terseLabel": "Expected volatility"
       }
      }
     },
     "localname": "MeasurementInputOptionVolatilityMember",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/FairValueMeasurementsFairValueAssumptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputRiskFreeInterestRateMember": {
     "auth_ref": [
      "r329"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Measurement input using interest rate on instrument with zero risk of financial loss.",
        "label": "Measurement Input, Risk Free Interest Rate [Member]",
        "terseLabel": "Risk-free interest rate"
       }
      }
     },
     "localname": "MeasurementInputRiskFreeInterestRateMember",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/FairValueMeasurementsFairValueAssumptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputTypeAxis": {
     "auth_ref": [
      "r329"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Axis]",
        "terseLabel": "Measurement Input Type [Axis]"
       }
      }
     },
     "localname": "MeasurementInputTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/FairValueMeasurementsFairValueAssumptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MeasurementInputTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Domain]",
        "terseLabel": "Measurement Input Type [Domain]"
       }
      }
     },
     "localname": "MeasurementInputTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/FairValueMeasurementsFairValueAssumptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MoneyMarketFundsMember": {
     "auth_ref": [
      "r225"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities.",
        "label": "Money Market Funds [Member]",
        "terseLabel": "Money market funds"
       }
      }
     },
     "localname": "MoneyMarketFundsMember",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/BalanceSheetComponentsFairValueofAvailableForSaleInvestmentsDetails",
      "http://silkroadmed.com/role/FairValueMeasurementsRecurringAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r96"
     ],
     "calculation": {
      "http://silkroadmed.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Cash flows from financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r96"
     ],
     "calculation": {
      "http://silkroadmed.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Cash flows from investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r96",
      "r98",
      "r101"
     ],
     "calculation": {
      "http://silkroadmed.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash used in operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Cash flows from operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r71",
      "r74",
      "r78",
      "r101",
      "r132",
      "r399",
      "r416"
     ],
     "calculation": {
      "http://silkroadmed.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "order": 1.0,
       "parentTag": "silk_NetIncomeLossAndComprehensiveIncomeLossNetOfTaxAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "totalLabel": "Net loss attributable to Silk Road Medical, Inc. common stockholders",
        "verboseLabel": "Net loss attributable to Silk Road Medical, Inc. common stockholders"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss",
      "http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesScheduleofEarningsPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r71",
      "r74",
      "r315",
      "r320"
     ],
     "calculation": {
      "http://silkroadmed.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.",
        "label": "Net Income (Loss) Attributable to Noncontrolling Interest",
        "negatedTerseLabel": "Net loss attributable to non-controlling interest"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock": {
     "auth_ref": [
      "r129"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure of changes in accounting principles, including adoption of new accounting pronouncements, that describes the new methods, amount and effects on financial statement line items.",
        "label": "New Accounting Pronouncements and Changes in Accounting Principles [Text Block]",
        "terseLabel": "Recent Accounting Pronouncements"
       }
      }
     },
     "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/RecentAccountingPronouncements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]",
        "terseLabel": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesASC842ImpactonCondensedConsolidatedBalanceSheetDetails",
      "http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesLeasesDetails",
      "http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesStockBasedCompensationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable": {
     "auth_ref": [
      "r122",
      "r124",
      "r125"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Summarization of the changes in an accounting principle or a new accounting pronouncement, including the line items affected by the change and the financial effects of the change on those particular line items.",
        "label": "New Accounting Pronouncements or Change in Accounting Principle [Table]",
        "terseLabel": "New Accounting Pronouncements or Change in Accounting Principle [Table]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleTable",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesASC842ImpactonCondensedConsolidatedBalanceSheetDetails",
      "http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesLeasesDetails",
      "http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesStockBasedCompensationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Recent Accounting Pronouncements"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncashInvestingAndFinancingItemsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Noncash Investing and Financing Items [Abstract]",
        "terseLabel": "Non-cash investing and financing activities:"
       }
      }
     },
     "localname": "NoncashInvestingAndFinancingItemsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NoncontrollingInterestInVariableInterestEntity": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Portion of equity (net assets) in a variable interest entity (VIE) not attributable, directly or indirectly, to the parent entity. That is, this is the portion of equity in a VIE that is attributable to the noncontrolling interest (previously referred to as minority interest).",
        "label": "Noncontrolling Interest in Variable Interest Entity",
        "terseLabel": "Carrying amount of the non-controlling interest"
       }
      }
     },
     "localname": "NoncontrollingInterestInVariableInterestEntity",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/AcquisitionofVariableInterestEntityNeuroCoDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance": {
     "auth_ref": [
      "r210",
      "r312",
      "r317"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase in noncontrolling interest from subsidiary issuance of equity interests to noncontrolling interest holders.",
        "label": "Noncontrolling Interest, Increase from Subsidiary Equity Issuance",
        "terseLabel": "NeuroCo common stock issuance"
       }
      }
     },
     "localname": "NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NoncontrollingInterestMember": {
     "auth_ref": [
      "r309"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.",
        "label": "Noncontrolling Interest [Member]",
        "terseLabel": "Non-controlling Interest"
       }
      }
     },
     "localname": "NoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NotesReceivableRelatedParties": {
     "auth_ref": [
      "r119",
      "r365",
      "r415"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "For an unclassified balance sheet, amounts due from parties associated with the reporting entity as evidenced by a written promise to pay.",
        "label": "Notes Receivable, Related Parties",
        "terseLabel": "Promissory note amount"
       }
      }
     },
     "localname": "NotesReceivableRelatedParties",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/AcquisitionofVariableInterestEntityNeuroCoDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NumberOfOperatingSegments": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.",
        "label": "Number of Operating Segments",
        "terseLabel": "Number of operating segments"
       }
      }
     },
     "localname": "NumberOfOperatingSegments",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesSegmentandGeographicalInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NumberOfReportableSegments": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.",
        "label": "Number of Reportable Segments",
        "terseLabel": "Number of reportable segments"
       }
      }
     },
     "localname": "NumberOfReportableSegments",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesSegmentandGeographicalInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://silkroadmed.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "totalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "Operating expenses:"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [],
     "calculation": {
      "http://silkroadmed.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Loss from operations"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseCost": {
     "auth_ref": [
      "r358",
      "r364"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.",
        "label": "Operating Lease, Cost",
        "terseLabel": "Operating lease costs"
       }
      }
     },
     "localname": "OperatingLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/CommitmentsandContingenciesLeaseNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r354"
     ],
     "calculation": {
      "http://silkroadmed.com/role/CommitmentsandContingenciesBalanceSheetInformationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://silkroadmed.com/role/CommitmentsandContingenciesOperatingLeaseMaturitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "terseLabel": "Present value of lease liabilities",
        "totalLabel": "Total operating lease liabilities",
        "verboseLabel": "Operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/CommitmentsandContingenciesBalanceSheetInformationDetails",
      "http://silkroadmed.com/role/CommitmentsandContingenciesOperatingLeaseMaturitiesDetails",
      "http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r354"
     ],
     "calculation": {
      "http://silkroadmed.com/role/BalanceSheetComponentsAccruedLiabilitiesDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      },
      "http://silkroadmed.com/role/CommitmentsandContingenciesBalanceSheetInformationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Operating lease liability"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/BalanceSheetComponentsAccruedLiabilitiesDetails",
      "http://silkroadmed.com/role/CommitmentsandContingenciesBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r354"
     ],
     "calculation": {
      "http://silkroadmed.com/role/CommitmentsandContingenciesBalanceSheetInformationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Operating lease liability in other liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/CommitmentsandContingenciesBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r355",
      "r359"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating Lease, Payments",
        "terseLabel": "Operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/CommitmentsandContingenciesLeaseNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r353"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating lease right-of-use asset in other non-current assets",
        "verboseLabel": "Operating lease right-of-use asset"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/CommitmentsandContingenciesBalanceSheetInformationDetails",
      "http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r362",
      "r364"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Weighted average discount rate"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/CommitmentsandContingenciesLeaseNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r361",
      "r364"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Weighted average remaining lease term"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/CommitmentsandContingenciesLeaseNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsDue": {
     "auth_ref": [
      "r349",
      "r350"
     ],
     "calculation": {
      "http://silkroadmed.com/role/CommitmentsandContingenciesTopic840AggregateFutureMinimumLeasePaymentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of required minimum rental payments for leases having an initial or remaining non-cancelable letter-terms in excess of one year.",
        "label": "Operating Leases, Future Minimum Payments Due",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/CommitmentsandContingenciesTopic840AggregateFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent": {
     "auth_ref": [
      "r349",
      "r350"
     ],
     "calculation": {
      "http://silkroadmed.com/role/CommitmentsandContingenciesTopic840AggregateFutureMinimumLeasePaymentsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingLeasesFutureMinimumPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Operating Leases, Future Minimum Payments Due, Next Twelve Months",
        "verboseLabel": "2019"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsDueCurrent",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/CommitmentsandContingenciesTopic840AggregateFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears": {
     "auth_ref": [
      "r349",
      "r350"
     ],
     "calculation": {
      "http://silkroadmed.com/role/CommitmentsandContingenciesTopic840AggregateFutureMinimumLeasePaymentsDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_OperatingLeasesFutureMinimumPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Operating Leases, Future Minimum Payments, Due in Five Years",
        "terseLabel": "2023 and thereafter"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsDueInFiveYears",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/CommitmentsandContingenciesTopic840AggregateFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears": {
     "auth_ref": [
      "r349",
      "r350"
     ],
     "calculation": {
      "http://silkroadmed.com/role/CommitmentsandContingenciesTopic840AggregateFutureMinimumLeasePaymentsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_OperatingLeasesFutureMinimumPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Operating Leases, Future Minimum Payments, Due in Four Years",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsDueInFourYears",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/CommitmentsandContingenciesTopic840AggregateFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears": {
     "auth_ref": [
      "r349",
      "r350"
     ],
     "calculation": {
      "http://silkroadmed.com/role/CommitmentsandContingenciesTopic840AggregateFutureMinimumLeasePaymentsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingLeasesFutureMinimumPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Operating Leases, Future Minimum Payments, Due in Three Years",
        "terseLabel": "2021"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsDueInThreeYears",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/CommitmentsandContingenciesTopic840AggregateFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears": {
     "auth_ref": [
      "r349",
      "r350"
     ],
     "calculation": {
      "http://silkroadmed.com/role/CommitmentsandContingenciesTopic840AggregateFutureMinimumLeasePaymentsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingLeasesFutureMinimumPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Operating Leases, Future Minimum Payments, Due in Two Years",
        "terseLabel": "2020"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsDueInTwoYears",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/CommitmentsandContingenciesTopic840AggregateFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLossCarryforwards": {
     "auth_ref": [
      "r296"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Operating Loss Carryforwards",
        "terseLabel": "Operating loss carryforwards"
       }
      }
     },
     "localname": "OperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLossCarryforwardsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Operating Loss Carryforwards [Line Items]",
        "terseLabel": "Operating Loss Carryforwards [Line Items]"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLossCarryforwardsTable": {
     "auth_ref": [
      "r297"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule reflecting pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization.",
        "label": "Operating Loss Carryforwards [Table]",
        "terseLabel": "Operating Loss Carryforwards [Table]"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsTable",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "auth_ref": [
      "r0",
      "r324"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]",
        "terseLabel": "Formation and Business of the Company"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/FormationandBusinessoftheCompany"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r6",
      "r7",
      "r8",
      "r47"
     ],
     "calculation": {
      "http://silkroadmed.com/role/BalanceSheetComponentsAccruedLiabilitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Current",
        "terseLabel": "Accrued other expenses"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/BalanceSheetComponentsAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r44"
     ],
     "calculation": {
      "http://silkroadmed.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other non-current assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/ConsolidatedBalanceSheets",
      "http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesASC842ImpactonCondensedConsolidatedBalanceSheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax": {
     "auth_ref": [
      "r65",
      "r67"
     ],
     "calculation": {
      "http://silkroadmed.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax",
        "terseLabel": "Unrealized gain on investments, net"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss",
      "http://silkroadmed.com/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r72",
      "r75",
      "r76",
      "r202"
     ],
     "calculation": {
      "http://silkroadmed.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "order": 2.0,
       "parentTag": "silk_NetIncomeLossAndComprehensiveIncomeLossNetOfTaxAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "totalLabel": "Net change in other comprehensive loss"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Other comprehensive loss:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r51"
     ],
     "calculation": {
      "http://silkroadmed.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/ConsolidatedBalanceSheets",
      "http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesASC842ImpactonCondensedConsolidatedBalanceSheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r85"
     ],
     "calculation": {
      "http://silkroadmed.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "order": 4.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "terseLabel": "Other income (expense), net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OverAllotmentOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Right given to the underwriter to sell additional shares over the initial allotment.",
        "label": "Over-Allotment Option [Member]",
        "terseLabel": "Over-Allotment Option"
       }
      }
     },
     "localname": "OverAllotmentOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/FormationandBusinessoftheCompanyDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PaidInKindInterest": {
     "auth_ref": [
      "r100"
     ],
     "calculation": {
      "http://silkroadmed.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Interest paid other than in cash for example by issuing additional debt securities. As a noncash item, it is added to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Paid-in-Kind Interest",
        "terseLabel": "Non-cash interest expense"
       }
      }
     },
     "localname": "PaidInKindInterest",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForTenantImprovements": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash outflow for the allowance granted to lessee and/or direct costs incurred by lessor used to prepare the leased premises for tenant's occupancy.",
        "label": "Payments for Tenant Improvements",
        "terseLabel": "Landlord paid tenant improvements"
       }
      }
     },
     "localname": "PaymentsForTenantImprovements",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfStockIssuanceCosts": {
     "auth_ref": [
      "r93"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security.",
        "label": "Payments of Stock Issuance Costs",
        "terseLabel": "Offering costs",
        "verboseLabel": "Payments of deferred offering costs"
       }
      }
     },
     "localname": "PaymentsOfStockIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficitParenthetical",
      "http://silkroadmed.com/role/FormationandBusinessoftheCompanyDetails",
      "http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesDeferredInitialPublicOfferingCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireInvestments": {
     "auth_ref": [
      "r89"
     ],
     "calculation": {
      "http://silkroadmed.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow associated with the purchase of all investments (debt, security, other) during the period.",
        "label": "Payments to Acquire Investments",
        "negatedLabel": "Purchases of investments"
       }
      }
     },
     "localname": "PaymentsToAcquireInvestments",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r88"
     ],
     "calculation": {
      "http://silkroadmed.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedTerseLabel": "Purchase of property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r232",
      "r257"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by plan name pertaining to equity-based compensation arrangements.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/StockOptionPlansNarrativeDetails",
      "http://silkroadmed.com/role/SubsequentEventsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the equity-based compensation arrangement plan.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name [Domain]"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/StockOptionPlansNarrativeDetails",
      "http://silkroadmed.com/role/SubsequentEventsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company.",
        "label": "Preferred Stock [Member]",
        "terseLabel": "Redeemable Convertible Preferred Stock"
       }
      }
     },
     "localname": "PreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Preferred Stock, Number of Shares, Par Value and Other Disclosures [Abstract]",
        "terseLabel": "Preferred stock, $0.001 par value"
       }
      }
     },
     "localname": "PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r22"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred shares (in USD per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://silkroadmed.com/role/StockholdersEquityDeficitNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r22"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred shares authorized (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://silkroadmed.com/role/StockholdersEquityDeficitNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r22"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock, shares issued (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r22"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r22"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Shares authorized: 5,000,000 and none at December 31, 2019 and 2018, respectively"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r3",
      "r37",
      "r38"
     ],
     "calculation": {
      "http://silkroadmed.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrincipalOwnerMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Owner of record or known beneficial owner of more than 10 percent of the voting interests of the entity.",
        "label": "Principal Owner [Member]",
        "terseLabel": "10% Stockholders"
       }
      }
     },
     "localname": "PrincipalOwnerMember",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/StockOptionPlansNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProceedsFromIssuanceInitialPublicOffering": {
     "auth_ref": [
      "r90"
     ],
     "calculation": {
      "http://silkroadmed.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from entity's first offering of stock to the public.",
        "label": "Proceeds from Issuance Initial Public Offering",
        "terseLabel": "Proceeds from initial public offering, net of underwriting discount, commissions and offering costs paid"
       }
      }
     },
     "localname": "ProceedsFromIssuanceInitialPublicOffering",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "auth_ref": [
      "r90"
     ],
     "calculation": {
      "http://silkroadmed.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash inflow from the additional capital contribution to the entity.",
        "label": "Proceeds from Issuance of Common Stock",
        "terseLabel": "Proceeds from issuance of common stock"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfLongTermDebt": {
     "auth_ref": [
      "r91"
     ],
     "calculation": {
      "http://silkroadmed.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.",
        "label": "Proceeds from Issuance of Long-term Debt",
        "terseLabel": "Proceeds from long-term debt"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromMinorityShareholders": {
     "auth_ref": [
      "r92"
     ],
     "calculation": {
      "http://silkroadmed.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow from a noncontrolling interest. Includes, but is not limited to, purchase of additional shares or other increase in noncontrolling interest ownership.",
        "label": "Proceeds from Noncontrolling Interests",
        "terseLabel": "Non-controlling interest"
       }
      }
     },
     "localname": "ProceedsFromMinorityShareholders",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment": {
     "auth_ref": [
      "r87"
     ],
     "calculation": {
      "http://silkroadmed.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.",
        "label": "Proceeds from Sale of Property, Plant, and Equipment",
        "terseLabel": "Proceeds from sale of property and equipment"
       }
      }
     },
     "localname": "ProceedsFromSaleOfPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromWarrantExercises": {
     "auth_ref": [
      "r90"
     ],
     "calculation": {
      "http://silkroadmed.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from holders exercising their stock warrants.",
        "label": "Proceeds from Warrant Exercises",
        "terseLabel": "Proceeds from exercise of warrants"
       }
      }
     },
     "localname": "ProceedsFromWarrantExercises",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r71",
      "r74",
      "r95",
      "r149",
      "r150",
      "r311",
      "r314",
      "r316",
      "r320",
      "r321"
     ],
     "calculation": {
      "http://silkroadmed.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      },
      "http://silkroadmed.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Net loss",
        "totalLabel": "Nett loss"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss",
      "http://silkroadmed.com/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit",
      "http://silkroadmed.com/role/ConsolidatedStatementsofCashFlows",
      "http://silkroadmed.com/role/QuarterlyFinancialInformationunauditedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r43",
      "r183"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Property, Plant and Equipment, Type [Axis]",
        "terseLabel": "Property, Plant and Equipment, Type [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/BalanceSheetComponentsPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r42",
      "r181"
     ],
     "calculation": {
      "http://silkroadmed.com/role/BalanceSheetComponentsPropertyPlantandEquipmentDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "terseLabel": "Property and equipment, gross"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/BalanceSheetComponentsPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]",
        "terseLabel": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/BalanceSheetComponentsPropertyPlantandEquipmentDetails",
      "http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r12",
      "r13",
      "r183",
      "r413"
     ],
     "calculation": {
      "http://silkroadmed.com/role/BalanceSheetComponentsPropertyPlantandEquipmentDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://silkroadmed.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property and equipment, net",
        "totalLabel": "Property and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/BalanceSheetComponentsPropertyPlantandEquipmentDetails",
      "http://silkroadmed.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "auth_ref": [
      "r41",
      "r109",
      "r183"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for long-lived, physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, basis of assets, depreciation and depletion methods used, including composite deprecation, estimated useful lives, capitalization policy, accounting treatment for costs incurred for repairs and maintenance, capitalized interest and the method it is calculated, disposals and impairments.",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "terseLabel": "Property and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r12",
      "r183"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "terseLabel": "Property, Plant and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/BalanceSheetComponentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r12",
      "r181"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Property, Plant and Equipment, Type [Domain]",
        "terseLabel": "Property, Plant and Equipment, Type [Domain]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/BalanceSheetComponentsPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
        "label": "Property, Plant and Equipment, Useful Life",
        "terseLabel": "Property and equipment, useful life"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ProvisionForDoubtfulAccounts": {
     "auth_ref": [
      "r83",
      "r218"
     ],
     "calculation": {
      "http://silkroadmed.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of expense related to write-down of receivables to the amount expected to be collected. Includes, but is not limited to, accounts receivable and notes receivable.",
        "label": "Provision for Doubtful Accounts",
        "terseLabel": "Provision for doubtful accounts receivable"
       }
      }
     },
     "localname": "ProvisionForDoubtfulAccounts",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PurchaseObligation": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Minimum amount of purchase arrangement in which the entity has agreed to expend funds to procure goods or services from a supplier.",
        "label": "Purchase Obligation",
        "terseLabel": "Purchase obligation"
       }
      }
     },
     "localname": "PurchaseObligation",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/CommitmentsandContingenciesPurchaseObligationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_QuarterlyFinancialInformationDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Quarterly Financial Information Disclosure [Abstract]"
       }
      }
     },
     "localname": "QuarterlyFinancialInformationDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_QuarterlyFinancialInformationTextBlock": {
     "auth_ref": [
      "r136"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for quarterly financial data. Includes, but is not limited to, tabular presentation of financial information for fiscal quarters, effect of year-end adjustments, and an explanation of matters or transactions that affect comparability of the information.",
        "label": "Quarterly Financial Information [Text Block]",
        "terseLabel": "Quarterly Financial Information (unaudited)"
       }
      }
     },
     "localname": "QuarterlyFinancialInformationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/QuarterlyFinancialInformationunaudited"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]",
        "terseLabel": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]"
       }
      }
     },
     "localname": "ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/IncomeTaxesReconciliationofUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RedeemableConvertiblePreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Description of type or class of redeemable convertible preferred stock. Convertible redeemable preferred stock possess conversion and redemption features. The stock has redemption features that are outside the control of the issuer.",
        "label": "Redeemable Convertible Preferred Stock [Member]",
        "terseLabel": "Redeemable convertible preferred stock outstanding"
       }
      }
     },
     "localname": "RedeemableConvertiblePreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesScheduleofPotentiallyDilutiveSecuritiesNotIncludedinCalculationofEarningsperShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RedeemablePreferredStockMember": {
     "auth_ref": [
      "r10",
      "r198"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Description of type or class of redeemable preferred stock. For instance, cumulative preferred stock, noncumulative preferred stock, convertible or series.",
        "label": "Redeemable Preferred Stock [Member]",
        "terseLabel": "Redeemable Preferred Stock"
       }
      }
     },
     "localname": "RedeemablePreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/FairValueMeasurementsRecurringAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyDomain": {
     "auth_ref": [
      "r368"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Domain]",
        "terseLabel": "Related Party [Domain]"
       }
      }
     },
     "localname": "RelatedPartyDomain",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/StockOptionPlansNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "auth_ref": [
      "r227",
      "r366",
      "r367",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Axis]",
        "terseLabel": "Related Party [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/StockOptionPlansNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r272",
      "r420"
     ],
     "calculation": {
      "http://silkroadmed.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.",
        "label": "Research and Development Expense [Member]",
        "terseLabel": "Research and development expenses"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/StockOptionPlansStockbasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpensePolicy": {
     "auth_ref": [
      "r109",
      "r272"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.",
        "label": "Research and Development Expense, Policy [Policy Text Block]",
        "terseLabel": "Research and Development and Clinical Trials"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpensePolicy",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ResearchMember": {
     "auth_ref": [
      "r297"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Research tax credit carryforwards arising from certain qualifying expenditures incurred to develop new products and processes.",
        "label": "Research Tax Credit Carryforward [Member]",
        "terseLabel": "Research Tax Credit Carryforward"
       }
      }
     },
     "localname": "ResearchMember",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis": {
     "auth_ref": [
      "r39"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by category of cash or cash equivalent items which are restricted as to withdrawal or usage.",
        "label": "Restricted Cash and Cash Equivalents [Axis]",
        "terseLabel": "Restricted Cash and Cash Equivalents [Axis]"
       }
      }
     },
     "localname": "RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesCashCashEquivalentsandRestrictedCashDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Type of cash and cash equivalent. Cash is currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents [Domain]",
        "terseLabel": "Cash and Cash Equivalents [Domain]"
       }
      }
     },
     "localname": "RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesCashCashEquivalentsandRestrictedCashDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Restricted Cash and Cash Equivalents Items [Line Items]",
        "terseLabel": "Restricted Cash and Cash Equivalents Items [Line Items]"
       }
      }
     },
     "localname": "RestrictedCashAndCashEquivalentsItemsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesCashCashEquivalentsandRestrictedCashDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestrictedCashNoncurrent": {
     "auth_ref": [
      "r5",
      "r14",
      "r108",
      "r418"
     ],
     "calculation": {
      "http://silkroadmed.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesCashCashEquivalentsandRestrictedCashDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.",
        "label": "Restricted Cash, Noncurrent",
        "terseLabel": "Restricted cash"
       }
      }
     },
     "localname": "RestrictedCashNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/ConsolidatedBalanceSheets",
      "http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesCashCashEquivalentsandRestrictedCashDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r26",
      "r209",
      "r410"
     ],
     "calculation": {
      "http://silkroadmed.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "negatedLabel": "Accumulated deficit",
        "terseLabel": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/ConsolidatedBalanceSheets",
      "http://silkroadmed.com/role/FormationandBusinessoftheCompanyDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Accumulated Deficit"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit",
      "http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesStockBasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r219",
      "r220",
      "r221"
     ],
     "calculation": {
      "http://silkroadmed.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Revenue"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss",
      "http://silkroadmed.com/role/QuarterlyFinancialInformationunauditedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "auth_ref": [
      "r110",
      "r224"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue from contract with customer.",
        "label": "Revenue from Contract with Customer [Policy Text Block]",
        "terseLabel": "Revenue Recognition and Cost of Goods Sold"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "auth_ref": [
      "r360",
      "r364"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "terseLabel": "Right-of-use asset obtained in exchange for lease obligation"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SaleOfStockConsiderationReceivedOnTransaction": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cash received on stock transaction after deduction of issuance costs.",
        "label": "Sale of Stock, Consideration Received on Transaction",
        "terseLabel": "Net proceeds"
       }
      }
     },
     "localname": "SaleOfStockConsiderationReceivedOnTransaction",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/FormationandBusinessoftheCompanyDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.",
        "label": "Sale of Stock [Domain]",
        "terseLabel": "Sale of Stock [Domain]"
       }
      }
     },
     "localname": "SaleOfStockNameOfTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit",
      "http://silkroadmed.com/role/FormationandBusinessoftheCompanyDetails",
      "http://silkroadmed.com/role/RedeemableConvertiblePreferredStockNarrativeDetails",
      "http://silkroadmed.com/role/StockholdersEquityDeficitNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.",
        "label": "Sale of Stock, Number of Shares Issued in Transaction",
        "terseLabel": "Issued and sold common stock (in shares)",
        "verboseLabel": "Temporary equity, shares issued (in shares)"
       }
      }
     },
     "localname": "SaleOfStockNumberOfSharesIssuedInTransaction",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/FormationandBusinessoftheCompanyDetails",
      "http://silkroadmed.com/role/LongtermDebtSeriesCNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SaleOfStockPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.",
        "label": "Sale of Stock, Price Per Share",
        "terseLabel": "Stock issued, price per share (in USD per share)"
       }
      }
     },
     "localname": "SaleOfStockPricePerShare",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/FormationandBusinessoftheCompanyDetails",
      "http://silkroadmed.com/role/LongtermDebtSeriesCNarrativeDetails",
      "http://silkroadmed.com/role/RedeemableConvertiblePreferredStockNarrativeDetails",
      "http://silkroadmed.com/role/StockholdersEquityDeficitNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ScenarioForecastMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The reporting scenario used to indicate financial results forecast for a future period.",
        "label": "Scenario, Forecast [Member]",
        "terseLabel": "Scenario, Forecast"
       }
      }
     },
     "localname": "ScenarioForecastMember",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/LongtermDebtTermLoanNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScenarioUnspecifiedDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Any scenario, that is, the particular reporting scenario is left unspecified. Scenarios distinguish among different kinds of business reporting facts, as for example actual versus budgeted figures.",
        "label": "Scenario, Unspecified [Domain]",
        "terseLabel": "Scenario, Unspecified [Domain]"
       }
      }
     },
     "localname": "ScenarioUnspecifiedDomain",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/LongtermDebtTermLoanNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the components of accrued liabilities.",
        "label": "Schedule of Accrued Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Accrued Liabilities"
       }
      }
     },
     "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/BalanceSheetComponentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "auth_ref": [
      "r131"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesScheduleofPotentiallyDilutiveSecuritiesNotIncludedinCalculationofEarningsperShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "auth_ref": [
      "r131"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
        "terseLabel": "Schedule of Potentially Dilutive Securities Outstanding Excluded from Diluted Weighted Average Shares Outstanding"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Securities, Available-for-sale [Line Items]",
        "terseLabel": "Debt Securities, Available-for-sale [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/BalanceSheetComponentsAvailableforSaleInvestmentsinUnrealizedLossPositionDetails",
      "http://silkroadmed.com/role/BalanceSheetComponentsFairValueofAvailableForSaleInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r305",
      "r306"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/AcquisitionofVariableInterestEntityNeuroCoDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the components of cash and cash equivalents.",
        "label": "Schedule of Cash and Cash Equivalents [Table Text Block]",
        "terseLabel": "Schedule of Cash and Cash Equivalents"
       }
      }
     },
     "localname": "ScheduleOfCashAndCashEquivalentsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "auth_ref": [
      "r300"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.",
        "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]",
        "terseLabel": "Schedule of Components of Income Tax Expense (Benefit)"
       }
      }
     },
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "auth_ref": [
      "r294"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.",
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Deferred Tax Assets and Liabilities"
       }
      }
     },
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r132"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Net Loss Per Share Determination"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "auth_ref": [
      "r279"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "terseLabel": "Schedule of Effective Income Tax Rate Reconciliation"
       }
      }
     },
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": {
     "auth_ref": [
      "r231",
      "r254",
      "r269"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule that sets forth the allocation of equity-based compensation costs to a given line item on the balance sheet and income statement for the period. This may include the reporting line for the costs and the amount capitalized and expensed.",
        "label": "Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table]",
        "terseLabel": "Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table]"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/StockOptionPlansStockbasedCompensationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": {
     "auth_ref": [
      "r231",
      "r254",
      "r269"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the allocation of equity-based compensation costs to a given line item on the balance sheet and income statement for the period. This may include the reporting line for the costs and the amount capitalized and expensed.",
        "label": "Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block]",
        "terseLabel": "Stock-Based Compensation Expense Relating to Stock Options to Employees and Nonemployees"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/StockOptionPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable": {
     "auth_ref": [
      "r126",
      "r127",
      "r128"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule of prior period adjustments to correct an error in previously issued financial statements. The disclosure may include, but is not limited to: (1) the effect of the correction on each financial statement line item and any per-share amounts affected for each prior period presented (2) the cumulative effect of the change on retained earnings or other appropriate components of equity or net assets in the statement of financial position, as of the beginning of the earliest period presented, and (3) the effect of the prior period adjustment (both gross and net of applicable income tax) on the net income of each prior period presented in the entity's annual report for the year in which the adjustments are made. This table can be used to disclose the amounts as previously reported and the effect of the correction or other adjustment on per line item or per share amount basis. This table uses as its line items financial statement line items that are affected by prior period adjustments.",
        "label": "Schedule of Error Corrections and Prior Period Adjustment Restatement [Table]",
        "terseLabel": "Schedule of Error Corrections and Prior Period Adjustment Restatement [Table]"
       }
      }
     },
     "localname": "ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesAdjustmenttoPriorPeriodFinancialStatementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "auth_ref": [
      "r325"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Financial Liabilities Measure on a Recurring Basis"
       }
      }
     },
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock": {
     "auth_ref": [
      "r351"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of future minimum payments required in the aggregate and for each of the five succeeding fiscal years for operating leases having initial or remaining noncancelable lease terms in excess of one year and the total minimum rentals to be received in the future under noncancelable subleases as of the balance sheet date.",
        "label": "Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]",
        "terseLabel": "Minimum Future Lease Payment Previously Disclosed Under ASC 840"
       }
      }
     },
     "localname": "ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/CommitmentsandContingenciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r9",
      "r34",
      "r35",
      "r36"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "terseLabel": "Schedule of Inventories"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/BalanceSheetComponentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": {
     "auth_ref": [
      "r190"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the combined aggregate amount of maturities and sinking fund requirements for all long-term borrowings for each of the five years following the date of the latest balance sheet date presented.",
        "label": "Schedule of Maturities of Long-term Debt [Table Text Block]",
        "terseLabel": "Future Maturities Under the Term Loan Agreement"
       }
      }
     },
     "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/LongtermDebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r43",
      "r183"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]",
        "terseLabel": "Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/BalanceSheetComponentsPropertyPlantandEquipmentDetails",
      "http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock": {
     "auth_ref": [
      "r135"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of quarterly financial data. Includes, but is not limited to, financial information for fiscal quarters, cumulative effect of a change in accounting principle and earnings per share data.",
        "label": "Quarterly Financial Information [Table Text Block]",
        "terseLabel": "Unaudited Quarterly Financial Information"
       }
      }
     },
     "localname": "ScheduleOfQuarterlyFinancialInformationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/QuarterlyFinancialInformationunauditedTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable": {
     "auth_ref": [
      "r11",
      "r108",
      "r388",
      "r409"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about cash and cash equivalents restricted as to withdrawal or usage.",
        "label": "Restrictions on Cash and Cash Equivalents [Table]",
        "terseLabel": "Restrictions on Cash and Cash Equivalents [Table]"
       }
      }
     },
     "localname": "ScheduleOfRestrictedCashAndCashEquivalentsTable",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesCashCashEquivalentsandRestrictedCashDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock": {
     "auth_ref": [
      "r11",
      "r108",
      "r388",
      "r409"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of cash and cash equivalents restricted as to withdrawal or usage.",
        "label": "Restrictions on Cash and Cash Equivalents [Table Text Block]",
        "terseLabel": "Restrictions on Cash and Cash Equivalents"
       }
      }
     },
     "localname": "ScheduleOfRestrictedCashAndCashEquivalentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r232",
      "r257"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Components of an equity-based arrangement under which compensation is awarded to employees, typically comprised of compensation expense; changes in the quantity and fair value of the shares (or other type of equity) granted, exercised, forfeited, and issued and outstanding pertaining to that plan; and cash flow effects resulting from the equity-based payment arrangement. Component disclosures are by type of award and plan name.",
        "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/StockOptionPlansNarrativeDetails",
      "http://silkroadmed.com/role/StockOptionPlansStockOptionAssumptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable": {
     "auth_ref": [
      "r257"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Details comprising a table providing supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices.",
        "label": "Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table]",
        "terseLabel": "Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/StockOptionPlansInformationbyExercisePriceDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock": {
     "auth_ref": [
      "r257"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.",
        "label": "Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table Text Block]",
        "terseLabel": "Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/StockOptionPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r238",
      "r244",
      "r247"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Share-based Compensation, Stock Options, Activity [Table Text Block]",
        "terseLabel": "Share-based Compensation, Stock Options, Activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/StockOptionPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r250"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "terseLabel": "Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/StockOptionPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "auth_ref": [
      "r54",
      "r115",
      "r197",
      "r200",
      "r201",
      "r203",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.",
        "label": "Schedule of Stock by Class [Table]",
        "terseLabel": "Schedule of Stock by Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfStockByClassTable",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/FairValueMeasurementsNarrativeDetails",
      "http://silkroadmed.com/role/LongtermDebtSeriesCNarrativeDetails",
      "http://silkroadmed.com/role/StockholdersEquityDeficitSharesReservedforFutureIssuanceDetails",
      "http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesRedeemableConvertiblePreferredStockDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfStockByClassTextBlock": {
     "auth_ref": [
      "r21",
      "r22",
      "r23",
      "r111",
      "r198",
      "r200",
      "r201",
      "r203",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of an entity's stock, including par or stated value per share, number and dollar amount of share subscriptions, shares authorized, shares issued, shares outstanding, number and dollar amount of shares held in an employee trust, dividend per share, total dividends, share conversion features, par value plus additional paid in capital, the value of treasury stock and other information necessary to a fair presentation, and EPS information.  Stock by class includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. Includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity. If more than one issue is outstanding, state the title of each issue and the corresponding dollar amount; dollar amount of any shares subscribed but unissued and the deduction of subscriptions receivable there from; number of shares authorized, issued, and outstanding.",
        "label": "Schedule of Stock by Class [Table Text Block]",
        "terseLabel": "Reserved Common Stock for Future Issuances"
       }
      }
     },
     "localname": "ScheduleOfStockByClassTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/StockholdersEquityDeficitTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock": {
     "auth_ref": [
      "r165"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "For all investments in an unrealized loss position, including those for which other-than-temporary impairments have not been recognized in earnings (including investments for which a portion of an other-than-temporary impairment has been recognized in other comprehensive income), a tabular disclosure of the aggregate related fair value of investments with unrealized losses and the aggregate amount of unrealized losses (that is, the amount by which amortized cost basis exceeds fair value).",
        "label": "Schedule of Unrealized Loss on Investments [Table Text Block]",
        "terseLabel": "Available-For-Sale Investments in Unrealized Loss Position"
       }
      }
     },
     "localname": "ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/BalanceSheetComponentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingPolicyPolicyTextBlock": {
     "auth_ref": [
      "r109"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for segment reporting.",
        "label": "Segment Reporting, Policy [Policy Text Block]",
        "terseLabel": "Segment and Geographical Information"
       }
      }
     },
     "localname": "SegmentReportingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r82",
      "r168"
     ],
     "calculation": {
      "http://silkroadmed.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "terseLabel": "Selling, general and administrative"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpensesMember": {
     "auth_ref": [
      "r86"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primary financial statement caption encompassing selling, general and administrative expense.",
        "label": "Selling, General and Administrative Expenses [Member]",
        "terseLabel": "Selling, general and administrative expenses"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpensesMember",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/StockOptionPlansStockbasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeriesAPreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Outstanding nonredeemable series A preferred stock or outstanding series A preferred stock. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Series A Preferred Stock [Member]",
        "terseLabel": "Series A",
        "verboseLabel": "Conversion of Series A redeemable convertible preferred stock"
       }
      }
     },
     "localname": "SeriesAPreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/RedeemableConvertiblePreferredStockScheduleofRedeemableConvertiblePreferredStockDetails",
      "http://silkroadmed.com/role/StockholdersEquityDeficitSharesReservedforFutureIssuanceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeriesBPreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Outstanding nonredeemable series B preferred stock or outstanding series B preferred stock. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Series B Preferred Stock [Member]",
        "terseLabel": "Series B",
        "verboseLabel": "Conversion of Series B redeemable convertible preferred stock"
       }
      }
     },
     "localname": "SeriesBPreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/RedeemableConvertiblePreferredStockScheduleofRedeemableConvertiblePreferredStockDetails",
      "http://silkroadmed.com/role/StockholdersEquityDeficitSharesReservedforFutureIssuanceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeriesCPreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Outstanding nonredeemable series C preferred stock or outstanding series C preferred stock. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Series C Preferred Stock [Member]",
        "terseLabel": "Series C",
        "verboseLabel": "Conversion of Series C redeemable convertible preferred stock and warrants"
       }
      }
     },
     "localname": "SeriesCPreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/LongtermDebtSeriesCNarrativeDetails",
      "http://silkroadmed.com/role/RedeemableConvertiblePreferredStockScheduleofRedeemableConvertiblePreferredStockDetails",
      "http://silkroadmed.com/role/StockholdersEquityDeficitSharesReservedforFutureIssuanceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r99"
     ],
     "calculation": {
      "http://silkroadmed.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.",
        "label": "Share-based Compensation",
        "terseLabel": "Stock-based compensation expense"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r233"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Period which an employee's right to exercise an award is no longer contingent on satisfaction of either a service condition, market condition or a performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period",
        "terseLabel": "Option vesting term"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/StockOptionPlansNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "auth_ref": [
      "r252"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "terseLabel": "Dividend yield"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/StockOptionPlansStockOptionAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum",
        "terseLabel": "Expected volatility, maximum"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/StockOptionPlansStockOptionAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum",
        "terseLabel": "Expected volatility, minimum"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/StockOptionPlansStockOptionAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum",
        "terseLabel": "Risk-free interest rate, maximum"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/StockOptionPlansStockOptionAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum",
        "terseLabel": "Risk-free interest rate, minimum"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/StockOptionPlansStockOptionAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/StockOptionPlansNarrativeDetails",
      "http://silkroadmed.com/role/StockOptionPlansStockOptionAssumptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of additional shares authorized for issuance under an established share-based compensation plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized",
        "terseLabel": "Authorized (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/StockOptionPlansActivityUnderCompensationPlanDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "auth_ref": [
      "r235"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The maximum number of shares (or other type of equity) originally approved (usually by shareholders and board of directors), net of any subsequent amendments and adjustments, for awards under the equity-based compensation plan. As stock or unit options and equity instruments other than options are awarded to participants, the shares or units remain authorized and become reserved for issuance under outstanding awards (not necessarily vested).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized",
        "terseLabel": "Shares of common stock reserved for issuance (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/StockOptionPlansNarrativeDetails",
      "http://silkroadmed.com/role/SubsequentEventsNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "auth_ref": [
      "r257"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant",
        "periodEndLabel": "Ending balance (in shares)",
        "periodStartLabel": "Beginning balance (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/StockOptionPlansActivityUnderCompensationPlanDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "auth_ref": [
      "r241"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number",
        "terseLabel": "Number of Shares, vested and exercisable (in shares)",
        "verboseLabel": "Number Exercisable (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/StockOptionPlansActivityUnderCompensationPlanDetails",
      "http://silkroadmed.com/role/StockOptionPlansInformationbyExercisePriceDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r241"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "terseLabel": "Weighted Average Exercise Price, vested and exercisable (in USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/StockOptionPlansActivityUnderCompensationPlanDetails",
      "http://silkroadmed.com/role/StockOptionPlansInformationbyExercisePriceDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": {
     "auth_ref": [
      "r246"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value",
        "terseLabel": "Aggregate intrinsic value of options exercised"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/StockOptionPlansNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod": {
     "auth_ref": [
      "r243"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period",
        "negatedLabel": "Options cancelled (in shares)",
        "negatedTerseLabel": "Options cancelled (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/StockOptionPlansActivityUnderCompensationPlanDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r243"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average price of options that were either forfeited or expired.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price",
        "terseLabel": "Options cancelled (in USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/StockOptionPlansActivityUnderCompensationPlanDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross",
        "negatedLabel": "Options granted (in shares)",
        "terseLabel": "Shares of common stock reserved for issuance (in shares)",
        "verboseLabel": "Options granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/StockOptionPlansActivityUnderCompensationPlanDetails",
      "http://silkroadmed.com/role/StockOptionPlansNarrativeDetails",
      "http://silkroadmed.com/role/SubsequentEventsNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r245"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted average grant date fair value (in USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/StockOptionPlansNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r257"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value",
        "terseLabel": "Aggregate Intrinsic Value, awards outstanding"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/StockOptionPlansActivityUnderCompensationPlanDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r240",
      "r257"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Ending balance (in shares)",
        "periodStartLabel": "Beginning balance (in shares)",
        "terseLabel": "Options Outstanding (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/StockOptionPlansActivityUnderCompensationPlanDetails",
      "http://silkroadmed.com/role/StockOptionPlansInformationbyExercisePriceDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]",
        "terseLabel": "Number of Shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/StockOptionPlansActivityUnderCompensationPlanDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r239"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Ending balance (in USD per share)",
        "periodStartLabel": "Beginning balance (in USD per share)",
        "terseLabel": "Weighted Average Exercise Price (in USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/StockOptionPlansActivityUnderCompensationPlanDetails",
      "http://silkroadmed.com/role/StockOptionPlansInformationbyExercisePriceDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]",
        "terseLabel": "Weighted Average Exercise Price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/StockOptionPlansActivityUnderCompensationPlanDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue": {
     "auth_ref": [
      "r247"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value",
        "terseLabel": "Aggregate Intrinsic Value, vested and expected to vest"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/StockOptionPlansActivityUnderCompensationPlanDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber": {
     "auth_ref": [
      "r248"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number",
        "terseLabel": "Number of Shares, vested and expect to vest (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/StockOptionPlansActivityUnderCompensationPlanDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r248"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price",
        "terseLabel": "Weighted Average Exercise Price, vested and expected to vest (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/StockOptionPlansActivityUnderCompensationPlanDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Maximum number of shares that may be issued in accordance with the plan as a proportion of outstanding capital stock.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Percentage of Outstanding Stock Maximum",
        "terseLabel": "Percent of outstanding shares of common stock"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/StockOptionPlansNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r230",
      "r236"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Equity-based compensation award.",
        "label": "Equity Award [Domain]",
        "terseLabel": "Equity Award [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/StockOptionPlansNarrativeDetails",
      "http://silkroadmed.com/role/StockOptionPlansStockOptionAssumptionsDetails",
      "http://silkroadmed.com/role/StockholdersEquityDeficitSharesReservedforFutureIssuanceDetails",
      "http://silkroadmed.com/role/SubsequentEventsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "terseLabel": "Options exercised (in USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/StockOptionPlansActivityUnderCompensationPlanDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "terseLabel": "Options granted (in USD per share)",
        "verboseLabel": "Exercise price (in USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/StockOptionPlansActivityUnderCompensationPlanDetails",
      "http://silkroadmed.com/role/SubsequentEventsNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "auth_ref": [
      "r109",
      "r232",
      "r237"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for stock option and stock incentive plans. This disclosure may include (1) the types of stock option or incentive plans sponsored by the entity (2) the groups that participate in (or are covered by) each plan (3) significant plan provisions and (4) how stock compensation is measured, and the methodologies and significant assumptions used to determine that measurement.",
        "label": "Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]",
        "terseLabel": "Stock-Based Compensation"
       }
      }
     },
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis": {
     "auth_ref": [
      "r249"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by range of option prices pertaining to options granted.",
        "label": "Exercise Price Range [Axis]",
        "terseLabel": "Exercise Price Range [Axis]"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/StockOptionPlansInformationbyExercisePriceDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain": {
     "auth_ref": [
      "r253"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices.",
        "label": "Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Domain]",
        "terseLabel": "Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/StockOptionPlansInformationbyExercisePriceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]",
        "terseLabel": "Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/StockOptionPlansInformationbyExercisePriceDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SharePrice": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Price of a single share of a number of saleable stocks of a company.",
        "label": "Share Price",
        "terseLabel": "Fair value of stock (in USD per share)"
       }
      }
     },
     "localname": "SharePrice",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "auth_ref": [
      "r234"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period",
        "terseLabel": "Option term"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/StockOptionPlansNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r251",
      "r268"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Expected term of share-based compensation awards, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term",
        "terseLabel": "Expected term (in years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/StockOptionPlansStockOptionAssumptionsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "auth_ref": [
      "r257"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value",
        "terseLabel": "Aggregate Intrinsic Value, vested and exercisable"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/StockOptionPlansActivityUnderCompensationPlanDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r257"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term",
        "terseLabel": "Weighted Average Remaining Contractual Term (in Years), vested and exercisable"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/StockOptionPlansActivityUnderCompensationPlanDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r248"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Weighted Average Remaining Contractual Term (in Years), awards outstanding",
        "verboseLabel": "Weighted Average Remaining Contractual Term (in Years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/StockOptionPlansActivityUnderCompensationPlanDetails",
      "http://silkroadmed.com/role/StockOptionPlansInformationbyExercisePriceDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r248"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Weighted Average Remaining Contractual Term (in Years), vested and expected to vest"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/StockOptionPlansActivityUnderCompensationPlanDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average grant-date fair value of options vested.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value",
        "terseLabel": "Fair value of options vested (in USD per share)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/StockOptionPlansNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Purchase price of common stock expressed as a percentage of its fair value.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent",
        "terseLabel": "Percent of purchase of price of common stock"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/StockOptionPlansNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_SharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.",
        "label": "Shares, Outstanding",
        "periodEndLabel": "Ending balance (in shares)",
        "periodStartLabel": "Beginning balance (in shares)"
       }
      }
     },
     "localname": "SharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShortTermInvestments": {
     "auth_ref": [
      "r15",
      "r393",
      "r394",
      "r396",
      "r406"
     ],
     "calculation": {
      "http://silkroadmed.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.",
        "label": "Short-term Investments",
        "terseLabel": "Short-term investments"
       }
      }
     },
     "localname": "ShortTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShortTermInvestmentsMember": {
     "auth_ref": [
      "r393",
      "r394",
      "r406",
      "r417"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Investments which are not otherwise included in another category or item that the entity has the intent to sell or dispose of within one year from the date of the balance sheet.",
        "label": "Short-term Investments [Member]",
        "terseLabel": "Short-term investments"
       }
      }
     },
     "localname": "ShortTermInvestmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/BalanceSheetComponentsFairValueofAvailableForSaleInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SoftwareAndSoftwareDevelopmentCostsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Purchased software applications and internally developed software for sale, licensing or long-term internal use.",
        "label": "Software and Software Development Costs [Member]",
        "terseLabel": "Software"
       }
      }
     },
     "localname": "SoftwareAndSoftwareDevelopmentCostsMember",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/BalanceSheetComponentsPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StateAndLocalJurisdictionMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Designated tax department of a state or local government entitled to levy and collect income taxes from the entity.",
        "label": "State and Local Jurisdiction [Member]",
        "terseLabel": "State and Local Jurisdiction"
       }
      }
     },
     "localname": "StateAndLocalJurisdictionMember",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r21",
      "r22",
      "r23",
      "r202"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/FairValueMeasurementsNarrativeDetails",
      "http://silkroadmed.com/role/LongtermDebtSeriesCNarrativeDetails",
      "http://silkroadmed.com/role/RedeemableConvertiblePreferredStockNarrativeDetails",
      "http://silkroadmed.com/role/RedeemableConvertiblePreferredStockScheduleofRedeemableConvertiblePreferredStockDetails",
      "http://silkroadmed.com/role/StockholdersEquityDeficitSharesReservedforFutureIssuanceDetails",
      "http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesRedeemableConvertiblePreferredStockDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r56",
      "r202"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit",
      "http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesStockBasedCompensationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit",
      "http://silkroadmed.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementScenarioAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by scenario to be reported. Scenarios distinguish among different kinds of business reporting facts, as for example actual versus budgeted figures.",
        "label": "Scenario [Axis]",
        "terseLabel": "Scenario [Axis]"
       }
      }
     },
     "localname": "StatementScenarioAxis",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/LongtermDebtTermLoanNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit",
      "http://silkroadmed.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesAcquisitions": {
     "auth_ref": [
      "r22",
      "r23",
      "r209"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of shares of stock issued during the period pursuant to acquisitions.",
        "label": "Stock Issued During Period, Shares, Acquisitions",
        "terseLabel": "Issuance of common stock in connection with NeuroCo merger (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesAcquisitions",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits": {
     "auth_ref": [
      "r22",
      "r23",
      "r202",
      "r203",
      "r209"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The number of shares issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit).",
        "label": "Stock Issued During Period, Shares, Conversion of Units",
        "terseLabel": "Conversion of preferred stock to common stock upon IPO (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesConversionOfUnits",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit",
      "http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesRedeemableConvertiblePreferredStockDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": {
     "auth_ref": [
      "r22",
      "r23",
      "r202",
      "r209"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan.",
        "label": "Stock Issued During Period, Shares, Employee Stock Purchase Plans",
        "terseLabel": "Issuance of common stock under employee stock purchase plan (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit",
      "http://silkroadmed.com/role/StockOptionPlansNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [
      "r22",
      "r23",
      "r202",
      "r209"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of new stock issued during the period.",
        "label": "Stock Issued During Period, Shares, New Issues",
        "terseLabel": "Issuance of common stock in connection with IPO, net of underwriting discount, commissions and offering costs (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r22",
      "r23",
      "r202",
      "r209",
      "r242"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period",
        "negatedTerseLabel": "Options exercised (in shares)",
        "terseLabel": "Exercise of stock options (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit",
      "http://silkroadmed.com/role/StockOptionPlansActivityUnderCompensationPlanDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueAcquisitions": {
     "auth_ref": [
      "r56",
      "r202",
      "r209"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Value of stock issued pursuant to acquisitions during the period.",
        "label": "Stock Issued During Period, Value, Acquisitions",
        "terseLabel": "Issuance of common stock in connection with NeuroCo merger"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueAcquisitions",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueConversionOfUnits": {
     "auth_ref": [
      "r56",
      "r202",
      "r209"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Value of stock issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit).",
        "label": "Stock Issued During Period, Value, Conversion of Units",
        "terseLabel": "Conversion of preferred stock to common stock upon IPO"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueConversionOfUnits",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit",
      "http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesRedeemableConvertiblePreferredStockDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan": {
     "auth_ref": [
      "r22",
      "r23",
      "r202",
      "r209"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.",
        "label": "Stock Issued During Period, Value, Employee Stock Purchase Plan",
        "terseLabel": "Issuance of common stock under employee stock purchase plan"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueEmployeeStockPurchasePlan",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "auth_ref": [
      "r22",
      "r23",
      "r202",
      "r209"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.",
        "label": "Stock Issued During Period, Value, New Issues",
        "terseLabel": "Issuance of common stock in connection with IPO, net of underwriting discount, commissions and offering costs of $2,481",
        "verboseLabel": "Value of common stock issued"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/AcquisitionofVariableInterestEntityNeuroCoDetails",
      "http://silkroadmed.com/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r56",
      "r202",
      "r209"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "terseLabel": "Exercise of stock options"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r23",
      "r27",
      "r28",
      "r156"
     ],
     "calculation": {
      "http://silkroadmed.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "totalLabel": "Total stockholders\u2019 equity (deficit)"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Stockholders\u2019 equity (deficit):"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r309",
      "r310",
      "r319"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r215"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "Redeemable Convertible Preferred Stock",
        "verboseLabel": "Stockholders' Equity (Deficit)"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/RedeemableConvertiblePreferredStock",
      "http://silkroadmed.com/role/StockholdersEquityDeficit"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StockholdersEquityNoteRedeemablePreferredStockIssuePolicy": {
     "auth_ref": [
      "r19",
      "r20",
      "r109",
      "r199"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for redeemable preferred stock issued. This disclosure may include the accounting treatment for the difference, if there is any, between the carrying value and redemption amount. For example, describe whether the issuer accretes changes in the redemption value.",
        "label": "Stockholders' Equity Note, Redeemable Preferred Stock, Issue, Policy [Policy Text Block]",
        "terseLabel": "Redeemable Convertible Preferred Stock"
       }
      }
     },
     "localname": "StockholdersEquityNoteRedeemablePreferredStockIssuePolicy",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StockholdersEquityNoteStockSplitConversionRatio1": {
     "auth_ref": [
      "r211"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Ratio applied to the conversion of stock split, for example but not limited to, one share converted to two or two shares converted to one.",
        "label": "Stockholders' Equity Note, Stock Split, Conversion Ratio",
        "terseLabel": "Reverse stock split"
       }
      }
     },
     "localname": "StockholdersEquityNoteStockSplitConversionRatio1",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/FormationandBusinessoftheCompanyDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "us-gaap_SubsequentEventLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.",
        "label": "Subsequent Event [Line Items]",
        "terseLabel": "Subsequent Event [Line Items]"
       }
      }
     },
     "localname": "SubsequentEventLineItems",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/A401kPlanDetails",
      "http://silkroadmed.com/role/FormationandBusinessoftheCompanyDetails",
      "http://silkroadmed.com/role/SubsequentEventsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/A401kPlanDetails",
      "http://silkroadmed.com/role/SubsequentEventsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTable": {
     "auth_ref": [
      "r369"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.",
        "label": "Subsequent Event [Table]",
        "terseLabel": "Subsequent Event [Table]"
       }
      }
     },
     "localname": "SubsequentEventTable",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/A401kPlanDetails",
      "http://silkroadmed.com/role/FormationandBusinessoftheCompanyDetails",
      "http://silkroadmed.com/role/SubsequentEventsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r369"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/A401kPlanDetails",
      "http://silkroadmed.com/role/SubsequentEventsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r369"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/A401kPlanDetails",
      "http://silkroadmed.com/role/SubsequentEventsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Subsequent Events [Abstract]",
        "terseLabel": "Subsequent Events [Abstract]"
       }
      }
     },
     "localname": "SubsequentEventsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "auth_ref": [
      "r370"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.",
        "label": "Subsequent Events [Text Block]",
        "terseLabel": "Subsequent Events"
       }
      }
     },
     "localname": "SubsequentEventsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/SubsequentEvents"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of sale of the entity's stock.",
        "label": "Sale of Stock [Axis]",
        "terseLabel": "Sale of Stock [Axis]"
       }
      }
     },
     "localname": "SubsidiarySaleOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit",
      "http://silkroadmed.com/role/FormationandBusinessoftheCompanyDetails",
      "http://silkroadmed.com/role/RedeemableConvertiblePreferredStockNarrativeDetails",
      "http://silkroadmed.com/role/StockholdersEquityDeficitNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock": {
     "auth_ref": [
      "r282"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of unrecognized tax benefits for which a material change is reasonably possible in the next twelve months, typically including the nature of the uncertainty, the event(s) that could cause a material change, and an estimate of the range of the reasonably possible change or a statement that an estimate of the range cannot be made. An unrecognized tax benefit is the difference between a tax position taken in a tax return and the amounts recognized in the financial statements for which it is more likely than not, based on the technical merits of the position, that the tax position will not be sustained upon examination.",
        "label": "Summary of Positions for which Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Table Text Block]",
        "terseLabel": "Reconciliation of Unrecognized Tax Benefits"
       }
      }
     },
     "localname": "SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalBalanceSheetDisclosuresTextBlock": {
     "auth_ref": [
      "r64"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity.",
        "label": "Supplemental Balance Sheet Disclosures [Text Block]",
        "terseLabel": "Balance Sheet Components"
       }
      }
     },
     "localname": "SupplementalBalanceSheetDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/BalanceSheetComponents"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "Supplemental disclosure of cash flow information"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxCreditCarryforwardAmount": {
     "auth_ref": [
      "r296"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Tax Credit Carryforward, Amount",
        "verboseLabel": "Research and development tax credits"
       }
      }
     },
     "localname": "TaxCreditCarryforwardAmount",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TaxCreditCarryforwardAxis": {
     "auth_ref": [
      "r297"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by specific tax credit related to an unused tax credit.",
        "label": "Tax Credit Carryforward [Axis]",
        "terseLabel": "Tax Credit Carryforward [Axis]"
       }
      }
     },
     "localname": "TaxCreditCarryforwardAxis",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxCreditCarryforwardNameDomain": {
     "auth_ref": [
      "r297"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The name of the tax credit carryforward.",
        "label": "Tax Credit Carryforward, Name [Domain]",
        "terseLabel": "Tax Credit Carryforward, Name [Domain]"
       }
      }
     },
     "localname": "TaxCreditCarryforwardNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TemporaryEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Temporary Equity [Abstract]",
        "terseLabel": "Temporary Equity [Abstract]"
       }
      }
     },
     "localname": "TemporaryEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TemporaryEquityByClassOfStockTable": {
     "auth_ref": [
      "r10",
      "r198"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Table of capital stock that is classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer. This table may include a description by series, value, shares authorized, shares issued and outstanding, redemption price per share and subscription receivable.",
        "label": "Temporary Equity, by Class of Stock [Table]",
        "terseLabel": "Temporary Equity, by Class of Stock [Table]"
       }
      }
     },
     "localname": "TemporaryEquityByClassOfStockTable",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/RedeemableConvertiblePreferredStockNarrativeDetails",
      "http://silkroadmed.com/role/RedeemableConvertiblePreferredStockScheduleofRedeemableConvertiblePreferredStockDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TemporaryEquityCarryingAmountAttributableToParent": {
     "auth_ref": [],
     "calculation": {
      "http://silkroadmed.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Carrying Amount, Attributable to Parent",
        "periodEndLabel": "Temporary equity, ending balance",
        "periodStartLabel": "Temporary equity, beginning balance",
        "terseLabel": "Liquidation preference: $121,144 at December 31, 2017 and 2018",
        "verboseLabel": "Carrying Value (in thousands)"
       }
      }
     },
     "localname": "TemporaryEquityCarryingAmountAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit",
      "http://silkroadmed.com/role/ConsolidatedBalanceSheets",
      "http://silkroadmed.com/role/RedeemableConvertiblePreferredStockScheduleofRedeemableConvertiblePreferredStockDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterestsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests [Abstract]",
        "terseLabel": "Redeemable convertible preferred stock issuable in series, $0.001 par value"
       }
      }
     },
     "localname": "TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterestsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TemporaryEquityDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Temporary Equity Disclosure [Abstract]",
        "terseLabel": "Temporary Equity Disclosure [Abstract]"
       }
      }
     },
     "localname": "TemporaryEquityDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_TemporaryEquityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Temporary Equity [Line Items]",
        "terseLabel": "Temporary Equity [Line Items]"
       }
      }
     },
     "localname": "TemporaryEquityLineItems",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/RedeemableConvertiblePreferredStockNarrativeDetails",
      "http://silkroadmed.com/role/RedeemableConvertiblePreferredStockScheduleofRedeemableConvertiblePreferredStockDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TemporaryEquityLiquidationPreference": {
     "auth_ref": [
      "r53"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate liquidation preference (or restrictions) of stock classified as temporary equity that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Liquidation Preference",
        "terseLabel": "Preferential Liquidation Value (in thousands)",
        "verboseLabel": "Liquidation preference"
       }
      }
     },
     "localname": "TemporaryEquityLiquidationPreference",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://silkroadmed.com/role/RedeemableConvertiblePreferredStockScheduleofRedeemableConvertiblePreferredStockDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TemporaryEquityLiquidationPreferencePerShare": {
     "auth_ref": [
      "r53"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The per share liquidation preference (or restrictions) of stock classified as temporary equity that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Liquidation Preference Per Share",
        "terseLabel": "Per share Preference (in USD per share)"
       }
      }
     },
     "localname": "TemporaryEquityLiquidationPreferencePerShare",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/RedeemableConvertiblePreferredStockScheduleofRedeemableConvertiblePreferredStockDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_TemporaryEquityParOrStatedValuePerShare": {
     "auth_ref": [
      "r10",
      "r198"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Per share amount of par value or stated value of stock classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable.",
        "label": "Temporary Equity, Par or Stated Value Per Share",
        "terseLabel": "Temporary equity, par value (in USD per share)"
       }
      }
     },
     "localname": "TemporaryEquityParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_TemporaryEquitySharesAuthorized": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The maximum number of securities classified as temporary equity that are permitted to be issued by an entity's charter and bylaws. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Shares Authorized",
        "terseLabel": "Temporary equity, shares authorized (in shares)",
        "verboseLabel": "Shares Authorized (in shares)"
       }
      }
     },
     "localname": "TemporaryEquitySharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://silkroadmed.com/role/RedeemableConvertiblePreferredStockScheduleofRedeemableConvertiblePreferredStockDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TemporaryEquitySharesIssued": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Shares Issued",
        "terseLabel": "Temporary equity, shares issued (in shares)",
        "verboseLabel": "Shares Issued (in shares)"
       }
      }
     },
     "localname": "TemporaryEquitySharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://silkroadmed.com/role/RedeemableConvertiblePreferredStockNarrativeDetails",
      "http://silkroadmed.com/role/RedeemableConvertiblePreferredStockScheduleofRedeemableConvertiblePreferredStockDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TemporaryEquitySharesOutstanding": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Shares Outstanding",
        "periodEndLabel": "Temporary equity, ending balance (in shares)",
        "periodStartLabel": "Temporary equity, beginning balance (in shares)",
        "terseLabel": "Temporary equity, shares outstanding (in shares)",
        "verboseLabel": "Shares Outstanding (in shares)"
       }
      }
     },
     "localname": "TemporaryEquitySharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit",
      "http://silkroadmed.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://silkroadmed.com/role/RedeemableConvertiblePreferredStockNarrativeDetails",
      "http://silkroadmed.com/role/RedeemableConvertiblePreferredStockScheduleofRedeemableConvertiblePreferredStockDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TemporaryEquityTableTextBlock": {
     "auth_ref": [
      "r10",
      "r198"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity [Table Text Block]",
        "terseLabel": "Redeemable Convertible Preferred Stock Issued and Outstanding"
       }
      }
     },
     "localname": "TemporaryEquityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/RedeemableConvertiblePreferredStockTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_TradeAndOtherAccountsReceivablePolicy": {
     "auth_ref": [
      "r24",
      "r30",
      "r109",
      "r152",
      "r153",
      "r155",
      "r157",
      "r397",
      "r412"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for trade and other accounts receivables. This disclosure may include the basis at which such receivables are carried in the entity's statements of financial position (for example, net realizable value), how the entity determines the level of its allowance for doubtful accounts, when impairments, charge-offs or recoveries are recognized, and the entity's income recognition policies for such receivables, including its treatment of related fees and costs, its treatment of premiums, discounts or unearned income, when accrual of interest is discontinued, how the entity records payments received on nonaccrual receivables and its policy for resuming accrual of interest on such receivables.  If the enterprise holds a large number of similar loans, disclosure may include the accounting policy for the anticipation of prepayments and significant assumptions underlying prepayment estimates for amortization of premiums, discounts, and nonrefundable fees and costs.",
        "label": "Trade and Other Accounts Receivable, Policy [Policy Text Block]",
        "terseLabel": "Accounts Receivable"
       }
      }
     },
     "localname": "TradeAndOtherAccountsReceivablePolicy",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r375"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
        "label": "Financial Instruments [Domain]",
        "terseLabel": "Financial Instruments [Domain]"
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/BalanceSheetComponentsAvailableforSaleInvestmentsinUnrealizedLossPositionDetails",
      "http://silkroadmed.com/role/BalanceSheetComponentsFairValueofAvailableForSaleInvestmentsDetails",
      "http://silkroadmed.com/role/FairValueMeasurementsRecurringAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TypeOfAdoptionMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Adoption and early adoption of sources of change to generally accepted accounting principles (GAAP) in the United States. The FASB released the FASB Accounting Standards Codification as the authoritative source of literature effective for interim and annual periods ending after September 15, 2009. As part of the Codification process, the FASB issues Accounting Standards Updates to amend the Codification but otherwise the Accounting Standards Updates are not authoritative in their own right. All previous accounting standards (such as FASB Statements of Financial Accounting Standards, FASB Interpretations, FASB Staff Positions, Emerging Issues Task Force Consensuses, other pronouncements of the FASB or other designated bodies, or other forms of GAAP are considered accounting pronouncements) were superseded upon the adoption of the Codification. For an interim period, references to the superseded standards are included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.",
        "label": "Type of Adoption [Domain]",
        "terseLabel": "Type of Adoption [Domain]"
       }
      }
     },
     "localname": "TypeOfAdoptionMember",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit",
      "http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesASC842ImpactonCondensedConsolidatedBalanceSheetDetails",
      "http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesLeasesDetails",
      "http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesStockBasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_USGovernmentAgenciesDebtSecuritiesMember": {
     "auth_ref": [
      "r225",
      "r395"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debentures, notes, and other debt securities issued by US government agencies, for example, but not limited to, Government National Mortgage Association (GNMA or Ginnie Mae). Excludes US treasury securities and debt issued by government-sponsored Enterprises (GSEs), for example, but is not limited to, Federal Home Loan Mortgage Corporation (FHLMC or Freddie Mac), Federal National Mortgage Association (FNMA or Fannie Mae), and the Federal Home Loan Bank (FHLB).",
        "label": "US Government Agencies Debt Securities [Member]",
        "terseLabel": "US Government Agencies Debt Securities"
       }
      }
     },
     "localname": "USGovernmentAgenciesDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/FairValueMeasurementsRecurringAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember": {
     "auth_ref": [
      "r225",
      "r395"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debentures, bonds and other debt securities issued by US government sponsored entities (GSEs), for example, but not limited to, Federal Home Loan Mortgage Corporation (FHLMC or Freddie Mac), Federal National Mortgage Association (FNMA or Fannie Mae), and the Federal Home Loan Bank (FHLB). Excludes debt issued by the Government National Mortgage Association (GNMA or Ginnie Mae).",
        "label": "US Government-sponsored Enterprises Debt Securities [Member]",
        "terseLabel": "U.S. government securities"
       }
      }
     },
     "localname": "USGovernmentSponsoredEnterprisesDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/BalanceSheetComponentsAvailableforSaleInvestmentsinUnrealizedLossPositionDetails",
      "http://silkroadmed.com/role/BalanceSheetComponentsFairValueofAvailableForSaleInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnbilledReceivablesCurrent": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount received for services rendered and products shipped, but not yet billed, for non-contractual agreements due within one year or the normal operating cycle, if longer.",
        "label": "Unbilled Receivables, Current",
        "terseLabel": "Unbilled receivables"
       }
      }
     },
     "localname": "UnbilledReceivablesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesRevenueRecognitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "auth_ref": [
      "r275",
      "r284"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of unrecognized tax benefits.",
        "label": "Unrecognized Tax Benefits",
        "periodEndLabel": "Balance at end of year",
        "periodStartLabel": "Balance at the beginning of year",
        "terseLabel": "Unrecognized tax benefits"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefits",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/IncomeTaxesNarrativeDetails",
      "http://silkroadmed.com/role/IncomeTaxesReconciliationofUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense": {
     "auth_ref": [
      "r281"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of expense for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.",
        "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense",
        "terseLabel": "Unrecognized tax benefits, income tax penalties and interest expense"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions": {
     "auth_ref": [
      "r286"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions",
        "terseLabel": "Increases related to current years\u2019 tax positions"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/IncomeTaxesReconciliationofUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions": {
     "auth_ref": [
      "r285"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions",
        "terseLabel": "Increases/(decreases) related to prior years\u2019 tax positions"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/IncomeTaxesReconciliationofUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate": {
     "auth_ref": [
      "r287"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.",
        "label": "Unrecognized Tax Benefits that Would Impact Effective Tax Rate",
        "terseLabel": "Unrecognized tax benefits that would impact effective tax rate"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r137",
      "r138",
      "r140",
      "r141",
      "r142",
      "r143",
      "r144"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount": {
     "auth_ref": [
      "r276"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.",
        "label": "Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount",
        "terseLabel": "Increase (decrease) in deferred tax asset valuation allowance"
       }
      }
     },
     "localname": "ValuationAllowanceDeferredTaxAssetChangeInAmount",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_WarrantsAndRightsOutstandingMeasurementInput": {
     "auth_ref": [
      "r330"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Value of input used to measure outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur.",
        "label": "Warrants and Rights Outstanding, Measurement Input",
        "terseLabel": "Measurement input"
       }
      }
     },
     "localname": "WarrantsAndRightsOutstandingMeasurementInput",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/FairValueMeasurementsFairValueAssumptionsDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "us-gaap_WarrantsAndRightsOutstandingTerm": {
     "auth_ref": [
      "r330"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Warrants and Rights Outstanding, Term",
        "terseLabel": "Time to liquidity (years)"
       }
      }
     },
     "localname": "WarrantsAndRightsOutstandingTerm",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/FairValueMeasurementsFairValueAssumptionsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).",
        "label": "Weighted Average Number of Shares Outstanding, Basic and Diluted",
        "terseLabel": "Weighted average common shares used to compute net loss per share attributable to Silk Road Medical, Inc. common stockholders, basic and diluted (in shares)",
        "verboseLabel": "Weighted average common stock outstanding used to compute net loss per share, basic and diluted (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted",
     "nsuri": "http://fasb.org/us-gaap/2018-01-31",
     "presentation": [
      "http://silkroadmed.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss",
      "http://silkroadmed.com/role/SummaryofSignificantAccountingPoliciesScheduleofEarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 6
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "http://asc.fasb.org/topic&trid=2122149"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=82887183&loc=d3e6676-107765"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(27)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=109223946&loc=d3e3602-108585"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=109223946&loc=d3e3602-108585"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=109223946&loc=d3e3044-108585"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=98513485&loc=d3e4273-108586"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=98513485&loc=d3e4297-108586"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=98513485&loc=d3e4304-108586"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=98513485&loc=d3e4313-108586"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=98513485&loc=d3e4332-108586"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=98513485&loc=SL98516268-108586"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18823-107790"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(i))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(d),(e))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(e),(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(h)(1)(i))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(i))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(k)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04.(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e24072-122690"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22580-107794"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "250",
   "URI": "http://asc.fasb.org/topic&trid=2122394"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=109260490&loc=d3e1337-109256"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "270",
   "URI": "http://asc.fasb.org/extlink&oid=109236672&loc=d3e543-108305"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "270",
   "URI": "http://asc.fasb.org/extlink&oid=109225645&loc=d3e1280-108306"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "270",
   "URI": "http://asc.fasb.org/topic&trid=2126967"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(2))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8933-108599"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Topic": "305",
   "URI": "http://asc.fasb.org/extlink&oid=6375392&loc=d3e26790-107797"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=84173941&loc=SL6953423-111524"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=84173941&loc=d3e5212-111524"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=84173941&loc=d3e5074-111524"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=84173941&loc=d3e5093-111524"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=109979856&loc=d3e26610-111562"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=109979856&loc=d3e26626-111562"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=82897076&loc=d3e27161-111563"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aa)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=82897076&loc=d3e27161-111563"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=82897076&loc=d3e27161-111563"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=82897076&loc=d3e27161-111563"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=82897076&loc=d3e27232-111563"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=82897076&loc=d3e27290-111563"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=82897076&loc=d3e27337-111563"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "http://asc.fasb.org/topic&trid=2196928"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=68048583&loc=d3e3636-108311"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=68049868&loc=SL66093879-108312"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=68049868&loc=SL66093883-108312"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=68049868&loc=d3e3927-108312"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=66092785&loc=d3e4492-108314"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=66092785&loc=d3e4542-108314"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=66092785&loc=d3e4556-108314"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.BB)",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.A)",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=27011391&loc=d3e105025-122735"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=84159346&loc=d3e8275-108329"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=68054294&loc=d3e8384-108330"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226317&loc=d3e202-110218"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.CC)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=27011434&loc=d3e125687-122742"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=82911808&loc=d3e14326-108349"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=99376301&loc=SL5988623-112600"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=d3e1835-112601"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=SL6230698-112601"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=109500613&loc=SL6031897-161870"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=109500613&loc=SL6031897-161870"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=109500613&loc=SL6031897-161870"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=109262497&loc=d3e20148-110875"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(CFRR 211.02)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=d3e177068-122764"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=d3e177068-122764"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6403650&loc=d3e20905-112640"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=82887183&loc=d3e6676-107765"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27)(c))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21553-112644"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21484-112644"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21488-112644"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 4.C)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=27012166&loc=d3e187143-122770"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=68057994&loc=d3e25284-112666"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "50",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "50",
   "Topic": "505",
   "URI": "http://asc.fasb.org/subtopic&trid=2208855"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "http://asc.fasb.org/topic&trid=2208762"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=82913815&loc=SL49130531-203044"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=82913815&loc=SL49130532-203044"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=82913815&loc=SL49130534-203044"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=109196051&loc=SL49130539-203045"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=109196051&loc=SL49130543-203045"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=109196051&loc=SL49130545-203045"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=109196051&loc=SL49130549-203045"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=113356391&loc=SL49131195-203048"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "http://asc.fasb.org/topic&trid=49130388"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=108410482&loc=d3e1928-114920"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=108410482&loc=d3e1928-114920"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=108410482&loc=d3e1928-114920"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=112275985&loc=d3e4179-114921"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "70",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=109197908&loc=d3e5047-113901"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=109197908&loc=d3e5047-113901"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=109197908&loc=d3e5047-113901"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b),(f)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)-(4)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=109253770&loc=SL79507997-165333"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=109253770&loc=SL79507997-165333"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=109253770&loc=SL79508013-165333"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=109253770&loc=SL79508013-165333"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=109253770&loc=SL79508029-165333"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=109253770&loc=SL79508029-165333"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=109253770&loc=SL79508043-165333"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=109253770&loc=SL79508043-165333"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=109253770&loc=SL79508057-165333"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=109253770&loc=SL79508057-165333"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "http://asc.fasb.org/topic&trid=2228938"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "35",
   "Subparagraph": "(b)",
   "Topic": "720",
   "URI": "http://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=115928272&loc=d3e28680-109314"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=115928272&loc=d3e28680-109314"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84176650&loc=SL37586934-109318"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84176650&loc=d3e32123-109318"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84176650&loc=d3e32247-109318"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84176650&loc=d3e32280-109318"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32687-109319"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32698-109319"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32809-109319"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32840-109319"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b),(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32847-109319"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32559-109319"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32559-109319"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32621-109319"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32632-109319"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=82887183&loc=d3e6676-107765"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=109238882&loc=d3e38679-109324"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "30",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=65884525&loc=d3e40913-109327"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(4)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=35744584&loc=d3e6927-128479"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "http://asc.fasb.org/topic&trid=2303972"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568447-111683"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568740-111683"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569655-111683"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=84234705&loc=SL4590271-111686"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=84234705&loc=SL4591551-111686"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=84234705&loc=SL4591552-111686"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3A-02)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=27015204&loc=d3e355033-122828"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3A-03)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=27015204&loc=d3e355100-122828"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "http://asc.fasb.org/topic&trid=2197479"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=99377789&loc=d3e19190-110258"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=99377789&loc=d3e19207-110258"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=99377789&loc=d3e19207-110258"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=99377789&loc=d3e19207-110258"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=99377789&loc=d3e19207-110258"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=99377789&loc=d3e19207-110258"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=99377789&loc=d3e19207-110258"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=99377789&loc=d3e19207-110258"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=99377789&loc=d3e19207-110258"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=99377789&loc=SL7498348-110258"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=99377789&loc=d3e19279-110258"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "60",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "820",
   "URI": "http://asc.fasb.org/topic&trid=2155941"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=109250915&loc=d3e13279-108611"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=109250915&loc=d3e13433-108611"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=109250915&loc=d3e13467-108611"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450222&loc=d3e30840-110895"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775744&loc=d3e28541-108399"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775744&loc=d3e28551-108399"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775744&loc=d3e28555-108399"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(Note 3)",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=82846649&loc=d3e38371-112697"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=77902758&loc=d3e41502-112717"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=77902758&loc=d3e41502-112717"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=113997351&loc=SL77916155-209984"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=77888419&loc=SL77918627-209977"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=77888419&loc=SL77918627-209977"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=77888419&loc=SL77918643-209977"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918666-209980"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918673-209980"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918686-209980"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918686-209980"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(2)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918686-209980"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918686-209980"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918686-209980"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918701-209980"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=77888399&loc=SL77918982-209971"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "850",
   "URI": "http://asc.fasb.org/topic&trid=2122745"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "855",
   "URI": "http://asc.fasb.org/topic&trid=2122774"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=109247956&loc=d3e107207-111719"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=109247956&loc=d3e107207-111719"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=109247956&loc=d3e107207-111719"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=109247956&loc=d3e107207-111719"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=68078379&loc=d3e122625-111746"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61929-109447"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61929-109447"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62059-109447"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62059-109447"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62395-109447"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62395-109447"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62479-109447"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62479-109447"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=SL6807758-109447"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=SL6807758-109447"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(1)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61872-109447"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(2)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61872-109447"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(4))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(5))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(6)(a)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(6))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(9))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=114873765&loc=SL114874048-224260"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=82887183&loc=d3e6801-107765"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.12)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=114873765&loc=SL114874048-224260"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "405",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6957935&loc=d3e64057-112817"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=108315417&loc=d3e61044-112788"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(15)(b)(2))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(1)(g))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(5))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.3)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=114873790&loc=SL114874131-224263"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=6484115&loc=d3e19393-158473"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "305",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=84242212&loc=d3e2352-115587"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "740",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491622&loc=d3e9504-115650"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r421": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r422": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r423": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1-"
  },
  "r424": {
   "Name": "Forms 10-K, 20-F, 40-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d-1"
  },
  "r425": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r426": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r427": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.14)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=82887183&loc=d3e6812-107765"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.28(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.28,29)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=82887183&loc=d3e6911-107765"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.8)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "210",
   "URI": "http://asc.fasb.org/topic&trid=2122208"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=114867106&loc=SL7669646-108580"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=114867106&loc=SL7669646-108580"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=114867106&loc=d3e637-108580"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=114867106&loc=d3e681-108580"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=114867106&loc=SL7669686-108580"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=82887183&loc=d3e6935-107765"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=114867106&loc=SL34724394-108580"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=114867106&loc=SL7669619-108580"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=114867106&loc=SL7669619-108580"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=114867106&loc=SL7669619-108580"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=114867106&loc=SL7669625-108580"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=114867106&loc=SL7669625-108580"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=109228884&loc=d3e1436-108581"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=82887183&loc=d3e7018-107765"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.5)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(b))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=109223946&loc=d3e3179-108585"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=109223946&loc=d3e3213-108585"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=109223946&loc=d3e3213-108585"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=109223946&loc=d3e3255-108585"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=109223946&loc=d3e3255-108585"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=109223946&loc=d3e3255-108585"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=109223946&loc=d3e3291-108585"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=109223946&loc=d3e3367-108585"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=109223946&loc=d3e3000-108585"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=109223946&loc=d3e3521-108585"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=109223946&loc=d3e3536-108585"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=109223946&loc=d3e3536-108585"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=109223946&loc=d3e3602-108585"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6800578960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-term Debt - Series C Narrative (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jul. 31, 2017</div></th>
<th class="th"><div>Oct. 31, 2015</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=silk_PreferredStockWarrantsMember', window );">Preferred Stock Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">163,877<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,672,502<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember', window );">Series C</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Temporary equity, shares issued (in shares)</a></td>
<td class="nump">163,877<span></span>
</td>
<td class="nump">327,759<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Stock issued, price per share (in USD per share)</a></td>
<td class="nump">$ 6.11<span></span>
</td>
<td class="nump">$ 6.11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=silk_PreferredStockWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=silk_PreferredStockWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6958780592">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Revenue Recognition (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnbilledReceivablesCurrent', window );">Unbilled receivables</a></td>
<td class="nump">$ 102<span></span>
</td>
<td class="nump">$ 128<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnbilledReceivablesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount received for services rendered and products shipped, but not yet billed, for non-contractual agreements due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnbilledReceivablesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6806970608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Schedule of Potentially Dilutive Securities Not Included in Calculation of Earnings per Share (Details) - shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share (in shares)</a></td>
<td class="nump">4,310,790<span></span>
</td>
<td class="nump">28,277,596<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RedeemableConvertiblePreferredStockMember', window );">Redeemable convertible preferred stock outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">21,233,190<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=silk_RedeemableConvertiblePreferredStockWarrantsMember', window );">Redeemable convertible preferred stock warrants outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,672,502<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Common stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share (in shares)</a></td>
<td class="nump">4,310,790<span></span>
</td>
<td class="nump">4,364,377<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=silk_CommonStockWarrantMember', window );">Common stock warrants outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">7,527<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RedeemableConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RedeemableConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=silk_RedeemableConvertiblePreferredStockWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=silk_RedeemableConvertiblePreferredStockWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=silk_CommonStockWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=silk_CommonStockWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6792797904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-term Debt (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock', window );">Future Maturities Under the Term Loan Agreement</a></td>
<td class="text"><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Future maturities under the term loan agreement as of December&#160;31, 2019 are as follows (in thousands):</span></div><div style="margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:83.256%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.943%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Year Ending December 31:</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Amount</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,454&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2021</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,442&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2022</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">48,256&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">57,152&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Add: Accretion of closing fees</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,205&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">58,357&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Less: Amount representing interest</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(13,339)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Less: Amount representing debt discount and debt issuance costs</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(139)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:36pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Present value of minimum payments</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">44,879&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the combined aggregate amount of maturities and sinking fund requirements for all long-term borrowings for each of the five years following the date of the latest balance sheet date presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6800504176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Preparation</a></td>
<td class="text"><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Basis of Preparation</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The accompanying financial statements have been prepared in accordance with the accounting principles generally accepted in the United States of America (&#8220;U.S. GAAP&#8221;).  </span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Adjustment to Prior Period Financial Statements</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company has adjusted the accompanying December 31, 2018 balance sheet to increase each of the accounts receivable and accrued liabilities balances by $1,860,000 to correct for an immaterial prior year error in the classification of provisions for returns from customers.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of Consolidation</a></td>
<td class="text">Principles of ConsolidationAs of December 31, 2017, the consolidated financial statements of the Company include the accounts of Silk Road Medical, Inc. and its consolidated variable interest entity (&#8220;VIE&#8221;).  Disclosure regarding the Company&#8217;s participation in the VIE is included in Note 12, &#8220;Variable Interest Entity &#8211; NeuroCo&#8221;.  On December 17, 2018, the Company acquired all assets and assumed all liabilities of its VIE.  All intercompany balances and transactions have been eliminated in consolidation.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Use of Estimates</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The preparation of financial statements in conformity with U.S.&#160;GAAP requires management to make estimates and assumptions that affect the amounts and disclosures reported in the financial statements.  Management uses judgment when making estimates related to provisions for accounts receivable and excess and obsolete inventories, the valuation of deferred tax assets, the reserves for sales returns, stock-based compensation, and for periods prior to the Company's IPO, the valuation of common stock and redeemable convertible preferred stock warrants.  Management bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources.  Although these estimates are based on the Company&#8217;s knowledge of current events and actions it may undertake in the future, actual results may ultimately differ from these estimates and assumptions.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair Value of Financial Instruments</a></td>
<td class="text"><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Fair Value of Financial Instruments</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company has evaluated the estimated fair value of its financial instruments as of December&#160;31, 2019 and 2018.  The carrying amounts of certain of the Company&#8217;s financial instruments, which include cash equivalents, short-term investments, long-term investments, restricted cash, accounts receivable, accounts payable and accrued liabilities approximate their respective fair values because of the short-term nature of these instruments.  Management believes that its long-term debt bears interest at the prevailing market rates for instruments with similar characteristics (Level 2 within the fair value hierarchy); accordingly, the carrying value of this instrument approximates its fair value.  Prior to the Company's IPO, fair value accounting was applied to the redeemable convertible preferred stock warrant liability.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy', window );">Cash, Cash Equivalents and Restricted Cash</a></td>
<td class="text"><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Cash, Cash Equivalents and Restricted Cash</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company considers all highly liquid investments with an original maturity of three months or less at the time of purchase to be cash equivalents.  Cash equivalents are considered available-for-sale marketable securities and are recorded at fair value, based on quoted market prices.  As of December&#160;31, 2019 and 2018, the Company&#8217;s cash equivalents are entirely comprised of investments in money market funds.  </span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the balance sheets that sum to the total of the same amounts shown in the statements of cash flows (in thousands):</span></div><div style="margin-bottom:12pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:69.314%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:11.942%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.943%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 31,</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cash and cash equivalents</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">39,181&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">24,990&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Restricted cash</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">310&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">310&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total cash, cash equivalents and restricted cash</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">39,491&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">25,300&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">    </span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Restricted cash as of December&#160;31, 2019 and 2018 consists of a letter of credit of $310,000 representing collateral for the Company&#8217;s facility lease. </span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Investments</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Short-term investments consist of debt securities classified as available-for-sale and have original maturities greater than 90 days, but less than one year as of the balance sheet date. Long-term investments have maturities greater than one year as of the balance sheet date. All investments are recorded at fair value based on the fair value hierarchy.  Money market funds are classified within Level 1 of the fair value hierarchy, and commercial paper, corporate bonds/notes, United States Government securities, and asset-backed securities are classified within Level 2 of the fair value hierarchy. </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Unrealized gains and losses, deemed temporary in nature, are reported as a separate component of accumulated other comprehensive income (loss).  The cost of available-for-sale investments sold is based on the specific-identification method. Realized gains and losses are included in earnings, and are der</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">ived for specific-identification method for determining the costs of investments sold. Amortization of premiums and accretion of discounts are reported as a component of interest income.</span></div>A decline in the fair value of any security below cost that is deemed other than temporary results in a charge to earnings and the corresponding establishment of a new cost basis for the investment.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentration of Credit Risk, and Other Risks and Uncertainties</a></td>
<td class="text"><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Concentration of Credit Risk, and Other Risks and Uncertainties</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Financial instruments that potentially subject the Company to credit risk consist of cash and cash equivalents, investments and accounts receivable to the extent of the amounts recorded on the balance sheet.  Cash, cash equivalents, and investments are deposited in financial institutions which, at times, may be in excess of federally insured limits. Cash equivalents are invested in highly rated money market funds. The Company invests in a variety of financial instruments, such as, but not limited to, commercial paper, corporate bonds/notes, United States Government securities, asset-backed securities and, by policy, limits the amount of credit exposure with any one financial institution or commercial issuer. The Company has not experienced any material losses on its deposits of cash and cash equivalents or investments during the years ended December 31, 2019 and 2018.</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company&#8217;s accounts receivable are due from a variety of health care organizations in the United States.  At December&#160;31, 2019 and 2018, no customer represented 10% or more of the Company&#8217;s accounts receivable.  For the years ended December&#160;31, 2019 and 2018, there were no customers that represented 10% or more of revenue.  </span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company provides for uncollectible amounts when specific credit problems are identified.  In doing so, the Company analyzes historical bad debt trends, customer credit worthiness, current economic trends and changes in customer payment patterns when evaluating the adequacy of the allowance for doubtful accounts.</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company manufactures certain of its commercial products in-house.  Certain of the Company&#8217;s product components and sub-assemblies continue to be manufactured by sole suppliers, the most significant of which is the ENROUTE stent.  Disruption in component or sub-assembly supply from these manufacturers or from in-house production would have a negative impact on the Company&#8217;s financial position and results of operations.</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company is subject to certain risks, including that its devices may not be approved or cleared for marketing by governmental authorities or be successfully marketed.  There can be no assurance that the Company&#8217;s products will achieve widespread adoption in the marketplace, nor can there be any assurance that existing devices or any future devices can be developed or manufactured at an acceptable cost and with appropriate performance characteristics.  The Company is also subject to risks common to companies in the medical device industry, including, but not limited to, new technological innovations, dependence upon third-party payers to provide adequate coverage and reimbursement, dependence on key personnel and suppliers, protection of proprietary technology, product liability claims, and compliance with government regulations.</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Existing or future devices developed by the Company may require approvals or clearances from the FDA or international regulatory agencies.  In addition, in order to continue the Company&#8217;s operations, compliance with various federal and state laws is required.  If the Company were denied or delayed in receiving such approvals or clearances, it may be necessary to adjust operations to align with the Company&#8217;s currently approved portfolio.  If clearance for the products in the current portfolio were withdrawn by the FDA, this would have a material adverse impact on the Company.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TradeAndOtherAccountsReceivablePolicy', window );">Accounts Receivable</a></td>
<td class="text"><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Accounts Receivable</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Trade accounts receivable are recorded at the invoiced amount and do not bear interest.  The Company estimates allowances for doubtful accounts.  Specifically, the Company makes estimates on the collectability of customer accounts based primarily on analysis of historical trends and experience and changes in customers&#8217; financial condition.  The Company uses its judgment, based on the best available facts and circumstances, and records an allowance against amounts due to reduce the receivable to the amount that is expected to be collected.  These specific allowances are reevaluated and adjusted as additional information is received that impacts the amount reserved.  During the years ended December 31, 2019 and 2018, the Company did not experience any material credit-related losses.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryPolicyTextBlock', window );">Inventories</a></td>
<td class="text"><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Inventories</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Inventories are valued at the lower of cost to purchase or manufacture the inventory or net realizable value.  Cost is determined using the first-in, first-out method for all inventories.  Net realizable value is determined as the estimated selling prices in the ordinary course of business, less reasonably predictable costs of completion, disposal and transportation.  The Company regularly reviews inventory quantities in consideration of actual loss experiences, projected future demand, and remaining shelf life prior to sale to record a provision for excess and obsolete inventory when appropriate.  The Company&#8217;s policy is to write down inventory that has become obsolete, inventory that has a cost basis in excess of its expected lower of cost or net realizable value, and inventory in excess of expected requirements.  The estimate of excess quantities is judgmental and primarily dependent on the Company&#8217;s estimates of future demand for a particular product.  If the estimate of future demand is too high, the Company may have to increase the reserve for excess inventory for that product and record a charge to the cost of goods sold.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property and Equipment</a></td>
<td class="text"><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Property and Equipment</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Property and equipment are recorded at cost less accumulated depreciation or amortization.  Repairs and maintenance costs are expensed as incurred.  Depreciation and amortization are calculated using the straight-line method over the estimated useful lives of the assets, typically <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90ZXh0cmVnaW9uOjZmZWQwNzhkNzVjYTQ1NWU4OTcyY2RkYjU1Nzc0NWRkXzMyOTg1MzQ5NDkxMTE_2fc458bb-3e66-4101-b8da-1c4fb228a229">three</span> to <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90ZXh0cmVnaW9uOjZmZWQwNzhkNzVjYTQ1NWU4OTcyY2RkYjU1Nzc0NWRkXzMyOTg1MzQ5NDkxMTU_fb1b7f55-5035-426c-9941-0c64a4cba092">five</span> years.  Leasehold </span></div>improvements are amortized using the straight-line method over the shorter of the lease term or estimated useful economic life of the asset.  When assets are retired or otherwise disposed of, the cost and accumulated depreciation are removed from the balance sheet and any resulting gain or loss is reflected in operations in the period realized.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredChargesPolicyTextBlock', window );">Deferred Public Offering Costs</a></td>
<td class="text">Deferred Public Offering Costs<span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Specific incremental legal, accounting and other fees and costs directly attributable to a proposed or actual offering of securities may properly be deferred and charged against the gross proceeds of the offering.  </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">As of December&#160;31, 2018, there were $950,000 of offering costs primarily consisting of legal and accounting fees that were capitalized in other non-current assets on the balance sheet of which $233,000 had been paid.  No deferred offering costs were capitalized as of </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">December&#160;31, 2019</span>.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock', window );">Impairment of Long-Lived Assets</a></td>
<td class="text">Impairment of Long-Lived AssetsThe Company reviews long-lived assets, including property and equipment, for impairment whenever events or changes in business circumstances indicate that the carrying amount of the assets may not be fully recoverable.  If indicators of impairment exist, an impairment loss would be recognized when estimated undiscounted future cash flows expected to result from the use of the assets and their eventual disposition are less than their carrying amount.  Impairment, if any, is measured as the amount by which the carrying amount of the long-lived assets exceeds their fair value.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Leases</a></td>
<td class="text"><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Leases</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company adopted Accounting Standards Codification (&#8220;ASC&#8221;) 842, "Leases," on January 1, 2019 and used the modified retrospective method for all leases not substantially completed as of the date of adoption and the package of practical expedients available in the standard.  As a result of adopting ASC 842, the Company recorded an operating lease right-of-use ("ROU") asset of $3,982,000 included within other non-current assets and operating lease liabilities of $5,190,000 included within accrued liabilities and other liabilities on the balance sheet related to its facility lease, based on the present value of the future lease payments on the date of adoption.  The operating lease right-of-use asset also includes adjustments for prepayments and excludes lease incentives.  The adoption did not have an impact on prior periods or on the Company's statements of operations and comprehensive loss.</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The disclosure impact of the adoption of ASC 842 on the balance sheet was as follows (in thousands):</span></div><div style="margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:51.685%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:13.224%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.441%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.903%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.441%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.906%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance Sheet:</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance at December 31, 2018</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Adjustments Due to ASC 842</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance at January 1, 2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other non-current assets</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,982&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,982&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accrued liabilities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">139&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">582&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">721&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other liabilities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,069&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,400&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,469&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div style="margin-bottom:12pt;"><span><br/></span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company considers if an arrangement is a lease at inception if it obtains the right to control the use of an identified asset under a leasing arrangement with an initial term greater than twelve months.  The Company determines whether a contract conveys the right to control the use of an identified asset for a period of time if the contract contains both the right to obtain substantially all of the economic benefits from the use of the identified asset and the right to direct the use of the identified asset.  The Company also evaluates the nature of each lease to determine whether it is an operating or financing lease and recognizes the right-of-use asset and lease liabilities based on the present value of future minimum lease </span></div>payments over the expected lease term.  The Company&#8217;s leases do not generally contain an implicit interest rate and therefore the Company uses the incremental borrowing rate it would expect to pay to borrow on a similar collateralized basis over a similar term in order to determine the present value of its lease payments.  The Company&#8217;s considers renewal options in the determination of the lease term if the option to renew is reasonably certain.  Variable lease costs represent payments that are dependent on usage, a rate or index.  Variable lease costs, which consists primarily of taxes, insurance and common area maintenance costs, are expensed as incurred, as the Company has elected to account separately for contracts that contain lease and non-lease components, consistent with its historical practice.  The Company does not have any finance leases.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_silk_WarrantsClassifiedAsLiabilitiesPolicyTextBlock', window );">Redeemable Convertible Preferred Stock Warrant Liability</a></td>
<td class="text"><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Redeemable Convertible Preferred Stock Warrant Liability</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Prior to its IPO, the Company accounted for its warrants for shares of redeemable convertible preferred stock as a liability based upon the characteristics and provisions of each instrument.  Redeemable convertible preferred stock warrants classified as a liability were initially recorded at their fair value on the date of issuance and are subject to remeasurement at each subsequent balance sheet date.  Any change in fair value as a result of a remeasurement was recognized as a component of other income (expense), net in the statements of operations and comprehensive loss.  </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company recorded adjustments to the estimated fair value of the redeemable convertible preferred stock warrants until they were exercised. Upon their exercise, the final fair value of the warrant liability was reclassified to stockholders&#8217; equity (deficit). Subsequent to its IPO, the Company no longer recorded any related periodic fair value adjustments.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteRedeemablePreferredStockIssuePolicy', window );">Redeemable Convertible Preferred Stock</a></td>
<td class="text"><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Redeemable Convertible Preferred Stock</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Prior to its IPO, the Company recorded its redeemable convertible preferred stock at fair value on the dates of issuance, net of issuance costs, and classified the redeemable convertible preferred stock outside of stockholders&#8217; equity (deficit) on the balance sheet as events triggering the liquidation preferences were not solely within the Company&#8217;s control. Upon the closing of the Company's IPO, all shares of convertible preferred stock then outstanding converted into an aggregate of 23,178,555 shares of common stock resulting in the reclassification of $144,140,000 from outside of stockholders&#8217; equity (deficit) to additional paid-in capital.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenue Recognition and Cost of Goods Sold</a></td>
<td class="text"><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Revenue Recognition</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">On&#160;January&#160;1, 2018, the Company adopted ASC Topic 606,&#160;&#8220;Revenue from Contracts with Customers,&#8221; using the modified retrospective method applied to contracts which were not completed as of that date.&#160;&#160;Under ASC 606, revenue is recognized when a customer obtains control of promised goods or services, in an amount that reflects the consideration which the entity expects to receive in exchange for those goods or services.  To determine revenue recognition for arrangements that an entity determines are within the scope of ASC 606, the Company performs the following five steps: </span></div><div style="text-indent:-26.88pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">(i)</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18pt;">identify the contract(s) with a customer; </span></div><div style="text-indent:-29.1pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">(ii)</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18pt;">identify the performance obligations in the contract; </span></div><div style="text-indent:-31.32pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">(iii)</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18pt;">determine the transaction price;</span></div><div style="text-indent:-31.88pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">(iv)</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18pt;">allocate the transaction price to the performance obligations in the contract; and </span></div><div style="text-indent:-29.66pt;padding-left:36pt;margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">(v)</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18pt;">recognize revenue when (or as) the entity satisfies a performance obligation.</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Under ASC 606, assuming all other revenue recognition criteria have been met, the Company will recognize revenue earlier for arrangements where the Company has satisfied its performance obligations </span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">but have not issued invoices.&#160;&#160;As of December&#160;31, 2019 and 2018, the Company recorded $102,000 and $128,000, respectively, of unbilled receivables, which are included in accounts receivable, net on the balance sheet, as the Company has an unconditional right to payment as of the end of the applicable period.&#160;&#160;</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company&#8217;s revenue is generated from the sale of its products to hospitals and medical centers in the United States through direct sales representatives.  Revenue is recognized when obligations under the terms of a contract with customers are satisfied, which occurs with the transfer of control of the Company&#8217;s products to its customers, either upon shipment of the product or delivery of the product to the customer under the Company&#8217;s standard terms and conditions.&#160;&#160;The Company&#8217;s products are readily available for usage as soon as the customer possesses it.  Upon receipt, the customer controls the economic benefits of the product, has significant risks and rewards, and the legal title.  The Company has present right to payment; therefore, the transfer of control is deemed to happen at a point in time.  Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring the goods.</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">For sales where the Company&#8217;s sales representative hand delivers product directly to the hospital or medical center from the sales representative&#8217;s trunk stock inventory, the Company recognizes revenue upon delivery, which represents the point in time when control transfers to the customer.  Upon delivery there are legally-enforceable rights and obligations between the parties which can be identified, commercial substance exists and collectibility is probable.  For sales which are sent directly from the Company to hospitals and medical centers, the transfer of control occurs at the time of shipment or delivery of the product.&#160; There are no further performance obligations by the Company or the sales representative to the customer after delivery under either method of sale.  As allowed under the practical expedient, the Company does not disclose the value of unsatisfied performance obligations for (i) contracts with an original expected length of one year or less and (ii) contracts for which it recognizes revenue at the amount to which it has the right to invoice for services performed.</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company&#160;is entitled to the total consideration for the products ordered by customers&#160;as&#160;product pricing&#160;is&#160;fixed according to the terms of customer contracts and payment terms&#160;are&#160;short.  Payment terms fall within the one-year guidance for the practical expedient which allows the Company to forgo adjustment of the promised amount of consideration for the effects of a significant financing component.  The Company&#160;excludes&#160;taxes assessed by governmental authorities on revenue-producing transactions from the measurement of the transaction price.</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Costs associated with product sales include commissions and royalties.  The Company applies the practical expedient and recognizes commissions and royalties as expense when incurred because the expense is incurred at a point in time and the amortization period is less than one year.&#160; Commissions are recorded as selling expense&#160;and royalties are recorded as&#160;cost of revenue&#160;in the&#160;statements of operations and comprehensive loss.</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company accepts product returns at its discretion or if the product is defective as manufactured.  The Company establishes estimated provisions for returns based on historical experience and considers other factors that it believes could significantly impact its expected returns, which provisions are classified within accrued liabilities on our balance sheet.&#160; The Company elected to expense shipping and handling costs as incurred and includes them in the cost of goods sold.  In those cases where the Company bills shipping and handling costs to customers, it will classify the amounts billed as a component of revenue.</span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Cost of Goods Sold</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company manufactures certain of its portfolio of TCAR products at its facility and purchases other products from third party manufacturers.  Cost of goods sold consists primarily of costs related to </span></div>materials, components and subassemblies, manufacturing overhead costs, direct labor, reserves for excess, obsolete and non-sellable inventories as well as distribution-related expenses.  A significant portion of the Company&#8217;s cost of goods sold currently consists of manufacturing overhead costs.  These overhead costs include the cost of quality assurance, material procurement, inventory control, facilities, equipment and operations supervision and management.  Cost of goods sold also includes depreciation expense for production equipment and certain direct costs such as shipping costs and royalties.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research and Development and Clinical Trials</a></td>
<td class="text"><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Research and Development</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company expenses research and development costs as incurred.  Research and development expenses consist primarily of engineering, product development, clinical studies to develop and support the Company&#8217;s products, regulatory expenses, medical affairs and other costs associated with products and technologies that are in development.  Research and development expenses include employee compensation, including stock-based compensation, supplies, consulting, prototyping, testing, materials, travel expenses, depreciation and an allocation of facility overhead expenses.  Additionally, research and development expenses include costs associated with our clinical studies including clinical trial design, clinical site reimbursement, data management, travel expenses and the cost of products used for clinical trials and internal and external costs associated with the Company&#8217;s regulatory compliance and quality assurance functions, including the costs of outside consultants and contractors that assist in the process of submitting and maintaining regulatory filings, and overhead costs. </span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Clinical Trials</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company accrues and expenses costs for its clinical trial activities performed by third parties, including clinical research organizations and other service providers, based upon estimates of the work completed over the life of the individual study in accordance with associated agreements.  The Company determines these accruals through discussion with internal personnel and outside service providers as to progress or stage of completion of trials or services pursuant to contracts with clinical research organizations and other service providers and the agreed-upon fee to be paid for such services.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdvertisingCostsPolicyTextBlock', window );">Advertising Costs</a></td>
<td class="text">Advertising CostsThe Company expenses advertising costs as incurred.  Advertising costs include design and production costs, including website development, physician and patient testimonial videos, written media campaigns, and other items.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Foreign Currency</a></td>
<td class="text"><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Foreign Currency</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company records net gains and losses resulting from foreign exchange transactions as a component of foreign currency exchange gains or losses in other income (expense), net.  The Company had no material foreign currency exchange gains or losses during the years ended December&#160;31, 2019 and 2018.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Stock-Based Compensation</a></td>
<td class="text"><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Stock&#8211;Based Compensation</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company accounts for stock-based compensation in accordance with Financial Accounting Standards Board (&#8220;FASB&#8221;) ASC 718,&#160;&#8220;Compensation-Stock Compensation.&#8221;  ASC 718 requires the recognition of compensation expense, using a fair-value based method, for costs related to all share-based payments including stock options.  ASC 718 requires companies to estimate the fair value of all share-based payment option awards on the date of grant using an option pricing model.  The fair value of stock options is recognized over the period during which an optionee is required to provide services in exchange for the option award, known as the requisite service period (usually the vesting period), on a </span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">straight-line basis.  For performance-based stock options, the Company will assess the probability of performance conditions being achieved in each reporting period.  The amount of stock-based compensation expense recognized in any one period related to performance-based stock options can vary based on the achievement or anticipated achievement of the performance conditions.</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In March 2016, the FASB issued Accounting Standards Update ("ASU") No. 2016-09,&#160;&#8220;Stock Compensation (Topic 718): Improvements to Employee Shared-Based Payment Accounting.&#8221;&#160; Under ASU 2016-09, entities are permitted to make an accounting policy election to either estimate forfeitures on share-based payment awards, as previously required, or to recognize forfeitures as they occur.  The Company made an accounting policy election to account for forfeitures as they occur.  This change has been applied on a modified retrospective basis, resulting in a cumulative-effect adjustment to increase the beginning accumulated deficit by $13,000&#160;as of January&#160;1, 2018, the date of adoption.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Income Taxes</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company accounts for income taxes under the liability method, whereby deferred tax assets and liabilities are determined based on the difference between the financial statements and tax bases of assets and liabilities using the enacted tax rates in effect for the year in which the differences are expected to affect taxable income.  A valuation allowance is established when necessary to reduce deferred tax assets to the amounts expected to be realized.</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company also follows the provisions of ASC 740-10, &#8220;Accounting for Uncertainty in Income Taxes.&#8221;  ASC 740-10 prescribes a comprehensive model for the recognition, measurement, presentation and disclosure in financial statements of any uncertain tax positions that have been taken or expected to be taken on a tax return.  No liability related to uncertain tax positions is recorded on the financial statements.  It is the Company&#8217;s policy to include penalties and interest expense related to income taxes as part of the provision for income taxes.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock', window );">Comprehensive Loss</a></td>
<td class="text">Comprehensive Loss<span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Comprehensive loss consists of net loss and changes in unrealized gains and losses on investments classified as available-for-sale.  For the year ended </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">December&#160;31, 2019</span>, the Company&#8217;s unrealized gains and losses on available-for-sale investments represent the only component of other comprehensive loss that are excluded from the reported net loss and that are presented in the statements of operations and comprehensive income.  Accumulated other comprehensive loss is presented in the accompanying balance sheets as a component of stockholders' equity (deficit).  For the year ended December&#160;31, 2018, there was no difference between the Company's comprehensive loss and its net loss.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Net Loss per Share Attributable to Common Stockholders and Unaudited Pro Forma Net Loss per Share Attributable to Common Stockholders</a></td>
<td class="text"><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Net Loss per Share Attributable to Common Stockholders</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Basic net loss per share is computed by dividing the net loss attributable to common stockholders by the weighted average number of shares of common stock outstanding during the period, without consideration for potential dilutive common shares.  Diluted net loss per share is computed by dividing the net loss attributable to common stockholders by the weighted average number of shares of common stock and potentially dilutive securities outstanding for the period.  For purposes of the diluted net loss per share calculation, redeemable convertible preferred stock and warrants, and common stock options are considered to be potentially dilutive securities.  Since the Company was in a loss position for all periods presented, basic net loss per share is the same as diluted net loss per share as the inclusion of all potential dilutive common shares would have been anti-dilutive.</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company allocates no loss to participating securities because they have no contractual obligation to share in the losses of the Company.  The shares of the Company&#8217;s redeemable convertible preferred </span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">stock participate in any dividends declared by the Company and are therefore considered to be participating securities.</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Net loss per share was determined as follows (in thousands, except share and per share data):</span></div><div style="margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:69.314%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:11.942%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.943%;"/><td style="width:1.0%;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Year Ended December 31,</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net loss attributable to Silk Road Medical, Inc. common stockholders</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(52,415)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(37,629)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted average common stock outstanding used to compute net loss per share, basic and diluted</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">22,956,679&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">960,882&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net loss per share attributable to Silk Road Medical, Inc. common stockholders, basic and diluted</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.28)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(39.16)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr></table></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following potentially dilutive securities outstanding have been excluded from the computation of diluted weighted average shares outstanding because such securities have an antidilutive impact due to the Company&#8217;s net loss:</span></div><div style="text-align:center;margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:69.314%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:11.942%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.943%;"/><td style="width:1.0%;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 31,</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Redeemable convertible preferred stock outstanding</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">21,233,190&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Redeemable convertible preferred stock warrants outstanding</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,672,502&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Common stock options</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,310,790&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,364,377&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Common stock warrants outstanding</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7,527&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,310,790&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">28,277,596&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingPolicyPolicyTextBlock', window );">Segment and Geographical Information</a></td>
<td class="text"><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Segment and Geographical Information</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company operates and manages its business as one reportable and operating segment.  The Company&#8217;s chief executive officer, who is the chief operating decision maker, reviews financial information on an aggregate basis for purposes of allocating resources and evaluating financial performance.  All of the Company&#8217;s long-lived assets are based in the United States.  Long-lived assets are comprised of property and equipment.  All of the Company&#8217;s revenue was in the United States for the years ended December&#160;31, 2019 and 2018, based on the shipping location of the external customer.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Pronouncements</a></td>
<td class="text">Recent Accounting Pronouncements<div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Recently Adopted Accounting Standards</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In February 2016, the FASB issued ASU No. 2016-02, "Leases," that supersedes ASC 840, "Leases." Subsequently, the FASB issued several updates to ASU No. 2016-02, codified in ASC Topic 842 (&#8220;ASC 842&#8221;). The Company adopted ASC 842 on January 1, 2019 using the modified retrospective method for all leases not substantially completed as of the date of adoption.  The Company elected to apply the package of practical expedients, which allowed the Company to not reassess: (i) whether expired or existing contracts contain leases; (ii) lease classification for any expired or existing leases; and (iii) initial direct costs for any existing lease.</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Recently Issued Accounting Standards</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In June 2016, the FASB issued ASU 2016-13, Measurement of Credit Losses on Financial Statements.  This update provides financial statement users with more decision-useful information about the expected credit losses on financial instruments and other commitments to extend credit held by a reporting entity at each reporting date.  The update replaces the incurred loss impairment methodology in current GAAP with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates.  ASU 2016-13 became effective for the Company on January 1, 2020.  The Company does not believe that the adoption of this new guidance will have a material impact on its financial statements.</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In August 2018, the FASB issued ASU 2018-13, Fair Value Measurement, which changed the disclosure requirements for fair value measurements by removing, adding and modifying certain disclosures.  ASU 2018-13 became effective for the Company on January 1, 2020.  </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company does not believe that the adoption of this new guidance will have a material impact on its financial statements and related disclosures.</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In August 2018, the FASB issued ASU 2018-15, Cloud Computing Arrangements, which aligns the requirements for capitalizing implementation costs in a Cloud Computing Arrangement service contract with the requirements for capitalizing implementation costs incurred for an internal-use software license.  ASU 2018-15 became effective for the Company on January 1, 2020.</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">  The Company does not believe that the adoption of this new guidance will have a material impact on its financial statements and related disclosures.</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes, which enhances and simplifies various aspects of the income tax accounting guidance related to intraperiod tax allocation, interim period accounting for enacted changes in tax law, and the year-to-date loss limitation in interim period tax accounting.  ASU 2019-12 also amends other aspects of the guidance to reduce complexity in certain areas.  ASU 2019-12 will become effective for the Company on January 1, 2021.  Early adoption is permitted.  The Company is evaluating the impact of adopting this guidance to its financial statements and related disclosures.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_silk_WarrantsClassifiedAsLiabilitiesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warrants Classified As Liabilities [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">silk_WarrantsClassifiedAsLiabilitiesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>silk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for advertising costs. For those costs that cannot be capitalized, discloses whether such costs are expensed as incurred or the first period in which the advertising takes place. For direct response advertising costs that are capitalized, describes those assets and the accounting policy used, including a description of the qualifying activity, the types of costs capitalized and the related amortization period. An entity also may disclose its accounting policy for cooperative advertising arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84159346&amp;loc=d3e8275-108329<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 20<br> -Section 55<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68054294&amp;loc=d3e8384-108330<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Entity's cash and cash equivalents accounting policy with respect to restricted balances.  Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 305<br> -SubTopic 10<br> -Section 05<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6375392&amp;loc=d3e26790-107797<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4273-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomePolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=108315417&amp;loc=d3e61044-112788<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.3A-02)<br> -URI http://asc.fasb.org/extlink&amp;oid=27015204&amp;loc=d3e355033-122828<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.3A-03)<br> -URI http://asc.fasb.org/extlink&amp;oid=27015204&amp;loc=d3e355100-122828<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredChargesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for deferral and amortization of significant deferred charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredChargesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 60<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=7493716&amp;loc=d3e21868-110260<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109250915&amp;loc=d3e13279-108611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450222&amp;loc=d3e30840-110895<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109226317&amp;loc=d3e202-110218<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.CC)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011434&amp;loc=d3e125687-122742<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32847-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 740<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6491622&amp;loc=d3e9504-115650<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32809-109319<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32840-109319<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=84176650&amp;loc=d3e32247-109318<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=84176650&amp;loc=d3e32280-109318<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 05<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=65884525&amp;loc=d3e40913-109327<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=66092785&amp;loc=d3e4556-108314<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109236672&amp;loc=d3e543-108305<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=66092785&amp;loc=d3e4492-108314<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918666-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, basis of assets, depreciation and depletion methods used, including composite deprecation, estimated useful lives, capitalization policy, accounting treatment for costs incurred for repairs and maintenance, capitalized interest and the method it is calculated, disposals and impairments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18823-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for stock option and stock incentive plans. This disclosure may include (1) the types of stock option or incentive plans sponsored by the entity (2) the groups that participate in (or are covered by) each plan (3) significant plan provisions and (4) how stock compensation is measured, and the methodologies and significant assumptions used to determine that measurement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteRedeemablePreferredStockIssuePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for redeemable preferred stock issued. This disclosure may include the accounting treatment for the difference, if there is any, between the carrying value and redemption amount. For example, describe whether the issuer accretes changes in the redemption value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 05<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6403650&amp;loc=d3e20905-112640<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteRedeemablePreferredStockIssuePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TradeAndOtherAccountsReceivablePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for trade and other accounts receivables. This disclosure may include the basis at which such receivables are carried in the entity's statements of financial position (for example, net realizable value), how the entity determines the level of its allowance for doubtful accounts, when impairments, charge-offs or recoveries are recognized, and the entity's income recognition policies for such receivables, including its treatment of related fees and costs, its treatment of premiums, discounts or unearned income, when accrual of interest is discontinued, how the entity records payments received on nonaccrual receivables and its policy for resuming accrual of interest on such receivables.  If the enterprise holds a large number of similar loans, disclosure may include the accounting policy for the anticipation of prepayments and significant assumptions underlying prepayment estimates for amortization of premiums, discounts, and nonrefundable fees and costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=84173941&amp;loc=d3e5212-111524<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84173941&amp;loc=SL6953423-111524<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84173941&amp;loc=d3e5093-111524<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10133-111534<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TradeAndOtherAccountsReceivablePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6808948992">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders' Equity (Deficit) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>IPO</div></th>
<th class="th"><div>Redeemable Convertible Preferred Stock</div></th>
<th class="th">
<div>Redeemable Convertible Preferred Stock </div>
<div>IPO</div>
</th>
<th class="th"><div>Common Stock</div></th>
<th class="th">
<div>Common Stock </div>
<div>IPO</div>
</th>
<th class="th"><div>Additional Paid-in Capital</div></th>
<th class="th"><div>Accumulated Deficit</div></th>
<th class="th"><div>Accumulated Other Comprehensive Income</div></th>
<th class="th"><div>Non-controlling Interest</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Temporary equity, beginning balance at Dec. 31, 2017</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 105,235<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Temporary equity, beginning balance (in shares) at Dec. 31, 2017</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,233,190<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Temporary equity, ending balance at Dec. 31, 2018</a></td>
<td class="nump">$ 105,235<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 105,235<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Temporary equity, ending balance (in shares) at Dec. 31, 2018</a></td>
<td class="nump">21,233,190<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,233,190<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2017</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">663,270<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Dec. 31, 2017</a></td>
<td class="num">$ (98,578)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,977<span></span>
</td>
<td class="num">$ (101,556)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">$ 656<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">656<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="nump">438,578<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">438,578<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition', window );">Employee stock-based compensation</a></td>
<td class="nump">$ 728<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">728<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition', window );">Nonemployee stock-based compensation</a></td>
<td class="nump">183<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">183<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance', window );">NeuroCo common stock issuance</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Issuance of common stock in connection with NeuroCo merger (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,462<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Issuance of common stock in connection with NeuroCo merger</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="num">(37,630)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(37,629)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Comprehensive loss</a></td>
<td class="num">(37,630)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(37,629)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Unrealized gain on investments, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Dec. 31, 2018</a></td>
<td class="num">(134,553)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,557<span></span>
</td>
<td class="num">(139,111)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Dec. 31, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,135,310<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityAbstract', window );"><strong>Temporary Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_silk_StockIssuedDuringPeriodValueExerciseOfWarrants', window );">Exercise of warrants</a></td>
<td class="nump">31<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 1,784<span></span>
</td>
<td class="nump">$ 37,121<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_silk_StockIssuedDuringPeriodSharesExerciseOfWarrants', window );">Exercise of warrants (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">292,361<span></span>
</td>
<td class="nump">1,653,004<span></span>
</td>
<td class="nump">3,764<span></span>
</td>
<td class="nump">2,204<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Temporary equity, ending balance at Dec. 31, 2019</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Temporary equity, ending balance (in shares) at Dec. 31, 2019</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">$ 1,542<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,541<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="nump">873,786<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">873,786<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock in connection with IPO, net of underwriting discount, commissions and offering costs of $2,481</a></td>
<td class="nump">$ 109,119<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">109,113<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock in connection with IPO, net of underwriting discount, commissions and offering costs (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits', window );">Conversion of preferred stock to common stock upon IPO (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(23,178,555)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,178,555<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfUnits', window );">Conversion of preferred stock to common stock upon IPO</a></td>
<td class="nump">144,140<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (144,140)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">144,117<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Issuance of common stock under employee stock purchase plan</a></td>
<td class="nump">1,048<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,048<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Issuance of common stock under employee stock purchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">61,648<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition', window );">Employee stock-based compensation</a></td>
<td class="nump">2,887<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,887<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition', window );">Nonemployee stock-based compensation</a></td>
<td class="nump">90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="num">(52,415)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(52,415)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Unrealized gain on investments, net</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Dec. 31, 2019</a></td>
<td class="nump">$ 71,891<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 263,384<span></span>
</td>
<td class="num">$ (191,526)<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31,255,267<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_silk_StockIssuedDuringPeriodSharesExerciseOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period, Shares, Exercise Of Warrants</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">silk_StockIssuedDuringPeriodSharesExerciseOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>silk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_silk_StockIssuedDuringPeriodValueExerciseOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period, Value, Exercise Of Warrants</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">silk_StockIssuedDuringPeriodValueExerciseOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>silk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in additional paid-in capital (APIC) from recognition of equity-based compensation for employee stock purchase program.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) from recognition of equity-based compensation for stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=84234705&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669619-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669625-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in noncontrolling interest from subsidiary issuance of equity interests to noncontrolling interest holders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569655-111683<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669625-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=84234705&amp;loc=SL4591551-111686<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3000-108585<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=84234705&amp;loc=SL4591552-111686<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued during the period pursuant to acquisitions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued pursuant to acquisitions during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueConversionOfUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueConversionOfUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568740-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=84234705&amp;loc=SL4590271-111686<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568447-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6807092624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Feb. 28, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover page.</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">SILK ROAD MEDICAL, INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001397702<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-38847<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">20-8777622<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1213 Innsbruck Dr.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Sunnyvale<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">94089<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">408<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">720-9002<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">SILK<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 818.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31,353,906<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 20-F, 40-F<br> -Number 240<br> -Section 15<br> -Subsection d-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1-<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6795068960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock', window );">Summary of Significant Accounting Policies</a></td>
<td class="text">Summary of Significant Accounting Policies<div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Basis of Preparation</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The accompanying financial statements have been prepared in accordance with the accounting principles generally accepted in the United States of America (&#8220;U.S. GAAP&#8221;).  </span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Adjustment to Prior Period Financial Statements</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company has adjusted the accompanying December 31, 2018 balance sheet to increase each of the accounts receivable and accrued liabilities balances by $1,860,000 to correct for an immaterial prior year error in the classification of provisions for returns from customers.</span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Principles of Consolidation</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">As of December 31, 2017, the consolidated financial statements of the Company include the accounts of Silk Road Medical, Inc. and its consolidated variable interest entity (&#8220;VIE&#8221;).  Disclosure regarding the Company&#8217;s participation in the VIE is included in Note 12, &#8220;Variable Interest Entity &#8211; NeuroCo&#8221;.  On December 17, 2018, the Company acquired all assets and assumed all liabilities of its VIE.  All intercompany balances and transactions have been eliminated in consolidation.  </span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Use of Estimates</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The preparation of financial statements in conformity with U.S.&#160;GAAP requires management to make estimates and assumptions that affect the amounts and disclosures reported in the financial statements.  Management uses judgment when making estimates related to provisions for accounts receivable and excess and obsolete inventories, the valuation of deferred tax assets, the reserves for sales returns, stock-based compensation, and for periods prior to the Company's IPO, the valuation of common stock and redeemable convertible preferred stock warrants.  Management bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources.  Although these estimates are based on the Company&#8217;s knowledge of current events and actions it may undertake in the future, actual results may ultimately differ from these estimates and assumptions.</span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Fair Value of Financial Instruments</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company has evaluated the estimated fair value of its financial instruments as of December&#160;31, 2019 and 2018.  The carrying amounts of certain of the Company&#8217;s financial instruments, which include cash equivalents, short-term investments, long-term investments, restricted cash, accounts receivable, accounts payable and accrued liabilities approximate their respective fair values because of the short-term nature of these instruments.  Management believes that its long-term debt bears interest at the prevailing market rates for instruments with similar characteristics (Level 2 within the fair value hierarchy); accordingly, the carrying value of this instrument approximates its fair value.  Prior to the Company's IPO, fair value accounting was applied to the redeemable convertible preferred stock warrant liability.</span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Cash, Cash Equivalents and Restricted Cash</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company considers all highly liquid investments with an original maturity of three months or less at the time of purchase to be cash equivalents.  Cash equivalents are considered available-for-sale marketable securities and are recorded at fair value, based on quoted market prices.  As of December&#160;31, 2019 and 2018, the Company&#8217;s cash equivalents are entirely comprised of investments in money market funds.  </span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the balance sheets that sum to the total of the same amounts shown in the statements of cash flows (in thousands):</span></div><div style="margin-bottom:12pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:69.314%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:11.942%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.943%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 31,</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cash and cash equivalents</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">39,181&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">24,990&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Restricted cash</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">310&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">310&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total cash, cash equivalents and restricted cash</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">39,491&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">25,300&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">    </span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Restricted cash as of December&#160;31, 2019 and 2018 consists of a letter of credit of $310,000 representing collateral for the Company&#8217;s facility lease. </span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Investments</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Short-term investments consist of debt securities classified as available-for-sale and have original maturities greater than 90 days, but less than one year as of the balance sheet date. Long-term investments have maturities greater than one year as of the balance sheet date. All investments are recorded at fair value based on the fair value hierarchy.  Money market funds are classified within Level 1 of the fair value hierarchy, and commercial paper, corporate bonds/notes, United States Government securities, and asset-backed securities are classified within Level 2 of the fair value hierarchy. </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Unrealized gains and losses, deemed temporary in nature, are reported as a separate component of accumulated other comprehensive income (loss).  The cost of available-for-sale investments sold is based on the specific-identification method. Realized gains and losses are included in earnings, and are der</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">ived for specific-identification method for determining the costs of investments sold. Amortization of premiums and accretion of discounts are reported as a component of interest income.</span></div><div style="margin-bottom:12pt;"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">A decline in the fair value of any security below cost that is deemed other than temporary results in a charge to earnings and the corresponding establishment of a new cost basis for the investment. </span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Concentration of Credit Risk, and Other Risks and Uncertainties</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Financial instruments that potentially subject the Company to credit risk consist of cash and cash equivalents, investments and accounts receivable to the extent of the amounts recorded on the balance sheet.  Cash, cash equivalents, and investments are deposited in financial institutions which, at times, may be in excess of federally insured limits. Cash equivalents are invested in highly rated money market funds. The Company invests in a variety of financial instruments, such as, but not limited to, commercial paper, corporate bonds/notes, United States Government securities, asset-backed securities and, by policy, limits the amount of credit exposure with any one financial institution or commercial issuer. The Company has not experienced any material losses on its deposits of cash and cash equivalents or investments during the years ended December 31, 2019 and 2018.</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company&#8217;s accounts receivable are due from a variety of health care organizations in the United States.  At December&#160;31, 2019 and 2018, no customer represented 10% or more of the Company&#8217;s accounts receivable.  For the years ended December&#160;31, 2019 and 2018, there were no customers that represented 10% or more of revenue.  </span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company provides for uncollectible amounts when specific credit problems are identified.  In doing so, the Company analyzes historical bad debt trends, customer credit worthiness, current economic trends and changes in customer payment patterns when evaluating the adequacy of the allowance for doubtful accounts.</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company manufactures certain of its commercial products in-house.  Certain of the Company&#8217;s product components and sub-assemblies continue to be manufactured by sole suppliers, the most significant of which is the ENROUTE stent.  Disruption in component or sub-assembly supply from these manufacturers or from in-house production would have a negative impact on the Company&#8217;s financial position and results of operations.</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company is subject to certain risks, including that its devices may not be approved or cleared for marketing by governmental authorities or be successfully marketed.  There can be no assurance that the Company&#8217;s products will achieve widespread adoption in the marketplace, nor can there be any assurance that existing devices or any future devices can be developed or manufactured at an acceptable cost and with appropriate performance characteristics.  The Company is also subject to risks common to companies in the medical device industry, including, but not limited to, new technological innovations, dependence upon third-party payers to provide adequate coverage and reimbursement, dependence on key personnel and suppliers, protection of proprietary technology, product liability claims, and compliance with government regulations.</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Existing or future devices developed by the Company may require approvals or clearances from the FDA or international regulatory agencies.  In addition, in order to continue the Company&#8217;s operations, compliance with various federal and state laws is required.  If the Company were denied or delayed in receiving such approvals or clearances, it may be necessary to adjust operations to align with the Company&#8217;s currently approved portfolio.  If clearance for the products in the current portfolio were withdrawn by the FDA, this would have a material adverse impact on the Company.</span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Accounts Receivable</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Trade accounts receivable are recorded at the invoiced amount and do not bear interest.  The Company estimates allowances for doubtful accounts.  Specifically, the Company makes estimates on the collectability of customer accounts based primarily on analysis of historical trends and experience and changes in customers&#8217; financial condition.  The Company uses its judgment, based on the best available facts and circumstances, and records an allowance against amounts due to reduce the receivable to the amount that is expected to be collected.  These specific allowances are reevaluated and adjusted as additional information is received that impacts the amount reserved.  During the years ended December 31, 2019 and 2018, the Company did not experience any material credit-related losses.</span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Inventories</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Inventories are valued at the lower of cost to purchase or manufacture the inventory or net realizable value.  Cost is determined using the first-in, first-out method for all inventories.  Net realizable value is determined as the estimated selling prices in the ordinary course of business, less reasonably predictable costs of completion, disposal and transportation.  The Company regularly reviews inventory quantities in consideration of actual loss experiences, projected future demand, and remaining shelf life prior to sale to record a provision for excess and obsolete inventory when appropriate.  The Company&#8217;s policy is to write down inventory that has become obsolete, inventory that has a cost basis in excess of its expected lower of cost or net realizable value, and inventory in excess of expected requirements.  The estimate of excess quantities is judgmental and primarily dependent on the Company&#8217;s estimates of future demand for a particular product.  If the estimate of future demand is too high, the Company may have to increase the reserve for excess inventory for that product and record a charge to the cost of goods sold.</span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Property and Equipment</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Property and equipment are recorded at cost less accumulated depreciation or amortization.  Repairs and maintenance costs are expensed as incurred.  Depreciation and amortization are calculated using the straight-line method over the estimated useful lives of the assets, typically <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90ZXh0cmVnaW9uOjZmZWQwNzhkNzVjYTQ1NWU4OTcyY2RkYjU1Nzc0NWRkXzMyOTg1MzQ5NDkxMTE_2fc458bb-3e66-4101-b8da-1c4fb228a229">three</span> to <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjU4ZjM5N2U4NmRmZDRmYzRhYzNiODY5NWNkMzEyMzhlL3NlYzo1OGYzOTdlODZkZmQ0ZmM0YWMzYjg2OTVjZDMxMjM4ZV8xMTUvZnJhZzo2ZmVkMDc4ZDc1Y2E0NTVlODk3MmNkZGI1NTc3NDVkZC90ZXh0cmVnaW9uOjZmZWQwNzhkNzVjYTQ1NWU4OTcyY2RkYjU1Nzc0NWRkXzMyOTg1MzQ5NDkxMTU_fb1b7f55-5035-426c-9941-0c64a4cba092">five</span> years.  Leasehold </span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">improvements are amortized using the straight-line method over the shorter of the lease term or estimated useful economic life of the asset.  When assets are retired or otherwise disposed of, the cost and accumulated depreciation are removed from the balance sheet and any resulting gain or loss is reflected in operations in the period realized.</span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Deferred Public Offering Costs</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Specific incremental legal, accounting and other fees and costs directly attributable to a proposed or actual offering of securities may properly be deferred and charged against the gross proceeds of the offering.  </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">As of December&#160;31, 2018, there were $950,000 of offering costs primarily consisting of legal and accounting fees that were capitalized in other non-current assets on the balance sheet of which $233,000 had been paid.  No deferred offering costs were capitalized as of </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">December&#160;31, 2019</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">. </span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Impairment of Long-Lived Assets</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company reviews long-lived assets, including property and equipment, for impairment whenever events or changes in business circumstances indicate that the carrying amount of the assets may not be fully recoverable.  If indicators of impairment exist, an impairment loss would be recognized when estimated undiscounted future cash flows expected to result from the use of the assets and their eventual disposition are less than their carrying amount.  Impairment, if any, is measured as the amount by which the carrying amount of the long-lived assets exceeds their fair value.  The Company did not record any impairment of long-lived assets during the years ended December&#160;31, 2019 and 2018.</span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Leases</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company adopted Accounting Standards Codification (&#8220;ASC&#8221;) 842, "Leases," on January 1, 2019 and used the modified retrospective method for all leases not substantially completed as of the date of adoption and the package of practical expedients available in the standard.  As a result of adopting ASC 842, the Company recorded an operating lease right-of-use ("ROU") asset of $3,982,000 included within other non-current assets and operating lease liabilities of $5,190,000 included within accrued liabilities and other liabilities on the balance sheet related to its facility lease, based on the present value of the future lease payments on the date of adoption.  The operating lease right-of-use asset also includes adjustments for prepayments and excludes lease incentives.  The adoption did not have an impact on prior periods or on the Company's statements of operations and comprehensive loss.</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The disclosure impact of the adoption of ASC 842 on the balance sheet was as follows (in thousands):</span></div><div style="margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:51.685%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:13.224%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.441%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.903%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.441%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.906%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance Sheet:</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance at December 31, 2018</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Adjustments Due to ASC 842</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance at January 1, 2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other non-current assets</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,982&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,982&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accrued liabilities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">139&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">582&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">721&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other liabilities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,069&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,400&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,469&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div style="margin-bottom:12pt;"><span><br/></span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company considers if an arrangement is a lease at inception if it obtains the right to control the use of an identified asset under a leasing arrangement with an initial term greater than twelve months.  The Company determines whether a contract conveys the right to control the use of an identified asset for a period of time if the contract contains both the right to obtain substantially all of the economic benefits from the use of the identified asset and the right to direct the use of the identified asset.  The Company also evaluates the nature of each lease to determine whether it is an operating or financing lease and recognizes the right-of-use asset and lease liabilities based on the present value of future minimum lease </span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">payments over the expected lease term.  The Company&#8217;s leases do not generally contain an implicit interest rate and therefore the Company uses the incremental borrowing rate it would expect to pay to borrow on a similar collateralized basis over a similar term in order to determine the present value of its lease payments.  The Company&#8217;s considers renewal options in the determination of the lease term if the option to renew is reasonably certain.  Variable lease costs represent payments that are dependent on usage, a rate or index.  Variable lease costs, which consists primarily of taxes, insurance and common area maintenance costs, are expensed as incurred, as the Company has elected to account separately for contracts that contain lease and non-lease components, consistent with its historical practice.  The Company does not have any finance leases.</span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Redeemable Convertible Preferred Stock Warrant Liability</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Prior to its IPO, the Company accounted for its warrants for shares of redeemable convertible preferred stock as a liability based upon the characteristics and provisions of each instrument.  Redeemable convertible preferred stock warrants classified as a liability were initially recorded at their fair value on the date of issuance and are subject to remeasurement at each subsequent balance sheet date.  Any change in fair value as a result of a remeasurement was recognized as a component of other income (expense), net in the statements of operations and comprehensive loss.  </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company recorded adjustments to the estimated fair value of the redeemable convertible preferred stock warrants until they were exercised. Upon their exercise, the final fair value of the warrant liability was reclassified to stockholders&#8217; equity (deficit). Subsequent to its IPO, the Company no longer recorded any related periodic fair value adjustments.</span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Redeemable Convertible Preferred Stock</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Prior to its IPO, the Company recorded its redeemable convertible preferred stock at fair value on the dates of issuance, net of issuance costs, and classified the redeemable convertible preferred stock outside of stockholders&#8217; equity (deficit) on the balance sheet as events triggering the liquidation preferences were not solely within the Company&#8217;s control. Upon the closing of the Company's IPO, all shares of convertible preferred stock then outstanding converted into an aggregate of 23,178,555 shares of common stock resulting in the reclassification of $144,140,000 from outside of stockholders&#8217; equity (deficit) to additional paid-in capital.</span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Revenue Recognition</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">On&#160;January&#160;1, 2018, the Company adopted ASC Topic 606,&#160;&#8220;Revenue from Contracts with Customers,&#8221; using the modified retrospective method applied to contracts which were not completed as of that date.&#160;&#160;Under ASC 606, revenue is recognized when a customer obtains control of promised goods or services, in an amount that reflects the consideration which the entity expects to receive in exchange for those goods or services.  To determine revenue recognition for arrangements that an entity determines are within the scope of ASC 606, the Company performs the following five steps: </span></div><div style="text-indent:-26.88pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">(i)</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18pt;">identify the contract(s) with a customer; </span></div><div style="text-indent:-29.1pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">(ii)</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18pt;">identify the performance obligations in the contract; </span></div><div style="text-indent:-31.32pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">(iii)</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18pt;">determine the transaction price;</span></div><div style="text-indent:-31.88pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">(iv)</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18pt;">allocate the transaction price to the performance obligations in the contract; and </span></div><div style="text-indent:-29.66pt;padding-left:36pt;margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">(v)</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18pt;">recognize revenue when (or as) the entity satisfies a performance obligation.</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Under ASC 606, assuming all other revenue recognition criteria have been met, the Company will recognize revenue earlier for arrangements where the Company has satisfied its performance obligations </span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">but have not issued invoices.&#160;&#160;As of December&#160;31, 2019 and 2018, the Company recorded $102,000 and $128,000, respectively, of unbilled receivables, which are included in accounts receivable, net on the balance sheet, as the Company has an unconditional right to payment as of the end of the applicable period.&#160;&#160;</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company&#8217;s revenue is generated from the sale of its products to hospitals and medical centers in the United States through direct sales representatives.  Revenue is recognized when obligations under the terms of a contract with customers are satisfied, which occurs with the transfer of control of the Company&#8217;s products to its customers, either upon shipment of the product or delivery of the product to the customer under the Company&#8217;s standard terms and conditions.&#160;&#160;The Company&#8217;s products are readily available for usage as soon as the customer possesses it.  Upon receipt, the customer controls the economic benefits of the product, has significant risks and rewards, and the legal title.  The Company has present right to payment; therefore, the transfer of control is deemed to happen at a point in time.  Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring the goods.</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">For sales where the Company&#8217;s sales representative hand delivers product directly to the hospital or medical center from the sales representative&#8217;s trunk stock inventory, the Company recognizes revenue upon delivery, which represents the point in time when control transfers to the customer.  Upon delivery there are legally-enforceable rights and obligations between the parties which can be identified, commercial substance exists and collectibility is probable.  For sales which are sent directly from the Company to hospitals and medical centers, the transfer of control occurs at the time of shipment or delivery of the product.&#160; There are no further performance obligations by the Company or the sales representative to the customer after delivery under either method of sale.  As allowed under the practical expedient, the Company does not disclose the value of unsatisfied performance obligations for (i) contracts with an original expected length of one year or less and (ii) contracts for which it recognizes revenue at the amount to which it has the right to invoice for services performed.</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company&#160;is entitled to the total consideration for the products ordered by customers&#160;as&#160;product pricing&#160;is&#160;fixed according to the terms of customer contracts and payment terms&#160;are&#160;short.  Payment terms fall within the one-year guidance for the practical expedient which allows the Company to forgo adjustment of the promised amount of consideration for the effects of a significant financing component.  The Company&#160;excludes&#160;taxes assessed by governmental authorities on revenue-producing transactions from the measurement of the transaction price.</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Costs associated with product sales include commissions and royalties.  The Company applies the practical expedient and recognizes commissions and royalties as expense when incurred because the expense is incurred at a point in time and the amortization period is less than one year.&#160; Commissions are recorded as selling expense&#160;and royalties are recorded as&#160;cost of revenue&#160;in the&#160;statements of operations and comprehensive loss.</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company accepts product returns at its discretion or if the product is defective as manufactured.  The Company establishes estimated provisions for returns based on historical experience and considers other factors that it believes could significantly impact its expected returns, which provisions are classified within accrued liabilities on our balance sheet.&#160; The Company elected to expense shipping and handling costs as incurred and includes them in the cost of goods sold.  In those cases where the Company bills shipping and handling costs to customers, it will classify the amounts billed as a component of revenue.</span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Cost of Goods Sold</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company manufactures certain of its portfolio of TCAR products at its facility and purchases other products from third party manufacturers.  Cost of goods sold consists primarily of costs related to </span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">materials, components and subassemblies, manufacturing overhead costs, direct labor, reserves for excess, obsolete and non-sellable inventories as well as distribution-related expenses.  A significant portion of the Company&#8217;s cost of goods sold currently consists of manufacturing overhead costs.  These overhead costs include the cost of quality assurance, material procurement, inventory control, facilities, equipment and operations supervision and management.  Cost of goods sold also includes depreciation expense for production equipment and certain direct costs such as shipping costs and royalties.</span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Research and Development</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company expenses research and development costs as incurred.  Research and development expenses consist primarily of engineering, product development, clinical studies to develop and support the Company&#8217;s products, regulatory expenses, medical affairs and other costs associated with products and technologies that are in development.  Research and development expenses include employee compensation, including stock-based compensation, supplies, consulting, prototyping, testing, materials, travel expenses, depreciation and an allocation of facility overhead expenses.  Additionally, research and development expenses include costs associated with our clinical studies including clinical trial design, clinical site reimbursement, data management, travel expenses and the cost of products used for clinical trials and internal and external costs associated with the Company&#8217;s regulatory compliance and quality assurance functions, including the costs of outside consultants and contractors that assist in the process of submitting and maintaining regulatory filings, and overhead costs. </span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Clinical Trials</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company accrues and expenses costs for its clinical trial activities performed by third parties, including clinical research organizations and other service providers, based upon estimates of the work completed over the life of the individual study in accordance with associated agreements.  The Company determines these accruals through discussion with internal personnel and outside service providers as to progress or stage of completion of trials or services pursuant to contracts with clinical research organizations and other service providers and the agreed-upon fee to be paid for such services.</span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Advertising Costs</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company expenses advertising costs as incurred.  Advertising costs include design and production costs, including website development, physician and patient testimonial videos, written media campaigns, and other items.  Advertising costs of $362,000 and $186,000 were expensed during the years ended December&#160;31, 2019 and 2018, respectively.</span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Foreign Currency</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company records net gains and losses resulting from foreign exchange transactions as a component of foreign currency exchange gains or losses in other income (expense), net.  The Company had no material foreign currency exchange gains or losses during the years ended December&#160;31, 2019 and 2018.</span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Stock&#8211;Based Compensation</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company accounts for stock-based compensation in accordance with Financial Accounting Standards Board (&#8220;FASB&#8221;) ASC 718,&#160;&#8220;Compensation-Stock Compensation.&#8221;  ASC 718 requires the recognition of compensation expense, using a fair-value based method, for costs related to all share-based payments including stock options.  ASC 718 requires companies to estimate the fair value of all share-based payment option awards on the date of grant using an option pricing model.  The fair value of stock options is recognized over the period during which an optionee is required to provide services in exchange for the option award, known as the requisite service period (usually the vesting period), on a </span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">straight-line basis.  For performance-based stock options, the Company will assess the probability of performance conditions being achieved in each reporting period.  The amount of stock-based compensation expense recognized in any one period related to performance-based stock options can vary based on the achievement or anticipated achievement of the performance conditions.</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In March 2016, the FASB issued Accounting Standards Update ("ASU") No. 2016-09,&#160;&#8220;Stock Compensation (Topic 718): Improvements to Employee Shared-Based Payment Accounting.&#8221;&#160; Under ASU 2016-09, entities are permitted to make an accounting policy election to either estimate forfeitures on share-based payment awards, as previously required, or to recognize forfeitures as they occur.  The Company made an accounting policy election to account for forfeitures as they occur.  This change has been applied on a modified retrospective basis, resulting in a cumulative-effect adjustment to increase the beginning accumulated deficit by $13,000&#160;as of January&#160;1, 2018, the date of adoption.</span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Income Taxes</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company accounts for income taxes under the liability method, whereby deferred tax assets and liabilities are determined based on the difference between the financial statements and tax bases of assets and liabilities using the enacted tax rates in effect for the year in which the differences are expected to affect taxable income.  A valuation allowance is established when necessary to reduce deferred tax assets to the amounts expected to be realized.</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company also follows the provisions of ASC 740-10, &#8220;Accounting for Uncertainty in Income Taxes.&#8221;  ASC 740-10 prescribes a comprehensive model for the recognition, measurement, presentation and disclosure in financial statements of any uncertain tax positions that have been taken or expected to be taken on a tax return.  No liability related to uncertain tax positions is recorded on the financial statements.  It is the Company&#8217;s policy to include penalties and interest expense related to income taxes as part of the provision for income taxes.</span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Comprehensive Loss</span></div><div style="margin-bottom:9pt;"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Comprehensive loss consists of net loss and changes in unrealized gains and losses on investments classified as available-for-sale.  For the year ended </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">December&#160;31, 2019</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">, the Company&#8217;s unrealized gains and losses on available-for-sale investments represent the only component of other comprehensive loss that are excluded from the reported net loss and that are presented in the statements of operations and comprehensive income.  Accumulated other comprehensive loss is presented in the accompanying balance sheets as a component of stockholders' equity (deficit).  For the year ended December&#160;31, 2018, there was no difference between the Company's comprehensive loss and its net loss.  </span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Net Loss per Share Attributable to Common Stockholders</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Basic net loss per share is computed by dividing the net loss attributable to common stockholders by the weighted average number of shares of common stock outstanding during the period, without consideration for potential dilutive common shares.  Diluted net loss per share is computed by dividing the net loss attributable to common stockholders by the weighted average number of shares of common stock and potentially dilutive securities outstanding for the period.  For purposes of the diluted net loss per share calculation, redeemable convertible preferred stock and warrants, and common stock options are considered to be potentially dilutive securities.  Since the Company was in a loss position for all periods presented, basic net loss per share is the same as diluted net loss per share as the inclusion of all potential dilutive common shares would have been anti-dilutive.</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company allocates no loss to participating securities because they have no contractual obligation to share in the losses of the Company.  The shares of the Company&#8217;s redeemable convertible preferred </span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">stock participate in any dividends declared by the Company and are therefore considered to be participating securities.</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Net loss per share was determined as follows (in thousands, except share and per share data):</span></div><div style="margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:69.314%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:11.942%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.943%;"/><td style="width:1.0%;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Year Ended December 31,</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net loss attributable to Silk Road Medical, Inc. common stockholders</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(52,415)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(37,629)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted average common stock outstanding used to compute net loss per share, basic and diluted</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">22,956,679&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">960,882&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net loss per share attributable to Silk Road Medical, Inc. common stockholders, basic and diluted</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.28)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(39.16)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr></table></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following potentially dilutive securities outstanding have been excluded from the computation of diluted weighted average shares outstanding because such securities have an antidilutive impact due to the Company&#8217;s net loss:</span></div><div style="text-align:center;margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:69.314%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:11.942%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.943%;"/><td style="width:1.0%;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 31,</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Redeemable convertible preferred stock outstanding</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">21,233,190&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Redeemable convertible preferred stock warrants outstanding</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,672,502&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Common stock options</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,310,790&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,364,377&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Common stock warrants outstanding</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7,527&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,310,790&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">28,277,596&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr></table></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Segment and Geographical Information</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company operates and manages its business as one reportable and operating segment.  The Company&#8217;s chief executive officer, who is the chief operating decision maker, reviews financial information on an aggregate basis for purposes of allocating resources and evaluating financial performance.  All of the Company&#8217;s long-lived assets are based in the United States.  Long-lived assets are comprised of property and equipment.  All of the Company&#8217;s revenue was in the United States for the years ended December&#160;31, 2019 and 2018, based on the shipping location of the external customer.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).  Accounting policies describe all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6960050592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Schedule of Components of Income Tax Expense (Benefit)</a></td>
<td class="text"><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The components of income before taxes are as follows (in thousands):</span></div><div style="text-align:right;margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:69.314%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:11.942%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.943%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Year Ended December 31,</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">United States</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(52,415)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(37,630)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">International</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(52,415)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(37,630)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of Effective Income Tax Rate Reconciliation</a></td>
<td class="text"><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">A reconciliation of the statutory U.S. federal rate to the Company&#8217;s effective tax rate is as follows (in thousands):</span></div><div style="text-align:center;margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:69.314%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:11.942%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.943%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Year Ended December 31,</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Tax at federal statutory rate</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(11,007)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(7,902)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">State taxes, net of federal benefit</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2,270)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1,582)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Permanent differences</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(4,731)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">289&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Loss on Series C warrant liability</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,330&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,500&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Change in valuation allowance</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12,797&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6,197&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">General business credits</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(319)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">136&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">208&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">376&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Provision for income taxes</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">14&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of Deferred Tax Assets and Liabilities</a></td>
<td class="text"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Significant components of the Company&#8217;s net deferred tax assets as of December&#160;31, 2019 and 2018 consist of the following (in thousands):</span></div><div style="text-align:center;margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:69.314%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:11.942%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.943%;"/><td style="width:1.0%;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 31,</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Deferred tax assets:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net operating loss carryforwards</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">44,574&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">33,815&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Research and development credits</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,287&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,944&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Capitalized start-up costs/Intangibles</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">16&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accruals and reserves</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,227&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,169&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Property and equipment</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">188&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">82&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Stock-based compensation</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">568&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">274&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operating lease liability</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,133&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total deferred tax assets</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">53,988&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">40,300&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Less:  Valuation allowance</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(53,126)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(40,300)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operating lease asset</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(862)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total deferred tax liabilities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(862)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net deferred tax assets</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock', window );">Reconciliation of Unrecognized Tax Benefits</a></td>
<td class="text"><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">A reconciliation of the unrecognized tax benefits from January 1, 2018 to December&#160;31, 2019 is as follows (in thousands):</span></div><div style="text-align:center;margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:69.314%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:11.942%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.943%;"/><td style="width:1.0%;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 31,</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance at the beginning of year</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,348&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">615&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Increases related to current years&#8217; tax positions</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">88&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">118&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Increases/(decreases) related to prior years&#8217; tax positions</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">615&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance at end of year</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,436&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,348&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of unrecognized tax benefits for which a material change is reasonably possible in the next twelve months, typically including the nature of the uncertainty, the event(s) that could cause a material change, and an estimate of the range of the reasonably possible change or a statement that an estimate of the range cannot be made. An unrecognized tax benefit is the difference between a tax position taken in a tax return and the amounts recognized in the financial statements for which it is more likely than not, based on the technical merits of the position, that the tax position will not be sustained upon examination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6800024544">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Cash, Cash Equivalents and Restricted Cash (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems', window );"><strong>Restricted Cash and Cash Equivalents Items [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 39,181<span></span>
</td>
<td class="nump">$ 24,990<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashNoncurrent', window );">Restricted cash</a></td>
<td class="nump">310<span></span>
</td>
<td class="nump">310<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Total cash, cash equivalents and restricted cash</a></td>
<td class="nump">39,491<span></span>
</td>
<td class="nump">25,300<span></span>
</td>
<td class="nump">$ 33,841<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis=us-gaap_LetterOfCreditMember', window );">Letter of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems', window );"><strong>Restricted Cash and Cash Equivalents Items [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashNoncurrent', window );">Restricted cash</a></td>
<td class="nump">$ 310<span></span>
</td>
<td class="nump">$ 310<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6812-107765<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=SL98516268-108586<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 305<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=84242212&amp;loc=d3e2352-115587<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis=us-gaap_LetterOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis=us-gaap_LetterOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6958878880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisition of Variable Interest Entity - NeuroCo<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">Acquisition of Variable Interest Entity - NeuroCo</a></td>
<td class="text">Acquisition of Variable Interest Entity - NeuroCo<div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In December&#160;2014, the Board of Directors of the Company approved the sale of certain intellectual property of Silk Road Medical, Inc., to a newly incorporated entity, NeuroCo, Inc.  In consideration for the intellectual property, a promissory note was executed between the two parties for the principal sum of $498,000 with an interest rate of 2.74% per annum, payable on the earlier of 10 years from the date of promissory note, or upon the occurrence of an event of default.  The intellectual property transfer was recorded at its carrying value of zero as of December&#160;31, 2014.  During 2015 NeuroCo issued $154,000 in common stock to stockholders of the Company.  During the year ended December 31, 2018, NeuroCo issued common stock upon the exercise of stock options.  These common stock issuance amounts, as they are related to non-controlling investors, were reported as non-controlling interests in subsidiary in the Company&#8217;s financial statements and are offset by NeuroCo losses consolidated by the Company.</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Additionally, NeuroCo incurred research and development related expenses paid for by the Company which were added in to the original promissory note.  </span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company had identified NeuroCo as a VIE of which the Company is the primary beneficiary.  Pursuant to the accounting guidance for consolidating VIEs the main consideration was given to the fact that the amount of total equity investment at risk is not sufficient to permit NeuroCo to finance its activities without additional subordinated financial support.  Additionally, NeuroCo and Silk Road Medical had the same Board of Directors and senior management composition, determining the Company to have the power to direct the activities that most significantly impact NeuroCo&#8217;s economic performance and the obligation to absorb losses and the right to receive benefits.  Accordingly, the financial results of NeuroCo were included in the Company&#8217;s financial statements.  </span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">On December 17, 2018, the Company and NeuroCo entered into the Agreement and Plan of Merger (the &#8220;Merger Agreement&#8221;) pursuant to which the Company acquired all assets and assumed all liabilities of NeuroCo (the &#8220;Merger&#8221;).  The Merger closed on the same day (the &#8220;Closing&#8221;) and was consummated through a stock-for-stock transaction based on the relative values of the Company&#8217;s and NeuroCo&#8217;s equity.  In consideration for 100% equity interest of NeuroCo, the Company issued 33,462 shares of its common stock and the above promissory note in the amount of approximately $1,600,000 as of the Closing was settled and canceled.  As a result of the Merger, NeuroCo merged into the Company with the Company being the surviving corporation.</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">As the Company already controlled and consolidated NeuroCo and retained the control over NeuroCo&#8217;s business after the Merger, the Company accounted for the acquisition of equity interest in NeuroCo as an equity transaction.  Therefore, the Company did not recognize a gain or loss in its net loss or comprehensive loss for acquisition of NeuroCo.  As the carrying amount of the non-controlling interest as of the Closing was zero, the Company recorded the consideration paid as a decrease to the Company&#8217;s additional paid-in capital within stockholder&#8217;s equity (deficit). </span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">As part of the Merger, the Company assumed NeuroCo&#8217;s 2015 Equity Incentive Plan (the &#8220;NeuroCo Plan&#8221;) along with all of NeuroCo&#8217;s rights and obligations under the NeuroCo Plan, except that the number of shares and exercise price of the assumed options have been adjusted based on the Merger exchange ratio of the Company&#8217;s common stock and NeuroCo&#8217;s common stock.  Similarly, the Company assumed outstanding warrants to purchase NeuroCo&#8217;s common stock such that the number of shares and exercise price of the assumed warrants have been adjusted based on the Merger exchange ratio of the Company&#8217;s common stock and NeuroCo&#8217;s common stock.  The options and warrants to purchase shares of the Company&#8217;s common stock were fully vested upon issuance, as they were replacing fully vested options and warrants to purchase NeuroCo common stock.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI http://asc.fasb.org/topic&amp;trid=2303972<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6795095904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Redeemable Convertible Preferred Stock<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityDisclosureAbstract', window );"><strong>Temporary Equity Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Redeemable Convertible Preferred Stock</a></td>
<td class="text">Redeemable Convertible Preferred Stock<div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company had the following redeemable convertible preferred stock issued and outstanding at December&#160;31, 2018 (in thousands except share amounts): </span></div><div style="text-align:center;margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:99.839%;"><tr><td style="width:1.0%;"/><td style="width:23.040%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:11.964%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.602%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.964%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.602%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.964%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.602%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.927%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.602%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.933%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Shares<br/>Authorized</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Shares Issued and<br/>Outstanding</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Per share <br/>Preference</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Preferential<br/>Liquidation Value (in thousands)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Carrying Value (in thousands)</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Series</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Series A</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,629,629&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,629,626&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.70&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,400&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,369&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Series A-1</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,111,111&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,111,109&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.38&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,755&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,723&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Series B</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6,264,470&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6,264,463&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6.11&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">38,276&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">38,014&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Series C</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">15,064,405&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12,227,992&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6.11&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">74,713&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">59,129&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">24,069,615&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">21,233,190&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">121,144&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">105,235&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr></table></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Upon the closing of the IPO, all shares of redeemable convertible preferred stock then outstanding converted into shares of common stock.  As of December&#160;31, 2019, the Company does not have any redeemable convertible preferred stock issued or outstanding.</span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Redeemable Convertible Preferred Stock Warrant</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">s</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Upon the closing of the IPO, all of the outstanding redeemable convertible preferred stock warrants were exercised, or net exercised based on the IPO price of $20.00 per share, into 1,945,365 shares of common stock.  As of December&#160;31, 2019 and 2018, warrants to purchase an aggregate of 0 and  2,672,502, respectively, shares of Series C redeemable convertible preferred stock were outstanding.</span></div>Stockholders' Equity (Deficit)<div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Preferred Stock</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">At December&#160;31, 2019, the Company&#8217;s certificate of incorporation, as amended and restated, authorizes the Company to issue up to 5,000,000 shares of preferred stock with $0.001 par value per share, of which no shares were issued and outstanding.</span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Common Stock</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">At December&#160;31, 2019, the Company&#8217;s certificate of incorporation, as amended and restated, authorizes the Company to issue up to 100,000,000 shares of common stock with $0.001 par value per share, of which 31,255,267 shares were issued and outstanding.  The holders of common stock are also entitled to receive dividends whenever funds are legally available, when and if declared by the Board of Directors.  As of December&#160;31, 2019, no dividends have been declared to date.  Each share of common stock is entitled to one vote.</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">At December&#160;31, 2019 and 2018, the Company had reserved common stock for future issuances as follows:</span></div><div style="text-align:center;margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:70.596%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:11.301%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.302%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 31,</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Conversion of Series A redeemable convertible preferred stock</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,629,629&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Conversion of Series A-1 redeemable convertible preferred stock</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,111,111&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Conversion of Series B redeemable convertible preferred stock</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6,264,470&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Conversion of Series C redeemable convertible preferred stock and warrants</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">15,064,405&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Exercise of options under stock plan</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,310,790&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,364,377&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Issuance of options under stock plan</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,554,690&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">57,889&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Issuance of common stock under employee stock purchase plan</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">372,352&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Warrants to purchase common stock</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7,527&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6,237,832&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">28,499,408&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Common Stock Warrant</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">s</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In connection with the IPO, the common stock warrants were cash, or net exercised based on the IPO price of $20.00 per share into 5,968 shares of common stock.  As of December&#160;31, 2019 and 2018, warrants to purchase an aggregate of 0 and 7,527 shares of common stock were outstanding.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6795044144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurements</a></td>
<td class="text">Fair Value Measurements<div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company measures certain financial assets and liabilities at fair value on a recurring basis, including cash equivalents, investments, and the Company's previously outstanding preferred stock warrants.  Fair value is an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants.  As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or a liability.  A three-tier fair value hierarchy is established as a basis for considering such assumptions and for inputs used in the valuation methodologies in measuring fair value:</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Level 1 &#8211; quoted prices in active markets are identical assets and liabilities;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Level 2 &#8211; observable inputs other than quotes prizes in active markets for identical assets and liabilities;</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Level 3 &#8211; unobservable inputs.</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Assets and liabilities measured at fair value are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. The Company&#8217;s assessment of the significance of a particular input to the fair value measurement in its entirety requires management to make judgments and consider factors specific to the asset or liability.  The Company&#8217;s cash equivalents are classified within </span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Level 1 of the fair value hierarchy because they are valued using quoted market prices, broker or dealer quotations, or alternative pricing sources with reasonable levels of price transparency.  The corporate bonds/notes, commercial paper, asset-backed securities and U.S. government securities are classified as Level 2 as they are valued based upon quoted market prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active and model-based valuation techniques for which all significant inputs are observable in the market or can be corroborated by observable market data for substantially the full term of the assets. </span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following tables sets forth by level within the fair value hierarchy the Company&#8217;s assets and liabilities that are reported at fair value as of December&#160;31, 2019 and 2018, using the inputs defined above (in thousands):</span></div><div style="margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:37.743%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:12.583%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.441%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.583%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.441%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.583%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.441%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.585%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-style:italic;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:9pt;font-weight:400;font-style:italic;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="21" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 31, 2019</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Level 1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Level 2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Level 3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Assets:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Money market funds</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">34,363&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">34,363&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Commercial paper</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9,919&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9,919&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Corporate bonds/notes</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10,176&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10,176&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">U.S. government securities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">44,456&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">44,456&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Asset-backed securities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,181&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,181&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">34,363&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">69,732&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">104,095&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span></div><div style="margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:37.743%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:12.583%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.441%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.583%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.441%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.583%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.441%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.585%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-style:italic;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:9pt;font-weight:400;font-style:italic;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="21" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 31, 2018</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Level 1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Level 2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Level 3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Assets:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Money market funds</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10,495&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10,495&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Redeemable convertible warrant liability</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">16,091&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">16,091&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">As a derivative liability, the redeemable convertible warrants were initially recorded at fair value and were subject to remeasurement at each balance sheet date.  Any change in fair value as a result of a remeasurement was recognized as a component of other income (expense), net in the statements of operations and comprehensive loss.  The Company&#8217;s redeemable convertible warrant liability was classified within Level 3 of the fair value hierarchy.  </span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">At December&#160;31, 2018, the fair value of the redeemable convertible warrant liability was determined by using an option pricing model to allocate the total enterprise value to the various securities within the Company&#8217;s capital structure.  The fair value of the redeemable convertible warrant liability was based on both the estimated fair value of the Company&#8217;s common stock of $11.29 as of December&#160;31, 2018 and on valuation models discounted at current implied market rates which are based on Level 3 inputs.  </span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Additionally, the model&#8217;s inputs reflected assumptions that market participants would use in pricing the instrument in a current period transaction and included:</span></div><div style="text-align:center;margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:99.839%;"><tr><td style="width:1.0%;"/><td style="width:80.182%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:15.818%;"/><td style="width:1.0%;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 31,</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Time to liquidity (years)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.57</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Expected volatility</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">62.5%&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Discounted cash flow rate</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12.0%&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Risk-free interest rate</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.6%&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Marketability discount rate</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">14%&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr></table></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The final fair value of the redeemable convertible warrants was remeasured on the date of the Company's initial public offering in April 2019. The final fair value of the redeemable convertible warrant liability was based on the fair value of the Company's common stock at the time of its initial public offering. The following table provides a reconciliation of the beginning and ending balances of the Company's redeemable convertible warrant liability are summarized below (in thousands):</span></div><div style="margin-bottom:9pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:84.057%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:11.943%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fair value at December 31, 2017</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,185&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Change in fair value recorded in other income (expense), net</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11,906&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fair value at December 31, 2018</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">16,091&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Change in fair value recorded in other income (expense), net</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">21,030&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Reclassification upon IPO</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(37,121)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fair Value at December 31, 2019</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">There were no transfers between fair value hierarchy levels during the years ended December&#160;31, 2019 and 2018.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -URI http://asc.fasb.org/topic&amp;trid=2155941<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6801249968">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Stockholders' Equity (Deficit) - Shares Reserved for Future Issuance (Details) - shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock reserved for future issuance (in shares)</a></td>
<td class="nump">6,237,832<span></span>
</td>
<td class="nump">28,499,408<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=silk_CommonStockWarrantsMember', window );">Warrants to purchase common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock reserved for future issuance (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">7,527<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=silk_IncentiveandNonqualifiedStockOptionExercisedMember', window );">Exercise of options under stock plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock reserved for future issuance (in shares)</a></td>
<td class="nump">4,310,790<span></span>
</td>
<td class="nump">4,364,377<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=silk_IncentiveandNonqualifiedStockOptionIssuedMember', window );">Issuance of options under stock plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock reserved for future issuance (in shares)</a></td>
<td class="nump">1,554,690<span></span>
</td>
<td class="nump">57,889<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=silk_EmployeeStockPurchasePlanMember', window );">Issuance of common stock under employee stock purchase plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock reserved for future issuance (in shares)</a></td>
<td class="nump">372,352<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember', window );">Conversion of Series A redeemable convertible preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock reserved for future issuance (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,629,629<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=silk_SeriesA1PreferredStockMember', window );">Conversion of Series A-1 redeemable convertible preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock reserved for future issuance (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,111,111<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember', window );">Conversion of Series B redeemable convertible preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock reserved for future issuance (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">6,264,470<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember', window );">Conversion of Series C redeemable convertible preferred stock and warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock reserved for future issuance (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">15,064,405<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=silk_CommonStockWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=silk_CommonStockWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=silk_IncentiveandNonqualifiedStockOptionExercisedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=silk_IncentiveandNonqualifiedStockOptionExercisedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=silk_IncentiveandNonqualifiedStockOptionIssuedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=silk_IncentiveandNonqualifiedStockOptionIssuedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=silk_EmployeeStockPurchasePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=silk_EmployeeStockPurchasePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=silk_SeriesA1PreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=silk_SeriesA1PreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6661555264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Reconciliation of Unrecognized Tax Benefits (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward', window );"><strong>Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Balance at the beginning of year</a></td>
<td class="nump">$ 1,348<span></span>
</td>
<td class="nump">$ 615<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions', window );">Increases related to current years&#8217; tax positions</a></td>
<td class="nump">88<span></span>
</td>
<td class="nump">118<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions', window );">Increases/(decreases) related to prior years&#8217; tax positions</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">615<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Balance at end of year</a></td>
<td class="nump">$ 1,436<span></span>
</td>
<td class="nump">$ 1,348<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI http://asc.fasb.org/extlink&amp;oid=84176650&amp;loc=SL37586934-109318<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>111
<FILENAME>R84.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6605840080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Quarterly Financial Information (unaudited) (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="8">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
<th class="th"><div>Mar. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_QuarterlyFinancialInformationDisclosureAbstract', window );"><strong>Quarterly Financial Information Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 18,634<span></span>
</td>
<td class="nump">$ 17,026<span></span>
</td>
<td class="nump">$ 14,928<span></span>
</td>
<td class="nump">$ 12,766<span></span>
</td>
<td class="nump">$ 11,470<span></span>
</td>
<td class="nump">$ 9,614<span></span>
</td>
<td class="nump">$ 7,767<span></span>
</td>
<td class="nump">$ 5,706<span></span>
</td>
<td class="nump">$ 63,354<span></span>
</td>
<td class="nump">$ 34,557<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross Profit</a></td>
<td class="nump">13,913<span></span>
</td>
<td class="nump">12,856<span></span>
</td>
<td class="nump">11,231<span></span>
</td>
<td class="nump">9,427<span></span>
</td>
<td class="nump">7,803<span></span>
</td>
<td class="nump">6,732<span></span>
</td>
<td class="nump">5,376<span></span>
</td>
<td class="nump">3,772<span></span>
</td>
<td class="nump">47,427<span></span>
</td>
<td class="nump">23,683<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="num">$ (8,291)<span></span>
</td>
<td class="num">$ (8,007)<span></span>
</td>
<td class="num">$ (11,959)<span></span>
</td>
<td class="num">$ (24,158)<span></span>
</td>
<td class="num">$ (15,618)<span></span>
</td>
<td class="num">$ (8,953)<span></span>
</td>
<td class="num">$ (7,651)<span></span>
</td>
<td class="num">$ (5,408)<span></span>
</td>
<td class="num">$ (52,415)<span></span>
</td>
<td class="num">$ (37,630)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Net loss per share, basic and diluted (in USD per share)</a></td>
<td class="num">$ (0.27)<span></span>
</td>
<td class="num">$ (0.26)<span></span>
</td>
<td class="num">$ (0.42)<span></span>
</td>
<td class="num">$ (20.12)<span></span>
</td>
<td class="num">$ (14.12)<span></span>
</td>
<td class="num">$ (8.49)<span></span>
</td>
<td class="num">$ (8.16)<span></span>
</td>
<td class="num">$ (7.31)<span></span>
</td>
<td class="num">$ (2.28)<span></span>
</td>
<td class="num">$ (39.16)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109260490&amp;loc=d3e1337-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669625-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=84234705&amp;loc=SL4591551-111686<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3000-108585<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=84234705&amp;loc=SL4591552-111686<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_QuarterlyFinancialInformationDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_QuarterlyFinancialInformationDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109196051&amp;loc=SL49130543-203045<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109196051&amp;loc=SL49130539-203045<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=109196051&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>112
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6643318032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Option Plans - Stock Option Assumptions (Details)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum', window );">Expected volatility, minimum</a></td>
<td class="nump">42.40%<span></span>
</td>
<td class="nump">38.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum', window );">Expected volatility, maximum</a></td>
<td class="nump">42.90%<span></span>
</td>
<td class="nump">38.80%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum', window );">Risk-free interest rate, minimum</a></td>
<td class="nump">1.47%<span></span>
</td>
<td class="nump">2.68%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum', window );">Risk-free interest rate, maximum</a></td>
<td class="nump">2.54%<span></span>
</td>
<td class="nump">2.98%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">2019 ESPP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum', window );">Expected volatility, minimum</a></td>
<td class="nump">44.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum', window );">Expected volatility, maximum</a></td>
<td class="nump">47.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum', window );">Risk-free interest rate, minimum</a></td>
<td class="nump">1.58%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum', window );">Risk-free interest rate, maximum</a></td>
<td class="nump">2.45%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (in years)</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | 2019 ESPP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (in years)</a></td>
<td class="text">6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (in years)</a></td>
<td class="text">6 years 3 months<span></span>
</td>
<td class="text">6 years 3 months<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | 2019 ESPP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (in years)</a></td>
<td class="text">7 months 17 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of share-based compensation awards, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>113
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6606315472">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes - Net Deferred Tax Assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNetAbstract', window );"><strong>Deferred tax assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">$ 44,574<span></span>
</td>
<td class="nump">$ 33,815<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch', window );">Research and development credits</a></td>
<td class="nump">5,287<span></span>
</td>
<td class="nump">4,944<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets', window );">Capitalized start-up costs/Intangibles</a></td>
<td class="nump">11<span></span>
</td>
<td class="nump">16<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals', window );">Accruals and reserves</a></td>
<td class="nump">2,227<span></span>
</td>
<td class="nump">1,169<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment', window );">Property and equipment</a></td>
<td class="nump">188<span></span>
</td>
<td class="nump">82<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost', window );">Stock-based compensation</a></td>
<td class="nump">568<span></span>
</td>
<td class="nump">274<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_silk_DeferredTaxAssetsOperatingLeaseLiability', window );">Operating lease liability</a></td>
<td class="nump">1,133<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Total deferred tax assets</a></td>
<td class="nump">53,988<span></span>
</td>
<td class="nump">40,300<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Less: Valuation allowance</a></td>
<td class="num">(53,126)<span></span>
</td>
<td class="num">(40,300)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_silk_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset', window );">Operating lease asset</a></td>
<td class="num">(862)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilities', window );">Total deferred tax liabilities</a></td>
<td class="num">(862)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Net deferred tax assets</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_silk_DeferredTaxAssetsOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Operating Lease, Liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">silk_DeferredTaxAssetsOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>silk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_silk_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Liabilities, Operating Lease, Right-Of-Use Asset</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">silk_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>silk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(15)(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from intangible assets including goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115928272&amp;loc=d3e28680-109314<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from property, plant, and equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32559-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115928272&amp;loc=d3e28680-109314<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from reserves and accruals.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=115928272&amp;loc=d3e28680-109314<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>115
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6807613440">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Components - Property, Plant and Equipment (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">$ 3,961<span></span>
</td>
<td class="nump">$ 3,788<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less: Accumulated depreciation and amortization</a></td>
<td class="num">(1,550)<span></span>
</td>
<td class="num">(946)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">2,734<span></span>
</td>
<td class="nump">2,880<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and fixtures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">657<span></span>
</td>
<td class="nump">517<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember', window );">Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">1,295<span></span>
</td>
<td class="nump">1,217<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember', window );">Software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">18<span></span>
</td>
<td class="nump">76<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">1,991<span></span>
</td>
<td class="nump">1,978<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember', window );">Construction-in-progress</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">$ 323<span></span>
</td>
<td class="nump">$ 38<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>116
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6795011248">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Components - Fair Value of Cash Equivalents, Short-Term and Long-Term Investments (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_silk_CashAndCashEquivalentsFairValueDisclosureMaturingWithinOneYear', window );">Amounts maturing within one year</a></td>
<td class="nump">$ 85,871<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_silk_CashAndCashEquivalentsFairValueDisclosureMaturingAfterOneYearThroughTwoYears', window );">Amounts maturing after one year through two years</a></td>
<td class="nump">18,224<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Total</a></td>
<td class="nump">$ 104,095<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_silk_CashAndCashEquivalentsFairValueDisclosureMaturingAfterOneYearThroughTwoYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash And Cash Equivalents, Fair Value Disclosure, Maturing After One Year Through Two Years</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">silk_CashAndCashEquivalentsFairValueDisclosureMaturingAfterOneYearThroughTwoYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>silk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_silk_CashAndCashEquivalentsFairValueDisclosureMaturingWithinOneYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash And Cash Equivalents, Fair Value Disclosure, Maturing Within One Year</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">silk_CashAndCashEquivalentsFairValueDisclosureMaturingWithinOneYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>silk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
